PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kok, BPC; Skene-Arnold, TD; Ling, J; Benesch, MGK; Dewald, J; Harris, TE; Holmes, CFB; Brindley, DN				Kok, Bernard P. C.; Skene-Arnold, Tamara D.; Ling, Ji; Benesch, Matthew G. K.; Dewald, Jay; Harris, Thurl E.; Holmes, Charles F. B.; Brindley, David N.			Conserved Residues in the N Terminus of Lipin-1 Are Required for Binding to Protein Phosphatase-1c, Nuclear Translocation, and Phosphatidate Phosphatase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Nuclear Translocation; Phosphatidate; Protein Phosphatase; Protein Phosphorylation; Transcription Regulation; Yeast Metabolism; Lipin	UNSATURATED FATTY-ACIDS; RAT HEPATOCYTES; SUBCELLULAR-LOCALIZATION; AFFINITY-CHROMATOGRAPHY; MICROCYSTIN-SEPHAROSE; STRUCTURAL BASIS; PHOSPHORYLATION; PHOSPHOHYDROLASE; YEAST; METABOLISM	Background: Lipin-1 functions as a phosphatidate phosphatase in glycerolipid synthesis and as a co-transcriptional regulator. Results: Lipin-1 contains conserved N-terminal motifs, which when mutated decrease phosphatase activity, nuclear localization, and binding to protein phosphatase-1c. Conclusion: The lipin-1 N-terminal domain is important in regulating its activities. Significance: Lipin-1 binds to protein phosphatase-1c through its N-terminal domain, and this potentially regulates lipin-1 localization and function. Lipin-1 is a phosphatidate phosphatase in glycerolipid biosynthesis and signal transduction. It also serves as a transcriptional co-regulator to control lipid metabolism and adipogenesis. These functions are controlled partly by its subcellular distribution. Hyperphosphorylated lipin-1 remains sequestered in the cytosol, whereas hypophosphorylated lipin-1 translocates to the endoplasmic reticulum and nucleus. The serine/threonine protein phosphatase-1 catalytic subunit (PP-1c) is a major protein dephosphorylation enzyme. Its activity is controlled by interactions with different regulatory proteins, many of which contain conserved RVXF binding motifs. We found that lipin-1 binds to PP-1c through a similar HVRF binding motif. This interaction depends on Mg2+ or Mn2+ and is competitively inhibited by (R/H)VXF-containing peptides. Mutating the HVRF motif in the highly conserved N terminus of lipin-1 greatly decreases PP-1c interaction. Moreover, mutations of other residues in the N terminus of lipin-1 also modulate PP-1c binding. PP-1c binds poorly to a phosphomimetic mutant of lipin-1 and binds well to the non-phosphorylatable lipin-1 mutant. This indicates that lipin-1 is dephosphorylated before PP-1c binds to its HVRF motif. Importantly, mutating the HVRF motif also abrogates the nuclear translocation and phosphatidate phosphatase activity of lipin-1. In conclusion, we provide novel evidence of the importance of the lipin-1 N-terminal domain for its catalytic activity, nuclear localization, and binding to PP-1c.	[Kok, Bernard P. C.; Skene-Arnold, Tamara D.; Ling, Ji; Benesch, Matthew G. K.; Dewald, Jay; Holmes, Charles F. B.; Brindley, David N.] Univ Alberta, Dept Biochem, Signal Transduct Res Grp, Edmonton, AB T6G 2S2, Canada; [Harris, Thurl E.] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA	University of Alberta; University of Virginia	Brindley, DN (corresponding author), Univ Alberta, Dept Biochem, Signal Transduct Res Grp, Heritage Med Res Ctr 357, Edmonton, AB T6G 2S2, Canada.	david.brindley@ualberta.ca	Benesch, Matthew/GRF-0677-2022	Benesch, Matthew/0000-0002-1326-684X; Kok, Bernard/0000-0002-9073-9700	Canadian Institutes of Health Research [CIHR 89726]; Heart and Stroke Foundation of Alberta; Northwest Territories; American Diabetes Association Junior Investigator Award [7-11-JF-21]; Alberta Ingenuity Graduate Studentship; Government of Canada CIHR Vanier Studentship; Alberta Innovates-Health Solutions MD/PhD Studentship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101946] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Alberta; Northwest Territories; American Diabetes Association Junior Investigator Award(American Diabetes Association); Alberta Ingenuity Graduate Studentship; Government of Canada CIHR Vanier Studentship; Alberta Innovates-Health Solutions MD/PhD Studentship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Canadian Institutes of Health Research (CIHR 89726) (to D. N. B. and C. F. B. H.) and the Heart and Stroke Foundation of Alberta and the Northwest Territories (to D. N. B.) and American Diabetes Association Junior Investigator Award 7-11-JF-21 (to T. E. H.).; Supported by an Alberta Ingenuity Graduate Studentship.; Recipient of a Government of Canada CIHR Vanier Studentship and an Alberta Innovates-Health Solutions MD/PhD Studentship.	BOWLEY M, 1977, BIOCHEM J, V165, P447, DOI 10.1042/bj1650447; CASCALES C, 1984, BIOCHEM J, V219, P911, DOI 10.1042/bj2190911; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Csaki LS, 2013, PROG LIPID RES, V52, P305, DOI 10.1016/j.plipres.2013.04.001; Dephoure N, 2013, MOL BIOL CELL, V24, P535, DOI 10.1091/mbc.E12-09-0677; Eaton JM, 2013, J BIOL CHEM, V288, P9933, DOI 10.1074/jbc.M112.441493; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; GOMEZMUNOZ A, 1992, BIOCHIM BIOPHYS ACTA, V1127, P49, DOI 10.1016/0005-2760(92)90200-F; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han S, 2012, J BIOL CHEM, V287, P3123, DOI 10.1074/jbc.M111.324350; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Harris TE, 2011, TRENDS ENDOCRIN MET, V22, P226, DOI 10.1016/j.tem.2011.02.006; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; HOPEWELL R, 1985, BIOCHEM J, V232, P485, DOI 10.1042/bj2320485; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Huffman TA, 2002, P NATL ACAD SCI USA, V99, P1047, DOI 10.1073/pnas.022634399; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Kok BPC, 2012, CHEM REV, V112, P5121, DOI 10.1021/cr200433m; Manmontri B, 2008, J LIPID RES, V49, P1056, DOI 10.1194/jlr.M800013-JLR200; MARTIN A, 1986, BIOCHIM BIOPHYS ACTA, V876, P581, DOI 10.1016/0005-2760(86)90047-0; MARTINSANZ P, 1984, FEBS LETT, V175, P284, DOI 10.1016/0014-5793(84)80752-8; MOORHEAD G, 1994, FEBS LETT, V356, P46, DOI 10.1016/0014-5793(94)01232-6; Moorhead Greg B. G., 2008, BMC Biochemistry, V9, P28, DOI 10.1186/1471-2091-9-28; Moorhead Greg B. G., 2007, V365, P39; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Peterfy M, 2010, J BIOL CHEM, V285, P3857, DOI 10.1074/jbc.M109.072488; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Peti W, 2013, FEBS J, V280, P596, DOI 10.1111/j.1742-4658.2012.08509.x; Popescu M, 2009, J BIOL CHEM, V284, P13869, DOI 10.1074/jbc.M900209200; Ren HM, 2010, MOL BIOL CELL, V21, P3171, DOI 10.1091/mbc.E10-01-0073; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Skene-Arnold TD, 2013, BIOCHEM J, V449, P649, DOI 10.1042/BJ20120506; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Ulke-Lemee A, 2007, BBA-PROTEINS PROTEOM, V1774, P1339, DOI 10.1016/j.bbapap.2007.07.015; Wakula P, 2003, J BIOL CHEM, V278, P18817, DOI 10.1074/jbc.M300175200	45	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10876	10886		10.1074/jbc.M114.552612	http://dx.doi.org/10.1074/jbc.M114.552612			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24558042	Green Published, hybrid			2022-12-28	WOS:000334226400055
J	Li, W; Zhang, XL; Zhuang, HX; Chen, HG; Chen, YQ; Tian, WL; Wu, WX; Li, Y; Wang, SJ; Zhang, LQ; Chen, YS; Li, LX; Zhao, B; Sui, SF; Hu, Z; Feng, D				Li, Wen; Zhang, Xingli; Zhuang, Haixia; Chen, He-ge; Chen, Yinqin; Tian, Weili; Wu, Wenxian; Li, Ying; Wang, Sijie; Zhang, Liangqing; Chen, Yusen; Li, Longxuan; Zhao, Bin; Sui, Senfang; Hu, Zhe; Feng, Du			MicroRNA-137 Is a Novel Hypoxia-responsive MicroRNA That Inhibits Mitophagy via Regulation of Two Mitophagy Receptors FUNDC1 and NIX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Hypoxia; MicroRNA; Mitochondria; Parkin; FUNDC1; Mitophagy; NIX	MITOCHONDRIAL AUTOPHAGY; OXIDATIVE STRESS; IN-VIVO; PARKIN; PROTEIN; MIR-137; MECHANISMS; INDUCTION; BNIP3; GLIOBLASTOMA	Background: Mitophagy and microRNA both regulate the occurrence of neurodegenerative diseases and cancers. Results: MicroRNA-137, a hypoxia responsive microRNA, inhibits mitophagy via targeting two mitophagy receptors. Conclusion: A novel link between miR-137 and mitophagy has been revealed. Significance: Understanding mitophagy regulation and microRNA functions may provide new concepts to fight human diseases. Mitophagy receptors mediate the selective recognition and targeting of damaged mitochondria by autophagosomes. The mechanism for the regulation of these receptors remains unknown. Here, we demonstrated that a novel hypoxia-responsive microRNA, microRNA-137 (miR-137), markedly inhibits mitochondrial degradation by autophagy without affecting global autophagy. miR-137 targets the expression of two mitophagy receptors NIX and FUNDC1. Impaired mitophagy in response to hypoxia caused by miR-137 is reversed by re-expression of FUNDC1 and NIX expression vectors lacking the miR-137 recognition sites at their 3 UTR. Conversely, miR-137 also suppresses the mitophagy induced by fundc1 (CDS+3UTR) but not fundc1 (CDS) overexpression. Finally, we found that miR-137 inhibits mitophagy by reducing the expression of the mitophagy receptor thereby leads to inadequate interaction between mitophagy receptor and LC3. Our results demonstrated the regulatory role of miRNA to mitophagy receptors and revealed a novel link between miR-137 and mitophagy.	[Li, Wen; Zhang, Xingli; Tian, Weili; Wu, Wenxian; Chen, Yusen; Li, Longxuan; Zhao, Bin; Feng, Du] Guangdong Med Coll, Affiliated Hosp, Inst Neurol, Guangdong Key Lab Age Related Cardiac Cerebral Va, Zhanjiang 524001, Guangdong, Peoples R China; [Zhuang, Haixia; Zhang, Liangqing; Hu, Zhe] Guangdong Med Coll, Affiliated Hosp, Dept Anesthesiol, Zhanjiang 524001, Guangdong, Peoples R China; [Chen, He-ge] Guangdong Med Coll, Affiliated Hosp, Dept Urol, Zhanjiang 524001, Guangdong, Peoples R China; [Chen, Yinqin] Guangdong Med Coll, Affiliated Hosp, Dept Intervent Radiol, Zhanjiang 524001, Guangdong, Peoples R China; [Wang, Sijie] Guangdong Med Coll, Affiliated Hosp, Clin Res Ctr, Zhanjiang 524001, Guangdong, Peoples R China; [Li, Ying] Tsinghua Univ, Ctr Biomed Anal, Cell Biol Core Facil, Beijing 100084, Peoples R China; [Li, Longxuan] Gongli Hosp, Dept Neurol, Shanghai 200135, Peoples R China; [Sui, Senfang] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Guangdong Medical University; Guangdong Medical University; Guangdong Medical University; Guangdong Medical University; Guangdong Medical University; Tsinghua University; Tsinghua University	Hu, Z (corresponding author), Guangdong Med Coll, Affiliated Hosp, Dept Anesthesiol, Zhanjiang 524001, Guangdong, Peoples R China.	biohuzhe@hotmail.com; feng_du@foxmail.com	Wu, Wenxian/AAG-9752-2019; chen, hege/GYV-5810-2022	Feng, Du/0000-0002-2489-4702; Li, Wen/0000-0001-7530-199X; Wu, Wenxian/0000-0003-4059-5945	Guangdong Medical College [B2012043, B2012044, 701B01206]; National Natural Science Foundation of China [81171244, 31301104]; Guangdong Natural Science Foundation of China [S2011010004095]; Ministry of Education for returning-back scholars of China [[2012]940]; Foundation for Distinguished Young Talents in Higher Education of Guangdong, China [2013LYM_0035]	Guangdong Medical College; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province); Ministry of Education for returning-back scholars of China; Foundation for Distinguished Young Talents in Higher Education of Guangdong, China	This work was supported by grants from the Scientific Research Start-up from Guangdong Medical College (B2012043, B2012044, and 701B01206), the National Natural Science Foundation of China (81171244 and 31301104), the Guangdong Natural Science Foundation of China (S2011010004095), the Startup fund of the Ministry of Education for returning-back scholars of China ([2012]940), and the Foundation for Distinguished Young Talents in Higher Education of Guangdong, China (2013LYM_0035).	Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Attaix D, 2012, CELL METAB, V16, P551, DOI 10.1016/j.cmet.2012.10.013; Band M, 2009, FASEB J, V23, P2327, DOI 10.1096/fj.08-122978; Barde I, 2013, SCIENCE, V340, P350, DOI 10.1126/science.1232398; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; Birse-Archbold JLA, 2005, J CEREBR BLOOD F MET, V25, P1356, DOI 10.1038/sj.jcbfm.9600133; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chen LC, 2012, EUR J CANCER, V48, P3104, DOI 10.1016/j.ejca.2012.02.007; Chen Z, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/378484; Chu CT, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/789431; de Vries RLA, 2013, MOL CELL NEUROSCI, V55, P37, DOI 10.1016/j.mcn.2012.07.008; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Feng D, 2013, EXP CELL RES, V319, P1697, DOI 10.1016/j.yexcr.2013.03.034; Feng D, 2010, TRAFFIC, V11, P675, DOI 10.1111/j.1600-0854.2010.01041.x; Geekiyanage H, 2011, J NEUROSCI, V31, P14820, DOI 10.1523/JNEUROSCI.3883-11.2011; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Germain D, 2008, MOL MICROBIOL, V70, P1334, DOI 10.1111/j.1365-2958.2008.06502.x; Hanna RA, 2012, J BIOL CHEM, V287, P19094, DOI 10.1074/jbc.M111.322933; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Jin SM, 2012, J CELL SCI, V125, P795, DOI 10.1242/jcs.093849; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Lisanti MP, 2010, CANCER BIOL THER, V10, P537, DOI 10.4161/cbt.10.6.13370; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Lokireddy S, 2012, CELL METAB, V16, P613, DOI 10.1016/j.cmet.2012.10.005; Loscalzo J, 2010, J CLIN INVEST, V120, P3815, DOI 10.1172/JCI45105; Mazure NM, 2010, CURR OPIN CELL BIOL, V22, P177, DOI 10.1016/j.ceb.2009.11.015; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Novak I, 2012, ANTIOXID REDOX SIGN, V17, P794, DOI 10.1089/ars.2011.4407; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Smrt RD, 2010, STEM CELLS, V28, P1060, DOI 10.1002/stem.431; Sun GQ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1532; Tolkovsky AM, 2009, BBA-MOL CELL RES, V1793, P1508, DOI 10.1016/j.bbamcr.2009.03.002; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang PP, 2013, EMBO REP, V14, P568, DOI 10.1038/embor.2013.53	55	98	107	7	80	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10691	10701		10.1074/jbc.M113.537050	http://dx.doi.org/10.1074/jbc.M113.537050			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24573672	hybrid, Green Published			2022-12-28	WOS:000334226400039
J	Ohnishi, T; Murata, T; Watanabe, A; Hida, A; Ohba, H; Iwayama, Y; Mishima, K; Gondo, Y; Yoshikawa, T				Ohnishi, Tetsuo; Murata, Takuya; Watanabe, Akiko; Hida, Akiko; Ohba, Hisako; Iwayama, Yoshimi; Mishima, Kazuo; Gondo, Yoichi; Yoshikawa, Takeo			Defective Craniofacial Development and Brain Function in a Mouse Model for Depletion of Intracellular Inositol Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Brain; Circadian Rhythms; Craniofacial Development; Inositol Phosphates; Mouse Genetics; Mutagenesis; Neurodevelopment; Phosphatase	MYOINOSITOL MONOPHOSPHATASE GENE; BIPOLAR DISORDER; MOOD DISORDER; MISSENSE MUTATIONS; CIRCADIAN-RHYTHMS; TARGETING SYSTEM; FEBRILE SEIZURES; MESSENGER-RNA; IMPA2 GENE; MICE	Background: Lithium exerts a mood-stabilizing effect and inhibits myo-inositol monophosphatase (IMPase). Results: IMPase mutant mice had impaired jaw formation and mimicked lithium-induced behaviors. Conclusion: Craniofacial development and brain function require intracellular inositol production. Significance: This mouse model reveals molecular mechanisms relevant to understanding lithium's efficacy and inositol-mediated developmental processes. myo-Inositol is an essential biomolecule that is synthesized by myo-inositol monophosphatase (IMPase) from inositol monophosphate species. The enzymatic activity of IMPase is inhibited by lithium, a drug used for the treatment of mood swings seen in bipolar disorder. Therefore, myo-inositol is thought to have an important role in the mechanism of bipolar disorder, although the details remain elusive. We screened an ethyl nitrosourea mutant mouse library for IMPase gene (Impa) mutations and identified an Impa1 T95K missense mutation. The mutant protein possessed undetectable enzymatic activity. Homozygotes died perinatally, and E18.5 embryos exhibited striking developmental defects, including hypoplasia of the mandible and asymmetric fusion of ribs to the sternum. Perinatal lethality and morphological defects in homozygotes were rescued by dietary myo-inositol. Rescued homozygotes raised on normal drinking water after weaning exhibited a hyper-locomotive trait and prolonged circadian periods, as reported in rodents treated with lithium. Our mice should be advantageous, compared with those generated by the conventional gene knock-out strategy, because they carry minimal genomic damage, e.g. a point mutation. In conclusion, our results reveal critical roles for intracellular myo-inositol synthesis in craniofacial development and the maintenance of proper brain function. Furthermore, this mouse model for cellular inositol depletion could be beneficial for understanding the molecular mechanisms underlying the clinical effect of lithium and myo-inositol-mediated skeletal development.	[Ohnishi, Tetsuo; Watanabe, Akiko; Ohba, Hisako; Iwayama, Yoshimi; Yoshikawa, Takeo] RIKEN Brain Sci Inst, Lab Mol Psychiat, Wako, Saitama 3510198, Japan; [Murata, Takuya; Gondo, Yoichi] RIKEN BioResource Ctr, Mutagenesis & Genom Team, Tsukuba, Ibaraki 3050074, Japan; [Hida, Akiko; Mishima, Kazuo] Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Dept Psychophysiol, Kodaira, Tokyo 1878553, Japan	RIKEN; RIKEN; National Center for Neurology & Psychiatry - Japan	Ohnishi, T (corresponding author), RIKEN Brain Sci Inst, Lab Mol Psychiat, Wako, Saitama 3510198, Japan.	tohnishi@brain.riken.jp	Murata, Takuya/L-3298-2016; Gondo, Yoichi/A-5375-2016; Murata, Takuya/AAE-8001-2020; Yoshikawa, Takeo/F-9599-2019; Ohnishi, Tetsuo/AAC-2767-2022; Ohnishi, Tetsuo/D-3791-2018; Ohnishi, Tetsuo/AAC-5694-2019	Murata, Takuya/0000-0003-4185-1883; Gondo, Yoichi/0000-0003-2184-6489; Murata, Takuya/0000-0003-4185-1883; Ohnishi, Tetsuo/0000-0002-6696-9725; Ohnishi, Tetsuo/0000-0002-6696-9725; MISHIMA, KAZUO/0000-0003-1182-1181	Ministry of Education, Culture, Sports, Science and Technology of Japan; RIKEN BSI funds; Mitsubishi Pharma Research Foundation; Astra Zeneca; Takeda Science Foundation; JSPS KAKENHI Grants [15200032, 21240043, 25241016]; Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN BSI funds; Mitsubishi Pharma Research Foundation; Astra Zeneca(AstraZeneca); Takeda Science Foundation(Takeda Science Foundation (TSF)); JSPS KAKENHI Grants; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by in part by grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to T. O. and T. Y.), RIKEN BSI funds, grants from the Mitsubishi Pharma Research Foundation (to T. Y.), Astra Zeneca (to T. O.), Takeda Science Foundation (to T. O.), JSPS KAKENHI Grants 15200032 (to Y. G.), 21240043 (to Y. G. and T. M.), and 25241016 (to Y. G.), and grant-in-aid for scientific research on innovative areas (Unraveling the Micro-endophenotypes of Psychiatric Disorders at the Molecular, Cellular and Circuit Levels) from the Ministry of Education, Culture, Sports, Science and Technology (to T. Y.). A portion of this study is the result of the "Development of Biomarker Candidates for Social Behavior" Project carried out under the Strategic Research Program for Brain Sciences from Ministry of Education, Culture, Sports, Science and Technology (to T. Y.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Andreassi C, 2010, NAT NEUROSCI, V13, P291, DOI 10.1038/nn.2486; Arai R, 2007, PROTEINS, V67, P732, DOI 10.1002/prot.21299; Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Artioli P, 2007, EUR NEUROPSYCHOPHARM, V17, P587, DOI 10.1016/j.euroneuro.2007.03.004; Baker M, 2011, NATURE, V475, P123, DOI 10.1038/475123a; Barnard AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000040; Beaulieu JM, 2008, P NATL ACAD SCI USA, V105, P1333, DOI 10.1073/pnas.0711496105; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; Berry GT, 2003, J BIOL CHEM, V278, P18297, DOI 10.1074/jbc.M213176200; Chau JFL, 2005, FASEB J, V19, P1887, DOI 10.1096/fj.05-4192fje; Clapcote SJ, 2007, NEURON, V54, P387, DOI 10.1016/j.neuron.2007.04.015; Compagni A, 2003, DEV CELL, V5, P217, DOI 10.1016/S1534-5807(03)00198-9; Cryns K, 2008, NEUROPSYCHOPHARMACOL, V33, P674, DOI 10.1038/sj.npp.1301431; Cryns K, 2007, NEUROPSYCHOPHARMACOL, V32, P881, DOI 10.1038/sj.npp.1301154; Dai ZJ, 2011, J BONE MINER RES, V26, P582, DOI 10.1002/jbmr.240; del Pino I, 2013, NEURON, V79, P1152, DOI 10.1016/j.neuron.2013.07.010; Depew MJ, 2002, SCIENCE, V298, P381, DOI 10.1126/science.1075703; DIEHL RE, 1990, J BIOL CHEM, V265, P5946; Dokucu ME, 2005, NEUROPSYCHOPHARMACOL, V30, P2216, DOI 10.1038/sj.npp.1300764; Fujita S, 2011, J MOL MODEL, V17, P2559, DOI 10.1007/s00894-010-0937-8; Gondo Y, 2010, EXP ANIM TOKYO, V59, P537, DOI 10.1538/expanim.59.537; Gondo Y, 2009, PROG BRAIN RES, V179, P29, DOI 10.1016/S0079-6123(09)17904-9; Gondo Y, 2009, BMB REP, V42, P315, DOI 10.5483/BMBRep.2009.42.6.315; Harwood AJ, 2005, MOL PSYCHIATR, V10, P117, DOI 10.1038/sj.mp.4001618; Inoue T, 2004, DEV BIOL, V270, P146, DOI 10.1016/j.ydbio.2004.02.017; Kasahara T, 2006, MOL PSYCHIATR, V11, P577, DOI 10.1038/sj.mp.4001824; Kimata T, 2012, GENETICS, V191, P509, DOI 10.1534/genetics.111.137844; Kripke Daniel F, 2009, J Circadian Rhythms, V7, P2, DOI 10.1186/1740-3391-7-2; Lamont Elaine Waddington, 2007, Dialogues Clin Neurosci, V9, P333; Lavoie J, 2013, BEHAV BRAIN RES, V253, P262, DOI 10.1016/j.bbr.2013.08.001; Madan B, 2009, MOL CELL BIOL, V29, P3186, DOI 10.1128/MCB.01970-08; MCALLISTER G, 1992, BIOCHEM J, V284, P749, DOI 10.1042/bj2840749; McClung CA, 2007, PHARMACOL THERAPEUT, V114, P222, DOI 10.1016/j.pharmthera.2007.02.003; McClung CA, 2013, BIOL PSYCHIAT, V74, P242, DOI 10.1016/j.biopsych.2013.02.019; McClung CA, 2011, EUR NEUROPSYCHOPHARM, V21, pS683, DOI 10.1016/j.euroneuro.2011.07.008; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Mendlewicz J, 2009, CNS DRUGS, V23, P15, DOI 10.2165/11318630-000000000-00000; Nakayama J, 2004, NEUROLOGY, V63, P1803, DOI 10.1212/01.WNL.0000144499.34164.E0; Ohnishi T, 2007, NEUROPSYCHOPHARMACOL, V32, P1727, DOI 10.1038/sj.npp.1301307; Ohnishi T, 2007, J BIOL CHEM, V282, P637, DOI 10.1074/jbc.M604474200; Ohnishi T, 2013, J NEUROCHEM, V124, P685, DOI 10.1111/jnc.12112; Ohnishi T, 2010, NEUROSCI RES, V67, P86, DOI 10.1016/j.neures.2010.02.003; Powell CM, 2006, BIOL PSYCHIAT, V59, P1198, DOI 10.1016/j.biopsych.2006.05.008; Sakuraba Y, 2005, BIOCHEM BIOPH RES CO, V336, P609, DOI 10.1016/j.bbrc.2005.08.134; Singh N, 2012, ACTA CRYSTALLOGR F, V68, P1149, DOI 10.1107/S1744309112035191; Sjoholt G, 2004, MOL PSYCHIATR, V9, P621, DOI 10.1038/sj.mp.4001460; Sjoholt G, 1997, GENOMICS, V45, P113, DOI 10.1006/geno.1997.4862; Stottmann RW, 2001, DEV BIOL, V240, P457, DOI 10.1006/dbio.2001.0479; Tanizawa Y, 2006, GENE DEV, V20, P3296, DOI 10.1101/gad.1497806; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yoshikawa T, 1997, MOL PSYCHIATR, V2, P393, DOI 10.1038/sj.mp.4000325; Yoshikawa T, 2001, MOL PSYCHIATR, V6, P202, DOI 10.1038/sj.mp.4000835	55	18	18	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10785	10796		10.1074/jbc.M113.536706	http://dx.doi.org/10.1074/jbc.M113.536706			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24554717	Green Published, hybrid			2022-12-28	WOS:000334226400047
J	Pan, TC; Zhang, RZ; Arita, M; Bogdanovich, S; Adams, SM; Gara, SK; Wagener, R; Khurana, TS; Birk, DE; Chu, ML				Pan, Te-Cheng; Zhang, Rui-Zhu; Arita, Machiko; Bogdanovich, Sasha; Adams, Sheila M.; Gara, Sudheer Kumar; Wagener, Raimund; Khurana, Tejvior S.; Birk, David E.; Chu, Mon-Li			A Mouse Model for Dominant Collagen VI Disorders	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Connective Tissue; Extracellular Matrix; Fibroblast; Muscle; Tendon	CONGENITAL MUSCULAR-DYSTROPHY; MITOCHONDRIAL DYSFUNCTION; BETHLEM MYOPATHY; TENASCIN-X; VONWILLEBRAND-FACTOR; ALPHA-2(VI) CHAINS; GLOBULAR DOMAINS; MUSCLE; MUTATIONS; DEFICIENCY	Background: Dominant collagen VI gene mutations cause the severe Ullrich congenital muscular dystrophy (UCMD) and mild Bethlem myopathy. Results: A mutant mouse mimicking the most common molecular defect in dominant UCMD patients was generated and characterized. Conclusion: The mutant mouse displays muscle and connective tissue abnormalities. Significance: The mutant mouse provides an animal model for dominant collagen VI disorders. Dominant and recessive mutations in collagen VI genes, COL6A1, COL6A2, and COL6A3, cause a continuous spectrum of disorders characterized by muscle weakness and connective tissue abnormalities ranging from the severe Ullrich congenital muscular dystrophy to the mild Bethlem myopathy. Herein, we report the development of a mouse model for dominant collagen VI disorders by deleting exon 16 in the Col6a3 gene. The resulting heterozygous mouse, Col6a3(+/d16), produced comparable amounts of normal Col6a3 mRNA and a mutant transcript with an in-frame deletion of 54 bp of triple-helical coding sequences, thus mimicking the most common molecular defect found in dominant Ullrich congenital muscular dystrophy patients. Biosynthetic studies of mutant fibroblasts indicated that the mutant 3(VI) collagen protein was produced and exerted a dominant-negative effect on collagen VI microfibrillar assembly. The distribution of the 3(VI)-like chains of collagen VI was not altered in mutant mice during development. The Col6a3(+/d16) mice developed histopathologic signs of myopathy and showed ultrastructural alterations of mitochondria and sarcoplasmic reticulum in muscle and abnormal collagen fibrils in tendons. The Col6a3(+/d16) mice displayed compromised muscle contractile functions and thereby provide an essential preclinical platform for developing treatment strategies for dominant collagen VI disorders.	[Pan, Te-Cheng; Zhang, Rui-Zhu; Arita, Machiko; Chu, Mon-Li] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [Bogdanovich, Sasha; Khurana, Tejvior S.] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Bogdanovich, Sasha; Khurana, Tejvior S.] Univ Penn, Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Adams, Sheila M.; Birk, David E.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33612 USA; [Gara, Sudheer Kumar; Wagener, Raimund] Univ Cologne, Med Fac Cologne, Ctr Biochem, D-50931 Cologne, Germany; [Wagener, Raimund] Univ Cologne, Med Fac Cologne, Ctr Mol Med, D-50931 Cologne, Germany	Jefferson University; University of Pennsylvania; University of Pennsylvania; State University System of Florida; University of South Florida; University of Cologne; University of Cologne	Chu, ML (corresponding author), Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, 233 South 10th St, Philadelphia, PA 19107 USA.	mon-li.chu@jefferson.edu	Gara, Sudheer Kumar/E-8084-2016; Birk, David/I-4072-2012	Birk, David/0000-0002-4865-9088	National Institutes of Health [AR053251, AR44745]; German Research Foundation [SFB829]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053251, R01AR044745] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR053251 (to M.-L.C.) and AR44745 (to D.E.B.). This work was also supported by the German Research Foundation (SFB829; to R.W.).	Allamand V, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-30; Angelin A, 2007, P NATL ACAD SCI USA, V104, P991, DOI 10.1073/pnas.0610270104; Baker NL, 2005, HUM MOL GENET, V14, P279, DOI 10.1093/hmg/ddi025; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Bogdanovich S, 2008, MUSCLE NERVE, V37, P308, DOI 10.1002/mus.20920; Bonaldo P, 1998, HUM MOL GENET, V7, P2135, DOI 10.1093/hmg/7.13.2135; Bonnemann CG, 2011, NAT REV NEUROL, V7, P379, DOI 10.1038/nrneurol.2011.81; Brinas L, 2010, ANN NEUROL, V68, P511, DOI 10.1002/ana.22087; BROOKS SV, 1990, AM J PHYSIOL, V258, pC436, DOI 10.1152/ajpcell.1990.258.3.C436; Camacho V.O., 2001, P NATL ACAD SCI USA, V98, P7516, DOI DOI 10.1073/PNAS.121027598; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; CHU ML, 1990, EMBO J, V9, P385, DOI 10.1002/j.1460-2075.1990.tb08122.x; CHU ML, 1988, J BIOL CHEM, V263, P18601; CHU ML, 1989, EMBO J, V8, P1939, DOI 10.1002/j.1460-2075.1989.tb03598.x; ENGEL J, 1985, ANN NY ACAD SCI, V460, P25, DOI 10.1111/j.1749-6632.1985.tb51154.x; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200; Gara SK, 2011, MATRIX BIOL, V30, P248, DOI 10.1016/j.matbio.2011.03.006; Giusti B, 2005, ANN NEUROL, V58, P400, DOI 10.1002/ana.20586; Gualandi F, 2012, HUM GENE THER, V23, P1313, DOI 10.1089/hum.2012.109; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Izu Y, 2011, MATRIX BIOL, V30, P53, DOI 10.1016/j.matbio.2010.10.001; Jobsis GJ, 1999, BRAIN, V122, P649, DOI 10.1093/brain/122.4.649; Kirschner J, 2005, AM J MED GENET A, V132A, P296, DOI 10.1002/ajmg.a.30443; Lamande SR, 2002, J BIOL CHEM, V277, P1949, DOI 10.1074/jbc.M109932200; Lampe AK, 2008, HUM MUTAT, V29, P809, DOI 10.1002/humu.20704; Lorts A, 2012, P NATL ACAD SCI USA, V109, P10978, DOI 10.1073/pnas.1204708109; Mercuri E, 2012, ANN NEUROL, V72, P9, DOI 10.1002/ana.23548; Merlini L, 2008, NEUROLOGY, V71, P1245, DOI 10.1212/01.wnl.0000327611.01687.5e; Merlini L, 2008, P NATL ACAD SCI USA, V105, P5225, DOI 10.1073/pnas.0800962105; Minamitani T, 2004, EXP CELL RES, V298, P305, DOI 10.1016/j.yexcr.2004.04.030; Minamitani T, 2004, EXP CELL RES, V297, P49, DOI 10.1016/j.yexcr.2004.03.002; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Norwood FLM, 2009, BRAIN, V132, P3175, DOI 10.1093/brain/awp236; Okada M, 2007, NEUROLOGY, V69, P1035, DOI 10.1212/01.wnl.0000271387.10404.4e; Pan TC, 2003, AM J HUM GENET, V73, P355, DOI 10.1086/377107; Pan TC, 2013, J BIOL CHEM, V288, P14320, DOI 10.1074/jbc.M112.433078; Peat RA, 2007, NEUROMUSCULAR DISORD, V17, P547, DOI 10.1016/j.nmd.2007.03.017; Persikov AV, 2000, BIOCHEMISTRY-US, V39, P14960, DOI 10.1021/bi001560d; Ritty TM, 2003, STRUCTURE, V11, P1179, DOI 10.1016/S0969-2126(03)00181-3; Sabatelli P, 2012, MATRIX BIOL, V31, P187, DOI 10.1016/j.matbio.2011.12.003; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Scacheri PC, 2002, NEUROLOGY, V58, P593, DOI 10.1212/WNL.58.4.593; Schalkwijk J, 2001, NEW ENGL J MED, V345, P1167, DOI 10.1056/NEJMoa002939; SPECKS U, 1992, EMBO J, V11, P4281, DOI 10.1002/j.1460-2075.1992.tb05527.x; TILLET E, 1994, EUR J BIOCHEM, V221, P177, DOI 10.1111/j.1432-1033.1994.tb18727.x; Urciuolo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2964; Voermans NC, 2011, CONNECT TISSUE RES, V52, P422, DOI 10.3109/03008207.2010.551616; Wiberg C, 2001, J BIOL CHEM, V276, P18947, DOI 10.1074/jbc.M100625200; Zhang RZ, 2002, J BIOL CHEM, V277, P43557, DOI 10.1074/jbc.M207696200	50	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10293	10307		10.1074/jbc.M114.549311	http://dx.doi.org/10.1074/jbc.M114.549311			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24563484	Green Published, hybrid			2022-12-28	WOS:000334226400006
J	Simon, NC; Barbieri, JT				Simon, Nathan C.; Barbieri, Joseph T.			Bacillus cereus Certhrax ADP-ribosylates Vinculin to Disrupt Focal Adhesion Complexes and Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; ADP-ribosylation; Bacillus; Bacterial Toxins; Microscopic Imaging	ANTHRACIS LETHAL TOXIN; EXOENZYME-S; ESCHERICHIA-COLI; STRUCTURAL BASIS; RIBOSYLTRANSFERASE; ACTIVATION; PROTEIN; ACTIN; MACROPHAGES; EXPRESSION	Background: The host substrate for Certhrax toxin is unknown. Results: Certhrax toxin ADP-ribosylates vinculin at Arg-433, which disrupts focal adhesion complexes and host cell adhesion. Conclusion: Certhrax toxin is the first bacterial toxin to add a post-translational modification to vinculin to disrupt the actin cytoskeleton. Significance: This explains how Certhrax toxin can contribute to evasion of the host innate immune system. Bacillus cereus is often associated with mild to moderate gastroenteritis; however, some recent isolates cause inhalational anthrax-like diseases and death. These potential emerging human pathogens express multiple virulence factors. B. cereus strain G9241 expresses anthrax toxin, several polysaccharide capsules, and the novel ADP-ribosyltransferase, Certhrax. In this study, we show that Certhrax ADP-ribosylates Arg-433 of vinculin, a protein that coordinates actin cytoskeleton and extracellular matrix interactions. ADP-ribosylation of vinculin disrupted focal adhesion complexes and redistributed vinculin to the cytoplasm. Exogenous vinculin rescued these phenotypes. This provides a mechanism for strain G9241 to breach host barrier defenses and promote bacterial growth and spread. Certhrax is the first bacterial toxin to add a post-translational modification to vinculin to disrupt the actin cytoskeleton.	[Simon, Nathan C.; Barbieri, Joseph T.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Barbieri, JT (corresponding author), 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jtb01@mcw.edu			National Institutes of Health [R01 AI031062, U54 AI057153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI111101, U54AI057153, R01AI030162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI031062 and U54 AI057153.	AKTORIES K, 1989, BIOCHEM BIOPH RES CO, V158, P209, DOI 10.1016/S0006-291X(89)80199-8; Aktories K, 2011, FEBS J, V278, P4526, DOI 10.1111/j.1742-4658.2011.08113.x; Alrutz MA, 1998, P NATL ACAD SCI USA, V95, P13658, DOI 10.1073/pnas.95.23.13658; Andersson K, 1996, MOL MICROBIOL, V20, P1057, DOI 10.1111/j.1365-2958.1996.tb02546.x; Avashia SB, 2007, CLIN INFECT DIS, V44, P414, DOI 10.1086/510429; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Black DS, 1997, EMBO J, V16, P2730, DOI 10.1093/emboj/16.10.2730; BOBAK DA, 1990, BIOCHEMISTRY-US, V29, P855, DOI 10.1021/bi00456a600; Bois PRJ, 2006, J BIOL CHEM, V281, P7228, DOI 10.1074/jbc.M510397200; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Cappello RE, 2011, FEMS IMMUNOL MED MIC, V61, P301, DOI 10.1111/j.1574-695X.2010.00776.x; Carisey A, 2011, EUR J CELL BIOL, V90, P157, DOI 10.1016/j.ejcb.2010.06.007; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; COBURN J, 1991, J BIOL CHEM, V266, P6438; Davies JA, 1997, BIOESSAYS, V19, P699, DOI 10.1002/bies.950190810; Eisele NA, 2011, J PATHOG, V2011, DOI 10.4061/2011/249802; FERNANDEZ JLR, 1993, J CELL BIOL, V122, P1285, DOI 10.1083/jcb.122.6.1285; Fieldhouse RJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001029; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Garlick KM, 2012, BIOCHEMISTRY-US, V51, P1249, DOI 10.1021/bi2016469; GEIGER B, 1979, CELL, V18, P193, DOI 10.1016/0092-8674(79)90368-4; Go MY, 2009, INFECT IMMUN, V77, P52, DOI 10.1128/IAI.01073-08; Golji J, 2012, BIOPHYS J, V102, P2022, DOI 10.1016/j.bpj.2012.01.062; Golji J, 2011, BIOPHYS J, V100, P332, DOI 10.1016/j.bpj.2010.11.024; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Haglund CM, 2011, J CELL BIOL, V195, P7, DOI 10.1083/jcb.201103148; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; HANNA PC, 1993, P NATL ACAD SCI USA, V90, P10198, DOI 10.1073/pnas.90.21.10198; Hoffmaster AR, 2006, J CLIN MICROBIOL, V44, P3352, DOI 10.1128/JCM.00561-06; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Kim M, 2010, CELL HOST MICROBE, V8, P20, DOI 10.1016/j.chom.2010.06.006; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; Klee SR, 2006, J BACTERIOL, V188, P5333, DOI 10.1128/JB.00303-06; Kogan TV, 2004, J INFECT DIS, V189, P1965, DOI 10.1086/420850; Kupper K, 2010, BIOCHEM BIOPH RES CO, V399, P560, DOI 10.1016/j.bbrc.2010.07.110; Langer M, 2012, INFECT IMMUN, V80, P4374, DOI 10.1128/IAI.01011-12; Lehmann M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004755; Liu SY, 1997, J BACTERIOL, V179, P1609, DOI 10.1128/jb.179.5.1609-1613.1997; Maddugoda MP, 2007, J CELL BIOL, V178, P529, DOI 10.1083/jcb.200612042; Mierke CT, 2010, J BIOL CHEM, V285, P13121, DOI 10.1074/jbc.M109.087171; Miller JM, 1997, J CLIN MICROBIOL, V35, P504, DOI 10.1128/JCM.35.2.504-507.1997; MILNE JC, 1994, J BIOL CHEM, V269, P20607; Moese S, 2007, CELL MICROBIOL, V9, P1148, DOI 10.1111/j.1462-5822.2006.00856.x; Mogridge J, 2002, BIOCHEMISTRY-US, V41, P1079, DOI 10.1021/bi015860m; Oh SY, 2013, INFECT IMMUN, V81, P1008, DOI 10.1128/IAI.01346-12; Oh SY, 2011, MOL MICROBIOL, V80, P455, DOI 10.1111/j.1365-2958.2011.07582.x; Okinaka R, 1999, J APPL MICROBIOL, V87, P261, DOI 10.1046/j.1365-2672.1999.00883.x; Okinaka RT, 1999, J BACTERIOL, V181, P6509, DOI 10.1128/JB.181.20.6509-6515.1999; Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093; Pederson KJ, 1998, MOL MICROBIOL, V30, P751, DOI 10.1046/j.1365-2958.1998.01106.x; Peng XA, 2011, INT REV CEL MOL BIO, V287, P191, DOI 10.1016/B978-0-12-386043-9.00005-0; Ruoslahti E, 1997, SCIENCE, V276, P1345, DOI 10.1126/science.276.5317.1345; Sauvonnet N, 2002, MOL MICROBIOL, V45, P805, DOI 10.1046/j.1365-2958.2002.03053.x; Schiavo G, 2001, NAT REV MOL CELL BIO, V2, P530, DOI 10.1038/35080089; Simon NC, 2013, BIOCHEMISTRY-US, V52, P2309, DOI 10.1021/bi300692g; Turnbull PCB, 2004, J CLIN MICROBIOL, V42, P3626, DOI 10.1128/jcm.42.8.3626-3634.2004; VanNhieu GT, 1997, EMBO J, V16, P2717, DOI 10.1093/emboj/16.10.2717; Visschedyk D, 2012, J BIOL CHEM, V287, P41089, DOI 10.1074/jbc.M112.412809; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P569, DOI 10.1016/j.ceb.2012.06.010; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107; Wilson MK, 2011, INFECT IMMUN, V79, P3012, DOI 10.1128/IAI.00205-11; Xu WM, 1998, DEVELOPMENT, V125, P327; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	66	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10650	10659		10.1074/jbc.M113.500710	http://dx.doi.org/10.1074/jbc.M113.500710			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24573681	Green Published, hybrid			2022-12-28	WOS:000334226400035
J	Wehmeyer, L; Du Toit, A; Lang, DM; Hapgood, JP				Wehmeyer, Lancelot; Du Toit, Andrea; Lang, Dirk M.; Hapgood, Janet P.			Lipid Raft-and Protein Kinase C-mediated Synergism between Glucocorticoid-and Gonadotropin-releasing Hormone Signaling Results in Decreased Cell Proliferation*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Proliferation; Gene Regulation; Glucocorticoid Receptor; Glucocorticoids; Protein Kinase C (PKC); GnRH Receptor; SGK-1; Flotillin-1; Lipid Rafts; Synergism	FOLLICLE-STIMULATING-HORMONE; GENE-EXPRESSION; GNRH RECEPTOR; CYCLE REGULATION; JNK PATHWAY; IN-VITRO; MEMBRANE; PHOSPHORYLATION; TRANSCRIPTION; INHIBITION	Background: The glucocorticoid receptor cross-talks with other receptors to integrate cell signaling. Results: Glucocorticoids and GnRH synergistically up-regulate select mRNA levels via protein kinase C and flotillin-1 to repress cell proliferation. Conclusion: Cross-talk between membrane-associated receptors modulates protein kinase C-dependent synergistic and gene-specific transcription by intracellular glucocorticoid receptor. Significance: Glucocorticoid and GnRH receptor cross-talk integrates adrenal and gonadal signaling to fine-tune cell proliferation. Cross-talk between the glucocorticoid receptor (GR) and other receptors is emerging as a mechanism for fine-tuning cellular responses. We have previously shown that gonadotropin-releasing hormone (GnRH) ligand-independently activates the GR and synergistically modulates glucocorticoid-induced transcription of an endogenous gene in LT2 pituitary gonadotrope precursor cells. Here, we investigated GR and GnRH receptor (GnRHR) cross-talk that involves co-localization with lipid rafts in LT2 cells. We report that the GnRHR and a small population of the GR co-localize with the lipid raft protein flotillin-1 (Flot-1) at the plasma membrane and that the GR is present in a complex with Flot-1, independent of the presence of ligands. We found that the SGK-1 gene is up-regulated by Dex and GnRH alone, whereas a combination of both ligands resulted in a synergistic increase in SGK-1 mRNA levels. Using siRNA-mediated knockdown and antagonist strategies, we show that the gene-specific synergistic transcriptional response requires the GR, GnRHR, and Flot-1 as well as the protein kinase C pathway. Interestingly, although several GR cofactors are differentially recruited to the SGK-1 promoter in the presence of Dex and GnRH, GR levels remain unchanged compared with Dex treatment alone, suggesting that lipid raft association of the GR has a role in enhancing its transcriptional output in the nucleus. Finally, we show that Dex plus GnRH synergistically inhibit cell proliferation in a manner dependent on SGK-1 and Flot-1. Collectively the results support a mechanism whereby GR and GnRHR cross-talk within Flot-1-containing lipid rafts modulates cell proliferation via PKC activation and SGK-1 up-regulation.	[Wehmeyer, Lancelot; Du Toit, Andrea; Hapgood, Janet P.] Univ Cape Town, Dept Mol & Cell Biol, Fac Sci, ZA-7700 Rondebosch, South Africa; [Lang, Dirk M.] Univ Cape Town, Dept Human Biol, Fac Hlth Sci, ZA-7700 Rondebosch, South Africa	University of Cape Town; University of Cape Town	Hapgood, JP (corresponding author), Univ Cape Town, Dept Mol & Cell Biol, Fac Sci, Private Bag X1, ZA-7700 Rondebosch, South Africa.	Janet.Hapgood@uct.ac.za	Lang, Dirk/I-2554-2015; Hapgood, Janet P/P-2549-2018	Lang, Dirk/0000-0003-3901-2079; Hapgood, Janet P/0000-0002-4414-4861	National Research Foundation, South Africa	National Research Foundation, South Africa(National Research Foundation - South Africa)	This work was supported by the National Research Foundation, South Africa (to J. H.).	Abel GA, 2002, MOL ENDOCRINOL, V16, P1352, DOI 10.1210/me.16.6.1352; Anacker C, 2013, NEUROPSYCHOPHARMACOL, V38, P872, DOI 10.1038/npp.2012.253; Arteaga MF, 2008, P NATL ACAD SCI USA, V105, P4459, DOI 10.1073/pnas.0800958105; Asselin-Labat ML, 2004, BLOOD, V104, P215, DOI 10.1182/blood-2003-12-4295; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Barr FD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006766; Bartholome B, 2004, FASEB J, V18, P70, DOI 10.1096/fj.03-0328com; Bartis D, 2006, J STEROID BIOCHEM, V98, P147, DOI 10.1016/j.jsbmb.2005.01.032; Bartis D, 2007, BIOCHEM BIOPH RES CO, V354, P253, DOI 10.1016/j.bbrc.2006.12.211; Bliss SP, 2007, MOL ENDOCRINOL, V21, P538, DOI 10.1210/me.2006-0289; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Bruna A, 2003, EMBO J, V22, P6035, DOI 10.1093/emboj/cdg590; Caelles C, 1997, GENE DEV, V11, P3351, DOI 10.1101/gad.11.24.3351; Chen WW, 2008, MOL ENDOCRINOL, V22, P1754, DOI 10.1210/me.2007-0219; Cheung LWT, 2011, CARDIOVASC RES, V89, P419, DOI 10.1093/cvr/cvq300; Croxtall JD, 2000, BRIT J PHARMACOL, V130, P289, DOI 10.1038/sj.bjp.0703272; Eickelberg O, 1999, J BIOL CHEM, V274, P1005, DOI 10.1074/jbc.274.2.1005; Feng J, 2008, BIOL REPROD, V79, P546, DOI 10.1095/biolreprod.108.068106; FERNANDES PA, 1989, AM J VET RES, V50, P64; Galliher-Beckley AJ, 2011, MOL CELL BIOL, V31, P4663, DOI 10.1128/MCB.05866-11; Gametchu B, 1999, STEROIDS, V64, P107, DOI 10.1016/S0039-128X(98)00097-X; GAMETCHU B, 1993, FASEB J, V7, P1283, DOI 10.1096/fasebj.7.13.8405814; Grafer CM, 2009, MOL ENDOCRINOL, V23, P1022, DOI 10.1210/me.2008-0477; Grossmann C, 2010, BBA-MOL CELL RES, V1803, P584, DOI 10.1016/j.bbamcr.2010.02.008; HSU SC, 1995, J BIOL CHEM, V270, P3359, DOI 10.1074/jbc.270.7.3359; HSU SC, 1992, EMBO J, V11, P3457, DOI 10.1002/j.1460-2075.1992.tb05425.x; Hu AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060452; Jain S, 2005, BIOCHEM BIOPH RES CO, V336, P3, DOI 10.1016/j.bbrc.2005.08.057; Jayakody SA, 2012, J CLIN INVEST, V122, P3635, DOI 10.1172/JCI64311; Klengel T, 2013, NAT NEUROSCI, V16, P33, DOI 10.1038/nn.3275; Kotitschke A, 2009, MOL ENDOCRINOL, V23, P1726, DOI 10.1210/me.2008-0462; Lafont F, 2001, P NATL ACAD SCI USA, V98, P3180, DOI 10.1073/pnas.051003498; Langlais D, 2013, MOL ENDOCRINOL, V27, P1103, DOI 10.1210/me.2012-1407; Lannan EA, 2012, ENDOCRINOLOGY, V153, P3701, DOI 10.1210/en.2012-1020; Lariviere S, 2007, ENDOCRINOLOGY, V148, P1099, DOI 10.1210/en.2006-1473; Li LB, 2010, AM J RESP CRIT CARE, V182, P877, DOI 10.1164/rccm.201001-0015OC; LIPOSITS Z, 1993, J NEUROSCI RES, V35, P14, DOI 10.1002/jnr.490350103; Lister K, 2006, CARDIOVASC RES, V70, P555, DOI 10.1016/j.cardiores.2006.02.010; Losel R, 2003, NAT REV MOL CELL BIO, V4, P46, DOI 10.1038/nrm1009; Lowenberg M, 2005, BLOOD, V106, P1703, DOI 10.1182/blood-2004-12-4790; Lowenberg M, 2006, ENDOCRINOLOGY, V147, P3555, DOI 10.1210/en.2005-1602; Lowenberg M, 2006, EMBO REP, V7, P1023, DOI 10.1038/sj.embor.7400775; Manders E., 1993, Acta Oto-Rhino-Laryngologica Belgica, V47, P27; Mathews WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024946; Matthews L, 2008, MOL ENDOCRINOL, V22, P1320, DOI 10.1210/me.2007-0154; Matthews L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022289; McGillivray SM, 2007, ENDOCRINOLOGY, V148, P762, DOI 10.1210/en.2006-0952; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Navratil AM, 2003, J BIOL CHEM, V278, P31593, DOI 10.1074/jbc.M304273200; Newton R, 2010, PHARMACOL THERAPEUT, V125, P286, DOI 10.1016/j.pharmthera.2009.11.003; Nystrom FH, 1999, MOL ENDOCRINOL, V13, P2013, DOI 10.1210/me.13.12.2013; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Razandi M, 2002, MOL ENDOCRINOL, V16, P100, DOI 10.1210/me.16.1.100; Rees DA, 2002, ENDOCRINOLOGY, V143, P2427, DOI 10.1210/en.143.6.2427; Revollo JR, 2009, ANN NY ACAD SCI, V1179, P167, DOI 10.1111/j.1749-6632.2009.04986.x; Rogatsky I, 1997, MOL CELL BIOL, V17, P3181, DOI 10.1128/MCB.17.6.3181; Ronacher K, 2009, MOL CELL ENDOCRINOL, V299, P219, DOI 10.1016/j.mce.2008.10.008; Samarasinghe RA, 2011, P NATL ACAD SCI USA, V108, P16657, DOI 10.1073/pnas.1102821108; Sasson R, 2003, BIOCHEM BIOPH RES CO, V311, P1047, DOI 10.1016/j.bbrc.2003.10.097; Schmidt P, 2001, MOL ENDOCRINOL, V15, P553, DOI 10.1210/me.15.4.553; Shen L, 2004, LEUKEMIA, V18, P1850; Stahn C, 2008, NAT CLIN PRACT RHEUM, V4, P525, DOI 10.1038/ncprheum0898; Tasker JG, 2006, ENDOCRINOLOGY, V147, P5549, DOI 10.1210/en.2006-0981; Turgeon JL, 1996, MOL ENDOCRINOL, V10, P439, DOI 10.1210/me.10.4.439; Vasudevan N, 2001, MOL BRAIN RES, V95, P9, DOI 10.1016/S0169-328X(01)00165-6; Verhoog NJD, 2011, J BIOL CHEM, V286, P19297, DOI 10.1074/jbc.M110.193672; Wang JR, 2004, BIOL REPROD, V70, P577, DOI 10.1095/biolreprod.103.023234; Wang Z, 2007, MOL ENDOCRINOL, V21, P625, DOI 10.1210/me.2005-0338; Wu J, 2007, MOL CELL BIOL, V27, P2411, DOI 10.1128/MCB.02152-06	69	22	22	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10235	10251		10.1074/jbc.M113.544742	http://dx.doi.org/10.1074/jbc.M113.544742			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24558046	hybrid, Green Published			2022-12-28	WOS:000333807000068
J	Zhang, ZY; Yang, QY; Sun, GY; Chen, S; He, Q; Li, SJ; Liu, Y				Zhang, Zhenyu; Yang, Qiuying; Sun, Guangyan; Chen, She; He, Qun; Li, Shaojie; Liu, Yi			Histone H3K56 Acetylation Is Required for Quelling-induced Small RNA Production through Its Role in Homologous Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Homologous Recombination; Neurospora; RNA Interference (RNAi); RNA Silencing; siRNA	INTERFERENCE PATHWAYS; NEUROSPORA-CRASSA; DNA; GENE; LYSINE-56; RTT109; PROTEIN; H3; ACETYLTRANSFERASE; TRANSCRIPTION	Background: Quelling and DNA damage induce small RNA from repetitive DNA regions. Results: Genetic Screen identified RTT109 as a critical component of the siRNA production pathway in Neurospora. Conclusion: RTT109 acts as a histone H3K56 acetyltransferase to mediate siRNA biogenesis through its role in homologous recombination. Significance: This study identifies a new link between DNA damage response and small RNA production at the chromatin level. Quelling and DNA damage-induced small RNA (qiRNA) production are RNA interference (RNAi)-related phenomenon from repetitive genomic loci in Neurospora. We have recently proposed that homologous recombination from repetitive DNA loci allows the RNAi pathway to recognize repetitive DNA to produce small RNA. However, the mechanistic detail of this pathway remains largely unclear. By systematically screening the Neurospora knock-out library, we identified RTT109 as a novel component required for small RNA production. RTT109 is a histone acetyltransferase for histone H3 lysine 56 (H3K56) and H3K56 acetylation is essential for the small RNA biogenesis pathway. Furthermore, we showed that RTT109 is required for homologous recombination and H3K56Ac is enriched around double strand break, which overlaps with RAD51 binding. Taken together, our results suggest that H3K56 acetylation is required for small RNA production through its role in homologous recombination.	[Zhang, Zhenyu; Yang, Qiuying; Liu, Yi] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Sun, Guangyan; He, Qun] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Chen, She] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Li, Shaojie] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing 100080, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; China Agricultural University; National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Institute of Microbiology, CAS	Liu, Y (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, ND13-214A,5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Yi.Liu@UTsouthwestern.edu		Yang, Qiuying/0000-0002-9168-7842	National Institutes of Health [GM084283]; Welch Foundation [I-1560]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118118, R01GM084283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (GM084283) and the Welch Foundation (I-1560) (to Y. L.).	Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Catalanotto C, 2006, FEMS MICROBIOL LETT, V254, P182, DOI 10.1111/j.1574-6968.2005.00037.x; Cecere G, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-44; Chang SS, 2012, ANNU REV MICROBIOL, V66, P305, DOI 10.1146/annurev-micro-092611-150138; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Choudhary S, 2007, MOL CELL BIOL, V27, P3995, DOI 10.1128/MCB.00186-07; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1996, EMBO J, V15, P3153, DOI 10.1002/j.1460-2075.1996.tb00678.x; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Fillingham J, 2008, MOL CELL BIOL, V28, P4342, DOI 10.1128/MCB.00182-08; Francia S, 2012, NATURE, V488, P231, DOI 10.1038/nature11179; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Hsieh J, 2000, ANNU REV GENET, V34, P187, DOI 10.1146/annurev.genet.34.1.187; Ishibashi K, 2006, P NATL ACAD SCI USA, V103, P14871, DOI 10.1073/pnas.0604477103; Kaplan T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000270; Lee HC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000496; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; Li LD, 2010, CELL MOL LIFE SCI, V67, P3849, DOI 10.1007/s00018-010-0471-y; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Luo CH, 1998, EMBO J, V17, P1228, DOI 10.1093/emboj/17.5.1228; Maiti M, 2007, GENE DEV, V21, P590, DOI 10.1101/gad.1497607; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Michalik KM, 2012, NUCLEIC ACIDS RES, V40, P9596, DOI 10.1093/nar/gks711; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; Nolan T, 2008, NUCLEIC ACIDS RES, V36, P532, DOI 10.1093/nar/gkm1071; ROMANO N, 1992, MOL MICROBIOL, V6, P3343, DOI 10.1111/j.1365-2958.1992.tb02202.x; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Siomi MC, 2008, FEBS LETT, V582, P2473, DOI 10.1016/j.febslet.2008.06.018; Tang Y, 2008, NAT STRUCT MOL BIOL, V15, P738, DOI 10.1038/nsmb.1448; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Wang XY, 2010, GENE DEV, V24, P2566, DOI 10.1101/gad.1970910; Watanabe S, 2013, SCIENCE, V340, P195, DOI 10.1126/science.1229758; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Zhang ZY, 2013, GENE DEV, V27, P145, DOI 10.1101/gad.209494.112	42	13	12	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9365	9371		10.1074/jbc.M113.528521	http://dx.doi.org/10.1074/jbc.M113.528521			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24554705	Green Published, hybrid			2022-12-28	WOS:000333472100052
J	Loo, TW; Clarke, DM				Loo, Tip W.; Clarke, David M.			Identification of the Distance between the Homologous Halves of P-glycoprotein That Triggers the High/Low ATPase Activity Switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Drug Resistance; Membrane Enzymes; Membrane Proteins; Protein Cross-linking	NUCLEOTIDE-BINDING DOMAINS; ACUTE MYELOID-LEUKEMIA; BLOOD-BRAIN-BARRIER; DRUG-BINDING; MULTIDRUG-RESISTANCE; ABC TRANSPORTER; CROSS-LINKING; TRANSMEMBRANE SEGMENT-11; HYDROLYSIS; SITES	Background: The mechanism for activation of P-glycoprotein ATPase activity during its reaction cycle is unknown. Results: Cross-linking the homologous halves within 6-19 highly activated ATPase activity but cross-linking >20 did not. Conclusion: ATPase activation switch is turned on when halves clamped at less than 20 . Significance: A key conformational switch in the P-gp reaction cycle is identified. P-glycoprotein (P-gp, ABCB1) is an ATP-binding cassette drug pump that protects us from toxic compounds and confers multidrug resistance. Each homologous half contains a transmembrane domain with six transmembrane segments followed by a nucleotide-binding domain (NBD). The drug- and ATP-binding sites reside at the interface between the transmembrane domain and NBDs, respectively. Drug binding activates ATPase activity by an unknown mechanism. There is no high resolution structure of human P-gp, but homology models based on the crystal structures of bacterial, mouse, and Caenorhabditis elegans ATP-binding cassette drug pumps yield both open (NBDs apart) and closed (NBDs together) conformations. Molecular dynamics simulations predict that the NBDs can be separated over a range of distances (over 20 ). To determine the distance that show high or low ATPase activity, we cross-linked reporter cysteines L175C (N-half) and N820C (C-half) with cross-linkers of various lengths that separated the halves between 6 and 30 (-carbons). We observed that ATPase activity increased over 10-fold when the cysteines were cross-linked at distances between 6 and 19 , although cross-linking at distances greater than 20 yielded basal levels of activity. The results suggest that the ATPase activation switch appears to be turned on or off when L175C/N820 are clamped at distances less than or greater than 20 , respectively. We predict that the high/low ATPase activity switch may occur at a distance where the NBDs are predicted in molecular dynamic simulations to undergo pronounced twisting as they approach each other (Wise, J. G. (2012) Biochemistry 51, 5125-5141).	[Clarke, David M.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Clarke, DM (corresponding author), Univ Toronto, Dept Med, 1 Kings Coll Circle,Rm 7342,Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	david.clarke@utoronto.ca	Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research (to D. M. C.).	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 1997, J BIOL CHEM, V272, P21160, DOI 10.1074/jbc.272.34.21160; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Chan Helen S L, 2005, Ophthalmol Clin North Am, V18, P55, DOI 10.1016/j.ohc.2004.11.002; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; Cooper RS, 2013, J BIOL CHEM, V288, P20785, DOI 10.1074/jbc.M113.477976; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Delannoy S, 2005, BIOCHEMISTRY-US, V44, P14010, DOI 10.1021/bi0512445; DeLano W.L, PYMOL MOL GRAPHICS S; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; Eckford PDW, 2009, CHEM REV, V109, P2989, DOI 10.1021/cr9000226; Gannon MK, 2009, J MED CHEM, V52, P3328, DOI 10.1021/jm900253g; Globisch C, 2008, CHEMMEDCHEM, V3, P280, DOI 10.1002/cmdc.200700249; Gottesman MM, 2009, NAT BIOTECHNOL, V27, P546, DOI 10.1038/nbt0609-546; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Jones PM, 2013, CRIT REV BIOCHEM MOL, V48, P39, DOI 10.3109/10409238.2012.735644; Jones PM, 2012, J PHYS CHEM A, V116, P3004, DOI 10.1021/jp211139s; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Karaszi E, 2001, BRIT J HAEMATOL, V112, P308, DOI 10.1046/j.1365-2141.2001.02554.x; Kim RB, 1998, J CLIN INVEST, V101, P289, DOI 10.1172/JCI1269; Lee JY, 2002, J BIOL CHEM, V277, P40125, DOI 10.1074/jbc.M206871200; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Loo TW, 2008, J BIOL CHEM, V283, P28190, DOI 10.1074/jbc.M805834200; Loo TW, 2008, J BIOL CHEM, V283, P24860, DOI 10.1074/jbc.M803351200; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Loo TW, 2006, BIOCHEM J, V396, P537, DOI 10.1042/BJ20060012; Loo TW, 2014, J BIOL CHEM, V289, P229, DOI 10.1074/jbc.M113.527804; Loo TW, 2013, J BIOL CHEM, V288, P20326, DOI 10.1074/jbc.M113.484550; Loo TW, 2012, J BIOL CHEM, V287, P26806, DOI 10.1074/jbc.M112.376202; Loo TW, 2010, BIOCHEM BIOPH RES CO, V395, P436, DOI 10.1016/j.bbrc.2010.04.057; Loo TW, 2009, J BIOL CHEM, V284, P24074, DOI 10.1074/jbc.M109.023267; Loo TW, 2003, J BIOL CHEM, V278, P39706, DOI 10.1074/jbc.M308559200; Loo TW, 2003, J BIOL CHEM, V278, P1575, DOI 10.1074/jbc.M211307200; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Loo TW, 2004, J BIOL CHEM, V279, P18232, DOI 10.1074/jbc.M400229200; Loo TW, 2004, J BIOL CHEM, V279, P7692, DOI 10.1074/jbc.M311825200; Loo TW, 2003, J BIOL CHEM, V278, P50136, DOI 10.1074/jbc.M310448200; Loo TW, 1999, J BIOL CHEM, V274, P35388, DOI 10.1074/jbc.274.50.35388; Loo TW, 2002, J BIOL CHEM, V277, P44332, DOI 10.1074/jbc.M208433200; Loo TW, 2002, P NATL ACAD SCI USA, V99, P3511, DOI 10.1073/pnas.022049799; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; Loo TW, 2001, J BIOL CHEM, V276, P31800, DOI 10.1074/jbc.M103498200; LOO TW, 1995, J BIOL CHEM, V270, P21449, DOI 10.1074/jbc.270.37.21449; Loo TW, 2001, J BIOL CHEM, V276, P14972, DOI 10.1074/jbc.M100407200; LOO TW, 1995, J BIOL CHEM, V270, P21839, DOI 10.1074/jbc.270.37.21839; LOO TW, 1995, J BIOL CHEM, V270, P22957, DOI 10.1074/jbc.270.39.22957; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P643, DOI 10.1021/bi0485326; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P14020, DOI 10.1021/bi0511179; Mazzolini M, 2008, EUR BIOPHYS J BIOPHY, V37, P947, DOI 10.1007/s00249-008-0312-1; Miller DS, 2008, PHARMACOL REV, V60, P196, DOI 10.1124/pr.107.07109; Omote H, 2002, J BIOL CHEM, V277, P45688, DOI 10.1074/jbc.M206479200; Pallis M, 2004, LEUKEMIA, V18, P1927, DOI 10.1038/sj.leu.2403511; Qu Q, 2003, BIOCHEMISTRY-US, V42, P1345, DOI 10.1021/bi0267745; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Sharom FJ, 2006, BIOCHEM CELL BIOL, V84, P979, DOI 10.1139/O06-199; Siarheyeva A, 2010, J BIOL CHEM, V285, P7575, DOI 10.1074/jbc.M109.047290; Smirnova I, 2007, P NATL ACAD SCI USA, V104, P16504, DOI 10.1073/pnas.0708258104; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; van der Holt B, 2005, BLOOD, V106, P2646, DOI 10.1182/blood-2005-04-1395; Verhalen B, 2011, J BIOL CHEM, V286, P10476, DOI 10.1074/jbc.M110.193151; Wen PC, 2013, J BIOL CHEM, V288, P19211, DOI 10.1074/jbc.M113.450114; Wise JG, 2012, BIOCHEMISTRY-US, V51, P5125, DOI 10.1021/bi300299z; Zhou YG, 2008, P NATL ACAD SCI USA, V105, P3774, DOI 10.1073/pnas.0800825105; Zoghbi ME, 2012, J BIOL CHEM, V287, P14994, DOI 10.1074/jbc.M112.340281; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	69	19	19	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8484	8492		10.1074/jbc.M114.552075	http://dx.doi.org/10.1074/jbc.M114.552075			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24523403	Green Published, hybrid			2022-12-28	WOS:000333157500040
J	Ma, J; Tang, XY; Wong, PK; Jacobs, B; Borden, EC; Bedogni, B				Ma, Jun; Tang, Xiaoying; Wong, Poki; Jacobs, Barbara; Borden, Ernest C.; Bedogni, Barbara			Noncanonical Activation of Notch1 Protein by Membrane Type 1 Matrix Metalloproteinase (MT1-MMP) Controls Melanoma Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Proliferation; Matrix Metalloproteinase (MMP); Melanoma; Notch Receptor; Protein-Protein Interactions	TUMOR-CELLS; DROSOPHILA; PROGRESSION; MIGRATION; CLEAVES; GROWTH; DIFFERENTIATION; MELANOCYTES; INHIBITION; EXPRESSION	Background: Notch1 is highly activated in melanoma where it plays protumorigenic functions, yet no Notch1-activating mutations have been identified in melanoma. Results: MT1-MMP operates as a novel protease that promotes Notch1 activation in melanoma cells. Conclusion: An MT1-MMP/Notch1 signaling pathway supports melanoma cell growth. Significance: Notch1 emerges as a new MT1-MMP substrate that plays important biological roles in melanoma. Notch1 is an evolutionarily conserved signaling molecule required for stem cell maintenance that is inappropriately reactivated in several cancers. We have previously shown that melanomas reactivate Notch1 and require its function for growth and survival. However, no Notch1-activating mutations have been observed in melanoma, suggesting the involvement of other activating mechanisms. Notch1 activation requires two cleavage steps: first by a protease and then by -secretase, which releases the active intracellular domain (Notch1(NIC)). Interestingly, although ADAM10 and -17 are generally accepted as the proteases responsible of Notch1 cleavage, here we show that MT1-MMP, a membrane-tethered matrix metalloproteinase involved in the pathogenesis of a number of tumors, is a novel protease required for the cleavage of Notch1 in melanoma cells. We find that active Notch1 and MT1-MMP expression correlate significantly in over 70% of melanoma tumors and 80% of melanoma cell lines, whereas such correlation does not exist between Notch1(NIC) and ADAM10 or -17. Modulation of MT1-MMP expression in melanoma cells affects Notch1 cleavage, whereas MT1-MMP expression in ADAM10/17 double knock-out fibroblasts restores the processing of Notch1, indicating that MT1-MMP is sufficient to promote Notch1 activation independently of the canonical proteases. Importantly, we find that MT1-MMP interacts with Notch1 at the cell membrane, supporting a potential direct cleavage mechanism of MT1-MMP on Notch1, and that MT1-MMP-dependent activation of Notch1 sustains melanoma cell growth. Together, the data highlight a novel mechanism of activation of Notch1 in melanoma cells and identify Notch1 as a new MT1-MMP substrate that plays important biological roles in melanoma.	[Ma, Jun; Tang, Xiaoying; Wong, Poki; Bedogni, Barbara] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Jacobs, Barbara; Borden, Ernest C.] Cleveland Clin Fdn, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation	Bedogni, B (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Wood Bldg,Rm RT400-8,10900 Euclid Ave, Cleveland, OH 44106 USA.	barbara.bedogni@case.edu			Harry Lloyd Charitable Trust	Harry Lloyd Charitable Trust	This work was supported by funding from the Harry Lloyd Charitable Trust.	Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Bedogni B, 2008, J CLIN INVEST, V118, P3660, DOI 10.1172/JCI36157; Bozkulak EC, 2009, MOL CELL BIOL, V29, P5679, DOI 10.1128/MCB.00406-09; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Buas MF, 2009, J CELL PHYSIOL, V218, P84, DOI 10.1002/jcp.21571; Ferrando Adolfo A, 2009, Hematology Am Soc Hematol Educ Program, P353, DOI 10.1182/asheducation-2009.1.353; Golubkov VS, 2011, J BIOL CHEM, V286, P20970, DOI 10.1074/jbc.M111.237669; Golubkov VS, 2010, J BIOL CHEM, V285, P35740, DOI 10.1074/jbc.M110.165159; Gordon WR, 2008, J CELL SCI, V121, P3109, DOI 10.1242/jcs.035683; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Harrison M, 2004, DEV DYNAM, V231, P214, DOI 10.1002/dvdy.20113; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Herzog C, 2007, NIH PUBLICATION, V06-5767, P53; Hofmann UB, 2000, J INVEST DERMATOL, V115, P337, DOI 10.1046/j.1523-1747.2000.00068.x; Hofmann UB, 2000, J PATHOL, V191, P245; Howlader N, 2011, SEER CANC STAT REV 1; Jin GX, 2011, EMBO J, V30, P2281, DOI 10.1038/emboj.2011.136; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Koshikawa N, 2010, CANCER RES, V70, P6093, DOI 10.1158/0008-5472.CAN-10-0346; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Miele L, 2006, CURR CANCER DRUG TAR, V6, P313, DOI 10.2174/156800906777441771; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Nishimura M, 1998, GENOMICS, V49, P69, DOI 10.1006/geno.1998.5213; OKADA A, 1995, P NATL ACAD SCI USA, V92, P2730, DOI 10.1073/pnas.92.7.2730; Osawa M, 2008, J INVEST DERMATOL, V128, P2571, DOI 10.1038/jid.2008.289; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Pinnix CC, 2009, CANCER RES, V69, P5312, DOI 10.1158/0008-5472.CAN-08-3767; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Postovit LM, 2007, J CELL BIOCHEM, V101, P908, DOI 10.1002/jcb.21227; Proweller A, 2005, J BIOL CHEM, V280, P8994, DOI 10.1074/jbc.M413316200; Razorenova O V, 2005, Mol Biol (Mosk), V39, P286; Sabbota AL, 2010, CANCER RES, V70, P5558, DOI 10.1158/0008-5472.CAN-09-4416; Sato H, 2005, CANCER SCI, V96, P212, DOI 10.1111/j.1349-7006.2005.00039.x; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sotillos S, 1997, DEVELOPMENT, V124, P4769; Strizzi L, 2009, CANCER RES, V69, P7131, DOI 10.1158/0008-5472.CAN-09-1199; Sulis ML, 2011, LEUKEMIA, V25, P1564, DOI 10.1038/leu.2011.130; Tomlinson ML, 2009, CHEM BIOL, V16, P93, DOI 10.1016/j.chembiol.2008.12.005; van Tetering G, 2009, J BIOL CHEM, V284, P31018, DOI 10.1074/jbc.M109.006775; Wen CH, 1997, DEVELOPMENT, V124, P4759; Zhang K, 2012, ONCOGENE, V31, P4609, DOI 10.1038/onc.2011.606	43	26	27	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8442	8449		10.1074/jbc.M113.516039	http://dx.doi.org/10.1074/jbc.M113.516039			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24492617	Green Published, hybrid			2022-12-28	WOS:000333157500036
J	Vicente, JB; Colaco, HG; Mendes, MIS; Sarti, P; Leandro, P; Giuffre, A				Vicente, Joao B.; Colaco, Henrique G.; Mendes, Marisa I. S.; Sarti, Paolo; Leandro, Paula; Giuffre, Alessandro			NO(center dot)Binds Human Cystathionine beta- Synthase Quickly and Tightly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Enzyme Kinetics; Heme; Hydrogen Sulfide; Redox Regulation	NITRIC-OXIDE; CARBON-MONOXIDE; HYDROGEN-SULFIDE; RESONANCE RAMAN; CYTOCHROME C'; NO BINDING; HEME; CO; REACTIVITY; PROTEIN	Background: The H2S-generating human enzyme cystathionine -synthase (CBS) is inhibited by NO center dot and CO. Results: NO center dot binds to the ferrous heme in human CBS much more quickly than CO and much more tightly than currently thought. Conclusion: Results support the physiological role of NO center dot in CBS regulation. Significance: CBS may integrate the cross-talk among NO center dot, CO, and H2S, major modulators in human (patho)physiology. The hexa-coordinate heme in the H2S-generating human enzyme cystathionine -synthase (CBS) acts as a redox-sensitive regulator that impairs CBS activity upon binding of NO center dot or CO at the reduced iron. Despite the proposed physiological relevance of this inhibitory mechanism, unlike CO, NO center dot was reported to bind at the CBS heme with very low affinity (K-d = 30-281 m). This discrepancy was herein reconciled by investigating the NO center dot reactivity of recombinant human CBS by static and stopped-flow UV-visible absorption spectroscopy. We found that NO center dot binds tightly to the ferrous CBS heme, with an apparent K-d 0.23 m. In line with this result, at 25 degrees C, NO center dot binds quickly to CBS (k(on) approximate to 8 x 10(3) m(-1) s(-1)) and dissociates slowly from the enzyme (k(off) approximate to 0.003 s(-1)). The observed rate constants for NO center dot binding were found to be linearly dependent on [NO center dot] up to approximate to 800 m NO center dot, and >100-fold higher than those measured for CO, indicating that the reaction is not limited by the slow dissociation of Cys-52 from the heme iron, as reported for CO. For the first time the heme of human CBS is reported to bind NO center dot quickly and tightly, providing a mechanistic basis for the in vivo regulation of the enzyme by NO center dot. The novel findings reported here shed new light on CBS regulation by NO center dot and its possible (patho)physiological relevance, enforcing the growing evidence for an interplay among the gasotransmitters NO center dot, CO, and H2S in cell signaling.	[Vicente, Joao B.; Colaco, Henrique G.; Mendes, Marisa I. S.; Leandro, Paula] Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci iMed UL, Metab & Genet Grp, P-1649003 Lisbon, Portugal; [Vicente, Joao B.; Leandro, Paula] Univ Lisbon, Fac Pharm, Dept Biochem & Human Biol, P-1649003 Lisbon, Portugal; [Sarti, Paolo] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; [Sarti, Paolo] Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Sarti, Paolo; Giuffre, Alessandro] CNR, Inst Mol Biol & Pathol, I-00185 Rome, Italy	Universidade de Lisboa; Universidade de Lisboa; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Giuffre, A (corresponding author), Univ Roma La Sapienza, Dipartimento Sci Biochim, CNR, Ist Biol & Patol Mol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	alessandro.giuffre@uniroma1.it	Leandro, Paula/A-8323-2014; Vicente, Joao B/L-8732-2016; Vicente, João B/B-9623-2014; iMed.ULisboa, MetGen/B-5293-2014; Colaço, Henrique G/M-5790-2014; Colaço, Henrique/AAV-2243-2020; Giuffrè, Alessandro/K-4341-2015	Leandro, Paula/0000-0002-2946-9342; Vicente, João B/0000-0003-3919-8280; Colaço, Henrique G/0000-0002-2026-0163; Giuffrè, Alessandro/0000-0001-5301-0681; Sarti, Paolo/0000-0002-8219-4827; Vicente, Joao/0000-0001-5244-8059	Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy; FIRB [RBFR08F41U_001, RBIN06E9Z8]; PRIN [20107Z8XBW_005]; Consiglio Nazionale delle Ricerche of Italy; Fundacao para a Ciencia e Tecnologia of Portugal;  [PEst-OE/SAU/UI4013/2011];  [SFRH/BD/43934/2008]	Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy(Ministry of Education, Universities and Research (MIUR)); FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Consiglio Nazionale delle Ricerche of Italy(Consiglio Nazionale delle Ricerche (CNR)); Fundacao para a Ciencia e Tecnologia of Portugal(Portuguese Foundation for Science and Technology); ; 	This work was supported in part by PEst-OE/SAU/UI4013/2011, SFRH/BD/43934/2008 (to M. I. S. M.), by Ministero dell'Istruzione, dell'Universita e della Ricerca of Italy (PNR-CNR Aging Program 2012-2014 and FIRB RBFR08F41U_001 (to A. G.), FIRB RBIN06E9Z8 and PRIN 20107Z8XBW_ 005 (to P. S.)), and by a bilateral grant award by Consiglio Nazionale delle Ricerche of Italy and Fundacao para a Ciencia e Tecnologia of Portugal (to A. G. and J. B. V.).	Andrew CR, 2001, BIOCHEMISTRY-US, V40, P4115, DOI 10.1021/bi0023652; Antonyuk SV, 2011, P NATL ACAD SCI USA, V108, P15780, DOI 10.1073/pnas.1109051108; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; Carballal S, 2008, BIOCHEMISTRY-US, V47, P3194, DOI 10.1021/bi700912k; Carballal S, 2013, BIOCHEMISTRY-US, V52, P4553, DOI 10.1021/bi4004556; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; DIXON M, 1971, BIOCHIM BIOPHYS ACTA, V226, P241, DOI 10.1016/0005-2728(71)90092-2; Garton EM, 2012, J AM CHEM SOC, V134, P1461, DOI 10.1021/ja209770p; Gherasim C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085544; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; Igarashi J, 2004, J BIOL CHEM, V279, P15752, DOI 10.1074/jbc.M310273200; Kabil O, 2014, ANTIOXID REDOX SIGN, V20, P770, DOI 10.1089/ars.2013.5339; Kabil O, 2011, BIOCHEMISTRY-US, V50, P8261, DOI 10.1021/bi201270q; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kajimura M, 2010, ANTIOXID REDOX SIGN, V13, P157, DOI 10.1089/ars.2009.2657; Kakar S, 2010, BIOPHYS CHEM, V152, P1, DOI 10.1016/j.bpc.2010.08.008; Koutmos M, 2010, P NATL ACAD SCI USA, V107, P20958, DOI 10.1073/pnas.1011448107; Kwiatkoski M, 2012, NEUROSCIENCE, V201, P146, DOI 10.1016/j.neuroscience.2011.11.030; Lawson DM, 2000, EMBO J, V19, P5661, DOI 10.1093/emboj/19.21.5661; Li L, 2009, PHARMACOL THERAPEUT, V123, P386, DOI 10.1016/j.pharmthera.2009.05.005; Martin E, 2012, BIOCHEMISTRY-US, V51, P2737, DOI 10.1021/bi300105s; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; Mendes M. I., 2014, J INHERIT METAB DIS, DOI 10.1007/s10545-013-9647-6; MOORE EG, 1976, J BIOL CHEM, V251, P2788; Morikawa T, 2012, P NATL ACAD SCI USA, V109, P1293, DOI 10.1073/pnas.1119658109; Ojha S, 2000, BIOCHEMISTRY-US, V39, P10542, DOI 10.1021/bi000831h; Pey AL, 2013, BIOCHEM J, V449, P109, DOI 10.1042/BJ20120731; Prathapasinghe GA, 2008, AM J PHYSIOL-RENAL, V295, pF912, DOI 10.1152/ajprenal.00040.2008; Puranik M, 2006, J BIOL CHEM, V281, P13433, DOI 10.1074/jbc.M600246200; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Singh S, 2009, J INORG BIOCHEM, V103, P689, DOI 10.1016/j.jinorgbio.2009.01.009; Smith AT, 2012, BIOCHEMISTRY-US, V51, P6360, DOI 10.1021/bi300421z; Snyder S. H., 2009, SCI SIGNAL, V2; Stubauer G, 1998, BIOCHEM BIOPH RES CO, V245, P459, DOI 10.1006/bbrc.1998.8457; Su Y, 2013, BIOCHEMISTRY-US, V52, P741, DOI 10.1021/bi300615c; TANG XY, 2013, PLOS ONE, V8; Taoka S, 1999, BIOCHEMISTRY-US, V38, P2738, DOI 10.1021/bi9826052; Taoka S, 2002, BIOCHEMISTRY-US, V41, P10454, DOI 10.1021/bi026052d; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; Tsai AL, 2012, ANTIOXID REDOX SIGN, V17, P1246, DOI 10.1089/ars.2012.4564; Tsai AL, 2012, BIOCHEMISTRY-US, V51, P172, DOI 10.1021/bi2015629; Weeks CL, 2009, J AM CHEM SOC, V131, P12809, DOI 10.1021/ja904468w; Yadav PK, 2013, J BIOL CHEM, V288, P20002, DOI 10.1074/jbc.M113.466177	43	50	51	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8579	8587		10.1074/jbc.M113.507533	http://dx.doi.org/10.1074/jbc.M113.507533			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24515102	hybrid, Green Published			2022-12-28	WOS:000333157500048
J	Tanimizu, N; Nishikawa, Y; Ichinohe, N; Akiyama, H; Mitaka, T				Tanimizu, Naoki; Nishikawa, Yuji; Ichinohe, Norihisa; Akiyama, Haruhiko; Mitaka, Toshihiro			Sry HMG Box Protein 9-positive (Sox9(+)) Epithelial Cell Adhesion Molecule-negative (EpCAM(-)) Biphenotypic Cells Derived from Hepatocytes Are Involved in Mouse Liver Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Differentiation; Cell Polarity; Hepatocyte; Liver; Regeneration; Biphenotypic Cells; Ductular Reaction; Liver Stem; Progenitor Cells	PROGENITOR CELLS; STEM-CELLS; BILIARY TREE; MORPHOGENESIS; HEPATOBLASTS; EXPRESSION; DEVELOP; FATE	Background: Biphenotypic hepatocytes expressing Sox9 emerge upon liver injuries associated with ductular reaction. Results: Sox9(+) biphenotypic hepatocytes are derived from mature hepatocytes (MHs). Some of them are incorporated into ductular structures, whereas they efficiently differentiate to functional hepatocytes. Conclusion: Biphenotypic hepatocytes not only terminally convert to cholangiocytes but also differentiate back to MHs. Significance: Mature epithelial cells can show plasticity upon severe injuries and contribute to regeneration. It has been shown that mature hepatocytes compensate tissue damages not only by proliferation and/or hypertrophy but also by conversion into cholangiocyte-like cells. We found that Sry HMG box protein 9-positive (Sox9(+)) epithelial cell adhesion molecule-negative (EpCAM(-)) hepatocyte nuclear factor 4-positive (HNF4(+)) biphenotypic cells showing hepatocytic morphology appeared near EpCAM(+) ductular structures in the livers of mice fed 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)-containing diet. When Mx1-Cre:ROSA mice, which were injected with poly(I:C) to label mature hepatocytes, were fed with the DDC diet, we found LacZ(+)Sox9(+) cells near ductular structures. Although Sox9(+)EpCAM(-) cells adjacent to expanding ducts likely further converted into ductular cells, the incidence was rare. To know the cellular characteristics of Sox9(+)EpCAM(-) cells, we isolated them as GFP(+)EpCAM(-) cells from DDC-injured livers of Sox9-EGFP mice. Sox9(+)EpCAM(-) cells proliferated and could differentiate to functional hepatocytes in vitro. In addition, Sox9(+)EpCAM(-) cells formed cysts with a small central lumen in collagen gels containing Matrigel (R) without expressing EpCAM. These results suggest that Sox9(+)EpCAM(-) cells maintaining biphenotypic status can establish cholangiocyte-type polarity. Interestingly, we found that some of the Sox9(+) cells surrounded luminal spaces in DDC-injured liver while they expressed HNF4. Taken together, we consider that in addition to converting to cholangiocyte-like cells, Sox9(+)EpCAM(-) cells provide luminal space near expanded ductular structures to prevent deterioration of the injuries and potentially supply new hepatocytes to repair damaged tissues.	[Tanimizu, Naoki; Ichinohe, Norihisa; Mitaka, Toshihiro] Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Tissue Develop & Regenerat, Sapporo, Hokkaido 0608556, Japan; [Nishikawa, Yuji] Asahikawa Med Univ, Dept Pathol, Div Tumor Pathol, Asahikawa, Hokkaido 0788510, Japan; [Akiyama, Haruhiko] Kyoto Univ, Sch Med, Dept Orthoped Surg, Kyoto 6068501, Japan	Sapporo Medical University; Asahikawa Medical College; Kyoto University	Tanimizu, N (corresponding author), Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Tissue Develop & Regenerat,Chuo Ku, S-1,W-17, Sapporo, Hokkaido 0608556, Japan.	tanimizu@sapmed.ac.jp	Mitaka, Toshihiro/K-9424-2013	Mitaka, Toshihiro/0000-0001-9467-4871; Ichinohe, Norihisa/0000-0003-3723-7418	Ministry of Education, Culture, Sports, Science and Technology, Japan [22790386, 25460271, 21390365, 24390304]; Grants-in-Aid for Scientific Research [25282135, 25293289] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Young Scientists (B) and for Scientific Research (C) 22790386 and 25460271 (to N. T.) and Grants-in-Aid for Scientific Research (B) 21390365 and 24390304 (to T. M.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Antoniou A, 2009, GASTROENTEROLOGY, V136, P2325, DOI 10.1053/j.gastro.2009.02.051; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Cardinale V, 2012, NAT REV GASTRO HEPAT, V9, P231, DOI 10.1038/nrgastro.2012.23; Cardinale V, 2011, HEPATOLOGY, V54, P2159, DOI 10.1002/hep.24590; Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; Espanol-Suner R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024; Fan B, 2012, J CLIN INVEST, V122, P2911, DOI 10.1172/JCI63212; Fu D, 2011, P NATL ACAD SCI USA, V108, P1403, DOI 10.1073/pnas.1018376108; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Ishikawa T, 2012, HEPATOLOGY, V55, P1215, DOI 10.1002/hep.24796; Jeliazkova P, 2013, HEPATOLOGY, V57, P2469, DOI 10.1002/hep.26254; Kamiya A, 2009, GASTROENTEROLOGY, V137, P1114, DOI 10.1053/j.gastro.2009.06.001; Kawelke N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028181; Malato Y, 2011, J CLIN INVEST, V121, P4850, DOI 10.1172/JCI59261; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Miyaoka Y, 2012, CURR BIOL, V22, P1166, DOI 10.1016/j.cub.2012.05.016; Nejak-Bowen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059836; Nel-Themaat L, 2009, DEV DYNAM, V238, P1100, DOI 10.1002/dvdy.21954; Nishikawa Y, 2005, AM J PATHOL, V166, P1077, DOI 10.1016/S0002-9440(10)62328-0; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Senga K, 2012, MOL BIOL CELL, V23, P2845, DOI 10.1091/mbc.E12-02-0097; Sharma N, 2006, J CELL BIOL, V173, P937, DOI 10.1083/jcb.200603132; Shin S, 2011, GENE DEV, V25, P1185, DOI 10.1101/gad.2027811; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Suzuki A, 2008, HEPATOLOGY, V48, P1964, DOI 10.1002/hep.22558; Takase HM, 2013, GENE DEV, V27, P169, DOI 10.1101/gad.204776.112; Tanaka M, 2011, J BIOCHEM, V149, P231, DOI 10.1093/jb/mvr001; Tanimizu N, 2003, J CELL SCI, V116, P1775, DOI 10.1242/jcs.00388; Tanimizu N, 2007, MOL BIOL CELL, V18, P1472, DOI 10.1091/mbc.E06-09-0848; Thompson MD, 2010, AM J PATHOL, V177, P1812, DOI 10.2353/ajpath.2010.100173; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	35	67	71	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7589	7598		10.1074/jbc.M113.517243	http://dx.doi.org/10.1074/jbc.M113.517243			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24482234	hybrid, Green Published			2022-12-28	WOS:000332761500029
J	Mantilidewi, KI; Murata, Y; Mori, M; Otsubo, C; Kotani, T; Kusakari, S; Ohnishi, H; Matozaki, T				Mantilidewi, Kemala Isnainiasih; Murata, Yoji; Mori, Munemasa; Otsubo, Chihiro; Kotani, Takenori; Kusakari, Shinya; Ohnishi, Hiroshi; Matozaki, Takashi			Shear Stress-induced Redistribution of Vascular Endothelial-Protein-tyrosine Phosphatase (VE-PTP) in Endothelial Cells and Its Role in Cell Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endothelial Cell; Membrane Proteins; Shear Stress; Small GTPases; Protein-tyrosine Phosphatase (Tyrosine Phosphatase)	VEGFR2 ACTIVITY; CDC42; INTEGRINS; ACTIVATION; MIGRATION; RESPONSES; GTPASES; RHO; PHOSPHORYLATION; REORGANIZATION	Background: Mechanical stimuli such as shear stress regulate endothelial cell (EC) function. Results: Shear stress induced a rapid redistribution of the protein-tyrosine phosphatase VE-PTP in ECs, and knockdown of VE-PTP prevented shear stress-induced EC elongation. Conclusion: VE-PTP is important for shear stress-induced changes in EC morphology. Significance: VE-PTP is implicated in regulation of EC function by shear stress. Vascular endothelial cells (ECs) are continuously exposed to shear stress (SS) generated by blood flow. Such stress plays a key role in regulation of various aspects of EC function including cell proliferation and motility as well as changes in cell morphology. Vascular endothelial-protein-tyrosine phosphatase (VE-PTP) is an R3-subtype PTP that possesses multiple fibronectin type III-like domains in its extracellular region and is expressed specifically in ECs. The role of VE-PTP in EC responses to SS has remained unknown, however. Here we show that VE-PTP is diffusely localized in ECs maintained under static culture conditions, whereas it undergoes rapid accumulation at the downstream edge of the cells relative to the direction of flow in response to SS. This redistribution of VE-PTP triggered by SS was found to require its extracellular and transmembrane regions and was promoted by integrin engagement of extracellular matrix ligands. Inhibition of actin polymerization or of Cdc42, Rab5, or Arf6 activities attenuated the SS-induced redistribution of VE-PTP. VE-PTP also underwent endocytosis in the static and SS conditions. SS induced the polarized distribution of internalized VE-PTP. Such an effect was promoted by integrin engagement of fibronectin but prevented by inhibition of Cdc42 activity or of actin polymerization. In addition, depletion of VE-PTP by RNA interference in human umbilical vein ECs blocked cell elongation in the direction of flow induced by SS. Our results suggest that the polarized redistribution of VE-PTP in response to SS plays an important role in the regulation of EC function by blood flow.	[Mantilidewi, Kemala Isnainiasih; Murata, Yoji; Otsubo, Chihiro; Kotani, Takenori; Matozaki, Takashi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Signaling,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Mori, Munemasa; Kusakari, Shinya; Matozaki, Takashi] Gunma Univ, Inst Mol & Cellular Regulat, Lab Biosignal Sci, Maebashi, Gunma 3718512, Japan; [Ohnishi, Hiroshi] Gunma Univ, Grad Sch Hlth Sci, Dept Lab Sci, Maebashi, Gunma 3718514, Japan	Kobe University; Gunma University; Gunma University	Murata, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Signaling,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	ymurata@med.kobe-u.ac.jp; matozaki@med.kobe-u.ac.jp		Murata, Yoji/0000-0002-9576-7030; Mori, Munemasa/0000-0002-7283-7198; Kotani, Takenori/0000-0001-8571-4210; Mantilidewi, Kemala/0000-0003-4588-8018	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for Scientific Research (B) and (C), a grant-in-aid for Scientific Research on Innovative Areas, and a grant to the Global Center of Excellence Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; ANDO J, 1993, BIOCHEM BIOPH RES CO, V190, P716, DOI 10.1006/bbrc.1993.1108; Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583; Baumer S, 2006, BLOOD, V107, P4754, DOI 10.1182/blood-2006-01-0141; BARBEE KA, 1994, CIRC RES, V74, P163, DOI 10.1161/01.RES.74.1.163; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Davies PF, 1995, J BIOMECH, V28, P1553, DOI 10.1016/0021-9290(95)00102-6; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; Dominguez MG, 2007, P NATL ACAD SCI USA, V104, P3243, DOI 10.1073/pnas.0611510104; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fachinger G, 1999, ONCOGENE, V18, P5948, DOI 10.1038/sj.onc.1202992; Fisslthaler B, 2008, CIRC RES, V102, P1520, DOI 10.1161/CIRCRESAHA.108.172072; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Harris KP, 2010, TRAFFIC, V11, P1272, DOI 10.1111/j.1600-0854.2010.01102.x; Hayashi M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2683; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; KAMIYA A, 1984, B MATH BIOL, V46, P127, DOI 10.1016/S0092-8240(84)80038-5; Kotani T, 2010, J COMP NEUROL, V518, P119, DOI 10.1002/cne.22239; KRUEGER NX, 1990, EMBO J, V9, P3241, DOI 10.1002/j.1460-2075.1990.tb07523.x; Kusakari S, 2008, J CELL SCI, V121, P1213, DOI 10.1242/jcs.025015; Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030; Matozaki T, 2010, CELL SIGNAL, V22, P1811, DOI 10.1016/j.cellsig.2010.07.001; Mellberg S, 2009, FASEB J, V23, P1490, DOI 10.1096/fj.08-123810; Miyake A, 2008, GENES CELLS, V13, P209, DOI 10.1111/j.1365-2443.2007.01161.x; Miyashita M, 2004, MOL BIOL CELL, V15, P3950, DOI 10.1091/mbc.E04-01-0019; Mori M, 2010, J CELL PHYSIOL, V224, P195, DOI 10.1002/jcp.22122; Murata Y, 2010, GENES CELLS, V15, P513, DOI 10.1111/j.1365-2443.2010.01398.x; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406; Orlando K., 2009, COLD SPRING HARB PER, V1; Potter BA, 2006, TRAFFIC, V7, P146, DOI 10.1111/j.1600-0854.2005.00371.x; Sadakata H, 2009, GENES CELLS, V14, P295, DOI 10.1111/j.1365-2443.2008.01270.x; Stamatas GN, 1997, TISSUE ENG, V3, P391, DOI 10.1089/ten.1997.3.391; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tai LK, 2002, ARTERIOSCL THROM VAS, V22, P1790, DOI 10.1161/01.ATV.0000034475.40227.40; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Tzima E, 2002, EMBO J, V21, P6791, DOI 10.1093/emboj/cdf688; Tzima E, 2003, J BIOL CHEM, V278, P31020, DOI 10.1074/jbc.M301179200; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; Wojciak-Stothard B, 2003, J CELL BIOL, V161, P429, DOI 10.1083/jcb.200210135	46	16	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6451	6461		10.1074/jbc.M113.529503	http://dx.doi.org/10.1074/jbc.M113.529503			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24451369	Green Published, hybrid			2022-12-28	WOS:000332389400013
J	Nasirikenari, M; Veillon, L; Collins, CC; Azadi, P; Lau, JTY				Nasirikenari, Mehrab; Veillon, Lucas; Collins, Christine C.; Azadi, Parastoo; Lau, Joseph T. Y.			Remodeling of Marrow Hematopoietic Stem and Progenitor Cells by Non-self ST6Gal-1 Sialyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycosylation; Hematopoiesis; Plasma; Serum; Sialic Acid; Sialyltransferase; Hematopoietic Stem and Progenitor Cells; st6gal1	DROSOPHILA-MELANOGASTER EMBRYO; E-SELECTIN LIGAND; DEATH RECEPTOR; BREAST-CANCER; P1 PROMOTER; INFLAMMATION; SIALYLATION; EXPRESSION; MICE; GLYCOPROTEINS	Background: The circulatory ST6Gal-1 level is inversely related to hematopoietic activity, but the biochemical function of systemic ST6Gal-1 is unknown. Results: Hematopoietic progenitors do not express self-ST6Gal-1 but are acted upon by remotely produced enzyme. Conclusion: Distally produced rather than endogenous ST6Gal-1 is the principal modifier of the early hematopoietic progenitor cell surface. Significance: Extrinsic ST6Gal-1 may be a potent systemic regulator of hematopoiesis. Glycans occupy the critical cell surface interface between hematopoietic cells and their marrow niches. Typically, glycosyltransferases reside within the intracellular secretory apparatus, and each cell autonomously generates its own cell surface glycans. In this study, we report an alternate pathway to generate cell surface glycans where remotely produced glycosyltransferases remodel surfaces of target cells and for which endogenous expression of the cognate enzymes is not required. Our data show that extracellular ST6Gal-1 sialyltransferase, originating mostly from the liver and released into circulation, targets marrow hematopoietic stem and progenitor cells (HSPCs) and mediates the formation of cell surface 2,6-linked sialic acids on HSPCs as assessed by binding to the specific lectins Sambucus nigra agglutinin and Polysporus squamosus lectin and confirmed by mass spectrometry. Marrow HSPCs, operationally defined as the Lin-c-Kit+ and Lin-Sca-1+c-Kit+ populations, express negligible endogenous ST6Gal-1. Animals with reduced circulatory ST6Gal-1 have marrow Lin-Sca-1+c-Kit+ cells with reduced S. nigra agglutinin reactivity. Bone marrow chimeras demonstrated that 2,6-sialylation of HSPCs is profoundly dependent on circulatory ST6Gal-1 status of the recipients and independent of the ability of HSPCs to express endogenous ST6Gal-1. Biologically, HSPC abundance in the marrow is inversely related to circulatory ST6Gal-1 status, and this relationship is recapitulated in the bone marrow chimeras. We propose that remotely produced, rather than the endogenously expressed, ST6Gal-1 is the principal modifier of HSPC glycans for 2,6-sialic acids. In so doing, liver-produced ST6Gal-1 may be a potent systemic regulator of hematopoiesis.	[Nasirikenari, Mehrab; Lau, Joseph T. Y.] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; [Veillon, Lucas; Azadi, Parastoo] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Veillon, Lucas; Azadi, Parastoo] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	Roswell Park Cancer Institute; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Lau, JTY (corresponding author), Roswell Pk Canc Inst, MRC 330,Elm & Carlton Sts, Buffalo, NY 14263 USA.	joseph.lau@roswellpark.org			National Cancer Institute Cancer Center Support Grant [CA15056]; National Institutes of Health/National Center for Research Resources [8P41GM103490]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER	National Cancer Institute Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The core facilities of Roswell Park Cancer Institute used in this work were supported in part by National Cancer Institute Cancer Center Support Grant CA15056. Glycomics analysis was supported by National Institutes of Health/National Center for Research Resources Grant 8P41GM103490 to the Complex Carbohydrate Research Center, University of Georgia.	Anthony RM, 2008, SCIENCE, V320, P373, DOI 10.1126/science.1154315; ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Appenheimer MM, 2003, GLYCOBIOLOGY, V13, P591, DOI 10.1093/glycob/cwg066; Arata-Kawai H, 2011, AM J PATHOL, V178, P423, DOI 10.1016/j.ajpath.2010.11.009; Audry M, 2011, GLYCOBIOLOGY, V21, P716, DOI 10.1093/glycob/cwq189; BERGE PG, 1982, KLIN WOCHENSCHR, V60, P445, DOI 10.1007/BF01720358; Dalziel M, 1999, GLYCOBIOLOGY, V9, P1003, DOI 10.1093/glycob/9.10.1003; DELL A, 1993, GLYCOBIOLOGY PRACTIC, P187; Dimitroff CJ, 2001, J CELL BIOL, V153, P1277, DOI 10.1083/jcb.153.6.1277; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hu YP, 1997, GLYCOCONJUGATE J, V14, P407, DOI 10.1023/A:1018535014976; Hui N, 2001, J HEMATOTH STEM CELL, V10, P661, DOI 10.1089/152581601753193878; Ilarregui JM, 2005, ANN RHEUM DIS, V64, P96, DOI 10.1136/ard.2005.044347; JAMIESON JC, 1987, COMP BIOCHEM PHYS B, V87, P11, DOI 10.1016/0305-0491(87)90463-9; KITAGAWA H, 1994, J BIOL CHEM, V269, P17872; Kobayashi M, 2012, SEMIN IMMUNOPATHOL, V34, P401, DOI 10.1007/s00281-012-0302-3; Liu ZY, 2011, J BIOL CHEM, V286, P39654, DOI 10.1074/jbc.M111.276063; Martin LT, 2002, J BIOL CHEM, V277, P32930, DOI 10.1074/jbc.M203362200; Nasirikenari M, 2006, BLOOD, V108, P3397, DOI 10.1182/blood-2006-04-014779; Nasirikenari M, 2010, J LEUKOCYTE BIOL, V87, P457, DOI 10.1189/jlb.1108704; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Sackstein R, 2008, NAT MED, V14, P181, DOI 10.1038/nm1703; Seales EC, 2005, J BIOL CHEM, V280, P37610, DOI 10.1074/jbc.M508476200; Seppo A, 2000, EUR J BIOCHEM, V267, P3549, DOI 10.1046/j.1432-1327.2000.01383.x; Shi XF, 2009, J BIOL CHEM, V284, P11806, DOI 10.1074/jbc.M809637200; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; Stubke K, 2012, CANCER LETT, V321, P89, DOI 10.1016/j.canlet.2012.02.019; SVENNERHOLM L, 1980, BIOCHIM BIOPHYS ACTA, V617, P97, DOI 10.1016/0005-2760(80)90227-1; Swindall AF, 2013, CANCER RES, V73, P2368, DOI 10.1158/0008-5472.CAN-12-3424; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; Toma V, 2001, HISTOCHEM CELL BIOL, V116, P183; Wandall HH, 2012, BLOOD, V120, P626, DOI 10.1182/blood-2012-02-409235; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184; WANG XC, 1990, J BIOL CHEM, V265, P17849; WEISER MM, 1981, CRC CR REV CL LAB SC, V14, P189, DOI 10.3109/10408368109105864; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Winkler IG, 2012, NAT MED, V18, P1651, DOI 10.1038/nm.2969; Woodard-Grice AV, 2008, J BIOL CHEM, V283, P26364, DOI 10.1074/jbc.M800836200; Yasukawa Z, 2005, GLYCOBIOLOGY, V15, P827, DOI 10.1093/glycob/cwi068; Zen K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001826	41	38	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7178	7189		10.1074/jbc.M113.508457	http://dx.doi.org/10.1074/jbc.M113.508457			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24425878	hybrid, Green Published			2022-12-28	WOS:000332389400076
J	Shi, ZX; Shen, TJ; Liu, YL; Huang, YY; Jiao, JW				Shi, Zixiao; Shen, Tianjin; Liu, Yanli; Huang, Yuanyuan; Jiao, Jianwei			Retinoic Acid Receptor gamma (Rarg) and Nuclear Receptor Subfamily 5, Group A, Member 2 (Nr5a2) Promote Conversion of Fibroblasts to Functional Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adenovirus; Fibroblast; Neurons; Nuclear Receptors; Retinoid	ADENOVIRAL GENE DELIVERY; PLURIPOTENT STEM-CELLS; MOUSE-BRAIN; EXPRESSION; DIFFERENTIATION; INDUCTION; ALPHA	Background: It is necessary to identify more factors to increase fibroblast to neuron conversion with non-integration adenovirus. Results: Nuclear receptor Rarg and Nr5a2 or agonist greatly enhance the conversion efficiency. Conclusion: Rarg and Nr5a2 both promote transdifferentiation and improve neuronal function. Significance: It would be of potential advantage to obtain safe and functional neurons with high efficiency. Somatic cells can be reprogrammed to neurons and various other cell types with retrovirus or lentivirus. The limitation of this technology is that these genome-integration viruses may increase the risk of gene mutation and cause insertional mutagenesis. We recently found that non-integration adenovirus carrying neuronal transcription factors can induce fibroblasts to neurons. However, the conversion efficiency by the adenovirus is lower than that of the retrovirus or lentivirus. Therefore, it is crucial to identify other factors or chemical compounds to obtain neurons with high efficiency. In this study we show that the combination of Rarg (retinoic acid receptor ) and Nr5a2 (nuclear receptor subfamily 5, group A, member 2; also known as Lrh-1 (liver receptor homologue 1)) rapidly promote the iN cell maturation within 1 week and greatly facilitate the conversion with neuronal purities of approximate to 50% and yields of >130%. They also improve neuronal pattern formation, electrophysiological characteristics, and functional integration in vivo. Moreover, the chemical compound agonists to Rarg and Nr5a2 function effectively as well. This approach may be used for the generation and application of iN cells in regenerative medicine.	[Shi, Zixiao; Liu, Yanli; Huang, Yuanyuan; Jiao, Jianwei] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Shi, Zixiao] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Shen, Tianjin] Anhui Univ, Sch Life Sci, Hefei 230601, Anhui, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Anhui University	Jiao, JW (corresponding author), Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China.	jwjiao@ioz.ac.cn	Jiao, Jianwei/AAA-7902-2020; Jiao, Jianwei/I-1452-2013	Jiao, Jianwei/0000-0002-7893-0721; Jiao, Jianwei/0000-0002-7893-0721	National Basic Research Program of China [2014CBCB964903]; National Science Foundation of China [31371477]; Strategic Priority Stem Cell Program Grant [XDA01020301]; Hundreds Talent Program	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Stem Cell Program Grant; Hundreds Talent Program	This work was supported by National Basic Research Program of China Grant 2014CBCB964903, National Science Foundation of China Grant 31371477, Strategic Priority Stem Cell Program Grant XDA01020301, and the Hundreds Talent Program.	Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; BOYLAN JF, 1995, MOL CELL BIOL, V15, P843; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Drager Ursula C, 2006, Sci STKE, V2006, ppe10, DOI 10.1126/stke.3242006pe10; GIANNI M, 1993, BIOCHEM BIOPH RES CO, V196, P252, DOI 10.1006/bbrc.1993.2242; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; Goslin K., 1998, CULTURING NERVE CELL, P339; Grgurevic N, 2005, NEUROENDOCRINOL LETT, V26, P541; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; Ladewig J, 2012, NAT METHODS, V9, P575, DOI [10.1038/NMETH.1972, 10.1038/nmeth.1972]; Lane MA, 2005, PROG NEUROBIOL, V75, P275, DOI 10.1016/j.pneurobio.2005.03.002; Lee JM, 2011, NATURE, V474, P506, DOI 10.1038/nature10111; Li WL, 2013, CELL RES, V23, P81, DOI 10.1038/cr.2012.182; Lu JF, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-57; Luo T, 2004, BIOL PSYCHIAT, V56, P971, DOI 10.1016/j.biopsych.2004.09.020; Maden M, 2002, NAT REV NEUROSCI, V3, P843, DOI 10.1038/nrn963; McCaffery P, 2006, J NEUROBIOL, V66, P780, DOI 10.1002/neu.20237; Meng FX, 2012, CELL RES, V22, P436, DOI 10.1038/cr.2011.185; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang WJ, 2011, APPL CATAL B-ENVIRON, V108, P108, DOI 10.1016/j.apcatb.2011.08.015; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zechel C, 2005, MOL ENDOCRINOL, V19, P1629, DOI 10.1210/me.2004-0540; Zhou WB, 2009, STEM CELLS, V27, P2667, DOI 10.1002/stem.201	28	15	15	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6415	6428		10.1074/jbc.M113.515601	http://dx.doi.org/10.1074/jbc.M113.515601			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24459144	Green Published, hybrid			2022-12-28	WOS:000332389400010
J	Wu, D; Asiedu, M; Matsumura, F; Wei, QZ				Wu, Di; Asiedu, Michael; Matsumura, Fumio; Wei, Qize			Phosphorylation of Myosin II-interacting Guanine Nucleotide Exchange Factor (MyoGEF) at Threonine 544 by Aurora B Kinase Promotes the Binding of Polo-like Kinase 1 to MyoGEF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokinesis; Guanine Nucleotide Exchange Factor (GEF); Mitosis; Phosphorylation; Rho GTPases; MyoGEF; Aurora B Kinase; Central Spindle; Plk1	REGULATORY LIGHT-CHAIN; CENTRAL SPINDLE; CELL-DIVISION; CITRON KINASE; MITOTIC KINASES; CULTURED-CELLS; PLK1 DOCKING; BOX DOMAIN; CYTOKINESIS; RHO	Background: Aurora B kinase (aurora B) and polo-like kinase 1 (Plk1) are critical regulators of cytokinesis. Results: Phosphorylation of MyoGEF at Thr-544 by aurora B promotes the binding of Plk1 to MyoGEF. Conclusion: Phosphorylation of MyoGEF by aurora B creates a docking site for Plk1. Significance: Coordinated regulation of MyoGEF localization and activation by aurora B and Plk1 contributes to the regulation of cytokinesis. We previously reported that phosphorylation of myosin II-interacting guanine nucleotide exchange factor (MyoGEF) by polo-like kinase 1 (Plk1) promotes the localization of MyoGEF to the central spindle and increases MyoGEF activity toward RhoA during mitosis. In this study we report that aurora B-mediated phosphorylation of MyoGEF at Thr-544 creates a docking site for Plk1, leading to the localization and activation of MyoGEF at the central spindle. In vitro kinase assays show that aurora B can phosphorylate MyoGEF. T544A mutation drastically decreases aurora B-mediated phosphorylation of MyoGEF in vitro and in transfected HeLa cells. Coimmunoprecipitation and in vitro pulldown assays reveal that phosphorylation of MyoGEF at Thr-544 enhances the binding of Plk1 to MyoGEF. Immunofluorescence analysis shows that aurora B colocalizes with MyoGEF at the central spindle and midbody during cytokinesis. Suppression of aurora B activity by an aurora B inhibitor disrupts the localization of MyoGEF to the central spindle. In addition, T544A mutation interferes with the localization of MyoGEF to the cleavage furrow and decreases MyoGEF activity toward RhoA during mitosis. Taken together, our results suggest that aurora B coordinates with Plk1 to regulate MyoGEF activation and localization, thus contributing to the regulation of cytokinesis.	[Wu, Di; Wei, Qize] Fordham Univ, Dept Biol Sci, Bronx, NY 10458 USA; [Asiedu, Michael] Mayo Clin Rochester, Coll Med, Dept Surg, Rochester, MN 55902 USA; [Matsumura, Fumio] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA	Fordham University; Mayo Clinic; Rutgers State University New Brunswick	Wei, QZ (corresponding author), Fordham Univ, Dept Biol Sci, 441 E Fordham Rd,Larkin Hall,Rm 160, Bronx, NY 10458 USA.	qwei3@fordham.edu		Matsumura, Fumio/0000-0002-8204-153X	National Institutes of Health [R15GM097702]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM097702] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R15GM097702 (to Q. W.).	Asiedu M, 2008, J BIOL CHEM, V283, P28392, DOI 10.1074/jbc.M801801200; Asiedu M, 2009, MOL BIOL CELL, V20, P1428, DOI 10.1091/mbc.E08-01-0001; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Bement WM, 2005, J CELL BIOL, V170, P91, DOI 10.1083/jcb.200501131; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Cook Danielle R, 2011, Genes Cancer, V2, P932, DOI 10.1177/1947601912437035; Di Cunto F, 2000, NEURON, V28, P115, DOI 10.1016/S0896-6273(00)00090-8; Di Cunto F, 2002, J CELL SCI, V115, P4819, DOI 10.1242/jcs.00163; Wu D, 2006, CELL CYCLE, V5, P1234, DOI 10.4161/cc.5.11.2815; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Fabbro M, 2005, DEV CELL, V9, P477, DOI 10.1016/j.devcel.2005.09.003; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Gadea BB, 2005, MOL BIOL CELL, V16, P1305, DOI 10.1091/mbc.E04-10-0891; Goto H, 2006, NAT CELL BIOL, V8, P180, DOI 10.1038/ncb1350; Guse A, 2005, CURR BIOL, V15, P778, DOI 10.1016/j.cub.2005.03.041; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Kamijo K, 2006, MOL BIOL CELL, V17, P43, DOI 10.1091/mbc.e05-06-0569; Kanada M, 2008, MOL BIOL CELL, V19, P8, DOI 10.1091/mbc.E07-04-0370; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; Lee YH, 2011, GENE DEV, V25, P176, DOI 10.1101/gad.1975811; Litvak V, 2004, MOL CELL, V14, P319, DOI 10.1016/S1097-2765(04)00214-X; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Ma XF, 2012, P NATL ACAD SCI USA, V109, P4509, DOI 10.1073/pnas.1116268109; Madaule P, 2000, MICROSC RES TECHNIQ, V49, P123, DOI 10.1002/(SICI)1097-0029(20000415)49:2<123::AID-JEMT3>3.0.CO;2-R; Madaule P, 1998, NATURE, V394, P491, DOI 10.1038/28873; Martz MK, 2013, MOL BIOL CELL, V24, P2785, DOI 10.1091/mbc.E12-07-0533; Matsumura F, 1998, J CELL BIOL, V140, P119, DOI 10.1083/jcb.140.1.119; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Niiya F, 2006, ONCOGENE, V25, P827, DOI 10.1038/sj.onc.1209124; Nishimura Y, 2006, J CELL SCI, V119, P104, DOI 10.1242/jcs.02737; Pal D, 2010, CELL CYCLE, V9, P4117, DOI 10.4161/cc.9.20.13387; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Preisinger C, 2005, EMBO J, V24, P753, DOI 10.1038/sj.emboj.7600569; Qi W, 2006, MOL BIOL CELL, V17, P3705, DOI 10.1091/mbc.E06-03-0240; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Uyeda TQP, 2004, INT REV CYTOL, V240, P377, DOI 10.1016/S0074-7696(04)40004-7; Wei QZ, 2005, J BIOL CHEM, V280, P37790, DOI 10.1074/jbc.M502974200; Wolfe BA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000110; Wu D, 2009, ONCOGENE, V28, P2219, DOI 10.1038/onc.2009.96; Yamaguchi T, 2005, J CELL BIOL, V171, P431, DOI 10.1083/jcb.200504091; YAMAKITA Y, 1994, J CELL BIOL, V124, P129, DOI 10.1083/jcb.124.1.129; Yamashiro S, 2003, MOL BIOL CELL, V14, P1745, DOI 10.1091/mbc.E02-07-0427; Yamashiro S, 2008, DEV CELL, V14, P787, DOI 10.1016/j.devcel.2008.02.013; Yoshizaki H, 2004, J BIOL CHEM, V279, P44756, DOI 10.1074/jbc.M402292200; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097; Zhou T, 2003, DEV CELL, V5, P127, DOI 10.1016/S1534-5807(03)00186-2	60	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7142	7150		10.1074/jbc.M113.510388	http://dx.doi.org/10.1074/jbc.M113.510388			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24482237	Green Published, hybrid			2022-12-28	WOS:000332389400073
J	Xu, JX; Si, M; Zhang, HR; Chen, XJ; Zhang, XD; Wang, C; Du, XN; Zhang, HL				Xu, Jia-Xi; Si, Man; Zhang, Hui-Ran; Chen, Xing-Juan; Zhang, Xi-Dong; Wang, Chuan; Du, Xiao-Na; Zhang, Hai-Lin			Phosphoinositide Kinases Play Key Roles in Norepinephrine- and Angiotensin II-induced Increase in Phosphatidylinositol 4,5-Bisphosphate and Modulation of Cardiac Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiac Hypertrophy; G Protein-coupled Receptors (GPCR); Phosphatidylinositol Kinase; Phospholipid Metabolism; Signal Transduction	HEART-FAILURE; PHOSPHOLIPASE-C; SIGNAL-TRANSDUCTION; PANCREAS SLICES; GENE-EXPRESSION; PIP2; HYPERTROPHY; CARDIOMYOCYTES; MECHANISMS; INHIBITION	Background: The mechanism and significance of phosphoinositide metabolism during heart stress stimulations are not clear. Results: Norepinephrine and angiotensin II increase cardiac phosphatidylinositol 4,5-bisphosphate levels via an enhanced interaction between phosphatidylinositol 4-kinase III and PKC, which correlate with a maintained systolic function. Conclusion: Cardiac phosphoinositide turnover is enhanced. Significance: A novel mechanism of phosphoinositide metabolism is described for modulation of cardiac function. The seemly paradoxical G(q) agonist-stimulated phosphoinositide production has long been known, but the underlying mechanism and its physiological significance are not known. In this study, we studied cardiac phosphoinositide levels in both cells and whole animals under the stimulation of norepinephrine (NE), angiotensin II (Ang II), and other physiologically relevant interventions. The results demonstrated that activation of membrane receptors related to NE or Ang II caused an initial increase and a later fall in phosphatidylinositol 4,5-bisphosphate (PIP2) levels in the primary cultured cardiomyocytes from adult rats. The possible mechanism underlying this increase in PIP2 was found to be through an enhanced activity of phosphatidylinositol 4-kinase III, which was mediated by an up-regulated interaction between phosphatidylinositol 4-kinase III and PKC; the increased activity of phosphatidylinositol 4-phosphate 5-kinase was also involved for NE-induced increase of PIP2. When the systolic functions of the NE/Ang II-treated cells were measured, a maintained or failed contractility was found to be correlated with a rise or fall in corresponding PIP2 levels. In two animal models of cardiac hypertrophy, PIP2 levels were significantly reduced in hypertrophic hearts induced by isoprenaline but not in those induced by swimming exercise. This study describes a novel mechanism for phosphoinositide metabolism and modulation of cardiac function.	Hebei Med Univ, Key Lab Neural & Vasc Biol, Minist Educ, Shijiazhuang 050017, Hebei, Peoples R China; Hebei Med Univ, Key Lab New Drug Pharmacol & Toxicol, Shijiazhuang 050017, Hebei, Peoples R China; [Zhang, Hai-Lin] Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University	Zhang, HL (corresponding author), Hebei Med Univ, Dept Pharmacol, 361 East Zhongshan Rd, Shijiazhuang 050017, Hebei, Peoples R China.	zhanghl@hebmu.edu.cn	Xu, Jiaxi/N-3532-2018; xu, jia/GSD-6347-2022	Xu, Jiaxi/0000-0002-0694-813X	National Natural Science Foundation of China [31270882]; National Basic Research Program of China [2013CB531302]; NATIONAL EYE INSTITUTE [R01EY018417, R01EY013147] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work supported by National Natural Science Foundation of China Grant 31270882 (to H.Z.) and National Basic Research Program of China Grant 2013CB531302 (to H.Z.).	Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Banyasz T, 2008, EXP PHYSIOL, V93, P370, DOI 10.1113/expphysiol.2007.040659; Chen XJ, 2011, J BIOL CHEM, V286, P39760, DOI 10.1074/jbc.M111.289090; Cho H, 2005, P NATL ACAD SCI USA, V102, P4643, DOI 10.1073/pnas.0408844102; Cho H, 2006, MOL CELLS, V22, P97; Clayton EL, 2013, MOL NEUROBIOL, V47, P361, DOI 10.1007/s12035-012-8358-6; Clerk A, 1999, AM J CARDIOL, V83, p64H; Colucci WS, 1998, CLIN CARDIOL, V21, P20, DOI 10.1002/clc.4960211305; Dent MR, 2006, J CELL MOL MED, V10, P470, DOI 10.1111/j.1582-4934.2006.tb00412.x; Ding WG, 2004, J BIOL CHEM, V279, P50726, DOI 10.1074/jbc.M409374200; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Gamper N, 2007, J PHYSIOL-LONDON, V582, P967, DOI 10.1113/jphysiol.2007.132787; Gray A, 2003, ANAL BIOCHEM, V313, P234, DOI 10.1016/S0003-2697(02)00607-3; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hilgemann DW, 2007, PFLUG ARCH EUR J PHY, V455, P55, DOI 10.1007/s00424-007-0280-9; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; HOKIN LE, 1967, J CELL BIOL, V33, P521, DOI 10.1083/jcb.33.3.521; HOKIN LE, 1956, CAN J BIOCHEM PHYS, V34, P349; HOKIN LE, 1955, BIOCHIM BIOPHYS ACTA, V18, P102, DOI 10.1016/0006-3002(55)90013-5; Howes AL, 2003, J BIOL CHEM, V278, P40343, DOI 10.1074/jbc.M305964200; Jalili T, 1999, CARDIOVASC RES, V44, P5, DOI 10.1016/S0008-6363(99)00211-4; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Liu QH, 2006, MOL CELL BIOL, V26, P3785, DOI 10.1128/MCB.26.10.3785-3797.2006; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Mellman DL, 2009, ADV ENZYME REGUL, V49, P11, DOI 10.1016/j.advenzreg.2009.01.007; Min L, 2000, REGUL PEPTIDES, V95, P93, DOI 10.1016/S0167-0115(00)00162-2; Minogue Shane, 2012, Subcell Biochem, V58, P1, DOI 10.1007/978-94-007-3012-0_1; Nakayama H, 2010, CIRC RES, V107, P659, DOI 10.1161/CIRCRESAHA.110.220038; Nasuhoglu C, 2002, AM J PHYSIOL-CELL PH, V283, pC223, DOI 10.1152/ajpcell.00486.2001; Nicolas CS, 2008, CARDIOVASC RES, V79, P427, DOI 10.1093/cvr/cvn085; Nienaber JJ, 2003, J CLIN INVEST, V112, P1067, DOI 10.1172/JCI200318213; Prasad SVN, 2003, TRENDS CARDIOVAS MED, V13, P206, DOI 10.1016/S1050-1738(03)00080-X; Rajala RVS, 2010, EXP EYE RES, V91, P324, DOI 10.1016/j.exer.2010.05.001; Singal T, 2006, J MOL CELL CARDIOL, V41, P126, DOI 10.1016/j.yjmcc.2006.03.004; Singh K, 2001, J CELL PHYSIOL, V189, P257, DOI 10.1002/jcp.10024; SINGHAL RL, 1994, CANCER RES, V54, P5574; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Toth B, 2006, J BIOL CHEM, V281, P36369, DOI 10.1074/jbc.M604935200; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Vanamala SK, 2009, BIOCHEM BIOPH RES CO, V386, P386, DOI 10.1016/j.bbrc.2009.05.151; Wang Yibin, 2001, Current Opinion in Pharmacology, V1, P134, DOI 10.1016/S1471-4892(01)00029-7; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005; Xu C, 2003, J CELL BIOL, V161, P779, DOI 10.1083/jcb.200301070; Yaradanakul A, 2007, J PHYSIOL-LONDON, V582, P991, DOI 10.1113/jphysiol.2007.132712; Yue JC, 2001, J BIOL CHEM, V276, P49093, DOI 10.1074/jbc.M101328200; Zhang X, 2010, J BIOL CHEM, V285, P9402, DOI 10.1074/jbc.M109.068205	50	10	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6941	6948		10.1074/jbc.M113.527952	http://dx.doi.org/10.1074/jbc.M113.527952			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24448808	hybrid, Green Published			2022-12-28	WOS:000332389400054
J	Goshima, T; Shimada, M; Sharif, J; Matsuo, H; Misaki, T; Johmura, Y; Murata, K; Koseki, H; Nakanishi, M				Goshima, Takahiro; Shimada, Midori; Sharif, Jafar; Matsuo, Hiromi; Misaki, Toshinori; Johmura, Yoshikazu; Murata, Kazuhiro; Koseki, Haruhiko; Nakanishi, Makoto			Mammal-specific H2A Variant, H2ABbd, Is Involved in Apoptotic Induction via Activation of NF- kappa B Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cell Cycle; Chromatin Histone Modification; DNA Damage; Gene Expression; Histones	DNA-DAMAGE; TRANSCRIPTIONAL REPRESSION; HISTONE VARIANTS; CELL-DEATH; NUCLEOSOME; PROTEIN; KINASE; SPERMATOGENESIS; CHROMOSOME; H2A.BBD	Background: H2ABbd is an H2A variant possessing a highly divergent structure. However, the in vivo function of H2ABbd is not understood. Results: Expression of H2ABbd caused DNA damage, induced apoptotis, and finally led to cell death. Conclusion: H2ABbd caused apoptosis in caspase 3- and NF-B-dependent manners. Significance: This work describes a novel role for human H2ABbd in gene regulation and cell death. Histone variants play specific roles in maintenance and regulation of chromatin structures. H2ABbd, an H2A variant, possesses a highly divergent structure compared with canonical H2A and is highly expressed in postmeiotic germ cells, but its functions in the regulation of gene expression are largely unknown. In the present study, we investigated the cellular phenotype associated with enforced H2ABbd expression. Among H2A variants, H2ABbd specifically caused growth defect in human cells and induced apoptosis. H2ABbd expression resulted in degradation of inhibitor of B- and translocation of NF-B into nuclei, indicating the activation of NF-B. Intriguingly, NF-B activity was essential for H2ABbd-induced apoptosis. H2ABbd overexpression resulted in DNA damage after release from G(1)/S, progressed through the S phase slowly, and induced apoptosis. Furthermore, gene expression microarray analysis revealed that expression of H2ABbd activates groups of genes involved in apoptosis and postmeiotic germ cell development, suggesting that H2ABbd might influence transcription. Taken together, our data suggest that H2ABbd may contribute to specific chromatin structures and promote NF-B activation, which could in turn induce apoptosis in mammalian cells.	[Goshima, Takahiro; Shimada, Midori; Matsuo, Hiromi; Misaki, Toshinori; Johmura, Yoshikazu; Murata, Kazuhiro; Nakanishi, Makoto] Nagoya City Univ, Grad Sch Med Sci, Dept Cell Biol, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Sharif, Jafar; Koseki, Haruhiko] RIKEN Ctr Integrat Med Sci IMS, Dev Genet Grp, Yokohama, Kanagawa 2300045, Japan	Nagoya City University; RIKEN	Shimada, M (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Cell Biol, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	midorism@med.nagoya-cu.ac.jp; mkt-naka@med.nagoya-cu.ac.jp	Koseki, Haruhiko/I-3825-2014	Koseki, Haruhiko/0000-0001-8424-5854; Goshima, Takahiro/0000-0002-9284-2584	NEXT program [LS105]; Naito Foundation; Grants-in-Aid for Scientific Research [24659137] Funding Source: KAKEN	NEXT program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the NEXT program (LS105) and the Naito Foundation (to M. S.).	Angelov D, 2004, EMBO J, V23, P3815, DOI 10.1038/sj.emboj.7600400; Bao YH, 2004, EMBO J, V23, P3314, DOI 10.1038/sj.emboj.7600316; BESSHO R, 1994, BIOCHEM PHARMACOL, V48, P1883, DOI 10.1016/0006-2952(94)90586-X; Chadwick BP, 2001, J CELL BIOL, V152, P375, DOI 10.1083/jcb.152.2.375; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Gan HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2995; Gautier T, 2004, EMBO REP, V5, P715, DOI 10.1038/sj.embor.7400182; Govin J, 2007, J CELL BIOL, V176, P283, DOI 10.1083/jcb.200604141; Gu CH, 2010, GENOMICS, V95, P278, DOI 10.1016/j.ygeno.2010.02.005; Gunjan A, 2003, CELL, V115, P537, DOI 10.1016/S0092-8674(03)00896-1; Ioudinkova ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047157; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Lorch Y, 1999, CELL, V96, P389, DOI 10.1016/S0092-8674(00)80551-6; MEEKSWAGNER D, 1986, CELL, V44, P43, DOI 10.1016/0092-8674(86)90483-6; Montel F, 2007, BIOPHYS J, V93, P566, DOI 10.1529/biophysj.107.105569; Nowsheen S., 2012, Experimental Oncology, V34, P243; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Shimada M, 2006, J MOL HISTOL, V37, P253, DOI 10.1007/s10735-006-9039-4; Shimada M, 2010, EMBO REP, V11, P883, DOI 10.1038/embor.2010.152; Soboleva TA, 2012, NAT STRUCT MOL BIOL, V19, P25, DOI 10.1038/nsmb.2161; Talbert PB, 2010, NAT REV MOL CELL BIO, V11, P264, DOI 10.1038/nrm2861; Tolstorukov MY, 2012, MOL CELL, V47, P596, DOI 10.1016/j.molcel.2012.06.011; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Ye XF, 2003, MOL CELL, V11, P341, DOI 10.1016/S1097-2765(03)00037-6; Zhou JS, 2007, NAT STRUCT MOL BIOL, V14, P1070, DOI 10.1038/nsmb1323	25	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11656	11666		10.1074/jbc.M113.541664	http://dx.doi.org/10.1074/jbc.M113.541664			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24584930	hybrid, Green Published			2022-12-28	WOS:000335010600009
J	Sparacino-Watkins, CE; Tejero, J; Sun, B; Gauthier, MC; Thomas, J; Ragireddy, V; Merchant, BA; Wang, J; Azarov, I; Basu, P; Gladwin, MT				Sparacino-Watkins, Courtney E.; Tejero, Jesus; Sun, Bin; Gauthier, Marc C.; Thomas, John; Ragireddy, Venkata; Merchant, Bonnie A.; Wang, Jun; Azarov, Ivan; Basu, Partha; Gladwin, Mark T.			Nitrite Reductase and Nitric-oxide Synthase Activity of the Mitochondrial Molybdopterin Enzymes mARC1 and mARC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hypoxia; Mitochondria; Molybdenum; Nitric Oxide; Reductase; Vascular Biology	XANTHINE OXIDOREDUCTASE; PULMONARY-HYPERTENSION; LUNG INJURY; MOLYBDENUM COFACTOR; HYPOXIC CONDITIONS; ELECTRON-TRANSFER; ESCHERICHIA-COLI; SULFITE OXIDASE; DIETARY NITRATE; ANOXIC TISSUES	Background: Nitrite reduction pathways are critical for biological NO production under hypoxia. Results: The mitochondrial enzyme mARC reduces nitrite to NO using cytochrome b(5) as electron donor. Conclusion: mARC forms an electron transfer chain with NADH, cytochrome b(5), and cytochrome b(5) reductase to reduce nitrite to NO. Significance: mARC proteins may constitute a new pathway for hypoxic NO production in vivo. Mitochondrial amidoxime reducing component (mARC) proteins are molybdopterin-containing enzymes of unclear physiological function. Both human isoforms mARC-1 and mARC-2 are able to catalyze the reduction of nitrite when they are in the reduced form. Moreover, our results indicate that mARC can generate nitric oxide (NO) from nitrite when forming an electron transfer chain with NADH, cytochrome b(5), and NADH-dependent cytochrome b(5) reductase. The rate of NO formation increases almost 3-fold when pH was lowered from 7.5 to 6.5. To determine if nitrite reduction is catalyzed by molybdenum in the active site of mARC-1, we mutated the putative active site cysteine residue (Cys-273), known to coordinate molybdenum binding. NO formation was abolished by the C273A mutation in mARC-1. Supplementation of transformed Escherichia coli with tungsten facilitated the replacement of molybdenum in recombinant mARC-1 and abolished NO formation. Therefore, we conclude that human mARC-1 and mARC-2 are capable of catalyzing reduction of nitrite to NO through reaction with its molybdenum cofactor. Finally, expression of mARC-1 in HEK cells using a lentivirus vector was used to confirm cellular nitrite reduction to NO. A comparison of NO formation profiles between mARC and xanthine oxidase reveals similar K-cat and V-max values but more sustained NO formation from mARC, possibly because it is not vulnerable to autoinhibition via molybdenum desulfuration. The reduction of nitrite by mARC in the mitochondria may represent a new signaling pathway for NADH-dependent hypoxic NO production.	[Sparacino-Watkins, Courtney E.; Tejero, Jesus; Sun, Bin; Gauthier, Marc C.; Ragireddy, Venkata; Merchant, Bonnie A.; Wang, Jun; Azarov, Ivan; Gladwin, Mark T.] Univ Pittsburgh, Vasc Med Inst, Pittsburgh, PA 15261 USA; [Sparacino-Watkins, Courtney E.; Sun, Bin; Gauthier, Marc C.; Gladwin, Mark T.] Univ Pittsburgh, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA; [Thomas, John; Basu, Partha] Duquesne Univ, Dept Chem & Biochem, Pittsburgh, PA 15282 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Duquesne University	Gladwin, MT (corresponding author), Univ Pittsburgh, Vasc Med Inst, Div Pulm Allergy & Crit Care Med, E1244 Biomed Sci Tower,200 Lothrope St, Pittsburgh, PA 15261 USA.	gladwinmt@upmc.edu	Tejero, Jesus/G-3953-2017	Tejero, Jesus/0000-0003-3245-9978; Azarov, Ivan/0000-0002-9886-3298; Sparacino-Watkins, Courtney/0000-0002-2954-9633; Gauthier, Marc/0000-0001-5037-2804; Wang, Jun/0000-0001-7564-2364	National Institutes of Health [HL098032, HL096973, DK085852, 2T32HL007563-26]; Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania; Competitive Medical Research Fund of the UPMC Health System; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007563, R01HL098032, R01HL096973, P01HL103455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK085852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Transfusion Medicine; Hemophilia Center of Western Pennsylvania; Competitive Medical Research Fund of the UPMC Health System; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL098032, HL096973, and DK085852. This work was also supported by the Institute for Transfusion Medicine and the Hemophilia Center of Western Pennsylvania (to M. T. G.) and by the Competitive Medical Research Fund of the UPMC Health System (to J. T.).; Supported by National Institute of Health Institutional Training Grant 2T32HL007563-26 (to the division of Pulmonary, Allergy, and Critical Care Medicine at the University of Pittsburgh).	Alef MJ, 2011, J CLIN INVEST, V121, P1646, DOI 10.1172/JCI44079; Allen JD, 2012, NITRIC OXIDE-BIOL CH, V26, P217, DOI 10.1016/j.niox.2012.03.003; Altuve A, 2004, BIOCHEM BIOPH RES CO, V314, P602, DOI 10.1016/j.bbrc.2003.12.138; Ascenzi P, 2013, J BIOL INORG CHEM, V18, P939, DOI 10.1007/s00775-013-1040-2; Baker JE, 2007, J MOL CELL CARDIOL, V43, P437, DOI 10.1016/j.yjmcc.2007.07.057; Baliga RS, 2012, CIRCULATION, V125, P2922, DOI 10.1161/CIRCULATIONAHA.112.100586; Basu S, 2008, J BIOL CHEM, V283, P32590, DOI 10.1074/jbc.M806934200; Bueno M, 2013, ANTIOXID REDOX SIGN, V18, P1797, DOI 10.1089/ars.2012.4833; Castello PR, 2006, CELL METAB, V3, P277, DOI 10.1016/j.cmet.2006.02.011; Chamizo-Ampudia A, 2011, EUKARYOT CELL, V10, P1270, DOI 10.1128/EC.05096-11; Dejam A, 2007, CIRCULATION, V116, P1821, DOI 10.1161/CIRCULATIONAHA.107.712133; DOYLE MP, 1981, J BIOL CHEM, V256, P2393; DOYLE MP, 1984, J BIOL CHEM, V259, P80; Garrett RM, 1996, J BIOL CHEM, V271, P7387, DOI 10.1074/jbc.271.13.7387; Gharib SA, 2005, PHYSIOL GENOMICS, V22, P14, DOI 10.1152/physiolgenomics.00265.2004; Ghorbel MT, 2012, PHYSIOL GENOMICS, V44, P1098, DOI 10.1152/physiolgenomics.00072.2012; Gladwin MT, 2006, AM J PHYSIOL-HEART C, V291, pH2026, DOI 10.1152/ajpheart.00407.2006; Gruenewald S, 2008, J MED CHEM, V51, P8173, DOI 10.1021/jm8010417; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Havemeyer A, 2006, J BIOL CHEM, V281, P34796, DOI 10.1074/jbc.M607697200; Havemeyer A, 2011, DRUG METAB REV, V43, P524, DOI 10.3109/03602532.2011.608682; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; JOHNSON JL, 1984, J BIOL CHEM, V259, P5414; Klein JM, 2012, J BIOL CHEM, V287, P42795, DOI 10.1074/jbc.M112.419424; Kotthaus J, 2011, BIOCHEM J, V433, P383, DOI 10.1042/BJ20100960; Kozlov AV, 1999, FEBS LETT, V454, P127, DOI 10.1016/S0014-5793(99)00788-7; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Li HT, 2009, J BIOL CHEM, V284, P33850, DOI 10.1074/jbc.M109.019125; Li HT, 2004, J BIOL CHEM, V279, P16939, DOI 10.1074/jbc.M314336200; Li HT, 2003, BIOCHEMISTRY-US, V42, P1150, DOI 10.1021/bi026385a; Li HT, 2001, J BIOL CHEM, V276, P24482, DOI 10.1074/jbc.M011648200; Lu Ping, 2005, Hepatobiliary Pancreat Dis Int, V4, P350; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; MacArthur PH, 2007, J CHROMATOGR B, V851, P93, DOI 10.1016/j.jchromb.2006.12.012; Maia LB, 2011, J BIOL INORG CHEM, V16, P443, DOI 10.1007/s00775-010-0741-z; Mendel RR, 2011, COORDIN CHEM REV, V255, P1145, DOI 10.1016/j.ccr.2011.01.054; Millar TM, 1998, FEBS LETT, V427, P225, DOI 10.1016/S0014-5793(98)00430-X; Navas-Acien A, 2005, ENVIRON HEALTH PERSP, V113, P164, DOI 10.1289/ehp.7329; Neumann M, 2008, FEBS J, V275, P5678, DOI 10.1111/j.1742-4658.2008.06694.x; Nohl H, 2005, REDOX REP, V10, P281, DOI 10.1179/135100005X83707; Nohl H, 2000, ACTA BIOCHIM POL, V47, P913, DOI 10.18388/abp.2000_3946; OZOLS J, 1974, BIOCHEMISTRY-US, V13, P426, DOI 10.1021/bi00700a005; PAI TG, 1987, ANAL BIOCHEM, V166, P150, DOI 10.1016/0003-2697(87)90557-4; Pickerodt PA, 2012, ANESTHESIOLOGY, V117, P592, DOI 10.1097/ALN.0b013e3182655f80; Plitzko B, 2013, J BIOL CHEM, V288, P20228, DOI 10.1074/jbc.M113.474916; Pollock VV, 2002, ARCH BIOCHEM BIOPHYS, V403, P237, DOI 10.1016/S0003-9861(02)00215-1; Poyton RO, 2011, DISCOV MED, V11, P154; Qiu JA, 2010, BIOCHEMISTRY-US, V49, P3989, DOI 10.1021/bi1001954; Samal AA, 2012, FREE RADICAL BIO MED, V53, P1431, DOI 10.1016/j.freeradbiomed.2012.08.007; SHIRABE K, 1989, BIOCHIM BIOPHYS ACTA, V1008, P189, DOI 10.1016/0167-4781(80)90007-X; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Shiva S, 2007, CIRC RES, V100, P654, DOI 10.1161/01.RES.0000260171.52224.6b; Shiva S, 2010, NITRIC OXIDE-BIOL CH, V22, P64, DOI 10.1016/j.niox.2009.09.002; Sparacino-Watkins C, 2014, CHEM SOC REV, V43, P676, DOI 10.1039/c3cs60249d; Sparacino-Watkins CE, 2012, CIRCULATION, V125, P2824, DOI 10.1161/CIRCULATIONAHA.112.107821; Sugimoto R, 2012, AM J TRANSPLANT, V12, P2938, DOI 10.1111/j.1600-6143.2012.04169.x; TAN S, 1993, FREE RADICAL BIO MED, V15, P407, DOI 10.1016/0891-5849(93)90040-2; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Wahl B, 2010, J BIOL CHEM, V285, P37847, DOI 10.1074/jbc.M110.169532; Wang J, 2013, NITRIC OXIDE-BIOL CH, V31, pS39, DOI 10.1016/j.niox.2013.02.064; Webb A, 2004, P NATL ACAD SCI USA, V101, P13683, DOI 10.1073/pnas.0402927101; Webb AJ, 2008, HYPERTENSION, V51, P784, DOI 10.1161/HYPERTENSIONAHA.107.103523; Zuckerbraun BS, 2010, CIRCULATION, V121, P98, DOI 10.1161/CIRCULATIONAHA.109.891077	63	105	108	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10345	10358		10.1074/jbc.M114.555177	http://dx.doi.org/10.1074/jbc.M114.555177			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24500710	Green Published, hybrid			2022-12-28	WOS:000334226400010
J	Zheng, ZQ; Keifer, J				Zheng, Zhaoqing; Keifer, Joyce			Sequential Delivery of Synaptic GluA1-and GluA4-containing AMPA Receptors ( AMPARs) by SAP97 Anchored Protein Complexes in Classical Conditioning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Surface Receptor; Confocal Microscopy; Glutamate Receptors Ionotropic (AMPA; NMDA); Neuroscience; Protein Targeting; Signal Transduction	LONG-TERM POTENTIATION; GLUTAMATE RECEPTORS; PHOSPHORYLATION; TRAFFICKING; SUBUNIT; GLUR1; STARGAZIN; PLASTICITY; REQUIRES; MEMORY	Background: Subunit-specific synaptic delivery of AMPARs during associative learning is not well characterized. Results: SAP97-AKAP/PKA-GluA1 followed by SAP97-KSR1/PKC-GluA4 complexes function for surface delivery of AMPARs. Conclusion: SAP97 interacts with AKAP and KSR1 proteins to coordinate the sequential synaptic delivery of AMPAR subunits during in vitro classical conditioning. Significance: A cooperative interaction of multiple scaffolding proteins selectively delivers AMPARs to synapses during conditioning. Multiple signaling pathways are involved in AMPAR trafficking to synapses during synaptic plasticity and learning. The mechanisms for how these pathways are coordinated in parallel but maintain their functional specificity involves subcellular compartmentalization of kinase function by scaffolding proteins, but how this is accomplished is not well understood. Here, we focused on characterizing the molecular machinery that functions in the sequential synaptic delivery of GluA1- and GluA4-containing AMPARs using an in vitro model of eyeblink classical conditioning. We show that conditioning induces the interaction of selective protein complexes with the key structural protein SAP97, which tightly regulates the synaptic delivery of GluA1 and GluA4 AMPAR subunits. The results demonstrate that in the early stages of conditioning the initial activation of PKA stimulates the formation of a SAP97-AKAP/PKA-GluA1 protein complex leading to synaptic delivery of GluA1-containing AMPARs through a SAP97-PSD95 interaction. This is followed shortly thereafter by generation of a SAP97-KSR1/PKC-GluA4 complex for GluA4 AMPAR subunit delivery again through a SAP97-PSD95 interaction. These data suggest that SAP97 forms the molecular backbone of a protein scaffold critical for delivery of AMPARs to the PSD during conditioning. Together, the findings reveal a cooperative interaction of multiple scaffolding proteins for appropriately timed delivery of subunit-specific AMPARs to synapses and support a sequential two-stage model of AMPAR synaptic delivery during classical conditioning.	[Zheng, Zhaoqing; Keifer, Joyce] Univ S Dakota, Neurosci Grp, Div Basic Biomed Sci, Sanford Sch Med, Vermillion, SD 57069 USA	University of South Dakota	Keifer, J (corresponding author), Univ S Dakota, Neurosci Grp, Sanford Sch Med, 414 E Clark St, Vermillion, SD 57069 USA.	jkeifer@usd.edu		Keifer, Joyce/0000-0002-5900-0414	National Institutes of Health [NS051187]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS051187 (to J.K.).	Anderson CW, 1999, J NEUROPHYSIOL, V81, P1242, DOI 10.1152/jn.1999.81.3.1242; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Cacace AM, 1999, MOL CELL BIOL, V19, P229; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Gardner LA, 2007, J BIOL CHEM, V282, P5085, DOI 10.1074/jbc.M608871200; Granger AJ, 2013, NATURE, V493, P495, DOI 10.1038/nature11775; Greger IH, 2007, TRENDS NEUROSCI, V30, P407, DOI 10.1016/j.tins.2007.06.005; Keifer J, 2010, EUR J NEUROSCI, V32, P269, DOI 10.1111/j.1460-9568.2010.07339.x; Kessels HW, 2009, NAT NEUROSCI, V12, P888, DOI 10.1038/nn.2340; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Li W, 2009, NEUROBIOL LEARN MEM, V91, P243, DOI 10.1016/j.nlm.2008.10.002; Mokin M, 2006, J NEUROSCI METH, V157, P218, DOI 10.1016/j.jneumeth.2006.04.016; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Nie T, 2007, J NEUROSCI, V27, P10278, DOI 10.1523/JNEUROSCI.1602-07.2007; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Opazo P, 2010, NEURON, V67, P239, DOI 10.1016/j.neuron.2010.06.007; Shalin SC, 2006, NEURON, V50, P765, DOI 10.1016/j.neuron.2006.04.029; Sun X, 2005, J NEUROSCI, V25, P7342, DOI 10.1523/JNEUROSCI.4603-04.2005; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yang YL, 2008, P NATL ACAD SCI USA, V105, P11388, DOI 10.1073/pnas.0802978105; Yu W, 1998, CURR BIOL, V8, P56, DOI 10.1016/S0960-9822(98)70020-X; Zheng CY, 2011, NEUROSCIENTIST, V17, P493, DOI 10.1177/1073858410386384; Zheng Z, 2008, NEUROSCIENCE, V156, P872, DOI 10.1016/j.neuroscience.2008.08.042; Zheng ZQ, 2012, J NEUROPHYSIOL, V108, P101, DOI 10.1152/jn.01097.2011; Zheng ZQ, 2009, J NEUROPHYSIOL, V101, P2539, DOI 10.1152/jn.91282.2008	26	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10540	10550		10.1074/jbc.M113.535179	http://dx.doi.org/10.1074/jbc.M113.535179			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24567325	Green Published, hybrid			2022-12-28	WOS:000334226400027
J	LaRonde, NA				LaRonde, Nicole A.			The Ancient Microbial RIO Kinases*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						ATPases; Bacterial Protein Kinases; Prokaryotic Protein Kinases; Ribosomal RNA Processing; Ribosome Assembly; Serine; Threonine Protein Kinase; RIO Kinase; Archaeal Protein Kinases	PRE-RIBOSOMAL-RNA; PROTEIN-KINASES; CYTOPLASMIC MATURATION; CRYSTAL-STRUCTURE; FULGIDUS RIO2; FAMILY; SUBUNIT	The RIO kinases existed before the split between Archaea and Eubacteria and are essential in eukaryotes. Although much has been elucidated in the past few years regarding the function of these proteins in eukaryotes, questions remain about their role in prokaryotes. Comparison of structure and sequence suggests that the ancient RIO kinases may have similar functional properties in prokaryotes as they do in eukaryotes. The conservation of charge distribution, functional residues, and overall structure supports a role for these proteins in ribosome interactions, as is their purpose in eukaryotes. However, a lack of study in this area has left little direct evidence in support of this function.	[LaRonde, Nicole A.] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [LaRonde, Nicole A.] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland Baltimore	LaRonde, NA (corresponding author), Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.	nlaronde@umd.edu	LaRonde-LeBlanc, Nicole A/C-3399-2009	LaRonde-LeBlanc, Nicole A/0000-0002-2778-8358	National Science Foundation [MCB0953493]; Div Of Molecular and Cellular Bioscience [0953493] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This is the fourth article in the Thematic Minireview Series "Protein Serine/Threonine and Tyrosine Phosphorylation in Prokaryotes." This work was supported in part by National Science Foundation Career Award Grant MCB0953493.	Angermayr M, 2002, FEBS LETT, V524, P31, DOI 10.1016/S0014-5793(02)02993-9; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Esser D, 2013, BIOCHEM SOC T, V41, P399, DOI 10.1042/BST20120317; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Fenner BJ, 2009, BBA-PROTEINS PROTEOM, V1794, P1010, DOI 10.1016/j.bbapap.2009.02.013; Ferreira-Cerca S, 2012, NAT STRUCT MOL BIOL, V19, P1316, DOI 10.1038/nsmb.2403; Geerlings TH, 2003, J BIOL CHEM, V278, P22537, DOI 10.1074/jbc.M300759200; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Humbard MA, 2010, ARCHAEA, V2010, DOI 10.1155/2010/481725; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kiburu IN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037371; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LaRonde-LeBlanc N, 2005, J BIOL CHEM, V280, P37297, DOI 10.1074/jbc.R500013200; LaRonde-LeBlanc N, 2005, FEBS J, V272, P3698, DOI 10.1111/j.1742-4658.2005.04796.x; LaRonde-LeBlanc N, 2005, FEBS J, V272, P2800, DOI 10.1111/j.1742-4658.2005.04702.x; LaRonde-LeBlanc N, 2004, STRUCTURE, V12, P1585, DOI 10.1016/j.str.2004.06.016; Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mielecki M, 2013, BBA-PROTEINS PROTEOM, V1834, P1292, DOI 10.1016/j.bbapap.2013.03.012; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schwartz PA, 2011, BIOORG CHEM, V39, P192, DOI 10.1016/j.bioorg.2011.07.004; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Vanrobays E, 2003, MOL CELL BIOL, V23, P2083, DOI 10.1128/MCB.23.6.2083-2095.2003; Vanrobays E, 2001, EMBO J, V20, P4204, DOI 10.1093/emboj/20.15.4204; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Widmann B, 2012, MOL BIOL CELL, V23, P22, DOI 10.1091/mbc.E11-07-0639	28	34	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9488	9492		10.1074/jbc.R113.538090	http://dx.doi.org/10.1074/jbc.R113.538090			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24554707	hybrid, Green Published			2022-12-28	WOS:000333807000005
J	Nakamura, Y; Hasebe, A; Takahashi, K; Iijima, M; Yoshimoto, N; Maturana, AD; Ting, K; Kuroda, S; Niimi, T				Nakamura, Yoko; Hasebe, Ai; Takahashi, Kaneyoshi; Iijima, Masumi; Yoshimoto, Nobuo; Maturana, Andres D.; Ting, Kang; Kuroda, Shun'ichi; Niimi, Tomoaki			Oligomerization-induced Conformational Change in the C-terminal Region of Nel-like Molecule 1 (NELL1) Protein Is Necessary for the Efficient Mediation of Murine MC3T3-E1 Cell Adhesion and Spreading*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Adhesion; Disulfide; Extracellular Matrix; Osteoblasts; Protein Conformation	IN-VIVO; INTEGRIN; CRANIOSYNOSTOSIS; DIFFERENTIATION; EXPRESSION; THROMBOSPONDIN-1; LAMININ-10/11; REGENERATION; INVOLVEMENT; ECHISTATIN	Background: NELL1, an oligomeric glycoprotein, is an osteoinductive factor. Results: The C-terminal cysteine-rich region of NELL1 has cell-binding activity. Intermolecular, but not intramolecular, disulfide bonding is important for the oligomerization and cell adhesion activity of NELL1. Conclusion: NELL1 requires oligomerization-induced conformational change for efficient mediation of cell adhesion and spreading. Significance: The structural basis of NELL1-mediated cell adhesion is identified. NELL1 is a large oligomeric secretory glycoprotein that functions as an osteoinductive factor. NELL1 contains several conserved domains, has structural similarities to thrombospondin 1, and supports osteoblastic cell adhesion through integrins. To define the structural requirements for NELL1-mediated cell adhesion, we prepared a series of recombinant NELL1 proteins (intact, deleted, and cysteine-mutant) from a mammalian expression system and tested their activities. A deletion analysis demonstrated that the C-terminal cysteine-rich region of NELL1 is critical for the cell adhesion activity of NELL1. Reducing agent treatment decreased the cell adhesion activity of full-length NELL1 but not of its C-terminal fragments, suggesting that the intramolecular disulfide bonds within this region are not functionally necessary but that other disulfide linkages in the N-terminal region of NELL1 may be involved in cell adhesion activity. By replacing cysteine residues with serines around the coiled-coil domain of NELL1, which is responsible for oligomerization, we created a mutant NELL1 protein that was unable to form homo-oligomers, and this monomeric mutant showed substantially lower cell adhesion activity than intact NELL1. These results suggest that an oligomerization-induced conformational change in the C-terminal region of NELL1 is important for the efficient mediation of cell adhesion and spreading by NELL1.	[Nakamura, Yoko; Hasebe, Ai; Takahashi, Kaneyoshi; Iijima, Masumi; Yoshimoto, Nobuo; Maturana, Andres D.; Kuroda, Shun'ichi; Niimi, Tomoaki] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Ting, Kang] Univ Calif Los Angeles, Sch Dent, Sect Orthodont, Los Angeles, CA 90095 USA	Nagoya University; University of California System; University of California Los Angeles	Kuroda, S (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	skuroda@agr.nagoya-u.ac.jp; tniimi@agr.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23510255]; Grants-in-Aid for Scientific Research [25870310] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Education, Culture, Sports, Science, and Technology of Japan Grant-in-aid for Scientific Research 23510255.	Abreu JG, 2002, GENE, V287, P39, DOI 10.1016/S0378-1119(01)00827-7; Adams JC, 2001, ANNU REV CELL DEV BI, V17, P25, DOI 10.1146/annurev.cellbio.17.1.25; Aghaloo T, 2006, AM J PATHOL, V169, P903, DOI 10.2353/ajpath.2006.051210; Aghaloo T, 2010, J ORAL MAXIL SURG, V68, P300, DOI 10.1016/j.joms.2009.03.066; Aihara K, 2003, MOL BRAIN RES, V116, P86, DOI 10.1016/S0169-328X(03)00256-0; Anilkumar N, 2002, J CELL SCI, V115, P2357; Bokui N, 2008, FEBS LETT, V582, P365, DOI 10.1016/j.febslet.2007.12.006; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Cowan CM, 2007, J BONE MINER RES, V22, P918, DOI 10.1359/JBMR.070312; Cowan CM, 2006, BONE, V38, P48, DOI 10.1016/j.bone.2005.06.023; Desai J, 2006, HUM MOL GENET, V15, P1329, DOI 10.1093/hmg/ddl053; Gu JG, 2002, J BIOL CHEM, V277, P19922, DOI 10.1074/jbc.M200383200; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Hasebe A, 2012, FEBS LETT, V586, P2500, DOI 10.1016/j.febslet.2012.06.014; Hasebe A, 2012, MOL BIOTECHNOL, V51, P58, DOI 10.1007/s12033-011-9440-4; HEALY JM, 1995, BIOCHEMISTRY-US, V34, P3948, DOI 10.1021/bi00012a012; Hughes FJ, 2006, PERIODONTOL 2000, V41, P48, DOI 10.1111/j.1600-0757.2006.00161.x; James AW, 2012, STEM CELLS DEV, V21, P2170, DOI 10.1089/scd.2011.0461; KOIVUNEN E, 1994, J CELL BIOL, V124, P373, DOI 10.1083/jcb.124.3.373; KOIVUNEN E, 1993, J BIOL CHEM, V268, P20205; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V265, P79, DOI 10.1006/bbrc.1999.1638; Kuroda S, 1999, BIOCHEM BIOPH RES CO, V265, P752, DOI 10.1006/bbrc.1999.1753; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Lu SS, 2007, SPINE J, V7, P50, DOI 10.1016/j.spinee.2006.04.020; Maeda K, 2001, NEUROL MED-CHIR, V41, P582, DOI 10.2176/nmc.41.582; Matsuyama S, 2004, NEUROREPORT, V15, P417, DOI 10.1097/00001756-200403010-00007; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McLane MA, 1996, FEBS LETT, V391, P139, DOI 10.1016/0014-5793(96)00716-8; Nakamura R, 2012, J BIOL CHEM, V287, P3282, DOI 10.1074/jbc.M111.281485; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Phan HP, 2009, PROTEIN EXPRES PURIF, V68, P79, DOI 10.1016/j.pep.2009.07.005; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shen J, 2012, J CELL BIOCHEM, V113, P3620, DOI 10.1002/jcb.24253; Siu RK, 2012, TISSUE ENG PT A, V18, P252, DOI [10.1089/ten.tea.2011.0142, 10.1089/ten.TEA.2011.0142]; Tan K, 2006, STRUCTURE, V14, P33, DOI 10.1016/j.str.2005.09.017; Ting K, 1999, J BONE MINER RES, V14, P80, DOI 10.1359/jbmr.1999.14.1.80; Watanabe TK, 1996, GENOMICS, V38, P273, DOI 10.1006/geno.1996.0628; Xue J, 2011, BONE, V48, P485, DOI 10.1016/j.bone.2010.10.166; Yamada T, 1996, FEBS LETT, V387, P11, DOI 10.1016/0014-5793(96)00409-7; Zhang X, 2010, J DENT RES, V89, P865, DOI 10.1177/0022034510376401; Zhang XL, 2012, J CRANIOFAC SURG, V23, P61, DOI 10.1097/SCS.0b013e318240c8c4; Zhang XL, 2002, J CLIN INVEST, V110, P861, DOI 10.1172/JCI200215375; Zhang XL, 2003, J BONE MINER RES, V18, P2126, DOI 10.1359/jbmr.2003.18.12.2126; Zhou YF, 2012, BLOOD, V120, P449, DOI 10.1182/blood-2012-01-405134	45	12	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9781	9794		10.1074/jbc.M113.507020	http://dx.doi.org/10.1074/jbc.M113.507020			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24563467	hybrid, Green Published			2022-12-28	WOS:000333807000029
J	Damerow, M; Rodrigues, JA; Wu, D; Guther, MLS; Mehlert, A; Ferguson, MAJ				Damerow, Manuela; Rodrigues, Joao A.; Wu, Di; Guether, M. Lucia S.; Mehlert, Angela; Ferguson, Michael A. J.			Identification and Functional Characterization of a Highly Divergent N-Acetylglucosaminyltransferase I ( TbGnTI) in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glycobiology; Glycosyltransferases; Parasite; Post-translational Modification; Trypanosoma brucei; N-Acetylglucosamine	VARIANT SURFACE GLYCOPROTEIN; ASPARAGINE-LINKED OLIGOSACCHARIDES; GLYCOSYLATION MUTANTS RESISTANT; MEMBRANE ANCHOR; CLONING; GLYCOSYLPHOSPHATIDYLINOSITOL; BIOSYNTHESIS; GLYCANS; COMPLEX; GLYCOSYLTRANSFERASES	Background:Trypanosoma brucei expresses a highly glycosylated surface coat that is essential for parasite survival. Results: The T. brucei gene TbGT11 encodes an N-acetylglucosaminyltransferase I, the key enzyme for initiating the biosynthesis of complex N-glycans. Conclusion:T. brucei GnTI is not a homologue of metazoan GnTI, but a highly divergent enzyme belonging to the 3-glycosyltransferase family. Significance: Deeper understanding of T. brucei N-glycosylation pathway. Trypanosoma brucei expresses a diverse repertoire of N-glycans, ranging from oligomannose and paucimannose structures to exceptionally large complex N-glycans. Despite the presence of the latter, no obvious homologues of known 1-4-galactosyltransferase or 1-2- or 1-6-N-acetylglucosaminyltransferase genes have been found in the parasite genome. However, we previously reported a family of putative UDP-sugar-dependent glycosyltransferases with similarity to the mammalian 1-3-glycosyltransferase family. Here we characterize one of these genes, TbGT11, and show that it encodes a Golgi apparatus resident UDP-GlcNAc:3-d-mannoside 1-2-N-acetylglucosaminyltransferase I activity (TbGnTI). The bloodstream-form TbGT11 null mutant exhibited significantly modified protein N-glycans but normal growth in vitro and infectivity to rodents. In contrast to multicellular organisms, where the GnTI reaction is essential for biosynthesis of both complex and hybrid N-glycans, T. brucei TbGT11 null mutants expressed atypical pseudohybrid glycans, indicating that TbGnTII activity is not dependent on prior TbGnTI action. Using a functional in vitro assay, we showed that TbGnTI transfers UDP-GlcNAc to biantennary Man(3)GlcNAc(2), but not to triantennary Man(5)GlcNAc(2), which is the preferred substrate for metazoan GnTIs. Sequence alignment reveals that the T. brucei enzyme is far removed from the metazoan GnTI family and suggests that the parasite has adapted the 3-glycosyltransferase family to catalyze 1-2 linkages.	[Damerow, Manuela; Wu, Di; Guether, M. Lucia S.; Mehlert, Angela; Ferguson, Michael A. J.] Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Dundee DD1 5EH, Scotland; [Rodrigues, Joao A.] Univ Lisbon, Inst Mol Med, Fac Med, P-1649028 Lisbon, Portugal	University of Dundee; Universidade de Lisboa	Ferguson, MAJ (corresponding author), Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Dundee DD1 5EH, Scotland.	m.a.j.ferguson@dundee.ac.uk	Rodrigues, Joao A/I-5462-2018; Wu, Di/AAF-2276-2020; Rodrigues, Joao A/A-5886-2009	Rodrigues, Joao A/0000-0001-7006-3048; Rodrigues, Joao A/0000-0001-7006-3048; Ferguson, Michael/0000-0003-1321-8714	Wellcome Trust [097945]	Wellcome Trust(Wellcome TrustEuropean Commission)	Mass spectrometry was performed in the Fingerprint Proteomics Facility supported by Wellcome Trust Strategic Award 097945.	Acosta-Serrano A, 2000, J MOL BIOL, V304, P633, DOI 10.1006/jmbi.2000.4246; Atrih A, 2005, J BIOL CHEM, V280, P865, DOI 10.1074/jbc.M411061200; BANGS JD, 1993, J CELL SCI, V105, P1101; BANGS JD, 1988, J BIOL CHEM, V263, P17697; BENDIAK B, 1987, J BIOL CHEM, V262, P5784; Chang TH, 2002, J BIOL CHEM, V277, P50176, DOI 10.1074/jbc.M208374200; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; Cross GAM, 1996, BIOESSAYS, V18, P283, DOI 10.1002/bies.950180406; CROSS GAM, 1984, J CELL BIOCHEM, V24, P79, DOI 10.1002/jcb.240240107; DOERING TL, 1989, J BIOL CHEM, V264, P11168; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4963; FERGUSON MAJ, 1994, GLYCOBIOLOGY PRACTIC, P349; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; GRAB DJ, 1984, J CELL BIOL, V99, P569, DOI 10.1083/jcb.99.2.569; Guther MLS, 2001, EMBO J, V20, P4923, DOI 10.1093/emboj/20.17.4923; HARPAZ N, 1980, J BIOL CHEM, V255, P4894; Ho HH, 2006, P NATL ACAD SCI USA, V103, P7676, DOI 10.1073/pnas.0602595103; Hwa KY, 2000, MOL BIOCHEM PARASIT, V111, P173, DOI 10.1016/S0166-6851(00)00310-8; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Izquierdo L, 2009, MOL MICROBIOL, V71, P478, DOI 10.1111/j.1365-2958.2008.06542.x; Izquierdo Luis, 2013, Methods Mol Biol, V1022, P249, DOI 10.1007/978-1-62703-465-4_19; Izquierdo L, 2012, GLYCOBIOLOGY, V22, P696, DOI 10.1093/glycob/cws003; Izquierdo L, 2009, EMBO J, V28, P2650, DOI 10.1038/emboj.2009.203; Izquierdo L, 2009, EUKARYOT CELL, V8, P230, DOI 10.1128/EC.00361-08; Jones DC, 2005, J BIOL CHEM, V280, P35929, DOI 10.1074/jbc.M509130200; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Leal S, 2004, J BIOL CHEM, V279, P28979, DOI 10.1074/jbc.M403479200; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Manthri S, 2008, GLYCOBIOLOGY, V18, P367, DOI 10.1093/glycob/cwn014; MazhariTabrizi R, 1996, BIOCHEM J, V316, P853, DOI 10.1042/bj3160853; Mehlert A, 2002, GLYCOBIOLOGY, V12, P607, DOI 10.1093/glycob/cwf079; Mehlert A, 1998, MOL BIOCHEM PARASIT, V91, P145, DOI 10.1016/S0166-6851(97)00187-4; Mehlert A, 1998, J MOL BIOL, V277, P379, DOI 10.1006/jmbi.1997.1600; Mehlert A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002618; Mehlert A, 2010, MOL BIOCHEM PARASIT, V174, P74, DOI 10.1016/j.molbiopara.2010.06.007; METZLER M, 1994, EMBO J, V13, P2056, DOI 10.1002/j.1460-2075.1994.tb06480.x; Milne KG, 2001, MOL BIOCHEM PARASIT, V112, P301, DOI 10.1016/S0166-6851(00)00369-8; Nagamune K, 2000, P NATL ACAD SCI USA, V97, P10336, DOI 10.1073/pnas.180230697; Narimatsu H, 2006, CURR OPIN STRUC BIOL, V16, P567, DOI 10.1016/j.sbi.2006.09.001; Nolan DP, 1999, CURR BIOL, V9, P1169, DOI 10.1016/S0960-9822(00)80018-4; Paschinger K, 2012, GLYCOBIOLOGY, V22, P300, DOI 10.1093/glycob/cwr149; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Pays E, 1998, MOL BIOCHEM PARASIT, V91, P3, DOI 10.1016/S0166-6851(97)00183-7; ROVIS L, 1982, MOL BIOCHEM PARASIT, V5, P173, DOI 10.1016/0166-6851(82)90019-6; Schachter H, 2010, SEMIN CELL DEV BIOL, V21, P609, DOI 10.1016/j.semcdb.2010.02.010; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; TABAS I, 1978, J BIOL CHEM, V253, P716; Tazeh NN, 2009, EUKARYOT CELL, V8, P1352, DOI 10.1128/EC.00156-09; Urbaniak MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036619; VELLA GJ, 1984, CAN J BIOCHEM CELL B, V62, P409, DOI 10.1139/o84-056; VISSER N, 1980, EUR J BIOCHEM, V103, P623, DOI 10.1111/j.1432-1033.1980.tb05988.x; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; ZAMZE SE, 1991, J BIOL CHEM, V266, P20244	55	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9328	9339		10.1074/jbc.M114.555029	http://dx.doi.org/10.1074/jbc.M114.555029			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24550396	hybrid, Green Published			2022-12-28	WOS:000333472100049
J	Herrera-Molina, R; Sarto-Jackson, I; Montenegro-Venegas, C; Heine, M; Smalla, KH; Seidenbecher, CI; Beesley, PW; Gundelfinger, ED; Montag, D				Herrera-Molina, Rodrigo; Sarto-Jackson, Isabella; Montenegro-Venegas, Carolina; Heine, Martin; Smalla, Karl-Heinz; Seidenbecher, Constanze I.; Beesley, Philip W.; Gundelfinger, Eckart D.; Montag, Dirk			Structure of Excitatory Synapses and GABAA Receptor Localization at Inhibitory Synapses Are Regulated by Neuroplastin-65	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Adhesion; GABA Receptors; Neurons; Synapses; Synaptic Plasticity; Cell Adhesion Molecule CAM; Ig-superfamily; Neuroplastin; Synapse Formation and Maintenance	LONG-TERM POTENTIATION; CELL-ADHESION MOLECULE; SYNAPTIC GLYCOPROTEIN NEUROPLASTIN; HIPPOCAMPAL; NEURONS; NEUROLIGIN-1; TRANSMITTER; RECRUITMENT; ACTIVATION; MECHANISMS	Background: Synaptic excitatory to inhibitory ratio is crucial for brain function but its regulation is poorly understood. Results: The cell adhesion molecule neuroplastin-65 regulates contact and stability of excitatory synapses and localization of GABA(A)R 2 subunits at inhibitory synapses. Conclusion: Neuroplastin-65 mediates specific neuronal connections and regulates the number and function of synapses in hippocampal neurons. Significance: Correct neuronal network activity in specific brain regions may depend on neuroplastin-65. Formation, maintenance, and activity of excitatory and inhibitory synapses are essential for neuronal network function. Cell adhesion molecules (CAMs) are crucially involved in these processes. The CAM neuroplastin-65 (Np65) highly expressed during periods of synapse formation and stabilization is present at the pre- and postsynaptic membranes. Np65 can translocate into synapses in response to electrical stimulation and it interacts with subtypes of GABA(A) receptors in inhibitory synapses. Here, we report that in the murine hippocampus and in hippocampal primary culture, neurons of the CA1 region and the dentate gyrus (DG) express high Np65 levels, whereas expression in CA3 neurons is lower. In neuroplastin-deficient (Np-/-) mice the number of excitatory synapses in CA1 and DG, but not CA3 regions is reduced. Notably this picture is mirrored in mature Np-/- hippocampal cultures or in mature CA1 and DG wild-type (Np+/+) neurons treated with a function-blocking recombinant Np65-Fc extracellular fragment. Although the number of GABAergic synapses was unchanged in Np-/- neurons or in mature Np65-Fc-treated Np+/+ neurons, the ratio of excitatory to inhibitory synapses was significantly lower in Np-/- cultures. Furthermore, GABA(A) receptor composition was altered at inhibitory synapses in Np-/- neurons as the 1 to 2 GABA(A) receptor subunit ratio was increased. Changes of excitatory and inhibitory synaptic function in Np-/- neurons were confirmed evaluating the presynaptic release function and using patch clamp recording. These data demonstrate that Np65 is an important regulator of the number and function of synapses in the hippocampus.	[Herrera-Molina, Rodrigo; Montenegro-Venegas, Carolina; Seidenbecher, Constanze I.; Gundelfinger, Eckart D.] Otto Von Guericke Univ, Dept Neurochem & Mol Biol, D-39118 Magdeburg, Germany; [Herrera-Molina, Rodrigo; Smalla, Karl-Heinz] Otto Von Guericke Univ, Special Lab Mol Biol Techn, D-39118 Magdeburg, Germany; [Heine, Martin] Otto Von Guericke Univ, Res Grp Mol Physiol, D-39118 Magdeburg, Germany; [Montag, Dirk] Otto Von Guericke Univ, Neurogenet Special Lab, Leibniz Inst Neurobiol, D-39118 Magdeburg, Germany; [Smalla, Karl-Heinz; Seidenbecher, Constanze I.; Gundelfinger, Eckart D.] Otto Von Guericke Univ, CBBS, D-39118 Magdeburg, Germany; [Gundelfinger, Eckart D.] Otto Von Guericke Univ, Fac Med, D-39118 Magdeburg, Germany; [Sarto-Jackson, Isabella] Med Univ Vienna, Dept Biochem & Mol Biol Nervous Syst, Ctr Brain Res, A-1090 Vienna, Austria; [Beesley, Philip W.] Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England; [Herrera-Molina, Rodrigo] Univ Chile, Programa Biol Celular & Mol, Inst Ciencias Biomed, Fac Med, Independencia Santiago 8380453, Chile	Otto von Guericke University; Otto von Guericke University; Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University; Otto von Guericke University; Otto von Guericke University; Medical University of Vienna; University of London; Royal Holloway University London; Universidad de Chile	Montag, D (corresponding author), Leibniz Inst Neurobiol, Brenneckestr 6, D-39118 Magdeburg, Germany.	montag@LIN-magdeburg.de	Smalla, Dr. Karl-Heinz/C-3950-2012; Montag, Dirk/D-3925-2014; Herrera-Molina, Rodrigo/GLU-3904-2022	Smalla, Dr. Karl-Heinz/0000-0002-0269-0311; Montag, Dirk/0000-0002-4964-1330; Seidenbecher, Constanze/0000-0002-7433-2716	Deutsche Forschungsgemeinschaft [SFB426, SFB779, GRK1167, GU 230/6-1, SM38/8-1]; COST action ECMNet; Federal State of Saxony-Anhalt; European Regional Development Fund [ERDF 2007-2013]; Center for Dynamic Systems at the Otto von Guericke University Magdeburg; Deutscher Akademischer Austauschdienst; ERANET-Neuron/BMBF AMRePACELL; Land Sachsen-Anhalt Research Group Molecular Physiology	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); COST action ECMNet(European Cooperation in Science and Technology (COST)); Federal State of Saxony-Anhalt; European Regional Development Fund(European Commission); Center for Dynamic Systems at the Otto von Guericke University Magdeburg; Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); ERANET-Neuron/BMBF AMRePACELL; Land Sachsen-Anhalt Research Group Molecular Physiology	* This work was supported in part by Deutsche Forschungsgemeinschaft Grants SFB426, SFB779, GRK1167, GU 230/6-1, and SM38/8-1), the COST action ECMNet, the Federal State of Saxony-Anhalt, the "European Regional Development Fund" (ERDF 2007-2013), and the Center for Dynamic Systems at the Otto von Guericke University Magdeburg (to D. M., C. I. S., K-H. S., and E. D. G.).; <SUP>1</SUP> Supported by Deutscher Akademischer Austauschdienst.; <SUP>2</SUP> Supported by ERANET-Neuron/BMBF AMRePACELL.; <SUP>3</SUP> Supported by Land Sachsen-Anhalt Research Group Molecular Physiology.	Anderson TR, 2004, NEUROPHARMACOLOGY, V47, P694, DOI 10.1016/j.neuropharm.2004.07.023; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bagri A, 2002, DEVELOPMENT, V129, P4249; BENARI Y, 1994, PROG BRAIN RES, V102, P261; Benson DL, 2012, CURR OPIN NEUROBIOL, V22, P397, DOI 10.1016/j.conb.2011.09.011; Boyken J, 2013, NEURON, V78, P285, DOI 10.1016/j.neuron.2013.02.027; Brussaard AB, 1997, NEURON, V19, P1103, DOI 10.1016/S0896-6273(00)80401-8; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Desrivieres S, 2015, MOL PSYCHIATR, V20, P263, DOI 10.1038/mp.2013.197; Empson RM, 2006, J NEUROCHEM, V99, P850, DOI 10.1111/j.1471-4159.2006.04123.x; Engin E, 2012, PHARMACOL THERAPEUT, V136, P142, DOI 10.1016/j.pharmthera.2012.08.006; Giannone G, 2013, CELL REP, V3, P1996, DOI 10.1016/j.celrep.2013.05.013; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Herrera-Molina R, 2012, J NEUROCHEM, V123, P113, DOI 10.1111/j.1471-4159.2012.07887.x; Herrera-Molina R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034295; Ippolito Dominic M, 2010, J Vis Exp, DOI 10.3791/2270; Kreutz MR, 2001, INVEST OPHTH VIS SCI, V42, P1907; Langnaese K, 1997, J BIOL CHEM, V272, P821, DOI 10.1074/jbc.272.2.821; Lauri SE, 1999, J NEUROSCI, V19, P1226; Lazarevic V, 2011, J NEUROSCI, V31, P10189, DOI 10.1523/JNEUROSCI.2088-11.2011; Lisman J, 2012, CURR OPIN NEUROBIOL, V22, P537, DOI 10.1016/j.conb.2011.10.018; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Mendez P, 2010, J CELL BIOL, V189, P589, DOI 10.1083/jcb.201003007; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4; Ortinski PI, 2004, J NEUROPHYSIOL, V92, P1718, DOI 10.1152/jn.00243.2004; Owczarek S, 2012, INT J BIOCHEM CELL B, V44, P1, DOI 10.1016/j.biocel.2011.10.006; Owczarek S, 2011, J NEUROCHEM, V117, P984, DOI 10.1111/j.1471-4159.2011.07269.x; Panzanelli P, 2011, J PHYSIOL-LONDON, V589, P4959, DOI 10.1113/jphysiol.2011.216028; Rao A, 2000, J NEUROSCI, V20, P8344, DOI 10.1523/JNEUROSCI.20-22-08344.2000; RONN LCB, 1995, BRAIN RES, V677, P145, DOI 10.1016/0006-8993(95)00147-I; Saito A, 2007, NEUROSCI LETT, V411, P168, DOI 10.1016/j.neulet.2006.08.042; Sakurai E, 1998, NEUROREPORT, V9, P881, DOI 10.1097/00001756-199803300-00022; Sarto-Jackson I, 2012, J BIOL CHEM, V287, P14201, DOI 10.1074/jbc.M111.293175; Schneider Gasser E. M., 2007, EUR J NEUROSCI, V25, P3287, DOI DOI 10.1111/J.1460-9568.2007.05558.X; Schobel SA, 2009, ARCH GEN PSYCHIAT, V66, P938, DOI 10.1001/archgenpsychiatry.2009.115; Schubert V, 2006, J CELL BIOL, V172, P453, DOI 10.1083/jcb.200506136; Smalla KH, 2000, P NATL ACAD SCI USA, V97, P4327, DOI 10.1073/pnas.080389297; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sylwestrak EL, 2012, SCIENCE, V338, P536, DOI 10.1126/science.1222482; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Tsuriel S, 2006, PLOS BIOL, V4, P1572, DOI 10.1371/journal.pbio.0040271; Vernes SC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002145; Watson RE, 2006, BIRTH DEFECTS RES B, V77, P471, DOI 10.1002/bdrb.20090; Williams ME, 2011, NEURON, V71, P640, DOI 10.1016/j.neuron.2011.06.019; Williams ME, 2010, NEURON, V68, P9, DOI 10.1016/j.neuron.2010.09.007; Winsky-Sommerer R, 2008, NEUROSCIENCE, V154, P595, DOI 10.1016/j.neuroscience.2008.03.081; Wouterlood FG, 2008, J NEUROSCI METH, V171, P296, DOI 10.1016/j.jneumeth.2008.03.014; Zhang C, 2010, NEURON, V66, P403, DOI 10.1016/j.neuron.2010.04.008	53	36	36	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8973	8988		10.1074/jbc.M113.514992	http://dx.doi.org/10.1074/jbc.M113.514992			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24554721	Green Published, hybrid			2022-12-28	WOS:000333472100020
J	Stewart, SE; Kondos, SC; Matthews, AY; D'Angelo, ME; Dunstone, MA; Whisstock, JC; Trapani, JA; Bird, PI				Stewart, Sarah E.; Kondos, Stephanie C.; Matthews, Antony Y.; D'Angelo, Michael E.; Dunstone, Michelle A.; Whisstock, James C.; Trapani, Joseph A.; Bird, Phillip I.			The Perforin Pore Facilitates the Delivery of Cationic Cargos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Death; Cell Permeabilization; Cellular Immune Response; Natural Killer (NK) Cell; T Cell Biology; Granzyme; MACPF; Perforin; Pore; Streptolysin O	HUMAN GRANZYME-B; PLASMA-MEMBRANE-REPAIR; MOUSE GRANZYME; CYTOCHROME-C; KILLER-CELLS; 2-COMPONENT CYTOLYSIN; CRYSTAL-STRUCTURE; STREPTOLYSIN-O; PROTEIN; TRANSLOCATION	Background: Perforin is a pore-forming protein that delivers granzymes to eliminate compromised cells. Results: The perforin pore preferentially delivers cationic molecules in comparison to anionic or neutrally charged cargo, which are inefficiently delivered. Conclusion: Perforin delivers cationic cargos more efficiently than anionic or neutral cargos. Significance: This is the first report of charge-based discrimination by the perforin pore. Cytotoxic lymphocytes eliminate virally infected or neoplastic cells through the action of cytotoxic proteases (granzymes). The pore-forming protein perforin is essential for delivery of granzymes into the cytoplasm of target cells; however the mechanism of this delivery is incompletely understood. Perforin contains a membrane attack complex/perforin (MACPF) domain and oligomerizes to form an aqueous pore in the plasma membrane; therefore the simplest (and best supported) model suggests that granzymes passively diffuse through the perforin pore into the cytoplasm of the target cell. Here we demonstrate that perforin preferentially delivers cationic molecules while anionic and neutral cargoes are delivered inefficiently. Furthermore, another distantly related pore-forming MACPF protein, pleurotolysin (from the oyster mushroom), also favors the delivery of cationic molecules, and efficiently delivers human granzyme B. We propose that this facilitated diffusion is due to conserved features of oligomerized MACPF proteins, which may include an anionic lumen.	[Whisstock, James C.; Bird, Phillip I.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Whisstock, James C.] Monash Univ, ARC Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia; [Dunstone, Michelle A.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Trapani, Joseph A.] Peter MacCallum Canc Ctr, Canc Immunol Program, East Melbourne, Vic 3002, Australia	Monash University; Monash University; Monash University; Peter Maccallum Cancer Center	Bird, PI (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	phil.bird@monash.edu	; Dunstone, Michelle/I-2895-2014	Trapani, Joseph/0000-0003-0983-1532; Whisstock, James/0000-0003-4200-5611; D'Angelo, Michael/0000-0001-9342-0132; Stewart, Sarah E/0000-0003-3712-9898; Dunstone, Michelle/0000-0002-6026-648X; Bird, Phillip/0000-0002-6695-606X	National Health and Medical Research Council (Australia)	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants (to P. I. B., J. C. W., and J. A. T.) from the National Health and Medical Research Council (Australia).	Anderluh G, 2003, J BIOL CHEM, V278, P45216, DOI 10.1074/jbc.M305916200; Anderson DH, 2003, J MOL BIOL, V325, P355, DOI 10.1016/S0022-2836(02)01234-2; BHAKDI S, 1985, INFECT IMMUN, V47, P52; Bird CH, 2005, MOL CELL BIOL, V25, P7854, DOI 10.1128/MCB.25.17.7854-7867.2005; BLUMENTHAL R, 1984, P NATL ACAD SCI-BIOL, V81, P5551, DOI 10.1073/pnas.81.17.5551; Browne KA, 1999, MOL CELL BIOL, V19, P8604; CHAN SK, 1966, BIOCHEMISTRY-US, V5, P2586, DOI 10.1021/bi00872a016; CRIADO M, 1985, J IMMUNOL, V135, P4245; DENNERT G, 1983, J EXP MED, V157, P1483, DOI 10.1084/jem.157.5.1483; DOURMASHKIN RR, 1980, CLIN EXP IMMUNOL, V42, P554; Dunstone MA, 2012, CURR OPIN STRUC BIOL, V22, P342, DOI 10.1016/j.sbi.2012.04.008; Esposti MD, 2002, APOPTOSIS, V7, P433, DOI 10.1023/A:1020035124855; Estebanez-Perpina E, 2000, BIOL CHEM, V381, P1203, DOI 10.1515/BC.2000.148; Feld GK, 2012, PROTEIN SCI, V21, P606, DOI 10.1002/pro.2052; Gilbert RJC, 2013, CELL MOL LIFE SCI, V70, P2083, DOI 10.1007/s00018-012-1153-8; Granath KA., 1958, J COLLOID SCI, V13, P308; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; Joeckel LT, 2011, CELL DEATH DIFFER, V18, P1112, DOI 10.1038/cdd.2011.5; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; Kaiserman D, 2006, J CELL BIOL, V175, P619, DOI 10.1083/jcb.200606073; Kawasaki Y, 2000, J IMMUNOL, V164, P4641, DOI 10.4049/jimmunol.164.9.4641; Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001; Kulikov AV, 2012, CELL MOL LIFE SCI, V69, P1787, DOI 10.1007/s00018-011-0895-z; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Lopez JA, 2013, J IMMUNOL, V191, P2328, DOI 10.4049/jimmunol.1301205; Lopez JA, 2013, BLOOD, V121, P2659, DOI 10.1182/blood-2012-07-446146; MALMGREN L, 1978, BRAIN RES, V153, P477, DOI 10.1016/0006-8993(78)90333-5; MASSON D, 1985, J BIOL CHEM, V260, P9069; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Metkar SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024286; Palmer M, 1998, EMBO J, V17, P1598, DOI 10.1093/emboj/17.6.1598; PETERS PJ, 1991, J EXP MED, V173, P1099, DOI 10.1084/jem.173.5.1099; PETERS R, 1990, EMBO J, V9, P2447, DOI 10.1002/j.1460-2075.1990.tb07421.x; Praper T, 2011, J BIOL CHEM, V286, P2946, DOI 10.1074/jbc.M110.169417; Richards DP, 1999, J CHROMATOGR A, V853, P21, DOI 10.1016/S0021-9673(99)00687-1; Rotonda J, 2001, CHEM BIOL, V8, P357, DOI 10.1016/S1074-5521(01)00018-7; Saini RV, 2011, J IMMUNOL, V186, P3497, DOI 10.4049/jimmunol.1003409; Sakurai N, 2004, BBA-GENE STRUCT EXPR, V1679, P65, DOI 10.1016/j.bbaexp.2004.05.002; SAUER H, 1991, BIOCHIM BIOPHYS ACTA, V1063, P137, DOI 10.1016/0005-2736(91)90363-D; Shi L, 2005, J IMMUNOL, V174, P5456, DOI 10.4049/jimmunol.174.9.5456; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Stewart SE, 2012, BBA-PROTEINS PROTEOM, V1824, P59, DOI 10.1016/j.bbapap.2011.05.020; Stewart SE, 2012, METHODS MOL BIOL, V844, P251, DOI 10.1007/978-1-61779-527-5_18; Sun JR, 1999, BIOCHEM BIOPH RES CO, V261, P251, DOI 10.1006/bbrc.1999.0989; Sun JR, 2004, J BIOL CHEM, V279, P16907, DOI 10.1074/jbc.M400563200; Sutton VR, 2008, METHODS, V44, P241, DOI 10.1016/j.ymeth.2007.11.011; Thiery J, 2011, NAT IMMUNOL, V12, P770, DOI 10.1038/ni.2050; Thiery J, 2010, BLOOD, V115, P1582, DOI 10.1182/blood-2009-10-246116; Thompson DB, 2012, CHEM BIOL, V19, P831, DOI 10.1016/j.chembiol.2012.06.014; Tomita T, 2004, J BIOL CHEM, V279, P26975, DOI 10.1074/jbc.M402676200; Trapani JA, 1998, CELL DEATH DIFFER, V5, P488, DOI 10.1038/sj.cdd.4400373; VanHaverbeke C, 2004, BIOCHEM J, V384, P93, DOI 10.1042/BJ20040757; von Ahsen O, 2000, J CELL BIOL, V150, P1027, DOI 10.1083/jcb.150.5.1027; Walev I, 2001, P NATL ACAD SCI USA, V98, P3185, DOI 10.1073/pnas.051429498; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Weller U, 1996, EUR J BIOCHEM, V236, P34, DOI 10.1111/j.1432-1033.1996.00034.x; Wilkins MR, 1999, METH MOL B, V112, P531; Wu JR, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940576	60	24	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9172	9181		10.1074/jbc.M113.544890	http://dx.doi.org/10.1074/jbc.M113.544890			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24558045	hybrid, Green Published			2022-12-28	WOS:000333472100036
J	Xu, XH; Yu, TX; Shi, JD; Chen, X; Zhang, W; Lin, T; Liu, ZH; Wang, YD; Zeng, Z; Wang, C; Li, MS; Liu, CM				Xu, Xuehe; Yu, Tianxin; Shi, Jiandang; Chen, Xi; Zhang, Wen; Lin, Ting; Liu, Zhihong; Wang, Yadong; Zeng, Zheng; Wang, Chi; Li, Mingsong; Liu, Chunming			Thymine DNA Glycosylase Is a Positive Regulator of Wnt Signaling in Colorectal Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Growth; Colorectal Cancer; Protein-Protein Interactions; Transcription Coactivators; Wnt Signaling	BETA-CATENIN; COLON-CANCER; RECTAL-CANCER; TRANSCRIPTION; CELLS; GENE; DEMETHYLATION; ACETYLATION; PROTEINS; CBP/P300	Background: Dysregulation of Wnt signaling plays a key role in colorectal cancer (CRC). Results: Thymine DNA glycosylase (TDG) enhances Wnt signaling and is required for CRC growth. Conclusion: TDG is a novel positive regulator in the Wnt pathway and CRC. Significance: TDG could be a novel biomarker and therapeutic target for CRC. Wnt signaling plays an important role in colorectal cancer (CRC). Although the mechanisms of -catenin degradation have been well studied, the mechanism by which -catenin activates transcription is still not fully understood. While screening a panel of DNA demethylases, we found that thymine DNA glycosylase (TDG) up-regulated Wnt signaling. TDG interacts with the transcription factor TCF4 and coactivator CREB-binding protein/p300 in the Wnt pathway. Knocking down TDG by shRNAs inhibited the proliferation of CRC cells in vitro and in vivo. In CRC patients, TDG levels were significantly higher in tumor tissues than in the adjacent normal tissues. These results suggest that TDG warrants consideration as a potential biomarker for CRC and as a target for CRC treatment.	[Xu, Xuehe; Yu, Tianxin; Shi, Jiandang; Chen, Xi; Zhang, Wen; Lin, Ting; Liu, Chunming] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA; [Xu, Xuehe; Lin, Ting; Liu, Zhihong; Wang, Yadong; Li, Mingsong] Southern Med Univ, Nanfang Hosp, Guangzhou 510515, Guangdong, Peoples R China; [Xu, Xuehe; Yu, Tianxin; Shi, Jiandang; Chen, Xi; Zhang, Wen; Lin, Ting; Zeng, Zheng; Wang, Chi; Liu, Chunming] Lucille P Markey Canc Ctr, Lexington, KY 40506 USA	University of Kentucky; Southern Medical University - China	Li, MS (corresponding author), Southern Med Univ, Nanfang Hosp, Guangzhou 510515, Guangdong, Peoples R China.	lims661216@foxmail.com; chunming.liu@uky.edu			National Institutes of Health [R01 DK071976, R01 CA172379]; NATIONAL CANCER INSTITUTE [P30CA177558, R01CA172379] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071976] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK071976 and R01 CA172379 (to C. L.).	Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Aravind L, 2000, GENOME BIOL, V1, P1, DOI DOI 10.1186/GB-2000-1-4-RESEARCH0007; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bhakat KK, 2004, NUCLEIC ACIDS RES, V32, P3033, DOI 10.1093/nar/gkh632; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Chen DS, 2003, J BIOL CHEM, V278, P38586, DOI 10.1074/jbc.M304286200; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; da Costa NM, 2012, CELL CYCLE, V11, P4570, DOI 10.4161/cc.22843; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Evans PM, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-22; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gong ZZ, 2011, CELL RES, V21, P1649, DOI 10.1038/cr.2011.140; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Hardeland U, 2000, J BIOL CHEM, V275, P33449, DOI 10.1074/jbc.M005095200; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Ji J, 2007, ONCOGENE, V26, P6396, DOI 10.1038/sj.onc.1210469; Kim EJ, 2008, BIOCHEM BIOPH RES CO, V377, P838, DOI 10.1016/j.bbrc.2008.10.058; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Missero C, 2001, J BIOL CHEM, V276, P33569, DOI 10.1074/jbc.M104963200; Mohan RD, 2007, MOL CELL BIOL, V27, P229, DOI 10.1128/MCB.00323-06; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; NEDDERMANN P, 1993, J BIOL CHEM, V268, P21218; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sjolund AB, 2012, MUTAT RES, V743-744, P12; Smalley MJ, 1999, EMBO J, V18, P2823, DOI 10.1093/emboj/18.10.2823; Smet-Nocca C, 2008, BIOCHEMISTRY-US, V47, P6519, DOI 10.1021/bi7022283; Smet-Nocca C, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-4; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Sun WP, 2010, J CANCER, V1, P136; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Um S, 1998, J BIOL CHEM, V273, P20728, DOI 10.1074/jbc.273.33.20728; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Vasovcak P, 2012, DNA REPAIR, V11, P616, DOI 10.1016/j.dnarep.2012.04.004; Wang F, 2013, CELL MOL LIFE SCI, V70, P3989, DOI 10.1007/s00018-012-1254-4; Waters TR, 1999, J BIOL CHEM, V274, P67, DOI 10.1074/jbc.274.1.67; WIEBAUER K, 1989, NATURE, V339, P234, DOI 10.1038/339234a0; Wolf D, 2002, J BIOL CHEM, V277, P25562, DOI 10.1074/jbc.M201196200; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Yang J, 2006, J BIOL CHEM, V281, P17751, DOI 10.1074/jbc.M600831200; Yu TX, 2012, J BIOL CHEM, V287, P3760, DOI 10.1074/jbc.M111.316349; Zhang W, 2006, MOL CELL BIOL, V26, P2055, DOI 10.1128/MCB.26.6.2055-2064.2006; Zhang W, 2009, J BIOL CHEM, V284, P22649, DOI 10.1074/jbc.M109.013698	45	18	19	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8881	8890		10.1074/jbc.M113.538835	http://dx.doi.org/10.1074/jbc.M113.538835			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24532795	hybrid, Green Published			2022-12-28	WOS:000333472100013
J	dela Paz, NG; Melchior, B; Shayo, FY; Frangos, JA				dela Paz, Nathaniel G.; Melchior, Benoit; Shayo, Francisca Y.; Frangos, John A.			Heparan Sulfates Mediate the Interaction between Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1) and the G alpha(q/11) Subunits of Heterotrimeric G Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Endothelial Cell; G Protein-coupled Receptors (GPCR); Heparan Sulfate; Heterotrimeric G Proteins; Proteoglycan; Shear Stress; PECAM-1	FLUID SHEAR-STRESS; HEMOPHILIC BINDING; TEMPORAL GRADIENT; EPITHELIAL-CELLS; RECEPTOR; FLOW; GLYCOCALYX; GLYCOSAMINOGLYCANS; PROTEOGLYCAN; SYNDECAN-1	Background: The mechanisms by which the PECAM-1G(q/11) mechanosensitive complex mediates endothelial flow responses remain unclear. Results: The PECAM-1G(q/11) complex contains heparan sulfate proteoglycans (HSPGs) and is disrupted by inhibition of HS. Conclusion: The interaction between PECAM-1 and G(q/11) may be mediated by the HS of the HSPG syndecan-1. Significance: Targeting specific HSPGs may be an effective strategy for the therapeutic treatment of vascular diseases. The endothelial cell-cell junction has emerged as a major cell signaling structure that responds to shear stress by eliciting the activation of signaling pathways. Platelet endothelial cell adhesion molecule-1 (PECAM-1) and heterotrimeric G protein subunits G(q) and 11 (G(q/11)) are junctional proteins that have been independently proposed as mechanosensors. Our previous findings suggest that they form a mechanosensitive junctional complex that discriminates between different flow profiles. The nature of the PECAM-1G(q/11) interaction is still unclear although it is likely an indirect association. Here, we investigated the role of heparan sulfates (HS) in mediating this interaction and in regulating downstream signaling in response to flow. Co-immunoprecipitation studies show that PECAM-1G(q/11) binding is dramatically decreased by competitive inhibition with heparin, pharmacological inhibition with the HS antagonist surfen, and enzymatic removal of HS chains with heparinase III treatment as well as by site-directed mutagenesis of basic residues within the extracellular domain of PECAM-1. Using an in situ proximity ligation assay, we show that endogenous PECAM-1G(q/11) interactions in endothelial cells are disrupted by both competitive inhibition and HS degradation. Furthermore, we identified the heparan sulfate proteoglycan syndecan-1 in complexes with PECAM-1 that are rapidly decreased in response to flow. Finally, we demonstrate that flow-induced Akt activation is attenuated in endothelial cells in which PECAM-1 was knocked down and reconstituted with a binding mutant. Taken together, our results indicate that the PECAM-1G(q/11) mechanosensitive complex contains an endogenous heparan sulfate proteoglycan with HS chains that is critical for junctional complex assembly and regulating the flow response.	[dela Paz, Nathaniel G.; Melchior, Benoit; Shayo, Francisca Y.; Frangos, John A.] La Jolla Bioengn Inst, San Diego, CA 92121 USA	La Jolla Bioengineering Institute	dela Paz, NG (corresponding author), La Jolla Bioengn Inst, 3535 Gen Atom Ct,Suite 210, San Diego, CA 92121 USA.	ndelapaz@ljbi.org		Melchior, Ben/0000-0002-6972-1653	National Institutes of Health MERIT Award [5R37HL040696]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL040696] Funding Source: NIH RePORTER	National Institutes of Health MERIT Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health MERIT Award 5R37HL040696.	ADAMSON RH, 1992, J PHYSIOL-LONDON, V445, P473, DOI 10.1113/jphysiol.1992.sp018934; ALBELDA SM, 1991, J CELL BIOL, V114, P1059, DOI 10.1083/jcb.114.5.1059; Ando J, 2013, CARDIOVASC RES, V99, P260, DOI 10.1093/cvr/cvt084; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Bao XP, 1999, ARTERIOSCL THROM VAS, V19, P996, DOI 10.1161/01.ATV.19.4.996; Bao XP, 2000, AM J PHYSIOL-HEART C, V278, pH1598, DOI 10.1152/ajpheart.2000.278.5.H1598; Chachisvilis M, 2006, P NATL ACAD SCI USA, V103, P15463, DOI 10.1073/pnas.0607224103; Cheng F, 2002, J BIOL CHEM, V277, P44431, DOI 10.1074/jbc.M205241200; Coombe DR, 2008, BIOCHEMISTRY-US, V47, P4863, DOI 10.1021/bi7024595; DELISSER HM, 1993, J BIOL CHEM, V268, P16037; Fleming I, 2005, J CELL SCI, V118, P4103, DOI 10.1242/jcs.02541; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; FRANGOS JA, 1985, SCIENCE, V227, P1477, DOI 10.1126/science.3883488; Fuki IV, 2003, J BIOL CHEM, V278, P34331, DOI 10.1074/jbc.M302181200; FUNG YC, 1993, J BIOMECH ENG-T ASME, V115, P1, DOI 10.1115/1.2895465; Gandhi NS, 2008, BIOCHEMISTRY-US, V47, P4851, DOI 10.1021/bi702455e; GOLDSTEIN JL, 1976, CELL, V7, P85, DOI 10.1016/0092-8674(76)90258-0; Gudi S, 1998, P NATL ACAD SCI USA, V95, P2515, DOI 10.1073/pnas.95.5.2515; Gudi SRP, 1996, CIRC RES, V79, P834, DOI 10.1161/01.RES.79.4.834; Hamon M, 2004, GLYCOBIOLOGY, V14, P311, DOI 10.1093/glycob/cwh038; Johnson BD, 2011, VASC MED, V16, P365, DOI 10.1177/1358863X11422109; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Knox S, 2005, FEBS LETT, V579, P5019, DOI 10.1016/j.febslet.2005.07.090; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Maghazachi AA, 1997, BIOCHEM BIOPH RES CO, V236, P270, DOI 10.1006/bbrc.1997.6937; MARGALIT H, 1993, J BIOL CHEM, V268, P19228; Melchior B, 2014, J CELL BIOCHEM, V115, P121, DOI 10.1002/jcb.24639; Melchior B, 2012, AM J PHYSIOL-CELL PH, V303, pC467, DOI 10.1152/ajpcell.00117.2012; Melchior B, 2010, AM J PHYSIOL-CELL PH, V299, pC621, DOI 10.1152/ajpcell.00156.2010; Nam D, 2009, AM J PHYSIOL-HEART C, V297, pH1535, DOI 10.1152/ajpheart.00510.2009; Newton JP, 1997, J BIOL CHEM, V272, P20555, DOI 10.1074/jbc.272.33.20555; Noel J, 2013, AM J PHYSIOL-LUNG C, V305, pL805, DOI 10.1152/ajplung.00123.2013; Osawa M, 2002, J CELL BIOL, V158, P773, DOI 10.1083/jcb.200205049; Otte LA, 2009, J PHYSIOL-LONDON, V587, P2365, DOI 10.1113/jphysiol.2009.172643; Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; Rosenberg RD, 1997, J CLIN INVEST, V100, pS67; Sarrazin S, 2011, COLD SPRING HARB PER, V3; Schuksz M, 2008, P NATL ACAD SCI USA, V105, P13075, DOI 10.1073/pnas.0805862105; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Slimani H, 2003, BBA-BIOMEMBRANES, V1617, P80, DOI 10.1016/j.bbamem.2003.09.006; Slimani H, 2003, GLYCOBIOLOGY, V13, P623, DOI 10.1093/glycob/cwg083; Sun QH, 1996, J BIOL CHEM, V271, P11090, DOI 10.1074/jbc.271.19.11090; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Wang DZ, 2003, BIOCHEMISTRY-US, V42, P1071, DOI 10.1021/bi026425a; WATT SM, 1993, BLOOD, V82, P2649; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Xu D, 2011, J BIOL CHEM, V286, P737, DOI 10.1074/jbc.M110.177006; Yao Y, 2007, AM J PHYSIOL-HEART C, V293, pH1023, DOI 10.1152/ajpheart.00162.2007; Yates TJ, 2013, CANCER-AM CANCER SOC, V119, P61, DOI 10.1002/cncr.27661; Yeh JC, 2008, BIOCHEMISTRY-US, V47, P9029, DOI 10.1021/bi8003846; Zako M, 2003, J BIOL CHEM, V278, P13561, DOI 10.1074/jbc.M209658200; Zeng Y, 2013, AM J PHYSIOL-HEART C, V305, pH811, DOI 10.1152/ajpheart.00764.2012	53	26	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7413	7424		10.1074/jbc.M113.542514	http://dx.doi.org/10.1074/jbc.M113.542514			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24497640	Green Published, hybrid			2022-12-28	WOS:000332761500013
J	Atkin, G; Hunt, J; Minakawa, E; Sharkey, L; Tipper, N; Tennant, W; Paulson, HL				Atkin, Graham; Hunt, Jack; Minakawa, Eiko; Sharkey, Lisa; Tipper, Nathan; Tennant, William; Paulson, Henry L.			F-box Only Protein 2 (Fbxo2) Regulates Amyloid Precursor Protein Levels and Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid Precursor Protein; Neurobiology; Protein Targeting; Synapses; Ubiquitination	ALZHEIMERS-DISEASE; UBIQUITIN LIGASE; BETA; DEGRADATION; TRAFFICKING; DYSFUNCTION; TURNOVER; SURFACE; CHIP; MICE	Background: The amyloid precursor protein (APP) is strongly implicated in the pathogenesis of Alzheimer disease. Results: The loss of Fbxo2, a brain-enriched substrate adaptor for ubiquitin ligases, leads to increased neuronal APP levels and processing. Conclusion: Fbxo2 regulates APP levels in a brain region-specific manner. Significance: These findings suggest a novel mechanism for ubiquitin-mediated regulation of amyloid- production. The amyloid precursor protein (APP) is an integral membrane glycoprotein whose cleavage products, particularly amyloid-, accumulate in Alzheimer disease (AD). APP is present at synapses and is thought to play a role in both the formation and plasticity of these critical neuronal structures. Despite the central role suggested for APP in AD pathogenesis, the mechanisms regulating APP in neurons and its processing into cleavage products remain incompletely understood. F-box only protein 2 (Fbxo2), a neuron-enriched ubiquitin ligase substrate adaptor that preferentially binds high-mannose glycans on glycoproteins, was previously implicated in APP processing by facilitating the degradation of the APP-cleaving -secretase, -site APP-cleaving enzyme. Here, we sought to determine whether Fbxo2 plays a similar role for other glycoproteins in the amyloid processing pathway. We present in vitro and in vivo evidence that APP is itself a substrate for Fbxo2. APP levels were decreased in the presence of Fbxo2 in non-neuronal cells, and increased in both cultured hippocampal neurons and brain tissue from Fbxo2 knock-out mice. The processing of APP into its cleavage products was also increased in hippocampi and cultured hippocampal neurons lacking Fbxo2. In hippocampal slices, this increase in cleavage products was accompanied by a significant reduction in APP at the cell surface. Taken together, these results suggest that Fbxo2 regulates APP levels and processing in the brain and may play a role in modulating AD pathogenesis.	[Atkin, Graham; Hunt, Jack; Minakawa, Eiko; Sharkey, Lisa; Tipper, Nathan; Tennant, William; Paulson, Henry L.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48104 USA	University of Michigan System; University of Michigan	Atkin, G (corresponding author), Rm 4160,Biomed Sci Res Bldg,109 Zina Pitcher Pl, Ann Arbor, MI 48104 USA.	atking@umich.edu; henryp@umich.edu	Hunt, Jack/AAP-3813-2021; Minakawa, Eiko N./AAB-2167-2019	Hunt, Jack/0000-0002-5719-9028; Minakawa, Eiko/0000-0002-6204-9104	National Institutes of Health [RO1 AG034228]; Michigan Alzheimer's Disease Center; NIA, National Institutes of Health [T32-AG000114]; University of Michigan Protein Folding Diseases Initiative; NATIONAL INSTITUTE ON AGING [R01AG034228, T32AG000114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Alzheimer's Disease Center; NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Michigan Protein Folding Diseases Initiative; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant RO1 AG034228, pilot research funds from the Michigan Alzheimer's Disease Center, and NIA, National Institutes of Health Grant T32-AG000114. This work was also supported by the University of Michigan Protein Folding Diseases Initiative.	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Brouwers N, 2006, BRAIN, V129, P2984, DOI 10.1093/brain/awl212; Choy RWY, 2012, P NATL ACAD SCI USA, V109, pE2077, DOI 10.1073/pnas.1208635109; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Cousins SL, 2009, J NEUROCHEM, V111, P1501, DOI 10.1111/j.1471-4159.2009.06424.x; De Strooper B, 2000, J CELL SCI, V113, P1857; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; El Ayadi A, 2012, P NATL ACAD SCI USA, V109, P13416, DOI 10.1073/pnas.1206786109; Escrevente C, 2008, BBA-GEN SUBJECTS, V1780, P905, DOI 10.1016/j.bbagen.2008.03.004; Frisoni GB, 2008, BRAIN, V131, P3266, DOI 10.1093/brain/awn280; Glenn KA, 2008, J BIOL CHEM, V283, P12717, DOI 10.1074/jbc.M709508200; Gong B, 2010, AGING CELL, V9, P1018, DOI 10.1111/j.1474-9726.2010.00632.x; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hoe HS, 2009, J BIOL CHEM, V284, P8495, DOI 10.1074/jbc.M900141200; Hooper N.M., 2010, INT J ALZHEIMERS DIS, V2011; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; Iliff AJ, 2013, HUM MOL GENET, V22, P1180, DOI 10.1093/hmg/dds525; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kaneko M, 2010, J NEUROSCI, V30, P3924, DOI 10.1523/JNEUROSCI.2422-09.2010; Kato A, 2005, P NATL ACAD SCI USA, V102, P5600, DOI 10.1073/pnas.0501769102; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Miller VM, 2005, J NEUROSCI, V25, P9152, DOI 10.1523/JNEUROSCI.3001-05.2005; Morales-Corraliza J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007134; Nelson RF, 2007, J NEUROSCI, V27, P5163, DOI 10.1523/JNEUROSCI.0206-07.2007; Nelson RF, 2006, J BIOL CHEM, V281, P20242, DOI 10.1074/jbc.M602423200; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Purro SA, 2012, J NEUROSCI, V32, P3492, DOI 10.1523/JNEUROSCI.4562-11.2012; Puzzo D, 2011, ANN NEUROL, V69, P819, DOI 10.1002/ana.22313; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sanchez MM, 2012, BIOL PSYCHIAT, V71, P403, DOI 10.1016/j.biopsych.2011.08.016; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Thomas-Crusells J, 2003, J NEUROSCI METH, V125, P159, DOI 10.1016/S0165-0270(03)00050-5; Tyan SH, 2012, MOL CELL NEUROSCI, V51, P43, DOI 10.1016/j.mcn.2012.07.009; Wang YJ, 2010, J ALZHEIMERS DIS, V21, P1065, DOI 10.3233/JAD-2010-100195; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890	38	27	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7038	7048		10.1074/jbc.M113.515056	http://dx.doi.org/10.1074/jbc.M113.515056			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24469452	Green Published, hybrid			2022-12-28	WOS:000332389400063
J	Collins, PE; Kiely, PA; Carmody, RJ				Collins, Patricia E.; Kiely, Patrick A.; Carmody, Ruaidhri J.			Inhibition of Transcription by B Cell Leukemia 3 (Bcl-3) Protein Requires Interaction with Nuclear Factor kappa B (NF-kappa B) p50	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine Induction; Inflammation; Mutagenesis; NF-B transcription factor; Ubiquitination	GENE-EXPRESSION; C-REL; RECEPTOR; PHOSPHORYLATION; COACTIVATOR; REPRESSION; REPEAT; KINASE; DOMAIN; ALPHA	Background: Bcl-3 is an essential negative regulator of cytokine expression. Results: A mutation in NF-B p50 that prevents interaction with Bcl-3 abrogates Bcl-3 inhibition of gene expression. Conclusion: The inhibition of cytokine expression by Bcl-3 requires interaction with NF-B p50. Significance: NF-B p50 is the key target of Bcl-3 anti-inflammatory activity. B cell leukemia 3 (Bcl-3) is an essential negative regulator of NF-B during Toll-like receptor and TNF receptor signaling. Bcl-3 also interacts with a number of transcriptional regulators, including homodimers of the NF-B p50 subunit. Deletion of Bcl-3 results in increased NF-B p50 ubiquitination and proteasomal degradation and increased inflammatory gene expression. We employed immobilized peptide array technology to define a region of p50 required for the formation of a Bcl-3p50 homodimer immunosuppressor complex. Our data demonstrate that amino acids 359-361 and 363 of p50 are critical for interaction with Bcl-3 and essential for Bcl-3-mediated inhibition of inflammatory gene expression. Bcl-3 is unable to interact with p50 when these amino acids are mutated, rendering it incapable of inhibiting the transcriptional activity of NF-B. Bcl-3 interaction-defective p50 is hyperubiquitinated and has a significantly reduced half-life relative to wild-type p50. Nfkb1(-/-) cells reconstituted with mutated p50 precursor p105 are hyperresponsive to TNF stimulation relative to wild-type p105, as measured by inflammatory gene expression. Mutant p105 recapitulates a Bcl3(-/-) phenotype. This study demonstrates that interaction with p50 is necessary and sufficient for the anti-inflammatory properties of Bcl-3 and further highlights the importance of p50 homodimer stability in the control of NF-B target gene expression.	[Collins, Patricia E.] Natl Univ Ireland Univ Coll Cork, Dept Biochem, Cork, Ireland; [Kiely, Patrick A.] Univ Limerick, Dept Life Sci, Limerick, Ireland; [Kiely, Patrick A.] Univ Limerick, Mat & Surface Sci Inst, Limerick, Ireland; [Carmody, Ruaidhri J.] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Ctr Immunobiol, Glasgow G12 8TA, Lanark, Scotland	University College Cork; University of Limerick; University of Limerick; University of Glasgow	Carmody, RJ (corresponding author), Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow G12 8TA, Lanark, Scotland.	ruaidhri.carmody@glasgow.ac.uk	Carmody, Ruaidhri/H-5396-2019	Collins, Patricia/0000-0002-0218-7847	Science Foundation Ireland [08/IN.1/B1843]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Science Foundation Ireland Grant 08/IN.1/B1843.	Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; Carmody RJ, 2007, SCIENCE, V317, P675, DOI 10.1126/science.1142953; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; Cheng CS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001501; Colleran A, 2013, P NATL ACAD SCI USA, V110, P618, DOI 10.1073/pnas.1208446110; COWAN R, 1990, Peptide Research, V3, P75; Dyer BW, 2000, ANAL BIOCHEM, V282, P158, DOI 10.1006/abio.2000.4605; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hishiki T, 2007, J BIOL CHEM, V282, P28335, DOI 10.1074/jbc.M702656200; Jamaluddin M, 2005, J VIROL, V79, P15302, DOI 10.1128/JVI.79.24.15302-15313.2005; Kabuta T, 2010, BIOCHEM BIOPH RES CO, V394, P697, DOI 10.1016/j.bbrc.2010.03.054; Kiely PA, 2009, J BIOL CHEM, V284, P20263, DOI 10.1074/jbc.M109.017640; Kramer A, 1998, METH MOL B, V87, P25; Latimer M, 1998, MOL CELL BIOL, V18, P2640, DOI 10.1128/MCB.18.5.2640; Michel F, 2001, EMBO J, V20, P6180, DOI 10.1093/emboj/20.22.6180; Muhlbauer M, 2008, J BIOL CHEM, V283, P14182, DOI 10.1074/jbc.M709029200; Na SY, 1998, J BIOL CHEM, V273, P30933, DOI 10.1074/jbc.273.47.30933; Na SY, 1999, J BIOL CHEM, V274, P28491, DOI 10.1074/jbc.274.40.28491; Neasta J, 2012, J BIOL CHEM, V287, P322, DOI 10.1074/jbc.M111.272195; Palmer S, 2008, IMMUNOL RES, V42, P210, DOI 10.1007/s12026-008-8075-4; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Southern SL, 2012, ONCOGENE, V31, P2761, DOI 10.1038/onc.2011.452; Viatour P, 2004, MOL CELL, V16, P35, DOI 10.1016/j.molcel.2004.09.004; Weyrich AS, 1998, P NATL ACAD SCI USA, V95, P5556, DOI 10.1073/pnas.95.10.5556; Yan Q, 2012, P NATL ACAD SCI USA, V109, P14140, DOI 10.1073/pnas.1119842109; Yang J, 2009, MOL CELL BIOL, V29, P4091, DOI 10.1128/MCB.01669-08; Zhao YJ, 2005, BIOCHEM BIOPH RES CO, V335, P865, DOI 10.1016/j.bbrc.2005.07.162	29	42	42	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7059	7067		10.1074/jbc.M114.551986	http://dx.doi.org/10.1074/jbc.M114.551986			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24459141	hybrid, Green Published			2022-12-28	WOS:000332389400065
J	Grunberg, JR; Hammarstedt, A; Hedjazifar, S; Smith, U				Grunberg, John R.; Hammarstedt, Ann; Hedjazifar, Shahram; Smith, Ulf			The Novel Secreted Adipokine WNT1-inducible Signaling Pathway Protein 2 (WISP2) Is a Mesenchymal Cell Activator of Canonical WNT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipose Tissue; Beta-catenin; Bone Morphogenetic Protein (BMP); Cell Biology; Obesity; Peroxisome Proliferator-activated receptor (PPAR); Wnt Pathway	PLURIPOTENT STEM-CELLS; HYPERTROPHIC OBESITY; METABOLIC SYNDROME; ABDOMINAL OBESITY; DIFFERENTIATION; ADIPOGENESIS; COMMITMENT; DEDIFFERENTIATION; ACCUMULATION; INFLAMMATION	Background: WISP2 is a cytosolic and secreted protein produced by precursor cells. Results: Secreted, but not cytosolic, WISP2 activates canonical WNT and prevents adipogenic differentiation. Conclusion: WISP2 is an important regulator of both adipogenic commitment and differentiation. Significance: Secreted WISP2 is a novel regulator of canonical WNT and PPAR activation. WNT1-inducible-signaling pathway protein 2 (WISP2) is primarily expressed in mesenchymal stem cells, fibroblasts, and adipogenic precursor cells. It is both a secreted and cytosolic protein, the latter regulating precursor cell adipogenic commitment and PPAR induction by BMP4. To examine the effect of the secreted protein, we expressed a full-length and a truncated, non-secreted WISP2 in NIH3T3 fibroblasts. Secreted, but not truncated WISP2 activated the canonical WNT pathway with increased -catenin levels, its nuclear targeting phosphorylation, and LRP5/6 phosphorylation. It also inhibited Pparg activation and the effect of secreted WISP2 was reversed by the WNT antagonist DICKKOPF-1. Differentiated 3T3-L1 adipose cells were also target cells where extracellular WISP2 activated the canonical WNT pathway, inhibited Pparg and associated adipose genes and, similar to WNT3a, promoted partial dedifferentiation of the cells and the induction of a myofibroblast phenotype with activation of markers of fibrosis. Thus, WISP2 exerts dual actions in mesenchymal precursor cells; secreted WISP2 activates canonical WNT and maintains the cells in an undifferentiated state, whereas cytosolic WISP2 regulates adipogenic commitment.	[Grunberg, John R.; Hammarstedt, Ann; Hedjazifar, Shahram; Smith, Ulf] Univ Gothenburg, Dept Mol & Clin Med, Lundberg Lab Diabet Res, Ctr Excellence Cardiovasc & Metab Res,Sahlgrenska, SE-41345 Gothenburg, Sweden	University of Gothenburg	Smith, U (corresponding author), Sahlgrens Univ Hosp, Dept Mol & Clin Med, Vita Straket 12 L, SE-41345 Gothenburg, Sweden.	ulf.smith@medic.gu.se		Grunberg, John/0000-0002-7839-2302	Swedish Medical Research Council [K2013-54X-03506-42-5]; Swedish ALF funds; Torsten Soderbergs Foundation; O.E and Edla Johansson Foundation; Fredrik and Ingrid Thuring Foundation; Wilhelm and Martina Lundgren Foundation; Edgar Sjolund Foundation; Novo Nordisk Foundation	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish ALF funds; Torsten Soderbergs Foundation; O.E and Edla Johansson Foundation; Fredrik and Ingrid Thuring Foundation; Wilhelm and Martina Lundgren Foundation; Edgar Sjolund Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by grants from the Swedish Medical Research Council (K2013-54X-03506-42-5), the Swedish ALF funds, the Torsten Soderbergs Foundation, the O.E and Edla Johansson Foundation, the Fredrik and Ingrid Thuring Foundation, the Wilhelm and Martina Lundgren Foundation, the Edgar Sjolund Foundation, and the Novo Nordisk Foundation.	Cervenka I, 2011, MOL CELL BIOL, V31, P179, DOI 10.1128/MCB.00550-10; Cruciat C. M., 2013, COLD SPRING HARB PER, V5; Dahlman I, 2012, ARCH PHYSIOL BIOCHEM, V118, P84, DOI 10.3109/13813455.2012.685745; Despres JP, 2008, ARTERIOSCL THROM VAS, V28, P1039, DOI 10.1161/ATVBAHA.107.159228; Fritah A, 2008, MOL CELL BIOL, V28, P1114, DOI 10.1128/MCB.01335-07; Gupta RK, 2010, NATURE, V464, P619, DOI 10.1038/nature08816; Gustafson B, 2006, J BIOL CHEM, V281, P9507, DOI 10.1074/jbc.M512077200; Gustafson B, 2013, DIABETES, V62, P2997, DOI 10.2337/db13-0473; Gustafson B, 2012, DIABETES, V61, P1217, DOI 10.2337/db11-1419; Gustafson B, 2010, J BIOL CHEM, V285, P14031, DOI 10.1074/jbc.M110.102855; Gustafson B, 2009, AM J PHYSIOL-ENDOC M, V297, pE999, DOI 10.1152/ajpendo.00377.2009; Hammarstedt A, 2013, P NATL ACAD SCI USA, V110, P2563, DOI 10.1073/pnas.1211255110; He X, 2006, CELL, V127, P40, DOI 10.1016/j.cell.2006.09.016; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Laudes M, 2011, J MOL ENDOCRINOL, V46, pR65, DOI 10.1530/JME-10-0169; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Niehrs C, 2010, CELL MOL LIFE SCI, V67, P2551, DOI 10.1007/s00018-010-0329-3; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Ohkawara B, 2011, DEV CELL, V20, P303, DOI 10.1016/j.devcel.2011.01.006; Perbal B, 2013, J CELL COMMUN SIGNAL, V7, P169, DOI 10.1007/s12079-013-0193-7; Ren SY, 2013, P NATL ACAD SCI USA, V110, P1440, DOI 10.1073/pnas.1211179110; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010; Wei J, 2011, ARTHRITIS RHEUM-US, V63, P1707, DOI 10.1002/art.30312; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Willert K., 2012, COLD SPRING HARB PER, V4	34	51	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6899	6907		10.1074/jbc.M113.511964	http://dx.doi.org/10.1074/jbc.M113.511964			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24451367	hybrid, Green Published			2022-12-28	WOS:000332389400050
J	Li, JH; Zhuo, M; Pei, L; Rajagopal, M; Yu, ASL				Li, Jiahua; Zhuo, Min; Pei, Lei; Rajagopal, Madhumitha; Yu, Alan S. L.			Comprehensive Cysteine-scanning Mutagenesis Reveals Claudin-2 Pore-lining Residues with Different Intrapore Locations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epithelial Cell; Ion Channels; Membrane Transport; Sodium Transport; Tight Junctions	TIGHT JUNCTION; CATION SELECTIVITY; EPITHELIAL-CELLS; EXPRESSION; MEMBRANE; CHANNELS	Background: The composition of the claudin paracellular pore region is incompletely known. Results: Cysteine-scanning mutagenesis of the first extracellular domain of claudin-2 was used to identify all pore-lining residues and their intrapore locations. Conclusion: This study maps out the claudin-2 pore region. Significance: This advances understanding of the structure-function relationship of claudin pores. The first extracellular loop (ECL1) of claudins forms paracellular pores in the tight junction that determine ion permselectivity. We aimed to map the pore-lining residues of claudin-2 by comprehensive cysteine-scanning mutagenesis of ECL1. We screened 45 cysteine mutations within the ECL1 by expression in polyclonal Madin-Darby canine kidney II Tet-Off cells and found nine mutants that displayed a significant decrease of conductance after treatment with the thiol-reactive reagent 2-(trimethylammonium)ethyl methanethiosulfonate, indicating the location of candidate pore-lining residues. Next, we stably expressed these candidates in monoclonal Madin-Darby canine kidney I Tet-Off cells and exposed them to thiol-reactive reagents. The maximum degree of inhibition of conductance, size selectivity of degree of inhibition, and size dependence of the kinetics of reaction were used to deduce the location of residues within the pore. Our data support the following sequence of pore-lining residues located from the narrowest to the widest part of the pore: Ser(68), Ser(47), Thr(62)/Ile(66), Thr(56), Thr(32)/Gly(45), and Met(52). The paracellular pore appears to primarily be lined by polar side chains, as expected for a predominantly aqueous environment. Furthermore, our results strongly suggest the existence of a continuous sequence of residues in the ECL1 centered around Asp(65)-Ser(68) that form a major part of the lining of the pore.	[Li, Jiahua; Zhuo, Min; Pei, Lei; Rajagopal, Madhumitha; Yu, Alan S. L.] Univ Kansas, Med Ctr, Div Nephrol & Hypertens, Kansas City, KS 66160 USA; [Li, Jiahua; Zhuo, Min; Pei, Lei; Rajagopal, Madhumitha; Yu, Alan S. L.] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66160 USA; [Pei, Lei; Yu, Alan S. L.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA; [Li, Jiahua] John H Stroger Jr Hosp Cook Cty, Dept Med, Chicago, IL 60612 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Yu, ASL (corresponding author), Univ Kansas, Med Ctr, Kidney Inst, 3901 Rainbow Blvd,Mail Stop 3018, Kansas City, KS 66160 USA.	ayu@kumc.edu	Yu, Alan/AID-7467-2022	Yu, Alan/0000-0002-1776-2533	National Institutes of Health [R01DK062283, U01GM094627]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094627] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK062283 and U01GM094627 (to A. Y.).	AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Angelow S, 2009, J BIOL CHEM, V284, P29205, DOI 10.1074/jbc.M109.043752; Colegio OR, 2002, AM J PHYSIOL-CELL PH, V283, pC142, DOI 10.1152/ajpcell.00038.2002; Colegio OR, 2003, AM J PHYSIOL-CELL PH, V284, pC1346, DOI 10.1152/ajpcell.00547.2002; Cukierman L, 2009, J VIROL, V83, P5477, DOI 10.1128/JVI.02262-08; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Karlin A, 1998, METHOD ENZYMOL, V293, P123; KIMIZUKA H, 1964, J THEOR BIOL, V6, P290, DOI 10.1016/0022-5193(64)90035-9; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li JH, 2013, J BIOL CHEM, V288, P22790, DOI 10.1074/jbc.M113.484238; Li JH, 2013, AM J PHYSIOL-CELL PH, V305, pC190, DOI 10.1152/ajpcell.00074.2013; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; Van Itallie CM, 2011, J BIOL CHEM, V286, P3442, DOI 10.1074/jbc.M110.195578; Yu ASL, 2011, METHODS MOL BIOL, V762, P27, DOI 10.1007/978-1-61779-185-7_3; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154	19	34	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6475	6484		10.1074/jbc.M113.536888	http://dx.doi.org/10.1074/jbc.M113.536888			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24436330	Green Published, hybrid			2022-12-28	WOS:000332389400015
J	Liu, C; Chen, XR; Yang, L; Kisseleva, T; Brenner, DA; Seki, E				Liu, Cheng; Chen, Xiaorong; Yang, Ling; Kisseleva, Tatiana; Brenner, David A.; Seki, Ekihiro			Transcriptional Repression of the Transforming Growth Factor beta (TGF-beta) Pseudoreceptor BMP and Activin Membrane-bound Inhibitor (BAMBI) by Nuclear Factor kappa B (NF-kappa B) p50 Enhances TGF-beta Signaling in Hepatic Stellate Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hepatic Stellate Cells; Lipopolysaccharide (LPS); NF-B; Toll-like Receptors (TLR); Transcription Promoter; Transforming Growth Factor (TGF-)	LIVER; FIBROSIS; IDENTIFICATION; INFLAMMATION; MECHANISMS; CYTOKINES; SUBUNIT; TARGET; GENE	Background: Toll-like receptor 4 (TLR4) mediates BAMBI down-regulation, which activates hepatic stellate cells (HSCs). Results: LPS and TNF- induced binding of NF-Bp50 to HDAC1, which suppressed BAMBI promoter activity and mRNA expression in HSCs. Conclusion: TLR4-mediated HSC activation is regulated by promoter regulation of BAMBI. Significance: Studying the regulation of BAMBI expression by TLR4 is important for understanding liver fibrosis. TLR4 signaling induces down-regulation of the bone morphogenic protein (BMP) and activin membrane-bound inhibitor (BAMBI), which enhances TGF- signaling during hepatic stellate cell (HSC) activation. We investigated the mechanism by which TLR4 signaling down-regulates BAMBI expression in HSCs and found that TLR4- and TNF--mediated BAMBI down-regulation is dependent on regulation of BAMBI promoter activity through the interaction with NF-Bp50 and HDAC1 in HSCs. Bambi was predominantly expressed in HSCs, at high levels in quiescent HSCs but at low levels in in vivo-activated and LPS-stimulated HSCs. In human HSCs, BAMBI expression was down-regulated in response to LPS and TNF-. A BAMBI reporter assay demonstrated that the regulatory element to repress BAMBI transcription is located between 3384 and 1560 bp upstream from the transcription start site. LPS stimulation down-regulated BAMBI expression in cells with NF-Bp65 knockdown. However, it failed to down-regulate BAMBI in cells with inactivation of NF-B or NF-Bp50 silencing, indicating that NF-Bp50 is a factor for BAMBI down-regulation. ChIP analysis revealed that LPS and TNF- induced binding of the NF-Bp50/p50 homodimer to the BAMBI promoter region. We also found that HDAC1 is bound to this region as part of the NF-Bp50-HDAC1 complex, repressing transcriptional activity of the BAMBI promoter. Finally, we confirmed that LPS does not repress BAMBI reporter activity using a BAMBI reporter construct with a mutation at 3166 bp upstream of the coding region. In summary, our study demonstrates that LPS- and TNF--induced NF-Bp50-HDAC1 interaction represses BAMBI transcriptional activity, which contributes to TLR4-mediated enhancement of TGF- signaling in HSCs during liver fibrosis.	[Liu, Cheng; Yang, Ling; Kisseleva, Tatiana; Brenner, David A.; Seki, Ekihiro] Univ Calif San Diego, Sch Med, Div Gastroenterol, Dept Med, La Jolla, CA 92093 USA; [Liu, Cheng] Shanghai Publ Clin Hlth Ctr, Ctr Sci Res, Shanghai 201508, Peoples R China; [Liu, Cheng; Chen, Xiaorong] Shanghai Publ Clin Hlth Ctr, Dept Tradit Chinese Med, Shanghai 201508, Peoples R China	University of California System; University of California San Diego	Seki, E (corresponding author), Univ Calif San Diego, Sch Med, Div Gastroenterol, Dept Med, 9500 Gilman Dr,MC 0063,LBR 118B, La Jolla, CA 92093 USA.	ekseki@ucsd.edu	Seki, Ekihiro/K-2481-2016; Liu, Cheng/I-3979-2015	Seki, Ekihiro/0000-0002-9472-6085; Brenner, David/0000-0003-2573-525X	National Institutes of Health [R01DK085252, R01AA020172, R01 GM041804]; NIEHS, National Institutes of Health [P42ES010337, 5]; National Institutes of Health/National Center for Advancing Translational Sciences/Clinical and Translational Research Institute [KL2TR000099]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099205, R01DK085252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA021856, R01AA020172, P50AA011999] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health/National Center for Advancing Translational Sciences/Clinical and Translational Research Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK085252 and R01AA020172 and NIEHS, National Institutes of Health Grant P42ES010337 (Project 5) (to E. S.); National Institutes of Health/National Center for Advancing Translational Sciences/Clinical and Translational Research Institute Grant KL2TR000099 (to T. K.); and National Institutes of Health Grant R01 GM041804 (to D. A. B.).	Aoyama T, 2010, HEPATOLOGY, V52, P1390, DOI 10.1002/hep.23795; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Baer M, 1998, MOL CELL BIOL, V18, P5678, DOI 10.1128/MCB.18.10.5678; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Cao SJ, 2006, J BIOL CHEM, V281, P26041, DOI 10.1074/jbc.M602222200; De Minicis S, 2013, AM J PATHOL, V183, P820, DOI 10.1016/j.ajpath.2013.05.030; Elsharkawy AM, 2010, J HEPATOL, V53, P519, DOI 10.1016/j.jhep.2010.03.025; Friedman SL, 2007, NAT MED, V13, P1281, DOI 10.1038/nm1107-1281; Friedman SL, 2004, HEPATOLOGY, V40, P1041, DOI 10.1002/hep.20476; Fritzmann J, 2009, GASTROENTEROLOGY, V137, P165, DOI 10.1053/j.gastro.2009.03.041; Gao ZG, 2009, J BIOL CHEM, V284, P18368, DOI 10.1074/jbc.M109.007260; Grotewold L, 2001, MECH DEVELOP, V100, P327, DOI 10.1016/S0925-4773(00)00524-4; Grundstrom S, 2004, J BIOL CHEM, V279, P8460, DOI 10.1074/jbc.M312398200; Hatano E, 2001, GASTROENTEROLOGY, V120, P1251, DOI 10.1053/gast.2001.23239; KUNSCH C, 1993, MOL CELL BIOL, V13, P6137, DOI 10.1128/MCB.13.10.6137; LEDEBUR HC, 1995, J BIOL CHEM, V270, P933, DOI 10.1074/jbc.270.2.933; Lee UE, 2011, BEST PRACT RES CL GA, V25, P195, DOI 10.1016/j.bpg.2011.02.005; Lei SG, 2012, STEM CELLS, V30, P2810, DOI 10.1002/stem.1251; Liu C, 2010, LAB INVEST, V90, P1805, DOI 10.1038/labinvest.2010.123; Luedde Tom, 2008, Hepatology, V47, P1089, DOI 10.1002/hep.22232; Luo X, 2012, DIABETES, V61, P124, DOI 10.2337/db11-0998; O'Hara SP, 2010, J BIOL CHEM, V285, P216, DOI 10.1074/jbc.M109.041640; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Schwabe RF, 2003, AM J PHYSIOL-GASTR L, V285, pG949, DOI 10.1152/ajpgi.00215.2003; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sekiya T, 2004, BIOCHEM BIOPH RES CO, V320, P680, DOI 10.1016/j.bbrc.2004.06.017; Sekiya T, 2004, J BIOL CHEM, V279, P6840, DOI 10.1074/jbc.M310876200; Villar AV, 2013, BBA-MOL BASIS DIS, V1832, P323, DOI 10.1016/j.bbadis.2012.11.007; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xavier S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012995; Yan XH, 2009, J BIOL CHEM, V284, P30097, DOI 10.1074/jbc.M109.049304; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	33	68	80	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7082	7091		10.1074/jbc.M113.543769	http://dx.doi.org/10.1074/jbc.M113.543769			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24448807	Green Published, hybrid			2022-12-28	WOS:000332389400067
J	Wan, L; Huang, J				Wan, Li; Huang, Jun			The PSO4 Protein Complex Associates with Replication Protein A (RPA) and Modulates the Activation of Ataxia Telangiectasia-mutated and Rad3-related (ATR)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Checkpoint Control; DNA Damage Response; DNA Repair; Signal Transduction	PRE-MESSENGER-RNA; DNA-DAMAGE; U-BOX; PRP19-ASSOCIATED COMPLEX; SPLICEOSOME; REPAIR; CDC5L; PRIMPOL; BINDING; PRP19	Background: The function of the PSO4 complex in response to DNA damage remains unclear. Results: The PSO4 complex is required for efficient accumulation of ATRIP at DNA damage sites and the subsequent CHK1 activation and RPA2 phosphorylation. Conclusion: The PSO4 complex modulates ATR activation through interaction with RPA. Significance: We reveal a role for RNA processing factor PSO4 in ATR activation. The PSO4 core complex is composed of PSO4/PRP19/SNEV, CDC5L, PLRG1, and BCAS2/SPF27. Besides its well defined functions in pre-mRNA splicing, the PSO4 complex has been shown recently to participate in the DNA damage response. However, the specific role for the PSO4 complex in the DNA damage response pathways is still not clear. Here we show that both the BCAS2 and PSO4 subunits of the PSO4 complex directly interact and colocalize with replication protein A (RPA). Depletion of BCAS2 or PSO4 impairs the recruitment of ATR-interacting protein (ATRIP) to DNA damage sites and compromises CHK1 activation and RPA2 phosphorylation. Moreover, we demonstrate that both the RPA1-binding ability of BCAS2 and the E3 ligase activity of PSO4 are required for efficient accumulation of ATRIP at DNA damage sites and the subsequent CHK1 activation and RPA2 phosphorylation. Our results suggest that the PSO4 complex functionally interacts with RPA and plays an important role in the DNA damage response.	[Huang, Jun] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; Zhejiang Univ, Innovat Ctr Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Huang, J (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	jhuang@zju.edu.cn	Wan, Li/AFR-0017-2022		National Program for Special Support of Eminent Professionals; National Basic Research Program of China [2012CB944402, 2013CB911003]; National Natural Science Funds for Distinguished Young Scholars; Zhejiang University K.P. Chao's High Technology Development Foundation; China Fundamental Research Funds for the Central Universities	National Program for Special Support of Eminent Professionals; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Funds for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Zhejiang University K.P. Chao's High Technology Development Foundation; China Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Program for Special Support of Eminent Professionals, National Basic Research Program of China Grants 2012CB944402 and 2013CB911003, by National Natural Science Funds for Distinguished Young Scholars, by Zhejiang University K.P. Chao's High Technology Development Foundation, and by China Fundamental Research Funds for the Central Universities.	Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Ajuh P, 2001, J BIOL CHEM, V276, P42370, DOI 10.1074/jbc.M105453200; Ball HL, 2005, MOL BIOL CELL, V16, P2372, DOI 10.1091/mbc.e04-11-1006; Beck BD, 2008, J BIOL CHEM, V283, P9023, DOI 10.1074/jbc.M800150200; Bianchi J, 2013, MOL CELL, V52, P566, DOI 10.1016/j.molcel.2013.10.035; Chan SP, 2005, J BIOL CHEM, V280, P31190, DOI 10.1074/jbc.M505060200; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Chen CH, 2006, RNA, V12, P765, DOI 10.1261/rna.2292106; Chen PH, 2013, RNA, V19, P208, DOI 10.1261/rna.034835.112; CHENG SC, 1993, MOL CELL BIOL, V13, P1876, DOI 10.1128/MCB.13.3.1876; Garcia-Gomez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025; Grey M, 1996, NUCLEIC ACIDS RES, V24, P4009, DOI 10.1093/nar/24.20.4009; Groenen PMA, 1998, GENOMICS, V49, P218, DOI 10.1006/geno.1998.5254; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Helleday T, 2013, NAT STRUCT MOL BIOL, V20, P1348, DOI 10.1038/nsmb.2727; HENRIQUES JAP, 1989, MUTAT RES, V218, P111, DOI 10.1016/0921-8777(89)90017-7; Im JS, 2013, EMBO REP, V14, P1032, DOI 10.1038/embor.2013.171; Kleinridders A, 2009, MOL CELL BIOL, V29, P3173, DOI 10.1128/MCB.01807-08; Legerski RJ, 2009, CELL CYCLE, V8, P3448, DOI 10.4161/cc.8.21.9760; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; Loscher M, 2005, BIOCHEM J, V388, P593, DOI 10.1042/BJ20041517; Lu XY, 2007, BIOCHEM BIOPH RES CO, V354, P968, DOI 10.1016/j.bbrc.2007.01.097; Maass N, 2002, CANCER LETT, V185, P219, DOI 10.1016/S0304-3835(02)00286-0; Mahajan KN, 2003, P NATL ACAD SCI USA, V100, P10746, DOI 10.1073/pnas.1631060100; Marechal A., 2014, MOL CELL, V10; Mouron S, 2013, NAT STRUCT MOL BIOL, V20, P1383, DOI 10.1038/nsmb.2719; Ohi MD, 2003, NAT STRUCT BIOL, V10, P250, DOI 10.1038/nsb906; TARN WY, 1993, MOL CELL BIOL, V13, P1883, DOI 10.1128/MCB.13.3.1883; Vander Kooi CW, 2006, BIOCHEMISTRY-US, V45, P121, DOI 10.1021/bi051787e; Wan L, 2013, EMBO REP, V14, P1104, DOI 10.1038/embor.2013.159; Wan L, 2013, P NATL ACAD SCI USA, V110, P10646, DOI 10.1073/pnas.1220921110; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Zhang NX, 2009, EMBO REP, V10, P1029, DOI 10.1038/embor.2009.122; Zhang NX, 2005, J BIOL CHEM, V280, P40559, DOI 10.1074/jbc.M508453200; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	36	43	43	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6619	6626		10.1074/jbc.M113.543439	http://dx.doi.org/10.1074/jbc.M113.543439			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24443570	hybrid, Green Published			2022-12-28	WOS:000332389400026
J	Jemth, P; Mu, X; Engstrom, A; Dogan, J				Jemth, Per; Mu, Xin; Engstrom, Ake; Dogan, Jakob			A Frustrated Binding Interface for Intrinsically Disordered Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Intrinsically Disordered Proteins; Kinetics; Protein Domains; Protein Engineering; Protein-Protein Interactions	TRANSACTIVATION DOMAIN; ACTIVATION DOMAIN; TRANSITION-STATE; COACTIVATOR; COMPLEX; MECHANISM; RECOGNITION; MODULATION; CBP/P300; SLOW	Background: Protein-protein interactions often involve intrinsically disordered protein domains. Results: The binding interface between two disordered protein domains is suboptimal, or frustrated, with regard to the energetics. Conclusion: The frustration likely results from the promiscuous binding behavior of these disordered domains. Significance: Suboptimal binding interfaces may be common among intrinsically disordered proteins with multiple binding partners. Intrinsically disordered proteins are very common in the eukaryotic proteome, and many of them are associated with diseases. Disordered proteins usually undergo a coupled binding and folding reaction and often interact with many different binding partners. Using double mutant cycles, we mapped the energy landscape of the binding interface for two interacting disordered domains and found it to be largely suboptimal in terms of interaction free energies, despite relatively high affinity. These data depict a frustrated energy landscape for interactions involving intrinsically disordered proteins, which is likely a result of their functional promiscuity.	[Jemth, Per; Mu, Xin; Engstrom, Ake; Dogan, Jakob] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden	Uppsala University	Jemth, P (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden.	per.jemth@imbim.uu.se; jakob.dogan@imbim.uu.se			Swedish Research Council (Natural and Engineering Sciences); Human Frontiers Young Investigator Science Program; Magnus Bergvall Foundation	Swedish Research Council (Natural and Engineering Sciences)(Swedish Research Council); Human Frontiers Young Investigator Science Program; Magnus Bergvall Foundation	This work was supported by the Swedish Research Council (Natural and Engineering Sciences) and the Human Frontiers Young Investigator Science Program (to P. J.) and by the Magnus Bergvall Foundation (to J. D.).	BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Dall'Acqua W, 1998, BIOCHEMISTRY-US, V37, P7981, DOI 10.1021/bi980148j; del Sol A, 2009, STRUCTURE, V17, P1042, DOI 10.1016/j.str.2009.06.008; DeLano W.L, PYMOL MOL GRAPHICS S; Demarest SJ, 2004, PROTEIN SCI, V13, P203, DOI 10.1110/ps.03366504; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Dogan J, 2013, SCI REP-UK, V3, DOI 10.1038/srep02076; Dogan J, 2012, J BIOL CHEM, V287, P34316, DOI 10.1074/jbc.M112.399436; Drobnak I, 2013, J AM CHEM SOC, V135, P1288, DOI 10.1021/ja305081b; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ebert MO, 2008, BIOCHEMISTRY-US, V47, P1299, DOI 10.1021/bi701767j; Gianni S, 2012, BIOCHEM BIOPH RES CO, V428, P205, DOI 10.1016/j.bbrc.2012.09.112; Gianni S, 2011, J BIOL CHEM, V286, P27167, DOI 10.1074/jbc.M111.239541; Goldman ER, 1997, BIOCHEMISTRY-US, V36, P49, DOI 10.1021/bi961769k; Huang YQ, 2009, J MOL BIOL, V393, P1143, DOI 10.1016/j.jmb.2009.09.010; Hultqvist G, 2013, STRUCTURE, V21, P1193, DOI 10.1016/j.str.2013.05.010; Iesmantavicius V, 2014, ANGEW CHEM INT EDIT, V53, P1548, DOI 10.1002/anie.201307712; ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616; Kiel C, 2004, J MOL BIOL, V340, P1039, DOI 10.1016/j.jmb.2004.05.050; Kjaergaard M, 2010, P NATL ACAD SCI USA, V107, P12535, DOI 10.1073/pnas.1001693107; Lee CW, 2010, BIOCHEMISTRY-US, V49, P9964, DOI 10.1021/bi1012996; Lin CH, 2001, MOL CELL, V8, P581, DOI 10.1016/S1097-2765(01)00333-1; Malatesta F, 2005, BIOPHYS CHEM, V116, P251, DOI 10.1016/j.bpc.2005.04.006; Mas C, 2011, P NATL ACAD SCI USA, V108, P10484, DOI 10.1073/pnas.1017029108; Matsuda S, 2004, J BIOL CHEM, V279, P14055, DOI 10.1074/jbc.M310188200; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Pons J, 1999, PROTEIN SCI, V8, P958, DOI 10.1110/ps.8.5.958; Qin BY, 2005, STRUCTURE, V13, P1269, DOI 10.1016/j.str.2005.06.011; Reichmann D, 2007, J MOL BIOL, V365, P663, DOI 10.1016/j.jmb.2006.09.076; Rogers JM, 2013, J AM CHEM SOC, V135, P1415, DOI 10.1021/ja309527h; Ryan CM, 2006, CELL CYCLE, V5, P2146, DOI 10.4161/cc.5.18.3207; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Shammas SL, 2012, BIOPHYS J, V103, P2203, DOI 10.1016/j.bpj.2012.10.012; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Waters L, 2006, J BIOL CHEM, V281, P14787, DOI 10.1074/jbc.M600237200; Zhou HX, 2012, TRENDS BIOCHEM SCI, V37, P43, DOI 10.1016/j.tibs.2011.11.002	39	28	28	6	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5528	5533		10.1074/jbc.M113.537068	http://dx.doi.org/10.1074/jbc.M113.537068			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24421312	Green Published, hybrid			2022-12-28	WOS:000332015500017
J	Legrain, Y; Touat-Hamici, Z; Chavatte, L				Legrain, Yona; Touat-Hamici, Zahia; Chavatte, Laurent			Interplay between Selenium Levels, Selenoprotein Expression, and Replicative Senescence in WI-38 Human Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cellular Senescence; Glutathione Peroxidase; Selenium; Thioredoxin Reductase; Translation Control; SECIS; UGA Recoding; Selenoproteome	NONSENSE-MEDIATED DECAY; RNA-BINDING PROTEIN; SELENOCYSTEINE INCORPORATION; MESSENGER-RNAS; CELLULAR SENESCENCE; UGA; TRANSLATION; DEFICIENCY; MACHINERY; COMPLEXES	Background: Selenoproteins are important enzymes for antioxidant defense, redox homeostasis, and redox signaling. Results: We report that, in WI-38 human fibroblasts, replicative senescence is controlled by selenium levels and selectively modulates selenoprotein expression. Conclusion: Our data indicate that the selenoproteome is regulated at the translational and mRNA levels in WI-38 cells. Significance: We have characterized a strong interplay between selenium levels, selenoprotein expression, and replicative senescence. Selenium is an essential trace element, which is incorporated as selenocysteine into at least 25 selenoproteins using a unique translational UGA-recoding mechanism. Selenoproteins are important enzymes involved in antioxidant defense, redox homeostasis, and redox signaling pathways. Selenium levels decline during aging, and its deficiency is associated with a marked increase in mortality for people over 60 years of age. Here, we investigate the relationship between selenium levels in the culture medium, selenoprotein expression, and replicative life span of human embryonic lung fibroblast WI-38 cells. Selenium levels regulate the entry into replicative senescence and modify the cellular markers characteristic for senescent cells. Whereas selenium supplementation extends the number of population doublings, its deficiency impairs the proliferative capacity of WI-38 cells. We observe that the expression of several selenoproteins involved in antioxidant defense is specifically affected in response to cellular senescence. Their expression is selectively controlled by the modulation of mRNA levels and translational recoding efficiencies. Our data provide novel mechanistic insights into how selenium impacts the replicative life span of mammalian cells by identifying several selenoproteins as new targets of senescence.	[Legrain, Yona; Touat-Hamici, Zahia; Chavatte, Laurent] CNRS, Ctr Genet Mol, UPR3404, F-91198 Gif Sur Yvette, France; [Chavatte, Laurent] CNRS UPPA, Lab Chim Analyt Bioinorgan & Environm, UMR5254, F-64000 Pau, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Pau et des Pays de l'Adour	Chavatte, L (corresponding author), CNRS UPPA, Lab Chim Analyt Bioinorgan & Environm, UMR5254, F-64000 Pau, France.	laurent.chavatte@univ-pau.fr		Chavatte, Laurent/0000-0001-7696-2431	CNRS (ATIP program); Fondation pour la Recherche Medicale; Ligue Contre le Cancer (Comite de l'Essonne); Association pour la Recherche sur le Cancer Grant [4849]; Programme Interdisciplinaire de Recherche du CNRS Longevite et Vieillissement; Agence Nationale de la Recherche [ANR-09-BLAN-0048]	CNRS (ATIP program); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ligue Contre le Cancer (Comite de l'Essonne); Association pour la Recherche sur le Cancer Grant; Programme Interdisciplinaire de Recherche du CNRS Longevite et Vieillissement; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the CNRS (ATIP program) (to L. C.), the Fondation pour la Recherche Medicale (to L. C.), the Ligue Contre le Cancer (Comite de l'Essonne) (to L. C.), Association pour la Recherche sur le Cancer Grant 4849 (to L. C.), the Programme Interdisciplinaire de Recherche du CNRS Longevite et Vieillissement (to L. C.), and Agence Nationale de la Recherche Grant ANR-09-BLAN-0048 (to L.C.).	Ahmed EK, 2007, ANN NY ACAD SCI, V1119, P88, DOI 10.1196/annals.1404.020; Akbaraly NT, 2005, CLIN CHEM, V51, P2117, DOI 10.1373/clinchem.2005.055301; Allmang C, 2009, BBA-GEN SUBJECTS, V1790, P1415, DOI 10.1016/j.bbagen.2009.03.003; Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Arner ESJ, 2002, METHOD ENZYMOL, V347, P226; Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; BERMANO G, 1995, BIOCHEM J, V311, P425, DOI 10.1042/bj3110425; BERRY MJ, 1994, NUCLEIC ACIDS RES, V22, P3753, DOI 10.1093/nar/22.18.3753; Berry MJ, 2001, BIOFACTORS, V14, P17, DOI 10.1002/biof.5520140104; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Budiman ME, 2009, MOL CELL, V35, P479, DOI 10.1016/j.molcel.2009.06.026; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chavatte L, 2005, NAT STRUCT MOL BIOL, V12, P408, DOI 10.1038/nsmb922; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; de Jesus LA, 2006, MOL CELL BIOL, V26, P1795, DOI 10.1128/MCB.26.5.1795-1805.2006; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Grune T, 2005, FREE RADICAL BIO MED, V39, P1208, DOI 10.1016/j.freeradbiomed.2005.06.009; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; HILL KE, 1992, BIOCHEM BIOPH RES CO, V185, P260, DOI 10.1016/S0006-291X(05)80984-2; HORNSBY PJ, 1987, EXP CELL RES, V168, P203, DOI 10.1016/0014-4827(87)90429-0; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Latreche L, 2012, RNA BIOL, V9, P681, DOI 10.4161/rna.20147; Latreche L, 2009, NUCLEIC ACIDS RES, V37, P5868, DOI 10.1093/nar/gkp635; Low SC, 2000, EMBO J, V19, P6882, DOI 10.1093/emboj/19.24.6882; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; OLIVIERI O, 1994, AM J CLIN NUTR, V60, P510, DOI 10.1093/ajcn/60.4.510; Papp LV, 2006, MOL CELL BIOL, V26, P4895, DOI 10.1128/MCB.02284-05; Ray AL, 2006, J NUTR, V136, P172, DOI 10.1093/jn/136.1.172; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Shchedrina VA, 2010, ANTIOXID REDOX SIGN, V12, P839, DOI 10.1089/ars.2009.2865; Small-Howard A, 2006, MOL CELL BIOL, V26, P2337, DOI 10.1128/MCB.26.6.2337-2346.2006; Squires JE, 2007, MOL CELL BIOL, V27, P7848, DOI 10.1128/MCB.00793-07; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Yoo MH, 2010, ANTIOXID REDOX SIGN, V12, P819, DOI 10.1089/ars.2009.2891	37	45	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6299	6310		10.1074/jbc.M113.526863	http://dx.doi.org/10.1074/jbc.M113.526863			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24425862	Green Published, hybrid			2022-12-28	WOS:000332015500081
J	Shabaneh, M; Rosental, N; Kanner, BI				Shabaneh, Mustafa; Rosental, Noa; Kanner, Baruch I.			Disulfide Cross-linking of Transport and Trimerization Domains of a Neuronal Glutamate Transporter Restricts the Role of the Substrate to the Gating of the Anion Conductance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gating; Glutamate; Membrane Biophysics; Membrane Energetics; Membrane Transport; Neurotransmitter Transport	PAIRED CYSTEINE MUTAGENESIS; AMINO-ACID TRANSPORTER; RAT-BRAIN; SULFHYDRYL MODIFICATION; CHLORIDE CONDUCTANCE; INDIVIDUAL SUBUNITS; MEMBRANE-VESICLES; REENTRANT LOOP; SODIUM; GLT-1	Background: Glutamate transporters gate anion conductance and structures of homologues are available. Results: Disulfide cross-linking of transport and trimerization domains leaves the anion conductance intact. Conclusion: The anion conducting conformation of brain glutamate transporters is associated with a limited inward movement of the transport domain. Significance: The new insights into ion conducting modes may be relevant for other transporters. Excitatory amino acid transporters remove synaptically released glutamate and maintain its concentrations below neurotoxic levels. EAATs also mediate a thermodynamically uncoupled substrate-gated anion conductance that may modulate cell excitability. A structure of an archeal homologue, which reflects an early intermediate on the proposed substrate translocation path, has been suggested to be similar to an anion conducting conformation. To probe this idea by functional studies, we have introduced two cysteine residues in the neuronal glutamate transporter EAAC1 at positions predicted to be close enough to form a disulfide bond only in outward-facing and early intermediate conformations of the homologue. Upon treatment of Xenopus laevis oocytes expressing the W441C/K269C double mutant with dithiothreitol, radioactive transport was stimulated >2-fold but potently inhibited by low micromolar concentrations of the oxidizing reagent copper(II)(1,10-phenanthroline)(3). The substrate-induced currents by the untreated double mutant, reversed at approximately -20 mV, close to the reversal potential of chloride, but treatment with dithiothreitol resulted in transport currents with the same voltage dependence as the wild type. It appears therefore that in the oocyte expression system the introduced cysteine residues in many of the mutant transporters are already cross-linked and are only capable of mediating the substrate-gated anion conductance. Reduction of the disulfide bond now allows these transporters to execute the full transport cycle. Our functional data support the idea that the anion conducting conformation of the neuronal glutamate transporter is associated with an early step of the transport cycle.	[Shabaneh, Mustafa; Rosental, Noa; Kanner, Baruch I.] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Kanner, BI (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel.	baruch.kanner@mail.huji.ac.il			National Institutes of Health from NINDS [NS 16708]; United States-Israel Binational Science Foundation [2011268]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016708, R56NS016708] Funding Source: NIH RePORTER	National Institutes of Health from NINDS; United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS 16708 from NINDS. This work was also supported by United States-Israel Binational Science Foundation Grant 2011268.	Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Auger C, 2000, NEURON, V28, P547, DOI 10.1016/S0896-6273(00)00132-X; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Benitah JP, 1996, P NATL ACAD SCI USA, V93, P7392, DOI 10.1073/pnas.93.14.7392; Borre L, 2004, J BIOL CHEM, V279, P2513, DOI 10.1074/jbc.M311446200; Borre L, 2002, J BIOL CHEM, V277, P13501, DOI 10.1074/jbc.M110861200; Borre L, 2001, J BIOL CHEM, V276, P40396, DOI 10.1074/jbc.M104926200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; Brocke L, 2002, J BIOL CHEM, V277, P3985, DOI 10.1074/jbc.M107735200; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Felts B, 2014, J BIOL CHEM, V289, P1825, DOI 10.1074/jbc.M113.504654; Focke PJ, 2011, J NEUROSCI, V31, P6255, DOI 10.1523/JNEUROSCI.6096-10.2011; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Groeneveld M, 2007, J MOL BIOL, V372, P565, DOI 10.1016/j.jmb.2007.06.067; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1982, BIOCHEMISTRY-US, V21, P6327, DOI 10.1021/bi00267a044; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; KEYNAN S, 1992, BIOCHEMISTRY-US, V31, P1974, DOI 10.1021/bi00122a011; Koch HP, 2007, J NEUROSCI, V27, P2943, DOI 10.1523/JNEUROSCI.0118-07.2007; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Leary GP, 2007, J NEUROSCI, V27, P2938, DOI 10.1523/JNEUROSCI.4851-06.2007; Levy LM, 1998, J NEUROSCI, V18, P9620, DOI 10.1523/jneurosci.18-23-09620.1998; Li J, 2013, P NATL ACAD SCI USA, V110, P7696, DOI 10.1073/pnas.1218986110; Otis TS, 2000, J NEUROSCI, V20, P2749; PerezGarcia MT, 1996, P NATL ACAD SCI USA, V93, P300, DOI 10.1073/pnas.93.1.300; PICAUD S, 1995, P NATL ACAD SCI USA, V92, P9417, DOI 10.1073/pnas.92.20.9417; PINES G, 1995, J BIOL CHEM, V270, P17093, DOI 10.1074/jbc.270.29.17093; PINES G, 1990, BIOCHEMISTRY-US, V29, P11209, DOI 10.1021/bi00503a008; Reyes N, 2009, NATURE, V462, P880, DOI 10.1038/nature08616; Ryan RM, 2007, NAT STRUCT MOL BIOL, V14, P365, DOI 10.1038/nsmb1230; Ryan RM, 2002, J BIOL CHEM, V277, P13494, DOI 10.1074/jbc.M109970200; Schicker K, 2012, J BIOL CHEM, V287, P438, DOI 10.1074/jbc.M111.304261; Seal RP, 2001, P NATL ACAD SCI USA, V98, P15324, DOI 10.1073/pnas.011400198; Shachnai L, 2005, NEUROPHARMACOLOGY, V49, P862, DOI 10.1016/j.neuropharm.2005.07.005; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; Teichman S, 2007, J GEN PHYSIOL, V129, P527, DOI 10.1085/jgp.200609707; Verdon G, 2012, NAT STRUCT MOL BIOL, V19, P355, DOI 10.1038/nsmb.2233; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0; Zhang YM, 1999, P NATL ACAD SCI USA, V96, P1710, DOI 10.1073/pnas.96.4.1710; Zhang YM, 1998, P NATL ACAD SCI USA, V95, P751, DOI 10.1073/pnas.95.2.751	52	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11175	11182		10.1074/jbc.M114.550277	http://dx.doi.org/10.1074/jbc.M114.550277			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24584931	hybrid, Green Published			2022-12-28	WOS:000334638500021
J	Galkin, A; Kulakova, L; Lim, K; Chen, CZ; Zheng, W; Turko, IV; Herzberg, O				Galkin, Andrey; Kulakova, Liudmila; Lim, Kap; Chen, Catherine Z.; Zheng, Wei; Turko, Illarion V.; Herzberg, Osnat			Structural Basis for Inactivation of Giardia lamblia Carbamate Kinase by Disulfiram	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Animal Models; Crystallography; Drug Discovery; Enzyme Inhibitors; Enzyme Structure; Parasite; Carbamate Kinase; Disulfiram; Giardia lamblia	ALDEHYDE DEHYDROGENASE; METRONIDAZOLE; RESISTANCE; MECHANISMS; TINIDAZOLE; RADIATION; CHILDREN; DAMAGE	Background: Carbamate kinase is an essential Giardia lamblia enzyme, and the anti-alcoholism drug disulfiram kills the trophozoites and inhibits the enzyme. Results: Disulfiram acts by modifying Cys-242 adjacent to the active site and cures giardiasis in mice. Conclusion:G. lamblia CK is a good drug target and disulfiram may be repurposed as antigiardiasis drug. Significance: We need new antigiardiasis drugs because current treatments fail frequently. Carbamate kinase from Giardia lamblia is an essential enzyme for the survival of the organism. The enzyme catalyzes the final step in the arginine dihydrolase pathway converting ADP and carbamoyl phosphate to ATP and carbamate. We previously reported that disulfiram, a drug used to treat chronic alcoholism, inhibits G. lamblia CK and kills G. lamblia trophozoites in vitro at submicromolar IC50 values. Here, we examine the structural basis for G. lamblia CK inhibition of disulfiram and its analog, thiram, their activities against both metronidazole-susceptible and metronidazole-resistant G. lamblia isolates, and their efficacy in a mouse model of giardiasis. The crystal structure of G. lamblia CK soaked with disulfiram revealed that the compound thiocarbamoylated Cys-242, a residue located at the edge of the active site. The modified Cys-242 prevents a conformational transition of a loop adjacent to the ADP/ATP binding site, which is required for the stacking of Tyr-245 side chain against the adenine moiety, an interaction seen in the structure of G. lamblia CK in complex with AMP-PNP. Mass spectrometry coupled with trypsin digestion confirmed the selective covalent thiocarbamoylation of Cys-242 in solution. The Giardia viability studies in the metronidazole-resistant strain and the G. lamblia CK irreversible inactivation mechanism show that the thiuram compounds can circumvent the resistance mechanism that renders metronidazole ineffectiveness in drug resistance cases of giardiasis. Together, the studies suggest that G. lamblia CK is an attractive drug target for development of novel antigiardial therapies and that disulfiram, an FDA-approved drug, is a promising candidate for drug repurposing.	[Galkin, Andrey; Kulakova, Liudmila; Lim, Kap; Turko, Illarion V.; Herzberg, Osnat] Univ Maryland, Inst Biosci & Biotechnol Res, Rockville, MD 20850 USA; [Chen, Catherine Z.; Zheng, Wei] NIH, Natl Ctr Adv Translat Sci, Bethesda, MD 20892 USA; [Turko, Illarion V.] NIST, Gaithersburg, MD 20899 USA; [Herzberg, Osnat] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park	Herzberg, O (corresponding author), Univ Maryland, Inst Biosci & Biotechnol, 9600 Gudelsky Dr, Rockville, MD 20850 USA.	osnat@umd.edu	Zheng, Wei/GOE-5990-2022; Zheng, Wei/J-8889-2014	Zheng, Wei/0000-0003-1034-0757; Herzberg, Osnat/0000-0003-2823-7627	National Institutes of Health [R56AI059733, 11XS049]; Science Applications International Corporation/NCI; Intramural Research Programs of the Therapeutics for Rare and Neglected Diseases, National Center for Advancing Translational Sciences, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI059733] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Applications International Corporation/NCI; Intramural Research Programs of the Therapeutics for Rare and Neglected Diseases, National Center for Advancing Translational Sciences, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Grant R56AI059733 (to O. H.) and Science Applications International Corporation/NCI, National Institutes of Health contract 11XS049 (to O. H.), and the Intramural Research Programs of the Therapeutics for Rare and Neglected Diseases, National Center for Advancing Translational Sciences, National Institutes of Health (to C. Z. C. and W. Z.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ankarklev J, 2010, NAT REV MICROBIOL, V8, P413, DOI 10.1038/nrmicro2317; BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; BYRD LG, 1994, INFECT IMMUN, V62, P3583, DOI 10.1128/IAI.62.8.3583-3585.1994; Canete R, 2006, CURR MED RES OPIN, V22, P2131, DOI 10.1185/030079906X132497; Chen Catherine Z, 2012, Curr Chem Genomics, V6, P93, DOI 10.2174/1875397301206010093; Chen CZ, 2011, ANTIMICROB AGENTS CH, V55, P667, DOI 10.1128/AAC.00618-10; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Escobedo AA, 2008, ANN TROP MED PARASIT, V102, P199, DOI 10.1179/136485908X267894; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fuller RK, 2004, ADDICTION, V99, P21, DOI 10.1111/j.1360-0443.2004.00597.x; Galkin A, 2010, ACTA CRYSTALLOGR F, V66, P386, DOI 10.1107/S1744309110004665; Garman EF, 2010, ACTA CRYSTALLOGR D, V66, P339, DOI 10.1107/S0907444910008656; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KARLE IL, 1967, ACTA CRYSTALLOGR, V22, P273, DOI 10.1107/S0365110X67000465; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; KITSON TM, 1983, BIOCHEM J, V213, P551, DOI 10.1042/bj2130551; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemee V, 2000, J ANTIMICROB CHEMOTH, V46, P819, DOI 10.1093/jac/46.5.819; Lim K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064004; Lipsky JJ, 2001, CHEM-BIOL INTERACT, V130, P93, DOI 10.1016/S0009-2797(00)00225-8; Malcolm R, 2008, EXPERT OPIN DRUG SAF, V7, P459, DOI [10.1517/14740338.7.4.459, 10.1517/14740338.7.4.459 ]; Nash T, 1998, ANTIMICROB AGENTS CH, V42, P1488, DOI 10.1128/AAC.42.6.1488; NASH TE, 1985, J INFECT DIS, V152, P64, DOI 10.1093/infdis/152.1.64; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; SCHOFIELD PJ, 1990, INT J PARASITOL, V20, P697, DOI 10.1016/0020-7519(90)90133-8; Tejman-Yarden N, 2011, ANTIMICROB AGENTS CH, V55, P4643, DOI 10.1128/AAC.00384-11; TOWNSON SM, 1992, T ROY SOC TROP MED H, V86, P521, DOI 10.1016/0035-9203(92)90095-T; Upcroft P, 2001, CLIN MICROBIOL REV, V14, P150, DOI 10.1128/CMR.14.1.150-164.2001; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; Wensaas KA, 2009, SCAND J PRIM HEALTH, V27, P12, DOI 10.1080/02813430802602393; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	33	44	45	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10502	10509		10.1074/jbc.M114.553123	http://dx.doi.org/10.1074/jbc.M114.553123			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24558036	Green Published, hybrid			2022-12-28	WOS:000334226400023
J	Miranda, DA; Kim, JH; Nguyen, LN; Cheng, W; Tan, BC; Goh, VJ; Tan, JSY; Yaligar, J; Prakash, KNB; Velan, SS; Wang, HY; Silver, DL				Miranda, Diego A.; Kim, Ji-Hyun; Nguyen, Long N.; Cheng, Wang; Tan, Bryan C.; Goh, Vera J.; Tan, Jolene S. Y.; Yaligar, Jadegoud; Prakash, Bhanu K. N.; Velan, S. Sendhil; Wang, Hongyan; Silver, David L.			Fat Storage-inducing Transmembrane Protein 2 Is Required for Normal Fat Storage in Adipose Tissue*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); Lipid Droplets; Lipodystrophy; Membrane Proteins; Obesity	LIPID DROPLET FORMATION; INSULIN-RESISTANCE; PPAR-GAMMA; LIPODYSTROPHY; ADIPOCYTES; PROMOTES; BINDING; FSP27	Background: FIT2 is an ER protein purported to be important for triglyceride lipid droplet formation. Results: FIT2 deficiency in adipose tissue results in lipodystrophy and metabolic dysfunction. Conclusion: FIT2 is required for normal triglyceride storage in adipose tissue. Significance: This study provides the first proof-of-principle mouse models indicating that FIT2 is essential for normal triglyceride storage in adipose tissue. Triglycerides within the cytosol of cells are stored in a phylogenetically conserved organelle called the lipid droplet (LD). LDs can be formed at the endoplasmic reticulum, but mechanisms that regulate the formation of LDs are incompletely understood. Adipose tissue has a high capacity to form lipid droplets and store triglycerides. Fat storage-inducing transmembrane protein 2 (FITM2/FIT2) is highly expressed in adipocytes, and data indicate that FIT2 has an important role in the formation of LDs in cells, but whether FIT2 has a physiological role in triglyceride storage in adipose tissue remains unproven. Here we show that adipose-specific deficiency of FIT2 (AF2KO) in mice results in progressive lipodystrophy of white adipose depots and metabolic dysfunction. In contrast, interscapular brown adipose tissue of AF2KO mice accumulated few but large LDs without changes in cellular triglyceride levels. High fat feeding of AF2KO mice or AF2KO mice on the genetically obese ob/ob background accelerated the onset of lipodystrophy. At the cellular level, primary adipocyte precursors of white and brown adipose tissue differentiated in vitro produced fewer but larger LDs without changes in total cellular triglyceride or triglyceride biosynthesis. These data support the conclusion that FIT2 plays an essential, physiological role in fat storage in vivo.	[Miranda, Diego A.; Kim, Ji-Hyun; Nguyen, Long N.; Tan, Bryan C.; Goh, Vera J.; Tan, Jolene S. Y.; Silver, David L.] Duke NUS Grad Med Sch Singapore, Signature Res Program Cardiovasc & Metab Disorder, Singapore 169857, Singapore; [Cheng, Wang; Wang, Hongyan] Duke NUS Grad Med Sch Singapore, Signature Res Program Neurosci & Behav Disorders, Singapore 169857, Singapore; [Yaligar, Jadegoud; Prakash, Bhanu K. N.; Velan, S. Sendhil] Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Lab Mol Imaging, Singapore 138667, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC)	Silver, DL (corresponding author), Duke NUS Grad Med Sch Singapore, Signature Res Program Cardiovasc & Metab Disorder, 8 Coll Rd, Singapore 169857, Singapore.	David.silver@duke-nus.edu.sg	Nguyen, Long/AAY-6172-2021; Velan, S. Sendhil/B-6374-2017; Wang, Hongyan/AAB-3030-2019; KN, Bhanu Prakash/AAI-7884-2020	Velan, S. Sendhil/0000-0002-4096-0722; Wang, Hongyan/0000-0003-4623-1878; KN, Bhanu Prakash/0000-0002-7555-7431; Yu, Fengwei/0000-0003-0268-199X; Goh, Vera/0000-0001-5260-6280; Nguyen, Long N/0000-0002-9857-2239; TAN, BRYAN CASSIDY/0000-0001-6399-8814; Silver, David/0000-0002-7289-9890	Singapore Ministry of Health's National Medical Research Council [CBRG/0012/2012]; National Research Foundation Singapore under its NRF fellowship Award [NRF2008NRF-RF001-117]; Singapore Bioimaging Consortium, from the Agency for Science, Technology and Research (A*STAR); National Science Scholarship award	Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore); National Research Foundation Singapore under its NRF fellowship Award; Singapore Bioimaging Consortium, from the Agency for Science, Technology and Research (A*STAR); National Science Scholarship award	This work was supported in part by grants from the Singapore Ministry of Health's National Medical Research Council CBRG/0012/2012 (to D. L. S.), the National Research Foundation Singapore under its NRF fellowship Award No. NRF2008NRF-RF001-117 (to H. W.), the Singapore Bioimaging Consortium, from the Agency for Science, Technology and Research (A*STAR) (to V. S. S.), and the National Science Scholarship award (to V. J. G.).	BEZDEK JC, 1981, SIAM J APPL MATH, V40, P339, DOI 10.1137/0140029; Duan SZ, 2007, J CLIN INVEST, V117, P812, DOI 10.1172/JCI28859; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Grahn THM, 2013, BIOCHEM BIOPH RES CO, V432, P296, DOI 10.1016/j.bbrc.2013.01.113; Gray SL, 2007, NUTR REV, V65, pS7, DOI [10.1111/j.1753-4887.2007.tb00331.x, 10.1301/nr.2007.jun.S7-S12]; Gross DA, 2011, P NATL ACAD SCI USA, V108, P19581, DOI 10.1073/pnas.1110817108; Gross DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010796; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Kadereit B, 2008, P NATL ACAD SCI USA, V105, P94, DOI 10.1073/pnas.0708579105; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Lankton S, 2008, IEEE T IMAGE PROCESS, V17, P2029, DOI 10.1109/TIP.2008.2004611; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Li CM, 2010, IEEE T IMAGE PROCESS, V19, P3243, DOI 10.1109/TIP.2010.2069690; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Mottillo EP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1188, DOI 10.1152/ajpendo.00051.2007; Patsouris D, 2009, J BIOL CHEM, V284, P31223, DOI 10.1074/jbc.M109.041665; Savage DB, 2009, DIS MODEL MECH, V2, P554, DOI 10.1242/dmm.002907; Soccio RE, 2011, MOL ENDOCRINOL, V25, P694, DOI 10.1210/me.2010-0454; Sun L, 2011, NAT CELL BIOL, V13, P958, DOI 10.1038/ncb2286; Sun ZQ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2581; Villanueva CJ, 2011, CELL METAB, V13, P413, DOI 10.1016/j.cmet.2011.02.014; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Yang HY, 2012, CURR OPIN CELL BIOL, V24, P509, DOI 10.1016/j.ceb.2012.05.012	25	42	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9560	9572		10.1074/jbc.M114.547687	http://dx.doi.org/10.1074/jbc.M114.547687			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24519944	Green Published, hybrid			2022-12-28	WOS:000333807000012
J	Cone, AC; Cavin, G; Ambrosi, C; Hakozaki, H; Wu-Zhang, AX; Kunkel, MT; Newton, AC; Sosinsky, GE				Cone, Angela C.; Cavin, Gabriel; Ambrosi, Cinzia; Hakozaki, Hiroyuki; Wu-Zhang, Alyssa X.; Kunkel, Maya T.; Newton, Alexandra C.; Sosinsky, Gina E.			Protein Kinase C delta- mediated Phosphorylation of Connexin43 Gap Junction Channels Causes Movement within Gap Junctions followed by Vesicle Internalization and Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Junctions; Connexin; Gap Junctions; Protein Kinase C (PKC); Protein Phosphorylation; Hemichannels; Intercellular Communication; Membrane Protein Degradation; Membrane Protein Trafficking	INTERCELLULAR COMMUNICATION; PLASMA-MEMBRANE; ZONULA OCCLUDENS-1; STRUCTURAL-CHANGES; ACTIVITY REPORTER; LIVING CELLS; LIFE-CYCLE; SERINE 368; ENDOCYTOSIS; TRAFFICKING	Background: Connexin43, a ubiquitous gap junction protein, is phosphorylated by protein kinase C on serine 368. Results: After PKC activation, phospho-Ser-368 Connexin43 channels segregated into the gap junction center and were subsequently internalized and degraded. Conclusion: PKC phosphorylation triggered internalization and degradation of Connexin43 channels without dephosphorylation. Significance: Differential phosphorylation events are used to sort and traffic Connexin43 channels within gap junctions and into the cytoplasm. Phosphorylation of gap junction proteins, connexins, plays a role in global signaling events involving kinases. Connexin43 (Cx43), a ubiquitous and important connexin, has several phosphorylation sites for specific kinases. We appended an imaging reporter tag for the activity of the isoform of protein kinase C (PKC) to the carboxyl terminus of Cx43. The FRET signal of this reporter is inversely related to the phosphorylation of serine 368 of Cx43. By activating PKC with the phorbol ester phorbol 12,13-dibutyrate (PDBu) or a natural stimulant, UTP, time lapse live cell imaging movies indicated phosphorylated Ser-368 Cx43 separated into discrete domains within gap junctions and was internalized in small vesicles, after which it was degraded by lysosomes and proteasomes. Mutation of Ser-368 to an Ala eliminated the response to PDBu and changes in phosphorylation of the reporter. A phosphatase inhibitor, calyculin A, does not change this pattern, indicating PKC phosphorylation causes degradation of Cx43 without dephosphorylation, which is in accordance with current hypotheses that cells control their intercellular communication by a fast and constant turnover of connexins, using phosphorylation as part of this mechanism.	[Cone, Angela C.; Cavin, Gabriel; Ambrosi, Cinzia; Hakozaki, Hiroyuki; Sosinsky, Gina E.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, San Diego, CA 92093 USA; [Wu-Zhang, Alyssa X.; Kunkel, Maya T.; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92093 USA; [Wu-Zhang, Alyssa X.] Univ Calif San Diego, Biomed Sci Grad Program, San Diego, CA 92093 USA; [Sosinsky, Gina E.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Sosinsky, GE (corresponding author), BSB 1070,9500 Gilman Dr, La Jolla, CA 92093 USA.	gsosinsky@ucsd.edu			National Institutes of Health [GM072881, GM043154, P01 DK054441, GM103412]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072881, P41GM103412, R01GM065937, R37GM043154, R01GM043154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM072881 (to G. E. S.) and GM043154 and P01 DK054441 (to A. C. N.). Most of the work presented here was conducted at the National Center for Microscopy and Imaging Research at San Diego, supported by National Institutes of Health Grant GM103412 (to M. Ellisman).	Bao XY, 2004, J BIOL CHEM, V279, P20058, DOI 10.1074/jbc.M311137200; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bukauskas FF, 2000, P NATL ACAD SCI USA, V97, P2556, DOI 10.1073/pnas.050588497; Cochrane K, 2013, CELL COMMUN ADHES, V20, P53, DOI 10.3109/15419061.2013.784745; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; DellAngelica EC, 1997, EMBO J, V16, P917, DOI 10.1093/emboj/16.5.917; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Ek-Vitorin JF, 2006, CIRC RES, V98, P1498, DOI 10.1161/01.RES.0000227572.45891.2c; ELFGANG C, 1995, J CELL BIOL, V129, P805, DOI 10.1083/jcb.129.3.805; Fagerholm AE, 2010, MAR DRUGS, V8, P122, DOI 10.3390/md80100122; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Gilleron J, 2011, INT J BIOCHEM CELL B, V43, P1208, DOI 10.1016/j.biocel.2011.04.014; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gumpert AM, 2008, FEBS LETT, V582, P2887, DOI 10.1016/j.febslet.2008.07.024; Hatanka K, 2004, JPN HEART J, V45, P1007, DOI 10.1536/jhj.45.1007; Hoshi N, 2010, MOL CELL, V37, P541, DOI 10.1016/j.molcel.2010.01.014; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Johnson RG, 2012, MOL BIOL CELL, V23, P71, DOI 10.1091/mbc.E11-02-0141; Kajimoto T, 2010, J BIOL CHEM, V285, P41896, DOI 10.1074/jbc.M110.184028; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; Lampe PD, 2000, ARCH BIOCHEM BIOPHYS, V384, P205, DOI 10.1006/abbi.2000.2131; Lan Z, 2005, BIOCHEMISTRY-US, V44, P2385, DOI 10.1021/bi048306w; Lauf U, 2002, P NATL ACAD SCI USA, V99, P10446, DOI 10.1073/pnas.162055899; Leithe E, 2003, CARCINOGENESIS, V24, P1239, DOI 10.1093/carcin/bgg066; Leithe E, 2012, BBA-BIOMEMBRANES, V1818, P1870, DOI 10.1016/j.bbamem.2011.09.029; Liang JY, 2008, CELL BIOL INT, V32, P1371, DOI 10.1016/j.cellbi.2008.08.007; Macia E, 2011, CIRC-ARRHYTHMIA ELEC, V4, P344, DOI 10.1161/CIRCEP.110.959312; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Mohrmann K, 2002, J BIOL CHEM, V277, P32029, DOI 10.1074/jbc.M203064200; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Nickel BM, 2008, BIOCHEM BIOPH RES CO, V374, P679, DOI 10.1016/j.bbrc.2008.07.108; Niger C, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-14; Palatinus JA, 2011, CHANNELS, V5, P236, DOI 10.4161/chan.5.3.15834; Piehl M, 2007, MOL BIOL CELL, V18, P337, DOI 10.1091/mbc.E06-06-0487; Ren P, 1998, CARCINOGENESIS, V19, P169, DOI 10.1093/carcin/19.1.169; Richards TS, 2004, J CELL BIOL, V167, P555, DOI 10.1083/jcb.200404142; Ruch RJ, 2001, J CELL BIOCHEM, V83, P163, DOI 10.1002/jcb.1227; Saez JC, 1997, J MOL CELL CARDIOL, V29, P2131, DOI 10.1006/jmcc.1997.0447; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sirnes S, 2009, BIOCHEM BIOPH RES CO, V382, P41, DOI 10.1016/j.bbrc.2009.02.141; Solan JL, 2003, J CELL SCI, V116, P2203, DOI 10.1242/jcs.00428; Solan JL, 2007, J MEMBRANE BIOL, V217, P35, DOI 10.1007/s00232-007-9035-y; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Sorgen PL, 2004, J BIOL CHEM, V279, P54695, DOI 10.1074/jbc.M409552200; Sosinsky GE, 2007, BIOCHEM J, V408, P375, DOI 10.1042/BJ20070550; Su V, 2012, J MEMBRANE BIOL, V245, P389, DOI 10.1007/s00232-012-9461-3; Su V, 2012, ARCH BIOCHEM BIOPHYS, V524, P16, DOI 10.1016/j.abb.2011.12.027; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; WarnCramer BJ, 1996, J BIOL CHEM, V271, P3779; Wu-Zhang AX, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412635	57	32	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8781	8798		10.1074/jbc.M113.533265	http://dx.doi.org/10.1074/jbc.M113.533265			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24500718	hybrid, Green Published			2022-12-28	WOS:000333472100005
J	Schafer, CM; Sheikh, MO; Zhang, DM; West, CM				Schafer, Christopher M.; Sheikh, M. Osman; Zhang, Dongmei; West, Christopher M.			Novel Regulation of Skp1 by the Dictyostelium AgtA alpha-Galactosyltransferase Involves the Skp1-binding Activity of Its WD40 Repeat Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Development; Dictyostelium; E3 Ubiquitin Ligase; Glycosylation; Glycosyltransferases; Skp1; WD40 Repeat; Cellular Slime Mold; Oxygen Sensing; Prolyl Hydroxylation	TRANSFERASE 3 BETA-4GALNAC-T3; N-ACETYLGALACTOSAMINE; PROLYL 4-HYDROXYLASE; LINKED GLYCANS; GLYCOSYLTRANSFERASES; PROTEIN; SCF; O-2	Background: AgtA mediates terminal -galactosylation of Skp1, but genetic studies show an unexpectedly profound role in oxygen sensing. Results: AgtA exhibits salt-sensitive Skp1-binding activity that competes with other Skp1 interactions but subsequently activates -galactosylation that alters Skp1 binding. AgtA regulates development through non-enzymatic mechanisms. Conclusion: AgtA modulates Skp1 interactions by a self-limiting glycosylation mechanism. Significance: Polypeptide recognition by a glycosyltransferase mediates non-enzymatic functions. The role of Skp1 as an adaptor protein that links Cullin-1 to F-box proteins in E3 Skp1/Cullin-1/F-box protein (SCF) ubiquitin ligases is well characterized. In the social amoeba Dictyostelium and probably many other unicellular eukaryotes, Skp1 is modified by a pentasaccharide attached to a hydroxyproline near its C terminus. This modification is important for oxygen-sensing during Dictyostelium development and is mediated by a HIF- type prolyl 4-hydroxylase and five sequentially acting cytoplasmic glycosyltransferase activities. Gene disruption studies show that AgtA, the enzyme responsible for addition of the final two galactose residues, in -linkages to the Skp1 core trisaccharide, is unexpectedly critical for oxygen-dependent terminal development. AgtA possesses a WD40 repeat domain C-terminal to its single catalytic domain and, by use of domain deletions, binding studies, and enzyme assays, we find that the WD40 repeats confer a salt-sensitive second-site binding interaction with Skp1 that mediates novel catalytic activation in addition to simple substrate recognition. In addition, AgtA binds similarly well to precursor isoforms of Skp1 by a salt-sensitive mechanism that competes with binding to an F-box protein and recognition by early modification enzymes, and the effect of binding is diminished when AgtA modifies Skp1. Genetic studies show that loss of AgtA is more severe when an earlier glycosylation step is blocked, and overexpressed AgtA is deleterious if catalytically inactivated. Together, the findings suggest that AgtA mediates non-enzymatic control of unmodified and substrate precursor forms of Skp1 by a binding mechanism that is normally relieved by switch-like activation of its glycosylation function.	[Schafer, Christopher M.; Sheikh, M. Osman; Zhang, Dongmei; West, Christopher M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	West, CM (corresponding author), 975 NE 10th St,BRC-417, Oklahoma City, OK 73104 USA.	Cwest2@ouhsc.edu			National Institutes of Health [R01-GM084383, R01-GM037539]; Oklahoma Center for Advancement of Science and Technology [HR10-0181]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037539, R01GM084383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for Advancement of Science and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM084383 and R01-GM037539 and Oklahoma Center for Advancement of Science and Technology Grant HR10-0181.	Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; Ercan A, 2006, J BIOL CHEM, V281, P12713, DOI 10.1074/jbc.M513664200; Fiete D, 2012, J BIOL CHEM, V287, P29194, DOI 10.1074/jbc.M112.371567; Fiete D, 2012, J BIOL CHEM, V287, P29204, DOI 10.1074/jbc.M112.371880; FUDEMGOLDIN B, 1988, J BIOCHEM BIOPH METH, V17, P199, DOI 10.1016/0165-022X(88)90004-8; FURUKAWA R, 1990, J CELL BIOL, V110, P1947, DOI 10.1083/jcb.110.6.1947; Ihara H, 2007, GLYCOBIOLOGY, V17, P455, DOI 10.1093/glycob/cwl079; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Ketcham C, 2004, J BIOL CHEM, V279, P29050, DOI 10.1074/jbc.M313858200; Mohanty S, 2001, GENE DEV, V15, P1435, DOI 10.1101/gad.871101; Oyama M, 1997, J BIOCHEM-TOKYO, V122, P64; Parikh A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r35; Pedersen JW, 2011, J BIOL CHEM, V286, P32684, DOI 10.1074/jbc.M111.273722; Pierce NW, 2013, CELL, V153, P206, DOI 10.1016/j.cell.2013.02.024; Qasba PK, 2007, GLYCOBIOLOGY, V17, p7G, DOI 10.1093/glycob/cwm013; Qian Y, 2013, P NATL ACAD SCI USA, V110, P10246, DOI 10.1073/pnas.1308453110; Sheikh M. O., 2014, BIOCHEMISTR IN PRESS; Steck TL, 1997, J EUKARYOT MICROBIOL, V44, P503, DOI 10.1111/j.1550-7408.1997.tb05731.x; Steimle PA, 2001, J BIOL CHEM, V276, P6853, DOI 10.1074/jbc.M008992200; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Tan A, 2008, BIOPHYS CHEM, V134, P64, DOI 10.1016/j.bpc.2008.01.005; van der Wel H, 2011, BIOCHEMISTRY-US, V50, P1700, DOI 10.1021/bi101977w; Wang ZA, 2011, DEV BIOL, V349, P283, DOI 10.1016/j.ydbio.2010.10.013; Wang ZA, 2009, J BIOL CHEM, V284, P28896, DOI 10.1074/jbc.M109.022574; West CM, 2007, DEVELOPMENT, V134, P3349, DOI 10.1242/dev.000893; West CM, 2010, BBA-GEN SUBJECTS, V1800, P160, DOI 10.1016/j.bbagen.2009.11.006; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wu SD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2636; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Xu YC, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-31; Xu YC, 2012, J BIOL CHEM, V287, P25098, DOI 10.1074/jbc.M112.355446; Yu LH, 2000, PROTEIN SCI, V9, P2470, DOI 10.1110/ps.9.12.2470; Zapater JL, 2012, J BIOL CHEM, V287, P6441, DOI 10.1074/jbc.M111.322024; Zemla A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2628; Zhang DM, 2012, J BIOL CHEM, V287, P2006, DOI 10.1074/jbc.M111.314021	35	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9076	9088		10.1074/jbc.M113.528679	http://dx.doi.org/10.1074/jbc.M113.528679			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24550398	hybrid, Green Published			2022-12-28	WOS:000333472100028
J	Loibl, M; Wunderle, L; Hutzler, J; Schulz, BL; Aebi, M; Strahl, S				Loibl, Martin; Wunderle, Lina; Hutzler, Johannes; Schulz, Benjamin L.; Aebi, Markus; Strahl, Sabine			Protein O-Mannosyltransferases Associate with the Translocon to Modify Translocating Polypeptide Chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); Glycosylation; Glycosyltransferases; Protein Translocation; Yeast; O-Mannosylation; OST; PMT	ENDOPLASMIC-RETICULUM MEMBRANE; PREPRO-ALPHA-FACTOR; YEAST SACCHAROMYCES-CEREVISIAE; SECRETORY PROTEIN; N-GLYCOSYLATION; OLIGOSACCHARYLTRANSFERASE COMPLEX; POSTTRANSLATIONAL TRANSLOCATION; SIGNAL SEQUENCES; SHUTTLE VECTORS; BAKERS-YEAST	Background:O-Mannosylation is a conserved, essential protein modification that is initiated in the endoplasmic reticulum (ER). Results: Protein O-mannosyltransferases act at the translocon complex to modify proteins entering the ER. Conclusion: Protein translocation into the ER, O-mannosylation, and N-glycosylation are coordinated processes. Significance: Defining the mechanism of O-mannosylation is crucial to understand its diverse physiological roles for ER homeostasis. O-Mannosylation and N-glycosylation are essential protein modifications that are initiated in the endoplasmic reticulum (ER). Protein translocation across the ER membrane and N-glycosylation are highly coordinated processes that take place at the translocon-oligosaccharyltransferase (OST) complex. In analogy, it was assumed that protein O-mannosyltransferases (PMTs) also act at the translocon, however, in recent years it turned out that prolonged ER residence allows O-mannosylation of un-/misfolded proteins or slow folding intermediates by Pmt1-Pmt2 complexes. Here, we reinvestigate protein O-mannosylation in the context of protein translocation. We demonstrate the association of Pmt1-Pmt2 with the OST, the trimeric Sec61, and the tetrameric Sec63 complex in vivo by co-immunoprecipitation. The coordinated interplay between PMTs and OST in vivo is further shown by a comprehensive mass spectrometry-based analysis of N-glycosylation site occupancy in pmt mutants. In addition, we established a microsomal translation/translocation/O-mannosylation system. Using the serine/threonine-rich cell wall protein Ccw5 as a model, we show that PMTs efficiently mannosylate proteins during their translocation into microsomes. This in vitro system will help to unravel mechanistic differences between co- and post-translocational O-mannosylation.	[Loibl, Martin; Wunderle, Lina; Hutzler, Johannes; Strahl, Sabine] Heidelberg Univ, Ctr Organismal Studies, D-69120 Heidelberg, Germany; [Schulz, Benjamin L.; Aebi, Markus] ETH, Inst Microbiol, Dept Biol, CH-8093 Zurich, Switzerland	Ruprecht Karls University Heidelberg; ETH Zurich	Strahl, S (corresponding author), Neuenheimer Feld 360, D-69120 Heidelberg, Germany.	sabine.strahl@cos.uni-heidelberg.de	Schulz, Benjamin L/B-3911-2009	Schulz, Benjamin L/0000-0002-4823-7758	Deutsche Forschungsgemeinschaft [SFB638, A18]; Swiss National Science Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft Grant SFB638, project A18, and grants from the Swiss National Science Foundation.	Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; ALBRIGHT CF, 1990, J BIOL CHEM, V265, P7042; Arroyo J, 2011, MOL MICROBIOL, V79, P1529, DOI 10.1111/j.1365-2958.2011.07537.x; ASH J, 1995, J BIOL CHEM, V270, P20847, DOI 10.1074/jbc.270.35.20847; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Cawley NX, 1998, J BIOL CHEM, V273, P584, DOI 10.1074/jbc.273.1.584; Chavan M, 2006, TRENDS BIOCHEM SCI, V31, P17, DOI 10.1016/j.tibs.2005.11.010; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dan N, 1996, J BIOL CHEM, V271, P30717, DOI 10.1074/jbc.271.48.30717; DESHAIES RJ, 1990, MOL CELL BIOL, V10, P6024, DOI 10.1128/MCB.10.11.6024; Ecker M, 2003, EMBO REP, V4, P628, DOI 10.1038/sj.embor.embor864; ESNAULT Y, 1993, EMBO J, V12, P4083, DOI 10.1002/j.1460-2075.1993.tb06092.x; FELDHEIM D, 1992, MOL CELL BIOL, V12, P3288, DOI 10.1128/MCB.12.7.3288; FELDHEIM D, 1994, J CELL BIOL, V126, P935, DOI 10.1083/jcb.126.4.935; FERRONOVICK S, 1984, J CELL BIOL, V98, P35, DOI 10.1083/jcb.98.1.35; Gao XD, 2004, GLYCOBIOLOGY, V14, P559, DOI 10.1093/glycob/cwh072; Gentzsch M, 1995, FEBS LETT, V377, P128, DOI 10.1016/0014-5793(95)01324-5; Gentzsch M, 1996, EMBO J, V15, P5752, DOI 10.1002/j.1460-2075.1996.tb00961.x; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GILMORE R, 1982, J CELL BIOL, V95, P470, DOI 10.1083/jcb.95.2.470; Girrbach V, 2003, J BIOL CHEM, V278, P12554, DOI 10.1074/jbc.M212582200; Girrbach V, 2000, J BIOL CHEM, V275, P19288, DOI 10.1074/jbc.M001771200; Gonzalez M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-213; HANSEN W, 1986, CELL, V45, P397, DOI 10.1016/0092-8674(86)90325-9; Harada Y, 2011, J BIOL CHEM, V286, P2956, DOI 10.1074/jbc.M110.159517; Harty C, 2001, MOL BIOL CELL, V12, P1093, DOI 10.1091/mbc.12.4.1093; HEESEN ST, 1993, EMBO J, V12, P279, DOI 10.1002/j.1460-2075.1993.tb05654.x; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HIGH S, 1993, J BIOL CHEM, V268, P26745; Hirayama H, 2008, J BIOCHEM, V143, P555, DOI 10.1093/jb/mvm249; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hutzler J, 2007, P NATL ACAD SCI USA, V104, P7827, DOI 10.1073/pnas.0700374104; IMMERVOLL T, 1995, YEAST, V11, P1345, DOI 10.1002/yea.320111403; KEPES F, 1988, J BIOL CHEM, V263, P9155; Knauer R, 1999, J BIOL CHEM, V274, P17249, DOI 10.1074/jbc.274.24.17249; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARRIBA G, 1976, FEBS LETT, V71, P316, DOI 10.1016/0014-5793(76)80960-X; Lehle L, 2006, ANGEW CHEM INT EDIT, V45, P6802, DOI 10.1002/anie.200601645; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Loibl M, 2013, BBA-MOL CELL RES, V1833, P2438, DOI 10.1016/j.bbamcr.2013.02.008; Lommel M, 2004, MOL CELL BIOL, V24, P46, DOI 10.1128/MCB.24.1.46-57.2004; LUSSIER M, 1995, J BIOL CHEM, V270, P2770, DOI 10.1074/jbc.270.6.2770; LYMAN SK, 1995, J CELL BIOL, V131, P1163, DOI 10.1083/jcb.131.5.1163; MEYER DI, 1982, NATURE, V297, P647, DOI 10.1038/297647a0; Nakatsukasa K, 2004, J BIOL CHEM, V279, P49762, DOI 10.1074/jbc.M403234200; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Noffz C, 2009, GLYCOBIOLOGY, V19, P472, DOI 10.1093/glycob/cwp001; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; ROTHBLATT JA, 1986, CELL, V44, P619, DOI 10.1016/0092-8674(86)90271-0; ROTHBLATT JA, 1987, EMBO J, V6, P3455, DOI 10.1002/j.1460-2075.1987.tb02669.x; ROTHBLATT JA, 1986, EMBO J, V5, P1031; Sambrook J., 2001, MOL CLONING LAB MANU; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schulz BL, 2009, MOL CELL PROTEOMICS, V8, P357, DOI 10.1074/mcp.M800219-MCP200; SIKORSKI RS, 1989, GENETICS, V122, P19; SILBERSTEIN S, 1995, J CELL BIOL, V128, P525, DOI 10.1083/jcb.128.4.525; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Strahl-Bolsinger S, 1999, J BIOL CHEM, V274, P9068, DOI 10.1074/jbc.274.13.9068; STRAHLBOLSINGER S, 1991, EUR J BIOCHEM, V196, P185, DOI 10.1111/j.1432-1033.1991.tb15802.x; Surma MA, 2013, MOL CELL, V51, P519, DOI 10.1016/j.molcel.2013.06.014; Toikkanen J, 1996, YEAST, V12, P425, DOI 10.1002/(SICI)1097-0061(199604)12:5<425::AID-YEA924>3.3.CO;2-2; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; WALTER P, 1983, METHOD ENZYMOL, V96, P84; WATZELE M, 1988, EMBO J, V7, P1483, DOI 10.1002/j.1460-2075.1988.tb02966.x; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Whitley P, 1996, J BIOL CHEM, V271, P6241, DOI 10.1074/jbc.271.11.6241; Wittke S, 2002, MOL BIOL CELL, V13, P2223, DOI 10.1091/mbc.01-10-0518; Xu CC, 2013, SCIENCE, V340, P978, DOI 10.1126/science.1234055	73	12	12	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8599	8611		10.1074/jbc.M113.543116	http://dx.doi.org/10.1074/jbc.M113.543116			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24519942	Green Published, hybrid			2022-12-28	WOS:000333157500050
J	Xie, Y; An, J; Yang, GY; Wu, G; Zhang, Y; Cui, L; Feng, Y				Xie, Yuan; An, Jiao; Yang, Guangyu; Wu, Geng; Zhang, Yong; Cui, Li; Feng, Yan			Enhanced Enzyme Kinetic Stability by Increasing Rigidity within the Active Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Lipase; Mutagenesis; Protein Design; Protein Stability; Active Site; Local Rigidity	ANTARCTICA LIPASE-B; ITERATIVE SATURATION MUTAGENESIS; ACYLPEPTIDE HYDROLASE; DIRECTED EVOLUTION; CRYSTAL-STRUCTURE; THERMOSTABILITY; STABILIZATION; INACTIVATION; EXPRESSION; RESIDUES	Background: Improving the kinetic stability of enzymes is a key issue for protein engineers. Results: Mutagenesis of residues with a high B factor located within 10 of the catalytic Ser(105) residue enhances kinetic stability dramatically. Conclusion: Increasing the rigidity of the flexible segment within the active site improves enzymatic kinetic stability. Significance: Optimization of the active site may an alternative, efficient approach for enhancing protein stabilization. Enzyme stability is an important issue for protein engineers. Understanding how rigidity in the active site affects protein kinetic stability will provide new insight into enzyme stabilization. In this study, we demonstrated enhanced kinetic stability of Candida antarctica lipase B (CalB) by mutating the structurally flexible residues within the active site. Six residues within 10 of the catalytic Ser(105) residue with a high B factor were selected for iterative saturation mutagenesis. After screening 2200 colonies, we obtained the D223G/L278M mutant, which exhibited a 13-fold increase in half-life at 48 degrees C and a 12 degrees C higher T-50(15), the temperature at which enzyme activity is reduced to 50% after a 15-min heat treatment. Further characterization showed that global unfolding resistance against both thermal and chemical denaturation also improved. Analysis of the crystal structures of wild-type CalB and the D223G/L278M mutant revealed that the latter formed an extra main chain hydrogen bond network with seven structurally coupled residues within the flexible 10 helix that are primarily involved in forming the active site. Further investigation of the relative B factor profile and molecular dynamics simulation confirmed that the enhanced rigidity decreased fluctuation of the active site residues at high temperature. These results indicate that enhancing the rigidity of the flexible segment within the active site may provide an efficient method for improving enzyme kinetic stability.	[Xie, Yuan; An, Jiao; Yang, Guangyu; Wu, Geng; Zhang, Yong; Cui, Li; Feng, Yan] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, Shanghai 200240, Peoples R China; [Xie, Yuan; An, Jiao] Jilin Univ, Key Lab Mol Enzymol & Engn, Minist Educ, Changchun 130023, Peoples R China	Shanghai Jiao Tong University; Jilin University	Feng, Y (corresponding author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, State Key Lab Microbial Metab, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	yfeng2009@sjtu.edu.cn			National Basic Research Program of China (973 Program) [2012CB721003, 2011CBA00800]; Natural Science Foundation of China [31370106]; National High Technology Research and Development Program of China [2013AA102801]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National Basic Research Program of China (973 Program Grants 2012CB721003 and 2011CBA00800), the Natural Science Foundation of China (Grant 31370106), and the National High Technology Research and Development Program of China (Grant 2013AA102801).	Acharya P, 2004, J MOL BIOL, V341, P1271, DOI 10.1016/j.jmb.2004.06.059; Ahmad S, 2008, J MOL BIOL, V381, P324, DOI 10.1016/j.jmb.2008.05.063; Eijsink VGH, 2004, J BIOTECHNOL, V113, P105, DOI 10.1016/j.jbiotec.2004.03.026; Gallardo O, 2010, J BIOL CHEM, V285, P2721, DOI 10.1074/jbc.M109.064394; Hasan F, 2006, ENZYME MICROB TECH, V39, P235, DOI 10.1016/j.enzmictec.2005.10.016; Imani M, 2010, PHOTOCH PHOTOBIO SCI, V9, P1167, DOI 10.1039/c0pp00105h; Iyer PV, 2008, PROCESS BIOCHEM, V43, P1019, DOI 10.1016/j.procbio.2008.06.004; Jaeger KE, 1998, TRENDS BIOTECHNOL, V16, P396, DOI 10.1016/S0167-7799(98)01195-0; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; Joo JC, 2010, J BIOTECHNOL, V146, P31, DOI 10.1016/j.jbiotec.2009.12.021; Kamal MZ, 2011, J MOL BIOL, V413, P726, DOI 10.1016/j.jmb.2011.09.002; Kamondi S, 2008, BIOCHEM BIOPH RES CO, V374, P725, DOI 10.1016/j.bbrc.2008.07.095; Kim HS, 2010, ENZYME MICROB TECH, V47, P1, DOI 10.1016/j.enzmictec.2010.04.003; Kim SJ, 2010, BIOTECHNOL PROGR, V26, P1038, DOI 10.1002/btpr.408; Koudelakova T, 2013, ANGEW CHEM INT EDIT, V52, P1959, DOI 10.1002/anie.201206708; Larsen MW, 2008, PROTEIN EXPRES PURIF, V62, P90, DOI 10.1016/j.pep.2008.07.012; Li BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041629; Liang XL, 2010, APPL MICROBIOL BIOT, V87, P999, DOI 10.1007/s00253-010-2534-2; MASUI A, 1994, APPL ENVIRON MICROB, V60, P3579, DOI 10.1128/AEM.60.10.3579-3584.1994; Perl D, 2002, CHEMBIOCHEM, V3, P39, DOI 10.1002/1439-7633(20020104)3:1<39::AID-CBIC39>3.0.CO;2-D; Quang ATL, 2012, BIOTECHNOL BIOENG, V109, P867, DOI 10.1002/bit.24371; Reetz MT, 2008, CHEMBIOCHEM, V9, P1797, DOI 10.1002/cbic.200800298; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Reetz MT, 2006, ANGEW CHEM INT EDIT, V45, P7745, DOI 10.1002/anie.200602795; Reetz MT, 2009, ANGEW CHEM INT EDIT, V48, P8268, DOI 10.1002/anie.200904209; Singh AK, 2012, APPL BIOCHEM BIOTECH, V166, P486, DOI 10.1007/s12010-011-9444-3; Skjot M, 2009, CHEMBIOCHEM, V10, P520, DOI 10.1002/cbic.200800668; Tian JA, 2010, FEBS J, V277, P4901, DOI 10.1111/j.1742-4658.2010.07895.x; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Treichel H, 2010, FOOD BIOPROCESS TECH, V3, P182, DOI 10.1007/s11947-009-0202-2; TSOU CL, 1993, SCIENCE, V262, P380, DOI 10.1126/science.8211158; TSOU CL, 1995, BBA-PROTEIN STRUCT M, V1253, P151, DOI 10.1016/0167-4838(95)00172-5; UPPENBERG J, 1994, STRUCTURE, V2, P293, DOI 10.1016/S0969-2126(00)00031-9; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Voutilainen SP, 2010, PROTEIN ENG DES SEL, V23, P69, DOI 10.1093/protein/gzp072; Voutilainen SP, 2009, APPL MICROBIOL BIOT, V83, P261, DOI 10.1007/s00253-008-1848-9; Wulf H, 2012, ENZYME MICROB TECH, V51, P217, DOI 10.1016/j.enzmictec.2012.06.006; Yang GY, 2009, BBA-PROTEINS PROTEOM, V1794, P94, DOI 10.1016/j.bbapap.2008.09.007; Yi ZL, 2011, BIORESOURCE TECHNOL, V102, P3636, DOI 10.1016/j.biortech.2010.11.043; Yu XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046388; Yun BY, 2011, BIOCHEM BIOPH RES CO, V416, P92, DOI 10.1016/j.bbrc.2011.11.002; Zhang JH, 2012, ENZYME MICROB TECH, V50, P325, DOI 10.1016/j.enzmictec.2012.03.002; Zhang NY, 2003, PROTEIN ENG, V16, P599, DOI 10.1093/protein/gzg074; Zhang ZM, 2008, BBA-PROTEINS PROTEOM, V1784, P1176, DOI 10.1016/j.bbapap.2008.05.011	44	169	188	8	157	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7994	8006		10.1074/jbc.M113.536045	http://dx.doi.org/10.1074/jbc.M113.536045			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24448805	hybrid, Green Published			2022-12-28	WOS:000332761500063
J	Kuo, NW; Gao, YG; Schill, MS; Isern, N; Dupureur, CM; LiWang, PJ				Kuo, Nai-Wei; Gao, Yong-Guang; Schill, Megan S.; Isern, Nancy; Dupureur, Cynthia M.; LiWang, Patricia J.			Structural Insights into the Interaction between a Potent Anti-inflammatory Protein, Viral CC Chemokine Inhibitor (vCCI), and the Human CC Chemokine, Eotaxin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biophysics; Chemokines; Molecular Docking; NMR; Protein-Protein Interactions; Anti-inflammatory Protein; Chemokine-binding Protein; Eotaxin; Fluorescence Anisotropy; vCCI	TRIPLE-RESONANCE EXPERIMENTS; BINDING-PROTEIN; VACCINIA VIRUS; DECOY RECEPTOR; CRYSTAL-STRUCTURE; WEB SERVER; INFLAMMATION; RECOGNITION; BLOCKADE; DETERMINANTS	Background: The mechanism used by viral protein vCCI to tightly bind to many CC chemokines is not known. Results: Specific positively charged residues in the chemokine eotaxin-1 mediate binding to vCCI. Conclusion: Basic residues in the chemokine each provide incremental affinity for vCCI. Significance: This work shows how vCCI can bind a variety of CC chemokines. Chemokines play important roles in the immune system, not only recruiting leukocytes to the site of infection and inflammation but also guiding cell homing and cell development. The soluble poxvirus-encoded protein viral CC chemokine inhibitor (vCCI), a CC chemokine inhibitor, can bind to human CC chemokines tightly to impair the host immune defense. This protein has no known homologs in eukaryotes and may represent a potent method to stop inflammation. Previously, our structure of the vCCIMIP-1 (macrophage inflammatory protein-1) complex indicated that vCCI uses negatively charged residues in -sheet II to interact with positively charged residues in the MIP-1 N terminus, 20s region and 40s loop. However, the interactions between vCCI and other CC chemokines have not yet been fully explored. Here, we used NMR and fluorescence anisotropy to study the interaction between vCCI and eotaxin-1 (CCL11), a CC chemokine that is an important factor in the asthma response. NMR results reveal that the binding pattern is very similar to the vCCIMIP-1 complex and suggest that electrostatic interactions provide a major contribution to binding. Fluorescence anisotropy results on variants of eotaxin-1 further confirm the critical roles of the charged residues in eotaxin-1. In addition, the binding affinity between vCCI and other wild type CC chemokines, MCP-1 (monocyte chemoattractant protein-1), MIP-1, and RANTES (regulated on activation normal T cell expressed and secreted), were determined as 1.1, 1.2, and 0.22 nm, respectively. To our knowledge, this is the first work quantitatively measuring the binding affinity between vCCI and multiple CC chemokines.	[Kuo, Nai-Wei; Schill, Megan S.; LiWang, Patricia J.] Univ Calif, Merced, CA 95343 USA; [Gao, Yong-Guang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Isern, Nancy] William R Wiley Environm Mol Sci Lab, High Field NMR Facil, Richland, WA 99352 USA; [Dupureur, Cynthia M.] Univ Missouri, Dept Chem & Biochem, St Louis, MO 63121 USA	University of California System; University of California Merced; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Missouri System; University of Missouri Saint Louis	LiWang, PJ (corresponding author), Univ Calif, Dept Mol Cell Biol, 5200 N Lake Rd, Merced, CA 95343 USA.	pliwang@ucmerced.edu	Gao, Yongguang/B-8546-2012	Gao, Yongguang/0000-0002-9359-4252	Department of Energy's Office of Biological and Environmental Research	Department of Energy's Office of Biological and Environmental Research(United States Department of Energy (DOE))	We thank Dr. Yong-Gang Chang and Dr. Li Zhang. A portion of the research was performed using EMSL, a national scientific user facility sponsored by the Department of Energy's Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory.	Alcami A, 1998, J IMMUNOL, V160, P624; Alexander JM, 2002, CELL, V111, P343, DOI 10.1016/S0092-8674(02)01007-3; Alexander-Brett JM, 2007, J EXP MED, V204, P3157, DOI 10.1084/jem.20071677; Antonets Denis V, 2010, BMC Res Notes, V3, P271, DOI 10.1186/1756-0500-3-271; Arnold PL, 2006, J VIROL, V80, P7439, DOI 10.1128/JVI.00576-06; Bahar MW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040005; Beck CG, 2001, J BIOL CHEM, V276, P43270, DOI 10.1074/jbc.M106305200; Bisset LR, 2005, CURR OPIN PULM MED, V11, P35, DOI 10.1097/01.mcp.0000144502.50149.e0; Boshoff C, 1997, SCIENCE, V278, P290, DOI 10.1126/science.278.5336.290; Burns JM, 2002, J BIOL CHEM, V277, P2785, DOI 10.1074/jbc.M109884200; Carfi A, 1999, P NATL ACAD SCI USA, V96, P12379, DOI 10.1073/pnas.96.22.12379; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Conlan LH, 2002, BIOCHEMISTRY-US, V41, P1335, DOI 10.1021/bi015843x; Crump MP, 1998, J BIOL CHEM, V273, P22471, DOI 10.1074/jbc.273.35.22471; Dabbagh K, 2000, J IMMUNOL, V165, P3418, DOI 10.4049/jimmunol.165.6.3418; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delaglio L. K., 2004, DYNAMO STRUCTURE CAL; DeRider ML, 2006, J BIOMOL NMR, V36, P22, DOI [10.1007/s10858-005-6276-x, 10.1007/s10858-006-9021-1]; Dias JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008514; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Gabriel P, 2012, VIRAL IMMUNOL, V25, P411, DOI 10.1089/vim.2011.0090; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; Goddard T. D., SPARKY 3; Graham KA, 1997, VIROLOGY, V229, P12, DOI 10.1006/viro.1996.8423; Hemmerich S, 1999, BIOCHEMISTRY-US, V38, P13013, DOI 10.1021/bi991029m; Hogan SP, 2007, INT ARCH ALLERGY IMM, V143, P3, DOI 10.1159/000101398; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; Kledal TN, 1997, SCIENCE, V277, P1656, DOI 10.1126/science.277.5332.1656; Kledal TN, 1998, FEBS LETT, V441, P209, DOI 10.1016/S0014-5793(98)01551-8; Koopmann W, 1999, J IMMUNOL, V163, P2120; KUHN DE, 1995, BIOCHEM BIOPH RES CO, V211, P325, DOI 10.1006/bbrc.1995.1814; Kunkel SL, 1996, J LEUKOCYTE BIOL, V59, P6, DOI 10.1002/jlb.59.1.6; Lalani AS, 1999, CYTOKINE GROWTH F R, V10, P219, DOI 10.1016/S1359-6101(99)00018-0; Lalani AS, 1997, J VIROL, V71, P4356, DOI 10.1128/JVI.71.6.4356-4363.1997; Lau EK, 2004, ADV PROTEIN CHEM, V68, P351; Laurence JS, 2000, BIOCHEMISTRY-US, V39, P3401, DOI 10.1021/bi9923196; Loria JP, 1999, J MAGN RESON, V141, P180, DOI 10.1006/jmre.1999.1891; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; McCornack MA, 2003, J BIOL CHEM, V278, P1946, DOI 10.1074/jbc.M207440200; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Nardese V, 2001, NAT STRUCT BIOL, V8, P611, DOI 10.1038/89653; Pease JE, 2011, BIOCHEM J, V434, P11, DOI 10.1042/BJ20101132; Pickup JC, 2004, DIABETES CARE, V27, P813, DOI 10.2337/diacare.27.3.813; Reid SL, 2001, BIOCHEMISTRY-US, V40, P2484, DOI 10.1021/bi001956p; RIVADEPATY I, 1994, EXP NEUROL, V128, P77, DOI 10.1006/exnr.1994.1114; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004; Salzmann M, 1999, J BIOMOL NMR, V15, P181, DOI 10.1023/A:1008358030477; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Seet BT, 2002, J LEUKOCYTE BIOL, V72, P24; Seet BT, 2001, P NATL ACAD SCI USA, V98, P9008, DOI 10.1073/pnas.171069398; Smith CA, 1997, VIROLOGY, V236, P316, DOI 10.1006/viro.1997.8730; Sozzani S, 1998, BLOOD, V92, P4036, DOI 10.1182/blood.V92.11.4036.423k17_4036_4039; Terkeltaub R, 1998, CURR OPIN LIPIDOL, V9, P397, DOI 10.1097/00041433-199810000-00003; Tjandra N, 1996, J AM CHEM SOC, V118, P6264, DOI 10.1021/ja960106n; vanAcker FAA, 1996, MEDIAT INFLAMM, V5, P393, DOI 10.1155/S0962935196000567; Vicari AP, 2002, CYTOKINE GROWTH F R, V13, P143, DOI 10.1016/S1359-6101(01)00033-8; Webb LMC, 2004, FASEB J, V18, P571, DOI 10.1096/fj.03-0485fje; Weber KSC, 2001, EUR J IMMUNOL, V31, P2458, DOI 10.1002/1521-4141(200108)31:8<2458::AID-IMMU2458>3.0.CO;2-L; Wells TNC, 2006, TRENDS PHARMACOL SCI, V27, P41, DOI 10.1016/j.tips.2005.11.001; White GE, 2011, MOL PHARMACOL, V80, P328, DOI 10.1124/mol.111.071985; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Xue J., 2013, BIOCH PHYSL, DOI [10.4172/2168-9652.S2-005, DOI 10.4172/2168-9652.S2-005]; Zhang L, 2006, P NATL ACAD SCI USA, V103, P13985, DOI 10.1073/pnas.0602142103; Zimmermann N, 2003, J ALLERGY CLIN IMMUN, V111, P227, DOI 10.1067/mai.2003.139	70	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6592	6603		10.1074/jbc.M113.538991	http://dx.doi.org/10.1074/jbc.M113.538991			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24482230	Green Published, hybrid			2022-12-28	WOS:000332389400024
J	Glauben, R; Sonnenberg, E; Wetzel, M; Mascagni, P; Siegmund, B				Glauben, Rainer; Sonnenberg, Elena; Wetzel, Martin; Mascagni, Paolo; Siegmund, Britta			Histone Deacetylase Inhibitors Modulate Interleukin 6-dependent CD4(+) T Cell Polarization in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Colitis; Histone Deacetylase Inhibitors; Inflammatory Bowel Disease; Macrophages; STAT3; IL-6R; Il-17; T Helper Cells; Promoter Acetylation	INFLAMMATORY-BOWEL-DISEASE; SUBEROYLANILIDE HYDROXAMIC ACID; ACTIVE CROHNS-DISEASE; GROWTH-FACTOR-BETA; TH17 CELLS; MULTIPLE-MYELOMA; INTESTINAL INFLAMMATION; EXPERIMENTAL COLITIS; SIGNAL TRANSDUCER; DOUBLE-BLIND	Background: HDAC inhibitors exert anti-inflammatory properties. Results: ITF2357 shifts the balance from Th17 cells toward regulatory T cells via suppression of the IL-6R expression on naive T cells. Conclusion: The HDAC inhibitor ITF2357 modulates T cell polarization in experimental colitis. Significance: Learning the mode of action of this compound class will serve to optimize future therapeutic strategies. Histone deacetylase (HDAC) inhibitors have been associated primarily with an anti-proliferative effect in vitro and in vivo. Recent data provide evidence for an anti-inflammatory potency of HDAC inhibitors in models of experimental colitis. Because the balance of T cell subpopulations is critical for the balance of the mucosal immune system, this study explores the regulatory potency of HDAC inhibitors on T cell polarization as a mechanistic explanation for the observed anti-inflammatory effects. Although HDAC inhibition suppressed the polarization toward the pro-inflammatory T helper 17 (Th17) cells, it enhanced forkhead box P3 (FoxP3)(+) regulatory T cell polarization in vitro and in vivo at the site of inflammation in the lamina propria. This was paralleled by a down-regulation of the interleukin 6 receptor (IL-6R) on naive CD4(+) T cells on the mRNA as well as on the protein level and changes in the chromatin acetylation at the IL6R gene and its promoter. Downstream of the IL-6R, HDAC inhibition was followed by a decrease in STAT3 phosphorylation as well as retinoic acid receptor-related orphan receptor T (RORT) expression, thus identifying the IL-6/STAT3/IL-17 pathway as an important target of HDAC inhibitors. These results directly translated to experimental colitis, where IL-6R expression was suppressed in naive T cells, paralleled by a significant reduction of Th17 cells in the lamina propria of ITF2357-treated animals, resulting in the amelioration of disease. This study indicates that, in experimental colitis, inhibition of HDAC exerts an anti-inflammatory potency by directing T helper cell polarization via targeting the IL-6 pathway.	[Glauben, Rainer; Sonnenberg, Elena; Wetzel, Martin; Siegmund, Britta] Charite, Campus Benjamin Franklin, Dept Med 1, D-12200 Berlin, Germany; [Mascagni, Paolo] Italfarmaco SpA, Res Ctr, I-20092 Cinisello Balsamo, Italy	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Italfarmaco	Siegmund, B (corresponding author), Charite, Campus Benjamin Franklin, Dept Med 1, Hindenburgdamm 30, D-12200 Berlin, Germany.	britta.siegmund@charite.de	Siegmund, Britta/E-6929-2018	Siegmund, Britta/0000-0002-0055-958X; Sonnenberg, Elena/0000-0002-9513-8816	Deutsche Forschungsgemeinschaft [SI 749/5-3]; Helmholtz Alliance Preclinical Cancer Comprehensive Center	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Alliance Preclinical Cancer Comprehensive Center	This work was supported by the Deutsche Forschungsgemeinschaft Grant SI 749/5-3 and by the Helmholtz Alliance Preclinical Cancer Comprehensive Center.	Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bosisio D, 2008, J LEUKOCYTE BIOL, V84, P1540, DOI 10.1189/jlb.0708401; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Choi JH, 2005, CLIN EXP ALLERGY, V35, P89, DOI 10.1111/j.1365-2222.2004.02006.x; de Zoeten EF, 2010, GASTROENTEROLOGY, V138, P583, DOI 10.1053/j.gastro.2009.10.037; Dohi T, 2006, CURR OPIN GASTROEN, V22, P651, DOI 10.1097/01.mog.0000245545.80160.0f; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Fantini MC, 2007, EUR J IMMUNOL, V37, P3155, DOI 10.1002/eji.200737766; Farache J, 2013, IMMUNOL CELL BIOL, V91, P232, DOI 10.1038/icb.2012.79; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Glauben R, 2008, GUT, V57, P613, DOI 10.1136/gut.2007.134650; Glauben R, 2006, J IMMUNOL, V176, P5015, DOI 10.4049/jimmunol.176.8.5015; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; Hideshima T, 2007, NAT REV CANCER, V7, P585, DOI 10.1038/nrc2189; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; Hosokawa T, 1999, J GASTROEN HEPATOL, V14, P987, DOI 10.1046/j.1440-1746.1999.01989.x; Ichiyama K, 2008, J BIOL CHEM, V283, P17003, DOI 10.1074/jbc.M801286200; Ito H, 2004, GASTROENTEROLOGY, V126, P989, DOI 10.1053/j.gastro.2004.01.012; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Jones GW, 2010, J IMMUNOL, V184, P2130, DOI 10.4049/jimmunol.0901528; Kelly WK, 2005, NAT CLIN PRACT ONCOL, V2, P150, DOI 10.1038/ncponc0106; Kjellev S, 2006, INT IMMUNOPHARMACOL, V6, P1341, DOI 10.1016/j.intimp.2006.04.017; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Kramer OH, 2006, GENE DEV, V20, P473, DOI 10.1101/gad.364306; Leoni F, 2005, MOL MED, V11, P1, DOI 10.2119/2006-00005.Dinarello; Leoni F, 2002, P NATL ACAD SCI USA, V99, P2995, DOI 10.1073/pnas.052702999; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Maini RN, 2006, ARTHRITIS RHEUM-US, V54, P2817, DOI 10.1002/art.22033; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Mishra N, 2003, J CLIN INVEST, V111, P539, DOI 10.1172/JC1200316153; Mitsiades CS, 2004, P NATL ACAD SCI USA, V101, P540, DOI 10.1073/pnas.2536759100; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nishida K, 2004, ARTHRITIS RHEUM-US, V50, P3365, DOI 10.1002/art.20709; Noguchi D, 2011, IMMUNOL LETT, V136, P146, DOI 10.1016/j.imlet.2011.01.004; Powrie F, 2004, ANN NY ACAD SCI, V1029, P132, DOI 10.1196/annals.1309.030; Reddy P, 2008, J CLIN INVEST, V118, P2562, DOI 10.1172/JCI34712; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Sands BE, 2010, INFLAMM BOWEL DIS, V16, P1209, DOI 10.1002/ibd.21159; Siegmund B, 2009, EUR J IMMUNOL, V39, P2026, DOI 10.1002/eji.200939601; Stephanou A, 1998, BIOCHEM J, V330, P189, DOI 10.1042/bj3300189; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Todoerti K, 2010, HAEMATOL-HEMATOL J, V95, P260, DOI 10.3324/haematol.2009.012088; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vojinovic J, 2011, ARTHRITIS RHEUM-US, V63, P1452, DOI 10.1002/art.30238; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Weber DM, 2012, CL LYMPH MYELOM LEUK, V12, P319, DOI 10.1016/j.clml.2012.07.007; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200	53	51	54	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6142	6151		10.1074/jbc.M113.517599	http://dx.doi.org/10.1074/jbc.M113.517599			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24421314	hybrid, Green Published			2022-12-28	WOS:000332015500068
J	Cote, CD; Zadeh-Tahmasebi, M; Rasmussen, BA; Duca, FA; Lam, TKT				Cote, Clemence D.; Zadeh-Tahmasebi, Melika; Rasmussen, Brittany A.; Duca, Frank A.; Lam, Tony K. T.			Hormonal Signaling in the Gut	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Diabetes; Fatty Acid; Glucose Metabolism; Hormones; Intestine; Bariatric Surgery; Food Intake	GLUCAGON-LIKE PEPTIDE-1; DUODENAL-JEJUNAL BYPASS; VERTICAL SLEEVE GASTRECTOMY; FOOD-INTAKE; LEPTIN RECEPTOR; GLUCOSE-HOMEOSTASIS; GASTRIC BYPASS; INSULIN SENSITIVITY; EXOCRINE SECRETION; BARIATRIC SURGERY	The gut is anatomically positioned to play a critical role in the regulation of metabolic homeostasis, providing negative feedback via nutrient sensing and local hormonal signaling. Gut hormones, such as cholecystokinin (CCK) and glucagon-like peptide-1 (GLP-1), are released following a meal and act on local receptors to regulate glycemia via a neuronal gut-brain axis. Additionally, jejunal nutrient sensing and leptin action are demonstrated to suppress glucose production, and both are required for the rapid antidiabetic effect of duodenal jejunal bypass surgery. Strategies aimed at targeting local gut hormonal signaling pathways may prove to be efficacious therapeutic options to improve glucose control in diabetes.	[Cote, Clemence D.; Zadeh-Tahmasebi, Melika; Rasmussen, Brittany A.; Duca, Frank A.; Lam, Tony K. T.] Univ Hlth Network, Toronto Gen Res Inst, Toronto, ON M5G 1L7, Canada; [Cote, Clemence D.; Zadeh-Tahmasebi, Melika; Rasmussen, Brittany A.; Lam, Tony K. T.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Duca, Frank A.; Lam, Tony K. T.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Lam, Tony K. T.] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5G 2C4, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Toronto	Lam, TKT (corresponding author), MaRS Ctr, Toronto Med Discovery Tower,Rm 10-705,101 Coll St, Toronto, ON M5G 1L7, Canada.	tony.lam@uhnres.utoronto.ca		Cote, Clemence/0000-0001-9200-7688	Canadian Institutes of Health Research (CIHR) [CIHR-MOP-82701]; Banting and Best Diabetes Centre graduate studentship; CIHR Doctoral Vanier Canada scholarship; Toronto General Research Institute postdoctoral fellowship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Banting and Best Diabetes Centre graduate studentship; CIHR Doctoral Vanier Canada scholarship(Canadian Institutes of Health Research (CIHR)); Toronto General Research Institute postdoctoral fellowship	This work was supported by Canadian Institutes of Health Research (CIHR) Grant CIHR-MOP-82701 (to T. K. T. L.).; Supported by a Banting and Best Diabetes Centre graduate studentship.; Supported by a CIHR Doctoral Vanier Canada scholarship.; Supported by a Toronto General Research Institute postdoctoral fellowship.	Rojas LBA, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-6; Bado A, 1998, NATURE, V394, P790, DOI 10.1038/29547; Balkan B, 2000, AM J PHYSIOL-REG I, V279, pR1449, DOI 10.1152/ajpregu.2000.279.4.R1449; Barrenetxe J, 2002, GUT, V50, P797, DOI 10.1136/gut.50.6.797; Bojsen-MOller K. N., 2013, DIABETES, DOI [10.2337/b13-1307, DOI 10.2337/B13-1307]; Bradley David, 2012, Gastroenterology, V143, P897, DOI 10.1053/j.gastro.2012.07.114; Breen DM, 2013, DIABETES, V62, P3005, DOI 10.2337/db13-0523; Breen DM, 2012, NAT MED, V18, P950, DOI 10.1038/nm.2745; Breen DM, 2011, DIABETES, V60, P3148, DOI 10.2337/db11-0852; Buettner C, 2006, CELL METAB, V4, P49, DOI 10.1016/j.cmet.2006.04.014; Burcelin R, 2001, DIABETES, V50, P1720, DOI 10.2337/diabetes.50.8.1720; Burcelin R, 2009, CURR OPIN PHARMACOL, V9, P744, DOI 10.1016/j.coph.2009.09.003; Buyse M, 2001, EUR J NEUROSCI, V14, P64, DOI 10.1046/j.0953-816x.2001.01628.x; Cammisotto PG, 2006, AM J PHYSIOL-GASTR L, V290, pG242, DOI 10.1152/ajpgi.00334.2005; Cammisotto PG, 2005, J HISTOCHEM CYTOCHEM, V53, P851, DOI 10.1369/jhc.5A6620.2005; Cammisotto P, 2012, ANAT CELL BIOL, V45, P1, DOI 10.5115/acb.2012.45.1.1; Chambers AP, 2011, GASTROENTEROLOGY, V141, P950, DOI 10.1053/j.gastro.2011.05.050; Cheung GWC, 2009, CELL METAB, V10, P99, DOI 10.1016/j.cmet.2009.07.005; Chinookoswong N, 1999, DIABETES, V48, P1487, DOI 10.2337/diabetes.48.7.1487; Cinti S, 2000, INT J OBESITY, V24, P789, DOI 10.1038/sj.ijo.0801228; Clark CM, 1998, DIABETES CARE, V21, pC32, DOI 10.2337/diacare.21.3.C32; Cohen R, 2012, SURG OBES RELAT DIS, V8, P375, DOI 10.1016/j.soard.2012.01.017; Cohen RV, 2007, SURG OBES RELAT DIS, V3, P195, DOI 10.1016/j.soard.2007.01.009; Cohen RV, 2012, DIABETES CARE, V35, P1420, DOI 10.2337/dc11-2289; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Drazen DL, 2006, ENDOCRINOLOGY, V147, P23, DOI 10.1210/en.2005-0973; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Duca FA, 2012, BRIT J NUTR, V108, P778, DOI 10.1017/S0007114512000529; Ducroc R, 2005, DIABETES, V54, P348, DOI 10.2337/diabetes.54.2.348; El Homsi M, 2007, AM J PHYSIOL-GASTR L, V293, pG365, DOI 10.1152/ajpgi.00091.2007; Falken Y, 2010, NEUROGASTROENT MOTIL, V22, pe192, DOI 10.1111/j.1365-2982.2009.01463.x; Fujikawa T, 2013, CELL METAB, V18, P431, DOI 10.1016/j.cmet.2013.08.004; Geloneze B, 2012, ANN SURG, V256, P72, DOI 10.1097/SLA.0b013e3182592c62; German JP, 2011, ENDOCRINOLOGY, V152, P394, DOI 10.1210/en.2010-0890; Guilmeau S, 2003, DIABETES, V52, P1664, DOI 10.2337/diabetes.52.7.1664; Guo X, 2011, MUCOSAL IMMUNOL, V4, P294, DOI 10.1038/mi.2010.76; Habegger KM, 2014, DIABETES, V63, P505, DOI 10.2337/db13-0511; Habib AM, 2012, ENDOCRINOLOGY, V153, P3054, DOI 10.1210/en.2011-2170; Hayes MR, 2011, AM J PHYSIOL-REG I, V301, pR1479, DOI 10.1152/ajpregu.00356.2011; Holst JJ, 2005, DIABETOLOGIA, V48, P612, DOI 10.1007/s00125-005-1705-7; Iqbal J, 2010, J LIPID RES, V51, P1929, DOI 10.1194/jlr.M005744; Jiao J, 2013, DIABETES, V62, P1074, DOI 10.2337/db12-0681; Johnson KMS, 2008, AM J PHYSIOL-ENDOC M, V294, pE380, DOI 10.1152/ajpendo.00642.2007; Kievit P, 2006, CELL METAB, V4, P123, DOI 10.1016/j.cmet.2006.06.010; Knauf C, 2008, DIABETES, V57, P2603, DOI 10.2337/db07-1788; Kokorovic A, 2011, GASTROENTEROLOGY, V141, P1720, DOI 10.1053/j.gastro.2011.06.042; KREYMANN B, 1987, LANCET, V2, P1300; LAYER P, 1995, DIGEST DIS SCI, V40, P1074, DOI 10.1007/BF02064202; le Roux CW, 2005, J CLIN ENDOCR METAB, V90, P4521, DOI 10.1210/jc.2004-2537; Lee HC, 2010, OBES SURG, V20, P1530, DOI 10.1007/s11695-010-0248-2; Li Y, 2011, AM J PHYSIOL-GASTR L, V300, pG217, DOI 10.1152/ajpgi.00356.2010; Light PE, 2002, MOL ENDOCRINOL, V16, P2135, DOI 10.1210/me.2002-0084; Lovshin JA, 2009, NAT REV ENDOCRINOL, V5, P262, DOI 10.1038/nrendo.2009.48; Marina AL, 2012, DIABETES CARE, V35, P1119, DOI 10.2337/dc11-2050; Mingrone G, 2009, DIABETES METAB, V35, P518, DOI 10.1016/S1262-3636(09)73459-7; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Mix H, 2000, GUT, V47, P481, DOI 10.1136/gut.47.4.481; Mokadem M, 2014, MOL METAB, V3, P191, DOI 10.1016/j.molmet.2013.11.010; Monteleone P, 2003, J CLIN ENDOCR METAB, V88, P5510, DOI 10.1210/jc.2003-030797; Morton GJ, 2005, CELL METAB, V2, P411, DOI 10.1016/j.cmet.2005.10.009; Morton NM, 1998, J BIOL CHEM, V273, P26194, DOI 10.1074/jbc.273.40.26194; Nishizawa M, 1996, J AUTONOM NERV SYST, V61, P149, DOI 10.1016/S0165-1838(96)00071-9; Overduin J, 2005, ENDOCRINOLOGY, V146, P845, DOI 10.1210/en.2004-0609; Pacheco D, 2007, AM J SURG, V194, P221, DOI 10.1016/j.amjsurg.2006.11.015; Rasmussen BA, 2014, CELL METAB, V19, P155, DOI 10.1016/j.cmet.2013.11.014; Rasmussen BA, 2012, GASTROENTEROLOGY, V142, P834, DOI 10.1053/j.gastro.2011.12.053; Rasmussen BA, 2012, TRENDS ENDOCRIN MET, V23, P49, DOI 10.1016/j.tem.2011.11.001; RAYBOULD HE, 1988, J NEUROSCI, V8, P3018; Reimer MK, 2003, ENDOCRINOLOGY, V144, P916, DOI 10.1210/en.2002-220819; Rocca AS, 1999, ENDOCRINOLOGY, V140, P1687, DOI 10.1210/en.140.4.1687; Rodieux F, 2008, OBESITY, V16, P298, DOI 10.1038/oby.2007.83; Rubino FA, 2004, ANN SURG, V239, P1, DOI 10.1097/01.sla.0000102989.54824.fc; Rubino F, 2010, NAT REV ENDOCRINOL, V6, P102, DOI 10.1038/nrendo.2009.268; Rubino F, 2009, DIABETES CARE, V32, pS368, DOI 10.2337/dc09-S341; Rupprecht LE, 2013, AM J PHYSIOL-ENDOC M, V305, pE751, DOI 10.1152/ajpendo.00367.2013; Salinari S, 2014, DIABETES, V63, P1069, DOI 10.2337/db13-0856; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Schwartz MW, 2013, NATURE, V503, P59, DOI 10.1038/nature12709; Scully Tony, 2012, Nature, V485, pS2; Sobhani I, 2000, GUT, V47, P178, DOI 10.1136/gut.47.2.178; Speakman JR, 2012, DIS MODEL MECH, V5, P569, DOI 10.1242/dmm.010553; Sundaresan S, 2013, FASEB J, V27, P1191, DOI 10.1096/fj.12-217703; Sutton GM, 2004, J NEUROSCI, V24, P10240, DOI 10.1523/JNEUROSCI.2764-04.2004; Theodorakis MJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE550, DOI 10.1152/ajpendo.00326.2004; Tolhurst Gwen, 2012, Handb Exp Pharmacol, P309, DOI 10.1007/978-3-642-24716-3_14; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Vollmer K, 2008, DIABETES, V57, P678, DOI 10.2337/db07-1124; Waget A, 2011, ENDOCRINOLOGY, V152, P3018, DOI 10.1210/en.2011-0286; Wang MY, 2010, P NATL ACAD SCI USA, V107, P4813, DOI 10.1073/pnas.0909422107; Wang PYT, 2008, NATURE, V452, P1012, DOI 10.1038/nature06852; WILLIAMS JA, 1993, PHYSIOL REV, V73, P701, DOI 10.1152/physrev.1993.73.4.701; Williams JA, 2002, PHARMACOL TOXICOL, V91, P297, DOI 10.1034/j.1600-0773.2002.910606.x; Wilson-Perez HE, 2013, DIABETES, V62, P2380, DOI 10.2337/db12-1498; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Yang GQ, 2004, MOL ENDOCRINOL, V18, P1354, DOI 10.1210/me.2004-0027; Yu X, 2008, P NATL ACAD SCI USA, V105, P14070, DOI 10.1073/pnas.0806993105; Zastrow O, 2003, INT J OBESITY, V27, P1472, DOI 10.1038/sj.ijo.0802432; Zhang SY, 2014, OBES SURG, V24, P405, DOI 10.1007/s11695-013-1103-z	99	48	49	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11642	11649		10.1074/jbc.O114.556068	http://dx.doi.org/10.1074/jbc.O114.556068			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24577102	Green Published, hybrid			2022-12-28	WOS:000335010600007
J	Davis, MAM; Guo, JN; Price, DH; Luse, DS				Davis, Melissa A. Mullen; Guo, Jiannan; Price, David H.; Luse, Donal S.			Functional Interactions of the RNA Polymerase II-interacting Proteins Gdown1 and TFIIF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						General Transcription Factors; RNA Polymerase II; Transcription; Transcription Elongation Factors; Transcription Initiation Factors; GRINL1A; Gdown1; POLR2M; TFIIF; Preinitiation Complex	TRANSCRIPTION INITIATION-FACTOR; PREINITIATION COMPLEX; POL-II; ELONGATION; MEDIATOR; DNA; PHOSPHORYLATION; ORGANIZATION; ARCHITECTURE; MECHANISM	Background: Gdown1 modulates pausing in early elongation but also blocks binding of the essential initiation factor TFIIF to pol II. Results: TFIIF can compete successfully with Gdown1 to support preinitiation complex assembly. Conclusion: Gdown1 cannot functionally interact with already formed preinitiation complexes. Significance: Pathways exist allowing Gdown1 to enter the transcription complex early in elongation, thus allowing Gdown1 to affect pausing. Gdown1, the substoichiometric 13th subunit of RNA polymerase II (pol II), has an important role in pausing during the initial stage of transcript elongation. However, Gdown1 quantitatively displaces the essential initiation factor TFIIF from free pol II and elongating pol II. Thus, it is not clear how or even if pol II can initiate in the presence of Gdown1. Using an in vitro transcription system with purified factors and pol II lacking Gdown1, we found that although Gdown1 is strongly inhibitory to transcription when prebound to pol II, a fraction of complexes do remain active. Surprisingly, when Gdown1 is added to complete preinitiation complexes (PICs), it does not inhibit initiation or functionally associate with the PICs. Gdown1 does associate with pol II during the early stage of transcript elongation but this association is competitive with TFIIF. By phosphorylating TFIIF, PICs can be assembled that do not retain TFIIF. Gdown1 also fails to functionally associate with these TFIIF-less PICs, but once polymerase enters transcript elongation, complexes lacking TFIIF quantitatively bind Gdown1. Our results provide a partial resolution of the paradox of the competition between Gdown1 and TFIIF for association with pol II. Although Gdown1 completely displaces TFIIF from free pol II and elongation complexes, Gdown1 does not functionally associate with the PIC. Gdown1 can enter the transcription complex immediately after initiation. Modification of TFIIF provides one pathway through which efficient Gdown1 loading can occur early in elongation, allowing downstream pausing to be regulated.	[Davis, Melissa A. Mullen; Luse, Donal S.] Cleveland Clin, Dept Mol Genet, Lerner Res Inst, Cleveland, OH 44195 USA; [Guo, Jiannan; Price, David H.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Price, David H.] Univ Iowa, Mol & Cellular Biol Program, Iowa City, IA 52242 USA	Cleveland Clinic Foundation; University of Iowa; University of Iowa	Luse, DS (corresponding author), Cleveland Clin, Dept Mol Genet, Lerner Res Inst, 9500 Euclid Ave,NE20, Cleveland, OH 44195 USA.	lused@ccf.org		Price, David/0000-0002-5597-385X	National Institutes of Health [GM35500]; National Science Foundation [1121210]; American Heart Association Postdoctoral Fellowship [12POST12040106]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Heart Association Postdoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM35500 (to D. H. P.). This work was also supported by National Science Foundation Grant 1121210 (to D. S. L.) and American Heart Association Postdoctoral Fellowship 12POST12040106 (to J. G.).	Bernecky C, 2012, J MOL BIOL, V417, P387, DOI 10.1016/j.jmb.2012.02.014; Bernecky C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000603; BURTON ZF, 1988, MOL CELL BIOL, V8, P1602, DOI 10.1128/MCB.8.4.1602; Cabart P, 2011, P NATL ACAD SCI USA, V108, P15786, DOI 10.1073/pnas.1104591108; Cabrejos ME, 2004, J CELL BIOCHEM, V93, P2, DOI 10.1002/jcb.20209; Chen ZA, 2010, EMBO J, V29, P717, DOI 10.1038/emboj.2009.401; Cheng B, 2012, MOL CELL, V45, P38, DOI 10.1016/j.molcel.2011.10.022; Eichner J, 2010, EMBO J, V29, P706, DOI 10.1038/emboj.2009.386; FLORES O, 1989, J BIOL CHEM, V264, P8913; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Gilmour DS, 2009, CHROMOSOMA, V118, P1, DOI 10.1007/s00412-008-0182-4; Grunberg S, 2012, NAT STRUCT MOL BIOL, V19, P788, DOI 10.1038/nsmb.2334; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Hu X, 2006, P NATL ACAD SCI USA, V103, P9506, DOI 10.1073/pnas.0603702103; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; Jishage M, 2012, MOL CELL, V45, P51, DOI 10.1016/j.molcel.2011.12.014; KEPHART DD, 1994, J BIOL CHEM, V269, P13536; KITAJIMA S, 1994, J BIOL CHEM, V269, P29970; Koch F, 2011, NAT STRUCT MOL BIOL, V18, P956, DOI 10.1038/nsmb.2085; Lei L, 1998, MOL CELL BIOL, V18, P2130, DOI 10.1128/MCB.18.4.2130; Lewis BA, 2005, MOL CELL, V18, P471, DOI 10.1016/j.molcel.2005.04.005; Maldonado E, 1996, METHOD ENZYMOL, V274, P72; Meyer KD, 2010, NAT STRUCT MOL BIOL, V17, P753, DOI 10.1038/nsmb.1816; Murakami K, 2013, SCIENCE, V342, P709, DOI 10.1126/science.1238724; Nechaev S, 2008, CELL CYCLE, V7, P1539, DOI 10.4161/cc.7.11.6006; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; PAN GH, 1994, J BIOL CHEM, V269, P30101; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; PRICE DH, 1989, MOL CELL BIOL, V9, P1465, DOI 10.1128/MCB.9.4.1465; Roginski RS, 2004, GENOMICS, V84, P265, DOI 10.1016/j.ygeno.2004.04.004; Rossignol M, 1999, J BIOL CHEM, V274, P22387, DOI 10.1074/jbc.274.32.22387; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; SOPTA M, 1985, J BIOL CHEM, V260, P353; Ujvari A, 2006, NAT STRUCT MOL BIOL, V13, P49, DOI 10.1038/nsmb1026; Ujvari A, 2011, J BIOL CHEM, V286, P23160, DOI 10.1074/jbc.M110.205658; Wu YM, 2012, EMBO J, V31, P3575, DOI 10.1038/emboj.2012.205; YONAHA M, 1993, NUCLEIC ACIDS RES, V21, P273, DOI 10.1093/nar/21.2.273; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	39	7	7	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11143	11152		10.1074/jbc.M113.544395	http://dx.doi.org/10.1074/jbc.M113.544395			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24596085	hybrid, Green Published			2022-12-28	WOS:000334638500018
J	Kemter, E; Sklenak, S; Rathkolb, B; Hrabe de Angelis, M; Wolf, E; Aigner, B; Wanke, R				Kemter, Elisabeth; Sklenak, Stefanie; Rathkolb, Birgit; Hrabe de Angelis, Martin; Wolf, Eckhard; Aigner, Bernhard; Wanke, Ruediger			No Amelioration of Uromodulin Maturation and Trafficking Defect by Sodium 4-Phenylbutyrate in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum Stress; Genetic Diseases; Histone Deacetylase Inhibitors; Kidney; Molecular Chaperone; NF-B (NF-KB); 4-PBA; RelB; UAKD; Uromodulin (UMOD)	TAMM-HORSFALL GLYCOPROTEIN; KIDNEY-DISEASE; ER STRESS; UMOD GENE; PHENYLBUTYRATE; MUTATIONS; PROTEIN; EXPRESSION; NEPHROPATHY; SECRETION	Background:In vitro studies suggested the chemical chaperone 4-PBA as treatment of uromodulin-associated kidney disease (UAKD). Results: 4-PBA did not ameliorate uromodulin maturation defects in two UAKD mouse models. Renal abundance/phosphorylation of several NF-B pathway components was increased. Conclusion: 4-PBA failed to cure UAKD in vivo but deteriorated kidney function. Significance: NF-B pathway was revealed as a potential target for UAKD treatment. Uromodulin (UMOD)-associated kidney disease (UAKD) belongs to the hereditary progressive ER storage diseases caused by maturation defects of mutant UMOD protein. Current treatments of UAKD patients are symptomatic and cannot prevent disease progression. Two in vitro studies reported a positive effect of the chemical chaperone sodium 4-phenylbutyrate (4-PBA) on mutant UMOD maturation. Thus, 4-PBA was suggested as a potential treatment for UAKD. This study evaluated the effects of 4-PBA in two mouse models of UAKD. In contrast to previous in vitro studies, treatment with 4-PBA did not increase HSP70 expression or improve maturation and trafficking of mutant UMOD in vivo. Kidney function of UAKD mice was actually deteriorated by 4-PBA treatment. In transfected tubular epithelial cells, 4-PBA did not improve maturation but increased the expression level of both mutant and wild-type UMOD protein. Activation of NF-B pathway in thick ascending limb of Henle's loop cells of UAKD mice was detected by increased abundance of RelB and phospho-IB kinase /, an indirect activator of NF-B. Furthermore, the abundance of NF-B1 p105/p50, NF-B2 p100/p52, and TRAF2 was increased in UAKD. NF-B activation was identified as a novel disease mechanism of UAKD and might be a target for therapeutic intervention.	[Kemter, Elisabeth; Sklenak, Stefanie; Rathkolb, Birgit; Wolf, Eckhard; Aigner, Bernhard] Univ Munich, Gene Ctr, Chair Mol Anim Breeding & Biotechnol, D-81377 Munich, Germany; [Rathkolb, Birgit; Hrabe de Angelis, Martin] Helmholtz Zentrum Munchen, Inst Expt Genet, German Mouse Clin, D-85764 Neuherberg, Germany; [Rathkolb, Birgit; Hrabe de Angelis, Martin] Helmholtz Zentrum Munchen, German Res Ctr Diabet Res DZD, D-85764 Neuherberg, Germany; [Wanke, Ruediger] Univ Munich, Inst Vet Pathol, Ctr Clin Vet Med, D-80539 Munich, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Kemter, E (corresponding author), Univ Munich, Gene Ctr, Chair Mol Anim Breeding & Biotechnol, Feodor Lynen Str 25, D-81377 Munich, Germany.	kemter@lmb.uni-muenchen.de	de Angelis, Martin Hrabe/F-5531-2012	de Angelis, Martin Hrabe/0000-0002-7898-2353; Wolf, Eckhard/0000-0002-0430-9510; Kemter, Elisabeth/0000-0001-7785-7502; Aigner, Bernhard/0000-0003-1644-2711; Wanke, Rudiger/0000-0002-0153-224X	German Research Foundation (DFG) [KE1673/1-1]; Infrafrontier [01KX1012]	German Research Foundation (DFG)(German Research Foundation (DFG)); Infrafrontier	This work was supported by the German Research Foundation (DFG grant KE1673/1-1) and by Infrafrontier Grant 01KX1012.	Adam J, 2012, AM J KIDNEY DIS, V59, P117, DOI 10.1053/j.ajkd.2011.08.014; Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Bernascone I, 2006, TRAFFIC, V7, P1567, DOI 10.1111/j.1600-0854.2006.00481.x; Bleyer AJ, 2003, KIDNEY INT, V64, P36, DOI 10.1046/j.1523-1755.2003.00081.x; Bleyer AJ, 2011, NEPHRON CLIN PRACT, V118, pC31, DOI 10.1159/000320889; Bollee G, 2011, CLIN J AM SOC NEPHRO, V6, P2429, DOI 10.2215/CJN.01220211; Brusilow S W, 1996, Adv Pediatr, V43, P127; Burrows JAJ, 2000, P NATL ACAD SCI USA, V97, P1796, DOI 10.1073/pnas.97.4.1796; Choi SW, 2005, J AM SOC NEPHROL, V16, P3006, DOI 10.1681/ASN.2005050461; COLLINS AF, 1995, BLOOD, V85, P43, DOI 10.1182/blood.V85.1.43.bloodjournal85143; Hart TC, 2002, J MED GENET, V39, P882, DOI 10.1136/jmg.39.12.882; Iannitti T, 2011, DRUGS R&D, V11, P227, DOI 10.2165/11591280-000000000-00000; Jennings P, 2007, J AM SOC NEPHROL, V18, P264, DOI 10.1681/ASN.2006020158; Kemter E, 2013, HUM MOL GENET, V22, P4148, DOI 10.1093/hmg/ddt263; Kemter E, 2010, AM J PHYSIOL-RENAL, V298, pF1405, DOI 10.1152/ajprenal.00522.2009; Kemter E, 2009, AM J PHYSIOL-RENAL, V297, pF1391, DOI 10.1152/ajprenal.00261.2009; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Lim M, 2004, AM J RESP CELL MOL, V31, P351, DOI 10.1165/rcmb.2002-0086OC; Ma LJ, 2012, J BIOL CHEM, V287, P1290, DOI 10.1074/jbc.M111.283036; Mercuri E, 2004, NEUROMUSCULAR DISORD, V14, P130, DOI 10.1016/j.nmd.2003.11.006; Nasr SH, 2008, KIDNEY INT, V73, P971, DOI 10.1038/sj.ki.5002679; Neuhofer W, 2005, J PHYSIOL-LONDON, V564, P715, DOI 10.1113/jphysiol.2004.081463; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Rampoldi L, 2003, HUM MOL GENET, V12, P3369, DOI 10.1093/hmg/ddg353; Rampoldi L, 2011, KIDNEY INT, V80, P338, DOI 10.1038/ki.2011.134; Rathkolb B., 2011, CURRENT PROTOCOLS MO, P69; Ricobaraza A, 2009, NEUROPSYCHOPHARMACOL, V34, P1721, DOI 10.1038/npp.2008.229; Ryu H, 2005, J NEUROCHEM, V93, P1087, DOI 10.1111/j.1471-4159.2005.03077.x; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Scolari F, 2004, AM J KIDNEY DIS, V44, P987, DOI 10.1053/j.ajkd.2004.08.021; Serafini-Cessi F, 2003, AM J KIDNEY DIS, V42, P658, DOI 10.1016/S0272-6386(03)00829-1; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Suaud L, 2011, J BIOL CHEM, V286, P45083, DOI 10.1074/jbc.M111.293282; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Trudu M, 2013, NAT MED, V19, P1655, DOI 10.1038/nm.3384; Vylet'al P, 2006, KIDNEY INT, V70, P1155, DOI 10.1038/sj.ki.5001728; Wadman RI, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006282.pub4; Williams SE, 2009, HUM MOL GENET, V18, P2963, DOI 10.1093/hmg/ddp235; WOLF G, 1994, J AM SOC NEPHROL, V4, P1995; Zaucke F, 2010, HUM MOL GENET, V19, P1985, DOI 10.1093/hmg/ddq077	40	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10715	10726		10.1074/jbc.M113.537035	http://dx.doi.org/10.1074/jbc.M113.537035			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24567330	hybrid, Green Published			2022-12-28	WOS:000334226400041
J	Zhang, J; Xu, D; Nie, J; Cao, JS; Zhai, YG; Tong, DW; Shi, YG				Zhang, Jun; Xu, Dan; Nie, Jia; Cao, Jingsong; Zhai, Yonggong; Tong, Dewen; Shi, Yuguang			Monoacylglycerol Acyltransferase-2 Is a Tetrameric Enzyme That Selectively Heterodimerizes with Diacylglycerol Acyltransferase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Diacylglycerol; Lipid Absorption; Lipid Metabolism; Metabolism	DIETARY-FAT ABSORPTION; RAT INTESTINAL-MUCOSA; ACYL-COA; TRIACYLGLYCEROL SYNTHESIS; ENDOPLASMIC-RETICULUM; DRUG TARGETS; 1 DGAT1; MGAT2; IDENTIFICATION; MICE	Background: MGAT2 and DGAT1 play essential role in catalyzing the biosynthesis of triglyceride and mediating intestinal fat absorption. Results: MGAT2 heterodimerizes with DGAT1, a process that is mediated by amino acids 35-80 of DGAT1 but not an N-signal peptide of MGAT2. Conclusion: MGAT2 may be part of an enzyme complex. Significance: Our findings provide direct molecular evidence of the interactions of essential enzymes for fat absorption. Acyl-CoA:monoacylglycerol acyltransferases (MGATs) and diacylglycerol acyltransferases (DGATs) catalyze the two consecutive steps in the synthesis of triacylglycerol, a key process required for dietary fat absorption into the enterocytes of the small intestine. In this report, we investigated the tendency of MGAT2 to form an enzyme complex with DGAT1 and DGAT2 in intact cells. We demonstrated that in addition to the 38-kDa monomer of the MGAT2 enzyme predicted by its peptide sequence, a 76-kDa moiety was detected in SDS-PAGE without reducing agent and heat inactivation. The 76-kDa MGAT2 moiety was greatly enhanced by treatment with a cross-linking reagent in intact cells. Additionally, the cross-linking reagent dose-dependently yielded a band corresponding to the tetramer (152 kDa) in SDS-PAGE, suggesting that the MGAT2 enzyme primarily functions as a homotetrameric protein and as a tetrameric protein. Likewise, DGAT1 also forms a homodimer under nondenaturing conditions. When co-expressed in COS-7 cells, MGAT2 heterodimerized with DGAT1 without treatment with a cross-linking reagent. MGAT2 also co-eluted with DGAT1 on a gel filtration column, suggesting that the two enzymes form a complex in intact cells. In contrast, MGAT2 did not heterodimerize with DGAT2 when co-expressed in COS-7 cells, despite high sequence homology between the two enzymes. Furthermore, systematic deletion analysis demonstrates that N-terminal amino acids 35-80 of DGAT1, but not a signal peptide at the N terminus of MGAT2, is required for the heterodimerization. Finally, co-expression of MGAT2 with DGAT1 significantly increased lipogenesis in COS-7 cells, indicating the functional importance of the dimerization.	[Zhang, Jun; Xu, Dan; Nie, Jia; Cao, Jingsong; Shi, Yuguang] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Xu, Dan; Tong, Dewen] Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China; [Zhang, Jun; Zhai, Yonggong] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Northwest A&F University - China; Beijing Normal University	Tong, DW (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China.	dwtong@nwsuaf.edu.cn; yus11@psu.edu	nie, jia/AAE-8355-2019; Zhang, Jun/W-5146-2019	nie, jia/0000-0001-9085-7224; Zhang, Jun/0000-0002-8489-3699	National Institutes of Health Grant [DK076685]; Chinese National Scholarship Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK076685, R01DK076685] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese National Scholarship Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK076685 (to Y. S.). This work was also supported by a scholarship from the Chinese National Scholarship Council (to D. X.).	Barlind JG, 2013, BIOORG MED CHEM LETT, V23, P2721, DOI 10.1016/j.bmcl.2013.02.084; Birch AM, 2009, J MED CHEM, V52, P1558, DOI 10.1021/jm801507v; Cao Guoqing, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P197; Cao JS, 2007, J LIPID RES, V48, P583, DOI 10.1194/jlr.M600331-JLR200; Cao JS, 2011, J BIOL CHEM, V286, P41838, DOI 10.1074/jbc.M111.245456; Cao JS, 2004, J BIOL CHEM, V279, P18878, DOI 10.1074/jbc.M313272200; Cao JS, 2003, J BIOL CHEM, V278, P25657, DOI 10.1074/jbc.M302835200; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Cheng D, 2001, BIOCHEM J, V359, P707, DOI 10.1042/0264-6021:3590707; Cheng D, 2003, J BIOL CHEM, V278, P13611, DOI 10.1074/jbc.C300042200; Dow RL, 2013, BIOORGAN MED CHEM, V21, P5081, DOI 10.1016/j.bmc.2013.06.045; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; LEHNER R, 1995, J BIOL CHEM, V270, P13630, DOI 10.1074/jbc.270.23.13630; Lin L, 2001, AM J PHYSIOL-REG I, V280, pR504, DOI 10.1152/ajpregu.2001.280.2.R504; MANGANARO F, 1985, CAN J BIOCHEM CELL B, V63, P107, DOI 10.1139/o85-016; Mansbach CM, 1998, J LIPID RES, V39, P963; McFie PJ, 2011, J BIOL CHEM, V286, P28235, DOI 10.1074/jbc.M111.256008; McFie PJ, 2010, J BIOL CHEM, V285, P37377, DOI 10.1074/jbc.M110.163691; Nelson DW, 2011, J LIPID RES, V52, P1723, DOI 10.1194/jlr.M016840; Nordskog BK, 2001, ADV DRUG DELIVER REV, V50, P21, DOI 10.1016/S0169-409X(01)00147-8; Phan CT, 2001, FRONT BIOSCI-LANDMRK, V6, pD299, DOI 10.2741/Phan; Schober G, 2013, J LIPID RES, V54, P1369, DOI 10.1194/jlr.M035154; Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; TSO P, 2000, BIOCH PHYSL ASPECTS, P125; Tsuchida T, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-75; Wurie HR, 2011, J BIOL CHEM, V286, P36238, DOI 10.1074/jbc.M111.251900; Yeh VSC, 2012, J MED CHEM, V55, P1751, DOI 10.1021/jm201524g; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200; Yen CLE, 2005, J LIPID RES, V46, P1502, DOI 10.1194/jlr.M500036-JLR200; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899	35	14	14	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10909	10918		10.1074/jbc.M113.530022	http://dx.doi.org/10.1074/jbc.M113.530022			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24573674	hybrid, Green Published			2022-12-28	WOS:000334226400058
J	Canova, MJ; Molle, V				Canova, Marc J.; Molle, Virginie			Bacterial Serine/Threonine Protein Kinases in Host-Pathogen Interactions*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Bacterial Signal Transduction; Host-Pathogen Interactions; Protein Secretion; Serine; Threonine Protein Kinase; Virulence Factors	ACTIVATING TRANSCRIPTION FACTOR-2; III SECRETION SYSTEM; KAPPA-B PATHWAY; STAPHYLOCOCCUS-AUREUS; MYCOBACTERIUM-TUBERCULOSIS; SERINE/THREONINE KINASE; EPITHELIAL-CELLS; SER/THR KINASE; ACTIN-BINDING; C-ALPHA	In bacterial pathogenesis, monitoring and adapting to the dynamically changing environment in the host and an ability to disrupt host immune responses are critical. The virulence determinants of pathogenic bacteria include the sensor/signaling proteins of the serine/threonine protein kinase (STPK) family that have a dual role of sensing the environment and subverting specific host defense processes. STPKs can sense a wide range of signals and coordinate multiple cellular processes to mount an appropriate response. Here, we review some of the well studied bacterial STPKs that are essential virulence factors and that modify global host responses during infection.	[Molle, Virginie] Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, F-34095 Montpellier 05, France; Univ Montpellier I, CNRS, UMR 5235, F-34095 Montpellier 05, France	Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Molle, V (corresponding author), Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, F-34095 Montpellier 05, France.	virginie.molle@univ-montp2.fr	MOLLE, Virginie/D-4050-2019	MOLLE, Virginie/0000-0002-6573-3411	French National Research Agency [ANR-09-MIEN-004]; ATIP-Avenir Program	French National Research Agency(French National Research Agency (ANR)); ATIP-Avenir Program	This work was supported by French National Research Agency Grant ANR-09-MIEN-004 and the ATIP-Avenir Program (to V.M. and M.J.C.). This is the second article in the Thematic Minireview Series "Protein Serine/Threonine and Tyrosine Phosphorylation in Prokaryotes."	Alber T, 2009, CURR OPIN STRUC BIOL, V19, P650, DOI 10.1016/j.sbi.2009.10.017; Archambaud C, 2005, MOL MICROBIOL, V56, P383, DOI 10.1111/j.1365-2958.2005.04551.x; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Barz C, 2000, FEBS LETT, V482, P139, DOI 10.1016/S0014-5793(00)02045-7; Beier F, 2000, J BIOL CHEM, V275, P12948, DOI 10.1074/jbc.275.17.12948; Beltramini AM, 2009, INFECT IMMUN, V77, P1406, DOI 10.1128/IAI.01499-08; Bogoyevitch MA, 2005, BBA-PROTEINS PROTEOM, V1754, P79, DOI 10.1016/j.bbapap.2005.07.025; Buchrieser C, 2000, MOL MICROBIOL, V38, P760, DOI 10.1046/j.1365-2958.2000.02179.x; Chaba R, 2002, EUR J BIOCHEM, V269, P1078, DOI 10.1046/j.1432-1033.2002.02778.x; Chaurasiya SK, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-271; Cheng H, 2010, CIRC RES, V106, P21, DOI 10.1161/CIRCRESAHA.109.206920; COHEN P, 1991, METHOD ENZYMOL, V201, P389; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; Debarbouille M, 2009, J BACTERIOL, V191, P4070, DOI 10.1128/JB.01813-08; Dukuzumuremyi JM, 2000, J BIOL CHEM, V275, P35281, DOI 10.1074/jbc.M003009200; Dziewanowska K, 1999, INFECT IMMUN, V67, P4673, DOI 10.1128/IAI.67.9.4673-4678.1999; Echenique J, 2004, INFECT IMMUN, V72, P2434, DOI 10.1128/IAI.72.4.2434-2437.2004; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Foussard M, 2001, MICROBES INFECT, V3, P417, DOI 10.1016/S1286-4579(01)01390-9; GALYOV EE, 1993, NATURE, V361, P730, DOI 10.1038/361730a0; Gao XF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000708; Ge JN, 2009, P NATL ACAD SCI USA, V106, P13725, DOI 10.1073/pnas.0907200106; Gopalaswamy R, 2009, FEMS MICROBIOL LETT, V295, P23, DOI 10.1111/j.1574-6968.2009.01570.x; Greenstein AE, 2005, J MOL MICROB BIOTECH, V9, P167, DOI 10.1159/000089645; Grosdent N, 2002, INFECT IMMUN, V70, P4165, DOI 10.1128/IAI.70.8.4165-4176.2002; Hakansson S, 1996, MOL MICROBIOL, V20, P593, DOI 10.1046/j.1365-2958.1996.5251051.x; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hervet E, 2011, INFECT IMMUN, V79, P1936, DOI 10.1128/IAI.00805-10; Holm A, 2003, BIOCHEM BIOPH RES CO, V302, P653, DOI 10.1016/S0006-291X(03)00231-6; HORWITZ MA, 1983, J CLIN INVEST, V71, P1686, DOI 10.1172/JCI110923; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Hussain H, 2006, J BACTERIOL, V188, P1628, DOI 10.1128/JB.188.4.1628-1632.2006; Itoh S, 2002, BIOL PHARM BULL, V25, P837, DOI 10.1248/bpb.25.837; Jin H, 2006, J MOL BIOL, V357, P1351, DOI 10.1016/j.jmb.2006.01.020; Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997; Juris SJ, 2006, FEBS LETT, V580, P179, DOI 10.1016/j.febslet.2005.11.071; KAUFMANN AF, 1981, AM J EPIDEMIOL, V114, P337, DOI 10.1093/oxfordjournals.aje.a113200; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Kintarak S, 2004, INFECT IMMUN, V72, P5668, DOI 10.1128/IAI.72.10.5668-5675.2004; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Kristich CJ, 2007, P NATL ACAD SCI USA, V104, P3508, DOI 10.1073/pnas.0608742104; Kubica M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001409; Lima A, 2011, J PROTEOMICS, V74, P1720, DOI 10.1016/j.jprot.2011.03.005; Lu J, 2009, P NATL ACAD SCI USA, V106, P11697, DOI 10.1073/pnas.0905930106; Ma Q, 2007, J CELL BIOCHEM, V101, P477, DOI 10.1002/jcb.21198; Malhotra V, 2010, MICROBIOL-SGM, V156, P2829, DOI 10.1099/mic.0.040675-0; McConnell JL, 2009, MOL PHARMACOL, V75, P1249, DOI 10.1124/mol.108.053140; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; Miller M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009057; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Navarro L, 2007, MOL CELL, V26, P465, DOI 10.1016/j.molcel.2007.04.025; Odendall C, 2012, CELL HOST MICROBE, V12, P657, DOI 10.1016/j.chom.2012.09.011; Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005; Pham TH, 2013, J BIOL CHEM, V288, P34567, DOI 10.1074/jbc.M113.512376; Pham TH, 2012, INFECT IMMUN, V80, P2133, DOI 10.1128/IAI.06358-11; Poh J, 2008, CELL MICROBIOL, V10, P20, DOI 10.1111/j.1462-5822.2007.01010.x; Prehna G, 2006, CELL, V126, P869, DOI 10.1016/j.cell.2006.06.056; Rajagopal L, 2003, J BIOL CHEM, V278, P14429, DOI 10.1074/jbc.M212747200; Royan SV, 2010, MOL MICROBIOL, V78, P1232, DOI 10.1111/j.1365-2958.2010.07400.x; Sachsenmaier C, 2001, ONKOLOGIE, V24, P346, DOI 10.1159/000055106; Scherr N, 2009, J BACTERIOL, V191, P4546, DOI 10.1128/JB.00245-09; Sinha B, 2010, INT J MED MICROBIOL, V300, P170, DOI 10.1016/j.ijmm.2009.08.019; Song H, 2006, CANCER RES, V66, P10487, DOI 10.1158/0008-5472.CAN-06-1461; St-Denis A, 1999, J IMMUNOL, V163, P5505; Steele-Mortimer O, 2002, CELL MICROBIOL, V4, P43, DOI 10.1046/j.1462-5822.2002.00170.x; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tamber S, 2010, INFECT IMMUN, V78, P3637, DOI 10.1128/IAI.00296-10; Tiwari D, 2009, J BIOL CHEM, V284, P27467, DOI 10.1074/jbc.M109.036095; Trasak C, 2007, J BIOL CHEM, V282, P2268, DOI 10.1074/jbc.M610071200; Truong-Bolduc QC, 2008, J BACTERIOL, V190, P7375, DOI 10.1128/JB.01068-08; Truong-Bolduc QC, 2010, J BACTERIOL, V192, P2525, DOI 10.1128/JB.00018-10; van der Woude AD, 2014, CELL MICROBIOL, V16, P280, DOI 10.1111/cmi.12221; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wan FY, 2011, NAT IMMUNOL, V12, P335, DOI 10.1038/ni.2007; Wang JY, 1998, J BACTERIOL, V180, P6764, DOI 10.1128/JB.180.24.6764-6768.1998; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; Wiley DJ, 2006, MICROB PATHOGENESIS, V40, P234, DOI 10.1016/j.micpath.2006.02.001; YANHING JDN, 2004, BIOCHEM BIOPH RES CO, V319, P810; Zhou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057558	86	52	55	3	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9473	9479		10.1074/jbc.R113.529917	http://dx.doi.org/10.1074/jbc.R113.529917			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24554701	Green Published, hybrid			2022-12-28	WOS:000333807000003
J	Parisotto, D; Pfau, M; Scheutzow, A; Wild, K; Mayer, MP; Malsam, J; Sinning, I; Sollner, TH				Parisotto, Daniel; Pfau, Maximilian; Scheutzow, Andrea; Wild, Klemens; Mayer, Matthias P.; Malsam, Joerg; Sinning, Irmgard; Soellner, Thomas H.			An Extended Helical Conformation in Domain 3a of Munc18-1 Provides a Template for SNARE ( Soluble N- Ethylmaleimidesensitive Factor Attachment Protein Receptor) Complex Assembly*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Exocytosis; Membrane Fusion; Membrane Reconstitution; Membrane Trafficking; Snare Proteins; SM Protein; VAMP2; Synaptobrevin; Synaptic Vesicle	SECONDARY STRUCTURE PREDICTION; SYNAPTIC VESICLE FUSION; MEMBRANE-FUSION; NEUROTRANSMITTER RELEASE; SEC1/MUNC18 PROTEINS; SECRETORY VESICLES; PROLINE RESIDUE; SYNAPTOTAGMIN-I; SYNTAXIN; EXOCYTOSIS	Background: Munc18-1 is required for membrane fusion, but the underlying mechanism is unknown. Results: Distinct point mutations in domain 3a of Munc18-1 differentially affect the conformation of helix 12, VAMP2 binding, and membrane fusion. Conclusion: A conformational switch in helix 12 promotes SNAREpin assembly via the VAMP2 interaction. Significance: The Munc18-1-VAMP2 interaction may represent a general molecular mechanism of how SM proteins accelerate membrane fusion. Munc18-1, a SEC1/Munc18 protein and key regulatory protein in synaptic transmission, can either promote or inhibit SNARE complex assembly. Although the binary inhibitory interaction between Munc18-1 and closed syntaxin 1 is well described, the mechanism of how Munc18-1 stimulates membrane fusion remains elusive. Using a reconstituted assay that resolves vesicle docking, priming, clamping, and fusion during synaptic exocytosis, we show that helix 12 in domain 3a of Munc18-1 stimulates SNAREpin assembly and membrane fusion. A single point mutation (L348R) within helix 12 selectively abolishes VAMP2 binding and the stimulatory function of Munc18-1 in membrane fusion. In contrast, targeting a natural switch site (P335A) at the start of helix 12, which can result in an extended -helical conformation, further accelerates lipid-mixing. Together with structural modeling, the data suggest that helix 12 provides a folding template for VAMP2, accelerating SNAREpin assembly and membrane fusion. Analogous SEC1/Munc18-SNARE interactions at other transport steps may provide a general mechanism to drive lipid bilayer merger. At the neuronal synapse, Munc18-1 may convert docked synaptic vesicles into a readily releasable pool.	[Parisotto, Daniel; Pfau, Maximilian; Scheutzow, Andrea; Wild, Klemens; Malsam, Joerg; Sinning, Irmgard; Soellner, Thomas H.] Heidelberg Univ Biochem Ctr BZH, D-69120 Heidelberg, Germany; [Mayer, Matthias P.] Heidelberg Univ ZMBH, DKFZ ZMBH Alliance, Ctr Mol Biol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Sollner, TH (corresponding author), Heidelberg Univ Biochem Ctr BZH, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	thomas.soellner@bzh.uni-heidelberg.de	Pfau, Maximilian/N-1888-2019; Mayer, Matthias P./B-9340-2013	Pfau, Maximilian/0000-0001-9761-9640; Mayer, Matthias P./0000-0002-7859-3112	German Research Foundation [SFB/TRR 83]	German Research Foundation(German Research Foundation (DFG))	This work was supported by a German Research Foundation grant (SFB/TRR 83 (to D. P. and T. H. S.).	Al Hawas R, 2012, BLOOD, V120, P2493, DOI 10.1182/blood-2012-05-430629; Aoki S, 2012, BBA-BIOMEMBRANES, V1818, P12, DOI 10.1016/j.bbamem.2011.09.009; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Baker RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067409; Boyd A, 2008, GENETICS, V180, P165, DOI 10.1534/genetics.108.090423; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Chen XC, 2008, J BIOMOL NMR, V41, P43, DOI 10.1007/s10858-008-9239-1; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Ellena JF, 2009, P NATL ACAD SCI USA, V106, P20306, DOI 10.1073/pnas.0908317106; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Hackmann Y, 2013, P NATL ACAD SCI USA, V110, pE4482, DOI 10.1073/pnas.1313474110; Han GA, 2013, J CELL SCI, V126, P2361, DOI 10.1242/jcs.126862; Han L, 2009, MOL BIOL CELL, V20, P4962, DOI 10.1091/mbc.E09-08-0712; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Honigmann A, 2013, NAT STRUCT MOL BIOL, V20, P679, DOI 10.1038/nsmb.2570; HOSONO R, 1992, J NEUROCHEM, V58, P1517, DOI 10.1111/j.1471-4159.1992.tb11373.x; Hu SH, 2011, P NATL ACAD SCI USA, V108, P1040, DOI 10.1073/pnas.0914906108; Huntwork S, 2007, NAT NEUROSCI, V10, P1235, DOI 10.1038/nn1980; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Johnson JR, 2009, BIOCHEM J, V418, P73, DOI 10.1042/BJ20081956; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jorquera RA, 2012, J NEUROSCI, V32, P18234, DOI 10.1523/JNEUROSCI.3212-12.2012; Khvotchev M, 2007, J NEUROSCI, V27, P12147, DOI 10.1523/JNEUROSCI.3655-07.2007; Kim JY, 2012, EMBO J, V31, P2144, DOI 10.1038/emboj.2012.57; Krishnakumar SS, 2013, BIOPHYS J, V105, P2507, DOI 10.1016/j.bpj.2013.10.029; Kummel D, 2011, NAT STRUCT MOL BIOL, V18, P927, DOI 10.1038/nsmb.2101; Kyoung M, 2011, P NATL ACAD SCI USA, V108, pE304, DOI 10.1073/pnas.1107900108; Lam PPL, 2013, DIABETES, V62, P2416, DOI 10.2337/db12-1380; Lee HK, 2010, SCIENCE, V328, P760, DOI 10.1126/science.1187722; Li F, 2011, NAT STRUCT MOL BIOL, V18, P941, DOI 10.1038/nsmb.2102; Lin JC, 2004, J AM CHEM SOC, V126, P13679, DOI 10.1021/ja047265o; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Ma C, 2011, NAT STRUCT MOL BIOL, V18, P542, DOI 10.1038/nsmb.2047; Malintan NT, 2009, J BIOL CHEM, V284, P21637, DOI 10.1074/jbc.M109.013508; Malsam J, 2008, CELL MOL LIFE SCI, V65, P2814, DOI 10.1007/s00018-008-8352-3; Malsam J, 2012, EMBO J, V31, P3270, DOI 10.1038/emboj.2012.164; Malsam J, 2009, P NATL ACAD SCI USA, V106, P2001, DOI 10.1073/pnas.0812813106; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Martin S, 2013, J CELL SCI, V126, P2353, DOI 10.1242/jcs.126813; Maximov A, 2009, SCIENCE, V323, P516, DOI 10.1126/science.1166505; McEwen JM, 2008, MOL BIOL CELL, V19, P3836, DOI 10.1091/mbc.E08-02-0160; Meijer M, 2012, EMBO J, V31, P2156, DOI 10.1038/emboj.2012.72; Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081; Min D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2692; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; Parisotto D, 2012, J BIOL CHEM, V287, P31041, DOI 10.1074/jbc.M112.386805; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Reist NE, 1998, J NEUROSCI, V18, P7662; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Rickman C, 2010, J BIOL CHEM, V285, P3965, DOI 10.1074/jbc.M109.040402; Rizo J, 2012, ANNU REV CELL DEV BI, V28, P279, DOI 10.1146/annurev-cellbio-101011-155818; Rowe J, 1999, J CELL SCI, V112, P1865; Schollmeier Y, 2011, J BIOL CHEM, V286, P30582, DOI 10.1074/jbc.M111.269886; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shen JS, 2010, J CELL BIOL, V190, P55, DOI 10.1083/jcb.201003148; Shi L, 2011, MOL BIOL CELL, V22, P4150, DOI 10.1091/mbc.E11-02-0150; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Suh JY, 1999, EUR J BIOCHEM, V266, P665, DOI 10.1046/j.1432-1327.1999.00917.x; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Tareste D, 2008, P NATL ACAD SCI USA, V105, P2380, DOI 10.1073/pnas.0712125105; Toonen RF, 2006, EMBO J, V25, P3725, DOI 10.1038/sj.emboj.7601256; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Wang Z, 2011, J CELL BIOL, V195, P1159, DOI 10.1083/jcb.201104079; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Xu Y, 2010, BIOCHEMISTRY-US, V49, P1568, DOI 10.1021/bi9021878; Yoon TY, 2008, NAT STRUCT MOL BIOL, V15, P707, DOI 10.1038/nsmb.1446	89	71	72	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9639	9650		10.1074/jbc.M113.514273	http://dx.doi.org/10.1074/jbc.M113.514273			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24532794	Green Published, hybrid			2022-12-28	WOS:000333807000018
J	Pascual, F; Hsieh, LS; Soto-Cardalda, A; Carman, GM				Pascual, Florencia; Hsieh, Lu-Sheng; Soto-Cardalda, Anibal; Carman, George M.			Yeast Pah1p Phosphatidate Phosphatase Is Regulated by Proteasome-mediated Degradation*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Glycerophospholipid; Phosphatidate; Phospholipid; Phospholipid Metabolism; Proteasome; Yeast	NUCLEAR-MEMBRANE GROWTH; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-SYNTHESIS; ENDOPLASMIC-RETICULUM; DIACYLGLYCEROL KINASE; LIPID-METABOLISM; DEUBIQUITINATING ENZYME; TRANSCRIPTION FACTOR; PROTEIN-DEGRADATION; SIGNALING FUNCTIONS	Background: Yeast Pah1p phosphatidate phosphatase is most active in stationary phase to produce diacylglycerol for triacylglycerol synthesis. Results: Pah1p is degraded in stationary phase and stabilized by proteasome inhibitor MG132, mutations in proteasome function and ubiquitination, and elevated levels of phosphatidate. Conclusion: Pah1p is regulated by proteasome-mediated degradation. Significance: Regulation of Pah1p stability/degradation is important to lipid homeostatic mechanisms. Yeast PAH1-encoded phosphatidate phosphatase is the enzyme responsible for the production of the diacylglycerol used for the synthesis of triacylglycerol that accumulates in the stationary phase of growth. Paradoxically, the growth phase-mediated inductions of PAH1 and phosphatidate phosphatase activity do not correlate with the amount of Pah1p; enzyme abundance declined in a growth phase-dependent manner. Pah1p from exponential phase cells was a relatively stable protein, and its abundance was not affected by incubation with an extract from stationary phase cells. Recombinant Pah1p was degraded upon incubation with the 100,000 x g pellet fraction of stationary phase cells, although the enzyme was stable when incubated with the same fraction of exponential phase cells. MG132, an inhibitor of proteasome function, prevented degradation of the recombinant enzyme. Endogenously expressed and plasmid-mediated overexpressed levels of Pah1p were more abundant in the stationary phase of cells treated with MG132. Pah1p was stabilized in mutants with impaired proteasome (rpn4, blm10, ump1, and pre1 pre2) and ubiquitination (hrd1, ubc4, ubc7, ubc8, and doa4) functions. The pre1 pre2 mutations that eliminate nearly all chymotrypsin-like activity of the 20 S proteasome had the greatest stabilizing effect on enzyme levels. Taken together, these results supported the conclusion that Pah1p is subject to proteasome-mediated degradation in the stationary phase. That Pah1p abundance was stabilized in pah1 mutant cells expressing catalytically inactive forms of Pah1p and dgk1 mutant cells with induced expression of DGK1-encoded diacylglycerol kinase indicated that alteration in phosphatidate and/or diacylglycerol levels might be the signal that triggers Pah1p degradation.	Rutgers State Univ, Dept Food Sci, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu	Lu-Sheng, Hsieh/AAZ-9188-2020	Lu-Sheng, Hsieh/0000-0001-7555-759X	National Institutes of Health from USPHS [GM028140]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028140, R37GM028140] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM028140 from USPHS.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; BAELEE M, 1990, J BIOL CHEM, V265, P7221; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; BISHOP WR, 1986, J BIOL CHEM, V261, P6993; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Brachmann CB, 1998, YEAST, V14, P115; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; BROWN MG, 1993, ENZYME PROTEIN, V47, P343, DOI 10.1159/000468692; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman George M, 2011, Front Biol (Beijing), V6, P172; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 2009, J BIOL CHEM, V284, P2593, DOI 10.1074/jbc.R800059200; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chae M, 2012, J BIOL CHEM, V287, P40186, DOI 10.1074/jbc.M112.421776; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Cowart LA, 2007, BBA-MOL CELL BIOL L, V1771, P421, DOI 10.1016/j.bbalip.2006.08.005; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Deng M, 2006, NATURE, V443, P827, DOI 10.1038/nature05170; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Eastmond PJ, 2010, PLANT CELL, V22, P2796, DOI 10.1105/tpc.109.071423; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Fakas S, 2011, J BIOL CHEM, V286, P1464, DOI 10.1074/jbc.M110.194308; Fehlker M, 2003, EMBO REP, V4, P959, DOI 10.1038/sj.embor.embor938; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Finley D, 1998, TRENDS BIOCHEM SCI, V23, P244, DOI 10.1016/S0968-0004(98)01222-5; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Gillette TG, 2001, GENE DEV, V15, P1528, DOI 10.1101/gad.869601; Golden A, 2009, J CELL SCI, V122, P1970, DOI 10.1242/jcs.044743; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; HAID A, 1983, METHOD ENZYMOL, V96, P192; HAMPTON RY, 1994, J CELL BIOL, V125, P299, DOI 10.1083/jcb.125.2.299; Han GS, 2008, J BIOL CHEM, V283, P20443, DOI 10.1074/jbc.M802866200; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Hanscho M, 2012, FEMS YEAST RES, V12, P796, DOI 10.1111/j.1567-1364.2012.00830.x; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; HEINEMEYER W, 1993, J BIOL CHEM, V268, P5115; Henderson RJ, 1992, LIPID ANAL PRACTICAL, P65; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; HILT W, 1993, J BIOL CHEM, V268, P3479; HOSAKA K, 1984, BIOCHIM BIOPHYS ACTA, V796, P110; Howe AG, 2006, CAN J PHYSIOL PHARM, V84, P29, DOI 10.1139/Y05-138; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; Jacquier N, 2013, J CELL SCI, V126, P5198, DOI 10.1242/jcs.131896; Karanasios E, 2013, MOL BIOL CELL, V24, P2124, DOI 10.1091/mbc.E13-01-0021; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; Knop M, 1993, CURR OPIN CELL BIOL, V5, P990, DOI 10.1016/0955-0674(93)90082-2; Kohlwein SD, 2013, GENETICS, V193, P1, DOI 10.1534/genetics.112.143362; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; LEPPERT G, 1990, GENETICS, V125, P13; Li X, 2007, EMBO J, V26, P2339, DOI 10.1038/sj.emboj.7601681; London MK, 2004, FEBS LETT, V567, P259, DOI 10.1016/j.febslet.2004.04.078; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; Nakamura Y, 2009, P NATL ACAD SCI USA, V106, P20978, DOI 10.1073/pnas.0907173106; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; Papa FR, 1999, MOL BIOL CELL, V10, P741, DOI 10.1091/mbc.10.3.741; PAPA FR, 1993, NATURE, V366, P313, DOI 10.1038/366313a0; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; QIN S, 1991, J BIOL CHEM, V266, P15549; Qiu YX, 2013, J BIOL CHEM, V288, P29124, DOI 10.1074/jbc.M113.507392; Rajakumari S, 2008, PROG LIPID RES, V47, P157, DOI 10.1016/j.plipres.2008.01.001; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Roberts GG, 2006, MOL GENET GENOMICS, V276, P170, DOI 10.1007/s00438-006-0133-9; Rose MD., 1990, METHODS YEAST GENETI; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Schmidt M, 2005, NAT STRUCT MOL BIOL, V12, P294, DOI 10.1038/nsmb914; Schule T, 2000, EMBO J, V19, P2161, DOI 10.1093/emboj/19.10.2161; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449; SMITH SW, 1957, J BIOL CHEM, V228, P915; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Ugrankar R, 2011, MOL CELL BIOL, V31, P1646, DOI 10.1128/MCB.01335-10; Ustrell V, 2002, EMBO J, V21, P3516, DOI 10.1093/emboj/cdf333; Valente V, 2010, FEBS J, V277, P4775, DOI 10.1111/j.1742-4658.2010.07883.x; VASSAL A, 1992, BIOCHIM BIOPHYS ACTA, V1132, P211, DOI 10.1016/0167-4781(92)90015-R; Waggoner DW, 1999, BBA-MOL CELL BIOL L, V1439, P299, DOI 10.1016/S1388-1981(99)00102-X; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; WERNERWASHBURNE M, 1993, MICROBIOL REV, V57, P383, DOI 10.1128/MMBR.57.2.383-401.1993; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; WOOLFORD CA, 1993, J BIOL CHEM, V268, P8990; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Xu Z, 2012, J LIPID RES, V53, P522, DOI 10.1194/jlr.M022798	115	28	31	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9811	9822		10.1074/jbc.M114.550103	http://dx.doi.org/10.1074/jbc.M114.550103			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24563465	Green Published, hybrid			2022-12-28	WOS:000333807000031
J	Peshenko, IV; Olshevskaya, EV; Lim, S; Ames, JB; Dizhoor, AM				Peshenko, Igor V.; Olshevskaya, Elena V.; Lim, Sunghyuk; Ames, James B.; Dizhoor, Alexander M.			Identification of Target Binding Site in Photoreceptor Guanylyl Cyclase-activating Protein 1 (GCAP1)*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium-binding Proteins; Cyclic GMP (cGMP); Eye; Guanylate Cyclase; Neurobiology; Phototransduction	LEBER CONGENITAL AMAUROSIS; NEURONAL CALCIUM SENSOR; CRYSTAL-STRUCTURE; ROD; MUTATION; GCAP1; GENE; DEGENERATION; RETGC; CA2+	Background: GCAP1 regulates cGMP synthesis in photoreceptors in response to light. Results: Mutagenesis of the entire GCAP1 surface reveals its guanylyl cyclase interface. Conclusion: The interface forms a compact patch that enables both primary binding to and allosteric activation of the target enzyme. Significance: Guanylyl cyclase activation by GCAP1 is indispensable for vision and survival of photoreceptors. Retinal guanylyl cyclase (RetGC)-activating proteins (GCAPs) regulate visual photoresponse and trigger congenital retinal diseases in humans, but GCAP interaction with its target enzyme remains obscure. We mapped GCAP1 residues comprising the RetGC1 binding site by mutagenizing the entire surface of GCAP1 and testing the ability of each mutant to bind RetGC1 in a cell-based assay and to activate it in vitro. Mutations that most strongly affected the activation of RetGC1 localized to a distinct patch formed by the surface of non-metal-binding EF-hand 1, the loop and the exiting helix of EF-hand 2, and the entering helix of EF-hand 3. Mutations in the binding patch completely blocked activation of the cyclase without affecting Ca2+ binding stoichiometry of GCAP1 or its tertiary fold. Exposed residues in the C-terminal portion of GCAP1, including EF-hand 4 and the helix connecting it with the N-terminal lobe of GCAP1, are not critical for activation of the cyclase. GCAP1 mutants that failed to activate RetGC1 in vitro were GFP-tagged and co-expressed in HEK293 cells with mOrange-tagged RetGC1 to test their direct binding in cyto. Most of the GCAP1 mutations introduced into the binding patch prevented co-localization with RetGC1, except for Met-26, Lys-85, and Trp-94. With these residues mutated, GCAP1 completely failed to stimulate cyclase activity but still bound RetGC1 and competed with the wild type GCAP1. Thus, RetGC1 activation by GCAP1 involves establishing a tight complex through the binding patch with an additional activation step involving Met-26, Lys-85, and Trp-94.	[Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.] Salus Univ, Dept Basic Sci, Elkins Pk, PA 19027 USA; [Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.] Salus Univ, Penn Coll Optometry, Elkins Pk, PA 19027 USA; [Lim, Sunghyuk; Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California Davis	Dizhoor, AM (corresponding author), Salus Univ, Dept Basic Sci, 8360 Old York Rd, Elkins Pk, PA 19027 USA.	adizhoor@salus.edu		Dizhoor, Alexander/0000-0001-6770-9186	National Institutes of Health from NEI [EY11522, EY012347]; Pennsylvania Department of Health; NATIONAL EYE INSTITUTE [R01EY012347, R01EY011522] Funding Source: NIH RePORTER	National Institutes of Health from NEI; Pennsylvania Department of Health; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY11522 (to A. M. D.) and EY012347 (to J. B. A.) from NEI. This work was also supported by a CURE Formula Grant (to A. M. D.) from the Pennsylvania Department of Health.	Ames JB, 2012, BBA-GEN SUBJECTS, V1820, P1205, DOI 10.1016/j.bbagen.2011.10.003; Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Dizhoor AM, 1996, J BIOL CHEM, V271, P19346, DOI 10.1074/jbc.271.32.19346; Ermilov AN, 2001, J BIOL CHEM, V276, P48143, DOI 10.1074/jbc.M107539200; GRAYKELLER MP, 1994, NEURON, V13, P849, DOI 10.1016/0896-6273(94)90251-8; Hughes RE, 1998, PROTEIN SCI, V7, P2675, DOI 10.1002/pro.5560071222; Hwang JY, 2004, EUR J BIOCHEM, V271, P3785, DOI 10.1111/j.1432-1033.2004.04320.x; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Jacobson SG, 2013, HUM MOL GENET, V22, P168, DOI 10.1093/hmg/dds421; Jiang L, 2011, P NATL ACAD SCI USA, V108, P18476, DOI 10.1073/pnas.1112758108; Kelsell RE, 1998, HUM MOL GENET, V7, P1179, DOI 10.1093/hmg/7.7.1179; Kitiratschky VBD, 2009, HUM MUTAT, V30, pE782, DOI 10.1002/humu.21055; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; Krylov DM, 2001, J BIOL CHEM, V276, P30648, DOI 10.1074/jbc.M104121200; Laura RP, 1996, J BIOL CHEM, V271, P11646, DOI 10.1074/jbc.271.20.11646; Laura RP, 1998, BIOCHEMISTRY-US, V37, P11264, DOI 10.1021/bi9809674; Lim S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081822; Lim S, 2013, BIOMOL NMR ASSIGN, V7, P39, DOI 10.1007/s12104-012-9373-2; Lim S, 2009, BIOCHEMISTRY-US, V48, P850, DOI 10.1021/bi801897p; Liu Y, 1997, P NATL ACAD SCI USA, V94, P13414, DOI 10.1073/pnas.94.25.13414; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Makino CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047637; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Olshevskaya EV, 2012, J NEUROSCI, V32, P7208, DOI 10.1523/JNEUROSCI.0976-12.2012; Olshevskaya EV, 1999, J BIOL CHEM, V274, P10823, DOI 10.1074/jbc.274.16.10823; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; Perrault I, 1998, AM J HUM GENET, V63, P651, DOI 10.1086/301985; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Peshenko IV, 2008, J BIOL CHEM, V283, P21747, DOI 10.1074/jbc.M801899200; Peshenko IV, 2007, J BIOL CHEM, V282, P21645, DOI 10.1074/jbc.M702368200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2012, J BIOL CHEM, V287, P13972, DOI 10.1074/jbc.M112.341883; Peshenko IV, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00019; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peshenko IV, 2010, BIOCHEMISTRY-US, V49, P709, DOI 10.1021/bi901495y; Peshenko IV, 2004, BIOCHEMISTRY-US, V43, P13796, DOI 10.1021/bi048943m; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; Pugh EN, 1997, BIOSCIENCE REP, V17, P429; Ramamurthy V, 2001, J BIOL CHEM, V276, P26218, DOI 10.1074/jbc.M010495200; Sakurai K, 2011, J NEUROSCI, V31, P7991, DOI 10.1523/JNEUROSCI.6650-10.2011; Sato M, 2005, GRAEF ARCH CLIN EXP, V243, P235, DOI 10.1007/s00417-004-1015-7; Scholten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023117; Sokal I, 2005, INVEST OPHTH VIS SCI, V46, P1124, DOI 10.1167/iovs.04-1431; Sokal I, 2001, J BIOL CHEM, V276, P43361, DOI 10.1074/jbc.M103614200; Stephen R, 2007, STRUCTURE, V15, P1392, DOI 10.1016/j.str.2007.09.013; Stephen R, 2006, J MOL BIOL, V359, P266, DOI 10.1016/j.jmb.2006.03.042; Stone EM, 2007, AM J OPHTHALMOL, V144, P791, DOI 10.1016/j.ajo.2007.08.022; Takemoto N, 2009, P NATL ACAD SCI USA, V106, P11788, DOI 10.1073/pnas.0812781106; Tucker CL, 1999, P NATL ACAD SCI USA, V96, P9039, DOI 10.1073/pnas.96.16.9039; Wilkie SE, 2001, AM J HUM GENET, V69, P471, DOI 10.1086/323265; Woodruff ML, 2007, J NEUROSCI, V27, P8805, DOI 10.1523/JNEUROSCI.2751-07.2007; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; Xu JH, 2013, J NEUROSCI, V33, P14939, DOI 10.1523/JNEUROSCI.0909-13.2013; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602; Yu H, 1999, J BIOL CHEM, V274, P15547, DOI 10.1074/jbc.274.22.15547; Zinchuk V Zinchuk O., 2008, CURR PROTOC CELL BIO, V39	67	27	28	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10140	10154		10.1074/jbc.M113.540716	http://dx.doi.org/10.1074/jbc.M113.540716			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24567338	Green Published, hybrid			2022-12-28	WOS:000333807000060
J	Chen, YY; Jastrzebska, B; Cao, PX; Zhang, JY; Wang, BL; Sun, WY; Yuan, YY; Feng, ZY; Palczewski, K				Chen, Yuanyuan; Jastrzebska, Beata; Cao, Pengxiu; Zhang, Jianye; Wang, Benlian; Sun, Wenyu; Yuan, Yiyuan; Feng, Zhaoyang; Palczewski, Krzysztof			Inherent Instability of the Retinitis Pigmentosa P23H Mutant Opsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Protein-coupled Receptors; Retina; Retinal Degeneration; Vision; Vitamin A	PROTEIN-COUPLED RECEPTORS; TRANSGENIC MICE; DISULFIDE BOND; HETEROLOGOUS EXPRESSION; CAENORHABDITIS-ELEGANS; TRANSDUCIN ACTIVATION; RETINAL DEGENERATION; CYSTEINE RESIDUE-110; PHOTORECEPTOR CELLS; RIBOZYME RESCUE	Background: The P23H opsin mutant causes the blinding human disease, retinitis pigmentosa. Results: Molecular properties of bovine P23H mutant opsin were characterized in both in vitro and a transgenic C. elegans model. Conclusion: Thermally unstable P23H isorhodopsin containing correct disulfide bond can be slowly regenerated in transgenic C. elegans.Significance: This study produced novel information about the disease-causing P23H mutant opsin. The P23H opsin mutation is the most common cause of autosomal dominant retinitis pigmentosa. Even though the pathobiology of the resulting retinal degeneration has been characterized in several animal models, its complex molecular mechanism is not well understood. Here, we expressed P23H bovine rod opsin in the nervous system of Caenorhabditis elegans. Expression was low due to enhanced protein degradation. The mutant opsin was glycosylated, but the polysaccharide size differed from that of the normal protein. Although P23H opsin aggregated in the nervous system of C. elegans, the pharmacological chaperone 9-cis-retinal stabilized it during biogenesis, producing a variant of rhodopsin called P23H isorhodopsin. In vitro, P23H isorhodopsin folded correctly, formed the appropriate disulfide bond, could be photoactivated but with reduced sensitivity, and underwent Meta II decay at a rate similar to wild type isorhodopsin. In worm neurons, P23H isorhodopsin initiated phototransduction by coupling with the endogenous G(i/o) signaling cascade that induced loss of locomotion. Using pharmacological interventions affecting protein synthesis and degradation, we showed that the chromophore could be incorporated either during or after mutant protein translation. However, regeneration of P23H isorhodopsin with chromophore was significantly slower than that of wild type isorhodopsin. This effect, combined with the inherent instability of P23H rhodopsin, could lead to the structural cellular changes and photoreceptor death found in autosomal dominant retinitis pigmentosa. These results also suggest that slow regeneration of P23H rhodopsin could prevent endogenous chromophore-mediated stabilization of rhodopsin in the retina.	[Chen, Yuanyuan; Jastrzebska, Beata; Cao, Pengxiu; Zhang, Jianye; Yuan, Yiyuan; Feng, Zhaoyang; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Wang, Benlian] Case Western Reserve Univ, Sch Med, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Sun, Wenyu] Polgenix Inc, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu		Chen, Yuanyuan/0000-0001-9625-1610; CAO, PENGXIU/0000-0002-5900-5645	National Institutes of Health [EY008061, EY019478]; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [R01EY019478, R01EY008061, R29EY008061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY008061 and EY019478. This work was also supported by a grant from the Foundation Fighting Blindness.	Aguila M., 2013, HUM MOL GENET, DOI 10.1093/hmg/ddt613; Artal-Sanz Marto, 2006, Biotechnology Journal, V1, P1405, DOI 10.1002/biot.200600176; Athanasiou D, 2013, FEBS LETT, V587, P2008, DOI 10.1016/j.febslet.2013.05.020; BERSON EL, 1991, ARCH OPHTHALMOL-CHIC, V109, P92, DOI 10.1001/archopht.1991.01080010094039; Berson EL, 1996, P NATL ACAD SCI USA, V93, P4526, DOI 10.1073/pnas.93.10.4526; Burkewitz K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034153; Cao PX, 2012, FASEB J, V26, P480, DOI 10.1096/fj.11-197798; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; Chrysostomou V, 2008, INVEST OPHTH VIS SCI, V49, P1116, DOI 10.1167/iovs.07-1158; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; EDGAR RS, 1977, SCIENCE, V198, P1285, DOI 10.1126/science.929205; Epstein HF, 1995, METHOD CELL BIOL, V48, P437; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P9165, DOI 10.1021/bi00086a023; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fernandez-Sanchez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043074; Fernandez-Sanchez L, 2011, INVEST OPHTH VIS SCI, V52, P4998, DOI 10.1167/iovs.11-7496; Frederick JM, 2001, INVEST OPHTH VIS SCI, V42, P826; FUKUDA MN, 1982, METHOD ENZYMOL, V81, P214; FUKUDA MN, 1979, J BIOL CHEM, V254, P8201; Glover-Cutter KM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003701; Goc A, 2008, BIOCHEMISTRY-US, V47, P12409, DOI 10.1021/bi8015444; Gorbatyuk MS, 2012, ADV EXP MED BIOL, V723, P191, DOI 10.1007/978-1-4614-0631-0_26; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; GOTO Y, 1995, INVEST OPHTH VIS SCI, V36, P62; Griciuc A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001075; Haeri Mohammad, 2012, J Ophthalmic Vis Res, V7, P45; Haeri M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030101; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Heck M, 2003, J BIOL CHEM, V278, P3162, DOI 10.1074/jbc.M209675200; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Hwa J, 2001, P NATL ACAD SCI USA, V98, P4872, DOI 10.1073/pnas.061632798; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; JACOBSON SG, 1991, AM J OPHTHALMOL, V112, P256, DOI 10.1016/S0002-9394(14)76726-1; Jastrzebska B, 2013, METHOD ENZYMOL, V520, P239, DOI 10.1016/B978-0-12-391861-1.00011-3; KARNIK SS, 1990, J BIOL CHEM, V265, P17520; KARNIK SS, 1988, P NATL ACAD SCI USA, V85, P8459, DOI 10.1073/pnas.85.22.8459; KAUSHAL S, 1994, P NATL ACAD SCI USA, V91, P4024, DOI 10.1073/pnas.91.9.4024; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Kiser PD, 2012, BBA-MOL CELL BIOL L, V1821, P137, DOI 10.1016/j.bbalip.2011.03.005; LaVail MM, 2000, P NATL ACAD SCI USA, V97, P11488, DOI 10.1073/pnas.210319397; Leung CK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062166; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; LIANG CJ, 1979, J BIOL CHEM, V254, P6414; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lin JH, 2010, ADV EXP MED BIOL, V664, P115, DOI 10.1007/978-1-4419-1399-9_14; Lobanova ES, 2013, P NATL ACAD SCI USA, V110, P9986, DOI 10.1073/pnas.1305521110; McKibbin C, 2007, J MOL BIOL, V374, P1309, DOI 10.1016/j.jmb.2007.10.013; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Mendes HF, 2008, HUM MOL GENET, V17, P3043, DOI 10.1093/hmg/ddn202; Murray AR, 2009, OPHTHALMIC GENET, V30, P109, DOI 10.1080/13816810902962405; NAASH MI, 1993, P NATL ACAD SCI USA, V90, P5499, DOI 10.1073/pnas.90.12.5499; Noorwez SM, 2004, J BIOL CHEM, V279, P16278, DOI 10.1074/jbc.M312101200; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; Nunes AF, 2012, MOL NEUROBIOL, V45, P440, DOI 10.1007/s12035-012-8256-y; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 1999, BIOCHEMISTRY-US, V38, P12012, DOI 10.1021/bi990504d; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Palczewski K, 2010, TRENDS PHARMACOL SCI, V31, P284, DOI 10.1016/j.tips.2010.03.001; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; Ridge KD, 2007, J BIOL CHEM, V282, P9297, DOI 10.1074/jbc.R600032200; ROOF DJ, 1994, INVEST OPHTH VIS SCI, V35, P4049; Ross JW, 2012, INVEST OPHTH VIS SCI, V53, P501, DOI 10.1167/iovs.11-8784; Rossmiller B, 2012, MOL VIS, V18, P2479; Sakami S, 2014, HUM MOL GENET, V23, P1723, DOI 10.1093/hmg/ddt561; Sakami S, 2011, J BIOL CHEM, V286, P10551, DOI 10.1074/jbc.M110.209759; Saliba RS, 2002, J CELL SCI, V115, P2907; Salom D, 2012, FASEB J, V26, P492, DOI 10.1096/fj.11-197780; Salom D, 2008, BIOCHEMISTRY-US, V47, P13296, DOI 10.1021/bi8018527; Segref A, 2011, GENETICS, V187, P1235, DOI 10.1534/genetics.111.126797; STENICO M, 1994, NUCLEIC ACIDS RES, V22, P2437, DOI 10.1093/nar/22.13.2437; Stiernagle Theresa, 2006, WormBook, P1; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; Tam BM, 2006, INVEST OPHTH VIS SCI, V47, P3234, DOI 10.1167/iovs.06-0213; Tsybovsky Y, 2011, BIOCHEMISTRY-US, V50, P6855, DOI 10.1021/bi200774w; Vasireddy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021193; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wu TP, 1998, NEUROSCIENCE, V87, P709, DOI 10.1016/S0306-4522(98)00173-0; Yabe T, 2005, DEVELOPMENT, V132, P3197, DOI 10.1242/dev.01909; Zhang SJ, 2011, J NEUROSCI METH, V197, P315, DOI 10.1016/j.jneumeth.2011.02.014; Zhu L, 2006, J BIOL CHEM, V281, P22289, DOI 10.1074/jbc.M602664200	86	34	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9288	9303		10.1074/jbc.M114.551713	http://dx.doi.org/10.1074/jbc.M114.551713			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24515108	Green Published, hybrid			2022-12-28	WOS:000333472100046
J	Jung, M; Philpott, M; Muller, S; Schulze, J; Badock, V; Eberspacher, U; Moosmayer, D; Bader, B; Schmees, N; Fernandez-Montalvan, A; Haendler, B				Jung, Marie; Philpott, Martin; Mueller, Susanne; Schulze, Jessica; Badock, Volker; Eberspaecher, Uwe; Moosmayer, Dieter; Bader, Benjamin; Schmees, Norbert; Fernandez-Montalvan, Amaury; Haendler, Bernard			Affinity Map of Bromodomain Protein 4 ( BRD4) Interactions with the Histone H4 Tail and the Small Molecule Inhibitor JQ1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anticancer Drug; Cancer Therapy; Chromatin; Histones; Mutant; Acetylation; BET Family; BRD4; Bromodomain	ACUTE MYELOID-LEUKEMIA; BET BROMODOMAINS; STRUCTURAL BASIS; SELECTIVE-INHIBITION; AGGRESSIVE CARCINOMA; ACETYLATED CHROMATIN; BINDING; RECOGNITION; TRANSCRIPTION; CANCER	Background: BRD4 is a reader of acetylated histones. Results: Mutational analysis of BRD4 BD1 allowed the identification of three groups with different binding profiles. Conclusion: Pro-82, Leu-94, Asp-145, and Ile-146 have a differentiated role in acetyl-lysine and inhibitor interaction. Significance: Identification of residues essential for BRD4 function will guide the design of novel inhibitors. Bromodomain protein 4 (BRD4) is a member of the bromodomain and extra-terminal domain (BET) protein family. It binds to acetylated histone tails via its tandem bromodomains BD1 and BD2 and forms a complex with the positive transcription elongation factor b, which controls phosphorylation of RNA polymerase II, ultimately leading to stimulation of transcription elongation. An essential role of BRD4 in cell proliferation and cancer growth has been reported in several recent studies. We analyzed the binding of BRD4 BD1 and BD2 to different partners and showed that the strongest interactions took place with di- and tetra-acetylated peptides derived from the histone 4 N-terminal tail. We also found that several histone 4 residues neighboring the acetylated lysines significantly influenced binding. We generated 10 different BRD4 BD1 mutants and analyzed their affinities to acetylated histone tails and to the BET inhibitor JQ1 using several complementary biochemical and biophysical methods. The impact of these mutations was confirmed in a cellular environment. Altogether, the results show that Trp-81, Tyr-97, Asn-140, and Met-149 play similarly important roles in the recognition of acetylated histones and JQ1. Pro-82, Leu-94, Asp-145, and Ile-146 have a more differentiated role, suggesting that different kinds of interactions take place and that resistance mutations compatible with BRD4 function are possible. Our study extends the knowledge on the contribution of individual BRD4 amino acids to histone and JQ1 binding and may help in the design of new BET antagonists with improved pharmacological properties.	[Jung, Marie; Schulze, Jessica; Badock, Volker; Eberspaecher, Uwe; Moosmayer, Dieter; Bader, Benjamin; Schmees, Norbert; Fernandez-Montalvan, Amaury; Haendler, Bernard] Bayer HealthCare, Global Drug Discovery, D-13353 Berlin, Germany; [Jung, Marie] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Philpott, Martin; Mueller, Susanne] Univ Oxford, Struct Genom Consortium, Nuffield Dept Clin Med, Oxford OX3 7DQ, England; [Philpott, Martin; Mueller, Susanne] Univ Oxford, Target Discovery Inst, Nuffield Dept Clin Med, Oxford OX3 7DQ, England	Bayer AG; Bayer Healthcare Pharmaceuticals; Free University of Berlin; University of Oxford; University of Oxford	Haendler, B (corresponding author), Bayer HealthCare, Dept Chromatin Modulat & OncoGen, Therapeut Res Grp Oncol Gynecol Therapies, Global Drug Discovery, Mullerstr 178, D-13353 Berlin, Germany.	bernard.haendler@bayer.com		Muller-Knapp, Susanne/0000-0003-2402-4157; Bader, Benjamin/0000-0002-5299-396X; Philpott, Martin/0000-0003-3632-0084; Fernandez-Montalvan, Amaury/0000-0001-9156-0000	SGC [1097737]; AbbVie; Boehringer Ingelheim; Canada Foundation for Innovation; Canadian Institutes for Health Research; Genome Canada; GlaxoSmithKline; Janssen; Lilly Canada; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Takeda; Wellcome Trust [092809/Z/10/Z]	SGC; AbbVie(AbbVie); Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the SGC, a registered charity (1097737) that receives funds from AbbVie, Boehringer Ingelheim, the Canada Foundation for Innovation, the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Takeda, and the Wellcome Trust (092809/Z/10/Z).	Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Barik S, 1993, Methods Mol Biol, V15, P277, DOI 10.1385/0-89603-244-2:277; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bjerke L, 2013, CANCER DISCOV, V3, P512, DOI 10.1158/2159-8290.CD-12-0426; BRANDTS JF, 1990, BIOCHEMISTRY-US, V29, P6927, DOI 10.1021/bi00481a024; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chiang Cheng-Ming, 2009, F1000 Biol Rep, V1, P98, DOI 10.3410/B1-98; Chung CW, 2011, J BIOMOL SCREEN, V16, P1170, DOI 10.1177/1087057111421372; Da Costa D, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.24; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Florence B, 2001, FRONT BIOSCI-LANDMRK, V6, pD1008, DOI 10.2741/Florence; French CA, 2013, HEAD NECK PATHOL, V7, P11, DOI 10.1007/s12105-013-0428-1; French CA, 2003, CANCER RES, V63, P304; French CA, 2001, AM J PATHOL, V159, P1987, DOI 10.1016/S0002-9440(10)63049-0; Gamsjaeger R, 2011, MOL CELL BIOL, V31, P2632, DOI 10.1128/MCB.05413-11; Herrmann H, 2012, ONCOTARGET, V3, P1588, DOI 10.18632/oncotarget.733; Hewings DS, 2012, J MED CHEM, V55, P9393, DOI 10.1021/jm300915b; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Ito T, 2011, CHEM BIOL, V18, P495, DOI 10.1016/j.chembiol.2011.02.009; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Layton CJ, 2010, BIOCHEMISTRY-US, V49, P10831, DOI 10.1021/bi101414z; Lockwood WW, 2012, P NATL ACAD SCI USA, V109, P19408, DOI 10.1073/pnas.1216363109; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Muller S, 2011, EXPERT REV MOL MED, V13, P1, DOI 10.1017/S1462399411001992; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Oliver SS, 2011, ANGEW CHEM INT EDIT, V50, P5801, DOI 10.1002/anie.201101414; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Picaud S, 2013, CANCER RES, V73, P3336, DOI 10.1158/0008-5472.CAN-12-3292; Pivot-Pajot C, 2003, MOL CELL BIOL, V23, P5354, DOI 10.1128/MCB.23.15.5354-5365.2003; Plass C, 2013, NAT REV GENET, V14, P765, DOI 10.1038/nrg3554; Prinjha RK, 2012, TRENDS PHARMACOL SCI, V33, P146, DOI 10.1016/j.tips.2011.12.002; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Rahman S, 2011, MOL CELL BIOL, V31, P2641, DOI 10.1128/MCB.01341-10; Schroder S, 2012, J BIOL CHEM, V287, P1090, DOI 10.1074/jbc.M111.282855; Segura MF, 2013, CANCER RES, V73, P6264, DOI 10.1158/0008-5472.CAN-13-0122-T; Shimamura T, 2013, CLIN CANCER RES, V19, P6183, DOI 10.1158/1078-0432.CCR-12-3904; Sierra JR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-75; Steiner S, 2013, FEBS LETT, V587, P2158, DOI 10.1016/j.febslet.2013.05.032; Sun HB, 2007, BIOCHEM BIOPH RES CO, V358, P435, DOI 10.1016/j.bbrc.2007.04.139; Umehara T, 2010, J BIOL CHEM, V285, P7610, DOI 10.1074/jbc.M109.062422; Vidler LR, 2012, J MED CHEM, V55, P7346, DOI 10.1021/jm300346w; Vollmuth F, 2009, J BIOL CHEM, V284, P36547, DOI 10.1074/jbc.M109.033712; Wang RR, 2012, J BIOL CHEM, V287, P10738, DOI 10.1074/jbc.M111.323493; Weidner-Glunde M, 2010, FRONT BIOSCI-LANDMRK, V15, P537, DOI 10.2741/3632; Wu SY, 2013, MOL CELL, V49, P843, DOI 10.1016/j.molcel.2012.12.006; Wyce A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072967; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zhang GT, 2012, J BIOL CHEM, V287, P28840, DOI 10.1074/jbc.M112.359505; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhang WS, 2012, J BIOL CHEM, V287, P43137, DOI 10.1074/jbc.M112.413047; Zou Z., 2013, ONCOGENE, DOI 10.1038/onc.2013.179; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	67	98	118	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9304	9319		10.1074/jbc.M113.523019	http://dx.doi.org/10.1074/jbc.M113.523019			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24497639	Green Published, hybrid			2022-12-28	WOS:000333472100047
J	Yi, TF; Weng, JS; Siwko, S; Luo, J; Li, DL; Liu, MY				Yi, Tingfang; Weng, Jinsheng; Siwko, Stefan; Luo, Jian; Li, Dali; Liu, Mingyao			LGR4/GPR48 Inactivation Leads to Aniridia-Genitourinary Anomalies-Mental Retardation Syndrome Defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CREB; G-protein-coupled Receptors (GPCR); Histone Methylation; Kidney; Ovary; AGR Syndrome; Fbxl10; Jmjd2a; LGR4; Histone Demethylase	MULLERIAN-INHIBITING SUBSTANCE; HISTONE DEMETHYLASE; GROWTH-FACTOR; POSTNATAL-DEVELOPMENT; CELL-PROLIFERATION; REPRODUCTIVE-TRACT; GENE-REGULATION; DOWN-REGULATION; WAGR SYNDROME; LGR4	Background: The pathogenic mechanisms of aniridia-genitourinary anomalies-mental retardation (AGR) syndrome are obscure. Results: Depletion of Lgr4 in mouse leads to aniridia, polycystic kidney disease, genitourinary anomalies, and mental retardation, similar to the pathological defects of AGR syndrome. Conclusion: Lgr4 is a candidate gene for the pathogenesis of AGR syndrome. Significance: Understanding the mechanisms of the pathogenesis of AGR syndrome. AGR syndrome (the clinical triad of aniridia, genitourinary anomalies, and mental retardation, a subgroup of WAGR syndrome for Wilm's tumor, aniridia, genitourinary anomalies, and mental retardation) is a rare syndrome caused by a contiguous gene deletion in the 11p13-14 region. However, the mechanisms of WAGR syndrome pathogenesis are elusive. In this study we provide evidence that LGR4 (also named GPR48), the only G-protein-coupled receptor gene in the human chromosome 11p12-11p14.4 fragment, is the key gene responsible for the diseases of AGR syndrome. Deletion of Lgr4 in mouse led to aniridia, polycystic kidney disease, genitourinary anomalies, and mental retardation, similar to the pathological defects of AGR syndrome. Furthermore, Lgr4 inactivation significantly increased cell apoptosis and decreased the expression of multiple important genes involved in the development of WAGR syndrome related organs. Specifically, deletion of Lgr4 down-regulated the expression of histone demethylases Jmjd2a and Fbxl10 through cAMP-CREB signaling pathways both in mouse embryonic fibroblast cells and in urinary and reproductive system mouse tissues. Our data suggest that Lgr4, which regulates eye, kidney, testis, ovary, and uterine organ development as well as mental development through genetic and epigenetic surveillance, is a novel candidate gene for the pathogenesis of AGR syndrome.	[Yi, Tingfang; Weng, Jinsheng; Siwko, Stefan; Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX 77030 USA; [Yi, Tingfang; Weng, Jinsheng; Siwko, Stefan; Liu, Mingyao] Texas A&M Univ, Hlth Sci Ctr, Dept Mol & Cellular Med, Houston, TX 77030 USA; [Luo, Jian; Li, Dali; Liu, Mingyao] E China Normal Univ, Shanghai Key Lab Regulatory Biol, Inst Biomed Sci, Shanghai 200241, Peoples R China; [Luo, Jian; Li, Dali; Liu, Mingyao] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; East China Normal University; East China Normal University	Liu, MY (corresponding author), Texas A&M Univ, Hlth Sci Ctr, Inst Biosci & Technol, 2121 W Holcombe Blvd, Houston, TX 77030 USA.	mliu@ibt.tamhsc.edu	; Luo, Jian/H-3362-2016	Liu, Mingyao/0000-0001-7339-5048; Luo, Jian/0000-0003-3583-0154; Siwko, Stefan/0000-0003-4260-2985	State Key Development Programs of China [2012CB910400]; National Institutes of Health (NCI) [1R01CA134731]; NATIONAL CANCER INSTITUTE [R01CA134731] Funding Source: NIH RePORTER	State Key Development Programs of China; National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by grants from the State Key Development Programs of China (2012CB910400) and the National Institutes of Health (NCI Grant 1R01CA134731 (to M.L.)).	Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chen TT, 1997, MOL CELL BIOL, V17, P3056, DOI 10.1128/MCB.17.6.3056; Connell KA, 2008, J CLIN INVEST, V118, P1050, DOI 10.1172/JCI34193; Couture JF, 2007, NAT STRUCT MOL BIOL, V14, P689, DOI 10.1038/nsmb1273; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Deng C, 2013, J CELL SCI, V126, P2060, DOI 10.1242/jcs.123471; Du B, 2013, J BIOL CHEM, V288, P15131, DOI 10.1074/jbc.M113.455535; Dunn RK, 2007, MOL CELL, V28, P708, DOI 10.1016/j.molcel.2007.11.022; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Fischbach BV, 2005, PEDIATRICS, V116, P984, DOI 10.1542/peds.2004-0467; Gao Y, 2006, CANCER RES, V66, P11623, DOI 10.1158/0008-5472.CAN-06-2629; GESSLER M, 1988, Genomics, V3, P117, DOI 10.1016/0888-7543(88)90141-3; Han JC, 2008, NEW ENGL J MED, V359, P918, DOI 10.1056/NEJMoa0801119; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Heikinheimo M, 1997, ENDOCRINOLOGY, V138, P3505, DOI 10.1210/en.138.8.3505; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; HOLMES SD, 1986, J BIOL CHEM, V261, P4076; Hoshii T, 2007, BIOL REPROD, V76, P303, DOI 10.1095/biolreprod.106.054619; Jin C, 2008, INVEST OPHTH VIS SCI, V49, P4245, DOI 10.1167/iovs.08-1860; JORDAN T, 1992, NAT GENET, V1, P328, DOI 10.1038/ng0892-328; Kato S, 2006, NEPHRON EXP NEPHROL, V104, pE63, DOI 10.1159/000093999; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Kobayashi A, 2004, DEVELOPMENT, V131, P539, DOI 10.1242/dev.00951; Lennon PA, 2006, AM J MED GENET A, V140A, P1214, DOI 10.1002/ajmg.a.31229; Li Y, 2012, CELL SIGNAL, V24, P2297, DOI 10.1016/j.cellsig.2012.07.010; Loh ED, 2000, CYTOGENET CELL GENET, V89, P2, DOI 10.1159/000015576; Luo J, 2009, DEVELOPMENT, V136, P2747, DOI 10.1242/dev.033571; Luo WJ, 2013, STEM CELLS, V31, P2492, DOI 10.1002/stem.1484; Manuylov NL, 2008, DEVELOPMENT, V135, P3731, DOI 10.1242/dev.024653; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P2241, DOI 10.1210/me.2004-0133; Mendive F, 2006, DEV BIOL, V290, P421, DOI 10.1016/j.ydbio.2005.11.043; Mittag J, 2007, ENDOCRINOLOGY, V148, P719, DOI 10.1210/en.2006-1054; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nancy P, 2012, SCIENCE, V336, P1317, DOI 10.1126/science.1220030; NARAHARA K, 1984, HUM GENET, V66, P181, DOI 10.1007/BF00286597; Nottoli T, 1998, P NATL ACAD SCI USA, V95, P13714, DOI 10.1073/pnas.95.23.13714; Peng YB, 2009, ANIM GENET, V40, P242, DOI 10.1111/j.1365-2052.2008.01818.x; Pereira F, 2011, HUM MOL GENET, V20, P4655, DOI 10.1093/hmg/ddr399; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; PRITCHARDJONES K, 1990, NATURE, V346, P194, DOI 10.1038/346194a0; Qian Y, 2013, DEVELOPMENT, V140, P1751, DOI 10.1242/dev.093641; RALL LB, 1985, NATURE, V313, P228, DOI 10.1038/313228a0; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Richards WG, 1998, J CLIN INVEST, V101, P935, DOI 10.1172/JCI2071; Ruffner H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040976; Scott DA, 2005, AM J MED GENET A, V134A, P430, DOI 10.1002/ajmg.a.30654; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Shin S, 2007, BIOCHEM BIOPH RES CO, V359, P742, DOI 10.1016/j.bbrc.2007.05.179; Shinawi M, 2011, AM J MED GENET A, V155A, P1272, DOI 10.1002/ajmg.a.33878; Sim CK, 2012, GENE DEV, V26, P2483, DOI 10.1101/gad.201665.112; Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Van Schoore G, 2005, HISTOCHEM CELL BIOL, V124, P35, DOI 10.1007/s00418-005-0002-3; Viger RS, 1998, DEVELOPMENT, V125, P2665; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wang Y, 2013, STEM CELLS, V31, P1921, DOI 10.1002/stem.1438; Watanabe K, 2000, P NATL ACAD SCI USA, V97, P1624, DOI 10.1073/pnas.97.4.1624; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Xu S, 2008, CYTOGENET GENOME RES, V122, P181, DOI 10.1159/000172086; Yamamoto S, 2013, CARCINOGENESIS, V34, P2380, DOI 10.1093/carcin/bgt174; Yao HHC, 2002, GENE DEV, V16, P1433, DOI 10.1101/gad.981202; Yi TF, 2010, J BIOL CHEM, V285, P17811, DOI 10.1074/jbc.M110.130740; Zhang DZ, 2005, MOL CELL BIOL, V25, P6404, DOI 10.1128/MCB.25.15.6404-6414.2005	66	21	21	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8767	8780		10.1074/jbc.M113.530816	http://dx.doi.org/10.1074/jbc.M113.530816			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24519938	hybrid, Green Published			2022-12-28	WOS:000333472100004
J	Abeykoon, A; Wang, GH; Chao, CC; Chock, PB; Gucek, M; Ching, WM; Yang, DCH				Abeykoon, Amila; Wang, Guanghui; Chao, Chien-Chung; Chock, P. Boon; Gucek, Marjan; Ching, Wei-Mei; Yang, David C. H.			Multimethylation of Rickettsia OmpB Catalyzed by Lysine Methyltransferases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Cell Surface Protein; Enzyme Catalysis; Mass Spectrometry (MS); Protein Methylation	OUTER-MEMBRANE-PROTEIN; PROTEOMIC ANALYSIS; METHYLATION; PROWAZEKII; INFECTION; TYPHI; TRIMETHYLLYSINE; RECOGNITION; ANTIGENS; INVASION	Background: Methylation of OmpB has been implicated in rickettsial virulence. Results: Native OmpBs purified from Rickettsia contain mono- and trimethyllysine at specific locations that coincide with those catalyzed by methyltransferases in vitro. Conclusion: The number of trimethyllysine clusters in OmpBs correlates with degree of virulence. Significance: This study provides new insight into methylation of OmpB and its correlation with virulence. Methylation of rickettsial OmpB (outer membrane protein B) has been implicated in bacterial virulence. Rickettsial methyltransferases RP789 and RP027-028 are the first biochemically characterized methyltransferases to catalyze methylation of outer membrane protein (OMP). Methylation in OMP remains poorly understood. Using semiquantitative integrated liquid chromatography-tandem mass spectroscopy, we characterize methylation of (i) recombinantly expressed fragments of Rickettsia typhi OmpB exposed in vitro to trimethyltransferases of Rickettsia prowazekii RP027-028 and of R. typhi RT0101 and to monomethyltransferases of R. prowazekii RP789 and of R. typhi RT0776, and (ii) native OmpBs purified from R. typhi and R. prowazekii strains Breinl, RP22, and Madrid E. We found that in vitro trimethylation occurs at relatively specific locations in OmpB with consensus motifs, KX(G/A/V/I)N and KT(I/L/F), whereas monomethylation is pervasive throughout OmpB. Native OmpB from virulent R. typhi contains mono- and trimethyllysines at locations well correlated with methylation in recombinant OmpB catalyzed by methyltransferases in vitro. Native OmpBs from highly virulent R. prowazekii strains Breinl and RP22 contain multiple clusters of trimethyllysine in contrast to a single cluster in OmpB from mildly virulent R. typhi. Furthermore, OmpB from the avirulent strain Madrid E contains mostly monomethyllysine and no trimethyllysine. The native OmpB from Madrid E was minimally trimethylated by RT0101 or RP027-028, consistent with a processive mechanism of trimethylation. This study provides the first in-depth characterization of methylation of an OMP at the molecular level and may lead to uncovering the link between OmpB methylation and rickettsial virulence.	[Abeykoon, Amila; Yang, David C. H.] Georgetown Univ, Dept Chem, Washington, DC 20057 USA; [Wang, Guanghui; Gucek, Marjan] NHLBI, Prote Core Facil, NIH, Bethesda, MD 20892 USA; [Chao, Chien-Chung; Ching, Wei-Mei] Naval Med Res Ctr, Viral & Rickettsial Dis Dept, Infect Dis Directorate, Silver Spring, MD 20910 USA; [Chock, P. Boon] NHLBI, Biochem Lab, Bethesda, MD 20892 USA	Georgetown University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Naval Medical Research Center (NMRC); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Yang, DCH (corresponding author), Georgetown Univ, Dept Chem, Washington, DC 20057 USA.	yangdc@georgetown.edu	Yang, David/A-7294-2009		Naval Medical Logistic Command Award [N62645];  [6000.RAD1.J.A0310]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000202, ZICHL005903] Funding Source: NIH RePORTER	Naval Medical Logistic Command Award; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by Naval Medical Logistic Command Award N62645 (to Georgetown University) and Work Unit 6000.RAD1.J.A0310 (to the Naval Medical Research Center).	Abeykoon AH, 2012, J BACTERIOL, V194, P6410, DOI 10.1128/JB.01379-12; Anacker RL., 1981, RICKETTSIAE RICKETTS, P71; Barnard TJ, 2007, NAT STRUCT MOL BIOL, V14, P1214, DOI 10.1038/nsmb1322; Bechah Y, 2010, GENOME RES, V20, P655, DOI 10.1101/gr.103564.109; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Botelho-Nevers E, 2011, EUR J CLIN MICROBIOL, V30, P1139, DOI 10.1007/s10096-011-1208-z; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Buchanan SK, 1999, CURR OPIN STRUC BIOL, V9, P455, DOI 10.1016/S0959-440X(99)80064-5; Chan YGY, 2009, CELL MICROBIOL, V11, P629, DOI 10.1111/j.1462-5822.2008.01279.x; Chan YGY, 2011, INFECT IMMUN, V79, P2303, DOI 10.1128/IAI.01324-10; Chao CC, 2008, CLIN VACCINE IMMUNOL, V15, P684, DOI 10.1128/CVI.00281-07; Chao CC, 2007, BBA-PROTEINS PROTEOM, V1774, P373, DOI 10.1016/j.bbapap.2007.01.001; Ching W.M., 1993, TECHNIQUES PROTEIN C, P307; Chou M. F., 2011, CURR PROTOC BIOINFOR, V2011, P15; DASCH GA, 1981, J CLIN MICROBIOL, V14, P333, DOI 10.1128/JCM.14.3.333-341.1981; DASCH GA, 1981, INFECT IMMUN, V31, P276, DOI 10.1128/IAI.31.1.276-288.1981; Daze KD, 2013, ACCOUNTS CHEM RES, V46, P937, DOI 10.1021/ar300072g; Daze KD, 2012, CHEM SCI, V3, P2695, DOI 10.1039/c2sc20583a; Erce MA, 2012, PROTEOMICS, V12, P564, DOI 10.1002/pmic.201100397; Feng HM, 2004, INFECT IMMUN, V72, P2222, DOI 10.1128/IAI.72.4.2222-2228.2004; Georgiades K., 2011, PLOS ONE, V6; GILMORE RD, 1991, MOL MICROBIOL, V5, P2361, DOI 10.1111/j.1365-2958.1991.tb02082.x; GRANADOS EN, 1980, BIOCHEMISTRY-US, V19, P3227, DOI 10.1021/bi00555a020; Hackstadt T, 1996, INFECT AGENT DIS, V5, P127; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Hughes RM, 2007, P NATL ACAD SCI USA, V104, P11184, DOI 10.1073/pnas.0610850104; Kinter M., 2000, PROTEIN SEQUENCING I, P154; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Li H, 1998, MICROB PATHOGENESIS, V24, P289, DOI 10.1006/mpat.1997.0197; Lu ZY, 2009, J AM CHEM SOC, V131, P14928, DOI 10.1021/ja904951t; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; PAIK WK, 1971, SCIENCE, V174, P114, DOI 10.1126/science.174.4005.114; Paik WK, 2007, TRENDS BIOCHEM SCI, V32, P146, DOI 10.1016/j.tibs.2007.01.006; Renesto P, 2006, RES MICROBIOL, V157, P605, DOI 10.1016/j.resmic.2006.02.002; ROBERTS DM, 1986, J BIOL CHEM, V261, P1491; RODIONOV AV, 1990, BIOORG KHIM+, V16, P1687; Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Uchiyama T, 2006, MICROBES INFECT, V8, P801, DOI 10.1016/j.micinf.2005.10.003; Wagner T, 2012, NAT BIOTECHNOL, V30, P622, DOI 10.1038/nbt.2300; Walker DH, 2008, NAT REV MICROBIOL, V6, P375, DOI 10.1038/nrmicro1866; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470; Zhang JZ, 2006, VACCINE, V24, P2317, DOI 10.1016/j.vaccine.2005.11.044; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	44	18	19	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7691	7701		10.1074/jbc.M113.535567	http://dx.doi.org/10.1074/jbc.M113.535567			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24497633	hybrid, Green Published			2022-12-28	WOS:000332761500037
J	Hassan, I; Gaines, KS; Hottel, WJ; Wishy, RM; Miller, SE; Powers, LS; Rutkowski, DT; Monick, MM				Hassan, Ihab; Gaines, Kayla S.; Hottel, Wesley J.; Wishy, Ryan M.; Miller, Sara E.; Powers, Linda S.; Rutkowski, D. Thomas; Monick, Martha M.			Inositol-requiring Enzyme 1 Inhibits Respiratory Syncytial Virus Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Cell Signaling; ER Stress; Negative-strand RNA Viruses; Viral Replication; IRE1	ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; HEPATITIS-C VIRUS; ER STRESS; EPITHELIAL-CELLS; AIRWAY EPITHELIA; MESSENGER-RNA; INFECTION; ACTIVATION; INDUCTION	Background: The endoplasmic reticulum (ER) stress response is increasingly implicated in the pathogenesis of viral infections. Results: Respiratory syncytial virus (RSV) infection induces the inositol-requiring enzyme 1 (IRE1) stress pathway. IRE1 activity inhibits RSV replication. Conclusion: ER stress may be a novel cellular anti-RSV defense mechanism. Significance: Identification of a novel regulator of RSV replication may have therapeutic implications. Despite being a major health problem, respiratory syncytial virus (RSV) infections remain without specific therapy. Identification of novel host cellular responses that play a role in the pathogenesis of RSV infection is needed for therapeutic development. The endoplasmic reticulum (ER) stress response is an evolutionarily conserved cellular signaling cascade that has been implicated in multiple biological phenomena, including the pathogenesis of some viral infections. In this study, we investigate the role of the ER stress response in RSV infection using an in vitro A549 cell culture model. We found that RSV infection induces a non-canonical ER stress response with preferential activation of the inositol-requiring enzyme 1 (IRE1) and activated transcription factor 6 (ATF6) pathways with no concomitant significant activation of the protein kinase R-like ER kinase (PERK) pathway. Furthermore, we discovered that IRE1 has an inhibitory effect on RSV replication. Our data characterize, for the first time, the nature of the ER stress response in the setting of RSV infection and identify the IRE1 stress pathway as a novel cellular anti-RSV defense mechanism.	[Hassan, Ihab; Gaines, Kayla S.; Hottel, Wesley J.; Wishy, Ryan M.; Miller, Sara E.; Powers, Linda S.; Monick, Martha M.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Rutkowski, D. Thomas] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Hassan, I (corresponding author), Univ Iowa, Div Pulm Crit Care & Occupat Med, Rm 100 EMRB, Iowa City, IA 52242 USA.	ihab-hassan@uiowa.edu		Rutkowski, Thomas/0000-0001-6586-4449	National Institutes of Health [R01 HL079901, R01 HL096625, R21 HL109589, R01 DK084058]; NIEHS, National Institutes of Health [P30 ES005605]; National Center for Research Resources (NCRR), National Institutes of Health [UL1RR024979]; American Thoracic Society Foundation Research Grant [2012-04]; National Institute for Environmental Health Sciences through the University of Iowa Environmental Health Sciences Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096625, R01HL079901, R21HL109589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Center for Research Resources (NCRR), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Thoracic Society Foundation Research Grant; National Institute for Environmental Health Sciences through the University of Iowa Environmental Health Sciences Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project was supported, in whole or in part, by National Institutes of Health Grants R01 HL079901, R01 HL096625, and R21 HL109589 (to M. M. M.); R01 DK084058 (to D. T. R.); NIEHS, National Institutes of Health Grant P30 ES005605; and National Center for Research Resources (NCRR), National Institutes of Health Grant UL1RR024979. This work was also supported by American Thoracic Society Foundation Research Grant 2012-04 (to I. H.) and by the National Institute for Environmental Health Sciences through the University of Iowa Environmental Health Sciences Research Center.	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Ambrose RL, 2011, J VIROL, V85, P2723, DOI 10.1128/JVI.02050-10; Arensdorf AM, 2013, J CELL SCI, V126, P4026, DOI 10.1242/jcs.130757; Bechill J, 2008, J VIROL, V82, P4492, DOI 10.1128/JVI.00017-08; Beeler JA, 2013, MICROB PATHOGENESIS, V55, P9, DOI 10.1016/j.micpath.2012.11.013; Dickey DD, 2012, J GENE MED, V14, P366, DOI 10.1002/jgm.2632; Dimcheff DE, 2004, J BIOL CHEM, V279, P33782, DOI 10.1074/jbc.M403304200; Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951; Gardner BM, 2011, SCIENCE, V333, P1891, DOI 10.1126/science.1209126; GLEZEN WP, 1986, AM J DIS CHILD, V140, P543, DOI 10.1001/archpedi.1986.02140200053026; Groskreutz DJ, 2006, J IMMUNOL, V176, P1733, DOI 10.4049/jimmunol.176.3.1733; Gupta S., 2010, INT J CELL BIOL, V2010; Hassan IH, 2012, J BIOL CHEM, V287, P4679, DOI 10.1074/jbc.M111.284695; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hirota Morihiko, 2006, Journal of Toxicological Sciences, V31, P149, DOI 10.2131/jts.31.149; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; HUNTER JA, 1985, P NATL ACAD SCI USA, V82, P4633, DOI 10.1073/pnas.82.14.4633; Jheng JR, 2010, CELL MICROBIOL, V12, P796, DOI 10.1111/j.1462-5822.2010.01434.x; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Kim HT, 2004, LAB INVEST, V84, P816, DOI 10.1038/labinvest.3700104; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Li BZ, 2007, VIRUS RES, V124, P44, DOI 10.1016/j.virusres.2006.09.011; Li XD, 2005, VIROLOGY, V333, P180, DOI 10.1016/j.virol.2005.01.002; LOOK DC, 1992, AM J PHYSIOL, V263, pL79, DOI 10.1152/ajplung.1992.263.1.L79; Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07; Monick MM, 2007, J IMMUNOL, V179, P1648, DOI 10.4049/jimmunol.179.3.1648; Monick MM, 2005, J BIOL CHEM, V280, P2147, DOI 10.1074/jbc.M408745200; Monick MM, 2003, J BIOL CHEM, V278, P53035, DOI 10.1074/jbc.M308093200; Naidoo N, 2009, AGEING RES REV, V8, P150, DOI 10.1016/j.arr.2009.03.001; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Nakajima S, 2011, MOL CELL BIOL, V31, P1710, DOI 10.1128/MCB.00939-10; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Onn A, 2010, NAT STRUCT MOL BIOL, V17, P924, DOI 10.1038/nsmb0810-924; Pahl HL, 1996, FEBS LETT, V392, P129, DOI 10.1016/0014-5793(96)00800-9; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Promlek T, 2011, MOL BIOL CELL, V22, P3520, DOI 10.1091/mbc.E11-04-0295; Rallabhandi P, 2012, MBIO, V3, DOI 10.1128/mBio.00218-12; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Stewart MJ, 2006, J INTERF CYTOK RES, V26, P521, DOI 10.1089/jir.2006.26.521; Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002; Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004; Tardif KD, 2004, J BIOL CHEM, V279, P17158, DOI 10.1074/jbc.M312144200; Volkmann K, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199737; Walsh EE, 1999, AM J RESP CRIT CARE, V160, P791, DOI 10.1164/ajrccm.160.3.9901004; Wiseman RL, 2010, MOL CELL, V38, P291, DOI 10.1016/j.molcel.2010.04.001; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Ye ZD, 2008, BBA-GEN SUBJECTS, V1780, P1383, DOI 10.1016/j.bbagen.2008.07.009; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	55	28	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7537	7546		10.1074/jbc.M113.510594	http://dx.doi.org/10.1074/jbc.M113.510594			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24497642	Green Published, hybrid			2022-12-28	WOS:000332761500024
J	Cebotaru, V; Cebotaru, L; Kim, H; Chiaravalli, M; Boletta, A; Qian, F; Guggino, WB				Cebotaru, Valeriu; Cebotaru, Liudmila; Kim, Hyunho; Chiaravalli, Marco; Boletta, Alessandra; Qian, Feng; Guggino, William B.			Polycystin-1 Negatively Regulates Polycystin-2 Expression via the Aggresome/Autophagosome Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Channels; Physiology; Protein Degradation; Protein Processing; Trafficking	KIDNEY-DISEASE; LIVER-DISEASE; CELL-PROLIFERATION; GENE-PRODUCT; PKD1; PROTEIN; DEGRADATION; MUTATIONS; DOMAIN; MATURATION	Background: PC1 and PC2 function as a complex, but their interrelations are not completely understood. Results: Expression of PC1 accelerates degradation of PC2. Conclusion: PC1 negatively regulates PC2 expression, presumptively by enhancing degradation via the aggresome/autophagosome pathway. Significance: Understanding how PC1 regulates PC2 within a critical range may help elucidate the pathogenesis of cyst formation. Mutations of the PKD1 and PKD2 genes, encoding polycystin-1 (PC1) and polycystin-2 (PC2), respectively, lead to autosomal dominant polycystic kidney disease. Interestingly, up-regulation or down-regulation of PKD1 or PKD2 leads to polycystic kidney disease in animal models, but their interrelations are not completely understood. We show here that full-length PC1 that interacts with PC2 via a C-terminal coiled-coil domain regulates PC2 expression in vivo and in vitro by down-regulating PC2 expression in a dose-dependent manner. Expression of the pathogenic mutant R4227X, which lacks the C-terminal coiled-coil domain, failed to down-regulate PC2 expression, suggesting that PC1-PC2 interaction is necessary for PC2 regulation. The proteasome and autophagy are two pathways that control protein degradation. Proteins that are not degraded by proteasomes precipitate in the cytoplasm and are transported via histone deacetylase 6 (HDAC6) toward the aggresomes. We found that HDAC6 binds to PC2 and that expression of full-length PC1 accelerates the transport of the HDAC6-PC2 complex toward aggresomes, whereas expression of the R4227X mutant fails to do so. Aggresomes are engulfed by autophagosomes, which then fuse with the lysosome for degradation; this process is also known as autophagy. We have now shown that PC1 overexpression leads to increased degradation of PC2 via autophagy. Interestingly, PC1 does not activate autophagy generally. Thus, we have now uncovered a new pathway suggesting that when PC1 is expressed, PC2 that is not bound to PC1 is directed to aggresomes and subsequently degraded via autophagy, a control mechanism that may play a role in autosomal dominant polycystic kidney disease pathogenesis.	[Cebotaru, Valeriu] Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA; [Cebotaru, Liudmila] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Guggino, William B.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Kim, Hyunho; Qian, Feng] Univ Maryland, Dept Med, Div Nephrol, Baltimore, MD 21201 USA; [Chiaravalli, Marco; Boletta, Alessandra] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Guggino, WB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, Wood Basic Sci Bldg 214A,725 N Wolfe St, Baltimore, MD 21205 USA.	wguggino@jhmi.edu		chiaravalli, marco/0000-0003-0369-1989	National Institutes of Health [R01 DK 32753, DK062199, P30 DK090868]; National Kidney Foundation of Maryland Professional Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062199, R01DK032753, P30DK090868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Kidney Foundation of Maryland Professional Development Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK 32753 (to W. G.), DK062199 (to F. Q.), and P30 DK090868 (to the Baltimore Polycystic Kidney Disease Research and Clinical Core Center). This work was also supported by a National Kidney Foundation of Maryland Professional Development Award (to V. C.).	Boletta A, 2000, MOL CELL, V6, P1267, DOI 10.1016/S1097-2765(00)00123-4; Chauvet V, 2002, AM J PATHOL, V160, P973, DOI 10.1016/S0002-9440(10)64919-X; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Dallavalle S, 2012, BIOCHEM PHARMACOL, V84, P756, DOI 10.1016/j.bcp.2012.06.014; Drenth JPH, 2003, NAT GENET, V33, P345, DOI 10.1038/ng1104; Fedeles SV, 2011, NAT GENET, V43, P639, DOI 10.1038/ng.860; Gao HY, 2010, HUM MOL GENET, V19, P16, DOI 10.1093/hmg/ddp463; Geng L, 1996, J CLIN INVEST, V98, P2674, DOI 10.1172/JCI119090; Grimm DH, 2006, J BIOL CHEM, V281, P137, DOI 10.1074/jbc.M507845200; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hideshima T, 2005, P NATL ACAD SCI USA, V102, P8567, DOI 10.1073/pnas.0503221102; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Lantinga-van Leeuwen IS, 2004, HUM MOL GENET, V13, P3069, DOI 10.1093/hmg/ddh336; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; Li AR, 2003, AM J HUM GENET, V72, P691, DOI 10.1086/368295; Liang GQ, 2008, HUM MOL GENET, V17, P3254, DOI 10.1093/hmg/ddn221; Liang GQ, 2008, HUM MOL GENET, V17, P1109, DOI 10.1093/hmg/ddm383; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; McConkey DJ, 2012, ADV CANCER RES, V116, P131, DOI 10.1016/B978-0-12-394387-3.00004-5; Merrick D, 2012, DEV CELL, V22, P197, DOI 10.1016/j.devcel.2011.10.028; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; Nims N, 2003, BIOCHEMISTRY-US, V42, P13035, DOI 10.1021/bi035074c; Ong ACM, 1999, KIDNEY INT, V56, P1324, DOI 10.1046/j.1523-1755.1999.00659.x; Park EY, 2009, J BIOL CHEM, V284, P7214, DOI 10.1074/jbc.M805890200; Patel V, 2012, J AM SOC NEPHROL, V23, P1941, DOI 10.1681/ASN.2012030321; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Ramasubbu K, 1998, J AM SOC NEPHROL, V9, P937; Rodriguez-Gonzalez A, 2008, CANCER RES, V68, P2557, DOI 10.1158/0008-5472.CAN-07-5989; Simms-Waldrip T, 2008, MOL GENET METAB, V94, P283, DOI 10.1016/j.ymgme.2008.03.012; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Thivierge C, 2006, MOL CELL BIOL, V26, P1538, DOI 10.1128/MCB.26.4.1538-1548.2006; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Wodarczyk C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007137; Wu GQ, 2000, NAT GENET, V24, P75, DOI 10.1038/71724; Wu WKK, 2010, DRUG RESIST UPDATE, V13, P87, DOI 10.1016/j.drup.2010.04.003; Xiong R, 2013, CHEM-BIOL INTERACT, V204, P116, DOI 10.1016/j.cbi.2013.04.016; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	42	24	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6404	6414		10.1074/jbc.M113.501205	http://dx.doi.org/10.1074/jbc.M113.501205			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24459142	hybrid, Green Published			2022-12-28	WOS:000332389400009
J	Lemmin, T; Dimitrov, M; Fraering, PC; Dal Peraro, M				Lemmin, Thomas; Dimitrov, Mitko; Fraering, Patrick C.; Dal Peraro, Matteo			Perturbations of the Straight Transmembrane alpha-Helical Structure of the Amyloid Precursor Protein Affect Its Processing by gamma-Secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Amyloid Precursor Protein; Mass Spectrometry (MS); Molecular Dynamics; Secretases; electron paramagnetic resonance (EPR) spectroscopy; double electron-electron resonance (DEER); metadynamics	MOLECULAR-DYNAMICS SIMULATION; ALZHEIMERS-DISEASE; DISTANCE MEASUREMENTS; FIBRIL FORMATION; GXXXG MOTIF; MEMBRANE; DOMAIN; CHOLESTEROL; RESONANCE; PEPTIDE	Background: Amyloid- neurotoxicity depends on the specificity of the proteolytic cleavage of the amyloid precursor protein (APP) transmembrane domain. Results: The APP transmembrane -helix is straight in a biological membrane bilayer. Conclusion: The flexibility of APP is key for adapting to the lipid environment and modulating proteolytic processing by -secretase. Significance: The dynamic characterization of APP is expected to rationalize the design of -secretase modulators. The amyloid precursor protein (APP) is a widely expressed type I transmembrane (TM) glycoprotein present at the neuronal synapse. The proteolytic cleavage by -secretase of its C-terminal fragment produces amyloid- (A) peptides of different lengths, the deposition of which is an early indicator of Alzheimer disease. At present, there is no consensus on the conformation of the APP-TM domain at the biological membrane. Although structures have been determined by NMR in detergent micelles, their conformation is markedly different. Here we show by using molecular simulations that the APP-TM region systematically prefers a straight -helical conformation once embedded in a membrane bilayer. However, APP-TM is highly flexible, and its secondary structure is strongly influenced by the surrounding lipid environment, as when enclosed in detergent micelles. This behavior is confirmed when analyzing in silico the atomistic APP-TM population observed by residual dipolar couplings and double electron-electron resonance spectroscopy. These structural and dynamic features are critical in the proteolytic processing of APP by the -secretase enzyme, as suggested by a series of Gly(700) mutants. Affecting the hydration and flexibility of APP-TM, these mutants invariantly show an increase in the production of A38 compared with A40 peptides, which is reminiscent of the effect of -secretase modulators inhibitors.	[Lemmin, Thomas; Dal Peraro, Matteo] Ecole Polytech Fed Lausanne, Inst Bioengn, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Dimitrov, Mitko; Fraering, Patrick C.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Lemmin, Thomas; Dal Peraro, Matteo] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics	Dal Peraro, M (corresponding author), Ecole Polytech Fed Lausanne, EPFL SV IBI LBM, AAB010 Stn 19, CH-1015 Lausanne, Switzerland.	matteo.dalperaro@epfl.ch	Lemmin, Thomas/AAO-7849-2021	Lemmin, Thomas/0000-0001-5705-4964; Fraering, Patrick/0000-0002-5841-5327	Swiss National Science Foundation [200020_138013, 31003A_134938/1]; Swiss National Centres of Competence in Research, Neural Plasticity, and Repair; Strauss Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Centres of Competence in Research, Neural Plasticity, and Repair; Strauss Foundation	This work was supported by Swiss National Science Foundation Grants 200020_138013 (to M. D. P.) and 31003A_134938/1 (to P. C. F.) and by funds from the Swiss National Centres of Competence in Research, Neural Plasticity, and Repair (to P. C. F.) and the Strauss Foundation (to P. C. F.).	Alattia JR, 2013, BIOTECHNOL BIOENG, V110, P1995, DOI 10.1002/bit.24851; Alattia JR, 2011, FASEB J, V25, P2287, DOI 10.1096/fj.10-174078; Barnham KJ, 2003, J BIOL CHEM, V278, P17401, DOI 10.1074/jbc.M300629200; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Beel AJ, 2008, BIOCHEMISTRY-US, V47, P9428, DOI 10.1021/bi800993c; Bokvist M, 2004, J MOL BIOL, V335, P1039, DOI 10.1016/j.jmb.2003.11.046; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BRUNGER A, 1984, CHEM PHYS LETT, V105, P495, DOI 10.1016/0009-2614(84)80098-6; Buchet R, 2000, ACTA BIOCHIM POL, V47, P725, DOI 10.18388/abp.2000_3991; Cacquevel M, 2008, J NEUROCHEM, V104, P210, DOI 10.1111/j.1471-4159.2007.05041.x; COTMAN C, 1969, BIOCHEMISTRY-US, V8, P4606, DOI 10.1021/bi00839a056; Degiacomi MT, 2013, STRUCTURE, V21, P1097, DOI 10.1016/j.str.2013.05.014; Dimitrov M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3246; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Frazier AA, 2002, BIOCHEMISTRY-US, V41, P6282, DOI 10.1021/bi0160821; Georgieva ER, 2008, J AM CHEM SOC, V130, P12856, DOI 10.1021/ja804517m; GRUBMULLER H, 1995, PHYS REV E, V52, P2893, DOI 10.1103/PhysRevE.52.2893; Hagelueken G, 2012, APPL MAGN RESON, V42, P377, DOI 10.1007/s00723-012-0314-0; Hatmal MM, 2012, BIOPOLYMERS, V97, P35, DOI 10.1002/bip.21699; Henin J, 2010, J CHEM THEORY COMPUT, V6, P35, DOI 10.1021/ct9004432; HUBER T, 1994, J COMPUT AID MOL DES, V8, P695, DOI 10.1007/BF00124016; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JARVIS RA, 1973, IEEE T COMPUT, VC-22, P1025, DOI 10.1109/T-C.1973.223640; Jeschke G, 2007, PHYS CHEM CHEM PHYS, V9, P1895, DOI 10.1039/b614920k; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Ji SR, 2002, J BIOL CHEM, V277, P6273, DOI 10.1074/jbc.M104146200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Lemmin T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002878; Lillington JED, 2011, J MOL BIOL, V405, P427, DOI 10.1016/j.jmb.2010.10.053; Malmberg NJ, 2005, ANNU REV BIOPH BIOM, V34, P71, DOI 10.1146/annurev.biophys.34.040204.144534; MARTIN RC, 1998, C++ REP, V10, P8; Mchaourab HS, 2011, STRUCTURE, V19, P1549, DOI 10.1016/j.str.2011.10.009; Milov AD, 2001, J AM CHEM SOC, V123, P3784, DOI 10.1021/ja0033990; Miyashita N, 2010, QTM PROB WHT NOI, V26, P361, DOI 10.1142/9789814304061_0030; Miyashita N, 2009, J AM CHEM SOC, V131, P17843, DOI 10.1021/ja905457d; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Munter LM, 2010, J BIOL CHEM, V285, P21636, DOI 10.1074/jbc.M109.088005; Nadezhdin KD, 2011, ACTA NATURAE, V3, P69, DOI 10.32607/20758251-2011-3-1-69-76; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Page RM, 2010, J BIOL CHEM, V285, P17798, DOI 10.1074/jbc.M110.103283; Pannier M, 2000, J MAGN RESON, V142, P331, DOI 10.1006/jmre.1999.1944; Pester O, 2013, J AM CHEM SOC, V135, P1317, DOI 10.1021/ja3112093; Pettegrew JW, 2001, NEUROCHEM RES, V26, P771, DOI 10.1023/A:1011603916962; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Renzi F, 2011, J BIOL CHEM, V286, P21440, DOI 10.1074/jbc.M110.193326; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sezer D, 2008, J PHYS CHEM B, V112, P5755, DOI 10.1021/jp711375x; Showalter SA, 2007, J AM CHEM SOC, V129, P4158, DOI 10.1021/ja070658d	51	30	30	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6763	6774		10.1074/jbc.M113.470781	http://dx.doi.org/10.1074/jbc.M113.470781			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24469457	hybrid, Green Published			2022-12-28	WOS:000332389400037
J	Polito, D; Cukras, S; Wang, XZ; Spence, P; Moreau, L; D'Andrea, AD; Kee, Y				Polito, David; Cukras, Scott; Wang, Xiaozhe; Spence, Paige; Moreau, Lisa; D'Andrea, Alan D.; Kee, Younghoon			The Carboxyl Terminus of FANCE Recruits FANCD2 to the Fanconi Anemia (FA) E3 Ligase Complex to Promote the FA DNA Repair Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Damage; DNA Repair; E3 Ubiquitin Ligase; Protein Degradation; Protein Dynamics; Protein Folding; Protein Targeting; Protein-protein Interactions; Ubiquitin	CROSS-LINK REPAIR; MONOUBIQUITINATED FANCD2; NUCLEAR ACCUMULATION; SENSITIZES CELLS; DAMAGE RESPONSE; CORE COMPLEX; S-PHASE; PROTEIN; INHIBITION; IDENTIFICATION	Background: Monoubiquitination of FANCD2 and FANCI is critical in the FA pathway. Results: Specific mutations in FANCE that disrupt FANCD2 binding impair the FA pathway. Conclusion: Inhibition of the FANCE-FANCD2 interaction via FANCE point mutations in the C terminus disrupts the FA pathway. Significance: Recruitment of FANCD2 and FANCI to the FA E3 ligase is a critical step in the FA pathway. Fanconi anemia (FA) is a genome instability syndrome characterized by bone marrow failure and cellular hypersensitivity to DNA cross-linking agents. In response to DNA damage, the FA pathway is activated through the cooperation of 16 FA proteins. A central player in the pathway is a multisubunit E3 ubiquitin ligase complex or the FA core complex, which monoubiquitinates its substrates FANCD2 and FANCI. FANCE, a subunit of the FA core complex, plays an essential role by promoting the integrity of the complex and by directly recognizing FANCD2. To delineate its role in substrate ubiquitination from the core complex assembly, we analyzed a series of mutations within FANCE. We report that a phenylalanine located at the highly conserved extreme C terminus, referred to as Phe-522, is a critical residue for mediating the monoubiquitination of the FANCD2-FANCI complex. Using the FANCE mutant that specifically disrupts the FANCE-FANCD2 interaction as a tool, we found that the interaction-deficient mutant conferred cellular sensitivity in reconstituted FANCE-deficient cells to a similar degree as FANCE null cells, suggesting the significance of the FANCE-FANCD2 interaction in promoting cisplatin resistance. Intriguingly, ectopic expression of the FANCE C terminus fragment alone in FA normal cells disrupts DNA repair, consolidating the importance of the FANCE-FANCD2 interaction in the DNA cross-link repair.	[Polito, David; Cukras, Scott; Spence, Paige; Kee, Younghoon] Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA; [Wang, Xiaozhe; D'Andrea, Alan D.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Moreau, Lisa] Dana Farber Canc Inst, Cytogenet Core Lab, Boston, MA 02115 USA	State University System of Florida; University of South Florida; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Kee, Y (corresponding author), Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.	Ykee@usf.edu	Kee, Younghoon/J-4107-2019		National Institutes of Health [RO1HL52725]; University of South Florida departmental startup funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of South Florida departmental startup funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1HL52725 (to A.D.D.) and University of South Florida departmental startup funds (to Y.K.).	Bogliolo M, 2013, AM J HUM GENET, V92, P800, DOI 10.1016/j.ajhg.2013.04.002; Chen CC, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-24; Dorsman JC, 2007, CELL ONCOL, V29, P211; Fu DC, 2013, CELL CYCLE, V12, P803, DOI 10.4161/cc.23755; Garcia-Higuera I, 2000, BLOOD, V96, P3224, DOI 10.1182/blood.V96.9.3224.h8003224_3224_3230; Gordon SM, 2005, J BIOL CHEM, V280, P36118, DOI 10.1074/jbc.M507758200; Gordon SM, 2003, BLOOD, V102, P136, DOI 10.1182/blood-2002-11-3517; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Jacquemont C, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-26; Joo W, 2011, SCIENCE, V333, P312, DOI 10.1126/science.1205805; Kee Y, 2012, J CLIN INVEST, V122, P3799, DOI 10.1172/JCI58321; Kee Y, 2012, MOL CANCER RES, V10, P369, DOI 10.1158/1541-7786.MCR-11-0497; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Leveille F, 2006, DNA REPAIR, V5, P556, DOI 10.1016/j.dnarep.2006.01.005; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; Matsushita N, 2005, MOL CELL, V19, P841, DOI 10.1016/j.molcel.2005.08.018; Mirchandani KD, 2008, DNA REPAIR, V7, P902, DOI 10.1016/j.dnarep.2008.03.001; Nookala RK, 2007, NUCLEIC ACIDS RES, V35, P1638, DOI 10.1093/nar/gkm033; Osorio A, 2013, HUM MUTAT, V34, P1615, DOI 10.1002/humu.22438; Pace P, 2002, EMBO J, V21, P3414, DOI 10.1093/emboj/cdf355; Sareen A, 2012, NUCLEIC ACIDS RES, V40, P8425, DOI 10.1093/nar/gks638; Sims AE, 2007, NAT STRUCT MOL BIOL, V14, P564, DOI 10.1038/nsmb1252; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Taniguchi T, 2003, NAT MED, V9, P568, DOI 10.1038/nm852; Wang XZ, 2007, MOL CELL BIOL, V27, P3098, DOI 10.1128/MCB.02357-06; Wang XZ, 2004, MOL CELL BIOL, V24, P5850, DOI 10.1128/MCB.24.13.5850-5862.2004; Yamamoto KN, 2011, P NATL ACAD SCI USA, V108, P6492, DOI 10.1073/pnas.1018487108	31	20	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7003	7010		10.1074/jbc.M113.533976	http://dx.doi.org/10.1074/jbc.M113.533976			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24451376	Green Published, hybrid			2022-12-28	WOS:000332389400060
J	Haines, E; Saucier, C; Claing, A				Haines, Eric; Saucier, Caroline; Claing, Audrey			The Adaptor Proteins p66Shc and Grb2 Regulate the Activation of the GTPases ARF1 and ARF6 in Invasive Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adaptor Proteins; ARF; Breast Cancer; Epidermal Growth Factor Receptor (EGFR); GTPase	EPIDERMAL-GROWTH-FACTOR; GUANINE-NUCLEOTIDE EXCHANGE; RECEPTOR TYROSINE KINASES; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; EGF RECEPTOR; SHC; RAS; P66(SHC); PATHWAY	Background: ADP-ribosylation factors (ARF) 1 and 6 play an important role in breast cancer cell proliferation, migration, and invasion. Results: In invasive breast cancer cells, EGF-mediated ARF1 and ARF6 activation is regulated by p66Shc and Grb2. Conclusion: Adaptor proteins are required to promote ARF activation. Significance: Understanding the signaling mechanisms leading to ARF activation may identify novel therapeutic targets for the treatment of breast cancer. Signals downstream of growth factor receptors play an important role in mammary carcinogenesis. Recently, we demonstrated that the small GTPases ARF1 and ARF6 were shown to be activated downstream of the epidermal growth factor receptor (EGFR) and act as a key regulator of growth, migration, and invasion of breast cancer cells. However, the mechanism via which the EGFR recruits and activates ARF1 and ARF6 to transmit signals has yet to be fully elucidated. Here, we identify adaptor proteins Grb2 and p66Shc as important regulators mediating ARF activation. We demonstrate that ARF1 can be found in complex with Grb2 and p66Shc upon EGF stimulation of the basal-like breast cancer MDA-MB-231 cell line. However, we report that these two adaptors regulate ARF1 activation differently, with Grb2 promoting ARF1 activation and p66Shc blocking this response. Furthermore, we show that Grb2 is essential for the recruitment of ARF1 to the EGFR, whereas p66Shc hindered ARF1 receptor recruitment. We demonstrate that the negative regulatory role of p66Shc stemmed from its ability to block the recruitment of Grb2/ARF1 to the EGFR. Conversely, p66Shc potentiates ARF6 activation as well as the recruitment of this ARF isoform to the EGFR. Interestingly, we demonstrate that Grb2 is also required for the activation and receptor recruitment of ARF6. Additionally, we show an important role for p66Shc in modulating ARF activation, cell growth, and migration in HER2-positive breast cancer cells. Together, our results highlight a central role for adaptor proteins p66Shc and Grb2 in the regulation of ARF1 and ARF6 activation in invasive breast cancer cells.	[Haines, Eric; Claing, Audrey] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Saucier, Caroline] Univ Sherbrooke, Dept Anat & Biol Cellulaire, Sherbrooke, PQ J1E 4K8, Canada	Universite de Montreal; University of Sherbrooke	Claing, A (corresponding author), Downtown Stn, POB 6128, Montreal, PQ H3C 3J7, Canada.	audrey.claing@umontreal.ca	Saucier, Caroline/Q-9250-2019	Saucier, Caroline/0000-0001-7678-9886	Canadian Institutes of Health Research [MOP-106596]; Natural Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by Canadian Institutes of Health Research Grant MOP-106596 (to A. C.).; Recipient of the Canadian Institutes of Health Research Fredrick Banting and Charles Best Doctoral Award.; Supported by the Natural Sciences and Engineering Research Council of Canada (NSERC).	Arany I, 2008, J BIOL CHEM, V283, P6110, DOI 10.1074/jbc.M708799200; BATZER AG, 1994, MOL CELL BIOL, V14, P5192, DOI 10.1128/MCB.14.8.5192; Beltrami E, 2013, CURR PHARM DESIGN, V19, P2708, DOI 10.2174/1381612811319150005; Borkowska A, 2012, EUR J NUTR, V51, P817, DOI 10.1007/s00394-011-0260-x; BORRELLO MG, 1994, ONCOGENE, V9, P1661; Boulay PL, 2008, J BIOL CHEM, V283, P36425, DOI 10.1074/jbc.M803603200; Bourguignon LYW, 2001, J BIOL CHEM, V276, P48679, DOI 10.1074/jbc.M106759200; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Chen RH, 1997, EMBO J, V16, P1351, DOI 10.1093/emboj/16.6.1351; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; COHEN S, 1982, P NATL ACAD SCI-BIOL, V79, P6237, DOI 10.1073/pnas.79.20.6237; Cohen S, 1974, Recent Prog Horm Res, V30, P533; Cooke T, 2001, EUR J CANCER, V37, pS3, DOI 10.1016/S0959-8049(00)00402-0; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DALY RJ, 1994, ONCOGENE, V9, P2723; Dankort D, 2001, MOL CELL BIOL, V21, P1540, DOI 10.1128/MCB.21.5.1540-1551.2001; Davol PA, 2003, CANCER RES, V63, P6772; Debnath J, 2010, ONCOGENE, V29, P5556, DOI 10.1038/onc.2010.347; Elias AD, 2010, AM J CLIN ONCOL-CANC, V33, P637, DOI 10.1097/COC.0b013e3181b8afcf; Frackelton AR, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1631; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; Giguere P, 2006, CELL SIGNAL, V18, P1988, DOI 10.1016/j.cellsig.2006.03.003; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Grossman SR, 2007, CLIN CANCER RES, V13, P5798, DOI 10.1158/1078-0432.CCR-07-0073; HAIGLER HT, 1979, J CELL BIOL, V81, P382, DOI 10.1083/jcb.81.2.382; Hashimoto S, 2004, P NATL ACAD SCI USA, V101, P6647, DOI 10.1073/pnas.0401753101; Hawley SP, 2011, DEV DYNAM, V240, P221, DOI 10.1002/dvdy.22506; Jackson JG, 2000, CLIN CANCER RES, V6, P1135; Jones N, 2007, MOL CELL BIOL, V27, P4759, DOI 10.1128/MCB.00184-07; Kannan S, 1997, J BIOL CHEM, V272, P3330, DOI 10.1074/jbc.272.6.3330; Kirmani D, 2013, J RECEPT SIG TRANSD, V33, P107, DOI 10.3109/10799893.2013.770527; Kisielow M, 2002, BIOCHEM J, V363, P1, DOI 10.1042/0264-6021:3630001; Lee MS, 2004, ONCOGENE, V23, P3048, DOI 10.1038/sj.onc.1207451; Lewis-Saravalli S, 2013, CELL SIGNAL, V25, P1813, DOI 10.1016/j.cellsig.2013.05.011; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; Lo HW, 2006, BREAST CANCER RES TR, V95, P211, DOI 10.1007/s10549-005-9011-0; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; Ma Z, 2010, ONCOGENE, V29, P5559, DOI 10.1038/onc.2010.326; MARGOLIS B, 1994, J AM SOC NEPHROL, V5, P1288; Menju T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025301; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Okada S, 1997, J BIOL CHEM, V272, P28042, DOI 10.1074/jbc.272.44.28042; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; Pacini S, 2004, MOL CELL BIOL, V24, P1747, DOI 10.1128/MCB.24.4.1747-1757.2004; Pelicci G, 1996, ONCOGENE, V13, P633; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Rajendran M, 2010, CANCER METAST REV, V29, P207, DOI 10.1007/s10555-010-9213-8; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; Sabe H, 2008, CELL ADHES MIGR, V2, P71, DOI 10.4161/cam.2.2.6191; Sakai R, 2000, NEURON, V28, P819, DOI 10.1016/S0896-6273(00)00156-2; Sakao K, 2012, J CELL BIOCHEM, V113, P599, DOI 10.1002/jcb.23386; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; SKOLNIK EY, 1993, SCIENCE, V260, P1953, DOI 10.1126/science.8316835; SUEN KL, 1993, MOL CELL BIOL, V13, P5500, DOI 10.1128/MCB.13.9.5500; Ursini-Siegel J, 2008, CELL CYCLE, V7, P1936, DOI 10.4161/cc.7.13.6205; VANDERGEER P, 1995, TRENDS BIOCHEM SCI, V20, P277, DOI 10.1016/S0968-0004(00)89043-X; Veeramani S, 2005, ONCOGENE, V24, P7203, DOI 10.1038/sj.onc.1208852; Veeramani S, 2012, FREE RADICAL BIO MED, V53, P95, DOI 10.1016/j.freeradbiomed.2012.03.024; Verbeek BS, 1997, J PATHOL, V183, P195; Walker RA, 1999, BREAST CANCER RES TR, V53, P167, DOI 10.1023/A:1006194700667; Webster MA, 1998, MOL CELL BIOL, V18, P2344, DOI 10.1128/MCB.18.4.2344; Woodburn JR, 1999, PHARMACOL THERAPEUT, V82, P241, DOI 10.1016/S0163-7258(98)00045-X; Xi G, 2008, MOL ENDOCRINOL, V22, P2162, DOI 10.1210/me.2008-0079; Xi G, 2010, ENDOCRINOLOGY, V151, P3611, DOI 10.1210/en.2010-0242; Xiao D, 2010, CANCER RES, V70, P3150, DOI 10.1158/0008-5472.CAN-09-4451; Xie YM, 1996, BIOCHEM BIOPH RES CO, V221, P140, DOI 10.1006/bbrc.1996.0559	69	38	38	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5687	5703		10.1074/jbc.M113.516047	http://dx.doi.org/10.1074/jbc.M113.516047			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24407288	Green Published, hybrid			2022-12-28	WOS:000332015500031
J	Ranjha, L; Anand, R; Cejka, P				Ranjha, Lepakshi; Anand, Roopesh; Cejka, Petr			The Saccharomyces cerevisiae Mlh1-Mlh3 Heterodimer Is an Endonuclease That Preferentially Binds to Holliday Junctions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding Protein; DNA Mismatch Repair; DNA Repair; Homologous Recombination; Meiosis; DNA Endonuclease; Holliday Junction; Mlh1; Mlh3; MutL	DNA MISMATCH-REPAIR; DOUBLE-STRAND BREAK; MUTL-ALPHA; MEIOTIC CHROMOSOMES; DISTINCT FUNCTIONS; YEAST MLH1; MEIOSIS; COMPLEX; RECOMBINATION; RECOGNITION	Background: Mlh1-Mlh3 is required for meiotic interference-dependent crossovers. Results: We produced recombinant Mlh1-Mlh3 and show that it is an endonuclease that binds specifically Holliday junctions. Conclusion: Mlh1-Mlh3 prefers to bind the open conformation of Holliday junctions, which infers that it acts as part of a larger complex to process Holliday junctions in meiosis. Significance: Recombinant Mlh1-Mlh3 complexes will be invaluable for further studies. MutL, a heterodimer of the MutL homologues Mlh1 and Mlh3, plays a critical role during meiotic homologous recombination. The meiotic function of Mlh3 is fully dependent on the integrity of a putative nuclease motif DQHAX(2)EX(4)E, inferring that the anticipated nuclease activity of Mlh1-Mlh3 is involved in the processing of joint molecules to generate crossover recombination products. Although a vast body of genetic and cell biological data regarding Mlh1-Mlh3 is available, mechanistic insights into its function have been lacking due to the unavailability of the recombinant protein complex. Here we expressed the yeast Mlh1-Mlh3 heterodimer and purified it into near homogeneity. We show that recombinant MutL is a nuclease that nicks double-stranded DNA. We demonstrate that MutL binds DNA with a high affinity and shows a marked preference for Holliday junctions. We also expressed the human MLH1-MLH3 complex and show that preferential binding to Holliday junctions is a conserved capacity of eukaryotic MutL complexes. Specific DNA recognition has never been observed with any other eukaryotic MutL homologue. MutL thus represents a new paradigm for the function of the eukaryotic MutL protein family. We provide insights into the mode of Holliday junction recognition and show that Mlh1-Mlh3 prefers to bind the open unstacked Holliday junction form. This further supports the model where MutL is part of a complex acting on joint molecules to generate crossovers in meiosis.	[Ranjha, Lepakshi; Anand, Roopesh; Cejka, Petr] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland	University of Zurich	Cejka, P (corresponding author), Univ Zurich, Inst Mol Canc Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	cejka@imcr.uzh.ch		Cejka, Petr/0000-0002-9087-032X	Swiss National Science Foundation [PP00P3 133636, PDFMP3 141759]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grants discontinuous strand and generates new entry points for the PP00P3 133636 (to P. C.) and PDFMP3 141759 (to J. Jiricny (University of Zurich) and P. C.).	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; Baker SM, 1996, NAT GENET, V13, P336, DOI 10.1038/ng0796-336; Barlow AL, 1998, EUR J HUM GENET, V6, P350, DOI 10.1038/sj.ejhg.5200200; BENNETT RJ, 1995, J MOL BIOL, V252, P213, DOI 10.1006/jmbi.1995.0489; Biswas EE, 1995, PROTEIN EXPRES PURIF, V6, P763, DOI 10.1006/prep.1995.0007; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Brown MS, 2013, G3-GENES GENOM GENET, V3, P9, DOI 10.1534/g3.112.004622; Cannavo E, 2005, CANCER RES, V65, P10759, DOI 10.1158/0008-5472.CAN-05-2528; Cannavo E, 2013, P NATL ACAD SCI USA, V110, pE1661, DOI 10.1073/pnas.1305166110; Cejka P, 2012, MOL CELL, V47, P886, DOI 10.1016/j.molcel.2012.06.032; Cejka Petr, 2010, J Biol Chem, V285, P8290, DOI 10.1074/jbc.M109.083196; de los Santos T, 2003, GENETICS, V164, P81; De Muyt A, 2012, MOL CELL, V46, P43, DOI 10.1016/j.molcel.2012.02.020; DUCKETT DR, 1988, CELL, V55, P79, DOI 10.1016/0092-8674(88)90011-6; Finkelstein J, 2003, ANAL BIOCHEM, V319, P78, DOI 10.1016/S0003-2697(03)00273-2; Flores-Rozas H, 1998, P NATL ACAD SCI USA, V95, P12404, DOI 10.1073/pnas.95.21.12404; Gorman J, 2010, NAT STRUCT MOL BIOL, V17, P932, DOI 10.1038/nsmb.1858; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Guarne A, 2012, PROG MOL BIOL TRANSL, V110, P41, DOI 10.1016/B978-0-12-387665-2.00003-1; Gueneau E, 2013, NAT STRUCT MOL BIOL, V20, P461, DOI 10.1038/nsmb.2511; Habraken Y, 1997, CURR BIOL, V7, P790, DOI 10.1016/S0960-9822(06)00337-X; Habraken Y, 1998, J BIOL CHEM, V273, P9837, DOI 10.1074/jbc.273.16.9837; Hall MC, 2003, NUCLEIC ACIDS RES, V31, P2025, DOI 10.1093/nar/gkg324; Hall MC, 2002, J BIOL CHEM, V277, P3673, DOI 10.1074/jbc.M106120200; Hall MC, 2001, J MOL BIOL, V312, P637, DOI 10.1006/jmbi.2001.4958; Harfe BD, 2000, CURR BIOL, V10, P145, DOI 10.1016/S0960-9822(00)00314-6; Hombauer H, 2011, CELL, V147, P1040, DOI 10.1016/j.cell.2011.10.025; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jiricny J., 2013, COLD SPRING HARB PER, V5; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Keeney Scott, 2008, V2, P81, DOI 10.1007/7050_2007_026; Kneitz B, 2000, GENE DEV, V14, P1085; Kolas NK, 2005, J CELL BIOL, V171, P447, DOI 10.1083/jcb.200506170; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lenzi ML, 2005, AM J HUM GENET, V76, P112, DOI 10.1086/427268; LILLEY DMJ, 1993, ANNU REV BIOPH BIOM, V22, P299, DOI 10.1146/annurev.bb.22.060193.001503; Lipkin SM, 2002, NAT GENET, V31, P385, DOI 10.1038/ng931; Lipkin SM, 2000, NAT GENET, V24, P27, DOI 10.1038/71643; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; Marcon E, 2003, GENETICS, V165, P2283; Marsischky GT, 1999, J BIOL CHEM, V274, P26668, DOI 10.1074/jbc.274.38.26668; Nishant KT, 2008, GENETICS, V179, P747, DOI 10.1534/genetics.108.086645; Phadnis N, 2011, TRENDS GENET, V27, P411, DOI 10.1016/j.tig.2011.06.007; Pillon MC, 2010, MOL CELL, V39, P145, DOI 10.1016/j.molcel.2010.06.027; Plys AJ, 2012, J MOL BIOL, V422, P192, DOI 10.1016/j.jmb.2012.05.030; Raschle M, 2002, J BIOL CHEM, V277, P21810, DOI 10.1074/jbc.M108787200; Raschle M, 1999, J BIOL CHEM, V274, P32368, DOI 10.1074/jbc.274.45.32368; Rass U, 2010, GENE DEV, V24, P1559, DOI 10.1101/gad.585310; Santucci-Darmanin S, 2002, HUM MOL GENET, V11, P1697, DOI 10.1093/hmg/11.15.1697; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Snowden T, 2008, J BIOL CHEM, V283, P145, DOI 10.1074/jbc.M704060200; Svetlanov A, 2008, GENETICS, V178, P1937, DOI 10.1534/genetics.107.084798; Tran PT, 2002, DNA REPAIR, V1, P895, DOI 10.1016/S1568-7864(02)00114-3; Wang TF, 2002, BIOCHEM BIOPH RES CO, V296, P949, DOI 10.1016/S0006-291X(02)02034-X; Wang TF, 1999, P NATL ACAD SCI USA, V96, P13914, DOI 10.1073/pnas.96.24.13914; White MF, 1997, J MOL BIOL, V266, P122, DOI 10.1006/jmbi.1996.0795; Zakharyevich K, 2012, CELL, V149, P334, DOI 10.1016/j.cell.2012.03.023; Zakharyevich K, 2010, MOL CELL, V40, P1001, DOI 10.1016/j.molcel.2010.11.032; Zickler D, 2006, CHROMOSOMA, V115, P158, DOI 10.1007/s00412-006-0048-6	62	78	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5674	5686		10.1074/jbc.M113.533810	http://dx.doi.org/10.1074/jbc.M113.533810			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24443562	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000332015500030
J	Yang, CD; Harrison, C; Jin, ES; Chuang, DT; Sherry, AD; Malloy, CR; Merritt, ME; DeBerardinis, RJ				Yang, Chendong; Harrison, Crystal; Jin, Eunsook S.; Chuang, David T.; Sherry, A. Dean; Malloy, Craig R.; Merritt, Matthew E.; DeBerardinis, Ralph J.			Simultaneous Steady-state and Dynamic C-13 NMR Can Differentiate Alternative Routes of Pyruvate Metabolism in Living Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Imaging; Metabolism; Nuclear Magnetic Resonance; Pyruvate; Anaplerosis; Hyperpolarization	ISOTOPE-RESOLVED METABOLOMICS; TRICARBOXYLIC-ACID CYCLE; BAYESIAN-ANALYSIS; SUBSTRATE OXIDATION; AEROBIC GLYCOLYSIS; SIGNAL-DETECTION; LUNG-CANCER; MUTATIONS; COMPLEX; MODEL	Background: C-13 hyperpolarization sensitively and non-destructively detects pyruvate-lactate exchanges in cancer cells. Results: Combining C-13 hyperpolarization with isotopomer analysis allowed many pyruvate-dependent pathways to be quantified simultaneously. Conclusion: Monitoring H[C-13]O-3(-) production from hyperpolarized [1-C-13]pyruvate yielded a quantitative readout of oncogene-regulated pyruvate dehydrogenase activity. Significance: This approach might enable a broader quantitative assessment of metabolic activity in tumors. Metabolic reprogramming facilitates cancer cell growth, so quantitative metabolic flux measurements could produce useful biomarkers. However, current methods to analyze flux in vivo provide either a steady-state overview of relative activities (infusion of C-13 and analysis of extracted metabolites) or a dynamic view of a few reactions (hyperpolarized C-13 spectroscopy). Moreover, although hyperpolarization has successfully quantified pyruvate-lactate exchanges, its ability to assess mitochondrial pyruvate metabolism is unproven in cancer. Here, we combined C-13 hyperpolarization and isotopomer analysis to quantify multiple fates of pyruvate simultaneously. Two cancer cell lines with divergent pyruvate metabolism were incubated with thermally polarized [3-C-13]pyruvate for several hours, then briefly exposed to hyperpolarized [1-C-13]pyruvate during acquisition of NMR spectra using selective excitation to maximize detection of H[C-13]O-3(-) and [1-C-13]lactate. Metabolites were then extracted and subjected to isotopomer analysis to determine relative rates of pathways involving [3-C-13]pyruvate. Quantitation of hyperpolarized H[C-13]O-3(-) provided a single definitive metabolic rate, which was then used to convert relative rates derived from isotopomer analysis into quantitative fluxes. This revealed that H[C-13]O-3(-) appearance reflects activity of pyruvate dehydrogenase rather than pyruvate carboxylation followed by subsequent decarboxylation reactions. Glucose substantially altered [1-C-13]pyruvate metabolism, enhancing exchanges with [1-C-13]lactate and suppressing H[C-13]O-3(-) formation. Furthermore, inhibiting Akt, an oncogenic kinase that stimulates glycolysis, reversed these effects, indicating that metabolism of pyruvate by both LDH and pyruvate dehydrogenase is subject to the acute effects of oncogenic signaling on glycolysis. The data suggest that combining C-13 isotopomer analyses and dynamic hyperpolarized C-13 spectroscopy may enable quantitative flux measurements in living tumors.	[Yang, Chendong; DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Childrens Med Ctr, Res Inst, Dallas, TX 75390 USA; [Harrison, Crystal; Jin, Eunsook S.; Sherry, A. Dean; Malloy, Craig R.; Merritt, Matthew E.] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Merritt, Matthew E.] Univ Texas SW Med Ctr Dallas, Dept Mol Biophys, Dallas, TX 75390 USA; [Merritt, Matthew E.] Univ Texas SW Med Ctr Dallas, Dept Biomed Engn, Dallas, TX 75390 USA; [Malloy, Craig R.] Vet Affairs North Texas Healthcare Syst, Lancaster, TX 75216 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Merritt, ME (corresponding author), Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	matthew.merritt@utsouthwestern.edu	Harrison, Crystal/F-2295-2011; Sherry, Dean/P-2348-2018	Harrison, Crystal/0000-0002-8884-2805; Malloy, Craig/0000-0001-5077-0642; Merritt, Matthew/0000-0003-4617-9651; Sherry, Dean/0000-0001-7150-8301	National Institutes of Health [P41-EB015908, RR-02584, CA157996, R37-HL34557]; Cancer Prevention and Research Institute of Texas [RP101243]; Robert A. Welch Foundation [I-1733]; Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA157996] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002584] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL034557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Robert A. Welch Foundation(The Welch Foundation); Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grant P41-EB015908, RR-02584, CA157996, and R37-HL34557. This work was also supported by a multi-investigator award from the Cancer Prevention and Research Institute of Texas (RP101243).r Supported by grants from the Robert A. Welch Foundation (I-1733) and Damon Runyon Cancer Research Foundation. To whom correspondence may be addressed: Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-8502. Tel.: 214-633-1804; Fax: 214-648-5515; E-mail: Ralph.deberardinis@utsouthwestern.edu.	Albers MJ, 2008, CANCER RES, V68, P8607, DOI 10.1158/0008-5472.CAN-08-0749; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; BRETTHORST GL, 1990, J MAGN RESON, V88, P533, DOI 10.1016/0022-2364(90)90287-J; BRETTHORST GL, 1990, J MAGN RESON, V88, P571, DOI 10.1016/0022-2364(90)90289-L; BRETTHORST GL, 1990, J MAGN RESON, V88, P552, DOI 10.1016/0022-2364(90)90288-K; BRETTHORST GL, 1991, J MAGN RESON, V93, P369, DOI 10.1016/0022-2364(91)90013-J; Brindle KM, 2011, MAGN RESON MED, V66, P505, DOI 10.1002/mrm.22999; Burgess SC, 2004, J BIOL CHEM, V279, P48941, DOI 10.1074/jbc.M407120200; Caro P, 2012, CANCER CELL, V22, P547, DOI 10.1016/j.ccr.2012.08.014; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P8674, DOI 10.1073/pnas.1016627108; Chuang JL, 2000, METHOD ENZYMOL, V324, P192; CURI R, 1988, BIOCHEM J, V250, P383, DOI 10.1042/bj2500383; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Fan TWM, 2011, METABOLOMICS, V7, P257, DOI 10.1007/s11306-010-0249-0; Fan TWM, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-41; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; FLIER JS, 1987, SCIENCE, V235, P1492, DOI 10.1126/science.3103217; Golman K, 2006, CANCER RES, V66, P10855, DOI 10.1158/0008-5472.CAN-06-2564; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrison C, 2012, NMR BIOMED, V25, P1286, DOI 10.1002/nbm.2801; Hu S, 2011, CELL METAB, V14, P131, DOI 10.1016/j.cmet.2011.04.012; Jeffrey FMH, 1996, AM J PHYSIOL-ENDOC M, V271, pE788, DOI 10.1152/ajpendo.1996.271.4.E788; Kurhanewicz J, 2011, NEOPLASIA, V13, P81, DOI 10.1593/neo.101102; Larson PEZ, 2008, J MAGN RESON, V194, P121, DOI 10.1016/j.jmr.2008.06.010; Maher EA, 2012, NMR BIOMED, V25, P1234, DOI 10.1002/nbm.2794; MALLOY CR, 1990, AM J PHYSIOL, V259, pH987, DOI 10.1152/ajpheart.1990.259.3.H987; Marin-Valencia I, 2012, NMR BIOMED, V25, P1177, DOI 10.1002/nbm.2787; Marin-Valencia I, 2012, CELL METAB, V15, P827, DOI 10.1016/j.cmet.2012.05.001; Merritt ME, 2007, P NATL ACAD SCI USA, V104, P19773, DOI 10.1073/pnas.0706235104; Merritt ME, 2011, P NATL ACAD SCI USA, V108, P19084, DOI 10.1073/pnas.1111247108; Nelson SJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006070; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; RACKER E, 1985, P NATL ACAD SCI USA, V82, P3535, DOI 10.1073/pnas.82.11.3535; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Sherry AD, 2004, METAB ENG, V6, P12, DOI 10.1016/j.ymben.2003.10.007; Swisher CL, 2014, MAGN RESON MED, V71, P1, DOI 10.1002/mrm.24634; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; von Morze C, 2012, MAGN RESON IMAGING, V20, P305, DOI 10.1016/j.mri.2011.09.026; WARBURG O, 1956, SCIENCE, V124, P269; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058	50	39	41	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6212	6224		10.1074/jbc.M113.543637	http://dx.doi.org/10.1074/jbc.M113.543637			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24415759	Green Published, hybrid			2022-12-28	WOS:000332015500074
J	Kusuyama, J; Bandow, K; Shamoto, M; Kakimoto, K; Ohnishi, T; Matsuguchi, T				Kusuyama, Joji; Bandow, Kenjiro; Shamoto, Mitsuo; Kakimoto, Kyoko; Ohnishi, Tomokazu; Matsuguchi, Tetsuya			Low Intensity Pulsed Ultrasound ( LIPUS) Influences the Multilineage Differentiation of Mesenchymal Stem and Progenitor Cell Lines through ROCK-Cot/Tpl2-MEK-ERK Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipogenesis; Cell Differentiation; MAP Kinases (MAPKs); Mechanotransduction; Mesenchymal Stem Cells; LIPUS; Osteogenesis	ACTIVATED-RECEPTOR-GAMMA; FOCAL ADHESION KINASE; SMOOTH-MUSCLE-CELLS; PPAR-GAMMA; BONE-MARROW; OSTEOBLAST DIFFERENTIATION; PROTEIN-KINASE; ADIPOGENIC DIFFERENTIATION; INHIBITS ADIPOGENESIS; GENE-EXPRESSION	Background: Low intensity pulsed ultrasound (LIPUS) is a mechanical stimulus clinically used to promote bone fracture healing. Results: LIPUS suppresses adipogenesis and promotes osteogenesis of mesenchyme stem/progenitor cell lines by inhibiting PPAR2 through ROCK-Cot/Tpl2-MEK-ERK pathway. Conclusion: LIPUS influences multilineage differentiation of mesenchymal stem and progenitor cells. Significance: LIPUS may be a new clinical approach to chronic bone metabolic disorders, including osteoporosis. Mesenchymal stem cells (MSCs) are pluripotent cells that can differentiate into multilineage cell types, including adipocytes and osteoblasts. Mechanical stimulus is one of the crucial factors in regulating MSC differentiation. However, it remains unknown how mechanical stimulus affects the balance between adipogenesis and osteogenesis. Low intensity pulsed ultrasound (LIPUS) therapy is a clinical application of mechanical stimulus and facilitates bone fracture healing. Here, we applied LIPUS to adipogenic progenitor cell and MSC lines to analyze how multilineage cell differentiation was affected. We found that LIPUS suppressed adipogenic differentiation of both cell types, represented by impaired lipid droplet appearance and decreased gene expression of peroxisome proliferator-activated receptor 2 (Pparg2) and fatty acid-binding protein 4 (Fabp4). LIPUS also down-regulated the phosphorylation level of peroxisome proliferator-activated receptor 2 protein, inhibiting its transcriptional activity. In contrast, LIPUS promoted osteogenic differentiation of the MSC line, characterized by increased cell calcification as well as inductions of runt-related transcription factor 2 (Runx2) and Osteocalcin mRNAs. LIPUS induced phosphorylation of cancer Osaka thyroid oncogene/tumor progression locus 2 (Cot/Tpl2) kinase, which was essential for the phosphorylation of mitogen-activated kinase kinase 1 (MEK1) and p44/p42 extracellular signal-regulated kinases (ERKs). Notably, effects of LIPUS on both adipogenesis and osteogenesis were prevented by a Cot/Tpl2-specific inhibitor. Furthermore, effects of LIPUS on MSC differentiation as well as Cot/Tpl2 phosphorylation were attenuated by the inhibition of Rho-associated kinase. Taken together, these results indicate that mechanical stimulus with LIPUS suppresses adipogenesis and promotes osteogenesis of MSCs through Rho-associated kinase-Cot/Tpl2-MEK-ERK signaling pathway.	[Kusuyama, Joji; Bandow, Kenjiro; Shamoto, Mitsuo; Kakimoto, Kyoko; Ohnishi, Tomokazu; Matsuguchi, Tetsuya] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biochem & Mol Dent, Field Dev Med, Kagoshima 8908544, Japan	Kagoshima University	Matsuguchi, T (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biochem & Mol Dent, Field Dev Med, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	tmatsugu@dent.kagoshima-u.ac.jp	Matsuguchi, Tetsuya/HGU-0412-2022; Kusuyama, Joji/AAQ-7547-2020	Kusuyama, Joji/0000-0003-4054-1939; Bandow, Kenjiro/0000-0002-1362-3034	Ministry of Education, Culture, Sports, Science and Technology of Japan; Iwadare Scholarship Foundation; Terayama Foundation; Grants-in-Aid for Scientific Research [26462817] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Iwadare Scholarship Foundation; Terayama Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Iwadare Scholarship Foundation; and Terayama Foundation and by Teijin Pharma, which supplied the LIPUS device.	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Appleton CTG, 2010, LAB INVEST, V90, P20, DOI 10.1038/labinvest.2009.111; Bandow K, 2007, J CELL PHYSIOL, V211, P392, DOI 10.1002/jcp.20944; Bandow K, 2012, FEBS LETT, V586, P1540, DOI 10.1016/j.febslet.2012.04.018; Bandow K, 2010, BIOCHEM BIOPH RES CO, V402, P755, DOI 10.1016/j.bbrc.2010.10.103; Bielby R, 2007, INJURY, V38, pS26, DOI 10.1016/j.injury.2007.02.007; Bost F, 2002, BIOCHEM J, V361, P621, DOI 10.1042/0264-6021:3610621; de Gusmao CVB, 2010, CLIN ORTHOP RELAT R, V468, P1149, DOI 10.1007/s11999-009-1146-6; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; Chao JT, 2011, CURR HYPERTENS REP, V13, P421, DOI 10.1007/s11906-011-0227-6; Chapados R, 2006, CIRC RES, V99, P837, DOI 10.1161/01.RES.0000246172.77441.f1; Chiba N, 2010, BIOCHEM BIOPH RES CO, V402, P1, DOI 10.1016/j.bbrc.2010.08.075; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Diradourian C, 2005, BIOCHIMIE, V87, P33, DOI 10.1016/j.biochi.2004.11.010; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Harris IS, 2004, CIRCULATION, V110, P718, DOI 10.1161/01.CIR.0000138190.50127.6A; Hauser J, 2009, J ORTHOP RES, V27, P286, DOI 10.1002/jor.20741; Hodges RR, 2011, INVEST OPHTH VIS SCI, V52, P2199, DOI 10.1167/iovs.10-6209; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hsu HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012470; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Hughes-Fulford Millie, 2004, Sci STKE, V2004, pRE12; Ji HJ, 2011, BIOMED PHARMACOTHER, V65, P369, DOI 10.1016/j.biopha.2011.04.020; Kawamura S, 2003, J BIOL CHEM, V278, P31111, DOI 10.1074/jbc.M300725200; Kirkland JL, 2002, EXP GERONTOL, V37, P757, DOI 10.1016/S0531-5565(02)00014-1; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Liao DK, 2007, J CARDIOVASC PHARM, V50, P17, DOI 10.1097/FJC.0b013e318070d1bd; Liedert A, 2006, BIOCHEM BIOPH RES CO, V349, P1, DOI 10.1016/j.bbrc.2006.07.214; Luconi M, 2010, STEROIDS, V75, P585, DOI 10.1016/j.steroids.2009.10.012; Mammoto A, 2009, CURR OPIN CELL BIOL, V21, P864, DOI 10.1016/j.ceb.2009.08.001; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Miyaoka Y, 2006, J BIOL CHEM, V281, P37913, DOI 10.1074/jbc.M606089200; Muruganandan S, 2009, CELL MOL LIFE SCI, V66, P236, DOI 10.1007/s00018-008-8429-z; Nakao J, 2014, BONE, V58, P17, DOI 10.1016/j.bone.2013.09.018; Naruse K, 2003, J BONE MINER RES, V18, P360, DOI 10.1359/jbmr.2003.18.2.360; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Nishikawa K, 2010, J CLIN INVEST, V120, P3455, DOI 10.1172/JCI42528; Nuttall ME, 1998, J BONE MINER RES, V13, P371, DOI 10.1359/jbmr.1998.13.3.371; Papachristou DJ, 2009, BIOESSAYS, V31, P794, DOI 10.1002/bies.200800223; Papachroni KK, 2009, TRENDS MOL MED, V15, P208, DOI 10.1016/j.molmed.2009.03.001; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200; Puklin-Faucher E, 2009, J CELL SCI, V122, P179, DOI 10.1242/jcs.042127; Qiu WM, 2007, J BONE MINER RES, V22, P1720, DOI 10.1359/JBMR.070721; Rodriguez JP, 2004, J CELL BIOCHEM, V93, P721, DOI 10.1002/jcb.20234; Romano CL, 2009, ULTRASOUND MED BIOL, V35, P529, DOI 10.1016/j.ultrasmedbio.2008.09.029; Saito M, 2004, BONE, V35, P644, DOI 10.1016/j.bone.2004.04.024; Sarasa-Renedo A, 2006, EXP CELL RES, V312, P1361, DOI 10.1016/j.yexcr.2005.12.025; Sena K, 2005, ULTRASOUND MED BIOL, V31, P703, DOI 10.1016/j.ultrasmedbio.2005.01.013; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Storch U, 2012, AM J PHYSIOL-HEART C, V302, pH1241, DOI 10.1152/ajpheart.00818.2011; Sugimoto K, 2004, J CLIN INVEST, V114, P857, DOI 10.1172/JCI200420014; TAYLOR SM, 1979, CELL, V17, P771, DOI 10.1016/0092-8674(79)90317-9; Than A, 2012, MOL CELL ENDOCRINOL, V362, P227, DOI 10.1016/j.mce.2012.07.002; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; van Beekum O, 2009, OBESITY, V17, P213, DOI 10.1038/oby.2008.473; Verma S, 2002, J CLIN PATHOL, V55, P693, DOI 10.1136/jcp.55.9.693; VidalPuig AJ, 1997, J CLIN INVEST, V99, P2416, DOI 10.1172/JCI119424; Wan YH, 2010, TRENDS ENDOCRIN MET, V21, P722, DOI 10.1016/j.tem.2010.08.006; Wang B, 2011, BIOCHEM BIOPH RES CO, V410, P671, DOI 10.1016/j.bbrc.2011.06.054; Watabe H, 2011, EXP CELL RES, V317, P2642, DOI 10.1016/j.yexcr.2011.07.015; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; WRONSKI TJ, 1982, METAB BONE DIS RELAT, V4, P69, DOI 10.1016/0221-8747(82)90011-X; Xu BY, 2012, J CELL PHYSIOL, V227, P2722, DOI 10.1002/jcp.23016; Yin J, 2010, BIOTECHNOL LETT, V32, P195, DOI 10.1007/s10529-009-0142-y; Zhao Y, 2013, BIOCHEM BIOPH RES CO, V432, P488, DOI 10.1016/j.bbrc.2013.02.009	72	84	93	3	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10330	10344		10.1074/jbc.M113.546382	http://dx.doi.org/10.1074/jbc.M113.546382			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24550383	Green Published, hybrid			2022-12-28	WOS:000334226400009
J	Namadurai, S; Balasuriya, D; Rajappa, R; Wiemhofer, M; Stott, K; Klingauf, J; Edwardson, JM; Chirgadze, DY; Jackson, AP				Namadurai, Sivakumar; Balasuriya, Dilshan; Rajappa, Rajit; Wiemhoefer, Martin; Stott, Katherine; Klingauf, Jurgen; Edwardson, J. Michael; Chirgadze, Dimitri Y.; Jackson, Antony P.			Crystal Structure and Molecular Imaging of the Nav Channel beta 3 Subunit Indicates a Trimeric Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Analytical Ultracentrifugation; Atomic Force Microscopy; In Vivo Imaging; Sodium Channels; X-ray Crystallography; Photoactivated Localization Microscopy; Protein Trimerization	GATED SODIUM-CHANNELS; AUXILIARY SUBUNIT; SIGMA-1 RECEPTOR; MUTATION; ADHESION; DOMAIN; DETERMINANTS; DIMERIZATION; TRAFFICKING; KINETICS	Background: The vertebrate sodium channel 3 subunit regulates channel behavior. Results: The immunoglobulin domain of the human 3 subunit crystallizes as a trimer, and the full-length protein assembles as a trimer in vivo. Conclusion: Our results reveal an unexpected organization of the 3 subunit. Significance: A new structural insight into the sodium channel is presented. The vertebrate sodium (Na-v) channel is composed of an ion-conducting subunit and associated subunits. Here, we report the crystal structure of the human 3 subunit immunoglobulin (Ig) domain, a functionally important component of Na-v channels in neurons and cardiomyocytes. Surprisingly, we found that the 3 subunit Ig domain assembles as a trimer in the crystal asymmetric unit. Analytical ultracentrifugation confirmed the presence of Ig domain monomers, dimers, and trimers in free solution, and atomic force microscopy imaging also detected full-length 3 subunit monomers, dimers, and trimers. Mutation of a cysteine residue critical for maintaining the trimer interface destabilized both dimers and trimers. Using fluorescence photoactivated localization microscopy, we detected full-length 3 subunit trimers on the plasma membrane of transfected HEK293 cells. We further show that 3 subunits can bind to more than one site on the Na-v 1.5 subunit and induce the formation of subunit oligomers, including trimers. Our results suggest a new and unexpected role for the 3 subunits in Na-v channel cross-linking and provide new structural insights into some pathological Na-v channel mutations.	[Namadurai, Sivakumar; Stott, Katherine; Chirgadze, Dimitri Y.; Jackson, Antony P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Balasuriya, Dilshan; Edwardson, J. Michael] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Rajappa, Rajit; Wiemhoefer, Martin; Klingauf, Jurgen] Univ Munster, Inst Med Phys & Biophys, D-3148149 Munster, Germany	University of Cambridge; University of Cambridge; University of Munster	Chirgadze, DY (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	dyc21@cam.ac.uk; apj10@cam.ac.uk		Stott, Katherine/0000-0002-4014-1188; Chirgadze, Dimitri/0000-0001-9942-0993; Jackson, Antony Philip/0000-0002-2895-7387	Parke Davis/Pfizer; University of Cambridge	Parke Davis/Pfizer; University of Cambridge(University of Cambridge)	This work was supported in part by an unrestricted grant from Parke Davis/Pfizer (to A. P. J.) and funds from the University of Cambridge.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Balasuriya D, 2013, J NEUROSCI, V33, P18219, DOI 10.1523/JNEUROSCI.3360-13.2013; Balasuriya D, 2012, J BIOL CHEM, V287, P37021, DOI 10.1074/jbc.M112.382077; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Brackenbury WJ, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00053; Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204; Chaudhuri S, 2011, BIOPHYS CHEM, V154, P26, DOI 10.1016/j.bpc.2010.12.003; Chen CL, 2012, J BIOL CHEM, V287, P39061, DOI 10.1074/jbc.M112.397646; Cusdin FS, 2008, TRAFFIC, V9, P17, DOI 10.1111/j.1600-0854.2007.00673.x; Cusdin FS, 2010, J BIOL CHEM, V285, P33404, DOI 10.1074/jbc.M110.114058; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fahmi AI, 2001, J PHYSIOL-LONDON, V537, P693; Fendri-Kriaa N, 2011, EUR J NEUROL, V18, P695, DOI 10.1111/j.1468-1331.2010.03216.x; Gilchrist J, 2013, P NATL ACAD SCI USA, V110, pE5016, DOI 10.1073/pnas.1314557110; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Hakim P, 2010, ACTA PHYSIOL, V198, P47, DOI 10.1111/j.1748-1716.2009.02048.x; Hakim P, 2008, PROG BIOPHYS MOL BIO, V98, P251, DOI 10.1016/j.pbiomolbio.2009.01.005; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Ishikawa T, 2013, CIRC J, V77, P959, DOI 10.1253/circj.CJ-12-0995; Islas AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081995; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kostrewa D, 2001, EMBO J, V20, P4391, DOI 10.1093/emboj/20.16.4391; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lei M, 2008, PROG BIOPHYS MOL BIO, V98, P171, DOI 10.1016/j.pbiomolbio.2008.10.003; Leppanen VM, 2010, P NATL ACAD SCI USA, V107, P2425, DOI 10.1073/pnas.0914318107; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCormick KA, 1998, J BIOL CHEM, V273, P3954, DOI 10.1074/jbc.273.7.3954; McEwen DP, 2004, J BIOL CHEM, V279, P52744, DOI 10.1074/jbc.M405990200; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Mercier A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048690; Morgan K, 2000, P NATL ACAD SCI USA, V97, P2308, DOI 10.1073/pnas.030362197; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neaves KJ, 2009, NUCLEIC ACIDS RES, V37, P2053, DOI 10.1093/nar/gkp042; Niu LL, 2008, BIOPHYS J, V95, P2009, DOI 10.1529/biophysj.108.128751; Patino GA, 2010, NEUROSCI LETT, V486, P53, DOI 10.1016/j.neulet.2010.06.050; Patino GA, 2009, J NEUROSCI, V29, P10764, DOI 10.1523/JNEUROSCI.2475-09.2009; Ratcliffe CF, 2001, J CELL BIOL, V154, P427, DOI 10.1083/jcb.200102086; Schneider SW, 1998, PFLUG ARCH EUR J PHY, V435, P362, DOI 10.1007/s004240050524; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SCOTT DW, 1979, BIOMETRIKA, V66, P605, DOI 10.1093/biomet/66.3.605; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Sherwood TW, 2012, AM J PHYSIOL-CELL PH, V303, pC699, DOI 10.1152/ajpcell.00188.2012; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Spampanato J, 2004, J NEUROSCI, V24, P10022, DOI 10.1523/JNEUROSCI.2034-04.2004; Srinivasan J, 1998, P NATL ACAD SCI USA, V95, P15753, DOI 10.1073/pnas.95.26.15753; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Tan BH, 2010, HEART RHYTHM, V7, P771, DOI 10.1016/j.hrthm.2010.01.032; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Valdivia CR, 2010, CARDIOVASC RES, V86, P392, DOI 10.1093/cvr/cvp417; VANDERMERWE PA, 1994, TRENDS BIOCHEM SCI, V19, P354; Veatch SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031457; Veitia RA, 2007, PLANT CELL, V19, P3843, DOI 10.1105/tpc.107.055053; Wang PY, 2010, BIOCHEM BIOPH RES CO, V398, P98, DOI 10.1016/j.bbrc.2010.06.042; Waxman SG, 2012, J PHYSIOL-LONDON, V590, P2601, DOI 10.1113/jphysiol.2012.228460; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Yereddi NR, 2013, FASEB J, V27, P568, DOI 10.1096/fj.12-209445; Yu EJ, 2005, BIOCHEM J, V392, P519, DOI 10.1042/BJ20050518; Yu FH, 2003, J NEUROSCI, V23, P7577	62	53	54	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10797	10811		10.1074/jbc.M113.527994	http://dx.doi.org/10.1074/jbc.M113.527994			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24567321	Green Published, hybrid			2022-12-28	WOS:000334226400048
J	Wie, SM; Adwan, TS; DeGregori, J; Anderson, SM; Reyland, ME				Wie, Sten M.; Adwan, Tariq S.; DeGregori, James; Anderson, Steven M.; Reyland, Mary E.			Inhibiting Tyrosine Phosphorylation of Protein Kinase C delta( PKC delta) Protects the Salivary Gland from Radiation Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Nonreceptor Tyrosine Kinase; Protein Kinase C (PKC); Radiation Biology; Salivary Gland	GROWTH-FACTOR RECEPTOR; C-DELTA; PKC-DELTA; INDUCED APOPTOSIS; INDUCED ACTIVATION; SRC FAMILY; DASATINIB; ABL; ALPHA; HEAD	Background: Nuclear import of protein kinase C is required for DNA-damage-induced apoptosis. Results: c-Src and c-Abl phosphorylate PKC to regulate nuclear import. Tyrosine kinase inhibitors block nuclear translocation of PKC and suppress apoptosis. Conclusion: Tyrosine kinase inhibitors can regulate the pro-apoptotic function of protein kinase C. Significance: Tyrosine kinase inhibitors may improve the quality of life in cancer patients receiving radiation therapy. Radiation therapy for head and neck cancer can result in extensive damage to normal adjacent tissues such as the salivary gland and oral mucosa. We have shown previously that tyrosine phosphorylation at Tyr-64 and Tyr-155 activates PKC in response to apoptotic stimuli by facilitating its nuclear import. Here we have identified the tyrosine kinases that mediate activation of PKC in apoptotic cells and have explored the use of tyrosine kinase inhibitors for suppression of irradiation-induced apoptosis. We identify the damage-inducible kinase, c-Abl, as the PKC Tyr-155 kinase and c-Src as the Tyr-64 kinase. Depletion of c-Abl or c-Src with shRNA decreased irradiation- and etoposide-induced apoptosis, suggesting that inhibitors of these kinases may be useful therapeutically. Pretreatment with dasatinib, a broad spectrum tyrosine kinase inhibitor, blocked phosphorylation of PKC at both Tyr-64 and Tyr-155. Expression of gate-keeper mutants of c-Abl or c-Src that are active in the presence of dasatinib restored phosphorylation of PKC at Tyr-155 and Tyr-64, respectively. Imatinib, a c-Abl-selective inhibitor, also specifically blocked PKC Tyr-155 phosphorylation. Dasatinib and imatinib both blocked binding of PKC to importin- and nuclear import, demonstrating that tyrosine kinase inhibitors can inhibit nuclear accumulation of PKC. Likewise, pretreatment with dasatinib also suppressed etoposide and radiation induced apoptosis in vitro. In vivo, pre-treatment of mice with dasatinib blocked radiation-induced apoptosis in the salivary gland by >60%. These data suggest that tyrosine kinase inhibitors may be useful prophylactically for protection of nontumor tissues in patients undergoing radiotherapy of the head and neck.	[Wie, Sten M.] Univ Colorado, Sch Med, Program Struct Biol & Biochem, Aurora, CO 80045 USA; [DeGregori, James] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Anderson, Steven M.] Univ Colorado, Sch Med, Dept Pathol, Aurora, CO 80045 USA; [Wie, Sten M.; Adwan, Tariq S.; Reyland, Mary E.] Univ Colorado, Sch Dent Med, Dept Craniofacial Biol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Reyland, ME (corresponding author), Univ Colorado, Sch Dent Med, Dept Craniofacial Biol, MS 8120,Med Campus, Aurora, CO 80045 USA.	mary.reyland@ucdenver.edu		DeGregori, James/0000-0002-1287-1976	National Institutes of Health Grants [5R01DE015648, 1R01CA180175, R01CA138482, P30CA046934]; NATIONAL CANCER INSTITUTE [R01CA138482, R01CA180175, R21CA179501, R01CA157850, P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015648] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01DE015648 (to M. E. R.), 1R01CA180175 (to J. D.), R01CA138482 (to S. M. A.), and P30CA046934 (Cancer Center Support; DNA Sequencing, Tissue Culture, Histology and Radiation Cores).	Adwan TS, 2011, J BIOL CHEM, V286, P35716, DOI 10.1074/jbc.M111.255950; Allen-Petersen BL, 2014, ONCOGENE, V33, P1306, DOI 10.1038/onc.2013.59; Amos S, 2005, J BIOL CHEM, V280, P7729, DOI 10.1074/jbc.M409056200; Anderson SM, 1999, CELL DEATH DIFFER, V6, P454, DOI 10.1038/sj.cdd.4400507; Arany S, 2013, MOL THER, V21, P1182, DOI 10.1038/mt.2013.42; Arany S, 2012, J CELL BIOCHEM, V113, P1955, DOI 10.1002/jcb.24064; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Banninger GP, 2011, ORAL DIS, V17, P601, DOI 10.1111/j.1601-0825.2011.01819.x; Blake RA, 1999, CELL GROWTH DIFFER, V10, P231; Bright R, 2004, J NEUROSCI, V24, P6880, DOI 10.1523/JNEUROSCI.4474-03.2004; Brooks HD, 2011, CANCER-AM CANCER SOC, V117, P2112, DOI 10.1002/cncr.25769; Chan CM, 2012, CLIN CANCER RES, V18, P3580, DOI 10.1158/1078-0432.CCR-11-3359; Chari R, 2009, BLOOD, V114, P3056, DOI 10.1182/blood-2008-11-188516; Demetri GD, 2009, CLIN CANCER RES, V15, P6232, DOI 10.1158/1078-0432.CCR-09-0224; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; Furmanski BD, 2013, CLIN CANCER RES, V19, P4359, DOI 10.1158/1078-0432.CCR-13-0980; Gomel R, 2007, MOL CANCER RES, V5, P627, DOI 10.1158/1541-7786.MCR-06-0255; Gonfloni S., 2012, INT J CELL BIOL, V2012; Hantschel O, 2008, LEUKEMIA LYMPHOMA, V49, P615, DOI 10.1080/10428190801896103; Haughian JM, 2006, ENDOCR-RELAT CANCER, V13, P1251, DOI 10.1677/erc.1.01278; Humphries MJ, 2008, ONCOGENE, V27, P3045, DOI 10.1038/sj.onc.1210967; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Kajimoto T, 2010, J BIOL CHEM, V285, P41896, DOI 10.1074/jbc.M110.184028; Kaul S, 2005, J BIOL CHEM, V280, P28721, DOI 10.1074/jbc.M501092200; Korichneva I, 2002, J BIOL CHEM, V277, P44327, DOI 10.1074/jbc.M205634200; Lasfer M, 2006, FEBS LETT, V580, P2547, DOI 10.1016/j.febslet.2006.03.089; Leitges M, 2001, J CLIN INVEST, V108, P1505; Levitzki A, 2013, ANNU REV PHARMACOL, V53, P161, DOI 10.1146/annurev-pharmtox-011112-140341; Lin DB, 2005, J BIOL CHEM, V280, P13682, DOI 10.1074/jbc.M407762200; Lin YC, 2012, NEOPLASIA, V14, P463, DOI 10.1596/neo.12300; Majumder PK, 2001, CELL GROWTH DIFFER, V12, P465; Nam S, 2005, CANCER RES, V65, P9185, DOI 10.1158/0008-5472.CAN-05-1731; Pabla N, 2011, J CLIN INVEST, V121, P2709, DOI 10.1172/JCI45586; Paugh BS, 2008, FASEB J, V22, P455, DOI 10.1096/fj.07-8276com; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Rosenzweig T, 2004, CELL SIGNAL, V16, P1299, DOI 10.1016/j.cellsig.2004.03.015; Rybin VO, 2008, J BIOL CHEM, V283, P17777, DOI 10.1074/jbc.M800333200; Rybin VO, 2007, J BIOL CHEM, V282, P23631, DOI 10.1074/jbc.M701676200; Saito S, 2002, J BIOL CHEM, V277, P44695, DOI 10.1074/jbc.M208332200; Soref CM, 2012, INT J RADIAT ONCOL, V82, pE701, DOI 10.1016/j.ijrobp.2011.11.038; Sun XG, 2000, J BIOL CHEM, V275, P17237, DOI 10.1074/jbc.C000099200; Vissink A, 2003, CRIT REV ORAL BIOL M, V14, P199, DOI 10.1177/154411130301400305; Vissink A, 2010, INT J RADIAT ONCOL, V78, P983, DOI 10.1016/j.ijrobp.2010.06.052; Wang HB, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227991; Yamanouchi D, 2010, CARDIOVASC RES, V85, P434, DOI 10.1093/cvr/cvp328; Yoshida K, 2006, MOL CELL BIOL, V26, P3414, DOI 10.1128/MCB.26.9.3414-3431.2006; Yuan ZM, 1998, ONCOGENE, V16, P1643, DOI 10.1038/sj.onc.1201698	49	20	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10900	10908		10.1074/jbc.M114.551366	http://dx.doi.org/10.1074/jbc.M114.551366			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24569990	Green Published, hybrid			2022-12-28	WOS:000334226400057
J	Parthasarathy, S; Yoo, B; McElheny, D; Tay, W; Ishii, Y				Parthasarathy, Sudhakar; Yoo, Brian; McElheny, Dan; Tay, William; Ishii, Yoshitaka			Capturing a Reactive State of Amyloid Aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid; Ascorbic Acid; Hydrogen Peroxide; Reactive Oxygen Species (ROS); Amyloid; Copper Binding; Fibril; Redox Reaction; Solid-state NMR	ALZHEIMER A-BETA; ZINC SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; METAL-IONS; SALMONELLA-ENTERICA; COPPER(II) BINDING; STRUCTURAL MODEL; NMR-SPECTROSCOPY; FIBRILLAR FORMS	Background: Association of redox-active Cu2+ with aggregated A in amyloid plaques has been linked with ROS and oxidative stress in AD. Results: Cu2+/Cu+-bound A fibrils undergo a redox cycle reaction with ascorbate and oxygen to produce H2O2. Conclusion: Cu2+/Cu+ ions bound to histidines of A fibril offer enzyme-like reaction centers. Significance: The first site-specific structural evidence is presented on Cu+-bound A fibrils that generate ROS. The interaction of redox-active copper ions with misfolded amyloid (A) is linked to production of reactive oxygen species (ROS), which has been associated with oxidative stress and neuronal damages in Alzheimer disease. Despite intensive studies, it is still not conclusive how the interaction of Cu+/Cu2+ with A aggregates leads to ROS production even at the in vitro level. In this study, we examined the interaction between Cu+/Cu2+ and A fibrils by solid-state NMR (SSNMR) and other spectroscopic methods. Our photometric studies confirmed the production of approximate to 60 m hydrogen peroxide (H2O2) from a solution of 20 m Cu2+ ions in complex with A(1-40) in fibrils ([Cu2+]/[A] = 0.4) within 2 h of incubation after addition of biological reducing agent ascorbate at the physiological concentration (approximate to 1 mm). Furthermore, SSNMR H-1 T-1 measurements demonstrated that during ROS production the conversion of paramagnetic Cu2+ into diamagnetic Cu+ occurs while the reactive Cu+ ions remain bound to the amyloid fibrils. The results also suggest that O-2 is required for rapid recycling of Cu+ bound to A back to Cu2+, which allows for continuous production of H2O2. Both C-13 and N-15 SSNMR results show that Cu+ coordinates to A(1-40) fibrils primarily through the side chain N of both His-13 and His-14, suggesting major rearrangements from the Cu2+ coordination via N-E in the redox cycle. C-13 SSNMR chemical shift analysis suggests that the overall A conformations are largely unaffected by Cu+ binding. These results present crucial site-specific evidence of how the full-length A in amyloid fibrils offers catalytic Cu+ centers.	[Parthasarathy, Sudhakar; Yoo, Brian; McElheny, Dan; Tay, William; Ishii, Yoshitaka] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Ishii, Yoshitaka] Univ Illinois, Struct Biol Ctr, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Ishii, Y (corresponding author), Univ Illinois, Dept Chem, Chicago, IL 60607 USA.	yishii@uic.edu	Ishii, Yoshitaka/F-4558-2014	Ishii, Yoshitaka/0000-0002-7724-6469	National Institutes of Health [9R01 GM098033]; Alzheimer Association Grant IIRG [08-91256]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association Grant IIRG; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 9R01 GM098033. This work was also supported by Alzheimer Association Grant IIRG; 08-91256.	AKSNES A, 1981, FOOD CHEM, V7, P305, DOI 10.1016/0308-8146(81)90035-2; Ali FE, 2005, J PEPT SCI, V11, P353, DOI 10.1002/psc.626; Ali FE, 2006, INT J PEPT RES THER, V12, P153, DOI 10.1007/s10989-006-9012-9; Alies B, 2012, CHEM-EUR J, V18, P1161, DOI 10.1002/chem.201102746; Atwood CS, 2003, BRAIN RES REV, V43, P1, DOI 10.1016/S0165-0173(03)00174-7; Atwood CS, 2000, CELL MOL BIOL, V46, P777; Atwood CS, 1999, MET IONS BIOL SYST, V36, P309; Balayssac S, 2007, J AM CHEM SOC, V129, P2218, DOI 10.1021/ja068105a; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Barnham KJ, 2003, J BIOL CHEM, V278, P42959, DOI 10.1074/jbc.M305494200; Barraud P, 2012, J BIOMOL NMR, V53, P93, DOI 10.1007/s10858-012-9625-6; Bertini I., 2001, SOLUTION NMR PARAMAG; Bertini I, 2011, J AM CHEM SOC, V133, P16013, DOI 10.1021/ja2035859; Bush AI, 2002, P NATL ACAD SCI USA, V99, P7317, DOI 10.1073/pnas.122249699; Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-5; Bush AI, 2008, NEUROTHERAPEUTICS, V5, P421, DOI 10.1016/j.nurt.2008.05.001; Butterfield DA, 2002, FREE RADICAL RES, V36, P1307, DOI 10.1080/1071576021000049890; Cady SD, 2010, NATURE, V463, P689, DOI 10.1038/nature08722; Castellani RJ, 2004, AGEING RES REV, V3, P319, DOI 10.1016/j.arr.2004.01.002; Chimon S, 2005, J AM CHEM SOC, V127, P13472, DOI 10.1021/ja054039l; Chimon S, 2007, NAT STRUCT MOL BIOL, V14, P1157, DOI 10.1038/nsmb1345; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dikalov SI, 2004, FREE RADICAL BIO MED, V36, P340, DOI 10.1016/j.freeradbiomed.2003.11.004; Dong J, 2003, BIOCHEMISTRY-US, V42, P2768, DOI 10.1021/bi0272151; Drew SC, 2009, J AM CHEM SOC, V131, P8760, DOI 10.1021/ja903669a; Drew SC, 2009, J AM CHEM SOC, V131, P1195, DOI 10.1021/ja808073b; Faller P, 2009, CHEMBIOCHEM, V10, P2837, DOI 10.1002/cbic.200900321; Feaga HA, 2011, INORG CHEM, V50, P1614, DOI 10.1021/ic100967s; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; FIELDS CG, 1989, INT J PEPT PROT RES, V33, P298; Gehman JD, 2008, EUR BIOPHYS J BIOPHY, V37, P333, DOI 10.1007/s00249-007-0251-2; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Guilloreau L, 2007, CHEMBIOCHEM, V8, P1317, DOI 10.1002/cbic.200700111; Hatcher LQ, 2008, J PHYS CHEM B, V112, P8160, DOI 10.1021/jp710806s; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Himes RA, 2008, ANGEW CHEM INT EDIT, V47, P9084, DOI 10.1002/anie.200803908; Hou LM, 2006, J AM CHEM SOC, V128, P9260, DOI 10.1021/ja046032u; Hu FH, 2012, J AM CHEM SOC, V134, P3703, DOI 10.1021/ja2081185; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Hung YH, 2010, J BIOL INORG CHEM, V15, P61, DOI 10.1007/s00775-009-0600-y; Hureau C, 2009, J BIOL INORG CHEM, V14, P995, DOI 10.1007/s00775-009-0570-0; Hureau C, 2009, BIOCHIMIE, V91, P1212, DOI 10.1016/j.biochi.2009.03.013; Ishii Y, 2001, J CHEM PHYS, V114, P8473, DOI 10.1063/1.1359445; Ismail N, 2012, INT J MOL SCI, V13, P9692, DOI 10.3390/ijms13089692; Jimenez B, 2007, BIOMOL NMR ASSIGM, V1, P65, DOI 10.1007/s12104-007-9017-0; Jun S, 2009, BIOCHEMISTRY-US, V48, P10724, DOI 10.1021/bi9012935; Karr JW, 2008, BIOCHEMISTRY-US, V47, P5006, DOI 10.1021/bi702423h; Karr JW, 2004, J AM CHEM SOC, V126, P13534, DOI 10.1021/ja0488028; Knight MJ, 2012, P NATL ACAD SCI USA, V109, P11095, DOI 10.1073/pnas.1204515109; Lange A, 2006, NATURE, V440, P959, DOI 10.1038/nature04649; Li SH, 2011, J AM CHEM SOC, V133, P1534, DOI 10.1021/ja108943n; Loquet A, 2012, NATURE, V486, P276, DOI 10.1038/nature11079; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Lu Y, 2010, METALLOMICS, V2, P474, DOI 10.1039/c004693k; Mantri Y, 2008, J BIOL INORG CHEM, V13, P1197, DOI 10.1007/s00775-008-0403-6; Matsumura S, 2011, J BIOL CHEM, V286, P11555, DOI 10.1074/jbc.M110.181313; Meloni G, 2008, NAT CHEM BIOL, V4, P366, DOI 10.1038/nchembio.89; Miller LM, 2006, J STRUCT BIOL, V155, P30, DOI 10.1016/j.jsb.2005.09.004; Miller Y, 2012, COORDIN CHEM REV, V256, P2245, DOI 10.1016/j.ccr.2011.12.022; Mori M, 2008, BIOCHEMISTRY-US, V47, P12954, DOI 10.1021/bi801252e; Mukrasch MD, 2004, J BIOMOL NMR, V28, P297, DOI 10.1023/B:JNMR.0000013687.83263.b5; Nadal RC, 2008, BIOCHEMISTRY-US, V47, P11653, DOI 10.1021/bi8011093; Nakamura M, 2007, BIOCHEMISTRY-US, V46, P12737, DOI 10.1021/bi701079z; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; Olivieri G, 2003, NEUROSCIENCE, V120, P659, DOI 10.1016/S0306-4522(03)00342-7; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Parthasarathy S, 2011, J AM CHEM SOC, V133, P3390, DOI 10.1021/ja1072178; Perry George, 2002, Journal of Biomedicine & Biotechnology, V2, P120, DOI 10.1155/S1110724302203010; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Rice ME, 2000, TRENDS NEUROSCI, V23, P209, DOI 10.1016/S0166-2236(99)01543-X; Roberts BR, 2012, J NEUROCHEM, V120, P149, DOI 10.1111/j.1471-4159.2011.07500.x; Sarell CJ, 2009, BIOCHEMISTRY-US, V48, P4388, DOI 10.1021/bi900254n; Sayre LM, 1997, J NEUROCHEM, V68, P2092; Schiewe AJ, 2004, PHARM RES-DORDR, V21, P1094, DOI 10.1023/B:PHAM.0000032994.36343.02; Schoneich C, 2002, CHEM RES TOXICOL, V15, P717, DOI 10.1021/tx025504k; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Sengupta I, 2012, NAT CHEM, V4, P410, DOI [10.1038/NCHEM.1299, 10.1038/nchem.1299]; Shearer J, 2010, CHEM COMMUN, V46, P9137, DOI 10.1039/c0cc02446e; Shearer J, 2008, J AM CHEM SOC, V130, P17826, DOI 10.1021/ja805940m; Smith DP, 2006, J BIOL CHEM, V281, P15145, DOI 10.1074/jbc.M600417200; Su YC, 2012, J AM CHEM SOC, V134, P8693, DOI 10.1021/ja3026328; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Viles JH, 2012, COORDIN CHEM REV, V256, P2271, DOI 10.1016/j.ccr.2012.05.003; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Wickramasinghe NP, 2007, J MAGN RESON, V184, P350, DOI 10.1016/j.jmr.2006.10.012; Zhu X, 2007, CELL MOL LIFE SCI, V64, P2202, DOI 10.1007/s00018-007-7218-4	92	37	38	0	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9998	10010		10.1074/jbc.M113.511345	http://dx.doi.org/10.1074/jbc.M113.511345			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24523414	hybrid, Green Published			2022-12-28	WOS:000333807000048
J	Lee, C; Liu, AG; Miranda-Ribera, A; Hyun, SW; Lillehoj, EP; Cross, AS; Passaniti, A; Grimm, PR; Kim, BY; Welling, PA; Madri, JA; DeLisser, HM; Goldblum, SE				Lee, Chunsik; Liu, Anguo; Miranda-Ribera, Alba; Hyun, Sang Won; Lillehoj, Erik P.; Cross, Alan S.; Passaniti, Antonino; Grimm, P. Richard; Kim, Bo-Young; Welling, Paul A.; Madri, Joseph A.; DeLisser, Horace M.; Goldblum, Simeon E.			NEU1 Sialidase Regulates the Sialylation State of CD31 and Disrupts CD31-driven Capillary-like Tube Formation in Human Lung Microvascular Endothelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Endothelial Cell; Glycobiology; Sialic Acid; Sialyltransferase; CD31; PECAM-1; Neuraminidase; Sialidase; Sialoproteins	CELL ADHESION MOLECULE; BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; LYSOSOMAL SIALIDASE; PLASMA-MEMBRANE; IN-VITRO; PLATELET; PECAM-1; INTEGRIN; SURFACE; COMPLEX	Background: Endothelia express NEU1 sialidase and undergo changes in sialylation during angiogenesis. Results: CD31 is a NEU1 substrate, and NEU1 disrupts endothelial cell capillary-like tube formation. Conclusion: NEU1 works through its substrate, CD31, to dysregulate angiogenesis. Significance: Human NEU1 is the first sialidase found to regulate angiogenesis, and the CD31 sialylation state dictates its ability to influence endothelial cell differentiation and tube formation. The highly sialylated vascular endothelial surface undergoes changes in sialylation upon adopting the migratory/angiogenic phenotype. We recently established endothelial cell (EC) expression of NEU1 sialidase (Cross, A. S., Hyun, S. W., Miranda-Ribera, A., Feng, C., Liu, A., Nguyen, C., Zhang, L., Luzina, I. G., Atamas, S. P., Twaddell, W. S., Guang, W., Lillehoj, E. P., Puche, A. C., Huang, W., Wang, L. X., Passaniti, A., and Goldblum, S. E. (2012) NEU1 and NEU3 sialidase activity expressed in human lung microvascular endothelia. NEU1 restrains endothelial cell migration whereas NEU3 does not. J. Biol. Chem. 287, 15966-15980). We asked whether NEU1 might regulate EC capillary-like tube formation on a Matrigel substrate. In human pulmonary microvascular ECs (HPMECs), prior silencing of NEU1 did not alter tube formation. Infection of HPMECs with increasing multiplicities of infection of an adenovirus encoding for catalytically active WT NEU1 dose-dependently impaired tube formation, whereas overexpression of either a catalytically dead NEU1 mutant, NEU1-G68V, or another human sialidase, NEU3, did not. NEU1 overexpression also diminished EC adhesion to the Matrigel substrate and restrained EC migration in a wounding assay. In HPMECs, the adhesion molecule, CD31, also known as platelet endothelial cell adhesion molecule-1, was sialylated via 2,6-linkages, as shown by Sambucus nigra agglutinin lectin blotting. NEU1 overexpression increased CD31 binding to Arachis hypogaea or peanut agglutinin lectin, indicating CD31 desialylation. In the postconfluent state, when CD31 ectodomains are homophilically engaged, NEU1 was recruited to and desialylated CD31. In postconfluent ECs, CD31 was desialylated compared with subconfluent cells, and prior NEU1 silencing completely protected against CD31 desialylation. Prior CD31 silencing and the use of CD31-null ECs each abrogated the NEU1 inhibitory effect on EC tube formation. Sialyltransferase 6 GAL-I overexpression increased 2,6-linked CD31 sialylation and dose-dependently counteracted NEU1-mediated inhibition of EC tube formation. These combined data indicate that catalytically active NEU1 inhibits in vitro angiogenesis through desialylation of its substrate, CD31.	[Lee, Chunsik; Liu, Anguo; Miranda-Ribera, Alba; Hyun, Sang Won; Cross, Alan S.; Goldblum, Simeon E.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Lillehoj, Erik P.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Passaniti, Antonino; Goldblum, Simeon E.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Grimm, P. Richard; Kim, Bo-Young; Welling, Paul A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Cross, Alan S.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Passaniti, Antonino; Goldblum, Simeon E.] Dept Vet Affairs, Baltimore, MD 21201 USA; [Madri, Joseph A.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [DeLisser, Horace M.] Univ Penn, Sch Med, Pulm Allergy & Crit Care Div, Dept Med, Philadelphia, PA 19104 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Yale University; University of Pennsylvania	Goldblum, SE (corresponding author), Univ Maryland, Sch Med, 20 Penn St,HSF2,Rm 351, Baltimore, MD 21201 USA.	sgoldblu@mbrc.umaryland.edu	DeLisser, Horace/AFM-1942-2022	, Erik/0000-0003-0910-6074; Grimm, Paul/0000-0002-9368-0601; Lillehoj, Erik/0000-0002-2710-1704	National Institutes of Health [R01 HL 084223A]; VA Research Service, Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063049, R01DK054231] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002205, I01BX002352] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Research Service, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grant R01 HL 084223A (to S. E. G.) and the VA Research Service, Department of Veterans Affairs.	Amith SR, 2010, CELL SIGNAL, V22, P314, DOI 10.1016/j.cellsig.2009.09.038; AUGUSTINVOSS HG, 1992, J CELL BIOL, V119, P483, DOI 10.1083/jcb.119.2.483; BERMAN ME, 1995, J IMMUNOL, V154, P299; Berman ME, 1996, J IMMUNOL, V156, P1515; Biswas P, 2006, AM J PATHOL, V169, P314, DOI 10.2353/ajpath.2006.051112; Bonten EJ, 2000, J BIOL CHEM, V275, P37657, DOI 10.1074/jbc.M007380200; Bonten EJ, 2009, J BIOL CHEM, V284, P28430, DOI 10.1074/jbc.M109.031419; BORN GVR, 1985, BRIT J EXP PATHOL, V66, P543; Cao GY, 2002, AM J PHYSIOL-CELL PH, V282, pC1181, DOI 10.1152/ajpcell.00524.2001; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chiba R, 1999, BLOOD, V94, P1319, DOI 10.1182/blood.V94.4.1319.416k28_1319_1329; Chiodelli P, 2012, J BIOL CHEM, V287, P20456, DOI 10.1074/jbc.M111.337139; Cioffi DL, 2012, AM J PHYSIOL-LUNG C, V302, pL1067, DOI 10.1152/ajplung.00190.2011; Constantinescu AA, 2003, ARTERIOSCL THROM VAS, V23, P1541, DOI 10.1161/01.ATV.0000085630.24353.3D; Cross AS, 2012, J BIOL CHEM, V287, P15966, DOI 10.1074/jbc.M112.346817; D'Avila F, 2013, J CELL BIOCHEM, V114, P204, DOI 10.1002/jcb.24355; DeLisser HM, 1997, AM J PATHOL, V151, P671; Duca L, 2007, J BIOL CHEM, V282, P12484, DOI 10.1074/jbc.M609505200; Duchesne L, 2006, J BIOL CHEM, V281, P27178, DOI 10.1074/jbc.M601248200; Fischer E, 2000, HISTOCHEM J, V32, P105, DOI 10.1023/A:1004066212317; Geyer H, 1999, GLYCOBIOLOGY, V9, P915, DOI 10.1093/glycob/9.9.915; Giacopuzzi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044193; Gong NL, 2003, MOL CELL BIOCHEM, V253, P151, DOI 10.1023/A:1026016628386; Gratzinger D, 2003, FASEB J, V17, P1458, DOI 10.1096/fj.02-1040com; HANASAKI K, 1994, J BIOL CHEM, V269, P10637; HANASAKI K, 1995, J BIOL CHEM, V270, P7533, DOI 10.1074/jbc.270.13.7533; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Hinek A, 2006, J BIOL CHEM, V281, P3698, DOI 10.1074/jbc.M508736200; Hyun SW, 2011, EXP LUNG RES, V37, P327, DOI 10.3109/01902148.2011.566673; Ilan N, 2003, CURR OPIN CELL BIOL, V15, P515, DOI 10.1016/S0955-0674(03)00100-5; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; KOCH AE, 1995, NATURE, V376, P517, DOI 10.1038/376517a0; LEAVESLEY DI, 1994, J IMMUNOL, V153, P4673; Liang F, 2006, J BIOL CHEM, V281, P27526, DOI 10.1074/jbc.M605633200; Lillehoj EP, 2012, J BIOL CHEM, V287, P8214, DOI 10.1074/jbc.M111.292888; Lukong KE, 2000, HUM MOL GENET, V9, P1075, DOI 10.1093/hmg/9.7.1075; Lukong KE, 2001, J BIOL CHEM, V276, P46172, DOI 10.1074/jbc.M104547200; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Monti E, 2002, NEUROCHEM RES, V27, P649, DOI 10.1023/A:1020276000901; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; Nan XL, 2007, J LEUKOCYTE BIOL, V81, P284, DOI 10.1189/jlb.1105692; Nangia-Makker P, 2000, AM J PATHOL, V156, P899, DOI 10.1016/S0002-9440(10)64959-0; Nangia-Makker P, 2000, CANCER METAST REV, V19, P51, DOI 10.1023/A:1026540129688; Newman PJ, 1997, J CLIN INVEST, V99, P3, DOI 10.1172/JCI119129; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9; Newton JP, 1999, BIOCHEM BIOPH RES CO, V261, P283, DOI 10.1006/bbrc.1999.1018; Nguyen LL, 2001, INT REV CYTOL, V204, P1, DOI 10.1016/S0074-7696(01)04002-5; NGUYEN M, 1992, J BIOL CHEM, V267, P26157; Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137; PIALI L, 1993, EUR J IMMUNOL, V23, P2464, DOI 10.1002/eji.1830231013; Pierce AD, 2012, J CELL BIOCHEM, V113, P282, DOI 10.1002/jcb.23354; Pshezhetsky AV, 2001, PROG NUCLEIC ACID RE, V69, P81, DOI 10.1016/S0079-6603(01)69045-7; Sakarya S, 2004, GLYCOBIOLOGY, V14, P481, DOI 10.1093/glycob/cwh065; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Sharan N., 2003, LECTINS; SIMMONS DL, 1990, J EXP MED, V171, P2147, DOI 10.1084/jem.171.6.2147; Skelton TP, 1998, J CELL BIOL, V140, P431, DOI 10.1083/jcb.140.2.431; Solowiej A, 2003, AM J PATHOL, V162, P953, DOI 10.1016/S0002-9440(10)63890-4; Sun QH, 1996, J BIOL CHEM, V271, P11090, DOI 10.1074/jbc.271.19.11090; Takashima S, 2002, J BIOL CHEM, V277, P45719, DOI 10.1074/jbc.M206808200; TANAKA Y, 1992, J EXP MED, V176, P245, DOI 10.1084/jem.176.1.245; van der Spoel A, 1998, EMBO J, V17, P1588, DOI 10.1093/emboj/17.6.1588; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; Wang PH, 2005, J CANC MOL, V1, P73, DOI DOI 10.29685/JCM.200512.0001; Weber KSC, 2004, INFLAMMATION, V28, P177, DOI 10.1023/B:IFLA.0000049042.73926.eb; Willhauck-Fleckenstein M, 2010, ANGIOGENESIS, V13, P25, DOI 10.1007/s10456-010-9162-4; Zhou Z, 1999, Angiogenesis, V3, P181, DOI 10.1023/A:1009092107382	68	50	52	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9121	9135		10.1074/jbc.M114.555888	http://dx.doi.org/10.1074/jbc.M114.555888			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24550400	hybrid, Green Published			2022-12-28	WOS:000333472100032
J	Tie, JK; Jin, DY; Stafford, DW				Tie, Jian-Ke; Jin, Da-Yun; Stafford, Darrel W.			Conserved Loop Cysteines of Vitamin K Epoxide Reductase Complex Subunit 1-like 1 ( VKORC1L1) Are Involved in Its Active Site Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Disulfide; Electron Transfer; Endoplasmic Reticulum (ER); Enzymes; Membrane Proteins; Post-translational Modification; Protein Carboxylation; Vitamin K	MEMBRANE-PROTEIN TOPOLOGY; WARFARIN RESISTANCE; DEPENDENT CARBOXYLATION; BACTERIAL HOMOLOG; THIOREDOXIN; DISULFIDE; IDENTIFICATION; PREDICTIONS; DEFICIENCY; MECHANISMS	Background: The structure and the physiological function(s) of vitamin K epoxide reductase complex subunit 1-like 1 (VKORC1L1) are unknown. Results: VKORC1L1 has four transmembrane domains and employs an intra-molecular electron transfer pathway for active site regeneration. Conclusion: The different structure and reaction mechanism of VKORC1L1, as compared with VKORC1, suggest that VKORC1L1 has different physiological function(s). Significance: Four conserved cysteines in VKORC1L1 function in concert for active site reduction. Vitamin K epoxide reductase complex subunit 1 (VKORC1) reduces vitamin K epoxide in the vitamin K cycle for post-translational modification of proteins that are involved in a variety of biological functions. However, the physiological function of VKORC1-like 1 (VKORC1L1), a paralogous enzyme sharing about 50% protein identity with VKORC1, is unknown. Here we determined the structural and functional differences of these two enzymes using fluorescence protease protection (FPP) assay and an in vivo cell-based activity assay. We show that in vivo VKORC1L1 reduces vitamin K epoxide to support vitamin K-dependent carboxylation as efficiently as does VKORC1. However, FPP assays show that unlike VKORC1, VKORC1L1 is a four-transmembrane domain protein with both its termini located in the cytoplasm. Moreover, the conserved loop cysteines, which are not required for VKORC1 activity, are essential for VKORC1L1's active site regeneration. Results from domain exchanges between VKORC1L1 and VKORC1 suggest that it is VKORC1L1's overall structure that uniquely allows for active site regeneration by the conserved loop cysteines. Intermediate disulfide trapping results confirmed an intra-molecular electron transfer pathway for VKORC1L1's active site reduction. Our results allow us to propose a concerted action of the four conserved cysteines of VKORC1L1 for active site regeneration; the second loop cysteine, Cys-58, attacks the active site disulfide, forming an intermediate disulfide with Cys-139; the first loop cysteine, Cys-50, attacks the intermediate disulfide resulting in active site reduction. The different membrane topologies and reaction mechanisms between VKORC1L1 and VKORC1 suggest that these two proteins might have different physiological functions.	[Tie, Jian-Ke; Jin, Da-Yun; Stafford, Darrel W.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Tie, JK (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.	jktie@email.unc.edu		Tie, Jian-Ke/0000-0002-8447-3408	National Institutes of Health [HL077740]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in whole or in part by National Institutes of Health Grant HL077740 (to D. W. S.).	Aran M, 2009, FEBS J, V276, P2478, DOI 10.1111/j.1742-4658.2009.06984.x; Bandyopadhyay PK, 2008, VITAM HORM, V78, P157, DOI 10.1016/S0083-6729(07)00008-8; Chu PH, 2006, P NATL ACAD SCI USA, V103, P19308, DOI 10.1073/pnas.0609401103; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Eriksson N, 2012, PHARMACOGENOMICS, V13, P429, DOI [10.2217/pgs.11.184, 10.2217/PGS.11.184]; Fregin A, 2013, J THROMB HAEMOST, V11, P872, DOI 10.1111/jth.12185; Gage BF, 2008, CLIN PHARMACOL THER, V84, P326, DOI 10.1038/clpt.2008.10; GARDILL SL, 1990, BIOCHEM PHARMACOL, V40, P1055, DOI 10.1016/0006-2952(90)90493-5; Goodstadt L, 2004, TRENDS BIOCHEM SCI, V29, P289, DOI 10.1016/j.tibs.2004.04.004; Hammed A, 2013, J BIOL CHEM, V288, P28733, DOI 10.1074/jbc.M113.457119; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; Hennerdal A, 2011, BIOINFORMATICS, V27, P1322, DOI 10.1093/bioinformatics/btr119; Jin DY, 2007, BIOCHEMISTRY-US, V46, P7279, DOI 10.1021/bi700527j; Kadokura H, 2002, EMBO J, V21, P2354, DOI 10.1093/emboj/21.10.2354; Li T, 2004, NATURE, V427, P541, DOI 10.1038/nature02254; Li WK, 2010, NATURE, V463, P507, DOI 10.1038/nature08720; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; Lund K, 2012, BRIT J HAEMATOL, V158, P256, DOI 10.1111/j.1365-2141.2012.09150.x; Moualla H, 2011, THROMB RES, V128, P210, DOI 10.1016/j.thromres.2011.04.011; Nilsson J, 2000, FEBS LETT, V486, P267, DOI 10.1016/S0014-5793(00)02321-8; PREUSCH PC, 1992, FEBS LETT, V305, P257, DOI 10.1016/0014-5793(92)80681-6; Rishavy MA, 2011, J BIOL CHEM, V286, P7267, DOI 10.1074/jbc.M110.172213; Rost S, 2005, THROMB HAEMOSTASIS, V94, P780, DOI 10.1160/TH05-02-0082; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; Saxena SP, 2001, APOPTOSIS, V6, P57, DOI 10.1023/A:1009624111275; Schulman S, 2010, P NATL ACAD SCI USA, V107, P15027, DOI 10.1073/pnas.1009972107; Schurgers LJ, 2013, TRENDS MOL MED, V19, P217, DOI 10.1016/j.molmed.2012.12.008; SILVERMAN RB, 1988, BIOCHEM BIOPH RES CO, V155, P1248, DOI 10.1016/S0006-291X(88)81274-9; Singh AK, 2008, J BIOL CHEM, V283, P15762, DOI 10.1074/jbc.M800982200; SOUTE BAM, 1992, BIOCHEM J, V281, P255, DOI 10.1042/bj2810255; Spohn G, 2009, THROMB HAEMOSTASIS, V101, P1044, DOI 10.1160/TH09-03-0204; Stafford DW, 2005, J THROMB HAEMOST, V3, P1873, DOI 10.1111/j.1538-7836.2005.01419.x; Theuwissen E, 2012, ADV NUTR, V3, P166, DOI 10.3945/an.111.001628; Tie JK, 2013, J THROMB HAEMOST, V11, P1556, DOI 10.1111/jth.12306; Tie JK, 2008, VITAM HORM, V78, P103, DOI 10.1016/S0083-6729(07)00006-4; Tie JK, 2012, J BIOL CHEM, V287, P33945, DOI 10.1074/jbc.M112.402941; Tie JK, 2012, ANTIOXID REDOX SIGN, V16, P329, DOI 10.1089/ars.2011.4043; Tie JK, 2011, BLOOD, V117, P2967, DOI 10.1182/blood-2010-08-304303; Tie JK, 2005, J BIOL CHEM, V280, P16410, DOI 10.1074/jbc.M500765200; Tishler M, 1940, J AM CHEM SOC, V62, P2866, DOI 10.1021/ja01867a066; Tsirigos KD, 2012, PROTEOMICS, V12, P2282, DOI 10.1002/pmic.201100495; VANHAARLEM LJM, 1987, FEBS LETT, V222, P353, DOI 10.1016/0014-5793(87)80401-5; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Wajih N, 2005, J BIOL CHEM, V280, P10540, DOI 10.1074/jbc.M413982200; Wang XY, 2011, ANTIOXID REDOX SIGN, V14, P1413, DOI 10.1089/ars.2010.3558; Westhofen P, 2011, J BIOL CHEM, V286, P15085, DOI 10.1074/jbc.M110.210971; Yin T, 2008, THROMB RES, V122, P179, DOI 10.1016/j.thromres.2007.09.015	47	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9396	9407		10.1074/jbc.M113.534446	http://dx.doi.org/10.1074/jbc.M113.534446			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24532791	Green Published, hybrid			2022-12-28	WOS:000333472100055
J	He, LZ; Marneros, AG				He, Lizhi; Marneros, Alexander G.			Doxycycline Inhibits Polarization of Macrophages to the Proangiogenic M2-type and Subsequent Neovascularization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Antibiotics; Inflammation; Innate Immunity; Macrophages; Wound Healing; Macular Degeneration	CHOROIDAL NEOVASCULARIZATION; MACULAR DEGENERATION; MEDIATED INHIBITION; ANGIOGENESIS; PREVENTS; RANIBIZUMAB; BEVACIZUMAB; PROGRESSION; MECHANISM	Background: M2-type macrophages are proangiogenic and protumorigenic, whereas M1-type macrophages are antiangiogenic. Results: Doxycycline is a potent inhibitor of M2-type macrophage polarization in both human and mouse macrophages in vitro and in vivo. Conclusion: Preventing M2-type macrophage polarization correlates with inhibition of pathological angiogenesis. Significance: Doxycycline may be used to enhance current antiangiogenic treatment approaches in neovascular age-related macular degeneration and in certain cancers. Macrophages occur along a continuum of functional states between M1-type polarized macrophages with antiangiogenic and antitumor activity and M2-type polarized macrophages, which have been implicated to promote angiogenesis and tumor growth. Proangiogenic M2-type macrophages promote various pathologic conditions, including choroidal neovascularization in models of neovascular age-related macular degeneration, or certain cancers, such as glioblastoma multiforme. Thus, a potential novel therapeutic approach to target pathological angiogenesis in these conditions would be to inhibit the polarization of macrophages toward the proangiogenic M2-type. However, no pharmacological inhibitors of M2-type macrophage polarization have been identified yet. Here we performed an unbiased pharmacological and small chemical screen to identify drugs that inhibit proangiogenic M2-type macrophage polarization and block pathologic macrophage-driven neovascularization. We identified the well tolerated and commonly used antibiotic doxycycline as a potent inhibitor of M2-type polarization of macrophages. Doxycycline inhibited, in a dose-dependent manner, M2-type polarization of human and bone marrow-derived mouse macrophages without affecting cell viability. Furthermore, doxycycline inhibited M2-type macrophage polarization and subsequent neovascularization in vivo in a laser injury model of choroidal neovascularization. Thus, doxycycline could be used to enhance current antiangiogenic treatment approaches in various conditions that are promoted by proangiogenic M2-type macrophages, including neovascular age-related macular degeneration and certain cancers.	Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Dermatol, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University	Marneros, AG (corresponding author), CBRC, MGH East, CNY-149,Rm 3-216,13th St, Charlestown, MA 02129 USA.	amarneros@mgh.harvard.edu		Marneros, Alexander/0000-0003-3866-020X	NEI, National Institutes of Health [NEI R01-EY019297]; Shiseido research grant; Dermatology Foundation; NATIONAL EYE INSTITUTE [R01EY019297] Funding Source: NIH RePORTER	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Shiseido research grant; Dermatology Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported, in whole or in part, by NEI, National Institutes of Health Grant NEI R01-EY019297 (to A. G. M.). This work was also supported by a Shiseido research grant (to A. G. M.) and by a Dermatology Foundation research grant (to L. H.).	Cox CA, 2010, OPHTHALMOLOGY, V117, P1782, DOI 10.1016/j.ophtha.2010.01.037; Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236; Fainaru O, 2008, FASEB J, V22, P3728, DOI 10.1096/fj.08-110494; GILBERTSONBEADLING S, 1995, CANCER CHEMOTH PHARM, V36, P418, DOI 10.1007/BF00686191; He LZ, 2013, AM J PATHOL, V182, P2407, DOI 10.1016/j.ajpath.2013.02.032; Lavalette S, 2011, AM J PATHOL, V178, P2416, DOI 10.1016/j.ajpath.2011.01.013; Liang D, 2008, CURR EYE RES, V33, P653, DOI 10.1080/02713680802245772; Marneros AG, 2013, CELL REP, V4, P945, DOI 10.1016/j.celrep.2013.08.002; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Rofagha S, 2013, OPHTHALMOLOGY, V120, P2292, DOI 10.1016/j.ophtha.2013.03.046; Roychoudhury J, 2010, INVEST OPHTH VIS SCI, V51, P3560, DOI 10.1167/iovs.09-3890; Samtani S, 2009, INVEST OPHTH VIS SCI, V50, P5098, DOI 10.1167/iovs.08-3174; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Su WR, 2013, INVEST OPHTH VIS SCI, V54, P783, DOI 10.1167/iovs.12-10323; Su WR, 2011, INVEST OPHTH VIS SCI, V52, P9108, DOI 10.1167/iovs.11-7255; SUOMALAINEN K, 1992, ANTIMICROB AGENTS CH, V36, P227, DOI 10.1128/AAC.36.1.227	18	57	61	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8019	8028		10.1074/jbc.M113.535765	http://dx.doi.org/10.1074/jbc.M113.535765			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24505138	Green Published, hybrid			2022-12-28	WOS:000333157500002
J	Shi, L; Zhang, QP; Xu, BQ; Jiang, XH; Dai, YT; Zhang, CY; Zen, K				Shi, Lei; Zhang, Qipeng; Xu, Binqiang; Jiang, Xiaohong; Dai, Yutian; Zhang, Chen-Yu; Zen, Ke			Sustained High Protein-tyrosine Phosphatase 1B Activity in the Sperm of Obese Males Impairs the Sperm Acrosome Reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Obesity; Phosphatase; Phosphorylation; SNARE Proteins; Sperm; Obesity; Subfertility; Infertility; PTP1B; Dephosphorylation; N-Ethylmaleimide-sensitive Factor	SKELETAL-MUSCLE; TC-PTP; INSULIN SENSITIVITY; EXPRESSION; COMPLEX; EXOCYTOSIS; RECEPTOR; TISSUE; ROLES; INFLAMMATION	Background: Obesity can cause male infertility or subfertility. The underlying mechanism, however, remains unclear. Results: PTP1B level/activity in obese sperm are significantly higher than those in non-obese sperm. Sustained high PTP1B activity causes a prolonged NSF dephosphorylation, which impedes reassembly of the trans-SNARE complexes. Conclusion: PTP1B serves as a link between male obesity and infertility/subfertility. Significance: Identifying PTP1B as a novel therapeutic target in obesity-related male infertility/subfertility. Evidence of a causal link between male obesity and subfertility or infertility has been demonstrated previously. However, the mechanism underlying this link is incompletely understood. Here, we report that sustained high protein-tyrosine phosphatase 1B (PTP1B) activity in sperm of obese donors plays an essential role in coupling male obesity and subfertility or infertility. First, PTP1B level and activity were significantly higher in sperm from ob/ob mice than in wild-type littermates. High PTP1B level and activity in sperm was also observed in obese patients compared with non-obese donors. The enhanced sperm PTP1B level and activity in ob/ob mice and obese patients correlated with a defect of the sperm acrosome reaction (AR). Second, treating sperm from male ob/ob mice or obese men with a specific PTP1B inhibitor largely restored the sperm AR. Finally, blockade of sperm AR by enhanced PTP1B activity in male ob/ob mice or obese men was due to prolonged dephosphorylation of N-ethylmaleimide-sensitive factor by PTP1B, leading to the inability to reassemble the trans-SNARE complexes, which is a critical step in sperm acrosomal exocytosis. In summary, our study demonstrates for the first time that a sustained high PTP1B level or activity in the sperm of obese donors causes a defect of sperm AR and that PTP1B is a novel potential therapeutic target for male infertility treatment.	[Shi, Lei; Zhang, Qipeng; Jiang, Xiaohong; Zhang, Chen-Yu; Zen, Ke] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Nanjing 210093, Jiangsu, Peoples R China; [Xu, Binqiang; Dai, Yutian] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Urol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Dai, YT (corresponding author), Nanjing Drum Tower Hosp, Dept Urol, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China.	ytdai@hotmail.com; cyzhang@nju.edu.cn; kzen@nju.edu.cn	Shi, Lei/AAJ-1586-2020	Shi, Lei/0000-0002-6631-6732	National Basic Research Program of China [2012CB517603, 2011CB504803863]; National Natural Science Foundation of China [30988003, 30890044, 30800946, 30871019, 30890032, 31071232, 31100777, 31000323, 90608010, 90813035]; Research Fund for the Doctoral Program of Higher Education of China [20100091120026, 20100091120023]; Natural Science Foundation of Jiangsu Province [BK2011013]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by National Basic Research Program of China Grants 2012CB517603 and 2011CB504803863; National Natural Science Foundation of China Grants 30988003, 30890044, 30800946, 30871019, 30890032, 31071232, 31100777, 31000323, 90608010, and 90813035; Research Fund for the Doctoral Program of Higher Education of China Grants 20100091120026 and 20100091120023; and Natural Science Foundation of Jiangsu Province Grant BK2011013.	Ahmad F, 1997, J CLIN INVEST, V100, P449, DOI 10.1172/JCI119552; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Calera MR, 2000, J BIOL CHEM, V275, P6308, DOI 10.1074/jbc.275.9.6308; Cheung A, 1999, J LAB CLIN MED, V134, P115, DOI 10.1016/S0022-2143(99)90115-4; Dadke SS, 2000, BIOCHEM BIOPH RES CO, V274, P583, DOI 10.1006/bbrc.2000.3188; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; Dube N, 2005, BBA-PROTEINS PROTEOM, V1754, P108, DOI 10.1016/j.bbapap.2005.07.030; Giraudo CG, 2006, SCIENCE, V313, P676, DOI 10.1126/science.1129450; Goldstein BJ, 2002, J CLIN ENDOCR METAB, V87, P2474, DOI 10.1210/jc.87.6.2474; Goldstein BJ, 2000, J BIOL CHEM, V275, P4283, DOI 10.1074/jbc.275.6.4283; Gum RJ, 2003, DIABETES, V52, P21, DOI 10.2337/diabetes.52.1.21; Hammoud AO, 2008, FERTIL STERIL, V90, P897, DOI 10.1016/j.fertnstert.2008.08.026; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Heinonen KM, 2009, P NATL ACAD SCI USA, V106, P9368, DOI 10.1073/pnas.0812109106; Huynh H, 2004, NAT CELL BIOL, V6, P831, DOI 10.1038/ncb1164; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Lacobellis G, 2008, HORM METAB RES, V40, P442, DOI 10.1055/s-2008-1062724; Lam NT, 2006, J MOL ENDOCRINOL, V36, P163, DOI 10.1677/jme.1.01937; LEE MA, 1987, FERTIL STERIL, V48, P649; Michaut M, 2000, P NATL ACAD SCI USA, V97, P9996, DOI 10.1073/pnas.180206197; Prada PO, 2005, ENDOCRINOLOGY, V146, P1576, DOI 10.1210/en.2004-0767; Reis LO, 2012, REPROD SCI, V19, P778, DOI 10.1177/1933719112440053; Rodriguez F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021925; Roggero CM, 2007, J BIOL CHEM, V282, P26335, DOI 10.1074/jbc.M700854200; SHI QX, 1995, BIOL REPROD, V52, P373, DOI 10.1095/biolreprod52.2.373; Simoncic PD, 2006, CAN J PHYSIOL PHARM, V84, P667, DOI 10.1139/Y06-012; Simoncic PD, 2006, MOL CELL BIOL, V26, P4149, DOI 10.1128/MCB.01932-05; Sollner TH, 2003, MOL MEMBR BIOL, V20, P209, DOI 10.1080/0968768031000104953; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Taghibiglou C, 2002, J BIOL CHEM, V277, P793, DOI 10.1074/jbc.M106737200; Tomes CN, 2005, MOL HUM REPROD, V11, P43, DOI 10.1093/molehr/gah126; Tomes CN, 2004, DEV BIOL, V265, P399, DOI 10.1016/j.ydbio.2003.09.032; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tonks NK, 2001, CURR OPIN CELL BIOL, V13, P182, DOI 10.1016/S0955-0674(00)00196-4; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; Wu Y, 2005, BRIT J PHARMACOL, V146, P234, DOI 10.1038/sj.bjp.0706306; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Zabolotny JM, 2008, J BIOL CHEM, V283, P14230, DOI 10.1074/jbc.M800061200; Zarelli VEP, 2009, J BIOL CHEM, V284, P10491, DOI 10.1074/jbc.M807614200; Zinker BA, 2002, P NATL ACAD SCI USA, V99, P11357, DOI 10.1073/pnas.142298199	44	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8432	8441		10.1074/jbc.M113.517466	http://dx.doi.org/10.1074/jbc.M113.517466			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24519936	Green Published, hybrid			2022-12-28	WOS:000333157500035
J	Stark, R; Guebre-Egziabher, F; Zhao, XJ; Feriod, C; Dong, JY; Alves, TC; Ioja, S; Pongratz, RL; Bhanot, S; Roden, M; Cline, GW; Shulman, GI; Kibbey, RG				Stark, Romana; Guebre-Egziabher, Fitsum; Zhao, Xiaojian; Feriod, Colleen; Dong, Jianying; Alves, Tiago C.; Ioja, Simona; Pongratz, Rebecca L.; Bhanot, Sanjay; Roden, Michael; Cline, Gary W.; Shulman, Gerald I.; Kibbey, Richard G.			A Role for Mitochondrial Phosphoenolpyruvate Carboxykinase (PEPCK-M) in the Regulation of Hepatic Gluconeogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Gluconeogenesis; Glyceroneogenesis; GTPase; Intermediary Metabolism; Metabolic Regulation; Metabolic Tracers; Metabolism; Mitochondrial Metabolism; Phosphoenolpyruvate Carboxykinase	GUINEA-PIG LIVER; INTRACELLULAR-DISTRIBUTION; INSULIN-RESISTANCE; GLUCOSE-PRODUCTION; DIABETES-MELLITUS; MOUSE-LIVER; RAT-LIVER; EXPRESSION; PYRUVATE; HYPERGLYCEMIA	Background: PEPCK-M is generally considered irrelevant for glucose production, although gluconeogenesis has never been characterized in its absence. Results: PEPCK-M loss impaired gluconeogenesis from lactate, lowered plasma glucose, insulin, and triglycerides, reduced hepatic glycogen, and increased glycerol turnover. Conclusion: Approximately a third of gluconeogenesis comes from PEPCK-M. Significance: The nutrient-sensitive PEPCK-M has been overlooked and is potentially important for metabolic diseases such as diabetes. Synthesis of phosphoenolpyruvate (PEP) from oxaloacetate is an absolute requirement for gluconeogenesis from mitochondrial substrates. Generally, this reaction has solely been attributed to the cytosolic isoform of PEPCK (PEPCK-C), although loss of the mitochondrial isoform (PEPCK-M) has never been assessed. Despite catalyzing the same reaction, to date the only significant role reported in mammals for the mitochondrial isoform is as a glucose sensor necessary for insulin secretion. We hypothesized that this nutrient-sensing mitochondrial GTP-dependent pathway contributes importantly to gluconeogenesis. PEPCK-M was acutely silenced in gluconeogenic tissues of rats using antisense oligonucleotides both in vivo and in isolated hepatocytes. Silencing PEPCK-M lowers plasma glucose, insulin, and triglycerides, reduces white adipose, and depletes hepatic glycogen, but raises lactate. There is a switch of gluconeogenic substrate preference to glycerol that quantitatively accounts for a third of glucose production. In contrast to the severe mitochondrial deficiency characteristic of PEPCK-C knock-out livers, hepatocytes from PEPCK-M-deficient livers maintained normal oxidative function. Consistent with its predicted role, gluconeogenesis rates from hepatocytes lacking PEPCK-M are severely reduced for lactate, alanine, and glutamine, but not for pyruvate and glycerol. Thus, PEPCK-M has a direct role in fasted and fed glucose homeostasis, and this mitochondrial GTP-dependent pathway should be reconsidered for its involvement in both normal and diabetic metabolism.	[Stark, Romana; Guebre-Egziabher, Fitsum; Zhao, Xiaojian; Dong, Jianying; Alves, Tiago C.; Ioja, Simona; Pongratz, Rebecca L.; Cline, Gary W.; Shulman, Gerald I.; Kibbey, Richard G.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Feriod, Colleen; Shulman, Gerald I.; Kibbey, Richard G.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Dong, Jianying; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Bhanot, Sanjay] ISIS Pharmaceut, Carlsbad, CA 92010 USA; [Roden, Michael] German Diabet Ctr, Inst Clin Diabetol, D-40225 Dusseldorf, Germany	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Isis Pharmaceuticals Inc; Deutsches Diabetes-Zentrum (DDZ)	Kibbey, RG (corresponding author), Yale Univ, Sch Med, Dept Internal Med, POB 208020, New Haven, CT 06520 USA.	richard.kibbey@yale.edu	Carmen, Team1/Y-7382-2019; Roden, Michael/AAD-3843-2019; Carmen, Team3/Y-7384-2019; Shulman, Gerald I./P-7176-2019	Carmen, Team1/0000-0003-4234-1746; Carmen, Team3/0000-0002-3614-0924; Shulman, Gerald I./0000-0003-1529-5668; Stark, Romana/0000-0002-4264-0060; Lab, Carmen/0000-0002-5935-3236	National Institutes of Health [R01 DK092606, K08 DK080142, R01 DK-40936, R24 DK-085638, U24 DK-059635, P30 DK79310-01, P30 DK34989, P30 DK45735]; American Diabetes Association [7-12-BS-092]; Societe Francophone de Nephrologie, Hospices Civils de Lyon; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, K08DK080142, R24DK085638, P30DK079310, U24DK059635, P30DK034989, R01DK040936, R01DK092606] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Societe Francophone de Nephrologie, Hospices Civils de Lyon; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK092606 (to R. G. K.), K08 DK080142 (to R. G. K.), R01 DK-40936 (to G. I. S.), R24 DK-085638 (to G. I. S.), U24 DK-059635, P30 DK79310-01, P30 DK34989, and P30 DK45735. This work was also supported by the American Diabetes Association (Grant 7-12-BS-092) (to R. G. K.), and Societe Francophone de Nephrologie, Hospices Civils de Lyon (to F. G. E.). S. B. is employed by and holds stocks in ISIS Pharmaceuticals.	BALLARD FJ, 1967, BIOCHEM J, V104, P866, DOI 10.1042/bj1040866; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Caton PW, 2009, LIFE SCI, V84, P738, DOI 10.1016/j.lfs.2009.02.024; CORNELL NW, 1986, J NUTR, V116, P1101, DOI 10.1093/jn/116.6.1101; DIESTERHAFT M, 1971, BIOCHEM MED METAB B, V5, P297, DOI 10.1016/0006-2944(71)90032-9; Erion DM, 2009, CELL METAB, V10, P499, DOI 10.1016/j.cmet.2009.10.007; GARBER AJ, 1969, J BIOL CHEM, V244, P4696; Gastaldelli A, 2004, J CLIN ENDOCR METAB, V89, P3914, DOI 10.1210/jc.2003-031941; Hakimi Parvin, 2005, Nutr Metab (Lond), V2, P33, DOI 10.1186/1743-7075-2-33; Hanson RW, 2009, J BIOL CHEM, V284, P27021, DOI 10.1074/jbc.R109.040519; HEITZMAN RJ, 1972, FEBS LETT, V20, P19, DOI 10.1016/0014-5793(72)80006-1; Horn DB, 1997, METABOLISM, V46, P414, DOI 10.1016/S0026-0495(97)90058-5; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Jamison RA, 2011, AM J PHYSIOL-ENDOC M, V301, pE1174, DOI 10.1152/ajpendo.00175.2011; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; MACDONALD MJ, 1978, J BIOL CHEM, V253, P116; Maggs DG, 1998, ANN INTERN MED, V128, P176, DOI 10.7326/0003-4819-128-3-199802010-00002; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; Mendez-Lucas A, 2013, J HEPATOL, V59, P105, DOI 10.1016/j.jhep.2013.02.020; Modaressi S, 1998, BIOCHEM J, V333, P359, DOI 10.1042/bj3330359; NORDLIE RC, 1963, J BIOL CHEM, V238, P2259; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; SAGGERSON ED, 1975, BIOCHEM J, V146, P329, DOI 10.1042/bj1460329; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2009, P NATL ACAD SCI USA, V106, P12121, DOI 10.1073/pnas.0812547106; She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000; She PX, 2003, DIABETES, V52, P1649, DOI 10.2337/diabetes.52.7.1649; SIESS EA, 1977, BIOCHEM J, V166, P225, DOI 10.1042/bj1660225; SOLING HD, 1970, EUR J BIOCHEM, V16, P289, DOI 10.1111/j.1432-1033.1970.tb01084.x; SOLING HD, 1973, EUR J BIOCHEM, V37, P233, DOI 10.1111/j.1432-1033.1973.tb02980.x; Stark R., 2013, BIOCH BIOPHYS ACTA, DOI 10.1016/j.bbagen.2013.10.033; Stark R, 2009, J BIOL CHEM, V284, P26578, DOI 10.1074/jbc.M109.011775; USATENKO MS, 1970, BIOCHEM MED METAB B, V3, P298, DOI 10.1016/0006-2944(70)90030-X; UTTER MF, 1954, J BIOL CHEM, V207, P787; Vozza A, 2004, J BIOL CHEM, V279, P20850, DOI 10.1074/jbc.M313610200; WIESE TJ, 1991, COMP BIOCHEM PHYS B, V100, P297, DOI 10.1016/0305-0491(91)90378-Q; WOLFE RR, 1988, AM J PHYSIOL, V254, pE532, DOI 10.1152/ajpendo.1988.254.4.E532; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; Yu RZ, 2007, DRUG METAB DISPOS, V35, P460, DOI 10.1124/dmd.106.012401	41	64	66	4	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7257	7263		10.1074/jbc.C113.544759	http://dx.doi.org/10.1074/jbc.C113.544759			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24497630	Green Published, hybrid			2022-12-28	WOS:000332761500001
J	Dowling, JK; Becker, CE; Bourke, NM; Corr, SC; Connolly, DJ; Quinn, SR; Pandolfi, PP; Mansell, A; O'Neill, LAJ				Dowling, Jennifer K.; Becker, Christine E.; Bourke, Nollaig M.; Corr, Sinead C.; Connolly, Dympna J.; Quinn, Susan R.; Pandolfi, Paolo P.; Mansell, Ashley; O'Neill, Luke A. J.			Promyelocytic Leukemia Protein Interacts with the Apoptosis-associated Speck-like Protein to Limit Inflammasome Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Cytokine; Inflammation; Innate Immunity; Nod-like Receptors (NLR); Inflammasome	HOST-DEFENSE; ASC; PML; RECOGNITION; ADAPTER; NLRP3; DNA	Background: ASC is the common adaptor of caspase-1 activation in several inflammasomes. Results: A novel interaction between PML and ASC is identified. PML-deficient macrophages display enhanced levels of IL-1 secretion and higher levels of ASC in the cytosol. Conclusion: PML retains ASC in the nucleus limiting inflammasome activation. Significance: Understanding the regulation of inflammasome components will aid in the development of therapeutics to alleviate IL-1-mediated diseases. The apoptosis-associated speck-like protein containing a caspase-activating recruitment domain (ASC) is an essential component of several inflammasomes, multiprotein complexes that regulate caspase-1 activation and inflammation. We report here an interaction between promyelocytic leukemia protein (PML) and ASC. We observed enhanced formation of ASC dimers in PML-deficient macrophages. These macrophages also display enhanced levels of ASC in the cytosol. Furthermore, IL-1 production was markedly enhanced in these macrophages in response to both NLRP3 and AIM2 inflammasome activation and following bone marrow-derived macrophage infection with herpes simplex virus-1 (HSV-1) and Salmonella typhimurium. Collectively, our data indicate that PML limits ASC function, retaining ASC in the nucleus.	[Dowling, Jennifer K.; Becker, Christine E.; Corr, Sinead C.; Connolly, Dympna J.; Quinn, Susan R.; O'Neill, Luke A. J.] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin 2, Ireland; [Pandolfi, Paolo P.] Harvard Univ, Beth Israel Deaconess Med Ctr, Beth Israel Deaconess Canc Ctr, Canc Genet Program,Dept Med,Med Sch, Boston, MA 01605 USA; [Bourke, Nollaig M.; Mansell, Ashley] Monash Univ, Ctr Innate Immun & Infect Dis, MIMR PHI Inst Med Res, Clayton, Vic 3168, Australia	Trinity College Dublin; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Monash University; Prince Henry's Institute of Medical Research	O'Neill, LAJ (corresponding author), Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Inflammat Res Grp, 152-160 Pearse St, Dublin 2, Ireland.	laoneill@tcd.ie	Bourke, Nollaig M/A-9840-2017; Bourke, Nollaig/AAE-7279-2019; Dowling, Jennifer/ABA-6670-2020; Mansell, Ashley/B-9553-2008	Bourke, Nollaig M/0000-0003-4313-6859; Bourke, Nollaig/0000-0003-4313-6859; Mansell, Ashley/0000-0002-6540-1281; Dowling, Jennifer/0000-0003-2842-1504; O'Neill, Luke/0000-0002-4333-2748; Corr, Sinead/0000-0001-9930-5039; Pandolfi, Pier Paolo/0000-0002-5352-5295	Victorian Government's Operational Infrastructure Support Program; Science Foundation Ireland	Victorian Government's Operational Infrastructure Support Program; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by the Victorian Government's Operational Infrastructure Support Program along with Science Foundation Ireland.	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Arlehamn CSL, 2011, CELL MICROBIOL, V13, P388, DOI 10.1111/j.1462-5822.2010.01541.x; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Bryan NB, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-23; Bryan NB, 2009, J IMMUNOL, V182, P3173, DOI 10.4049/jimmunol.0802367; Condemine W, 2006, CANCER RES, V66, P6192, DOI 10.1158/0008-5472.CAN-05-3792; Conway KE, 2000, CANCER RES, V60, P6236; Creagh EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005055; Dowling JK, 2012, CRIT REV BIOCHEM MOL, V47, P424, DOI 10.3109/10409238.2012.694844; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; FAGIOLI M, 1992, ONCOGENE, V7, P1083; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Geoffroy MC, 2011, J INTERF CYTOK RES, V31, P145, DOI 10.1089/jir.2010.0111; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Khare S, 2012, IMMUNITY, V36, P464, DOI 10.1016/j.immuni.2012.02.001; Kim HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026264; Lo YH, 2013, BLOOD, V121, P3185, DOI 10.1182/blood-2012-05-432104; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Masumoto J, 1999, J BIOL CHEM, V274, P33835, DOI 10.1074/jbc.274.48.33835; Matsushita K, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/287387; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; O'Riordan JM, 2005, AM J GASTROENTEROL, V100, P1257, DOI 10.1111/j.1572-0241.2005.41338.x; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Salomoni P, 2007, HISTOL HISTOPATHOL, V22, P937, DOI 10.14670/HH-22.937; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Yamamoto M, 2004, GENES CELLS, V9, P1055, DOI 10.1111/j.1365-2443.2004.00789.x; Zhu P, 2006, CELL, V124, P615, DOI 10.1016/j.cell.2005.12.032	31	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6429	6437		10.1074/jbc.M113.539692	http://dx.doi.org/10.1074/jbc.M113.539692			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24407287	Green Published, hybrid			2022-12-28	WOS:000332389400011
J	Dufort, FJ; Gumina, MR; Ta, NL; Tao, YZ; Heyse, SA; Scott, DA; Richardson, AD; Seyfried, TN; Chiles, TC				Dufort, Fay J.; Gumina, Maria R.; Ta, Nathan L.; Tao, Yongzhen; Heyse, Shannon A.; Scott, David A.; Richardson, Adam D.; Seyfried, Thomas N.; Chiles, Thomas C.			Glucose-dependent de Novo Lipogenesis in B Lymphocytes A REQUIREMENT FOR ATP-CITRATE LYASE IN LIPOPOLYSACCHARIDE-INDUCED DIFFERENTIATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetyl Coenzyme A; Cell Metabolism; Differentiation; Glucose Metabolism; Lipogenesis; Lipopolysaccharide (LPS)	FUNCTIONALLY RELATED PROTEINS; FATTY-ACID SYNTHASE; ENDOPLASMIC-RETICULUM; CELL DIFFERENTIATION; BRAIN LIPIDS; HUMAN CANCER; IN-VIVO; METABOLISM; MEMBRANE; GLYCOSYLATION	Background: The metabolic requirements underlying B lymphocyte differentiation are poorly understood. Results: Differentiation is accompanied by glucose metabolism into fatty acid and cholesterol synthesis, mediated by ATP-citrate lyase (ACLY). Conclusion: ACLY-dependent lipogenesis is required for several phenotypic changes defining plasma cell differentiation. Significance: This study proposes a critical role for ACLY coupled glucose-dependent de novo lipogenesis in LPS-induced B lymphocyte differentiation. Bacterially derived lipopolysaccharide (LPS) stimulates naive B lymphocytes to differentiate into immunoglobulin (Ig)-secreting plasma cells. Differentiation of B lymphocytes is characterized by a proliferative phase followed by expansion of the intracellular membrane secretory network to support Ig production. A key question in lymphocyte biology is how naive B cells reprogram metabolism to support de novo lipogenesis necessary for proliferation and expansion of the endomembrane network in response to LPS. We report that extracellularly acquired glucose is metabolized, in part, to support de novo lipogenesis in response to LPS stimulation of splenic B lymphocytes. LPS stimulation leads to increased levels of endogenous ATP-citrate lyase (ACLY), and this is accompanied by increased ACLY enzymatic activity. ACLY produces cytosolic acetyl-CoA from mitochondrially derived citrate. Inhibition of ACLY activity in LPS-stimulated B cells with the selective inhibitor 2-hydroxy-N-arylbenzenesulfonamide (compound-9; C-9) blocks glucose incorporation into de novo lipid biosynthesis, including cholesterol, free fatty acids, and neutral and acidic phospholipids. Moreover, inhibition of ACLY activity in splenic B cells results in inhibition of proliferation and defective endomembrane expansion and reduced expression of CD138 and Blimp-1, markers for plasma-like B cell differentiation. ACLY activity is also required for LPS-induced IgM production in CH12 B lymphoma cells. These data demonstrate that ACLY mediates glucose-dependent de novo lipogenesis in response to LPS signaling and identify a role for ACLY in several phenotypic changes that define plasma cell differentiation.	[Dufort, Fay J.; Gumina, Maria R.; Ta, Nathan L.; Heyse, Shannon A.; Seyfried, Thomas N.; Chiles, Thomas C.] Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA; [Tao, Yongzhen; Scott, David A.; Richardson, Adam D.] Sanford Burnham Med Res Inst La Jolla, La Jolla, CA 92037 USA	Boston College; Sanford Burnham Prebys Medical Discovery Institute	Chiles, TC (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA.	chilest@bc.edu	Richardson, Adam D/N-7845-2014	Richardson, Adam D/0000-0003-3646-2584; , Yongzhen/0000-0003-1710-5346; Scott, David/0000-0002-8668-2449; Seyfried, Thomas/0000-0003-1491-3989	National Institutes of Health [5R01AI074687]; Margaret Walsh Faculty Research Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Margaret Walsh Faculty Research Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01AI074687 (to T.C.C.). This work was also supported by the Margaret Walsh Faculty Research Fund (to T.C.C.)	Abramson HN, 2011, J MED CHEM, V54, P5615, DOI 10.1021/jm2005805; Baek RC, 2009, LIPIDS, V44, P197, DOI 10.1007/s11745-008-3268-0; Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Beigneux AP, 2004, J BIOL CHEM, V279, P9557, DOI 10.1074/jbc.M310512200; Berwick DC, 2002, J BIOL CHEM, V277, P33895, DOI 10.1074/jbc.M204681200; Brewer J. W., 2012, BIOCH RES INT; CALDER PC, 1994, BIOCHEM J, V300, P509, DOI 10.1042/bj3000509; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Chu KY, 2010, J BIOL CHEM, V285, P32606, DOI 10.1074/jbc.M110.157172; Chypre M, 2012, BIOCHEM BIOPH RES CO, V422, P1, DOI 10.1016/j.bbrc.2012.04.144; Costello LC, 2005, MOL CELL BIOCHEM, V280, P1, DOI 10.1007/s11010-005-8841-8; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Doughty CA, 2006, BLOOD, V107, P4458, DOI 10.1182/blood-2005-12-4788; Fagone P, 2007, J BIOL CHEM, V282, P7591, DOI 10.1074/jbc.M608175200; Fagone P, 2009, J BIOL CHEM, V284, P6847, DOI 10.1074/jbc.M807338200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Garcia-Manteiga JM, 2011, J PROTEOME RES, V10, P4165, DOI 10.1021/pr200328f; Goldfinger M, 2009, J IMMUNOL, V182, P7038, DOI 10.4049/jimmunol.0802990; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Hanai J, 2012, J CELL PHYSIOL, V227, P1709, DOI 10.1002/jcp.22895; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Icard P, 2012, BBA-REV CANCER, V1825, P111, DOI 10.1016/j.bbcan.2011.10.007; Joseph JW, 2007, J BIOL CHEM, V282, P31592, DOI 10.1074/jbc.M706080200; Karnell FG, 2005, J BIOL CHEM, V280, P25621, DOI 10.1074/jbc.M503162200; Kirk SJ, 2010, J LEUKOCYTE BIOL, V87, P245, DOI 10.1189/jlb.1208774; Krauss S, 2001, IMMUNITY, V15, P497, DOI 10.1016/S1074-7613(01)00205-9; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; LEE WNP, 1994, AM J PHYSIOL, V266, pE699, DOI 10.1152/ajpendo.1994.266.5.E699; Li JJ, 2007, BIOORG MED CHEM LETT, V17, P3208, DOI 10.1016/j.bmcl.2007.03.017; LINN TC, 1979, J BIOL CHEM, V254, P1691; Ma ZP, 2009, J LIPID RES, V50, P2131, DOI 10.1194/jlr.D900008-JLR200; MACALA LJ, 1983, J LIPID RES, V24, P1243; Maddaly R, 2010, FEBS LETT, V584, P4883, DOI 10.1016/j.febslet.2010.08.022; Mashima T, 2009, BRIT J CANCER, V100, P1369, DOI 10.1038/sj.bjc.6605007; McGehee AM, 2009, J IMMUNOL, V183, P3690, DOI 10.4049/jimmunol.0900953; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Migita T, 2008, CANCER RES, V68, P8547, DOI 10.1158/0008-5472.CAN-08-1235; Potapova IA, 2000, BIOCHEMISTRY-US, V39, P1169, DOI 10.1021/bi992159y; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Romijn EP, 2005, MOL CELL PROTEOMICS, V4, P1297, DOI 10.1074/mcp.M500123-MCP200; RUSH JS, 1991, ARCH BIOCHEM BIOPHYS, V284, P63, DOI 10.1016/0003-9861(91)90264-J; Schug ZT, 2012, ACTA ONCOL, V51, P301, DOI 10.3109/0284186X.2011.643823; Scott DA, 2011, J BIOL CHEM, V286, P42626, DOI 10.1074/jbc.M111.282046; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; SRERE PA, 1975, ADV ENZYMOL RAMB, V43, P57; SRERE PA, 1959, J BIOL CHEM, V234, P2544; STOCKDALE AM, 1987, J IMMUNOL, V139, P3527; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; WATSON JA, 1969, ARCH BIOCHEM BIOPHYS, V135, P209, DOI 10.1016/0003-9861(69)90532-3; WIEST DL, 1990, J CELL BIOL, V110, P1501, DOI 10.1083/jcb.110.5.1501; Yang C, 2008, METABOLOMICS, V4, P13, DOI 10.1007/s11306-007-0094-y; Yoo H, 2008, J BIOL CHEM, V283, P20621, DOI 10.1074/jbc.M706494200; Yoshii Y, 2009, CANCER SCI, V100, P821, DOI 10.1111/j.1349-7006.2009.01099.x; Zaidi N, 2012, CANCER RES, V72, P3709, DOI 10.1158/0008-5472.CAN-11-4112	58	97	98	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7011	7024		10.1074/jbc.M114.551051	http://dx.doi.org/10.1074/jbc.M114.551051			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24469453	Green Published, hybrid			2022-12-28	WOS:000332389400061
J	Sun, L; Li, P; Carr, AL; Gorsuch, R; Yarka, C; Li, JL; Bartlett, M; Pfister, D; Hyde, DR; Li, L				Sun, Lei; Li, Ping; Carr, Aprell L.; Gorsuch, Ryne; Yarka, Clare; Li, Jingling; Bartlett, Michael; Pfister, Delaney; Hyde, David R.; Li, Lei			Transcription of the SCL/TAL1 Interrupting Locus (Stil) Is Required for Cell Proliferation in Adult Zebrafish Retinas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Proliferation; Neurons; Oncogene; Retina; Zebrafish	GOLDFISH RETINA; SIL GENE; MULLER GLIA; DOPAMINERGIC-NEURONS; REGENERATION; EXPRESSION; ROD; 6-HYDROXYDOPAMINE; PROGENITORS; LEUKEMIA	Background:Stil is a human oncogene that is involved in cancer cell proliferation and survival. Results: In adult zebrafish retinas, knockdown of Stil expression decreases the rate of cell proliferation after degeneration. Conclusion: Through the Shh signal transduction pathway, Stil plays important roles in regulating cell proliferation. Significance: The results uncover a novel function of Stil in adult tissues, namely neural regeneration. The human oncogene SCL/TAL1 interrupting locus (Stil) is highly conserved in vertebrate species. Previously, we identified a homolog of the Stil gene in zebrafish mutant (night blindness b, nbb), which showed neural defects in the retina (e.g. dopaminergic cell degeneration and/or lack of regeneration). In this research, we examined the roles of Stil in cell proliferation after degeneration in adult zebrafish retinas. We demonstrated that knockdown of Stil gene expression or inhibition of Sonic hedgehog (Shh) signaling transduction decreases the rate of cell proliferation. In contrast, activation of Shh signal transduction promotes cell proliferation. In nbb(+/-) retinas, inhibition of SUFU (a repressor in the Shh pathway) rescues the defects in cell proliferation due to down-regulation of Stil gene expression. The latter data suggest that Stil play a role in cell proliferation through the Shh signal transduction pathway.	[Sun, Lei; Li, Ping; Carr, Aprell L.; Gorsuch, Ryne; Yarka, Clare; Li, Jingling; Bartlett, Michael; Pfister, Delaney; Hyde, David R.; Li, Lei] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Carr, Aprell L.; Gorsuch, Ryne; Li, Jingling; Hyde, David R.; Li, Lei] Univ Notre Dame, Ctr Zebrafish Res, Notre Dame, IN 46556 USA; [Sun, Lei] Nankai Univ, Dept Physiol, Tianjin 370001, Peoples R China	University of Notre Dame; University of Notre Dame; Nankai University	Li, L (corresponding author), 100 Galvin Life Sci Bldg, Notre Dame, IN 46556 USA.	Li.78@nd.edu	Li, Lei/F-5722-2015	Li, Lei/0000-0001-9703-2102	National Institutes of Health [R01-EY013147, R01-EY018417]; Chinese Natural Science Foundation [81171066]; Tianjin Science and Technology Grant [12JCZDJC24000]; University of Notre Dame Center for Zebrafish Research; NATIONAL EYE INSTITUTE [R01EY018417, R01EY013147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Tianjin Science and Technology Grant; University of Notre Dame Center for Zebrafish Research; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-EY013147 and R01-EY018417, Chinese Natural Science Foundation Grant 81171066, Tianjin Science and Technology Grant 12JCZDJC24000, and the University of Notre Dame Center for Zebrafish Research.	APLAN PD, 1990, SCIENCE, V250, P1426, DOI 10.1126/science.2255914; APLAN PD, 1991, MOL CELL BIOL, V11, P5462, DOI 10.1128/MCB.11.11.5462; Arquint C, 2012, J CELL SCI, V125, P1342, DOI 10.1242/jcs.099887; Biehlmaier O, 2007, INVEST OPHTH VIS SCI, V48, P2887, DOI 10.1167/iovs.06-1212; BRAISTED JE, 1992, DEVELOPMENT, V114, P913; BRAISTED JE, 1994, DEVELOPMENT, V120, P2409; BRAISTED JE, 1993, DEV BRAIN RES, V76, P221, DOI 10.1016/0165-3806(93)90210-2; Brockerhoff SE, 2011, CELL MOL LIFE SCI, V68, P651, DOI 10.1007/s00018-010-0563-8; Buttner A, 2012, REPROD TOXICOL, V33, P254, DOI 10.1016/j.reprotox.2011.12.010; Campaner S, 2005, MOL CELL BIOL, V25, P6660, DOI 10.1128/MCB.25.15.6660-6672.2005; Castiel A, 2011, J CELL SCI, V124, P532, DOI 10.1242/jcs.079731; COHEN JL, 1983, BRAIN RES, V264, P307, DOI 10.1016/0006-8993(83)90830-2; CollazoGarcia N, 1995, GENOMICS, V30, P506, DOI 10.1006/geno.1995.1271; Craig SEL, 2010, INVEST OPHTH VIS SCI, V51, P3244, DOI 10.1167/iovs.09-4879; Curry JD, 2003, LEUKEMIA RES, V27, P575, DOI 10.1016/S0145-2126(02)00260-6; Erez A, 2007, CANCER RES, V67, P4022, DOI 10.1158/0008-5472.CAN-07-0064; Feijoo CG, 2011, EUR J NEUROSCI, V33, P589, DOI 10.1111/j.1460-9568.2010.07560.x; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; Gosse NJ, 2009, P NATL ACAD SCI USA, V106, P2236, DOI 10.1073/pnas.0803202106; HITCHCOCK PF, 1994, VISUAL NEUROSCI, V11, P209, DOI 10.1017/S0952523800001577; Izraeli S, 2001, GENESIS, V31, P72, DOI 10.1002/gene.10004; Izraeli S, 1999, NATURE, V399, P691, DOI 10.1038/21429; Izraeli S, 1997, CELL GROWTH DIFFER, V8, P1171; Jusuf PR, 2011, J NEUROSCI, V31, P2549, DOI 10.1523/JNEUROSCI.4713-10.2011; Kasai K, 2008, CANCER RES, V68, P7723, DOI 10.1158/0008-5472.CAN-07-6661; Li JL, 2013, J BIOL CHEM, V288, P886, DOI 10.1074/jbc.M112.417089; Li L, 2000, J NEUROSCI, V20, P1883; Li L, 2000, J NEUROSCI, V20, P1893; Link BA, 2001, DEV BIOL, V236, P436, DOI 10.1006/dbio.2001.0340; Morris AC, 2008, DEV NEUROBIOL, V68, P605, DOI 10.1002/dneu.20610; NEGISHI K, 1991, CELL MOL NEUROBIOL, V11, P639, DOI 10.1007/BF00741451; NEGISHI K, 1985, DEV BRAIN RES, V20, P291, DOI 10.1016/0165-3806(85)90117-8; O'Neil J, 2004, CANCER CELL, V5, P587, DOI 10.1016/j.ccr.2004.05.023; Pfaff KL, 2007, MOL CELL BIOL, V27, P5887, DOI 10.1128/MCB.00175-07; Powell C, 2012, J NEUROSCI, V32, P1096, DOI 10.1523/JNEUROSCI.5603-11.2012; Qin Zhao, 2012, Methods Mol Biol, V884, P255, DOI 10.1007/978-1-61779-848-1_18; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; Stenkamp DL, 2011, PROG RETIN EYE RES, V30, P395, DOI 10.1016/j.preteyeres.2011.06.004; Sugiyama M, 2009, P NATL ACAD SCI USA, V106, P20812, DOI 10.1073/pnas.0906464106; Tang CJC, 2011, EMBO J, V30, P4790, DOI 10.1038/emboj.2011.378; Thummel R, 2008, EXP EYE RES, V87, P433, DOI 10.1016/j.exer.2008.07.009; Thummel R, 2008, DEV NEUROBIOL, V68, P392, DOI 10.1002/dneu.20596; Tyler MJ, 2005, J NEUROSCI, V25, P4565, DOI 10.1523/JNEUROSCI.0588-05.2005; Vihtelic TS, 2000, J NEUROBIOL, V44, P289, DOI 10.1002/1097-4695(20000905)44:3<289::AID-NEU1>3.0.CO;2-H; Vulprecht J, 2012, J CELL SCI, V125, P1353, DOI 10.1242/jcs.104109; WATLING KJ, 1982, BRAIN RES, V253, P334, DOI 10.1016/0006-8993(82)90704-1; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Wong KS, 2012, DEV BIOL, V361, P377, DOI 10.1016/j.ydbio.2011.11.004; Zhang XM, 2009, BREAST CANCER RES TR, V115, P505, DOI 10.1007/s10549-008-0093-3	49	12	13	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6934	6940		10.1074/jbc.M113.506295	http://dx.doi.org/10.1074/jbc.M113.506295			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24469449	Green Published, hybrid			2022-12-28	WOS:000332389400053
J	Yoo, JE; Park, YN; Oh, BK				Yoo, Jeong Eun; Park, Young Nyun; Oh, Bong-Kyeong			PinX1, a Telomere Repeat-binding Factor 1 (TRF1)-interacting Protein, Maintains Telomere Integrity by Modulating TRF1 Homeostasis, the Process in Which Human Telomerase Reverse Transcriptase (hTERT) Plays Dual Roles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Damage Response; Telomerase; Telomeres; Tumor Cell Biology; Tumor Suppressor Gene; DNA Damage Response; TERT; Chromosomal Instability; Telomere Deficiency; Telomeric Repeat-binding Factor 1	IMMORTAL CELLS; CANCER; FIBROBLASTS; STABILIZES; ACTIVATION; COMPLEX; LENGTH	Background: PinX1 interacts with TRF1 and hTERT, but the significance of the physical association is not fully understood. Results: PinX1 is involved in chromosome stability by regulating TRF1 protein stability, and the function of PinX1 is linked to hTERT. Conclusion: PinX1 is functionally connected with hTERT to maintain TRF1 stability. Significance: These findings suggest that a TRF1 turnover mechanism is linked to telomerase. TRF1, a telomere-binding protein, is important for telomere protection and homeostasis. PinX1 interacts with TRF1, but the physiological consequences of their interaction in telomere protection are not yet understood. Here we investigated PinX1 function on TRF1 stability in HeLa cells. PinX1 overexpression stabilized TRF1, but PinX1 depletion by siRNA led to TRF1 degradation, TRF1 ubiquitination, and less TRF1 telomere association. The depletion also induced DNA damage responses at telomeres and chromosome instability. These telomere dysfunctional phenotypes were in fact due to TRF1 deficiency. We also report that hTERT, a catalytic component of telomerase, plays dual roles in the TRF1 steady state pathway. PinX1-mediated TRF1 stability was not observed in hTERT-negative immortal cells, but was pronounced when hTERT was ectopically expressed in the cells, suggesting that hTERT may be needed in the PinX1-mediated TRF1 stability pathway. Interestingly, the knockdown of both PinX1 and hTERT in HeLa cells stabilized TRF1, suppressed DNA damage response activation, and restored chromosome stability. In summary, our findings suggested that PinX1 may maintain telomere integrity by regulating TRF1 stability and that hTERT may act as both a positive and a negative regulator of TRF1 homeostasis in a PinX1-dependent manner.	[Yoo, Jeong Eun; Park, Young Nyun] Yonsei Univ, Coll Med, Dept Pathol, Brain Korea PLUS Project Med Sci 21, Seoul 120752, South Korea; [Park, Young Nyun] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul 120752, South Korea; [Oh, Bong-Kyeong] Hanyang Univ, Coll Med, Inst Med Sci, Dept Obstet & Gynecol, Seoul 133791, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Hanyang University	Park, YN (corresponding author), Yonsei Univ, Coll Med, Dept Pathol, Brain Korea PLUS Project Med Sci 21, 250 Seongsan Ro, Seoul 120752, South Korea.	young0608@yuhs.ac; bongoh0401@hanyang.ac.kr		Park, Young Nyun/0000-0003-0357-7967	National Research Foundation of Korea [2013R1A2A2A05005990, 2012M3A9B6055350, 2011-0030086, 2010-0008254, 2011-0015638]; Ministry of Education, Science and Technology	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by National Research Foundation of Korea Grants 2013R1A2A2A05005990, 2012M3A9B6055350, and 2011-0030086 (to Y.N.P.) and 2010-0008254 and 2011-0015638 (to B.K.O.) funded by the Ministry of Education, Science and Technology.	Ancelin K, 2002, MOL CELL BIOL, V22, P3474, DOI 10.1128/MCB.22.10.3474-3487.2002; Autexier C, 1996, TRENDS BIOCHEM SCI, V21, P387, DOI 10.1016/S0968-0004(96)90128-0; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Chen GM, 2011, GASTROENTEROLOGY, V140, P332, DOI 10.1053/j.gastro.2010.08.046; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; Collins K, 2000, CURR OPIN CELL BIOL, V12, P378, DOI 10.1016/S0955-0674(00)00103-4; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 1998, SCIENCE, V279, P334, DOI 10.1126/science.279.5349.334; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Iwano T, 2004, J BIOL CHEM, V279, P1442, DOI 10.1074/jbc.M309138200; Jung AR, 2013, ANTICANCER RES, V33, P821; Karlseder J, 2003, MOL CELL BIOL, V23, P6533, DOI 10.1128/MCB.23.18.6533-6541.2003; Kim MK, 2008, J BIOL CHEM, V283, P14144, DOI 10.1074/jbc.M710065200; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Lackner DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021407; Lee TH, 2009, NAT CELL BIOL, V11, P97, DOI 10.1038/ncb1818; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Nakayama JI, 1998, NAT GENET, V18, P65, DOI 10.1038/ng0198-65; Okamoto K, 2008, J BIOL CHEM, V283, P23981, DOI 10.1074/jbc.M802395200; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Soohoo CY, 2011, J BIOL CHEM, V286, P3894, DOI 10.1074/jbc.M110.180174; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Yonekawa T, 2012, MOL CELL BIOL, V32, P1387, DOI 10.1128/MCB.05641-11; Yoo JE, 2009, J MOL BIOL, V388, P928, DOI 10.1016/j.jmb.2009.02.051; Zhou XZ, 2011, J CLIN INVEST, V121, P1266, DOI 10.1172/JCI43452; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4; Zhu QB, 2009, J CELL BIOL, V185, P827, DOI 10.1083/jcb.200812121	32	14	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6886	6898		10.1074/jbc.M113.506006	http://dx.doi.org/10.1074/jbc.M113.506006			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24415760	Green Published, hybrid			2022-12-28	WOS:000332389400049
J	Patzina, C; Haller, O; Kochs, G				Patzina, Corinna; Haller, Otto; Kochs, Georg			Structural Requirements for the Antiviral Activity of the Human MxA Protein against Thogoto and Influenza A Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antiviral Agents; GTPase; Influenza Virus; Innate Immunity; Interferon; MxA; Dynamin; Myxovirus Resistance	RESISTANCE GENE; GTPASE; SPECIFICITY; SENSITIVITY; LOCALIZES; INHIBITOR; INFECTION; DOMAIN	Background: Interferon-induced human MxA GTPase is an innate immunity factor with broad antiviral activity. Results: Antiviral specificity against orthomyxoviruses (influenza A and Thogoto viruses) is determined by a bipartite element in disordered loop L4. Conclusion: A few critical amino acids allow multiple antiviral conformations of L4. Significance: The MxA antiviral interface may provide clues for the design of novel antivirals. The interferon-induced dynamin-like MxA protein has broad antiviral activity against many viruses, including orthomyxoviruses such as influenza A and Thogoto virus and bunyaviruses such as La Crosse virus. MxA consists of an N-terminal globular GTPase domain, a connecting bundle signaling element, and the C-terminal stalk that mediates oligomerization and antiviral specificity. We previously reported that the disordered loop L4 that protrudes from the compact stalk is a key determinant of antiviral specificity against influenza A and Thogoto virus. However, the role of individual amino acids for viral target recognition remained largely undefined. By mutational analyses, we identified two regions in the C-terminal part of L4 that contribute to an antiviral interface. Mutations in the proximal motif, at positions 561 and 562, abolished antiviral activity against orthomyxoviruses but not bunyaviruses. In contrast, mutations in the distal motif, around position 577, abolished antiviral activity against both viruses. These results indicate that at least two structural elements in L4 are responsible for antiviral activity and that the proximal motif determines specificity for orthomyxoviruses, whereas the distal sequence serves a conserved structural function.	[Patzina, Corinna; Haller, Otto; Kochs, Georg] Univ Freiburg, Inst Virol, D-79008 Freiburg, Germany	University of Freiburg	Kochs, G (corresponding author), Univ Med Ctr, Inst Virol, Hermann Herder Str 11, D-79104 Freiburg, Germany.	georg.kochs@uniklinik-freiburg.de			Deutsche Forschungsgemeinschaft [Ko 1579/8-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft Grant Ko 1579/8-2 (to G. K.).	Accola MA, 2002, J BIOL CHEM, V277, P21829, DOI 10.1074/jbc.M201641200; Dittmann J, 2008, J VIROL, V82, P3624, DOI 10.1128/JVI.01753-07; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Gao S, 2011, IMMUNITY, V35, P514, DOI 10.1016/j.immuni.2011.07.012; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; HALLER O, 1995, J VIROL, V69, P2596, DOI 10.1128/JVI.69.4.2596-2601.1995; Haller O, 2013, CELL HOST MICROBE, V14, P371, DOI 10.1016/j.chom.2013.10.002; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; Kochs G, 2002, J BIOL CHEM, V277, P14172, DOI 10.1074/jbc.M200244200; Kochs G, 2000, J VIROL, V74, P10785, DOI 10.1128/JVI.74.22.10785-10789.2000; Kochs G, 1999, J BIOL CHEM, V274, P4370, DOI 10.1074/jbc.274.7.4370; Kochs G, 2002, P NATL ACAD SCI USA, V99, P3153, DOI 10.1073/pnas.052430399; Kochs G, 1999, P NATL ACAD SCI USA, V96, P2082, DOI 10.1073/pnas.96.5.2082; Liu ZL, 2013, CELL HOST MICROBE, V14, P398, DOI 10.1016/j.chom.2013.08.015; Lutz A, 2005, J VIROL METHODS, V126, P13, DOI 10.1016/j.jviromet.2005.01.016; Manz B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003279; Matzinger SR, 2013, J VIROL, V87, P1150, DOI 10.1128/JVI.02271-12; Mitchell PS, 2013, CURR OPIN MICROBIOL, V16, P493, DOI 10.1016/j.mib.2013.04.005; Mitchell PS, 2012, CELL HOST MICROBE, V12, P598, DOI 10.1016/j.chom.2012.09.005; PAVLOVIC J, 1992, J VIROL, V66, P2564, DOI 10.1128/JVI.66.4.2564-2569.1992; Reichelt M, 2004, TRAFFIC, V5, P772, DOI 10.1111/j.1600-0854.2004.00219.x; Stertz S, 2006, J INTERF CYTOK RES, V26, P650, DOI 10.1089/jir.2006.26.650; THOMPSON WH, 1965, AM J EPIDEMIOL, V81, P245, DOI 10.1093/oxfordjournals.aje.a120512; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Verhelst J, 2012, J VIROL, V86, P13445, DOI 10.1128/JVI.01682-12; von der Malsburg A, 2011, J BIOL CHEM, V286, P37858, DOI 10.1074/jbc.M111.249037; Xiao H, 2013, J VIROL, V87, P13053, DOI 10.1128/JVI.02220-13; Zimmermann P, 2011, J VIROL, V85, P8133, DOI 10.1128/JVI.00712-11	30	43	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6020	6027		10.1074/jbc.M113.543892	http://dx.doi.org/10.1074/jbc.M113.543892			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24448803	hybrid, Green Published			2022-12-28	WOS:000332015500057
J	Sobierajska, K; Skurzynski, S; Stasiak, M; Kryczka, J; Cierniewski, CS; Swiatkowska, M				Sobierajska, Katarzyna; Skurzynski, Szymon; Stasiak, Marta; Kryczka, Jakub; Cierniewski, Czeslaw S.; Swiatkowska, Maria			Protein Disulfide Isomerase Directly Interacts with beta-Actin Cys(374) and Regulates Cytoskeleton Reorganization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Adhesion; Cytoskeleton; Disulfide; Thiol	S-GLUTATHIONYLATION; REDOX REGULATION; CELL-ADHESION; POLYMERIZATION; ISOMERIZATION; ASSOCIATION; ACTIVATION; OXIDATION; INTEGRIN; SURFACE	Background: PDI regulates cytoskeleton reorganization by the thiol-disulfide exchange in -actin. Results: PDI directly binds to Cys(374) of -actin during cell adhesion and spreading. Conclusion: Interaction of PDI with -actin is induced by integrin-mediated cell adhesion and promotes cytoskeleton reorganization. Significance: PDI is a new regulator of the intramolecular disulfide-thiol rearrangement of -actin in response to IIb3 integrin engagement. Recent studies support the role of cysteine oxidation in actin cytoskeleton reorganization during cell adhesion. The aim of this study was to explain whether protein disulfide isomerase (PDI) is responsible for the thiol-disulfide rearrangement in the -actin molecule of adhering cells. First, we showed that PDI forms a disulfide-bonded complex with -actin with a molecular mass of 110 kDa. Specific interaction of both proteins was demonstrated by a solid phase binding assay, surface plasmon resonance analysis, and immunoprecipitation experiments. Second, using confocal microscopy, we found that both proteins colocalized when spreading MEG-01 cells on fibronectin. Colocalization of PDI and -actin could be abolished by the membrane-permeable sulfhydryl blocker, N-ethylmaleimide, by the RGD peptide, and by anti-IIb3 antibodies. Consequently, down-regulation of PDI expression by antisense oligonucleotides impaired the spreading of cells and initiated reorganization of the cytoskeleton. Third, because of transfection experiments followed by immunoprecipitation and confocal analysis, we provided evidence that PDI binds to the -actin Cys(374) thiol. Formation of the -actin-PDI complex was mediated by integrin-dependent signaling in response to the adhesion of cells to the extracellular matrix. Our data suggest that PDI is released from subcellular compartments to the cytosol and translocated toward the periphery of the cell, where it forms a disulfide bond with -actin when MEG-01 cells adhere via the IIb3 integrin to fibronectin. Thus, PDI appears to regulate cytoskeletal reorganization by the thiol-disulfide exchange in -actin via a redox-dependent mechanism.	[Sobierajska, Katarzyna; Skurzynski, Szymon; Stasiak, Marta; Kryczka, Jakub; Cierniewski, Czeslaw S.; Swiatkowska, Maria] Med Univ Lodz, Dept Mol & Med Biophys, PL-92215 Lodz, Poland; [Kryczka, Jakub; Cierniewski, Czeslaw S.] Polish Acad Sci, Inst Med Biol, PL-93232 Lodz, Poland	Medical University Lodz; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences	Swiatkowska, M (corresponding author), Med Univ Lodz, Dept Mol & Med Biophys, 6-8 Mazowiecka St, PL-92215 Lodz, Poland.	maria.swiatkowska@umed.lodz.pl	Sobierajska, Katarzyna/S-6650-2016	Sobierajska, Katarzyna/0000-0003-3510-0098; Kryczka, Jakub/0000-0002-5719-4139	Polish National Science Center [N401 140939]; National Science Center [2011/02/A/NZ3/00068]	Polish National Science Center; National Science Center(National Science Centre, Poland)	This work was supported by Project N401 140939 from the Polish National Science Center (to M. S.).; Supported by Project 2011/02/A/NZ3/00068 from the National Science Center.	Chiarugi P, 2007, CELL SIGNAL, V19, P672, DOI 10.1016/j.cellsig.2006.11.009; Dalle-Donne I, 2005, FREE RADICAL BIO MED, V38, P1501, DOI 10.1016/j.freeradbiomed.2005.02.019; Dalle-Donne I, 2003, FREE RADICAL BIO MED, V34, P23, DOI 10.1016/S0891-5849(02)01182-6; Dalle-Donne I, 2008, ANTIOXID REDOX SIGN, V10, P445, DOI 10.1089/ars.2007.1716; Dugina V, 2009, J CELL SCI, V122, P2980, DOI 10.1242/jcs.041970; Essex DW, 2003, BIOCHEMISTRY-US, V42, P129, DOI 10.1021/bi0205045; ESSEX DW, 1995, BLOOD, V86, P2168, DOI 10.1182/blood.V86.6.2168.bloodjournal8662168; FARWELL AP, 1990, J BIOL CHEM, V265, P18546; Fiaschi T, 2006, J BIOL CHEM, V281, P22983, DOI 10.1074/jbc.M603040200; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; HINSHAW DB, 1991, ARCH BIOCHEM BIOPHYS, V288, P311, DOI 10.1016/0003-9861(91)90200-3; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jasuja R, 2010, BLOOD, V116, P4665, DOI 10.1182/blood-2010-04-278184; Lassing I, 2007, J MOL BIOL, V370, P331, DOI 10.1016/j.jmb.2007.04.056; Laurindo FRM, 2012, FREE RADICAL BIO MED, V52, P1954, DOI 10.1016/j.freeradbiomed.2012.02.037; Lopez-Mirabal HR, 2008, BBA-MOL CELL RES, V1783, P629, DOI 10.1016/j.bbamcr.2007.10.013; Noiva R, 1999, SEMIN CELL DEV BIOL, V10, P481, DOI 10.1006/scdb.1999.0319; OGURA M, 1985, BLOOD, V66, P1384; OMANN GM, 1994, ARCH BIOCHEM BIOPHYS, V308, P407, DOI 10.1006/abbi.1994.1057; Paes AMD, 2011, J LEUKOCYTE BIOL, V90, P799, DOI 10.1189/jlb.0610324; Peltoniemi MJ, 2006, J BIOL CHEM, V281, P33107, DOI 10.1074/jbc.M605602200; Reinhardt C, 2008, J CLIN INVEST, V118, P1110, DOI 10.1172/JCI32376; RUOPPOLO M, 1995, BIOCHEMISTRY-US, V34, P9380, DOI 10.1021/bi00029a014; Ruoppolo M, 1996, BIOCHEMISTRY-US, V35, P13636, DOI 10.1021/bi960755b; SAFRAN M, 1992, ENDOCRINOLOGY, V131, P2413, DOI 10.1210/en.131.5.2413; STOURNARAS C, 1990, ANTICANCER RES, V10, P1651; Swiatkowska M, 2008, FEBS J, V275, P1813, DOI 10.1111/j.1742-4658.2008.06339.x; Tang JX, 1999, BIOPHYS J, V76, P2208, DOI 10.1016/S0006-3495(99)77376-5; Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsapara A, 1999, FEBS LETT, V455, P117, DOI 10.1016/S0014-5793(99)00848-0; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Zai A, 1999, J CLIN INVEST, V103, P393, DOI 10.1172/JCI4890	33	38	38	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5758	5773		10.1074/jbc.M113.479477	http://dx.doi.org/10.1074/jbc.M113.479477			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24415753	Green Published, hybrid			2022-12-28	WOS:000332015500036
J	Guo, MH; Vidhyasagar, V; Ding, H; Wu, YL				Guo, Manhong; Vidhyasagar, Venkatasubramanian; Ding, Hao; Wu, Yuliang			Insight into the Roles of Helicase Motif Ia by Characterizing Fanconi Anemia Group J Protein ( FANCJ) Patient Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Helicase; DNA Repair; Enzymes; Mutant; Pathogenesis; FANCJ; Fanconi Anemia; Helicase; Motif Ia	FAMILIAL BREAST-CANCER; DNA-REPAIR FUNCTION; G-QUADRUPLEX DNA; SINGLE-STRANDED-DNA; CROSS-LINK REPAIR; INACTIVATING MUTATIONS; CRYSTAL-STRUCTURES; BINDING PROTEIN; OVARIAN-CANCER; BACH1	Background: Two Fanconi anemia patient missense mutations are localized in FANCJ helicase motif Ia. Results: Mutant R251C impairs the DNA binding ability of FANCJ; Q255H uncouples DNA translocation from helicase activity. Conclusion: Helicase motif Ia plays critical roles in FANCJ enzymatic activity and DNA repair. Significance: Helicase motif Ia is involved not only in nucleic acid binding but also ATP binding and coupling ATP hydrolysis to unwinding. Helicases are molecular motors that couple the energy of ATP hydrolysis to the unwinding and remodeling of structured DNA or RNA, which is coordinated by conserved helicase motifs. FANCJ is a DNA helicase that is genetically linked to Fanconi anemia, breast cancer, and ovarian cancer. Here, we characterized two Fanconi anemia patient mutations, R251C and Q255H, that are localized in helicase motif Ia. Our genetic complementation analysis revealed that both the R251C and Q255H alleles failed to rescue cisplatin sensitivity of a FANCJ null cell line as detected by cell survival or -H2AX foci formation. Furthermore, our biochemical assays demonstrated that both purified recombinant proteins abolished DNA helicase activity and failed to disrupt the DNA-protein complex. Intriguingly, R251C impaired DNA binding ability to single-strand DNA and double-strand DNA, whereas Q255H retained higher binding activity to these DNA substrates compared with wild-type FANCJ protein. Consequently, R251C abolished its DNA-dependent ATP hydrolysis activity, whereas Q255H retained normal ATPase activity. Physically, R251C had reduced ATP binding ability, whereas Q255H had normal ATP binding ability and could translocate on single-strand DNA. Although both proteins were recruited to damage sites in our laser-activated confocal assays, they lost their DNA repair function, which explains why they exerted a domain negative effect when expressed in a wild-type background. Taken together, our work not only reveals the structural function of helicase motif Ia but also provides the molecular pathology of FANCJ in related diseases.	[Guo, Manhong; Vidhyasagar, Venkatasubramanian; Ding, Hao; Wu, Yuliang] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan	Wu, YL (corresponding author), Univ Saskatchewan, Dept Biochem, Hlth Sci Bldg,107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	Yuliang.wu@usask.ca	Vidhyasagar, Venkatasubramanian/M-9442-2013	Vidhyasagar, Venkatasubramanian/0000-0001-8679-4021	Saskatchewan Health Research Foundation; Natural Sciences and Engineering Research Council of Canada; Canadian Breast Cancer Foundation	Saskatchewan Health Research Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS))	This work was supported, in whole or in part, by the Saskatchewan Health Research Foundation, the Natural Sciences and Engineering Research Council of Canada, and the Canadian Breast Cancer Foundation (to Y.W.).	Bernstein KA, 2010, ANNU REV GENET, V44, P393, DOI 10.1146/annurev-genet-102209-163602; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cao AY, 2009, BREAST CANCER RES TR, V115, P51, DOI 10.1007/s10549-008-0052-z; Chang TH, 1997, NUCLEIC ACIDS RES, V25, P5033, DOI 10.1093/nar/25.24.5033; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Dillingham MS, 2011, BIOCHEM SOC T, V39, P413, DOI 10.1042/BST0390413; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Frank B, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-83; Gong ZH, 2010, MOL CELL, V37, P438, DOI 10.1016/j.molcel.2010.01.002; Gross CH, 1998, J VIROL, V72, P4729, DOI 10.1128/JVI.72.6.4729-4736.1998; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Gupta R, 2007, BLOOD, V110, P2390, DOI 10.1182/blood-2006-11-057273; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Kumaraswamy E, 2007, MOL CELL BIOL, V27, P6733, DOI 10.1128/MCB.00961-07; Kuper J, 2012, EMBO J, V31, P494, DOI 10.1038/emboj.2011.374; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Lewis AG, 2005, BREAST CANCER RES, V7, pR1005, DOI 10.1186/bcr1336; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; London TBC, 2008, J BIOL CHEM, V283, P36132, DOI 10.1074/jbc.M808152200; Marintcheva B, 2003, J VIROL, V77, P2477, DOI 10.1128/JVI.77.4.2477-2488.2003; Peng M, 2007, EMBO J, V26, P3238, DOI 10.1038/sj.emboj.7601754; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; Rutter JL, 2003, HUM MUTAT, V22, P121, DOI 10.1002/humu.10238; Sarkies P, 2012, NUCLEIC ACIDS RES, V40, P1485, DOI 10.1093/nar/gkr868; Satapathy AK, 2008, FEBS J, V275, P1835, DOI 10.1111/j.1742-4658.2008.06342.x; Schneider S, 2004, J BIOL CHEM, V279, P8617, DOI 10.1074/jbc.M312715200; Schwab RA, 2013, J CELL BIOL, V201, P33, DOI 10.1083/jcb.201208009; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Sigurdson AJ, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-9; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sommers JA, 2009, J BIOL CHEM, V284, P7505, DOI 10.1074/jbc.M809019200; Suhasini AN, 2013, MOL CELL BIOL, V33, P2212, DOI 10.1128/MCB.01256-12; Suhasini AN, 2011, EMBO J, V30, P692, DOI 10.1038/emboj.2010.362; Tanaka N, 2006, BIOCHEMISTRY-US, V45, P6510, DOI 10.1021/bi052656g; Vahteristo P, 2005, BMC CANCER, V6, P1, DOI 10.1186/1471-2407-6-19; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Wolski SC, 2008, PLOS BIOL, V6, P1332, DOI 10.1371/journal.pbio.0060149; Wu Y, 2009, CELL MOL LIFE SCI, V66, P1209, DOI 10.1007/s00018-008-8580-6; Wu YL, 2008, MOL CELL BIOL, V28, P4116, DOI 10.1128/MCB.02210-07; Wu YL, 2012, J BIOL CHEM, V287, P21699, DOI 10.1074/jbc.M112.351338; Wu YL, 2010, BLOOD, V116, P3780, DOI 10.1182/blood-2009-11-256016; Wu YL, 2010, CELL CYCLE, V9, P4080, DOI 10.4161/cc.9.20.13667; Wu YL, 2009, CURR MOL MED, V9, P470, DOI 10.2174/156652409788167159; Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463	56	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10551	10565		10.1074/jbc.M113.538892	http://dx.doi.org/10.1074/jbc.M113.538892			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24573678	hybrid, Green Published			2022-12-28	WOS:000334226400028
J	Kobayashi, N; Tamura, N; van Veen, HW; Yamaguchi, A; Murakami, S				Kobayashi, Naoki; Tamura, Norihisa; van Veen, Hendrik W.; Yamaguchi, Akihito; Murakami, Satoshi			beta-Lactam Selectivity of Multidrug Transporters AcrB and AcrD Resides in the Proximal Binding Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotic Resistance; Drug Resistance; Membrane Proteins; Membrane Transport; Multidrug Transporters	GRAM-NEGATIVE BACTERIA; RESISTANCE PROTEIN ABCG2; LARGE PERIPLASMIC LOOPS; EFFLUX PUMP ACRB; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; EXPORTER ACRB; SUBSTRATE-SPECIFICITY; CLONING VECTORS; MECHANISM	Background: Bacterial multidrug transporters AcrB and AcrD export -lactam antibiotics. Results: Charged residues in the proximal binding pocket play a crucial role in -lactam selectivity. Conclusion: Proximal pocket acts as a substrate selection filter at the site of entry into the substrate translocation pathway. Significance: Our understanding of molecular mechanisms of antibiotic recognition is essential for overcoming drug resistance. -Lactams are mainstream antibiotics that are indicated for the prophylaxis and treatment of bacterial infections. The AcrA-AcrD-TolC multidrug efflux system confers much stronger resistance on Escherichia coli to clinically relevant anionic -lactam antibiotics than the homologous AcrA-AcrB-TolC system. Using an extensive combination of chimeric analysis and site-directed mutagenesis, we searched for residues that determine the difference in -lactam specificity between AcrB and AcrD. We identified three crucial residues at the proximal (or access) substrate binding pocket. The simultaneous replacement of these residues in AcrB by those in AcrD (Q569R, I626R, and E673G) transferred the -lactam specificity of AcrD to AcrB. Our findings indicate for the first time that the difference in -lactam specificity between AcrB and AcrD relates to interactions of the antibiotic with residues in the proximal binding pocket.	[Kobayashi, Naoki; Tamura, Norihisa; Yamaguchi, Akihito; Murakami, Satoshi] Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Ibaraki, Osaka 5670047, Japan; [Kobayashi, Naoki] Teikyo Heisei Univ, Fac Pharmaceut Sci, Nakano Ku, Tokyo 1648530, Japan; [Kobayashi, Naoki; Tamura, Norihisa; Yamaguchi, Akihito] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [van Veen, Hendrik W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Murakami, Satoshi] Tokyo Inst Technol, Dept Life Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan	Osaka University; Osaka University; University of Cambridge; Tokyo Institute of Technology	Murakami, S (corresponding author), Tokyo Inst Technol, Dept Life Sci, Midori Ku, Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.	murakami@bio.titech.ac.jp	Murakami, Satoshi/E-8155-2015; van Veen, Hendrik W./A-4162-2008	Murakami, Satoshi/0000-0001-5553-7663; van Veen, Hendrik W./0000-0002-9658-8077	Ministry of Education, Culture, Sports, Science and Technology of Japan; Next Generation World-Leading Researchers (NEXT Program); Japan Society for the Promotion of Science (JSPS); Japan Science and Technology Agency (JST); Advanced Research for Medical Products Mining Programme of the National Institute of Biomedical Innovation (NIBIO), Japan; Strategic International Cooperative Program (JST, Japan); Royal Society (UK); International Human Frontier Science Program Organization (HFSPO); BBSRC [BB/K017713/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K017713/1] Funding Source: researchfish	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Next Generation World-Leading Researchers (NEXT Program); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Advanced Research for Medical Products Mining Programme of the National Institute of Biomedical Innovation (NIBIO), Japan; Strategic International Cooperative Program (JST, Japan); Royal Society (UK)(Royal Society of London); International Human Frontier Science Program Organization (HFSPO)(Human Frontier Science Program); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grant-in-aid for Targeted Proteins Research Program (to S. M.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the funding program for Next Generation World-Leading Researchers (NEXT Program), the Japan Society for the Promotion of Science (JSPS), ERATO "Lipid Active Structure Project" from the Japan Science and Technology Agency (JST) and the Advanced Research for Medical Products Mining Programme of the National Institute of Biomedical Innovation (NIBIO), Japan, and also supported by grants from the Strategic International Cooperative Program (JST, Japan), Royal Society (UK), and International Human Frontier Science Program Organization (HFSPO) for collaborative research (to S. M. and H. W. v. V.).	Allen JD, 2002, CANCER RES, V62, P2294; Bohnert JA, 2008, J BACTERIOL, V190, P8225, DOI 10.1128/JB.00912-08; Chen ZS, 2003, CANCER RES, V63, P4048; DINH T, 1994, J BACTERIOL, V176, P3825, DOI 10.1128/JB.176.13.3825-3831.1994; Eda S, 2003, J BIOL CHEM, V278, P2085, DOI 10.1074/jbc.C200661200; Eicher T, 2012, P NATL ACAD SCI USA, V109, P5687, DOI 10.1073/pnas.1114944109; Ejendal KFK, 2006, PROTEIN SCI, V15, P1597, DOI 10.1110/ps.051998406; Elkins CA, 2002, J BACTERIOL, V184, P6490, DOI 10.1128/JB.184.23.6490-6499.2002; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; Hardwick LJA, 2007, BRIT J PHARMACOL, V151, P163, DOI 10.1038/sj.bjp.0707218; Hashimoto-Gotoh T, 2000, GENE, V241, P185, DOI 10.1016/S0378-1119(99)00434-5; Hirakawa H, 2003, J BACTERIOL, V185, P1851, DOI 10.1128/JB.185.6.1851-1856.2003; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lim SP, 2010, ANTIMICROB AGENTS CH, V54, P1800, DOI 10.1128/AAC.01714-09; Livermore DM, 2002, CLIN INFECT DIS, V34, P634, DOI 10.1086/338782; Mao WM, 2002, MOL MICROBIOL, V46, P889, DOI 10.1046/j.1365-2958.2002.03223.x; Middlemiss JK, 2004, J BACTERIOL, V186, P1258, DOI 10.1128/JB.186.5.1258-1269.2004; Miwa M, 2003, INT J CANCER, V107, P757, DOI 10.1002/ijc.11484; Morita Y, 1998, ANTIMICROB AGENTS CH, V42, P1778, DOI 10.1128/AAC.42.7.1778; Murakami S, 2004, J BIOL CHEM, V279, P3743, DOI 10.1074/jbc.M308893200; Murakami S, 2003, CURR OPIN STRUC BIOL, V13, P443, DOI 10.1016/S0959-440X(03)00109-X; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2008, CURR OPIN STRUC BIOL, V18, P459, DOI 10.1016/j.sbi.2008.06.007; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nagano K, 2009, P NATL ACAD SCI USA, V106, P5854, DOI 10.1073/pnas.0901695106; Nakashima R, 2011, NATURE, V480, P565, DOI 10.1038/nature10641; Nikaido H, 1998, CLIN INFECT DIS, V27, pS32, DOI 10.1086/514920; Nishino K, 2001, J BACTERIOL, V183, P5803, DOI 10.1128/JB.183.20.5803-5812.2001; Nishino K, 2003, ANTIMICROB AGENTS CH, V47, P3030, DOI 10.1128/AAC.47.9.3030-3033.2003; Paulsen IT, 1997, FEMS MICROBIOL LETT, V156, P1, DOI 10.1111/j.1574-6968.1997.tb12697.x; Pozza A, 2006, CELL MOL LIFE SCI, V63, P1912, DOI 10.1007/s00018-006-6159-7; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Sennhauser G, 2007, PLOS BIOL, V5, P106, DOI 10.1371/journal.pbio.0050007; Sulavik MC, 2001, ANTIMICROB AGENTS CH, V45, P1126, DOI 10.1128/AAC.45.4.1126-1136.2001; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8765; Tikhonova EB, 2002, J BACTERIOL, V184, P6499, DOI 10.1128/JB.184.23.6499-6507.2002; Vazquez-Laslop N, 1999, BIOCHEMISTRY-US, V38, P16925, DOI 10.1021/bi991988g; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yu J, 2010, BIOINFORMATICS, V26, P46, DOI 10.1093/bioinformatics/btp599; Zheleznova EE, 1999, CELL, V96, P353, DOI 10.1016/S0092-8674(00)80548-6	42	49	49	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10680	10690		10.1074/jbc.M114.547794	http://dx.doi.org/10.1074/jbc.M114.547794			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24558035	hybrid, Green Published			2022-12-28	WOS:000334226400038
J	Saha, PP; Kumar, SKP; Srivastava, S; Sinha, D; Pareek, G; D'Silva, P				Saha, Prasenjit Prasad; Kumar, Praveen S. K.; Srivastava, Shubhi; Sinha, Devanjan; Pareek, Gautam; D'Silva, Patrick			The Presence of Multiple Cellular Defects Associated with a Novel G50E Iron-Sulfur Cluster Scaffold Protein ( ISCU) Mutation Leads to Development of Mitochondrial Myopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electron Transport System (ETS); Iron-Sulfur Protein; Mitochondrial Diseases; Molecular Chaperone; Reactive Oxygen Species (ROS); Hsp70; J-protein; Iron-Sulfur Cluster; Myopathy	RESPIRATORY COMPLEX-I; SACCHAROMYCES-CEREVISIAE; SUCCINATE-DEHYDROGENASE; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; CHAPERONE JAC1; ATP SYNTHESIS; CO-CHAPERONE; BIOGENESIS; METABOLISM	Background: Muscle-specific deficiency of iron-sulfur (Fe-S) cluster scaffold protein (ISCU) leads to myopathy. Results: Cells carrying the myopathy-associated G50E ISCU mutation demonstrate impaired Fe-S cluster biogenesis and mitochondrial dysfunction. Conclusion: Reduced mitochondrial respiration as a result of diminished Fe-S cluster synthesis results in muscle weakness in myopathy patients. Significance: The molecular mechanism behind disease progression should provide invaluable information to combat ISCU myopathy. Iron-sulfur (Fe-S) clusters are versatile cofactors involved in regulating multiple physiological activities, including energy generation through cellular respiration. Initially, the Fe-S clusters are assembled on a conserved scaffold protein, iron-sulfur cluster scaffold protein (ISCU), in coordination with iron and sulfur donor proteins in human mitochondria. Loss of ISCU function leads to myopathy, characterized by muscle wasting and cardiac hypertrophy. In addition to the homozygous ISCU mutation (g.7044GC), compound heterozygous patients with severe myopathy have been identified to carry the c.149GA missense mutation converting the glycine 50 residue to glutamate. However, the physiological defects and molecular mechanism associated with G50E mutation have not been elucidated. In this report, we uncover mechanistic insights concerning how the G50E ISCU mutation in humans leads to the development of severe ISCU myopathy, using a human cell line and yeast as the model systems. The biochemical results highlight that the G50E mutation results in compromised interaction with the sulfur donor NFS1 and the J-protein HSCB, thus impairing the rate of Fe-S cluster synthesis. As a result, electron transport chain complexes show significant reduction in their redox properties, leading to loss of cellular respiration. Furthermore, the G50E mutant mitochondria display enhancement in iron level and reactive oxygen species, thereby causing oxidative stress leading to impairment in the mitochondrial functions. Thus, our findings provide compelling evidence that the respiration defect due to impaired biogenesis of Fe-S clusters in myopathy patients leads to manifestation of complex clinical symptoms.	[Saha, Prasenjit Prasad; Kumar, Praveen S. K.; Srivastava, Shubhi; Sinha, Devanjan; Pareek, Gautam; D'Silva, Patrick] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	D'Silva, P (corresponding author), Indian Inst Sci, Dept Biochem, Biol Sci Bldg, Bangalore 560012, Karnataka, India.	patrick@biochem.iisc.ernet.in	S K, Praveen Kumar/AAA-8999-2022; PAREEK, GAUTAM/AAN-4638-2020; D'Silva, Patrick/L-6653-2019; Saha, Prasenjit/ABC-6481-2020; Sinha, Devanjan/A-3953-2017	S K, Praveen Kumar/0000-0002-9696-9734; PAREEK, GAUTAM/0000-0001-8430-9870; Sinha, Devanjan/0000-0001-5060-2075; Saha, Prasenjit/0000-0003-4679-2368	Council of Scientific and Industrial Research, India [37(1534)/12/EMR-II]; Department of Biotechnology, India; Department of Science and Technology (DST), India	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, India(Department of Biotechnology (DBT) India); Department of Science and Technology (DST), India(Department of Science & Technology (India))	This work was supported by Council of Scientific and Industrial Research, India, Grant 37(1534)/12/EMR-II (to P. D. S).; Recipient of a research associate fellowship from the Department of Biotechnology, India.; Recipient of an INSPIRE fellowship from the Department of Science and Technology (DST), India.	Adinolfi S, 2004, EUR J BIOCHEM, V271, P2093, DOI 10.1111/j.1432-1033.2004.04112.x; Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Andrew AJ, 2006, J BIOL CHEM, V281, P14580, DOI 10.1074/jbc.M600842200; Batandier C, 2002, J CELL MOL MED, V6, P175, DOI 10.1111/j.1582-4934.2002.tb00185.x; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Bencze KZ, 2006, CRIT REV BIOCHEM MOL, V41, P269, DOI 10.1080/10409230600846058; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; Ciesielski SJ, 2012, J MOL BIOL, V417, P1, DOI 10.1016/j.jmb.2012.01.022; Craig EA, 2006, REV PHYSIOL BIOCH P, V156, P1, DOI 10.1007/s10254-005-0001-8; Craig EA, 1999, BIOL CHEM, V380, P1167, DOI 10.1515/BC.1999.148; Craig EA, 2002, CELL MOL LIFE SCI, V59, P1658, DOI 10.1007/PL00012493; de Moura MB, 2010, ENVIRON MOL MUTAGEN, V51, P391, DOI 10.1002/em.20575; Delatycki MB, 1999, ANN NEUROL, V45, P673, DOI 10.1002/1531-8249(199905)45:5<673::AID-ANA20>3.3.CO;2-H; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Dutkiewicz R, 2004, J BIOL CHEM, V279, P29167, DOI 10.1074/jbc.M402947200; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; GALLET PF, 1995, EUR J BIOCHEM, V228, P113, DOI 10.1111/j.1432-1033.1995.tb20238.x; Garland SA, 1999, J MOL BIOL, V294, P897, DOI 10.1006/jmbi.1999.3294; Goswami AV, 2012, HUM MOL GENET, V21, P3317, DOI 10.1093/hmg/dds162; GUTTERIDGE JMC, 1990, BIOCHEM J, V269, P169, DOI 10.1042/bj2690169; HALL RE, 1993, J CLIN INVEST, V92, P2660, DOI 10.1172/JCI116882; Hinchliffe P, 2005, SCIENCE, V309, P771, DOI 10.1126/science.1113988; Jang SJ, 2007, J BIOL CHEM, V282, P929, DOI 10.1074/jbc.M607646200; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; JOHNSON LV, 1981, J CELL BIOL, V88, P526, DOI 10.1083/jcb.88.3.526; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; Kato S, 2002, P NATL ACAD SCI USA, V99, P5948, DOI 10.1073/pnas.082123599; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Kirkinezos IG, 2001, SEMIN CELL DEV BIOL, V12, P449, DOI 10.1006/scdb.2001.0282; Kollberg G, 2011, NEUROMUSCULAR DISORD, V21, P115, DOI 10.1016/j.nmd.2010.11.010; Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P833, DOI 10.1016/j.nmd.2009.09.011; Kollberg G, 2009, BRAIN, V132, P2170, DOI 10.1093/brain/awp152; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; LARSSON LE, 1964, J NEUROL NEUROSUR PS, V27, P361, DOI 10.1136/jnnp.27.5.361; Lee S, 2012, INVEST OPHTH VIS SCI, V53, P2431, DOI 10.1167/iovs.12-9596; Levi S, 2009, BBA-GEN SUBJECTS, V1790, P629, DOI 10.1016/j.bbagen.2008.09.008; Lill R, 2006, BBA-MOL CELL RES, V1763, P652, DOI 10.1016/j.bbamcr.2006.05.011; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Majewska J, 2013, J BIOL CHEM, V288, P29134, DOI 10.1074/jbc.M113.503524; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Meyer J, 2008, J BIOL INORG CHEM, V13, P157, DOI 10.1007/s00775-007-0318-7; Mochel F, 2008, AM J HUM GENET, V82, P652, DOI 10.1016/j.ajhg.2007.12.012; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; Olsson A, 2008, HUM MOL GENET, V17, P1666, DOI 10.1093/hmg/ddn057; Pierik AJ, 2009, NAT PROTOC, V4, P753, DOI 10.1038/nprot.2009.39; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; Richardson DR, 2010, P NATL ACAD SCI USA, V107, P10775, DOI 10.1073/pnas.0912925107; Sanaker PS, 2010, BBA-MOL BASIS DIS, V1802, P539, DOI 10.1016/j.bbadis.2010.02.010; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Schilke B, 2006, CURR BIOL, V16, P1660, DOI 10.1016/j.cub.2006.06.069; Sheftel A, 2010, TRENDS ENDOCRIN MET, V21, P302, DOI 10.1016/j.tem.2009.12.006; Shimomura Y, 2008, J MOL BIOL, V383, P133, DOI 10.1016/j.jmb.2008.08.015; Shimomura Y, 2007, J BIOCHEM, V142, P577, DOI 10.1093/jb/mvm163; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Uchiyama A, 2008, HEPATOLOGY, V48, P1644, DOI 10.1002/hep.22498; Uhrigshardt H, 2010, HUM MOL GENET, V19, P3816, DOI 10.1093/hmg/ddq301; Wen JJ, 2010, ANTIOXID REDOX SIGN, V12, P27, DOI [10.1089/ars.2008.2418, 10.1089/ARS.2008.2418]; Wu G, 2002, BIOCHEMISTRY-US, V41, P5024, DOI 10.1021/bi016073s	64	23	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10359	10377		10.1074/jbc.M113.526665	http://dx.doi.org/10.1074/jbc.M113.526665			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24573684	Green Published, hybrid			2022-12-28	WOS:000334226400011
J	Kyriakis, JM				Kyriakis, John M.			In the Beginning, There Was Protein Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Archaea; Bacterial Protein Kinases; Bacterial Signal Transduction; Prokaryotic Protein Kinases; Prokaryotic Signal Transduction; Protein Kinases	CANCER; INFLAMMATION; KINASES; PATHWAY	The importance of reversible protein phosphorylation to cellular regulation cannot be overstated. In eukaryotic cells, protein kinase/phosphatase signaling pathways regulate a staggering number of cellular processes, including cell proliferation, cell death (apoptosis, necroptosis, necrosis), metabolism (at both the cellular and organismal levels), behavior and neurological function, development, and pathogen resistance. Although protein phosphorylation as a mode of eukaryotic cell regulation is familiar to most biochemists, many are less familiar with protein kinase/phosphatase signaling networks that function in prokaryotes. In this thematic minireview series, we present four minireviews that cover the important field of prokaryotic protein phosphorylation.	Mercury Therapeut Inc, Woburn, MA 01801 USA		Kyriakis, JM (corresponding author), Mercury Therapeut Inc, Woburn, MA 01801 USA.	jkyriakis@asbmb.org						Canova MJ, 2014, J BIOL CHEM, V289, P9473, DOI 10.1074/jbc.R113.529917; Chao JD, 2014, J BIOL CHEM, V289, P9463, DOI 10.1074/jbc.R113.520015; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; FISCHER EH, 1955, J BIOL CHEM, V216, P121; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Kennelly PJ, 2014, J BIOL CHEM, V289, P9480, DOI 10.1074/jbc.R113.529412; KREBS EG, 1958, J BIOL CHEM, V231, P73; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; LaRonde NA, 2014, J BIOL CHEM, V289, P9488, DOI 10.1074/jbc.R113.538090; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	16	14	15	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9460	9462		10.1074/jbc.R114.557926	http://dx.doi.org/10.1074/jbc.R114.557926			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24554697	Green Published, hybrid			2022-12-28	WOS:000333807000001
J	Wang, JY; Liu, X; Dou, Z; Chen, L; Jiang, H; Fu, CH; Fu, GS; Liu, D; Zhang, JC; Zhu, TG; Fang, JW; Zang, JY; Cheng, JK; Teng, MK; Ding, X; Yao, XB				Wang, Jianyu; Liu, Xing; Dou, Zhen; Chen, Liang; Jiang, Hao; Fu, Chuanhai; Fu, Guosheng; Liu, Dan; Zhang, Jiancun; Zhu, Tongge; Fang, Jingwen; Zang, Jianye; Cheng, Jinke; Teng, Maikun; Ding, Xia; Yao, Xuebiao			Mitotic Regulator Mis18 beta Interacts with and Specifies the Centromeric Assembly of Molecular Chaperone Holliday Junction Recognition Protein (HJURP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Division; Centromeres; Chromatin Structure; Histone Chaperone; Phosphorylation	CENP-A CHROMATIN; FISSION YEAST SCM3; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SEGREGATION; EPIGENETIC REGULATION; KINETOCHORE; NUCLEOSOMES; DEPOSITION; COMPLEX; REQUIRES	Background: HJURP is a molecular chaperone essential for the deposition of the centromere marker CENP-A. Results: Mis18 binds with and specifies the centromere localization of HJURP. Conclusion: Mis18 governs centromere assembly via the Mis18-HJURP-CENP-A axis. Significance: Our finding reveals a novel mechanism underlying CENP-A incorporation into the centromere. The centromere is essential for precise and equal segregation of the parental genome into two daughter cells during mitosis. CENP-A is a unique histone H3 variant conserved in eukaryotic centromeres. The assembly of CENP-A to the centromere is mediated by Holliday junction recognition protein (HJURP) in early G(1) phase. However, it remains elusive how HJURP governs CENP-A incorporation into the centromere. Here we show that human HJURP directly binds to Mis18, a component of the Mis18 complex conserved in the eukaryotic kingdom. A minimal region of HJURP for Mis18 binding was mapped to residues 437-460. Depletion of Mis18 by RNA interference dramatically impaired HJURP recruitment to the centromere, indicating the importance of Mis18 in HJURP loading. Interestingly, phosphorylation of HJURP by CDK1 weakens its interaction with Mis18, consistent with the notion that assembly of CENP-A to the centromere is achieved after mitosis. Taken together, these data define a novel molecular mechanism underlying the temporal regulation of CENP-A incorporation into the centromere by accurate Mis18-HJURP interaction.	[Wang, Jianyu; Liu, Xing; Dou, Zhen; Jiang, Hao; Fu, Chuanhai; Fu, Guosheng; Liu, Dan; Zhang, Jiancun; Zhu, Tongge; Fang, Jingwen; Zang, Jianye; Teng, Maikun; Yao, Xuebiao] Univ Sci & Technol China, Sch Life Sci, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Peoples R China; [Chen, Liang; Ding, Xia] Beijing Univ Chinese Med, Beijing 100029, Peoples R China; [Liu, Xing; Zhu, Tongge] Morehouse Sch Med, Atlanta, GA 30310 USA; [Zhang, Jiancun] Guangzhou Inst Biomed & Hlth, Guangzhou 510515, Guangdong, Peoples R China; [Cheng, Jinke] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Beijing University of Chinese Medicine; Morehouse School of Medicine; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Shanghai Jiao Tong University	Ding, X (corresponding author), Beijing Univ Chinese Med, Beijing 100029, Peoples R China.	dingx@bucm.edu.cn; yaoxb@ustc.edu.cn	Liu, Xing/H-2989-2018; Yao, Xuebiao/P-5771-2014; Liu, Dan/G-9006-2018; Zang, Jianye/E-5228-2013; Fu, Chuanhai/G-8303-2016; DOU, ZHEN/N-2022-2013	Liu, Xing/0000-0002-7480-5085; Liu, Dan/0000-0003-4017-3136; Fu, Chuanhai/0000-0003-4354-3796; DOU, ZHEN/0000-0003-3303-9393	National Institutes of Health [DK56292, CA164133, 8G12MD007602, G12RR03034]; Chinese 973 Projects [2010CB912103, 2012CB917204, 2013CB911203]; Chinese Academy of Science [KSCX1-YW-R-65, KSCX2-YW-R-195]; MOST [2009DFA31010]; MOE [20113402130010, IRT13038]; Chinese Natural Science Foundation [91313303, 31320103904, 90508002, 91129714, 81270466, 31271518, 31371363, 90913016]; China Fellowship [2012M510210]; Fundamental Research Funds for Central Universities [WK2340000032, WK2060190018]; NATIONAL CANCER INSTITUTE [R01CA164133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056292] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007602, S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese 973 Projects(National Basic Research Program of China); Chinese Academy of Science(Chinese Academy of Sciences); MOST; MOE(Ministry of Higher Education & Scientific Research (MHESR)); Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); China Fellowship; Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants DK56292, CA164133, 8G12MD007602, and G12RR03034. This work was also supported by Chinese 973 Projects 2010CB912103, 2012CB917204, and 2013CB911203; Chinese Academy of Science Grants KSCX1-YW-R-65 and KSCX2-YW-R-195; MOSTGrant 2009DFA31010; MOE Grants 20113402130010 and IRT13038; Chinese Natural Science Foundation Grants 91313303, 31320103904, 90508002, 91129714, 81270466, 31271518, 31371363, and 90913016; China Fellowship 2012M510210; and Fundamental Research Funds for Central Universities Grants WK2340000032 and WK2060190018.	Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Amor DJ, 2004, P NATL ACAD SCI USA, V101, P6542, DOI 10.1073/pnas.0308637101; Barnhart MC, 2011, J CELL BIOL, V194, P229, DOI 10.1083/jcb.201012017; Bassett EA, 2012, DEV CELL, V22, P749, DOI 10.1016/j.devcel.2012.02.001; Black BE, 2010, COLD SH Q B, V75, P403, DOI 10.1101/sqb.2010.75.038; Black BE, 2007, P NATL ACAD SCI USA, V104, P5008, DOI 10.1073/pnas.0700390104; Camahort R, 2007, MOL CELL, V26, P853, DOI 10.1016/j.molcel.2007.05.013; Carroll CW, 2010, J CELL BIOL, V189, P1143, DOI 10.1083/jcb.201001013; Carroll CW, 2009, NAT CELL BIOL, V11, P896, DOI 10.1038/ncb1899; Chu LL, 2012, J MOL CELL BIOL, V4, P331, DOI 10.1093/jmcb/mjs023; Chu YJ, 2011, J MOL CELL BIOL, V3, P260, DOI 10.1093/jmcb/mjq037; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Dambacher S, 2012, NUCLEUS-PHILA, V3, P101, DOI 10.4161/nucl.18955; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Fachinetti D, 2013, NAT CELL BIOL, V15, P1056, DOI 10.1038/ncb2805; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Guse A, 2011, NATURE, V477, P354, DOI 10.1038/nature10379; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148; Hu H, 2011, GENE DEV, V25, P901, DOI 10.1101/gad.2045111; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Kim IS, 2012, MOL CELL, V46, P260, DOI 10.1016/j.molcel.2012.03.021; Liu D, 2007, J BIOL CHEM, V282, P21415, DOI 10.1074/jbc.M609026200; Liu ST, 2006, J CELL BIOL, V175, P41, DOI 10.1083/jcb.200606020; Maddox PS, 2007, J CELL BIOL, V176, P757, DOI 10.1083/jcb.200701065; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Moree B, 2011, J CELL BIOL, V194, P855, DOI 10.1083/jcb.201106079; Morris CA, 2007, CELL, V128, P647, DOI 10.1016/j.cell.2007.02.002; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; Perpelescu M, 2009, J CELL BIOL, V185, P397, DOI 10.1083/jcb.200903088; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Regnier V, 2005, MOL CELL BIOL, V25, P3967, DOI 10.1128/MCB.25.10.3967-3981.2005; Sanchez-Pulido L, 2009, CELL, V137, P1173, DOI 10.1016/j.cell.2009.06.010; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; Silva MCC, 2012, DEV CELL, V22, P52, DOI 10.1016/j.devcel.2011.10.014; Stoler S, 2007, P NATL ACAD SCI USA, V104, P10571, DOI 10.1073/pnas.0703178104; Tao YY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1779; Williams JS, 2009, MOL CELL, V33, P287, DOI 10.1016/j.molcel.2009.01.017; Xia P, 2012, P NATL ACAD SCI USA, V109, P16564, DOI 10.1073/pnas.1202639109; Zasadzinska E, 2013, EMBO J, V32, P2113, DOI 10.1038/emboj.2013.142; Zhu M, 2008, J BIOL CHEM, V283, P18916, DOI 10.1074/jbc.M710591200	49	59	61	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8326	8336		10.1074/jbc.M113.529958	http://dx.doi.org/10.1074/jbc.M113.529958			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24519934	Green Published, hybrid			2022-12-28	WOS:000333157500026
J	Wang, ZP; Mu, XY; Guo, M; Wang, YJ; Teng, Z; Mao, GP; Niu, WB; Feng, LZ; Zhao, LH; Xia, GL				Wang, Zheng-Pin; Mu, Xin-Yi; Guo, Meng; Wang, Yi-Jing; Teng, Zhen; Mao, Guan-Ping; Niu, Wan-Bao; Feng, Li-Zhao; Zhao, Li-Hua; Xia, Guo-Liang			Transforming Growth Factor- beta Signaling Participates in the Maintenance of the Primordial Follicle Pool in the Mouse Ovary	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Growth; Mouse; Oocyte; Ovary; Transforming Growth Factor- (TGF)	MESENCHYMAL TRANSITION; GERM-CELL; MICE; ACTIVATION; EXPRESSION; DIFFERENTIATION; SUPPRESSION; SURVIVAL; DEFECTS; PATHWAY	Background: Why only a few follicles are activated to enter the growing follicle pool each wave remains unclear. Results: TGF- regulates oocyte growth through p70 S6 kinase 1/ribosomal protein S6 signaling. Conclusion: TGF- participates in maintenance of the primordial follicle pool. Significance: Learning how TGF- acts on primordial follicle growth. Physiologically, only a few primordial follicles are activated to enter the growing follicle pool each wave. Recent studies in knock-out mice show that early follicular activation depends on signaling from the tuberous sclerosis complex, the mammalian target of rapamycin complex 1 (mTORC1), phosphatase and tensin homolog deleted on chromosome 10, and phosphatidylinositol 3-kinase (PI3K) pathways. However, the manner in which these pathways are normally regulated, and whether or not TGF- acts on them are poorly understood. So, this study aims to identify whether or not TGF- acts on the process. Ovary organ culture experiments showed that the culture of 18.5 days post-coitus (dpc) ovaries with TGF-1 reduced the total population of oocytes and activated follicles, accelerated oocyte growth was observed in ovaries treated with TGF-R1 inhibitor 2-(5-chloro-2-fluorophenyl)pteridin-4-yl]pyridin-4-yl-amine (SD208) compared with control ovaries, the down-regulation of TGF-R1 gene expression also activated early primordial follicle oocyte growth. We further showed that there was dramatically more proliferation of granulosa cells in SD208-treated ovaries and less proliferation in TGF-1-treated ovaries. Western blot and morphological analyses indicated that TGF- signaling manipulated primordial follicle growth through tuberous sclerosis complex/mTORC1 signaling in oocytes, and the mTORC1-specific inhibitor rapamycin could partially reverse the stimulated effect of SD208 on the oocyte growth and decreased the numbers of growing follicles. In conclusion, our results suggest that TGF- signaling plays an important physiological role in the maintenance of the dormant pool of primordial follicles, which functions through activation of p70 S6 kinase 1 (S6K1)/ribosomal protein S6 (rpS6) signaling in mouse ovaries.	[Wang, Zheng-Pin; Mu, Xin-Yi; Guo, Meng; Wang, Yi-Jing; Teng, Zhen; Mao, Guan-Ping; Niu, Wan-Bao; Feng, Li-Zhao; Zhao, Li-Hua; Xia, Guo-Liang] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China	China Agricultural University	Xia, GL (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.	glxiachina@sohu.com	Teng, Zhen/I-4601-2019; Wang, Zhengpin/AAM-3021-2020	Teng, Zhen/0000-0002-3827-2197; Xia, Guoliang/0000-0003-3674-0142; Mu, Xinyi/0000-0002-3738-0882; Feng, Lizhao/0000-0002-9843-3941; Wang, Zhengpin/0000-0001-5388-1516	National Basic Research Program of China (973) [2013CB945500, 2012CB944701, 2012CB944401]	National Basic Research Program of China (973)(National Basic Research Program of China)	This work was supported by the National Basic Research Program Grants 2013CB945500, 2012CB944701, and 2012CB944401 of China (973).	Adhikari BN, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075072, 10.1371/journal.pone.0053810]; Adhikari D, 2010, HUM MOL GENET, V19, P397, DOI 10.1093/hmg/ddp483; Adhikari D, 2009, MOL HUM REPROD, V15, P765, DOI 10.1093/molehr/gap092; Anderson L D, 1992, Md Med J, V41, P614; BAARENDS WM, 1995, ENDOCRINOLOGY, V136, P4951, DOI 10.1210/en.136.11.4951; Bakin AV, 2000, J BIOL CHEM, V275, P36803, DOI 10.1074/jbc.M005912200; Bristol-Gould SK, 2006, DEV BIOL, V298, P132, DOI 10.1016/j.ydbio.2006.06.025; Broekmans FJ, 2007, TRENDS ENDOCRIN MET, V18, P58, DOI 10.1016/j.tem.2007.01.004; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Drummond AE, 2005, CELL TISSUE RES, V322, P107, DOI 10.1007/s00441-005-1153-1; Flaws JA, 2001, BIOL REPROD, V64, P1153, DOI 10.1095/biolreprod64.4.1153; Godkin JD, 1998, REV REPROD, V3, P1; Gueripel X, 2004, BIOL REPROD, V70, P640, DOI 10.1095/biolreprod.103.021162; Hayashi M, 1999, ENDOCRINOLOGY, V140, P1236, DOI 10.1210/en.140.3.1236; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Ingman WV, 2006, ENDOCRINOLOGY, V147, P835, DOI 10.1210/en.2005-1189; Ingman WV, 2002, BIOESSAYS, V24, P904, DOI 10.1002/bies.10155; John GB, 2008, DEV BIOL, V321, P197, DOI 10.1016/j.ydbio.2008.06.017; John GB, 2007, REPRODUCTION, V133, P855, DOI 10.1530/REP-06-0051; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Kaivo-Oja N, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-21; Kato M, 2006, J AM SOC NEPHROL, V17, P3325, DOI 10.1681/ASN.2006070754; KNECHT M, 1987, ENDOCRINOLOGY, V120, P1243, DOI 10.1210/endo-120-4-1243; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Li QL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002320; Liu L, 2007, DEVELOPMENT, V134, P199, DOI 10.1242/dev.02667; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; Myers M, 2009, DEV BIOL, V334, P458, DOI 10.1016/j.ydbio.2009.08.001; Nilsson EE, 2002, BIOL REPROD, V67, P1018, DOI 10.1095/biolreprod.101.002527; Parrott JA, 1999, ENDOCRINOLOGY, V140, P4262, DOI 10.1210/en.140.9.4262; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258; Rahimi RA, 2009, CANCER RES, V69, P84, DOI 10.1158/0008-5472.CAN-08-2146; Reddy P, 2008, SCIENCE, V319, P611, DOI 10.1126/science.1152257; Reddy P, 2009, HUM MOL GENET, V18, P2813, DOI 10.1093/hmg/ddp217; Rosairo D, 2008, REPRODUCTION, V136, P799, DOI 10.1530/REP-08-0310; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Schindler R., 2010, PLOS ONE, V5; SHULL MM, 1994, MOL REPROD DEV, V39, P239, DOI 10.1002/mrd.1080390218; Trombly DJ, 2009, ENDOCRINOLOGY, V150, P1014, DOI 10.1210/en.2008-0213; Uhl M, 2004, CANCER RES, V64, P7954, DOI 10.1158/0008-5472.CAN-04-1013; Wang HB, 2001, CHINESE SCI BULL, V46, P672, DOI 10.1007/BF03182833	46	50	59	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8299	8311		10.1074/jbc.M113.532952	http://dx.doi.org/10.1074/jbc.M113.532952			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24515103	Green Published, hybrid			2022-12-28	WOS:000333157500024
J	D'Annibale, S; Kim, J; Magliozzi, R; Low, TY; Mohammed, S; Heck, AJR; Guardavaccaro, D				D'Annibale, Sara; Kim, Jihoon; Magliozzi, Roberto; Low, Teck Yew; Mohammed, Shabaz; Heck, Albert J. R.; Guardavaccaro, Daniele			Proteasome-dependent Degradation of Transcription Factor Activating Enhancer-binding Protein 4 (TFAP4) Controls Mitotic Division	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; E3 Ubiquitin Ligase; Mitosis; Protein Degradation; Ubiquitin; TFAP4; BetaTrCP	TRCP-MEDIATED DEGRADATION; SCF-BETA-TRCP; PEPTIDE IDENTIFICATION; DESTRUCTION MOTIF; UBIQUITIN LIGASE; DNA-DAMAGE; CANCER; PROGRESSION; CDC25A; PHASE	Background: TFAP4 is a transcription factor that controls cell proliferation, stemness and epithelial-mesenchymal transition and is up-regulated in colorectal cancer. Results: TFAP4 is targeted for degradation by the SCFTrCP ubiquitin ligase. Failure to degrade TFAP4 leads to aberrant mitosis. Conclusion: TFAP4 degradation is required for the fidelity of mitosis. Significance: Misregulation of TFAP4 might contribute to genomic instability and tumorigenesis. TFAP4, a basic helix-loop-helix transcription factor that regulates the expression of a multitude of genes involved in the regulation of cellular proliferation, stemness, and epithelial-mesenchymal transition, is up-regulated in colorectal cancer and a number of other human malignancies. We have found that, during the G(2) phase of the cell division cycle, TFAP4 is targeted for proteasome-dependent degradation by the SCFTrCP ubiquitin ligase. This event requires phosphorylation of TFAP4 on a conserved degron. Expression of a stable TFAP4 mutant unable to interact with TrCP results in a number of mitotic defects, including chromosome missegregation and multipolar spindles, which eventually lead to the activation of the DNA damage response. Our findings reveal that TrCP-dependent degradation of TFAP4 is required for the fidelity of mitotic division.	[D'Annibale, Sara; Kim, Jihoon; Magliozzi, Roberto; Guardavaccaro, Daniele] Hubrecht Inst KNAW, NL-3584 CH Utrecht, Netherlands; [D'Annibale, Sara; Kim, Jihoon; Magliozzi, Roberto; Guardavaccaro, Daniele] Univ Med Ctr Utrecht, NL-3584 CH Utrecht, Netherlands; [Low, Teck Yew; Mohammed, Shabaz; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Low, Teck Yew; Mohammed, Shabaz; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Low, Teck Yew; Mohammed, Shabaz; Heck, Albert J. R.] Netherlands Prote Ctr, NL-3584 CH Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University	Guardavaccaro, D (corresponding author), Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	d.guardavaccaro@hubrecht.eu	Mohammed, Shabaz/AAY-6313-2020; Mohammed, Shabaz/D-1042-2010; Low, Teck Yew/J-4403-2014; Low, Teck Yew/Q-5946-2019; Heck, Albert/D-7098-2011	Mohammed, Shabaz/0000-0003-2640-9560; Mohammed, Shabaz/0000-0003-2640-9560; Low, Teck Yew/0000-0001-7878-7534; Low, Teck Yew/0000-0001-7878-7534; Heck, Albert/0000-0002-2405-4404; Guardavaccaro, Daniele/0000-0002-4517-1765	Royal Dutch Academy of Arts and Sciences; Dutch Cancer Society; Cancer Genomics Center; European Union under Marie Curie Actions (FP7)	Royal Dutch Academy of Arts and Sciences; Dutch Cancer Society(KWF Kankerbestrijding); Cancer Genomics Center; European Union under Marie Curie Actions (FP7)	Work in the Guardavaccaro laboratory was supported by the Royal Dutch Academy of Arts and Sciences, the Dutch Cancer Society, the Cancer Genomics Center, and the European Union under Marie Curie Actions (FP7).	Busino L, 2003, NATURE, V426, P87, DOI 10.1038/nature02082; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Frese CK, 2011, J PROTEOME RES, V10, P2377, DOI 10.1021/pr1011729; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Hu BS, 2013, TUMOR BIOL, V34, P271, DOI 10.1007/s13277-012-0547-4; Jackstadt R, 2013, J EXP MED, V210, P1331, DOI 10.1084/jem.20120812; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Jung P, 2009, CELL CYCLE, V8, P982, DOI 10.4161/cc.8.7.7949; Jung P, 2008, P NATL ACAD SCI USA, V105, P15046, DOI 10.1073/pnas.0801773105; Kanemori Y, 2005, P NATL ACAD SCI USA, V102, P6279, DOI 10.1073/pnas.0501873102; Kruiswijk F, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002718; Liu XH, 2012, MED ONCOL, V29, P871, DOI 10.1007/s12032-011-9845-8; Magliozzi R, 2013, DEV CELL, V27, P574, DOI 10.1016/j.devcel.2013.10.023; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Ping Z, 2012, CELL CYCLE, V11, P1999, DOI 10.4161/cc.20402; Raijmakers R, 2008, MOL CELL PROTEOMICS, V7, P1755, DOI 10.1074/mcp.M800093-MCP200; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Swaney DL, 2008, NAT METHODS, V5, P959, DOI 10.1038/nmeth.1260; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X	27	19	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7730	7737		10.1074/jbc.M114.549535	http://dx.doi.org/10.1074/jbc.M114.549535			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24500709	hybrid, Green Published			2022-12-28	WOS:000332761500040
J	Inoue, A; Kikuchi, S; Hishiki, A; Shao, YM; Heath, R; Evison, BJ; Actis, M; Canman, CE; Hashimoto, H; Fujii, N				Inoue, Akira; Kikuchi, Sotaro; Hishiki, Asami; Shao, Youming; Heath, Richard; Evison, Benjamin J.; Actis, Marcelo; Canman, Christine E.; Hashimoto, Hiroshi; Fujii, Naoaki			A Small Molecule Inhibitor of Monoubiquitinated Proliferating Cell Nuclear Antigen (PCNA) Inhibits Repair of Interstrand DNA Cross-link, Enhances DNA Double Strand Break, and Sensitizes Cancer Cells to Cisplatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystallography; DNA Damage; Small Molecules; Structural Biology; Ubiquitination; PCNA; Interstrand Cross-link	UBIQUITIN-BINDING MOTIFS; POLYMERASE-ZETA; HOMOLOGOUS RECOMBINATION; TRANSLESION SYNTHESIS; ACCESSORY SUBUNITS; STRUCTURAL BASIS; DAMAGE RESPONSE; REV1 PROTEIN; ETA; REPLICATION	Background: Lys-164-monoubiquitinated PCNA is essential for interstrand DNA cross-link (ICL) repair. Results: A small molecule, T2AA, bi-molecularly binds to PCNA at a PIP-box cavity and close to Lys-164. T2AA inhibited monoubiquitinated PCNA interactions and ICL repair and enhanced DNA double strand breaks. Conclusion: An inhibitor of monoubiquitinated PCNA inhibits ICL repair. Significance: Inhibition of monoubiquitinated PCNA could improve chemotherapeutic efficacy. Small molecule inhibitors of proliferating cell nuclear antigen (PCNA)/PCNA interacting protein box (PIP-Box) interactions, including T2 amino alcohol (T2AA), inhibit translesion DNA synthesis. The crystal structure of PCNA in complex with T2AA revealed that T2AA bound to the surface adjacent to the subunit interface of the homotrimer of PCNA in addition to the PIP-box binding cavity. Because this site is close to Lys-164, which is monoubiquitinated by RAD18, we postulated that T2AA would affect monoubiquitinated PCNA interactions. Binding of monoubiquitinated PCNA and a purified pol fragment containing the UBZ and PIP-box was inhibited by T2AA in vitro. T2AA decreased PCNA/pol and PCNA/REV1 chromatin colocalization but did not inhibit PCNA monoubiquitination, suggesting that T2AA hinders interactions of pol and REV1 with monoubiquitinated PCNA. Interstrand DNA cross-links (ICLs) are repaired by mechanisms using translesion DNA synthesis that is regulated by monoubiquitinated PCNA. T2AA significantly delayed reactivation of a reporter plasmid containing an ICL. Neutral comet analysis of cells receiving T2AA in addition to cisplatin revealed that T2AA significantly enhanced formation of DNA double strand breaks (DSBs) by cisplatin. T2AA promoted colocalized foci formation of phospho-ATM and 53BP1 and up-regulated phospho-BRCA1 in cisplatin-treated cells, suggesting that T2AA increases DSBs. When cells were treated by cisplatin and T2AA, their clonogenic survival was significantly less than that of those treated by cisplatin only. These findings show that the inhibitors of monoubiquitinated PCNA chemosensitize cells by inhibiting repair of ICLs and DSBs.	[Inoue, Akira; Evison, Benjamin J.; Actis, Marcelo; Fujii, Naoaki] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38138 USA; [Shao, Youming; Heath, Richard] St Jude Childrens Res Hosp, Prot Prod Facil, Memphis, TN 38138 USA; [Kikuchi, Sotaro; Hishiki, Asami; Hashimoto, Hiroshi] Yokohama City Univ, Grad Sch Med Life Sci, Dept Med Life Sci, Yokohama, Kanagawa 2300045, Japan; [Canman, Christine E.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; Yokohama City University; University of Michigan System; University of Michigan	Fujii, N (corresponding author), St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	naoaki.fujii@stjude.org	Fujii, Naoaki/I-6423-2013	, Christine/0000-0001-8892-7430; Hashimoto, Hiroshi/0000-0003-1503-6789; Heath, Richard/0000-0002-1795-1254	American Lebanese Syrian Associated Charities; American Cancer Society [RSG CDD-120969]; KAKENHI from MEXT, Japan; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); American Cancer Society(American Cancer Society); KAKENHI from MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the American Lebanese Syrian Associated Charities and American Cancer Society Research Scholar Grant RSG CDD-120969 (to N. F.), and KAKENHI from MEXT, Japan (to A. H. and H. H.).	Actis M, 2013, BIOORGAN MED CHEM, V21, P1972, DOI 10.1016/j.bmc.2013.01.022; Baranovskiy AG, 2012, J BIOL CHEM, V287, P17281, DOI 10.1074/jbc.M112.351122; Bomar MG, 2007, EMBO REP, V8, P247, DOI 10.1038/sj.embor.7400901; Centore RC, 2012, MOL CELL, V46, P625, DOI 10.1016/j.molcel.2012.05.020; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Despras E, 2012, ENVIRON MOL MUTAGEN, V53, P752, DOI 10.1002/em.21741; Durando M, 2013, NUCLEIC ACIDS RES, V41, P3079, DOI 10.1093/nar/gkt016; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enoiu M, 2012, NUCLEIC ACIDS RES, V40, P8953, DOI 10.1093/nar/gks670; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Garg P, 2005, P NATL ACAD SCI USA, V102, P18361, DOI 10.1073/pnas.0505949102; Geng LY, 2010, J CELL BIOL, V191, P249, DOI 10.1083/jcb.201005101; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; Guo CX, 2006, MOL CELL, V23, P265, DOI 10.1016/j.molcel.2006.05.038; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Hicks JK, 2010, MOL CELL BIOL, V30, P1217, DOI 10.1128/MCB.00993-09; Johnson RE, 2012, P NATL ACAD SCI USA, V109, P12455, DOI 10.1073/pnas.1206052109; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kikuchi S, 2012, J BIOL CHEM, V287, P33847, DOI 10.1074/jbc.M112.396838; Li J, 2013, P NATL ACAD SCI USA, V110, P7672, DOI 10.1073/pnas.1222241110; Li X, 2009, MOL CELL, V36, P704, DOI 10.1016/j.molcel.2009.09.036; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Makarova AV, 2012, NUCLEIC ACIDS RES, V40, P11618, DOI 10.1093/nar/gks948; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Moldovan GL, 2012, MOL CELL, V45, P75, DOI 10.1016/j.molcel.2011.11.010; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OLIVE PL, 1991, CANCER RES, V51, P4671; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Punchihewa C, 2012, J BIOL CHEM, V287, P14289, DOI 10.1074/jbc.M112.353201; Pustovalova Y, 2013, J MOL BIOL, V425, P3091, DOI 10.1016/j.jmb.2013.05.029; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Sarkar S, 2006, EMBO J, V25, P1285, DOI 10.1038/sj.emboj.7600993; Sebesta M, 2013, DNA REPAIR, V12, P691, DOI 10.1016/j.dnarep.2013.05.001; Sengerova B, 2011, CELL CYCLE, V10, P3999, DOI 10.4161/cc.10.23.18385; Sharma NM, 2011, J BIOL CHEM, V286, P33557, DOI 10.1074/jbc.M110.206680; Sharma S, 2012, NUCLEIC ACIDS RES, V40, P682, DOI 10.1093/nar/gkr769; Tan ZQ, 2012, MOL PHARMACOL, V81, P811, DOI 10.1124/mol.112.077735; TSENG BY, 1984, P NATL ACAD SCI-BIOL, V81, P2342, DOI 10.1073/pnas.81.8.2342; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Williams HL, 2012, MOL CELL, V47, P140, DOI 10.1016/j.molcel.2012.05.001; Wojtaszek J, 2012, J BIOL CHEM, V287, P33836, DOI 10.1074/jbc.M112.394841; Wood A, 2007, J BIOL CHEM, V282, P20256, DOI 10.1074/jbc.M702366200; Zhang ZT, 2012, CELL CYCLE, V11, P2128, DOI 10.4161/cc.20595	50	62	63	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7109	7120		10.1074/jbc.M113.520429	http://dx.doi.org/10.1074/jbc.M113.520429			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24474685	Green Published, hybrid			2022-12-28	WOS:000332389400070
J	Roy, A; Kim, JH				Roy, Adhiraj; Kim, Jeong-Ho			Endocytosis and Vacuolar Degradation of the Yeast Cell Surface Glucose Sensors Rgt2 and Snf3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Gene Expression; Glucose; Receptors; Yeast	SACCHAROMYCES-CEREVISIAE; DNA-BINDING; HEXOSE TRANSPORTERS; SIGNALING PATHWAYS; MALTOSE PERMEASE; PLASMA-MEMBRANE; GENE-EXPRESSION; REPRESSOR RGT1; UBIQUITIN; TRANSCRIPTION	Background: In yeast, glucose is sensed by two cell surface glucose sensors. Results: The glucose sensors are down-regulated by ubiquitination and degradation. Conclusion: The stability of the glucose sensors may be associated with their ability to sense glucose. Significance: Differential regulation of the abundance of glucose sensors enables yeast cells to respond rapidly to changing glucose levels. Sensing and signaling the presence of extracellular glucose is crucial for the yeast Saccharomyces cerevisiae because of its fermentative metabolism, characterized by high glucose flux through glycolysis. The yeast senses glucose through the cell surface glucose sensors Rgt2 and Snf3, which serve as glucose receptors that generate the signal for induction of genes involved in glucose uptake and metabolism. Rgt2 and Snf3 detect high and low glucose concentrations, respectively, perhaps because of their different affinities for glucose. Here, we provide evidence that cell surface levels of glucose sensors are regulated by ubiquitination and degradation. The glucose sensors are removed from the plasma membrane through endocytosis and targeted to the vacuole for degradation upon glucose depletion. The turnover of the glucose sensors is inhibited in endocytosis defective mutants, and the sensor proteins with a mutation at their putative ubiquitin-acceptor lysine residues are resistant to degradation. Of note, the low affinity glucose sensor Rgt2 remains stable only in high glucose grown cells, and the high affinity glucose sensor Snf3 is stable only in cells grown in low glucose. In addition, constitutively active, signaling forms of glucose sensors do not undergo endocytosis, whereas signaling defective sensors are constitutively targeted for degradation, suggesting that the stability of the glucose sensors may be associated with their ability to sense glucose. Therefore, our findings demonstrate that the amount of glucose available dictates the cell surface levels of the glucose sensors and that the regulation of glucose sensors by glucose concentration may enable yeast cells to maintain glucose sensing activity at the cell surface over a wide range of glucose concentrations.	[Roy, Adhiraj; Kim, Jeong-Ho] George Washington Univ, Med Ctr, Dept Biochem & Mol Med, Washington, DC 20037 USA	George Washington University	Kim, JH (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Med, 2300 Eye St, Washington, DC 20037 USA.	jh_kim@gwu.edu			National Institutes of Health [GM087470]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM087470 (to J.-H. K.).	Amerik AY, 2000, MOL BIOL CELL, V11, P3365, DOI 10.1091/mbc.11.10.3365; Boles E, 1997, FEMS MICROBIOL REV, V21, P85, DOI 10.1016/S0168-6445(97)00052-1; Busti S, 2010, SENSORS-BASEL, V10, P6195, DOI 10.3390/s100606195; Flick KM, 2003, MOL BIOL CELL, V14, P3230, DOI 10.1091/mbc.E03-03-0135; Gadura N, 2006, CURR GENET, V50, P101, DOI 10.1007/s00294-006-0080-3; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; Gitan RS, 1998, J BIOL CHEM, V273, P28617, DOI 10.1074/jbc.273.44.28617; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Holsbeeks I, 2004, TRENDS BIOCHEM SCI, V29, P556, DOI 10.1016/j.tibs.2004.08.010; Johnston M, 2005, BIOCHEM SOC T, V33, P247, DOI 10.1042/BST0330247; Jouandot D, 2011, J CELL BIOCHEM, V112, P3268, DOI 10.1002/jcb.23253; Kaniak A, 2004, EUKARYOT CELL, V3, P221, DOI 10.1128/EC.3.1.221-231.2004; Kasahara T, 2000, J BIOL CHEM, V275, P4422, DOI 10.1074/jbc.275.6.4422; Kim JH, 2006, J BIOL CHEM, V281, P26144, DOI 10.1074/jbc.M603636200; Kim JH, 2013, BBA-GEN SUBJECTS, V1830, P5204, DOI 10.1016/j.bbagen.2013.07.025; Kim JH, 2009, BIOCHIMIE, V91, P300, DOI 10.1016/j.biochi.2008.09.002; Kim JH, 2006, EUKARYOT CELL, V5, P167, DOI 10.1128/EC.5.1.167-173.2006; Kim JH, 2004, ANAL BIOCHEM, V334, P401, DOI 10.1016/j.ab.2004.06.045; Kim JH, 2003, MOL CELL BIOL, V23, P5208, DOI 10.1128/MCB.23.15.5208-5216.2003; KO CH, 1993, MOL CELL BIOL, V13, P638, DOI 10.1128/MCB.13.1.638; Kriel J, 2011, BIOESSAYS, V33, P870, DOI 10.1002/bies.201100100; Kruckeberg AL, 1996, ARCH MICROBIOL, V166, P283, DOI 10.1007/s002030050385; Liu JX, 2007, TRAFFIC, V8, P1375, DOI 10.1111/j.1600-0854.2007.00616.x; Medintz I, 1998, J BIOL CHEM, V273, P34454, DOI 10.1074/jbc.273.51.34454; Moriya H, 2004, P NATL ACAD SCI USA, V101, P1572, DOI 10.1073/pnas.0305901101; Mosley AL, 2003, J BIOL CHEM, V278, P10322, DOI 10.1074/jbc.M212802200; Ozcan S, 1998, EMBO J, V17, P2566, DOI 10.1093/emboj/17.9.2566; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Ozcan S, 1996, MOL CELL BIOL, V16, P6419; OZCAN S, 1995, MOL CELL BIOL, V15, P1564; Ozcan S, 1996, P NATL ACAD SCI USA, V93, P12428, DOI 10.1073/pnas.93.22.12428; Palomino A, 2006, NUCLEIC ACIDS RES, V34, P1427, DOI 10.1093/nar/gkl028; Pasula S, 2007, FEBS LETT, V581, P3230, DOI 10.1016/j.febslet.2007.06.013; Pasula S, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-17; Reddi AR, 2009, CHEM REV, V109, P4722, DOI 10.1021/cr900031u; Reifenberger E, 1997, EUR J BIOCHEM, V245, P324, DOI 10.1111/j.1432-1033.1997.00324.x; Rolland F, 2001, FEMS YEAST RES, V1, P33, DOI 10.1111/j.1567-1364.2001.tb00011.x; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Roy A, 2013, ANAL BIOCHEM, V436, P53, DOI 10.1016/j.ab.2013.01.013; Rutherford JC, 2004, EUKARYOT CELL, V3, P1, DOI 10.1128/EC.3.1.1-13.2004; Schmidt MC, 1999, MOL CELL BIOL, V19, P4561; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Spielewoy N, 2004, MOL CELL BIOL, V24, P8994, DOI 10.1128/MCB.24.20.8994-9005.2004; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; Towle HC, 2005, TRENDS ENDOCRIN MET, V16, P489, DOI 10.1016/j.tem.2005.10.003; Van Zeebroeck G, 2009, NAT CHEM BIOL, V5, P45, DOI 10.1038/nchembio.132; Wu BQ, 2006, J CELL BIOL, V173, P327, DOI 10.1083/jcb.200602089	49	12	12	9	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7247	7256		10.1074/jbc.M113.539411	http://dx.doi.org/10.1074/jbc.M113.539411			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24451370	hybrid, Green Published			2022-12-28	WOS:000332389400082
J	Sundriyal, A; Massa, C; Samoray, D; Zehender, F; Sharpe, T; Jenal, U; Schirmer, T				Sundriyal, Amit; Massa, Claudia; Samoray, Dietrich; Zehender, Fabian; Sharpe, Timothy; Jenal, Urs; Schirmer, Tilman			Inherent Regulation of EAL Domain-catalyzed Hydrolysis of Second Messenger Cyclic di-GMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Bacterial Signal Transduction; Chromatography; Crystal Structure; Phosphodiesterases; c-di-GMP Signaling; Second Messenger	ESCHERICHIA-COLI; MECHANISM; PROTEIN; PHOSPHODIESTERASE; ACTIVATION; ROCR	Background: The bacterial second messenger cyclic di-GMP (c-di-GMP) is degraded by EAL phosphodiesterases. Results: The isolated EAL domain is active only as a homodimer. Substrate binding is coupled with EAL dimerization. Conclusion: Activity of many full-length EAL phosphodiesterases may be regulated by catalytic domain dimerization. Significance: A generic mechanism for the regulation of a central node of c-di-GMP signaling is provided. The universal second messenger cyclic di-GMP (cdG) is involved in the regulation of a diverse range of cellular processes in bacteria. The intracellular concentration of the dinucleotide is determined by the opposing actions of diguanylate cyclases and cdG-specific phosphodiesterases (PDEs). Whereas most PDEs have accessory domains that are involved in the regulation of their activity, the regulatory mechanism of this class of enzymes has remained unclear. Here, we use biophysical and functional analyses to show that the isolated EAL domain of a PDE from Escherichia coli (YahA) is in a fast thermodynamic monomer-dimer equilibrium, and that the domain is active only in its dimeric state. Furthermore, our data indicate thermodynamic coupling between substrate binding and EAL dimerization with the dimerization affinity being increased about 100-fold upon substrate binding. Crystal structures of the YahA-EAL domain determined under various conditions (apo, Mg2+, cdGCa(2+) complex) confirm structural coupling between the dimer interface and the catalytic center. The built-in regulatory properties of the EAL domain probably facilitate its modular, functional combination with the diverse repertoire of accessory domains.	[Sundriyal, Amit; Massa, Claudia; Samoray, Dietrich; Zehender, Fabian; Schirmer, Tilman] Univ Basel, Biozentrum, Focal Area Struct Biol & Biophys, CH-4056 Basel, Switzerland; [Sharpe, Timothy] Univ Basel, Biozentrum, Biophys Facil, CH-4056 Basel, Switzerland; [Jenal, Urs] Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland	University of Basel; University of Basel; University of Basel	Schirmer, T (corresponding author), Klingelbergstr 70, CH-4056 Basel, Switzerland.	tilman.schirmer@unibas.ch		Sharpe, Timothy/0000-0002-4980-1330	Swiss National Science Foundation [31003A_138414, 31003A_130469]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grants 31003A_138414 (to T. Sch.) and 31003A_130469 (to U. J.).	Barends TRM, 2009, NATURE, V459, P1015, DOI 10.1038/nature07966; Benfield CTO, 2011, J BIOL CHEM, V286, P20727, DOI 10.1074/jbc.M111.231381; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chen MW, 2012, J BACTERIOL, V194, P4837, DOI 10.1128/JB.00560-12; Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200; Claret L, 2007, J BIOL CHEM, V282, P33275, DOI 10.1074/jbc.M702800200; De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gao R, 2010, CURR OPIN MICROBIOL, V13, P160, DOI 10.1016/j.mib.2009.12.009; Gentner M, 2012, J AM CHEM SOC, V134, P1019, DOI 10.1021/ja207742q; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kurokawa H, 2004, J BIOL CHEM, V279, P20186, DOI 10.1074/jbc.M314199200; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minasov G, 2009, J BIOL CHEM, V284, P13174, DOI 10.1074/jbc.M808221200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588; Navarro MVAS, 2009, STRUCTURE, V17, P1104, DOI 10.1016/j.str.2009.06.010; Paul R, 2007, J BIOL CHEM, V282, P29170, DOI 10.1074/jbc.M704702200; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Rao F, 2009, J BACTERIOL, V191, P4722, DOI 10.1128/JB.00327-09; Robert-Paganin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052424; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Tarnawski M, 2013, ACTA CRYSTALLOGR D, V69, P1045, DOI 10.1107/S0907444913004423; Tchigvintsev A, 2010, J MOL BIOL, V402, P524, DOI 10.1016/j.jmb.2010.07.050; WALKER GM, 1994, CRIT REV BIOTECHNOL, V14, P311, DOI 10.3109/07388559409063643; Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016; Zahringer F, 2013, STRUCTURE, V21, P1149, DOI 10.1016/j.str.2013.04.026; Zahringer F, 2011, APPL BIOCHEM BIOTECH, V163, P71, DOI 10.1007/s12010-010-9017-x	37	51	54	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6978	6990		10.1074/jbc.M113.516195	http://dx.doi.org/10.1074/jbc.M113.516195			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24451384	Green Published, hybrid			2022-12-28	WOS:000332389400058
J	Bojjireddy, N; Botyanszki, J; Hammond, G; Creech, D; Peterson, R; Kemp, DC; Snead, M; Brown, R; Morrison, A; Wilson, S; Harrison, S; Moore, C; Balla, T				Bojjireddy, Naveen; Botyanszki, Janos; Hammond, Gerald; Creech, Donald; Peterson, Richard; Kemp, Daniel C.; Snead, Mark; Brown, Randy; Morrison, Alastair; Wilson, Steve; Harrison, Steve; Moore, Chris; Balla, Tamas			Pharmacological and Genetic Targeting of the PI4KA Enzyme Reveals Its Important Role in Maintaining Plasma Membrane Phosphatidylinositol 4-Phosphate and Phosphatidylinositol 4,5-Bisphosphate Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiotensin II; G Protein-coupled Receptors; Phosphatidylinositol; Phosphatidylinositol Kinase; Phospholipase C	C VIRUS-REPLICATION; III-ALPHA; 4-KINASE; PHOSPHOINOSITIDES; DOMAINS; KINASE; POOLS; PTDINS(4,5)P-2; TRAFFICKING; ACTIVATION	Background: PI4KA is a critical host factor for replication of hepatitis C virus in liver and a potential therapeutic target. Results: PI4KA inhibitors prevent the maintenance of PtdIns(4,5)P-2 pools during strong PLC activation. Conclusion: PI4KA plays a critical role in maintaining plasma membrane phosphoinositide pools. Significance: Safe pharmacological targeting of PI4KA is not feasible. Phosphatidylinositol 4-kinase type III (PI4KA) is a host factor essential for hepatitis C virus replication and hence is a target for drug development. PI4KA has also been linked to endoplasmic reticulum exit sites and generation of plasma membrane phosphoinositides. Here, we developed highly specific and potent inhibitors of PI4KA and conditional knock-out mice to study the importance of this enzyme in vitro and in vivo. Our studies showed that PI4KA is essential for the maintenance of plasma membrane phosphatidylinositol 4,5-bisphosphate pools but only during strong stimulation of receptors coupled to phospholipase C activation. Pharmacological blockade of PI4KA in adult animals leads to sudden death closely correlating with the drug's ability to induce phosphatidylinositol 4,5-bisphosphate depletion after agonist stimulation. Genetic inactivation of PI4KA also leads to death; however, the cause in this case is due to severe intestinal necrosis. These studies highlight the risks of targeting PI4KA as an anti-hepatitis C virus strategy and also point to important distinctions between genetic and pharmacological studies when selecting host factors as putative therapeutic targets.	[Bojjireddy, Naveen; Hammond, Gerald; Balla, Tamas] Eunice Kennedy Shriver NICHD, Sect Mol Signal Transduct, Program Dev Neurosci, NIH, Bethesda, MD 20892 USA; [Botyanszki, Janos; Creech, Donald; Moore, Chris] GlaxoSmithKline, Infect Dis Discovery Performance Unit, Res Triangle Pk, NC 27709 USA; [Peterson, Richard; Kemp, Daniel C.; Brown, Randy] GlaxoSmithKline, Safety Assessment, Res Triangle Pk, NC 27709 USA; [Snead, Mark; Morrison, Alastair; Wilson, Steve; Harrison, Steve] GlaxoSmithKline, Lab Anim Serv, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Moore, C (corresponding author), GlaxoSmithKline, Infect Dis Discovery Performance Unit, Rm 3-3245,5 Moore Dr, Res Triangle Pk, NC 27709 USA.	christopher.b.moore@gsk.com; ballat@mail.nih.gov	Hammond, Gerald R/A-5759-2016	Hammond, Gerald R/0000-0002-6660-3272; Balla, Tamas/0000-0002-9077-3335	National Institutes of Health from the Intramural Research Program of the Eunice Kennedy Shriver NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000196] Funding Source: NIH RePORTER	National Institutes of Health from the Intramural Research Program of the Eunice Kennedy Shriver NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health grants from the Intramural Research Program of the Eunice Kennedy Shriver NICHD (to N. B., G. H., and T. B.).	Adams N. D., 2008, PCT International Patent Application, Patent No. [WO 2008157191 A2, 201287938A1]; Altan-Bonnet N, 2012, TRENDS BIOCHEM SCI, V37, P293, DOI 10.1016/j.tibs.2012.03.004; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; Baird D, 2008, J CELL BIOL, V183, P1061, DOI 10.1083/jcb.200804003; Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Balla A, 2008, MOL BIOL CELL, V19, P711, DOI 10.1091/mbc.E07-07-0713; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Balla Tamas, 2009, Curr Protoc Cell Biol, VChapter 24, DOI 10.1002/0471143030.cb2404s42; Banka A. L., 2012, PCT International Patent Application, Patent No. [WO 201287938 A1, 201287938A1]; Bengtsson M. L., 2006, PCT International Patent Application, Patent No. [WO 2006051270 A1, 201287938A1]; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Borawski J, 2009, J VIROL, V83, P10058, DOI 10.1128/JVI.02418-08; Botyanszki J., 2012, PCT International Patent Application, Patent No. [WO 2012174312 A2, 2012174312A2]; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; D'Angelo G, 2008, J CELL SCI, V121, P1955, DOI 10.1242/jcs.023630; D'Angelo Giovanni, 2012, Subcell Biochem, V59, P255, DOI 10.1007/978-94-007-3015-1_8; Downing GJ, 1996, BIOCHEMISTRY-US, V35, P3587, DOI 10.1021/bi9517493; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Hammond GRV, 2012, SCIENCE, V337, P727, DOI 10.1126/science.1222483; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Leivers A.L., 2013, J MED CHEM; Minogue Shane, 2012, Subcell Biochem, V58, P1, DOI 10.1007/978-94-007-3012-0_1; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Nakatsu F, 2012, J CELL BIOL, V199, P1003, DOI 10.1083/jcb.201206095; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Rozelle AL, 2000, CURR BIOL, V10, P311, DOI 10.1016/S0960-9822(00)00384-5; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Szentpetery Z, 2010, P NATL ACAD SCI USA, V107, P8225, DOI 10.1073/pnas.1000157107; Szentpetery Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-67; Tai AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026300; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Trotard M, 2009, FASEB J, V23, P3780, DOI 10.1096/fj.09-131920; Vaillancourt FH, 2012, J VIROL, V86, P11595, DOI 10.1128/JVI.01320-12; Vaillancourt FH, 2009, VIROLOGY, V387, P5, DOI 10.1016/j.virol.2009.02.039; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Verrou C, 1999, BIOL CHEM, V380, P1435, DOI 10.1515/BC.1999.184; Walch-Solimena C, 1999, NAT CELL BIOL, V1, P523, DOI 10.1038/70319; Wong K, 1997, J BIOL CHEM, V272, P13236, DOI 10.1074/jbc.272.20.13236	43	100	100	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6120	6132		10.1074/jbc.M113.531426	http://dx.doi.org/10.1074/jbc.M113.531426			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24415756	Green Published, hybrid			2022-12-28	WOS:000332015500066
J	Nakamoto, H; Fujita, K; Ohtaki, A; Watanabe, S; Narumi, S; Maruyama, T; Suenaga, E; Misono, TS; Kumar, PKR; Goloubinoff, P; Yoshikawa, H				Nakamoto, Hitoshi; Fujita, Kensaku; Ohtaki, Aguru; Watanabe, Satoru; Narumi, Shoichi; Maruyama, Takahiro; Suenaga, Emi; Misono, Tomoko S.; Kumar, Penmetcha K. R.; Goloubinoff, Pierre; Yoshikawa, Hirofumi			Physical Interaction between Bacterial Heat Shock Protein (Hsp) 90 and Hsp70 Chaperones Mediates Their Cooperative Action to Refold Denatured Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyanobacteria; Heat Shock Protein; Hsp90; Molecular Chaperone; Protein Aggregation; DnaJ; DnaK; Hsp70; HtpG	MOLECULAR CHAPERONE; ESCHERICHIA-COLI; CONFORMATIONAL DYNAMICS; MULTIGENE FAMILY; HTPG; DNAK; STABILIZES; PROTECTION; SYSTEM; GENE	Background: HtpG, a bacterial heat shock protein 90 (Hsp90), is essential for thermotolerance in some prokaryotes. Results: HtpG functions with DnaK2/DnaJ2/GrpE to assist unfolding/folding of denatured proteins in both ATP-dependent and -independent fashions. Conclusion: The cooperative action of HtpG and DnaK2 might play a key role under stress. Significance: This might be the first sign of a prokaryotic Hsp90 foldosome. In eukaryotes, heat shock protein 90 (Hsp90) is an essential ATP-dependent molecular chaperone that associates with numerous client proteins. HtpG, a prokaryotic homolog of Hsp90, is essential for thermotolerance in cyanobacteria, and in vitro it suppresses the aggregation of denatured proteins efficiently. Understanding how the non-native client proteins bound to HtpG refold is of central importance to comprehend the essential role of HtpG under stress. Here, we demonstrate by yeast two-hybrid method, immunoprecipitation assays, and surface plasmon resonance techniques that HtpG physically interacts with DnaJ2 and DnaK2. DnaJ2, which belongs to the type II J-protein family, bound DnaK2 or HtpG with submicromolar affinity, and HtpG bound DnaK2 with micromolar affinity. Not only DnaJ2 but also HtpG enhanced the ATP hydrolysis by DnaK2. Although assisted by the DnaK2 chaperone system, HtpG enhanced native refolding of urea-denatured lactate dehydrogenase and heat-denatured glucose-6-phosphate dehydrogenase. HtpG did not substitute for DnaJ2 or GrpE in the DnaK2-assisted refolding of the denatured substrates. The heat-denatured malate dehydrogenase that did not refold by the assistance of the DnaK2 chaperone system alone was trapped by HtpG first and then transferred to DnaK2 where it refolded. Dissociation of substrates from HtpG was either ATP-dependent or -independent depending on the substrate, indicating the presence of two mechanisms of cooperative action between the HtpG and the DnaK2 chaperone system.	[Nakamoto, Hitoshi; Fujita, Kensaku; Ohtaki, Aguru; Narumi, Shoichi; Maruyama, Takahiro] Saitama Univ, Dept Biochem & Mol Biol, Saitama 3388570, Japan; [Nakamoto, Hitoshi] Saitama Univ, Inst Environm Sci & Technol, Saitama 3388570, Japan; [Watanabe, Satoru; Yoshikawa, Hirofumi] Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo 1568502, Japan; [Suenaga, Emi; Misono, Tomoko S.; Kumar, Penmetcha K. R.] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki 3058566, Japan; [Goloubinoff, Pierre] Univ Lausanne, Fac Biol & Med, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland; [Yoshikawa, Hirofumi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Saitama 3320012, Japan	Saitama University; Saitama University; Tokyo University of Agriculture; National Institute of Advanced Industrial Science & Technology (AIST); University of Lausanne; Japan Science & Technology Agency (JST)	Nakamoto, H (corresponding author), Saitama Univ, Dept Biochem & Mol Biol, Saitama 3388570, Japan.	nakamoto@mail.saitama-u.ac.jp	Nakamoto, Hitoshi/H-5315-2012; Penmetcha, Kumar/K-8834-2017	Penmetcha, Kumar/0000-0002-3512-704X; Goloubinoff, Pierre/0000-0002-4802-0807	Ministry of Education, Science, Sports and Culture of Japan [24580102]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid for Scientific Research (C) 24580102 (to H. N.) from the Ministry of Education, Science, Sports and Culture of Japan.	Arike L, 2012, J PROTEOMICS, V75, P5437, DOI 10.1016/j.jprot.2012.06.020; BARDWELL JCA, 1988, J BACTERIOL, V170, P2977, DOI 10.1128/jb.170.7.2977-2983.1988; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Dang W, 2011, VET MICROBIOL, V152, P394, DOI 10.1016/j.vetmic.2011.05.030; Diamant S, 2000, J BIOL CHEM, V275, P21107, DOI 10.1074/jbc.M001293200; Finka A, 2013, CELL STRESS CHAPERON, V18, P591, DOI 10.1007/s12192-013-0413-3; Garcia-Descalzo L, 2011, CELL STRESS CHAPERON, V16, P203, DOI 10.1007/s12192-010-0233-7; Genest O, 2011, P NATL ACAD SCI USA, V108, P8206, DOI 10.1073/pnas.1104703108; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; Hinault MP, 2010, J BIOL CHEM, V285, P38173, DOI 10.1074/jbc.M110.127753; Hossain M, 2003, CURR MICROBIOL, V46, P70, DOI 10.1007/s00284-002-3831-5; Hossain MM, 2002, CURR MICROBIOL, V44, P291, DOI 10.1007/s00284-001-0005-9; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Mayer MP, 1999, J MOL BIOL, V289, P1131, DOI 10.1006/jmbi.1999.2844; Miyata Y, 2013, CURR PHARM DESIGN, V19, P347, DOI 10.2174/138161213804143725; Motojima-Miyazaki Y, 2010, BIOCHEM BIOPH RES CO, V400, P241, DOI 10.1016/j.bbrc.2010.08.047; Nimura K, 2001, J BACTERIOL, V183, P1320, DOI 10.1128/JB.183.4.1320-1328.2001; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Roe SM, 1999, J MED CHEM, V42, P260, DOI 10.1021/jm980403y; Rowland JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010511; Roy SK, 1999, EUR J BIOCHEM, V262, P406, DOI 10.1046/j.1432-1327.1999.00380.x; Sato M, 2007, BIOSCI BIOTECH BIOCH, V71, P1021, DOI 10.1271/bbb.60691; Sato T, 2010, MOL MICROBIOL, V76, P576, DOI 10.1111/j.1365-2958.2010.07139.x; Sharma SK, 2010, NAT CHEM BIOL, V6, P914, DOI 10.1038/NCHEMBIO.455; Tanaka N, 1999, FEBS LETT, V458, P117, DOI 10.1016/S0014-5793(99)01134-5; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; Versteeg S, 1999, MOL GEN GENET, V261, P582, DOI 10.1007/s004380051004; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Watanabe S, 2007, BIOSCI BIOTECH BIOCH, V71, P279, DOI 10.1271/bbb.60647; Watanabe S, 2007, BIOCHEM BIOPH RES CO, V352, P36, DOI 10.1016/j.bbrc.2006.10.144; Wegele H, 2006, J MOL BIOL, V356, P802, DOI 10.1016/j.jmb.2005.12.008; WIECH H, 1992, NATURE, V358, P169, DOI 10.1038/358169a0	35	53	53	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6110	6119		10.1074/jbc.M113.524801	http://dx.doi.org/10.1074/jbc.M113.524801			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24415765	Green Published, hybrid			2022-12-28	WOS:000332015500065
J	Minicozzi, V; Chiaraluce, R; Consalvi, V; Giordano, C; Narcisi, C; Punzi, P; Rossi, GC; Morante, S				Minicozzi, Velia; Chiaraluce, Roberta; Consalvi, Valerio; Giordano, Cesare; Narcisi, Claudia; Punzi, Pasqualina; Rossi, Giancarlo C.; Morante, Silvia			Computational and Experimental Studies on beta-Sheet Breakers Targeting A beta(1-40) Fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Fluorescence; Mass Spectrometry (MS); Molecular Dynamics; Protein Misfolding; Amyloid Peptide; -Sheet Breakers	IONIZATION MASS-SPECTROMETRY; ALZHEIMERS-DISEASE; MOLECULAR-DYNAMICS; AMYLOID FIBRILS; PEPTIDE; AGGREGATION; INHIBITORS; FIBRILLOGENESIS; CONFORMATION; SIMULATIONS	Background: -Amyloid aggregates are at the basis of Alzheimer disease development. Short synthetic peptides are seen to inhibit polymerization. Results: Various synthetic peptides have been studied by MD simulations and tested experimentally. Conclusion: Combined results indicate Ac-LPFFN-NH2 as an effective lead compound able to slow down A(1-40) aggregation. Significance: Designing potential A aggregation inhibitors will help fight Alzheimer disease. In this work we present and compare the results of extensive molecular dynamics simulations of model systems comprising an A(1-40) peptide in water in interaction with short peptides (-sheet breakers) mimicking the 17-21 region of the A(1-40) sequence. Various systems differing in the customized -sheet breaker structure have been studied. Specifically we have considered three kinds of -sheet breakers, namely Ac-LPFFD-NH2 and two variants thereof, one obtained by substituting the acetyl group with the sulfonic amino acid taurine (Tau-LPFFD-NH2) and a second novel one in which the aspartic acid is substituted by an asparagine (Ac-LPFFN-NH2). Thioflavin T fluorescence, circular dichroism, and mass spectrometry experiments have been performed indicating that -sheet breakers are able to inhibit in vitro fibril formation and prevent the sheet folding of portions of the A(1-40) peptide. We show that molecular dynamics simulations and far UV circular dichroism provide consistent evidence that the new Ac-LPFFN-NH2 -sheet breaker is more effective than the other two in stabilizing the native -helix structure of A(1-40). In agreement with these results thioflavin T fluorescence experiments confirm the higher efficiency in inhibiting A(1-40) aggregation. Furthermore, mass spectrometry data and molecular dynamics simulations consistently identified the 17-21 A(1-40) portion as the location of the interaction region between peptide and the Ac-LPFFN-NH2 -sheet breaker.	[Minicozzi, Velia; Narcisi, Claudia; Rossi, Giancarlo C.; Morante, Silvia] Univ Roma Tor Vergata, Dept Phys, I-00133 Rome, Italy; [Minicozzi, Velia; Narcisi, Claudia; Rossi, Giancarlo C.; Morante, Silvia] Ist Nazl Fis Nucl, I-00133 Rome, Italy; [Chiaraluce, Roberta; Consalvi, Valerio] Univ Roma La Sapienza, Dept Biochem, I-00185 Rome, Italy; [Giordano, Cesare] Univ Roma La Sapienza, Biomol Chem CNR Inst, I-00185 Rome, Italy; [Punzi, Pasqualina] Univ Roma La Sapienza, Dept Chem, I-00185 Rome, Italy	University of Rome Tor Vergata; Istituto Nazionale di Fisica Nucleare (INFN); Sapienza University Rome; Sapienza University Rome; Sapienza University Rome	Minicozzi, V (corresponding author), Univ Roma Tor Vergata, Dept Phys, Viadella Ric,Sci 1, I-00133 Rome, Italy.	minicozzi@roma2.infn.it	consalvi, valerio/F-1918-2011	Minicozzi, Velia/0000-0001-9851-9932; Morante, Silvia/0000-0002-3913-5733; Rossi, Giancarlo/0000-0001-9688-9454	PAT; INFN	PAT; INFN(Istituto Nazionale di Fisica Nucleare (INFN))	We thank the AuroraScience project (funded by PAT and INFN) for allocating the computing resources for this project.	Adessi C, 2003, J BIOL CHEM, V278, P13905, DOI 10.1074/jbc.M211976200; Allen M.P., 1987, COMPUTER SIMULATION, DOI [10.2307/2938686, DOI 10.2307/2938686]; Atherton E., 1989, SOLID PHASE SYNTHESI; Bartolini M, 2007, CHEMBIOCHEM, V8, P2152, DOI 10.1002/cbic.200700427; Bazoti FN, 2005, J MASS SPECTROM, V40, P182, DOI 10.1002/jms.738; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Brouwer AJ, 2000, SYNTHESIS-STUTTGART, P1579; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Crescenzi O, 2002, EUR J BIOCHEM, V269, P5642, DOI 10.1046/j.1432-1033.2002.03271.x; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ghanta J, 1996, J BIOL CHEM, V271, P29525, DOI 10.1074/jbc.271.47.29525; Giannozzi P, 2012, METALLOMICS, V4, P156, DOI 10.1039/c2mt00148a; Giordano C, 2012, CHEM BIOL DRUG DES, V79, P30, DOI 10.1111/j.1747-0285.2011.01259.x; Giordano C, 2009, EUR J MED CHEM, V44, P179, DOI 10.1016/j.ejmech.2008.03.036; Gordon DJ, 2003, BIOCHEMISTRY-US, V42, P475, DOI 10.1021/bi0259857; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HILBICH C, 1992, J MOL BIOL, V228, P460, DOI 10.1016/0022-2836(92)90835-8; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Ionescu RM, 2000, BIOCHEMISTRY-US, V39, P9540, DOI 10.1021/bi000511y; Ito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030510; Ito M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017587; JOHNSON WC, 1992, METHOD ENZYMOL, V210, P426; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Laczko I, 2008, J PEPT SCI, V14, P731, DOI 10.1002/psc.990; Lemkul JA, 2012, ACS CHEM NEUROSCI, V3, P845, DOI 10.1021/cn300091a; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Loo JA, 2000, INT J MASS SPECTROM, V200, P175, DOI 10.1016/S1387-3806(00)00298-0; MAIOROV VN, 1995, PROTEINS, V22, P273, DOI 10.1002/prot.340220308; Malde AK, 2011, J CHEM THEORY COMPUT, V7, P4026, DOI 10.1021/ct200196m; Miller Y, 2010, P NATL ACAD SCI USA, V107, P9490, DOI 10.1073/pnas.0913114107; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Novick PA, 2012, J MED CHEM, V55, P3002, DOI 10.1021/jm201332p; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Pepys MB, 2001, PHILOS T R SOC B, V356, P203, DOI 10.1098/rstb.2000.0766; Permanne B, 2002, FASEB J, V16, P860, DOI 10.1096/fj.01-0841fje; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822; Soto C, 1996, BIOCHEM BIOPH RES CO, V226, P672, DOI 10.1006/bbrc.1996.1413; Soto C, 1999, MOL MED TODAY, V5, P343, DOI 10.1016/S1357-4310(99)01508-7; SOTO C, 1995, J BIOL CHEM, V270, P3063, DOI 10.1074/jbc.270.7.3063; Tomaselli S, 2006, CHEMBIOCHEM, V7, P257, DOI 10.1002/cbic.200500223; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Woody R. W., 1996, CIRCULAR DICHROISM C, P25	49	54	55	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11242	11252		10.1074/jbc.M113.537472	http://dx.doi.org/10.1074/jbc.M113.537472			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24584938	hybrid, Green Published			2022-12-28	WOS:000334638500027
J	Braunger, JA; Bruckner, BR; Nehls, S; Pietuch, A; Gerke, V; Mey, I; Janshoff, A; Steinem, C				Braunger, Julia A.; Brueckner, Bastian R.; Nehls, Stefan; Pietuch, Anna; Gerke, Volker; Mey, Ingo; Janshoff, Andreas; Steinem, Claudia			Phosphatidylinositol 4,5-Bisphosphate Alters the Number of Attachment Sites between Ezrin and Actin Filaments A COLLOIDAL PROBE STUDY*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Atomic Force Microscopy; Ezrin; Phosphatidylinositol; Phosphorylation	ATOMIC-FORCE MICROSCOPE; ERM PROTEINS; PLASMA-MEMBRANE; 4,5 BISPHOSPHATE; CELL-ADHESION; IN-VIVO; ACTIVATION; BINDING; PHOSPHORYLATION; MOESIN	Background: Ezrin can establish a dynamic linkage between plasma membrane and cytoskeleton. Results: The individual bond strength between ezrin and F-actin is small, but the number of attachment sites is significantly altered by phosphatidylinositol 4,5-bisphosphate (PIP2). Conclusion: PIP2 activates ezrin to establish multiple weak ezrin/F-actin interactions. Significance: Plasma membrane tension is maintained by ezrin/F-actin interactions. Direct linkage between the plasma membrane and the actin cytoskeleton is controlled by the protein ezrin, a member of the ezrin-radixin-moesin protein family. To function as a membrane-cytoskeleton linker, ezrin needs to be activated in a process that involves binding of ezrin to phosphatidylinositol 4,5-bisphosphate (PIP2) and phosphorylation of a conserved threonine residue. Here, we used colloidal probe microscopy to quantitatively analyze the interaction between ezrin and F-actin as a function of these activating factors. We show that the measured individual unbinding forces between ezrin and F-actin are independent of the activating parameters, in the range of approximately 50 piconewtons. However, the cumulative adhesion energy greatly increases in the presence of PIP2 demonstrating that a larger number of bonds between ezrin and F-actin has formed. In contrast, the phosphorylation state, represented by phosphor-mimetic mutants of ezrin, only plays a minor role in the activation process. These results are in line with in vivo experiments demonstrating that an increase in PIP2 concentration recruits more ezrin to the apical plasma membrane of polarized cells and significantly increases the membrane tension serving as a measure of the adhesion sites between the plasma membrane and the F-actin network.	[Steinem, Claudia] Univ Gottingen, Inst Organ & Biomol Chem, D-37077 Gottingen, Germany; [Brueckner, Bastian R.; Nehls, Stefan; Pietuch, Anna; Janshoff, Andreas] Univ Gottingen, Inst Phys Chem, D-37077 Gottingen, Germany; [Gerke, Volker] Univ Munster, Inst Med Biochem, Ctr Mol Biol Inflammat, D-48149 Munster, Germany	University of Gottingen; University of Gottingen; University of Munster	Steinem, C (corresponding author), Univ Gottingen, Inst Organ & Biomol Chem, Tammannstr 2, D-37077 Gottingen, Germany.	csteine@gwdg.de	Steinem, Claudia/K-7534-2018; Steinem, Claudia/O-4801-2019	Steinem, Claudia/0000-0001-8778-9283; Janshoff, Andreas/0000-0002-0773-2963; Bruckner, Bastian Rouven/0000-0002-2860-3538	Deutsche Forschungsgemeinschaft [STE 884/11-1, GE 514/8-1, GE 514/9-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant STE 884/11-1, GE 514/8-1, and GE 514/9-1.	Arpin M, 2011, CELL ADHES MIGR, V5, P199, DOI 10.4161/cam.5.2.15081; Ben-Aissa K, 2012, J BIOL CHEM, V287, P16311, DOI 10.1074/jbc.M111.304881; Bizzarri AR, 2010, CHEM SOC REV, V39, P734, DOI 10.1039/b811426a; Bosk S, 2011, BIOPHYS J, V100, P1708, DOI 10.1016/j.bpj.2011.02.039; Brambilla D, 2009, INT J CANCER, V125, P2239, DOI 10.1002/ijc.24734; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bretscher A, 1997, J CELL SCI, V110, P3011; Brochard-Wyart F, 2006, P NATL ACAD SCI USA, V103, P7660, DOI 10.1073/pnas.0602012103; Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003; Carvalho K, 2010, BIOCHEMISTRY-US, V49, P9318, DOI 10.1021/bi101141d; Chambers DN, 2005, BIOCHEMISTRY-US, V44, P3926, DOI 10.1021/bi0480382; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Crepaldi T, 1997, J CELL BIOL, V138, P423, DOI 10.1083/jcb.138.2.423; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; Diz-Munoz A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000544; Erdmann T, 2004, J CHEM PHYS, V121, P8997, DOI 10.1063/1.1805496; Evans E, 1997, BIOPHYS J, V72, P1541, DOI 10.1016/S0006-3495(97)78802-7; Evans E, 1999, BIOPHYS J, V76, P2439, DOI 10.1016/S0006-3495(99)77399-6; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Fievet BT, 2004, J CELL BIOL, V164, P653, DOI 10.1083/jcb.200307032; Gandy KAO, 2013, BIOCHEM J, V449, P661, DOI 10.1042/BJ20120213; GARY R, 1995, MOL BIOL CELL, V6, P1061, DOI 10.1091/mbc.6.8.1061; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Golebiewska U, 2008, MOL BIOL CELL, V19, P1663, DOI 10.1091/mbc.E07-12-1208; Herrig A, 2006, BIOCHEMISTRY-US, V45, P13025, DOI 10.1021/bi061064a; Hertz H., 1882, J ANGEW MATH, V92, P156, DOI [10.1515/9783112342404-004, DOI 10.1515/CRLL.1882.92.156, 10.1515/crll.1882.92.156]; Hochmuth RM, 2002, BIOPHYS J, V82, P2964, DOI 10.1016/S0006-3495(02)75637-3; Hoeflich KP, 2003, BIOCHEMISTRY-US, V42, P11634, DOI 10.1021/bi0350497; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Janke M, 2008, BIOCHEMISTRY-US, V47, P3762, DOI 10.1021/bi702542s; Jayasundar JJ, 2012, J BIOL CHEM, V287, P37119, DOI 10.1074/jbc.M112.380972; Koltzscher M, 2003, MOL BIOL CELL, V14, P2372, DOI 10.1091/mbc.E02-09-0553; Krieg M, 2008, ANGEW CHEM INT EDIT, V47, P9775, DOI 10.1002/anie.200803552; LaLonde DP, 2010, MOL BIOL CELL, V21, P1519, DOI 10.1091/mbc.E10-01-0008; Larson SM, 2010, MOL BIOL CELL, V21, P3182, DOI 10.1091/mbc.E10-01-0066; Liu Y, 2012, BLOOD, V119, P445, DOI 10.1182/blood-2011-07-368860; Lorenz B, 2012, J AM CHEM SOC, V134, P3326, DOI 10.1021/ja210304j; Lorenz B, 2010, BIOPHYS CHEM, V150, P54, DOI 10.1016/j.bpc.2010.02.008; Maniti O, 2012, BBA-BIOMEMBRANES, V1818, P2839, DOI 10.1016/j.bbamem.2012.07.004; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Moens PDJ, 2007, BBA-BIOMEMBRANES, V1768, P439, DOI 10.1016/j.bbamem.2006.12.012; Nakamura F, 1995, J BIOL CHEM, V270, P31377, DOI 10.1074/jbc.270.52.31377; Ng T, 2001, EMBO J, V20, P2723, DOI 10.1093/emboj/20.11.2723; NIGGLI V, 1995, FEBS LETT, V376, P172, DOI 10.1016/0014-5793(95)01270-1; Pietuch A, 2013, SOFT MATTER, V9, P11490, DOI 10.1039/c3sm51610e; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Ren L, 2009, ONCOGENE, V28, P792, DOI 10.1038/onc.2008.437; Roch F, 2010, J CELL SCI, V123, P2057, DOI 10.1242/jcs.064550; Sader JE, 1999, REV SCI INSTRUM, V70, P3967, DOI 10.1063/1.1150021; Saotome I, 2004, DEV CELL, V6, P855, DOI 10.1016/j.devcel.2004.05.007; Seifert U, 2000, PHYS REV LETT, V84, P2750, DOI 10.1103/PhysRevLett.84.2750; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Simons PC, 1998, BIOCHEM BIOPH RES CO, V253, P561, DOI 10.1006/bbrc.1998.9823; Yonemura S, 2002, J CELL SCI, V115, P2569; Yonemura S, 1999, J CELL BIOL, V145, P1497, DOI 10.1083/jcb.145.7.1497; Zwaenepoel I, 2012, MOL BIOL CELL, V23, P1080, DOI 10.1091/mbc.E11-07-0588	57	26	26	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9833	9843		10.1074/jbc.M113.530659	http://dx.doi.org/10.1074/jbc.M113.530659			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24500715	Green Published, hybrid			2022-12-28	WOS:000333807000033
J	Byrns, CN; Pitts, MW; Gilman, CA; Hashimoto, AC; Berry, MJ				Byrns, China N.; Pitts, Matthew W.; Gilman, Christy A.; Hashimoto, Ann C.; Berry, Marla J.			Mice Lacking Selenoprotein P and Selenocysteine Lyase Exhibit Severe Neurological Dysfunction, Neurodegeneration, and Audiogenic Seizures*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epilepsy; Neurodegeneration; Oxidative Stress; Selenocysteine; Selenoprotein; Inferior Colliculus; Parvalbumin Interneurons; Selenocysteine Lyase; Selenoprotein P	INFERIOR COLLICULUS; INHIBITORY NEURONS; OXIDATIVE STRESS; BRAIN SELENIUM; DEFICIENCY; PARVALBUMIN; EXPRESSION; DELETION; INTERNEURONS; DISRUPTION	Background: Selenoproteins play a critical role in neuroprotection. Results: Deletion of selenocysteine lyase (Scly) in combination with selenoprotein P (Sepp1) further aggravates the phenotype of Sepp1(-/-) mice, as Scly(-/-)Sepp1(-/-) mice have impaired survival and surviving mice exhibit neurological dysfunction. Conclusion: Sepp1 and Scly work cooperatively to maintain selenoprotein function in the brain. Significance: Deficient brain selenoprotein levels may contribute to epilepsy and neurodegeneration. Selenoproteins are a unique family of proteins, characterized by the co-translational incorporation of selenium as selenocysteine, which play key roles in antioxidant defense. Among selenoproteins, selenoprotein P (Sepp1) is particularly distinctive due to the fact that it contains multiple selenocysteine residues and has been postulated to act in selenium transport. Within the brain, Sepp1 delivers selenium to neurons by binding to the ApoER2 receptor. Upon feeding a selenium-deficient diet, mice lacking ApoER2 or Sepp1 develop severe neurological dysfunction and exhibit widespread brainstem neurodegeneration, indicating an important role for ApoER2-mediated Sepp1 uptake in normal brain function. Selenocysteine lyase (Scly) is an enzyme that plays an important role in selenium homeostasis, in that it catalyzes the decomposition of selenocysteine and allows selenium to be recycled for additional selenoprotein synthesis. We previously reported that constitutive deletion of Scly results in neurological deficits only when mice are challenged with a low selenium diet. To gain insight into the relationship between Sepp1 and Scly in selenium metabolism, we created novel transgenic mice constitutively lacking both genes (Scly(-/-)Sepp1(-/-)) and characterized the neurobehavioral phenotype. We report that deletion of Scly in conjunction with Sepp1 further aggravates the phenotype of Sepp1(-/-) mice, as these mice needed supraphysiological selenium supplementation to survive, and surviving mice exhibited impaired motor coordination, audiogenic seizures, and brainstem neurodegeneration. These findings provide the first in vivo evidence that Scly and Sepp1 work cooperatively to maintain selenoprotein function in the mammalian brain.	[Byrns, China N.; Pitts, Matthew W.; Gilman, Christy A.; Hashimoto, Ann C.; Berry, Marla J.] Univ Hawaii, Dept Cell & Mol Biol, John A Burns Sch Med, Honolulu, HI 96813 USA	University of Hawaii System	Pitts, MW (corresponding author), 651 Ilalo St, Honolulu, HI 96813 USA.	mwpitts@hawaii.edu		Pitts, Matthew/0000-0002-0994-7466; Byrns, China/0000-0002-8091-9353	National Institutes of Health [RO1 DK47320, G12 MD007601, G12 RR003061]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103341] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK47320, G12 MD007601, and G12 RR003061.	Agamy O, 2010, AM J HUM GENET, V87, P538, DOI 10.1016/j.ajhg.2010.09.007; Ashrafi MR, 2007, EPILEPSIA, V48, P1750, DOI 10.1111/j.1528-1167.2007.01143.x; Behrens MM, 2007, SCIENCE, V318, P1645, DOI 10.1126/science.1148045; Burk RF, 2007, J NEUROSCI, V27, P6207, DOI 10.1523/JNEUROSCI.1153-07.2007; Burk RF, 2009, BBA-GEN SUBJECTS, V1790, P1441, DOI 10.1016/j.bbagen.2009.03.026; Cabungcal JH, 2013, BIOL PSYCHIAT, V73, P574, DOI 10.1016/j.biopsych.2012.09.020; Caito SW, 2011, BRAIN RES, V1398, P1, DOI 10.1016/j.brainres.2011.04.046; Carlson BA, 2009, BIOCHEM J, V418, P61, DOI 10.1042/BJ20081304; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; ESAKI N, 1982, J BIOL CHEM, V257, P4386; FAINGOLD CL, 1986, EXP NEUROL, V93, P145, DOI 10.1016/0014-4886(86)90154-8; FAINGOLD CL, 1991, EXP NEUROL, V113, P354, DOI 10.1016/0014-4886(91)90026-9; Faingold CL, 2002, HEARING RES, V168, P223, DOI 10.1016/S0378-5955(02)00373-8; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Gulyas AI, 2006, EUR J NEUROSCI, V23, P2581, DOI 10.1111/j.1460-9568.2006.04814.x; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Hill KE, 2004, J NUTR, V134, P157, DOI 10.1093/jn/134.1.157; JAY TM, 1988, J CEREBR BLOOD F MET, V8, P121, DOI 10.1038/jcbfm.1988.16; Jiang ZH, 2013, BIOL PSYCHIAT, V73, P1024, DOI 10.1016/j.biopsych.2012.12.004; Kinney JW, 2006, J NEUROSCI, V26, P1604, DOI 10.1523/JNEUROSCI.4722-05.2006; Kurokawa S, 2011, J NUTR SCI VITAMINOL, V57, P298, DOI 10.3177/jnsv.57.298; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lucas EK, 2010, J NEUROSCI, V30, P7227, DOI 10.1523/JNEUROSCI.0698-10.2010; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Peters MM, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-12; Pitts MW, 2012, NEUROSCIENCE, V208, P58, DOI 10.1016/j.neuroscience.2012.02.017; RAMAEKERS VT, 1994, NEUROPEDIATRICS, V25, P217, DOI 10.1055/s-2008-1073025; Raman AV, 2012, GENES BRAIN BEHAV, V11, P601, DOI 10.1111/j.1601-183X.2012.00794.x; Ross KC, 2000, NEUROSCI BIOBEHAV R, V24, P639, DOI 10.1016/S0149-7634(00)00029-4; Scharpf M, 2007, J NEURAL TRANSM, V114, P877, DOI 10.1007/s00702-006-0617-0; Schoenmakers E, 2010, J CLIN INVEST, V120, P4220, DOI 10.1172/JCI43653; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Schweizer U, 2004, BIOCHEM J, V378, P21, DOI 10.1042/BJ20031795; Schweizer U, 2005, BIOCHEM J, V386, P221, DOI 10.1042/BJ20041973; Schweizer U, 2011, CURR OPIN PEDIATR, V23, P429, DOI 10.1097/MOP.0b013e32834877da; Seale LA, 2012, MOL CELL BIOL, V32, P4141, DOI 10.1128/MCB.00293-12; SOKOLOFF L, 1981, J CEREBR BLOOD F MET, V1, P7, DOI 10.1038/jcbfm.1981.4; Valentine WM, 2008, J NEUROPATH EXP NEUR, V67, P68, DOI 10.1097/NEN.0b013e318160f347; WEBER GF, 1991, LANCET, V337, P1443, DOI 10.1016/0140-6736(91)93130-2; Wirth EK, 2010, FASEB J, V24, P844, DOI 10.1096/fj.09-143974	40	43	43	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9662	9674		10.1074/jbc.M113.540682	http://dx.doi.org/10.1074/jbc.M113.540682			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24519931	Green Published, hybrid			2022-12-28	WOS:000333807000020
J	Liu, PY; Xiang, YH; Fujinaga, K; Bartholomeeusen, K; Nilson, KA; Price, DH; Peterlin, BM				Liu, Pingyang; Xiang, Yanhui; Fujinaga, Koh; Bartholomeeusen, Koen; Nilson, Kyle A.; Price, David H.; Peterlin, B. Matija			Release of Positive Transcription Elongation Factor b(P-TEFb)from 7SK Small Nuclear Ribonucleoprotein ( snRNP) Activates Hexamethylene Bisacetamide- inducible Protein ( HEXIM1) Transcription*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclin-dependent Kinase (CDK); Cyclins; Promoters; RNA Polymerase II; Transcription	RNA-POLYMERASE-II; C-TERMINAL DOMAIN; HEAT-SHOCK GENES; B P-TEFB; IN-VIVO; EUKARYOTIC TRANSCRIPTION; COUPLES TRANSCRIPTION; HIV TRANSCRIPTION; CTD KINASE; COMPLEX	Background: HEXIM1 inhibits P-TEFb in the 7SK snRNP. Results: The critical promoter driving HEXIM1 expression was identified and was found to respond to levels of free P-TEFb. Conclusion: HEXIM1 expression levels rise to compensate for excessive P-TEFb activity. Significance: Increased levels of free P-TEFb lead to induction of HEXIM1 to maintain transcriptional homeostasis. By phosphorylating negative elongation factors and the C-terminal domain of RNA polymerase II (RNAPII), positive transcription elongation factor b (P-TEFb), which is composed of CycT1 or CycT2 and CDK9, activates eukaryotic transcription elongation. In growing cells, it is found in active and inactive forms. In the former, free P-TEFb is a potent transcriptional coactivator. In the latter, it is inhibited by HEXIM1 or HEXIM2 in the 7SK small nuclear ribonucleoprotein (snRNP), which contains, additionally, 7SK snRNA, methyl phosphate-capping enzyme (MePCE), and La-related protein 7 (LARP7). This P-TEFb equilibrium determines the state of growth and proliferation of the cell. In this study, the release of P-TEFb from the 7SK snRNP led to increased synthesis of HEXIM1 but not HEXIM2 in HeLa cells, and this occurred only from an unannotated, proximal promoter. ChIP with sequencing revealed P-TEFb-sensitive poised RNA polymerase II at this proximal but not the previously annotated distal HEXIM1 promoter. Its immediate upstream sequences were fused to luciferase reporters and were found to be responsive to many P-TEFb-releasing compounds. The superelongation complex subunits AF4/FMR2 family member 4 (AFF4) and elongation factor RNA polymerase II 2 (ELL2) were recruited to this proximal promoter after P-TEFb release and were required for its transcriptional effects. Thus, P-TEFb regulates its own equilibrium in cells, most likely to maintain optimal cellular homeostasis.	[Liu, Pingyang; Xiang, Yanhui; Fujinaga, Koh; Bartholomeeusen, Koen; Peterlin, B. Matija] Univ Calif San Francisco, Rosalind Russell Med Res Ctr, Dept Med, San Francisco, CA 94143 USA; [Liu, Pingyang; Xiang, Yanhui; Fujinaga, Koh; Bartholomeeusen, Koen; Peterlin, B. Matija] Univ Calif San Francisco, Rosalind Russell Med Res Ctr, Dept Microbiol, San Francisco, CA 94143 USA; [Liu, Pingyang; Xiang, Yanhui; Fujinaga, Koh; Bartholomeeusen, Koen; Peterlin, B. Matija] Univ Calif San Francisco, Rosalind Russell Med Res Ctr, Dept Immunol, San Francisco, CA 94143 USA; [Nilson, Kyle A.; Price, David H.] Univ Iowa, Mol & Cellular Biol Program, Iowa City, IA 52242 USA; [Price, David H.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Iowa; University of Iowa	Peterlin, BM (corresponding author), UCSF, Rm U432,533 Parnassus Ave, San Francisco, CA 94143 USA.	matija.peterlin@ucsf.edu	bartholomeeusen, koen/J-1843-2015; Liu, Pingyang/G-7796-2014	bartholomeeusen, koen/0000-0001-9576-2400; Liu, Pingyang/0000-0001-5060-5807; Price, David/0000-0002-5597-385X	National Institutes of Health Collaboratory of AIDS Researchers for Eradication (CARE) Center [U19 AI096113]; HIV Accessory and Regulatory Complexes (HARC) Center [P50 GM082250, RO1 AI049104, GM35500]; University of Iowa; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049104, U19AI096113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250, R01GM035500] Funding Source: NIH RePORTER	National Institutes of Health Collaboratory of AIDS Researchers for Eradication (CARE) Center; HIV Accessory and Regulatory Complexes (HARC) Center; University of Iowa; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Collaboratory of AIDS Researchers for Eradication (CARE) Center Grant U19 AI096113, HIV Accessory and Regulatory Complexes (HARC) Center Grant P50 GM082250, Grant RO1 AI049104 (to B. M. P.), and Grant GM35500 (to D. H. P.). This work was also supported by a University of Iowa Presidential Graduate Fellowship (to K. A. N.).	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Barboric M, 2009, P NATL ACAD SCI USA, V106, P7798, DOI 10.1073/pnas.0903188106; Bartholomeeusen K, 2013, J BIOL CHEM, V288, P14400, DOI 10.1074/jbc.M113.464834; Bartholomeeusen K, 2012, J BIOL CHEM, V287, P36609, DOI 10.1074/jbc.M112.410746; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Blazek D, 2005, NUCLEIC ACIDS RES, V33, P7000, DOI 10.1093/nar/gki997; Blazek D, 2011, GENE DEV, V25, P2158, DOI 10.1101/gad.16962311; Castelo-Branco G, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r98; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen RC, 2008, GENE DEV, V22, P1356, DOI 10.1101/gad.1636008; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; FEAVER WJ, 1994, CELL, V79, P1103, DOI 10.1016/0092-8674(94)90040-X; Fujinaga K, 2012, NUCLEIC ACIDS RES, V40, P9160, DOI 10.1093/nar/gks682; Guo JN, 2013, CHEM REV, V113, P8583, DOI 10.1021/cr400105n; He NH, 2006, MOL CELL BIOL, V26, P7068, DOI 10.1128/MCB.00778-06; He NH, 2011, P NATL ACAD SCI USA, V108, pE636, DOI 10.1073/pnas.1107107108; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Krueger BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012335; Li QT, 2007, NUCLEIC ACIDS RES, V35, P2503, DOI 10.1093/nar/gkm150; Lin X, 2002, J BIOL CHEM, V277, P16873, DOI 10.1074/jbc.M200117200; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275; OBRIEN T, 1994, NATURE, V370, P75, DOI 10.1038/370075a0; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Peterlin BM, 2012, WIRES RNA, V3, P92, DOI 10.1002/wrna.106; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; RASMUSSEN EB, 1993, P NATL ACAD SCI USA, V90, P7923, DOI 10.1073/pnas.90.17.7923; ROEDER RG, 1991, TRENDS BIOCHEM SCI, V16, P402, DOI 10.1016/0968-0004(91)90164-Q; STROBL LJ, 1992, EMBO J, V11, P3307, DOI 10.1002/j.1460-2075.1992.tb05409.x; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Taube R, 2013, VIRUSES-BASEL, V5, P902, DOI 10.3390/v5030902	40	38	39	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9918	9925		10.1074/jbc.M113.539015	http://dx.doi.org/10.1074/jbc.M113.539015			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24515107	Green Published, hybrid			2022-12-28	WOS:000333807000041
J	Liu, ZH; Li, FD; Ruan, K; Zhang, JH; Mei, YD; Wu, JH; Shi, YY				Liu, Zhonghua; Li, Fudong; Ruan, Ke; Zhang, Jiahai; Mei, Yide; Wu, Jihui; Shi, Yunyu			Structural and Functional Insights into the Human Borjeson- Forssman- Lehmann Syndrome- associated Protein PHF6*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Genetic Diseases; Protein-DNA Interaction; Protein Folding; Transcription Regulation; Tumor Suppressor Gene; BFLS; NuRD; PHF6; RBBP4; Extended PHD	ACUTE LYMPHOBLASTIC-LEUKEMIA; PHF6 MUTATION; PHD FINGER; INTELLECTUAL DISABILITY; BINDING; REFINEMENT; ALIGNMENT; FEATURES; NETWORK; COMPLEX	Background:PHF6 gene is mutated in BFLS and adult acute myeloid and T-cell acute lymphoblastic leukemias. Results: Crystal structure of the second extended PHD domain of PHF6 was solved. Conclusion: PHF6-ePHD2 is a novel structural module and binds dsDNA. Significance: PHF6 may function as a transcriptional repressor using its ePHD domains binding to DNA and recruiting NuRD complex through its NoLS region to regulate gene transcription. The plant homeodomain finger 6 (PHF6) was originally identified as the gene mutated in the X-linked mental retardation disorder Borjeson-Forssman-Lehmann syndrome. Mutations in the PHF6 gene have also been associated with T-cell acute lymphoblastic leukemia and acute myeloid leukemia. Approximately half of the disease-associated mutations are distributed in the second conserved extended plant homeodomain (ePHD2) of PHF6, indicating the functional importance of the ePHD2 domain. Here, we report the high resolution crystal structure of the ePHD2 domain of PHF6, which contains an N-terminal pre-PHD (C2HC zinc finger), a long linker, and an atypical PHD finger. PHF6-ePHD2 appears to fold as a novel integrated structural module. Structural analysis of PHF6-ePHD2 reveals pathological implication of PHF6 gene mutations in Borjeson-Forssman-Lehmann syndrome, T-cell acute lymphoblastic leukemia, and acute myeloid leukemia. The binding experiments show that PHF6-ePHD2 can bind dsDNA but not histones. We also demonstrate PHF6 protein directly interacts with the nucleosome remodeling and deacetylation complex component RBBP4. Via this interaction, PHF6 exerts its transcriptional repression activity. Taken together, these data support the hypothesis that PHF6 may function as a transcriptional repressor using its ePHD domains binding to the promoter region of its repressed gene, and this process was regulated by the nucleosome remodeling and deacetylation complex that was recruited to the genomic target site by NoLS region of PHF6.	[Wu, Jihui] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wu, JH (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.	wujihui@ustc.edu.cn; yyshi@ustc.edu.cn	Mei, Yide/M-4468-2013; Shi, Yunyu/B-3240-2009; Ruan, Ke/N-1995-2013	Shi, Yunyu/0000-0002-1348-4759; Ruan, Ke/0000-0001-9358-0451	National Basic Research Program of China, 973 Program [2011CB966302, 2012CB917201, 2011CB911104]; Chinese National Natural Science Foundation [31170693, 31330018]; Chinese Academy of Science [KJZD-EW-L05]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08010100]	National Basic Research Program of China, 973 Program(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Basic Research Program of China, 973 Program, Grants 2011CB966302, 2012CB917201, and 2011CB911104, Chinese National Natural Science Foundation Grants 31170693 and 31330018, Chinese Academy of Science Grant KJZD-EW-L05, and Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB08010100.	AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Baumstark A, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.4.e50; Berland S, 2010, MOL SYNDROMOL, V1, P294, DOI 10.1159/000330111; BORJESON M, 1962, ACTA MED SCAND, V171, P13; Capili AD, 2001, EMBO J, V20, P165, DOI 10.1093/emboj/20.1.165; Carter MT, 2009, AM J MED GENET A, V149A, P246, DOI 10.1002/ajmg.a.32624; Chao MM, 2010, PEDIATR BLOOD CANCER, V55, P722, DOI 10.1002/pbc.22574; Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594; de Winter CF, 2009, J INTELL DISABIL RES, V53, P319, DOI 10.1111/j.1365-2788.2009.01156.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fiedler M, 2008, MOL CELL, V30, P507, DOI 10.1016/j.molcel.2008.03.011; Gecz J, 2006, EUR J HUM GENET, V14, P1233, DOI 10.1038/sj.ejhg.5201639; Gedeon AK, 1996, AM J MED GENET, V64, P63, DOI 10.1002/(SICI)1096-8628(19960712)64:1<63::AID-AJMG9>3.0.CO;2-S; Grossmann V, 2013, GENE CHROMOSOME CANC, V52, P410, DOI 10.1002/gcc.22039; He C, 2013, J BIOL CHEM, V288, P4692, DOI 10.1074/jbc.M112.426148; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huh HJ, 2013, ANN HEMATOL, V92, P635, DOI 10.1007/s00277-012-1664-2; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lejon S, 2011, J BIOL CHEM, V286, P1196, DOI 10.1074/jbc.M110.195842; Li YY, 2012, ACTA BIOCH BIOPH SIN, V44, P28, DOI 10.1093/abbs/gmr117; Linder B, 2000, J MOL BIOL, V299, P369, DOI 10.1006/jmbi.2000.3766; Liu L, 2012, J STRUCT BIOL, V180, P165, DOI 10.1016/j.jsb.2012.06.014; Lower KM, 2004, EUR J HUM GENET, V12, P787, DOI 10.1038/sj.ejhg.5201228; Lower KM, 2002, NAT GENET, V32, P661, DOI 10.1038/ng1040; Mangelsdorf M, 2009, J CHILD NEUROL, V24, P610, DOI 10.1177/0883073808327830; Mavrakis KJ, 2011, NAT GENET, V43, P673, DOI 10.1038/ng.858; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Pena PV, 2008, J MOL BIOL, V380, P303, DOI 10.1016/j.jmb.2008.04.061; Sanchez R, 2011, TRENDS BIOCHEM SCI, V36, P364, DOI 10.1016/j.tibs.2011.03.005; SCHINDLER U, 1993, PLANT J, V4, P137, DOI 10.1046/j.1365-313X.1993.04010137.x; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Todd MAM, 2012, J PROTEOME RES, V11, P4326, DOI 10.1021/pr3004369; Turner G, 2004, CLIN GENET, V65, P226, DOI 10.1111/j.0009-9163.2004.00215.x; Vallee D, 2004, J MED GENET, V41, P778, DOI 10.1136/jmg.2004.020370; Van Vlierberghe P, 2011, LEUKEMIA, V25, P130, DOI 10.1038/leu.2010.247; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Visootsak J, 2004, J PEDIATR-US, V145, P819, DOI 10.1016/j.jpeds.2004.07.041; Voss AK, 2007, GENE EXPR PATTERNS, V7, P858, DOI 10.1016/j.modgep.2007.06.007; Wang JD, 2013, J BIOL CHEM, V288, P3174, DOI 10.1074/jbc.M112.414839; Wang QJ, 2011, BIORESOURCES, V6, P1; Xi QR, 2011, CELL, V147, P1511, DOI 10.1016/j.cell.2011.11.032; Zhang C, 2013, NEURON, V78, P986, DOI 10.1016/j.neuron.2013.04.021; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	49	44	48	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10069	10083		10.1074/jbc.M113.535351	http://dx.doi.org/10.1074/jbc.M113.535351			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24554700	hybrid, Green Published			2022-12-28	WOS:000333807000054
J	Lorca, RA; Stamnes, SJ; Pillai, MK; Hsiao, JJ; Wright, ME; England, SK				Lorca, Ramon A.; Stamnes, Susan J.; Pillai, Meghan K.; Hsiao, Jordy J.; Wright, Michael E.; England, Sarah K.			N-terminal Isoforms of the Large- conductance Ca2-activated K Channel Are Differentially Modulated by the Auxiliary beta 1-Subunit*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electrophysiology; Ion Channels; Patch Clamp Electrophysiology; Potassium Channels; Smooth Muscle; BKCa Channel; Auxiliary Subunits; Single-Channel Recordings	ACTIVATED POTASSIUM CHANNEL; ALTERNATIVE TRANSLATION INITIATION; BETA-SUBUNIT; BK CHANNEL; SMOOTH-MUSCLE; CA2+ SENSITIVITY; ALPHA-SUBUNITS; CALCIUM; VOLTAGE; DOMAINS	Background: The large-conductance Ca2+-activated K+ channel (BKCa) is an important regulator of membrane excitability. Results: N-terminal isoforms of the BKCa channel are differentially modulated by the regulatory 1-subunit. Conclusion: Expression of different N-terminal isoforms is a novel mechanism of BKCa channel regulation. Significance: Elucidating the modulation of BKCa activity by 1 provides a new understanding of ion channel physiology. The large-conductance Ca2+-activated K+ (BKCa) channel is essential for maintaining the membrane in a hyperpolarized state, thereby regulating neuronal excitability, smooth muscle contraction, and secretion. The BKCa -subunit has three predicted initiation codons that generate proteins with N-terminal ends starting with the amino acid sequences MANG, MSSN, or MDAL. Because the N-terminal region and first transmembrane domain of the -subunit are required for modulation by auxiliary 1-subunits, we examined whether 1 differentially modulates the N-terminal BKCa -subunit isoforms. In the absence of 1, all isoforms had similar single-channel conductances and voltage-dependent activation. However, whereas 1 did not modulate the voltage-activation curve of MSSN, 1 induced a significant leftward shift of the voltage activation curves of both the MDAL and MANG isoforms. These shifts, of which the MDAL was larger, occurred at both 10 m and 100 m Ca2+. The 1-subunit increased the open dwell times of all three isoforms and decreased the closed dwell times of MANG and MDAL but increased the closed dwell times of MSSN. The distinct modulation of voltage activation by the 1-subunit may be due to the differential effect of 1 on burst duration and interburst intervals observed among these isoforms. Additionally, we observed that the related 2-subunit induced comparable leftward shifts in the voltage-activation curves of all three isoforms, indicating that the differential modulation of these isoforms was specific to 1. These findings suggest that the relative expression of the N-terminal isoforms can fine-tune BKCa channel activity in cells, highlighting a novel mechanism of BKCa channel regulation.	[Lorca, Ramon A.; Pillai, Meghan K.; England, Sarah K.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Lorca, Ramon A.; Stamnes, Susan J.; Hsiao, Jordy J.; Wright, Michael E.; England, Sarah K.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	Washington University (WUSTL); University of Iowa	England, SK (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, 425 South Euclid Ave,Campus Bx 8064, St Louis, MO 63110 USA.	englands@wustl.edu		Wright, Michael/0000-0002-4243-2931; Hsiao, Jordy/0000-0002-2487-5034	National Institutes of Health [R01 HD037831]; American Heart Association [12GRNT10990002]; American Heart Association Postdoctoral Fellowship [12POST10660000]; National Center for Research Resources, Clinical and Translational Science Award [M01-RR-00059]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037831] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000059] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Heart Association Postdoctoral Fellowship(American Heart Association); National Center for Research Resources, Clinical and Translational Science Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institutes of Health Grant R01 HD037831 and American Heart Association Grant 12GRNT10990002 (to S. K. E.), American Heart Association Postdoctoral Fellowship 12POST10660000 (to R. A. L.), and National Center for Research Resources, Clinical and Translational Science Award M01-RR-00059 for human tissue obtainment.	Bao L, 2005, J GEN PHYSIOL, V126, P393, DOI 10.1085/jgp.200509346; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Brainard AM, 2007, SEMIN CELL DEV BIOL, V18, P332, DOI 10.1016/j.semcdb.2007.05.008; BRAYDEN JE, 1992, SCIENCE, V256, P532, DOI 10.1126/science.1373909; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Cai J, 2006, PROTEINS, V62, P793, DOI 10.1002/prot.20785; Chan YW, 2014, EXP PHYSIOL, V99, P510, DOI 10.1113/expphysiol.2013.072868; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Contreras GF, 2012, P NATL ACAD SCI USA, V109, P18991, DOI 10.1073/pnas.1216953109; Cox DH, 2000, J GEN PHYSIOL, V116, P411, DOI 10.1085/jgp.116.3.411; Cui J, 1997, J GEN PHYSIOL, V109, P647, DOI 10.1085/jgp.109.5.647; Erxleben C, 2002, J BIOL CHEM, V277, P27045, DOI 10.1074/jbc.M203087200; Essin K, 2009, BLOOD, V113, P1326, DOI 10.1182/blood-2008-07-166660; Fernandez FR, 2003, J BIOL CHEM, V278, P40890, DOI 10.1074/jbc.M304235200; KNAUS HG, 1994, J BIOL CHEM, V269, P3921; KNAUS HG, 1994, J BIOL CHEM, V269, P17274; Korovkina VP, 2006, J PHYSIOL-LONDON, V573, P329, DOI 10.1113/jphysiol.2006.106922; Kozak M, 1997, EMBO J, V16, P2482, DOI 10.1093/emboj/16.9.2482; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Lee US, 2010, J NEUROSCI, V30, P16170, DOI 10.1523/JNEUROSCI.2323-10.2010; Matharoo-Ball B, 2003, BIOL REPROD, V68, P2135, DOI 10.1095/biolreprod.102.010454; MCCOBB DP, 1995, AM J PHYSIOL-HEART C, V269, pH767, DOI 10.1152/ajpheart.1995.269.3.H767; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Morrow JP, 2006, P NATL ACAD SCI USA, V103, P5096, DOI 10.1073/pnas.0600907103; Nimigean CM, 2000, J GEN PHYSIOL, V115, P719, DOI 10.1085/jgp.115.6.719; Nimigean CM, 1999, J GEN PHYSIOL, V113, P425, DOI 10.1085/jgp.113.3.425; Orio P, 2006, J GEN PHYSIOL, V127, P191, DOI 10.1085/jgp.200509370; Orio P, 2005, J GEN PHYSIOL, V125, P395, DOI 10.1085/jgp.200409236; Petkov GV, 2001, J PHYSIOL-LONDON, V537, P443, DOI 10.1111/j.1469-7793.2001.00443.x; Pluger S, 2000, CIRC RES, V87, pE53, DOI 10.1161/01.RES.87.11.e53; Scott RS, 2011, PFLUG ARCH EUR J PHY, V462, P545, DOI 10.1007/s00424-011-0991-9; Simkin D, 2008, J PHYSIOL-LONDON, V586, P5651, DOI 10.1113/jphysiol.2008.161927; Sun XH, 2013, J NEUROSCI, V33, P11253, DOI 10.1523/JNEUROSCI.0620-13.2013; Tanaka Y, 1997, J PHYSIOL-LONDON, V502, P545, DOI 10.1111/j.1469-7793.1997.545bj.x; Thomas D, 2008, NEURON, V58, P859, DOI 10.1016/j.neuron.2008.04.016; Tian LJ, 2001, J BIOL CHEM, V276, P7717, DOI 10.1074/jbc.C000741200; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wallner M, 1995, RECEPTOR CHANNEL, V3, P185; Wang YW, 2002, J NEUROSCI, V22, P1550, DOI 10.1523/JNEUROSCI.22-05-01550.2002; Yan JS, 2012, P NATL ACAD SCI USA, V109, P7917, DOI 10.1073/pnas.1205435109; Yang HH, 2008, BIOPHYS J, V94, P4678, DOI 10.1529/biophysj.107.121590; Yazejian B, 2000, NAT NEUROSCI, V3, P566, DOI 10.1038/75737	43	10	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10095	10103		10.1074/jbc.M113.521526	http://dx.doi.org/10.1074/jbc.M113.521526			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24569989	hybrid, Green Published			2022-12-28	WOS:000333807000056
J	Song, WS; Wang, F; Lotfi, P; Sardiello, M; Segatori, L				Song, Wensi; Wang, Fan; Lotfi, Parisa; Sardiello, Marco; Segatori, Laura			2-Hydroxypropyl-beta-cyclodextrin Promotes Transcription Factor EB- mediated Activation of Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Autophagy; Lipoprotein; Lysosomal Storage Disease; Lysosomes; Ceroid Lipopigment; Cyclodextrin; Neuronal Ceroid Lipofuscinosis; TFEB	CELL-DEATH; CHOLESTEROL; DISEASE; CYCLODEXTRINS; PROTEIN; LIFE; NEURODEGENERATION; RECOGNITION; DEGRADATION; HOMEOSTASIS	Background: The drug delivery vehicle 2-hydroxypropyl--cyclodextrin (HPCD) prevents cholesterol storage. Results: HPCD treatment induces TFEB mediated activation of autophagy and clearance of the autophagic substrate ceroid lipopigment. Conclusion: HPCD administration results in enhancement of the innate autophagic clearance capacity. Significance: Dissecting the cellular pathways impacted by HPCD is crucial to design HPCD-based therapeutic modalities. 2-Hydroxypropyl--cyclodextrin (HPCD) is a Food and Drug Administration-approved excipient used to improve the stability and bioavailability of drugs. Despite its wide use as a drug delivery vehicle and the recent approval of a clinical trial to evaluate its potential for the treatment of a cholesterol storage disorder, the cellular pathways involved in the adaptive response that is activated upon exposure to HPCD are still poorly defined. Here, we show that cell treatment with HPCD results in the activation of the transcription factor EB, a master regulator of lysosomal function and autophagy, and in enhancement of the cellular autophagic clearance capacity. HPCD administration promotes transcription factor EB-mediated clearance of proteolipid aggregates that accumulate due to inefficient activity of the lysosome-autophagy system in cells derived from a patient with a lysosomal storage disorder. Interestingly, HPCD-mediated activation of autophagy was found not to be associated with activation of apoptotic pathways. This study provides a mechanistic understanding of the cellular response to HPCD treatment, which will inform the development of safe HPCD-based therapeutic modalities and may enable engineering HPCD as a platform technology to reduce the accumulation of lysosomal storage material.	Rice Univ, Dept Chem & Biomol Engn, Houston, TX 77005 USA; [Segatori, Laura] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; [Segatori, Laura] Rice Univ, Dept Bioengn, Houston, TX 77005 USA; [Lotfi, Parisa; Sardiello, Marco] Texas Childrens Hosp, Dept Mol & Human Genet, Baylor Coll Med, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA	Rice University; Rice University; Rice University; Baylor College of Medicine	Segatori, L (corresponding author), Rice Univ, MS-362,6100 Main St, Houston, TX 77005 USA.	segatori@rice.edu			Welch Foundation [C-1824]; National Science Foundation [CBET 1254318]; Beyond Batten Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS084005] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); National Science Foundation(National Science Foundation (NSF)); Beyond Batten Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Welch Foundation (C-1824; to L. S.), the National Science Foundation (CBET 1254318; to L. S.), and the Beyond Batten Disease Foundation (to M. S.).	Abi-Mosleh L, 2009, P NATL ACAD SCI USA, V106, P19316, DOI 10.1073/pnas.0910916106; Atger VM, 1997, J CLIN INVEST, V99, P773, DOI 10.1172/JCI119223; Bacus SS, 2001, ONCOGENE, V20, P147, DOI 10.1038/sj.onc.1204062; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Cao Y, 2006, J BIOL CHEM, V281, P20483, DOI 10.1074/jbc.M602180200; Cheng JL, 2006, BIOCHEM BIOPH RES CO, V351, P246, DOI 10.1016/j.bbrc.2006.10.042; Christian AE, 1997, J LIPID RES, V38, P2264; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Davis ME, 2004, NAT REV DRUG DISCOV, V3, P1023, DOI 10.1038/nrd1576; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Delgado M, 2009, IMMUNOL REV, V227, P189, DOI 10.1111/j.1600-065X.2008.00725.x; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Ghosh A, 2012, J BIOL CHEM, V287, P38922, DOI 10.1074/jbc.M112.365148; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gorski SM, 2003, CURR BIOL, V13, P358, DOI 10.1016/S0960-9822(03)00082-4; Hait WN, 2006, CLIN CANCER RES, V12, P1961, DOI 10.1158/1078-0432.CCR-06-0011; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kohlschutter A, 2009, BRAIN DEV-JPN, V31, P499, DOI 10.1016/j.braindev.2008.12.008; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kondo S, 2006, ONCOGENE, V25, P1099, DOI 10.1038/sj.onc.1209129; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Lee CY, 2003, CURR BIOL, V13, P350, DOI 10.1016/S0960-9822(03)00085-X; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liu B, 2008, J LIPID RES, V49, P663, DOI 10.1194/jlr.M700525-JLR200; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Maxfield FR, 2010, CURR OPIN CELL BIOL, V22, P422, DOI 10.1016/j.ceb.2010.05.004; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mukhejee S, 2004, BBA-MOL CELL BIOL L, V1685, P28, DOI 10.1016/j.bbalip.2004.08.009; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Ogier-Denis E, 2003, BBA-REV CANCER, V1603, P113, DOI 10.1016/S0304-419X(03)00004-0; Oh JE, 2012, YONSEI MED J, V53, P241, DOI 10.3349/ymj.2012.53.2.241; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Persaud-Sawin DA, 2007, PEDIATR RES, V61, P146, DOI 10.1203/pdr.0b013e31802d8a4a; Pierret C, 2008, ACTA NEUROBIOL EXP, V68, P429; Rajewski RA, 1996, J PHARM SCI, V85, P1142, DOI 10.1021/js960075u; Rosenbaum AI, 2010, P NATL ACAD SCI USA, V107, P5477, DOI 10.1073/pnas.0914309107; Sardiello M, 2009, CELL CYCLE, V8, P4021, DOI 10.4161/cc.8.24.10263; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Settembre C, 2008, AUTOPHAGY, V4, P113, DOI 10.4161/auto.5227; Settembre C, 2011, AUTOPHAGY, V7, P1379, DOI 10.4161/auto.7.11.17166; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Sleat DE, 1997, SCIENCE, V277, P1802, DOI 10.1126/science.277.5333.1802; Song WS, 2013, HUM MOL GENET, V22, P1994, DOI 10.1093/hmg/ddt052; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Wang F, 2011, J BIOL CHEM, V286, P43454, DOI 10.1074/jbc.M111.274332; Wang F, 2011, CHEM BIOL, V18, P766, DOI 10.1016/j.chembiol.2011.04.008; Williams RE, 2012, NEUROLOGY, V79, P183, DOI 10.1212/WNL.0b013e31825f0547	57	80	83	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10211	10222		10.1074/jbc.M113.506246	http://dx.doi.org/10.1074/jbc.M113.506246			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24558044	Green Published, hybrid			2022-12-28	WOS:000333807000066
J	Kaiserman, D; Stewart, SE; Plasman, K; Gevaert, K; Van Damme, P; Bird, PI				Kaiserman, Dion; Stewart, Sarah E.; Plasman, Kim; Gevaert, Kris; Van Damme, Petra; Bird, Phillip I.			Identification of Serpinb6b as a Species-specific Mouse Granzyme A Inhibitor Suggests Functional Divergence between Human and Mouse Granzyme A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Inhibitors; Immunology; Proteomics; Serine Protease; Serpin; COFRADIC; Granzyme A	PROTEASE GRANZYME; SERINE PROTEASES; SUBSTRATE; PURIFICATION; APOPTOSIS; DISTINCT; EFFECTOR; INDUCE; FAMILY; DEATH	Background: There are conflicting reports on the ability of granzyme A (GzmA) to kill cells. Results: Substrate specificity mapping of human and mouse GzmA was used to identify Serpinb6b as a mouse-specific GzmA inhibitor. Conclusion: Mouse but not human GzmA is controlled by an intracellular inhibitor. Significance: The GzmA debate is partly explained by species-specific divergence in cytotoxicity. The granzyme family serine proteases are key effector molecules expressed by cytotoxic lymphocytes. The physiological role of granzyme (Gzm) A is controversial, with significant debate over its ability to induce death in target cells. Here, we investigate the natural inhibitors of GzmA. We employed substrate phage display and positional proteomics to compare substrate specificities of mouse (m) and human (h) GzmA at the peptide and proteome-wide levels and we used the resulting substrate specificity profiles to search for potential inhibitors from the intracellular serpin family. We identified Serpinb6b as a potent inhibitor of mGzmA. Serpinb6b interacts with mGzmA, but not hGzmA, with an association constant of 1.9 +/- 0.8 x 10(5) m(-1) s(-1) and a stoichiometry of inhibition of 1.8. Mouse GzmA is over five times more cytotoxic than hGzmA when delivered into P815 target cells with streptolysin O, whereas transfection of target cells with a Serpinb6b cDNA increases the EC50 value of mGzmA 13-fold, without affecting hGzmA cytotoxicity. Unexpectedly, we also found that Serpinb6b employs an exosite to specifically inhibit dimeric but not monomeric mGzmA. The identification of an intracellular inhibitor specific for mGzmA only indicates that a lineage-specific increase in GzmA cytotoxic potential has driven cognate inhibitor evolution.	[Kaiserman, Dion; Stewart, Sarah E.; Bird, Phillip I.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Plasman, Kim; Gevaert, Kris; Van Damme, Petra] Univ Ghent VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Plasman, Kim; Gevaert, Kris; Van Damme, Petra] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium	Monash University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Kaiserman, D (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Wellington Rd, Clayton, Vic 3800, Australia.	dion.kaiserman@monash.edu	Van Damme, Petra/C-7269-2008; Gevaert, Kris/D-6489-2017; Gevaert, Kris/AAE-4212-2019	Van Damme, Petra/0000-0001-9090-027X; Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Bird, Phillip/0000-0002-6695-606X; Stewart, Sarah E/0000-0003-3712-9898				Adrain C, 2005, J BIOL CHEM, V280, P4663, DOI 10.1074/jbc.M410915200; Bell JK, 2003, NAT STRUCT BIOL, V10, P527, DOI 10.1038/nsb944; Bird CH, 1998, MOL CELL BIOL, V18, P6387, DOI 10.1128/MCB.18.11.6387; Bots M, 2005, BLOOD, V105, P1153, DOI 10.1182/blood-2004-03-0791; Buzza MS, 2006, BIOL CHEM, V387, P827, DOI 10.1515/BC.2006.106; Casciola-Rosen L, 2007, J BIOL CHEM, V282, P4545, DOI 10.1074/jbc.M606564200; Chen VC, 2000, J BIOL CHEM, V275, P40371, DOI 10.1074/jbc.M005691200; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Cullen SP, 2007, J CELL BIOL, V176, P435, DOI 10.1083/jcb.200612025; de Koning PJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022645; Gettins PGW, 2009, J BIOL CHEM, V284, P20441, DOI 10.1074/jbc.R800064200; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Hink-Schauer C, 2003, NAT STRUCT BIOL, V10, P535, DOI 10.1038/nsb945; Ibarra CA, 2004, J BIOL CHEM, V279, P3643, DOI 10.1074/jbc.M310601200; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Joeckel LT, 2014, BIOL CHEM, V395, P181, DOI 10.1515/hsz-2013-0238; Kaiserman D, 2002, GENOMICS, V79, P349, DOI 10.1006/geno.2002.6716; Kaiserman D, 2010, CELL DEATH DIFFER, V17, P586, DOI 10.1038/cdd.2009.169; Kaiserman D, 2006, J CELL BIOL, V175, P619, DOI 10.1083/jcb.200606073; Lieberman J, 2010, IMMUNOL REV, V235, P93, DOI 10.1111/j.0105-2896.2010.00902.x; Mahrus S, 2005, CHEM BIOL, V12, P567, DOI 10.1016/j.chembiol.2005.03.006; MASSON D, 1988, MOL IMMUNOL, V25, P1283, DOI 10.1016/0161-5890(88)90043-0; MASSON D, 1986, FEBS LETT, V208, P84, DOI 10.1016/0014-5793(86)81537-X; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; PEMBERTON PA, 1995, J BIOL CHEM, V270, P15832, DOI 10.1074/jbc.270.26.15832; Pike RN, 2005, FEBS J, V272, P4842, DOI 10.1111/j.1742-4658.2005.04880.x; Plasman K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003301; REMOLDODONNELL E, 1993, FEBS LETT, V315, P105, DOI 10.1016/0014-5793(93)81143-N; Scott FL, 1996, J BIOL CHEM, V271, P1605, DOI 10.1074/jbc.271.3.1605; SHI LF, 1992, J EXP MED, V176, P1521, DOI 10.1084/jem.176.6.1521; Shresta S, 1999, IMMUNITY, V10, P595, DOI 10.1016/S1074-7613(00)80059-X; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; Sower LE, 1996, CELL IMMUNOL, V171, P159, DOI 10.1006/cimm.1996.0187; Staes A, 2011, NAT PROTOC, V6, P1130, DOI 10.1038/nprot.2011.355; Sun J, 2001, J BIOL CHEM, V276, P15177, DOI 10.1074/jbc.M006645200; Sun JR, 1999, BIOCHEM BIOPH RES CO, V261, P251, DOI 10.1006/bbrc.1999.0989; SUN JR, 1995, BBA-PROTEIN STRUCT M, V1252, P28, DOI 10.1016/0167-4838(95)00108-7; Sun JR, 1997, J BIOL CHEM, V272, P15434, DOI 10.1074/jbc.272.24.15434; Susanto O, 2013, CELL DEATH DIFFER, V20, P1183, DOI 10.1038/cdd.2013.59; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; Tsuzuki S, 2003, BIOCHEM J, V372, P227, DOI 10.1042/BJ20021891; Van Damme P, 2009, MOL CELL PROTEOMICS, V8, P258, DOI 10.1074/mcp.M800060-MCP200; Van Damme P, 2010, BIOL CHEM, V391, P983, DOI 10.1515/BC.2010.096; Voskoboinik I, 2010, IMMUNOL REV, V235, P35, DOI 10.1111/j.0105-2896.2010.00896.x; Wang L, 2013, J IMMUNOL, V190, P1319, DOI 10.4049/jimmunol.1202542	45	20	22	4	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9408	9417		10.1074/jbc.M113.525808	http://dx.doi.org/10.1074/jbc.M113.525808			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24505135	Green Published, hybrid			2022-12-28	WOS:000333472100056
J	Koehler, C; Bonnet, J; Stierle, M; Romier, C; Devys, D; Kieffer, B				Koehler, Christian; Bonnet, Jacques; Stierle, Matthieu; Romier, Christophe; Devys, Didier; Kieffer, Bruno			DNA Binding by Sgf11 Protein Affects Histone H2B Deubiquitination by Spt-Ada-Gcn5-Acetyltransferase ( SAGA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Deubiquitination; DNA-Protein Interaction; Epigenetics; NMR; Zinc Finger	NMR STRUCTURE DETERMINATION; ZINC; ASSIGNMENT; DOMAINS; MODULE; RESONANCES; NUCLEOSOME; COMPLEXES; CHROMATIN; DYNAMICS	Background: Histone deubiquitination by SAGA is a core mechanism in gene expression regulation. Results: The zinc finger domain of SAGA subunit Sgf11 interacts with nucleosomal DNA via a positively charged surface patch. Conclusion: This interaction is required for optimal deubiquitination activity. Significance: This work highlights the unexpected role of C2H2-like zinc fingers in SAGA complex. The yeast Spt-Ada-Gcn5-acetyltransferase (SAGA) complex is a transcription coactivator that contains a histone H2B deubiquitination activity mediated by its Ubp8 subunit. Full enzymatic activity requires the formation of a quaternary complex, the deubiquitination module (DUBm) of SAGA, which is composed of Ubp8, Sus1, Sgf11, and Sgf73. The crystal structures of the DUBm have shed light on the structure/function relationship of this complex. Specifically, both Sgf11 and Sgf73 contain zinc finger domains (ZnF) that appear essential for the DUBm activity. Whereas Sgf73 N-terminal ZnF is important for DUBm stability, Sgf11 C-terminal ZnF appears to be involved in DUBm function. To further characterize the role of these two zinc fingers, we have solved their structure by NMR. We show that, contrary to the previously reported structures, Sgf73 ZnF adopts a C2H2 coordination with unusual tautomeric forms for the coordinating histidines. We further report that the Sgf11 ZnF, but not the Sgf73 ZnF, binds to nucleosomal DNA with a binding interface composed of arginine residues located within the ZnF -helix. Mutational analyses both in vitro and in vivo provide evidence for the functional relevance of our structural observations. The combined interpretation of our results leads to an uncommon ZnF-DNA interaction between the SAGA DUBm and nucleosomes, thus providing further functional insights into SAGA's epigenetic modulation of the chromatin structure.	[Koehler, Christian; Romier, Christophe; Kieffer, Bruno] Inst Genet & Biol Mol & Cellulaire, Dept Integrated Struct Biol, F-67404 Illkirch Graffenstaden, France; [Bonnet, Jacques; Stierle, Matthieu; Devys, Didier] Inst Genet & Biol Mol & Cellulaire, Dept Funct Genom & Canc, F-67404 Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Kieffer, B (corresponding author), Inst Genet & Biol Mol & Cellulaire, Dept Integrated Struct Biol, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, France.	kieffer@igbmc.fr	Kieffer, Bruno/AAE-8999-2019	Devys, Didier/0000-0001-9655-3512; Kieffer, Bruno/0000-0002-2033-4679; Romier, Christophe/0000-0002-3680-935X	French Infrastructure for Integrated Structural Biology [ANR-10-INSB-05-01]; ANR Program Grant HISTONEDUB [ANR-09-PIRI-0031]; Instruct, part of the European Strategy Forum on Research Infrastructures	French Infrastructure for Integrated Structural Biology; ANR Program Grant HISTONEDUB(French National Research Agency (ANR)); Instruct, part of the European Strategy Forum on Research Infrastructures	This work was supported by French Infrastructure for Integrated Structural Biology Grant ANR-10-INSB-05-01, ANR Program Grant HISTONEDUB ANR-09-PIRI-0031, and by Instruct, part of the European Strategy Forum on Research Infrastructures, and by national member agreements.	Andreini C, 2006, J PROTEOME RES, V5, P3173, DOI 10.1021/pr0603699; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bonnet J, 2008, TRENDS BIOCHEM SCI, V33, P369, DOI 10.1016/j.tibs.2008.05.005; Bonnet J, 2010, EMBO REP, V11, P612, DOI 10.1038/embor.2010.98; Brayer KJ, 2008, CELL BIOCHEM BIOPHYS, V50, P111, DOI 10.1007/s12013-008-9008-5; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Clore G., 1992, PROG NUCL MAGN RESON, V23, P43; Daniel JA, 2007, MUTAT RES-FUND MOL M, V618, P135, DOI 10.1016/j.mrfmmm.2006.09.008; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Goddard T., 2008, SPARKY, V3; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Houbaviy HB, 1996, P NATL ACAD SCI USA, V93, P13577, DOI 10.1073/pnas.93.24.13577; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Kato H, 2011, P NATL ACAD SCI USA, V108, P12283, DOI 10.1073/pnas.1105848108; KAY LE, 1990, J AM CHEM SOC, V112, P888, DOI 10.1021/ja00158a070; Kohler A, 2010, CELL, V141, P606, DOI 10.1016/j.cell.2010.04.026; Kostic M, 2006, J MOL BIOL, V363, P433, DOI 10.1016/j.jmb.2006.08.027; Lai CH, 2010, BIOCHEM BIOPH RES CO, V397, P436, DOI 10.1016/j.bbrc.2010.05.118; Lang G, 2011, MOL CELL BIOL, V31, P3734, DOI 10.1128/MCB.05231-11; Lee KK, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-2; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; PELTON JG, 1993, PROTEIN SCI, V2, P543; Podjarny A, 2011, RSC BIOMOL SCI, P1, DOI 10.1039/9781849732666; Samara NL, 2012, STRUCTURE, V20, P1414, DOI 10.1016/j.str.2012.05.015; Samara NL, 2010, SCIENCE, V328, P1025, DOI 10.1126/science.1190049; Schnitzler G R, 2001, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2105s50; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Stoll R, 2007, J MOL BIOL, V372, P1227, DOI 10.1016/j.jmb.2007.07.017; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Weake VM, 2008, EMBO J, V27, P394, DOI 10.1038/sj.emboj.7601966; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183	37	18	19	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8989	8999		10.1074/jbc.M113.500868	http://dx.doi.org/10.1074/jbc.M113.500868			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24509845	Green Published, hybrid			2022-12-28	WOS:000333472100021
J	Makhmoudova, A; Williams, D; Brewer, D; Massey, S; Patterson, J; Silva, A; Vassall, KA; Liu, FS; Subedi, S; Harauz, G; Siu, KWM; Tetlow, IJ; Emes, MJ				Makhmoudova, Amina; Williams, Declan; Brewer, Dyanne; Massey, Sarah; Patterson, Jenelle; Silva, Anjali; Vassall, Kenrick A.; Liu, Fushan; Subedi, Sanjeena; Harauz, George; Siu, K. W. Michael; Tetlow, Ian J.; Emes, Michael J.			Identification of Multiple Phosphorylation Sites on Maize Endosperm Starch Branching Enzyme IIb, a Key Enzyme in Amylopectin Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Biosynthesis; Molecular Modeling; Plant Biochemistry; Protein Kinases; Protein Phosphorylation; Starch; Branching Enzyme; Maize	PROTEIN-PROTEIN INTERACTIONS; STRUCTURE PREDICTION; MOLECULAR-DYNAMICS; RICE ENDOSPERM; I-TASSER; AMYLOPLASTS; AMYLOSE; GRANULES; BINDING; SERVER	Background: Starch is the major component of cereal yield, yet the biochemical regulation of its synthesis is poorly understood. Results: Starch branching enzyme IIb is phosphorylated at three sites by two Ca2+-dependent protein kinases. Conclusion: Two phosphorylation sites represent a general mechanism of control in plants, the third is cereal specific. Significance: Identification of post-translational regulatory mechanism offers possibilities for targeted manipulation of starch. Starch branching enzyme IIb (SBEIIb) plays a crucial role in amylopectin biosynthesis in maize endosperm by defining the structural and functional properties of storage starch and is regulated by protein phosphorylation. Native and recombinant maize SBEIIb were used as substrates for amyloplast protein kinases to identify phosphorylation sites on the protein. A multidisciplinary approach involving bioinformatics, site-directed mutagenesis, and mass spectrometry identified three phosphorylation sites at Ser residues: Ser(649), Ser(286), and Ser(297). Two Ca2+-dependent protein kinase activities were partially purified from amyloplasts, termed K1, responsible for Ser(649) and Ser(286) phosphorylation, and K2, responsible for Ser(649) and Ser(297) phosphorylation. The Ser(286) and Ser(297) phosphorylation sites are conserved in all plant branching enzymes and are located at opposite openings of the 8-stranded parallel -barrel of the active site, which is involved with substrate binding and catalysis. Molecular dynamics simulation analysis indicates that phospho-Ser(297) forms a stable salt bridge with Arg(665), part of a conserved Cys-containing domain in plant branching enzymes. Ser(649) conservation appears confined to the enzyme in cereals and is not universal, and is presumably associated with functions specific to seed storage. The implications of SBEIIb phosphorylation are considered in terms of the role of the enzyme and the importance of starch biosynthesis for yield and biotechnological application.	[Makhmoudova, Amina; Massey, Sarah; Patterson, Jenelle; Silva, Anjali; Vassall, Kenrick A.; Liu, Fushan; Harauz, George; Tetlow, Ian J.; Emes, Michael J.] Univ Guelph, Coll Biol Sci, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Brewer, Dyanne] Univ Guelph, Coll Biol Sci, Adv Anal Ctr, Guelph, ON N1G 2W1, Canada; [Subedi, Sanjeena] Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada; [Williams, Declan; Siu, K. W. Michael] York Univ, Dept Chem, Ctr Res Mass Spectrometry, Toronto, ON M3J 1P3, Canada; [Siu, K. W. Michael] Univ Windsor, Dept Chem & Biochem, Windsor, ON N9B 3P4, Canada	University of Guelph; University of Guelph; University of Guelph; York University - Canada; University of Windsor	Emes, MJ (corresponding author), Univ Guelph, Coll Biol Sci, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	memes@uoguelph.ca	Liu, Fushan/R-8998-2017	Liu, Fushan/0000-0002-9830-9086; Williams, Declan/0000-0002-6754-1624; Harauz, George/0000-0002-6114-9947				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BHATTACHARYYA MK, 1990, CELL, V60, P115, DOI 10.1016/0092-8674(90)90721-P; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Butardo VM, 2011, J EXP BOT, V62, P4927, DOI 10.1093/jxb/err188; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Gao M, 1997, PLANT PHYSIOL, V114, P69, DOI 10.1104/pp.114.1.69; GUAN HP, 1993, PLANT PHYSIOL, V102, P1269, DOI 10.1104/pp.102.4.1269; Hansson T, 1997, J MOL BIOL, V265, P118, DOI 10.1006/jmbi.1996.0716; Hennen-Bierwagen TA, 2012, ESSENTIAL REV EXPT B, V5, P179; Hennen-Bierwagen TA, 2008, PLANT PHYSIOL, V146, P1892, DOI 10.1104/pp.108.116285; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JAMES MG, 1995, PLANT CELL, V7, P417, DOI 10.1105/tpc.7.4.417; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kim KN, 1998, PLANT MOL BIOL, V38, P945, DOI 10.1023/A:1006057609995; Kuriki T, 1997, J BIOL CHEM, V272, P28999, DOI 10.1074/jbc.272.46.28999; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Lawless C, 2012, OMICS, V16, P449, DOI 10.1089/omi.2011.0156; Liu FS, 2012, BIOCHEM J, V448, P373, DOI 10.1042/BJ20120573; Liu FS, 2012, J EXP BOT, V63, P1167, DOI 10.1093/jxb/err341; Liu FS, 2009, J EXP BOT, V60, P4423, DOI 10.1093/jxb/erp297; MIZUNO K, 1993, J BIOL CHEM, V268, P19084; Mu HH, 2001, ARCH BIOCHEM BIOPHYS, V388, P155, DOI 10.1006/abbi.2000.2267; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Noguchi J, 2011, GLYCOBIOLOGY, V21, P1108, DOI 10.1093/glycob/cwr049; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Perez S, 2010, STARCH-STARKE, V62, P389, DOI 10.1002/star.201000013; Regina A, 2005, PLANTA, V222, P899, DOI 10.1007/s00425-005-0032-z; Regina A, 2010, J EXP BOT, V61, P1469, DOI 10.1093/jxb/erq011; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Satoh H, 2003, PLANT PHYSIOL, V133, P1111, DOI 10.1104/pp.103.021527; TAKEDA Y, 1993, CARBOHYD RES, V240, P253, DOI 10.1016/0008-6215(93)84188-C; Tanaka N, 2004, PLANT BIOTECHNOL J, V2, P507, DOI 10.1111/j.1467-7652.2004.00097.x; Tetlow I. J., 2012, ESSENTIAL REV EXPT B, V5, P141; Tetlow IJ, 2008, PLANT PHYSIOL, V146, P1878, DOI 10.1104/pp.108.116244; Tetlow IJ, 2004, PLANT CELL, V16, P694, DOI 10.1105/tpc.017400; TETLOW IJ, 1994, PLANTA, V194, P454, DOI 10.1007/BF00714456; Van Der Geer P., 1993, PROTEIN PHOSPHORYLAT, P31; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	47	34	37	4	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9233	9246		10.1074/jbc.M114.551093	http://dx.doi.org/10.1074/jbc.M114.551093			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24550386	Green Published, hybrid			2022-12-28	WOS:000333472100041
J	Wang, AM; Ren, J; Wang, CP; Hascall, VC				Wang, Aimin; Ren, Juan; Wang, Christina P.; Hascall, Vincent C.			Heparin Prevents Intracellular Hyaluronan Synthesis and Autophagy Responses in Hyperglycemic Dividing Mesangial Cells and Activates Synthesis of an Extensive Extracellular Monocyte-adhesive Hyaluronan Matrix after Completing Cell Division	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Diabetes; ER Stress; Glucose Metabolism; Heparin; Hyaluronate; Inflammation; Lipids; Diabetic Nephropathy; Monocyte Adhesive Hyaluronan Matrix	CARBOHYDRATE ELECTROPHORESIS FACE; EXPERIMENTAL DIABETIC-NEPHROPATHY; UDP-N-ACETYLHEXOSAMINES; SMOOTH-MUSCLE-CELLS; C-FOS INDUCTION; GLUTAMINE-FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE; CYCLIN D3; DOWN-REGULATION; GENE PROMOTER; SYNTHASE 2	Background: Hyperglycemic dividing mesangial cells initiate intracellular hyaluronan synthesis, autophagy, and cyclin D3-mediated hyaluronan matrix formation. Results: Heparin prevents the intracellular responses but induces synthesis of a monocyte-adhesive extracellular hyaluronan matrix after cell division. Conclusion: Heparin inhibits inflammatory responses in diabetic glomeruli. Significance: Responses of dividing cells to hyperglycemia contribute to diabetic pathologies. Growth-arrested rat mesangial cells (RMCs) at a G(0)/G(1) interphase stimulated to divide in hyperglycemic medium initiate intracellular hyaluronan synthesis that induces autophagy/cyclin D3-induced formation of a monocyte-adhesive extracellular hyaluronan matrix after completing cell division. This study shows that heparin inhibits the intracellular hyaluronan synthesis and autophagy responses, but at the end of cell division it induces synthesis of a much larger extracellular monocyte-adhesive hyaluronan matrix. Heparin bound to RMC surfaces by 1 h, internalizes into the Golgi/endoplasmic reticulum region by 2 h, and was nearly gone by 4 h. Treatment by heparin for only the first 4 h was sufficient for its function. Streptozotocin diabetic rats treated daily with heparin showed similar results. Glomeruli in sections of diabetic kidneys showed extensive accumulation of autophagic RMCs, increased hyaluronan matrix, and influx of macrophages over 6 weeks. Hyaluronan staining in the glomeruli of heparin-treated diabetic rats was very high at week 1 and decreased to near control level by 6 weeks without any RMC autophagy. However, the influx of macrophages by 6 weeks was as pronounced as in diabetic glomeruli. The results are as follows: 1) heparin blocks synthesis of hyaluronan in intracellular compartments, which prevents the autophagy and cyclin D3 responses thereby allowing RMCs to complete cell division and sustain function; 2) interaction of heparin with RMCs in early G(1) phase is sufficient to induce signaling pathway(s) for its functions; and 3) influxed macrophages effectively remove the hyaluronan matrix without inducing pro-fibrotic responses that lead to nephropathy and proteinurea in diabetic kidneys.	[Wang, Aimin; Ren, Juan; Wang, Christina P.; Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Wang, AM (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Biomed Engn, ND20, Cleveland, OH 44195 USA.	wanga@ccf.org			National Institutes of Health, NHLBI [P01 HL107147]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062934] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Hyaluronan Matrices in Vascular Pathologies is funded in its entirety by National Institutes of Health P01 HL107147 from NHLBI.	Barski OA, 1999, GENOMICS, V60, P188, DOI 10.1006/geno.1999.5915; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Calabro A, 2000, GLYCOBIOLOGY, V10, P283, DOI 10.1093/glycob/10.3.283; Calabro A, 2001, OSTEOARTHR CARTILAGE, V9, pS16, DOI 10.1053/joca.2001.0439; CASTELLOT JJ, 1986, AM J PATHOL, V125, P493; CASTELLOT JJ, 1985, AM J PATHOL, V120, P427; COFFEY AK, 1985, AM J PATHOL, V120, P248; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; DIAMOND JR, 1991, AM J PHYSIOL, V260, pF779, DOI 10.1152/ajprenal.1991.260.6.F779; DIAMOND JR, 1986, RENAL PHYSIOL BIOCH, V9, P366; DOHI K, 1982, ACTA PATHOL JAPON, V32, P1047; Dunlop M, 2000, KIDNEY INT, V58, pS3, DOI 10.1046/j.1523-1755.2000.07702.x; Dunlop ME, 1996, KIDNEY INT, V50, P40, DOI 10.1038/ki.1996.284; Erikstrup C, 2001, EUR J ENDOCRINOL, V145, P193, DOI 10.1530/eje.0.1450193; FLOEGE J, 1993, KIDNEY INT, V43, P369, DOI 10.1038/ki.1993.55; FURUTA T, 1993, AM J KIDNEY DIS, V21, P480, DOI 10.1016/S0272-6386(12)80393-3; GAMBARO G, 1992, KIDNEY INT, V42, P285, DOI 10.1038/ki.1992.288; GAMBARO G, 1994, KIDNEY INT, V46, P797, DOI 10.1038/ki.1994.335; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; GUIJARRO C, 1995, AM J KIDNEY DIS, V26, P152, DOI 10.1016/0272-6386(95)90169-8; HANEDA M, 1990, METABOLISM, V39, P40, DOI 10.1016/0026-0495(90)90145-3; Haneda M, 2003, J AM SOC NEPHROL, V14, P1374, DOI 10.1097/01.ASN.0000064500.89551.76; HEGELE RG, 1989, CLIN INVEST MED, V12, P181; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Jokela TA, 2011, J BIOL CHEM, V286, P33632, DOI 10.1074/jbc.M111.265637; Jones S, 2001, KIDNEY INT, V59, P1739, DOI 10.1046/j.1523-1755.2001.0590051739.x; Keane WF, 2000, KIDNEY INT, V57, pS27, DOI 10.1046/j.1523-1755.2000.07503.x; Kikkawa R, 2003, AM J KIDNEY DIS, V41, pS19, DOI 10.1053/ajkd.2003.50077; Kim YH, 2007, J CELL BIOCHEM, V101, P987, DOI 10.1002/jcb.21316; Kimmelstiel P, 1936, AM J PATHOL, V12, P83; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Lane MD, 1996, INT J OBESITY, V20, pS91; Lauer ME, 2007, J BIOL CHEM, V282, P843, DOI 10.1074/jbc.M608823200; LEE HS, 1991, CLIN NEPHROL, V36, P67; Majors AK, 1997, J ORTHOPAED RES, V15, P546, DOI 10.1002/jor.1100150410; MARSHALL S, 1991, J BIOL CHEM, V266, P10155; Masson E, 2006, IUBMB LIFE, V58, P381, DOI 10.1080/15216540600755980; MAUER SM, 1994, KIDNEY INT, V45, P612, DOI 10.1038/ki.1994.80; MENE P, 1989, PHYSIOL REV, V69, P1347, DOI 10.1152/physrev.1989.69.4.1347; Mene P, 2001, NEPHROL DIAL TRANSPL, V16, P913, DOI 10.1093/ndt/16.5.913; Miralem T, 1996, J BIOL CHEM, V271, P17100, DOI 10.1074/jbc.271.29.17100; NAPARSTEK Y, 1990, ARTHRITIS RHEUM, V33, P1554, DOI 10.1002/art.1780331013; Nigro J, 2009, J BIOL CHEM, V284, P16832, DOI 10.1074/jbc.M109.002956; Noh H, 2007, KIDNEY INT, V72, pS49, DOI 10.1038/sj.ki.5002386; Oates PJ, 2008, CURR DRUG TARGETS, V9, P14, DOI 10.2174/138945008783431781; Oda H, 1997, KIDNEY INT, V52, pS36; Ren J, 2009, J BIOL CHEM, V284, P16621, DOI 10.1074/jbc.M806430200; Rosen ED, 2005, PROSTAG LEUKOTR ESS, V73, P31, DOI 10.1016/j.plefa.2005.04.004; Sarruf DA, 2005, MOL CELL BIOL, V25, P9985, DOI 10.1128/MCB.25.22.9985-9995.2005; Sayeski PP, 1997, NUCLEIC ACIDS RES, V25, P1458, DOI 10.1093/nar/25.7.1458; Schleicher ED, 2000, KIDNEY INT, V58, pS13, DOI 10.1046/j.1523-1755.2000.07703.x; SIMONSON MS, 1990, METHOD ENZYMOL, V187, P544; Singh LP, 2004, AM J PHYSIOL-RENAL, V286, pF409, DOI 10.1152/ajprenal.00007.2003; Sun LJ, 2002, J BIOL CHEM, V277, P18919, DOI 10.1074/jbc.M110650200; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; TEMPLETON DM, 1990, J BIOL CHEM, V265, P21764; Urbonaviciute V., 2003, BIOLOGIJA, V3, P45; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Wang AM, 1996, KIDNEY INT, V49, P437, DOI 10.1038/ki.1996.63; WANG AM, 1994, J CELL PHYSIOL, V159, P295, DOI 10.1002/jcp.1041590213; Whiteside CI, 2002, AM J PHYSIOL-RENAL, V282, pF975, DOI 10.1152/ajprenal.00014.2002; Wolf G, 1999, KIDNEY INT, V56, P1262, DOI 10.1046/j.1523-1755.1999.00695.x; Yamamoto D, 2003, CELL SIGNAL, V15, P575, DOI 10.1016/S0898-6568(02)00142-0; Yamazaki K, 2000, GENE, V261, P329, DOI 10.1016/S0378-1119(00)00497-2; Young B., 1992, Journal of the American Society of Nephrology, V3, P770; YOUNG BA, 1995, KIDNEY INT, V47, P935, DOI 10.1038/ki.1995.139	69	19	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9418	9429		10.1074/jbc.M113.541441	http://dx.doi.org/10.1074/jbc.M113.541441			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24482224	Green Published, hybrid			2022-12-28	WOS:000333472100057
J	Wei, SS; Wang, HB; Lu, CW; Malmut, S; Zhang, JQ; Ren, SM; Yu, GH; Wang, W; Tang, DD; Yan, CH				Wei, Saisai; Wang, Hongbo; Lu, Chunwan; Malmut, Sarah; Zhang, Jianqiao; Ren, Shumei; Yu, Guohua; Wang, Wei; Tang, Dale D.; Yan, Chunhong			The Activating Transcription Factor 3 Protein Suppresses the Oncogenic Function of Mutant p53 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drug Resistance; Invasion; Lung Cancer; Migration; p53; ATF3; Mutant p53	PROSTATE-CANCER; GENE-EXPRESSION; ATF3; GAIN; METASTASIS; DEGRADATION; UBIQUITINATION; REPRESSION; MUTATIONS; STABILITY	Background: Mutant p53 often acquires tumor-promoting activities, including the promotion of cancer cell survival, invasion, and metastasis. Results: Activating transcription factor 3 (ATF3) bound mutant p53 proteins, sensitized cancer cells to chemotherapy, and suppressed mutant p53-mediated cell migration. Conclusion: ATF3 suppressed the tumor-promoting function of mutant p53. Significance: Targeting ATF3 could be a novel strategy for treating p53-mutated cancer. Mutant p53 proteins (mutp53) often acquire oncogenic activities, conferring drug resistance and/or promoting cancer cell migration and invasion. Although it has been well established that such a gain of function is mainly achieved through interaction with transcriptional regulators, thereby modulating cancer-associated gene expression, how the mutp53 function is regulated remains elusive. Here we report that activating transcription factor 3 (ATF3) bound common mutp53 (e.g. R175H and R273H) and, subsequently, suppressed their oncogenic activities. ATF3 repressed mutp53-induced NFKB2 expression and sensitized R175H-expressing cancer cells to cisplatin and etoposide treatments. Moreover, ATF3 appeared to suppress R175H- and R273H-mediated cancer cell migration and invasion as a consequence of preventing the transcription factor p63 from inactivation by mutp53. Accordingly, ATF3 promoted the expression of the metastasis suppressor SHARP1 in mutp53-expressing cells. An ATF3 mutant devoid of the mutp53-binding domain failed to disrupt the mutp53-p63 binding and, thus, lost the activity to suppress mutp53-mediated migration, suggesting that ATF3 binds to mutp53 to suppress its oncogenic function. In line with these results, we found that down-regulation of ATF3 expression correlated with lymph node metastasis in TP53-mutated human lung cancer. We conclude that ATF3 can suppress mutp53 oncogenic function, thereby contributing to tumor suppression in TP53-mutated cancer.	[Wei, Saisai; Wang, Hongbo; Malmut, Sarah; Ren, Shumei; Yan, Chunhong] Albany Med Coll, Ctr Cell Biol & Canc Res, Albany, NY 12208 USA; [Wei, Saisai; Tang, Dale D.] Albany Med Coll, Ctr Cardiovasc Sci, Albany, NY 12208 USA; [Lu, Chunwan; Yan, Chunhong] Georgia Regents Univ, GRU Canc Ctr, Augusta, GA 30912 USA; [Yan, Chunhong] Georgia Regents Univ, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Wang, Hongbo; Zhang, Jianqiao] Yantai Univ, Key Lab Mol Pharmacol & Drug Evaluat, Sch Pharm, Yantai 264005, Peoples R China; [Yu, Guohua; Wang, Wei] Qingdao Univ, Coll Med, Dept Pathol, Affiliated Yantai Yuhuangding Hosp, Yantai 264000, Peoples R China	Albany Medical College; Albany Medical College; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Yantai University; Qingdao University	Yan, CH (corresponding author), GRU Canc Ctr, 1410 Laney Walker Blvd,CN 2134, Augusta, GA 30912 USA.	cyan@gru.edu	王, 洪波/A-6767-2019; Wang, Hongbo/AHC-7831-2022; T, Dale/AAE-9643-2020; Lu, Chunwan/V-6216-2019	王, 洪波/0000-0001-8530-2339; Wang, Hongbo/0000-0001-8530-2339; T, Dale/0000-0002-7339-9249; Yan, Chunhong/0000-0002-3974-7991; qiao, jian/0000-0002-4941-7013	NCI, National Institutes of Health [RO1CA139107, RO1CA164006]; National Natural Science Foundation of China [81202038]; Scientific Research Foundation for Returned Overseas Chinese Scholars; NATIONAL CANCER INSTITUTE [R01CA139107, R01CA164006] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110951, R01HL113208] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	* This work was supported, in whole or in part, by NCI, National Institutes of Health Grants RO1CA139107 and RO1CA164006 (to C. Y.).; <SUP>1</SUP> Supported by National Natural Science Foundation of China Grant 81202038 and by the Scientific Research Foundation for Returned Overseas Chinese Scholars.	Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Bottone FG, 2005, MOL CANCER THER, V4, P693, DOI 10.1158/1535-7163.MCT-04-0337; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Buganim Y, 2006, CANCER RES, V66, P10750, DOI 10.1158/0008-5472.CAN-06-0916; Do PM, 2012, GENE DEV, V26, P830, DOI 10.1101/gad.181685.111; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Gargiulo G, 2013, CANCER CELL, V23, P660, DOI 10.1016/j.ccr.2013.03.030; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; Hackl C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-668; Huang XW, 2008, J BIOL CHEM, V283, P29795, DOI 10.1074/jbc.M802515200; Ishiguro T, 1996, CANCER RES, V56, P875; Jan YH, 2012, CANCER RES, V72, P5119, DOI 10.1158/0008-5472.CAN-12-1842; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Liu K, 2011, MOL CELL BIOL, V31, P4464, DOI 10.1128/MCB.05574-11; Liu W, 2011, J BIOL CHEM, V286, P18949, DOI 10.1074/jbc.M111.232637; Lukashchuk N, 2007, MOL CELL BIOL, V27, P8284, DOI 10.1128/MCB.00050-07; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Mo PL, 2010, J BIOL CHEM, V285, P26908, DOI 10.1074/jbc.M110.132597; Montagner M, 2012, NATURE, V487, P380, DOI 10.1038/nature11207; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Nair RR, 2008, MOL PHARMACOL, V73, P919, DOI 10.1124/mol.107.042606; Neilsen PM, 2011, ONCOTARGET, V2, P1203; Noll JE, 2012, ONCOGENE, V31, P2836, DOI 10.1038/onc.2011.456; Oh YK, 2008, MOL CANCER RES, V6, P1232, DOI 10.1158/1541-7786.MCR-07-0297; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Scian MJ, 2005, MOL CELL BIOL, V25, P10097, DOI 10.1128/MCB.25.22.10097-10110.2005; Stambolsky P, 2010, CANCER CELL, V17, P273, DOI 10.1016/j.ccr.2009.11.025; Stearns ME, 2004, MOL CANCER RES, V2, P403; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Valenti F, 2011, CELL CYCLE, V10, P4330, DOI 10.4161/cc.10.24.18682; Wang GC, 2013, NAT GENET, V45, P739, DOI 10.1038/ng.2654; Wang HB, 2012, MOL CELL BIOL, V32, P3190, DOI 10.1128/MCB.00159-12; Wang HB, 2010, J BIOL CHEM, V285, P13201, DOI 10.1074/jbc.M109.058669; Wu XW, 2010, NATURE, V465, P368, DOI 10.1038/nature08996; Yan CH, 2005, EMBO J, V24, P2425, DOI 10.1038/sj.emboj.7600712; Yan CH, 2002, J BIOL CHEM, V277, P10804, DOI 10.1074/jbc.M112069200; Yan CH, 2003, J BIOL CHEM, V278, P2309, DOI 10.1074/jbc.M210369200; Yan CH, 2006, MOL CELL BIOL, V26, P6357, DOI 10.1128/MCB.00311-06; Yan CH, 2006, CELL CYCLE, V5, P926, DOI 10.4161/cc.5.9.2714; Yemelyanova A, 2011, MODERN PATHOL, V24, P1248, DOI 10.1038/modpathol.2011.85; Yin X, 2010, J CELL SCI, V123, P3558, DOI 10.1242/jcs.064915; Yuan XL, 2013, CANCER RES, V73, P3625, DOI 10.1158/0008-5472.CAN-12-3879; Zigler M, 2011, CANCER RES, V71, P3494, DOI 10.1158/0008-5472.CAN-10-3555	47	42	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8947	8959		10.1074/jbc.M113.503755	http://dx.doi.org/10.1074/jbc.M113.503755			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24554706	Green Published, hybrid			2022-12-28	WOS:000333472100018
J	Pacheco-Costa, R; Hassan, I; Reginato, RD; Davis, HM; Bruzzaniti, A; Allen, MR; Plotkin, LI				Pacheco-Costa, Rafael; Hassan, Iraj; Reginato, Rejane D.; Davis, Hannah M.; Bruzzaniti, Angela; Allen, Matthew R.; Plotkin, Lilian I.			High Bone Mass in Mice Lacking Cx37 Because of Defective Osteoclast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Gap Junctions; Osteoblasts; Osteoclast; Osteocyte; Cx37	GAP JUNCTIONAL COMMUNICATION; OSTEOBLAST LINEAGE; CONNEXIN43; OSTEOCYTE; CHANNELS; ABNORMALITIES; ACTIVATION; RESORPTION; APOPTOSIS; MATRIX	Background: Connexin proteins are essential for cell differentiation, function, and survival. Results: Global deletion of Cx37 results in increased bone mass caused by reduced osteoclast maturation. Conclusion: Our findings demonstrate a previously unrecognized role of Cx37 in bone homeostasis in vivo. Significance: Therapeutic approaches to increase bone mass might be developed by interfering with Cx37 function. Connexin (Cx) proteins are essential for cell differentiation, function, and survival in all tissues with Cx43 being the most studied in bone. We now report that Cx37, another member of the connexin family of proteins, is expressed in osteoclasts, osteoblasts, and osteocytes. Mice with global deletion of Cx37 (Cx37(-/-)) exhibit higher bone mineral density, cancellous bone volume, and mechanical strength compared with wild type littermates. Osteoclast number and surface are significantly lower in bone of Cx37(-/-) mice. In contrast, osteoblast number and surface and bone formation rate in bones from Cx37(-/-) mice are unchanged. Moreover, markers of osteoblast activity ex vivo and in vivo are similar to those of Cx37(+/+) littermates. sRANKL/M-CSF treatment of nonadherent Cx37(-/-) bone marrow cells rendered a 5-fold lower level of osteoclast differentiation compared with Cx37(+/+) cell cultures. Further, Cx37(-/-) osteoclasts are smaller and have fewer nuclei per cell. Expression of RANK, TRAP, cathepsin K, calcitonin receptor, matrix metalloproteinase 9, NFATc1, DC-STAMP, ATP6v0d1, and CD44, markers of osteoclast number, fusion, or activity, is lower in Cx37(-/-) osteoclasts compared with controls. In addition, nonadherent bone marrow cells from Cx37(-/-) mice exhibit higher levels of markers for osteoclast precursors, suggesting altered osteoclast differentiation. The reduction of osteoclast differentiation is associated with activation of Notch signaling. We conclude that Cx37 is required for osteoclast differentiation and fusion, and its absence leads to arrested osteoclast maturation and high bone mass in mice. These findings demonstrate a previously unrecognized role of Cx37 in bone homeostasis that is not compensated for by Cx43 in vivo.	[Pacheco-Costa, Rafael; Hassan, Iraj; Davis, Hannah M.; Allen, Matthew R.; Plotkin, Lilian I.] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Pacheco-Costa, Rafael; Reginato, Rejane D.] Univ Fed Sao Paulo, Sch Med, Dept Morphol & Genet, BR-04023 Sao Paulo, Brazil; [Bruzzaniti, Angela] Indiana Univ, Sch Dent, Dept Oral Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Universidade Federal de Sao Paulo (UNIFESP); Indiana University System; Indiana University-Purdue University Indianapolis	Plotkin, LI (corresponding author), Indiana Univ Sch Med, Dept Anat & Cell Biol, 635 Barnhill Dr,MS-5035, Indianapolis, IN 46202 USA.	lplotkin@iupui.edu	REGINATO, REJANE/G-6579-2013; Bruzzaniti, Angela/AAP-2225-2020; Plotkin, Lilian/H-7188-2019; Pacheco-Costa, Rafael/K-8924-2012	REGINATO, REJANE/0000-0002-4370-9111; Plotkin, Lilian/0000-0002-9537-4544; Pacheco-Costa, Rafael/0000-0001-7259-079X	National Institutes of Health [R01-AR053643, S10-RR023710]; Clinical and Transitional Sciences Institute Project Development Team (PDT) from Indiana University [TR000006]; Coordination of Improvement of Higher Level Personnel (CAPES) (Brazil) [1065/11-4]; Ronald E. McNair Post-baccalaureate Achievement Program from the U.S. Dept. of Education; Clinical and Transitional Sciences Institute Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000006] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Transitional Sciences Institute Project Development Team (PDT) from Indiana University; Coordination of Improvement of Higher Level Personnel (CAPES) (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ronald E. McNair Post-baccalaureate Achievement Program from the U.S. Dept. of Education; Clinical and Transitional Sciences Institute Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AR053643 (to L. I. P.). This work was also supported by Clinical and Transitional Sciences Institute Project Development Team (PDT) Grant TR000006 from Indiana University (to L. I. P. and M. R. A.). mu CT studies were performed using equipment obtained with the National Institutes of Health Grant S10-RR023710.; Recipient of Scholarship Grant 1065/11-4 from Coordination of Improvement of Higher Level Personnel (CAPES) (Brazil).; Recipient of scholarships from the Ronald E. McNair Post-baccalaureate Achievement Program from the U.S. Dept. of Education (2012) and Clinical and Transitional Sciences Institute Award (2013).	Albers J, 2013, J CELL BIOL, V200, P537, DOI 10.1083/jcb.201207142; Allen MR, 2008, CALCIFIED TISSUE INT, V82, P354, DOI 10.1007/s00223-008-9131-8; Bai S, 2008, J BIOL CHEM, V283, P6509, DOI 10.1074/jbc.M707000200; Bivi N, 2013, J ORTHOP RES, V31, P1075, DOI 10.1002/jor.22341; Bivi N, 2012, CALCIFIED TISSUE INT, V91, P215, DOI 10.1007/s00223-012-9628-z; Bivi N, 2012, J BONE MINER RES, V27, P374, DOI 10.1002/jbmr.548; Bivi N, 2011, J CELL BIOCHEM, V112, P2920, DOI 10.1002/jcb.23208; Bivi N, 2009, J PROTEOME RES, V8, P1131, DOI 10.1021/pr8005606; Burt JM, 2008, AM J PHYSIOL-CELL PH, V295, pC1103, DOI 10.1152/ajpcell.299.2008; Cackowski FC, 2010, BLOOD, V115, P140, DOI 10.1182/blood-2009-08-237628; Chanson M, 2007, J MOL MED, V85, P787, DOI 10.1007/s00109-007-0169-2; De Bock M, 2011, J CEREBR BLOOD F MET, V31, P1942, DOI 10.1038/jcbfm.2011.86; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Ek-Vitorin JF, 2013, BBA-BIOMEMBRANES, V1828, P51, DOI 10.1016/j.bbamem.2012.02.003; Evans WH, 2007, CELL COMMUN ADHES, V14, P265, DOI 10.1080/15419060801891034; Figueroa XF, 2009, ANTIOXID REDOX SIGN, V11, P251, DOI 10.1089/ars.2008.2117; Hanner F, 2010, AM J PHYSIOL-REG I, V298, pR1143, DOI 10.1152/ajpregu.00808.2009; Herve JC, 2012, BBA-BIOMEMBRANES, V1818, P1844, DOI 10.1016/j.bbamem.2011.12.009; Ilvesaro J, 2001, BMC Musculoskelet Disord, V2, P10, DOI 10.1186/1471-2474-2-10; Ilvesaro J, 2003, CRIT REV EUKAR GENE, V13, P133; Jiao QJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027646; Kalajzic I, 2004, BONE, V35, P74, DOI 10.1016/j.bone.2004.03.006; Kania JR, 1997, J BONE MINER RES, V12, P1155, DOI 10.1359/jbmr.1997.12.8.1155; Kylmaoja E, 2013, CALCIFIED TISSUE INT, V92, P270, DOI 10.1007/s00223-012-9680-8; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; Li TY, 2007, J CELL SCI, V120, P4117, DOI 10.1242/jcs.03488; Ma J, 2013, MOL BIOL REP, V40, P2097, DOI 10.1007/s11033-012-2268-6; MacLauchlan S, 2009, J LEUKOCYTE BIOL, V85, P617, DOI 10.1189/jlb.1008588; Matemba SF, 2006, J CELL BIOCHEM, V99, P528, DOI 10.1002/jcb.20866; Morel S, 2010, CARCINOGENESIS, V31, P1922, DOI 10.1093/carcin/bgq170; Nelson TK, 2013, AM J PHYSIOL-CELL PH, V305, pC1246, DOI 10.1152/ajpcell.00159.2013; Nielsen MS, 2012, COMPR PHYSIOL, V2, P1981, DOI 10.1002/cphy.c110051; Niranjan T, 2008, NAT MED, V14, P290, DOI 10.1038/nm1731; O'Carroll SJ, 2013, NEUROSCI RES, V75, P256, DOI 10.1016/j.neures.2013.01.004; Paic F, 2009, BONE, V45, P682, DOI 10.1016/j.bone.2009.06.010; Plotkin LI, 2011, BONE, V49, P122, DOI 10.1016/j.bone.2010.08.011; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Plotkin LI, 2002, J BIOL CHEM, V277, P8648, DOI 10.1074/jbc.M108625200; Plotkin LI, 2013, BONE, V52, P157, DOI 10.1016/j.bone.2012.09.030; Rhee Y, 2011, J BONE MINER RES, V26, P1035, DOI 10.1002/jbmr.304; Rodriguez S, 2009, BLOOD, V114, P4064, DOI 10.1182/blood-2009-04-214916; Schilling AF, 2008, J CELL MOL MED, V12, P2497, DOI 10.1111/j.1582-4934.2008.00275.x; Segretain D, 2004, BBA-BIOMEMBRANES, V1662, P3, DOI 10.1016/j.bbamem.2004.01.007; Simon AM, 1997, NATURE, V385, P525, DOI 10.1038/385525a0; Simon AM, 2002, DEV BIOL, V251, P206, DOI 10.1006/dbio.2002.0826; Sohl G, 2004, CARDIOVASC RES, V62, P228, DOI 10.1016/j.cardiores.2003.11.013; Sternlieb M., 2012, J BONE MINER RES, V27, pS53; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Thi MM, 2010, AM J PHYSIOL-CELL PH, V299, pC994, DOI 10.1152/ajpcell.00544.2009; Tu XL, 2007, DEV CELL, V12, P113, DOI 10.1016/j.devcel.2006.11.003; Watkins M, 2011, MOL BIOL CELL, V22, P1240, DOI 10.1091/mbc.E10-07-0571; WHITE TW, 1995, MOL BIOL CELL, V6, P459, DOI 10.1091/mbc.6.4.459; Yamada Y, 2007, INT J MOL MED, V19, P791; Zappitelli T, 2013, J BONE MINER RES, V28, P2400, DOI 10.1002/jbmr.1965	54	49	53	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8508	8520		10.1074/jbc.M113.529735	http://dx.doi.org/10.1074/jbc.M113.529735			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24509854	Green Published, hybrid			2022-12-28	WOS:000333157500042
J	Koorella, C; Nair, JR; Murray, ME; Carlson, LM; Watkins, SK; Lee, KP				Koorella, Chandana; Nair, Jayakumar R.; Murray, Megan E.; Carlson, Louise M.; Watkins, Stephanie K.; Lee, Kelvin P.			Novel Regulation of CD80/CD86-induced Phosphatidylinositol 3-Kinase Signaling by NOTCH1 Protein in Interleukin-6 and Indoleamine 2,3-Dioxygenase Production by Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dendritic Cells; Interleukin; NOTCH Pathway; PI 3-Kinase (PI3K); Signal Transduction; Indoleamine 2; 3-Dioxygenase	NITRIC-OXIDE SYNTHASE; CD4(+) T-CELLS; MALIGNANT PLASMA-CELLS; TRANSCRIPTION FACTOR; TRYPTOPHAN CATABOLISM; DEPENDENT PATHWAY; STROMAL CELLS; CD28 FUNCTION; IN-VITRO; PTEN	Background: Engagement of CD80/CD86 on dendritic cells by CD28 on T cells induces dendritic cell production of IL-6 and IDO. Results: The NOTCH pathway modulates activation of the PI3K pathway downstream of CD80/CD86 ligation and regulates IL-6 and IDO production. Conclusion: Cross-talk between NOTCH and PI3K pathways modulates dendritic cell production of IL-6 and IDO. Significance: Elucidating the molecular mechanism of NOTCH-PI3K cross-talk will have broad implications in human disease. Dendritic cells (DC) play a critical role in modulating antigen-specific immune responses elicited by T cells via engagement of the prototypic T cell costimulatory receptor CD28 by the cognate ligands CD80/CD86, expressed on DC. Although CD28 signaling in T cell activation has been well characterized, it has only recently been shown that CD80/CD86, which have no demonstrated binding domains for signaling proteins in their cytoplasmic tails, nonetheless also transduce signals to the DC. Functionally, CD80/CD86 engagement results in DC production of the pro-inflammatory cytokine IL-6, which is necessary for full T cell activation. However, ligation of CD80/CD86 by CTLA4 also induces DC production of the immunosuppressive enzyme indoleamine 2,3-dioxygenase (IDO), which depletes local pools of the essential amino acid tryptophan, resulting in blockade of T cell activation. Despite the significant role of CD80/CD86 in immunological processes and the seemingly opposing roles they play by producing IL-6 and IDO upon their activation, how CD80/CD86 signal remains poorly understood. We have now found that cross-linking CD80/CD86 in human DC activates the PI3K/AKT pathway. This results in phosphorylation/inactivation of its downstream target, FOXO3A, and alleviates FOXO3A-mediated suppression of IL-6 expression. A second event downstream of AKT phosphorylation is activation of the canonical NF-B pathway, which induces IL-6 expression. In addition to these downstream pathways, we unexpectedly found that CD80/CD86-induced PI3K signaling is regulated by previously unrecognized cross-talk with NOTCH1 signaling. This cross-talk is facilitated by NOTCH-mediated up-regulation of the expression of prolyl isomerase PIN1, which in turn increases enzyme activity of casein kinase II. Subsequently, phosphatase and tensin homolog (which suppresses PI3K activity) is inactivated via phosphorylation by casein kinase II. This results in full activation of PI3K signaling upon cross-linking CD80/CD86. Similar to IL-6, we have found that CD80/CD86-induced IDO production by DC at late time points is also dependent upon the PI3K AKT NF-B pathway and requires cross-talk with NOTCH signaling. These data further suggest that the same signaling pathways downstream of DC CD80/CD86 cross-linking induce early IL-6 production to enhance T cell activation, followed by later IDO production to self-limit this activation. In addition to characterizing the pathways downstream of CD80/CD86 in IL-6 and IDO production, identification of a novel cross-talk between NOTCH1 and PI3K signaling may provide new insights in other biological processes where PI3K signaling plays a major role.	[Koorella, Chandana; Nair, Jayakumar R.; Murray, Megan E.; Carlson, Louise M.; Lee, Kelvin P.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Watkins, Stephanie K.] NCI, Natl Inst Hlth, Frederick, MD 21702 USA	Roswell Park Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lee, KP (corresponding author), Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA.	Kelvin.Lee@roswellpark.org	Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552	National Institutes of Health [R01 CA140622, R01 CA121044, R01 AI10015, T32 CA085183]; Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE [T32CA085183, R01CA140622, R01CA121044, P30CA016056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100157, F32AI010015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA140622, R01 CA121044, R01 AI10015, and T32 CA085183. This work was also supported by the Multiple Myeloma Research Foundation.	Ande SR, 2009, BIOCHEM BIOPH RES CO, V390, P1023, DOI 10.1016/j.bbrc.2009.10.101; Bahlis NJ, 2007, BLOOD, V109, P5002, DOI 10.1182/blood-2006-03-012542; Bhattacharyya S, 2004, BLOOD, V104, P1100, DOI 10.1182/blood-2003-12-4302; Bour-Jordan H, 2002, J CLIN IMMUNOL, V22, P1, DOI 10.1023/A:1014256417651; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cejas PJ, 2005, J BIOL CHEM, V280, P28412, DOI 10.1074/jbc.M500345200; Cibelli G, 2002, J NEUROSCI RES, V67, P450, DOI 10.1002/jnr.10141; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Fallarino F, 2003, NAT IMMUNOL, V4, P1206, DOI 10.1038/ni1003; Fallarino F, 2004, J EXP MED, V200, P1051, DOI 10.1084/jem.20040942; Forrester K, 1996, P NATL ACAD SCI USA, V93, P2442, DOI 10.1073/pnas.93.6.2442; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; GAJEWSKI TF, 1995, J IMMUNOL, V154, P5637; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Han EKH, 2008, ANTICANCER RES, V28, P957; HOLSTI MA, 1994, J IMMUNOL, V152, P1618; Houde C, 2004, BLOOD, V104, P3697, DOI 10.1182/blood-2003-12-4114; JUNE CH, 1994, IMMUNOL TODAY, V15, P321, DOI 10.1016/0167-5699(94)90080-9; KAWANO M, 1988, NATURE, V332, P83, DOI 10.1038/332083a0; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Kim KY, 2004, J PHARMACOL EXP THER, V308, P97, DOI 10.1124/jpet.103.058768; Kin NW, 2006, J IMMUNOL, V176, P6727, DOI 10.4049/jimmunol.176.11.6727; LANIER LL, 1995, J IMMUNOL, V154, P97; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; Liu K, 2001, J IMMUNOL, V166, P7335, DOI 10.4049/jimmunol.166.12.7335; Liu P, 2000, NAT MED, V6, P429, DOI 10.1038/74689; Lu LN, 1996, J IMMUNOL, V157, P3577; Lucas CR, 2013, J IMMUNOL, V190, P723, DOI 10.4049/jimmunol.1201646; Munn DH, 2004, J IMMUNOL, V172, P4100, DOI 10.4049/jimmunol.172.7.4100; Nair JR, 2011, J IMMUNOL, V187, P1243, DOI 10.4049/jimmunol.1100016; Orabona C, 2004, NAT IMMUNOL, V5, P1134, DOI 10.1038/ni1124; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Paolucci C, 2003, J LEUKOCYTE BIOL, V73, P253, DOI 10.1189/jlb.0902447; Rozanski CH, 2011, J EXP MED, V208, P1435, DOI 10.1084/jem.20110040; Rustighi A, 2009, NAT CELL BIOL, V11, P133, DOI 10.1038/ncb1822; Sade H, 2004, J BIOL CHEM, V279, P2937, DOI 10.1074/jbc.M309924200; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Silva A, 2010, HAEMATOL-HEMATOL J, V95, P674, DOI 10.3324/haematol.2009.011999; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Tsao PN, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-56; UCHIYAMA H, 1993, BLOOD, V82, P3712; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Vo K, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-138; WEINBERG JB, 1994, J EXP MED, V179, P651, DOI 10.1084/jem.179.2.651; Wols HAM, 2002, J IMMUNOL, V169, P4213, DOI 10.4049/jimmunol.169.8.4213; Wu Y, 2010, NATURE, V464, P1052, DOI 10.1038/nature08878	51	54	58	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7747	7762		10.1074/jbc.M113.519686	http://dx.doi.org/10.1074/jbc.M113.519686			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24415757	Green Published, hybrid			2022-12-28	WOS:000332761500042
J	Prosdocimo, DA; Anand, P; Liao, XD; Zhu, H; Shelkay, S; Artero-Calderon, P; Zhang, LL; Kirsh, J; Moore, D; Rosca, MG; Vazquez, E; Kerner, J; Akat, KM; Williams, Z; Zhao, JH; Fujioka, H; Tuschl, T; Bai, XD; Schulze, PC; Hoppel, CL; Jain, MK; Haldar, SM				Prosdocimo, Domenick A.; Anand, Priti; Liao, Xudong; Zhu, Han; Shelkay, Shamanthika; Artero-Calderon, Pedro; Zhang, Lilei; Kirsh, Jacob; Moore, D'Vesharronne; Rosca, Mariana G.; Vazquez, Edwin; Kerner, Janos; Akat, Kemal M.; Williams, Zev; Zhao, Jihe; Fujioka, Hisashi; Tuschl, Thomas; Bai, Xiaodong; Schulze, P. Christian; Hoppel, Charles L.; Jain, Mukesh K.; Haldar, Saptarsi M.			Kruppel-like Factor 15 Is a Critical Regulator of Cardiac Lipid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiac Metabolism; Cardiovascular; Kruppel-like Factor (KLF); Lipid Metabolism; Transcription Factors	FATTY-ACID OXIDATION; TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; HISTONE ACETYLTRANSFERASE ACTIVITY; GENE-EXPRESSION; TRANSPORT PROTEIN-1; INSULIN-RESISTANCE; ACTIVATION DOMAIN; FAILING HEART; PPAR-ALPHA; RECEPTOR	Background: Metabolic homeostasis is central to normal cardiac function. The molecular mechanisms underlying metabolic plasticity in the heart remain poorly understood. Results: Kruppel-like factor 15 (KLF15) is a direct and independent regulator of myocardial lipid flux. Conclusion: KLF15 is a core component of the transcriptional circuitry that governs cardiac metabolism. Significance: This work is the first to implicate the KLF transcription factor family in cardiac metabolism. The mammalian heart, the body's largest energy consumer, has evolved robust mechanisms to tightly couple fuel supply with energy demand across a wide range of physiologic and pathophysiologic states, yet, when compared with other organs, relatively little is known about the molecular machinery that directly governs metabolic plasticity in the heart. Although previous studies have defined Kruppel-like factor 15 (KLF15) as a transcriptional repressor of pathologic cardiac hypertrophy, a direct role for the KLF family in cardiac metabolism has not been previously established. We show in human heart samples that KLF15 is induced after birth and reduced in heart failure, a myocardial expression pattern that parallels reliance on lipid oxidation. Isolated working heart studies and unbiased transcriptomic profiling in Klf15-deficient hearts demonstrate that KLF15 is an essential regulator of lipid flux and metabolic homeostasis in the adult myocardium. An important mechanism by which KLF15 regulates its direct transcriptional targets is via interaction with p300 and recruitment of this critical co-activator to promoters. This study establishes KLF15 as a key regulator of myocardial lipid utilization and is the first to implicate the KLF transcription factor family in cardiac metabolism.	[Prosdocimo, Domenick A.; Anand, Priti; Liao, Xudong; Zhu, Han; Shelkay, Shamanthika; Artero-Calderon, Pedro; Zhang, Lilei; Kirsh, Jacob; Jain, Mukesh K.; Haldar, Saptarsi M.] Case Cardiovasc Res Inst, Cleveland, OH 44106 USA; [Prosdocimo, Domenick A.; Anand, Priti; Liao, Xudong; Zhu, Han; Shelkay, Shamanthika; Artero-Calderon, Pedro; Zhang, Lilei; Kirsh, Jacob; Hoppel, Charles L.; Jain, Mukesh K.; Haldar, Saptarsi M.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Rosca, Mariana G.; Vazquez, Edwin; Kerner, Janos; Fujioka, Hisashi; Hoppel, Charles L.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Ctr Mitochondrial Dis, Cleveland, OH 44106 USA; [Rosca, Mariana G.; Vazquez, Edwin; Kerner, Janos; Fujioka, Hisashi; Hoppel, Charles L.] Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Zhao, Jihe] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32827 USA; [Akat, Kemal M.; Williams, Zev; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10065 USA; [Moore, D'Vesharronne; Schulze, P. Christian] Columbia Univ, Med Ctr, Dept Med, Div Cardiol, New York, NY 10032 USA; [Williams, Zev] Albert Einstein Coll Med, Dept Obstet & Gynecol & Womens Hlth, Program Early & Recurrent Pregnancy Loss, New York, NY 10461 USA; [Bai, Xiaodong] Case Western Reserve Univ, Sch Med, Ctr RNA Mol Biol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; State University System of Florida; University of Central Florida; Howard Hughes Medical Institute; Rockefeller University; Columbia University; Yeshiva University; Case Western Reserve University	Jain, MK (corresponding author), Case Cardiovasc Res Inst, 2103 Cornell Rd,Rm 4-522, Cleveland, OH 44106 USA.	mukesh.jain2@case.edu; saptarsi.haldar@case.edu	Rosca, Mariana/ABH-7847-2020; Schulze, Christian/AGJ-7744-2022	Schulze, Christian/0000-0001-9442-7141; Zhu, Han/0000-0002-2751-7814; Rosca, Mariana/0000-0003-3605-9787	National Institutes of Health [T32HL105338, F32HL110538, HL086614, DK093821, HL072952, HL084154, CA043703, HL074237, HL095742, HL101272, CA132977, UL1RR024143]; American Heart Association [12SDG12070077]; Hartwell Foundation; German Research Foundation [AK137/1-1]; Genome and Transcriptome Sequencing Core at Case Western Reserve University; Visconsi Research Scholar Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD068546] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA043703, R01CA132977] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072952, K08HL086614, P01HL074237, K23HL095742, R01HL119195, P30HL101272, R01HL084154, T32HL105338, R01HL112486, F32HL110538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093821] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Hartwell Foundation; German Research Foundation(German Research Foundation (DFG)); Genome and Transcriptome Sequencing Core at Case Western Reserve University; Visconsi Research Scholar Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants T32HL105338 and F32HL110538 (to D. A. P.), HL086614 and DK093821 (to S. M. H.), HL072952 and HL084154 (to M. K. J.), CA043703 and HL074237 (to C. L. H.), HL095742 and HL101272 (to P. C. S.), CA132977 (to J. Z.), and UL1RR024143 (National Center for Research Resources) (to K. M. A. and T. T.). This work was also supported by American Heart Association Grant 12SDG12070077 (to X. L.), the Hartwell Foundation (to S. M. H.), German Research Foundation Fellowship Grant AK137/1-1 (to K. M. A.), the Genome and Transcriptome Sequencing Core at Case Western Reserve University (to X. B.), and the Visconsi Research Scholar Fund (to S. M. H.).	Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Banke NH, 2010, CIRC RES, V107, P233, DOI 10.1161/CIRCRESAHA.110.221713; Barth AS, 2009, CIRC-CARDIOVASC GENE, V2, P371, DOI 10.1161/CIRCGENETICS.108.832345; Battiprolu PK, 2012, J CLIN INVEST, V122, P1109, DOI 10.1172/JCI60329; Belke DD, 1999, AM J PHYSIOL-REG I, V277, pR1210, DOI 10.1152/ajpregu.1999.277.4.R1210; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertrand L, 2008, CARDIOVASC RES, V79, P238, DOI 10.1093/cvr/cvn093; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Campbell FM, 2002, J BIOL CHEM, V277, P4098, DOI 10.1074/jbc.M106054200; Cheng LH, 2004, NAT MED, V10, P1245, DOI 10.1038/nm1116; Chiu HC, 2005, CIRC RES, V96, P225, DOI 10.1161/01.RES.0000154079.20681.B9; Chokshi A, 2012, CIRCULATION, V125, P2844, DOI 10.1161/CIRCULATIONAHA.111.060889; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Frohnert BI, 1999, J BIOL CHEM, V274, P3970, DOI 10.1074/jbc.274.7.3970; Fujioka H, 2012, ANAT REC, V295, P1455, DOI 10.1002/ar.22523; Goldberg IJ, 2012, CELL METAB, V15, P805, DOI 10.1016/j.cmet.2012.04.006; Gray S, 2002, J BIOL CHEM, V277, P34322, DOI 10.1074/jbc.M201304200; Gray S, 2007, CELL METAB, V5, P305, DOI 10.1016/j.cmet.2007.03.002; Gupta A, 2012, J CLIN INVEST, V122, P291, DOI 10.1172/JCI57426; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Haldar SM, 2012, P NATL ACAD SCI USA, V109, P6739, DOI 10.1073/pnas.1121060109; Haldar SM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000502; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3; Ingwall JS, 2009, CIRC-HEART FAIL, V2, P275, DOI 10.1161/CIRCHEARTFAILURE.109.885301; Jeyaraj D, 2012, CELL METAB, V15, P311, DOI 10.1016/j.cmet.2012.01.020; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; Kim JK, 2004, J CLIN INVEST, V113, P756, DOI 10.1172/JCI200418917; Kolwicz SC, 2012, CIRC RES, V111, P728, DOI 10.1161/CIRCRESAHA.112.268128; Kolwicz SC, 2009, TRENDS CARDIOVAS MED, V19, P201, DOI 10.1016/j.tcm.2009.12.005; Le PP, 2005, PLOS GENET, V1, P159, DOI 10.1371/journal.pgen.0010016; Lehman JJ, 2008, AM J PHYSIOL-HEART C, V295, pH185, DOI 10.1152/ajpheart.00081.2008; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Mallipattu SK, 2012, J BIOL CHEM, V287, P19122, DOI 10.1074/jbc.M112.345983; Mas C, 2011, P NATL ACAD SCI USA, V108, P10484, DOI 10.1073/pnas.1017029108; Masuno K, 2011, AM J RESP CELL MOL, V45, P642, DOI 10.1165/rcmb.2010-0369OC; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; Miyamoto S, 2006, CIRCULATION, V113, P679, DOI 10.1161/CIRCULATIONAHA.105.585182; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; PALMER JW, 1977, J BIOL CHEM, V252, P8731; Poulin DL, 2004, J VIROL, V78, P8245, DOI 10.1128/JVI.78.15.8245-8253.2004; Puchowicz MA, 2004, MITOCHONDRION, V4, P377, DOI 10.1016/j.mito.2004.07.004; Randle P J, 1978, Biochem Soc Symp, P47; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Takaya T, 2008, J BIOL CHEM, V283, P9828, DOI 10.1074/jbc.M707391200; Teshigawara K, 2005, BIOCHEM BIOPH RES CO, V327, P920, DOI 10.1016/j.bbrc.2004.12.096; Urvalek AM, 2010, CELL CYCLE, V9, P601, DOI 10.4161/cc.9.3.10606; van Berlo JH, 2013, J CLIN INVEST, V123, P37, DOI 10.1172/JCI62839; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Wang B, 2008, J MOL CELL CARDIOL, V45, P193, DOI 10.1016/j.yjmcc.2008.05.005; Wei JQ, 2008, CIRCULATION, V118, P934, DOI 10.1161/CIRCULATIONAHA.107.760488; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Zhang J, 2011, J MOL BIOL, V411, P537, DOI 10.1016/j.jmb.2011.06.011; Zhao GX, 2008, AM J PHYSIOL-HEART C, V294, pH936, DOI 10.1152/ajpheart.00870.2007	59	84	87	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5914	5924		10.1074/jbc.M113.531384	http://dx.doi.org/10.1074/jbc.M113.531384			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24407292	Green Published, hybrid			2022-12-28	WOS:000332015500048
J	Santos-Sacchi, J; Song, L				Santos-Sacchi, Joseph; Song, Lei			Chloride and Salicylate Influence Prestin-dependent Specific Membrane Capacitance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biosensors; Chloride Transport; Hair Cell; Kinetics; Molecular Motors; Capacitance; Kinetic Model; slc26	OUTER HAIR CELL; MAMMALIAN COCHLEAR AMPLIFICATION; EXTERNAL ELECTRIC-FIELD; LATERAL MEMBRANE; GUINEA-PIG; MOTOR PROTEIN; MECHANICAL RESPONSES; VOLTAGE-SENSOR; GATING CHARGE; MOTILITY	Background: The SLC26a5 outer hair cell motor drives electromechanical behavior of this sensory/effector cell. Results: A kinetic model fits the combined effects of salicylate and chloride on prestin-associated membrane capacitance. Conclusion: Data support a theory whereby prestin differentially changes area state upon binding of chloride and salicylate. Significance: The model of prestin activity points to the molecular underpinnings of electromotility in outer hair cells. The outer hair cell is electromotile, its membrane motor identified as the protein SLC26a5 (prestin). An area motor model, based on two-state Boltzmann statistics, was developed about two decades ago and derives from the observation that outer hair cell surface area is voltage-dependent. Indeed, aside from the nonlinear capacitance imparted by the voltage sensor charge movement of prestin, linear capacitance (C-lin) also displays voltage dependence as motors move between expanded and compact states. Naturally, motor surface area changes alter membrane capacitance. Unit linear motor capacitance fluctuation (C-sa) is on the order of 140 zeptofarads. A recent three-state model of prestin provides an alternative view, suggesting that voltage-dependent linear capacitance changes are not real but only apparent because the two component Boltzmann functions shift their midpoint voltages (V-h) in opposite directions during treatment with salicylate, a known competitor of required chloride binding. We show here using manipulations of nonlinear capacitance with both salicylate and chloride that an enhanced area motor model, including augmented C-sa by salicylate, can accurately account for our novel findings. We also show that although the three-state model implicitly avoids measuring voltage-dependent motor capacitance, it registers C-sa effects as a byproduct of its assessment of C-lin, which increases during salicylate treatment as motors are locked in the expanded state. The area motor model, in contrast, captures the characteristics of the voltage dependence of C-sa, leading to a better understanding of prestin.	Yale Univ Sch Med, Dept Surg Otolaryngol, New Haven, CT 06510 USA; [Santos-Sacchi, Joseph] Yale Univ Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Santos-Sacchi, Joseph] Yale Univ Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Santos-Sacchi, J (corresponding author), Yale Univ Sch Med, Dept Surg Otolaryngol, BML 224, 333 Cedar St, New Haven, CT 06510 USA.	joseph.santos-sacchi@yale.edu			National Institutes of Health [NIDCD DC00273]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000273] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant NIDCD DC00273 (to J. S. S.).	Abe T, 2007, J MEMBRANE BIOL, V215, P49, DOI 10.1007/s00232-007-9004-5; Adachi M, 1999, P NATL ACAD SCI USA, V96, P7244, DOI 10.1073/pnas.96.13.7244; ASHMORE JF, 1987, J PHYSIOL-LONDON, V388, P323, DOI 10.1113/jphysiol.1987.sp016617; ASHMORE JF, 1990, NEUROSCI RES       S, V12, P39; Bezanilla F, 2013, J GEN PHYSIOL, V142, P575, DOI 10.1085/jgp.201311056; BROWNELL WE, 1985, SCIENCE, V227, P194, DOI 10.1126/science.3966153; Colquhoun D, 2004, BIOPHYS J, V86, P3510, DOI 10.1529/biophysj.103.038679; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; GALE JE, 1994, P ROY SOC B-BIOL SCI, V255, P243, DOI 10.1098/rspb.1994.0035; Homma Kazuaki, 2011, Commun Integr Biol, V4, P450, DOI 10.4161/cib.4.4.15463; Homma K, 2011, J BIOL CHEM, V286, P2297, DOI 10.1074/jbc.M110.185694; IWASA KH, 1994, J ACOUST SOC AM, V96, P2216, DOI 10.1121/1.410094; IWASA KH, 1993, BIOPHYS J, V65, P492, DOI 10.1016/S0006-3495(93)81053-1; Iwasa KH, 2001, BIOPHYS J, V81, P2495, DOI 10.1016/S0006-3495(01)75895-X; IWASA KH, 1989, HEARING RES, V40, P247, DOI 10.1016/0378-5955(89)90165-2; JERRY RA, 1995, J ACOUST SOC AM, V98, P2000, DOI 10.1121/1.413318; KACHAR B, 1986, NATURE, V322, P365, DOI 10.1038/322365a0; Kakehata S, 1996, J NEUROSCI, V16, P4881; KALINEC F, 1992, P NATL ACAD SCI USA, V89, P8671, DOI 10.1073/pnas.89.18.8671; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Okunade O, 2013, BIOPHYS J, V105, P1822, DOI 10.1016/j.bpj.2013.09.008; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Raphael RM, 2000, BIOPHYS J, V78, P2844, DOI 10.1016/S0006-3495(00)76827-5; Santos-Sacchi J, 2006, J NEUROSCI, V26, P3992, DOI 10.1523/JNEUROSCI.4548-05.2006; SANTOS-SACCHI J, 1988, HEARING RES, V35, P143, DOI 10.1016/0378-5955(88)90113-X; Santos-Sacchi J, 2004, J MEMBRANE BIOL, V200, P83, DOI 10.1007/s00232-004-0699-2; Santos-Sacchi J, 2004, BIOPHYS J, V87, P714, DOI 10.1529/biophysj.103.033993; SANTOS-SACCHI J, 1993, BIOPHYS J, V65, P2217, DOI 10.1016/S0006-3495(93)81247-5; Santos-Sacchi J, 2003, CURR OPIN NEUROBIOL, V13, P459, DOI 10.1016/S0959-4388(03)00100-4; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 2002, PFLUG ARCH EUR J PHY, V444, P99, DOI 10.1007/s00424-002-0804-2; Santos-Sacchi J, 2001, J PHYSIOL-LONDON, V531, P661, DOI 10.1111/j.1469-7793.2001.0661h.x; Santos-Sacchi J, 1998, J PHYSIOL-LONDON, V510, P225, DOI 10.1111/j.1469-7793.1998.225bz.x; SANTOS-SACCHI J, 1992, J NEUROSCI, V12, P1906; Santos-Sacchi J, 2009, BIOPHYS J, V96, P739, DOI 10.1016/j.bpj.2008.10.015; Song L, 2005, BIOPHYS J, V88, P2350, DOI 10.1529/biophysj.104.053579; Song L., 2012, AIP C P, V1403, P179; Song L., 2011, ABSTRACTS ASS RES OT; Song L, 2013, P NATL ACAD SCI USA, V110, P3883, DOI 10.1073/pnas.1218341110; TUNSTALL MJ, 1995, J PHYSIOL-LONDON, V485, P739, DOI 10.1113/jphysiol.1995.sp020765; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009	41	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10823	10830		10.1074/jbc.M114.549329	http://dx.doi.org/10.1074/jbc.M114.549329			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24554714	Green Published, hybrid			2022-12-28	WOS:000334226400050
J	Plante, S; Ioannoni, R; Beaudoin, J; Labbe, S				Plante, Samuel; Ioannoni, Raphael; Beaudoin, Jude; Labbe, Simon			Characterization of Schizosaccharomyces pombe Copper Transporter Proteins in Meiotic and Sporulating Cells*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Copper; Gene Regulation; Meiosis; Metalloproteins; Yeast	FORESPORE MEMBRANE FORMATION; BINDING FACTOR PHP4; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; MAMMALIAN OOCYTES; IRON-DEFICIENCY; MEIOSIS; HOMOLOG; IDENTIFICATION	Background: Despite a requirement for copper during meiosis, the role of copper transporters (Ctrs) in this process remains poorly understood. Results: Ctrs exhibit temporal and dynamic cellular localization patterns during meiotic differentiation. Conclusion: Whereas Ctr4/5 is primarily involved during early meiosis, Ctr6 is present throughout the entire program and is associated with a non-canonical cellular location. Significance: A dynamic interplay between copper transport systems occurs during meiosis. Meiosis requires copper to undertake its program in which haploid gametes are produced from diploid precursor cells. In Schizosaccharomyces pombe, copper is transported by three members of the copper transporter (Ctr) family, namely Ctr4, Ctr5, and Ctr6. Although central for sexual differentiation, very little is known about the expression profile, cellular localization, and physiological contribution of the Ctr proteins during meiosis. Analysis of gene expression of ctr4(+) and ctr5(+) revealed that they are primarily expressed in early meiosis under low copper conditions. In the case of ctr6(+), its expression is broader, being detected throughout the entire meiotic process with an increase during middle- and late-phase meiosis. Whereas the expression of ctr4(+) and ctr5(+) is exclusively dependent on the presence of Cuf1, ctr6(+) gene expression relies on two distinct regulators, Cuf1 and Mei4. Ctr4 and Ctr5 proteins co-localize at the plasma membrane shortly after meiotic induction, whereas Ctr6 is located on the membrane of vacuoles. After meiotic divisions, Ctr4 and Ctr5 disappear from the cell surface, whereas Ctr6 undergoes an intracellular re-location to co-localize with the forespore membrane. Under copper-limiting conditions, disruption of ctr4(+) and ctr6(+) results in altered SOD1 activity, whereas these mutant cells exhibit substantially decreased levels of CAO activity mostly in early- and middle-phase meiosis. Collectively, these results emphasize the notion that Ctr proteins exhibit differential expression, localization, and contribution in delivering copper to SOD1 and Cao1 proteins during meiosis.	[Plante, Samuel; Ioannoni, Raphael; Beaudoin, Jude; Labbe, Simon] Univ Sherbrooke, Dept Biochim, Fac Med & Sci Sante, Sherbrooke, PQ J1E 4K8, Canada	University of Sherbrooke	Labbe, S (corresponding author), Fac Med & Sci Sante, 3201 Pavillon Z-8, Sherbrooke, PQ J1E 4K8, Canada.	Simon.Labbe@USherbrooke.ca			Canadian Institutes of Health Research [MOP-CP-243929]; Foundation of Stars for Children's Health Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Foundation of Stars for Children's Health Research; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Canadian Institutes of Health Research Grant MOP-CP-243929 (to S. L.).; Recipient of a studentship from the Foundation of Stars for Children's Health Research.; Recipient of a studentship from the Natural Sciences and Engineering Research Council of Canada.	Abe H, 2000, GENETICS, V154, P1497; Aller SG, 2004, J BIOL CHEM, V279, P53435, DOI 10.1074/jbc.M409421200; BAHLER J, 1991, CURR GENET, V19, P445, DOI 10.1007/BF00312735; Beaudoin J, 2006, MICROBIOL-SGM, V152, P209, DOI 10.1099/mic.0.28392-0; Beaudoin J, 2001, J BIOL CHEM, V276, P15472, DOI 10.1074/jbc.M011256200; Beaudoin J, 2013, BIOCHEM SOC T, V41, P1679, DOI 10.1042/BST2013089; Beaudoin J, 2011, J BIOL CHEM, V286, P34356, DOI 10.1074/jbc.M111.280396; Beaudoin J, 2011, MICROBIOL-SGM, V157, P1021, DOI 10.1099/mic.0.046854-0; Bellemare DR, 2002, J BIOL CHEM, V277, P46676, DOI 10.1074/jbc.M206444200; Bernhardt ML, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097253; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Doll E, 2008, GENETICS, V180, P727, DOI 10.1534/genetics.108.092619; HALLIWELL B, 1992, FEBS LETT, V307, P108, DOI 10.1016/0014-5793(92)80911-Y; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Harigaya Y, 2007, CHROMOSOME RES, V15, P523, DOI 10.1007/s10577-007-1151-0; Ioannoni R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036338; Ioannoni R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011964; KEENEY JB, 1994, GENETICS, V136, P849; Kim AM, 2010, NAT CHEM BIOL, V6, P674, DOI [10.1038/NCHEMBIO.419, 10.1038/nchembio.419]; Labbe S, 1999, J BIOL CHEM, V274, P36252, DOI 10.1074/jbc.274.51.36252; Labbe S., 2013, METALS IN CELLS, P163; Laliberte J, 2004, J BIOL CHEM, V279, P28744, DOI 10.1074/jbc.M403426200; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; LIU XF, 1992, J BIOL CHEM, V267, P18298; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; MacDiarmid CW, 2002, J BIOL CHEM, V277, P39187, DOI 10.1074/jbc.M205052200; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; Mata J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r217; Mercier A, 2008, EUKARYOT CELL, V7, P493, DOI 10.1128/EC.00446-07; Mercier A, 2006, EUKARYOT CELL, V5, P1866, DOI 10.1128/EC.00199-06; Miller EW, 2006, NAT PROTOC, V1, P824, DOI 10.1038/nprot.2006.140; Nakamura T, 2005, CELL STRUCT FUNCT, V30, P15, DOI 10.1247/csf.30.15; Nakamura T, 2001, MOL BIOL CELL, V12, P3955, DOI 10.1091/mbc.12.12.3955; Nakamura T, 2008, MOL BIOL CELL, V19, P3544, DOI 10.1091/mbc.E08-04-0414; Nakamura-Kubo M, 2003, MOL BIOL CELL, V14, P1109, DOI 10.1091/mbc.E02-08-0504; Nakase Y, 2001, MOL BIOL CELL, V12, P901, DOI 10.1091/mbc.12.4.901; Nevitt T, 2012, BBA-MOL CELL RES, V1823, P1580, DOI 10.1016/j.bbamcr.2012.02.011; Nevitt T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001322; Ohtaka A, 2008, J CELL SCI, V121, P1547, DOI 10.1242/jcs.022830; Peter C, 2008, EUKARYOT CELL, V7, P1781, DOI 10.1128/EC.00230-08; Pouliot B, 2010, EUKARYOT CELL, V9, P59, DOI 10.1128/EC.00262-09; Puig S, 2002, J BIOL CHEM, V277, P26021, DOI 10.1074/jbc.M202547200; Rees EM, 2004, J BIOL CHEM, V279, P54221, DOI 10.1074/jbc.M411669200; Rees EM, 2007, J BIOL CHEM, V282, P21629, DOI 10.1074/jbc.M703397200; Sabatinos SA, 2010, METHOD ENZYMOL, V470, P759, DOI 10.1016/S0076-6879(10)70032-X; Takegawa K, 2003, CELL STRUCT FUNCT, V28, P399, DOI 10.1247/csf.28.399; Zeng L, 2006, J AM CHEM SOC, V128, P10, DOI 10.1021/ja055064u; Zhang MZM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001597; Zhou H, 2001, J BIOL CHEM, V276, P20529, DOI 10.1074/jbc.M102004200	50	10	10	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10168	10181		10.1074/jbc.M113.543678	http://dx.doi.org/10.1074/jbc.M113.543678			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24569997	hybrid, Green Published			2022-12-28	WOS:000333807000062
J	He, H; Li, S; Chen, HY; Li, L; Xu, CS; Ding, F; Zhan, Y; Ma, JL; Zhang, SG; Shi, YT; Qu, CF; Liu, ZH				He, Huan; Li, Sheng; Chen, Hongyan; Li, Lin; Xu, Chengshan; Ding, Fang; Zhan, Yun; Ma, Jianlin; Zhang, Shuguang; Shi, Yaoting; Qu, Chunfeng; Liu, Zhihua			12-O-Tetradecanoylphorbol-13-acetate Promotes Breast Cancer Cell Motility by Increasing S100A14 Level in a Kruppel-like Transcription Factor 4 ( KLF4)-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Cell Motility; Gene Regulation; Kruppel-like Factor (KLF); S100 Proteins; TPA	KINASE-C-DELTA; ESTER-INDUCED APOPTOSIS; PKC-DELTA; GENE-TRANSCRIPTION; ENDOTHELIAL-CELLS; FAMILY-MEMBERS; PROTEIN; EXPRESSION; KLF4; ACTIVATION	Background: The transcriptional regulation of S100A14 and its underlying mechanism have not been fully elucidated. Results: The activation of S100A14 promoter by KLF4 mediates its up-regulation upon TPA stimulation. Conclusion: S100A14 partly mediates TPA-induced cell motility in a KLF4-dependent manner. Significance: KLF4 plays a significant and previously unrecognized role in regulation of S100A14. The S100 protein family represents the largest subgroup of calcium binding EF-hand type proteins. These proteins have been reported to be involved in a wide range of biological functions that are related to normal cell development and tumorigenesis. S100A14 is a recently identified member of the S100 protein family and differentially expressed in a number of different human malignancies. However, the transcriptional regulation of S100A14 and its role in breast cancer needs to be further investigated. Here, we determined that 12-O-tetradecanoylphorbol-13-acetate (TPA) up-regulated the expression of KLF4 and facilitated its binding directly to two conserved GC-rich DNA segments within the S100A14 promoter, which is essential for the transactivation of KLF4 induced S100A14 expression. Furthermore, stable silencing of KLF4 significantly suppressed breast cancer cell migration induced by TPA. Collectively, these results offer insights into the fact that TPA provokes cell motility through regulating the expression and function of S100A14 in a KLF4-dependent manner.	[He, Huan; Li, Sheng; Chen, Hongyan; Li, Lin; Xu, Chengshan; Ding, Fang; Zhan, Yun; Ma, Jianlin; Zhang, Shuguang; Shi, Yaoting; Qu, Chunfeng; Liu, Zhihua] Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst & Hosp, Beijing 100021, Peoples R China; [He, Huan; Li, Sheng; Chen, Hongyan; Li, Lin; Xu, Chengshan; Ding, Fang; Zhan, Yun; Ma, Jianlin; Zhang, Shuguang; Shi, Yaoting; Qu, Chunfeng; Liu, Zhihua] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, ZH (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst & Hosp, Beijing 100021, Peoples R China.	liuzh@cicams.ac.cn		Li, Sheng/0000-0001-8080-9712	National Basic Research Program of China [2011CB504205]; National Natural Science Foundation of China [81130043, 81021061, 81302329]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2011CB504205 and National Natural Science Foundation of China Grants 81130043, 81021061, and 81302329.	Bertini I, 2013, J BIOL INORG CHEM, V18, P183, DOI 10.1007/s00775-012-0963-3; Bigelow RLH, 2009, BREAST CANCER RES TR, V117, P31, DOI 10.1007/s10549-008-0170-7; Brosh R, 2013, CELL DEATH DIFFER, V20, P312, DOI 10.1038/cdd.2012.125; Caino MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031714; Castets F, 1997, MOL BRAIN RES, V46, P208, DOI 10.1016/S0169-328X(96)00298-7; Chen HY, 2012, J BIOL CHEM, V287, P17109, DOI 10.1074/jbc.M111.326975; Chen HY, 2009, CANCER RES, V69, P3451, DOI 10.1158/0008-5472.CAN-08-4231; Chew YC, 2013, J BIOL CHEM, V288, P17759, DOI 10.1074/jbc.M113.477133; Chew YC, 2011, J BIOL CHEM, V286, P28772, DOI 10.1074/jbc.M110.205245; Choi JH, 2010, FOOD CHEM TOXICOL, V48, P564, DOI 10.1016/j.fct.2009.11.033; CRAIG RW, 1994, GENOMICS, V23, P457, DOI 10.1006/geno.1994.1523; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Gebhardt C, 2002, ONCOGENE, V21, P4266, DOI 10.1038/sj.onc.1205521; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Gonzalez-Guerrico AM, 2005, J BIOL CHEM, V280, P38982, DOI 10.1074/jbc.M506767200; Han HH, 2010, MOL CANCER RES, V8, P1477, DOI 10.1158/1541-7786.MCR-10-0114; He H, 2012, MOL CANCER RES, V10, P273, DOI 10.1158/1541-7786.MCR-11-0419; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Ji JF, 2004, J CANCER RES CLIN, V130, P480, DOI 10.1007/s00432-004-0555-x; Jin Q, 2011, PLOS ONE, V6; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kim G, 2013, PATHOBIOLOGY, V80, P95, DOI 10.1159/000342394; KRAFT AS, 1983, NATURE, V301, P621, DOI 10.1038/301621a0; Kypriotou M, 2012, EXP DERMATOL, V21, P643, DOI 10.1111/j.1600-0625.2012.01472.x; Lesniak W, 2011, CLIN EPIGENETICS, V2, P77, DOI 10.1007/s13148-011-0023-9; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li S, 2013, J BIOL CHEM, V288, P4076, DOI 10.1074/jbc.M111.317487; McKiernan E, 2011, TUMOR BIOL, V32, P441, DOI 10.1007/s13277-010-0137-2; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Okuda H, 2013, CANCER RES, V73, P1434, DOI 10.1158/0008-5472.CAN-12-2037; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Pietas A, 2002, GENOMICS, V79, P513, DOI 10.1006/geno.2002.6744; Rammes A, 1997, J BIOL CHEM, V272, P9496; Rosenzweig JM, 2013, J BIOL CHEM, V288, P23868, DOI 10.1074/jbc.M113.479576; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Sapkota D, 2008, J ORAL PATHOL MED, V37, P607, DOI 10.1111/j.1600-0714.2008.00683.x; Sapkota D, 2012, ORAL ONCOL, V48, P219, DOI 10.1016/j.oraloncology.2011.10.001; Shields JM, 1998, NUCLEIC ACIDS RES, V26, P796, DOI 10.1093/nar/26.3.796; Shum CKY, 2013, ONCOGENE, V32, P4086, DOI 10.1038/onc.2012.437; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Xu K, 2000, J IMMUNOL, V164, P4916, DOI 10.4049/jimmunol.164.9.4916; Yao R, 2007, ANTICANCER RES, V27, P3051; Yen T, 1997, BLOOD, V90, P4812, DOI 10.1182/blood.V90.12.4812.4812_4812_4821; Yet SF, 1998, J BIOL CHEM, V273, P1026, DOI 10.1074/jbc.273.2.1026; Zhang XH, 2012, ARTERIOSCL THROM VAS, V32, P1015, DOI 10.1161/ATVBAHA.111.244962; Zhou QB, 2009, CANCER RES, V69, P8284, DOI 10.1158/0008-5472.CAN-09-1345	51	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9089	9099		10.1074/jbc.M113.534271	http://dx.doi.org/10.1074/jbc.M113.534271			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24532790	Green Published, hybrid			2022-12-28	WOS:000333472100029
J	Sies, H				Sies, Helmut			Role of Metabolic H2O2 Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Aquaporin; Glutathione Peroxidase; Hydrogen Peroxide; Insulin; Mitochondria; NADPH Oxidase; Peroxiredoxin; Redox; Catalase; Second Messenger	HYDROGEN-PEROXIDE PRODUCTION; PERFUSED-RAT-LIVER; AQUAPORINS FACILITATE; SUPEROXIDE-PRODUCTION; ANTIOXIDANT DEFENSE; FLUORESCENT-PROBES; REDOX REGULATION; NAD(P)H OXIDASE; COMPOUND-I; PROTEIN	Hydrogen peroxide, the nonradical 2-electron reduction product of oxygen, is a normal aerobic metabolite occurring at about 10 nm intracellular concentration. In liver, it is produced at 50 nmol/min/g of tissue, which is about 2% of total oxygen uptake at steady state. Metabolically generated H2O2 emerged from recent research as a central hub in redox signaling and oxidative stress. Upon generation by major sources, the NADPH oxidases or Complex III of the mitochondrial respiratory chain, H2O2 is under sophisticated fine control of peroxiredoxins and glutathione peroxidases with their backup systems as well as by catalase. Of note, H2O2 is a second messenger in insulin signaling and in several growth factor-induced signaling cascades. H2O2 transport across membranes is facilitated by aquaporins, denoted as peroxiporins. Specialized protein cysteines operate as redox switches using H2O2 as thiol oxidant, making this reactive oxygen species essential for poising the set point of the redox proteome. Major processes including proliferation, differentiation, tissue repair, inflammation, circadian rhythm, and aging use this low molecular weight oxygen metabolite as signaling compound.	[Sies, Helmut] Univ Dusseldorf, Inst Biochem & Mol Biol 1, D-40225 Dusseldorf, Germany; [Sies, Helmut] Univ Dusseldorf, Leibniz Res Inst Environm Med, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF)	Sies, H (corresponding author), Univ Dusseldorf, Inst Biochem & Mol Biol 1, Univ St 1,Bldg 22-03, D-40225 Dusseldorf, Germany.	sies@uni-duesseldorf.de	Sies, Helmut/ABE-7355-2020		Deutsche Forschungsgemeinschaft (DFG), Bonn, Germany; National Foundation for Cancer Research (NFCR), Bethesda, MD	Deutsche Forschungsgemeinschaft (DFG), Bonn, Germany(German Research Foundation (DFG)); National Foundation for Cancer Research (NFCR), Bethesda, MD	This work was supported by the Deutsche Forschungsgemeinschaft (DFG), Bonn, Germany and by the National Foundation for Cancer Research (NFCR), Bethesda, MD. This minireview forms part of the Trevor Slater Award Lecture at the Society for Free Radical Research International (SFRRI) meeting at Kyoto, Japan, March 23, 2014.	Albrecht SC, 2011, CELL METAB, V14, P819, DOI 10.1016/j.cmet.2011.10.010; Antunes F, 2000, FEBS LETT, V475, P121, DOI 10.1016/S0014-5793(00)01638-0; BABIOR BM, 1973, J CLIN INVEST, V52, P741, DOI 10.1172/JCI107236; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bertolotti M, 2013, ANTIOXID REDOX SIGN, V19, P1447, DOI 10.1089/ars.2013.5330; Bienert G.P., 2013, BIOCHIM BIOPHYS ACTA; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Bienert GP, 2006, BBA-BIOMEMBRANES, V1758, P994, DOI 10.1016/j.bbamem.2006.02.015; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Brigelius-Flohe R, 2011, ANTIOXID REDOX SIGN, V15, P2335, DOI 10.1089/ars.2010.3534; Calabrese EJ, 2003, NATURE, V421, P691, DOI 10.1038/421691a; CHANCE B, 1947, ACTA CHEM SCAND, V1, P236, DOI 10.3891/acta.chem.scand.01-0236; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; CHANCE B, 1951, ADV ENZYMOL REL S BI, V12, P153; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Cordeiro JV, 2013, NAT REV MOL CELL BIO, V14, P249, DOI 10.1038/nrm3541; Cortassa S, 2014, BBA-BIOENERGETICS, V1837, P287, DOI 10.1016/j.bbabio.2013.11.007; Covas G, 2013, METHOD ENZYMOL, V528, P157, DOI 10.1016/B978-0-12-405881-1.00009-4; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; Cremers CM, 2013, J BIOL CHEM, V288, P26489, DOI 10.1074/jbc.R113.462929; Dalla Sega FV, 2014, BBA-MOL CELL RES, V1843, P806, DOI 10.1016/j.bbamcr.2014.01.011; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Enyedi B, 2013, ANTIOXID REDOX SIGN, V19, P523, DOI 10.1089/ars.2012.4594; Enyedi B, 2013, METHOD ENZYMOL, V528, P237, DOI 10.1016/B978-0-12-405881-1.00014-8; Ezerina D., 2014, J MOL CELL CARDIOL, DOI 10.1016/j.yjmcc.2013.12.023; Finkel T, 2012, J BIOL CHEM, V287, P4434, DOI 10.1074/jbc.R111.271999; Flohe L, 2010, METHOD ENZYMOL, V473, P1, DOI 10.1016/S0076-6879(10)73001-9; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Go YM, 2013, J BIOL CHEM, V288, P26512, DOI 10.1074/jbc.R113.464131; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Grisham MB, 2013, COMP BIOCHEM PHYS A, V165, P429, DOI 10.1016/j.cbpa.2013.02.003; Hall A, 2011, ANTIOXID REDOX SIGN, V15, P795, DOI 10.1089/ars.2010.3624; Hancock J, 2006, J EXP BOT, V57, P1711, DOI 10.1093/jxb/erj180; HEFFETZ D, 1990, J BIOL CHEM, V265, P2896; Henzler T, 2000, J EXP BOT, V51, P2053, DOI 10.1093/jexbot/51.353.2053; Jackson MJ, 2011, ANTIOXID REDOX SIGN, V15, P2477, DOI 10.1089/ars.2011.3976; Jacob C, 2003, ANGEW CHEM INT EDIT, V42, P4742, DOI 10.1002/anie.200300573; Jeong W, 2012, FREE RADICAL BIO MED, V53, P447, DOI 10.1016/j.freeradbiomed.2012.05.020; Marchissio MJ, 2012, TOXICOL APPL PHARM, V264, P246, DOI 10.1016/j.taap.2012.08.005; Kapahi P, 2000, J BIOL CHEM, V275, P36062, DOI 10.1074/jbc.M007204200; KAPPUS H, 1981, EXPERIENTIA, V37, P1233, DOI 10.1007/BF01948335; KEILIN D, 1945, BIOCHEM J, V39, P293, DOI 10.1042/bj0390293; KIM KW, 1988, J BIOL CHEM, V263, P4704; Lin VS, 2013, METHOD ENZYMOL, V526, P19, DOI 10.1016/B978-0-12-405883-5.00002-8; LO YYC, 1995, J BIOL CHEM, V270, P11727, DOI 10.1074/jbc.270.20.11727; Logan A, 2014, BBA-GEN SUBJECTS, V1840, P923, DOI 10.1016/j.bbagen.2013.05.026; Loh K, 2009, CELL METAB, V10, P260, DOI 10.1016/j.cmet.2009.08.009; LOSCHEN G, 1974, FEBS LETT, V42, P68, DOI 10.1016/0014-5793(74)80281-4; LOSCHEN G, 1971, FEBS LETT, V18, P261, DOI 10.1016/0014-5793(71)80459-3; Love NR, 2013, NAT CELL BIOL, V15, P222, DOI 10.1038/ncb2659; Lukyanov KA, 2014, BBA-GEN SUBJECTS, V1840, P745, DOI 10.1016/j.bbagen.2013.05.030; Matlashov ME, 2014, ANTIOXID REDOX SIGN, V20, P1039, DOI 10.1089/ars.2013.5618; MAY JM, 1979, J BIOL CHEM, V254, P2214; MEIER B, 1989, BIOCHEM J, V263, P539, DOI 10.1042/bj2630539; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Mueller S, 2009, ADV MED SCI-POLAND, V54, P121, DOI 10.2478/v10039-009-0042-3; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Nauseef WM, 2014, BBA-GEN SUBJECTS, V1840, P757, DOI 10.1016/j.bbagen.2013.04.040; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Oakley FD, 2009, ANTIOXID REDOX SIGN, V11, P1313, DOI 10.1089/ARS.2008.2363; OSHINO N, 1975, BIOCHEM J, V146, P67, DOI 10.1042/bj1460067; OSHINO N, 1973, ARCH BIOCHEM BIOPHYS, V154, P117, DOI 10.1016/0003-9861(73)90040-4; Paulsen CE, 2012, NAT CHEM BIOL, V8, P57, DOI 10.1038/nchembio.736; Petrov VD, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls014; Radi R, 2013, ACCOUNTS CHEM RES, V46, P550, DOI 10.1021/ar300234c; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Sen CK, 2008, BBA-GEN SUBJECTS, V1780, P1348, DOI 10.1016/j.bbagen.2008.01.006; Siebels I, 2013, BBA-BIOENERGETICS, V1827, P1156, DOI 10.1016/j.bbabio.2013.06.005; Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X; SIES H, 1974, ANGEW CHEM INT EDIT, V13, P706, DOI 10.1002/anie.197407061; SIES H, 1975, EUR J BIOCHEM, V57, P503, DOI 10.1111/j.1432-1033.1975.tb02325.x; SIES H, 1970, FEBS LETT, V11, P172, DOI 10.1016/0014-5793(70)80521-X; SIES H, 1986, ANGEW CHEM INT EDIT, V25, P1058, DOI 10.1002/anie.198610581; SIES H, 1973, ARCH BIOCHEM BIOPHYS, V154, P106, DOI 10.1016/0003-9861(73)90039-8; Sies H., 2007, ENCY STRESS, V2nd ed., P45, DOI DOI 10.1016/B978-012373947-6.00285-3; Soares H, 2014, GENES NUTR, V9, DOI 10.1007/s12263-013-0371-5; Sobotta MC, 2013, FREE RADICAL BIO MED, V60, P325, DOI 10.1016/j.freeradbiomed.2013.02.017; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Steinbrenner H, 2013, FREE RADICAL BIO MED, V65, P1538, DOI 10.1016/j.freeradbiomed.2013.07.016; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Szypowska AA, 2011, ANTIOXID REDOX SIGN, V15, P219, DOI 10.1089/ars.2010.3794; Tiganis T, 2011, TRENDS PHARMACOL SCI, V32, P82, DOI 10.1016/j.tips.2010.11.006; Truong TH, 2013, CRIT REV BIOCHEM MOL, V48, P332, DOI 10.3109/10409238.2013.790873; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Ullrich V, 2006, J INORG BIOCHEM, V100, P2079, DOI 10.1016/j.jinorgbio.2006.09.019; Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8; Ushio-Fukai M, 1999, J BIOL CHEM, V274, P22699, DOI 10.1074/jbc.274.32.22699; Vestergaard CL, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00295; Warburg O. H., 1928, CATALYTIC ACTIONS LI; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Winterbourn CC, 2014, BBA-GEN SUBJECTS, V1840, P730, DOI 10.1016/j.bbagen.2013.05.004; Winterbourn CC, 2013, METHOD ENZYMOL, V528, P3, DOI 10.1016/B978-0-12-405881-1.00001-X; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Zielonka J, 2012, CHEM RES TOXICOL, V25, P1793, DOI 10.1021/tx300164j	100	466	478	18	90	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8735	8741		10.1074/jbc.R113.544635	http://dx.doi.org/10.1074/jbc.R113.544635			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24515117	Green Published, hybrid			2022-12-28	WOS:000333472100001
J	Yao, ZY; Zhang, Q; Li, X; Zhao, DZ; Liu, YQ; Zhao, K; Liu, Y; Wang, CM; Jiang, MH; Li, N; Cao, XT				Yao, Zhenyu; Zhang, Qian; Li, Xia; Zhao, Dezhi; Liu, Yiqi; Zhao, Kai; Liu, Yin; Wang, Chunmei; Jiang, Minghong; Li, Nan; Cao, Xuetao			Death Domain-associated Protein 6 ( Daxx) Selectively Represses IL-6 Transcription through Histone Deacetylase 1 ( HDAC1)-mediated Histone Deacetylation in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Histone Deacetylase; Innate Immunity; Lipopolysaccharide (LPS); Macrophages; Toll-like Receptors (TLR); Daxx; Histone Acetylation; IL-6	NF-KAPPA-B; INNATE IMMUNE-RESPONSES; GENE-EXPRESSION; CHROMATIN MODIFICATIONS; INFLAMMATORY RESPONSES; INTERACTING PROTEIN; BINDING PROTEIN; CELL-DEATH; METHYLATION; ACETYLATION	Background: The role and underlying mechanism of Daxx in innate immunity remain to be investigated. Results: Daxx interacts with HDAC1 and binds to the promoter of IL-6. Daxx selectively represses IL-6 transcription through HDAC1-mediated histone deacetylation. Conclusion: Daxx selectively represses IL-6 transcription in TLR-triggered macrophages. Significance: Discovering a new negative regulator of IL-6 and providing insight to epigenetic mechanism of IL-6 production. As a multifunctional nuclear protein, death domain-associated protein 6 (Daxx) regulates a wide range of biological processes, including cell apoptosis and gene transcription. However, the function of Daxx in innate immunity remains unclear. In our study, we show that Daxx is highly expressed in macrophages and localized in nucleus of macrophages. The expression of Daxx is significantly up-regulated by stimulation with TLR ligands LPS and poly(I:C). Silence of Daxx selectively represses IL-6 expression at transcription level in LPS-activated macrophages. Upon stimulation of LPS, Daxx specifically binds to the promoter of IL-6 and inhibits histone acetylation at IL-6 promoter region. Further mechanism analyses show that histone deacetylase 1 (HDAC1) interacts with Daxx and binds to the promoter of IL-6. Daxx silencing decreases the association of HDAC1 to IL-6 promoter. Therefore, our data reveal that Daxx selectively represses IL-6 transcription through HDAC1-mediated histone deacetylation in LPS-induced macrophages, acting as a negative regulator of IL-6 during innate immunity and potentially preventing inflammatory response because of overproduction of IL-6.	[Yao, Zhenyu; Zhang, Qian; Zhao, Kai; Liu, Yin; Wang, Chunmei; Jiang, Minghong; Cao, Xuetao] Chinese Acad Med Sci, Natl Key Lab Med Mol Biol, Beijing 100005, Peoples R China; [Yao, Zhenyu; Zhang, Qian; Zhao, Kai; Liu, Yin; Wang, Chunmei; Jiang, Minghong; Cao, Xuetao] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Immunol, Beijing 100005, Peoples R China; [Yao, Zhenyu; Zhang, Qian; Li, Nan; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Yao, Zhenyu; Zhang, Qian; Li, Nan; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China; [Li, Xia; Zhao, Dezhi; Liu, Yiqi; Cao, Xuetao] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310058, Zhejiang, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Naval Medical University; Naval Medical University; Zhejiang University	Cao, XT (corresponding author), Chinese Acad Med Sci, Natl Key Lab Med Mol Biol, Beijing 100005, Peoples R China.	caoxt@immunol.org	, 姚/ABF-5141-2020; Li, Xia/AAB-9647-2019	, 姚/0000-0002-5796-7189; 	National Key Basic Research Program of China [2013CB530503]; National 125 Key Project [2013ZX10002002-002-002, 2012AA020901]; National Natural Science Foundation of China [81230074, 81123006, 31390431]	National Key Basic Research Program of China(National Basic Research Program of China); National 125 Key Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by grants from the National Key Basic Research Program of China (2013CB530503), National 125 Key Project (2013ZX10002002-002-002 and 2012AA020901), and National Natural Science Foundation of China (81230074, 81123006, and 31390431).	Aung HT, 2006, FASEB J, V20, P1315, DOI 10.1096/fj.05-5360com; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Chang CC, 2005, J BIOL CHEM, V280, P10164, DOI 10.1074/jbc.M409161200; Chen WL, 2013, CELL, V152, P467, DOI 10.1016/j.cell.2013.01.011; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; Dandrea M, 2009, NUCLEIC ACIDS RES, V37, P6681, DOI 10.1093/nar/gkp723; Dovey OM, 2013, BLOOD, V121, P1335, DOI 10.1182/blood-2012-07-441949; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Hollenbach AD, 2002, J CELL SCI, V115, P3319; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Jung YS, 2007, FEBS LETT, V581, P843, DOI 10.1016/j.febslet.2007.01.055; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; Lehembre F, 2001, ONCOGENE, V20, P1, DOI 10.1038/sj.onc.1204063; Liu XG, 2013, P NATL ACAD SCI USA, V110, P11097, DOI 10.1073/pnas.1301257110; Michaelson JS, 1999, GENE DEV, V13, P1918, DOI 10.1101/gad.13.15.1918; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; Park J, 2007, J MOL BIOL, V368, P388, DOI 10.1016/j.jmb.2007.02.047; Patel DJ, 2013, ANNU REV BIOCHEM, V82, P81, DOI 10.1146/annurev-biochem-072711-165700; Pluta AF, 1998, J CELL SCI, V111, P2029; Roger T, 2011, BLOOD, V117, P1205, DOI 10.1182/blood-2010-05-284711; Saffert RT, 2006, J VIROL, V80, P3863, DOI 10.1128/JVI.80.8.3863-3871.2006; Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Sub HS, 2010, J NEUROIMMUNE PHARM, V5, P521, DOI 10.1007/s11481-010-9192-0; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Tanaka T, 2012, ANNU REV PHARMACOL, V52, P199, DOI 10.1146/annurev-pharmtox-010611-134715; Tang J, 2004, J BIOL CHEM, V279, P20369, DOI 10.1074/jbc.M401321200; Tropberger P, 2013, CELL, V152, P859, DOI 10.1016/j.cell.2013.01.032; Ullman AJ, 2008, J VIROL, V82, P7325, DOI 10.1128/JVI.00723-08; Wang J, 2009, INT IMMUNOL, V21, P227, DOI 10.1093/intimm/dxn143; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Wessells J, 2004, J BIOL CHEM, V279, P49995, DOI 10.1074/jbc.M404246200; Xu S, 2012, NAT IMMUNOL, V13, P551, DOI 10.1038/ni.2283; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Yao YX, 2005, J EXP MED, V201, P1899, DOI 10.1084/jem.20050324; Zhang X, 2006, J IMMUNOL, V177, P1282, DOI 10.4049/jimmunol.177.2.1282	43	22	24	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9372	9379		10.1074/jbc.M113.533992	http://dx.doi.org/10.1074/jbc.M113.533992			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24550390	hybrid, Green Published			2022-12-28	WOS:000333472100053
J	Labasque, M; Hivert, B; Nogales-Gadea, G; Querol, L; Illa, I; Faivre-Sarrailh, C				Labasque, Marilyne; Hivert, Bruno; Nogales-Gadea, Gisela; Querol, Luis; Illa, Isabel; Faivre-Sarrailh, Catherine			Specific Contactin N-Glycans Are Implicated in Neurofascin Binding and Autoimmune Targeting in Peripheral Neuropathies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Adhesion; Cell Surface Protein; Glycoprotein; Myelin; Neuroinflammation	MYELINATED AXONS; CELL-ADHESION; MYASTHENIA-GRAVIS; CRYSTAL-STRUCTURE; RANVIER; GLIOMEDIN; COMPLEX; NODES; DOMAINS; TAG-1	Background: The glycoproteins contactin and neurofascin-155 are implicated in axo-glial junctions insulating the node of Ranvier. Results:N-Glycosylated contactin is targeted in inflammatory neuropathy. Conclusion: Autoantibodies reveal specific N-glycans that are implicated in adhesive interaction between contactin and neurofascin-155. Significance: Autoantibodies against N-glycosylated contactin may be pathogenic via functional blocking. Cell adhesion molecules (CAMs) play a crucial role in the formation of the nodes of Ranvier and in the rapid propagation of the nerve impulses along myelinated axons. These CAMs are the targets of autoimmunity in inflammatory neuropathies. We recently showed that a subgroup of patients with aggressive chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) shows autoantibodies to contactin (1). The complex of contactinCasprneurofascin-155 (NF155) enables the formation of paranodal junctions, suggesting that antibody attack against paranodes may participate in the severity of CIDP. In the present study, we mapped the molecular determinants of contactin targeted by the autoantibodies. In three patients, immunoreactivity was directed against the Ig domains of contactin and was dependent on N-glycans. The serum of one patient was selectively directed against contactin bearing mannose-rich N-glycans. Strikingly, the oligomannose type sugars of contactin are required for association with its glial partner NF155 (2). To investigate precisely the role of contactin N-glycans, we have mutated each of the nine consensus N-glycosylation sites independently. We found that the mutation of three sites (N467Q/N473Q/N494Q) in Ig domain 5 of contactin prevented soluble NF155-Fc binding. In contrast, these mutations did not abolish cis-association with Caspr. Next, we showed that the cluster of N-glycosylation sites (Asn-467, Asn-473, and Asn-494) was required for immunoreactivity in one patient. Using cell aggregation assays, we showed that the IgGs from the four CIDP patients prevented adhesive interaction between contactinCaspr and NF155. Importantly, we showed that the anti-contactin autoantibodies induced alteration of paranodal junctions in myelinated neuronal culture. These results strongly suggest that antibodies to CAMs may be pathogenic and induce demyelination via functional blocking activity.	[Labasque, Marilyne; Hivert, Bruno; Faivre-Sarrailh, Catherine] Aix Marseille Univ, CNRS, Ctr Rech Neurobiol & Neurophysiol Marseille, UMR7286, F-13344 Marseille, France; [Nogales-Gadea, Gisela; Querol, Luis; Illa, Isabel] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Neuromuscular Dis Unit, Barcelona 08025, Spain; [Nogales-Gadea, Gisela; Querol, Luis; Illa, Isabel] Inst Salud Carlos III, CIBER Enfermedades Neurodegenerat CIBERNED, Madrid 28031, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; CIBERNED; Instituto de Salud Carlos III	Faivre-Sarrailh, C (corresponding author), Fac Med Nord, CRN2M UMR7286, Ctr Rech Neurobiol & Neurophysiol Marseille, Bd Pierre Dramard, F-13344 Marseille 15, France.	catherine.sarrailh@univ-amu.fr	Faivre-Sarrailh, Catherine/M-6738-2016; ILLA, Isabel/AAD-1816-2019; Nogales-Gadea, Gisela/N-4004-2014; Querol, Luis/H-2119-2015; Labasque, Marilyne/AAE-2498-2022	Nogales-Gadea, Gisela/0000-0002-7414-212X; Querol, Luis/0000-0002-4289-8264; Labasque, Marilyne/0000-0002-1467-2866; Faivre-Sarrailh, Catherine/0000-0002-1718-0533	Association pour la Recherche sur la Sclerose en Plaques; European E-rare-2 project	Association pour la Recherche sur la Sclerose en Plaques; European E-rare-2 project	This work was supported by the Association pour la Recherche sur la Sclerose en Plaques (to C. F.-S.) and the European E-rare-2 project (to C. F.-S. and I. I.).	Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; Bonnon C, 2003, J BIOL CHEM, V278, P48339, DOI 10.1074/jbc.M309120200; Bonnon C, 2007, MOL BIOL CELL, V18, P229, DOI 10.1091/mbc.E06-06-0570; Bouyain S, 2010, P NATL ACAD SCI USA, V107, P2443, DOI 10.1073/pnas.0911235107; Boyle MET, 2001, NEURON, V30, P385, DOI 10.1016/S0896-6273(01)00296-3; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Cervello M, 1996, J CELL SCI, V109, P699; Charles P, 2002, CURR BIOL, V12, P217, DOI 10.1016/S0960-9822(01)00680-7; Devaux JJ, 2012, AM J PATHOL, V181, P1402, DOI 10.1016/j.ajpath.2012.06.034; Devaux JJ, 2012, J PERIPHER NERV SYST, V17, P62, DOI 10.1111/j.1529-8027.2012.00372.x; Eshed Y, 2005, NEURON, V47, P215, DOI 10.1016/j.neuron.2005.06.026; Faivre-Sarrailh C, 2000, J CELL BIOL, V149, P491, DOI 10.1083/jcb.149.2.491; Feinberg K, 2010, NEURON, V65, P490, DOI 10.1016/j.neuron.2010.02.004; Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1; Huijbers MG, 2013, P NATL ACAD SCI USA, V110, P20783, DOI 10.1073/pnas.1313944110; Labasque M, 2011, J BIOL CHEM, V286, P42426, DOI 10.1074/jbc.M111.266353; Labasque M, 2010, FEBS LETT, V584, P1787, DOI 10.1016/j.febslet.2009.08.025; Lamprianou S, 2011, P NATL ACAD SCI USA, V108, P17498, DOI 10.1073/pnas.1108774108; Laursen LS, 2009, J NEUROSCI, V29, P9174, DOI 10.1523/JNEUROSCI.5942-08.2009; Lonigro A, 2009, BRAIN, V132, P260, DOI 10.1093/brain/awn281; Menegoz M, 1997, NEURON, V19, P319, DOI 10.1016/S0896-6273(00)80942-3; Mortl M, 2007, PROTEIN SCI, V16, P2174, DOI 10.1110/ps.072802707; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Ng JKM, 2012, NEUROLOGY, V79, P2241, DOI 10.1212/WNL.0b013e31827689ad; Nirula A, 2011, CURR OPIN RHEUMATOL, V23, P119, DOI 10.1097/BOR.0b013e3283412fd4; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Pruss H, 2011, BRAIN, V134, DOI 10.1093/brain/awq372; Querol L., 2014, NEUROLOGY IN PRESS; Querol L, 2013, CURR OPIN NEUROL, V26, P459, DOI 10.1097/WCO.0b013e328364c079; Querol L, 2013, ANN NEUROL, V73, P370, DOI 10.1002/ana.23794; Schuurman J, 1999, IMMUNOLOGY, V97, P693, DOI 10.1046/j.1365-2567.1999.00845.x; Sherman DL, 2005, NEURON, V48, P737, DOI 10.1016/j.neuron.2005.10.019; STANLEY P, 1995, FASEB J, V9, P1436, DOI 10.1096/fasebj.9.14.7589985; Thaxton C, 2010, J NEUROSCI, V30, P4868, DOI 10.1523/JNEUROSCI.5951-09.2010; Traka M, 2003, J CELL BIOL, V162, P1161, DOI 10.1083/jcb.200305078; Volkmer H, 1998, J CELL BIOL, V142, P1083, DOI 10.1083/jcb.142.4.1083; ZISCH AH, 1992, J CELL BIOL, V119, P203, DOI 10.1083/jcb.119.1.203; ZISCH AH, 1995, MOL CELL NEUROSCI, V6, P263, DOI 10.1006/mcne.1995.1021	38	74	75	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7907	7918		10.1074/jbc.M113.528489	http://dx.doi.org/10.1074/jbc.M113.528489			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24497634	Green Published, hybrid			2022-12-28	WOS:000332761500055
J	Zemoura, K; Benke, D				Zemoura, Khaled; Benke, Dietmar			Proteasomal Degradation of gamma-Aminobutyric Acid(B) Receptors Is Mediated by the Interaction of the GABA(B2) C Terminus with the Proteasomal ATPase Rtp6 and Regulated by Neuronal Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); ER-associated Degradation; GABA Receptors; Proteasome; Ubiquitin	RETICULUM-ASSOCIATED DEGRADATION; SYNAPTIC PLASTICITY; LYSOSOMAL DEGRADATION; HIPPOCAMPAL-NEURONS; PROTEIN-DEGRADATION; PROXIMITY LIGATION; 26S PROTEASOME; UBIQUITINATION; SUBUNIT; SUG1	Background: The expression level of GABA(B) receptors is controlled by proteasomal degradation. Results: Proteasomal degradation of GABA(B) receptors is mediated by interaction with Rpt6 and modulated by neuronal activity. Conclusion: The level of neuronal activity regulates via proteasomal degradation the ER pool of GABA(B) receptor competent for forward trafficking. Significance: This mechanism might contribute to homeostatic neuronal plasticity. Regulation of cell surface expression of neurotransmitter receptors is crucial for determining synaptic strength and plasticity, but the underlying mechanisms are not well understood. We previously showed that proteasomal degradation of GABA(B) receptors via the endoplasmic reticulum (ER)-associated protein degradation (ERAD) machinery determines the number of cell surface GABA(B) receptors and thereby GABA(B) receptor-mediated neuronal inhibition. Here, we show that proteasomal degradation of GABA(B) receptors requires the interaction of the GABA(B2) C terminus with the proteasomal AAA-ATPase Rpt6. A mutant of Rpt6 lacking ATPase activity prevented degradation of GABA(B) receptors but not the removal of Lys(48)-linked ubiquitin from GABA(B2). Blocking ERAD activity diminished the interaction of Rtp6 with GABA(B) receptors resulting in increased total as well as cell surface expression of GABA(B) receptors. Modulating neuronal activity affected proteasomal activity and correspondingly the interaction level of Rpt6 with GABA(B2). This resulted in altered cell surface expression of the receptors. Thus, neuronal activity-dependent proteasomal degradation of GABA(B) receptors by the ERAD machinery is a potent mechanism regulating the number of GABA(B) receptors available for signaling and is expected to contribute to homeostatic neuronal plasticity.	[Zemoura, Khaled; Benke, Dietmar] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland; [Zemoura, Khaled; Benke, Dietmar] Univ Zurich, Neurosci Ctr Zurich, CH-8057 Zurich, Switzerland; [Zemoura, Khaled; Benke, Dietmar] ETH, CH-8057 Zurich, Switzerland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Benke, D (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	benke@pharma.uzh.ch			Swiss National Science Foundation [31003A_121963, 31003A_138382]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grants 31003A_121963 and 31003A_138382 (to D. B.).	Benke D, 2010, ADV PHARMACOL, V58, P93, DOI 10.1016/S1054-3589(10)58004-9; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bingol B, 2010, CELL, V140, P567, DOI 10.1016/j.cell.2010.01.024; Buerli T, 2007, NAT PROTOC, V2, P3090, DOI 10.1038/nprot.2007.445; Cajigas IJ, 2010, EMBO J, V29, P2746, DOI 10.1038/emboj.2010.173; Djakovic SN, 2012, J NEUROSCI, V32, P5126, DOI 10.1523/JNEUROSCI.4427-11.2012; Djakovic SN, 2009, J BIOL CHEM, V284, P26655, DOI 10.1074/jbc.M109.021956; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Fiebiger E, 2004, MOL BIOL CELL, V15, P1635, DOI 10.1091/mbc.E03-07-0506; Fu AKY, 2011, NAT NEUROSCI, V14, P181, DOI 10.1038/nn.2715; Gianni M, 2002, EMBO J, V21, P3760, DOI 10.1093/emboj/cdf374; Grampp T, 2008, MOL CELL NEUROSCI, V39, P628, DOI 10.1016/j.mcn.2008.09.004; Hegde AN, 2010, LEARN MEMORY, V17, P314, DOI 10.1101/lm.1504010; Inoue T, 2006, BIOCHEM BIOPH RES CO, V342, P829, DOI 10.1016/j.bbrc.2006.02.025; Jakawich SK, 2010, NEUROSCIENCE, V171, P1016, DOI 10.1016/j.neuroscience.2010.09.061; Kato A, 2005, P NATL ACAD SCI USA, V102, P5600, DOI 10.1073/pnas.0501769102; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kumar Y, 2010, BIOCHEM J, V427, P91, DOI 10.1042/BJ20091349; Leuchowius KJ, 2010, MOL CELL PROTEOMICS, V9, P178, DOI 10.1074/mcp.M900331-MCP200; Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129; Maier PJ, 2010, J BIOL CHEM, V285, P35606, DOI 10.1074/jbc.M110.142406; Masuyama H, 1998, J CELL BIOCHEM, V71, P429, DOI 10.1002/(SICI)1097-4644(19981201)71:3<429::AID-JCB11>3.0.CO;2-P; Pagano A, 2001, J NEUROSCI, V21, P1189; Rezvani K, 2012, J NEUROCHEM, V122, P24, DOI 10.1111/j.1471-4159.2012.07752.x; Rubin DM, 1996, NATURE, V379, P655, DOI 10.1038/379655a0; Saliba RS, 2007, J NEUROSCI, V27, P13341, DOI 10.1523/JNEUROSCI.3277-07.2007; Saliba RS, 2009, J BIOL CHEM, V284, P32544, DOI 10.1074/jbc.M109.040071; Schneider S, 1997, GENE, V197, P337, DOI 10.1016/S0378-1119(97)00280-1; Sledz P, 2013, J MOL BIOL, V425, P1415, DOI 10.1016/j.jmb.2013.01.036; Smith DM, 2006, J STRUCT BIOL, V156, P72, DOI 10.1016/j.jsb.2006.04.012; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Sorokin AV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1411, DOI 10.1134/S000629790913001X; Su KH, 2000, BIOCHEM J, V348, P281, DOI 10.1042/0264-6021:3480281; Takeuchi T, 2006, ACS CHEM BIOL, V1, P299, DOI 10.1021/cb600127m; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang HF, 2007, J NEUROCHEM, V101, P1651, DOI 10.1111/j.1471-4159.2007.04460.x; Wang QY, 2008, J BIOL CHEM, V283, P7445, DOI 10.1074/jbc.M708347200; Wang YF, 2012, EMBO REP, V13, P1004, DOI 10.1038/embor.2012.144; Zemoura K, 2013, J BIOL CHEM, V288, P34897, DOI 10.1074/jbc.M113.514745	41	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7738	7746		10.1074/jbc.M113.541987	http://dx.doi.org/10.1074/jbc.M113.541987			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24482233	Green Published, hybrid			2022-12-28	WOS:000332761500041
J	Wei, CY; Wang, HP; Zhu, ZY; Sun, YH				Wei, Chang-Yong; Wang, Hou-Peng; Zhu, Zuo-Yan; Sun, Yong-Hua			Transcriptional Factors Smad1 and Smad9 Act Redundantly to Mediate Zebrafish Ventral Specification Downstream of Smad5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone Morphogenetic Protein (BMP); Development; Gene Regulation; SMAD Transcription Factor; Zebrafish; Dorso-ventral Patterning; Myelopoiesis	DORSOVENTRAL PATTERN-FORMATION; PROTEIN; EXPRESSION; GENES; IDENTIFICATION; SOMITABUN; TERMINUS; DEFECTS; REVEALS; SIGNALS	Background: Ventral specification is regulated by Smad1-, Smad5-, and/or Smad9-mediated bone morphogenetic protein (BMP) signaling. Results: Double knockdown instead of single knockdown of smad1 and smad9 induces dorsalization, which cannot be rescued by smad5 overexpression. Conclusion:smad1 and smad9 act redundantly and downstream of smad5 to mediate ventral specification. Significance: The regulation network and cooperative roles of BMP R-Smads in early development are clarified. Bone morphogenetic proteins (BMPs) are multifunctional growth factors that play crucial roles during embryonic development and cell fate determination. Nuclear transduction of BMP signals requires the receptor type Smad proteins, Smad1, Smad5, and Smad9. However, how these Smad proteins cooperate in vivo to regulate various developmental processes is largely unknown. In zebrafish, it was widely believed that the maternally expressed smad5 is essential for dorso-ventral (DV) patterning, and the zygotically transcribed smad1 is not required for normal DV axis establishment. In the present study, we have identified zygotically expressed smad9, which cooperates with smad1 downstream of smad5, to mediate zebrafish early DV patterning in a functional redundant manner. Although knockdown of smad1 or smad9 alone does not lead to visible dorsalization, double knockdown strongly dorsalizes zebrafish embryos, which cannot be efficiently rescued by smad5 overexpression, whereas the dorsalization induced by smad5 knockdown can be fully rescued by overexpression of smad1 or smad9. We have further revealed that the transcription initiations of smad1 and smad9 are repressed by each other, that they are direct transcriptional targets of Smad5, and that smad9, like smad1, is required for myelopoiesis. In conclusion, our study uncovers that smad1 and smad9 act redundantly to each other downstream of smad5 to mediate ventral specification and to regulate embryonic myelopoiesis.	[Wei, Chang-Yong; Wang, Hou-Peng; Zhu, Zuo-Yan; Sun, Yong-Hua] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan 430072, Peoples R China; [Wei, Chang-Yong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Sun, YH (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, 7 Donghu South Rd, Wuhan 430072, Peoples R China.	yhsun@ihb.ac.cn	Sun, Yonghua/B-5025-2012	Sun, Yonghua/0000-0001-9368-6969; Wei, Changyong/0000-0002-0390-4094	China 973 Project [2010CB126306, 2012CB944504]; National Natural Science Foundation of China (NSFC) [31222052]; NSFC [30771100]; FEBL Grant [2011FBZ23]	China 973 Project(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC)); FEBL Grant	This work was supported by China 973 Project Grants 2010CB126306 and 2012CB944504, the National Science Fund for Excellent Young Scholars of the National Natural Science Foundation of China (NSFC) Grant 31222052, NSFC Grant 30771100, and FEBL Grant 2011FBZ23 (to Y. H. S.).	Alcaraz-Perez F, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-81; Arnold SJ, 2006, DEV BIOL, V296, P104, DOI 10.1016/j.ydbio.2006.04.442; Attisano L, 2000, CURR OPIN CELL BIOL, V12, P235, DOI 10.1016/S0955-0674(99)00081-2; Belting HG, 2011, DEV BIOL, V356, P323, DOI 10.1016/j.ydbio.2011.05.660; Bennett CM, 2001, BLOOD, V98, P643, DOI 10.1182/blood.V98.3.643; Chang H, 1999, DEVELOPMENT, V126, P1631; Chen CH, 2009, DEV DYNAM, V238, P2850, DOI 10.1002/dvdy.22105; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; de Jong JLO, 2005, ANNU REV GENET, V39, P481, DOI 10.1146/annurev.genet.39.073003.095931; Dee CT, 2007, INT J DEV BIOL, V51, P79, DOI 10.1387/ijdb.062204cd; Derynck R, 1997, BBA-REV CANCER, V1333, pF105, DOI 10.1016/S0304-419X(97)00017-6; Dick A, 1999, DEV DYNAM, V216, P285, DOI 10.1002/(SICI)1097-0177(199911)216:3<285::AID-DVDY7>3.0.CO;2-L; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gilardelli CN, 2004, DEV DYNAM, V230, P494, DOI 10.1002/dvdy.20073; Graff JM, 1996, CELL, V85, P479, DOI 10.1016/S0092-8674(00)81249-0; Haffter P, 1996, DEVELOPMENT, V123, P1; Hammerschmidt M, 1996, GENE DEV, V10, P2452, DOI 10.1101/gad.10.19.2452; Hazen VM, 2012, DEV BIOL, V367, P216, DOI 10.1016/j.ydbio.2012.05.014; He C, 2005, BIOCHEM BIOPH RES CO, V329, P324, DOI 10.1016/j.bbrc.2005.01.133; Henningfeld KA, 2002, J BIOL CHEM, V277, P2097, DOI 10.1074/jbc.M108524200; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Hild M, 1999, DEVELOPMENT, V126, P2149; Jia SJ, 2012, DEV CELL, V22, P1065, DOI 10.1016/j.devcel.2012.03.001; Kafri R, 2009, CELL, V136, P389, DOI 10.1016/j.cell.2009.01.027; Keegan BR, 2002, DEVELOPMENT, V129, P1623; Kim RH, 2000, GENE DEV, V14, P1605; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Kramer C, 2002, DEV BIOL, V250, P263, DOI 10.1006/dbio.2002.0805; Kudoh T, 2001, GENOME RES, V11, P1979, DOI 10.1101/gr.209601; Labbe E, 1998, MOL CELL, V2, P109, DOI 10.1016/S1097-2765(00)80119-7; Le Dreau G, 2012, DEVELOPMENT, V139, P259, DOI 10.1242/dev.074948; Lechleider RJ, 2001, DEV BIOL, V240, P157, DOI 10.1006/dbio.2001.0469; Lele Z, 2001, GENESIS, V30, P190, DOI 10.1002/gene.1063; Li W, 2001, BIOCHEM BIOPH RES CO, V286, P1163, DOI 10.1006/bbrc.2001.5529; Liu YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000707; Liu ZT, 2011, J BIOL CHEM, V286, P28520, DOI 10.1074/jbc.M111.236307; MAENO M, 1994, P NATL ACAD SCI USA, V91, P10260, DOI 10.1073/pnas.91.22.10260; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McReynolds LJ, 2007, BLOOD, V110, P3881, DOI 10.1182/blood-2007-04-085753; Muller F, 1999, MECH DEVELOP, V88, P73, DOI 10.1016/S0925-4773(99)00173-2; Mullins MC, 1996, DEVELOPMENT, V123, P81; NORDNES S, 1994, BBA-GENE STRUCT EXPR, V1219, P529, DOI 10.1016/0167-4781(94)90081-7; Orvis GD, 2008, BIOL REPROD, V78, P994, DOI 10.1095/biolreprod.107.066605; Pangas SA, 2008, MOL CELL BIOL, V28, P248, DOI 10.1128/MCB.01404-07; Park S, 2004, MOL CELL BIOL, V24, P10256, DOI 10.1128/MCB.24.23.10256-10262.2004; Poulain M, 2002, DEVELOPMENT, V129, P4901; Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926; Rhinn M, 2005, DEVELOPMENT, V132, P1261, DOI 10.1242/dev.01685; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Schmerer M, 2003, BLOOD, V102, P3196, DOI 10.1182/blood-2003-04-1094; Shima DT, 1996, J BIOL CHEM, V271, P3877, DOI 10.1074/jbc.271.7.3877; Suzuki A, 1997, DEV BIOL, V184, P402, DOI 10.1006/dbio.1997.8548; Thisse B, 2004, METHOD CELL BIOL, V77, P505; Tremblay KD, 2001, DEVELOPMENT, V128, P3609; von Bubnoff A, 2001, DEV BIOL, V239, P1, DOI 10.1006/dbio.2001.0388; Wang H, 1998, NAT GENET, V20, P239, DOI 10.1038/3041; Wang L, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201814; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Whitman M, 2005, DEVELOPMENT, V132, P4205, DOI 10.1242/dev.02023; Wong YL, 2012, DEV BIOL, V363, P247, DOI 10.1016/j.ydbio.2011.12.037; Xu C, 2012, DEV CELL, V22, P625, DOI 10.1016/j.devcel.2012.01.003; Yabe T, 2003, DEVELOPMENT, V130, P2705, DOI 10.1242/dev.00506; Yang X, 1999, DEVELOPMENT, V126, P1571	66	26	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6604	6618		10.1074/jbc.M114.549758	http://dx.doi.org/10.1074/jbc.M114.549758			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24488494	hybrid, Green Published			2022-12-28	WOS:000332389400025
J	Xu, S; Hermanson, DJ; Banerjee, S; Ghebreselasie, K; Clayton, GM; Garavito, RM; Marnett, LJ				Xu, Shu; Hermanson, Daniel J.; Banerjee, Surajit; Ghebreselasie, Kebreab; Clayton, Gina M.; Garavito, R. Michael; Marnett, Lawrence J.			Oxicams Bind in a Novel Mode to the Cyclooxygenase Active Site via a Two-water-mediated H-bonding Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclooxygenase (COX) Pathway; Drug Action; Enzyme Structure; Protein Drug Interactions; X-ray Crystallography	STRUCTURAL BASIS; CRYSTAL-STRUCTURE; ANTIINFLAMMATORY ACTIVITY; SELECTIVE-INHIBITION; ARACHIDONIC-ACID; NSAID BINDING; COX-2; OXYGENATION; MECHANISM; INSIGHTS	Background: The oxicams are anti-inflammatory drugs targeting the cyclooxygenase enzymes. Results: Crystal complexes of mCOX-2isoxicam, mCOX-2meloxicam, and oCOX-1meloxicam are solved. Conclusion: Oxicams bind to the cyclooxygenase active sites in a novel mode. Significance: The first structural description of cyclooxygenase-oxicam complexes reveal a new binding pocket of inhibitors to cyclooxygenases. Oxicams are widely used nonsteroidal anti-inflammatory drugs (NSAIDs), but little is known about the molecular basis of the interaction with their target enzymes, the cyclooxygenases (COX). Isoxicam is a nonselective inhibitor of COX-1 and COX-2 whereas meloxicam displays some selectivity for COX-2. Here we report crystal complexes of COX-2 with isoxicam and meloxicam at 2.0 and 2.45 angstroms, respectively, and a crystal complex of COX-1 with meloxicam at 2.4 angstroms. These structures reveal that the oxicams bind to the active site of COX-2 using a binding pose not seen with other NSAIDs through two highly coordinated water molecules. The 4-hydroxyl group on the thiazine ring partners with Ser-530 via hydrogen bonding, and the heteroatom of the carboxamide ring of the oxicam scaffold interacts with Tyr-385 and Ser-530 through a highly coordinated water molecule. The nitrogen atom of the thiazine and the oxygen atom of the carboxamide bind to Arg-120 and Tyr-355 via another highly ordered water molecule. The rotation of Leu-531 in the structure opens a novel binding pocket, which is not utilized for the binding of other NSAIDs. In addition, a detailed study of meloxicamCOX-2 interactions revealed that mutation of Val-434 to Ile significantly reduces inhibition by meloxicam due to subtle changes around Phe-518, giving rise to the preferential inhibition of COX-2 over COX-1.	[Xu, Shu; Hermanson, Daniel J.; Ghebreselasie, Kebreab; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res,Vanderbilt Ingram, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol,Dept Bi, Nashville, TN 37232 USA; [Xu, Shu; Hermanson, Daniel J.; Ghebreselasie, Kebreab; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res,Vanderbilt Ingram, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol,Dept Ch, Nashville, TN 37232 USA; [Xu, Shu; Hermanson, Daniel J.; Ghebreselasie, Kebreab; Marnett, Lawrence J.] Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res,Vanderbilt Ingram, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol,Dept Ph, Nashville, TN 37232 USA; [Banerjee, Surajit] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Banerjee, Surajit] Argonne Natl Lab, Northeastern Collaborat Access Team, Argonne, IL 60439 USA; [Clayton, Gina M.; Garavito, R. Michael] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Michigan State University	Marnett, LJ (corresponding author), Vanderbilt Univ, Sch Med, AB Hancock Jr Mem Lab Canc Res,Vanderbilt Ingram, Vanderbilt Inst Chem Biol,Ctr Mol Toxicol,Dept Bi, Nashville, TN 37232 USA.	larry.marnett@vanderbilt.edu	Xu, Shu/K-6089-2013; Xu, Shu/O-6667-2019	Xu, Shu/0000-0002-6876-7991; Xu, Shu/0000-0002-6876-7991; Banerjee, Surajit/0000-0002-9414-7163	National Institutes of Health Research and Training Grants [CA089450, GM15431, DA031572]; National Institutes of Health from the NIGMS [P41 GM103403]; United States DOE [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [R01CA089450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM015431, P41GM103403, P50GM015431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA031572] Funding Source: NIH RePORTER	National Institutes of Health Research and Training Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States DOE(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Research and Training Grants CA089450 (to L. J. M.), GM15431 (to L. J. M.), and DA031572 (to D. J. H.). This work is based upon research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by National Institutes of Health Grant P41 GM103403 from the NIGMS. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the United States DOE under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BINDER D, 1987, J MED CHEM, V30, P678, DOI 10.1021/jm00387a017; CARTY TJ, 1993, AGENTS ACTIONS, V39, P157, DOI 10.1007/BF01998969; Davies NM, 1999, CLIN PHARMACOKINET, V36, P115, DOI 10.2165/00003088-199936020-00003; Dong L, 2011, J BIOL CHEM, V286, P19035, DOI 10.1074/jbc.M111.231969; Duggan KC, 2010, J BIOL CHEM, V285, P34950, DOI 10.1074/jbc.M110.162982; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FARRE AJ, 1986, METHOD FIND EXP CLIN, V8, P407; Fleischmann Roy, 2002, Expert Opin Pharmacother, V3, P1501, DOI 10.1517/14656566.3.10.1501; Forli S, 2012, J MED CHEM, V55, P623, DOI 10.1021/jm2005145; Gupta K, 2004, J MOL BIOL, V335, P503, DOI 10.1016/j.jmb.2003.10.073; Harman CA, 2007, J BIOL CHEM, V282, P28096, DOI 10.1074/jbc.M701335200; Ho JM, 2010, J PHYS CHEM A, V114, P11992, DOI 10.1021/jp107890p; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalgutkar AS, 1998, J MED CHEM, V41, P4800, DOI 10.1021/jm980303s; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; Kothekar V, 2001, INDIAN J BIOCHEM BIO, V38, P56; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Lazer ES, 1997, J MED CHEM, V40, P980, DOI 10.1021/jm9607010; LOLL PJ, 1995, NAT STRUCT BIOL, V2, P637, DOI 10.1038/nsb0895-637; LOMBARDINO JG, 1971, J MED CHEM, V14, P1171, DOI 10.1021/jm00294a008; Luong C, 1996, NAT STRUCT BIOL, V3, P927, DOI 10.1038/nsb1196-927; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Marnett LJ, 2002, PROSTAG OTH LIPID M, V68-9, P153, DOI 10.1016/S0090-6980(02)00027-8; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Noble S, 1996, DRUGS, V51, P424, DOI 10.2165/00003495-199651030-00007; ODENWALLER R, 1990, METHOD ENZYMOL, V187, P479; Park H, 2005, J COMPUT AID MOL DES, V19, P17, DOI 10.1007/s10822-005-0098-5; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Prusakiewicz JJ, 2009, BIOCHEMISTRY-US, V48, P7353, DOI 10.1021/bi900999z; Rowlinson SW, 2003, J BIOL CHEM, V278, P45763, DOI 10.1074/jbc.M305481200; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Selinsky BS, 2001, BIOCHEMISTRY-US, V40, P5172, DOI 10.1021/bi010045s; Smith CJ, 1998, P NATL ACAD SCI USA, V95, P13313, DOI 10.1073/pnas.95.22.13313; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Vecchio AJ, 2012, J BIOL CHEM, V287, P24619, DOI 10.1074/jbc.M112.372243; Vecchio AJ, 2011, J BIOL CHEM, V286, P20736, DOI 10.1074/jbc.M111.230367; Vecchio AJ, 2010, J BIOL CHEM, V285, P22152, DOI 10.1074/jbc.M110.119867; Wang JL, 2010, BIOORG MED CHEM LETT, V20, P7159, DOI 10.1016/j.bmcl.2010.07.054; Windsor MA, 2012, ACS MED CHEM LETT, V3, P759, DOI 10.1021/ml3001616; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	41	79	81	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6799	6808		10.1074/jbc.M113.517987	http://dx.doi.org/10.1074/jbc.M113.517987			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24425867	hybrid, Green Published			2022-12-28	WOS:000332389400040
J	Collen, PN; Jeudy, A; Sassi, JF; Groisillier, A; Czjzek, M; Coutinho, PM; Helbert, W				Collen, Pi Nyvall; Jeudy, Alexandra; Sassi, Jean-Francois; Groisillier, Agnes; Czjzek, Mirjam; Coutinho, Pedro M.; Helbert, William			A Novel Unsaturated beta-Glucuronyl Hydrolase Involved in Ulvan Degradation Unveils the Versatility of Stereochemistry Requirements in Family GH105	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biodegradation; Crystal Structure; Enzyme Catalysis; Glycoside Hydrolases; Polysaccharide; GH105; Ulvan	ASYMMETRIC INTERLACED PCR; CELL-WALL POLYSACCHARIDES; CHEMICAL-STRUCTURE; PERSICIVIRGA-ULVANIVORANS; RHEOLOGICAL PROPERTIES; SP NOV.; CHLOROPHYTA; GLYCOSAMINOGLYCAN; OLIGOSACCHARIDES; SEQUENCE	Background: Biodegradation of green algal cell wall requires specialized enzymatic machinery, which is not yet well characterized. Results: Structural and biochemical characterization of a new -glucuronyl hydrolase belonging to family GH105 active on oligo-ulvans. Conclusion: The GH105 family encompasses enzymes cleaving both - and -linked glycosides. Significance: Investigations of enzymatic degradation of marine polysaccharides reveals enzymes with unique characteristics. Ulvans are cell wall matrix polysaccharides in green algae belonging to the genus Ulva. Enzymatic degradation of the polysaccharide by ulvan lyases leads to the production of oligosaccharides with an unsaturated -glucuronyl residue located at the non-reducing end. Exploration of the genomic environment around the Nonlabens ulvanivorans (previously Percicivirga ulvanivorans) ulvan lyase revealed a gene highly similar to known unsaturated uronyl hydrolases classified in the CAZy glycoside hydrolase family 105. The gene was cloned, the protein was overexpressed in Escherichia coli, and enzymology experiments demonstrated its unsaturated -glucuronyl activity. Kinetic analysis of purified oligo-ulvans incubated with the new enzyme showed that the full substrate specificity is attained by three subsites that preferentially bind anionic residues (sulfated rhamnose, glucuronic/iduronic acid). The three-dimensional crystal structure of the native enzyme reveals that a trimeric organization is required for substrate binding and recognition at the +2 binding subsite. This novel unsaturated -glucuronyl hydrolase is part of a previously uncharacterized subgroup of GH105 members and exhibits only a very limited sequence similarity to known unsaturated -glucuronyl sequences previously found only in family GH88. Clan-O formed by families GH88 and GH105 was singular in the fact that it covered families acting on both axial and equatorial glycosidic linkages, respectively. The overall comparison of active site structures between enzymes from these two families highlights how that within family GH105, and unlike for classical glycoside hydrolysis, the hydrolysis of vinyl ether groups from unsaturated saccharides occurs independently of the or configuration of the cleaved linkage.	[Collen, Pi Nyvall; Jeudy, Alexandra; Groisillier, Agnes; Czjzek, Mirjam; Helbert, William] Univ Paris 06, CNRS, Unite Mixte Rech Marine Plants & Biomol 7139, Biol Stn, F-29682 Roscoff, France; [Sassi, Jean-Francois] Ctr Etud & Valorisat Algues, F-22610 Pleubian, France; [Coutinho, Pedro M.] Aix Marseille Univ, CNRS, Unite Mixte Rech 7257, F-13288 Marseille, France; [Helbert, William] Univ Grenoble 1, Ctr Rech Macromol Vegetales, UPR CNRS 5301, Grenoble 9, France; [Helbert, William] Inst Chim Mol Grenoble, FR CNRS 2607, Grenoble 9, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Helbert, W (corresponding author), CERMAV CNRS, Rue Chim,BP53x, F-38041 Grenoble 9, France.	helbert@cermav.cnrs.fr	SASSI, Jean Francois/D-4076-2013		French National Research Agency (ANR; Recherche et Innovation en Biotechnologie) [ANR-07-RIB-019]; Pole Mer Bretagne competitiveness cluster; CNRS; Brittany Regional Council	French National Research Agency (ANR; Recherche et Innovation en Biotechnologie)(French National Research Agency (ANR)); Pole Mer Bretagne competitiveness cluster(Region Bretagne); CNRS(Centre National de la Recherche Scientifique (CNRS)); Brittany Regional Council(Region Bretagne)	This work was supported in part by the French National Research Agency (ANR; Recherche et Innovation en Biotechnologie, Grant ANR-07-RIB-019 for the Ulvoligo Project), the Pole Mer Bretagne competitiveness cluster, the CNRS, and the Brittany Regional Council.	Barbeyron T, 2011, INT J SYST EVOL MICR, V61, P1899, DOI 10.1099/ijs.0.024489-0; Boutachfaiti R., 2009, Method for enzyme cleavage of polysaccharides derived from algae, Patent No. [WO 2009/016275 A2, 2009016275A2]; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Collen PN, 2011, J BIOL CHEM, V286, P42063, DOI 10.1074/jbc.M111.271825; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008571; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Han C, 2009, STAND GENOMIC SCI, V1, P54, DOI 10.4056/sigs.22138; Hashimoto W, 2007, INT MICROBIOL, V10, P233, DOI 10.2436/20.1501.01.32; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Itoh T, 2004, J BIOL CHEM, V279, P31804, DOI 10.1074/jbc.M403288200; Itoh T, 2006, J MOL BIOL, V360, P573, DOI 10.1016/j.jmb.2006.04.047; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jongkees SAK, 2011, J AM CHEM SOC, V133, P19334, DOI 10.1021/ja209067v; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Korf U, 2005, PROTEOMICS, V5, P3571, DOI 10.1002/pmic.200401195; Lahaye M, 1997, CARBOHYD RES, V304, P325, DOI 10.1016/S0008-6215(97)00270-X; Lahaye M, 1998, CARBOHYD POLYM, V36, P239, DOI 10.1016/S0144-8617(98)00026-5; Lahaye M, 2007, BIOMACROMOLECULES, V8, P1765, DOI 10.1021/bm061185q; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Maruyama Y, 2009, J BIOL CHEM, V284, P18059, DOI 10.1074/jbc.M109.005660; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Percival E., 1967, CHEM ENZYMOLOGY MARI, DOI DOI 10.1002/ANGE; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Quemener B, 1997, J APPL PHYCOL, V9, P179, DOI 10.1023/A:1007971023478; RAY B, 1995, CARBOHYD RES, V274, P313, DOI 10.1016/0008-6215(95)00059-3; Robic A, 2008, CARBOHYD POLYM, V74, P344, DOI 10.1016/j.carbpol.2008.02.020; Robic A, 2009, CARBOHYD POLYM, V77, P206, DOI 10.1016/j.carbpol.2008.12.023; Robic A, 2009, J PHYCOL, V45, P962, DOI 10.1111/j.1529-8817.2009.00699.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Yi H, 2012, SYST APPL MICROBIOL, V35, P150, DOI 10.1016/j.syapm.2011.12.002; Yip VL, 2006, CURR OPIN CHEM BIOL, V10, P147, DOI 10.1016/j.cbpa.2006.02.005; Yoshinari S, 2006, BIOCHEM BIOPH RES CO, V346, P1024, DOI 10.1016/j.bbrc.2006.06.011; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X	40	33	34	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6199	6211		10.1074/jbc.M113.537480	http://dx.doi.org/10.1074/jbc.M113.537480			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24407291	Green Published, hybrid			2022-12-28	WOS:000332015500073
J	Son, D; Na, YR; Hwang, ES; Seok, SH				Son, Dain; Na, Yi Rang; Hwang, Eung-Soo; Seok, Seung Hyeok			Platelet-derived Growth Factor-C (PDGF-C) Induces Anti-apoptotic Effects on Macrophages through Akt and Bad Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Apoptosis; Breast Cancer; Caspase; Macrophages; PI 3-kinase (PI3K); Bad; Platelet-derived Growth Factor-C (PDGF-C)	TUMOR-ASSOCIATED MACROPHAGES; EPITHELIAL-MESENCHYMAL TRANSITION; PROTEASE-ACTIVATED LIGAND; SMOOTH-MUSCLE-CELLS; BREAST-CANCER; INHIBITION; SURVIVAL; TARGET; BETA; EXPRESSION	Background: Aggressive breast tumor cells secrete platelet-derived growth factor C (PDGF-C). Results: PDGF-C prevents staurosporine-induced macrophage apoptosis through PI3K/Akt activation and Bad phosphorylation, resulting in the inhibition of caspase activation and PARP cleavage. Conclusion: PDGF-C has an anti-apoptotic effect on macrophages. Significance: PDGF-C secreted from malignant tumor cells could affect the survival of tumor-associated macrophages. PDGF-C, which is abundant in the malignant breast tumor microenvironment, plays an important role in cell growth and survival. Because tumor-associated macrophages (TAMs) contribute to cancer malignancy, macrophage survival mechanisms are an attractive area of research into controlling tumor progression. In this study, we investigated PDGF-C-mediated signaling pathways involved in anti-apoptotic effects in macrophages. We found that the human malignant breast cancer cell line MDA-MB-231 produced high quantities of PDGF-C, whereas benign MCF-7 cells did not. Recombinant PDGF-C induced PDGF receptor chain phosphorylation, followed by Akt and Bad phosphorylation in THP-1-derived macrophages. MDA-MB-231 culture supernatants also activated macrophage PDGF-R. PDGF-C prevented staurosporine-induced macrophage apoptosis by inhibiting the activation of caspase-3, -7, -8, and -9 and cleavage of poly(ADP-ribose) polymerase. Finally, TAMs isolated from the PDGF-C knockdown murine breast cancer cell line 4T1 and PDGF-C knockdown MDA-MB-231-derived tumor mass showed higher rates of apoptosis than the respective WT controls. Collectively, our results suggest that tumor cell-derived PDGF-C enhances TAM survival, promoting tumor malignancy.	[Seok, Seung Hyeok] Seoul Natl Univ, Dept Microbiol & Immunol, Coll Med, Seoul 110799, South Korea; Seoul Natl Univ, Inst Endem Dis, Coll Med, Seoul 110799, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Seok, SH (corresponding author), Seoul Natl Univ, Dept Microbiol & Immunol, Coll Med, 103 Daehak Ro, Seoul 110799, South Korea.	lamseok@snu.ac.kr	Seok, Seung Hyeok/J-3279-2012	Seok, Seung Hyeok/0000-0002-4315-0688; Hwang, Eung Soo/0000-0001-9562-4577	Seoul National University Hospital Research Fund [04-2012-0190]	Seoul National University Hospital Research Fund	This work was supported by the Seoul National University Hospital Research Fund (04-2012-0190).	Andrae J, 2002, BIOCHEM BIOPH RES CO, V296, P604, DOI 10.1016/S0006-291X(02)00917-8; Azenshtein E, 2002, CANCER RES, V62, P1093; Badgett A, 1996, J LIPID MEDIAT CELL, V13, P89, DOI 10.1016/0929-7855(95)00048-8; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; BERGER NA, 1985, BIOCHEMISTRY-US, V24, P4352, DOI 10.1021/bi00337a015; Bergsten E, 2001, NAT CELL BIOL, V3, P512, DOI 10.1038/35074588; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Brigati C, 2002, CLIN EXP METASTAS, V19, P247, DOI 10.1023/A:1015587423262; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P1396, DOI 10.1038/sj.cdd.4401963; CLAESSONWELSH L, 1994, J BIOL CHEM, V269, P32023; Cluff CW, 2009, ADV EXP MED BIOL, V667, P111, DOI 10.1007/978-1-4419-1603-7_10; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Coward J, 2011, CLIN CANCER RES, V17, P6083, DOI 10.1158/1078-0432.CCR-11-0945; Danial NN, 2008, ONCOGENE, V27, pS53, DOI 10.1038/onc.2009.44; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dey JH, 2010, CANCER RES, V70, P4151, DOI 10.1158/0008-5472.CAN-09-4479; Ding H, 2000, MECH DEVELOP, V96, P209, DOI 10.1016/S0925-4773(00)00425-1; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; Edwards JP, 2010, INT IMMUNOPHARMACOL, V10, P1220, DOI 10.1016/j.intimp.2010.07.002; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Gazzaniga S, 2007, J INVEST DERMATOL, V127, P2031, DOI 10.1038/sj.jid.5700827; Gehmert S, 2010, BIOCHEM BIOPH RES CO, V398, P601, DOI 10.1016/j.bbrc.2010.06.132; Gilbertson DG, 2001, J BIOL CHEM, V276, P27406, DOI 10.1074/jbc.M101056200; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; HARRINGTON EA, 1994, EMBO J, V13, P3286, DOI 10.1002/j.1460-2075.1994.tb06630.x; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; HERMANSSON M, 1988, P NATL ACAD SCI USA, V85, P7748, DOI 10.1073/pnas.85.20.7748; Hiraoka K, 2008, CANCER SCI, V99, P1595, DOI 10.1111/j.1349-7006.2008.00880.x; HU QJ, 1995, SCIENCE, V268, P100, DOI 10.1126/science.7701328; Hurst NJ, 2012, BIOCHEM J, V441, P909, DOI 10.1042/BJ20111020; Jain RK, 2008, PLOS MED, V5, P20, DOI 10.1371/journal.pmed.0050024; Jeong SJ, 2008, VIROLOGY, V370, P264, DOI 10.1016/j.virol.2007.09.003; JOHNSSON A, 1982, BIOCHEM BIOPH RES CO, V104, P66, DOI 10.1016/0006-291X(82)91941-6; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; Kawata M, 2012, J BIOCHEM, V151, P205, DOI 10.1093/jb/mvr136; LaRochelle WJ, 2001, NAT CELL BIOL, V3, P517, DOI 10.1038/35074593; Leek RD, 2000, J PATHOL, V190, P430, DOI 10.1002/(SICI)1096-9896(200003)190:4<430::AID-PATH538>3.0.CO;2-6; Leek RD, 2002, J MAMMARY GLAND BIOL, V7, P177, DOI 10.1023/A:1020304003704; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Lin EY, 2002, J MAMMARY GLAND BIOL, V7, P147, DOI 10.1023/A:1020399802795; Lokker NA, 2002, CANCER RES, V62, P3729; Lui XY, 2010, J GEN VIROL, V91, P1439, DOI 10.1099/vir.0.018465-0; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Marconi C, 2008, CLIN EXP METASTAS, V25, P225, DOI 10.1007/s10585-007-9136-0; Marx J, 2004, SCIENCE, V306, P966, DOI 10.1126/science.306.5698.966; MCDONALD NQ, 1993, CELL, V73, P421, DOI 10.1016/0092-8674(93)90127-C; Nagai T, 2009, CANCER IMMUNOL IMMUN, V58, P1577, DOI 10.1007/s00262-009-0667-x; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Popivanova BK, 2009, CANCER RES, V69, P7884, DOI 10.1158/0008-5472.CAN-09-1451; Quan JH, 2013, EXP PARASITOL, V133, P462, DOI 10.1016/j.exppara.2013.01.005; Reigstad LJ, 2005, FEBS J, V272, P5723, DOI 10.1111/j.1742-4658.2005.04989.x; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Shime H, 2012, P NATL ACAD SCI USA, V109, P2066, DOI 10.1073/pnas.1113099109; SHIMOKADO K, 1985, CELL, V43, P277, DOI 10.1016/0092-8674(85)90033-9; Sitohy B, 2012, CANCER RES, V72, P1909, DOI 10.1158/0008-5472.CAN-11-3406; Skommer J, 2007, LEUKEMIA RES, V31, P277, DOI 10.1016/j.leukres.2006.06.027; Smith HA, 2013, J MOL MED, V91, P411, DOI 10.1007/s00109-013-1021-5; Smith KJ, 2004, CLIN EXP DERMATOL, V29, P505, DOI 10.1111/j.1365-2230.2004.01593.x; Soria G, 2008, CANCER LETT, V267, P271, DOI 10.1016/j.canlet.2008.03.018; SUN PD, 1995, ANNU REV BIOPH BIOM, V24, P269, DOI 10.1146/annurev.bb.24.060195.001413; Tang XQ, 2013, IMMUNOLOGY, V138, P93, DOI 10.1111/imm.12023; Tejada ML, 2006, CLIN CANCER RES, V12, P2676, DOI 10.1158/1078-0432.CCR-05-1770; Tsagozis P, 2008, CANCER IMMUNOL IMMUN, V57, P1451, DOI 10.1007/s00262-008-0482-9; TSAI JC, 1995, J NEUROSURG, V82, P864, DOI 10.3171/jns.1995.82.5.0864; Tsutsui S, 2005, ONCOL REP, V14, P425; Vantler M, 2005, J BIOL CHEM, V280, P14168, DOI 10.1074/jbc.M413310200; Vitt UA, 2001, MOL ENDOCRINOL, V15, P681, DOI 10.1210/me.15.5.681; Wei Q., 2012, THYROID, V22, P905; Weigert A, 2009, IMMUNOTHERAPY-UK, V1, P83, DOI 10.2217/1750743X.1.1.83; Weisser SB, 2011, EUR J IMMUNOL, V41, P1742, DOI 10.1002/eji.201041105; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Xin H, 2009, CANCER RES, V69, P2506, DOI 10.1158/0008-5472.CAN-08-4323; Yang J, 2010, BLOOD, V115, P51, DOI 10.1182/blood-2009-06-223719; Yue ZQ, 2012, CHINESE MED J-PEKING, V125, P3305, DOI 10.3760/cma.j.issn.0366-6999.2012.18.020; Zhu XM, 2011, J NEURO-ONCOL, V104, P83, DOI 10.1007/s11060-010-0473-5	82	28	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6225	6235		10.1074/jbc.M113.508994	http://dx.doi.org/10.1074/jbc.M113.508994			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24421315	Green Published, hybrid			2022-12-28	WOS:000332015500075
J	Lanz, MA; Farhat, M; Klostermeier, D				Lanz, Martin A.; Farhat, Mohamad; Klostermeier, Dagmar			The Acidic C-terminal Tail of the GyrA Subunit Moderates the DNA Supercoiling Activity of Bacillus subtilis Gyrase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Gyrase; DNA Topology; Enzyme Mechanisms; Protein Conformation; Single Molecule Biophysics; ATP-dependent Conformational Changes; C-terminal Domain; Negative Supercoiling; Regulation	STRAND-PASSAGE; 2-GATE MECHANISM; TOPOISOMERASE-II; CONFORMATIONAL-CHANGES; CLOSED CONFORMATION; CRYSTAL-STRUCTURE; NUCLEOTIDE CYCLE; B-PROTEIN; SET-POINT; BINDING	Background: DNA gyrase catalyzes ATP-dependent negative DNA supercoiling. Results: Deletion of the acidic C-terminal tail causes stronger DNA bending by the B. subtilis gyrase C-terminal domains and accelerated DNA-stimulated ATPase and supercoiling activities of gyrase. Conclusion: The C-tail down-regulates negative supercoiling by B. subtilis gyrase. Significance: The C-tail is a versatile element that differentially regulates the activity of different gyrases. Gyrase is a type II DNA topoisomerase that introduces negative supercoils into DNA in an ATP-dependent reaction. It consists of a topoisomerase core, formed by the N-terminal domains of the two GyrA subunits and by the two GyrB subunits, that catalyzes double-stranded DNA cleavage and passage of a second double-stranded DNA through the gap in the first. The C-terminal domains (CTDs) of the GyrA subunits form a -pinwheel and bind DNA around their positively charged perimeter. As a result, DNA is bound as a positive supercoil that is converted into a negative supercoil by strand passage. The CTDs contain a conserved 7-amino acid motif that connects blades 1 and 6 of the -pinwheel and is a hallmark feature of gyrases. Deletion of this so-called GyrA-box abrogates DNA bending by the CTDs and DNA-induced narrowing of the N-gate, affects T-segment presentation, reduces the coupling of DNA binding to ATP hydrolysis, and leads to supercoiling deficiency. Recently, a severe loss of supercoiling activity of Escherichia coli gyrase upon deletion of the non-conserved acidic C-terminal tail (C-tail) of the CTDs has been reported. We show here that, in contrast to E. coli gyrase, the C-tail is a very moderate negative regulator of Bacillus subtilis gyrase activity. The C-tail reduces the degree of DNA bending by the CTDs but has no effect on DNA-induced conformational changes of gyrase that precede strand passage and reduces DNA-stimulated ATPase and DNA supercoiling activities only 2-fold. Our results are in agreement with species-specific, differential regulatory effects of the C-tail in gyrases from different organisms.	[Lanz, Martin A.; Farhat, Mohamad; Klostermeier, Dagmar] Univ Munster, Inst Phys Chem, D-48149 Munster, Germany	University of Munster	Klostermeier, D (corresponding author), Univ Munster, Inst Phys Chem, Corrensstr 30, D-48149 Munster, Germany.	dagmar.klostermeier@uni-muenster.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft.	ALI JA, 1995, BIOCHEMISTRY-US, V34, P9801, DOI 10.1021/bi00030a018; Andreou AZ, 2012, METHOD ENZYMOL, V511, P75, DOI 10.1016/B978-0-12-396546-2.00004-8; Baird CL, 1999, P NATL ACAD SCI USA, V96, P13685, DOI 10.1073/pnas.96.24.13685; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Corbett KD, 2004, P NATL ACAD SCI USA, V101, P7293, DOI 10.1073/pnas.0401595101; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872; Gottler T, 2007, J MOL BIOL, V367, P1392, DOI 10.1016/j.jmb.2007.01.055; Gubaev A, 2014, DNA REPAIR, V16, P23, DOI 10.1016/j.dnarep.2014.01.011; Gubaev A, 2011, P NATL ACAD SCI USA, V108, P14085, DOI 10.1073/pnas.1102100108; Gubaev A, 2009, P NATL ACAD SCI USA, V106, P13278, DOI 10.1073/pnas.0902493106; Harkins TT, 1998, BIOCHEMISTRY-US, V37, P7299, DOI 10.1021/bi9729108; HIGGINS NP, 1978, P NATL ACAD SCI USA, V75, P1773, DOI 10.1073/pnas.75.4.1773; HOROWITZ DS, 1987, J BIOL CHEM, V262, P5339; Hsieh TJ, 2010, NUCLEIC ACIDS RES, V38, P4173, DOI 10.1093/nar/gkq153; Kampranis SC, 1996, P NATL ACAD SCI USA, V93, P14416, DOI 10.1073/pnas.93.25.14416; KIRKEGAARD K, 1981, CELL, V23, P721, DOI 10.1016/0092-8674(81)90435-9; KLEVAN L, 1980, BIOCHEMISTRY-US, V19, P5229, DOI 10.1021/bi00564a012; Kramlinger VM, 2006, J BIOL CHEM, V281, P3738, DOI 10.1074/jbc.M511160200; KREUZER KN, 1980, CELL, V20, P245, DOI 10.1016/0092-8674(80)90252-4; Lanz MA, 2012, NUCLEIC ACIDS RES, V40, P10893, DOI 10.1093/nar/gks852; Lanz MA, 2011, NUCLEIC ACIDS RES, V39, P9681, DOI 10.1093/nar/gkr680; LIU LF, 1978, CELL, V15, P979, DOI 10.1016/0092-8674(78)90281-7; Noble CG, 2002, J MOL BIOL, V318, P361, DOI 10.1016/S0022-2836(02)00049-9; Papillon J, 2013, NUCLEIC ACIDS RES, V41, P7815, DOI 10.1093/nar/gkt560; REECE RJ, 1989, J BIOL CHEM, V264, P19648; REECE RJ, 1991, NUCLEIC ACIDS RES, V19, P1399, DOI 10.1093/nar/19.7.1399; Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057; Roca J, 2004, J BIOL CHEM, V279, P25783, DOI 10.1074/jbc.M402555200; ROCA J, 1994, CELL, V77, P609, DOI 10.1016/0092-8674(94)90222-4; Ruthenburg AJ, 2005, J BIOL CHEM, V280, P26177, DOI 10.1074/jbc.M502838200; SUGINO A, 1980, NUCLEIC ACIDS RES, V8, P3865, DOI 10.1093/nar/8.17.3865; Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105; Tingey AP, 1996, NUCLEIC ACIDS RES, V24, P4868, DOI 10.1093/nar/24.24.4868; Tretter EM, 2012, J BIOL CHEM, V287, P18636, DOI 10.1074/jbc.M112.345678; Tretter EM, 2012, J BIOL CHEM, V287, P18645, DOI 10.1074/jbc.M112.345736; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Ward D, 1997, MOL MICROBIOL, V26, P897, DOI 10.1046/j.1365-2958.1997.6242005.x; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; Williams NL, 1999, BIOCHEMISTRY-US, V38, P13502, DOI 10.1021/bi9912488	39	13	13	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12275	12285		10.1074/jbc.M114.547745	http://dx.doi.org/10.1074/jbc.M114.547745			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24563461	Green Published, hybrid			2022-12-28	WOS:000335581400008
J	Mustaev, A; Malik, M; Zhao, XL; Kurepina, N; Luan, G; Oppegard, LM; Hiasa, H; Marks, KR; Kerns, RJ; Berger, JM; Drlica, K				Mustaev, Arkady; Malik, Muhammad; Zhao, Xilin; Kurepina, Natalia; Luan, Gan; Oppegard, Lisa M.; Hiasa, Hiroshi; Marks, Kevin R.; Kerns, Robert J.; Berger, James M.; Drlica, Karl			Fluoroquinolone-Gyrase-DNA Complexes TWO MODES OF DRUG BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibiotic Action; Bacteria; DNA Topoisomerase; Enzyme Inhibitors; Escherichia coli; Mycobacterium smegmatis; Bacterium; Cleaved Complexes; Cross-linking; Resistance Mutations	TOPOISOMERASE IV-QUINOLONE; RESISTANCE-DETERMINING REGION; ESCHERICHIA-COLI; IIA TOPOISOMERASES; NALIDIXIC-ACID; IN-VITRO; STRUCTURAL BASIS; CLEAVAGE; MECHANISM; GENE	Background: X-ray crystal structures of fluoroquinolone-gyrase-DNA complexes reveal a single drug-binding mode. Results: A ciprofloxacin derivative with a chloroacetyl moiety at the C-7 end cross-linked with cysteine substitutions in both GyrA and GyrB that were 17 apart. Conclusion: Cleaved complexes containing gyrase have two fluoroquinolone-binding modes. Significance: The additional drug-binding mode provides new ways to investigate inhibitor-topoisomerase interactions. DNA gyrase and topoisomerase IV control bacterial DNA topology by breaking DNA, passing duplex DNA through the break, and then resealing the break. This process is subject to reversible corruption by fluoroquinolones, antibacterials that form drug-enzyme-DNA complexes in which the DNA is broken. The complexes, called cleaved complexes because of the presence of DNA breaks, have been crystallized and found to have the fluoroquinolone C-7 ring system facing the GyrB/ParE subunits. As expected from x-ray crystallography, a thiol-reactive, C-7-modified chloroacetyl derivative of ciprofloxacin (Cip-AcCl) formed cross-linked cleaved complexes with mutant GyrB-Cys(466) gyrase as evidenced by resistance to reversal by both EDTA and thermal treatments. Surprisingly, cross-linking was also readily seen with complexes formed by mutant GyrA-G81C gyrase, thereby revealing a novel drug-gyrase interaction not observed in crystal structures. The cross-link between fluoroquinolone and GyrA-G81C gyrase correlated with exceptional bacteriostatic activity for Cip-AcCl with a quinolone-resistant GyrA-G81C variant of Escherichia coli and its Mycobacterium smegmatis equivalent (GyrA-G89C). Cip-AcCl-mediated, irreversible inhibition of DNA replication provided further evidence for a GyrA-drug cross-link. Collectively these data establish the existence of interactions between the fluoroquinolone C-7 ring and both GyrA and GyrB. Because the GyrA-Gly(81) and GyrB-Glu(466) residues are far apart (17 ) in the crystal structure of cleaved complexes, two modes of quinolone binding must exist. The presence of two binding modes raises the possibility that multiple quinolone-enzyme-DNA complexes can form, a discovery that opens new avenues for exploring and exploiting relationships between drug structure and activity with type II DNA topoisomerases.	[Mustaev, Arkady; Malik, Muhammad; Zhao, Xilin; Kurepina, Natalia; Luan, Gan; Drlica, Karl] Rutgers Biomed & Hlth Sci, New Jersey Med Sch, Publ Hlth Res Inst, Newark, NJ 07103 USA; [Mustaev, Arkady; Malik, Muhammad; Zhao, Xilin; Kurepina, Natalia; Luan, Gan; Drlica, Karl] Rutgers Biomed & Hlth Sci, New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ 07103 USA; [Oppegard, Lisa M.; Hiasa, Hiroshi] Univ Minnesota, Dept Pharmacol, Sch Med, Minneapolis, MN 55455 USA; [Marks, Kevin R.; Kerns, Robert J.] Univ Iowa, Div Med & Nat Prod Chem, Iowa City, IA 52242 USA; [Berger, James M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Minnesota System; University of Minnesota Twin Cities; University of Iowa; University of California System; University of California Berkeley	Drlica, K (corresponding author), Publ Hlth Res Inst, 225 Warren St, Newark, NJ 07103 USA.	drlicaka@njms.rutgers.edu	Zhao, Xilin/Y-6795-2019	Zhao, Xilin/0000-0001-8375-8658	National Institutes of Health from the NIAID [R01AI073491, R01AI87671]; NIGMS [R01GM-30717]; NCI [R01-CA077373]; NATIONAL CANCER INSTITUTE [R01CA077373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087671, R01AI073491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008365, R01GM030717] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI073491 and R01AI87671 from the NIAID, R01GM-30717 from the NIGMS, and R01-CA077373 from the NCI.	Aedo S, 2012, ANTIMICROB AGENTS CH, V56, P5458, DOI 10.1128/AAC.01182-12; Aldred KJ, 2013, NUCLEIC ACIDS RES, V41, P4628, DOI 10.1093/nar/gkt124; Aldred KJ, 2012, BIOCHEMISTRY-US, V51, P370, DOI 10.1021/bi2013905; Azema J, 2009, BIOORGAN MED CHEM, V17, P5396, DOI 10.1016/j.bmc.2009.06.053; Bax BD, 2010, NATURE, V466, P935, DOI 10.1038/nature09197; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Critchlow SE, 1996, BIOCHEMISTRY-US, V35, P7387, DOI 10.1021/bi9603175; Deweese JE, 2010, METALLOMICS, V2, P450, DOI 10.1039/c003759a; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; GELLERT M, 1977, P NATL ACAD SCI USA, V74, P4772, DOI 10.1073/pnas.74.11.4772; Golanbar GD, 2011, J CLIN MICROBIOL, V49, P2121, DOI 10.1128/JCM.02373-10; GOSS WA, 1965, J BACTERIOL, V89, P1068, DOI 10.1128/JB.89.4.1068-1074.1965; Hiasa H, 2000, J BIOL CHEM, V275, P34780, DOI 10.1074/jbc.M001608200; HIASA H, 1994, J BIOL CHEM, V269, P2093; Hiasa H, 2002, BIOCHEMISTRY-US, V41, P11779, DOI 10.1021/bi026352v; HORTON RM, 1993, METHOD ENZYMOL, V217, P270; JACOBS WR, 1991, METHOD ENZYMOL, V204, P537; Kampranis SC, 1998, J BIOL CHEM, V273, P22615, DOI 10.1074/jbc.273.35.22615; KATO J, 1990, CELL, V63, P393, DOI 10.1016/0092-8674(90)90172-B; KREUZER KN, 1980, CELL, V20, P245, DOI 10.1016/0092-8674(80)90252-4; Laponogov I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011338; Laponogov I, 2009, NAT STRUCT MOL BIOL, V16, P667, DOI 10.1038/nsmb.1604; LIU LF, 1983, J BIOL CHEM, V258, P5365; Lu T, 1999, ANTIMICROB AGENTS CH, V43, P2969, DOI 10.1128/AAC.43.12.2969; Malik M, 2011, ANTIMICROB AGENTS CH, V55, P2335, DOI 10.1128/AAC.00033-11; Malik M, 2010, ANTIMICROB AGENTS CH, V54, P149, DOI 10.1128/AAC.01035-09; Malik M, 2009, ANTIMICROB AGENTS CH, V53, P3103, DOI 10.1128/AAC.00019-09; Miller J. H., 1972, EXPT MOL GENETICS, P433; MIZUUCHI K, 1980, P NATL ACAD SCI-BIOL, V77, P1847, DOI 10.1073/pnas.77.4.1847; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Oppegard LM, 2009, ANTIMICROB AGENTS CH, V53, P2110, DOI 10.1128/AAC.01440-08; Pan XS, 2009, ANTIMICROB AGENTS CH, V53, P3822, DOI 10.1128/AAC.00113-09; Perlman DC, 1997, AIDS, V11, P1473, DOI 10.1097/00002030-199712000-00011; Pohlhaus JR, 2005, MOL MICROBIOL, V56, P1416, DOI 10.1111/j.1365-2958.2005.04638.x; Schoeffler AJ, 2010, NUCLEIC ACIDS RES, V38, P7830, DOI 10.1093/nar/gkq665; Shea ME, 1999, J BIOL CHEM, V274, P22747, DOI 10.1074/jbc.274.32.22747; Sindelar G, 2000, ANTIMICROB AGENTS CH, V44, P3337, DOI 10.1128/AAC.44.12.3337-3343.2000; SNYDER M, 1979, J MOL BIOL, V131, P287, DOI 10.1016/0022-2836(79)90077-9; STERNGLANZ R, 1981, P NATL ACAD SCI-BIOL, V78, P2747, DOI 10.1073/pnas.78.5.2747; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; SUGINO A, 1977, P NATL ACAD SCI USA, V74, P4767, DOI 10.1073/pnas.74.11.4767; TRISLER P, 1984, J BACTERIOL, V160, P184, DOI 10.1128/JB.160.1.184-191.1984; WALL JD, 1974, VIROLOGY, V59, P532, DOI 10.1016/0042-6822(74)90463-2; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Weigel LM, 1998, ANTIMICROB AGENTS CH, V42, P2661, DOI 10.1128/AAC.42.10.2661; Wentzell LM, 2000, J MOL BIOL, V304, P779, DOI 10.1006/jmbi.2000.4266; Wohlkonig A, 2010, NAT STRUCT MOL BIOL, V17, P1152, DOI 10.1038/nsmb.1892; YOSHIDA H, 1990, ANTIMICROB AGENTS CH, V34, P1271, DOI 10.1128/AAC.34.6.1271; YOSHIDA H, 1991, ANTIMICROB AGENTS CH, V35, P1647, DOI 10.1128/AAC.35.8.1647; Zhou JF, 2000, J INFECT DIS, V182, P517, DOI 10.1086/315708	52	92	94	2	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12300	12312		10.1074/jbc.M113.529164	http://dx.doi.org/10.1074/jbc.M113.529164			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24497635	Green Published, hybrid			2022-12-28	WOS:000335581400010
J	Jongkees, SAK; Yoo, H; Withers, SG				Jongkees, Seino A. K.; Yoo, Hayoung; Withers, Stephen G.			Mechanistic Investigations of Unsaturated Glucuronyl Hydrolase from Clostridium perfringens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate Metabolism; Chemical Biology; Enzyme Mechanisms; Glycosaminoglycan; Glycosidases; Glycoside Hydrolases; Isotope Effects; Enzyme; Hydratases	VINYL ETHER HYDROLYSIS; ACID-CATALYZED HYDROLYSIS; ENOLPYRUVYLSHIKIMATE 3-PHOSPHATE EPSP; TRANSITION-STATE ANALYSIS; BACILLUS-SP GL1; POLYSACCHARIDE LYASES; ESCHERICHIA-COLI; METHYL 2,3-ANHYDRO-ALPHA-D-MANNOSIDE; CARBON PROTONATION; CRYSTAL-STRUCTURE	Background: Unsaturated glucuronyl hydrolases (UGL) from GH88 are bacterial enzymes involved in the degradation of glycosaminoglycans and are virulence factors. Results: Mechanistic data inconsistent with the currently accepted mechanism of UGL are presented. Conclusion: A revised mechanism is proposed to explain all mechanistic data published to date. Significance: Understanding of the mechanism of UGL may allow design of bacteriostatic agents. Experiments were carried out to probe the details of the hydration-initiated hydrolysis catalyzed by the Clostridium perfringens unsaturated glucuronyl hydrolase of glycoside hydrolase family 88 in the CAZy classification system. Direct H-1 NMR monitoring of the enzymatic reaction detected no accumulated reaction intermediates in solution, suggesting that rearrangement of the initial hydration product occurs on-enzyme. An attempt at mechanism-based trapping of on-enzyme intermediates using a 1,1-difluoro-substrate was unsuccessful because the probe was too deactivated to be turned over by the enzyme. Kinetic isotope effects arising from deuterium-for-hydrogen substitution at carbons 1 and 4 provide evidence for separate first-irreversible and overall rate-determining steps in the hydration reaction, with two potential mechanisms proposed to explain these results. Based on the positioning of catalytic residues in the enzyme active site, the lack of efficient turnover of a 2-deoxy-2-fluoro-substrate, and several unsuccessful attempts at confirmation of a simpler mechanism involving a covalent glycosyl-enzyme intermediate, the most plausible mechanism is one involving an intermediate bearing an epoxide on carbons 1 and 2.	[Withers, Stephen G.] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; Univ British Columbia, Dept Biochem, Vancouver, BC V6T 1Z1, Canada	University of British Columbia; University of British Columbia	Withers, SG (corresponding author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z1, Canada.	withers@chem.ubc.ca	Jongkees, Seino A K/I-7722-2016	Jongkees, Seino A K/0000-0002-4796-0557	Natural Sciences and Engineering Research Council of Canada; Canadian Foundation for Innovation; British Columbia Knowledge Development Fund	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation(Canada Foundation for Innovation); British Columbia Knowledge Development Fund	This work was supported in part by funding from the Natural Sciences and Engineering Research Council of Canada, the Canadian Foundation for Innovation, and the British Columbia Knowledge Development Fund.	BRIMACOMBE JS, 1968, J CHEM SOC C, P562, DOI 10.1039/j39680000562; BROCKHAUS M, 1979, CARBOHYD RES, V69, P264, DOI 10.1016/S0008-6215(00)85773-0; BUCHANAN JG, 1958, J CHEM SOC, P2511, DOI 10.1039/jr9580002511; BUCHANAN JG, 1962, J CHEM SOC, P4770, DOI 10.1039/jr9620004770; BUCHANAN JG, 1964, J CHEM SOC, P1791, DOI 10.1039/jr9640001791; BURT RA, 1980, CAN J CHEM, V58, P2199, DOI 10.1139/v80-353; BURT RA, 1987, J AM CHEM SOC, V109, P3787, DOI 10.1021/ja00246a050; CAPON B, 1969, CHEM REV, V69, P407, DOI 10.1021/cr60260a001; CHIANG Y, 1989, J AM CHEM SOC, V111, P7185, DOI 10.1021/ja00200a043; CLAYTON CJ, 1967, J CHEM SOC C, P644, DOI 10.1039/j39670000644; COOPER JD, 1971, J AM CHEM SOC, V93, P6294, DOI 10.1021/ja00752a064; Duran-Reynals F, 1933, J EXP MED, V58, P161, DOI 10.1084/jem.58.2.161; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; FRANCK RW, 1992, BIOORG CHEM, V20, P77, DOI 10.1016/0045-2068(92)90028-2; FRIEBOLIN H, 1981, TETRAHEDRON LETT, V22, P1383, DOI 10.1016/S0040-4039(01)90327-2; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; GASMAN RC, 1966, J ORG CHEM, V31, P1830, DOI 10.1021/jo01344a037; Guazzelli L, 2010, CARBOHYD RES, V345, P369, DOI 10.1016/j.carres.2009.11.027; Hashimoto W, 1999, ARCH BIOCHEM BIOPHYS, V368, P367, DOI 10.1006/abbi.1999.1305; Itoh T, 2004, J BIOL CHEM, V279, P31804, DOI 10.1074/jbc.M403288200; Itoh T, 2006, J BIOL CHEM, V281, P29807, DOI 10.1074/jbc.M604975200; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Jongkees SAK, 2014, ACCOUNTS CHEM RES, V47, P226, DOI 10.1021/ar4001313; Jongkees SAK, 2014, CHEMBIOCHEM, V15, P124, DOI 10.1002/cbic.201300547; Jongkees SAK, 2011, J AM CHEM SOC, V133, P19334, DOI 10.1021/ja209067v; Klinman J P, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P415; KONSTANTINIDIS A, 1991, BIOCHEM J, V279, P587, DOI 10.1042/bj2790587; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; KRESGE AJ, 1987, CAN J CHEM, V65, P1753, DOI 10.1139/v87-295; KRESGE AJ, 1991, CAN J CHEM, V69, P84, DOI 10.1139/v91-012; Krezel A, 2004, J INORG BIOCHEM, V98, P161, DOI 10.1016/j.jinorgbio.2003.10.001; LEGLER G, 1990, ADV CARBOHYD CHEM BI, V48, P319, DOI 10.1016/S0065-2318(08)60034-7; Lou MY, 2012, J AM CHEM SOC, V134, P12947, DOI 10.1021/ja3043382; Lou MY, 2012, J AM CHEM SOC, V134, P12958, DOI 10.1021/ja304339h; MCCARTER JD, 1992, BIOCHEM J, V286, P721, DOI 10.1042/bj2860721; MCCLOSKEY CM, 1945, J ORG CHEM, V10, P184, DOI 10.1021/jo01179a004; Namchuk MN, 2000, J AM CHEM SOC, V122, P1270, DOI 10.1021/ja992044h; Namchuk MN, 1995, BIOCHEMISTRY-US, V34, P16194, DOI 10.1021/bi00049a035; Pearce AJ, 1999, EUR J ORG CHEM, V1999, P2103; REIST EJ, 1958, J AM CHEM SOC, V80, P3962, DOI 10.1021/ja01548a041; Satoh H, 2011, J AM CHEM SOC, V133, P5610, DOI 10.1021/ja201024a; SHIPLEY DS, 1994, J ORG CHEM, V59, P977, DOI 10.1021/jo00084a012; SONE T, 1989, CHEM PHARM BULL, V37, P1922; SUTHERLAND IW, 1995, FEMS MICROBIOL REV, V16, P323, DOI 10.1016/0168-6445(95)00020-D; Telford JC, 2011, J BIOL CHEM, V286, P10783, DOI 10.1074/jbc.M110.207043; Thompson AJ, 2012, P NATL ACAD SCI USA, V109, P781, DOI 10.1073/pnas.1111482109; Watts AG, 2006, J BIOL CHEM, V281, P4149, DOI 10.1074/jbc.M510677200; WITHERS SG, 1986, CARBOHYD RES, V154, P127, DOI 10.1016/S0008-6215(00)90028-4; WITHERS SG, 1988, J BIOL CHEM, V263, P7929; Wong AW, 2001, CAN J CHEM, V79, P510, DOI 10.1139/cjc-79-5-6-510; Yip VL, 2006, CURR OPIN CHEM BIOL, V10, P147, DOI 10.1016/j.cbpa.2006.02.005; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	53	7	7	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11385	11395		10.1074/jbc.M113.545293	http://dx.doi.org/10.1074/jbc.M113.545293			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24573682	Green Published, hybrid			2022-12-28	WOS:000334638500040
J	Kan, W; Adjobo-Hermans, M; Burroughs, M; Faibis, G; Malik, S; Tall, GG; Smrcka, AV				Kan, Wei; Adjobo-Hermans, Merel; Burroughs, Michael; Faibis, Guy; Malik, Sundeep; Tall, Gregory G.; Smrcka, Alan V.			M3 Muscarinic Receptor Interaction with Phospholipase C beta(3) Determines Its Signaling Efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Protein-coupled Receptors (GPCR); G Proteins; Phosphatidylinositol Signaling; Phospholipase C; Protein-Protein Interactions; Scaffolding	PROTEIN-COUPLED RECEPTOR; HETEROTRIMERIC G-PROTEINS; MUSCARINIC ACETYLCHOLINE-RECEPTOR; RECTIFYING POTASSIUM CHANNELS; FORM STABLE COMPLEXES; G-ALPHA-Q; LIVING CELLS; STRUCTURAL BASIS; TERNARY COMPLEX; GAMMA-SUBUNITS	Background: Scaffolding of signaling proteins to GPCRs may increase signaling efficiency and spatial fidelity. Results: Phospholipase C (PLC) 3 binding directly to M3 muscarinic receptor intracellular loops involves a non-canonical PDZ interaction. Conclusion: M3 muscarinic receptor binding to PLC3 optimizes interactions with substrate and G protein activator. Significance: Scaffolding of PLC enzymes to GPCRs may be important for spatial signal specificity and efficacy. Phospholipase C (PLC) enzymes are activated by G protein-coupled receptors through receptor-catalyzed guanine nucleotide exchange on G heterotrimers containing G(q) family G proteins. Here we report evidence for a direct interaction between M3 muscarinic receptor (M3R) and PLC3. Both expressed and endogenous M3R interacted with PLC in coimmunoprecipitation experiments. Stimulation of M3R with carbachol significantly increased this association. Expression of M3R in CHO cells promoted plasma membrane localization of YFP-PLC3. Deletion of the PLC3 C terminus or deletion of the PLC3 PDZ ligand inhibited coimmunoprecipitation with M3R and M3R-dependent PLC3 plasma membrane localization. Purified PLC3 bound directly to glutathione S-transferase (GST)-fused M3R intracellular loops 2 and 3 (M3Ri2 and M3Ri3) as well as M3R C terminus (M3R/H8-CT). PLC3 binding to M3Ri3 was inhibited when the PDZ ligand was removed. In assays using reconstituted purified components in vitro, M3Ri2, M3Ri3, and M3R/H8-CT potentiated G(q)-dependent but not G-dependent PLC3 activation. Disruption of key residues in M3Ri3N and of the PDZ ligand in PLC3 inhibited M3Ri3-mediated potentiation. We propose that the M3 muscarinic receptor maximizes the efficiency of PLC3 signaling beyond its canonical role as a guanine nucleotide exchange factor for G.	[Kan, Wei; Burroughs, Michael; Faibis, Guy; Malik, Sundeep; Tall, Gregory G.; Smrcka, Alan V.] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Smrcka, Alan V.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Smrcka, Alan V.] Univ Rochester, Sch Med & Dent, Aab Inst Cardiovasc Res, Rochester, NY 14642 USA; [Adjobo-Hermans, Merel] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6525 GA Nijmegen, Netherlands	University of Rochester; University of Rochester; University of Rochester; Radboud University Nijmegen	Smrcka, AV (corresponding author), Univ Rochester, 601 Elmwood Ave, Rochester, NY 14642 USA.	alan_smrcka@urmc.rochester.edu	Adjobo-Hermans, Merel/AAN-5989-2020; Adjobo-Hermans, M.J.W./L-4170-2015	Adjobo-Hermans, Merel/0000-0002-5947-2876; Adjobo-Hermans, M.J.W./0000-0002-5947-2876; Kan, Wei/0000-0002-6830-6714	National Institutes of Health [GM053536]; American Heart Association Predoctoral Fellowship [10PRE3490032]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088242, R01GM053536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Predoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM053536 (to A. V. S.). This work was also supported by American Heart Association Predoctoral Fellowship 10PRE3490032 (to W. K.).	Adjobo-Hermans MJW, 2013, CELL SIGNAL, V25, P255, DOI 10.1016/j.cellsig.2012.09.022; Benians A, 2003, J BIOL CHEM, V278, P10851, DOI 10.1074/jbc.M212299200; Bonacci TM, 2005, J BIOL CHEM, V280, P10174, DOI 10.1074/jbc.M412514200; Chan P, 2011, J BIOL CHEM, V286, P2625, DOI 10.1074/jbc.M110.178897; Choi JW, 2010, CELL SIGNAL, V22, P1153, DOI 10.1016/j.cellsig.2010.03.010; Daulat AM, 2007, MOL CELL PROTEOMICS, V6, P835, DOI 10.1074/mcp.M600298-MCP200; David M, 2006, CELL SIGNAL, V18, P2172, DOI 10.1016/j.cellsig.2006.05.014; Fowler CE, 2007, J PHYSIOL-LONDON, V580, P51, DOI 10.1113/jphysiol.2006.123216; Gales C, 2005, NAT METHODS, V2, P177, DOI 10.1038/NMETH743; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Harden TK, 2011, CHEM REV, V111, P6120, DOI 10.1021/cr200209p; Hein P, 2009, N-S ARCH PHARMACOL, V379, P435, DOI 10.1007/s00210-008-0383-7; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; Hwang JI, 2005, J BIOL CHEM, V280, P12467, DOI 10.1074/jbc.M410740200; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kim JK, 2012, J BIOL CHEM, V287, P21012, DOI 10.1074/jbc.M111.337865; Kim JK, 2011, ADV ENZYME REGUL, V51, P138, DOI 10.1016/j.advenzreg.2010.10.004; Klenk C, 2010, J BIOL CHEM, V285, P30355, DOI 10.1074/jbc.M110.114900; Lavine N, 2002, J BIOL CHEM, V277, P46010, DOI 10.1074/jbc.M205035200; Lehmann DM, 2007, METHOD ENZYMOL, V434, P29, DOI 10.1016/S0076-6879(07)34003-2; Li B, 2007, NAT METHODS, V4, P169, DOI 10.1038/nmeth990; Lyon AM, 2013, MOL PHARMACOL, V84, P488, DOI 10.1124/mol.113.087403; Lyon AM, 2013, NAT STRUCT MOL BIOL, V20, P355, DOI 10.1038/nsmb.2497; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; McMillin SM, 2011, J BIOL CHEM, V286, P28584, DOI 10.1074/jbc.M111.259788; MUMBY SM, 1991, METHOD ENZYMOL, V195, P215; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; Oh YS, 2004, MOL CELL BIOL, V24, P5069, DOI 10.1128/MCB.24.11.5069-5079.2004; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; PANG IH, 1990, J BIOL CHEM, V265, P18707; Patowary S, 2013, BIOCHEM J, V452, P303, DOI 10.1042/BJ20121902; Philip F, 2010, CURR BIOL, V20, P1327, DOI 10.1016/j.cub.2010.06.013; Qin K, 2011, NAT CHEM BIOL, V7, P740, DOI [10.1038/nchembio.642, 10.1038/NCHEMBIO.642]; Ranganathan R, 1997, CURR BIOL, V7, pR770, DOI 10.1016/S0960-9822(06)00401-5; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rebois RV, 2006, J CELL SCI, V119, P2807, DOI 10.1242/jcs.03021; Ross EM, 2008, CURR BIOL, V18, pR777, DOI 10.1016/j.cub.2008.07.035; SCHONEBERG T, 1995, J BIOL CHEM, V270, P18000; Singer AU, 2002, NAT STRUCT BIOL, V9, P32, DOI 10.1038/nsb731; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; STERNWEIS PC, 1992, TRENDS BIOCHEM SCI, V17, P502, DOI 10.1016/0968-0004(92)90340-F; Suh PG, 2001, BIOCHEM BIOPH RES CO, V288, P1, DOI 10.1006/bbrc.2001.5710; van Huizen R, 1998, EMBO J, V17, P2285, DOI 10.1093/emboj/17.8.2285; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; WU DQ, 1993, J BIOL CHEM, V268, P3704; Wu GY, 2000, J BIOL CHEM, V275, P9026, DOI 10.1074/jbc.275.12.9026; Wu GY, 1998, J BIOL CHEM, V273, P7197, DOI 10.1074/jbc.273.13.7197; Yamada M, 2001, NATURE, V410, P207, DOI 10.1038/35065604; Zeng FY, 1999, J BIOL CHEM, V274, P19487, DOI 10.1074/jbc.274.27.19487; Zeng FY, 1999, J NEUROCHEM, V72, P2404, DOI 10.1046/j.1471-4159.1999.0722404.x	51	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11206	11218		10.1074/jbc.M113.538546	http://dx.doi.org/10.1074/jbc.M113.538546			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24596086	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000334638500024
J	Cole, CL; Rushton, G; Jayson, GC; Avizienyte, E				Cole, Claire L.; Rushton, Graham; Jayson, Gordon C.; Avizienyte, Egle			Ovarian Cancer Cell Heparan Sulfate 6-O-Sulfotransferases Regulate an Angiogenic Program Induced by Heparin-binding Epidermal Growth Factor ( EGF)-like Growth Factor/EGF Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Epidermal Growth Factor Receptor (EGFR); Heparan Sulfate; Sulfotransferase; Tumor Microenvironment; HB-EGF; IL-6; IL-8	EPITHELIAL OVARIAN; DOMAIN; BEVACIZUMAB; OLIGOSACCHARIDES; 6-O-SULFATION; INTERLEUKIN-8; REQUIREMENTS; SITES; TRIAL; FGF-2	Background: Numerous angiogenic growth factors depend on heparan sulfate for their activity. Results: Heparan sulfate 6-O-sulfotransferases induce angiogenesis through HB-EGF/EGFR signaling and angiogenic cytokine expression in ovarian cancer cells. Conclusion: Ovarian cancer cell 6-O-sulfation levels influence angiogenic responses. Significance: HS6ST inhibitors and HS mimetics should be explored in the development of new anti-angiogenic agents. Heparan sulfate (HS) is a component of cell surface and extracellular matrix proteoglycans that regulates numerous signaling pathways by binding and activating multiple growth factors and chemokines. The amount and pattern of HS sulfation are key determinants for the assembly of the trimolecular, HS-growth factor-receptor, signaling complex. Here we demonstrate that HS 6-O-sulfotransferases 1 and 2 (HS6ST-1 and HS6ST-2), which perform sulfation at 6-O position in glucosamine in HS, impact ovarian cancer angiogenesis through the HS-dependent HB-EGF/EGFR axis that subsequently modulates the expression of multiple angiogenic cytokines. Down-regulation of HS6ST-1 or HS6ST-2 in human ovarian cancer cell lines results in 30-50% reduction in glucosamine 6-O-sulfate levels in HS, impairing HB-EGF-dependent EGFR signaling and diminishing FGF2, IL-6, and IL-8 mRNA and protein levels in cancer cells. These cancer cell-related changes reduce endothelial cell signaling and tubule formation in vitro. In vivo, the development of subcutaneous tumor nodules with reduced 6-O-sulfation is significantly delayed at the initial stages of tumor establishment with further reduction in angiogenesis occurring throughout tumor growth. Our results show that in addition to the critical role that 6-O-sulfate moieties play in angiogenic cytokine activation, HS 6-O-sulfation level, determined by the expression of HS6ST isoforms in ovarian cancer cells, is a major regulator of angiogenic program in ovarian cancer cells impacting HB-EGF signaling and subsequent expression of angiogenic cytokines by cancer cells.	[Cole, Claire L.; Rushton, Graham; Jayson, Gordon C.; Avizienyte, Egle] Univ Manchester, Fac Med & Human Sci, Inst Canc Sci, Manchester M20 4BX, Lancs, England	University of Manchester	Avizienyte, E (corresponding author), Univ Manchester, Fac Med & Human Sci, Inst Canc Sci, Paterson Bldg,Wilmslow Rd, Manchester M20 4BX, Lancs, England.	egle.avizienyte@ics.manchester.ac.uk	Jayson, Gordon C/O-8224-2015	Jayson, Gordon C/0000-0002-8515-8944	Medical Research Council [G0902173] Funding Source: Medline; MRC [G0902173] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aghajanian C, 2012, J CLIN ONCOL, V30, P2039, DOI 10.1200/JCO.2012.42.0505; Ai XB, 2006, J BIOL CHEM, V281, P4969, DOI 10.1074/jbc.M511902200; Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Ashikari-Hada S, 2009, GLYCOBIOLOGY, V19, P644, DOI 10.1093/glycob/cwp031; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Backen AC, 2007, BRIT J CANCER, V96, P1544, DOI 10.1038/sj.bjc.6603747; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Chu CL, 2005, BIOCHEMISTRY-US, V44, P12203, DOI 10.1021/bi050241p; Cole CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011644; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Ferreras C, 2012, J BIOL CHEM, V287, P36132, DOI 10.1074/jbc.M112.384875; Fuster MM, 2007, J CELL BIOL, V177, P539, DOI 10.1083/jcb.200610086; Gallagher JT, 2006, BIOCHEM SOC T, V34, P438, DOI 10.1042/BST0340438; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Habuchi H, 2000, J BIOL CHEM, V275, P2859, DOI 10.1074/jbc.275.4.2859; Hansen SU, 2013, ORG LETT, V15, P88, DOI 10.1021/ol303112y; Hansen SU, 2012, J ORG CHEM, V77, P7823, DOI 10.1021/jo300722y; Hansen SU, 2009, ORG LETT, V11, P4528, DOI 10.1021/ol901723m; Jastrebova N, 2010, J BIOL CHEM, V285, P26842, DOI 10.1074/jbc.M109.093542; Khurana A, 2013, AM J CANCER RES, V3, P34; Kulbe H, 2012, CANCER RES, V72, P66, DOI 10.1158/0008-5472.CAN-11-2178; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Merritt WM, 2008, J NATL CANCER I, V100, P359, DOI 10.1093/jnci/djn024; Mummery RS, 2000, J IMMUNOL, V165, P5671, DOI 10.4049/jimmunol.165.10.5671; Narita K, 2006, CANCER RES, V66, P6025, DOI 10.1158/0008-5472.CAN-05-3582; Peifley KA, 1996, CIRC RES, V79, P263, DOI 10.1161/01.RES.79.2.263; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Phillips JJ, 2012, J CLIN INVEST, V122, P911, DOI 10.1172/JCI58215; Pichert A, 2012, GLYCOBIOLOGY, V22, P134, DOI 10.1093/glycob/cwr120; Pinciroli P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-508; Pye DA, 2000, GLYCOBIOLOGY, V10, P1183, DOI 10.1093/glycob/10.11.1183; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Robinson CJ, 2006, J BIOL CHEM, V281, P1731, DOI 10.1074/jbc.M510760200; Schlorke D, 2012, CARBOHYD RES, V356, P196, DOI 10.1016/j.carres.2012.02.025; Spillmann D, 1998, J BIOL CHEM, V273, P15487, DOI 10.1074/jbc.273.25.15487; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Tsujioka H, 2011, CURR OPIN OBSTET GYN, V23, P24, DOI 10.1097/GCO.0b013e3283409c91; Uchimura Kenji, 2006, BMC Biochem, V7, P2, DOI 10.1186/1471-2091-7-2; Yagi H, 2009, INT J CANCER, V124, P1429, DOI 10.1002/ijc.24031	41	41	41	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10488	10501		10.1074/jbc.M113.534263	http://dx.doi.org/10.1074/jbc.M113.534263			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24563483	Green Published, hybrid			2022-12-28	WOS:000334226400022
J	Jiang, K; Rankin, CR; Nava, P; Sumagin, R; Kamekura, R; Stowell, SR; Feng, ML; Parkos, CA; Nusrat, A				Jiang, Kun; Rankin, Carl R.; Nava, Porfirio; Sumagin, Ronen; Kamekura, Ryuta; Stowell, Sean R.; Feng, Mingli; Parkos, Charles A.; Nusrat, Asma			Galectin-3 Regulates Desmoglein-2 and Intestinal Epithelial Intercellular Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell-Cell Interaction; Desmosome; Galectin; Intestinal Epithelium; Protein Stability; Desmoglein-2; Galectin-3f	CELL-ADHESION; CROHNS-DISEASE; DESMOSOMAL CADHERINS; CARCINOMA CELLS; MESSENGER-RNA; BRUSH-BORDER; EXPRESSION; BINDING; LECTIN; INTERNALIZATION	Background: Desmoglein-2 mediates intestinal epithelial intercellular adhesion. Results: Galectin-3 was identified to associate with the ectodomain of desmoglein-2 and inhibit the degradation of desmoglein-2 and enhance intercellular adhesion. Conclusion: Galectin-3 lattices stabilize desmoglein-2 at the cell surface to regulate intercellular adhesion in intestinal epithelial cells. Significance: This study identifies a novel role of galectin-3 in controlling desmosome structure and function. The desmosomal cadherins, desmogleins, and desmocollins mediate strong intercellular adhesion. Human intestinal epithelial cells express the desmoglein-2 isoform. A proteomic screen for Dsg2-associated proteins in intestinal epithelial cells identified a lectin referred to as galectin-3 (Gal3). Gal3 bound to N-linked -galactosides in Dsg2 extracellular domain and co-sedimented with caveolin-1 in lipid rafts. Down-regulation of Gal3 protein or incubation with lactose, a galactose-containing disaccharide that competitively inhibits galectin binding to Dsg2, decreased intercellular adhesion in intestinal epithelial cells. In the absence of functional Gal3, Dsg2 protein was internalized from the plasma membrane and degraded in the proteasome. These results report a novel role of Gal3 in stabilizing a desmosomal cadherin and intercellular adhesion in intestinal epithelial cells.	[Jiang, Kun; Rankin, Carl R.; Nava, Porfirio; Sumagin, Ronen; Kamekura, Ryuta; Stowell, Sean R.; Feng, Mingli; Parkos, Charles A.; Nusrat, Asma] Emory Univ, Dept Pathol & Lab Med, Epithelial Pathobiol & Mucosal Inflammat Res Unit, Atlanta, GA 30322 USA; [Nava, Porfirio] CINVESTAV IPN, Dept Physiol Biophys & Neurosci, Ciudad De Mexico 07360, DF, Mexico	Emory University; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Nusrat, A (corresponding author), Emory Univ, Dept Pathol & Lab Med, Whitehead Res Bldg,Rm 105E,615 Michael St, Atlanta, GA 30322 USA.	anusrat@emory.edu	Nava, Porfirio/D-8306-2012	Nava, Porfirio/0000-0002-0506-1510; JIANG, KUN/0000-0001-8531-7813	National Institutes of Health [R01 DK072564, R01 DK061379, R01 DK079392, R01 DK055679, DK059888, DK064399]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007771, R24DK064399, R01DK055679, R01DK079392, R01DK061379, R01DK072564, R01DK059888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK072564, R01 DK061379, and R01 DK079392 (to C. A. P.); R01 DK055679 and DK059888 (to A. N.); and DK064399 (National Institutes of Health Digestive Diseases Research Development Center (DDRDC) tissue culture and morphology grant).	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Bodger K, 2006, GUT, V55, P973, DOI 10.1136/gut.2005.086413; Boscher C, 2013, MOL BIOL CELL, V24, P2134, DOI 10.1091/mbc.E13-02-0095; Boscher C, 2012, J BIOL CHEM, V287, P32940, DOI 10.1074/jbc.M112.353334; Brazowski E, 2009, PATHOL RES PRACT, V205, P551, DOI 10.1016/j.prp.2009.02.001; Brennan D, 2012, ONCOGENE, V31, P1636, DOI 10.1038/onc.2011.346; Brooke MA, 2012, J PATHOL, V226, P158, DOI 10.1002/path.3027; Campbell B, 2001, SMITHSONIAN, V32, P18; Chabot S, 2002, GLYCOBIOLOGY, V12, P111, DOI 10.1093/glycob/12.2.111; Chen J, 2012, J CELL BIOL, V199, P699, DOI 10.1083/jcb.201202105; Chen R, 2009, J PROTEOME RES, V8, P651, DOI 10.1021/pr8008012; Cheng X, 2004, J DERMATOL, V31, P171, DOI 10.1111/j.1346-8138.2004.tb00654.x; CHERAYIL BJ, 1990, P NATL ACAD SCI USA, V87, P7324, DOI 10.1073/pnas.87.18.7324; CHO MJ, 1995, J BIOL CHEM, V270, P5207, DOI 10.1074/jbc.270.10.5207; Danielsen EM, 1997, MOL BIOL CELL, V8, P2241, DOI 10.1091/mbc.8.11.2241; Dusek RL, 2011, NAT REV CANCER, V11, P317, DOI 10.1038/nrc3051; Eshkind L, 2002, EUR J CELL BIOL, V81, P592, DOI 10.1078/0171-9335-00278; Friedrichs J, 2008, J BIOL CHEM, V283, P32264, DOI 10.1074/jbc.M803634200; Fukushima K, 2003, INFLAMM BOWEL DIS, V9, P290, DOI 10.1097/00054725-200309000-00002; Furtak V, 2001, BIOCHEM BIOPH RES CO, V289, P845, DOI 10.1006/bbrc.2001.6064; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Hartsock A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037476; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; HO MK, 1982, J IMMUNOL, V128, P1221; Holthofer B, 2007, INT REV CYTOL, V264, P65, DOI 10.1016/S0074-7696(07)64003-0; Inohara H, 1996, CANCER RES, V56, P4530; INOHARA H, 1995, CANCER RES, V55, P3267; Jensen-Jarolim E, 2002, EUR J GASTROEN HEPAT, V14, P145, DOI 10.1097/00042737-200202000-00008; Jensen-Jarolim E, 2001, J CLIN IMMUNOL, V21, P348, DOI 10.1023/A:1012240719801; Kamekura R, 2014, ONCOGENE, V33, P4531, DOI 10.1038/onc.2013.442; Klessner JL, 2009, MOL BIOL CELL, V20, P328, DOI 10.1091/mbc.E08-04-0356; Kolegraff K, 2011, CELL ADHES MIGR, V5, P306, DOI 10.4161/cam.5.4.16911; Kolegraff K, 2011, MOL BIOL CELL, V22, P1121, DOI 10.1091/mbc.E10-10-0845; Kowalczyk AP, 1999, INT REV CYTOL, V185, P237; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Langer MD, 2012, J CELL SCI, V125, P2478, DOI 10.1242/jcs.101147; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lepur A, 2012, J BIOL CHEM, V287, P21751, DOI 10.1074/jbc.C112.358002; Mahoney MG, 2006, EXP DERMATOL, V15, P101, DOI 10.1111/j.1600-0625.2006.00391.x; Marcozzi C, 1998, J CELL SCI, V111, P495; Monteiro AC, 2013, MOL BIOL CELL, V24, P2849, DOI 10.1091/mbc.E13-06-0298; Morris S, 2004, GLYCOBIOLOGY, V14, P293, DOI 10.1093/glycob/cwh029; MOUTSATSOS IK, 1986, J CELL BIOL, V102, P477, DOI 10.1083/jcb.102.2.477; Nava P, 2007, MOL BIOL CELL, V18, P4565, DOI 10.1091/mbc.E07-05-0426; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Rankin CR, 2013, J BIOL CHEM, V288, P15229, DOI 10.1074/jbc.M112.440909; Resnik N, 2011, J BIOL CHEM, V286, P1499, DOI 10.1074/jbc.M110.189464; Schlegel N, 2010, AM J PHYSIOL-GASTR L, V298, pG774, DOI 10.1152/ajpgi.00239.2009; SHIMOYAMA Y, 1989, CANCER RES, V49, P2128; Shinzaki S, 2013, INFLAMM BOWEL DIS, V19, P321, DOI 10.1097/MIB.0b013e318280eade; Sumagin R, 2014, MUCOSAL IMMUNOL, V7, P905, DOI 10.1038/mi.2013.106; Syed SEH, 2002, BIOCHEM J, V362, P317, DOI 10.1042/0264-6021:3620317; Thomsen MK, 2009, MOL MEMBR BIOL, V26, P347, DOI 10.1080/09687680903167781; Vasioukhin V, 2001, NAT CELL BIOL, V3, P1076, DOI 10.1038/ncb1201-1076; Wang HJ, 2013, J VIROL, V87, P11346, DOI 10.1128/JVI.01825-13; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; Yashiro M, 2006, EUR J CANCER, V42, P2397, DOI 10.1016/j.ejca.2006.03.024; Zou J, 2005, CARCINOGENESIS, V26, P309, DOI 10.1093/carcin/bgh329	59	38	38	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10510	10517		10.1074/jbc.M113.538538	http://dx.doi.org/10.1074/jbc.M113.538538			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24567334	Green Published, hybrid			2022-12-28	WOS:000334226400024
J	Tanaka, T; Doe, JM; Horstmann, SA; Ahmad, S; Ahmad, A; Min, SJ; Reynolds, PR; Suram, S; Gaydos, J; Burnham, EL; Vandivier, RW				Tanaka, Takeshi; Doe, Jenna M.; Horstmann, Sarah A.; Ahmad, Shama; Ahmad, Aftab; Min, Sung-Joon; Reynolds, Paul R.; Suram, Saritha; Gaydos, Jeanette; Burnham, Ellen L.; Vandivier, R. William			Neuroendocrine Signaling Via the Serotonin Transporter Regulates Clearance of Apoptotic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autoimmune Diseases; Inflammation; Lung; Phagocytosis; RhoA; Efferocytosis; Rho Kinase; Serotonin Receptors	OBSTRUCTIVE PULMONARY-DISEASE; RED-BLOOD-CELLS; DEFICIENT MICE; ALVEOLAR MACROPHAGES; RHEUMATOID-ARTHRITIS; IMMUNE-RESPONSES; CYSTIC-FIBROSIS; LUNG-DISEASE; PHAGOCYTOSIS; PHOSPHATIDYLSERINE	Background: Serotonin (5-HT) contributes to the pathogenesis of chronic inflammatory diseases known to have defects in apoptotic cell removal (i.e. efferocytosis). Results: 5-HT impairs macrophage efferocytosis via 5-HT transporter-dependent activation of the RhoA/Rho kinase pathway. Conclusion: Results show a novel mechanism by which 5-HT might disrupt resolution of inflammation. Significance: Targeting the 5-HT transporter may have a therapeutic role in chronic inflammatory disorders. Serotonin (5-hydroxytryptamine; 5-HT) is a CNS neurotransmitter increasingly recognized to exert immunomodulatory effects outside the CNS that contribute to the pathogenesis of autoimmune and chronic inflammatory diseases. 5-HT signals to activate the RhoA/Rho kinase (ROCK) pathway, a pathway known for its ability to regulate phagocytosis. The clearance of apoptotic cells (i.e. efferocytosis) is a key modulator of the immune response that is inhibited by the RhoA/ROCK pathway. Because efferocytosis is defective in many of the same illnesses where 5-HT has been implicated in disease pathogenesis, we hypothesized that 5-HT would suppress efferocytosis via activation of RhoA/ROCK. The effect of 5-HT on efferocytosis was examined in murine peritoneal and human alveolar macrophages, and its mechanisms were investigated using pharmacologic blockade and genetic deletion. 5-HT impaired efferocytosis by murine peritoneal macrophages and human alveolar macrophages. 5-HT increased phosphorylation of myosin phosphatase subunit 1 (Mypt-1), a known ROCK target, and inhibitors of RhoA and ROCK reversed the suppressive effect of 5-HT on efferocytosis. Peritoneal macrophages expressed the 5-HT transporter and 5-HT receptors (R) 2a, 2b, but not 2c. Inhibition of 5-HTR2a and 5-HTR2b had no effect on efferocytosis, but blockade of the 5-HT transporter prevented 5-HT-impaired efferocytosis. Genetic deletion of the 5-HT transporter inhibited 5-HT uptake into peritoneal macrophages, prevented 5-HT-induced phosphorylation of Mypt-1, reversed the inhibitory effect of 5-HT on efferocytosis, and decreased cellular peritoneal inflammation. These results suggest a novel mechanism by which 5-HT might disrupt efferocytosis and contribute to the pathogenesis of autoimmune and chronic inflammatory diseases.	[Tanaka, Takeshi; Doe, Jenna M.; Horstmann, Sarah A.; Suram, Saritha; Gaydos, Jeanette; Burnham, Ellen L.; Vandivier, R. William] Univ Colorado, COPD Ctr, Div Pulm Sci & Crit Care Med, Aurora, CO 80045 USA; [Ahmad, Shama; Ahmad, Aftab] Univ Colorado, Pediat Airway Res Ctr, Dept Pediat, Aurora, CO 80045 USA; [Min, Sung-Joon] Univ Colorado, Div Hlth Care Policy & Res, Aurora, CO 80045 USA; [Reynolds, Paul R.] Natl Jewish Hlth, Dept Pediat, Div Cell Biol, Denver, CO 80206 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health	Vandivier, RW (corresponding author), Box C272,9th Floor,12700 East 19th Ave, Aurora, CO 80045 USA.	Bill.Vandivier@ucdenver.edu	ahmad, shama/GNH-1803-2022; Ahmad, Aftab/ABC-2734-2020	ahmad, shama/0000-0003-1049-5054; Ahmad, Aftab/0000-0003-0686-0987	National Institutes of Health from the NHLBI [HL-088138]; National Institutes of Health from the NIAAA [R24 AAO19661]; Flight Attendant Medical Research Institute [CIA092054]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R24AA019661] Funding Source: NIH RePORTER	National Institutes of Health from the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health from the NIAAA; Flight Attendant Medical Research Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-088138 from the NHLBI (to R. W. V.) and Grant R24 AAO19661 from the NIAAA (to E. L. B.) and Clinical Innovator Award CIA092054 from the Flight Attendant Medical Research Institute.	Amireault P, 2011, P NATL ACAD SCI USA, V108, P13141, DOI 10.1073/pnas.1103964108; Artigas MS, 2011, AM J RESP CRIT CARE, V184, P786, DOI 10.1164/rccm.201102-0192OC; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; Boe DM, 2010, ALCOHOL CLIN EXP RES, V34, P1723, DOI 10.1111/j.1530-0277.2010.01259.x; Bratton DL, 2011, TRENDS IMMUNOL, V32, P350, DOI 10.1016/j.it.2011.04.009; Chabbi-Achengli Y, 2012, P NATL ACAD SCI USA, V109, P2567, DOI 10.1073/pnas.1117792109; CONNOR J, 1994, J BIOL CHEM, V269, P2399; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; de Jong K, 2001, BLOOD, V98, P1577, DOI 10.1182/blood.V98.5.1577; Durk T, 2013, AM J RESP CRIT CARE, V187, P476, DOI 10.1164/rccm.201208-1440OC; Duerschmied D, 2013, BLOOD, V121, P1008, DOI 10.1182/blood-2012-06-437392; Eddahibi S, 2001, J CLIN INVEST, V108, P1141, DOI 10.1172/JCI12805; Elliott MR, 2010, J CELL BIOL, V189, P1059, DOI 10.1083/jcb.201004096; Erwig LP, 2006, P NATL ACAD SCI USA, V103, P12825, DOI 10.1073/pnas.0605331103; Fernandez-Boyanapalli R, 2013, J ALLERGY CLIN IMMUN, V131, P1041, DOI 10.1016/j.jaci.2012.09.028; Fernandez-Boyanapalli RF, 2009, BLOOD, V113, P2047, DOI 10.1182/blood-2008-05-160564; Freire-Garabal M, 2003, BRIT J PHARMACOL, V139, P457, DOI 10.1038/sj.bjp.0705188; GERSHON MD, 1965, SCIENCE, V149, P197, DOI 10.1126/science.149.3680.197; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Ghia JE, 2009, GASTROENTEROLOGY, V137, P1649, DOI 10.1053/j.gastro.2009.08.041; Goolaerts A, 2010, AM J RESP CELL MOL, V43, P99, DOI 10.1165/rcmb.2008-0472OC; Guilluy C, 2007, J BIOL CHEM, V282, P2918, DOI 10.1074/jbc.M604195200; Guilluy C, 2009, AM J RESP CRIT CARE, V179, P1151, DOI 10.1164/rccm.200805-691OC; Holmes A, 2003, GENES BRAIN BEHAV, V2, P365, DOI 10.1046/j.1601-1848.2003.00050.x; Hummerich R, 2012, FEBS LETT, V586, P3421, DOI 10.1016/j.febslet.2012.07.062; Huynh MLN, 2005, AM J RESP CRIT CARE, V172, P972, DOI 10.1164/rccm.200501-035OC; Ishii T, 2011, J HUM GENET, V56, P41, DOI 10.1038/jhg.2010.133; Kim JJ, 2013, J IMMUNOL, V190, P4795, DOI 10.4049/jimmunol.1201887; Krabbe G, 2012, BRAIN BEHAV IMMUN, V26, P419, DOI 10.1016/j.bbi.2011.12.002; Lang KS, 2003, CELL DEATH DIFFER, V10, P249, DOI 10.1038/sj.cdd.4401144; Lau W. K., 2012, PLOS ONE, V7; Margolis KG, 2009, GASTROENTEROLOGY, V137, P1562, DOI 10.1053/j.gastro.2009.09.027; MCEVOY L, 1986, P NATL ACAD SCI USA, V83, P3311, DOI 10.1073/pnas.83.10.3311; Mikulski Z, 2010, AM J PHYSIOL-LUNG C, V299, pL272, DOI 10.1152/ajplung.00032.2010; Millan MJ, 2008, TRENDS PHARMACOL SCI, V29, P454, DOI 10.1016/j.tips.2008.06.007; Morimoto K, 2006, J IMMUNOL, V176, P7657, DOI 10.4049/jimmunol.176.12.7657; Mossner R, 1998, BRAIN BEHAV IMMUN, V12, P249, DOI 10.1006/brbi.1998.0532; Murphy DL, 2008, NEUROPHARMACOLOGY, V55, P932, DOI 10.1016/j.neuropharm.2008.08.034; Murphy DL, 2008, NAT REV NEUROSCI, V9, P85, DOI 10.1038/nrn2284; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; Richens TR, 2009, AM J RESP CRIT CARE, V179, P1011, DOI 10.1164/rccm.200807-1148OC; Roszer T, 2011, J IMMUNOL, V186, P621, DOI 10.4049/jimmunol.1002230; Rudd ML, 2005, J NEUROIMMUNOL, V159, P113, DOI 10.1016/j.jneuroim.2004.10.013; Seddighzadeh M, 2010, EUR J HUM GENET, V18, P821, DOI 10.1038/ejhg.2010.12; Snir O, 2013, GENES IMMUN, V14, P83, DOI 10.1038/gene.2012.56; STERNBERG EM, 1987, J IMMUNOL, V138, P4360; Tosello-Trampont AC, 2003, J BIOL CHEM, V278, P49911, DOI 10.1074/jbc.M306079200; Van Vre EA, 2012, ARTERIOSCL THROM VAS, V32, P887, DOI 10.1161/ATVBAHA.111.224873; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Vandivier RW, 2009, AM J PHYSIOL-LUNG C, V297, pL677, DOI 10.1152/ajplung.00030.2009; Vandivier RW, 2002, J CLIN INVEST, V109, P661, DOI 10.1172/JCI200213572; Walther DJ, 2011, FEBS J, V278, P4740, DOI 10.1111/j.1742-4658.2011.08347.x; Walther DJ, 2003, CELL, V115, P851, DOI 10.1016/S0092-8674(03)01014-6; Wei L, 2012, AM J PHYSIOL-LUNG C, V302, pL1273, DOI 10.1152/ajplung.00082.2012; Wilk JB, 2012, AM J RESP CRIT CARE, V186, P622, DOI 10.1164/rccm.201202-0366OC	55	16	16	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10466	10475		10.1074/jbc.M113.482299	http://dx.doi.org/10.1074/jbc.M113.482299			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24570000	hybrid, Green Published			2022-12-28	WOS:000334226400020
J	Chen, CC; Shi, ZB; Zhang, WQ; Chen, M; He, F; Zhang, ZZ; Wang, YC; Feng, M; Wang, WJ; Zhao, Y; Brown, JH; Jiao, S; Zhou, ZC				Chen, Cuicui; Shi, Zhubing; Zhang, Wenqing; Chen, Min; He, Feng; Zhang, Zhenzhen; Wang, Yicui; Feng, Miao; Wang, Wenjia; Zhao, Yun; Brown, Jerry H.; Jiao, Shi; Zhou, Zhaocai			Striatins Contain a Noncanonical Coiled Coil That Binds Protein Phosphatase 2A A Subunit to Form a 2: 2 Heterotetrameric Core of Striatin- interacting Phosphatase and Kinase ( STRIPAK) Complex*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Phosphatase; PP2A; Protein Complexes; Protein Kinases; Protein Structure; Coiled Coil; Parallel Dimer; STRIPAK Complex; Striatin	CALMODULIN-BINDING; NUCLEAR AUTOANTIGEN; S-PHASE; FAMILY; ACTIVATION; PP2A; INSIGHTS; MECHANISM; APOPTOSIS; ESTROGEN	Background: Striatins are novel regulatory subunits of PP2A in the striatin-interacting phosphatase and kinase (STRIPAK) complex. Results: The striatin coiled coil forms a noncanonical dimer required for PP2A A subunit binding. Conclusion: The coiled coil of striatins bind PP2A A subunits to form a 2:2 heterotetrameric core of the STRIPAK complex. Significance: The current structural analysis provides insights into the assembly of the STRIPAK complex. The protein phosphatase 2A (PP2A) and kinases such as germinal center kinase III (GCKIII) can interact with striatins to form a supramolecular complex called striatin-interacting phosphatase and kinase (STRIPAK) complex. Despite the fact that the STRIPAK complex regulates multiple cellular events, it remains only partially understood how this complex itself is assembled and regulated for differential biological functions. Our recent work revealed the activation mechanism of GCKIIIs by MO25, as well as how GCKIIIs heterodimerize with CCM3, a molecular bridge between GCKIII and striatins. Here we dissect the structural features of the coiled coil domain of striatin 3, a novel type of PP2A regulatory subunit that functions as a scaffold for the assembly of the STRIPAK complex. We have determined the crystal structure of a selenomethionine-labeled striatin 3 coiled coil domain, which shows it to assume a parallel dimeric but asymmetric conformation containing a large bend. This result combined with a number of biophysical analyses provide evidence that the coiled coil domain of striatin 3 and the PP2A A subunit form a stable core complex with a 2:2 stoichiometry. Structure-based mutational studies reveal that homodimerization of striatin 3 is essential for its interaction with PP2A and therefore assembly of the STRIPAK complex. Wild-type striatin 3 but not the mutants defective in PP2A binding strongly suppresses apoptosis of Jurkat cells induced by the GCKIII kinase MST3, most likely through a mechanism in which striatin recruits PP2A to negatively regulate the activation of MST3. Collectively, our work provides structural insights into the organization of the STRIPAK complex and will facilitate further functional studies.	[Chen, Cuicui; Shi, Zhubing; Zhang, Wenqing; Chen, Min; He, Feng; Zhang, Zhenzhen; Wang, Yicui; Feng, Miao; Wang, Wenjia; Zhao, Yun; Jiao, Shi; Zhou, Zhaocai] Chinese Acad Sci, Natl Ctr Prot Sci Shanghai, State Key Lab Cell Biol, Inst Biochem & Cell Biol,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Shi, Zhubing; Zhou, Zhaocai] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Brown, Jerry H.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Waltham, MA 02454 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tongji University; Brandeis University	Jiao, S (corresponding author), Chinese Acad Sci, Natl Ctr Prot Sci Shanghai, State Key Lab Cell Biol, Inst Biochem & Cell Biol,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.	jiaoshi@sibcb.ac.cn; zczhou@sibcb.ac.cn	Shi, Zhubing/F-9490-2010; zhang, wenqing/GYA-0786-2022	Shi, Zhubing/0000-0002-9624-4960; He, Feng/0000-0002-6286-8134	973 program of the Ministry of Science and Technology of China [2010CB529701, 2012CB910204]; National Natural Science Foundation of China [31270808, 31300734]; Science and Technology Commission of Shanghai Municipality [11JC14140000, 13ZR1446400]; "Cross and cooperation in science and technology innovation team" project of the Chinese Academy of Sciences	973 program of the Ministry of Science and Technology of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); "Cross and cooperation in science and technology innovation team" project of the Chinese Academy of Sciences	This work was supported by grants from the 973 program of the Ministry of Science and Technology of China (2010CB529701 and 2012CB910204), the National Natural Science Foundation of China (31270808 and 31300734), the Science and Technology Commission of Shanghai Municipality (11JC14140000 and 13ZR1446400), and the "Cross and cooperation in science and technology innovation team" project of the Chinese Academy of Sciences.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aurora R, 1998, PROTEIN SCI, V7, P21, DOI 10.1002/pro.5560070103; Bailly Y. J., 2007, CEREBELLUM, P1; Bartoli M, 1999, J NEUROBIOL, V40, P234, DOI 10.1002/(SICI)1097-4695(199908)40:2<234::AID-NEU9>3.3.CO;2-K; Bartoli M, 1998, J BIOL CHEM, V273, P22248, DOI 10.1074/jbc.273.35.22248; Benoist M, 2006, J PHYSIOL-PARIS, V99, P146, DOI 10.1016/j.jphysparis.2005.12.006; Breitman M, 2008, BBA-MOL CELL RES, V1783, P1792, DOI 10.1016/j.bbamcr.2008.04.017; Brown JH, 2010, PROTEIN SCI, V19, P1366, DOI 10.1002/pro.415; Brown JH, 2006, PROTEIN SCI, V15, P1, DOI 10.1110/ps.051658406; Castermans D, 2012, CELL RES, V22, P1058, DOI 10.1038/cr.2012.20; Castets F, 2000, J BIOL CHEM, V275, P19970, DOI 10.1074/jbc.M909782199; Castets F, 1996, J CELL BIOL, V134, P1051, DOI 10.1083/jcb.134.4.1051; Chen YK, 2012, MOL BIOL CELL, V23, P4383, DOI 10.1091/mbc.E12-05-0365; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feng X, 2001, J BIOL CHEM, V276, P8341, DOI 10.1074/jbc.M007116200; Gaillard S, 2006, TRAFFIC, V7, P74, DOI 10.1111/j.1600-0854.2005.00363.x; Gaillard S, 2001, FEBS LETT, V508, P49, DOI 10.1016/S0014-5793(01)03020-4; Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75; Gordon J, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-54; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Huang CYF, 2002, J BIOL CHEM, V277, P34367, DOI 10.1074/jbc.M202468200; Hyodo T, 2012, J BIOL CHEM, V287, P25019, DOI 10.1074/jbc.M112.372342; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kean MJ, 2011, J BIOL CHEM, V286, P25065, DOI 10.1074/jbc.M110.214486; LANDBERG G, 1994, EXP CELL RES, V212, P255, DOI 10.1006/excr.1994.1141; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; Li HY, 2004, AM J PHYSIOL-RENAL, V286, pF711, DOI 10.1152/ajprenal.00308.2003; Lin CY, 2010, INT J BIOCHEM CELL B, V42, P98, DOI 10.1016/j.biocel.2009.09.012; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moens SJB, 2012, CIRCULATION, V126, P1993, DOI 10.1161/CIRCULATIONAHA.112.124529; Moqrich A, 1998, GENOMICS, V51, P136, DOI 10.1006/geno.1998.5342; Moreno CS, 2000, J BIOL CHEM, V275, P5257, DOI 10.1074/jbc.275.8.5257; Moreno CS, 2001, J BIOL CHEM, V276, P24253, DOI 10.1074/jbc.M102398200; MURO Y, 1995, BIOCHEM BIOPH RES CO, V207, P1029, DOI 10.1006/bbrc.1995.1288; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrotti D, 2013, LANCET ONCOL, V14, pE229, DOI 10.1016/S1470-2045(12)70558-2; Qing L, 2004, P NATL ACAD SCI USA, V101, P17126, DOI 10.1073/pnas.0407492101; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Salin P, 1998, J COMP NEUROL, V397, P41; Sengupta P, 2008, J CELL SCI, V121, P1363, DOI 10.1242/jcs.020081; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shi ZB, 2013, STRUCTURE, V21, P449, DOI 10.1016/j.str.2013.01.007; Sontag E, 2001, CELL SIGNAL, V13, P7, DOI 10.1016/S0898-6568(00)00123-6; Sugden PH, 2013, BIOCHEM J, V454, P13, DOI 10.1042/BJ20130219; Tan BL, 2008, J MOL ENDOCRINOL, V40, P199, DOI 10.1677/JME-07-0132; ten Klooster JP, 2009, DEV CELL, V16, P551, DOI 10.1016/j.devcel.2009.01.016; Wlodarchak N, 2013, CELL RES, V23, P931, DOI 10.1038/cr.2013.77; Wu HY, 2008, APOPTOSIS, V13, P283, DOI 10.1007/s10495-007-0161-x; Xu YH, 2008, MOL CELL, V31, P873, DOI 10.1016/j.molcel.2008.08.006; Xu Z, 2009, MOL CELL, V35, P426, DOI 10.1016/j.molcel.2009.06.031; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zhang HY, 2012, FRONT BIOSCI-LANDMRK, V17, P2295, DOI 10.2741/4053; Zhang M, 2013, STRUCTURE, V21, P680, DOI 10.1016/j.str.2013.02.015	54	32	33	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9651	9661		10.1074/jbc.M113.529297	http://dx.doi.org/10.1074/jbc.M113.529297			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24550388	hybrid, Green Published			2022-12-28	WOS:000333807000019
J	Guzman, C; Solman, M; Ligabue, A; Blazevits, O; Andrade, DM; Reymond, L; Eggeling, C; Abankwa, D				Guzman, Camilo; Solman, Maja; Ligabue, Alessio; Blazevits, Olga; Andrade, Debora M.; Reymond, Luc; Eggeling, Christian; Abankwa, Daniel			The Efficacy of Raf Kinase Recruitment to the GTPase H-ras Depends on H-ras Membrane Conformer-specific Nanoclustering*.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Fluorescence Correlation Spectroscopy; Fluorescence Resonance Energy Transfer (FRET); Ras; Signaling; Fluorescence Recovery after Photobleaching (FRAP); Fluorescence-lifetime Microscopy Imaging (FLIM); Stimulated Emission Depletion (STED); Membrane; Nanocluster	PLASMA-MEMBRANE; SINGLE-MOLECULE; K-RAS; ESCHERICHIA-COLI; PROTEIN; BINDING; ORGANIZATION; ORIENTATION; GALECTIN-1; DYNAMICS	Background: Ras nanoclusters contain 6-8 Ras proteins on the plasma membrane and serve as indispensable signaling platforms for Ras-MAPK signaling. Results: Ras membrane conformer mutants impart specific galectin-1-dependent nanoclustering responses. Conclusion: Mutations in Ras can affect its nanoclustering response and thus allosterically effector recruitment and downstream signaling. Significance: Disease-associated mutations that perturb Ras membrane conformers may alter signaling through nanoclustering. Solution structures and biochemical data have provided a wealth of mechanistic insight into Ras GTPases. However, information on how much the membrane organization of these lipid-modified proteins impacts on their signaling is still scarce. Ras proteins are organized into membrane nanoclusters, which are necessary for Ras-MAPK signaling. Using quantitative conventional and super-resolution fluorescence methods, as well as mathematical modeling, we investigated nanoclustering of H-ras helix 4 and hypervariable region mutants that have different bona fide conformations on the membrane. By following the emergence of conformer-specific nanoclusters in the plasma membrane of mammalian cells, we found that conformers impart distinct nanoclustering responses depending on the cytoplasmic levels of the nanocluster scaffold galectin-1. Computational modeling revealed that complexes containing H-ras conformers and galectin-1 affect both the number and lifetime of nanoclusters and thus determine the specific Raf effector recruitment. Our results show that mutations in Ras can affect its nanoclustering response and thus allosterically effector recruitment and downstream signaling. We postulate that cancer- and developmental disease-linked mutations that are associated with the Ras membrane conformation may exhibit so far unrecognized Ras nanoclustering and therefore signaling alterations.	[Guzman, Camilo; Solman, Maja; Ligabue, Alessio; Blazevits, Olga; Abankwa, Daniel] Abo Akad Univ, Turku Ctr Biotechnol, FIN-20520 Turku, Finland; [Andrade, Debora M.; Eggeling, Christian] Max Planck Inst Biophys Chem, Dept Nanobiophoton, D-37077 Gottingen, Germany; [Reymond, Luc] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland; [Eggeling, Christian] Univ Oxford, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England	Abo Akademi University; Max Planck Society; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Oxford	Abankwa, D (corresponding author), Abo Akad Univ, Turku Ctr Biotechnol, Tykistokatu 6B, FIN-20520 Turku, Finland.	daniel.abankwa@btk.fi		REYMOND, Luc/0000-0001-5282-9273; Abankwa, Daniel/0000-0003-2769-0745	Academy of Finland; Sigrid Juselius Foundation; Cancer Society of Finland; Marie-Curie Reintegration Grant; Medical Research Council [MR/K01577X/1, MC_UU_12010/9] Funding Source: researchfish; Cancer Foundation Finland sr [130067, 110051] Funding Source: researchfish; MRC [MC_UU_12010/9, MR/K01577X/1] Funding Source: UKRI	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Society of Finland; Marie-Curie Reintegration Grant(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Cancer Foundation Finland sr; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by an Academy of Finland fellowship grant, the Sigrid Juselius Foundation, the Cancer Society of Finland, and a Marie-Curie Reintegration Grant (to D. A.).	Abankwa D, 2007, SEMIN CELL DEV BIOL, V18, P599, DOI 10.1016/j.semcdb.2007.08.003; Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Abankwa D, 2007, J CELL SCI, V120, P2953, DOI 10.1242/jcs.001404; Abankwa D, 2010, P NATL ACAD SCI USA, V107, P1130, DOI 10.1073/pnas.0903907107; Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Amor JC, 2001, J BIOL CHEM, V276, P42477, DOI 10.1074/jbc.M106660200; Belanis L, 2008, MOL BIOL CELL, V19, P1404, DOI 10.1091/mbc.E07-10-1053; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Billaudeau C, 2013, METHOD ENZYMOL, V519, P277, DOI 10.1016/B978-0-12-405539-1.00010-5; Cho KJ, 2012, CURR BIOL, V22, P945, DOI 10.1016/j.cub.2012.03.067; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Gorfe AA, 2007, J MED CHEM, V50, P674, DOI 10.1021/jm061053f; Grant BJ, 2010, BIOPHYS J, V99, pL87, DOI 10.1016/j.bpj.2010.10.020; Grant BJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000325; Grunberg R, 2013, NAT METHODS, V10, P1021, DOI [10.1038/nmeth.2625, 10.1038/NMETH.2625]; Guldenhaupt J, 2012, BIOPHYS J, V103, P1585, DOI 10.1016/j.bpj.2012.08.043; Gurry T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006148; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; He HT, 2011, ANNU REV PHYS CHEM, V62, P417, DOI 10.1146/annurev-physchem-032210-103402; Hibino K, 2003, CHEMPHYSCHEM, V4, P748, DOI 10.1002/cphc.200300731; Janosi L, 2012, P NATL ACAD SCI USA, V109, P8097, DOI 10.1073/pnas.1200773109; Kapoor S, 2012, EUR BIOPHYS J BIOPHY, V41, P801, DOI 10.1007/s00249-012-0841-5; Kapoor S, 2012, P NATL ACAD SCI USA, V109, P460, DOI 10.1073/pnas.1110553109; Keppler A, 2004, P NATL ACAD SCI USA, V101, P9955, DOI 10.1073/pnas.0401923101; Kiel C, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000245; Kohnke M, 2012, CHEM BIOL, V19, P866, DOI 10.1016/j.chembiol.2012.05.019; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, V3rd, P353; Lee HW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2507; Levy R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027490; Li HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071018; Li ZL, 2012, J AM CHEM SOC, V134, P17278, DOI 10.1021/ja307716z; LiCata VJ, 2008, METHOD CELL BIOL, V84, P243, DOI 10.1016/S009l-679X(07)84009-X; Lommerse PHM, 2005, J CELL SCI, V118, P1799, DOI 10.1242/jcs.02300; Lukinavicius G, 2013, NAT CHEM, V5, P132, DOI [10.1038/NCHEM.1546, 10.1038/nchem.1546]; Majoul I., HDB BIOL CONFOCAL MI, P788, DOI DOI 10.1007/978-0-387-45524-2_45; Mazhab-Jafari MT, 2013, J AM CHEM SOC, V135, P3367, DOI 10.1021/ja312508w; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Mueller V, 2011, BIOPHYS J, V101, P1651, DOI 10.1016/j.bpj.2011.09.006; Murakoshi H, 2004, P NATL ACAD SCI USA, V101, P7317, DOI 10.1073/pnas.0401354101; Najumudeen AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066425; Nguyen UTT, 2009, NAT CHEM BIOL, V5, P227, DOI 10.1038/nchembio.149; Nussinov R, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/4/045004; Paz A, 2001, ONCOGENE, V20, P7486, DOI 10.1038/sj.onc.1204950; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Rocks O, 2006, CURR OPIN CELL BIOL, V18, P351, DOI 10.1016/j.ceb.2006.06.007; Rotblat B, 2004, CANCER RES, V64, P3112, DOI 10.1158/0008-5472.CAN-04-0026; Rotblat B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011991; Shalom-Feuerstein R, 2008, CANCER RES, V68, P6608, DOI 10.1158/0008-5472.CAN-08-1117; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; Tian TH, 2007, NAT CELL BIOL, V9, P905, DOI 10.1038/ncb1615; Tian TH, 2010, BIOPHYS J, V99, P534, DOI 10.1016/j.bpj.2010.04.055; TUCKER J, 1986, EMBO J, V5, P1351, DOI 10.1002/j.1460-2075.1986.tb04366.x; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wong KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045360; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang XD, 2006, J BIOL CHEM, V281, P12655, DOI 10.1074/jbc.M513089200; Zhou Y, 2012, J BIOL CHEM, V287, P16586, DOI 10.1074/jbc.M112.348490; Zhou Z, 2007, ACS CHEM BIOL, V2, P337, DOI 10.1021/cb700054k	64	35	35	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9519	9533		10.1074/jbc.M113.537001	http://dx.doi.org/10.1074/jbc.M113.537001			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24569991	Green Published, hybrid			2022-12-28	WOS:000333807000009
J	Trcka, F; Durech, M; Man, P; Hernychova, L; Muller, P; Vojtesek, B				Trcka, Filip; Durech, Michal; Man, Petr; Hernychova, Lenka; Muller, Petr; Vojtesek, Borivoj			The Assembly and Intermolecular Properties of the Hsp70-Tomm34-Hsp90 Molecular Chaperone Complex*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hsp90; Molecular Chaperone; Protein Assembly; Protein Folding; Protein-Protein Interactions; Co-chaperone; H; D Exchange; Hsp70; TPR Domain	TETRATRICOPEPTIDE REPEAT DOMAIN; MITOCHONDRIAL PROTEIN IMPORT; ORGANIZING PROTEIN; HSP90; BINDING; TPR; HSP70; HOP; COCHAPERONE; SEQUENCES	Background: Hsp70 and Hsp90 molecular chaperones associate with the network of co-chaperone proteins. Results: Tomm34 protein interacts with both Hsp70 and Hsp90 chaperones. Conclusion: Tomm34 scaffolds Hsp70/Hsp90 chaperones by their simultaneous binding. Significance: Tomm34 represents a novel Hsp70/Hsp90 co-chaperone. Maintenance of protein homeostasis by molecular chaperones Hsp70 and Hsp90 requires their spatial and functional coordination. The cooperation of Hsp70 and Hsp90 is influenced by their interaction with the network of co-chaperone proteins, some of which contain tetratricopeptide repeat (TPR) domains. Critical to these interactions are TPR domains that target co-chaperone binding to the EEVD-COOH motif that terminates Hsp70/Hsp90. Recently, the two-TPR domain-containing protein, Tomm34, was reported to bind both Hsp70 and Hsp90. Here we characterize the structural basis of Tomm34-Hsp70/Hsp90 interactions. Using multiple methods, including pull-down assays, fluorescence polarization, hydrogen/deuterium exchange, and site-directed mutagenesis, we defined the binding activities and specificities of Tomm34 TPR domains toward Hsp70 and Hsp90. We found that Tomm34 TPR1 domain specifically binds Hsp70. This interaction is partly mediated by a non-canonical TPR1 two-carboxylate clamp and is strengthened by so far unidentified additional intermolecular contacts. The two-carboxylate clamp of the isolated TPR2 domain has affinity for both chaperones, but as part of the full-length Tomm34 protein, the TPR2 domain binds specifically Hsp90. These binding properties of Tomm34 TPR domains thus enable simultaneous binding of Hsp70 and Hsp90. Importantly, we provide evidence for the existence of an Hsp70-Tomm34-Hsp90 tripartite complex. In addition, we defined the basic conformational demands of the Tomm34-Hsp90 interaction. These results suggest that Tomm34 represents a novel scaffolding co-chaperone of Hsp70 and Hsp90, which may facilitate Hsp70/Hsp90 cooperation during protein folding.	[Trcka, Filip; Durech, Michal; Hernychova, Lenka; Muller, Petr; Vojtesek, Borivoj] Masaryk Mem Canc Inst, Reg Ctr Appl Mol Oncol, Brno 65653, Czech Republic; [Man, Petr] Acad Sci Czech Republic, Inst Microbiol, Vvi, Prague 14220, Czech Republic; [Man, Petr] Charles Univ Prague, Fac Sci, Dept Biochem, Prague 12843, Czech Republic	Masaryk Memorial Cancer Institute; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague	Muller, P (corresponding author), Masaryk Mem Canc Inst, Reg Ctr Appl Mol Oncol, Zluty Kopec 7, Brno 65653, Czech Republic.	muller@mou.cz; vojtesek@mou.cz	Muller, Petr/AAK-5014-2021; Muller, Petr/F-7762-2015; Man, Petr/H-2451-2014; Hernychova, Lenka/J-6714-2014	Muller, Petr/0000-0002-8404-4494; Muller, Petr/0000-0002-8404-4494; Man, Petr/0000-0002-1485-2197; Hernychova, Lenka/0000-0002-4352-0626; Durech, Michal/0000-0002-4054-4315; Trcka, Filip/0000-0001-6307-8129	Czech Science Foundation [P301/11/1678]; European Regional Development Fund; State Budget of the Czech Republic (Regional Center for Applied Molecular Oncology) [CZ.1.05/2.1.00/03.0101]; Ministr of Health, Czech Republic, conceptual development of research organization Masaryk Memorial Cancer Institute [00209805]	Czech Science Foundation(Grant Agency of the Czech Republic); European Regional Development Fund(European Commission); State Budget of the Czech Republic (Regional Center for Applied Molecular Oncology); Ministr of Health, Czech Republic, conceptual development of research organization Masaryk Memorial Cancer Institute	This work was supported by Czech Science Foundation Grant P301/11/1678, by the European Regional Development Fund and the State Budget of the Czech Republic (Regional Center for Applied Molecular Oncology), CZ.1.05/2.1.00/03.0101), and by the Ministr of Health, Czech Republic, conceptual development of research organization Masaryk Memorial Cancer Institute Grant, 00209805.	Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; Aprile FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067961; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Carrigan PE, 2006, PROTEIN SCI, V15, P522, DOI 10.1110/ps.051810106; Carrigan PE, 2004, J BIOL CHEM, V279, P16185, DOI 10.1074/jbc.M314130200; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Cheung-Flynn J, 2003, J BIOL CHEM, V278, P17388, DOI 10.1074/jbc.M300955200; Chewawiwat N, 1999, J BIOCHEM, V125, P721, DOI 10.1093/oxfordjournals.jbchem.a022342; Cliff MJ, 2006, STRUCTURE, V14, P415, DOI 10.1016/j.str.2005.12.009; Faou P, 2012, BBA-MOL CELL RES, V1823, P348, DOI 10.1016/j.bbamcr.2011.12.001; Glover D. M., 1986, DNA CLONING PRACTICA, VI, II, P1985; Hernandez MP, 2002, J BIOL CHEM, V277, P38294, DOI 10.1074/jbc.M206566200; Jimenez B, 2012, J BIOL CHEM, V287, P5698, DOI 10.1074/jbc.M111.287458; Kajander T, 2009, J BIOL CHEM, V284, P25364, DOI 10.1074/jbc.M109.033894; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Kavan D, 2011, INT J MASS SPECTROM, V302, P53, DOI 10.1016/j.ijms.2010.07.030; Koulov AV, 2010, MOL BIOL CELL, V21, P871, DOI 10.1091/mbc.E09-12-1017; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Lee CT, 2012, EMBO J, V31, P1518, DOI 10.1038/emboj.2012.37; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nuttall SD, 1997, DNA CELL BIOL, V16, P1067, DOI 10.1089/dna.1997.16.1067; Odunuga OO, 2003, J BIOL CHEM, V278, P6896, DOI 10.1074/jbc.M206867200; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Rezabkova L, 2011, J BIOL CHEM, V286, P43527, DOI 10.1074/jbc.M111.273573; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Sullivan WP, 2002, J BIOL CHEM, V277, P45942, DOI 10.1074/jbc.M207754200; Sun L, 2012, BBA-MOL CELL RES, V1823, P1092, DOI 10.1016/j.bbamcr.2012.03.014; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Tsaytler PA, 2009, CELL STRESS CHAPERON, V14, P629, DOI 10.1007/s12192-009-0115-z; Ward BK, 2002, J BIOL CHEM, V277, P40799, DOI 10.1074/jbc.M207097200; Wayne N, 2007, J BIOL CHEM, V282, P35386, DOI 10.1074/jbc.M703844200; Young JC, 1998, J BIOL CHEM, V273, P18007, DOI 10.1074/jbc.273.29.18007	37	35	35	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9887	9901		10.1074/jbc.M113.526046	http://dx.doi.org/10.1074/jbc.M113.526046			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24567332	Green Published, hybrid			2022-12-28	WOS:000333807000038
J	Kichev, A; Rousset, CI; Baburamani, AA; Levison, SW; Wood, TL; Gressens, P; Thornton, C; Hagberg, H				Kichev, Anton; Rousset, Catherine I.; Baburamani, Ana A.; Levison, Steven W.; Wood, Teresa L.; Gressens, Pierre; Thornton, Claire; Hagberg, Henrik			Tumor Necrosis Factor-related Apoptosis-inducing Ligand ( TRAIL) Signaling and Cell Death in the Immature Central Nervous System after Hypoxia-Ischemia and Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Death; Hypoxia; Neuroinflammation; Neurons; Oligodendrocytes; Trail; Immature CNS	MULTIPLE-SCLEROSIS; BRAIN-DAMAGE; RECEPTOR; INJURY; ENCEPHALOPATHY; INFECTION; CONTAINS; FAMILY; MOUSE; TNF	Background: TRAIL induces apoptosis through interaction with receptor DR5. Results: Animal model of neonatal hypoxia-ischemia (HI) and primary cultures subjected to oxygen glucose deprivation show increased expression of TRAIL and DR5; TRAIL is toxic for primary neurons. Conclusion: TRAIL-mediated cell death contributes to brain injury after HI. Significance: TRAIL signaling pathways may represent a valid drug target for protection against neonatal HI. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a member of the TNF family. The interaction of TRAIL with death receptor 4 (DR4) and DR5 can trigger apoptotic cell death. The aim of this study was to investigate the role of TRAIL signaling in neonatal hypoxia-ischemia (HI). Using a neonatal mouse model of HI, mRNA, and protein expression of TRAIL, DR5 and the TRAIL decoy receptors osteoprotegerin (OPG), mDcTRAILR1, and mDcTRAILR2 were determined. In vitro, mRNA expression of these genes was measured in primary neurons and oligodendrocyte progenitor cells (OPCs) after inflammatory cytokine (TNF-/IFN-) treatment and/or oxygen and glucose deprivation (OGD). The toxicity of these various paradigms was also measured. The expression of TRAIL, DR5, OPG, and mDcTRAILR2 was significantly increased after HI. In vitro, inflammatory cytokines and OGD treatment significantly induced mRNAs for TRAIL, DR5, OPG, and mDcTRAILR2 in primary neurons and of TRAIL and OPG in OPCs. TRAIL protein was expressed primarily in microglia and astroglia, whereas DR5 co-localized with neurons and OPCs in vivo. OGD enhanced TNF-/IFN- toxicity in both neuronal and OPC cultures. Recombinant TRAIL exerted toxicity alone or in combination with OGD and TNF-/IFN- in primary neurons but not in OPC cultures. The marked increases in the expression of TRAIL and its receptors after cytokine exposure and OGD in primary neurons and OPCs were similar to those found in our animal model of neonatal HI. The toxicity of TRAIL in primary neurons suggests that TRAIL signaling participates in neonatal brain injury after inflammation and HI.	[Kichev, Anton; Rousset, Catherine I.; Gressens, Pierre; Thornton, Claire; Hagberg, Henrik] Kings Coll London, Perinatal Brain Injury Grp, Ctr Developing Brain, London SE1 7EH, England; [Baburamani, Ana A.; Hagberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Perinatal Ctr, Inst Clin Sci, S-40530 Gothenburg, Sweden; [Baburamani, Ana A.; Hagberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Perinatal Ctr, Inst Neurosci, S-40530 Gothenburg, Sweden; [Baburamani, Ana A.; Hagberg, Henrik] Univ Gothenburg, Sahlgrenska Acad, Perinatal Ctr, Inst Physiol, S-40530 Gothenburg, Sweden; [Levison, Steven W.; Wood, Teresa L.] Rutgers State Univ, New Jersey Med Sch, Dept Neurol & Neurosci, Newark, NJ 07103 USA; [Gressens, Pierre] INSERM, U676, F-75019 Paris, France	University of London; King's College London; University of Gothenburg; University of Gothenburg; University of Gothenburg; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Institut National de la Sante et de la Recherche Medicale (Inserm)	Kichev, A (corresponding author), Kings Coll London, Perinatal Brain Injury Grp, Ctr Developing Brain, St Thomas Hosp, 1st Fl South Wing, London SE1 7EH, England.	anton.kichev@kcl.ac.uk	Levison, Steven W./Q-6903-2019; Thornton, Claire/AAF-7481-2019; Baburamani, Ana/AGD-2259-2022; gressens, pierre/M-7557-2017; Baburamani, Ana/J-4920-2019	Levison, Steven W./0000-0002-1264-7309; Thornton, Claire/0000-0001-7676-3272; Baburamani, Ana/0000-0002-7537-6534; gressens, pierre/0000-0002-0909-4221; Wood, Teresa/0000-0002-4480-660X; Hagberg, Henrik/0000-0003-3962-1448	Medical Research Council (United Kingdom) [P19381]; Medical Research Council (Sweden) [2012-2642]; ALF-LUA Grant [ALFGBG2863]; Leducq Foundation; Wellcome Trust [WT094823MA]; Action Medical Research sp4506 Henry Smith Charity; National Multiple Sclerosis Society [RG4015]; Wilhelm and Martina Lundgren Foundation; Action Medical Research [1764] Funding Source: researchfish	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council (Sweden)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ALF-LUA Grant; Leducq Foundation(Leducq Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Action Medical Research sp4506 Henry Smith Charity; National Multiple Sclerosis Society(National Multiple Sclerosis Society); Wilhelm and Martina Lundgren Foundation; Action Medical Research	This work was supported by a Medical Research Council Strategic Award P19381 (United Kingdom), Medical Research Council Grant 2012-2642 (Sweden; to H. H.), ALF-LUA Grant ALFGBG2863, the Leducq Foundation, Wellcome Trust Programme Grant WT094823MA, Action Medical Research sp4506 Henry Smith Charity and National Multiple Sclerosis Society Grant RG4015, and the Wilhelm and Martina Lundgren Foundation.	Andrews T, 1998, J NEUROSCI RES, V54, P574, DOI 10.1002/(SICI)1097-4547(19981201)54:5<574::AID-JNR2>3.3.CO;2-S; Bona E, 1999, PEDIATR RES, V45, P500, DOI 10.1203/00006450-199904010-00008; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Cannella B, 2007, J NEUROIMMUNOL, V188, P128, DOI 10.1016/j.jneuroim.2007.05.018; Clarke P, 2014, J VIROL, V88, P1080, DOI 10.1128/JVI.02944-13; Cui M, 2010, NEUROBIOL DIS, V39, P138, DOI 10.1016/j.nbd.2010.03.018; Dammann O, 1997, PEDIATR RES, V42, P1, DOI 10.1203/00006450-199707000-00001; Eklind S, 2001, EUR J NEUROSCI, V13, P1101, DOI 10.1046/j.0953-816x.2001.01474.x; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Fatemi A, 2009, CLIN PERINATOL, V36, P835, DOI 10.1016/j.clp.2009.07.011; Favrais G, 2011, ANN NEUROL, V70, P550, DOI 10.1002/ana.22489; Felderhoff-Mueser U, 2000, BRAIN PATHOL, V10, P17; Graham EM, 2004, NEUROBIOL DIS, V17, P89, DOI 10.1016/j.nbd.2004.05.007; Hagberg H, 2005, CURR OPIN NEUROL, V18, P117, DOI 10.1097/01.wco.0000162851.44897.8f; Hagberg H, 2012, ANN NEUROL, V71, P444, DOI 10.1002/ana.22620; Hedtjarn M, 2002, J NEUROSCI, V22, P5910; Hoffmann O, 2009, J MOL MED, V87, P753, DOI 10.1007/s00109-009-0484-x; Huang ZH, 2011, DEV NEUROSCI-BASEL, V33, P519, DOI 10.1159/000334475; Kendall GS, 2011, LAB INVEST, V91, P328, DOI 10.1038/labinvest.2010.192; Krajewska M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024341; LEVISON SW, 1991, J NEUROCHEM, V57, P782, DOI 10.1111/j.1471-4159.1991.tb08220.x; Markus T, 2009, J CEREBR BLOOD F MET, V29, P73, DOI 10.1038/jcbfm.2008.90; Marsters SA, 1997, CURR BIOL, V7, P1003, DOI 10.1016/S0960-9822(06)00422-2; Mc Guire C, 2011, TRENDS NEUROSCI, V34, P619, DOI 10.1016/j.tins.2011.09.002; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Schneider P, 2003, J BIOL CHEM, V278, P5444, DOI 10.1074/jbc.M210783200; Sheldon RA, 1998, BRAIN RES, V810, P114, DOI 10.1016/S0006-8993(98)00892-0; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Taylor DL, 2005, J NEUROSCI, V25, P2952, DOI 10.1523/JNEUROSCI.4456-04.2005; Thornton C, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/506320; Thornton C, 2011, BIOCHEM J, V434, P503, DOI 10.1042/BJ20101485; Volpe JJ, 2011, ANN NEUROL, V70, P525, DOI 10.1002/ana.22533; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wang XY, 2007, J NEUROPATH EXP NEUR, V66, P552, DOI 10.1097/01.jnen.0000263870.91811.6f; Wosik K, 2003, J NEUROCHEM, V85, P635, DOI 10.1046/j.1471-4159.2003.01674.x; Wu GS, 1999, CANCER RES, V59, P2770; Yepes M, 2005, AM J PATHOL, V166, P511, DOI 10.1016/S0002-9440(10)62273-0	40	64	71	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9430	9439		10.1074/jbc.M113.512350	http://dx.doi.org/10.1074/jbc.M113.512350			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24509861	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000333472100058
J	Radu, RA; Hu, J; Jiang, ZC; Bok, D				Radu, Roxana A.; Hu, Jane; Jiang, Zhichun; Bok, Dean			Bisretinoid-mediated Complement Activation on Retinal Pigment Epithelial Cells Is Dependent on Complement Factor H Haplotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Complement System; Epithelium; Inflammation; Retinal Degeneration; Retinoid; Age-related Macular Degeneration (AMD); Bisretinoids; Complement Factor H (CFH); Recessive Stargardt Macular Degeneration (STGD1); Retinal Pigment Epithelium	MANNOSE-BINDING LECTIN; HUMAN RPE CELLS; MACULAR DEGENERATION; REGULATORY PROTEINS; LIPOFUSCIN FLUOROPHORE; STARGARDT DISEASE; OXIDATIVE STRESS; MOUSE MODEL; RISK; A2E	Background: AMD and STGD1 are blinding diseases with similar clinical presentations but unrelated genetic causes. Results: Bisretinoid-dependent complement reactivity on RPE cells involves the alternative pathway and depends on the CFH haplotype. Conclusion: Inefficient CFH synthesis because of either Y402H and I62V substitutions or bisretinoid accumulation predisposes RPE cells to disease. Significance: These results suggest a common inflammatory etiology for AMD and STGD1. Age-related macular degeneration (AMD) is a common central blinding disease of the elderly. Homozygosity for a sequence variant causing Y402H and I62V substitutions in the gene for complement factor H (CFH) is strongly associated with risk of AMD. CFH, secreted by many cell types, including those of the retinal pigment epithelium (RPE), is a regulatory protein that inhibits complement activation. Recessive Stargardt maculopathy is another central blinding disease caused by mutations in the gene for ABCA4, a transporter in photoreceptor outer segments (OS) that clears retinaldehyde and prevents formation of toxic bisretinoids. Photoreceptors daily shed their distal OS, which are phagocytosed by the RPE cells. Here, we investigated the relationship between the CFH haplotype of human RPE (hRPE) cells, exposure to OS containing bisretinoids, and complement activation. We show that hRPE cells of the AMD-predisposing CFH haplotype (HH402/VV62) are attacked by complement following exposure to bisretinoid-containing Abca4(-/-) OS. This activation was dependent on factor B, indicating involvement of the alternative pathway. In contrast, hRPE cells of the AMD-protective CFH haplotype (YY402/II62) showed no complement activation following exposure to either Abca4(-/-) or wild-type OS. The AMD-protective YY402/II62 hRPE cells were more resistant to the membrane attack complex, whereas HH402/VV62 hRPE cells showed significant membrane attack complex deposition following ingestion of Abca4(-/-) OS. These results suggest that bisretinoid accumulation in hRPE cells stimulates activation and dysregulation of complement. Cells with an intact complement negative regulatory system are protected from complement attack, whereas cells with reduced CFH synthesis because of the Y402H and I62V substitutions are vulnerable to disease.	[Radu, Roxana A.; Hu, Jane; Jiang, Zhichun; Bok, Dean] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Bok, Dean] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Bok, Dean] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Radu, RA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Dept Ophthalmol, 100 Stein Plaza, Los Angeles, CA 90095 USA.	radu@jsei.ucla.edu	Radu, Roxana A./K-8924-2019	Radu, Roxana/0000-0002-5064-6403	Stein/Oppenheimer Endowment Award grant; National Eye Institute/Jules Stein Eye Institute [EY000331]; Macula Vision Research Foundation [20081840]; Arnold and Mabel Beckman Initiative for Macular Degeneration Award [1102]; NATIONAL EYE INSTITUTE [P30EY000331] Funding Source: NIH RePORTER	Stein/Oppenheimer Endowment Award grant; National Eye Institute/Jules Stein Eye Institute; Macula Vision Research Foundation; Arnold and Mabel Beckman Initiative for Macular Degeneration Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a Stein/Oppenheimer Endowment Award grant (to R. A. R.), by National Eye Institute/Jules Stein Eye Institute Core Grant EY000331 (to R. A. R. and D. B.), by Macula Vision Research Foundation Award 20081840 (to D. B.), and by Arnold and Mabel Beckman Initiative for Macular Degeneration Award 1102 (to D. B.).	Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Berchuck JE, 2013, INVEST OPHTH VIS SCI, V54, P2669, DOI 10.1167/iovs.12-11020; Bradley DT, 2011, EYE, V25, P683, DOI 10.1038/eye.2011.37; De S, 2002, J GEN PHYSIOL, V120, P147, DOI 10.1085/jgp.20028566; Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Endo Y, 2011, INT J BIOCHEM CELL B, V43, P705, DOI 10.1016/j.biocel.2011.02.003; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Fritsche LG, 2012, INVEST OPHTH VIS SCI, V53, P2112, DOI 10.1167/iovs.11-8785; Fritsche LG, 2010, HUM MOL GENET, V19, P4694, DOI 10.1093/hmg/ddq399; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hu J, 2001, MOL VIS, V7, P14; Hu J., 2013, EXP EYE RES, DOI 10.1016/j.exer.2013.09.009; Hu J, 2010, METHODS MOL BIOL, V652, P55, DOI 10.1007/978-1-60327-325-1_2; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Johnson LV, 2011, P NATL ACAD SCI USA, V108, P18277, DOI 10.1073/pnas.1109703108; Johnson PT, 2006, P NATL ACAD SCI USA, V103, P17456, DOI 10.1073/pnas.0606234103; Joseph K, 2013, J BIOL CHEM, V288, P12753, DOI 10.1074/jbc.M112.421891; Kjaer TR, 2013, MOL IMMUNOL, V56, P413, DOI 10.1016/j.molimm.2013.05.007; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Liu JH, 2000, J BIOL CHEM, V275, P29354, DOI 10.1074/jbc.M910191199; Lueck K, 2011, EYE, V25, P1074, DOI 10.1038/eye.2011.109; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; Quazi F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1927; Radu RA, 2008, INVEST OPHTH VIS SCI, V49, P3821, DOI 10.1167/iovs.07-1470; Radu RA, 2011, J BIOL CHEM, V286, P18593, DOI 10.1074/jbc.M110.191866; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Rein DB, 2009, ARCH OPHTHALMOL-CHIC, V127, P533, DOI 10.1001/archophthalmol.2009.58; Schutt F, 2000, INVEST OPHTH VIS SCI, V41, P2303; Sohn JH, 2000, INVEST OPHTH VIS SCI, V41, P3492; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Sparrow JR, 2003, INVEST OPHTH VIS SCI, V44, P2245, DOI 10.1167/iovs.02-0746; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Turner MW, 2003, MOL IMMUNOL, V40, P423, DOI 10.1016/S0161-5890(03)00155-X; Turner MW, 1998, IMMUNOBIOLOGY, V199, P327, DOI 10.1016/S0171-2985(98)80037-5; Weismann D, 2011, NATURE, V478, P76, DOI 10.1038/nature10449; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wu Y, 2009, J BIOL CHEM, V284, P20155, DOI 10.1074/jbc.M109.021345; Yang P, 2009, INVEST OPHTH VIS SCI, V50, P3473, DOI 10.1167/iovs.08-3202; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103; Zhou J, 2009, INVEST OPHTH VIS SCI, V50, P1392, DOI 10.1167/iovs.08-2868	49	35	35	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9113	9120		10.1074/jbc.M114.548669	http://dx.doi.org/10.1074/jbc.M114.548669			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24550392	Green Published, hybrid			2022-12-28	WOS:000333472100031
J	Gelinas, AD; Davies, DR; Edwards, TE; Rohloff, JC; Carter, JD; Zhang, C; Gupta, S; Ishikawa, Y; Hirota, M; Nakaishi, Y; Jarvis, TC; Janjic, N				Gelinas, Amy D.; Davies, Douglas R.; Edwards, Thomas E.; Rohloff, John C.; Carter, Jeffrey D.; Zhang, Chi; Gupta, Shashi; Ishikawa, Yuichi; Hirota, Masao; Nakaishi, Yuichiro; Jarvis, Thale C.; Janjic, Nebojsa			Crystal Structure of Interleukin-6 in Complex with a Modified Nucleic Acid Ligand	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aptamers; DNA Structure; Drug Discovery; Interleukin; Molecular Evolution; Nucleic Acid Chemistry; Protein-Nucleic Acid Interaction; G-quartet; SELEX	SIGNAL TRANSDUCER; HIGH-AFFINITY; DNA APTAMER; RECEPTOR; BINDING; IL-6; ASSOCIATION; EXPRESSION; RNA	Background: Traditional aptamers favor polar interactions with protein binding partners. Results: The IL-6SOMAmer structure reveals an interface rich in hydrophobic interactions that overlap the binding sites of IL-6 receptors. Conclusion: Hydrophobic modifications on DNA scaffolds generate diverse and novel structural motifs. Significance: Synthetic SOMAmers are potent, specific, and chemically versatile ligands with distinct binding properties compared with conventional aptamers. IL-6 is a secreted cytokine that functions through binding two cell surface receptors, IL-6R and gp130. Because of its involvement in the progression of several chronic inflammatory diseases, IL-6 is a target of pharmacologic interest. We have recently identified a novel class of ligands called SOMAmers (S low Off-rate Modified Aptamers) that bind IL-6 and inhibit its biologic activity. SOMAmers exploit the chemical diversity of protein-like side chains assembled on flexible nucleic acid scaffolds, resulting in an expanded repertoire of intra- and intermolecular interactions not achievable with conventional aptamers. Here, we report the co-crystal structure of a high affinity SOMAmer (K-d = 0.20 nm) modified at the 5-position of deoxyuridine in a complex with IL-6. The SOMAmer, comprised of a G-quartet domain and a stem-loop domain, engages IL-6 in a clamp-like manner over an extended surface exhibiting close shape complementarity with the protein. The interface is characterized by substantial hydrophobic interactions overlapping the binding surfaces of the IL-6R and gp130 receptors. The G-quartet domain retains considerable binding activity as a disconnected autonomous fragment (K-d = 270 nm). A single substitution from our diversely modified nucleotide library leads to a 37-fold enhancement in binding affinity of the G-quartet fragment (K-d = 7.4 nm). The ability to probe ligand surfaces in this manner is a powerful tool in the development of new therapeutic reagents with improved pharmacologic properties. The SOMAmerIL-6 structure also expands our understanding of the diverse structural motifs achievable with modified nucleic acid libraries and elucidates the nature with which these unique ligands interact with their protein targets.	[Gelinas, Amy D.; Rohloff, John C.; Carter, Jeffrey D.; Zhang, Chi; Gupta, Shashi; Jarvis, Thale C.; Janjic, Nebojsa] SomaLog Inc, Boulder, CO 80301 USA; [Davies, Douglas R.; Edwards, Thomas E.] Emerald Bio, Bainbridge Isl, WA 98110 USA; [Ishikawa, Yuichi; Hirota, Masao; Nakaishi, Yuichiro] Otsuka Pharmaceut Co Ltd, Kawaguchi, Tokushima 7710192, Japan	Otsuka Pharmaceutical	Janjic, N (corresponding author), SomaLog Inc, 2945 Wilderness Pl, Boulder, CO 80301 USA.	njanjic@somalogic.com		Edwards, Thomas/0000-0002-0474-8003				Ataie-Kachoie P, 2013, CYTOKINE GROWTH F R, V24, P163, DOI 10.1016/j.cytogfr.2012.09.001; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEREK C, 1993, IMMUNOL TODAY, V14, P400, DOI 10.1016/0167-5699(93)90143-9; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; BRAKENHOFF JPJ, 1990, J IMMUNOL, V145, P561; BRAKENHOFF JPJ, 1994, J BIOL CHEM, V269, P86; Silva MW, 2007, CHEM-EUR J, V13, P9738, DOI 10.1002/chem.200701255; Davies DR, 2012, P NATL ACAD SCI USA, V109, P19971, DOI 10.1073/pnas.1213933109; DeLano W.L, PYMOL MOL GRAPHICS S; Gao YG, 1997, J AM CHEM SOC, V119, P1496, DOI 10.1021/ja963793r; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Gupta S, 2014, J BIOL CHEM, V289, P8706, DOI 10.1074/jbc.M113.532580; HEINEMANN U, 1992, J BIOL CHEM, V267, P7332; HIBI M, 1990, CELL, V63, P1149, DOI 10.1016/0092-8674(90)90411-7; HIRANO T, 1990, INT J CELL CLONING, V8, P155, DOI 10.1002/stem.5530080714; Huang DB, 2003, P NATL ACAD SCI USA, V100, P9268, DOI 10.1073/pnas.1632011100; Huang RH, 2009, STRUCTURE, V17, P1476, DOI 10.1016/j.str.2009.09.011; IHLE JN, 1994, TRENDS BIOCHEM SCI, V19, P222, DOI 10.1016/0968-0004(94)90026-4; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Jones SA, 2005, J INTERF CYTOK RES, V25, P241, DOI 10.1089/jir.2005.25.241; KISHIMOTO T, 1992, SCIENCE, V258, P593, DOI 10.1126/science.1411569; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; MOTT HR, 1995, CURR OPIN STRUC BIOL, V5, P114, DOI 10.1016/0959-440X(95)80016-T; Nomura Y, 2010, NUCLEIC ACIDS RES, V38, P7822, DOI 10.1093/nar/gkq615; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; SCHULTZE P, 1994, J MOL BIOL, V235, P1532, DOI 10.1006/jmbi.1994.1105; Simpson RJ, 1997, PROTEIN SCI, V6, P929, DOI 10.1002/pro.5560060501; Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989; SPRANG SR, 1993, CURR OPIN STRUC BIOL, V3, P815, DOI 10.1016/0959-440X(93)90144-A; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; Vaught JD, 2010, J AM CHEM SOC, V132, P4141, DOI 10.1021/ja908035g; YASUKAWA K, 1987, EMBO J, V6, P2939, DOI 10.1002/j.1460-2075.1987.tb02598.x; Zheng GH, 2009, NUCLEIC ACIDS RES, V37, pW240, DOI 10.1093/nar/gkp358; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	36	67	68	1	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8720	8734		10.1074/jbc.M113.532697	http://dx.doi.org/10.1074/jbc.M113.532697			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24415767	hybrid, Green Published			2022-12-28	WOS:000333157500060
J	Whelly, S; Serobian, G; Borchardt, C; Powell, J; Johnson, S; Hakansson, K; Lindstrom, V; Abrahamson, M; Grubb, A; Cornwall, GA				Whelly, Sandra; Serobian, Gaiane; Borchardt, Clinton; Powell, Jonathan; Johnson, Seethal; Hakansson, Katarina; Lindstrom, Veronica; Abrahamson, Magnus; Grubb, Anders; Cornwall, Gail A.			Fertility Defects in Mice Expressing the L68Q Variant of Human Cystatin C A ROLE FOR AMYLOID IN MALE INFERTILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Animal models; Epididymis; Neurodegenerative Diseases; Protein Aggregation; Reproduction; Spermatozoa; Cystatin C; Hereditary Cystatin c Amyloid Angiopathy; Male Fertility	HEREDITARY CEREBRAL-HEMORRHAGE; CATHEPSIN-B; IN-VITRO; CRYSTAL-STRUCTURE; PROTEIN; GENE; ANGIOPATHY; FIBRILS; BRAIN; INHIBITORS	Background: The L68Q variant of cystatin C is highly amyloidogenic forming aggregates in individuals with HCCAA. Results: Spermatozoa from mice expressing human L68Q cystatin C exhibit fertility defects and increased levels of amyloid. Conclusion: L68Q epididymal fluid containing cystatin C amyloid is harmful for sperm function. Significance: Amyloid in the reproductive tract may contribute to male factor infertility. Hereditary cystatin C amyloid angiopathy is an autosomal dominant disorder in which a variant form of cystatin C (L68Q) readily forms amyloid deposits in cerebral arteries in affected individuals resulting in early death. L68Q protein deposits in human cystatin C amyloid angiopathy patients have also been found in tissues outside of the brain including the testis, suggesting possible effects on fertility. Heterozygous transgenic mice (L68Q) that express the human L68Q variant of cystatin C under the control of the mouse cystatin C promoter were unable to generate offspring, suggesting the presence of L68Q cystatin C amyloid affected sperm function. In vitro studies showed that epididymal spermatozoa from L68Q mice were unable to fertilize oocytes and exhibited poor sperm motility. Furthermore, spermatozoa from L68Q mice exhibited reduced cell viability compared with wild type (WT) spermatozoa and often were detected in large agglutinated clumps. Examination of the epididymal fluid and spermatozoa from L68Q mice showed increased levels and distinct forms of cystatin C amyloid that were not present in WT mice. The addition of epididymal fluid from L68Q mice to WT spermatozoa resulted in a recapitulation of the L68Q phenotype in that WT spermatozoa showed reduced cell viability and motility compared with WT spermatozoa incubated in epididymal fluid from WT mice. L68Q epididymal fluid that was depleted of cystatin C amyloids, however, did not impair the motility of WT spermatozoa. Taken together these studies suggest that amyloids in the epididymal fluid can be cytotoxic to the maturing spermatozoa resulting in male infertility.	[Whelly, Sandra; Serobian, Gaiane; Borchardt, Clinton; Powell, Jonathan; Johnson, Seethal; Cornwall, Gail A.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA; [Hakansson, Katarina; Lindstrom, Veronica; Abrahamson, Magnus; Grubb, Anders] Lund Univ, Dept Clin Chem & Pharmacol, S-22185 Lund, Sweden	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Lund University	Cornwall, GA (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, 3601 4th St, Lubbock, TX 79430 USA.	gail.cornwall@ttuhsc.edu	Abrahamson, Magnus/CAG-9507-2022	Grubb, Anders/0000-0002-0125-3662	National Institutes of Health [RO1HD056182]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056182] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1HD056182 (to G. A. C.).	ABRAHAMSON M, 1989, HUM GENET, V82, P223, DOI 10.1007/BF00291159; Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; Brage M, 2005, CALCIFIED TISSUE INT, V76, P439, DOI 10.1007/s00223-004-0043-y; Calero M, 2001, J NEUROCHEM, V77, P628, DOI 10.1046/j.1471-4159.2001.00256.x; CALKINS CC, 1995, BIOL CHEM H-S, V376, P71; Chau KM, 2011, BIOL REPROD, V84, P140, DOI 10.1095/biolreprod.110.084855; Cornwall GA, 1999, BIOCHEM J, V340, P85, DOI 10.1042/0264-6021:3400085; Cornwall GA, 2003, MOL CELL ENDOCRINOL, V200, P1, DOI 10.1016/S0303-7207(02)00408-2; Crawford FC, 2000, NEUROLOGY, V55, P763, DOI 10.1212/WNL.55.6.763; ESNARD A, 1992, FEBS LETT, V300, P131, DOI 10.1016/0014-5793(92)80180-O; Finckh U, 2000, ARCH NEUROL-CHICAGO, V57, P1579, DOI 10.1001/archneur.57.11.1579; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Gerhartz B, 2002, BIOL CHEM, V383, P301, DOI 10.1515/BC.2002.032; GHISO J, 1986, P NATL ACAD SCI USA, V83, P2974, DOI 10.1073/pnas.83.9.2974; Grubb AO, 2001, ADV CLIN CHEM, V35, P63, DOI 10.1016/S0065-2423(01)35015-1; Huh CG, 1999, J CLIN PATHOL-MOL PA, V52, P332, DOI 10.1136/mp.52.6.332; Janowski R, 2005, PROTEINS, V61, P570, DOI 10.1002/prot.20633; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Jaskolski M, 2001, ACTA BIOCHIM POL, V48, P807; JEPPSSON JO, 1979, CLIN CHEM, V25, P629; JOHNSON WG, 1995, AM J MED GENET, V59, P149, DOI 10.1002/ajmg.1320590206; Kaeser SA, 2007, NAT GENET, V39, P1437, DOI 10.1038/ng.2007.23; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Kolodziejczyk R, 2010, FEBS J, V277, P1726, DOI 10.1111/j.1742-4658.2010.07596.x; LAWITTS JA, 1993, METHOD ENZYMOL, V225, P153; Levy E, 2001, J NEUROPATH EXP NEUR, V60, P94, DOI 10.1093/jnen/60.1.94; Liu C, 2011, NAT STRUCT MOL BIOL, V18, P49, DOI 10.1038/nsmb.1948; LOFBERG H, 1987, STROKE, V18, P431, DOI 10.1161/01.STR.18.2.431; Loksztejn A, 2009, BIOCHEMISTRY-US, V48, P4846, DOI 10.1021/bi900394b; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Mi W, 2007, NAT GENET, V39, P1440, DOI 10.1038/ng.2007.29; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Nilsson M, 2004, J BIOL CHEM, V279, P24236, DOI 10.1074/jbc.M402621200; Olafsson I, 1996, BRAIN PATHOL, V6, P121, DOI 10.1111/j.1750-3639.1996.tb00795.x; OLAFSSON I, 1988, SCAND J CLIN LAB INV, V48, P573, DOI 10.3109/00365518809085775; Orlikowska M, 2011, J STRUCT BIOL, V173, P406, DOI 10.1016/j.jsb.2010.11.009; Palsdottir A, 2006, BRAIN PATHOL, V16, P55; Palsdottir A, 1989, Prog Clin Biol Res, V317, P241; Pawlik M, 2004, J MOL NEUROSCI, V22, P13, DOI 10.1385/JMN:22:1-2:13; Roan NR, 2011, CELL HOST MICROBE, V10, P541, DOI 10.1016/j.chom.2011.10.010; Sastre M, 2004, NEUROBIOL AGING, V25, P1033, DOI 10.1016/j.neurobiolaging.2003.11.006; Scalvini T, 2007, J UROLOGY, V178, P344, DOI 10.1016/j.juro.2007.03.005; SCHNITTGER S, 1993, GENOMICS, V16, P50, DOI 10.1006/geno.1993.1139; Selenica ML, 2007, SCAND J CLIN LAB INV, V67, P179, DOI 10.1080/00365510601009738; Siricoon S, 2012, MOL BIOCHEM PARASIT, V186, P126, DOI 10.1016/j.molbiopara.2012.10.003; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; Tizon B, 2010, J ALZHEIMERS DIS, V19, P885, DOI 10.3233/JAD-2010-1291; TURK V, 1991, FEBS LETT, V285, P213, DOI 10.1016/0014-5793(91)80804-C; TURNER TT, 1982, AM J PHYSIOL, V242, pR199, DOI 10.1152/ajpregu.1982.242.3.R199; Wahlbom M., 2007, THESIS LUND U LUND; Wahlbom M, 2007, J BIOL CHEM, V282, P18318, DOI 10.1074/jbc.M611368200; WANG PH, 1991, J BIOL CHEM, V266, P12633; Wei LH, 1998, J BIOL CHEM, V273, P11806, DOI 10.1074/jbc.273.19.11806; Whelly S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036394	54	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7718	7729		10.1074/jbc.M113.515759	http://dx.doi.org/10.1074/jbc.M113.515759			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24500719	hybrid, Green Published			2022-12-28	WOS:000332761500039
J	Zhang, Y; Park, S; Blaser, S; Sheets, MD				Zhang, Yan; Park, Sookhee; Blaser, Susanne; Sheets, Michael D.			Determinants of RNA Binding and Translational Repression by the Bicaudal-C Regulatory Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Development; Kidney; mRNA; RNA Binding Protein; RNA Silencing; Transforming Growth Factor Beta (TGFbeta); Translation Regulation; Xenopus; Maternal mRNA	MENTAL-RETARDATION PROTEIN; MESSENGER-RNAS; XENOPUS EMBRYOS; KH DOMAINS; RECOGNITION; PATHWAY	Background: Bicaudal-C RNA binding proteins are important translational repressors in many different biological contexts. Results: A minimal site for RNA binding and translation repression by Bicaudal-C was identified. Conclusion: The RNA binding site for Bicaudal-C forms a stem-loop structure important for binding and translational repression. Significance: This will facilitate the identification of Bicaudal-C binding sites in other mRNAs. Bicaudal-C (Bic-C) RNA binding proteins function as important translational repressors in multiple biological contexts within metazoans. However, their RNA binding sites are unknown. We recently demonstrated that Bic-C functions in spatially regulated translational repression of the xCR1 mRNA during Xenopus development. This repression contributes to normal development by confining the xCR1 protein, a regulator of key signaling pathways, to specific cells of the embryo. In this report, we combined biochemical approaches with in vivo mRNA reporter assays to define the minimal Bic-C target site within the xCR1 mRNA. This 32-nucleotide Bic-C target site is predicted to fold into a stem-loop secondary structure. Mutational analyses provided evidence that this stem-loop structure is important for Bic-C binding. The Bic-C target site was sufficient for Bic-C mediated repression in vivo. Thus, we describe the first RNA binding site for a Bic-C protein. This identification provides an important step toward understanding the mechanisms by which evolutionarily conserved Bic-C proteins control cellular function in metazoans.	[Zhang, Yan; Park, Sookhee; Blaser, Susanne; Sheets, Michael D.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Sheets, MD (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, 440 Henry Mall, Madison, WI 53706 USA.	mdsheets@wisc.edu		Sheets, Michael/0000-0002-5786-9407	National Science Foundation [1050395]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant 1050395 (to M. D. S.).	Anko ML, 2012, TRENDS BIOCHEM SCI, V37, P255, DOI 10.1016/j.tibs.2012.02.005; Chicoine J, 2007, DEV CELL, V13, P691, DOI 10.1016/j.devcel.2007.10.002; Darnell JC, 2004, MENT RETARD DEV D R, V10, P49, DOI 10.1002/mrdd.20008; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Dorey K, 2006, DEV BIOL, V292, P303, DOI 10.1016/j.ydbio.2006.01.006; Fritz BR, 2001, DEV BIOL, V236, P230, DOI 10.1006/dbio.2001.0324; Gamberi C, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/141386; Hou ZG, 2005, P NATL ACAD SCI USA, V102, P8489, DOI 10.1073/pnas.0503525102; Hou ZG, 2009, MOL CELL BIOL, V29, P687, DOI 10.1128/MCB.00202-08; Jensen KB, 2000, P NATL ACAD SCI USA, V97, P5740, DOI 10.1073/pnas.090553997; Kraus MRC, 2012, HUM MUTAT, V33, P86, DOI 10.1002/humu.21610; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Maisonneuve C, 2009, DEVELOPMENT, V136, P3019, DOI 10.1242/dev.038174; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; MEADOR J, 1990, EUR J BIOCHEM, V187, P549, DOI 10.1111/j.1432-1033.1990.tb15336.x; MEADOR J, 1990, GENE, V95, P1, DOI 10.1016/0378-1119(90)90406-H; Nakel K, 2010, RNA, V16, P2058, DOI 10.1261/rna.2315010; Piazzon N, 2012, J MOL CELL BIOL, V4, P398, DOI 10.1093/jmcb/mjs027; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Saffman EE, 1998, MOL CELL BIOL, V18, P4855, DOI 10.1128/MCB.18.8.4855; SHEETS MD, 1994, GENE DEV, V8, P926, DOI 10.1101/gad.8.8.926; Takahashi K, 1970, Adv Biophys, V1, P53; Tran U, 2010, DEVELOPMENT, V137, P1107, DOI 10.1242/dev.046045; Valverde R, 2008, FEBS J, V275, P2712, DOI 10.1111/j.1742-4658.2008.06411.x; Wessely O, 2000, DEVELOPMENT, V127, P2053; Zhang Y, 2013, RNA, V19, P1575, DOI 10.1261/rna.041665.113; Zhang Y, 2009, MOL CELL BIOL, V29, P3791, DOI 10.1128/MCB.01865-08; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	28	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7497	7504		10.1074/jbc.M113.526426	http://dx.doi.org/10.1074/jbc.M113.526426			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24478311	hybrid, Green Published			2022-12-28	WOS:000332761500020
J	Gao, CX; Chen, GM; Romero, G; Moschos, S; Xu, X; Hu, J				Gao, Chenxi; Chen, Guangming; Romero, Guillermo; Moschos, Stergios; Xu, Xiang; Hu, Jing			Induction of Gsk3 beta-beta-TrCP Interaction Is Required for Late Phase Stabilization of beta-Catenin in Canonical Wnt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta-catenin; Glycogen Synthase Kinase 3; Ubiquitin Ligase; Ubiquitination; Wnt Signaling	UBIQUITIN LIGASE; CYCLIN D1; KINASE; PHOSPHORYLATION; DEGRADATION; AXIN; EXPRESSION; MECHANISM; PROTEIN; INHIBITION	Background: Despite being a key component of the Wnt pathway, how Gsk3 is regulated in Wnt signaling remains elusive. Results: Wnt simulation induces Gsk3--TrCP interaction and monoubiquitination of Gsk3, leading to inhibition of -catenin recruitment of -TrCP. Conclusion: -Catenin stabilization in late Wnt signaling requires increased Gsk3--TrCP interaction. Significance: First evidence that Gsk3 is regulated by monoubiquitination in Wnt signaling. A pivotal step in canonical Wnt signaling is Wnt-induced -catenin stabilization. In the absence of Wnt, -catenin is targeted for -transducin repeats-containing proteins (-TrCP)-mediated degradation due to phosphorylation by glycogen synthase kinase 3 (Gsk3). How canonical Wnt signaling regulates Gsk3 to inhibit -catenin proteolysis remains largely elusive. This study reveals novel key molecular events in Wnt signaling: induction of Gsk3 ubiquitination and Gsk3--TrCP binding. We found that Wnt stimulation induced prolonged monoubiquitination of Gsk3 and Gsk3--TrCP interaction. Monoubiquitination did not cause Gsk3 degradation nor affects its enzymatic activity. Rather, increased monoubiquitination of Gsk3/Gsk3--TrCP association suppressed -catenin recruitment of -TrCP, leading to long-term inhibition of -catenin ubiquitination and degradation.	[Gao, Chenxi; Chen, Guangming; Romero, Guillermo; Xu, Xiang; Hu, Jing] Univ Pittsburgh Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Gao, Chenxi; Chen, Guangming; Moschos, Stergios; Xu, Xiang; Hu, Jing] Univ Pittsburgh Sch Med, Univ Pittsburgh Canc Inst, Pittsburgh, PA 15213 USA; [Moschos, Stergios] Univ Pittsburgh Sch Med, Dept Med, Div Hematol Oncol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hu, J (corresponding author), Univ Pittsburgh Canc Inst, Dept Pharmacol & Chem Biol, 2-42D Hillman Canc Ctr Res Pavil,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	huj3@upmc.edu	Hu, Jing/M-3130-2014; xu, xiang/L-2579-2014	xu, xiang/0000-0002-1026-2210	United States Public Health Service [CA166197]; NATIONAL CANCER INSTITUTE [R01CA166197] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This investigation was supported in part by United States Public Health Service Grant CA166197 (to J. H.).	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carlson ED, 2012, BIOTECHNOL ADV, V30, P1185, DOI 10.1016/j.biotechadv.2011.09.016; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cselenyi CS, 2008, P NATL ACAD SCI USA, V105, P8032, DOI 10.1073/pnas.0803025105; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Failor KL, 2007, MOL ENDOCRINOL, V21, P2403, DOI 10.1210/me.2007-0143; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Hernandez AR, 2012, SCIENCE, V338, P1337, DOI 10.1126/science.1228734; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Kim SE, 2013, SCIENCE, V340, P867, DOI 10.1126/science.1232389; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kishida M, 1999, ONCOGENE, V18, P979, DOI 10.1038/sj.onc.1202388; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu XX, 2005, CURR BIOL, V15, P1989, DOI 10.1016/j.cub.2005.10.050; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Spiegelman VS, 2000, MOL CELL, V5, P877, DOI 10.1016/S1097-2765(00)80327-5; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Takacs CM, 2008, SCIENCE, V319, P333, DOI 10.1126/science.1151232; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Vatsyayan J, 2008, EMBO REP, V9, P885, DOI 10.1038/embor.2008.122; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; Wei S, 2008, J BIOL CHEM, V283, P26759, DOI 10.1074/jbc.M802160200; Wu G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004926; Xia YF, 2009, P NATL ACAD SCI USA, V106, P2629, DOI 10.1073/pnas.0812256106; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185	34	23	23	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7099	7108		10.1074/jbc.M113.532606	http://dx.doi.org/10.1074/jbc.M113.532606			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24451375	Green Published, hybrid			2022-12-28	WOS:000332389400069
J	Hartmann, A; Hellmund, M; Lucius, R; Voelker, DR; Gupta, N				Hartmann, Anne; Hellmund, Maria; Lucius, Richard; Voelker, Dennis R.; Gupta, Nishith			Phosphatidylethanolamine Synthesis in the Parasite Mitochondrion Is Required for Efficient Growth but Dispensable for Survival of Toxoplasma gondii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Host-Pathogen Interactions; Membrane Biogenesis; Microbiology; Parasite Metabolism; Parasitology; Phosphatidylethanolamine; Phosphatidylserine Decarboxylase	PHOSPHATIDYLSERINE DECARBOXYLASE ACTIVITY; PHOSPHOLIPID BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; GENE; CLONING; MEMBRANE; YEAST; DISRUPTION; EXPRESSION; MARKER	Background:Toxoplasma gondii is a common intracellular parasite of diverse host cells. Results: The parasite can produce phosphatidylethanolamine in its mitochondrion, endoplasmic reticulum, and parasitophorous vacuole, which together allow versatile lipid biogenesis. Conclusion: Multiple routes of lipid synthesis ensure parasite survival in discrete nutrient milieus. Significance:T. gondii offers an instructive model to study membrane biology of parasitic protists. Toxoplasma gondii is a highly prevalent obligate intracellular parasite of the phylum Apicomplexa, which also includes other parasites of clinical and/or veterinary importance, such as Plasmodium, Cryptosporidium, and Eimeria. Acute infection by Toxoplasma is hallmarked by rapid proliferation in its host cells and requires a significant synthesis of parasite membranes. Phosphatidylethanolamine (PtdEtn) is the second major phospholipid class in T. gondii. Here, we reveal that PtdEtn is produced in the parasite mitochondrion and parasitophorous vacuole by decarboxylation of phosphatidylserine (PtdSer) and in the endoplasmic reticulum by fusion of CDP-ethanolamine and diacylglycerol. PtdEtn in the mitochondrion is synthesized by a phosphatidylserine decarboxylase (TgPSD1mt) of the type I class. TgPSD1mt harbors a targeting peptide at its N terminus that is required for the mitochondrial localization but not for the catalytic activity. Ablation of TgPSD1mt expression caused up to 45% growth impairment in the parasite mutant. The PtdEtn content of the mutant was unaffected, however, suggesting the presence of compensatory mechanisms. Indeed, metabolic labeling revealed an increased usage of ethanolamine for PtdEtn synthesis by the mutant. Likewise, depletion of nutrients exacerbated the growth defect (approximate to 56%), which was partially restored by ethanolamine. Besides, the survival and residual growth of the TgPSD1mt mutant in the nutrient-depleted medium also indicated additional routes of PtdEtn biogenesis, such as acquisition of host-derived lipid. Collectively, the work demonstrates a metabolic cooperativity between the parasite organelles, which ensures a sustained lipid synthesis, survival and growth of T. gondii in varying nutritional milieus.	[Hartmann, Anne; Hellmund, Maria; Lucius, Richard; Gupta, Nishith] Humboldt Univ, Dept Mol Parasitol, D-10115 Berlin, Germany; [Voelker, Dennis R.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Gupta, Nishith] Max Planck Inst Infect Biol, Dept Parasitol, D-10117 Berlin, Germany	Humboldt University of Berlin; National Jewish Health; Max Planck Society	Gupta, N (corresponding author), Humboldt Univ, Dept Mol Parasitol, Philippstr 13, D-10115 Berlin, Germany.	Gupta.Nishith@staff.hu-berlin.de		Gupta, Nishith/0000-0003-1452-5126	German Research Foundation (Deutsche Forschungsgemeinschaft; DFG) [SFB618/C7, GU1100/3-1]; Caroline von Humboldt Foundation	German Research Foundation (Deutsche Forschungsgemeinschaft; DFG)(German Research Foundation (DFG)); Caroline von Humboldt Foundation	This work was supported by German Research Foundation (Deutsche Forschungsgemeinschaft; DFG) Grants SFB618/C7 and GU1100/3-1 (to N. G.) and by a 6-month scholarship from the Caroline von Humboldt Foundation (to A. H.).	Agrawal S, 2009, J BIOL CHEM, V284, P33683, DOI 10.1074/jbc.M109.044024; Baunaure F, 2004, MOL MICROBIOL, V51, P33, DOI 10.1046/j.1365-2958.2003.03822.x; Besteiro S., 2011, PLOS PATHOG, V7; Black MW, 2000, MICROBIOL MOL BIOL R, V64, P607, DOI 10.1128/MMBR.64.3.607-623.2000; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chan EYL, 2012, J BIOL CHEM, V287, P40131, DOI 10.1074/jbc.M112.399428; Charron AJ, 2002, J CELL SCI, V115, P3049; CLAROS MG, 1995, COMPUT APPL BIOSCI, V11, P441; Coppens I, 2013, NAT REV MICROBIOL, V11, P823, DOI 10.1038/nrmicro3139; Dechamps S, 2010, MOL BIOCHEM PARASIT, V173, P69, DOI 10.1016/j.molbiopara.2010.05.006; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; DONALD RGK, 1995, P NATL ACAD SCI USA, V92, P5749, DOI 10.1073/pnas.92.12.5749; DONALD RGK, 1993, P NATL ACAD SCI USA, V90, P11703, DOI 10.1073/pnas.90.24.11703; Dowhan W, 1997, METHOD ENZYMOL, V280, P81; DOWHAN W, 1974, J BIOL CHEM, V249, P3079; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gibellini F, 2009, MOL MICROBIOL, V73, P826, DOI 10.1111/j.1365-2958.2009.06764.x; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Gupta N, 2005, J BIOL CHEM, V280, P16345, DOI 10.1074/jbc.M501523200; Gupta N, 2012, J BIOL CHEM, V287, P22938, DOI 10.1074/jbc.M112.373639; Horvath SE, 2012, J BIOL CHEM, V287, P36744, DOI 10.1074/jbc.M112.398107; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Kim K., 2014, PERSPECTIVES METHODS, P599; Kuge O, 1996, BIOCHEM J, V319, P33, DOI 10.1042/bj3190033; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Nerlich A, 2007, PLANT PHYSIOL, V144, P904, DOI 10.1104/pp.107.095414; OHTA A, 1981, J BACTERIOL, V147, P552, DOI 10.1128/JB.147.2.552-562.1981; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; PERCY AK, 1983, ARCH BIOCHEM BIOPHYS, V223, P484, DOI 10.1016/0003-9861(83)90613-6; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; Rontein D, 2003, PLANT PHYSIOL, V132, P1678, DOI 10.1104/pp.103.023242; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Sampels V, 2012, J BIOL CHEM, V287, P16289, DOI 10.1074/jbc.M112.347138; Sheiner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002392; Signorell A, 2009, MOL MICROBIOL, V72, P1068, DOI 10.1111/j.1365-2958.2009.06713.x; Sinai AP, 1997, J CELL SCI, V110, P2117; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; Sullivan WJ, 2012, FEMS MICROBIOL REV, V36, P717, DOI 10.1111/j.1574-6976.2011.00305.x; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; TROTTER PJ, 1995, J BIOL CHEM, V270, P6071, DOI 10.1074/jbc.270.11.6071; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; Voelker DR, 2005, TRENDS BIOCHEM SCI, V30, P396, DOI 10.1016/j.tibs.2005.05.008; Zhang K, 2007, EMBO J, V26, P1094, DOI 10.1038/sj.emboj.7601565	50	21	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6809	6824		10.1074/jbc.M113.509406	http://dx.doi.org/10.1074/jbc.M113.509406			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24429285	Green Published, hybrid			2022-12-28	WOS:000332389400041
J	Kovacev, J; Wu, K; Spratt, DE; Chong, RA; Lee, C; Nayak, J; Shaw, GS; Pan, ZQ				Kovacev, Jordan; Wu, Kenneth; Spratt, Donald E.; Chong, Robert A.; Lee, Chan; Nayak, Jaladhi; Shaw, Gary S.; Pan, Zhen-Qiang			A SnapShot of Ubiquitin Chain Elongation LYSINE 48-TETRA-UBIQUITIN SLOWS DOWN UBIQUITINATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Catenin; E3 Ubiquitin Ligase; Enzymes; Post Translational Modification; Protein Degradation; Ubiquitination; Cdc34; E2 Conjugating Enzyme; SCF; UbcH5c	RING E3 LIGASE; CULLIN; SCF; NEDD8; COMPLEX; TETRAUBIQUITIN; CONFORMATION; RECRUITMENT; INHIBITION; ACTIVATION	Background: Polyubiquitin chains are signaling polypeptides altering the fate of substrates. Results: A Lys-48-ubiquitin chain of a length greater than four, but not its Lys-63 linkage counterparts, slowed the rate of additional ubiquitin conjugation. Conclusion: The ubiquitin chain length and linkage may impact kinetic rates of chain elongation. Significance: Our findings suggest a self-restraining mechanism that limits Lys-48-polyubiquitination. We have explored the mechanisms of polyubiquitin chain assembly with reconstituted ubiquitination of IB and -catenin by the Skp1-cullin 1-TrCP F-box protein (SCFTrCP) E3 ubiquitin (Ub) ligase complex. Competition experiments revealed that SCFTrCP formed a complex with IB and that the Nedd8 modified E3-substrate platform engaged in dynamic interactions with the Cdc34 E2 Ub conjugating enzyme for chain elongation. Using elongation intermediates containing -catenin linked with Ub chains of defined length, it was observed that a Lys-48-Ub chain of a length greater than four, but not its Lys-63 linkage counterparts, slowed the rate of additional Ub conjugation. Thus, the Ub chain length and linkage impact kinetic rates of chain elongation. Given that Lys-48-tetra-Ub is packed into compact conformations due to extensive intrachain interactions between Ub subunits, this topology may limit the accessibility of SCFTrCP/Cdc34 to the distal Ub Lys-48 and result in slowed elongation.	[Kovacev, Jordan; Wu, Kenneth; Chong, Robert A.; Lee, Chan; Nayak, Jaladhi; Pan, Zhen-Qiang] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA; [Spratt, Donald E.; Shaw, Gary S.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON N6A 5C1, Canada; [Pan, Zhen-Qiang] Xuzhou Med Coll, Jiangsu Key Lab Biol Canc Therapy, Xuzhou 221002, Jiangsu, Peoples R China	Icahn School of Medicine at Mount Sinai; Western University (University of Western Ontario); Xuzhou Medical University	Pan, ZQ (corresponding author), Icahn Sch Med Mt Sinai, Dept Oncol Sci, One Gustave L Levy Pl, New York, NY 10029 USA.	zhen-qiang.pan@mssm.edu	Shaw, Gary S./C-7656-2009	Shaw, Gary S./0000-0002-4685-9625; Lee, Chan/0000-0002-5512-8146; Spratt, Donald/0000-0002-0699-155X	National Institutes of Health (Public Health Service) [GM61051, CA095634]; Canadian Institutes of Health Research [MOP-14606]; National Institutes of Health Fellowship [1F30DK095572-01]; NATIONAL CANCER INSTITUTE [R01CA095634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK095572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061051] Funding Source: NIH RePORTER	National Institutes of Health (Public Health Service)(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM61051 and CA095634 (Public Health Service; to Z.-Q.P.). This work was also supported by Canadian Institutes of Health Research Grant MOP-14606 (to G.S.S.).; Supported by National Institutes of Health Fellowship 1F30DK095572-01.	Choi YS, 2010, J BIOL CHEM, V285, P17754, DOI 10.1074/jbc.M109.090621; CIECHANOVER A, 1978, BIOCHEM BIOPH RES CO, V81, P1100, DOI 10.1016/0006-291X(78)91249-4; COOK WJ, 1994, J MOL BIOL, V236, P601, DOI 10.1006/jmbi.1994.1169; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Datta AB, 2009, J MOL BIOL, V392, P1117, DOI 10.1016/j.jmb.2009.07.090; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Duda DM, 2012, MOL CELL, V47, P371, DOI 10.1016/j.molcel.2012.05.044; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Gazdoiu S, 2007, MOL CELL BIOL, V27, P7041, DOI 10.1128/MCB.00812-07; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hirano T, 2011, J BIOL CHEM, V286, P37496, DOI 10.1074/jbc.M111.256354; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Lai MY, 2012, BBA-MOL CELL RES, V1823, P2046, DOI 10.1016/j.bbamcr.2012.04.003; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Phillips CL, 2001, ACTA CRYSTALLOGR D, V57, P341, DOI 10.1107/S090744490001800X; Pierce NW, 2013, CELL, V153, P206, DOI 10.1016/j.cell.2013.02.024; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Safadi SS, 2007, BIOCHEMISTRY-US, V46, P14162, DOI 10.1021/bi7016969; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Skaar JR, 2009, CELL, V137, P1358, DOI 10.1016/j.cell.2009.05.040; Skaar JR, 2009, CELL, V137, DOI 10.1016/j.cell.2009.05.039; Spratt DE, 2012, J BIOL CHEM, V287, P17374, DOI 10.1074/jbc.M112.353748; Spratt DE, 2011, J MOL BIOL, V407, P425, DOI 10.1016/j.jmb.2011.01.047; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Tron AE, 2012, MOL CELL, V46, P67, DOI 10.1016/j.molcel.2012.02.005; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Wu SD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2636; Yamoah K, 2008, P NATL ACAD SCI USA, V105, P12230, DOI 10.1073/pnas.0806155105; Ye Y, 2012, NATURE, V492, P266, DOI 10.1038/nature11722; Zemla A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2628; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	39	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7068	7081		10.1074/jbc.M113.530576	http://dx.doi.org/10.1074/jbc.M113.530576			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24464578	Green Published, hybrid			2022-12-28	WOS:000332389400066
J	Matsui, H; Fukuno, N; Kanda, Y; Kantoh, Y; Chida, T; Nagaura, Y; Suzuki, O; Nishitoh, H; Takeda, K; Ichijo, H; Sawada, Y; Sasaki, K; Kobayashi, T; Tamura, S				Matsui, Hiroyuki; Fukuno, Naoto; Kanda, Yoshiaki; Kantoh, Yusuke; Chida, Toko; Nagaura, Yuko; Suzuki, Osamu; Nishitoh, Hideki; Takeda, Kohsuke; Ichijo, Hidenori; Sawada, Yasuhiro; Sasaki, Keiichi; Kobayashi, Takayasu; Tamura, Shinri			The Expression of Fn14 via Mechanical Stress-activated JNK Contributes to Apoptosis Induction in Osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Jun N-terminal Kinase (JNK); Mechanotransduction; Osteoblasts; p38 MAPK; Fn14	INFLAMMATORY CYTOKINES; BONE-FORMATION; DIFFERENTIATION; TWEAK; HOMEOSTASIS; OSTEOCLASTS; OSTEOCYTES; MOUSE; MAPK; TNF	Background: Fn14 is a highly inducible member of the TNF receptor family. Results: Large-magnitude mechanical stress induced Fn14 expression via JNK in osteoblasts. Conclusion: Expression of Fn14 regulates mechanical stress-induced apoptosis in osteoblasts. Significance: This is the first elucidation of the mechanism of excessive mechanical stress-induced apoptosis mediated by Fn14. Bone mass is maintained by the balance between the activities of bone-forming osteoblasts and bone-resorbing osteoclasts. It is well known that adequate mechanical stress is essential for the maintenance of bone mass, whereas excess mechanical stress induces bone resorption. However, it has not been clarified how osteoblasts respond to different magnitudes of mechanical stress. Here we report that large-magnitude (12%) cyclic stretch induced Ca2+ influx, which activated reactive oxygen species generation in MC3T3-E1 osteoblasts. Reactive oxygen species then activated the ASK1-JNK/p38 pathways. The activated JNK led to transiently enhanced expression of FGF-inducible 14 (Fn14, a member of the TNF receptor superfamily) gene. Cells with enhanced expression of Fn14 subsequently acquired sensitivity to the ligand of Fn14, TNF-related weak inducer of apoptosis, and underwent apoptosis. On the other hand, the ASK1-p38 pathway induced expression of the monocyte chemoattractant protein 3 (MCP-3) gene, which promoted chemotaxis of preosteoclasts. In contrast, the ERK pathway was activated by small-magnitude stretching (1%) and induced expression of two osteogenic genes, collagen Ia (Col1a) and osteopontin (OPN). Moreover, activated JNK suppressed Col1a and OPN induction in large-magnitude mechanical stretch-loaded cells. The enhanced expression of Fn14 and MCP-3 by 12% stretch and the enhanced expression of Col1a and OPN by 1% stretch were also observed in mouse primary osteoblasts. These results suggest that differences in the response of osteoblasts to varying magnitudes of mechanical stress play a key role in switching the mode of bone metabolism between formation and resorption.	[Matsui, Hiroyuki; Fukuno, Naoto; Kantoh, Yusuke; Chida, Toko; Nagaura, Yuko; Kobayashi, Takayasu; Tamura, Shinri] Tohoku Univ, Dept Biochem, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; [Matsui, Hiroyuki; Fukuno, Naoto; Kanda, Yoshiaki; Kantoh, Yusuke; Sasaki, Keiichi] Tohoku Univ, Dept Adv Prosthet Dent, Sendai, Miyagi 9808575, Japan; [Suzuki, Osamu] Tohoku Univ, Grad Sch Dent, Div Craniofacial Funct Engn, Sendai, Miyagi 9808575, Japan; [Matsui, Hiroyuki; Sawada, Yasuhiro] Nadogaya Hosp, Locomot Syndrome Res Inst, Lab Mech Med, Kashiwa, Chiba 2770032, Japan; [Nishitoh, Hideki] Miyazaki Univ, Dept Med Sci, Div Biochem & Mol Biol, Kiyotake, Miyazaki 8891692, Japan; [Takeda, Kohsuke] Nagasaki Univ, Div Cell Regulat, Nagasaki 8528521, Japan; [Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Bunkyo Ku, Tokyo 1130033, Japan; [Sawada, Yasuhiro] Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore	Tohoku University; Tohoku University; Tohoku University; University of Miyazaki; Nagasaki University; University of Tokyo; National University of Singapore	Tamura, S (corresponding author), Tohoku Univ, Dept Biochem, Inst Dev Aging & Canc, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	tamura@idac.tohoku.ac.jp	Sawada, Yasuhiro/H-8044-2012	Sawada, Yasuhiro/0000-0003-0625-3335; Ichijo, Hidenori/0000-0002-5005-6438; Suzuki, Osamu/0000-0002-3566-5681; Takeda, Kohsuke/0000-0002-8359-8399; Nishitoh, Hideki/0000-0002-8652-4109	Japan Society for Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [25460353, 26861619, 24590339, 24659027] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for Scientific Research from the Japan Society for Promotion of Science and Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Ando T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2038; Binder NB, 2009, NAT MED, V15, P417, DOI 10.1038/nm.1945; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Brown SAN, 2006, BIOCHEM J, V397, P297, DOI 10.1042/BJ20051362; Ehrlich PJ, 2002, OSTEOPOROSIS INT, V13, P688, DOI 10.1007/s001980200095; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; Fu JH, 2012, EUR J ORAL IMPLANTOL, V5, pS91; Fukuno N, 2011, BIOCHEM BIOPH RES CO, V408, P202, DOI 10.1016/j.bbrc.2011.02.127; Goga Y, 2006, J DENT RES, V85, P240, DOI 10.1177/154405910608500307; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Hay E, 2004, J BIOL CHEM, V279, P1650, DOI 10.1074/jbc.M300969200; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Hoshino A, 2010, J BIOL CHEM, V285, P28826, DOI 10.1074/jbc.M109.099424; Jeon YM, 2009, MOL CELL BIOCHEM, V320, P45, DOI 10.1007/s11010-008-9897-z; Jilka RL, 2007, J BONE MINER RES, V22, P1492, DOI 10.1359/JBMR.070518; Kanno T, 2007, J CELL BIOCHEM, V101, P1266, DOI 10.1002/jcb.21249; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Loboa EG, 2001, J ORTHOP RES, V19, P1067, DOI 10.1016/S0736-0266(01)00028-6; Matsuguchi T, 2009, J BONE MINER RES, V24, P398, DOI 10.1359/JBMR.081107; Matsumoto T, 2013, J DENT RES, V92, P340, DOI 10.1177/0022034513476037; Menini M, 2012, J DENT RES, V91, P821, DOI 10.1177/0022034512455802; Menten P, 2001, EUR CYTOKINE NETW, V12, P554; Miura M, 2004, J CLIN INVEST, V114, P1704, DOI 10.1172/JCI200420427; MOREY ER, 1978, SCIENCE, V201, P1138, DOI 10.1126/science.150643; Moriishi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040143; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Ross TD, 2013, CURR OPIN CELL BIOL, V25, P613, DOI 10.1016/j.ceb.2013.05.006; Suenaga H, 2012, ANN NUCL MED, V26, P817, DOI 10.1007/s12149-012-0648-6; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Takeda K, 2011, ANTIOXID REDOX SIGN, V15, P719, DOI 10.1089/ars.2010.3392; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Vincent C, 2009, J BONE MINER RES, V24, P1434, DOI [10.1359/jbmr.090305, 10.1359/JBMR.090305]; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yu XF, 2004, J BONE MINER RES, V19, P2065, DOI 10.1359/JBMR.040910; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zhou HK, 2011, BONE, V49, P404, DOI 10.1016/j.bone.2011.04.020	39	32	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6438	6450		10.1074/jbc.M113.536300	http://dx.doi.org/10.1074/jbc.M113.536300			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24446436	Green Published, hybrid			2022-12-28	WOS:000332389400012
J	Mukherjee, P; Wilson, RC; Lahiri, I; Pata, JD				Mukherjee, Purba; Wilson, Ryan C.; Lahiri, Indrajit; Pata, Janice D.			Three Residues of the Interdomain Linker Determine the Conformation and Single-base Deletion Fidelity of Y-family Translesion Polymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Polymerase; DNA Replication; Enzyme Mutation; Kinetics; Protein Conformation; Structural Biology; Fidelity; Translesion Synthesis; Y-family Polymerase	DNA-POLYMERASE; CRYSTAL-STRUCTURE; ERROR-PRONE; BYPASS; MECHANISM; KAPPA; DINB; DOMAIN; IOTA; ETA	Background: Dpo4 and Dbh translesion polymerases show distinct mutagenic signatures and lesion bypass abilities. Results: Three residues in the interdomain linker are major determinants of polymerase conformation and nucleotide incorporation rate. Conclusion: Residues remote from the active site strongly influence single-base deletion and mispair extension efficiency by controlling polymerase conformation. Significance: This work suggests new possibilities for regulating translesion synthesis activity through altered conformation. Dpo4 and Dbh are from two closely related Sulfolobus species and are well studied archaeal homologues of pol IV, an error prone Y-family polymerase from Escherichia coli. Despite sharing 54% amino acid identity, these polymerases display distinct mutagenic and translesion specificities. Structurally, Dpo4 and Dbh adopt different conformations because of the difference in relative orientation of their N-terminal catalytic and C-terminal DNA binding domains. Using chimeric constructs of these two polymerases, we have previously demonstrated that the interdomain linker is a major determinant of polymerase conformation, base-substitution fidelity, and abasic-site translesion synthesis. Here we find that the interdomain linker also affects the single-base deletion frequency and the mispair extension efficiency of these polymerases. Exchanging just three amino acids in the linkers of Dbh and Dpo4 is sufficient to change the fidelity by up to 30-fold, predominantly by altering the rate of correct (but not incorrect) nucleotide incorporation. Additionally, from a 2.4 resolution crystal structure, we have found that the three linker amino acids from Dpo4 are sufficient to allow Dbh to adopt the standard conformation of Dpo4. Thus, a small region of the interdomain linker, located more than 11 away from the catalytic residues, determines the fidelity of these Y-family polymerases, by controlling the alignment of substrates at the active site.	[Mukherjee, Purba; Wilson, Ryan C.; Lahiri, Indrajit; Pata, Janice D.] SUNY Albany, Sch Publ Hlth, New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Mukherjee, Purba; Lahiri, Indrajit; Pata, Janice D.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12201 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Pata, JD (corresponding author), SUNY Albany, Sch Publ Hlth, New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA.	jpata@wadsworth.org	Mukherjee, Purba/Q-6811-2019	Mukherjee, Purba/0000-0001-9869-6509; Lahiri, Indrajit/0000-0002-5633-7978; Pata, Janice/0000-0001-5999-5442	National Institutes of Health [R01-GM080573]; Wadsworth Center; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244, R01GM080573] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wadsworth Center; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM080573 (to J. D. P.). This work was also supported by fellowship support from the Wadsworth Center (to P. M. and I. L.). Use of the National Synchrotron Light Source, Brookhaven National Laboratory, was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-98CH10886.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beard WA, 2002, J BIOL CHEM, V277, P47393, DOI 10.1074/jbc.M210036200; Boudsocq F, 2004, J BIOL CHEM, V279, P32932, DOI 10.1074/jbc.M405249200; Carlson KD, 2006, P NATL ACAD SCI USA, V103, P15776, DOI 10.1073/pnas.0605785103; DeLucia AM, 2007, BIOCHEMISTRY-US, V46, P10790, DOI 10.1021/bi7006756; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Foti JJ, 2011, J BACTERIOL, V193, P2637, DOI 10.1128/JB.00005-11; Godoy VG, 2007, MOL CELL, V28, P1058, DOI 10.1016/j.molcel.2007.10.025; Hayward S, 1997, PROTEINS, V27, P425, DOI 10.1002/(SICI)1097-0134(199703)27:3<425::AID-PROT10>3.0.CO;2-N; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 2000, P NATL ACAD SCI USA, V97, P3838, DOI 10.1073/pnas.97.8.3838; Kokoska RJ, 2002, J BIOL CHEM, V277, P19633, DOI 10.1074/jbc.M202021200; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Mukherjee P, 2013, NUCLEIC ACIDS RES, V41, P5024, DOI 10.1093/nar/gkt179; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Ohashi E, 2000, J BIOL CHEM, V275, P39678, DOI 10.1074/jbc.M005309200; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pata JD, 2010, BBA-PROTEINS PROTEOM, V1804, P1124, DOI 10.1016/j.bbapap.2010.01.020; Potapova O, 2002, J BIOL CHEM, V277, P28157, DOI 10.1074/jbc.M202607200; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Silvian LF, 2001, NAT STRUCT BIOL, V8, P984, DOI 10.1038/nsb1101-984; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; Washington MT, 2000, P NATL ACAD SCI USA, V97, P3094, DOI 10.1073/pnas.050491997; Wilson RC, 2008, MOL CELL, V29, P767, DOI 10.1016/j.molcel.2008.01.014; Wilson RC, 2013, STRUCTURE, V21, P20, DOI 10.1016/j.str.2012.11.005; Wu YF, 2011, J BACTERIOL, V193, P2630, DOI 10.1128/JB.00012-11; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106; Zhou BL, 2001, MOL CELL, V8, P427, DOI 10.1016/S1097-2765(01)00310-0	30	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6323	6331		10.1074/jbc.M113.537860	http://dx.doi.org/10.1074/jbc.M113.537860			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24415763	Green Published, hybrid			2022-12-28	WOS:000332389400001
J	Polling, S; Mok, YF; Ramdzan, YM; Turner, BJ; Yerbury, JJ; Hill, AF; Hatters, DM				Polling, Saskia; Mok, Yee-Foong; Ramdzan, Yasmin M.; Turner, Bradley J.; Yerbury, Justin J.; Hill, Andrew F.; Hatters, Danny M.			Misfolded Polyglutamine, Polyalanine, and Superoxide Dismutase 1 Aggregate via Distinct Pathways in the Cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease); Analytical Ultracentrifugation; Flow Cytometry; Polyglutamine; Protein Aggregation; Superoxide Dismutase (SOD); Inclusion; Polyalanine	AMYOTROPHIC-LATERAL-SCLEROSIS; SIZE-DISTRIBUTION ANALYSIS; ANALYTICAL ULTRACENTRIFUGATION; HUNTINGTIN AGGREGATION; MUTANT HUNTINGTIN; GLUTAMINE REPEATS; PROTEIN; SOD1; OLIGOMERIZATION; CHAPERONES	Background: Protein aggregation is associated with neurodegenerative diseases. Results: We defined how the oligomeric state of disease-relevant mutant protein and homopolypeptides relate to clustering into inclusion subtypes IPOD and JUNQ. Conclusion: JUNQ protein and homopolypeptides relate to constitutively disrupted oligomeric states irrespective of inclusion formation. Significance: JUNQ inclusions may arise by cellular failure in degradation of abnormal oligomeric states. Protein aggregation into intracellular inclusions is a key feature of many neurodegenerative disorders. A common theme has emerged that inappropriate self-aggregation of misfolded or mutant polypeptide sequences is detrimental to cell health. Yet protein quality control mechanisms may also deliberately cluster them together into distinct inclusion subtypes, including the insoluble protein deposit (IPOD) and the juxtanuclear quality control (JUNQ). Here we investigated how the intrinsic oligomeric state of three model systems of disease-relevant mutant protein and peptide sequences relates to the IPOD and JUNQ patterns of aggregation using sedimentation velocity analysis. Two of the models (polyalanine (37A) and superoxide dismutase 1 (SOD1) mutants A4V and G85R) accumulated into the same JUNQ-like inclusion whereas the other, polyglutamine (72Q), formed spatially distinct IPOD-like inclusions. Using flow cytometry pulse shape analysis (PulSA) to separate cells with inclusions from those without revealed the SOD1 mutants and 37A to have abruptly altered oligomeric states with respect to the nonaggregating forms, regardless of whether cells had inclusions or not, whereas 72Q was almost exclusively monomeric until inclusions formed. We propose that mutations leading to JUNQ inclusions induce a constitutively misfolded state exposing hydrophobic side chains that attract and ultimately overextend protein quality capacity, which leads to aggregation into JUNQ inclusions. Poly(Q) is not misfolded in this same sense due to universal polar side chains, but is highly prone to forming amyloid fibrils that we propose invoke a different engagement mechanism with quality control.	[Polling, Saskia; Mok, Yee-Foong; Ramdzan, Yasmin M.; Hill, Andrew F.; Hatters, Danny M.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Polling, Saskia; Mok, Yee-Foong; Ramdzan, Yasmin M.; Hill, Andrew F.; Hatters, Danny M.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Turner, Bradley J.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic 3010, Australia; [Turner, Bradley J.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia; [Yerbury, Justin J.] Univ Wollongong, Sch Biol Sci, Fac Sci, Wollongong, NSW 2522, Australia; [Yerbury, Justin J.] Univ Wollongong, Illawarra Hlth & Med Inst, Wollongong, NSW 2522, Australia	University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Wollongong; University of Wollongong	Hatters, DM (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, 30 Flemington Rd, Melbourne, Vic 3010, Australia.	dhatters@unimelb.edu.au	Yerbury, Justin/AAC-7054-2022; Hill, Andrew F/B-4527-2009; Hill, Andrew F./AAH-2854-2020; Hill, Andrew F./GZL-4124-2022	Yerbury, Justin/0000-0003-2528-7039; Hill, Andrew F/0000-0001-5581-2354; Hill, Andrew F./0000-0001-5581-2354; Turner, Bradley/0000-0001-6580-7655; Hatters, Danny/0000-0002-9965-2847	Australian Research Council (ARC) Discovery Grant [DP120102763]; ARC Future Fellowship Grant [FT120100039, FT100100560]	Australian Research Council (ARC) Discovery Grant(Australian Research Council); ARC Future Fellowship Grant(Australian Research Council)	This work was supported by Australian Research Council (ARC) Discovery Grant DP120102763 and ARC Future Fellowship Grant FT120100039 (to D. M. H.), and ARC Future Fellowship Grant FT100100560 (to A. F. H.).	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Bennett MJ, 2002, P NATL ACAD SCI USA, V99, P11634, DOI 10.1073/pnas.182393899; Berger Z, 2006, HUM MOL GENET, V15, P453, DOI 10.1093/hmg/ddi460; Bernacki JP, 2011, BIOCHEMISTRY-US, V50, P9200, DOI 10.1021/bi201155g; Blondelle SE, 1997, BIOCHEMISTRY-US, V36, P8393, DOI 10.1021/bi963015b; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Cecchi C, 2013, BIOPHYS CHEM, V182, P30, DOI 10.1016/j.bpc.2013.06.003; Chen SM, 2002, P NATL ACAD SCI USA, V99, P11884, DOI 10.1073/pnas.182276099; Chen SM, 2002, BIOCHEMISTRY-US, V41, P7391, DOI 10.1021/bi011772q; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hatters DM, 2012, CURR TOP MED CHEM, V12, P2611; Hughes J., 2013, TANDEM REPEATS GENES, P135; Irtegun S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071035; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Landis D., 1996, HDB INTERCULTURAL TR, V2nd; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Lotz GP, 2013, J MOL MED, V91, P653, DOI 10.1007/s00109-013-1025-1; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; Matsumoto G, 2006, J BIOL CHEM, V281, P4477, DOI 10.1074/jbc.M509201200; Matsumoto G, 2005, J CELL BIOL, V171, P75, DOI 10.1083/jcb.200504050; Munch C, 2010, J MOL BIOL, V399, P512, DOI 10.1016/j.jmb.2010.04.019; Nojima J, 2009, J NEUROSCI RES, V87, P2290, DOI 10.1002/jnr.22052; Olshina MA, 2010, J BIOL CHEM, V285, P21807, DOI 10.1074/jbc.M109.084434; Onodera O, 1997, BIOCHEM BIOPH RES CO, V238, P599, DOI 10.1006/bbrc.1997.7337; Ormsby AR, 2013, J BIOL CHEM, V288, P37192, DOI 10.1074/jbc.M113.486944; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Ramdzan YM, 2012, NAT METHODS, V9, P467, DOI [10.1038/NMETH.1930, 10.1038/nmeth.1930]; Ramdzan YM, 2010, CHEM BIOL, V17, P371, DOI 10.1016/j.chembiol.2010.03.011; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Rankin J, 2000, BIOCHEM J, V348, P15, DOI 10.1042/0264-6021:3480015; Robertson AL, 2010, CURR MED CHEM, V17, P3058; Robertson AL, 2010, P NATL ACAD SCI USA, V107, P10424, DOI 10.1073/pnas.0914773107; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; Sipe JD, 2010, AMYLOID, V17, P101, DOI 10.3109/13506129.2010.526812; Tsvetkov AS, 2013, NAT CHEM BIOL, V9, P586, DOI [10.1038/NCHEMBIO.1308, 10.1038/nchembio.1308]; Turner BJ, 2005, J NEUROSCI, V25, P108, DOI 10.1523/JNEUROSCI.4253-04.2005; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Wang J, 2009, P NATL ACAD SCI USA, V106, P1392, DOI 10.1073/pnas.0813045106; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Wang Y, 2009, FASEB J, V23, P451, DOI 10.1096/fj.08-117614; Weisberg SJ, 2012, P NATL ACAD SCI USA, V109, P15811, DOI 10.1073/pnas.1205829109; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	57	30	30	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6669	6680		10.1074/jbc.M113.520189	http://dx.doi.org/10.1074/jbc.M113.520189			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24425868	hybrid, Green Published			2022-12-28	WOS:000332389400030
J	Singh, R; Kraft, C; Jaiswal, R; Sejwal, K; Kasaragod, VB; Kuper, J; Burger, J; Mielke, T; Luirink, J; Bhushan, S				Singh, Rajkumar; Kraft, Christian; Jaiswal, Rahul; Sejwal, Kushal; Kasaragod, Vikram Babu; Kuper, Jochen; Buerger, Joerg; Mielke, Thorsten; Luirink, Joen; Bhushan, Shashi			Cryo-electron Microscopic Structure of SecA Protein Bound to the 70S Ribosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electron Microscopy (EM); Protein Secretion; Protein Translocation; Ribosomes; Single Particle Analysis; 70S; Cryo-EM; Ribosome; SecA; SecYEG	ION-CHANNEL ACTIVITY; ESCHERICHIA-COLI; SIGNAL-PEPTIDE; DIMERIC SECA; THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE; BINDING DOMAIN; ATPASE SECA; TRANSLOCATION; COMPLEX	Background: SecA targets preproteins to the protein-conducting channel in bacteria. Results: Both the single and double copies of SecA bind to the 70S ribosome. Conclusion: Two copies of SecA completely surround the polypeptide tunnel exit. Significance: The structures suggest a function of the dimeric form of SecA on the ribosome. SecA is an ATP-dependent molecular motor pumping secretory and outer membrane proteins across the cytoplasmic membrane in bacteria. SecA associates with the protein-conducting channel, the heterotrimeric SecYEG complex, in a so-called posttranslational manner. A recent study further showed binding of a monomeric state of SecA to the ribosome. However, the true oligomeric state of SecA remains controversial because SecA can also form functional dimers, and high-resolution crystal structures exist for both the monomer and the dimer. Here we present the cryo-electron microscopy structures of Escherichia coli SecA bound to the ribosome. We show that not only a monomeric SecA binds to the ribosome but also that two copies of SecA can be observed that form an elongated dimer. Two copies of SecA completely surround the tunnel exit, providing a unique environment to the nascent polypeptides emerging from the ribosome. We identified the N-terminal helix of SecA required for a stable association with the ribosome. The structures indicate a possible function of the dimeric form of SecA at the ribosome.	[Singh, Rajkumar; Kraft, Christian; Sejwal, Kushal; Kasaragod, Vikram Babu; Kuper, Jochen; Bhushan, Shashi] Univ Wurzburg, Rudolf Virchow Ctr, DFG Res Ctr Expt Biomed, D-97078 Wurzburg, Germany; [Jaiswal, Rahul; Bhushan, Shashi] Nanyang Technol Univ, Div Struct Biol & Biochem, Sch Biol Sci, Singapore 637551, Singapore; [Buerger, Joerg; Mielke, Thorsten] Max Planck Inst Mol Genet, UltraStrukturNetzwerk, D-14195 Berlin, Germany; [Buerger, Joerg; Mielke, Thorsten] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany; [Luirink, Joen] Vrije Univ Amsterdam, Dept Mol Microbiol, Inst Mol Cell Biol, NL-1081 HV Amsterdam, Netherlands	German Research Foundation (DFG); University of Wurzburg; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Vrije Universiteit Amsterdam	Bhushan, S (corresponding author), Nanyang Technol Univ, Div Struct Biol & Biochem, Sch Biol Sci, Singapore 639798, Singapore.	sbhushan@ntu.edu.sg	Jaiswal, Rahul/GLS-9380-2022; Luirink, Joen/AAB-8658-2021	Jaiswal, Rahul/0000-0002-4379-3798; Burger, Jorg/0000-0002-4326-5047; Bhushan, Shashi/0000-0002-8514-5959; Luirink, J./0000-0001-8431-0804; Kasaragod, Vikram Babu/0000-0002-1241-4038	Deutsche Forschungsgemeinschaft (Forschungszentrum, Rudolf-Virchow-Zentrum); School of Biological Sciences, Nanyang Technological University, Singapore; Deutsche Forschungsgemeinschaft [SFB740]	Deutsche Forschungsgemeinschaft (Forschungszentrum, Rudolf-Virchow-Zentrum)(German Research Foundation (DFG)); School of Biological Sciences, Nanyang Technological University, Singapore(Nanyang Technological University); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Forschungszentrum, Rudolf-Virchow-Zentrum), by the School of Biological Sciences, Nanyang Technological University, Singapore (to S. B.), and by Grant SFB740, Project Z1 from the Deutsche Forschungsgemeinschaft (to T. M.).	AKITA M, 1991, BIOCHEM BIOPH RES CO, V174, P211, DOI 10.1016/0006-291X(91)90507-4; Benach J, 2003, J BIOL CHEM, V278, P3628, DOI 10.1074/jbc.M205992200; Bhushan S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000581; Clemons WM, 2001, J MOL BIOL, V310, P827, DOI 10.1006/jmbi.2001.4778; Das S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182931; de Keyzer J, 2005, J BIOL CHEM, V280, P35255, DOI 10.1074/jbc.M506157200; Deville K, 2011, J BIOL CHEM, V286, P4659, DOI 10.1074/jbc.M110.175638; DRIESSEN AJM, 1993, BIOCHEMISTRY-US, V32, P13190, DOI 10.1021/bi00211a030; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erlandson KJ, 2008, NATURE, V455, P984, DOI 10.1038/nature07439; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Halic M, 2006, NATURE, V444, P507, DOI 10.1038/nature05326; Hsieh YH, 2013, BIOCHEM BIOPH RES CO, V431, P388, DOI 10.1016/j.bbrc.2013.01.042; Hsieh YH, 2011, J BIOL CHEM, V286, P44702, DOI 10.1074/jbc.M111.300111; Huber D, 2011, MOL CELL, V41, P343, DOI 10.1016/j.molcel.2010.12.028; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; Jilaveanu LB, 2006, J BACTERIOL, V188, P335, DOI 10.1128/JB.188.1.335-338.2006; Jilaveanu LB, 2005, P NATL ACAD SCI USA, V102, P7511, DOI 10.1073/pnas.0502774102; Karamanou S, 2005, FEBS LETT, V579, P1267, DOI 10.1016/j.febslet.2005.01.025; Karamyshev AL, 2005, J BIOL CHEM, V280, P37930, DOI 10.1074/jbc.M509100200; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Kusters I, 2011, STRUCTURE, V19, P430, DOI 10.1016/j.str.2010.12.016; Lin BR, 2012, J MEMBRANE BIOL, V245, P747, DOI 10.1007/s00232-012-9477-8; Merz F, 2008, EMBO J, V27, P1622, DOI 10.1038/emboj.2008.89; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Morita K, 2012, J BIOL CHEM, V287, P455, DOI 10.1074/jbc.M111.301754; Musial-Siwek M, 2005, BIOCHEMISTRY-US, V44, P13987, DOI 10.1021/bi050882k; Musial-Siwek M, 2007, J MOL BIOL, V365, P637, DOI 10.1016/j.jmb.2006.10.027; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; Or E, 2002, EMBO J, V21, P4470, DOI 10.1093/emboj/cdf471; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Osborne AR, 2004, P NATL ACAD SCI USA, V101, P10937, DOI 10.1073/pnas.0401742101; Papanikolau Y, 2007, J MOL BIOL, V366, P1545, DOI 10.1016/j.jmb.2006.12.049; Papanikou E, 2005, J BIOL CHEM, V280, P43209, DOI 10.1074/jbc.M509990200; Park E, 2012, ANNU REV BIOPHYS, V41, P21, DOI [10.1146/annurev-biophys-050511-102312, 10.1146/annurev-biophys-050511-402312]; Penczek PA, 2006, J STRUCT BIOL, V154, P184, DOI 10.1016/j.jsb.2005.12.013; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Randall LL, 2005, J MOL BIOL, V348, P479, DOI 10.1016/j.jmb.2005.02.036; ROLLO EE, 1988, J BACTERIOL, V170, P3281, DOI 10.1128/jb.170.7.3281-3282.1988; Sardis MF, 2010, MOL MICROBIOL, V76, P1070, DOI 10.1111/j.1365-2958.2010.07176.x; Schaffitzel C, 2006, NATURE, V444, P503, DOI 10.1038/nature05182; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; Tziatzios C, 2004, J MOL BIOL, V340, P513, DOI 10.1016/j.jmb.2004.04.076; Vassylyev DG, 2006, J MOL BIOL, V364, P248, DOI 10.1016/j.jmb.2006.09.061; Whitehouse S, 2012, J CELL BIOL, V199, P919, DOI 10.1083/jcb.201205191; Woodbury RL, 2002, PROTEIN SCI, V11, P875, DOI 10.1110/ps.4090102; Wu ZC, 2012, J BIOL CHEM, V287, P7885, DOI 10.1074/jbc.M111.297911; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335; Zimmer J, 2006, J MOL BIOL, V364, P259, DOI 10.1016/j.jmb.2006.08.044	53	34	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7190	7199		10.1074/jbc.M113.506634	http://dx.doi.org/10.1074/jbc.M113.506634			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24443566	Green Published, hybrid			2022-12-28	WOS:000332389400077
J	Ran, LY; Su, HN; Zhou, MY; Wang, L; Chen, XL; Xie, BB; Song, XY; Shi, M; Qin, QL; Pang, XH; Zhou, BC; Zhang, YZ; Zhang, XY				Ran, Li-Yuan; Su, Hai-Nan; Zhou, Ming-Yang; Wang, Lei; Chen, Xiu-Lan; Xie, Bin-Bin; Song, Xiao-Yan; Shi, Mei; Qin, Qi-Long; Pang, Xiuhua; Zhou, Bai-Cheng; Zhang, Yu-Zhong; Zhang, Xi-Ying			Characterization of a Novel Subtilisin-like Protease Myroicolsin from Deep Sea Bacterium Myroides profundi D25 and Molecular Insight into Its Collagenolytic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Biodegradation; Collagen; Enzyme Mechanisms; Serine Protease; Collagenolytic Mechanism; Deep Sea Sediment; Nitrogen Cycling; Structural Characteristics; Subtilisin-like Protease	PSEUDOALTEROMONAS SP SM9913; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; SERINE PROTEINASE; ORGANIC NITROGEN; STRUCTURAL BASIS; DESEASIN MCP-01; TRIPLE-HELIX; BINDING ABILITY; FIDDLER-CRAB	Background: The mechanism of marine collagen degradation is largely unknown. Results: Myroicolsin, a subtilisin-like protease from a marine bacterium, was characterized, and its collagenolytic mechanism was studied. Conclusion: Myroicolsin has a novel domain structure and a unique collagen degradation mechanism compared with other subtilisin-like proteases. Significance: This study provides new insights into the mechanism of subtilisin-like proteases' collagenolysis and marine nitrogen cycling. Collagen is an insoluble protein that widely distributes in the extracellular matrix of marine animals. Collagen degradation is an important step in the marine nitrogen cycle. However, the mechanism of marine collagen degradation is still largely unknown. Here, a novel subtilisin-like collagenolytic protease, myroicolsin, which is secreted by the deep sea bacterium Myroides profundi D25, was purified and characterized, and its collagenolytic mechanism was studied. Myroicolsin displays low identity (<30%) to previously characterized subtilisin-like proteases, and it contains a novel domain structure. Protein truncation indicated that the Pro secretion system C-terminal sorting domain in the precursor protein is involved in the cleavage of the N-propeptide, and the linker is required for protein folding during myroicolsin maturation. The C-terminal -jelly roll domain did not bind insoluble collagen fiber, suggesting that myroicolsin may degrade collagen without the assistance of a collagen-binding domain. Myroicolsin had broad specificity for various collagens, especially fish-insoluble collagen. The favored residue at the P1 site was basic arginine. Scanning electron microscopy and atomic force microscopy, together with biochemical analyses, confirmed that collagen fiber degradation by myroicolsin begins with the hydrolysis of proteoglycans and telopeptides in collagen fibers and fibrils. Myroicolsin showed strikingly different cleavage patterns between native and denatured collagens. A collagen degradation model of myroicolsin was proposed based on our results. Our study provides molecular insight into the collagen degradation mechanism and structural characterization of a subtilisin-like collagenolytic protease secreted by a deep sea bacterium, shedding light on the degradation mechanism of deep sea sedimentary organic nitrogen.	[Ran, Li-Yuan; Su, Hai-Nan; Zhou, Ming-Yang; Wang, Lei; Chen, Xiu-Lan; Xie, Bin-Bin; Song, Xiao-Yan; Shi, Mei; Qin, Qi-Long; Pang, Xiuhua; Zhang, Yu-Zhong; Zhang, Xi-Ying] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Ran, Li-Yuan; Su, Hai-Nan; Zhou, Ming-Yang; Wang, Lei; Chen, Xiu-Lan; Xie, Bin-Bin; Song, Xiao-Yan; Shi, Mei; Qin, Qi-Long; Pang, Xiuhua; Zhou, Bai-Cheng; Zhang, Yu-Zhong; Zhang, Xi-Ying] Shandong Univ, Marine Biotechnol Res Ctr, Jinan 250100, Peoples R China; [Su, Hai-Nan; Chen, Xiu-Lan; Xie, Bin-Bin; Song, Xiao-Yan; Shi, Mei; Qin, Qi-Long; Pang, Xiuhua; Zhang, Yu-Zhong; Zhang, Xi-Ying] Shandong Univ, Collaborat Innovat Ctr Deep Sea Biol, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University	Zhang, YZ (corresponding author), Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	zhangyz@sdu.edu.cn; zhangxiying@sdu.edu.cn		Ran, Liyuan/0000-0002-8241-7138	National Natural Science Foundation of China [91228210, 31290231, 31025001, 31170055]; Hi-Tech Research and Development Program of China [2011AA090703, 2012AA092103]; China Ocean Mineral Resources R&D Association (COMRA) Special Foundation [DY125-15-T-05, DY125-15-R-03]; Special Fund of China for Marine-Scientific Research in the Public Interest [201005032-6]; Program of Shandong for Taishan Scholars [2008BS02019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); China Ocean Mineral Resources R&D Association (COMRA) Special Foundation; Special Fund of China for Marine-Scientific Research in the Public Interest; Program of Shandong for Taishan Scholars	The work was supported by National Natural Science Foundation of China Grants 91228210, 31290231, 31025001, and 31170055; Hi-Tech Research and Development Program of China Grants 2011AA090703 and 2012AA092103; China Ocean Mineral Resources R&D Association (COMRA) Special Foundation Grants DY125-15-T-05 and DY125-15-R-03; Special Fund of China for Marine-Scientific Research in the Public Interest Grant 201005032-6; and Program of Shandong for Taishan Scholars Grant 2008BS02019.	Abraham LD, 1996, ENZYME MICROB TECH, V18, P133, DOI 10.1016/0141-0229(95)00098-4; Aluwihare LI, 2005, SCIENCE, V308, P1007, DOI 10.1126/science.1108925; BALLINGER MD, 1995, BIOCHEMISTRY-US, V34, P13312, DOI 10.1021/bi00041a006; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; Brunnegard J, 2004, PROG OCEANOGR, V63, P159, DOI 10.1016/j.pocean.2004.09.004; Chen XL, 2007, MICROBIOL-SGM, V153, P2116, DOI 10.1099/mic.0.2007/006056-0; Chen XL, 2009, APPL ENVIRON MICROB, V75, P1838, DOI 10.1128/AEM.02285-08; Chen YJ, 2008, CURR OPIN STRUC BIOL, V18, P765, DOI 10.1016/j.sbi.2008.10.005; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; COWAN PM, 1955, NATURE, V176, P1062, DOI 10.1038/1761062a0; Eckhard U, 2011, NAT STRUCT MOL BIOL, V18, P1109, DOI 10.1038/nsmb.2127; EDER J, 1993, J MOL BIOL, V233, P293, DOI 10.1006/jmbi.1993.1507; EISEN AZ, 1973, BIOCHEMISTRY-US, V12, P1814, DOI 10.1021/bi00733a024; Exposito JY, 2010, INT J MOL SCI, V11, P407, DOI 10.3390/ijms11020407; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Foophow T, 2010, J MOL BIOL, V400, P865, DOI 10.1016/j.jmb.2010.05.064; Gupta R, 2002, APPL MICROBIOL BIOT, V59, P15, DOI 10.1007/s00253-002-0975-y; He HL, 2004, FOOD CHEM, V84, P307, DOI 10.1016/S0308-8146(03)00242-5; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Itoi Y, 2006, J BACTERIOL, V188, P6572, DOI 10.1128/JB.00767-06; Kadler KE, 2007, J CELL SCI, V120, P1955, DOI 10.1242/jcs.03453; Kadler KE, 1996, BIOCHEM J, V316, P1; Kafienah W, 1998, BIOCHEM J, V331, P727, DOI 10.1042/bj3310727; Kim Hyo-Kyung, 2003, Korean Journal of Parasitology, V41, P189, DOI 10.3347/kjp.2003.41.4.189; Kim Won-Tae, 2006, Korean Journal of Parasitology, V44, P321, DOI 10.3347/kjp.2006.44.4.321; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Kurata A, 2010, APPL MICROBIOL BIOT, V86, P589, DOI 10.1007/s00253-009-2324-x; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; MACIVER B, 1994, APPL ENVIRON MICROB, V60, P3981, DOI 10.1128/AEM.60.11.3981-3988.1994; Manka SW, 2012, P NATL ACAD SCI USA, V109, P12461, DOI 10.1073/pnas.1204991109; Nonaka T, 2004, J BIOL CHEM, V279, P47344, DOI 10.1074/jbc.M409089200; O'Farrell TJ, 2006, BIOCHEMISTRY-US, V45, P15411, DOI 10.1021/bi060849d; Okamoto M, 2001, APPL MICROBIOL BIOT, V57, P103, DOI 10.1007/s002530100731; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Orgel JPRO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007028; Panwar P, 2013, J BIOL CHEM, V288, P5940, DOI 10.1074/jbc.M112.419689; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Perona JJ, 1997, BIOCHEMISTRY-US, V36, P5381, DOI 10.1021/bi9617522; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Robinson MW, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001012; Sankar S, 2008, INT J BIOL MACROMOL, V42, P6, DOI 10.1016/j.ijbiomac.2007.08.003; Sarkar S, 2010, MAR DRUGS, V8, P1323, DOI 10.3390/md8041323; SCOTT JE, 1981, BIOCHEM J, V195, P573, DOI 10.1042/bj1950573; Taddese S, 2010, BBA-PROTEINS PROTEOM, V1804, P731, DOI 10.1016/j.bbapap.2009.11.014; TAKEUCHI H, 1992, BIOCHEM J, V281, P703, DOI 10.1042/bj2810703; Tanaka S, 2008, FEBS LETT, V582, P3875, DOI 10.1016/j.febslet.2008.10.025; Tsu CA, 1997, BIOCHEMISTRY-US, V36, P5393, DOI 10.1021/bi961753u; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Walton RS, 2010, J MATER SCI-MATER M, V21, P451, DOI 10.1007/s10856-009-3910-2; Wang YK, 2010, J BIOL CHEM, V285, P14285, DOI 10.1074/jbc.M109.087023; Windhorst S, 2002, J BIOL CHEM, V277, P11042, DOI 10.1074/jbc.M109525200; Worthington Biochemical Co, 1993, WORTH ENZ MAN; YOSHIDA ETUSUKO, 1965, BIOCHIM BIOPHYSACTA, V105, P562; Zhang XY, 2008, FEMS MICROBIOL LETT, V287, P108, DOI 10.1111/j.1574-6968.2008.01299.x; Zhao GY, 2008, J BIOL CHEM, V283, P36100, DOI 10.1074/jbc.M804438200	56	26	26	3	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6041	6053		10.1074/jbc.M113.513861	http://dx.doi.org/10.1074/jbc.M113.513861			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24429289	hybrid, Green Published			2022-12-28	WOS:000332015500059
J	Branham-O'Connor, M; Robichaux, WG; Zhang, XK; Cho, H; Kehrl, JH; Lanier, SM; Blumer, JB				Branham-O'Connor, Melissa; Robichaux, William G., III; Zhang, Xian-Kui; Cho, Hyeseon; Kehrl, John H.; Lanier, Stephen M.; Blumer, Joe B.			Defective Chemokine Signal Integration in Leukocytes Lacking Activator of G Protein Signaling 3 ( AGS3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chemokines; Chemotaxis; Cxcr4; G-protein-coupled Receptors (GPCR); G Proteins; AGS3; Gi; G; GPR Motif; Gpsm1	G-BETA-GAMMA; ASYMMETRIC CELL-DIVISION; RECEPTOR-INDEPENDENT ACTIVATORS; NUCLEOTIDE EXCHANGE FACTOR; DIFFERENTIAL REGULATION; NEUTROPHIL CHEMOTAXIS; GOLOCO MOTIF; KINASE; EXPRESSION; MIGRATION	Background: Roles for AGS3/Gpsm1 in the immune system are not defined. Results: Loss of AGS3 expression results in defective leukocyte chemotaxis, calcium mobilization, and ERK1/2 and Akt activation. Conclusion: AGS3 is required for efficient chemokine receptor signal integration. Significance: These studies extend the functional repertoire for AGS3 in the immune system, providing unexpected regulatory mechanisms for immune function. Activator of G-protein signaling 3 (AGS3, gene name G-protein signaling modulator-1, Gpsm1), an accessory protein for G-protein signaling, has functional roles in the kidney and CNS. Here we show that AGS3 is expressed in spleen, thymus, and bone marrow-derived dendritic cells, and is up-regulated upon leukocyte activation. We explored the role of AGS3 in immune cell function by characterizing chemokine receptor signaling in leukocytes from mice lacking AGS3. No obvious differences in lymphocyte subsets were observed. Interestingly, however, AGS3-null B and T lymphocytes and bone marrow-derived dendritic cells exhibited significant chemotactic defects as well as reductions in chemokine-stimulated calcium mobilization and altered ERK and Akt activation. These studies indicate a role for AGS3 in the regulation of G-protein signaling in the immune system, providing unexpected venues for the potential development of therapeutic agents that modulate immune function by targeting these regulatory mechanisms.	[Branham-O'Connor, Melissa; Robichaux, William G., III; Lanier, Stephen M.; Blumer, Joe B.] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA; [Zhang, Xian-Kui] Med Univ S Carolina, Div Rheumatol, Dept Med, Charleston, SC 29425 USA; [Cho, Hyeseon; Kehrl, John H.] NIAID, B Cell Sect, NIH, Bethesda, MD 20892 USA	Medical University of South Carolina; Medical University of South Carolina; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Blumer, JB (corresponding author), Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, 173 Ashley Ave,BSB358,MSC509, Charleston, SC 29425 USA.	blumerjb@musc.edu	Kehrl, John/AAE-6292-2019	Blumer, Joe/0000-0002-0020-3815; Lanier, Stephen/0000-0002-2740-7607; Kehrl, John/0000-0002-6526-159X	Cancer Center Support grant [P30 CA138313]; National Center for Research Resources; Office of the Director of the National Institutes of Health [C06 RR015455, S10 RR027777]; Medical University of South Carolina (MUSC) institutional funds; National Institutes of Health [GM086510, DA025896, AR056670, T32CA119945]; Department of Veterans Affairs; National Institutes of Health NIGMS SC-INBRE [P20GM103499]; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000961, ZIAAI000738] Funding Source: NIH RePORTER	Cancer Center Support grant; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of the Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical University of South Carolina (MUSC) institutional funds; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health NIGMS SC-INBRE; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research presented in this article was supported in part by the Flow Cytometry and Cell Sorting Shared Resource, funded by a Cancer Center Support grant P30 CA138313 to the Hollings Cancer Center at the Medical University of South Carolina and in part by the National Center for Research Resources and the Office of the Director of the National Institutes of Health through grant number C06 RR015455 and S10 RR027777. This work was supported by Medical University of South Carolina (MUSC) institutional funds (to J. B. B.); National Institutes of Health Grants GM086510 (to J. B. B.), DA025896 (to S. M. L.), AR056670 (to X. Z.), and T32CA119945 (to M. B. O.); the Merit Review Award from the Department of Veterans Affairs (to X. Z.); National Institutes of Health NIGMS SC-INBRE Grant P20GM103499 (to M. B. O.); and the intramural research program of the National Institute of Allergy and Infectious Diseases (to H. C. and J. H. K.).	Arai H, 1997, P NATL ACAD SCI USA, V94, P14495, DOI 10.1073/pnas.94.26.14495; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Blumer JB, 2012, ACTA PHYSIOL, V204, P202, DOI 10.1111/j.1748-1716.2011.02327.x; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; Blumer JB, 2008, ENDOCRINOLOGY, V149, P3842, DOI 10.1210/en.2008-0050; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Bowers MS, 2008, P NATL ACAD SCI USA, V105, P12533, DOI 10.1073/pnas.0706999105; Bowers MS, 2004, NEURON, V42, P269, DOI 10.1016/S0896-6273(04)00159-X; Cho H, 2000, MOL PHARMACOL, V58, P569, DOI 10.1124/mol.58.3.569; Cho H, 2012, MOL CELL BIOL, V32, P4561, DOI 10.1128/MCB.00651-12; Cho H, 2009, PROG MOL BIOL TRANSL, V86, P249, DOI 10.1016/S1877-1173(09)86009-2; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; Conley JM, 2013, CELL MOL NEUROBIOL, V33, P551, DOI 10.1007/s10571-013-9925-8; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; Dalwadi H, 2003, J IMMUNOL, V170, P1707, DOI 10.4049/jimmunol.170.4.1707; Dehring DAK, 2011, J IMMUNOL, V186, P4805, DOI 10.4049/jimmunol.1003102; Delgado-Martin C, 2011, J BIOL CHEM, V286, P37222, DOI 10.1074/jbc.M111.294116; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; Fan PD, 2009, MOL PHARMACOL, V76, P526, DOI 10.1124/mol.109.057802; Ghosh M, 2003, J BIOL CHEM, V278, P34747, DOI 10.1074/jbc.C300271200; Giguere PM, 2013, MOL IMMUNOL, V54, P193, DOI 10.1016/j.molimm.2012.12.001; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Groves B, 2007, P NATL ACAD SCI USA, V104, P18103, DOI 10.1073/pnas.0709282104; Han SB, 2005, IMMUNITY, V22, P343, DOI 10.1016/j.immuni.2005.01.017; Huang TT, 2003, INT IMMUNOL, V15, P1359, DOI 10.1093/intimm/dxg135; Humrich JY, 2006, IMMUNOLOGY, V117, P238, DOI 10.1111/j.1365-2567.2005.02292.x; Hwang IY, 2007, J IMMUNOL, V179, P439, DOI 10.4049/jimmunol.179.1.439; Kamakura S, 2013, DEV CELL, V26, P292, DOI 10.1016/j.devcel.2013.06.008; Kehrl JH, 2009, CURR TOP MICROBIOL, V334, P107, DOI 10.1007/978-3-540-93864-4_5; Khan SM, 2013, PHARMACOL REV, V65, P545, DOI 10.1124/pr.111.005603; Kinoshita-Kawada M, 2004, MOL BRAIN RES, V132, P73, DOI 10.1016/j.molbrainres.2004.09.007; Kirui JK, 2010, J PHARMACOL EXP THER, V333, P393, DOI 10.1124/jpet.109.164814; Knoblich JA, 2010, NAT REV MOL CELL BIO, V11, P849, DOI 10.1038/nrm3010; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Kwon M, 2012, P NATL ACAD SCI USA, V109, P21462, DOI 10.1073/pnas.1216830110; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; MARKS PW, 1990, J CELL BIOL, V110, P43, DOI 10.1083/jcb.110.1.43; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Moratz C, 2004, METHOD ENZYMOL, V389, P15; Nadella R, 2010, J AM SOC NEPHROL, V21, P1275, DOI 10.1681/ASN.2009121224; Neptune ER, 1997, P NATL ACAD SCI USA, V94, P14489, DOI 10.1073/pnas.94.26.14489; Oliaro J, 2010, J IMMUNOL, V185, P367, DOI 10.4049/jimmunol.0903627; Oner SS, 2010, J BIOL CHEM, V285, P33949, DOI 10.1074/jbc.M110.138073; Oner SS, 2010, J BIOL CHEM, V285, P20588, DOI 10.1074/jbc.C109.088070; Pattingre S, 2003, J BIOL CHEM, V278, P20995, DOI 10.1074/jbc.M300917200; Peracino B, 1998, J CELL BIOL, V141, P1529, DOI 10.1083/jcb.141.7.1529; Pero RS, 2007, P NATL ACAD SCI USA, V104, P4371, DOI 10.1073/pnas.0700185104; Ponting CP, 1999, J MOL MED, V77, P695, DOI 10.1007/s001099900054; Regner KR, 2011, FASEB J, V25, P1844, DOI 10.1096/fj.10-169797; Ricart BG, 2011, J IMMUNOL, V186, P53, DOI 10.4049/jimmunol.1002358; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; Sagar D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-245; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Sato M, 2004, J BIOL CHEM, V279, P13375, DOI 10.1074/jbc.M312660200; Sato M, 2006, ANNU REV PHARMACOL, V46, P151, DOI 10.1146/annurev.pharmtox.46.120604.141115; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Skokowa J, 2005, J IMMUNOL, V174, P3041, DOI 10.4049/jimmunol.174.5.3041; Sozzani S, 1998, J IMMUNOL, V161, P1083; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sun ZZ, 2011, J BIOL CHEM, V286, P43902, DOI 10.1074/jbc.M111.301382; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Tilton B, 2000, J EXP MED, V192, P313, DOI 10.1084/jem.192.3.313; Ueda H, 2008, J BIOL CHEM, V283, P1946, DOI 10.1074/jbc.M707037200; Vecchi A, 1999, J LEUKOCYTE BIOL, V66, P489, DOI 10.1002/jlb.66.3.489; Vural A, 2010, MOL CELL BIOL, V30, P1528, DOI 10.1128/MCB.01018-09; Wang TL, 2000, J BIOL CHEM, V275, P7466, DOI 10.1074/jbc.275.11.7466; Webb CK, 2005, J NEUROCHEM, V92, P1408, DOI 10.1111/j.1471-4159.2004.02997.x; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wiege K, 2012, J IMMUNOL, V189, P980, DOI 10.4049/jimmunol.1200891; Wiser O, 2006, NEURON, V50, P561, DOI 10.1016/j.neuron.2006.03.046; Yao L, 2005, P NATL ACAD SCI USA, V102, P8746, DOI 10.1073/pnas.0503419102; Zarbock A, 2007, BLOOD, V110, P3773, DOI 10.1182/blood-2007-06-094565	76	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10738	10747		10.1074/jbc.M113.515031	http://dx.doi.org/10.1074/jbc.M113.515031			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24573680	Green Published, hybrid			2022-12-28	WOS:000334226400043
J	Jensen, CS; Watanabe, S; Rasmussen, HB; Schmitt, N; Olesen, SP; Frost, NA; Blanpied, TA; Misonou, H				Jensen, Camilla Stampe; Watanabe, Shoji; Rasmussen, Hanne Borger; Schmitt, Nicole; Olesen, Soren-Peter; Frost, Nicholas A.; Blanpied, Thomas A.; Misonou, Hiroaki			Specific Sorting and Post-Golgi Trafficking of Dendritic Potassium Channels in Living Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Golgi; Intracellular Trafficking; Ion Channels; Myosin; Protein Sorting; Myosin	KV2.1 K+ CHANNEL; TRANSPORT; PROTEINS; ACTIN; IDENTIFICATION; LOCALIZATION; MICROTUBULES; MODULATION; EXPRESSION; RECEPTORS	Background: Voltage-gated K+ (Kv) channels are localized in specific dendritic subcompartments of neurons to regulate dendritic excitability. Results: Dendritic Kv channels are sorted and trafficked in distinct populations of post-Golgi transport vesicles. Conclusion: Sorting of Kv channels and their subsequent trafficking by unique mechanisms are crucial for their specific localizations within dendrites. Significance: Our study reveals the existence of novel subcompartment-specific trafficking pathways for dendritic ion channels. Proper membrane localization of ion channels is essential for the function of neuronal cells. Particularly, the computational ability of dendrites depends on the localization of different ion channels in specific subcompartments. However, the molecular mechanisms that control ion channel localization in distinct dendritic subcompartments are largely unknown. Here, we developed a quantitative live cell imaging method to analyze protein sorting and post-Golgi vesicular trafficking. We focused on two dendritic voltage-gated potassium channels that exhibit distinct localizations: Kv2.1 in proximal dendrites and Kv4.2 in distal dendrites. Our results show that Kv2.1 and Kv4.2 channels are sorted into two distinct populations of vesicles at the Golgi apparatus. The targeting of Kv2.1 and Kv4.2 vesicles occurred by distinct mechanisms as evidenced by their requirement for specific peptide motifs, cytoskeletal elements, and motor proteins. By live cell and super-resolution imaging, we identified a novel trafficking machinery important for the localization of Kv2.1 channels. Particularly, we identified non-muscle myosin II as an important factor in Kv2.1 trafficking. These findings reveal that the sorting of ion channels at the Golgi apparatus and their subsequent trafficking by unique molecular mechanisms are crucial for their specific localizations within dendrites.	[Jensen, Camilla Stampe; Rasmussen, Hanne Borger; Schmitt, Nicole; Olesen, Soren-Peter] Univ Copenhagen, Dept Biomed Sci, DK-2200 Copenhagen N, Denmark; [Jensen, Camilla Stampe; Misonou, Hiroaki] Univ Maryland, Dept Neural & Pain Sci, Baltimore, MD 21201 USA; [Frost, Nicholas A.; Blanpied, Thomas A.] Univ Maryland, Dept Physiol, Baltimore, MD 21201 USA; [Watanabe, Shoji; Misonou, Hiroaki] Doshisha Univ, Grad Sch Brain Sci, Unit Brain Pathol, Kyoto 61902225, Japan	University of Copenhagen; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Doshisha University	Misonou, H (corresponding author), Doshisha Univ, Grad Sch Brain Sci, Unit Brain Pathol, Kyoto 61902225, Japan.	h_misonou@mac.com	Rasmussen, Hanne B/N-9652-2016; Schmitt, Nicole/B-8725-2012; Olesen, Soren-Peter/H-4206-2011	Rasmussen, Hanne B/0000-0002-2218-5646; Frost, Nicholas/0000-0002-2270-643X; Schmitt, Nicole/0000-0001-9482-9749; Blanpied, Thomas/0000-0003-4957-557X; Olesen, Soren-Peter/0000-0002-4381-5192; Misono, Hiroaki/0000-0001-5892-1804; Jensen, Camilla Stampe/0000-0001-6546-8630	Epilepsy Foundation; Takeda Science Foundation; Naito Foundation; Danish Medical Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008181] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080046] Funding Source: NIH RePORTER; Lundbeck Foundation [R19-2008-2141] Funding Source: researchfish	Epilepsy Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Lundbeck Foundation(Lundbeckfonden)	This work was supported in part by a grant from the Epilepsy Foundation (to H. M.), the Takeda Science Foundation (to H. M.), the Naito Foundation (to H. M.), and a framework grant from the Danish Medical Research Council (to S. P. O.).	Al-Bassam S, 2012, CELL REPORTS, V2, P89, DOI 10.1016/j.celrep.2012.05.018; Allingham JS, 2005, NAT STRUCT MOL BIOL, V12, P378, DOI 10.1038/nsmb908; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Brown JR, 2004, J NEUROBIOL, V58, P175, DOI 10.1002/neu.10317; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Chu PJ, 2006, J BIOL CHEM, V281, P365, DOI 10.1074/jbc.M508897200; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Edeling MA, 2006, NAT REV MOL CELL BIO, V7, P32, DOI 10.1038/nrm1786; Farias GG, 2012, NEURON, V75, P810, DOI 10.1016/j.neuron.2012.07.007; FRECH GC, 1989, NATURE, V340, P642, DOI 10.1038/340642a0; Frost NA, 2010, NEURON, V67, P86, DOI 10.1016/j.neuron.2010.05.026; Gilling Mette, 2013, Frontiers in Genetics, V4, P54, DOI 10.3389/fgene.2013.00054; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Howard J., 2001, MECH MOTOR PROTEINS; Jensen CS, 2011, MOL CELL NEUROSCI, V48, P288, DOI 10.1016/j.mcn.2011.05.007; Jeyifous O, 2009, NAT NEUROSCI, V12, P1011, DOI 10.1038/nn.2362; Kaech S, 1996, NEURON, V17, P1189, DOI 10.1016/S0896-6273(00)80249-4; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Korobova F, 2010, MOL BIOL CELL, V21, P165, DOI 10.1091/mbc.E09-07-0596; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; Lewis TL, 2009, NAT NEUROSCI, V12, P568, DOI 10.1038/nn.2318; Lim ST, 2000, NEURON, V25, P385, DOI 10.1016/S0896-6273(00)80902-2; Lock JG, 2005, MOL BIOL CELL, V16, P1744, DOI 10.1091/mbc.E04-10-0867; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Menegola M, 2008, NEUROSCIENCE, V154, P953, DOI 10.1016/j.neuroscience.2008.04.022; Mohapatra DP, 2008, J NEUROSCI, V28, P4982, DOI 10.1523/JNEUROSCI.0186-08.2008; Murakoshi H, 1999, J NEUROSCI, V19, P1728; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Norstrom MF, 2010, J BIOL CHEM, V285, P26326, DOI 10.1074/jbc.M110.123851; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Polishchuk EV, 2003, MOL BIOL CELL, V14, P4470, DOI 10.1091/mbc.E03-01-0033; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Sarmiere PD, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-112; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Subach FV, 2010, J AM CHEM SOC, V132, P6481, DOI 10.1021/ja100906g; Tamkun MM, 2007, J CELL SCI, V120, P2413, DOI 10.1242/jcs.007351; Toomre D, 1999, J CELL SCI, V112, P21; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; TRIMMER JS, 1991, P NATL ACAD SCI USA, V88, P10764, DOI 10.1073/pnas.88.23.10764; Watanabe K, 2012, CELL REP, V2, P1546, DOI 10.1016/j.celrep.2012.11.015; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251	49	33	34	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10566	10581		10.1074/jbc.M113.534495	http://dx.doi.org/10.1074/jbc.M113.534495			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24569993	hybrid, Green Published			2022-12-28	WOS:000334226400029
J	Qi, YL; Zhang, MF; Li, H; Frank, JA; Dai, L; Liu, HJ; Chen, G				Qi, Yuanlin; Zhang, Mingfang; Li, Hui; Frank, Jacqueline A.; Dai, Lu; Liu, Huijuan; Chen, Gang			MicroRNA-29b Regulates Ethanol-induced Neuronal Apoptosis in the Developing Cerebellum through SP1/RAX/PKR Cascade*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cerebellum; MicroRNA; Neurons; Signal Transduction; Ethanol; Fetal; PKR; MiR-29b	TRANSCRIPTION FACTOR SP1; INDUCED CELL-DEATH; ALZHEIMERS-DISEASE; RESISTANT PERIODS; MYELOID-LEUKEMIA; DEVELOPING MOUSE; GRANULE NEURONS; GENE-EXPRESSION; PROTEIN-KINASE; NEURAL CELLS	Background: We investigated the role of microRNAs in ethanol neurotoxicity in the developing cerebellum. Results: MiR-29b regulates ethanol-induced apoptosis of cerebellar granule neurons in the developing cerebellum via SP1/RAX/PKR cascade. Conclusion: MiR-29b plays an important role in ethanol neurotoxicity in the developing cerebellum. Significance: MiR-29b may be a new preventive/therapeutic target for fetal alcohol spectrum disorders. Neuronal loss is a prominent etiological factor for fetal alcohol spectrum disorders. The cerebellum is one of the areas in the developing central nervous system that is most sensitive to ethanol, especially during the temporal window of ethanol vulnerability. MicroRNAs are small, non-coding RNAs capable of regulating diverse cellular functions including apoptosis. Ethanol exposure has been shown to interfere with the expression of microRNAs. However, the role of microRNAs in ethanol neurotoxicity is still not clear. In the present study, we identified a particular microRNA, miR-29b, as a novel target of ethanol in the developing cerebellar granule neurons. We discovered that ethanol exposure suppressed miR-29b and induced neuronal apoptosis. Overexpression of miR-29b rendered neurons protection against ethanol-induced apoptosis. Furthermore, our data indicated that miR-29b mediated ethanol neurotoxicity through the SP1/RAX/PKR cascade. More importantly, the expression of miR-29b is developmentally regulated, which may account for, at least partially, the temporal window of ethanol sensitivity in the developing cerebellum.	[Qi, Yuanlin; Zhang, Mingfang; Li, Hui; Frank, Jacqueline A.; Liu, Huijuan; Chen, Gang] Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA; [Dai, Lu] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Qi, Yuanlin] Fujian Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Fuzhou 350004, Fujian, Peoples R China; [Zhang, Mingfang] Fujian Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Fuzhou 350004, Fujian, Peoples R China	University of Kentucky; University of Kentucky; Fujian Medical University; Fujian Medical University	Chen, G (corresponding author), Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, 125 Hlth Sci Res Bldg,800 Rose St, Lexington, KY 40536 USA.	gangchen6@uky.edu	Qi, Yuanlin/GLT-5376-2022	Qi, Yuanlin/0000-0002-5253-9732; Zhang, Mingfang/0000-0001-8061-5694	National Institutes of Health [RO1AA020051]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020051] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1AA020051 (to G. C.).	Alimov A, 2013, METAB BRAIN DIS, V28, P667, DOI 10.1007/s11011-013-9430-2; Amodio N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.175; Aranha MM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-514; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BONTHIUS DJ, 1990, ALCOHOL CLIN EXP RES, V14, P107, DOI 10.1111/j.1530-0277.1990.tb00455.x; Chen G, 2006, J BIOL CHEM, V281, P15909, DOI 10.1074/jbc.M600612200; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Dong XL, 2014, ALCOHOL CLIN EXP RES, V38, P68, DOI 10.1111/acer.12209; Fang MR, 2012, TOXICOL LETT, V209, P94, DOI 10.1016/j.toxlet.2011.11.032; Fasciano S, 2007, GENE, V388, P74, DOI 10.1016/j.gene.2006.10.003; Frank D, 2012, J MOL CELL CARDIOL, V52, P711, DOI 10.1016/j.yjmcc.2011.12.001; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Giordano G, 2011, METHODS MOL BIOL, V758, P13, DOI 10.1007/978-1-61779-170-3_2; Goodlett CR, 1996, PHARMACOL BIOCHEM BE, V55, P531, DOI 10.1016/S0091-3057(96)00248-1; Guidi M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-95; Guo YQ, 2012, ALCOHOL CLIN EXP RES, V36, P1058, DOI 10.1111/j.1530-0277.2011.01689.x; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Jagus R, 1999, INT J BIOCHEM CELL B, V31, P123, DOI 10.1016/S1357-2725(98)00136-8; Kang R, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003511; Karagay B, 2008, ALCOHOL CLIN EXP RES, V32, P1439, DOI 10.1111/j.1530-0277.2008.00720.x; Kawase-Koga Y, 2009, DEV DYNAM, V238, P2800, DOI 10.1002/dvdy.22109; Khanna S, 2013, J CEREBR BLOOD F MET, V33, P1197, DOI 10.1038/jcbfm.2013.68; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kole AJ, 2011, GENE DEV, V25, P125, DOI 10.1101/gad.1975411; Kos A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031022; Kouzoukas DE, 2013, J NEUROCHEM, V124, P323, DOI 10.1111/jnc.12076; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li QS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026000; Li Z, 2001, DEV BRAIN RES, V132, P47, DOI 10.1016/S0165-3806(01)00294-2; Liu N, 2012, NATURE, V482, P519, DOI 10.1038/nature10810; Liu SJ, 2010, CANCER CELL, V17, P333, DOI 10.1016/j.ccr.2010.03.008; Long JM, 2012, J BIOL CHEM, V287, P31298, DOI 10.1074/jbc.M112.366336; Long JM, 2011, BIOCHEM BIOPH RES CO, V404, P889, DOI 10.1016/j.bbrc.2010.12.053; Luo J, 1997, ALCOHOL CLIN EXP RES, V21, P1108; MARCUSSEN BL, 1994, ALCOHOL, V11, P147, DOI 10.1016/0741-8329(94)90056-6; Reyes-Fermin LM, 2012, NUTR NEUROSCI, V15, P34, DOI 10.1179/1476830512Y.0000000011; Mooney SM, 2003, DEV BRAIN RES, V147, P135, DOI 10.1016/j.devbrainres.2003.08.012; Patel CV, 2000, J BIOL CHEM, V275, P37993, DOI 10.1074/jbc.M004762200; Ro S, 2006, BIOCHEM BIOPH RES CO, V351, P756, DOI 10.1016/j.bbrc.2006.10.105; Russell JC, 2007, NEUROSCIENCE, V150, P563, DOI 10.1016/j.neuroscience.2007.09.076; Sano T, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.23; Sathyan P, 2007, J NEUROSCI, V27, P8546, DOI 10.1523/JNEUROSCI.1269-07.2007; Shi GD, 2012, EXP BRAIN RES, V216, P225, DOI 10.1007/s00221-011-2925-3; Silva VAO, 2011, MOL VIS, V17, P2228; Tang YM, 2008, ALCOHOL CLIN EXP RES, V32, P355, DOI 10.1111/j.1530-0277.2007.00584.x; van Spronsen M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074907; Villa C, 2013, J ALZHEIMERS DIS, V35, P487, DOI 10.3233/JAD-122263; Wang R, 2012, CELL PHYSIOL BIOCHEM, V29, P381, DOI 10.1159/000338493; Wang WX, 2010, AM J PATHOL, V177, P334, DOI 10.2353/ajpath.2010.091202; WILKE N, 1994, EXS, V71, P49; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Yadav S, 2011, J BIOL CHEM, V286, P37347, DOI 10.1074/jbc.M111.235531; Yin HQ, 2012, J BIOL CHEM, V287, P9817, DOI 10.1074/jbc.M111.333534; Yuva-Aydemir Y, 2011, RNA BIOL, V8, P557, DOI 10.4161/rna.8.4.16019; Zhang L, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-211	55	44	45	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10201	10210		10.1074/jbc.M113.535195	http://dx.doi.org/10.1074/jbc.M113.535195			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24554719	hybrid, Green Published			2022-12-28	WOS:000333807000065
J	Stelmashenko, O; Compan, V; Browne, LE; North, RA				Stelmashenko, Olga; Compan, Vincent; Browne, Liam E.; North, R. Alan			Ectodomain Movements of an ATP-gated Ion Channel ( P2X2 Receptor) Probed by Disulfide Locking*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; Disulfide; Ion Channels; Purinergic Receptor; Receptor Structure-function	TRANSMEMBRANE DOMAIN; AGONIST BINDING; P2X(2); RESIDUES; PORE; IDENTIFICATION; MUTAGENESIS; PROTEINS; SUBUNITS; SITE	Background: The ATP-gated channel (P2X2) receptor ectodomain is formed by -strands from three subunits. Results: ATP-induced channel opening was prevented by disulfide locking between pairs of substituted cysteines in different subunits. Conclusion: The turret region, the lower body wall, and the outer ends of transmembrane domains move significantly in channel opening. Significance: Large ectodomain movements couple ATP binding to channel opening in P2X receptors. The ectodomain of the P2X receptor is formed mainly from two- or three-stranded -sheets provided symmetrically by each of the three subunits. These enclose a central cavity that is closed off furthest from the plasma membrane (the turret) and that joins with the transmembrane helices to form the ion permeation pathway. Comparison of closed and open crystal structures indicates that ATP binds in a pocket positioned between strands provided by different subunits and that this flexes the -sheets of the lower body and enlarges the central cavity: this pulls apart the outer ends of the transmembrane helices and thereby opens an aperture, or gate, where they intersect within the membrane bilayer. In the present work, we examined this opening model by introducing pairs of cysteines into the rat P2X2 receptor that might form disulfide bonds within or between subunits. Receptors were expressed in human embryonic kidney cells, and disulfide formation was assessed by observing the effect of dithiothreitol on currents evoked by ATP. Substitutions in the turret (P90C, P89C/S97C), body wall (S65C/S190C, S65C/D315C) and the transmembrane domains (V48C/I328C, V51C/I328C, S54C/I328C) strongly inhibited ATP-evoked currents prior to reduction with dithiothreitol. Western blotting showed that these channels also formed predominately as dimers and/or trimers rather than monomers. The results strongly support the channel opening mechanism proposed on the basis of available crystal structures.	[Stelmashenko, Olga; North, R. Alan] Univ Manchester, Fac Med & Human Sci, Manchester M13 9PL, Lancs, England; [Compan, Vincent; Browne, Liam E.; North, R. Alan] Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester	North, RA (corresponding author), Univ Manchester, Fac Med & Human Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England.	r.a.north@manchester.ac.uk	Compan, Vincent/M-6977-2017; North, Richard/GQA-6156-2022	Compan, Vincent/0000-0001-6805-1179; Browne, Liam/0000-0002-5693-7703	Wellcome Trust [093140/Z/10/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by The Wellcome Trust (093140/Z/10/Z).	Allsopp RC, 2011, J BIOL CHEM, V286, P29207, DOI 10.1074/jbc.M111.260364; Browne LE, 2010, TRENDS PHARMACOL SCI, V31, P229, DOI 10.1016/j.tips.2010.02.004; Cao LS, 2009, J NEUROSCI, V29, P14257, DOI 10.1523/JNEUROSCI.4403-09.2009; Cederholm JME, 2009, EUR BIOPHYS J BIOPHY, V39, P37, DOI 10.1007/s00249-009-0452-y; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Egan TM, 1998, J NEUROSCI, V18, P2350; Haines WR, 2001, J BIOL CHEM, V276, P32793, DOI 10.1074/jbc.M104216200; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Hausmann R, 2013, MOL PHARMACOL, V83, P73, DOI 10.1124/mol.112.081489; HAZES B, 1988, PROTEIN ENG, V2, P119, DOI 10.1093/protein/2.2.119; Heymann G, 2013, P NATL ACAD SCI USA, V110, pE4045, DOI 10.1073/pnas.1311071110; Jiang LH, 2001, J BIOL CHEM, V276, P14902, DOI 10.1074/jbc.M011327200; Jiang LH, 2003, J NEUROSCI, V23, P8903; Jiang RT, 2013, TRENDS BIOCHEM SCI, V38, P20, DOI 10.1016/j.tibs.2012.10.006; Jiang RT, 2011, P NATL ACAD SCI USA, V108, P9066, DOI 10.1073/pnas.1102170108; Kawate T, 2011, J GEN PHYSIOL, V137, P579, DOI 10.1085/jgp.201010593; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2012, NEURON, V76, P51, DOI 10.1016/j.neuron.2012.09.024; Li MF, 2008, NAT NEUROSCI, V11, P883, DOI 10.1038/nn.2151; Li MF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1048; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; Marquez-Klaka B, 2009, EUR BIOPHYS J BIOPHY, V38, P329, DOI 10.1007/s00249-008-0325-9; Mayer ML, 2011, CURR OPIN NEUROBIOL, V21, P283, DOI 10.1016/j.conb.2011.02.001; Nagaya N, 2005, J BIOL CHEM, V280, P25982, DOI 10.1074/jbc.M504545200; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Roberts JA, 2008, J BIOL CHEM, V283, P20126, DOI 10.1074/jbc.M800294200; Roberts JA, 2012, P NATL ACAD SCI USA, V109, P4663, DOI 10.1073/pnas.1201872109; Rothwell SW, 2014, J BIOL CHEM, V289, P618, DOI 10.1074/jbc.M113.529099; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samways DSK, 2011, P NATL ACAD SCI USA, V108, P13800, DOI 10.1073/pnas.1017550108; Spelta V, 2003, BRIT J PHARMACOL, V138, P131, DOI 10.1038/sj.bjp.0705018; Stoop R, 1999, MOL PHARMACOL, V56, P973, DOI 10.1124/mol.56.5.973; Wilkinson WJ, 2006, MOL PHARMACOL, V70, P1159, DOI 10.1124/mol.106.026658	35	18	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9909	9917		10.1074/jbc.M113.542811	http://dx.doi.org/10.1074/jbc.M113.542811			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24515105	Green Published, hybrid			2022-12-28	WOS:000333807000040
J	Hsieh, MY; Chang, MY; Chen, YJ; Li, YK; Chuang, TH; Yu, GY; Cheung, CHA; Chen, HC; Maa, MC; Leu, TH				Hsieh, Ming-Yu; Chang, Miao Ying; Chen, Yen-Jen; Li, Yung Kuo; Chuang, Tsung-Hsien; Yu, Guann-Yi; Cheung, Chun Hei Antonio; Chen, Hui-Chen; Maa, Ming-Chei; Leu, Tzeng-Horng			The Inducible Nitric-oxide Synthase ( iNOS)/Src Axis Mediates Toll-like Receptor 3 Tyrosine 759 Phosphorylation and Enhances Its Signal Transduction, Leading to Interferon- beta Synthesis in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Double-stranded RNA; Interferon; Lipopolysaccharide (LPS); Macrophages; Src; Toll-like Receptors (TLR); iNOS	DOUBLE-STRANDED-RNA; NF-KAPPA-B; C-SRC; CONSTITUTIVE ACTIVATION; POSITIVE FEEDBACK; GENE-EXPRESSION; DNA-BINDING; KINASE; RECOGNITION; ALPHA	Background: TLR3 Tyr-759 phosphorylation is critical in dsRNA-mediated IFN- production. Results: iNOS-induced Src expression and activation amplify IFN- production through induction of TLR3 Tyr-759 phosphorylation in macrophages. Conclusion: Src-TLR3 interaction is important in dsRNA- and LPS-induced IFN- production. Significance: An essential role of the iNOS/Src/TLR3 axis is established in IFN- production in macrophages that might have clinical applications for infectious diseases. Double-stranded RNA (dsRNA) induces phosphorylation of Toll-like receptor 3 (TLR3) at tyrosine 759 and subsequently triggers signaling pathways to promote interferon- (IFN-) production. In this study, we found that dsRNA stimulation induces biphasic TLR3 Tyr-759 phosphorylation in macrophages. In addition to the immediate TLR3 Tyr-759 phosphorylation, we identified a second wave of Tyr-759 phosphorylation accompanied by an increase of both Src and ifn- transcription in the later phase of dsRNA stimulation. Interestingly, Src phosphorylated TLR3 Tyr-759 in vitro and in vivo. However, knockdown of Src abolished the late phase of TLR3 Tyr-759 phosphorylation and decreased the nuclear accumulation of interferon regulatory factors 3 and 7 (IRF3 and -7) and IFN- production. Reintroduction of Src restored all of these molecular changes. Notably, via down-regulation of Src, dsRNA-elicited TLR3 Tyr-759 phosphorylation, the nuclear accumulation of IRF3/IRF7, and IFN- generation were inhibited in inducible nitric-oxide synthase (iNOS)-null macrophages. TLR3 knockdown destabilized Src and reduced the nuclear level of IRF3/IRF7 and IFN- production in macrophages exposed to LPS (a TLR4 ligand known to induce Src and IFN- expression). Ectopic expression of wild type TLR3, but not its 759-phenylalanine mutant, restored Src activity and ifn- transcription. Taken together, these results suggested an essential role of the iNOS/Src/TLR3 axis in IFN- production in macrophages.	[Hsieh, Ming-Yu; Chen, Yen-Jen; Cheung, Chun Hei Antonio; Leu, Tzeng-Horng] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Hsieh, Ming-Yu; Chen, Yen-Jen; Cheung, Chun Hei Antonio; Leu, Tzeng-Horng] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan; [Hsieh, Ming-Yu; Chen, Yen-Jen; Yu, Guann-Yi; Leu, Tzeng-Horng] Natl Cheng Kung Univ, Coll Med, Ctr Infect Dis & Signaling Res, Tainan 70101, Taiwan; [Chang, Miao Ying] China Med Univ Hosp, Dept Med Res, Taichung 40402, Taiwan; [Li, Yung Kuo; Chen, Hui-Chen; Maa, Ming-Chei] China Med Univ, Grad Inst Basic Med Sci, Taichung 40402, Taiwan; [Chuang, Tsung-Hsien] Natl Hlth Res Inst, Immunol Res Ctr, Zhunan 35053, Miaoli County, Taiwan; [Yu, Guann-Yi] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan 35053, Miaoli County, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan	Maa, MC (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Taichung 40402, Taiwan.	mcmaa@mail.cmu.edu.tw; tzengleu@mail.ncku.edu.tw	Chuang, Tsung-Hsien/F-9679-2010; Yu, Guann-Yi/O-5139-2019; Chen, Hui-Chen/L-8149-2013	Yu, Guann-Yi/0000-0002-0580-8282; Chen, Hui-Chen/0000-0001-9751-5729; Cheung, Chun Hei Antonio/0000-0003-4181-1435	National Science Council [NSC 94-3112-B-001-003, NSC 94-3112-B-001-018-Y]	National Science Council(Ministry of Science and Technology, Taiwan)	Both TLR<SUP>-/-</SUP> and TRIF<SUP>-/-</SUP> mice were generously provided by Dr. Shizuo Akira (Osaka University). We thank Dr. Wen-Cheng Xiong for comments on the manuscript. The DNA constructs of pLKO.1-mfak-1, pLKO.1-mfak-2, pLKO.1-msrc-1, pLKO.1-mfgr-1, pLKO.1-mfgr2, pLKO.1-mhck-1, pLKO.1-mhck-2, pLKO.1-mlyn-1, pLKO.1-mlyn-2, pLKO.1-mtlr3-1, and pLKO.1-mtlr3-2 were provided by the National RNAi Core Facility located at the Institute of Molecular Biology/Genomic Research Center, Academia Sinica, supported by National Science Council National Research Program for Genomic Medicine Grants NSC 94-3112-B-001-003 and NSC 94-3112-B-001-018-Y.	Akhand AK, 1999, J BIOL CHEM, V274, P25821, DOI 10.1074/jbc.274.36.25821; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Au WC, 1998, J BIOL CHEM, V273, P29210, DOI 10.1074/jbc.273.44.29210; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Campbell GS, 1997, J BIOL CHEM, V272, P2591, DOI 10.1074/jbc.272.5.2591; Cao XM, 1996, MOL CELL BIOL, V16, P1595; Chaturvedi P, 1997, MOL CELL BIOL, V17, P3295, DOI 10.1128/MCB.17.6.3295; DALY C, 1993, MOL CELL BIOL, V13, P3756, DOI 10.1128/MCB.13.6.3756; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; De Maeyer E, 1998, Int Rev Immunol, V17, P53, DOI 10.3109/08830189809084487; Farlik M, 2010, IMMUNITY, V33, P25, DOI 10.1016/j.immuni.2010.07.001; Farrar JD, 2000, IMMUNOL TODAY, V21, P484, DOI 10.1016/S0167-5699(00)01710-2; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Fujishima H, 1998, INT J CANCER, V76, P423; Gao JJ, 1998, J IMMUNOL, V161, P4803; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Krumenacker J, 2004, BRAIN RES BULL, V62, P505, DOI 10.1016/S0361-9230(03)00102-3; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Lee KG, 2012, P NATL ACAD SCI USA, V109, P5791, DOI 10.1073/pnas.1119238109; Leu TH, 2006, MOL IMMUNOL, V43, P308, DOI 10.1016/j.molimm.2005.03.015; Levy DE, 2010, IMMUNITY, V33, P1, DOI 10.1016/j.immuni.2010.07.011; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Maa MC, 1999, BBA-MOL CELL RES, V1450, P341, DOI 10.1016/S0167-4889(99)00069-5; Maa MC, 2008, J BIOL CHEM, V283, P31408, DOI 10.1074/jbc.M801158200; Maa MC, 2011, BIOMEDICINE-TAIWAN, V1, P11, DOI 10.1016/j.biomed.2011.10.002; Maa MC, 2011, BBA-MOL CELL RES, V1813, P136, DOI 10.1016/j.bbamcr.2010.09.004; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Meng FY, 1997, J EXP MED, V185, P1661, DOI 10.1084/jem.185.9.1661; Murakami Y, 1998, J CELL PHYSIOL, V175, P220, DOI 10.1002/(SICI)1097-4652(199805)175:2<220::AID-JCP12>3.0.CO;2-C; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sarkar SN, 2007, J BIOL CHEM, V282, P3423, DOI 10.1074/jbc.C600226200; Sarkar SN, 2003, J BIOL CHEM, V278, P4393, DOI 10.1074/jbc.C200655200; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Solis M, 2006, BIOCHEM PHARMACOL, V72, P1469, DOI 10.1016/j.bcp.2006.06.002; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Toshchakov V, 2002, NAT IMMUNOL, V3, P392, DOI 10.1038/ni774; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamashita M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002581; Yang MJ, 2011, J EXP MED, V208, P2099, DOI 10.1084/jem.20102667; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Zhang LW, 1997, MOL CELL BIOL, V17, P5748, DOI 10.1128/MCB.17.10.5748; Zong C, 1996, EMBO J, V15, P4515, DOI 10.1002/j.1460-2075.1996.tb00829.x	59	16	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9208	9220		10.1074/jbc.M113.508663	http://dx.doi.org/10.1074/jbc.M113.508663			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24526685	Green Published, hybrid			2022-12-28	WOS:000333472100039
J	Jacobitz, AW; Wereszczynski, J; Yi, SW; Amer, BR; Huang, GL; Nguyen, AV; Sawaya, MR; Jung, ME; McCammon, JA; Clubb, RT				Jacobitz, Alex W.; Wereszczynski, Jeff; Yi, Sung Wook; Amer, Brendan R.; Huang, Grace L.; Nguyen, Angelyn V.; Sawaya, Michael R.; Jung, Michael E.; McCammon, J. Andrew; Clubb, Robert T.			Structural and Computational Studies of the Staphylococcus aureus Sortase B-Substrate Complex Reveal a Substrate-stabilized Oxyanion Hole	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Surface Enzymes; Crystal Structure; Enzyme Mechanisms; Molecular Dynamics; Staphylococcus aureus	GRAM-POSITIVE BACTERIA; SORTING SIGNAL BINDING; IMIDAZOLIUM ION-PAIR; CELL-WALL; SURFACE-PROTEINS; MOLECULAR-DYNAMICS; ACTIVE-SITE; KINETIC MECHANISM; A TRANSPEPTIDASE; HEME-IRON	Background: Sortase enzymes catalyze a transpeptidation reaction that displays bacterial surface proteins. Results: Structural and computational studies reveal how the sortase B enzyme recognizes its sorting signal substrate. Conclusion: Sortase enzymes catalyze transpeptidation using a substrate-stabilized oxyanion hole. Significance: The results of this work could facilitate the rational design of sortase inhibitors. Sortase cysteine transpeptidases covalently attach proteins to the bacterial cell wall or assemble fiber-like pili that promote bacterial adhesion. Members of this enzyme superfamily are widely distributed in Gram-positive bacteria that frequently utilize multiple sortases to elaborate their peptidoglycan. Sortases catalyze transpeptidation using a conserved active site His-Cys-Arg triad that joins a sorting signal located at the C terminus of their protein substrate to an amino nucleophile located on the cell surface. However, despite extensive study, the catalytic mechanism and molecular basis of substrate recognition remains poorly understood. Here we report the crystal structure of the Staphylococcus aureus sortase B enzyme in a covalent complex with an analog of its NPQTN sorting signal substrate, revealing the structural basis through which it displays the IsdC protein involved in heme-iron scavenging from human hemoglobin. The results of computational modeling, molecular dynamics simulations, and targeted amino acid mutagenesis indicate that the backbone amide of Glu(224) and the side chain of Arg(233) form an oxyanion hole in sortase B that stabilizes high energy tetrahedral catalytic intermediates. Surprisingly, a highly conserved threonine residue within the bound sorting signal substrate facilitates construction of the oxyanion hole by stabilizing the position of the active site arginine residue via hydrogen bonding. Molecular dynamics simulations and primary sequence conservation suggest that the sorting signal-stabilized oxyanion hole is a universal feature of enzymes within the sortase superfamily.	[Jacobitz, Alex W.; Yi, Sung Wook; Amer, Brendan R.; Huang, Grace L.; Nguyen, Angelyn V.; Jung, Michael E.; Clubb, Robert T.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Sawaya, Michael R.; Clubb, Robert T.] Univ Calif Los Angeles, UCLA DOE Inst Genom & Prote, Los Angeles, CA 90095 USA; [Clubb, Robert T.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Wereszczynski, Jeff; McCammon, J. Andrew] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California San Diego	Clubb, RT (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	rclubb@mbi.ucla.edu	McCammon, J. Andrew/AAG-1832-2021	McCammon, J. Andrew/0000-0003-3065-1456; Amer, Brendan/0000-0001-6564-3347	National Institutes of Health [AI52217, GM31749, T32 GM007185]; National Science Foundation; Howard Hughes Medical Institute; Center for Theoretical Biological Physics; National Biomedical Computation Resource; National Science Foundation Supercomputer Centers; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031749, T32GM007185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Center for Theoretical Biological Physics; National Biomedical Computation Resource; National Science Foundation Supercomputer Centers(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI52217 (to R. T. C. and M. E. J.), GM31749 (to J. A. M.), and T32 GM007185 (to A. W. J. and G. L. H.). This work was also supported by the National Science Foundation, the Howard Hughes Medical Institute, the Center for Theoretical Biological Physics, the National Biomedical Computation Resource, and the National Science Foundation Supercomputer Centers.	Bentley ML, 2008, J BIOL CHEM, V283, P14762, DOI 10.1074/jbc.M800974200; Bentley ML, 2007, J BIOL CHEM, V282, P6571, DOI 10.1074/jbc.M610519200; BRICOGNE G, 1993, ACTA CRYSTALLOGR D, V49, P37, DOI 10.1107/S0907444992010400; Case DA, 2012, AMBER 12; Clancy KW, 2010, BIOPOLYMERS, V94, P385, DOI 10.1002/bip.21472; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Connolly KM, 2003, J BIOL CHEM, V278, P34061, DOI 10.1074/jbc.M305245200; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Frankel BA, 2005, BIOCHEMISTRY-US, V44, P11188, DOI 10.1021/bi050141j; Frankel BA, 2007, BIOCHEMISTRY-US, V46, P7269, DOI 10.1021/bi700448e; Huang XY, 2003, BIOCHEMISTRY-US, V42, P11307, DOI 10.1021/bi034391g; Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198; Jiang W, 2012, J CHEM THEORY COMPUT, V8, P4672, DOI 10.1021/ct300468g; Jung ME, 2005, BIOORG MED CHEM LETT, V15, P5076, DOI 10.1016/j.bmcl.2005.07.073; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Khare B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022995; Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V; Kruger RG, 2004, BIOCHEMISTRY-US, V43, P1541, DOI 10.1021/bi035920j; Kruger RG, 2004, ANAL BIOCHEM, V326, P42, DOI 10.1016/j.ab.2003.10.023; Liew CK, 2004, FEBS LETT, V571, P221, DOI 10.1016/j.febslet.2004.06.070; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Maresso AW, 2006, BIOMETALS, V19, P193, DOI 10.1007/s10534-005-4863-7; Maresso AW, 2006, J BACTERIOL, V188, P8145, DOI 10.1128/JB.01011-06; Mariscotti JF, 2009, J BIOL CHEM, V284, P6140, DOI 10.1074/jbc.M807989200; Marraffini LA, 2005, J BIOL CHEM, V280, P16263, DOI 10.1074/jbc.M500071200; Marraffini LA, 2004, J BIOL CHEM, V279, P37763, DOI 10.1074/jbc.M405282200; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; Mazmanian SK, 2001, MOL MICROBIOL, V40, P1049, DOI 10.1046/j.1365-2958.2001.02411.x; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Naik MT, 2006, J BIOL CHEM, V281, P1817, DOI 10.1074/jbc.M506123200; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Nicola G, 2005, BIOCHEMISTRY-US, V44, P8207, DOI 10.1021/bi0473004; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piotukh K, 2011, J AM CHEM SOC, V133, P17536, DOI 10.1021/ja205630g; Popp MWL, 2011, ANGEW CHEM INT EDIT, V50, P5024, DOI 10.1002/anie.201008267; Proft T, 2010, BIOTECHNOL LETT, V32, P1, DOI 10.1007/s10529-009-0116-0; Race PR, 2009, J BIOL CHEM, V284, P6924, DOI 10.1074/jbc.M805406200; Ruzin A, 2002, J BACTERIOL, V184, P2141, DOI 10.1128/JB.184.8.2141-2147.2002; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Souaille M, 2001, COMPUT PHYS COMMUN, V135, P40, DOI 10.1016/S0010-4655(00)00215-0; Spirig T, 2011, MOL MICROBIOL, V82, P1044, DOI 10.1111/j.1365-2958.2011.07887.x; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Tian BX, 2011, J PHYS CHEM B, V115, P13003, DOI 10.1021/jp2058113; Ton-That H, 2002, J BIOL CHEM, V277, P7447, DOI 10.1074/jbc.M109945200; Tsukiji S, 2009, CHEMBIOCHEM, V10, P787, DOI 10.1002/cbic.200800724; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Weiner EM, 2010, J BIOL CHEM, V285, P23431, DOI 10.1074/jbc.M110.135434; Weiss WJ, 2004, J ANTIMICROB CHEMOTH, V53, P480, DOI 10.1093/jac/dkh078; Zhang RG, 2004, STRUCTURE, V12, P1147, DOI 10.1016/j.str.2004.06.001; Zong YN, 2004, STRUCTURE, V12, P105, DOI 10.1016/j.str.2003.11.021	64	32	34	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8891	8902		10.1074/jbc.M113.509273	http://dx.doi.org/10.1074/jbc.M113.509273			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24519933	hybrid, Green Published			2022-12-28	WOS:000333472100014
J	Forsyth, PA; Krishna, N; Lawn, S; Valadez, JG; Qu, XT; Fenstermacher, DA; Fournier, M; Potthast, L; Chinnaiyan, P; Gibney, GT; Zeinieh, M; Barker, PA; Carter, BD; Cooper, MK; Kenchappa, RS				Forsyth, Peter A.; Krishna, Niveditha; Lawn, Samuel; Valadez, J. Gerardo; Qu, Xiaotao; Fenstermacher, David A.; Fournier, Michelle; Potthast, Lisa; Chinnaiyan, Prakash; Gibney, Geoffrey T.; Zeinieh, Michele; Barker, Philip A.; Carter, Bruce D.; Cooper, Michael K.; Kenchappa, Rajappa S.			p75 Neurotrophin Receptor Cleavage by alpha- and gamma- Secretases Is Required for Neurotrophin-mediated Proliferation of Brain Tumor-initiating Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAM; ADAMTS; Brain Tumors; Cancer Stem Cells; Cell Surface Receptor; Glioblastoma; Neurotrophins; Proliferation; Nerve Growth Factor; p75 Neurotrophin Receptor	NERVE GROWTH-FACTOR; REGULATED INTRAMEMBRANE PROTEOLYSIS; CANCER STEM-CELLS; NUCLEAR TRANSLOCATION; INTRACELLULAR DOMAIN; DEPENDENT CLEAVAGE; CONVERTING ENZYME; HEDGEHOG PATHWAY; INHIBITS GROWTH; HUMAN-MELANOMA	Background: p75 neurotrophin receptor (p75NTR) is an important mediator of invasion of malignant gliomas, but its role in glioma proliferation is unknown. Results: p75NTR mediates proliferation of brain tumor-initiating cells (BTICs) via its cleavage and release of an intracellular domain. Conclusion: p75NTR also regulates proliferation of BTICs. Significance: p75NTR is a potential target for the treatment of malignant gliomas. Malignant gliomas are highly invasive, proliferative, and resistant to treatment. Previously, we have shown that p75 neurotrophin receptor (p75NTR) is a novel mediator of invasion of human glioma cells. However, the role of p75NTR in glioma proliferation is unknown. Here we used brain tumor-initiating cells (BTICs) and show that BTICs express neurotrophin receptors (p75NTR, TrkA, TrkB, and TrkC) and their ligands (NGF, brain-derived neurotrophic factor, and neurotrophin 3) and secrete NGF. Down-regulation of p75NTR significantly decreased proliferation of BTICs. Conversely, exogenouous NGF stimulated BTIC proliferation through - and -secretase-mediated p75NTR cleavage and release of its intracellular domain (ICD). In contrast, overexpression of the p75NTR ICD induced proliferation. Interestingly, inhibition of Trk signaling blocked NGF-stimulated BTIC proliferation and p75NTR cleavage, indicating a role of Trk in p75NTR signaling. Further, blocking p75NTR cleavage attenuated Akt activation in BTICs, suggesting role of Akt in p75NTR-mediated proliferation. We also found that p75NTR, -secretases, and the four subunits of the -secretase enzyme were elevated in glioblastoma multiformes patients. Importantly, the ICD of p75NTR was commonly found in malignant glioma patient specimens, suggesting that the receptor is activated and cleaved in patient tumors. These results suggest that p75NTR proteolysis is required for BTIC proliferation and is a novel potential clinical target.	[Forsyth, Peter A.; Krishna, Niveditha; Potthast, Lisa; Kenchappa, Rajappa S.] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Neurooncol, Tampa, FL 33612 USA; [Forsyth, Peter A.; Chinnaiyan, Prakash; Gibney, Geoffrey T.; Kenchappa, Rajappa S.] Univ S Florida, Dept Oncol Sci, Tampa, FL 33612 USA; [Forsyth, Peter A.; Lawn, Samuel] Univ Calgary, Southern Alberta Canc Res Inst, Tom Baker Canc Ctr, Calgary, AB, Canada; [Valadez, J. Gerardo; Cooper, Michael K.] Vanderbilt Univ, Sch Med, Dept Neurol, Nashville, TN 37232 USA; [Qu, Xiaotao; Fenstermacher, David A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Biomed Informat, Tampa, FL 33612 USA; [Fournier, Michelle] H Lee Moffitt Canc Ctr & Res Inst, Dept Tissue Core, Tampa, FL 33612 USA; [Chinnaiyan, Prakash] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL 33612 USA; [Gibney, Geoffrey T.] H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, Tampa, FL 33612 USA; [Zeinieh, Michele; Barker, Philip A.] McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada; [Carter, Bruce D.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Cooper, Michael K.] Vet Affairs Tennessee Valley Healthcare Syst, Neurol Serv, Nashville, TN 37212 USA; [Kenchappa, Rajappa S.] W Virginia Univ, Blanchette Rockefeller Neurosci Inst, Morgantown, WV 26505 USA; [Kenchappa, Rajappa S.] W Virginia Univ, Dept Biochem, Morgantown, WV 26505 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Tom Baker Cancer Clinic; University of Calgary; Vanderbilt University; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; McGill University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; West Virginia University; West Virginia University	Forsyth, PA (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Neurooncol, 12902 Magnolia Dr, Tampa, FL 33612 USA.	Peter.Forsyth@Moffitt.org			National Institutes of Health [R01NS038220, 1 I01 BX000744-1]; Moffitt Foundation; American Cancer Society [RSG-11-029-01-CSM]; Canadian Institutes of Health Research [MOP37850]; American Brain Tumor Association; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038220] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000744] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moffitt Foundation; American Cancer Society(American Cancer Society); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); American Brain Tumor Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS038220 (to B. D. C.) and 1 I01 BX000744-1 (to M. K. C.). This work was also supported by grants from the Moffitt Foundation (to P. A. F. and R. S. K.).; Supported by American Cancer Society Grant RSG-11-029-01-CSM).; Supported by Canadian Institutes of Health Research Grant MOP37850.; Recipient of an American Brain Tumor Association special discovery grant supported by an anonymous family foundation. To whom correspondence may be addressed: Dept. of Neuro-Oncology, Moffitt Cancer Center and Research Institute, 12902 Magnolia Dr., Tampa, FL 33612. Tel.: 813-745-3063; Fax: 813-745-3510; E-mail: Rajappa.Kenchappa@Moffitt.org.	Al-Mayhani TMF, 2009, J NEUROSCI METH, V176, P192, DOI 10.1016/j.jneumeth.2008.07.022; Amberger-Murphy V, 2009, CURR CANCER DRUG TAR, V9, P381, DOI 10.2174/156800909788166637; Antonyak MA, 2002, ONCOGENE, V21, P5038, DOI 10.1038/sj.onc.1205593; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; Bertrand MJM, 2008, CELL DEATH DIFFER, V15, P1921, DOI 10.1038/cdd.2008.127; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Bulstrode H, 2012, CANCER LETT, V326, P79, DOI 10.1016/j.canlet.2012.07.022; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; Casademunt E, 1999, EMBO J, V18, P6050, DOI 10.1093/emboj/18.21.6050; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; Ceni C, 2010, J CELL SCI, V123, P2299, DOI 10.1242/jcs.062612; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chittka A, 2004, J CELL BIOL, V164, P985, DOI 10.1083/jcb.200301106; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Cui J, 2006, CANCER RES, V66, P10024, DOI 10.1158/0008-5472.CAN-06-0136; Dai L, 2011, PROTEOMICS, V11, P4021, DOI 10.1002/pmic.201100014; Descamps S, 2001, CANCER RES, V61, P4337; Descamps S, 2001, J BIOL CHEM, V276, P17864, DOI 10.1074/jbc.M010499200; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; DISTEFANO PS, 1993, J NEUROSCI, V13, P2405, DOI 10.1523/JNEUROSCI.13-06-02405.1993; DISTEFANO PS, 1990, BRAIN RES, V534, P340, DOI 10.1016/0006-8993(90)90154-4; Domeniconi M, 2005, NEURON, V46, P849, DOI 10.1016/j.neuron.2005.05.029; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; Epa WR, 2004, J NEUROCHEM, V89, P344, DOI 10.1111/j.1471-4159.2004.02344.x; Eyler CE, 2008, STEM CELLS, V26, P3027, DOI 10.1634/stemcells.2007-1073; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gallia GL, 2009, MOL CANCER THER, V8, P386, DOI 10.1158/1535-7163.MCT-08-0680; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Geetha T, 2005, EMBO J, V24, P3859, DOI 10.1038/sj.emboj.7600845; Hart S, 2004, CANCER RES, V64, P1943, DOI 10.1158/0008-5472.CAN-03-3720; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HERRMANN JL, 1993, MOL BIOL CELL, V4, P1205, DOI 10.1091/mbc.4.11.1205; Holland EC, 2001, NAT REV GENET, V2, P120, DOI 10.1038/35052535; Hondermarck H, 2012, CYTOKINE GROWTH F R, V23, P357, DOI 10.1016/j.cytogfr.2012.06.004; Hu YY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-82; Jin HF, 2007, NEOPLASIA, V9, P471, DOI 10.1593/neo.07175; Jin HF, 2007, MOL CANCER RES, V5, P423, DOI 10.1158/1541-7786.MCR-06-0407; Johnston ALM, 2007, PLOS BIOL, V5, P1723, DOI 10.1371/journal.pbio.0050212; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kenchappa RS, 2010, J BIOL CHEM, V285, P20358, DOI 10.1074/jbc.M109.082834; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Khursigara G, 2001, J NEUROSCI, V21, P5854, DOI 10.1523/JNEUROSCI.21-16-05854.2001; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; Khwaja F, 2006, BIOCHEM BIOPH RES CO, V341, P1184, DOI 10.1016/j.bbrc.2006.01.073; KLEIHUES C, 2007, TUMORS NERVOUS SYSTE; Kodama T, 2004, AM J PATHOL, V165, P1743, DOI 10.1016/S0002-9440(10)63429-3; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Kommaddi RP, 2011, FASEB J, V25, P2061, DOI 10.1096/fj.10-173740; KURUVILLA R, 2004, CELL, V39, P57; Lagadec C, 2009, ONCOGENE, V28, P1960, DOI 10.1038/onc.2009.61; Le Moan N, 2011, MOL CELL, V44, P476, DOI 10.1016/j.molcel.2011.08.033; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lu Y, 2011, ONCOL REP, V25, P1329, DOI 10.3892/or.2011.1195; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Mangiola A, 2007, CLIN CANCER RES, V13, P6970, DOI 10.1158/1078-0432.CCR-07-1229; Marchetti D, 2004, J CELL BIOCHEM, V91, P206, DOI 10.1002/jcb.10649; MATTEI S, 1994, INT J CANCER, V56, P853, DOI 10.1002/ijc.2910560617; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Nakano I, 2006, PEDIATR RES, V59, p54R, DOI 10.1203/01.pdr.0000203568.63482.f9; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; Parkhurst CN, 2010, J BIOL CHEM, V285, P5361, DOI 10.1074/jbc.M109.045054; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Provenzano MJ, 2011, MOL CELL NEUROSCI, V47, P306, DOI 10.1016/j.mcn.2011.05.010; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Roux PP, 2001, J BIOL CHEM, V276, P23097, DOI 10.1074/jbc.M011520200; Salehi AH, 2000, NEURON, V27, P279, DOI 10.1016/S0896-6273(00)00036-2; Sarangi A, 2009, ONCOGENE, V28, P3468, DOI 10.1038/onc.2009.208; SCHLUTER C, 1993, J CELL BIOL, V123, P513, DOI 10.1083/jcb.123.3.513; Schnell O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030429; Seidl K, 1998, J CELL PHYSIOL, V176, P10, DOI 10.1002/(SICI)1097-4652(199807)176:1<10::AID-JCP2>3.0.CO;2-B; Shonukan T, 2003, ONCOGENE, V22, P3616, DOI 10.1038/sj.onc.1206561; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Srinivasan B, 2007, MOL CELL NEUROSCI, V36, P449, DOI 10.1016/j.mcn.2007.08.005; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tabassum A, 2003, INT J CANCER, V105, P47, DOI 10.1002/ijc.11038; Urra S, 2007, J BIOL CHEM, V282, P7606, DOI 10.1074/jbc.M610458200; Verbeke S, 2010, CELL SIGNAL, V22, P1864, DOI 10.1016/j.cellsig.2010.07.014; Vilar M, 2006, EMBO J, V25, P1219, DOI 10.1038/sj.emboj.7601017; Vilar M, 2009, NEURON, V62, P72, DOI 10.1016/j.neuron.2009.02.020; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Wang LM, 2008, PLOS BIOL, V6, P2496, DOI 10.1371/journal.pbio.0060289; Wang Yu-qing, 2012, Cancer Biology Medicine, V9, P248, DOI 10.7497/j.issn.2095-3941.2012.04.005; WEICHERT H, 1991, Allergie und Immunologie (Leipzig), V37, P139; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Wildeboer D, 2006, J NEUROPATH EXP NEUR, V65, P516, DOI 10.1097/01.jnen.0000229240.51490.d3; Xiong J, 2013, NEURO-ONCOLOGY, V15, P990, DOI 10.1093/neuonc/not039; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Young KM, 2007, J NEUROSCI, V27, P5146, DOI 10.1523/JNEUROSCI.0654-07.2007; Zampieri N, 2005, J BIOL CHEM, V280, P14563, DOI 10.1074/jbc.M412957200; Zheng X, 2009, CANCER BIOL THER, V8, P1045, DOI 10.4161/cbt.8.11.8539	106	43	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8067	8085		10.1074/jbc.M113.513762	http://dx.doi.org/10.1074/jbc.M113.513762			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24519935	hybrid, Green Published			2022-12-28	WOS:000333157500006
J	Numata, S; Nagata, M; Mao, H; Sekimizu, K; Kaito, C				Numata, Shunsuke; Nagata, Makiko; Mao, Han; Sekimizu, Kazuhisa; Kaito, Chikara			CvfA Protein and Polynucleotide Phosphorylase Act in an Opposing Manner to Regulate Staphylococcus aureus Virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Genetics; Bacterial Pathogenesis; Ribonuclease; RNA Metabolism; RNA Modification; RNA Processing; Staphylococcus aureus	ESCHERICHIA-COLI; BACILLUS-SUBTILIS; MESSENGER-RNA; GENE; DEGRADATION; EXPRESSION; AGR; ENDORIBONUCLEASE; IDENTIFICATION; BACTERIA	Background: Production of 3-phosphorylated RNA by CvfA affects S. aureus virulence gene expression. Results: Disrupting pnpA-encoding exonuclease suppressed the cvfA-deleted mutant phenotype. Purified PNPase did not degrade 3-phosphorylated RNA. Conclusion: CvfA-produced 3-phosphorylated RNA inhibits PNPase-induced RNA degradation, resulting in hemolysin production by S. aureus. Significance: Altering the nucleotide structure at the RNA 3 terminus regulates S. aureus virulence. We previously identified CvfA (SA1129) as a Staphylococcus aureus virulence factor using a silkworm infection model. S. aureus cvfA-deleted mutants exhibit decreased expression of the agr locus encoding a positive regulator of hemolysin genes and decreased hemolysin production. CvfA protein hydrolyzes a 2,3-cyclic phosphodiester bond at the RNA 3 terminus, producing RNA with a 3-phosphate (3-phosphorylated RNA, RNA with a 3-phosphate). Here, we report that the cvfA-deleted mutant phenotype (decreased agr expression and hemolysin production) was suppressed by disrupting pnpA-encoding polynucleotide phosphorylase (PNPase) with 3- to 5-exonuclease activity. The suppression was blocked by introducing a pnpA-encoding PNPase with exonuclease activity but not by a pnpA-encoding mutant PNPase without exonuclease activity. Therefore, loss of PNPase exonuclease activity suppressed the cvfA-deleted mutant phenotype. Purified PNPase efficiently degraded RNA with 2,3-cyclic phosphate at the 3 terminus (2,3-cyclic RNA), but it inefficiently degraded 3-phosphorylated RNA. These findings indicate that 3-phosphorylated RNA production from 2,3-cyclic RNA by CvfA prevents RNA degradation by PNPase and contributes to the expression of agr and hemolysin genes. We speculate that in the cvfA-deleted mutant, 2,3-cyclic RNA is not converted to the 3-phosphorylated form and is efficiently degraded by PNPase, resulting in the loss of RNA essential for expressing agr and hemolysin genes, whereas in the cvfA/pnpA double-disrupted mutant, 2,3-cyclic RNA is not degraded by PNPase, leading to hemolysin production. These findings suggest that CvfA and PNPase competitively regulate RNA degradation essential for S. aureus virulence.	[Numata, Shunsuke; Nagata, Makiko; Mao, Han; Sekimizu, Kazuhisa; Kaito, Chikara] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Kaito, C (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, 3-1,7 Chome, Tokyo 1130033, Japan.	kaito@mol.f.u-tokyo.ac.jp	Kaito, Chikara/G-1248-2017; Kaito, Chikara/W-1815-2019	Kaito, Chikara/0000-0002-2895-3386; Kaito, Chikara/0000-0002-2895-3386	Mochida Memorial Foundation for Medical and Pharmaceutical Research; Genome Pharmaceuticals Institute	Mochida Memorial Foundation for Medical and Pharmaceutical Research; Genome Pharmaceuticals Institute	This work was supported by grants-in-aid for scientific research and in part by the Mochida Memorial Foundation for Medical and Pharmaceutical Research and the Genome Pharmaceuticals Institute.	ABDELNOUR A, 1993, INFECT IMMUN, V61, P3879, DOI 10.1128/IAI.61.9.3879-3885.1993; Anderson Kelsi L, 2009, Int J Microbiol, V2009, P525491, DOI 10.1155/2009/525491; Andrade JM, 2009, PROG MOL BIOL TRANSL, V85, P187, DOI 10.1016/S0079-6603(08)00805-2; Beran RK, 2001, MOL MICROBIOL, V39, P112, DOI 10.1046/j.1365-2958.2001.02216.x; Bermudez-Cruz RM, 2005, BIOCHIMIE, V87, P737, DOI 10.1016/j.biochi.2005.03.005; Blum E, 1999, J BIOL CHEM, V274, P4009, DOI 10.1074/jbc.274.7.4009; Caiazza NC, 2003, J BACTERIOL, V185, P3214, DOI 10.1128/JB.185.10.3214-3217.2003; Clements MO, 2002, P NATL ACAD SCI USA, V99, P8784, DOI 10.1073/pnas.132047099; Commichau FM, 2009, MOL CELL PROTEOMICS, V8, P1350, DOI 10.1074/mcp.M800546-MCP200; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; DRAPER DE, 1977, P NATL ACAD SCI USA, V74, P4786, DOI 10.1073/pnas.74.11.4786; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; Genschik P, 1997, EMBO J, V16, P2955, DOI 10.1093/emboj/16.10.2955; Giraudo AT, 1997, ARCH MICROBIOL, V168, P53, DOI 10.1007/s002030050469; Hardwick SW, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120028; Hunt A, 2006, MICROBIOL-SGM, V152, P2895, DOI 10.1099/mic.0.29152-0; Jarrige AC, 2002, J MOL BIOL, V321, P397, DOI 10.1016/S0022-2836(02)00645-9; Jarry TM, 2008, CELL MICROBIOL, V10, P1801, DOI 10.1111/j.1462-5822.2008.01166.x; Jeong DW, 2012, MOL MICROBIOL, V86, P331, DOI 10.1111/j.1365-2958.2012.08198.x; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Kaito C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003269; Kang SO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037367; Kang SO, 2010, INFECT IMMUN, V78, P2754, DOI 10.1128/IAI.01370-09; Kuroda H, 2007, FEMS MICROBIOL LETT, V268, P98, DOI 10.1111/j.1574-6968.2006.00568.x; Lehnik-Habrink M, 2012, MOL MICROBIOL, V84, P1005, DOI 10.1111/j.1365-2958.2012.08072.x; Li SL, 1997, BIOTECHNIQUES, V23, P588, DOI 10.2144/97234bm05; Luttinger A, 1996, MOL MICROBIOL, V19, P343, DOI 10.1046/j.1365-2958.1996.380907.x; Marincola G, 2012, MOL MICROBIOL, V85, P817, DOI 10.1111/j.1365-2958.2012.08144.x; MARKHAM R, 1952, BIOCHEM J, V52, P552, DOI 10.1042/bj0520552; Matsumoto Y, 2007, INFECT IMMUN, V75, P1964, DOI 10.1128/IAI.01552-06; Matsuo M, 2003, FEMS MICROBIOL LETT, V222, P107, DOI 10.1016/S0378-1097(03)00260-X; Miyazaki S, 2012, FEMS MICROBIOL LETT, V326, P116, DOI 10.1111/j.1574-6968.2011.02439.x; Moriya S, 1998, MOL MICROBIOL, V29, P179, DOI 10.1046/j.1365-2958.1998.00919.x; Nagata M, 2008, J BIOL CHEM, V283, P2176, DOI 10.1074/jbc.M705309200; Naimi TS, 2001, CLIN INFECT DIS, V33, P990, DOI 10.1086/322693; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Piazza F, 1996, J BACTERIOL, V178, P5513, DOI 10.1128/jb.178.18.5513-5521.1996; Polissi A, 2003, RES MICROBIOL, V154, P573, DOI 10.1016/S0923-2508(03)00167-0; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Romilly C, 2012, RNA BIOL, V9, P402, DOI 10.4161/rna.20103; Rosenzweig JA, 2005, J BIOL CHEM, V280, P156, DOI 10.1074/jbc.M405662200; Rosenzweig JA, 2007, FEMS MICROBIOL LETT, V270, P255, DOI 10.1111/j.1574-6968.2007.00689.x; Roux CM, 2011, J BACTERIOL, V193, P5520, DOI 10.1128/JB.05485-11; Sambrook J., 2001, MOL CLONING LAB MANU; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; Shahbabian K, 2009, EMBO J, V28, P3523, DOI 10.1038/emboj.2009.283; Shi ZH, 2008, RNA, V14, P2361, DOI 10.1261/rna.1244308; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Vagner V, 1998, MICROBIOL-SGM, V144, P3097, DOI 10.1099/00221287-144-11-3097; Wang W, 1996, J BACTERIOL, V178, P2375, DOI 10.1128/jb.178.8.2375-2382.1996; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; XU FF, 1995, NATURE, V374, P180, DOI 10.1038/374180a0; Yao SY, 2010, J BACTERIOL, V192, P3279, DOI 10.1128/JB.00230-10; Zangrossi S, 2000, MOL MICROBIOL, V36, P1470, DOI 10.1046/j.1365-2958.2000.01971.x; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	59	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8420	8431		10.1074/jbc.M114.554329	http://dx.doi.org/10.1074/jbc.M114.554329			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24492613	hybrid, Green Published			2022-12-28	WOS:000333157500034
J	Gould, N; Mor, DE; Lightfoot, R; Malkus, K; Giasson, B; Ischiropoulos, H				Gould, Neal; Mor, Danielle E.; Lightfoot, Richard; Malkus, Kristen; Giasson, Benoit; Ischiropoulos, Harry			Evidence of Native alpha-Synuclein Conformers in the Human Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alpha-Synuclein; Neurodegenerative Diseases; Parkinson Disease; Protein Conformation; Protein Folding; Human Brain; Native State	N-TERMINAL ACETYLATION; ALZHEIMERS-DISEASE; BETA-SYNUCLEIN; WILD-TYPE; IN-VIVO; PROTEIN; BINDING; NMR; OLIGOMERIZATION; STABILIZATION	Background: -Synuclein aggregation is associated with Parkinson disease. The native state of -synuclein in the human brain is unclear. Results: Evidence consistent with the presence of conformationally diverse metastable multimers of -synuclein in the human brain is presented. Conclusion: Multimeric species of -synuclein are present within the human brain. Significance: Understanding the native state of -synuclein in the brain is critical for determining the causes or propensity for aggregation. -Synuclein aggregation is central to the pathogenesis of several brain disorders. However, the native conformations and functions of this protein in the human brain are not precisely known. The native state of -synuclein was probed by gel filtration coupled with native gradient gel separation, an array of antibodies with non-overlapping epitopes, and mass spectrometry. The existence of metastable conformers and stable monomer was revealed in the human brain.	[Gould, Neal; Lightfoot, Richard; Ischiropoulos, Harry] Childrens Hosp Philadelphia, Res Inst, Dept Pediat, Philadelphia, PA 19104 USA; [Gould, Neal; Lightfoot, Richard; Ischiropoulos, Harry] Childrens Hosp Philadelphia, Res Inst, Dept Pharmacol, Philadelphia, PA 19104 USA; [Mor, Danielle E.; Malkus, Kristen; Giasson, Benoit; Ischiropoulos, Harry] Univ Penn, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Ischiropoulos, H (corresponding author), Childrens Hosp Philadelphia, Res Inst, Dept Pediat, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	ischirop@mail.med.upenn.edu	Kashfi, Khosrow/A-4351-2008	Kashfi, Khosrow/0000-0002-4060-7283; Mor, Danielle/0000-0003-3851-5010	National Institutes of Health [AG013966]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG013966 (to H. I.).	Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Binolfi A, 2012, BIOCHEM SOC T, V40, P950, DOI 10.1042/BST20120096; Burre J, 2013, NATURE, V498, pE4, DOI 10.1038/nature12125; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Cole NB, 2002, J BIOL CHEM, V277, P6344, DOI 10.1074/jbc.M108414200; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Dettmer U, 2013, J BIOL CHEM, V288, P6371, DOI 10.1074/jbc.M112.403311; Diao JJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00592; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Gurry T, 2013, J AM CHEM SOC, V135, P3865, DOI 10.1021/ja310518p; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Maltsev AS, 2012, BIOCHEMISTRY-US, V51, P5004, DOI 10.1021/bi300642h; Mazzulli JR, 2007, J BIOL CHEM, V282, P31621, DOI 10.1074/jbc.M704737200; McLean PJ, 2000, J BIOL CHEM, V275, P8812, DOI 10.1074/jbc.275.12.8812; Robotta M, 2011, CHEMPHYSCHEM, V12, P267, DOI 10.1002/cphc.201000815; Souza JM, 2000, FEBS LETT, V474, P116, DOI 10.1016/S0014-5793(00)01563-5; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Trexler AJ, 2012, PROTEIN SCI, V21, P601, DOI 10.1002/pro.2056; Tsika E, 2010, J NEUROSCI, V30, P3409, DOI 10.1523/JNEUROSCI.4977-09.2010; Ullman O, 2011, J AM CHEM SOC, V133, P19536, DOI 10.1021/ja208657z; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wersinger C, 2003, NEUROSCI LETT, V340, P189, DOI 10.1016/S0304-3940(03)00097-1; Wittig I, 2005, PROTEOMICS, V5, P4338, DOI 10.1002/pmic.200500081; Woods WS, 2007, J BIOL CHEM, V282, P34555, DOI 10.1074/jbc.M705283200	35	54	55	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7929	7934		10.1074/jbc.C113.538249	http://dx.doi.org/10.1074/jbc.C113.538249			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24474688	Green Published, hybrid			2022-12-28	WOS:000332761500057
J	Heilmann, M; Wellner, A; Gadermaier, G; Ilchmann, A; Briza, P; Krause, M; Nagai, R; Burgdorf, S; Scheurer, S; Vieths, S; Henle, T; Toda, M				Heilmann, Monika; Wellner, Anne; Gadermaier, Gabriele; Ilchmann, Anne; Briza, Peter; Krause, Maren; Nagai, Ryoji; Burgdorf, Sven; Scheurer, Stephan; Vieths, Stefan; Henle, Thomas; Toda, Masako			Ovalbumin Modified with Pyrraline, a Maillard Reaction Product, shows Enhanced T-cell Immunogenicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allergen; Carbohydrate; Dendritic Cells; Glycation; Scavenger Receptor	GLYCATION END-PRODUCTS; MACROPHAGE SCAVENGER RECEPTORS; DENDRITIC CELLS; RECOGNITION; PROTEINS; MATURATION; ANTIGEN; ATHEROSCLEROSIS; IDENTIFICATION; ALLERGENICITY	Background: Maillard reaction (MR) modifies food allergens with various glycation structures during thermal processing of foods. Results: We show that pyrraline, a glycation structure, enhances potential allergenicity of ovalbumin, a model allergen, by promoting scavenger receptor class A-mediated allergen uptake by dendritic cells. Conclusion: Pyrraline could act as a pathogenesis-related component in food allergies. Significance: We reveal how MR links to food allergies. The Maillard reaction (also referred to as glycation) takes place between reducing sugars and compounds with free amino groups during thermal processing of foods. In the final stage of the complex reaction cascade, the so-called advanced glycation end products (AGEs) are formed, including proteins with various glycation structures. It has been suggested that some AGEs could have immunostimulatory effects. Here, we aimed to identify specific glycation structure(s) that could influence the T-cell immunogenicity and potential allergenicity of food allergens, using ovalbumin (OVA, an egg white allergen) as a model allergen. OVA was specifically modified with representative glycation structures: N-E-carboxymethyl lysine (CM-OVA), N-E-carboxyethyl lysine (CE-OVA), pyrraline (Pyr-OVA), or methylglyoxal-derived arginine derivatives (MGO-OVA). As well as AGE-OVA, a crude glycation product in thermal incubation of OVA with glucose, only Pyr-OVA, and not other modified OVAs, was efficiently taken up by bone marrow-derived murine dendritic cells (BMDCs). The uptake of Pyr-OVA was reduced in scavenger receptor class A (SR-A)-deficient BMDCs, but not in cells treated with inhibitors of scavenger receptor class B, galectin-3, or blocking antibodies against CD36, suggesting that pyrraline binds to SR-A. Compared with other modified OVAs, Pyr-OVA induced higher activation of OVA-specific CD4(+) T-cells in co-culture with BMDCs. Furthermore, compared with native OVA, AGE-OVA and Pyr-OVA induced higher IgE production in mice. Pyrraline could induce better allergen uptake by DCs via association with SR-A and subsequently enhance CD4(+) T-cell activation and IgE production. Our findings help us to understand how Maillard reaction enhances the potential allergenicity of food allergens.	[Heilmann, Monika; Ilchmann, Anne; Krause, Maren; Toda, Masako] Paul Ehrlich Inst, Jr Res Grp 1, D-63225 Langen, Germany; [Scheurer, Stephan; Vieths, Stefan] Paul Ehrlich Inst, Div Allergol, D-63225 Langen, Germany; [Wellner, Anne; Henle, Thomas] Tech Univ Dresden, Inst Food Chem, D-01062 Dresden, Germany; [Gadermaier, Gabriele; Briza, Peter] Salzburg Univ, Dept Mol Biol, Christian Doppler Lab Allergy Diag & Therapy, A-5020 Salzburg, Austria; [Nagai, Ryoji] Tokai Univ, Sch Agr, Dept Biosci, Lab Food & Regulat Biol, Kumamoto 8691404, Japan; [Burgdorf, Sven] Univ Bonn, Cellular Immunol Lab, Life & Med Sci LIMES Inst, D-53105 Bonn, Germany	Paul Ehrlich Institute; Paul Ehrlich Institute; Technische Universitat Dresden; Salzburg University; Tokai University; University of Bonn	Toda, M (corresponding author), Expt Allergy Models Paul Ehrlich Inst, Jr Res Grp 1, Paul Ehrlich Str 59, D-63225 Langen, Germany.	Masako.Toda@pei.de	Briza, Peter/D-7309-2012; Gadermaier, Gabriele/L-5997-2015; Scheurer, Stephan/A-6509-2019; Toda, Masako/S-9810-2019	Briza, Peter/0000-0002-4941-6782; Gadermaier, Gabriele/0000-0002-4886-417X; Scheurer, Stephan/0000-0002-2859-562X; 	Christian Doppler Research Association and Biomay	Christian Doppler Research Association and Biomay	This work was supported by funds from the Christian Doppler Research Association and Biomay (to G. G. and P. B.).	ABRAHAM R, 1995, J IMMUNOL, V154, P1; ACTON S, 1993, J BIOL CHEM, V268, P3530; Ames JM, 2007, MOL NUTR FOOD RES, V51, P1085, DOI 10.1002/mnfr.200600304; Andersson L, 1998, J BIOL CHEM, V273, P19592, DOI 10.1074/jbc.273.31.19592; ARAKI N, 1995, EUR J BIOCHEM, V230, P408, DOI 10.1111/j.1432-1033.1995.0408h.x; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Burggraf M, 2011, MOL NUTR FOOD RES, V55, P1475, DOI 10.1002/mnfr.201000634; Buttari B, 2011, BLOOD, V117, P6152, DOI 10.1182/blood-2010-12-325514; CHERAYIL BJ, 1989, J EXP MED, V170, P1959, DOI 10.1084/jem.170.6.1959; DOI T, 1993, J BIOL CHEM, V268, P2126; Forster A, 2005, ANN NY ACAD SCI, V1043, P474, DOI 10.1196/annals.1333.054; Ge JB, 2005, ARTERIOSCL THROM VAS, V25, P2157, DOI 10.1161/01.ATV.0000181744.58265.63; Glorieux G, 2004, KIDNEY INT, V66, P1873, DOI 10.1111/j.1523-1755.2004.00961.x; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Gruber P, 2004, J AGR FOOD CHEM, V52, P4002, DOI 10.1021/jf035458+; Henle T, 2005, AMINO ACIDS, V29, P313, DOI 10.1007/s00726-005-0200-2; Henle T, 1996, Z LEBENSM UNTERS FOR, V202, P72, DOI 10.1007/BF01229689; HENLE T, 1994, Z LEBENSM UNTERS FOR, V199, P55, DOI 10.1007/BF01192954; Henle T, 1991, INT DAIRY J, V1, P125, DOI 10.1016/0958-6946(91)90004-R; Huntington JA, 2001, J CHROMATOGR B, V756, P189, DOI 10.1016/S0378-4347(01)00108-6; Ilchmann A, 2010, J ALLERGY CLIN IMMUN, V125, P175, DOI 10.1016/j.jaci.2009.08.013; Iwan M, 2011, J AGR FOOD CHEM, V59, P7163, DOI 10.1021/jf2007375; Jimenez-Saiz R, 2011, J AGR FOOD CHEM, V59, P10044, DOI 10.1021/jf2014638; Lepur A, 2012, BBA-GEN SUBJECTS, V1820, P804, DOI 10.1016/j.bbagen.2012.02.018; Nagai R, 2000, DIABETES, V49, P1714, DOI 10.2337/diabetes.49.10.1714; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nicoletti A, 1999, EUR J IMMUNOL, V29, P512, DOI 10.1002/(SICI)1521-4141(199902)29:02<512::AID-IMMU512>3.0.CO;2-Y; Nieland TJF, 2002, P NATL ACAD SCI USA, V99, P15422, DOI 10.1073/pnas.222421399; Nogueira-Machado JA, 2011, EXPERT OPIN THER TAR, V15, P1023, DOI 10.1517/14728222.2011.575360; Ohgami N, 2001, J BIOL CHEM, V276, P13348, DOI 10.1074/jbc.M011613200; Ohgami N, 2001, J BIOL CHEM, V276, P3195, DOI 10.1074/jbc.M006545200; Pluddemann A, 2007, METHODS, V43, P207, DOI 10.1016/j.ymeth.2007.06.004; Price CL, 2004, DIABETES, V53, P1452, DOI 10.2337/diabetes.53.6.1452; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Taheri-Kafrani A, 2009, J AGR FOOD CHEM, V57, P4974, DOI 10.1021/jf804038t; Turner SJ, 1997, J IMMUNOL, V159, P2312; Vissers YM, 2011, CLIN EXP ALLERGY, V41, P1631, DOI 10.1111/j.1365-2222.2011.03830.x; VLASSARA H, 1995, MOL MED, V1, P634, DOI 10.1007/BF03401604; Wellner A, 2012, EUR FOOD RES TECHNOL, V234, P423, DOI 10.1007/s00217-011-1649-8; Wellner A, 2011, J AGR FOOD CHEM, V59, P7992, DOI 10.1021/jf2013293	41	50	50	2	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7919	7928		10.1074/jbc.M113.523621	http://dx.doi.org/10.1074/jbc.M113.523621			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24505139	hybrid, Green Published			2022-12-28	WOS:000332761500056
J	Melo, FR; Vita, F; Berent-Maoz, B; Levi-Schaffer, F; Zabucchi, G; Pejler, G				Melo, Fabio R.; Vita, Francesca; Berent-Maoz, Beata; Levi-Schaffer, Francesca; Zabucchi, Giuliano; Pejler, Gunnar			Proteolytic Histone Modification by Mast Cell Tryptase, a Serglycin Proteoglycan-dependent Secretory Granule Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Histone Modification; Mast Cell; Protease; Proteoglycan; Proteolytic Enzymes; mMCP-6; Secretory Granules; Serglycin; Tryptase	APOPTOSIS; IMMUNITY; DEATH; REGULATORS; TETRAMER	Background: Tryptase is a serglycin proteoglycan-dependent protease localized in mast cell granules. Results: Tryptase was found to degrade core histones, both during apoptosis and in viable cells. Conclusion: A serglycin-tryptase axis is identified as a novel mechanism for histone modification. Significance: Secretory granule compounds are implicated in the regulation of nuclear events. A hallmark feature of mast cells is their high content of cytoplasmic secretory granules filled with various preformed compounds, including proteases of tryptase-, chymase-, and carboxypeptidase A3 type that are electrostatically bound to serglycin proteoglycan. Apart from participating in extracellular processes, serglycin proteoglycan and one of its associated proteases, tryptase, are known to regulate cell death by promoting apoptosis over necrosis. Here we sought to outline the underlying mechanism and identify core histones as primary proteolytic targets for the serglycin-tryptase axis. During the cell death process, tryptase was found to relocalize from granules into the cytosol and nucleus, and it was found that the absence of tryptase was associated with a pronounced accumulation of core histones both in the cytosol and in the nucleus. Intriguingly, tryptase deficiency resulted in defective proteolytic modification of core histones even at baseline conditions, i.e. in the absence of cytotoxic agent, suggesting that tryptase has a homeostatic impact on nuclear events. Indeed, tryptase was found in the nucleus of viable cells and was shown to cleave core histones in their N-terminal tail. Moreover, it was shown that the absence of the serglycin-tryptase axis resulted in altered chromatin composition. Together, these findings implicate histone proteolysis through a secretory granule-derived serglycin-tryptase axis as a novel principle for histone modification, during both cell homeostasis and cell death.	[Melo, Fabio R.; Pejler, Gunnar] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, S-75123 Uppsala, Sweden; [Vita, Francesca; Zabucchi, Giuliano] Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy; [Berent-Maoz, Beata; Levi-Schaffer, Francesca] Hebrew Univ Jerusalem, Fac Med, Inst Drug Res, Dept Pharmacol, IL-91120 Jerusalem, Israel	Swedish University of Agricultural Sciences; University of Trieste; Hebrew University of Jerusalem	Melo, FR (corresponding author), Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, BMC, Box 575, S-75123 Uppsala, Sweden.	Fabio.Melo@slu.se; Gunnar.Pejler@slu.se	Melo, Fabio Rabelo/GQP-0844-2022	Levi-Schaffer, Francesca/0000-0003-0620-2810	Swedish Research Council; Swedish Cancer Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation	This work was supported by grants from The Swedish Research Council (to G. P.) and The Swedish Cancer Foundation (to G.P.).	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; Bird PI, 2009, NAT REV IMMUNOL, V9, P871, DOI 10.1038/nri2671; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; GRIFFITHS G, 1986, J HISTOCHEM CYTOCHEM, V34, P1389, DOI 10.1177/34.11.3534077; GURISH MF, 1992, J EXP MED, V175, P1003, DOI 10.1084/jem.175.4.1003; Kim JA, 2012, P NATL ACAD SCI USA, V109, P5779, DOI 10.1073/pnas.1203453109; Kolset SO, 2011, J IMMUNOL, V187, P4927, DOI 10.4049/jimmunol.1100806; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lundequist A, 2011, CELL MOL LIFE SCI, V68, P965, DOI 10.1007/s00018-010-0587-0; Melo FR, 2012, J BIOL CHEM, V287, P18142, DOI 10.1074/jbc.M112.344796; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Pereira PJB, 1998, NATURE, V392, P306, DOI 10.1038/32703; Rivera J, 2008, ADV IMMUNOL, V98, P85, DOI 10.1016/S0065-2776(08)00403-3; Ronnberg E, 2012, METHODS MOL BIOL, V836, P201, DOI 10.1007/978-1-61779-498-8_14; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Sommerhoff CP, 1999, P NATL ACAD SCI USA, V96, P10984, DOI 10.1073/pnas.96.20.10984; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Teoh SSY, 2010, J BIOL CHEM, V285, P10862, DOI 10.1074/jbc.M109.073171; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711; ZABUCCHI G, 1992, BLOOD, V80, P2903	26	27	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7682	7690		10.1074/jbc.M113.546895	http://dx.doi.org/10.1074/jbc.M113.546895			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24478313	Green Published, hybrid			2022-12-28	WOS:000332761500036
J	Azzaz, AM; Vitalini, MW; Thomas, AS; Price, JP; Blacketer, MJ; Cryderman, DE; Zirbel, LN; Woodcock, CL; Elcock, AH; Wallrath, LL; Shogren-Knaak, MA				Azzaz, Abdelhamid M.; Vitalini, Michael W.; Thomas, Andrew S.; Price, Jason P.; Blacketer, Melissa J.; Cryderman, Diane E.; Zirbel, Luka N.; Woodcock, Christopher L.; Elcock, Adrian H.; Wallrath, Lori L.; Shogren-Knaak, Michael A.			Human Heterochromatin Protein 1 alpha Promotes Nucleosome Associations That Drive Chromatin Condensation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Structure; Chromosomes; DNA Binding Protein; Heterochromatin; Histone Modification	POSITION-EFFECT VARIEGATION; HISTONE H3; LYSINE 9; PERICENTRIC HETEROCHROMATIN; GENE-EXPRESSION; CORE PARTICLE; HP1 SUGGESTS; DROSOPHILA; METHYLATION; DOMAIN	Background: Heterochromatin is enriched for di- and tri-methylated lysine 9 of histone H3 (H3K9Me2/3) and heterochromatin protein 1 (HP1(Hs .)). Results: The association of HP1(Hs) with H3K9Me3-containing nucleosome arrays facilitated array compaction and cross-array interactions. Conclusion: HP1(Hs) association caused intra- and inter-array associations, leading to chromatin condensation and looping. Significance: An understanding of HP1(Hs)-nucleosome interactions provides insights on the structure and functions of heterochromatin. HP1(Hs)-containing heterochromatin is located near centric regions of chromosomes and regulates DNA-mediated processes such as DNA repair and transcription. The higher-order structure of heterochromatin contributes to this regulation, yet the structure of heterochromatin is not well understood. We took a multidisciplinary approach to determine how HP1(Hs)-nucleosome interactions contribute to the structure of heterochromatin. We show that HP1(Hs) preferentially binds histone H3K9Me3-containing nucleosomal arrays in favor of non-methylated nucleosomal arrays and that nonspecific DNA interactions and pre-existing chromatin compaction promote binding. The chromo and chromo shadow domains of HP1(Hs) play an essential role in HP1(Hs)-nucleosome interactions, whereas the hinge region appears to have a less significant role. Electron microscopy of HP1(Hs)-associated nucleosomal arrays showed that HP1(Hs) caused nucleosome associations within an array, facilitating chromatin condensation. Differential sedimentation of HP1(Hs)-associated nucleosomal arrays showed that HP1(Hs) promotes interactions between arrays. These strand-to-strand interactions are supported by in vivo studies where tethering the Drosophila homologue HP1a to specific sites promotes interactions with distant chromosomal sites. Our findings demonstrate that HP1(Hs)-nucleosome interactions cause chromatin condensation, a process that regulates many chromosome events.	[Azzaz, Abdelhamid M.; Blacketer, Melissa J.; Shogren-Knaak, Michael A.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [Vitalini, Michael W.; Thomas, Andrew S.; Price, Jason P.; Cryderman, Diane E.; Zirbel, Luka N.; Elcock, Adrian H.; Wallrath, Lori L.] Univ Iowa, Dept Biochem, Iowa City, IA 52241 USA; [Woodcock, Christopher L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	Iowa State University; University of Iowa; University of Massachusetts System; University of Massachusetts Amherst	Wallrath, LL (corresponding author), Dept Biochem, 3136 MERF,375 Newton Rd, Iowa City, IA 52241 USA.	lori-wallrath@uiowa.edu; knaak@iastate.edu		Wallrath, Lori/0000-0002-4391-7199; Elcock, Adrian/0000-0003-2820-1376	National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061513, T34GM008574, R01GM079663] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	K. Gadhok and A. Peterson are acknowledged for technical assistance with Drosophila experiments. K. Wakeland is acknowledged for help with the statistical analysis of the EM images. Computational time on the TACC supercomputing resource Ranger provided through the National Science Foundation funded TeraGrid and XSEDE programs is acknowledged.	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Blacketer MJ, 2010, J BIOL CHEM, V285, P34597, DOI 10.1074/jbc.M110.140061; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Canzio D, 2011, MOL CELL, V41, P67, DOI 10.1016/j.molcel.2010.12.016; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; Cryderman DE, 1998, CHROMOSOMA, V107, P277, DOI 10.1007/s004120050309; Cryderman DE, 2005, DEV DYNAM, V232, P767, DOI 10.1002/dvdy.20310; Danzer JR, 2004, DEVELOPMENT, V131, P3571, DOI 10.1242/dev.01223; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; de Wit E, 2005, GENOME RES, V15, P1265, DOI 10.1101/gr.3198905; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Dialynas GK, 2008, MUTAT RES-FUND MOL M, V647, P13, DOI 10.1016/j.mrfmmm.2008.09.007; Dorigo B, 2003, J MOL BIOL, V327, P85, DOI 10.1016/S0022-2836(03)00025-1; Eskeland R, 2007, MOL CELL BIOL, V27, P453, DOI 10.1128/MCB.01576-06; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Fanti L, 1998, MOL CELL, V2, P527, DOI 10.1016/S1097-2765(00)80152-5; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; HANSEN JC, 1989, BIOCHEMISTRY-US, V28, P9129, DOI 10.1021/bi00449a026; Heitz E., 1928, JAHRB WISS BOT, V69, P762; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Honda S, 2012, NAT STRUCT MOL BIOL, V19, P471, DOI 10.1038/nsmb.2274; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; Jacobs SA, 2001, EMBO J, V20, P5232, DOI 10.1093/emboj/20.18.5232; Kaustov L, 2011, J BIOL CHEM, V286, P521, DOI 10.1074/jbc.M110.191411; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Li S, 2008, P NATL ACAD SCI USA, V105, P18243, DOI 10.1073/pnas.0804530105; Li YH, 2003, DEVELOPMENT, V130, P1817, DOI 10.1242/dev.00405; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Luger K, 1999, METHOD ENZYMOL, V304, P3; Maison C, 2011, NAT GENET, V43, P220, DOI 10.1038/ng.765; Mateescu B, 2004, EMBO REP, V5, P490, DOI 10.1038/sj.embor.7400139; Munari F, 2012, J BIOL CHEM, V287, P33756, DOI 10.1074/jbc.M112.390849; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Norwood LE, 2004, GENE, V336, P37, DOI 10.1016/j.gene.2004.04.003; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; Seum C, 2000, CHROMOSOMA, V109, P453, DOI 10.1007/s004120000101; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sinha D, 2010, J BIOL CHEM, V285, P16572, DOI 10.1074/jbc.M109.091298; Sun FL, 2001, MOL CELL BIOL, V21, P2867, DOI 10.1128/MCB.21.8.2867-2879.2001; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045; Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699; Zhao T, 2000, J BIOL CHEM, V275, P28332	46	63	64	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6850	6861		10.1074/jbc.M113.512137	http://dx.doi.org/10.1074/jbc.M113.512137			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24415761	hybrid, Green Published			2022-12-28	WOS:000332389400046
J	Kaur, S; Kroczynska, B; Sharma, B; Sassano, A; Arslan, AD; Majchrzak-Kita, B; Stein, BL; McMahon, B; Altman, JK; Su, B; Calogero, RA; Fish, EN; Platanias, LC				Kaur, Surinder; Kroczynska, Barbara; Sharma, Bhumika; Sassano, Antonella; Arslan, Ahmet Dirim; Majchrzak-Kita, Beata; Stein, Brady L.; McMahon, Brandon; Altman, Jessica K.; Su, Bing; Calogero, Raffaele A.; Fish, Eleanor N.; Platanias, Leonidas C.			Critical Roles for Rictor/Sin1 Complexes in Interferon-dependent Gene Transcription and Generation of Antiproliferative Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; Antiviral Agents; Cell Signaling; Cytokines; Interferon; Gene Regulation; Interferon; Signal Transduction	PROTEIN-KINASE-C; GROWTH-INHIBITORY RESPONSES; DELTA PKC-DELTA; I INTERFERONS; PHOSPHATIDYLINOSITOL 3-KINASE; SERINE PHOSPHORYLATION; IFN RESPONSES; STAT PROTEINS; ACTIVATION; ALPHA	Background: The precise roles for Rictor/Sin1 complexes in IFN signaling remain to be defined. Results: Targeted disruption Rictor/Sin1 results in defects in activation of elements of Stat pathways. These proteins are required for IFN antineoplastic effects on malignant erythroid precursors. Conclusion: Rictor/Sin1 play critical roles in IFN signaling. Significance: This study provides evidence for a key mechanism for gene regulation associated with generation of IFN antineoplastic responses. We provide evidence that type I IFN-induced STAT activation is diminished in cells with targeted disruption of the Rictor gene, whose protein product is a key element of mTOR complex 2. Our studies show that transient or stable knockdown of Rictor or Sin1 results in defects in activation of elements of the STAT pathway and reduced STAT-DNA binding complexes. This leads to decreased expression of several IFN-inducible genes that mediate important biological functions. Our studies also demonstrate that Rictor and Sin1 play essential roles in the generation of the suppressive effects of IFN on malignant erythroid precursors from patients with myeloproliferative neoplasms. Altogether, these findings provide evidence for critical functions for Rictor/Sin1 complexes in type I IFN signaling and the generation of type I IFN antineoplastic responses.	[Kaur, Surinder; Kroczynska, Barbara; Sharma, Bhumika; Sassano, Antonella; Arslan, Ahmet Dirim; Stein, Brady L.; McMahon, Brandon; Altman, Jessica K.; Platanias, Leonidas C.] Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Kaur, Surinder; Kroczynska, Barbara; Sharma, Bhumika; Sassano, Antonella; Arslan, Ahmet Dirim; Stein, Brady L.; McMahon, Brandon; Altman, Jessica K.; Platanias, Leonidas C.] Northwestern Univ, Sch Med, Div Hematol Oncol, Dept Med, Chicago, IL 60611 USA; [Altman, Jessica K.; Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Dept Med, Div Hematol Oncol, Chicago, IL 60612 USA; [Majchrzak-Kita, Beata; Fish, Eleanor N.] Univ Toronto, Univ Hlth Network, Toronto Res Inst, Toronto, ON M5S 2J7, Canada; [Majchrzak-Kita, Beata; Fish, Eleanor N.] Univ Toronto, Dept Immunol, Toronto, ON M5S 2J7, Canada; [Su, Bing] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Calogero, Raffaele A.] Univ Turin, Dept Biotechnol & Hlth Sci, I-8 Turin, Italy	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Yale University; University of Turin	Platanias, LC (corresponding author), Robert H Lurie Comprehens Canc Ctr, 303 East Super St,Lurie 3-107, Chicago, IL 60611 USA.	l-platanias@northwestern.edu	Calogero, Raffaele/K-9428-2019	Calogero, Raffaele/0000-0002-2848-628X	National Institutes of Health [CA77816, CA155566, CA161796]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA155566, P30CA060553, R01CA077816, T32CA070085, R01CA161796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA77816, CA155566, and CA161796. This work was also supported by a merit review grant from the Department of Veterans Affairs and by funds made available to ENF as a Tier 1 Canada Research Chair.	Bancerek J, 2013, IMMUNITY, V38, P250, DOI 10.1016/j.immuni.2012.10.017; Beauchamp EM, 2013, ONCOGENE, V32, P3923, DOI 10.1038/onc.2012.567; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Bracarda S, 2010, EUR J CANCER, V46, P284, DOI 10.1016/j.ejca.2009.10.013; Choudhury GG, 2004, J BIOL CHEM, V279, P27399, DOI 10.1074/jbc.M403530200; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Deb DK, 2003, J IMMUNOL, V171, P267, DOI 10.4049/jimmunol.171.1.267; Decker T, 1999, CELL MOL LIFE SCI, V55, P1535, DOI 10.1007/s000180050393; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Dionne KR, 2013, J VIROL, V87, P3447, DOI 10.1128/JVI.02324-12; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fagerlund R, 2002, J BIOL CHEM, V277, P30072, DOI 10.1074/jbc.M202943200; Fuchs SY, 2013, J INTERF CYTOK RES, V33, P211, DOI 10.1089/jir.2012.0117; Ghosh D, 2008, P NATL ACAD SCI USA, V105, P11673, DOI 10.1073/pnas.0803182105; Haller O, 2007, CYTOKINE GROWTH F R, V18, P425, DOI 10.1016/j.cytogfr.2007.06.001; Hervas-Stubbs S, 2011, CLIN CANCER RES, V17, P2619, DOI 10.1158/1078-0432.CCR-10-1114; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Joshi S, 2009, P NATL ACAD SCI USA, V106, P12097, DOI 10.1073/pnas.0900562106; Katsoulidis E, 2009, J BIOL CHEM, V284, P25051, DOI 10.1074/jbc.M109.030445; Kaur S, 2005, EXP HEMATOL, V33, P550, DOI 10.1016/j.exphem.2005.01.014; Kaur S, 2008, J IMMUNOL, V181, P7316, DOI 10.4049/jimmunol.181.10.7316; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kaur S, 2012, P NATL ACAD SCI USA, V109, P7723, DOI 10.1073/pnas.1118122109; Kiladjian JJ, 2011, BLOOD, V117, P4706, DOI 10.1182/blood-2010-08-258772; Kotenko SV, 2011, CURR OPIN IMMUNOL, V23, P583, DOI 10.1016/j.coi.2011.07.007; Kotredes KP, 2013, J INTERF CYTOK RES, V33, P162, DOI 10.1089/jir.2012.0110; Kroczynska B, 2012, MOL CELL BIOL, V32, P2809, DOI 10.1128/MCB.00310-12; Kroczynska B, 2009, MOL CELL BIOL, V29, P2865, DOI 10.1128/MCB.01537-08; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001; Lim CP, 2006, MOL BIOSYST, V2, P536, DOI 10.1039/b606246f; Piehler J, 2012, IMMUNOL REV, V250, P317, DOI 10.1111/imr.12001; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Platanias LC, 2013, J INTERF CYTOK RES, V33, P143, DOI 10.1089/jir.2013.0019; Qureshi SA, 1996, MOL CELL BIOL, V16, P288; QURESHI SA, 1995, P NATL ACAD SCI USA, V92, P3829, DOI 10.1073/pnas.92.9.3829; Rahman N, 2010, IMMUNOL CELL BIOL, V88, P817, DOI 10.1038/icb.2010.57; Redig AJ, 2009, J BIOL CHEM, V284, P10301, DOI 10.1074/jbc.M807254200; Reich NC, 2013, J INTERF CYTOK RES, V33, P199, DOI 10.1089/jir.2012.0159; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Sadzak I, 2008, P NATL ACAD SCI USA, V105, P8944, DOI 10.1073/pnas.0801794105; Sanges R, 2007, BIOINFORMATICS, V23, P3406, DOI 10.1093/bioinformatics/btm469; Schattgen SA, 2011, IMMUNOL REV, V243, P109, DOI 10.1111/j.1600-065X.2011.01053.x; Sharma B, 2012, J BIOL CHEM, V287, P42352, DOI 10.1074/jbc.M112.400721; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Stark GR, 2007, CYTOKINE GROWTH F R, V18, P419, DOI 10.1016/j.cytogfr.2007.06.013; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Tahk S, 2007, P NATL ACAD SCI USA, V104, P11643, DOI 10.1073/pnas.0701877104; Takauji R, 2002, J LEUKOCYTE BIOL, V72, P1011; Tefferi A, 2011, J CLIN ONCOL, V29, P573, DOI 10.1200/JCO.2010.29.8711; Uddin S, 1999, J BIOL CHEM, V274, P30127, DOI 10.1074/jbc.274.42.30127; Uddin S, 2002, J BIOL CHEM, V277, P14408, DOI 10.1074/jbc.M109671200; Wang SZ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-13; Wang SZ, 2004, ENDOCRINOLOGY, V145, P5820, DOI 10.1210/en.2004-0991; Yanase N, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-7	61	16	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6581	6591		10.1074/jbc.M113.537852	http://dx.doi.org/10.1074/jbc.M113.537852			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24469448	Green Published, hybrid			2022-12-28	WOS:000332389400023
J	Serrano, S; Araujo, A; Apellaniz, B; Bryson, S; Carravilla, P; de la Arada, I; Huarte, N; Rujas, E; Pai, EF; Arrondo, JLR; Domene, C; Jimenez, MA; Nieva, JL				Serrano, Soraya; Araujo, Aitziber; Apellaniz, Beatriz; Bryson, Steve; Carravilla, Pablo; de la Arada, Igor; Huarte, Nerea; Rujas, Edurne; Pai, Emil F.; Arrondo, Jose L. R.; Domene, Carmen; Angeles Jimenez, Maria; Nieva, Jose L.			Structure and Immunogenicity of a Peptide Vaccine, Including the Complete HIV-1 gp41 2F5 Epitope IMPLICATIONS FOR ANTIBODY RECOGNITION MECHANISM AND IMMUNOGEN DESIGN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fourier Transform IR (FTIR); HIV-1; Liposomes; Nuclear Magnetic Resonance; Peptide Conformation; Vaccine Development	IMMUNODEFICIENCY-VIRUS TYPE-1; PROXIMAL EXTERNAL REGION; HUMAN MONOCLONAL-ANTIBODY; BROADLY NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEIN; MOLECULAR-DYNAMICS; MEDIATED FUSION; NMR STRUCTURE; FORCE-FIELD; MEMBRANE	Background: HIV-1 vaccines should elicit broadly neutralizing antibodies as the gp41 membrane-proximal external region targeting MAb2F5. Results: NMR disclosed unprecedented 2F5 peptide-epitope structures. Although overall conformation was preserved in different adjuvants, recovered antibodies after vaccination were functionally different. Conclusion: Membrane-inserted helical oligomers may encompass effective 2F5 peptide vaccines. Significance: Disclosing the structures that generate 2F5-like antibodies may guide future vaccine development. The membrane-proximal external region (MPER) of gp41 harbors the epitope recognized by the broadly neutralizing anti-HIV 2F5 antibody, a research focus in HIV-1 vaccine development. In this work, we analyze the structure and immunogenic properties of MPERp, a peptide vaccine that includes the following: (i) the complete sequence protected from proteolysis by the 2F5 paratope; (ii) downstream residues postulated to establish weak contacts with the CDR-H3 loop of the antibody, which are believed to be crucial for neutralization; and (iii) an aromatic rich anchor to the membrane interface. MPERp structures solved in dodecylphosphocholine micelles and 25% 1,1,1,3,3,3-hexafluoro-2-propanol (v/v) confirmed folding of the complete 2F5 epitope within continuous kinked helices. Infrared spectroscopy (IR) measurements demonstrated the retention of main helical conformations in immunogenic formulations based on alum, Freund's adjuvant, or two different types of liposomes. Binding to membrane-inserted MPERp, IR, molecular dynamics simulations, and characterization of the immune responses further suggested that packed helical bundles partially inserted into the lipid bilayer, rather than monomeric helices adsorbed to the membrane interface, could encompass effective MPER peptide vaccines. Together, our data constitute a proof-of-concept to support MPER-based peptides in combination with liposomes as stand-alone immunogens and suggest new approaches for structure-aided MPER vaccine development.	[Serrano, Soraya; Angeles Jimenez, Maria] Consejo Super Invest Cient IQFR CSIC, Inst Phys Chem Rocasolano, E-28006 Madrid, Spain; [Araujo, Aitziber; Apellaniz, Beatriz; Carravilla, Pablo; de la Arada, Igor; Huarte, Nerea; Rujas, Edurne; Arrondo, Jose L. R.; Nieva, Jose L.] CSIC, Biophys Unit, Bilbao 48080, Spain; [Araujo, Aitziber; Apellaniz, Beatriz; Carravilla, Pablo; de la Arada, Igor; Huarte, Nerea; Rujas, Edurne; Arrondo, Jose L. R.; Nieva, Jose L.] Univ Basque Country, CSIC, UPV EHU, Bilbao 48080, Spain; [Araujo, Aitziber; Apellaniz, Beatriz; Carravilla, Pablo; de la Arada, Igor; Huarte, Nerea; Rujas, Edurne; Arrondo, Jose L. R.; Nieva, Jose L.] Univ Basque Country UPV EHU, Dept Biochem & Mol Biol, Bilbao 48080, Spain; [Bryson, Steve; Pai, Emil F.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Bryson, Steve; Pai, Emil F.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada; [Bryson, Steve; Pai, Emil F.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Bryson, Steve; Pai, Emil F.] Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Canc Res, Toronto, ON M5G 1L7, Canada; [Domene, Carmen] Univ Oxford, Chem Res Lab, Oxford OX1 3TA, England; [Domene, Carmen] Kings Coll London, Dept Chem, London SE1 9NH, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; University of Basque Country; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Oxford; University of London; King's College London	Jimenez, MA (corresponding author), Consejo Super Invest Cient IQFR CSIC, Inst Phys Chem Rocasolano, Serrano 119, E-28006 Madrid, Spain.	majimenez@iqfr.csic.es; gbpniesj@lg.ehu.es	Apellaniz, Beatriz/E-9291-2012; de la Arada, Igor/L-9036-2014; Rujas, Edurne/P-1969-2018; Nieva, Jose L/Q-2063-2019; Pai, Emil/R-8908-2019; Carravilla, Pablo/AAV-9168-2020; Rujas, Edurne/GXG-7368-2022; Jimenez, M. Angeles/C-7193-2008; Rujas, Edurne/AGV-1475-2022; Domene, Carmen/A-2711-2019	de la Arada, Igor/0000-0001-6777-1238; Nieva, Jose L/0000-0001-6446-5649; Pai, Emil/0000-0002-1162-7242; Jimenez, M. Angeles/0000-0001-6835-5850; HUARTE ARRAYAGO, NEREA/0000-0002-6675-4150; APELLANIZ, BEATRIZ/0000-0003-1573-5440; Domene, Carmen/0000-0001-7115-4232; Rujas, Edurne/0000-0002-4465-5071; Bryson, Steve/0000-0001-8924-4201; Carravilla Palomanes, Pablo/0000-0001-6592-7630	Spanish MINECO [BIO2011-29792, BFU2010-22103, CTQ2011-22514]; Basque Government [IT838-13, IT852-13]; Canadian Institutes for Health Research [NRF-126638]; Canada Research Chairs Program; National Science Foundation [CNS-09-58854]	Spanish MINECO(Spanish Government); Basque Government(Basque Government); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); National Science Foundation(National Science Foundation (NSF))	This work was supported in part by Spanish MINECO Grants BIO2011-29792 (to J. L. N.), BFU2010-22103 (to J. L. R. A.), and CTQ2011-22514 (to M. A. J.) and Basque Government Grants IT838-13 and IT852-13 (to J. L. N. and J. L. R. A., respectively).; Recipient of a predoctoral fellowship from Spanish MINECO.; Recipients of predoctoral fellowships from the Basque Government.; Supported by Canadian Institutes for Health Research Grant NRF-126638 and the Canada Research Chairs Program.; Supported in part by the National Science Foundation through Major Research Instrumentation Grant CNS-09-58854.	Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Alving CR, 2012, EXPERT REV VACCINES, V11, P733, DOI [10.1586/ERV.12.35, 10.1586/erv.12.35]; Arrondo JLR, 1999, PROG BIOPHYS MOL BIO, V72, P367, DOI 10.1016/S0079-6107(99)00007-3; Barbato G, 2003, J MOL BIOL, V330, P1101, DOI 10.1016/S0022-2836(03)00611-9; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Biron Z, 2002, BIOCHEMISTRY-US, V41, P12687, DOI 10.1021/bi026261y; Blumenthal R, 2012, J BIOL CHEM, V287, P40841, DOI 10.1074/jbc.R112.406272; Bryson S, 2009, J VIROL, V83, P11862, DOI 10.1128/JVI.01604-09; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Cardoso RMF, 2007, J MOL BIOL, V365, P1533, DOI 10.1016/j.jmb.2006.10.088; Coeffier E, 2000, VACCINE, V19, P684, DOI 10.1016/S0264-410X(00)00267-X; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; CONLEY AJ, 1994, P NATL ACAD SCI USA, V91, P3348, DOI 10.1073/pnas.91.8.3348; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cournia Z, 2005, J COMPUT CHEM, V26, P1383, DOI 10.1002/jcc.20277; Coutant J, 2008, FASEB J, V22, P4338, DOI 10.1096/fj.08-113142; Dennison SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027824; Depetris RS, 2012, J BIOL CHEM, V287, P24239, DOI 10.1074/jbc.M112.371898; Dokter AM, 2006, P NATL ACAD SCI USA, V103, P15355, DOI 10.1073/pnas.0603239103; DREESMAN GR, 1982, NATURE, V295, P158, DOI 10.1038/295158a0; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Gray ES, 2009, J VIROL, V83, P11265, DOI 10.1128/JVI.01359-09; Guenaga J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002806; Guenaga J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016074; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gulzar N., 2013, AIDS RES HUM RETROV, V29, P13; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HARIS PI, 1994, FEBS LETT, V349, P371, DOI 10.1016/0014-5793(94)00704-7; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Huarte N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052740; Jones LS, 2005, J BIOL CHEM, V280, P13406, DOI 10.1074/jbc.M500687200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joyce JG, 2002, J BIOL CHEM, V277, P45811, DOI 10.1074/jbc.M205862200; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2010, J VIROL, V84, P4136, DOI 10.1128/JVI.02357-09; Julien JP, 2008, J MOL BIOL, V384, P377, DOI 10.1016/j.jmb.2008.09.024; Kim M, 2011, NAT STRUCT MOL BIOL, V18, P1235, DOI 10.1038/nsmb.2154; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lorizate M, 2008, BBA-BIOMEMBRANES, V1778, P1624, DOI 10.1016/j.bbamem.2007.12.018; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maeso R, 2011, AIDS RES HUM RETROV, V27, P863, DOI [10.1089/AID.2010.0265, 10.1089/aid.2010.0265]; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Matyas GR, 2009, AIDS, V23, P2069, DOI 10.1097/QAD.0b013e32832faea5; McGaughey GB, 2003, BIOCHEMISTRY-US, V42, P3214, DOI 10.1021/bi026952u; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; Menendez A, 2004, J MOL BIOL, V338, P311, DOI 10.1016/j.jmb.2004.02.051; Merk A, 2013, CURR OPIN STRUC BIOL, V23, P268, DOI 10.1016/j.sbi.2013.03.007; Mirassou Y, 2009, CHEMBIOCHEM, V10, P902, DOI 10.1002/cbic.200800834; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Montero M, 2012, J VIROL, V86, P2930, DOI 10.1128/JVI.06349-11; Mukherjee S, 2007, LANGMUIR, V23, P11174, DOI 10.1021/la701686g; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Parker CE, 2001, J VIROL, V75, P10906, DOI 10.1128/JVI.75.22.10906-10911.2001; Pejchal R, 2009, J VIROL, V83, P8451, DOI 10.1128/JVI.00685-09; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Polonis VR, 2008, VIROLOGY, V375, P315, DOI 10.1016/j.virol.2008.02.007; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Reisdorf WC, 1996, BIOCHEMISTRY-US, V35, P1383, DOI 10.1021/bi951589v; Sanchez-Martinez S, 2006, AIDS RES HUM RETROV, V22, P998, DOI 10.1089/aid.2006.22.998; Schibli DJ, 2001, BIOCHEMISTRY-US, V40, P9570, DOI 10.1021/bi010640u; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Suarez T, 2000, J VIROL, V74, P8038, DOI 10.1128/JVI.74.17.8038-8047.2000; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Vu DM, 2004, BIOCHEMISTRY-US, V43, P3582, DOI 10.1021/bi036203s; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Walsh STR, 2003, PROTEIN SCI, V12, P520, DOI 10.1110/ps.0223003; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WUTHRICH K, 1984, J MOL BIOL, V180, P715, DOI 10.1016/0022-2836(84)90034-2; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Zhu ZY, 2011, J VIROL, V85, P11401, DOI 10.1128/JVI.05312-11; Zwick MB, 2004, J VIROL, V78, P3155, DOI 10.1128/JVI.78.6.3155-3161.2004; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001; Zwick MB, 2005, AIDS, V19, P1725, DOI 10.1097/01.aids.0000189850.83322.41	86	22	23	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6565	6580		10.1074/jbc.M113.527747	http://dx.doi.org/10.1074/jbc.M113.527747			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24429284	Green Published, hybrid			2022-12-28	WOS:000332389400022
J	Coe, LM; Madathil, SV; Casu, C; Lanske, B; Rivella, S; Sitara, D				Coe, Lindsay M.; Madathil, Sangeetha Vadakke; Casu, Carla; Lanske, Beate; Rivella, Stefano; Sitara, Despina			FGF-23 Is a Negative Regulator of Prenatal and Postnatal Erythropoiesis*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Bone Marrow; Erythrocyte; Erythropoeisis; Hematopoiesis; Kidney; FGF-23; Anemia	CHRONIC KIDNEY-DISEASE; GROWTH-FACTOR 23; DOMINANT HYPOPHOSPHATEMIC RICKETS; FAMILIAL TUMORAL CALCINOSIS; HEMATOPOIETIC STEM-CELLS; VITAMIN-D METABOLISM; IN-VIVO; PARATHYROID-HORMONE; RENAL-FAILURE; FGF23	Background: FGF-23, a bone-derived hormone, regulates phosphate and vitamin D in the kidney. Results: Genetic and pharmacological manipulations of FGF-23 alter erythropoiesis and HSC frequency both in young adult age and embryonically. Conclusion: Fgf-23 regulates erythropoiesis through Epo and independent of vitamin D. Significance: These findings provide a new target for treating blood disorders associated with bone and renal defects. Abnormal blood cell production is associated with chronic kidney disease (CKD) and cardiovascular disease (CVD). Bone-derived FGF-23 (fibroblast growth factor-23) regulates phosphate homeostasis and bone mineralization. Genetic deletion of Fgf-23 in mice (Fgf-23(-/-)) results in hypervitaminosis D, abnormal mineral metabolism, and reduced lymphatic organ size. Elevated FGF-23 levels are linked to CKD and greater risk of CVD, left ventricular hypertrophy, and mortality in dialysis patients. However, whether FGF-23 is involved in the regulation of erythropoiesis is unknown. Here we report that loss of FGF-23 results in increased hematopoietic stem cell frequency associated with increased erythropoiesis in peripheral blood and bone marrow in young adult mice. In particular, these hematopoietic changes are also detected in fetal livers, suggesting that they are not the result of altered bone marrow niche alone. Most importantly, administration of FGF-23 in wild-type mice results in a rapid decrease in erythropoiesis. Finally, we show that the effect of FGF-23 on erythropoiesis is independent of the high vitamin D levels in these mice. Our studies suggest a novel role for FGF-23 in erythrocyte production and differentiation and suggest that elevated FGF-23 levels contribute to the pathogenesis of anemia in patients with CKD and CVD.	[Coe, Lindsay M.; Madathil, Sangeetha Vadakke; Sitara, Despina] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10010 USA; [Casu, Carla; Rivella, Stefano] Weill Cornell Med Coll, Dept Pediat Hematol, New York, NY 10021 USA; [Lanske, Beate] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Sitara, Despina] NYU, Sch Med, Dept Med, New York, NY 10016 USA	New York University; Cornell University; Harvard University; Harvard School of Dental Medicine; New York University	Sitara, D (corresponding author), NYU, Coll Dent, 345 E 24th St,Rm 902C, New York, NY 10010 USA.	ds199@nyu.edu	Vadakke-Madathil, Sangeetha/B-5340-2011	Vadakke-Madathil, Sangeetha/0000-0002-4948-9412; Rivella, Stefano/0000-0002-0938-6558; SITARA, DESPINA/0000-0002-4836-5039; Lanske, Beate/0000-0003-4638-804X	National Institutes of Health [P30DE020754]; American Heart Association [12SDG12080152]; American Society for Bone and Mineral Research Career Enhancement Award [A13-0052-001]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P30DE020754] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Society for Bone and Mineral Research Career Enhancement Award; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant P30DE020754. This work was also supported by American Heart Association Scientist Development Grant 12SDG12080152 and American Society for Bone and Mineral Research Career Enhancement Award A13-0052-001 (to D. S.).	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Asari S, 2005, EXP HEMATOL, V33, P26, DOI 10.1016/j.exphem.2004.10.001; Benet-Pages A, 2005, HUM MOL GENET, V14, P385, DOI 10.1093/hmg/ddi034; Bernhardt WM, 2010, J AM SOC NEPHROL, V21, P2151, DOI 10.1681/ASN.2010010116; Bogdanova A, 2013, INT J MOL SCI, V14, P9848, DOI 10.3390/ijms14059848; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Christensen JL, 2004, PLOS BIOL, V2, P368, DOI 10.1371/journal.pbio.0020075; Colvin GA, 2007, J CELL PHYSIOL, V211, P386, DOI 10.1002/jcp.20945; Damasiewicz MJ, 2011, NEPHROLOGY, V16, P261, DOI 10.1111/j.1440-1797.2011.01443.x; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Farrow EG, 2011, BEST PRACT RES CL RH, V25, P735, DOI 10.1016/j.berh.2011.10.020; Farrow EG, 2011, P NATL ACAD SCI USA, V108, pE1146, DOI 10.1073/pnas.1110905108; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jonsson KB, 2003, NEW ENGL J MED, V348, P1656, DOI 10.1056/NEJMoa020881; Koulnis M, 2011, JOVE-J VIS EXP, P1; Kuznetsov SA, 2004, J CELL BIOL, V167, P1113, DOI 10.1083/jcb.200408079; Larsson T, 2003, KIDNEY INT, V64, P2272, DOI 10.1046/j.1523-1755.2003.00328.x; Lin CS, 1996, GENE DEV, V10, P154, DOI 10.1101/gad.10.2.154; LIPKIN GW, 1990, NEPHROL DIAL TRANSPL, V5, P920, DOI 10.1093/ndt/5.11.920; Liu SG, 2003, J BIOL CHEM, V278, P37419, DOI 10.1074/jbc.M304544200; Mirams M, 2004, BONE, V35, P1192, DOI 10.1016/j.bone.2004.06.014; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Perwad F, 2007, AM J PHYSIOL-RENAL, V293, pF1577, DOI 10.1152/ajprenal.00463.2006; Plett PA, 2002, BLOOD, V100, P3545, DOI 10.1182/blood.V100.10.3545; Rankin EB, 2012, CELL, V149, P63, DOI 10.1016/j.cell.2012.01.051; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Sitara D, 2004, MATRIX BIOL, V23, P421, DOI 10.1016/j.matbio.2004.09.007; Sitara D, 2006, AM J PATHOL, V169, P2161, DOI 10.2353/ajpath.2006.060329; Sitara D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000154; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; Sugiyama D, 2011, THESCIENTIFICWORLDJO, V11, P1770, DOI 10.1100/2011/598097; Taylor EN, 2011, AM HEART J, V161, P956, DOI 10.1016/j.ahj.2011.02.012; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Yoshiko Y, 2007, BONE, V40, P1565, DOI 10.1016/j.bone.2007.01.017; Zeigler BM, 2010, DIS MODEL MECH, V3, P763, DOI 10.1242/dmm.004788; Zhang F, 1996, EXP HEMATOL, V24, P1469; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384	46	86	87	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9795	9810		10.1074/jbc.M113.527150	http://dx.doi.org/10.1074/jbc.M113.527150			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24509850	Green Published, hybrid			2022-12-28	WOS:000333807000030
J	Zimmermann, J; Latta, L; Beck, A; Leidinger, P; Fecher-Trost, C; Schlenstedt, G; Meese, E; Wissenbach, U; Flockerzi, V				Zimmermann, Jasmin; Latta, Lorenz; Beck, Andreas; Leidinger, Petra; Fecher-Trost, Claudia; Schlenstedt, Gabriel; Meese, Eckart; Wissenbach, Ulrich; Flockerzi, Veit			Trans-activation Response ( TAR) RNA-binding Protein 2 Is a Novel Modulator of Transient Receptor Potential Canonical 4 (TRPC4) Protein*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Signaling; Cell Signaling; Dicer; Protein-Protein Interactions; TRP Channels	HUMAN DICER; CATION CHANNEL; S4-S5 LINKER; DOMAIN; TRBP; ACTIVATION; CALMODULIN; IDENTIFICATION; ROLES; MICE	Background: The molecular composition of native TRPC4 channels is unknown. Results: Tarbp2, like Ago2 and Dicer, a protein of the RNA-induced silencing complex, binds to and functionally interacts with TRPC4. Conclusion: Upon TRPC4 binding, Tarbp2 modulates Ca2+ entry and promotes Ca2+-dependent proteolytic activation of Dicer. Significance: Mechanistic insight into coupling TRPC4 activity and Dicer-dependent formation of noncoding RNAs is provided. TRPC4 proteins function as Ca2+ conducting, non-selective cation channels in endothelial, smooth muscle, and neuronal cells. To further characterize the roles of TRPC4 in vivo, detailed information about the molecular composition of native channel complexes and their association with cellular signaling networks is needed. Therefore, a mouse brain cDNA library was searched for novel TRPC4-interacting proteins using a modified yeast two-hybrid assay. This screen identified Trans-activation Response RNA-binding protein 2 (Tarpb2), a protein that recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Tarbp2 was found to bind to the C terminus of TRPC4 and TRPC5 and to modulate agonist-dependent TRPC4-induced Ca2+ entry. A stretch of basic residues within the Tarbp2 protein is required for these actions. Tarbp2 binding to and modulation of TRPC4 occurs in the presence of endogenously expressed Dicer but is no longer detectable when the Dicer cDNA is overexpressed. Dicer activity in crude cell lysates is increased in the presence of Ca2+, most probably by Ca2+-dependent proteolytic activation of Dicer. Apparently, Tarbp2 binding to TRPC4 promotes changes of cytosolic Ca2+ and, thereby, leads to a dynamic regulation of Dicer activity, essentially at low endogenous Dicer concentrations.	[Zimmermann, Jasmin; Latta, Lorenz; Beck, Andreas; Fecher-Trost, Claudia; Wissenbach, Ulrich; Flockerzi, Veit] Univ Saarland, Inst Expt & Klin Pharmakol & Toxikol, D-66421 Homburg, Germany; [Leidinger, Petra; Meese, Eckart] Univ Saarland, Inst Humangenet, D-66421 Homburg, Germany; [Schlenstedt, Gabriel] Univ Saarland, Inst Med Biochem & Mol Biol, D-66421 Homburg, Germany	Saarland University; Saarland University; Saarland University	Flockerzi, V (corresponding author), Inst Expt & Klin Pharmakol & Toxikol, D-66421 Homburg, Germany.	veit.flockerzi@uniklinikum-saarland.de	Meese, Eckart Ulrich/ABD-1983-2021		Deutsche Forschungsgemeinschaft; Forschungsausschuss der Medizinischen Fakultat "HOMFOR"; Forschungsausschuss der Universitat des Saarlandes	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Forschungsausschuss der Medizinischen Fakultat "HOMFOR"; Forschungsausschuss der Universitat des Saarlandes	This work was supported by the Deutsche Forschungsgemeinschaft (to A. B., P. L., and V. F.), by the Forschungsausschuss der Medizinischen Fakultat "HOMFOR," and by the Forschungsausschuss der Universitat des Saarlandes (to P. L., E. M., C. F.-T., and V. F.).	Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Beck A, 2013, J BIOL CHEM, V288, P19471, DOI 10.1074/jbc.M113.478305; Blair NT, 2009, J GEN PHYSIOL, V133, P525, DOI 10.1085/jgp.200810153; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cioffi DL, 2005, CIRC RES, V97, P1164, DOI 10.1161/01.RES.0000193597.65217.00; Daniels SM, 2012, MICROBIOL MOL BIOL R, V76, P652, DOI 10.1128/MMBR.00012-12; Daniels SM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-38; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flockerzi V., 2007, V179, P1; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; GATIGNOL A, 1993, MOL CELL BIOL, V13, P2193, DOI 10.1128/MCB.13.4.2193; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Grabe M, 2007, NATURE, V445, P550, DOI 10.1038/nature05494; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kerstein PC, 2013, J NEUROSCI, V33, P273, DOI 10.1523/JNEUROSCI.2142-12.2013; Konopka W, 2010, J NEUROSCI, V30, P14835, DOI 10.1523/JNEUROSCI.3030-10.2010; Kwon Y, 2007, MOL CELL, V25, P491, DOI 10.1016/j.molcel.2007.01.021; Labro AJ, 2011, J BIOL CHEM, V286, P717, DOI 10.1074/jbc.M110.146977; Labro AJ, 2008, J GEN PHYSIOL, V132, P667, DOI 10.1085/jgp.200810048; Lugli G, 2005, J NEUROCHEM, V94, P896, DOI 10.1111/j.1471-4159.2005.03224.x; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; Ma EB, 2012, J MOL BIOL, V422, P466, DOI 10.1016/j.jmb.2012.06.009; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Meister G, 2013, NAT REV GENET, V14, P447, DOI 10.1038/nrg3462; Miehe S, 2010, J BIOL CHEM, V285, P12426, DOI 10.1074/jbc.M109.068304; Miller M, 2011, J BIOL CHEM, V286, P33436, DOI 10.1074/jbc.M111.274167; Munsch T, 2003, P NATL ACAD SCI USA, V100, P16065, DOI 10.1073/pnas.2535311100; Odell AF, 2008, J BIOL CHEM, V283, P4395, DOI 10.1074/jbc.M709729200; Otsuguro KI, 2008, J BIOL CHEM, V283, P10026, DOI 10.1074/jbc.M707306200; Phelan KD, 2012, MOL PHARMACOL, V81, P384, DOI 10.1124/mol.111.075341; Philipp S, 1996, EMBO J, V15, P6166, DOI 10.1002/j.1460-2075.1996.tb01004.x; Prole DL, 2006, J GEN PHYSIOL, V128, P273, DOI 10.1085/jgp.200609590; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rossi JJ, 2005, EMBO REP, V6, P927, DOI 10.1038/sj.embor.7400531; Sawh AN, 2013, CELL REP, V4, P454, DOI 10.1016/j.celrep.2013.07.013; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Sinkins WG, 2004, J BIOL CHEM, V279, P34521, DOI 10.1074/jbc.M401156200; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Tang J, 2001, J BIOL CHEM, V276, P21303, DOI 10.1074/jbc.M102316200; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Trost C, 2001, BIOCHEM J, V355, P663, DOI 10.1042/bj3550663; Tsvilovskyy VV, 2009, GASTROENTEROLOGY, V137, P1415, DOI 10.1053/j.gastro.2009.06.046; Valente P, 2008, FASEB J, V22, P3298, DOI 10.1096/fj.08-107425; Voets T, 2007, J PHYSIOL-LONDON, V582, P939, DOI 10.1113/jphysiol.2007.132522; Wang T, 2005, J CELL BIOL, V171, P685, DOI 10.1083/jcb.200508030; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	54	6	7	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9766	9780		10.1074/jbc.M114.557066	http://dx.doi.org/10.1074/jbc.M114.557066			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24563462	hybrid, Green Published			2022-12-28	WOS:000333807000028
J	Fu, HL; Valiathan, RR; Payne, L; Kumarasiri, M; Mahasenan, KV; Mobashery, S; Huang, P; Fridman, R				Fu, Hsueh-Liang; Valiathan, Rajeshwari R.; Payne, Leo; Kumarasiri, Malika; Mahasenan, Kiran V.; Mobashery, Shahriar; Huang, Paul; Fridman, Rafael			Glycosylation at Asn211 Regulates the Activation State of the Discoidin Domain Receptor 1 ( DDR1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Collagen; Glycosylation; Mutagenesis Site-specific; Receptor Regulation; Receptor Tyrosine Kinase	GROWTH-FACTOR RECEPTOR; STRUCTURE PREDICTION SERVER; COLLAGEN RECEPTORS; TYROSINE KINASES; N-GLYCOSYLATION; DIMERIZATION; BINDING; MATRIX; PHOSPHORYLATION; ENDOCYTOSIS	Background: DDR1 is a receptor tyrosine kinase that signals in response to collagen. Results: Mutagenesis at the (NDS)-N-211 glycosylation site enhances receptor dimerization and results in ligand-independent receptor autophosphorylation. Conclusion:N-Glycosylation of DDR1 plays a critical role in maintenance of the inactive state of the receptor dimers. Significance: These studies highlight a new structural feature that regulates DDR1 activation. Discoidin domain receptor 1 (DDR1) belongs to a unique family of receptor tyrosine kinases that signal in response to collagens. DDR1 undergoes autophosphorylation in response to collagen binding with a slow and sustained kinetics that is unique among members of the receptor tyrosine kinase family. DDR1 dimerization precedes receptor activation suggesting a structural inhibitory mechanism to prevent unwarranted phosphorylation. However, the mechanism(s) that maintains the autoinhibitory state of the DDR1 dimers is unknown. Here, we report that N-glycosylation at the Asn(211) residue plays a unique role in the control of DDR1 dimerization and autophosphorylation. Using site-directed mutagenesis, we found that mutations that disrupt the conserved (NDS)-N-211 N-glycosylation motif, but not other N-glycosylation sites (Asn(260), Asn(371), and Asn(394)), result in collagen I-independent constitutive phosphorylation. Mass spectrometry revealed that the N211Q mutant undergoes phosphorylation at Tyr(484), Tyr(520), Tyr(792), and Tyr(797). The N211Q traffics to the cell surface, and its ectodomain displays collagen I binding with an affinity similar to that of the wild-type DDR1 ectodomain. However, unlike the wild-type receptor, the N211Q mutant exhibits enhanced receptor dimerization and sustained activation upon ligand withdrawal. Taken together, these data suggest that N-glycosylation at the highly conserved (NDS)-N-211 motif evolved to act as a negative repressor of DDR1 phosphorylation in the absence of ligand. The presence of glycan moieties at that site may help to lock the collagen-binding domain in the inactive state and prevent unwarranted signaling by receptor dimers. These studies provide a novel insight into the structural mechanisms that regulate DDR activation.	[Fu, Hsueh-Liang; Valiathan, Rajeshwari R.; Fridman, Rafael] Wayne State Univ, Dept Pathol, Detroit, MI 48201 USA; [Kumarasiri, Malika; Mahasenan, Kiran V.; Mobashery, Shahriar] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Kumarasiri, Malika; Mahasenan, Kiran V.; Mobashery, Shahriar] Univ Notre Dame, Walther Canc Res Ctr, Notre Dame, IN 46556 USA; [Payne, Leo; Huang, Paul] Inst Canc Res, Div Canc Biol, London SW3 6JB, England	Wayne State University; University of Notre Dame; University of Notre Dame; Walther Cancer Institute; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Fridman, R (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, 540 E Canfield Ave, Detroit, MI 48201 USA.	rfridman@med.wayne.edu	Huang, Paul H./H-8591-2015	Huang, Paul H./0000-0003-3972-5087	National Institutes of Health [CA-61986]; Wellcome Trust [WT089028]; Biotechnology and Biological Sciences Research Council [BB/I014276/1]; NATIONAL CANCER INSTITUTE [R01CA061986] Funding Source: NIH RePORTER; BBSRC [BB/I014276/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-61986 (to R. F.). This work was also supported by Wellcome Trust Grant WT089028 and Biotechnology and Biological Sciences Research Council Grant BB/I014276/1 (to P. H.).	Abdulhussein R, 2004, J BIOL CHEM, V279, P31462, DOI 10.1074/jbc.M400651200; Agarwal G, 2007, J MOL BIOL, V367, P443, DOI 10.1016/j.jmb.2006.12.073; Arancibia-Carcamo I. L., 2006, DYNAMIC SYNAPSE MOL; Carafoli F, 2013, BBA-PROTEINS PROTEOM, V1834, P2187, DOI 10.1016/j.bbapap.2012.10.014; Carafoli F, 2012, STRUCTURE, V20, P688, DOI 10.1016/j.str.2012.02.011; Cho JA, 2008, J BIOL CHEM, V283, P17391, DOI 10.1074/jbc.M708943200; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Curat CA, 2001, J BIOL CHEM, V276, P45952, DOI 10.1074/jbc.M104360200; Finger C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000547; Fu HL, 2013, J BIOL CHEM, V288, P12114, DOI 10.1074/jbc.M112.409599; Fu HL, 2013, J BIOL CHEM, V288, P7430, DOI 10.1074/jbc.R112.444158; Guo HB, 2009, GLYCOBIOLOGY, V19, P547, DOI 10.1093/glycob/cwp023; Iwai LK, 2013, BIOCHEM J, V454, P501, DOI 10.1042/BJ20121750; Iwai LK, 2013, CELL ADHES MIGR, V7, P161, DOI 10.4161/cam.22572; Kim HG, 2013, ACS CHEM BIOL, V8, P2145, DOI 10.1021/cb400430t; Kim HG, 2011, J BIOL CHEM, V286, P17672, DOI 10.1074/jbc.M111.236612; L'hote CGML, 2001, FASEB J, V15, P234, DOI 10.1096/fj.01-0414fje; Leitinger B, 2003, J BIOL CHEM, V278, P16761, DOI 10.1074/jbc.M301370200; Leitinger B, 2007, MATRIX BIOL, V26, P146, DOI 10.1016/j.matbio.2006.10.007; Leitinger B, 2006, MATRIX BIOL, V25, P355, DOI 10.1016/j.matbio.2006.05.006; Leitinger B, 2011, ANNU REV CELL DEV BI, V27, P265, DOI 10.1146/annurev-cellbio-092910-154013; Lemeer S, 2012, J PROTEOMICS, V75, P3465, DOI 10.1016/j.jprot.2011.10.007; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Liu YC, 2011, P NATL ACAD SCI USA, V108, P11332, DOI 10.1073/pnas.1107385108; Mazumder R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036212; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Mihai C, 2009, J MOL BIOL, V385, P432, DOI 10.1016/j.jmb.2008.10.067; Noordeen NA, 2006, J BIOL CHEM, V281, P22744, DOI 10.1074/jbc.M603233200; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0; Takahashi M, 2003, GLYCOCONJUGATE J, V20, P207, DOI 10.1023/B:GLYC.0000024252.63695.5c; Phan TN, 2013, BIOSCI BIOTECH BIOCH, V77, P1907, DOI 10.1271/bbb.130351; Tsuda T, 2000, J BIOL CHEM, V275, P21988, DOI 10.1074/jbc.M003400200; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; Vogel W, 2000, J BIOL CHEM, V275, P5779, DOI 10.1074/jbc.275.8.5779; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Vogel WF, 2006, CELL SIGNAL, V18, P1108, DOI 10.1016/j.cellsig.2006.02.012; Wang CZ, 2006, MOL BIOL CELL, V17, P2839, DOI 10.1091/mbc.E05-11-1068; Wang Y, 2007, J BIOL CHEM, V282, P36561, DOI 10.1074/jbc.M703903200; Watson FL, 1999, J NEUROBIOL, V39, P323, DOI 10.1002/(SICI)1097-4695(199905)39:2<323::AID-NEU15>3.0.CO;2-4; Whitson KB, 2005, BIOCHEMISTRY-US, V44, P14920, DOI 10.1021/bi050751j; Xu HF, 2011, MATRIX BIOL, V30, P16, DOI 10.1016/j.matbio.2010.10.004; Yeh YC, 2012, AM J PHYSIOL-CELL PH, V303, pC1207, DOI 10.1152/ajpcell.00253.2012; Yokoe S, 2007, CANCER RES, V67, P1935, DOI 10.1158/0008-5472.CAN-06-3023	47	25	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9275	9287		10.1074/jbc.M113.541102	http://dx.doi.org/10.1074/jbc.M113.541102			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24509848	Green Published, hybrid			2022-12-28	WOS:000333472100045
J	Jozsef, L; Tashiro, K; Kuo, A; Park, E; Skoura, A; Albinsson, S; Rivera-Molina, F; Harrison, KD; Iwakiri, Y; Toomre, D; Sessa, WC				Jozsef, Levente; Tashiro, Keitaro; Kuo, Andrew; Park, Eonjoo; Skoura, Athanasia; Albinsson, Sebastian; Rivera-Molina, Felix; Harrison, Kenneth D.; Iwakiri, Yasuko; Toomre, Derek; Sessa, William C.			Reticulon 4 Is Necessary for Endoplasmic Reticulum Tubulation, STIM1-Orai1 Coupling, and Store-operated Calcium Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cell Signaling; Endoplasmic Reticulum (ER); Imaging; Membrane; reticulons	MITOTIC HELA-CELLS; INTRACELLULAR CA2+; CANCER CELLS; MEMBRANE-PROTEINS; CHANNEL FUNCTION; CRAC CHANNELS; ER STRUCTURE; GENE FAMILY; STIM1; NOGO	Background: Store-operated calcium entry requires the redistribution of ER localized STIM1 to ER-PM junctions. Results: Altering ER morphology by modulating reticulon expression affects STIM1 redistribution and consequently calcium entry. Conclusion: Reticulon shaping of the ER is critical for store-operated calcium entry. Significance: Understanding how membrane shaping proteins participate in the regulation of organelle function is essential in elucidating the structure-function interdependence of organelles. Despite recent advances in understanding store-operated calcium entry (SOCE) regulation, the fundamental question of how ER morphology affects this process remains unanswered. Here we show that the loss of RTN4, is sufficient to alter ER morphology and severely compromise SOCE. Mechanistically, we show this to be the result of defective STIM1-Orai1 coupling because of loss of ER tubulation and redistribution of STIM1 to ER sheets. As a functional consequence, RTN4-depleted cells fail to sustain elevated cytoplasmic Ca2+ levels via SOCE and therefor are less susceptible to Ca2+ overload induced apoptosis. Thus, for the first time, our results show a direct correlation between ER morphology and SOCE and highlight the importance of RTN4 in cellular Ca2+ homeostasis.	[Jozsef, Levente; Kuo, Andrew; Park, Eonjoo; Skoura, Athanasia; Albinsson, Sebastian; Harrison, Kenneth D.; Sessa, William C.] Yale Univ, Sch Med, Vasc Biol & Therapeut Program, Dept Pharmacol, New Haven, CT 06520 USA; [Tashiro, Keitaro; Iwakiri, Yasuko] Yale Univ, Sch Med, Dept Internal Med, Sect Digest Dis, New Haven, CT 06520 USA; [Rivera-Molina, Felix; Toomre, Derek] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Sessa, WC (corresponding author), Yale Univ, Sch Med, Vasc Biol & Therapeut Program, Amistad Res Bldg,10 Amistad St, New Haven, CT 06520 USA.	william.sessa@yale.edu	Albinsson, Sebastian/B-4105-2010; Sessa, William C/B-6844-2011	Albinsson, Sebastian/0000-0001-6936-3967; Sessa, William C/0000-0001-5759-1938	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082600, P30DK034989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007324] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL081190] Funding Source: Medline; NIDDK NIH HHS [R01 DK082600, P30 DK034989] Funding Source: Medline; NIGMS NIH HHS [T32 GM007324] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acevedo L, 2004, NAT MED, V10, P382, DOI 10.1038/nm1020; Anderson DJ, 2008, J CELL BIOL, V182, P911, DOI 10.1083/jcb.200805140; BERG OG, 1985, ANNU REV BIOPHYS BIO, V14, P131, DOI 10.1146/annurev.biophys.14.1.131; Cafferty WBJ, 2006, J NEUROSCI, V26, P12242, DOI 10.1523/JNEUROSCI.3827-06.2006; Chen SL, 2013, CURR OPIN CELL BIOL, V25, P428, DOI 10.1016/j.ceb.2013.02.006; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; De Craene JO, 2006, MOL BIOL CELL, V17, P3009, DOI 10.1091/mbc.e06-01-0080; Di Lorenzo A, 2011, BLOOD, V117, P2284, DOI 10.1182/blood-2010-04-281956; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Flourakis M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.52; FURUYA Y, 1994, CANCER RES, V54, P6167; Goyal U, 2013, BBA-MOL CELL RES, V1833, P2492, DOI 10.1016/j.bbamcr.2013.04.009; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Iwahashi J, 2007, BIOCHEM BIOPH RES CO, V355, P508, DOI 10.1016/j.bbrc.2007.02.001; JIANG S, 1994, EXP CELL RES, V212, P84, DOI 10.1006/excr.1994.1121; Kim KD, 2011, J IMMUNOL, V187, P3620, DOI 10.4049/jimmunol.1100847; LEE C, 1988, CELL, V54, P37, DOI 10.1016/0092-8674(88)90177-8; Lehner R, 1999, BIOCHEM J, V343, P1, DOI 10.1042/0264-6021:3430001; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Liu HM, 2012, TOXICOL LETT, V208, P254, DOI 10.1016/j.toxlet.2011.11.007; Lu L, 2009, MOL BIOL CELL, V20, P3471, DOI 10.1091/mbc.E09-04-0327; McCullough S, 2005, J ANAT, V206, P415, DOI 10.1111/j.1469-7580.2005.00407.x; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Norberg E, 2008, CELL DEATH DIFFER, V15, P1857, DOI 10.1038/cdd.2008.123; Oertle T, 2003, FASEB J, V17, P1238, DOI 10.1096/fj.02-1166hyp; Oertle T, 2003, J NEUROSCI, V23, P5393; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Park SH, 2010, EMBO REP, V11, P515, DOI 10.1038/embor.2010.92; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Pigozzi D, 2004, CELL CALCIUM, V36, P421, DOI 10.1016/j.ceca.2004.04.002; Pozo-Guisado E, 2010, J CELL SCI, V123, P3084, DOI 10.1242/jcs.067215; Puhka M, 2012, MOL BIOL CELL, V23, P2424, DOI 10.1091/mbc.E10-12-0950; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Russa AD, 2008, ARCH HISTOL CYTOL, V71, P249, DOI 10.1679/aohc.71.249; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Seo SR, 2009, EXP MOL MED, V41, P269, DOI 10.3858/emm.2009.41.4.030; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Simonen M, 2003, NEURON, V38, P201, DOI 10.1016/S0896-6273(03)00226-5; Smyth JT, 2007, J CELL SCI, V120, P3762, DOI 10.1242/jcs.015735; Smyth JT, 2009, NAT CELL BIOL, V11, P1465, DOI 10.1038/ncb1995; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Sun SX, 2012, BIOSCIENCE REP, V32, P83, DOI 10.1042/BSR20110062; TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557; Tojima T, 2011, NAT REV NEUROSCI, V12, P191, DOI 10.1038/nrn2996; Vaca L, 2010, CELL CALCIUM, V47, P199, DOI 10.1016/j.ceca.2010.01.002; VANDEVELDE HJK, 1994, J CELL SCI, V107, P2403; Verkhratsky A., 2007, V45, P465; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; VOLPI M, 1988, J CELL BIOL, V107, P2533, DOI 10.1083/jcb.107.6.2533; West M, 2011, J CELL BIOL, V193, P333, DOI 10.1083/jcb.201011039; Xu YK, 2011, CURR OPIN CHEM BIOL, V15, P822, DOI 10.1016/j.cbpa.2011.10.016; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; Yu F, 2009, P NATL ACAD SCI USA, V106, P17401, DOI 10.1073/pnas.0904651106; Yu J, 2009, P NATL ACAD SCI USA, V106, P17511, DOI 10.1073/pnas.0907359106; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zheng BH, 2003, NEURON, V38, P213, DOI 10.1016/S0896-6273(03)00225-3; Zurek N, 2011, TRAFFIC, V12, P28, DOI 10.1111/j.1600-0854.2010.01134.x	65	45	48	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9380	9395		10.1074/jbc.M114.548602	http://dx.doi.org/10.1074/jbc.M114.548602			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24558039	Green Published, hybrid			2022-12-28	WOS:000333472100054
J	Iqbal, MA; Siddiqui, FA; Chaman, N; Gupta, V; Kumar, B; Gopinath, P; Bamezai, RNK				Iqbal, Mohd Askandar; Siddiqui, Farid Ahmad; Chaman, Noor; Gupta, Vibhor; Kumar, Bhupender; Gopinath, Prakasam; Bamezai, Rameshwar N. K.			Missense Mutations in Pyruvate Kinase M2 Promote Cancer Metabolism, Oxidative Endurance, Anchorage Independence, and Tumor Growth in a Dominant Negative Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Tumor Promoter; Enzyme Mutation; Glycolysis; Pyruvate Kinase; Tumor Metabolism; Bloom Syndrome; Dominant Negative Mutation; PKM2	AEROBIC GLYCOLYSIS; CELL-METABOLISM; ISOFORM; PKM2; PROLIFERATION; PROTEIN; TARGET; DOMAIN	Background: We earlier reported novel mutations in PKM2 that reduce its activity. Results: These mutations promoted cancer features and tumor growth in a dominant negative manner. Conclusion: Impaired PKM2 activity due to mutations benefits cancer. Significance: This study provides the first evidence linking natural mutations in PKM2 with cancer. The present study was designed to examine the functional relevance of two heterozygous mutations (H391Y and K422R), observed earlier by us in the Bloom syndrome condition. Cells stably expressing exogenous wild-type or mutant PKM2 (K422R or H391Y) or co-expressing both wild type and mutant (PKM2-K422R or PKM2-H391Y) were assessed for cancer metabolism and tumorigenic potential. Interestingly, cells co-expressing PKM2 and mutant (K422R or H391Y) showed significantly aggressive cancer metabolism as compared with cells expressing either wild-type or mutant PKM2 independently. A similar trend was observed for oxidative endurance, tumorigenic potential, cellular proliferation, and tumor growth. These observations signify the dominant negative nature of mutations. Remarkably, PKM2-H391Y co-expressed cells showed a maximal effect on all the studied parameters. Such a dominant negative impaired function of PKM2 in tumor development is not known; this study demonstrates for the first time the possible predisposition of Bloom syndrome patients with impaired PKM2 activity to cancer and the importance of studying genetic variations in PKM2 in the future to understand their relevance in cancer in general.	[Iqbal, Mohd Askandar; Siddiqui, Farid Ahmad; Chaman, Noor; Gupta, Vibhor; Kumar, Bhupender; Gopinath, Prakasam; Bamezai, Rameshwar N. K.] Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Bamezai, RNK (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Natl Ctr Appl Human Genet, New Mehrauli Rd, New Delhi 110067, India.	bame0200@mail.jnu.ac.in	Kumar, Bhupender/GLR-8413-2022; prakasam, Gopinath/S-8438-2017; Siddiqui, Farid/AAI-2408-2021	Kumar, Bhupender/0000-0003-3887-5040; prakasam, Gopinath/0000-0003-1839-7969; Siddiqui, Farid/0000-0002-3292-2363; Iqbal, Mohammad Askandar/0000-0003-3485-3530	University Grants Commission (UGC), Government of India; UGC	University Grants Commission (UGC), Government of India(University Grants Commission, India); UGC(University Grants Commission, India)	Supported by a research fellowship from the University Grants Commission (UGC), Government of India.; Supported by research funds from the UGC. To whom correspondence should be addressed. Tel.: 91-11-26704518; Fax: 91-11-26742211; E-mail: bame0200@mail.jnu.ac.in or bamezai@hotmail.com.	Akhtar K, 2009, J BIOL CHEM, V284, P11971, DOI 10.1074/jbc.M808761200; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Anitha M, 2004, DNA CELL BIOL, V23, P442, DOI 10.1089/1044549041474797; [Anonymous], 2013, CANC DISCOV, V3, pOF14; Brachmann RK, 1996, P NATL ACAD SCI USA, V93, P4091, DOI 10.1073/pnas.93.9.4091; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chaneton B, 2012, TRENDS BIOCHEM SCI, V37, P309, DOI 10.1016/j.tibs.2012.04.003; Chenevix-Trench G, 2002, JNCI-J NATL CANCER I, V94, P205, DOI 10.1093/jnci/94.3.205; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Fritsch A, 2009, J BIOL CHEM, V284, P30248, DOI 10.1074/jbc.M109.045294; Gajko-Galicka A, 2002, ACTA BIOCHIM POL, V49, P433; Gao XL, 2012, MOL CELL, V45, P598, DOI 10.1016/j.molcel.2012.01.001; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; German J, 1997, CANCER GENET CYTOGEN, V93, P100, DOI 10.1016/S0165-4608(96)00336-6; Gupta V, 2010, J BIOL CHEM, V285, P16864, DOI 10.1074/jbc.M109.065029; Gutman M, 2003, INT J CANCER, V103, P268, DOI 10.1002/ijc.10803; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Iqbal MA, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-72; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Lee CC, 2010, BIOCHEM J, V430, P425, DOI 10.1042/BJ20100609; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Luo WB, 2012, TRENDS ENDOCRIN MET, V23, P560, DOI 10.1016/j.tem.2012.06.010; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Mori S, 2009, ONCOGENE, V28, P2796, DOI 10.1038/onc.2009.139; Ryu H, 2008, BRIT J PHARMACOL, V154, P1035, DOI 10.1038/bjp.2008.148; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Tamada M, 2012, CLIN CANCER RES, V18, P5554, DOI 10.1158/1078-0432.CCR-12-0859; Tian WN, 1998, J BIOL CHEM, V273, P10609, DOI 10.1074/jbc.273.17.10609; Yoshioka N, 2006, P NATL ACAD SCI USA, V103, P14519, DOI 10.1073/pnas.0606708103; Zwerschke W, 1999, P NATL ACAD SCI USA, V96, P1291, DOI 10.1073/pnas.96.4.1291	35	17	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8098	8105		10.1074/jbc.M113.515742	http://dx.doi.org/10.1074/jbc.M113.515742			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24492614	hybrid, Green Published			2022-12-28	WOS:000333157500008
J	Basak, NP; Roy, A; Banerjee, S				Basak, Nandini Pal; Roy, Anita; Banerjee, Subrata			Alteration of Mitochondrial Proteome Due to Activation of Notch1 Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glutamine; Mitochondria; Notch Pathway; Proteomics; Respiratory Chain; Complex 1	ACUTE LYMPHOBLASTIC-LEUKEMIA; INTRACELLULAR DOMAIN; GLUTAMINE-METABOLISM; CELL-SURVIVAL; CANCER-CELLS; COMPLEX-I; T-CELLS; PROTEINS; GROWTH; MUTATIONS	Background: The role of Notch signaling in regulation of cell metabolism remains to be elucidated. Results: A two-dimensional DIGE study shows Notch signaling activation alters the expression of proteins of various metabolic pathways. Conclusion: Notch signaling activation leads to the remodeling of cellular metabolic pathways. Glutamine catabolism pathway proteins deregulated via canonical Notch pathway. Significance: This study connects an important signaling pathway to cellular metabolism. The Notch signaling pathway, a known regulator of cell fate decisions, proliferation, and apoptosis, has recently been implicated in the regulation of glycolysis, which affects tumor progression. However, the impact of Notch on other metabolic pathways remains to be elucidated. To gain more insights into the Notch signaling and its role in regulation of metabolism, we studied the mitochondrial proteome in Notch1-activated K562 cells using a comparative proteomics approach. The proteomic study led to the identification of 10 unique proteins that were altered due to Notch1 activation. Eight of these proteins belonged to mitochondria-localized metabolic pathways like oxidative phosphorylation, glutamine metabolism, Krebs cycle, and fatty acid oxidation. Validation of some of these findings showed that constitutive activation of Notch1 deregulated glutamine metabolism and Complex 1 of the respiratory chain. Furthermore, the deregulation of glutamine metabolism involved the canonical Notch signaling and its downstream effectors. The study also reports the effect of Notch signaling on mitochondrial function and status of high energy intermediates ATP, NADH, and NADPH. Thus our study shows the effect of Notch signaling on mitochondrial proteome, which in turn affects the functioning of key metabolic pathways, thereby connecting an important signaling pathway to the regulation of cellular metabolism.	[Basak, Nandini Pal; Roy, Anita; Banerjee, Subrata] Saha Inst Nucl Phys, Biophys & Struct Genom Div, Kolkata 700064, India	Saha Institute of Nuclear Physics	Banerjee, S (corresponding author), Saha Inst Nucl Phys, Biophys & Struct Genom Div, 1-AF Bidhannagar, Kolkata 700064, India.	subrata.banerjee@saha.ac.in		Roy, Anita/0000-0002-7297-2920	Integrative Biology on Omics Platform project of Dept. of Atomic Energy, Government of India; Council of Scientific and Industrial Research, Government of India	Integrative Biology on Omics Platform project of Dept. of Atomic Energy, Government of India; Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	The work was supported by the Integrative Biology on Omics Platform project of Dept. of Atomic Energy, Government of India.; Recipient of a fellowship from Council of Scientific and Industrial Research, Government of India.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Callahan R, 2004, J MAMMARY GLAND BIOL, V9, P145, DOI 10.1023/B:JOMG.0000037159.63644.81; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Chadwick N, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-35; Chang WK, 2002, CLIN IMMUNOL, V104, P151, DOI 10.1006/clim.2002.5257; Cheng P, 2008, IMMUNOL RES, V41, P1, DOI 10.1007/s12026-007-8011-z; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; de la Pena P, 2001, NEUROLOGY, V57, P1235, DOI 10.1212/WNL.57.7.1235; Eagar TN, 2004, IMMUNITY, V20, P407, DOI 10.1016/S1074-7613(04)00081-0; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Hoefs SJG, 2010, MOL GENET METAB, V100, P251, DOI 10.1016/j.ymgme.2010.03.015; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI [10.1038/nchembio.467, 10.1038/NCHEMBIO.467]; Ishiko E, 2005, J BIOL CHEM, V280, P4929, DOI 10.1074/jbc.M406788200; Iso T, 2001, MOL CELL BIOL, V21, P6080, DOI 10.1128/MCB.21.17.6080-6089.2001; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Kannan S, 2013, J EXP MED, V210, P321, DOI 10.1084/jem.20121527; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Landor SKJ, 2011, P NATL ACAD SCI USA, V108, P18814, DOI 10.1073/pnas.1104943108; Leal MC, 2012, BBA-MOL CELL RES, V1823, P227, DOI 10.1016/j.bbamcr.2011.09.014; Lee SF, 2011, J BIOL CHEM, V286, P27447, DOI 10.1074/jbc.M111.243154; Liu HY, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-29; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Oka S, 2012, CIRC RES, V111, P611, DOI 10.1161/CIRCRESAHA.111.247932; Perumalsamy LR, 2009, CELL DEATH DIFFER, V16, P879, DOI 10.1038/cdd.2009.20; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Rao SS, 2009, CANCER RES, V69, P3060, DOI 10.1158/0008-5472.CAN-08-4295; Rathore MG, 2012, INT J BIOCHEM CELL B, V44, P1448, DOI 10.1016/j.biocel.2012.05.011; Rezaul K, 2005, MOL CELL PROTEOMICS, V4, P169, DOI 10.1074/mcp.M400115-MCP200; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Roy A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.119; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shelton LM, 2010, INT J CANCER, V127, P2478, DOI 10.1002/ijc.25431; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Tyagi M, 2007, EMBO J, V26, P4985, DOI 10.1038/sj.emboj.7601928; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yin DD, 2009, LEUKEMIA RES, V33, P109, DOI 10.1016/j.leukres.2008.06.023	46	36	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7320	7334		10.1074/jbc.M113.519405	http://dx.doi.org/10.1074/jbc.M113.519405			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24474689	Green Published, hybrid			2022-12-28	WOS:000332761500006
J	Rossa, J; Ploeger, C; Vorreiter, F; Saleh, T; Protze, J; Gunzel, D; Wolburg, H; Krause, G; Piontek, J				Rossa, Jan; Ploeger, Carolin; Vorreiter, Fraenze; Saleh, Tarek; Protze, Jonas; Guenzel, Dorothee; Wolburg, Hartwig; Krause, Gerd; Piontek, Joerg			Claudin-3 and Claudin-5 Protein Folding and Assembly into the Tight Junction Are Controlled by Non-conserved Residues in the Transmembrane 3 (TM3) and Extracellular Loop 2 (ECL2) Segments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Confocal Microscopy; Electron Microscopy (EM); Membrane Proteins; Protein Assembly; Tight Junctions; Claudin; Freeze Fracture; Mutagenesis; Protein-Protein Interaction	BLOOD-BRAIN-BARRIER; DETERMINANTS; SELECTIVITY; RESISTANCE; FRACTURE; OCCLUDIN; STRANDS; MODEL	Background: The transmembrane claudins assemble into polymeric tight junction strands. Results: Residues involved in differential folding and assembly of claudin-3 and claudin-5 were identified. Conclusion: Subtype-specific cis-dimerization contributes to the differing ultrastructure of tight junction strands. Significance: The molecular insights improve the understanding of the formation of paracellular barriers to molecules. The mechanism of tight junction (TJ) assembly and the structure of claudins (Cldn) that form the TJ strands are unclear. This limits the molecular understanding of paracellular barriers and strategies for drug delivery across tissue barriers. Cldn3 and Cldn5 are both common in the blood-brain barrier but form TJ strands with different ultrastructures. To identify the molecular determinants of folding and assembly of these classic claudins, Cldn3/Cldn5 chimeric mutants were generated and analyzed by cellular reconstitution of TJ strands, live cell confocal imaging, and freeze-fracture electron microscopy. A comprehensive screening was performed on the basis of the rescue of mutants deficient for strand formation. Cldn3/Cldn5 residues in transmembrane segment 3, TM3 (Ala-127/Cys-128, Ser-136/Cys-137, Ser-138/Phe-139), and the transition of TM3 to extracellular loop 2, ECL2 (Thr-141/Ile-142) and ECL2 (Asn-148/Asp-149, Leu-150/Thr-151, Arg-157/Tyr-158), were identified to be involved in claudin folding and/or assembly. Blue native PAGE and FRET assays revealed 1% n-dodecyl -d-maltoside-resistant cis-dimerization for Cldn5 but not for Cldn3. This homophilic interaction was found to be stabilized by residues in TM3. The resulting subtype-specific cis-dimer is suggested to be a subunit of polymeric TJ strands and contributes to the specific ultrastructure of the TJ detected by freeze-fracture electron microscopy. In particular, the Cldn5-like exoplasmic face-associated and particle-type strands were found to be related to cis-dimerization. These results provide new insight into the mechanisms of paracellular barrier formation by demonstrating that defined non-conserved residues in TM3 and ECL2 of classic claudins contribute to the formation of TJ strands with differing ultrastructures.	[Rossa, Jan; Ploeger, Carolin; Vorreiter, Fraenze; Saleh, Tarek; Protze, Jonas; Krause, Gerd; Piontek, Joerg] Leibniz Inst Mol Pharmacol, Dept Biol Struct, D-13125 Berlin, Germany; [Saleh, Tarek; Guenzel, Dorothee; Piontek, Joerg] Charite, Inst Clin Physiol, D-12203 Berlin, Germany; [Wolburg, Hartwig] Univ Tubingen, Inst Pathol & Neuropathol, Dept Gen Pathol, D-72076 Tubingen, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Piontek, J (corresponding author), Charite, Inst Clin Physiol, Hindenburgdamm 30, D-12203 Berlin, Germany.	joerg.piontek@charite.de	Piontek, Joerg/K-6305-2013; Protze, Jonas/ABB-9737-2020	Piontek, Joerg/0000-0002-0880-8915; Protze, Jonas/0000-0002-1506-9831; Gunzel, Dorothee/0000-0002-7998-7164	Deutsche Forschungsgesellschaft (DFG) [PI 837/2-1]; DFG Research Unit [FOR 721/2 TP6, TP7]; Forschungsverbund Berlin e.V.	Deutsche Forschungsgesellschaft (DFG)(German Research Foundation (DFG)); DFG Research Unit(German Research Foundation (DFG)); Forschungsverbund Berlin e.V.	This work was supported by Deutsche Forschungsgesellschaft (DFG) Grant PI 837/2-1, by DFG Research Unit Grant FOR 721/2 TP6 and TP7, and by the Forschungsverbund Berlin e.V.	Amasheh S, 2005, CELL TISSUE RES, V321, P89, DOI 10.1007/s00441-005-1101-0; Claessen JHL, 2012, TRENDS CELL BIOL, V22, P22, DOI 10.1016/j.tcb.2011.09.010; CLAUDE P, 1978, J MEMBRANE BIOL, V39, P219, DOI 10.1007/BF01870332; CLAUDE P, 1973, J CELL BIOL, V58, P390, DOI 10.1083/jcb.58.2.390; Colegio OR, 2003, AM J PHYSIOL-CELL PH, V284, pC1346, DOI 10.1152/ajpcell.00547.2002; Cording J, 2013, J CELL SCI, V126, P554, DOI 10.1242/jcs.114306; Daugherty BL, 2007, J BIOL CHEM, V282, P30005, DOI 10.1074/jbc.M703547200; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Inai T, 2010, EUR J CELL BIOL, V89, P547, DOI 10.1016/j.ejcb.2010.01.003; Inai T, 2009, HISTOCHEM CELL BIOL, V131, P681, DOI 10.1007/s00418-009-0571-7; Kaufmann R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031128; Koval M, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24518; Krause G, 2008, BBA-BIOMEMBRANES, V1778, P631, DOI 10.1016/j.bbamem.2007.10.018; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Liebner S, 2000, ACTA NEUROPATHOL, V100, P323, DOI 10.1007/s004010000180; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Milatz S, 2010, BBA-BIOMEMBRANES, V1798, P2048, DOI 10.1016/j.bbamem.2010.07.014; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Piehl C, 2010, CELL MOL LIFE SCI, V67, P2131, DOI 10.1007/s00018-010-0332-8; Piontek J, 2008, FASEB J, V22, P146, DOI 10.1096/fj.07-8319com; Piontek J, 2011, CELL MOL LIFE SCI, V68, P3903, DOI 10.1007/s00018-011-0680-z; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; STAEHELIN LA, 1974, INT REV CYTOL, V39, P191, DOI 10.1016/S0074-7696(08)60940-7; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Van Itallie CM, 2011, J BIOL CHEM, V286, P3442, DOI 10.1074/jbc.M110.195578; Veshnyakova A, 2012, J BIOL CHEM, V287, P1698, DOI 10.1074/jbc.M111.312165; Winkler L, 2009, J BIOL CHEM, V284, P18863, DOI 10.1074/jbc.M109.008623; Wolburg H, 2003, ACTA NEUROPATHOL, V105, P586, DOI 10.1007/s00401-003-0688-z; Wolburg Hartwig, 2003, Methods Mol Med, V89, P51; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154; Zhang JJ, 2010, P NATL ACAD SCI USA, V107, P1425, DOI 10.1073/pnas.0911996107	34	58	59	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7641	7653		10.1074/jbc.M113.531012	http://dx.doi.org/10.1074/jbc.M113.531012			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24478310	Green Published, hybrid			2022-12-28	WOS:000332761500033
J	Jia, XY; Schulte, L; Loukas, A; Pickering, D; Pearson, M; Mobli, M; Jones, A; Rosengren, KJ; Daly, NL; Gobert, GN; Jones, MK; Craik, DJ; Mulvenna, J				Jia, Xinying; Schulte, Leigh; Loukas, Alex; Pickering, Darren; Pearson, Mark; Mobli, Mehdi; Jones, Alun; Rosengren, Karl J.; Daly, Norelle L.; Gobert, Geoffrey N.; Jones, Malcolm K.; Craik, David J.; Mulvenna, Jason			Solution Structure, Membrane Interactions, and Protein Binding Partners of the Tetraspanin Sm-TSP-2, a Vaccine Antigen from the Human Blood Fluke Schistosoma mansoni	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Membrane Proteins; Protein Structure; Proteomics; Tetraspanins; Vaccines; Schistosoma mansoni; Schistosomiasis	EXTRACELLULAR DOMAIN; CALPAIN; CELL; INFECTION; EXOSOMES; SURFACE; FUSION; REPAIR	Background: Schistosome tetraspanin Sm-TSP-2 is a vaccine antigen. Results: We describe the structure of the large extracellular domain of Sm-TSP-2, develop a model of its interactions with Tetraspanin-enriched-microdomain proteins and plasma membrane, and identify TEM constituents. Conclusion: Structural conservation of the domain means this model is likely applicable to TSPs in general. Significance: Tetraspanin-enriched-microdomain proteins provide further targets for multiplex vaccines and/or novel drug targets. The tetraspanins (TSPs) are a family of integral membrane proteins that are ubiquitously expressed at the surface of eukaryotic cells. TSPs mediate a range of processes at the surface of the plasma membrane by providing a scaffold for the assembly of protein complexes known as tetraspanin-enriched microdomains (TEMs). We report here the structure of the surface-exposed EC2 domain from Sm-TSP-2, a TSP from Schistosoma mansoni and one of the better prospects for the development of a vaccine against schistosomiasis. This is the first solution structure of this domain, and our investigations of its interactions with lipid micelles provide a general model for interactions between TSPs, membranes, and other proteins. Using chemical cross-linking, eight potential protein constituents of Sm-TSP-2-mediated TEMs were also identified. These include proteins important for membrane maintenance and repair, providing further evidence for the functional role of Sm-TSP-2- and Sm-TSP-2-mediated TEMs. The identification of calpain, Sm29, and fructose-bisphosphate aldolase, themselves potential vaccine antigens, suggests that the Sm-TSP-2-mediated TEMs could be disrupted via multiple targets. The identification of further Sm-TSP-2-mediated TEM proteins increases the available candidates for multiplex vaccines and/or novel drugs targeting TEMs in the schistosome tegument.	[Jia, Xinying; Schulte, Leigh; Gobert, Geoffrey N.; Jones, Malcolm K.; Mulvenna, Jason] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Schulte, Leigh; Jones, Malcolm K.] Univ Queensland, Sch Vet Sci, Gatton, Qld 4343, Australia; [Loukas, Alex; Pickering, Darren; Pearson, Mark; Daly, Norelle L.] James Cook Univ, Ctr Biodiscovery & Mol Dev Therapeut, Queensland Trop Hlth Alliance, Cairns, Qld 4878, Australia; [Mobli, Mehdi] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld 4072, Australia; [Jones, Alun; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Rosengren, Karl J.; Mulvenna, Jason] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; James Cook University; University of Queensland; University of Queensland; University of Queensland	Mulvenna, J (corresponding author), QIMR Berghofer Med Res Inst, Brisbane, Qld 4006, Australia.	Jason.Mulvenna@qimrberghofer.edu.au	Jia, Xinying/B-8949-2016; Gobert, Geoffrey/V-2985-2019; Craik, David/B-1695-2010; Mobli, Mehdi/O-7244-2014; Daly, Norelle L/D-4302-2013; Mulvenna, Jason/H-7110-2014; Rosengren, K. Johan/P-4450-2016; Pearson, Mark S/O-5636-2014; Jones, Malcolm K/A-1097-2009; Loukas, Alex/B-7355-2014	Jia, Xinying/0000-0003-0133-8321; Craik, David/0000-0003-0007-6796; Mobli, Mehdi/0000-0003-2420-4262; Daly, Norelle L/0000-0002-4697-6602; Mulvenna, Jason/0000-0003-3521-8061; Rosengren, K. Johan/0000-0002-5007-8434; Jones, Malcolm K/0000-0002-0035-6141; Pearson, Mark/0000-0002-0002-1544; Gobert, Geoffrey/0000-0001-5884-6453; Loukas, Alex/0000-0002-0896-8441	National Health and Medical Research Council, Australia (NHMRC) [613682]; National Health and Medical Research Council	National Health and Medical Research Council, Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council, Australia (NHMRC) Project Grant 613682.; Supported by Career Development Fellowships from the National Health and Medical Research Council.	ALLAN D, 1987, MOL BIOCHEM PARASIT, V23, P123, DOI 10.1016/0166-6851(87)90147-2; ALTIERI AS, 1995, J AM CHEM SOC, V117, P7566, DOI 10.1021/ja00133a039; Bader R., 2008, PROTEIN SCI ENCY, P95; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bax Ad, 2011, J Magn Reson, V213, P442, DOI 10.1016/j.jmr.2011.08.003; Braschi S, 2006, MOL CELL PROTEOMICS, V5, P347, DOI 10.1074/mcp.M500287-MCP200; Cardoso FC, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000308; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Drummer HE, 2005, BIOCHEM BIOPH RES CO, V328, P251, DOI 10.1016/j.bbrc.2004.12.160; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Gobert GN, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000600; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hawthorne PL, 2004, MOL BIOCHEM PARASIT, V136, P181, DOI 10.1016/j.molbiopara.2004.03.013; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Hofmann A, 2010, BIOESSAYS, V32, P967, DOI 10.1002/bies.200900195; Hotez PJ, 2010, NAT REV MICROBIOL, V8, P814, DOI 10.1038/nrmicro2438; Huang YC, 2005, EUR J HUM GENET, V13, P721, DOI 10.1038/sj.ejhg.5201414; Jones JA, 1997, J BIOMOL NMR, V10, P199, DOI 10.1023/A:1018304117895; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kovalenko OV, 2004, BIOCHEM J, V377, P407, DOI 10.1042/BJ20031037; Lakkaraju A, 2008, TRENDS CELL BIOL, V18, P199, DOI 10.1016/j.tcb.2008.03.002; LAUTERWEIN J, 1979, BIOCHIM BIOPHYS ACTA, V556, P244, DOI 10.1016/0005-2736(79)90046-4; Lennon NJ, 2003, J BIOL CHEM, V278, P50466, DOI 10.1074/jbc.M307247200; Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lohr F, 2007, J BIOMOL NMR, V37, P205, DOI 10.1007/s10858-006-9128-4; Loukas A, 2007, INT J PARASITOL, V37, P257, DOI 10.1016/j.ijpara.2006.12.001; Loukas A, 2011, OMICS, V15, P567, DOI 10.1089/omi.2010.0150; Marcilla A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045974; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Marques HH, 2008, IMMUNOBIOLOGY, V213, P437, DOI 10.1016/j.imbio.2007.10.002; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; Mellgren RL, 2007, J BIOL CHEM, V282, P2567, DOI 10.1074/jbc.M604560200; Mobli M, 2007, NAT METHODS, V4, P467, DOI 10.1038/nmeth0607-467; Mobli M, 2010, J MAGN RESON, V204, P160, DOI 10.1016/j.jmr.2010.02.012; Mulvenna J, 2010, INT J PARASITOL, V40, P543, DOI 10.1016/j.ijpara.2009.10.002; PARTEARROYO MA, 1988, BIOCHEM INT, V16, P259; Rajesh S, 2012, J VIROL, V86, P9606, DOI 10.1128/JVI.00559-12; Rana S, 2011, BIOCHEM SOC T, V39, P559, DOI 10.1042/BST0390559; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Seigneuret M, 2001, J BIOL CHEM, V276, P40055, DOI 10.1074/jbc.M105557200; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SIDDIQUI AA, 1993, BIOCHIM BIOPHYS ACTA, V1181, P37, DOI 10.1016/0925-4439(93)90087-H; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Tao H, 2010, BIOTECHNIQUES, V48, P61, DOI 10.2144/000113304; Tran MH, 2006, NAT MED, V12, P835, DOI 10.1038/nm1430; Tran MH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000840; van Balkom BWM, 2005, J PROTEOME RES, V4, P958, DOI 10.1021/pr050036w; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Zhang RL, 2001, INFECT IMMUN, V69, P386, DOI 10.1128/IAI.69.1.386-391.2001; Zoller M, 2006, Z GASTROENTEROL, V44, P573, DOI 10.1055/s-2006-926795	60	23	24	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7151	7163		10.1074/jbc.M113.531558	http://dx.doi.org/10.1074/jbc.M113.531558			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24429291	Green Published, hybrid			2022-12-28	WOS:000332389400074
J	Kamat, S; Yeola, S; Zhang, WY; Bianchi, L; Driscoll, M				Kamat, Shaunak; Yeola, Shrutika; Zhang, Wenying; Bianchi, Laura; Driscoll, Monica			NRA-2, a Nicalin Homolog, Regulates Neuronal Death by Controlling Surface Localization of Toxic Caenorhabditis elegans DEG/ENaC Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						C; elegans; ER Quality Control; Intracellular Trafficking; Ion Channels; Neurodegeneration; C; elegans; Nicalin; Quality Control; Trafficking	TOUCH RECEPTOR NEURONS; SENSING ION CHANNELS; CALCIUM; MEC-2; NECROSIS; COMPLEX; GENE; PROTEASES; STOMATIN; SUBUNIT	Background: Mechanisms that regulate plasma membrane expression of neuronally toxic DEG/ENaC channels are unclear. Results: Disruption of ER NRA-2, a Nicalin homolog, enhances C. elegans MEC-10(d) DEG/ENaC neurotoxicity. Immunocytochemistry, TIRF imaging, and electrophysiological assays support that NRA-2 controls relative MEC-10(d) distribution between ER and cell surface to regulate channel activity levels. Conclusion: NRA-2 regulates surface expression of a mutant DEG/ENaC channel. Significance: NRA-2 Nicalin can modulate DEG/ENaC pathophysiology. Hyperactivated DEG/ENaCs induce neuronal death through excessive cation influx and disruption of intracellular calcium homeostasis. Caenorhabditis elegans DEG/ENaC MEC-4 is hyperactivated by the (d) mutation and induces death of touch neurons. The analogous substitution in MEC-10 (MEC-10(d)) co-expressed in the same neurons is only mildly neurotoxic. We exploited the lower toxicity of MEC-10(d) to identify RNAi knockdowns that enhance neuronal death. We report here that knock-out of the C. elegans nicalin homolog NRA-2 enhances MEC-10(d)-induced neuronal death. Cell biological assays in C. elegans neurons show that NRA-2 controls the distribution of MEC-10(d) between the endoplasmic reticulum and the cell surface. Electrophysiological experiments in Xenopus oocytes support this notion and suggest that control of channel distribution by NRA-2 is dependent on the subunit composition. We propose that nicalin/NRA-2 functions in a quality control mechanism to retain mutant channels in the endoplasmic reticulum, influencing the extent of neuronal death. Mammalian nicalin may have a similar role in DEG/ENaC biology, therefore influencing pathological conditions like ischemia.	[Kamat, Shaunak; Yeola, Shrutika; Zhang, Wenying; Driscoll, Monica] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; [Bianchi, Laura] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA	Rutgers State University New Brunswick; University of Miami	Bianchi, L (corresponding author), Univ Miami, Dept Physiol & Biophys, Rm 5133,1600 NW 10th Ave, Miami, FL 33136 USA.	lbianchi@med.miami.edu; driscoll@dls.rutgers.edu			National Institutes of Health Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034435, R01NS070969] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health Office of Research Infrastructure Programs; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Donald Winkelmann for help with TIRF microscopy and instrument sharing, Jian Xue and Helen Ushakov for generating the Ex221 transgenic nra-2 rescue strain, and Dr. Barth Grant and Dr. Anne Norris for help with immunofluorescence experiments. Some strains were provided by the Caenorhabditis Genetics Center (CGC), which is funded by National Institutes of Health Office of Research Infrastructure Programs (Grant P40 OD010440).	Almedom RB, 2009, EMBO J, V28, P2636, DOI 10.1038/emboj.2009.204; Alvarez de la Rosa Diego, 2013, Curr Mol Pharmacol, V6, P35; Bianchi L, 2004, NAT NEUROSCI, V7, P1337, DOI 10.1038/nn1347; Bianchi Laura, 2006, WormBook, P1; BRENNER S, 1974, GENETICS, V77, P71; Brown AL, 2008, J GEN PHYSIOL, V131, P605, DOI 10.1085/jgp.200709910; Brown AL, 2007, J GEN PHYSIOL, V129, P161, DOI 10.1085/jgp.200609672; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Chai S, 2010, J BIOL CHEM, V285, P13002, DOI 10.1074/jbc.M109.086041; Chatzigeorgiou M, 2010, J NEUROPHYSIOL, V104, P3334, DOI 10.1152/jn.00330.2010; Chelur DS, 2002, NATURE, V420, P669, DOI 10.1038/nature01205; Christensen M, 2002, NEURON, V33, P503, DOI 10.1016/S0896-6273(02)00591-3; Chu XP, 2013, ADV EXP MED BIOL, V961, P419, DOI 10.1007/978-1-4614-4756-6_36; Dettmer U, 2010, J BIOL CHEM, V285, P26174, DOI 10.1074/jbc.M110.132548; Driscoll M, 2003, NAT REV GENET, V4, P181, DOI 10.1038/nrg1018; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Eshcol JO, 2008, AM J PHYSIOL-CELL PH, V295, pC732, DOI 10.1152/ajpcell.00514.2007; FIRE A, 1986, EMBO J, V5, P2673, DOI 10.1002/j.1460-2075.1986.tb04550.x; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; Gessmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012814; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; Gottschalk A, 2005, EMBO J, V24, P2566, DOI 10.1038/sj.emboj.7600741; Haffner C, 2004, EMBO J, V23, P3041, DOI 10.1038/sj.emboj.7600307; Hobbs CA, 2013, J PHYSIOL-LONDON, V591, P4377, DOI 10.1113/jphysiol.2012.240861; Hong K, 2000, J NEUROSCI, V20, P2575; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kweon HJ, 2013, BMB REP, V46, P295, DOI 10.5483/BMBRep.2013.46.6.121; Luke CJ, 2007, CELL, V130, P1108, DOI 10.1016/j.cell.2007.07.013; Martin-Fernandez ML, 2013, J MICROSC-OXFORD, V252, P16, DOI 10.1111/jmi.12070; McCall K, 2010, CURR OPIN CELL BIOL, V22, P882, DOI 10.1016/j.ceb.2010.09.002; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Sangaletti R, 2013, JOVE-J VIS EXP, DOI 10.3791/50649; Sedensky MM, 2004, AM J PHYSIOL-CELL PH, V287, pC468, DOI 10.1152/ajpcell.00182.2003; Sendrowski K, 2013, PHARMACOL REP, V65, P730, DOI 10.1016/S1734-1140(13)71052-1; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; SHREFFLER W, 1995, GENETICS, V139, P1261; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Wang Y, 2013, J GEN PHYSIOL, V142, P157, DOI 10.1085/jgp.201310974; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xu KL, 2001, NEURON, V31, P957, DOI 10.1016/S0896-6273(01)00432-9; Yamashima T, 2004, CELL CALCIUM, V36, P285, DOI 10.1016/j.ceca.2004.03.001; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Zhang SF, 2004, CURR BIOL, V14, P1888, DOI 10.1016/j.cub.2004.10.030; Zhang W, 2008, CELL DEATH DIFFER, V15, P1794, DOI 10.1038/cdd.2008.114; Zhang W., 2008, THESIS RUTGERS U PIS	47	7	9	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11916	11926		10.1074/jbc.M113.533695	http://dx.doi.org/10.1074/jbc.M113.533695			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24567339	Green Published, hybrid			2022-12-28	WOS:000335010600032
J	Kim, HS; Chen, QJ; Kim, SK; Nickoloff, JA; Hromas, R; Georgiadis, MM; Lee, SH				Kim, Hyun-Suk; Chen, Qiujia; Kim, Sung-Kyung; Nickoloff, Jac A.; Hromas, Robert; Georgiadis, Millie M.; Lee, Suk-Hee			The DDN Catalytic Motif Is Required for Metnase Functions in Non-homologous End Joining ( NHEJ) Repair and Replication Restart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Binding Protein; DNA Damage; DNA Enzymes; DNA Repair; DNA Replication	ENHANCES DNA-REPAIR; TRANSPOSASE DOMAIN; BIOCHEMICAL-CHARACTERIZATION; MARINER TRANSPOSON; CRYSTAL-STRUCTURE; SETMAR PROTEIN; MOS1; EVOLUTION; ELEMENT; HSMAR1	Background: Metnase, a transposase-containing DNA repair protein, retains DNA cleavage activity with a DDN motif. Results: Substitution with the ancestral transposase DDD/DDE catalytic motif results in a decrease in ssDNA binding and ss-overhang cleavage activities. Conclusion: The DDN motif is required for Metnase DNA repair activities. Significance: Understanding the requirements for catalytic activity provides insights on how Metnase functions as a DNA repair protein. Metnase (or SETMAR) arose from a chimeric fusion of the Hsmar1 transposase downstream of a protein methylase in anthropoid primates. Although the Metnase transposase domain has been largely conserved, its catalytic motif (DDN) differs from the DDD motif of related transposases, which may be important for its role as a DNA repair factor and its enzymatic activities. Here, we show that substitution of DDN610 with either DDD610 or DDE610 significantly reduced in vivo functions of Metnase in NHEJ repair and accelerated restart of replication forks. We next tested whether the DDD or DDE mutants cleave single-strand extensions and flaps in partial duplex DNA and pseudo-Tyr structures that mimic stalled replication forks. Neither substrate is cleaved by the DDD or DDE mutant, under the conditions where wild-type Metnase effectively cleaves ssDNA overhangs. We then characterized the ssDNA-binding activity of the Metnase transposase domain and found that the catalytic domain binds ssDNA but not dsDNA, whereas dsDNA binding activity resides in the helix-turn-helix DNA binding domain. Substitution of Asn-610 with either Asp or Glu within the transposase domain significantly reduces ssDNA binding activity. Collectively, our results suggest that a single mutation DDN610 DDD610, which restores the ancestral catalytic site, results in loss of function in Metnase.	[Kim, Hyun-Suk; Chen, Qiujia; Kim, Sung-Kyung; Georgiadis, Millie M.; Lee, Suk-Hee] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Nickoloff, Jac A.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Hromas, Robert] Univ Florida, Dept Med, Gainesville, FL 32610 USA; [Hromas, Robert] Shands Hlth Care Syst, Gainesville, FL 32610 USA; [Georgiadis, Millie M.] Indiana Univ Purdue Univ, Dept Chem & Chem Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Colorado State University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Indiana University System; Indiana University-Purdue University Indianapolis	Lee, SH (corresponding author), Indiana Univ Sch Med, Indiana Univ, Simon Canc Ctr, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	slee@iu.edu			National Institutes of Health [R01 CA151367, R01 GM084020, R01 CA140422]; Indiana University Simon Cancer Center; NATIONAL CANCER INSTITUTE [P30CA082709, R01CA140422, R01CA151367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084020] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana University Simon Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 CA151367 (to S.-H. L.), R01 GM084020 (to J. A. N.), R01 CA140422 (to R. H.), and the Indiana University Simon Cancer Center.	Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Beck BD, 2008, J BIOL CHEM, V283, P9023, DOI 10.1074/jbc.M800150200; Beck BD, 2011, BIOCHEMISTRY-US, V50, P4360, DOI 10.1021/bi200333k; Cordaux R, 2006, P NATL ACAD SCI USA, V103, P8101, DOI 10.1073/pnas.0601161103; Craig NL, 1997, ANNU REV BIOCHEM, V66, P437, DOI 10.1146/annurev.biochem.66.1.437; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Dawson A, 2003, MOL CELL, V11, P225, DOI 10.1016/S1097-2765(02)00798-0; De Haro LP, 2010, NUCLEIC ACIDS RES, V38, P5681, DOI 10.1093/nar/gkq339; Delauriere L, 2009, BIOCHEMISTRY-US, V48, P7279, DOI 10.1021/bi900609v; Fnu S, 2011, P NATL ACAD SCI USA, V108, P540, DOI 10.1073/pnas.1013571108; Frokjaer-Jensen C, 2012, NAT METHODS, V9, P117, DOI 10.1038/nmeth.1865; Goodwin KD, 2010, BIOCHEMISTRY-US, V49, P5705, DOI 10.1021/bi100171x; Hromas R, 2012, ONCOGENE, V31, P4245, DOI 10.1038/onc.2011.586; Hromas R, 2008, DNA REPAIR, V7, P1927, DOI 10.1016/j.dnarep.2008.08.002; Lee SH, 2005, P NATL ACAD SCI USA, V102, P18075, DOI 10.1073/pnas.0503676102; Liu DX, 2007, MOL CELL BIOL, V27, P1125, DOI 10.1128/MCB.01899-06; Lohe AR, 1997, P NATL ACAD SCI USA, V94, P1293, DOI 10.1073/pnas.94.4.1293; Melek M, 1998, SCIENCE, V280, P301, DOI 10.1126/science.280.5361.301; Miskey C, 2007, MOL CELL BIOL, V27, P4589, DOI 10.1128/MCB.02027-06; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Pace JK, 2007, GENOME RES, V17, P422, DOI 10.1101/gr.5826307; Richardson JM, 2006, EMBO J, V25, P1324, DOI 10.1038/sj.emboj.7601018; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; Robertson HM, 1997, GENE, V205, P203, DOI 10.1016/S0378-1119(97)00472-1; Roman Y, 2007, BIOCHEMISTRY-US, V46, P11369, DOI 10.1021/bi7005477; Shaheen M, 2010, GENETICA, V138, P559, DOI 10.1007/s10709-010-9452-1; Sinzelle L, 2009, CELL MOL LIFE SCI, V66, P1073, DOI 10.1007/s00018-009-8376-3; Tosi LRO, 2000, NUCLEIC ACIDS RES, V28, P784, DOI 10.1093/nar/28.3.784; Williamson EA, 2008, NUCLEIC ACIDS RES, V36, P5822, DOI 10.1093/nar/gkn560; Williamson EA, 2008, BIOCHIMIE, V90, P1422, DOI 10.1016/j.biochi.2008.05.010; Williamson EA, 2012, CANCER RES, V72, P6200, DOI 10.1158/0008-5472.CAN-12-0313; Wolkowicz UM, 2014, ACS CHEM BIOL, V9, P743, DOI 10.1021/cb400791u; Wray J, 2010, CANCER GENET CYTOGEN, V200, P184, DOI 10.1016/j.cancergencyto.2010.04.011; Wray J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005323; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181	35	22	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10930	10938		10.1074/jbc.M113.533216	http://dx.doi.org/10.1074/jbc.M113.533216			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24573677	Green Published, hybrid			2022-12-28	WOS:000334226400060
J	Dathe, C; Daigeler, AL; Seifert, W; Jankowski, V; Mrowka, R; Kalis, R; Wanker, E; Mutig, K; Bachmann, S; Paliege, A				Dathe, Christin; Daigeler, Anna-Lena; Seifert, Wenke; Jankowski, Vera; Mrowka, Ralf; Kalis, Ronny; Wanker, Erich; Mutig, Kerim; Bachmann, Sebastian; Paliege, Alexander			Annexin A2 Mediates Apical Trafficking of Renal Na+-K+-2Cl(-) Cotransporter*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Annexin; Chloride Channels; Kidney; Phosphorylation; Trafficking	THICK ASCENDING LIMB; LIPID RAFTS; MEMBRANE-BINDING; GENE-EXPRESSION; CYCLOOXYGENASE-2 EXPRESSION; SODIUM TRANSPORTERS; SURFACE EXPRESSION; 2-S100A10 COMPLEX; PROTEIN; NKCC2	Background: Regulated membrane expression of the renal furosemide-sensitive Na+-K+-2Cl(-) cotransporter (NKCC2) determines essential functions of the kidney. Results: Annexin A2 (AnxA2) is a new interaction partner of NKCC2 with respect to its adluminal trafficking and activation. Conclusion: Discussion focuses on trafficking, membrane association, and phosphorylation of NKCC2 and its cellular ligand AnxA2. Significance: AnxA2 is relevant for the activation of NKCC2. The furosemide-sensitive Na+-K+-2Cl(-) cotransporter (NKCC2) is responsible for urine concentration and helps maintain systemic salt homeostasis. Its activity depends on trafficking to, and insertion into, the apical membrane, as well as on phosphorylation of conserved N-terminal serine and threonine residues. Vasopressin (AVP) signaling via PKA and other kinases activates NKCC2. Association of NKCC2 with lipid rafts facilitates its AVP-induced apical translocation and activation at the surface. Lipid raft microdomains typically serve as platforms for membrane proteins to facilitate their interactions with other proteins, but little is known about partners that interact with NKCC2. Yeast two-hybrid screening identified an interaction between NKCC2 and the cytosolic protein, annexin A2 (AnxA2). Annexins mediate lipid raft-dependent trafficking of transmembrane proteins, including the AVP-regulated water channel, aquaporin 2. Here, we demonstrate that AnxA2, which binds to phospholipids in a Ca2+-dependent manner and may organize microdomains, is codistributed with NKCC2 to promote its apical translocation in response to AVP stimulation and low chloride hypotonic stress. NKCC2 and AnxA2 interact in a phosphorylation-dependent manner. Phosphomimetic AnxA2 carrying a mutant phosphoacceptor (AnxA2-Y24D-GFP) enhanced surface expression and raft association of NKCC2 by 5-fold upon low chloride hypotonic stimulation, whereas AnxA2-Y24A-GFP and PKC-dependent AnxA2-S26D-GFP did not. As the AnxA2 effect involved only nonphosphorylated NKCC2, it appears to affect NKCC2 trafficking. Overexpression or knockdown experiments further supported the role of AnxA2 in the apical translocation and surface expression of NKCC2. In summary, this study identifies AnxA2 as a lipid raft-associated trafficking factor for NKCC2 and provides mechanistic insight into the regulation of this essential cotransporter.	[Dathe, Christin; Daigeler, Anna-Lena; Seifert, Wenke; Mutig, Kerim; Bachmann, Sebastian; Paliege, Alexander] Charite, Dept Anat, D-10115 Berlin, Germany; [Jankowski, Vera] Charite, Dept Nephrol, D-12203 Berlin, Germany; [Mrowka, Ralf] Univ Klinikum Jena, Innere Med Klin 3, D-07749 Jena, Germany; [Kalis, Ronny; Wanker, Erich] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Friedrich Schiller University of Jena; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Bachmann, S (corresponding author), Charite, Dept Anat, D-10115 Berlin, Germany.	sebastian.bachmann@charite.de; alexander.paliege@charite.de	Mutig, Kerim/L-9010-2017; Mrowka, Ralf/AAW-1480-2021; Seifert, Wenke/B-8772-2011	Mutig, Kerim/0000-0001-9006-5112; Mrowka, Ralf/0000-0002-0991-3418; Seifert, Wenke/0000-0003-1432-9862; Paliege, Alexander/0000-0001-5092-5472; Wanker, Erich/0000-0001-8072-1630	Federal Ministry of Education and Research [NGFN/01GR0807, 13920B]; European Union [FP7-HEALTH-2009-2.4.5-2, 241544, HEALTH 2011.2.4.2-2, 278249]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Union(European Commission)	This work was supported by Grants NGFN/01GR0807 and 13920B from the Federal Ministry of Education and Research and by Grants FP7-HEALTH-2009-2.4.5-2 to "SYSKID" (241544) and "HEALTH 2011.2.4.2-2" to "Mascara" (278249) from the European Union.	Ares GR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.386425; Ares GR, 2011, AM J PHYSIOL-RENAL, V301, pF1143, DOI 10.1152/ajprenal.00396.2011; Ares GR, 2010, AM J PHYSIOL-RENAL, V299, pF1193, DOI 10.1152/ajprenal.00307.2010; Ayala-Sanmartin J, 2001, BBA-BIOMEMBRANES, V1510, P18, DOI 10.1016/S0005-2736(00)00262-5; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Borthwick LA, 2008, CELL CALCIUM, V44, P147, DOI 10.1016/j.ceca.2007.11.001; Borthwick LA, 2007, MOL BIOL CELL, V18, P3388, DOI 10.1091/mbc.E07-02-0126; Borthwick LA, 2008, CELL SIGNAL, V20, P1073, DOI 10.1016/j.cellsig.2008.01.021; Brandherm I, 2013, BLOOD, V122, P1042, DOI 10.1182/blood-2012-12-475251; Caceres PS, 2009, J BIOL CHEM, V284, P24965, DOI 10.1074/jbc.M109.037135; Cavallone D, 2001, BIOCHEM BIOPH RES CO, V280, P110, DOI 10.1006/bbrc.2000.4090; Chabardes-Garonne D, 2003, P NATL ACAD SCI USA, V100, P13710, DOI 10.1073/pnas.2234604100; Chasserot-Golaz S, 2005, MOL BIOL CELL, V16, P1108, DOI 10.1091/mbc.E04-07-0627; Cheng HF, 2000, J CLIN INVEST, V106, P681, DOI 10.1172/JCI10318; Chu PY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072969; de Graauw M, 2014, ONCOGENE, V33, P2610, DOI 10.1038/onc.2013.219; Dihazi H, 2005, MOL CELL PROTEOMICS, V4, P1445, DOI 10.1074/mcp.M400184-MCP200; Drucker P, 2013, J BIOL CHEM, V288, P24764, DOI 10.1074/jbc.M113.474023; Ecelbarger CA, 2001, EXP NEUROL, V171, P227, DOI 10.1006/exnr.2001.7775; Eng B, 2007, AM J PHYSIOL-RENAL, V293, pF1413, DOI 10.1152/ajprenal.00426.2006; Fenton RA, 2008, PROG BRAIN RES, V170, P571, DOI 10.1016/S0079-6123(08)00444-5; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Fraser SA, 2007, BIOCHEM J, V405, P85, DOI 10.1042/BJ20061850; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; GERKE V, 1985, EMBO J, V4, P2917, DOI 10.1002/j.1460-2075.1985.tb04023.x; Gerke V, 1997, BBA-MOL CELL RES, V1357, P129, DOI 10.1016/S0167-4889(97)00038-4; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gimenez I, 2005, AM J PHYSIOL-RENAL, V289, pF1341, DOI 10.1152/ajprenal.00214.2005; Gimenez I, 2003, J BIOL CHEM, V278, P26946, DOI 10.1074/jbc.M303435200; Gimenez I, 2006, CURR OPIN NEPHROL HY, V15, P517, DOI 10.1097/01.mnh.0000242178.44576.b0; GLENNEY JR, 1985, P NATL ACAD SCI USA, V82, P7884, DOI 10.1073/pnas.82.23.7884; Grewal T, 2009, CELL SIGNAL, V21, P847, DOI 10.1016/j.cellsig.2009.01.031; Grieve Adam G, 2012, Int J Cell Biol, V2012, P852430, DOI 10.1155/2012/852430; GUBERMAN JM, 2011, BIOMART CENTRAL PORT, pAR41; Gunaratne R, 2010, P NATL ACAD SCI USA, V107, P15653, DOI 10.1073/pnas.1007424107; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; HEBERT SC, 1984, J MEMBRANE BIOL, V80, P201, DOI 10.1007/BF01868439; HOYER JR, 1980, KIDNEY INT, V17, P284, DOI 10.1038/ki.1980.34; JOHNSTONE SA, 1992, J BIOL CHEM, V267, P25976; Jost M, 1996, BBA-MOL CELL RES, V1313, P283, DOI 10.1016/0167-4889(96)00101-2; Knepper MA, 1999, J AM SOC NEPHROL, V10, P628; Krager KJ, 2012, J LIPID RES, V53, P2214, DOI 10.1194/jlr.D026468; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magee AI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-234; Mayer G, 2008, J BIOL CHEM, V283, P31791, DOI 10.1074/jbc.M805971200; Mazzone A, 2006, HEPATOLOGY, V43, P287, DOI 10.1002/hep.21039; McCormick JA, 2011, CELL METAB, V14, P352, DOI 10.1016/j.cmet.2011.07.009; Meade P, 2003, AM J PHYSIOL-RENAL, V284, pF1145, DOI 10.1152/ajprenal.00421.2002; Menke M, 2005, BIOCHEMISTRY-US, V44, P15296, DOI 10.1021/bi051585i; Menke M, 2004, CHEMBIOCHEM, V5, P1003, DOI 10.1002/cbic.200400004; Moeller HB, 2012, PFLUG ARCH EUR J PHY, V464, P133, DOI 10.1007/s00424-012-1129-4; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Mount DB, 2006, AM J PHYSIOL-RENAL, V290, pF606, DOI 10.1152/ajprenal.00410.2005; Mutig K, 2007, AM J PHYSIOL-RENAL, V293, pF1166, DOI 10.1152/ajprenal.00196.2007; Okuse K, 2002, NATURE, V417, P653, DOI 10.1038/nature00781; Ortiz PA, 2006, AM J PHYSIOL-RENAL, V290, pF608, DOI 10.1152/ajprenal.00248.2005; Paliege A, 2012, AM J PHYSIOL-RENAL, V302, pF865, DOI 10.1152/ajprenal.00222.2011; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; Poon WYL, 2004, FEBS LETT, V558, P114, DOI 10.1016/S0014-5793(03)01512-6; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Reiche J, 2010, MOL CELL BIOL, V30, P3027, DOI 10.1128/MCB.01560-09; Rescher U, 2004, J CELL SCI, V117, P3473, DOI 10.1242/jcs.01208; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Rescher U, 2008, PFLUG ARCH EUR J PHY, V455, P575, DOI 10.1007/s00424-007-0313-4; Richardson C, 2011, J CELL SCI, V124, P789, DOI 10.1242/jcs.077230; Rieg T, 2013, AM J PATHOL, V182, P96, DOI 10.1016/j.ajpath.2012.09.014; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Santamaria A, 2005, MOL CELL BIOL, V25, P1900, DOI 10.1128/MCB.25.5.1900-1911.2005; Saritas T, 2013, J AM SOC NEPHROL, V24, P407, DOI 10.1681/ASN.2012040404; Schmitt JM, 2002, MOL CELL, V9, P85, DOI 10.1016/S1097-2765(01)00432-4; Schmitt R, 2003, AM J PHYSIOL-RENAL, V284, pF1097, DOI 10.1152/ajprenal.00368.2002; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Starremans PGJF, 2003, J AM SOC NEPHROL, V14, P1419, DOI 10.1097/01.ASN.0000064948.39199.A0; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Suter B, 2012, METHODS MOL BIOL, V812, pV; Takahashi N, 2000, P NATL ACAD SCI USA, V97, P5434, DOI 10.1073/pnas.090091297; Tamma G, 2008, PFLUG ARCH EUR J PHY, V456, P729, DOI 10.1007/s00424-008-0453-1; Urbanska A, 2011, TRAFFIC, V12, P1227, DOI 10.1111/j.1600-0854.2011.01226.x; van de Graaf SFJ, 2006, AM J PHYSIOL-RENAL, V290, pF1295, DOI 10.1152/ajprenal.00443.2005; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; Wanker EE, 1997, HUM MOL GENET, V6, P487, DOI 10.1093/hmg/6.3.487; Welker P, 2008, AM J PHYSIOL-RENAL, V295, pF789, DOI 10.1152/ajprenal.90227.2008; Welker P, 2007, AM J PHYSIOL-REG I, V292, pR1328, DOI 10.1152/ajpregu.00166.2006; Wilson BS, 2004, MOL BIOL CELL, V15, P2580, DOI 10.1091/mbc.E03-08-0574; Yang TX, 2000, J BIOL CHEM, V275, P37922, DOI 10.1074/jbc.M006218200; Yu MJ, 2009, P NATL ACAD SCI USA, V106, P2441, DOI 10.1073/pnas.0813002106; Zaarour N, 2012, J BIOL CHEM, V287, P42642, DOI 10.1074/jbc.M112.399162; Zaarour N, 2011, J BIOL CHEM, V286, P9489, DOI 10.1074/jbc.M110.166546; Zaarour N, 2009, J BIOL CHEM, V284, P21752, DOI 10.1074/jbc.M109.000679	89	18	19	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9983	9997		10.1074/jbc.M113.540948	http://dx.doi.org/10.1074/jbc.M113.540948			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24526686	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000333807000047
J	Cheng, XG; Ratner, L				Cheng, Xiaogang; Ratner, Lee			HIV-2 Vpx Protein Interacts with Interferon Regulatory Factor 5 ( IRF5) and Inhibits Its Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine; HIV; Innate Immunity; Interferon; Myeloid Cell	RESTRICTION FACTOR SAMHD1; DENDRITIC CELLS; TRANSCRIPTION FACTORS; ANTIVIRAL RESPONSE; GENE INDUCTION; INFECTION; ACTIVATION; REPLICATION; PATHWAY; SIV	Background: HIV-2 Vpx modulates innate immunity by overcoming restrictions for infection of myeloid cells. Results: Vpx binds IRF5 and inhibits its ability to bind to IL6, IL12, and TNF promoters. Conclusion: Effects of Vpx on the innate immune system are at least partially due to its inhibition of TLR activation of IRF5. Significance: Understanding the mechanism of HIV immunomodulation is critical for vaccine development. Interferon regulatory factor (IRF) family members have been implicated as critical transcription factors that function in immune responses, hematopoietic differentiation, and cell growth regulation. Activation of IRF5 results in the production of pro-inflammatory cytokines such as TNF, IL6, and IL12, as well as type I interferons. In this study, we demonstrate that HIV-2 Vpx interacts with IRF5, and Vpx inhibits IRF5-mediated transactivation. Expression of Vpx in THP-1 cells reduced mRNA levels and protein production of Toll-like receptor-dependent IL6, IL12p40, and TNF induced by lipopolysaccharide, R848, and ODN2216. Chromatin immunoprecipitation assays show that Vpx expression results in decreased promoter binding activity of IRF5. This study provides new insights into mechanisms employed by HIV-2 to counteract innate immune defenses against viral infection.	[Cheng, Xiaogang; Ratner, Lee] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA	Washington University (WUSTL)	Ratner, L (corresponding author), Washington Univ, Sch Med, Dept Med, Box 8069,660 S Euclid Ave, St Louis, MO 63110 USA.	lratner@dom.wustl.edu		Ratner, Lee/0000-0003-2744-7294	National Institutes of Health [R21 AI093175]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI093175] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 AI093175.	Accola MA, 1999, J VIROL, V73, P9992, DOI 10.1128/JVI.73.12.9992-9999.1999; Ahn J, 2012, J BIOL CHEM, V287, P12550, DOI 10.1074/jbc.M112.340711; Akira S, 2006, CURR TOP MICROBIOL, V311, P1; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Balkhi MY, 2008, MOL CELL BIOL, V28, P7296, DOI 10.1128/MCB.00662-08; Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200; Barnes BJ, 2003, CANCER RES, V63, P6424; Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Battistini A, 2009, J INTERF CYTOK RES, V29, P765, DOI 10.1089/jir.2009.0030; Belshan M, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-32; Brandariz-Nunez A, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-49; Cheng TF, 2006, J IMMUNOL, V176, P7462, DOI 10.4049/jimmunol.176.12.7462; Doehle BP, 2012, J VIROL, V86, P8367, DOI 10.1128/JVI.00423-12; Feng D, 2010, J IMMUNOL, V185, P6003, DOI 10.4049/jimmunol.1000482; Foreman HCC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033098; Fujita M, 2008, J VIROL, V82, P7752, DOI 10.1128/JVI.01003-07; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; GIBBS JS, 1995, J VIROL, V69, P2378, DOI 10.1128/JVI.69.4.2378-2383.1995; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Granelli-Piperno A, 2004, P NATL ACAD SCI USA, V101, P7669, DOI 10.1073/pnas.0402431101; GUYADER M, 1989, EMBO J, V8, P1169, DOI 10.1002/j.1460-2075.1989.tb03488.x; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Harman AN, 2011, BLOOD, V118, P298, DOI 10.1182/blood-2010-07-297721; HENDERSON LE, 1988, SCIENCE, V241, P199, DOI 10.1126/science.3388031; Hirsch VM, 1998, NAT MED, V4, P1401, DOI 10.1038/3992; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Hu GD, 2005, CANCER RES, V65, P7403, DOI 10.1158/0008-5472.CAN-05-0583; Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000; KAWAMURA M, 1994, MICROBIOL IMMUNOL, V38, P871, DOI 10.1111/j.1348-0421.1994.tb02140.x; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; Korczeniewska J, 2013, MOL CELL BIOL, V33, P1124, DOI 10.1128/MCB.00802-12; Krausgruber T, 2010, BLOOD, V115, P4421, DOI 10.1182/blood-2010-01-263020; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, M S-MED SCI, V28, P909, DOI 10.1051/medsci/20122811002; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118; Lin RT, 2005, J BIOL CHEM, V280, P3088, DOI 10.1074/jbc.M408452200; Mancl ME, 2005, J BIOL CHEM, V280, P21078, DOI 10.1074/jbc.M500543200; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Mangeot PE, 2002, MOL THER, V5, P283, DOI 10.1006/mthe.2002.0541; Mogensen TH, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-54; Mori T, 2002, ONCOGENE, V21, P2914, DOI 10.1038/sj.onc.1205459; O'Geen H, 2011, METHODS MOL BIOL, V791, P265, DOI 10.1007/978-1-61779-316-5_20; Okumura A, 2008, VIROLOGY, V373, P85, DOI 10.1016/j.virol.2007.10.042; Pancio HA, 1998, J VIROL, V72, P5271, DOI 10.1128/JVI.72.6.5271-5275.1998; Paun A, 2008, J BIOL CHEM, V283, P14295, DOI 10.1074/jbc.M800501200; Pitha PM, 2011, VIRUSES-BASEL, V3, P1179, DOI 10.3390/v3071179; Savitsky D, 2010, CANCER IMMUNOL IMMUN, V59, P489, DOI 10.1007/s00262-009-0804-6; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Selig L, 1999, J VIROL, V73, P592, DOI 10.1128/JVI.73.1.592-600.1999; Sewell AK, 2001, TRENDS IMMUNOL, V22, P173, DOI 10.1016/S1471-4906(01)01866-X; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Solis M, 2011, J VIROL, V85, P1224, DOI 10.1128/JVI.01635-10; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Yanai H, 2007, P NATL ACAD SCI USA, V104, P3402, DOI 10.1073/pnas.0611559104; Yang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005500; YU XF, 1988, NATURE, V335, P262, DOI 10.1038/335262a0; YU XF, 1991, J VIROL, V65, P5088, DOI 10.1128/JVI.65.9.5088-5091.1991	65	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9146	9157		10.1074/jbc.M113.534321	http://dx.doi.org/10.1074/jbc.M113.534321			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24532789	Green Published, hybrid			2022-12-28	WOS:000333472100034
J	Gordillo, GM; Biswas, A; Khanna, S; Pan, X; Sinha, M; Roy, S; Sen, CK				Gordillo, Gayle M.; Biswas, Ayan; Khanna, Savita; Pan, Xueliang; Sinha, Mithun; Roy, Sashwati; Sen, Chandan K.			Dicer Knockdown Inhibits Endothelial Cell Tumor Growth via MicroRNA 21a-3p Targeting of Nox-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dicer; Endothelial Cell; MicroRNA; NADPH Oxidase; Tumor; Hemangioendothelioma; miR-21a-3p; Monocyte Chemoattractant Protein-1	DOWN-REGULATION; WOUND ANGIOGENESIS; OXIDATIVE STRESS; EXPRESSION; HEMANGIOMA; 8-OHDG; THROMBOCYTOPENIA; ASSOCIATION; ANEMIA; DROSHA	Background: Endothelial cell tumors are the most common soft tissue tumor in infants. Results: Dicer knockdown up-regulated miR-21a-3p that targeted nox-4 mRNA preventing endothelial cell tumor formation in vivo. Conclusion: Nox-4 silencing inhibits endothelial cell tumor formation. Dicer knockdown up-regulates miR 21a-3p, which targets the Nox-4 3-UTR. Significance: Novel drivers of endothelial cell tumor formation are reported. MicroRNAs (miR) are emerging as biomarkers and potential therapeutic targets in tumor management. Endothelial cell tumors are the most common soft tissue tumors in infants, yet little is known about the significance of miR in regulating their growth. A validated mouse endothelial cell (EOMA) tumor model was used to demonstrate that post-transcriptional gene silencing of dicer, the enzyme that converts pre-miR to mature miR, can prevent tumor formation in vivo. Tumors were formed in eight of eight mice injected with EOMA cells transfected with control shRNA but formed in only four of ten mice injected with EOMA cells transfected with dicer shRNA. Tumors that formed in the dicer shRNA group were significantly smaller than tumors in the control group. This response to dicer knockdown was mediated by up-regulated miR 21a-3p activity targeting the nox-4 3-UTR. EOMA cells were transfected with miR 21a-3p mimic and luciferase reporter plasmids containing either intact nox-4 3-UTR or with mutation of the proposed 3-UTR miR21a-3p binding sites. Mean luciferase activity was decreased by 85% in the intact compared with the site mutated vectors (p < 0.01). Attenuated Nox-4 activity resulted in decreased cellular hydrogen peroxide production and decreased production of oxidant-inducible monocyte chemoattractant protein-1, which we have previously shown to be critically required for endothelial cell tumor formation. These findings provide the first evidence establishing the significance of dicer and microRNA in promoting endothelial cell tumor growth in vivo.	[Gordillo, Gayle M.; Biswas, Ayan] Ohio State Univ, Wexner Med Ctr, Dept Plast Surg, Columbus, OH 43210 USA; [Khanna, Savita; Sinha, Mithun; Roy, Sashwati; Sen, Chandan K.] Ohio State Univ, Wexner Med Ctr, Dept Surg, Columbus, OH 43210 USA; [Gordillo, Gayle M.; Biswas, Ayan; Khanna, Savita; Sinha, Mithun; Roy, Sashwati; Sen, Chandan K.] Ohio State Univ, Wexner Med Ctr, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Pan, Xueliang] Ohio State Univ, Wexner Med Ctr, Ctr Biostat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Gordillo, GM (corresponding author), 915 Olentangy River Rd Ste 2100, Columbus, OH 43212 USA.	gayle.gordillo@osumc.edu	Gordillo, Gayle M/E-3136-2011; Roy, sashwati/E-3990-2011; Sinha, Mithun/N-8172-2019	Sinha, Mithun/0000-0002-9222-1921; Pan, Xueliang/0000-0002-2342-3212	National Institutes of Health [GM095657, DK076566, GM069589, GM077185]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076566, R56DK076566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077185, R01GM095657, R01GM069589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM095657 (to G. M. G.), DK076566 (to S. R.), and GM069589 and GM077185 (to C. K. S.).	Anglesio MS, 2013, J PATHOL, V229, P400, DOI 10.1002/path.4135; Berger SM, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq616; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chamberlain J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005073; Chan YC, 2012, J BIOL CHEM, V287, P41032, DOI 10.1074/jbc.M112.413294; Chan YC, 2012, ARTERIOSCL THROM VAS, V32, P1372, DOI 10.1161/ATVBAHA.112.248583; Chen JQ, 2013, ANAL BIOCHEM, V442, P97, DOI 10.1016/j.ab.2013.07.022; Das A, 2014, J IMMUNOL, V192, P1120, DOI 10.4049/jimmunol.1300613; Dudek H, 2014, MOL THER, V22, P92, DOI 10.1038/mt.2013.233; Fish JE, 2009, SCI SIGNAL, V1, DOI 10.1126/scisignal.252pe1; Fu YB, 2010, AM J NEPHROL, V32, P581, DOI 10.1159/000322105; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; Gordillo G, 2009, ANTIOXID REDOX SIGN, V11, P47, DOI 10.1089/ars.2008.2150; Gordillo G, 2010, ANTIOXID REDOX SIGN, V12, P933, DOI 10.1089/ars.2009.2917; Gordillo GM, 2004, AM J PHYSIOL-CELL PH, V287, pC866, DOI 10.1152/ajpcell.00238.2003; Gordillo GM, 2002, METHOD ENZYMOL, V352, P422; Grelier G, 2009, BRIT J CANCER, V101, P673, DOI 10.1038/sj.bjc.6605193; Haggstrom AN, 2006, PEDIATRICS, V118, P882, DOI 10.1542/peds.2006-0413; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hinkal GW, 2011, BRIT J CANCER, V104, P387, DOI 10.1038/sj.bjc.6606022; HOAK JC, 1971, J LAB CLIN MED, V77, P941; JACOBS AH, 1976, PEDIATRICS, V58, P218; Jakymiw A, 2010, GENE CHROMOSOME CANC, V49, P549, DOI 10.1002/gcc.20765; Kitagawa N, 2013, CANCER SCI, V104, P543, DOI 10.1111/cas.12126; Koscianska E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028548; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Kumarswamy R, 2011, RNA BIOL, V8, P706, DOI 10.4161/rna.8.5.16154; Kuo HW, 2007, MUTAT RES-GEN TOX EN, V631, P62, DOI 10.1016/j.mrgentox.2007.04.009; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma X., 2014, UROL ONCOL, V32, P46; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Mulliken JB, 1988, VASCULAR BIRTHMARKS, P41; Pache JC, 2011, NAT MED, V17, P31, DOI 10.1038/nm0111-31; Paller AS, 2000, J INVEST DERM SYMP P, V5, P83, DOI 10.1046/j.1087-0024.2000.00011.x; Park HA, 2011, STROKE, V42, P2308, DOI 10.1161/STROKEAHA.110.608547; Pesta M, 2010, ANTICANCER RES, V30, P3579; Roy S, 2009, CARDIOVASC RES, V82, P21, DOI 10.1093/cvr/cvp015; Rustandi RR, 2012, ELECTROPHORESIS, V33, P2790, DOI 10.1002/elps.201200095; Sand M, 2010, CANCER INVEST, V28, P649, DOI 10.3109/07357901003630918; Schmittgen TD, 2008, J CELL MOL MED, V12, P1811, DOI 10.1111/j.1582-4934.2008.00483.x; Shilo S, 2008, ARTERIOSCL THROM VAS, V28, P471, DOI 10.1161/ATVBAHA.107.160655; Slack FJ, 2008, NEW ENGL J MED, V359, P2720, DOI 10.1056/NEJMe0808667; Soini Y, 2011, INT J CLIN EXP PATHO, V4, P267; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Tan LP, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp715; Taulli R, 2009, J CLIN INVEST, V119, P2366, DOI 10.1172/JCI38075; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; WARNER ED, 1971, ARCH PATHOL, V91, P523; Yano T, 2009, LUNG CANCER, V63, P111, DOI 10.1016/j.lungcan.2008.04.014; Yu H., 2011, PLOS ONE, V6; Ziech D, 2011, MUTAT RES-FUND MOL M, V711, P167, DOI 10.1016/j.mrfmmm.2011.02.015	54	35	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9027	9038		10.1074/jbc.M113.519264	http://dx.doi.org/10.1074/jbc.M113.519264			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24497637	Green Published, hybrid			2022-12-28	WOS:000333472100024
J	Alam, MS; Getz, M; Yi, S; Kurkewich, J; Safeukui, I; Haldar, K				Alam, Md. Suhail; Getz, Michelle; Yi, Sue; Kurkewich, Jeffrey; Safeukui, Innocent; Haldar, Kasturi			Plasma Signature of Neurological Disease in the Monogenetic Disorder Niemann-Pick Type C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biomarkers; Genetic Diseases; Inflammation; Neurodegeneration; Neuroinflammation; Cathepsin S; Lysozyme	LYSOSOMAL STORAGE DISEASE; CHOLESTEROL ACCUMULATION; EVERY ORGAN; MOUSE MODEL; CATHEPSIN-D; CELL-DEATH; EXPRESSION; MICE; OXYSTEROLS; NEUROINFLAMMATION	Background: Neurodegenerative diseases are associated with inflammation in the brain and other organs. Results: In murine Niemann-Pick Type C, cathepsin S was elevated and a plasma marker of liver inflammation. Lysozyme was an inflammatory plasma marker derived from both liver and brain. Conclusion: Their dual analysis suggested four distinct severity states of neurodegeneration. Significance: Cerebral inflammatory disease may be detectable in plasma. Early diagnosis of neurological disorders would greatly improve their management and treatment. A major hurdle is that inflammatory products of cerebral disease are not easily detected in blood. Inflammation in multiple organs and heterogeneity in disease present additional challenges in distinguishing the extent to which a blood-based marker reflects disease in brain or other afflicted organs. Murine models of the monogenetic disorder Niemann-Pick Type C present aggressive forms of cerebral and liver inflammatory disease. Microarray analyses previously revealed age-dependent changes in innate immunity transcripts in the mouse brain. We have now validated four putative secretory inflammatory markers that are also elevated in mouse liver. We include limited, first time analysis of human Niemann-Pick Type C liver and cerebellum. Furthermore, we utilized 2-hydroxypropyl--cyclodextrin (HPCD, an emerging therapeutic) administered intraperitoneally in mice, which abrogates inflammatory pathology in the liver but has limited effect on the brain. By analyzing the corresponding effects on inflammatory plasma proteins, we identified cathepsin S as a lead indicator of liver disease. In contrast, lysozyme was a marker of both brain and liver disease. 2-Hydroxypropyl--cyclodextrin had no effect on transcripts of neuron-specific 24-hydroxylase, and its product 24(S)-hydroxycholesterol was not a useful indicator in mouse plasma. Our data suggest that dual analysis of levels of the inflammatory markers lysozyme and cathepsin S may enable detection of multiple distinct states of neurodegeneration in plasma.	Univ Notre Dame, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA; Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Haldar, K (corresponding author), Univ Notre Dame, Dept Biol Sci, Ctr Rare & Neglected Dis, 103 Galvin Life Sci, Notre Dame, IN 46556 USA.	khaldar@nd.edu	Haldar, Kasturi/C-6685-2014		National Institutes of Health [P01HL078826]; Center for Rare and Neglected Diseases at the University of Notre Dame, Indiana; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078826] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Rare and Neglected Diseases at the University of Notre Dame, Indiana; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01HL078826 (to K. H.). This work was also supported by the Center for Rare and Neglected Diseases at the University of Notre Dame, Indiana.	Alam MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048273; Amritraj A, 2013, J BIOL CHEM, V288, P3136, DOI 10.1074/jbc.M112.412460; Amritraj A, 2009, AM J PATHOL, V175, P2540, DOI 10.2353/ajpath.2009.081096; Beltroy EP, 2005, HEPATOLOGY, V42, P886, DOI 10.1002/hep.20868; Brown AJ, 2009, MOL ASPECTS MED, V30, P111, DOI 10.1016/j.mam.2009.02.005; Cappellano Giuseppe, 2013, Am J Neurodegener Dis, V2, P89; Cluzeau CVM, 2012, HUM MOL GENET, V21, P3632, DOI 10.1093/hmg/dds193; Cologna SM, 2014, J INHERIT METAB DIS, V37, P83, DOI 10.1007/s10545-013-9610-6; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; De Windt A, 2007, DNA CELL BIOL, V26, P665, DOI 10.1089/dna.2006.0570; Garver WS, 2007, AM J MED GENET A, V143A, P1204, DOI 10.1002/ajmg.a.31735; German DC, 2002, NEUROSCIENCE, V109, P437, DOI 10.1016/S0306-4522(01)00517-6; Grammatikakis I, 2009, CLIN EXP OBSTET GYN, V36, P235; Herszenyi L, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-194; Hruz T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-156; Hughes TM, 2013, J ALZHEIMERS DIS, V33, P891, DOI 10.3233/JAD-2012-121585; Imrie J, 2007, J INHERIT METAB DIS, V30, P51, DOI 10.1007/s10545-006-0384-7; Jiang XT, 2011, J LIPID RES, V52, P1435, DOI 10.1194/jlr.D015735; KELLY DA, 1993, J PEDIATR-US, V123, P242, DOI 10.1016/S0022-3476(05)81695-6; Ko DC, 2005, PLOS GENET, V1, P81, DOI 10.1371/journal.pgen.0010007; Leoni V, 2011, CHEM PHYS LIPIDS, V164, P515, DOI 10.1016/j.chemphyslip.2011.04.002; Leto G, 1996, EUR J CLIN CHEM CLIN, V34, P555; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; Liu B, 2008, J LIPID RES, V49, P663, DOI 10.1194/jlr.M700525-JLR200; Liu B, 2010, J LIPID RES, V51, P933, DOI 10.1194/jlr.M000257; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Lopez ME, 2011, J NEUROSCI, V31, P4367, DOI 10.1523/JNEUROSCI.5981-10.2011; Lv BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041813; Maue RA, 2012, HUM MOL GENET, V21, P730, DOI 10.1093/hmg/ddr505; Nakanishi H, 2003, MOL NEUROBIOL, V27, P163, DOI 10.1385/MN:27:2:163; Ohmi K, 2009, P NATL ACAD SCI USA, V106, P8332, DOI 10.1073/pnas.0903223106; Olsen BN, 2012, BBA-BIOMEMBRANES, V1818, P330, DOI 10.1016/j.bbamem.2011.06.014; Parkinson-Lawrence EJ, 2010, PHYSIOLOGY, V25, P102, DOI 10.1152/physiol.00041.2009; Patterson MC, 2012, MOL GENET METAB, V106, P330, DOI 10.1016/j.ymgme.2012.03.012; PILAR A, 2013, MOL NEUROBIOL; Porter FD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001417; Pressey SNR, 2012, NEUROBIOL DIS, V45, P1086, DOI 10.1016/j.nbd.2011.12.027; Ramirez CM, 2011, J LIPID RES, V52, P688, DOI 10.1194/jlr.M013789; Ramirez CM, 2010, PEDIATR RES, V68, P309, DOI 10.1203/00006450-201011001-00604; Reddy JV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000019; Repa JJ, 2007, J NEUROSCI, V27, P14470, DOI 10.1523/JNEUROSCI.4823-07.2007; Rimkunas VM, 2008, HEPATOLOGY, V47, P1504, DOI 10.1002/hep.22327; Sagiv Y, 2006, J IMMUNOL, V177, P26, DOI 10.4049/jimmunol.177.1.26; Sayre NL, 2010, J LIPID RES, V51, P2372, DOI 10.1194/jlr.M007211; Schrantz N, 2007, J EXP MED, V204, P841, DOI 10.1084/jem.20061562; Smith D, 2009, NEUROBIOL DIS, V36, P242, DOI 10.1016/j.nbd.2009.07.010; Taylor AM, 2012, J LIPID RES, V53, P2331, DOI 10.1194/jlr.M028241; Trexler AJ, 2007, CURR PROTEIN PEPT SC, V8, P537, DOI 10.2174/138920307783018659; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; Vazquez MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028777; Vieira MNN, 2007, J NEUROCHEM, V103, P736, DOI 10.1111/j.1471-4159.2007.04809.x; Vitner EB, 2010, HUM MOL GENET, V19, P3583, DOI 10.1093/hmg/ddq273; Vitner EB, 2010, J BIOL CHEM, V285, P20423, DOI 10.1074/jbc.R110.134452; Wilms H, 2007, CURR PHARM DESIGN, V13, P1925; Yerushalmi B, 2002, J PEDIATR GASTR NUTR, V35, P44, DOI 10.1097/00005176-200207000-00011; Yu T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003462	57	24	24	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8051	8066		10.1074/jbc.M113.526392	http://dx.doi.org/10.1074/jbc.M113.526392			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24488491	Green Published, hybrid			2022-12-28	WOS:000333157500005
J	Duan, MR; Smerdon, MJ				Duan, Ming-Rui; Smerdon, Michael J.			Histone H3 Lysine 14 (H3K14) Acetylation Facilitates DNA Repair in a Positioned Nucleosome by Stabilizing the Binding of the Chromatin Remodeler RSC (Remodels Structure of Chromatin)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Histone Modification; Chromatin Remodeling; DNA Damage; DNA Repair; Nucleosome; UV Photolyase; Ultraviolet Radiation	NUCLEOTIDE EXCISION-REPAIR; STRAND BREAK REPAIR; CYCLOBUTANE PYRIMIDINE DIMERS; SACCHAROMYCES-CEREVISIAE; UV LESIONS; COMPLEX; ACCESSIBILITY; DAMAGE; PHOTOLYASE; YEAST	Background: Histone H3K14 acetylation is induced by UV damage. Results: Nucleosomes with acetylated H3K14 show greater CPD repair than unacetylated nucleosomes in the presence of the chromatin remodeling complex RSC. Conclusion: H3K14ac acts as a docking site to retain RSC on nucleosomes and facilitate DNA repair. Significance: DNA repair is accelerated by an orchestrated action between UV-induced histone acetylation and chromatin remodeling. Histone H3 acetylation is induced by UV damage in yeast and may play an important role in regulating the repair of UV photolesions in nucleosome-loaded genomic loci. However, it remains elusive how H3 acetylation facilitates repair. We generated a strongly positioned nucleosome containing homogeneously acetylated H3 at Lys-14 (H3K14ac) and investigated possible mechanisms by which H3K14 acetylation modulates repair. We show that H3K14ac does not alter nucleosome unfolding dynamics or enhance the repair of UV-induced cyclobutane pyrimidine dimers by UV photolyase. Importantly, however, nucleosomes with H3K14ac have a higher affinity for purified chromatin remodeling complex RSC (Remodels the Structure of Chromatin) and show greater cyclobutane pyrimidine dimer repair compared with unacetylated nucleosomes. Our study indicates that, by anchoring RSC, H3K14 acetylation plays an important role in the unfolding of strongly positioned nucleosomes during repair of UV damage.	[Duan, Ming-Rui; Smerdon, Michael J.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA	Washington State University	Smerdon, MJ (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	smerdon@wsu.edu			NIEHS, National Institutes of Health [ES004106]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004106] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by NIEHS, National Institutes of Health Grant ES004106.	Anderson JD, 2001, J MOL BIOL, V307, P977, DOI 10.1006/jmbi.2001.4528; Araujo SJ, 2000, GENE DEV, V14, P349; Beard BC, 2003, P NATL ACAD SCI USA, V100, P7465, DOI 10.1073/pnas.1330328100; BROWN DW, 1993, BIOCHEMISTRY-US, V32, P10527, DOI 10.1021/bi00091a001; Bucceri A, 2006, EMBO J, V25, P3123, DOI 10.1038/sj.emboj.7601196; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Chaban Y, 2008, NAT STRUCT MOL BIOL, V15, P1272, DOI 10.1038/nsmb.1524; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; Chatterjee N, 2011, NUCLEIC ACIDS RES, V39, P8378, DOI 10.1093/nar/gkr535; Cole HA, 2010, J BIOL CHEM, V285, P2876, DOI 10.1074/jbc.M109.073544; Duan MR, 2010, J BIOL CHEM, V285, P26295, DOI 10.1074/jbc.M110.140087; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Fernandez AG, 2007, J MOL BIOL, V371, P649, DOI 10.1016/j.jmb.2007.05.090; Flaus A, 2004, CURR OPIN GENET DEV, V14, P165, DOI 10.1016/j.gde.2004.01.007; Friedberg EC, 2006, DNA REPAIR MUTAGENES, pxxix; Gaillard H, 2003, J BIOL CHEM, V278, P17655, DOI 10.1074/jbc.M300770200; Gong F, 2006, NAT STRUCT MOL BIOL, V13, P902, DOI 10.1038/nsmb1152; Gospodinov A, 2011, MOL CELL BIOL, V31, P4735, DOI 10.1128/MCB.06182-11; Green CM, 2002, EMBO REP, V3, P28, DOI 10.1093/embo-reports/kvf005; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Jiang YJ, 2010, P NATL ACAD SCI USA, V107, P17274, DOI 10.1073/pnas.1008388107; Kasten M, 2004, EMBO J, V23, P1348, DOI 10.1038/sj.emboj.7600143; Kornberg RD, 1999, CURR OPIN GENET DEV, V9, P148, DOI 10.1016/S0959-437X(99)80022-7; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Li SS, 2000, METHODS, V22, P170, DOI 10.1006/meth.2000.1058; Li SS, 1999, NUCLEIC ACIDS RES, V27, P3610, DOI 10.1093/nar/27.17.3610; Lorch Y, 2004, METHOD ENZYMOL, V377, P316; Lorch Y, 1998, CELL, V94, P29, DOI 10.1016/S0092-8674(00)81218-0; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Mees A, 2004, SCIENCE, V306, P1789, DOI 10.1126/science.1101598; Mellor J, 2005, MOL CELL, V19, P147, DOI 10.1016/j.molcel.2005.06.023; Neely KE, 1999, MOL CELL, V4, P649, DOI 10.1016/S1097-2765(00)80216-6; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Ozturk N, 2008, BIOCHEMISTRY-US, V47, P10255, DOI 10.1021/bi801085a; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; Rodriguez Y, 2013, J BIOL CHEM, V288, P13863, DOI 10.1074/jbc.M112.441444; Rubbi CP, 2003, EMBO J, V22, P975, DOI 10.1093/emboj/cdg082; Saha A, 2005, NAT STRUCT MOL BIOL, V12, P747, DOI 10.1038/nsmb973; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Schieferstein U, 1998, EMBO J, V17, P306, DOI 10.1093/emboj/17.1.306; Shim EY, 2007, MOL CELL BIOL, V27, P1602, DOI 10.1128/MCB.01956-06; Shim Y, 2012, ANAL BIOCHEM, V427, P190, DOI 10.1016/j.ab.2012.05.006; Shuck SC, 2008, CELL RES, V18, P64, DOI 10.1038/cr.2008.2; Simon M, 2011, P NATL ACAD SCI USA, V108, P12711, DOI 10.1073/pnas.1106264108; Sinha M, 2009, CELL, V138, P1109, DOI 10.1016/j.cell.2009.07.013; Smerdon MJ, 1991, CURR OPIN CELL BIOL, V3, P422, DOI 10.1016/0955-0674(91)90069-B; SMERDON MJ, 1978, P NATL ACAD SCI USA, V75, P4238, DOI 10.1073/pnas.75.9.4238; SMERDON MJ, 1982, J BIOL CHEM, V257, P13441; Smith CL, 2005, CURR TOP DEV BIOL, V65, P115; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Teng YM, 2002, J MOL BIOL, V316, P489, DOI 10.1006/jmbi.2001.5383; Thoma F, 2005, DNA REPAIR, V4, P855, DOI 10.1016/j.dnarep.2005.04.005; Thoma F, 1999, EMBO J, V18, P6585, DOI 10.1093/emboj/18.23.6585; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Wang Y, 2012, J BIOL CHEM, V287, P4386, DOI 10.1074/jbc.M111.329417; Wellinger RE, 1997, EMBO J, V16, P5046, DOI 10.1093/emboj/16.16.5046; Wittmeyer J, 2004, METHOD ENZYMOL, V377, P322; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Yu YC, 2005, P NATL ACAD SCI USA, V102, P8650, DOI 10.1073/pnas.0501458102; Yudkovsky N, 1999, GENE DEV, V13, P2369, DOI 10.1101/gad.13.18.2369	67	54	57	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8353	8363		10.1074/jbc.M113.540732	http://dx.doi.org/10.1074/jbc.M113.540732			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24515106	Green Published, hybrid			2022-12-28	WOS:000333157500028
J	Pham, TTK; Stinson, B; Thiyagarajan, N; Lizotte-Waniewski, M; Brew, K; Acharya, KR				Pham, Tram T. K.; Stinson, Brittany; Thiyagarajan, Nethaji; Lizotte-Waniewski, Michelle; Brew, Keith; Acharya, K. Ravi			Structures of Complexes of a Metal-independent Glycosyltransferase GT6 from Bacteroides ovatus with UDP-N-Acetylgalactosamine (UDP-GalNAc) and Its Hydrolysis Products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Crystal Structure; Enzyme Mechanisms; Glycosyltransferases; X-ray Crystallography	BLOOD-GROUP-B; GROUP-A; FAMILY; BINDING; GENE; EVOLUTION; SUBSTRATE; MUTANTS; SYSTEM	Background: Bacterial homologues of human blood group synthases (glycosyltransferase family GT6) differ in being metal-independent. Results: The structure has been determined of a GT6 from Bacteroides ovatus in a complex with the substrate UDP-GalNAc. Conclusion: Interactions with the polypeptide replace substrate-metal interactions in metal-dependent mammalian homologues. Significance: Metal independence in GT6 is attainable because the metal acts in substrate binding but not directly in catalysis. Mammalian members of glycosyltransferase family 6 (GT6) of the CAZy database have a GT-A fold containing a conserved Asp-X-Asp (DXD) sequence that binds an essential metal cofactor. Bacteroides ovatus GT6a represents a GT6 clade found in more than 30 Gram-negative bacteria that is similar in sequence to the catalytic domains of mammalian GT6, but has an Asn(95)-Ala-Asn(97) (NXN) sequence substituted for the DXD motif and metal-independent catalytic activity. Co-crystals of a low activity mutant of BoGT6a (E192Q) with UDP-GalNAc contained protein complexes with intact UDP-GalNAc and two forms with hydrolysis products (UDP plus GalNAc) representing an initial closed complex and later open form primed for product release. Two cationic residues near the C terminus of BoGT6a, Lys(231) and Arg(243), interact with the diphosphate moiety of UDP-GalNAc, but only Lys(231) interacts with the UDP product and may function in leaving group stabilization. The amide group of Asn(95), the first Asn of the NXN motif, interacts with the ribose moiety of the substrate. This metal-independent GT6 resembles its metal-dependent homologs in undergoing conformational changes on binding UDP-GalNAc that arise from structuring the C terminus to cover this substrate. It appears that in the GT6 family, the metal cofactor functions specifically in binding the UDP moiety in the donor substrate and transition state, actions that can be efficiently performed by components of the polypeptide chain.	[Pham, Tram T. K.; Thiyagarajan, Nethaji; Acharya, K. Ravi] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Stinson, Brittany; Lizotte-Waniewski, Michelle; Brew, Keith] Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Biomed Sci, Boca Raton, FL 33431 USA	University of Bath; State University System of Florida; Florida Atlantic University	Brew, K (corresponding author), Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Biomed Sci, 777 Glades Rd, Boca Raton, FL 33431 USA.	kbrew@fau.edu; bsskra@bath.ac.uk	Brew, Keith/W-1643-2019	Acharya, K. Ravi/0000-0002-3009-4058	Wellcome Trust [088464]; Biotechnology Center of Ho Chi Minh City, Vietnam; University of Bath; National Science Foundation; National Institutes of Health [AR40994]	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology Center of Ho Chi Minh City, Vietnam; University of Bath; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Wellcome Trust equipment grant (number 088464) (to K. R. A.).; Supported by the Biotechnology Center of Ho Chi Minh City, Vietnam and University of Bath for a postgraduate studentship.; Partly funded by the National Science Foundation GK-12 Program.; Supported by National Institutes of Health Grant AR40994. To whom correspondence may be addressed: Dept. of Biomedical Science, Charles E. Schmidt College of Medicine, Florida Atlantic University, 777 Glades Rd., Boca Raton, FL 33431. Tel.: 561-297-0407; E-mail: kbrew@fau.edu.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alfaro JA, 2008, J BIOL CHEM, V283, P10097, DOI 10.1074/jbc.M708669200; Audry M, 2011, GLYCOBIOLOGY, V21, P716, DOI 10.1093/glycob/cwq189; Boix E, 2001, J BIOL CHEM, V276, P48608, DOI 10.1074/jbc.M108828200; Boix E, 2002, J BIOL CHEM, V277, P28310, DOI 10.1074/jbc.M202631200; Bovin N, 2012, BBA-GEN SUBJECTS, V1820, P1373, DOI 10.1016/j.bbagen.2012.02.005; Breton C, 1998, J BIOCHEM, V123, P1000; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; Brew K, 2010, J BIOL CHEM, V285, P37121, DOI 10.1074/jbc.R110.176248; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Debbink K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002921; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Hosseini-Maaf B, 2007, TRANSFUSION, V47, P864, DOI 10.1111/j.1537-2995.2007.01203.x; Jamaluddin H, 2007, J MOL BIOL, V369, P1270, DOI 10.1016/j.jmb.2007.04.012; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Macher BA, 2008, BBA-GEN SUBJECTS, V1780, P75, DOI 10.1016/j.bbagen.2007.11.003; Pak JE, 2006, J BIOL CHEM, V281, P26693, DOI 10.1074/jbc.M603534200; Pak JE, 2011, J MOL BIOL, V414, P798, DOI 10.1016/j.jmb.2011.10.039; Patenaude SI, 2002, NAT STRUCT BIOL, V9, P685, DOI 10.1038/nsb832; Seto NOL, 1997, J BIOL CHEM, V272, P14133, DOI 10.1074/jbc.272.22.14133; Sun HY, 2007, J BIOL CHEM, V282, P9973, DOI 10.1074/jbc.M610285200; Svensson L, 2013, BLOOD, V121, P1459, DOI 10.1182/blood-2012-10-455055; Thiyagarajan N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00940; Tumbale P, 2008, BIOCHEMISTRY-US, V47, P8711, DOI 10.1021/bi800852a; Tumbale P, 2009, J BIOL CHEM, V284, P25126, DOI 10.1074/jbc.M109.033878; Tumbale P, 2008, GLYCOBIOLOGY, V18, P1036, DOI 10.1093/glycob/cwn083; Turcot-Dubois AL, 2007, GLYCOBIOLOGY, V17, P516, DOI 10.1093/glycob/cwm016; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Xu HJ, 1999, J BIOL CHEM, V274, P29390, DOI 10.1074/jbc.274.41.29390	33	15	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8041	8050		10.1074/jbc.M113.545384	http://dx.doi.org/10.1074/jbc.M113.545384			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24459149	Green Published, hybrid			2022-12-28	WOS:000333157500004
J	Printsev, I; Yen, L; Sweeney, C; Carraway, KL				Printsev, Ignat; Yen, Lily; Sweeney, Colleen; Carraway, Kermit L., III			Oligomerization of the Nrdp1 E3 Ubiquitin Ligase Is Necessary for Efficient Autoubiquitination but Not ErbB3 Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; E3 Ubiquitin Ligase; Receptor Tyrosine Kinase; Signal Transduction; Ubiquitination	GROWTH-FACTOR RECEPTOR; NEGATIVE REGULATOR; TYROSINE KINASE; TRIPARTITE MOTIF; COILED COILS; FAMILY; DEGRADATION; EXPRESSION; CYTOKINE; PROTEINS	Background: Nrdp1 ubiquitinates itself and ErbB3 to facilitate the degradation of both proteins. Result: Coiled-coil domain deletion abrogates Nrdp1 oligomerization and suppresses Nrdp1 but not ErbB3 ubiquitination and degradation. Conclusion: Oligomerization is required for efficient Nrdp1-mediated autoubiquitination but not ErbB3 ubiquitination. Significance: Nrdp1 autoubiquitination and substrate ubiquitination may be functionally separated, allowing a novel treatment strategy for breast cancer patients. Overexpression of the ErbB3 receptor tyrosine kinase protein in breast and other cancers contributes to tumor malignancy and therapeutic resistance. The RBCC/TRIM family RING finger E3 ubiquitin ligase Nrdp1 mediates the ubiquitination of ErbB3 in normal mammary epithelial cells to facilitate receptor degradation and suppress steady-state receptor levels. Post-transcriptional loss of Nrdp1 in patient breast tumors allows ErbB3 overexpression and receptor contribution to tumor progression, and elevated lability through autoubiquitination contributes to the observed loss of Nrdp1 in tumors relative to normal tissue. To begin to understand the mechanisms underlying Nrdp1 protein self-regulation through lability, we investigated the structural determinants required for efficient autoubiquitination and ErbB3 ubiquitination. Using mutagenesis, chemical cross-linking, size exclusion chromatography, and native polyacrylamide gel electrophoresis, we demonstrate that Nrdp1 self-associates into a stable oligomeric complex in cells. Deletion of its coiled-coil domain abrogates oligomerization but does not affect Nrdp1-mediated ErbB3 ubiquitination or degradation. On the other hand, the presence of the coiled-coil domain is necessary for efficient Nrdp1 autoubiquitination via a trans mechanism, indicating that Nrdp1 ubiquitination of its various targets is functionally separable. Finally, a GFP fusion of the coiled-coil domain stabilizes Nrdp1 and potentiates ErbB3 ubiquitination and degradation. These observations point to a model whereby the coiled-coil domain plays a key role in regulating Nrdp1 lability by promoting its assembly into an oligomeric complex, and raise the possibility that inhibition of ligase oligomerization via its coiled-coil domain could be of therapeutic benefit to breast cancer patients by restoring Nrdp1 protein.	Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Carraway, Kermit L., III] Univ Calif Davis, Ctr Comprehens Canc, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Carraway, KL (corresponding author), Univ Calif Davis, Ctr Comprehens Canc, Res Bldg 3,Rm 1100B,4645 2nd Ave, Sacramento, CA 95817 USA.	klcarraway@ucdavis.edu			National Institutes of Health [CA123541, GM068994, CA118384, CA167746]; NATIONAL CANCER INSTITUTE [R01CA118384, P30CA093373, R01CA123541, F31CA165546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA123541 and GM068994 (to K. L. C.) and CA118384 (to C. S.).; Supported by National Institutes of Health Predoctoral Fellowship CA167746.	Amin DN, 2010, SEMIN CELL DEV BIOL, V21, P944, DOI 10.1016/j.semcdb.2010.08.007; Apostolovic B, 2010, CHEM SOC REV, V39, P3541, DOI 10.1039/b914339b; Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Bouyain S, 2007, PROTEIN SCI, V16, P654, DOI 10.1110/ps.062700307; Cambiaghi V, 2012, ADV EXP MED BIOL, V770, P77; Cammas F, 2012, ADV EXP MED BIOL, V770, P59; Cao TY, 1997, J CELL SCI, V110, P1563; Cao ZW, 2007, MOL CELL BIOL, V27, P2180, DOI 10.1128/MCB.01245-06; Carraway KL, 2010, SEMIN CELL DEV BIOL, V21, P936, DOI 10.1016/j.semcdb.2010.09.006; Chen LQ, 2010, CANCER RES, V70, P5994, DOI 10.1158/0008-5472.CAN-09-4440; De Ceuninck L, 2013, J CELL SCI, V126, P3770, DOI 10.1242/jcs.131250; Diamonti AJ, 2002, P NATL ACAD SCI USA, V99, P2866, DOI 10.1073/pnas.052709799; Engelman JA, 2006, CLIN CANCER RES, V12, p4372S, DOI 10.1158/1078-0432.CCR-06-0795; Erickson SL, 1997, DEVELOPMENT, V124, P4999; Fletcher AJ, 2013, CURR TOP MICROBIOL, V371, P29, DOI 10.1007/978-3-642-37765-5_2; Fry WHD, 2011, MOL CELL BIOL, V31, P3009, DOI 10.1128/MCB.05105-11; Fry WHD, 2009, EXP CELL RES, V315, P697, DOI 10.1016/j.yexcr.2008.07.022; Hamburger AW, 2008, J MAMMARY GLAND BIOL, V13, P225, DOI 10.1007/s10911-008-9077-5; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Ingalla EQ, 2010, J BIOL CHEM, V285, P28691, DOI 10.1074/jbc.M110.127977; Jackson-Fisher AJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2198; Jiao QJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027646; Jing X, 2008, EXP HEMATOL, V36, P1110, DOI 10.1016/j.exphem.2008.04.001; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; LEMOINE NR, 1992, BRIT J CANCER, V66, P1116, DOI 10.1038/bjc.1992.420; Marsden HR, 2010, ANGEW CHEM INT EDIT, V49, P2988, DOI 10.1002/anie.200904943; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Miller JK, 2008, CANCER RES, V68, P8286, DOI 10.1158/0008-5472.CAN-07-6316; Napolitano LM, 2012, IUBMB LIFE, V64, P64, DOI 10.1002/iub.580; Napolitano LM, 2011, BIOCHEM J, V434, P309, DOI 10.1042/BJ20101487; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Qiu XB, 2002, P NATL ACAD SCI USA, V99, P14843, DOI 10.1073/pnas.232580999; Qiu XB, 2004, EMBO J, V23, P800, DOI 10.1038/sj.emboj.7600075; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; Stern DF, 2008, J MAMMARY GLAND BIOL, V13, P215, DOI 10.1007/s10911-008-9083-7; Streich FC, 2013, J BIOL CHEM, V288, P8209, DOI 10.1074/jbc.M113.451567; Torok M, 2001, DIFFERENTIATION, V67, P63, DOI 10.1046/j.1432-0436.2001.067003063.x; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wauman J, 2011, J CELL SCI, V124, P921, DOI 10.1242/jcs.078055; Wu XL, 2004, MOL CELL BIOL, V24, P7748, DOI 10.1128/MCB.24.17.7748-7757.2004; Ye S, 2012, J BIOL CHEM, V287, P26740, DOI 10.1074/jbc.M112.383265; Yen L, 2006, CANCER RES, V66, P11279, DOI 10.1158/0008-5472.CAN-06-2319; Yu FR, 2008, NEUROSCI LETT, V440, P4, DOI 10.1016/j.neulet.2008.05.052; Zhang YA, 2011, BASIC RES CARDIOL, V106, P371, DOI 10.1007/s00395-011-0157-0	49	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8570	8578		10.1074/jbc.M113.527036	http://dx.doi.org/10.1074/jbc.M113.527036			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24519943	Green Published, hybrid			2022-12-28	WOS:000333157500047
J	David, M; Machuca-Gayet, I; Kikuta, J; Ottewell, P; Mima, F; Leblanc, R; Bonnelye, E; Ribeiro, J; Holen, I; Vales, RL; Jurdic, P; Chun, J; Clezardin, P; Ishii, M; Peyruchaud, O				David, Marion; Machuca-Gayet, Irma; Kikuta, Junichi; Ottewell, Penelope; Mima, Fuka; Leblanc, Raphael; Bonnelye, Edith; Ribeiro, Johnny; Holen, Ingunn; Lopez Vales, Ruben; Jurdic, Pierre; Chun, Jerold; Clezardin, Philippe; Ishii, Masaru; Peyruchaud, Olivier			Lysophosphatidic Acid Receptor Type 1 (LPA(1)) Plays a Functional Role in Osteoclast Differentiation and Bone Resorption Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; Differentiation; Lysophospholipid; Osteoclast; Osteoporosis; Receptors	PROTEIN-COUPLED RECEPTOR; PARATHYROID-HORMONE; TARGETED DELETION; SEALING ZONE; EXPRESSION; MICE; RESPONSES; GENE; REQUIREMENT; ACTIVATION	Background: Lysophosphatidic acid (LPA) is a bioactive lipid with pleiotropic activities due to activation of six receptors (LPA(1-6)). Results: Genetic deletion and pharmacological blockade of LPA(1) inhibit differentiation and bone degradation activity of osteoclasts. Conclusion: LPA controls bone homeostasis through the activation of LPA(1) expressed by osteoclasts. Significance: LPA(1) is a new therapeutic target of diseases with excess bone degradation. Lysophosphatidic acid (LPA) is a natural bioactive lipid that acts through six different G protein-coupled receptors (LPA(1-6)) with pleiotropic activities on multiple cell types. We have previously demonstrated that LPA is necessary for successful in vitro osteoclastogenesis of bone marrow cells. Bone cells controlling bone remodeling (i.e. osteoblasts, osteoclasts, and osteocytes) express LPA(1), but delineating the role of this receptor in bone remodeling is still pending. Despite Lpar1(-/-) mice displaying a low bone mass phenotype, we demonstrated that bone marrow cell-induced osteoclastogenesis was reduced in Lpar1(-/-) mice but not in Lpar2(-/-) and Lpar3(-/-) animals. Expression of LPA(1) was up-regulated during osteoclastogenesis, and LPA(1) antagonists (Ki16425, Debio0719, and VPC12249) inhibited osteoclast differentiation. Blocking LPA(1) activity with Ki16425 inhibited expression of nuclear factor of activated T-cell cytoplasmic 1 (NFATc1) and dendritic cell-specific transmembrane protein and interfered with the fusion but not the proliferation of osteoclast precursors. Similar to wild type osteoclasts treated with Ki16425, mature Lpar1(-/-) osteoclasts had reduced podosome belt and sealing zone resulting in reduced mineralized matrix resorption. Additionally, LPA(1) expression markedly increased in the bone of ovariectomized mice, which was blocked by bisphosphonate treatment. Conversely, systemic treatment with Debio0719 prevented ovariectomy-induced cancellous bone loss. Moreover, intravital multiphoton microscopy revealed that Debio0719 reduced the retention of CX(3)CR1-EGFP(+) osteoclast precursors in bone by increasing their mobility in the bone marrow cavity. Overall, our results demonstrate that LPA(1) is essential for in vitro and in vivo osteoclast activities. Therefore, LPA(1) emerges as a new target for the treatment of diseases associated with excess bone loss.	[David, Marion; Leblanc, Raphael; Bonnelye, Edith; Ribeiro, Johnny; Clezardin, Philippe; Peyruchaud, Olivier] UCB Lyon 1, INSERM, UMR1033, Fac Med Lyon Est, F-69732 Lyon, France; [Machuca-Gayet, Irma; Jurdic, Pierre] UCB Lyon 1, Equipe Biol Cellulaire & Physiopathol Osseuse, Inst Genom Fonct Lyon, CNRS,UMR5242,ENS, F-69007 Lyon, France; [Kikuta, Junichi; Mima, Fuka; Ishii, Masaru] Osaka Univ, Grad Sch Med & Frontier Biosci, Dept Immunol & Cell Biol, Osaka 5650871, Japan; [Kikuta, Junichi; Mima, Fuka; Ishii, Masaru] Japan Sci & Technol Agcy, CREST, Tokyo 1020076, Japan; [Ottewell, Penelope; Holen, Ingunn] Univ Sheffield, Sch Med, Acad Unit Clin Oncol, Sheffield S10 2RX, S Yorkshire, England; [Lopez Vales, Ruben] Univ Autonoma Barcelona, Fac Med, Unitat Fisiol Med, Grp Neuroplasticitat & Regeneracio, E-08193 Barcelona, Spain; [Chun, Jerold] Scripps Res Inst, Dorris Neurosci Ctr, Dept Mol Biol, La Jolla, CA 92037 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Osaka University; Japan Science & Technology Agency (JST); University of Sheffield; Autonomous University of Barcelona; University of Barcelona; Scripps Research Institute	Peyruchaud, O (corresponding author), Fac Med Lyon Est, INSERM, U1033, Rue Guillaume Paradin, F-69372 Lyon 08, France.	olivier.peyruchaud@inserm.fr	Kikuta, Junichi/HHS-8875-2022; Lopez-Vales, Ruben/E-2150-2011; Clezardin, Philippe/M-8071-2014; Chun, Jerold/Y-4670-2019; Bonnelye, Edith/AAT-9134-2021	Lopez-Vales, Ruben/0000-0001-7615-9550; Clezardin, Philippe/0000-0003-0149-4463; Peyruchaud, Olivier/0000-0002-5393-4945; Leblanc, Raphael/0000-0002-1976-9587; Machuca- Gayet, irma/0000-0002-3010-9774; Holen, Ingunn/0000-0002-8759-6913; Ottewell, Penelope/0000-0002-4826-0771	INSERM; Comite Departemental de la Loire de la Ligue Nationale Contre le Cancer; French Association pour la Recherche sur le Cancer; Ligue Nationale Contre le Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Comite Departemental de la Loire de la Ligue Nationale Contre le Cancer; French Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants from INSERM (to O. P. and P. C.), the Comite Departemental de la Loire de la Ligue Nationale Contre le Cancer (to O. P.), and the French Association pour la Recherche sur le Cancer (to O. P.).; Recipient of a fellowship from the French Association pour la Recherche sur le Cancer.; Recipients of a fellowship from the Ligue Nationale Contre le Cancer.	An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; Boucharaba A, 2004, J CLIN INVEST, V114, P1714, DOI 10.1172/JCI200422123; Boucharaba A, 2006, P NATL ACAD SCI USA, V103, P9643, DOI 10.1073/pnas.0600979103; Boucharaba A, 2009, ONCOL RES, V18, P173, DOI 10.3727/096504009790217399; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Choi KU, 2011, INT J CANCER, V128, P332, DOI 10.1002/ijc.25341; Coleman R, 2011, ANN NY ACAD SCI, V1218, P3, DOI 10.1111/j.1749-6632.2010.05766.x; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Daaka Y, 2002, BBA-MOL CELL BIOL L, V1582, P265, DOI 10.1016/S1388-1981(02)00180-4; David M, 2012, INT J ONCOL, V40, P1133, DOI 10.3892/ijo.2011.1309; David M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009741; DELMAS PD, 1995, BONE, V16, P603, DOI 10.1016/8756-3282(95)00113-R; Duong CQ, 2004, BBA-MOL CELL BIOL L, V1682, P112; Dusaulcy R, 2009, J PHYSIOL BIOCHEM, V65, P345, DOI 10.1007/BF03185929; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; Faccio R, 2003, J CLIN INVEST, V111, P749, DOI 10.1172/JCI200316924; Ferrari SL, 2005, ENDOCRINOLOGY, V146, P1854, DOI 10.1210/en.2004-1282; Fueller M, 2003, CELL SIGNAL, V15, P367, DOI 10.1016/S0898-6568(02)00117-1; Fukushima N, 1998, P NATL ACAD SCI USA, V95, P6151, DOI 10.1073/pnas.95.11.6151; Gennero I, 2011, BONE, V49, P395, DOI 10.1016/j.bone.2011.04.018; Gidley J, 2006, PROSTAG OTH LIPID M, V80, P46, DOI 10.1016/j.prostaglandins.2006.04.001; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Heise CE, 2001, MOL PHARMACOL, V60, P1173, DOI 10.1124/mol.60.6.1173; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Jacobs CR, 2010, ANNU REV BIOMED ENG, V12, P369, DOI 10.1146/annurev-bioeng-070909-105302; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; KALU DN, 1991, BONE MINER, V15, P175, DOI 10.1016/0169-6009(91)90124-I; Karagiosis SA, 2007, BIOCHEM BIOPH RES CO, V357, P194, DOI 10.1016/j.bbrc.2007.03.121; Kingsbury MA, 2003, NAT NEUROSCI, V6, P1292, DOI 10.1038/nn1157; Lapierre DM, 2010, J BIOL CHEM, V285, P25792, DOI 10.1074/jbc.M110.109322; Lattin J, 2007, J LEUKOCYTE BIOL, V82, P16, DOI 10.1189/jlb.0107051; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lin ME, 2012, J BIOL CHEM, V287, P17608, DOI 10.1074/jbc.M111.330183; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; Lin SB, 2010, GASTROENTEROLOGY, V138, P649, DOI 10.1053/j.gastro.2009.09.055; Liu YB, 2010, J CELL BIOCHEM, V109, P794, DOI 10.1002/jcb.22471; Mansell JP, 2011, PROSTAG OTH LIPID M, V95, P45, DOI [10.1016/j.prostaglandins.2011.05.003, 10.1016/j.prostaglandins.2011.05.002]; Marx UC, 2000, BIOCHEM BIOPH RES CO, V267, P213, DOI 10.1006/bbrc.1999.1958; McMichael BK, 2010, J BIOL CHEM, V285, P26641, DOI 10.1074/jbc.M110.119909; Miyabe Y, 2013, ARTHRITIS RHEUM-US, V65, P2037, DOI 10.1002/art.37991; Moolenaar WH, 2000, ANN NY ACAD SCI, V905, P1; Moolenaar WH, 1997, CURR OPIN CELL BIOL, V9, P168, DOI 10.1016/S0955-0674(97)80059-2; Mutoh T, 2012, BRIT J PHARMACOL, V165, P829, DOI 10.1111/j.1476-5381.2011.01622.x; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Nakashima T, 2012, TRENDS ENDOCRIN MET, V23, P582, DOI 10.1016/j.tem.2012.05.005; Noguchi K, 2009, CURR OPIN PHARMACOL, V9, P15, DOI 10.1016/j.coph.2008.11.010; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Onyia JE, 2005, J CELL BIOCHEM, V95, P403, DOI 10.1002/jcb.20438; Ory S, 2008, EUR J CELL BIOL, V87, P469, DOI 10.1016/j.ejcb.2008.03.002; Panchatcharam M, 2008, CIRC RES, V103, P662, DOI 10.1161/CIRCRESAHA.108.180778; Panupinthu N, 2008, J CELL BIOL, V181, P859, DOI 10.1083/jcb.200708037; Peyruchaud O, 2013, BBA-MOL CELL BIOL L, V1831, P99, DOI 10.1016/j.bbalip.2012.06.004; Rissanen JP, 2008, CALCIFIED TISSUE INT, V82, P108, DOI 10.1007/s00223-007-9091-4; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Rogers Michael J., 2003, Current Pharmaceutical Design, V9, P2643, DOI 10.2174/1381612033453640; Sakai N, 2013, FASEB J, V27, P1830, DOI 10.1096/fj.12-219378; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sims SM, 2013, BBA-MOL CELL BIOL L, V1831, P109, DOI 10.1016/j.bbalip.2012.08.001; Spencer JA, 1999, ONCOGENE, V18, P7319, DOI 10.1038/sj.onc.1203121; Sumida H, 2010, BLOOD, V116, P5060, DOI 10.1182/blood-2010-03-272443; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Takeda S, 2001, J BONE MINER METAB, V19, P195, DOI 10.1007/s007740170042; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Wysolmerski JJ, 2012, J CLIN ENDOCR METAB, V97, P2947, DOI 10.1210/jc.2012-2142; Yanagida K, 2009, J BIOL CHEM, V284, P17731, DOI 10.1074/jbc.M808506200; Ye XQ, 2008, BIOL REPROD, V79, P328, DOI 10.1095/biolreprod.108.068783; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Yu SX, 2008, JNCI-J NATL CANCER I, V100, P1630, DOI 10.1093/jnci/djn378; Yung YC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002095; Zhang QH, 1997, MOL BIOL CELL, V8, P1415, DOI 10.1091/mbc.8.8.1415	75	37	41	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6551	6564		10.1074/jbc.M113.533232	http://dx.doi.org/10.1074/jbc.M113.533232			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24429286	Green Published, hybrid			2022-12-28	WOS:000332389400021
J	Luo, J; Baranov, P; Patel, S; Ouyang, H; Quach, J; Wu, F; Qiu, A; Luo, HR; Hicks, C; Zeng, J; Zhu, J; Lu, J; Sfeir, N; Wen, C; Zhang, MX; Reade, V; Patel, S; Sinden, J; Sun, XD; Shaw, P; Young, M; Zhang, K				Luo, Jing; Baranov, Petr; Patel, Sherrina; Ouyang, Hong; Quach, John; Wu, Frances; Qiu, Austin; Luo, Hongrong; Hicks, Caroline; Zeng, Jing; Zhu, Jing; Lu, Jessica; Sfeir, Nicole; Wen, Cindy; Zhang, Meixia; Reade, Victoria; Patel, Sara; Sinden, John; Sun, Xiaodong; Shaw, Peter; Young, Michael; Zhang, Kang			Human Retinal Progenitor Cell Transplantation Preserves Vision	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Eye; Neuroprogenitor Cell; Retinal Degeneration; Stem Cells; Transplantation; Retinal Progenitor Cells	VISUAL FUNCTION; PHOTORECEPTOR DEGENERATION; GEOGRAPHIC ATROPHY; ROYAL-COLLEGE; RCS RATS; RESTORATION; RESCUE; GENERATION; PROTECTION; MODEL	Background: Human retinal progenitor cells (hRPCs) are expandable in vitro and represent a possible therapy for retinal degenerative diseases. Results: In a rat model of retinal degeneration, transplantation of hRPCs preserved photoreceptors and visual function. Conclusion: Subretinal injection of hRPCs rescues photoreceptors without causing adverse effects. Significance: This study provides proof of concept for hRPC transplantation and paves the way for further studies and human trials. Cell transplantation is a potential therapeutic strategy for retinal degenerative diseases involving the loss of photoreceptors. However, it faces challenges to clinical translation due to safety concerns and a limited supply of cells. Human retinal progenitor cells (hRPCs) from fetal neural retina are expandable in vitro and maintain an undifferentiated state. This study aimed to investigate the therapeutic potential of hRPCs transplanted into a Royal College of Surgeons (RCS) rat model of retinal degeneration. At 12 weeks, optokinetic response showed that hRPC-grafted eyes had significantly superior visual acuity compared with vehicle-treated eyes. Histological evaluation of outer nuclear layer (ONL) characteristics such as ONL thickness, spread distance, and cell count demonstrated a significantly greater preservation of the ONL in hRPC-treated eyes compared with both vehicle-treated and control eyes. The transplanted hRPCs arrested visual decline over time in the RCS rat and rescued retinal morphology, demonstrating their potential as a therapy for retinal diseases. We suggest that the preservation of visual acuity was likely achieved through host photoreceptor rescue. We found that hRPC transplantation into the subretinal space of RCS rats was well tolerated, with no adverse effects such as tumor formation noted at 12 weeks after treatment.	[Luo, Jing; Zhang, Kang] Cent S Univ, Xiangya Hosp 2, Dept Ophthalmol, Changsha 410011, Hunan, Peoples R China; [Luo, Jing; Zhang, Kang] Cent S Univ, Int Acad Translat Med, Changsha 410011, Hunan, Peoples R China; [Luo, Jing; Patel, Sherrina; Ouyang, Hong; Quach, John; Wu, Frances; Qiu, Austin; Luo, Hongrong; Zeng, Jing; Zhu, Jing; Lu, Jessica; Sfeir, Nicole; Wen, Cindy; Shaw, Peter; Zhang, Kang] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Luo, Jing; Patel, Sherrina; Ouyang, Hong; Quach, John; Wu, Frances; Qiu, Austin; Luo, Hongrong; Zeng, Jing; Zhu, Jing; Lu, Jessica; Sfeir, Nicole; Wen, Cindy; Shaw, Peter; Zhang, Kang] Univ Calif San Diego, Shiley Eye Ctr, La Jolla, CA 92093 USA; [Baranov, Petr; Young, Michael] Massachusetts Eye & Ear Infirm, Schepens Eye Res Inst, Boston, MA 02114 USA; [Qiu, Austin; Luo, Hongrong; Zhu, Jing; Zhang, Meixia; Patel, Sara; Sinden, John; Zhang, Kang] West China Hosp, Mol Med Res Ctr, Chengdu 610041, Sichuan, Peoples R China; [Hicks, Caroline] ReNeuron Ltd, Guildford GU2 7AF, Surrey, England; [Zeng, Jing] Guangxi Med Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanning 530021, Guangxi, Peoples R China; [Reade, Victoria] Da Vinci Consulting, Los Angeles, CA 90069 USA; [Sun, Xiaodong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200080, Peoples R China; [Sun, Xiaodong] Shanghai Jiao Tong Univ, Eye Res Inst, Shanghai 200080, Peoples R China; [Zhang, Kang] Vet Affairs Healthcare Syst, San Diego, CA 92161 USA	Central South University; Central South University; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; Guangxi Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Sun, XD (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200080, Peoples R China.	xdsun@sjtu.edu.cn; kang.zhang@gmail.com	Quach, John/AAS-9482-2021; Zhang, Kang/Y-2740-2019; luo, hongrong/B-2714-2015	Zhang, Kang/0000-0002-4549-1697; luo, hongrong/0000-0001-7994-1193; Ouyang, Hong/0000-0002-7622-7733; Luo, Jing/0000-0002-8905-9388	973 Program [2013CB967504, 2014CB964900]; Natural Science Foundation of China [81130017, 81276019]; National Institutes of Health Director's Transformative R01 Program [R01 EY021374]; National Institutes of Health, NEI [R01 EY018660, P30 EY022589]; King Abdulaziz City for Science and Technology-University of California San Diego Center of Excellence in Nanomedicine; Macula Vision Research Foundation; Beckman Initiative for Macular Research; Macular Society; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research; ReNeuron Ltd.; NATIONAL EYE INSTITUTE [P30EY022589, R01EY018660, R01EY021374] Funding Source: NIH RePORTER	973 Program(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health Director's Transformative R01 Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); King Abdulaziz City for Science and Technology-University of California San Diego Center of Excellence in Nanomedicine; Macula Vision Research Foundation; Beckman Initiative for Macular Research; Macular Society; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); ReNeuron Ltd.; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the 973 Program (2013CB967504 and 2014CB964900), Natural Science Foundation of China (81130017 and 81276019), National Institutes of Health Director's Transformative R01 Program (Grant R01 EY021374), and National Institutes of Health Grants R01 EY018660 and P30 EY022589 from the NEI. This work was also supported by a grant from the King Abdulaziz City for Science and Technology-University of California San Diego Center of Excellence in Nanomedicine, Macula Vision Research Foundation, Beckman Initiative for Macular Research, Macular Society, the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, and a contract from ReNeuron Ltd.	Aftab U, 2009, EXP EYE RES, V89, P301, DOI 10.1016/j.exer.2009.03.025; Baranov P, 2013, TISSUE ENG PART C-ME, V19, P265, DOI [10.1089/ten.tec.2012.0217, 10.1089/ten.TEC.2012.0217]; Barraud P, 2007, J NEUROSCI RES, V85, P250, DOI 10.1002/jnr.21116; Coffey PJ, 2002, NAT NEUROSCI, V5, P53, DOI 10.1038/nn782; Coles BLK, 2004, P NATL ACAD SCI USA, V101, P15772, DOI 10.1073/pnas.0401596101; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; Du HJ, 2011, SEMIN OPHTHALMOL, V26, P216, DOI 10.3109/08820538.2011.577498; FAKTOROVICH EG, 1990, NATURE, V347, P83, DOI 10.1038/347083a0; Frasson M, 1999, INVEST OPHTH VIS SCI, V40, P2724; Karalija A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041086; Klassen HJ, 2004, INVEST OPHTH VIS SCI, V45, P4167, DOI 10.1167/iovs.04-0511; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Lamba DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008763; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Larsen KB, 2009, INT J DEV NEUROSCI, V27, P485, DOI 10.1016/j.ijdevneu.2009.04.004; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; Lawrence JM, 2004, INVEST OPHTH VIS SCI, V45, P267, DOI 10.1167/iovs.03-0093; Lu B, 2010, INVEST OPHTH VIS SCI, V51, P2269, DOI 10.1167/iovs.09-4526; Lund RD, 2007, STEM CELLS, V25, P602, DOI 10.1634/stemcells.2006-0308; Lund RD, 2006, CLONING STEM CELLS, V8, P189, DOI 10.1089/clo.2006.8.189; Lund RD, 2001, PROG RETIN EYE RES, V20, P415, DOI 10.1016/S1350-9462(01)00003-9; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; McGill TJ, 2004, INVEST OPHTH VIS SCI, V45, P932, DOI 10.1167/iovs.03-0964; Mitton KP, 2000, J BIOL CHEM, V275, P29794, DOI 10.1074/jbc.M003658200; MURAKAMI A, 1992, BIOCHEM BIOPH RES CO, V187, P234, DOI 10.1016/S0006-291X(05)81483-4; Oron-Karni V, 2008, DEVELOPMENT, V135, P4037, DOI 10.1242/dev.028308; Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997; PERRY J, 1995, CURR EYE RES, V14, P585, DOI 10.3109/02713689508998406; Sauve Y, 2004, VISION RES, V44, P9, DOI 10.1016/j.visres.2003.08.015; Seiler MJ, 2010, EUR J NEUROSCI, V31, P508, DOI 10.1111/j.1460-9568.2010.07085.x; Singh MS, 2013, P NATL ACAD SCI USA, V110, P1101, DOI 10.1073/pnas.1119416110; Wang SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009200; Zhang K, 2012, NAT REV DRUG DISCOV, V11, P541, DOI 10.1038/nrd3745; Zhang K, 2011, NEW ENGL J MED, V365, P370, DOI 10.1056/NEJMcibr1105280; Zhang K, 2011, P NATL ACAD SCI USA, V108, P6241, DOI 10.1073/pnas.1018987108	35	77	84	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6362	6371		10.1074/jbc.M113.513713	http://dx.doi.org/10.1074/jbc.M113.513713			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24407289	hybrid, Green Published			2022-12-28	WOS:000332389400005
J	Okayama, S; Kopelovich, L; Balmus, G; Weiss, RS; Herbert, BS; Dannenberg, AJ; Subbaramaiah, K				Okayama, Sachiyo; Kopelovich, Levy; Balmus, Gabriel; Weiss, Robert S.; Herbert, Brittney-Shea; Dannenberg, Andrew J.; Subbaramaiah, Kotha			RETRACTED: p53 Protein Regulates Hsp90 ATPase Activity and Thereby Wnt Signaling by Modulating Aha1 Expression (Retracted article. See vol. 295, pg. 289, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication						-Catenin; Colon Cancer; Hsp90; p53; Wnt Pathway	COLORECTAL-CANCER; DOWN-REGULATION; BETA-CATENIN; ACTIVATION; INHIBITORS; CELLS; CHAPERONES; MUTATIONS; FAMILIES; PATHWAY	Background: The mechanism by which p53, a tumor suppressor gene, regulates Wnt signaling is incompletely understood. Results: p53 modulates Hsp90 ATPase activity via effects on Aha1 leading to changes in the expression of Wnt target genes. Conclusion: p53 regulates Hsp90 ATPase activity and thereby Wnt signaling. Significance: We describe a new mechanism by which p53 affects Wnt signaling. The p53 tumor suppressor gene encodes a homotetrameric transcription factor which is activated in response to a variety of cellular stressors, including DNA damage and oncogene activation. p53 mutations occur in >50% of human cancers. Although p53 has been shown to regulate Wnt signaling, the underlying mechanisms are not well understood. Here we show that silencing p53 in colon cancer cells led to increased expression of Aha1, a co-chaperone of Hsp90. Heat shock factor-1 was important for mediating the changes in Aha1 levels. Increased Aha1 levels were associated with enhanced interactions with Hsp90, resulting in increased Hsp90 ATPase activity. Moreover, increased Hsp90 ATPase activity resulted in increased phosphorylation of Akt and glycogen synthase kinase-3 (GSK3), leading to enhanced expression of Wnt target genes. Significantly, levels of Aha1, Hsp90 ATPase activity, Akt, and GSK3 phosphorylation and expression of Wnt target genes were increased in the colons of p53-null as compared with p53 wild type mice. Using p53 heterozygous mutant epithelial cells from Li-Fraumeni syndrome patients, we show that a monoallelic mutation of p53 was sufficient to activate the Aha1/Hsp90 ATPase axis leading to stimulation of Wnt signaling and increased expression of Wnt target genes. Pharmacologic intervention with CP-31398, a p53 rescue agent, inhibited recruitment of Aha1 to Hsp90 and suppressed Wnt-mediated gene expression in colon cancer cells. Taken together, this study provides new insights into the mechanism by which p53 regulates Wnt signaling and raises the intriguing possibility that p53 status may affect the efficacy of anticancer therapies targeting Hsp90 ATPase.	[Okayama, Sachiyo; Kopelovich, Levy; Dannenberg, Andrew J.; Subbaramaiah, Kotha] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Balmus, Gabriel; Weiss, Robert S.] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA; [Herbert, Brittney-Shea] Indiana Univ Sch Med, Indiana Univ Simon Canc Ctr, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Cornell University; Cornell University; Indiana University System; Indiana University Bloomington	Subbaramaiah, K (corresponding author), Weill Cornell Med Coll, 525 E 68th St,Rm F-203A, New York, NY 10065 USA.	ksubba@med.cornell.edu	Balmus, Gabriel/GZM-2145-2022; Balmus, Gabriel/G-3497-2017	Balmus, Gabriel/0000-0003-2872-4468; Balmus, Gabriel/0000-0003-2872-4468	National Institutes of Health [R01 CA108773]; New York Crohn's Foundation; Tokyo Clinical Surgical Association; NATIONAL CANCER INSTITUTE [R01CA108773] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Crohn's Foundation; Tokyo Clinical Surgical Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA108773. This work was also supported by the New York Crohn's Foundation and the Tokyo Clinical Surgical Association.	ALI JA, 1993, BIOCHEMISTRY-US, V32, P2717, DOI 10.1021/bi00061a033; Anderson EC, 2010, GASTROENTEROLOGY, V139, P718, DOI 10.1053/j.gastro.2010.07.012; Armstrong H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049322; Athar M, 2011, CURR PHARM DESIGN, V17, P631, DOI 10.2174/138161211795222595; Basso AD, 2002, J BIOL CHEM, V277, P39858, DOI 10.1074/jbc.M206322200; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Chen DD, 2011, CIRCULATION, V124; Chen YY, 2013, ONCOTARGET, V4, P816, DOI 10.18632/oncotarget.991; Cox MB, 2011, METHODS MOL BIOL, V787, P45, DOI 10.1007/978-1-61779-295-3_4; DONEHOWER LA, 1995, GENE DEV, V9, P882, DOI 10.1101/gad.9.7.882; Evans DGR, 2002, J MED GENET, V39, P941, DOI 10.1136/jmg.39.12.941; Gaglia G, 2013, P NATL ACAD SCI USA, V110, P15497, DOI 10.1073/pnas.1311126110; Garcia-Carbonero R, 2013, LANCET ONCOL, V14, pE358, DOI 10.1016/S1470-2045(13)70169-4; He HZ, 2006, J MED CHEM, V49, P381, DOI 10.1021/jm0508078; Herbert BS, 2010, ONCOTARGET, V1, P405; Holmes JL, 2008, CANCER RES, V68, P1187, DOI 10.1158/0008-5472.CAN-07-3268; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kim NH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001744; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kurashina R, 2009, CANCER LETT, V284, P62, DOI 10.1016/j.canlet.2009.04.012; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levina E, 2004, ONCOGENE, V23, P4444, DOI 10.1038/sj.onc.1207587; Li J, 2012, BBA-MOL CELL RES, V1823, P624, DOI 10.1016/j.bbamcr.2011.09.003; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3; Maloney A, 2003, CURR CANCER DRUG TAR, V3, P331, DOI 10.2174/1568009033481822; Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053; Mohebati A, 2012, CANCER PREV RES, V5, P593, DOI 10.1158/1940-6207.CAPR-12-0002; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Nakayama M, 2009, J BIOL CHEM, V284, P1612, DOI 10.1074/jbc.M806981200; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Polakis P, 2000, GENE DEV, V14, P1837; Rao CV, 2008, CANCER RES, V68, P7670, DOI 10.1158/0008-5472.CAN-08-1610; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Ruijs MWG, 2010, J MED GENET, V47, P421, DOI 10.1136/jmg.2009.073429; Sadot E, 2001, MOL CELL BIOL, V21, P6768, DOI 10.1128/MCB.21.20.6768-6781.2001; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schneikert J, 2007, GUT, V56, P417, DOI 10.1136/gut.2006.093310; SHAW P, 1992, P NATL ACAD SCI USA, V89, P4495, DOI 10.1073/pnas.89.10.4495; SHAY JW, 1995, MOL CELL BIOL, V15, P425, DOI 10.1128/MCB.15.1.425; Soussi T, 2006, NAT REV CANCER, V6, P83, DOI 10.1038/nrc1783; SRIVASTAVA S, 1990, NATURE, V348, P747, DOI 10.1038/348747a0; Swick L, 2006, J NEUROCHEM, V97, P1447, DOI 10.1111/j.1471-4159.2006.03836.x; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wong P, 2006, GASTROENTEROLOGY, V130, P73, DOI 10.1053/j.gastro.2005.10.014; Zhang H, 2004, J MOL MED, V82, P488, DOI 10.1007/s00109-004-0549-9; Zhao RB, 2000, GENE DEV, V14, P981; Zurawska A, 2010, BBA-MOL CELL RES, V1803, P575, DOI 10.1016/j.bbamcr.2010.03.002	51	30	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6513	6525		10.1074/jbc.M113.532523	http://dx.doi.org/10.1074/jbc.M113.532523			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24451373	hybrid, Green Published			2022-12-28	WOS:000332389400018
J	Romano, M; Buratti, E; Romano, G; Klima, R; Belluz, LD; Stuani, C; Baralle, F; Feiguin, F				Romano, Maurizio; Buratti, Emanuele; Romano, Giulia; Klima, Raffaella; Belluz, Lisa Del Bel; Stuani, Cristiana; Baralle, Francisco; Feiguin, Fabian			Evolutionarily Conserved Heterogeneous Nuclear Ribonucleoprotein (hnRNP) A/B Proteins Functionally Interact with Human and Drosophila TAR DNA-binding Protein 43 (TDP-43)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drosophila; Neuroscience; Retinal Degeneration; RNA Splicing; RNA-binding Proteins; Hrb98DE; Hrp38; TBPH; TDP-43; hnRNP A; B	FRONTOTEMPORAL LOBAR DEGENERATION; MEDIATES NEURODEGENERATION; INTERACTION NETWORK; SPLICING REGULATION; ACID BINDING; RNA TARGETS; RICH DOMAIN; AGGREGATION; EXON-9; MUTATIONS	Background: TDP-43 and hnRNPA1/A2 factors are implicated in neurodegeneration. Results: The human and fruit fly TDP-43 and hnRNPA1/A2 orthologs show physical, genetic, and functional interplays. Conclusion: The functional cooperation between TBPH/Hrp38 and TDP-43/hnRNP A/B is conserved throughout evolution. Significance: TBPH/Hrp38 interplay can be critical for neurodegeneration, and Drosophila is a model suitable to study the impact of this interaction. Human TDP-43 represents the main component of neuronal inclusions found in patients with neurodegenerative diseases, especially frontotemporal lobar degeneration and amyotrophic lateral sclerosis. In vitro and in vivo studies have shown that the TAR DNA-binding protein 43 (TDP-43) Drosophila ortholog (TBPH) can biochemically and functionally overlap the properties of the human factor. The recent direct implication of the human heterogeneous nuclear ribonucleoproteins (hnRNPs) A2B1 and A1, known TDP-43 partners, in the pathogenesis of multisystem proteinopathy and amyotrophic lateral sclerosis supports the hypothesis that the physical and functional interplay between TDP-43 and hnRNP A/B orthologs might play a crucial role in the pathogenesis of neurodegenerative diseases. To test this hypothesis and further validate the fly system as a useful model to study this type of diseases, we have now characterized human TDP-43 and Drosophila TBPH similarity in terms of protein-protein interaction pathways. In this work we show that TDP-43 and TBPH share the ability to associate in vitro with Hrp38/Hrb98DE/CG9983, the fruit fly ortholog of the human hnRNP A1/A2 factors. Interestingly, the protein regions of TDP-43 and Hrp38 responsible for reciprocal interactions are conserved through evolution. Functionally, experiments in HeLa cells demonstrate that TDP-43 is necessary for the inhibitory activity of Hrp38 on splicing. Finally, Drosophila in vivo studies show that Hrp38 deficiency produces locomotive defects and life span shortening in TDP-43 with and without animals. These results suggest that hnRNP protein levels can play a modulatory role on TDP-43 functions.	[Romano, Maurizio; Belluz, Lisa Del Bel] Univ Trieste, Dept Life Sci, I-34127 Trieste, Italy; [Buratti, Emanuele; Romano, Giulia; Klima, Raffaella; Stuani, Cristiana; Baralle, Francisco; Feiguin, Fabian] Int Ctr Genet Engn Biotechnol, I-34149 Trieste, Italy	University of Trieste; International Center for Genetic Engineering & Biotechnology (ICGEB)	Romano, M (corresponding author), Univ Trieste, Dept Life Sci, Via A Valerio 28, I-34127 Trieste, Italy.	mromano@units.it	Romano, Giulia/U-4156-2018; Romano, Maurizio/G-9431-2012; Buratti, Emanuele/K-4691-2016; Feiguin, Fabian/ABC-2514-2020	Romano, Giulia/0000-0003-0356-4947; Romano, Maurizio/0000-0002-4820-2897; Buratti, Emanuele/0000-0002-1356-9074; 	AriSLA (TARMA); AriSLA (ALSMNDTDP-43); Thierry Latran Foundation (REHNPALS); University of Trieste-Finanziamento per Ricercatori di Ateneo	AriSLA (TARMA); AriSLA (ALSMNDTDP-43); Thierry Latran Foundation (REHNPALS); University of Trieste-Finanziamento per Ricercatori di Ateneo	This work was supported by AriSLA (TARMA; to F. B.) and (ALSMNDTDP-43; to F. F.), Thierry Latran Foundation (REHNPALS; to E. B. and F. F.), and University of Trieste-Finanziamento per Ricercatori di Ateneo.	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arrisi-Mercado P, 2004, J BIOL CHEM, V279, P39331, DOI 10.1074/jbc.M405566200; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Baloh RH, 2011, FEBS J, V278, P3539, DOI 10.1111/j.1742-4658.2011.08256.x; Banks GT, 2008, MAMM GENOME, V19, P299, DOI 10.1007/s00335-008-9117-x; Bentmann E, 2012, J BIOL CHEM, V287, P23079, DOI 10.1074/jbc.M111.328757; Bolker J, 2012, NATURE, V491, P31, DOI 10.1038/491031a; Budini M, 2012, BRAIN RES, V1462, P139, DOI 10.1016/j.brainres.2012.02.031; Budini M, 2012, J BIOL CHEM, V287, P7512, DOI 10.1074/jbc.M111.288720; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2004, AM J HUM GENET, V74, P1322, DOI 10.1086/420978; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Buratti E, 2012, TRENDS BIOCHEM SCI, V37, P237, DOI 10.1016/j.tibs.2012.03.003; Cartegni L, 1996, J MOL BIOL, V259, P337, DOI 10.1006/jmbi.1996.0324; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039; Godena VK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017808; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Greenberg SA, 2011, CURR OPIN RHEUMATOL, V23, P574, DOI 10.1097/BOR.0b013e32834b53cc; Hahm B, 1998, FEBS LETT, V425, P401, DOI 10.1016/S0014-5793(98)00269-5; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Ji YBA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1759; Kawahara Y, 2012, P NATL ACAD SCI USA, V109, P3347, DOI 10.1073/pnas.1112427109; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kim JH, 2000, J MOL BIOL, V298, P395, DOI 10.1006/jmbi.2000.3687; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Lehner B, 2004, GENOME RES, V14, P1315, DOI 10.1101/gr.2122004; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; MATUNIS EL, 1992, J CELL BIOL, V116, P257, DOI 10.1083/jcb.116.2.257; MATUNIS MJ, 1992, J CELL BIOL, V116, P245, DOI 10.1083/jcb.116.2.245; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Mikula M, 2006, PROTEOMICS, V6, P2395, DOI 10.1002/pmic.200500632; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Niksic M, 1999, HUM MOL GENET, V8, P2339, DOI 10.1093/hmg/8.13.2339; Oltvai ZN, 2002, SCIENCE, V298, P763, DOI 10.1126/science.1078563; Pagani F, 2000, J BIOL CHEM, V275, P21041, DOI 10.1074/jbc.M910165199; PINOLROMA S, 1988, GENE DEV, V2, P215, DOI 10.1101/gad.2.2.215; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Romano M., 2012, J AMINO ACIDS, V2012; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Shiina Y, 2010, CELL MOL NEUROBIOL, V30, P641, DOI 10.1007/s10571-009-9489-9; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106; Zu K, 1996, MOL BIOL CELL, V7, P1059, DOI 10.1091/mbc.7.7.1059	61	32	33	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7121	7130		10.1074/jbc.M114.548859	http://dx.doi.org/10.1074/jbc.M114.548859			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24492607	Green Published, hybrid			2022-12-28	WOS:000332389400071
J	Berko, D; Herkon, O; Braunstein, I; Isakov, E; David, Y; Ziv, T; Navon, A; Stanhill, A				Berko, Dikla; Herkon, Ora; Braunstein, Ilana; Isakov, Elada; David, Yael; Ziv, Tamar; Navon, Ami; Stanhill, Ariel			Inherent Asymmetry in the 26S Proteasome Is Defined by the Ubiquitin Receptor RPN13	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Proteasome; Protein Complexes; Protein Degradation; Proteolytic Enzymes; Ubiquitin; S5a; Ubiquitin Receptor; rpn13; Stoichiometry	REGULATORY PARTICLE; 20S PROTEASOME; ABSOLUTE QUANTIFICATION; DEUBIQUITINATING ENZYME; TRANSCRIPTION FACTOR; SUBUNIT; PROTEINS; BINDING; ARCHITECTURE; RECOGNITION	Background: The double-capped 26S proteasome complex is viewed as a symmetrical particle. Results: The ubiquitin receptor subunit Rpn13 is found in an asymmetrical ratio. Conclusion: Rpn13 ubiquitin receptor may dictate preference in substrate recruitment and processing. Significance: The ubiquitin receptor Rpn13 defines asymmetry and thus imposes directionality in the 26S proteasome. The 26S double-capped proteasome is assembled in a hierarchic event that is orchestrated by dedicated set of chaperons. To date, all stoichiometric subunits are considered to be present in equal ratios, thus providing symmetry to the double-capped complex. Here, we show that although the vast majority (if not all) of the double-capped 26S proteasomes, both 19S complexes, contain the ubiquitin receptor Rpn10/S5a, only one of these 19S particles contains the additional ubiquitin receptor Rpn13, thereby defining asymmetry in the 26S proteasome. These results were validated in yeast and mammals, utilizing biochemical and unbiased AQUA-MS methodologies. Thus, the double-capped 26S proteasomes are asymmetric in their polyubiquitin binding capacity. Our data point to a potential new role for ubiquitin receptors as directionality factors that may participate in the prevention of simultaneous substrates translocation into the 20S from both 19S caps.	[Berko, Dikla; Herkon, Ora; Braunstein, Ilana; Isakov, Elada; Stanhill, Ariel] Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Dept Biochem, IL-31096 Haifa, Israel; [Berko, Dikla; David, Yael; Navon, Ami] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Ziv, Tamar] Technion Israel Inst Technol, Smoler Prote Ctr, IL-32000 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Weizmann Institute of Science; Technion Israel Institute of Technology	Stanhill, A (corresponding author), Technion Israel Inst Technol, Rappaport Family Inst Res Med Sci, Dept Biochem, IL-31096 Haifa, Israel.	ami.navon@weizmann.ac.il; stanhill@tx.technion.ac.il		Ziv, Tamar/0000-0003-4299-7454; stanhill, ariel/0000-0002-0318-2212	Israel Science Foundation [ISF 497/08]; Minerva Foundation (Munich, Germany); German-Israeli Foundation for Scientific Research and Development; Technion-Israel Institute of Technology	Israel Science Foundation(Israel Science Foundation); Minerva Foundation (Munich, Germany); German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Technion-Israel Institute of Technology	An incumbent of the Recanati career development chair of cancer research and supported by the Israel Science Foundation, the Minerva Foundation (Munich, Germany), the German-Israeli Foundation for Scientific Research and Development, and a special gift from Rolando Uziel. To whom correspondence may be addressed. Tel.: 972-8-9343719; Fax: 972-8-9344116; E-mail: ami.navon@weizmann.ac.il.; Supported in part by the Israel Science Foundation (ISF 497/08) and the Technion-Israel Institute of Technology. To whom correspondence may be addressed. Tel.: 972-4-8295306; Fax: 972-4-8535245; E-mail: stanhill@tx.technion.ac.il.	AHN JY, 1995, FEBS LETT, V366, P37, DOI 10.1016/0014-5793(95)00492-R; Beck F, 2012, P NATL ACAD SCI USA, V109, P14870, DOI 10.1073/pnas.1213333109; Bohn S, 2010, P NATL ACAD SCI USA, V107, P20992, DOI 10.1073/pnas.1015530107; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Kirkpatrick DS, 2005, METHODS, V35, P265, DOI 10.1016/j.ymeth.2004.08.018; Kleijnen MF, 2007, NAT STRUCT MOL BIOL, V14, P1180, DOI 10.1038/nsmb1335; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kusmierczyk AR, 2011, NAT STRUCT MOL BIOL, V18, P622, DOI 10.1038/nsmb.2027; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lin YL, 2011, PLANT CELL, V23, P2754, DOI 10.1105/tpc.111.086702; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Nickell S, 2009, P NATL ACAD SCI USA, V106, P11943, DOI 10.1073/pnas.0905081106; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Sakata E, 2012, P NATL ACAD SCI USA, V109, P1479, DOI 10.1073/pnas.1119394109; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021; Zhang NX, 2009, MOL CELL, V35, P280, DOI 10.1016/j.molcel.2009.06.010	39	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5609	5618		10.1074/jbc.M113.509380	http://dx.doi.org/10.1074/jbc.M113.509380			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24429290	Green Published, hybrid			2022-12-28	WOS:000332015500025
J	Stahlschmidt, W; Robertson, MJ; Robinson, PJ; McCluskey, A; Haucke, V				Stahlschmidt, Wiebke; Robertson, Mark J.; Robinson, Phillip J.; McCluskey, Adam; Haucke, Volker			Clathrin Terminal Domain- Ligand Interactions Regulate Sorting of Mannose 6-Phosphate Receptors Mediated by AP-1 and GGA Adaptors*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Endosomes; Lysosomes; Membrane Trafficking; Molecular Cell Biology; Protein Sorting	GOLGI; TRAFFICKING; COMPLEX; DYNAMIN; UBIQUITINATION; INACTIVATION; DIVERSITY; ENDOSOMES; MECHANISM; PROTEINS	Background: Clathrin is a coat protein involved in intracellular membrane traffic. Results: Acute inhibition of clathrin-ligand association by Pitstop (R) compounds perturbs intracellular receptor sorting mediated by AP-1 and GGA adaptors. Conclusion: Clathrin is required for intracellular receptor sorting by AP-1 and GGA adaptor proteins. Significance: Pitstop (R) compounds are tools for the functional dissection of intracellular trafficking pathways. Clathrin plays important roles in intracellular membrane traffic including endocytosis of plasma membrane proteins and receptors and protein sorting between the trans-Golgi network (TGN) and endosomes. Whether clathrin serves additional roles in receptor recycling, degradative sorting, or constitutive secretion has remained somewhat controversial. Here we have used acute pharmacological perturbation of clathrin terminal domain (TD) function to dissect the role of clathrin in intracellular membrane traffic. We report that internalization of major histocompatibility complex I (MHCI) is inhibited in cells depleted of clathrin or its major clathrin adaptor complex 2 (AP-2), a phenotype mimicked by application of Pitstop (R) inhibitors of clathrin TD function. Hence, MHCI endocytosis occurs via a clathrin/AP-2-dependent pathway. Acute perturbation of clathrin also impairs the dynamics of intracellular clathrin/adaptor complex 1 (AP-1)- or GGA (Golgi-localized, -ear-containing, Arf-binding protein)-coated structures at the TGN/endosomal interface, resulting in the peripheral dispersion of mannose 6-phosphate receptors. By contrast, secretory traffic of vesicular stomatitis virus G protein, recycling of internalized transferrin from endosomes, or degradation of EGF receptor proceeds unperturbed in cells with impaired clathrin TD function. These data indicate that clathrin is required for the function of AP-1- and GGA-coated carriers at the TGN but may be dispensable for outward traffic en route to the plasma membrane.	[Stahlschmidt, Wiebke; Haucke, Volker] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Robertson, Mark J.; McCluskey, Adam] Univ Newcastle, Ctr Chem Biol, Callaghan, NSW 2308, Australia; [Robinson, Phillip J.] Univ Sydney, Childrens Med Res Inst, Cell Signalling Unit, Sydney, NSW 2145, Australia	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); University of Newcastle; Children's Medical Research Institute - Australia; University of Sydney	Haucke, V (corresponding author), Leibniz Inst Mol Pharmacol, Robert Rossle Str 10, D-13125 Berlin, Germany.	haucke@fmp-berlin.de	Robinson, Phillip J/G-4008-2011; Robertson, Mark/E-9173-2014	Robinson, Phillip J/0000-0002-7878-0313; Robertson, Mark/0000-0002-2140-2717; McCluskey, Adam/0000-0001-7125-863X; Haucke, Volker/0000-0003-3119-6993	Deutsche Forschungsgemeinschaft Grants [FOR 806-HA2686/3-1,3-2, SFB765/B4]; National Health and Medical Research Council	Deutsche Forschungsgemeinschaft Grants(German Research Foundation (DFG)); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Deutsche Forschungsgemeinschaft Grants FOR 806-HA2686/3-1,3-2 and SFB765/B4 (to V. H.) and grants from the National Health and Medical Research Council. The equipment supported by the Ramaciotti Foundation, the Australian Cancer Research Foundation, and the Cancer Institute NSW (to P. J. R. and A. M.).	Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Anitei M, 2010, NAT CELL BIOL, V12, P330, DOI 10.1038/ncb2034; Bennett EM, 2001, MOL BIOL CELL, V12, P2790, DOI 10.1091/mbc.12.9.2790; Brodsky FM, 2012, ANNU REV CELL DEV BI, V28, P309, DOI 10.1146/annurev-cellbio-101011-155716; Chaineau M, 2013, TRAFFIC, V14, P1109, DOI 10.1111/tra.12096; Cullen PJ, 2012, NAT CELL BIOL, V14, P29, DOI 10.1038/ncb2374; Daboussi L, 2012, NAT CELL BIOL, V14, P239, DOI 10.1038/ncb2427; Dai J, 2004, DEV CELL, V7, P771, DOI 10.1016/j.devcel.2004.10.002; Deborde S, 2008, NATURE, V452, P719, DOI 10.1038/nature06828; Donaldson JG, 2009, CELL SIGNAL, V21, P1, DOI 10.1016/j.cellsig.2008.06.020; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Dutta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045799; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Garrison AR, 2013, VIROLOGY, V444, P45, DOI 10.1016/j.virol.2013.05.030; GEUZE HJ, 1985, J CELL BIOL, V101, P2253, DOI 10.1083/jcb.101.6.2253; Ghosh P, 2003, J BIOL CHEM, V278, P14543, DOI 10.1074/jbc.M212543200; Goto E, 2010, J BIOL CHEM, V285, P35311, DOI 10.1074/jbc.M110.112763; Govero J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030184; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Hirst J, 2012, CURR BIOL, V22, P1711, DOI 10.1016/j.cub.2012.07.012; Huser S, 2013, BIOCHEM J, V450, P73, DOI 10.1042/BJ20121373; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Jovic M, 2009, MOL BIOL CELL, V20, P2731, DOI 10.1091/mbc.E08-11-1102; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Klumperman J, 1998, J CELL BIOL, V141, P359, DOI 10.1083/jcb.141.2.359; Kural C, 2012, CELL REP, V2, P1111, DOI 10.1016/j.celrep.2012.09.025; Larsen JE, 2004, MOL BIOL CELL, V15, P323, DOI 10.1091/mbc.E03-08-0578; Li J, 2007, J CELL BIOL, V178, P453, DOI 10.1083/jcb.200608033; Luo Y, 2013, TRAFFIC, V14, P97, DOI 10.1111/tra.12014; Marks MS, 2013, CURR OPIN CELL BIOL, V25, P495, DOI 10.1016/j.ceb.2013.04.008; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Moskowitz HS, 2003, MOL BIOL CELL, V14, P4437, DOI 10.1091/mbc.e03-04-0230; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Park RJ, 2013, J CELL SCI, V126, P5305, DOI 10.1242/jcs.138578; Polishchuk EV, 2003, MOL BIOL CELL, V14, P4470, DOI 10.1091/mbc.E03-01-0033; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Raiborg C, 2006, J CELL SCI, V119, P2414, DOI 10.1242/jcs.02978; Robinson MS, 2010, DEV CELL, V18, P324, DOI 10.1016/j.devcel.2009.12.015; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Sharma Mahak, 2009, Commun Integr Biol, V2, P431; Stoorvogel W, 1996, J CELL BIOL, V132, P21, DOI 10.1083/jcb.132.1.21; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Traub L. M., 2013, COLD SPRING HARBOR P, V5; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; van Dam EM, 2002, MOL BIOL CELL, V13, P169, DOI 10.1091/mbc.01-07-0380; von Kleist L, 2012, TRAFFIC, V13, P495, DOI 10.1111/j.1600-0854.2011.01292.x; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Waguri S, 2003, MOL BIOL CELL, V14, P142, DOI 10.1091/mbc.E02-06-0338; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Wieffer M, 2009, CELL, V137, DOI 10.1016/j.cell.2009.04.012	56	22	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4906	4918		10.1074/jbc.M113.535211	http://dx.doi.org/10.1074/jbc.M113.535211			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24407285	Green Published, hybrid			2022-12-28	WOS:000331607900037
J	Girotto, S; Cendron, L; Bisaglia, M; Tessari, I; Mammi, S; Zanotti, G; Bubacco, L				Girotto, Stefania; Cendron, Laura; Bisaglia, Marco; Tessari, Isabella; Mammi, Stefano; Zanotti, Giuseppe; Bubacco, Luigi			DJ-1 Is a Copper Chaperone Acting on SOD1 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease); Copper; DJ-1; Metalloproteins; Parkinson Disease; Superoxide Dismutase (SOD); Cys-106	ZINC SUPEROXIDE-DISMUTASE; CYSTEINE-SULFINIC ACID; DISEASE PROTEIN DJ-1; ALCALIGENES-DENITRIFICANS; CRYSTAL-STRUCTURE; BINDING SITE; MUTANT SOD1; FORMS; AZURIN; APO	Background: DJ-1 and SOD1 are proteins involved in Parkinson disease and ALS, respectively. Results: A novel DJ-1 copper binding site is characterized together with its ability to activate SOD1 through copper transfer. Conclusion: We have identified a putative role for DJ-1 as a copper chaperone. Significance: Alterations of the coordination of the copper ion in DJ-1 may affect neurodegenerative etiopathogenesis. Lack of oxidative stress control is a common and often prime feature observed in many neurodegenerative diseases. Both DJ-1 and SOD1, proteins involved in familial Parkinson disease and amyotrophic lateral sclerosis, respectively, play a protective role against oxidative stress. Impaired activity and modified expression of both proteins have been observed in different neurodegenerative diseases. A potential cooperative action of DJ-1 and SOD1 in the same oxidative stress response pathway may be suggested based on a copper-mediated interaction between the two proteins reported here. To investigate the mechanisms underlying the antioxidative function of DJ-1 in relation to SOD1 activity, we investigated the ability of DJ-1 to bind copper ions. We structurally characterized a novel copper binding site involving Cys-106, and we investigated, using different techniques, the kinetics of DJ-1 binding to copper ions. The copper transfer between the two proteins was also examined using both fluorescence spectroscopy and specific biochemical assays for SOD1 activity. The structural and functional analysis of the novel DJ-1 copper binding site led us to identify a putative role for DJ-1 as a copper chaperone. Alteration of the coordination geometry of the copper ion in DJ-1 may be correlated to the physiological role of the protein, to a potential failure in metal transfer to SOD1, and to successive implications in neurodegenerative etiopathogenesis.	[Girotto, Stefania; Mammi, Stefano] Univ Padua, Dept Chem Sci, I-35131 Padua, Italy; [Girotto, Stefania] Ist Italiano Tecnol, Dept Drug Discovery & Dev, I-16163 Genoa, Italy; [Cendron, Laura; Zanotti, Giuseppe] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [Cendron, Laura; Bisaglia, Marco; Tessari, Isabella; Bubacco, Luigi] Univ Padua, Dept Biol, I-35121 Padua, Italy	University of Padua; Istituto Italiano di Tecnologia - IIT; University of Padua; University of Padua	Bubacco, L (corresponding author), Univ Padua, Dept Biol, Via Ugo Bassi 58b, I-35121 Padua, Italy.	luigi.bubacco@unipd.it	Tessari, Isabella/K-7847-2016; Bubacco, Luigi/B-5602-2012	Tessari, Isabella/0000-0002-5823-645X; Bubacco, Luigi/0000-0001-7927-9208; Cendron, Laura/0000-0002-0125-0461; Zanotti, Giuseppe/0000-0002-0945-6501	Italian Ministry of Education, University and Research Grant [PRIN2010-M2JARJ]; University of Padova Grant [PRAT2010-CPDA103503]	Italian Ministry of Education, University and Research Grant; University of Padova Grant	This work was supported by Italian Ministry of Education, University and Research Grant PRIN2010-M2JARJ and University of Padova Grant PRAT2010-CPDA103503.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER EN, 1988, J MOL BIOL, V203, P1071, DOI 10.1016/0022-2836(88)90129-5; Banci L, 1998, BIOCHEMISTRY-US, V37, P11780, DOI 10.1021/bi9803473; Banci L, 2004, BIOCHEMISTRY-US, V43, P3396, DOI 10.1021/bi036042s; Banci L, 2001, J BIOL CHEM, V276, P8415, DOI 10.1074/jbc.M008389200; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Banci L, 2009, HFSP J, V3, P165, DOI 10.2976/1.3078306; Bandopadhyay R, 2004, BRAIN, V127, P420, DOI 10.1093/brain/awh054; Bjorkblom B, 2013, J BIOL CHEM, V288, P22809, DOI 10.1074/jbc.M113.482091; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Brown NM, 2004, P NATL ACAD SCI USA, V101, P5518, DOI 10.1073/pnas.0401175101; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; CARLIOZ A, 1986, EMBO J, V5, P623, DOI 10.1002/j.1460-2075.1986.tb04256.x; Cookson MR, 2010, MOVEMENT DISORD, V25, pS44, DOI 10.1002/mds.22713; Corbett MC, 2007, ACTA CRYSTALLOGR D, V63, P951, DOI 10.1107/S0907444907035160; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; DeSilva TM, 2005, PROTEINS, V61, P1038, DOI 10.1002/prot.20639; DURLEY R, 1993, PROTEIN SCI, V2, P739, DOI 10.1002/pro.5560020506; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FORMAN HJ, 1973, J BIOL CHEM, V248, P2645; Furukawa Y, 2006, ANTIOXID REDOX SIGN, V8, P847, DOI 10.1089/ars.2006.8.847; Girotto S, 2012, J BIOL CHEM, V287, P18738, DOI 10.1074/jbc.M111.311589; Jensen LT, 2005, J BIOL CHEM, V280, P41373, DOI 10.1074/jbc.M509142200; Kahle PJ, 2009, FREE RADICAL BIO MED, V47, P1354, DOI 10.1016/j.freeradbiomed.2009.08.003; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Kirby K, 2008, J BIOL CHEM, V283, P35393, DOI 10.1074/jbc.M807131200; Lacroix JS, 1996, BRIT J PHARMACOL, V118, P2079, DOI 10.1111/j.1476-5381.1996.tb15647.x; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Lev N, 2009, J MOL NEUROSCI, V38, P94, DOI 10.1007/s12031-008-9138-7; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Noor R, 2002, MED SCI MONITOR, V8, P210; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Potter SZ, 2007, J AM CHEM SOC, V129, P4575, DOI 10.1021/ja066690+; Puno MR, 2013, J AM CHEM SOC, V135, P15974, DOI 10.1021/ja406010m; ROSATO N, 1990, BIOPHYS CHEM, V36, P41, DOI 10.1016/0301-4622(90)85005-Q; Schmidt PJ, 1999, J BIOL CHEM, V274, P23719, DOI 10.1074/jbc.274.34.23719; SHEPARD WEB, 1993, ACTA CRYSTALLOGR D, V49, P331, DOI 10.1107/S0907444992013544; SZABO AG, 1983, BIOPHYS J, V41, P233, DOI 10.1016/S0006-3495(83)84433-6; Trempe JF, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00038; Valentine JS, 2005, ANNU REV BIOCHEM, V74, P563, DOI 10.1146/annurev.biochem.72.121801.161647; Wang ZQ, 2011, ANN NEUROL, V70, P591, DOI 10.1002/ana.22514; Waragai M, 2006, BIOCHEM BIOPH RES CO, V345, P967, DOI 10.1016/j.bbrc.2006.05.011; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Witt AC, 2008, BIOCHEMISTRY-US, V47, P7430, DOI 10.1021/bi800282d; Wong PC, 2000, P NATL ACAD SCI USA, V97, P2886, DOI 10.1073/pnas.040461197; Xu XM, 2010, J CELL SCI, V123, P1644, DOI 10.1242/jcs.063222; Yamashita S, 2010, J NEUROCHEM, V113, P860, DOI 10.1111/j.1471-4159.2010.06658.x; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211	54	62	63	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10887	10899		10.1074/jbc.M113.535112	http://dx.doi.org/10.1074/jbc.M113.535112			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24567322	Green Published, hybrid			2022-12-28	WOS:000334226400056
J	Harms, JE; Benveniste, M; Kessler, M; Stone, LM; Arai, AC; Partin, KM				Harms, Jonathan E.; Benveniste, Morris; Kessler, Markus; Stone, Leslie M.; Arai, Amy C.; Partin, Kathryn M.			A Charge-inverting Mutation in the "Linker" Region of alpha- Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid ( AMPA) Receptors Alters Agonist Binding and Gating Kinetics Independently of Allosteric Modulators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Computer Modeling; Electrophysiology; Gating; Glutamate Receptors; Ionotropic (AMPA; NMDA); Glutamate Receptors; Metabotropic; Structural Biology	GLUTAMATE-RECEPTOR; FUNCTIONAL-ANALYSIS; CHANNEL PROPERTIES; LURCHER MUTATION; DESENSITIZATION; CYCLOTHIAZIDE; ACTIVATION; MECHANISM; DEACTIVATION; HIPPOCAMPAL	Background: Ligand-gated ionotropic glutamate receptors conduct current in response to binding of synaptically released neurotransmitter. Results: A point mutation (R628E) of GluA2 alters ligand binding and the processes of channel deactivation and desensitization. Conclusion: Residues within the extracellular vestibule may serve as an intermolecular latch, stabilizing the closed state of the pore. Significance: The extracellular vestibule is a viable target for new positive allosteric modulators. AMPA receptors are gated through binding of glutamate to a solvent-accessible ligand-binding domain. Upon glutamate binding, these receptors undergo a series of conformational rearrangements regulating channel function. Allosteric modulators can bind within a pocket adjacent to the ligand-binding domain to stabilize specific conformations and prevent desensitization. Yelshansky et al. (Yelshansky, M. V., Sobolevsky, A. I., Jatzke, C., and Wollmuth, L. P. (2004) J. Neurosci. 24, 4728-4736) described a model of an electrostatic interaction between the ligand-binding domain and linker region to the pore that regulated channel desensitization. To test this hypothesis, we have conducted a series of experiments focusing on the R628E mutation. Using ultrafast perfusion with voltage clamp, we applied glutamate to outside-out patches pulled from transiently transfected HEK 293 cells expressing wild type or R628E mutant GluA2. In response to a brief pulse of glutamate (1 ms), mutant receptors deactivated with significantly slower kinetics than wild type receptors. In addition, R628E receptors showed significantly more steady-state current in response to a prolonged (500-ms) glutamate application. These changes in receptor kinetics occur through a pathway that is independent of that of allosteric modulators, which show an additive effect on R628E receptors. In addition, ligand binding assays revealed the R628E mutation to have increased affinity for agonist. Finally, we reconciled experimental data with computer simulations that explicitly model mutant and modulator interactions. Our data suggest that R628E stabilizes the receptor closed cleft conformation by reducing agonist dissociation and the transition to the desensitized state. These results suggest that the AMPA receptor external vestibule is a viable target for new positive allosteric modulators.	[Harms, Jonathan E.; Stone, Leslie M.; Partin, Kathryn M.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Benveniste, Morris] Morehouse Sch Med, Neurosci Inst, Atlanta, GA 30310 USA; [Kessler, Markus; Arai, Amy C.] Southern Illinois Univ Sch Med, Dept Pharmacol, Springfield, IL 62794 USA	Colorado State University; Morehouse School of Medicine	Partin, KM (corresponding author), Colorado State Univ, Dept Biomed Sci, 1680 Campus Delivery, Ft Collins, CO 80523 USA.	Kathy.partin@colostate.edu	Partin, Kathryn/A-8706-2015; Partin, Kathryn/AAI-5412-2021	Partin, Kathryn/0000-0003-3801-3299; Partin, Kathryn/0000-0003-3801-3299	National Institutes of Health [R01 MH064700, S11NS055883]; NINDS [U54NS083932]; NIA [SC1AG046907]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [S11NS055883, U54NS083932, U54NS060659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [SC1AG046907] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 MH064700 (to K. M. P.), S11NS055883 and U54NS083932 from the NINDS, and SC1AG046907 from the NIA (to M. B.).	ARAI A, 1995, NEUROSCIENCE, V66, P815, DOI 10.1016/0306-4522(94)00616-D; Arai AC, 2000, MOL PHARMACOL, V58, P802, DOI 10.1124/mol.58.4.802; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Balannik V, 2005, NEURON, V48, P279, DOI 10.1016/j.neuron.2005.09.024; Bedoukian MA, 2006, J BIOL CHEM, V281, P23908, DOI 10.1074/jbc.M600679200; BENVENISTE M, 1990, J PHYSIOL-LONDON, V428, P333, DOI 10.1113/jphysiol.1990.sp018215; CACHELIN AB, 1989, J PHYSIOL-LONDON, V415, P159, DOI 10.1113/jphysiol.1989.sp017717; Cho CH, 2007, NEURON, V55, P890, DOI 10.1016/j.neuron.2007.08.024; Corboy Michael J., 2005, V301, P305; DONEVAN SD, 1993, NEURON, V10, P51, DOI 10.1016/0896-6273(93)90241-I; Dong H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1362; Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Hald H, 2009, J MOL BIOL, V391, P906, DOI 10.1016/j.jmb.2009.07.002; Harms JE, 2013, NEUROPHARMACOLOGY, V64, P45, DOI 10.1016/j.neuropharm.2012.06.008; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2005, J NEUROSCI, V25, P9027, DOI 10.1523/JNEUROSCI.2567-05.2005; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Kessler M, 2006, BRAIN RES, V1076, P25, DOI 10.1016/j.brainres.2005.09.024; Kessler M, 2000, NEUROSCI LETT, V287, P161, DOI 10.1016/S0304-3940(00)01180-0; Klein RM, 2004, J NEUROSCI, V24, P4941, DOI 10.1523/JNEUROSCI.0660-04.2004; Korber C, 2007, J NEUROSCI, V27, P8442, DOI 10.1523/JNEUROSCI.0424-07.2007; Kohda K, 2000, NAT NEUROSCI, V3, P315, DOI 10.1038/73877; Koike M, 2000, J NEUROSCI, V20, P2166; Krampfl K, 2001, J NEUROL SCI, V191, P19, DOI 10.1016/S0022-510X(01)00626-8; Leever JD, 2003, MOL PHARMACOL, V64, P5, DOI 10.1124/mol.64.1.5; Matsubara A, 1996, J NEUROSCI, V16, P4457; Meyer AC, 2009, NAT NEUROSCI, V12, P444, DOI 10.1038/nn.2293; Mitchell NA, 2007, BIOPHYS J, V92, P2392, DOI 10.1529/biophysj.106.095091; Nusser Z, 2000, CURR OPIN NEUROBIOL, V10, P337, DOI 10.1016/S0959-4388(00)00086-6; Partin KM, 1996, MOL PHARMACOL, V49, P142; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; PATNEAU DK, 1992, J NEUROSCI, V12, P595; Plested AJR, 2009, J NEUROSCI, V29, P11912, DOI 10.1523/JNEUROSCI.2971-09.2009; Ptak CP, 2009, BIOCHEMISTRY-US, V48, P8594, DOI 10.1021/bi901127s; PUCHALSKI RB, 1994, NEURON, V13, P131, DOI 10.1016/0896-6273(94)90464-2; Ripellino JA, 1998, NEUROSCIENCE, V82, P485; Robert A, 2005, J NEUROSCI, V25, P3752, DOI 10.1523/JNEUROSCI.0188-05.2005; Robert A, 2003, J NEUROSCI, V23, P847; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Taverna F, 2000, J BIOL CHEM, V275, P8475, DOI 10.1074/jbc.275.12.8475; Timm DE, 2011, MOL PHARMACOL, V80, P267, DOI 10.1124/mol.110.070243; Tomita S, 2006, P NATL ACAD SCI USA, V103, P10064, DOI 10.1073/pnas.0603128103; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Xia YF, 2005, J PHARMACOL EXP THER, V313, P277, DOI 10.1124/jpet.104.078196; Yelshansky MV, 2004, J NEUROSCI, V24, P4728, DOI 10.1523/JNEUROSCI.0757-04.2004; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	51	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10702	10714		10.1074/jbc.M113.526921	http://dx.doi.org/10.1074/jbc.M113.526921			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24550387	Green Published, hybrid			2022-12-28	WOS:000334226400040
J	Byun, MR; Sung, MK; Kim, AR; Lee, CH; Jang, EJ; Jeong, MG; Noh, M; Hwang, ES; Hong, JH				Byun, Mi Ran; Sung, Mi Kyung; Kim, A. Rum; Lee, Cham Han; Jang, Eun Jung; Jeong, Mi Gyeong; Noh, Minsoo; Hwang, Eun Sook; Hong, Jeong-Ho			(-)-Epicatechin Gallate ( ECG) Stimulates Osteoblast Differentiation via Runt- related Transcription Factor 2 ( RUNX2) and Transcriptional Coactivator with PDZ- binding Motif ( TAZ)-mediated Transcriptional Activation*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Differentiation; Mesenchymal Stem Cells; Molecular Cell Biology; Osteoblasts; Pharmacology	EPITHELIAL-MESENCHYMAL TRANSITION; GREEN TEA; HSP27 INDUCTION; BONE-FORMATION; TAZ INTERACTS; HIPPO PATHWAY; DEFECTS; KINASE; GROWTH; CELLS	Background: Catechins in green tea have a beneficial effect in bone formation, but the detailed mechanism is not fully understood. Results: ECG, a major compound of green tea, stimulates TAZ- and RUNX2-mediated osteogenic gene transcription through PP1A. Conclusion: ECG stimulates osteoblast differentiation through a transcriptional activation. Significance: A novel mechanism for green tea-stimulated osteoblast differentiation is revealed. Osteoporosis is a degenerative bone disease characterized by low bone mass and is caused by an imbalance between osteoblastic bone formation and osteoclastic bone resorption. It is known that the bioactive compounds present in green tea increase osteogenic activity and decrease the risk of fracture by improving bone mineral density. However, the detailed mechanism underlying these beneficial effects has yet to be elucidated. In this study, we investigated the osteogenic effect of (-)-epicatechin gallate (ECG), a major bioactive compound found in green tea. We found that ECG effectively stimulates osteoblast differentiation, indicated by the increased expression of osteoblastic marker genes. Up-regulation of osteoblast marker genes is mediated by increased expression and interaction of the transcriptional coactivator with PDZ-binding motif (TAZ) and Runt-related transcription factor 2 (RUNX2). ECG facilitates nuclear localization of TAZ through PP1A. PP1A is essential for osteoblast differentiation because inhibition of PP1A activity was shown to suppress ECG-mediated osteogenic differentiation. Taken together, the results showed that ECG stimulates osteoblast differentiation through the activation of TAZ and RUNX2, revealing a novel mechanism for green tea-stimulated osteoblast differentiation.	[Byun, Mi Ran; Sung, Mi Kyung; Kim, A. Rum; Lee, Cham Han; Hong, Jeong-Ho] Korea Univ, Div Life Sci, Seoul 136701, South Korea; [Jang, Eun Jung; Jeong, Mi Gyeong; Hwang, Eun Sook] Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea; [Jang, Eun Jung; Jeong, Mi Gyeong; Hwang, Eun Sook] Ewha Womans Univ, Global Top5 Res Program, Seoul 120750, South Korea; [Noh, Minsoo] Seoul Natl Univ, Coll Pharm, Seoul 151742, South Korea	Korea University; Ewha Womans University; Ewha Womans University; Seoul National University (SNU)	Hwang, ES (corresponding author), Ewha Womans Univ, Coll Pharm, Seoul 120750, South Korea.	eshwang@ewha.ac.kr; jh_hong@korea.ac.kr		NOH, MINSOO/0000-0002-4020-5372	Korea Healthcare Technology R&D project grant, Ministry for Health and Welfare [A120349, A120476]; Basic Science Research Program Grant through the National Research Foundation of Korea, Republic of Korea [2011-0022926]; Korea University	Korea Healthcare Technology R&D project grant, Ministry for Health and Welfare; Basic Science Research Program Grant through the National Research Foundation of Korea, Republic of Korea; Korea University	This work was supported by the Korea Healthcare Technology R&D project grant, Ministry for Health and Welfare Grants A120349 and A120476, and Basic Science Research Program Grant 2011-0022926 through the National Research Foundation of Korea, Republic of Korea. This work was also supported by a Korea University grant (to M. R. B.).	Acampora D, 1999, DEVELOPMENT, V126, P3795; Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Barry ER, 2013, CURR OPIN CELL BIOL, V25, P247, DOI 10.1016/j.ceb.2012.12.006; Byun MR, 2012, BONE, V50, P364, DOI 10.1016/j.bone.2011.10.035; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Chen CH, 2005, OSTEOPOROSIS INT, V16, P2039, DOI 10.1007/s00198-005-1995-0; Deal C, 2009, NAT CLIN PRACT RHEUM, V5, P20, DOI 10.1038/ncprheum0977; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Greenblatt MB, 2013, ANNU REV CELL DEV BI, V29, P63, DOI 10.1146/annurev-cellbio-101512-122347; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Hayashi K, 2008, LIFE SCI, V82, P1012, DOI 10.1016/j.lfs.2008.02.017; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Islam S, 2000, BIOCHEM BIOPH RES CO, V270, P793, DOI 10.1006/bbrc.2000.2536; Jeong H, 2010, FASEB J, V24, P3310, DOI 10.1096/fj.09-151324; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2005, J CELL BIOCHEM, V95, P445, DOI 10.1002/jcb.20420; Lee JH, 2010, MOL PHARMACOL, V77, P17, DOI 10.1124/mol.109.057877; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Lin RW, 2009, BIOCHEM BIOPH RES CO, V379, P1033, DOI 10.1016/j.bbrc.2009.01.007; Liu CY, 2011, J BIOL CHEM, V286, P5558, DOI 10.1074/jbc.M110.194019; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Murakami M, 2006, BIOCHEM BIOPH RES CO, V339, P533, DOI 10.1016/j.bbrc.2005.10.214; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Nakagawa H, 2002, BIOCHEM BIOPH RES CO, V292, P94, DOI 10.1006/bbrc.2002.6622; Nakashima K, 2003, TRENDS GENET, V19, P458, DOI 10.1016/S0168-9525(03)00176-8; Park KS, 2004, J BIOL CHEM, V279, P17384, DOI 10.1074/jbc.M312569200; Samee N, 2008, AM J PATHOL, V173, P773, DOI 10.2353/ajpath.2008.080243; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Shen CL, 2011, PHARMACOL RES, V64, P155, DOI 10.1016/j.phrs.2011.03.012; Shen CL, 2009, NUTR RES, V29, P437, DOI 10.1016/j.nutres.2009.06.008; SHENOLIKAR S, 1991, ADV SEC MESS PHOSPH, V23, P1; Tokuda H, 2007, J CELL BIOCHEM, V100, P1146, DOI 10.1002/jcb.21104; Trivedi R, 2010, CURR MOL MED, V10, P14, DOI 10.2174/156652410791065372; Vali B, 2007, J NUTR BIOCHEM, V18, P341, DOI 10.1016/j.jnutbio.2006.06.005; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Wei YJ, 2011, OSTEOPOROSIS INT, V22, P1469, DOI 10.1007/s00198-010-1352-9; Wilkie AOM, 2000, NAT GENET, V24, P387, DOI 10.1038/74224; Yamauchi J, 2007, PROSTAG LEUKOTR ESS, V77, P173, DOI 10.1016/j.plefa.2007.09.001; Yang CS, 2000, J NUTR, V130, P2409, DOI 10.1093/jn/130.10.2409; Yang J. Y., 2013, PLOS ONE, V8; Yang XL, 2002, TRENDS MOL MED, V8, P340, DOI 10.1016/S1471-4914(02)02340-7; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200	45	37	38	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9926	9935		10.1074/jbc.M113.522870	http://dx.doi.org/10.1074/jbc.M113.522870			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24515112	Green Published, hybrid			2022-12-28	WOS:000333807000042
J	Heinrich, F; Nanda, H; Goh, HZ; Bachert, C; Losche, M; Linstedt, AD				Heinrich, Frank; Nanda, Hirsh; Goh, Haw Zan; Bachert, Collin; Loesche, Mathias; Linstedt, Adam D.			Myristoylation Restricts Orientation of the GRASP Domain on Membranes and Promotes Membrane Tethering*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fluorescence; Golgi; Membrane Bilayer; Membrane Fusion; Membrane Trafficking; Neutron Scattering	NEUTRON REFLECTOMETRY; GOLGI RIBBON; STACKING; DYNAMICS; BINDING; ANCHOR; GM130; DEPTH; CELL	Background: An unknown mechanism promotes trans interactions by the GRASP homotypic membrane tethers rather than unproductive cis interactions. Results: Neutron reflection shows that the myristoylated GRASP domain has a fixed, upright orientation on the membrane incompatible with cis interactions. Conclusion: Myristoylation restricts the orientation of the protein on the membrane to favor interactions in trans. Significance: Orientation of membrane proteins is functionally significant and may be regulated by myristoylation. The mammalian Golgi reassembly stacking protein (GRASP) proteins are Golgi-localized homotypic membrane tethers that organize Golgi stacks into a long, contiguous ribbon-like structure. It is unknown how GRASPs undergo trans pairing given that cis interactions between the proteins in the plane of the membrane are intrinsically favored. To test the hypothesis that myristoylation of the self-interacting GRASP domain restricts its orientation on the membrane to favor trans pairing, we established an in vitro assay that recapitulates GRASP-dependent membrane tethering and used neutron reflection under similar conditions to determine the orientation of the GRASP domain. In vivo, the membrane association of GRASP proteins is conferred by the simultaneous insertion of an N-terminal myristic acid and binding to a Golgi-associated binding partner. In our assay, the latter contact was replaced using a C-terminal hexa-His moiety, which bound to Ni2+-conjugated lipids incorporated into a substrate-supported bilayer lipid membrane. Nonmyristoylated protein lacked a fixed orientation on the membrane and inefficiently tethered liposomes. In contrast, myristoylated GRASP promoted tethering and exhibited a unique membrane complex. Thus, myristoylation restricts the membrane orientation of the GRASP domain favoring interactions in trans for membrane tethering.	[Heinrich, Frank; Nanda, Hirsh; Goh, Haw Zan; Loesche, Mathias] Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA; [Bachert, Collin; Linstedt, Adam D.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; [Loesche, Mathias] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Heinrich, Frank; Nanda, Hirsh; Loesche, Mathias] Natl Inst Stand & Technol NIST Ctr Neutron Res, Gaithersburg, MD 20899 USA	Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; National Institute of Standards & Technology (NIST) - USA	Losche, M (corresponding author), Carnegie Mellon Univ, Dept Phys, 5000 Forbes Ave, Pittsburgh, PA 15213 USA.	quench@cmu.edu; linstedt@andrew.cmu.edu	Lösche, Mathias/J-2986-2013; Heinrich, Frank/A-5339-2010	Lösche, Mathias/0000-0001-6666-916X; Heinrich, Frank/0000-0002-8579-553X	Carnegie Mellon University Mellon College of Science; National Institutes of Health [R01 GM0095549, R01 GM101647]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095549, R01GM101647] Funding Source: NIH RePORTER	Carnegie Mellon University Mellon College of Science; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from Dr. Fred Gilman, Dean of the Carnegie Mellon University Mellon College of Science to the CMU Membrane Biophysics Group and National Institutes of Health Grants R01 GM0095549 (to A. D. L.) and R01 GM101647 (to M. L.).	Bachert C, 2010, J BIOL CHEM, V285, P16294, DOI 10.1074/jbc.M110.116129; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Berkhout B, 2012, CURR OPIN VIROL, V2, P50, DOI 10.1016/j.coviro.2012.01.002; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; Budvytyte R, 2013, LANGMUIR, V29, P8645, DOI 10.1021/la401132c; Cornell BA, 1997, NATURE, V387, P580, DOI 10.1038/42432; Datta SAK, 2011, J MOL BIOL, V406, P205, DOI 10.1016/j.jmb.2010.11.051; Dura JA, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2219744; Feinstein TN, 2008, MOL BIOL CELL, V19, P2696, DOI 10.1091/mbc.E07-11-1200; Gizeli E, 2004, ANAL CHEM, V76, P3995, DOI 10.1021/ac034855g; Heinrich F, 2009, LANGMUIR, V25, P4219, DOI 10.1021/la8033275; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Jarvela T, 2014, MOL BIOL CELL, V25, P133, DOI 10.1091/mbc.E13-07-0395; Kirby BJ, 2012, CURR OPIN COLLOID IN, V17, P44, DOI 10.1016/j.cocis.2011.11.001; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McGillivray DJ, 2007, BIOINTERPHASES, V2, P21, DOI 10.1116/1.2709308; McGillivray DJ, 2009, BIOPHYS J, V96, P1547, DOI 10.1016/j.bpj.2008.11.020; Nanda H, 2010, BIOPHYS J, V99, P2516, DOI 10.1016/j.bpj.2010.07.062; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Nye JA, 2008, LANGMUIR, V24, P4145, DOI 10.1021/la703788h; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; Pfefferkorn CM, 2012, BIOPHYS J, V102, P613, DOI 10.1016/j.bpj.2011.12.051; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Sengupta D, 2010, J BIOL CHEM, V285, P39994, DOI 10.1074/jbc.M110.189449; Sengupta D, 2009, J CELL BIOL, V186, P41, DOI 10.1083/jcb.200902110; Shekhar P, 2011, J APPL PHYS, V110, DOI 10.1063/1.3661986; Shenoy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032591; Shenoy S, 2010, SOFT MATTER, V6, P1263, DOI 10.1039/b919988h; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; TORQUATO S, 1995, PHYS REV LETT, V74, P2156, DOI 10.1103/PhysRevLett.74.2156; Truschel ST, 2012, J BIOL CHEM, V287, P19870, DOI 10.1074/jbc.M111.326256; Truschel ST, 2011, J BIOL CHEM, V286, P20125, DOI 10.1074/jbc.C111.245324; Valincius G, 2006, J PHYS CHEM B, V110, P10213, DOI 10.1021/jp0616516; Voeltz GK, 2007, NAT REV MOL CELL BIO, V8, P258, DOI 10.1038/nrm2119; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Xiang Y, 2010, J CELL BIOL, V188, P237, DOI 10.1083/jcb.200907132	40	25	25	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9683	9691		10.1074/jbc.M113.543561	http://dx.doi.org/10.1074/jbc.M113.543561			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24505136	Green Published, hybrid			2022-12-28	WOS:000333807000022
J	McNamara, DE; Cascio, D; Jorda, J; Bustos, C; Wang, TC; Rasche, ME; Yeates, TO; Bobik, TA				McNamara, Dan E.; Cascio, Duilio; Jorda, Julien; Bustos, Cheene; Wang, Tzu-Chi; Rasche, Madeline E.; Yeates, Todd O.; Bobik, Thomas A.			Structure of Dihydromethanopterin Reductase, a Cubic Protein Cage for Redox Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Archaea; Flavoproteins; Nanotechnology; Obesity; Pterin; Burkholderia; Dihydromethanopterin Reductase; Methanopterin	METHYLOBACTERIUM-EXTORQUENS AM1; MULTIPLE SEQUENCE ALIGNMENT; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; METHANOBREVIBACTER-SMITHII; METHYLOTROPHIC BACTERIA; BINDING PROTEIN; HUMAN GUT; TETRAHYDROMETHANOPTERIN; DECARBOXYLASE	Background: Dihydromethanopterin reductase catalyzes the final step of methanopterin biosynthesis. Results: The crystal structure is a 24-subunit cubic protein cage with 48 molecules of bound FMN. Conclusion: Analyses indicate a reaction mechanism in which distinct FMNs act as cofactor and electron donor. Significance: The structures illuminate a new mechanism for pterin reduction and reveal an extraordinarily elaborate assembly for electron transfer in the cell. Dihydromethanopterin reductase (Dmr) is a redox enzyme that plays a key role in generating tetrahydromethanopterin (H4MPT) for use in one-carbon metabolism by archaea and some bacteria. DmrB is a bacterial enzyme understood to reduce dihydromethanopterin (H2MPT) to H4MPT using flavins as the source of reducing equivalents, but the mechanistic details have not been elucidated previously. Here we report the crystal structure of DmrB from Burkholderia xenovorans at a resolution of 1.9 . Unexpectedly, the biological unit is a 24-mer composed of eight homotrimers located at the corners of a cubic cage-like structure. Within a homotrimer, each monomer-monomer interface exhibits an active site with two adjacently bound flavin mononucleotide (FMN) ligands, one deeply buried and tightly bound and one more peripheral, for a total of 48 ligands in the biological unit. Computational docking suggested that the peripheral site could bind either the observed FMN (the electron donor for the overall reaction) or the pterin, H2MPT (the electron acceptor for the overall reaction), in configurations ideal for electron transfer to and from the tightly bound FMN. On this basis, we propose that DmrB uses a ping-pong mechanism to transfer reducing equivalents from FMN to the pterin substrate. Sequence comparisons suggested that the catalytic mechanism is conserved among the bacterial homologs of DmrB and partially conserved in archaeal homologs, where an alternate electron donor is likely used. In addition to the mechanistic revelations, the structure of DmrB could help guide the development of anti-obesity drugs based on modification of the ecology of the human gut.	[McNamara, Dan E.; Yeates, Todd O.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Cascio, Duilio; Yeates, Todd O.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Cascio, Duilio; Jorda, Julien; Yeates, Todd O.] Univ Calif Los Angeles, Dept Energy, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Bustos, Cheene; Wang, Tzu-Chi; Rasche, Madeline E.] Calif State Univ Fullerton, Dept Chem & Biochem, Fullerton, CA 92831 USA; [Bobik, Thomas A.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; California State University System; California State University Fullerton; Iowa State University	Bobik, TA (corresponding author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, 2152 Mol Biol Bldg, Ames, IA 50011 USA.	bobik@iastate.edu		McNamara, Dan/0000-0003-0600-7847; Yeates, Todd/0000-0001-5709-9839	U. S. Department of Energy (DOE) [DE-FC02-02ER63421]; National Center for Research Resources [5P41RR015301-10]; National Institutes of Health [8 P41 GM103403-10]; DOE [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	U. S. Department of Energy (DOE)(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Michael Sawaya and members of the Yeates laboratory for valuable discussions and general assistance. Our thanks go to Dan Anderson for assistance with the HPLC, Margaret Condron for assistance with amino acid analysis, Michael Collazo for help with setting crystal trays, and David Leibly for crystallographic data collection. We thank M. Capel, K. Rajashankar, N. Sukumar, J. Schuermann, I. Kourinov, and F. Murphy at NECAT beamline 24-ID of the Argonne National Laboratory Advanced Photon Source (APS). Initial crystallization trials were performed at the UCLA-DOE X-ray Crystallization and Crystallography Core Facilities, which are supported by U. S. Department of Energy (DOE) Grant DE-FC02-02ER63421. X-ray diffraction data were collected at the Argonne National Laboratory APS, which is supported by National Center for Research Resources Grant 5P41RR015301-10, National Institutes of Health Grant 8 P41 GM103403-10, and the DOE under Contract DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Albert A, 2000, STRUCTURE, V8, P961, DOI 10.1016/S0969-2126(00)00187-8; Aliverti A, 1999, METH MOL B, V131, P9; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blaesse M, 2000, EMBO J, V19, P6299, DOI 10.1093/emboj/19.23.6299; Blaesse M, 2003, ACTA CRYSTALLOGR D, V59, P1414, DOI 10.1107/S0907444903011831; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chistoserdova L, 1998, SCIENCE, V281, P99, DOI 10.1126/science.281.5373.99; Chistoserdova L, 2009, ANNU REV MICROBIOL, V63, P477, DOI 10.1146/annurev.micro.091208.073600; Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352; de Crecy-Lagard V, 2012, ACS CHEM BIOL, V7, P1807, DOI 10.1021/cb300342u; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; DIMARCO AA, 1990, ANNU REV BIOCHEM, V59, P355, DOI 10.1146/annurev.biochem.59.1.355; Ding YHR, 2004, J BACTERIOL, V186, P90, DOI 10.1128/JB.186.1.90-97.2004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flenniken ML, 2009, CURR TOP MICROBIOL, V327, P71; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; Hansen EE, 2011, P NATL ACAD SCI USA, V108, P4599, DOI 10.1073/pnas.1000071108; Houtman JCD, 2007, PROTEIN SCI, V16, P30, DOI 10.1110/ps.062558507; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalyuzhnaya MG, 2005, J BACTERIOL, V187, P4607, DOI 10.1128/JB.187.13.4607-4614.2005; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kohli RM, 1998, J BIOL CHEM, V273, P32763, DOI 10.1074/jbc.273.49.32763; Kopec J, 2011, ACTA CRYSTALLOGR F, V67, P1184, DOI 10.1107/S174430911102923X; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kupke T, 2000, J BIOL CHEM, V275, P31838, DOI 10.1074/jbc.M004273200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Maden BEH, 2000, BIOCHEM J, V350, P609, DOI 10.1042/0264-6021:3500609; Manoj N, 2003, ACTA CRYSTALLOGR D, V59, P1762, DOI 10.1107/S0907444903016214; Marx CJ, 2003, J BACTERIOL, V185, P7160, DOI 10.1128/JB.185.23.7160-7168.2003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MOLLERZINKHAN D, 1989, ARCH MICROBIOL, V152, P362, DOI 10.1007/BF00425174; Nissen MS, 2008, J BIOL CHEM, V283, P28710, DOI 10.1074/jbc.M804535200; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Peti W, 2007, PROTEIN EXPRES PURIF, V51, P1, DOI 10.1016/j.pep.2006.06.024; Rangarajan ES, 2004, PROTEIN SCI, V13, P3006, DOI 10.1110/ps.04953004; Rome LH, 2013, ACS NANO, V7, P889, DOI 10.1021/nn3052082; Sambrook J., 2001, MOL CLONING LAB MANU; Samuel BS, 2007, P NATL ACAD SCI USA, V104, P10643, DOI 10.1073/pnas.0704189104; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; Sharma M, 2012, FUTURE MED CHEM, V4, P1335, DOI [10.4155/fmc.12.68, 10.4155/FMC.12.68]; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; SPYROU G, 1991, J BACTERIOL, V173, P3673, DOI 10.1128/JB.173.12.3673-3679.1991; Steinbacher S, 2003, J MOL BIOL, V327, P193, DOI 10.1016/S0022-2836(03)00092-5; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; Vorholt JA, 1999, J BACTERIOL, V181, P5750, DOI 10.1128/JB.181.18.5750-5757.1999; Vorholt JA, 2000, J BACTERIOL, V182, P6645, DOI 10.1128/JB.182.23.6645-6650.2000; Wang SX, 2014, J BACTERIOL, V196, P203, DOI 10.1128/JB.00457-13; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; White RH, 2001, VITAM HORM, V61, P299; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Worsdorfer B, 2011, SCIENCE, V331, P589, DOI 10.1126/science.1199081; Zhou ZM, 1996, BIOCHEMISTRY-US, V35, P15980, DOI 10.1021/bi962124n	62	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8852	8864		10.1074/jbc.M113.522342	http://dx.doi.org/10.1074/jbc.M113.522342			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24523405	Green Published, hybrid			2022-12-28	WOS:000333472100011
J	Park, EY; Kim, BH; Lee, EJ; Chang, E; Kim, DW; Choi, SY; Park, JH				Park, Eun Young; Kim, Bo Hye; Lee, Eun Ji; Chang, EunSun; Kim, Dae Won; Choi, Soo Young; Park, Jong Hoon			Targeting of Receptor for Advanced Glycation End Products Suppresses Cyst Growth in Polycystic Kidney Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adenovirus; Inflammation; Kidney; Proliferation; Receptor for Advanced Glycation End Products (RAGE); Transgenic Mice; Cystic Disease; Cystogenesis	AUTOSOMAL-DOMINANT; DIABETIC-NEPHROPATHY; RAGE; INHIBITION; SIROLIMUS; BLOCKADE; PKD1; MICE; INACTIVATION; PROGRESSION	Background: Receptor of advanced glycation end product (RAGE) mediates not only proinflammatory signaling, but also stimulates cell proliferation and survival-related signaling. Results: Inhibiting RAGE resulted in slowed cyst growth in an autosomal dominant polycystic kidney disease (ADPKD) mouse model and improved renal function. Conclusion: RAGE inhibition is highly effective against cyst enlargement in vivo. Significance: RAGE signaling may play a role in cystogenesis and could be a new therapeutic target for PKD. Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited renal disorder. Although a myriad of research groups have attempted to identify a new therapeutic target for ADPKD, no drug has worked well in clinical trials. Our research group has focused on the receptor for advanced glycation end products (RAGE) gene as a novel target for ADPKD. This gene is involved in inflammation and cell proliferation. We have already confirmed that blocking RAGE function attenuates cyst growth in vitro. Based on this previous investigation, our group examined the effect of RAGE on cyst enlargement in vivo. PC2R mice, a severe ADPKD mouse model that we generated, were utilized. An adenovirus containing anti-RAGE shRNA was injected intravenously into this model. We observed that RAGE gene knockdown resulted in loss of kidney weight and volume. Additionally, the cystic area that originated from different nephron segments decreased in size because of down-regulation of the RAGE gene. Blood urea nitrogen and creatinine values tended to be lower after inhibiting RAGE. Based on these results, we confirmed that the RAGE gene could be an effective target for ADPKD treatment.	[Park, Eun Young; Kim, Bo Hye; Lee, Eun Ji; Chang, EunSun; Park, Jong Hoon] Sookmyung Womens Univ, Dept Biol Sci, Seoul 140742, South Korea; [Kim, Dae Won; Choi, Soo Young] Hallym Univ, Dept Biomed Sci, Chunchon 200702, South Korea; [Kim, Dae Won; Choi, Soo Young] Hallym Univ, Res Inst Biosci & Biotechnol, Chunchon 200702, South Korea	Sookmyung Women's University; Hallym University; Hallym University	Park, JH (corresponding author), Sookmyung Womens Univ, Dept Biol Sci, Seoul 140742, South Korea.	parkjh@sookmyung.ac.kr			Cr analyses agency; Cr official agency	Cr analyses agency; Cr official agency	We thank Dr. Chulho Lee for the BUN and Cr analyses and official agencies for financial support.	Arumugam T, 2004, J BIOL CHEM, V279, P5059, DOI 10.1074/jbc.M310124200; Bello-Reuss E, 2001, KIDNEY INT, V60, P37, DOI 10.1046/j.1523-1755.2001.00768.x; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Bohlender JM, 2005, AM J PHYSIOL-RENAL, V289, pF645, DOI 10.1152/ajprenal.00398.2004; Bukanov NO, 2006, NATURE, V444, P949, DOI 10.1038/nature05348; Busch M, 2010, EUR J CLIN INVEST, V40, P742, DOI 10.1111/j.1365-2362.2010.02317.x; Chapin HC, 2010, J CELL BIOL, V191, P701, DOI 10.1083/jcb.201006173; Chung ACK, 2010, J AM SOC NEPHROL, V21, P249, DOI 10.1681/ASN.2009010018; COHEN MP, 1995, J CLIN INVEST, V95, P2338, DOI 10.1172/JCI117926; Cowley BD, 2001, KIDNEY INT, V60, P2087, DOI 10.1046/j.1523-1755.2001.00065.x; DAgati V, 2010, TRENDS ENDOCRIN MET, V21, P50, DOI 10.1016/j.tem.2009.07.003; Forbes JM, 2005, J AM SOC NEPHROL, V16, P2363, DOI 10.1681/ASN.2005010062; Giannini C, 2012, PEDIATR NEPHROL, V27, P269, DOI 10.1007/s00467-011-1988-5; Guo JC, 2008, J AM SOC NEPHROL, V19, P961, DOI 10.1681/ASN.2007101109; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Ishihara K, 2003, FEBS LETT, V550, P107, DOI 10.1016/S0014-5793(03)00846-9; Kelly DJ, 2001, J AM SOC NEPHROL, V12, P2098, DOI 10.1681/ASN.V12102098; Li XG, 2008, NAT MED, V14, P863, DOI 10.1038/nm1783; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Natoli TA, 2010, NAT MED, V16, P788, DOI 10.1038/nm.2171; Novalic Z, 2012, J AM SOC NEPHROL, V23, P842, DOI 10.1681/ASN.2011040340; Omori S, 2006, J AM SOC NEPHROL, V17, P1604, DOI 10.1681/ASN.2004090800; Park EY, 2010, AM J NEPHROL, V32, P169, DOI 10.1159/000315859; Park EY, 2009, J BIOL CHEM, V284, P7214, DOI 10.1074/jbc.M805890200; Riehl A, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-12; Serra AL, 2010, NEW ENGL J MED, V363, P820, DOI 10.1056/NEJMoa0907419; Shibazaki S, 2008, HUM MOL GENET, V17, P1505, DOI 10.1093/hmg/ddn039; Sourris KC, 2010, DIABETOLOGIA, V53, P2442, DOI 10.1007/s00125-010-1837-2; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Takiar V, 2011, P NATL ACAD SCI USA, V108, P2462, DOI 10.1073/pnas.1011498108; Torres VE, 2007, J INTERN MED, V261, P17, DOI 10.1111/j.1365-2796.2006.01743.x; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; Walz G, 2010, NEW ENGL J MED, V363, P830, DOI 10.1056/NEJMoa1003491; Wei F, 2008, KIDNEY INT, V74, P1310, DOI 10.1038/ki.2008.395; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Xia S, 2010, DEVELOPMENT, V137, P1075, DOI 10.1242/dev.049437; Xu N, 2006, J NEPHROL, V19, P529; Zafar I, 2010, KIDNEY INT, V78, P754, DOI 10.1038/ki.2010.250; Zhu P, 2012, EXP DERMATOL, V21, P123, DOI 10.1111/j.1600-0625.2011.01408.x	40	13	14	4	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9254	9262		10.1074/jbc.M113.514166	http://dx.doi.org/10.1074/jbc.M113.514166			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24515114	Green Published, hybrid			2022-12-28	WOS:000333472100043
J	Thom, R; Rowe, GC; Jang, C; Safdar, A; Arany, Z				Thom, Robyn; Rowe, Glenn C.; Jang, Cholsoon; Safdar, Adeel; Arany, Zoltan			Hypoxic Induction of Vascular Endothelial Growth Factor ( VEGF) and Angiogenesis in Muscle by Truncated Peroxisome Proliferator-activated Receptor gamma Coactivator ( PGC)-1 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Hypoxia; Hypoxia-inducible Factor (HIF); Metabolism; Mitochondria; RNA Splicing; PGC-1; PGC-1alpha	PGC-1-ALPHA; EXPRESSION	Background: Peroxisomal proliferator activator receptor coactivator (PGC)-1 induces both mitochondrial biogenesis and angiogenesis in skeletal muscle. Results: Hypoxic induction of an alternative spliced form of PGC-1 induces only angiogenesis in skeletal muscle, and not mitochondrial biogenesis. Conclusion: Alternative splicing of PGC-1 explains how PGC-1 achieves specific induction of angiogenesis during hypoxia. Significance: The findings suggest novel ways to induce angiogenesis in muscle without simultaneously inducing mitochondrial biogenesis. The transcriptional coactivator peroxisome proliferator-activator receptor coactivator (PGC)-1 is required for full hypoxic induction of vascular endothelial growth factor (VEGF) in skeletal muscle cells. Under normoxic conditions, PGC-1 also strongly induces mitochondrial biogenesis, but PGC-1 does not activate this program under hypoxic conditions. How this specificity is achieved is not known. We show here that hypoxia specifically induces alternatively spliced species encoding for truncated forms of PGC-1: NT-PGC-1 and PGC-14. NT-PGC-1 strongly induces VEGF expression, whereas having little effect on mitochondrial genes. Conditioned medium from cells expressing NT-PGC-1 robustly induces endothelial migration and tube formation, hallmarks of angiogenesis. Transgenic expression of PGC-14 in skeletal muscle in mice induces angiogenesis in vivo. Finally, knockdown of these PGC-1 isoforms and hypoxia-inducible factor-1 (HIF-1) abrogates the induction of VEGF in response to hypoxia. NT-PGC-1 and/or PGC-14 thus confer angiogenic specificity to the PGC-1-mediated hypoxic response in skeletal muscle cells.	Harvard Univ, Sch Med, Cardiovasc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Arany, Z (corresponding author), Beth Israel Deaconess Med Ctr, Cardiovasc Inst, ECLS906,330 Brookline Ave, Boston, MA 02215 USA.	zarany@bidmc.harvard.edu	Thom, Robyn/AAN-2244-2020; Rowe, Glenn/N-5314-2019	Thom, Robyn/0000-0002-8026-6970; Jang, Cholsoon/0000-0001-6651-4213; Rowe, Glenn/0000-0002-8195-9605; Safdar, Adeel/0000-0003-2469-0467	National Institutes of Health through the NIAMS [1K01AR062128]; Banting Fellowship; National Institutes of Health through the NHLBI [HL094499]; American Diabetes Association; Ellison Medical Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR062128] Funding Source: NIH RePORTER	National Institutes of Health through the NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Banting Fellowship; National Institutes of Health through the NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Diabetes Association(American Diabetes Association); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	<SUP>1</SUP> Supported by Grants 1K01AR062128 from the National Institutes of Health through the NIAMS.; <SUP>2</SUP> Supported by a Banting Fellowship.; <SUP>3</SUP> Supported by National Institutes of Health Grant HL094499 through the NHLBI and grants from the American Diabetes Association and the Ellison Medical Foundation. To whom correspondence should be addressed: Cardiovascular Institute at the Beth Israel Deaconess Medical Center, ECLS906, 330 Brookline Ave., Boston MA 02215. Tel.: 617-735-4252; Fax: 617-735-4253; E-mail:zarany@bidmc.harvard.edu.	Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Chang JS, 2010, J BIOL CHEM, V285, P18039, DOI 10.1074/jbc.M109.083121; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; O'Hagan KA, 2009, P NATL ACAD SCI USA, V106, P2188, DOI 10.1073/pnas.0808801106; Patten IS, 2012, NATURE, V485, P333, DOI 10.1038/nature11040; Rowe GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041817; Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Shoag J, ARTERIOSCLER THROMB, V30, P662; Takacs M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067810; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556	15	50	56	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8810	8817		10.1074/jbc.M114.554394	http://dx.doi.org/10.1074/jbc.M114.554394			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24505137	Green Published, hybrid			2022-12-28	WOS:000333472100007
J	Yoon, WJ; Cho, YD; Kim, WJ; Bae, HS; Islam, R; Woo, KM; Baek, JH; Bae, SC; Ryoo, HM				Yoon, Won-Joon; Cho, Young-Dan; Kim, Woo-Jin; Bae, Han-Sol; Islam, Rabia; Woo, Kyung-Mi; Baek, Jeong-Hwa; Bae, Suk-Chul; Ryoo, Hyun-Mo			Prolyl Isomerase Pin1-mediated Conformational Change and Subnuclear Focal Accumulation of Runx2 Are Crucial for Fibroblast Growth Factor 2 ( FGF2)-induced Osteoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Differentiation; Osteoblasts; Protein Conformation; Protein Phosphorylation; Transcription Factors; FGF Signaling; Pin1; Runx2; Acetylation; Subnuclear Accumulation	BONE-FORMATION; FUNCTIONAL-ANALYSIS; OSTEOCALCIN GENE; PROSTATE-CANCER; BETA-CATENIN; PHOSPHORYLATION; KINASE; PIN1; EXPRESSION; ISOMERIZATION	Background: Genetic interaction between Runx2 and Pin1 is critical for embryonic bone formation. Results: Pin1 is a critical modifying enzyme promoting both subnuclear accumulation and protein acetylation of Runx2. Conclusion: Pin1 determines the fate of Runx2 protein in osteoblast differentiation. Significance: The modulation of Pin1 activity may be a clinical target for the regulation of bone formation. Fibroblast growth factor 2 (FGF2) signaling plays a pivotal role in bone growth/differentiation through the activation of osteogenic master transcription factor Runx2, which is mediated by the ERK/MAPK-dependent phosphorylation and the p300-dependent acetylation of Runx2. In this study, we found that Pin1-dependent isomerization of Runx2 is the critical step for FGF2-induced Runx2 transactivation function. We identified four serine or threonine residues in the C-terminal domain of Runx2 that are responsible for Pin1 binding and structural modification. Confocal imaging studies indicated that FGF2 treatment strongly stimulated the focal accumulation of Pin1 in the subnuclear area, which recruited Runx2. In addition, active forms of RNA polymerase-II also colocalized in the same subnuclear compartment. Dipentamethylene thiuram monosulfide, a Pin1 inhibitor, strongly attenuated their focal accumulation as well as Runx2 transactivation activity. The Pin1-mediated structural modification of Runx2 is an indispensable step connecting phosphorylation and acetylation and, consequently, transcriptional activation of Runx2 by FGF signaling. Thus, the modulation of Pin1 activity may be a target for the regulation of bone formation.	[Yoon, Won-Joon; Cho, Young-Dan; Kim, Woo-Jin; Bae, Han-Sol; Islam, Rabia; Woo, Kyung-Mi; Baek, Jeong-Hwa; Ryoo, Hyun-Mo] Seoul Natl Univ, Dept Mol Genet, Sch Dent, Seoul 110749, South Korea; [Yoon, Won-Joon; Cho, Young-Dan; Kim, Woo-Jin; Bae, Han-Sol; Islam, Rabia; Woo, Kyung-Mi; Baek, Jeong-Hwa; Ryoo, Hyun-Mo] Seoul Natl Univ, Dent Res Inst, Seoul 110749, South Korea; [Bae, Suk-Chul] Chungbuk Natl Univ, Dept Biochem, Sch Med, Inst Tumor Res, Cheongju 361763, South Korea	Seoul National University (SNU); Seoul National University (SNU); Chungbuk National University	Ryoo, HM (corresponding author), Seoul Natl Univ, Dept Mol Genet, Sch Dent, 28 Yeongeon Dong, Seoul 110749, South Korea.	hmryoo@snu.ac.kr	Cho, Young-Dan/AAR-4573-2021; Ryoo, Hyun-Mo/D-5839-2012; Woo, Kyung Mi/A-2793-2009	Ryoo, Hyun-Mo/0000-0001-6769-8341; Woo, Kyung Mi/0000-0002-2782-1189; Islam, Rabia/0000-0001-7378-9071	Bio & Medical Technology Development Program [20100030015]; General Researcher Program [20100010590]; Korean-Japanese International Research Program from the National Research Foundation of Korea [K20802001314-09B1200-11110]	Bio & Medical Technology Development Program; General Researcher Program; Korean-Japanese International Research Program from the National Research Foundation of Korea	This work was supported by The Bio & Medical Technology Development Program Grant 20100030015, the General Researcher Program Grant 20100010590, and the Korean-Japanese International Research Program Grant K20802001314-09B1200-11110 from the National Research Foundation of Korea.	Baniwal SK, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-258; CANALIS E, 1988, J CLIN INVEST, V81, P1572, DOI 10.1172/JCI113490; Chen SY, 2006, MOL CELL BIOL, V26, P929, DOI 10.1128/MCB.26.3.929-939.2006; Cho YD, 2009, J BIOL CHEM, V284, P25230, DOI 10.1074/jbc.M109.008391; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Ge CX, 2012, J BONE MINER RES, V27, P538, DOI 10.1002/jbmr.561; Ge CX, 2009, J BIOL CHEM, V284, P32533, DOI 10.1074/jbc.M109.040980; Geoffroy V, 1995, J BIOL CHEM, V270, P30973, DOI 10.1074/jbc.270.52.30973; Harrington KS, 2002, J CELL SCI, V115, P4167, DOI 10.1242/jcs.00095; Hennig L, 1998, BIOCHEMISTRY-US, V37, P5953, DOI 10.1021/bi973162p; Hsu T, 2001, NAT CELL BIOL, V3, P538, DOI 10.1038/35078508; Hurley MM, 1996, J BONE MINER RES, V11, P1256; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Kim BG, 2006, PROTEOMICS, V6, P1166, DOI 10.1002/pmic.200500289; Kim HJ, 2004, J CELL BIOCHEM, V91, P1239, DOI 10.1002/jcb.20038; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Mantovani F, 2004, MOL CELL, V14, P625, DOI 10.1016/j.molcel.2004.05.007; Mantovani F, 2007, NAT STRUCT MOL BIOL, V14, P912, DOI 10.1038/nsmb1306; MAYAHARA H, 1993, GROWTH FACTORS, V9, P73, DOI 10.3109/08977199308991583; Monje P, 2005, J BIOL CHEM, V280, P35081, DOI 10.1074/jbc.C500353200; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Munoz JP, 2007, J CELL BIOCHEM, V100, P738, DOI 10.1002/jcb.21041; Murakami M, 2008, J CLIN INVEST, V118, P3355, DOI 10.1172/JCI35298; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Park J, 2012, J CELL BIOCHEM, V113, P457, DOI 10.1002/jcb.23368; Park OJ, 2010, J BIOL CHEM, V285, P3568, DOI 10.1074/jbc.M109.055053; Patra D, 1999, J BIOL CHEM, V274, P36839, DOI 10.1074/jbc.274.52.36839; PETERS KG, 1992, DEVELOPMENT, V114, P233; Rajgopal A, 2007, J CELL BIOCHEM, V100, P1509, DOI 10.1002/jcb.21137; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Shukla V, 2007, NAT GENET, V39, P1145, DOI 10.1038/ng2096; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Stein GS, 2003, CONNECT TISSUE RES, V44, P149, DOI 10.1080/03008900390152241; SULLIVAN R, 1985, J BIOL CHEM, V260, P2399; Tatara Y, 2009, BIOCHEM BIOPH RES CO, V384, P394, DOI 10.1016/j.bbrc.2009.04.144; Walshe J, 2000, MECH DEVELOP, V90, P103, DOI 10.1016/S0925-4773(99)00225-7; Wee HJ, 2002, EMBO REP, V3, P967, DOI 10.1093/embo-reports/kvf193; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Yoon WJ, 2013, J CELL PHYSIOL, V228, P2377, DOI 10.1002/jcp.24403; Yoshida T, 2002, AM J HUM GENET, V71, P724, DOI 10.1086/342717; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zaidi SK, 2001, J CELL SCI, V114, P3093; ZHOU D, 1993, EXP NEUROL, V122, P171, DOI 10.1006/exnr.1993.1118; Zita MM, 2007, EMBO J, V26, P1761, DOI 10.1038/sj.emboj.7601625	54	35	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8828	8838		10.1074/jbc.M113.516237	http://dx.doi.org/10.1074/jbc.M113.516237			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24509851	Green Published, hybrid			2022-12-28	WOS:000333472100009
J	Zhang, PL; Chang, WH; Fong, B; Gao, F; Liu, CM; Al Alam, D; Bellusci, S; Lu, WG				Zhang, Peilin; Chang, Wen-Hsuan; Fong, Brendan; Gao, Fan; Liu, Chunming; Al Alam, Denise; Bellusci, Saverio; Lu, Wange			Regulation of Induced Pluripotent Stem ( iPS) Cell Induction by Wnt/beta-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta-catenin; Gene Expression; Induced Pluripotent Stem (iPS) Cell; Reprogramming; Wnt Signaling; c-myc	EMBRYONIC STEM; BETA-CATENIN; SOMATIC-CELLS; SELF-RENEWAL; EXPRESSION; MYC; DIFFERENTIATION; ACTIVATION; NETWORK; TARGET	Background: Wnt signaling plays an important role in somatic cell reprogramming. Results: Through interaction with Klf4, Oct4 and Sox2, -catenin enhances expression of pluripotency circuitry genes to promote somatic cell reprogramming. However, -catenin is not required for pluripotent stem cell self-renewal. Conclusion: Wnt/-catenin signaling has different roles in pluripotent stem cell self-renewal and somatic cell reprogramming. Significance: These studies reveal novel mechanisms underlying the reprogramming process by Wnt/-catenin signaling. Wnt signaling has been implicated in promoting somatic cell reprogramming. However, its molecular mechanisms remain unknown. Here we report that Wnt/-catenin enhances iPSCs induction at the early stage of reprogramming. The augmented reprogramming induced by -catenin is not due to increased total cell population or activation of c-Myc. In addition, -catenin interacts with reprogramming factors Klf4, Oct4, and Sox2, further enhancing expression of pluripotency circuitry genes. These studies reveal novel mechanisms underlying the regulation of reprogramming somatic cells to pluripotency by Wnt/-catenin signaling.	[Zhang, Peilin; Chang, Wen-Hsuan; Fong, Brendan; Gao, Fan; Lu, Wange] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Chang, Wen-Hsuan] Univ So Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA; [Liu, Chunming; Bellusci, Saverio] Univ Kentucky, Dept Mol & Cellular Biochem, Lucille P Markey Canc Ctr, Lexington, KY 40506 USA; [Al Alam, Denise] Childrens Hosp Los Angeles, Dev Biol & Regenerat Med, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Kentucky; Children's Hospital Los Angeles	Zhang, PL (corresponding author), Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA.	peilinzh@usc.edu; wangelu@usc.edu	Alam, Denise Al/AAG-9406-2019	Chang, Wen-Hsuan/0000-0002-6155-8644	California Institute of Regenerative Medicine [RB1-01353]	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine)	This research was supported by a grant from the California Institute of Regenerative Medicine (RB1-01353).	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Evans P, 2010, TLS-TIMES LIT SUPPL, P30; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Lee SMK, 2000, DEVELOPMENT, V127, P457; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lluis F, 2008, CELL STEM CELL, V3, P493, DOI 10.1016/j.stem.2008.08.017; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Miki T, 2011, STEM CELL REV REP, V7, P836, DOI 10.1007/s12015-011-9275-1; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Otero JJ, 2004, DEVELOPMENT, V131, P3545, DOI 10.1242/dev.01218; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takao Y, 2007, BIOCHEM BIOPH RES CO, V353, P699, DOI 10.1016/j.bbrc.2006.12.072; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wei Z, 2009, STEM CELLS, V27, P2969, DOI 10.1002/stem.231; Wu D., TRENDS BIOCH SCI, V35, P161; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958	34	36	37	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9221	9232		10.1074/jbc.M113.542845	http://dx.doi.org/10.1074/jbc.M113.542845			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24482235	Green Published, hybrid			2022-12-28	WOS:000333472100040
J	Ding, SY; Lee, MJ; Summer, R; Liu, LB; Fried, SK; Pilch, PF				Ding, Shi-Ying; Lee, Mi-Jeong; Summer, Ross; Liu, Libin; Fried, Susan K.; Pilch, Paul F.			Pleiotropic Effects of Cavin-1 Deficiency on Lipid Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipocyte; Caveolae; Lipodystrophy; Lipolysis; Triacylglycerol	TRANSCRIPT-RELEASE FACTOR; CONGENITAL GENERALIZED LIPODYSTROPHY; FATTY-ACID; ADIPOSE-TISSUE; PLASMA-MEMBRANE; POLYMERASE-I; CAVEOLIN-1-DEFICIENT MICE; STIMULATED LIPOLYSIS; PTRF MUTATIONS; PERILIPIN-A	Background: Cavin-1 expression is critical for the formation of caveolae, exceptionally abundant structure in adipocytes. Results: Adipocytes from cavin-1-null mice are markedly dysfunctional exhibiting decreased insulin-dependent glucose uptake, fatty acid uptake, and lipolysis. Conclusion: Cavin-1/caveolae have major roles in the regulation of adipocyte metabolism. Significance: Fat cell cavin-1/caveolae functions are important for organismal lipid metabolism in mice and men. Mice and humans lacking caveolae due to gene knock-out or inactivating mutations of cavin-1/PTRF have numerous pathologies including markedly aberrant fuel metabolism, lipodystrophy, and muscular dystrophy. We characterized the physiologic/metabolic profile of cavin-1 knock-out mice and determined that they were lean because of reduced white adipose depots. The knock-out mice were resistant to diet-induced obesity and had abnormal lipid metabolism in the major metabolic organs of white and brown fat and liver. Epididymal white fat cells from cavin-1-null mice were small and insensitive to insulin and -adrenergic agonists resulting in reduced adipocyte lipid storage and impaired lipid tolerance. At the molecular level, the lipolytic defects in white fat were caused by impaired perilipin phosphorylation, and the reduced triglyceride accumulation was caused by decreased fatty acid uptake and incorporation as well as the virtual absence of insulin-stimulated glucose transport. The livers of cavin-1-null mice were mildly steatotic and did not accumulate more lipid after high-fat feeding. The brown adipose tissues of cavin-1-null mice exhibited decreased mitochondria protein expression, which was restored upon high fat feeding. Taken together, these data suggest that dysfunction in fat, muscle, and liver metabolism in cavin-1-null mice causes a pleiotropic phenotype, one apparently identical to that of humans lacking caveolae in all tissues.	[Ding, Shi-Ying; Liu, Libin; Pilch, Paul F.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Lee, Mi-Jeong; Summer, Ross; Fried, Susan K.; Pilch, Paul F.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Lee, Mi-Jeong; Fried, Susan K.] Boston Univ, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Boston, MA 02118 USA; [Summer, Ross] Boston Univ, Sch Med, Dept Med, Ctr Pulm, Boston, MA 02118 USA	Boston University; Boston University; Boston University; Boston University	Fried, SK (corresponding author), Boston Univ, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, 650 Albany St,EBRC 810, Boston, MA 02118 USA.	skfried@bu.edu; ppilch@bu.edu	Lee, Mi-Jeong/GXV-9843-2022; Liu, Libin/ABH-6019-2020; Lee, Mi-Jeong/ABE-1084-2020	Lee, Mi-Jeong/0000-0002-8171-7913; Lee, Mi-Jeong/0000-0002-8171-7913; Liu, Libin/0000-0001-5056-1517; Pilch, Paul/0000-0003-1997-0499	National Institutes of Health [R01 DK097708, R01 DK092942, R01 DK080448, P30 DK046200, R01 HL105490]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092942, P30DK046200, R01DK080448, R01DK097708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by Grants R01 DK097708 and R01 DK092942 (to P. F. P.); R01 DK080448 and P30 DK046200 (to S. K. F.); and R01 HL105490 (to R. S.) from the National Institutes of Health.	Aboulaich N, 2011, DIABETES, V60, P757, DOI 10.2337/db10-0744; ABUMRAD NA, 1981, J BIOL CHEM, V256, P9183; Asterholm IW, 2012, CELL METAB, V15, P171, DOI 10.1016/j.cmet.2012.01.004; Bastiani M, 2010, J CELL SCI, V123, P3831, DOI 10.1242/jcs.070102; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Breen MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034516; Briand N, 2011, DIABETES, V60, P448, DOI 10.2337/db10-0856; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Cao H, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-3; CARPENTIER JL, 1976, J LIPID RES, V17, P335; Cohen AW, 2004, DIABETES, V53, P1261, DOI 10.2337/diabetes.53.5.1261; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V285, pC222, DOI 10.1152/ajpcell.00006.2003; CUSHMAN SW, 1970, J CELL BIOL, V46, P326, DOI 10.1083/jcb.46.2.326; DOLE VP, 1960, J BIOL CHEM, V235, P2595; Dwianingsih EK, 2010, MOL GENET METAB, V101, P233, DOI 10.1016/j.ymgme.2010.06.016; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Fernandez-Real JM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-20; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garg A, 2011, J CLIN ENDOCR METAB, V96, P3313, DOI 10.1210/jc.2011-1159; GOLDRICK RB, 1967, AM J PHYSIOL, V212, P777, DOI 10.1152/ajplegacy.1967.212.4.777; Govender P., 2013, PLOS ONE, V8; Greenberg AS, 2011, J CLIN INVEST, V121, P2102, DOI 10.1172/JCI46069; Gross DN, 2006, MOL ENDOCRINOL, V20, P459, DOI 10.1210/me.2005-0323; Hansen CG, 2010, TRENDS CELL BIOL, V20, P177, DOI 10.1016/j.tcb.2010.01.005; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Hansen CG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2808; Hasegawa T, 2000, BIOCHEM J, V347, P55, DOI 10.1042/0264-6021:3470055; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Ikonen E, 2004, BIOCHEM SOC T, V32, P121, DOI 10.1042/BST0320121; Jansa P, 1998, EMBO J, V17, P2855, DOI 10.1093/emboj/17.10.2855; Jansa P, 2001, NUCLEIC ACIDS RES, V29, P423, DOI 10.1093/nar/29.2.423; KANDROR KV, 1995, J CELL BIOL, V129, P999, DOI 10.1083/jcb.129.4.999; Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328; Kozak LP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011015; LAURELL S, 1966, CLIN CHIM ACTA, V13, P317, DOI 10.1016/0009-8981(66)90210-5; Le Lay S, 2010, AUTOPHAGY, V6, P754, DOI 10.4161/auto.6.6.12574; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Martin S., 2012, PLOS ONE, V7; McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46; Meshulam T, 2006, BIOCHEMISTRY-US, V45, P2882, DOI 10.1021/bi051999b; Meshulam T, 2011, J LIPID RES, V52, P1526, DOI 10.1194/jlr.M015628; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; NAPOLITANO L, 1963, J CELL BIOL, V18, P663, DOI 10.1083/jcb.18.3.663; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Ost A, 2005, J BIOL CHEM, V280, P5, DOI 10.1074/jbc.C400429200; Pilch PF, 2007, J LIPID RES, V48, P2103, DOI 10.1194/jlr.R700009-JLR200; Pilch PF, 2011, TRENDS ENDOCRIN MET, V22, P318, DOI 10.1016/j.tem.2011.04.001; Rajab A, 2010, PLOS GENET, V6, DOI 10.1371/ journal. pgen. 1000874.; Razani B, 2002, MOL CELL BIOL, V22, P2329, DOI 10.1128/MCB.22.7.2329-2344.2002; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Ring A, 2006, BBA-MOL CELL BIOL L, V1761, P416, DOI 10.1016/j.bbalip.2006.03.016; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; SCHERER PE, 1994, J CELL BIOL, V127, P1233, DOI 10.1083/jcb.127.5.1233; Shastry S, 2010, AM J MED GENET A, V152A, P2245, DOI 10.1002/ajmg.a.33578; Shaughnessy S, 2000, DIABETES, V49, P904, DOI 10.2337/diabetes.49.6.904; Simard JR, 2010, J LIPID RES, V51, P914, DOI 10.1194/jlr.M900251; Souza SC, 2002, J BIOL CHEM, V277, P8267, DOI 10.1074/jbc.M108329200; Thorn H, 2003, MOL BIOL CELL, V14, P3967, DOI 10.1091/mbc.E03-01-0050	60	46	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8473	8483		10.1074/jbc.M113.546242	http://dx.doi.org/10.1074/jbc.M113.546242			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24509860	Green Published, hybrid			2022-12-28	WOS:000333157500039
J	Vlach, J; Samal, AB; Saad, JS				Vlach, Jiri; Samal, Alexandra B.; Saad, Jamil S.			Solution Structure of Calmodulin Bound to the Binding Domain of the HIV-1 Matrix Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calmodulin; HIV-1; NMR; Peptides; Viral Replication; Gag; Matrix	VIRUS TYPE-1 MATRIX; PLASMA-MEMBRANE; GAG PROTEIN; TARGET RECOGNITION; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; INTRACELLULAR TRAFFICKING; MYRISTATE EXPOSURE; EF-HANDS; NMR; PEPTIDE	Background: Calmodulin (CaM) binds to the matrix (MA) domain of HIV-1 Gag. Results: We present the NMR structure of CaM bound to the minimal binding domain of MA. Conclusion: Data offer a structural basis for Gag-CaM interactions during HIV-1 replication. Significance: Characterization of the MA-CaM interaction may help in understanding the functional role of CaM in HIV-1 replication. Subcellular distribution of calmodulin (CaM) in human immunodeficiency virus type-1 (HIV-1)-infected cells is distinct from that observed in uninfected cells. CaM co-localizes and interacts with the HIV-1 Gag protein in the cytosol of infected cells. Although it has been shown that binding of Gag to CaM is mediated by the matrix (MA) domain, the structural details of this interaction are not known. We have recently shown that binding of CaM to MA induces a conformational change that triggers myristate exposure, and that the CaM-binding domain of MA is confined to a region spanning residues 8-43 (MA-(8-43)). Here, we present the NMR structure of CaM bound to MA-(8-43). Our data revealed that MA-(8-43), which contains a novel CaM-binding motif, binds to CaM in an antiparallel mode with the N-terminal helix (1) anchored to the CaM C-terminal lobe, and the C-terminal helix (2) of MA-(8-43) bound to the N-terminal lobe of CaM. The CaM protein preserves a semiextended conformation. Binding of MA-(8-43) to CaM is mediated by numerous hydrophobic interactions and stabilized by favorable electrostatic contacts. Our structural data are consistent with the findings that CaM induces unfolding of the MA protein to have access to helices 1 and 2. It is noteworthy that several MA residues involved in CaM binding have been previously implicated in membrane binding, envelope incorporation, and particle production. The present findings may ultimately help in identification of the functional role of CaM in HIV-1 replication.	[Vlach, Jiri; Samal, Alexandra B.; Saad, Jamil S.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Saad, JS (corresponding author), 845 19th St South, Birmingham, AL 35294 USA.	saad@uab.edu		Vlach, Jiri/0000-0002-0874-2055; Saad, Jamil/0000-0001-9503-6484	National Institutes of Health [1R01AI087101]; University of Albama at Birmingham Center for AIDS Research; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Albama at Birmingham Center for AIDS Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01AI087101 (to J. S. S.) and intramural funding from the University of Albama at Birmingham Center for AIDS Research.	Alston RW, 2004, BIOPHYS J, V87, P4036, DOI 10.1529/biophysj.104.050377; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Batonick M, 2005, VIROLOGY, V342, P190, DOI 10.1016/j.virol.2005.08.001; Biekofsky RR, 1998, BIOCHEMISTRY-US, V37, P7617, DOI 10.1021/bi9800449; BRYANT M, 1990, P NATL ACAD SCI USA, V87, P523, DOI 10.1073/pnas.87.2.523; Camus G, 2007, MOL BIOL CELL, V18, P3193, DOI 10.1091/mbc.E06-12-1147; Cao CK, 2013, J BIOL CHEM, V288, P5278, DOI 10.1074/jbc.M112.409482; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chow JYH, 2010, J MOL BIOL, V400, P702, DOI 10.1016/j.jmb.2010.05.022; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Chukkapalli V, 2010, P NATL ACAD SCI USA, V107, P1600, DOI 10.1073/pnas.0908661107; Cooper J, 2011, J BIOL CHEM, V286, P28498, DOI 10.1074/jbc.M111.239053; Coticchia CM, 2009, BREAST CANCER RES TR, V115, P545, DOI 10.1007/s10549-008-0097-z; Davis MR, 2006, J VIROL, V80, P2405, DOI 10.1128/JVI.80.5.2405-2417.2006; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deng W., 2013, PLOS ONE, V8; Dick RA, 2012, P NATL ACAD SCI USA, V109, P18761, DOI 10.1073/pnas.1209408109; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dong B, 2007, J BIOL CHEM, V282, P25131, DOI 10.1074/jbc.M702123200; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; DORFMAN T, 1994, J VIROL, V68, P1689, DOI 10.1128/JVI.68.3.1689-1696.1994; DORFMAN T, 1994, J VIROL, V68, P8180, DOI 10.1128/JVI.68.12.8180-8187.1994; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; Engeland CE, 2011, J VIROL, V85, P13322, DOI 10.1128/JVI.00174-11; Fledderman EL, 2010, BIOCHEMISTRY-US, V49, P9551, DOI 10.1021/bi101245j; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ghanam RH, 2010, J BIOL CHEM, V285, P41911, DOI 10.1074/jbc.M110.179093; GIETZEN K, 1982, BIOCHEM J, V207, P541, DOI 10.1042/bj2070541; GRONENBORN AM, 1994, J BIOMOL NMR, V4, P455; Han Z, 2007, VIRUS GENES, V35, P511, DOI 10.1007/s11262-007-0125-9; Hayashi N, 2002, PROTEIN SCI, V11, P529, DOI 10.1110/ps.23702; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Hokanson DE, 2006, P NATL ACAD SCI USA, V103, P3118, DOI 10.1073/pnas.0505685103; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishida H, 2006, PROTEIN PEPTIDE LETT, V13, P455, DOI 10.2174/092986606776819600; Ishida H, 2010, J BIOL CHEM, V285, P38502, DOI 10.1074/jbc.M110.131201; Ishii M, 2005, BIOCHEM J, V385, P65, DOI 10.1042/BJ20040404; Izumi Y, 2008, BIOCHEMISTRY-US, V47, P7158, DOI 10.1021/bi702416b; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Joshi A, 2008, MOL CELL, V30, P227, DOI 10.1016/j.molcel.2008.03.015; Joshi A, 2011, J BIOL CHEM, V286, P29861, DOI 10.1074/jbc.M111.241521; Joshi A, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-72; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Jouvenet N, 2009, P NATL ACAD SCI USA, V106, P19114, DOI 10.1073/pnas.0907364106; Kretsinger RH, 1996, NAT STRUCT BIOL, V3, P12, DOI 10.1038/nsb0196-12; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lohr F, 2007, J BIOMOL NMR, V37, P205, DOI 10.1007/s10858-006-9128-4; Lopez-Verges S, 2006, P NATL ACAD SCI USA, V103, P14947, DOI 10.1073/pnas.0602941103; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; MASSIAH MA, 1994, J MOL BIOL, V244, P198, DOI 10.1006/jmbi.1994.1719; Matsubara M, 1996, BIOCHEMISTRY-US, V35, P14651, DOI 10.1021/bi9613988; Matsubara M, 2005, PROTEIN SCI, V14, P494, DOI 10.1110/ps.04969605; Matsubara M, 2004, EMBO J, V23, P712, DOI 10.1038/sj.emboj.7600093; Matsubara M, 2003, J BIOL CHEM, V278, P48898, DOI 10.1074/jbc.M305488200; McQueen P, 2011, PROTEINS, V79, P2233, DOI 10.1002/prot.23048; MILLER MA, 1993, AIDS RES HUM RETROV, V9, P1057, DOI 10.1089/aid.1993.9.1057; Moorthy AK, 2001, J BIOMOL STRUCT DYN, V19, P47, DOI 10.1080/07391102.2001.10506719; Nagasaki N, 2008, FEBS J, V275, P2267, DOI 10.1111/j.1742-4658.2008.06379.x; Nishi M, 2009, FEBS LETT, V583, P1243, DOI 10.1016/j.febslet.2009.03.041; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 2009, FUTURE VIROL, V4, P241, DOI 10.2217/FVL.09.4; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Popov SG, 2000, J BIOL CHEM, V275, P18962, DOI 10.1074/jbc.M001128200; Radding W, 2000, AIDS RES HUM RETROV, V16, P1519, DOI 10.1089/088922200750006047; Radding W, 1996, BIOCHEM BIOPH RES CO, V218, P192, DOI 10.1006/bbrc.1996.0034; Reil H, 1998, EMBO J, V17, P2699, DOI 10.1093/emboj/17.9.2699; Rodriguez-Castaneda F, 2010, EMBO J, V29, P680, DOI 10.1038/emboj.2009.373; Ryo A, 2008, P NATL ACAD SCI USA, V105, P294, DOI 10.1073/pnas.0704831105; Saad JS, 2007, J MOL BIOL, V366, P574, DOI 10.1016/j.jmb.2006.11.068; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Samal AB, 2011, J BIOL CHEM, V286, P33533, DOI 10.1074/jbc.M111.273623; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; SRINIVAS SK, 1993, J BIOL CHEM, V268, P22895; Strasner AB, 2008, J IMMUNOL, V181, P3706, DOI 10.4049/jimmunol.181.5.3706; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; Taylor JE, 2012, BIOPHYS J, V103, P541, DOI 10.1016/j.bpj.2012.06.042; Tomita Y, 2011, J VIROL, V85, P5618, DOI 10.1128/JVI.00846-10; TOWLER DA, 1988, J BIOL CHEM, V263, P1784; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Vlach J, 2013, P NATL ACAD SCI USA, V110, P3525, DOI 10.1073/pnas.1216655110; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Yuan T, 1999, J BIOL CHEM, V274, P8411, DOI 10.1074/jbc.274.13.8411; Yuan T, 2001, BIOPOLYMERS, V58, P50, DOI 10.1002/1097-0282(200101)58:1<50::AID-BIP60>3.0.CO;2-S; Zhang MJ, 1998, BIOCHEM CELL BIOL, V76, P313, DOI 10.1139/bcb-76-2-3-313; ZHOU WJ, 1994, J VIROL, V68, P2556, DOI 10.1128/JVI.68.4.2556-2569.1994	92	21	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8697	8705		10.1074/jbc.M113.543694	http://dx.doi.org/10.1074/jbc.M113.543694			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24500712	hybrid, Green Published			2022-12-28	WOS:000333157500058
J	Calco, GN; Stephens, OR; Donahue, LM; Tsui, CC; Pierchala, BA				Calco, Gina N.; Stephens, Olivia R.; Donahue, Laura M.; Tsui, Cynthia C.; Pierchala, Brian A.			CD2-associated Protein (CD2AP) Enhances Casitas B Lineage Lymphoma-3/c (Cbl-3/c)-mediated Ret Isoform-specific Ubiquitination and Degradation via Its Amino-terminal Src Homology 3 Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Neurodevelopment; Neurotrophic Factor; Protein Degradation; Receptor Tyrosine Kinase; Ubiquitination	DOWN-REGULATION; C-CBL; NEUROTROPHIC FACTOR; GDNF FAMILY; ALZHEIMERS-DISEASE; NEURONAL SURVIVAL; COMMON VARIANTS; LIGASE ACTIVITY; COMPLEX; RING	Background: Ubiquitination and degradation promote signal termination of the Ret receptor. Results: Cbl-3/c and CD2AP are both required for the ubiquitination of Ret51 on Lys(1060) and Lys(1107). Conclusion: The Ret51 isoform-specific ubiquitination on Lys(1060) and Lys(1107) may underlie its rapid degradation. Significance: Regulation of CD2APCbl-3/c activity may underlie the diversity of functional outcomes of Ret signal transduction. Ret is the receptor tyrosine kinase for the glial cell line-derived neurotrophic factor (GDNF) family of neuronal growth factors. Upon activation by GDNF, Ret is rapidly polyubiquitinated and degraded. This degradation process is isoform-selective, with the longer Ret51 isoform exhibiting different degradation kinetics than the shorter isoform, Ret9. In sympathetic neurons, Ret degradation is induced, at least in part, by a complex consisting of the adaptor protein CD2AP and the E3-ligase Cbl-3/c. Knockdown of Cbl-3/c using siRNA reduced the GDNF-induced ubiquitination and degradation of Ret51 in neurons and podocytes, suggesting that Cbl-3/c was a predominant E3 ligase for Ret. Coexpression of CD2AP with Cbl-3/c augmented the ubiquitination of Ret51 as compared with the expression of Cbl-3/c alone. Ret51 ubiquitination by the CD2APCbl-3/c complex required a functional ring finger and TKB domain in Cbl-3/c. The SH3 domains of CD2AP were sufficient to drive the Cbl-3/c-dependent ubiquitination of Ret51, whereas the carboxyl-terminal coiled-coil domain of CD2AP was dispensable. Interestingly, activated Ret induced the degradation of CD2AP, but not Cbl-3/c, suggesting a potential inhibitory feedback mechanism. There were only two major ubiquitination sites in Ret51, Lys(1060) and Lys(1107), and the combined mutation of these lysines almost completely eliminated both the ubiquitination and degradation of Ret51. Ret9 was not ubiquitinated by the CD2APCbl-3/c complex, suggesting that Ret9 was down-regulated by a fundamentally different mechanism. Taken together, these results suggest that only the SH3 domains of CD2AP were necessary to enhance the E3 ligase activity of Cbl-3/c toward Ret51.	[Calco, Gina N.; Stephens, Olivia R.; Donahue, Laura M.; Pierchala, Brian A.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA; [Tsui, Cynthia C.] Univ Michigan, Sch Med, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Tsui, CC (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Div Nephrol, 1150 West Med Ctr Dr,MSRB 1 A520D, Ann Arbor, MI 48109 USA.	cyntsui@umich.edu; pierchal@umich.edu			National Institutes of Health [NS058510, DK084210]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK084210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058510] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01, NS058510 (B. A. P.) and National Institutes of Health Career Development Award K08, DK084210 (to C. C. T.).	Aguilar RC, 2003, CURR OPIN CELL BIOL, V15, P184, DOI 10.1016/S0955-0674(03)00010-3; Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Bespalov MM, 2007, TRENDS PHARMACOL SCI, V28, P68, DOI 10.1016/j.tips.2006.12.005; Bonanomi D, 2012, CELL, V148, P568, DOI 10.1016/j.cell.2012.01.024; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Cormont M, 2003, TRAFFIC, V4, P97, DOI 10.1034/j.1600-0854.2003.40205.x; Duan L, 2004, IMMUNITY, V21, P7, DOI 10.1016/j.immuni.2004.06.012; Encinas M, 2004, J BIOL CHEM, V279, P18262, DOI 10.1074/jbc.M400505200; Encinas M, 2001, J NEUROSCI, V21, P1464, DOI 10.1523/JNEUROSCI.21-05-01464.2001; Freemont PS, 2000, CURR BIOL, V10, pR84, DOI 10.1016/S0960-9822(00)00287-6; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Keane MM, 1999, ONCOGENE, V18, P3365, DOI 10.1038/sj.onc.1202753; Kim M, 1999, GENE, V239, P145, DOI 10.1016/S0378-1119(99)00356-X; Kim M, 2004, ONCOGENE, V23, P1645, DOI 10.1038/sj.onc.1207298; Kirsch KH, 2001, J BIOL CHEM, V276, P4957, DOI 10.1074/jbc.M005784200; Kobayashi S, 2004, FASEB J, V18, P929, DOI 10.1096/fj.03-0767fje; Kowanetz K, 2003, J BIOL CHEM, V278, P39735, DOI 10.1074/jbc.M304541200; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Pierchala BA, 2006, J NEUROSCI, V26, P2777, DOI 10.1523/JNEUROSCI.3420-05.2006; Pierchala BA, 2010, KIDNEY INT, V78, P868, DOI 10.1038/ki.2010.212; Richardson DS, 2012, MOL BIOL CELL, V23, P3838, DOI 10.1091/mbc.E12-02-0114; Ryan PE, 2010, J BIOL CHEM, V285, P23687, DOI 10.1074/jbc.M109.091157; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Scott RP, 2005, J BIOL CHEM, V280, P13442, DOI 10.1074/jbc.M500507200; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Szymkiewicz I, 2002, J BIOL CHEM, V277, P39666, DOI 10.1074/jbc.M205535200; Thien CBF, 2001, MOL CELL, V7, P355, DOI 10.1016/S1097-2765(01)00183-6; Tossidou I, 2007, J BIOL CHEM, V282, P7457, DOI 10.1074/jbc.M608519200; Tsui CC, 2006, J AM SOC NEPHROL, V17, P1543, DOI 10.1681/ASN.2005080835; Tsui CC, 2008, J NEUROSCI, V28, P8789, DOI 10.1523/JNEUROSCI.2738-08.2008; Tsui CC, 2010, J NEUROSCI, V30, P5149, DOI 10.1523/JNEUROSCI.5246-09.2010; Tsui-Pierchala BA, 1999, J NEUROSCI, V19, P8207; Tsui-Pierchala BA, 2002, J BIOL CHEM, V277, P34618, DOI 10.1074/jbc.M203580200; Wells SA, 2009, CLIN CANCER RES, V15, P7119, DOI 10.1158/1078-0432.CCR-08-2742	40	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7307	7319		10.1074/jbc.M113.537878	http://dx.doi.org/10.1074/jbc.M113.537878			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24425877	hybrid, Green Published			2022-12-28	WOS:000332761500005
J	Kubota, S; Fukumoto, Y; Ishibashi, K; Soeda, S; Kubota, S; Yuki, R; Nakayama, Y; Aoyama, K; Yamaguchi, N; Yamaguchi, N				Kubota, Shoichi; Fukumoto, Yasunori; Ishibashi, Kenichi; Soeda, Shuhei; Kubota, Sho; Yuki, Ryuzaburo; Nakayama, Yuji; Aoyama, Kazumasa; Yamaguchi, Noritaka; Yamaguchi, Naoto			Activation of the Prereplication Complex Is Blocked by Mimosine through Reactive Oxygen Species-activated Ataxia Telangiectasia Mutated (ATM) Protein without DNA Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Checkpoint Control; DNA Damage Response; DNA Replication; Oxidative Stress	CHK TYROSINE KINASE; CELL-CYCLE; S-PHASE; CENTROSOME DUPLICATION; NUCLEAR-LOCALIZATION; A RPA; C-SRC; REPLICATION; PHOSPHORYLATION; LYN	Background: Mimosine is a cell synchronization reagent used for arresting cells in late G(1) and S phases. Results: Replication fork assembly is reversibly blocked by ATM activation through mimosine-generated reactive oxygen species. Conclusion: Mimosine induces cell cycle arrest strictly at the G(1)-S phase boundary, which prevents replication fork stalling-induced DNA damage. Significance: These findings provide a novel mechanism of the mimosine-induced G(1) checkpoint. Mimosine is an effective cell synchronization reagent used for arresting cells in late G(1) phase. However, the mechanism underlying mimosine-induced G(1) cell cycle arrest remains unclear. Using highly synchronous cell populations, we show here that mimosine blocks S phase entry through ATM activation. HeLa S3 cells are exposed to thymidine for 15 h, released for 9 h by washing out the thymidine, and subsequently treated with 1 mm mimosine for a further 15 h (thymidine mimosine). In contrast to thymidine-induced S phase arrest, mimosine treatment synchronizes >90% of cells at the G(1)-S phase boundary by inhibiting the transition of the prereplication complex to the preinitiation complex. Mimosine treatment activates ataxia telangiectasia mutated (ATM)/ataxia telangiectasia and Rad3-related (ATR)-mediated checkpoint signaling without inducing DNA damage. Inhibition of ATM activity is found to induce mimosine-arrested cells to enter S phase. In addition, ATM activation by mimosine treatment is mediated by reactive oxygen species (ROS). These results suggest that, upon mimosine treatment, ATM blocks S phase entry in response to ROS, which prevents replication fork stalling-induced DNA damage.	[Kubota, Shoichi; Fukumoto, Yasunori; Ishibashi, Kenichi; Soeda, Shuhei; Kubota, Sho; Yuki, Ryuzaburo; Nakayama, Yuji; Aoyama, Kazumasa; Yamaguchi, Noritaka; Yamaguchi, Naoto] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cell Biol, Chiba 2608675, Japan	Chiba University	Yamaguchi, N (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Dept Mol Cell Biol, Chuo Ku, Inohana 1-8-1, Chiba 2608675, Japan.	nyama@faculty.chiba-u.jp		Kubota, Sho/0000-0001-6119-1259; Nakayama, Yuji/0000-0001-7882-0066	Japanese Ministry of Education, Culture, Sports, Science and Technology	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for Scientific Research, Global Center of Excellence (COE) Program (Global Center for Education and Research in Immune Regulation and Treatment) and Special Funds for Education and Research (Development of single photon emission computed tomography (SPECT) probes for Pharmaceutical Innovation) from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Aoyama K, 2013, EXP CELL RES, V319, P3251, DOI 10.1016/j.yexcr.2013.09.003; Aoyama K, 2011, EXP CELL RES, V317, P2874, DOI 10.1016/j.yexcr.2011.09.013; Ben-Yehoyada M, 2007, DNA REPAIR, V6, P914, DOI 10.1016/j.dnarep.2007.02.005; Bencokova Z, 2009, MOL CELL BIOL, V29, P526, DOI 10.1128/MCB.01301-08; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bolderson E, 2004, HUM MOL GENET, V13, P2937, DOI 10.1093/hmg/ddh316; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Cardoso M. C., 1995, CELL CYCLE MAT METHO, P15; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Correia SC, 2010, J NEUROCHEM, V112, P1, DOI 10.1111/j.1471-4159.2009.06443.x; DAI YM, 1994, VIROLOGY, V205, P210, DOI 10.1006/viro.1994.1636; Das KC, 2004, AM J PHYSIOL-LUNG C, V286, pL87, DOI 10.1152/ajplung.00203.2002; Ditch S, 2012, TRENDS BIOCHEM SCI, V37, P15, DOI 10.1016/j.tibs.2011.10.002; DULIC V, 1992, SCIENCE, V257, P1958, DOI 10.1126/science.1329201; Durcan TM, 2008, J CELL PHYSIOL, V215, P182, DOI 10.1002/jcp.21298; ERIKSSON S, 1979, BIOCHEMISTRY-US, V18, P2948, DOI 10.1021/bi00581a005; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Gagou ME, 2010, MOL BIOL CELL, V21, P739, DOI 10.1091/mbc.E09-07-0618; GILBERT DM, 1995, J BIOL CHEM, V270, P9597, DOI 10.1074/jbc.270.16.9597; Hallak M, 2008, APOPTOSIS, V13, P147, DOI 10.1007/s10495-007-0156-7; Harper Jane V., 2004, V296, P157; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Ikeda K, 2008, EXP CELL RES, V314, P3392, DOI 10.1016/j.yexcr.2008.08.019; Ishibashi K, 2013, J CELL SCI, V126, P625, DOI 10.1242/jcs.116277; Jones RM, 2012, BIOCHEM J, V443, P13, DOI 10.1042/BJ20112100; Julias JG, 1998, J VIROL, V72, P7941, DOI 10.1128/JVI.72.10.7941-7949.1998; Kalejta RF, 1997, EXP CELL RES, V231, P173, DOI 10.1006/excr.1996.3444; Kasahara K, 2004, J CELL BIOL, V165, P641, DOI 10.1083/jcb.200403011; Kasahara K, 2007, J CELL PHYSIOL, V211, P220, DOI 10.1002/jcp.20931; Kasahara K, 2007, J BIOL CHEM, V282, P5327, DOI 10.1074/jbc.M608396200; Kikuchi I, 2010, CELL BIOL INT, V34, P645, DOI 10.1042/CBI20090398; KNEHR M, 1995, EXP CELL RES, V217, P546, DOI 10.1006/excr.1995.1121; Krude T, 1999, EXP CELL RES, V247, P148, DOI 10.1006/excr.1998.4342; Kubota S, 2013, J BIOL CHEM, V288, P17871, DOI 10.1074/jbc.M112.437756; Kuga T, 2007, ARCH BIOCHEM BIOPHYS, V466, P116, DOI 10.1016/j.abb.2007.07.002; Kurz EU, 2004, J BIOL CHEM, V279, P53272, DOI 10.1074/jbc.M406879200; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; LALANDE M, 1990, EXP CELL RES, V186, P332, DOI 10.1016/0014-4827(90)90313-Y; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; LEVENSON V, 1993, NUCLEIC ACIDS RES, V21, P3997, DOI 10.1093/nar/21.17.3997; Lundin C, 2002, MOL CELL BIOL, V22, P5869, DOI 10.1128/MCB.22.16.5869-5878.2002; Matsuda D, 2006, EXP CELL RES, V312, P1205, DOI 10.1016/j.yexcr.2006.02.003; Matsui Y, 2012, EUR J CELL BIOL, V91, P413, DOI 10.1016/j.ejcb.2011.12.008; Matsumoto Y, 1999, CURR BIOL, V9, P429, DOI 10.1016/S0960-9822(99)80191-2; Mechali M, 2010, NAT REV MOL CELL BIO, V11, P728, DOI 10.1038/nrm2976; Mikhailov I, 2000, MUTAT RES-DNA REPAIR, V459, P299, DOI 10.1016/S0921-8777(00)00007-0; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Nakayama Y, 2005, EXP CELL RES, V304, P570, DOI 10.1016/j.yexcr.2004.11.027; Nakayama Y, 2006, EXP CELL RES, V312, P2252, DOI 10.1016/j.yexcr.2006.03.021; Nakayama Y, 2012, J BIOL CHEM, V287, P24905, DOI 10.1074/jbc.M112.341578; Nakayama Y, 2009, EXP CELL RES, V315, P2515, DOI 10.1016/j.yexcr.2009.06.007; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Paddenberg R, 2003, AM J PHYSIOL-LUNG C, V284, pL710, DOI 10.1152/ajplung.00149.2002; Panopoulos A, 2005, J BIOL CHEM, V280, P2912, DOI 10.1074/jbc.M409524200; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; Semenza GL, 1999, CELL, V98, P281, DOI 10.1016/S0092-8674(00)81957-1; Shields BJ, 2008, CANCER CELL, V14, P166, DOI 10.1016/j.ccr.2008.06.003; Swingle Mark, 2007, V365, P23; Szuts D, 2004, J CELL SCI, V117, P4897, DOI 10.1242/jcs.01374; Tada J, 1999, BLOOD, V93, P3723, DOI 10.1182/blood.V93.11.3723.411k02_3723_3735; Takahashi A, 2009, EXP CELL RES, V315, P1117, DOI 10.1016/j.yexcr.2009.02.010; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Warnecke C, 2003, FASEB J, V17, P1186, DOI 10.1096/fj.02-1062fje; YAMAGUCHI N, 1995, J BIOL CHEM, V270, P12170, DOI 10.1074/jbc.270.20.12170; Yamaguchi N, 2001, J CELL SCI, V114, P1631; Yang YT, 2005, J NEUROCHEM, V93, P513, DOI 10.1111/j.1471-4159.2005.03032.x; Zou Y, 2006, J CELL PHYSIOL, V208, P267, DOI 10.1002/jcp.20622	73	28	28	5	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5730	5746		10.1074/jbc.M113.546655	http://dx.doi.org/10.1074/jbc.M113.546655			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24421316	hybrid, Green Published			2022-12-28	WOS:000332015500034
J	Benevento, M; Di Palma, S; Snijder, J; Moyer, CL; Reddy, VS; Nemerow, GR; Heck, AJR				Benevento, Marco; Di Palma, Serena; Snijder, Joost; Moyer, Crystal L.; Reddy, Vijay S.; Nemerow, Glen R.; Heck, Albert J. R.			Adenovirus Composition, Proteolysis, and Disassembly Studied by In-depth Qualitative and Quantitative Proteomics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adenovirus; Mass Spectrometry (MS); Proteomics; Virus Entry; Virus Structure	MASS-SPECTROMETRY; MESSENGER-RNA; PROTEIN; PEPTIDE; IDENTIFICATIONS; DISSOCIATION; PERFORMANCE; RESOLUTION; COMPLEX; SYSTEM	Background: Adenoviruses (AdV) are broadly employed as gene delivery vectors. Results: Copy numbers of all AdV proteins were measured, and the release of proteins upon heat stress investigated. Conclusion: The viral protease plays a distinct role in the segmented release of AdV proteins. Significance: Our characterization by mass spectrometry provides new insight in HAdV disassembly during entry into host cells. Using high-resolution MS-based proteomics in combination with multiple protease digestion, we profiled, with on average 90% sequence coverage, all 13 viral proteins present in an human adenovirus (HAdV) vector. This in-depth profile provided multiple peptide-based evidence on intrinsic protease activity affecting several HAdV proteins. Next, the generated peptide library was used to develop a targeted proteomics method using selected reaction monitoring (SRM) aimed at quantitative profiling of the stoichiometry of all 13 proteins present in the HAdV. We also used this method to probe the release of specific virus proteins initiated by thermal stimulation, mimicking the early stage of HAdV disassembly during entry into host cells. We confirmed the copy numbers of the most well characterized viral capsid components and established the copy numbers for proteins whose stoichiometry has so far not been accurately defined. We also found that heating HAdV induces the complete release of the penton base and fiber proteins as well as a substantial release of protein VIII and VI. For these latter proteins, maturational proteolysis by the adenoviral protease leads to the differential release of fragments with certain peptides being fully released and others largely retained in the AdV particles. This information is likely to be beneficial for the ongoing interpretation of high resolution cryoEM and x-ray electron density maps.	[Benevento, Marco; Di Palma, Serena; Snijder, Joost; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Benevento, Marco; Di Palma, Serena; Snijder, Joost; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Benevento, Marco; Di Palma, Serena; Snijder, Joost; Heck, Albert J. R.] Netherlands Prote Ctr, NL-3584 CH Utrecht, Netherlands; [Moyer, Crystal L.; Nemerow, Glen R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Reddy, Vijay S.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA	Utrecht University; Utrecht University; Scripps Research Institute; Scripps Research Institute	Heck, AJR (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	A.J.R.Heck@uu.nl	Heck, Albert/D-7098-2011	Heck, Albert/0000-0002-2405-4404	Netherlands Proteomics Centre; European Community [262067]; National Institutes of Health [5T32 AI007354, AI070771, HL054352]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR007707] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070771, T32AI007354] Funding Source: NIH RePORTER	Netherlands Proteomics Centre; European Community(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Netherlands Proteomics Centre and by the European Community's Seventh Framework Programme FP7/2007-2013 through PRIME-XS Project Grant Agreement 262067 (to M. B., S. D. P., J. S., and A. J. R. H.).; Supported by National Institutes of Health Grant 5T32 AI007354.; Supported by National Institutes of Health Grant AI070771.; Supported by National Institutes of Health Grant HL054352.	Altelaar AFM, 2013, NAT REV GENET, V14, P35, DOI 10.1038/nrg3356; ANDERSON CW, 1990, VIROLOGY, V177, P259, DOI 10.1016/0042-6822(90)90479-B; Andrews GL, 2011, ANAL CHEM, V83, P5442, DOI 10.1021/ac200812d; Bensimon A, 2012, ANNU REV BIOCHEM, V81, P379, DOI 10.1146/annurev-biochem-072909-100424; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; BURNETT RM, 1985, J MOL BIOL, V185, P125, DOI 10.1016/0022-2836(85)90187-1; Chelius D, 2002, J PROTEOME RES, V1, P501, DOI 10.1021/pr025528c; CHOW LT, 1977, CELL, V12, P1, DOI 10.1016/0092-8674(77)90180-5; Christensen JB, 2008, J VIROL, V82, P9086, DOI 10.1128/JVI.01024-08; Craig R, 2004, J PROTEOME RES, V3, P1234, DOI 10.1021/pr049882h; Cristobal A, 2012, ANALYST, V137, P3541, DOI 10.1039/c2an35445d; Davison AJ, 2003, J GEN VIROL, V84, P2895, DOI 10.1099/vir.0.19497-0; Desiere F, 2006, NUCLEIC ACIDS RES, V34, pD655, DOI [10.1093/nar/gkj040, 10.1007/978-1-60761-444-9_19]; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z; Liu HR, 2011, J MOL BIOL, V406, P764, DOI 10.1016/j.jmb.2010.11.043; Liu HR, 2010, SCIENCE, V329, P1038, DOI 10.1126/science.1187433; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mangel WF, 2003, CELL MOL LIFE SCI, V60, P2347, DOI 10.1007/s00018-003-2318-2; Mann M, 2013, MOL CELL, V49, P583, DOI 10.1016/j.molcel.2013.01.029; McGrath WJ, 2003, BBA-PROTEINS PROTEOM, V1648, P1, DOI 10.1016/S1570-9639(03)00024-4; Moyer CL, 2012, VIROLOGY, V428, P41, DOI 10.1016/j.virol.2012.03.024; Moyer CL, 2011, J VIROL, V85, P2631, DOI 10.1128/JVI.02321-10; Nagaraj N, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013722; Nemerow GR, 2009, VIROLOGY, V384, P380, DOI 10.1016/j.virol.2008.10.016; Nemerow GR, 2000, VIROLOGY, V274, P1, DOI 10.1006/viro.2000.0468; Olsen JV, 2007, NAT METHODS, V4, P709, DOI 10.1038/NMETH1060; Olsen JV, 2009, MOL CELL PROTEOMICS, V8, P2759, DOI 10.1074/mcp.M900375-MCP200; Peng M, 2012, NAT METHODS, V9, P524, DOI 10.1038/nmeth.2031; Perez-Berna AJ, 2012, J BIOL CHEM, V287, P31582, DOI 10.1074/jbc.M112.389957; Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/NMETH.2015, 10.1038/nmeth.2015]; Prince JT, 2004, NAT BIOTECHNOL, V22, P471, DOI 10.1038/nbt0404-471; Reddy VS, 2010, VIROLOGY, V402, P209, DOI 10.1016/j.virol.2010.03.028; Reddy VS, 2010, SCIENCE, V329, P1071, DOI 10.1126/science.1187292; Rexroad J, 2003, J PHARM SCI, V92, P665, DOI 10.1002/jps.10340; Russell W C, 1967, J Gen Virol, V1, P509, DOI 10.1099/0022-1317-1-4-509; Russell WC, 2009, J GEN VIROL, V90, P1, DOI 10.1099/vir.0.003087-0; Second TP, 2009, ANAL CHEM, V81, P7757, DOI 10.1021/ac901278y; Sharma A, 2009, CURR DRUG THER, V4, P117, DOI 10.2174/157488509788185123; Smith JG, 2008, CELL HOST MICROBE, V3, P11, DOI 10.1016/j.chom.2007.12.001; Snijder J, 2014, J MOL BIOL, V426, P1971, DOI 10.1016/j.jmb.2014.02.022; Swaney DL, 2010, J PROTEOME RES, V9, P1323, DOI 10.1021/pr900863u; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Taouatas N, 2010, J PROTEOME RES, V9, P4282, DOI 10.1021/pr100341e; VANOOSTRUM J, 1985, J VIROL, V56, P439, DOI 10.1128/JVI.56.2.439-448.1985; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; WEBER J, 1976, J VIROL, V17, P462, DOI 10.1128/JVI.17.2.462-471.1976; WEBSTER A, 1989, J GEN VIROL, V70, P3225, DOI 10.1099/0022-1317-70-12-3225; Wiethoff CM, 2005, J VIROL, V79, P1992, DOI 10.1128/JVI.79.4.1992-2000.2005; Wodrich H, 2003, EMBO J, V22, P6245, DOI 10.1093/emboj/cdg614; Xin KQ, 2007, VACCINE, V25, P3809, DOI 10.1016/j.vaccine.2007.01.117	52	71	74	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11421	11430		10.1074/jbc.M113.537498	http://dx.doi.org/10.1074/jbc.M113.537498			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24591515	hybrid, Green Published			2022-12-28	WOS:000334638500043
J	Tashima, Y; Stanley, P				Tashima, Yuko; Stanley, Pamela			Antibodies That Detect O-Linked beta-D-N-Acetylglucosamine on the Extracellular Domain of Cell Surface Glycoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibodies; Flow Cytometry; Mutant; O-GlcNAc; O-GlcNAcylation; CHO; GlcNAc-terminating N-Glycans; Lec1; Lec8	KIDNEY BHK CELLS; MONOCLONAL-ANTIBODIES; NOTCH RECEPTORS; GLCNAC; MUTANTS; FRINGE; NUCLEAR; GLYCOSYLTRANSFERASE; SWAINSONINE; MODULATION	Background: Seven antibodies that detect cytosolic and nuclear O-GlcNAc were examined for recognition of O-GlcNAc on cell surface glycoproteins. Results: Three antibodies recognized cell surface O-GlcNAc and also bound terminal -GlcNAc on N-glycans. Conclusion: With careful controls, cell surface O-GlcNAc can be detected using antibodies CTD110.6, 18B10.C7, and 9D1.E4. Significance: Antibodies to monitor cell surface O-GlcNAcylated proteins were characterized. The transfer of N-acetylglucosamine (GlcNAc) to Ser or Thr in cytoplasmic and nuclear proteins is a well known post-translational modification that is catalyzed by the O-GlcNAc transferase OGT. A more recently identified O-GlcNAc transferase, EOGT, functions in the secretory pathway and transfers O-GlcNAc to proteins with epidermal growth factor-like (EGF) repeats. A number of antibodies that detect O-GlcNAc in cytosolic and nuclear extracts have been described previously. Here we compare seven of these antibodies (CTD110.6, 10D8, RL2, HGAC85, 18B10.C7(#3), 9D1.E4(#10), and 1F5.D6 (#14) for detection of the O-GlcNAc modification on extracellular domains of membrane or secreted glycoproteins that may also carry various N- and O-glycans. We found that CTD110.6 binds not only to O-GlcNAc on proteins but also to terminal -GlcNAc on the complex N-glycans of Lec8 Chinese hamster ovary (CHO) cells that lack UDP-Gal transporter activity and express GlcNAc-terminating, complex N-glycans. We show that CTD110.6, #3, and #10 antibodies can be used to detect cell surface glycoproteins bearing O-GlcNAc. Cell surface glycoproteins recognized by CTD110.6 antibody included NOTCH1 that possesses many EGF repeats with a consensus site for EOGT. Knockdown of CHO Eogt reduced binding of CTD110.6 to Lec1 CHO cells, and expression of a human EOGT cDNA increased the O-GlcNAc signal on Lec1 cells and the extracellular domain of NOTCH1. Thus, with careful controls, antibodies CTD110.6 (IgM), #3 (IgG), and #10 (IgG) can be used to detect membrane and secreted proteins modified by O-GlcNAc on EGF repeats.	[Tashima, Yuko; Stanley, Pamela] Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA	Yeshiva University	Stanley, P (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA.	pamela.stanley@einstein.yu.edu		Stanley, Pamela/0000-0001-5704-3747	National Institutes of Health from the NCI [R01 CA095022]; National Institutes of Health from the NIGMS [R01 GM106417]; NATIONAL CANCER INSTITUTE [P30CA013330, R01CA095022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106417] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA095022 from the NCI and R01 GM106417 from the NIGMS (to P. S.).	Aguilan JT, 2009, GLYCOBIOLOGY, V19, P971, DOI 10.1093/glycob/cwp074; Alfaro JF, 2012, P NATL ACAD SCI USA, V109, P7280, DOI 10.1073/pnas.1200425109; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; Chen W, 2003, GLYCOBIOLOGY, V13, P43, DOI 10.1093/glycob/cwg003; Comer FI, 2001, ANAL BIOCHEM, V293, P169, DOI 10.1006/abio.2001.5132; Eckhardt M, 1998, J BIOL CHEM, V273, P20189, DOI 10.1074/jbc.273.32.20189; FODDY L, 1986, CARBOHYD RES, V151, P293, DOI 10.1016/S0008-6215(00)90349-5; FODDY L, 1986, BIOCHEM J, V233, P697, DOI 10.1042/bj2330697; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; Hoffmann BR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032762; Hou XH, 2012, J BIOL CHEM, V287, P474, DOI 10.1074/jbc.M111.317578; Isono T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018959; Joutel A, 2000, J CLIN INVEST, V105, P597, DOI 10.1172/JCI8047; Kawar ZS, 2005, J BIOL CHEM, V280, P12810, DOI 10.1074/jbc.M414273200; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Muller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062835; North SJ, 2010, J BIOL CHEM, V285, P5759, DOI 10.1074/jbc.M109.068353; Oelmann S, 2001, J BIOL CHEM, V276, P26291, DOI 10.1074/jbc.M011124200; Ogawa M, 2013, BIOCHEM BIOPH RES CO, V440, P88, DOI 10.1016/j.bbrc.2013.09.022; Sakaidani Y, 2012, BIOCHEM BIOPH RES CO, V419, P14, DOI 10.1016/j.bbrc.2012.01.098; Sakaidani Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1591; Sakaidani Y, 2010, METHOD ENZYMOL, V480, P355, DOI 10.1016/S0076-6879(10)80016-3; Sanjabi S, 2005, GENE DEV, V19, P2138, DOI 10.1101/gad.1329805; SNOW CM, 1987, J CELL BIOL, V104, P1143, DOI 10.1083/jcb.104.5.1143; Teo CF, 2010, NAT CHEM BIOL, V6, P338, DOI 10.1038/nchembio.338; TORRES CR, 1984, J BIOL CHEM, V259, P3308; TURNER JR, 1990, P NATL ACAD SCI USA, V87, P5608, DOI 10.1073/pnas.87.15.5608; Varki A., 2009, ESSENTIALS GLYCOBIOL; YOSHIDA N, 1989, INFECT IMMUN, V57, P1663, DOI 10.1128/IAI.57.6.1663-1667.1989	32	41	42	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11132	11142		10.1074/jbc.M113.492512	http://dx.doi.org/10.1074/jbc.M113.492512			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24573683	Green Published, hybrid			2022-12-28	WOS:000334638500017
J	Burgess, RJ; Han, JH; Zhang, ZG				Burgess, Rebecca J.; Han, Junhong; Zhang, Zhiguo			The Ddc1-Mec3-Rad17 Sliding Clamp Regulates HistoneHistone Chaperone Interactions and DNA Replicationcoupled Nucleosome Assembly in Budding Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Checkpoint Control; Chromatin; Chromatin Regulation; DNA Damage Response; DNA Replication; Histone Chaperone; Histones; CAF-1; Rtt106; Nucleosome Assembly	DAMAGE CHECKPOINT; HISTONE-H3 LYSINE-56; FORK PROGRESSION; GENOME; ACETYLATION; RESPONSES; REPAIR; ASF1; RECOGNITION; INHERITANCE	Background: Genome stability is maintained in part by chromatin structure and checkpoint factors. Results: Yeast cells harboring mutations in the Ddc1-Mec3-Rad17 checkpoint complex exhibit synthetic phenotypes with histone chaperone mutants. Conclusion: The Ddc1-Mec3-Rad17 complex regulates nucleosome assembly. Significance: Checkpoint factors and histone chaperones coordinate to maintain genome integrity. The maintenance of genome integrity is regulated in part by chromatin structure and factors involved in the DNA damage response pathway. Nucleosome assembly is a highly regulated process that restores chromatin structure after DNA replication, DNA repair, and gene transcription. During S phase the histone chaperones Asf1, CAF-1, and Rtt106 coordinate to deposit newly synthesized histones H3-H4 onto replicated DNA in budding yeast. Here we describe synthetic genetic interactions between RTT106 and the DDC1-MEC3-RAD17 (9-1-1) complex, a sliding clamp functioning in the S phase DNA damage and replication checkpoint response, upon treatment with DNA damaging agents. The DNA damage sensitivity of rad17 rtt106 cells depends on the function of Rtt106 in nucleosome assembly. Epistasis analysis reveals that 9-1-1 complex components interact with multiple DNA replication-coupled nucleosome assembly factors, including Rtt106, CAF-1, and lysine residues of H3-H4. Furthermore, rad17 cells exhibit defects in the deposition of newly synthesized H3-H4 onto replicated DNA. Finally, deletion of RAD17 results in increased association of Asf1 with checkpoint kinase Rad53, which may lead to the observed reduction in Asf1-H3 interaction in rad17 mutant cells. In addition, we observed that the interaction between histone H3-H4 with histone chaperone CAF-1 or Rtt106 increases in cells lacking Rad17. These results support the idea that the 9-1-1 checkpoint protein regulates DNA replication-coupled nucleosome assembly in part through regulating histone-histone chaperone interactions.	[Burgess, Rebecca J.; Han, Junhong; Zhang, Zhiguo] Mayo Clin, Coll Med, Ctr Individualized Med, Dept Biochem & Mol Biol,Epigen Translat Program, Rochester, MN 55905 USA	Mayo Clinic	Zhang, ZG (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, 200 First St SW, Rochester, MN 55905 USA.	zhang.zhiguo@mayo.edu		Han, Junhong/0000-0002-3371-8698	National Institutes of Health [GM72719, GM81838]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072719, R01GM081838] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM72719 and GM81838.	Adam S, 2013, CELL, V155, P94, DOI 10.1016/j.cell.2013.08.029; Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; Bandyopadhyay S, 2010, SCIENCE, V330, P1385, DOI 10.1126/science.1195618; Beli P, 2012, MOL CELL, V46, P212, DOI 10.1016/j.molcel.2012.01.026; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; Burgess RJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002846; Burgess RJ, 2010, PROTEIN CELL, V1, P607, DOI 10.1007/s13238-010-0086-y; Burgess RJ, 2010, CELL CYCLE, V9, P2979, DOI 10.4161/cc.9.15.12498; Burgess RJ, 2010, MOL CELL, V37, P469, DOI 10.1016/j.molcel.2010.01.020; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Cook AJL, 2011, MOL CELL, V44, P918, DOI 10.1016/j.molcel.2011.11.021; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Emili A, 2001, MOL CELL, V7, P13, DOI 10.1016/S1097-2765(01)00150-2; Fazly A, 2012, J BIOL CHEM, V287, P10753, DOI 10.1074/jbc.M112.347450; Fry RC, 2005, ANNU REV MICROBIOL, V59, P357, DOI 10.1146/annurev.micro.59.031805.133658; Gamper AM, 2012, J BIOL CHEM, V287, P12445, DOI 10.1074/jbc.M112.352310; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Green CM, 2000, CURR BIOL, V10, P39, DOI 10.1016/S0960-9822(99)00263-8; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Guenole A, 2013, MOL CELL, V49, P346, DOI 10.1016/j.molcel.2012.11.023; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Han JH, 2013, CELL, V155, P817, DOI 10.1016/j.cell.2013.10.014; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hu FH, 2001, GENE DEV, V15, P1061, DOI 10.1101/gad.873201; Huang SB, 2005, P NATL ACAD SCI USA, V102, P13410, DOI 10.1073/pnas.0506176102; Karras GI, 2013, MOL CELL, V49, P536, DOI 10.1016/j.molcel.2012.11.016; Komata M, 2009, MOL CELL BIOL, V29, P5008, DOI 10.1128/MCB.01934-08; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Li Q, 2012, BBA-GENE REGUL MECH, V1819, P238, DOI 10.1016/j.bbagrm.2011.06.013; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Liu HD, 2013, MOL CELL, V50, P723, DOI 10.1016/j.molcel.2013.04.025; Liu LF, 2000, ANN NY ACAD SCI, V922, P1; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Majka J, 2003, P NATL ACAD SCI USA, V100, P2249, DOI 10.1073/pnas.0437148100; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Majka J, 2006, J BIOL CHEM, V281, P27855, DOI 10.1074/jbc.M605176200; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; Myung K, 2003, P NATL ACAD SCI USA, V100, P6640, DOI 10.1073/pnas.1232239100; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Povlsen LK, 2012, NAT CELL BIOL, V14, P1089, DOI 10.1038/ncb2579; Ramey CJ, 2004, MOL CELL BIOL, V24, P10313, DOI 10.1128/MCB.24.23.10313-10327.2004; Ransom M, 2010, CELL, V140, P183, DOI 10.1016/j.cell.2010.01.004; Redon C, 2003, EMBO REP, V4, P678, DOI 10.1038/sj.embor.embor871; Rodriguez J, 2013, GENE DEV, V27, P74, DOI 10.1101/gad.202978.112; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sabbioneda S, 2005, J BIOL CHEM, V280, P38657, DOI 10.1074/jbc.M507638200; Sharp JA, 2005, GENETICS, V171, P885, DOI 10.1534/genetics.105.044719; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Su D, 2012, NATURE, V483, P104, DOI 10.1038/nature10861; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Tkach JM, 2012, NAT CELL BIOL, V14, P966, DOI 10.1038/ncb2549; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	62	2	2	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10518	10529		10.1074/jbc.M114.552463	http://dx.doi.org/10.1074/jbc.M114.552463			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24573675	Green Published, hybrid			2022-12-28	WOS:000334226400025
J	Miranda-Laferte, E; Ewers, D; Guzman, RE; Jordan, N; Schmidt, S; Hidalgo, P				Miranda-Laferte, Erick; Ewers, David; Guzman, Raul E.; Jordan, Nadine; Schmidt, Silke; Hidalgo, Patricia			The N-terminal Domain Tethers the Voltage-gated Calcium Channel beta(2e)- subunit to the Plasma Membrane via Electrostatic and Hydrophobic Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Channels; Electrophysiology; Phospholipid; Plasma Membrane; Tryptophan	FLUORESCENCE-SPECTRA; PROTEIN INTERACTIONS; SECONDARY STRUCTURE; PREDICTION; PALMITOYLATION; INACTIVATION; MODULATION; SEQUENCE; COMPLEX; HELICES	Background: Membrane recruitment of the calcium channel (2e)-subunit remains elusive. Results: Charge neutralization of (2e) N-terminal residues abolishes its lipid-binding and surface-targeting abilities and its slow inactivation-conferring phenotype. Conclusion: The (2e)-subunit anchors to the membrane via electrostatic interactions likely involving an N-terminal in-plane -helix and a tryptophan side-chain penetration. Significance: A novel mechanism for -subunit membrane-anchoring supporting slow inactivation is presented. The -subunit associates with the (1) pore-forming subunit of high voltage-activated calcium channels and modulates several aspects of ion conduction. Four -subunits are encoded by four different genes with multiple splice variants. Only two members of this family, (2a) and (2e), associate with the plasma membrane in the absence of the (1)-subunit. Palmitoylation on a di-cysteine motif located at the N terminus of (2a) promotes membrane targeting and correlates with the unique ability of this protein to slow down inactivation. In contrast, the mechanism by which (2e) anchors to the plasma membrane remains elusive. Here, we identified an N-terminal segment in (2e) encompassing a cluster of positively charged residues, which is strictly required for membrane anchoring, and when transferred to the cytoplasmic (1b) isoform it confers membrane localization to the latter. In the presence of negatively charged phospholipid vesicles, this segment binds to acidic liposomes dependently on the ionic strength, and the intrinsic fluorescence emission maxima of its single tryptophan blue shifts considerably. Simultaneous substitution of more than two basic residues impairs membrane targeting. Coexpression of the fast inactivating R-type calcium channels with wild-type (2e), but not with a (2e) membrane association-deficient mutant, slows down inactivation. We propose that a predicted -helix within this domain orienting parallel to the membrane tethers the (2e)-subunit to the lipid bilayer via electrostatic interactions. Penetration of the tryptophan side chain into the lipidic core stabilizes the membrane-bound conformation. This constitutes a new mechanism for membrane anchoring among the -subunit family that also sustains slowed inactivation.	[Miranda-Laferte, Erick; Guzman, Raul E.; Jordan, Nadine; Hidalgo, Patricia] Forschungszentrum Julich, Inst Complex Syst 4, Zellulare Biophys ICS 4, D-52425 Julich, Germany; [Ewers, David; Schmidt, Silke] Hannover Med Sch, Inst Neurophysiol, D-30625 Hannover, Germany	Helmholtz Association; Research Center Julich; Hannover Medical School	Hidalgo, P (corresponding author), Forschungszentrum Julich, Inst Complex Syst, Zellulare Biophys ICS 4, D-52425 Julich, Germany.	pa.hidalgo@fz-juelich.de	Hidalgo, Patricia/I-7506-2013; Ewers, David/AAG-8478-2021	Hidalgo, Patricia/0000-0002-4162-6590; Ewers, David/0000-0003-1037-1027	Deutsche Forschungsgemeinschaft [Hi 800/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant Hi 800/3-1 (to P. H.).	Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Burstein EA, 1996, PHOTOCHEM PHOTOBIOL, V64, P316, DOI 10.1111/j.1751-1097.1996.tb02464.x; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Chien AJ, 1998, J BIOENERG BIOMEMBR, V30, P377, DOI 10.1023/A:1021941706726; Chien AJ, 1998, J BIOL CHEM, V273, P23590, DOI 10.1074/jbc.273.36.23590; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; CHUNG LA, 1992, BIOCHEMISTRY-US, V31, P6608, DOI 10.1021/bi00143a035; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Gonzalez-Gutierrez G, 2008, P NATL ACAD SCI USA, V105, P14198, DOI 10.1073/pnas.0806558105; Hidalgo P, 2007, CELL CALCIUM, V42, P389, DOI 10.1016/j.ceca.2007.05.009; Hidalgo P, 2006, J BIOL CHEM, V281, P24104, DOI 10.1074/jbc.M605930200; Hui EF, 2006, BIOPHYS J, V91, P1767, DOI 10.1529/biophysj.105.080325; Jones LP, 1998, J GEN PHYSIOL, V112, P125, DOI 10.1085/jgp.112.2.125; Keller S, 2007, CHEMBIOCHEM, V8, P546, DOI 10.1002/cbic.200600553; Khandelia H, 2008, BBA-BIOMEMBRANES, V1778, P1528, DOI 10.1016/j.bbamem.2008.02.009; Link S, 2009, J BIOL CHEM, V284, P30129, DOI 10.1074/jbc.M109.045583; Lomize AL, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-44; MAO D, 1984, BIOCHEMISTRY-US, V23, P2667, DOI 10.1021/bi00307a020; Martin SW, 2006, CELL CALCIUM, V39, P275, DOI 10.1016/j.ceca.2005.11.002; Mui B, 2003, METHOD ENZYMOL, V367, P3; OLCESE R, 1994, NEURON, V13, P1433, DOI 10.1016/0896-6273(94)90428-6; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; Reshetnyak YK, 2001, BIOPHYS J, V81, P1735, DOI 10.1016/S0006-3495(01)75825-0; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Sapay N, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-255; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stotz SC, 2004, J PHYSIOL-LONDON, V554, P263, DOI 10.1113/jphysiol.2003.047068; Takahashi SX, 2003, BIOPHYS J, V84, P3007, DOI 10.1016/S0006-3495(03)70027-7; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x	37	27	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10387	10398		10.1074/jbc.M113.507244	http://dx.doi.org/10.1074/jbc.M113.507244			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24519939	Green Published, hybrid			2022-12-28	WOS:000334226400013
J	Chen, CC; Chen, LL; Hsu, YT; Liu, KJ; Fan, CS; Huang, TS				Chen, Chia-Chi; Chen, Li-Li; Hsu, Yu-Ting; Liu, Ko-Jiunn; Fan, Chi-Shuan; Huang, Tze-Sing			The Endothelin-Integrin Axis Is Involved in Macrophage- induced Breast Cancer Cell Chemotactic Interactions with Endothelial Cells*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell-Cell Interaction; Chemotaxis; Endothelin; Macrophages; Tumor Microenvironment	OVARIAN-CARCINOMA CELLS; TUMOR-CELLS; E-SELECTIN; TRANSENDOTHELIAL MIGRATION; INVASION; METASTASIS; EXPRESSION; ACTIVATION; GROWTH; INFLAMMATION	Background: The relation between tumor-infiltrating macrophages and tumor cell migration/invasion toward blood vessels remained unclear. Results: Macrophage induced the endothelin-integrin axis to stimulate breast cancer cell chemotaxis and adhesion toward endothelial cells and transendothelial migration. Conclusion: Our data suggest how macrophages affect cancer cell interactions with endothelial cells. Significance: The endothelin-integrin axis has a pivotal role in breast cancer microenvironment. Elevated macrophage infiltration in tumor tissues is associated with breast cancer metastasis. Cancer cell migration/invasion toward angiogenic microvasculature is a key step in metastatic spread. We therefore studied how macrophages stimulated breast cancer cell interactions with endothelial cells. Macrophages produced cytokines, such as interleukin-8 and tumor necrosis factor-, to stimulate endothelin (ET) and ET receptor (ETR) expression in breast cancer cells and human umbilical vascular endothelial cells (HUVECs). ET-1 was induced to a greater extent from HUVECs than from breast cancer cells, resulting in a density difference that facilitated cancer cell chemotaxis toward HUVECs. Macrophages also stimulated breast cancer cell adhesion to HUVECs and transendothelial migration, which were repressed by ET-1 antibody or ETR inhibitors. The ET axis induced integrins, such as (V) and (1), and their counterligands, such as intercellular adhesion molecule-2 and P-selectin, in breast cancer cells and HUVECs, and antibodies against these integrins efficiently suppressed macrophage-stimulated breast cancer cell interactions with HUVECs. ET-1 induced Ets-like kinase-1 (Elk-1), signal transducer and activator of transcription-3 (STAT-3), and nuclear factor-B (NF-B) phosphorylation in breast cancer cells. The use of inhibitors to prevent their phosphorylation or ectopic overexpression of dominant-negative IB perturbed ET-1-induced integrin (V) and integrin (1) expression. The physical associations of these three transcriptional factors with the gene promoters of the two integrins were furthermore evidenced by a chromatin immunoprecipitation assay. Finally, our mouse orthotopic tumor model revealed an ET axis-mediated lung metastasis of macrophage-stimulated breast cancer cells, suggesting that the ET axis was involved in macrophage-enhanced breast cancer cell endothelial interactions.	[Chen, Chia-Chi; Chen, Li-Li; Hsu, Yu-Ting; Liu, Ko-Jiunn; Fan, Chi-Shuan; Huang, Tze-Sing] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan Town 350, Miaoli, Taiwan	National Health Research Institutes - Taiwan	Huang, TS (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, 35 Keyan Rd, Zhunan Town 350, Miaoli, Taiwan.	tshuang@nhri.org.tw	Liu, Ko-Jiunn/D-2098-2010; Huang, Tze-Sing/E-3667-2010; Huang, Tze-Sing/C-9361-2013	Huang, Tze-Sing/0000-0001-8736-4330	National Health Research Institutes [CA-099-PP-10]; Department of Health, Taiwan, Republic of China [DOH102-TD-C-111-004]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan); Department of Health, Taiwan, Republic of China	This work was supported by National Health Research Institutes Grant CA-099-PP-10 and Department of Health Grant DOH102-TD-C-111-004, Taiwan, Republic of China.	Bagnato A, 1999, CANCER RES, V59, P720; Bagnato Anna, 2004, J Transl Med, V2, P16, DOI 10.1186/1479-5876-2-16; Baldwin AL, 2001, CRIT REV BIOMED ENG, V29, P247, DOI 10.1615/CritRevBiomedEng.v29.i2.20; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bar-Eli M, 1999, PATHOBIOLOGY, V67, P12, DOI 10.1159/000028045; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bingle L, 2006, BRIT J CANCER, V94, P101, DOI 10.1038/sj.bjc.6602901; Chen WS, 2013, J BIOL CHEM, V288, P9001, DOI 10.1074/jbc.M112.437897; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Davis DM, 2004, TRENDS IMMUNOL, V25, P323, DOI 10.1016/j.it.2004.03.007; Dua RS, 2005, EJSO-EUR J SURG ONC, V31, P824, DOI 10.1016/j.ejso.2005.05.015; Dustin ML, 2012, J CLIN INVEST, V122, P1149, DOI 10.1172/JCI58705; Grant K, 2003, BRIT J CANCER, V88, P163, DOI 10.1038/sj.bjc.6700750; Grimshaw MJ, 2005, CANCER LETT, V222, P129, DOI 10.1016/j.canlet.2004.08.029; Guise TA, 2003, CANCER-AM CANCER SOC, V97, P779, DOI 10.1002/cncr.11129; Haier J, 2001, DIS COLON RECTUM, V44, P876, DOI 10.1007/BF02234713; Haynes WG, 1998, J HYPERTENS, V16, P1081, DOI 10.1097/00004872-199816080-00001; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hordijk PL, 2006, FEBS J, V273, P4408, DOI 10.1111/j.1742-4658.2006.05440.x; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; Hu YY, 2000, J IMMUNOL, V165, P2142, DOI 10.4049/jimmunol.165.4.2142; Huang TS, 1996, CANCER LETT, V110, P77, DOI 10.1016/S0304-3835(96)04464-3; Huang TS, 2003, BIOCHEM BIOPH RES CO, V300, P901, DOI 10.1016/S0006-291X(02)02962-5; Jovanovic M, 2009, PLACENTA, V30, P320, DOI 10.1016/j.placenta.2009.01.013; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; KUSUHARA M, 1990, CANCER RES, V50, P3257; Laferriere J, 2001, J BIOL CHEM, V276, P33762, DOI 10.1074/jbc.M008564200; Lee C-C, 2006, J CANC MOL, V2, P155; Lee CC, 2006, J CANC MOL, V2, P135; Lee CY, 2011, J CELL BIOCHEM, V112, P2549, DOI 10.1002/jcb.23179; Leek RD, 1996, CANCER RES, V56, P4625; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; MCEVER RP, 1995, J BIOL CHEM, V270, P11025, DOI 10.1074/jbc.270.19.11025; Montecucco F, 2008, CELL SIGNAL, V20, P557, DOI 10.1016/j.cellsig.2007.11.008; Nelson J, 2003, NAT REV CANCER, V3, P110, DOI 10.1038/nrc990; Penna C, 2006, J CARDIOVASC MED, V7, P645, DOI 10.2459/01.JCM.0000242996.19077.ba; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Pukrop T, 2006, P NATL ACAD SCI USA, V103, P5454, DOI 10.1073/pnas.0509703103; Robinson-Smith TM, 2007, CANCER RES, V67, P5708, DOI 10.1158/0008-5472.CAN-06-4375; Rosano L, 2002, CLIN SCI, V103, p306S, DOI 10.1042/CS103S306S; Rosano L, 2001, CANCER RES, V61, P8340; Said N, 2011, J CLIN INVEST, V121, P132, DOI 10.1172/JCI42912; Salani D, 2000, AM J PATHOL, V157, P1537, DOI 10.1016/S0002-9440(10)64791-8; Shih JY, 2006, J CANC MOL, V2, P101; Spinella F, 2002, J BIOL CHEM, V277, P27850, DOI 10.1074/jbc.M202421200; Stefanidakis M, 2006, BLOOD, V108, P1441, DOI 10.1182/blood-2006-02-005363; Tremblay PL, 2006, ONCOGENE, V25, P6563, DOI 10.1038/sj.onc.1209664; Tucker Gordon C, 2006, Curr Oncol Rep, V8, P96, DOI 10.1007/s11912-006-0043-3; von Bulow C, 2001, J PATHOL, V193, P367, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH810>3.0.CO;2-1; Waterston A, 2004, CANC THERAPY, V2, P131; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Wiesner S, 2005, CELL MOL LIFE SCI, V62, P1081, DOI 10.1007/s00018-005-4522-8; WONG M, 1995, BIOCHEM MOL BIOL INT, V35, P1359; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Zouki C, 1999, BRIT J PHARMACOL, V127, P969, DOI 10.1038/sj.bjp.0702593	57	16	17	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10029	10044		10.1074/jbc.M113.528406	http://dx.doi.org/10.1074/jbc.M113.528406			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24550382	hybrid, Green Published			2022-12-28	WOS:000333807000051
J	Eresheim, C; Leeb, C; Buchegger, P; Nimpf, J				Eresheim, Christine; Leeb, Christian; Buchegger, Patricia; Nimpf, Johannes			Signaling by the Extracellular Matrix Protein Reelin Promotes Granulosa Cell Proliferation in the Chicken Follicle*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Proliferation; Lipoprotein Receptor; Molecular Cell Biology; Phosphotyrosine Signaling; Signal Transduction	DENSITY-LIPOPROTEIN RECEPTOR; LIGAND-BINDING REPEATS; VLDL RECEPTOR; TYROSINE PHOSPHORYLATION; NEURONAL MIGRATION; BRAIN-DEVELOPMENT; DOMINANT; MOUSE; DAB1; EXPRESSION	Background: The control of rapid proliferation of granulosa cells during chicken oocyte growth is unknown. Results: Reelin is expressed in theca cells and triggers disabled-1 phosphorylation in granulosa cells via ApoER2 and the VLDL receptor. Conclusion: The Reelin signaling pathway stimulates granulosa cell proliferation during folliculogenesis. Significance: This work demonstrates a novel function of Reelin. Chicken oocytes develop in follicles and reach an enormous size because of a massive uptake of yolk precursors such as very low density lipoprotein and vitellogenin. Oocyte growth is supported by theca cells and granulosa cells, which establish dynamic and highly organized cell layers surrounding the oocyte. The signaling processes orchestrating the development of these layered structures are largely unknown. Here we demonstrate that the Reelin pathway, which determines the development of layered neuronal structures in the brain, is also active in chicken follicles. Reelin, which is expressed in theca cells, triggers a signal in granulosa cells via apolipoprotein E receptor 2 and the very low density lipoprotein receptor, resulting in the phosphorylation of disabled-1 and consecutive activation of the phosphatidylinositol 3-kinase/Akt pathway. This signaling pathway supports the proliferation of differentiated granulosa cells to keep up with the demand of cells to cover the rapidly increasing surface of the giant germ cell.	[Eresheim, Christine; Leeb, Christian; Buchegger, Patricia; Nimpf, Johannes] Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Nimpf, J (corresponding author), Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, Dr Bohr Gasse 9-2, A-1030 Vienna, Austria.	Johannes.Nimpf@meduniwien.ac.at		Nimpf, Johannes/0000-0002-9273-3492	Austrian Science Fund (FWF) [P 24767-B21]; Austrian Science Fund (FWF) [P 24767] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund (FWF) Grant P 24767-B21 (to J. N.).	Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Blake SM, 2008, EMBO J, V27, P3069, DOI 10.1038/emboj.2008.223; Bock HH, 2003, J BIOL CHEM, V278, P38772, DOI 10.1074/jbc.M306416200; Brandes C, 2001, J BIOL CHEM, V276, P22160, DOI 10.1074/jbc.M102662200; BUJO H, 1995, J BIOL CHEM, V270, P23546, DOI 10.1074/jbc.270.40.23546; BUJO H, 1994, EMBO J, V13, P5165, DOI 10.1002/j.1460-2075.1994.tb06847.x; Cooper JA, 2008, TRENDS NEUROSCI, V31, P113, DOI 10.1016/j.tins.2007.12.003; Fayad T, 2004, BIOL REPROD, V70, P523, DOI 10.1095/biolreprod.103.021709; Fayad T, 2007, BIOL REPROD, V76, P466, DOI 10.1095/biolreprod.106.057216; Frotscher M, 2010, TRENDS NEUROSCI, V33, P407, DOI 10.1016/j.tins.2010.06.001; Gao ZH, 2013, CELL MOL LIFE SCI, V70, P2319, DOI 10.1007/s00018-012-1171-6; Gao ZH, 2010, MOL CELL BIOL, V30, P4339, DOI 10.1128/MCB.00545-10; Hermann M, 1998, FASEB J, V12, P897, DOI 10.1096/fasebj.12.10.897; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; HUANG ESR, 1979, BIOL REPROD, V20, P454, DOI 10.1095/biolreprod20.3.454; Hummel S, 2007, J BIOL CHEM, V282, P8011, DOI 10.1074/jbc.M606029200; JOHNSON A L, 1990, Critical Reviews in Poultry Biology, V2, P319; Jossin Yves, 2011, Small GTPases, V2, P322; Katyal S, 2004, EMBO J, V23, P1878, DOI 10.1038/sj.emboj.7600185; Kim D, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.109694; Kisliouk T, 2013, NEUROSCIENCE, V238, P114, DOI 10.1016/j.neuroscience.2013.02.020; Koch S, 2002, EMBO J, V21, P5996, DOI 10.1093/emboj/cdf599; Mayer H, 2006, MOL CELL BIOL, V26, P19, DOI 10.1128/MCB.26.1.19-27.2006; Nimpf J, 1998, ATHEROSCLEROSIS, V141, P191, DOI 10.1016/S0021-9150(98)00172-5; Novak S, 1996, J BIOL CHEM, V271, P11732, DOI 10.1074/jbc.271.20.11732; PERRY MM, 1978, J ANAT, V125, P481; Recheis B, 2000, J BIOL CHEM, V275, P35320, DOI 10.1074/jbc.M005025200; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Rice DS, 2001, NEURON, V31, P929, DOI 10.1016/S0896-6273(01)00436-6; Schmierer B, 2003, BIOL REPROD, V68, P620, DOI 10.1095/biolreprod.102.008714; Schneider WJ, 2003, CELL MOL LIFE SCI, V60, P892, DOI 10.1007/s00018-003-2183-z; Schuster MK, 2004, BIOL REPROD, V70, P1493, DOI 10.1095/biolreprod.103.024331; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Sisco B, 2003, ENDOCRINOLOGY, V144, P3904, DOI 10.1210/en.2003-0485; Strasser V, 2004, MOL CELL BIOL, V24, P1378, DOI 10.1128/MCB.24.3.1378-1386.2004; TAKAHASHI S, 1992, P NATL ACAD SCI USA, V89, P9252, DOI 10.1073/pnas.89.19.9252; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Willnow TE, 1998, BIOL CHEM, V379, P1025	40	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10182	10191		10.1074/jbc.M113.533489	http://dx.doi.org/10.1074/jbc.M113.533489			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24573679	Green Published, hybrid			2022-12-28	WOS:000333807000063
J	Joe, MK; Kwon, HS; Cojocaru, R; Tomarev, SI				Joe, Myung Kuk; Kwon, Heung Sun; Cojocaru, Radu; Tomarev, Stanislav I.			Myocilin Regulates Cell Proliferation and Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Cell Growth; Cell Proliferation; Cell Signaling; ERK; Mesenchymal Stem Cells	OPEN-ANGLE GLAUCOMA; TRABECULAR MESHWORK CELLS; MESENCHYMAL STEM-CELLS; GENE-EXPRESSION; PROTEIN COMPLEX; GASTRIC-CANCER; KINASE KINASE; NON-SECRETION; TUMOR-GROWTH; ER STRESS	Background: The physiological function(s) of myocilin, a glaucoma-associated protein, is poorly understood. Results: Myocilin enhances cell proliferation and survival together with the activation of the ERK signaling pathway. Myocilin-deficient mesenchymal stem cells demonstrate reduced proliferation and survival. Conclusion: Myocilin participates in the regulation of cell growth and survival. Significance: This study provides new insight into the role of myocilin in ocular and non-ocular tissues. Myocilin, a causative gene for open angle glaucoma, encodes a secreted glycoprotein with poorly understood functions. To gain insight into its functions, we produced a stably transfected HEK293 cell line expressing myocilin under an inducible promoter and compared gene expression profiles between myocilin-expressing and vector control cell lines by a microarray analysis. A significant fraction of differentially expressed genes in myocilin-expressing cells was associated with cell growth and cell death, suggesting that myocilin may have a role in the regulation of cell growth and survival. Increased proliferation of myocilin-expressing cells was demonstrated by the WST-1 proliferation assay, direct cell counting, and immunostaining with antibodies against Ki-67, a cellular proliferation marker. Myocilin-containing conditioned medium also increased proliferation of unmodified HEK293 cells. Myocilin-expressing cells were more resistant to serum starvation-induced apoptosis than control cells. TUNEL-positive apoptotic cells were dramatically decreased, and two apoptotic marker proteins, cleaved caspase 7 and cleaved poly(ADP-ribose) polymerase, were significantly reduced in myocilin-expressing cells as compared with control cells under apoptotic conditions. In addition, myocilin-deficient mesenchymal stem cells exhibited reduced proliferation and enhanced susceptibility to serum starvation-induced apoptosis as compared with wild-type mesenchymal stem cells. Phosphorylation of ERK1/2 and its upstream kinases, c-Raf and MEK, was increased in myocilin-expressing cells compared with control cells. Elevated phosphorylation of ERK1/2 was also observed in the trabecular meshwork of transgenic mice expressing 6-fold higher levels of myocilin when compared with their wild-type littermates. These results suggest that myocilin promotes cell proliferation and resistance to apoptosis via the ERK1/2 MAPK signaling pathway.	[Tomarev, Stanislav I.] NEI, SRGCB, LRCMB, NIH, Bethesda, MD 20892 USA; [Cojocaru, Radu] Elsevier Life Sci Solut, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Reed Elsevier; Elsevier	Tomarev, SI (corresponding author), NEI, SRGCB, LRCMB, NIH, Bldg 6,Rm 212,6 Ctr Dr, Bethesda, MD 20892 USA.	tomarevs@nei.nih.gov			National Institutes of Health, NEI, Intramural Research Program; NATIONAL EYE INSTITUTE [ZIAEY000318] Funding Source: NIH RePORTER	National Institutes of Health, NEI, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by the National Institutes of Health, NEI, Intramural Research Program.	Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; ALVARADO J, 1981, INVEST OPHTH VIS SCI, V21, P714; Alward WLM, 1998, NEW ENGL J MED, V338, P1022, DOI 10.1056/NEJM199804093381503; Aroca-Aguilar JD, 2011, INVEST OPHTH VIS SCI, V52, P179, DOI 10.1167/iovs.09-4866; Aung PP, 2006, ONCOGENE, V25, P2546, DOI 10.1038/sj.onc.1209279; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boquest AC, 2005, MOL BIOL CELL, V16, P1131, DOI 10.1091/mbc.E04-10-0949; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Conlon I, 1999, CELL, V96, P235, DOI 10.1016/S0092-8674(00)80563-2; Dismuke WM, 2012, BIOCHEMISTRY-US, V51, P3606, DOI 10.1021/bi300073r; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Fautsch MP, 2006, EXP EYE RES, V82, P1046, DOI 10.1016/j.exer.2005.09.016; Fautsch MP, 2001, INVEST OPHTH VIS SCI, V42, P2324; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fingert JH, 1998, GENOME RES, V8, P377, DOI 10.1101/gr.8.4.377; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; GERDES J, 1984, J IMMUNOL, V133, P1710; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gobeil S, 2004, INVEST OPHTH VIS SCI, V45, P3560, DOI 10.1167/iovs.04-0300; Gong G, 2004, HUM MOL GENET, V13, pR91, DOI 10.1093/hmg/ddh074; Gould DB, 2004, MOL CELL BIOL, V24, P9019, DOI 10.1128/MCB.24.20.9019-9025.2004; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacobson N, 2001, HUM MOL GENET, V10, P117, DOI 10.1093/hmg/10.2.117; Joe MK, 2005, BIOCHEM BIOPH RES CO, V336, P1201, DOI 10.1016/j.bbrc.2005.09.006; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Joe MK, 2012, J BIOL CHEM, V287, P13216, DOI 10.1074/jbc.M111.224063; Joe MK, 2010, AM J PATHOL, V176, P2880, DOI 10.2353/ajpath.2010.090853; Johnson TV, 2014, BRAIN, V137, P503, DOI 10.1093/brain/awt292; Kandyba E, 2013, P NATL ACAD SCI USA, V110, P1351, DOI 10.1073/pnas.1121312110; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Kim BS, 2001, MOL CELL BIOL, V21, P7707, DOI 10.1128/MCB.21.22.7707-7713.2001; Kim KK, 2010, MOL CARCINOGEN, V49, P259, DOI 10.1002/mc.20596; Knepper PA, 1996, INVEST OPHTH VIS SCI, V37, P1360; Koshida S, 2007, CANCER SCI, V98, P315, DOI 10.1111/j.1349-7006.2006.00383.x; Kubota R, 1997, GENOMICS, V41, P360, DOI 10.1006/geno.1997.4682; Kurata H, 2000, EXP CELL RES, V254, P180, DOI 10.1006/excr.1999.4738; Kwon HS, 2013, J BIOL CHEM, V288, P26357, DOI 10.1074/jbc.M112.446138; Kwon HS, 2011, J CELL PHYSIOL, V226, P3392, DOI 10.1002/jcp.22701; Kwon HS, 2013, J BIOL CHEM, V288, P16882, DOI 10.1074/jbc.M112.422972; Kwon HS, 2009, MOL CELL BIOL, V29, P2139, DOI 10.1128/MCB.01274-08; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Liu YH, 2004, HUM MOL GENET, V13, P1193, DOI 10.1093/hmg/ddh128; LUTJENDRECOLL E, 1981, INVEST OPHTH VIS SCI, V21, P563; Malyukova I, 2006, INVEST OPHTH VIS SCI, V47, P206, DOI 10.1167/iovs.05-0220; Marimuthu A, 2013, BBA-PROTEINS PROTEOM, V1834, P2308, DOI 10.1016/j.bbapap.2013.04.029; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Miljkovic-Licina M, 2012, MOL CANCER THER, V11, P2588, DOI 10.1158/1535-7163.MCT-12-0245; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Ohlmann A, 2003, GLIA, V43, P128, DOI 10.1002/glia.10233; Ortego J, 1997, FEBS LETT, V413, P349, DOI 10.1016/S0014-5793(97)00934-4; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Polansky JR, 1997, OPHTHALMOLOGICA, V211, P126, DOI 10.1159/000310780; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Shearer T, 2001, EXP EYE RES, V73, P25, DOI 10.1006/exer.2001.1007; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Starborg M, 1996, J CELL SCI, V109, P143; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Sudbeck BD, 1999, BIOCHEM J, V339, P167, DOI 10.1042/0264-6021:3390167; Tamm ER, 2002, PROG RETIN EYE RES, V21, P395, DOI 10.1016/S1350-9462(02)00010-1; Tomarev SI, 2003, INVEST OPHTH VIS SCI, V44, P2588, DOI 10.1167/iovs.02-1099; Tomarev SI, 1998, BIOCHEM BIOPH RES CO, V245, P887, DOI 10.1006/bbrc.1998.8541; Tomarev SI, 2009, MOL NEUROBIOL, V40, P122, DOI 10.1007/s12035-009-8076-x; Torrado M, 2002, HUM MOL GENET, V11, P1291, DOI 10.1093/hmg/11.11.1291; Ueda J, 2002, INVEST OPHTH VIS SCI, V43, P1068; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; Wentz-Hunter K, 2002, INVEST OPHTH VIS SCI, V43, P176; Wordinger RJ, 1999, PROG RETIN EYE RES, V18, P629, DOI 10.1016/S1350-9462(98)00035-4; Zhang XW, 2004, CANCER RES, V64, P2474, DOI 10.1158/0008-5472.CAN-03-3443; Zhou Y, 2008, INVEST OPHTH VIS SCI, V49, P1932, DOI 10.1167/iovs.07-1339; Zhou ZH, 1999, HUM MOL GENET, V8, P2221, DOI 10.1093/hmg/8.12.2221; Zode GS, 2011, J CLIN INVEST, V121, P3542, DOI 10.1172/JCI58183	76	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10155	10167		10.1074/jbc.M113.547091	http://dx.doi.org/10.1074/jbc.M113.547091			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24563482	hybrid, Green Published			2022-12-28	WOS:000333807000061
J	Shih, PM; Zarzycki, J; Niyogi, KK; Kerfeld, CA				Shih, Patrick M.; Zarzycki, Jan; Niyogi, Krishna K.; Kerfeld, Cheryl A.			Introduction of a Synthetic CO2fixing Photorespiratory Bypass into a Cyanobacterium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergy; Cyanobacteria; Metabolic Engineering; Photosynthesis; Rubisco; Synthetic Biology; 3-Hydroxypropionate Bi-cycle; Chloroflexus; Synechococcus	CHLOROFLEXUS-AURANTIACUS; 3-HYDROXYPROPIONATE CYCLE; KEY ENZYME; PHOTOSYNTHESIS; METABOLISM; OPTIMALITY; PATHWAYS; COLI	Background: Photorespiration limits carbon fixation. Results: Heterologous expression and functional activity of six enzymes from the 3-hydroxypropionate bi-cycle are demonstrated in cyanobacteria. Conclusion: A synthetic CO2-fixing photorespiratory bypass can be introduced into cyanobacteria. Significance: The results lay the foundation for expressing an alternative CO2 fixation pathway in cyanobacteria, algae, and plants. Global photosynthetic productivity is limited by the enzymatic assimilation of CO2 into organic carbon compounds. Ribulose-1,5-bisphosphate carboxylase/oxygenase (RuBisCO), the carboxylating enzyme of the Calvin-Benson cycle, poorly discriminates between CO2 and O-2, leading to photorespiration and the loss of fixed carbon and nitrogen. With the advent of synthetic biology, it is now feasible to design, synthesize, and introduce biochemical pathways in vivo. We engineered a synthetic photorespiratory bypass based on the 3-hydroxypropionate bi-cycle into the model cyanobacterium, Synechococcus elongatus sp. PCC 7942. The heterologously expressed cycle is designed to function as both a photorespiratory bypass and an additional CO2-fixing pathway, supplementing the Calvin-Benson cycle. We demonstrate the function of all six introduced enzymes and identify bottlenecks to be targeted in subsequent bioengineering. These results have implications for efforts to improve photosynthesis and for the green production of high value products of biotechnological interest.	[Shih, Patrick M.; Niyogi, Krishna K.; Kerfeld, Cheryl A.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Shih, Patrick M.; Niyogi, Krishna K.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Kerfeld, Cheryl A.] Univ Calif Berkeley, Synthet Biol Inst, Berkeley, CA 94720 USA; [Zarzycki, Jan; Kerfeld, Cheryl A.] Michigan State Univ, Dept Energy Plant, Res Labs, Dept Biochem & Mol Biol, E Lansing, MI USA; [Zarzycki, Jan; Niyogi, Krishna K.; Kerfeld, Cheryl A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Michigan State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Niyogi, KK (corresponding author), Univ Calif Berkeley, 111 Koshland Hall, Berkeley, CA 94720 USA.	niyogi@berkeley.edu; ckerfeld@lbl.gov		Zarzycki, Jan/0000-0002-6307-6497	National Science Foundation [MCB0851054]; Gordon and Betty Moore Foundation [GBMF3070]; United States Department of Energy [DE-AC02 05CH11231]	National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); United States Department of Energy(United States Department of Energy (DOE))	Supported by National Science Foundation Grant MCB0851054 (to C. A. K.) and by Gordon and Betty Moore Foundation Grant GBMF3070 (to K. K. N.).; Supported by United States Department of Energy Contract DE-AC02 05CH11231.	Alber BE, 2002, J BIOL CHEM, V277, P12137, DOI 10.1074/jbc.M110802200; Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; Blankenship RE, 2011, SCIENCE, V332, P805, DOI 10.1126/science.1200165; Clerico Eugenia M, 2007, Methods Mol Biol, V362, P155; Dahl RH, 2013, NAT BIOTECHNOL, V31, P1039, DOI 10.1038/nbt.2689; Ducat DC, 2011, P NATL ACAD SCI USA, V108, P3941, DOI 10.1073/pnas.1016026108; Eisenhut M, 2008, P NATL ACAD SCI USA, V105, P17199, DOI 10.1073/pnas.0807043105; Eisenhut M, 2006, PLANT PHYSIOL, V142, P333, DOI 10.1104/pp.106.082982; Fuchs G, 2011, ANNU REV MICROBIOL, V65, P631, DOI 10.1146/annurev-micro-090110-102801; Hesselmann RPX, 1999, SYST APPL MICROBIOL, V22, P454, DOI 10.1016/S0723-2020(99)80055-1; Horswill AR, 2001, J BIOL CHEM, V276, P19094, DOI 10.1074/jbc.M100244200; Hu Z.-H., 2010, ENV ANAEROBIC TECHNO, P259; Hugler M, 2002, J BACTERIOL, V184, P2404, DOI 10.1128/JB.184.9.2404-2410.2002; Keasling JD, 2010, SCIENCE, V330, P1355, DOI 10.1126/science.1193990; Kebeish R, 2007, NAT BIOTECHNOL, V25, P593, DOI 10.1038/nbt1299; Kizer L, 2008, APPL ENVIRON MICROB, V74, P3229, DOI 10.1128/AEM.02750-07; Lipscomb T. W., 2012, ENG COMPLEX PHENOTYP, P185, DOI [10.1002/9781118433034.ch7, DOI 10.1002/9781118433034.CH7]; Mackey Shannon R, 2007, Methods Mol Biol, V362, P115; Maier A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00038; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Mattozzi MD, 2013, METAB ENG, V16, P130, DOI 10.1016/j.ymben.2013.01.005; Niederholtmeyer H, 2010, APPL ENVIRON MICROB, V76, P3462, DOI 10.1128/AEM.00202-10; Nogales J, 2012, P NATL ACAD SCI USA, V109, P2678, DOI 10.1073/pnas.1117907109; Pellicer MT, 1996, J BACTERIOL, V178, P2051, DOI 10.1128/jb.178.7.2051-2059.1996; SASAKI Y, 1995, PLANT PHYSIOL, V108, P445, DOI 10.1104/pp.108.2.445; Savir Y, 2010, P NATL ACAD SCI USA, V107, P3475, DOI 10.1073/pnas.0911663107; SHARKEY TD, 1988, PHYSIOL PLANTARUM, V73, P147, DOI 10.1111/j.1399-3054.1988.tb09205.x; Tcherkez GGB, 2006, P NATL ACAD SCI USA, V103, P7246, DOI 10.1073/pnas.0600605103; Zarzycki J, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-28; Zarzycki J, 2013, J EXP BOT, V64, P787, DOI 10.1093/jxb/ers294; Zarzycki J, 2011, APPL ENVIRON MICROB, V77, P6181, DOI 10.1128/AEM.00705-11; Zarzycki J, 2009, P NATL ACAD SCI USA, V106, P21317, DOI 10.1073/pnas.0908356106	32	62	66	3	73	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9493	9500		10.1074/jbc.C113.543132	http://dx.doi.org/10.1074/jbc.C113.543132			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24558040	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000333807000006
J	Faure, L; Nagarajan, S; Hwang, H; Montgomery, CL; Khan, BR; John, G; Koulen, P; Blancaflor, EB; Chapman, KD				Faure, Lionel; Nagarajan, Subbiah; Hwang, Hyeondo; Montgomery, Christa L.; Khan, Bibi Rafeiza; John, George; Koulen, Peter; Blancaflor, Elison B.; Chapman, Kent D.			Synthesis of Phenoxyacyl-Ethanolamides and Their Effects on Fatty Acid Amide Hydrolase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis; Enzyme Kinetics; Lipids; Plant; Signaling; N-Acylethanolamines; Fatty Acid Amide Hydrolase; Synthetic Compounds	N-ACYLETHANOLAMINE; ANANDAMIDE; METABOLISM; OVEREXPRESSION; IDENTIFICATION; CONSTITUENT; HYDROLYSIS; INHIBITOR; PATHWAY; ANALOGS	Background: Fatty acid amide hydrolase (FAAH) belongs to the family of amidase signature proteins and is involved in N-acylethanolamine (NAE) metabolism. Results: New synthetic phenoxyacyl-ethanolamide compounds increased the amidohydrolase activity of FAAH. Conclusion: Phenoxyacyl-ethanolamide compounds increased the activity of the FAAH enzyme in plants and animals. Significance: New properties of FAAH proteins were revealed with these phenoxyacyl-ethanolamide compounds, and the potential for their applications in vivo was demonstrated. N-Acylethanolamines (NAEs) are involved in numerous biological activities in plant and animal systems. The metabolism of these lipids by fatty acid amide hydrolase (FAAH) is a key regulatory point in NAE signaling activity. Several active site-directed inhibitors of FAAH have been identified, but few compounds have been described that enhance FAAH activity. Here we synthesized two sets of phenoxyacyl-ethanolamides from natural products, 3-n-pentadecylphenolethanolamide and cardanolethanolamide, with structural similarity to NAEs and characterized their effects on the hydrolytic activity of FAAH. Both compounds increased the apparent V-max of recombinant FAAH proteins from both plant (Arabidopsis) and mammalian (Rattus) sources. These NAE-like compounds appeared to act by reducing the negative feedback regulation of FAAH activity by free ethanolamine. Both compounds added to seedlings relieved, in part, the negative growth effects of exogenous NAE12:0. Cardanolethanolamide reduced neuronal viability and exacerbated oxidative stress-mediated cell death in primary cultured neurons at nanomolar concentrations. This was reversed by FAAH inhibitors or exogenous NAE substrate. Collectively, our data suggest that these phenoxyacyl-ethanolamides act to enhance the activity of FAAH and may stimulate the turnover of NAEs in vivo. Hence, these compounds might be useful pharmacological tools for manipulating FAAH-mediated regulation of NAE signaling in plants or animals.	[Faure, Lionel; Koulen, Peter; Blancaflor, Elison B.; Chapman, Kent D.] Univ N Texas, Dept Biol Sci, Ctr Plant Lipid Res, Denton, TX 76203 USA; [Nagarajan, Subbiah; Hwang, Hyeondo; John, George] CUNY City Coll, Dept Chem, New York, NY 10031 USA; [Montgomery, Christa L.; Koulen, Peter] Univ Missouri, Vis Res Ctr, Dept Ophthalmol, Sch Med, Kansas City, MO 64108 USA; [Koulen, Peter] Univ Missouri, Dept Basic Med Sci, Sch Med, Kansas City, MO 64108 USA; [Khan, Bibi Rafeiza; Blancaflor, Elison B.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73401 USA	University of North Texas System; University of North Texas Denton; City University of New York (CUNY) System; City College of New York (CUNY); University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Noble Research Institute	Chapman, KD (corresponding author), Univ N Texas, Dept Biol Sci, Ctr Plant Lipid Res, 1155 Union Circle,305220, Denton, TX 76203 USA.	chapman@unt.edu		Chapman, Kent/0000-0003-0489-3072; Faure, Lionel/0000-0002-7022-3934; Blancaflor, Elison/0000-0001-6115-9670; Subbiah, Nagarajan/0000-0003-2233-4872; Khan, Bibi/0000-0002-7661-0142	National Institutes of Health (NIH), NEI [EY022774]; NIH, NIA [AG010485, AG022550, AG027956]; NIH NCRR; NIH, NIGMS [RR027093]; United States Department of Energy, Office of Science, Division of Basic Energy Sciences [DE-FG02-05ER15647]; Research to Prevent Blindness; Felix and Carmen Sabates Missouri Endowed Chair in Vision Research; Vision Research Foundation of Kansas City; National Science Foundation Chemical, Bioengineering, Environmental, and Transport Systems (CBET) (Rapid) [1046099]; Gulf of Mexico Research Initiative (GoMRI) [SA 12-05/GoMRI-002, TUL-626-11/12]; Professional Staff Congress-City University of New York (PSC-CUNY) awards; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027093] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022550, P01AG027956, P01AG010485] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Department of Energy, Office of Science, Division of Basic Energy Sciences(United States Department of Energy (DOE)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Felix and Carmen Sabates Missouri Endowed Chair in Vision Research; Vision Research Foundation of Kansas City; National Science Foundation Chemical, Bioengineering, Environmental, and Transport Systems (CBET) (Rapid); Gulf of Mexico Research Initiative (GoMRI); Professional Staff Congress-City University of New York (PSC-CUNY) awards; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NEI, Grant EY022774; NIH, NIA, Grants AG010485, AG022550, and AG027956; the NIH NCRR; and NIH, NIGMS, Grant RR027093 (to P. K.). This work was also supported by the United States Department of Energy, Office of Science, Division of Basic Energy Sciences, Grant DE-FG02-05ER15647 (to K. D. C. and E. B. B.).; Supported by a Challenge Grant from Research to Prevent Blindness, the Felix and Carmen Sabates Missouri Endowed Chair in Vision Research, and the Vision Research Foundation of Kansas City.; Supported in part by National Science Foundation Chemical, Bioengineering, Environmental, and Transport Systems (CBET) (Rapid) Grant 1046099, Gulf of Mexico Research Initiative (GoMRI) Grant SA 12-05/GoMRI-002 (subcontract TUL-626-11/12), and Professional Staff Congress-City University of New York (PSC-CUNY) awards.	Balachandran VS, 2010, ANGEW CHEM INT EDIT, V49, P9509, DOI 10.1002/anie.201002260; Balachandran VS, 2013, CHEM SOC REV, V42, P427, DOI 10.1039/c2cs35344j; Blancaflor EB, 2003, PLANTA, V217, P206, DOI 10.1007/s00425-003-0985-8; Boger DL, 2000, BIOORG MED CHEM LETT, V10, P2613, DOI 10.1016/S0960-894X(00)00528-X; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; Busquets-Garcia A, 2011, BIOL PSYCHIAT, V70, P479, DOI 10.1016/j.biopsych.2011.04.022; Chapman KD, 2004, PROG LIPID RES, V43, P302, DOI 10.1016/j.plipres.2004.03.002; Cota D, 2003, J ENDOCRINOL INVEST, V26, P1041, DOI 10.1007/BF03348205; Cota D, 2003, INT J OBESITY, V27, P289, DOI 10.1038/sj.ijo.0802250; Cotter MQ, 2011, PLANT SIGNAL BEHAV, V6, P671, DOI 10.4161/psb.6.5.14704; Coulon D, 2012, PLANT SCI, V184, P129, DOI 10.1016/j.plantsci.2011.12.015; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Cravatt BF, 2003, CURR OPIN CHEM BIOL, V7, P469, DOI 10.1016/S1367-5931(03)00079-6; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2002, PROSTAG LEUKOTR ESS, V66, P377, DOI 10.1054/plef.2001.0349; Duncan RS, 2011, CLIN OPHTHALMOL, V5, P543, DOI 10.2147/OPTH.S18309; Duncan RS, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-50; Garg P, 2010, NEUROSCIENCE, V166, P252, DOI 10.1016/j.neuroscience.2009.11.069; Garg P, 2011, NEUROSCI LETT, V492, P134, DOI 10.1016/j.neulet.2011.01.073; HILLARD CJ, 1995, BBA-LIPID LIPID MET, V1257, P249, DOI 10.1016/0005-2760(95)00087-S; Jonsson KO, 2001, BRIT J PHARMACOL, V133, P1263, DOI 10.1038/sj.bjp.0704199; Kang L, 2008, PLANT J, V56, P336, DOI 10.1111/j.1365-313X.2008.03603.x; Katayama K, 1999, BBA-MOL CELL BIOL L, V1440, P205, DOI 10.1016/S1388-1981(99)00124-9; Kilaru A, 2007, CHEM BIODIVERS, V4, P1933, DOI 10.1002/cbdv.200790161; Kim SC, 2009, J BIOL CHEM, V284, P34065, DOI 10.1074/jbc.M109.059022; Kozubek A, 1999, CHEM REV, V99, P1, DOI 10.1021/cr970464o; Lang WS, 1999, J MED CHEM, V42, P1682, DOI 10.1021/jm990139o; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.0601832103; Luchicchi A, 2012, MOL NEUROBIOL, V46, P374, DOI 10.1007/s12035-012-8299-0; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Mileni M, 2008, P NATL ACAD SCI USA, V105, P12820, DOI 10.1073/pnas.0806121105; NATARAJAN V, 1984, J NEUROCHEM, V42, P1613, DOI 10.1111/j.1471-4159.1984.tb12750.x; Patricelli MP, 1998, BIOCHEMISTRY-US, V37, P15177, DOI 10.1021/bi981733n; Patricelli MP, 1998, BIOORG MED CHEM LETT, V8, P613, DOI 10.1016/S0960-894X(98)00073-0; Shrestha R, 2003, J BIOL CHEM, V278, P34990, DOI 10.1074/jbc.M305613200; Shrestha R, 2002, PLANT PHYSIOL, V130, P391, DOI 10.1104/pp.004689; Shrestha R, 2006, BBA-MOL CELL BIOL L, V1761, P324, DOI 10.1016/j.bbalip.2006.03.004; Teaster ND, 2007, PLANT CELL, V19, P2454, DOI 10.1105/tpc.106.048702; Teaster ND, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00032; Tripathy S, 1999, PLANT PHYSIOL, V121, P1299, DOI 10.1104/pp.121.4.1299; Trox J, 2010, J AGR FOOD CHEM, V58, P5341, DOI 10.1021/jf904580k; Vandevoorde S, 2005, BIOCHEM BIOPH RES CO, V337, P104, DOI 10.1016/j.bbrc.2005.09.015; Wang YS, 2006, P NATL ACAD SCI USA, V103, P12197, DOI 10.1073/pnas.0603571103; Wei BQQ, 2006, J BIOL CHEM, V281, P36569, DOI 10.1074/jbc.M606646200	45	14	14	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9340	9351		10.1074/jbc.M113.533315	http://dx.doi.org/10.1074/jbc.M113.533315			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24558037	Green Published, hybrid			2022-12-28	WOS:000333472100050
J	Kurokawa, S; Bellinger, FP; Hill, KE; Burk, RF; Berry, MJ				Kurokawa, Suguru; Bellinger, Frederick P.; Hill, Kristina E.; Burk, Raymond F.; Berry, Marla J.			Isoform-specific Binding of Selenoprotein P to the beta- Propeller Domain of Apolipoprotein E Receptor 2 Mediates Selenium Supply	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Lipoprotein Receptor; Selenium; Selenocysteine; Selenoprotein; Site-directed Mutagenesis	DENSITY-LIPOPROTEIN RECEPTOR; SELENOCYSTEINE INSERTION; GLUTATHIONE-PEROXIDASE; DIFFERENTIAL FUNCTIONS; MESSENGER-RNA; SPERM DEVELOPMENT; PROXIMAL TUBULE; UGA CODONS; MOUSE; APOER2	Background: ApoER2 facilitates uptake of Sepp1, but the binding mechanism has not been elucidated. Results: The two longest isoforms of Sepp1 bind to the YWTD -propeller domain of apoER2, which functions as a Sepp1 receptor. Conclusion: Only longer Sepp1 isoforms with six or more selenocysteine residues can interact with a unique binding site of apoER2. Significance: ApoER2 takes up long isoform Sepp1 through its YWTD -propeller domain. Sepp1 supplies selenium to tissues via receptor-mediated endocytosis. Mice, rats, and humans have 10 selenocysteines in Sepp1, which are incorporated via recoding of the stop codon, UGA. Four isoforms of rat Sepp1 have been identified, including full-length Sepp1 and three others, which terminate at the second, third, and seventh UGA codons. Previous studies have shown that the longer Sepp1 isoforms bind to the low density lipoprotein receptor apoER2, but the mechanism remains unclear. To identify the essential residues for apoER2 binding, an in vitro Sepp1 binding assay was developed using different Sec to Cys substituted variants of Sepp1 produced in HEK293T cells. ApoER2 was found to bind the two longest isoforms. These results suggest that Sepp1 isoforms with six or more selenocysteines are taken up by apoER2. Furthermore, the C-terminal domain of Sepp1 alone can bind to apoER2. These results indicate that apoER2 binds to the Sepp1 C-terminal domain and does not require the heparin-binding site, which is located in the N-terminal domain. Site-directed mutagenesis identified three residues of Sepp1 that are necessary for apoER2 binding. Sequential deletion of extracellular domains of apoER2 surprisingly identified the YWTD -propeller domain as the Sepp1 binding site. Finally, we show that apoER2 missing the ligand-binding repeat region, which can result from cleavage at a furin cleavage site present in some apoER2 isoforms, can act as a receptor for Sepp1. Thus, longer isoforms of Sepp1 with high selenium content interact with a binding site distinct from the ligand-binding domain of apoER2 for selenium delivery.	[Kurokawa, Suguru; Bellinger, Frederick P.; Berry, Marla J.] Univ Hawaii, Dept Cell & Mol Biol, John A Burns Sch Med, Honolulu, HI 96813 USA; [Hill, Kristina E.; Burk, Raymond F.] Vanderbilt Univ, Sch Med, Div Gastroenterol Hepatol & Nutr, Dept Med, Nashville, TN 37232 USA	University of Hawaii System; Vanderbilt University	Kurokawa, S (corresponding author), Univ Hawaii, Dept Cell & Mol Biol, John A Burns Sch Med, 651 Ilalo St, Honolulu, HI 96813 USA.	kurokawasuguru@gmail.com			National Institutes of Health [DK047320, G12 MD007601]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK047320, R01DK047320] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants DK047320 and G12 MD007601 (to M. J. B.).	Andersen OM, 2003, BIOCHEMISTRY-US, V42, P9355, DOI 10.1021/bi034475p; Andersen OM, 2003, J BIOL CHEM, V278, P23989, DOI 10.1074/jbc.M302157200; BAKER RD, 1993, ARCH BIOCHEM BIOPHYS, V304, P53, DOI 10.1006/abbi.1993.1320; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Beglova N, 2004, MOL CELL, V16, P281, DOI 10.1016/j.molcel.2004.09.038; BERRY MJ, 1993, EMBO J, V12, P3315, DOI 10.1002/j.1460-2075.1993.tb06001.x; BERRY MJ, 1991, NATURE, V353, P273, DOI 10.1038/353273a0; Bosschaerts T, 2008, J IMMUNOL, V180, P6168, DOI 10.4049/jimmunol.180.9.6168; Brandes C, 2001, J BIOL CHEM, V276, P22160, DOI 10.1074/jbc.M102662200; BROWN MS, 1983, CELL, V32, P663, DOI 10.1016/0092-8674(83)90052-1; Bu GJ, 1998, TRENDS CELL BIOL, V8, P272, DOI 10.1016/S0962-8924(98)01283-5; Burk RF, 2013, FASEB J, V27, P3249, DOI 10.1096/fj.13-231852; Chittum HS, 1996, ARCH BIOCHEM BIOPHYS, V325, P124, DOI 10.1006/abbi.1996.0015; Chiu-Ugalde J, 2010, BIOCHEM J, V431, P103, DOI 10.1042/BJ20100779; Christensen EI, 1999, J AM SOC NEPHROL, V10, P2224; Duit S, 2010, J BIOL CHEM, V285, P4896, DOI 10.1074/jbc.M109.025973; Fuentealba RA, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-14; Hibi T, 2009, NEUROSCI RES, V63, P251, DOI 10.1016/j.neures.2008.12.009; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Hill KE, 2004, J NUTR, V134, P157, DOI 10.1093/jn/134.1.157; Hill KE, 1996, J NUTR, V126, P138, DOI 10.1093/jn/126.1.138; Hill KE, 2007, J BIOL CHEM, V282, P10972, DOI 10.1074/jbc.M700436200; Hill KE, 2012, J BIOL CHEM, V287, P40414, DOI 10.1074/jbc.M112.421404; Hondal RJ, 2001, J BIOL CHEM, V276, P15823, DOI 10.1074/jbc.M010405200; Kim DH, 1996, J BIOL CHEM, V271, P8373, DOI 10.1074/jbc.271.14.8373; Koch S, 2002, EMBO J, V21, P5996, DOI 10.1093/emboj/cdf599; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kurokawa S, 2014, FREE RADICAL BIO MED, V69, P67, DOI 10.1016/j.freeradbiomed.2014.01.010; Kurokawa S, 2012, J BIOL CHEM, V287, P28717, DOI 10.1074/jbc.M112.383521; Li YH, 2001, J BIOL CHEM, V276, P18000, DOI 10.1074/jbc.M101589200; Ma SG, 2003, BIOCHEMISTRY-US, V42, P9703, DOI 10.1021/bi0346300; Ma SG, 2002, J BIOL CHEM, V277, P12749, DOI 10.1074/jbc.M111462200; Masiulis I, 2009, BIOL CHEM, V390, P67, DOI 10.1515/BC.2009.011; May P, 2005, CELL MOL LIFE SCI, V62, P2325, DOI 10.1007/s00018-005-5231-z; Mehta A, 2004, J BIOL CHEM, V279, P37852, DOI 10.1074/jbc.M404639200; Olson GE, 2008, J BIOL CHEM, V283, P6854, DOI 10.1074/jbc.M709945200; Olson GE, 2007, J BIOL CHEM, V282, P12290, DOI 10.1074/jbc.M611403200; Olson GE, 2005, BIOL REPROD, V73, P201, DOI 10.1095/biolreprod.105.040360; Saito Y, 1999, J BIOL CHEM, V274, P2866, DOI 10.1074/jbc.274.5.2866; Saito Y, 2004, BIOCHEM J, V381, P841, DOI 10.1042/BJ20040328; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Seale LA, 2012, MOL CELL BIOL, V32, P4141, DOI 10.1128/MCB.00293-12; Stoytcheva Z, 2006, MOL CELL BIOL, V26, P9177, DOI 10.1128/MCB.00856-06; Sun XM, 1999, EUR J BIOCHEM, V262, P230, DOI 10.1046/j.1432-1327.1999.00394.x; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; Wingler K, 1999, EUR J BIOCHEM, V259, P149, DOI 10.1046/j.1432-1327.1999.00012.x; Yamagata M, 2005, J AM SOC NEPHROL, V16, P2338, DOI 10.1681/ASN.2004070599	47	30	31	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9195	9207		10.1074/jbc.M114.549014	http://dx.doi.org/10.1074/jbc.M114.549014			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24532792	Green Published, hybrid			2022-12-28	WOS:000333472100038
J	Murdoch, CE; Shuler, M; Haeussler, DJF; Kikuchi, R; Bearelly, P; Han, JY; Watanabe, Y; Fuster, JJ; Walsh, K; Ho, YS; Bachschmid, MM; Cohen, RA; Matsui, R				Murdoch, Colin E.; Shuler, Michaela; Haeussler, Dagmar J. F.; Kikuchi, Ryosuke; Bearelly, Priyanka; Han, Jingyan; Watanabe, Yosuke; Fuster, Jose J.; Walsh, Kenneth; Ho, Ye-Shih; Bachschmid, Markus M.; Cohen, Richard A.; Matsui, Reiko			Glutaredoxin-1 Up-regulation Induces Soluble Vascular Endothelial Growth Factor Receptor 1, Attenuating Post-ischemia Limb Revascularization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Angiogenesis; Animal Models; Glutathionylation; Ischemia; NF-kappa B (NF-B); Redox Regulation; Vascular Endothelial Growth Factor (VEGF)	NF-KAPPA-B; S-GLUTATHIONYLATION; REDOX REGULATION; ANGIOTENSIN-II; CELL FUNCTION; MOUSE MODEL; DNA-BINDING; ANGIOGENESIS; GLUTATHIOLATION; ACTIVATION	Background: Glutaredoxin-1 (Glrx) inhibits endothelial cell migration by reversing protein-glutathione adducts. Results: Revascularization after hind limb ischemia was inhibited in Glrx transgenic mice. Glrx overexpression increased soluble VEGF receptor 1 (sFlt) in endothelial cells via NF-B-dependent Wnt5a production. Conclusion: Glrx enhances Wnt5a-induced anti-angiogenic sFlt in endothelial cells. Significance: Up-regulated Glrx inhibits VEGF signaling by increased sFlt causing impaired vascularization. Glutaredoxin-1 (Glrx) is a cytosolic enzyme that regulates diverse cellular function by removal of GSH adducts from S-glutathionylated proteins including signaling molecules and transcription factors. Glrx is up-regulated during inflammation and diabetes, and Glrx overexpression inhibits VEGF-induced EC migration. The aim was to investigate the role of up-regulated Glrx in EC angiogenic capacities and in vivo revascularization in the setting of hind limb ischemia. Glrx-overexpressing EC from Glrx transgenic (TG) mice showed impaired migration and network formation and secreted higher levels of soluble VEGF receptor 1 (sFlt), an antagonizing factor to VEGF. After hind limb ischemia surgery Glrx TG mice demonstrated impaired blood flow recovery, associated with lower capillary density and poorer limb motor function compared with wild type littermates. There were also higher levels of anti-angiogenic sFlt expression in the muscle and plasma of Glrx TG mice after surgery. Noncanonical Wnt5a is known to induce sFlt. Wnt5a was highly expressed in ischemic muscles and EC from Glrx TG mice, and exogenous Wnt5a induced sFlt expression and inhibited network formation in human microvascular EC. Adenoviral Glrx-induced sFlt in EC was inhibited by a competitive Wnt5a inhibitor. Furthermore, Glrx overexpression removed GSH adducts on p65 in ischemic muscle and EC and enhanced NF-B activity, which was responsible for Wnt5a-sFlt induction. Taken together, up-regulated Glrx induces sFlt in EC via NF-B-dependent Wnt5a, resulting in attenuated revascularization in hind limb ischemia. The Glrx-induced sFlt explains part of the mechanism of redox-regulated VEGF signaling.	[Murdoch, Colin E.; Shuler, Michaela; Haeussler, Dagmar J. F.; Bearelly, Priyanka; Han, Jingyan; Watanabe, Yosuke; Bachschmid, Markus M.; Cohen, Richard A.; Matsui, Reiko] Boston Univ, Vasc Biol Sect, Dept Med, Boston, MA 02118 USA; [Murdoch, Colin E.; Shuler, Michaela; Haeussler, Dagmar J. F.; Kikuchi, Ryosuke; Bearelly, Priyanka; Han, Jingyan; Watanabe, Yosuke; Fuster, Jose J.; Walsh, Kenneth; Bachschmid, Markus M.; Cohen, Richard A.; Matsui, Reiko] Boston Univ, Whitaker Cardiovasc Inst, Dept Med, Boston, MA 02118 USA; [Ho, Ye-Shih] Wayne State Univ, Inst Environm Hlth Sci, Dept Biochem & Mol Biol, Detroit, MI 48202 USA	Boston University; Boston University; Wayne State University	Matsui, R (corresponding author), Boston Univ, Vasc Biol Sect, Dept Med, 650 Albany St, Boston, MA 02118 USA.	rmatsui@bu.edu	Kikuchi, Ryosuke/AAX-4971-2021; Murdoch, Colin Edward/I-1106-2019	Murdoch, Colin Edward/0000-0002-0274-819X; Bachschmid, Markus Michael/0000-0002-0748-5528; /0000-0002-1070-6408; Fuster, Jose Javier/0000-0002-5970-629X	National Institutes of Health [PO1 HL 068758, R37 HL104017, HL081587, HL007224]; NHLBI [HHSN268201000031C]; Department of Medicine, Boston University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007224, R37HL104017, P01HL068758, P01HL081587] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Medicine, Boston University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL 068758, R37 HL104017 (to R. A. C.), and HL081587 (to K. W.) and NHLBI Contract HHSN268201000031C (to R. A. C.). This work was also supported by Robert Dawson Evans Scholar Award from the Department of Medicine, Boston University School of Medicine (to R. A. C.).; Supported by a Cardiovascular post-doctoral Training Grant from the National Institutes of Health, HL007224.	Abdelsaid MA, 2012, J CELL SCI, V125, P4751, DOI 10.1242/jcs.103481; Adachi T, 2004, NAT MED, V10, P1200, DOI 10.1038/nm1119; Adachi T, 2004, J BIOL CHEM, V279, P29857, DOI 10.1074/jbc.M313320200; Adluri RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034790; Aesif SW, 2011, FREE RADICAL BIO MED, V51, P1249, DOI 10.1016/j.freeradbiomed.2011.06.025; Ahmad S, 2004, CIRC RES, V95, P884, DOI 10.1161/01.RES.0000147365.86159.f5; Ahmad S, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-15; Bachschmid MM, 2010, FREE RADICAL BIO MED, V49, P1221, DOI 10.1016/j.freeradbiomed.2010.07.005; Barrett WC, 1999, J BIOL CHEM, V274, P34543, DOI 10.1074/jbc.274.49.34543; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Boeckel JN, 2011, P NATL ACAD SCI USA, V108, P3276, DOI 10.1073/pnas.1008098108; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Clavreul N, 2006, FASEB J, V20, P518, DOI 10.1096/fj.05-4875fje; Clavreul N, 2006, ARTERIOSCL THROM VAS, V26, P2454, DOI 10.1161/01.ATV.0000242791.28953.4c; Du Y., 2013, ACTA DIABETOL, DOI 10.1007/s00592-013-0498-2; Dulce RA, 2011, CIRC RES, V108, P531, DOI 10.1161/RES.0b013e3182147d74; Evangelista AM, 2012, ANTIOXID REDOX SIGN, V17, P1099, DOI 10.1089/ars.2011.4022; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Haeussler DJ, 2013, J BIOL CHEM, V288, P15380, DOI 10.1074/jbc.M112.427765; Hazarika S, 2007, CIRC RES, V101, P948, DOI 10.1161/CIRCRESAHA.107.160630; Jacobi J, 2004, CIRCULATION, V110, P2424, DOI 10.1161/01.CIR.0000145142.85645.EA; Jenei V, 2009, P NATL ACAD SCI USA, V106, P19473, DOI 10.1073/pnas.0909409106; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Khazaei M, 2011, CLINICS, V66, P1419, DOI 10.1590/S1807-59322011000800019; Kikuchi A, 2012, ACTA PHYSIOL, V204, P17, DOI 10.1111/j.1748-1716.2011.02294.x; Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181; Kisseleva T, 2006, J CLIN INVEST, V116, P2955, DOI 10.1172/JCI27392; Klatt P, 1999, J BIOL CHEM, V274, P15857, DOI 10.1074/jbc.274.22.15857; Klatt P, 2000, EUR J BIOCHEM, V267, P4928, DOI 10.1046/j.1432-1327.2000.01601.x; Koch S., 2012, COLD SPRING HARBOR P, P2; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Liu QH, 2012, CIRC RES, V110, P1077, DOI 10.1161/CIRCRESAHA.111.260729; Lukosz M, 2010, ANTIOXID REDOX SIGN, V12, P713, DOI 10.1089/ars.2009.2609; LUTHMAN M, 1982, J BIOL CHEM, V257, P6686; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Mikels A, 2009, J BIOL CHEM, V284, P30167, DOI 10.1074/jbc.M109.041715; Nanbara H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034434; O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305; Ohashi K, 2010, J BIOL CHEM, V285, P22291, DOI 10.1074/jbc.M110.123794; Okuda M, 2001, ARTERIOSCL THROM VAS, V21, P1483, DOI 10.1161/hq0901.095550; Patten IS, 2012, NATURE, V485, P333, DOI 10.1038/nature11040; Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o; Qanungo S, 2007, J BIOL CHEM, V282, P18427, DOI 10.1074/jbc.M610934200; Rahimi N, 2009, CANCER RES, V69, P2607, DOI 10.1158/0008-5472.CAN-08-2905; Reynaert NL, 2007, AM J RESP CELL MOL, V36, P147, DOI 10.1165/rcmb.2006-0259RC; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Shao D., 2014, J BIOL CHEM, DOI 10.1074/jbc.M113.520403; Shelton MD, 2008, MOL CELLS, V25, P332; Shelton MD, 2007, J BIOL CHEM, V282, P12467, DOI 10.1074/jbc.M610863200; Shelton MD, 2009, J BIOL CHEM, V284, P4759, DOI 10.1074/jbc.M805464200; Song JJ, 2003, BIOCHEM J, V373, P845, DOI 10.1042/BJ20030275; Stefater JA, 2013, BLOOD, V121, P2574, DOI 10.1182/blood-2012-06-434621; Stefater JA, 2011, NATURE, V474, P511, DOI 10.1038/nature10085; Tabruyn SP, 2007, CELL DEATH DIFFER, V14, P1393, DOI 10.1038/sj.cdd.4402156; Tirziu D, 2012, CIRCULATION, V126, P2589, DOI 10.1161/CIRCULATIONAHA.112.119321; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; Velu CS, 2007, BIOCHEMISTRY-US, V46, P7765, DOI 10.1021/bi700425y; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200; Zee RS, 2010, ANTIOXID REDOX SIGN, V13, P1023, DOI 10.1089/ars.2010.3251	60	50	52	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8633	8644		10.1074/jbc.M113.517219	http://dx.doi.org/10.1074/jbc.M113.517219			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24482236	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000333157500053
J	Otzen, C; Bardl, B; Jacobsen, ID; Nett, M; Brock, M				Otzen, Christian; Bardl, Bettina; Jacobsen, Ilse D.; Nett, Markus; Brock, Matthias			Candida albicans Utilizes a Modified beta-Oxidation Pathway for the Degradation of Toxic Propionyl-CoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid; Candida albicans; Enzyme Kinetics; Fatty Acid Metabolism; Fatty Acid Oxidation; Pathogenesis; CUG clade; -Hydroxypropionate; Odd-chain Fatty Acids	METHYLMALONATE-SEMIALDEHYDE DEHYDROGENASE; FUNGUS ASPERGILLUS-FUMIGATUS; SACCHAROMYCES-CEREVISIAE; COENZYME-A; 3-HYDROXYISOBUTYRATE DEHYDROGENASE; METHYLCITRATE SYNTHASE; ESCHERICHIA-COLI; GLYOXYLATE CYCLE; PHENOTYPIC CHARACTERIZATION; TRANSCRIPTIONAL RESPONSE	Background: Propionyl-CoA is a common metabolic intermediate that requires degradation to avoid intoxication of cellular metabolism. Results: A key enzyme involved in a modified -oxidation pathway in Candida albicans has been identified. Conclusion: Although fungi generally use the methyl citrate cycle to degrade propionyl-CoA, CUG clade yeasts form an exception. Significance: The modified -oxidation pathway could provide a target for new antifungal compounds. Propionyl-CoA arises as a metabolic intermediate from the degradation of propionate, odd-chain fatty acids, and some amino acids. Thus, pathways for catabolism of this intermediate have evolved in all kingdoms of life, preventing the accumulation of toxic propionyl-CoA concentrations. Previous studies have shown that fungi generally use the methyl citrate cycle for propionyl-CoA degradation. Here, we show that this is not the case for the pathogenic fungus Candida albicans despite its ability to use propionate and valerate as carbon sources. Comparative proteome analyses suggested the presence of a modified -oxidation pathway with the key intermediate 3-hydroxypropionate. Gene deletion analyses confirmed that the enoyl-CoA hydratase/dehydrogenase Fox2p, the putative 3-hydroxypropionyl-CoA hydrolase Ehd3p, the 3-hydroxypropionate dehydrogenase Hpd1p, and the putative malonate semialdehyde dehydrogenase Ald6p essentially contribute to propionyl-CoA degradation and its conversion to acetyl-CoA. The function of Hpd1p was further supported by the detection of accumulating 3-hydroxypropionate in the hpd1 mutant on propionyl-CoA-generating nutrients. Substrate specificity of Hpd1p was determined from recombinant purified enzyme, which revealed a preference for 3-hydroxypropionate, although serine and 3-hydroxyisobutyrate could also serve as substrates. Finally, virulence studies in a murine sepsis model revealed attenuated virulence of the hpd1 mutant, which indicates generation of propionyl-CoA from host-provided nutrients during infection.	[Otzen, Christian; Bardl, Bettina; Jacobsen, Ilse D.; Nett, Markus] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, D-07745 Jena, Germany; [Brock, Matthias] Univ Jena, Inst Microbiol, D-07745 Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Brock, M (corresponding author), Univ Jena, Beutenbergstr 11a, D-07745 Jena, Germany.	Matthias.brock@hki-jena.de	Jacobsen, Ilse/B-3155-2011; Brock, Matthias/AAX-1430-2021	Jacobsen, Ilse/0000-0002-6033-9984; Nett, Markus/0000-0003-0847-086X; Brock, Matthias/0000-0003-2774-1856	Hans-Knoell-Institute; Jena School for Microbial Communication	Hans-Knoell-Institute; Jena School for Microbial Communication	This work was supported by funds from the Hans-Knoell-Institute and the Jena School for Microbial Communication.	Ansede JH, 1999, APPL ENVIRON MICROB, V65, P5075; Barelle CJ, 2006, CELL MICROBIOL, V8, P961, DOI 10.1111/j.1462-5822.2005.00676.x; Brock M, 2005, APPL ENVIRON MICROB, V71, P5465, DOI 10.1128/AEM.71.9.5465-5475.2005; Brock M, 2004, EUR J BIOCHEM, V271, P3227, DOI 10.1111/j.1432-1033.2004.04255.x; Brock M, 2002, EUR J BIOCHEM, V269, P6184, DOI 10.1046/j.1432-1033.2002.03336.x; Brock M, 2001, EUR J BIOCHEM, V268, P3577, DOI 10.1046/j.1432-1327.2001.02262.x; Brock M, 2000, MOL MICROBIOL, V35, P961, DOI 10.1046/j.1365-2958.2000.01737.x; Brock M., 2010, HDB HYDROCARBON LIPI, P3279; Brock M, 2009, CURR OPIN MICROBIOL, V12, P371, DOI 10.1016/j.mib.2009.05.004; Brzostek A, 2009, J BACTERIOL, V191, P6584, DOI 10.1128/JB.00488-09; Chandler RJ, 2005, MOL GENET METAB, V86, P34, DOI 10.1016/j.ymgme.2005.07.020; Chowdhury EK, 1996, BIOSCI BIOTECH BIOCH, V60, P2043, DOI 10.1271/bbb.60.2043; De Lucas JR, 1999, ARCH MICROBIOL, V171, P386, DOI 10.1007/s002030050725; De Lucas JR, 2001, FEMS MICROBIOL LETT, V201, P193, DOI 10.1016/S0378-1097(01)00261-0; Domin N, 2009, MICROBIOL-SGM, V155, P3903, DOI 10.1099/mic.0.031781-0; Fazius F, 2012, MOL MICROBIOL, V86, P1508, DOI 10.1111/mmi.12076; Fleck CB, 2011, INT J MED MICROBIOL, V301, P400, DOI 10.1016/j.ijmm.2011.04.007; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; GOODWIN GW, 1989, J BIOL CHEM, V264, P14965; Gow NAR, 2012, CURR OPIN MICROBIOL, V15, P406, DOI 10.1016/j.mib.2012.04.005; Graybill ER, 2007, ARCH BIOCHEM BIOPHYS, V465, P26, DOI 10.1016/j.abb.2007.04.039; Griffin JE, 2012, CHEM BIOL, V19, P218, DOI 10.1016/j.chembiol.2011.12.016; Grimm C, 2003, J MOL BIOL, V328, P609, DOI 10.1016/S0022-2836(03)00358-9; HALARNKAR PP, 1989, COMP BIOCHEM PHYS B, V92, P227, DOI 10.1016/0305-0491(89)90270-8; HASEGAWA J, 1982, J FERMENT TECHNOL, V60, P591; HASEGAWA J, 1981, AGR BIOL CHEM TOKYO, V45, P2805, DOI 10.1080/00021369.1981.10864958; Hawes JW, 1996, J BIOL CHEM, V271, P26430, DOI 10.1074/jbc.271.42.26430; Hortschansky P, 2007, EMBO J, V26, P3157, DOI 10.1038/sj.emboj.7601752; Hynes MJ, 2011, EUKARYOT CELL, V10, P547, DOI 10.1128/EC.00295-10; Ibrahim-Granet O, 2008, CELL MICROBIOL, V10, P134, DOI 10.1111/j.1462-5822.2007.01025.x; Ishigure K, 2001, CLIN CHIM ACTA, V312, P115, DOI 10.1016/S0009-8981(01)00597-6; Kim J, 2011, J MICROBIOL, V49, P171, DOI 10.1007/s12275-011-1064-7; Kniemeyer O, 2006, CURR GENET, V49, P178, DOI 10.1007/s00294-005-0047-9; Lee SH, 2009, J MICROBIOL BIOTECHN, V19, P474, DOI 10.4014/jmb.0808.473; Lee SH, 2009, EUKARYOT CELL, V8, P1155, DOI 10.1128/EC.00335-08; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Lorenz MC, 2002, EUKARYOT CELL, V1, P657, DOI 10.1128/EC.1.5.657-662.2002; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Lucas KA, 2007, J BIOL CHEM, V282, P24980, DOI 10.1074/jbc.M701028200; Luttik MAH, 2000, J BACTERIOL, V182, P7007, DOI 10.1128/JB.182.24.7007-7013.2000; Maerker C, 2005, FEBS J, V272, P3615, DOI 10.1111/j.1742-4658.2005.04784.x; MIYAKOSHI S, 1987, AGR BIOL CHEM TOKYO, V51, P2381; Moran C, 2009, PEDIATR INFECT DIS J, V28, P433, DOI 10.1097/INF.0b013e3181920ffd; Morath MA, 2008, J INHERIT METAB DIS, V31, P35, DOI 10.1007/s10545-007-0571-5; Muller S, 2011, ENVIRON MICROBIOL, V13, P1534, DOI 10.1111/j.1462-2920.2011.02458.x; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; OOIWA T, 1995, BBA-GEN SUBJECTS, V1243, P216, DOI 10.1016/0304-4165(94)00061-2; Otzen C, 2013, FEMS YEAST RES, V13, P553, DOI 10.1111/1567-1364.12057; Piekarska K, 2008, MICROBIOL-SGM, V154, P3061, DOI 10.1099/mic.0.2008/020289-0; Piekarska K, 2006, EUKARYOT CELL, V5, P1847, DOI 10.1128/EC.00093-06; POPOV KM, 1992, BIOCHIM BIOPHYS ACTA, V1119, P69, DOI 10.1016/0167-4838(92)90236-7; PRONK JT, 1994, MICROBIOL-UK, V140, P717, DOI 10.1099/00221287-140-4-717; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x; Rubin-Bejerano I, 2003, P NATL ACAD SCI USA, V100, P11007, DOI 10.1073/pnas.1834481100; Schwab MA, 2006, BIOCHEM J, V398, P107, DOI 10.1042/BJ20060221; Shareck J, 2011, EUKARYOT CELL, V10, P1004, DOI 10.1128/EC.05030-11; Shen YQ, 2009, FUNCT INTEGR GENOMIC, V9, P145, DOI 10.1007/s10142-008-0095-6; SHIMOMURA Y, 1994, J BIOL CHEM, V269, P14248; STEELE MI, 1992, J BIOL CHEM, V267, P13585; Stines-Chaumeil C, 2006, BIOCHEM J, V395, P107, DOI 10.1042/BJ20051525; Strijbis K, 2008, EUKARYOT CELL, V7, P610, DOI 10.1128/EC.00017-08; Talfournier F, 2011, J BIOL CHEM, V286, P21971, DOI 10.1074/jbc.M110.213280; Villas-Boas SG, 2006, ANAL BIOCHEM, V349, P297, DOI 10.1016/j.ab.2005.11.019; Vodisch M, 2009, PROTEOMICS, V9, P1407, DOI 10.1002/pmic.200800394; Yao TR, 2010, APPL BIOCHEM BIOTECH, V160, P694, DOI 10.1007/s12010-009-8685-x; Zhang YQ, 2004, GENETICS, V168, P785, DOI 10.1534/genetics.104.027540; Zhou H, 2008, MICROBIOL-SGM, V154, P500, DOI 10.1099/mic.0.2007/014555-0	68	24	24	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8151	8169		10.1074/jbc.M113.517672	http://dx.doi.org/10.1074/jbc.M113.517672			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24497638	hybrid, Green Published			2022-12-28	WOS:000333157500012
J	Pupo, E; Hamstra, HJ; Meiring, H; van der Ley, P				Pupo, Elder; Hamstra, Hendrik-Jan; Meiring, Hugo; van der Ley, Peter			Lipopolysaccharide Engineering in Neisseria meningitidis STRUCTURAL ANALYSIS OF DIFFERENT PENTAACYL LIPID A MUTANTS AND COMPARISON OF THEIR MODIFIED AGONIST PROPERTIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biotechnology; Carbohydrate Biosynthesis; Glycolipids; Lipopolysaccharide (LPS); Mass Spectrometry (MS); Neisseria meningitidis; adjuvant; human monocyte; lpxL1; pagL	GRAM-NEGATIVE BACTERIA; ADJUVANT ACTIVITY; IMMUNE-RESPONSE; DC-SIGN; VACCINE; PAGL; BIOSYNTHESIS; EXPRESSION; PROTEIN; CELLS	Background: LPS biosynthesis modification offers the potential to create detoxified variants with improved immunostimulatory properties. Results: Pentaacyl LPS molecules from pagL(+) and lpxL1(-) meningococcal mutants were structurally characterized and found to activate human monocytic cells differentially. Conclusion: PagL-deacylated meningococcal LPS has potential for human immunopotentiation. Significance: These findings expand the knowledge on structure-function relationships of meningococcal LPS in relation to its immunomodulatory properties. Engineering the lipopolysaccharide (LPS) biosynthetic pathway offers the potential to obtain modified derivatives with optimized adjuvant properties. Neisseria meningitidis strain H44/76 was modified by expression of the pagL gene encoding lipid A 3-O-deacylase from Bordetella bronchiseptica and by inactivation of the lgtB gene encoding the terminal oligosaccharide galactosyltransferase. Mass spectrometry analysis of purified mutant LPS was used for detailed compositional analysis of all present molecular species. This determined that the modified LPS was mainly pentaacylated, demonstrating high efficiency of conversion from the hexaacyl to the 3-O-deacylated form by heterologous lipid A 3-O-deacylase (PagL) expression. MS analyses also provided evidence for expression of only one major oligosaccharide glycoform, which lacked the terminal galactose residue as expected from inactivation of the lgtB gene. The immunomodulatory properties of PagL-deacylated LPS were compared with another pentaacyl form obtained from an lpxL1(-) mutant, which lacks the 2 secondary acyl chain. Although both LPS mutants displayed impaired capacity to induce production of the pro-inflammatory cytokine IL-6 in the monocytic cell line Mono Mac 6, induction of the Toll-interleukin-1 receptor domain-containing adaptor-inducing interferon--dependent chemokine interferon--induced protein 10 was largely retained only for the lgtB(-)/pagL(+) mutant. Removal of remaining hexaacyl species exclusively present in lgtB(-)/pagL(+) LPS demonstrated that these minor species potentiate but do not determine the activity of this LPS. These results are the first to indicate a qualitatively different response of human innate cells to pentaacyl lpxL1(-) and pagL(+) LPS and show the importance of detailed structure-function analysis when working with modified lipid A structures. The pagL(+) LPS has significant potential as immune modulator in humans.	[Pupo, Elder; Meiring, Hugo; van der Ley, Peter] Inst Translat Vaccinol, NL-3720 AL Bilthoven, Netherlands; [Hamstra, Hendrik-Jan] Natl Inst Publ Hlth & Environm, NL-3721 MA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment	van der Ley, P (corresponding author), Inst Translat Vaccinol, POB 450, NL-3720 AL Bilthoven, Netherlands.	peter.van.der.ley@intravacc.nl			Marie Curie Intra-European Fellowship [PIEF-GA-2009-252934]	Marie Curie Intra-European Fellowship(European Commission)	This work was supported by Marie Curie Intra-European Fellowship PIEF-GA-2009-252934 (to E. P.).	Arenas J, 2010, CLIN VACCINE IMMUNOL, V17, P487, DOI 10.1128/CVI.00423-09; Baart GJE, 2007, VACCINE, V25, P6399, DOI 10.1016/j.vaccine.2007.06.008; Basu SS, 1999, J BIOL CHEM, V274, P11150, DOI 10.1074/jbc.274.16.11150; Bonasera V, 2007, BIOTECHNIQUES, V43, P173, DOI 10.2144/000112500; Brandtzaeg P, 2002, CURR OPIN INFECT DIS, V15, P247, DOI 10.1097/00001432-200206000-00006; Cox AD, 2002, EUR J BIOCHEM, V269, P4169, DOI 10.1046/j.1432-1033.2002.03131.x; de Vries JJC, 2009, VACCINE, V27, P947, DOI 10.1016/j.vaccine.2008.11.046; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Fransen F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000396; Geurtsen J, 2005, J BIOL CHEM, V280, P8248, DOI 10.1074/jbc.M414235200; Geurtsen J, 2006, INFECT IMMUN, V74, P5574, DOI 10.1128/IAI.00834-06; Gupta G, 2011, MED MICROBIOL IMMUN, V200, P241, DOI 10.1007/s00430-011-0197-y; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; Jennings MP, 1999, MICROBIOL-UK, V145, P3013, DOI 10.1099/00221287-145-11-3013; Jones H. E., 2013, CELL MICROBIOL, DOI 10.1111/cmi.12231; Kang TH, 2009, J GENE MED, V11, P889, DOI 10.1002/jgm.1371; KARKHANIS YD, 1978, ANAL BIOCHEM, V85, P595, DOI 10.1016/0003-2697(78)90260-9; Kondakov A, 2005, EUR J MASS SPECTROM, V11, P535, DOI 10.1255/ejms.721; Lee FKN, 1999, INFECT IMMUN, V67, P1405, DOI 10.1128/IAI.67.3.1405-1414.1999; Maass K, 2007, PROTEOMICS, V7, P4435, DOI 10.1002/pmic.200700253; Maeshima N, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00003; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Miyake K, 2004, TRENDS MICROBIOL, V12, P186, DOI 10.1016/j.tim.2004.02.009; Moran AP, 1996, FEMS IMMUNOL MED MIC, V16, P105, DOI 10.1111/j.1574-695X.1996.tb00127.x; Needham BD, 2013, P NATL ACAD SCI USA, V110, P1464, DOI 10.1073/pnas.1218080110; PAVLIAK V, 1993, J BIOL CHEM, V268, P14146; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; Puig-Kroger A, 2004, J BIOL CHEM, V279, P25680, DOI 10.1074/jbc.M311516200; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Sanders H, 2011, EXPERT REV VACCINES, V10, P323, DOI [10.1586/erv.11.10, 10.1586/ERV.11.10]; Steeghs L, 2006, CELL MICROBIOL, V8, P316, DOI 10.1111/j.1462-5822.2005.00623.x; Steeghs L, 2008, INFECT IMMUN, V76, P3801, DOI 10.1128/IAI.00005-08; Trent MS, 2001, J BIOL CHEM, V276, P9083, DOI 10.1074/jbc.M010730200; van der Ley P, 2001, INFECT IMMUN, V69, P5981, DOI 10.1128/IAI.69.10.5981-5990.2001; van der Ley P, 2011, HUM VACCINES, V7, P886, DOI 10.4161/hv.7.8.16086; van Kooyk Y, 2013, MOL IMMUNOL, V55, P143, DOI 10.1016/j.molimm.2012.10.031; VANDERLEY P, 1995, VACCINE, V13, P401, DOI 10.1016/0264-410X(95)98264-B; vanderLey P, 1997, FEMS MICROBIOL LETT, V146, P247, DOI 10.1016/S0378-1097(96)00484-3; Wakarchuk W, 1996, J BIOL CHEM, V271, P19166, DOI 10.1074/jbc.271.32.19166; Wang XY, 2006, BIOCHEMISTRY-US, V45, P14427, DOI 10.1021/bi061767s; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; WILM MS, 1994, INT J MASS SPECTROM, V136, P167, DOI 10.1016/0168-1176(94)04024-9; Xu W, 2012, J EXP MED, V209, P1813, DOI 10.1084/jem.20112142; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324	45	14	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8668	8680		10.1074/jbc.M114.554345	http://dx.doi.org/10.1074/jbc.M114.554345			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24492609	Green Published, hybrid			2022-12-28	WOS:000333157500056
J	Freemerman, AJ; Johnson, AR; Sacks, GN; Milner, JJ; Kirk, EL; Troester, MA; Macintyre, AN; Goraksha-Hicks, P; Rathmell, JC; Makowski, L				Freemerman, Alex J.; Johnson, Amy R.; Sacks, Gina N.; Milner, J. Justin; Kirk, Erin L.; Troester, Melissa A.; Macintyre, Andrew N.; Goraksha-Hicks, Pankuri; Rathmell, Jeffery C.; Makowski, Liza			Metabolic Reprogramming of Macrophages GLUCOSE TRANSPORTER 1 (GLUT1)-MEDIATED GLUCOSE METABOLISM DRIVES A PROINFLAMMATORY PHENOTYPE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glucose Transport; Glycolysis; Inflammation; Macrophages; Metabolomics; Mitochondrial Metabolism; Obesity; Pentose Phosphate Pathway; Crown-like Structure	ACID-BINDING PROTEIN; ADIPOSE-TISSUE; CHOLESTEROL-BIOSYNTHESIS; ENDOPLASMIC-RETICULUM; DIETARY-CHOLESTEROL; INSULIN-RESISTANCE; CELL ACTIVATION; NADPH OXIDASE; FATTY-ACIDS; EXPRESSION	Background: GLUT1 is the main glucose transporter in certain immune cells. Results: Overexpressing GLUT1 in macrophages results in increased glucose uptake and glucose utilization. Conclusion: Driving glucose uptake and metabolism through GLUT1 induces a proinflammatory response that is dependent upon glycolysis and reactive oxygen species. Significance: Understanding how macrophage substrate metabolism impacts inflammation is crucial to develop novel therapeutics for obesity and diabetes. Glucose is a critical component in the proinflammatory response of macrophages (M phi s). However, the contribution of glucose transporters (GLUTs) and the mechanisms regulating subsequent glucose metabolism in the inflammatory response are not well understood. Because M phi s contribute to obesity-induced inflammation, it is important to understand how substrate metabolism may alter inflammatory function. We report that GLUT1 (SLC2A1) is the primary rate-limiting glucose transporter on proinflammatory-polarized M phi s. Furthermore, in high fat diet-fed rodents, M phi s in crown-like structures and inflammatory loci in adipose and liver, respectively, stain positively for GLUT1. We hypothesized that metabolic reprogramming via increased glucose availability could modulate the M phi inflammatory response. To increase glucose uptake, we stably overexpressed the GLUT1 transporter in RAW264.7 M phi s (GLUT1-OE M phi s). Cellular bioenergetics analysis, metabolomics, and radiotracer studies demonstrated that GLUT1 overexpression resulted in elevated glucose uptake and metabolism, increased pentose phosphate pathway intermediates, with a complimentary reduction in cellular oxygen consumption rates. Gene expression and proteome profiling analysis revealed that GLUT1-OE M phi s demonstrated a hyperinflammatory state characterized by elevated secretion of inflammatory mediators and that this effect could be blunted by pharmacologic inhibition of glycolysis. Finally, reactive oxygen species production and evidence of oxidative stress were significantly enhanced in GLUT1-OE M phi s; antioxidant treatment blunted the expression of inflammatory mediators such as PAI-1 (plasminogen activator inhibitor 1), suggesting that glucose-mediated oxidative stress was driving the proinflammatory response. Our results indicate that increased utilization of glucose induced a ROS-driven proinflammatory phenotype in M phi s, which may play an integral role in the promotion of obesity-associated insulin resistance.	[Freemerman, Alex J.; Johnson, Amy R.; Sacks, Gina N.; Milner, J. Justin; Makowski, Liza] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Nutr, Chapel Hill, NC 27599 USA; [Kirk, Erin L.; Troester, Melissa A.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Kirk, Erin L.; Troester, Melissa A.] Univ N Carolina, Sch Med, Dept Med, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Troester, Melissa A.; Makowski, Liza] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Makowski, Liza] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA; [Macintyre, Andrew N.; Goraksha-Hicks, Pankuri; Rathmell, Jeffery C.] Duke Univ, Sarah W Stedman Ctr Nutr & Metab, Dept Immunol, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University	Makowski, L (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, CB 7461 Dept Nutr,2203 McGavran Greenberg Hall, Chapel Hill, NC 27599 USA.	liza.makowski@unc.edu		Makowski, Liza/0000-0002-5337-8037; Macintyre, Andrew/0000-0002-5297-0207	National Institutes of Health [AA017376, ES019472, P30DK034987, P30DK056350, R01HL108006]; NATIONAL CANCER INSTITUTE [P50CA058223, P30CA014236] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987, P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126, U01ES019472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K99AA017376, R00AA017376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA017376 (UNC University Cancer Research Fund), ES019472, and P30DK034987; to L. M.), P30DK056350 (UNC Nutrition Obesity Research Consortium (to L. M. and M. T.), and R01HL108006 (J. C. R.).	Bentley J, 2003, J BIOL CHEM, V278, P39337, DOI 10.1074/jbc.M305689200; Bhatt AP, 2012, P NATL ACAD SCI USA, V109, P11818, DOI 10.1073/pnas.1205995109; Buller CL, 2008, AM J PHYSIOL-CELL PH, V295, pC836, DOI 10.1152/ajpcell.00554.2007; Chang M, 2009, CELL SIGNAL, V21, P1361, DOI 10.1016/j.cellsig.2009.04.003; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fu YC, 2004, BLOOD CELL MOL DIS, V32, P182, DOI 10.1016/j.bcmd.2003.09.002; Fukuzumi M, 1996, INFECT IMMUN, V64, P108, DOI 10.1128/IAI.64.1.108-112.1996; Gamelli RL, 1996, J LEUKOCYTE BIOL, V59, P639, DOI 10.1002/jlb.59.5.639; Griffin E, 2001, NAT MED, V7, P840, DOI 10.1038/89969; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Hayek T, 2007, ATHEROSCLEROSIS, V195, P277, DOI 10.1016/j.atherosclerosis.2006.12.026; Johnson AR, 2012, IMMUNOL REV, V249, P218, DOI 10.1111/j.1600-065X.2012.01151.x; Kaplan M, 2008, J CARDIOVASC PHARM, V52, P324, DOI 10.1097/FJC.0b013e3181879d98; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; MacIver NJ, 2008, J LEUKOCYTE BIOL, V84, P949, DOI 10.1189/jlb.0108024; Makowski L, 2005, J BIOL CHEM, V280, P12888, DOI 10.1074/jbc.M413788200; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Malide D, 1998, AM J PHYSIOL-ENDOC M, V274, pE516, DOI 10.1152/ajpendo.1998.274.3.E516; Mauerer R, 2009, EXP MOL MED, V41, P126, DOI 10.3858/emm.2009.41.2.015; Mauldin JP, 2008, CIRCULATION, V117, P2785, DOI 10.1161/CIRCULATIONAHA.107.741314; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; NEWSHOLME P, 1986, BIOCHEM J, V239, P121, DOI 10.1042/bj2390121; Nishi T, 2002, J BIOL CHEM, V277, P44548, DOI 10.1074/jbc.M202970200; O'Rourke L, 2002, J BIOL CHEM, V277, P42557, DOI 10.1074/jbc.M202151200; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ogden Cynthia L, 2013, NCHS Data Brief, P1; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Qin YY, 2014, ALCOHOL CLIN EXP RES, V38, P204, DOI 10.1111/acer.12210; Salh B, 1998, J IMMUNOL, V161, P6947; Sampey BP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038812; Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; SPOLARICS Z, 1994, J LEUKOCYTE BIOL, V56, P453, DOI 10.1002/jlb.56.4.453; Stewart DA, 2012, MOL CANCER RES, V10, P727, DOI 10.1158/1541-7786.MCR-11-0604; Subramanian S, 2008, ARTERIOSCL THROM VAS, V28, P685, DOI 10.1161/ATVBAHA.107.157685; Subramanian S, 2009, CURR OPIN LIPIDOL, V20, P39, DOI 10.1097/MOL.0b013e32831bef8b; TADA H, 1994, DIABETES RES CLIN PR, V24, P33, DOI 10.1016/0168-8227(94)90083-3; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; YEOP HC, 2010, DIABETES, V59, P386, DOI DOI 10.2337/DB09-0925)	48	459	473	17	112	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7884	7896		10.1074/jbc.M113.522037	http://dx.doi.org/10.1074/jbc.M113.522037			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24492615	Green Published, hybrid			2022-12-28	WOS:000332761500053
J	Rasmussen, JE; Sheridan, JT; Polk, W; Davies, CM; Tarran, R				Rasmussen, Julia E.; Sheridan, John T.; Polk, William; Davies, Catrin M.; Tarran, Robert			Cigarette Smoke-induced Ca2+ Release Leads to Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chronic Obstructive Pulmonary Disease (COPD); Cystic Fibrosis; Epithelium; Ion Channels; Lysosomes	CALCIUM-ENTRY; AIRWAY; TRAFFICKING; INTERNALIZATION; MECHANISMS; STIM	Background: COPD is the 4th leading cause of death worldwide, yet little is known about its pathogenesis. Results: Exposure to cigarette smoke elevated intracellular Ca2+ levels, which triggered CFTR internalization/inhibition. Conclusion: Cigarette smoke-induced Ca2+ release and CFTR inhibition may be involved in COPD pathogenesis. Significance: Our data provide novel information regarding the underlying mechanism of cigarette smoke-induced lung injury. Chronic obstructive pulmonary disease affects 64 million people and is currently the fourth leading cause of death worldwide. Chronic obstructive pulmonary disease includes both emphysema and chronic bronchitis, and in the case of chronic bronchitis represents an inflammatory response of the airways that is associated with mucus hypersecretion and obstruction of small airways. Recently, it has emerged that exposure to cigarette smoke (CS) leads to an inhibition of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel, causing airway surface liquid dehydration, which may play a role in the development of chronic bronchitis. CS rapidly clears CFTR from the plasma membrane and causes it to be deposited into aggresome-like compartments. However, little is known about the mechanism(s) responsible for the internalization of CFTR following CS exposure. Our studies revealed that CS triggered a rise in cytoplasmic Ca2+ that may have emanated from lysosomes. Furthermore, chelation of cytoplasmic Ca2+, but not inhibition of protein kinases/phosphatases, prevented CS-induced CFTR internalization. The macrolide antibiotic bafilomycin A1 inhibited CS-induced Ca2+ release and prevented CFTR clearance from the plasma membrane, further linking cytoplasmic Ca2+ and CFTR internalization. We hypothesize that CS-induced Ca2+ release prevents normal sorting/degradation of CFTR and causes internalized CFTR to reroute to aggresomes. Our data provide mechanistic insight into the potentially deleterious effects of CS on airway epithelia and outline a hitherto unrecognized signaling event triggered by CS that may affect the long term transition of the lung into a hyper-inflammatory/dehydrated environment.	[Rasmussen, Julia E.; Polk, William; Davies, Catrin M.; Tarran, Robert] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA; [Sheridan, John T.; Tarran, Robert] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Tarran, R (corresponding author), Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA.	robert_tarran@med.unc.edu			National Institutes of Health [RO1 HL108927, PPG P01 HL034322, P30 ES10126]; British American Tobacco Research Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034322, R01HL108927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British American Tobacco Research Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL108927, PPG P01 HL034322, and P30 ES10126. This work was also supported by a British American Tobacco Research Grant.	Agopyan N, 2004, AM J PHYSIOL-LUNG C, V286, pL563, DOI 10.1152/ajplung.00299.2003; Bartlett Jennifer A., 2008, V15, P147, DOI 10.1159/000136349; Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; Bird GS, 2009, CURR BIOL, V19, P1724, DOI 10.1016/j.cub.2009.08.022; Cantin AM, 2006, AM J PHYSIOL-CELL PH, V290, pC262, DOI 10.1152/ajpcell.00070.2005; Cantin AM, 2006, AM J RESP CRIT CARE, V173, P1139, DOI 10.1164/rccm.200508-1330OC; Cheung KL, 2011, CHEM RES TOXICOL, V24, P670, DOI 10.1021/tx1004369; Chmiel JF, 2003, RESPIR RES, V4, DOI 10.1186/1465-9921-4-8; Christensen KA, 2002, J CELL SCI, V115, P599; Clunes LA, 2008, J ANAL TOXICOL, V32, P201, DOI 10.1093/jat/32.3.201; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; Coakley RD, 2008, J CLIN INVEST, V118, P4025, DOI 10.1172/JCI33893; Com Gulnur, 2009, Handb Exp Pharmacol, P363, DOI 10.1007/978-3-540-89615-9_12; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Davis CW, 2008, RESP PHYSIOL NEUROBI, V163, P208, DOI 10.1016/j.resp.2008.05.015; Donnelly LE, 2012, CHEST, V141, P1055, DOI 10.1378/chest.11-2348; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Feske S, 2009, IMMUNOL REV, V231, P189, DOI 10.1111/j.1600-065X.2009.00818.x; Fukumori R, 2010, NEUROCHEM INT, V57, P730, DOI 10.1016/j.neuint.2010.08.009; Galietta LJV, 2009, BIOPHYS J, V97, P3047, DOI 10.1016/j.bpj.2009.09.024; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Haggie PM, 2002, J BIOL CHEM, V277, P16419, DOI 10.1074/jbc.M112361200; Hogg J C, 2005, Exp Lung Res, V31 Suppl 1, P72; Homolya L, 1999, J BIOL CHEM, V274, P26454, DOI 10.1074/jbc.274.37.26454; Jia YL, 1997, J BIOL CHEM, V272, P4978, DOI 10.1074/jbc.272.8.4978; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; Kim Victor, 2008, Proc Am Thorac Soc, V5, P478, DOI 10.1513/pats.200802-014ET; Kiselyov K, 2010, CELL CALCIUM, V47, P103, DOI 10.1016/j.ceca.2009.12.007; Korngreen A, 1996, J PHYSIOL-LONDON, V497, P53, DOI 10.1113/jphysiol.1996.sp021749; Lazarowski ER, 2001, NEWS PHYSIOL SCI, V16, P1; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lorenzo IM, 2008, P NATL ACAD SCI USA, V105, P12611, DOI 10.1073/pnas.0803970105; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Mccue HV, 2013, BIOCHEM J, V449, P449, DOI 10.1042/BJ20120898; Morgan AJ, 2011, BIOCHEM J, V439, P349, DOI 10.1042/BJ20110949; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Okiyoneda T, 2007, BBA-MOL CELL RES, V1773, P476, DOI 10.1016/j.bbamcr.2007.01.004; Okiyoneda T, 2006, BBA-MOL CELL RES, V1763, P1017, DOI 10.1016/j.bbamcr.2006.08.032; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Petty TL, 2002, CHEST, V121, p116S, DOI 10.1378/chest.121.5_suppl.116S; Ribeiro CMP, 2003, J GEN PHYSIOL, V122, P377, DOI 10.1085/jgp.200308893; RUBIN BK, 1992, AM REV RESPIR DIS, V145, P545, DOI 10.1164/ajrccm/145.3.545; Ryter SW, 2012, ANNU REV PHYSIOL, V74, P377, DOI 10.1146/annurev-physiol-020911-153348; Sammels E, 2010, CELL CALCIUM, V47, P297, DOI 10.1016/j.ceca.2010.02.001; Schmid A, 2011, SUBCELL BIOCHEM, V55, P95, DOI 10.1007/978-94-007-1217-1_5; Sheridan JT, 2011, J BIOL CHEM, V286, P1381, DOI 10.1074/jbc.M110.174847; Sloane PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039809; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Sun-Wada GH, 2003, CELL STRUCT FUNCT, V28, P455, DOI 10.1247/csf.28.455; TAKEMURA H, 1989, BIOCHEM J, V258, P409, DOI 10.1042/bj2580409; Thelin WR, 2005, J BIOL CHEM, V280, P41512, DOI 10.1074/jbc.M507308200; Vareille M, 2011, CLIN MICROBIOL REV, V24, P210, DOI 10.1128/CMR.00014-10; Yates LL, 2006, ACTA BIOCHIM POL, V53, P651, DOI 10.18388/abp.2006_3293; Young GS, 2006, COMB CHEM HIGH T SCR, V9, P633, DOI 10.2174/138620706778249749; Zhang Q, 2006, J BIOL CHEM, V281, P10174, DOI 10.1074/jbc.M513008200	55	72	74	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7671	7681		10.1074/jbc.M113.545137	http://dx.doi.org/10.1074/jbc.M113.545137			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24448802	Green Published, hybrid			2022-12-28	WOS:000332761500035
J	Brendel, J; Stoll, B; Lange, SJ; Sharma, K; Lenz, C; Stachler, AE; Maier, LK; Richter, H; Nickel, L; Schmitz, RA; Randau, L; Allers, T; Urlaub, H; Backofen, R; Marchfelder, A				Brendel, Jutta; Stoll, Britta; Lange, Sita J.; Sharma, Kundan; Lenz, Christof; Stachler, Aris-Edda; Maier, Lisa-Katharina; Richter, Hagen; Nickel, Lisa; Schmitz, Ruth A.; Randau, Lennart; Allers, Thorsten; Urlaub, Henning; Backofen, Rolf; Marchfelder, Anita			A Complex of Cas Proteins 5, 6, and 7 Is Required for the Biogenesis and Stability of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-derived RNAs (crRNAs) in Haloferax volcanii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Archaea; Microbiology; Molecular Biology; Molecular Genetics; Protein Complexes; CRISPR; Cas; Cas6; Haloferax volcanii; crRNA; Type I-B	PROCESSES PRE-CRRNA; CRISPR RNA; ANTIVIRAL DEFENSE; IMMUNE-SYSTEM; SEQUENCE; DNA; RECOGNITION; MECHANISM; CLEAVAGE; INTERFERENCE	Background: The Cas6 protein is required for generating crRNAs in CRISPR-Cas I and III systems. Results: The Cas6 protein is necessary for crRNA production but not sufficient for crRNA maintenance in Haloferax. Conclusion: A Cascade-like complex is required in the type I-B system for a stable crRNA population. Significance: The CRISPR-Cas system I-B has a similar Cascade complex like types I-A and I-E. The clustered regularly interspaced short palindromic repeats/CRISPR-associated (CRISPR-Cas) system is a prokaryotic defense mechanism against foreign genetic elements. A plethora of CRISPR-Cas versions exist, with more than 40 different Cas protein families and several different molecular approaches to fight the invading DNA. One of the key players in the system is the CRISPR-derived RNA (crRNA), which directs the invader-degrading Cas protein complex to the invader. The CRISPR-Cas types I and III use the Cas6 protein to generate mature crRNAs. Here, we show that the Cas6 protein is necessary for crRNA production but that additional Cas proteins that form a CRISPR-associated complex for antiviral defense (Cascade)-like complex are needed for crRNA stability in the CRISPR-Cas type I-B system in Haloferax volcanii in vivo. Deletion of the cas6 gene results in the loss of mature crRNAs and interference. However, cells that have the complete cas gene cluster (cas1-8b) removed and are transformed with the cas6 gene are not able to produce and stably maintain mature crRNAs. crRNA production and stability is rescued only if cas5, -6, and -7 are present. Mutational analysis of the cas6 gene reveals three amino acids (His-41, Gly-256, and Gly-258) that are essential for pre-crRNA cleavage, whereas the mutation of two amino acids (Ser-115 and Ser-224) leads to an increase of crRNA amounts. This is the first systematic in vivo analysis of Cas6 protein variants. In addition, we show that the H. volcanii I-B system contains a Cascade-like complex with a Cas7, Cas5, and Cas6 core that protects the crRNA.	[Brendel, Jutta; Stoll, Britta; Stachler, Aris-Edda; Maier, Lisa-Katharina; Marchfelder, Anita] Univ Ulm, Dept Biol 2, D-89069 Ulm, Germany; [Lange, Sita J.; Backofen, Rolf] Univ Freiburg, Dept Comp Sci, Bioinformat Grp, D-79110 Freiburg, Germany; [Sharma, Kundan; Lenz, Christof; Urlaub, Henning] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Richter, Hagen; Randau, Lennart] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Nickel, Lisa; Schmitz, Ruth A.] Univ Kiel, Inst Gen Microbiol, D-24118 Kiel, Germany; [Allers, Thorsten] Univ Nottingham, Sch Life Sci, Queens Med Ctr, Nottingham NG7 2UH, England; [Backofen, Rolf] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, Cluster Excellence, D-79110 Freiburg, Germany; [Lenz, Christof; Urlaub, Henning] Univ Med Ctr Gottingen, Inst Clin Chem, D-37075 Gottingen, Germany	Ulm University; University of Freiburg; Max Planck Society; Max Planck Society; University of Kiel; University of Nottingham; University of Freiburg; University of Gottingen	Marchfelder, A (corresponding author), Univ Ulm, Dept Biol 2, D-89069 Ulm, Germany.	anita.marchfelder@uni-ulm.de		Randau, Lennart/0000-0002-2780-2076; Marchfelder, Anita/0000-0002-1382-1794; Allers, Thorsten/0000-0002-7308-3332; Saunders, Sita/0000-0002-2243-5422; Backofen, Rolf/0000-0001-8231-3323; Schmitz-Streit, Ruth Anne/0000-0002-6788-0829	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) in the framework of Research Group 1680, "Unraveling the Prokaryotic Immune System."	Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Allers T, 2004, APPL ENVIRON MICROB, V70, P943, DOI 10.1128/AEM.70.2.943-953.2004; Allers T, 2010, APPL ENVIRON MICROB, V76, P1759, DOI 10.1128/AEM.02670-09; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2010, RNA, V16, P2181, DOI 10.1261/rna.2230110; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Charpentier E, 2013, CRISPR CAS SYSTEMS, P115; Chylinski K, 2013, RNA BIOL, V10, P726, DOI 10.4161/rna.24321; CLINE SW, 1989, J BACTERIOL, V171, P4987, DOI 10.1128/jb.171.9.4987-4991.1989; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Fischer S, 2012, J BIOL CHEM, V287, P33351, DOI 10.1074/jbc.M112.377002; Fischer S, 2010, J BIOL CHEM, V285, P34429, DOI 10.1074/jbc.M110.118950; Frols S, 2012, ENVIRON MICROBIOL, V14, P3159, DOI 10.1111/j.1462-2920.2012.02895.x; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Garrett RA, 2011, TRENDS MICROBIOL, V19, P549, DOI 10.1016/j.tim.2011.08.002; Garside EL, 2012, RNA, V18, P2020, DOI 10.1261/rna.033100.112; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; Gudbergsdottir S, 2011, MOL MICROBIOL, V79, P35, DOI 10.1111/j.1365-2958.2010.07452.x; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hatoum-Aslan A, 2011, P NATL ACAD SCI USA, V108, P21218, DOI 10.1073/pnas.1112832108; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Juranek S, 2012, RNA, V18, P783, DOI 10.1261/rna.031468.111; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lange SJ, 2013, NUCLEIC ACIDS RES, V41, P8034, DOI 10.1093/nar/gkt606; Li M, 2013, J BACTERIOL, V195, P867, DOI 10.1128/JB.01688-12; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Maier Lisa-Katharina, 2012, Mob Genet Elements, V2, P228; Maier LK, 2013, RNA BIOL, V10, P865, DOI 10.4161/rna.24282; Maier LK, 2013, BIOCHEM SOC T, V41, P374, DOI 10.1042/BST20120263; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marchfelder A, 2012, EXTREMOPHILES, V16, P685, DOI 10.1007/s00792-012-0469-5; Nam KH, 2012, STRUCTURE, V20, P1574, DOI 10.1016/j.str.2012.06.016; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nickel L, 2013, RNA BIOL, V10, P779, DOI 10.4161/rna.23928; Nieuwlandt D. T., 1995, P161; Pfeiffer F, 2008, ARCH MICROBIOL, V190, P281, DOI 10.1007/s00203-008-0389-z; Randau L, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r63; Reeks J, 2013, RNA BIOL, V10, P762, DOI 10.4161/rna.23854; Reeks J, 2013, BIOCHEM J, V453, P155, DOI 10.1042/BJ20130316; Reeks J, 2013, BIOCHEM J, V452, P223, DOI 10.1042/BJ20130269; Richter H, 2012, NUCLEIC ACIDS RES, V40, P9887, DOI 10.1093/nar/gks737; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Scholz I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056470; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shao YM, 2013, STRUCTURE, V21, P385, DOI 10.1016/j.str.2013.01.010; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Sternberg SH, 2012, RNA, V18, P661, DOI 10.1261/rna.030882.111; Stroud A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00224; van Duijn E, 2012, MOL CELL PROTEOMICS, V11, P1430, DOI 10.1074/mcp.M112.020263; Voss B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-123; Wang RY, 2012, PROTEIN SCI, V21, P405, DOI 10.1002/pro.2028; Wang RY, 2011, STRUCTURE, V19, P257, DOI 10.1016/j.str.2010.11.014; Westra ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003742; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108	66	52	59	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7164	7177		10.1074/jbc.M113.508184	http://dx.doi.org/10.1074/jbc.M113.508184			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24459147	Green Published, hybrid			2022-12-28	WOS:000332389400075
J	Herve, V; Meudal, H; Labas, V; Rehault-Godbert, S; Gautron, J; Berges, M; Guyot, N; Delmas, AF; Nys, Y; Landon, C				Herve, Virginie; Meudal, Herve; Labas, Valerie; Rehault-Godbert, Sophie; Gautron, Joel; Berges, Magali; Guyot, Nicolas; Delmas, Agnes F.; Nys, Yves; Landon, Celine			Three-dimensional NMR Structure of Hen Egg Gallin (Chicken Ovodefensin) Reveals a New Variation of the beta-Defensin Fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antimicrobial Peptides; Defensins; Host Defense; NMR; Protein Structure; AvBD; SPPS; Ovodefensin	ANTIMICROBIAL PEPTIDES; PROTEOMIC ANALYSIS; PROTEIN; RESISTANCE; SEQUENCE; PROGRAM; MECHANISMS; EXPRESSION; PENGUIN; LEAD	Background: Ovodefensins are small peptides from eggs, related to avian antimicrobial defensins. Results: The first three-dimensional structure of ovodefensins (gallin) is solved, and its antimicrobial properties are screened. Conclusion: Gallin adopts a -defensin fold, with significant variations. Its antibacterial spectrum was restricted to E. coli. Significance: The first structural features may be related to E. coli specificity and/or other yet unknown functions. Gallin is a 41-residue protein, first identified as a minor component of hen egg white and found to be antimicrobial against Escherichia coli. Gallin may participate in the protection of the embryo during its development in the egg. Its sequence is related to antimicrobial -defensin peptides. In the present study, gallin was chemically synthesized 1) to further investigate its antimicrobial spectrum and 2) to solve its three-dimensional NMR structure and thus gain insight into structure-function relationships, a prerequisite to understanding its mode(s) of action. Antibacterial assays confirmed that gallin was active against Escherichia coli, but no additional antibacterial activity was observed against the other Gram-positive or Gram-negative bacteria tested. The three-dimensional structure of gallin, which is the first ovodefensin structure to have been solved to date, displays a new five-stranded arrangement. The gallin three-dimensional fold contains the three-stranded antiparallel -sheet and the disulfide bridge array typical of vertebrate -defensins. Gallin can therefore be unambiguously classified as a -defensin. However, an additional short two-stranded -sheet reveals that gallin and presumably the other ovodefensins form a new structural subfamily of -defensins. Moreover, gallin and the other ovodefensins calculated by homology modeling exhibit atypical hydrophobic surface properties, compared with the already known vertebrate -defensins. These specific structural features of gallin might be related to its restricted activity against E. coli and/or to other yet unknown functions. This work provides initial understanding of a critical sequence-structure-function relationship for the ovodefensin family.	[Herve, Virginie; Rehault-Godbert, Sophie; Gautron, Joel; Berges, Magali; Guyot, Nicolas; Nys, Yves] INRA, Rech Avicoles Fonct & Regulat Proteines Oeuf, F-37380 Nouzilly, France; [Herve, Virginie] Univ Tours, UMR 1100, F-37032 Tours, France; [Herve, Virginie] INSERM, Ctr Etud Pathol Resp, UMR EA6305 1100, F-37032 Tours, France; [Meudal, Herve; Delmas, Agnes F.; Landon, Celine] Univ Orleans, Ctr Biophys Mol, CNRS UPR 4301, F-45071 Orleans, France; [Labas, Valerie] Univ Tours, Plate Forme Anal Integrat Biomol, UMR INRA CNRS 7247 85, IFCE, F-37380 Nouzilly, France	INRAE; Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Orleans; INRAE; Universite de Tours	Nys, Y (corresponding author), INRA, F-37380 Nouzilly, France.	Yves.Nys@tours.inra.fr; celine.landon@cnrs-orleans.fr	GAUTRON, Joël/A-1753-2017; Meudal, Hervé/B-5851-2016; REHAULT-GODBERT, Sophie/Y-3890-2019	GAUTRON, Joël/0000-0001-7800-0578; Meudal, Hervé/0000-0002-9642-3643; Rehault-Godbert, Sophie/0000-0003-2800-3417	French National Research Agency (OVO-mining) [ANR-09-BLAN-0136]	French National Research Agency (OVO-mining)(French National Research Agency (ANR))	This work was supported by the French National Research Agency (OVO-mining, ANR-09-BLAN-0136).	Alba A, 2012, BIOPOLYMERS, V98, P251, DOI 10.1002/bip.22076; Bayer AS, 2013, ANN NY ACAD SCI, V1277, P139, DOI 10.1111/j.1749-6632.2012.06819.x; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Brogden NK, 2011, INT J ANTIMICROB AG, V38, P217, DOI 10.1016/j.ijantimicag.2011.05.004; Cederlund A, 2011, FEBS J, V278, P3942, DOI 10.1111/j.1742-4658.2011.08302.x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cremer GA, 2006, J PEPT SCI, V12, P437, DOI 10.1002/psc.746; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derache C, 2012, J BIOL CHEM, V287, P7746, DOI 10.1074/jbc.M111.312108; Derache C, 2009, ANTIMICROB AGENTS CH, V53, P4647, DOI 10.1128/AAC.00301-09; Ebers KL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-153; Evans EW, 1995, VET MICROBIOL, V47, P295, DOI 10.1016/0378-1135(95)00126-3; Gong DQ, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-12; Guani-Guerra E, 2010, CLIN IMMUNOL, V135, P1, DOI 10.1016/j.clim.2009.12.004; Harmon BG, 1998, POULTRY SCI, V77, P972, DOI 10.1093/ps/77.7.972; Hazlett L, 2011, CELL TISSUE RES, V343, P175, DOI 10.1007/s00441-010-1022-4; Hellgren Olof, 2010, Immunome Res, V6, P3, DOI 10.1186/1745-7580-6-3; Herve-Grepinet V, 2010, ANTIMICROB AGENTS CH, V54, P4401, DOI 10.1128/AAC.00204-10; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Landon C, 2004, J BIOL CHEM, V279, P30433, DOI 10.1074/jbc.M401338200; Landon C, 2004, PROTEIN SCI, V13, P703, DOI 10.1110/ps.03404404; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Lynn DJ, 2007, IMMUNOL LETT, V110, P86, DOI 10.1016/j.imlet.2007.03.007; Mann K, 2008, WORLD POULTRY SCI J, V64, P209, DOI 10.1017/S0043933907001808; Mann K, 2008, PROTEOMICS, V8, P2322, DOI 10.1002/pmic.200800032; Mann K, 2008, PROTEOMICS, V8, P178, DOI 10.1002/pmic.200700790; Mann K, 2007, PROTEOMICS, V7, P3558, DOI 10.1002/pmic.200700397; Mann K, 2006, PROTEOMICS, V6, P3801, DOI 10.1002/pmic.200600120; Master RN, 2013, ANN NY ACAD SCI, V1277, P1, DOI 10.1111/nyas.12022; Meade KG, 2009, DEV COMP IMMUNOL, V33, P516, DOI 10.1016/j.dci.2008.10.003; Naknukool S, 2008, BIOSCI BIOTECH BIOCH, V72, P2082, DOI 10.1271/bbb.80178; Naknukool S, 2011, J AGR FOOD CHEM, V59, P5081, DOI 10.1021/jf2004404; ODANI S, 1989, J BIOCHEM, V105, P660, DOI 10.1093/oxfordjournals.jbchem.a122721; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SIMPSON RJ, 1983, INT J PEPT PROT RES, V22, P476; Smith PA, 2007, NAT CHEM BIOL, V3, P549, DOI 10.1038/nchembio.2007.27; Subedi K, 2007, REPRODUCTION, V133, P127, DOI 10.1530/REP-06-0083; Sugiarto H, 2004, BIOCHEM BIOPH RES CO, V323, P721, DOI 10.1016/j.bbrc.2004.08.162; Thouzeau C, 2003, J BIOL CHEM, V278, P51053, DOI 10.1074/jbc.M306839200; van Dijk A, 2008, VET IMMUNOL IMMUNOP, V124, P1, DOI 10.1016/j.vetimm.2007.12.006; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Xiao YJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-56; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Yount NY, 2013, ANN NY ACAD SCI, V1277, P127, DOI 10.1111/nyas.12005; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	52	21	21	0	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7211	7220		10.1074/jbc.M113.507046	http://dx.doi.org/10.1074/jbc.M113.507046			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24443564	Green Published, hybrid			2022-12-28	WOS:000332389400079
J	Maghzal, GJ; Cergol, KM; Shengule, SR; Suarna, C; Newington, D; Kettle, AJ; Payne, RJ; Stocker, R				Maghzal, Ghassan J.; Cergol, Katie M.; Shengule, Sudhir R.; Suarna, Cacang; Newington, Darren; Kettle, Anthony J.; Payne, Richard J.; Stocker, Roland			Assessment of Myeloperoxidase Activity by the Conversion of Hydroethidine to 2-Chloroethidium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						HPLC; Inflammation; Mass Spectrometry (MS); Neutrophil; Oxidative Stress; 3-Chlorotyrosine; Chloramines; Dihydroethidium; Hypochlorous Acid	HYPOCHLOROUS ACID; INTRACELLULAR SUPEROXIDE; FLUORESCENCE DETECTION; TYROSYL RESIDUES; PROTEIN DAMAGE; CYTOCHROME-C; OXIDATION; 3-CHLOROTYROSINE; PLASMA; MARKER	Background: Myeloperoxidase activity is commonly assessed in vivo by the accumulation of 3-chlorotyrosine. Results: Myeloperoxidase-derived chlorinating species specifically converted hydroethidine to 2-chloroethidium with efficiency superior to that of the corresponding conversion of tyrosine to 3-chlorotyrosine. Conclusion: Hydroethidine is useful to assess myeloperoxidase activity in vivo, in parallel with its simultaneous use to detect superoxide. Significance: 2-Chloroethidium is a useful additional marker of myeloperoxidase activity. Oxidants derived from myeloperoxidase (MPO) contribute to inflammatory diseases. In vivo MPO activity is commonly assessed by the accumulation of 3-chlorotyrosine (3-Cl-Tyr), although 3-Cl-Tyr is formed at low yield and is subject to metabolism. Here we show that MPO activity can be assessed using hydroethidine (HE), a probe commonly employed for the detection of superoxide. Using LC/MS/MS, H-1 NMR, and two-dimensional NOESY, we identified 2-chloroethidium (2-Cl-E+) as a specific product when HE was exposed to hypochlorous acid (HOCl), chloramines, MPO/H2O2/chloride, and activated human neutrophils. The rate constant for HOCl-mediated conversion of HE to 2-Cl-E+ was estimated to be 1.5 x 10(5) m(-1)s(-1). To investigate the utility of 2-Cl-E+ to assess MPO activity in vivo, HE was injected into wild-type and MPO-deficient (Mpo(-/-)) mice with established peritonitis or localized arterial inflammation, and tissue levels of 2-Cl-E+ and 3-Cl-Tyr were then determined by LC/MS/MS. In wild-type mice, 2-Cl-E+ and 3-Cl-Tyr were detected readily in the peritonitis model, whereas in the arterial inflammation model 2-Cl-E+ was present at comparatively lower concentrations (17 versus 0.3 pmol/mg of protein), and 3-Cl-Tyr could not be detected. Similar to the situation with 3-Cl-Tyr, tissue levels of 2-Cl-E+ were decreased substantially in Mpo(-/-) mice, indicative of the specificity of the assay. In the arterial inflammation model, 2-Cl-E+ was absent from non-inflamed arteries and blood, suggesting that HE oxidation occurred locally in the inflamed artery. Our data suggest that the conversion of exogenous HE to 2-Cl-E+ may be a useful selective and sensitive marker for MPO activity in addition to 3-Cl-Tyr.	[Maghzal, Ghassan J.; Shengule, Sudhir R.; Suarna, Cacang; Newington, Darren; Stocker, Roland] Victor Chang Cardiac Res Inst, Vasc Biol Div, Darlinghurst, NSW 2010, Australia; [Cergol, Katie M.; Payne, Richard J.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [Kettle, Anthony J.] Univ Otago Christchurch, Dept Pathol, Ctr Free Radical Res, Christchurch, New Zealand	Victor Chang Cardiac Research Institute; University of Sydney; University of Otago	Maghzal, GJ (corresponding author), Victor Chang Cardiac Res Inst, Vasc Biol Div, 405 Liverpool St, Darlinghurst, NSW 2010, Australia.	g.maghzal@victorchang.edu.au	Stocker, Roland/AAV-4489-2021; Payne, Richard/AAH-3666-2021; maghzal, ghassan/A-9692-2015	Kettle, Tony/0000-0002-8218-7766; Payne, Richard/0000-0002-3618-9226	Australian Research Council [DP 110102135]; National Health and Medical Research Council of Australia [455395, 1020776, 1037879]; National Health and Medical Research Council of Australia Senior Principal Research Fellowship	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian Research Council Discovery Project Grant DP 110102135 (to G. J. M.) and by National Health and Medical Research Council of Australia Program Grant 455395 and Project Grants 1020776 and 1037879 (to R. S.).; Supported by a National Health and Medical Research Council of Australia Senior Principal Research Fellowship.	Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Brennan ML, 2001, J CLIN INVEST, V107, P419, DOI 10.1172/JCI8797; Buss IH, 2003, PEDIATR RES, V53, P455, DOI 10.1203/01.PDR.0000050655.25689.CE; Cash JL, 2009, METHOD ENZYMOL, V461, P379, DOI 10.1016/S0076-6879(09)05417-2; Clayden J., 2006, ORGANIC CHEM; Curtis MP, 2011, CHEM RES TOXICOL, V24, P418, DOI 10.1021/tx100380d; DAUGHERTY A, 1994, J CLIN INVEST, V94, P437, DOI 10.1172/JCI117342; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; FOLKES LK, 1995, ARCH BIOCHEM BIOPHYS, V323, P120, DOI 10.1006/abbi.1995.0017; Fu SL, 2000, J BIOL CHEM, V275, P10851, DOI 10.1074/jbc.275.15.10851; Gaut JP, 2002, ANAL BIOCHEM, V300, P252, DOI 10.1006/abio.2001.5469; Halliwell B., 2007, FREE RADICAL BIO MED, P46; Hawkins CL, 1999, BIOCHEM J, V340, P539, DOI 10.1042/0264-6021:3400539; Hazell LJ, 1996, J CLIN INVEST, V97, P1535, DOI 10.1172/JCI118576; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Kapralov AA, 2007, BIOCHEMISTRY-US, V46, P14232, DOI 10.1021/bi701237b; Kettle AJ, 2004, AM J RESP CRIT CARE, V170, P1317, DOI 10.1164/rccm.200311-1516OC; Kettle AJ, 1996, FEBS LETT, V379, P103, DOI 10.1016/0014-5793(95)01494-2; KETTLE AJ, 1994, METHOD ENZYMOL, V233, P502; Kettle AJ, 2014, BBA-GEN SUBJECTS, V1840, P781, DOI 10.1016/j.bbagen.2013.07.004; KOCKX MM, 1993, ARTERIOSCLER THROMB, V13, P1874, DOI 10.1161/01.ATV.13.12.1874; Kundu K, 2010, ANGEW CHEM INT EDIT, V49, P6134, DOI 10.1002/anie.201002228; LEHRER RI, 1972, J CLIN INVEST, V51, P2566, DOI 10.1172/JCI107073; Li H, 2012, FREE RADICAL BIO MED, V53, P1954, DOI 10.1016/j.freeradbiomed.2012.08.597; LOCKSLEY RM, 1983, BLOOD, V62, P902; Mani AR, 2007, J BIOL CHEM, V282, P29114, DOI 10.1074/jbc.M704270200; Masuda M, 2001, J BIOL CHEM, V276, P40486, DOI 10.1074/jbc.M102700200; Moroi M, 1998, J CLIN INVEST, V101, P1225, DOI 10.1172/JCI1293; O'Donnell C, 2010, COPD, V7, P411, DOI 10.3109/15412555.2010.528086; Patsoukis N, 2005, ANAL BIOANAL CHEM, V381, P1065, DOI 10.1007/s00216-004-2999-x; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; PINCUS SH, 1971, NEW ENGL J MED, V284, P744, DOI 10.1056/NEJM197104082841402; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; Pulli B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067976; RADI R, 1991, J BIOL CHEM, V266, P4244; Ross SA, 2000, J CHEM SOC PERK T 1, P571, DOI 10.1039/a908389h; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; STOCKER R, 1982, FEBS LETT, V144, P199, DOI 10.1016/0014-5793(82)80637-6; SUARNA C, 1995, ARTERIOSCL THROM VAS, V15, P1616, DOI 10.1161/01.ATV.15.10.1616; Talib J, 2012, FREE RADICAL BIO MED, V53, P20, DOI 10.1016/j.freeradbiomed.2012.04.018; Van Put DJM, 1998, ARTERIOSCL THROM VAS, V18, P915, DOI 10.1161/01.ATV.18.6.915; Vivero-Escoto JL, 2010, BIOMATERIALS, V31, P1325, DOI 10.1016/j.biomaterials.2009.11.009; Wang WY, 2013, ANAL BIOCHEM, V443, P148, DOI 10.1016/j.ab.2013.09.016; Whiteman M, 2008, BIOCHEM BIOPH RES CO, V371, P50, DOI 10.1016/j.bbrc.2008.03.153; Winterbourn CC, 2000, FREE RADICAL BIO MED, V29, P403, DOI 10.1016/S0891-5849(00)00204-5; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Witting PK, 2000, ARTERIOSCL THROM VAS, V20, pE26, DOI 10.1161/01.ATV.20.8.e26; Zhao HT, 2003, FREE RADICAL BIO MED, V34, P1359, DOI 10.1016/S0891-5849(03)00142-4; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391; Zielonka J, 2005, FREE RADICAL BIO MED, V39, P853, DOI 10.1016/j.freeradbiomed.2005.05.001; Zielonka J, 2008, FREE RADICAL BIO MED, V44, P835, DOI 10.1016/j.freeradbiomed.2007.11.013; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473; Zielonka J, 2006, ARCH BIOCHEM BIOPHYS, V456, P39, DOI 10.1016/j.abb.2006.09.031; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028; Zielonka J, 2009, FREE RADICAL BIO MED, V46, P329, DOI 10.1016/j.freeradbiomed.2008.10.031	56	32	33	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5580	5595		10.1074/jbc.M113.539486	http://dx.doi.org/10.1074/jbc.M113.539486			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24436331	Green Published, hybrid			2022-12-28	WOS:000332015500023
J	Wang, Q; Chen, WS; Bai, L; Chen, WJ; Padilla, MT; Lin, AS; Shi, SQ; Wang, X; Lin, Y				Wang, Qiong; Chen, Wenshu; Bai, Lang; Chen, Wenjie; Padilla, Mabel T.; Lin, Amy S.; Shi, Shaoqing; Wang, Xia; Lin, Yong			Receptor-interacting Protein 1 Increases Chemoresistance by Maintaining Inhibitor of Apoptosis Protein Levels and Reducing Reactive Oxygen Species through a microRNA-146a-mediated Catalase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Chemoresistance; Lung Cancer; Reactive Oxygen Species (ROS); RIP	NF-KAPPA-B; DEATH DOMAIN KINASE; MEDIATED SENSITIZATION; CANCER PREVENTION; ACTIVATION; RIP1; CELLS; ROS; CHEMOTHERAPY; LUTEOLIN	Background: Whether RIP1 directly contributes to chemotherapy response in cancer has not been determined. Results: RIP1 knockdown resulted in miR-146a-mediated catalase reduction, ROS induction, IAP degradation, and increased cisplatin cytotoxicity. Conclusion: RIP1 blunts the anticancer activity of cisplatin by releasing miR-146a-mediated catalase suppression. Significance: Our results establish a chemoresistant role for RIP1, and intervention within the RIP1-mediated pathway may be exploited for chemosensitization. Although receptor-interacting protein 1 (RIP1) is well known as a key mediator in cell survival and death signaling, whether RIP1 directly contributes to chemotherapy response in cancer has not been determined. In this report, we found that, in human lung cancer cells, knockdown of RIP1 substantially increased cytotoxicity induced by the frontline anticancer therapeutic drug cisplatin, which has been associated with robust cellular reactive oxygen species (ROS) accumulation and enhanced apoptosis. Scavenging ROS dramatically protected RIP1 knockdown cells against cisplatin-induced cytotoxicity. Furthermore, we found that, in RIP1 knockdown cells, the expression of the hydrogen peroxide-reducing enzyme catalase was dramatically reduced, which was associated with increased miR-146a expression. Inhibition of microRNA-146a restored catalase expression, suppressed ROS induction, and protected against cytotoxicity in cisplatin-treated RIP1 knockdown cells, suggesting that RIP1 maintains catalase expression to restrain ROS levels in therapy response in cancer cells. Additionally, cisplatin significantly triggered the proteasomal degradation of cellular inhibitor of apoptosis protein 1 and 2 (c-IAP1 and c-IAP2), and X-linked inhibitor of apoptosis (XIAP) in a ROS-dependent manner, and in RIP1 knockdown cells, ectopic expression of c-IAP2 attenuated cisplatin-induced cytotoxicity. Thus, our results establish a chemoresistant role for RIP1 that maintains inhibitor of apoptosis protein (IAP) expression by release of microRNA-146a-mediated catalase suppression, where intervention within this pathway may be exploited for chemosensitization.	[Wang, Qiong; Chen, Wenshu; Bai, Lang; Chen, Wenjie; Padilla, Mabel T.; Lin, Amy S.; Shi, Shaoqing; Lin, Yong] Lovelace Resp Res Inst, Mol Biol & Lung Canc Program, Albuquerque, NM 87108 USA; [Wang, Qiong; Shi, Shaoqing; Wang, Xia] Sichuan Univ, West China Univ Hosp 2, Minist Educ,Dept Obstet & Gynecol, Lab Mol & Translat Med,Key Lab Birth Defects & Re, Chengdu 610041, Peoples R China	Lovelace Respiratory Research Institute; Sichuan University	Lin, Y (corresponding author), Lovelace Resp Res Inst, Mol Biol & Lung Canc Program, 2425 Ridgecrest Dr SE, Albuquerque, NM 87108 USA.	ylin@lrri.org			NIEHS, National Institutes of Health [R01ES017328]; Department of Energy Low Dose Radiation Research Program [DE-SC0001173]; National Natural Science Foundation of China [30973403]	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Department of Energy Low Dose Radiation Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by NIEHS, National Institutes of Health Grant R01ES017328. This work was also supported by Department of Energy Low Dose Radiation Research Program Grant DE-SC0001173 and by National Natural Science Foundation of China Grant 30973403.	Bai L, 2012, MOL PHARMACOL, V81, P549, DOI 10.1124/mol.111.076653; Basit F, 2012, J BIOL CHEM, V287, P38767, DOI 10.1074/jbc.M112.398966; Bauer G, 2012, ANTICANCER RES, V32, P2599; Caputo F, 2012, BIOCHEM PHARMACOL, V84, P1292, DOI 10.1016/j.bcp.2012.07.022; Chang A, 2011, LUNG CANCER, V71, P3, DOI 10.1016/j.lungcan.2010.08.022; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; Epperly MW, 2009, RADIAT RES, V171, P588, DOI 10.1667/RR1424.1; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He WY, 2012, AUTOPHAGY, V8, P1811, DOI 10.4161/auto.22145; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hur GM, 2003, GENE DEV, V17, P873, DOI 10.1101/gad.1062403; Ju W, 2007, MOL PHARMACOL, V71, P1381, DOI 10.1124/mol.106.032185; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Krepler C, 2013, CLIN CANCER RES, V19, P1784, DOI 10.1158/1078-0432.CCR-12-2518; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Lai L, 2009, MOL CANCER THER, V8, P1636, DOI 10.1158/1535-7163.MCT-09-0068; Lin Y, 2000, MOL CELL BIOL, V20, P6638, DOI 10.1128/MCB.20.18.6638-6645.2000; Lin Y, 2004, J BIOL CHEM, V279, P10822, DOI 10.1074/jbc.M313141200; Lin Y, 2010, EXPERT OPIN THER TAR, V14, P45, DOI 10.1517/14728220903431069; Lin Y, 2008, CURR CANCER DRUG TAR, V8, P634, DOI 10.2174/156800908786241050; Loder S, 2012, LEUKEMIA, V26, P1020, DOI 10.1038/leu.2011.353; Maione P, 2010, EXPERT OPIN PHARMACO, V11, P2997, DOI 10.1517/14656566.2010.511615; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Park J, 2012, BIOCHEM BIOPH RES CO, V422, P291, DOI 10.1016/j.bbrc.2012.04.150; Sakon S, 2003, EMBO J, V22, P3898, DOI 10.1093/emboj/cdg379; Starkov AA, 2008, ANN NY ACAD SCI, V1147, P37, DOI 10.1196/annals.1427.015; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Ting AT, 1996, EMBO J, V15, P6189, DOI 10.1002/j.1460-2075.1996.tb01007.x; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Ulahannan SV, 2011, CANCER INVEST, V29, P325, DOI 10.3109/07357907.2011.554476; Vanlangenakker N, 2012, CELL DEATH DIFFER, V19, P75, DOI 10.1038/cdd.2011.164; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Wang J, 2008, CANCER BIOL THER, V7, P1875, DOI 10.4161/cbt.7.12.7067; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang Q, 2013, CARCINOGENESIS, V34, P2119, DOI 10.1093/carcin/bgt143; Wang X, 2007, BIOCHEM BIOPH RES CO, V355, P807, DOI 10.1016/j.bbrc.2007.02.030; Yang L, 2013, APOPTOSIS, V18, P618, DOI 10.1007/s10495-013-0808-8; Yang YB, 2011, MOL CELL BIOL, V31, P2774, DOI 10.1128/MCB.01139-10	40	37	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5654	5663		10.1074/jbc.M113.526152	http://dx.doi.org/10.1074/jbc.M113.526152			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24425875	Green Published, hybrid			2022-12-28	WOS:000332015500028
J	Kazi, A; Ozcan, S; Tecleab, A; Sun, Y; Lawrence, HR; Sebti, SM				Kazi, Aslamuzzaman; Ozcan, Sevil; Tecleab, Awet; Sun, Ying; Lawrence, Harshani R.; Sebti, Said M.			Discovery of PI-1840, a Novel Noncovalent and Rapidly Reversible Proteasome Inhibitor with Anti-tumor Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anticancer Drug; Apoptosis; Bcl-2 Family Proteins; Cancer Therapy; Cell Proliferation; p53; Proteasome; CT-L; PI-1840; Noncovalent	PROTEIN-DEGRADATION; 20S PROTEASOME; P53 PATHWAY; UBIQUITIN; CANCER; CELL; TMC-95A; TARGET; IMMUNOPROTEASOME; LACTACYSTIN	Background: Food and Drug Administration-approved proteasome inhibitors act covalently, which hampers their safety. Results: Structure activity relationship (SAR) studies, mass spectrometry, and dialysis identified PI-1840 as a noncovalent proteasome inhibitor that sensitizes human cancer cells to p53 and Bcl2 antagonists. Conclusion: Noncovalent proteasome inhibitors suppress in vivo tumor growth with little toxicity in mouse xenografts. Significance: Discovery of noncovalent proteasome inhibitors warrants their development as anti-cancer drugs. The proteasome inhibitor bortezomib is effective in hematologic malignancies such as multiple myeloma but has little activity against solid tumors, acts covalently, and is associated with undesired side effects. Therefore, noncovalent inhibitors that are less toxic and more effective against solid tumors are desirable. Structure activity relationship studies led to the discovery of PI-1840, a potent and selective inhibitor for chymotrypsin-like (CT-L) (IC50 value = 27 +/- 0.14 nm) over trypsin-like and peptidylglutamyl peptide hydrolyzing (IC50 values >100 m) activities of the proteasome. Furthermore, PI-1840 is over 100-fold more selective for the constitutive proteasome over the immunoproteasome. Mass spectrometry and dialysis studies demonstrate that PI-1840 is a noncovalent and rapidly reversible CT-L inhibitor. In intact cancer cells, PI-1840 inhibits CT-L activity, induces the accumulation of proteasome substrates p27, Bax, and IB-, inhibits survival pathways and viability, and induces apoptosis. Furthermore, PI-1840 sensitizes human cancer cells to the mdm2/p53 disruptor, nutlin, and to the pan-Bcl-2 antagonist BH3-M6. Finally, in vivo, PI-1840 but not bortezomib suppresses the growth in nude mice of human breast tumor xenografts. These results warrant further evaluation of a noncovalent and rapidly reversible proteasome inhibitor as potential anticancer agents against solid tumors.	[Kazi, Aslamuzzaman; Ozcan, Sevil; Tecleab, Awet; Sun, Ying; Lawrence, Harshani R.; Sebti, Said M.] H Lee Moffitt Canc Ctr & Res Inst, Drug Discovery Dept, Tampa, FL 33612 USA; [Kazi, Aslamuzzaman; Lawrence, Harshani R.; Sebti, Said M.] H Lee Moffitt Canc Ctr & Res Inst, Chem Biol Core, Tampa, FL 33612 USA; [Lawrence, Harshani R.] Univ S Florida, Dept Oncol Sci, Tampa, FL 33620 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Sebti, SM (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, 12902 Magnolia Dr, Tampa, FL 33612 USA.	said.sebti@moffitt.org			National Institutes of Health [P01-CA118210]; NATIONAL CANCER INSTITUTE [P30CA076292, P01CA118210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-CA118210.	Adams J, 2003, CANCER TREAT REV, V29, P3, DOI 10.1016/S0305-7372(03)00081-1; Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Bellavista E, 2013, CURR PHARM DESIGN, V19, P702, DOI 10.2174/138161213804581927; Blackburn C, 2010, BIOCHEM J, V430, P461, DOI 10.1042/BJ20100383; Burger AM, 2004, EUR J CANCER, V40, P2217, DOI 10.1016/j.ejca.2004.07.006; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Corey EJ, 1999, CHEM PHARM BULL, V47, P1; Desvergne A, 2013, J MED CHEM, V56, P3367, DOI 10.1021/jm4002007; Dick LR, 2010, DRUG DISCOV TODAY, V15, P243, DOI 10.1016/j.drudis.2010.01.008; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Endo S, 2011, CANCER SCI, V102, P605, DOI 10.1111/j.1349-7006.2010.01821.x; Favrot M, 1998, GENE THER, V5, P728, DOI 10.1038/sj.gt.3300661; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; Gallastegui N, 2012, ANGEW CHEM INT EDIT, V51, P247, DOI 10.1002/anie.201106010; Groll M, 2001, J MOL BIOL, V311, P543, DOI 10.1006/jmbi.2001.4869; Groll M, 2010, CHEMMEDCHEM, V5, P1701, DOI 10.1002/cmdc.201000293; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Hupp TR, 2000, BIOCHEM J, V352, P1, DOI 10.1042/0264-6021:3520001; Hutter G, 2012, LEUKEMIA, V26, P2442, DOI 10.1038/leu.2012.118; Kawai H, 2003, MOL CELL BIOL, V23, P4939, DOI 10.1128/MCB.23.14.4939-4947.2003; Kazi A, 2011, J BIOL CHEM, V286, P9382, DOI 10.1074/jbc.M110.203638; Kazi A, 2009, CELL CYCLE, V8, P1940, DOI 10.4161/cc.8.12.8798; Kisselev AF, 2012, CHEM BIOL, V19, P99, DOI 10.1016/j.chembiol.2012.01.003; Kuhn DJ, 2012, SEMIN HEMATOL, V49, P258, DOI 10.1053/j.seminhematol.2012.04.003; Love I. M., 2013, METHOD MOL BIOL, V53, P63; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Ozcan S, 2013, J MED CHEM, V56, P3783, DOI 10.1021/jm400221d; Pagano M, 2003, CANCER CELL, V4, P251, DOI 10.1016/S1535-6108(03)00243-5; Papandreou CN, 2004, CANCER RES, V64, P5036, DOI 10.1158/0008-5472.CAN-03-2707; Ruschak AM, 2011, J NATL CANCER I, V103, P1007, DOI 10.1093/jnci/djr160; Satija YK, 2013, INT J CANCER, V133, P2759, DOI 10.1002/ijc.28129; Schwartz AL, 1999, ANNU REV MED, V50, P57; Singh J, 2011, NAT REV DRUG DISCOV, V10, P307, DOI 10.1038/nrd3410; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Villalonga-Planells R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018588; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	39	18	20	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11906	11915		10.1074/jbc.M113.533950	http://dx.doi.org/10.1074/jbc.M113.533950			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24570003	hybrid, Green Published			2022-12-28	WOS:000335010600031
J	Srivastava, SS; Mishra, A; Krishnan, B; Sharma, Y				Srivastava, Shanti Swaroop; Mishra, Amita; Krishnan, Bal; Sharma, Yogendra			Ca2+ -binding Motif of beta gamma- Crystallins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Calcium; Calcium-binding Proteins; Crystallin; Protein Stability; Protein Structure; Beta Gamma-Crystallin; Greek Key Motif	TREFOIL FACTOR COMPLEX; DEVELOPMENT-SPECIFIC PROTEIN; SPORE COAT PROTEIN; X-RAY-ANALYSIS; CALCIUM-BINDING; MYXOCOCCUS-XANTHUS; EYE LENS; SPHERULIN 3A; STRUCTURAL CHARACTERISTICS; AMPHIBIAN SKIN	-Crystallin-type double clamp (N/D)(N/D)XX(S/T)S motif is an established but sparsely investigated motif for Ca2+ binding. A -crystallin domain is formed of two Greek key motifs, accommodating two Ca2+-binding sites. -Crystallins make a separate class of Ca2+-binding proteins (CaBP), apparently a major group of CaBP in bacteria. Paralleling the diversity in -crystallin domains, these motifs also show great diversity, both in structure and in function. Although the expression of some of them has been associated with stress, virulence, and adhesion, the functional implications of Ca2+ binding to -crystallins in mediating biological processes are yet to be elucidated.	[Srivastava, Shanti Swaroop; Mishra, Amita; Krishnan, Bal; Sharma, Yogendra] CSIR, CCMB, Hyderabad 500007, Andhra Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Sharma, Y (corresponding author), CSIR, CCMB, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.	yogendra@ccmb.res.in		Srivastava, Shanti Swaroop/0000-0002-4208-6127; Krishnan, Bal/0000-0002-7764-4213	CSIR XII five year network grant; Council of Scientific and Industrial Research, India; University Grants Commission, NewDelhi, India	CSIR XII five year network grant; Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, NewDelhi, India(University Grants Commission, India)	This work was supported in part by the CSIR XII five year network grant.; Recipient of a fellowship from the Council of Scientific and Industrial Research, India.; Recipient of a fellowship from the University Grants Commission, NewDelhi, India.	Antuch W, 1996, NAT STRUCT BIOL, V3, P662, DOI 10.1038/nsb0896-662; Aravind P, 2008, J MOL BIOL, V381, P509, DOI 10.1016/j.jmb.2008.06.019; Aravind P, 2009, BIOCHEMISTRY-US, V48, P12180, DOI 10.1021/bi9017076; Aravind P, 2009, J MOL BIOL, V385, P163, DOI 10.1016/j.jmb.2008.10.035; BAGBY S, 1994, P NATL ACAD SCI USA, V91, P4308, DOI 10.1073/pnas.91.10.4308; Barnwal RP, 2009, J MOL BIOL, V386, P675, DOI 10.1016/j.jmb.2008.12.058; BERNIER F, 1987, GENE, V59, P265, DOI 10.1016/0378-1119(87)90334-9; Bhat SP, 2003, PROG DRUG RES, V60, P205; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; BLUNDELL T, 1981, NATURE, V289, P771, DOI 10.1038/289771a0; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Cates MS, 1999, STRUCTURE, V7, P1269, DOI 10.1016/S0969-2126(00)80060-X; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Cheng Y, 2004, PROTEIN SCI, V13, P2665, DOI 10.1110/ps.04832604; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clout NJ, 2001, STRUCTURE, V9, P115, DOI 10.1016/S0969-2126(01)00573-1; Clout NJ, 1997, NAT STRUCT BIOL, V4, P685, DOI 10.1038/nsb0997-685; DEJONG WW, 1989, TRENDS BIOCHEM SCI, V14, P365, DOI 10.1016/0968-0004(89)90009-1; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; Fu SJ, 2008, PROTEIN PEPTIDE LETT, V15, P39, DOI 10.2174/092986608783330404; Ganguly K, 2008, INVEST OPHTH VIS SCI, V49, P1533, DOI 10.1167/iovs.07-0788; Gao Q, 2011, BIOCHIMIE, V93, P1865, DOI 10.1016/j.biochi.2011.07.013; Gao Q, 2011, THROMB HAEMOSTASIS, V105, P846, DOI 10.1160/TH10-10-0690; Giancola C, 2005, FEBS J, V272, P1023, DOI 10.1111/j.1742-4658.2004.04536.x; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Golubov A, 2003, FEMS IMMUNOL MED MIC, V38, P107, DOI 10.1016/S0928-8244(03)00182-2; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; HUTCHINSON EG, 1993, PROTEIN ENG, V6, P233, DOI 10.1093/protein/6.3.233; INOUYE M, 1979, DEV BIOL, V68, P579, DOI 10.1016/0012-1606(79)90228-8; INOUYE S, 1983, P NATL ACAD SCI-BIOL, V80, P6829, DOI 10.1073/pnas.80.22.6829; INOUYE S, 1980, J BIOL CHEM, V255, P3713; Jaenicke R, 2001, CRIT REV BIOCHEM MOL, V36, P435, DOI 10.1080/20014091074237; Jobby MK, 2007, FEBS J, V274, P4135, DOI 10.1111/j.1742-4658.2007.05941.x; Jobby MK, 2005, J BIOL CHEM, V280, P1209, DOI 10.1074/jbc.M409253200; Kappe G, 2010, J MOL EVOL, V71, P219, DOI 10.1007/s00239-010-9379-2; Kirberger M, 2008, J BIOL INORG CHEM, V13, P1169, DOI 10.1007/s00775-008-0402-7; Kretschmar M, 1999, J MOL BIOL, V291, P1147, DOI 10.1006/jmbi.1999.3037; Kretschmar W, 1999, J MOL BIOL, V289, P701, DOI 10.1006/jmbi.1999.2833; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Lin YP, 2008, J BIOL CHEM, V283, P25140, DOI 10.1074/jbc.M801350200; Lin Z, 2006, NAT STRUCT MOL BIOL, V13, P1016, DOI 10.1038/nsmb1162; Liu SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001770; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; MCPHALEN CA, 1991, ADV PROTEIN CHEM, V42, P77; Michiels J, 2002, TRENDS MICROBIOL, V10, P87, DOI 10.1016/S0966-842X(01)02284-3; Mills IA, 2007, PROTEIN SCI, V16, P2427, DOI 10.1110/ps.072970207; Mishra A, 2012, J MOL BIOL, V415, P75, DOI 10.1016/j.jmb.2011.10.037; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Nalefski EA, 2002, BIOCHEMISTRY-US, V41, P1109, DOI 10.1021/bi011798h; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Ogawa M, 1998, DEV GROWTH DIFFER, V40, P465; Ohki S, 2001, J MOL BIOL, V305, P109, DOI 10.1006/jmbi.2000.4244; Ohno A, 1998, J MOL BIOL, V282, P421, DOI 10.1006/jmbi.1998.2022; Oyston PCF, 2000, INFECT IMMUN, V68, P3419, DOI 10.1128/IAI.68.6.3419-3425.2000; Pidcock E, 2001, J BIOL INORG CHEM, V6, P479, DOI 10.1007/s007750100214; Qian JQ, 2008, TOXICON, V52, P285, DOI 10.1016/j.toxicon.2008.05.017; Qian JQ, 2008, TOXICON, V52, P22, DOI 10.1016/j.toxicon.2008.05.007; Rajanikanth V, 2012, BIOCHEMISTRY-US, V51, P8502, DOI 10.1021/bi300844u; Rajini B, 2003, BIOCHEMISTRY-US, V42, P4552, DOI 10.1021/bi027384l; Rajini B, 2001, J BIOL CHEM, V276, P38464, DOI 10.1074/jbc.M102164200; Raman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014377; RICHARDSON JS, 1976, P NATL ACAD SCI USA, V73, P2619, DOI 10.1073/pnas.73.8.2619; RICHARDSON JS, 1977, NATURE, V268, P495, DOI 10.1038/268495a0; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Rosinke B, 1997, J MOL BIOL, V271, P645, DOI 10.1006/jmbi.1997.1184; Shao XG, 1996, SCIENCE, V273, P248, DOI 10.1126/science.273.5272.248; SHARMA Y, 1989, J BIOL CHEM, V264, P20923; SHARMA Y, 1989, J BIOL CHEM, V264, P12794; Shimeld SM, 2005, CURR BIOL, V15, P1684, DOI 10.1016/j.cub.2005.08.046; Slingsby C, 1997, PROG RETIN EYE RES, V16, P3, DOI 10.1016/S1350-9462(96)00018-3; Slingsby C, 2013, PROTEIN SCI, V22, P367, DOI 10.1002/pro.2229; Sriskanthadevan S, 2011, DEVELOPMENT, V138, P2487, DOI 10.1242/dev.060129; Sriskanthadevan S, 2009, J BIOL CHEM, V284, P36377, DOI 10.1074/jbc.M109.057257; Srivastava AK, 2010, BIOCHEMISTRY-US, V49, P9746, DOI 10.1021/bi101000m; Stenflo J, 2000, BBA-PROTEIN STRUCT M, V1477, P51, DOI 10.1016/S0167-4838(99)00262-9; Sudhof TC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011353; Suman SK, 2013, BIOCHEMISTRY-US, V52, P9047, DOI 10.1021/bi401093n; Suman SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053610; Suman SK, 2011, J BIOL CHEM, V286, P43891, DOI 10.1074/jbc.M111.247890; Sun MX, 2013, MAMM GENOME, V24, P333, DOI 10.1007/s00335-013-9478-7; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; TEINTZE M, 1988, J BIOL CHEM, V263, P1199; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; VANRENS GLM, 1992, MOL BIOL REP, V16, P1; Vergara A, 2013, ACTA CRYSTALLOGR D, V69, P960, DOI 10.1107/S0907444913003569; Wenk M, 1999, J MOL BIOL, V286, P1533, DOI 10.1006/jmbi.1999.2582; Wenk M, 1999, J MOL BIOL, V293, P117, DOI 10.1006/jmbi.1999.3146; Wenk M, 1998, EUR J BIOCHEM, V255, P604, DOI 10.1046/j.1432-1327.1998.2550604.x; WISTOW G, 1983, J MOL BIOL, V170, P175, DOI 10.1016/S0022-2836(83)80232-0; WISTOW G, 1990, J MOL EVOL, V30, P140, DOI 10.1007/BF02099940; WISTOW GJ, 1988, ANNU REV BIOCHEM, V57, P479, DOI 10.1146/annurev.bi.57.070188.002403; Wouters MA, 2005, PROTEIN SCI, V14, P1091, DOI 10.1110/ps.041207005; Yang J, 2002, P NATL ACAD SCI USA, V99, P7711, DOI 10.1073/pnas.102006299; Yang W, 2002, PROTEINS, V47, P344, DOI 10.1002/prot.10093	96	31	31	4	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					10958	10966		10.1074/jbc.O113.539569	http://dx.doi.org/10.1074/jbc.O113.539569			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24567326	Green Published, hybrid			2022-12-28	WOS:000334638500002
J	Vogel, S; Chatterjee, M; Metzger, K; Borst, O; Geisler, T; Seizer, P; Muller, I; Mack, A; Schumann, S; Buhring, HJ; Lang, F; Sorg, RV; Langer, H; Gawaz, M				Vogel, Sebastian; Chatterjee, Madhumita; Metzger, Katja; Borst, Oliver; Geisler, Tobias; Seizer, Peter; Mueller, Iris; Mack, Andreas; Schumann, Susanne; Buehring, Hans-Joerg; Lang, Florian; Sorg, Ruediger V.; Langer, Harald; Gawaz, Meinrad			Activated Platelets Interfere with Recruitment of Mesenchymal Stem Cells to Apoptotic Cardiac Cells via High Mobility Group Box 1/Toll-like Receptor 4-mediated Down-regulation of Hepatocyte Growth Factor Receptor MET	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Migration; Mesenchymal Stem Cells; Myocardial Infarction; Platelets; Toll-like Receptors (TLR); HMGB1; Cardiac Repair and Regeneration	ACUTE MYOCARDIAL-INFARCTION; TOLL-LIKE RECEPTORS; ENDOTHELIAL PROGENITOR CELLS; ISCHEMIA-REPERFUSION INJURY; STROMAL CELLS; IN-VITRO; CLINICAL IMPLICATIONS; STERILE INFLAMMATION; PROTEIN; BONE	Background: Mesenchymal stem cells (MSC) contribute to cardiac repair after myocardial injury. Underlying molecular mechanisms remain unexplored. Results: Activated platelets inhibit recruitment of MSC to apoptotic cardiac myocytes and fibroblasts via HMGB1/TLR-4-mediated down-regulation of HGF receptor MET. Conclusion: We identify a novel mechanism by which platelets impair MSC migration to damaged cardiac cells. Significance: The cross-talk between platelets and MSC might be critical for myocardial repair. Recruitment of mesenchymal stem cells (MSC) following cardiac injury, such as myocardial infarction, plays a critical role in tissue repair and may contribute to myocardial recovery. However, the mechanisms that regulate migration of MSC to the site of tissue damage remain elusive. Here, we demonstrate in vitro that activated platelets substantially inhibit recruitment of MSC toward apoptotic cardiac myocytes and fibroblasts. The alarmin high mobility group box 1 (HMGB1) was released by platelets upon activation and mediated inhibition of the cell death-dependent migratory response through Toll-like receptor (TLR)-4 expressed on the MSC. Migration of MSC to apoptotic cardiac myocytes and fibroblasts was driven by hepatocyte growth factor (HGF), and platelet activation was followed by HMGB1/TLR-4-dependent down-regulation of HGF receptor MET on MSC, thereby impairing HGF-driven MSC recruitment. We identify a novel mechanism by which platelets, upon activation, interfere with MSC recruitment to apoptotic cardiac cells, a process that may be of particular relevance for myocardial repair and regeneration.	[Vogel, Sebastian; Chatterjee, Madhumita; Metzger, Katja; Borst, Oliver; Geisler, Tobias; Seizer, Peter; Mueller, Iris; Langer, Harald; Gawaz, Meinrad] Eberhard Karls Univ Tubingen, Dept Cardiol & Cardiovasc Dis, D-72076 Tubingen, Germany; [Mack, Andreas] Eberhard Karls Univ Tubingen, Inst Anat, D-72076 Tubingen, Germany; [Schumann, Susanne; Buehring, Hans-Joerg] Eberhard Karls Univ Tubingen, Dept Oncol Haematol Immunol Rheumatol & Pulmonol, D-72076 Tubingen, Germany; [Lang, Florian] Eberhard Karls Univ Tubingen, Inst Physiol, D-72076 Tubingen, Germany; [Sorg, Ruediger V.] Univ Dusseldorf, Inst Transplantat Diagnost & Cell Therapeut, D-40225 Dusseldorf, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Heinrich Heine University Dusseldorf	Gawaz, M (corresponding author), Univ Tubingen, Med Klin 3, Otfried Muller Str 10, D-72076 Tubingen, Germany.	meinrad.gawaz@med.uni-tuebingen.de	Geisler, Tobias/AAO-4472-2020; Chatterjee, Madhumita/AAJ-1802-2020	Chatterjee, Madhumita/0000-0002-3428-4107; Mack, Andreas/0000-0001-7591-4374; Borst, Oliver/0000-0003-4002-4085; Vogel, Sebastian/0000-0002-3284-0464	German Heart Foundation/German Foundation of Heart Research Grant [F/19/13]; Deutsche Forschungsgemeinschaft (DFG) Klinische Forschergruppe [KFO 274]	German Heart Foundation/German Foundation of Heart Research Grant; Deutsche Forschungsgemeinschaft (DFG) Klinische Forschergruppe(German Research Foundation (DFG))	This work was supported by German Heart Foundation/German Foundation of Heart Research Grant F/19/13 and the Deutsche Forschungsgemeinschaft (DFG) Klinische Forschergruppe KFO 274 "Platelets: Basic Mechanisms and Translational Implications."	Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Aoki M, 2000, GENE THER, V7, P417, DOI 10.1038/sj.gt.3301104; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Borst O, 2012, CIRC RES, V111, P1297, DOI 10.1161/CIRCRESAHA.112.276444; Britten MB, 2003, CIRCULATION, V108, P2212, DOI 10.1161/01.CIR.0000095788.78169.AF; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Ertl G, 2005, CARDIOVASC RES, V66, P22, DOI 10.1016/j.cardiores.2005.01.011; FITZGERALD DJ, 1986, NEW ENGL J MED, V315, P983, DOI 10.1056/NEJM198610163151602; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Gawaz M, 1998, CIRCULATION, V98, P1164, DOI 10.1161/01.CIR.98.12.1164; Gawaz M, 2013, BLOOD, V122, P2550, DOI 10.1182/blood-2013-05-468694; Gerczuk PZ, 2012, J AM COLL CARDIOL, V59, P969, DOI 10.1016/j.jacc.2011.07.054; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Harris HE, 2004, EUR J IMMUNOL, V34, P1503, DOI 10.1002/eji.200424916; Kitahara T, 2008, CARDIOVASC RES, V80, P40, DOI 10.1093/cvr/cvn163; Kohno T, 2009, CARDIOVASC RES, V81, P565, DOI 10.1093/cvr/cvn291; Kume S, 2005, J BONE MINER RES, V20, P1647, DOI 10.1359/JBMR.050514; Langer H, 2006, CIRC RES, V98, pE2, DOI 10.1161/01.RES.0000201285.87524.9e; Langer HF, 2009, J MOL CELL CARDIOL, V47, P315, DOI 10.1016/j.yjmcc.2009.03.011; Lee CH, 2010, J CLIN INVEST, V120, P3340, DOI 10.1172/JCI43230; Li JH, 2008, J ENDOCRINOL INVEST, V31, P103, DOI 10.1007/BF03345575; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Massberg S, 2006, J EXP MED, V203, P1221, DOI 10.1084/jem.20051772; Mias C, 2009, STEM CELLS, V27, P2734, DOI 10.1002/stem.169; Muller I, 2006, CYTOTHERAPY, V8, P437, DOI 10.1080/14653240600920782; Murphy MB, 2012, BIOMATERIALS, V33, P5308, DOI 10.1016/j.biomaterials.2012.04.007; Nagaya N, 2004, AM J PHYSIOL-HEART C, V287, pH2670, DOI 10.1152/ajpheart.01071.2003; Nakamura T, 2000, J CLIN INVEST, V106, P1511, DOI 10.1172/JCI10226; Nomura S, 2011, PLATELETS, V22, P396, DOI 10.3109/09537104.2011.553970; Okunishi K, 2005, J IMMUNOL, V175, P4745, DOI 10.4049/jimmunol.175.7.4745; Ono K, 1997, CIRCULATION, V95, P2552, DOI 10.1161/01.CIR.95.11.2552; Oozawa S, 2008, CIRC J, V72, P1178, DOI 10.1253/circj.72.1178; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rouhiainen A, 2000, THROMB HAEMOSTASIS, V84, P1087; Stellos K, 2010, J THROMB HAEMOST, V8, P205, DOI 10.1111/j.1538-7836.2009.03659.x; Stellos K, 2008, CIRCULATION, V117, P206, DOI 10.1161/CIRCULATIONAHA.107.714691; Tomchuck SL, 2008, STEM CELLS, V26, P99, DOI 10.1634/stemcells.2007-0563; TRIP MD, 1990, NEW ENGL J MED, V322, P1549, DOI 10.1056/NEJM199005313222201; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Vogel S, 2013, BIOCHEM BIOPH RES CO, V431, P428, DOI 10.1016/j.bbrc.2012.12.153; Vogel S, 2010, CELL MOL LIFE SCI, V67, P295, DOI 10.1007/s00018-009-0183-3; Wang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013951; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; Wen ZZ, 2011, J CELL MOL MED, V15, P1032, DOI 10.1111/j.1582-4934.2010.01255.x; WILLERSON JT, 1989, CIRCULATION, V80, P198, DOI 10.1161/01.CIR.80.1.198; Wollert KC, 2005, CIRCULATION, V112, P151, DOI 10.1161/CIRCULATIONAHA.105.551895; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Xiao GH, 2001, P NATL ACAD SCI USA, V98, P247, DOI 10.1073/pnas.011532898; Zhu Y, 2000, HEART, V83, P450, DOI 10.1136/heart.83.4.450	59	31	33	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11068	11082		10.1074/jbc.M113.530287	http://dx.doi.org/10.1074/jbc.M113.530287			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24567328	Green Published, hybrid			2022-12-28	WOS:000334638500012
J	Wang, AM; Midura, RJ; Vasanji, A; Wang, AJ; Hascall, VC				Wang, Aimin; Midura, Ronald J.; Vasanji, Amit; Wang, Andrew J.; Hascall, Vincent C.			Hyperglycemia Diverts Dividing Osteoblastic Precursor Cells to an Adipogenic Pathway and Induces Synthesis of a Hyaluronan Matrix That Is Adhesive for Monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipogenesis; Autophagy; Diabetes; ER Stress; Heparin; Inflammation; Stromal Cell; Monocyte Adhesive Hyaluronan Matrix; Osteogenesis; Osteopenia	SMOOTH-MUSCLE-CELLS; EXPERIMENTAL DIABETIC-NEPHROPATHY; ENDOPLASMIC-RETICULUM STRESS; MESENCHYMAL STEM-CELLS; BONE-MINERAL DENSITY; MESANGIAL CELLS; RESORBING CELLS; MURINE MODEL; CYCLIN D3; MELLITUS	Background: Adipocytes accumulate in diabetic bone marrow. Results: Bone marrow stromal cells that divide in hyperglycemia divert from the osteoblast lineage to pathological adipogenesis and produce an extensive monocyte-adhesive hyaluronan matrix with consequent demineralization of trabecular bone. Conclusion: This mechanism diminishes the stromal cell population with an accumulation of metabolically stressed adipocytes. Significance: This provides new insights into diabetic osteopenia. Isolated rat bone marrow stromal cells cultured in osteogenic medium in which the normal 5.6 mm glucose is changed to hyperglycemic 25.6 mm glucose greatly increase lipid formation between 21-31 days of culture that is associated with decreased biomineralization, up-regulate expression of cyclin D3 and two adipogenic markers (CCAAT/enhancer binding protein and peroxisome proliferator-activated receptor ) within 5 days of culture, increase neutral and polar lipid synthesis within 5 days of culture, and form a monocyte-adhesive hyaluronan matrix through an endoplasmic reticulum stress-induced autophagic mechanism. Evidence is also provided that, by 4 weeks after diabetes onset in the streptozotocin-induced diabetic rat model, there is a large loss of trabecular bone mineral density without apparent proportional changes in underlying collagen matrices, a large accumulation of a hyaluronan matrix within the trabecular bone marrow, and adipocytes and macrophages embedded in this hyaluronan matrix. These results support the hypothesis that hyperglycemia in bone marrow diverts dividing osteoblastic precursor cells (bone marrow stromal cells) to a metabolically stressed adipogenic pathway that induces synthesis of a hyaluronan matrix that recruits inflammatory cells and establishes a chronic inflammatory process that demineralizes trabecular cancellous bone.	[Wang, Aimin; Midura, Ronald J.; Vasanji, Amit; Wang, Andrew J.; Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Wang, AM (corresponding author), Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, ND20, Cleveland, OH 44106 USA.	wanga@ccf.org			National Institutes of Health [R01 DK62934, P01 HL107147]; NHLBI, National Institutes of Health [P01 HL107147]; Mizutani Foundation [1000057]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062934] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Mizutani Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK62934 (to A. W.) and P01 HL107147 (to V. H. and A. W., Project 1) and by NHLBI, National Institutes of Health Grant P01 HL107147 (to Hyaluronan Matrices in Vascular Pathologies). This work was also supported by Mizutani Foundation Grant 1000057 (to V. H. and A. W.).	Athanasou NA, 1996, J BONE JOINT SURG AM, V78A, P1096, DOI 10.2106/00004623-199607000-00016; Botolin S, 2005, ENDOCRINOLOGY, V146, P3622, DOI 10.1210/en.2004-1677; Botolin S, 2007, ENDOCRINOLOGY, V148, P198, DOI 10.1210/en.2006-1006; BOUILLON R, 1995, J CLIN ENDOCR METAB, V80, P1194, DOI 10.1210/jc.80.4.1194; BOUILLON R, 1991, CALCIFIED TISSUE INT, V49, P155, DOI 10.1007/BF02556109; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Calabro A, 2000, GLYCOBIOLOGY, V10, P283, DOI 10.1093/glycob/10.3.283; CALABRO A, 2000, PROTEOGLYCANS STRUCT, P5; CALVO JC, 1993, ARCH BIOCHEM BIOPHYS, V302, P468, DOI 10.1006/abbi.1993.1241; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; Folk JW, 1999, J ORTHOP TRAUMA, V13, P369, DOI 10.1097/00005131-199906000-00008; GAMBARO G, 1992, KIDNEY INT, V42, P285, DOI 10.1038/ki.1992.288; GAMBARO G, 1994, KIDNEY INT, V46, P797, DOI 10.1038/ki.1994.335; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; GOODMAN WG, 1984, DIABETES, V33, P825, DOI 10.2337/diabetes.33.9.825; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; Hascall VC, 2000, GLYCOCONJUGATE J, V17, P607, DOI 10.1023/A:1011082728155; Herrero S, 1998, CALCIFIED TISSUE INT, V62, P260, DOI 10.1007/s002239900427; HERSKIND AM, 1992, DIABETES METAB, V18, P63; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Jilka RL, 1996, J CLIN INVEST, V97, P1732, DOI 10.1172/JCI118600; Kajkenova O, 1997, J BONE MINER RES, V12, P1772, DOI 10.1359/jbmr.1997.12.11.1772; Kemink SAG, 2000, J ENDOCRINOL INVEST, V23, P295, DOI 10.1007/BF03343726; KLEIN DJ, 1986, DIABETES, V35, P1130, DOI 10.2337/diabetes.35.10.1130; KRAKAUER JC, 1995, DIABETES, V44, P775, DOI 10.2337/diabetes.44.7.775; Kurihara N, 1996, BLOOD, V87, P3704, DOI 10.1182/blood.V87.9.3704.bloodjournal8793704; Lassus J, 1998, CLIN ORTHOP RELAT R, P7; Lauer ME, 2008, J BIOL CHEM, V283, P26283, DOI 10.1074/jbc.M803350200; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; LOCATTO ME, 1993, BONE MINER, V23, P129, DOI 10.1016/S0169-6009(08)80049-9; Majors AK, 1997, J ORTHOPAED RES, V15, P546, DOI 10.1002/jor.1100150410; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Masson E, 2006, IUBMB LIFE, V58, P381, DOI 10.1080/15216540600755980; McCabe LR, 2007, J CELL BIOCHEM, V102, P1343, DOI 10.1002/jcb.21573; McCabe NP, 2011, NEOPLASIA, V13, P31, DOI 10.1593/neo.10998; Meirelles LD, 2003, BRIT J HAEMATOL, V123, P702, DOI 10.1046/j.1365-2141.2003.04669.x; Miazgowski T, 1998, OSTEOPOROSIS INT, V8, P399, DOI 10.1007/s001980050082; Midura RJ, 2004, J BIOL CHEM, V279, P25464, DOI 10.1074/jbc.M312409200; Moerman EJ, 2004, AGING CELL, V3, P379, DOI 10.1111/j.1474-9728.2004.00127.x; Motyl KJ, 2009, J CELL PHYSIOL, V218, P575, DOI 10.1002/jcp.21626; Nigro J, 2009, J BIOL CHEM, V284, P16832, DOI 10.1074/jbc.M109.002956; Nuttall ME, 2004, CURR OPIN PHARMACOL, V4, P290, DOI 10.1016/j.coph.2004.03.002; Nuttall ME, 2000, BONE, V27, P177, DOI 10.1016/S8756-3282(00)00317-3; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Pittenger MF, 2000, CURR TOP MICROBIOL, V251, P3; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Quinn JMW, 1996, J PATHOL, V179, P106; Reddy G, 2001, DIABETES RES CLIN PR, V54, P1, DOI 10.1016/S0168-8227(01)00273-X; Ren J, 2009, J BIOL CHEM, V284, P16621, DOI 10.1074/jbc.M806430200; Rosen ED, 2005, PROSTAG LEUKOTR ESS, V73, P31, DOI 10.1016/j.plefa.2005.04.004; Rosen ED, 2002, ANN ENDOCRINOL-PARIS, V63, P79; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Sarruf DA, 2005, MOL CELL BIOL, V25, P9985, DOI 10.1128/MCB.25.22.9985-9995.2005; Shyng YC, 2001, INT J ORAL MAX SURG, V30, P70, DOI 10.1054/ijom.2000.0004; TOOLE BP, 2000, PROTEOGLYCANS STRUCT, P61; Verhaeghe J, 2000, BONE, V27, P249, DOI 10.1016/S8756-3282(00)00308-2; VERHAEGHE J, 1990, DIABETES, V39, P477, DOI 10.2337/diabetes.39.4.477; Verma S, 2002, J CLIN PATHOL, V55, P693, DOI 10.1136/jcp.55.9.693; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; Wang AM, 2009, AUTOPHAGY, V5, P864, DOI 10.4161/auto.9041; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Wang AM, 2000, J BIOL CHEM, V275, P11082, DOI 10.1074/jbc.275.15.11082; Wang T, 2007, PATTERN RECOGN LETT, V28, P501, DOI 10.1016/j.patrec.2006.09.004; Ward DT, 2001, J AM SOC NEPHROL, V12, P779, DOI 10.1681/ASN.V124779; WAUD CE, 1994, CALCIFIED TISSUE INT, V54, P237, DOI 10.1007/BF00301685; White CB, 2003, CLIN ORTHOP RELAT R, P37, DOI 10.1097/01.blo.0000084402.53464.90; Yevdokimova NY, 2006, ACTA BIOCHIM POL, V53, P383; YOUNG BA, 1995, KIDNEY INT, V47, P935, DOI 10.1038/ki.1995.139	72	46	49	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11410	11420		10.1074/jbc.M113.541458	http://dx.doi.org/10.1074/jbc.M113.541458			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24569987	Green Published, hybrid			2022-12-28	WOS:000334638500042
J	Zhao, W; Chang, CJ; Cui, YY; Zhao, XZ; Yang, J; Shen, L; Zhou, J; Hou, ZB; Zhang, Z; Ye, CX; Hasenmayer, D; Perkins, R; Huang, XJ; Yao, X; Yu, LK; Huang, RM; Zhang, DZ; Guo, HQ; Yan, J				Zhao, Wei; Chang, Cunjie; Cui, Yangyan; Zhao, Xiaozhi; Yang, Jun; Shen, Lan; Zhou, Ji; Hou, Zhibo; Zhang, Zhen; Ye, Changxiao; Hasenmayer, Donald; Perkins, Robert; Huang, Xiaojing; Yao, Xin; Yu, Like; Huang, Ruimin; Zhang, Dianzheng; Guo, Hongqian; Yan, Jun			Steroid Receptor Coactivator-3 Regulates Glucose Metabolism in Bladder Cancer Cells through Coactivation of Hypoxia Inducible Factor 1 beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Cell Proliferation; Glycolysis; Transcription Coactivators; Tumor Metabolism; HIF1; SRC-3; Urinary Bladder Cancer	TRANSCRIPTIONAL COACTIVATOR; LACTATE-DEHYDROGENASE; UROTHELIAL CARCINOMA; SRC-3 COACTIVATOR; GENE-EXPRESSION; AIB1; PROLIFERATION; ACTIVATION; BREAST; OVEREXPRESSION	Background: Steroid receptor coactivator-3 (SRC-3) is frequently overexpressed in human urinary bladder cancer. Results: SRC-3 promotes urinary bladder cancer (UBC) cells proliferation through coactivating HIF1 and up-regulating the expression of genes involved in the glycolytic pathway. Conclusion: SRC-3 plays an important role in UBC development through enhancing glycolysis. Significance: Targeting SRC-3 or enzymes in glycolytic pathway could be an attractive approach in UBC therapy. Cancer cell proliferation is a metabolically demanding process, requiring high glycolysis, which is known as Warburg effect, to support anabolic growth. Steroid receptor coactivator-3 (SRC-3), a steroid receptor coactivator, is overexpressed and/or amplified in multiple cancer types, including non-steroid targeted cancers, such as urinary bladder cancer (UBC). However, whether SRC-3 regulates the metabolic reprogramming for cancer cell growth is unknown. Here, we reported that overexpression of SRC-3 accelerated UBC cell growth, accompanied by the increased expression of genes involved in glycolysis. Knockdown of SRC-3 reduced the UBC cell glycolytic rate under hypoxia, decreased tumor growth in nude mice, with reduction of proliferating cell nuclear antigen and lactate dehydrogenase expression levels. We further revealed that SRC-3 could interact with hypoxia inducible factor 1 (HIF1), which is a key transcription factor required for glycolysis, and coactivate its transcriptional activity. SRC-3 was recruited to the promoters of HIF1-target genes, such as glut1 and pgk1. The positive correlation of expression levels between SRC-3 and Glut1 proteins was demonstrated in human UBC patient samples. Inhibition of glycolysis through targeting HK2 or LDHA decelerated SRC-3 overexpression-induced cell growth. In summary, overexpression of SRC-3 promoted glycolysis in bladder cancer cells through HIF1 to facilitate tumorigenesis, which may be an intriguing drug target for bladder cancer therapy.	[Zhao, Wei; Chang, Cunjie; Cui, Yangyan; Shen, Lan; Huang, Xiaojing; Yan, Jun] Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing Biomed Res Inst, Nanjing 210008, Jiangsu, Peoples R China; [Zhang, Zhen; Yan, Jun] Wenzhou Med Coll, Zhejiang Prov Key Lab Technol & Applicat Model Or, Sch Life Sci, Wenzhou 325035, Zhejiang, Peoples R China; [Zhao, Xiaozhi; Ye, Changxiao; Guo, Hongqian] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Urol, Nanjing 210008, Jiangsu, Peoples R China; [Yang, Jun] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Pathol, Nanjing 210008, Jiangsu, Peoples R China; [Zhao, Xiaozhi; Guo, Hongqian] Nanjing Urol Res Ctr, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Ji; Yao, Xin] Nanjing Med Univ, Affiliated Hosp 1, Dept Resp Med, Nanjing 210029, Jiangsu, Peoples R China; [Hou, Zhibo; Yu, Like] Nanjing Chest Hosp, Dept Resp Med 1, Nanjing 210029, Jiangsu, Peoples R China; [Hasenmayer, Donald; Perkins, Robert; Zhang, Dianzheng] Philadelphia Coll Osteopath Med, Philadelphia, PA 19131 USA; [Huang, Ruimin] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA	Nanjing University; Wenzhou Medical University; Nanjing University; Nanjing University; Nanjing Medical University; Memorial Sloan Kettering Cancer Center	Guo, HQ (corresponding author), Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China.	dr.ghq@163.com; yanjun@nju.edu.cn	Zhao, Wei/AAC-6849-2020; Yan, Jun/Q-3031-2017	Zhao, Wei/0000-0003-2421-7311; Yan, Jun/0000-0002-1303-1952	Ministry of Science and Technology [2011CB944104, 2010CB945101]; National Natural Science Foundation [81172009, 81372168]; Ministry of Education of China [20110091120028]; Fundamental Research Funds for the Central Universities [090314340001]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The work was supported by grants from Ministry of Science and Technology (2011CB944104, 2010CB945101), the National Natural Science Foundation (81172009, 81372168), Doctoral Fund of Ministry of Education of China (20110091120028), and Fundamental Research Funds for the Central Universities (090314340001) (to J. Y.).	Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315, DOI 10.1007/BF03262330; Brader P, 2007, MOL CANCER THER, V6, P2900, DOI 10.1158/1535-7163.MCT-07-0432; Castillo-Martin M, 2010, UROL ONCOL-SEMIN ORI, V28, P401, DOI 10.1016/j.urolonc.2009.04.019; Cheng G, 2012, CANCER RES, V72, P2634, DOI 10.1158/0008-5472.CAN-11-3928; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; Datta K, 2004, CANCER RES, V64, P456, DOI 10.1158/0008-5472.CAN-03-2706; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Gerlinger M, 2012, J PATHOL, V227, P146, DOI 10.1002/path.4006; Han SJ, 2006, MOL ENDOCRINOL, V20, P45, DOI 10.1210/me.2005-0310; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Lanz RB, 2010, MOL ENDOCRINOL, V24, P859, DOI 10.1210/me.2009-0499; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Lonard DM, 2004, MOL CELL BIOL, V24, P14, DOI 10.1128/MCB.24.1.14-24.2004; Long WW, 2012, J CLIN INVEST, V122, P1869, DOI 10.1172/JCI61492; Louie MC, 2004, MOL CELL BIOL, V24, P5157, DOI 10.1128/MCB.24.12.5157-5171.2004; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Luo JH, 2008, INT J CANCER, V122, P2554, DOI 10.1002/ijc.23399; Mussi P, 2006, MOL ENDOCRINOL, V20, P3105, DOI 10.1210/me.2005-0522; Ord JJ, 2007, J UROLOGY, V178, P677, DOI 10.1016/j.juro.2007.03.112; Patra KC, 2013, CANCER CELL, V24, P213, DOI 10.1016/j.ccr.2013.06.014; PORRECA E, 1994, ARTERIOSCLER THROMB, V14, P299, DOI 10.1161/01.ATV.14.2.299; Qin L, 2008, MOL CELL BIOL, V28, P5937, DOI 10.1128/MCB.00579-08; Robey IF, 2005, NEOPLASIA, V7, P324, DOI 10.1593/neo.04430; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Semenza GL, 2002, P NATL ACAD SCI USA, V99, P11570, DOI 10.1073/pnas.192442299; Semenza GL, 2007, J BIOENERG BIOMEMBR, V39, P231, DOI 10.1007/s10863-007-9081-2; Shi WF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007398; Tickoo SK, 2011, BJU INT, V107, P844, DOI 10.1111/j.1464-410X.2010.09517.x; Tong ZT, 2013, BRIT J CANCER, V108, P1470, DOI 10.1038/bjc.2013.81; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; van de Sluis B, 2010, J CLIN INVEST, V120, P2119, DOI 10.1172/JCI40583; Vander Heiden MG, 2011, COLD SH Q B, V76, P325, DOI 10.1101/sqb.2012.76.010900; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Xu Y, 2010, ONCOGENE, V29, P3386, DOI 10.1038/onc.2010.90; Yan J, 2006, ACTA PHARMACOL SIN, V27, P387, DOI 10.1111/j.1745-7254.2006.00315.x; Yan J, 2004, ONCOGENE, V23, P1939, DOI 10.1038/sj.onc.1207306; Yan J, 2008, CANCER RES, V68, P5460, DOI 10.1158/0008-5472.CAN-08-0955; Yan J, 2006, CANCER RES, V66, P11039, DOI 10.1158/0008-5472.CAN-06-2442; Zhou M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-33; Zou JX, 2006, PROSTATE, V66, P1474, DOI 10.1002/pros.20477	46	42	47	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11219	11229		10.1074/jbc.M113.535989	http://dx.doi.org/10.1074/jbc.M113.535989			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24584933	Green Published, hybrid			2022-12-28	WOS:000334638500025
J	Kumagai, K; Kawano-Kawada, M; Hanada, K				Kumagai, Keigo; Kawano-Kawada, Miyuki; Hanada, Kentaro			Phosphoregulation of the Ceramide Transport Protein CERT at Serine 315 in the Interaction with VAMP-associated Protein ( VAP) for Inter-organelle Trafficking of Ceramide in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endoplasmic Reticulum (ER); Golgi; Lipid-binding Protein; Lipid Transport; Sphingolipid	PLECKSTRIN-HOMOLOGY-DOMAIN; NONVESICULAR TRAFFICKING; ENDOPLASMIC-RETICULUM; SPHINGOLIPID METABOLISM; MOLECULAR MACHINERY; SEMIINTACT CELLS; STRUCTURAL BASIS; BINDING PROTEIN; PHOSPHORYLATION; KINASE	Background: CERT transports ceramide from the ER to the Golgi apparatus and is supported by its FFAT motif-dependent binding to the ER membrane protein VAP. Results: CERT is phosphorylated at Ser-315 near the FFAT motif. Conclusion: The phosphorylation strengthens the CERT-VAP-A interaction to up-regulate ceramide trafficking. Significance: This provides new insights into molecular mechanisms underlying functional regulation of FFAT-containing proteins for the inter-organelle lipid trafficking. The ceramide transport protein CERT mediates the inter-organelle transport of ceramide for the synthesis of sphingomyelin, presumably through endoplasmic reticulum (ER)-Golgi membrane contact sites. CERT has a short peptide motif named FFAT, which associates with the ER-resident membrane protein VAP. We show that the phosphorylation of CERT at serine 315, which is adjacent to the FFAT motif, markedly enhanced the interaction of CERT with VAP. The phosphomimetic CERT S315E mutant exhibited higher activity to support the ER-to-Golgi transport of ceramide than the wild-type control in a semi-intact cell system, and this enhanced activity was abrogated when its FFAT motif was deleted. The level of phosphorylation of CERT at Ser-315 increased in HeLa cells treated with a sphingolipid biosynthesis inhibitor or exogenous sphingomyelinase. Expression of CERT S315E induced intracellular punctate structures, to which CERT and VAP were co-localized, and the occurrence of the structure was dependent on both phosphatidylinositol 4-monophosphate binding and VAP binding activities of CERT. Phosphorylation of another region (named a serine-rich motif) in CERT is known to down-regulate the activity of CERT. Analysis of various CERT mutant constructs showed that the de-phosphorylation of the serine-rich motif and the phosphorylation of Ser-315 likely have the additive contribution to enhance the activity of CERT. These results demonstrate that the phosphorylation of CERT at the FFAT motif-adjacent serine affected its affinity for VAP, which may regulate the inter-organelle trafficking of ceramide in response to the perturbation of cellular sphingomyelin and/or other sphingolipids.	[Kumagai, Keigo; Kawano-Kawada, Miyuki; Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan	National Institute of Infectious Diseases (NIID)	Hanada, K (corresponding author), Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	hanak@nih.go.jp	Kumagai, Keigo/AAG-1385-2021	KAWANO-KAWADA, Miyuki/0000-0002-1168-9291; Kumagai, Keigo/0000-0002-1663-2905; Hanada, Kentaro/0000-0003-1383-2781	Japan Society for the Promotion of Science KAKENHI [23790118, 25460086, 22370054, 25670045]; Takeda Science Foundation	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 23790118 and 25460086 (to K. K.), 22370054 and 25670045 (to K. H.), and by the Takeda Science Foundation.	Alpy F, 2013, J CELL SCI, V126, P5500, DOI 10.1242/jcs.139295; Amako Y, 2011, J BIOL CHEM, V286, P11265, DOI 10.1074/jbc.M110.182097; Charruyer A, 2008, J BIOL CHEM, V283, P16682, DOI 10.1074/jbc.M800799200; Derre I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002092; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Elwell CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002198; Florin L, 2009, J BIOTECHNOL, V141, P84, DOI 10.1016/j.jbiotec.2009.02.014; Fugmann T, 2007, J CELL BIOL, V178, P15, DOI 10.1083/jcb.200612017; Funakoshi T, 2000, J BIOL CHEM, V275, P29938, DOI 10.1074/jbc.M004470200; Furuita K, 2010, J BIOL CHEM, V285, P12961, DOI 10.1074/jbc.M109.082602; Guo J, 2010, CELL PHYSIOL BIOCHEM, V26, P717, DOI 10.1159/000322339; HANADA K, 1985, FEBS LETT, V191, P278, DOI 10.1016/0014-5793(85)80024-7; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2013, BIOCH BIOPH IN PRESS, DOI [10.1016/j.bbalip/2013.06.006, DOI 10.1016/J.BBALIP/2013.06.006]; Hanada K, 2006, MOL CELL BIOCHEM, V286, P23, DOI 10.1007/s11010-005-9044-z; Hanada K, 2009, BBA-MOL CELL BIOL L, V1791, P684, DOI 10.1016/j.bbalip.2009.01.006; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Ishibashi Y, 2013, BBA-MOL CELL BIOL L, V1831, P1475, DOI 10.1016/j.bbalip.2013.06.001; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kolter T, 2006, BBA-BIOMEMBRANES, V1758, P2057, DOI 10.1016/j.bbamem.2006.05.027; Kudo N, 2008, P NATL ACAD SCI USA, V105, P488, DOI 10.1073/pnas.0709191105; Kumagai K, 2005, J BIOL CHEM, V280, P6488, DOI 10.1074/jbc.M409290200; Kumagai K, 2007, J BIOL CHEM, V282, P17758, DOI 10.1074/jbc.M702291200; Kumagai K, 2012, METHOD CELL BIOL, V108, P117, DOI 10.1016/B978-0-12-386487-1.00006-7; Lamour NF, 2007, J LIPID RES, V48, P1293, DOI 10.1194/jlr.M700083-JLR200; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Mikitova V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030455; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Raya A, 2000, J BIOL CHEM, V275, P40392, DOI 10.1074/jbc.M002769200; Saito S, 2008, J BIOL CHEM, V283, P6584, DOI 10.1074/jbc.M707691200; Shi L, 1998, FEMS MICROBIOL REV, V22, P229, DOI 10.1016/S0168-6445(98)00015-1; Simanshu DK, 2013, NATURE, V500, P463, DOI 10.1038/nature12332; Sugiki T, 2012, J BIOL CHEM, V287, P33706, DOI 10.1074/jbc.M112.367730; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Tomishige N, 2009, MOL BIOL CELL, V20, P348, DOI 10.1091/mbc.E08-07-0669; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330	41	58	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10748	10760		10.1074/jbc.M113.528380	http://dx.doi.org/10.1074/jbc.M113.528380			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24569996	hybrid, Green Published			2022-12-28	WOS:000334226400044
J	Nakano, S; Okazaki, S; Tokiwa, H; Asano, Y				Nakano, Shogo; Okazaki, Seiji; Tokiwa, Hiroaki; Asano, Yasuhisa			Binding of NAD(+) and L-Threonine Induces Stepwise Structural and Flexibility Changes in Cupriavidus necator L-Threonine Dehydrogenase*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Dehydrogenase; Enzyme Kinetics; Molecular Dynamics; NAD	ARCHAEON PYROCOCCUS-HORIKOSHII; MOLECULAR-DYNAMICS SIMULATIONS; LIVER ALCOHOL-DEHYDROGENASE; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; ESCHERICHIA-COLI; SUPERFAMILY; REFINEMENT; CATALYSIS; PROGRAM	Background: The structural changes in short chain dehydrogenase-like l-threonine dehydrogenase (SDR-like l-ThrDH) that occur during catalysis remain unknown. Results: Several analyses revealed dynamical changes in SDR-like l-ThrDH. Conclusion: NAD(+) and l-threonine binding induced changes in flexibility and structure. Significance: This report demonstrates that the dynamical structural changes of SDR-like l-ThrDH are important for the reactivity and specificity of the enzyme. Crystal structures of short chain dehydrogenase-like l-threonine dehydrogenase from Cupriavidus necator (CnThrDH) in the apo and holo forms were determined at 2.25 and 2.5 , respectively. Structural comparison between the apo and holo forms revealed that four regions of CnThrDH adopted flexible conformations when neither NAD(+) nor l-Thr were bound: residues 38-59, residues 77-87, residues 180-186, and the catalytic domain. Molecular dynamics simulations performed at the 50-ns time scale revealed that three of these regions remained flexible when NAD(+) was bound to CnThrDH: residues 80-87, residues 180-186, and the catalytic domain. Molecular dynamics simulations also indicated that the structure of CnThrDH changed from a closed form to an open form upon NAD(+) binding. The newly formed cleft in the open form may function as a conduit for substrate entry and product exit. These computational results led us to hypothesize that the CnThrDH reaction progresses by switching between the closed and open forms. Enzyme kinetics parameters of the L80G, G184A, and T186N variants also supported this prediction: the k(cat)/K-m,K- l-Thr value of the variants was >330-fold lower than that of the wild type; this decrease suggested that the variants mostly adopt the open form when l-Thr is bound to the active site. These results are summarized in a schematic model of the stepwise changes in flexibility and structure that occur in CnThrDH upon binding of NAD(+) and l-Thr. This demonstrates that the dynamical structural changes of short chain dehydrogenase-like l-threonine dehydrogenase are important for the reactivity and specificity of the enzyme.	[Nakano, Shogo; Okazaki, Seiji; Asano, Yasuhisa] Toyama Prefectural Univ, Biotechnol Res Ctr, Imizu, Toyama 9390398, Japan; [Nakano, Shogo; Okazaki, Seiji; Asano, Yasuhisa] Toyama Prefectural Univ, Dept Biotechnol, Imizu, Toyama 9390398, Japan; [Tokiwa, Hiroaki] Rikkyo Univ, Res Ctr Smart Mol, Toshima Ku, Tokyo 1718501, Japan; [Nakano, Shogo; Okazaki, Seiji; Tokiwa, Hiroaki; Asano, Yasuhisa] JST, ERATO, Asano Act Enzyme Mol Project, Imizu, Toyama 9390398, Japan	Toyama Prefectural University; Toyama Prefectural University; Rikkyo University; Japan Science & Technology Agency (JST)	Asano, Y (corresponding author), Toyama Prefectural Univ, Biotechnol Res Ctr, 5180 Kurokawa, Imizu, Toyama 9390398, Japan.	asano@pu-toyama.ac.jp	Asano, Yasuhisa/K-5898-2016; Nakano, Shogo/AAN-1455-2020	Asano, Yasuhisa/0000-0003-3645-3952; Nakano, Shogo/0000-0002-6614-7158	ERATO Asano Active Enzyme Molecule Project from the Japan Science and Technology Agency	ERATO Asano Active Enzyme Molecule Project from the Japan Science and Technology Agency	This work was supported by a grant from the ERATO Asano Active Enzyme Molecule Project from the Japan Science and Technology Agency.	ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1; Bashir Q, 2009, J BIOCHEM, V146, P95, DOI 10.1093/jb/mvp051; Bowyer A, 2009, J STRUCT BIOL, V168, P294, DOI 10.1016/j.jsb.2009.07.011; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Ebara S, 2001, BBA-GEN SUBJECTS, V1568, P111, DOI 10.1016/S0304-4165(01)00207-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; EPPERLY BR, 1991, J BIOL CHEM, V266, P6086; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Friedman AJ, 2012, CHEM BIOL DRUG DES, V80, P173, DOI 10.1111/j.1747-0285.2012.01392.x; Gil-Ortiz F, 2010, J MOL BIOL, V399, P476, DOI 10.1016/j.jmb.2010.04.025; Hayward S, 2006, BIOPHYS J, V91, P1823, DOI 10.1529/biophysj.106.085910; Higashi N, 2005, J BIOSCI BIOENG, V99, P175, DOI 10.1263/jbb.99.175; Ishikawa K, 2007, J MOL BIOL, V366, P857, DOI 10.1016/j.jmb.2006.11.060; KAMIYA Y, 1995, INTERNAL MED, V34, P679, DOI 10.2169/internalmedicine.34.679; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kazuoka T, 2003, J BACTERIOL, V185, P4483, DOI 10.1128/JB.185.15.4483-4489.2003; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Millerioux Y, 2013, MOL MICROBIOL, V90, P114, DOI 10.1111/mmi.12351; MISONO H, 1987, AGR BIOL CHEM TOKYO, V51, P1467, DOI 10.1080/00021369.1987.10868209; MOE, 2012, MOL OP ENV; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagel ZD, 2012, BIOCHEMISTRY-US, V51, P4147, DOI 10.1021/bi3001352; Nashine VC, 2010, CURR OPIN CHEM BIOL, V14, P644, DOI 10.1016/j.cbpa.2010.07.020; Nordling E, 2002, EUR J BIOCHEM, V269, P4267, DOI 10.1046/j.1432-1033.2002.03114.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Persson B, 2008, CELL MOL LIFE SCI, V65, P3879, DOI 10.1007/s00018-008-8587-z; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plapp BV, 2010, ARCH BIOCHEM BIOPHYS, V493, P3, DOI 10.1016/j.abb.2009.07.001; Ramaswamy S, 1999, BIOCHEMISTRY-US, V38, P13951, DOI 10.1021/bi991731i; Sakuraba H, 2011, ARCH BIOCHEM BIOPHYS, V512, P126, DOI 10.1016/j.abb.2011.05.013; Seeber M, 2007, BIOINFORMATICS, V23, P2625, DOI 10.1093/bioinformatics/btm378; Shimizu Y, 2005, EXTREMOPHILES, V9, P317, DOI 10.1007/s00792-005-0447-2; Timson DJ, 2013, GENE, V526, P318, DOI 10.1016/j.gene.2013.05.027; Tsutsui Y, 2013, J BIOL CHEM, V288, P31963, DOI 10.1074/jbc.M113.509984; Ueatrongchit T, 2011, ANAL BIOCHEM, V410, P44, DOI 10.1016/j.ab.2010.11.003; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Yoneda K, 2012, J BIOL CHEM, V287, P12966, DOI 10.1074/jbc.M111.336958; Yoneda K, 2010, FEBS J, V277, P5124, DOI 10.1111/j.1742-4658.2010.07916.x	39	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10445	10454		10.1074/jbc.M113.540773	http://dx.doi.org/10.1074/jbc.M113.540773			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24558034	hybrid, Green Published			2022-12-28	WOS:000334226400018
J	Arif, E; Rathore, YS; Kumari, B; Ashish, F; Wong, HN; Holzman, LB; Nihalani, D				Arif, Ehtesham; Rathore, Yogendra S.; Kumari, Babita; Ashish, Fnu; Wong, Hetty N.; Holzman, Lawrence B.; Nihalani, Deepak			Slit Diaphragm Protein Neph1 and Its Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Cell Signaling; Kidney; Phosphorylation; Podocytes; Neph1; Renal Injury	ISCHEMIC BRAIN-INJURY; FUSION PROTEIN; ACTIN CYTOSKELETON; PODOCYTE PROTEIN; IN-VIVO; DOMAIN; MECHANISMS; ZEBRAFISH; PEPTIDES; MODEL	Background: Neph1 is a podocyte protein that is critical for maintaining renal function. Results: Inhibiting Neph1 signaling preserves podocyte structure and function in response to glomerular injury-inducing agents. Conclusion: Maintaining a robust expression of Neph1 at the podocyte cell membrane protects podocytes from renal injury. Significance: This is the first report demonstrating that Neph1 signaling is a therapeutic target for preventing podocyte damage. Podocytes are specialized epithelial cells that are critical components of the glomerular filtration barrier, and their dysfunction leads to proteinuria and renal failure. Therefore, preserving podocyte function is therapeutically significant. In this study, we identified Neph1 signaling as a therapeutic target that upon inhibition prevented podocyte damage from a glomerular injury-inducing agent puromycin aminonucleoside (PAN). To specifically inhibit Neph1 signaling, we used a protein transduction approach, where the cytoplasmic domain of Neph1 (Neph1CD) tagged with a protein transduction domain trans-activator of transcription was transduced in cultured podocytes prior to treatment with PAN. The PAN-induced Neph1 phosphorylation was significantly reduced in Neph1CD-transduced cells; in addition, these cells were resistant to PAN-induced cytoskeletal damage. The biochemical analysis using subfractionation studies showed that unlike control cells Neph1 was retained in the lipid raft fractions in the transduced cells following treatment with PAN, indicating that transduction of Neph1CD in podocytes prevented PAN-induced mislocalization of Neph1. In accordance, the immunofluorescence analysis further suggested that Neph1CD-transduced cells had increased ability to retain endogenous Neph1 at the membrane in response to PAN-induced injury. Similar results were obtained when angiotensin was used as an injury-inducing agent. Consistent with these observations, maintaining high levels of Neph1 at the membrane using a podocyte cell line overexpressing chimeric Neph1 increased the ability of podocytes to resist PAN-induced injury and PAN-induced albumin leakage. Using a zebrafish in vivo PAN and adriamycin injury models, we further demonstrated the ability of transduced Neph1CD to preserve glomerular function. Collectively, these results support the conclusion that inhibiting Neph1 signaling is therapeutically significant in preventing podocyte damage from glomerular injury.	[Arif, Ehtesham; Rathore, Yogendra S.; Kumari, Babita; Wong, Hetty N.; Holzman, Lawrence B.; Nihalani, Deepak] Univ Penn, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; [Rathore, Yogendra S.; Ashish, Fnu] Inst Microbial Technol, Ctr Sci & Ind Res, Chandigarh 160036, India	University of Pennsylvania; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Arif, E (corresponding author), Univ Penn, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA.	ehtesham@mail.med.upenn.edu; deepakn@mail.med.upenn.edu	Arif, Ehtesham/AAV-8272-2020; nihalani, deepak/AAK-9453-2020	Holzman, Lawrence/0000-0002-8961-234X; Arif, Ehtesham/0000-0001-9638-3189	National Institutes of Health [P30 DK050306]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087956, P30DK050306, R01DK080751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The imaging core was supported by Center Grant P30 DK050306 from the National Institutes of Health.	Albarran B, 2005, PROTEIN ENG DES SEL, V18, P147, DOI 10.1093/protein/gzi014; Arif E, 2011, MOL CELL BIOL, V31, P2134, DOI 10.1128/MCB.05051-11; Arif E, 2013, KIDNEY INT, V84, P1154, DOI 10.1038/ki.2013.201; Cao GD, 2002, J NEUROSCI, V22, P5423; Del Gaizo V, 2003, MOL THER, V7, P720, DOI 10.1016/S1525-0016(03)00130-8; Donnini S, 2009, CELL CYCLE, V8, P1271, DOI 10.4161/cc.8.8.8301; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Durvasula RV, 2006, CURR OPIN NEPHROL HY, V15, P1, DOI 10.1097/01.mnh.0000199012.79670.0b; Eto N, 2007, KIDNEY INT, V72, P455, DOI 10.1038/sj.ki.5002311; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Guan N, 2004, PATHOL INT, V54, P703, DOI 10.1111/j.1440-1827.2004.01683.x; Guo JK, 2002, HUM MOL GENET, V11, P651, DOI 10.1093/hmg/11.6.651; Hagiwara M, 2006, KIDNEY INT, V69, P1146, DOI 10.1038/sj.ki.5000207; Hamano Y, 2002, J BIOL CHEM, V277, P31154, DOI 10.1074/jbc.M204806200; Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006; Harita Y, 2008, J BIOL CHEM, V283, P9177, DOI 10.1074/jbc.M707247200; Harita Y, 2009, J BIOL CHEM, V284, P8951, DOI 10.1074/jbc.M806851200; Hentschel DM, 2007, AM J PHYSIOL-RENAL, V293, pF1746, DOI 10.1152/ajprenal.00009.2007; Hotchkiss RS, 2006, J IMMUNOL, V176, P5471, DOI 10.4049/jimmunol.176.9.5471; Hsu HH, 2008, J MOL MED, V86, P1379, DOI 10.1007/s00109-008-0399-y; Huber TB, 2003, J BIOL CHEM, V278, P13417, DOI 10.1074/jbc.C200678200; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kari G, 2007, CLIN PHARMACOL THER, V82, P70, DOI 10.1038/sj.clpt.6100223; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Liu G, 2003, J CLIN INVEST, V112, P209, DOI 10.1172/JCI200318242; Liu HF, 2010, NEPHROLOGY, V15, P75, DOI 10.1111/j.1440-1797.2009.01146.x; Mallik L, 2012, J BIOL CHEM, V287, P9441, DOI 10.1074/jbc.M111.284927; Matsusaka T, 2010, HYPERTENSION, V55, P967, DOI 10.1161/HYPERTENSIONAHA.109.141994; Morris MC, 2008, BIOL CELL, V100, P201, DOI 10.1042/BC20070116; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Neumann-Haefelin E, 2010, HUM MOL GENET, V19, P2347, DOI 10.1093/hmg/ddq108; Oh J, 2004, PEDIATR NEPHROL, V19, P130, DOI 10.1007/s00467-003-1367-y; Otaki Y, 2008, AM J PHYSIOL-RENAL, V295, pF1376, DOI 10.1152/ajprenal.00075.2008; Panchapakesan U, 2005, NAT CLIN PRACT NEPHR, V1, P33, DOI 10.1038/ncpneph0029; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Picard F, 2002, ANNU REV NUTR, V22, P167, DOI 10.1146/annurev.nutr.22.010402.102808; Putaala H, 2000, J AM SOC NEPHROL, V11, P991, DOI 10.1681/ASN.V116991; Rantanen M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016142.29721.22; Reiser J, 2010, KIDNEY INT, V77, P662, DOI 10.1038/ki.2009.559; Rico M, 2005, AM J PHYSIOL-RENAL, V289, pF431, DOI 10.1152/ajprenal.00389.2004; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sawant R, 2010, MOL BIOSYST, V6, P628, DOI 10.1039/b916297f; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; Srivastava T, 2013, J CELL COMMUN SIGNAL, V7, P49, DOI 10.1007/s12079-012-0184-0; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Tryggvason K, 2006, CELL, V125, P221, DOI 10.1016/j.cell.2006.04.002; Tunnemann G, 2006, FASEB J, V20, P1775, DOI 10.1096/fj.05-5523com; Vazquez J, 2003, HYPERTENSION, V41, P751, DOI 10.1161/01.HYP.0000047878.13793.41; Vega-Warner V, 2004, KIDNEY INT, V66, P1881, DOI 10.1111/j.1523-1755.2004.00962.x; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Wagner MC, 2008, J BIOL CHEM, V283, P35579, DOI 10.1074/jbc.M805507200; Zhang Chaojie, 2003, Curr Protoc Toxicol, VChapter 1, DOI 10.1002/0471140856.tx0107s17; Zheng CX, 2008, KIDNEY INT, V74, P596, DOI 10.1038/ki.2008.203; Zhou WB, 2012, J AM SOC NEPHROL, V23, P1039, DOI 10.1681/ASN.2011080776; Zhu J, 2008, KIDNEY INT, V73, P556, DOI 10.1038/sj.ki.5002691	56	34	35	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9502	9518		10.1074/jbc.M113.505743	http://dx.doi.org/10.1074/jbc.M113.505743			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24554715	Green Published, hybrid			2022-12-28	WOS:000333807000008
J	Chao, JD; Wong, D; Av-Gay, Y				Chao, Joseph D.; Wong, Dennis; Av-Gay, Yossef			Microbial Protein-tyrosine Kinases*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Bacterial Protein Kinases; Bacterial Signal Transduction; Signal Transduction; Signaling; Protein-tyrosine Kinase (Tyrosine Kinase); BY-kinases; Mycobacterium tuberculosis PtkA; Tyr Kinase	GROUP-1 CAPSULAR POLYSACCHARIDES; ESCHERICHIA-COLI K-12; MYCOBACTERIUM-TUBERCULOSIS; BACILLUS-SUBTILIS; STAPHYLOCOCCUS-AUREUS; MYXOCOCCUS-XANTHUS; BIOFILM FORMATION; PHOSPHOTYROSINE PHOSPHATASE; STREPTOCOCCUS-PNEUMONIAE; PSEUDOMONAS-AERUGINOSA	Microbial ester kinases identified in the past 3 decades came as a surprise, as protein phosphorylation on Ser, Thr, and Tyr amino acids was thought to be unique to eukaryotes. Current analysis of available microbial genomes reveals that eukaryote-like protein kinases are prevalent in prokaryotes and can converge in the same signaling pathway with the classical microbial two-component systems. Most microbial tyrosine kinases lack the eukaryotic Hanks domain signature and are designated tyrosine kinases based upon their biochemical activity. These include the tyrosine kinases termed bacterial tyrosine kinases (BY-kinases), which are responsible for the majority of known bacterial tyrosine phosphorylation events. Although termed generally as bacterial tyrosine kinases, BY-kinases can be considered as one family belonging to the superfamily of prokaryotic protein-tyrosine kinases in bacteria. Other members of this superfamily include atypical odd tyrosine kinases with diverse mechanisms of protein phosphorylation and the eukaryote-like Hanks-type tyrosine kinases. Here, we discuss the distribution, phylogeny, and function of the various prokaryotic protein-tyrosine kinases, focusing on the recently discovered Mycobacterium tuberculosis PtkA and its relationship with other members of this diverse family of proteins.	[Chao, Joseph D.; Av-Gay, Yossef] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6H 3Z6, Canada; [Wong, Dennis; Av-Gay, Yossef] Univ British Columbia, Dept Med, Div Infect Dis, Vancouver, BC V6H 3Z6, Canada	University of British Columbia; University of British Columbia	Av-Gay, Y (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6H 3Z6, Canada.	yossi@mail.ubc.ca	Av-Gay, Yossef/H-2311-2014; Av-Gay, Yossef/H-5128-2019	Av-Gay, Yossef/0000-0002-9547-0237; Chao, Joseph/0000-0003-1212-7570	Canadian Institutes of Health Research (CIHR) [MOP-106622]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) Operating Grant MOP-106622. This is the first article in the Thematic Minireview Series "Protein Serine/Threonine and Tyrosine Phosphorylation in Prokaryotes."	Anderson I, 2005, FEMS MICROBIOL LETT, V250, P175, DOI 10.1016/j.femsle.2005.07.008; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Arora G, 2012, J BIOL CHEM, V287, P26749, DOI 10.1074/jbc.M112.351304; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; Bach H, 2009, BIOCHEM J, V420, P155, DOI 10.1042/BJ20090478; Bechet E, 2010, MOL MICROBIOL, V77, P1315, DOI 10.1111/j.1365-2958.2010.07291.x; Bechet E, 2009, AMINO ACIDS, V37, P499, DOI 10.1007/s00726-009-0237-8; Bender MH, 2001, J BIOL CHEM, V276, P47966, DOI 10.1074/jbc.M105448200; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Chao J, 2010, BBA-PROTEINS PROTEOM, V1804, P620, DOI 10.1016/j.bbapap.2009.09.008; Chao JD, 2010, J BIOL CHEM, V285, P29239, DOI 10.1074/jbc.M110.132894; Collins RF, 2007, P NATL ACAD SCI USA, V104, P2390, DOI 10.1073/pnas.0607763104; Cuthbertson L, 2009, MICROBIOL MOL BIOL R, V73, P155, DOI 10.1128/MMBR.00024-08; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Deutscher J, 2005, J MOL MICROB BIOTECH, V9, P125, DOI 10.1159/000089641; Ferreira AS, 2007, APPL ENVIRON MICROB, V73, P524, DOI 10.1128/AEM.01450-06; Ferreira AS, 2013, APPL ENVIRON MICROB, V79, P3009, DOI 10.1128/AEM.00222-13; Fuhrmann J, 2013, CELL REP, V3, P1832, DOI 10.1016/j.celrep.2013.05.023; Fuhrmann J, 2009, SCIENCE, V324, P1323, DOI 10.1126/science.1170088; Grangeasse C, 2003, J BIOL CHEM, V278, P39323, DOI 10.1074/jbc.M305134200; Grangeasse C, 1997, GENE, V204, P259, DOI 10.1016/S0378-1119(97)00554-4; Grangeasse C, 2007, TRENDS BIOCHEM SCI, V32, P86, DOI 10.1016/j.tibs.2006.12.004; Grangeasse C, 2012, PHILOS T R SOC B, V367, P2640, DOI 10.1098/rstb.2011.0424; Grangeasse C, 2010, BBA-PROTEINS PROTEOM, V1804, P628, DOI 10.1016/j.bbapap.2009.08.018; Grebe TW, 1999, ADV MICROB PHYSIOL, V41, P139, DOI 10.1016/S0065-2911(08)60167-8; Hansen AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003403; Horn N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059957; Ilan O, 1999, EMBO J, V18, P3241, DOI 10.1093/emboj/18.12.3241; Jadeau F, 2008, BIOINFORMATICS, V24, P2427, DOI 10.1093/bioinformatics/btn462; Jadeau F, 2012, NUCLEIC ACIDS RES, V40, pD321, DOI 10.1093/nar/gkr915; Jers C, 2010, MOL MICROBIOL, V77, P287, DOI 10.1111/j.1365-2958.2010.07227.x; Johnson DL, 2007, J BACTERIOL, V189, P7549, DOI 10.1128/JB.00893-07; Johnson DL, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-218; Jung K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.296pe71; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kiley TB, 2010, MOL MICROBIOL, V78, P947, DOI 10.1111/j.1365-2958.2010.07382.x; Kimura Y, 2012, FEMS MICROBIOL LETT, V336, P45, DOI 10.1111/j.1574-6968.2012.02651.x; Kimura Y, 2011, J BACTERIOL, V193, P5853, DOI 10.1128/JB.05750-11; Kirstein J, 2005, EMBO J, V24, P3435, DOI 10.1038/sj.emboj.7600780; Klein G, 2003, MOL MICROBIOL, V48, P269, DOI 10.1046/j.1365-2958.2003.03449.x; Lacour S, 2006, RES MICROBIOL, V157, P637, DOI 10.1016/j.resmic.2006.01.003; LAPORTE DC, 1985, J BIOL CHEM, V260, P5291; Lee DC, 2008, EMBO J, V27, P1758, DOI 10.1038/emboj.2008.97; Lee DC, 2009, TRENDS BIOCHEM SCI, V34, P351, DOI 10.1016/j.tibs.2009.03.003; Lomas-Lopez R, 2007, FEMS MICROBIOL LETT, V272, P35, DOI 10.1111/j.1574-6968.2007.00742.x; Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200; MANAI M, 1979, BIOCHEM BIOPH RES CO, V91, P819, DOI 10.1016/0006-291X(79)91953-3; Mawuenyega KG, 2005, MOL BIOL CELL, V16, P396, DOI 10.1091/mbc.e04-04-0329; Mijakovic I, 2006, NUCLEIC ACIDS RES, V34, P1588, DOI 10.1093/nar/gkj514; Mijakovic I, 2003, EMBO J, V22, P4709, DOI 10.1093/emboj/cdg458; Milling A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015853; Minic Z, 2007, J BACTERIOL, V189, P1351, DOI 10.1128/JB.01122-06; MIZUNO T, 1982, J BIOL CHEM, V257, P13692; Moreira LM, 2004, J MOL MICROB BIOTECH, V8, P43, DOI 10.1159/000082080; Morona JK, 2006, P NATL ACAD SCI USA, V103, P8505, DOI 10.1073/pnas.0602148103; MUNOZDORADO J, 1991, CELL, V67, P995, DOI 10.1016/0092-8674(91)90372-6; Nadler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037984; Nakar D, 2003, J BACTERIOL, V185, P1001, DOI 10.1128/JB.185.3.1001-1009.2003; Niemeyer D, 2001, J BACTERIOL, V183, P5163, DOI 10.1128/JB.183.17.5163-5170.2001; Obadia B, 2007, J MOL BIOL, V367, P42, DOI 10.1016/j.jmb.2006.12.048; Olivares-Illana V, 2008, PLOS BIOL, V6, P1321, DOI 10.1371/journal.pbio.0060143; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; OSTROVSKY PC, 1995, GENE DEV, V9, P2034, DOI 10.1101/gad.9.16.2034; Paiment A, 2002, J BACTERIOL, V184, P6437, DOI 10.1128/JB.184.23.6437-6447.2002; Pawson T, 2005, TRENDS BIOCHEM SCI, V30, P286, DOI 10.1016/j.tibs.2005.04.013; Petranovic D, 2007, MOL MICROBIOL, V63, P1797, DOI 10.1111/j.1365-2958.2007.05625.x; Preneta R, 2002, COMP BIOCHEM PHYS B, V131, P103, DOI 10.1016/S1096-4959(01)00490-0; Reisinger SJ, 2007, J BACTERIOL, V189, P8308, DOI 10.1128/JB.00868-07; RUBENS CE, 1993, MOL MICROBIOL, V8, P843, DOI 10.1111/j.1365-2958.1993.tb01631.x; Russo TA, 2010, INFECT IMMUN, V78, P3993, DOI 10.1128/IAI.00366-10; Song H, 2008, TUBERCULOSIS, V88, P526, DOI 10.1016/j.tube.2008.02.004; Soulat D, 2007, J MOL MICROB BIOTECH, V13, P45, DOI 10.1159/000103596; Soulat D, 2006, J BIOL CHEM, V281, P14048, DOI 10.1074/jbc.M513600200; Stehle T, 2012, J BIOL CHEM, V287, P34569, DOI 10.1074/jbc.M112.399261; Tailor P, 1997, J BIOL CHEM, V272, P5371, DOI 10.1074/jbc.272.9.5371; Temel DB, 2013, J BIOL CHEM, V288, P15212, DOI 10.1074/jbc.M113.457804; Thomasson B, 2002, MOL MICROBIOL, V46, P1399, DOI 10.1046/j.1365-2958.2002.03258.x; TOMMASSEN J, 1982, J MOL BIOL, V157, P265, DOI 10.1016/0022-2836(82)90233-9; Tyler JS, 2004, J BACTERIOL, V186, P3472, DOI 10.1128/JB.186.11.3472-3479.2004; Vincent C, 1999, J BACTERIOL, V181, P3472, DOI 10.1128/JB.181.11.3472-3477.1999; Walsh AG, 2000, MOL MICROBIOL, V35, P718, DOI 10.1046/j.1365-2958.2000.01741.x; WANG JYJ, 1978, J BIOL CHEM, V253, P7605; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Whitmore SE, 2012, INT J ORAL SCI, V4, P1, DOI 10.1038/ijos.2012.6; Wong D, 2013, TRENDS MICROBIOL, V21, P100, DOI 10.1016/j.tim.2012.09.002; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; Wu JG, 1999, P NATL ACAD SCI USA, V96, P13068, DOI 10.1073/pnas.96.23.13068; Wugeditsch T, 2001, J BIOL CHEM, V276, P2361, DOI 10.1074/jbc.M009092200; Zhao X, 2002, J BIOL CHEM, V277, P4722, DOI 10.1074/jbc.M107803200	90	47	48	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9463	9472		10.1074/jbc.R113.520015	http://dx.doi.org/10.1074/jbc.R113.520015			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24554699	Green Published, hybrid			2022-12-28	WOS:000333807000002
J	Berry, R; Headey, SJ; Call, MJ; McCluskey, J; Tregaskes, CA; Kaufman, J; Koh, R; Scanlon, MJ; Call, ME; Rossjohn, J				Berry, Richard; Headey, Stephen J.; Call, Melissa J.; McCluskey, James; Tregaskes, Clive A.; Kaufman, Jim; Koh, Ruide; Scanlon, Martin J.; Call, Matthew E.; Rossjohn, Jamie			Structure of the Chicken CD3 epsilon delta/gamma Heterodimer and Its Assembly with the alpha beta T Cell Receptor*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Immunology; Protein Assembly; Protein Evolution; Protein Structure	INDUCED CONFORMATIONAL-CHANGE; ANTIGEN RECEPTOR; SURFACE EXPRESSION; CRYSTAL-STRUCTURE; TYROSINE KINASE; CD3-GAMMA CHAIN; ZETA-CHAIN; COMPLEX; TCR; CD3-EPSILON-GAMMA	Background: Chickens possess a CD3/ chain that assembles with T cell receptor to mediate immune signaling. Results: Chicken CD3E/ has an atypical heterodimer interface and surface but associates with TCR. Conclusion: Chicken CD3/ represents a hybrid chain possessing features in common with human CD3 and CD3. Significance: Understanding the ancestral TCR signaling complex provides insights into the evolution of this signaling apparatus. In mammals, the T cell receptor (TCR) signaling complex is composed of a TCR heterodimer that is noncovalently coupled to three dimeric signaling molecules, CD3E, CD3E, and CD3. The nature of the TCR signaling complex and subunit arrangement in different species remains unclear however. Here we present a structural and biochemical analysis of the more primitive ancestral form of the TCR signaling complex found in chickens. In contrast to mammals, chickens do not express separate CD3 and CD3 chains but instead encode a single hybrid chain, termed CD3/, that is capable of pairing with CD3E. The NMR structure of the chicken CD3E/ heterodimer revealed a unique dimer interface that results in a heterodimer with considerable deviation from the distinct side-by-side architecture found in human and murine CD3E and CD3E. The chicken CD3E/ heterodimer also contains a unique molecular surface, with the vast majority of surface-exposed, nonconserved residues being clustered to a single face of the heterodimer. Using an in vitro biochemical assay, we demonstrate that CD3E/ can assemble with both chicken TCR and TCR via conserved polar transmembrane sites. Moreover, analogous to the human TCR signaling complex, the presence of two copies of CD3E/ is required for assembly. These data provide insight into the evolution of this critical receptor signaling apparatus.	[Berry, Richard; Koh, Ruide; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Headey, Stephen J.; Scanlon, Martin J.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Call, Melissa J.; Call, Matthew E.] Walter & Eliza Hall Inst Med Res, Struct Biol Div, Parkville, Vic 3052, Australia; [Call, Melissa J.; Call, Matthew E.] Univ Melbourne, Parkville, Vic 3010, Australia; [McCluskey, James] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Tregaskes, Clive A.; Kaufman, Jim] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Rossjohn, Jamie] Cardiff Univ, Inst Infect & Immun, Sch Med, Cardiff CF14 4XN, S Glam, Wales	Monash University; Monash University; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; University of Cambridge; Cardiff University	Call, ME (corresponding author), Walter & Eliza Hall Inst Med Res, Struct Biol Div, Parkville, Vic 3052, Australia.	mecall@wehi.edu.au; Jamie.rossjohn@monash.edu	Call, Melissa/HHZ-6671-2022; McCluskey, James/A-1291-2007; Rossjohn, Jamie/F-9032-2013	Call, Melissa/0000-0001-7684-5841; McCluskey, James/0000-0002-8597-815X; Rossjohn, Jamie/0000-0002-2020-7522; Scanlon, Martin/0000-0002-9230-7506; Call, Matthew/0000-0001-5846-6469; berry, richard/0000-0001-7043-0469; Kaufman, Jim/0000-0002-7216-8422; Headey, Stephen/0000-0001-8015-7064	Australian Research Council (ARC); National Health and Medical Research Council (NHMRC); ARC; VESKI; NHMRC Australia	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council); VESKI; NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an Australian Research Council (ARC) grant.; Supported by an National Health and Medical Research Council (NHMRC) Peter Doherty Fellowship.; Supported by an ARC Future Fellowship.; Supported by a VESKI Innovation Fellowship and an ARC Queen Elizabeth II Fellowship (QEII) Fellowship. To whom correspondence may be addressed. Tel.: 61-3-9345-2306; Fax: 61-3-9345-2686; E-mail: mecall@wehi.edu.au.; Supported by an NHMRC Australia Fellowship. To whom correspondence may be addressed. Tel.: 61-3-9902-9236; Fax: 61-3-9905-4699; E-mail: Jamie.rossjohn@monash.edu.	AKIYAMA Y, 1974, BIKEN J, V17, P105; ALCOVER A, 1990, J BIOL CHEM, V265, P4131; Arnett KL, 2004, P NATL ACAD SCI USA, V101, P16268, DOI 10.1073/pnas.0407359101; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; BERNOT A, 1991, P NATL ACAD SCI USA, V88, P2550, DOI 10.1073/pnas.88.6.2550; Berry R, 2011, TRENDS IMMUNOL, V32, P165, DOI 10.1016/j.it.2011.01.007; Birkinshaw RW, 2014, CURR OPIN IMMUNOL, V26, P7, DOI 10.1016/j.coi.2013.09.007; BLUMBERG RS, 1990, J BIOL CHEM, V265, P14036; BRENNER MB, 1985, CELL, V40, P183, DOI 10.1016/0092-8674(85)90321-6; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Call ME, 2004, EMBO J, V23, P2348, DOI 10.1038/sj.emboj.7600245; Chen W, 2013, IMMUNOL REV, V256, P160, DOI 10.1111/imr.12122; Dave VP, 1997, EMBO J, V16, P1360, DOI 10.1093/emboj/16.6.1360; Delgado P, 2005, J EXP MED, V201, P555, DOI 10.1084/jem.20041133; Dunstone MA, 2004, ACTA CRYSTALLOGR D, V60, P1425, DOI 10.1107/S0907444904012041; Eckle SBG, 2013, CURR OPIN IMMUNOL, V25, P653, DOI 10.1016/j.coi.2013.07.010; Ghendler Y, 1998, J EXP MED, V187, P1529, DOI 10.1084/jem.187.9.1529; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Gobel TWF, 1998, J IMMUNOL, V160, P1552; Gobel TWF, 2000, J IMMUNOL, V164, P879, DOI 10.4049/jimmunol.164.2.879; Gouaillard C, 2001, EUR J IMMUNOL, V31, P3798, DOI 10.1002/1521-4141(200112)31:12<3798::AID-IMMU3798>3.0.CO;2-Z; Gras S, 2012, IMMUNOL REV, V250, P61, DOI 10.1111/j.1600-065X.2012.01159.x; Haks MC, 1998, EMBO J, V17, P1871, DOI 10.1093/emboj/17.7.1871; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Hayes SM, 2006, J EXP MED, V203, P47, DOI 10.1084/jem.20051886; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Huppa JB, 1997, J EXP MED, V186, P393, DOI 10.1084/jem.186.3.393; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; Kim ST, 2010, J IMMUNOL, V185, P2951, DOI 10.4049/jimmunol.1000732; Kjer-Nielsen L, 2004, P NATL ACAD SCI USA, V101, P7675, DOI 10.1073/pnas.0402295101; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuhns MS, 2007, IMMUNITY, V26, P357, DOI 10.1016/j.immuni.2007.01.015; Kuhns MS, 2006, IMMUNITY, V24, P133, DOI 10.1016/j.immuni.2006.01.006; Laird DJ, 2000, P NATL ACAD SCI USA, V97, P6924, DOI 10.1073/pnas.97.13.6924; LETOURNEUR F, 1992, SCIENCE, V255, P79, DOI 10.1126/science.1532456; Minguet S, 2007, IMMUNITY, V26, P43, DOI 10.1016/j.immuni.2006.10.019; Pang SS, 2010, NATURE, V467, P844, DOI 10.1038/nature09448; Risueno RM, 2005, BLOOD, V106, P601, DOI 10.1182/blood-2004-12-4763; ROMEO C, 1992, CELL, V68, P889, DOI 10.1016/0092-8674(92)90032-8; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; SAMELSON LE, 1986, CELL, V46, P1083, DOI 10.1016/0092-8674(86)90708-7; Schamel WWA, 2013, IMMUNOL REV, V251, P13, DOI 10.1111/imr.12019; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Siegers GM, 2007, J EXP MED, V204, P2537, DOI 10.1084/jem.20070782; Sun ZYJ, 2004, P NATL ACAD SCI USA, V101, P16867, DOI 10.1073/pnas.0407576101; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; TJOELKER LW, 1990, P NATL ACAD SCI USA, V87, P7856, DOI 10.1073/pnas.87.20.7856; Touma M, 2006, J IMMUNOL, V176, P6812, DOI 10.4049/jimmunol.176.11.6812; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Wang YB, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000253; WEGENER AMK, 1995, J BIOL CHEM, V270, P4675, DOI 10.1074/jbc.270.9.4675; Xu CQ, 2006, J BIOL CHEM, V281, P36977, DOI 10.1074/jbc.M607164200	55	11	12	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8240	8251		10.1074/jbc.M113.544965	http://dx.doi.org/10.1074/jbc.M113.544965			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24488493	hybrid, Green Published			2022-12-28	WOS:000333157500019
J	Chang, Q; Berdyshev, E; Cao, DC; Bogaard, JD; White, JJ; Chen, SQ; Shah, R; Mu, WB; Grantner, R; Bettis, S; Grassi, MA				Chang, Qing; Berdyshev, Evgeny; Cao, Dingcai; Bogaard, Joseph D.; White, Jerry J.; Chen, Siquan; Shah, Ravi; Mu, Wenbo; Grantner, Rita; Bettis, Sam; Grassi, Michael A.			Cytochrome P450 2C Epoxygenases Mediate Photochemical Stress-induced Death of Photoreceptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Calcium; Cytochrome P450; Drug Screening; Eicosanoid; Fatty Acid; Necrosis (Necrotic Death)	INDUCED RETINAL DEGENERATION; MACULAR DEGENERATION; RETINITIS-PIGMENTOSA; ARACHIDONIC-ACID; LIGHT DAMAGE; CELL-DEATH; DOCOSAHEXAENOIC ACID; ROD PHOTORECEPTORS; RAT RETINA; VISUAL IMPAIRMENT	Background: New pharmacological entities are actively sought for treatment of inherited and age-related retinal degenerative diseases. Results: Sulfaphenazole, a selective inhibitor of human cytochrome P450 (CYP) 2C9 enzyme, was identified as a novel cytoprotective agent against light-induced death of photoreceptors. Conclusion: Cytochrome P450 CYP2C epoxygenases mediate photochemical stress-induced death of photoreceptors. Significance: The CYP monooxygenase system is a risk factor for retinal photodamage. Degenerative loss of photoreceptors occurs in inherited and age-related retinal degenerative diseases. A chemical screen facilitates development of new testing routes for neuroprotection and mechanistic investigation. Herein, we conducted a mouse-derived photoreceptor (661W cell)-based high throughput screen of the Food and Drug Administration-approved Prestwick drug library to identify putative cytoprotective compounds against light-induced, synthetic visual chromophore-precipitated cell death. Different classes of hit compounds were identified, some of which target known genes or pathways pathologically associated with retinitis pigmentosa. Sulfaphenazole (SFZ), a selective inhibitor of human cytochrome P450 (CYP) 2C9 isozyme, was identified as a novel and leading cytoprotective compound. Expression of CYP2C proteins was induced by light. Gene-targeted knockdown of CYP2C55, the homologous gene of CYP2C9, demonstrated viability rescue to light-induced cell death, whereas stable expression of functional CYP2C9-GFP fusion protein further exacerbated light-induced cell death. Mechanistically, SFZ inhibited light-induced necrosis and mitochondrial stress-initiated apoptosis. Light elicited calcium influx, which was mitigated by SFZ. Light provoked the release of arachidonic acid from membrane phospholipids and production of non-epoxyeicosatrienoic acid metabolites. Administration of SFZ further stimulated the production of non-epoxyeicosatrienoic acid metabolites, suggesting a metabolic shift of arachidonic acid under inhibition of the CYP2C pathway. Together, our findings indicate that CYP2C genes play a direct causative role in photochemical stress-induced death of photoreceptors and suggest that the CYP monooxygenase system is a risk factor for retinal photodamage, especially in individuals with Stargardt disease and age-related macular degeneration that deposit condensation products of retinoids.	[Chang, Qing; Cao, Dingcai; Bogaard, Joseph D.; Shah, Ravi; Mu, Wenbo; Grassi, Michael A.] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA; [White, Jerry J.] Univ Illinois, Res Resources Ctr, Chicago, IL 60612 USA; [Berdyshev, Evgeny] Univ Illinois, Sect Pulm Crit Care Sleep & Allergy, Chicago, IL 60612 USA; [Chen, Siquan; Grantner, Rita; Bettis, Sam] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago	Chang, Q (corresponding author), Univ Illinois, Dept Ophthalmol & Visual Sci, 1905 West Taylor St, Chicago, IL 60612 USA.	changq@uic.edu; grassim@uic.edu			National Institutes of Health, NEI [EY001792]; Hope for Vision; Foundation Fighting Blindness; Parent Petroleum; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY001792] Funding Source: NIH RePORTER	National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Hope for Vision; Foundation Fighting Blindness(European Commission); Parent Petroleum; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY001792, an NEI core grant. This work was also supported by funding from Hope for Vision, Foundation Fighting Blindness, Parent Petroleum, and Research to Prevent Blindness.	Al-Merjan JI, 2005, OPHTHAL EPIDEMIOL, V12, P251, DOI 10.1080/09286580591005813; Arnold C, 2010, J BIOL CHEM, V285, P32720, DOI 10.1074/jbc.M110.118406; Babai N, 2009, J PHYSIOL-LONDON, V587, P2353, DOI 10.1113/jphysiol.2009.169656; Barabas P, 2010, ADV EXP MED BIOL, V664, P491, DOI 10.1007/978-1-4419-1399-9_56; Bazan NG, 2010, J LIPID RES, V51, P2018, DOI 10.1194/jlr.R001131; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BERSON EL, 1993, ARCH OPHTHALMOL-CHIC, V111, P761, DOI 10.1001/archopht.1993.01090060049022; Biber K, 2007, TRENDS NEUROSCI, V30, P596, DOI 10.1016/j.tins.2007.08.007; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bressler SB, 2008, ARCH OPHTHALMOL-CHIC, V126, P241, DOI 10.1001/archophthalmol.2007.53; BUBENIK GA, 1980, CAN J PHYSIOL PHARM, V58, P1457, DOI 10.1139/y80-220; Buch H, 2004, OPHTHALMOLOGY, V111, P53, DOI 10.1016/j.ophtha.2003.05.010; Bursch W, 2000, J CELL SCI, V113, P1189; Bush E, 2004, P NATL ACAD SCI USA, V101, P2870, DOI 10.1073/pnas.0308723101; Caro AA, 2006, FREE RADICAL BIO MED, V40, P364, DOI 10.1016/j.freeradbiomed.2005.10.044; Cayouette M, 1998, J NEUROSCI, V18, P9282; Chang Q, 2012, INVEST OPHTH VIS SCI, V53, P3703, DOI 10.1167/iovs.11-8928; Chen Y, 2012, J BIOL CHEM, V287, P5059, DOI 10.1074/jbc.M111.315432; Chew EY, 2013, OPHTHALMOLOGY, V120, P1604, DOI 10.1016/j.ophtha.2013.01.021; COHEN AI, 1992, P NATL ACAD SCI USA, V89, P12093, DOI 10.1073/pnas.89.24.12093; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; DAIKH BE, 1994, J PHARMACOL EXP THER, V271, P1427; de Lera AR, 2007, NAT REV DRUG DISCOV, V6, P811, DOI 10.1038/nrd2398; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Ding XY, 2009, PROG RETIN EYE RES, V28, P1, DOI 10.1016/j.preteyeres.2008.10.001; Dumlao DS, 2011, BBA-MOL CELL BIOL L, V1811, P724, DOI 10.1016/j.bbalip.2011.06.005; FAKTOROVICH EG, 1990, NATURE, V347, P83, DOI 10.1038/347083a0; FARBER DB, 1995, INVEST OPHTH VIS SCI, V36, P263; Fer M, 2008, ARCH BIOCHEM BIOPHYS, V471, P116, DOI 10.1016/j.abb.2008.01.002; Fleming I, 2007, ARTERIOSCL THROM VAS, V27, P2612, DOI 10.1161/ATVBAHA.107.152074; Frasson M, 1999, INVEST OPHTH VIS SCI, V40, P2724; Frick KD, 2012, ARCH OPHTHALMOL-CHIC, V130, P629, DOI 10.1001/archophthalmol.2011.2820; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gonzalez FJ, 2005, MUTAT RES-FUND MOL M, V569, P101, DOI 10.1016/j.mrfmmm.2004.04.021; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hata H, 2003, JPN J CLIN OPHTHAL, V57, P259; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; JUNG H, 1994, GRAEF ARCH CLIN EXP, V232, P167, DOI 10.1007/BF00176787; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Kijas JW, 2002, P NATL ACAD SCI USA, V99, P6328, DOI 10.1073/pnas.082714499; Koch S, 2012, HUM MOL GENET, V21, P4486, DOI 10.1093/hmg/dds290; Kolko M, 2004, J NEUROSCI RES, V77, P517, DOI 10.1002/jnr.20187; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Krishnamoorthy RR, 1999, J BIOL CHEM, V274, P3734, DOI 10.1074/jbc.274.6.3734; Kronke G, 2009, J IMMUNOL, V183, P3383, DOI 10.4049/jimmunol.0900327; Luo G, 1998, ARCH BIOCHEM BIOPHYS, V357, P45, DOI 10.1006/abbi.1998.0806; Maeda A, 2009, INVEST OPHTH VIS SCI, V50, P5435, DOI 10.1167/iovs.09-3944; Mancy A, 1996, BIOCHEMISTRY-US, V35, P16205, DOI 10.1021/bi961950t; Marc RE, 2008, MOL VIS, V14, P782; Marill J, 2000, MOL PHARMACOL, V58, P1341, DOI 10.1124/mol.58.6.1341; McCaffery P, 1996, P NATL ACAD SCI USA, V93, P12570, DOI 10.1073/pnas.93.22.12570; Michaelis UR, 2005, ARTERIOSCL THROM VAS, V25, P321, DOI 10.1161/01.ATV.0000151648.58516.eb; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Naash ML, 1996, INVEST OPHTH VIS SCI, V37, P775; Neve EPA, 2008, ANAL BIOANAL CHEM, V392, P1075, DOI 10.1007/s00216-008-2200-z; NguyenLegros J, 1996, J NEUROCHEM, V67, P2514; Ogilvie JM, 2002, NEUROBIOL DIS, V10, P33, DOI 10.1006/nbdi.2002.0489; Otani A, 2004, J CLIN INVEST, V114, P765, DOI 10.1172/JCI200421686; Pang JJ, 2008, INVEST OPHTH VIS SCI, V49, P4278, DOI 10.1167/iovs.07-1622; Paskowitz DM, 2006, BRIT J OPHTHALMOL, V90, P1060, DOI 10.1136/bjo.2006.097436; PENN JS, 1987, EXP EYE RES, V44, P779, DOI 10.1016/S0014-4835(87)80041-6; Pollitt SK, 2003, NEURON, V40, P685, DOI 10.1016/S0896-6273(03)00697-4; Qian LX, 2010, J LIPID RES, V51, P1781, DOI 10.1194/jlr.M002840; Radu RA, 2008, INVEST OPHTH VIS SCI, V49, P3821, DOI 10.1167/iovs.07-1470; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Rutar M, 2011, INVEST OPHTH VIS SCI, V52, P5347, DOI 10.1167/iovs.10-7119; Rutar M, 2010, CURR EYE RES, V35, P631, DOI 10.3109/02713681003682925; Rzigalinski BA, 1999, J BIOL CHEM, V274, P175, DOI 10.1074/jbc.274.1.175; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Somwar R, 2009, J BIOMOL SCREEN, V14, P1176, DOI 10.1177/1087057109350919; Sparrow JR, 2003, VISION RES, V43, P2983, DOI 10.1016/S0042-6989(03)00475-9; Spector AA, 2004, PROG LIPID RES, V43, P55, DOI 10.1016/S0163-7827(03)00049-3; Sugawara T, 1998, INVEST OPHTH VIS SCI, V39, P2458; Tang DG, 1996, P NATL ACAD SCI USA, V93, P5241, DOI 10.1073/pnas.93.11.5241; Tanito M, 2005, INVEST OPHTH VIS SCI, V46, P979, DOI 10.1167/iovs.04-1120; Tanito M, 2002, INVEST OPHTH VIS SCI, V43, P2392; Trump BF, 1996, BBA-MOL CELL RES, V1313, P173, DOI 10.1016/0167-4889(96)00086-9; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Wang H, 2004, MOL PHARMACOL, V65, P1148, DOI 10.1124/mol.65.5.1148; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Wenzel A, 2001, INVEST OPHTH VIS SCI, V42, P1653; WIECHMANN AF, 1992, INVEST OPHTH VIS SCI, V33, P1894; Williams PA, 2003, NATURE, V424, P464, DOI 10.1038/nature01862; Wu HM, 2006, AM J HUM GENET, V79, P574, DOI 10.1086/507568; Yang LP, 2007, MOL VIS, V13, P2048; Zangar RC, 2004, TOXICOL APPL PHARM, V199, P316, DOI 10.1016/j.taap.2004.01.018; Zhang C, 2004, INVEST OPHTH VIS SCI, V45, P2753, DOI 10.1167/iovs.03-1344; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	90	13	13	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8337	8352		10.1074/jbc.M113.507152	http://dx.doi.org/10.1074/jbc.M113.507152			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24519941	hybrid, Green Published			2022-12-28	WOS:000333157500027
J	Eliezer, Y; Argaman, L; Kornowski, M; Roniger, M; Goldberg, M				Eliezer, Yifat; Argaman, Liron; Kornowski, Maya; Roniger, Maayan; Goldberg, Michal			Interplay between the DNA Damage Proteins MDC1 and ATM in the Regulation of the Spindle Assembly Checkpoint	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Checkpoint Control; DNA Damage Response; Kinetochore; Mitosis	DOUBLE-STRAND BREAKS; ATAXIA-TELANGIECTASIA; MITOTIC CHECKPOINT; AURORA-B; KINETOCHORE LOCALIZATION; IONIZING-RADIATION; CELLULAR-RESPONSE; GENOME INTEGRITY; HISTONE H2AX; HUMAN-CELLS	Background: The spindle assembly checkpoint (SAC) and the DNA damage response (DDR) are two distinct pathways designed to ensure genomic stability. Results: ATM phosphorylation of H2AX at kinetochores recruits MDC1. ATM and MDC1 modulate kinetochore localization and proper assembly of key SAC factors. Conclusion: ATM and MDC1 regulate the SAC. Significance: DDR core proteins maintain genomic stability also by regulating mitosis progression. To avoid genomic instability, cells have developed surveillance mechanisms such as the spindle assembly checkpoint (SAC) and the DNA damage response. ATM and MDC1 are central players of the cellular response to DNA double-strand breaks. Here, we identify a new role for these proteins in the regulation of mitotic progression and in SAC activation. MDC1 localizes at mitotic kinetochores following SAC activation in an ATM-dependent manner. ATM phosphorylates histone H2AX at mitotic kinetochores, and this phosphorylation is required for MDC1 localization at kinetochores. ATM and MDC1 are needed for kinetochore localization of the inhibitory mitotic checkpoint complex components, Mad2 and Cdc20, and for the maintenance of the mitotic checkpoint complex integrity. This probably relies on the interaction of MDC1 with the MCC. In this work, we have established that ATM and MDC1 maintain genomic stability not only by controlling the DNA damage response, but also by regulating SAC activation, providing an important link between these two essential biological processes.	[Eliezer, Yifat; Argaman, Liron; Kornowski, Maya; Roniger, Maayan; Goldberg, Michal] Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Goldberg, M (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel.	goldbergm@mail.huji.ac.il		Goldberg, Michal/0000-0001-9397-2383				Banerjee T, 2009, NUCLEIC ACIDS RES, V37, P2688, DOI 10.1093/nar/gkp110; Bartek J, 2007, CURR OPIN CELL BIOL, V19, P238, DOI 10.1016/j.ceb.2007.02.009; Braunstein I, 2007, P NATL ACAD SCI USA, V104, P4870, DOI 10.1073/pnas.0700523104; Bu YQ, 2010, BIOCHEM BIOPH RES CO, V397, P157, DOI 10.1016/j.bbrc.2010.05.063; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Coster G, 2010, NUCLEUS-PHILA, V1, P166, DOI 10.4161/nucl.1.2.11176; Davenport J, 2006, EXP CELL RES, V312, P1831, DOI 10.1016/j.yexcr.2006.02.018; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dimitrova N, 2006, GENE DEV, V20, P3238, DOI 10.1101/gad.1496606; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dotiwala F, 2010, CURR BIOL, V20, P328, DOI 10.1016/j.cub.2009.12.033; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Iourov IY, 2009, HUM MOL GENET, V18, P2656, DOI 10.1093/hmg/ddp207; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Jungmichel S, 2010, CHROMOSOMA, V119, P337, DOI 10.1007/s00412-010-0266-9; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Lee HJ, 2010, CELL CYCLE, V9, P2389, DOI 10.4161/cc.9.12.11904; Lee KJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.212969; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Logarinho E, 2008, CELL CYCLE, V7, P1763, DOI 10.4161/cc.7.12.6180; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Manchado E, 2010, BIOCHEM SOC T, V38, P65, DOI 10.1042/BST0380065; May KM, 2006, J CELL SCI, V119, P4139, DOI 10.1242/jcs.03165; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Mikhailov A, 2002, CURR BIOL, V12, P1797, DOI 10.1016/S0960-9822(02)01226-5; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Oricchio E, 2006, CELL CYCLE, V5, P88, DOI 10.4161/cc.5.1.2269; Riches LC, 2008, MUTAGENESIS, V23, P331, DOI 10.1093/mutage/gen039; Rieder CL, 2004, DEV CELL, V7, P637, DOI 10.1016/j.devcel.2004.09.002; Sabisz M, 2008, CURR PHARM BIOTECHNO, V9, P325, DOI 10.2174/138920108785161497; Shah JV, 2004, CURR BIOL, V14, P942, DOI 10.1016/j.cub.2004.05.046; Shen KC, 2005, CANCER RES, V65, P8747, DOI 10.1158/0008-5472.CAN-05-1471; Smeenk G, 2013, ANNU REV BIOCHEM, V82, P55, DOI 10.1146/annurev-biochem-061809-174504; Smith E, 2009, NAT CELL BIOL, V11, P278, DOI 10.1038/ncb1835; Solomon MJ, 2008, NAT CELL BIOL, V10, P381, DOI 10.1038/ncb0408-381; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Takagi M, 1998, CANCER RES, V58, P4923; Taylor SS, 2001, J CELL SCI, V114, P4385; Townsend K, 2009, J BIOL CHEM, V284, P33939, DOI 10.1074/jbc.M109.009191; Tritarelli A, 2004, MOL BIOL CELL, V15, P3751, DOI 10.1091/mbc.E03-12-0900; Vader G, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-10; Vagnarelli P, 2008, FEBS LETT, V582, P1950, DOI 10.1016/j.febslet.2008.04.014; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Wysong DR, 2009, CELL CYCLE, V8, P876, DOI 10.4161/cc.8.6.7897; Xie P, 2011, BIOCHEM BIOPH RES CO, V404, P413, DOI 10.1016/j.bbrc.2010.11.135; Xu XZ, 2003, FASEB J, V17, P1842, DOI 10.1096/fj.03-0310com; Xu XZ, 2003, J BIOL CHEM, V278, P8795, DOI 10.1074/jbc.M211392200; Yang CY, 2011, MOL CELL, V44, P597, DOI 10.1016/j.molcel.2011.09.016; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003; Zhang SS, 2007, J CELL BIOCHEM, V101, P451, DOI 10.1002/jcb.21195; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319	59	46	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8182	8193		10.1074/jbc.M113.532739	http://dx.doi.org/10.1074/jbc.M113.532739			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24509855	hybrid, Green Published			2022-12-28	WOS:000333157500014
J	Henry, C; Close, AF; Buteau, J				Henry, Cyndi; Close, Anne-Francoise; Buteau, Jean			A Critical Role for the Neural Zinc Factor ST18 in Pancreatic beta-Cell Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Beta Cell; Insulin Secretion; Lipotoxicity; Obesity; Zinc Finger	DIFFERENTIATION; EXPRESSION; GENE; MYT1; FAILURE; GLUCOSE; FINGER; FAMILY; DEATH	Background: The biological roles of the neural zinc finger transcription factor ST18 remain elusive. Results: ST18 expression and activity are increased in cytotoxic conditions in pancreatic -cells. Overexpression of ST18 causes apoptosis. ST18 knockdown prevents palmitate- and cytokine-induced apoptosis. Conclusion: ST18 plays a critical role in -cell apoptosis. Significance: ST18 could represent a novel therapeutic target in diabetes. The tumor suppressor gene ST18 was originally characterized as the third member of the neural zinc finger transcription factor family. However, little is known about its biological functions. Herein, we demonstrate that, in the pancreas, ST18 expression is restricted to endocrine cells. The detection of ST18 expression in pancreatic -cells prompted us to investigate its regulation and its role in -cell mass and function. We show that ST18 expression and activity are increased by cytotoxic concentrations of fatty acids and cytokines in INS832/13 cells. Furthermore, ST18 is also increased in islets of diet-induced obese animals. Overexpression and RNA interference knockdown studies demonstrate that ST18 induces -cell apoptosis and curtails -cell replication. Finally, our data suggest that ST18 impairs insulin secretion. Taken together, our findings indicate that ST18 could represent a novel transcriptional mediator of lipotoxicity and cytokine-induced -cell death. We suggest that genetic or pharmacologic manipulations of ST18 could help maintain a functional -cell mass.	[Henry, Cyndi] Univ Laval, Ste Foy, PQ G1V 4G5, Canada; [Henry, Cyndi] CRIUCPQ, Ste Foy, PQ G1V 4G5, Canada; [Close, Anne-Francoise; Buteau, Jean] Univ Alberta, Edmonton, AB T6G 2E1, Canada	Laval University; University of Alberta	Buteau, J (corresponding author), Alberta Diabet Inst, 5-126B Li Ka Shing Ctr, Edmonton, AB T6G 2E1, Canada.	jbuteau@ualberta.ca	Close, Anne-Françoise/GWZ-2344-2022		Canadian Institutes of Health Research; Diabete Quebec; Montreal Diabetes Research Center; Wallonie-Bruxelles, International	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Diabete Quebec; Montreal Diabetes Research Center; Wallonie-Bruxelles, International	This work was supported by the Canadian Institutes of Health Research, Diabete Quebec, and Montreal Diabetes Research Center.; Supported by Wallonie-Bruxelles, International.; A Fonds de Recherche en Sante du Quebec Junior Investigator and a Canadian Diabetes Association Scholar and supported by a Canadian Institutes of Health Research New Investigator award. To whom correspondence should be addressed: Alberta Diabetes Institute,	Buteau J, 1999, DIABETOLOGIA, V42, P856, DOI 10.1007/s001250051238; Buteau J, 2006, DIABETES, V55, P1190, DOI 10.2337/db05-0825; Buteau J, 2004, DIABETOLOGIA, V47, P806, DOI 10.1007/s00125-004-1379-6; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Gu GQ, 2004, DEVELOPMENT, V131, P165, DOI 10.1242/dev.00921; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Jandrig B, 2004, ONCOGENE, V23, P9295, DOI 10.1038/sj.onc.1208131; Kameyama T, 2011, NEUROSCI LETT, V497, P74, DOI 10.1016/j.neulet.2011.04.033; Kim JG, 1997, J NEUROSCI RES, V50, P272, DOI 10.1002/(SICI)1097-4547(19971015)50:2<272::AID-JNR16>3.0.CO;2-A; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Wang S, 2008, DEV BIOL, V317, P531, DOI 10.1016/j.ydbio.2008.02.052; Wang S, 2007, MECH DEVELOP, V124, P898, DOI 10.1016/j.mod.2007.08.004; Yang JL, 2008, FASEB J, V22, P3956, DOI 10.1096/fj.08-111013; Yee KSY, 1998, J BIOL CHEM, V273, P5366, DOI 10.1074/jbc.273.9.5366	16	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8413	8419		10.1074/jbc.M114.554915	http://dx.doi.org/10.1074/jbc.M114.554915			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24509857	hybrid, Green Published			2022-12-28	WOS:000333157500033
J	Kach, J; Sandbo, N; La, J; Denner, D; Reed, EB; Akimova, O; Koltsova, S; Orlov, SN; Dulin, NO				Kach, Jacob; Sandbo, Nathan; La, Jennifer; Denner, Darcy; Reed, Eleanor B.; Akimova, Olga; Koltsova, Svetlana; Orlov, Sergei N.; Dulin, Nickolai O.			Antifibrotic Effects of Noscapine through Activation of Prostaglandin E-2 Receptors and Protein Kinase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fibrosis; Microtubules; Myofibroblast; Prostaglandins; Protein Kinase A (PKA); Noscapine; SRF; Stress Fibers	IDIOPATHIC PULMONARY-FIBROSIS; SERUM RESPONSE FACTOR; GROWTH-FACTOR-BETA; MYOFIBROBLAST DIFFERENTIATION; MICROTUBULE DYNAMICS; LUNG FIBROBLASTS; GENE-EXPRESSION; CYCLOOXYGENASE-2-DEFICIENT MICE; OVARIAN-CANCER; H-3 NOSCAPINE	Background: Noscapine is a safe orally available anticough medicine also known to bind microtubules and induce cancer cell death. Results: Noscapine inhibits myofibroblast differentiation and pulmonary fibrosis through prostaglandin receptors and activation of PKA. Conclusion: Noscapine is an antifibrotic drug acting through PKA activation via EP2 prostaglandin receptors. Significance: This study describes a novel antifibrotic function and novel mechanism of action of noscapine. Myofibroblast differentiation is a key process in the pathogenesis of fibrotic disease. We have shown previously that differentiation of myofibroblasts is regulated by microtubule polymerization state. In this work, we examined the potential antifibrotic effects of the antitussive drug, noscapine, recently found to bind microtubules and affect microtubule dynamics. Noscapine inhibited TGF--induced differentiation of cultured human lung fibroblasts (HLFs). Therapeutic noscapine treatment resulted in a significant attenuation of pulmonary fibrosis in the bleomycin model of the disease. Noscapine did not affect gross microtubule content in HLFs, but inhibited TGF--induced stress fiber formation and activation of serum response factor without affecting Smad signaling. Furthermore, noscapine stimulated a rapid and profound activation of protein kinase A (PKA), which mediated the antifibrotic effect of noscapine in HLFs, as assessed with the PKA inhibitor, PKI. In contrast, noscapine did not activate PKA in human bronchial or alveolar epithelial cells. Finally, activation of PKA and the antifibrotic effect of noscapine in HLFs were blocked by the EP2 prostaglandin E-2 receptor antagonist, PF-04418948, but not by the antagonists of EP4, prostaglandin D-2, or prostacyclin receptors. Together, we demonstrate for the first time the antifibrotic effect of noscapine in vitro and in vivo, and we describe a novel mechanism of noscapine action through EP2 prostaglandin E-2 receptor-mediated activation of PKA in pulmonary fibroblasts.	[Kach, Jacob; La, Jennifer; Denner, Darcy; Reed, Eleanor B.; Dulin, Nickolai O.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Sandbo, Nathan] Univ Wisconsin, Dept Med, Madison, WI 53792 USA; [Akimova, Olga; Koltsova, Svetlana; Orlov, Sergei N.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow 119991, Russia	University of Chicago; University of Wisconsin System; University of Wisconsin Madison; Lomonosov Moscow State University	Dulin, NO (corresponding author), Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, 5841 S Maryland Ave,MC6076, Chicago, IL 60637 USA.	ndulin@medicine.bsd.uchicago.edu	Akimova, Olga/I-2669-2014		National Institutes of Health [R01 GM85058, K08 HL093367-01A1, T32HL007237]; American Heart Association [10PRE4190120]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL093367, T32HL007237, T32HL007605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM85058 (to N. O. D), K08 HL093367-01A1 (to N. S.), and T32HL007237 (to J. K.). This work was also supported by American Heart Association Fellowship 10PRE4190120 (to J. K.).	Aneja R, 2006, BLOOD, V107, P2486, DOI 10.1182/blood-2005-08-3516; Aneja R, 2006, BIOCHEM PHARMACOL, V72, P415, DOI 10.1016/j.bcp.2006.05.004; Aneja R, 2006, BIOORGAN MED CHEM, V14, P8352, DOI 10.1016/j.bmc.2006.09.012; Aneja R, 2006, MOL PHARMACOL, V69, P1801, DOI 10.1124/mol.105.021899; Ayabe S, 2013, J PHARMACOL SCI, V121, P312, DOI 10.1254/jphs.12275FP; Barken I, 2008, ANTICANCER RES, V28, P3701; Bonner JC, 2002, AM J PATHOL, V161, P459, DOI 10.1016/S0002-9440(10)64202-2; BROEKELMANN TJ, 1991, P NATL ACAD SCI USA, V88, P6642, DOI 10.1073/pnas.88.15.6642; Dackor RT, 2011, AM J PHYSIOL-LUNG C, V301, pL645, DOI 10.1152/ajplung.00176.2011; DAHLSTROM B, 1982, EUR J CLIN PHARMACOL, V22, P535, DOI 10.1007/BF00609627; Davis A, 2003, CELL SIGNAL, V15, P597, DOI 10.1016/S0898-6568(02)00148-1; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; EMPEY DW, 1979, EUR J CLIN PHARMACOL, V16, P393, DOI 10.1007/BF00568199; Hardie WD, 2009, AM J PATHOL, V175, P3, DOI 10.2353/ajpath.2009.081170; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hodges RJ, 2004, AM J PATHOL, V165, P1663, DOI 10.1016/S0002-9440(10)63423-2; Hogarth DK, 2004, AM J PHYSIOL-CELL PH, V287, pC449, DOI 10.1152/ajpcell.00547.2003; Huang S, 2007, AM J PHYSIOL-LUNG C, V292, pL405, DOI 10.1152/ajplung.00232.2006; Jackson T, 2008, CANCER CHEMOTH PHARM, V63, P117, DOI 10.1007/s00280-008-0720-z; Kach J, 2013, AM J PHYSIOL-LUNG C, V304, pL757, DOI 10.1152/ajplung.00262.2012; KAMEI J, 1993, EUR J PHARMACOL, V242, P209, DOI 10.1016/0014-2999(93)90083-T; Kaminski N, 2000, P NATL ACAD SCI USA, V97, P1778, DOI 10.1073/pnas.97.4.1778; KARLSSON MO, 1990, EUR J CLIN PHARMACOL, V39, P275, DOI 10.1007/BF00315110; KARLSSON MO, 1988, EUR J PHARMACOL, V145, P195, DOI 10.1016/0014-2999(88)90230-0; Keerthisingam CB, 2001, AM J PATHOL, V158, P1411, DOI 10.1016/S0002-9440(10)64092-8; Landen JW, 2004, CLIN CANCER RES, V10, P5187, DOI 10.1158/1078-0432.CCR-04-0360; Landen JW, 2002, CANCER RES, V62, P4109; Mack CP, 2000, CIRC RES, V86, P221, DOI 10.1161/01.RES.86.2.221; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; MOUREY RJ, 1992, MOL PHARMACOL, V42, P619; Noble PW, 2005, AM J RESP CELL MOL, V33, P113, DOI 10.1165/rcmb.F301; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; Petkova DK, 2003, HISTOPATHOLOGY, V43, P381, DOI 10.1046/j.1365-2559.2003.01718.x; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; Sandbo N, 2013, J BIOL CHEM, V288, P15466, DOI 10.1074/jbc.M113.464461; Sandbo N, 2011, AM J PHYSIOL-LUNG C, V301, pL656, DOI 10.1152/ajplung.00166.2011; Sandbo N, 2009, AM J RESP CELL MOL, V41, P332, DOI 10.1165/rcmb.2008-0288OC; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Sime PJ, 1997, J CLIN INVEST, V100, P768, DOI 10.1172/JCI119590; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Taurin S, 2007, J BIOL CHEM, V282, P19518, DOI 10.1074/jbc.M702655200; Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.med.55.091902.103810; White ES, 2003, J PATHOL, V201, P343, DOI 10.1002/path.1446; WILBORN J, 1995, J CLIN INVEST, V95, P1861, DOI 10.1172/JCI117866; Xaubet A, 2004, SARCOIDOSIS VASC DIF, V21, P35; Ye KQ, 1998, P NATL ACAD SCI USA, V95, P1601, DOI 10.1073/pnas.95.4.1601; Zhou J, 2002, J BIOL CHEM, V277, P17200, DOI 10.1074/jbc.M110369200; Zhu YJ, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-34	49	29	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7505	7513		10.1074/jbc.M113.546812	http://dx.doi.org/10.1074/jbc.M113.546812			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24492608	hybrid, Green Published			2022-12-28	WOS:000332761500021
J	Park, H; Dovas, A; Hanna, S; Lastrucci, C; Cougoule, C; Guiet, R; Maridonneau-Parini, I; Cox, D				Park, Haein; Dovas, Athanassios; Hanna, Samer; Lastrucci, Claire; Cougoule, Celine; Guiet, Romain; Maridonneau-Parini, Isabelle; Cox, Dianne			Tyrosine Phosphorylation of Wiskott-Aldrich Syndrome Protein (WASP) by Hck Regulates Macrophage Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chemotaxis; Extracellular Matrix; Invasion; Nonreceptor Tyrosine Kinase; Phagocytosis; Hck; Macrophage; WASP	SRC-FAMILY KINASES; RECEPTOR-MEDIATED PHAGOCYTOSIS; DIFFERENTIAL INVOLVEMENT; 3-DIMENSIONAL MIGRATION; ACTIN REORGANIZATION; PLASMA-MEMBRANE; CELL MIGRATION; PARACRINE LOOP; TUMOR-CELLS; ACTIVATION	Background: Tyrosine phosphorylation of WASP is required for macrophage functions. Results: WASP phosphorylation is dependent on the Src tyrosine kinase Hck. Conclusion: Hck is the predominant kinase that phosphorylates WASP in cells and is required for WASP-dependent functions. Significance: Although many tyrosine kinases can phosphorylate WASP, Hck appears to be the predominant kinase to phosphorylate WASP in macrophages in response to physiological ligands. We have shown previously that tyrosine phosphorylation of Wiskott-Aldrich syndrome protein (WASP) is important for diverse macrophage functions including phagocytosis, chemotaxis, podosome dynamics, and matrix degradation. However, the specific tyrosine kinase mediating WASP phosphorylation is still unclear. Here, we provide evidence that Hck, which is predominantly expressed in leukocytes, can tyrosine phosphorylate WASP and regulates WASP-mediated macrophage functions. We demonstrate that tyrosine phosphorylation of WASP in response to stimulation with CX3CL1 or via Fc receptor ligation were severely reduced in Hck(-/-) bone marrow-derived macrophages (BMMs) or in RAW/LR5 macrophages in which Hck expression was silenced using RNA-mediated interference (Hck shRNA). Consistent with reduced WASP tyrosine phosphorylation, phagocytosis, chemotaxis, and matrix degradation are reduced in Hck(-/-) BMMs or Hck shRNA cells. In particular, WASP phosphorylation was primarily mediated by the p61 isoform of Hck. Our studies also show that Hck and WASP are required for passage through a dense three-dimensional matrix and transendothelial migration, suggesting that tyrosine phosphorylation of WASP by Hck may play a role in tissue infiltration of macrophages. Consistent with a role for this pathway in invasion, WASP(-/-) BMMs do not invade into tumor spheroids with the same efficiency as WT BMMs and cells expressing phospho-deficient WASP have reduced ability to promote carcinoma cell invasion. Altogether, our results indicate that tyrosine phosphorylation of WASP by Hck is required for proper macrophage functions.	[Park, Haein; Dovas, Athanassios; Hanna, Samer; Cox, Dianne] Yeshiva Univ, Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Lastrucci, Claire; Cougoule, Celine; Guiet, Romain; Maridonneau-Parini, Isabelle] CNRS, Inst Pharmacol & Biol Struct, Dept Mech Mol Infect Mycobacteriennes, F-31077 Toulouse, France; [Lastrucci, Claire; Cougoule, Celine; Guiet, Romain; Maridonneau-Parini, Isabelle] Univ Toulouse 3, UPS, IPBS, F-31077 Toulouse, France	Yeshiva University; Albert Einstein College of Medicine; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Cox, D (corresponding author), 1300 Morris Pk Ave,MRRC306, Bronx, NY 10461 USA.	dianne.cox@einstein.yu.edu	COUGOULE, Céline/ABB-4180-2021; Maridonneau-Parini, Isabelle/F-1985-2011	Maridonneau-Parini, Isabelle/0000-0003-0189-0976; Cox, Dianne/0000-0002-0591-9767	National Institutes of Health [GM071828]; ANR [2010-01301 MigreFlame]; FRM DEQ [20110421312]; European Community [HEALTH-F4-2011-282095-TARKINAID]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071828] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ANR(French National Research Agency (ANR)); FRM DEQ; European Community(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM071828 (to D.C.) and ANR 2010-01301 MigreFlame, FRM DEQ 20110421312, and European Community's seventh framework programme (FP7-2007-2013) under Grant HEALTH-F4-2011-282095-TARKINAID.	Baruzzi A, 2008, CELL MOL LIFE SCI, V65, P2175, DOI 10.1007/s00018-008-8005-6; Bodour K, 2004, J EXP MED, V199, P99, DOI 10.1084/jem.20030976; Cammer M, 2009, J BIOL CHEM, V284, P23302, DOI 10.1074/jbc.M109.036384; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Carreno S, 2000, J BIOL CHEM, V275, P36223, DOI 10.1074/jbc.M003901200; Carreno S, 2002, J BIOL CHEM, V277, P21007, DOI 10.1074/jbc.M201212200; Cory GOC, 2002, J BIOL CHEM, V277, P45115, DOI 10.1074/jbc.M203346200; Cougoule C, 2005, TRAFFIC, V6, P682, DOI 10.1111/j.1600-0854.2005.00307.x; Cougoule C, 2012, EUR J CELL BIOL, V91, P938, DOI 10.1016/j.ejcb.2012.07.002; Cougoule C, 2010, BLOOD, V115, P1444, DOI 10.1182/blood-2009-04-218735; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Destaing O, 2008, MOL BIOL CELL, V19, P394, DOI 10.1091/mbc.E07-03-0227; Dovas A, 2011, CELL SIGNAL, V23, P1225, DOI 10.1016/j.cellsig.2011.02.004; Dovas Athanassios, 2010, Commun Integr Biol, V3, P101; Dovas A, 2009, J CELL SCI, V122, P3873, DOI 10.1242/jcs.051755; Ernst M, 2002, J EXP MED, V196, P589, DOI 10.1084/jem.20020873; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Gevrey JC, 2005, J IMMUNOL, V175, P3737, DOI 10.4049/jimmunol.175.6.3737; Giagulli C, 2006, J IMMUNOL, V177, P604, DOI 10.4049/jimmunol.177.1.604; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Guiet R, 2008, EUR J CELL BIOL, V87, P527, DOI 10.1016/j.ejcb.2008.03.008; Guiet R, 2011, J IMMUNOL, V187, P3806, DOI 10.4049/jimmunol.1101245; Guinamard R, 1998, FEBS LETT, V434, P431, DOI 10.1016/S0014-5793(98)01016-3; Ishihara D, 2013, CELL REP, V4, P429, DOI 10.1016/j.celrep.2013.07.007; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Linder S, 1999, P NATL ACAD SCI USA, V96, P9648, DOI 10.1073/pnas.96.17.9648; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; LOCK P, 1991, MOL CELL BIOL, V11, P4363, DOI 10.1128/MCB.11.9.4363; Lorenzi R, 2000, BLOOD, V95, P2943, DOI 10.1182/blood.V95.9.2943.009k17_2943_2946; LOWELL CA, 1994, GENE DEV, V8, P387, DOI 10.1101/gad.8.4.387; Majeed M, 2001, J LEUKOCYTE BIOL, V70, P801; Meng FY, 1997, J EXP MED, V185, P1661, DOI 10.1084/jem.185.9.1661; Park H, 2011, J BIOL CHEM, V286, P14762, DOI 10.1074/jbc.M110.185181; Park H, 2009, MOL BIOL CELL, V20, P4500, DOI 10.1091/mbc.E09-03-0230; Scholz G, 2000, J BIOL CHEM, V275, P14615, DOI 10.1074/jbc.275.19.14615; Shi YQ, 2009, BIOCHEM CELL BIOL, V87, P207, DOI 10.1139/O08-130; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Stabile H, 2010, BLOOD, V115, P2818, DOI 10.1182/blood-2009-07-235804; Stanley E R, 1997, Methods Mol Biol, V75, P301; Suzuki T, 2000, J IMMUNOL, V165, P473, DOI 10.4049/jimmunol.165.1.473; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tsuboi S, 2007, J IMMUNOL, V178, P2987, DOI 10.4049/jimmunol.178.5.2987; Van Goethem E, 2011, EUR J CELL BIOL, V90, P224, DOI 10.1016/j.ejcb.2010.07.011; Van Goethem E, 2010, J IMMUNOL, V184, P1049, DOI 10.4049/jimmunol.0902223; Verollet C, 2013, FASEB J, V27, P3608, DOI 10.1096/fj.13-232736; Verollet C, 2011, EUR J IMMUNOL, V41, P2805, DOI 10.1002/eji.201141538; Vincent C, 2007, J BIOL CHEM, V282, P19565, DOI 10.1074/jbc.M701501200; Welch H, 1997, J BIOL CHEM, V272, P102; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Zhang H, 2006, IMMUNITY, V25, P285, DOI 10.1016/j.immuni.2006.06.014	50	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7897	7906		10.1074/jbc.M113.509497	http://dx.doi.org/10.1074/jbc.M113.509497			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24482227	Green Published, hybrid			2022-12-28	WOS:000332761500054
J	Haseeb, A; Makki, MS; Haqqi, TM				Haseeb, Abdul; Makki, Mohammad Shahidul; Haqqi, Tariq M.			Modulation of Ten-Eleven Translocation 1 (TET1), Isocitrate Dehydrogenase (IDH) Expression, alpha-Ketoglutarate (alpha-KG), and DNA Hydroxymethylation Levels by Interleukin-1 beta in Primary Human Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chondrocytes; Cytokine; Dioxygenase; DNA Methylation; Epigenetics; 5-hmC; IL-1; TNF-	CPG SITES; 5-HYDROXYMETHYLCYTOSINE; PROMOTER; 5-METHYLCYTOSINE; DEMETHYLATION; CONVERSION; PROTEINS	Background: Cytosine hydroxymethylation in the genomic DNA controls gene expression. Results: Treatment of primary chondrocytes with IL-1 alone or in conjunction with TNF- inhibited TET1 and IDH expression and suppressed cytosine hydroxymethylation. Conclusion: IL-1 and TNF- decrease DNA hydroxymethylation by suppressing the expression and activity of TET1 and IDH. Significance: Pro-inflammatory cytokines likely control gene expression by modulating the 5-hmC levels. 5-Hydroxymethylcytosine (5-hmC) generated by ten-eleven translocation 1-3 (TET1-3) enzymes is an epigenetic mark present in many tissues with different degrees of abundance. IL-1 and TNF- are the two major cytokines present in arthritic joints that modulate the expression of many genes associated with cartilage degradation in osteoarthritis. In the present study, we investigated the global 5-hmC content, the effects of IL-1 and TNF- on 5-hmC content, and the expression and activity of TETs and isocitrate dehydrogenases in primary human chondrocytes. The global 5-hmC content was found to be approximate to 0.1% of the total genome. There was a significant decrease in the levels of 5-hmC and the TET enzyme activity upon treatment of chondrocytes with IL-1 alone or in combination with TNF-. We observed a dramatic (10-20-fold) decrease in the levels of TET1 mRNA expression and a small increase (2-3-fold) in TET3 expression in chondrocytes stimulated with IL-1 and TNF-. IL-1 and TNF- significantly suppressed the activity and expression of IDHs, which correlated with the reduced -ketoglutarate levels. Whole genome profiling showed an erasure effect of IL-1 and TNF-, resulting in a significant decrease in hydroxymethylation in a myriad of genes including many genes that are important in chondrocyte physiology. Our data demonstrate that DNA hydroxymethylation is modulated by pro-inflammatory cytokines via suppression of the cytosine hydroxymethylation machinery. These data point to new mechanisms of epigenetic control of gene expression by pro-inflammatory cytokines in human chondrocytes.	[Haseeb, Abdul; Makki, Mohammad Shahidul; Haqqi, Tariq M.] Northeast Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH 44272 USA	Northeast Ohio Medical University (NEOMED)	Haqqi, TM (corresponding author), 4209 St Rt 44,Rm 144, Rootstown, OH 44272 USA.	thaqqi@neomed.edu	Haseeb, Abdul/I-5278-2017; Haseeb, Abdul/Q-2788-2015	Haseeb, Abdul/0000-0002-2623-1275; Haqqi, Tariq/0000-0003-3506-6133	National Institutes of Health [AT003627, AT005520]; Northeast Ohio Medical University; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [R01AT005520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT003627] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT007373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeast Ohio Medical University; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants AT003627 and AT005520 (to T.M.H.). This work was also supported by the Northeast Ohio Medical University (to T.M.H.).	Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Cheung KSC, 2009, RHEUMATOL INT, V29, P525, DOI 10.1007/s00296-008-0744-z; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Haseeb A, 2013, RHEUMATOLOGY, V52, P998, DOI 10.1093/rheumatology/kes363; Hashimoto K, 2013, J BIOL CHEM, V288, P10061, DOI 10.1074/jbc.M112.421156; Hashimoto K, 2009, ARTHRITIS RHEUM-US, V60, P3303, DOI 10.1002/art.24882; Imagawa K, 2011, BIOCHEM BIOPH RES CO, V405, P362, DOI 10.1016/j.bbrc.2011.01.007; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Li W, 2011, J NUCL ACIDS, V2011; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Neves-Costa A, 2013, MOL IMMUNOL, V54, P264, DOI 10.1016/j.molimm.2012.12.014; POMERANTZ SC, 1990, METHOD ENZYMOL, V193, P796, DOI 10.1016/0076-6879(90)93452-Q; Rasheed Z, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2700; Roach HI, 2005, ARTHRITIS RHEUM-US, V52, P3110, DOI 10.1002/art.21300; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240	18	56	57	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6877	6885		10.1074/jbc.M113.512269	http://dx.doi.org/10.1074/jbc.M113.512269			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24469454	Green Published, hybrid			2022-12-28	WOS:000332389400048
J	Nin, V; Chini, CCS; Escande, C; Capellini, V; Chini, EN				Nin, Veronica; Chini, Claudia C. S.; Escande, Carlos; Capellini, Verena; Chini, Eduardo N.			Deleted in Breast Cancer 1 (DBC1) Protein Regulates Hepatic Gluconeogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gluconeogenesis; Metabolism; Nuclear Receptors; Signal Transduction; SIRT1; Deleted In Breast Cancer 1; Rev-erb	REV-ERB-ALPHA; GLUCOSE-HOMEOSTASIS; CIRCADIAN BEHAVIOR; SIRT1; METABOLISM; HEME; DEACETYLATION; BETA; MICE; INHIBITION	Background: Gluconeogenesis is an important physiological pathway in response to fasting and stress. Results: DBC1 regulates gluconeogenesis and PEPCK expression by a mechanism that is at least in part explained by the Rev-erb and the deacetylase SIRT1. Conclusion: A new role for DBC1as a regulator of PEPCK expression is described. Significance: We aim to understand the molecular mechanisms of glucose metabolism and response to fasting. Liver gluconeogenesis is essential to provide energy to glycolytic tissues during fasting periods. However, aberrant up-regulation of this metabolic pathway contributes to the progression of glucose intolerance in individuals with diabetes. Phosphoenolpyruvate carboxykinase (PEPCK) expression plays a critical role in the modulation of gluconeogenesis. Several pathways contribute to the regulation of PEPCK, including the nuclear receptor Rev-erb and the histone deacetylase SIRT1. Deleted in breast cancer 1 (DBC1) is a nuclear protein that binds to and regulates both Rev-erb and SIRT1 and, therefore, is a candidate to participate in the regulation of PEPCK. In this work, we provide evidence that DBC1 regulates glucose metabolism and the expression of PEPCK. We show that DBC1 levels decrease early in the fasting state. Also, DBC1 KO mice display higher gluconeogenesis in a normal and a high-fat diet. DBC1 absence leads to an increase in PEPCK mRNA and protein expression. Conversely, overexpression of DBC1 results in a decrease in PEPCK mRNA and protein levels. DBC1 regulates the levels of Rev-erb, and manipulation of Rev-erb activity or levels prevents the effect of DBC1 on PEPCK. In addition, Rev-erb levels decrease in the first hours of fasting. Finally, knockdown of the deacetylase SIRT1 eliminates the effect of DBC1 knockdown on Rev-erb levels and PEPCK expression, suggesting that the mechanism of PEPCK regulation is, at least in part, dependent on the activity of this enzyme. Our results point to DBC1 as a novel regulator of gluconeogenesis.	[Chini, Eduardo N.] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA; Mayo Clin, Kogod Ctr Aging, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Chini, EN (corresponding author), Mayo Clin, Ctr GI Signaling, Ctr Canc, Lab Signal Transduct,Dept Anesthesiol, Rochester, MN 55905 USA.	chini.eduardo@mayo.edu			NIDDK, National Institutes of Health [DK-084055]; American Federation of Aging Research; Mayo Foundation; Strickland Career Development Award; Mayo-UOFM Decade of Discovery Grant [63-01]; Minnesota Obesity Council [DK-50456-15]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050456, R01DK084055] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Federation of Aging Research; Mayo Foundation; Strickland Career Development Award; Mayo-UOFM Decade of Discovery Grant; Minnesota Obesity Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by NIDDK, National Institutes of Health Grant DK-084055. This work was also supported by grants from the American Federation of Aging Research and from the Mayo Foundation, by the Strickland Career Development Award, by Mayo-UOFM Decade of Discovery Grant 63-01, and by Minnesota Obesity Council grant DK-50456-15.	Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Chini CCS, 2013, BIOCHEM J, V451, P453, DOI 10.1042/BJ20121085; Chini CCS, 2010, J BIOL CHEM, V285, P40830, DOI 10.1074/jbc.M110.153270; Chini E. N., 2013, BIOSCI REP, V33; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Duez H, 2009, J APPL PHYSIOL, V107, P1972, DOI 10.1152/japplphysiol.00570.2009; Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106; Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Gastaldelli A, 2000, DIABETES, V49, P1367, DOI 10.2337/diabetes.49.8.1367; Grant D, 2010, ACS CHEM BIOL, V5, P925, DOI 10.1021/cb100141y; Guillaumond F, 2010, MOL CELL BIOL, V30, P3059, DOI 10.1128/MCB.01141-09; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Hellerstein MK, 1997, J CLIN INVEST, V100, P1305, DOI 10.1172/JCI119644; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kojetin D, 2011, ACS CHEM BIOL, V6, P131, DOI 10.1021/cb1002575; Li ZY, 2009, J BIOL CHEM, V284, P10361, DOI 10.1074/jbc.M900956200; Linares A., 2006, Cardiovascular & Hematological Disorders - Drug Targets, V6, P151, DOI 10.2174/187152906778249545; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; Nin V, 2012, J BIOL CHEM, V287, P23489, DOI 10.1074/jbc.M112.365874; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Sun Z, 2012, NAT MED, V18, P934, DOI 10.1038/nm.2744; VALERA A, 1994, P NATL ACAD SCI USA, V91, P9151, DOI 10.1073/pnas.91.19.9151; Vieira E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069939; Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243; Wei D, 2011, AM J PHYSIOL-ENDOC M, V300, pE312, DOI 10.1152/ajpendo.00524.2010; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yin L, 2010, P NATL ACAD SCI USA, V107, P11614, DOI 10.1073/pnas.1000438107; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	41	13	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5518	5527		10.1074/jbc.M113.512913	http://dx.doi.org/10.1074/jbc.M113.512913			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24415752	Green Published, hybrid			2022-12-28	WOS:000332015500016
J	Papa, L; Hahn, M; Marsh, EL; Evans, BS; Germain, D				Papa, Luena; Hahn, Mary; Marsh, Ellen L.; Evans, Bradley S.; Germain, Doris			SOD2 to SOD1 Switch in Breast Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer; Glucose Metabolism; Mitochondria; Reactive Oxygen Species (ROS); Superoxide Dismutase (SOD); ROS	AMYOTROPHIC-LATERAL-SCLEROSIS; SUPEROXIDE-DISMUTASE; TRANSGENIC MICE; MITOCHONDRIA; SIRT3; METABOLISM; STRESS	Background: Cancer cells are characterized by elevated mitochondrial ROS. The dismutases SOD1 and SOD2 regulate ROS. Results: SOD2 is down-regulated following oncogenic activation in breast cancers. However, SOD1 is overexpressed, and its inhibition by LCS-1 leads to mitochondrial fragmentation. Conclusion: In the absence of SOD2, inhibition of SOD1 abolishes the integrity of the mitochondria. Significance: Our data suggest a SOD switch during transformation. Cancer cells are characterized by elevated levels of reactive oxygen species, which are produced mainly by the mitochondria. The dismutase SOD2 localizes in the matrix and is a major antioxidant. The activity of SOD2 is regulated by the deacetylase SIRT3. Recent studies indicated that SIRT3 is decreased in 87% of breast cancers, implying that the activity of SOD2 is compromised. The resulting elevation in reactive oxygen species was shown to be essential for the metabolic reprograming toward glycolysis. Here, we show that SOD2 itself is down-regulated in breast cancer cell lines. Further, activation of oncogenes, such as Ras, promotes the rapid down-regulation of SOD2. Because in the absence of SOD2, superoxide levels are elevated in the matrix, we reasoned that mechanisms must exist to retain low levels of superoxide in other cellular compartments especially in the intermembrane space of the mitochondrial to avoid irreversible damage. The dismutase SOD1 also acts as an antioxidant, but it localizes to the cytoplasm and the intermembrane space of the mitochondria. We report here that loss of SOD2 correlates with the overexpression of SOD1. Further, we show that mitochondrial SOD1 is the main dismutase activity in breast cancer cells but not in non-transformed cells. In addition, we show that the SOD1 inhibitor LCS-1 leads to a drastic fragmentation and swelling of the matrix, suggesting that in the absence of SOD2, SOD1 is required to maintain the integrity of the organelle. We propose that by analogy to the cadherin switch during epithelial-mesenchymal transition, cancer cells also undergo a SOD switch during transformation.	[Papa, Luena; Hahn, Mary; Germain, Doris] Mt Sinai Sch Med, Dept Med, Tisch Canc Inst, Div Hematol Oncol, New York, NY 10029 USA; [Marsh, Ellen L.; Evans, Bradley S.] Donald Danforth Plant Sci Ctr, Prote & Mass Spectrometry Core Facil, St Louis, MO 63132 USA	Icahn School of Medicine at Mount Sinai; Donald Danforth Plant Science Center	Germain, D (corresponding author), Gustave L Levy Pl,Box 1079, New York, NY 10029 USA.	doris.germain@mssm.edu	Evans, Bradley S/M-2842-2013	Evans, Bradley S/0000-0002-1207-9006	National Institutes of Health [5R24 CA095823-04, 1 S10RRO 9145-01]; National Science Foundation [DBI-9724504]; NATIONAL CANCER INSTITUTE [R01CA109482, R24CA095823, T32CA078207] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Tumor sections from the MMTV mouse models were obtained from the laboratory of Dr. Rafael Mira-Lopez. Electron microscopy was performed by the shared facility at Mount Sinai, which is supported by National Institutes of Health shared resources Grant 5R24 CA095823-04, National Science Foundation Major Research Instrumentation Grant DBI-9724504, and National Institutes of Health shared instrumentation Grant 1 S10RRO 9145-01. HPLC analysis of 2-hydroxyethidium was performed at the Donald Danforth Plant Science Center, Proteomics and Mass Spectrometry Core Facility, St. Louis, MO under the supervision of Dr. Bradley S. Evans through Science Exchange.	Bellot GL, 2013, MITOCHONDRION, V13, P155, DOI 10.1016/j.mito.2012.06.007; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Fischer LR, 2011, BRAIN, V134, P196, DOI 10.1093/brain/awq314; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Higgins CMJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-06-j0001.2002; Jaarsma D, 2001, ACTA NEUROPATHOL, V102, P293; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Lu Weiqin, 2007, Drug Discov Today Dis Models, V4, P67, DOI 10.1016/j.ddmod.2007.10.005; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Papa L, 2014, MOL CELL BIOL, V34, P699, DOI 10.1128/MCB.01337-13; Radke S, 2005, ONCOGENE, V24, P3448, DOI 10.1038/sj.onc.1208328; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Somwar R, 2011, P NATL ACAD SCI USA, V108, P16375, DOI 10.1073/pnas.1113554108; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028; Zielonka J, 2009, FREE RADICAL BIO MED, V46, P329, DOI 10.1016/j.freeradbiomed.2008.10.031	17	82	88	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5412	5416		10.1074/jbc.C113.526475	http://dx.doi.org/10.1074/jbc.C113.526475			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24448804	Green Published, hybrid			2022-12-28	WOS:000332015500006
J	Ramakrishnan, G; Davaakhuu, G; Kaplun, L; Chung, WC; Rana, A; Atfi, A; Miele, L; Tzivion, G				Ramakrishnan, Gopalakrishnan; Davaakhuu, Gantulga; Kaplun, Ludmila; Chung, Wen-Cheng; Rana, Ajay; Atfi, Azeddine; Miele, Lucio; Tzivion, Guri			Sirt2 Deacetylase Is a Novel AKT Binding Partner Critical for AKT Activation by Insulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; AMP-activated Kinase (AMPK); Insulin; Phosphorylation; Sirtuins	SIRTUINS; PATHWAY; TARGET; TUMORIGENESIS; LOCALIZATION; DEFICIENCY; INSIGHTS; 3-KINASE; KINASES; GLUCOSE	Background: AKT kinases mediate insulin signaling downstream of phosphatidylinositol-3 kinase (PI3K). Results: AKT binds Sirt2 in insulin-responsive cells and Sirt2 inhibition blocks AKT activation, whereas Sirt2 overexpression sensitizes cells to insulin. Conclusion: Sirt2 deacetylase is an essential factor in AKT activation. Significance: Sirt2 modulators could be useful in treatment of diseases involving AKT, such as type 2 diabetes and cancer. AKT/PKB kinases transmit insulin and growth factor signals downstream of phosphatidylinositol 3-kinase (PI3K). AKT activation involves phosphorylation at two residues, Thr(308) and Ser(473), mediated by PDK1 and the mammalian target of rapamycin complex 2 (mTORC2), respectively. Impaired AKT activation is a key factor in metabolic disorders involving insulin resistance, whereas hyperactivation of AKT is linked to cancer pathogenesis. Here, we identify the cytoplasmic NAD(+)-dependent deacetylase, Sirt2, as a novel AKT interactor, required for optimal AKT activation. Pharmacological inhibition or genetic down-regulation of Sirt2 diminished AKT activation in insulin and growth factor-responsive cells, whereas Sirt2 overexpression enhanced the activation of AKT and its downstream targets. AKT was prebound with Sirt2 in serum or glucose-deprived cells, and the complex dissociated following insulin treatment. The binding was mediated by the pleckstrin homology and the kinase domains of AKT and was dependent on AMP-activated kinase. This regulation involved a novel AMP-activated kinase-dependent Sirt2 phosphorylation at Thr(101). In cells with constitutive PI3K activation, we found that AKT also associated with a nuclear sirtuin, Sirt1; however, inhibition of PI3K resulted in dissociation from Sirt1 and increased association with Sirt2. Sirt1 and Sirt2 inhibitors additively inhibited the constitutive AKT activity in these cells. Our results suggest potential usefulness of Sirt1 and Sirt2 inhibitors in the treatment of cancer cells with up-regulated PI3K activity and of Sirt2 activators in the treatment of insulin-resistant metabolic disorders.	[Ramakrishnan, Gopalakrishnan; Davaakhuu, Gantulga; Chung, Wen-Cheng; Atfi, Azeddine; Miele, Lucio; Tzivion, Guri] Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA; [Ramakrishnan, Gopalakrishnan; Davaakhuu, Gantulga; Chung, Wen-Cheng; Atfi, Azeddine; Miele, Lucio; Tzivion, Guri] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA; [Kaplun, Ludmila; Tzivion, Guri] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA; [Rana, Ajay] Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; Barbara Ann Karmanos Cancer Institute; Wayne State University; Loyola University Chicago	Tzivion, G (corresponding author), Univ Mississippi, Med Ctr, Inst Canc, 2500 N State St,Rm G759, Jackson, MS 39216 USA.	gtzivion@umc.edu	Rana, Ajay/ABE-3739-2020	Rana, Ajay/0000-0003-0951-2566; Davaakhuu, Gantulga/0000-0003-3792-7101; Miele, Lucio/0000-0002-5853-7287	National Institutes of Health [R01 GM067134, R01 CA176846]; NATIONAL CANCER INSTITUTE [R01CA176846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM067134 (to G. T.) and R01 CA176846 (to A. R.).	Ahn JY, 2004, J BIOL CHEM, V279, P16441, DOI 10.1074/jbc.M312175200; Bobrowska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034805; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Bosch-Presegue Laia, 2011, Genes Cancer, V2, P648, DOI 10.1177/1947601911417862; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cheung M, 2013, CURR CANCER DRUG TAR, V13, P234, DOI 10.2174/1568009611313030002; Dan L, 2012, HAEMATOL-HEMATOL J, V97, P551, DOI 10.3324/haematol.2011.055236; de Oliveira RM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00082; Dobson M, 2011, BBA-MOL CELL RES, V1813, P1453, DOI 10.1016/j.bbamcr.2011.05.001; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Frojdo S, 2011, MOL CELL ENDOCRINOL, V335, P166, DOI 10.1016/j.mce.2011.01.008; Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Horio Y, 2012, NAT REV ENDOCRINOL, V8, P131, DOI 10.1038/nrendo.2011.208; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Ishfaq M, 2012, FEBS LETT, V586, P3236, DOI 10.1016/j.febslet.2012.06.042; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Lu M, 2013, J BIOL CHEM, V288, P10722, DOI 10.1074/jbc.M112.443606; Luthi-Carter R, 2010, P NATL ACAD SCI USA, V107, P7927, DOI 10.1073/pnas.1002924107; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martelli AM, 2012, BBA-MOL CELL RES, V1823, P2168, DOI 10.1016/j.bbamcr.2012.08.017; Martini M, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00108; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Narayan N, 2012, NATURE, V492, P199, DOI 10.1038/nature11700; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2007, J BIOL CHEM, V282, P19546, DOI 10.1074/jbc.M702990200; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pandithage R, 2008, J CELL BIOL, V180, P915, DOI 10.1083/jcb.200707126; Park SH, 2012, TRANSL CANCER RES, V1, P15, DOI 10.3978/j.issn.2218-676X.2012.05.01; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10; Roth M., 2013, ONCOGENE, DOI 10. 1038/onc. 2013. 120; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Schultze SM, 2012, EXPERT REV MOL MED, V14, DOI 10.1017/S1462399411002109; Siddle K, 2011, J MOL ENDOCRINOL, V47, pR1, DOI 10.1530/JME-11-0022; Snider NT, 2013, J CELL BIOL, V200, P241, DOI 10.1083/jcb.201209028; Sundaresan NR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001465; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Wang F, 2009, MOL BIOL CELL, V20, P801, DOI 10.1091/mbc.E08-06-0647; Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243; Zhu J, 2005, MOL BIOL CELL, V16, P4733, DOI 10.1091/mbc.E05-02-0090	48	81	85	3	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6054	6066		10.1074/jbc.M113.537266	http://dx.doi.org/10.1074/jbc.M113.537266			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24446434	Green Published, hybrid			2022-12-28	WOS:000332015500060
J	Li, XL; Zhao, YX; Tian, B; Jamaluddin, M; Mitra, A; Yang, J; Rowicka, M; Brasier, AR; Kudlicki, A				Li, Xueling; Zhao, Yingxin; Tian, Bing; Jamaluddin, Mohammad; Mitra, Abhishek; Yang, Jun; Rowicka, Maga; Brasier, Allan R.; Kudlicki, Andrzej			Modulation of Gene Expression Regulated by the Transcription Factor NF-kappa B/RelA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Computational Biology; Functional Genomics; Gene Expression; NF-B Transcription Factor; Proteomics; Transcription Regulation; Transcription Target Genes; Action Mode of Modulation; Modulatory Network	ESTROGEN-RECEPTOR; CELL-SURVIVAL; B ACTIVATION; NUCLEAR; NETWORKS; IDENTIFICATION; ACETYLATION; INDUCTION; INFERENCE; APOPTOSIS	Background: Interacting proteins modulate the activity of NF-B/RelA transcription factor and expression of its targets. Results: By analyzing gene expression, protein binding, and DNA binding, we inferred and characterized 8349 such modulations. Conclusion: Different modulator groups affect separate pathways. Significance: We provide new insight into the activity of NF-B/RelA. Our inference model can be applied to other processes and pathways. Modulators (Ms) are proteins that modify the activity of transcription factors (TFs) and influence expression of their target genes (TGs). To discover modulators of NF-B/RelA, we first identified 365 NF-B/RelA-binding proteins using liquid chromatography-tandem mass spectrometry (LC-MS/MS). We used a probabilistic model to infer 8349 (M, NF-B/RelA, TG) triplets and their modes of modulatory action from our combined LC-MS/MS and ChIP-Seq (ChIP followed by next generation sequencing) data, published RelA modulators and TGs, and a compendium of gene expression profiles. Hierarchical clustering of the derived modulatory network revealed functional subnetworks and suggested new pathways modulating RelA transcriptional activity. The modulators with the highest number of TGs and most non-random distribution of action modes (measured by Shannon entropy) are consistent with published reports. Our results provide a repertoire of testable hypotheses for experimental validation. One of the NF-B/RelA modulators we identified is STAT1. The inferred (STAT1, NF-B/RelA, TG) triplets were validated by LC-selected reaction monitoring-MS and the results of STAT1 deletion in human fibrosarcoma cells. Overall, we have identified 562 NF-B/RelA modulators, which are potential drug targets, and clarified mechanisms of achieving NF-B/RelA multiple functions through modulators. Our approach can be readily applied to other TFs.	[Li, Xueling; Zhao, Yingxin; Tian, Bing; Jamaluddin, Mohammad; Mitra, Abhishek; Rowicka, Maga; Brasier, Allan R.; Kudlicki, Andrzej] Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA; [Li, Xueling; Zhao, Yingxin; Tian, Bing; Jamaluddin, Mohammad; Mitra, Abhishek; Yang, Jun; Rowicka, Maga; Brasier, Allan R.; Kudlicki, Andrzej] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA; [Li, Xueling; Rowicka, Maga; Kudlicki, Andrzej] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Tian, Bing; Yang, Jun; Brasier, Allan R.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Zhao, Yingxin; Brasier, Allan R.] Univ Texas Med Branch, Ctr Clin Prote, Galveston, TX 77555 USA; [Li, Xueling] Chinese Acad Sci, Hefei Inst Intelligent Machines, Hefei 230031, Peoples R China	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Chinese Academy of Sciences	Kudlicki, A (corresponding author), Univ Texas Med Branch, Inst Translat Sci, Galveston, TX 77555 USA.	askudlic@utmb.edu	Rowicka, Maga/E-2496-2012; Kudlicki, Andrzej/AAG-8537-2019	Rowicka, Maga/0000-0002-4011-071X; Kudlicki, Andrzej/0000-0001-8158-9600; MITRA, ABHISHEK/0000-0002-7378-4147; Brasier, Allan/0000-0002-5012-4090	Institute for Translational Sciences at the University of Texas Medical Branch; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER	Institute for Translational Sciences at the University of Texas Medical Branch; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was conducted with the support of the Institute for Translational Sciences at the University of Texas Medical Branch. We thank Thomas Wood for performing the sequencing experiments. We thank Heather Lander for comments and editing of the manuscript.	Antonov AV, 2009, PROTEOMICS, V9, P2740, DOI 10.1002/pmic.200800612; Babur O, 2010, NUCLEIC ACIDS RES, V38, P5648, DOI 10.1093/nar/gkq287; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Bauer T, 2011, BIOINFORMATICS, V27, P2239, DOI 10.1093/bioinformatics/btr366; Bhasin MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062817; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Brasier AR, 2011, J VIROL, V85, P11752, DOI 10.1128/JVI.05360-11; Casal C, 2004, NEUROSCI RES, V48, P315, DOI 10.1016/j.neures.2003.11.006; Cheng C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002190; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Dale E, 2006, ADV PHYSIOL EDUC, V30, P152, DOI 10.1152/advan.00065.2006; Everett LJ, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr172; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Forbus J, 2006, PROTEOMICS, V6, P2656, DOI 10.1002/pmic.200500652; Gao XF, 2013, CELL HOST MICROBE, V13, P87, DOI 10.1016/j.chom.2012.11.010; Gavert N, 2010, J CELL SCI, V123, P2134, DOI 10.1242/jcs.069542; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gionet N, 2009, J CELL BIOCHEM, V107, P448, DOI 10.1002/jcb.22141; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hansen M, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-4; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Ivetic A, 2004, IMMUNOLOGY, V112, P165, DOI 10.1111/j.1365-2567.2004.01882.x; Jennewein C, 2012, ONCOGENE, V31, P1468, DOI 10.1038/onc.2011.333; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karrich JJ, 2012, BLOOD, V119, P5191, DOI 10.1182/blood-2011-07-370239; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Kramer OH, 2006, GENE DEV, V20, P473, DOI 10.1101/gad.364306; Kuffner R, 2012, BIOINFORMATICS, V28, P1376, DOI 10.1093/bioinformatics/bts143; Kustermans G, 2005, BIOCHEM J, V387, P531, DOI 10.1042/BJ20041318; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-520; Lim S, 2009, ARTERIOSCL THROM VAS, V29, P2138, DOI 10.1161/ATVBAHA.109.195735; Longpre F, 2006, FREE RADICAL BIO MED, V41, P1781, DOI 10.1016/j.freeradbiomed.2006.08.015; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Luo WJ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-467; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marbach D, 2012, GENOME RES, V22, P1334, DOI 10.1101/gr.127191.111; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; McCloskey A, 2012, SCIENCE, V335, P1643, DOI 10.1126/science.1218469; Mookherjee N, 2009, J IMMUNOL, V183, P2688, DOI 10.4049/jimmunol.0802586; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Nemeth ZH, 2004, J CELL PHYSIOL, V200, P71, DOI 10.1002/jcp.10477; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Parker MH, 2012, SKELET MUSCLE, V2, DOI [10.1186/2044-5040-2-4, 10.1186/2044-5040-2-6]; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rao SY, 2012, BLOOD, V120, P3764, DOI 10.1182/blood-2012-03-415349; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Sahin F, 2005, PANCREAS, V30, P158, DOI 10.1097/01.mpa.0000151581.45156.e4; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tian B, 2012, METHODS MOL BIOL, V809, P105, DOI 10.1007/978-1-61779-376-9_7; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Wang TL, 2002, INT IMMUNOPHARMACOL, V2, P1509, DOI 10.1016/S1567-5769(02)00058-9; Yang J, 2013, NUCLEIC ACIDS RES, V41, P7240, DOI 10.1093/nar/gkt493; Yao Z, 2010, ONCOGENE, V29, P1821, DOI 10.1038/onc.2009.473; Zhang XJ, 2012, BIOINFORMATICS, V28, P98, DOI 10.1093/bioinformatics/btr626; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao TT, 2009, CELL DEATH DIFFER, V16, P244, DOI 10.1038/cdd.2008.146; Zhao W, 2012, J IMMUNOL, V188, P3179, DOI 10.4049/jimmunol.1101175; Zhao YX, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008771	67	23	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11927	11944		10.1074/jbc.M113.539965	http://dx.doi.org/10.1074/jbc.M113.539965			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24523406	Green Published, hybrid			2022-12-28	WOS:000335010600033
J	Goetzman, ES; Alcorn, JF; Bharathi, SS; Uppala, R; McHugh, KJ; Kosmider, B; Chen, RM; Zuo, YY; Beck, ME; McKinney, RW; Skilling, H; Suhrie, KR; Karunanidhi, A; Yeasted, R; Otsubo, C; Ellis, B; Tyurina, YY; Kagan, VE; Mallampalli, RK; Vockley, J				Goetzman, Eric S.; Alcorn, John F.; Bharathi, Sivakama S.; Uppala, Radha; McHugh, Kevin J.; Kosmider, Beata; Chen, Rimei; Zuo, Yi Y.; Beck, Megan E.; McKinney, Richard W.; Skilling, Helen; Suhrie, Kristen R.; Karunanidhi, Anuradha; Yeasted, Renita; Otsubo, Chikara; Ellis, Bryon; Tyurina, Yulia Y.; Kagan, Valerian E.; Mallampalli, Rama K.; Vockley, Jerry			Long-chain Acyl-CoA Dehydrogenase Deficiency as a Cause of Pulmonary Surfactant Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fatty Acid Oxidation; Genetic Diseases; Lung; Mitochondrial Metabolism; Pulmonary Surfactant; Acyl-CoA Dehydrogenase	ACID BETA-OXIDATION; ORGANIC CATION/CARNITINE TRANSPORTER; RESPIRATORY-DISTRESS-SYNDROME; ALVEOLAR EPITHELIAL-CELLS; CAPTIVE BUBBLE METHOD; FREE CARNITINE LEVELS; INFLUENZA-A VIRUS; LUNG SURFACTANT; IN-VITRO; COMPLEX I	Background: The contribution of long-chain acyl-CoA dehydrogenase (LCAD) to human fatty acid oxidation is not understood. Results: LCAD localizes to lung alveolar type II cells, which produce pulmonary surfactant; LCAD-deficient mice have surfactant dysfunction. Conclusion: LCAD is important for lung energy metabolism and lung function. Significance: LCAD may play a role in human lung disease and unexplained sudden infant death. Long-chain acyl-CoA dehydrogenase (LCAD) is a mitochondrial fatty acid oxidation enzyme whose expression in humans is low or absent in organs known to utilize fatty acids for energy such as heart, muscle, and liver. This study demonstrates localization of LCAD to human alveolar type II pneumocytes, which synthesize and secrete pulmonary surfactant. The physiological role of LCAD and the fatty acid oxidation pathway in lung was subsequently studied using LCAD knock-out mice. Lung fatty acid oxidation was reduced in LCAD(-/-) mice. LCAD(-/-) mice demonstrated reduced pulmonary compliance, but histological examination of lung tissue revealed no obvious signs of inflammation or pathology. The changes in lung mechanics were found to be due to pulmonary surfactant dysfunction. Large aggregate surfactant isolated from LCAD(-/-) mouse lavage fluid had significantly reduced phospholipid content as well as alterations in the acyl chain composition of phosphatidylcholine and phosphatidylglycerol. LCAD(-/-) surfactant demonstrated functional abnormalities when subjected to dynamic compression-expansion cycling on a constrained drop surfactometer. Serum albumin, which has been shown to degrade and inactivate pulmonary surfactant, was significantly increased in LCAD(-/-) lavage fluid, suggesting increased epithelial permeability. Finally, we identified two cases of sudden unexplained infant death where no lung LCAD antigen was detectable. Both infants were homozygous for an amino acid changing polymorphism (K333Q). These findings for the first time identify the fatty acid oxidation pathway and LCAD in particular as factors contributing to the pathophysiology of pulmonary disease.	[Goetzman, Eric S.; Alcorn, John F.; Bharathi, Sivakama S.; Uppala, Radha; McHugh, Kevin J.; McKinney, Richard W.; Skilling, Helen; Suhrie, Kristen R.; Karunanidhi, Anuradha; Yeasted, Renita; Otsubo, Chikara; Vockley, Jerry] Univ Pittsburgh Sch Med, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15224 USA; [Goetzman, Eric S.; Beck, Megan E.; Vockley, Jerry] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15213 USA; [Kosmider, Beata] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Chen, Rimei; Zuo, Yi Y.] Univ Hawaii Manoa, Dept Mech Engn, Honolulu, HI 96822 USA; [Ellis, Bryon; Mallampalli, Rama K.] Univ Pittsburgh, Dept Med, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15213 USA; [Tyurina, Yulia Y.; Kagan, Valerian E.] Univ Pittsburgh, Ctr Free Radical & Antioxidant Hlth, Pittsburgh, PA 15260 USA; [Tyurina, Yulia Y.; Kagan, Valerian E.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15260 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Jewish Health; University of Hawaii System; University of Hawaii Manoa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Goetzman, ES (corresponding author), 4401 Penn Ave,Rangos 5117, Pittsburgh, PA 15224 USA.	eric.goetzman@chp.edu	Zuo, Yi Y./B-3177-2013; Vockley, Jerry/AAF-8523-2020; Vockley, Jerry/B-5210-2016	Zuo, Yi Y./0000-0002-3992-3238; Vockley, Jerry/0000-0002-8180-6457; Vockley, Jerry/0000-0002-8180-6457; Kagan, Valerian E./0000-0002-7245-1885; Chen, Rimei/0000-0003-3940-6692; Tyurina, Yulia/0000-0003-0287-2091	National Institutes of Health [DK090242]; NIDDK [DK78775]; NHLBI [HL107380, HL096376, HL097376, HL098174, P01 HL114453]; Directorate For Engineering [1254795] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098174, R01HL107380, R01HL097376, R01HL096376, P01HL114453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090242, R01DK078775] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007584] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grants DK090242 (to E. S. G.) and DK78775 (to J. V.) from NIDDK and Grants HL107380 (to J. F. A.), HL096376, HL097376, and HL098174 (to R. K. M.), P01 HL114453 (to R. K. M. and V. E. K.) from NHLBI.	Alcorn JF, 2010, AM J PHYSIOL-LUNG C, V298, pL57, DOI 10.1152/ajplung.00037.2009; Asilsoy S, 2009, WORLD J PEDIATR, V5, P60, DOI 10.1007/s12519-009-0011-8; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bartlett K, 2004, EUR J BIOCHEM, V271, P462, DOI 10.1046/j.1432-1033.2003.03947.x; Bates JHT, 2003, J APPL PHYSIOL, V94, P1297, DOI 10.1152/japplphysiol.00706.2002; Bharathi SS, 2013, J BIOL CHEM, V288, P33837, DOI 10.1074/jbc.M113.510354; Blank R, 2011, CRIT CARE CLIN, V27, P439, DOI 10.1016/j.ccc.2011.05.005; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boles RG, 1998, J PEDIATR-US, V132, P924, DOI 10.1016/S0022-3476(98)70385-3; Borghi-Silva A, 2006, BRAZ J MED BIOL RES, V39, P465, DOI 10.1590/S0100-879X2006000400006; Bottcher CJF, 1961, ANAL CHIM ACTA, V24, P203; Chegary M, 2009, BBA-MOL CELL BIOL L, V1791, P806, DOI 10.1016/j.bbalip.2009.05.006; Chintagari NR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009228; Cox KB, 2001, HUM MOL GENET, V10, P2069, DOI 10.1093/hmg/10.19.2069; Damas JE, 2011, AM J PHYSIOL-LUNG C, V301, pL966, DOI 10.1152/ajplung.00103.2011; Das AM, 2006, CLIN CHEM, V52, P530, DOI 10.1373/clinchem.2005.062000; De Luca D, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-101; DEBUYSERE MS, 1983, ANAL BIOCHEM, V133, P373, DOI 10.1016/0003-2697(83)90097-0; Diao L, 2009, PHARM RES-DORDR, V26, P1890, DOI 10.1007/s11095-009-9905-3; Ergur AT, 1997, ACTA PAEDIATR JAPON, V39, P406; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ganapathy ME, 2000, J BIOL CHEM, V275, P1699, DOI 10.1074/jbc.275.3.1699; Goetzman ES, 2009, OBESITY, V17, P196, DOI 10.1038/oby.2008.467; Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706; He M, 2007, AM J HUM GENET, V81, P87, DOI 10.1086/519219; Hong MG, 2013, HUM MUTAT, V34, P515, DOI 10.1002/humu.22267; Horvath G, 2007, AM J RESP CELL MOL, V36, P53, DOI 10.1165/rcmb.2006-0230OC; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Hu CX, 2012, MOL CANCER THER, V11, P921, DOI 10.1158/1535-7163.MCT-11-0980; Ikegami M, 1998, AM J PHYSIOL-LUNG C, V275, pL247, DOI 10.1152/ajplung.1998.275.2.L247; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; JUANEDA P, 1985, LIPIDS, V20, P40, DOI 10.1007/BF02534360; Kim KJ, 2003, AM J PHYSIOL-LUNG C, V284, pL247, DOI 10.1152/ajplung.00235.2002; Kitsiouli E, 2009, BBA-MOL BASIS DIS, V1792, P941, DOI 10.1016/j.bbadis.2009.06.007; Korkmaz A, 2005, PEDIATR INT, V47, P49, DOI 10.1111/j.1442-200x.2005.01998.x; Kosmider B, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-43; Kosmider B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026059; Lundy CT, 2003, J INHERIT METAB DIS, V26, P537, DOI 10.1023/A:1025995813914; Maher AC, 2010, MOL GENET METAB, V100, P163, DOI 10.1016/j.ymgme.2010.03.011; Mallampalli RK, 2000, J BIOL CHEM, V275, P9699, DOI 10.1074/jbc.275.13.9699; Mendez-Figueroa H, 2013, J MATERN-FETAL NEO M, V26, P150, DOI 10.3109/14767058.2012.722721; Moczulski D, 2009, POSTEP HIG MED DOSW, V63, P266; NIEWOEHNER DE, 1989, J APPL PHYSIOL, V66, P261, DOI 10.1152/jappl.1989.66.1.261; Nouws J, 2010, CELL METAB, V12, P283, DOI 10.1016/j.cmet.2010.08.002; Parker JC, 2004, AM J PHYSIOL-LUNG C, V286, pL231, DOI 10.1152/ajplung.00049.2003; Perez-Gil J, 2010, PHYSIOLOGY, V25, P132, DOI 10.1152/physiol.00006.2010; Saad SMI, 2012, BBA-BIOMEMBRANES, V1818, P103, DOI 10.1016/j.bbamem.2011.10.004; SCHULZ H, 1994, J NUTR, V124, P165, DOI 10.1093/jn/124.2.165; SCHURCH S, 1989, J APPL PHYSIOL, V67, P2389, DOI 10.1152/jappl.1989.67.6.2389; SCHURCH S, 1992, BIOCHIM BIOPHYS ACTA, V1103, P127, DOI 10.1016/0005-2736(92)90066-U; Spiekerkoetter U, 2009, J INHERIT METAB DIS, V32, P488, DOI 10.1007/s10545-009-1125-9; Sunaga H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3563; Tamai I, 2013, BIOPHARM DRUG DISPOS, V34, P29, DOI 10.1002/bdd.1816; Tyni T, 1997, J PEDIATR-US, V130, P67, DOI 10.1016/S0022-3476(97)70312-3; Tyurina YY, 2011, ACS NANO, V5, P7342, DOI 10.1021/nn202201j; Verhoeven NM, 1998, J LIPID RES, V39, P66; Wanders RJA, 2010, BBA-MOL CELL BIOL L, V1801, P272, DOI 10.1016/j.bbalip.2010.01.001; Wanders RJA, 1998, BBA-LIPID LIPID MET, V1393, P35, DOI 10.1016/S0005-2760(98)00053-8; Wanders RJA, 2010, J INHERIT METAB DIS, V33, P479, DOI 10.1007/s10545-010-9104-8; Wang JR, 2007, AM J RESP CELL MOL, V36, P661, DOI 10.1165/rcmb.2006-0410OC; Wang JR, 2011, AM J RESP CELL MOL, V45, P582, DOI 10.1165/rcmb.2010-0108OC; Yu LMY, 2004, J APPL PHYSIOL, V97, P704, DOI 10.1152/japplphysiol.00089.2003; Zheng XW, 2010, BIOCHEM PHARMACOL, V80, P1087, DOI 10.1016/j.bcp.2010.06.012; Zhou JM, 2004, J LIPID RES, V45, P1758, DOI 10.1194/jlr.M400179-JLR200; Zuo YY, 2008, BIOPHYS J, V95, P2779, DOI 10.1529/biophysj.108.130732; Zuo YY, 2006, BBA-BIOMEMBRANES, V1758, P1609, DOI 10.1016/j.bbamem.2006.07.004; Zuo YY, 2006, PEDIATR RES, V60, P125, DOI 10.1203/01.pdr.0000227558.14024.57; Zuo YY, 2004, BBA-GEN SUBJECTS, V1675, P12, DOI 10.1016/j.bbagen.2004.08.003	69	31	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10668	10679		10.1074/jbc.M113.540260	http://dx.doi.org/10.1074/jbc.M113.540260			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24591516	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000334226400037
J	Kawaguchi, K; Saito, K; Asami, H; Ohta, Y				Kawaguchi, Kaori; Saito, Koji; Asami, Hisayo; Ohta, Yasutaka			ADP Ribosylation Factor 6 ( Arf6) Acts through FilGAP Protein to Down- regulate Rac Protein and Regulates Plasma Membrane Blebbing*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Cell Migration; Cytoskeleton; PI 3-kinase; Rac; Rho; Signal Transduction; Small GTPases; Arf6; Cell Polarization	GTPASE-ACTIVATING PROTEIN; FAMILY GTPASES; FILAMIN-A; EXCHANGE FACTORS; STRUCTURAL BASIS; CELL-MIGRATION; GROWTH-FACTOR; RECRUITS; INVASION; LOCALIZATION	Background: FilGAP is a Rac GTPase-activating protein, but how it is regulated remains unclear. Results: GTPase Arf6 binds to FilGAP and stimulates its RacGAP activity to induce plasma membrane blebbing. Conclusion: GTPase Arf6 is a novel physiological regulator of FilGAP. Significance: This study establishes a novel molecular link between Arf6 and FilGAP that may have a role in Arf6-dependent inactivation of Rac. The small GTP-binding protein Arf6 reorganizes the actin cytoskeleton through the regulation of Rac activity. We identified FilGAP, a Rac-specific Rho GTPase-activating protein that is recruited to plasma membranes by binding to activated Arf6. FilGAP binds to Arf6 through its pleckstrin homology domain. Activated Arf6 stimulated RacGAP activity of FilGAP, and knockdown of endogenous Arf6 by siRNA suppresses FilGAP-mediated bleb formation. Mutant FilGAP lacking phosphatidylinositol 3,4,5-trisphosphate (PIP3) binding (FilGAP R39C) binds to activated Arf6 and induces bleb formation. Moreover, bleb formation induced by wild-type FilGAP occurs in the presence of phosphatidylinositol 3-kinase inhibitors, suggesting a PIP3-independent interaction between FilGAP and Arf6. We propose that FilGAP may function as a mediator of the regulation of Rac by Arf6.	[Kawaguchi, Kaori; Saito, Koji; Asami, Hisayo; Ohta, Yasutaka] Kitasato Univ, Sch Sci, Div Cell Biol, Dept Biosci,Minami Ku, Sagamihara, Kanagawa 2520373, Japan	Kitasato University	Ohta, Y (corresponding author), Kitasato Univ, Sch Sci, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.	yohta@kitasato-u.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Kitasato University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kitasato University	This work was supported by grants-in-aid for scientific research from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology of Japan; by a grant for the All Kitasato Project Study; and by a Kitasato University research grant for young researchers.	Allen WE, 1998, J CELL BIOL, V141, P1147, DOI 10.1083/jcb.141.5.1147; Banyard J, 2000, ONCOGENE, V19, P580, DOI 10.1038/sj.onc.1203338; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Cronin TC, 2004, EMBO J, V23, P3711, DOI 10.1038/sj.emboj.7600388; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Donaldson JG, 2005, BIOCHEM SOC T, V33, P639, DOI 10.1042/BST0330639; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Hofmann I, 2007, CURR BIOL, V17, P711, DOI 10.1016/j.cub.2007.03.007; Hosaka M, 1996, J BIOCHEM-TOKYO, V120, P813; Hu B, 2009, CANCER RES, V69, P794, DOI 10.1158/0008-5472.CAN-08-2110; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Klarlund JK, 2000, J BIOL CHEM, V275, P32816, DOI 10.1074/jbc.M002435200; Koo TH, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-29; Li CC, 2007, MOL BIOL CELL, V18, P4420, DOI 10.1091/mbc.E07-02-0149; Madsen CD, 2010, DEV CELL, V19, P13, DOI 10.1016/j.devcel.2010.06.013; Malaby AW, 2013, P NATL ACAD SCI USA, V110, P14213, DOI 10.1073/pnas.1301883110; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2013, BIOCHEM J, V453, P17, DOI 10.1042/BJ20130290; Nakamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004928; Nieves B, 2010, J CELL SCI, V123, P1216, DOI 10.1242/jcs.056549; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Palacios F, 2003, J BIOL CHEM, V278, P17395, DOI 10.1074/jbc.M300998200; Pankov R, 2005, J CELL BIOL, V170, P793, DOI 10.1083/jcb.200503152; Radhakrishna H, 1999, J CELL SCI, V112, P855; Sabe H, 2009, TRAFFIC, V10, P982, DOI 10.1111/j.1600-0854.2009.00917.x; Saito K, 2012, MOL BIOL CELL, V23, P4739, DOI 10.1091/mbc.E12-04-0310; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Schwartz MA, 1998, ONCOGENE, V17, P625, DOI 10.1038/sj.onc.1201977; Schweitzer JK, 2011, SEMIN CELL DEV BIOL, V22, P39, DOI 10.1016/j.semcdb.2010.09.002; Shifrin Y, 2009, MOL BIOL CELL, V20, P1269, DOI 10.1091/mbc.E08-08-0872; Shinotsuka C, 2002, J BIOL CHEM, V277, P9468, DOI 10.1074/jbc.M112427200; Vidali L, 2006, MOL BIOL CELL, V17, P2377, DOI 10.1091/mbc.e05-10-0955; Zhang Q, 1999, MOL CELL BIOL, V19, P8158	42	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9675	9682		10.1074/jbc.M113.546051	http://dx.doi.org/10.1074/jbc.M113.546051			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24526684	Green Published, hybrid			2022-12-28	WOS:000333807000021
J	Yamamoto, S; Subedi, GP; Hanashima, S; Satoh, T; Otaka, M; Wakui, H; Sawada, KI; Yokota, SI; Yamaguchi, Y; Kubota, H; Itoh, H				Yamamoto, Soh; Subedi, Ganesh Prasad; Hanashima, Shinya; Satoh, Tadashi; Otaka, Michiro; Wakui, Hideki; Sawada, Ken-ichi; Yokota, Shin-ichi; Yamaguchi, Yoshiki; Kubota, Hiroshi; Itoh, Hideaki			ATPase Activity and ATP-dependent Conformational Change in the Co-chaperone HSP70/HSP90-organizing Protein ( HOP)*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Heat Shock Protein; Hsp90; Molecular Chaperone; Protein Complexes; Protein Structure	STRESS-INDUCIBLE PROTEIN-1; MOLECULAR CHAPERONES; ORGANIZING PROTEIN; TETRATRICOPEPTIDE REPEAT; CRYSTAL-STRUCTURE; CELLULAR PRION; HSP90; HSP70; HOP; COMPLEXES	Background: HOP assists protein transfer in the HSP70- and HSP90-dependent protein-folding pathway. Results: HOP hydrolyzed ATP, and the region containing amino acids 1-359 (TPR1-TPR2A) was required for hydrolysis and direct interaction with ATP. Conclusion: HOP has slow ATPase activity and changes its conformation upon ATP hydrolysis. Significance: This is the first demonstration of the ATPase activity of HOP, and may enhance our understanding of the physiological function. Co-chaperones help to maintain cellular homeostasis by modulating the activities of molecular chaperones involved in protein quality control. The HSP70/HSP90-organizing protein (HOP) is a co-chaperone that cooperates with HSP70 and HSP90 in catalysis of protein folding and maturation in the cytosol. We show here that HOP has ATP-binding activity comparable to that of HSP70/HSP90, and that HOP slowly hydrolyzes ATP. Analysis of deletion mutants revealed that the ATPase domain of HOP is in the N-terminal TPR1-DP1-TPR2A segment. In addition, HOP changes its conformation in the presence of ATP. These results indicate that HOP is a unique co-chaperone that undergoes an ATP-dependent conformational change.	[Yamamoto, Soh; Wakui, Hideki; Kubota, Hiroshi; Itoh, Hideaki] Akita Univ, Fac & Grad Sch Engn & Resource Sci, Dept Life Sci, Akita 0108502, Japan; [Yamamoto, Soh; Yokota, Shin-ichi] Sapporo Med Univ, Sch Med, Dept Microbiol, Sapporo, Hokkaido 0608556, Japan; [Subedi, Ganesh Prasad; Hanashima, Shinya; Satoh, Tadashi; Yamaguchi, Yoshiki] RIKEN Max Planck Joint Res Cluster Syst Chem Biol, Struct Glycobiol Team, Syst Glycobiol Res Grp, Wako, Saitama 3510198, Japan; [Otaka, Michiro] Juntendo Univ, Sch Med, Dept Gastroenterol, Bunkyo Ku, Tokyo 113, Japan; [Wakui, Hideki; Sawada, Ken-ichi] Akita Univ, Sch Med, Dept Internal Med 3, Akita 0108543, Japan	Akita University; Sapporo Medical University; RIKEN; Juntendo University; Akita University	Itoh, H (corresponding author), Fac Engn & Resource Sci, Dept Life Sci, 1-1 Tegata Gakuen Town, Akita 0108502, Japan.	itohh@ipc.akita-u.ac.jp	Yamaguchi, Yoshiki/N-5246-2015; Satoh, Tadashi/M-5157-2017; Yokota, Shin-ichi/K-8139-2019; Hanashima, Shinya/AGN-0921-2022	Yamaguchi, Yoshiki/0000-0003-0100-5439; Satoh, Tadashi/0000-0002-4493-4978; Yokota, Shin-ichi/0000-0002-0831-3429; Hanashima, Shinya/0000-0003-3102-7890	Japan Science Society; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [24770102] Funding Source: KAKEN	Japan Science Society; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Young Scientists (B), a Sasakawa Scientific Research Grant from the Japan Science Society (to S. Y.), and Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to H. K. and H. I.).	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Boisvert DC, 1996, NAT STRUCT BIOL, V3, P170, DOI 10.1038/nsb0296-170; Carrigan PE, 2005, J BIOL CHEM, V280, P8906, DOI 10.1074/jbc.M414245200; Chen LT, 2010, CELL HOST MICROBE, V7, P185, DOI 10.1016/j.chom.2010.02.008; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Flom G, 2006, GENETICS, V172, P41, DOI 10.1534/genetics.105.045815; Flom G, 2007, BIOCHEM J, V404, P159, DOI 10.1042/BJ20070084; Gaiser AM, 2009, J MOL BIOL, V391, P621, DOI 10.1016/j.jmb.2009.06.051; Gangaraju VK, 2011, NAT GENET, V43, P153, DOI 10.1038/ng.743; Ghosh JG, 2006, J MOL BIOL, V364, P364, DOI 10.1016/j.jmb.2006.09.003; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hessling M, 2009, NAT STRUCT MOL BIOL, V16, P287, DOI 10.1038/nsmb.1565; Ishida R, 2008, FEBS LETT, V582, P3879, DOI 10.1016/j.febslet.2008.10.029; ITOH H, 1991, INT J BIOCHEM, V23, P1185; Kajander T, 2009, J BIOL CHEM, V284, P25364, DOI 10.1074/jbc.M109.033894; Kubota H, 2010, CELL STRESS CHAPERON, V15, P1003, DOI 10.1007/s12192-010-0211-0; Kubota H, 2009, J BIOCHEM, V146, P609, DOI 10.1093/jb/mvp139; Li J, 2011, NAT STRUCT MOL BIOL, V18, P61, DOI 10.1038/nsmb.1965; Longshaw VM, 2004, J CELL SCI, V117, P701, DOI 10.1242/jcs.00905; Lopes MH, 2005, J NEUROSCI, V25, P11330, DOI 10.1523/JNEUROSCI.2313-05.2005; Marozkina NV, 2010, P NATL ACAD SCI USA, V107, P11393, DOI 10.1073/pnas.0909128107; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meyer AS, 2003, CELL, V113, P369, DOI 10.1016/S0092-8674(03)00307-6; Morshauser RC, 1999, J MOL BIOL, V289, P1387, DOI 10.1006/jmbi.1999.2776; Odunuga OO, 2004, BIOESSAYS, V26, P1058, DOI 10.1002/bies.20107; Onuoha SC, 2008, J MOL BIOL, V379, P732, DOI 10.1016/j.jmb.2008.02.013; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Richter K, 2003, J BIOL CHEM, V278, P10328, DOI 10.1074/jbc.M213094200; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schmid A. B., 2012, EMBO J; Smith DF, 2008, MOL ENDOCRINOL, V22, P2229, DOI 10.1210/me.2008-0089; Song HO, 2009, J MOL BIOL, V390, P604, DOI 10.1016/j.jmb.2009.05.035; TRAUT TW, 1994, EUR J BIOCHEM, V222, P9, DOI 10.1111/j.1432-1033.1994.tb18835.x; Vetter IR, 1999, Q REV BIOPHYS, V32, P1, DOI 10.1017/S0033583599003480; Wegele H, 2006, J MOL BIOL, V356, P802, DOI 10.1016/j.jmb.2005.12.008; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Wegele H, 2003, J BIOL CHEM, V278, P25970, DOI 10.1074/jbc.M301548200; Yamamoto S, 2010, FEBS LETT, V584, P645, DOI 10.1016/j.febslet.2009.12.021; Yi F, 2010, PROTEIN SCI, V19, P19, DOI 10.1002/pro.278; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325	42	17	17	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9880	9886		10.1074/jbc.M114.553255	http://dx.doi.org/10.1074/jbc.M114.553255			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24535459	hybrid, Green Published			2022-12-28	WOS:000333807000037
J	Srivatsan, A; Bowen, N; Kolodner, RD				Srivatsan, Anjana; Bowen, Nikki; Kolodner, Richard D.			Mispair-specific Recruitment of the Mlh1-Pms1 Complex Identifies Repair Substrates of the Saccharomyces cerevisiae Msh2-Msh3 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Mismatch Repair; DNA Recombination; DNA Repair; DNA Replication; Mutagenesis Mechanisms; Mismatch Binding; Mismatch Repair Specificity; Msh6; Replication Fidelity	DNA MISMATCH-REPAIR; ESCHERICHIA-COLI MUTS; HETERODUPLEX REJECTION; ATPASE ACTIVITY; SLIDING CLAMP; PROTEINS MSH2; BINDING; RECOGNITION; ALPHA; YEAST	Background: Msh2-Msh6 and Msh2-Msh3 bind to and initiate the repair of mismatched DNA. Results: Purified Msh2-Msh3 binds specific base:base mispairs and small to large insertion/deletions and recruits a downstream mismatch repair component, Mlh1-Pms1. Conclusion: Msh2-Msh3 functions in the repair of specific base:base and insertion/deletion mispairs. Significance: Our results show that mispair specificity of Mlh1-Pms1 recruitment by Msh2-Msh3 explains the specificity of Msh2-Msh3 in mismatch repair. DNA mismatch repair is initiated by either the Msh2-Msh6 or the Msh2-Msh3 mispair recognition heterodimer. Here we optimized the expression and purification of Saccharomyces cerevisiae Msh2-Msh3 and performed a comparative study of Msh2-Msh3 and Msh2-Msh6 for mispair binding, sliding clamp formation, and Mlh1-Pms1 recruitment. Msh2-Msh3 formed sliding clamps and recruited Mlh1-Pms1 on +1, +2, +3, and +4 insertion/deletions and CC, AA, and possibly GG mispairs, whereas Msh2-Msh6 formed mispair-dependent sliding clamps and recruited Mlh1-Pms1 on 7 of the 8 possible base:base mispairs, the +1 insertion/deletion mispair, and to a low level on the +2 but not the +3 or +4 insertion/deletion mispairs and not on the CC mispair. The mispair specificity of sliding clamp formation and Mlh1-Pms1 recruitment but not mispair binding alone correlated best with genetic data on the mispair specificity of Msh2-Msh3- and Msh2-Msh6-dependent mismatch repair in vivo. Analysis of an Msh2-Msh6/Msh3 chimeric protein and mutant Msh2-Msh3 complexes showed that the nucleotide binding domain and communicating regions but not the mispair binding domain of Msh2-Msh3 are responsible for the extremely rapid dissociation of Msh2-Msh3 sliding clamps from DNA relative to that seen for Msh2-Msh6, and that amino acid residues predicted to stabilize Msh2-Msh3 interactions with bent, strand-separated mispair-containing DNA are more critical for the recognition of small +1 insertion/deletions than larger +4 insertion/deletions.	[Srivatsan, Anjana; Bowen, Nikki; Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Inst Genom Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	rkolodner@ucsd.edu	Srivatsan, Anjana/S-1518-2017; Srivatsan, Anjana/Q-6312-2017	Srivatsan, Anjana/0000-0003-1645-7075; Srivatsan, Anjana/0000-0003-1645-7075	National Institutes of Health [GM50006]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM50006 (to R. D. K.).	Abdullah MFF, 2004, CYTOGENET GENOME RES, V107, P180, DOI 10.1159/000080596; Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Antony E, 2003, BIOCHEMISTRY-US, V42, P7682, DOI 10.1021/bi034602h; ARNOLD FH, 1987, BIOCHEMISTRY-US, V26, P4068, DOI 10.1021/bi00387a049; BISHOP DK, 1989, P NATL ACAD SCI USA, V86, P3713, DOI 10.1073/pnas.86.10.3713; Blackwell LJ, 2001, J BIOL CHEM, V276, P33233, DOI 10.1074/jbc.M105076200; Blackwell LJ, 1998, J BIOL CHEM, V273, P32055, DOI 10.1074/jbc.273.48.32055; BORDEN KLB, 1992, BIOCHEMISTRY-US, V31, P5411, DOI 10.1021/bi00138a024; BORRESEN AL, 1995, HUM MOL GENET, V4, P2065, DOI 10.1093/hmg/4.11.2065; Bowen N, 2013, P NATL ACAD SCI USA, V110, P18472, DOI 10.1073/pnas.1318971110; Bowers J, 1999, J BIOL CHEM, V274, P16115, DOI 10.1074/jbc.274.23.16115; Charbonneau N, 2009, CANCER BIOL THER, V8, P1411, DOI 10.4161/cbt.8.14.8886; Datta A, 1996, MOL CELL BIOL, V16, P1085; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; Dowen JM, 2010, MOL CELL BIOL, V30, P3321, DOI 10.1128/MCB.01558-09; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Edelmann W, 2000, CANCER RES, V60, P803; Flores-Rozas H, 1998, P NATL ACAD SCI USA, V95, P12404, DOI 10.1073/pnas.95.21.12404; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Genschel J, 2002, J BIOL CHEM, V277, P13302, DOI 10.1074/jbc.M111854200; Gerik KJ, 1997, J BIOL CHEM, V272, P1256, DOI 10.1074/jbc.272.2.1256; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; Gupta S, 2012, NAT STRUCT MOL BIOL, V19, P72, DOI 10.1038/nsmb.2175; Habraken Y, 1997, CURR BIOL, V7, P790, DOI 10.1016/S0960-9822(06)00337-X; Habraken Y, 1998, J BIOL CHEM, V273, P9837, DOI 10.1074/jbc.273.16.9837; Habraken Y, 1996, CURR BIOL, V6, P1185, DOI 10.1016/S0960-9822(02)70686-6; Harfe BD, 2000, CURR BIOL, V10, P145, DOI 10.1016/S0960-9822(00)00314-6; Harfe BD, 1999, MOL CELL BIOL, V19, P4766; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Harfe BD, 2000, MUTAT RES-FUND MOL M, V451, P151, DOI 10.1016/S0027-5107(00)00047-6; Hargreaves VV, 2010, J BIOL CHEM, V285, P9301, DOI 10.1074/jbc.M109.096388; Harrington JA, 2007, MOL CELL BIOL, V27, P6546, DOI 10.1128/MCB.00855-07; Hombauer H, 2011, SCIENCE, V334, P1713, DOI 10.1126/science.1210770; Hombauer H, 2011, CELL, V147, P1040, DOI 10.1016/j.cell.2011.10.025; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiang JJ, 2005, MOL CELL, V20, P771, DOI 10.1016/j.molcel.2005.10.014; Jiricny J., 2013, COLD SPRING HARB PER, V5; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kane MF, 1997, CANCER RES, V57, P808; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; KOUCHAKDJIAN M, 1988, J MOL BIOL, V202, P139, DOI 10.1016/0022-2836(88)90526-8; KRAMER B, 1984, CELL, V38, P879, DOI 10.1016/0092-8674(84)90283-6; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; LANE AN, 1995, EUR J BIOCHEM, V230, P1073, DOI 10.1111/j.1432-1033.1995.tb20658.x; LANE AN, 1991, BIOCHEM J, V279, P269, DOI 10.1042/bj2790269; Lee SD, 2007, J MOL BIOL, V366, P53, DOI 10.1016/j.jmb.2006.10.099; Lin YL, 1998, J BIOL CHEM, V273, P1453, DOI 10.1074/jbc.273.3.1453; Luhr B, 1998, MOL GEN GENET, V257, P362, DOI 10.1007/s004380050658; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; MATIC I, 1995, CELL, V80, P507, DOI 10.1016/0092-8674(95)90501-4; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; Mendillo ML, 2010, J BIOL CHEM, V285, P13170, DOI 10.1074/jbc.M110.108894; Mendillo ML, 2009, P NATL ACAD SCI USA, V106, P22223, DOI 10.1073/pnas.0912250106; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; MODRICH P, 1991, ANNU REV GENET, V25, P229, DOI 10.1146/annurev.ge.25.120191.001305; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Modrich P, 2006, J BIOL CHEM, V281, P30305, DOI 10.1074/jbc.R600022200; Nishant KT, 2008, GENETICS, V179, P747, DOI 10.1534/genetics.108.086645; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; PALOMBO F, 1995, SCIENCE, V268, P1912, DOI 10.1126/science.7604265; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Peltomaki P, 1997, GASTROENTEROLOGY, V113, P1146, DOI 10.1053/gast.1997.v113.pm9322509; Pluciennik A, 2010, P NATL ACAD SCI USA, V107, P16066, DOI 10.1073/pnas.1010662107; PROLLA TA, 1994, SCIENCE, V265, P1091, DOI 10.1126/science.8066446; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; Risinger JI, 1996, NAT GENET, V14, P102, DOI 10.1038/ng0996-102; SELVA EM, 1995, GENETICS, V139, P1175; Shell SS, 2007, P NATL ACAD SCI USA, V104, P10956, DOI 10.1073/pnas.0704148104; Sia EA, 1997, MOL CELL BIOL, V17, P2851, DOI 10.1128/MCB.17.5.2851; Smith CE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003869; Stambuk S, 1998, GENETICS, V150, P533; SU SS, 1986, P NATL ACAD SCI USA, V83, P5057, DOI 10.1073/pnas.83.14.5057; SU SS, 1988, J BIOL CHEM, V263, P6829; Sugawara N, 2004, P NATL ACAD SCI USA, V101, P9315, DOI 10.1073/pnas.0305749101; Sugawara N, 1997, P NATL ACAD SCI USA, V94, P9214, DOI 10.1073/pnas.94.17.9214; Surtees JA, 2006, J MOL BIOL, V360, P523, DOI 10.1016/j.jmb.2006.05.032; Swint-Kruse L, 2001, PROTEIN SCI, V10, P262, DOI 10.1110/ps.35801; Wang TF, 1999, P NATL ACAD SCI USA, V96, P13914, DOI 10.1073/pnas.96.24.13914; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Wilson T, 1999, J BIOL CHEM, V274, P21659, DOI 10.1074/jbc.274.31.21659; Wycuff DR, 2000, ANAL BIOCHEM, V277, P67, DOI 10.1006/abio.1999.4385; Zakharyevich K, 2012, CELL, V149, P334, DOI 10.1016/j.cell.2012.03.023; Zhan HL, 2006, BIOCHEMISTRY-US, V45, P5896, DOI 10.1021/bi052619p; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027	92	32	32	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9352	9364		10.1074/jbc.M114.552190	http://dx.doi.org/10.1074/jbc.M114.552190			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24550389	Green Published, hybrid			2022-12-28	WOS:000333472100051
J	Weber, K; Schilling, JD				Weber, Kassandra; Schilling, Joel D.			Lysosomes Integrate Metabolic-Inflammatory Cross-talk in Primary Macrophage Inflammasome Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcineurin; Diabetes; Inflammation; Lipids; Lysosomes; Macrophages	NLRP3 INFLAMMASOME; NALP3 INFLAMMASOME; DIABETIC MICE; PHENOTYPE; CRYSTALS; PROMOTES; PATHWAY; DISEASE; INTERLEUKIN-1-BETA; DYSFUNCTION	Background: Although macrophage inflammasome activation has been implicated in metabolic diseases, its regulation is not well understood. Results: Palmitate and LPS trigger IL-1 release via lysosome- and calcineurin-mediated pathways. Conclusion: The lysosome is a key regulator of signal 1 and signal 2 in lipotoxic inflammasome activation. Significance: Molecular pathways involved in lipid-induced inflammasome activation may be useful targets for obesity- and diabetes-related disorders. Macrophage dysfunction and inflammasome activation have been implicated in the pathogenesis of diabetes and its complications. Prolonged inflammation and impaired healing are hallmarks of the diabetic response to tissue injury, and excessive inflammasome activation has been associated in these phenotypes. However, the mechanisms that regulate the inflammasome in response to lipid metabolic and inflammatory stress are incompletely understood. We have shown previously that IL-1 secretion is induced in primary macrophages exposed to the dietary saturated fatty acid palmitate in combination with LPS. In this study, we sought to unravel the mechanisms underlying the activation of this lipotoxic inflammasome. We demonstrate that palmitate-loaded primary macrophages challenged with LPS activate the NLRP3 inflammasome through a mechanism that involves the lysosome. Interestingly, the lysosome was involved in both the regulation of pro-IL-1 levels and its subsequent cleavage/release. The lysosomal protease cathepsin B was required for IL-1 release but not pro-IL-1 production. In contrast, disrupting lysosomal calcium regulation decreased IL-1 release by reducing pro-IL-1 levels. The calcium pathway involved the calcium-activated phosphatase calcineurin, which stabilized IL-1 mRNA. Our findings provide evidence that the lysosome plays a key role in both the priming and assembly phases of the lipostoxic inflammasome. These findings have potential relevance to the hyperinflammatory phenotypes observed in diabetics during tissue damage or infection and identify lysosomes and calcineurin as potential therapeutic targets.	[Weber, Kassandra; Schilling, Joel D.] Washington Univ, Sch Med, Diabet Cardiovasc Dis Ctr, St Louis, MO 63110 USA; [Weber, Kassandra; Schilling, Joel D.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Schilling, Joel D.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Schilling, JD (corresponding author), Washington Univ, Sch Med, Diabet Cardiovasc Dis Ctr, St Louis, MO 63110 USA.	jschilli@dom.wustl.edu			National Institutes of Health [K08HL098373]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL098373] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant K08HL098373 (to J. D. S.).	Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bracey NA, 2013, EXP PHYSIOL, V98, P462, DOI 10.1113/expphysiol.2012.068338; Brookheart RT, 2009, CELL METAB, V10, P9, DOI 10.1016/j.cmet.2009.03.011; Christensen KA, 2002, J CELL SCI, V115, P599; De Nardo D, 2011, TRENDS IMMUNOL, V32, P373, DOI 10.1016/j.it.2011.05.004; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Erdmann F, 2010, J BIOL CHEM, V285, P1888, DOI 10.1074/jbc.M109.024844; Henao-Mejia J, 2012, NAT IMMUNOL, V13, P321, DOI 10.1038/ni.2257; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kanter JE, 2012, P NATL ACAD SCI USA, V109, pE715, DOI 10.1073/pnas.1111600109; Khanna S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009539; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee HM, 2013, DIABETES, V62, P194, DOI 10.2337/db12-0420; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mezzaroma E, 2011, P NATL ACAD SCI USA, V108, P19725, DOI 10.1073/pnas.1108586108; Mirza R, 2011, CYTOKINE, V56, P256, DOI 10.1016/j.cyto.2011.06.016; Mirza RE, 2013, DIABETES, V62, P2579, DOI 10.2337/db12-1450; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Patel S, 2010, TRENDS CELL BIOL, V20, P277, DOI 10.1016/j.tcb.2010.02.003; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Schilling JD, 2013, J BIOL CHEM, V288, P2923, DOI 10.1074/jbc.M112.419978; Schilling JD, 2013, J IMMUNOL, V190, P1285, DOI 10.4049/jimmunol.1202208; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022	31	84	87	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9158	9171		10.1074/jbc.M113.531202	http://dx.doi.org/10.1074/jbc.M113.531202			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24532802	Green Published, hybrid			2022-12-28	WOS:000333472100035
J	Chaube, R; Hess, DT; Wang, YJ; Plummer, B; Sun, QA; Laurita, K; Stamler, JS				Chaube, Ruchi; Hess, Douglas T.; Wang, Ya-Juan; Plummer, Bradley; Sun, Qi-An; Laurita, Kennneth; Stamler, Jonathan S.			Regulation of the Skeletal Muscle Ryanodine Receptor/Ca2+ -release Channel RyR1 by S-Palmitoylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Intracellular Release; Post-translational Modification; Protein Palmitoylation; Ryanodine Receptor; Skeletal Muscle	COUPLED REDOX REGULATION; RESIN-ASSISTED CAPTURE; BETA-SUBUNIT; PROTEOMIC ANALYSIS; CALCIUM; NITROSYLATION; PROTEINS; VOLTAGE; IDENTIFICATION; MODULATION	Background: Excitation-contraction coupling in striated muscle requires intracellular Ca2+ release through ryanodine receptor/Ca2+-release channels (RyRs). Results:S-Palmitoylation is a previously unidentified post-translational modification of skeletal muscle RyR1. Diminishing S-palmitoylation significantly diminishes RyR1 activity including stimulus-dependent Ca2+ release. Conclusion:S-Palmitoylation provides a previously unidentified mechanism to regulate Ca2+ flux in skeletal muscle. Significance:S-Palmitoylation is likely to regulate Ca2+ flux in many cell types. The ryanodine receptor/Ca2+-release channels (RyRs) of skeletal and cardiac muscle are essential for Ca2+ release from the sarcoplasmic reticulum that mediates excitation-contraction coupling. It has been shown that RyR activity is regulated by dynamic post-translational modifications of Cys residues, in particular S-nitrosylation and S-oxidation. Here we show that the predominant form of RyR in skeletal muscle, RyR1, is subject to Cys-directed modification by S-palmitoylation. S-Palmitoylation targets 18 Cys within the N-terminal, cytoplasmic region of RyR1, which are clustered in multiple functional domains including those implicated in the activity-governing protein-protein interactions of RyR1 with the L-type Ca2+ channel Ca(V)1.1, calmodulin, and the FK506-binding protein FKBP12, as well as in hot spot regions containing sites of mutations implicated in malignant hyperthermia and central core disease. Eight of these Cys have been identified previously as subject to physiological S-nitrosylation or S-oxidation. Diminishing S-palmitoylation directly suppresses RyR1 activity as well as stimulus-coupled Ca2+ release through RyR1. These findings demonstrate functional regulation of RyR1 by a previously unreported post-translational modification and indicate the potential for extensive Cys-based signaling cross-talk. In addition, we identify the sarco/endoplasmic reticular Ca2+-ATPase 1A and the (1S) subunit of the L-type Ca2+ channel Ca(V)1.1 as S-palmitoylated proteins, indicating that S-palmitoylation may regulate all principal governors of Ca2+ flux in skeletal muscle that mediates excitation-contraction coupling.	[Chaube, Ruchi; Hess, Douglas T.; Sun, Qi-An; Stamler, Jonathan S.] Case Western Reserve Univ, Sch Med, Inst Transformat Mol Med, Cleveland, OH 44106 USA; [Chaube, Ruchi; Hess, Douglas T.; Sun, Qi-An; Stamler, Jonathan S.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Chaube, Ruchi; Hess, Douglas T.; Sun, Qi-An; Stamler, Jonathan S.] Univ Hosp Cleveland, Cleveland, OH 44106 USA; [Wang, Ya-Juan] Case Western Reserve Univ, Sch Med, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Plummer, Bradley; Laurita, Kennneth] Case Western Reserve Univ, Heart & Vasc Res Ctr, Cleveland, OH 44109 USA; [Stamler, Jonathan S.] Univ Hosp Cleveland, Case Med Ctr, Harrington Discovery Inst, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland	Stamler, JS (corresponding author), Inst Transformat Mol Med, Wolstein Res Bldg 4129,2103 Cornell Rd, Cleveland, OH 44106 USA.	jonathan.stamler@case.edu		Wang, Yajuan (Megan)/0000-0002-3284-9012; Stamler, Jonathan/0000-0002-6866-1572	National Institutes of Health [R01 HL0591130, R01 AR018687]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR018687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL0591130 and R01 AR018687.	Ahearn IM, 2011, MOL CELL, V41, P173, DOI 10.1016/j.molcel.2011.01.001; ANDERSON K, 1994, AM J PHYSIOL, V266, pC462, DOI 10.1152/ajpcell.1994.266.2.C462; Betzenhauser MJ, 2010, PFLUG ARCH EUR J PHY, V460, P467, DOI 10.1007/s00424-010-0794-4; Blaskovic S, 2013, FEBS J, V280, P2766, DOI 10.1111/febs.12263; Bosmans F, 2011, P NATL ACAD SCI USA, V108, P20213, DOI 10.1073/pnas.1108497108; Cociorva Daniel, 2007, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1304s16; Dowal L, 2011, BLOOD, V118, pE62, DOI 10.1182/blood-2011-05-353078; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Gubitosi-Klug RA, 2005, P NATL ACAD SCI USA, V102, P5964, DOI 10.1073/pnas.0501999102; Hannoush RN, 2009, ACS CHEM BIOL, V4, P581, DOI 10.1021/cb900085z; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Ho GPH, 2011, NEURON, V71, P131, DOI 10.1016/j.neuron.2011.05.033; Hwang JH, 2012, TRENDS MOL MED, V18, P644, DOI 10.1016/j.molmed.2012.09.006; Jeffries O, 2010, J BIOL CHEM, V285, P33307, DOI 10.1074/jbc.M110.153940; KOSOWER NS, 1987, METHOD ENZYMOL, V143, P76; LAI FA, 1987, BIOCHEM BIOPH RES CO, V143, P704, DOI 10.1016/0006-291X(87)91411-2; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Mueller GM, 2010, J BIOL CHEM, V285, P30453, DOI 10.1074/jbc.M110.151845; OLSON EN, 1984, J BIOL CHEM, V259, P5364; Petrotchenko E. V., 2011, RES REP BIOL, V2011, P13; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; Shefer Gabi, 2005, Methods Mol Biol, V290, P281; Shipston MJ, 2011, J BIOL CHEM, V286, P8709, DOI 10.1074/jbc.R110.210005; Stephens GJ, 2000, J PHYSIOL-LONDON, V525, P377, DOI 10.1111/j.1469-7793.2000.t01-1-00377.x; Sun JH, 2003, J BIOL CHEM, V278, P8184, DOI 10.1074/jbc.M211940200; Sun JH, 2001, P NATL ACAD SCI USA, V98, P11158, DOI 10.1073/pnas.201289098; Sun QA, 2013, J BIOL CHEM, V288, P22961, DOI 10.1074/jbc.M113.480228; Sun QA, 2011, P NATL ACAD SCI USA, V108, P16098, DOI 10.1073/pnas.1109546108; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Xu H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-133; Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174; Yap MC, 2010, J LIPID RES, V51, P1566, DOI 10.1194/jlr.D002790; Zalk R, 2007, ANNU REV BIOCHEM, V76, P367, DOI 10.1146/annurev.biochem.76.053105.094237; Zhou XB, 2012, J BIOL CHEM, V287, P32161, DOI 10.1074/jbc.M112.386359	39	23	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8612	8619		10.1074/jbc.M114.548925	http://dx.doi.org/10.1074/jbc.M114.548925			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24509862	Green Published, hybrid			2022-12-28	WOS:000333157500051
J	Duan, ZC; Zhao, XJ; Fu, X; Su, C; Xin, LB; Saarikettu, J; Yang, X; Yao, Z; Silvennoinen, O; Wei, MX; Yang, J				Duan, Zhongchao; Zhao, Xiujuan; Fu, Xiao; Su, Chao; Xin, Lingbiao; Saarikettu, Juha; Yang, Xi; Yao, Zhi; Silvennoinen, Olli; Wei, Minxin; Yang, Jie			Tudor-SN, a Novel Coactivator of Peroxisome Proliferatoractivated Receptor gamma Protein, Is Essential for Adipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipogenesis; C; EBP Transcription Factor; Histone Deacetylase; Histone Modification; Peroxisome Proliferator-activated Receptor (PPAR); C; EBP; HDAC; PPAR; Tudor-SN	TRANSCRIPTIONAL REGULATION; PPAR-GAMMA; P100 COACTIVATOR; GENE-EXPRESSION; C-MYB; STAT6; DIFFERENTIATION; COMPLEX; OBESITY; CELLS	Background: Tudor-SN has been observed in lipid droplets, but its role in lipid homeostasis remains unclear. Results: Tudor-SN and PPAR are both regulated by C/EBP during adipogenesis and significantly influence the regulation of PPAR target genes. Conclusion: Tudor-SN functions as a co-activator of PPAR in adipogenesis. Significance: The study has elucidated a new functional mechanism for the regulation of adipogenesis. Adipogenesis, in which mesenchymal precursor cells differentiate into mature adipocytes, is a well orchestrated process. In the present study we identified Tudor-SN as a novel co-activator of the transcription factor peroxisome proliferator-activated receptor (PPAR). We provide the first evidence that Tudor-SN and PPAR exist in the same complex. Both are up-regulated by the early factor C/EBP during adipogenesis and significantly influence the regulation of PPAR target genes in both 3T3-L1 pre-adipocyte and mouse embryonic fibroblasts (MEF) upon exposure to a mixture of hormonal mixture. Moreover, aP2-PPAR response element (PPRE) interacts with both PPAR and Tudor-SN, and the gene transcriptional activation of PPRE-luc is enhanced by ectopic expression of Tudor-SN. Deletion of Tudor-SN protein (MEF-KO) affects but does not completely abolish the association of PPAR and aP2-PPRE. Loss-of-function studies further verified that Tudor-SN is required for adipogenesis, as deletion of Tudor-SN (MEF-KO) impairs dexamethasone, 3-isobutyl-1-methylxanthine, and insulin (DMI)-induced adipocyte differentiation and the expression of PPAR target genes, such as aP2 and adipsin. Furthermore, H3 acetylation levels were lower in MEF-KO than MEF-WT. Both HDAC1 and HDAC3 are stably associated with PPAR in MEF-KO, whereas only a small amount of association was observed in MEF-WT after 5 days of treatment during adipogenesis. PPAR requires various co-activators or co-repressors, which may dynamically associate with and regulate the higher order chromatin remodeling of the promoter region of PPAR-bound target genes; Tudor-SN is likely one of these co-activators.	[Duan, Zhongchao; Zhao, Xiujuan; Fu, Xiao; Su, Chao; Xin, Lingbiao; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Sch Basic Med Sci, Dept Immunol, Dept Biochem & Mol Biol, Tianjin 300070, Peoples R China; [Duan, Zhongchao; Su, Chao; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Res Ctr Basic Med Sci, Lab Mol Immunol, Tianjin 300070, Peoples R China; [Duan, Zhongchao; Zhao, Xiujuan; Fu, Xiao; Su, Chao; Xin, Lingbiao; Yao, Zhi; Yang, Jie] Tianjin Med Univ, Tianjin Key Lab Cellular & Mol Immunol, Tianjin 300070, Peoples R China; [Duan, Zhongchao; Zhao, Xiujuan; Fu, Xiao; Su, Chao; Xin, Lingbiao; Yang, Jie] Tianjin Med Univ, Key Lab Educ Minist China, Tianjin 300070, Peoples R China; [Saarikettu, Juha; Silvennoinen, Olli] Univ Tampere, Tampere Univ Hosp, Inst Med Technol, FI-33014 Tampere, Finland; [Yang, Xi] Univ Manitoba, Dept Immunol, Winnipeg, MB R3E 0T5, Canada; [Wei, Minxin] Tianjin Med Univ, Gen Hosp, Dept Cardiovasc Surg, Tianjin 300070, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tampere University; Tampere University Hospital; University of Manitoba; Tianjin Medical University	Wei, MX (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Cardiovasc Surg, Tianjin 300070, Peoples R China.	minxinw@126.com; yangj@tijmu.edu.cn		Yang, Xi/0000-0002-8831-7488	National Science Foundation for Distinguished Young Scholars of China [31125012]; National Science Foundation of China [31370749, 31100967, 31170830]	National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Science Foundation for Distinguished Young Scholars of China (31125012) and the National Science Foundation of China (31370749, 31100967, 31170830).	Broadhurst MK, 2001, J ENDOCRINOL, V171, P329, DOI 10.1677/joe.0.1710329; Dash AB, 1996, GENE DEV, V10, P1858, DOI 10.1101/gad.10.15.1858; Dong LJ, 2011, J BIOL CHEM, V286, P3451, DOI 10.1074/jbc.M110.168377; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Gao XJ, 2012, J BIOL CHEM, V287, P18130, DOI 10.1074/jbc.M111.311852; Haberland M, 2010, J BIOL CHEM, V285, P14663, DOI 10.1074/jbc.M109.081679; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Keenan TW, 2000, BBA-GEN SUBJECTS, V1523, P84, DOI 10.1016/S0304-4165(00)00106-9; Leverson JD, 1998, MOL CELL, V2, P417, DOI 10.1016/S1097-2765(00)80141-0; Low SH, 2006, DEV CELL, V10, P57, DOI 10.1016/j.devcel.2005.12.005; Misra P, 2002, J BIOL CHEM, V277, P20011, DOI 10.1074/jbc.M201739200; Morrison RF, 2000, J NUTR, V130, p3116S, DOI 10.1093/jn/130.12.3116S; NTAMBI JM, 1988, J BIOL CHEM, V263, P17291; Palacios L, 2006, BBA-MOL CELL BIOL L, V1761, P698, DOI 10.1016/j.bbalip.2006.05.005; Paukku K, 2003, MOL ENDOCRINOL, V17, P1805, DOI 10.1210/me.2002-0256; Qi C, 2003, J BIOL CHEM, V278, P25281, DOI 10.1074/jbc.C300175200; Rodriguez L, 2007, BIOCHEM BIOPH RES CO, V356, P226, DOI 10.1016/j.bbrc.2007.02.110; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; TONG X, 1995, MOL CELL BIOL, V15, P4735; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Valineva T, 2005, J BIOL CHEM, V280, P14989, DOI 10.1074/jbc.M410465200; VidalPuig A, 1996, J CLIN INVEST, V97, P2553, DOI 10.1172/JCI118703; Yang J, 2002, EMBO J, V21, P4950, DOI 10.1093/emboj/cdf463; ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921	28	23	26	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8364	8374		10.1074/jbc.M113.523456	http://dx.doi.org/10.1074/jbc.M113.523456			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24523408	Green Published, hybrid			2022-12-28	WOS:000333157500029
J	Fujiwara, T; Saitoh, H; Inoue, A; Kobayashi, M; Okitsu, Y; Katsuoka, Y; Fukuhara, N; Onishi, Y; Ishizawa, K; Ichinohasama, R; Harigae, H				Fujiwara, Tohru; Saitoh, Haruka; Inoue, Ai; Kobayashi, Masahiro; Okitsu, Yoko; Katsuoka, Yuna; Fukuhara, Noriko; Onishi, Yasushi; Ishizawa, Kenichi; Ichinohasama, Ryo; Harigae, Hideo			3-Deazaneplanocin A (DZNep), an Inhibitor of S-Adenosylmethionine-dependent Methyltransferase, Promotes Erythroid Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Erythropoeisis; Gene Transcription; Hemoglobin; Histone Deacetylase; Histone Methylation; DZNep; ETO2; EZH2	COMBINED EPIGENETIC THERAPY; REPRESSIVE COMPLEX 2; HISTONE METHYLATION; MICE LACKING; LEUKEMIA; BINDING; GATA-1; EZH2; SCL; EXPRESSION	Background:S-adenosylmethionine-dependent methyltransferase inhibitor, DZNep, targets the degradation of histone methyltransferase EZH2 that catalyzes H3K27 trimethylation. Results: DZNep induced erythroid-related genes, which may not be directly related to EZH2 inhibition but may be partly associated with reduced protein level of hematopoietic corepressor ETO2. Conclusion: DZNep has the capacity to induce erythroid differentiation. Significance: Our data may be exploited for therapeutic applications for hematological diseases, including anemia. EZH2, a core component of polycomb repressive complex 2 (PRC2), plays a role in transcriptional repression through histone H3 Lys-27 trimethylation and is involved in various biological processes, including hematopoiesis. It is well known that 3-deazaneplanocin A (DZNep), an inhibitor of S-adenosylmethionine-dependent methyltransferase that targets the degradation of EZH2, preferentially induces apoptosis in various hematological malignancies, suggesting that EZH2 may be a new target for epigenetic treatment. Because PRC2 participates in epigenetic silencing of a subset of GATA-1 target genes during erythroid differentiation, inhibition of EZH2 may influence erythropoiesis. To explore this possibility, we evaluated the impact of DZNep on erythropoiesis. DZNep treatment significantly induced erythroid differentiation of K562 cells, as assessed by benzidine staining and quantitative RT-PCR analysis for representative erythroid-related genes, including globins. When we evaluated the effects of DZNep in human primary erythroblasts derived from cord blood CD34-positive cells, the treatment significantly induced erythroid-related genes, as observed in K562 cells, suggesting that DZNep induces erythroid differentiation. Unexpectedly, siRNA-mediated EZH2 knockdown had no significant effect on the expression of erythroid-related genes. Transcriptional profiling of DZNep-treated K562 cells revealed marked up-regulation of SLC4A1 and EPB42, previously reported as representative targets of the transcriptional corepressor ETO2. In addition, DZNep treatment reduced the protein level of ETO2. These data suggest that erythroid differentiation by DZNep may not be directly related to EZH2 inhibition but may be partly associated with reduced protein level of hematopoietic corepressor ETO2. These data provide a better understanding of the mechanism of action of DZNep, which may be exploited for therapeutic applications for hematological diseases, including anemia.	[Fujiwara, Tohru; Saitoh, Haruka; Inoue, Ai; Kobayashi, Masahiro; Okitsu, Yoko; Katsuoka, Yuna; Fukuhara, Noriko; Onishi, Yasushi; Ishizawa, Kenichi; Harigae, Hideo] Tohoku Univ, Grad Sch Med, Dept Hematol & Rheumatol, Sendai, Miyagi 9808575, Japan; [Fujiwara, Tohru; Harigae, Hideo] Tohoku Univ, Grad Sch Med, Dept Mol Hematol Oncol, Sendai, Miyagi 9808575, Japan; [Ichinohasama, Ryo] Tohoku Univ, Grad Sch, Dept Hematopathol, Sendai, Miyagi 9808575, Japan; [Ishizawa, Kenichi] Tohoku Univ Hosp, Clin Res Innovat & Educ Ctr, Sendai, Miyagi 9808575, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University	Fujiwara, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Hematol & Rheumatol, Sendai, Miyagi 9808575, Japan.	fujiwarato@apple.email.ne.jp	Fujiwara, Tohru/GOG-9775-2022; Inoue, Akihisa/E-5271-2015		Biomedical Research Core of Tohoku University School of Medicine; Grants-in-Aid for Scientific Research [23791067] Funding Source: KAKEN	Biomedical Research Core of Tohoku University School of Medicine; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the members of the Hematology and Rheumatology department of Tohoku University Graduate School of Medicine for helpful comments. We also acknowledge the support of Biomedical Research Core of Tohoku University School of Medicine.	Amann JM, 2001, MOL CELL BIOL, V21, P6470, DOI 10.1128/MCB.21.19.6470-6483.2001; Benjamini Y, 2001, ANN STAT, V29, P1165; Bresnick EH, 2010, J BIOL CHEM, V285, P31087, DOI 10.1074/jbc.R110.159079; Cheng LL, 2012, CLIN CANCER RES, V18, P4201, DOI 10.1158/1078-0432.CCR-12-0036; Chiang PK, 1998, PHARMACOL THERAPEUT, V77, P115, DOI 10.1016/S0163-7258(97)00089-2; COOPER MC, 1974, P NATL ACAD SCI USA, V71, P1677, DOI 10.1073/pnas.71.5.1677; EVANS T, 1988, P NATL ACAD SCI USA, V85, P5976, DOI 10.1073/pnas.85.16.5976; Fibach E, 2003, BLOOD, V102, P1276, DOI 10.1182/blood-2002-10-3096; Fiskus W, 2012, CLIN CANCER RES, V18, P6227, DOI 10.1158/1078-0432.CCR-12-0873; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Fujiwara T., 2012, PLOS ONE, V7; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Fujiwara T, 2013, EXP HEMATOL, V41, P303, DOI 10.1016/j.exphem.2012.10.015; Fujiwara T, 2010, P NATL ACAD SCI USA, V107, P20429, DOI 10.1073/pnas.1007804107; Gambari R, 2003, MINERVA BIOTECNOL, V15, P123; GLAZER RI, 1986, BIOCHEM BIOPH RES CO, V135, P688, DOI 10.1016/0006-291X(86)90048-3; GLAZER RI, 1986, BIOCHEM PHARMACOL, V35, P4523, DOI 10.1016/0006-2952(86)90774-4; Gottgens B, 2002, EMBO J, V21, P3039, DOI 10.1093/emboj/cdf286; He S, 2012, BLOOD, V119, P1274, DOI 10.1182/blood-2011-06-364422; Hong W, 2005, EMBO J, V24, P2367, DOI 10.1038/sj.emboj.7600703; Kang YA, 2012, MOL CELL BIOL, V32, P226, DOI 10.1128/MCB.06166-11; Kerenyi MA, 2010, J EXP MED, V207, P2537, DOI 10.1084/jem.20102260; Kikuchi J, 2012, LUNG CANCER, V78, P138, DOI 10.1016/j.lungcan.2012.08.003; Lahlil R, 2004, MOL CELL BIOL, V24, P1439, DOI 10.1128/MCB.24.4.1439-1452.2004; Lim KC, 2000, NAT GENET, V25, P209, DOI 10.1038/76080; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Mochizuki-Kashio M, 2011, BLOOD, V118, P6553, DOI 10.1182/blood-2011-03-340554; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Rodriguez P, 2005, EMBO J, V24, P2354, DOI 10.1038/sj.emboj.7600702; Ross J, 2012, MOL CELL BIOL, V32, P3624, DOI 10.1128/MCB.00163-12; Rossetti S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-93; Saleque S, 2007, MOL CELL, V27, P562, DOI 10.1016/j.molcel.2007.06.039; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Szyf M, 2009, ANNU REV PHARMACOL, V49, P243, DOI 10.1146/annurev-pharmtox-061008-103102; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Xie Z., 2011, PLOS ONE, V6; YAMAMOTO M, 1990, GENE DEV, V4, P1650, DOI 10.1101/gad.4.10.1650; Zoabi M, 2011, BIOCHEM BIOPH RES CO, V408, P393, DOI 10.1016/j.bbrc.2011.04.025	44	39	39	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8121	8134		10.1074/jbc.M114.548651	http://dx.doi.org/10.1074/jbc.M114.548651			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24492606	Green Published, hybrid			2022-12-28	WOS:000333157500010
J	Gall, DL; Kim, H; Lu, FC; Donohue, TJ; Noguera, DR; Ralph, J				Gall, Daniel L.; Kim, Hoon; Lu, Fachuang; Donohue, Timothy J.; Noguera, Daniel R.; Ralph, John			Stereochemical Features of Glutathione-dependent Enzymes in the Sphingobium sp Strain SYK-6 beta-Aryl Etherase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Metabolism; Enzyme Catalysis; Glutathione; Lignin Degradation; Thiol; beta-S-Thioetherase; beta-Aryl Etherase; Glutathione S-Transferase; Stereoselectivity; Stereospecificity	POLYPROTEIN CLEAVAGE SITE; PSEUDOMONAS-PAUCIMOBILIS; MUTATIONAL ANALYSIS; GUAIACYL ETHER; LIGNIN MODEL; DFRC METHOD; TRANSFERASES; GENE; IDENTIFICATION; SUPERFAMILY	Background: A bacterial -etherase pathway uses glutathione-dependent enzymes for catabolism of -ether-linked substructures found in lignin. Results: Racemic -ether-linked substructures are stereoselectively converted to thioether-linked monoaromatic compounds by -etherase pathway enzymes. Conclusion: Multiple enzymes with complementary stereochemical features are needed to catabolize racemic lignin substructures. Significance: Understanding the -etherase pathway metabolism of lignin enhances our potential to use lignin for agricultural, industrial, and biotechnological purposes. Glutathione-dependent enzymes play important protective, repair, or metabolic roles in cells. In particular, enzymes in the glutathione S-transferase (GST) superfamily function in stress responses, defense systems, or xenobiotic detoxification. Here, we identify novel features of bacterial GSTs that cleave -aryl ether bonds typically found in plant lignin. Our data reveal several original features of the reaction cycle of these GSTs, including stereospecific substrate recognition and stereoselective formation of -S-thioether linkages. Products of recombinant GSTs (LigE, LigP, and LigF) are -S-glutathionyl--keto-thioethers that are degraded by a -S-thioetherase (LigG). All three Lig GSTs produced the ketone product (-S-glutathionyl--veratrylethanone) from an achiral side chain-truncated model substrate (-guaiacyl--veratrylethanone). However, when -etherase assays were conducted with a racemic model substrate, -guaiacyl--veratrylglycerone, LigE- or LigP-catalyzed reactions yielded only one of two potential product (-S-glutathionyl--veratrylglycerone) epimers, whereas the other diastereomer (differing in configuration at the -position (i.e. its -epimer)) was produced only in the LigF-catalyzed reaction. Thus, -etherase catalysis causes stereochemical inversion of the chiral center, converting a (R)-substrate to a (S)-product (LigE and LigP), and a (S)-substrate to a (R)-product (LigF). Further, LigG catalyzed glutathione-dependent -S-thioether cleavage with -S-glutathionyl--veratrylethanone and with (R)-configured -S-glutathionyl--veratrylglycerone but exhibited no or significantly reduced -S-thioether-cleaving activity with the (S)-epimer, demonstrating that LigG is a stereospecific -thioetherase. We therefore propose that multiple Lig enzymes are needed in this -aryl etherase pathway in order to cleave the racemic -ether linkages that are present in the backbone of the lignin polymer.	[Gall, Daniel L.; Noguera, Daniel R.] Univ Wisconsin, Dept Civil & Environm Engn, Madison, WI 53706 USA; [Kim, Hoon; Lu, Fachuang; Ralph, John] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Donohue, Timothy J.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Noguera, Daniel R.] Univ Wisconsin, Environm Chem & Technol Program, Madison, WI 53706 USA; [Gall, Daniel L.; Kim, Hoon; Lu, Fachuang; Donohue, Timothy J.; Noguera, Daniel R.; Ralph, John] Univ Wisconsin, Wisconsin Energy Inst, US DOE, Great Lakes Bioenergy Res Ctr, Madison, WI 53726 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison	Ralph, J (corresponding author), 2113 Wisconsin Energy Inst,1552 Univ Ave, Madison, WI 53726 USA.	jralph@wisc.edu	Lu, Fachuang/K-6487-2019; Kim, Hoon/E-8245-2013; Ralph, John/C-3161-2009; Donohue, Timothy/C-3273-2015	Kim, Hoon/0000-0001-7425-7464; Ralph, John/0000-0002-6093-4521; Donohue, Timothy/0000-0001-8738-2467; Noguera, Daniel/0000-0003-0372-3063	National Institutes of Health, NIGMS [T32 GM08349]; Department of Energy Office of Science's Great Lakes Bioenergy Research Center [DE-FC02-07ER64494]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008349] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy Office of Science's Great Lakes Bioenergy Research Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant T32 GM08349 (traineeship to D. G.). This work was also supported by the Department of Energy Office of Science's Great Lakes Bioenergy Research Center, Grant DE-FC02-07ER64494.	ADLER E, 1977, WOOD SCI TECHNOL, V11, P169, DOI 10.1007/BF00365615; ADLER E, 1955, ACTA CHEM SCAND, V9, P341, DOI 10.3891/acta.chem.scand.09-0341; Akiyama T, 2002, J WOOD SCI, V48, P210, DOI 10.1007/BF00771369; Akiyama T, 2000, J WOOD SCI, V46, P414, DOI 10.1007/BF00776407; Bertani G, 2004, J BACTERIOL, V186, P595, DOI 10.1128/JB.186.3.595-600.2004; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; CARRINGTON JC, 1988, J VIROL, V62, P2313, DOI 10.1128/JVI.62.7.2313-2320.1988; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; DOUGHERTY WG, 1991, VIROLOGY, V183, P449, DOI 10.1016/0042-6822(91)90974-G; DOUGHERTY WG, 1988, EMBO J, V7, P1281, DOI 10.1002/j.1460-2075.1988.tb02942.x; DOUGHERTY WG, 1989, VIROLOGY, V171, P356, DOI 10.1016/0042-6822(89)90603-X; FREUDENBERG K, 1959, NATURE, V183, P1152, DOI 10.1038/1831152a0; Fukuzumi T., 1977, MOKUZAI GAKKAISHI, V23; Hara H, 2000, J BACTERIOL, V182, P6950, DOI 10.1128/JB.182.24.6950-6957.2000; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Higuchi T., 1980, LIGNIN BIODEGRADATIO, P1; Hishiyama S, 2012, TETRAHEDRON LETT, V53, P842, DOI 10.1016/j.tetlet.2011.12.016; Horton R M, 1993, Methods Mol Biol, V15, P251, DOI 10.1385/0-89603-244-2:251; Horton RM, 2013, BIOTECHNIQUES, V54, P129; Kingston, 2003, CURRENT PROTOCOLS MO; LEWIS NG, 1990, ANNU REV PLANT PHYS, V41, P455, DOI 10.1146/annurev.pp.41.060190.002323; Lu FC, 1997, J AGR FOOD CHEM, V45, P4655, DOI 10.1021/jf970539p; Lu FC, 1997, J AGR FOOD CHEM, V45, P2590, DOI 10.1021/jf970258h; Masai E, 2003, J BACTERIOL, V185, P1768, DOI 10.1128/JB.185.6.1768-1775.2003; MASAI E, 1993, FEBS LETT, V323, P135, DOI 10.1016/0014-5793(93)81465-C; MASAI E, 1991, J BACTERIOL, V173, P7950, DOI 10.1128/jb.173.24.7950-7955.1991; MASAI E, 1989, FEBS LETT, V249, P348, DOI 10.1016/0014-5793(89)80656-8; MASAI E, 1993, BIOSCI BIOTECH BIOCH, V57, P1655, DOI 10.1271/bbb.57.1655; Masai E, 2007, BIOSCI BIOTECH BIOCH, V71, P1, DOI 10.1271/bbb.60437; Oakley AJ, 2005, CURR OPIN STRUC BIOL, V15, P716, DOI 10.1016/j.sbi.2005.10.005; Prochazkova K, 2009, J BIOL CHEM, V284, P26557, DOI 10.1074/jbc.M109.025510; Ralph J, 1999, J AGR FOOD CHEM, V47, P2991, DOI 10.1021/jf9901136; Ralph J., 2010, LIGNIN LIGNANS ADV C, P137, DOI DOI 10.1201/EBK1574444865-C5; Sarkanen K. V., 1971, LIGNINS OCCURRENCE F, P43; Sato Y, 2009, APPL ENVIRON MICROB, V75, P5195, DOI 10.1128/AEM.00880-09; Sheahan KL, 2007, EMBO J, V26, P2552, DOI 10.1038/sj.emboj.7601700; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Shen A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008119; Shen A, 2009, NAT CHEM BIOL, V5, P469, DOI 10.1038/nchembio.178; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; Simmons BA, 2010, CURR OPIN PLANT BIOL, V13, P313, DOI 10.1016/j.pbi.2010.03.001; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tanamura K, 2011, BIOSCI BIOTECH BIOCH, V75, P2404, DOI 10.1271/bbb.110525; Vuilleumier S, 1997, J BACTERIOL, V179, P1431, DOI 10.1128/jb.179.5.1431-1441.1997; Zakzeski J, 2010, CHEM REV, V110, P3552, DOI 10.1021/cr900354u	49	52	58	0	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8656	8667		10.1074/jbc.M113.536250	http://dx.doi.org/10.1074/jbc.M113.536250			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24509858	hybrid, Green Published			2022-12-28	WOS:000333157500055
J	Ramachandran, H; Schafer, T; Kim, Y; Herfurth, K; Hoff, S; Lienkamp, SS; Kramer-Zucker, A; Walz, G				Ramachandran, Haribaskar; Schaefer, Tobias; Kim, Yunhee; Herfurth, Konstantin; Hoff, Sylvia; Lienkamp, Soeren S.; Kramer-Zucker, Albrecht; Walz, Gerd			Interaction with the Bardet-Biedl Gene Product TRIM32/BBS11 Modifies the Half-life and Localization of Glis2/NPHP7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Genetic Diseases; Protein Degradation; Protein Stability; Transcription Regulation; Ubiquitylation; Bardet-Biedl Syndrome; Ciliopathies; Nephronophthisis	FINGER PROTEIN GLIS2; E3 UBIQUITIN LIGASE; DYSTROPHY TYPE 2H; ACUTE MEGAKARYOBLASTIC LEUKEMIA; TRANSCRIPTION FACTOR; KIDNEY-DISEASE; NEPHRONOPHTHISIS; CILIOPATHY; MUTATIONS; APOPTOSIS	Background: NPHP and BBS are closely related syndromes, but the underlying mechanisms are unclear. Results: BBS11 promotes accumulation of NPHP7, changing the properties of NPHP7. Conclusion: NPHP and BBS gene products may be involved in similar signaling pathways. Significance: These findings may help to explain the clinical overlap between certain ciliopathies. Although the two ciliopathies Bardet-Biedl syndrome and nephronophthisis share multiple clinical manifestations, the molecular basis for this overlap remains largely unknown. Both BBS11 and NPHP7 are unusual members of their respective gene families. Although BBS11/TRIM32 represents a RING finger E3 ubiquitin ligase also involved in hereditary forms of muscular dystrophy, NPHP7/Glis2 is a Gli-like transcriptional repressor that localizes to the nucleus, deviating from the ciliary localization of most other ciliopathy-associated gene products. We found that BBS11/TRIM32 and NPHP7/Glis2 can physically interact with each other, suggesting that both proteins form a functionally relevant protein complex in vivo. This hypothesis was further supported by the genetic interaction and synergist cyst formation in the zebrafish pronephros model. However, contrary to our expectation, the E3 ubiquitin ligase BBS11/TRIM32 was not responsible for the short half-life of NPHP7/Glis2 but instead promoted the accumulation of mixed Lys(48)/Lys(63)-polyubiquitylated NPHP7/Glis2 species. This modification not only prolonged the half-life of NPHP7/Glis2, but also altered the subnuclear localization and the transcriptional activity of NPHP7/Glis2. Thus, physical and functional interactions between NPHP and Bardet-Biedl syndrome gene products, demonstrated for Glis2 and TRIM32, may help to explain the phenotypic similarities between these two syndromes.	[Ramachandran, Haribaskar; Schaefer, Tobias; Kim, Yunhee; Herfurth, Konstantin; Hoff, Sylvia; Lienkamp, Soeren S.; Kramer-Zucker, Albrecht; Walz, Gerd] Univ Freiburg, Med Ctr, Dept Med, Div Renal, D-79106 Freiburg, Germany; [Kim, Yunhee; Hoff, Sylvia] Univ Freiburg, Spemann Grad Sch Biol & Med, D-79085 Freiburg, Germany; [Kim, Yunhee; Hoff, Sylvia] Univ Freiburg, Fac Biol, D-79085 Freiburg, Germany; [Walz, Gerd] BIOSS Ctr Biol Signaling Studies, D-79108 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Walz, G (corresponding author), Div Renal, Hugstetter Str 55, D-79106 Freiburg, Germany.	gerd.walz@uniklinik-freiburg.de/	Lienkamp, Soeren/AAH-6296-2020	Lienkamp, Soeren/0000-0003-2963-6865	Deutsche Forschungsgemeinschaft [KFO 201]; European Community [241955];  [Sonderforschungsbereich 746]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Community(European Commission); 	This work was supported by Deutsche Forschungsgemeinschaft Grant KFO 201 (to S. S. L. and A. K.-Z.), Sonderforschungsbereich 746 (to T. S. and G. W.), and the European Community's Seventh Framework Program Grant Agreement 241955 (SYSCILIA; to G. W.).	Aguilar RC, 2003, CURR OPIN CELL BIOL, V15, P184, DOI 10.1016/S0955-0674(03)00010-3; Albor A, 2006, J BIOL CHEM, V281, P25850, DOI 10.1074/jbc.M601655200; Attanasio M, 2007, NAT GENET, V39, P1018, DOI 10.1038/ng2072; Badano JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/hmg/ddg188; Cammas F, 2012, ADV EXP MED BIOL, V770, P59; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Chiang AP, 2006, P NATL ACAD SCI USA, V103, P6287, DOI 10.1073/pnas.0600158103; Cohen S, 2012, J CELL BIOL, V198, P575, DOI 10.1083/jcb.201110067; Cossee M, 2009, NEUROMUSCULAR DISORD, V19, P255, DOI 10.1016/j.nmd.2009.02.003; Frosk P, 2002, AM J HUM GENET, V70, P663, DOI 10.1086/339083; Gonzalez-Cano L, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.224; Gruber TA, 2012, CANCER CELL, V22, P683, DOI 10.1016/j.ccr.2012.10.007; Halbritter J, 2013, HUM GENET, V132, P865, DOI 10.1007/s00439-013-1297-0; Haribaskar R, 2009, BIOCHEM BIOPH RES CO, V387, P212, DOI 10.1016/j.bbrc.2009.07.012; Hatakeyama S, 2011, NAT REV CANCER, V11, P792, DOI 10.1038/nrc3139; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hosking CR, 2007, MOL BIOL CELL, V18, P1918, DOI 10.1091/mbc.E06-10-0941; Jauregui AR, 2008, J CELL BIOL, V180, P973, DOI 10.1083/jcb.200707090; Kang HS, 2010, HISTOL HISTOPATHOL, V25, P1481, DOI 10.14670/HH-25.1481; Kang HS, 2009, MOL CELL BIOL, V29, P2556, DOI 10.1128/MCB.01620-08; Kano S, 2008, CANCER RES, V68, P5572, DOI 10.1158/0008-5472.CAN-07-6231; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Kim SC, 2005, NUCLEIC ACIDS RES, V33, P6805, DOI 10.1093/nar/gki985; KIM YH, 2013, PLOS ONE, V8; Kim YS, 2008, MOL CELL BIOL, V28, P2358, DOI 10.1128/MCB.01722-07; Kim YS, 2007, FEBS LETT, V581, P858, DOI 10.1016/j.febslet.2007.01.058; Kudryashova E, 2005, J MOL BIOL, V354, P413, DOI 10.1016/j.jmb.2005.09.068; Kudryashova E, 2011, HUM MOL GENET, V20, P3925, DOI 10.1093/hmg/ddr311; Kudryashova E, 2009, HUM MOL GENET, V18, P1353, DOI 10.1093/hmg/ddp036; LaBeau-DiMenna EM, 2012, P NATL ACAD SCI USA, V109, P17983, DOI 10.1073/pnas.1208408109; Li B, 2011, HUM MOL GENET, V20, P4155, DOI 10.1093/hmg/ddr339; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; Masetti R, 2013, BLOOD, V121, P3469, DOI 10.1182/blood-2012-11-469825; Micale L, 2012, ADV EXP MED BIOL, V770, P11; Muller J, 2010, HUM GENET, V127, P583, DOI 10.1007/s00439-010-0804-9; Mund T, 2010, P NATL ACAD SCI USA, V107, P11429, DOI 10.1073/pnas.0911714107; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Ryu YS, 2011, J BIOL CHEM, V286, P25729, DOI 10.1074/jbc.M111.241893; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Schafer T, 2008, HUM MOL GENET, V17, P3655, DOI 10.1093/hmg/ddn260; Thiollier C, 2012, J EXP MED, V209, P2017, DOI 10.1084/jem.20121343; Vasanth S, 2011, J BIOL CHEM, V286, P4749, DOI 10.1074/jbc.M110.165951; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116; Williams CL, 2010, J AM SOC NEPHROL, V21, P782, DOI 10.1681/ASN.2009060597; Wolf MTF, 2011, PEDIATR NEPHROL, V26, P181, DOI 10.1007/s00467-010-1585-z; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041; Zhang F, 2002, J BIOL CHEM, V277, P10139, DOI 10.1074/jbc.M108062200; Zhang F, 2001, GENE, V280, P49, DOI 10.1016/S0378-1119(01)00764-8; Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608	51	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8390	8401		10.1074/jbc.M113.534024	http://dx.doi.org/10.1074/jbc.M113.534024			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24500717	Green Published, hybrid			2022-12-28	WOS:000333157500031
J	Manzoor, R; Kuroda, K; Yoshida, R; Tsuda, Y; Fujikura, D; Miyamoto, H; Kajihara, M; Kida, H; Takada, A				Manzoor, Rashid; Kuroda, Kazumichi; Yoshida, Reiko; Tsuda, Yoshimi; Fujikura, Daisuke; Miyamoto, Hiroko; Kajihara, Masahiro; Kida, Hiroshi; Takada, Ayato			Heat Shock Protein 70 Modulates Influenza A Virus Polymerase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Fractionation; Influenza Virus; NF-kappa B (NF-kB); RNA Viruses; Viral Polymerase; Viral Replication; Heat Shock; Heat Shock Protein 70	NF-KAPPA-B; HEAT-SHOCK RESPONSE; RNA-POLYMERASE; PA SUBUNIT; MOLECULAR CHAPERONES; CAP-BINDING; PROSTAGLANDIN A(1); NUCLEAR IMPORT; PB1 PROTEIN; HUMAN HSP70	Background: It has been shown that heat shock protein 70 (Hsp70) plays a role in influenza A virus replication. Results: A correlation between viral replication/transcription activities and nuclear/cytoplasmic shuttling of Hsp70 was observed. Conclusion: Hsp70 modulates the influenza A virus polymerase activity. Significance: This study, for the first time, suggests that Hsp70 may actually assist in influenza A virus replication. The role of heat shock protein 70 (Hsp70) in virus replication has been discussed for many viruses. The known suppressive role of Hsp70 in influenza virus replication is based on studies conducted in cells with various Hsp70 expression levels. In this study, we determined the role of Hsp70 in influenza virus replication in HeLa and HEK293T cells, which express Hsp70 constitutively. Co-immunoprecipitation and immunofluorescence studies revealed that Hsp70 interacted with PB2 or PB1 monomers and PB2/PB1 heterodimer but not with the PB1/PA heterodimer or PB2/PB1/PA heterotrimer and translocated into the nucleus with PB2 monomers or PB2/PB1 heterodimers. Knocking down Hsp70 resulted in reduced virus transcription and replication activities. Reporter gene assay, immunofluorescence assay, and Western blot analysis of nuclear and cytoplasmic fractions from infected cells demonstrated that the increase in viral polymerase activity during the heat shock phase was accompanied with an increase in Hsp70 and viral polymerases levels in the nuclei, where influenza virus replication takes place, whereas a reduction in viral polymerase activity was accompanied with an increase in cytoplasmic relocation of Hsp70 along with viral polymerases. Moreover, significantly higher levels of viral genomic RNA (vRNA) were observed during the heat shock phase than during the recovery phase. Overall, for the first time, these findings suggest that Hsp70 may act as a chaperone for influenza virus polymerase, and the modulatory effect of Hsp70 appears to be a sequel of shuttling of Hsp70 between nuclear and cytoplasmic compartments.	[Manzoor, Rashid; Yoshida, Reiko; Tsuda, Yoshimi; Miyamoto, Hiroko; Kajihara, Masahiro; Takada, Ayato] Hokkaido Univ, Res Ctr Zoonosis Control, Div Global Epidemiol, Sapporo, Hokkaido 0010020, Japan; [Fujikura, Daisuke] Hokkaido Univ, Res Ctr Zoonosis Control, Div Infect & Immun, Sapporo, Hokkaido 0010020, Japan; [Kuroda, Kazumichi] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Microbiol, Tokyo 1738610, Japan; [Kida, Hiroshi] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Microbiol Lab, Sapporo, Hokkaido 0600818, Japan; [Takada, Ayato] Univ Zambia, Sch Vet Med, Lusaka, Zambia	Hokkaido University; Hokkaido University; Nihon University; Hokkaido University; University of Zambia	Takada, A (corresponding author), Hokkaido Univ, Res Ctr Zoonosis Control, Div Global Epidemiol, Kita Ku, Kita 20 Nishi 10, Sapporo, Hokkaido 0010020, Japan.	atakada@czc.hokudai.ac.jp	Manzoor, Rashid/ABB-8209-2020; YOSHIDA, Reiko/F-6883-2012; Kajihara, Masahiro/AAF-5724-2020		Japan Society for the Promotion of Science; MEXT; Japan Initiative for Global Research Network on Infectious Diseases	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Initiative for Global Research Network on Infectious Diseases(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by funds from the Japan Society for the Promotion of Science (to R. M.), the Strategic Research Base Development Program for Private Universities subsidized by MEXT (2010), and the Japan Initiative for Global Research Network on Infectious Diseases and a grant-in-aid for scientific research by the Japan Society for the Promotion of Science.	AKKINA RK, 1987, J VIROL, V61, P2217, DOI 10.1128/JVI.61.7.2217-2224.1987; Boivin S, 2010, J BIOL CHEM, V285, P28411, DOI 10.1074/jbc.R110.117531; Bortz E, 2011, MBIO, V2, DOI 10.1128/mBio.00151-11; Broquet AH, 2007, J VIROL, V81, P1297, DOI 10.1128/JVI.01336-06; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; CAIZERGUESFERRER M, 1980, BIOCHEM BIOPH RES CO, V97, P538, DOI 10.1016/0006-291X(80)90297-1; Chromy LR, 2003, P NATL ACAD SCI USA, V100, P10477, DOI 10.1073/pnas.1832245100; Dalton RM, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-58; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Deng T, 2006, J VIROL, V80, P11911, DOI 10.1128/JVI.01565-06; Ding XZ, 1998, FASEB J, V12, P451, DOI 10.1096/fasebj.12.6.451; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Fislova T, 2010, J VIROL, V84, P8691, DOI 10.1128/JVI.00813-10; Fodor E, 2004, J VIROL, V78, P9144, DOI 10.1128/JVI.78.17.9144-9153.2004; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Ghoshal K, 1996, BIOCHEM J, V317, P689, DOI 10.1042/bj3170689; Glotzer JB, 2000, NATURE, V407, P207, DOI 10.1038/35025102; Gonzalez S, 1999, EMBO J, V18, P3767, DOI 10.1093/emboj/18.13.3767; Gonzalez S, 1999, J VIROL, V73, P631; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Guzhova IV, 1997, CELL STRESS CHAPERON, V2, P132, DOI 10.1379/1466-1268(1997)002<0132:MSPHIW>2.3.CO;2; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hatta M, 2000, ARCH VIROL, V145, P1947, DOI 10.1007/s007050070068; Hatta M, 2000, ARCH VIROL, V145, P957, DOI 10.1007/s007050050687; Hatta M., 2000, THESIS HOKKAIDO U JA; Hemerka JN, 2009, J VIROL, V83, P3944, DOI 10.1128/JVI.02300-08; Hirayama E, 2004, J VIROL, V78, P1263, DOI 10.1128/JVI.78.3.1263-1270.2004; Hoffmann E, 2000, VIROLOGY, V267, P310, DOI 10.1006/viro.1999.0140; Honda A, 1999, GENES CELLS, V4, P475, DOI 10.1046/j.1365-2443.1999.00275.x; Honda A, 1997, BIOL CHEM, V378, P483; Iordanskiy S, 2004, BLOOD, V104, P1867, DOI 10.1182/blood-2004-01-0081; Iordanskiy S, 2004, J VIROL, V78, P9697, DOI 10.1128/JVI.78.18.9697-9704.2004; Iwai A, 2010, J BIOL CHEM, V285, P32064, DOI 10.1074/jbc.M110.112458; Kawaguchi A, 2005, J VIROL, V79, P732, DOI 10.1128/JVI.79.2.732-744.2005; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Kumar N, 2008, J VIROL, V82, P9880, DOI 10.1128/JVI.00909-08; Lang V, 2011, ARCH VIROL, V156, P987, DOI 10.1007/s00705-011-0933-z; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016546; LIU RY, 1992, CANCER RES, V52, P3667; Maier HJ, 2008, VIROLOGY, V370, P194, DOI 10.1016/j.virol.2007.08.029; Malhotra V, 2002, CRIT CARE MED, V30, pS89, DOI 10.1097/00003246-200201001-00012; Mayer D, 2007, J PROTEOME RES, V6, P672, DOI 10.1021/pr060432u; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Momose F, 2002, J BIOL CHEM, V277, P45306, DOI 10.1074/jbc.M206822200; Morano KA, 2007, ANN NY ACAD SCI, V1113, P1, DOI 10.1196/annals.1391.018; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Naito T, 2007, J VIROL, V81, P1339, DOI 10.1128/JVI.01917-06; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; NGUYEN VT, 1989, J BIOL CHEM, V264, P10487; Nimmerjahn F, 2004, J GEN VIROL, V85, P2347, DOI 10.1099/vir.0.79958-0; Oza J, 2008, CELL STRESS CHAPERON, V13, P73, DOI 10.1007/s12192-008-0013-9; PARAG HA, 1987, EMBO J, V6, P55, DOI 10.1002/j.1460-2075.1987.tb04718.x; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PINTO M, 1991, J BIOL CHEM, V266, P13941; Pogany J, 2008, P NATL ACAD SCI USA, V105, P19956, DOI 10.1073/pnas.0810851105; Promega Corp, 2011, PROT APPL GUID; Ran RQ, 2004, GENE DEV, V18, P1466, DOI 10.1101/gad.1188204; RATTNER A, 1993, EMBO J, V12, P4261, DOI 10.1002/j.1460-2075.1993.tb06110.x; Resa-Infante P, 2011, RNA BIOL, V8, P207, DOI 10.4161/rna.8.2.14513; Resa-Infante P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003904; Rossi A, 1997, P NATL ACAD SCI USA, V94, P746, DOI 10.1073/pnas.94.2.746; SANZEZQUERRO JJ, 1995, J VIROL, V69, P2420, DOI 10.1128/JVI.69.4.2420-2426.1995; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Schell MT, 2005, J SURG RES, V129, P90, DOI 10.1016/j.jss.2005.05.025; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; Stahl M, 2007, J VIROL, V81, P13354, DOI 10.1128/JVI.01196-07; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Tavaria M, 1996, CELL STRESS CHAPERON, V1, P23, DOI 10.1379/1466-1268(1996)001<0023:AHSGTT>2.3.CO;2; THEODORAKIS NG, 1987, MOL CELL BIOL, V7, P4357, DOI 10.1128/MCB.7.12.4357; Thomas SC, 1998, FASEB J, V12, P1371, DOI 10.1096/fasebj.12.13.1371; Tschuch C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-60; Van Nieuwenhoven FA, 2001, EUR J CELL BIOL, V80, P586, DOI 10.1078/0171-9335-00192; Velichko AK, 2013, CELL MOL LIFE SCI, V70, P4229, DOI 10.1007/s00018-013-1348-7; Vert JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-520; Volloch VZ, 1999, ONCOGENE, V18, P3648, DOI 10.1038/sj.onc.1202525; Wang RYL, 2009, J VIROL, V83, P3276, DOI 10.1128/JVI.02313-08; Wang SH, 2008, BIOTECHNOL BIOENG, V99, P146, DOI 10.1002/bit.21512; Wong HR, 1999, CELL STRESS CHAPERON, V4, P1; Wurzer WJ, 2004, J BIOL CHEM, V279, P30931, DOI 10.1074/jbc.M403258200; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720; Zeng XC, 2004, J CELL SCI, V117, P4991, DOI 10.1242/jcs.01373	85	47	51	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7599	7614		10.1074/jbc.M113.507798	http://dx.doi.org/10.1074/jbc.M113.507798			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24474693	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000332761500030
J	Shao, D; Fry, JL; Han, JY; Hou, XY; Pimentel, DR; Matsui, R; Cohen, RA; Bachschmid, MM				Shao, Di; Fry, Jessica L.; Han, Jingyan; Hou, Xiuyun; Pimentel, David R.; Matsui, Reiko; Cohen, Richard A.; Bachschmid, Markus M.			A Redox-resistant Sirtuin-1 Mutant Protects against Hepatic Metabolic and Oxidant Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glutathionylation; Metabolic Diseases; Oxidative Stress; Polyphenols; Resveratrol; Glutathiolation; High Fat High Sucrose Diet; Reactive Oxygen and Nitrogen Species	HIGH-FAT DIET; NF-KAPPA-B; REGULATES SIRT1; CELL-SURVIVAL; HEPATOCYTE APOPTOSIS; ANTIOXIDANT STATUS; LIVER; P53; EXPRESSION; PHOSPHORYLATION	Background: Sirtuin-1 improves metabolic disease, but oxidants may inhibit it. Results: Metabolic stress increased glutathione adducts, inactivated endogenous Sirtuin-1, and promoted apoptosis. A novel Sirtuin-1 oxidation-insensitive mutant or glutaredoxin-1 prevented metabolic dysregulation and apoptosis. Conclusion: A novel Sirtuin-1 mutant circumvents oxidation and more effectively inhibits metabolic dysregulation and apoptosis. Significance: Oxidative inactivation of Sirtuin-1 contributes to metabolic disease. Sirtuin-1 (SirT1), a member of the NAD(+)-dependent class III histone deacetylase family, is inactivated in vitro by oxidation of critical cysteine thiols. In a model of metabolic syndrome, SirT1 activation attenuated apoptosis of hepatocytes and improved liver function including lipid metabolism. We show in SirT1-overexpressing HepG2 cells that oxidants (nitrosocysteine and hydrogen peroxide) or metabolic stress (high palmitate and high glucose) inactivated SirT1 by reversible oxidative post-translational modifications (OPTMs) on three cysteines. Mutating these oxidation-sensitive cysteines to serine preserved SirT1 activity and abolished reversible OPTMs. Overexpressed mutant SirT1 maintained deacetylase activity and attenuated proapoptotic signaling, whereas overexpressed wild type SirT1 was less protective in metabolically or oxidant-stressed cells. To prove that OPTMs of SirT1 are glutathione (GSH) adducts, glutaredoxin-1 was overexpressed to remove this modification. Glutaredoxin-1 overexpression maintained endogenous SirT1 activity and prevented proapoptotic signaling in metabolically stressed HepG2 cells. The in vivo significance of oxidative inactivation of SirT1 was investigated in livers of high fat diet-fed C57/B6J mice. SirT1 deacetylase activity was decreased in the absence of changes in SirT1 expression and associated with a marked increase in OPTMs. These results indicate that glutathione adducts on specific SirT1 thiols may be responsible for dysfunctional SirT1 associated with liver disease in metabolic syndrome.	[Shao, Di; Fry, Jessica L.; Han, Jingyan; Hou, Xiuyun; Matsui, Reiko; Cohen, Richard A.; Bachschmid, Markus M.] Boston Univ, Sch Med, Vasc Biol Sect, Boston, MA 02118 USA; [Pimentel, David R.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Myocardial Biol Unit, Boston, MA 02118 USA; [Cohen, Richard A.; Bachschmid, Markus M.] Boston Univ, Sch Med, Cardiovasc Proteom Ctr, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Bachschmid, MM (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Vasc Biol Sect, Boston, MA 02118 USA.	bach@bu.edu	Shao, Di/F-9758-2016	/0000-0002-1070-6408; Bachschmid, Markus Michael/0000-0002-0748-5528; Fry, Jessica/0000-0003-2748-0334	National Institutes of Health [PO1 HL 068758, R37 HL104017]; NHLBI, National Institutes of Health, Department of Health and Human Services [HHSN268201000031C]; National Institutes of Health Cardiovascular Post-doctoral Training Grant [HL007224]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068758, T32HL007224, R37HL104017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI, National Institutes of Health, Department of Health and Human Services; National Institutes of Health Cardiovascular Post-doctoral Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL 068758 and R37 HL104017 and the NHLBI, National Institutes of Health, Department of Health and Human Services under Contract HHSN268201000031C.; Supported by National Institutes of Health Cardiovascular Post-doctoral Training Grant HL007224.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Cao J, 2012, MOL CELL BIOCHEM, V364, P115, DOI 10.1007/s11010-011-1211-9; Caton PW, 2013, DIABETOLOGIA, V56, P1068, DOI 10.1007/s00125-013-2851-y; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Costantini S, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-60; Deng XQ, 2007, LIVER INT, V27, P708, DOI 10.1111/j.1478-3231.2007.01497.x; Elliott PJ, 2008, CURR OPIN INVEST DR, V9, P371; Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319; Feldstein AE, 2003, GASTROENTEROLOGY, V125, P437, DOI 10.1016/S0016-5085(03)00907-7; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Furukawa A, 2007, CELL PHYSIOL BIOCHEM, V20, P45, DOI 10.1159/000104152; Gao ZG, 2011, J BIOL CHEM, V286, P22227, DOI 10.1074/jbc.M111.228874; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Haeussler DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023160; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Ishikawa S, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-187; Joshi-Barve S, 2007, HEPATOLOGY, V46, P823, DOI 10.1002/hep.21752; Jung SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080115; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Koruk M, 2004, ANN CLIN LAB SCI, V34, P57; Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Li S., 2010, PLOS ONE, V5; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Madan K, 2006, J CLIN GASTROENTEROL, V40, P930, DOI 10.1097/01.mcg.0000212608.59090.08; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Nin V, 2012, J BIOL CHEM, V287, P23489, DOI 10.1074/jbc.M112.365874; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Olmos Y, 2013, ANTIOXID REDOX SIGN, V19, P1507, DOI 10.1089/ars.2012.4713; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Potente M, 2008, CELL CYCLE, V7, P2117, DOI 10.4161/cc.7.14.6267; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Qin FZ, 2012, CIRCULATION, V125, P1757, DOI 10.1161/CIRCULATIONAHA.111.067801; Ribeiro PS, 2004, AM J GASTROENTEROL, V99, P1708, DOI 10.1111/j.1572-0241.2004.40009.x; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Ruiz-Ramirez A, 2011, AM J PHYSIOL-ENDOC M, V301, pE1198, DOI 10.1152/ajpendo.00631.2010; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Shin JY, 2013, CELL REP, V5, P654, DOI 10.1016/j.celrep.2013.10.007; Strum JC, 2009, MOL ENDOCRINOL, V23, P1876, DOI 10.1210/me.2009-0117; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Westphal CH, 2007, TRENDS BIOCHEM SCI, V32, P555, DOI 10.1016/j.tibs.2007.09.008; Xu SQ, 2011, J CARDIOVASC PHARM, V58, P263, DOI 10.1097/FJC.0b013e3182239eb7; Yamazaki Y, 2009, AM J PHYSIOL-ENDOC M, V297, pE1179, DOI 10.1152/ajpendo.90997.2008; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; You M, 2008, J NUTR, V138, P497, DOI 10.1093/jn/138.3.497; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Yu JJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02806; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zee RS, 2010, ANTIOXID REDOX SIGN, V13, P1023, DOI 10.1089/ars.2010.3251; Zhang YH, 2004, P NATL ACAD SCI USA, V101, P7891, DOI 10.1073/pnas.0401167101; Zschoernig B, 2009, BIOCHEM BIOPH RES CO, V381, P372, DOI 10.1016/j.bbrc.2009.02.085	72	52	52	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7293	7306		10.1074/jbc.M113.520403	http://dx.doi.org/10.1074/jbc.M113.520403			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24451382	Green Published, hybrid			2022-12-28	WOS:000332761500004
J	Dickson, CF; Kumar, KK; Jacques, DA; Malmirchegini, GR; Spirig, T; Mackay, JP; Clubb, RT; Guss, JM; Gell, DA				Dickson, Claire F.; Kumar, Kaavya Krishna; Jacques, David A.; Malmirchegini, G. Reza; Spirig, Thomas; Mackay, Joel P.; Clubb, Robert T.; Guss, J. Mitchell; Gell, David A.			Structure of the Hemoglobin-IsdH Complex Reveals the Molecular Basis of Iron Capture by Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystallography; Heme; Hemoglobin; Protein Domains; Staphylococcus aureus; NEAT Domain; Heme; Iron-regulated Surface Determinant	SMALL-ANGLE SCATTERING; SURFACE PROTEIN; NEAT DOMAIN; HEME-IRON; INFECTIVE ENDOCARDITIS; QUATERNARY STRUCTURE; ANTHRAX HEMOPHORE; EXTRACT HEME; NATIVE VALVE; CELL-WALL	Background: IsdB and IsdH proteins from Staphylococcus aureus strip heme iron from human hemoglobin. Results: The IsdHhemoglobin complex shows how globin-binding and heme-binding NEAT domains of IsdH cooperate to remove heme from both chains of hemoglobin. Conclusion: The supradomain architecture of IsdH confers activity by precisely positioning the heme acceptor domain. Significance: Multiple IsdHhemoglobin interfaces may be targets for new antibiotics. Staphylococcus aureus causes life-threatening disease in humans. The S. aureus surface protein iron-regulated surface determinant H (IsdH) binds to mammalian hemoglobin (Hb) and extracts heme as a source of iron, which is an essential nutrient for the bacteria. However, the process of heme transfer from Hb is poorly understood. We have determined the structure of IsdH bound to human Hb by x-ray crystallography at 4.2 resolution, revealing the structural basis for heme transfer. One IsdH molecule is bound to each and Hb subunit, suggesting that the receptor acquires iron from both chains by a similar mechanism. Remarkably, two near iron transporter (NEAT) domains in IsdH perform very different functions. An N-terminal NEAT domain binds / globin through a site distant from the globin heme pocket and, via an intervening structural domain, positions the C-terminal heme-binding NEAT domain perfectly for heme transfer. These data, together with a 2.3 resolution crystal structure of the isolated N-terminal domain bound to Hb and small-angle x-ray scattering of free IsdH, reveal how multiple domains of IsdH cooperate to strip heme from Hb. Many bacterial pathogens obtain iron from human hemoglobin using proteins that contain multiple NEAT domains and other domains whose functions are poorly understood. Our results suggest that, rather than acting as isolated units, NEAT domains may be integrated into higher order architectures that employ multiple interaction interfaces to efficiently extract heme from host proteins.	[Dickson, Claire F.; Gell, David A.] Univ Tasmania, Menzies Res Inst Tasmania, Hobart, Tas 7000, Australia; [Kumar, Kaavya Krishna; Jacques, David A.; Mackay, Joel P.; Guss, J. Mitchell] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Malmirchegini, G. Reza; Spirig, Thomas; Clubb, Robert T.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of Tasmania; University of Sydney; University of California System; University of California Los Angeles	Gell, DA (corresponding author), Univ Tasmania, Menzies Res Inst Tasmania, 17 Liverpool St, Hobart, Tas 7000, Australia.	david.gell@utas.edu.au	Mackay, Joel P/D-6834-2011; Guss, Jules Mitchell/N-1387-2019	Mackay, Joel P/0000-0001-7508-8033; Guss, Jules Mitchell/0000-0003-4259-6079; Jacques, David/0000-0002-6426-4510; Gell, David/0000-0003-0382-1181; Spirig, Thomas/0000-0001-8936-238X	National Institutes of Health Grant [AI52217]; University of Tasmania; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052217] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Tasmania; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI52217 (to R. T. C.). This work was also supported by the University of Tasmania (to D. A. G.).	Abe R, 2012, J BIOL CHEM, V287, P16477, DOI 10.1074/jbc.M112.346700; Andersen CBF, 2012, NATURE, V489, P456, DOI 10.1038/nature11369; Anguera I, 2005, HEART, V91, DOI 10.1136/hrt.2004.040659; Ascoli F, 1981, Methods Enzymol, V76, P72; Balderas MA, 2012, J BACTERIOL, V194, P5513, DOI 10.1128/JB.00685-12; Banci L, 2006, NAT CHEM BIOL, V2, P367, DOI 10.1038/nchembio797; Bauer J, 2013, MOL PLANT, V6, P959, DOI 10.1093/mp/sss126; Bricogne G., 2011, BUSTER VERSION 2 10; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; Crowley PB, 2003, ACCOUNTS CHEM RES, V36, P723, DOI 10.1021/ar0200955; Daou N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000675; del Rio A, 2009, CLIN INFECT DIS, V48, pS246, DOI 10.1086/598187; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; Dukic VM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052722; Ekworomadu MT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002559; Eliezer D, 1996, J MOL BIOL, V263, P531, DOI 10.1006/jmbi.1996.0596; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Fusco WG, 2013, J BACTERIOL, V195, P3115, DOI 10.1128/JB.00199-13; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Grigg JC, 2011, J MOL BIOL, V413, P684, DOI 10.1016/j.jmb.2011.08.047; Hargrove MS, 1997, J BIOL CHEM, V272, P17385, DOI 10.1074/jbc.272.28.17385; Hempel K, 2011, J PROTEOME RES, V10, P1657, DOI 10.1021/pr1009838; Honsa ES, 2013, J BIOL CHEM, V288, P8479, DOI 10.1074/jbc.M112.430009; Honsa ES, 2011, J BIOL CHEM, V286, P33652, DOI 10.1074/jbc.M111.241687; Jacques DA, 2010, PROTEIN SCI, V19, P642, DOI 10.1002/pro.351; Klein E, 2007, EMERG INFECT DIS, V13, P1840, DOI 10.3201/eid1312.070629; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kumar KK, 2011, J BIOL CHEM, V286, P38439, DOI 10.1074/jbc.M111.287300; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Mack J, 2004, BIOCHEM BIOPH RES CO, V320, P781, DOI 10.1016/j.bbrc.2004.06.025; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miro JM, 2005, CLIN INFECT DIS, V41, P507, DOI 10.1086/431979; Moriwaki Y, 2011, BIOCHEMISTRY-US, V50, P7311, DOI 10.1021/bi200493h; Morrissey JA, 2002, INFECT IMMUN, V70, P2399, DOI 10.1128/IAI.70.5.2399-2407.2002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Nairz M, 2010, CELL MICROBIOL, V12, P1691, DOI 10.1111/j.1462-5822.2010.01529.x; Nepluev I, 2009, INFECT IMMUN, V77, P3065, DOI 10.1128/IAI.00034-09; Noinaj N, 2012, NATURE, V483, P53, DOI 10.1038/nature10823; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouattara M, 2013, ARCH BIOCHEM BIOPHYS, V538, P71, DOI 10.1016/j.abb.2013.08.009; Ouattara M, 2010, MOL MICROBIOL, V78, P739, DOI 10.1111/j.1365-2958.2010.07367.x; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; Pilpa RM, 2009, J BIOL CHEM, V284, P1166, DOI 10.1074/jbc.M806007200; Pishchany G, 2010, CELL HOST MICROBE, V8, P544, DOI 10.1016/j.chom.2010.11.002; Pishchany G, 2009, INFECT IMMUN, V77, P2624, DOI 10.1128/IAI.01531-08; SILVA MM, 1992, J BIOL CHEM, V267, P17248; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Spirig T, 2013, J BIOL CHEM, V288, P1065, DOI 10.1074/jbc.M112.419119; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tiedemann MT, 2012, J AM CHEM SOC, V134, P16578, DOI 10.1021/ja305115y; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Torres VJ, 2010, INFECT IMMUN, V78, P1618, DOI 10.1128/IAI.01423-09; Villareal VA, 2011, J AM CHEM SOC, V133, P14176, DOI 10.1021/ja203805b; Visai L, 2009, MICROBIOL-SGM, V155, P667, DOI 10.1099/mic.0.025684-0; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vu NT, 2013, PROTEIN SCI, V22, P942, DOI 10.1002/pro.2276; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Yi J, 2011, ACTA CRYSTALLOGR F, V67, P647, DOI 10.1107/S1744309111012528; Zapf J, 2000, STRUCTURE, V8, P851, DOI 10.1016/S0969-2126(00)00174-X; Zapotoczna M, 2012, J BACTERIOL, V194, P6453, DOI 10.1128/JB.01195-12; Zhao XD, 2008, J MOL BIOL, V375, P1141, DOI 10.1016/j.jmb.2007.11.045; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200	72	36	37	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6728	6738		10.1074/jbc.M113.545566	http://dx.doi.org/10.1074/jbc.M113.545566			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24425866	Green Published, hybrid			2022-12-28	WOS:000332389400034
J	Ma, LF; Wang, JY; Lin, JF; Pan, QH; Yu, YC; Sun, FY				Ma, Lifang; Wang, Jiayi; Lin, Jiafei; Pan, Qiuhui; Yu, Yongchun; Sun, Fenyong			Cluster of Differentiation 166 (CD166) Regulated by Phosphatidylinositide 3-Kinase (PI3K)/AKT Signaling to Exert Its Anti-apoptotic Role via Yes-associated Protein (YAP) in Liver Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; CREB; Hepatocellular Carcinoma; Membrane Proteins; Signal Transduction	INDEPENDENT PROGNOSTIC MARKER; ORGAN SIZE CONTROL; HIPPO PATHWAY; HEPATOCELLULAR-CARCINOMA; MUTUAL INTERACTION; COLORECTAL-CANCER; BREAST-CANCER; CELLS; EXPRESSION; PHOSPHORYLATION	Background: CD166 is overexpressed and regarded as a valuable prognostic marker in tumors. Results: An autoregulatory feedback between PI3K/AKT and CD166 was revealed, and YAP was identified as a CD166 downstream effecter. Conclusion: CD166 is regulated by PI3K/AKT to exert its anti-apoptotic role via YAP. Significance: The relationship between CD166 and YAP provides new therapeutic insights into liver cancer. Cluster of differentiation 166 (CD166 or Alcam) is a cell surface molecule that can be greatly induced in liver cancer cells after serum deprivation, suggesting its role in influencing cell survival. However, whether and how CD166 acts as an anti-apoptotic regulator needs to be further investigated. Here, we report that gene silencing of CD166 promoted apoptosis via down-regulation of Bcl-2 in liver cancer cells. PI3K/AKT signaling was found to up-regulate CD166 expression independently of transcription. We also revealed that CD166 promoted both AKT expression and activity, thus providing a novel positive regulatory feedback between PI3K/AKT signaling and CD166. Moreover, Yes-associated protein (YAP) was identified as a CD166 downstream effecter, which can partly rescue CD166 knockdown-induced apoptosis and reduced in vivo cancer cell growth. Mechanically, CD166 modulated YAP expression and activity through at least two different ways, transcriptional regulation of YAP through cAMP-response element-binding protein and post-transcriptional control of YAP stability through inhibition to AMOT130. We also showed that CD9 enhanced CD166-mediated regulation of YAP via a mechanism involving facilitating CD166-CD166 homophilic interaction. Tissue microarray analysis revealed that CD166 and YAP were up-regulated and closely correlated in liver cancer samples, demonstrating the importance of their relationship. Taken together, this work summarizes a novel link between CD166 and YAP, explores the interplay among related important signaling pathways, and may lead to more effective therapeutic strategies for liver cancer.	[Ma, Lifang; Wang, Jiayi; Sun, Fenyong] Tongji Univ, Dept Clin Lab Med, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China; [Lin, Jiafei] Shanghai Jiao Tong Univ, Sch Med, Dept Clin Lab Med, Ruijin Hosp, Shanghai 200025, Peoples R China; [Pan, Qiuhui; Yu, Yongchun] Tongji Univ, Dept Cent Lab, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China	Tongji University; Shanghai Jiao Tong University; Tongji University	Wang, JY (corresponding author), Tongji Univ, Dept Clin Lab Med, Shanghai Peoples Hosp 10, 301 Middle Yanchang Rd, Shanghai 200072, Peoples R China.	karajan2@163.com; sunfenyong@126.com		Wang, Jiayi/0000-0003-1688-2864	China National 973 projects [20111812, 20110402]; Natural Science Foundation of China [81301689]; Shanghai Tenth People's Hospital Climbing Training Program; China Central High School basic research-specific grant	China National 973 projects(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Tenth People's Hospital Climbing Training Program; China Central High School basic research-specific grant	This work was supported by China National 973 projects (Grants 20111812 and 20110402), Natural Science Foundation of China Grant 81301689, the Shanghai Tenth People's Hospital Climbing Training Program (to J.W.), and a China Central High School basic research-specific grant (to J.X.).	Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Burkhardt M, 2006, J CLIN PATHOL, V59, P403, DOI 10.1136/jcp.2005.028209; Cheng JCH, 2006, ONCOGENE, V25, P7009, DOI 10.1038/sj.onc.1209706; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Fan R, 2013, P NATL ACAD SCI USA, V110, P2569, DOI 10.1073/pnas.1216462110; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Fernandez A, 2012, ONCOGENE, V31, P1923, DOI 10.1038/onc.2011.379; Gilsanz A, 2013, CELL MOL LIFE SCI, V70, P475, DOI 10.1007/s00018-012-1132-0; Gown AM, 2002, J HISTOCHEM CYTOCHEM, V50, P449, DOI 10.1177/002215540205000401; Graham TR, 2009, PROSTATE, V69, P168, DOI 10.1002/pros.20870; Huo XY, 2013, ONCOL REP, V29, P840, DOI 10.3892/or.2012.2176; Jezierska A, 2006, MED SCI MONITOR, V12, pBR263; Jiao J, 2012, PLOS ONE, V7; Kahlert C, 2009, BRIT J CANCER, V101, P457, DOI 10.1038/sj.bjc.6605136; Kim M, 2013, EMBO J, V32, P1543, DOI 10.1038/emboj.2013.102; Levin TG, 2010, GASTROENTEROLOGY, V139, P2072, DOI 10.1053/j.gastro.2010.08.053; Li LL, 2013, FEBS LETT, V587, P3921, DOI 10.1016/j.febslet.2013.10.042; Li Y, 2002, J BIOL CHEM, V277, P11352, DOI 10.1074/jbc.M109062200; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Lugli A, 2010, BRIT J CANCER, V103, P382, DOI 10.1038/sj.bjc.6605762; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Urtasun R, 2011, HEPATOLOGY, V54, P2149, DOI 10.1002/hep.24587; van Kempen LCLT, 2001, J BIOL CHEM, V276, P25783, DOI 10.1074/jbc.M011272200; Wang J., 2014, CELL SIGNAL, DOI 10.1016/j.cellsig.2014.01.022; Wang JY, 2013, HEPATOLOGY, V58, P1011, DOI 10.1002/hep.26420; Wang JY, 2013, MOL CELL, V51, P211, DOI 10.1016/j.molcel.2013.05.013; Wang JY, 2011, NUCLEIC ACIDS RES, V39, P6440, DOI 10.1093/nar/gkr302; Weichert W, 2004, J CLIN PATHOL, V57, P1160, DOI 10.1136/jcp.2004.016238; Xiao WF, 2013, BIOCHEM BIOPH RES CO, V439, P167, DOI 10.1016/j.bbrc.2013.08.071; Xu MZ, 2009, CANCER-AM CANCER SOC, V115, P4576, DOI 10.1002/cncr.24495; Yang ZZ, 2005, MOL CELL BIOL, V25, P10407, DOI 10.1128/MCB.25.23.10407-10418.2005; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhang T, 2012, HEPATOLOGY, V56, P2051, DOI 10.1002/hep.25899; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	38	41	43	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6921	6933		10.1074/jbc.M113.524819	http://dx.doi.org/10.1074/jbc.M113.524819			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24482231	Green Published, hybrid			2022-12-28	WOS:000332389400052
J	Walker, RG; Deng, XD; Melchior, JT; Morris, J; Tso, P; Jones, MK; Segrest, JP; Thompson, TB; Davidson, WS				Walker, Ryan G.; Deng, Xiaodi; Melchior, John T.; Morris, Jamie; Tso, Patrick; Jones, Martin K.; Segrest, Jere P.; Thompson, Thomas B.; Davidson, W. Sean			The Structure of Human Apolipoprotein A-IV as Revealed by Stable Isotope-assisted Cross-linking, Molecular Dynamics, and Small Angle X-ray Scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apolipoproteins; Lipid-binding Protein; Mass Spectrometry (MS); Molecular Dynamics; Protein Cross-linking; Protein Structure; Apolipoprotein A-IV; Lipid-free; Small Angle X-ray Scattering	HIGH-DENSITY-LIPOPROTEINS; INTERFACIAL PROPERTIES; LIPID-BINDING; SEQUENCE; PROTEIN; MODEL; IDENTIFICATION; CONFORMATION; FLEXIBILITY; SECRETION	Background: Apolipoprotein (apo)A-IV is involved in lipid and glucose metabolism, but its full-length structure is not known. Results: Stable isotope-assisted cross-linking combined with molecular modeling produced new models of the full-length protein. Conclusion: At least three hydrophobic residues participate in a unique clasp mechanism that regulates apoA-IV function. Significance: We report the most detailed models of lipid-free apoA-IV to date and demonstrate their utility in terms of functional predictions. Apolipoprotein (apo)A-IV plays important roles in dietary lipid and glucose metabolism, and knowledge of its structure is required to fully understand the molecular basis of these functions. However, typical of the entire class of exchangeable apolipoproteins, its dynamic nature and affinity for lipid has posed challenges to traditional high resolution structural approaches. We previously reported an x-ray crystal structure of a dimeric truncation mutant of apoA-IV, which showed a unique helix-swapping molecular interface. Unfortunately, the structures of the N and C termini that are important for lipid binding were not visualized. To build a more complete model, we used chemical cross-linking to derive distance constraints across the full-length protein. The approach was enhanced with stable isotope labeling to overcome ambiguities in determining molecular span of the cross-links given the remarkable similarities in the monomeric and dimeric apoA-IV structures. Using 51 distance constraints, we created a starting model for full-length monomeric apoA-IV and then subjected it to two modeling approaches: (i) molecular dynamics simulations and (ii) fitting to small angle x-ray scattering data. This resulted in the most detailed models yet for lipid-free monomeric or dimeric apoA-IV. Importantly, these models were of sufficient detail to direct the experimental identification of new functional residues that participate in a clasp mechanism to modulate apoA-IV lipid affinity. The isotope-assisted cross-linking approach should prove useful for further study of this family of apolipoproteins in both the lipid-free and -bound states.	[Walker, Ryan G.; Deng, Xiaodi; Thompson, Thomas B.] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45237 USA; [Melchior, John T.; Morris, Jamie; Tso, Patrick; Davidson, W. Sean] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45237 USA; [Jones, Martin K.; Segrest, Jere P.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Jones, Martin K.; Segrest, Jere P.] Univ Alabama Birmingham, Atherosclerosis Res Unit, Birmingham, AL 35294 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Thompson, TB (corresponding author), Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45237 USA.	Tom.Thompson@uc.edu; Sean.Davidson@UC.edu		Thompson, Thomas/0000-0002-7041-5047; Davidson, William/0000-0003-2756-2989; Walker, Ryan/0000-0001-6160-8026	National Institutes of Health [RO1 GM098458, HL67093]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098458] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 GM098458 (to W. S. D. and T. B. T.) and HL67093 (to W. S. D.).	Bhat S, 2005, J BIOL CHEM, V280, P33015, DOI 10.1074/jbc.M505081200; BOGUSKI MS, 1985, P NATL ACAD SCI USA, V82, P992, DOI 10.1073/pnas.82.4.992; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Deng XD, 2013, J BIOL CHEM, V288, P4854, DOI 10.1074/jbc.M112.436709; Deng XD, 2012, STRUCTURE, V20, P767, DOI 10.1016/j.str.2012.02.020; DUVERGER N, 1994, BBA-LIPID LIPID MET, V1211, P23, DOI 10.1016/0005-2760(94)90134-1; DVORIN E, 1985, J LIPID RES, V26, P38; ELSHOURBAGY NA, 1987, J BIOL CHEM, V262, P7973; EMMANUEL F, 1994, J BIOL CHEM, V269, P29883; FUJIMOTO K, 1992, AM J PHYSIOL, V262, pG1002, DOI 10.1152/ajpgi.1992.262.6.G1002; Gallagher JW, 2004, J LIPID RES, V45, P1826, DOI 10.1194/jlr.M400188-JLR200; GREEN PHR, 1980, J CLIN INVEST, V65, P911, DOI 10.1172/JCI109745; Hammel M, 2012, EUR BIOPHYS J BIOPHY, V41, P789, DOI 10.1007/s00249-012-0820-x; HAYASHI H, 1990, J LIPID RES, V31, P1613; Huang R, 2011, NAT STRUCT MOL BIOL, V18, P416, DOI 10.1038/nsmb.2028; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JONAS A, 1993, J BIOL CHEM, V268, P1596; Jones MK, 2009, BIOPHYS J, V96, P354, DOI 10.1016/j.bpj.2008.09.041; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KARATHANASIS SK, 1986, P NATL ACAD SCI USA, V83, P8457, DOI 10.1073/pnas.83.22.8457; Kratz M, 2003, J NUTR, V133, P1821, DOI 10.1093/jn/133.6.1821; Lu S, 2006, J BIOL CHEM, V281, P3473, DOI 10.1074/jbc.M502501200; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Main LA, 1996, BBA-LIPID LIPID MET, V1300, P17, DOI 10.1016/0005-2760(95)00228-6; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Mei XH, 2011, J BIOL CHEM, V286, P38570, DOI 10.1074/jbc.M111.260422; Nema V, 2013, BIOINFORMATION, V9, P796, DOI 10.6026/97320630009796; Okumura T, 1996, AM J PHYSIOL-GASTR L, V270, pG49, DOI 10.1152/ajpgi.1996.270.1.G49; Panagotopulos SE, 2002, J BIOL CHEM, V277, P39477, DOI 10.1074/jbc.M207005200; Pearson K, 2004, BIOCHEMISTRY-US, V43, P10719, DOI 10.1021/bi048978m; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qin XF, 1998, AM J PHYSIOL-HEART C, V274, pH1836, DOI 10.1152/ajpheart.1998.274.5.H1836; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Raybould HE, 1998, AM J PHYSIOL-REG I, V274, pR1834, DOI 10.1152/ajpregu.1998.274.6.R1834; Remaley AT, 2001, BIOCHEM BIOPH RES CO, V280, P818, DOI 10.1006/bbrc.2000.4219; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Silva RAGD, 2007, J BIOL CHEM, V282, P9713, DOI 10.1074/jbc.M610380200; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P8600, DOI 10.1021/bi050421z; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P2759, DOI 10.1021/bi047717+; Tubb MR, 2008, J BIOL CHEM, V283, P17314, DOI 10.1074/jbc.M800036200; Tubb MR, 2007, J BIOL CHEM, V282, P28385, DOI 10.1074/jbc.M704070200; Tubb MR, 2009, J LIPID RES, V50, P1497, DOI 10.1194/jlr.D900003-JLR200; Wang F, 2012, P NATL ACAD SCI USA, V109, P9641, DOI 10.1073/pnas.1201433109; WEINBERG RB, 1985, J BIOL CHEM, V260, P4914; WEINBERG RB, 1985, J BIOL CHEM, V260, P4279; WEINBERG RB, 1994, J LIPID RES, V35, P2212; WEINBERG RB, 1990, J BIOL CHEM, V265, P8081; Weinberg RB, 2000, J LIPID RES, V41, P1419; Weinberg RB, 2000, J LIPID RES, V41, P1410; Weinkam P, 2012, P NATL ACAD SCI USA, V109, P4875, DOI 10.1073/pnas.1116274109; Wu ZP, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209130	54	21	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5596	5608		10.1074/jbc.M113.541037	http://dx.doi.org/10.1074/jbc.M113.541037			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24425874	Green Published, hybrid			2022-12-28	WOS:000332015500024
J	Sankella, S; Garg, A; Horton, JD; Agarwal, AK				Sankella, Shireesha; Garg, Abhimanyu; Horton, Jay D.; Agarwal, Anil K.			Hepatic Gluconeogenesis Is Enhanced by Phosphatidic Acid Which Remains Uninhibited by Insulin in Lipodystrophic Agpat2 Mice*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gluconeogenesis; Insulin Resistance; Lipids; Lipodystrophy; Phosphatidic Acid	3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE-1; CONGENITAL GENERALIZED LIPODYSTROPHY; QUANTITATIVE-ANALYSIS; ACYLTRANSFERASE-BETA; NEGATIVE REGULATION; BINDING DOMAIN; PHOSPHORYLATION; PDK1; ACTIVATION; MEMBRANE	Background: Lipodystrophic Agpat2(-/-) mice are severely diabetic and insulin resistant. Results: Livers of Agpat2(-/-) mice have elevated levels of phosphatidic acids (PAs), which enhance gluconeogenesis. Conclusion: PA enhanced hepatic gluconeogenesis contributes to the hyperglycemia present in Agpat2(-/-) mice. Significance: PA enhanced hepatic gluconeogenesis might have wider implications in understanding the development of hyperglycemia in type 2 diabetes. In this study we examined the role of phosphatidic acid (PA) in hepatic glucose production (HGP) and development of hepatic insulin resistance in mice that lack 1-acylglycerol-3-phosphate O-acyltransferase 2 (AGPAT2). Liver lysophosphatidic acid and PA levels were increased approximate to 2- and approximate to 5-fold, respectively, in male Agpat2(-/-) mice compared with wild type mice. In the absence of AGPAT2, the liver can synthesize PAs by activating diacylglycerol kinase or phospholipase D, both of which were elevated in the livers of Agpat2(-/-) mice. We found that PAs C16:0/18:1 and C18:1/20:4 enhanced HGP in primary WT hepatocytes, an effect that was further enhanced in primary hepatocytes from Agpat2(-/-) mice. Lysophosphatidic acids C16:0 and C18:1 failed to increase HGP in primary hepatocytes. The activation of HGP was accompanied by an up-regulation of the key gluconeogenic enzymes glucose-6-phosphatase and phosphoenolpyruvate carboxykinase. This activation was suppressed by insulin in the WT primary hepatocytes but not in the Agpat2(-/-) primary hepatocytes. Thus, the lack of normal insulin signaling in Agpat2(-/-) livers allows unrestricted PA-induced gluconeogenesis significantly contributing to the development of hyperglycemia in these mice.	[Sankella, Shireesha; Garg, Abhimanyu; Agarwal, Anil K.] Univ Texas SW Med Ctr Dallas, Div Nutr & Metab Dis, Dept Internal Med, Dallas, TX 75390 USA; [Sankella, Shireesha; Garg, Abhimanyu; Agarwal, Anil K.] Univ Texas SW Med Ctr Dallas, Ctr Human Nutr, Dallas, TX 75390 USA; [Horton, Jay D.] Univ Texas SW Med Ctr Dallas, Div Digest & Liver Dis, Dallas, TX 75390 USA; [Horton, Jay D.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Horton, Jay D.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Agarwal, AK (corresponding author), Univ Texas SW Med Ctr Dallas, Div Nutr & Metab Dis, Dept Internal Med, Dallas, TX 75390 USA.	Anil.Agarwal@utsouthwestern.edu			National Science Foundation [EPS 0236913, MCB 0455318, 0920663, DBI 0521587]; Kansas Technology Enterprise Corporation; K-IDeA Networks of Bio-medical Research Excellence (INBRE) by National Institute of Health [P20RR16475]; Kansas State University; Div Of Molecular and Cellular Bioscience [0920663] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054387] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Kansas Technology Enterprise Corporation; K-IDeA Networks of Bio-medical Research Excellence (INBRE) by National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas State University; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Katie Tunison M.S. from the University of Texas Southwestern Medical Center for technical assistance and copyediting, Anh Nguyen for assistance with gas chromatography, and Baris Akinci for help with immunoblotting. The mass spectrometry analysis described in this work was performed at the Kansas Lipidomics Research Center Analytical Laboratory. The method of development and instrument acquisition at the Kansas Lipidomics Research Center were supported by National Science Foundation Grants EPS 0236913, MCB 0455318, 0920663 and DBI 0521587, Kansas Technology Enterprise Corporation, K-IDeA Networks of Bio-medical Research Excellence (INBRE) by National Institute of Health Grant P20RR16475, and the Kansas State University.	Agarwal AK, 2003, TRENDS ENDOCRIN MET, V14, P214, DOI 10.1016/S1043-2760(03)00078-X; Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; Agarwal AK, 2012, CURR OPIN LIPIDOL, V23, P290, DOI 10.1097/MOL.0b013e328354fcf4; Agarwal AK, 2011, J BIOL CHEM, V286, P37676, DOI 10.1074/jbc.M111.250449; Alessi DR, 2001, BIOCHEM SOC T, V29, P1, DOI 10.1042/bst029a059; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Arneson LS, 1999, J BIOL CHEM, V274, P17794, DOI 10.1074/jbc.274.25.17794; Baker DL, 2001, ANAL BIOCHEM, V292, P287, DOI 10.1006/abio.2001.5063; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; BECART J, 1990, HRC-J HIGH RES CHROM, V13, P126; Camargo DCR, 2012, BIOCHEMISTRY-US, V51, P4909, DOI 10.1021/bi3002133; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Finley L. W., 2013, CELL METAB, V17; Gale SE, 2006, J BIOL CHEM, V281, P11082, DOI 10.1074/jbc.M509612200; Garg A, 2011, J CLIN ENDOCR METAB, V96, P3313, DOI 10.1210/jc.2011-1159; HENRY RA, 1995, AM J PHYSIOL-CELL PH, V269, pC349, DOI 10.1152/ajpcell.1995.269.2.C349; Hollenback D, 2006, J LIPID RES, V47, P593, DOI 10.1194/jlr.M500435-JLR200; Jones JA, 2005, BIOCHEMISTRY-US, V44, P13235, DOI 10.1021/bi0505159; LEPAGE G, 1986, J LIPID RES, V27, P114; LIMATOLA C, 1994, BIOCHEM J, V304, P1001, DOI 10.1042/bj3041001; Martelli AM, 2000, CANCER RES, V60, P815; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; MORITZ A, 1992, J BIOL CHEM, V267, P7207; Potting C, 2013, CELL METAB, V18, P287, DOI 10.1016/j.cmet.2013.07.008; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Ryu D, 2009, CELL METAB, V9, P240, DOI 10.1016/j.cmet.2009.01.007; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Seong HA, 2012, J BIOL CHEM, V287, P20811, DOI 10.1074/jbc.M111.331827; Seong HA, 2010, J BIOL CHEM, V285, P2397, DOI 10.1074/jbc.M109.064295; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Shin JJH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-85; Springett GM, 2005, CANCER RES, V65, P9415, DOI 10.1158/0008-5472.CAN-05-0516; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Vantyghem MC, 2012, ANN ENDOCRINOL-PARIS, V73, P170, DOI 10.1016/j.ando.2012.04.010; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Wu XD, 2012, ARTERIOSCL THROM VAS, V32, P1236, DOI 10.1161/ATVBAHA.111.244525; Yoon MS, 2011, J BIOL CHEM, V286, P29568, DOI 10.1074/jbc.M111.262816; Zhang CB, 2012, P NATL ACAD SCI USA, V109, P1667, DOI 10.1073/pnas.1110730109	45	10	11	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4762	4777		10.1074/jbc.M113.530998	http://dx.doi.org/10.1074/jbc.M113.530998			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24425876	Green Published, hybrid			2022-12-28	WOS:000331607900023
J	Herva, ME; Zibaee, S; Fraser, G; Barker, RA; Goedert, M; Spillantini, MG				Herva, Maria Eugenia; Zibaee, Shahin; Fraser, Graham; Barker, Roger A.; Goedert, Michel; Spillantini, Maria Grazia			Anti-amyloid Compounds Inhibit alpha- Synuclein Aggregation Induced by Protein Misfolding Cyclic Amplification ( PMCA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-Synuclein; Amyloid; Cell Therapy; Drug Screening; Protein Aggregation; PMCA	TO-NEURON TRANSMISSION; PARKINSONS-DISEASE; PRION PROTEIN; CONGO RED; LEWY BODIES; FIBRILS; INCLUSIONS; SCRAPIE; BETA; FLUORESCENCE	Background: -Synuclein filaments can be formed in vitro, but the process is slow and unreliable, unsuitable for high throughput screening. Results: Protein misfolding cyclic amplification (PMCA) rapidly assembles -synuclein into filaments that form aggregates in cell culture and whose formation is inhibited by anti-amyloid compounds. Conclusion: Anti-amyloid compounds affect PMCA cell-transmissible -synuclein fibril formation. Significance: -Synuclein PMCA is useful for the screening of anti-aggregation compounds as treatments for -synucleinopathies. Filaments made of -synuclein form the characteristic Lewy pathology in Parkinson and other diseases. The formation of -synuclein filaments can be reproduced in vitro by incubation of recombinant protein, but the filament growth is very slow and highly variable and so unsuitable for fast high throughput anti-aggregation drug screening. To overcome this obstacle we have investigated whether the protein misfolding cyclic amplification (PMCA) technique, used for fast amplification of prion protein aggregates, could be adapted for growing -synuclein aggregates and thus suitable for screening of drugs to affect -synuclein aggregation for the treatment of the yet incurable -synucleinopathies. Circular dichroism, electron microscopy, and native and SDS-polyacrylamide gels were used to demonstrate -synuclein aggregate formation by PMCA, and the strain imprint of the -synuclein fibrils was studied by proteinase K digestion. We also demonstrated that -synuclein fibrils are able to seed new -synuclein PMCA reactions and to enter and aggregate in cells in culture. In particular, we have generated a line of chronically infected cells, which transmit -synuclein aggregates even after multiple passages. To evaluate the sensitivity of the PMCA system as an -synuclein anti-aggregating drug screening assay a panel of 10 drugs was tested. Anti-amyloid compounds proved efficient in inhibiting -synuclein fibril formation induced by PMCA. Our results show that -synuclein PMCA is a fast and reproducible system that could be used as a high throughput screening method for finding new -synuclein anti-aggregating compounds.	[Herva, Maria Eugenia; Barker, Roger A.; Spillantini, Maria Grazia] John Van Geest Ctr Brain Repair, Cambridge CB2 0PY, England; [Zibaee, Shahin; Fraser, Graham; Goedert, Michel] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Spillantini, MG (corresponding author), John Van Geest Brain Repair Ctr, Forvie Site,Robinson Way, Cambridge CB2 0PY, England.	mgs11@cam.ac.uk	zibaee, shahin/AAK-9497-2021	Barker, Roger Alistair/0000-0001-8843-7730	Parkinson's UK; UK Medical Research Council; NC3Rs fellowship; Parkinson&quot;s UK [G-1102, K-1012] Funding Source: researchfish	Parkinson's UK(Parkinson's UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NC3Rs fellowship; Parkinson&quot;s UK(Parkinson&apos;s UK)	This work was supported by a grant from the Parkinson's UK (to R. A. B., M. G. S., and M. E. H.) and by funding from the UK Medical Research Council (to M. G., S. Z., and G. F.).; Recipient of a NC3Rs fellowship. To whom the correspondence may be addressed: John Van Geest Brain Repair Centre, Forvie Site, Robinson way, Cambridge CB2 0PY, UK. E-mail: meh67@cam.ac.uk.	Ahn JS, 2007, ANAL BIOCHEM, V367, P259, DOI 10.1016/j.ab.2007.05.023; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Campioni S, 2014, J AM CHEM SOC, V136, P2866, DOI 10.1021/ja412105t; Caruana M, 2011, FEBS LETT, V585, P1113, DOI 10.1016/j.febslet.2011.03.046; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; El-Agnaf OMA, 1998, FEBS LETT, V440, P67, DOI 10.1016/S0014-5793(98)01419-7; Freundt EC, 2012, ANN NEUROL, V72, P517, DOI 10.1002/ana.23747; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Grelle G, 2011, BIOCHEMISTRY-US, V50, P10624, DOI 10.1021/bi2012383; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Hirohata M, 2008, CURR PHARM DESIGN, V14, P3280, DOI 10.2174/138161208786404173; Houlden H, 2012, ACTA NEUROPATHOL, V124, P325, DOI 10.1007/s00401-012-1013-5; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jakes R, 1999, NEUROSCI LETT, V269, P13, DOI 10.1016/S0304-3940(99)00411-5; Lendel C, 2009, BIOCHEMISTRY-US, V48, P8322, DOI 10.1021/bi901285x; Locke CJ, 2008, NEUROSCI LETT, V439, P129, DOI 10.1016/j.neulet.2008.05.003; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Maltsev AS, 2012, BIOCHEMISTRY-US, V51, P631, DOI 10.1021/bi201435d; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; O'Hare E, 2010, BEHAV BRAIN RES, V208, P274, DOI 10.1016/j.bbr.2009.11.027; Ono K, 2007, J NEUROSCI RES, V85, P1547, DOI 10.1002/jnr.21271; Pandey N, 2008, ACTA NEUROPATHOL, V115, P479, DOI 10.1007/s00401-007-0332-4; Pienaar IS, 2012, MOL NEUROBIOL, V45, P126, DOI 10.1007/s12035-011-8226-9; Pinotsi D, 2013, CHEMBIOCHEM, V14, P846, DOI 10.1002/cbic.201300103; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Rees K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008454.pub2; Roostaee A, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-5; Rudyk H, 2000, J GEN VIROL, V81, P1155, DOI 10.1099/0022-1317-81-4-1155; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sahay S, 2014, BIOCHEMISTRY-US, V53, P807, DOI 10.1021/bi401543z; Samii A, 2009, DRUG AGING, V26, P769, DOI 10.2165/11316780-000000000-00000; Singleton AB, 2013, MOVEMENT DISORD, V28, P14, DOI 10.1002/mds.25249; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Uversky VN, 2009, CURR PROTEIN PEPT SC, V10, P483, DOI 10.2174/138920309789351921; Vekrellis K, 2011, LANCET NEUROL, V10, P1041, DOI 10.1016/S1474-4422(11)70213-7; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Yamin G, 2005, BIOCHEMISTRY-US, V44, P9096, DOI 10.1021/bi048778a	43	62	68	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11897	11905		10.1074/jbc.M113.542340	http://dx.doi.org/10.1074/jbc.M113.542340			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24584936	hybrid, Green Published			2022-12-28	WOS:000335010600030
J	Bullen, JW; Balsbaugh, JL; Chanda, D; Shabanowitz, J; Hunt, DF; Neumann, D; Hart, GW				Bullen, John W.; Balsbaugh, Jeremy L.; Chanda, Dipanjan; Shabanowitz, Jeffrey; Hunt, Donald F.; Neumann, Dietbert; Hart, Gerald W.			Cross-talk between Two Essential Nutrient-sensitive Enzymes O-GlcNAc TRANSFERASE ( OGT) AND AMP-ACTIVATED PROTEIN KINASE ( AMPK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated Kinase (AMPK); Histones; Nuclear Translocation; O-GlcNAc; O-GlcNAcylation; Skeletal Muscle; O-GlcNAc Transferase; Nutrient Sensing	MASS-SPECTROMETRY; PHOSPHORYLATION; GLCNACYLATION; GLYCOSYLATION; COEXPRESSION; METABOLISM; INHIBITOR; MECHANISM; DYNAMICS; INSIGHTS	Background: OGT and AMPK collectively target hundreds of intracellular signaling processes, but no study has addressed whether they regulate each other. Results: AMPK activity mediates the substrate selectivity of OGT, and O-GlcNAcylation modulates the activity of AMPK. Conclusion: There is significant cross-talk between the O-GlcNAc and AMPK systems. Significance: OGT and AMPK may synergistically regulate numerous nutrient-sensitive processes essential for life. Nutrient-sensitive pathways regulate both O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK), cooperatively connecting metabolic homeostasis to regulation of numerous intracellular processes essential for life. Similar to phosphorylation, catalyzed by kinases such as AMPK, O-GlcNAcylation is a highly dynamic Ser/Thr-specific post-translational modification of nuclear, cytoplasmic, and mitochondrial proteins catalyzed exclusively by OGT. OGT and AMPK target a multitude of intracellular proteins, with the net effect to protect cells from the damaging effects of metabolic stress. Despite hundreds of studies demonstrating significant overlap in upstream and downstream signaling processes, no study has investigated if OGT and AMPK can directly regulate each other. We show acute activation of AMPK alters the substrate selectivity of OGT in several cell lines and nuclear localization of OGT in C2C12 skeletal muscle myotubes. Nuclear localization of OGT affects O-GlcNAcylation of numerous nuclear proteins and acetylation of Lys-9 on histone 3 in myotubes. AMPK phosphorylates Thr-444 on OGT in vitro; phosphorylation of Thr-444 is tightly associated with AMPK activity and nuclear localization of OGT in myotubes, and phospho-mimetic T444E-OGT exhibits altered substrate selectivity. Conversely, the - and -subunits of AMPK are O-GlcNAcylated, O-GlcNAcylation of the 1-subunit increases with AMPK activity, and acute inhibition of O-GlcNAc cycling disrupts activation of AMPK. We have demonstrated significant cross-talk between the O-GlcNAc and AMPK systems, suggesting OGT and AMPK may cooperatively regulate nutrient-sensitive intracellular processes that mediate cellular metabolism, growth, proliferation, and/or tissue function.	[Bullen, John W.; Hart, Gerald W.] Johns Hopkins Univ Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Balsbaugh, Jeremy L.; Shabanowitz, Jeffrey; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [Hunt, Donald F.] Univ Virginia, Dept Pathol, Charlottesville, VA 22904 USA; [Chanda, Dipanjan; Neumann, Dietbert] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands	Johns Hopkins University; University of Virginia; University of Virginia; Maastricht University	Hart, GW (corresponding author), Johns Hopkins Univ Sch Med, Dept Biol Chem, 725 North Wolfe St, Baltimore, MD 21205 USA.	gwhart@jhmi.edu	Chanda, Dipanjan/AAU-3996-2021	Chanda, Dipanjan/0000-0003-0685-187X; Hart, Gerald/0000-0001-7812-4351; Neumann, Dietbert/0000-0002-4316-684X; BALSBAUGH, JEREMY/0000-0002-1852-8749	National Institutes of Health [R01CA42486, R01DK61671, GM037537, N01-HV-00240, P01HL107153, R24DK084949]; Netherlands Organization for Scientific Research VIDI Grant [864.10.007]; Patrick C. Walsh Prostate Cancer Research Fund; NATIONAL CANCER INSTITUTE [R01CA042486] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK084949, R01DK061671, P30DK079637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research VIDI Grant; Patrick C. Walsh Prostate Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or in part, by National Institutes of Health Grants R01CA42486, R01DK61671, GM037537; N01-HV-00240; P01HL107153, R24DK084949, The Netherlands Organization for Scientific Research VIDI Grant (864.10.007), and the Patrick C. Walsh Prostate Cancer Research Fund.	Akimoto Y, 2003, BRAIN RES, V966, P194, DOI 10.1016/S0006-8993(02)04158-6; Chatham JC, 2008, SHOCK, V29, P431, DOI 10.1097/SHK.0b013e3181598bad; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Copeland RJ, 2008, AM J PHYSIOL-ENDOC M, V295, pE17, DOI 10.1152/ajpendo.90281.2008; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Graham DRM, 2005, PROTEOMICS, V5, P2309, DOI 10.1002/pmic.200401249; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; Hall EH, 2010, MOL CELL PROTEOMICS, V9, P2853, DOI 10.1074/mcp.M110.003665; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2000, METH MOL B, V99, P63; Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Kuhajda FP, 2008, INT J OBESITY, V32, pS36, DOI 10.1038/ijo.2008.121; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Li X, 2009, J BIOL CHEM, V284, P19248, DOI 10.1074/jbc.M109.005678; Mcgee SL, 2008, DIABETES, V57, P860, DOI 10.2337/db07-0843; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Neumann D, 2007, MOL BIOTECHNOL, V36, P220, DOI 10.1007/s12033-007-0029-x; Ramirez-Correa GA, 2008, CIRC RES, V103, P1354, DOI 10.1161/CIRCRESAHA.108.184978; Sakabe K, 2010, J BIOL CHEM, V285, P34460, DOI 10.1074/jbc.M110.158170; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Shen DL, 2012, J BIOL CHEM, V287, P15395, DOI 10.1074/jbc.M111.310664; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Udeshi ND, 2008, NAT PROTOC, V3, P1709, DOI 10.1038/nprot.2008.159; Whelan SA, 2008, J BIOL CHEM, V283, P21411, DOI 10.1074/jbc.M800677200; Whitworth GE, 2007, J AM CHEM SOC, V129, P635, DOI 10.1021/ja065697o; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zeidan Q, 2010, MOL BIOL CELL, V21, P1922, DOI 10.1091/mbc.E09-11-0941	32	119	120	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10592	10606		10.1074/jbc.M113.523068	http://dx.doi.org/10.1074/jbc.M113.523068			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24563466	hybrid, Green Published			2022-12-28	WOS:000334226400031
J	Stribl, C; Samara, A; Trumbach, D; Peis, R; Neumann, M; Fuchs, H; Gailus-Durner, V; Hrabe de Angelis, M; Rathkolb, B; Wolf, E; Beckers, J; Horsch, M; Neff, F; Kremmer, E; Koob, S; Reichert, AS; Hans, W; Rozman, J; Klingenspor, M; Aichler, M; Walch, AK; Becker, L; Klopstock, T; Glasl, L; Holter, SM; Wurst, W; Floss, T				Stribl, Carola; Samara, Aladin; Truembach, Dietrich; Peis, Regina; Neumann, Manuela; Fuchs, Helmut; Gailus-Durner, Valerie; Hrabe de Angelis, Martin; Rathkolb, Birgit; Wolf, Eckhard; Beckers, Johannes; Horsch, Marion; Neff, Frauke; Kremmer, Elisabeth; Koob, Sebastian; Reichert, Andreas S.; Hans, Wolfgang; Rozman, Jan; Klingenspor, Martin; Aichler, Michaela; Walch, Axel Karl; Becker, Lore; Klopstock, Thomas; Glasl, Lisa; Hoelter, Sabine M.; Wurst, Wolfgang; Floss, Thomas			Mitochondrial Dysfunction and Decrease in Body Weight of a Transgenic Knock-in Mouse Model for TDP-43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease); Mitochondrial Metabolism; Mouse Genetics; Mutagenesis Site-specific; Neurological Diseases	AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; BINDING PROTEIN 43; GENE-EXPRESSION; RNA TARGETS; SPLICING REGULATION; ALZHEIMER-DISEASE; DROSOPHILA MODEL; STRESS GRANULES; MOTOR DEFICITS	Background: Mutations in TDP-43 are frequently found in ALS patients. Results: A315T TDP-43 protein is elevated from this transgenic knock-in allele due to disturbed feedback regulation. Conclusion: Elevation of A315T TDP-43 was insufficient to cause ALS in this mutant. Significance: This TDP-43 allele could be valuable in determining genetic or environmental factors that cause full-blown FTLD or ALS. The majority of amyotrophic lateral sclerosis (ALS) cases as well as many patients suffering from frontotemporal lobar dementia (FTLD) with ubiquitinated inclusion bodies show TDP-43 pathology, the protein encoded by the TAR DNA-binding protein (Tardbp) gene. We used recombinase-mediated cassette exchange to introduce an ALS patient cDNA into the mouse Tdp-43 locus. Expression levels of human A315T TDP-43 protein were 300% elevated in heterozygotes, whereas the endogenous mouse Tdp-43 was decreased to 20% of wild type levels as a result of disturbed feedback regulation. Heterozygous TDP-43(A315TKi) mutants lost 10% of their body weight and developed insoluble TDP-43 protein starting as early as 3 months after birth, a pathology that was exacerbated with age. We analyzed the splicing patterns of known Tdp-43 target genes as well as genome-wide gene expression levels in different tissues that indicated mitochondrial dysfunction. In heterozygous mutant animals, we observed a relative decrease in expression of Parkin (Park2) and the fatty acid transporter CD36 along with an increase in fatty acids, HDL cholesterol, and glucose in the blood. As seen in transmission electron microscopy, neuronal cells in motor cortices of TDP-43(A315TKi) animals had abnormal neuronal mitochondrial cristae formation. Motor neurons were reduced to 90%, but only slight motoric impairment was detected. The observed phenotype was interpreted as a predisease model, which might be valuable for the identification of further environmental or genetic triggers of neurodegeneration.	[Stribl, Carola; Samara, Aladin; Truembach, Dietrich; Peis, Regina; Glasl, Lisa; Hoelter, Sabine M.; Wurst, Wolfgang; Floss, Thomas] Helmholtz Zentrum Munchen, Inst Dev Genet, D-85764 Neuherberg, Germany; [Neumann, Manuela] Inst Neuropathol, CH-8091 Zurich, Switzerland; [Fuchs, Helmut; Gailus-Durner, Valerie; Hrabe de Angelis, Martin; Rathkolb, Birgit; Beckers, Johannes; Horsch, Marion; Hans, Wolfgang; Rozman, Jan; Becker, Lore] Helmholtz Zentrum Munchen, Inst Expt Genet, German Mouse Clin, D-85764 Neuherberg, Germany; [Rathkolb, Birgit; Wolf, Eckhard] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Neff, Frauke] Helmholtz Zentrum Munchen, Inst Pathol, German Mouse Clin, D-85764 Neuherberg, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Helmholtz Inst Mol Immunol IMI, D-85764 Neuherberg, Germany; [Hrabe de Angelis, Martin; Beckers, Johannes; Hoelter, Sabine M.; Wurst, Wolfgang; Floss, Thomas] Tech Univ Munich, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany; [Koob, Sebastian; Reichert, Andreas S.] Buchmann Inst Mol Life Sci, D-60438 Frankfurt, Germany; [Koob, Sebastian; Reichert, Andreas S.] Goethe Univ Frankfurt, Zentrum Mol Med, D-60590 Frankfurt, Germany; [Klopstock, Thomas; Wurst, Wolfgang] Deutsch Zentrum Neurodegenerat Erkrankungen eV DZ, D-80336 Munich, Germany; [Wurst, Wolfgang] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Hans, Wolfgang; Rozman, Jan; Klingenspor, Martin] Tech Univ Munich, Else Kroner Fresenius Ctr, D-85350 Freising Weihenstephan, Germany; [Hans, Wolfgang; Rozman, Jan; Klingenspor, Martin] Tech Univ Munich, ZIEL Res Ctr Nutr & Food Sci, D-85350 Freising Weihenstephan, Germany; [Aichler, Michaela; Walch, Axel Karl; Klopstock, Thomas] Helmholtz Zentrum Munchen, Inst Pathol, Res Unit Analyt Pathol, D-85764 Neuherberg, Germany; [Becker, Lore; Klopstock, Thomas] Univ Munich, Friedrich Baur Inst, Dept Neurol, D-80336 Munich, Germany; [Hrabe de Angelis, Martin] Univ Munich, German Ctr Vertigo & Balance Disorders, D-80336 Munich, Germany; [Reichert, Andreas S.] Goethe Univ Frankfurt, Zentrum Mol Med, D-60438 Frankfurt, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Goethe University Frankfurt; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Max Planck Society; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Goethe University Frankfurt	Floss, T (corresponding author), Helmholtz Zentrum Munchen, Inst Dev Genet, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	tfloss@helmholtz-muenchen.de	Gailus-Durner, Valerie/M-7337-2014; Klingenspor, Martin/D-6930-2011; Walch, Axel/B-4554-2012; Becker, Lore/E-3717-2010; Klingenspor, Martin/K-5033-2019; Aichler, Michaela/B-5356-2014; Becker, Lore/AAJ-1203-2020; Hölter, Sabine M./N-5868-2014; de Angelis, Martin Hrabe/F-5531-2012; Rozman, Jan/A-2540-2010; Neumann, Manuela/F-6558-2011; Beckers, Johannes/K-7237-2012; Fuchs, Helmut/M-7347-2014; Reichert, Andreas/A-4090-2012	Klingenspor, Martin/0000-0002-4502-6664; Walch, Axel/0000-0001-5578-4023; Becker, Lore/0000-0002-6890-4984; Hölter, Sabine M./0000-0003-4878-5241; de Angelis, Martin Hrabe/0000-0002-7898-2353; Rozman, Jan/0000-0002-8035-8904; Neumann, Manuela/0000-0002-6232-4057; Beckers, Johannes/0000-0001-7874-3822; Fuchs, Helmut/0000-0002-5143-2677; Reichert, Andreas/0000-0001-9340-3113; Wolf, Eckhard/0000-0002-0430-9510; Wurst, Wolfgang/0000-0003-4422-7410	KNDD2 Grant [FKZ 01 GI 1005D]; Federal Ministry for Education and Research (BMBF) [01GS08133]; grant "Verhalten" [01GS0850]; Helmholtz Alliance "Mental Health in an Aging Society" (HELMA) [HA215]; Cluster of Excellence Frankfurt Macromolecular Complexes at the Goethe University Frankfurt DFG [EXC 115]; German Federal Ministry of Education and Research (BMBF); German Center for Diabetes Research (DZD e.V.); NGFN plus [01GS0850]; BMBF [01KX1012]; EU [EUMODIC LSHG-2006-037188]; National Genome Research Network [NGFN 01GR]; German Federal Ministry of Education and Research (German Center for Vertigo and Balance Disorders) [01 EO 0901]	KNDD2 Grant; Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); grant "Verhalten"; Helmholtz Alliance "Mental Health in an Aging Society" (HELMA); Cluster of Excellence Frankfurt Macromolecular Complexes at the Goethe University Frankfurt DFG(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Center for Diabetes Research (DZD e.V.); NGFN plus; BMBF(Federal Ministry of Education & Research (BMBF)); EU(European Commission); National Genome Research Network; German Federal Ministry of Education and Research (German Center for Vertigo and Balance Disorders)	This work was supported by KNDD2 Grant FKZ 01 GI 1005D (to T. F.). This work was also supported by the program for medical genome research with financial support from the Federal Ministry for Education and Research (BMBF) grant "Funktionelle Tiermodelle fur die Kandidatengene der Alzheimerschen Erkrankung" (01GS08133), the grant "Verhalten" (01GS0850), and furthermore by the Helmholtz Alliance "Mental Health in an Aging Society" (HELMA) (HA215). This work was supported by the Cluster of Excellence Frankfurt Macromolecular Complexes at the Goethe University Frankfurt DFG project EXC 115(to A. R. and S. K.). This study was also supported in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). The German Mouse Clinic was supported by NGFN plus Grant 01GS0850 and Infrafrontier Grant 01KX1012 from the BMBF and the EU (EUMODIC LSHG-2006-037188). This work was also supported by grants from the National Genome Research Network (NGFN 01GR) (to J. B.). This project was also supported by funds from the German Federal Ministry of Education and Research (German Center for Vertigo and Balance Disorders Grant 01 EO 0901).	Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Augustin Regina, 2011, Int J Alzheimers Dis, V2011, P154325, DOI 10.4061/2011/154325; Avendano-Vazquez SE, 2012, GENE DEV, V26, P1679, DOI 10.1101/gad.194829.112; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bonini NM, 2011, J MOL NEUROSCI, V45, P676, DOI 10.1007/s12031-011-9548-9; Budini M, 2011, J MOL NEUROSCI, V45, P473, DOI 10.1007/s12031-011-9573-8; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Caccamo A, 2012, AM J PATHOL, V180, P293, DOI 10.1016/j.ajpath.2011.09.022; Cannon A, 2012, ACTA NEUROPATHOL, V123, P807, DOI 10.1007/s00401-012-0979-3; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; Chen-Plotkin AS, 2008, HUM MOL GENET, V17, P1349, DOI 10.1093/hmg/ddn023; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Chiang PM, 2010, P NATL ACAD SCI USA, V107, P16320, DOI 10.1073/pnas.1002176107; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Dance A, 2010, J ALZHEIMERS DIS, V21, P1403, DOI 10.3233/JAD-2010-101543; Dewey CM, 2012, BRAIN RES, V1462, P16, DOI 10.1016/j.brainres.2012.02.032; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Dorst J, 2011, J NEUROL, V258, P613, DOI 10.1007/s00415-010-5805-z; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Estes PS, 2011, HUM MOL GENET, V20, P2308, DOI 10.1093/hmg/ddr124; Fergani A, 2007, J LIPID RES, V48, P1571, DOI 10.1194/jlr.M700017-JLR200; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Gendron TF, 2010, NEUROPATH APPL NEURO, V36, P97, DOI [10.1111/j.1365-2990.2009.01060.x, 10.1111/j.1365-2990.2010.01060.x]; Gendron TF, 2011, J MOL NEUROSCI, V45, P486, DOI 10.1007/s12031-011-9610-7; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Gitcho MA, 2009, ACTA NEUROPATHOL, V118, P633, DOI 10.1007/s00401-009-0571-7; Herman AM, 2011, BRAIN RES, V1386, P191, DOI 10.1016/j.brainres.2011.02.052; HILL DP, 1993, METHOD ENZYMOL, V225, P664; Hirano K, 2003, TRENDS CARDIOVAS MED, V13, P136, DOI 10.1016/S1050-1738(03)00026-4; Holter SM, 2011, NEUROMETHODS, V61, P109, DOI 10.1007/978-1-61779-298-4_7; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Huang C, 2012, J CLIN INVEST, V122, P107, DOI 10.1172/JCI59130; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Janssens J, 2011, BIOCHEM SOC T, V39, P954, DOI 10.1042/BST0390954; Jellinger KA, 2008, NEURODEGENER DIS, V5, P118, DOI 10.1159/000113679; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kametani F, 2009, BIOCHEM BIOPH RES CO, V382, P405, DOI 10.1016/j.bbrc.2009.03.038; Kawahara Y, 2012, P NATL ACAD SCI USA, V109, P3347, DOI 10.1073/pnas.1112427109; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kim KY, 2011, J CLIN INVEST, V121, P3701, DOI 10.1172/JCI44736; Klinkenberg M, 2012, NEUROGENETICS, V13, P9, DOI 10.1007/s10048-011-0303-8; Kraemer BC, 2010, ACTA NEUROPATHOL, V119, P409, DOI 10.1007/s00401-010-0659-0; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Li M, 1998, CURR BIOL, V8, P971, DOI 10.1016/S0960-9822(98)70399-9; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Lillo P, 2009, J CLIN NEUROSCI, V16, P1131, DOI 10.1016/j.jocn.2009.03.005; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Mandillo S, 2008, PHYSIOL GENOMICS, V34, P243, DOI 10.1152/physiolgenomics.90207.2008; Meyre D, 2008, HUM MOL GENET, V17, P1798, DOI 10.1093/hmg/ddn070; Mishra M, 2007, ACTA NEUROPATHOL, V114, P81, DOI 10.1007/s00401-007-0240-7; Miyaoka K, 2001, LANCET, V357, P686, DOI 10.1016/S0140-6736(00)04138-6; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Polymenidou M, 2012, BRAIN RES, V1462, P3, DOI 10.1016/j.brainres.2012.02.059; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Schebelle L, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq044; Sephton CF, 2011, J BIOL CHEM, V286, P1204, DOI 10.1074/jbc.M110.190884; Sephton CF, 2010, J BIOL CHEM, V285, P6826, DOI 10.1074/jbc.M109.061846; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; Stallings NR, 2010, NEUROBIOL DIS, V40, P404, DOI 10.1016/j.nbd.2010.06.017; Stone S, 2006, HUM MOL GENET, V15, P2709, DOI 10.1093/hmg/ddl204; Subramanian A, 2000, J BIOL CHEM, V275, P5958, DOI 10.1074/jbc.275.8.5958; Suzuki H, 2012, J NEUROSCI RES, V90, P641, DOI 10.1002/jnr.22777; Swarup V, 2011, J EXP MED, V208, P2429, DOI 10.1084/jem.20111313; Takahashi M, 2007, ADV EXP MED BIOL, V598, P93; Teusink B, 2003, DIABETES, V52, P614, DOI 10.2337/diabetes.52.3.614; Ticozzi N, 2010, CNS NEUROL DISORD-DR, V9, P285, DOI 10.2174/187152710791292585; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Tsai KJ, 2010, J EXP MED, V207, P1661, DOI 10.1084/jem.20092164; Tsao W, 2012, BRAIN RES, V1462, P26, DOI 10.1016/j.brainres.2012.04.031; Turner BJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-104; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wang IF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1766; Wang Q, 2011, NEURODEGENER DIS, V8, P310, DOI 10.1159/000323469; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Weihl CC, 2008, J NEUROL NEUROSUR PS, V79, P1186, DOI 10.1136/jnnp.2007.131334; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107; Wilson AC, 2011, INT J CLIN EXP PATHO, V4, P147; Wu LS, 2010, GENESIS, V48, P56, DOI 10.1002/dvg.20584; Xiao SX, 2011, MOL CELL NEUROSCI, V47, P167, DOI 10.1016/j.mcn.2011.02.013; Xu YF, 2010, J NEUROSCI, V30, P10851, DOI 10.1523/JNEUROSCI.1630-10.2010; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zhang YJ, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-33; Zhou X, 2007, BIOINFORMATICS, V23, P1106, DOI 10.1093/bioinformatics/btm036	97	74	74	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10769	10784		10.1074/jbc.M113.515940	http://dx.doi.org/10.1074/jbc.M113.515940			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24515116	Green Published, hybrid			2022-12-28	WOS:000334226400046
J	Xu, XY; Nie, Y; Wang, FF; Bai, Y; Lv, ZZ; Zhang, YY; Li, ZJ; Gao, W				Xu, Xin-ye; Nie, Ying; Wang, Fang-fang; Bai, Yan; Lv, Zhi-zhen; Zhang, You-yi; Li, Zi-jian; Gao, Wei			Growth Differentiation Factor (GDF)-15 Blocks Norepinephrineinduced Myocardial Hypertrophy via a Novel Pathway Involving Inhibition of Epidermal Growth Factor Receptor Transactivation*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cardiac Hypertrophy; Cell Signaling; Epidermal Growth Factor Receptor (EGFR); Growth Factors; Hypertension; Growth Differentiation Factor 15; Norepinephrine; Transactivation	SYMPATHETIC-NERVOUS-SYSTEM; CHRONIC HEART-FAILURE; MOLECULAR-MECHANISMS; DISEASE SEVERITY; MEMBER; EGFR; HYPERTENSION; ASSOCIATION; ACTIVATION; SURVIVAL	Background: The effect of GDF-15 on the regulation of cardiac remodeling is poorly understood. Results: GDF-15 inhibits norepinephrine induced EGF receptor transactivation and associated hypertrophy and positively associates with myocardial hypertrophy of hypertension patients. Conclusion: GDF-15 blocks norepinephrine-induced myocardial hypertrophy via a novel pathway involving inhibition of EGF receptor transactivation. Significance: We indicate a negative feedback mechanism of GDF-15 in regulating catecholamine-induced cardiac remodeling. Accumulating evidence suggests that growth differentiation factor 15 (GDF-15) is associated with the severity and prognosis of various cardiovascular diseases. However, the effect of GDF-15 on the regulation of cardiac remodeling is still poorly understood. In this present study, we demonstrate that GDF-15 blocks norepinephrine (NE)-induced myocardial hypertrophy through a novel pathway involving inhibition of EGFR transactivation. Both in vivo and in vitro assay indicate that NE was able to stimulate the synthesis of GDF-15. The up-regulation of GDF-15 feedback inhibits NE-induced myocardial hypertrophy, including quantitation of [H-3]leucine incorporation, protein/DNA ratio, cell surface area, and ANP mRNA level. Further research shows that GDF-15 could inhibit the phosphorylation of EGF receptor and downstream kinases (AKT and ERK1/2) induced by NE. Clinical research also shows that serum GDF-15 levels in hypertensive patients were significant higher than in healthy volunteers and were positively correlated with the thickness of the posterior wall of the left ventricle, interventricular septum, and left ventricular mass, as well as the serum level of norepinephrine. In conclusion, NE induces myocardial hypertrophy and up-regulates GDF-15, and this up-regulation of GDF-15 negatively regulates NE-induced myocardial hypertrophy by inhibiting EGF receptor transactivation following NE stimulation.	[Li, Zi-jian] Peking Univ, Dept Cardiol, Hosp 3, Beijing 100191, Peoples R China; Minist Educ, Key Lab Cardiovasc Mol Biol & Regulatory Peptides, Minist Hlth, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China; Beijing Key Lab Cardiovasic Receptors Res, Beijing 100191, Peoples R China	Peking University	Li, ZJ (corresponding author), Peking Univ, Dept Cardiol, Hosp 3, Beijing 100191, Peoples R China.	lizijian@bjmu.edu.cn; weigao@bjmu.edu.cn	wang, fang/GYD-4295-2022		Key Construction Program of the National 985 Project [PUCRP-004]; National Natural Science Foundation of China [30910103902, 81270157, 81070078, 81121061]; 973 Program of the Major State Basic Research Development Program of China [2011CB503903]; Beijing Municipal Natural Science Foundation [7102158]	Key Construction Program of the National 985 Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program of the Major State Basic Research Development Program of China(National Basic Research Program of China); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by Grant PUCRP-004 from the Key Construction Program of the National 985 Project, National Natural Science Foundation of China Grants 30910103902, 81270157, 81070078, and 81121061, Grant from the 973 Program of the Major State Basic Research Development Program of China 2011CB503903, and Beijing Municipal Natural Science Foundation Grant 7102158.	Anand IS, 2010, CIRCULATION, V122, P1387, DOI 10.1161/CIRCULATIONAHA.109.928846; Bjornstad JL, 2008, EUR J HEART FAIL, V10, P1201, DOI 10.1016/j.ejheart.2008.09.010; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Cacciapuoti F, 2011, J AM SOC HYPERTENS, V5, P449, DOI 10.1016/j.jash.2011.08.006; Chen ZJ, 2006, J BIOL CHEM, V281, P12414, DOI 10.1074/jbc.M508651200; Dominguez-Rodriguez A, 2011, AM J CARDIOL, V108, P955, DOI 10.1016/j.amjcard.2011.05.028; Eggers KM, 2012, SCAND J CLIN LAB INV, V72, P45, DOI 10.3109/00365513.2011.626072; Eggers KM, 2010, CIRC-CARDIOVASC GENE, V3, P88, DOI 10.1161/CIRCGENETICS.109.877456; Heger J, 2010, J CELL PHYSIOL, V224, P120, DOI 10.1002/jcp.22102; Howes AL, 2006, J MOL CELL CARDIOL, V40, P597, DOI 10.1016/j.yjmcc.2005.12.003; Kempf T, 2006, CIRC RES, V98, P351, DOI 10.1161/01.RES.0000202805.73038.48; Kempf T, 2007, EUR HEART J, V28, P2858, DOI 10.1093/eurheartj/ehm465; Kempf T, 2007, J AM COLL CARDIOL, V50, P1054, DOI 10.1016/j.jacc.2007.04.091; Kempf T, 2007, CLIN CHEM, V53, P284, DOI 10.1373/clinchem.2006.076828; Kempf T, 2011, NAT MED, V17, P581, DOI 10.1038/nm.2354; Khan SQ, 2009, EUR HEART J, V30, P1057, DOI 10.1093/eurheartj/ehn600; LEE SJ, 1990, MOL ENDOCRINOL, V4, P1034, DOI 10.1210/mend-4-7-1034; Li Y, 2011, AM J PHYSIOL-HEART C, V301, pH1941, DOI 10.1152/ajpheart.00338.2011; Lind L, 2009, EUR HEART J, V30, P2346, DOI 10.1093/eurheartj/ehp261; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Montoro-Garcia S, 2012, EUR J INTERN MED, V23, P169, DOI 10.1016/j.ejim.2011.08.022; Muslin AJ, 2008, CLIN SCI, V115, P203, DOI 10.1042/CS20070430; Muslin Anthony J, 2006, Novartis Found Symp, V274, P118; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Parati G, 2012, EUR HEART J, V33, P1058, DOI 10.1093/eurheartj/ehs041; Petzhold D, 2011, J MUSCLE RES CELL M, V32, P243, DOI 10.1007/s10974-011-9259-4; RUSKOAHO H, 1988, CIRC RES, V62, P384, DOI 10.1161/01.RES.62.2.384; Schillaci G, 2011, J CARDIOVASC MED, V12, P609, DOI 10.2459/JCM.0b013e328348d925; Wang FF, 2010, BIOMARKERS, V15, P671, DOI 10.3109/1354750X.2010.510580; Wang XJ, 2010, CLIN SCI, V118, P137, DOI 10.1042/CS20080637; Wollert KC, 2007, CIRCULATION, V115, P962, DOI 10.1161/CIRCULATIONAHA.106.650846; Xu J, 2006, CIRC RES, V98, P342, DOI 10.1161/01.RES.0000202804.84885.d0; Xu XY, 2011, BIOMARKERS, V16, P466, DOI 10.3109/1354750X.2011.580006; Xue Hao, 2012, PLoS One, V7, pe46534, DOI 10.1371/journal.pone.0046534	35	40	45	0	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10084	10094		10.1074/jbc.M113.516278	http://dx.doi.org/10.1074/jbc.M113.516278			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24554716	hybrid, Green Published			2022-12-28	WOS:000333807000055
J	Gui, SY; Gathiaka, S; Li, J; Qu, J; Acevedo, O; Hevel, JM				Gui, Shanying; Gathiaka, Symon; Li, Jun; Qu, Jun; Acevedo, Orlando; Hevel, Joan M.			A Remodeled Protein Arginine Methyltransferase 1 ( PRMT1) Generates Symmetric Dimethylarginine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Computer Modeling; Enzyme Mechanisms; Histone Methylation; Protein Methylation; S-adenosylmethionine (SAM); Site-directed Mutagenesis; Dimethylarginine; Product Specificity; Protein Arginine Methyltransferase	FREE-ENERGY SIMULATIONS; PRODUCT SPECIFICITY; ASYMMETRIC DIMETHYLARGININE; LYSINE METHYLTRANSFERASES; SUBSTRATE-SPECIFICITY; KINETIC MECHANISM; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; METHYLATION; RESIDUES	Background: Asymmetric and symmetric dimethylarginine (ADMA and SDMA) residues are biologically distinct products of protein arginine methyltransferase (PRMT) isoforms. Results: Met-48 in PRMT1 regulates the regiochemistry of dimethylation, and SDMA formation is energetically costly. Conclusion: Steric changes in the PRMT1 active site can reprogram product formation. Significance: SDMA-forming PRMTs may require additional factors to overcome the energetic cost of SDMA. Protein arginine methylation is emerging as a significant post-translational modification involved in various cell processes and human diseases. As the major arginine methylation enzyme, protein arginine methyltransferase 1 (PRMT1) strictly generates monomethylarginine and asymmetric dimethylarginine (ADMA), but not symmetric dimethylarginine (SDMA). The two types of dimethylarginines can lead to distinct biological outputs, as highlighted in the PRMT-dependent epigenetic control of transcription. However, it remains unclear how PRMT1 product specificity is regulated. We discovered that a single amino acid mutation (Met-48 to Phe) in the PRMT1 active site enables PRMT1 to generate both ADMA and SDMA. Due to the limited amount of SDMA formed, we carried out quantum mechanical calculations to determine the free energies of activation of ADMA and SDMA synthesis. Our results indicate that the higher energy barrier of SDMA formation (G(double dagger) = 3.2 kcal/mol as compared with ADMA) may explain the small amount of SDMA generated by M48F-PRMT1. Our study reveals unique energetic challenges for SDMA-forming methyltransferases and highlights the exquisite control of product formation by active site residues in the PRMTs.	[Gui, Shanying; Hevel, Joan M.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA; [Gathiaka, Symon; Acevedo, Orlando] Auburn Univ, Dept Chem & Biochem, Auburn, AL 36849 USA; [Li, Jun; Qu, Jun] SUNY Buffalo, Dept Pharmaceut Sci, Amherst, NY 14260 USA	Utah System of Higher Education; Utah State University; Auburn University System; Auburn University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Hevel, JM (corresponding author), Utah State Univ, Dept Chem & Biochem, 0300 Old Main Hill, Logan, UT 84322 USA.	Joanie.Hevel@usu.edu	Gui, Shanying/AAM-8633-2021; Li, Jun/N-3806-2014	Li, Jun/0000-0001-9940-3421; Hevel, Joan/0000-0002-9559-4635	National Science Foundation [0920776]; American Recovery and Reinvestment Act; Auburn University; Alabama Supercomputer Center; National Institutes of Health [U54HD071594, DA027528, AI060260, HD075363, HL103411]; Center for Protein Therapeutics; American Heart Association (AHA) [12SDG9450036]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD071594, R21HD075363] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060260, R56AI060260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027528] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); American Recovery and Reinvestment Act; Auburn University; Alabama Supercomputer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Protein Therapeutics; American Heart Association (AHA)(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Science Foundation Award 0920776 (to J. M. H.); the American Recovery and Reinvestment Act, Auburn University, and the Alabama Supercomputer Center (to O. A.); National Institutes of Health Grants U54HD071594, DA027528, AI060260, HD075363, and HL103411 (to J. Q.); the Center for Protein Therapeutics (to J. Q.); and American Heart Association (AHA) Award 12SDG9450036 (to J. Q.).	Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Boger RH, 2003, CARDIOVASC RES, V59, P824, DOI 10.1016/S0008-6363(03)00500-5; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Chu YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037674; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Cornell KA, 1996, BIOCHEM BIOPH RES CO, V228, P724, DOI 10.1006/bbrc.1996.1723; De Gennaro Colonna V., 2009, MED SCI MONIT, V15, pRA91; Duan XT, 2009, J PROTEOME RES, V8, P2838, DOI 10.1021/pr900001t; Fisk JC, 2013, MOL CELL PROTEOMICS, V12, P302, DOI 10.1074/mcp.M112.022533; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Gui SY, 2013, BIOCHEMISTRY-US, V52, P199, DOI 10.1021/bi301283t; Gui SY, 2011, J BIOL CHEM, V286, P29118, DOI 10.1074/jbc.M111.224097; Gunaydin H, 2007, J CHEM THEORY COMPUT, V3, P1028, DOI 10.1021/ct050318n; Hu P, 2006, J AM CHEM SOC, V128, P1272, DOI 10.1021/ja056153+; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Levine T. B., 2006, METABOLIC SYNDROME C, P421; Markowski P, 2007, ANAL CHIM ACTA, V605, P205, DOI 10.1016/j.aca.2007.10.033; MATSUOKA Y, 1972, SEIKAGAKU, V44, P364; Obianyo O, 2008, BIOCHEMISTRY-US, V47, P10420, DOI 10.1021/bi800904m; Ochterski JW, 1996, J CHEM PHYS, V104, P2598, DOI 10.1063/1.470985; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Paik W. K., 1980, PROTEIN METHYLATION, P8; Parr R. G., 1989, DENSITY FUNCTIONAL T; Qu J, 2007, ANAL CHEM, V79, P3786, DOI 10.1021/ac062184r; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; Rust HL, 2011, BIOCHEMISTRY-US, V50, P3332, DOI 10.1021/bi102022e; Sun LT, 2011, P NATL ACAD SCI USA, V108, P20538, DOI 10.1073/pnas.1106946108; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; Wang H, 2009, J AM SOC MASS SPECTR, V20, P507, DOI 10.1016/j.jasms.2008.11.008; Wang M, 2013, BIOCHEMISTRY-US, V52, P5430, DOI 10.1021/bi4005123; Wysocka J, 2006, FRONT BIOSCI-LANDMRK, V11, P344, DOI 10.2741/1802; Xu Q, 2009, CHEM-EUR J, V15, P12596, DOI 10.1002/chem.200902297; Yao JZ, 2012, J CHEM INF MODEL, V52, P449, DOI 10.1021/ci200364m; Zhang RH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072424; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	43	20	20	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9320	9327		10.1074/jbc.M113.535278	http://dx.doi.org/10.1074/jbc.M113.535278			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24478314	Green Published, hybrid			2022-12-28	WOS:000333472100048
J	Witayavanitkul, N; Mou, YA; Kuster, DWD; Khairallah, RJ; Sarkey, J; Govindan, S; Chen, X; Ge, Y; Rajan, S; Wieczorek, DF; Irving, T; Westfall, MV; de Tombe, PP; Sadayappan, S				Witayavanitkul, Namthip; Mou, Younss Ait; Kuster, Diederik W. D.; Khairallah, Ramzi J.; Sarkey, Jason; Govindan, Suresh; Chen, Xin; Ge, Ying; Rajan, Sudarsan; Wieczorek, David F.; Irving, Thomas; Westfall, Margaret V.; de Tombe, Pieter P.; Sadayappan, Sakthivel			Myocardial Infarction-induced N-terminal Fragment of Cardiac Myosin-binding Protein C ( cMyBP-C) Impairs Myofilament Function in Human Myocardium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Contractile Protein; Heart Failure; Myocardial Infarction; Protein Degradation; Protein-Protein Interactions	KINASE-A; MYBP-C; PHOSPHORYLATION; ACTIN; ACTIVATION; HEART; IDENTIFICATION; CONTRACTILITY; EXPRESSION; DOMAINS	Background: Myocardial infarction (MI) leads to proteolytic cleavage of cMyBP-C (hC0C1f) and decreased contractility. Results: hC0C1f can incorporate into the human cardiac sarcomere, depressing force generation and increasing tension cost. Conclusion: Interaction between hC0C1f and both actin and -tropomyosin causes disruption of intact cMyBP-C function. Significance: Proteolytic cleavage of cMyBP-C is sufficient to cause contractile dysfunction following MI. Myocardial infarction (MI) is associated with depressed cardiac contractile function and progression to heart failure. Cardiac myosin-binding protein C, a cardiac-specific myofilament protein, is proteolyzed post-MI in humans, which results in an N-terminal fragment, C0-C1f. The presence of C0-C1f in cultured cardiomyocytes results in decreased Ca2+ transients and cell shortening, abnormalities sufficient for the induction of heart failure in a mouse model. However, the underlying mechanisms remain unclear. Here, we investigate the association between C0-C1f and altered contractility in human cardiac myofilaments in vitro. To accomplish this, we generated recombinant human C0-C1f (hC0C1f) and incorporated it into permeabilized human left ventricular myocardium. Mechanical properties were studied at short (2 m) and long (2.3 m) sarcomere length (SL). Our data demonstrate that the presence of hC0C1f in the sarcomere had the greatest effect at short, but not long, SL, decreasing maximal force and myofilament Ca2+ sensitivity. Moreover, hC0C1f led to increased cooperative activation, cross-bridge cycling kinetics, and tension cost, with greater effects at short SL. We further established that the effects of hC0C1f occur through direct interaction with actin and -tropomyosin. Our data demonstrate that the presence of hC0C1f in the sarcomere is sufficient to induce depressed myofilament function and Ca2+ sensitivity in otherwise healthy human donor myocardium. Decreased cardiac function post-MI may result, in part, from the ability of hC0C1f to bind actin and -tropomyosin, suggesting that cleaved C0-C1f could act as a poison polypeptide and disrupt the interaction of native cardiac myosin-binding protein C with the thin filament.	[Witayavanitkul, Namthip; Mou, Younss Ait; Kuster, Diederik W. D.; Khairallah, Ramzi J.; Sarkey, Jason; Govindan, Suresh; de Tombe, Pieter P.; Sadayappan, Sakthivel] Loyola Univ Chicago, Dept Cell & Mol Physiol, Div Hlth Sci, Maywood, IL 60153 USA; [Chen, Xin; Ge, Ying] Univ Wisconsin, Human Prote Program, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Rajan, Sudarsan; Wieczorek, David F.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Irving, Thomas] IIT, Dept Biol & Chem Sci, Chicago, IL 60616 USA; [Westfall, Margaret V.] Univ Michigan, Dept Cardiac Surg, Ann Arbor, MI 48109 USA	Loyola University Chicago; University of Wisconsin System; University of Wisconsin Madison; University System of Ohio; University of Cincinnati; Illinois Institute of Technology; University of Michigan System; University of Michigan	Sadayappan, S (corresponding author), Loyola Univ Chicago, Dept Cell & Mol Physiol, Div Hlth Sci, 2160 S First Ave, Maywood, IL 60153 USA.	ssadayappan@lumc.edu	Kuster, Diederik/AAD-9272-2019	Kuster, Diederik/0000-0003-1498-6862; Sadayappan, Sakthivel/0000-0003-2006-7678; Westfall, Margaret/0000-0001-9491-0125	National Institutes of Health [R01HL105826, K02HL114749, HL007692, HL101297, HL75494, HL62426, 2P41RR008630-17, 9P41GM103622-17, HL096971]; American Heart Association [11POST5260038, 13POST14720024, 13POST17220009]; U.S. Department of Energy [DE-AC02-06CH11357]; National Institute of General Medical Sciences of the National Institutes of Health [9 P41 GM103622-18]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008630] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL114749, T32HL007692, R01HL096971, F32HL120643, R01HL105826, R01HL075494, P30HL101297, P01HL062426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103622] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); U.S. Department of Energy(United States Department of Energy (DOE)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL105826 and K02HL114749 (to S. S.); HL007692 (to J. S.); HL101297, HL75494, and HL62426 (to P. P. d. T.); 2P41RR008630-17 and 9P41GM103622-17 (to T. I.); and HL096971 (to Y. G.). This work was also supported by American Heart Association Midwest Fellowships 11POST5260038 (to Y. A.), 13POST14720024 (to S. G.), and 13POST17220009 (to D. W. D. K.). Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy Office of Science by Argonne National Laboratory, was supported by the U.S. Department of Energy under Contract DE-AC02-06CH11357. The Bio-CAT facility is supported by grants from the National Institute of General Medical Sciences of the National Institutes of Health (9 P41 GM103622-18).	Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014; Chandra M, 2001, AM J PHYSIOL-HEART C, V280, pH705, DOI 10.1152/ajpheart.2001.280.2.H705; Chen PP, 2010, J GEN PHYSIOL, V136, P615, DOI 10.1085/jgp.201010448; Decker RS, 2005, CIRCULATION, V111, P906, DOI 10.1161/01.CIR.0000155609.95618.75; DETOMBE PP, 1995, CIRC RES, V76, P734, DOI 10.1161/01.RES.76.5.734; DETOMBE PP, 1990, CIRC RES, V66, P1239, DOI 10.1161/01.RES.66.5.1239; F'entzke RC, 1999, J PHYSIOL-LONDON, V517, P143, DOI 10.1111/j.1469-7793.1999.0143z.x; Ge Y, 2009, P NATL ACAD SCI USA, V106, P12658, DOI 10.1073/pnas.0813369106; Govindan S, 2012, J MUSCLE RES CELL M, V33, P17, DOI 10.1007/s10974-012-9292-y; Govindan S, 2012, J MOL CELL CARDIOL, V52, P154, DOI 10.1016/j.yjmcc.2011.09.011; Gruen M, 1999, FEBS LETT, V453, P254, DOI 10.1016/S0014-5793(99)00727-9; GUTH K, 1986, PFLUG ARCH EUR J PHY, V407, P552, DOI 10.1007/BF00657515; Harris SP, 2004, CIRC RES, V95, P930, DOI 10.1161/01.RES.0000147312.02673.56; Herron TJ, 2006, CIRC RES, V98, P1290, DOI 10.1161/01.RES.0000222059.54917.ef; Irving TC, 2000, AM J PHYSIOL-HEART C, V279, pH2568, DOI 10.1152/ajpheart.2000.279.5.H2568; Kensler RW, 2011, J STRUCT BIOL, V174, P44, DOI 10.1016/j.jsb.2010.12.003; Kulikovskaya I, 2003, J GEN PHYSIOL, V122, P761, DOI 10.1085/jgp.200308941; Luther Pradeep K, 2011, Bioarchitecture, V1, P277; Luther PK, 2011, P NATL ACAD SCI USA, V108, P11423, DOI 10.1073/pnas.1103216108; Mou YA, 2009, CARDIOVASC RES, V81, P555, DOI 10.1093/cvr/cvn229; Previs MJ, 2012, SCIENCE, V337, P1215, DOI 10.1126/science.1223602; Ratti J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.156646; Razumova MV, 2006, J BIOL CHEM, V281, P35846, DOI 10.1074/jbc.M606949200; Razzaque MA, 2013, CIRC RES, V113, P553, DOI 10.1161/CIRCRESAHA.113.301225; Rundell VLM, 2005, AM J PHYSIOL-HEART C, V288, pH896, DOI 10.1152/ajpheart.00407.2004; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan S, 2008, ANN NY ACAD SCI, V1123, P1, DOI 10.1196/annals.1420.002; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Shaffer JF, 2009, J MUSCLE RES CELL M, V30, P303, DOI 10.1007/s10974-010-9207-8; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; Squire JM, 2003, J MOL BIOL, V331, P713, DOI 10.1016/S0022-2836(03)00781-2; Stelzer JE, 2006, CIRC RES, V99, P884, DOI 10.1161/01.RES.0000245191.34690.66; Sumandea MP, 2003, J BIOL CHEM, V278, P35135, DOI 10.1074/jbc.M306325200; van der Velden J, 1998, J PHYSIOL-LONDON, V507, P497, DOI 10.1111/j.1469-7793.1998.497bt.x; van der Velden J, 2004, CIRC RES, V95, pE85, DOI 10.1161/01.RES.0000149531.02904.09; Weith A, 2012, J MOL CELL CARDIOL, V52, P219, DOI 10.1016/j.yjmcc.2011.09.019; YASUDA M, 1995, J MOL CELL CARDIOL, V27, P2275, DOI 10.1016/S0022-2828(95)91731-4	37	33	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8818	8827		10.1074/jbc.M113.541128	http://dx.doi.org/10.1074/jbc.M113.541128			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24509847	hybrid, Green Published			2022-12-28	WOS:000333472100008
J	Zeth, K; Fokina, O; Forchhammer, K				Zeth, Kornelius; Fokina, Oleksandra; Forchhammer, Karl			Structural Basis and Target-specific Modulation of ADP Sensing by the Synechococcus elongatus PII Signaling Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adenosine; ADP; Cooperativity; Cyanobacteria; Nitrogen Metabolism; Protein-Protein Interactions; 2-Oxoglutarate; Nitrogen Control factor NtcA	ADENYLATE ENERGY-CHARGE; P-II; TRANSDUCTION PROTEIN; COMPLEX-FORMATION; RHODOSPIRILLUM-RUBRUM; NITROGEN REGULATION; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; GLUTAMATE KINASE; 2-OXOGLUTARATE	Background: Highly conserved P-II signaling proteins monitor carbon/nitrogen balance and energy status. Results: Crystals of homotrimeric Synechococcus elongatus P-II with ADP reveal the structural basis of anti-cooperative ADP binding. Interaction with PipX receptor changes the ATP/ADP preference of P-II. Conclusion: P-II signaling is modulated by conformational states imposed by the receptor protein. Significance: Molecular information is processed through protein structure plasticity. P-II signaling proteins comprise one of the most versatile signaling devices in nature and have a highly conserved structure. In cyanobacteria, PipX and N-acetyl-l-glutamate kinase are receptors of P-II signaling, and these interactions are modulated by ADP, ATP, and 2-oxoglutarate. These effector molecules bind interdependently to three anti-cooperative binding sites on the trimeric P-II protein and thereby affect its structure. Here we used the P-II protein from Synechococcus elongatus PCC 7942 to reveal the structural basis of anti-cooperative ADP binding. Furthermore, we clarified the mutual influence of P-II-receptor interaction and sensing of the ATP/ADP ratio. The crystal structures of two forms of trimeric P-II, one with one ADP bound and the other with all three ADP-binding sites occupied, revealed significant differences in the ADP binding mode: at one site (S1) ADP is tightly bound through side-chain and main-chain interactions, whereas at the other two sites (S2 and S3) the ADP molecules are only bound by main-chain interactions. In the presence of the P-II-receptor PipX, the affinity of ADP to the first binding site S1 strongly increases, whereas the affinity for ATP decreases due to PipX favoring the S1 conformation of P-II-ADP. In consequence, the P-II-PipX interaction is highly sensitive to subtle fluctuations in the ATP/ADP ratio. By contrast, the P-II-N-acetyl-l-glutamate kinase interaction, which is negatively affected by ADP, is insensitive to these fluctuations. Modulation of the metabolite-sensing properties of P-II by its receptors allows P-II to differentially perceive signals in a target-specific manner and to perform multitasking signal transduction.	[Zeth, Kornelius] Max Planck Inst Dev Biol, Dept Prot Evolut, D-72076 Tubingen, Germany; [Fokina, Oleksandra; Forchhammer, Karl] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Div Organism Interact, D-72076 Tubingen, Germany	Max Planck Society; Eberhard Karls University of Tubingen	Forchhammer, K (corresponding author), Univ Tubingen, Interfac Inst Microbiol & Infect Med, Div Organism Interact, Morgenstelle 28, D-72076 Tubingen, Germany.	karl.forchhammer@uni-tuebingen.de			Max Planck Society; University of Tubingen, Germany; German Science Foundation [FO195/9-1]	Max Planck Society(Max Planck Society); University of Tubingen, Germany; German Science Foundation(German Research Foundation (DFG))	This work was supported by the Max Planck Society, the University of Tubingen, Germany, and German Science Foundation Grant FO195/9-1 (to K. F.).	Beez S, 2009, J MOL BIOL, V389, P748, DOI 10.1016/j.jmb.2009.04.053; BUENO R, 1985, J BACTERIOL, V164, P816, DOI 10.1128/JB.164.2.816-822.1985; Burillo S, 2004, J BACTERIOL, V186, P3346, DOI 10.1128/JB.186.11.3346-3354.2004; Chapman A G, 1977, Adv Microb Physiol, V15, P253, DOI 10.1016/S0065-2911(08)60318-5; CHAPMAN AG, 1971, J BACTERIOL, V108, P1072, DOI 10.1128/JB.108.3.1072-1086.1971; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espinosa J, 2007, MICROBIOL-SGM, V153, P711, DOI 10.1099/mic.0.2006/003574-0; Espinosa J, 2006, MOL MICROBIOL, V61, P457, DOI 10.1111/j.1365-2958.2006.05231.x; Fokina O, 2011, BIOCHEM J, V440, P147, DOI 10.1042/BJ20110536; Fokina O, 2010, P NATL ACAD SCI USA, V107, P19760, DOI 10.1073/pnas.1007653107; Fokina O, 2010, J MOL BIOL, V399, P410, DOI 10.1016/j.jmb.2010.04.018; Forchhammer K, 1997, EUR J BIOCHEM, V244, P869, DOI 10.1111/j.1432-1033.1997.00869.x; Forchhammer K, 2008, TRENDS MICROBIOL, V16, P65, DOI 10.1016/j.tim.2007.11.004; Heinrich A, 2004, MOL MICROBIOL, V52, P1303, DOI 10.1111/j.1365-2958.2004.04058.x; Helfmann S, 2010, J MOL BIOL, V402, P165, DOI 10.1016/j.jmb.2010.07.020; Huergo LF, 2013, FEMS MICROBIOL REV, V37, P251, DOI 10.1111/j.1574-6976.2012.00351.x; Huergo LF, 2012, MICROBIOL-SGM, V158, P176, DOI 10.1099/mic.0.049783-0; Jiang P, 2007, BIOCHEMISTRY-US, V46, P12979, DOI 10.1021/bi701062t; Jiang P, 2009, BIOCHEMISTRY-US, V48, P11522, DOI 10.1021/bi9011594; Jiang P, 2009, BIOCHEMISTRY-US, V48, P11514, DOI 10.1021/bi901158h; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KALLAS T, 1982, J BACTERIOL, V149, P229, DOI 10.1128/JB.149.1.229-236.1982; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leigh JA, 2007, ANNU REV MICROBIOL, V61, P349, DOI 10.1146/annurev.micro.61.080706.093409; Llacer JL, 2007, P NATL ACAD SCI USA, V104, P17644, DOI 10.1073/pnas.0705987104; Llacer JL, 2010, P NATL ACAD SCI USA, V107, P15397, DOI 10.1073/pnas.1007015107; Luddecke J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083181; Ma C. W., 2013, PROTEINS, DOI 10.1002/prot.24477; Maheswaran M, 2004, J BIOL CHEM, V279, P55202, DOI 10.1074/jbc.M410971200; Maier S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026327; Muro-Pastor MI, 2001, J BIOL CHEM, V276, P38320; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ninfa AJ, 2005, CURR OPIN MICROBIOL, V8, P168, DOI 10.1016/j.mib.2005.02.011; Radchenko MV, 2013, P NATL ACAD SCI USA, V110, P12948, DOI 10.1073/pnas.1304386110; Radchenko MV, 2010, J BIOL CHEM, V285, P31037, DOI 10.1074/jbc.M110.153908; Sakai H, 2005, J STRUCT BIOL, V149, P99, DOI 10.1016/j.jsb.2004.08.007; Sant'Anna F, 2009, J MOL EVOL, V68, P322, DOI 10.1007/s00239-009-9209-6; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Teixeira PF, 2008, MICROBIOL-SGM, V154, P2336, DOI 10.1099/mic.0.2008/017533-0; Truan D, 2010, J MOL BIOL, V400, P531, DOI 10.1016/j.jmb.2010.05.036; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Xu YB, 1998, J MOL BIOL, V282, P149, DOI 10.1006/jmbi.1998.1979; Xu YB, 2003, ACTA CRYSTALLOGR D, V59, P2183, DOI 10.1107/S0907444903019589; Yildiz O, 2007, EMBO J, V26, P589, DOI 10.1038/sj.emboj.7601492; Zeth K, 2012, ACTA CRYSTALLOGR D, V68, P901, DOI 10.1107/S0907444912016447; Zhang YP, 2003, SYMBIOSIS, V35, P85; Zhang YP, 2001, J BACTERIOL, V183, P1610, DOI 10.1128/JB.183.5.1610-1620.2001; Zhao MX, 2010, J MOL BIOL, V402, P552, DOI 10.1016/j.jmb.2010.08.006	48	45	45	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8960	8972		10.1074/jbc.M113.536557	http://dx.doi.org/10.1074/jbc.M113.536557			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24519945	hybrid, Green Published			2022-12-28	WOS:000333472100019
J	Brown, LM; Rogers, KE; McCammon, JA; Insel, PA				Brown, Loren M.; Rogers, Kathleen E.; McCammon, J. Andrew; Insel, Paul A.			Identification and Validation of Modulators of Exchange Protein Activated by cAMP (Epac) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioluminescence Resonance Energy Transfer (BRET); Cyclic AMP (cAMP); Enzyme Inhibitors; Guanine Nucleotide Exchange Factor (GEF); Molecular Docking; Molecular Pharmacology; Epac1	RESONANCE ENERGY-TRANSFER; ANALOGS; KINASE; RAP1; MECHANISM; BINDING; SIMULATION; DYNAMICS; FAMILY; TOOLS	Background: Epac1 is a guanine nucleotide exchange factor for Rap1 activated by cAMP. Results: We use a BRET-based method to identify modulators of Epac1 activity. Conclusion: Molecules that displace cAMP but do not stabilize the lid of Epac are novel inhibitors. Significance: Understanding how cAMP analogs influence movement of Epac can aid in designing inhibitors for Epac-mediated cAMP signaling. The signaling molecule cAMP primarily mediates its effects by activating PKA and/or exchange protein activated by cAMP (Epac). Epac has been implicated in many responses in cells, but its precise roles have been difficult to define in the absence of Epac inhibitors. Epac, a guanine nucleotide exchange factor for the low molecular weight G protein Rap, is directly activated by cAMP. Using a bioluminescence resonance energy transfer-based assay (CAMYEL) to examine modulators of Epac activity, we took advantage of its intramolecular movement that occurs upon cAMP binding to assess Epac activation. We found that the use of CAMYEL can detect the binding of cAMP analogs to Epac and their modulation of its activity and can distinguish between agonists (cAMP), partial agonists (8-chlorophenylthio-cAMP), and super agonists (8-chlorophenylthio-2-O-Me-cAMP). The CAMYEL assay can also identify competitive and uncompetitive Epac inhibitors, e.g. (R-p)-cAMPS and CE3F4, respectively. To confirm the results with the CAMYEL assay, we used Swiss 3T3 cells and assessed the ability of cyclic nucleotide analogs to modulate the activity of Epac or PKA, determined by Rap1 activity or VASP phosphorylation, respectively. We used computational molecular modeling to analyze the interaction of analogs with Epac1. The results reveal a rapid means to identify modulators (potentially including allosteric inhibitors) of Epac activity that also provides insight into the mechanisms of Epac activation and inhibition.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [McCammon, J. Andrew] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [McCammon, J. Andrew] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Insel, Paul A.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Insel, PA (corresponding author), Univ Calif San Diego, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	pinsel@ucsd.edu	McCammon, J. Andrew/AAG-1832-2021	McCammon, J. Andrew/0000-0003-3065-1456	National Institutes of Health [5T32DK007541-27, GM31749]; National Science Foundation [MCB1020765]; Howard Hughes Medical Institute; National Biomedical Computation Resource; Center for Theoretical Biological Physics; National Science Foundation Supercomputer Centers; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R01GM031749] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Biomedical Computation Resource; Center for Theoretical Biological Physics; National Science Foundation Supercomputer Centers(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Training Grant 5T32DK007541-27 and Grant GM31749 (to J. A. M.). This work was also supported by National Science Foundation Grant MCB1020765 (to J. A. M.), the Howard Hughes Medical Institute, the National Biomedical Computation Resource, the Center for Theoretical Biological Physics, and National Science Foundation Supercomputer Centers.	Altschuler DL, 1998, P NATL ACAD SCI USA, V95, P7475, DOI 10.1073/pnas.95.13.7475; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Billington CK, 2013, PULM PHARMACOL THER, V26, P112, DOI 10.1016/j.pupt.2012.05.007; Boute N, 2002, TRENDS PHARMACOL SCI, V23, P351, DOI 10.1016/S0165-6147(02)02062-X; Case DA, 2012, AMBER 12; Christen M, 2005, J COMPUT CHEM, V26, P1719, DOI 10.1002/jcc.20303; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; Consonni SV, 2012, P NATL ACAD SCI USA, V109, P3814, DOI 10.1073/pnas.1117599109; Courilleau D, 2013, BIOCHEM BIOPH RES CO, V440, P443, DOI 10.1016/j.bbrc.2013.09.107; Courilleau D, 2012, J BIOL CHEM, V287, P44192, DOI 10.1074/jbc.M112.422956; Dao KK, 2006, J BIOL CHEM, V281, P21500, DOI 10.1074/jbc.M603116200; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DeLano W. L., 2013, SMALL MOL DRUG DISCO; DeLano W. L., 2013, LIGPREP VERSION 2 6; DeLano W. L., 2013, PROTEIN PREPARATION; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; GJERTSEN BT, 1995, J BIOL CHEM, V270, P20599, DOI 10.1074/jbc.270.35.20599; Harper SM, 2008, J BIOL CHEM, V283, P6501, DOI 10.1074/jbc.M707849200; Henzler AM, 2010, MOL INFORM, V29, P164, DOI 10.1002/minf.200900078; Insel PA, 2012, ACTA PHYSIOL, V204, P277, DOI 10.1111/j.1748-1716.2011.02273.x; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Liu C, 2008, MOL CELL BIOL, V28, P7109, DOI 10.1128/MCB.01060-08; Matthiesen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024392; McPhee I, 2005, BIOCHEM SOC T, V33, P1330, DOI 10.1042/BST0331330; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Rehmann H, 2003, J BIOL CHEM, V278, P38548, DOI 10.1074/jbc.M306292200; Rehmann H, 2008, NATURE, V455, P124, DOI 10.1038/nature07187; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schwede F, 2000, PHARMACOL THERAPEUT, V87, P199, DOI 10.1016/S0163-7258(00)00051-6; Sechi AS, 2004, FRONT BIOSCI, V9, P1294, DOI 10.2741/1324; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Tsalkova T., 2012, PLOS ONE, V7; Tsalkova T, 2009, J BIOL CHEM, V284, P23644, DOI 10.1074/jbc.M109.024950; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wu J, 2004, BIOCHEMISTRY-US, V43, P6620, DOI 10.1021/bi0302503; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	45	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8217	8230		10.1074/jbc.M114.548636	http://dx.doi.org/10.1074/jbc.M114.548636			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24497631	Green Published, hybrid			2022-12-28	WOS:000333157500017
J	Ghatak, S; Misra, S; Norris, RA; Moreno-Rodriguez, RA; Hoffman, S; Levine, RA; Hascall, VC; Markwald, RR				Ghatak, Shibnath; Misra, Suniti; Norris, Russell A.; Moreno-Rodriguez, Ricardo A.; Hoffman, Stanley; Levine, Robert A.; Hascall, Vincent C.; Markwald, Roger R.			Periostin Induces Intracellular Cross-talk between Kinases and Hyaluronan in Atrioventricular Valvulogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cd44; Cell Adhesion; Cell Migration; Collagen; Hyaluronate; Integrins; Atrioventricular Valve; Intracellular Kinase Signaling; Periostin; Prevalvular Cushion Cells	FOCAL ADHESION KINASE; ACTIVATED PROTEIN-KINASE; CONSTITUTIVELY REGULATES ACTIVATION; VALVULAR DYSTROPHY; FILAMIN-A; GROWTH-FACTOR; CELL-BINDING; CANCER-CELLS; MAP KINASE; CD44	Background: Periostin-null mice exhibit a myxomatous atrioventricular valve phenotype. We propose two mechanisms as follows: periostin binds to collagen and links it to cell-surface receptors; periostin/-INTEGRIN signaling promotes valve morphogenesis. Results: Periostin/-INTEGRINs/focal adhesion kinase/PI3K/ERK signals promote hyaluronan synthase-2 activation, matrix remodeling, and valve progenitor cell survival/differentiation. Conclusion: The phenotype of periostin-null valves is consistent with a role for PN cell signaling through INTEGRIN receptors. Significance: Periostin is a valvulogenic signaling morphogen. Periostin (PN), a novel fasciclin-related matricellular protein, has been implicated in cardiac development and postnatal remodeling, but the mechanism remains unknown. We examined the role of PN in mediating intracellular kinase activation for atrioventricular valve morphogenesis using well defined explant cultures, gene transfection systems, and Western blotting. The results show that valve progenitor (cushion) cells secrete PN into the extracellular matrix, where it can bind to INTEGRINs and activate INTEGRIN/focal adhesion kinase signaling pathways and downstream kinases, PI3K/AKT and ERK. Functional assays with prevalvular progenitor cells showed that activating these signaling pathways promoted adhesion, migration, and anti-apoptosis. Through activation of PI3K/ERK, PN directly enhanced collagen expression. Comparing PN-null to WT mice also revealed that expression of hyaluronan (HA) and activation of hyaluronan synthase-2 (Has2) are also enhanced upon PN/INTEGRIN/focal adhesion kinase-mediated activation of PI3K and/or ERK, an effect confirmed by the reduction of HA synthase-2 in PN-null mice. We also identified in valve progenitor cells a potential autocrine signaling feedback loop between PN and HA through PI3K and/or ERK. Finally, in a three-dimensional assay to simulate normal valve maturation in vitro, PN promoted collagen compaction in a kinase-dependent fashion. In summary, this study provides the first direct evidence that PN can act to stimulate a valvulogenic signaling pathway.	[Ghatak, Shibnath; Misra, Suniti; Norris, Russell A.; Moreno-Rodriguez, Ricardo A.; Markwald, Roger R.] Med Univ S Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC 29425 USA; [Hoffman, Stanley] Med Univ S Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA; [Levine, Robert A.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn ND20, Cleveland, OH 44195 USA	Medical University of South Carolina; Medical University of South Carolina; Harvard University; Massachusetts General Hospital; Cleveland Clinic Foundation	Markwald, RR (corresponding author), Med Univ S Carolina, Dept Regenerat Med & Cell Biol, 173 Ashley Ave, Charleston, SC 29425 USA.	markwald@musc.edu	Moreno-Rodriguez, Ricardo/GPT-4006-2022; moreno, ricardo/AAS-5868-2021	Moreno Rodriguez, Ricardo Alberto/0000-0002-5420-4231	National Institutes of Health [1R03CA167722-01A1, P20RR021949, P20RR016434, P20RR16461-05, RO1-HL033756-24, P01HL107147, 1P30AR050953]; EPS [0903795]; MCRC [39919]; COBRE [IP30-GM103342, 8P20 GM103444]; Fondation Leducq (Paris, France) Transatlantic Network of Excellence [07CDV04]; American Heart Association [11SDG5270006]; NATIONAL CANCER INSTITUTE [R03CA167722] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016461, P20RR016434, P20RR021949] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107147, R01HL033756, R01HL072265, R01HL109506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103342, P20GM103444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPS; MCRC; COBRE; Fondation Leducq (Paris, France) Transatlantic Network of Excellence(Leducq Foundation); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R03CA167722-01A1 (to S. M. and S. G.), P20RR021949 (to S. G.), P20RR016434 (to S. M., S. G., and R. R. M.), P20RR16461-05 (to S. G. and R. R. M), RO1-HL033756-24 and (to S. M., S. G., and R. R. M.), P01HL107147 and 1P30AR050953 (to V. C. H.), EPS 0903795 (to S. M.), MCRC 39919 (to S. G. and S. M.), COBRE IP30-GM103342 (to R. R. M. and R. A. N.), and 8P20 GM103444 (to R. R. M. and R. A. N.). This work was also supported by Fondation Leducq (Paris, France) Transatlantic Network of Excellence Grant 07CDV04 (to R. A. L.) and American Heart Association Grant 11SDG5270006 (to R. A. N.).	Bandyopadhyay SK, 2010, J INTERF CYTOK RES, V30, P809, DOI 10.1089/jir.2009.0061; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Butcher JT, 2007, DEV BIOL, V302, P256, DOI 10.1016/j.ydbio.2006.09.048; Calve S, 2012, AM J PHYSIOL-CELL PH, V303, pC577, DOI 10.1152/ajpcell.00057.2012; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Chen HC, 1996, J BIOL CHEM, V271, P26329, DOI 10.1074/jbc.271.42.26329; Conway S. J., 2013, CELL MOL LIFE SCI, DOI 10.1007/s00018-013-1494-y; DOWNWARD J, 1994, FEBS LETT, V338, P113, DOI 10.1016/0014-5793(94)80346-3; Doyle AJ, 2012, NAT GENET, V44, P1249, DOI 10.1038/ng.2421; Duval D, 2014, BBA-MOL CELL RES, V1843, P234, DOI 10.1016/j.bbamcr.2013.10.022; Ebi H, 2013, P NATL ACAD SCI USA, V110, P21124, DOI 10.1073/pnas.1314124110; EIDE BL, 1995, MOL CELL BIOL, V15, P2819; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; Gabarra-Niecko V, 2002, BIOCHEM J, V365, P591, DOI 10.1042/BJ20020065; Gayer CP, 2009, J BIOL CHEM, V284, P2001, DOI 10.1074/jbc.M804576200; Ghatak S, 2005, J BIOL CHEM, V280, P8875, DOI 10.1074/jbc.M410882200; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; Ghatak S, 2010, J BIOL CHEM, V285, P19821, DOI 10.1074/jbc.M110.104273; Hamilton DW, 2008, J CELL COMMUN SIGNAL, V2, P9, DOI 10.1007/s12079-008-0023-5; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hascall V. C., 2014, MATRIX BIOL, DOI 10.1016/j.matbio.2014.01.014; Hayashida T, 1999, KIDNEY INT, V56, P1710, DOI 10.1046/j.1523-1755.1999.00733.x; Hayashida T, 2003, FASEB J, V17, P1576, DOI 10.1096/fj.03-0037fje; Kallergi G, 2007, MOL MED, V13, P79, DOI 10.2119/2006-00083.Kallergi; Kim H, 2008, EXP CELL RES, V314, P834, DOI 10.1016/j.yexcr.2007.11.022; Kruithof BPT, 2007, DEV BIOL, V302, P208, DOI 10.1016/j.ydbio.2006.09.024; Kruzynska-Frejtag A, 2001, MECH DEVELOP, V103, P183, DOI 10.1016/S0925-4773(01)00356-2; Kumar CC, 1998, ONCOGENE, V17, P1365, DOI 10.1038/sj.onc.1202172; Kyndt F, 2007, ARCH MAL COEUR VAISS, V100, P1013; Kyndt F, 1998, AM J HUM GENET, V62, P627, DOI 10.1086/301747; Kyndt F, 2007, CIRCULATION, V115, P40, DOI 10.1161/CIRCULATIONAHA.106.622621; Lardeux A, 2011, J CARDIOVASC TRANSL, V4, P748, DOI 10.1007/s12265-011-9308-9; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lesley J, 2000, EUR J IMMUNOL, V30, P245, DOI 10.1002/1521-4141(200001)30:1<245::AID-IMMU245>3.3.CO;2-O; Li GH, 2010, ATHEROSCLEROSIS, V208, P358, DOI 10.1016/j.atherosclerosis.2009.07.046; McDonald J, 2002, J BIOL CHEM, V277, P4575, DOI 10.1074/jbc.R100064200; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Misra S, 2005, J BIOL CHEM, V280, P20310, DOI 10.1074/jbc.M500737200; Misra S, 2003, J BIOL CHEM, V278, P25285, DOI 10.1074/jbc.C300173200; Misra S, 2008, CONNECT TISSUE RES, V49, P219, DOI 10.1080/03008200802143356; Misra S, 2008, J BIOL CHEM, V283, P14335, DOI 10.1074/jbc.M703811200; Misra S, 2006, J BIOL CHEM, V281, P34936, DOI 10.1074/jbc.C600138200; Misra S, 2013, BIOORGAN MED CHEM, V21, P2551, DOI 10.1016/j.bmc.2013.02.033; Misra S, 2009, J BIOL CHEM, V284, P12432, DOI 10.1074/jbc.M806772200; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Norris RA, 2010, DEV DYNAM, V239, P2118, DOI 10.1002/dvdy.22346; Norris RA, 2008, DEV BIOL, V316, P200, DOI 10.1016/j.ydbio.2008.01.003; Norris RA, 2008, ANN NY ACAD SCI, V1123, P30, DOI 10.1196/annals.1420.005; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Norris RA, 2009, J CELL COMMUN SIGNAL, V3, P275, DOI 10.1007/s12079-009-0063-5; Norris RA, 2009, DEV DYNAM, V238, P1052, DOI 10.1002/dvdy.21933; Orecchia P, 2011, EUR J CANCER, V47, P2221, DOI 10.1016/j.ejca.2011.04.026; Paranya G, 2001, AM J PATHOL, V159, P1335, DOI 10.1016/S0002-9440(10)62520-5; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Shinohara ML, 2008, IMMUNITY, V29, P68, DOI 10.1016/j.immuni.2008.05.008; Snider P, 2008, CIRC RES, V102, P752, DOI 10.1161/CIRCRESAHA.107.159517; Snider P, 2009, CIRC RES, V105, P934, DOI 10.1161/CIRCRESAHA.109.201400; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Tkatchenko TV, 2009, PHYSIOL GENOMICS, V39, P160, DOI 10.1152/physiolgenomics.00078.2009; Todorovic V, 2011, DEV DYNAM, V240, P176, DOI 10.1002/dvdy.22521; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vigetti D., 2013, MATRIX BIOL, DOI 10.1016/j.matbio.2013.10.002; Vigetti D, 2011, J BIOL CHEM, V286, P7917, DOI 10.1074/jbc.M110.193656; Vigetti D, 2009, J BIOL CHEM, V284, P30684, DOI 10.1074/jbc.M109.040386; Xu SW, 2004, MOL BIOL CELL, V15, P2707, DOI 10.1091/mbc.E03-12-0902; Yang L., 2012, PLOS ONE, V7	72	41	42	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8545	8561		10.1074/jbc.M113.539882	http://dx.doi.org/10.1074/jbc.M113.539882			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24469446	Green Published, hybrid			2022-12-28	WOS:000333157500045
J	Suzuki, T; Suzuki, J; Nagata, S				Suzuki, Takayuki; Suzuki, Jun; Nagata, Shigekazu			Functional Swapping between Transmembrane Proteins TMEM16A and TMEM16F	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chloride Channels; Enzyme Mutation; Phosphatidylserine; Plasma Membrane; Protein Domains	CA2+-ACTIVATED CL-CHANNEL; ACTIVATED CHLORIDE CHANNEL; GNATHODIAPHYSEAL-DYSPLASIA; SCRAMBLASE ACTIVITY; MEMBRANE-PROTEIN; FAMILY-MEMBERS; GREEN TEA; EXPRESSION; CELLS; PHOSPHATIDYLSERINE	Background: TMEM16A and -16F function as a Ca2+-dependent Cl- channel and phospholipid scramblase, respectively. Results: The N- and C-terminal domains of TMEM16A and -16F are exchangeable and are necessary for ER exit and stability. Conclusion: TMEM16A and -16F use a similar mechanism for transporting and stabilizing protein, but their functional domains differ. Significance: Identifying functional domains will lead to better understanding of TMEM16 family. The transmembrane proteins TMEM16A and -16F each carry eight transmembrane regions with cytoplasmic N and C termini. TMEM16A carries out Ca2+-dependent Cl- ion transport, and TMEM16F is responsible for Ca2+-dependent phospholipid scrambling. Here we established assay systems for the Ca2+-dependent Cl- channel activity using 293T cells and for the phospholipid scramblase activity using TMEM16F(-/-) immortalized fetal thymocytes. Chemical cross-linking analysis showed that TMEM16A and -16F form homodimers in both 293T cells and immortalized fetal thymocytes. Successive deletion from the N or C terminus of both proteins and the swapping of regions between TMEM16A and -16F indicated that their cytoplasmic N-terminal (147 amino acids for TMEM16A and 95 for 16F) and C-terminal (88 amino acids for TMEM16A and 68 for 16F) regions were essential for their localization at plasma membranes and protein stability, respectively, and could be exchanged. Analyses of TMEM16A and -16F mutants with point mutations in the pore region (located between the fifth and sixth transmembrane regions) indicated that the pore region is essential for both the Cl- channel activity of TMEM16A and the phospholipid scramblase activity of TMEM16F. Some chemicals such as epigallocatechin-3-gallate and digallic acid inhibited the Cl- channel activity of TMEM16A and the scramblase activity of TMEM16F with an opposite preference. These results indicate that TMEM16A and -16F use a similar mechanism for sorting to plasma membrane and protein stabilization, but their functional domains significantly differ.	[Suzuki, Takayuki; Suzuki, Jun; Nagata, Shigekazu] Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan; [Nagata, Shigekazu] Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kyoto 6068501, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Nagata, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem, Sakyo Ku, Kyoto 6068501, Japan.	snagata@mfour.med.kyoto-u.ac.jp	Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426	Ministry of Education, Science, Sports, and Culture in Japan; Grants-in-Aid for Scientific Research [22000013] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Ministry of Education, Science, Sports, and Culture in Japan.	Almaca J, 2009, J BIOL CHEM, V284, P28571, DOI 10.1074/jbc.M109.010074; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Charlesworth G, 2012, AM J HUM GENET, V91, P1041, DOI 10.1016/j.ajhg.2012.10.024; Das S, 2007, CANCER RES, V67, P1594, DOI 10.1158/0008-5472.CAN-06-2673; Duran C, 2012, AM J PHYSIOL-CELL PH, V302, pC482, DOI 10.1152/ajpcell.00140.2011; Duran C, 2011, ACTA PHARMACOL SIN, V32, P685, DOI 10.1038/aps.2011.48; Ehlen HWA, 2013, J BONE MINER RES, V28, P246, DOI 10.1002/jbmr.1751; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; Flores CA, 2009, BRAZ J MED BIOL RES, V42, P993, DOI 10.1590/S0100-879X2009005000028; Folmer DE, 2009, BBA-MOL CELL BIOL L, V1791, P628, DOI 10.1016/j.bbalip.2009.02.008; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kang WS, 1999, THROMB RES, V96, P229, DOI 10.1016/S0049-3848(99)00104-8; Kashyap MK, 2009, CANCER BIOL THER, V8, P36, DOI 10.4161/cbt.8.1.7090; Klenk C, 2006, J BIOL CHEM, V281, P8357, DOI 10.1074/jbc.M513703200; Kuba H, 2003, J PHYSIOL-LONDON, V552, P611, DOI 10.1113/jphysiol.2003.041574; Lhermusier T, 2011, J THROMB HAEMOST, V9, P1883, DOI 10.1111/j.1538-7836.2011.04478.x; Martins JR, 2011, P NATL ACAD SCI USA, V108, P18168, DOI 10.1073/pnas.1108094108; Mizuta K, 2007, BIOCHEM BIOPH RES CO, V357, P126, DOI 10.1016/j.bbrc.2007.03.108; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Murai K, 1998, P NATL ACAD SCI USA, V95, P3461, DOI 10.1073/pnas.95.7.3461; Muthusamy BP, 2009, BBA-MOL CELL BIOL L, V1791, P612, DOI 10.1016/j.bbalip.2009.03.004; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Schreiber R, 2010, J BIOL CHEM, V285, P7838, DOI 10.1074/jbc.M109.065367; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Segawa K, 2011, P NATL ACAD SCI USA, V108, P19246, DOI 10.1073/pnas.1114799108; Sheridan JT, 2011, J BIOL CHEM, V286, P1381, DOI 10.1074/jbc.M110.174847; Shimizu T, 2013, AM J PHYSIOL-CELL PH, V304, pC748, DOI 10.1152/ajpcell.00228.2012; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Szteyn K, 2012, CELL PHYSIOL BIOCHEM, V30, P1319, DOI 10.1159/000343321; TRAUT TW, 1988, P NATL ACAD SCI USA, V85, P2944, DOI 10.1073/pnas.85.9.2944; Tsutsumi S, 2004, AM J HUM GENET, V74, P1255, DOI 10.1086/421527; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Vermeer S, 2010, AM J HUM GENET, V87, P813, DOI 10.1016/j.ajhg.2010.10.015; Wan NK, 2011, FASEB J, V25, P4048, DOI 10.1096/fj.11-191627; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	43	21	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7438	7447		10.1074/jbc.M113.542324	http://dx.doi.org/10.1074/jbc.M113.542324			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24478309	hybrid, Green Published			2022-12-28	WOS:000332761500015
J	Hou, SK; Ge, KK; Zheng, XD; Wei, HM; Sun, R; Tian, ZG				Hou, Shengke; Ge, Kuikui; Zheng, Xiaodong; Wei, Haiming; Sun, Rui; Tian, Zhigang			CD226 Protein Is Involved in Immune Synapse Formation and Triggers Natural Killer (NK) Cell Activation via Its First Extracellular Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Cell Junctions; ERK; Natural Killer (NK) Cell; Phosphorylation	IMMUNOGLOBULIN SUPERFAMILY; NECTIN-2 CD112; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; T-LYMPHOCYTES; PVR CD155; ADHESION; RECEPTOR; DNAM-1; MOLECULE	Background: CD226 is an activating receptor on NK cells that mediates NK cell cytotoxicity. Results: The first extracellular domain of CD226 (CD226-ECD1) mediates NK cell recognition, adhesion, immune synapse formation, and cytotoxicity against target cells. Conclusion: CD226-ECD1 retains almost all functions of the full-length CD226 protein. Significance: The conclusion is helpful to understand the mechanism by which CD226 recognizes its ligands. CD226, an activating receptor that interacts with the ligands CD155 and CD112, activates natural killer (NK) cells via its immunoreceptor tyrosine-based activatory motif (ITAM). There are two extracellular domains of CD226; however, the comparative functional relevance of these domains remains unknown. In this study, two different deletion mutants, rCD226-ECD1 (the first extracellular domain) and rCD226-ECD (full extracellular domains), were recombinantly expressed. We observed that rCD226-ECD1, similar to rCD226-ECD, specifically bound to ligand-positive cell lines and that this interaction could be competitively blocked by an anti-CD226 mAb. In addition, rCD226-ECD1 was able to block the binding of CD112 mAb to tumor cells in a competitive binding assay. Importantly, based on surface plasmon resonance (SPR), we determined that rCD226-ECD1, similar to rCD226-ECD, directly bound to its ligand CD155 on a protein chip. Functionally, NK cell cytotoxicity against K562 or HeLa cells was blocked by rCD226-ECD1 by reducing the expression of CD69 and granzyme B, indicating the critical role of ECD1 in NK cell activation. We also examined the role of rCD226-ECD1 in effector/target interactions by using rCD226-ECD to block these interactions. Using flow cytometry, we found that the number of conjugates between IL-2-dependent NKL cells and HeLa cells was reduced and observed that the formation of immune synapses was also decreased under confocal microscopy. In addition, we prepared two anti-rCD226-ECD1 agonistic antibodies, 2E6 and 3B9. Both 2E6 and 3B9 antibodies could induce the phosphorylation of ERK in NK-92 cells. Taken together, our results show that CD226 functions via its first extracellular domain.	[Hou, Shengke; Ge, Kuikui; Zheng, Xiaodong; Wei, Haiming; Sun, Rui; Tian, Zhigang] Univ Sci & Technol China, Sch Life Sci, Dept Immunol, Hefei 230027, Anhui, Peoples R China; [Wei, Haiming; Sun, Rui; Tian, Zhigang] Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS	Sun, R (corresponding author), Univ Sci & Technol China, Sch Life Sci, Dept Immunol, Hefei 230027, Anhui, Peoples R China.	sunr@ustc.edu.cn; tzg@ustc.edu.cn	Tian, Zhigang/J-3512-2013; Zheng, Xiaodong/N-2830-2013		Ministry of Science and Technology of China (973 Basic Science Project) [2010CB911901, 2013CB530506]; Natural Science Foundation of China [91029303, 31021061]	Ministry of Science and Technology of China (973 Basic Science Project)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Ministry of Science and Technology of China (973 Basic Science Project; Grants 2010CB911901 and 2013CB530506) and the Natural Science Foundation of China (Grants 91029303 and 31021061).	Aricescu AR, 2007, CURR OPIN CELL BIOL, V19, P543, DOI 10.1016/j.ceb.2007.09.010; Bachelet I, 2006, J BIOL CHEM, V281, P27190, DOI 10.1074/jbc.M602359200; Barber DF, 2003, J IMMUNOL, V170, P294, DOI 10.4049/jimmunol.170.1.294; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; BURNS GF, 1985, J EXP MED, V161, P1063, DOI 10.1084/jem.161.5.1063; Carlsten M, 2007, CANCER RES, V67, P1317, DOI 10.1158/0008-5472.CAN-06-2264; Castriconi R, 2004, CANCER RES, V64, P9180, DOI 10.1158/0008-5472.CAN-04-2682; Castriconi R, 2007, BLOOD, V109, P4873, DOI 10.1182/blood-2006-08-038760; Cerwenka A, 2001, IMMUNOL REV, V181, P158, DOI 10.1034/j.1600-065X.2001.1810113.x; Chen LH, 2003, LIFE SCI, V73, P2373, DOI 10.1016/S0024-3205(03)00606-4; Diefenbach A, 2001, IMMUNOL REV, V181, P170, DOI 10.1034/j.1600-065X.2001.1810114.x; Djeu JY, 2002, CLIN CANCER RES, V8, P636; El-Sherbiny YM, 2007, CANCER RES, V67, P8444, DOI 10.1158/0008-5472.CAN-06-4230; Elishmereni M, 2008, CURR OPIN INVEST DR, V9, P491; Friberg Diana D., 1996, Methods (Orlando), V9, P316, DOI 10.1006/meth.1996.0037; Kojima H, 2003, J BIOL CHEM, V278, P36748, DOI 10.1074/jbc.M300702200; Krzewski K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00335; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Liu J, 2012, J IMMUNOL, V188, P5511, DOI 10.4049/jimmunol.1200324; Ma DC, 2005, EUR J HAEMATOL, V74, P228, DOI 10.1111/j.1600-0609.2004.00345.x; McVicar D W, 2001, Sci STKE, V2001, pre1, DOI 10.1126/stke.2001.75.re1; Meyer D, 2009, J BIOL CHEM, V284, P2235, DOI 10.1074/jbc.M807698200; Moretta L, 2006, SEMIN IMMUNOL, V18, P151, DOI 10.1016/j.smim.2006.03.002; Pala P, 2000, J IMMUNOL METHODS, V243, P107, DOI 10.1016/S0022-1759(00)00230-1; Peggs KS, 2005, BRIT J HAEMATOL, V130, P809, DOI 10.1111/j.1365-2141.2005.05627.x; Pende D, 2005, MOL IMMUNOL, V42, P463, DOI 10.1016/j.molimm.2004.07.028; Pende D, 2005, BLOOD, V105, P2066, DOI 10.1182/blood-2004-09-3548; SchartonKersten TM, 1997, CURR OPIN IMMUNOL, V9, P44, DOI 10.1016/S0952-7915(97)80157-4; Seth S, 2009, J LEUKOCYTE BIOL, V86, P91, DOI [10.1189/JLB.1208745, 10.1189/jlb.1208745]; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Stanietsky N, 2009, P NATL ACAD SCI USA, V106, P17858, DOI 10.1073/pnas.0903474106; Stengel KF, 2012, P NATL ACAD SCI USA, V109, P5399, DOI 10.1073/pnas.1120606109; TALMADGE JE, 1980, J NATL CANCER I, V65, P929; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Xu ZW, 2010, CELL MOL IMMUNOL, V7, P11, DOI 10.1038/cmi.2009.108; Ye XH, 2006, VIRAL IMMUNOL, V19, P576, DOI 10.1089/vim.2006.19.576; Zhang P, 2008, P NATL ACAD SCI USA, V105, P18284, DOI 10.1073/pnas.0807848105; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	39	19	23	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6969	6977		10.1074/jbc.M113.498253	http://dx.doi.org/10.1074/jbc.M113.498253			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24451371	hybrid, Green Published			2022-12-28	WOS:000332389400057
J	Lee, KP; Choi, S; Hong, JH; Ahuja, M; Graham, S; Ma, R; So, I; Shin, DM; Muallem, S; Yuan, JP				Lee, Kyu Pil; Choi, Seok; Hong, Jeong Hee; Ahuja, Malini; Graham, Sarabeth; Ma, Rong; So, Insuk; Shin, Dong Min; Muallem, Shmuel; Yuan, Joseph P.			Molecular Determinants Mediating Gating of Transient Receptor Potential Canonical (TRPC) Channels by Stromal Interaction Molecule 1 (STIM1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Calcium Signaling; Gating; Signaling; TRP Channels; Gating Mechanism; STIM1	STORE-OPERATED CHANNELS; PLASMA-MEMBRANE; ORAI CHANNELS; CA2+ INFLUX; MECHANISTIC INSIGHTS; CRAC CHANNELS; DOMAIN; ENTRY; CALCIUM; OLIGOMERIZATION	Background: STIM1 gates TRPC channels, but the interacting domains are unknown. Results: The TRPC N and C terminus coiled coil domains interact to restrict access of STIM1. Their dissociation by cell stimulation promotes STIM1 interaction. Conclusion: The STIM1 Orai1-activating region (SOAR) domain interacts with the TRPC C terminus CCD to open the channels. Significance: The findings reveal how STIM1 opens the TRPC channels to control receptor-stimulated Ca2+ influx. Transient receptor potential canonical (TRPC) channels mediate a critical part of the receptor-evoked Ca2+ influx. TRPCs are gated open by the endoplasmic reticulum Ca2+ sensor STIM1. Here we asked which stromal interaction molecule 1 (STIM1) and TRPC domains mediate the interaction between them and how this interaction is used to open the channels. We report that the STIM1 Orai1-activating region domain of STIM1 interacts with the TRPC channel coiled coil domains (CCDs) and that this interaction is essential for opening the channels by STIM1. Thus, disruption of the N-terminal (NT) CCDs by triple mutations eliminated TRPC surface localization and reduced binding of STIM1 to TRPC1 and TRPC5 while increasing binding to TRPC3 and TRPC6. Single mutations in TRPC1 NT or C-terminal (CT) CCDs reduced interaction and activation of TRPC1 by STIM1. Remarkably, single mutations in the TRPC3 NT CCD enhanced interaction and regulation by STIM1. Disruption in the TRPC3 CT CCD eliminated regulation by STIM1 and the enhanced interaction caused by NT CCD mutations. The NT CCD mutations converted TRPC3 from a TRPC1-dependent to a TRPC1-independent, STIM1-regulated channel. TRPC1 reduced the FRET between BFP-TRPC3 and TRPC3-YFP and between CFP-TRPC3-YFP upon stimulation. Accordingly, knockdown of TRPC1 made TRPC3 STIM1-independent. STIM1 dependence of TRPC3 was reconstituted by the TRPC1 CT CCD alone. Knockout of Trpc1 and Trpc3 similarly inhibited Ca2+ influx, and inhibition of Trpc3 had no further effect on Ca2+ influx in Trpc1(-/-) cells. Cell stimulation enhanced the formation of Trpc1-Stim1-Trpc3 complexes. These findings support a model in which the TRPC3 NT and CT CCDs interact to shield the CT CCD from interaction with STIM1. The TRPC1 CT CCD dissociates this interaction to allow the STIM1 Orai1-activating region within STIM1 access to the TRPC3 CT CCD and regulation of TRPC3 by STIM1. These studies provide evidence that the TRPC channel CCDs participate in channel gating.	[Lee, Kyu Pil] Chungnam Natl Univ, Coll Vet Med, Dept Physiol, Taejon 305764, South Korea; [Choi, Seok; Hong, Jeong Hee; Ahuja, Malini; Muallem, Shmuel] NIDCR, Epithelial Signaling & Transport Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA; [Graham, Sarabeth; Ma, Rong; Yuan, Joseph P.] Univ N Texas, Hlth Sci Ctr, Cardiovasc Res Inst, Dept Integrat Physiol, Ft Worth, TX 76107 USA; [So, Insuk] Seoul Natl Univ, Coll Med, Dept Physiol & Biophys, Seoul 110799, South Korea; [Shin, Dong Min] Yonsei Univ, Dept Oral Biol, PLUS Project BK21, Seoul 120752, South Korea; [Choi, Seok] Chosun Univ, Coll Med, Dept Physiol, Kwangju 501759, South Korea	Chungnam National University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of North Texas System; University of North Texas Health Science Center; Seoul National University (SNU); Yonsei University; Chosun University	Muallem, S (corresponding author), NIDCR, Epithelial Signaling & Transport Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA.	shmuel.muallem@nih.gov	rchnds, rchnds/D-7595-2016; Hong, Jeong Hee/AAX-7824-2020; ma, rong/GVU-3096-2022	Shin, Dong Min/0000-0001-6042-0435; lee, kyu pil/0000-0002-7192-4791	National Institute of Health [Z1A-DE000735, Z01-ES101684, 5R00HL093297]; National Research Foundation of Korea (NRF) [NRF-2013R1A1A1010783, 20070056092, 2012R1A2A1A01003487]; Korean government; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL093297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101684] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government(Korean Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded, in whole or in part, by intramural National Institute of Health grant Z1A-DE000735 (to S. M.); National Institutes of Health Grant Z01-ES101684 (to L. B.); and National Institutes of Health Grant 5R00HL093297 (to J. P. Y.). This work was also supported by National Research Foundation of Korea (NRF) grants (MSIP) NRF-2013R1A1A1010783 (to K. P. L.) and 20070056092 and 2012R1A2A1A01003487 (to D. M. S.) funded by the Korean government.	Birnbaumer L, 2009, ANNU REV PHARMACOL, V49, P395, DOI 10.1146/annurev.pharmtox.48.113006.094928; Cheung KK, 2011, MUSCLE NERVE, V44, P358, DOI 10.1002/mus.22060; Derler I, 2012, FRONT BIOSCI-LANDMRK, V17, P1304, DOI 10.2741/3988; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Frischauf I, 2009, J BIOL CHEM, V284, P21696, DOI 10.1074/jbc.M109.018408; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Jardin I, 2013, CELL SIGNAL, V25, P1328, DOI 10.1016/j.cellsig.2013.01.025; Jha A, 2013, J CELL BIOL, V202, P71, DOI 10.1083/jcb.201301148; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Kim MS, 2009, GASTROENTEROLOGY, V137, P1509, DOI 10.1053/j.gastro.2009.07.042; Kim MS, 2009, J BIOL CHEM, V284, P9733, DOI 10.1074/jbc.M808097200; Lee KP, 2010, J BIOL CHEM, V285, P38666, DOI 10.1074/jbc.M110.155036; Lee KP, 2009, P NATL ACAD SCI USA, V106, P14687, DOI 10.1073/pnas.0904664106; Lee MG, 1998, J PHYSIOL-LONDON, V513, P341, DOI 10.1111/j.1469-7793.1998.341bb.x; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Liu XB, 2005, J BIOL CHEM, V280, P21600, DOI 10.1074/jbc.c400492200; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Schleifer H, 2012, BRIT J PHARMACOL, V167, P1712, DOI 10.1111/j.1476-5381.2012.02126.x; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Tong Q, 2008, J BIOL CHEM, V283, P10385, DOI 10.1074/jbc.M710231200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wedel BJ, 2003, J BIOL CHEM, V278, P25758, DOI 10.1074/jbc.M303890200; Worley PF, 2007, CELL CALCIUM, V42, P205, DOI 10.1016/j.ceca.2007.03.004; Yang X, 2012, P NATL ACAD SCI USA, V109, P5657, DOI 10.1073/pnas.1118947109; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zeng WZ, 2008, MOL CELL, V32, P439, DOI 10.1016/j.molcel.2008.09.020; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103	34	71	72	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6372	6382		10.1074/jbc.M113.546556	http://dx.doi.org/10.1074/jbc.M113.546556			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24464579	Green Published, hybrid			2022-12-28	WOS:000332389400006
J	Morrison, EA; Henzler-Wildman, KA				Morrison, Emma A.; Henzler-Wildman, Katherine A.			Transported Substrate Determines Exchange Rate in the Multidrug Resistance Transporter EmrE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Membrane Transport; Multidrug Transporters; NMR; Protein Drug Interactions; Protein Dynamics	INDUCED CONFORMATIONAL-CHANGES; ESCHERICHIA-COLI; ETHIDIUM-BROMIDE; BINDING; DYNAMICS; MODEL; MECHANISM; PROTEINS; DOMAIN; STATE	Background: EmrE transports a broad range of compounds. Results: EmrE converts between open-in and open-out states with rates that vary over 3 orders of magnitude, depending on substrate. Conclusion: Substrate affects both ground-state and transition-state energies for conformational exchange, emphasizing the coupling between substrate binding and transport. Significance: Drug identity determines its own rate of transport by EmrE. EmrE, a small multidrug resistance transporter, serves as an ideal model to study coupling between multidrug recognition and protein function. EmrE has a single small binding pocket that must accommodate the full range of diverse substrates recognized by this transporter. We have studied a series of tetrahedral compounds, as well as several planar substrates, to examine multidrug recognition and transport by EmrE. Here we show that even within this limited series, the rate of interconversion between the inward- and outward-facing states of EmrE varies over 3 orders of magnitude. Thus, the identity of the bound substrate controls the rate of this critical step in the transport process. The binding affinity also varies over a similar range and is correlated with substrate hydrophobicity within the tetrahedral substrate series. Substrate identity influences both the ground-state and transition-state energies for the conformational exchange process, highlighting the coupling between substrate binding and transport required for alternating access antiport.	[Morrison, Emma A.; Henzler-Wildman, Katherine A.] Washington Univ, St Louis Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Saint Louis University; Washington University (WUSTL)	Henzler-Wildman, KA (corresponding author), 660 S Euclid Ave,Box 8231, St Louis, MO 63110 USA.	khenzler@biochem.wustl.edu		Morrison, Emma/0000-0001-6722-7961; Henzler-Wildman, Katherine/0000-0002-5295-2121	National Institutes of Health [P41RR02301, P41GM66326, RR02781, RR08438]; University of Wisconsin; National Science Foundation [DMB-8415048, OIA-9977486, BIR-9214394]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002301, S10RR002781, S10RR008438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095839, P41GM066326] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Scott Wildman for medicinal chemistry advice, Tim Lohman and Jim Janetka for the use of the fluorimeter and HPLC, and G. Chang for the EmrE expression plasmid. We thank Greg DeKoster, Marco Tonelli (NMRFAM), and Geoffrey Armstrong (Rocky Mountain NMR Facility) for assistance with NMR acquisition. This study made use of the Rocky Mountain NMR Facility and the National Magnetic Resonance Facility at Madison (NMRFAM). NMRFAM is supported by National Institutes of Health Grants P41RR02301 (BRTP/NCRR) and P41GM66326 (NIGMS), the University of Wisconsin, National Institutes of Health Grant RR02781 and RR08438, National Science Foundation Grants DMB-8415048, OIA-9977486, and BIR-9214394, and the USDA.	Adam Y, 2007, P NATL ACAD SCI USA, V104, P17989, DOI 10.1073/pnas.0704425104; Akke M, 2002, CURR OPIN STRUC BIOL, V12, P642, DOI 10.1016/S0959-440X(02)00369-X; Amadi ST, 2010, J BIOL CHEM, V285, P26710, DOI 10.1074/jbc.M110.132621; Bachas S, 2011, P NATL ACAD SCI USA, V108, P11046, DOI 10.1073/pnas.1104850108; Brill S, 2012, P NATL ACAD SCI USA, V109, P16894, DOI 10.1073/pnas.1211831109; Chen YJ, 2007, P NATL ACAD SCI USA, V104, P18999, DOI 10.1073/pnas.0709387104; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Elbaz Y, 2005, BIOCHEMISTRY-US, V44, P7369, DOI 10.1021/bi050356t; Elbaz Y, 2008, J BIOL CHEM, V283, P12276, DOI 10.1074/jbc.M710338200; Garbett NC, 2004, BIOPHYS J, V87, P3974, DOI 10.1529/biophysj.104.047415; Gardino AK, 2009, CELL, V139, P1109, DOI 10.1016/j.cell.2009.11.022; Gayen A, 2013, ANGEW CHEM INT EDIT, V52, P10321, DOI 10.1002/anie.201303091; Glover KJ, 2001, BIOPHYS J, V81, P2163, DOI 10.1016/S0006-3495(01)75864-X; Gutman N, 2003, J BIOL CHEM, V278, P16082, DOI 10.1074/jbc.M213120200; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman K, 2012, CURR OPIN STRUC BIOL, V22, P38, DOI 10.1016/j.sbi.2011.10.004; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Korkhov VM, 2008, J MOL BIOL, V377, P1094, DOI 10.1016/j.jmb.2008.01.056; Kovrigin EL, 2012, J BIOMOL NMR, V53, P257, DOI 10.1007/s10858-012-9636-3; Labeikovsky W, 2007, J MOL BIOL, V367, P1370, DOI 10.1016/j.jmb.2007.01.049; LAMBERT B, 1984, BIOCHEMISTRY-US, V23, P166, DOI 10.1021/bi00296a027; Li Y, 2009, J BIOMOL NMR, V45, P357, DOI 10.1007/s10858-009-9385-0; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; Miloushev VZ, 2008, STRUCTURE, V16, P1195, DOI 10.1016/j.str.2008.05.009; Morrison EA, 2012, BBA-BIOMEMBRANES, V1818, P814, DOI 10.1016/j.bbamem.2011.12.020; Neyfakh AA, 2002, MOL MICROBIOL, V44, P1123, DOI 10.1046/j.1365-2958.2002.02965.x; OECD, 2009, OECD GUID TEST CHEM, V2, DOI [10.1787/9789264070264-en, DOI 10.1787/9789264069947-EN, 10.1787/9789264076228-en]; Ong YS, 2013, J AM CHEM SOC, V135, P15754, DOI 10.1021/ja402605s; Poulsen BE, 2011, J BACTERIOL, V193, P5929, DOI 10.1128/JB.05846-11; Rotem D, 2004, J BIOL CHEM, V279, P48787, DOI 10.1074/jbc.M408187200; Rotem D, 2006, J BIOL CHEM, V281, P18715, DOI 10.1074/jbc.M602088200; Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Tugarinov V, 2003, J MOL BIOL, V327, P1121, DOI 10.1016/S0022-2836(03)00238-9; Ubarretxena-Belandia I, 2003, EMBO J, V22, P6175, DOI 10.1093/emboj/cdg611; Veglia G, 2013, FEBS J, V280, P5608, DOI 10.1111/febs.12462; Velyvis A, 2007, P NATL ACAD SCI USA, V104, P8815, DOI 10.1073/pnas.0703347104; Villali J, 2010, CURR OPIN CHEM BIOL, V14, P636, DOI 10.1016/j.cbpa.2010.08.007; Vogt AD, 2013, BIOCHEMISTRY-US, V52, P5723, DOI 10.1021/bi400929b; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wade H, 2010, CURR OPIN STRUC BIOL, V20, P489, DOI 10.1016/j.sbi.2010.06.003; WRIGHT RGM, 1980, BIOCHEMISTRY-US, V19, P5825, DOI 10.1021/bi00566a026; Yerushalmi H, 2000, BIOCHEMISTRY-US, V39, P14711, DOI 10.1021/bi001892i; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971	50	32	32	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6825	6836		10.1074/jbc.M113.535328	http://dx.doi.org/10.1074/jbc.M113.535328			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24448799	hybrid, Green Published			2022-12-28	WOS:000332389400042
J	Cushing, L; Stochaj, W; Siegel, M; Czerwinski, R; Dower, K; Wright, Q; Hirschfield, M; Casanova, JL; Picard, C; Puel, A; Lin, LL; Rao, VR				Cushing, Leah; Stochaj, Wayne; Siegel, Marshall; Czerwinski, Robert; Dower, Ken; Wright, Quentin; Hirschfield, Margaret; Casanova, Jean-Laurent; Picard, Capucine; Puel, Anne; Lin, Lih-Ling; Rao, Vikram R.			Interleukin 1/Toll-like Receptor-induced Autophosphorylation Activates Interleukin 1 Receptor-associated Kinase 4 and Controls Cytokine Induction in a Cell Type-specific Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Innate Immunity; Interleukin Receptor-associated Kinase (IRAK); Protein Kinases; Protein Phosphorylation; Toll-like Receptors (TLR); Interleukin 1 (IL-1); Interleukin Receptor-associated Kinase 4 (IRAK4)	PYOGENIC BACTERIAL-INFECTIONS; DEPENDENT PROTEIN-KINASE; MYD88 DEFICIENCY; IRAK-4 KINASE; PHOSPHORYLATION; REDUNDANT; COMPLEX; LOOP; FEATURES; IMMUNITY	Background: IRAK4 is a central kinase in IL-1R/TLR signaling. Results: IRAK4 is activated by autophosphorylation, and its inhibition reduces cytokine induction in human monocytes but not dermal fibroblasts. Conclusion: IL-1R/TLR-induced autophosphorylation activates IRAK4 and controls cytokine induction in a cell type-specific manner. Significance: Our data provide the mechanism of IRAK4 activation and role in cytokine induction in human cells. IRAK4 is a central kinase in innate immunity, but the role of its kinase activity is controversial. The mechanism of activation for IRAK4 is currently unknown, and little is known about the role of IRAK4 kinase in cytokine production, particularly in different human cell types. We show IRAK4 autophosphorylation occurs by an intermolecular reaction and that autophosphorylation is required for full catalytic activity of the kinase. Phosphorylation of any two of the residues Thr-342, Thr-345, and Ser-346 is required for full activity, and the death domain regulates the activation of IRAK4. Using antibodies against activated IRAK4, we demonstrate that IRAK4 becomes phosphorylated in human cells following stimulation by IL-1R and Toll-like receptor agonists, which can be blocked pharmacologically by a dual inhibitor of IRAK4 and IRAK1. Interestingly, in dermal fibroblasts, although complete inhibition of IRAK4 kinase activity does not inhibit IL-1-induced IL-6 production, NF-B, or MAPK activation, there is complete ablation of these processes in IRAK4-deficient cells. In contrast, the inhibition of IRAK kinase activity in primary human monocytes reduces R848-induced IL-6 production with minimal effect on NF-B or MAPK activation. Taken together, these studies define the mechanism of IRAK4 activation and highlight the differential role of IRAK4 kinase activity in different human cell types as well as the distinct roles IRAK4 scaffolding and kinase functions play.	[Cushing, Leah; Czerwinski, Robert; Dower, Ken; Wright, Quentin; Hirschfield, Margaret; Lin, Lih-Ling; Rao, Vikram R.] Pfizer Res, Inflammat & Remodeling Res Unit, Cambridge, MA 02140 USA; [Stochaj, Wayne] Pfizer Res, Global Biol Technol, Cambridge, MA 02140 USA; [Siegel, Marshall] Pfizer Chem Technol Sect, Pearl River, NY 10965 USA; [Casanova, Jean-Laurent; Puel, Anne] Rockefeller Univ, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA; [Casanova, Jean-Laurent] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Casanova, Jean-Laurent] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Pediat Hematol Immunol Unit, F-75015 Paris, France; [Casanova, Jean-Laurent; Picard, Capucine; Puel, Anne] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Imagine Inst, Lab Human Genet Infect Dis, F-75015 Paris, France; [Picard, Capucine] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Study Ctr Primary Immunodeficiencies, F-75015 Paris, France; [Casanova, Jean-Laurent; Picard, Capucine; Puel, Anne] Univ Paris 05, F-75006 Paris, France	Pfizer; Pfizer; Pfizer; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Lin, LL (corresponding author), Pfizer, Inflammat & Remodeling Res Unit, 200 Cambridge Pk Dr, Cambridge, MA 02140 USA.	Lih-Ling.Lin@pfizer.com; Vikram.Rao@pfizer.com	Puel, Anne/H-7305-2017; Picard, Capucine/H-3914-2017; Casanova, Jean-Laurent/I-3418-2017	Puel, Anne/0000-0003-2603-0323; Picard, Capucine/0000-0001-8788-5056; Wright, Quentin/0000-0001-9628-0200; Casanova, Jean-Laurent/0000-0002-7782-4169				Cameron B, 2012, J NEUROSCI, V32, P15112, DOI 10.1523/JNEUROSCI.1729-12.2012; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Cheng H, 2007, BIOCHEM BIOPH RES CO, V352, P609, DOI 10.1016/j.bbrc.2006.11.068; Chiang EY, 2011, J IMMUNOL, V186, P1279, DOI 10.4049/jimmunol.1002821; Czerwinski R, 2005, BIOCHEMISTRY-US, V44, P9563, DOI 10.1021/bi050608q; Fraczek J, 2008, J BIOL CHEM, V283, P31697, DOI 10.1074/jbc.M804779200; Hatao F, 2004, J LEUKOCYTE BIOL, V76, P904, DOI 10.1189/jlb.0504277; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Kim TW, 2011, J IMMUNOL, V186, P2871, DOI 10.4049/jimmunol.1002242; Koziczak-Holbro M, 2009, ARTHRITIS RHEUM-US, V60, P1661, DOI 10.1002/art.24552; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Kuglstatter A, 2007, J IMMUNOL, V178, P2641, DOI 10.4049/jimmunol.178.5.2641; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Luciano BS, 2004, J BIOL CHEM, V279, P52117, DOI 10.1074/jbc.M403716200; Moncrieffe MC, 2008, J BIOL CHEM, V283, P33447, DOI 10.1074/jbc.M805427200; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; O'Neill LA, 2003, CURR OPIN PHARMACOL, V3, P396, DOI 10.1016/S1471-4892(03)00080-8; Patricelli MP, 2011, CHEM BIOL, V18, P699, DOI 10.1016/j.chembiol.2011.04.011; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; Qin JZ, 2004, J BIOL CHEM, V279, P26748, DOI 10.1074/jbc.M400785200; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Shen BH, 2002, DEVELOPMENT, V129, P1925; Smith JA, 1996, J BIOL CHEM, V271, P20756, DOI 10.1074/jbc.271.34.20756; Song KW, 2009, MOL IMMUNOL, V46, P1458, DOI 10.1016/j.molimm.2008.12.012; Staschke KA, 2009, J IMMUNOL, V183, P568, DOI 10.4049/jimmunol.0802361; STEINBERG RA, 1993, MOL CELL BIOL, V13, P2332, DOI 10.1128/MCB.13.4.2332; Tuazon PT, 1998, BIOCHEMISTRY-US, V37, P17024, DOI 10.1021/bi982103o; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wang ZL, 2006, STRUCTURE, V14, P1835, DOI 10.1016/j.str.2006.11.001; Zhang GL, 2002, J BIOL CHEM, V277, P7059, DOI 10.1074/jbc.M109537200	33	36	38	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10865	10875		10.1074/jbc.M113.544809	http://dx.doi.org/10.1074/jbc.M113.544809			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24567333	Green Published, hybrid			2022-12-28	WOS:000334226400054
J	Vild, CJ; Xu, ZH				Vild, Cody J.; Xu, Zhaohui			Vfa1 Binds to the N-terminal Microtubule-interacting and Trafficking ( MIT) Domain of Vps4 and Stimulates Its ATPase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; Crystal Structure; Endosomes; Membrane Trafficking; Protein-Protein Interactions; ESCRT; MVB; Vfa1; Vps4	ESCRT-III CHMP3; STRUCTURAL BASIS; AAA-ATPASE; PROTEIN; MACHINERY; COMPLEX; CYTOKINESIS; RECOGNITION; PATHWAY; BIOGENESIS	Background: Vfa1 was recently identified as a Vps4-binding protein, yet its function was unknown. Results: Vfa1 potently stimulates Vps4 ATPase activity, and Vps4-Vfa1 interaction consists of a binding mechanism previously seen in other Vps4 regulator structures. Conclusion: Biochemical and biophysical studies show that Vfa1 is a novel regulator of Vps4 in the multivesicular body pathway. Significance: Vps4-Vfa1 interaction further expands the complexity of Vps4 regulation. The endosomal sorting complexes required for transport (ESCRT) are responsible for multivesicular body biogenesis, membrane abscission during cytokinesis, and retroviral budding. They function as transiently assembled molecular complexes on the membrane, and their disassembly requires the action of the AAA-ATPase Vps4. Vps4 is regulated by a multitude of ESCRT and ESCRT-related proteins. Binding of these proteins to Vps4 is often mediated via the microtubule-interacting and trafficking (MIT) domain of Vps4. Recently, a new Vps4-binding protein Vfa1 was identified in a yeast genetic screen, where overexpression of Vfa1 caused defects in vacuolar morphology. However, the function of Vfa1 and its role in vacuolar biology were largely unknown. Here, we provide the first detailed biochemical and biophysical study of Vps4-Vfa1 interaction. The MIT domain of Vps4 binds to the C-terminal 17 residues of Vfa1. This interaction is of high affinity and greatly stimulates the ATPase activity of Vps4. The crystal structure of the Vps4-Vfa1 complex shows that Vfa1 adopts a canonical MIT-interacting motif 2 structure that has been observed previously in other Vps4-ESCRT interactions. These findings suggest that Vfa1 is a novel positive regulator of Vps4 function.	[Xu, Zhaohui] Univ Michigan, Sch Med, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Xu, ZH (corresponding author), Univ Michigan, Sch Med, Inst Life Sci, Ann Arbor, MI 48109 USA.	zhaohui@umich.edu			National Institutes of Health [GM095769]; Department of Energy [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM095769 (to Z. X.). Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the Department of Energy under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (Grant 085P1000817).	Arlt H, 2011, TRAFFIC, V12, P1592, DOI 10.1111/j.1600-0854.2011.01252.x; Azmi I, 2006, J CELL BIOL, V172, P705, DOI 10.1083/jcb.200508166; Azmi IF, 2008, DEV CELL, V14, P50, DOI 10.1016/j.devcel.2007.10.021; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Bajorek M, 2009, MOL BIOL CELL, V20, P1360, DOI 10.1091/mbc.E08-05-0475; Baumgartel V, 2011, NAT CELL BIOL, V13, P469, DOI 10.1038/ncb2215; Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; Elia N, 2012, BIOPHYS J, V102, P2309, DOI 10.1016/j.bpj.2012.04.007; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gonciarz MD, 2008, J MOL BIOL, V384, P878, DOI 10.1016/j.jmb.2008.09.066; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hill CP, 2012, BBA-MOL CELL RES, V1823, P172, DOI 10.1016/j.bbamcr.2011.08.017; Hurley JH, 2008, DEV CELL, V14, P6, DOI 10.1016/j.devcel.2007.12.013; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Kieffer C, 2008, DEV CELL, V15, P62, DOI 10.1016/j.devcel.2008.05.014; Landsberg MJ, 2009, STRUCTURE, V17, P427, DOI 10.1016/j.str.2008.12.020; Lata S, 2008, J MOL BIOL, V378, P818, DOI 10.1016/j.jmb.2008.03.030; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Merrill SA, 2010, J BIOL CHEM, V285, P35428, DOI 10.1074/jbc.M110.126318; Monroe N, 2014, J MOL BIOL, V426, P510, DOI 10.1016/j.jmb.2013.09.043; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Nickerson DP, 2010, MOL BIOL CELL, V21, P1023, DOI 10.1091/mbc.E09-09-0776; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Renvoise B, 2010, MOL BIOL CELL, V21, P3293, DOI 10.1091/mbc.E09-10-0879; Rozycki B, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002736; Rozycki B, 2011, STRUCTURE, V19, P109, DOI 10.1016/j.str.2010.10.006; Rue SM, 2008, MOL BIOL CELL, V19, P475, DOI 10.1091/mbc.E07-07-0694; Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102; Shestakova A, 2010, MOL BIOL CELL, V21, P1059, DOI 10.1091/mbc.E09-07-0572; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Skalicky JJ, 2012, J BIOL CHEM, V287, P43910, DOI 10.1074/jbc.M112.417899; Solomons J, 2011, STRUCTURE, V19, P1149, DOI 10.1016/j.str.2011.05.011; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Winter V, 2006, TRENDS PLANT SCI, V11, P115, DOI 10.1016/j.tplants.2006.01.008; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Xiao JY, 2008, DEV CELL, V14, P37, DOI 10.1016/j.devcel.2007.10.013; Xiao JY, 2007, J MOL BIOL, V374, P655, DOI 10.1016/j.jmb.2007.09.067; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512; Yang ZZ, 2012, J BIOL CHEM, V287, P43899, DOI 10.1074/jbc.M112.390724; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	52	11	12	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10378	10386		10.1074/jbc.M113.532960	http://dx.doi.org/10.1074/jbc.M113.532960			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24567329	Green Published, hybrid			2022-12-28	WOS:000334226400012
J	Morin, B; Whelan, SPJ				Morin, Benjamin; Whelan, Sean P. J.			Sensitivity of the Polymerase of Vesicular Stomatitis Virus to 2 Substitutions in the Template and Nucleotide Triphosphate during Initiation and Elongation*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Inhibitors; Negative-strand RNA Viruses; Nucleoside Nucleotide Analogs; RNA; RNA Polymerase	DEPENDENT RNA-POLYMERASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; COMPLEX; MECHANISM; RNA-POLYMERASE-(3D(POL)); POLYMERIZATION; TRANSCRIPTION; ARCHITECTURE; TRANSITION	Background: Non-segmented negative-strand RNA (NNS) virus polymerase initiation and elongation are targets for intervention. Results: 2 modifications to the template and NTP inhibit elongation more than initiation by the vesicular stomatitis virus polymerase. Conclusion: Polymerase is sensitive to template and substrate modifications, and its active site is directly influenced by the nucleoprotein. Significance: Nucleoprotein influences the substrate utilization of an NNS RNA virus polymerase. The RNA synthesis machinery of non-segmented negative-sense RNA viruses comprises a ribonucleoprotein complex of the genomic RNA coated by a nucleocapsid protein (N) and associated with polymerase. Work with vesicular stomatitis virus (VSV), a prototype, supports a model of RNA synthesis whereby N is displaced from the template to allow the catalytic subunit of the polymerase, the large protein (L) to gain access to the RNA. Consistent with that model, purified L can copy synthetic RNA that contains requisite promoter sequences. Full processivity of L requires its phosphoprotein cofactor and the template-associated N. Here we demonstrate the importance of the 2 position of the RNA template and the substrate nucleotide triphosphates during initiation and elongation by L. The VSV polymerase can initiate on both DNA and RNA and can incorporate dNTPs. During elongation, the polymerase is sensitive to 2 modifications, although dNTPs can be incorporated, and mixed DNA-RNA templates can function. Modifications to the 2 position of the NTP, including 2,3-ddCTP, arabinose-CTP, and 2-O-methyl-CTP, inhibit polymerase, whereas 2-amino-CTP is incorporated. The inhibitory effects of the NTPs were more pronounced on authentic N-RNA with the exception of dGTP, which is incorporated. This work underscores the sensitivity of the VSV polymerase to nucleotide modifications during initiation and elongation and highlights the importance of the 2-hydroxyl of both template and substrate NTP. Moreover, this study demonstrates a critical role of the template-associated N protein in the architecture of the RNA-dependent RNA polymerase domain of L.	[Morin, Benjamin; Whelan, Sean P. J.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Whelan, SPJ (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	swhelan@hms.harvard.edu		Whelan, Sean/0000-0003-1564-8590	National Institutes of Health [AI059371, AI057159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, R37AI059371, R01AI059371] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI059371 and AI057159.	Albertini AAV, 2006, SCIENCE, V313, P360, DOI 10.1126/science.1125280; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5138, DOI 10.1021/bi035213q; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Ferrer-Orta C, 2006, CURR OPIN STRUC BIOL, V16, P27, DOI 10.1016/j.sbi.2005.12.002; Ferrer-Orta C, 2004, J BIOL CHEM, V279, P47212, DOI 10.1074/jbc.M405465200; Gohara DW, 2000, J BIOL CHEM, V275, P25523, DOI 10.1074/jbc.M002671200; Gohara DW, 2004, BIOCHEMISTRY-US, V43, P5149, DOI 10.1021/bi035429s; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; Green TJ, 2006, SCIENCE, V313, P357, DOI 10.1126/science.1126953; Kao CC, 2001, VIROLOGY, V287, P251, DOI 10.1006/viro.2001.1039; Kranzusch PJ, 2011, P NATL ACAD SCI USA, V108, P19743, DOI 10.1073/pnas.1112742108; Li JR, 2006, P NATL ACAD SCI USA, V103, P8493, DOI 10.1073/pnas.0509821103; Li JR, 2005, J VIROL, V79, P13373, DOI 10.1128/JVI.79.21.13373-13384.2005; Lij J, 2008, J VIROL, V82, P775, DOI 10.1128/JVI.02107-07; Morin B, 2012, EMBO J, V31, P1320, DOI 10.1038/emboj.2011.483; Ng KKS, 2008, CURR TOP MICROBIOL, V320, P137; Noton SL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002980; Ogino T, 2007, MOL CELL, V25, P85, DOI 10.1016/j.molcel.2006.11.013; Rahmeh AA, 2012, P NATL ACAD SCI USA, V109, P14628, DOI 10.1073/pnas.1209147109; Rahmeh AA, 2010, P NATL ACAD SCI USA, V107, P20075, DOI 10.1073/pnas.1013559107; SCHUBERT M, 1982, J BIOL CHEM, V257, P2968; Siegel RW, 1999, J VIROL, V73, P6424, DOI 10.1128/JVI.73.8.6424-6429.1999; SLEAT DE, 1993, J VIROL, V67, P1334, DOI 10.1128/JVI.67.3.1334-1339.1993; Sofia MJ, 2012, J MED CHEM, V55, P2481, DOI 10.1021/jm201384j; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Tawar RG, 2009, SCIENCE, V326, P1279, DOI 10.1126/science.1177634; Tayon R, 2001, NUCLEIC ACIDS RES, V29, P3576, DOI 10.1093/nar/29.17.3576; van Dijk AA, 2004, J GEN VIROL, V85, P1077, DOI 10.1099/vir.0.19731-0; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464; Zamyatkin DF, 2008, J BIOL CHEM, V283, P7705, DOI 10.1074/jbc.M709563200; Zhong WD, 1998, J VIROL, V72, P9365, DOI 10.1128/JVI.72.11.9365-9369.1998	32	12	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9961	9969		10.1074/jbc.M113.542761	http://dx.doi.org/10.1074/jbc.M113.542761			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24526687	Green Published, hybrid			2022-12-28	WOS:000333807000045
J	Semeniuk, A; Sohlenkamp, C; Duda, K; Holzl, G				Semeniuk, Adrian; Sohlenkamp, Christian; Duda, Katarzyna; Hoelzl, Georg			A Bifunctional Glycosyltransferase from Agrobacterium tumefaciens Synthesizes Monoglucosyl and Glucuronosyl Diacylglycerol under Phosphate Deprivation*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Chromatography; Glycolipids; Glycosyltransferases; Membrane Bilayer; Gram-negative; Q-TOF; Bifunctional; Glucuronic Acid	ACHOLEPLASMA-LAIDLAWII MEMBRANES; UDP-GLUCOSE 4-EPIMERASE; SINORHIZOBIUM-MELILOTI; RHIZOBIUM-MELILOTI; DIGLUCOSYLDIACYLGLYCEROL SYNTHASE; SUCCINOGLYCAN BIOSYNTHESIS; PHOSPHORUS LIMITATION; PSEUDOMONAS-DIMINUTA; ARABIDOPSIS-THALIANA; FAMILY RHIZOBIACEAE	Background: Despite the high diversity of glycolipids found in many organisms, only a few glycosyltransferases have been isolated. Results: A bifunctional glycosyltransferase, synthesizing glucuronosyl or monoglucosyl diacylglycerol, was isolated from Agrobacterium. Conclusion: Glycolipids and other nonphospholipids can mutually replace each other, enhancing the ability to adapt to changing environments. Significance: This is the first report on the isolation of a glucuronosyl diacylglycerol synthase. Glycolipids are mainly found in phototrophic organisms (like plants and cyanobacteria), in Gram-positive bacteria, and a few other bacterial phyla. Besides the function as bulk membrane lipids, they often play a role under phosphate deprivation as surrogates for phospholipids. The Gram-negative Agrobacterium tumefaciens accumulates four different glycolipids under phosphate deficiency, including digalactosyl diacylglycerol and glucosylgalactosyl diacylglycerol synthesized by a processive glycosyltransferase. The other two glycolipids have now been identified by mass spectrometry and nuclear magnetic resonance spectroscopy as monoglucosyl diacylglycerol and glucuronosyl diacylglycerol. These two lipids are synthesized by a single promiscuous glycosyltransferase encoded by the ORF atu2297, with UDP-glucose or UDP-glucuronic acid as sugar donors. The transfer of sugars differing in their chemistry is a novel feature not observed before for lipid glycosyltransferases. Furthermore, this enzyme is the first glucuronosyl diacylglycerol synthase isolated. Deletion mutants of Agrobacterium lacking monoglucosyl diacylglycerol and glucuronosyl diacylglycerol or all glycolipids are not impaired in growth or virulence during infection of tobacco leaf discs. Our data suggest that the four glycolipids and the nonphospholipid diacylglyceryl trimethylhomoserine can mutually replace each other during phosphate deprivation. This redundancy of different nonphospholipids may represent an adaptation mechanism to enhance the competitiveness in nature.	[Semeniuk, Adrian; Hoelzl, Georg] Univ Bonn, Inst Mol Physiol & Biotechnol Plants, D-53113 Bonn, Germany; [Sohlenkamp, Christian] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca 62210, Morelos, Mexico; [Duda, Katarzyna] Leibniz Ctr Med & Biosci, Div Struct Biochem, Res Ctr Borstel, D-23845 Borstel, Germany	University of Bonn; Universidad Nacional Autonoma de Mexico; Forschungszentrum Borstel	Holzl, G (corresponding author), Univ Bonn, Inst Mol Physiol & Biotechnol Plants, Karlrobert Kreiten Str 13, D-53115 Bonn, Germany.	hoelzl@uni-bonn.de	Sohlenkamp, Christian/C-6219-2018	Sohlenkamp, Christian/0000-0002-9962-2859; Semeniuk, Adrian David/0000-0002-5751-8068	Deutsche Forschungsgemeinschaft [Ho 3870/1-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant Ho 3870/1-3 (to G. H.). Part of this work was presented at the FEBS Workshop on Microbial Lipids: Diversity in Structure and Formation, May 16-19, 2013, Bern, Switzerland (BALI-009).	Abraham WR, 2004, INT J SYST EVOL MICR, V54, P1227, DOI 10.1099/ijs.0.02943-0; Abraham WR, 1999, INT J SYST BACTERIOL, V49, P1053, DOI 10.1099/00207713-49-3-1053; Andres E, 2011, J BIOL CHEM, V286, P35367, DOI 10.1074/jbc.M110.214148; Vences-Guzman MA, 2013, ENVIRON MICROBIOL, V15, P895, DOI 10.1111/j.1462-2920.2012.02867.x; Awai K, 2001, P NATL ACAD SCI USA, V98, P10960, DOI 10.1073/pnas.181331498; Awai K, 2006, PLANT PHYSIOL, V141, P1120, DOI 10.1104/pp.106.082859; Batrakov SG, 1997, BBA-LIPID LIPID MET, V1347, P127, DOI 10.1016/S0005-2760(97)00060-X; BATRAKOV SG, 1978, CHEM PHYS LIPIDS, V21, P1, DOI 10.1016/0009-3084(78)90052-X; Batrakov SG, 1996, BBA-LIPID LIPID MET, V1302, P167, DOI 10.1016/0005-2760(96)00060-4; Berg S, 2001, J BIOL CHEM, V276, P22056, DOI 10.1074/jbc.M102576200; BREEDVELD MW, 1994, MICROBIOL REV, V58, P145, DOI 10.1128/MMBR.58.2.145-161.1994; BUENDIA AM, 1991, MOL MICROBIOL, V5, P1519, DOI 10.1111/j.1365-2958.1991.tb00799.x; CANGELOSI GA, 1987, J BACTERIOL, V169, P2086, DOI 10.1128/jb.169.5.2086-2091.1987; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CEDERGREN RA, 1994, J LIPID RES, V35, P1452; CREMERS HCJC, 1990, J BIOL CHEM, V265, P21122; Danhorn T, 2004, J BACTERIOL, V186, P4492, DOI 10.1128/JB.186.14.4492-4501.2004; De Castro C, 2008, CARBOHYD RES, V343, P1924, DOI 10.1016/j.carres.2008.01.036; Devers EA, 2011, J BACTERIOL, V193, P1377, DOI 10.1128/JB.00768-10; Dormann P, 1999, SCIENCE, V284, P2181, DOI 10.1126/science.284.5423.2181; Edman M, 2003, J BIOL CHEM, V278, P8420, DOI 10.1074/jbc.M211492200; Geiger O, 1999, MOL MICROBIOL, V32, P63, DOI 10.1046/j.1365-2958.1999.01325.x; Geiger O, 2010, PROG LIPID RES, V49, P46, DOI 10.1016/j.plipres.2009.08.002; GERWIG GJ, 1979, CARBOHYD RES, V77, P1, DOI 10.1016/S0008-6215(00)83788-X; Geske T, 2013, GLYCOBIOLOGY, V23, P69, DOI 10.1093/glycob/cws124; GLUCKSMANN MA, 1993, J BACTERIOL, V175, P7045, DOI 10.1128/jb.175.21.7045-7055.1993; Hoelzl G, 2007, PROG LIPID RES, V46, P225, DOI 10.1016/j.plipres.2007.05.001; Holzl G, 2005, PLANT CELL PHYSIOL, V46, P1766, DOI 10.1093/pcp/pci189; Holzl G, 2005, GLYCOBIOLOGY, V15, P874, DOI 10.1093/glycob/cwi066; Jorasch P, 1998, MOL MICROBIOL, V29, P419, DOI 10.1046/j.1365-2958.1998.00930.x; Jorasch P, 2000, EUR J BIOCHEM, V267, P3770, DOI 10.1046/j.1432-1327.2000.01414.x; Karlsson OP, 1996, BIOCHEMISTRY-US, V35, P10094, DOI 10.1021/bi9602876; Kelly AA, 2003, PLANT CELL, V15, P2694, DOI 10.1105/tpc.016675; Kereszt A, 1998, J BACTERIOL, V180, P5426, DOI 10.1128/JB.180.20.5426-5431.1998; Klement MLR, 2007, MOL MICROBIOL, V65, P1444, DOI 10.1111/j.1365-2958.2007.05865.x; KOYNOVA RD, 1993, BIOCHEMISTRY-US, V32, P12437, DOI 10.1021/bi00097a023; Linscheid M, 1997, BBA-LIPID LIPID MET, V1347, P151, DOI 10.1016/S0005-2760(97)00065-9; Lopez-Lara IM, 2005, MOL PLANT MICROBE IN, V18, P973, DOI 10.1094/MPMI-18-0973; Lopez-Lara IM, 2003, MOL PLANT MICROBE IN, V16, P567, DOI 10.1094/MPMI.2003.16.7.567; MATTHYSSE AG, 1995, J BACTERIOL, V177, P1076, DOI 10.1128/jb.177.4.1076-1081.1995; MINNIKIN DE, 1974, NATURE, V249, P268, DOI 10.1038/249268a0; MINNIKIN DE, 1971, BIOCHIM BIOPHYS ACTA, V249, P651, DOI 10.1016/0005-2736(71)90148-9; Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801; Okazaki Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2512; Ostberg Y, 2007, FEMS MICROBIOL LETT, V272, P22, DOI 10.1111/j.1574-6968.2007.00728.x; Reichmann NT, 2011, FEMS MICROBIOL LETT, V319, P97, DOI 10.1111/j.1574-6968.2011.02260.x; Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P7485, DOI 10.1128/JB.181.24.7485-7492.1999; SEGERS P, 1994, INT J SYST BACTERIOL, V44, P499, DOI 10.1099/00207713-44-3-499; STERN N, 1971, FEBS LETT, V19, P217, DOI 10.1016/0014-5793(71)80517-3; Tomlinson AD, 2010, MICROBIOL-SGM, V156, P2670, DOI 10.1099/mic.0.039032-0; Vikstrom S, 1999, BIOCHEMISTRY-US, V38, P5511, DOI 10.1021/bi982532m; Vikstrom S, 2000, J BIOL CHEM, V275, P9296, DOI 10.1074/jbc.275.13.9296; Weissenmayer B, 2000, MOL PLANT MICROBE IN, V13, P666, DOI 10.1094/MPMI.2000.13.6.666; Wieslander A, 1997, CURR TOP MEMBR, V44, P517; WOLUCKA BA, 1993, BIOCHIM BIOPHYS ACTA, V1170, P131, DOI 10.1016/0005-2760(93)90062-E; Yuan ZC, 2006, NUCLEIC ACIDS RES, V34, P2686, DOI 10.1093/nar/gkl365; Zavaleta-Pastor M, 2010, P NATL ACAD SCI USA, V107, P302, DOI 10.1073/pnas.0912930107	57	18	18	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10104	10114		10.1074/jbc.M113.519298	http://dx.doi.org/10.1074/jbc.M113.519298			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24558041	Green Published, hybrid			2022-12-28	WOS:000333807000057
J	Liu, L; Huang, C; He, ZG				Liu, Lei; Huang, Cheng; He, Zheng-Guo			A TetR Family Transcriptional Factor Directly Regulates the Expression of a 3-Methyladenine DNA Glycosylase and Physically Interacts with the Enzyme to Stimulate Its Base Excision Activity in Mycobacterium bovis BCG	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Genetics; DNA Enzymes; DNA Nucleotide Excision Repair; DNA-Protein Interaction; Enzymes; Gene Expression; General Transcription Factors; Protein-Protein Interactions	MICROSATELLITE INSTABILITY; SUBSTRATE-SPECIFICITY; 2-COMPONENT SYSTEM; DRUG-RESISTANCE; TUBERCULOSIS; PROTEIN; GENES; CHEMISTRY; PROMOTER; BIOLOGY	Background: No transcriptional factor has been found to directly regulate expression of the DNA glycosylase in bacteria to date. Results: BCG0878c negatively regulates the expression of MbAAG and stimulates its base excision activity in Mycobacterium bovis BCG. Conclusion: BCG0878c regulates the function of MbAAG both at the transcriptional and post-translational levels. Significance: Our findings reveal a novel mode of regulation of 3MeA DNA glycosylase. 3-Methyladenine DNA glycosylase recognizes and excises a wide range of damaged bases and thus plays a critical role in base excision repair. However, knowledge on the regulation of DNA glycosylase in prokaryotes and eukaryotes is limited. In this study, we successfully characterized a TetR family transcriptional factor from Mycobacterium bovis bacillus Calmette-Guerin (BCG), namely BCG0878c, which directly regulates the expression of 3-methyladenine DNA glycosylase (designated as MbAAG) and influences the base excision activity of this glycosylase at the post-translational level. Using electrophoretic mobility shift assay and DNase I footprinting experiments, we identified two conserved motifs within the upstream region of mbaag specifically recognized by BCG0878c. Significant down-regulation of mbaag was observed in BCG0878c-overexpressed M. bovis BCG strains. By contrast, about 12-fold up-regulation of mbaag expression was found in bcg0878c-deleted mutant M. bovis BCG strains. -Galactosidase activity assays also confirmed these results. Thus, BCG0878c can function as a negative regulator of mbaag expression. In addition, the regulator was shown to physically interact with MbAAG to enhance the ability of the glycosylase to bind damaged DNA. Interaction between the two proteins was further found to facilitate AAG-catalyzed removal of hypoxanthine from DNA. These results indicate that a TetR family protein can dually regulate the function of 3-methyladenine DNA glycosylase in M. bovis BCG both at the transcriptional and post-translational levels. These findings enhance our understanding of the expression and regulation of AAG in mycobacteria.	[Liu, Lei; Huang, Cheng; He, Zheng-Guo] Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Ctr Prote Res, Coll Life Sci & Technol, Wuhan 430070, Peoples R China	Huazhong Agricultural University	He, ZG (corresponding author), Huazhong Agr Univ, Natl Key Lab Agr Microbiol, Ctr Prote Res, Coll Life Sci & Technol, Wuhan 430070, Peoples R China.	he.zhengguo@hotmail.com	He, Zheng-Guo/P-3647-2014		National Natural Science Foundation of China [31025002]; Creative Research Groups of Hubei, Hubei Chutian Scholars Program; Chang Jiang Scholars Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Creative Research Groups of Hubei, Hubei Chutian Scholars Program; Chang Jiang Scholars Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China Grant 31025002, Creative Research Groups of Hubei, Hubei Chutian Scholars Program, and the Chang Jiang Scholars Program (to Z.-G. H.).	Acharya N, 2002, J MOL BIOL, V318, P1251, DOI 10.1016/S0022-2836(02)00053-0; Adams LB, 1997, TUBERCLE LUNG DIS, V78, P237, DOI 10.1016/S0962-8479(97)90004-6; Asaeda A, 2000, BIOCHEMISTRY-US, V39, P1959, DOI 10.1021/bi9917075; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dos Vultos T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001538; Gao CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036255; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Guo MM, 2009, GENOME RES, V19, P1301, DOI 10.1101/gr.086595.108; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Hofseth LJ, 2003, J CLIN INVEST, V112, P1887, DOI 10.1172/JCI200319757; Huang F, 2010, NUCLEIC ACIDS RES, V38, P8219, DOI 10.1093/nar/gkq737; Kedzierska B, 2007, NUCLEIC ACIDS RES, V35, P325, DOI 10.1093/nar/gkl1028; Klapacz J, 2010, MOL CELL, V37, P843, DOI 10.1016/j.molcel.2010.01.038; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; Li YQ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-242; Lindahl T, 1986, Basic Life Sci, V38, P335; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lingaraju GM, 2008, DNA REPAIR, V7, P970, DOI 10.1016/j.dnarep.2008.03.024; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marianovsky I, 2001, J BIOL CHEM, V276, P5975, DOI 10.1074/jbc.M008832200; Moker N, 2004, MOL MICROBIOL, V54, P420, DOI 10.1111/j.1365-2958.2004.04249.x; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Rao MD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.383604; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Scharer OD, 2001, BIOESSAYS, V23, P270, DOI 10.1002/1521-1878(200103)23:3<270::AID-BIES1037>3.0.CO;2-J; Srinath T, 2007, DNA REPAIR, V6, P1517, DOI 10.1016/j.dnarep.2007.05.001; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Wang Y, 2011, J BIOL CHEM, V286, P31159, DOI 10.1074/jbc.M111.241802; Warner DF, 2006, CLIN MICROBIOL REV, V19, P558, DOI 10.1128/CMR.00060-05; World Health Organization, 2010, GLOB TUB CONTR REP 2; Wyatt MD, 1999, BIOESSAYS, V21, P668, DOI 10.1002/(SICI)1521-1878(199908)21:8<668::AID-BIES6>3.3.CO;2-4; Xie YC, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1320, DOI 10.1134/S0006297909120049; Yang M, 2012, NUCLEIC ACIDS RES, V40, P1009, DOI 10.1093/nar/gkr830; Yang Q, 2012, BIOCHEMISTRY-MOSCOW+, V77, P378, DOI 10.1134/S0006297912040098; Zhang L, 2009, P NATL ACAD SCI USA, V106, P7792, DOI 10.1073/pnas.0813056106	39	7	7	0	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9065	9075		10.1074/jbc.M113.528919	http://dx.doi.org/10.1074/jbc.M113.528919			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24509852	Green Published, hybrid			2022-12-28	WOS:000333472100027
J	Xifro, X; Minano-Molina, AJ; Saura, CA; Rodriguez-Alvarez, J				Xifro, Xavier; Minano-Molina, Alfredo J.; Saura, Carlos A.; Rodriguez-Alvarez, Jose			Ras Protein Activation Is a Key Event in Activity-dependent Survival of Cerebellar Granule Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Apoptosis; ERK; Lentivirus; Phosphatidylinositol 3-Kinase; Rap-1; Potassium Depolarization	METHYL-D-ASPARTATE; NERVE GROWTH-FACTOR; KINASE SIGNALING PATHWAYS; PHOSPHATIDYLINOSITOL 3-KINASE; NEUROTROPHIC FACTOR; NMDA RECEPTORS; PC12 CELLS; POTASSIUM DEPOLARIZATION; POSSIBLE INVOLVEMENT; CALCIUM INFLUX	Background: Contradictory results exist on the survival role of PI3K/Akt and ERK pathways in cerebellar granule neurons. Results: Both pathways are involved in activity-dependent survival of cerebellar granule cells when they are activated by Ras. Conclusion: Ras is a central mediator of survival in cerebellar granule neurons. Significance: The biological significance of PI3K/Akt and ERK pathway activation depends on which monomeric-G-protein is acting upstream. Neuronal activity promotes the survival of cerebellar granule neurons (CGNs) during the postnatal development of cerebellum. CGNs that fail to receive excitatory inputs will die by apoptosis. This process could be mimicked in culture by exposing CGNs to either a physiological concentration of KCl (5 mm or K5) plus N-methyl-d-aspartate (NMDA) or to 25 mm KCl (K25). We have previously described that a 24-h exposure to NMDA (100 m) or K25 at 2 days in vitro induced long term survival of CGNs in K5 conditions. Here we have studied the molecular mechanisms activated at 2 days in vitro in these conditions. First we showed that NMDA or K25 addition promoted a rapid stimulation of PI3K and a biphasic phosphorylation on Ser-473 of Akt, a PI3K substrate. Interestingly, we demonstrated that only the first wave of Akt phosphorylation is necessary for the NMDA- and K25-mediated survival. Additionally, we detected that both NMDA and K25 increased ERK activity with a similar time-course. Moreover, our results showed that NMDA-mediated activation of the small G-protein Ras is necessary for PI3K/Akt pathway activation, whereas Rap1 was involved in NMDA phosphorylation of ERK. On the other hand, Ras, but not Rap1, mediates K25 activation of PI3K/Akt and MEK/ERK pathways. Because neuroprotection by NMDA or K25 is mediated by Ras (and not by Rap1) activation, we propose that Ras stimulation is a crucial event in NMDA- and K25-mediated survival of CGNs through the activation of PI3K/Akt and MEK/ERK pathways.	[Xifro, Xavier; Minano-Molina, Alfredo J.; Saura, Carlos A.; Rodriguez-Alvarez, Jose] Univ Autonoma Barcelona, Inst Neurociencies, Cerdanyola Del Valles 08193, Spain; [Xifro, Xavier; Minano-Molina, Alfredo J.; Saura, Carlos A.; Rodriguez-Alvarez, Jose] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Cerdanyola Del Valles 08193, Spain; [Xifro, Xavier] Univ Girona, Fac Med, Dept Med Sci, NEOMA Res Grp,Unit Neurosci, Girona 17071, Spain; [Minano-Molina, Alfredo J.; Saura, Carlos A.; Rodriguez-Alvarez, Jose] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona 08193, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Universitat de Girona; CIBERNED	Xifro, X (corresponding author), Univ Girona, Fac Med, Dept Ciencies Med, C Emili Grahit 77, Girona 17071, Spain.	xavier.xifro@udg.edu	Rodriguez-Alvarez, Jose/F-8403-2011; Xifro, Xavier/ABH-2365-2020; Saura, Carlos A/AFM-9239-2022; Miñano-Molina, Alfredo J/C-9863-2011; Saura, Carlos/D-2727-2011	Rodriguez-Alvarez, Jose/0000-0001-8582-8082; Xifro, Xavier/0000-0002-7417-9475; Miñano-Molina, Alfredo J/0000-0002-7761-5682; Saura, Carlos/0000-0003-3692-5657	Ministerio de Ciencia e Innovacion [SAF2011-30281]; CIBERNED [CB06/05/0042]; Generalitat de Catalunya [SGR2009-1231]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); CIBERNED(Instituto de Salud Carlos III); Generalitat de Catalunya(Generalitat de Catalunya)	This work was supported by grants from Ministerio de Ciencia e Innovacion SAF2011-30281), CIBERNED (CB06/05/0042), and Generalitat de Catalunya (SGR2009-1231) (to J. R. A.).	Adams SM, 2004, J NEUROSCI, V24, P9441, DOI 10.1523/JNEUROSCI.3290-04.2004; BALAZS R, 1988, NEUROSCIENCE, V27, P437, DOI 10.1016/0306-4522(88)90279-5; Barneda-Zahonero B, 2012, J BIOL CHEM, V287, P11351, DOI 10.1074/jbc.M111.272427; Bazan-Peregrino M, 2007, J NEUROSCI RES, V85, P332, DOI 10.1002/jnr.21112; Bhave SV, 1999, J NEUROSCI, V19, P3277, DOI 10.1523/jneurosci.19-09-03277.1999; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BURGOYNE RD, 1993, J NEUROCYTOL, V22, P689, DOI 10.1007/BF01181314; Burke RE, 2007, PHARMACOL THERAPEUT, V114, P261, DOI 10.1016/j.pharmthera.2007.02.002; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; D'Mello SR, 1997, J NEUROSCI, V17, P1548; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Egea J, 1999, J BIOL CHEM, V274, P75, DOI 10.1074/jbc.274.1.75; Franke B, 1997, EMBO J, V16, P252, DOI 10.1093/emboj/16.2.252; GALLO V, 1987, J NEUROSCI, V7, P2203; GOULD E, 1994, J COMP NEUROL, V340, P551, DOI 10.1002/cne.903400408; Iida N, 2001, J NEUROSCI, V21, P6459, DOI 10.1523/JNEUROSCI.21-17-06459.2001; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Imamura Y, 2003, NEUROREPORT, V14, P1203, DOI 10.1097/00001756-200307010-00003; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Klesse LJ, 1998, J NEUROSCI, V18, P10420; Lafon-Cazal M, 2002, EUR J NEUROSCI, V16, P575, DOI 10.1046/j.1460-9568.2002.02124.x; Marini AM, 1998, J BIOL CHEM, V273, P29394, DOI 10.1074/jbc.273.45.29394; Miller TM, 1997, J BIOL CHEM, V272, P9847; Minano A, 2008, MOL CELL NEUROSCI, V39, P143, DOI 10.1016/j.mcn.2008.06.001; Monti B, 2002, EUR J NEUROSCI, V16, P1490, DOI 10.1046/j.1460-9568.2002.02232.x; Obara Y, 2007, J NEUROCHEM, V101, P470, DOI 10.1111/j.1471-4159.2006.04390.x; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Perkinton MS, 2002, J NEUROCHEM, V80, P239, DOI 10.1046/j.0022-3042.2001.00699.x; Ravni A, 2008, MOL PHARMACOL, V73, P1688, DOI 10.1124/mol.107.044792; Roy BC, 2002, GENES CELLS, V7, P607; Shi Geng-Xian, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P114; Shimoke K, 1999, DEV BRAIN RES, V112, P245, DOI 10.1016/S0165-3806(98)00172-2; Sutton G, 2002, J NEUROCHEM, V82, P1097, DOI 10.1046/j.1471-4159.2002.01031.x; Vaudry D, 2000, P NATL ACAD SCI USA, V97, P13390, DOI 10.1073/pnas.97.24.13390; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Wang G, 2012, PROG NEUROBIOL, V98, P207, DOI 10.1016/j.pneurobio.2012.06.003; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xifro X, 2006, J BIOL CHEM, V281, P6801, DOI 10.1074/jbc.M504571200; Xifro X, 2005, EUR J NEUROSCI, V21, P827, DOI 10.1111/j.1460-9568.2005.03935.x; Xifro X., 2007, RES SIGNPOST, V1, P157; Xue LZ, 2000, J BIOL CHEM, V275, P8817, DOI 10.1074/jbc.275.12.8817; YAN GM, 1994, BRAIN RES, V656, P43, DOI 10.1016/0006-8993(94)91364-1; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zhang FX, 1998, J BIOL CHEM, V273, P26596, DOI 10.1074/jbc.273.41.26596; Zhong J, 2004, J NEUROSCI RES, V75, P794, DOI 10.1002/jnr.20024	47	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8462	8472		10.1074/jbc.M113.536375	http://dx.doi.org/10.1074/jbc.M113.536375			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24523415	Green Published, hybrid			2022-12-28	WOS:000333157500038
J	Blackstock, CD; Higashi, Y; Sukhanov, S; Shai, SY; Stefanovic, B; Tabony, AM; Yoshida, T; Delafontaine, P				Blackstock, Christopher D.; Higashi, Yusuke; Sukhanov, Sergiy; Shai, Shaw-Yung; Stefanovic, Branko; Tabony, A. Michael; Yoshida, Tadashi; Delafontaine, Patrice			Insulin-like Growth Factor-1 Increases Synthesis of Collagen Type I via Induction of the mRNA-binding Protein LARP6 Expression and Binding to the 5 ' Stem-loop of COL1a1 and COL1a2 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Atherosclerosis; Insulin-like Growth Factor (IGF); Protein Synthesis; Translation; Vascular Smooth Muscle Cells; 5 Stem-loop; Acheron; Fibrillogenesis; Post-transcriptional	ATHEROSCLEROTIC PLAQUES; TRANSLATION; ACTIVATION; OVEREXPRESSION; PROLIFERATION; 5'-STEM-LOOP; PROGRESSION; FEATURES; BIOLOGY; ACHERON	Background: The la ribonucleoprotein domain family member 6, LARP6, regulates collagen type 1 mRNA translation. Results: IGF-1 increases LARP6 expression, resulting in increased LARP6-collagen type 1 mRNA complex and collagen synthesis in smooth muscle. Conclusion: IGF-1 enhances collagen fibrillogenesis via induction of LARP6. Significance: This report uncovers a critical mechanism whereby IGF-1 induces a more stable plaque phenotype in atherosclerosis. Collagen content in atherosclerotic plaque is a hallmark of plaque stability. Our earlier studies showed that insulin-like growth factor-1 (IGF-1) increases collagen content in atherosclerotic plaques of Apoe(-/-) mice. To identify mechanisms we investigated the effect of IGF-1 on the la ribonucleoprotein domain family member 6 (LARP6). LARP6 binds a stem-loop motif in the 5-UTR of the mRNAs encoding the collagen type I -subunits (1(I) and 2(I)), and coordinates their translation into the heterotrimeric collagen type I molecule. In human aortic smooth muscle cells (SMCs), IGF-1 rapidly increased LARP6 expression and the rate of collagen synthesis and extracellular accumulation. IGF-1 increased both LARP6 and collagen type I expression via a post-transcriptional and translation-dependent mechanism involving PI3K/Akt/p70S6k-signaling. Immunoprecipitation of LARP6, followed by qPCR indicated that IGF-1 increased the level of COL1a1 and COL1a2 mRNA bound to LARP6. Mutation of the 5 stem-loop of Col1a1 mRNA, which inhibits binding of LARP6, abolished the ability of IGF-1 to increase synthesis of collagen type I. Furthermore, overexpression of a 5 stem-loop RNA molecular decoy that sequesters LARP6, prevented the ability of IGF-1 to increase pro-1(I) and mature 1(I) expression in cultured medium. IGF-1 infusion in Apoe(-/-) mice increased expression of LARP6 and pro-1(I) in aortic lysates, and SMC-specific IGF-1-overexpression robustly increased collagen fibrillogenesis in atherosclerotic plaque. In conclusion, we identify LARP6 as a critical mediator by which IGF-1 augments synthesis of collagen type I in vascular smooth muscle, which may play an important role in promoting atherosclerotic plaque stability.	[Blackstock, Christopher D.; Higashi, Yusuke; Sukhanov, Sergiy; Shai, Shaw-Yung; Tabony, A. Michael; Yoshida, Tadashi; Delafontaine, Patrice] Tulane Univ, Sch Med, Inst Heart & Vasc, New Orleans, LA 70112 USA; [Blackstock, Christopher D.; Higashi, Yusuke; Sukhanov, Sergiy; Shai, Shaw-Yung; Tabony, A. Michael; Yoshida, Tadashi; Delafontaine, Patrice] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; [Stefanovic, Branko] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	Tulane University; Tulane University; State University System of Florida; Florida State University	Delafontaine, P (corresponding author), Tulane Univ, Sch Med, Inst Heart & Vasc, 1430 Tulane Ave,SL-48, New Orleans, LA 70112 USA.	pdelafon@tulane.edu		Sukhanov, Sergiy/0000-0002-9223-4263; Delafontaine, Patrice/0000-0003-3744-3617; Yoshida, Tadashi/0000-0002-4544-1497	National Institutes of Health: NHLBI [R01-HL070241, R01-HL080682, R21-HL113705-01A1]; National Institutes of Health: NCRR [P20-RR018766]; National Institutes of Health: NIGMS [P20-GM103514, P30-GM103337, U54-GM104940]; American Heart Association [13GRNT17230069]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070241, R21HL113705, R01HL080682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940, P30GM103337, P20GM103514] Funding Source: NIH RePORTER	National Institutes of Health: NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health: NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health: NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by grants from the National Institutes of Health: NHLBI R01-HL070241, R01-HL080682, and R21-HL113705-01A1, NCRR P20-RR018766, and NIGMS P20-GM103514, P30-GM103337, and U54-GM104940. This work was also supported by the American Heart Association (13GRNT17230069).	Adiguzel E, 2009, VASC MED, V14, P73, DOI 10.1177/1358863X08094801; Bayfield MA, 2010, BBA-GENE REGUL MECH, V1799, P365, DOI 10.1016/j.bbagrm.2010.01.011; Beck K, 1996, J BIOL CHEM, V271, P21566, DOI 10.1074/jbc.271.35.21566; Cai L, 2010, J MOL BIOL, V401, P564, DOI 10.1016/j.jmb.2010.06.057; Cai L, 2010, J MOL BIOL, V395, P309, DOI 10.1016/j.jmb.2009.11.020; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Challa AA, 2011, MOL CELL BIOL, V31, P3773, DOI 10.1128/MCB.05263-11; Chang SW, 2012, BIOPHYS J, V102, P640, DOI 10.1016/j.bpj.2011.11.3999; Chung HJ, 2008, J BIOL CHEM, V283, P25879, DOI 10.1074/jbc.M804272200; DAYAN D, 1989, HISTOCHEMISTRY, V93, P27, DOI 10.1007/BF00266843; Deguchi JO, 2005, CIRCULATION, V112, P2708, DOI 10.1161/CIRCULATIONAHA.105.562041; Fuster V, 2005, J AM COLL CARDIOL, V46, P937, DOI 10.1016/j.jacc.2005.03.074; Garnero P, 2009, BONE, V44, P461, DOI 10.1016/j.bone.2008.11.006; Gherzi R, 2010, CELL DEATH DIFFER, V17, P975, DOI 10.1038/cdd.2009.194; GRIMM C, 1993, EMBO J, V12, P1229, DOI 10.1002/j.1460-2075.1993.tb05764.x; Higashi Y, 2013, BBA-MOL BASIS DIS, V1832, P391, DOI 10.1016/j.bbadis.2012.12.005; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Lee RT, 1997, ARTERIOSCL THROM VAS, V17, P1859, DOI 10.1161/01.ATV.17.10.1859; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Manojlovic Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065897; Manojlovic Z, 2012, RNA, V18, P321, DOI 10.1261/rna.030288.111; McDaniel DP, 2007, BIOPHYS J, V92, P1759, DOI 10.1529/biophysj.106.089003; Ovchinnikova O, 2009, AM J PATHOL, V174, P693, DOI 10.2353/ajpath.2009.080561; Parsons CJ, 2011, J BIOL CHEM, V286, P8609, DOI 10.1074/jbc.M110.189118; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Rajavashisth TB, 1999, CIRCULATION, V99, P3103, DOI 10.1161/01.CIR.99.24.3103; Rekhter MD, 1999, CARDIOVASC RES, V41, P376, DOI 10.1016/S0008-6363(98)00321-6; Rich Lillian, 2005, Brazilian Journal of Morphological Sciences, V22, P97; Shai SY, 2010, ARTERIOSCL THROM VAS, V30, P1916, DOI 10.1161/ATVBAHA.110.210831; Shao R, 2012, INT J CANCER, V130, P544, DOI 10.1002/ijc.26015; Stefanovic B, 1999, MOL CELL BIOL, V19, P4334; Stefanovic B, 2003, J BIOL CHEM, V278, P927, DOI 10.1074/jbc.M209175200; Stefanovic B, 2002, J BIOL CHEM, V277, P18229, DOI 10.1074/jbc.M108065200; Sukhanov S, 2007, ARTERIOSCL THROM VAS, V27, P2684, DOI 10.1161/ATVBAHA.107.156257; Sukhanov S, 2011, FEBS LETT, V585, P3065, DOI 10.1016/j.febslet.2011.08.029; Sun RJ, 2011, CELL BIOCHEM FUNCT, V29, P636, DOI 10.1002/cbf.1799; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Valavanis C, 2007, GENE, V393, P101, DOI 10.1016/j.gene.2007.01.033; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Wang JW, 1997, J CLIN INVEST, V100, P1425, DOI 10.1172/JCI119663; Wei YH, 2013, P NATL ACAD SCI USA, V110, pE3910, DOI 10.1073/pnas.1309276110; Yoshida T, 2013, J BIOL CHEM, V288, P23823, DOI 10.1074/jbc.M112.449074; Zhao X, 2008, HYPERTENS RES, V31, P1619, DOI 10.1291/hypres.31.1619	44	58	61	4	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7264	7274		10.1074/jbc.M113.518951	http://dx.doi.org/10.1074/jbc.M113.518951			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24469459	Green Published, hybrid			2022-12-28	WOS:000332761500002
J	Cruz, JW; Rothenbacher, FP; Maehigashi, T; Lane, WS; Dunham, CM; Woychik, NA				Cruz, Jonathan W.; Rothenbacher, Francesca P.; Maehigashi, Tatsuya; Lane, William S.; Dunham, Christine M.; Woychik, Nancy A.			Doc Toxin Is a Kinase That Inactivates Elongation Factor Tu	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GTPase; Phosphorylation; Post-translational Modification; Protein Synthesis; Translation; Translation Elongation Factors; Fic; Adenylylation; Antitoxin	FACTOR-EF-TU; ANTITOXIN SYSTEMS; CRYSTAL-STRUCTURE; TERNARY COMPLEX; PROPHAGE P1; PROTEIN; PHD; AMPYLATION; MECHANISM; SUBSTRATE	Background: Doc toxin, of the phd-doc toxin-antitoxin system, belongs to the Fic protein family found in all domains of life. Results: Doc inactivates elongation factor Tu by phosphorylation of a single amino acid. Conclusion: This phosphorylation event inhibits protein synthesis and thereby arrests cell growth. Significance: The phosphorylation activity of Doc toxin represents a new catalytic activity for members of the Fic protein family. The Doc toxin from bacteriophage P1 (of the phd-doc toxin-antitoxin system) has served as a model for the family of Doc toxins, many of which are harbored in the genomes of pathogens. We have shown previously that the mode of action of this toxin is distinct from the majority derived from toxin-antitoxin systems: it does not cleave RNA; in fact P1 Doc expression leads to mRNA stabilization. However, the molecular triggers that lead to translation arrest are not understood. The presence of a Fic domain, albeit slightly altered in length and at the catalytic site, provided a clue to the mechanism of P1 Doc action, as most proteins with this conserved domain inactivate GTPases through addition of an adenylyl group (also referred to as AMPylation). We demonstrated that P1 Doc added a single phosphate group to the essential translation elongation factor and GTPase, elongation factor (EF)-Tu. The phosphorylation site was at a highly conserved threonine, Thr-382, which was blocked when EF-Tu was treated with the antibiotic kirromycin. Therefore, we have established that Fic domain proteins can function as kinases. This distinct enzymatic activity exhibited by P1 Doc also solves the mystery of the degenerate Fic motif unique to the Doc family of toxins. Moreover, we have established that all characterized Fic domain proteins, even those that phosphorylate, target pivotal GTPases for inactivation through a post-translational modification at a single functionally critical acceptor site.	[Cruz, Jonathan W.; Rothenbacher, Francesca P.; Woychik, Nancy A.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA; [Cruz, Jonathan W.; Rothenbacher, Francesca P.; Woychik, Nancy A.] Rutgers Canc Inst New Jersey, Piscataway, NJ 08854 USA; [Maehigashi, Tatsuya; Dunham, Christine M.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Lane, William S.] Harvard Univ, FAS Ctr Syst Biol, Mass Spectrometry & Prote Resource Lab, Cambridge, MA 02138 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Emory University; Harvard University	Woychik, NA (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Biochem & Mol Biol, 683 Hoes La, Piscataway, NJ 08854 USA.	nancy.woychik@rutgers.edu			National Institutes of Health from the NIGMS [R01GM093279, R01GM095693]; National Science Foundation CAREER Award [MCB 0953714]; National Institutes of Health from the NIAID [T32AI007403]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095693, R01GM093279, R01GM093278] Funding Source: NIH RePORTER	National Institutes of Health from the NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation CAREER Award(National Science Foundation (NSF)); National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM093279 (to C. M. D.) and R01GM095693 (to N. A. W.) from the NIGMS, National Science Foundation CAREER Award MCB 0953714 (to C. M. D.), and National Institutes of Health Training Grant T32AI007403, Virus-Host Interactions in Eukaryotic Cells (to J. W. C. and F. P. R., awarded to G. Brewer), from the NIAID.	ALEXANDER C, 1995, J BIOL CHEM, V270, P14541, DOI 10.1074/jbc.270.24.14541; Arbing MA, 2010, STRUCTURE, V18, P996, DOI 10.1016/j.str.2010.04.018; BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; Castro-Roa D, 2013, NAT CHEM BIOL, V9, P811, DOI [10.1038/NCHEMBIO.1364, 10.1038/nchembio.1364]; Dawson CC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002121; Engel P, 2012, NATURE, V482, P107, DOI 10.1038/nature10729; Garcia-Pino A, 2008, J BIOL CHEM, V283, P30821, DOI 10.1074/jbc.M805654200; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Gazit E, 1999, J BIOL CHEM, V274, P2652, DOI 10.1074/jbc.274.5.2652; Gazit E, 1999, J BIOL CHEM, V274, P16813, DOI 10.1074/jbc.274.24.16813; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; Goepfert A, 2013, PROKARYOTIC TOXIN AN, DOI [10.1007/978-3-642-33253-1_10, DOI 10.1007/978-3-642-33253-1_10]; Goepfert A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064901; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Itzen A, 2011, TRENDS BIOCHEM SCI, V36, P219, DOI 10.1016/j.tibs.2010.12.004; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; Kint CI, 2012, TRENDS MICROBIOL, V20, P577, DOI 10.1016/j.tim.2012.08.009; KJELDGAARD M, 1992, J MOL BIOL, V223, P721, DOI 10.1016/0022-2836(92)90986-T; KJELDGAARD M, 1993, STRUCTURE, V1, P35, DOI 10.1016/0969-2126(93)90007-4; LEHNHERR H, 1995, P NATL ACAD SCI USA, V92, P3274, DOI 10.1073/pnas.92.8.3274; LIPPMANN C, 1993, J BIOL CHEM, V268, P601; Liu M, 2008, P NATL ACAD SCI USA, V105, P5885, DOI 10.1073/pnas.0711949105; Lobocka MB, 2004, J BACTERIOL, V186, P7032, DOI 10.1128/JB.186.21.7032-7068.2004; Lyskov S, 2008, NUCLEIC ACIDS RES, V36, pW233, DOI 10.1093/nar/gkn216; Magnuson P, 1996, J BIOL CHEM, V271, P18705, DOI 10.1074/jbc.271.31.18705; Magnuson R, 1998, J BACTERIOL, V180, P6342; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Mattoo S, 2011, J BIOL CHEM, V286, P32834, DOI 10.1074/jbc.M111.227603; McKinley JE, 2005, J BACTERIOL, V187, P765, DOI 10.1128/JB.187.2.765-770.2005; Mishra S, 2012, PROTEIN EXPRES PURIF, V86, P58, DOI 10.1016/j.pep.2012.08.020; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; NINIO J, 1975, BIOCHIMIE, V57, P587, DOI 10.1016/S0300-9084(75)80139-8; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Palanivelu DV, 2011, PROTEIN SCI, V20, P492, DOI 10.1002/pro.581; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; PARMEGGIANI A, 1985, ANNU REV MICROBIOL, V39, P557, DOI 10.1146/annurev.mi.39.100185.003013; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Tan YH, 2011, P NATL ACAD SCI USA, V108, P21212, DOI 10.1073/pnas.1114023109; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; WEIJLAND A, 1992, MOL MICROBIOL, V6, P683, DOI 10.1111/j.1365-2958.1992.tb01516.x; Williams JJ, 2012, TRENDS MICROBIOL, V20, P291, DOI 10.1016/j.tim.2012.02.005; WOLF H, 1974, P NATL ACAD SCI USA, V71, P4910, DOI 10.1073/pnas.71.12.4910; Woolery AR, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00113; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Xiao JY, 2010, NAT STRUCT MOL BIOL, V17, P1004, DOI 10.1038/nsmb.1867; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382	51	50	51	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7788	7798		10.1074/jbc.M113.544429	http://dx.doi.org/10.1074/jbc.M113.544429			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24448800	Green Published, hybrid			2022-12-28	WOS:000332761500045
J	Keiffer, TR; Bond, JS				Keiffer, Timothy R.; Bond, Judith S.			Meprin Metalloproteases Inactivate Interleukin 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Culture; Cytokine; Inflammation; Interleukin; Metalloprotease; Protease; Meprins	INFLAMMATORY-BOWEL-DISEASE; CANCER; IL-6; KIDNEY; OLIGOMERIZATION; INVOLVEMENT; EXPRESSION; STABILITY; SUBSTRATE; TERMINUS	Background: Meprin metalloproteinases are implicated in the pathogenesis of inflammatory diseases where the cytokine IL-6 plays a role. Results: Meprins cleave and decrease the biological activity of IL-6. Conclusion: IL-6 activity at inflammatory sites is regulated in part by meprins. Significance: Decreasing IL-6 bioactivity is an underlying mechanism for meprin regulation of inflammation. Meprins have been implicated in the pathogenesis of several inflammatory diseases, including inflammatory bowel disease, in which the cytokine IL-6 is a prominent effector molecule. Because IL-6 levels are elevated markedly in meprin and / knockout mice in an experimental model of inflammatory bowel disease, the interaction between meprins and IL-6 was studied. The results demonstrate that rodent and human meprin A and B cleave IL-6 to a smaller product and, subsequently, are capable of extensive degradation of the cytokine. Analysis of the limited degradation product formed by meprin A indicated that three to five amino acids are removed from the C terminus of the cytokine. Meprin A and meprin B cleaved IL-6 with micromolar affinities (K-m of 4.7 and 12.0 m, respectively) and with high efficiencies (k(cat)/K-m of 0.2 and 2.5 (m(-1)/s(-1)) x 10(6), respectively). These efficiency constants are among the highest for known meprin substrates. Madin-Darby canine kidney cells transiently transfected with meprin or meprin constructs also cleave exogenous IL-6. Both human and murine IL-6 cleaved by meprin A or B are inactivated, as demonstrated by their decreased capability to stimulate proliferation of B9 cells. These results are consistent with the proposition that one function of meprin metalloproteases is to modulate inflammation by inactivating IL-6.	[Keiffer, Timothy R.; Bond, Judith S.] Penn State Univ, Dept Biochem & Mol Biol, Coll Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Bond, JS (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Coll Med, 500 Univ Dr, Hershey, PA 17033 USA.	jbond@psu.edu		R. Keiffer, Timothy/0000-0001-7104-6338	National Institutes of Health [R01 DK019691]; Pennsylvania Department of Health tobacco settlement funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019691] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health tobacco settlement funds; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health grant R01 DK019691 (to J. S. B.). This work was also supported by Pennsylvania Department of Health tobacco settlement funds (to J. S. B.).	Atreya R, 2005, CLIN REV ALLERG IMMU, V28, P187, DOI 10.1385/CRIAI:28:3:187; Banbula A, 1999, BIOCHEM BIOPH RES CO, V261, P598, DOI 10.1006/bbrc.1999.1075; Banerjee S, 2009, MUCOSAL IMMUNOL, V2, P220, DOI 10.1038/mi.2009.3; Banerjee S, 2008, J BIOL CHEM, V283, P31371, DOI 10.1074/jbc.M802814200; Banerjee S, 2011, AM J PHYSIOL-GASTR L, V300, pG273, DOI 10.1152/ajpgi.00504.2009; Bank U, 1999, FEBS LETT, V461, P235, DOI 10.1016/S0014-5793(99)01466-0; Bao JL, 2013, AM J PHYSIOL-RENAL, V305, pF714, DOI 10.1152/ajprenal.00179.2012; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Bertenshaw GP, 2003, J BIOL CHEM, V278, P2522, DOI 10.1074/jbc.M208808200; Bertenshaw GP, 2002, BIOL CHEM, V383, P1175, DOI 10.1515/BC.2002.129; Bertenshaw GP, 2001, J BIOL CHEM, V276, P13248, DOI 10.1074/jbc.M011414200; Bond JS, 2005, FEBS LETT, V579, P3317, DOI 10.1016/j.febslet.2005.03.045; Broder C, 2013, BIOCHEM J, V450, P253, DOI 10.1042/BJ20121751; Bylander JE, 2007, BIOL CHEM, V388, P1163, DOI 10.1515/BC.2007.156; COULIE PG, 1989, EUR J IMMUNOL, V19, P2107, DOI 10.1002/eji.1830191121; Doan T., 2007, IMMUNOLOGY, P384; Fisman EZ, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-62; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hanel KH, 2013, INT J MOL SCI, V14, P6720, DOI 10.3390/ijms14046720; Hengst JA, 2004, J BIOL CHEM, V279, P34856, DOI 10.1074/jbc.M405774200; Herzog C, 2005, CYTOKINE, V31, P394, DOI 10.1016/j.cyto.2005.06.012; Herzog C, 2009, BIOCHEM BIOPH RES CO, V379, P904, DOI 10.1016/j.bbrc.2008.12.161; Ishmael SS, 2006, J BIOL CHEM, V281, P37404, DOI 10.1074/jbc.M602769200; Jones LL, 2011, IMMUNOL RES, V51, P5, DOI 10.1007/s12026-011-8209-y; Kaushal GP, 2013, AM J PHYSIOL-RENAL, V304, pF1150, DOI 10.1152/ajprenal.00014.2013; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Kruse MN, 2004, BIOCHEM J, V378, P383, DOI 10.1042/BJ20031163; KRUTTGEN A, 1990, FEBS LETT, V262, P323, DOI 10.1016/0014-5793(90)80219-9; Norman LP, 2003, CURR TOP DEV BIOL, V54, P145, DOI 10.1016/S0070-2153(03)54008-X; Ongeri EM, 2011, AM J PHYSIOL-RENAL, V301, pF871, DOI 10.1152/ajprenal.00703.2010; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Scott TR, 2006, VET IMMUNOL IMMUNOP, V114, P173, DOI 10.1016/j.vetimm.2006.07.009; Simpson RJ, 1997, PROTEIN SCI, V6, P929, DOI 10.1002/pro.5560060501; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Tanaka T, 2012, INT J BIOL SCI, V8, P1227, DOI 10.7150/ijbs.4666; Tsukuba T, 2002, ARCH BIOCHEM BIOPHYS, V397, P191, DOI 10.1006/abbi.2001.2672; WARD LD, 1993, PROTEIN SCI, V2, P1472, DOI 10.1002/pro.5560020911; Yura RE, 2009, AM J PHYSIOL-RENAL, V296, pF135, DOI 10.1152/ajprenal.90524.2008; Zhang HC, 2007, AM J PHYSIOL-HEART C, V292, pH2408, DOI 10.1152/ajpheart.01150.2006	39	31	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7580	7588		10.1074/jbc.M113.546309	http://dx.doi.org/10.1074/jbc.M113.546309			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24474695	hybrid, Green Published			2022-12-28	WOS:000332761500028
J	Li, SC; Chang, HH; Niewolik, D; Hedrick, MP; Pinkerton, AB; Hassig, CA; Schwarz, K; Lieber, MR				Li, Sicong; Chang, Howard H.; Niewolik, Doris; Hedrick, Michael P.; Pinkerton, Anthony B.; Hassig, Christian A.; Schwarz, Klaus; Lieber, Michael R.			Evidence That the DNA Endonuclease ARTEMIS also Has Intrinsic 5 '-Exonuclease Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Repair; Nucleic Acid; Nucleic Acid Enzymology; Nucleic Acid Structure; Protein DNA-Interaction; Nonhomologous DNA End Joining	POLYADENYLATION FACTOR CPSF-73; DEPENDENT PROTEIN-KINASE; V(D)J RECOMBINATION; BREAK REPAIR; NUCLEASE; MECHANISM; PATHWAY	Background: DNA-PKcs stimulates the endonucleolytic activities of ARTEMIS but not the 5-exonuclease activity. Results: Point mutagenesis, small molecule inhibitors, and modulation of divalent cation concentrations all affect both the endonuclease and 5-exonuclease activities in parallel. Conclusion: ARTEMIS has intrinsic 5-exonuclease activity, in addition to its known endonuclease activity. Significance: ARTEMIS may use both its endo- and its 5-exonuclease activity in NHEJ. ARTEMIS is a member of the metallo--lactamase protein family. ARTEMIS has endonuclease activity at DNA hairpins and at 5- and 3-DNA overhangs of duplex DNA, and this endonucleolytic activity is dependent upon DNA-PKcs. There has been uncertainty about whether ARTEMIS also has 5-exonuclease activity on single-stranded DNA and 5-overhangs, because this 5-exonuclease is not dependent upon DNA-PKcs. Here, we show that the 5-exonuclease and the endonuclease activities co-purify. Second, we show that a point mutant of ARTEMIS at a putative active site residue (H115A) markedly reduces both the endonuclease activity and the 5-exonuclease activity. Third, divalent cation effects on the 5-exonuclease and the endonuclease parallel one another. Fourth, both the endonuclease activity and 5-exonuclease activity of ARTEMIS can be blocked in parallel by small molecule inhibitors, which do not block unrelated nucleases. We conclude that the 5-exonuclease is intrinsic to ARTEMIS, making it relevant to the role of ARTEMIS in nonhomologous DNA end joining.	[Li, Sicong; Chang, Howard H.; Lieber, Michael R.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90089 USA; [Li, Sicong; Chang, Howard H.; Lieber, Michael R.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Li, Sicong; Chang, Howard H.; Lieber, Michael R.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Biol Sci, Los Angeles, CA 90089 USA; [Li, Sicong; Chang, Howard H.; Lieber, Michael R.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Mol Microbiol & Immunol, Los Angeles, CA 90089 USA; [Niewolik, Doris; Schwarz, Klaus] Univ Hosp, Inst Transfus Med, D-89081 Ulm, Germany; [Hedrick, Michael P.; Pinkerton, Anthony B.; Hassig, Christian A.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; Ulm University; Sanford Burnham Prebys Medical Discovery Institute	Lieber, MR (corresponding author), Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90089 USA.	lieber@usc.edu		Lieber, Michael/0000-0003-3700-6345; Pinkerton, Anthony/0000-0003-4571-152X; Lieber, Michael/0000-0001-8809-0909	National Institutes of Health [R01 CA100504, R01 CA51105]; BMBF (German Federal Ministry of Education Research) [01GM1111F]; NATIONAL CANCER INSTITUTE [R01CA051105, R01CA100504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BMBF (German Federal Ministry of Education Research)(Federal Ministry of Education & Research (BMBF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a National Institutes of Health Grants R01 CA100504 and R01 CA51105 (to M. R. L.) and the BMBF (German Federal Ministry of Education & Research) Grant 01GM1111F (to K. S.).	Aravind L, 1999, In Silico Biol, V1, P69; Chan DW, 1996, BIOCHEM CELL BIOL, V74, P67, DOI 10.1139/o96-007; Dominski Z, 2007, CRIT REV BIOCHEM MOL, V42, P67, DOI 10.1080/10409230701279118; Dronkert MLG, 2000, MOL CELL BIOL, V20, P4553, DOI 10.1128/MCB.20.13.4553-4561.2000; Gu JF, 2010, DNA REPAIR, V9, P429, DOI 10.1016/j.dnarep.2010.01.001; Kurosawa A, 2008, DNA CELL BIOL, V27, P55, DOI 10.1089/dna.2007.0649; LARSEN KS, 1989, BIOCHEMISTRY-US, V28, P9620, DOI 10.1021/bi00451a012; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lu H, 2008, MOL CELL, V31, P485, DOI 10.1016/j.molcel.2008.05.029; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; Moshous D, 2001, CELL, V105, P177, DOI 10.1016/S0092-8674(01)00309-9; Niewolik D, 2006, J BIOL CHEM, V281, P33900, DOI 10.1074/jbc.M606023200; Pannicke U, 2004, EMBO J, V23, P1987, DOI 10.1038/sj.emboj.7600206; Pawelczak KS, 2010, DNA REPAIR, V9, P670, DOI 10.1016/j.dnarep.2010.03.002; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rooney S, 2003, J EXP MED, V197, P553, DOI 10.1084/jem.20021891; Ryan K, 2004, RNA, V10, P565, DOI 10.1261/rna.5214404; Sengerova B, 2012, J BIOL CHEM, V287, P26254, DOI 10.1074/jbc.M112.367243; van Overbeek M, 2006, CURR BIOL, V16, P1295, DOI 10.1016/j.cub.2006.05.022; Yannone SM, 2008, NUCLEIC ACIDS RES, V36, P3354, DOI 10.1093/nar/gkn205	21	36	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7825	7834		10.1074/jbc.M113.544874	http://dx.doi.org/10.1074/jbc.M113.544874			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24500713	hybrid, Green Published			2022-12-28	WOS:000332761500048
J	Afroze, T; Yang, G; Khoshbin, A; Tanwir, M; Tabish, T; Momen, A; Husain, M				Afroze, Talat; Yang, Ge; Khoshbin, Amir; Tanwir, Mansoor; Tabish, Taha; Momen, Abdul; Husain, Mansoor			Calcium Efflux Activity of Plasma Membrane Ca2+ ATPase-4 (PMCA4) Mediates Cell Cycle Progression in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alternative Splicing; Calcium ATPase; Cell Cycle; Cell Proliferation; Vascular Smooth Muscle Cells; AP-2; Decorin; Plasma Membrane Calcium Atpase-4; Rgs16; p15(Ink4b)	EPIDERMAL-GROWTH-FACTOR; MESSENGER-RNA; C-MYB; TRANSCRIPTIONAL ACTIVATION; FUNCTIONAL INTERACTION; CA2+-ATPASE PMCA; FACTOR RECEPTOR; SPERM MOTILITY; UP-REGULATION; KINASE	Background: PMCA4 actions in vascular smooth muscle are not understood. Results: Alternative splicing of PMCA4 changes during vessel injury. Cell cycle arrest and downstream effectors of PMCA4 deletion are rescued by PMCA4a, PMCA4b, and PMCA4b unable to bind PDZ- proteins but not by inactive PMCA4. Conclusion: Ca2+ efflux activity of PMCA4 regulates G(1) progression. Significance: PMCA4 Ca2+ efflux regulates cell cycle. We explored the role played by plasma membrane calcium ATPase-4 (PMCA4) and its alternative splice variants in the cell cycle of vascular smooth muscle cells (VSMC). A novel variant (PMCA4e) was discovered. Quantitative real-time-PCR-quantified PMCA4 splice variant proportions differed in specific organs. The PMCA4a:4b ratio in uninjured carotid arteries (approximate to 1:1) was significantly reduced by wire denudation injury (to approximate to 1:3) by modulation of alternative splicing, as confirmed by novel antibodies against PMCA4a/e and PMCA4b. Laser capture microdissection localized this shift to the media and adventitia. Primary carotid VSMC from PMCA4 knock-out (P4KO) mice showed impaired [H-3]thymidine incorporation and G(1) phase arrest as compared with wild type (P4WT). Electroporation of expression constructs encoding PMCA4a, PMCA4b, and a PMCA4b mutant lacking PDZ binding rescued this phenotype of P4KO cells, whereas a mutant with only 10% of normal Ca2+ efflux activity could not. Microarray of early G(1)-synchronized VSMC showed 39-fold higher Rgs16 (NFAT (nuclear factor of activated T-cells) target; MAPK inhibitor) and 69-fold higher Decorin (G(1) arrest marker) expression in P4KO versus P4WT. Validation by Western blot also revealed decreased levels of Cyclin D1 and NFATc3 in P4KO. Microarrays of P4KO VSMC rescued by PMCA4a or PMCA4b expression showed reversal of perturbed Rgs16, Decorin, and NFATc3 expression levels. However, PMCA4a rescue caused a 44-fold reduction in AP-2, a known anti-proliferative transcription factor, whereas PMCA4b rescue resulted in a 50-fold reduction in p15 (Cyclin D1/Cdk4 inhibitor). We conclude that Ca2+ efflux activity of PMCA4 underlies G(1) progression in VSMC and that PMCA4a and PMCA4b differentially regulate specific downstream mediators.	[Afroze, Talat; Khoshbin, Amir; Tanwir, Mansoor; Tabish, Taha; Momen, Abdul; Husain, Mansoor] Univ Hlth Network, Toronto Gen Res Inst, Div Expt Therapeut, Toronto, ON M5G 2C4, Canada; [Yang, Ge; Husain, Mansoor] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Husain, Mansoor] Heart & Stroke Richard Lewar Ctr Excellence Cardi, Toronto, ON M5G 1L7, Canada; [Husain, Mansoor] Univ Toronto, Dept Med, Toronto, ON M5G 2C4, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto	Husain, M (corresponding author), TMDT 3-909,200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	mansoor.husain@uhn.ca	; Khoshbin, Amir/V-2276-2018	Husain, Mansoor/0000-0002-3740-6739; Afroze, Talat/0000-0003-2988-1342; Khoshbin, Amir/0000-0002-0891-3424	Canadian Institutes of Health Research [MOP-64352]; Heart and Stroke Foundation of Ontario [T-5254, NA6713]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by operating grants (to M. H.) from the Canadian Institutes of Health Research (MOP-64352) and the Heart and Stroke Foundation of Ontario (T-5254 and NA6713).	Afroze T, 2003, AM J PHYSIOL-CELL PH, V285, pC88, DOI 10.1152/ajpcell.00518.2002; Afroze T, 2000, J BIOL CHEM, V275, P9062, DOI 10.1074/jbc.275.12.9062; Armesilla AL, 2004, J BIOL CHEM, V279, P31318, DOI 10.1074/jbc.M307557200; Becchetti A, 2011, AM J PHYSIOL-CELL PH, V301, pC255, DOI 10.1152/ajpcell.00047.2011; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brandenburger T, 2011, J BIOL CHEM, V286, P7938, DOI 10.1074/jbc.M110.142836; BUETTNER R, 1993, MOL CELL BIOL, V13, P4174, DOI 10.1128/MCB.13.7.4174; Buraschi Simone, 2010, J Biol Chem, V285, P42075, DOI 10.1074/jbc.M110.172841; Carafoli E, 2000, CURR OPIN CHEM BIOL, V4, P152, DOI 10.1016/S1367-5931(99)00069-1; DeLuca A, 1996, J BIOL CHEM, V271, P18961, DOI 10.1074/jbc.271.31.18961; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Fong CW, 2000, BIOCHEM J, V352, P747, DOI 10.1042/0264-6021:3520747; Frost SJ, 2001, MOL CELL ENDOCRINOL, V176, P29, DOI 10.1016/S0303-7207(01)00477-4; GAUBATZ S, 1995, EMBO J, V14, P1508, DOI 10.1002/j.1460-2075.1995.tb07137.x; Gros R, 2003, CIRC RES, V93, P614, DOI 10.1161/01.RES.0000092142.19896.D9; Han CY, 2008, CANCER SCI, V99, P502, DOI 10.1111/j.1349-7006.2007.00718.x; Hu YP, 2009, NEOPLASIA, V11, P1042, DOI 10.1593/neo.09760; Huang H, 2006, BIOCHEM BIOPH RES CO, V351, P99, DOI 10.1016/j.bbrc.2006.10.011; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Husain M, 1997, AM J PHYSIOL-CELL PH, V272, pC1947, DOI 10.1152/ajpcell.1997.272.6.C1947; Husain M, 1997, CIRC RES, V80, P617, DOI 10.1161/01.RES.80.5.617; Iozzo RV, 1999, J BIOL CHEM, V274, P4489, DOI 10.1074/jbc.274.8.4489; Karpurapu M, 2010, J BIOL CHEM, V285, P3510, DOI 10.1074/jbc.M109.063727; KEETON TP, 1993, J BIOL CHEM, V268, P2740; Kim DI, 2008, CARCINOGENESIS, V29, P1701, DOI 10.1093/carcin/bgn055; Liang GQ, 2009, J BIOL CHEM, V284, P21719, DOI 10.1074/jbc.M109.028407; Lipskaia L, 2004, BIOL CELL, V96, P55, DOI 10.1016/j.biolcel.2003.11.001; Liu G, 2011, J HYPERTENS, V29, P696, DOI 10.1097/HJH.0b013e328343c62b; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Oceandy D, 2007, BIOCHEM SOC T, V35, P927, DOI 10.1042/BST0350927; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Pillozzi S, 2010, ADV EXP MED BIOL, V674, P55; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; SantiagoGarcia J, 1996, MOL CELL BIOCHEM, V155, P173; Schonherr E, 2001, J BIOL CHEM, V276, P40687, DOI 10.1074/jbc.M105426200; Schuh K, 2004, J BIOL CHEM, V279, P28220, DOI 10.1074/jbc.M312599200; Schuh K, 2003, J BIOL CHEM, V278, P9778, DOI 10.1074/jbc.M212507200; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Singh NK, 2011, J BIOL CHEM, V286, P22478, DOI 10.1074/jbc.M111.225060; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Stander M, 1999, CELL TISSUE RES, V296, P221, DOI 10.1007/s004410051283; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Tharaux PL, 2000, HYPERTENSION, V36, P330, DOI 10.1161/01.HYP.36.3.330; Xie JY, 2005, RNA, V11, P1825, DOI 10.1261/rna.2171205; You XM, 2003, CIRC RES, V92, P314, DOI 10.1161/01.RES.0000056758.73215.5A; Yucel G, 2013, GENE DEV, V27, P1217, DOI 10.1101/gad.216556.113; Zhang Y, 1999, J BIOL CHEM, V274, P2851, DOI 10.1074/jbc.274.5.2851; ZHAO F, 2011, PLOS ONE, V6	49	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7221	7231		10.1074/jbc.M113.533638	http://dx.doi.org/10.1074/jbc.M113.533638			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24448801	Green Published, hybrid			2022-12-28	WOS:000332389400080
J	Dahl, JM; Wang, HY; Lazaro, JM; Salas, M; Lieberman, KR				Dahl, Joseph M.; Wang, Hongyun; Lazaro, Jose M.; Salas, Margarita; Lieberman, Kate R.			Dynamics of Translocation and Substrate Binding in Individual Complexes Formed with Active Site Mutants of Phi 29 DNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Polymerase; Enzyme Kinetics; Enzyme Mechanisms; Molecular Motors; Single Molecule Biophysics; Translocation Mechanism	DNTP BINDING; REPLICATION; MECHANISM; MOLECULES; NANOPORE	Background: Tyr-226 and Tyr-390 in the 29 DNA polymerase active site are implicated in the mechanism of translocation. Results: Y226F and Y390F differ in their effects on translocation and on dNTP and pyrophosphate binding. Conclusion: Mutations in the 29 DNA polymerase and exonuclease active sites perturb dNTP or pyrophosphate binding rates. Significance: DNA polymerase architecture is finely tuned to integrate translocation and substrate binding. The phi 29 DNA polymerase (DNAP) is a processive B-family replicative DNAP. Fluctuations between the pre-translocation and post-translocation states can be quantified from ionic current traces, when individual phi 29 DNAP-DNA complexes are held atop a nanopore in an electric field. Based upon crystal structures of the phi 29 DNAP-DNA binary complex and the phi 29 DNAP-DNA-dNTP ternary complex, residues Tyr-226 and Tyr-390 in the polymerase active site were implicated in the structural basis of translocation. Here, we have examined the dynamics of translocation and substrate binding in complexes formed with the Y226F and Y390F mutants. The Y226F mutation diminished the forward and reverse rates of translocation, increased the affinity for dNTP in the post-translocation state by decreasing the dNTP dissociation rate, and increased the affinity for pyrophosphate in the pre-translocation state. The Y390F mutation significantly decreased the affinity for dNTP in the post-translocation state by decreasing the association rate approximate to 2-fold and increasing the dissociation rate approximate to 10-fold, implicating this as a mechanism by which this mutation impedes DNA synthesis. The Y390F dissociation rate increase is suppressed when complexes are examined in the presence of Mn2+ rather than Mg2+. The same effects of the Y226F or Y390F mutations were observed in the background of the D12A/D66A mutations, located in the exonuclease active site, approximate to 30 from the polymerase active site. Although translocation rates were unaffected in the D12A/D66A mutant, these exonuclease site mutations caused a decrease in the dNTP dissociation rate, suggesting that they perturb phi 29 DNAP interdomain architecture.	[Dahl, Joseph M.; Lieberman, Kate R.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Wang, Hongyun] Univ Calif Santa Cruz, Dept Appl Math & Stat, Santa Cruz, CA 95064 USA; [Lazaro, Jose M.; Salas, Margarita] Univ Autonoma Madrid, Inst Biol Mol Eladio Vinuela, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Wang, HY (corresponding author), Univ Calif Santa Cruz, Baskin Sch Engn, Dept Appl Math & Stat, 1156 High St, Santa Cruz, CA 95064 USA.	hongwang@soe.ucsc.edu; msalas@cbm.uam.es; krlieberman@gmail.com	Salas, Margarita/J-9873-2014	Salas, Margarita/0000-0001-5939-3441	National Institutes of Health, NIGMS [1R01GM087484]; United States National Science Foundation [DMS-0719361]; Spanish Ministry of Economy and Competitiveness [BFU2011-23645]; University of California Santa Cruz Research Mentoring Institute fellowship from the National Genome Research Institute [R25HG006836]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087484] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States National Science Foundation(National Science Foundation (NSF)); Spanish Ministry of Economy and Competitiveness(Spanish Government); University of California Santa Cruz Research Mentoring Institute fellowship from the National Genome Research Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health, NIGMS, Grant 1R01GM087484 (to K. R. L.). This work was also supported by United States National Science Foundation Grant DMS-0719361 (to H. W.) and by Spanish Ministry of Economy and Competitiveness Grant BFU2011-23645 (to M. S.).; Supported by a University of California Santa Cruz Research Mentoring Institute fellowship from the National Genome Research Institute Grant R25HG006836.	Akeson M, 1999, BIOPHYS J, V77, P3227, DOI 10.1016/S0006-3495(99)77153-5; Benner S, 2007, NAT NANOTECHNOL, V2, P718, DOI 10.1038/nnano.2007.344; Berman AJ, 2007, EMBO J, V26, P3494, DOI 10.1038/sj.emboj.7601780; BLANCO L, 1989, J BIOL CHEM, V264, P8935; BLANCO L, 1991, GENE, V100, P27, DOI 10.1016/0378-1119(91)90346-D; Blanco L, 1996, J BIOL CHEM, V271, P8509, DOI 10.1074/jbc.271.15.8509; BLASCO MA, 1992, J BIOL CHEM, V267, P19427; Colquhoun David, 1995, P483; Dahl JM, 2012, J BIOL CHEM, V287, P13407, DOI 10.1074/jbc.M111.338418; ESTEBAN JA, 1994, J BIOL CHEM, V269, P31946; Garalde DR, 2011, J BIOL CHEM, V286, P14480, DOI 10.1074/jbc.M111.218750; Kamtekar S, 2004, MOL CELL, V16, P609, DOI 10.1016/j.molcel.2004.10.019; Lazaro JM, 1995, METHOD ENZYMOL, V262, P42; Lieberman KR, 2013, J AM CHEM SOC, V135, P9149, DOI 10.1021/ja403640b; Lieberman KR, 2012, J AM CHEM SOC, V134, P18816, DOI 10.1021/ja3090302; Lieberman KR, 2010, J AM CHEM SOC, V132, P17961, DOI 10.1021/ja1087612; Morin JA, 2012, P NATL ACAD SCI USA, V109, P8115, DOI 10.1073/pnas.1204759109; Salas M, 2008, IUBMB LIFE, V60, P82, DOI 10.1002/iub.19; Saturno J, 1995, J BIOL CHEM, V270, P31235, DOI 10.1074/jbc.270.52.31235; Truniger V, 1996, EMBO J, V15, P3430, DOI 10.1002/j.1460-2075.1996.tb00709.x; Wang MN, 2011, BIOCHEMISTRY-US, V50, P581, DOI 10.1021/bi101192f	21	5	8	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6350	6361		10.1074/jbc.M113.535666	http://dx.doi.org/10.1074/jbc.M113.535666			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24464581	Green Published, hybrid			2022-12-28	WOS:000332389400004
J	Rivera, J; Sellers, RS; Zeng, WY; van Rooijen, N; Casadevall, A; Goldman, DL				Rivera, Johanna; Sellers, Rani S.; Zeng, Wangyong; van Rooijen, Nico; Casadevall, Arturo; Goldman, David L.			Platelet-activating Factor Contributes to Bacillus anthracis Lethal Toxin-associated Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anthrax Toxin; Bacterial Pathogenesis; Cytokine; Lipids; Macrophages; Platelet-activating Factor	FACTOR ACETYLHYDROLASE ACTIVITY; PERFUSED-RAT-LIVER; FACTOR PAF; IN-VIVO; INHALATIONAL ANTHRAX; PROTECTIVE ANTIGEN; PULMONARY-FUNCTION; EPITHELIAL-CELLS; CLINICAL SEPSIS; ILL PATIENTS	Background: PAF has been implicated as a potent lipid mediator of endotoxin-induced sepsis, but its role in anthrax-associated shock is unknown. Results: Increased serum levels of PAF were present in LeTx-challenged mice. Inhibition of PAF activity prolonged survival ameliorated increased vascular permeability and hepatic necrosis. Conclusion: PAF appears to be a mediator in lethal toxin-associated damage. Significance: PAF antagonists may be helpful as adjunctive therapy for anthrax-associated shock. The lethal toxin (LeTx) of Bacillus anthracis plays a central role in the pathogenesis of anthrax-associated shock. Platelet-activating factor (PAF) is a potent lipid mediator that has been implicated in endotoxin-associated shock. In this study, we examined the contribution of PAF to the manifestations of lethal toxin challenge in WT mice. LeTx challenge resulted in transient increase in serum PAF levels and a concurrent decrease in PAF acetylhydrolase activity. Inhibition of PAF activity using PAF antagonists or toxin challenge of PAF receptor negative mice reversed or ameliorated many of the pathologic features of LeTx-induced damage, including changes in vascular permeability, hepatic necrosis, and cellular apoptosis. In contrast, PAF inhibition had minimal effects on cytokine levels. Findings from these studies support the continued study of PAF antagonists as potential adjunctive agents in the treatment of anthrax-associated shock.	[Rivera, Johanna; Casadevall, Arturo; Goldman, David L.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Sellers, Rani S.; Casadevall, Arturo] Albert Einstein Coll Med, Dept Med, Div Infect Dis, Bronx, NY 10461 USA; [Zeng, Wangyong] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; [Goldman, David L.] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10461 USA; [van Rooijen, Nico] Vrije Univ Amsterdam, Dept Mol Cell Biol, NL-1081 BT Amsterdam, Netherlands	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Vrije Universiteit Amsterdam	Goldman, DL (corresponding author), Albert Einstein Coll Med, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	david.goldman@einstein.yu.edu	Van Rooijen, Nico/Z-1578-2019		National Institutes of Health [AI33774-11, HL59842-07, AI33142-11, AI52733-02]; Northeastern Biodefense Center [U54-AI057158-Lipkin]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033142, R37AI033142, U54AI057158, R01AI052733, R01AI033774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeastern Biodefense Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI33774-11, HL59842-07, AI33142-11, and AI52733-02 (to A. C.). This work was also supported by the Northeastern Biodefense Center under Grant U54-AI057158-Lipkin.	ALTIN JG, 1987, BIOCHEM J, V245, P145, DOI 10.1042/bj2450145; BENVENISTE J, 1972, J EXP MED, V136, P1356, DOI 10.1084/jem.136.6.1356; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Brossier F, 2004, INFECT IMMUN, V72, P6313, DOI 10.1128/IAI.72.11.6313-6317.2004; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P909; CHANG SW, 1987, J CLIN INVEST, V79, P1498, DOI 10.1172/JCI112980; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; Claud EC, 2008, AM J PHYSIOL-GASTR L, V294, pG1191, DOI 10.1152/ajpgi.00318.2007; Claus RA, 2005, CRIT CARE MED, V33, P1416, DOI 10.1097/01.CCM.0000165807.26485.ED; CRISCUOLI M, 1987, BRIT J PHARMACOL, V90, P203, DOI 10.1111/j.1476-5381.1987.tb16841.x; Cui XZ, 2004, AM J PHYSIOL-REG I, V286, pR699, DOI 10.1152/ajpregu.00593.2003; Del Sorbo L, 2001, EUR J IMMUNOL, V31, P376, DOI 10.1002/1521-4141(200102)31:2<376::AID-IMMU376>3.0.CO;2-5; DeLorme MP, 2002, J PHARMACOL TOXICOL, V47, P1, DOI 10.1016/S1056-8719(02)00191-0; DIEZ FL, 1989, J CLIN INVEST, V83, P1733, DOI 10.1172/JCI114074; DOEBBER TW, 1985, BIOCHEM BIOPH RES CO, V127, P799, DOI 10.1016/S0006-291X(85)80014-0; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; Glaab T, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-63; Goldman DL, 2008, CLIN VACCINE IMMUNOL, V15, P970, DOI 10.1128/CVI.00064-08; GRAHAM RM, 1994, CRIT CARE MED, V22, P204, DOI 10.1097/00003246-199402000-00009; Grinberg LM, 2001, MODERN PATHOL, V14, P482, DOI 10.1038/modpathol.3880337; Grypioti AD, 2006, LIVER INT, V26, P97, DOI 10.1111/j.1478-3231.2005.01186.x; HANNA PC, 1993, P NATL ACAD SCI USA, V90, P10198, DOI 10.1073/pnas.90.21.10198; Hoymann Heinz Gerd, 2007, Journal of Pharmacological and Toxicological Methods, V55, P16, DOI 10.1016/j.vascn.2006.04.006; Huang D, 2008, CANCER RES, V68, P81, DOI 10.1158/0008-5472.CAN-07-5311; Kimura K, 1998, J BIOCHEM-TOKYO, V123, P142; Kirby JE, 2004, INFECT IMMUN, V72, P430, DOI 10.1128/IAI.72.1.430-439.2004; KUIPER J, 1988, BIOCHEM BIOPH RES CO, V157, P1288, DOI 10.1016/S0006-291X(88)81014-3; Kuo SR, 2008, MICROB PATHOGENESIS, V44, P467, DOI 10.1016/j.micpath.2007.12.001; Bachi ALL, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/610371; Ma X, 2001, CURR EYE RES, V23, P326, DOI 10.1076/ceyr.23.5.326.5445; Mathiak G, 1997, SHOCK, V7, P391, DOI 10.1097/00024382-199706000-00001; Migone TS, 2009, NEW ENGL J MED, V361, P135, DOI 10.1056/NEJMoa0810603; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Moayeri M, 2009, MOL ASPECTS MED, V30, P439, DOI 10.1016/j.mam.2009.07.003; Montrucchio G, 1996, CIRCULATION, V93, P2152, DOI 10.1161/01.CIR.93.12.2152; Muehlbauer SM, 2007, CELL CYCLE, V6, P758, DOI 10.4161/cc.6.6.3991; Muehlbauer SM, 2010, AM J PATHOL, V177, P735, DOI 10.2353/ajpath.2010.090828; Murohisa G, 2002, LIVER, V22, P394, DOI 10.1034/j.1600-0676.2002.01552.x; Neufeld D S, 1997, Methods Mol Biol, V75, P145; Pandey J, 2004, MICROBES INFECT, V6, P835, DOI 10.1016/j.micinf.2004.04.013; Partrick DA, 1997, SHOCK, V7, P170, DOI 10.1097/00024382-199703000-00003; Radin JN, 2005, INFECT IMMUN, V73, P7827, DOI 10.1128/IAI.73.12.7827-7835.2005; Rivera J, 2006, INFECT IMMUN, V74, P4149, DOI 10.1128/IAI.00150-06; Ryan SD, 2008, J LIPID RES, V49, P2250, DOI 10.1194/jlr.M800263-JLR200; Salles II, 2003, P NATL ACAD SCI USA, V100, P12426, DOI 10.1073/pnas.2134042100; Serizawa A, 1996, HEPATOLOGY, V23, P1656; SILVESTRO L, 1994, SEMIN THROMB HEMOST, V20, P214, DOI 10.1055/s-2007-1001905; SORENSEN J, 1994, INTENS CARE MED, V20, P555, DOI 10.1007/BF01705721; STAFFORINI DM, 1990, J BIOL CHEM, V265, P9682; Stafforini DM, 2003, CRIT REV CL LAB SCI, V40, P643, DOI 10.1080/714037693; TERASHITA Z, 1985, EUR J PHARMACOL, V109, P257, DOI 10.1016/0014-2999(85)90427-3; Terra JK, 2010, J IMMUNOL, V184, P17, DOI 10.4049/jimmunol.0903114; Vadas P, 2008, NEW ENGL J MED, V358, P28, DOI 10.1056/NEJMoa070030; Victorino GP, 2004, J TRAUMA, V56, P379, DOI 10.1097/01.TA.0000042156.89779.6C; Vincent JL, 2000, CRIT CARE MED, V28, P638, DOI 10.1097/00003246-200003000-00006; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Warfel JM, 2005, AM J PATHOL, V166, P1871, DOI 10.1016/S0002-9440(10)62496-0; Yang JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009190; Zimmerman GA, 2002, CRIT CARE MED, V30, pS294, DOI 10.1097/00003246-200205001-00020	60	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7131	7141		10.1074/jbc.M113.524900	http://dx.doi.org/10.1074/jbc.M113.524900			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24478317	hybrid, Green Published			2022-12-28	WOS:000332389400072
J	Dixon, C; Sah, P; Lynch, JW; Keramidas, A				Dixon, Christine; Sah, Pankaj; Lynch, Joseph W.; Keramidas, Angelo			GABA(A) Receptor alpha and gamma Subunits Shape Synaptic Currents via Different Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chloride Channels; Cys-loop Receptors; GABA Receptors; Kinetics; Synapses	ACID TYPE-A; FUNCTIONAL GABAERGIC SYNAPSES; INTERMEDIATE STATES; DIRECT BINDING; GEPHYRIN; SUBTYPES; AFFINITY; CHANNELS; ACTIVATIONS; COLLYBISTIN	Background: GABA(A)R 2 and 1 subunits are highly expressed in amygdala but their influence on synaptic currents is unknown. Results: 2 subunits increased GABA affinity thereby slowing current deactivation; 1 subunits reduced synaptic receptor clustering. Conclusion: These subunits may differentially shape synaptic kinetics. Significance: Understanding how 2 and 1 subunits shape synaptic currents may help us understand amygdala processing mechanisms. Synaptic GABA(A) receptors (GABA(A)Rs) mediate most of the inhibitory neurotransmission in the brain. The majority of these receptors are comprised of 1, 2, and 2 subunits. The amygdala, a structure involved in processing emotional stimuli, expresses 2 and 1 subunits at high levels. The effect of these subunits on GABA(A)R-mediated synaptic transmission is not known. Understanding the influence of these subunits on GABA(A)R-mediated synaptic currents may help in identifying the roles and locations of amygdala synapses that contain these subunits. Here, we describe the biophysical and synaptic properties of pure populations of 122, 222, 121 and 221 GABA(A)Rs. Their synaptic properties were examined in engineered synapses, whereas their kinetic properties were studied using rapid agonist application, and single channel recordings. All macropatch currents activated rapidly (<1 ms) and deactivated as a function of the -subunit, with 2-containing GABA(A)Rs consistently deactivating approximate to 10-fold more slowly. Single channel analysis revealed that the slower current decay of 2-containing GABA(A)Rs was due to longer burst durations at low GABA concentrations, corresponding to a approximate to 4-fold higher affinity for GABA. Synaptic currents revealed a different pattern of activation and deactivation to that of macropatch data. The inclusion of 2 and 1 subunits slowed both the activation and deactivation rates, suggesting that receptors containing these subunits cluster more diffusely at synapses. Switching the intracellular domains of the 2 and 1 subunits substantiated this inference. Because this region determines post-synaptic localization, we hypothesize that GABA(A)Rs containing 1 and 2 use different mechanisms for synaptic clustering.	[Dixon, Christine; Sah, Pankaj; Lynch, Joseph W.; Keramidas, Angelo] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia	University of Queensland	Keramidas, A (corresponding author), Queensland Brain Inst, QBI Bldg 79, St Lucia, Qld 4072, Australia.	a.keramidas@uq.edu.au	Keramidas, Angelo/I-1704-2013	Keramidas, Angelo/0000-0003-2846-052X; Sah, Pankaj/0000-0001-5063-1589	Australian Research Council [DP120104373]; National Health and Medical Research Council of Australia	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by Australian Research Council Grant ID-DP120104373.; Supported by a fellowship from the National Health and Medical Research Council of Australia.	Alldred MJ, 2005, J NEUROSCI, V25, P594, DOI 10.1523/JNEUROSCI.4011-04.2005; ANGELOTTI TP, 1993, J NEUROSCI, V13, P1429; Bannai H, 2009, NEURON, V62, P670, DOI 10.1016/j.neuron.2009.04.023; BARRY PH, 1994, J NEUROSCI METH, V51, P107, DOI 10.1016/0165-0270(94)90031-0; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Buhr A, 1997, P NATL ACAD SCI USA, V94, P8824, DOI 10.1073/pnas.94.16.8824; Buhr A, 1997, J BIOL CHEM, V272, P11799, DOI 10.1074/jbc.272.18.11799; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Colquhoun D., 1995, SINGLE CHANNEL RECOR, P483; Crestani F, 1999, NAT NEUROSCI, V2, P833, DOI 10.1038/12207; Delaney AJ, 2001, J NEUROPHYSIOL, V86, P717, DOI 10.1152/jn.2001.86.2.717; Dong N, 2007, MOL CELL NEUROSCI, V35, P14, DOI 10.1016/j.mcn.2007.01.013; Elenes S, 2006, J GEN PHYSIOL, V128, P615, DOI 10.1085/jgp.200609570; Esmaeili A, 2009, J NEUROPHYSIOL, V101, P341, DOI 10.1152/jn.90991.2008; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Eyre MD, 2012, J NEUROSCI, V32, P5853, DOI 10.1523/JNEUROSCI.6495-11.2012; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Gielen MC, 2012, J NEUROSCI, V32, P5707, DOI 10.1523/JNEUROSCI.5663-11.2012; GUNTHER U, 1995, P NATL ACAD SCI USA, V92, P7749, DOI 10.1073/pnas.92.17.7749; Hanson SM, 2008, J NEUROSCI, V28, P3490, DOI 10.1523/JNEUROSCI.5727-07.2008; Jadey S, 2012, J GEN PHYSIOL, V140, P17, DOI 10.1085/jgp.201210801; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; Keramidas A, 2008, J GEN PHYSIOL, V131, P163, DOI 10.1085/jgp.200709871; Keramidas A, 2006, J PHYSIOL-LONDON, V575, P11, DOI 10.1113/jphysiol.2005.102756; Keramidas A, 2010, J GEN PHYSIOL, V135, P59, DOI 10.1085/jgp.200910317; Kneussel M, 2001, MOL CELL NEUROSCI, V17, P973, DOI 10.1006/mcne.2001.0983; Korber C, 2012, MOL CELL NEUROSCI, V50, P250, DOI 10.1016/j.mcn.2012.05.006; Kowalczyk S, 2013, EUR J NEUROSCI, V37, P544, DOI 10.1111/ejn.12078; Krashia P, 2011, J GEN PHYSIOL, V137, P197, DOI 10.1085/jgp.201010521; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Lape R, 2012, J NEUROSCI, V32, P1336, DOI 10.1523/JNEUROSCI.4346-11.2012; Lavoie AM, 1997, BIOPHYS J, V73, P2518, DOI 10.1016/S0006-3495(97)78280-8; Lema GMC, 2006, J PHYSIOL-LONDON, V572, P183, DOI 10.1113/jphysiol.2005.099093; Levi S, 2004, J NEUROSCI, V24, P207, DOI 10.1523/JNEUROSCI.1661-03.2004; Loebrich S, 2006, EMBO J, V25, P987, DOI 10.1038/sj.emboj.7600995; Lorez Matthias, 2000, Journal of Physiology (Cambridge), V527, P11, DOI 10.1111/j.1469-7793.2000.t01-1-00011.x; Maric HM, 2011, J BIOL CHEM, V286, P42105, DOI 10.1074/jbc.M111.303412; McClellan AML, 1999, J PHYSIOL-LONDON, V515, P711, DOI 10.1111/j.1469-7793.1999.711ab.x; Mohler H, 2001, Curr Opin Pharmacol, V1, P22, DOI 10.1016/S1471-4892(01)00008-X; Mukhtasimova N, 2009, NATURE, V459, P451, DOI 10.1038/nature07923; Nusser Z, 1998, J NEUROSCI, V18, P1693; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Okada M, 2000, J NEUROSCI, V20, P2202; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Panzanelli P, 2011, J PHYSIOL-LONDON, V589, P4959, DOI 10.1113/jphysiol.2011.216028; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Ribrault C, 2011, NAT REV NEUROSCI, V12, P375, DOI 10.1038/nrn3025; Saiepour L, 2010, J BIOL CHEM, V285, P29623, DOI 10.1074/jbc.M110.121368; Schofield CM, 2007, J NEUROSCI, V27, P7954, DOI 10.1523/JNEUROSCI.0377-07.2007; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Thomson AM, 2010, EUR J NEUROSCI, V31, P2193, DOI 10.1111/j.1460-9568.2010.07252.x; Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008; WAFFORD KA, 1993, MOL PHARMACOL, V43, P240; Wingrove PB, 1997, MOL PHARMACOL, V52, P874, DOI 10.1124/mol.52.5.874; Wu X, 2012, J BIOL CHEM, V287, P27417, DOI 10.1074/jbc.M112.360461; Wyllie DJA, 1998, J PHYSIOL-LONDON, V510, P1, DOI 10.1111/j.1469-7793.1998.001bz.x; YMER S, 1990, EMBO J, V9, P3261, DOI 10.1002/j.1460-2075.1990.tb07525.x	59	60	61	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5399	5411		10.1074/jbc.M113.514695	http://dx.doi.org/10.1074/jbc.M113.514695			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24425869	Green Published, hybrid			2022-12-28	WOS:000332015500005
J	DiDonato, JA; Aulak, K; Huang, Y; Wagner, M; Gerstenecker, G; Topbas, C; Gogonea, V; DiDonato, AJ; Tang, WHW; Mehl, RA; Fox, PL; Plow, EF; Smith, JD; Fisher, EA; Hazen, SL				DiDonato, Joseph A.; Aulak, Kulwant; Huang, Ying; Wagner, Matthew; Gerstenecker, Gary; Topbas, Celalettin; Gogonea, Valentin; DiDonato, Anthony J.; Tang, W. H. Wilson; Mehl, Ryan A.; Fox, Paul L.; Plow, Edward F.; Smith, Jonathan D.; Fisher, Edward A.; Hazen, Stanley L.			Site-specific Nitration of Apolipoprotein A-I at Tyrosine 166 Is Both Abundant within Human Atherosclerotic Plaque and Dysfunctional	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aminoacyl-tRNA Synthetase; Apolipoproteins; Atherosclerosis; Peroxidase; Post-translational Modification; Dysfunctional HDL; Nitrotyrosine; Orthogonal Amino Acid; Protein Nitration; Unnatural Amino Acid (uAA)	HIGH-DENSITY-LIPOPROTEIN; ABCA1-DEPENDENT CHOLESTEROL TRANSPORT; MYELOPEROXIDASE-CATALYZED OXIDATION; RANDOMIZED CONTROLLED-TRIAL; CORONARY-ARTERY-DISEASE; CARDIOVASCULAR-DISEASE; ESCHERICHIA-COLI; STATIN THERAPY; HUMAN ATHEROMA; HEART-DISEASE	Background: The functional importance of apolipoprotein A-I (apoA-I) nitration at tyrosine 166 (Tyr(166)) in vivo is controversial. Results: Nitrotyrosine 166-apoA-I accounts for 8% of apoA-I within human atheroma, is not HDL-associated, and is functionally impaired. Conclusion: Buoyant density ultracentrifugation of HDL can lead to erroneous results, particularly with modified apoA-I forms. Significance: Detection and quantification of nitrotyrosine 166-apoA-I may provide insights into a pathophysiological process within the artery wall. We reported previously that apolipoprotein A-I (apoA-I) is oxidatively modified in the artery wall at tyrosine 166 (Tyr(166)), serving as a preferred site for post-translational modification through nitration. Recent studies, however, question the extent and functional importance of apoA-I Tyr(166) nitration based upon studies of HDL-like particles recovered from atherosclerotic lesions. We developed a monoclonal antibody (mAb 4G11.2) that recognizes, in both free and HDL-bound forms, apoA-I harboring a 3-nitrotyrosine at position 166 apoA-I (NO2-Tyr(166)-apoA-I) to investigate the presence, distribution, and function of this modified apoA-I form in atherosclerotic and normal artery wall. We also developed recombinant apoA-I with site-specific 3-nitrotyrosine incorporation only at position 166 using an evolved orthogonal nitro-Tyr-aminoacyl-tRNA synthetase/tRNA(CUA) pair for functional studies. Studies with mAb 4G11.2 showed that NO2-Tyr(166)-apoA-I was easily detected in atherosclerotic human coronary arteries and accounted for approximate to 8% of total apoA-I within the artery wall but was nearly undetectable (>100-fold less) in normal coronary arteries. Buoyant density ultracentrifugation analyses showed that NO2-Tyr(166)-apoA-I existed as a lipid-poor lipoprotein with <3% recovered within the HDL-like fraction (d = 1.063-1.21). NO2-Tyr(166)-apoA-I in plasma showed a similar distribution. Recovery of NO2-Tyr(166)-apoA-I using immobilized mAb 4G11.2 showed an apoA-I form with 88.1 +/- 8.5% reduction in lecithin-cholesterol acyltransferase activity, a finding corroborated using a recombinant apoA-I specifically designed to include the unnatural amino acid exclusively at position 166. Thus, site-specific nitration of apoA-I at Tyr(166) is an abundant modification within the artery wall that results in selective functional impairments. Plasma levels of this modified apoA-I form may provide insights into a pathophysiological process within the diseased artery wall.	[DiDonato, Joseph A.; Aulak, Kulwant; Huang, Ying; Wagner, Matthew; Gerstenecker, Gary; Topbas, Celalettin; Gogonea, Valentin; DiDonato, Anthony J.; Tang, W. H. Wilson; Fox, Paul L.; Smith, Jonathan D.; Hazen, Stanley L.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Plow, Edward F.] Cleveland Clin, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Tang, W. H. Wilson; Plow, Edward F.; Smith, Jonathan D.; Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [DiDonato, Joseph A.; Huang, Ying; Tang, W. H. Wilson; Smith, Jonathan D.; Hazen, Stanley L.] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Cleveland, OH 44195 USA; [Gerstenecker, Gary; Topbas, Celalettin; Gogonea, Valentin] Cleveland State Univ, Dept Chem, Cleveland, OH 44118 USA; [DiDonato, Anthony J.] John Carroll Univ, Dept Psychol, University Hts, OH 44118 USA; [Mehl, Ryan A.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA; [Fisher, Edward A.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Fisher, Edward A.] NYU, Sch Med, Dept Med, Leon H Charney Div Cardiol, New York, NY 10016 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; John Carroll University; Oregon State University; New York University; New York University	DiDonato, JA (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, 9500 Euclid Ave,NC-10, Cleveland, OH 44195 USA.	didonaj@ccf.org; hazens@ccf.org	Hazen, Stanley L/ABD-5845-2021; Fisher, Edward/ABE-7469-2020; Tang, Wai Hong Wilson/I-1238-2013; Smith, Jonathan D./H-9723-2013	Smith, Jonathan D./0000-0002-0415-386X; Tang, W. H. Wilson/0000-0002-8335-735X; Fisher, Edward/0000-0001-9802-143X	AB SCIEX; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098055, R01HL103931, P01HL076491, R01HL017964] Funding Source: NIH RePORTER	AB SCIEX; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Mass spectrometry studies were performed within the Lerner Research Institute mass spectrometry facility, which is partially supported through a Center of Innovation award by AB SCIEX.	BADIMON JJ, 1989, LAB INVEST, V60, P455; BADIMON JJ, 1990, J CLIN INVEST, V85, P1234, DOI 10.1172/JCI114558; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Boullier A, 2001, ANN NY ACAD SCI, V947, P214; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; DiDonato JA, 2013, CIRCULATION, V128, P1644, DOI 10.1161/CIRCULATIONAHA.113.002624; Feig JE, 2014, CIRC RES, V114, P205, DOI 10.1161/CIRCRESAHA.114.300760; Franco MC, 2013, P NATL ACAD SCI USA, V110, pE1102, DOI 10.1073/pnas.1215177110; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Hadfield KA, 2013, BIOCHEM J, V449, P531, DOI 10.1042/BJ20121210; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Hewing B., 2014, ARTERIOSCLER THROMB, DOI [10.1161/ATVBAHA.113.303044, DOI 10.1161/ATVBAHA. 113. 303044]; Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459; Hughes SD, 1997, ARTERIOSCL THROM VAS, V17, P1725, DOI 10.1161/01.ATV.17.9.1725; Kinlay S, 2001, CURR OPIN LIPIDOL, V12, P383, DOI 10.1097/00041433-200108000-00003; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li XM, 2013, ARTERIOSCL THROM VAS, V33, P1696, DOI 10.1161/ATVBAHA.113.301373; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MATZ CE, 1982, J BIOL CHEM, V257, P4535; MORITA Y, 1986, J BIOCHEM-TOKYO, V99, P761, DOI 10.1093/oxfordjournals.jbchem.a135535; MORRIS JC, 1966, J PHYS CHEM-US, V70, P3798, DOI 10.1021/j100884a007; Navab M, 2002, CURR OPIN LIPIDOL, V13, P363, DOI 10.1097/00041433-200208000-00003; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Neumann H, 2008, J AM CHEM SOC, V130, P4028, DOI 10.1021/ja710100d; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Nissen SE, 2007, NEW ENGL J MED, V356, P1304, DOI 10.1056/NEJMoa070635; Parks JS, 1999, METH MOL B, V109, P123; Peng DQ, 2008, ARTERIOSCL THROM VAS, V28, P2063, DOI 10.1161/ATVBAHA.108.173815; Peng DQ, 2005, J BIOL CHEM, V280, P33775, DOI 10.1074/jbc.M504092200; Pennathur S, 2004, J BIOL CHEM, V279, P42977, DOI 10.1074/jbc.M406762200; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; RAKITA RM, 1990, BIOCHEMISTRY-US, V29, P1075, DOI 10.1021/bi00456a033; Reiter CD, 2000, J BIOL CHEM, V275, P32460, DOI 10.1074/jbc.M910433199; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; Sacks FM, 2009, J LIPID RES, V50, P894, DOI 10.1194/jlr.M800622-JLR200; Samuelson J. C., 2013, ENZYME ENG, P93; Shao BH, 2012, J BIOL CHEM, V287, P6375, DOI 10.1074/jbc.M111.337345; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Shishehbor MH, 2003, JAMA-J AM MED ASSOC, V289, P1675, DOI 10.1001/jama.289.13.1675; Souza JM, 1999, ARCH BIOCHEM BIOPHYS, V371, P169, DOI 10.1006/abbi.1999.1480; Stahlman M, 2008, J LIPID RES, V49, P481, DOI 10.1194/jlr.D700025-JLR200; Tardif JC, 2007, JAMA-J AM MED ASSOC, V297, P1675, DOI 10.1001/jama.297.15.jpc70004; Undurti A, 2009, J BIOL CHEM, V284, P30825, DOI 10.1074/jbc.M109.047605; Vaisar Tomas, 2007, Curr Atheroscler Rep, V9, P417, DOI 10.1007/s11883-007-0054-z; Viera L, 1999, METHOD ENZYMOL, V301, P373; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Wu WJ, 2000, J CLIN INVEST, V105, P1455, DOI 10.1172/JCI9702; Wu Z, 2007, NAT STRUCT MOL BIOL, V14, P861, DOI 10.1038/nsmb1284; Wu ZP, 2009, J BIOL CHEM, V284, P36605, DOI 10.1074/jbc.M109.039537; Young TS, 2010, J BIOL CHEM, V285, P11039, DOI 10.1074/jbc.R109.091306; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	59	75	77	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10276	10292		10.1074/jbc.M114.556506	http://dx.doi.org/10.1074/jbc.M114.556506			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24558038	Green Published, hybrid			2022-12-28	WOS:000334226400005
J	Afrazi, A; Branca, MF; Sodhi, CP; Good, M; Yamaguchi, Y; Egan, CE; Lu, P; Jia, HP; Shaffiey, S; Lin, J; Ma, CR; Vincent, G; Prindle, T; Weyandt, S; Neal, MD; Ozolek, JA; Wiersch, J; Tschurtschenthaler, M; Shiota, C; Gittes, GK; Billiar, TR; Mollen, K; Kaser, A; Blumberg, R; Hackam, DJ				Afrazi, Amin; Branca, Maria F.; Sodhi, Chhinder P.; Good, Misty; Yamaguchi, Yukihiro; Egan, Charlotte E.; Lu, Peng; Jia, Hongpeng; Shaffiey, Shahab; Lin, Joyce; Ma, Congrong; Vincent, Garrett; Prindle, Thomas, Jr.; Weyandt, Samantha; Neal, Matthew D.; Ozolek, John A.; Wiersch, John; Tschurtschenthaler, Markus; Shiota, Chiyo; Gittes, George K.; Billiar, Timothy R.; Mollen, Kevin; Kaser, Arthur; Blumberg, Richard; Hackam, David J.			Toll-like Receptor 4-mediated Endoplasmic Reticulum Stress in Intestinal Crypts Induces Necrotizing Enterocolitis*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Inflammation; Innate Immunity; Necrotizing Enterocolitis; Sepsis; Toll-like Receptors (TLR)	UNFOLDED PROTEIN RESPONSE; STEM-CELLS; ENTEROCYTE MIGRATION; ER STRESS; NITRIC-OXIDE; TLR4; PATHOGENESIS; CHOP; PROLIFERATION; EPITHELIUM	Background: Cellular cues that regulate intestinal stem cell (ISC) apoptosis are unknown. Results: Toll-like-receptor 4 (TLR4) activation on ISCs induces endoplasmic reticulum (ER) stress, leading to ISC apoptosis and necrotizing enterocolitis (NEC). Conclusion: TLR4-induced ER stress in ISCs leads to apoptosis and NEC. Significance: This is the first study revealing that ER stress in ISCs via immune receptors induces NEC. The cellular cues that regulate the apoptosis of intestinal stem cells (ISCs) remain incompletely understood, yet may play a role in diseases characterized by ISC loss including necrotizing enterocolitis (NEC). Toll-like receptor-4 (TLR4) was recently found to be expressed on ISCs, where its activation leads to ISC apoptosis through mechanisms that remain incompletely explained. We now hypothesize that TLR4 induces endoplasmic reticulum (ER) stress within ISCs, leading to their apoptosis in NEC pathogenesis, and that high ER stress within the premature intestine predisposes to NEC development. Using transgenic mice and cultured enteroids, we now demonstrate that TLR4 induces ER stress within Lgr5 (leucine-rich repeat-containing G-protein-coupled receptor 5)-positive ISCs, resulting in crypt apoptosis. TLR4 signaling within crypts was required, because crypt ER stress and apoptosis occurred in TLR4(IEC-OVER) mice expressing TLR4 only within intestinal crypts and epithelium, but not TLR4(IEC) mice lacking intestinal TLR4. TLR4-mediated ER stress and apoptosis of ISCs required PERK (protein kinase-related PKR-like ER kinase), CHOP (C/EBP homologous protein), and MyD88 (myeloid differentiation primary response gene 88), but not ATF6 (activating transcription factor 6) or XBP1 (X-box-binding protein 1). Human and mouse NEC showed high crypt ER stress and apoptosis, whereas genetic inhibition of PERK or CHOP attenuated ER stress, crypt apoptosis, and NEC severity. Strikingly, using intragastric delivery into fetal mouse intestine, prevention of ER stress reduced TLR4-mediated ISC apoptosis and mucosal disruption. These findings identify a novel link between TLR4-induced ER stress and ISC apoptosis in NEC pathogenesis and suggest that increased ER stress within the premature bowel predisposes to NEC development.	[Afrazi, Amin; Branca, Maria F.; Sodhi, Chhinder P.; Yamaguchi, Yukihiro; Egan, Charlotte E.; Lu, Peng; Jia, Hongpeng; Shaffiey, Shahab; Lin, Joyce; Ma, Congrong; Vincent, Garrett; Prindle, Thomas, Jr.; Weyandt, Samantha; Neal, Matthew D.; Wiersch, John; Shiota, Chiyo; Gittes, George K.; Mollen, Kevin; Hackam, David J.] Univ Pittsburgh, Sch Med, Div Pediat Surg, Pittsburgh, PA 15224 USA; [Ozolek, John A.] Univ Pittsburgh, Sch Med, Div Pathol, Pittsburgh, PA 15224 USA; [Good, Misty] Univ Pittsburgh, Sch Med, Newborn Med Childrens Hosp Pittsburgh, Pittsburgh, PA 15224 USA; [Afrazi, Amin; Branca, Maria F.; Sodhi, Chhinder P.; Yamaguchi, Yukihiro; Egan, Charlotte E.; Lu, Peng; Jia, Hongpeng; Shaffiey, Shahab; Lin, Joyce; Ma, Congrong; Vincent, Garrett; Prindle, Thomas, Jr.; Weyandt, Samantha; Neal, Matthew D.; Wiersch, John; Shiota, Chiyo; Gittes, George K.; Billiar, Timothy R.; Mollen, Kevin; Hackam, David J.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA 15224 USA; [Good, Misty] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15224 USA; [Ozolek, John A.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15224 USA; [Tschurtschenthaler, Markus; Kaser, Arthur] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Gastroenterol & Hepatol, Cambridge CB2 0QQ, England; [Blumberg, Richard] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy,Dept Med, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Hackam, DJ (corresponding author), Childrens Hosp Pittsburgh UPMC, Div Pediat Surg, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	david.hackam@chp.edu	Good, Misty/AAI-6192-2020; Neal, Matthew/GMW-5601-2022; jia, jhp@mm8899/AAH-6611-2020; Tschurtschenthaler, Markus/O-8931-2019; Shaffiey, Shahab/AAN-1535-2021	Good, Misty/0000-0002-0264-5721; Neal, Matthew/0000-0001-8931-6236; Tschurtschenthaler, Markus/0000-0002-0060-4790; Mollen, Kevin/0000-0001-7629-2722; Hackam, David/0000-0001-5195-8807	National Institutes of Health [1R01GM078238, 1R01DK083752, P50GM053789, R01DK088199, R01-DK083541]; Hartwell Foundation; Harvard Digestive Diseases Center [DK0034854]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083541, R01DK083752, R01DK088199, P30DK034854, K08DK101753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078238, P50GM053789] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation; Harvard Digestive Diseases Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01GM078238 and 1R01DK083752 (to D. J. H.), P50GM053789 (to D. J. H. and T. R. B.), R01DK088199 (to R. B.), and R01-DK083541 (to G. K. G.). This work was also supported by funds from the Hartwell Foundation (to D. J. H.) and Harvard Digestive Diseases Center Grant DK0034854 (to R. B.).	Afrazi A, 2012, J IMMUNOL, V188, P4543, DOI 10.4049/jimmunol.1103114; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cao SS, 2013, GASTROENTEROLOGY, V144, P989, DOI 10.1053/j.gastro.2013.01.023; Cetin S, 2007, AM J PHYSIOL-GASTR L, V292, pG1347, DOI 10.1152/ajpgi.00375.2006; Chen CL, 2012, LAB INVEST, V92, P331, DOI 10.1038/labinvest.2011.167; Clevers H, 2013, CELL, V154, P274, DOI 10.1016/j.cell.2013.07.004; Feng JX, 2007, J PEDIATR SURG, V42, P214, DOI 10.1016/j.jpedsurg.2006.09.055; Ford H, 1997, J PEDIATR SURG, V32, P275, DOI 10.1016/S0022-3468(97)90194-9; Good M, 2012, P NATL ACAD SCI USA, V109, P11330, DOI 10.1073/pnas.1200856109; Gribar SC, 2009, J IMMUNOL, V182, P636, DOI 10.4049/jimmunol.182.1.636; Heijmans J, 2013, CELL REP, V3, P1128, DOI 10.1016/j.celrep.2013.02.031; Hikisz P, 2012, CELL MOL BIOL LETT, V17, P646, DOI 10.2478/s11658-012-0032-5; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaser A, 2013, SEMIN IMMUNOPATHOL, V35, P307, DOI 10.1007/s00281-013-0377-5; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; King SL, 2013, CURR OPIN GASTROEN, V29, P140, DOI 10.1097/MOG.0b013e32835cf253; Leaphart CL, 2007, J IMMUNOL, V179, P4808, DOI 10.4049/jimmunol.179.7.4808; Leaphart CL, 2007, GASTROENTEROLOGY, V132, P2395, DOI 10.1053/j.gastro.2007.03.029; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Neal MD, 2006, J IMMUNOL, V176, P3070, DOI 10.4049/jimmunol.176.5.3070; Neal MD, 2013, J IMMUNOL, V190, P3541, DOI 10.4049/jimmunol.1202264; Neal MD, 2012, J BIOL CHEM, V287, P37296, DOI 10.1074/jbc.M112.375881; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Qiu W, 2008, CELL STEM CELL, V2, P576, DOI 10.1016/j.stem.2008.03.009; Richardson WM, 2010, GASTROENTEROLOGY, V139, P904, DOI 10.1053/j.gastro.2010.05.038; Richter JM, 2012, J PEDIATR GASTR NUTR, V54, P639, DOI 10.1097/MPG.0b013e31823a895a; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Simons BD, 2011, EXP CELL RES, V317, P2719, DOI 10.1016/j.yexcr.2011.07.010; Sodhi CP, 2012, GASTROENTEROLOGY, V143, P708, DOI 10.1053/j.gastro.2012.05.053; Sodhi CP, 2010, GASTROENTEROLOGY, V138, P185, DOI 10.1053/j.gastro.2009.09.045; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Thorp E, 2009, CELL METAB, V9, P474, DOI 10.1016/j.cmet.2009.03.003; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996	39	108	111	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9584	9599		10.1074/jbc.M113.526517	http://dx.doi.org/10.1074/jbc.M113.526517			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24519940	Green Published, hybrid			2022-12-28	WOS:000333807000014
J	Sahni, S; Bae, DH; Lane, DJR; Kovacevic, Z; Kalinowski, DS; Jansson, PJ; Richardson, DR				Sahni, Sumit; Bae, Dong-Hun; Lane, Darius J. R.; Kovacevic, Zaklina; Kalinowski, Danuta S.; Jansson, Patric J.; Richardson, Des R.			The Metastasis Suppressor, N-myc Downstream-regulated Gene 1 (NDRG1), Inhibits Stress-induced Autophagy in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Iron; Iron Metabolism; Metastasis; Oxidative Stress; Stress; Dp44mT; Desferrioxamine; Iron Chelators; Iron-Protein Interactions; Ligand-Metal Interactions	EFFECTIVE ANTIPROLIFERATIVE AGENTS; PYRIDOXAL ISONICOTINOYL HYDRAZONE; SELECTIVE ANTITUMOR-ACTIVITY; UNFOLDED PROTEIN RESPONSE; PROSTATE EPITHELIAL-CELLS; IRON CHELATORS; ENDOPLASMIC-RETICULUM; MONITORING AUTOPHAGY; MAMMALIAN AUTOPHAGY; PANCREATIC-CANCER	Background: NDRG1 is an important iron-regulated metastasis suppressor that plays an undefined role in the stress response. Results: We demonstrate that NDRG1 suppresses the stress-induced, pro-survival autophagic pathway. Conclusion: Suppression of the autophagic pathway by NDRG1 makes cells more susceptible to apoptosis. Significance: These results indicate an important new mechanism through which NDRG1 exerts its metastasis suppressor activity. N-myc downstream regulated gene 1 (NDRG1) is a potent metastasis suppressor with an undefined role in the stress response. Autophagy is a pro-survival pathway and can be regulated via the protein kinase-like endoplasmic reticulum kinase (PERK)/eIF2-mediated endoplasmic reticulum (ER) stress pathway. Hence, we investigated the role of NDRG1 in stress-induced autophagy as a mechanism of inhibiting metastasis via the induction of apoptosis. As thiosemicarbazone chelators induce stress and up-regulate NDRG1 to inhibit metastasis, we studied their effects on the ER stress response and autophagy. This was important to assess, as little is understood regarding the role of the stress induced by iron depletion and its role in autophagy. We observed that the chelator, di-2-pyridylketone 4,4-dimethyl-3-thiosemicarbazone (Dp44mT), which forms redox-active iron and copper complexes, effectively induced ER stress as shown by activation of the PERK/eIF2 pathway. Dp44mT also increased the expression of the autophagic marker, LC3-II, and this was dependent on activation of the PERK/eIF2 axis, as silencing PERK prevented LC3-II accumulation. The effect of Dp44mT on LC3-II expression was at least partially due to iron-depletion, as this effect was also demonstrated with the classical iron chelator, desferrioxamine (DFO), and was not observed for the DFO-iron complex. NDRG1 overexpression also inhibited basal autophagic initiation and the ER stress-mediated autophagic pathway via suppression of the PERK/eIF2 axis. Moreover, NDRG1-mediated suppression of the pro-survival autophagic pathway probably plays a role in its anti-metastatic effects by inducing apoptosis. In fact, multiple pro-apoptotic markers were increased, whereas anti-apoptotic Bcl-2 was decreased upon NDRG1 overexpression. This study demonstrates the role of NDRG1 as an autophagic inhibitor that is important for understanding its mechanism of action.	[Jansson, Patric J.] Univ Sydney, Mol Pharmacol & Pathol Program, Dept Pathol, Sydney, NSW 2006, Australia; Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Jansson, PJ (corresponding author), Univ Sydney, Mol Pharmacol & Pathol Program, Dept Pathol, Blackburn Bldg D06, Sydney, NSW 2006, Australia.	patric.jansson@sydney.edu.au; d.richardson@sydney.edu.au	Kovacevic, Zaklina/ABD-9581-2021; Jansson, Patric/AAC-4221-2022	Kovacevic, Zaklina/0000-0002-4742-4690; Jansson, Patric/0000-0002-9322-653X; Sahni, Sumit/0000-0002-2900-8845; Bae, Dong-Hun/0000-0002-4109-7190; Richardson, Des/0000-0003-0960-6415; Richardson, Des/0000-0002-5506-3274; Lane, Darius/0000-0001-8725-6903; Kalinowski, Danuta/0000-0002-9303-7405	National Health and Medical Research Council; Cancer Institute NSW Early Career Fellowship; National Health and Medical Research Council of Australia; Cancer Institute of New South Wales (CINSW); Prostate Cancer Foundation Australia	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW Early Career Fellowship; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute of New South Wales (CINSW); Prostate Cancer Foundation Australia	Recipient of National Health and Medical Research Council Peter Doherty Fellowship and Cancer Institute NSW Early Career Fellowship.; Recipient of National Health and Medical Research Council of Australia Project grant support.; Recipient of National Health and Medical Research Council of Australia, Cancer Institute of New South Wales (CINSW) and Prostate Cancer Foundation Australia for Early Career Research Fellowships. To whom correspondence may be addressed: Tel.: 61-2-9036-67120; Fax: 61-2-9351-3429; E-mail: patric.jansson@sydney.edu.au.	Angst E, 2011, SURGERY, V149, P614, DOI 10.1016/j.surg.2010.11.002; Bandyopadhyay S, 2004, ONCOGENE, V23, P5675, DOI 10.1038/sj.onc.1207734; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Cangul H, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-27; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chen B, 2006, J BIOL CHEM, V281, P2764, DOI 10.1074/jbc.M507330200; Chen ZQ, 2012, J BIOL CHEM, V287, P17016, DOI 10.1074/jbc.M112.350470; De Domenico I, 2009, BLOOD, V114, P4546, DOI 10.1182/blood-2009-05-224188; Dixon KM, 2013, BRIT J CANCER, V108, P409, DOI 10.1038/bjc.2012.582; Ellen TP, 2008, CARCINOGENESIS, V29, P2, DOI 10.1093/carcin/bgm200; Fang BA, 2014, BBA-REV CANCER, V1845, P1, DOI 10.1016/j.bbcan.2013.11.002; Fujii S, 2008, CANCER SCI, V99, P1813, DOI 10.1111/j.1349-7006.2008.00893.x; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Gao J, 2001, BLOOD, V98, P842, DOI 10.1182/blood.V98.3.842; Ghalayini MK, 2013, BIOSCIENCE REP, V33, P451, DOI 10.1042/BSR20130042; Giatromanolaki A, 2010, J CLIN PATHOL, V63, P867, DOI 10.1136/jcp.2010.079525; Guang RJ, 2000, CANCER RES, V60, P749; Gurkar AU, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3189; Hamacher-Brady A, 2012, ANTIOXID REDOX SIGN, V17, P756, DOI 10.1089/ars.2011.4410; Hart LS, 2012, J CLIN INVEST, V122, P4621, DOI 10.1172/JCI62973; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hickok JR, 2011, J BIOL CHEM, V286, P41413, DOI 10.1074/jbc.M111.287052; Jansson PJ, 2010, J INORG BIOCHEM, V104, P1224, DOI 10.1016/j.jinorgbio.2010.07.012; Jansson PJ, 2010, J MED CHEM, V53, P5759, DOI 10.1021/jm100561b; Jiang C, 2001, CANCER RES, V61, P3062; Kalinowski DS, 2007, CHEM RES TOXICOL, V20, P715, DOI 10.1021/tx700039c; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kenific CM, 2010, CURR OPIN CELL BIOL, V22, P241, DOI 10.1016/j.ceb.2009.10.008; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kokame K, 1996, J BIOL CHEM, V271, P29659, DOI 10.1074/jbc.271.47.29659; Korolchuk V. I., 2012, BIOCHEMIST, V34, P8; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bgl146; Kovacevic Z, 2013, ANTIOXID REDOX SIGN, V18, P874, DOI 10.1089/ars.2011.4273; Kovacevic Z, 2011, MOL PHARMACOL, V80, P598, DOI 10.1124/mol.111.073627; Kovacevic Z, 2011, CARCINOGENESIS, V32, P732, DOI 10.1093/carcin/bgr046; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lachat P, 2002, HISTOCHEM CELL BIOL, V118, P399, DOI 10.1007/s00418-002-0460-9; Lane DJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057273; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Li J, 2003, MOL CELL BIOCHEM, V250, P91, DOI 10.1023/A:1024918328162; Liu W, 2012, EMBO MOL MED, V4, P93, DOI 10.1002/emmm.201100190; Lovejoy DB, 2012, J MED CHEM, V55, P7230, DOI 10.1021/jm300768u; Lovejoy DB, 2011, CANCER RES, V71, P5871, DOI 10.1158/0008-5472.CAN-11-1218; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morselli E, 2011, ANTIOXID REDOX SIGN, V14, P2251, DOI 10.1089/ars.2010.3478; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Platta HW, 2012, BIOCHEM J, V441, P399, DOI 10.1042/BJ20111424; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; RICHARDSON D, 1994, CANCER RES, V54, P685; Richardson DR, 2006, J MED CHEM, V49, P6510, DOI 10.1021/jm0606342; Richardson DR, 1997, BLOOD, V89, P3025, DOI 10.1182/blood.V89.8.3025; Salnikow K, 2004, J BIOL CHEM, V279, P40337, DOI 10.1074/jbc.M403057200; Salnikow K, 2000, CANCER RES, V60, P38; Shah MA, 2005, CLIN CANCER RES, V11, P3296, DOI 10.1158/1078-0432.CCR-04-2417; Shoushtari AN, 2011, NAT REV CLIN ONCOL, V8, P333, DOI 10.1038/nrclinonc.2011.65; Stafford LJ, 2008, INT J BIOCHEM CELL B, V40, P874, DOI 10.1016/j.biocel.2007.12.016; Stein S, 2004, J BIOL CHEM, V279, P48930, DOI 10.1074/jbc.M400386200; Sun J, 2013, MOL PHARMACOL, V83, P454, DOI 10.1124/mol.112.083097; Tsai Yien Che, 2010, Genes Cancer, V1, P764; Tsuchihara K, 2009, CANCER LETT, V278, P130, DOI 10.1016/j.canlet.2008.09.040; van Belzen N, 1998, HISTOL HISTOPATHOL, V13, P1233, DOI 10.14670/HH-13.1233; vanBelzen N, 1997, LAB INVEST, V77, P85; Vaux DL, 1996, P NATL ACAD SCI USA, V93, P2239, DOI 10.1073/pnas.93.6.2239; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; Whitnall M, 2006, P NATL ACAD SCI USA, V103, P14901, DOI 10.1073/pnas.0604979103; Wu CY, 2011, BIOCHEM BIOPH RES CO, V404, P802, DOI 10.1016/j.bbrc.2010.12.063; Xu YH, 2013, ONCOL LETT, V5, P411, DOI 10.3892/ol.2012.1015; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yan MS, 2008, NEOPLASIA, V10, P160, DOI 10.1593/neo.07935; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868	75	76	76	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9692	9709		10.1074/jbc.M113.529511	http://dx.doi.org/10.1074/jbc.M113.529511			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24532803	hybrid, Green Published			2022-12-28	WOS:000333807000023
J	Sterner, E; Masuko, S; Li, GY; Li, LY; Green, DE; Otto, NJ; Xu, YM; DeAngelis, PL; Liu, J; Dordick, JS; Linhardt, RJ				Sterner, Eric; Masuko, Sayaka; Li, Guoyun; Li, Lingyun; Green, Dixy E.; Otto, Nigel J.; Xu, Yongmei; DeAngelis, Paul L.; Liu, Jian; Dordick, Jonathan S.; Linhardt, Robert J.			Fibroblast Growth Factor-based Signaling through Synthetic Heparan Sulfate Blocks Copolymers Studied Using High Cell Density Three-dimensional Cell Printing*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fibroblast Growth Factor (FGF); Fibroblast Growth Factor Receptor (FGFR); Glycosaminoglycan; Heparan Sulfate; Polysaccharide; Three-dimensional Cellular Printing; Block Copolymers; Fibroblast Growth Factors; Signaling Complex	CHEMOENZYMATIC SYNTHESIS; HEPARIN/HEPARAN SULFATE; RECEPTOR SPECIFICITY; HEPAROSAN SYNTHASES; TERNARY COMPLEXES; CRYSTAL-STRUCTURE; FACTOR FAMILY; FGF; OLIGOSACCHARIDES; BIOSYNTHESIS	Background: Fibroblast growth factor-receptor-heparan sulfate (FGF-HS-FGFR) signals cell proliferation. Results: HS synthesized with sulfated domains at its non-reducing ends actively promotes cellular proliferation in a three-dimensional cell microarray. Conclusion: A symmetric 2:2:2 FGF-HS-FGFR complex is preferred over an asymmetric 2:1:2 model by these data. Significance: This paper suggests a preference for symmetry in the signal transduction complex having two FGF-FGFR on the non-reducing end of two HS chains. Four well-defined heparan sulfate (HS) block copolymers containing S-domains (high sulfo group content) placed adjacent to N-domains (low sulfo group content) were chemoenzymatically synthesized and characterized. The domain lengths in these HS block co-polymers were approximate to 40 saccharide units. Microtiter 96-well and three-dimensional cell-based microarray assays utilizing murine immortalized bone marrow (BaF3) cells were developed to evaluate the activity of these HS block co-polymers. Each recombinant BaF3 cell line expresses only a single type of fibroblast growth factor receptor (FGFR) but produces neither HS nor fibroblast growth factors (FGFs). In the presence of different FGFs, BaF3 cell proliferation showed clear differences for the four HS block co-polymers examined. These data were used to examine the two proposed signaling models, the symmetric FGF(2)-HS2-FGFR(2) ternary complex model and the asymmetric FGF(2)-HS1-FGFR(2) ternary complex model. In the symmetric FGF(2)-HS2-FGFR(2) model, two acidic HS chains bind in a basic canyon located on the top face of the FGF(2)-FGFR(2) protein complex. In this model the S-domains at the non-reducing ends of the two HS proteoglycan chains are proposed to interact with the FGF(2)-FGFR(2) protein complex. In contrast, in the asymmetric FGF(2)-HS1-FGFR(2) model, a single HS chain interacts with the FGF(2)-FGFR(2) protein complex through a single S-domain that can be located at any position within an HS chain. Our data comparing a series of synthetically prepared HS block copolymers support a preference for the symmetric FGF(2)-HS2-FGFR(2) ternary complex model.	[Sterner, Eric; Dordick, Jonathan S.; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Masuko, Sayaka; Li, Guoyun; Li, Lingyun; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Dordick, Jonathan S.; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA; [Dordick, Jonathan S.; Linhardt, Robert J.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Dordick, Jonathan S.] Rensselaer Polytech Inst, Dept Mat Sci, Troy, NY 12180 USA; [Green, Dixy E.; Otto, Nigel J.; DeAngelis, Paul L.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma Ctr Med Glycobiol, Oklahoma City, OK 73126 USA; [Xu, Yongmei; Liu, Jian] Univ N Carolina, Eshelman Sch Pharm, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of North Carolina; University of North Carolina Chapel Hill	Linhardt, RJ (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA.	linhar@rpi.edu			National Institutes of Health [HL62244, GM38060, HL096972, ES 020903, ES 018022]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096972, R01HL094463, R01HL062244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020903, R41ES018022, R42ES018022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038060, U01GM102137] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL62244, GM38060, HL096972, ES 020903, and ES 018022.	Brown A, 2013, BIOPHYS J, V104, P1720, DOI 10.1016/j.bpj.2013.02.051; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Caterson B, 2000, MATRIX BIOL, V19, P333, DOI 10.1016/S0945-053X(00)00078-0; Chen JH, 2005, J BIOL CHEM, V280, P42817, DOI 10.1074/jbc.M504338200; DeAngelis Paul L, 2013, Methods Mol Biol, V1022, P215, DOI 10.1007/978-1-62703-465-4_17; DeAngelis PL, 2013, GLYCOBIOLOGY, V23, P764, DOI 10.1093/glycob/cwt016; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fernandes TG, 2010, BIOTECHNOL BIOENG, V106, P106, DOI 10.1002/bit.22661; GALLAGHER JT, 1992, INT J BIOCHEM, V24, P553, DOI 10.1016/0020-711X(92)90326-V; Habuchi H, 1998, J BIOL CHEM, V273, P9208, DOI 10.1074/jbc.273.15.9208; Hileman RE, 1997, GLYCOBIOLOGY, V7, P231; Ibrahimi OA, 2004, BIOCHEMISTRY-US, V43, P4724, DOI 10.1021/bi0352320; Iwabu A, 2004, J BIOL CHEM, V279, P14551, DOI 10.1074/jbc.M311981200; JAYE M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P185, DOI 10.1016/0167-4889(92)90136-Y; Jin L, 1997, P NATL ACAD SCI USA, V94, P14683, DOI 10.1073/pnas.94.26.14683; Jing W, 2004, J BIOL CHEM, V279, P42345, DOI 10.1074/jbc.M402744200; Kresse H, 2001, J CELL PHYSIOL, V189, P266, DOI 10.1002/jcp.10030; Kusche-Gullberg M, 2012, J BIOL CHEM, V287, P21950, DOI 10.1074/jbc.M112.350389; Li GY, 2013, BIOPOLYMERS, V99, P675, DOI 10.1002/bip.22263; Li JP, 1997, J BIOL CHEM, V272, P28158, DOI 10.1074/jbc.272.44.28158; Linhardt RJ, 2012, CURR OPIN PHARMACOL, V12, P217, DOI 10.1016/j.coph.2011.12.002; Liu J, 2012, CURR OPIN STRUC BIOL, V22, P550, DOI 10.1016/j.sbi.2012.07.004; Liu RP, 2010, J BIOL CHEM, V285, P34240, DOI 10.1074/jbc.M110.159152; Ly M, 2010, OMICS, V14, P389, DOI 10.1089/omi.2009.0123; Marie PJ, 2003, GENE, V316, P23, DOI 10.1016/S0378-1119(03)00748-0; Maruyama T, 1998, CARBOHYD RES, V306, P35, DOI 10.1016/S0008-6215(97)10060-X; Masuko S, 2012, J ORG CHEM, V77, P1449, DOI 10.1021/jo202322k; Melder RJ, 1996, NAT MED, V2, P992, DOI 10.1038/nm0996-992; Meli L, 2012, BIOMATERIALS, V33, P9087, DOI 10.1016/j.biomaterials.2012.08.065; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; MONTESANO R, 1986, P NATL ACAD SCI USA, V83, P7297, DOI 10.1073/pnas.83.19.7297; Mulloy B, 2001, CURR OPIN STRUC BIOL, V11, P623, DOI 10.1016/S0959-440X(00)00257-8; Naimy H, 2011, J BIOL CHEM, V286, P19311, DOI 10.1074/jbc.M110.204693; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORNITZ DM, 1992, J BIOL CHEM, V267, P16305; Otto NJ, 2012, J BIOL CHEM, V287, P7203, DOI 10.1074/jbc.M111.311704; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; PERVIN A, 1995, GLYCOBIOLOGY, V5, P83, DOI 10.1093/glycob/5.1.83; Peterson S, 2009, NAT PROD REP, V26, P610, DOI 10.1039/b803795g; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; Powell AK, 2002, J BIOL CHEM, V277, P28554, DOI 10.1074/jbc.M111754200; Puvirajesinghe TM, 2012, CHEM BIOL, V19, P553, DOI 10.1016/j.chembiol.2012.03.011; Robinson CJ, 2005, J BIOL CHEM, V280, P42274, DOI 10.1074/jbc.M505720200; ROSENBERG RD, 1978, P NATL ACAD SCI USA, V75, P3065, DOI 10.1073/pnas.75.7.3065; RUSNATI M, 1994, BIOCHEM BIOPH RES CO, V203, P450, DOI 10.1006/bbrc.1994.2203; Sanchez-Heras E, 2006, J BIOL CHEM, V281, P35208, DOI 10.1074/jbc.M608655200; Saphire ACS, 1999, EMBO J, V18, P6771, DOI 10.1093/emboj/18.23.6771; Sasisekharan R, 2000, CURR OPIN CHEM BIOL, V4, P626, DOI 10.1016/S1367-5931(00)00145-9; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sheng JZ, 2012, J BIOL CHEM, V287, P20996, DOI 10.1074/jbc.M112.359885; Shworak NW, 1997, J BIOL CHEM, V272, P28008, DOI 10.1074/jbc.272.44.28008; Sismey-Ragatz AE, 2007, J BIOL CHEM, V282, P28321, DOI 10.1074/jbc.M701599200; Sterner E, 2013, BIOCHEMISTRY-US, V52, P9009, DOI 10.1021/bi401284r; Williams KJ, 2006, J BIOL CHEM, V281, P5391, DOI 10.1074/jbc.M510439200; Wu ZLL, 2003, J BIOL CHEM, V278, P17121, DOI 10.1074/jbc.M212590200; Xu YM, 2012, J BIOL CHEM, V287, P29054, DOI 10.1074/jbc.M112.358523; Xu YM, 2011, SCIENCE, V334, P498, DOI 10.1126/science.1207478; Yang B, 2012, J CHROMATOGR A, V1225, P91, DOI 10.1016/j.chroma.2011.12.063; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200	61	22	23	2	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9754	9765		10.1074/jbc.M113.546937	http://dx.doi.org/10.1074/jbc.M113.546937			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24563485	Green Published, hybrid			2022-12-28	WOS:000333807000027
J	Gupta, S; Hirota, M; Waugh, SM; Murakami, I; Suzuki, T; Muraguchi, M; Shibamori, M; Ishikawa, Y; Jarvis, TC; Carter, JD; Zhang, C; Gawande, B; Vrkljan, M; Janjic, N; Schneider, DJ				Gupta, Shashi; Hirota, Masao; Waugh, Sheela M.; Murakami, Ikuo; Suzuki, Tomoki; Muraguchi, Masahiro; Shibamori, Masafumi; Ishikawa, Yuichi; Jarvis, Thale C.; Carter, Jeffrey D.; Zhang, Chi; Gawande, Bharat; Vrkljan, Michael; Janjic, Nebojsa; Schneider, Daniel J.			Chemically Modified DNA Aptamers Bind Interleukin-6 with High Affinity and Inhibit Signaling by Blocking Its Interaction with Interleukin-6 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aptamers; Cell Signaling; Drug Discovery; Interleukin; Molecular Evolution; Nucleic Acid Chemistry; Protein-DNA Interaction; SELEX; SOMAmer; Nuclease Stability	SOLUBLE IL-6 RECEPTOR; RHEUMATOID-ARTHRITIS; IN-VITRO; VASCULAR-PERMEABILITY; CRYSTAL-STRUCTURE; RNA LIGANDS; ANTIBODY; TOCILIZUMAB; COMPLEX; CLAZAKIZUMAB	Background: IL-6 signaling is a key component of inflammatory diseases. Results: Modified DNA aptamers that inhibit IL-6 signaling were discovered and optimized. Conclusion: Modified aptamers are stable in serum and block the interaction of IL-6 with its receptor IL-6R. Significance: Modified aptamers are a new class of antagonist with properties potentially suitable for clinical treatment of inflammation. Interleukin-6 (IL-6) is a pleiotropic cytokine that regulates immune and inflammatory responses, and its overproduction is a hallmark of inflammatory diseases. Inhibition of IL-6 signaling with the anti-IL-6 receptor antibody tocilizumab has provided some clinical benefit to patients; however, direct cytokine inhibition may be a more effective option. We used the systematic evolution of ligands by exponential enrichment (SELEX) process to discover slow off-rate modified aptamers (SOMAmers) with hydrophobic base modifications that inhibit IL-6 signaling in vitro. Two classes of IL-6 SOMAmers were isolated from modified DNA libraries containing 40 random positions and either 5-(N-benzylcarboxamide)-2-deoxyuridine (Bn-dU) or 5-[N-(1-naphthylmethyl)carboxamide]-2-deoxyuridine (Nap-dU) replacing dT. These modifications facilitate the high affinity binding interaction with IL-6 and provide resistance against degradation by serum endonucleases. Post-SELEX optimization of one Bn-dU and one Nap-dU SOMAmer led to improvements in IL-6 binding (10-fold) and inhibition activity (greater than 20-fold), resulting in lead SOMAmers with sub-nanomolar affinity (K-d = 0.2 nm) and potency (IC50 = 0.2 nm). Although similar in inhibition properties, the two SOMAmers have unique sequences and different ortholog specificities. Furthermore, these SOMAmers were stable in human serum in vitro for more than 48 h. Both SOMAmers prevented IL-6 signaling by blocking the interaction of IL-6 with its receptor and inhibited the proliferation of tumor cells in vitro as effectively as tocilizumab. This new class of IL-6 inhibitor may be an effective therapeutic alternative for patients suffering from inflammatory diseases.	[Gupta, Shashi; Waugh, Sheela M.; Jarvis, Thale C.; Carter, Jeffrey D.; Zhang, Chi; Gawande, Bharat; Vrkljan, Michael; Janjic, Nebojsa; Schneider, Daniel J.] SomaLog Inc, Boulder, CO 80301 USA; [Hirota, Masao; Murakami, Ikuo; Suzuki, Tomoki; Muraguchi, Masahiro; Shibamori, Masafumi; Ishikawa, Yuichi] Otsuka Pharmaceut Co Ltd, Kawaguchi, Tokushima 7710192, Japan	Otsuka Pharmaceutical	Schneider, DJ (corresponding author), SomaLog Inc, 2945 Wilderness Pl, Boulder, CO 80301 USA.	dschneider@somalogic.com						Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Ara T, 2010, EUR J CANCER, V46, P1223, DOI 10.1016/j.ejca.2010.02.026; BEAUCAGE SL, 1981, TETRAHEDRON LETT, V22, P1859, DOI 10.1016/S0040-4039(01)90461-7; BEIGELMAN L, 1995, J BIOL CHEM, V270, P25702, DOI 10.1074/jbc.270.43.25702; Bouchard PR, 2010, ANNU REV PHARMACOL, V50, P237, DOI 10.1146/annurev.pharmtox.010909.105547; BOYER D, 2013, INVESTI OPHTHALMOL V, V54; Burnett JC, 2012, CHEM BIOL, V19, P60, DOI 10.1016/j.chembiol.2011.12.008; Chan MY, 2008, J THROMB HAEMOST, V6, P789, DOI 10.1111/j.1538-7836.2008.02932.x; Davies DR, 2012, P NATL ACAD SCI USA, V109, P19971, DOI 10.1073/pnas.1213933109; Dayer JM, 2010, RHEUMATOLOGY, V49, P15, DOI 10.1093/rheumatology/kep329; Eaton BE, 1997, BIOORGAN MED CHEM, V5, P1087, DOI 10.1016/S0968-0896(97)00044-8; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Gelinas AD, 2014, J BIOL CHEM, V289, P8720, DOI 10.1074/jbc.M113.532697; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; GREEN LS, 1995, CHEM BIOL, V2, P683, DOI 10.1016/1074-5521(95)90032-2; GRIFFIN LC, 1993, BLOOD, V81, P3271, DOI 10.1182/blood.V81.12.3271.3271; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Gupta S, 2011, APPL IMMUNOHISTO M M, V19, P273, DOI 10.1097/PAI.0b013e3182008c29; GUSCHLBAUER W, 1980, NUCLEIC ACIDS RES, V8, P1421, DOI 10.1093/nar/8.6.1421; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; HONDA M, 1992, J IMMUNOL, V148, P2175; JELLINEK D, 1994, BIOCHEMISTRY-US, V33, P10450, DOI 10.1021/bi00200a028; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; KAWAGUCHI T, 1995, BIOL PHARM BULL, V18, P474; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Kopf M, 2010, NAT REV DRUG DISCOV, V9, P703, DOI 10.1038/nrd2805; Mascini M, 2008, BIOMARKERS, V13, P637, DOI [10.1080/13547500802645905, 10.1080/13547500802645905 ]; Meyer C, 2014, RNA BIOL, V11, P57, DOI 10.4161/rna.27447; Nishimoto N, 2000, ANN RHEUM DIS, V59, P21, DOI 10.1136/ard.59.suppl_1.i21; Nishimoto N, 2008, BLOOD, V112, P3959, DOI 10.1182/blood-2008-05-155846; NOVICK D, 1989, J EXP MED, V170, P1409, DOI 10.1084/jem.170.4.1409; Pons M, 2010, INVEST OPHTH VIS SCI, V51; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Ruckman J, 1998, J BIOL CHEM, V273, P20556, DOI 10.1074/jbc.273.32.20556; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Singh JA, 2011, J RHEUMATOL, V38, P10, DOI 10.3899/jrheum.100717; Smolen JS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1969; Somers W, 1997, EMBO J, V16, P989, DOI 10.1093/emboj/16.5.989; Tanaka T, 2012, INT J BIOL SCI, V8, P1227, DOI 10.7150/ijbs.4666; Tanaka T, 2012, ANNU REV PHARMACOL, V52, P199, DOI 10.1146/annurev-pharmtox-010611-134715; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vaught JD, 2010, J AM CHEM SOC, V132, P4141, DOI 10.1021/ja908035g; WAAGE A, 1989, J EXP MED, V169, P333, DOI 10.1084/jem.169.1.333; Waetzig GH, 2012, EXPERT OPIN THER TAR, V16, P225, DOI 10.1517/14728222.2012.660307; Watson SR, 2000, ANTISENSE NUCLEIC A, V10, P63, DOI 10.1089/oli.1.2000.10.63; Weinblatt M, 2013, ARTHRITIS RHEUM-US, V65, pS735; Zhao Q, 2013, ARTHRITIS RHEUM-US, V65, pS1020	51	103	107	2	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8706	8719		10.1074/jbc.M113.532580	http://dx.doi.org/10.1074/jbc.M113.532580			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24415766	hybrid, Green Published			2022-12-28	WOS:000333157500059
J	Chung, J; Anderson, SA; Gwynn, B; Deck, KM; Chen, MJ; Langer, NB; Shaw, GC; Huston, NC; Boyer, LF; Datta, S; Paradkar, PN; Li, LT; Wei, Z; Lambert, AJ; Sahr, K; Wittig, JG; Chen, W; Lu, WG; Galy, B; Schlaeger, TM; Hentze, MW; Ward, DM; Kaplan, J; Eisenstein, RS; Peters, LL; Paw, BH				Chung, Jacky; Anderson, Sheila A.; Gwynn, Babette; Deck, Kathryn M.; Chen, Michael J.; Langer, Nathaniel B.; Shaw, George C.; Huston, Nicholas C.; Boyer, Leah F.; Datta, Sumon; Paradkar, Prasad N.; Li, Liangtao; Wei, Zong; Lambert, Amy J.; Sahr, Kenneth; Wittig, Johannes G.; Chen, Wen; Lu, Wange; Galy, Bruno; Schlaeger, Thorsten M.; Hentze, Matthias W.; Ward, Diane M.; Kaplan, Jerry; Eisenstein, Richard S.; Peters, Luanne L.; Paw, Barry H.			Iron Regulatory Protein-1 Protects against Mitoferrin-1-deficient Porphyria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Erythropoeisis; Heme; Iron; Iron-sulfur Protein; Mitochondrial Transport; Fe-S Cluster Biogenesis; Mitochondrial Solute Carrier; Protoporphyrin	INSERTIONAL MUTATIONS; HEME-SYNTHESIS; TRANSPORTER; GENE; IDENTIFICATION; HOMEOSTASIS; BIOGENESIS; METABOLISM; ANEMIA; MICE	Background: Heme and [Fe-S] cluster assembly are tightly regulated processes that require mitochondrial iron. Results: Loss of mitochondrial iron activates the [Fe-S]-dependent RNA-binding activity of IRP1 that inhibits protoporphyrin biosynthesis. Conclusion: IRP1 forms a critical feedback mechanism, preventing protoporphyrin accumulation under limiting mitochondrial iron conditions. Significance: This study provides evidence linking heme biogenesis to that of [Fe-S] clusters synthesis. Mitochondrial iron is essential for the biosynthesis of heme and iron-sulfur ([Fe-S]) clusters in mammalian cells. In developing erythrocytes, iron is imported into the mitochondria by MFRN1 (mitoferrin-1, SLC25A37). Although loss of MFRN1 in zebrafish and mice leads to profound anemia, mutant animals showed no overt signs of porphyria, suggesting that mitochondrial iron deficiency does not result in an accumulation of protoporphyrins. Here, we developed a gene trap model to provide in vitro and in vivo evidence that iron regulatory protein-1 (IRP1) inhibits protoporphyrin accumulation. Mfrn1(+/gt);Irp1(-/-) erythroid cells exhibit a significant increase in protoporphyrin levels. IRP1 attenuates protoporphyrin biosynthesis by binding to the 5-iron response element (IRE) of alas2 mRNA, inhibiting its translation. Ectopic expression of alas2 harboring a mutant IRE, preventing IRP1 binding, in Mfrn1(gt/gt) cells mimics Irp1 deficiency. Together, our data support a model whereby impaired mitochondrial [Fe-S] cluster biogenesis in Mfrn1(gt/gt) cells results in elevated IRP1 RNA-binding that attenuates ALAS2 mRNA translation and protoporphyrin accumulation.	[Chung, Jacky; Langer, Nathaniel B.; Shaw, George C.; Huston, Nicholas C.; Wittig, Johannes G.; Chen, Wen; Paw, Barry H.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Chung, Jacky; Langer, Nathaniel B.; Shaw, George C.; Huston, Nicholas C.; Wittig, Johannes G.; Chen, Wen; Paw, Barry H.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Chung, Jacky; Langer, Nathaniel B.; Shaw, George C.; Huston, Nicholas C.; Wittig, Johannes G.; Chen, Wen; Paw, Barry H.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Anderson, Sheila A.; Deck, Kathryn M.; Eisenstein, Richard S.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; [Gwynn, Babette; Lambert, Amy J.; Sahr, Kenneth; Peters, Luanne L.] Jackson Lab, Bar Harbor, ME 04609 USA; [Chen, Michael J.; Boyer, Leah F.; Datta, Sumon; Schlaeger, Thorsten M.] Harvard Univ, Boston Childrens Hosp, Sch Med, Stem Cell Program, Boston, MA 02115 USA; [Paradkar, Prasad N.; Li, Liangtao; Ward, Diane M.; Kaplan, Jerry] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA; [Wei, Zong; Lu, Wange] Univ So Calif, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; [Wei, Zong; Lu, Wange] Univ So Calif, Keck Sch Med, Los Angeles, CA 90089 USA; [Galy, Bruno; Hentze, Matthias W.] European Mol Biol Lab, D-69117 Heidelberg, Germany	Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison; Jackson Laboratory; Harvard University; Boston Children's Hospital; Harvard Medical School; Utah System of Higher Education; University of Utah; University of Southern California; University of Southern California; European Molecular Biology Laboratory (EMBL)	Peters, LL (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	luanne.peters@jax.org; bpaw@rics.bwh.harvard.edu	Hentze, Matthias W/V-3980-2017; Paradkar, Prasad/ABA-5851-2020; Shaw, George C/AAA-2678-2022	Hentze, Matthias W/0000-0002-4023-7876; Paradkar, Prasad/0000-0002-6553-2214; Paw, Barry/0000-0002-0492-1419; Galy, Bruno/0000-0002-0501-6357; Schlaeger, Thorsten/0000-0002-1599-9908; Boyer, Leah/0000-0002-0546-4344; Peters, Luanne/0000-0002-0784-0534	American Society of Hematology; Canadian Institutes of Health Research (CIHR); Federal Ministry of Education and Research (BMBF); March of Dimes Foundation [6-FY09-289]; National Institutes of Health [R01 HL088468, R01 DK052380, R01 DK066600, R01 DK070838, P01 HL032262]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088468, P01HL032262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070838, R01DK066600, R01DK052380] Funding Source: NIH RePORTER	American Society of Hematology; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); March of Dimes Foundation(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the American Society of Hematology (to G. C. S.), the Canadian Institutes of Health Research (CIHR postdoctoral fellowship (to J. C.), the Federal Ministry of Education and Research (BMBF, Virtual Liver (to M. W. H.), the March of Dimes Foundation (6-FY09-289) (to B. H. P.), and the National Institutes of Health R01 HL088468 (to L. L. P.), R01 DK052380 (to J. K.), R01 DK066600 (to R. S. E.), and R01 DK070838 and P01 HL032262 (to B. H. P.).	Amigo JD, 2011, MOL CELL BIOL, V31, P1344, DOI 10.1128/MCB.01010-10; Anderson CP, 2012, BBA-MOL CELL RES, V1823, P1468, DOI 10.1016/j.bbamcr.2012.05.010; Anderson SA, 2013, CELL METAB, V17, P282, DOI 10.1016/j.cmet.2013.01.007; Balwani Manisha, 2013, Mol Med, V19, P26, DOI 10.2119/molmed.2012.00340; Bishop DF, 2012, J BIOL CHEM, V287, P28943, DOI 10.1074/jbc.M111.306423; Brownlie A, 1998, NAT GENET, V20, P244, DOI 10.1038/3049; Cavadini P, 2007, BLOOD, V109, P3552, DOI 10.1182/blood-2006-08-041632; Chen CY, 2013, CELL METAB, V17, P343, DOI 10.1016/j.cmet.2013.01.013; Chen JC, 2000, EXP HEMATOL, V28, P442, DOI 10.1016/S0301-472X(99)00157-5; Chung J, 2012, CURR OPIN HEMATOL, V19, P156, DOI 10.1097/MOH.0b013e328351c48b; Chung J, 2010, EMBO REP, V11, P777, DOI 10.1038/embor.2010.125; Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954; COOK J, 1980, IRON; Cooperman SS, 2005, BLOOD, V106, P1084, DOI 10.1182/blood-2004-12-4703; Crooks DR, 2010, BLOOD, V115, P860, DOI 10.1182/blood-2009-09-243105; Csere P, 1998, FEBS LETT, V441, P266, DOI 10.1016/S0014-5793(98)01560-9; DANDEKAR T, 1991, EMBO J, V10, P1903, DOI 10.1002/j.1460-2075.1991.tb07716.x; Galy B, 2004, RNA, V10, P1019, DOI 10.1261/rna.7220704; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; Hamza I, 2012, BBA-MOL CELL RES, V1823, P1617, DOI 10.1016/j.bbamcr.2012.04.009; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Kadirvel S, 2012, EXP HEMATOL, V40, P477, DOI 10.1016/j.exphem.2012.01.013; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; Pondarre C, 2006, HUM MOL GENET, V15, P953, DOI 10.1093/hmg/ddl012; Robertson E. J., 1987, TERATOCARCINOMAS EMB; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Rouault TA, 2009, SCIENCE, V326, P676, DOI 10.1126/science.1181938; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Schranzhofer M, 2006, BLOOD, V107, P4159, DOI 10.1182/blood-2005-05-1809; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; Shah DI, 2012, NATURE, V491, P608, DOI 10.1038/nature11536; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Stachura DL, 2009, BLOOD, V114, P279, DOI 10.1182/blood-2009-02-203638; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; To-Figueras J, 2011, BLOOD, V118, P1443, DOI 10.1182/blood-2011-03-342873; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Townley DJ, 1997, GENOME RES, V7, P293, DOI 10.1101/gr.7.3.293; Troadec MB, 2011, BLOOD, V117, P5494, DOI 10.1182/blood-2010-11-319483; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Wang YM, 2011, EXP HEMATOL, V39, P784, DOI 10.1016/j.exphem.2011.05.003; Whatley SD, 2008, AM J HUM GENET, V83, P408, DOI 10.1016/j.ajhg.2008.08.003; Wingert RA, 2005, NATURE, V436, P1035, DOI 10.1038/nature03887; Woo AJ, 2008, MOL CELL BIOL, V28, P2675, DOI 10.1128/MCB.01945-07; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798; Ye H, 2010, J CLIN INVEST, V120, P1749, DOI 10.1172/JCI40372	50	31	32	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7835	7843		10.1074/jbc.M114.547778	http://dx.doi.org/10.1074/jbc.M114.547778			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24509859	Green Published, hybrid			2022-12-28	WOS:000332761500049
J	Han, SP; Gambin, Y; Gomez, GA; Verma, S; Giles, N; Michael, M; Wu, SK; Guo, Z; Johnston, W; Sierecki, E; Parton, RG; Alexandrov, K; Yap, AS				Han, Siew Ping; Gambin, Yann; Gomez, Guillermo A.; Verma, Suzie; Giles, Nichole; Michael, Magdalene; Wu, Selwin K.; Guo, Zhong; Johnston, Wayne; Sierecki, Emma; Parton, Robert G.; Alexandrov, Kirill; Yap, Alpha S.			Cortactin Scaffolds Arp2/3 and WAVE2 at the Epithelial Zonula Adherens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Actin; Cell Adhesion; Cell Junctions; Cytoskeleton; E-cadherin; Arp2; 3; Cortactin; WAVE2	SINGLE-MOLECULE; COINCIDENCE DETECTION; F-ACTIN; COMPLEX; ACTIVATION; MECHANISM; CATENIN; TUBA	Background: Productive epithelial interactions require actin filament assembly at E-cadherin adhesions. Results: Cortactin localizes to the zonula adherens through interactions with E-cadherin and N-WASP; there it recruits Arp2/3 and WAVE2 by separate mechanisms to support actin nucleation. Conclusion: Cortactin acts as a coincident scaffold. Significance: Cortactin can regulate the dynamic integration of cadherin adhesion with the actin cytoskeleton. Cadherin junctions arise from the integrated action of cell adhesion, signaling, and the cytoskeleton. At the zonula adherens (ZA), a WAVE2-Arp2/3 actin nucleation apparatus is necessary for junctional tension and integrity. But how this is coordinated with cadherin adhesion is not known. We now identify cortactin as a key scaffold for actin regulation at the ZA, which localizes to the ZA through influences from both E-cadherin and N-WASP. Using cell-free protein expression and fluorescent single molecule coincidence assays, we demonstrate that cortactin binds directly to the cadherin cytoplasmic tail. However, its concentration with cadherin at the apical ZA also requires N-WASP. Cortactin is known to bind Arp2/3 directly (Weed, S. A., Karginov, A. V., Schafer, D. A., Weaver, A. M., Kinley, A. W., Cooper, J. A., and Parsons, J. T. (2000) J. Cell Biol. 151, 29-40). We further show that cortactin can directly bind WAVE2, as well as Arp2/3, and both these interactions are necessary for actin assembly at the ZA. We propose that cortactin serves as a platform that integrates regulators of junctional actin assembly at the ZA.	[Han, Siew Ping; Gambin, Yann; Gomez, Guillermo A.; Verma, Suzie; Giles, Nichole; Michael, Magdalene; Wu, Selwin K.; Guo, Zhong; Johnston, Wayne; Sierecki, Emma; Parton, Robert G.; Alexandrov, Kirill; Yap, Alpha S.] Univ Queensland, Inst Mol Biosci, Mol Cell Biol Div, Brisbane, Qld 4072, Australia	University of Queensland	Yap, AS (corresponding author), Univ Queensland, Inst Mol Biosci, Mol Cell Biol Div, Brisbane, Qld 4072, Australia.	a.yap@uq.edu.au	Sierecki, Emma/A-4810-2012; GAMBIN, Yann/M-8799-2014; Yap, Alpha S./J-1554-2014; Gomez, Guillermo/J-2993-2014; SIERECKI, Emma/L-2556-2019; Wu, Selwin/V-3464-2019; Alexandrov, Kirill/A-5830-2013; GUO, Zhong/J-8723-2014; Michael, Magdalene/AAR-8700-2020; GAMBIN, Yann/AAI-8501-2021; Michael, Magdalene/K-1526-2014; Sierecki, Emma/I-2920-2019; GUO, Zhong/J-8723-2014; Parton, Robert/C-5673-2009; Johnston, Wayne/D-2095-2017	Yap, Alpha S./0000-0002-1038-8956; Gomez, Guillermo/0000-0002-0494-2404; SIERECKI, Emma/0000-0001-9970-868X; Wu, Selwin/0000-0002-5185-8467; Alexandrov, Kirill/0000-0002-0957-6511; GUO, Zhong/0000-0003-0285-5021; Michael, Magdalene/0000-0003-2577-729X; GUO, Zhong/0000-0002-2277-0087; GAMBIN, Yann/0000-0001-7378-8976; Parton, Robert/0000-0002-7494-5248; Johnston, Wayne/0000-0002-7485-8363	National Health and Medical Research Council of Australia [631377, APP1010489]; Australia Fellowship [569542]; Australian Research Council Future Fellowship [FT0991611]; Kid's Cancer Project of the Oncology Children's Foundation;  [631383];  [511005];  [1037320];  [DP120101423];  [FT110100478]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australia Fellowship; Australian Research Council Future Fellowship(Australian Research Council); Kid's Cancer Project of the Oncology Children's Foundation; ; ; ; ; 	This work was supported by the National Health and Medical Research Council of Australia Project Grants 631377, APP1010489, and Research Fellowship 631383 (to A. Y.), Program Grant 511005 (to K. A. and R. G. P.), Program Grant 1037320 (to A. Y., K. A., and R. G. P.), and Australia Fellowship 569542 (to R. G. P.), by Australian Research Council Future Fellowship FT0991611 and Project Grant DP120101423 (to K. A.) and Future Fellowship FT110100478 (to Y. G.), and by the Kid's Cancer Project of the Oncology Children's Foundation.	Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Carlton JG, 2005, TRENDS CELL BIOL, V15, P540, DOI 10.1016/j.tcb.2005.08.005; Chen ZC, 2010, NATURE, V468, P533, DOI 10.1038/nature09623; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Gambin Y, 2011, NAT METHODS, V8, P239, DOI 10.1038/NMETH.1568; Gambin Y, 2009, P NATL ACAD SCI USA, V106, P10153, DOI 10.1073/pnas.0904461106; Guo Z, 2013, PLOS ONE, V8; Helwani FM, 2004, J CELL BIOL, V164, P899, DOI 10.1083/jcb.200309034; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Ismail AM, 2009, NAT STRUCT MOL BIOL, V16, P561, DOI 10.1038/nsmb.1587; Ivanov AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000658; Kinley AW, 2003, CURR BIOL, V13, P384, DOI 10.1016/S0960-9822(03)00107-6; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Kovacs EM, 2011, CELL ADHES MIGR, V5, P344, DOI 10.4161/cam.5.4.16717; Kovacs EM, 2011, NAT CELL BIOL, V13, P934, DOI 10.1038/ncb2290; Kovtun O, 2011, METHODS, V55, P58, DOI 10.1016/j.ymeth.2011.06.006; Kowalski JR, 2005, J CELL SCI, V118, P79, DOI 10.1242/jcs.01586; Lebensohn AM, 2009, MOL CELL, V36, P512, DOI 10.1016/j.molcel.2009.10.024; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Mureev S, 2009, NAT BIOTECHNOL, V27, P747, DOI 10.1038/nbt.1556; Niessen CM, 2011, PHYSIOL REV, V91, P691, DOI 10.1152/physrev.00004.2010; Orte A, 2006, ANAL CHEM, V78, P7707, DOI 10.1021/ac061122y; Orte A, 2011, CHEMPHYSCHEM, V12, P491, DOI 10.1002/cphc.201000636; Orte A, 2010, BIOCHEM SOC T, V38, P914, DOI 10.1042/BST0380914; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Priya R, 2013, DIFFERENTIATION, V86, P133, DOI 10.1016/j.diff.2013.01.002; Rajput C, 2013, J BIOL CHEM, V288, P4241, DOI 10.1074/jbc.M112.440396; Ratheesh A, 2012, NAT REV MOL CELL BIO, V13, P673, DOI 10.1038/nrm3431; Ratheesh A, 2012, NAT CELL BIOL, V14, P818, DOI 10.1038/ncb2532; Ren G, 2009, J BIOL CHEM, V284, P18913, DOI 10.1074/jbc.M109.000307; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; Sierecki E, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2013.0018; Smutny M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022458; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Tang VW, 2012, J CELL BIOL, V196, P115, DOI 10.1083/jcb.201103116; Ullman EF, 1996, CLIN CHEM, V42, P1518; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Verma S, 2012, MOL BIOL CELL, V23, P4601, DOI 10.1091/mbc.E12-08-0574; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Wu SK, 2014, NAT CELL BIOL, V16, P167, DOI 10.1038/ncb2900; Xu XP, 2012, EMBO J, V31, P236, DOI 10.1038/emboj.2011.343; Yahiatene I, 2012, ANAL CHEM, V84, P2729, DOI 10.1021/ac2030283	46	46	46	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7764	7775		10.1074/jbc.M113.544478	http://dx.doi.org/10.1074/jbc.M113.544478			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24469447	Green Published, hybrid			2022-12-28	WOS:000332761500043
J	LeBlanc, PM; Doggett, TA; Choi, J; Hancock, MA; Durocher, Y; Frank, F; Nagar, B; Ferguson, TA; Saleh, M				LeBlanc, Philippe M.; Doggett, Teresa Ann; Choi, Jayoung; Hancock, Mark A.; Durocher, Yves; Frank, Filipp; Nagar, Bhushan; Ferguson, Thomas A.; Saleh, Maya			An Immunogenic Peptide in the A-box of HMGB1 Protein Reverses Apoptosis-induced Tolerance through RAGE Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Caspase; Inflammation; Innate Immunity; Receptor for Advanced Glycation End Products (RAGE); Sepsis; Tolerance	SEPSIS; ACTIVATION; BINDING; HYPERSENSITIVITY; INDUCTION; SURVIVAL; IMPROVES; LIPOPOLYSACCHARIDE; INFLAMMASOME; AMPHOTERIN	Background: The role of caspase-1 in regulating the immunogenic properties of HMGB1 has not been previously reported. Results: We have mapped a peptide in the A-box of HMGB1 that reverses tolerance through RAGE. Conclusion: Inflammasome signaling regulates the immunogenic activity of HMGB1. Significance: Immunogenic peptides within the HMGB1 A-box may be exploited to reverse immune tolerance in sepsis patients. Apoptotic cells trigger immune tolerance in engulfing phagocytes. This poorly understood process is believed to contribute to the severe immunosuppression and increased susceptibility to nosocomial infections observed in critically ill sepsis patients. Extracellular high mobility group box 1 (HMGB1) is an important mediator of both sepsis lethality and the induction of immune tolerance by apoptotic cells. We have found that HMGB1 is sensitive to processing by caspase-1, resulting in the production of a fragment within its N-terminal DNA-binding domain (the A-box) that signals through the receptor for advanced glycation end products (RAGE) to reverse apoptosis-induced tolerance. In a two-hit mouse model of sepsis, we show that tolerance to a secondary infection and its associated mortality were effectively reversed by active immunization with dendritic cells treated with HMGB1 or the A-box fragment, but not a noncleavable form of HMGB1. These findings represent a novel link between caspase-1 and HMGB1, with potential therapeutic implications in infectious and inflammatory diseases.	[LeBlanc, Philippe M.; Hancock, Mark A.; Frank, Filipp; Nagar, Bhushan; Saleh, Maya] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3G 0B1, Canada; [LeBlanc, Philippe M.; Hancock, Mark A.; Frank, Filipp; Nagar, Bhushan; Saleh, Maya] McGill Univ, SPR Facil, Montreal, PQ H3G 0B1, Canada; [LeBlanc, Philippe M.; Hancock, Mark A.; Frank, Filipp; Nagar, Bhushan; Saleh, Maya] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [LeBlanc, Philippe M.; Hancock, Mark A.; Frank, Filipp; Nagar, Bhushan; Saleh, Maya] McGill Univ, Dept Med, Montreal, PQ H3G 0B1, Canada; [Doggett, Teresa Ann; Choi, Jayoung; Ferguson, Thomas A.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Durocher, Yves] Natl Res Council Canada, Biotechnol Res Inst, Montreal, PQ H4P, Canada	McGill University; McGill University; McGill University; McGill University; Washington University (WUSTL); National Research Council Canada	Ferguson, TA (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	ferguson@vision.wustl.edu; maya.saleh@mcgill.ca	Durocher, Yves/K-8709-2019	Frank, Filipp/0000-0001-8680-2757; Saleh, Maya/0000-0003-1538-9146; Choi, Jayoung/0000-0003-0464-0649	Canada Foundation for Innovation (CFI); Canadian Institutes of Health Research (CIHR); NATIONAL EYE INSTITUTE [P30EY002687, R01EY015570] Funding Source: NIH RePORTER	Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Sylvie Perret at BRI for the purification of recombinant HMGB1 proteins, Dr. T. Sam Xiao at the National Institutes of Health for providing the RAGE constructs, Dr. Ann-Marie Schmidt for the Rage<SUP>-/-</SUP> mice, Dr. Vishva Dixit for the Nlrp3<SUP>-/-</SUP>, mice and Dr. Denise Monack for Aim2<SUP>-/-</SUP> mouse femurs. The McGill SPR Facility was supported by the Canada Foundation for Innovation (CFI) and by Canadian Institutes of Health Research (CIHR) research resource grants to the Sheldon Biotechnology Centre for infrastructure support.	Adrie C, 2001, AM J RESP CRIT CARE, V164, P389, DOI 10.1164/ajrccm.164.3.2009088; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Ayala A, 1996, BLOOD, V87, P4261, DOI 10.1182/blood.V87.10.4261.bloodjournal87104261; Cassetta L, 2009, AIDS, V23, P567, DOI 10.1097/QAD.0b013e328325a47e; CHRISTOU NV, 1995, ANN SURG, V222, P534; Chung CS, 2003, J LEUKOCYTE BIOL, V74, P344, DOI 10.1189/jlb.0102006; Efron PA, 2004, SHOCK, V21, P566, DOI 10.1097/01.shk.0000126648.58732.8c; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hreggvidsdottir HS, 2009, J LEUKOCYTE BIOL, V86, P655, DOI 10.1189/jlb.0908548; Ito T, 2008, ARTERIOSCL THROM VAS, V28, P1825, DOI 10.1161/ATVBAHA.107.150631; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Li JH, 2003, MOL MED, V9, P37, DOI 10.1007/BF03402105; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Lu Min-Chi, 2002, Journal of Microbiology Immunology and Infection, V35, P71; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MEAKINS JL, 1982, BRIT MED J, V285, P1207, DOI 10.1136/bmj.285.6349.1207-a; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Qin YH, 2009, J IMMUNOL, V183, P6244, DOI 10.4049/jimmunol.0900390; Schwulst SJ, 2008, SHOCK, V30, P127, DOI [10.1097/SHK.0b013e318162cf17, 10.1097/shk.0b013e318162cf17]; Sha YG, 2008, J IMMUNOL, V180, P2531, DOI 10.4049/jimmunol.180.4.2531; Shao W, 2007, J BIOL CHEM, V282, P36321, DOI 10.1074/jbc.M708182200; Sparatore B, 2001, BIOCHEM J, V357, P569, DOI 10.1042/0264-6021:3570569; Tang D, 2010, ONCOGENE, V29, P5299, DOI 10.1038/onc.2010.261; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tole S, 2009, J LEUKOCYTE BIOL, V86, P1403, DOI 10.1189/jlb.0609391; Unsinger J, 2010, J IMMUNOL, V184, P6766, DOI 10.4049/jimmunol.0904054; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wesche-Soldato DE, 2005, BLOOD, V106, P2295, DOI 10.1182/blood-2004-10-4086; Wynn JL, 2007, SHOCK, V28, P675, DOI 10.1097/shk.0b013e3180556d09; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang H, 2004, P NATL ACAD SCI USA, V101, P296, DOI 10.1073/pnas.2434651100; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Youn JH, 2008, J IMMUNOL, V180, P5067, DOI 10.4049/jimmunol.180.7.5067	38	45	50	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7777	7786		10.1074/jbc.M113.541474	http://dx.doi.org/10.1074/jbc.M113.541474			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24474694	hybrid, Green Published			2022-12-28	WOS:000332761500044
J	Ravachol, J; Borne, R; Tardif, C; de Philip, P; Fierobe, HP				Ravachol, Julie; Borne, Romain; Tardif, Chantal; de Philip, Pascale; Fierobe, Henri-Pierre			Characterization of All Family-9 Glycoside Hydrolases Synthesized by the Cellulosome-producing Bacterium Clostridium cellulolyticum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbohydrate; Cellulase; Enzyme Kinetics; Enzymes; Protein Complexes; GH9; Cellulose; Cellulosome; Clostridium cellulolyticum; Synergy	SUBSTRATE-SPECIFICITY; ENDOGLUCANASE; THERMOCELLUM; ENZYME; CELLULASE; MODULES; PURIFICATION; MECHANISM; CHIMERAS; GENOME	Background: Family-9 glycoside hydrolases displaying various organizations are plethoric in cellulosome-producing bacteria. Results: The 13 family-9 enzymes synthesized by Clostridium cellulolyticum exhibit different substrate specificities, activities, and relationships with key cellulosomal cellulases in artificial cellulosomes. Conclusion: This variety is required for efficient degradation of crystalline cellulose. Significance: This first global picture provides insights on the multiplicity and diversity of family-9 enzymes in bacterial cellulosomes. The genome of Clostridium cellulolyticum encodes 13 GH9 enzymes that display seven distinct domain organizations. All but one contain a dockerin module and were formerly detected in the cellulosomes, but only three of them were previously studied (Cel9E, Cel9G, and Cel9M). In this study, the 10 uncharacterized GH9 enzymes were overproduced in Escherichia coli and purified, and their activity pattern was investigated in the free state or in cellulosome chimeras with key cellulosomal cellulases. The newly purified GH9 enzymes, including those that share similar organization, all exhibited distinct activity patterns, various binding capacities on cellulosic substrates, and different synergies with pivotal cellulases in mini-cellulosomes. Furthermore, one enzyme (Cel9X) was characterized as the first genuine endoxyloglucanase belonging to this family, with no activity on soluble and insoluble celluloses. Another GH9 enzyme (Cel9V), whose sequence is 78% identical to the cellulosomal cellulase Cel9E, was found inactive in the free and complexed states on all tested substrates. The sole noncellulosomal GH9 (Cel9W) is a cellulase displaying a broad substrate specificity, whose engineered form bearing a dockerin can act synergistically in minicomplexes. Finally, incorporation of all GH9 cellulases in trivalent cellulosome chimera containing Cel48F and Cel9G generated a mixture of heterogeneous mini-cellulosomes that exhibit more activity on crystalline cellulose than the best homogeneous tri-functional complex. Altogether, our data emphasize the importance of GH9 diversity in bacterial cellulosomes, confirm that Cel9G is the most synergistic GH9 with the major endoprocessive cellulase Cel48F, but also identify Cel9U as an important cellulosomal component during cellulose depolymerization.	[Ravachol, Julie; Borne, Romain; Tardif, Chantal; de Philip, Pascale; Fierobe, Henri-Pierre] Aix Marseille Univ, CNRS, Inst Microbiol Mediterranee, Chim Bacterienne Lab,UMR7283, Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Fierobe, HP (corresponding author), CNRS, Inst Microbiol Mediterranee, Chim Bacterienne Lab, UMR7283, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	hpfierob@imm.cnrs.fr	FIEROBE, Henri-Pierre/P-4372-2019; Borne, Romain/AAC-6453-2019	de philip, pascale/0000-0002-9586-7680	Ministere de l'Enseignement Superieur et de la Recherche	Ministere de l'Enseignement Superieur et de la Recherche	This work was supported by a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche (to J. R.).	Abdou L, 2008, J BACTERIOL, V190, P1499, DOI 10.1128/JB.01160-07; Arai T, 2003, J BACTERIOL, V185, P504, DOI 10.1128/JB.185.2.504-512.2003; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Belaich A, 2002, J BACTERIOL, V184, P1378, DOI 10.1128/JB.184.5.1378-1384.2002; Blouzard JC, 2007, J BACTERIOL, V189, P2300, DOI 10.1128/JB.00917-06; Blouzard JC, 2010, PROTEOMICS, V10, P541, DOI 10.1002/pmic.200900311; Borne R, 2013, FEBS J, V280, P5764, DOI 10.1111/febs.12497; Burstein T, 2009, FEBS LETT, V583, P879, DOI 10.1016/j.febslet.2009.02.013; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Celik H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056063; Eckert K, 2002, APPL MICROBIOL BIOT, V60, P428, DOI 10.1007/s00253-002-1131-4; Eckert K, 2009, J MOL BIOL, V394, P61, DOI 10.1016/j.jmb.2009.08.060; Eklof JM, 2012, METHOD ENZYMOL, V510, P97, DOI 10.1016/B978-0-12-415931-0.00006-9; Feinberg L, 2011, J BACTERIOL, V193, P2906, DOI 10.1128/JB.00322-11; Fendri I, 2009, FEBS J, V276, P3076, DOI 10.1111/j.1742-4658.2009.07025.x; Fierobe HP, 2005, J BIOL CHEM, V280, P16325, DOI 10.1074/jbc.M414449200; FIEROBE HP, 1993, EUR J BIOCHEM, V217, P557, DOI 10.1111/j.1432-1033.1993.tb18277.x; FIEROBE HP, 1991, J BACTERIOL, V173, P7956, DOI 10.1128/jb.173.24.7956-7962.1991; Fierobe HP, 2002, J BIOL CHEM, V277, P49621, DOI 10.1074/jbc.M207672200; Fierobe HP, 2001, J BIOL CHEM, V276, P21257, DOI 10.1074/jbc.M102082200; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Gal L, 1997, APPL ENVIRON MICROB, V63, P903, DOI 10.1128/AEM.63.3.903-909.1997; Gal L, 1997, J BACTERIOL, V179, P6595, DOI 10.1128/jb.179.21.6595-6601.1997; Gaudin C, 2000, J BACTERIOL, V182, P1910, DOI 10.1128/JB.182.7.1910-1915.2000; HENRISSAT B, 1989, GENE, V81, P83, DOI 10.1016/0378-1119(89)90339-9; Hirano N, 2013, FEMS MICROBIOL LETT, V344, P25, DOI 10.1111/1574-6968.12149; Honda Y, 2011, GLYCOBIOLOGY, V21, P503, DOI 10.1093/glycob/cwq191; IRWIN DC, 1993, BIOTECHNOL BIOENG, V42, P1002, DOI 10.1002/bit.260420811; Jindou S, 2006, FEMS MICROBIOL LETT, V254, P308, DOI 10.1111/j.1574-6968.2005.00040.x; Kataeva IA, 2004, PROTEIN ENG DES SEL, V17, P759, DOI 10.1093/protein/gzh094; Mandelman D, 2003, J BACTERIOL, V185, P4127, DOI 10.1128/JB.185.14.4127-4135.2003; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; PARK JT, 1949, J BIOL CHEM, V181, P149; Pereira JH, 2009, ACTA CRYSTALLOGR D, V65, P744, DOI 10.1107/S0907444909012773; ReverbelLeroy C, 1997, J BACTERIOL, V179, P46, DOI 10.1128/jb.179.1.46-52.1997; Sakka K, 2009, FEMS MICROBIOL LETT, V300, P249, DOI 10.1111/j.1574-6968.2009.01788.x; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Schubot FD, 2004, BIOCHEMISTRY-US, V43, P1163, DOI 10.1021/bi030202i; Tamaru Y, 2011, MICROB BIOTECHNOL, V4, P64, DOI 10.1111/j.1751-7915.2010.00210.x; Warner CD, 2011, ENZYME MICROB TECH, V48, P27, DOI 10.1016/j.enzmictec.2010.08.009; WOOD TM, 1988, METHOD ENZYMOL, V160, P19; Yaniv Oren, 2012, Methods Mol Biol, V908, P101, DOI 10.1007/978-1-61779-956-3_10; Zhang XZ, 2010, BIORESOURCE TECHNOL, V101, P5534, DOI 10.1016/j.biortech.2010.01.152; Zverlov VV, 2005, MICROBIOL-SGM, V151, P3395, DOI 10.1099/mic.0.28206-0	44	58	58	2	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7335	7348		10.1074/jbc.M113.545046	http://dx.doi.org/10.1074/jbc.M113.545046			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24451379	Green Published, hybrid			2022-12-28	WOS:000332761500007
J	Wheatley, NM; Sundberg, CD; Gidaniyan, SD; Cascio, D; Yeates, TO				Wheatley, Nicole M.; Sundberg, Christopher D.; Gidaniyan, Soheil D.; Cascio, Duilio; Yeates, Todd O.			Structure and Identification of a Pterin Dehydratase-like Protein as a Ribulose-bisphosphate Carboxylase/Oxygenase (RuBisCO) Assembly Factor in the alpha-Carboxysome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carbon Dioxide; Molecular Chaperone; Protein Assembly; Protein Evolution; Protein Folding; RuBisCO; Carbon Fixation; Carboxysome; Pseudo-enzyme; Pterin Dehydratase	PENTAMERIC VERTEX PROTEINS; CRYSTAL-STRUCTURES; SHELL; ORGANELLES; MICROCOMPARTMENTS; CYANOBACTERIA; MECHANISMS; EVOLUTION; BACTERIA; SEQUENCE	Background: A gene encoding a distant homolog of pterin-4-carbinolamine dehydratase (PCD) is present in all -type carboxysome operons. Results: This conserved PCD-like protein promotes the assembly of native RuBisCO when overexpressed together with GroELS. Conclusion: The protein, named here acRAF for -carboxysome RuBisCO assembly factor, is a newly identified molecular chaperone. Significance: The activity of this chaperone toward RuBisCO has potential agricultural application. Carboxysomes are proteinaceous bacterial microcompartments that increase the efficiency of the rate-limiting step in carbon fixation by sequestering reaction substrates. Typically, -carboxysomes are genetically encoded as a single operon expressing the structural proteins and the encapsulated enzymes of the microcompartment. In addition, depending on phylogeny, as many as 13 other genes are found to co-occur near or within -carboxysome operons. One of these genes codes for a protein with distant homology to pterin-4-carbinolamine dehydratase (PCD) enzymes. It is present in all -carboxysome containing bacteria and has homologs in algae and higher plants. Canonical PCDs play an important role in amino acid hydroxylation, a reaction not associated with carbon fixation. We determined the crystal structure of an -carboxysome PCD-like protein from the chemoautotrophic bacterium Thiomonas intermedia K12, at 1.3- resolution. The protein retains a three-dimensional fold similar to canonical PCDs, although the prominent active site cleft present in PCD enzymes is disrupted in the -carboxysome PCD-like protein. Using a cell-based complementation assay, we tested the PCD-like proteins from T. intermedia and two additional bacteria, and found no evidence for PCD enzymatic activity. However, we discovered that heterologous co-expression of the PCD-like protein from Halothiobacillus neapolitanus with RuBisCO and GroELS in Escherichia coli increased the amount of soluble, assembled RuBisCO recovered from cell lysates compared with co-expression of RuBisCO with GroELS alone. We conclude that this conserved PCD-like protein, renamed here -carboxysome RuBisCO assembly factor (or acRAF), is a novel RuBisCO chaperone integral to -carboxysome function.	[Wheatley, Nicole M.; Yeates, Todd O.] Univ Calif Los Angeles, Mol Biol Interdept PhD Program, Los Angeles, CA 90095 USA; [Sundberg, Christopher D.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Gidaniyan, Soheil D.; Yeates, Todd O.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Cascio, Duilio; Yeates, Todd O.] Univ Calif Los Angeles, Dept Energy, Inst Genom & Prote, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Yeates, TO (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 611 Charles Young Dr, Los Angeles, CA 90095 USA.	yeates@mbi.ucla.edu		Yeates, Todd/0000-0001-5709-9839	Department of Energy [DE-FC02-02ER63421, DE-AC02-06CH11357]; National Institutes of Health [P41RR015301, P41GM103403]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185, P41GM103403] Funding Source: NIH RePORTER	Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Andrew Hanson and Mike Ziemak for providing PCD constructs, Dr. Sabeeha Merchant and Dr. Rikard Fristedt for valuable discussions and Arabidopsis constructs, Drs. Alice Barkan, Leila Feiz, and David Stern for discussions on acRAF homologs in plants. We thank M. Capel, K. Rajashankar, N. Sukumar, J. Schuermann, I. Kourinov, and F. Murphy at NECAT for synchrotron x-ray assistance. We thank Mike Collazo and Michael Sawaya in the UCLA-DOE x-ray Crystallization and Crystallography Core Facilities. We are indebted to an anonymous reviewer for making suggestions that were critical in establishing the function of acRAF. The UCLA-DOE X-ray Crystallography Core Facility is supported by Department of Energy Grant DE-FC02-02ER63421. APS beamline 24-ID is supported by National Institutes of Health Grants P41RR015301 and P41GM103403. Use of the APS is supported by the Department of Energy under contract DE-AC02-06CH11357.	Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; Andersson I, 2008, J EXP BOT, V59, P1555, DOI 10.1093/jxb/ern091; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; Bracher A, 2011, NAT STRUCT MOL BIOL, V18, P875, DOI 10.1038/nsmb.2090; Bricogne G., 2011, BUSTER VERSION X Y Z; Cai F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007521; Chen DH, 2013, CELL, V153, P1354, DOI 10.1016/j.cell.2013.04.052; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cronk JD, 1996, PROTEIN SCI, V5, P1963, DOI 10.1002/pro.5560051002; Ellis RJ, 2001, CURR BIOL, V11, pR1038, DOI 10.1016/S0960-9822(01)00620-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Espie GS, 2011, PHOTOSYNTH RES, V109, P7, DOI 10.1007/s11120-011-9656-y; Feiz L, 2012, PLANT CELL, V24, P3435, DOI 10.1105/tpc.112.102012; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hayashi NR, 1997, BIOCHEM BIOPH RES CO, V241, P565, DOI 10.1006/bbrc.1997.7853; Iancu CV, 2007, J MOL BIOL, V372, P764, DOI 10.1016/j.jmb.2007.06.059; Jeffery CJ, 2004, CURR OPIN STRUC BIOL, V14, P663, DOI 10.1016/j.sbi.2004.10.001; Jorda J, 2013, PROTEIN SCI, V22, P179, DOI 10.1002/pro.2196; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Leslie M, 2013, SCIENCE, V340, P25, DOI 10.1126/science.340.6128.27; Liu CM, 2010, NATURE, V463, P197, DOI 10.1038/nature08651; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marcus Y, 2011, J EXP BOT, V62, P4173, DOI 10.1093/jxb/err116; Mueller-Cajar O, 2011, NATURE, V479, P194, DOI 10.1038/nature10568; Naponelli V, 2008, PLANT PHYSIOL, V146, P1515, DOI 10.1104/pp.107.114090; Onizuka T, 2004, PLANT CELL PHYSIOL, V45, P1390, DOI 10.1093/pcp/pch160; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Piatigorsky Joram, 2003, Journal of Structural and Functional Genomics, V3, P131; Rae BD, 2013, MICROBIOL MOL BIOL R, V77, P357, DOI 10.1128/MMBR.00061-12; Roberts EW, 2012, J BACTERIOL, V194, P787, DOI 10.1128/JB.06444-11; Sage RF, 2002, J EXP BOT, V53, P609, DOI 10.1093/jexbot/53.369.609; Satagopan S, 2009, BIOCHEMISTRY-US, V48, P9076, DOI 10.1021/bi9006385; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; So AKC, 2004, J BACTERIOL, V186, P623, DOI 10.1128/JB.186.3.623-630.2004; Sourdive DJD, 1997, NUCLEIC ACIDS RES, V25, P1476, DOI 10.1093/nar/25.8.1476; Starkenburg SR, 2006, APPL ENVIRON MICROB, V72, P2050, DOI 10.1128/AEM.72.3.2050-2063.2006; Sutter M, 2013, PHOTOSYNTH RES, V118, P9, DOI 10.1007/s11120-013-9909-z; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Volner A, 2003, J BIOL INORG CHEM, V8, P121, DOI 10.1007/s00775-002-0395-6; Wheatley NM, 2013, PROTEIN SCI, V22, P660, DOI 10.1002/pro.2246; YEATES TO, 1995, J MOL BIOL, V249, P804, DOI 10.1006/jmbi.1995.0339; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377	44	39	41	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7973	7981		10.1074/jbc.M113.531236	http://dx.doi.org/10.1074/jbc.M113.531236			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24459150	Green Published, hybrid			2022-12-28	WOS:000332761500061
J	Ishida, M; Arai, SP; Ohbayashi, N; Fukuda, M				Ishida, Morie; Arai, Saki P.; Ohbayashi, Norihiko; Fukuda, Mitsunori			The GTPase-deficient Rab27A( Q78L) Mutant Inhibits Melanosome Transport in Melanocytes through Trapping of Rab27A Effector Protein Slac2-a/Melanophilin in Their Cytosol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Low Molecular Weight G Proteins; Melanogenesis; Membrane Trafficking; Protein Targeting; Rab; Small GTPases; Subcellular Organelles	REGULATES AMYLASE RELEASE; PAROTID ACINAR-CELLS; MYOSIN-VA; GRISCELLI-SYNDROME; ACTIVATING PROTEIN; HOMOLOGY DOMAIN; BINDING DOMAIN; MEMBRANE; IDENTIFICATION; SIGNALS	Background: A GTPase-deficient Rab27A(Q78L) mutation caused perinuclear melanosome aggregation by an unknown mechanism. Results: Forcible targeting of Rab27A(Q78L) to melanosomes by a novel melanosome-targeting tag restored peripheral melanosome distribution in Rab27A-deficient cells. Conclusion: The GTPase activity of Rab27A is required for its melanosome localization, not for melanosome transport. Significance: These findings provide new insights into the mechanism underlying the spatiotemporal regulation of Rab27A activity. The small GTPase Rab27A is a crucial regulator of actin-based melanosome transport in melanocytes, and functionally defective Rab27A causes human Griscelli syndrome type 2, which is characterized by silvery hair. A GTPase-deficient, constitutively active Rab27A(Q78L) mutant has been shown to act as an inhibitor of melanosome transport and to induce perinuclear aggregation of melanosomes, but the molecular mechanism by which Rab27A(Q78L) inhibits melanosome transport remained to be determined. In this study, we attempted to identify the primary cause of the perinuclear melanosome aggregation induced by Rab27A(Q78L). The results showed that Rab27A(Q78L) is unable to localize on mature melanosomes and that its inhibitory activity on melanosome transport is completely dependent on its binding to the Rab27A effector Slac2-a/melanophilin. When we forcibly expressed Rab27A(Q78L) on mature melanosomes by using a novel melanosome-targeting tag that we developed in this study and named the MST tag, the MST-Rab27A(Q78L) fusion protein behaved in the same manner as wild-type Rab27A. It localized on mature melanosomes without inducing melanosome aggregation and restored normal peripheral melanosome distribution in Rab27A-deficient cells. These findings indicate that the GTPase activity of Rab27A is required for its melanosome localization but is not required for melanosome transport.	[Ishida, Morie; Arai, Saki P.; Ohbayashi, Norihiko; Fukuda, Mitsunori] Tohoku Univ, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan	Tohoku University	Fukuda, M (corresponding author), Tohoku Univ, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci, Grad Sch Life Sci,Aoba Ku, Sendai, Miyagi 9808578, Japan.	nori@m.tohoku.ac.jp	Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan; Tokyo Biochemical Research Foundation; International Advanced Research and Education Organization of Tohoku University; Grants-in-Aid for Scientific Research [24570206] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokyo Biochemical Research Foundation; International Advanced Research and Education Organization of Tohoku University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, and Technology (MEXT) of Japan (to N. O. and M. F.); by a grant from the Tokyo Biochemical Research Foundation (to M. F.); and by the International Advanced Research and Education Organization of Tohoku University (to M. I.).	Bahadoran P, 2003, J BIOL CHEM, V278, P11386, DOI 10.1074/jbc.M211996200; Bahadoran P, 2001, J CELL BIOL, V152, P843, DOI 10.1083/jcb.152.4.843; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Calvo PA, 1999, J BIOL CHEM, V274, P12780, DOI 10.1074/jbc.274.18.12780; EMR SD, 1986, J CELL BIOL, V102, P523, DOI 10.1083/jcb.102.2.523; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 2005, METHOD ENZYMOL, V403, P445, DOI 10.1016/S0076-6879(05)03039-9; Fukuda M, 2004, J BIOL CHEM, V279, P22314, DOI 10.1074/jbc.401791200; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; Fukuda M, 2002, J BIOL CHEM, V277, P40118, DOI 10.1074/jbc.M205765200; Fukuda M, 2002, J BIOL CHEM, V277, P43096, DOI 10.1074/jbc.M203862200; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Fukuda M, 2013, TRAFFIC, V14, P949, DOI 10.1111/tra.12083; Fukuda M, 2011, BIOSCIENCE REP, V31, P159, DOI 10.1042/BSR20100112; Fukuda M, 2010, HISTOL HISTOPATHOL, V25, P1473, DOI 10.14670/HH-25.1473; GOULD SJ, 1988, J CELL BIOL, V107, P897, DOI 10.1083/jcb.107.3.897; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Imai A, 2004, J CELL SCI, V117, P1945, DOI 10.1242/jcs.01048; Imai A, 2011, J BIOL CHEM, V286, P33854, DOI 10.1074/jbc.M111.281394; Ishida M, 2012, J CELL SCI, V125, P5177, DOI 10.1242/jcs.109314; Itoh T, 2006, J BIOL CHEM, V281, P31823, DOI 10.1074/jbc.M603808200; Kobayashi H, 2012, J CELL SCI, V125, P2235, DOI 10.1242/jcs.098657; Kondo H, 2006, J BIOL CHEM, V281, P28657, DOI 10.1074/jbc.M603227200; Kukimoto-Niino M, 2008, STRUCTURE, V16, P1478, DOI 10.1016/j.str.2008.07.014; Kuroda TS, 2004, NAT CELL BIOL, V6, P1195, DOI 10.1038/ncb1197; Kuroda TS, 2003, MOL CELL BIOL, V23, P5245, DOI 10.1128/MCB.23.15.5245-5255.2003; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Matesic LE, 2001, P NATL ACAD SCI USA, V98, P10238, DOI 10.1073/pnas.181336698; Matsui T, 2012, J BIOL CHEM, V287, P28619, DOI 10.1074/jbc.M112.370544; Menasche G, 2003, J CLIN INVEST, V112, P450, DOI 10.1172/JCI200318264; Mori Y, 2012, J BIOL CHEM, V287, P8963, DOI 10.1074/jbc.M111.314385; O'Sullivan TN, 2004, P NATL ACAD SCI USA, V101, P16831, DOI 10.1073/pnas.0407339101; Ohbayashi N, 2012, J CELL SCI, V125, P1508, DOI 10.1242/jcs.094185; Ohbayashi N, 2010, PIGM CELL MELANOMA R, V23, P365, DOI 10.1111/j.1755-148X.2010.00705.x; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pfeffer SR, 2013, CURR OPIN CELL BIOL, V25, P414, DOI 10.1016/j.ceb.2013.04.002; Piccirillo R, 2006, J CELL SCI, V119, P2003, DOI 10.1242/jcs.02930; Sitaram A, 2012, PHYSIOLOGY, V27, P85, DOI 10.1152/physiol.00043.2011; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Tarafder AK, 2011, TRAFFIC, V12, P1056, DOI 10.1111/j.1600-0854.2011.01216.x; VIJAYASARADHI S, 1995, J CELL BIOL, V130, P807, DOI 10.1083/jcb.130.4.807; Wu XF, 2001, J CELL SCI, V114, P1091; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Wu XS, 2012, BIOCHEM BIOPH RES CO, V426, P209, DOI 10.1016/j.bbrc.2012.08.064; Wu XFS, 2012, P NATL ACAD SCI USA, V109, pE2101, DOI 10.1073/pnas.1209397109	49	9	9	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11059	11067		10.1074/jbc.M114.552281	http://dx.doi.org/10.1074/jbc.M114.552281			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24584932	hybrid, Green Published			2022-12-28	WOS:000334638500011
J	Cerutti, N; Killick, M; Jugnarain, V; Papathanasopoulos, M; Capovilla, A				Cerutti, Nichole; Killick, Mark; Jugnarain, Vinesh; Papathanasopoulos, Maria; Capovilla, Alexio			Disulfide Reduction in CD4 Domain 1 or 2 Is Essential for Interaction with HIV Glycoprotein 120 ( gp120), which Impairs Thioredoxin-driven CD4 Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Disulfide; HIV; Redox; Thiol; Thioredoxin; CD4; gp120	CLASS-II; THIOL/DISULFIDE EXCHANGE; ENVELOPE PROTEIN; RECEPTOR; ISOMERASE; COMPLEX; INHIBITION; LYMPHOCYTE; BINDING; OLIGOMERIZATION	Background: Interaction between HIV gp120 and cell CD4 initiates viral infection of host cells. Results: Only CD4 with reduced disulfides in domain 1 or 2 binds gp120, which inhibits thioredoxin-dependent CD4 dimerization. Conclusion: Cell surface oxidoreductases may prime CD4 for gp120 engagement, and impairment of redox-driven CD4 dimerization by gp120 may compromise CD4 function. Significance: Redox-dependent isomerization of CD4 is critical for HIV entry. Human CD4 is a membrane-bound glycoprotein expressed on the surface of certain leukocytes, where it plays a key role in the activation of immunostimulatory T cells and acts as the primary receptor for human immunodeficiency virus (HIV) glycoprotein (gp120). Although growing evidence suggests that redox exchange reactions involving CD4 disulfides, potentially catalyzed by cell surface-secreted oxidoreductases such as thioredoxin (Trx) and protein disulfide isomerase, play an essential role in regulating the activity of CD4, their mechanism(s) and biological utility remain incompletely understood. To gain more insights in this regard, we generated a panel of recombinant 2-domain CD4 proteins (2dCD4), including wild-type and Cys/Ala variants, and used these to show that while protein disulfide isomerase has little capacity for 2dCD4 reduction, Trx reduces 2dCD4 highly efficiently, catalyzing the formation of conformationally distinct monomeric 2dCD4 isomers, and a stable, disulfide-linked 2dCD4 dimer. Moreover, we show that HIV gp120 is incapable of binding a fully oxidized, monomeric 2dCD4 in which both domain 1 and 2 disulfides are intact, but binds robustly to reduced counterparts that are the ostensible products of Trx-mediated isomerization. Finally, we demonstrate that Trx-driven dimerization of CD4, a process believed to be critical for the establishment of functional MHCII-TCR-CD4 antigen presentation complexes, is impaired when CD4 is bound to gp120. These observations reinforce the importance of cell surface redox activity for HIV entry and posit the intriguing possibility that one of the many pathogenic effects of HIV may be related to gp120-mediated inhibition of oxidoreductive CD4 isomerization.	[Cerutti, Nichole; Killick, Mark; Jugnarain, Vinesh; Papathanasopoulos, Maria; Capovilla, Alexio] Univ Witwatersrand, Sch Med, Dept Mol Med & Haematol, HIV Pathogenesis Res Lab, ZA-2193 Johannesburg, South Africa	University of Witwatersrand	Capovilla, A (corresponding author), Univ Witwatersrand, Sch Med, Dept Mol Med & Haematol, 7 York Rd, ZA-2193 Johannesburg, South Africa.	alexio.capovilla@wits.ac.za			South African Medical Research Council; National Research Foundation; Poliomyelitis Research Foundation; Carnegie Foundation; South African HIV/AIDS Research Platform of the Department of Science and Technology	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation; Poliomyelitis Research Foundation; Carnegie Foundation; South African HIV/AIDS Research Platform of the Department of Science and Technology	This work was supported by the South African Medical Research Council, the National Research Foundation, the Poliomyelitis Research Foundation, the Carnegie Foundation, and the South African HIV/AIDS Research Platform of the Department of Science and Technology.	Auwerx J, 2009, INT J BIOCHEM CELL B, V41, P1269, DOI 10.1016/j.biocel.2008.10.031; BACHELDER RE, 1995, J VIROL, V69, P5734, DOI 10.1128/JVI.69.9.5734-5742.1995; Bourgeois R, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-31; Bulheller BM, 2009, BIOINFORMATICS, V25, P539, DOI 10.1093/bioinformatics/btp016; Cerutti N, 2010, J BIOL CHEM, V285, P25743, DOI 10.1074/jbc.M110.144121; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; DIAMOND DC, 1988, J IMMUNOL, V141, P3715; Fenouillet E, 2001, J INFECT DIS, V183, P744, DOI 10.1086/318823; Gallina A, 2002, J BIOL CHEM, V277, P50579, DOI 10.1074/jbc.M204547200; GURLEY RJ, 1989, P NATL ACAD SCI USA, V86, P1993, DOI 10.1073/pnas.86.6.1993; HOLMGREN A, 1979, J BIOL CHEM, V254, P9113; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; KONIG R, 1995, J EXP MED, V182, P779, DOI 10.1084/jem.182.3.779; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LUNDSTROM J, 1993, BIOCHEMISTRY-US, V32, P6649, DOI 10.1021/bi00077a018; Lynch GW, 2006, IMMUNOL CELL BIOL, V84, P154, DOI 10.1111/j.1440-1711.2005.01403.x; Lynch GW, 1999, EUR J IMMUNOL, V29, P2590, DOI 10.1002/(SICI)1521-4141(199908)29:08<2590::AID-IMMU2590>3.0.CO;2-R; Maekawa A, 2006, J IMMUNOL, V176, P6873, DOI 10.4049/jimmunol.176.11.6873; Markovic I, 2004, BLOOD, V103, P1586, DOI 10.1182/blood-2003-05-1390; MARTIN H, 1991, BIOCHEM BIOPH RES CO, V175, P123, DOI 10.1016/S0006-291X(05)81209-4; Matthias LJ, 2010, J BIOL CHEM, V285, P40793, DOI 10.1074/jbc.M110.190579; Matthias LJ, 2002, NAT IMMUNOL, V3, P727, DOI 10.1038/ni815; MCDOUGAL JS, 1986, COLD SPRING HARB SYM, V51, P703, DOI 10.1101/SQB.1986.051.01.083; Moldovan MC, 2006, J IMMUNOL, V176, P5438, DOI 10.4049/jimmunol.176.9.5438; Moldovan MC, 2002, J IMMUNOL, V169, P6261, DOI 10.4049/jimmunol.169.11.6261; NEWELL MK, 1990, NATURE, V347, P286, DOI 10.1038/347286a0; Ou W, 2006, VIROLOGY, V350, P406, DOI 10.1016/j.virol.2006.01.041; Reiser K, 2012, INT J BIOCHEM CELL B, V44, P556, DOI 10.1016/j.biocel.2011.12.015; RUBARTELLI A, 1992, J BIOL CHEM, V267, P24161; RYSER HJP, 1994, P NATL ACAD SCI USA, V91, P4559, DOI 10.1073/pnas.91.10.4559; Saha P, 2011, BIOCHEMISTRY-US, V50, P7891, DOI 10.1021/bi200870r; SAKIHAMA T, 1995, P NATL ACAD SCI USA, V92, P6444, DOI 10.1073/pnas.92.14.6444; SAKIHAMA T, 1995, IMMUNOL TODAY, V16, P581, DOI 10.1016/0167-5699(95)80081-6; Sanejouand YH, 2004, PROTEINS, V57, P205, DOI 10.1002/prot.20197; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Sharma D, 2005, BIOCHEMISTRY-US, V44, P16192, DOI 10.1021/bi051120s; Stantchev TS, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-97; SWEET RW, 1991, CURR OPIN BIOTECH, V2, P622, DOI 10.1016/0958-1669(91)90089-N; TERADA K, 1995, J BIOL CHEM, V270, P20410, DOI 10.1074/jbc.270.35.20410; Wang WC, 1997, BIOCHEM BIOPH RES CO, V240, P530, DOI 10.1006/bbrc.1997.7688; Wingfield P., 2001, CURRENT PROTOCOLS PR, pA.3F.1; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	43	28	30	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10455	10465		10.1074/jbc.M113.539353	http://dx.doi.org/10.1074/jbc.M113.539353			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24550395	Green Published, hybrid			2022-12-28	WOS:000334226400019
J	Harvey, MC; Fleet, A; Okolowsky, N; Hamel, PA				Harvey, Malcolm C.; Fleet, Andrew; Okolowsky, Nadia; Hamel, Paul A.			Distinct Effects of the mesenchymal dysplasia Gene Variant of Murine Patched-1 Protein on Canonical and Non-canonical Hedgehog Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Hedgehog; Receptor Modification; Receptor Regulation; SH3 Domains; Patched-1; Sonic Hedgehog; c-src	MAMMARY-GLAND MORPHOGENESIS; CELL-CYCLE PROGRESSION; SONIC HEDGEHOG; HUMAN HOMOLOG; NEURAL-TUBE; SRC; MICE; EXPRESSION; MOUSE; CDO	Background: Patched-1 is the primary ligand receptor in both canonical and non-canonical Hedgehog signaling. Results: Truncation of the Patched-1 C terminus impairs regulation of Patched-1-mediated c-src activation and elevates the expression of Hedgehog target genes. Conclusion: The Ptch1 C terminus is required for mediation of both canonical and non-canonical Hedgehog signaling. Significance: A mutant of Ptch1 differentially regulates canonical and non-canonical Hh signaling pathways. Hedgehog (Hh) signaling requires regulation of the receptor Patched-1 (Ptch1), which, in turn, regulates Smoothened activity (canonical Hh signaling) as well as other non-canonical signaling pathways. The mutant Ptch1 allele mesenchymal dysplasia (mes), which truncates the Ptch1 C terminus, produces a limited spectrum of developmental defects in mice as well as deregulation of canonical Hh signaling in some, but not all, affected tissues. Paradoxically, mes suppresses canonical Hh signaling and binds to Hh ligands with an affinity similar to wild-type mouse Ptch1 (mPtch1). We characterized the distinct activities of the mes variant of mPtch1 mediating Hh signaling through both canonical and non-canonical pathways. We demonstrated that mPtch1 bound c-src in an Hh-regulated manner. Stimulation with Sonic Hedgehog (Shh) of primary mammary mesenchymal cells from wild-type and mes animals activated Erk1/2. Although Shh activated c-src in wild-type cells, c-src was constitutively activated in mes mesenchymal cells. Transient assays showed that wild-type mPtch1, mes, or mPtch1 lacking the C terminus repressed Hh signaling in Ptch1-deficient mouse embryo fibroblasts and that repression was reversed by Shh, revealing that the C terminus was dispensable for mPtch1-dependent regulation of canonical Hh signaling. In contrast to these transient assays, constitutively high levels of mGli1 but not mPtch1 were present in primary mammary mesenchymal cells from mes mice, whereas the expression of mPtch1 was similarly induced in both mes and wild-type cells. These data define a novel signal transduction pathway involving c-src that is activated by the Hh ligands and reveals the requirement for the C terminus of Ptch in regulation of canonical and non-canonical Hh signaling pathways.	[Harvey, Malcolm C.; Fleet, Andrew; Okolowsky, Nadia; Hamel, Paul A.] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada	University of Toronto	Hamel, PA (corresponding author), Univ Toronto, Rm 6318,Med Sci Bldg,1 Kings Coll Cir, Toronto, ON M5S 1A8, Canada.	paul.hamel@utoronto.ca			Canadian Institutes of Health Research Grant [MOP-97929]	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR))	This project was funded by Canadian Institutes of Health Research Grant MOP-97929 (to P. A. H.).	Aboulkassim TO, 2003, ONCOGENE, V22, P2967, DOI 10.1038/sj.onc.1206513; Adolphe C, 2006, CANCER RES, V66, P2081, DOI 10.1158/0008-5472.CAN-05-2146; Allen BL, 2007, GENE DEV, V21, P1244, DOI 10.1101/gad.1543607; Allen BL, 2011, DEV CELL, V20, P775, DOI 10.1016/j.devcel.2011.04.018; Barnes EA, 2001, EMBO J, V20, P2214, DOI 10.1093/emboj/20.9.2214; Blair SS, 1997, DEVELOPMENT, V124, P4053; Carpenter D, 1998, P NATL ACAD SCI USA, V95, P13630, DOI 10.1073/pnas.95.23.13630; Chang H, 2012, DEV BIOL, V370, P187, DOI 10.1016/j.ydbio.2012.07.027; Chang H, 2010, INT J BIOCHEM CELL B, V42, P1462, DOI 10.1016/j.biocel.2010.04.016; Chatzizacharias NA, 2012, HISTOL HISTOPATHOL, V27, P677, DOI 10.14670/HH-27.677; Chen Y, 1998, DEVELOPMENT, V125, P4943; Chinchilla P, 2010, CELL CYCLE, V9, P570, DOI 10.4161/cc.9.3.10591; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hepker J, 1997, DEVELOPMENT, V124, P549; Ingham PW, 2000, CURR BIOL, V10, P1315, DOI 10.1016/S0960-9822(00)00755-7; Izzi L, 2011, DEV CELL, V20, P788, DOI 10.1016/j.devcel.2011.04.017; Jenkins D, 2007, J ANAT, V211, P620, DOI 10.1111/j.1469-7580.2007.00808.x; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kavran JM, 2010, J BIOL CHEM, V285, P24584, DOI 10.1074/jbc.M110.131680; Kim H, 2005, ONCOGENE, V24, P7599, DOI 10.1038/sj.onc.1208898; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Lee J, 1997, DEVELOPMENT, V124, P2537; Li Z, 2008, INT J BIOL SCI, V4, P29; Lin TL, 2012, ONCOTARGETS THER, V5, P47, DOI 10.2147/OTT.S21957; Makino S, 2001, DEV BIOL, V239, P95, DOI 10.1006/dbio.2001.0419; Marcotte R, 2009, MOL CELL BIOL, V29, P5858, DOI 10.1128/MCB.01731-08; Marigo V, 1996, P NATL ACAD SCI USA, V93, P9346, DOI 10.1073/pnas.93.18.9346; Marigo V, 1996, DEVELOPMENT, V122, P1225; Metcalfe C, 2011, CANCER RES, V71, P5057, DOI 10.1158/0008-5472.CAN-11-0923; Moraes RC, 2009, DEVELOPMENT, V136, P1423, DOI 10.1242/dev.023994; MULLER WJ, 1991, CANCER METAST REV, V10, P217, DOI 10.1007/BF00050793; Nieuwenhuis E, 2007, DEV BIOL, V308, P547, DOI 10.1016/j.ydbio.2007.06.016; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Pietsch T, 1997, CANCER RES, V57, P2085; Polizio AH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002396; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Smyth I, 1999, HUM MOL GENET, V8, P291, DOI 10.1093/hmg/8.2.291; Sweet HO, 1996, J HERED, V87, P87, DOI 10.1093/oxfordjournals.jhered.a022981; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Wakabayashi Y, 2007, NATURE, V445, P761, DOI 10.1038/nature05489; WEBSTER MA, 1995, P NATL ACAD SCI USA, V92, P7849, DOI 10.1073/pnas.92.17.7849; Wheeler DL, 2009, ONCOLOGIST, V14, P667, DOI 10.1634/theoncologist.2009-0009; Zhang XM, 2009, BREAST CANCER RES TR, V115, P505, DOI 10.1007/s10549-008-0093-3	46	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10939	10949		10.1074/jbc.M113.514844	http://dx.doi.org/10.1074/jbc.M113.514844			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24570001	hybrid, Green Published			2022-12-28	WOS:000334226400061
J	Yi, F; Wang, H; Chai, Q; Wang, XL; Shen, WK; Willis, MS; Lee, HC; Lu, T				Yi, Fu; Wang, Huan; Chai, Qiang; Wang, Xiaoli; Shen, Win-Kuang; Willis, Monte S.; Lee, Hon-Chi; Lu, Tong			Regulation of Large Conductance Ca2+ -activated K+ ( BK) Channel beta 1 Subunit Expression by Muscle RING Finger Protein 1 in Diabetic Vessels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Potassium Channels; Protein Degradation; Ubiquitin Ligase; Vascular Smooth Muscle Cells	ARTERIAL SMOOTH-MUSCLE; NF-KAPPA-B; POTASSIUM CHANNELS; UBIQUITIN LIGASE; IN-VIVO; MYOCARDIAL-INFARCTION; ACUTE HYPERGLYCEMIA; SPARKLET ACTIVITY; DOWN-REGULATION; CELLS	Background: Impaired BK channel function in diabetic vessels is associated with decreased BK channel 1 subunit (BK-1) expression. Results: Muscle RING finger protein 1 (MuRF1) physically interacts with BK-1 and accelerates BK-1 proteolysis. Conclusion: Increased MuRF1 expression is a novel mechanism underlying diabetic BK channelopathy and vasculopathy. Significance: MuRF1 is a potential therapeutic target of BK channel dysfunction and vascular complications in diabetes. The large conductance Ca2+-activated K+ (BK) channel, expressed abundantly in vascular smooth muscle cells (SMCs), is a key determinant of vascular tone. BK channel activity is tightly regulated by its accessory 1 subunit (BK-1). However, BK channel function is impaired in diabetic vessels by increased ubiquitin/proteasome-dependent BK-1 protein degradation. Muscle RING finger protein 1 (MuRF1), a muscle-specific ubiquitin ligase, is implicated in many cardiac and skeletal muscle diseases. However, the role of MuRF1 in the regulation of vascular BK channel and coronary function has not been examined. In this study, we hypothesized that MuRF1 participated in BK-1 proteolysis, leading to the down-regulation of BK channel activation and impaired coronary function in diabetes. Combining patch clamp and molecular biological approaches, we found that MuRF1 expression was enhanced, accompanied by reduced BK-1 expression, in high glucose-cultured human coronary SMCs and in diabetic vessels. Knockdown of MuRF1 by siRNA in cultured human SMCs attenuated BK-1 ubiquitination and increased BK-1 expression, whereas adenoviral expression of MuRF1 in mouse coronary arteries reduced BK-1 expression and diminished BK channel-mediated vasodilation. Physical interaction between the N terminus of BK-1 and the coiled-coil domain of MuRF1 was demonstrated by pulldown assay. Moreover, MuRF1 expression was regulated by NF-B. Most importantly, pharmacological inhibition of proteasome and NF-B activities preserved BK-1 expression and BK-channel-mediated coronary vasodilation in diabetic mice. Hence, our results provide the first evidence that the up-regulation of NF-B-dependent MuRF1 expression is a novel mechanism that leads to BK channelopathy and vasculopathy in diabetes.	[Yi, Fu; Wang, Huan; Chai, Qiang; Wang, Xiaoli; Lee, Hon-Chi; Lu, Tong] Mayo Clin, Dept Internal Med, Rochester, MN 55905 USA; [Yi, Fu] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Peoples R China; [Shen, Win-Kuang] Mayo Clin, Dept Internal Med, Scottsdale, AZ 85259 USA; [Willis, Monte S.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA	Mayo Clinic; Air Force Military Medical University; Mayo Clinic; Mayo Clinic Phoenix; University of North Carolina; University of North Carolina Chapel Hill	Lu, T (corresponding author), Mayo Clin, Dept Internal Med, Div Cardiovasc Dis, 200 First St SW, Rochester, MN 55905 USA.	lu.tong@mayo.edu	Willis, Monte S/J-9994-2015; yi, fu/HGE-6093-2022; Lu, Tong/A-7745-2009	Willis, Monte S/0000-0002-0769-5816; Lu, Tong/0000-0002-2393-7643	National Institutes of Health Grants [HL-74180, HL-080118]; American Diabetes Association Grants [ADA-JFA-07-39, 1-12-BS-119]; National Natural Science Foundation of the People's Republic of China [81000686]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080118, R01HL074180, R56HL074180, R01HL104129] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Grants(American Diabetes Association); National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-74180 and HL-080118. This work was also supported by American Diabetes Association Grants ADA-JFA-07-39 and 1-12-BS-119).; Supported by National Natural Science Foundation of the People's Republic of China Grant 81000686.	Abello N, 2009, J PROTEOME RES, V8, P3222, DOI 10.1021/pr900039c; Abriel H, 2000, FEBS LETT, V466, P377, DOI 10.1016/S0014-5793(00)01098-X; Althaus M, 2007, FASEB J, V21, P2389, DOI 10.1096/fj.06-7694com; Amberg GC, 2003, CIRC RES, V93, P965, DOI 10.1161/01.RES.0000100068.43006.36; BENHAM CD, 1986, J PHYSIOL-LONDON, V381, P385, DOI 10.1113/jphysiol.1986.sp016333; Bjarnegard N, 2009, DIABETES VASC DIS RE, V6, P25, DOI 10.3132/dvdr.2009.005; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Bruno RM, 2013, DIABETOLOGIA, V56, P2107, DOI 10.1007/s00125-013-3008-8; Chai Q, 2013, CARDIOVASC RES, V100, P151, DOI 10.1093/cvr/cvt157; Chen SN, 2012, CIRC RES, V111, P907, DOI 10.1161/CIRCRESAHA.112.270207; Chen YQ, 2010, AM J NEPHROL, V32, P414, DOI 10.1159/000320131; Cox DH, 2000, J GEN PHYSIOL, V116, P411, DOI 10.1085/jgp.116.3.411; Dick GM, 2001, J BIOL CHEM, V276, P44835, DOI 10.1074/jbc.M106851200; Dunn KM, 2010, AM J PHYSIOL-CELL PH, V298, pC203, DOI 10.1152/ajpcell.00499.2009; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Fang J, 2006, DIABETES, V55, P768, DOI 10.2337/diabetes.55.03.06.db05-1196; Fernandez-Fernandez JM, 2004, J CLIN INVEST, V113, P1032, DOI 10.1172/JCI200420347; Fielitz J, 2007, J CLIN INVEST, V117, P2486, DOI 10.1172/JCI32827; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoshi T, 2013, P NATL ACAD SCI USA, V110, P4822, DOI 10.1073/pnas.1222003110; Jaggar JH, 1998, ACTA PHYSIOL SCAND, V164, P577; Kawano N, 2012, J ATHEROSCLER THROMB, V19, P276, DOI 10.5551/jat.10629; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Li HH, 2011, AM J PATHOL, V178, P1043, DOI 10.1016/j.ajpath.2010.11.049; Li M, 2013, J BIOL CHEM, V288, P3668, DOI 10.1074/jbc.M112.426585; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lorenzo O, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/652097; Lu T, 2005, J BIOL CHEM, V280, P19097, DOI 10.1074/jbc.M414065200; Lu T, 2001, J PHYSIOL-LONDON, V534, P651, DOI 10.1111/j.1469-7793.2001.t01-1-00651.x; Lu T, 2008, BIOPHYS J, V95, P5165, DOI 10.1529/biophysj.108.138339; Lu T, 2012, DIABETES, V61, P1860, DOI 10.2337/db11-1658; Lu T, 2010, CIRC RES, V106, P1164, DOI 10.1161/CIRCRESAHA.109.209767; Mariappan N, 2010, CARDIOVASC RES, V85, P473, DOI 10.1093/cvr/cvp305; McElhinny AS, 2002, J CELL BIOL, V157, P125, DOI 10.1083/jcb.200108089; McGahon MK, 2007, CIRC RES, V100, P703, DOI 10.1161/01.RES.0000260182.36481.c9; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Meera P, 1996, FEBS LETT, V385, P127; Mori A, 2011, BIOL PHARM BULL, V34, P150, DOI 10.1248/bpb.34.150; Mrosek M, 2008, BIOCHEMISTRY-US, V47, P10722, DOI 10.1021/bi800733z; Nagar D, 2005, AM J PHYSIOL-HEART C, V289, pH1417, DOI 10.1152/ajpheart.01174.2004; Navedo MF, 2010, AM J PHYSIOL-CELL PH, V298, pC211, DOI 10.1152/ajpcell.00267.2009; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Nieves-Cintron M, 2007, J BIOL CHEM, V282, P3231, DOI 10.1074/jbc.M608822200; Norhammar A, 2007, HEART, V93, P1577, DOI 10.1136/hrt.2006.097956; Popov Doina, 2008, Archives of Physiology and Biochemistry, V114, P150, DOI [10.1080/13813450802033990, 10.1080/13813450802033990 ]; Powell SR, 2006, AM J PHYSIOL-HEART C, V291, pH1, DOI 10.1152/ajpheart.00062.2006; Rueda A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053321; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Searls YM, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-8; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Velmurugan GV, 2012, AM J PHYSIOL-HEART C, V302, pH124, DOI 10.1152/ajpheart.00218.2011; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Wan E, 2013, FASEB J, V27, P1859, DOI 10.1096/fj.12-223511; Wang RX, 2012, CHINESE MED J-PEKING, V125, P2548, DOI 10.3760/cma.j.issn.0366-6999.2012.14.028; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Werner ME, 2005, J PHYSIOL-LONDON, V567, P545, DOI 10.1113/jphysiol.2005.093823; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32; Willis MS, 2009, CIRC RES, V105, P80, DOI 10.1161/CIRCRESAHA.109.194928; Wojcik C, 2003, INT J BIOCHEM CELL B, V35, P579, DOI 10.1016/S1357-2725(02)00380-1; Xia XM, 1999, J NEUROSCI, V19, P5255, DOI 10.1523/jneurosci.19-13-05255.1999; Yang Y, 2013, HYPERTENSION, V61, P519, DOI 10.1161/HYPERTENSIONAHA.111.00211; Zhang DM, 2010, CIRC RES, V107, P1454, DOI 10.1161/CIRCRESAHA.110.228361	64	29	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10853	10864		10.1074/jbc.M113.520940	http://dx.doi.org/10.1074/jbc.M113.520940			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24570002	hybrid, Green Published			2022-12-28	WOS:000334226400053
J	Du, JB; Huang, YQ; Yan, H; Zhang, QL; Zhao, MM; Zhu, MZ; Liu, J; Chen, SX; Bu, DF; Tang, CS; Jin, HF				Du, Junbao; Huang, Yaqian; Yan, Hui; Zhang, Qiaoli; Zhao, Manman; Zhu, Mingzhu; Liu, Jia; Chen, Stella X.; Bu, Dingfang; Tang, Chaoshu; Jin, Hongfang			Hydrogen Sulfide Suppresses Oxidized Low-density Lipoprotein (Ox-LDL)-stimulated Monocyte Chemoattractant Protein 1 generation from Macrophages via the Nuclear Factor kB ( NF- kB) Pathway*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hydrogen Sulfide; Inflammation; Macrophages; NF-B; Sulfhydryl	FACTOR-KAPPA-B; HUMAN ENDOTHELIAL-CELLS; GENE-EXPRESSION; ALPHA KINASE; ACTIVATION; MCP-1; INDUCTION; CYSTEINE; GASOTRANSMITTER; P65/NF-KAPPA-B	Background: The mechanisms by which H2S regulates inflammation remain unclear. Results: H2S inhibits NF-B p65 phosphorylation, nuclear translocation, DNA binding activity, and recruitment to MCP-1 promoter in ox-LDL-treated macrophages by targeting the free sulfhydryl group on cysteine 38 in p65. Conclusion: H2S inhibits macrophage inflammation by suppressing NF-B activation. Significance: These findings reveal mechanisms for regulation of NF-B pathway by H2S. This study was designed to examine the role of hydrogen sulfide (H2S) in the generation of oxidized low-density lipoprotein (ox-LDL)-stimulated monocyte chemoattractant protein 1 (MCP-1) from macrophages and possible mechanisms. THP-1 cells and RAW macrophages were pretreated with sodium hydrosulfide (NaHS) and hexyl acrylate and then treated with ox-LDL. The results showed that ox-LDL treatment down-regulated the H2S/cystathionine--synthase pathway, with increased MCP-1 protein and mRNA expression in both THP-1 cells and RAW macrophages. Hexyl acrylate promoted ox-LDL-induced inflammation, whereas the H2S donor NaHS inhibited it. NaHS markedly suppressed NF-B p65 phosphorylation, nuclear translocation, DNA binding activity, and recruitment to the MCP-1 promoter in ox-LDL-treated macrophages. Furthermore, NaHS decreased the ratio of free thiol groups in p65, whereas the thiol reductant DTT reversed the inhibiting effect of H2S on the p65 DNA binding activity. Most importantly, site-specific mutation of cysteine 38 to serine in p65 abolished the effect of H2S on the sulfhydration of NF-B and ox-LDL-induced NF-B activation. These results suggested that endogenous H2S inhibited ox-LDL-induced macrophage inflammation by suppressing NF-B p65 phosphorylation, nuclear translocation, DNA binding activity, and recruitment to the MCP-1 promoter. The sulfhydration of free thiol group on cysteine 38 in p65 served as a molecular mechanism by which H2S inhibited NF-B pathway activation in ox-LDL-induced macrophage inflammation.	[Du, Junbao; Huang, Yaqian; Yan, Hui; Zhang, Qiaoli; Zhao, Manman; Zhu, Mingzhu; Liu, Jia; Jin, Hongfang] Peking Univ, Dept Pediat, Hosp 1, Beijing 100034, Peoples R China; [Bu, Dingfang] Peking Univ, Hosp 1, Cent Lab, Beijing 100034, Peoples R China; [Chen, Stella X.] Univ Calif San Diego, Dept Biochem & Cellular Biol, La Jolla, CA 92092 USA; [Tang, Chaoshu] Minist Educ, Key Lab Mol Cardiol, Beijing 100191, Peoples R China; [Tang, Chaoshu] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100191, Peoples R China	Peking University; Peking University; University of California System; University of California San Diego; Peking University	Jin, HF (corresponding author), Peking Univ, Dept Pediat, Hosp 1, Xi An Men Str 1, Beijing 100034, Peoples R China.	jinhongfang51@126.com		Jin, Hongfang/0000-0002-1606-8988	Major Basic Research Development Program of People's Republic of China [2011CB503904, 2012CB517806, 2013CB933801]; National Natural Science Foundation of China [30901620, 31130030, 30821001]; Beijing Natural Science Foundation [7122184, 7121014]	Major Basic Research Development Program of People's Republic of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by Major Basic Research Development Program of People's Republic of China Grants 2011CB503904, 2012CB517806, and 2013CB933801; by National Natural Science Foundation of China Grants 30901620, 31130030, and 30821001; and by Beijing Natural Science Foundation Grants 7122184 and 7121014.	AUWERX J, 1991, EXPERIENTIA, V47, P22, DOI 10.1007/BF02041244; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; BARNA BP, 1994, J NEUROIMMUNOL, V50, P101, DOI 10.1016/0165-5728(94)90220-8; Baskar R, 2011, EUR J PHARMACOL, V656, P5, DOI 10.1016/j.ejphar.2011.01.052; BROWN Z, 1992, KIDNEY INT, V42, P95, DOI 10.1038/ki.1992.266; Chen BF, 2013, ANALYST, V138, P946, DOI 10.1039/c2an36113b; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; CUSHING SD, 1990, P NATL ACAD SCI USA, V87, P5134, DOI 10.1073/pnas.87.13.5134; Du JB, 2006, CURR HYPERTENS REV, V2, P123, DOI 10.2174/157340206776877307; Freter RR, 1996, J BIOL CHEM, V271, P17417, DOI 10.1074/jbc.271.29.17417; Fruebis J, 1997, ARTERIOSCL THROM VAS, V17, P1289, DOI 10.1161/01.ATV.17.7.1289; Garcia-Pineres AJ, 2004, LIFE SCI, V75, P841, DOI 10.1016/j.lfs.2004.01.024; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Gong JH, 1997, J EXP MED, V186, P131, DOI 10.1084/jem.186.1.131; Ha HJ, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134894; Han YS, 2005, J PHARMACOL EXP THER, V312, P1097, DOI 10.1124/jpet.104.079707; Huang TT, 2001, MOL CELL BIOL, V21, P4737, DOI 10.1128/MCB.21.14.4737-4747.2001; Kelleher ZT, 2007, J BIOL CHEM, V282, P30667, DOI 10.1074/jbc.M705929200; Kimura H, 2014, ANTIOXID REDOX SIGN, V20, P783, DOI 10.1089/ars.2013.5309; Lefer DJ, 2007, P NATL ACAD SCI USA, V104, P17907, DOI 10.1073/pnas.0709010104; Li L, 2011, ANNU REV PHARMACOL, V51, P169, DOI 10.1146/annurev-pharmtox-010510-100505; Li L, 2009, FREE RADICAL BIO MED, V47, P103, DOI 10.1016/j.freeradbiomed.2009.04.014; Li TS, 2008, EXP BIOL MED, V233, P1081, DOI 10.3181/0712-RM-354; Li W, 2011, ATHEROSCLEROSIS, V215, P323, DOI 10.1016/j.atherosclerosis.2010.12.037; Liu YH, 2012, ANTIOXID REDOX SIGN, V17, P141, DOI 10.1089/ars.2011.4005; Liu Z, 2013, BRIT J PHARMACOL, V169, P1795, DOI 10.1111/bph.12246; Martin T, 1997, EUR J IMMUNOL, V27, P1091, DOI 10.1002/eji.1830270508; Marumo T, 1999, DIABETES, V48, P1131, DOI 10.2337/diabetes.48.5.1131; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Namekata K, 2004, J BIOL CHEM, V279, P52961, DOI 10.1074/jbc.M406820200; Olson KR, 2009, BBA-BIOENERGETICS, V1787, P856, DOI 10.1016/j.bbabio.2009.03.019; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sandur SK, 2006, J BIOL CHEM, V281, P17023, DOI 10.1074/jbc.M601595200; Sen N, 2012, MOL CELL, V45, P13, DOI 10.1016/j.molcel.2011.10.021; Shibuya Norihiro, 2013, Front Endocrinol (Lausanne), V4, P87, DOI 10.3389/fendo.2013.00087; Shibuya N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2371; Shioi A, 2002, CIRC RES, V91, P9, DOI 10.1161/01.RES.0000026421.61398.F2; SMITH RP, 1966, TOXICOL APPL PHARM, V9, P209, DOI 10.1016/0041-008X(66)90115-3; STANDIFORD TJ, 1991, J BIOL CHEM, V266, P9912; Tang Chaoshu, 2006, Current Vascular Pharmacology, V4, P17; UEDA A, 1994, J IMMUNOL, V153, P2052; Wang R, 2002, FASEB J, V16, P1792, DOI 10.1096/fj.02-0211hyp; Wang YF, 2009, ARTERIOSCL THROM VAS, V29, P173, DOI 10.1161/ATVBAHA.108.179333; Whiteman M, 2010, ANTIOXID REDOX SIGN, V12, P1147, DOI 10.1089/ars.2009.2899; Yadav VR, 2012, J BIOL CHEM, V287, P245, DOI 10.1074/jbc.M111.274613; YOSHIMURA T, 1989, FEBS LETT, V244, P487, DOI 10.1016/0014-5793(89)80590-3; YOSHIMURA T, 1989, J IMMUNOL, V142, P1956; Zhang RY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037073; Zhao ZZ, 2011, EXP BIOL MED, V236, P169, DOI 10.1258/ebm.2010.010308	50	98	106	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9741	9753		10.1074/jbc.M113.517995	http://dx.doi.org/10.1074/jbc.M113.517995			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24550391	hybrid, Green Published			2022-12-28	WOS:000333807000026
J	Donigan, KA; McLenigan, MP; Yang, W; Goodman, MF; Woodgate, R				Donigan, Katherine A.; McLenigan, Mary P.; Yang, Wei; Goodman, Myron F.; Woodgate, Roger			The Steric Gate of DNA Polymerase iota Regulates Ribonucleotide Incorporation and Deoxyribonucleotide Fidelity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding Protein; DNA Repair; DNA Synthesis; Enzyme Kinetics; Mutagenesis; DNA Polymerase Iota; Ribonucleotide Incorporation; Steric Gate Mutant; Y Family DNA Polymerase	ACTIVE-SITE; Y-FAMILY; REPLICATION; INSERTION; BYPASS; ETA; DISCRIMINATION; OPPOSITE; VARIANT; LESION	Background: Accurate bypass of DNA damage by translesion DNA polymerases is critical for cell survival. Results: Wild-type human DNA polymerase incorporates ribonucleotides, and a steric gate mutant increases both ribonucleotide incorporation and deoxyribonucleotide selectivity. Conclusion: A single amino acid residue in DNA polymerase limits incorporation of ribonucleotides into DNA. Significance: DNA polymerase may incorporate ribonucleotides during translesion DNA synthesis. Accurate DNA synthesis in vivo depends on the ability of DNA polymerases to select dNTPs from a nucleotide pool dominated by NTPs. High fidelity replicative polymerases have evolved to efficiently exclude NTPs while copying long stretches of undamaged DNA. However, to bypass DNA damage, cells utilize specialized low fidelity polymerases to perform translesion DNA synthesis (TLS). Of interest is human DNA polymerase (pol ), which has been implicated in TLS of oxidative and UV-induced lesions. Here, we evaluate the ability of pol to incorporate NTPs during DNA synthesis. pol incorporates and extends NTPs opposite damaged and undamaged template bases in a template-specific manner. The Y39A steric gate pol mutant is considerably more active in the presence of Mn2+ compared with Mg2+ and exhibits a marked increase in NTP incorporation and extension, and surprisingly, it also exhibits increased dNTP base selectivity. Our results indicate that a single residue in pol is able to discriminate between NTPs and dNTPs during DNA synthesis. Because wild-type pol incorporates NTPs in a template-specific manner, certain DNA sequences may be at risk for elevated mutagenesis during pol -dependent TLS. Molecular modeling indicates that the constricted active site of wild-type pol becomes more spacious in the Y39A variant. Therefore, the Y39A substitution not only permits incorporation of ribonucleotides but also causes the enzyme to favor faithful Watson-Crick base pairing over mutagenic configurations.	[Donigan, Katherine A.; McLenigan, Mary P.; Woodgate, Roger] NICHD, Lab Genom Integr, NIH, Bethesda, MD 20892 USA; [Yang, Wei] NICHD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Goodman, Myron F.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Goodman, Myron F.] Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Southern California; University of Southern California	Woodgate, R (corresponding author), NICHD, Lab Genom Integr, NIH, Bethesda, MD 20892 USA.	woodgate@nih.gov	Yang, Wei/ABB-4785-2020; Yang, Wei/D-4926-2011	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195; Woodgate, Roger/0000-0001-5581-4616	National Institutes of Health [GM21422, ESO12259]; NICHD, National Institutes of Health Intramural Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001500] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD, National Institutes of Health Intramural Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grants GM21422 and ESO12259 (to M. F. G.). This work was also supported by funds from the NICHD, National Institutes of Health Intramural Research Program (to R. W.) and the NICHD, National Institutes of Health Intramural Research Program (to W. Y.).	Bebenek K, 2001, SCIENCE, V291, P2156, DOI 10.1126/science.1058386; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; Brown JA, 2011, BIOCHEMISTRY-US, V50, P1135, DOI 10.1021/bi101915z; Cavanaugh NA, 2010, J BIOL CHEM, V285, P24457, DOI 10.1074/jbc.M110.132407; Dalal S, 2008, NUCLEIC ACIDS RES, V36, P411, DOI 10.1093/nar/gkm1053; DeLucia AM, 2006, J BIOL CHEM, V281, P27286, DOI 10.1074/jbc.M604393200; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Frank EG, 2007, J BIOL CHEM, V282, P24689, DOI 10.1074/jbc.M702159200; Frank EG, 2012, ANAL BIOCHEM, V429, P132, DOI 10.1016/j.ab.2012.07.016; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Ghodgaonkar MM, 2013, MOL CELL, V50, P323, DOI 10.1016/j.molcel.2013.03.019; Jain R, 2009, STRUCTURE, V17, P974, DOI 10.1016/j.str.2009.04.011; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Kannouche P, 2002, EMBO J, V21, P6246, DOI 10.1093/emboj/cdf618; Kirouac KN, 2011, P NATL ACAD SCI USA, V108, P3210, DOI 10.1073/pnas.1013909108; Kirouac KN, 2009, EMBO J, V28, P1644, DOI 10.1038/emboj.2009.122; KUNKEL TA, 1984, P NATL ACAD SCI-BIOL, V81, P1494, DOI 10.1073/pnas.81.5.1494; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Lujan SA, 2013, MOL CELL, V50, P437, DOI 10.1016/j.molcel.2013.03.017; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; McIntyre J, 2013, NUCLEIC ACIDS RES, V41, P1649, DOI 10.1093/nar/gks1277; MENDELMAN LV, 1989, J BIOL CHEM, V264, P14415; Murphy DL, 2008, BIOCHEMISTRY-US, V47, P8048, DOI 10.1021/bi702104y; Nair Deepak T, 2006, Nat Struct Mol Biol, V13, P619, DOI 10.1038/nsmb1118; Nair DT, 2009, STRUCTURE, V17, P530, DOI 10.1016/j.str.2009.02.015; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; Pence MG, 2009, J BIOL CHEM, V284, P1732, DOI 10.1074/jbc.M807296200; Petta TB, 2008, EMBO J, V27, P2883, DOI 10.1038/emboj.2008.210; Prasad R, 2003, J BIOL CHEM, V278, P29649, DOI 10.1074/jbc.M305399200; RANDALL SK, 1987, J BIOL CHEM, V262, P6864; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; SCHAAPER RM, 1983, P NATL ACAD SCI-BIOL, V80, P487, DOI 10.1073/pnas.80.2.487; Shurtleff BW, 2009, J BACTERIOL, V191, P4815, DOI 10.1128/JB.01742-08; Sparks JL, 2012, MOL CELL, V47, P980, DOI 10.1016/j.molcel.2012.06.035; STRAUSS BS, 1991, BIOESSAYS, V13, P79, DOI 10.1002/bies.950130206; Tissier A, 2000, GENE DEV, V14, P1642; Tissier A, 2000, EMBO J, V19, P5259, DOI 10.1093/emboj/19.19.5259; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vaisman A, 2004, ADV PROTEIN CHEM, V69, P205; Vaisman A, 2012, NUCLEIC ACIDS RES, V40, P6144, DOI 10.1093/nar/gks233; Wang Y, 2007, CANCER RES, V67, P3018, DOI 10.1158/0008-5472.CAN-06-3073; Washington MT, 2004, MOL CELL BIOL, V24, P936, DOI 10.1128/MCB.24.2.936-943.2004	44	31	31	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9136	9145		10.1074/jbc.M113.545442	http://dx.doi.org/10.1074/jbc.M113.545442			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24532793	Green Published, hybrid			2022-12-28	WOS:000333472100033
J	Hernandez-Ortega, A; Quesne, MG; Bui, S; Heuts, DPHM; Steiner, RA; Heyes, DJ; de Visser, SP; Scrutton, NS				Hernandez-Ortega, Aitor; Quesne, Matthew G.; Bui, Soi; Heuts, Dominic P. H. M.; Steiner, Roberto A.; Heyes, Derren J.; de Visser, Sam P.; Scrutton, Nigel S.			Origin of the Proton-transfer Step in the Cofactor-free (1H)-3-Hydroxy-4-oxoquinaldine 2,4-Dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Kinetics; Enzyme Mechanisms; Isotope Effects; Molecular Dynamics; Site-directed Mutagenesis; DFT Calculations; Quantum Mechanics; Molecular Mechanics	ALPHA/BETA-HYDROLASE-FOLD; GENERAL BASE CATALYSIS; 1H-3-HYDROXY-4-OXOQUINALDINE 2,4-DIOXYGENASE; TRIMETHYLAMINE DEHYDROGENASE; INDEPENDENT DIOXYGENATION; ELECTRON OXIDATION; STRUCTURAL BASIS; RING-CLEAVAGE; ACTIVE-SITE; ENZYMES	Background: The mechanism of cofactor-free dioxygenases has not been clearly elucidated. Results: Mutation of the His/Asp dyad in (1H)-3-hydroxy-4-oxoquinaldine 2,4-dioxygenase strongly affects substrate deprotonation and overall catalysis. Conclusion: Base mechanism is demonstrated where His-251 acts as catalytic base and Asp-126 modulates basicity. Significance: Many dioxygenases activate their substrates via deprotonation, which is an essential step for later reaction with oxygen. Dioxygenases catalyze a diverse range of chemical reactions that involve the incorporation of oxygen into a substrate and typically use a transition metal or organic cofactor for reaction. Bacterial (1H)-3-hydroxy-4-oxoquinaldine 2,4-dioxygenase (HOD) belongs to a class of oxygenases able to catalyze this energetically unfavorable reaction without any cofactor. In the quinaldine metabolic pathway, HOD breaks down its natural N-heteroaromatic substrate using a mechanism that is still incompletely understood. Experimental and computational approaches were combined to study the initial step of the catalytic cycle. We have investigated the role of the active site His-251/Asp-126 dyad, proposed to be involved in substrate hydroxyl group deprotonation, a critical requirement for subsequent oxygen reaction. The pH profiles obtained under steady-state conditions for the H251A and D126A variants show a strong pH effect on their k(cat) and k(cat)/K-m constants, with a decrease in k(cat)/K-m of 5500- and 9-fold at pH 10.5, respectively. Substrate deprotonation studies under transient-state conditions show that this step is not rate-limiting and yield a pK(a) value of approximate to 7.2 for WT HOD. A large solvent isotope effect was found, and the pK(a) value was shifted to approximate to 8.3 in D2O. Crystallographic and computational studies reveal that the mutations have a minor effect on substrate positioning. Computational work shows that both His-251 and Asp-126 are essential for the proton transfer driving force of the initial reaction. This multidisciplinary study offers unambiguous support to the view that substrate deprotonation, driven by the His/Asp dyad, is an essential requirement for its activation.	[Heyes, Derren J.; de Visser, Sam P.; Scrutton, Nigel S.] Univ Manchester, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England; [Bui, Soi; Steiner, Roberto A.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England	University of Manchester; University of London; King's College London	Steiner, RA (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England.	roberto.steiner@kcl.ac.uk; sam.devisser@manchester.ac.uk; nigel.scrutton@manchester.ac.uk	Steiner, Roberto/AAZ-9582-2021; de Visser, Samuel P/A-6960-2008; Quesne, Matthew/AAI-4136-2020; Quesne, Matthew/I-4938-2015; Scrutton, Nigel/B-7352-2017	Steiner, Roberto/0000-0001-7084-9745; de Visser, Samuel P/0000-0002-2620-8788; Quesne, Matthew/0000-0001-5130-1266; Heyes, Derren/0000-0002-7453-1571; Scrutton, Nigel/0000-0002-4182-3500	United Kingdom Biotechnology and Biological Sciences Research Council [BB/I020411/1, BB/I020543/1]; BBSRC [BB/I020543/1, BB/I020411/1] Funding Source: UKRI; EPSRC [EP/J020192/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I020411/1, BB/I020543/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J020192/1] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by United Kingdom Biotechnology and Biological Sciences Research Council Grants BB/I020411/1 (to R. A. S.), BB/I020543/1 (to N. S. S. and S. P. dV.), and a studentship (to M. G. Q.).	AHLRICHS R, 1989, CHEM PHYS LETT, V162, P165, DOI 10.1016/0009-2614(89)85118-8; Basran J, 2001, J BIOL CHEM, V276, P42887, DOI 10.1074/jbc.M108296200; Basran J, 2001, J BIOL CHEM, V276, P24581, DOI 10.1074/jbc.M101178200; Bauer I, 1996, EUR J BIOCHEM, V240, P576, DOI 10.1111/j.1432-1033.1996.0576h.x; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bugg TDH, 2001, CURR OPIN CHEM BIOL, V5, P550, DOI 10.1016/S1367-5931(00)00236-2; Bugg TDH, 2008, CURR OPIN CHEM BIOL, V12, P134, DOI 10.1016/j.cbpa.2007.12.007; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fetzner S, 2007, NAT CHEM BIOL, V3, P374, DOI 10.1038/nchembio0707-374; Fetzner S, 2010, APPL MICROBIOL BIOT, V86, P791, DOI 10.1007/s00253-010-2455-0; FIFE TH, 1961, J PHYS CHEM-US, V65, P1079, DOI 10.1021/j100824a525; Fischer F, 1999, J BACTERIOL, V181, P5725, DOI 10.1128/JB.181.18.5725-5733.1999; Fischer F, 2000, FEMS MICROBIOL LETT, V190, P21, DOI 10.1111/j.1574-6968.2000.tb09256.x; Frerichs-Deeken U, 2004, BIOCHEMISTRY-US, V43, P14485, DOI 10.1021/bi048735u; Frerichs-Deeken U, 2005, CURR MICROBIOL, V51, P344, DOI 10.1007/s00284-005-0065-3; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Furukawa K, 2000, CURR OPIN BIOTECH, V11, P244, DOI 10.1016/S0958-1669(00)00091-4; Ghanem M, 2005, BIOCHEMISTRY-US, V44, P893, DOI 10.1021/bi048056j; Gibson DT, 2000, CURR OPIN BIOTECH, V11, P236, DOI 10.1016/S0958-1669(00)00090-2; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Imhoff RD, 2003, BIOCHEMISTRY-US, V42, P4094, DOI 10.1021/bi027377x; Johnson K. A., 1992, ENZYMES, P61; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katz JB, 2008, IMMUNOL REV, V222, P206, DOI 10.1111/j.1600-065X.2008.00610.x; Kumar D, 2011, J AM CHEM SOC, V133, P3869, DOI 10.1021/ja107514f; Li JJ, 2007, ORG BIOMOL CHEM, V5, P507, DOI 10.1039/b615605c; Loening AM, 2007, J MOL BIOL, V374, P1017, DOI 10.1016/j.jmb.2007.09.078; Rebollar-Zepeda AM, 2011, J CHEM THEORY COMPUT, V7, P2528, DOI 10.1021/ct2001864; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Prescott AG, 1996, ANNU REV PLANT PHYS, V47, P245, DOI 10.1146/annurev.arplant.47.1.245; Prokop KA, 2011, J AM CHEM SOC, V133, P15874, DOI 10.1021/ja2066237; Quesne MG, 2014, CHEM-EUR J, V20, P435, DOI 10.1002/chem.201303282; Ratcliffe PJ, 2013, J PHYSIOL-LONDON, V591, P2027, DOI 10.1113/jphysiol.2013.251470; Smith W, 2002, MOL SIMULAT, V28, P385, DOI 10.1080/08927020290018769; Steiner RA, 2003, ACTA CRYSTALLOGR D, V59, P2114, DOI 10.1107/S0907444903018675; Steiner RA, 2002, P NATL ACAD SCI USA, V99, P16625, DOI 10.1073/pnas.262506299; Steiner RA, 2007, ACTA CRYSTALLOGR F, V63, P382, DOI 10.1107/S174430910701353X; Steiner RA, 2010, P NATL ACAD SCI USA, V107, P657, DOI 10.1073/pnas.0909033107; Steinmuller R., 2013, Ernahrungs Umschau Supplements, P1; Stipanuk MH, 2004, NEUROCHEM RES, V29, P105, DOI 10.1023/B:NERE.0000010438.40376.c9; Thierbach S., 2014, CHEM BIOL, V20, P1; Uderhardt S, 2012, J MOL MED, V90, P1247, DOI 10.1007/s00109-012-0954-4; Vardhaman AK, 2011, CHEM COMMUN, V47, P11044, DOI 10.1039/c1cc13775a; von Lintig J, 2012, AM J CLIN NUTR, V96, p1234S, DOI 10.3945/ajcn.112.034629; WARSHEL A, 1989, BIOCHEMISTRY-US, V28, P3629, DOI 10.1021/bi00435a001; Widboom PF, 2007, NATURE, V447, P342, DOI 10.1038/nature05702; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Woo JC, 2008, PROTEIN SCI, V17, P725, DOI 10.1110/ps.073355508; YAGIL G, 1967, TETRAHEDRON, V23, P2855, DOI 10.1016/0040-4020(67)85151-2; Zuegg J, 1999, PROTEIN SCI, V8, P1990, DOI 10.1110/ps.8.10.1990	56	25	26	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8620	8632		10.1074/jbc.M113.543033	http://dx.doi.org/10.1074/jbc.M113.543033			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24482238	Green Published, hybrid			2022-12-28	WOS:000333157500052
J	Da-Re, C; Franzolin, E; Biscontin, A; Piazzesi, A; Pacchioni, B; Gagliani, MC; Mazzotta, G; Tacchetti, C; Zordan, MA; Zeviani, M; Bernardi, P; Bianchi, V; De Pitta, C; Costa, R				Da-Re, Caterina; Franzolin, Elisa; Biscontin, Alberto; Piazzesi, Antonia; Pacchioni, Beniamina; Gagliani, Maria Cristina; Mazzotta, Gabriella; Tacchetti, Carlo; Zordan, Mauro A.; Zeviani, Massimo; Bernardi, Paolo; Bianchi, Vera; De Pitta, Cristiano; Costa, Rodolfo			Functional Characterization of drim2, the Drosophila melanogaster Homolog of the Yeast Mitochondrial Deoxynucleotide Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Drosophila; Mitochondria; Mitochondrial DNA; Mitochondrial Transport; Nucleotide	PYRIMIDINE NUCLEOTIDE CARRIER; THYMIDYLATE BIOSYNTHESIS PATHWAY; CULTURED HUMAN-CELLS; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; NERVOUS-SYSTEM; DNA; IDENTIFICATION; REPLICATION; TRIPHOSPHATES	Background: Carrier-mediated influx of cytosolic deoxynucleotides is a major source of precursors for mitochondrial DNA synthesis. Results: dRIM2 is required to maintain normal deoxynucleotide pools in Drosophila mitochondria, and its knock-out is lethal at the larval stage. Conclusion: dRIM2 is a deoxynucleotide carrier and is essential to maintain mitochondrial function. Significance: Our data provide the first animal model of RIM2 deficiency. The CG18317 gene (drim2) is the Drosophila melanogaster homolog of the Saccharomyces cerevisiae Rim2 gene, which encodes a pyrimidine (deoxy)nucleotide carrier. Here, we tested if the drim2 gene also encodes for a deoxynucleotide transporter in the fruit fly. The protein was localized to mitochondria. Drosophila S2R(+) cells, silenced for drim2 expression, contained markedly reduced pools of both purine and pyrimidine dNTPs in mitochondria, whereas cytosolic pools were unaffected. In vivo drim2 homozygous knock-out was lethal at the larval stage, preceded by the following: (i) impaired locomotor behavior; (ii) decreased rates of oxygen consumption, and (iii) depletion of mtDNA. We conclude that the Drosophila mitochondrial carrier dRIM2 transports all DNA precursors and is essential to maintain mitochondrial function.	[Da-Re, Caterina; Franzolin, Elisa; Biscontin, Alberto; Piazzesi, Antonia; Mazzotta, Gabriella; Zordan, Mauro A.; Bianchi, Vera; De Pitta, Cristiano; Costa, Rodolfo] Univ Padua, Dept Biol, I-35131 Padua, Italy; [Pacchioni, Beniamina] Univ Padua, CRIBI Biotechnol Ctr, I-35131 Padua, Italy; [Gagliani, Maria Cristina; Tacchetti, Carlo] Univ Genoa, Dept Expt Med, MicroScoBio Res Ctr, I-16132 Genoa, Italy; [Zeviani, Massimo] Univ Cambridge, MRC Mitocondrial Biol Unit, Cambridge CB2 0XY, England; [Bernardi, Paolo] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy; [Tacchetti, Carlo] Ist Sci San Raffaele, Expt Imaging Ctr, I-20132 Milan, Italy	University of Padua; University of Padua; University of Genoa; University of Cambridge; University of Padua; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	De Pitta, C (corresponding author), Univ Padua, Dept Biol, Viale Giuseppe Colombo 3, I-35121 Padua, Italy.	cristiano.depitta@unipd.it; rodolfo.costa@unipd.it	De Pitta, Cristiano/AAY-7302-2020; Zeviani, Massimo/K-2891-2014; Zeviani, Massimo/AAU-2632-2021; Bernardi, Paolo/C-3656-2008; Piazzesi, Antonia/AAA-7971-2022	De Pitta, Cristiano/0000-0001-8013-8162; Zeviani, Massimo/0000-0002-9067-5508; Bernardi, Paolo/0000-0001-9187-3736; Piazzesi, Antonia/0000-0002-7591-6473; MAZZOTTA, GABRIELLA MARGHERITA/0000-0001-5461-6837; TACCHETTI, CARLO/0000-0003-4602-000X; gagliani, maria cristina/0000-0002-2902-2719; Biscontin, Alberto/0000-0003-1492-7715	University of Padova Progetto Strategico di Ateneo; Fondazione CARIPLO-Scientific Research in Biomedicine; Telethon Project [GGP11011]; Italian Telethon [GGP09019]; Italian Association for Cancer Research [1091, 12035]; Fondazione Compagnia di San Paolo; Telethon Program [GPP10005]; MRC [MC_UP_1002/1] Funding Source: UKRI; Medical Research Council [MC_UP_1002/1] Funding Source: researchfish	University of Padova Progetto Strategico di Ateneo; Fondazione CARIPLO-Scientific Research in Biomedicine; Telethon Project(Fondazione Telethon); Italian Telethon(Fondazione Telethon); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Fondazione Compagnia di San Paolo(Compagnia di San Paolo); Telethon Program(Fondazione Telethon); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the University of Padova Progetto Strategico di Ateneo, 2008 ("Models of Mitochondrial Diseases") (to P. B., V. B., and R. C.), Fondazione CARIPLO-Scientific Research in Biomedicine 2011 ("MITGEN, Definition and Characterization of Disease Genes in Mitochondrial Disorders") (to M. Z. and R. C.), Telethon Project GGP11011 ("MitMed, A Multicenter Consortium for the Identification and Characterization of Nuclear Genes Responsible for Human Mitochondrial Disorders") (to M. Z. and R. C.), Italian Telethon Grant GGP09019 (to V. B.), Italian Association for Cancer Research Grant 1091 (to V. B.), Italian Association for Cancer Research Grant 12035 (to C. T.), Fondazione Compagnia di San Paolo (to C. T.), and Telethon Program Project N. GPP10005 "Therapeutic Strategies to Combat Mitochondrial Disorders" (to M. Z. and P. B.).	Anderson DD, 2011, P NATL ACAD SCI USA, V108, P15163, DOI 10.1073/pnas.1103623108; Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006; BIANCHI V, 1990, TOXICOL IN VITRO, V4, P9, DOI 10.1016/0887-2333(90)90003-C; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chabi B, 2003, CLIN CHEM, V49, P1309, DOI 10.1373/49.8.1309; del Arco A, 2005, CELL MOL LIFE SCI, V62, P2204, DOI 10.1007/s00018-005-5197-x; Eriksson S, 2002, CELL MOL LIFE SCI, V59, P1327, DOI 10.1007/s00018-002-8511-x; Favre C, 2010, ONCOGENE, V29, P3964, DOI 10.1038/onc.2010.146; Ferraro P, 2005, J BIOL CHEM, V280, P24472, DOI 10.1074/jbc.M502869200; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Flockhart IT, 2012, NUCLEIC ACIDS RES, V40, pD715, DOI 10.1093/nar/gkr953; Floyd S, 2007, MOL BIOL CELL, V18, P3545, DOI 10.1091/mbc.e06-12-1109; Franzolin E, 2012, EXP CELL RES, V318, P2226, DOI 10.1016/j.yexcr.2012.05.028; Froschauer EM, 2013, BIOCHEM J, V455, P57, DOI 10.1042/BJ20130144; Ghezzi D, 2011, NAT GENET, V43, P259, DOI 10.1038/ng.761; Haitina T, 2006, GENOMICS, V88, P779, DOI 10.1016/j.ygeno.2006.06.016; HAYWARD DC, 1993, P NATL ACAD SCI USA, V90, P2979, DOI 10.1073/pnas.90.7.2979; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iyengar B, 1999, GENETICS, V153, P1809; Kunji ERS, 2004, FEBS LETT, V564, P239, DOI 10.1016/S0014-5793(04)00242-X; Lin HL, 2011, J BIOL CHEM, V286, P3851, DOI 10.1074/jbc.M110.190959; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacFarlane AJ, 2011, J BIOL CHEM, V286, P44015, DOI 10.1074/jbc.M111.307629; Magnusson J, 2003, EXP CELL RES, V289, P133, DOI 10.1016/S0014-4827(03)00249-0; Marobbio CMT, 2006, BIOCHEM J, V393, P441, DOI 10.1042/BJ20051284; Mecleiros DM, 2008, METHODS, V46, P288, DOI 10.1016/j.ymeth.2008.09.026; Montier LLC, 2009, J GENET GENOMICS, V36, P125, DOI 10.1016/S1673-8527(08)60099-5; Munch-Petersen B, 1998, ADV EXP MED BIOL, V431, P465; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Oliveira MT, 2011, J BIOL CHEM, V286, P40649, DOI 10.1074/jbc.M111.289983; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Pontarin G, 2003, P NATL ACAD SCI USA, V100, P12159, DOI 10.1073/pnas.1635259100; Pontarin G, 2012, P NATL ACAD SCI USA, V109, P13302, DOI 10.1073/pnas.1211289109; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Rabouille C, 1999, METH MOL B, V117, P125; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; VANDYCK E, 1995, MOL GEN GENET, V246, P426, DOI 10.1007/BF00290446; von Stockum S, 2011, J BIOL CHEM, V286, P41163, DOI 10.1074/jbc.M111.268375; Vozza A, 2004, J BIOL CHEM, V279, P20850, DOI 10.1074/jbc.M313610200; Wenz T, 2013, MITOCHONDRION, V13, P134, DOI 10.1016/j.mito.2013.01.006; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yoon H, 2011, BIOCHEM J, V440, P137, DOI 10.1042/BJ20111036; Zordan MA, 2006, GENETICS, V172, P229, DOI 10.1534/genetics.105.049072	49	10	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7448	7459		10.1074/jbc.M113.543926	http://dx.doi.org/10.1074/jbc.M113.543926			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24469456	Green Published, hybrid			2022-12-28	WOS:000332761500016
J	Fritsch, J; Siebert, E; Priebe, J; Zebger, I; Lendzian, F; Teutloff, C; Friedrich, B; Lenz, O				Fritsch, Johannes; Siebert, Elisabeth; Priebe, Jacqueline; Zebger, Ingo; Lendzian, Friedhelm; Teutloff, Christian; Friedrich, Baerbel; Lenz, Oliver			Rubredoxin-related Maturation Factor Guarantees Metal Cofactor Integrity during Aerobic Biosynthesis of Membrane-bound [NiFe] Hydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Metabolism; Bioenergetics; Electron Transfer Complex; Biophysics; Electron Paramagnetic Resonance (EPR); Electron Transfer; Energy Metabolism; Enzyme Catalysis; Membrane Enzymes; Metalloproteins; Protein Chemistry	RALSTONIA-EUTROPHA H16; OXYGEN-TOLERANT HYDROGENASE; FE-S CLUSTERS; LOW-LEVEL H-2; ESCHERICHIA-COLI; ACTIVE-SITE; RHIZOBIUM-LEGUMINOSARUM; AQUIFEX-AEOLICUS; OXIDIZED STATES; 4FE-3S CLUSTER	Background: Biosynthesis of complex metal cofactors in [NiFe] hydrogenase is sensitive toward molecular oxygen. Results: A rubredoxin-like protein is required for hydrogenase maturation under aerobic conditions. Conclusion: The rubredoxin-like protein prevents oxidative damage of metallocenters, including the recently discovered [4Fe3S] center. Significance: Dedicated protection mechanisms enable biosynthesis of sophisticated metal centers in the presence of dioxygen. The membrane-bound [NiFe] hydrogenase (MBH) supports growth of Ralstonia eutropha H16 with H-2 as the sole energy source. The enzyme undergoes a complex biosynthesis process that proceeds during cell growth even at ambient O-2 levels and involves 14 specific maturation proteins. One of these is a rubredoxin-like protein, which is essential for biosynthesis of active MBH at high oxygen concentrations but dispensable under microaerobic growth conditions. To obtain insights into the function of HoxR, we investigated the MBH protein purified from the cytoplasmic membrane of hoxR mutant cells. Compared with wild-type MBH, the mutant enzyme displayed severely decreased hydrogenase activity. Electron paramagnetic resonance and infrared spectroscopic analyses revealed features resembling those of O-2-sensitive [NiFe] hydrogenases and/or oxidatively damaged protein. The catalytic center resided partially in an inactive Ni-u-A-like state, and the electron transfer chain consisting of three different Fe-S clusters showed marked alterations compared with wild-type enzyme. Purification of HoxR protein from its original host, R. eutropha, revealed only low protein amounts. Therefore, recombinant HoxR protein was isolated from Escherichia coli. Unlike common rubredoxins, the HoxR protein was colorless, rather unstable, and essentially metal-free. Conversion of the atypical iron-binding motif into a canonical one through genetic engineering led to a stable reddish rubredoxin. Remarkably, the modified HoxR protein did not support MBH-dependent growth at high O-2. Analysis of MBH-associated protein complexes points toward a specific interaction of HoxR with the Fe-S cluster-bearing small subunit. This supports the previously made notion that HoxR avoids oxidative damage of the metal centers of the MBH, in particular the unprecedented Cys(6)[4Fe-3S] cluster.	[Fritsch, Johannes; Friedrich, Baerbel; Lenz, Oliver] Humboldt Univ, Inst Biol Mikrobiol, D-10115 Berlin, Germany; [Siebert, Elisabeth; Priebe, Jacqueline; Zebger, Ingo; Lendzian, Friedhelm; Lenz, Oliver] Tech Univ Berlin, Inst Chem, Max Volmer Lab, D-10623 Berlin, Germany; [Teutloff, Christian] Free Univ Berlin, Inst Phys, D-14195 Berlin, Germany	Humboldt University of Berlin; Technical University of Berlin; Free University of Berlin	Lenz, O (corresponding author), Humboldt Univ, Inst Biol Mikrobiol, Chausseestr 117, D-10115 Berlin, Germany.	oliver.lenz@tu-berlin.de	Lenz, Oliver/C-1582-2019; Lenz, Oliver/N-5130-2019	Lenz, Oliver/0000-0003-4550-5128; Lenz, Oliver/0000-0003-4550-5128	European Union/Energy Network Project FP7 SOLAR-H2 Program [212508]; Deutsche Forschungsgemeinschaft through the Cluster of Excellence "Unifying Concepts in Catalysis"	European Union/Energy Network Project FP7 SOLAR-H2 Program; Deutsche Forschungsgemeinschaft through the Cluster of Excellence "Unifying Concepts in Catalysis"(German Research Foundation (DFG))	This work was supported by the European Union/Energy Network Project FP7 SOLAR-H2 Program Contract 212508 and by the Deutsche Forschungsgemeinschaft through the Cluster of Excellence "Unifying Concepts in Catalysis."	Albareda M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-256; ALBRACHT SPJ, 1994, BBA-BIOENERGETICS, V1188, P167, DOI 10.1016/0005-2728(94)90036-1; Bernhard M, 1997, EUR J BIOCHEM, V248, P179, DOI 10.1111/j.1432-1033.1997.00179.x; Bernhard M, 1996, J BACTERIOL, V178, P4522, DOI 10.1128/jb.178.15.4522-4529.1996; Bock A, 2006, ADV MICROB PHYSIOL, V51, P1, DOI 10.1016/S0065-2911(06)51001-X; Bonomi F, 1998, J BIOL INORG CHEM, V3, P595, DOI 10.1007/s007750050272; Bruska MK, 2013, DALTON T, V42, P8729, DOI 10.1039/c3dt50763g; Burgdorf T, 2005, J MOL MICROB BIOTECH, V10, P181, DOI 10.1159/000091564; Capozzi F, 1998, STRUCT BOND, V90, P127; Cracknell JA, 2009, P NATL ACAD SCI USA, V106, P20681, DOI 10.1073/pnas.0905959106; Cramm R, 2009, J MOL MICROB BIOTECH, V16, P38, DOI 10.1159/000142893; Darensbourg MY, 2011, EUR J INORG CHEM, P994, DOI 10.1002/ejic.201001148; De Lacey AL, 2007, CHEM REV, V107, P4304, DOI 10.1021/cr0501947; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; Forzi L, 2007, BIOMETALS, V20, P565, DOI 10.1007/s10534-006-9048-5; Frielingsdorf S, 2011, BIOCHEMISTRY-US, V50, P10836, DOI 10.1021/bi201594m; Fritsch J, 2013, NAT REV MICROBIOL, V11, P106, DOI 10.1038/nrmicro2940; Fritsch J, 2011, NATURE, V479, P249, DOI 10.1038/nature10505; Fritsch J, 2011, BIOCHEMISTRY-US, V50, P5858, DOI 10.1021/bi200367u; Fritsch J, 2011, J BACTERIOL, V193, P2487, DOI 10.1128/JB.01427-10; Goris T, 2011, NAT CHEM BIOL, V7, P310, DOI 10.1038/nchembio.555; Horch M, 2012, FEBS LETT, V586, P545, DOI 10.1016/j.febslet.2011.10.010; Ihara M, 2006, PHOTOCHEM PHOTOBIOL, V82, P676, DOI 10.1562/2006-01-16-RA-778; Jones AK, 2004, BIOCHEMISTRY-US, V43, P13467, DOI 10.1021/bi048837k; Krassen H, 2009, ACS NANO, V3, P4055, DOI 10.1021/nn900748j; LENZ O, 1994, J BACTERIOL, V176, P4385, DOI 10.1128/jb.176.14.4385-4393.1994; Lenz O, 2005, J BACTERIOL, V187, P6590, DOI 10.1128/JB.187.18.6590-6595.2005; Lenz O, 2010, CHEMPHYSCHEM, V11, P1107, DOI 10.1002/cphc.200901002; Ludwig M, 2009, J BIOL CHEM, V284, P2159, DOI 10.1074/jbc.M808488200; Ludwig M, 2009, J BIOL CHEM, V284, P465, DOI 10.1074/jbc.M803676200; Lukey MJ, 2011, J AM CHEM SOC, V133, P16881, DOI 10.1021/ja205393w; MA K, 1993, P NATL ACAD SCI USA, V90, P5341, DOI 10.1073/pnas.90.11.5341; Manyani H, 2005, J BACTERIOL, V187, P7018, DOI 10.1128/JB.187.20.7018-7026.2005; Ogata H, 2005, STRUCTURE, V13, P1635, DOI 10.1016/j.str.2005.07.018; Ogata H, 2010, J MOL BIOL, V402, P428, DOI 10.1016/j.jmb.2010.07.041; Pandelia ME, 2011, P NATL ACAD SCI USA, V108, P6097, DOI 10.1073/pnas.1100610108; Parish David, 2008, Journal of Structural and Functional Genomics, V9, P41, DOI 10.1007/s10969-008-9050-y; Parkin A, 2012, CURR OPIN CHEM BIOL, V16, P26, DOI 10.1016/j.cbpa.2012.01.012; Parkin A, 2012, FEBS LETT, V586, P536, DOI 10.1016/j.febslet.2011.07.044; Pohlmann A, 2006, NAT BIOTECHNOL, V24, P1257, DOI 10.1038/nbt1244; Py B, 2010, NAT REV MICROBIOL, V8, P436, DOI 10.1038/nrmicro2356; RAGSDALE SW, 1983, J BACTERIOL, V155, P1224, DOI 10.1128/JB.155.3.1224-1237.1983; Richie KA, 1996, PROTEIN SCI, V5, P883; Rodrigues JV, 2005, BIOCHEM BIOPH RES CO, V329, P1300, DOI 10.1016/j.bbrc.2005.02.114; Roessler MM, 2012, J AM CHEM SOC, V134, P15581, DOI 10.1021/ja307117y; Saggu M, 2010, CHEMPHYSCHEM, V11, P1215, DOI 10.1002/cphc.200900988; Saggu M, 2009, J BIOL CHEM, V284, P16264, DOI 10.1074/jbc.M805690200; Schafer C, 2013, APPL ENVIRON MICROB, V79, P5137, DOI 10.1128/AEM.01576-13; Schubert T, 2007, MOL MICROBIOL, V66, P453, DOI 10.1111/j.1365-2958.2007.05933.x; Schwartz E, 2003, J MOL BIOL, V332, P369, DOI 10.1016/S0022-2836(03)00894-5; Schwartz E., 2013, PROKARYOTES PROKARYO, P119, DOI [DOI 10.1007/978-3-642-30141-4_65, 10.1007/978-3-642-30141-4_65]; SEKI S, 1988, J BIOCHEM-TOKYO, V103, P583, DOI 10.1093/oxfordjournals.jbchem.a122310; Shen GZ, 2002, J BIOL CHEM, V277, P20355, DOI 10.1074/jbc.M201104200; Shomura Y, 2011, NATURE, V479, P253, DOI 10.1038/nature10504; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; van Beilen JB, 2002, J BACTERIOL, V184, P1722, DOI 10.1128/JB.184.6.1722-1732.2002; van Gastel M, 2006, J BIOL INORG CHEM, V11, P41, DOI 10.1007/s00775-005-0048-7; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; Vincent KA, 2006, CHEM COMMUN, P5033, DOI 10.1039/b614272a; Volbeda A, 2005, J BIOL INORG CHEM, V10, P239, DOI 10.1007/s00775-005-0632-x; Volbeda A, 1996, J AM CHEM SOC, V118, P12989, DOI 10.1021/ja962270g; Volbeda A, 2012, P NATL ACAD SCI USA, V109, P5305, DOI 10.1073/pnas.1119806109; Wait AF, 2010, J PHYS CHEM C, V114, P12003, DOI 10.1021/jp102616m; Zbell AL, 2007, MICROBIOL-SGM, V153, P3508, DOI 10.1099/mic.0.2007/009027-0	64	7	7	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7982	7993		10.1074/jbc.M113.544668	http://dx.doi.org/10.1074/jbc.M113.544668			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24448806	Green Published, hybrid			2022-12-28	WOS:000332761500062
J	Shao, W; Espenshade, PJ				Shao, Wei; Espenshade, Peter J.			Sterol Regulatory Element-binding Protein (SREBP) Cleavage Regulates Golgi-to-Endoplasmic Reticulum Recycling of SREBP Cleavage-activating Protein (SCAP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cholesterol; Lipids; Lysosomes; Protein Degradation; Transcription Factors; SCAP; SREBP; Recycling	HAMSTER OVARY CELLS; DSC E3 LIGASE; FISSION YEAST; PROTEASOME INHIBITORS; SITE-1 PROTEASE; LIPID-SYNTHESIS; COPII PROTEINS; ER MEMBRANES; FATTY LIVER; CHOLESTEROL	Background: The SREBP-SCAP pathway controls lipid homeostasis. Results: SCAP Golgi-to-ER transport requires cleavage of SREBP precursor, reductions in SREBP cleavage at site-1 lead to SCAP degradation in lysosomes, and SREBP control of SCAP expression is conserved in yeast. Conclusion: Site-1 protease activity and SREBP binding regulate SCAP expression through degradation. Sterol regulatory element-binding protein (SREBP) transcription factors are central regulators of cellular lipogenesis. Release of membrane-bound SREBP requires SREBP cleavage-activating protein (SCAP) to escort SREBP from the endoplasmic reticulum (ER) to the Golgi for cleavage by site-1 and site-2 proteases. SCAP then recycles to the ER for additional rounds of SREBP binding and transport. Mechanisms regulating ER-to-Golgi transport of SCAP-SREBP are understood in molecular detail, but little is known about SCAP recycling. Here, we have demonstrated that SCAP Golgi-to-ER transport requires cleavage of SREBP at site-1. Reductions in SREBP cleavage lead to SCAP degradation in lysosomes, providing additional negative feedback control to the SREBP pathway. Current models suggest that SREBP plays a passive role prior to cleavage. However, we show that SREBP actively prevents premature recycling of SCAP-SREBP until initiation of SREBP cleavage. SREBP regulates SCAP in human cells and yeast, indicating that this is an ancient regulatory mechanism.	[Shao, Wei; Espenshade, Peter J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Espenshade, PJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St,Physiol 107B, Baltimore, MD 21205 USA.	peter.espenshade@jhmi.edu		Shao, Wei/0000-0002-5966-4376	National Institutes of Health [HL077588]; Pancreatic Cancer Action Network-AACR Innovative Grant [12-60-25-ESPE]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pancreatic Cancer Action Network-AACR Innovative Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant HL077588. This work was also supported by Grant 12-60-25-ESPE, the 2012 Pancreatic Cancer Action Network-AACR Innovative Grant in memory of Bonnie L. Tobin.	Bien CM, 2010, EUKARYOT CELL, V9, P352, DOI 10.1128/EC.00358-09; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; COPELAND NG, 1979, CELL, V16, P347, DOI 10.1016/0092-8674(79)90011-4; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Duncan EA, 1997, J BIOL CHEM, V272, P12778, DOI 10.1074/jbc.272.19.12778; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Espenshade PJ, 2002, P NATL ACAD SCI USA, V99, P11694, DOI 10.1073/pnas.182412799; Espenshade PJ, 1999, J BIOL CHEM, V274, P22795, DOI 10.1074/jbc.274.32.22795; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1533, DOI 10.1172/JCI107331; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hachinski V, 1996, ARCH NEUROL-CHICAGO, V53, P303, DOI 10.1001/archneur.1996.00550040031011; HASAN MT, 1994, SOMAT CELL MOLEC GEN, V20, P183, DOI 10.1007/BF02254759; Hawkins JL, 2008, J PHARMACOL EXP THER, V326, P801, DOI 10.1124/jpet.108.139626; Hua XX, 1996, J BIOL CHEM, V271, P10379, DOI 10.1074/jbc.271.17.10379; Hughes AL, 2008, J LIPID RES, V49, P2001, DOI 10.1194/jlr.M800207-JLR200; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Kamisuki S, 2009, CHEM BIOL, V16, P882, DOI 10.1016/j.chembiol.2009.07.007; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li WC, 2010, METHODS MOL BIOL, V633, P185, DOI 10.1007/978-1-59745-019-5_13; Matsuda M, 2001, GENE DEV, V15, P1206, DOI 10.1101/gad.891301; MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.biochem.55.1.663; METHERALL JE, 1989, J BIOL CHEM, V264, P15634; Moon YA, 2012, CELL METAB, V15, P240, DOI 10.1016/j.cmet.2011.12.017; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Nohturfft A, 1999, P NATL ACAD SCI USA, V96, P11235, DOI 10.1073/pnas.96.20.11235; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Parraga A, 1998, STRUCT FOLD DES, V6, P661, DOI 10.1016/S0969-2126(98)00067-7; Porter JR, 2010, J BIOL CHEM, V285, P41051, DOI 10.1074/jbc.M110.144337; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Rawson RB, 1998, J BIOL CHEM, V273, P28261, DOI 10.1074/jbc.273.43.28261; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; SATO R, 1994, J BIOL CHEM, V269, P17267; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; Stewart EV, 2012, J BIOL CHEM, V287, P672, DOI 10.1074/jbc.M111.317370; Stewart EV, 2011, MOL CELL, V42, P160, DOI 10.1016/j.molcel.2011.02.035; Sun LP, 2005, J BIOL CHEM, V280, P26483, DOI 10.1074/jbc.M504041200; Tanida I, 2012, AUTOPHAGY, V8, P88, DOI 10.4161/auto.8.1.18339; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Xu F, 2005, P NATL ACAD SCI USA, V102, P14551, DOI 10.1073/pnas.0503590102; YANG JX, 1995, J BIOL CHEM, V270, P12152, DOI 10.1074/jbc.270.20.12152	55	50	55	3	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7547	7557		10.1074/jbc.M113.545699	http://dx.doi.org/10.1074/jbc.M113.545699			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24478315	Green Published, hybrid			2022-12-28	WOS:000332761500025
J	Kantamneni, S; Gonzalez-Gonzalez, IM; Luo, J; Cimarosti, H; Jacobs, SC; Jaafari, N; Henley, JM				Kantamneni, Sriharsha; Gonzalez-Gonzalez, Immaculada M.; Luo, Jia; Cimarosti, Helena; Jacobs, Susan C.; Jaafari, Nadia; Henley, Jeremy M.			Differential Regulation of GABA(B) Receptor Trafficking by Different Modes of N-methyl-D-aspartate (NMDA) Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G Protein-coupled Receptors (GPCR); GABA Receptors; Glutamate Receptor Ionotropic (AMPA; NMDA); Neurodegeneration; Neurotransmitter Receptors; Receptor Endocytosis; Receptor Recycling; GABAB Receptor; Chem-LTP; Oxygen-glucose Deprivation (OGD)	GAMMA-AMINOBUTYRIC-ACID; LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; LYSOSOMAL DEGRADATION; RAT HIPPOCAMPUS; AMPA RECEPTORS; SLICE CULTURES; PROTEIN; SUBUNITS; ACTIVATION	Background: Heterodimerization of GABA(B1) and GABA(B2) subunits is required for functional GABA(B)Rs. Results: GABA(B)R subunits are differentially regulated by activation of synaptic or extrasynaptic NMDARs. Conclusion: GABA(B)R trafficking and function is regulated by NMDARs. Significance: GABA(B)Rs are potential targets for treating diseases such as stroke and cerebral ischemia. Inhibitory GABA(B) receptors (GABA(B)Rs) can down-regulate most excitatory synapses in the CNS by reducing postsynaptic excitability. Functional GABA(B)Rs are heterodimers of GABA(B1) and GABA(B2) subunits and here we show that the trafficking and surface expression of GABA(B)Rs is differentially regulated by synaptic or pathophysiological activation of NMDA receptors (NMDARs). Activation of synaptic NMDARs using a chemLTP protocol increases GABA(B)R recycling and surface expression. In contrast, excitotoxic global activation of synaptic and extrasynaptic NMDARs by bath application of NMDA causes the loss of surface GABA(B)Rs. Intriguingly, exposing neurons to extreme metabolic stress using oxygen/glucose deprivation (OGD) increases GABA(B1) but decreases GABA(B2) surface expression. The increase in surface GABA(B1) involves enhanced recycling and is blocked by the NMDAR antagonist AP5. The decrease in surface GABA(B2) is also blocked by AP5 and by inhibiting degradation pathways. These results indicate that NMDAR activity is critical in GABA(B)R trafficking and function and that the individual subunits can be separately controlled to regulate neuronal responsiveness and survival.	[Kantamneni, Sriharsha; Gonzalez-Gonzalez, Immaculada M.; Luo, Jia; Cimarosti, Helena; Jacobs, Susan C.; Jaafari, Nadia; Henley, Jeremy M.] Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England	University of Bristol	Kantamneni, S (corresponding author), Univ Bradford, Bradford Sch Pharm, Sch Life Sci, Norcroft Bldg, Bradford BD7 1DP, W Yorkshire, England.	s.kantamneni@bradford.ac.uk; J.M.Henley@bristol.ac.uk	Cimarosti, Helena/F-3392-2014; Kantamneni, Sriharsha/G-6504-2012	Kantamneni, Sriharsha/0000-0002-3750-9447; Cimarosti, Helena/0000-0001-5336-480X; Henley, Jeremy/0000-0003-3589-8335; Gonzalez-Gonzalez, Maria Inmaculada/0000-0001-9888-0760	Biotechnology and Biological Sciences Research Council (BBSRC); Medical Research Council (MRC); European Research Council; BBSRC [BB/F00723X/1, BB/K014358/1] Funding Source: UKRI; MRC [G0601810] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K014358/1, BB/F00723X/1] Funding Source: researchfish; Medical Research Council [G0601810] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC), the Medical Research Council (MRC), and the European Research Council.	Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247; Calver AR, 2002, NEUROSIGNALS, V11, P299, DOI 10.1159/000068257; Chalifoux JR, 2010, NEURON, V66, P101, DOI 10.1016/j.neuron.2010.03.012; Cimarosti H, 2001, NEUROSCI LETT, V315, P33, DOI 10.1016/S0304-3940(01)02310-2; Cimarosti H, 2009, NEUROPHARMACOLOGY, V56, P1088, DOI 10.1016/j.neuropharm.2009.03.007; Couve A, 2004, BIOCHEM PHARMACOL, V68, P1527, DOI 10.1016/j.bcp.2004.06.036; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; Eriksen J, 2010, J BIOL CHEM, V285, P27289, DOI 10.1074/jbc.M110.131003; Fritschy JM, 1999, EUR J NEUROSCI, V11, P761, DOI 10.1046/j.1460-9568.1999.00481.x; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Grampp T, 2007, J BIOL CHEM, V282, P24157, DOI 10.1074/jbc.M702626200; Grampp T, 2008, MOL CELL NEUROSCI, V39, P628, DOI 10.1016/j.mcn.2008.09.004; Guetg N, 2010, P NATL ACAD SCI USA, V107, P13924, DOI 10.1073/pnas.1000909107; Guetg N, 2009, J NEUROSCI, V29, P1414, DOI 10.1523/JNEUROSCI.3697-08.2009; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Harlow E, 1988, ANTIBODIES LABORATOR, P471; Huang CS, 2005, CELL, V123, P105, DOI 10.1016/j.cell.2005.07.033; Jaafari N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052345; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Kantamneni S, 2007, J NEUROCHEM, V100, P1003, DOI 10.1111/j.1471-4159.2006.04271.x; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Laffray S, 2007, EUR J NEUROSCI, V25, P1402, DOI 10.1111/j.1460-9568.2007.05398.x; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Lujan R, 2006, EUR J NEUROSCI, V23, P1479, DOI 10.1111/j.1460-9568.2006.04669.x; Maier PJ, 2010, J BIOL CHEM, V285, P35606, DOI 10.1074/jbc.M110.142406; Malitschek B, 1999, MOL PHARMACOL, V56, P448, DOI 10.1124/mol.56.2.448; Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8; Martin S, 2004, EMBO J, V23, P4749, DOI 10.1038/sj.emboj.7600483; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; MORRISETT RA, 1991, J NEUROSCI, V11, P203; Otmakhova NA, 2004, J NEUROPHYSIOL, V92, P2027, DOI 10.1152/jn.00427.2004; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Perestenko PV, 2003, J BIOL CHEM, V278, P43525, DOI 10.1074/jbc.M306206200; Pooler AM, 2007, J BIOL CHEM, V282, P25349, DOI 10.1074/jbc.M702358200; Ramirez OA, 2009, J BIOL CHEM, V284, P13077, DOI 10.1074/jbc.M900575200; Ramoino P, 2005, MICROSC RES TECHNIQ, V68, P290, DOI 10.1002/jemt.20250; Robbins MJ, 2001, J NEUROSCI, V21, P8043, DOI 10.1523/JNEUROSCI.21-20-08043.2001; Terunuma M, 2010, P NATL ACAD SCI USA, V107, P13918, DOI 10.1073/pnas.1000853107; van der Sluijs P, 2011, SEMIN CELL DEV BIOL, V22, P499, DOI 10.1016/j.semcdb.2011.06.008; Vargas KJ, 2008, J BIOL CHEM, V283, P24641, DOI 10.1074/jbc.M802419200; Watanabe M, 2002, INT REV CYTOL, V213, P1; Wilkins ME, 2008, J BIOL CHEM, V283, P34745, DOI 10.1074/jbc.M803197200; Yudowski GA, 2009, MOL BIOL CELL, V20, P2774, DOI 10.1091/mbc.E08-08-0892	46	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6681	6694		10.1074/jbc.M113.487348	http://dx.doi.org/10.1074/jbc.M113.487348			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24425870	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000332389400031
J	Koike, T; Izumikawa, T; Sato, B; Kitagawa, H				Koike, Toshiyasu; Izumikawa, Tomomi; Sato, Ban; Kitagawa, Hiroshi			Identification of Phosphatase That Dephosphorylates Xylose in the Glycosaminoglycan-Protein Linkage Region of Proteoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chondroitin Sulfate; Glycosaminoglycan; Glycosyltransferases; Heparan Sulfate; Phosphatase; Phosphorylation; Proteoglycan; Proteoglycan Synthesis	CHONDROITIN SULFATE; MOLECULAR-CLONING; TUMOR SUPPRESSORS; N-ACETYLGALACTOSAMINYLTRANSFERASE; EXT FAMILY; BIOSYNTHESIS; GLUCURONOSYLTRANSFERASE; POLYMERIZATION; EXPRESSION; BETA-1,3-GLUCURONOSYLTRANSFERASE-I	Background: The enzyme responsible for the dephosphorylation of xylose in glycosaminoglycans remains unknown. Results: A protein that removed the phosphate from the phosphorylated linkage trisaccharide and localized in the Golgi was identified. Inhibition of this protein phosphatase resulted in decreased glycosaminoglycan levels in cells. Conclusion: We identified the phosphoxylose phosphatase that regulates glycosaminoglycan synthesis. Significance: Transient phosphorylation of xylose residues controls glycosaminoglycan synthesis. Recently, we demonstrated that FAM20B is a kinase that phosphorylates the xylose (Xyl) residue in the glycosaminoglycan-protein linkage region of proteoglycans. The phosphorylation of Xyl residues by FAM20B enhances the formation of the linkage region. Rapid dephosphorylation is probably induced just after synthesis of the linker and just before polymerization initiates. Indeed, in vitro chondroitin or heparan sulfate polymerization does not occur when the Xyl residue of the tetrasaccharide linkage region is phosphorylated. However, the enzyme responsible for the dephosphorylation of Xyl remains unknown. Here, we identified a novel protein that dephosphorylates the Xyl residue and designated it 2-phosphoxylose phosphatase. The phosphatase efficiently removed the phosphate from the phosphorylated trisaccharide, Gal1-3Gal1-4Xyl(2-O-phosphate), but not from phosphorylated tetrasaccharide, GlcUA1-3Gal1-3Gal1-4Xyl(2-O-phosphate). Additionally, RNA interference-mediated inhibition of 2-phosphoxylose phosphatase resulted in increased amounts of GlcNAc1-4GlcUA1-3Gal1-3Gal1-4Xyl(2-O-phosphate), Gal1-3Gal1-4Xyl(2-O-phosphate), and Gal1-4Xyl(2-O-phosphate) in the cells. Gel filtration analysis of the glycosaminoglycan chains synthesized in the knockdown cells revealed that these cells produced decreased amounts of glycosaminoglycan chains and that the chains had similar lengths to those in the mock-transfected cells. Transcripts encoding this phosphatase were ubiquitously, but differentially, expressed in human tissues. Moreover, the phosphatase localized to the Golgi and interacted with the glucuronyltransferase-I involved in the completion of the glycosaminoglycan-protein linkage region. Based on these findings, we conclude that transient phosphorylation of the Xyl residue in the glycosaminoglycan-protein linkage region controls the formation of glycosaminoglycan chains of proteoglycans.	[Koike, Toshiyasu; Izumikawa, Tomomi; Sato, Ban; Kitagawa, Hiroshi] Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Kobe Pharmaceutical University	Kitagawa, H (corresponding author), Kobe Pharmaceut Univ, Dept Biochem, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	kitagawa@kobepharma-u.ac.jp	Kitagawa, Hiroshi/AAJ-1344-2020	Kitagawa, Hiroshi/0000-0002-9307-7079	Ministry of Education, Culture, Sports, Science and Technology, Japan [25293014, 23110003]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research (B) 25293014 (to H. K.) and for Scientific Research on Innovative Areas 23110003 (to H. K.) and by the supported program for the Strategic Research Foundation at Private Universities, 2012-2016 (to H. K.), from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Eames BF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002246; Fansson LA, 2000, MATRIX BIOL, V19, P367, DOI 10.1016/S0945-053X(00)00083-4; FRANSSON LA, 1985, J BIOL CHEM, V260, P4722; Gulberti S, 2005, J BIOL CHEM, V280, P1417, DOI 10.1074/jbc.M411552200; Ishikawa HO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042988; Izumikawa T, 2008, J BIOL CHEM, V283, P11396, DOI 10.1074/jbc.M707549200; Izumikawa T, 2007, BIOCHEM J, V403, P545, DOI 10.1042/BJ20061876; Izumikawa T, 2014, SCI REP-UK, V4, DOI 10.1038/srep03701; Izumikawa T, 2012, BIOCHEM J, V441, P697, DOI 10.1042/BJ20111472; Izumikawa T, 2011, BIOCHEM J, V434, P321, DOI 10.1042/BJ20101456; Kim BT, 2003, J BIOL CHEM, V278, P41618, DOI 10.1074/jbc.M304831200; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; KITAGAWA H, 1995, J BIOL CHEM, V270, P22190, DOI 10.1074/jbc.270.38.22190; Kitagawa H, 1998, J BIOL CHEM, V273, P6615, DOI 10.1074/jbc.273.12.6615; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; KITAGAWA H, 1994, J BIOL CHEM, V269, P1394; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; Koike T, 2009, BIOCHEM J, V421, P157, DOI 10.1042/BJ20090474; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Mizumoto S, 2005, HANDBOOK OF CARBOHYDRATE ENGINEERING, P289; Moses J, 1999, EUR J BIOCHEM, V260, P879, DOI 10.1046/j.1432-1327.1999.00228.x; Moses J, 1997, EUR J BIOCHEM, V248, P521, DOI 10.1111/j.1432-1033.1997.00521.x; Nadanaka S, 1998, J BIOL CHEM, V273, P33728, DOI 10.1074/jbc.273.50.33728; Nadanaka S, 2008, J BIOCHEM, V144, P7, DOI 10.1093/jb/mvn040; Nadanaka S, 2013, BIOCHEM J, V454, P133, DOI 10.1042/BJ20130323; Nadanaka S, 2013, J BIOL CHEM, V288, P9321, DOI 10.1074/jbc.M112.416909; OEGEMA TR, 1984, J BIOL CHEM, V259, P1720; Pedersen LC, 2000, J BIOL CHEM, V275, P34580, DOI 10.1074/jbc.M007399200; Pedersen LC, 2002, J BIOL CHEM, V277, P21869, DOI 10.1074/jbc.M112343200; Purnomo E, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000405; Sakaguchi H, 2001, J BIOCHEM-TOKYO, V129, P107, DOI 10.1093/oxfordjournals.jbchem.a002820; Tone Y, 2008, J BIOL CHEM, V283, P16801, DOI 10.1074/jbc.M709556200; Uyama T, 2002, J BIOL CHEM, V277, P8841, DOI 10.1074/jbc.M111434200; Venkatesan N, 2004, P NATL ACAD SCI USA, V101, P18087, DOI 10.1073/pnas.0404504102	35	45	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6695	6708		10.1074/jbc.M113.520536	http://dx.doi.org/10.1074/jbc.M113.520536			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24425863	hybrid, Green Published			2022-12-28	WOS:000332389400032
J	Lavall, D; Selzer, C; Schuster, P; Lenski, M; Adam, O; Schafers, HJ; Bohm, M; Laufs, U				Lavall, Daniel; Selzer, Christian; Schuster, Pia; Lenski, Matthias; Adam, Oliver; Schaefers, Hans-Joachim; Boehm, Michael; Laufs, Ulrich			The Mineralocorticoid Receptor Promotes Fibrotic Remodeling in Atrial Fibrillation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fibrosis; Heart; Lysyl Oxidase; MicroRNA; Mineralocorticoid Receptor; CTGF	11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2; HEART-FAILURE; CARDIAC FIBROBLASTS; GENE-EXPRESSION; ALDOSTERONE; FIBROSIS; RAC1; MECHANISMS; KINASE; HYPERTROPHY	Background: We studied the role of the mineralocorticoid receptor (MR) for atrial fibrotic remodeling. Results: Increased 11-hydroxysteroid dehydrogenase type 2 in atrial fibrillation enhances mineralocorticoid receptor pro-fibrotic signaling through connective tissue growth factor, lysyl oxidase, and microRNA-21. Conclusion: The MR regulates fibrogenesis in atrial fibrillation. Significance: The MR may represent a target for the prevention of atrial fibrosis. We studied the role of the mineralocorticoid receptor (MR) in the signaling that promotes atrial fibrosis. Left atrial myocardium of patients with atrial fibrillation (AF) exhibited 4-fold increased hydroxyproline content compared with patients in sinus rhythm. Expression of MR was similar, as was 11-hydroxysteroid dehydrogenase type 2 (11-HSD2), which also increased. 11-HSD2 converts cortisol to receptor-inactive metabolites allowing aldosterone occupancy of MR. 11-HSD2 was up-regulated by arrhythmic pacing in cultured cardiomyocytes and in a mouse model of spontaneous AF (RacET). In cardiomyocytes, aldosterone induced connective tissue growth factor (CTGF) in the absence but not in the presence of cortisol. Hydroxyproline expression was increased in cardiac fibroblasts exposed to conditioned medium from aldosterone-treated cardiomyocytes but not from cardiomyocytes treated with both cortisol and aldosterone. Aldosterone increased connective tissue growth factor and hydroxyproline expression in cardiac fibroblasts, which were prevented by BR-4628, a dihydropyridine-derived selective MR antagonist, and by spironolactone. Aldosterone activated RhoA GTPase. Rho kinase inhibition by Y-27632 prevented CTGF and hydroxyproline, whereas the RhoA activator CN03 increased CTGF expression. Aldosterone and CTGF increased lysyl oxidase, and aldosterone enhanced miR-21 expression. MR antagonists reduced the aldosterone but not the CTGF effect. In conclusion, MR signaling promoted fibrotic remodeling. Increased expression of 11-HSD2 during AF leads to up-regulation of collagen and pro-fibrotic mediators by aldosterone, specifically RhoA activity as well as CTGF, lysyl oxidase, and microRNA-21 expression. The MR antagonists BR-4628 and spironolactone prevent these alterations. MR inhibition may, therefore, represent a potential pharmacologic target for the prevention of fibrotic remodeling of the atrial myocardium.	[Lavall, Daniel; Selzer, Christian; Schuster, Pia; Lenski, Matthias; Adam, Oliver; Boehm, Michael; Laufs, Ulrich] Univ Klinikum Saarlandes, Klin Innere Med Kardiol Angiol & Internist Intens, D-66421 Homburg, Germany; [Schaefers, Hans-Joachim] Univ Klinikum Saarlandes, Klin Thorax & Herz Gefasschirurg, D-66421 Homburg, Germany	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes	Lavall, D (corresponding author), Univ Klinikum Saarlandes, Klin Innere Med Kardiol Angiol & Internist Intens, Kirrberger Str, D-66421 Homburg, Germany.	daniel.lavall@uks.eu	Böhm, Michael/C-3638-2011	Lavall, Daniel/0000-0002-7932-212X	Universitat des Saarlandes; Bayer Pharma AG; Deutsche Forschungsgemeinschaft DFG [KFO 196, AD 455/1-1]	Universitat des Saarlandes; Bayer Pharma AG; Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This work was supported by the Universitat des Saarlandes, an unrestricted grant from Bayer Pharma AG to the Universitat des Saarlandes and by the Deutsche Forschungsgemeinschaft DFG (KFO 196, AD 455/1-1).	Adam O, 2007, J AM COLL CARDIOL, V50, P359, DOI 10.1016/j.jacc.2007.03.041; Adam O, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0278-0; Adam O, 2011, J MOL CELL CARDIOL, V50, P678, DOI 10.1016/j.yjmcc.2010.12.019; Adam O, 2010, J AM COLL CARDIOL, V55, P469, DOI 10.1016/j.jacc.2009.08.064; Azibani F, 2012, HYPERTENSION, V59, P1179, DOI 10.1161/HYPERTENSIONAHA.111.190512; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Briet M, 2010, NAT REV NEPHROL, V6, P261, DOI 10.1038/nrneph.2010.30; Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064; Cardin S, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1027, DOI 10.1161/CIRCEP.112.973214; Chen H, 2004, PHYSIOL GENOMICS, V18, P273, DOI 10.1152/physiolgenomics.00104.2004; Custodis F, 2006, CARDIOVASC RES, V71, P342, DOI 10.1016/j.cardiores.2006.04.005; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dobrev D, 2012, NAT REV DRUG DISCOV, V11, P275, DOI 10.1038/nrd3682; Fagart J, 2010, J BIOL CHEM, V285, P29932, DOI 10.1074/jbc.M110.131342; Flatau G, 1997, NATURE, V387, P729, DOI 10.1038/42743; Funder JW, 2009, HYPERTENSION, V53, P286, DOI 10.1161/HYPERTENSIONAHA.108.119966; GRILLO C, 1990, J STEROID BIOCHEM, V35, P11, DOI 10.1016/0022-4731(90)90138-I; Harris BS, 2011, AM J PHYSIOL-HEART C, V301, pH841, DOI 10.1152/ajpheart.01247.2010; He YH, 2011, CLIN EXP PHARMACOL P, V38, P739, DOI 10.1111/j.1440-1681.2011.05581.x; Jiang DP, 2008, EUR J APPL PHYSIOL, V103, P489, DOI 10.1007/s00421-008-0733-7; Kadereit B, 2005, J AM SOC NEPHROL, V16, P3507, DOI 10.1681/ASN.2005010108; KAGAN HM, 1991, AM J RESP CELL MOL, V5, P206, DOI 10.1165/ajrcmb/5.3.206; Klusonova P, 2009, ENDOCRINOLOGY, V150, P4270, DOI 10.1210/en.2008-1493; Koitabashi N, 2007, HYPERTENSION, V49, P1120, DOI 10.1161/HYPERTENSIONAHA.106.077537; Laufs U, 2002, CARDIOVASC RES, V53, P911, DOI 10.1016/S0008-6363(01)00540-5; Lip GYH, 2012, LANCET, V379, P648, DOI 10.1016/S0140-6736(11)61514-6; Lother A, 2011, HYPERTENSION, V57, P746, DOI 10.1161/HYPERTENSIONAHA.110.163287; McCurdy S, 2010, J MOL CELL CARDIOL, V48, P544, DOI 10.1016/j.yjmcc.2009.06.018; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Nattel S, 2008, CIRC-ARRHYTHMIA ELEC, V1, P62, DOI 10.1161/CIRCEP.107.754564; Odermatt A, 2012, MOL CELL ENDOCRINOL, V350, P168, DOI 10.1016/j.mce.2011.07.020; Odermatt A, 2009, STEROIDS, V74, P163, DOI 10.1016/j.steroids.2008.10.010; Pei DA, 2010, CLIN CARDIOL, V33, P23, DOI 10.1002/clc.20689; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Reil JC, 2012, EUR HEART J, V33, P2098, DOI 10.1093/eurheartj/ehr266; Reil JC, 2010, CARDIOVASC RES, V87, P485, DOI 10.1093/cvr/cvq079; Sun GP, 2006, J AM SOC NEPHROL, V17, P2193, DOI 10.1681/ASN.2005121375; Sussman MA, 2000, J CLIN INVEST, V105, P875, DOI 10.1172/JCI8497; Swedberg K, 2012, J AM COLL CARDIOL, V59, P1598, DOI 10.1016/j.jacc.2011.11.063; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; TOVAR O, 1992, AM J PHYSIOL, V263, pH1128, DOI 10.1152/ajpheart.1992.263.4.H1128; Tsai CT, 2010, J AM COLL CARDIOL, V55, P758, DOI 10.1016/j.jacc.2009.09.045; van Beek JP, 2004, J CLIN ENDOCR METAB, V89, P5614, DOI 10.1210/jc.2004-0113; Wang ZG, 2011, CARDIOVASC RES, V89, P710, DOI 10.1093/cvr/cvq350; Weber KT, 2001, NEW ENGL J MED, V345, P1689, DOI 10.1056/NEJMra000050; YOUNG M, 1994, J CLIN INVEST, V93, P2578, DOI 10.1172/JCI117269; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492; Zhou GP, 1996, MOL CELL BIOCHEM, V154, P171, DOI 10.1007/BF00226785	49	80	84	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6656	6668		10.1074/jbc.M113.519256	http://dx.doi.org/10.1074/jbc.M113.519256			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24469458	Green Published, hybrid			2022-12-28	WOS:000332389400029
J	Sankar, N; deTombe, PP; Mignery, GA				Sankar, Natesan; detombe, Pieter P.; Mignery, Gregory A.			Calcineurin-NFATc Regulates Type 2 Inositol 1,4,5-Trisphosphate Receptor (InsP(3)R2) Expression during Cardiac Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcineurin; Calcium Signaling; Cardiac Hypertrophy; Gene Transcription; Inositol 1; 4; 5-Trisphosphate	PROTEIN-KINASE-II; CA2+ RELEASE; EXCITATION-CONTRACTION; HEART-FAILURE; DILATED CARDIOMYOPATHY; SIGNALING PATHWAYS; GENE-EXPRESSION; ATRIAL MYOCYTES; HYPERTROPHY; IP3	Background: InsP(3)R2 is overexpressed during cardiac remodeling. The transcriptional regulation of InsP(3)R2 is not known. Results: InsP(3)R2 gene expression is regulated by calcineurin-NFATc signaling pathway. Conclusion: Calcineurin-NFATc signaling is a downstream target of the InsP(3)R2 that regulates InsP(3)R2 expression in a positive feedback loop. Significance: InsP(3)R2 Ca2+ channel-calcineurin-NFATc signaling network regulates ITPR2 gene and fetal gene expression during cardiac remodeling. In heart, the type 2 inositol 1,4,5-triphosphate receptor (InsP(3)R2) is the predominant isoform expressed and is localized in the nuclear membrane of ventricular myocytes. InsP(3)R2-mediated Ca2+ release regulates hypertrophy specific gene expression by modulating CaMKII, histone deacetylase, and calcineurin-NFATc signaling pathways. InsP(3)R2 protein is a hypertrophy specific marker and is overexpressed in heart failure animal models and in humans. However, the regulation of InsP(3)R2 mRNA and protein expression during cardiac hypertrophy and heart failure is not known. Here we show the transcriptional regulation of the Itpr2 gene in adult cardiomyocytes. Our data demonstrates that, InsP(3)R2 mRNA and protein expression is activated by hypertrophic agonists and attenuated by InsP(3)R inhibitors 2-aminoethoxyldiphenyl borate and xestospongin-C. The Itpr2 promoter is regulated by the calcineurin-NFATc signaling pathway. NFATc1 regulates Itpr2 gene expression by directly binding to the Itpr2 promoter. The calcineurin-NFATc mediated up-regulation of the Itpr2 promoter was attenuated by cyclosporine-A. InsP(3)R2 mRNA and protein expression was up-regulated in calcineurin-A transgenic mice and in human heart failure. Collectively, our data suggests that ITPR2 and hypertrophy specific gene expression is regulated, in part, by a positive feedback regulation between InsP(3)R2 and calcineurin-NFATc signaling pathways.	[Sankar, Natesan; detombe, Pieter P.; Mignery, Gregory A.] Loyola Univ Chicago, Stritch Sch Med, Dept Cell & Mol Physiol, Maywood, IL 60153 USA	Loyola University Chicago	Sankar, N (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Cell & Mol Physiol, Maywood, IL 60153 USA.	snatesan@lumc.edu; gmigner@lumc.edu	Natesan, Sankar/C-9866-2015		National Institutes of Health [PO1-HL080101]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1-HL080101 (to G. A. M.).	Abou-Saleh H, 2013, J BIOL CHEM, V288, P32941, DOI 10.1074/jbc.M113.496802; Anderson ME, 2000, CIRC RES, V86, P717, DOI 10.1161/01.RES.86.7.717; Bare DJ, 2005, J BIOL CHEM, V280, P15912, DOI 10.1074/jbc.M414212200; Borlak J, 2003, FASEB J, V17, P1592, DOI 10.1096/fj.02-0889com; Bossuyt J, 2008, CIRC RES, V102, P695, DOI 10.1161/CIRCRESAHA.107.169755; Cooley N, 2013, CIRC-HEART FAIL, V6, P318, DOI 10.1161/CIRCHEARTFAILURE.112.972158; Domeier TL, 2008, AM J PHYSIOL-HEART C, V294, pH596, DOI 10.1152/ajpheart.01155.2007; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Drawnel FM, 2012, J CELL BIOL, V199, P783, DOI 10.1083/jcb.201111095; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Genazzani AA, 1999, P NATL ACAD SCI USA, V96, P5797, DOI 10.1073/pnas.96.10.5797; Harzheim D, 2010, CHANNELS, V4, P67, DOI 10.4161/chan.4.1.10531; Harzheim D, 2009, P NATL ACAD SCI USA, V106, P11406, DOI 10.1073/pnas.0905485106; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Higazi DR, 2009, MOL CELL, V33, P472, DOI 10.1016/j.molcel.2009.02.005; Ibarra C, 2013, CIRC RES, V112, P236, DOI 10.1161/CIRCRESAHA.112.273839; Kockskamper J, 2008, J MOL CELL CARDIOL, V45, P128, DOI 10.1016/j.yjmcc.2008.05.014; Kockskamper J, 2001, BIOPHYS J, V81, P2590, DOI 10.1016/S0006-3495(01)75903-6; Kuwahara K, 2012, J PHARMACOL SCI, V119, P198, DOI 10.1254/jphs.12R04CP; Lipp P, 2000, CURR BIOL, V10, P939, DOI 10.1016/S0960-9822(00)00624-2; Lipp P, 1997, EMBO J, V16, P7166, DOI 10.1093/emboj/16.23.7166; Lorell BH, 2000, CIRCULATION, V102, P470; Mackenzie L, 2004, BIOL RES, V37, P553, DOI 10.4067/S0716-97602004000400008; Mackenzie L, 2002, J PHYSIOL-LONDON, V541, P395, DOI 10.1113/jphysiol.2001.013411; Maxwell JT, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.374058; Mizuno K, 2013, NEUROPHARMACOLOGY, V71, P264, DOI 10.1016/j.neuropharm.2013.03.036; MIZUSHIMA A, 1989, EUR J PHARMACOL, V168, P375; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Morikawa K, 1997, GENE, V196, P181, DOI 10.1016/S0378-1119(97)00224-2; Nakayama H, 2010, CIRC RES, V107, P659, DOI 10.1161/CIRCRESAHA.110.220038; NEWTON CL, 1994, J BIOL CHEM, V269, P28613; Perez PJ, 1997, J BIOL CHEM, V272, P23961, DOI 10.1074/jbc.272.38.23961; Rinne A, 2010, AM J PHYSIOL-HEART C, V299, pH1701, DOI 10.1152/ajpheart.00470.2010; Sankar N, 2008, ONCOGENE, V27, P5717, DOI 10.1038/onc.2008.181; Tilley DG, 2011, CIRC RES, V109, P217, DOI 10.1161/CIRCRESAHA.110.231225; Vaniotis G, 2011, AM J PHYSIOL-HEART C, V301, pH1754, DOI 10.1152/ajpheart.00657.2011; Vaniotis G, 2011, CELL SIGNAL, V23, P89, DOI 10.1016/j.cellsig.2010.08.007; Wu X, 2006, J CLIN INVEST, V116, P675, DOI 10.1172/JCI27374; Zhang LH, 2013, CELL, V153, P216, DOI 10.1016/j.cell.2013.02.047; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5; Zhang T, 2007, J BIOL CHEM, V282, P35078, DOI 10.1074/jbc.M707083200; Zima AV, 2007, J PHYSIOL-LONDON, V584, P601, DOI 10.1113/jphysiol.2007.140731	42	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6188	6198		10.1074/jbc.M113.495242	http://dx.doi.org/10.1074/jbc.M113.495242			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24415751	hybrid, Green Published			2022-12-28	WOS:000332015500072
J	Hosono, Y; Abe, T; Higuchi, M; Kajii, K; Sakuraba, S; Tada, S; Enomoto, T; Seki, M				Hosono, Yoshifumi; Abe, Takuya; Higuchi, Masato; Kajii, Kosa; Sakuraba, Shuichi; Tada, Shusuke; Enomoto, Takemi; Seki, Masayuki			Tipin Functions in the Protection against Topoisomerase I Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anticancer Drug; DNA Repair; DNA Replication; DNA Topoisomerase; Molecular Cell Biology; Camptothecin; DT40; Replication Fork; Tipin; Top1	SISTER-CHROMATID COHESION; XENOPUS EGG EXTRACTS; DNA-REPLICATION; S-PHASE; HOMOLOGOUS RECOMBINATION; GENOME STABILITY; SACCHAROMYCES-CEREVISIAE; TUMOR-CELLS; COMPLEX; CHECKPOINT	Background: The Tim-Tipin complex is a component of the DNA replication machinery that is conserved across eukaryotes. Results:TIPIN gene knock-out cells showed hypersensitivity to the topoisomerase I inhibitor camptothecin, decreased DNA synthesizing activity, and Top1 degradation. Conclusion: The Tim-Tipin complex destabilizes the Top1 cleavage complex. Significance: The Tim-Tipin complex could be a potential drug target in cancer chemotherapy. The replication fork temporarily stalls when encountering an obstacle on the DNA, and replication resumes after the barrier is removed. Simultaneously, activation of the replication checkpoint delays the progression of S phase and inhibits late origin firing. Camptothecin (CPT), a topoisomerase I (Top1) inhibitor, acts as a DNA replication barrier by inducing the covalent retention of Top1 on DNA. The Timeless-Tipin complex, a component of the replication fork machinery, plays a role in replication checkpoint activation and stabilization of the replication fork. However, the role of the Timeless-Tipin complex in overcoming the CPT-induced replication block remains elusive. Here, we generated viable TIPIN gene knock-out (KO) DT40 cells showing delayed S phase progression and increased cell death. TIPIN KO cells were hypersensitive to CPT. However, homologous recombination and replication checkpoint were activated normally, whereas DNA synthesis activity was markedly decreased in CPT-treated TIPIN KO cells. Proteasome-dependent degradation of chromatin-bound Top1 was induced in TIPIN KO cells upon CPT treatment, and pretreatment with aphidicolin, a DNA polymerase inhibitor, suppressed both CPT sensitivity and Top1 degradation. Taken together, our data indicate that replication forks formed without Tipin may collide at a high rate with Top1 retained on DNA by CPT treatment, leading to CPT hypersensitivity and Top1 degradation in TIPIN KO cells.	[Hosono, Yoshifumi; Higuchi, Masato; Sakuraba, Shuichi] Tohoku Univ, Grad Sch Pharmaceut Sci, Mol Cell Biol Lab, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Abe, Takuya] Fdn Italiana Ric Canc FIRC Inst Mol Oncol Fdn, Inst FIRC Oncol Mol IFOM, I-20139 Milan, Italy; [Kajii, Kosa; Seki, Masayuki] Tohoku Pharmaceut Univ, Dept Biochem, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Tada, Shusuke] Teikyo Heisei Univ, Fac Pharmaceut Sci, Nakano Ku, Tokyo 1648530, Japan; [Enomoto, Takemi] Musashino Univ, Pharmaceut Sci Res Inst, Mol Cell Biol Lab, Fac Pharm, Tokyo 2028585, Japan	Tohoku University; IFOM - FIRC Institute of Molecular Oncology; Tohoku Medical & Pharmaceutical University	Seki, M (corresponding author), Tohoku Pharmaceut Univ, Dept Biochem, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	seki@tohoku-pharm.ac.jp	ABE, TAKUYA/A-2861-2015	ABE, TAKUYA/0000-0001-5298-082X	Ministry of Education, Culture, Sports, Science and Technology of Japan (NEXT KAKENHI) [22131002, 24590089]; Grants-in-Aid for Scientific Research [12J07075] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan (NEXT KAKENHI); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (NEXT KAKENHI Grants 22131002 and 24590089).	Abe T, 2008, CELL SIGNAL, V20, P1978, DOI 10.1016/j.cellsig.2008.07.006; Aria V, 2013, J BIOL CHEM, V288, P12742, DOI 10.1074/jbc.M112.398073; Arnaudeau C, 2000, MUTAT RES-DNA REPAIR, V461, P221, DOI 10.1016/S0921-8777(00)00052-5; Aze A, 2013, CHROMOSOMA, V122, P401, DOI 10.1007/s00412-013-0411-3; Bando M, 2009, J BIOL CHEM, V284, P34355, DOI 10.1074/jbc.M109.065730; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Chaudhuri AR, 2012, NAT STRUCT MOL BIOL, V19, P417, DOI 10.1038/nsmb.2258; Cho WH, 2013, P NATL ACAD SCI USA, V110, P2523, DOI 10.1073/pnas.1222494110; Chou DM, 2006, P NATL ACAD SCI USA, V103, P18143, DOI 10.1073/pnas.0609251103; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Desai SD, 1997, J BIOL CHEM, V272, P24159, DOI 10.1074/jbc.272.39.24159; Desai SD, 2001, CANCER RES, V61, P5926; Errico A, 2007, P NATL ACAD SCI USA, V104, P14929, DOI 10.1073/pnas.0706347104; Errico A, 2010, EMBO REP, V11, P270, DOI 10.1038/embor.2010.27; Errico A, 2009, EMBO J, V28, P3681, DOI 10.1038/emboj.2009.304; Finn K, 2012, CELL MOL LIFE SCI, V69, P1447, DOI 10.1007/s00018-011-0875-3; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Hosono Y, 2011, BIOCHEM BIOPH RES CO, V410, P568, DOI 10.1016/j.bbrc.2011.06.027; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kemp MG, 2010, J BIOL CHEM, V285, P16562, DOI 10.1074/jbc.M110.110304; Kobayashi M, 2004, GENES CELLS, V9, P291, DOI 10.1111/j.1356-9597.2004.00728.x; Leman AR, 2012, CELL CYCLE, V11, P3945, DOI 10.4161/cc.21989; Leman AR, 2010, J CELL SCI, V123, P660, DOI 10.1242/jcs.057984; Lin CP, 2009, J BIOL CHEM, V284, P28084, DOI 10.1074/jbc.M109.030601; Mailand N, 2013, NAT REV MOL CELL BIO, V14, P269, DOI 10.1038/nrm3562; Maxwell KN, 2012, NAT REV CLIN ONCOL, V9, P520, DOI 10.1038/nrclinonc.2012.123; Park H, 1999, YEAST, V15, P35, DOI 10.1002/(SICI)1097-0061(19990115)15:1<35::AID-YEA340>3.0.CO;2-R; Petermann E, 2008, MOL BIOL CELL, V19, P2373, DOI 10.1091/mbc.E07-10-1035; Pommier Y, 2006, PROG NUCLEIC ACID RE, V81, P179, DOI 10.1016/S0079-6603(06)81005-6; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2013, ACS CHEM BIOL, V8, P82, DOI 10.1021/cb300648v; Qing Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002148; Rapp JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013379; Redon C, 2006, GENETICS, V172, P67, DOI 10.1534/genetics.105.046128; Roseaulin LC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003213; Seiler JA, 2007, MOL CELL BIOL, V27, P5806, DOI 10.1128/MCB.02278-06; Smith KD, 2009, J CELL BIOL, V187, P15, DOI 10.1083/jcb.200905006; Smith-Roe SL, 2011, CELL CYCLE, V10, P1618, DOI 10.4161/cc.10.10.15613; Sugimura K, 2008, J CELL BIOL, V183, P1203, DOI 10.1083/jcb.200806068; Tanaka H, 2009, GENES CELLS, V14, P949, DOI 10.1111/j.1365-2443.2009.01322.x; Thompson LH, 2001, MUTAT RES-FUND MOL M, V477, P131, DOI 10.1016/S0027-5107(01)00115-4; Tomicic MT, 2013, BBA-REV CANCER, V1835, P11, DOI 10.1016/j.bbcan.2012.09.002; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; Wang WS, 2003, MOL CELL BIOL, V23, P3527, DOI 10.1128/MCB.23.10.3527-3535.2003; Yoshimura A, 2011, BIOCHEM BIOPH RES CO, V414, P298, DOI 10.1016/j.bbrc.2011.09.037; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200; Zachos G, 2003, EMBO J, V22, P713, DOI 10.1093/emboj/cdg060; Zhang HF, 2004, CANCER RES, V64, P1114, DOI 10.1158/0008-5472.CAN-03-2858	52	10	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11374	11384		10.1074/jbc.M113.531707	http://dx.doi.org/10.1074/jbc.M113.531707			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24573676	Green Published, hybrid			2022-12-28	WOS:000334638500039
J	Akhter, R; Sanphui, P; Biswas, SC				Akhter, Rumana; Sanphui, Priyankar; Biswas, Subhas Chandra			The Essential Role of p53-up-regulated Modulator of Apoptosis ( Puma) and Its Regulation by FoxO3a Transcription Factor in beta- Amyloid- induced Neuron Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Amyloid; Bcl-2 Family Proteins; Cell Death; Foxo; Neurodegeneration; Neurons; siRNA; Bim; Puma	NERVE GROWTH-FACTOR; ENDOPLASMIC-RETICULUM STRESS; PLAY REQUIRED ROLES; CELL-DEATH; ALZHEIMERS-DISEASE; BH3-ONLY PROTEIN; PROAPOPTOTIC ACTIVITY; FACTOR DEPRIVATION; PROMOTE APOPTOSIS; CORTICAL-NEURONS	Background: -Amyloid-induced neuron death and degeneration is considered to be central to the pathogenesis of Alzheimer disease. Results: p53-up-regulated modulator of apoptosis (Puma), a protein of the B-cell lymphoma-2 family, is induced by transcription factor FoxO3a and participates in neuron death in response to -amyloid. Conclusion: -Amyloid-induced neuron death requires induction of Puma. Significance: Puma could be a potential target for disease therapeutics. Neurodegeneration underlies the pathology of Alzheimer disease (AD). The molecules responsible for such neurodegeneration in AD brain are mostly unknown. Recent findings indicate that the BH3-only proteins of the Bcl-2 family play an essential role in various cell death paradigms, including neurodegeneration. Here we report that Puma (p53-up-regulated modulator of apoptosis), an important member of the BH3-only protein family, is up-regulated in neurons upon toxic -amyloid 1-42 (A(1-42)) exposure both in vitro and in vivo. Down-regulation of Puma by specific siRNA provides significant protection against neuron death induced by A(1-42). We further demonstrate that the activation of p53 and inhibition of PI3K/Akt pathways induce Puma. The transcription factor FoxO3a, which is activated when PI3K/Akt signaling is inhibited, directly binds with the Puma gene and induces its expression upon exposure of neurons to oligomeric A(1-42). Moreover, Puma cooperates with another BH3-only protein, Bim, which is already implicated in AD. Our results thus suggest that Puma is activated by both p53 and PI3K/Akt/FoxO3a pathways and cooperates with Bim to induce neuron death in response to A(1-42).	[Akhter, Rumana; Sanphui, Priyankar; Biswas, Subhas Chandra] Indian Inst Chem Biol, CSIR, Cell Biol & Physiol Div, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Biswas, SC (corresponding author), Indian Inst Chem Biol, CSIR, Cell Biol & Physiol Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.	biswassc@gmail.com			Department of Biotechnology, Government of India [BT/PR14383/MED/12/475/2010]; CSIR-Supra Institutional Project BenD [BSC0206]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); CSIR-Supra Institutional Project BenD	This work is supported in part by the Department of Biotechnology, Government of India, Project BT/PR14383/MED/12/475/2010 and CSIR-Supra Institutional Project BenD BSC0206.	Amente S, 2011, NUCLEIC ACIDS RES, V39, P9498, DOI 10.1093/nar/gkr638; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bean GR, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003483; Biswas SC, 2005, J NEUROSCI, V25, P8349, DOI 10.1523/JNEUROSCI.1570-05.2005; Biswas SC, 2002, J BIOL CHEM, V277, P49511, DOI 10.1074/jbc.M208086200; Biswas SC, 2005, NEUROCHEM RES, V30, P839, DOI 10.1007/s11064-005-6877-5; Biswas SC, 2007, J BIOL CHEM, V282, P29368, DOI 10.1074/jbc.M702634200; Biswas SC, 2007, J NEUROSCI, V27, P893, DOI 10.1523/JNEUROSCI.3524-06.2007; Biswas SC, 2010, J NEUROSCI, V30, P3973, DOI 10.1523/JNEUROSCI.6421-09.2010; Bock FJ, 2011, MOL CELL, V42, P555, DOI 10.1016/j.molcel.2011.05.022; Braun F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023577; Cuesto G, 2011, J NEUROSCI, V31, P2721, DOI 10.1523/JNEUROSCI.4477-10.2011; Ekert PG, 2006, BLOOD, V108, P1461, DOI 10.1182/blood-2006-03-014209; Ekoff M, 2007, BLOOD, V110, P3209, DOI 10.1182/blood-2007-02-073957; Erlacher M, 2006, J EXP MED, V203, P2939, DOI 10.1084/jem.20061552; Estus S, 1997, J NEUROSCI, V17, P7736; Fogarty MP, 2010, NEUROBIOL AGING, V31, P1774, DOI 10.1016/j.neurobiolaging.2008.09.018; Fogarty MP, 2003, BIOCHEM J, V371, P789, DOI 10.1042/BJ20021660; Follis AV, 2013, NAT CHEM BIOL, V9, P163, DOI [10.1038/NCHEMBIO.1166, 10.1038/nchembio.1166]; FRAUTSCHY SA, 1991, P NATL ACAD SCI USA, V88, P8362, DOI 10.1073/pnas.88.19.8362; Futami T, 2005, J BIOL CHEM, V280, P826, DOI 10.1074/jbc.M409948200; Galehdar Z, 2010, J NEUROSCI, V30, P16938, DOI 10.1523/JNEUROSCI.1598-10.2010; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Gilbert BJ, 2013, J CLIN PATHOL, V66, P362, DOI 10.1136/jclinpath-2013-201515; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gray DHD, 2012, IMMUNITY, V37, P451, DOI 10.1016/j.immuni.2012.05.030; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Han JW, 2001, P NATL ACAD SCI USA, V98, P11318, DOI 10.1073/pnas.201208798; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hemann MT, 2004, P NATL ACAD SCI USA, V101, P9333, DOI 10.1073/pnas.0403286101; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Kieran D, 2007, P NATL ACAD SCI USA, V104, P20606, DOI 10.1073/pnas.0707906105; Kudo W, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.43; Kudo W, 2012, HUM MOL GENET, V21, P1138, DOI 10.1093/hmg/ddr542; Lee HK, 2009, MOL BIOL CELL, V20, P1533, DOI 10.1091/mbc.E08-07-0777; Lesne SE, 2013, BRAIN, V136, P1383, DOI 10.1093/brain/awt062; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Liu DX, 2004, J NEUROSCI, V24, P8720, DOI 10.1523/JNEUROSCI.1821-04.2004; Ming LH, 2008, CARCINOGENESIS, V29, P1878, DOI 10.1093/carcin/bgn150; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Niizuma K, 2009, STROKE, V40, P618, DOI 10.1161/STROKEAHA.108.524447; Park DS, 1998, J CELL BIOL, V143, P457, DOI 10.1083/jcb.143.2.457; PIKE CJ, 1991, BRAIN RES, V563, P311, DOI 10.1016/0006-8993(91)91553-D; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Rideout HJ, 2003, J NEUROSCI, V23, P1237, DOI 10.1523/JNEUROSCI.23-04-01237.2003; Sanphui P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.148; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; Selkoe DJ, 2012, SCIENCE, V337, P1488, DOI 10.1126/science.1228541; Selznick LA, 2000, J NEUROPATH EXP NEUR, V59, P271, DOI 10.1093/jnen/59.4.271; She QB, 2000, J BIOL CHEM, V275, P20444, DOI 10.1074/jbc.M001020200; Troy CM, 2000, J NEUROSCI, V20, P1386; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yoshiike Y, 2003, J BIOL CHEM, V278, P23648, DOI 10.1074/jbc.M212785200; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; You H, 2006, P NATL ACAD SCI USA, V103, P9051, DOI 10.1073/pnas.0600889103; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Zou CG, 2009, ENDOCRINOLOGY, V150, P277, DOI 10.1210/en.2008-0794	59	74	77	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10812	10822		10.1074/jbc.M113.519355	http://dx.doi.org/10.1074/jbc.M113.519355			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24567336	hybrid, Green Published			2022-12-28	WOS:000334226400049
J	Chatani, E; Imamura, H; Yamamoto, N; Kato, M				Chatani, Eri; Imamura, Hiroshi; Yamamoto, Naoki; Kato, Minoru			Stepwise Organization of the beta- Structure Identifies Key Regions Essential for the Propagation and Cytotoxicity of Insulin Amyloid Fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Insulin; Protein Aggregation; Protein Misfolding; Protein Structure; Cytotoxicity; Prefibrillar Intermediate; Propagation	ELECTRON-MICROSCOPY; HYDROGEN-EXCHANGE; HUMAN-DISEASE; OLIGOMERS; MECHANISM; FIBRILLATION; BETA(2)-MICROGLOBULIN; TOXICITY; KINETICS; PROTOFIBRILS	Background: Oligomers and protofibrils have been observed in the early stages of fibrillation. Results: Fibrillation of insulin at a high salt concentration identified a new species of prefibrillar intermediate. Conclusion: Structural comparison of the intermediate and mature fibrils suggested regions responsible for self-propagation and cytotoxicity. Significance: The trapping of intermediate is an effective way of revealing molecular details of the organization of fibril structure. Amyloid fibrils are supramolecular assemblies, the deposition of which is associated with many serious diseases including Alzheimer, prion, and Huntington diseases. Several smaller aggregates such as oligomers and protofibrils have been proposed to play a role in early stages of the fibrillation process; however, little is known about how these species contribute to the formation of mature amyloid fibrils with a rigid cross- structure. Here, we identified a new pathway for the formation of insulin amyloid fibrils at a high concentration of salt in which mature fibrils were formed in a stepwise manner via a prefibrillar intermediate: minute prefibrillar species initially accumulated, followed by the subsequent formation of thicker amyloid fibrils. Fourier transform infrared spectra suggested the sequential formation of two types of -sheets with different strength hydrogen bonds, one of which was developed concomitantly with the mutual assembly of the prefibrillar intermediate to form mature fibrils. Interestingly, fibril propagation and cellular toxicity appeared only after the later step of structural organization, and a comparison of -sheet regions between the prefibrillar intermediate and mature fibrils using proteolysis led to the proposal of specific regions essential for manifestation of these properties.	[Chatani, Eri] Kobe Univ, Grad Sch Sci, Dept Chem, Kobe, Hyogo 6578501, Japan; [Imamura, Hiroshi; Yamamoto, Naoki; Kato, Minoru] Ritsumeikan Univ, Coll Pharmaceut Sci, Kusatsu, Shiga 5258577, Japan	Kobe University; Ritsumeikan University	Chatani, E (corresponding author), 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan.	chatani@crystal.kobe-u.ac.jp; kato-m@ph.ritsumei.ac.jp	Imamura, Hiroshi/P-5916-2018	Imamura, Hiroshi/0000-0001-8924-747X	Ministry of Education, Culture, Sports, Science, and Technology in Japan KAKENHI Grant [23770188]; Astellas Foundation for Research into Metabolic Disorders; Hayashi Memorial Foundation for Female Natural Scientists; Tomizawa Foundation; Ritsumeikan Global Innovation Research Organization (R-GIRO); Grants-in-Aid for Scientific Research [25440071] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology in Japan KAKENHI Grant; Astellas Foundation for Research into Metabolic Disorders(Astellas Pharmaceuticals); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists); Tomizawa Foundation; Ritsumeikan Global Innovation Research Organization (R-GIRO); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Ministry of Education, Culture, Sports, Science, and Technology in Japan KAKENHI Grant 23770188, and grants from the Astellas Foundation for Research into Metabolic Disorders, Hayashi Memorial Foundation for Female Natural Scientists, and Tomizawa Foundation (to E. C.), and the Ritsumeikan Global Innovation Research Organization (R-GIRO) (to M. K.).	Ahmad A, 2005, J BIOL CHEM, V280, P42669, DOI 10.1074/jbc.M504298200; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; Bleiholder C, 2011, NAT CHEM, V3, P172, DOI 10.1038/NCHEM.945; Bocharova OV, 2006, J BIOL CHEM, V281, P2373, DOI 10.1074/jbc.M510840200; Bouchard M, 2000, PROTEIN SCI, V9, P1960, DOI 10.1110/ps.9.10.1960; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Carullaa N, 2009, P NATL ACAD SCI USA, V106, P7828, DOI 10.1073/pnas.0812227106; Chatani E, 2010, J MOL BIOL, V400, P1057, DOI 10.1016/j.jmb.2010.05.071; Chimon S, 2005, J AM CHEM SOC, V127, P13472, DOI 10.1021/ja054039l; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Esler WP, 2000, BIOCHEMISTRY-US, V39, P6288, DOI 10.1021/bi992933h; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Fodera V, 2009, J PHYS CHEM B, V113, P10830, DOI 10.1021/jp810972y; Furukawa Y, 2010, J BIOL CHEM, V285, P22221, DOI 10.1074/jbc.M110.113597; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Groenning M, 2009, CURR PROTEIN PEPT SC, V10, P509, DOI 10.2174/138920309789352038; Grudzielanek S, 2006, J MOL BIOL, V356, P497, DOI 10.1016/j.jmb.2005.11.075; He XL, 2010, J MOL BIOL, V395, P134, DOI 10.1016/j.jmb.2009.10.019; Hill SE, 2009, BIOPHYS J, V96, P3781, DOI 10.1016/j.bpj.2009.01.044; Hong DP, 2002, J BIOL CHEM, V277, P21554, DOI 10.1074/jbc.M200188200; Ivanova MI, 2009, P NATL ACAD SCI USA, V106, P18990, DOI 10.1073/pnas.0910080106; Ivanova MI, 2006, P NATL ACAD SCI USA, V103, P4079, DOI 10.1073/pnas.0511298103; Jansen R, 2005, BIOPHYS J, V88, P1344, DOI 10.1529/biophysj.104.048843; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kihara M, 2005, J BIOL CHEM, V280, P12012, DOI 10.1074/jbc.M411949200; Konuma T, 2011, J MOL BIOL, V405, P851, DOI 10.1016/j.jmb.2010.11.029; Manno M, 2010, LANGMUIR, V26, P1424, DOI 10.1021/la903340v; Monti M, 2005, BBA-PROTEINS PROTEOM, V1753, P44, DOI 10.1016/j.bbapap.2005.09.004; Muzaffar M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027906; Naiki H, 1997, AMYLOID, V4, P223, DOI 10.3109/13506129709003833; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Nielsen L, 2001, J PHARM SCI-US, V90, P29, DOI 10.1002/1520-6017(200101)90:1<29::AID-JPS4>3.0.CO;2-4; Ohhashi Y, 2010, NAT CHEM BIOL, V6, P225, DOI 10.1038/NCHEMBIO.306; Oliveira CLP, 2009, J MOL BIOL, V387, P147, DOI 10.1016/j.jmb.2009.01.020; Raman B, 2005, BIOCHEMISTRY-US, V44, P1288, DOI 10.1021/bi048029t; Reddy G, 2009, P NATL ACAD SCI USA, V106, P11948, DOI 10.1073/pnas.0902473106; Relini A, 2010, BIOPHYS J, V98, P1277, DOI 10.1016/j.bpj.2009.11.052; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schmit JD, 2011, BIOPHYS J, V100, P450, DOI 10.1016/j.bpj.2010.11.041; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Tito P, 2000, J MOL BIOL, V303, P267, DOI 10.1006/jmbi.2000.4142; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Vestergaard B, 2007, PLOS BIOL, V5, P1089, DOI 10.1371/journal.pbio.0050134; WAUGH DF, 1946, J AM CHEM SOC, V68, P247, DOI 10.1021/ja01206a030; Westermark GT, 2010, TRENDS MOL MED, V16, P501, DOI 10.1016/j.molmed.2010.08.004; Westermark P, 2007, AMYLOID, V14, P179, DOI 10.1080/13506120701460923; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P671, DOI 10.1021/ar050069h; Whittingham JL, 2002, J MOL BIOL, V318, P479, DOI 10.1016/S0022-2836(02)00021-9; Wilson LM, 2007, J MOL BIOL, V366, P1639, DOI 10.1016/j.jmb.2006.12.040; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Yanagi K, 2012, J MOL BIOL, V422, P390, DOI 10.1016/j.jmb.2012.05.034; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109; ZHU YF, 1995, RAPID COMMUN MASS SP, V9, P1315, DOI 10.1002/rcm.1290091318	59	42	42	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10399	10410		10.1074/jbc.M113.520874	http://dx.doi.org/10.1074/jbc.M113.520874			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24569992	Green Published, hybrid			2022-12-28	WOS:000334226400014
J	Hang, LE; Lopez, CR; Liu, XP; Williams, JM; Chung, I; Wei, L; Bertuch, AA; Zhao, XL				Hang, Lisa E.; Lopez, Christopher R.; Liu, Xianpeng; Williams, Jaime M.; Chung, Inn; Wei, Lei; Bertuch, Alison A.; Zhao, Xiaolan			Regulation of Ku-DNA Association by Yku70 C-terminal Tail and SUMO Modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Repair; Molecular Genetics; Sumoylation; Telomeres; Yeast; Ku Complex	DOUBLE-STRAND BREAKS; END-JOINING REPAIR; SACCHAROMYCES-CEREVISIAE; TELOMERE MAINTENANCE; BUDDING YEAST; CELL-CYCLE; HETERODIMER; COMPLEX; BINDING; SUMOYLATION	Background: The Ku70-Ku80 ring encloses DNA ends to enable telomere protection and DNA repair. Results: Conditional sumoylation of Ku70 is reduced by mutating C-terminal lysines and this mutant shows decreased DNA interaction, shortened telomeres, and altered DNA repair. Conclusion: Our analyses suggest that sumoylation modulates Ku function by enhancing its DNA association. Significance: Ku is regulated by Ku70 C-terminal lysines and SUMO modification. The Ku70-Ku80 ring complex encloses DNA ends to facilitate telomere maintenance and DNA break repair. Many studies focus on the ring-forming regions of subunits Ku70 and Ku80. Less is known about the Ku70 C-terminal tail, which lies outside the ring. Our results suggest that this region is responsible for dynamic sumoylation of Yku70 upon DNA association in budding yeast. Mutating a cluster of five lysines in this region largely eliminates Yku70 sumoylation. Chromatin immunoprecipitation analyses show that yku70 mutants with these lysines replaced by arginines exhibit reduced Ku-DNA association at both telomeres and internal DNA breaks. Consistent with this physical evidence, Yku70 sumoylation deficiency is associated with impaired ability to block DNA end resection and suppression of multiple defects caused by inefficient resection. Correlating with these, yku70 mutants with reduced sumoylation levels exhibit shorter telomeres, increased G overhang levels, and altered levels of non-homologous end joining. We also show that diminution of sumoylation does not affect Yku70 protein levels or its interactions with protein and RNA partners. These results suggest a model whereby Yku70 sumoylation upon DNA association strengthens Ku-DNA interaction to promote multiple functions of Ku.	[Hang, Lisa E.; Liu, Xianpeng; Chung, Inn; Wei, Lei; Zhao, Xiaolan] Mem Sloan Kettering Canc Ctr, Mol Biol Program, New York, NY 10065 USA; [Hang, Lisa E.; Zhao, Xiaolan] Cornell Univ, Weill Grad Sch Med Sci, Program Biochem, New York, NY 10065 USA; [Hang, Lisa E.; Zhao, Xiaolan] Cornell Univ, Weill Grad Sch Med Sci, Program Cell, New York, NY 10065 USA; [Hang, Lisa E.; Zhao, Xiaolan] Cornell Univ, Weill Grad Sch Med Sci, Program Mol Biol, New York, NY 10065 USA; [Wei, Lei; Zhao, Xiaolan] Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY 10065 USA; [Lopez, Christopher R.; Bertuch, Alison A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Williams, Jaime M.; Bertuch, Alison A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Baylor College of Medicine; Baylor College of Medicine	Zhao, XL (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Biol Program, New York, NY 10065 USA.	zhaox1@mskcc.org		Nagy, Jaime/0000-0002-7945-4050; Bertuch, Alison/0000-0003-1864-8502; Zhao, Xiaolan/0000-0002-8302-6905	National Institutes of Health [GM080670, GM077509, GM008307]; American Cancer Society [RSG-12-013-01-CCG]; Leukemia and Lymphoma Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077509, T32GM008307, R01GM080670] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM080670, American Cancer Society Grant RSG-12-013-01-CCG, and Leukemia and Lymphoma Society Scholar Award (to X. Z.), National Institutes of Health Grant GM077509 (to A. B.), and GM008307 (T32 trainee J. M. W.).	Bertuch AA, 2003, MOL CELL BIOL, V23, P8202, DOI 10.1128/MCB.23.22.8202-8215.2003; Bonetti D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000966; Boulton SJ, 1996, EMBO J, V15, P5093, DOI 10.1002/j.1460-2075.1996.tb00890.x; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Chen XL, 2007, GENETICS, V177, P17, DOI 10.1534/genetics.107.074708; Clerici M, 2008, EMBO REP, V9, P810, DOI 10.1038/embor.2008.121; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; Driller L, 2000, J BIOL CHEM, V275, P24921, DOI 10.1074/jbc.M002588200; Feng L, 2012, NAT STRUCT MOL BIOL, V19, P201, DOI 10.1038/nsmb.2211; Ferreira HC, 2011, NAT CELL BIOL, V13, P867, DOI 10.1038/ncb2263; Fisher TS, 2005, DNA REPAIR, V4, P1215, DOI 10.1016/j.dnarep.2005.04.021; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Hang LE, 2011, NAT STRUCT MOL BIOL, V18, P920, DOI 10.1038/nsmb.2100; Lopez CR, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002233; Maringele L, 2002, GENE DEV, V16, P1919, DOI 10.1101/gad.225102; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Moore JK, 1996, MOL CELL BIOL, V16, P2164, DOI 10.1128/mcb.16.5.2164; Nugent CI, 1998, CURR BIOL, V8, P657, DOI 10.1016/S0960-9822(98)70253-2; Palmbos PL, 2005, MOL CELL BIOL, V25, P10782, DOI 10.1128/MCB.25.24.10782-10790.2005; Pfingsten JS, 2012, CELL, V148, P922, DOI 10.1016/j.cell.2012.01.033; Polotnianka RM, 1998, CURR BIOL, V8, P831, DOI 10.1016/S0960-9822(98)70325-2; Porter SE, 1996, NUCLEIC ACIDS RES, V24, P582, DOI 10.1093/nar/24.4.582; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Ribes-Zamora A, 2007, NAT STRUCT MOL BIOL, V14, P301, DOI 10.1038/nsmb1214; Rivera-Calzada A, 2007, EMBO REP, V8, P56, DOI 10.1038/sj.embor.7400847; Roy R, 2004, J BIOL CHEM, V279, P86, DOI 10.1074/jbc.M306841200; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Silver HR, 2011, DNA REPAIR, V10, P1243, DOI 10.1016/j.dnarep.2011.09.013; Stellwagen AE, 2003, GENE DEV, V17, P2384, DOI 10.1101/gad.1125903; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang JS, 1998, J BIOL CHEM, V273, P842, DOI 10.1074/jbc.273.2.842; Wellinger RJ, 2012, GENETICS, V191, P1073, DOI 10.1534/genetics.111.137851; Zhang Y, 2007, NAT STRUCT MOL BIOL, V14, P639, DOI 10.1038/nsmb1261; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	39	23	24	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10308	10317		10.1074/jbc.M113.526178	http://dx.doi.org/10.1074/jbc.M113.526178			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24567323	Green Published, hybrid			2022-12-28	WOS:000334226400007
J	Lebbe, EKM; Peigneur, S; Maiti, M; Devi, P; Ravichandran, S; Lescrinier, E; Ulens, C; Waelkens, E; D'Souza, L; Herdewijn, P; Tytgat, J				Lebbe, Eline K. M.; Peigneur, Steve; Maiti, Mohitosh; Devi, Prabha; Ravichandran, Samuthirapandian; Lescrinier, Eveline; Ulens, Chris; Waelkens, Etienne; D'Souza, Lisette; Herdewijn, Piet; Tytgat, Jan			Structure-Function Elucidation of a New alpha-Conotoxin, Lo1a, from Conus longurionis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer Disease; Electrophysiology; Nicotinic Acetylcholine Receptors; NMR; Protein Engineering; Schizophrenia; Conotoxin; Conotoxin Structure-Function Relationship	NICOTINIC ACETYLCHOLINE-RECEPTORS; NACHR SUBTYPE SELECTIVITY; MOLECULAR DISSECTION; SUBUNIT INTERFACES; CRYSTAL-STRUCTURE; SOLUTION CONFORMATION; PEPTIDE ANTAGONIST; BINDING PROTEIN; LIGAND-BINDING; IDENTIFICATION	Background: -Conotoxins are small toxins produced by cone snails and antagonists of nicotinic acetylcholine receptors. Results: Two mutants were created to investigate the unusual C terminus of a novel -conotoxin from Conus longurionis. Conclusion: We characterized an important residue for discrimination between neuronal and muscle subtype nicotinic acetylcholine receptors. Significance: This opens perspectives for designing new ligands to affect brain disorders. -Conotoxins are peptide toxins found in the venom of marine cone snails and potent antagonists of various subtypes of nicotinic acetylcholine receptors (nAChRs). nAChRs are cholinergic receptors forming ligand-gated ion channels in the plasma membranes of certain neurons and the neuromuscular junction. Because nAChRs have an important role in regulating transmitter release, cell excitability, and neuronal integration, nAChR dysfunctions have been implicated in a variety of severe pathologies such as epilepsy, myasthenic syndromes, schizophrenia, Parkinson disease, and Alzheimer disease. To expand the knowledge concerning cone snail toxins, we examined the venom of Conus longurionis. We isolated an 18-amino acid peptide named -conotoxin Lo1a, which is active on nAChRs. To the best of our knowledge, this is the first characterization of a conotoxin from this species. The peptide was characterized by electrophysiological screening against several types of cloned nAChRs expressed in Xenopus laevis oocytes. The three-dimensional solution structure of the -conotoxin Lo1a was determined by NMR spectroscopy. Lo1a, a member of the 4/7 family, blocks the response to acetylcholine in oocytes expressing (7) nAChRs with an IC50 of 3.24 +/- 0.7 m. Furthermore, Lo1a shows a high selectivity for neuronal versus muscle subtype nAChRs. Because Lo1a has an unusual C terminus, we designed two mutants, Lo1a-D and Lo1a-RRR, to investigate the influence of the C-terminal residue. Lo1a-D has a C-terminal Asp deletion, whereas in Lo1a-RRR, a triple-Arg tail replaces the Asp. They blocked the neuronal nAChR (7) with a lower IC50 value, but remarkably, both adopted affinity for the muscle subtype E-11.	[Lebbe, Eline K. M.; Peigneur, Steve; Tytgat, Jan] Univ Leuven KU Leuven, B-3000 Louvain, Belgium; [Maiti, Mohitosh; Lescrinier, Eveline; Herdewijn, Piet] Univ Leuven KU Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium; [Devi, Prabha; D'Souza, Lisette] Natl Inst Oceanog, Council Sci & Ind Res CSIR, Panaji 403004, Goa, India; [Ravichandran, Samuthirapandian] Annamalai Univ, Ctr Adv Study Marine Biol, Parangipettai 608502, Tamil Nadu, India; [Ulens, Chris] Univ Leuven KU Leuven, Lab Struct Neurobiol, B-3000 Louvain, Belgium; [Waelkens, Etienne] Univ Leuven KU Leuven, Lab Prot Phosphorylat & Prote, B-3000 Louvain, Belgium	KU Leuven; KU Leuven; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO); Annamalai University; KU Leuven; KU Leuven	Tytgat, J (corresponding author), Katholieke Univ Leuven, Herestr 49, B-3000 Louvain, Belgium.	jan.tytgat@pharm.kuleuven.be	Lescrinier, Eveline/G-9339-2016; Samuthirapandiyan, Ravichandran/AAI-6658-2020	Lescrinier, Eveline/0000-0001-7066-4329; Samuthirapandiyan, Ravichandran/0000-0002-8632-5062; Herdewijn, Piet/0000-0003-3589-8503; Lebbe, Eline/0000-0001-8523-1518; Peigneur, Steve/0000-0003-0504-5702	F.W.O. Vlaanderen [G.0939.11, G.0762.13, G.0433.12, G.A071.10N, G.0257.08]; EU-FP7-MAREX; Inter-University Attraction Poles Program (Belgian State, Belgian Science Policy) [IUAP 7/10, IUAP 7/24]; University of Leuven [T/12/081, GOA12/016]; Academische Stichting Leuven [2013/146]	F.W.O. Vlaanderen(FWO); EU-FP7-MAREX; Inter-University Attraction Poles Program (Belgian State, Belgian Science Policy)(Belgian Federal Science Policy Office); University of Leuven(KU Leuven); Academische Stichting Leuven	Supported by Grants G.0939.11 and G.0762.13 (F.W.O. Vlaanderen).; Supported by Grants G.0433.12, G.A071.10N, and G.0257.08 from F.W.O. Vlaanderen; EU-FP7-MAREX, IUAP 7/10, and IUAP 7/24 from the Inter-University Attraction Poles Program (Belgian State, Belgian Science Policy); OT/12/081 and GOA12/016 from the University of Leuven; and 2013/146 from Academische Stichting Leuven. To whom correspondence should be addressed: Toxicology and Pharmacology, KU Leuven, Herestraat 49, 3000 Leuven, Belgium. Tel.: 32-16-32-34-04; Fax: 32-16-32-34-05; E-mail: jan.tytgat@pharm.kuleuven.be.	Alberola-Die A, 2011, J NEUROCHEM, V117, P1009, DOI 10.1111/j.1471-4159.2011.07271.x; Arias HR, 2000, INT J BIOCHEM CELL B, V32, P1017, DOI 10.1016/S1357-2725(00)00051-0; Armishaw C, 2009, J BIOL CHEM, V284, P9498, DOI 10.1074/jbc.M806136200; Breese CR, 1997, J COMP NEUROL, V387, P385, DOI 10.1002/(SICI)1096-9861(19971027)387:3<385::AID-CNE5>3.0.CO;2-X; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; CHANGEUX JP, 1990, TRENDS PHARMACOL SCI, V11, P485, DOI 10.1016/0165-6147(90)90049-E; Chi SW, 2004, BIOCHEM J, V380, P347, DOI 10.1042/BJ20031792; Colquhoun L M, 1997, Adv Pharmacol, V39, P191, DOI 10.1016/S1054-3589(08)60072-1; COOPER E, 1991, NATURE, V350, P235, DOI 10.1038/350235a0; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; DEROME AE, 1990, J MAGN RESON, V88, P177, DOI 10.1016/0022-2364(90)90123-Q; Dowell C, 2003, J NEUROSCI, V23, P8445; Dutertre S, 2004, EUR J BIOCHEM, V271, P2327, DOI 10.1111/j.1432-1033.2004.04147.x; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Dutertre S, 2006, BIOCHEM PHARMACOL, V72, P661, DOI 10.1016/j.bcp.2006.03.027; Everhart D, 2004, BIOCHEMISTRY-US, V43, P2732, DOI 10.1021/bi036180h; Franco A, 2012, BIOCHEM PHARMACOL, V83, P419, DOI 10.1016/j.bcp.2011.11.006; Gold AB, 2012, HUM GENET, V131, P857, DOI 10.1007/s00439-012-1143-9; Gotti C, 1997, PROG NEUROBIOL, V53, P199, DOI 10.1016/S0301-0082(97)00034-8; Gotti C, 2004, PROG NEUROBIOL, V74, P363, DOI 10.1016/j.pneurobio.2004.09.006; GROEBE DR, 1995, MOL PHARMACOL, V48, P105; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Hu SH, 1996, STRUCTURE, V4, P417, DOI 10.1016/S0969-2126(96)00047-0; Hu SH, 1997, BIOCHEMISTRY-US, V36, P11323, DOI 10.1021/bi9713052; Hwang TL, 1998, J MAGN RESON, V135, P280, DOI 10.1006/jmre.1998.1598; Inserra MC, 2013, BIOCHEM PHARMACOL, V86, P791, DOI 10.1016/j.bcp.2013.07.016; Jin AH, 2014, BIOCHEMISTRY-US, V53, P1, DOI 10.1021/bi400882s; JOHNSON DS, 1995, MOL PHARMACOL, V48, P194; Kaas Q, 2012, NUCLEIC ACIDS RES, V40, pD325, DOI 10.1093/nar/gkr886; Keller Martin, 2004, Tech Hand Up Extrem Surg, V8, P212, DOI 10.1097/00130911-200412000-00003; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Le Novere N, 2002, J NEUROBIOL, V53, P447, DOI 10.1002/neu.10153; LENOVERE N, 1995, J MOL EVOL, V40, P155, DOI 10.1007/BF00167110; Lewis RJ, 2012, PHARMACOL REV, V64, P259, DOI 10.1124/pr.111.005322; Lluisma AO, 2008, TOXICON, V51, P174, DOI 10.1016/j.toxicon.2007.07.009; Loughnan M, 1998, J BIOL CHEM, V273, P15667, DOI 10.1074/jbc.273.25.15667; Loughnan ML, 2004, J MED CHEM, V47, P1234, DOI 10.1021/jm031010o; Luo S, 1999, BIOCHEMISTRY-US, V38, P14542, DOI 10.1021/bi991252j; Luo SQ, 1998, J NEUROSCI, V18, P8571; MARTINEZ JS, 1995, BIOCHEMISTRY-US, V34, P14519, DOI 10.1021/bi00044a030; Marx UC, 2006, MAGN RESON CHEM, V44, pS41, DOI 10.1002/mrc.1821; McIntosh JM, 2005, J BIOL CHEM, V280, P30107, DOI 10.1074/jbc.M504102200; McIntosh JM, 2004, MOL PHARMACOL, V65, P944, DOI 10.1124/mol.65.4.944; McIntosh JM, 2002, J BIOL CHEM, V277, P33610, DOI 10.1074/jbc.M205102200; MCINTOSH JM, 1994, J BIOL CHEM, V269, P16733; Nicke A, 2003, J BIOL CHEM, V278, P3137, DOI 10.1074/jbc.M210280200; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; OLIVERA BM, 1990, SCIENCE, V249, P257, DOI 10.1126/science.2165278; Park KH, 2001, J BIOL CHEM, V276, P49028, DOI 10.1074/jbc.M107798200; Peng C, 2008, PEPTIDES, V29, P1700, DOI 10.1016/j.peptides.2008.05.028; Peng C, 2010, ACTA BIOCH BIOPH SIN, V42, P745, DOI 10.1093/abbs/gmq074; Prince RJ, 1996, J BIOL CHEM, V271, P25770, DOI 10.1074/jbc.271.42.25770; Quinton L, 2013, ANAL BIOANAL CHEM, V405, P5341, DOI 10.1007/s00216-013-6926-x; Quiram PA, 1998, J BIOL CHEM, V273, P11001, DOI 10.1074/jbc.273.18.11001; Quiram PA, 1998, J BIOL CHEM, V273, P11007, DOI 10.1074/jbc.273.18.11007; Rezvani AH, 2001, BIOL PSYCHIAT, V49, P258, DOI 10.1016/S0006-3223(00)01094-5; RUBBOLI F, 1994, EUR J NEUROSCI, V6, P1596, DOI 10.1111/j.1460-9568.1994.tb00550.x; Sacco KA, 2004, J PSYCHOPHARMACOL, V18, P457, DOI 10.1177/0269881104047273; Sandall DW, 2003, BIOCHEMISTRY-US, V42, P6904, DOI 10.1021/bi034043e; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SHAKA AJ, 1988, J MAGN RESON, V77, P274, DOI 10.1016/0022-2364(88)90178-3; SINE SM, 1991, J BIOL CHEM, V266, P19369; SINE SM, 1993, P NATL ACAD SCI USA, V90, P9436, DOI 10.1073/pnas.90.20.9436; SINE SM, 1995, NEURON, V15, P205, DOI 10.1016/0896-6273(95)90077-2; Spronk CAEM, 2002, J BIOMOL NMR, V22, P281, DOI 10.1023/A:1014971029663; Stein EG, 1997, J MAGN RESON, V124, P154, DOI 10.1006/jmre.1996.1027; Steinlein OK, 2010, PFLUG ARCH EUR J PHY, V460, P495, DOI 10.1007/s00424-009-0766-8; Talley TT, 2006, J BIOL CHEM, V281, P24678, DOI 10.1074/jbc.M602969200; Teichert RW, 2005, J NEUROSCI, V25, P732, DOI 10.1523/JNEUROSCI.4065-04.2005; Tsetlin VI, 2004, FEBS LETT, V557, P9, DOI 10.1016/S0014-5793(03)01454-6; Tucker JK, 2009, SYSTEMATIC CLASSIFIC; Van Der Haegen A, 2011, FEBS J, V278, P3408, DOI 10.1111/j.1742-4658.2011.08264.x; WEVERS A, 1994, MOL BRAIN RES, V25, P122, DOI 10.1016/0169-328X(94)90286-0; Whiteaker P, 2007, BIOCHEMISTRY-US, V46, P6628, DOI 10.1021/bi7004202; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yuan DD, 2007, TOXICON, V49, P1135, DOI 10.1016/j.toxicon.2007.02.011	77	18	23	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9573	9583		10.1074/jbc.M114.556175	http://dx.doi.org/10.1074/jbc.M114.556175			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24567324	Green Published, hybrid			2022-12-28	WOS:000333807000013
J	Paciotti, S; Persichetti, E; Klein, K; Tasegian, A; Duvet, S; Hartmann, D; Gieselmann, V; Beccari, T				Paciotti, Silvia; Persichetti, Emanuele; Klein, Katharina; Tasegian, Anna; Duvet, Sandrine; Hartmann, Dieter; Gieselmann, Volkmar; Beccari, Tommaso			Accumulation of Free Oligosaccharides and Tissue Damage in Cytosolic alpha-Mannosidase (Man2c1)- deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Animal Models; ER-associated Degradation; Gene Knockout; Glycosidases; Oligosaccharide; Cytosolic -Mannosidase	RETICULUM-ASSOCIATED DEGRADATION; POLYMANNOSE-TYPE OLIGOSACCHARIDES; ENDOPLASMIC-RETICULUM; HEPATIC GLUCONEOGENESIS; CELL LINE; ER STRESS; GLYCOPROTEINS; MAN2C1; EXPRESSION; CARCINOMA	Background: Cytosolic -mannosidase (Man2c1) is involved in the catabolism of free oligosaccharides (fOS). Results: Man2c1-deficient mice accumulate fOS in tissues and show biochemical and histological alterations in the CNS, liver, and intestine. Conclusion: Man2c1 plays an essential role in the catabolism of fOS. Significance: Man2c1-deficient mice could be a useful tool to examine the biological significance of Man2c1. Free Man(7-9)GlcNAc(2) is released during the biosynthesis pathway of N-linked glycans or from misfolded glycoproteins during the endoplasmic reticulum-associated degradation process and are reduced to Man(5)GlcNAc in the cytosol. In this form, free oligosaccharides can be transferred into the lysosomes to be degraded completely. -Mannosidase (MAN2C1) is the enzyme responsible for the partial demannosylation occurring in the cytosol. It has been demonstrated that the inhibition of MAN2C1 expression induces accumulation of Man(8-9)GlcNAc oligosaccharides and apoptosis in vitro. We investigated the consequences caused by the lack of cytosolic -mannosidase activity in vivo by the generation of Man2c1-deficient mice. Increased amounts of Man(8-9)GlcNAc oligosaccharides were recognized in all analyzed KO tissues. Histological analysis of the CNS revealed neuronal and glial degeneration with formation of multiple vacuoles in deep neocortical layers and major telencephalic white matter tracts. Enterocytes of the small intestine accumulate mannose-containing saccharides and glycogen particles in their apical cytoplasm as well as large clear vacuoles in retronuclear position. Liver tissue is characterized by groups of hepatocytes with increased content of mannosyl compounds and glycogen, some of them undergoing degeneration by hydropic swelling. In addition, lectin screening showed the presence of mannose-containing saccharides in the epithelium of proximal kidney tubules, whereas scattered glomeruli appeared collapsed or featured signs of fibrosis along Bowman's capsule. Except for a moderate enrichment of mannosyl compounds and glycogen, heterozygous mice were normal, arguing against possible toxic effects of truncated Man2c1. These findings confirm the key role played by Man2c1 in the catabolism of free oligosaccharides.	[Paciotti, Silvia; Persichetti, Emanuele; Tasegian, Anna; Beccari, Tommaso] Univ Perugia, Dipartimento Sci Farmaceut, I-06126 Perugia, Italy; [Klein, Katharina; Gieselmann, Volkmar] Univ Bonn, Inst Biochem & Mol Biol, D-53115 Bonn, Germany; [Duvet, Sandrine] Univ Sci & Technol Lille, Unite Glycobiol Struct & Fonct, F-59655 Villeneuve Dascq, France; [Hartmann, Dieter] Univ Bonn, Inst Anat, D-53115 Bonn, Germany	University of Perugia; University of Bonn; Universite de Lille - ISITE; Universite de Lille; University of Bonn	Beccari, T (corresponding author), Univ Perugia, Dipartimento Sci Farmaceut, I-06126 Perugia, Italy.	tbeccari@unipg.it	Tasegian, Anna/K-1051-2016; paciotti, silvia/O-6070-2019	Tasegian, Anna/0000-0001-6122-265X; paciotti, silvia/0000-0003-1467-0155				ANUMULA KR, 1983, J BIOL CHEM, V258, P5274; Aranda-Abreu GE, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-33; Ashktorab H, 2012, DIGEST DIS SCI, V57, P905, DOI 10.1007/s10620-011-2026-y; Barateiro A, 2012, NEUROMOL MED, V14, P285, DOI 10.1007/s12017-012-8187-9; Bernon C, 2011, GLYCOBIOLOGY, V21, P363, DOI 10.1093/glycob/cwq169; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cacan R, 1996, BIOCHEM J, V313, P597, DOI 10.1042/bj3130597; Chantret I, 2008, GLYCOBIOLOGY, V18, P210, DOI 10.1093/glycob/cwn003; Chantret I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011734; Costanzi E, 2006, BBA-GEN SUBJECTS, V1760, P1580, DOI 10.1016/j.bbagen.2006.06.011; Duvet S, 1998, BIOCHEM J, V335, P389, DOI 10.1042/bj3350389; Gauss R, 2011, MOL CELL, V42, P782, DOI 10.1016/j.molcel.2011.04.027; Gustafson LA, 1997, BBA-BIOENERGETICS, V1318, P184, DOI 10.1016/S0005-2728(96)00128-4; Hartmann D, 1999, CURR BIOL, V9, P719, DOI 10.1016/S0960-9822(99)80331-5; He LZ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1309; HENNIGAR RA, 1987, DIABETOLOGIA, V30, P804; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Kimura K, 2012, DIABETES, V61, P61, DOI 10.2337/db10-1684; KMIECIK D, 1995, GLYCOBIOLOGY, V5, P483, DOI 10.1093/glycob/5.5.483; Kukushkin NV, 2011, BIOCHEM J, V438, P133, DOI 10.1042/BJ20110186; Kuokkanen E, 2007, GLYCOBIOLOGY, V17, P1084, DOI 10.1093/glycob/cwm083; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Makioka K, 2010, J NEUROL SCI, V297, P60, DOI 10.1016/j.jns.2010.06.019; Mithieux G, 2001, CURR OPIN CLIN NUTR, V4, P267, DOI 10.1097/00075197-200107000-00004; Morelle Willy, 2009, V534, P5, DOI 10.1007/978-1-59745-022-5_1; OKU H, 1991, J BIOCHEM-TOKYO, V110, P29, DOI 10.1093/oxfordjournals.jbchem.a123538; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Saint-Pol A, 1999, J BIOL CHEM, V274, P13547, DOI 10.1074/jbc.274.19.13547; SaintPol A, 1997, J CELL BIOL, V136, P45, DOI 10.1083/jcb.136.1.45; Seo HY, 2010, ENDOCRINOLOGY, V151, P561, DOI 10.1210/en.2009-0641; SHOUP VA, 1976, J BIOL CHEM, V251, P3845; Stinchi S, 1999, HUM MOL GENET, V8, P1365, DOI 10.1093/hmg/8.8.1365; Suzuki T, 2002, FASEB J, V16, DOI 10.1096/fj.01-0889rev; Suzuki T, 2006, BIOCHEM J, V400, P33, DOI 10.1042/BJ20060945; Tian Y, 2008, CANCER SCI, V99, P2428, DOI 10.1111/j.1349-7006.2008.01019.x; van Sluijters DA, 1999, EUR J BIOCHEM, V266, P653, DOI 10.1046/j.1432-1327.1999.00914.x; Wang L, 2013, J BIOL CHEM, V288, P11887, DOI 10.1074/jbc.M112.425702; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Xiang ZG, 2010, TRANSGENIC RES, V19, P67, DOI 10.1007/s11248-009-9299-3; Yanagida K, 2006, GLYCOBIOLOGY, V16, P294, DOI 10.1093/glycob/cwj074; Yue W, 2004, INT J CANCER, V108, P189, DOI 10.1002/ijc.11536; Zhu M, 2006, HUM MOL GENET, V15, P493, DOI 10.1093/hmg/ddi465	42	18	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9611	9622		10.1074/jbc.M114.550509	http://dx.doi.org/10.1074/jbc.M114.550509			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24550399	Green Published, hybrid			2022-12-28	WOS:000333807000016
J	Voyvodic, PL; Min, D; Liu, R; Williams, E; Chitalia, V; Dunn, AK; Baker, AB				Voyvodic, Peter L.; Min, Daniel; Liu, Robert; Williams, Evan; Chitalia, Vipul; Dunn, Andrew K.; Baker, Aaron B.			Loss of Syndecan-1 Induces a Pro-inflammatory Phenotype in Endothelial Cells with a Dysregulated Response to Atheroprotective Flow*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Endothelial Cell; Inflammation; Leukocyte; Mechanotransduction; Shear Stress; Atheroprotective Flow; Flow; Glycocalyx; Syndecan-1	FLUID SHEAR-STRESS; HEPARAN-SULFATE PROTEOGLYCANS; IN-VITRO; GROWTH-FACTOR; NITRIC-OXIDE; GLYCOCALYX; MECHANOTRANSDUCTION; ACTIVATION; MICE; ATHEROSCLEROSIS	Background: The endothelial glycocalyx extends into the arterial lumen and experiences shear forces from blood flow. Results: The loss of syndecan-1 results in a pro-inflammatory phenotype in endothelial cells with an altered response to atheroprotective flow. Conclusion: Syndecan-1 plays an important role in maintaining healthy endothelial phenotype. Significance: Therapies that retain syndecan-1 on endothelial cells may have the potential to reduce the progression of vascular disease. Fluid shear stresses are potent regulators of vascular homeostasis and powerful determinants of vascular disease progression. The glycocalyx is a layer of glycoaminoglycans, proteoglycans, and glycoproteins that lines the luminal surface of arteries. The glycocalyx interacts directly with hemodynamic forces from blood flow and, consequently, is a prime candidate for the mechanosensing of fluidic shear stresses. Here, we investigated the role of the glycocalyx component syndecan-1 (sdc-1) in controlling the shear stress-induced signaling and flow-mediated phenotypic modulation in endothelial cells. We found that knock-out of sdc-1 abolished several key early signaling events of endothelial cells in response to shear stress including the phosphorylation of Akt, the formation of a spatial gradient in paxillin phosphorylation, and the activation of RhoA. After exposure to atheroprotective flow, we found that sdc-1 knock-out endothelial cells had a phenotypic shift to an inflammatory/pro-atherosclerotic phenotype in contrast to the atheroprotective phenotype of wild type cells. Consistent with these findings, we found increased leukocyte adhesion to sdc-1 knock-out endothelial cells in vitro that was reduced by re-expression of sdc-1. In vivo, we found increased leukocyte recruitment and vascular permeability/inflammation in sdc-1 knock-out mice. Taken together, our studies support a key role for sdc-1 in endothelial mechanosensing and regulation of endothelial phenotype.	[Voyvodic, Peter L.; Min, Daniel; Liu, Robert; Williams, Evan; Dunn, Andrew K.; Baker, Aaron B.] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Chitalia, Vipul] Boston Univ, Sch Med, Boston Med Ctr, Renal Sect,Dept Med, Boston, MA 02118 USA	University of Texas System; University of Texas Austin; Boston Medical Center; Boston University	Baker, AB (corresponding author), Univ Texas Austin, Dept Biomed Engn, 107 West Dean Keeton St,BME 5-202D,C0800, Austin, TX 78712 USA.	abbaker1@gmail.com	Baker, Aaron/AAT-4635-2020; Dunn, Andrew/I-9527-2014	Voyvodic, Peter/0000-0001-6578-8837	National Institutes of Health [DP2 OD008716-01]; American Heart Association [10SDG2630139]; NATIONAL CANCER INSTITUTE [R01CA175382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK080946] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008716] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Director's New Innovator Grant DP2 OD008716-01 (to A. B. B.). This work was also supported by American Heart Association Grant 10SDG2630139.	Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Baker AB, 2008, CIRC RES, V103, P289, DOI 10.1161/CIRCRESAHA.108.179465; Baker AB, 2012, J AM COLL CARDIOL, V59, P1551, DOI 10.1016/j.jacc.2011.11.057; Baker AB, 2010, ATHEROSCLEROSIS, V213, P436, DOI 10.1016/j.atherosclerosis.2010.09.003; Baker AB, 2009, CIRC RES, V104, P380, DOI 10.1161/CIRCRESAHA.108.180695; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Blich M, 2013, ARTERIOSCL THROM VAS, V33, pE56, DOI 10.1161/ATVBAHA.112.254961; Chatzizisis YS, 2011, CIRCULATION, V123, P621, DOI 10.1161/CIRCULATIONAHA.110.970038; Cicha I, 2008, ATHEROSCLEROSIS, V196, P136, DOI 10.1016/j.atherosclerosis.2007.03.016; Dai G, 2007, CIRC RES, V101, P723, DOI 10.1161/CIRCRESAHA.107.152942; Das S, 2014, BIOMATERIALS, V35, P196, DOI 10.1016/j.biomaterials.2013.09.105; Davies PF, 1997, ANNU REV PHYSIOL, V59, P527, DOI 10.1146/annurev.physiol.59.1.527; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dimmeler S, 1998, CIRC RES, V83, P334, DOI 10.1161/01.RES.83.3.334; Dong QG, 1997, ARTERIOSCL THROM VAS, V17, P1599, DOI 10.1161/01.ATV.17.8.1599; Dunn AK, 2012, ANN BIOMED ENG, V40, P367, DOI 10.1007/s10439-011-0469-0; Ebong EE, 2011, ARTERIOSCL THROM VAS, V31, P1908, DOI 10.1161/ATVBAHA.111.225268; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Hamik A, 2007, J BIOL CHEM, V282, P13769, DOI 10.1074/jbc.M700078200; HECKER M, 1993, AM J PHYSIOL, V265, pH828, DOI 10.1152/ajpheart.1993.265.3.H828; Hennig T, 2011, J VASC RES, V48, P453, DOI 10.1159/000327009; Hoger JH, 2002, P NATL ACAD SCI USA, V99, P7780, DOI 10.1073/pnas.102184999; Hoshino Y, 2000, CIRCULATION, V102, P2528, DOI 10.1161/01.CIR.102.20.2528; Hsia E, 2003, J CELL BIOCHEM, V88, P1214, DOI 10.1002/jcb.10470; Hutcheson IR, 1996, BRIT J PHARMACOL, V118, P720, DOI 10.1111/j.1476-5381.1996.tb15459.x; Iomini C, 2004, J CELL BIOL, V164, P811, DOI 10.1083/jcb.200312133; KAMIYA A, 1984, B MATH BIOL, V46, P127, DOI 10.1016/S0092-8240(84)80038-5; Koo A, 2013, AM J PHYSIOL-CELL PH, V304, pC137, DOI 10.1152/ajpcell.00187.2012; Koskinas KC, 2010, CIRCULATION, V121, P2092, DOI 10.1161/CIRCULATIONAHA.109.901678; Kumagai R, 2009, FREE RADICAL BIO MED, V47, P600, DOI 10.1016/j.freeradbiomed.2009.05.034; Kumekawa M, 2008, BIOL PHARM BULL, V31, P1609, DOI 10.1248/bpb.31.1609; Malek AM, 1999, J MOL CELL CARDIOL, V31, P387, DOI 10.1006/jmcc.1998.0873; Mobine HR, 2009, CIRC-HEART FAIL, V2, P121, DOI 10.1161/CIRCHEARTFAILURE.108.813261; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; Nam EJ, 2012, METHODS MOL BIOL, V836, P291, DOI 10.1007/978-1-61779-498-8_19; Okina E, 2009, SCAND J MED SCI SPOR, V19, P479, DOI 10.1111/j.1600-0838.2009.00941.x; Orr AW, 2006, MOL BIOL CELL, V17, P4686, DOI 10.1091/mbc.E06-04-0289; Pahakis MY, 2007, BIOCHEM BIOPH RES CO, V355, P228, DOI 10.1016/j.bbrc.2007.01.137; Pampori N, 1999, J BIOL CHEM, V274, P21609, DOI 10.1074/jbc.274.31.21609; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Pohl U., 1991, AM J PHYSIOL, V261, pH2016; Potter DR, 2008, CIRC RES, V102, P770, DOI 10.1161/CIRCRESAHA.107.160226; Potter DR, 2009, CIRC RES, V104, P1318, DOI 10.1161/CIRCRESAHA.108.191585; Ramani VC, 2013, FEBS J, V280, P2294, DOI 10.1111/febs.12168; Rapraeger AC, 2013, FEBS J, V280, P2207, DOI 10.1111/febs.12160; Roper JA, 2012, CURR OPIN STRUC BIOL, V22, P583, DOI 10.1016/j.sbi.2012.07.003; Savery MD, 2013, MICROVASC RES, V87, P83, DOI 10.1016/j.mvr.2013.02.001; Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843; Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; VanTeeffelen JW, 2007, TRENDS CARDIOVAS MED, V17, P101, DOI 10.1016/j.tcm.2007.02.002; Voyvodic PL, 2012, LAB CHIP, V12, P3322, DOI 10.1039/c2lc40526a; Weinbaum S, 2003, P NATL ACAD SCI USA, V100, P7988, DOI 10.1073/pnas.1332808100; Yang BH, 2011, ARTERIOSCL THROM VAS, V31, P376, DOI 10.1161/ATVBAHA.110.217794; Zaidel-Bar R, 2005, J CELL SCI, V118, P3997, DOI 10.1242/jcs.02523; Zhou GJ, 2012, J CLIN INVEST, V122, P4727, DOI 10.1172/JCI66056	60	82	85	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9547	9559		10.1074/jbc.M113.541573	http://dx.doi.org/10.1074/jbc.M113.541573			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24554698	Green Published, hybrid			2022-12-28	WOS:000333807000011
J	Abu-Odeh, M; Bar-Mag, T; Huang, HM; Kim, TH; Salah, ZD; Abdeen, SK; Sudol, M; Reichmann, D; Sidhu, S; Kim, PM; Aqeilan, RI				Abu-Odeh, Mohammad; Bar-Mag, Tomer; Huang, Haiming; Kim, TaeHyung; Salah, Zaidoun; Abdeen, Suhaib K.; Sudol, Marius; Reichmann, Dana; Sidhu, Sachdev; Kim, Philip M.; Aqeilan, Rami I.			CharacterizingWWDomain Interactions of Tumor Suppressor WWOX Reveals Its Association with Multiprotein Networks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 Ubiquitin Ligase; Mass Spectrometry (MS); Protein-Protein Interactions; Tumor Suppressor Gene; Ubiquitination; WW Domain; WWOX; Itch	DOMAIN-CONTAINING OXIDOREDUCTASE; YES-ASSOCIATED PROTEIN; PEPTIDE RECOGNITION MODULES; E3 UBIQUITIN LIGASE; PROLINE-RICH LIGAND; LARGE GENE LISTS; TYROSINE KINASE; IN-VITRO; ITCH; BINDING	Background: WWOX encodes a 46-kDa tumor suppressor. Results: WW1 domain of WWOX mediates its protein-protein interaction with PY motifs that are involved in molecular processes, including transcription, RNA processing, and metabolism. Conclusion: The WW1 domain of WWOX provides a versatile platform that links WWOX with individual proteins associated with physiologically important networks. Significance: This study provides a better understanding of WWOX biology in normal and disease states. WW domains are small modules present in regulatory and signaling proteins that mediate specific protein-protein interactions. The WW domain-containing oxidoreductase (WWOX) encodes a 46-kDa tumor suppressor that contains two N-terminal WW domains and a central short-chain dehydrogenase/reductase domain. Based on its ligand recognition motifs, the WW domain family is classified into four groups. The largest one, to which WWOX belongs, recognizes ligands with a PPXY motif. To pursue the functional properties of the WW domains of WWOX, we employed mass spectrometry and phage display experiments to identify putative WWOX-interacting partners. Our analysis revealed that the first WW (WW1) domain of WWOX is the main functional interacting domain. Furthermore, our study uncovered well known and new PPXY-WW1-interacting partners and shed light on novel LPXY-WW1-interacting partners of WWOX. Many of these proteins are components of multiprotein complexes involved in molecular processes, including transcription, RNA processing, tight junction, and metabolism. By utilizing GST pull-down and immunoprecipitation assays, we validated that WWOX is a substrate of the E3 ubiquitin ligase ITCH, which contains two LPXY motifs. We found that ITCH mediates Lys-63-linked polyubiquitination of WWOX, leading to its nuclear localization and increased cell death. Our data suggest that the WW1 domain of WWOX provides a versatile platform that links WWOX with individual proteins associated with physiologically important networks.	[Abu-Odeh, Mohammad; Bar-Mag, Tomer; Salah, Zaidoun; Abdeen, Suhaib K.; Aqeilan, Rami I.] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Immunol & Canc Res, IMRIC, IL-91120 Jerusalem, Israel; [Huang, Haiming; Kim, TaeHyung; Sidhu, Sachdev; Kim, Philip M.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Huang, Haiming; Kim, TaeHyung; Sidhu, Sachdev; Kim, Philip M.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Dept Comp Sci, Toronto, ON M5S 3E1, Canada; [Salah, Zaidoun] Al Quds Univ, Al Quds Bard Honors Coll, East Jerusalem, Abu Dies, Israel; [Sudol, Marius] Weis Ctr Res, Geisinger Clin, Lab Signal Transduct & Prote Profiling, Danville, PA 17822 USA; Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Reichmann, Dana] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Aqeilan, Rami I.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Ctr Comprehens Canc, Columbus, OH 43210 USA	Hebrew University of Jerusalem; University of Toronto; University of Toronto; Icahn School of Medicine at Mount Sinai; Hebrew University of Jerusalem; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Aqeilan, RI (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Immunol & Canc Res, POB 12272,Ein Karem Campus, IL-91120 Jerusalem, Israel.	ramiaq@mail.huji.ac.il	Reichmann, Dana/J-4999-2019; Aqeilan, Rami/R-4443-2016; Aqeilan, Rami/AAT-7785-2020	Reichmann, Dana/0000-0003-0315-5334; Aqeilan, Rami/0000-0002-6034-023X; 	Israel Science Foundation [12-542]; German Israel Foundation [1101-60.11/2010]; Pennsylvania Breast Cancer Coalition [60707, 920093]; Geisinger Clinic; Lejwa Fund for Biochemistry	Israel Science Foundation(Israel Science Foundation); German Israel Foundation(German-Israeli Foundation for Scientific Research and Development); Pennsylvania Breast Cancer Coalition; Geisinger Clinic; Lejwa Fund for Biochemistry	This work was supported in part by funds from Israel Science Foundation Grant 12-542 and German Israel Foundation Grant 1101-60.11/2010 (to R. I. A.); Pennsylvania Breast Cancer Coalition Grants 60707 and 920093 and the Geisinger Clinic (to M. S.); and the Lejwa Fund for Biochemistry (to D. R.).	Aqeilan RI, 2008, J BIOL CHEM, V283, P21629, DOI 10.1074/jbc.M800855200; Aqeilan RI, 2005, CANCER RES, V65, P6764, DOI 10.1158/0008-5472.CAN-05-1150; Aqeilan RI, 2004, P NATL ACAD SCI USA, V101, P4401, DOI 10.1073/pnas.0400805101; Aqeilan RI, 2004, CANCER RES, V64, P8256, DOI 10.1158/0008-5472.CAN-04-2055; Aqeilian RI, 2007, CANCER RES, V67, P9330, DOI 10.1158/0008-5472.CAN-07-2147; Aragon E, 2012, STRUCTURE, V20, P1726, DOI 10.1016/j.str.2012.07.014; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; Bouteille N, 2009, ONCOGENE, V28, P2569, DOI 10.1038/onc.2009.120; Bratt A, 2002, GENE, V298, P69, DOI 10.1016/S0378-1119(02)00928-9; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Chang NS, 2007, TRENDS MOL MED, V13, P12, DOI 10.1016/j.molmed.2006.11.006; Chang NS, 2005, J BIOL CHEM, V280, P43100, DOI 10.1074/jbc.M505590200; Chang NS, 2003, J BIOL CHEM, V278, P9195, DOI 10.1074/jbc.M208373200; Chang NS, 2001, J BIOL CHEM, V276, P3361, DOI 10.1074/jbc.M007140200; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Conforti F, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.27; Del Mare S, 2009, J CELL BIOCHEM, V108, P737, DOI 10.1002/jcb.22298; Di Marcotullio L, 2011, ONCOGENE, V30, P65, DOI 10.1038/onc.2010.394; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Gardenswartz A, 2014, EXP BIOL MED, V239, P253, DOI 10.1177/1535370213519213; Gaudio E, 2006, CANCER RES, V66, P11585, DOI 10.1158/0008-5472.CAN-06-3376; Hansen TM, 2007, BIOCHEM BIOPH RES CO, V361, P33, DOI 10.1016/j.bbrc.2007.06.104; Hu H, 2004, PROTEOMICS, V4, P643, DOI 10.1002/pmic.200300632; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jin CJ, 2006, BIOCHEM BIOPH RES CO, V341, P784, DOI 10.1016/j.bbrc.2006.01.023; Kang HS, 2009, MOL CELL BIOL, V29, P2556, DOI 10.1128/MCB.01620-08; Kim T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1294; Levy D, 2007, CELL DEATH DIFFER, V14, P743, DOI 10.1038/sj.cdd.4402063; Ludes-Meyers JH, 2004, ONCOGENE, V23, P5049, DOI 10.1038/sj.onc.1207680; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; McDonald CB, 2012, J MOL BIOL, V422, P58, DOI 10.1016/j.jmb.2012.05.015; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; O'Keefe LV, 2011, HUM MOL GENET, V20, P497, DOI 10.1093/hmg/ddq495; Oka T, 2012, ONCOGENE, V31, P128, DOI 10.1038/onc.2011.216; Omerovic J, 2007, FASEB J, V21, P2849, DOI 10.1096/fj.06-7925com; Paige AJW, 2001, P NATL ACAD SCI USA, V98, P11417, DOI 10.1073/pnas.191175898; Qiu L, 2000, J BIOL CHEM, V275, P35734, DOI 10.1074/jbc.M007300200; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Salah Z, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.6; Salah Z, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.53; Salah Z, 2012, FRONT BIOSCI-LANDMRK, V17, P331, DOI 10.2741/3930; Salah Z, 2010, FUTURE ONCOL, V6, P249, DOI [10.2217/fon.09.152, 10.2217/FON.09.152]; Schuchardt BJ, 2013, BIOCHEMISTRY-US, V52, P9223, DOI 10.1021/bi400987k; Scialpi F, 2008, BIOCHEM PHARMACOL, V76, P1515, DOI 10.1016/j.bcp.2008.07.028; Sudol M, 2005, IUBMB LIFE, V57, P773, DOI 10.1080/15216540500389039; SUDOL M, 1995, J BIOL CHEM, V270, P14733, DOI 10.1074/jbc.270.24.14733; Sudol M, 1996, PROG BIOPHYS MOL BIO, V65, P113, DOI 10.1016/S0079-6107(96)00008-9; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Sudol M, 2012, STRUCTURE, V20, P1619, DOI 10.1016/j.str.2012.09.007; Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010; Sundvall M, 2008, P NATL ACAD SCI USA, V105, P4162, DOI 10.1073/pnas.0708333105; Sze CI, 2004, J BIOL CHEM, V279, P30498, DOI 10.1074/jbc.M401399200; Tong AHY, 2002, SCIENCE, V295, P321, DOI 10.1126/science.1064987; Tonikian R, 2007, NAT PROTOC, V2, P1368, DOI 10.1038/nprot.2007.151; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Wang HY, 2012, CELL DEATH DIFFER, V19, P1049, DOI 10.1038/cdd.2011.188; Weidemann A, 2008, CELL DEATH DIFFER, V15, P621, DOI 10.1038/cdd.2008.12; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111	67	64	66	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8865	8880		10.1074/jbc.M113.506790	http://dx.doi.org/10.1074/jbc.M113.506790			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24550385	Green Published, hybrid			2022-12-28	WOS:000333472100012
J	Islam, MA; Thomas, SD; Murty, VV; Sedoris, KJ; Miller, DM				Islam, Md Ashraful; Thomas, Shelia D.; Murty, Vundavalli V.; Sedoris, Kara J.; Miller, Donald M.			c-Myc Quadruplex-forming Sequence Pu-27 Induces Extensive Damage in Both Telomeric and Nontelomeric Regions of DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Death; DNA Damage; Myc; Survivin; Telomeres; ATM; Alt Cell; G-quadruplex; Phospho-H2AX; Shelterin	NUCLEOTIDE EXCISION-REPAIR; SYNTHETIC LETHALITY; CELL-CYCLE; ATM; PROTEIN; GENOME; TRF2; APOPTOSIS; CANCER; RECOMBINATION	Background: G-quadruplex forming DNA of gene promoter associated with cell death and growth arrest. Results: G-quadruplex forming DNA at c-Myc promoter Pu27 destabilizes proteins at telomere and inhibits DNA repair molecules. Conclusion: Pu27 shows extensive DNA damage primarily at telomere that contributes to cell death. Significance: Learning how Pu27 destabilizes at telomeric region is crucial to understanding G-quadruplex-mediated cancer biology. Quadruplex-forming DNA sequences are present throughout the eukaryotic genome, including in telomeric DNA. We have shown that the c-Myc promoter quadruplex-forming sequence Pu-27 selectively kills transformed cells (Sedoris, K. C., Thomas, S. D., Clarkson, C. R., Muench, D., Islam, A., Singh, R., and Miller, D. M. (2012) Genomic c-Myc quadruplex DNA selectively kills leukemia. Mol. Cancer Ther. 11, 66-76). In this study, we show that Pu-27 induces profound DNA damage, resulting in striking chromosomal abnormalities in the form of chromatid or chromosomal breaks, radial formation, and telomeric DNA loss, which induces -H2AX in U937 cells. Pu-27 down-regulates telomeric shelterin proteins, DNA damage response mediators (RAD17 and RAD50), double-stranded break repair molecule 53BP1, G(2) checkpoint regulators (CHK1 and CHK2), and anti-apoptosis gene survivin. Interestingly, there are no changes of DNA repair molecules H(2)AX, BRCA1, and the telomere maintenance gene, hTERT. B-U937, where U937 cells stably transfected with deleted basic domain of TRF2 is partially sensitive to Pu-27 but exhibits no changes in expression of shelterin proteins. However, there is an up-regulation of CHK1, CHK2, H(2)AX, BRCA1, and survivin. Telomere dysfunction-induced foci assay revealed co-association of TRF1with -H2AX in ATM deficient cells, which are differentially sensitive to Pu-27 than ATM proficient cells. Alt (alternating lengthening of telomere) cells are relatively resistant to Pu-27, but there are no significant changes of telomerase activity in both Alt and non-Alt cells. Lastly, we show that this Pu-27-mediated sensitivity is p53-independent. The data therefore support two conclusions. First, Pu-27 induces DNA damage within both telomeric and nontelomeric regions of the genome. Second, Pu-27-mediated telomeric damage is due, at least in part, to compromise of the telomeric shelterin protein complex.	[Islam, Md Ashraful; Thomas, Shelia D.; Sedoris, Kara J.; Miller, Donald M.] Univ Louisville, James Graham Brown Canc Ctr, Dept Med, Louisville, KY 40202 USA; [Islam, Md Ashraful; Thomas, Shelia D.; Sedoris, Kara J.; Miller, Donald M.] Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40202 USA; [Murty, Vundavalli V.] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; [Murty, Vundavalli V.] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA	University of Louisville; University of Louisville; Columbia University; Columbia University	Islam, MA (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Dept Med, 505 S Hancock St,Ctr Bldg 442C, Louisville, KY 40202 USA.	ashrafulislam01@gmail.com	Islam, Ashraful/GYR-1579-2022	Islam, Ashraful/0000-0002-1742-6804	Grant COBRE National Institutes of Health: UPHS [1P30GM10639601]	Grant COBRE National Institutes of Health: UPHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Grant COBRE National Institutes of Health: UPHS Grant 1P30GM10639601 (to the James Graham Brown Cancer Center of the University of Louisville).	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Farokhzad OO, 1996, J IMMUNOL, V157, P5597; Flores I, 2006, MOL CELL BIOL, V26, P6130, DOI 10.1128/MCB.00543-06; FRIEDBERG EC, 1995, PHILOS T ROY SOC B, V347, P63, DOI 10.1098/rstb.1995.0010; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hoogstraten D, 2008, J CELL SCI, V121, P2850, DOI 10.1242/jcs.031708; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Hurley PJ, 2007, CELL CYCLE, V6, P414, DOI 10.4161/cc.6.4.3886; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Lavin MF, 2007, CELL CYCLE, V6, P931, DOI 10.4161/cc.6.8.4180; Liu HL, 2000, J BIOL CHEM, V275, P40155, DOI 10.1074/jbc.M001565200; Louis SF, 2005, P NATL ACAD SCI USA, V102, P9613, DOI 10.1073/pnas.0407512102; Lundblad V, 2000, MUTAT RES-FUND MOL M, V451, P227, DOI 10.1016/S0027-5107(00)00052-X; McLuckie KIE, 2013, J AM CHEM SOC, V135, P9640, DOI 10.1021/ja404868t; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Miller DM, 2012, CLIN CANCER RES, V18, P5546, DOI 10.1158/1078-0432.CCR-12-0977; Muraki K, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00135; Neidle S, 2010, FEBS J, V277, P1118, DOI 10.1111/j.1742-4658.2009.07463.x; OKAZAKI S, 1993, MOL CELL BIOL, V13, P1424, DOI 10.1128/MCB.13.3.1424; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pandita TK, 2000, ONCOGENE, V19, P1386, DOI 10.1038/sj.onc.1203444; Pandita TK, 2002, ONCOGENE, V21, P611, DOI 10.1038/sj.onc.1205060; POTTER H, 1984, P NATL ACAD SCI-BIOL, V81, P7161, DOI 10.1073/pnas.81.22.7161; Rawal P, 2006, GENOME RES, V16, P644, DOI 10.1101/gr.4508806; Robertson HM, 2006, GENOME RES, V16, P1345, DOI 10.1101/gr.5085606; Sedoris KC, 2012, MOL CANCER THER, V11, P66, DOI 10.1158/1535-7163.MCT-11-0515; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Simonsson T, 1998, NUCLEIC ACIDS RES, V26, P1167, DOI 10.1093/nar/26.5.1167; Smilenov LB, 1999, MOL CELL BIOL, V19, P6963; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tauchi T, 2003, ONCOGENE, V22, P5338, DOI 10.1038/sj.onc.1206833; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Xu Y, 1997, J CELL PHYSIOL, V170, P192, DOI 10.1002/(SICI)1097-4652(199702)170:2<192::AID-JCP11>3.0.CO;2-K; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	43	16	16	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8521	8531		10.1074/jbc.M113.505073	http://dx.doi.org/10.1074/jbc.M113.505073			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24464582	hybrid, Green Published			2022-12-28	WOS:000333157500043
J	Zeraik, AE; Pereira, HM; Santos, YV; Brandao-Neto, J; Spoerner, M; Santos, MS; Colnago, LA; Garratt, RC; Araujo, APU; DeMarco, R				Zeraik, Ana E.; Pereira, Humberto M.; Santos, Yuri V.; Brandao-Neto, Jose; Spoerner, Michael; Santos, Maiara S.; Colnago, Luiz A.; Garratt, Richard C.; Araujo, Ana P. U.; DeMarco, Ricardo			Crystal Structure of a Schistosoma mansoni Septin Reveals the Phenomenon of Strand Slippage in Septins Dependent on the Nature of the Bound Nucleotide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; GTPase; Protein Conformation; Protein Structure; X-ray Crystallography; Conformational Change; Filament; GTPase Domain; Schistosoma; Septin	FILAMENT FORMATION; MAMMALIAN SEPTINS; GTP-BINDING; FORMS FILAMENTS; YEAST SEPTIN; ARF; HYDROLYSIS; COMPLEXES; PROTEINS; FAMILY	Background: Septins are filament-forming proteins involved in membrane-remodeling events. Results: Two crystal structures of a septin with the highest resolution to date reveal the phenomenon of -strand slippage. Conclusion: A novel mechanistic framework for the influence of the nature of the bound nucleotide and the presence of Mg2+ in septins is proposed. Significance: Identification of strand slippage might contribute to elucidating the mechanism of septin association with membranes. Septins are filament-forming GTP-binding proteins involved in important cellular events, such as cytokinesis, barrier formation, and membrane remodeling. Here, we present two crystal structures of the GTPase domain of a Schistosoma mansoni septin (SmSEPT10), one bound to GDP and the other to GTP. The structures have been solved at an unprecedented resolution for septins (1.93 and 2.1 , respectively), which has allowed for unambiguous structural assignment of regions previously poorly defined. Consequently, we provide a reliable model for functional interpretation and a solid foundation for future structural studies. Upon comparing the two complexes, we observe for the first time the phenomenon of a strand slippage in septins. Such slippage generates a front-back communication mechanism between the G and NC interfaces. These data provide a novel mechanistic framework for the influence of nucleotide binding to the GTPase domain, opening new possibilities for the study of the dynamics of septin filaments.	[Zeraik, Ana E.; Pereira, Humberto M.; Santos, Yuri V.; Garratt, Richard C.; Araujo, Ana P. U.; DeMarco, Ricardo] Univ Sao Paulo, Inst Fis Sao Carlos, BR-13563120 Sao Carlos, SP, Brazil; [Brandao-Neto, Jose] Diamond Light Source, Didcot OX11 0DE, Oxon, England; [Spoerner, Michael] Univ Regensburg, Ctr Magnet Resonance Chem & Biomed, Inst Biophys & Phys Biochem, D-93053 Regensburg, Germany; [Santos, Maiara S.; Colnago, Luiz A.] Embrapa Instrumentacao, BR-13560970 Sao Carlos, SP, Brazil; [Santos, Maiara S.] Univ Sao Paulo, Inst Quim Sao Carlos, BR-13566590 Sao Carlos, SP, Brazil	Universidade de Sao Paulo; Diamond Light Source; University of Regensburg; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Sao Paulo	DeMarco, R (corresponding author), Univ Sao Paulo, Inst Fis Sao Carlos, BR-13563120 Sao Carlos, SP, Brazil.	rdemarco@ifsc.usp.br	Santos, Maiara/F-7766-2012; Colnago, Luiz Alberto/E-9693-2012; DeMarco, Ricardo/A-7773-2008; garratt, richard c/F-6921-2011; Spoerner, Michael/C-9035-2012; Araujo, Ana Paula U/I-6664-2012; Pereira, Humberto M/J-7824-2016; Zeraik, Ana/G-2974-2013	Colnago, Luiz Alberto/0000-0002-9516-9022; DeMarco, Ricardo/0000-0001-8944-1301; Araujo, Ana Paula U/0000-0001-5455-084X; Pereira, Humberto M/0000-0002-8652-6729; garratt, richard/0000-0002-2016-3179; Zeraik, Ana Eliza/0000-0001-9508-4283; Brandao-Neto, Jose/0000-0001-6015-320X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [550514/2011-2]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/57910-0]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Grant 550514/2011-2 and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grant 2008/57910-0 (to the Instituto Nacional de Ciencia e Tecnologia-Instituto Nacional de Biotecnologia Estrutural e Quimica Mecicinal em Doencas Infecciosas (INCT-INBEQMeDI).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AMOR JC, 1994, NATURE, V372, P704, DOI 10.1038/372704a0; Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Serrao VHB, 2011, FEBS LETT, V585, P3868, DOI 10.1016/j.febslet.2011.10.043; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Cao LH, 2009, CELL MOL LIFE SCI, V66, P3309, DOI 10.1007/s00018-009-0087-2; Casamayor A, 2003, MOL CELL BIOL, V23, P2762, DOI 10.1128/MCB.23.8.2762-2777.2003; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Eigenbrot C, 2001, STRUCTURE, V9, P627, DOI 10.1016/S0969-2126(01)00624-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eneqvist T, 2000, MOL CELL, V6, P1207, DOI 10.1016/S1097-2765(00)00117-9; Estey MP, 2011, CURR BIOL, V21, pR384, DOI 10.1016/j.cub.2011.03.067; Farkasovsky M, 2005, BIOL CHEM, V386, P643, DOI 10.1515/BC.2005.075; Field CM, 1996, J CELL BIOL, V133, P605, DOI 10.1083/jcb.133.3.605; Garcia W, 2008, BBA-PROTEINS PROTEOM, V1784, P1720, DOI 10.1016/j.bbapap.2008.06.005; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; GREASLEY SE, 1995, NAT STRUCT BIOL, V2, P797, DOI 10.1038/nsb0995-797; Grubbs RD, 2002, BIOMETALS, V15, P251, DOI 10.1023/A:1016026831789; Hall P. A., 2008, SEPTINS, P35; HEINZ DW, 1993, NATURE, V361, P561, DOI 10.1038/361561a0; Huang YW, 2006, FEBS J, V273, P3248, DOI 10.1111/j.1742-4658.2006.05333.x; JOHN J, 1993, J BIOL CHEM, V268, P923; KEEFE LJ, 1993, P NATL ACAD SCI USA, V90, P3275, DOI 10.1073/pnas.90.8.3275; Kinoshita M, 2003, J BIOCHEM, V134, P491, DOI 10.1093/jb/mvg182; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Lazarowski ER, 1997, J BIOL CHEM, V272, P20402, DOI 10.1074/jbc.272.33.20402; Macedo JNA, 2013, BIOCHEM J, V450, P95, DOI 10.1042/BJ20120851; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; Marques ID, 2012, CELL BIOCHEM BIOPHYS, V62, P317, DOI 10.1007/s12013-011-9307-0; Martinez C, 2004, BIOCHEM J, V382, P783, DOI 10.1042/BJ20040372; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; Nahum Laila A., 2012, Journal of Parasitology Research, P849132, DOI 10.1155/2012/849132; Nishihama R, 2011, BIOL CHEM, V392, P681, DOI 10.1515/BC.2011.086; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Pan FF, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-103; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Petkova AT, 2004, J MOL BIOL, V335, P247, DOI 10.1016/j.jmb.2003.10.044; Russell SEH, 2011, BIOL CHEM, V392, P763, DOI 10.1515/BC.2011.079; SECKLER R, 1990, J BIOL CHEM, V265, P7655; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Sirajuddin M, 2009, P NATL ACAD SCI USA, V106, P16592, DOI 10.1073/pnas.0902858106; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Tellinghuisen J, 2008, ANAL BIOCHEM, V373, P395, DOI 10.1016/j.ab.2007.08.039; van Boxel GI, 2010, J MOL BIOL, V400, P828, DOI 10.1016/j.jmb.2010.05.053; Versele M, 2005, TRENDS CELL BIOL, V15, P414, DOI 10.1016/j.tcb.2005.06.007; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Zent E, 2011, BIOL CHEM, V392, P791, DOI 10.1515/BC.2011.082; Zeraik AE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002602; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3	54	24	27	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7799	7811		10.1074/jbc.M113.525352	http://dx.doi.org/10.1074/jbc.M113.525352			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24464615	hybrid, Green Published			2022-12-28	WOS:000332761500046
J	Ebel, ME; Kansas, GS				Ebel, Mark E.; Kansas, Geoffrey S.			Defining the Functional Boundaries of the Murine alpha 1,3-Fucosyltransferase Fut7 Reveals a Remarkably Compact Locus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Adhesion; Gene Expression; Glycobiology; Glycosyltransferases; Immunology; Leukocyte; Transcription Regulation	SELECTIN-DEFICIENT MICE; ALPHA(1,3)FUCOSYLTRANSFERASE FUC-TVII; HIGH ENDOTHELIAL VENULES; JURKAT T-CELLS; SIALYL-LEWIS-X; P-SELECTIN; GENE-EXPRESSION; ALPHA(1,3)-FUCOSYL-TRANSFERASE VII; LEUKOCYTE RECRUITMENT; LIGAND EXPRESSION	Background: Fut7 gene expression is tightly regulated and controls leukocyte traffic. Results: A 12.7 kb genomic interval controls Fut7 gene expression in all cell types. Conclusion: This interval therefore represents the functional boundaries of the Fut7 locus. Significance: All cis-acting genetic elements that control Fut7 expression are within this genomic interval. Fut7 encodes an 1,3-fucosyltransferase critical for biosynthesis of glycan ligands for all three selectins. Consistent with this function, Fut7 expression is limited to hematopoietic cells and high endothelial cells which express selectin ligands. Mechanisms that govern Fut7 expression are poorly defined. To begin to understand the molecular genetic basis for transcriptional regulation of Fut7, a transgenic, gain-of-function, genetic complementation approach in mice was used to define the functional boundaries of the murine Fut7 locus, defined here as any uninterupted stretch of genomic DNA that contains all cis-acting genetic elements essential for accurate physiologic expression. A 12.7-kb contiguous genomic interval, which lies completely between the highly conserved flanking Npdc1 and Abca2 loci on chromosome 2 and which contains the complete transcriptional unit plus approximate to 7.4 kb upstream of the transcriptional start site and approximate to 2 kb downstream of the transcriptional termination and polyadenylation sites, was used as a transgene (Tg) on a Fut7 null background. Tg+ mice exhibited restoration of Fut7 gene expression and physiologic levels of selectin ligand expression and function on neutrophils, activated T cells, and high endothelial cells and corrected the functional defects in these cells found in Fut7 null mice without leading to detectable expression of Fut7 in normally non-expressing tissues. These results demonstrate that all genetic information essential for appropriate and selective expression of Fut7 in diverse cell types and in response to distinct developmental signals is contained within this comparatively small genetic region.	[Ebel, Mark E.; Kansas, Geoffrey S.] Northwestern Univ, Feinberg Med Sch, Dept Microbiol Immunol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Kansas, GS (corresponding author), Northwestern Univ, Feinberg Med Sch, Dept Microbiol Immunol, 320 E Super Ave, Chicago, IL 60611 USA.	gsk@northwestern.edu		Ebel, Mark/0000-0001-8833-7115	National Institutes of Health [CA60553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL092357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We gratefully acknowledge the efforts of Mark Singer and Dr. Steven D. Rosen, University of California, San Francisco, for performing immunohistochemistry for L-selectin ligands and MECA79 on peripheral lymph nodes (Fig. 5C) and for helpful advice and Dr. Dragana Jankovic, Laboratory of Parasitic Diseases, NIAID, National Institutes of Health for provision of T. gondii-containing brain lysates and critical advice. The genetically engineered mice were generated with the assistance of Northwestern University Transgenic and Targeted Mutagenesis Laboratory. The Northwestern University Transgenic and Targeted Mutagenesis Laboratory is supported in part by National Institutes of Health Grant CA60553 (to the Robert H. Lurie Comprehensive Cancer Center at Northwestern University).	ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Barry SM, 2003, BLOOD, V102, P1771, DOI 10.1182/blood-2002-11-3551; Blander JM, 1999, J IMMUNOL, V163, P3746; Brandt W, 2008, J BIOL CHEM, V283, P8976, DOI 10.1074/jbc.M709364200; Bullard DC, 1996, J EXP MED, V183, P2329, DOI 10.1084/jem.183.5.2329; Chen GY, 2006, P NATL ACAD SCI USA, V103, P16894, DOI 10.1073/pnas.0607926103; Dagia NM, 2006, NAT MED, V12, P1185, DOI 10.1038/nm1470; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Frenette PS, 1998, P NATL ACAD SCI USA, V95, P14423, DOI 10.1073/pnas.95.24.14423; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Hiraiwa N, 1997, BIOCHEM BIOPH RES CO, V231, P183, DOI 10.1006/bbrc.1997.6068; Hiraiwa N, 2003, BLOOD, V101, P3615, DOI 10.1182/blood-2002-07-2301; Homeister JW, 2001, IMMUNITY, V15, P115, DOI 10.1016/S1074-7613(01)00166-2; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; KISHIMOTO TK, 1990, P NATL ACAD SCI USA, V87, P2244, DOI 10.1073/pnas.87.6.2244; LABOW MA, 1994, IMMUNITY, V1, P709, DOI 10.1016/1074-7613(94)90041-8; LASKY LA, 1989, CELL, V56, P1045, DOI 10.1016/0092-8674(89)90637-5; Ley K, 2004, NAT REV IMMUNOL, V4, P325, DOI 10.1038/nri1351; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Maly P, 1996, CELL, V86, P643, DOI 10.1016/S0092-8674(00)80137-3; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; Moussion C, 2011, NATURE, V479, P542, DOI 10.1038/nature10540; Nabors LK, 2013, EXP HEMATOL, V41, P588, DOI 10.1016/j.exphem.2013.02.014; Pipkin ME, 2007, IMMUNITY, V26, P29, DOI 10.1016/j.immuni.2006.11.009; Robert C, 1999, J EXP MED, V189, P627, DOI 10.1084/jem.189.4.627; Robinson SD, 1999, P NATL ACAD SCI USA, V96, P11452, DOI 10.1073/pnas.96.20.11452; Smith PL, 1996, J BIOL CHEM, V271, P8250, DOI 10.1074/jbc.271.14.8250; STOOLMAN LM, 1987, BLOOD, V70, P1842; Underhill GH, 2005, BLOOD, V106, P3867, DOI 10.1182/blood-2005-03-0984; Underhill GH, 2002, BLOOD, V99, P2905, DOI 10.1182/blood.V99.8.2905; VanArsdale TL, 1997, P NATL ACAD SCI USA, V94, P2460, DOI 10.1073/pnas.94.6.2460; Wagers AJ, 2000, J IMMUNOL, V165, P5011, DOI 10.4049/jimmunol.165.9.5011; Wagers AJ, 1998, J EXP MED, V188, P2225, DOI 10.1084/jem.188.12.2225; White SJ, 2001, J IMMUNOL, V167, P628, DOI 10.4049/jimmunol.167.2.628; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007; Zisoulis DG, 2004, J BIOL CHEM, V279, P39495, DOI 10.1074/jbc.M407904200	38	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6341	6349		10.1074/jbc.M113.511790	http://dx.doi.org/10.1074/jbc.M113.511790			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24459148	Green Published, hybrid			2022-12-28	WOS:000332389400003
J	Jaiswal, M; Dvorsky, R; Amin, E; Risse, SL; Fansa, EK; Zhang, SC; Taha, MS; Gauhar, AR; Nakhaei-Rad, S; Kordes, C; Koessmeier, KT; Cirstea, IC; Olayioye, MA; Haussinger, D; Ahmadian, MR				Jaiswal, Mamta; Dvorsky, Radovan; Amin, Ehsan; Risse, Sarah L.; Fansa, Eyad K.; Zhang, Si-Cai; Taha, Mohamed S.; Gauhar, Aziz R.; Nakhaei-Rad, Saeideh; Kordes, Claus; Koessmeier, Katja T.; Cirstea, Ion C.; Olayioye, Monilola A.; Haeussinger, Dieter; Ahmadian, Mohammad R.			Functional Cross-talk between Ras and Rho Pathways A Ras-SPECIFIC GTPase-ACTIVATING PROTEIN (p120RasGAP) COMPETITIVELY INHIBITS THE RhoGAP ACTIVITY OF DELETED IN LIVER CANCER (DLC) TUMOR SUPPRESSOR BY MASKING THE CATALYTIC ARGININE FINGER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GTPase; Kinetics; Molecular Modeling; SH3 Domains; Structural Biology; Arginine Finger; DLC1; Deleted in Liver Cancer; RhoGAP; p120RasGAP	NUCLEOTIDE-EXCHANGE FACTORS; SH3 DOMAIN; HEPATOCELLULAR-CARCINOMA; STRUCTURAL BASIS; ONCOGENIC RAS; AUTOINHIBITORY MECHANISM; INDEPENDENT MECHANISMS; SIGNAL-TRANSDUCTION; HYDROLYSIS REACTION; BINDING PROTEINS	Background: The regulatory mechanism of the DLC1 tumor suppressor protein is unclear. Results: Structure-function analysis revealed determinants for the selectivity, activity, and inhibition of DLC1 RhoGAP function. Conclusion: p120RasGAP competitively and selectively inhibits DLC1 by targeting its catalytic arginine finger. Significance: This mechanistic study emphasizes the importance of the functional inter-relationships of GTPase-activating proteins mediating cross-talk between the Ras and Rho pathways. The three deleted in liver cancer genes (DLC1-3) encode Rho-specific GTPase-activating proteins (RhoGAPs). Their expression is frequently silenced in a variety of cancers. The RhoGAP activity, which is required for full DLC-dependent tumor suppressor activity, can be inhibited by the Src homology 3 (SH3) domain of a Ras-specific GAP (p120RasGAP). Here, we comprehensively investigated the molecular mechanism underlying cross-talk between two distinct regulators of small GTP-binding proteins using structural and biochemical methods. We demonstrate that only the SH3 domain of p120 selectively inhibits the RhoGAP activity of all three DLC isoforms as compared with a large set of other representative SH3 or RhoGAP proteins. Structural and mutational analyses provide new insights into a putative interaction mode of the p120 SH3 domain with the DLC1 RhoGAP domain that is atypical and does not follow the classical PXXP-directed interaction. Hence, p120 associates with the DLC1 RhoGAP domain by targeting the catalytic arginine finger and thus by competitively and very potently inhibiting RhoGAP activity. The novel findings of this study shed light on the molecular mechanisms underlying the DLC inhibitory effects of p120 and suggest a functional cross-talk between Ras and Rho proteins at the level of regulatory proteins.	[Jaiswal, Mamta; Dvorsky, Radovan; Amin, Ehsan; Risse, Sarah L.; Fansa, Eyad K.; Zhang, Si-Cai; Taha, Mohamed S.; Gauhar, Aziz R.; Nakhaei-Rad, Saeideh; Koessmeier, Katja T.; Cirstea, Ion C.; Ahmadian, Mohammad R.] Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fak Med, D-40225 Dusseldorf, Germany; [Kordes, Claus; Haeussinger, Dieter] Univ Dusseldorf, Clin Gastroenterol Hepatol & Infectiol, Fak Med, D-40225 Dusseldorf, Germany; [Cirstea, Ion C.] Leibniz Inst Age Res, D-07745 Jena, Germany; [Olayioye, Monilola A.] Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); University of Stuttgart	Ahmadian, MR (corresponding author), Univ Dusseldorf, Inst Biochem & Mol Biol 2, Fak Med, Univ Str 1,Gebaude 22-03, D-40255 Dusseldorf, Germany.	reza.ahmadian@uni-duesseldorf.de	Dvorsky, Radovan/ABE-3042-2020; Cirstea, Ion Cristian/AAQ-7670-2020; Kordes, Claus/AFM-1775-2022; jaiswal, mamta/E-5148-2016; Nakhaeirad, Saeideh/AAV-1771-2020; taha, mohamed/W-8321-2019	Cirstea, Ion Cristian/0000-0003-3204-1598; Kordes, Claus/0000-0003-0782-1998; jaiswal, mamta/0000-0002-5862-7506; Nakhaeirad, Saeideh/0000-0001-8966-8960; Amin, Ehsan/0000-0003-2995-8864; Taha, Mohamed/0000-0002-7121-9283	German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) through the Collaborative Research Center [974 (SFB 974)]; German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) through International Research Training Group [1902 (IRGT1902), AH 92/5-1]; National Genome Research Network Plus program of the German Ministry of Science and Education (Bundesministerium fur Bildung und Forschung) [01GS08100]; International North Rhine-Westphalia Research School BioStruct by Ministry of Innovation, Science and Research of the State North Rhine-Westphalia; Heinrich Heine University of Dusseldorf; Entrepreneur Foundation at the Heinrich Heine University of Dusseldorf; DFG Heisenberg program	German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) through the Collaborative Research Center; German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) through International Research Training Group(German Research Foundation (DFG)); National Genome Research Network Plus program of the German Ministry of Science and Education (Bundesministerium fur Bildung und Forschung); International North Rhine-Westphalia Research School BioStruct by Ministry of Innovation, Science and Research of the State North Rhine-Westphalia; Heinrich Heine University of Dusseldorf; Entrepreneur Foundation at the Heinrich Heine University of Dusseldorf; DFG Heisenberg program(German Research Foundation (DFG))	This work was supported in part by the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) through the Collaborative Research Center 974 (SFB 974) "Communication and Systems Relevance during Liver Injury and Regeneration," the International Research Training Group 1902 (IRGT1902), and Project Grant AH 92/5-1; the National Genome Research Network Plus program of the German Ministry of Science and Education (Bundesministerium fur Bildung und Forschung Grant 01GS08100); and the International North Rhine-Westphalia Research School BioStruct granted by the Ministry of Innovation, Science and Research of the State North Rhine-Westphalia, the Heinrich Heine University of Dusseldorf, and the Entrepreneur Foundation at the Heinrich Heine University of Dusseldorf.; Supported by the DFG Heisenberg program.	Ahmadian MR, 1997, BIOCHEMISTRY-US, V36, P4535, DOI 10.1021/bi962556y; Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686; Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Asnaghi L, 2010, ONCOGENE, V29, P2760, DOI 10.1038/onc.2010.39; Aznar S, 2001, PROG NUCLEIC ACID RE, V67, P193, DOI 10.1016/S0079-6603(01)67029-6; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chan FKC, 2012, NEUROSIGNALS, V20, P112, DOI 10.1159/000331240; Chan LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005572; Chan PC, 2012, CANCER RES, V72, P2405, DOI 10.1158/0008-5472.CAN-11-3078; Ching YP, 2003, J BIOL CHEM, V278, P10824, DOI 10.1074/jbc.M208310200; Clark GJ, 1997, J BIOL CHEM, V272, P1677, DOI 10.1074/jbc.272.3.1677; CLARK GJ, 1995, BREAST CANCER RES TR, V35, P133, DOI 10.1007/BF00694753; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Colon-Gonzalez F, 2008, J BIOL CHEM, V283, P35247, DOI 10.1074/jbc.M806264200; DiNitto JP, 2010, BIOCHEMISTRY-US, V49, P6083, DOI 10.1021/bi1000454; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Eberth A, 2005, BIOL CHEM, V386, P1105, DOI 10.1515/BC.2005.127; Eberth A., 2009, CURR PROTOC CELL BIO, P19; Eberth A, 2009, BIOCHEM J, V417, P371, DOI 10.1042/BJ20081535; ECCLESTON JF, 1993, J BIOL CHEM, V268, P27012; Erlmann P, 2009, MOL BIOL CELL, V20, P4400, DOI 10.1091/mbc.E09-03-0247; Fauchereau F, 2003, MOL CELL NEUROSCI, V23, P574, DOI 10.1016/S1044-7431(03)00078-2; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Gigoux V, 2002, J BIOL CHEM, V277, P23742, DOI 10.1074/jbc.C200121200; Gureasko J, 2010, P NATL ACAD SCI USA, V107, P3430, DOI 10.1073/pnas.0913915107; Harkiolaki M, 2003, EMBO J, V22, P2571, DOI 10.1093/emboj/cdg258; Healy KD, 2008, MOL CARCINOGEN, V47, P326, DOI 10.1002/mc.20389; Herbrand U, 2006, BIOL CHEM, V387, P311, DOI 10.1515/BC.2006.041; Holeiter G, 2008, CANCER RES, V68, P8743, DOI 10.1158/0008-5472.CAN-08-0984; Hu KQ, 1997, EMBO J, V16, P473, DOI 10.1093/emboj/16.3.473; Jaiswal M, 2012, METHODS MOL BIOL, V827, P37, DOI 10.1007/978-1-61779-442-1_3; Jaiswal M, 2011, J BIOL CHEM, V286, P18202, DOI 10.1074/jbc.M111.226431; Jian XY, 2009, J BIOL CHEM, V284, P1652, DOI 10.1074/jbc.M804218200; Karkkainen S, 2006, EMBO REP, V7, P186, DOI 10.1038/sj.embor.7400596; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kawai K, 2007, BIOCHEM BIOPH RES CO, V364, P783, DOI 10.1016/j.bbrc.2007.10.052; KhosraviFar R, 1998, ADV CANCER RES, V72, P57; Kim T, 2009, CANCER METAST REV, V28, P77, DOI 10.1007/s10555-008-9167-2; Kim TY, 2008, J BIOL CHEM, V283, P32762, DOI 10.1074/jbc.M800617200; Leblanc V, 1998, MOL CELL BIOL, V18, P5567, DOI 10.1128/MCB.18.9.5567; Leung THY, 2005, P NATL ACAD SCI USA, V102, P15207, DOI 10.1073/pnas.0504501102; Li GR, 2011, P NATL ACAD SCI USA, V108, P17129, DOI 10.1073/pnas.1112122108; Liao YC, 2008, INT J BIOCHEM CELL B, V40, P843, DOI 10.1016/j.biocel.2007.04.008; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; Ligeti E, 2012, PHYSIOL REV, V92, P237, DOI 10.1152/physrev.00045.2010; Lukasik D, 2011, ONCOL LETT, V2, P763, DOI 10.3892/ol.2011.345; Mitin N, 2007, NAT STRUCT MOL BIOL, V14, P814, DOI 10.1038/nsmb1290; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Moskwa P, 2005, J BIOL CHEM, V280, P6716, DOI 10.1074/jbc.M412563200; Pamonsinlapatham P, 2009, BIOCHIMIE, V91, P320, DOI 10.1016/j.biochi.2008.10.010; Pruitt K, 2001, CANCER LETT, V171, P1, DOI 10.1016/S0304-3835(01)00528-6; Qian XL, 2007, P NATL ACAD SCI USA, V104, P9012, DOI 10.1073/pnas.0703033104; Risse SL, 2013, BIOL CHEM, V394, P421, DOI 10.1515/hsz-2012-0246; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Roof RW, 1998, MOL CELL BIOL, V18, P7052, DOI 10.1128/MCB.18.12.7052; Ross B, 2007, BIOCHEM BIOPH RES CO, V353, P463, DOI 10.1016/j.bbrc.2006.12.044; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheffzek K, 2005, CELL MOL LIFE SCI, V62, P3014, DOI 10.1007/s00018-005-5136-x; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Scholz RP, 2011, EXP CELL RES, V317, P496, DOI 10.1016/j.yexcr.2010.11.003; Scholz RP, 2009, J CELL SCI, V122, P92, DOI 10.1242/jcs.036251; Scouras AD, 2011, PROTEIN SCI, V20, P341, DOI 10.1002/pro.565; Shang X, 2007, J BIOL CHEM, V282, P8801, DOI 10.1074/jbc.M609375200; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Tripathi V., 2013, ONCOGENE, V4, P1; Wang ZX, 1996, CELL GROWTH DIFFER, V7, P123; Wong CM, 2003, CANCER RES, V63, P7646; WU XD, 1995, STRUCTURE, V3, P215, DOI 10.1016/S0969-2126(01)00151-4; Yam JWP, 2006, CANCER RES, V66, P8367, DOI 10.1158/0008-5472.CAN-05-2850; Yang XY, 2009, ONCOGENE, V28, P1401, DOI 10.1038/onc.2008.498; YANG YS, 1994, EMBO J, V13, P1270, DOI 10.1002/j.1460-2075.1994.tb06379.x; Yuan BZ, 1998, CANCER RES, V58, P2196; Zhou YT, 2010, MOL BIOL CELL, V21, P3232, DOI 10.1091/mbc.E09-05-0408; Zimonjic DB, 2012, INT J ONCOL, V41, P393, DOI 10.3892/ijo.2012.1474; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775	80	21	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6839	6849		10.1074/jbc.M113.527655	http://dx.doi.org/10.1074/jbc.M113.527655			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24443565	Green Published, hybrid			2022-12-28	WOS:000332389400045
J	Kong, QR; Xie, BT; Li, JY; Huan, YJ; Huang, TQ; Wei, RY; Lv, JW; Liu, SC; Liu, ZH				Kong, Qingran; Xie, Bingteng; Li, Jingyu; Huan, Yanjun; Huang, Tianqing; Wei, Renyue; Lv, Jiawei; Liu, Shichao; Liu, Zhonghua			Identification and Characterization of an Oocyte Factor Required for Porcine Nuclear Reprogramming	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Remodeling; Cloning; DNA Damage; Oocyte; Reprogramming; Pig; Vimentin	FILAMENT PROTEIN VIMENTIN; IN-VITRO; INTERMEDIATE-FILAMENTS; PROTEOMIC ANALYSIS; MOUSE OOCYTES; HISTONE H2AX; CLONED PIGS; DNA; EXPRESSION; BINDING	Background: Oocyte factors can reprogram the somatic nucleus efficiently, but these factors still need to be defined. Results: Maternal vimentin acts as a genomic protector and results in p53 down-regulation during nuclear reprogramming. Conclusion: Maternal vimentin is crucial for nuclear reprogramming. Significance: We report the first evidence of vimentin as a reprogramming factor. Nuclear reprogramming of somatic cells can be induced by oocyte factors. Despite numerous attempts, the factors responsible for successful nuclear reprogramming remain elusive. In the present study, we found that porcine oocytes with the first polar body collected at 42 h of in vitro maturation had a stronger ability to support early development of cloned embryos than porcine oocytes with the first polar body collected at 33 h of in vitro maturation. To explore the key reprogramming factors responsible for the difference, we compared proteome signatures of the two groups of oocytes. 18 differentially expressed proteins between these two groups of oocytes were discovered by mass spectrometry (MS). Among these proteins, we especially focused on vimentin (VIM). A certain amount of VIM protein was stored in oocytes and accumulated during oocyte maturation, and maternal VIM was specifically incorporated into transferred somatic nuclei during nuclear reprogramming. When maternal VIM function was inhibited by anti-VIM antibody, the rate of cloned embryos developing to blastocysts was significantly lower than that of IgG antibody-injected embryos and non-injected embryos (12.24 versus 22.57 and 21.10%; p < 0.05), but the development of in vitro fertilization and parthenogenetic activation embryos was not affected. Furthermore, we found that DNA double strand breaks dramatically increased and that the p53 pathway was activated in cloned embryos when VIM function was inhibited. This study demonstrates that maternal VIM, as a genomic protector, is crucial for nuclear reprogramming in porcine cloned embryos.	[Kong, Qingran; Xie, Bingteng; Li, Jingyu; Huan, Yanjun; Huang, Tianqing; Wei, Renyue; Lv, Jiawei; Liu, Shichao; Liu, Zhonghua] Northeast Agr Univ, Coll Life Sci, Lab Embryo Biotechnol, Harbin 150030, Peoples R China	Northeast Agricultural University - China	Liu, ZH (corresponding author), Northeast Agr Univ, Coll Life Sci, Lab Embryo Biotechnol, Harbin 150030, Peoples R China.	liu086@yahoo.com	Liu, Shichao/J-2954-2019; Liu, Zhonghua/AAO-3590-2021; Liu, Zhunghua/F-2485-2010	Liu, Shichao/0000-0002-4156-3876; Liu, Zhonghua/0000-0002-9199-6493; Liu, Zhunghua/0000-0002-9199-6493; li, Jingyu/0000-0003-0136-532X; , Yanjun/0000-0001-7334-4582	Major State Basic Research Development Program [2011CB932004]; Chang Jiang Scholar Candidates Programme for Provincial Universities in Heilongjiang	Major State Basic Research Development Program(National Basic Research Program of China); Chang Jiang Scholar Candidates Programme for Provincial Universities in Heilongjiang	This work was supported by Major State Basic Research Development Program Grant 2011CB932004 and the Chang Jiang Scholar Candidates Programme for Provincial Universities in Heilongjiang.	Betthauser J, 2000, NAT BIOTECHNOL, V18, P1055, DOI 10.1038/80242; Boiani M, 2005, STEM CELLS, V23, P1089, DOI 10.1634/stemcells.2004-0352; Calvert Meredith E, 2003, Reprod Biol Endocrinol, V1, P27, DOI 10.1186/1477-7827-1-27; Campbell KHS, 2003, REPRODUCTION, P477; Cao SY, 2012, MOL REPROD DEV, V79, P413, DOI 10.1002/mrd.22044; CAPCO DG, 1982, CELL, V29, P847, DOI 10.1016/0092-8674(82)90446-9; DePianto D, 2004, EXP CELL RES, V301, P68, DOI 10.1016/j.yexcr.2004.08.007; Ellederova Z, 2004, BIOL REPROD, V71, P1533, DOI 10.1095/biolreprod.104.030304; ERIKSSON J E, 1992, Current Opinion in Cell Biology, V4, P99, DOI 10.1016/0955-0674(92)90065-K; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Fukuda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011274; Funahashi H, 1997, J REPROD FERTIL, P271; Gall L, 2012, CELL REPROGRAM, V14, P497, DOI 10.1089/cell.2012.0027; Gao SR, 2002, BIOL REPROD, V67, P928, DOI 10.1095/biolreprod.102.004606; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Hansis C, 2004, CURR BIOL, V14, P1475, DOI 10.1016/j.cub.2004.08.031; Hao YH, 2003, BIOL REPROD, V69, P501, DOI 10.1095/biolreprod.103.016170; Hartig R, 1998, J CELL SCI, V111, P3573; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Jiang G.-J., 2011, PLOS ONE, V6; Kikyo N, 2000, SCIENCE, V289, P2360, DOI 10.1126/science.289.5488.2360; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kong QR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006679; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Ma MY, 2008, J PROTEOME RES, V7, P4821, DOI 10.1021/pr800392s; Miyamoto K, 2011, P NATL ACAD SCI USA, V108, P7040, DOI 10.1073/pnas.1013634108; Miyamoto K, 2009, BIOL REPROD, V80, P935, DOI 10.1095/biolreprod.108.073676; Novak S, 2004, BIOL REPROD, V71, P1279, DOI 10.1095/biolreprod.103.027037; O'Neill C, 2012, THERIOGENOLOGY, V77, P773, DOI 10.1016/j.theriogenology.2011.12.016; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; Pfeiffer MJ, 2011, J PROTEOME RES, V10, P2140, DOI 10.1021/pr100706k; Podhorecka M, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/920161; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Rashi-Elkeles S, 2011, MOL ONCOL, V5, P336, DOI 10.1016/j.molonc.2011.06.004; Rodriguez-Osorio N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-190; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; SHOEMAN RL, 1988, J BIOL CHEM, V263, P18744; SHOEMAN RL, 1990, J BIOL CHEM, V265, P9055; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; Sun QY, 2001, MOL REPROD DEV, V59, P192, DOI 10.1002/mrd.1022; Sutovsky P, 2004, TRENDS BIOTECHNOL, V22, P205, DOI 10.1016/j.tibtech.2004.03.009; SUZUKI M, 1992, INT J RADIAT BIOL, V62, P581, DOI 10.1080/09553009214552501; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tamada H, 2006, MOL CELL BIOL, V26, P1259, DOI 10.1128/MCB.26.4.1259-1271.2006; Terzoudi GI, 2011, MUTAT RES-FUND MOL M, V711, P174, DOI 10.1016/j.mrfmmm.2010.12.011; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tolstonog GV, 2000, DNA CELL BIOL, V19, P647, DOI 10.1089/10445490050199054; Tolstonog GV, 2005, DNA CELL BIOL, V24, P85, DOI 10.1089/dna.2005.24.85; Tolstonog GV, 2002, DNA CELL BIOL, V21, P213, DOI 10.1089/10445490252925459; TRAUB P, 1994, BIOESSAYS, V16, P349, DOI 10.1002/bies.950160510; Vitale AM, 2007, MOL REPROD DEV, V74, P608, DOI 10.1002/mrd.20648; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wang SF, 2010, P NATL ACAD SCI USA, V107, P17639, DOI 10.1073/pnas.1013185107; Wang X, 1996, DNA CELL BIOL, V15, P209, DOI 10.1089/dna.1996.15.209; Watson AJ, 2007, J ANIM SCI, V85, pE1, DOI 10.2527/jas.2006-432; Whitworth KM, 2010, MOL REPROD DEV, V77, P1001, DOI 10.1002/mrd.21242; Wrenzycki C, 2001, BIOL REPROD, V65, P309, DOI 10.1095/biolreprod65.1.309; You J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048613; Zhang P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-348	62	18	18	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6960	6968		10.1074/jbc.M113.543793	http://dx.doi.org/10.1074/jbc.M113.543793			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24474691	Green Published, hybrid			2022-12-28	WOS:000332389400056
J	Hayashi, Y; Tsurumizu, R; Tsukahara, J; Takeda, K; Narita, S; Mori, M; Miki, K; Tokuda, H				Hayashi, Yumi; Tsurumizu, Ryoji; Tsukahara, Jun; Takeda, Kazuki; Narita, Shin-ichiro; Mori, Makiko; Miki, Kunio; Tokuda, Hajime			Roles of the Protruding Loop of Factor B Essential for the Localization of Lipoproteins ( LolB) in the Anchoring of Bacterial Triacylated Proteins to the Outer Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Escherichia coli; Lipoprotein; Membrane Proteins; Protein Export; Protein Sorting; Protein Structure; LolB; Bacterial Lipoprotein; Periplasm	ESCHERICHIA-COLI LIPOPROTEINS; OVEREXPRESSION; MECHANISM; CLEAVAGE; DELETION; MODEL	Background: LolB accepts lipoproteins from LolA and anchors them to the inner leaflet of outer membranes. Results: Membrane targeting of lipoproteins is defective in several mutants with substitutions of Leu-68 of LolB. Conclusion: The protruding loop of LolB plays critical roles in the membrane anchoring activity. Significance: A possible mechanism for the last step of lipoprotein sorting is proposed. The Lol system comprising five Lol proteins, LolA through LolE, sorts Escherichia coli lipoproteins to outer membranes. The LolCDE complex, an ATP binding cassette transporter in inner membranes, releases outer membrane-specific lipoproteins in an ATP-dependent manner, causing formation of the LolA-lipoprotein complex in the periplasm. LolA transports lipoproteins through the periplasm to LolB on outer membranes. LolB is itself a lipoprotein anchored to outer membranes, although the membrane anchor is functionally dispensable. LolB then localizes lipoproteins to outer membranes through largely unknown mechanisms. The crystal structure of LolB is similar to that of LolA, and it possesses a hydrophobic cavity that accommodates acyl chains of lipoproteins. To elucidate the molecular function of LolB, a periplasmic version of LolB, mLolB, was mutagenized at various conserved residues. Despite the lack of acyl chains, most defective mutants were insoluble. However, a derivative with glutamate in place of leucine 68 was soluble and unable to localize lipoproteins to outer membranes. This leucine is present in a loop protruding from mLolB into an aqueous environment, and no analogous loop is present in LolA. Thus, leucine 68 was replaced with other residues. Replacement by acidic, but not hydrophobic, residues generated for the first time mLolB derivatives that can accept but cannot localize lipoproteins to outer membranes. Moreover, deletion of the leucine with neighboring residues impaired the lipoprotein receptor activity. Based on these observations, the roles of the protruding loop of LolB in the last step of lipoprotein sorting are discussed.	[Hayashi, Yumi; Tsurumizu, Ryoji; Tsukahara, Jun] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; [Takeda, Kazuki; Miki, Kunio] Kyoto Univ, Grad Sch Sci, Dept Chem, Kyoto 6068502, Japan; [Narita, Shin-ichiro; Mori, Makiko; Tokuda, Hajime] Univ Morioka, Dept Nutr Sci, Takizawa, Iwate, Japan	University of Tokyo; Kyoto University	Tokuda, H (corresponding author), Univ Morioka, Dept Nutr Sci, 808 Sunakomi, Takizawa, Iwate, Japan.	htokuda@morioka-u.ac.jp	Takeda, Kazuki/AAQ-9238-2021	Narita, Shin-ichiro/0000-0001-9425-2943; Takeda, Kazuki/0000-0002-4094-6816	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [24570152] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Ministry of Education, Culture, Sports, Science, and Technology of Japan grants (to H. T.) and the Target Protein Research Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to K. M.).	BRAUN V, 1975, BIOCHIM BIOPHYS ACTA, V415, P335, DOI 10.1016/0304-4157(75)90013-1; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; HIROTA Y, 1977, P NATL ACAD SCI USA, V74, P1417, DOI 10.1073/pnas.74.4.1417; HUSSAIN M, 1982, J BIOL CHEM, V257, P5177; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATSUYAMA S, 1995, EMBO J, V14, P3365, DOI 10.1002/j.1460-2075.1995.tb07342.x; Matsuyama S, 1997, EMBO J, V16, P6947, DOI 10.1093/emboj/16.23.6947; MIZUSHIMA S, 1984, MOL CELL BIOCHEM, V60, P5; Nakada S, 2009, J BIOL CHEM, V284, P24634, DOI 10.1074/jbc.M109.001149; Narita S, 2011, J BACTERIOL, V193, P4832, DOI 10.1128/JB.05013-11; Okuda S, 2008, FEBS LETT, V582, P2247, DOI 10.1016/j.febslet.2008.05.022; Okuda S, 2011, ANNU REV MICROBIOL, V65, P239, DOI 10.1146/annurev-micro-090110-102859; Okuda S, 2009, P NATL ACAD SCI USA, V106, P5877, DOI 10.1073/pnas.0900896106; Sambrook J., 1989, MOL CLONING LAB MANU; Sugai R, 2001, J BACTERIOL, V183, P5523, DOI 10.1128/JB.183.19.5523-5528.2001; Takeda K, 2003, EMBO J, V22, P3199, DOI 10.1093/emboj/cdg324; Takeda K, 2003, ACTA CRYSTALLOGR D, V59, P1224, DOI 10.1107/S0907444903008709; Tanaka K, 2001, J BACTERIOL, V183, P6538, DOI 10.1128/JB.183.22.6538-6542.2001; Taniguchi N, 2005, J BIOL CHEM, V280, P34481, DOI 10.1074/jbc.M507388200; Tokuda H., 2014, BACTERIAL MEMBRANES, P133; Tsukahara J, 2009, FEBS J, V276, P4496, DOI 10.1111/j.1742-4658.2009.07156.x; Wada R, 2004, BIOCHEM BIOPH RES CO, V323, P1069, DOI 10.1016/j.bbrc.2004.08.200; Watanabe S, 2007, PROTEIN SCI, V16, P2741, DOI 10.1110/ps.073101307; Yakushi T, 1997, J BACTERIOL, V179, P2857, DOI 10.1128/jb.179.9.2857-2862.1997; YAMADA H, 1989, J BIOL CHEM, V264, P18577; Yokota N, 1999, J BIOL CHEM, V274, P30995, DOI 10.1074/jbc.274.43.30995	27	12	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10530	10539		10.1074/jbc.M113.539270	http://dx.doi.org/10.1074/jbc.M113.539270			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24569999	Green Published, hybrid			2022-12-28	WOS:000334226400026
J	Walsh, P; Vanderlee, G; Yau, J; Campeau, J; Sim, VL; Yip, CM; Sharpe, S				Walsh, Patrick; Vanderlee, Gillian; Yau, Jason; Campeau, Jody; Sim, Valerie L.; Yip, Christopher M.; Sharpe, Simon			The Mechanism of Membrane Disruption by Cytotoxic Amyloid Oligomers Formed by Prion Protein(106-126) Is Dependent on Bilayer Composition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Atomic Force Microscopy; Membrane Bilayer; Peptides; Solid State NMR; Amyloid Oligomers; Cytotoxicity; Membrane Disruption; TIRF	SUPPORTED LIPID-BILAYERS; PROTEIN-FRAGMENT 106-126; APOPTOTIC CELL-DEATH; SOLID-STATE NMR; CALCIUM-CHANNEL ACTIVITY; ANTIMICROBIAL PEPTIDE; TRANSMEMBRANE DOMAIN; ALZHEIMERS-DISEASE; PLASMA-MEMBRANE; ALPHA-SYNUCLEIN	Background: Nonfibrillar amyloid oligomers are cytotoxic and may act through physical disruption of cell membranes. Results: Cytotoxic oligomers of the amyloid peptide PrP(106-126) disrupt membranes through distinct mechanisms, depending on lipid composition. Conclusion: Cytotoxicity of PrP(106-126) oligomers can occur through at least two different physical processes. Significance: Mechanisms for the membrane disruption of amyloid oligomers are proposed, providing new insight into their cytotoxicity. The formation of fibrillar aggregates has long been associated with neurodegenerative disorders such as Alzheimer and Parkinson diseases. Although fibrils are still considered important to the pathology of these disorders, it is now widely understood that smaller amyloid oligomers are the toxic entities along the misfolding pathway. One characteristic shared by the majority of amyloid oligomers is the ability to disrupt membranes, a commonality proposed to be responsible for their toxicity, although the mechanisms linking this to cell death are poorly understood. Here, we describe the physical basis for the cytotoxicity of oligomers formed by the prion protein (PrP)-derived amyloid peptide PrP(106-126). We show that oligomers of this peptide kill several mammalian cells lines, as well as mouse cerebellar organotypic cultures, and we also show that they exhibit antimicrobial activity. Physical perturbation of model membranes mimicking bacterial or mammalian cells was investigated using atomic force microscopy, polarized total internal reflection fluorescence microscopy, and NMR spectroscopy. Disruption of anionic membranes proceeds through a carpet or detergent model as proposed for other antimicrobial peptides. By contrast, when added to zwitterionic membranes containing cholesterol-rich ordered domains, PrP(106-126) oligomers induce a loss of domain separation and decreased membrane disorder. Loss of raft-like domains may lead to activation of apoptotic pathways, resulting in cell death. This work sheds new light on the physical mechanisms of amyloid cytotoxicity and is the first to clearly show membrane type-specific modes of action for a cytotoxic peptide.	[Walsh, Patrick; Yau, Jason; Sharpe, Simon] Hosp Sick Children, Mol Struct & Funct Program, Toronto, ON M5G 1X8, Canada; [Walsh, Patrick; Yau, Jason; Yip, Christopher M.; Sharpe, Simon] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Vanderlee, Gillian; Yip, Christopher M.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Inst Biomat & Biomed Engn, Toronto, ON M5S 3E1, Canada; [Campeau, Jody; Sim, Valerie L.] Univ Alberta, Dept Med, Div Neurol, Edmonton, AB T6G 2G3, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Alberta	Sharpe, S (corresponding author), Hosp Sick Children, Mol Struct & Funct Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	ssharpe@sickkids.ca	Sim, Valerie/C-4137-2013; Walsh, Patrick/ABG-2479-2020	Sim, Valerie/0000-0002-0088-8666; Yip, Christopher/0000-0003-4507-556X; Walsh, Patrick/0000-0003-4597-0396	Natural Sciences and Engineering Council of Canada [RGPIN 342069, Yip-RGPIN 194435]; PrioNet Canada; Alberta Prion Research Institute; Ontario graduate scholarship; Restracomp (The Hospital for Sick Children)	Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); PrioNet Canada; Alberta Prion Research Institute; Ontario graduate scholarship(Ontario Graduate Scholarship); Restracomp (The Hospital for Sick Children)	This work was supported in part by the Natural Sciences and Engineering Council of Canada Discovery Grants RGPIN 342069 (to S. S.) and Yip-RGPIN 194435 (to C. M.) and an operating grant from PrioNet Canada and the Alberta Prion Research Institute (to V. S. and S. S.).; Supported by an Ontario graduate scholarship and a partial studentship from Restracomp (The Hospital for Sick Children).	Axelrod D, 1989, FLUORESCENCE POLARIZ, V30, P333; Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006; Baumgart T, 2007, BBA-BIOMEMBRANES, V1768, P2182, DOI 10.1016/j.bbamem.2007.05.012; Bemporad F, 2012, CHEM BIOL, V19, P315, DOI 10.1016/j.chembiol.2012.02.003; BERTRAND R, 1994, EXP CELL RES, V211, P314, DOI 10.1006/excr.1994.1093; Brender JR, 2007, BBA-BIOMEMBRANES, V1768, P2026, DOI 10.1016/j.bbamem.2007.07.001; Brender JR, 2012, ACCOUNTS CHEM RES, V45, P454, DOI 10.1021/ar200189b; Brown DR, 1996, NATURE, V380, P345, DOI 10.1038/380345a0; Brown DR, 1998, J NEUROSCI RES, V54, P331; Bucciantini M, 2012, FASEB J, V26, P818, DOI 10.1096/fj.11-189381; Carimalo J, 2005, EUR J NEUROSCI, V21, P2311, DOI 10.1111/j.1460-9568.2005.04080.x; Castro BM, 2011, BIOPHYS J, V101, P1632, DOI 10.1016/j.bpj.2011.08.022; Cecchi C, 2009, BBA-BIOMEMBRANES, V1788, P2204, DOI 10.1016/j.bbamem.2009.07.019; Comellas G, 2012, J AM CHEM SOC, V134, P5090, DOI 10.1021/ja209019s; Deli MA, 2000, NEUROREPORT, V11, P3931, DOI 10.1097/00001756-200011270-00064; Domingues TM, 2010, LANGMUIR, V26, P11077, DOI 10.1021/la100662a; Ettaiche M, 2000, J BIOL CHEM, V275, P36487, DOI 10.1074/jbc.C000579200; Fandrich M, 2012, J MOL BIOL, V421, P427, DOI 10.1016/j.jmb.2012.01.006; Falsig J, 2008, NAT PROTOC, V3, P555, DOI 10.1038/nprot.2008.13; Feigenson GW, 2006, NAT CHEM BIOL, V2, P560, DOI 10.1038/nchembio1106-560; Fioriti L, 2005, MOL CELL NEUROSCI, V28, P165, DOI 10.1016/j.mcn.2004.09.006; Florio T, 1998, J NEUROSCI RES, V54, P341, DOI 10.1002/(SICI)1097-4547(19981101)54:3<341::AID-JNR5>3.0.CO;2-G; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; Gajate C, 2009, BIOCHEM BIOPH RES CO, V380, P780, DOI 10.1016/j.bbrc.2009.01.147; George KS, 2012, TOXICOL APPL PHARM, V259, P311, DOI 10.1016/j.taap.2012.01.007; Glabe CG, 2006, NEUROBIOL AGING, V27, P570, DOI 10.1016/j.neurobiolaging.2005.04.017; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gu YP, 2002, J BIOL CHEM, V277, P2275, DOI 10.1074/jbc.M104345200; Hicks DA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00189; Kagan BL, 2012, MOL PHARMACEUT, V9, P708, DOI 10.1021/mp200419b; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; KENDALL DA, 1982, J BIOL CHEM, V257, P3892; Korlach J, 1999, P NATL ACAD SCI USA, V96, P8461, DOI 10.1073/pnas.96.15.8461; Kourie JI, 2001, J NEUROSCI RES, V66, P214, DOI 10.1002/jnr.1213; Kuerka N., 2011, BBA-BIOMEMBRANES, V1808, P2761, DOI DOI 10.1016/J.BBAMEM.2011.07.022; Kurganov B, 2004, PEPTIDES, V25, P217, DOI 10.1016/j.peptides.2004.01.001; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lin H, 1999, BIOCHEMISTRY-US, V38, P11189, DOI 10.1021/bi982997c; Lin MX, 1997, J BIOL CHEM, V272, P44; Lu JX, 2011, BIOPHYS J, V100, P711, DOI 10.1016/j.bpj.2010.12.3696; Malchiodi-Albedi F., 2011, INT J ALZHEIMERS DIS, DOI [10.4061/2011/906964, DOI 10.4061/2011/906964]; McMullen TPW, 2004, CURR OPIN COLLOID IN, V8, P459, DOI 10.1016/j.cocis.2004.01.007; Miret S, 2006, J BIOMOL SCREEN, V11, P184, DOI 10.1177/1087057105283787; Moore A, 1998, METHOD CELL BIOL, V57, P265; MOR A, 1991, BIOCHEMISTRY-US, V30, P8824, DOI 10.1021/bi00100a014; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Oreopoulos J, 2009, J STRUCT BIOL, V168, P21, DOI 10.1016/j.jsb.2009.02.011; Oreopoulos J, 2009, BIOPHYS J, V96, P1970, DOI 10.1016/j.bpj.2008.11.041; Owen DM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2273; Pietri M, 2006, J BIOL CHEM, V281, P28470, DOI 10.1074/jbc.M602774200; Pollard HB, 1995, CELL MOL NEUROBIOL, V15, P513, DOI 10.1007/BF02071314; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Ramamoorthy A, 2006, BIOPHYS J, V91, P206, DOI 10.1529/biophysj.105.073890; Russell AL, 2010, CHEM PHYS LIPIDS, V163, P488, DOI 10.1016/j.chemphyslip.2010.03.009; Salmona M, 1999, BIOCHEM J, V342, P207, DOI 10.1042/0264-6021:3420207; Salmona M, 1997, NEUROBIOL DIS, V4, P47, DOI 10.1006/nbdi.1997.0133; SEELIG J, 1978, BIOCHIM BIOPHYS ACTA, V515, P105, DOI 10.1016/0304-4157(78)90001-1; SELVAGGINI C, 1993, BIOCHEM BIOPH RES CO, V194, P1380, DOI 10.1006/bbrc.1993.1977; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Silei V, 1999, BRAIN RES, V818, P168, DOI 10.1016/S0006-8993(98)01272-4; Smith PES, 2009, J AM CHEM SOC, V131, P4470, DOI 10.1021/ja809002a; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; SPINK CH, 1990, BIOCHIM BIOPHYS ACTA, V1023, P25, DOI 10.1016/0005-2736(90)90005-9; TAYLOR MG, 1982, CHEM PHYS LIPIDS, V31, P359, DOI 10.1016/0009-3084(82)90072-X; Thellung S, 2000, NEUROBIOL DIS, V7, P299, DOI 10.1006/nbdi.2000.0301; TIMBS MM, 1990, BIOPHYS J, V58, P413, DOI 10.1016/S0006-3495(90)82387-0; Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Walsh P, 2010, J AM CHEM SOC, V132, P7684, DOI 10.1021/ja100431q; Walsh P, 2009, BIOCHEMISTRY-US, V48, P5779, DOI 10.1021/bi9007319; Walsh P, 2009, STRUCTURE, V17, P417, DOI 10.1016/j.str.2008.12.018; Williamson R, 2011, CURR ALZHEIMER RES, V8, P213, DOI 10.2174/156720511795256008; Wood WG, 2002, NEUROBIOL AGING, V23, P685, DOI 10.1016/S0197-4580(02)00018-0; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yip CM, 2002, J MOL BIOL, V318, P97, DOI 10.1016/S0022-2836(02)00028-1; Yip CM, 2001, J MOL BIOL, V311, P723, DOI 10.1006/jmbi.2001.4881; Yip CM, 2001, BIOPHYS J, V80, P1359, DOI 10.1016/S0006-3495(01)76109-7; Zhong J, 2007, BBA-BIOMEMBRANES, V1768, P1420, DOI 10.1016/j.bbamem.2007.03.003	82	47	48	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10419	10430		10.1074/jbc.M113.515866	http://dx.doi.org/10.1074/jbc.M113.515866			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24554723	hybrid, Green Published			2022-12-28	WOS:000334226400016
J	Sato, K; Sugiyama, T; Nagase, T; Kitade, Y; Ueda, H				Sato, Katsuya; Sugiyama, Tsuyoshi; Nagase, Takahiro; Kitade, Yukio; Ueda, Hiroshi			Threonine 680 Phosphorylation of FLJ00018/PLEKHG2, a Rho Family-specific Guanine Nucleotide Exchange Factor, by Epidermal Growth Factor Receptor Signaling Regulates Cell Morphology of Neuro-2a Cells*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epidermal Growth Factor Receptor (EGFR); Guanine Nucleotide Exchange Factor (GEF); Neurite Outgrowth; Protein phosphorylation; Rho GTPases	PROTEIN-KINASE-C; HETEROTRIMERIC G-PROTEINS; TAG SDS-PAGE; EGF RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; ADRENERGIC-RECEPTOR; NEURITE OUTGROWTH; TYROSINE PHOSPHORYLATION; LYSOPHOSPHATIDIC ACID; BREAST-CANCER	Background: RhoGEFs play important roles in regulation of the actin cytoskeleton. Results: The FLJ00018/PLEKHG2 was phosphorylated, and activated by EGF signaling might be interpreted as a direct effect on its GEF activity (which is not established). Conclusion: The phosphorylation of FLJ00018 was involved in the regulation of cell morphology. Significance: This study suggests that FLJ00018 receives and integrates different stimuli as a relay point in cell signaling. FLJ00018/PLEKHG2 is a guanine nucleotide exchange factor for the small GTPases Rac and Cdc42 and has been shown to mediate the signaling pathways leading to actin cytoskeleton reorganization. The function of FLJ00018 is regulated by the interaction of heterotrimeric GTP-binding protein G subunits or cytosolic actin. However, the details underlying the molecular mechanisms of FLJ00018 activation have yet to be elucidated. In the present study we show that FLJ00018 is phosphorylated and activated by (1)-adrenergic receptor stimulation-induced EGF receptor (EGFR) transactivation in addition to G signaling. FLJ00018 is also phosphorylated and activated by direct EGFR stimulation. The phosphorylation of FLJ00018 by EGFR stimulation is mediated by the Ras/mitogen-activated protein kinase (MAPK) pathway. Through deletion and site-directed mutagenesis studies, we have identified Thr-680 as the major site of phosphorylation by EGFR stimulation. FLJ00018 T680A, in which the phosphorylation site is replaced by alanine, showed a limited response of the Neuro-2a cell morphology to EGF stimulation. Our results provide evidence that stimulation of the Ras/MAPK pathway by EGFR results in FLJ00018 phosphorylation at Thr-680, which in turn controls changes in cell shape.	[Sato, Katsuya; Kitade, Yukio; Ueda, Hiroshi] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Fac Engn, Gifu 5011193, Japan; [Kitade, Yukio; Ueda, Hiroshi] Gifu Univ, Dept Chem & Biomol Sci, Fac Engn, Gifu 5011193, Japan; [Sugiyama, Tsuyoshi] Gifu Pharmaceut Univ, Dept Biopharmaceut Sci, Microbiol Lab, Gifu 5011196, Japan; [Nagase, Takahiro] Kazusa DNA Res Inst, Dept Biotechnol Res, Kisarazu 2920818, Japan	Gifu University; Gifu University; Gifu Pharmaceutical University; Kazusa DNA Research Institute	Ueda, H (corresponding author), Gifu Univ, Dept Chem & Biomol Sci, Fac Engn, Yanagido 1-1, Gifu 5011193, Japan.	hueda@gifu-u.ac.jp		Sato, Katsuya/0000-0002-5573-746X	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant-in-aid for Scientific Research (C) from Japan Society for the Promotion of Science.	Buchanan FG, 2000, J BIOL CHEM, V275, P9742, DOI 10.1074/jbc.275.13.9742; Montero JC, 2013, CELL SIGNAL, V25, P2281, DOI 10.1016/j.cellsig.2013.07.018; Chikumi H, 2002, J BIOL CHEM, V277, P12463, DOI 10.1074/jbc.M108504200; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; Drube S, 2006, CELL SIGNAL, V18, P1633, DOI 10.1016/j.cellsig.2006.01.003; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Fard SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009647; Feng QY, 2006, NAT CELL BIOL, V8, P945, DOI 10.1038/ncb1453; Fleming IN, 1997, J BIOL CHEM, V272, P33105, DOI 10.1074/jbc.272.52.33105; Fleming IN, 1998, FEBS LETT, V429, P229, DOI 10.1016/S0014-5793(98)00566-3; Friedman J, 2002, MOL PHARMACOL, V62, P1094, DOI 10.1124/mol.62.5.1094; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Fukuhara S, 1999, J BIOL CHEM, V274, P5868, DOI 10.1074/jbc.274.9.5868; Giguere PM, 2012, J BIOL CHEM, V287, P31270, DOI 10.1074/jbc.M112.394379; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Holinstat M, 2003, J BIOL CHEM, V278, P28793, DOI 10.1074/jbc.M303900200; Itoh RE, 2008, J CELL SCI, V121, P2635, DOI 10.1242/jcs.028647; Karasawa S, 2003, J BIOL CHEM, V278, P34167, DOI 10.1074/jbc.M304063200; Kim J, 2002, J BIOL CHEM, V277, P32116, DOI 10.1074/jbc.M204895200; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita E, 2009, NAT PROTOC, V4, P1513, DOI 10.1038/nprot.2009.154; Kinoshita E, 2009, PROTEOMICS, V9, P4098, DOI 10.1002/pmic.200900020; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; Liebmann C, 2011, MOL CELL ENDOCRINOL, V331, P222, DOI 10.1016/j.mce.2010.04.008; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; Nakajima D, 2002, DNA RES, V9, P99, DOI 10.1093/dnares/9.3.99; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Pak Y, 2002, MOL CELL BIOL, V22, P7942, DOI 10.1128/MCB.22.22.7942-7952.2002; Pandey A, 2000, P NATL ACAD SCI USA, V97, P179, DOI 10.1073/pnas.97.1.179; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Samson T, 2010, MOL BIOL CELL, V21, P1629, DOI 10.1091/mbc.E09-09-0809; Saneyoshi T, 2008, NEURON, V57, P94, DOI 10.1016/j.neuron.2007.11.016; Sato K, 2013, CELL SIGNAL, V25, P41, DOI 10.1016/j.cellsig.2012.09.015; Schiller MR, 2006, CELL SIGNAL, V18, P1834, DOI 10.1016/j.cellsig.2006.01.022; Sheridan DL, 2008, J BIOL CHEM, V283, P19511, DOI 10.1074/jbc.M801074200; Shin EY, 2002, J BIOL CHEM, V277, P44417, DOI 10.1074/jbc.M203754200; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; Tilley DG, 2009, J BIOL CHEM, V284, P20375, DOI 10.1074/jbc.M109.005793; Ueda H, 2008, J BIOL CHEM, V283, P1946, DOI 10.1074/jbc.M707037200; Wang D, 2009, CIRC RES, V104, P1066, DOI 10.1161/CIRCRESAHA.109.196691; Yano N, 2007, AM J PHYSIOL-HEART C, V293, pH385, DOI 10.1152/ajpheart.01318.2006; Zhang Y, 2007, J BIOL CHEM, V282, P31103, DOI 10.1074/jbc.M704430200	46	7	7	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10045	10056		10.1074/jbc.M113.521880	http://dx.doi.org/10.1074/jbc.M113.521880			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24554703	Green Published, hybrid			2022-12-28	WOS:000333807000052
J	Qiu, SL; Xiao, ZC; Piao, CM; Xian, YL; Jia, LX; Qi, YF; Han, JH; Zhang, YY; Du, J				Qiu, Shu-Lan; Xiao, Zhi-Cheng; Piao, Chun-Mei; Xian, Ying-Lin; Jia, Li-Xin; Qi, Yong-Fen; Han, Jia-Huai; Zhang, You-yi; Du, Jie			AMP-activated Protein Kinase alpha 2 Protects against Liver Injury from Metastasized Tumors via Reduced Glucose Deprivation-induced Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AMP-activated kinase (AMPK); Glucose; Metastasis; Oxidative Stress; Tumor	REACTIVE OXYGEN; CELL-DEATH; TNF-ALPHA; ENERGY; MITOCHONDRIA; AUTOPHAGY; CANCER; PHOSPHORYLATION; STARVATION; APOPTOSIS	Background: AMPK senses energetic changes and regulates glucose metabolism. Results: AMPK 2 deficiency aggravated the glucose deprivation and necrosis of the hepatocytes via increased ROS production and decreased mitophagy. Conclusion: AMPK 2 is essential for attenuation of liver injury during tumor metastasis. Significance: This is the first time to reveal the mechanism by which glucose/energy competition induced tissue damage in tumor. It is well known that tumors damage affected tissues; however, the specific mechanism underlying such damage remains elusive. AMP-activated protein kinase (AMPK) senses energetic changes and regulates glucose metabolism. In this study, we examined the mechanisms by which AMPK promotes metabolic adaptation in the tumor-bearing liver using a murine model of colon cancer liver metastasis. Knock-out of AMPK 2 significantly enhanced tumor-induced glucose deprivation in the liver and increased the extent of liver injury and hepatocyte death. Mechanistically, we observed that AMPK 2 deficiency resulted in elevated reactive oxygen species, reduced mitophagy, and increased cell death in response to tumors or glucose deprivation in vitro. These results imply that AMPK 2 is essential for attenuation of liver injury during tumor metastasis via hepatic glucose deprivation and mitophagy-mediated inhibition of reactive oxygen species production. Therefore, AMPK 2 might represent an important therapeutic target for colon cancer metastasis-induced liver injury.	[Qiu, Shu-Lan; Xiao, Zhi-Cheng; Piao, Chun-Mei; Xian, Ying-Lin; Jia, Li-Xin; Du, Jie] Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Minist Educ,Key Lab Remodeling Related Cardiovasc, Beijing 100029, Peoples R China; [Qi, Yong-Fen; Zhang, You-yi] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Lab Cardiovasc Bioact Mol, Beijing 100191, Peoples R China; [Han, Jia-Huai] Xiamen Univ, Sch Biol Sci, Xiamen 361005, Peoples R China	Capital Medical University; Peking University; Xiamen University	Du, J (corresponding author), Capital Med Univ, Inst Heart Lung & Blood Vessel Dis, Beijing Anzhen Hosp, Beijing 100029, Peoples R China.	jdu@bcm.edu	Han, J/G-4671-2010		Chinese Ministry of Science and Technology [2009CB522205, 2012AA02A201]; National Natural Science Foundation of China [81230006, 31090363, 81000871]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese Ministry of Science and Technology Grants 2009CB522205 and 2012AA02A201 and National Natural Science Foundation of China Grants 81230006, 31090363, and 81000871.	Ali SS, 2010, J BIOL CHEM, V285, P32522, DOI 10.1074/jbc.M110.155432; Andreelli F, 2006, ENDOCRINOLOGY, V147, P2432, DOI 10.1210/en.2005-0898; Bungard D, 2010, SCIENCE, V329, P1201, DOI 10.1126/science.1191241; Caro-Maldonado A, 2010, CELL DEATH DIFFER, V17, P1335, DOI 10.1038/cdd.2010.21; Dong YZ, 2010, CIRCULATION, V121, P792, DOI 10.1161/CIRCULATIONAHA.109.900928; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Graham NA, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.20; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Hashimoto K, 2002, BIOCHEM BIOPH RES CO, V290, P263, DOI 10.1006/bbrc.2001.6193; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Jaeschke H, 2011, J GASTROEN HEPATOL, V26, P173, DOI 10.1111/j.1440-1746.2010.06592.x; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V292, pE1308, DOI 10.1152/ajpendo.00456.2006; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kewalramani G, 2009, CARDIOVASC RES, V84, P42, DOI 10.1093/cvr/cvp166; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Leij-Halfwerk S, 2000, J HEPATOL, V32, P887, DOI 10.1016/S0168-8278(00)80092-6; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lohse Ansgar W, 2010, J Hepatol, V52, P136, DOI 10.1016/j.jhep.2009.10.016; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; Matsutani T, 2007, AM J PHYSIOL-GASTR L, V292, pG268, DOI 10.1152/ajpgi.00313.2006; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Monticone M, 2010, J CELL BIOCHEM, V111, P1149, DOI 10.1002/jcb.22801; Morimoto-Tomita M, 2005, CLIN EXP METASTAS, V22, P513, DOI 10.1007/s10585-005-3585-0; Neufeld TP, 2010, CURR OPIN CELL BIOL, V22, P157, DOI 10.1016/j.ceb.2009.11.005; NIEWOEHNER CB, 1988, DIABETES, V37, P1559, DOI 10.2337/diabetes.37.11.1559; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Palorini R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.257; Peng W, 2009, CARDIOVASC RES, V84, P1, DOI 10.1093/cvr/cvp272; Raney MA, 2008, J APPL PHYSIOL, V104, P1366, DOI 10.1152/japplphysiol.01282.2007; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Roy A, 2008, MOL PHARMACOL, V74, P1292, DOI 10.1124/mol.108.050161; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; SCHNEEBERGER AL, 1989, CANCER RES, V49, P1160; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108; Siwiak M, 2012, J MOL MODEL, V18, P83, DOI 10.1007/s00894-011-1029-0; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Suzuki SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017412; TSUBURAYA A, 1995, J SURG RES, V59, P421, DOI 10.1006/jsre.1995.1185; Varela-Rey M, 2011, EXP BIOL MED, V236, P402, DOI 10.1258/ebm.2011.010352; White E, 2010, CURR OPIN CELL BIOL, V22, P212, DOI 10.1016/j.ceb.2009.12.008; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Yaglom JA, 2003, J BIOL CHEM, V278, P50483, DOI 10.1074/jbc.M306903200; Yang ZG, 2010, J BIOL CHEM, V285, P19051, DOI 10.1074/jbc.M110.123620; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zheng J, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-141	52	18	21	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9449	9459		10.1074/jbc.M113.543447	http://dx.doi.org/10.1074/jbc.M113.543447			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24515110	Green Published, hybrid			2022-12-28	WOS:000333472100060
J	Dhar, SS; Alam, H; Li, N; Wagner, KW; Chung, JY; Ahn, YW; Lee, MG				Dhar, Shilpa S.; Alam, Hunain; Li, Na; Wagner, Klaus W.; Chung, Jimyung; Ahn, Yeo Won; Lee, Min Gyu			Transcriptional Repression of Histone Deacetylase 3 by the Histone Demethylase KDM2A Is Coupled to Tumorigenicity of Lung Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin; Gene Regulation; Histone Modification; Lung Cancer; Transcription Repressor	HUMAN COLON-CANCER; LYSINE METHYLATION; INK4A-ARF LOCUS; HUMAN GENOME; EXPRESSION; HDAC3; PROGNOSIS; APOPTOSIS; COMPLEX; MAINTENANCE	Background: Overexpression of the epigenetic repressor KDM2A promotes lung tumorigenesis. Results: Transcriptional inhibition of HDAC3 expression by KDM2A releases cell cycle and proinvasive genes from HDAC3-mediated repression and positively regulates cell proliferation and invasiveness. Conclusion: KDM2A-mediated repression of HDAC3 is linked to KDM2A-promoted tumorigenicity. Significance: Our findings provide a novel epigenetic insight into how KDM2A promotes lung tumorigenesis and have implications for therapeutic intervention. Dysregulated expression of histone methyltransferases and demethylases is an emerging epigenetic mechanism underlying cancer development and metastasis. We recently showed that the histone H3 lysine 36 (H3K36) demethylase KDM2A (also called FBXL11 and JHDM1A) is necessary for tumorigenic and metastatic capabilities of KDM2A-overexpressing non-small cell lung cancer (NSCLC) cells. Here, we report that KDM2A transcriptionally represses the histone deacetylase 3 (HDAC3) gene by removing methyl groups from dimethylated H3K36 at the HDAC3 promoter in KDM2A-overexpressing NSCLC cells. KDM2A depletion reduced expression levels of cell cycle-associated genes (e.g. CDK6) and cell invasion-related genes (e.g. NANOS1); these levels were rescued by ectopic expression of KDM2A but not its catalytic mutant. These genes were occupied and down-regulated by HDAC3. HDAC3 knockdown significantly recovered the proliferation and invasiveness of KDM2A-depleted NSCLC cells as well as the levels of CDK6 and NANOS1 expression in these cells. Similar to their previously reported functions in other cell types, CDK6 and NANOS1 were required for the proliferation and invasion, respectively, of KDM2A-overexpressing NSCLC cells. In a mouse xenograft model, HDAC3 depletion substantially restored the tumorigenic ability of KDM2A knockdown cells. These findings reveal a novel cancer-epigenetic pathway in which the antagonistic effect of KDM2A on HDAC3 expression releases cell cycle-associated genes and cell invasion-related genes from HDAC3 repression and indicate the importance of this pathway for tumorigenicity and invasiveness of KDM2A-overexpressing NSCLC cells.	[Dhar, Shilpa S.; Alam, Hunain; Li, Na; Wagner, Klaus W.; Lee, Min Gyu] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Wagner, Klaus W.] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA; [Chung, Jimyung] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea; [Ahn, Yeo Won] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Lee, Min Gyu] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Canc Biol Program, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Yonsei University; Emory University; University of Texas System; University of Texas Health Science Center Houston	Lee, MG (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	mglee@mdanderson.org	Li, Na/AAV-8761-2020; Alam, Hunain/H-2984-2019	Alam, Hunain/0000-0002-6183-3677	National Institutes of Health [CA157919, GM095659]; Cancer Prevention and Research Institute of Texas Grant [RP110183]; Center for Cancer Epigenetics at The University of Texas MD Anderson Cancer Center; Center for Cancer Epigenetics at MD Anderson Cancer Center; Odyssey Program; Estate of C. G. Johnson, Jr. at MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [R01CA157919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095659] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas Grant; Center for Cancer Epigenetics at The University of Texas MD Anderson Cancer Center; Center for Cancer Epigenetics at MD Anderson Cancer Center; Odyssey Program; Estate of C. G. Johnson, Jr. at MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA157919 and GM095659 (to M. G. L.). This work was also supported by Cancer Prevention and Research Institute of Texas Grant RP110183 (to M. G. L.), a fund from the Center for Cancer Epigenetics at The University of Texas MD Anderson Cancer Center (to M. G. L.), a scholar fellowship from the Center for Cancer Epigenetics at MD Anderson Cancer Center (to S. S. D.), and a fellowship from the Odyssey Program and the Estate of C. G. Johnson, Jr. at MD Anderson Cancer Center (to H. A.).	Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Alam H, 2011, J CELL SCI, V124, P2096, DOI 10.1242/jcs.073585; Asangani IA, 2013, MOL CELL, V49, P80, DOI 10.1016/j.molcel.2012.10.008; Barlesi F, 2007, J CLIN ONCOL, V25, P4358, DOI 10.1200/JCO.2007.11.2599; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bhaskara S, 2010, CANCER CELL, V18, P436, DOI 10.1016/j.ccr.2010.10.022; Blackledge NP, 2010, MOL CELL, V38, P179, DOI 10.1016/j.molcel.2010.04.009; Bonnomet A, 2008, ONCOGENE, V27, P3692, DOI 10.1038/sj.onc.1211035; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Braden WA, 2008, ONCOGENE, V27, P7083, DOI 10.1038/onc.2008.319; Chaturvedi CP, 2012, P NATL ACAD SCI USA, V109, P18845, DOI 10.1073/pnas.1213951109; Chen CQ, 2013, MOL CELL BIOCHEM, V383, P137, DOI 10.1007/s11010-013-1762-z; Chopin V, 2004, ONCOGENE, V23, P21, DOI 10.1038/sj.onc.1207020; Dhar SS, 2012, GENE DEV, V26, P2749, DOI 10.1101/gad.203356.112; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Frescas D, 2008, CELL CYCLE, V7, P3539, DOI 10.4161/cc.7.22.7062; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Guenther MG, 2000, GENE DEV, V14, P1048; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee MG, 2006, MOL CELL BIOL, V26, P6395, DOI 10.1128/MCB.00723-06; Lyulcheva E, 2008, DEV CELL, V15, P680, DOI 10.1016/j.devcel.2008.09.020; Ma HX, 2011, LUNG CANCER, V73, P32, DOI 10.1016/j.lungcan.2010.11.001; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Michaud K, 2010, CANCER RES, V70, P3228, DOI 10.1158/0008-5472.CAN-09-4559; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199; O'Regan L, 2009, MOL CELL BIOL, V29, P3975, DOI 10.1128/MCB.01867-08; Pfau R, 2008, P NATL ACAD SCI USA, V105, P1907, DOI 10.1073/pnas.0711865105; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Van Den Broeck A, 2008, CLIN CANCER RES, V14, P7237, DOI 10.1158/1078-0432.CCR-08-0869; Wagner KW, 2013, J CLIN INVEST, V123, P5231, DOI 10.1172/JCI68642; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Weichert W, 2008, BRIT J CANCER, V98, P604, DOI 10.1038/sj.bjc.6604199; Weichert W, 2008, CLIN CANCER RES, V14, P1669, DOI 10.1158/1078-0432.CCR-07-0990; Weichert W, 2008, LANCET ONCOL, V9, P139, DOI 10.1016/S1470-2045(08)70004-4; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Xia Y, 2007, MOL CELL, V25, P219, DOI 10.1016/j.molcel.2007.01.005	48	45	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7483	7496		10.1074/jbc.M113.521625	http://dx.doi.org/10.1074/jbc.M113.521625			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24482232	hybrid, Green Published			2022-12-28	WOS:000332761500019
J	Jurgensen, HJ; Johansson, K; Madsen, DH; Porse, A; Melander, MC; Sorensen, KR; Nielsen, C; Bugge, TH; Behrendt, N; Engelholm, LH				Juergensen, Henrik J.; Johansson, Kristina; Madsen, Daniel H.; Porse, Astrid; Melander, Maria C.; Sorensen, Kristine R.; Nielsen, Christoffer; Bugge, Thomas H.; Behrendt, Niels; Engelholm, Lars H.			Complex Determinants in Specific Members of the Mannose Receptor Family Govern Collagen Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Collagen; Endocytosis; Extracellular Matrix; Protein Chimeras; Receptor Structure-Function; Intracellular Collagen Degradation; Mannose Receptor; Cancer Invasion; Mannose Receptor Family; uPARAP; Endo180	GELATIN-BINDING SITE; PHOSPHOLIPASE A(2); ENDOTHELIAL-CELLS; MEMBRANE-RECEPTOR; DENDRITIC CELLS; ENDO180; DEGRADATION; FIBRONECTIN; ANTIGEN; PROTEIN	Background: Mannose receptor family members are candidate mediators of intracellular collagen degradation. Results: Despite common candidate collagen-binding domains and endocytic capacity throughout the family, only uPARAP/Endo180 and MR internalize collagens. Conclusion: A multi-domain interplay in the active receptors governs collagen endocytosis. Significance: Identification of the principal collagen receptors allows elucidation of the biological importance of intracellular collagen degradation. Members of the well-conserved mannose receptor (MR) protein family have been functionally implicated in diverse biological and pathological processes. Importantly, a proposed common function is the internalization of collagen for intracellular degradation occurring during bone development, cancer invasion, and fibrosis protection. This functional relationship is suggested by a common endocytic capability and a candidate collagen-binding domain. Here we conducted a comparative investigation of each member's ability to facilitate intracellular collagen degradation. As expected, the family members uPARAP/Endo180 and MR bound collagens in a purified system and internalized collagens for degradation in cellular settings. In contrast, the remaining family members, PLA(2)R and DEC-205, showed no collagen binding activity and were unable to mediate collagen internalization. To pinpoint the structural elements discriminating collagen from non-collagen receptors, we constructed a series of receptor chimeras and loss- and gain-of-function mutants. Using this approach we identified a critical collagen binding loop in the suggested collagen binding region (an FN-II domain) in uPARAP/Endo180 and MR, which was different in PLA(2)R or DEC-205. However, we also found that an active FN-II domain was not a sufficient determinant to allow collagen internalization through these receptors. Nevertheless, this ability could be acquired by the transfer of a larger segment of uPARAP/Endo180 (the Cys-rich domain, the FN-II domain and two CTLDs) to DEC-205. These data underscore the importance of the FN-II domain in uPARAP/Endo180 and MR-mediated collagen internalization but at the same time uncover a critical interplay with flanking domains.	[Juergensen, Henrik J.; Johansson, Kristina; Madsen, Daniel H.; Porse, Astrid; Melander, Maria C.; Sorensen, Kristine R.; Nielsen, Christoffer; Behrendt, Niels; Engelholm, Lars H.] Rigshosp, Finsen Lab, Biotech Res & Innovat Ctr, DK-2200 Copenhagen, Denmark; [Juergensen, Henrik J.; Madsen, Daniel H.; Bugge, Thomas H.] NIDCR, Proteases & Tissue Remodeling Sect, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD USA	Rigshospitalet; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Engelholm, LH (corresponding author), Rigshosp, Finsen Lab, Copenhagen Bioctr, BRIC, Ole Maaloesvej 5, DK-2200 Copenhagen N, Denmark.	lhe@finsenlab.dk		Behrendt, Niels/0000-0003-1833-3922; Madsen, Daniel Hargboel/0000-0002-3183-6201; Engelholm, Lars/0000-0002-6616-1232	NIDCR Intramural Research Program; Danish Cancer Society; Danish Medical Research Council; Danish Cancer Research Foundation; Novo Nordisk Foundation; Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer); European Community [201279]; Lundbeck Foundation; "Grosserer Alfred Nielsen og Hustrus" foundation; Rigshospitalet/Copenhagen University Hospital; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER; Lundbeck Foundation [R118-2012-11578] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC0002353] Funding Source: researchfish	NIDCR Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer)(Danmarks Grundforskningsfond); European Community(European Commission); Lundbeck Foundation(Lundbeckfonden); "Grosserer Alfred Nielsen og Hustrus" foundation; Rigshospitalet/Copenhagen University Hospital; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by the NIDCR Intramural Research Program (D. M. and T. H. B.), the Danish Cancer Society, the Danish Medical Research Council, the Danish Cancer Research Foundation, the Novo Nordisk Foundation, the Danish National Research Foundation (Danish-Chinese Center for Proteases and Cancer) and the European Community's Seventh Framework Programme FP7/2007-2011 under Grant agreement no 201279 (to M. C. M. and N. B.), by the Lundbeck Foundation (to D. H. M. and L. H. E.), the "Grosserer Alfred Nielsen og Hustrus" foundation (to L. H. E.). The work was also supported by personal grants from Rigshospitalet/Copenhagen University Hospital (to H. J. J. and A. P.).	ANCIAN P, 1995, BIOCHEMISTRY-US, V34, P13146, DOI 10.1021/bi00040a028; BANYAI L, 1994, BIOCHEM J, V298, P403, DOI 10.1042/bj2980403; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Behrendt N, 2000, J BIOL CHEM, V275, P1993, DOI 10.1074/jbc.275.3.1993; Boskovic J, 2006, J BIOL CHEM, V281, P8780, DOI 10.1074/jbc.M513277200; Briknarova K, 1999, STRUCTURE, V7, P1235, DOI 10.1016/S0969-2126(00)80057-X; Bugge TH, 2011, BIOL EXTRACELL MATR, P53, DOI 10.1007/978-3-642-16861-1_3; Bundesmann MM, 2012, AM J RESP CELL MOL, V46, P233, DOI 10.1165/rcmb.2010-0485OC; COLLIER IE, 1992, J BIOL CHEM, V267, P6776; Curino AC, 2005, J CELL BIOL, V169, P977, DOI 10.1083/jcb.200411153; East L, 2002, J BIOL CHEM, V277, P50469, DOI 10.1074/jbc.M208985200; East L, 2003, EMBO REP, V4, P710, DOI 10.1038/sj.embor.embor882; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Engelholm LH, 2003, J CELL BIOL, V160, P1009, DOI 10.1083/jcb.200211091; Everts V, 1996, HISTOCHEM J, V28, P229, DOI 10.1007/BF02409011; EZEKOWITZ RAB, 1990, J EXP MED, V172, P1785, DOI 10.1084/jem.172.6.1785; Fasquelle C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000666; Gardsvoll H, 2007, PROTEIN EXPRES PURIF, V52, P384, DOI 10.1016/j.pep.2006.11.013; Gravallese EM, 2002, ANN RHEUM DIS, V61, P84, DOI 10.1136/ard.61.suppl_2.ii84; Hanasaki K, 2002, PROSTAG OTH LIPID M, V68-9, P71, DOI 10.1016/S0090-6980(02)00022-9; Hanasaki K, 1997, J BIOL CHEM, V272, P32792, DOI 10.1074/jbc.272.52.32792; Holmbeck Kenn, 2006, Birth Defects Research, V78, P11, DOI 10.1002/bdrc.20064; Howard MJ, 2002, J BIOL CHEM, V277, P32320, DOI 10.1074/jbc.M203631200; Huijbers IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009808; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Jurgensen HJ, 2011, J BIOL CHEM, V286, P32736, DOI 10.1074/jbc.M111.266692; Kamphorst AO, 2010, J IMMUNOL, V185, P3426, DOI 10.4049/jimmunol.1001205; Katagiri Y, 2003, J BIOL CHEM, V278, P11897, DOI 10.1074/jbc.M212512200; Kjoller L, 2004, EXP CELL RES, V293, P106, DOI 10.1016/j.yexcr.2003.10.008; Kogianni G, 2009, EUR J CANCER, V45, P685, DOI 10.1016/j.ejca.2008.11.023; Kundu GC, 1997, J BIOL CHEM, V272, P2346; LAMBEAU G, 1994, J BIOL CHEM, V269, P1575; Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201; Llorca O, 2008, CELL MOL LIFE SCI, V65, P1302, DOI 10.1007/s00018-007-7497-9; Lopez-Guisa JM, 2012, J AM SOC NEPHROL, V23, P236, DOI 10.1681/ASN.2011030310; Madsen DH, 2007, J BIOL CHEM, V282, P27037, DOI 10.1074/jbc.M701088200; Madsen DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071261; Madsen DH, 2013, J CELL BIOL, V202, P951, DOI 10.1083/jcb.201301081; Madsen DH, 2012, J PATHOL, V227, P94, DOI 10.1002/path.3981; Madsen DH, 2011, J BIOL CHEM, V286, P26996, DOI 10.1074/jbc.M110.208033; Mahnke K, 2000, J CELL BIOL, V151, P673, DOI 10.1083/jcb.151.3.673; Malovic I, 2007, HEPATOLOGY, V45, P1454, DOI 10.1002/hep.21639; Martinez-Pomares L, 2006, EUR J IMMUNOL, V36, P1074, DOI 10.1002/eji.200535685; Martinez-Pomares L, 2012, J LEUKOCYTE BIOL, V92, P1177, DOI 10.1189/jlb.0512231; MEHDI S, 1991, TRENDS BIOCHEM SCI, V16, P150, DOI 10.1016/0968-0004(91)90058-4; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Napper CE, 2006, BIOCHEM J, V395, P579, DOI 10.1042/BJ20052027; Nielsen BS, 2002, INT J CANCER, V98, P656, DOI 10.1002/ijc.10227; Norholm MHH, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-21; Pickford AR, 1997, STRUCTURE, V5, P359, DOI 10.1016/S0969-2126(97)00193-7; Rivera-Calzada A, 2003, EMBO REP, V4, P807, DOI 10.1038/sj.embor.embor898; Rouault M, 2007, BIOCHEMISTRY-US, V46, P1647, DOI 10.1021/bi062119b; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; Schweizer A, 2000, J BIOL CHEM, V275, P29694, DOI 10.1074/jbc.M000571200; Segal G, 2001, J CELL SCI, V114, P119; Sheikh H, 2000, J CELL SCI, V113, P1021; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Sulek J, 2007, J HISTOCHEM CYTOCHEM, V55, P347, DOI 10.1369/jhc.6A7133.2006; Tamaru S, 2013, J IMMUNOL, V191, P1021, DOI 10.4049/jimmunol.1300738; Tordai H, 1999, EUR J BIOCHEM, V259, P513, DOI 10.1046/j.1432-1327.1999.00070.x; Wagenaar-Miller RA, 2007, MOL CELL BIOL, V27, P6309, DOI 10.1128/MCB.00291-07; Wienke D, 2003, MOL BIOL CELL, V14, P3592, DOI 10.1091/mbc.E02-12-0814; Wienke D, 2007, CANCER RES, V67, P10230, DOI 10.1158/0008-5472.CAN-06-3496; Wu K, 1996, J BIOL CHEM, V271, P21323, DOI 10.1074/jbc.271.35.21323; Xu XP, 2009, BIOCHEMISTRY-US, V48, P5822, DOI 10.1021/bi900513h; Yamaguchi T., 2013, ORAL DIS, DOI 10.1111/odi.12140; Zvaritch E, 1996, J BIOL CHEM, V271, P250, DOI 10.1074/jbc.271.1.250	67	40	43	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7935	7947		10.1074/jbc.M113.512780	http://dx.doi.org/10.1074/jbc.M113.512780			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24500714	Green Published, hybrid			2022-12-28	WOS:000332761500058
J	Chen, Y; Li, J; Dunn, S; Xiong, S; Chen, W; Zhao, YT; Chen, BB; Mallampalli, RK; Zou, CB				Chen, Yan; Li, Jin; Dunn, Sarah; Xiong, Sheng; Chen, Wei; Zhao, Yutong; Chen, Bill B.; Mallampalli, Rama K.; Zou, Chunbin			Histone Deacetylase 2 (HDAC2) Protein-dependent Deacetylation of Mortality Factor 4-like 1 (MORF4L1) Protein Enhances Its Homodimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Epigenetics; Histone Acetylase; Histone Deacetylase; Posttranslational Modification; Proliferation; Protein Complexes; Protein Structure; Site-directed Mutagenesis	CHROMODOMAIN PROTEIN; MESSENGER-RNA; DNA-REPAIR; MRG15; COMPLEX; DIFFERENTIATION; DOMAIN; DIMERIZATION; COMPONENT; PROMOTER	Background: Histone acetyltransferase MORF4L1 forms a homodimer to perform its epigenetic function, but the molecular mechanisms for its homodimerization are unknown. Results: Histone deacetylase HDAC2 deacetylates MORF4L1 at Lys-148 to enhance MORF4L1 homodimerization. Conclusion: HDAC2-dependent deacetylation of MORF4L1 enhances MORF4L1 homodimerization, which facilitates complex formation to repress cellular proliferation. Significance: The molecular control of MORF4L1 homodimerization may impact fundamental cellular processes such as proliferation. Histone acetyltransferase mortality factor 4-like 1 (MORF4L1) is a relatively new histone acetyltransferase component that exists as a homodimer to exert its epigenetic function. The mechanism of MORF4L1 self-assembly is unknown. Here we report that Lys-148 deacetylation is indispensable for facilitating MORF4L1 self-assembly into a homodimeric unit. Among a stretch of approximate to 10 amino acids in the NH2 terminus between the chromodomain and MORF4-related gene (MRG) domain within MORF4L1, Lys-148 is normally acetylated. Substitution of Lys-148 with arginine augments MORF4L1 self-assembly. However, acetylation mimics of MORF4L1, including K148L and K148Q, abolished its self-assembly of the histone acetyltransferase component. HDAC2, a deacetylase, interacts with and keeps MORF4L1 in a deacetylation status at Lys(148) that triggers MORF4L1 self-assembly. Knockdown of HDAC2 reduces MORF4L1 self-assembly. HDAC2-dependent deacetylation of MORF4L1 enhances MORF4L1 homodimerization, thus facilitating the functionality of complex formation to repress cell proliferation.	[Chen, Yan; Li, Jin; Dunn, Sarah; Xiong, Sheng; Chen, Wei; Zhao, Yutong; Chen, Bill B.; Mallampalli, Rama K.; Zou, Chunbin] Univ Pittsburgh, Dept Med, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15213 USA; [Zhao, Yutong; Chen, Bill B.; Mallampalli, Rama K.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA; [Zhao, Yutong; Chen, Bill B.; Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA 15240 USA; [Chen, Yan] Cent S Univ, Xiangya Hosp 2, Dept Resp Med, Changsha 410011, Hunan, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Central South University	Chen, Y (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Resp Med, Changsha 410011, Hunan, Peoples R China.	chenyan99727@163.com; zouc@upmc.edu	Zou, Chunbin/L-7488-2019	Zou, Chunbin/0000-0003-1355-4726	National Institutes of Health [HL096376, HL097376, HL098174, P01 HL114453]; American Heart Association [12SDG12040330]; United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; United States Department of Veterans Affairs; Natural Science Foundation of China [81070039, 81270100]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112791, R01HL098174, R01HL116472, R01HL096376, R01HL097376, UH2HL123502, P01HL114453] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); United States Department of Veterans Affairs(US Department of Veterans Affairs); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, National Institutes of Health Grants HL096376, HL097376, HL098174, and P01 HL114453 (to R. K. M.). This work was also supported by American Heart Association Award 12SDG12040330 (to C. Z.); by the United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; and by a merit review award from the United States Department of Veterans Affairs.; Supported by Natural Science Foundation of China Grants 81070039 and 81270100. To whom correspondence may be addressed: Dept. of Respiratory Medicine, The Second Xiangya Hospital, Central-South University, Changsha, Hunan 410011, China. E-mail: chenyan99727@163.com.	Bertram MJ, 2001, GENE, V266, P111, DOI 10.1016/S0378-1119(01)00372-9; Blus BJ, 2011, CRIT REV BIOCHEM MOL, V46, P507, DOI 10.3109/10409238.2011.619164; Boije H, 2013, J MOL NEUROSCI, V51, P615, DOI 10.1007/s12031-013-0034-4; Bryce SD, 1999, CANCER RES, V59, P2038; Chen M, 2009, J NEUROSCI RES, V87, P1522, DOI 10.1002/jnr.21976; Falvo JV, 2013, ADV IMMUNOL, V118, P37, DOI 10.1016/B978-0-12-407708-9.00002-9; Garcia SN, 2007, FEBS LETT, V581, P5275, DOI 10.1016/j.febslet.2007.10.017; Hayakawa T, 2007, GENES CELLS, V12, P811, DOI 10.1111/j.1365-2443.2007.01089.x; Khan DH, 2013, J BIOL CHEM, V288, P16518, DOI 10.1074/jbc.M112.440446; Kirkwood KJ, 2013, MOL CELL PROTEOMICS, V12, P3851, DOI 10.1074/mcp.M113.032367; Kumar GS, 2011, J MOL BIOL, V408, P987, DOI 10.1016/j.jmb.2011.03.043; Leung JK, 2001, J BIOL CHEM, V276, P39171, DOI 10.1074/jbc.M103435200; Liang Y, 2010, BBA-GEN SUBJECTS, V1800, P474, DOI 10.1016/j.bbagen.2010.01.010; Martrat G, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2862; Matsuoka Y, 2002, NEUROSCI RES, V42, P299, DOI 10.1016/S0168-0102(02)00010-X; Pardo PS, 2002, J BIOL CHEM, V277, P50860, DOI 10.1074/jbc.M203839200; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Pena AAN, 2007, ANN NY ACAD SCI, V1100, P299, DOI 10.1196/annals.1395.031; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; Qi HH, 2010, NATURE, V466, P503, DOI 10.1038/nature09261; Smith HF, 2013, GENETICS, V195, P127, DOI 10.1534/genetics.113.153544; Tominaga K, 2005, MOL CELL BIOL, V25, P2924, DOI 10.1128/MCB.25.8.2924-2937.2005; Tominaga K, 2002, GENE, V294, P215, DOI 10.1016/S0378-1119(02)00787-4; Yochum GS, 2002, MOL CELL BIOL, V22, P7868, DOI 10.1128/MCB.22.22.7868-7876.2002; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhang HJ, 2010, EXP GERONTOL, V45, P825, DOI 10.1016/j.exger.2010.06.002; Zhang P, 2006, NUCLEIC ACIDS RES, V34, P6621, DOI 10.1093/nar/gkl989; Zhang P, 2006, PROTEIN SCI, V15, P2423, DOI 10.1110/ps.062397806; Zou CB, 2013, J BIOL CHEM, V288, P6306, DOI 10.1074/jbc.M112.426882; Zou CB, 2011, J BIOL CHEM, V286, P2719, DOI 10.1074/jbc.M110.192377	30	8	9	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7092	7098		10.1074/jbc.M113.527507	http://dx.doi.org/10.1074/jbc.M113.527507			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24451372	Green Published, hybrid			2022-12-28	WOS:000332389400068
J	Stuible, M; Moraitis, A; Fortin, A; Saragosa, S; Kalbakji, A; Filion, M; Tremblay, GB				Stuible, Matthew; Moraitis, Anna; Fortin, Annie; Saragosa, Stefan; Kalbakji, Aida; Filion, Mario; Tremblay, Gilles B.			Mechanism and Function of Monoclonal Antibodies Targeting Siglec-15 for Therapeutic Inhibition of Osteoclastic Bone Resorption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibodies; Bone; Cell Signaling; Osteoclast; Receptor Endocytosis; Siglec-15; Anti-resorptive	DIFFERENTIATION; RECEPTOR; PROTEIN; HISTOMORPHOMETRY; BISPHOSPHONATE; OSTEOPETROSIS; ROLES; CD22	Background: Bone-resorbing osteoclasts express the Siglec-15 receptor on their plasma membrane. Results: Siglec-15 antibodies inhibit osteoclast differentiation and induce receptor endocytosis and degradation. Conclusion: These results establish that Siglec-15 antibodies target osteoclasts in vivo and reveal a likely mechanism of action. Significance: Siglec-15 could serve as a target of novel therapeutics for osteoporosis and cancer-associated bone loss. The use of monoclonal antibodies to target functionally important cell-surface proteins on bone-resorbing osteoclasts represents a promising approach for treatment of cancer-associated bone loss and other skeletal pathologies. Previously, we identified Siglec-15, a little studied sialic acid-binding receptor, as a candidate target that is highly up-regulated during osteoclast differentiation induced by the cytokine receptor activator of NF-B ligand (RANKL). In this report, we confirm that Siglec-15 is localized to the plasma membrane where it can be targeted by monoclonal antibodies to inhibit differentiation of functional osteoclasts in vitro. Furthermore, we found that treatment of mice with these antibodies led to a marked increase in bone mineral density, consistent with inhibition of osteoclast activity. Interestingly, osteoblast numbers were maintained despite the anti-resorptive activity. At the molecular level, Siglec-15 interacts with the adapter protein DAP12 and can induce Akt activation when clustered on the osteoclast cell surface, which likely represents its normal signaling function. Importantly, we discovered that monoclonal antibodies induce rapid internalization, lysosomal targeting, and degradation of Siglec-15 by inducing receptor dimerization. This study defines a key regulatory node that controls osteoclast differentiation and activity downstream of RANKL and supports further development of Siglec-15 antibodies as a novel class of bone loss therapeutics.	[Stuible, Matthew; Moraitis, Anna; Fortin, Annie; Saragosa, Stefan; Kalbakji, Aida; Filion, Mario; Tremblay, Gilles B.] Alethia Biotherapeut Inc, Montreal, PQ H2X 1Y4, Canada		Tremblay, GB (corresponding author), 141 President Kennedy Ave,Suite SB 5100, Montreal, PQ H2X 1Y4, Canada.	gilles.tremblay@alethiabio.com						Angata T, 2007, GLYCOBIOLOGY, V17, P838, DOI 10.1093/glycob/cwm049; Angata T, 2006, FASEB J, V20, P1964, DOI 10.1096/fj.06-5800com; Baron R, 2011, BONE, V48, P677, DOI 10.1016/j.bone.2010.11.020; Blasius AL, 2006, BLOOD, V107, P2474, DOI 10.1182/blood-2005-09-3746; Blasius AL, 2006, TRENDS IMMUNOL, V27, P255, DOI 10.1016/j.it.2006.04.005; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Crocker PR, 2008, BIOCHEM SOC T, V36, P1467, DOI 10.1042/BST0361467; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Egan KP, 2012, HISTOPATHOLOGY, V61, P1168, DOI 10.1111/j.1365-2559.2012.04333.x; Hiruma Y, 2013, BONE, V53, P87, DOI 10.1016/j.bone.2012.11.036; Hiruma Y, 2011, BIOCHEM BIOPH RES CO, V409, P424, DOI 10.1016/j.bbrc.2011.05.015; Humphrey MB, 2006, J BONE MINER RES, V21, P237, DOI 10.1359/JBMR.051016; Ishida-Kitagawa N, 2012, J BIOL CHEM, V287, P17493, DOI 10.1074/jbc.M111.324194; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Kameda Y, 2013, J BONE MINER RES, V28, P2463, DOI 10.1002/jbmr.1989; Karsdal MA, 2007, J BONE MINER RES, V22, P487, DOI 10.1359/JBMR.070109; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Lanier LL, 2009, IMMUNOL REV, V227, P150, DOI 10.1111/j.1600-065X.2008.00720.x; Law CL, 1996, J EXP MED, V183, P547, DOI 10.1084/jem.183.2.547; Liu QY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-286; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; MUHLBAUER RC, 1991, J BONE MINER RES, V6, P1003; O'Reilly MK, 2009, TRENDS PHARMACOL SCI, V30, P240, DOI 10.1016/j.tips.2009.02.005; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Park-Wyllie LY, 2011, JAMA-J AM MED ASSOC, V305, P783, DOI 10.1001/jama.2011.190; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Reid IR, 2012, NAT REV RHEUMATOL, V8, P90, DOI 10.1038/nrrheum.2011.181; Roelofs AJ, 2006, CLIN CANCER RES, V12, p6222S, DOI 10.1158/1078-0432.CCR-06-0843; Sooknanan R. R, 2011, Alethia Biotherapetuics, United States Patent, Patent No. [7,989,160, 7989160]; Takahata M, 2007, BONE, V41, P77, DOI 10.1016/j.bone.2007.03.016; Taylor VC, 1999, J BIOL CHEM, V274, P11505, DOI 10.1074/jbc.274.17.11505; Tomasello E, 2005, EUR J IMMUNOL, V35, P1670, DOI 10.1002/eji.200425932; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Turnbull IR, 2007, NAT REV IMMUNOL, V7, P155, DOI 10.1038/nri2014; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; Walker JA, 2008, IMMUNOLOGY, V123, P314, DOI 10.1111/j.1365-2567.2007.02752.x; Walsh MC, 2003, CYTOKINE GROWTH F R, V14, P251, DOI 10.1016/S1359-6101(03)00027-3	40	45	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6498	6512		10.1074/jbc.M113.494542	http://dx.doi.org/10.1074/jbc.M113.494542			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24446437	Green Published, hybrid			2022-12-28	WOS:000332389400017
J	Rispens, T; Davies, AM; Ooijevaar-de Heer, P; Absalah, S; Bende, O; Sutton, BJ; Vidarsson, G; Aalberse, RC				Rispens, Theo; Davies, Anna M.; Ooijevaar-de Heer, Pleuni; Absalah, Samira; Bende, Onno; Sutton, Brian J.; Vidarsson, Gestur; Aalberse, Rob C.			Dynamics of Inter-heavy Chain Interactions in Human Immunoglobulin G (IgG) Subclasses Studied by Kinetic Fab Arm Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibodies; Antibody Engineering; Protein Structure; Structural Biology; Sulfhydryl; Thermodynamics	ANTIBODY DOMAIN C(H)3; HUMAN FC FRAGMENT; STRUCTURAL-CHARACTERIZATION; EFFECTOR FUNCTIONS; CRYSTAL-STRUCTURE; HALF-LIFE; CARBOHYDRATE INTERACTIONS; MONOCLONAL-ANTIBODIES; BIOTIN ANTIBODIES; CH3 DOMAIN	Background: Fab arm exchange requires weak interactions between CH3 domains, such as in human IgG4. Results: CH3-CH3 interactions differ >1,000,000-fold between human subclasses and allotypes due to variations Lys/Asn-392, Val/Met-397, and Lys/Arg-409. Conclusion: For IgG2 and IgG3, but not IgG1, hinge disulfide bonds are essential to prevent half-molecule dissociation. Significance: Subclass/allotype variation in the CH3 domain can alter antibody stability and functionality. Interdomain interactions between the CH3 domains of antibody heavy chains are the first step in antibody assembly and are of prime importance for maintaining the native structure of IgG. For human IgG4 it was shown that CH3-CH3 interactions are weak, resulting in the potential for half-molecule exchange (Fab arm exchange). Here we systematically investigated non-covalent interchain interactions for CH3 domains in the other human subclasses, including polymorphisms (allotypes), using real-time monitoring of Fab arm exchange with a FRET-based kinetic assay. We identified structural variation between human IgG subclasses and allotypes at three amino acid positions (Lys/Asn-392, Val/Met-397, Lys/Arg-409) to alter the strength of inter-domain interactions by >6 orders of magnitude. Each substitution affected the interactions independent from the other substitutions in terms of affinity, but the enthalpic and entropic contributions were non-additive, suggesting a complex interplay. Allotypic variation in IgG3 resulted in widely different CH3 interaction strengths that were even weaker for IgG3 than for IgG4 in the case of allotype G3m(c3c5*/6,24*), whereas G3m(s*/15*) was equally stable to IgG1. These interactions are sufficiently strong to maintain the structural integrity of IgG1 during its normal life span; for IgG2 and IgG3 the inter-heavy chain disulfide bonds are essential to prevent half-molecule dissociation, whereas the labile hinge disulfide bonds favor half-molecule exchange in vivo for IgG4.	[Rispens, Theo; Ooijevaar-de Heer, Pleuni; Absalah, Samira; Bende, Onno; Vidarsson, Gestur; Aalberse, Rob C.] Sanquin Res, NL-1066 CX Amsterdam, Netherlands; [Rispens, Theo; Ooijevaar-de Heer, Pleuni; Absalah, Samira; Bende, Onno; Vidarsson, Gestur; Aalberse, Rob C.] Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Davies, Anna M.; Sutton, Brian J.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Davies, Anna M.; Sutton, Brian J.] MRC, London SE1 9RT, England; [Davies, Anna M.; Sutton, Brian J.] Asthma UK Ctr Allerg Mech Asthma, London SE1 9RT, England	University of Amsterdam; Academic Medical Center Amsterdam; University of London; King's College London; University of London; King's College London	Rispens, T (corresponding author), Sanquin Blood Supply Fdn, Plesmanlaan 125, NL-1066 CX Amsterdam, Netherlands.	T.Rispens@sanquin.nl	Davies, Anna Marie/G-4575-2014; Vidarsson, Gestur/A-9909-2009	Davies, Anna Marie/0000-0003-1498-1594; Vidarsson, Gestur/0000-0001-5621-003X; Absalah, Samira/0000-0002-8726-2542	Medical Research Council, UK [G1100090]; MRC [G1100090] Funding Source: UKRI; Medical Research Council [G1000758, G1000758B, G1100090] Funding Source: researchfish; Asthma UK [MRC-AsthmaUKCentre] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	Supported by the Medical Research Council, UK, Grant G1100090.	Aalberse RC, 1999, INT ARCH ALLERGY IMM, V118, P187, DOI 10.1159/000024062; ANGAL S, 1993, MOL IMMUNOL, V30, P105, DOI 10.1016/0161-5890(93)90432-B; BAGCI H, 1993, FEBS LETT, V322, P47, DOI 10.1016/0014-5793(93)81108-C; Baruah K, 2012, J MOL BIOL, V420, P1, DOI 10.1016/j.jmb.2012.04.002; Bertz M, 2013, J AM CHEM SOC, V135, P15085, DOI 10.1021/ja405076j; Bowden TA, 2012, J AM CHEM SOC, V134, P17554, DOI 10.1021/ja306068g; Brusco A, 1998, EUR J IMMUNOGENET, V25, P349, DOI 10.1046/j.1365-2370.1998.00113.x; Chennamsetty N, 2009, J MOL BIOL, V391, P404, DOI 10.1016/j.jmb.2009.06.028; Crispin M, 2009, J MOL BIOL, V387, P1061, DOI 10.1016/j.jmb.2009.02.033; Dall'Acqua W, 1998, BIOCHEMISTRY-US, V37, P9266, DOI 10.1021/bi980270i; Dard P, 2001, EUR J HUM GENET, V9, P765, DOI 10.1038/sj.ejhg.5200700; Davies AM, 2014, J MOL BIOL, V426, P630, DOI 10.1016/j.jmb.2013.10.039; Davies AM, 2013, MOL IMMUNOL, V54, P1, DOI 10.1016/j.molimm.2012.10.029; DELANGE GG, 1989, EXP CLIN IMMUNOGENET, V6, P7; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feige MJ, 2009, J MOL BIOL, V391, P599, DOI 10.1016/j.jmb.2009.06.048; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Goetze AM, 2011, MOL IMMUNOL, V49, P338, DOI 10.1016/j.molimm.2011.09.002; Guhr T, 2012, J PHARM SCI-US, V101, P978, DOI 10.1002/jps.22828; Hougs L, 2003, TISSUE ANTIGENS, V61, P231, DOI 10.1034/j.1399-0039.2003.00048.x; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; Ishikawa T, 2010, BIOL PHARM BULL, V33, P1413, DOI 10.1248/bpb.33.1413; Ishino T, 2013, J BIOL CHEM, V288, P16529, DOI 10.1074/jbc.M113.457689; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Jefferis R, 2009, MABS, V1, P332, DOI 10.4161/mabs.1.4.9122; Jones DP, 2009, FREE RADICAL BIO MED, V47, P1329, DOI 10.1016/j.freeradbiomed.2009.08.021; Jones DP, 2000, FREE RADICAL BIO MED, V28, P625, DOI 10.1016/S0891-5849(99)00275-0; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Kohen F, 1997, METHOD ENZYMOL, V279, P451; Kolenko P, 2009, IMMUNOLOGY, V126, P378, DOI 10.1111/j.1365-2567.2008.02904.x; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Labrijn AF, 2013, P NATL ACAD SCI USA, V110, P5145, DOI 10.1073/pnas.1220145110; Labrijn AF, 2011, J IMMUNOL, V187, P3238, DOI 10.4049/jimmunol.1003336; Labrijn AF, 2009, NAT BIOTECHNOL, V27, P767, DOI 10.1038/nbt.1553; Lefranc Marie-Paule, 2012, Methods Mol Biol, V882, P635, DOI 10.1007/978-1-61779-842-9_34; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Lewis KB, 2009, MOL IMMUNOL, V46, P3488, DOI 10.1016/j.molimm.2009.07.009; Liu HC, 2012, MABS-AUSTIN, V4, P17, DOI 10.4161/mabs.4.1.18347; Maskill H., 1986, PHYS BASIS ORGANIC C; Matsumiya S, 2007, J MOL BIOL, V368, P767, DOI 10.1016/j.jmb.2007.02.034; Mizushima T, 2011, GENES CELLS, V16, P1071, DOI 10.1111/j.1365-2443.2011.01552.x; Natsume A, 2008, CANCER RES, V68, P3863, DOI 10.1158/0008-5472.CAN-07-6297; Nomura Y, 2010, NUCLEIC ACIDS RES, V38, P7822, DOI 10.1093/nar/gkq615; Oganesyan V, 2008, ACTA CRYSTALLOGR D, V64, P700, DOI 10.1107/S0907444908007877; Oganesyan V, 2008, MOL IMMUNOL, V45, P1872, DOI 10.1016/j.molimm.2007.10.042; Oganesyan V, 2009, MOL IMMUNOL, V46, P1750, DOI 10.1016/j.molimm.2009.01.026; Rispens T, 2013, J PHARMACEUT BIOMED, V85, P179, DOI 10.1016/j.jpba.2013.07.022; Rispens T, 2013, ANAL BIOCHEM, V437, P118, DOI 10.1016/j.ab.2013.02.027; Rispens T, 2013, MOL IMMUNOL, V53, P35, DOI 10.1016/j.molimm.2012.06.012; Rispens T, 2011, J AM CHEM SOC, V133, P10302, DOI 10.1021/ja203638y; Rispens T, 2010, EUR J PHARM SCI, V40, P62, DOI 10.1016/j.ejps.2010.03.001; Rispens T, 2009, J IMMUNOL, V182, P4275, DOI 10.4049/jimmunol.0804338; SCHIFFER M, 1988, J MOL BIOL, V203, P799, DOI 10.1016/0022-2836(88)90210-0; Schuurman J, 2001, MOL IMMUNOL, V38, P1, DOI 10.1016/S0161-5890(01)00050-5; Shapiro RI, 2011, J PHARMACEUT BIOMED, V55, P168, DOI 10.1016/j.jpba.2011.01.006; Shitara K, 2007, U. S. patent, Patent No. [8,492,526, 8492526]; Siberil S, 2012, IMMUNOL LETT, V143, P60, DOI 10.1016/j.imlet.2012.02.002; Stapleton NM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1608; Stubenrauch K, 2010, DRUG METAB DISPOS, V38, P84, DOI 10.1124/dmd.109.029751; Taylor FR, 2006, ANAL BIOCHEM, V353, P204, DOI 10.1016/j.ab.2006.02.022; Teplyakov A, 2013, MOL IMMUNOL, V56, P131, DOI 10.1016/j.molimm.2013.03.018; Thies MJW, 1999, J MOL BIOL, V293, P67, DOI 10.1006/jmbi.1999.3128; Thies MJW, 2002, J MOL BIOL, V319, P1267, DOI 10.1016/S0022-2836(02)00375-3; Vafa O, 2014, METHODS, V65, P114, DOI 10.1016/j.ymeth.2013.06.035; van Schouwenburg PA, 2013, ANN RHEUM DIS, V72, P104, DOI 10.1136/annrheumdis-2012-201445; Wilkinson IC, 2013, MABS-AUSTIN, V5, P406, DOI 10.4161/mabs.23941; Yu XJ, 2013, J AM CHEM SOC, V135, P9723, DOI 10.1021/ja4014375	68	57	78	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6098	6109		10.1074/jbc.M113.541813	http://dx.doi.org/10.1074/jbc.M113.541813			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24425871	hybrid, Green Published			2022-12-28	WOS:000332015500064
J	Song, Y; Gong, K; Yan, H; Hong, W; Wang, L; Wu, YL; Li, WH; Li, WX; Cao, ZJ				Song, Yu; Gong, Ke; Yan, Hong; Hong, Wei; Wang, Le; Wu, Yingliang; Li, Wenhua; Li, Wenxin; Cao, Zhijian			Sj7170, a Unique Dual-function Peptide with a Specific alpha- Chymotrypsin Inhibitory Activity and a Potent Tumoractivating Effect from Scorpion Venom*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glioblastoma; Metastasis; Peptides; Proliferation; Protease Inhibitor	EPITHELIAL-MESENCHYMAL TRANSITION; ASCARIS TRYPSIN-INHIBITOR; PROTEINASE-INHIBITORS; PROTEASE INHIBITORS; TUMOR PROGRESSION; CELL INVASION; CANCER; GLIOMA; SUPERFAMILY; EVOLUTION	Background: Sj7170 is a new peptide from scorpion venom. Results: Sj7170 specifically inhibits the activity of -chymotrypsin. Sj7170 promotes glioblastoma tumorigenesis and metastasis by up-regulating cyclin D1 and Snail. Conclusion: Sj7170 not only specifically inhibits -chymotrypsin activity but also promotes the tumorigenesis and metastasis of glioblastoma. Significance: Sj7170 is a unique dual-function peptide with a protease inhibitory activity and a potent tumor-activating effect. A new peptide precursor, termed Sj7170, was characterized from the venomous gland cDNA library of the scorpion Scorpiops jendeki. Sj7170 was deduced to be a 62-amino acid peptide cross-linked by five disulfide bridges. The recombinant Sj7170 peptide (rSj7170) with chromatographic purity was produced by a prokaryotic expression system. Enzyme inhibition assay in vitro and in vivo showed that rSj7170 specifically inhibited the activity of -chymotrypsin at micromole concentrations. In addition, Sj7170 not only promoted cell proliferation and colony formation by up-regulating the expression of cyclin D1 in vitro but also enhanced tumor growth in nude mice. Finally, Sj7170 accelerated cellular migration and invasion by increasing the expression of the transcription factor Snail and then inducing the epithelial-mesenchymal transition. Moreover, Sj7170 changed cell morphology and cytoskeleton of U87 cells by the GTPase pathway. Taken together, Sj7170 is a unique dual-function peptide, i.e. a specific -chymotrypsin inhibitor and a potent tumorigenesis/metastasis activator. Our work not only opens an avenue of developing new modulators of tumorigenesis/metastasis from serine protease inhibitors but also strengthens the functional link between protease inhibitors and tumor activators.	[Song, Yu; Yan, Hong; Hong, Wei; Wang, Le; Wu, Yingliang; Li, Wenxin; Cao, Zhijian] Wuhan Univ, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Song, Yu; Gong, Ke; Yan, Hong; Hong, Wei; Wang, Le; Wu, Yingliang; Li, Wenhua; Li, Wenxin; Cao, Zhijian] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Wuhan University	Li, WH (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.	whli@whu.edu.cn; liwxlab@whu.edu.cn; zjcao@whu.edu.cn	Hong, Wei/AAJ-6912-2020	Hong, Wei/0000-0001-7410-4679	National Key Basic Research Program [2010CB529800, 2010CB530100]; China Specific Project for Developing New Drugs Grant [2011ZX09401-302]; Fundamental Research Funds for the Central Universities in China; National Nature Science Foundation of China [81273540]	National Key Basic Research Program(National Basic Research Program of China); China Specific Project for Developing New Drugs Grant; Fundamental Research Funds for the Central Universities in China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Basic Research Program Grants 2010CB529800 and 2010CB530100, China Specific Project for Developing New Drugs Grant 2011ZX09401-302, Fundamental Research Funds for the Central Universities in China and the National Nature Science Foundation of China Grant 81273540.	Arbiser JL, 2007, BLOOD, V109, P560, DOI 10.1182/blood-2006-06-029934; BABIN DR, 1984, ARCH BIOCHEM BIOPHYS, V232, P143, DOI 10.1016/0003-9861(84)90530-7; Bergeron S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-271; Chen ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057529; Cheng HX, 2009, CANCER RES, V69, P1828, DOI 10.1158/0008-5472.CAN-08-3728; Cierpicki T, 2000, PROTEIN SCI, V9, P976, DOI 10.1110/ps.9.5.976; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Deshane J, 2003, J BIOL CHEM, V278, P4135, DOI 10.1074/jbc.M205662200; DOWDY SF, 1993, CELL, V73, P499, DOI 10.1016/0092-8674(93)90137-F; Gessler F, 2011, NEUROSCI LETT, V497, P49, DOI 10.1016/j.neulet.2011.04.027; Goel A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.141; GRASBERGER BL, 1994, STRUCTURE, V2, P669, DOI 10.1016/S0969-2126(00)00067-8; GRONENBORN AM, 1990, BIOCHEMISTRY-US, V29, P183, DOI 10.1021/bi00453a025; Heinen TE, 2011, TOXICON, V57, P497, DOI 10.1016/j.toxicon.2011.01.002; HUANG K, 1994, STRUCTURE, V2, P679, DOI 10.1016/S0969-2126(00)00068-X; Jager H, 2004, MOL PHARMACOL, V65, P630, DOI 10.1124/mol.65.3.630; Jung H, 2008, ONCOGENE, V27, P2635, DOI 10.1038/sj.onc.1210914; Kataoka H, 2002, PATHOL INT, V52, P89, DOI 10.1046/j.1440-1827.2002.01320.x; Lamouille S, 2012, J CELL SCI, V125, P1259, DOI 10.1242/jcs.095299; Lee HC, 2005, J CELL BIOCHEM, V94, P597, DOI 10.1002/jcb.20312; Ma YB, 2012, J PROTEOMICS, V75, P1563, DOI 10.1016/j.jprot.2011.11.029; Mamelak AN, 2007, EXPERT OPIN DRUG DEL, V4, P175, DOI 10.1517/17425247.4.2.175; Mignogna G, 1996, PROTEIN SCI, V5, P357; Ohmuraya M, 2011, EXP ANIM TOKYO, V60, P433; Saini SS, 1999, TOXICON, V37, P1605, DOI 10.1016/S0041-0101(99)00110-5; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Wang ZW, 2010, CURR STEM CELL RES T, V5, P74, DOI 10.2174/157488810790442813; Yuan CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003414; Zeng XC, 2000, TOXICON, V38, P893, DOI 10.1016/S0041-0101(99)00192-0	30	12	13	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11667	11680		10.1074/jbc.M113.540419	http://dx.doi.org/10.1074/jbc.M113.540419			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24584937	hybrid, Green Published			2022-12-28	WOS:000335010600010
J	Ahlgren, H; Bas-Orth, C; Freitag, HE; Hellwig, A; Ottersen, OP; Bading, H				Ahlgren, Hanna; Bas-Orth, Carlos; Freitag, H. Eckehard; Hellwig, Andrea; Ottersen, Ole Petter; Bading, Hilmar			The Nuclear Calcium Signaling Target, Activating Transcription Factor 3 (ATF3), Protects against Dendrotoxicity and Facilitates the Recovery of Synaptic Transmission after an Excitotoxic Insult*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Signaling; Cell Signaling; Gene Expression; Glutamate Receptors Ionotropic (AMPA; NMDA); Neurobiology; Neurodegeneration; Neuroprotection; Neurotransmitters; Signal Transduction	ACTIVITY-DEPENDENT NEUROPROTECTION; GLUTAMATE-RECEPTOR ACTIVATION; METHYL-D-ASPARTATE; HIPPOCAMPAL-NEURONS; IN-VIVO; NMDA RECEPTORS; MITOCHONDRIAL DYSFUNCTION; MORPHOLOGICAL-CHANGES; DENDRITE MORPHOLOGY; REVERSIBLE CHANGES	Background: Injured neurons display dendritic beadings, which represent focal swellings of dendrites. Results: Increased synaptic activity and overexpression of ATF3 reduce dendritic beading after an excitotoxic insult. Conclusion: ATF3 overexpression facilitates recovery of neuronal network function after an excitotoxic insult. Significance: ATF3-based dendroprotection promotes functional recovery after neuronal injury. The focal swellings of dendrites (dendritic beading) are an early morphological hallmark of neuronal injury and dendrotoxicity. They are associated with a variety of pathological conditions, including brain ischemia, and cause an acute disruption of synaptic transmission and neuronal network function, which contribute to subsequent neuronal death. Here, we show that increased synaptic activity prior to excitotoxic injury protects, in a transcription-dependent manner, against dendritic beading. Expression of activating transcription factor 3 (ATF3), a nuclear calcium-regulated gene and member of the core gene program for acquired neuroprotection, can protect against dendritic beading. Conversely, knockdown of ATF3 exacerbates dendritic beading. Assessment of neuronal network functions using microelectrode array recordings revealed that hippocampal neurons expressing ATF3 were able to regain their ability for functional synaptic transmission and to participate in coherent neuronal network activity within 48 h after exposure to toxic concentrations of NMDA. Thus, in addition to attenuating cell death, synaptic activity and expression of ATF3 render hippocampal neurons more resistant to acute dendrotoxicity and loss of synapses. Dendroprotection can enhance recovery of neuronal network functions after excitotoxic insults.	[Ahlgren, Hanna; Bas-Orth, Carlos; Freitag, H. Eckehard; Hellwig, Andrea; Bading, Hilmar] Heidelberg Univ, Dept Neurobiol, Interdisciplinary Ctr Neurosci, D-69120 Heidelberg, Germany; [Ottersen, Ole Petter] Univ Oslo, Ctr Mol Biol & Neurosci, N-0317 Oslo, Norway; [Ottersen, Ole Petter] Univ Oslo, Dept Anat, Inst Basic Med Sci, N-0317 Oslo, Norway	Ruprecht Karls University Heidelberg; University of Oslo; University of Oslo	Bading, H (corresponding author), Heidelberg Univ, Dept Neurobiol, Interdisciplinary Ctr Neurosci, INF 364, D-69120 Heidelberg, Germany.	Hilmar.Bading@uni-hd.de		Bas Orth, Carlos/0000-0002-6037-8350	Letten Foundation; European Research Council; Deutsche Forschungsgemeinschaft [SFB488, SFB636]	Letten Foundation; European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Letten Foundation (to H. A.), a European Research Council Advanced Grant (to H. B.), and Deutsche Forschungsgemeinschaft Grants SFB488 and SFB636.	Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Anderson TR, 2005, J NEUROPHYSIOL, V93, P963, DOI 10.1152/jn.00654.2004; Andrew RD, 2007, CEREB CORTEX, V17, P787, DOI 10.1093/cercor/bhk032; Arnold FJL, 2005, J PHYSIOL-LONDON, V564, P3, DOI 10.1113/jphysiol.2004.077446; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bengtson CP, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-11; Brewer LD, 2007, BRAIN RES, V1151, P20, DOI 10.1016/j.brainres.2007.03.020; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; Dick O, 2010, J BIOL CHEM, V285, P19354, DOI 10.1074/jbc.M110.127654; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; EMERY DG, 1995, BRAIN RES, V692, P161, DOI 10.1016/0006-8993(95)00726-7; Enright LE, 2007, J CEREBR BLOOD F MET, V27, P1185, DOI 10.1038/sj.jcbfm.9600428; Faddis BT, 1997, J NEUROSCI, V17, P951; FURUKAWA K, 1995, BRAIN RES, V689, P141, DOI 10.1016/0006-8993(95)00537-Z; Greenwood SM, 2007, J BIOL CHEM, V282, P26235, DOI 10.1074/jbc.M704488200; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hasbani MJ, 2001, J NEUROSCI, V21, P2393, DOI 10.1523/JNEUROSCI.21-07-02393.2001; Hasbani MJ, 2001, NEUROREPORT, V12, P2731, DOI 10.1097/00001756-200108280-00028; Hasbani MJ, 1998, EXP NEUROL, V154, P241, DOI 10.1006/exnr.1998.6929; HORI N, 1994, EXP NEUROL, V129, P279, DOI 10.1006/exnr.1994.1170; Hoskison MM, 2006, EXP NEUROL, V202, P302, DOI 10.1016/j.expneurol.2006.06.010; Ikegaya Y, 2001, J CELL SCI, V114, P4083; Jagt TAV, 2008, J NEUROSCI, V28, P5029, DOI 10.1523/JNEUROSCI.5069-07.2008; KATSURA K, 1994, BIOCHEM SOC T, V22, P991, DOI 10.1042/bst0220991; Kintner DB, 2010, J BIOL CHEM, V285, P35155, DOI 10.1074/jbc.M110.101212; Klugmann M, 2005, MOL CELL NEUROSCI, V28, P347, DOI 10.1016/j.mcn.2004.10.002; Lau D, 2009, J NEUROSCI, V29, P4420, DOI 10.1523/JNEUROSCI.0802-09.2009; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Leveille F, 2008, FASEB J, V22, P4258, DOI 10.1096/fj.08-107268; Li P, 2008, J NEUROSCI, V28, P11970, DOI 10.1523/JNEUROSCI.3724-08.2008; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; MacAskill AF, 2009, NEURON, V61, P541, DOI 10.1016/j.neuron.2009.01.030; MacAulay N, 2010, NEUROSCIENCE, V168, P941, DOI 10.1016/j.neuroscience.2009.09.016; MATESIC DF, 1994, J NEUROCHEM, V63, P1012; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Nakagomi S, 2003, J NEUROSCI, V23, P5187; Nielsen S, 1997, J NEUROSCI, V17, P171; OLNEY JW, 1979, BRAIN RES, V176, P91, DOI 10.1016/0006-8993(79)90872-2; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Park JS, 1996, NEUROBIOL DIS, V3, P215, DOI 10.1006/nbdi.1996.0022; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; PETITO CK, 1984, J CEREBR BLOOD F MET, V4, P194, DOI 10.1038/jcbfm.1984.28; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Risher WC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022351; Risher WC, 2010, J NEUROSCI, V30, P9859, DOI 10.1523/JNEUROSCI.1917-10.2010; Risher WC, 2009, GLIA, V57, P207, DOI 10.1002/glia.20747; SCHLIWA M, 1981, P NATL ACAD SCI-BIOL, V78, P1037, DOI 10.1073/pnas.78.2.1037; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Seijffers R, 2006, MOL CELL NEUROSCI, V32, P143, DOI 10.1016/j.mcn.2006.03.005; Sigler A, 2010, STROKE, V41, pS117, DOI 10.1161/STROKEAHA.110.594648; SOMJEN GG, 1993, BRAIN RES, V632, P180, DOI 10.1016/0006-8993(93)91153-J; Soriano FX, 2006, J NEUROSCI, V26, P4509, DOI 10.1523/JNEUROSCI.0455-06.2006; Tauskela JS, 2001, NEUROSCIENCE, V107, P571, DOI 10.1016/S0306-4522(01)00381-5; Tseng CY, 2011, J NEUROSCI, V31, P15468, DOI 10.1523/JNEUROSCI.2442-11.2011; VONLUBITZ DKJE, 1983, ACTA NEUROPATHOL, V61, P52, DOI 10.1007/BF00688386; Wang JH, 1995, J BIOL CHEM, V270, P30245, DOI 10.1074/jbc.270.51.30245; Wiegert JS, 2007, J BIOL CHEM, V282, P29621, DOI 10.1074/jbc.M701448200; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhang SJ, 2011, J NEUROSCI, V31, P4978, DOI 10.1523/JNEUROSCI.2672-10.2011; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zhang SX, 2005, J NEUROSCI, V25, P5333, DOI 10.1523/JNEUROSCI.1085-05.2005	67	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9970	9982		10.1074/jbc.M113.502914	http://dx.doi.org/10.1074/jbc.M113.502914			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24515113	Green Published, hybrid			2022-12-28	WOS:000333807000046
J	Chen, XJ; Sun, WY; Gianaris, NG; Riley, AM; Cummins, TR; Fehrenbacher, JC; Obukhov, AG				Chen, Xingjuan; Sun, Weiyang; Gianaris, Nicholas G.; Riley, Ashley M.; Cummins, Theodore R.; Fehrenbacher, Jill C.; Obukhov, Alexander G.			Furanocoumarins Are a Novel Class of Modulators for the Transient Receptor Potential Vanilloid Type 1 (TRPV1) Channel*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Calcium Imaging; Calcium Signaling; Ion Channels; TRP Channels	ANGELICA-DAHURICA; SODIUM-CHANNELS; FORMALIN TEST; IMPERATORIN; CAPSAICIN; BINDING; PAIN; IDENTIFICATION; SUPPRESSION; RELEASE	Background: Furanocoumarin imperatorin is a major active component of Angelica dahurica root extracts exhibiting analgesic properties. Results: Imperatorin inhibited formalin- and capsaicin-induced nocifensive responses, facilitated TRPV1 desensitization, and sensitized TRPV1 to acid activation. Conclusion: Furanocoumarins represent a novel class of TRPV1 partial agonists exhibiting analgesic potential. Significance: Imperatorin is a lead compound for drug discovery aimed at developing new analgesics. Furanocoumarin imperatorin is the major active component of Angelica dahurica root extracts, widely used in traditional medicine to treat headache, toothache, and orbital eye pain. In this study, we investigated the mechanisms that may underlie the pain-relieving effects of the compound. We found that imperatorin significantly inhibited formalin- and capsaicin-induced nocifensive responses but did not alter baseline thermal withdrawal thresholds in the rat. We established that imperatorin is a weak agonist of TRPV1, a channel implicated in detecting several noxious stimuli, exhibiting a 50% effective concentration (EC50) of 12.6 +/- 3.2 m. A specific TRPV1 antagonist, JNJ-17203212 (0.5 m), potently inhibited imperatorin-induced TRPV1 activation. Site-directed mutagenesis studies revealed that imperatorin most likely acted via a site adjacent to or overlapping with the TRPV1 capsaicin-binding site. TRPV1 recovery from desensitization was delayed in the presence of imperatorin. Conversely, imperatorin sensitized TRPV1 to acid activation but did not affect the current amplitude and/or the activation-inactivation properties of Na(v)1.7, a channel important for transmission of nociceptive information. Thus, our data indicate that furanocoumarins represent a novel group of TRPV1 modulators that may become important lead compounds in the drug discovery process aimed at developing new treatments for pain management.	[Chen, Xingjuan; Sun, Weiyang; Gianaris, Nicholas G.; Riley, Ashley M.; Obukhov, Alexander G.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Cummins, Theodore R.; Fehrenbacher, Jill C.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Cummins, Theodore R.; Fehrenbacher, Jill C.; Obukhov, Alexander G.] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Sun, Weiyang] Shandong Univ Tradit Chinese Med, Sch Pharm, Jinan 250355, Shandong, Peoples R China	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Shandong University of Traditional Chinese Medicine	Obukhov, AG (corresponding author), Indiana Univ Sch Med, 635 Barnhill Dr,MS360A, Indianapolis, IN 46202 USA.	aobukhov@iupui.edu	Obukhov, Alexander G/C-7246-2008; chen, xingjuan/V-4064-2019	Obukhov, Alexander G/0000-0002-3862-6004; chen, xingjuan/0000-0002-7380-8399	National Institutes of Health [R01HL083381, R01HL115140]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083381, R01HL115140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL083381 and R01HL115140 (to A. G. O.).	[Anonymous], 2011, MED LETT DRUGS THER, V53, P42; Ban HS, 2003, PLANTA MED, V69, P408, DOI 10.1055/s-2003-39702; Brederson JD, 2013, EUR J PHARMACOL, V716, P61, DOI 10.1016/j.ejphar.2013.03.003; Brittain JM, 2011, NAT MED, V17, P822, DOI 10.1038/nm.2345; Btesh J, 2013, J NEUROSCI, V33, P9184, DOI 10.1523/JNEUROSCI.4991-12.2013; Chakraborty S, 2011, J PHARMACOL EXP THER, V339, P329, DOI 10.1124/jpet.111.183673; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Chung MK, 2008, NAT NEUROSCI, V11, P555, DOI 10.1038/nn.2102; Cortright DN, 2009, CURR PHARM DESIGN, V15, P1736, DOI 10.2174/138161209788186308; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Dib-Hajj SD, 2013, NAT REV NEUROSCI, V14, P49, DOI 10.1038/nrn3404; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Diogenes A, 2006, J NEUROSCI, V26, P8126, DOI 10.1523/JNEUROSCI.0793-06.2006; DUBUISSON D, 1977, PAIN, V4, P161, DOI 10.1016/0304-3959(77)90130-0; Farazifard R, 2005, BRAIN RES PROTOC, V16, P44, DOI 10.1016/j.brainresprot.2005.10.003; Guo A, 1999, EUR J NEUROSCI, V11, P946, DOI 10.1046/j.1460-9568.1999.00503.x; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hou XW, 2012, SCIENCE, V338, P1308, DOI 10.1126/science.1228757; Huang GJ, 2012, J AGR FOOD CHEM, V60, P1673, DOI 10.1021/jf204297e; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kumar S, 2012, J CELL PHYSIOL, V227, P1408, DOI 10.1002/jcp.22855; Liu RM, 2004, J CHROMATOGR A, V1052, P223, DOI 10.1016/j.chroma.2004.08.127; Lu H. C., 2005, CHINESE NATURAL CURE; Lu W, 2013, MED CHEM, V9, P993, DOI 10.2174/1573406411309070013; Lukacs V, 2013, J BIOL CHEM, V288, P35003, DOI 10.1074/jbc.M113.520288; Luszczki JJ, 2009, EPILEPSY RES, V85, P293, DOI 10.1016/j.eplepsyres.2009.03.027; Mathie A, 2010, J PHARM PHARMACOL, V62, P1089, DOI 10.1111/j.2042-7158.2010.01131.x; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Nakamura A, 2007, J CHEM NEUROANAT, V34, P95, DOI 10.1016/j.jchemneu.2007.05.005; Pabbidi RM, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-9; Planells-Cases R, 2011, ADV EXP MED BIOL, V704, P491, DOI 10.1007/978-94-007-0265-3_27; Premkumar LS, 2013, LIFE SCI, V92, P415, DOI 10.1016/j.lfs.2012.08.010; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Reilly RM, 2012, J PHARMACOL EXP THER, V342, P416, DOI 10.1124/jpet.111.190314; Rohacs Tibor, 2013, Advances in Biological Regulation, V53, P341, DOI 10.1016/j.jbior.2013.07.004; Ruparel NB, 2008, PAIN, V135, P271, DOI 10.1016/j.pain.2007.06.005; Salat K, 2013, CURR MED CHEM, V20, P1409, DOI 10.2174/09298673113209990107; Sarker SD, 2004, CURR MED CHEM, V11, P1479, DOI 10.2174/0929867043365189; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; SZOLCSANYI J, 1975, ARZNEIMITTEL-FORSCH, V25, P1877; Wu KC, 2013, EUR J PHARMACOL, V721, P49, DOI 10.1016/j.ejphar.2013.09.056; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Zhang H, 2009, RAPID COMMUN MASS SP, V23, P2167, DOI 10.1002/rcm.4123	44	29	33	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9600	9610		10.1074/jbc.M113.536862	http://dx.doi.org/10.1074/jbc.M113.536862			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24569998	hybrid, Green Published			2022-12-28	WOS:000333807000015
J	Fraga, H; Bech-Serra, JJ; Canals, F; Ortega, G; Millet, O; Ventura, S				Fraga, Hugo; Bech-Serra, Joan-Josep; Canals, Francesc; Ortega, Gabriel; Millet, Oscar; Ventura, Salvador			The Mitochondrial Intermembrane Space Oxireductase Mia40 Funnels the Oxidative Folding Pathway of the Cytochrome c Oxidase Assembly Protein Cox19*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biophysics; Disulfide; Mitochondria; Oxidation-Reduction; Protein Folding; Protein Translocation; Cox19; Mia40; Protein Oxidative Folding	DISULFIDE BOND FORMATION; SMALL TIM PROTEINS; SECONDARY STRUCTURE; RELAY SYSTEM; IMPORT; SIGNAL; BIOGENESIS; CYSTEINES; COX19	Background: Mia40 accelerates Cox19 folding through the specific recognition of the third Cys in the second CX9C motif. Results: The chaperone catalysis renders a native-like intermediate that oxidizes in a slow uncatalyzed reaction into native Cox19. Conclusion: The role of Mia40 is funnelling an already sequentially encoded, but rough, substrate folding landscape. Significance: These results provide a rationale for the substrate promiscuity of the chaperone Mia40. Mia40-catalyzed disulfide formation drives the import of many proteins into the mitochondria. Here we characterize the oxidative folding of Cox19, a twin CX9C Mia40 substrate. Cox19 oxidation is extremely slow, explaining the persistence of import-competent reduced species in the cytosol. Mia40 accelerates Cox19 folding through the specific recognition of the third Cys in the second helical CX9C motif and the subsequent oxidation of the inner disulfide bond. This renders a native-like intermediate that oxidizes in a slow uncatalyzed reaction into native Cox19. The same intermediate dominates the pathway in the absence of Mia40, and chemical induction of an -helical structure by trifluoroethanol suffices to accelerate productive folding and mimic the Mia40 folding template mechanism. The Mia40 role is to funnel a rough folding landscape, skipping the accumulation of kinetic traps, providing a rationale for the promiscuity of Mia40.	[Fraga, Hugo; Ventura, Salvador] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain; [Fraga, Hugo; Ventura, Salvador] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Bech-Serra, Joan-Josep; Canals, Francesc] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Barcelona 08135, Spain; [Ortega, Gabriel; Millet, Oscar] CIC BioGUNE, Struct Biol Unit, Metab & Dis Program, Derio 48160, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut d'Oncologia (VHIO); CIC bioGUNE	Fraga, H (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain.	hugofraga@gmail.com; salvador.ventura@uab.es	Ventura, Salvador/C-7021-2008; Bech-Serra, Joan Josep/AAA-2330-2020; Quintanilla, Gabriel Ortega/C-7850-2018; Ventura, Salvador/AAY-3170-2021; Quintanilla, Gabriel Ortega/AAC-6618-2021; Fraga, Hugo/X-4850-2019; Millet, Oscar/F-9696-2011	Ventura, Salvador/0000-0002-9652-6351; Bech-Serra, Joan Josep/0000-0003-3486-781X; Quintanilla, Gabriel Ortega/0000-0002-7126-9096; Ventura, Salvador/0000-0002-9652-6351; Quintanilla, Gabriel Ortega/0000-0002-7126-9096; Fraga, Hugo/0000-0001-7677-4086; Millet, Oscar/0000-0001-8748-4105	Ministerio de Ciencia e Innovacion, Spain [BFU2010-14901]; Generalitat de Catalunya [2009-SGR-760]; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BPD/ 87148/2012]	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	This work was supported by Grants BFU2010-14901 (Ministerio de Ciencia e Innovacion, Spain) and 2009-SGR-760 (Generalitat de Catalunya) grants.; Supported by Fundacao para a Ciencia e Tecnologia, Portugal (SFRH/BPD/ 87148/2012). To whom correspondence may be addressed. Tel.: 34-93-5812154; Fax: 34-93-5811264; E-mail: hugofraga@gmail.com.	Arolas JL, 2006, J BIOL CHEM, V281, P22906, DOI 10.1074/jbc.M602301200; Arolas JL, 2006, TRENDS BIOCHEM SCI, V31, P292, DOI 10.1016/j.tibs.2006.03.005; Banci L, 2010, P NATL ACAD SCI USA, V107, P20190, DOI 10.1073/pnas.1010095107; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Bien M, 2010, MOL CELL, V37, P516, DOI 10.1016/j.molcel.2010.01.017; Bourens M, 2012, J BIOL CHEM, V287, P31258, DOI 10.1074/jbc.M112.383562; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Chiti F, 1999, NAT STRUCT BIOL, V6, P380; Deponte M, 2009, J BIOCHEM, V146, P599, DOI 10.1093/jb/mvp133; Endo T, 2009, BIOL CHEM, V390, P723, DOI 10.1515/BC.2009.087; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; Fischer M, 2013, MOL BIOL CELL, V24, P2160, DOI 10.1091/mbc.E12-12-0862; Harrison P., 2008, PLOS COMPUT BIOL, V4; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI [10.1089/ars.2009.2466, 10.1089/ARS.2009.2466]; Hell K, 2008, BBA-MOL CELL RES, V1783, P601, DOI 10.1016/j.bbamcr.2007.12.005; Koehler CM, 2006, ANTIOXID REDOX SIGN, V8, P813, DOI 10.1089/ars.2006.8.813; Leary SC, 2013, MOL BIOL CELL, V24, P683, DOI 10.1091/mbc.E12-09-0705; Longen S, 2009, J MOL BIOL, V393, P356, DOI 10.1016/j.jmb.2009.08.041; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Milenkovic D, 2007, J BIOL CHEM, V282, P22472, DOI 10.1074/jbc.M703294200; Milenkovic D, 2009, MOL BIOL CELL, V20, P2530, DOI 10.1091/mbc.E08-11-1108; Morgan B, 2008, BIOCHEM J, V411, P115, DOI 10.1042/BJ20071476; Riemer J, 2011, BBA-BIOMEMBRANES, V1808, P981, DOI 10.1016/j.bbamem.2010.06.003; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Rigby K, 2007, J BIOL CHEM, V282, P10233, DOI 10.1074/jbc.M610082200; Sideris DP, 2007, MOL MICROBIOL, V65, P1360, DOI 10.1111/j.1365-2958.2007.05880.x; Sideris DP, 2009, J CELL BIOL, V187, P1007, DOI 10.1083/jcb.200905134; Tienson HL, 2009, MOL BIOL CELL, V20, P3481, DOI 10.1091/mbc.E08-10-1062; Ventura S, 2011, PROTEIN REV, V14, P1, DOI 10.1007/978-1-4419-7273-6_1; Voronova A, 2007, BIOCHEM J, V408, P139, DOI 10.1042/BJ20070804; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010	32	14	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9852	9864		10.1074/jbc.M114.553479	http://dx.doi.org/10.1074/jbc.M114.553479			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24569988	hybrid, Green Published			2022-12-28	WOS:000333807000035
J	Pavlovic, Z; Zhu, L; Pereira, L; Singh, RK; Cornell, RB; Bakovic, M				Pavlovic, Zvezdan; Zhu, Lin; Pereira, Leanne; Singh, Ratnesh Kumar; Cornell, Rosemary B.; Bakovic, Marica			Isoform-specific and Protein Kinase C-mediated Regulation of CTP: Phosphoethanolamine Cytidylyltransferase Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO SYNTHESIS; PHOSPHATIDYLETHANOLAMINE SYNTHESIS; BREAST; MOUSE; CELLS; GENE; EXPRESSION; REDISTRIBUTION; STIMULATION; PATHWAY	Background: Post-translational regulation of CTP:phosphoethanolamine cytidylyltransferase (Pcyt2) is largely unexplored. Results: Pcyt2 isoforms are characteristically phosphorylated within a newly identified central linker segment not present in other cytidylyltransferases. Conclusion: Pcyt2 phosphorylation influences cell growth and is regulated by conventional PKCs and serum deficiency. Significance: The isoform-specific phosphorylation reveals a post-translational regulation of Pcyt2 that is distinct from other cytidylyltransferases. CTP:phosphoethanolamine cytidylyltransferase (Pcyt2) is the main regulatory enzyme for de novo biosynthesis of phosphatidylethanolamine by the CDP-ethanolamine pathway. There are two isoforms of Pcyt2, - and -; however, very little is known about their specific roles in this important metabolic pathway. We previously demonstrated increased phosphatidylethanolamine biosynthesis subsequent to elevated activity and phosphorylation of Pcyt2 and - in MCF-7 breast cancer cells grown under conditions of serum deficiency. Mass spectroscopy analyses of Pcyt2 provided evidence for isoform-specific as well as shared phosphorylations. Pcyt2 was specifically phosphorylated at the end of the first cytidylyltransferase domain. Pcyt2 was phosphorylated within the -specific motif that is spliced out in Pcyt2 and on two PKC consensus serine residues, Ser-215 and Ser-223. Single and double mutations of PKC consensus sites reduced Pcyt2 phosphorylation, activity, and phosphatidylethanolamine synthesis by 50-90%. The phosphorylation and activity of endogenous Pcyt2 were dramatically increased with phorbol esters and reduced by specific PKC inhibitors. In vitro translated Pcyt2 was phosphorylated by PKC, PKCI, and PKCII. Pcyt2 Ser-215 was also directly phosphorylated with PKC. Mapping of the Pcyt2- and --phosphorylated sites to the solved structure of a human Pcyt2 showed that they clustered within and flanking the central linker region that connects the two catalytic domains and is a novel regulatory segment not present in other cytidylyltransferases. This study is the first to demonstrate differences in phosphorylation between Pcyt2 isoforms and to uncover the role of the PKC-regulated phosphorylation.	[Pavlovic, Zvezdan; Zhu, Lin; Pereira, Leanne; Singh, Ratnesh Kumar; Bakovic, Marica] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada; [Cornell, Rosemary B.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Cornell, Rosemary B.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	University of Guelph; Simon Fraser University; Simon Fraser University	Bakovic, M (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Anim Sci & Nutr Bldg,Rm 346, Guelph, ON N1G 2W1, Canada.	mbakovic@uoguelph.ca			Canadian Institutes of Health Research; Ontario President Research Excellence Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario President Research Excellence Award	This work was supported by grants from the Canadian Institutes of Health Research (to M. B. and R. C.) and Ontario President Research Excellence Award (to M. B.).	Bleijerveld OB, 2004, BIOCHEM J, V379, P711, DOI 10.1042/BJ20031422; Dixon RM, 1996, ANTICANCER RES, V16, P1351; Emoto K, 1996, P NATL ACAD SCI USA, V93, P12867, DOI 10.1073/pnas.93.23.12867; Emoto K, 2000, J CELL BIOL, V149, P1215, DOI 10.1083/jcb.149.6.1215; Folger O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.35; Fong DH, 2006, BBA-PROTEINS PROTEOM, V1764, P63, DOI 10.1016/j.bbapap.2005.10.015; Fullerton MD, 2007, MOL CELL BIOL, V27, P3327, DOI 10.1128/MCB.01527-06; Fullerton MD, 2010, METABOLISM, V59, P1691, DOI 10.1016/j.metabol.2010.03.022; Fullerton MD, 2009, J BIOL CHEM, V284, P25704, DOI 10.1074/jbc.M109.023846; Gibellini F, 2010, IUBMB LIFE, V62, P414, DOI 10.1002/iub.337; Girardi JP, 2011, MED HYPOTHESES, V77, P1083, DOI 10.1016/j.mehy.2011.09.008; Giritharan G, 2010, HUM REPROD, V25, P3012, DOI 10.1093/humrep/deq266; Gupta AK, 1996, CELL PROLIFERAT, V29, P655, DOI 10.1111/j.1365-2184.1996.tb00979.x; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Kiss Z, 1997, ARCH BIOCHEM BIOPHYS, V347, P37, DOI 10.1006/abbi.1997.0308; Kunz D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-90; Lahn M, 2004, ONCOLOGY-BASEL, V67, P1, DOI 10.1159/000080279; Lee JY, 2009, J BIOL CHEM, V284, P33535, DOI 10.1074/jbc.M109.053363; Leonardi R, 2009, J BIOL CHEM, V284, P27077, DOI 10.1074/jbc.M109.031336; Li H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-103; Momchilova A, 1999, CELL BIOL INT, V23, P603, DOI 10.1006/cbir.1999.0430; Pavlovic Z, 2013, INT J MOL SCI, V14, P2529, DOI 10.3390/ijms14022529; PEREIRA L, 2012, INT J CELL BIOL, V2012; Poloumienko A, 2004, GENE, V325, P145, DOI 10.1016/j.gene.2003.10.005; Serb JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012525; Singh R., 2012, INT J CELL BIOL, V2012; Swiss VA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018088; Taneva S, 2008, J BIOL CHEM, V283, P28137, DOI 10.1074/jbc.M802595200; Tie A, 2007, J LIPID RES, V48, P2172, DOI 10.1194/jlr.M600536-JLR200; TIJBURG LBM, 1987, BIOCHIM BIOPHYS ACTA, V922, P184, DOI 10.1016/0005-2760(87)90153-6; Weber CH, 1999, STRUCTURE, V7, P1113, DOI 10.1016/S0969-2126(99)80178-6; Woodfield GW, 2010, GENE CHROMOSOME CANC, V49, P948, DOI 10.1002/gcc.20807; Zhang RL, 2004, PROTEOMICS, V4, P244, DOI 10.1002/pmic.200300495; Zhu L, 2008, J LIPID RES, V49, P2197, DOI 10.1194/jlr.M800259-JLR200; Zhu L, 2012, BIOCHEM CELL BIOL, V90, P188, DOI [10.1139/O11-081, 10.1139/o11-081]; Zhu L, 2009, GENE, V447, P51, DOI 10.1016/j.gene.2009.07.014	36	13	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9053	9064		10.1074/jbc.M113.544932	http://dx.doi.org/10.1074/jbc.M113.544932			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24519946	Green Published, hybrid			2022-12-28	WOS:000333472100026
J	Valdes, R; Elferich, J; Shinde, U; Landfear, SM				Valdes, Raquel; Elferich, Johannes; Shinde, Ujwal; Landfear, Scott M.			Identification of the Intracellular Gate for a Member of the Equilibrative Nucleoside Transporter ( ENT) Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Computer Modeling; Gating; Nucleoside Nucleotide Transport; Purine; Transporters	NUCLEOBASE TRANSPORTER; LEISHMANIA-DONOVANI; CRYSTAL-STRUCTURE; STRUCTURAL MODEL; LACTOSE PERMEASE; CHEMOTHERAPY; EXPRESSION; SYMPORTER; PROXIMITY; MECHANISM	Background: Equilibrative nucleoside transporters (ENTs) play important roles in biology and disease. Results: The intracellular gate for an ENT, LdNT1.1, has been identified by computational and experimental methods. Conclusion: The intracellular gate consists of the ends of four transmembrane helices. Significance: An important functional component of ENTs has been identified. Equilibrative nucleoside transporters of the SLC29 family play important roles in many physiological and pharmacological processes, including import of drugs for treatment of cancer, AIDS, cardiovascular, and parasitic diseases. However, no crystal structure is available for any member of this family. In previous studies we generated a computational model of the Leishmania donovani nucleoside transporter 1.1 (LdNT1.1) that captured this permease in the outward-closed conformation, and we identified the extracellular gate. In the present study we have modeled the inward-closed conformation of LdNT1.1 using the crystal structure of the Escherichia coli fucose transporter FucP and have identified four transmembrane helices whose ends close to form a predicted intracellular gate. We have tested this prediction by site-directed mutagenesis of relevant helix residues and by cross-linking of introduced cysteine pairs. The results are consistent with the predictions of the computational model and suggest that a similarly constituted gate operates in other members of the equilibrative nucleoside transporter family.	[Valdes, Raquel; Landfear, Scott M.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA; [Elferich, Johannes; Shinde, Ujwal] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Landfear, SM (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	landfear@ohsu.edu		Landfear, Scott/0000-0002-1643-6664; Elferich, Johannes/0000-0002-9911-706X	National Institutes of Health [AI44138]; National Science Foundation [0746589]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044138, R01AI023682] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0746589] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported, in whole or in part, by National Institutes of Health Grant AI44138 (to S. M. L.). This work was also supported by National Science Foundation Grant 0746589 (to U.S.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Arastu-Kapur S, 2005, J BIOL CHEM, V280, P2213, DOI 10.1074/jbc.M408224200; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Baldwin SA, 2007, CURR PHARM DESIGN, V13, P569, DOI 10.2174/138161207780162845; Brocke L, 2002, J BIOL CHEM, V277, P3985, DOI 10.1074/jbc.M107735200; Crisman TJ, 2009, P NATL ACAD SCI USA, V106, P20752, DOI 10.1073/pnas.0908570106; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; de Koning HP, 1998, J BIOL CHEM, V273, P9486, DOI 10.1074/jbc.273.16.9486; Detke S, 2007, EXP CELL RES, V313, P1963, DOI 10.1016/j.yexcr.2007.02.027; DREW ME, 1995, MOL CELL BIOL, V15, P5508; Etchebest C, 2010, METHODS MOL BIOL, V654, P363, DOI 10.1007/978-1-60761-762-4_19; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; HAMMOND DJ, 1984, MOL BIOCHEM PARASIT, V13, P243, DOI 10.1016/0166-6851(84)90117-8; Hirai T, 2002, NAT STRUCT BIOL, V9, P597, DOI 10.1038/nsb821; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kavanaugh MP, 1998, P NATL ACAD SCI USA, V95, P12737, DOI 10.1073/pnas.95.22.12737; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; Kong W, 2004, CURR DRUG METAB, V5, P63, DOI 10.2174/1389200043489162; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; LEBOWITZ JH, 1994, METHOD CELL BIOL, V45, P65; LEBOWITZ JH, 1990, P NATL ACAD SCI USA, V87, P9736, DOI 10.1073/pnas.87.24.9736; Liu W, 2006, MOL BIOCHEM PARASIT, V150, P300, DOI 10.1016/j.molbiopara.2006.09.002; MILLER M, 1989, NATURE, V337, P576, DOI 10.1038/337576a0; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; Ortiz D, 2010, MOL MICROBIOL, V78, P108, DOI 10.1111/j.1365-2958.2010.07328.x; Ortiz D, 2009, J BIOL CHEM, V284, P16164, DOI 10.1074/jbc.M109.006718; Papageorgiou I, 2008, INT J PARASITOL, V38, P641, DOI 10.1016/j.ijpara.2007.10.005; Parkinson FE, 2011, CURR TOP MED CHEM, V11, P948; PEARL LH, 1987, NATURE, V329, P351, DOI 10.1038/329351a0; Pedersen BP, 2013, NATURE, V496, P533, DOI 10.1038/nature12042; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stein A, 2003, J BIOL CHEM, V278, P35127, DOI 10.1074/jbc.M306188200; TAYLOR WR, 1994, J BIOTECHNOL, V35, P281, DOI 10.1016/0168-1656(94)90042-6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valdes R, 2004, BIOCHEMISTRY-US, V43, P6793, DOI 10.1021/bi049873m; Valdes R, 2006, J BIOL CHEM, V281, P22647, DOI 10.1074/jbc.M602366200; Valdes R, 2012, J BIOL CHEM, V287, P44036, DOI 10.1074/jbc.M112.414433; Valdes R, 2009, J BIOL CHEM, V284, P19067, DOI 10.1074/jbc.M109.017947; Vasudevan G, 1998, P NATL ACAD SCI USA, V95, P9873, DOI 10.1073/pnas.95.17.9873; Wu JH, 1997, J MOL BIOL, V270, P285, DOI 10.1006/jmbi.1997.1099; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]; Young J.D., 2003, RED CELL MEMBRANE TR, P321; Zhang J, 2007, CANCER METAST REV, V26, P85, DOI 10.1007/s10555-007-9044-4; Zhang XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025822; Zhou YG, 2008, P NATL ACAD SCI USA, V105, P3774, DOI 10.1073/pnas.0800825105	50	26	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8799	8809		10.1074/jbc.M113.546960	http://dx.doi.org/10.1074/jbc.M113.546960			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24497645	hybrid, Green Published			2022-12-28	WOS:000333472100006
J	DeBalsi, KL; Wong, KE; Koves, TR; Slentz, DH; Seiler, SE; Wittmann, AH; Ilkayeva, OR; Stevens, RD; Perry, CGR; Lark, DS; Hui, ST; Szweda, L; Neufer, PD; Muoio, DM				DeBalsi, Karen L.; Wong, Kari E.; Koves, Timothy R.; Slentz, Dorothy H.; Seiler, Sarah E.; Wittmann, April H.; Ilkayeva, Olga R.; Stevens, Robert D.; Perry, Christopher G. R.; Lark, Daniel S.; Hui, Simon T.; Szweda, Luke; Neufer, P. Darrell; Muoio, Deborah M.			Targeted Metabolomics Connects Thioredoxin-interacting Protein (TXNIP) to Mitochondrial Fuel Selection and Regulation of Specific Oxidoreductase Enzymes in Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Energy Metabolism; Ketone Body Metabolism; Mitochondrial Metabolism; Redox; Skeletal Muscle Metabolism; Branched Chain Amino Acids; Thioredoxin Interacting Protein	CARNITINE PALMITOYLTRANSFERASE-I; ACID DEHYDROGENASE COMPLEX; CELLULAR REDOX STATE; INSULIN STIMULATION; OXIDATIVE STRESS; CHAIN; DELETION; CYCLE; METABOLISM; RESISTANCE	Background: Thioredoxin-interacting protein (TXNIP) is a redox sensor that opposes glucose uptake and glycolytic metabolism. Results: TXNIP-deficient skeletal muscles lose capacity for ketone and branched chain amino acid oxidation due to deficits in specific mitochondrial dehydrogenases. Conclusion: TXNIP permits muscle use of alternative respiratory fuels during glucose deprivation. Significance: Dysregulation of TXNIP might contribute to aberrant fuel selection in the context of metabolic disease. Thioredoxin-interacting protein (TXNIP) is an -arrestin family member involved in redox sensing and metabolic control. Growing evidence links TXNIP to mitochondrial function, but the molecular nature of this relationship has remained poorly defined. Herein, we employed targeted metabolomics and comprehensive bioenergetic analyses to evaluate oxidative metabolism and respiratory kinetics in mouse models of total body (TKO) and skeletal muscle-specific (TXNIPSKM-/-) Txnip deficiency. Compared with littermate controls, both TKO and TXNIPSKM-/- mice had reduced exercise tolerance in association with muscle-specific impairments in substrate oxidation. Oxidative insufficiencies in TXNIP null muscles were not due to perturbations in mitochondrial mass, the electron transport chain, or emission of reactive oxygen species. Instead, metabolic profiling analyses led to the discovery that TXNIP deficiency causes marked deficits in enzymes required for catabolism of branched chain amino acids, ketones, and lactate, along with more modest reductions in enzymes of -oxidation and the tricarboxylic acid cycle. The decrements in enzyme activity were accompanied by comparable deficits in protein abundance without changes in mRNA expression, implying dysregulation of protein synthesis or stability. Considering that TXNIP expression increases in response to starvation, diabetes, and exercise, these findings point to a novel role for TXNIP in coordinating mitochondrial fuel switching in response to nutrient availability.	[DeBalsi, Karen L.; Wong, Kari E.; Koves, Timothy R.; Slentz, Dorothy H.; Seiler, Sarah E.; Wittmann, April H.; Ilkayeva, Olga R.; Stevens, Robert D.] Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27704 USA; [Koves, Timothy R.; Muoio, Deborah M.] Duke Univ, Dept Med, Durham, NC 27704 USA; [DeBalsi, Karen L.; Seiler, Sarah E.; Muoio, Deborah M.] Duke Univ, Dept Pharmacol, Durham, NC 27704 USA; [DeBalsi, Karen L.; Seiler, Sarah E.; Muoio, Deborah M.] Duke Univ, Dept Canc Biol, Durham, NC 27704 USA; [Perry, Christopher G. R.; Lark, Daniel S.; Neufer, P. Darrell] E Carolina Univ, East Carolina Diabet & Obes Inst, Greenville, NC 27858 USA; [Perry, Christopher G. R.; Lark, Daniel S.; Neufer, P. Darrell] E Carolina Univ, Dept Physiol, Greenville, NC 27858 USA; [Hui, Simon T.] Univ Calif Los Angeles, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA; [Szweda, Luke] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA	Duke University; Duke University; Duke University; Duke University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of California System; University of California Los Angeles; Oklahoma Medical Research Foundation	Muoio, DM (corresponding author), Independence Pk Facil, 4321 Med Pk Dr,Suite 200, Durham, NC 27704 USA.	muoio@duke.edu	Koves, Tim/I-4806-2012; Muoio, Debbie Marie/E-1147-2012	Koves, Tim/0000-0001-8763-5866; Lark, Daniel/0000-0001-8386-8478; Muoio, Deborah/0000-0003-3760-9277	National Institutes of Health Grants from the United States Public Health Service [P01DK058398, R01DK080339]; American Heart Association Mid-Atlantic Affiliate Predoctoral Fellowship [10PRE4140033]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK058398, R01DK080339, R01DK073488] Funding Source: NIH RePORTER	National Institutes of Health Grants from the United States Public Health Service; American Heart Association Mid-Atlantic Affiliate Predoctoral Fellowship(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P01DK058398 (to D. M. M.) and R01DK080339 (to S. H.) from the United States Public Health Service and an American Heart Association Mid-Atlantic Affiliate Predoctoral Fellowship 10PRE4140033 (to K. L. D.).	Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Binstock J F, 1981, Methods Enzymol, V71 Pt C, P403; Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Bunik V, 1999, PROTEIN SCI, V8, P65; Bunik VI, 2003, EUR J BIOCHEM, V270, P1036, DOI 10.1046/j.1432-1033.2003.03470.x; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; Chuang D.T., 2001, METABOLIC MOL BASES, P1971; Chutkow WA, 2008, J BIOL CHEM, V283, P2397, DOI 10.1074/jbc.M708169200; Chutkow WA, 2010, DIABETES, V59, P1424, DOI 10.2337/db09-1212; DAWSON DM, 1964, SCIENCE, V143, P929, DOI 10.1126/science.143.3609.929; DOHM GL, 1988, J CLIN INVEST, V82, P486, DOI 10.1172/JCI113622; Donnelly KL, 2004, J NUTR, V134, P1475, DOI 10.1093/jn/134.6.1475; Elustondo PA, 2013, J BIOL CHEM, V288, P25309, DOI 10.1074/jbc.M113.476648; FUJII H, 1994, BBA-GEN SUBJECTS, V1199, P130, DOI 10.1016/0304-4165(94)90107-4; GRINBLAT L, 1986, BIOCHEM J, V240, P49, DOI 10.1042/bj2400049; Guo W, 2009, MITOCHONDRION, V9, P261, DOI 10.1016/j.mito.2009.03.003; Hale DE, 1997, CLIN CHEM, V43, P273; Holecek M, 2001, PHYSIOL RES, V50, P19; Hue L, 2009, AM J PHYSIOL-ENDOC M, V297, pE578, DOI 10.1152/ajpendo.00093.2009; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; Hui TY, 2004, J BIOL CHEM, V279, P24387, DOI 10.1074/jbc.M401280200; Jacobs RA, 2013, AM J PHYSIOL-ENDOC M, V304, pE686, DOI 10.1152/ajpendo.00476.2012; Kim JY, 2002, AM J PHYSIOL-ENDOC M, V282, pE1014, DOI 10.1152/ajpendo.00233.2001; Koeberl DD, 2003, PEDIATR RES, V54, P219, DOI 10.1203/01.PDR.0000074972.36356.89; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Kuznetsov AV, 1996, EUR J BIOCHEM, V241, P909, DOI 10.1111/j.1432-1033.1996.00909.x; LEHNINGER AL, 1960, J BIOL CHEM, V235, P2450; MCGARRY JD, 1978, J BIOL CHEM, V253, P4128; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; Muoio DM, 2012, CELL METAB, V15, P595, DOI 10.1016/j.cmet.2012.04.010; Muoio DM, 1999, AM J PHYSIOL-ENDOC M, V276, pE913, DOI 10.1152/ajpendo.1999.276.5.E913; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Oka S, 2006, FASEB J, V20, pA45, DOI 10.1096/fj.05-4439fje; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Perry CGR, 2011, BIOCHEM J, V437, P215, DOI 10.1042/BJ20110366; Reisch AS, 2007, METHOD CELL BIOL, V80, P199, DOI 10.1016/S0091-679X(06)80010-5; Rinaldo P, 2008, GENET MED, V10, P151, DOI 10.1097/GIM.0b013e3181614289; Saxena G, 2010, J BIOL CHEM, V285, P3997, DOI 10.1074/jbc.M109.034421; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Seo JH, 2005, MOL BIOL CELL, V16, P348, DOI 10.1091/mbc.E04-05-0369; Sheth SS, 2005, J LIPID RES, V46, P123, DOI 10.1194/jlr.M400341-JLR200; SHIMOMURA Y, 1995, J NUTR, V125, pS1762; Soeters MR, 2012, METABOLISM, V61, P966, DOI 10.1016/j.metabol.2011.11.009; Spindel ON, 2012, ANTIOXID REDOX SIGN, V16, P587, DOI 10.1089/ars.2011.4137; Stanton RC, 2012, IUBMB LIFE, V64, P362, DOI 10.1002/iub.1017; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; Summermatter S, 2013, P NATL ACAD SCI USA, V110, P8738, DOI 10.1073/pnas.1212976110; Tonkonogi M, 2003, PFLUG ARCH EUR J PHY, V446, P261, DOI 10.1007/s00424-003-1044-9; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035; Yarian CS, 2006, MECH AGEING DEV, V127, P79, DOI 10.1016/j.mad.2005.09.028; Yoshihara E, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1127; Yoshioka J, 2012, J CLIN INVEST, V122, P267, DOI 10.1172/JCI44927; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	59	42	42	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8106	8120		10.1074/jbc.M113.511535	http://dx.doi.org/10.1074/jbc.M113.511535			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24482226	hybrid, Green Published			2022-12-28	WOS:000333157500009
J	Lorey, S; Fiedler, E; Kunert, A; Nerkamp, J; Lange, C; Fiedler, M; Bosse-Doenecke, E; Meysing, M; Gloser, M; Rundfeldt, C; Rauchhaus, U; Hanssgen, I; Gottler, T; Steuernagel, A; Fiedler, U; Haupts, U				Lorey, Susan; Fiedler, Erik; Kunert, Anja; Nerkamp, Joerg; Lange, Christian; Fiedler, Markus; Bosse-Doenecke, Eva; Meysing, Maren; Gloser, Manja; Rundfeldt, Chris; Rauchhaus, Una; Haenssgen, Ilka; Goettler, Thomas; Steuernagel, Arnd; Fiedler, Ulrike; Haupts, Ulrich			Novel Ubiquitin-derived High Affinity Binding Proteins with Tumor Targeting Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Phage Display; Protein Engineering; Scaffold Proteins; Tumor Marker; Ubiquitin; Affilin; Biodistribution; Half-life Extension	CHEMOKINE RECEPTOR 4; ED-B DOMAIN; EXOGENOUS UBIQUITIN; CRYSTAL-STRUCTURE; REPEAT PROTEIN; SOLID TUMORS; PHASE I/II; TNF-ALPHA; IN-VITRO; FIBRONECTIN	Background: Targeting molecules to tumor cells is a promising mode of action for cancer therapy. Results: Ubiquitin-based high affinity, specific, and stable binding molecules for extradomain B are accumulated in the tumor. Conclusion: Ubiquitin may be engineered for high affinity target binding and modified with half-life extension technologies. Significance: Ubiquitin qualifies as a well suited scaffold protein adaptable to specific tasks. Targeting effector molecules to tumor cells is a promising mode of action for cancer therapy and diagnostics. Binding proteins with high affinity and specificity for a tumor target that carry effector molecules such as toxins, cytokines, or radiolabels to their intended site of action are required for these applications. In order to yield high tumor accumulation while maintaining low levels in healthy tissues and blood, the half-life of such conjugates needs to be in an optimal range. Scaffold-based binding molecules are small proteins with high affinity and short systemic circulation. Due to their low molecular complexity, they are well suited for combination with effector molecules as well as half-life extension technologies yielding therapeutics with half-lives adapted to the specific therapy. We have identified ubiquitin as an ideal scaffold protein due to its outstanding biophysical and biochemical properties. Based on a dimeric ubiquitin library, high affinity and specific binding molecules, so-called Affilin (R) molecules, have been selected against the extradomain B of fibronectin, a target almost exclusively expressed in tumor tissues. Extradomain B-binding molecules feature high thermal and serum stability as well as strong in vitro target binding and in vivo tumor accumulation. Application of several half-life extension technologies results in molecules of largely unaffected affinity but significantly prolonged in vivo half-life and tumor retention. Our results demonstrate the utility of ubiquitin as a scaffold for the generation of high affinity binders in a modular fashion, which can be combined with effector molecules and half-life extension technologies.	[Lorey, Susan; Fiedler, Erik; Kunert, Anja; Nerkamp, Joerg; Lange, Christian; Fiedler, Markus; Bosse-Doenecke, Eva; Meysing, Maren; Gloser, Manja; Rundfeldt, Chris; Rauchhaus, Una; Haenssgen, Ilka; Goettler, Thomas; Steuernagel, Arnd; Fiedler, Ulrike; Haupts, Ulrich] Scil Prot GmbH, D-06120 Halle, Saale, Germany		Lorey, S (corresponding author), Scil Prot GmbH, Heinrich Damerow Str 1, D-06120 Halle, Saale, Germany.	susan.lorey@scilproteins.com		Fiedler, Erik/0000-0001-7345-5266	investment bank Saxony-Anhalt	investment bank Saxony-Anhalt	This work was supported by funding by the investment bank Saxony-Anhalt.	Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; Bach HH, 2012, MOL MED, V18, P1056, DOI 10.2119/molmed.2011.00497; Baker TA, 2012, CRIT CARE MED, V40, P2376, DOI 10.1097/CCM.0b013e3182514ed9; Baum RP, 2010, J NUCL MED, V51, P892, DOI 10.2967/jnumed.109.073239; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Boersma YL, 2011, CURR OPIN BIOTECH, V22, P849, DOI 10.1016/j.copbio.2011.06.004; Borsi L, 2003, BLOOD, V102, P4384, DOI 10.1182/blood-2003-04-1039; Borsi L, 2002, INT J CANCER, V102, P75, DOI 10.1002/ijc.10662; Bosse-Doenecke E, 2008, PROTEIN EXPRES PURIF, V58, P114, DOI 10.1016/j.pep.2007.10.012; Campochiaro PA, 2013, AM J OPHTHALMOL, V155, P697, DOI 10.1016/j.ajo.2012.09.032; Catic A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000381; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; Chaudhury C, 2006, BIOCHEMISTRY-US, V45, P4983, DOI 10.1021/bi052628y; Demartis S, 2001, EUR J NUCL MED, V28, P534, DOI 10.1007/s002590100480; Dhalluin C, 2005, BIOCONJUGATE CHEM, V16, P518, DOI 10.1021/bc049780h; Earle SA, 2005, SURGERY, V138, P431, DOI 10.1016/j.surg.2005.06.026; Ebersbach H, 2007, J MOL BIOL, V372, P172, DOI 10.1016/j.jmb.2007.06.045; Eddins MJ, 2007, J MOL BIOL, V367, P204, DOI 10.1016/j.jmb.2006.12.065; Fee CJ, 2007, BIOTECHNOL BIOENG, V98, P725, DOI 10.1002/bit.21482; Fiedler M., 1980, Int. Appl, Patent No. [WO 2004 106368, 2004106368]; Garg PK, 1996, BIOCONJUGATE CHEM, V7, P233, DOI 10.1021/bc960001+; Gebauer M, 2013, J MOL BIOL, V425, P780, DOI 10.1016/j.jmb.2012.12.004; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; Grabulovski D, 2007, J BIOL CHEM, V282, P3196, DOI 10.1074/jbc.M609211200; Hey T, 2005, TRENDS BIOTECHNOL, V23, P514, DOI 10.1016/j.tibtech.2005.07.007; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; HOFFMANN A, 2012, PLOS ONE, V7; Hoppmann S, 2011, BIOCONJUGATE CHEM, V22, P413, DOI 10.1021/bc100432h; Jackson SE, 2006, ORG BIOMOL CHEM, V4, P1845, DOI 10.1039/b600829c; Johannsen M, 2010, EUR J CANCER, V46, P2926, DOI 10.1016/j.ejca.2010.07.033; Johdi NA, 2013, PROTEIN EXPRES PURIF, V88, P157, DOI 10.1016/j.pep.2012.12.002; KHORASANIZADEH S, 1993, BIOCHEMISTRY-US, V32, P7054, DOI 10.1021/bi00078a034; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Kontermann RE, 2011, CURR OPIN BIOTECH, V22, P868, DOI 10.1016/j.copbio.2011.06.012; Kubetzko S, 2005, MOL PHARMACOL, V68, P1439, DOI 10.1124/mol.105.014910; Kuo TT, 2011, MABS-AUSTIN, V3, P422, DOI 10.4161/mabs.3.5.16983; LINDMO T, 1984, J IMMUNOL METHODS, V72, P77, DOI 10.1016/0022-1759(84)90435-6; Majetschak M, 2004, SURGERY, V135, P536, DOI 10.1016/j.surg.2003.09.006; Majetschak M, 2004, J TRAUMA, V56, P991, DOI 10.1097/01.TA.0000127770.29009.5A; Majetschak M, 2003, BLOOD, V101, P1882, DOI 10.1182/blood-2002-03-0918; Majetschak M, 2011, J LEUKOCYTE BIOL, V89, P205, DOI 10.1189/jlb.0510316; Menrad A, 2005, EXPERT OPIN THER TAR, V9, P491, DOI 10.1517/14728222.9.3.491; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Paschke M, 2005, GENE, V350, P79, DOI 10.1016/j.gene.2005.02.005; Pini A, 1998, J BIOL CHEM, V273, P21769, DOI 10.1074/jbc.273.34.21769; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Reichert JM, 2012, MABS-AUSTIN, V4, P413, DOI 10.4161/mabs.19931; Ronca R, 2009, IMMUNOBIOLOGY, V214, P800, DOI 10.1016/j.imbio.2009.06.005; SAHA GB, 1989, NUCL MED BIOL, V16, P431, DOI 10.1016/0883-2897(89)90112-8; Saini V, 2011, J BIOL CHEM, V286, P44145, DOI 10.1074/jbc.M111.298505; Saini V, 2011, J BIOL CHEM, V286, P33466, DOI 10.1074/jbc.M111.233742; Saini Vikas, 2010, Commun Integr Biol, V3, P608, DOI 10.4161/cib.3.6.13375; Sauer S, 2009, BLOOD, V113, P2265, DOI 10.1182/blood-2008-06-160416; SCHWARZBAUER JE, 1987, EMBO J, V6, P2573, DOI 10.1002/j.1460-2075.1987.tb02547.x; Spitaleri G, 2013, J CANCER RES CLIN, V139, P447, DOI 10.1007/s00432-012-1327-7; Takada K, 1997, CLIN CHEM, V43, P1188; Tojo A., 2012, INT J NEPHROL, V2012, P481520, DOI 10.1155/2012/481520; Tolcher AW, 2011, CLIN CANCER RES, V17, P363, DOI 10.1158/1078-0432.CCR-10-1411; Vauquelin G, 2010, EXPERT OPIN DRUG DIS, V5, P927, DOI 10.1517/17460441.2010.512037; Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; Wang YMC, 2011, PHARM RES-DORDR, V28, P1931, DOI 10.1007/s11095-011-0420-y; Weidle UH, 2013, CANCER GENOM PROTEOM, V10, P155; Zahnd C, 2007, NAT METHODS, V4, P269, DOI 10.1038/NMETH1003	65	19	22	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8493	8507		10.1074/jbc.M113.519884	http://dx.doi.org/10.1074/jbc.M113.519884			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24474690	hybrid, Green Published			2022-12-28	WOS:000333157500041
J	Quinlan, CL; Goncalves, RLS; Hey-Mogensen, M; Yadava, N; Bunik, VI; Brand, MD				Quinlan, Casey L.; Goncalves, Renata L. S.; Hey-Mogensen, Martin; Yadava, Nagendra; Bunik, Victoria I.; Brand, Martin D.			The 2-Oxoacid Dehydrogenase Complexes in Mitochondria Can Produce Superoxide/Hydrogen Peroxide at Much Higher Rates Than Complex I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Mitochondria; Pyruvate Dehydrogenase Complex; Rat; Reactive Oxygen Species (ROS); Skeletal Muscle; 2-Oxoglutarate Dehydrogenase Complex; NADH Autofluorescence; -Ketoglutarate Dehydrogenase; Branched-chain 2-Oxoacid Dehydrogenase Complex; Branched-chain Ketoacid Dehydrogenase	ALPHA-KETOGLUTARATE DEHYDROGENASE; OXYGEN SPECIES GENERATION; BOVINE HEART-MITOCHONDRIA; PIGEON BREAST MUSCLE; PYRUVATE-DEHYDROGENASE; ACID DEHYDROGENASE; 2-OXOGLUTARATE DEHYDROGENASE; ELECTRON-TRANSPORT; GLUTATHIONE DEPLETION; PHOSPHONATE ANALOGS	Background: At the redox potential of NADH/NAD(+), at least four mitochondrial sites produce superoxide/H2O2. Results: We compare their capacities in situ in isolated mitochondria. Conclusion: Maximum capacities of complexes were 2-oxoglutarate dehydrogenase > pyruvate dehydrogenase > branched-chain 2-oxoacid dehydrogenase > complex I. Significance: H2O2 production from 2-oxoacid dehydrogenases can be considerable but may previously have been misattributed to complex I. Several flavin-dependent enzymes of the mitochondrial matrix utilize NAD(+) or NADH at about the same operating redox potential as the NADH/NAD(+) pool and comprise the NADH/NAD(+) isopotential enzyme group. Complex I (specifically the flavin, site I-F) is often regarded as the major source of matrix superoxide/H2O2 production at this redox potential. However, the 2-oxoglutarate dehydrogenase (OGDH), branched-chain 2-oxoacid dehydrogenase (BCKDH), and pyruvate dehydrogenase (PDH) complexes are also capable of considerable superoxide/H2O2 production. To differentiate the superoxide/H2O2-producing capacities of these different mitochondrial sites in situ, we compared the observed rates of H2O2 production over a range of different NAD(P)H reduction levels in isolated skeletal muscle mitochondria under conditions that favored superoxide/H2O2 production from complex I, the OGDH complex, the BCKDH complex, or the PDH complex. The rates from all four complexes increased at higher NAD(P)H/NAD(P)(+) ratios, although the 2-oxoacid dehydrogenase complexes produced superoxide/H2O2 at high rates only when oxidizing their specific 2-oxoacid substrates and not in the reverse reaction from NADH. At optimal conditions for each system, superoxide/H2O2 was produced by the OGDH complex at about twice the rate from the PDH complex, four times the rate from the BCKDH complex, and eight times the rate from site I-F of complex I. Depending on the substrates present, the dominant sites of superoxide/H2O2 production at the level of NADH may be the OGDH and PDH complexes, but these activities may often be misattributed to complex I.	[Quinlan, Casey L.; Goncalves, Renata L. S.; Hey-Mogensen, Martin; Brand, Martin D.] Buck Inst Res Aging, Novato, CA 94945 USA; [Hey-Mogensen, Martin] Univ Copenhagen, Dept Biomed Sci, Ctr Hlth Aging, DK-2200 Copenhagen, Denmark; [Yadava, Nagendra] Pioneer Valley Life Sci Inst, Springfield, MA 01107 USA; [Bunik, Victoria I.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119991, Russia; [Bunik, Victoria I.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow 119991, Russia	Buck Institute for Research on Aging; University of Copenhagen; Lomonosov Moscow State University; Lomonosov Moscow State University	Brand, MD (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	mbrand@buckinstitute.org	Bunik, Victoria/E-3427-2012; Brand, Martin D/A-9423-2012	Bunik, Victoria/0000-0002-2552-8560; Brand, Martin D/0000-0003-4418-6153; Quinlan, Casey/0000-0002-7808-8271	National Institutes of Health [TL1 AG032116]; Ellison Medical Foundation [AG-SS-2288-09]; Brazilian Government through the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) e ao Conselho de Nacional de Desenvolvimento Cientifico e Tecnologico programa Ciencias Sem Fronteiras (CNPq-CSF); Carlsberg Foundation; Center for Excellence in Apoptosis Research funds from Massachusetts Technology Collaborative Grant [A00000000004448]; Russian Foundation of Basic Research (RFBR) [12-04-01541]; NATIONAL INSTITUTE ON AGING [TL1AG032116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Brazilian Government through the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) e ao Conselho de Nacional de Desenvolvimento Cientifico e Tecnologico programa Ciencias Sem Fronteiras (CNPq-CSF)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Carlsberg Foundation(Carlsberg Foundation); Center for Excellence in Apoptosis Research funds from Massachusetts Technology Collaborative Grant; Russian Foundation of Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant TL1 AG032116 (to C. L. Q.). This work was also supported by The Ellison Medical Foundation Grant AG-SS-2288-09 (to M. D. B.), the Brazilian Government through the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) e ao Conselho de Nacional de Desenvolvimento Cientifico e Tecnologico programa Ciencias Sem Fronteiras (CNPq-CSF) (to R. L. S. G.), the Carlsberg Foundation (to M. H.-M.), the Center for Excellence in Apoptosis Research funds from Massachusetts Technology Collaborative Grant A00000000004448 (to N. Y.), and Russian Foundation of Basic Research (RFBR) Grant 12-04-01541 (to V. I. B.).	Affourtit C, 2012, METHODS MOL BIOL, V810, P165, DOI 10.1007/978-1-61779-382-0_11; Ambrus A, 2013, ARCH BIOCHEM BIOPHYS, V538, P145, DOI 10.1016/j.abb.2013.08.015; Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; ASMUS KD, 1990, METHOD ENZYMOL, V186, P168; Barja G, 1998, J BIOENERG BIOMEMBR, V30, P235, DOI 10.1023/A:1020592719405; Biryukov AI, 1996, FEBS LETT, V382, P167, DOI 10.1016/0014-5793(96)00166-4; Brand MD, 2013, BRIT J DERMATOL, V169, P1, DOI 10.1111/bjd.12208; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Bunik V, 2000, EUR J BIOCHEM, V267, P3583, DOI 10.1046/j.1432-1327.2000.01387.x; BUNIK VI, 1992, FEBS LETT, V303, P197, DOI 10.1016/0014-5793(92)80518-L; Bunik VI, 2005, BIOCHEMISTRY-US, V44, P10552, DOI 10.1021/bi0503100; Bunik VI, 2003, EUR J BIOCHEM, V270, P1036, DOI 10.1046/j.1432-1033.2003.03470.x; Bunik VI, 2002, EUR J BIOCHEM, V269, P5004, DOI 10.1046/j.1432-1033.2002.03204.x; BUNIK VI, 1991, FEBS LETT, V278, P147, DOI 10.1016/0014-5793(91)80104-B; BUNIK VI, 2011, ADV ENZYMOL REL AREA, V77, P305; Bunik VI, 2013, CURR CHEM BIOL, V7, P74; Bunik VI, 2009, BIOCHEM J, V422, P405, DOI 10.1042/BJ20090722; CHAN PC, 1974, J BIOL CHEM, V249, P1317; Cheshchevik V., 2010, MITOCHONDRIAL PHYSL, P76; Chinta SJ, 2009, FREE RADICAL BIO MED, V46, P939, DOI 10.1016/j.freeradbiomed.2009.01.010; Fisher-Wellman KH, 2013, FREE RADICAL BIO MED, V65, P1201, DOI 10.1016/j.freeradbiomed.2013.09.008; FORMAN HJ, 1975, J BIOL CHEM, V250, P4322; GARLAND PB, 1964, BIOCHEM J, V92, pC10, DOI 10.1042/bj0920010C; Grivennikova VG, 2013, BBA-BIOENERGETICS, V1827, P446, DOI 10.1016/j.bbabio.2013.01.002; Grivennikova VG, 2001, J BIOL CHEM, V276, P9038, DOI 10.1074/jbc.M009661200; GUTMAN, 1971, BIOCHEMISTRY-US, V10, P4763, DOI 10.1021/bi00801a025; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; HARRIS RA, 1995, ADV ENZYME REGUL, V35, P147, DOI 10.1016/0065-2571(94)00020-4; Harris RA, 2004, BIOCHEM BIOPH RES CO, V313, P391, DOI 10.1016/j.bbrc.2003.11.007; Huang BL, 1998, J BIOL CHEM, V273, P17680, DOI 10.1074/jbc.273.28.17680; Izard T, 1999, P NATL ACAD SCI USA, V96, P1240, DOI 10.1073/pnas.96.4.1240; Kareyeva AV, 2012, BBA-BIOENERGETICS, V1817, P1879, DOI 10.1016/j.bbabio.2012.03.033; Kareyeva AV, 2011, FEBS LETT, V585, P385, DOI 10.1016/j.febslet.2010.12.019; KERBEY AL, 1976, BIOCHEM J, V154, P327, DOI 10.1042/bj1540327; Kramer D, 2004, METHOD ENZYMOL, V382, P21; KUNZ WS, 1993, BIOCHEM MED METAB B, V50, P103, DOI 10.1006/bmmb.1993.1051; KUNZ WS, 1985, BIOCHIM BIOPHYS ACTA, V841, P237, DOI 10.1016/0304-4165(85)90064-9; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lambert AJ, 2008, FEBS LETT, V582, P1711, DOI 10.1016/j.febslet.2008.04.030; Lambert AJ, 2008, BBA-BIOENERGETICS, V1777, P397, DOI 10.1016/j.bbabio.2008.03.005; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Lambeth DO, 2004, J BIOL CHEM, V279, P36621, DOI 10.1074/jbc.M406884200; LINN TC, 1969, P NATL ACAD SCI USA, V62, P234, DOI 10.1073/pnas.62.1.234; MASSEY V, 1994, J BIOL CHEM, V269, P22459; MASSEY V, 1969, BIOCHEM BIOPH RES CO, V36, P891, DOI 10.1016/0006-291X(69)90287-3; MASSEY V, 1969, J BIOL CHEM, V244, P3999; Muller FL, 2003, BIOCHEMISTRY-US, V42, P6493, DOI 10.1021/bi0342160; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; NICHOLLS DG, 2013, BIOENERGETICS, V4, P107; Orr AL, 2013, FREE RADICAL BIO MED, V65, P1047, DOI 10.1016/j.freeradbiomed.2013.08.170; Orr AL, 2012, J BIOL CHEM, V287, P42921, DOI 10.1074/jbc.M112.397828; PANDE SV, 1976, J BIOL CHEM, V251, P6683; PARKER PJ, 1978, FEBS LETT, V90, P183, DOI 10.1016/0014-5793(78)80325-1; PARKER PJ, 1978, BIOCHEM J, V171, P751, DOI 10.1042/bj1710751; PATEL MS, 1974, BIOCHEM J, V144, P91, DOI 10.1042/bj1440091; PAXTON R, 1984, ARCH BIOCHEM BIOPHYS, V231, P48, DOI 10.1016/0003-9861(84)90361-8; Perevoshchikova IV, 2013, FREE RADICAL BIO MED, V61, P298, DOI 10.1016/j.freeradbiomed.2013.04.006; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; PETTIT FH, 1972, BIOCHEM BIOPH RES CO, V49, P563, DOI 10.1016/0006-291X(72)90448-2; Pryde KR, 2011, J BIOL CHEM, V286, P18056, DOI 10.1074/jbc.M110.186841; Qi F, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-53; Quinlan C.L., 2011, HDB BIOL AGING, V7th, P47; Quinlan CL, 2013, REDOX BIOL, V1, P304, DOI 10.1016/j.redox.2013.04.005; Quinlan CL, 2013, METHOD ENZYMOL, V526, P189, DOI 10.1016/B978-0-12-405883-5.00012-0; Quinlan CL, 2012, FREE RADICAL BIO MED, V53, P1807, DOI 10.1016/j.freeradbiomed.2012.08.015; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Quinlan CL, 2011, J BIOL CHEM, V286, P31361, DOI 10.1074/jbc.M111.267898; RAMSAY RR, 1975, FEBS LETT, V54, P21, DOI 10.1016/0014-5793(75)81059-3; Roche TE, 2003, EUR J BIOCHEM, V270, P1050, DOI 10.1046/j.1432-1033.2003.03468.x; Shestopalov AI, 2007, NEUROCHEM RES, V32, P947, DOI 10.1007/s11064-007-9291-3; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; STACPOOLE PW, 1989, METABOLISM, V38, P1124, DOI 10.1016/0026-0495(89)90051-6; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; THOMAS AP, 1986, BIOCHEM J, V238, P83, DOI 10.1042/bj2380083; Treberg JR, 2011, J BIOL CHEM, V286, P27103, DOI 10.1074/jbc.M111.252502; Treberg JR, 2010, FEBS J, V277, P2766, DOI 10.1111/j.1742-4658.2010.07693.x; Tretter L, 2005, PHILOS T R SOC B, V360, P2335, DOI 10.1098/rstb.2005.1764; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; White TA, 2007, J BIOL CHEM, V282, P14316, DOI 10.1074/jbc.M700912200; Yadava N, 2008, INT J BIOCHEM CELL B, V40, P447, DOI 10.1016/j.biocel.2007.08.015; Yadava N, 2004, J BIOL CHEM, V279, P12406, DOI 10.1074/jbc.M313588200; YEAMAN SJ, 1978, BIOCHEMISTRY-US, V17, P2364, DOI 10.1021/bi00605a017; Zhang L, 1998, J BIOL CHEM, V273, P33972, DOI 10.1074/jbc.273.51.33972; Zundorf G, 2009, NEUROSCIENCE, V158, P610, DOI 10.1016/j.neuroscience.2008.10.015; [No title captured], DOI DOI 10.1007/BFB0031008	87	214	219	1	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8312	8325		10.1074/jbc.M113.545301	http://dx.doi.org/10.1074/jbc.M113.545301			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24515115	hybrid, Green Published			2022-12-28	WOS:000333157500025
J	Wang, CC; Man, GCW; Chu, CY; Borchert, A; Ugun-Klusek, A; Billett, EE; Kuhn, H; Ufer, C				Wang, Chi Chiu; Man, Gene Chi Wai; Chu, Ching Yan; Borchert, Astrid; Ugun-Klusek, Aslihan; Billett, E. Ellen; Kuehn, Hartmut; Ufer, Christoph			Serotonin Receptor 6 Mediates Defective Brain Development in Monoamine Oxidase A-deficient Mouse Embryos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Eicosanoid; Embryo; Oxidase; Receptors; Serotonin; Signaling	PROGRAMMED CELL-DEATH; KNOCK-OUT MICE; TRYPTOPHAN-HYDROXYLASE; BCL-2 EXPRESSION; GENE-EXPRESSION; CEREBRAL-CORTEX; KINASE PATHWAY; MAO-A; APOPTOSIS; ACTIVATION	Background: Monoamine oxidase A (MAO-A) catalyzes the degradation of neurotransmitters such as serotonin. Results: Knockdown of MAO-A expression in embryos induces high serotonin levels and abnormal brain development, which can be rescued by inactivation of serotonin receptor-6 (5-Htr6). Conclusion: 5-Htr6 activation is vital for early development of the embryonic brain. Significance: Serotonin signaling and metabolism are important in early embryos. Monoamine oxidases A and B (MAO-A and MAO-B) are enzymes of the outer mitochondrial membrane that metabolize biogenic amines. In the adult central nervous system, MAOs have important functions for neurotransmitter homeostasis. Expression of MAO isoforms has been detected in the developing embryo. However, suppression of MAO-B does not induce developmental alterations. In contrast, targeted inhibition and knockdown of MAO-A expression (E7.5-E10.5) caused structural abnormalities in the brain. Here we explored the molecular mechanisms underlying defective brain development induced by MAO-A knockdown during in vitro embryogenesis. The developmental alterations were paralleled by diminished apoptotic activity in the affected neuronal structures. Moreover, dysfunctional MAO-A expression led to elevated levels of embryonic serotonin (5-hydroxytryptamine (5-HT)), and we found that knockdown of serotonin receptor-6 (5-Htr6) expression or pharmacologic inhibition of 5-Htr6 activity rescued the MAO-A knockdown phenotype and restored apoptotic activity in the developing brain. Our data suggest that excessive 5-Htr6 activation reduces activation of caspase-3 and -9 of the intrinsic apoptotic pathway and enhances expression of antiapoptotic proteins Bcl-2 and Bcl-XL. Moreover, we found that elevated 5-HT levels in MAO-A knockdown embryos coincided with an enhanced activation of extracellular signal-regulated kinase 1/2 (ERK1/2) and a reduction of proliferating cell numbers. In summary, our findings suggest that excessive 5-HT in MAO-A-deficient mouse embryos triggers cellular signaling cascades via 5-Htr6, which suppresses developmental apoptosis in the brain and thus induces developmental retardations.	[Wang, Chi Chiu; Man, Gene Chi Wai; Chu, Ching Yan] Chinese Univ Hong Kong, Sch Biomed Sci, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China; [Wang, Chi Chiu] Chinese Univ Hong Kong, Sch Biomed Sci, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Wang, Chi Chiu] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Borchert, Astrid; Kuehn, Hartmut; Ufer, Christoph] Charite, Inst Biochem, D-10117 Berlin, Germany; [Ugun-Klusek, Aslihan; Billett, E. Ellen] Nottingham Trent Univ, Sch Sci & Technol, Nottingham NG11 8NS, England	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Nottingham Trent University	Ufer, C (corresponding author), Charite, Inst Biochem, Charitepl 1, D-10117 Berlin, Germany.	christoph.ufer@charite.de	Wang, Ronald/C-6541-2014; Man, Gene Chi-Wai/AAH-4865-2019	Wang, Ronald/0000-0002-3928-7278; Man, Gene Chi-Wai/0000-0002-8608-9688; Billett, Ellen/0000-0001-8245-6519; Ugun Klusek, Aslihan/0000-0002-0199-0275; Borchert, Astrid/0000-0003-3551-5592				Amireault P, 2005, MOL PHARMACOL, V68, P1678, DOI 10.1124/mol.104.010124; Amireault P, 2013, ACS CHEM NEUROSCI, V4, P64, DOI 10.1021/cn300154j; Anderson DG, 2011, J BIOL CHEM, V286, P26978, DOI 10.1074/jbc.M111.249532; Azmitia EC, 2001, BRAIN RES BULL, V56, P413, DOI 10.1016/S0361-9230(01)00614-1; Basu B, 2008, REPRODUCTION, V135, P657, DOI 10.1530/REP-07-0577; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Billett EE, 2004, NEUROTOXICOLOGY, V25, P139, DOI 10.1016/S0161-813X(03)00094-9; Blaschke AJ, 1996, DEVELOPMENT, V122, P1165; Bortolato M, 2011, NEUROPSYCHOPHARMACOL, V36, P2674, DOI 10.1038/npp.2011.157; Bou-Flores C, 2000, J NEUROSCI, V20, P4646, DOI 10.1523/JNEUROSCI.20-12-04646.2000; Boumela I, 2011, REPRODUCTION, V141, P549, DOI 10.1530/REP-10-0504; Bras H, 2008, EUR J NEUROSCI, V28, P1097, DOI 10.1111/j.1460-9568.2008.06407.x; Brown P, 2006, J COMP NEUROL, V498, P415, DOI 10.1002/cne.21034; Burke WJ, 1999, BRAIN RES, V816, P633, DOI 10.1016/S0006-8993(98)01211-6; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; CASES O, 1995, SCIENCE, V268, P1763, DOI 10.1126/science.7792602; Chen K, 2005, J BIOL CHEM, V280, P11552, DOI 10.1074/jbc.M410033200; Chen K, 2004, NEUROTOXICOLOGY, V25, P31, DOI 10.1016/S0161-813X(03)00113-X; Cheng AW, 2010, J NEUROSCI, V30, P10752, DOI 10.1523/JNEUROSCI.2037-10.2010; Chiou SH, 2006, BRIT J PHARMACOL, V148, P587, DOI 10.1038/sj.bjp.0706766; Copp AJ, 2005, J ANAT, V207, P623, DOI 10.1111/j.1469-7580.2005.00476.x; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Desire L, 2000, J NEUROCHEM, V75, P151, DOI 10.1046/j.1471-4159.2000.0750151.x; Edmondson DE, 2009, BIOCHEMISTRY-US, V48, P4220, DOI 10.1021/bi900413g; Fidalgo S, 2013, BIOGERONTOLOGY, V14, P21, DOI 10.1007/s10522-012-9406-3; Fitzgerald JC, 2007, J NEUROCHEM, V103, P2189, DOI 10.1111/j.1471-4159.2007.04921.x; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Grimsby J, 1997, NAT GENET, V17, P206, DOI 10.1038/ng1097-206; Herlenius E, 2004, EXP NEUROL, V190, pS8, DOI 10.1016/j.expneurol.2004.03.027; Inaba-Hasegawa K, 2012, J NEURAL TRANSM, V119, P405, DOI 10.1007/s00702-011-0730-6; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jaworski J, 2003, J NEUROSCI, V23, P4519; Marazziti D, 2013, CURR MED CHEM, V20, P371; Nakamura K, 2007, MOL NEUROBIOL, V35, P45, DOI 10.1007/BF02700623; Naoi M, 2009, J NEURAL TRANSM, V116, P1371, DOI 10.1007/s00702-009-0309-7; Nicotra A, 2004, NEUROTOXICOLOGY, V25, P155, DOI 10.1016/S0161-813X(03)00095-0; Ou XM, 2006, P NATL ACAD SCI USA, V103, P10923, DOI 10.1073/pnas.0601515103; Pearson GW, 2006, MOL CELL BIOL, V26, P3039, DOI 10.1128/MCB.26.8.3039-3047.2006; Persico AM, 2003, NEUROREPORT, V14, P341, DOI 10.1097/01.wnr.0000058244.21747.83; Riccio O, 2009, MOL PSYCHIATR, V14, P280, DOI 10.1038/mp.2008.89; Rivera J, 2008, IMMUNITY, V28, P1, DOI 10.1016/j.immuni.2007.12.008; Saito M, 2014, BRAIN DEV-JPN, V36, P64, DOI 10.1016/j.braindev.2013.01.004; Salichon N, 2001, J NEUROSCI, V21, P884, DOI 10.1523/JNEUROSCI.21-03-00884.2001; Scott AL, 2008, NEUROREPORT, V19, P739, DOI 10.1097/WNR.0b013e3282fd6e88; Shih JC, 1999, BRAIN RES, V835, P104, DOI 10.1016/S0006-8993(99)01478-X; Stankovski L, 2007, J NEUROSCI, V27, P1315, DOI 10.1523/JNEUROSCI.4395-06.2007; Thyagarajan T, 2003, CRIT REV ORAL BIOL M, V14, P154, DOI 10.1177/154411130301400302; Ufer C, 2008, GENE DEV, V22, P1838, DOI 10.1101/gad.466308; Ufer C, 2010, ANTIOXID REDOX SIGN, V13, P833, DOI 10.1089/ars.2009.3044; Upton AL, 1999, J NEUROSCI, V19, P7007, DOI 10.1523/JNEUROSCI.19-16-07007.1999; VANMAELEFABRY G, 1990, TOXICOL IN VITRO, V4, P149, DOI 10.1016/0887-2333(90)90037-T; Vitalis T, 2007, EUR J NEUROSCI, V26, P331, DOI 10.1111/j.1460-9568.2007.05661.x; Walther DJ, 1999, MOL BRAIN RES, V68, P55, DOI 10.1016/S0169-328X(99)00046-7; Wang CC, 2013, CELL MOL LIFE SCI, V70, P599, DOI 10.1007/s00018-012-1065-7; Wang CC, 2011, J BIOL CHEM, V286, P28322, DOI 10.1074/jbc.M111.241422; Wang ZQ, 2011, J NEURAL TRANSM, V118, P997, DOI 10.1007/s00702-011-0655-0; Watts SW, 2001, J CARDIOVASC PHARM, V38, P539, DOI 10.1097/00005344-200110000-00006; Weiss KM, 2000, THEOR POPUL BIOL, V57, P187, DOI 10.1006/tpbi.2000.1460; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Yi H, 2006, J NEURAL TRANSM, V113, P21, DOI 10.1007/s00702-005-0299-z; Youdim MBH, 2006, NAT REV NEUROSCI, V7, P295, DOI 10.1038/nrn1883	62	10	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8252	8263		10.1074/jbc.M113.522094	http://dx.doi.org/10.1074/jbc.M113.522094			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24497636	hybrid, Green Published			2022-12-28	WOS:000333157500020
J	Kapoor-Vazirani, P; Vertino, PM				Kapoor-Vazirani, Priya; Vertino, Paula M.			A Dual Role for the Histone Methyltransferase PR-SET7/SETD8 and Histone H4 Lysine 20 Monomethylation in the Local Regulation of RNA Polymerase II Pausing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Histone Modification; Chromatin Structure; Gene Regulation; RNA Polymerase; Transcription Regulation; H4K20me1; MSL Complex; PR-SET7; SETD8; RNA Polymerase II Promoter-proximal Pausing; SUV420H2	BROMODOMAIN PROTEIN BRD4; P-TEFB; S-PHASE; TRANSCRIPTION ELONGATION; DOSAGE COMPENSATION; DNA METHYLATION; MSL COMPLEX; DEPENDENT TRANSCRIPTION; DROSOPHILA-MELANOGASTER; PRODUCTIVE ELONGATION	Background: MSL-mediated H4K16Ac allows release from Pol II promoter-proximal pausing, and SUV420H2-mediated H4K20me3 enforces pausing. Results: PR-SET7-mediated H4K20me1 is necessary for MSL recruitment and H4K16Ac and serves as a substrate for conversion to H4K20me3. Conclusion: H4K20me1 plays a dual role in pausing by regulating both H4K16Ac and H4K20me3. Significance: The local balance between H4K20me3 and H4K20me1/H4K16Ac levels controls pausing and, ultimately, transcriptional output. RNA polymerase II (Pol II) promoter-proximal pausing plays a critical role in postinitiation transcriptional regulation at many metazoan genes. We showed recently that histone H4 lysine 16 acetylation (H4K16Ac), mediated by the MSL complex, facilitates the release of paused Pol II. In contrast, H4 lysine 20 trimethylation (H4K20me3), mediated by SUV420H2, enforces Pol II pausing by inhibiting MSL recruitment. However, how the balance between H4K16Ac and H4K20me3 is locally regulated remains unclear. Here, we demonstrate that PR-SET7/SETD8, which monomethylates histone H4 lysine 20 (H4K20me1), controls both H4K16Ac and H4K20me3 and in doing so, regulates Pol II pausing dynamics. We find that PR-SET7-mediated H4K20me1 is necessary for the recruitment of the MSL complex, subsequent H4K16Ac, and release of Pol II into active elongation. Although dispensable for SUV420H2 recruitment, PR-SET7-mediated H4K20me1 is required for H4K20me3. Although depletion of SUV420H2 is sufficient to deplete H4K20me3 and relieve an H4K20me3-induced pause, pausing is maintained in the absence of PR-SET7 despite H4K20me3 depletion because of an inability to recruit the MSL complex in the absence of H4K20me1. These findings highlight the requirement for PR-SET7 and H4K20me1 in establishing both the H4K16Ac and H4K20me3 marks and point to a dual role in the local regulation of Pol II pausing.	[Vertino, Paula M.] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University	Vertino, PM (corresponding author), Emory Univ, Sch Med, Dept Radiat Oncol, 1365-C Clifton Rd,NE,Rm 4086, Atlanta, GA 30322 USA.	pvertin@emory.edu			National Institute of Health [2R01-CA077337, 5R01-CA132065]; NATIONAL CANCER INSTITUTE [P30CA138292, R01CA077337, R01CA132065] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institute of Health Grants 2R01-CA077337 and 5R01-CA132065 (to P. M. V.).	Abbas T, 2013, MOL CELL, V49, P1147, DOI 10.1016/j.molcel.2013.02.003; Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Barbieri I, 2013, BRIEF FUNCT GENOMICS, V12, P219, DOI 10.1093/bfgp/elt007; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bateman JR, 2012, G3-GENES GENOM GENET, V2, P731, DOI 10.1534/g3.112.002840; Beck DB, 2012, GENE DEV, V26, P2580, DOI 10.1101/gad.195636.112; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Byun JS, 2009, P NATL ACAD SCI USA, V106, P19292, DOI 10.1073/pnas.0905469106; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Congdon LM, 2010, J CELL BIOCHEM, V110, P609, DOI 10.1002/jcb.22570; Conrad T, 2012, DEV CELL, V22, P610, DOI 10.1016/j.devcel.2011.12.016; Conway KE, 2000, CANCER RES, V60, P6236; Crawford NPS, 2008, P NATL ACAD SCI USA, V105, P6380, DOI 10.1073/pnas.0710331105; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Demakova OV, 2003, CHROMOSOMA, V112, P103, DOI 10.1007/s00412-003-0249-1; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; French CA, 2001, AM J PATHOL, V159, P1987, DOI 10.1016/S0002-9440(10)63049-0; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Hallacli E, 2009, CHROMOSOME RES, V17, P603, DOI 10.1007/s10577-009-9054-x; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Jorgensen S, 2013, NUCLEIC ACIDS RES, V41, P2797, DOI 10.1093/nar/gkt012; Jorgensen S, 2011, J CELL BIOL, V192, P43, DOI 10.1083/jcb.201009076; Kagey JD, 2010, MOL CANCER RES, V8, P1048, DOI 10.1158/1541-7786.MCR-10-0189; Kapoor-Vazirani P, 2011, MOL CELL BIOL, V31, P1594, DOI 10.1128/MCB.00524-10; Kelley RL, 1999, CELL, V98, P513, DOI 10.1016/S0092-8674(00)81979-0; Kim D, 2010, NAT STRUCT MOL BIOL, V17, P1027, DOI 10.1038/nsmb.1856; Larschan E, 2007, MOL CELL, V28, P121, DOI 10.1016/j.molcel.2007.08.011; Li J, 2011, CURR OPIN GENET DEV, V21, P231, DOI 10.1016/j.gde.2011.01.010; Li YY, 2011, J BIOL CHEM, V286, P13925, DOI 10.1074/jbc.M111.223198; Li ZF, 2011, P NATL ACAD SCI USA, V108, P3116, DOI 10.1073/pnas.1009353108; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lu X, 2008, NAT STRUCT MOL BIOL, V15, P1122, DOI 10.1038/nsmb.1489; Lucchesi JC, 2009, CURR OPIN GENET DEV, V19, P550, DOI 10.1016/j.gde.2009.10.004; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; McCabe MT, 2009, CLIN CANCER RES, V15, P3927, DOI 10.1158/1078-0432.CCR-08-2784; Melendy T, 2001, FRONT BIOSCI-LANDMRK, V6, pD1048, DOI 10.2741/Melendy; Moore SA, 2010, J BIOL CHEM, V285, P40879, DOI 10.1074/jbc.M110.134312; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Pannetier M, 2008, EMBO REP, V9, P998, DOI 10.1038/embor.2008.147; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Pesavento JJ, 2008, J BIOL CHEM, V283, P14927, DOI 10.1074/jbc.M709796200; Pfister S, 2008, INT J CANCER, V122, P1207, DOI 10.1002/ijc.23283; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Sharma GG, 2010, MOL CELL BIOL, V30, P3582, DOI 10.1128/MCB.01476-09; Sims JK, 2008, MOL CELL BIOL, V28, P4459, DOI 10.1128/MCB.00410-08; Sural TH, 2008, NAT STRUCT MOL BIOL, V15, P1318, DOI 10.1038/nsmb.1520; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Takawa M, 2012, CANCER RES, V72, P3217, DOI 10.1158/0008-5472.CAN-11-3701; Takeshima H, 2009, GENOME RES, V19, P1974, DOI 10.1101/gr.093310.109; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Van Den Broeck A, 2008, CLIN CANCER RES, V14, P7237, DOI 10.1158/1078-0432.CCR-08-0869; Venters Bryan J, 2007, Genome Biol, V8, P319, DOI 10.1186/gb-2007-8-11-319; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wells MB, 2012, MOL CELL BIOL, V32, P1710, DOI 10.1128/MCB.06546-11; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yang F, 2012, EMBO J, V31, P110, DOI 10.1038/emboj.2011.364; Yang HB, 2008, J BIOL CHEM, V283, P12085, DOI 10.1074/jbc.M707974200; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	78	24	24	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7425	7437		10.1074/jbc.M113.520783	http://dx.doi.org/10.1074/jbc.M113.520783			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24459145	Green Published, hybrid			2022-12-28	WOS:000332761500014
J	Monette, MY; Somasekharan, S; Forbush, B				Monette, Michelle Y.; Somasekharan, Suma; Forbush, Biff			Molecular Motions Involved in Na-K-Cl Cotransporter-mediated Ion Transport and Transporter Activation Revealed by Internal Cross-linking between Transmembrane Domains 10 and 11/12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chloride Transport; Copper; Membrane Proteins; Membrane Transport; Protein Cross-linking; Protein Structure; Na-K-Cl Cotransporter; Iodine; Loop Diuretics; Phenanthroline	AMINO-ACID ANTIPORTER; PROTEIN-STRUCTURE; MECHANISM; PHOSPHORYLATION; NKCC1; CYSTEINE	Background: Na-K-Cl cotransporters (NKCCs) are responsible for volume and chloride homeostasis and chloride transport and are targets of loop diuretic drugs. Results: Cross-links between transmembrane domains (TMs) 10 and 11/12 of NKCC1 are identified as inhibitory and stimulatory. Conclusion: Activation of NKCC1 involves movement of TM12 relative to TM10. Significance: This identifies movement of TM12 as a key step in the molecular mechanism of NKCC activation. We examined the relationship between transmembrane domain (TM) 10 and TM11/12 in NKCC1, testing homology models based on the structure of AdiC in the same transporter superfamily. We hypothesized that introduced cysteine pairs would be close enough for disulfide formation and would alter transport function: indeed, evidence for cross-link formation with low micromolar concentrations of copper phenanthroline or iodine was found in 3 of 8 initially tested pairs and in 1 of 26 additionally tested pairs. Inhibition of transport was observed with copper phenanthroline and iodine treatment of P676C/A734C and I677C/A734C, consistent with the proximity of these residues and with movement of TM10 during the occlusion step of ion transport. We also found Cu2+ inhibition of the single-cysteine mutant A675C, suggesting that this residue and Met(382) of TM3 are involved in a Cu2+-binding site. Surprisingly, cross-linking of P676C/I730C was found to prevent rapid deactivation of the transporter while not affecting the dephosphorylation rate, thus uncoupling the phosphorylation and activation steps. Consistent with this, (a) cross-linking of P676C/I730C was dependent on activation state, and (b) mutants lacking the phosphoregulatory domain could still be activated by cross-linking. These results suggest a model of NKCC activation that involves movement of TM12 relative to TM10, which is likely tied to movement of the large C terminus, a process somehow triggered by phosphorylation of the regulatory domain in the N terminus.	[Monette, Michelle Y.; Somasekharan, Suma; Forbush, Biff] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Forbush, B (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, POB 208026, New Haven, CT 06520 USA.	biff.forbush@yale.edu			National Institutes of Health [P01-DK17433]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK017433] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-DK17433.	Aronica E, 2007, NEUROSCIENCE, V145, P185, DOI 10.1016/j.neuroscience.2006.11.041; Bass RB, 2007, METHOD ENZYMOL, V423, P25, DOI 10.1016/S0076-6879(07)23002-2; Carmosino M, 2008, MOL BIOL CELL, V19, P4341, DOI 10.1091/mbc.E08-05-0478; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; Delpire E, 2002, ANNU REV PHYSIOL, V64, P803, DOI 10.1146/annurev.physiol.64.081501.155847; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Flemmer AW, 2002, J BIOL CHEM, V277, P37551, DOI 10.1074/jbc.M206294200; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Khafizov K, 2010, BIOCHEMISTRY-US, V49, P10702, DOI 10.1021/bi101256x; Kowalczyk L, 2011, P NATL ACAD SCI USA, V108, P3935, DOI 10.1073/pnas.1018081108; LYTLE C, 1992, J BIOL CHEM, V267, P25438; Lytle C, 1996, AM J PHYSIOL-CELL PH, V270, pC437, DOI 10.1152/ajpcell.1996.270.2.C437; Lytle C, 1995, AM J PHYSIOL-CELL PH, V269, pC1496, DOI 10.1152/ajpcell.1995.269.6.C1496; Ma D, 2012, NATURE, V483, P632, DOI 10.1038/nature10917; Melo F, 2007, PROTEIN SCI, V16, P2412, DOI 10.1110/ps.072895107; Monette Michelle Y, 2012, J Biol Chem, V287, P2210, DOI 10.1074/jbc.M111.309211; Pedersen M, 2008, J BIOL CHEM, V283, P2663, DOI 10.1074/jbc.M708194200; Prudent M, 2009, METALLOMICS, V1, P157, DOI 10.1039/b817061d; Rinehart J, 2009, CELL, V138, P525, DOI 10.1016/j.cell.2009.05.031; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Somasekharan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082060; Somasekharan S, 2012, J BIOL CHEM, V287, P17308, DOI 10.1074/jbc.M112.356014	25	15	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7569	7579		10.1074/jbc.M113.542258	http://dx.doi.org/10.1074/jbc.M113.542258			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24451383	hybrid, Green Published			2022-12-28	WOS:000332761500027
J	Santos, CR; Polo, CC; Costa, MCMF; Nascimento, AFZ; Meza, AN; Cota, J; Hoffmam, ZB; Honorato, RV; Oliveira, PSL; Goldman, GH; Gilbert, HJ; Prade, RA; Ruller, R; Squina, FM; Wong, DWS; Murakami, MT				Santos, Camila R.; Polo, Carla C.; Costa, Maria C. M. F.; Nascimento, Andrey F. Z.; Meza, Andreia N.; Cota, Junio; Hoffmam, Zaira B.; Honorato, Rodrigo V.; Oliveira, Paulo S. L.; Goldman, Gustavo H.; Gilbert, Harry J.; Prade, Rolf A.; Ruller, Roberto; Squina, Fabio M.; Wong, Dominic W. S.; Murakami, Mario T.			Mechanistic Strategies for Catalysis Adopted by Evolutionary Distinct Family 43 Arabinanases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biotechnology; Enzyme Kinetics; Glycoside Hydrolases; Protein Chimeras; Protein Structure; GH43 Family; Accessory Domain; Activation Mechanism; Arabinanase; Endo; Exo Activities	CRYSTAL-STRUCTURE; GEOBACILLUS-STEAROTHERMOPHILUS; GLYCOSIDE HYDROLASE; STRUCTURAL BASIS; FUSION PROTEIN; BINDING; CRYSTALLIZATION; PURIFICATION; EXPRESSION; INSIGHTS	Background: Arabinanases are key enzymes involved in hemicellulose degradation. Results: Crystallographic, mutational, and biochemical assays of three arabinanases reveal the molecular mechanisms governing their catalysis and activation. Conclusion: Accessory domain and metal ion are essential for catalysis. Structural adaptations in the catalytic interface confer unique action modes to ruminal arabinanases. Significance: This work provides new molecular strategies for arabinan hydrolysis. Arabinanases (ABNs, EC 3.2.1.99) are promising catalysts for environmentally friendly biomass conversion into energy and chemicals. These enzymes catalyze the hydrolysis of the -1,5-linked l-arabinofuranoside backbone of plant cell wall arabinans releasing arabino-oligosaccharides and arabinose, the second most abundant pentose in nature. In this work, new findings about the molecular mechanisms governing activation, functional differentiation, and catalysis of GH43 ABNs are presented. Biophysical, mutational, and biochemical studies with the hyperthermostable two-domain endo-acting ABN from Thermotoga petrophila (TpABN) revealed how some GH43 ABNs are activated by calcium ions via hyperpolarization of the catalytically relevant histidine and the importance of the ancillary domain for catalysis and conformational stability. On the other hand, the two GH43 ABNs from rumen metagenome, ARN2 and ARN3, presented a calcium-independent mechanism in which sodium is the most likely substituent for calcium ions. The crystal structure of the two-domain endo-acting ARN2 showed that its ability to efficiently degrade branched substrates is due to a larger catalytic interface with higher accessibility than that observed in other ABNs with preference for linear arabinan. Moreover, crystallographic characterization of the single-domain exo-acting ARN3 indicated that its cleavage pattern producing arabinose is associated with the chemical recognition of the reducing end of the substrate imposed by steric impediments at the aglycone-binding site. By structure-guided rational design, ARN3 was converted into a classical endo enzyme, confirming the role of the extended Arg(203)-Ala(230) loop in determining its action mode. These results reveal novel molecular aspects concerning the functioning of GH43 ABNs and provide new strategies for arabinan degradation.	[Santos, Camila R.; Polo, Carla C.; Costa, Maria C. M. F.; Nascimento, Andrey F. Z.; Meza, Andreia N.; Honorato, Rodrigo V.; Oliveira, Paulo S. L.; Murakami, Mario T.] Brazilian Ctr Res Energy & Mat, Brazilian Biosci Natl Lab, BR-13083970 Campinas, SP, Brazil; [Cota, Junio; Hoffmam, Zaira B.; Goldman, Gustavo H.; Prade, Rolf A.; Ruller, Roberto; Squina, Fabio M.] Brazilian Ctr Res Energy & Mat, Brazilian Bioethanol Sci & Technol Lab, BR-13083970 Campinas, SP, Brazil; [Gilbert, Harry J.] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Wong, Dominic W. S.] USDA, ARS, Western Reg Res Ctr, Albany, CA 94710 USA	Newcastle University - UK; United States Department of Agriculture (USDA)	Murakami, MT (corresponding author), Giuseppe Maximo Scolfaro 10000, BR-13083970 Campinas, SP, Brazil.	mario.murakami@lnbio.cnpem.br	Squina, Fabio/J-8130-2012; Honorato, Rodrigo Vargas/AAY-9375-2020; Honorato, Rodrigo/H-9773-2013; Cota, Junio/J-7475-2012; Oliveira, Paulo S/K-5588-2013; Murakami, Mario T/C-2087-2012; Nascimento, Andrey Fabricio Ziem/M-1740-2016; Prade, Rolf/AAI-5104-2020; Goldman, Gustavo Henrique/F-1848-2013; Murakami, Mario T/F-5640-2016; Santos, Camila Ramos dos/F-7095-2013; Ruller, ROBERTO/D-1260-2014	Squina, Fabio/0000-0002-8154-7459; Honorato, Rodrigo Vargas/0000-0001-5267-3002; Honorato, Rodrigo/0000-0001-5267-3002; Cota, Junio/0000-0002-1547-4087; Nascimento, Andrey Fabricio Ziem/0000-0003-4692-5263; Prade, Rolf/0000-0002-8154-9286; Goldman, Gustavo Henrique/0000-0002-2986-350X; Murakami, Mario T/0000-0002-0405-8010; Santos, Camila Ramos dos/0000-0003-0652-4211; Ruller, Roberto/0000-0001-7501-5176; Polo, Carla Cristina/0000-0003-2245-7258; Ruller, ROBERTO/0000-0002-5087-9493	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [10/51890-8, 13/13309-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [476043/2011-5, 308092/2012-0]; Coordenacao de Aperfeicoamento de Pessoal de N vel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de N vel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grants 10/51890-8 and 13/13309-0, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Grants 476043/2011-5 and 308092/2012-0, and the Coordenacao de Aperfeicoamento de Pessoal de N vel Superior (CAPES).	Al-Tamimi MAHM, 2006, J APPL MICROBIOL, V100, P407, DOI 10.1111/j.1365-2672.2005.02780.x; Alhassid A, 2009, BIOCHEM J, V422, P73, DOI 10.1042/BJ20090180; Barr BK, 1996, BIOCHEMISTRY-US, V35, P586, DOI 10.1021/bi9520388; Berlin A, 2007, BIOTECHNOL BIOENG, V97, P287, DOI 10.1002/bit.21238; Boisset C, 2001, BIOTECHNOL BIOENG, V72, P339, DOI 10.1002/1097-0290(20010205)72:3<339::AID-BIT11>3.0.CO;2-#; Brux C, 2006, J MOL BIOL, V359, P97, DOI 10.1016/j.jmb.2006.03.005; Brunzelle JS, 2008, ARCH BIOCHEM BIOPHYS, V474, P157, DOI 10.1016/j.abb.2008.03.007; Center RJ, 1998, PROTEIN SCI, V7, P1612, DOI 10.1002/pro.5560070715; CHEN FTA, 1995, ANAL BIOCHEM, V230, P273, DOI 10.1006/abio.1995.1474; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corsini L, 2008, PROTEIN SCI, V17, P2070, DOI 10.1110/ps.037564.108; de Sanctis D, 2010, FEBS J, V277, P4562, DOI 10.1111/j.1742-4658.2010.07870.x; Delabona PD, 2013, BIORESOURCE TECHNOL, V131, P500, DOI 10.1016/j.biortech.2012.12.105; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erster O, 2010, METHODS MOL BIOL, V634, P157, DOI 10.1007/978-1-60761-652-8_12; Fujimoto Z, 2010, J BIOL CHEM, V285, P34134, DOI 10.1074/jbc.M110.164251; Fushinobu S, 2005, J BIOL CHEM, V280, P17180, DOI 10.1074/jbc.M413693200; Gao DH, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-5; HEMSLEY A, 1989, NUCLEIC ACIDS RES, V17, P6545, DOI 10.1093/nar/17.16.6545; Honda Y, 2004, J BIOL CHEM, V279, P55097, DOI 10.1074/jbc.M409832200; Ichinose H, 2006, BIOSCI BIOTECH BIOCH, V70, P2745, DOI 10.1271/bbb.60365; Inacio JM, 2008, J BACTERIOL, V190, P4272, DOI 10.1128/JB.00162-08; Jiang DH, 2012, J STRUCT BIOL, V180, P447, DOI 10.1016/j.jsb.2012.08.005; Jorgensen H, 2007, BIOFUEL BIOPROD BIOR, V1, P119, DOI 10.1002/bbb.4; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Ke A, 2003, PROTEIN SCI, V12, P306, DOI 10.1110/ps.0219103; Kobe B, 1999, P NATL ACAD SCI USA, V96, P4319, DOI 10.1073/pnas.96.8.4319; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; Kuge M, 1997, PROTEIN SCI, V6, P1783, DOI 10.1002/pro.5560060822; Li HF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042626, 10.1371/journal.pone.0048872]; Mckee LS, 2012, P NATL ACAD SCI USA, V109, P6537, DOI 10.1073/pnas.1117686109; McKie VA, 1997, BIOCHEM J, V323, P547, DOI 10.1042/bj3230547; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nurizzo D, 2002, NAT STRUCT BIOL, V9, P665, DOI 10.1038/nsb835; Osaki S, 2001, J NUTR, V131, P796, DOI 10.1093/jn/131.3.796; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pletnev S, 2009, ACTA CRYSTALLOGR D, V65, P906, DOI 10.1107/S0907444909020927; Proctor MR, 2005, P NATL ACAD SCI USA, V102, P2697, DOI 10.1073/pnas.0500051102; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Squina FM, 2010, BIOCHEM BIOPH RES CO, V399, P505, DOI 10.1016/j.bbrc.2010.07.097; Squina FM, 2009, ACTA CRYSTALLOGR F, V65, P902, DOI 10.1107/S1744309109029844; Srisodsuk M, 1998, EUR J BIOCHEM, V251, P885, DOI 10.1046/j.1432-1327.1998.2510885.x; Stoll VS, 1998, PROTEIN SCI, V7, P1147, DOI 10.1002/pro.5560070508; Takao M, 2002, APPL ENVIRON MICROB, V68, P1639, DOI 10.1128/AEM.68.4.1639-1646.2002; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang JM, 2005, ACTA CRYSTALLOGR D, V61, P67, DOI 10.1107/S0907444904026721; Ware S, 1999, PROTEIN SCI, V8, P2663, DOI 10.1110/ps.8.12.2663; Wong D, 2008, PROTEIN J, V27, P30, DOI 10.1007/s10930-007-9105-0; Wong DWS, 2008, APPL MICROBIOL BIOT, V79, P941, DOI 10.1007/s00253-008-1504-4; Wong DWS, 2009, PROTEIN PEPTIDE LETT, V16, P1435, DOI 10.2174/092986609789839313; WOODY RW, 1994, EUR BIOPHYS J BIOPHY, V23, P253, DOI 10.1007/BF00213575; Yamaguchi A, 2005, J BIOCHEM, V137, P587, DOI 10.1093/jb/mvi078	56	19	20	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7362	7373		10.1074/jbc.M113.537167	http://dx.doi.org/10.1074/jbc.M113.537167			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24469445	Green Published, hybrid			2022-12-28	WOS:000332761500009
J	Taniguchi, R; Fukushima, H; Osawa, K; Maruyama, T; Yasuda, H; Weih, F; Doi, T; Maki, K; Jimi, E				Taniguchi, Rei; Fukushima, Hidefumi; Osawa, Kenji; Maruyama, Toshimasa; Yasuda, Hisataka; Weih, Falk; Doi, Takahiro; Maki, Kenshi; Jimi, Eijiro			RelB-induced Expression of Cot, an MAP3K Family Member, Rescues RANKL-induced Osteoclastogenesis in Alymphoplasia Mice by Promoting NF-kappa B2 Processing by IKK alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone; NF-kappaB; Osteoclast; Phosphorylation; Signal Transduction	NF-KAPPA-B; PROTEIN-KINASE; DIFFERENTIATION; PHOSPHORYLATION; ACTIVATION; AKT2; P100; INDUCTION; REGULATOR; RECEPTOR	Background: The alternative NF-B pathway plays important roles in osteoclastogenesis through an unknown mechanism. Results: RelB-induced Cot expression rescues RANKL-induced osteoclastogenesis in cells isolated from aly/aly mice, which lack active NIK. Conclusion: The overexpression of RelB rescues RANKL-induced osteoclastogenesis by Cot/IKK-induced NF-B2 processing in aly/aly cells. Significance: The Akt/Cot/IKK pathway that is induced by RelB contributes to RANKL-induced osteoclastogenesis by activating the alternative NF-B pathway. The alternative nuclear factor-B (NF-B) pathway, mainly the RelB-p52 heterodimer, plays important roles in bone metabolism through an unknown mechanism. We have previously reported that alymphoplasia (aly/aly) mice, which lack active NF-B-inducing kinase (NIK), show mild osteopetrosis due to the inhibition of osteoclastogenesis. p100 retains RelB in the cytoplasm and inhibits RANKL-induced osteoclastogenesis in aly/aly cells. Furthermore, the overexpression of RelB in aly/aly cells rescues RANKL-induced osteoclastogenesis by inducing p100 processing. In contrast, the overexpression of p65 in aly/aly cells has no effect. However, the overexpression of RelB fails to rescue RANKL-induced osteoclastogenesis in the presence of p100GRR, which cannot be processed to p52, suggesting that p100 processing is a key step in RelB-rescued, RANKL-induced osteoclastogenesis in aly/aly cells. In this study, Cot (cancer Osaka thyroid), an MAP3K, was up-regulated by RelB overexpression. Analysis of the Cot promoter demonstrated that p65 and RelB bound to the distal NF-B-binding site and that RelB but not p65 bound to the proximal NF-B-binding site in the Cot promoter. The knocking down of Cot expression significantly reduced the RANKL-induced osteoclastogenesis induced by RelB overexpression. The phosphorylation of IKK at threonine 23 and its kinase activity were indispensable for the processing of p100 and osteoclastogenesis by RelB-induced Cot. Finally, constitutively activated Akt enhanced osteoclastogenesis by RelB-induced Cot, and a dominant-negative form of Akt significantly inhibited it. Taken together, these results indicate that the overexpression of RelB restores RANKL-induced osteoclastogenesis by activation of Akt/Cot/IKK-induced p100 processing.	[Taniguchi, Rei; Fukushima, Hidefumi; Osawa, Kenji; Maruyama, Toshimasa; Jimi, Eijiro] Kyushu Dent Univ, Dept Hlth Improvement, Div Mol Signaling & Biochem, Kokurakita Ku, Kitakyushu, Fukuoka 8038580, Japan; [Taniguchi, Rei; Maki, Kenshi] Kyushu Dent Univ, Dept Hlth Improvement, Div Dev Stomatognath Funct Sci, Kokurakita Ku, Kitakyushu, Fukuoka 8038580, Japan; [Yasuda, Hisataka] Oriental Yeast Co Ltd, Bioind Div, Itabashi Ku, Tokyo 1748505, Japan; [Weih, Falk] Fritz Lipmann Inst, Leibniz Inst Age Res, Res Grp Immunol, D-07745 Jena, Germany; [Doi, Takahiro] RIKEN BioResource Ctr, Technol & Dev Team BioSignal Program, Subteam BioSignal Integrat, Tsukuba, Ibaraki 3050074, Japan; [Jimi, Eijiro] Kyushu Dent Univ, Oral Biol Res Ctr, Kokurakita Ku, Kitakyushu, Fukuoka 8038580, Japan	Kyushu Dental University; Kyushu Dental University; Oriental Yeast Co., Ltd.; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); RIKEN; Kyushu Dental University	Jimi, E (corresponding author), Kyushu Dent Univ, Dept Hlth Improvement, Div Mol Signaling & Biochem, Kokurakita Ku, 2-6-1 Manazuru, Kitakyushu, Fukuoka 8038580, Japan.	ejimi@kyu-dent.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23390424, 23593039, 24890214]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Ministry of Education, Culture, Sports, Science, and Technology of Japan Grants 23390424 (to E. J.), 23593039 (to M. K.), and 24890214 (to K. O.).	Altomare DA, 1998, ONCOGENE, V16, P2407, DOI 10.1038/sj.onc.1201750; ALTOMARE DA, 1995, ONCOGENE, V11, P1055; Anderson DM, 1997, NATURE, V390, P175, DOI 10.1038/36593; Beinke S, 2004, MOL CELL BIOL, V24, P9658, DOI 10.1128/MCB.24.21.9658-9667.2004; Chiariello M, 2000, MOL CELL BIOL, V20, P1747, DOI 10.1128/MCB.20.5.1747-1758.2000; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Fukushima H, 2008, MOL CELL BIOL, V28, P6402, DOI 10.1128/MCB.00299-08; Fusco AJ, 2008, J BIOL CHEM, V283, P12324, DOI 10.1074/jbc.M707898200; Ghosh S, 2012, IMMUNOL REV, V246, P5, DOI 10.1111/j.1600-065X.2012.01111.x; Heusch M, 1999, ONCOGENE, V18, P6201, DOI 10.1038/sj.onc.1203022; Hirata K, 2010, BIOL PHARM BULL, V33, P133, DOI 10.1248/bpb.33.133; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Jimi E, 1999, J IMMUNOL, V163, P434; Kane LP, 2002, MOL CELL BIOL, V22, P5962, DOI 10.1128/MCB.22.16.5962-5974.2002; Kawamura N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001058; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kuroda Y, 2012, MOL CELL BIOL, V32, P2954, DOI 10.1128/MCB.05611-11; Lin X, 1999, IMMUNITY, V10, P271, DOI 10.1016/S1074-7613(00)80027-8; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Macpherson AJ, 2003, IMMUNOGENETICS, V54, P693, DOI 10.1007/s00251-002-0517-x; Maruyama T, 2010, J BONE MINER RES, V25, P1058, DOI 10.1359/jbmr.091032; Matsuo K, 2012, CELL ADHES MIGR, V6, P148, DOI 10.4161/cam.20888; MIYOSHI J, 1991, MOL CELL BIOL, V11, P4088, DOI 10.1128/MCB.11.8.4088; Moon JB, 2012, J IMMUNOL, V188, P163, DOI 10.4049/jimmunol.1101254; Nakashima T, 2012, TRENDS ENDOCRIN MET, V23, P582, DOI 10.1016/j.tem.2012.05.005; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; Ozes ON, 1999, NATURE, V401, P82; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Ramakrishnan P, 2004, IMMUNITY, V21, P477, DOI 10.1016/j.immuni.2004.08.009; Shinkura R, 1999, NAT GENET, V22, P74, DOI 10.1038/8780; Soysa NS, 2010, J BONE MINER RES, V25, P809, DOI 10.1359/jbmr.091030; Sugatani T, 2005, J BIOL CHEM, V280, P3583, DOI 10.1074/jbc.M410480200; Tanaka S, 2013, WORLD J ORTHOP, V4, P1, DOI 10.5312/wjo.v4.i1.1; Tucker E, 2007, J IMMUNOL, V179, P7514, DOI 10.4049/jimmunol.179.11.7514; Vaira S, 2008, P NATL ACAD SCI USA, V105, P3897, DOI 10.1073/pnas.0708576105; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Xiao GT, 2004, J BIOL CHEM, V279, P30099, DOI 10.1074/jbc.M401428200; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Yuan ZQ, 2002, J BIOL CHEM, V277, P29973, DOI 10.1074/jbc.M203636200; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	45	12	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7349	7361		10.1074/jbc.M113.538314	http://dx.doi.org/10.1074/jbc.M113.538314			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24488495	Green Published, hybrid			2022-12-28	WOS:000332761500008
J	Addis, PW; Hall, CJ; Bruton, S; Veverka, V; Wilkinson, IC; Muskett, FW; Renshaw, PS; Prosser, CE; Carrington, B; Lawson, ADG; Griffin, R; Taylor, RJ; Waters, LC; Henry, AJ; Carr, MD				Addis, Philip W.; Hall, Catherine J.; Bruton, Shaun; Veverka, Vaclav; Wilkinson, Ian C.; Muskett, Frederick W.; Renshaw, Philip S.; Prosser, Christine E.; Carrington, Bruce; Lawson, Alastair D. G.; Griffin, Robert; Taylor, Richard J.; Waters, Lorna C.; Henry, Alistair J.; Carr, Mark D.			Conformational Heterogeneity in Antibody-Protein Antigen Recognition IMPLICATIONS FOR HIGH AFFINITY PROTEIN COMPLEX FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibodies; NMR; Protein Conformation; Protein Structure; Protein-Protein Interactions; CDR; Conformational Heterogeneity	TISSUE INHIBITOR; MATRIX-METALLOPROTEINASE; LARGER PROTEINS; NMR METHODS; DOMAIN; SHIFT; TRANSFORMATION; REARRANGEMENTS; RELAXATION; SCLEROSTIN	Background: Antibodies are essential components of the immune system which recognize specific antigens with high affinity. Results: Protein antigen binding sites on antibodies show conformational exchange on a millisecond to second timescale. Conclusion: Conformational heterogeneity at high affinity protein-protein interaction sites may be common and facilitate efficient protein complex formation. Significance: High affinity protein-protein interactions are critical for many biological processes. Specific, high affinity protein-protein interactions lie at the heart of many essential biological processes, including the recognition of an apparently limitless range of foreign proteins by natural antibodies, which has been exploited to develop therapeutic antibodies. To mediate biological processes, high affinity protein complexes need to form on appropriate, relatively rapid timescales, which presents a challenge for the productive engagement of complexes with large and complex contact surfaces (approximate to 600-1800 (2)). We have obtained comprehensive backbone NMR assignments for two distinct, high affinity antibody fragments (single chain variable and antigen-binding (Fab) fragments), which recognize the structurally diverse cytokines interleukin-1 (IL-1, -sheet) and interleukin-6 (IL-6, -helical). NMR studies have revealed that the hearts of the antigen binding sites in both free anti-IL-1 Fab and anti-IL-6 single chain variable exist in multiple conformations, which interconvert on a timescale comparable with the rates of antibody-antigen complex formation. In addition, we have identified a conserved antigen binding-induced change in the orientation of the two variable domains. The observed conformational heterogeneity and slow dynamics at protein antigen binding sites appears to be a conserved feature of many high affinity protein-protein interfaces structurally characterized by NMR, suggesting an essential role in protein complex formation. We propose that this behavior may reflect a soft capture, protein-protein docking mechanism, facilitating formation of high affinity protein complexes on a timescale consistent with biological processes.	[Renshaw, Philip S.; Prosser, Christine E.; Waters, Lorna C.; Carr, Mark D.] Univ Leicester, Dept Biochem, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England; [Prosser, Christine E.; Carrington, Bruce; Lawson, Alastair D. G.; Griffin, Robert; Taylor, Richard J.; Henry, Alistair J.] UCB, Slough SL1 3WE, Berks, England; [Veverka, Vaclav] Inst Organ Chem & Biochem, Flemingovo Namesti 2, Prague 16610 6, Czech Republic	University of Leicester; UCB Pharma SA; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Waters, LC (corresponding author), Univ Leicester, Dept Biochem, Henry Wellcome Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	lw83@le.ac.uk; alistair.henry@ucb.com; mdc12@le.ac.uk	Veverka, Vaclav/G-9174-2014; Veverka, Vaclav/P-5251-2019	Veverka, Vaclav/0000-0003-3782-5279; Veverka, Vaclav/0000-0003-3782-5279; Carr, Mark/0000-0002-3939-0996; Addis, Philip/0000-0003-1185-651X				ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; BHAT TN, 1990, NATURE, V347, P483, DOI 10.1038/347483a0; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; COLMAN PM, 1987, NATURE, V326, P358, DOI 10.1038/326358a0; DAVIES D R, 1992, Current Biology, V2, P254, DOI 10.1016/0960-9822(92)90369-L; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; DRISCOLL PC, 1990, BIOCHEMISTRY-US, V29, P3542, DOI 10.1021/bi00466a018; Gao G, 2000, J MOL BIOL, V301, P537, DOI 10.1006/jmbi.2000.3976; Grishaev A, 2008, J BIOMOL NMR, V40, P95, DOI 10.1007/s10858-007-9211-5; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Holdsworth G, 2012, J BIOL CHEM, V287, P26464, DOI 10.1074/jbc.M112.350108; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Kay Lewis E, 2011, J Magn Reson, V213, P423, DOI 10.1016/j.jmr.2011.09.004; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kontaxis G, 2000, J MAGN RESON, V143, P184, DOI 10.1006/jmre.1999.1979; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Marintchev A, 2007, METHOD ENZYMOL, V430, P283, DOI 10.1016/S0076-6879(07)30012-8; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Prosser C. E., 2013, BIOMOL NMR ASSIGN, DOI 10.1007/s12104-013-9464-8; Reichert JM, 2010, MABS-AUSTIN, V2, P695, DOI 10.4161/mabs.2.6.13603; Ruschak AM, 2012, P NATL ACAD SCI USA, V109, pE3454, DOI 10.1073/pnas.1213640109; Sela-Culang I, 2012, J IMMUNOL, V189, P4890, DOI 10.4049/jimmunol.1201493; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; STANFIELD RL, 1993, STRUCTURE, V1, P83, DOI 10.1016/0969-2126(93)90024-B; Veverka V, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.405597; Veverka V, 2009, J BIOL CHEM, V284, P10890, DOI 10.1074/jbc.M807994200; Waters LC, 2007, ONCOGENE, V26, P4941, DOI 10.1038/sj.onc.1210305; Wilkinson IC, 2009, J BIOL CHEM, V284, P31928, DOI 10.1074/jbc.M109.025304; Williamson RA, 2001, J BIOL CHEM, V276, P32966, DOI 10.1074/jbc.M101843200; Williamson RA, 1997, BIOCHEMISTRY-US, V36, P13882, DOI 10.1021/bi9712091; Williamson RA, 1999, J BIOL CHEM, V274, P37226, DOI 10.1074/jbc.274.52.37226; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Xu GY, 1996, J BIOMOL NMR, V8, P123; Yoon S, 2010, BIOTECHNOL BIOPROC E, V15, P709, DOI 10.1007/s12257-009-3113-1; Zhu G, 1999, J BIOMOL NMR, V13, P77, DOI 10.1023/A:1008398227519	38	13	13	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7200	7210		10.1074/jbc.M113.492215	http://dx.doi.org/10.1074/jbc.M113.492215			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24436329	Green Published, hybrid			2022-12-28	WOS:000332389400078
J	Dorn, J; Ferrari, E; Imhof, R; Ziegler, N; Hubscher, U				Dorn, Julia; Ferrari, Elena; Imhof, Ralph; Ziegler, Nathalie; Huebscher, Ulrich			Regulation of Human MutYH DNA Glycosylase by the E3 Ubiquitin Ligase Mule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Base Excision Repair; DNA Damage; E3 Ubiquitin Ligase; Oxidative Stress; Ubiquitination; 8-Oxo-G; Mule; MutYH	BASE EXCISION-REPAIR; CELL NUCLEAR ANTIGEN; POLYMERASE-LAMBDA; SUBCELLULAR-LOCALIZATION; 8-OXO-GUANINE REPAIR; GENETIC INSTABILITY; DAMAGE; CANCER; PHOSPHORYLATION; MYH	Background: Regulation of MutYH DNA glycosylase is essential for genomic integrity. Results: MutYH is ubiquitinated by the E3 ligase Mule changing its protein levels and recruitment to chromatin. MutYH levels in cancer cells influence the mutagenic potential of reactive oxygen species. Conclusion: Ubiquitination of MutYH is an important regulatory step. Significance: We identified the residues that are targets for ubiquitination by Mule. Oxidation of DNA is a frequent and constantly occurring event. One of the best characterized oxidative DNA lesions is 7,8-dihydro-8-oxoguanine (8-oxo-G). It instructs most DNA polymerases to preferentially insert an adenine (A) opposite 8-oxo-G instead of the appropriate cytosine (C) thus showing miscoding potential. The MutY DNA glycosylase homologue (MutYH) recognizes A:8-oxo-G mispairs and removes the mispaired A giving way to the canonical base excision repair that ultimately restores undamaged guanine (G). Here we characterize for the first time in detail a posttranslational modification of the human MutYH DNA glycosylase. We show that MutYH is ubiquitinated in vitro and in vivo by the E3 ligase Mule between amino acids 475 and 535. Mutation of five lysine residues in this region significantly stabilizes MutYH, suggesting that these are the target sites for ubiquitination. The endogenous MutYH protein levels depend on the amount of expressed Mule. Furthermore, MutYH and Mule physically interact. We found that a ubiquitination-deficient MutYH mutant shows enhanced binding to chromatin. The mutation frequency of the ovarian cancer cell line A2780, analyzed at the HPRT locus can be increased upon oxidative stress and depends on the MutYH levels that are regulated by Mule. This reflects the importance of tightly regulated MutYH levels in the cell. In summary our data show that ubiquitination is an important regulatory mechanism for the essential MutYH DNA glycosylase in human cells.	[Dorn, Julia; Ferrari, Elena; Imhof, Ralph; Huebscher, Ulrich] Univ Zurich Irchel, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland; [Ziegler, Nathalie] ETH, Inst Food Nutr & Hlth, CH-8092 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Hubscher, U (corresponding author), Univ Zurich Irchel, Inst Vet Biochem & Mol Biol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	hubscher@vetbio.uzh.ch		Ziegler, Nathalie/0000-0003-1152-0645				Blasi MF, 2006, CANCER RES, V66, P9036, DOI 10.1158/0008-5472.CAN-06-1896; Boldogh I, 2001, NUCLEIC ACIDS RES, V29, P2802, DOI 10.1093/nar/29.13.2802; Braithwaite EK, 2005, J BIOL CHEM, V280, P31641, DOI 10.1074/jbc.C500256200; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Collins AR, 1999, BIOESSAYS, V21, P238, DOI 10.1002/(SICI)1521-1878(199903)21:3<238::AID-BIES8>3.0.CO;2-3; El-Shemerly M, 2005, CANCER RES, V65, P3604, DOI 10.1158/0008-5472.CAN-04-4069; Friedberg E.C., 2006, DNA REPAIR MUTAGENES, P16; Frouin I, 2005, NUCLEIC ACIDS RES, V33, P5354, DOI 10.1093/nar/gki845; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hirano S, 2003, J BIOL CHEM, V278, P38121, DOI 10.1074/jbc.C300316200; Hwang BJ, 2014, DNA REPAIR, V13, P10, DOI 10.1016/j.dnarep.2013.10.011; Khoronenkova SV, 2013, NUCLEIC ACIDS RES, V41, P1750, DOI 10.1093/nar/gks1359; Khoronenkova SV, 2012, MOL CELL, V45, P801, DOI 10.1016/j.molcel.2012.01.021; Laine A, 2007, ONCOGENE, V26, P1477, DOI 10.1038/sj.onc.1209924; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; Maga G, 2008, P NATL ACAD SCI USA, V105, P20689, DOI 10.1073/pnas.0811241106; Markkanen Enni, 2013, Frontiers in Genetics, V4, P18, DOI 10.3389/fgene.2013.00018; Markkanen E, 2012, P NATL ACAD SCI USA, V109, P437, DOI 10.1073/pnas.1110449109; Parker AR, 2002, CANCER RES, V62, P7230; Parsons JL, 2008, MOL CELL, V29, P477, DOI 10.1016/j.molcel.2007.12.027; Parsons JL, 2009, EMBO J, V28, P3207, DOI 10.1038/emboj.2009.243; Ruggieri V, 2013, ONCOGENE, V32, P4500, DOI 10.1038/onc.2012.479; Russo MT, 2009, CANCER RES, V69, P4372, DOI 10.1158/0008-5472.CAN-08-3292; Russo MT, 2004, CANCER RES, V64, P4411, DOI 10.1158/0008-5472.CAN-04-0355; Sakamoto K, 2007, CANCER RES, V67, P6599, DOI 10.1158/0008-5472.CAN-06-4802; Shinmura K, 2011, J PATHOL, V225, P414, DOI 10.1002/path.2953; Taghizadeh K, 2008, NAT PROTOC, V3, P1287, DOI 10.1038/nprot.2008.119; Takao M, 1999, NUCLEIC ACIDS RES, V27, P3638, DOI 10.1093/nar/27.18.3638; van Loon B, 2009, P NATL ACAD SCI USA, V106, P18201, DOI 10.1073/pnas.0907280106; Wimmer U, 2008, EMBO REP, V9, P1027, DOI 10.1038/embor.2008.148; Xie YL, 2004, CANCER RES, V64, P3096, DOI 10.1158/0008-5472.CAN-03-3834	31	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7049	7058		10.1074/jbc.M113.536094	http://dx.doi.org/10.1074/jbc.M113.536094			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24443563	Green Published, hybrid			2022-12-28	WOS:000332389400064
J	Nikolajsen, CL; Dyrlund, TF; Poulsen, ET; Enghild, JJ; Scavenius, C				Nikolajsen, Camilla Lund; Dyrlund, Thomas F.; Poulsen, Ebbe Toftgaard; Enghild, Jan J.; Scavenius, Carsten			Coagulation Factor XIIIa Substrates in Human Plasma IDENTIFICATION AND INCORPORATION INTO THE CLOT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Blood Coagulation Factors; Fibrinogenesis; Plasma; Proteomics; Transglutaminases	EXTRACELLULAR-MATRIX PROTEIN-1; COVALENT CROSS-LINKING; COMPLEMENT; INHIBITOR; FIBRIN; TRANSGLUTAMINASES; FIBRONECTIN; SPECIFICITY; PEPTIDE; ECM1	Background: Coagulation factor XIIIa (FXIIIa) catalyzes cross-linking of Gln and Lys residues during coagulation. Results: A total of 147 FXIIIa substrates were identified in human plasma, and 48 of these were incorporated into the clot. Conclusion: These results indicate that FXIIIa is involved in extensive functionalization of the plasma clot. Significance: We present new insights into roles of FXIIIa in physiological and pathological processes. Coagulation factor XIII (FXIII) is a transglutaminase with a well defined role in the final stages of blood coagulation. Active FXIII (FXIIIa) catalyzes the formation of E-(-glutamyl)lysine isopeptide bonds between specific Gln and Lys residues. The primary physiological outcome of this catalytic activity is stabilization of the fibrin clot during coagulation. The stabilization is achieved through the introduction of cross-links between fibrin monomers and through cross-linking of proteins with anti-fibrinolytic activity to fibrin. FXIIIa additionally cross-links several proteins with other functionalities to the clot. Cross-linking of proteins to the clot is generally believed to modify clot characteristics such as proteolytic susceptibility and hereby affect the outcome of tissue damage. In the present study, we use a proteomic approach in combination with transglutaminase-specific labeling to identify FXIIIa plasma protein substrates and their reactive residues. The results revealed a total of 147 FXIIIa substrates, of which 132 have not previously been described. We confirm that 48 of the FXIIIa substrates were indeed incorporated into the insoluble fibrin clot during the coagulation of plasma. The identified substrates are involved in, among other activities, complement activation, coagulation, inflammatory and immune responses, and extracellular matrix organization.	[Nikolajsen, Camilla Lund; Dyrlund, Thomas F.; Poulsen, Ebbe Toftgaard; Enghild, Jan J.; Scavenius, Carsten] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus C, Denmark; [Nikolajsen, Camilla Lund; Enghild, Jan J.] Aarhus Univ, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University	Enghild, JJ (corresponding author), Gustav Wieds Vej 10C, DK-8000 Aarhus, Denmark.	jje@mb.au.dk; csss@mb.au.dk	; Scavenius, Carsten/Q-5941-2017	Enghild, Jan Johannes/0000-0001-9292-9172; Toftgaard Poulsen, Ebbe/0000-0002-4416-0431; Scavenius, Carsten/0000-0002-4304-0681				Cho JH, 2006, BLOOD, V107, P3555, DOI 10.1182/blood-2005-10-4168; Corbett SA, 1997, J BIOL CHEM, V272, P24999, DOI 10.1074/jbc.272.40.24999; COUSSONS PJ, 1992, BIOCHEM J, V282, P929, DOI 10.1042/bj2820929; Csosz E, 2008, J MOL BIOL, V383, P390, DOI 10.1016/j.jmb.2008.08.026; Csosz E, 2009, AMINO ACIDS, V36, P615, DOI 10.1007/s00726-008-0121-y; Dorum S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014056; Dyrlund TF, 2012, PROTEOMICS, V12, P2792, DOI 10.1002/pmic.201200109; FRANCIS RT, 1986, J BIOL CHEM, V261, P9787; Fraser SR, 2011, BLOOD, V117, P6371, DOI 10.1182/blood-2011-02-333203; GORMAN JJ, 1984, J BIOL CHEM, V259, P9007; HADA M, 1986, BLOOD, V68, P95; HALKIER T, 1994, BIOCHEM BIOPH RES CO, V200, P78, DOI 10.1006/bbrc.1994.1416; Han ZQ, 2001, FASEB J, V15, P988, DOI 10.1096/fj.99-0934com; Hsieh L, 2008, HAEMOPHILIA, V14, P1190, DOI 10.1111/j.1365-2516.2008.01857.x; KRONVALL G, 1979, INFECT IMMUN, V25, P1; Kussmann M, 1997, J MASS SPECTROM, V32, P593; Lippi G, 2011, NAT REV CARDIOL, V8, P502, DOI 10.1038/nrcardio.2011.91; Loof TG, 2011, BLOOD, V118, P2589, DOI 10.1182/blood-2011-02-337568; Lorand L, 2005, J THROMB HAEMOST, V3, P1337, DOI 10.1111/j.1538-7836.2005.01213.x; Lorand L, 2001, ANN NY ACAD SCI, V936, P291; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Muszbek L, 2011, PHYSIOL REV, V91, P931, DOI 10.1152/physrev.00016.2010; Nahrendorf M, 2008, EUR HEART J, V29, P445, DOI 10.1093/eurheartj/ehm558; Ni HY, 2003, P NATL ACAD SCI USA, V100, P2415, DOI 10.1073/pnas.2628067100; Nikolajsen CL, 2012, BIOCHEMISTRY-US, V51, P4735, DOI 10.1021/bi3004022; OKAMOTO M, 1992, BIOCHIM BIOPHYS ACTA, V1138, P53, DOI 10.1016/0925-4439(92)90151-C; Omenn GS, 2005, PROTEOMICS, V5, P3226, DOI 10.1002/pmic.200500358; Richardson VR, 2013, CLIN SCI, V124, P123, DOI 10.1042/CS20120233; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ritchie H, 1999, THROMB HAEMOSTASIS, V81, P96; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Robinson BR, 2000, CIRCULATION, V102, P1151, DOI 10.1161/01.CIR.102.10.1151; Ruoppolo M, 2003, PROTEIN SCI, V12, P1290, DOI 10.1110/ps.0239103; SAKATA Y, 1982, J CLIN INVEST, V69, P536, DOI 10.1172/JCI110479; Scavenius C, 2011, BBA-PROTEINS PROTEOM, V1814, P1624, DOI 10.1016/j.bbapap.2011.08.017; Schroeder V, 2013, J THROMB HAEMOST, V11, P234, DOI 10.1111/jth.12074; Sercu S, 2008, J INVEST DERMATOL, V128, P1397, DOI 10.1038/sj.jid.5701231; Sugimura Y, 2006, J BIOL CHEM, V281, P17699, DOI 10.1074/jbc.M513538200; Valnickova Z, 1998, J BIOL CHEM, V273, P27220, DOI 10.1074/jbc.273.42.27220; Zhang Y., 2012, PLOS ONE, V7	41	42	44	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6526	6534		10.1074/jbc.M113.517904	http://dx.doi.org/10.1074/jbc.M113.517904			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24443567	hybrid, Green Published			2022-12-28	WOS:000332389400019
J	Tourette, C; Li, B; Bell, R; O'Hare, S; Kaltenbach, LS; Mooney, SD; Hughes, RE				Tourette, Cendrine; Li, Biao; Bell, Russell; O'Hare, Shannon; Kaltenbach, Linda S.; Mooney, Sean D.; Hughes, Robert E.			A Large Scale Huntingtin Protein Interaction Network Implicates Rho GTPase Signaling Pathways in Huntington Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Death; Cell Motility; Computational Biology; Huntington Disease; Neurodegeneration; Neurodegenerative Diseases; Protein-Protein Interactions; Proteomics; Rho GTPases	INSULIN-RECEPTOR SUBSTRATE; MUTANT HUNTINGTIN; GENE-EXPRESSION; HOMOLOGY DOMAIN; SPINY NEURONS; FF DOMAIN; WILD-TYPE; FILOPODIA; IRSP53; TOXICITY	Background: Huntington disease is a fatal neuropsychiatric disorder caused by aberrant protein folding and interactions. Results: An interaction network composed of primary and secondary huntingtin-interacting proteins is significantly enriched for pathways implicated in HD, including RhoGTPases. Conclusion: Huntingtin interacts with members of the Rho GTPase signaling pathways and regulates filipodial dynamics. Significance: This protein interaction network provides a resource for HD target discovery. Huntington disease (HD) is an inherited neurodegenerative disease caused by a CAG expansion in the HTT gene. Using yeast two-hybrid methods, we identified a large set of proteins that interact with huntingtin (HTT)-interacting proteins. This network, composed of HTT-interacting proteins (HIPs) and proteins interacting with these primary nodes, contains 3235 interactions among 2141 highly interconnected proteins. Analysis of functional annotations of these proteins indicates that primary and secondary HIPs are enriched in pathways implicated in HD, including mammalian target of rapamycin, Rho GTPase signaling, and oxidative stress response. To validate roles for HIPs in mutant HTT toxicity, we show that the Rho GTPase signaling components, BAIAP2, EZR, PIK3R1, PAK2, and RAC1, are modifiers of mutant HTT toxicity. We also demonstrate that Htt co-localizes with BAIAP2 in filopodia and that mutant HTT interferes with filopodial dynamics. These data indicate that HTT is involved directly in membrane dynamics, cell attachment, and motility. Furthermore, they implicate dysregulation in these pathways as pathological mechanisms in HD.	[Tourette, Cendrine; Li, Biao; O'Hare, Shannon; Mooney, Sean D.; Hughes, Robert E.] Buck Inst Res Aging, Novato, CA 94945 USA; [Bell, Russell; Kaltenbach, Linda S.] Prolexys Pharmaceut, Salt Lake City, UT 84116 USA; [Bell, Russell] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Kaltenbach, Linda S.] Duke Univ, Med Ctr, Ctr Drug Discovery, Durham, NC 27704 USA; [Kaltenbach, Linda S.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27704 USA	Buck Institute for Research on Aging; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Duke University; Duke University	Mooney, SD (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	smooney@buckinstitute.org; rhughes@buckinstitute.org	Tourette, Cendrine/U-2540-2017	MOONEY, SEAN D/0000-0003-2654-0833	National Institutes of Health [NS055247, GM084432, LM009722]; CHDI Foundation Inc.; National Center for Biomedical Ontology Grant [U54-HG004028]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055247] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHDI Foundation Inc.; National Center for Biomedical Ontology Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported, in whole or in part, by National Institutes of Health Grants NS055247 and GM084432 (to R. E. H.). This work was also supported by a grant from CHDI Foundation Inc. (to R. E. H.).; Supported by National Institutes of Health Grant LM009722, National Center for Biomedical Ontology Grant U54-HG004028, and the CHDI Foundation Inc.	Ahmed S, 2010, SEMIN CELL DEV BIOL, V21, P350, DOI 10.1016/j.semcdb.2009.11.008; Allen M, 2002, J MOL BIOL, V323, P411, DOI 10.1016/S0022-2836(02)00968-3; Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bauer PO, 2009, J BIOL CHEM, V284, P13153, DOI 10.1074/jbc.M809229200; Bedford MT, 1999, TRENDS BIOCHEM SCI, V24, P264, DOI 10.1016/S0968-0004(99)01417-6; Bedford MT, 1998, P NATL ACAD SCI USA, V95, P10602, DOI 10.1073/pnas.95.18.10602; Bell R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000414; Borgonovo JE, 2013, EXP NEUROL, V241, P75, DOI 10.1016/j.expneurol.2012.11.025; Borrell-Pages M, 2006, CELL MOL LIFE SCI, V63, P2642, DOI 10.1007/s00018-006-6242-0; Boutell JM, 1999, HUM MOL GENET, V8, P1647, DOI 10.1093/hmg/8.9.1647; Buchsbaum RJ, 2007, J CELL SCI, V120, P1149, DOI 10.1242/jcs.03428; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Caviston JP, 2007, P NATL ACAD SCI USA, V104, P10045, DOI 10.1073/pnas.0610628104; Chiang MC, 2010, HUM MOL GENET, V19, P4043, DOI 10.1093/hmg/ddq322; Chong ZZ, 2012, FUTUR NEUROL, V7, P733, DOI 10.2217/FNL.12.72; Chow WNV, 2012, BIOCHEM J, V443, P681, DOI 10.1042/BJ20112175; Chuang JZ, 2002, J BIOL CHEM, V277, P19831, DOI 10.1074/jbc.M109613200; Culver BP, 2012, J BIOL CHEM, V287, P21599, DOI 10.1074/jbc.M112.359307; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; Disanza A, 2006, NAT CELL BIOL, V8, P1337, DOI 10.1038/ncb1502; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; FERRANTE RJ, 1991, J NEUROSCI, V11, P3877; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875; Hodges A, 2006, HUM MOL GENET, V15, P965, DOI 10.1093/hmg/ddl013; Holbert S, 2001, P NATL ACAD SCI USA, V98, P1811, DOI 10.1073/pnas.041566798; Hori K, 2005, J NEUROSCI, V25, P2670, DOI 10.1523/JNEUROSCI.3638-04.2005; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; Jiang HB, 2006, NEUROBIOL DIS, V23, P543, DOI 10.1016/j.nbd.2006.04.011; Jiang YJ, 2011, J BIOL CHEM, V286, P25236, DOI 10.1074/jbc.M110.216333; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Lange A, 2009, NATURE, V461, P1002, DOI 10.1038/nature08468; Lee JY, 2012, ANN NY ACAD SCI, V1271, P68, DOI 10.1111/j.1749-6632.2012.06725.x; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Lu BX, 2013, NAT NEUROSCI, V16, P562, DOI 10.1038/nn.3367; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marsick BM, 2012, CYTOSKELETON, V69, P496, DOI 10.1002/cm.21016; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Menna E, 2011, EUR J NEUROSCI, V34, P1655, DOI 10.1111/j.1460-9568.2011.07897.x; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Miller JP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003042; Miller JP, 2010, NEURON, V67, P199, DOI 10.1016/j.neuron.2010.06.021; MORTON CJ, 1994, CURR BIOL, V4, P615, DOI 10.1016/S0960-9822(00)00134-2; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Nakagawa H, 2003, J CELL SCI, V116, P2577, DOI 10.1242/jcs.00462; Neisch AL, 2011, CURR OPIN CELL BIOL, V23, P377, DOI 10.1016/j.ceb.2011.04.011; Neveklovska M, 2012, J HUNTINGTONS DIS, V1, P71, DOI 10.3233/JHD-2012-120016; Passani LA, 2000, HUM MOL GENET, V9, P2175, DOI 10.1093/hmg/9.14.2175; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Qin J, 2012, CURR OPIN CELL BIOL, V24, P607, DOI 10.1016/j.ceb.2012.06.003; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; REINER A, 1988, P NATL ACAD SCI USA, V85, P5733, DOI 10.1073/pnas.85.15.5733; RIVAS JD, 2010, PLOS COMPUT BIOL, V6; Robens JM, 2010, MOL CELL BIOL, V30, P829, DOI 10.1128/MCB.01574-08; Rommel C, 2007, NAT REV IMMUNOL, V7, P191, DOI 10.1038/nri2036; Schaefer MH, 2012, NUCLEIC ACIDS RES, V40, P4273, DOI 10.1093/nar/gks011; Seredenina T, 2012, NEUROBIOL DIS, V45, P83, DOI 10.1016/j.nbd.2011.07.001; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shao J, 2008, FEBS LETT, V582, P1637, DOI 10.1016/j.febslet.2008.04.009; Shirasaki DI, 2012, NEURON, V75, P41, DOI 10.1016/j.neuron.2012.05.024; Soltau M, 2004, J NEUROCHEM, V90, P659, DOI 10.1111/j.1471-4159.2004.02523.x; Southwell AL, 2008, J NEUROSCI, V28, P9013, DOI 10.1523/JNEUROSCI.2747-08.2008; Spillane M, 2012, J NEUROSCI, V32, P17671, DOI 10.1523/JNEUROSCI.1079-12.2012; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Suetsugu S, 2006, J BIOL CHEM, V281, P35347, DOI 10.1074/jbc.M606814200; Suetsugu S, 2010, SEMIN CELL DEV BIOL, V21, P340, DOI 10.1016/j.semcdb.2009.12.002; Sun B, 2002, NEUROBIOL DIS, V11, P111, DOI 10.1006/nbdi.2002.0539; Thomas EA, 2001, NEUROSCI LETT, V309, P145, DOI 10.1016/S0304-3940(01)02064-X; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Trushina E, 2006, HUM MOL GENET, V15, P3578, DOI 10.1093/hmg/ddl434; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wetie AGN, 2014, CELL MOL LIFE SCI, V71, P205, DOI 10.1007/s00018-013-1333-1; Yu ZF, 2000, J MOL NEUROSCI, V15, P31, DOI 10.1385/JMN:15:1:31; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zheng SQ, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-28; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	92	60	61	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6709	6726		10.1074/jbc.M113.523696	http://dx.doi.org/10.1074/jbc.M113.523696			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24407293	hybrid, Green Published			2022-12-28	WOS:000332389400033
J	Wang, DR; Hsiao, JC; Wong, CH; Li, GC; Lin, SC; Yu, SSF; Chen, WL; Chang, W; Tzou, DLM				Wang, Da-Rong; Hsiao, Jye-Chian; Wong, Chien-Hsuan; Li, Guo-Chian; Lin, Su-Ching; Yu, Steve S. -F.; Chen, Wenlung; Chang, Wen; Tzou, Der-Lii M.			Vaccinia Viral Protein A27 Is Anchored to the Viral Membrane via a Cooperative Interaction with Viral Membrane Protein A17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Pox Viruses; Protein Structure; Protein-Protein Interactions; Viral Protein; Virus Assembly	PLAQUE SIZE PHENOTYPE; ENVELOPE PROTEIN; MATURE VIRIONS; VIRUS ENTRY; SECONDARY STRUCTURE; STABLE COMPLEX; CELL-SURFACES; GENE-PRODUCT; IDENTIFICATION; FUSION	Background: Vaccinia viral protein A27 associates with viral membrane protein A17 for anchoring to the viral membrane. Results: A27 specifically interacts with two binding regions within the N-terminal domain of A17. Conclusion: The A27-A17 interaction is mediated through a specific and cooperative binding mechanism. Significance: As demonstrated, the F1 and F2 bindings are critical for A27 anchoring to the viral membrane and virion assembly. The vaccinia viral protein A27 in mature viruses specifically interacts with heparan sulfate for cell surface attachment. In addition, A27 associates with the viral membrane protein A17 to anchor to the viral membrane; however, the specific interaction between A27 and A17 remains largely unclear. To uncover the active binding sites and the underlying binding mechanism, we expressed and purified the N-terminal (18-50 residues) and C-terminal (162-203 residues) fragments of A17, which are denoted A17-N and A17-C. Through surface plasmon resonance, the binding affinity of A27/A17-N (K-A = 3.40 x 10(8) m(-1)) was determined to be approximately 3 orders of magnitude stronger than that of A27/A17-C (K-A = 3.40 x 10(5) m(-1)), indicating that A27 prefers to interact with A17-N rather than A17-C. Despite the disordered nature of A17-N, the A27-A17 interaction is mediated by a specific and cooperative binding mechanism that includes two active binding sites, namely (SFMPK36)-S-32 (denoted as F1 binding) and (20)LDKDLFTEEQ(29) (F2). Further analysis showed that F1 has stronger binding affinity and is more resistant to acidic conditions than is F2. Furthermore, A27 mutant proteins that retained partial activity to interact with the F1 and F2 sites of the A17 protein were packaged into mature virus particles at a reduced level, demonstrating that the F1/F2 interaction plays a critical role in vivo. Using these results in combination with site-directed mutagenesis data, we established a computer model to explain the specific A27-A17 binding mechanism.	[Wang, Da-Rong; Lin, Su-Ching; Yu, Steve S. -F.; Tzou, Der-Lii M.] Acad Sinica, Inst Chem, Taipei, Taiwan; [Hsiao, Jye-Chian; Chang, Wen] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Wong, Chien-Hsuan; Li, Guo-Chian; Chen, Wenlung] Natl Chia Yi Univ, Dept Appl Chem, Chiayi 60004, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Chiayi University	Tzou, DLM (corresponding author), 128 Acad Rd,Sec 2, Taipei 11529, Taiwan.	tzougate@gate.sinica.edu.tw	Yu, Steve Sheng-Fa/E-4866-2015; Tzou, Der-Lii M/E-9499-2015; Lin, Su-Ching/E-3571-2015; Chang, Wen/AAA-5076-2021	Yu, Steve Sheng-Fa/0000-0002-3462-065X; Tzou, Der-Lii M/0000-0002-3755-8230; Chang, Wen/0000-0003-3369-083X	Academia Sinica; National Science Council [NSC 100-2113-M-001-016-MY2, NSC 101-2320-B-001-023-MY3]	Academia Sinica(Academia Sinica - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by Academia Sinica and the National Science Council Grants NSC 100-2113-M-001-016-MY2 (to D.-L. M. T.) and NSC 101-2320-B-001-023-MY3 (to W.C.).	Adamson A. W., 1960, PHYS CHEM SURFACES, P457; Akey DL, 2001, BIOCHEMISTRY-US, V40, P6352, DOI 10.1021/bi002829w; BAX A, 1994, METHOD ENZYMOL, V239, P79; Bengali Z, 2012, VIROLOGY, V433, P506, DOI 10.1016/j.virol.2012.08.044; Betakova T, 1999, J VIROL, V73, P3534, DOI 10.1128/JVI.73.5.3534-3543.1999; Betakova T, 2000, J VIROL, V74, P2438, DOI 10.1128/JVI.74.5.2438-2442.2000; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Chang SJ, 2012, J VIROL, V86, P3809, DOI 10.1128/JVI.06081-11; Chang SJ, 2010, J VIROL, V84, P8422, DOI 10.1128/JVI.00599-10; Chang TH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003563; Charles-Whitbeck J, 2009, VIROLOGY, V385, P383, DOI 10.1016/j.virol.2008.12.029; Ching YC, 2009, J VIROL, V83, P6464, DOI 10.1128/JVI.02295-08; Chiu WL, 2007, J VIROL, V81, P2149, DOI 10.1128/JVI.02302-06; Chung CS, 2006, J VIROL, V80, P2127, DOI 10.1128/JVI.80.5.2127-2140.2006; Chung CS, 1998, J VIROL, V72, P1577, DOI 10.1128/JVI.72.2.1577-1585.1998; Chung CS, 2005, J VIROL, V79, P1623, DOI 10.1128/JVI.79.3.1623-1634.2005; DALLO S, 1987, VIROLOGY, V159, P423, DOI 10.1016/0042-6822(87)90481-8; Derrien M, 1999, J VIROL, V73, P7287, DOI 10.1128/JVI.73.9.7287-7296.1999; ENGELSTAD M, 1993, VIROLOGY, V194, P627, DOI 10.1006/viro.1993.1302; Fass D, 1996, NAT STRUCT BIOL, V3, P465, DOI 10.1038/nsb0596-465; Foo CH, 2009, VIROLOGY, V385, P368, DOI 10.1016/j.virol.2008.12.019; GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2; GONG SC, 1989, J VIROL, V63, P4507, DOI 10.1128/JVI.63.11.4507-4514.1989; GRZESIEK S, 1992, BIOCHEMISTRY-US, V31, P8180, DOI 10.1021/bi00150a009; Ho Y, 2005, J MOL BIOL, V349, P1060, DOI 10.1016/j.jmb.2005.04.024; Howard AR, 2008, J VIROL, V82, P12384, DOI 10.1128/JVI.01524-08; Hsiao JC, 1999, J VIROL, V73, P8750, DOI 10.1128/JVI.73.10.8750-8761.1999; Hsiao JC, 1998, J VIROL, V72, P8374, DOI 10.1128/JVI.72.10.8374-8379.1998; Huang CY, 2008, J VIROL, V82, P7988, DOI 10.1128/JVI.00894-08; Izmailyan R, 2012, J VIROL, V86, P6677, DOI 10.1128/JVI.06860-11; Karlsson R, 1997, J IMMUNOL METHODS, V200, P121, DOI 10.1016/S0022-1759(96)00195-0; Kay LE, 1997, BIOCHEM CELL BIOL, V75, P1, DOI 10.1139/o97-023; Kochan G, 2008, CELL MICROBIOL, V10, P149, DOI 10.1111/j.1462-5822.2007.01026.x; KrijnseLocker J, 1996, J BIOL CHEM, V271, P14950, DOI 10.1074/jbc.271.25.14950; Lin CL, 2000, J VIROL, V74, P3353, DOI 10.1128/JVI.74.7.3353-3365.2000; Lin TH, 2002, J BIOL CHEM, V277, P20949, DOI 10.1074/jbc.M110403200; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; MORTON TA, 1995, ANAL BIOCHEM, V227, P176, DOI 10.1006/abio.1995.1268; Moss B, 2006, VIROLOGY, V344, P48, DOI 10.1016/j.virol.2005.09.037; Moss B., 1996, FIELDS VIROLOGY, P2637; PAYNE L, 1978, J VIROL, V27, P28, DOI 10.1128/JVI.27.1.28-37.1978; Resch W, 2007, VIROLOGY, V358, P233, DOI 10.1016/j.virol.2006.08.025; RODRIGUEZ D, 1993, J VIROL, V67, P3435, DOI 10.1128/JVI.67.6.3435-3440.1993; RODRIGUEZ D, 1995, J VIROL, V69, P4640; Rodriguez D, 1996, J VIROL, V70, P7641; RODRIGUEZ JF, 1990, NUCLEIC ACIDS RES, V18, P5347, DOI 10.1093/nar/18.18.5347; Schroeder N, 2012, J VIROL, V86, P4868, DOI 10.1128/JVI.06610-11; Shih PC, 2009, J BIOL CHEM, V284, P36535, DOI 10.1074/jbc.M109.037267; Townsley AC, 2006, J VIROL, V80, P8899, DOI 10.1128/JVI.01053-06; Unger B, 2013, J VIROL, V87, P1083, DOI 10.1128/JVI.02529-12; Vazquez MI, 1998, J VIROL, V72, P10126; Wallengren K, 2001, VIROLOGY, V290, P143, DOI 10.1006/viro.2001.1131; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WHITEHEAD SS, 1994, J VIROL, V68, P7603, DOI 10.1128/JVI.68.11.7603-7608.1994; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; Wolffe EJ, 1996, J VIROL, V70, P2797, DOI 10.1128/JVI.70.5.2797-2808.1996; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005; Yoder JD, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-10	59	8	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6639	6655		10.1074/jbc.M114.547372	http://dx.doi.org/10.1074/jbc.M114.547372			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24451374	hybrid, Green Published			2022-12-28	WOS:000332389400028
J	Chung, HH; Sze, SK; Woo, ARE; Sun, Y; Sim, KH; Dong, XM; Lin, VCL				Chung, Hwa Hwa; Sze, Siu Kwan; Woo, Amanda Rui En; Sun, Yang; Sim, Kae Hwan; Dong, Xue Ming; Lin, Valerie C-L.			Lysine Methylation of Progesterone Receptor at Activation Function 1 Regulates both Ligand-independent Activity and Ligand Sensitivity of the Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Post-translational Modification; Protein Methylation; Steroid Hormone; Steroid Hormone Receptor; Transcription	BREAST-CANCER CELLS; ESTROGEN PLUS PROGESTIN; TRANSCRIPTIONAL ACTIVITY; ISOFORM-B; CO-REPRESSOR; CROSS-TALK; ALPHA; PHOSPHORYLATION; RESISTANCE; DOMAINS	Background: Activation function 1 (AF-1) is important for the activity of progesterone receptor (PR), but its functional motif is not known. Results: AF-1 of progesterone receptor (PR) is monomethylated at Lys-464. Lys-464 mutation markedly alters PR properties and ligand sensitivity. Conclusion: Lys-464 is critical for AF-1 function. Significance: Lys-464 is a potential target for modulating AF-1 activity of PR. Progesterone receptor (PR) exists in two isoforms, PRA and PRB, and both contain activation functions AF-1 and AF-2. It is believed that AF-1 is primarily responsible for the ligand-independent activity, whereas AF-2 mediates ligand-dependent PR activation. Although more than a dozen post-translational modifications of PR have been reported, no post-translational modification on AF-1 or AF-2 has been reported. Using LC-MS/MS-based proteomic analysis, this study revealed AF-1 monomethylation at Lys-464. Mutational analysis revealed the remarkable importance of Lys-464 in regulating PR activity. Single point mutation K464Q or K464A led to ligand-independent PR gel upshift similar to the ligand-induced gel upshift. This upshift was associated with increases in both ligand-dependent and ligand-independent PR phosphorylation and PR activity due to the hyperactivation of AF-1. In contrast, mutation of Lys-464 to the bulkier phenylalanine to mimic the effect of methylation caused a drastic decrease in PR activity. Importantly, PR-K464Q also showed heightened ligand sensitivity, and this was associated with increases in its functional interaction with transcription co-regulators NCoR1 and SRC-1. These results suggest that monomethylation of PR at Lys-464 probably has a repressive effect on AF-1 activity and ligand sensitivity.	[Chung, Hwa Hwa; Sze, Siu Kwan; Woo, Amanda Rui En; Sun, Yang; Sim, Kae Hwan; Dong, Xue Ming; Lin, Valerie C-L.] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Lin, VCL (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	cllin@ntu.edu.sg	Sze, Siu_kwan Newman/A-2199-2011; Sze, Siu Kwan/AAO-3342-2020; Dong, Xueming/M-2137-2017; Chun Ling, Valerie Lin/A-2188-2011	Sze, Siu_kwan Newman/0000-0002-5652-1687; Sze, Siu Kwan/0000-0002-5652-1687; Dong, Xueming/0000-0001-8726-7565	Ministry of Education of Singapore	Ministry of Education of Singapore(Ministry of Education, Singapore)	This work was supported by a grant from the Ministry of Education of Singapore (to V. C.-L. L.).	Abdel-Hafiz H, 2002, J BIOL CHEM, V277, P33950, DOI 10.1074/jbc.M204573200; Abdel-Hafiz H, 2009, J BIOL CHEM, V284, P9099, DOI 10.1074/jbc.M805226200; Arao Y, 2011, P NATL ACAD SCI USA, V108, P14986, DOI 10.1073/pnas.1109180108; Arnal JF, 2013, STEROIDS, V78, P576, DOI 10.1016/j.steroids.2012.11.011; Ballare C, 2003, MOL CELL BIOL, V23, P1994, DOI 10.1128/MCB.23.6.1994-2008.2003; Bamberger AM, 1996, P NATL ACAD SCI USA, V93, P6169, DOI 10.1073/pnas.93.12.6169; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Baptist Alan P, 2004, Clin Mol Allergy, V2, P10, DOI 10.1186/1476-7961-2-10; Boonyaratanakornkit V, 2001, MOL CELL, V8, P269, DOI 10.1016/S1097-2765(01)00304-5; Borjesson AE, 2011, P NATL ACAD SCI USA, V108, P6288, DOI 10.1073/pnas.1100454108; Bottomley MJ, 2004, EMBO REP, V5, P464, DOI 10.1038/sj.embor.7400146; Brayman MJ, 2006, MOL ENDOCRINOL, V20, P2278, DOI 10.1210/me.2005-0343; Brezillon S, 2009, CANCER LETT, V283, P92, DOI 10.1016/j.canlet.2009.03.032; Bulun SE, 2006, MOL CELL ENDOCRINOL, V248, P94, DOI 10.1016/j.mce.2005.11.041; Bulun SE, 2010, SEMIN REPROD MED, V28, P36, DOI 10.1055/s-0029-1242991; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Buzdar A, 2001, J CLIN ONCOL, V19, P3357, DOI 10.1200/JCO.2001.19.14.3357; Chauchereau A, 2003, J BIOL CHEM, V278, P12335, DOI 10.1074/jbc.M207148200; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chlebowski RT, 2010, JAMA-J AM MED ASSOC, V304, P1684, DOI 10.1001/jama.2010.1500; Cittelly DM, 2013, ONCOGENE, V32, P2555, DOI 10.1038/onc.2012.275; Clemm DL, 2000, MOL ENDOCRINOL, V14, P52, DOI 10.1210/me.14.1.52; Daniel AR, 2010, MOL ENDOCRINOL, V24, P2126, DOI 10.1210/me.2010-0170; Dong X, 2004, J MOL ENDOCRINOL, V32, P843, DOI 10.1677/jme.0.0320843; Duplessis TT, 2011, ENDOCRINOLOGY, V152, P2517, DOI 10.1210/en.2010-1281; Faivre EJ, 2008, MOL ENDOCRINOL, V22, P823, DOI 10.1210/me.2007-0437; Gan CS, 2008, J PROTEOME RES, V7, P4869, DOI 10.1021/pr800473j; Goldhar AS, 2011, MOL CELL ENDOCRINOL, V335, P148, DOI 10.1016/j.mce.2011.01.004; Graham JD, 2005, MOL ENDOCRINOL, V19, P2713, DOI 10.1210/me.2005-0126; Hao PL, 2010, J PROTEOME RES, V9, P3520, DOI 10.1021/pr100037h; Hopp TA, 2004, CLIN CANCER RES, V10, P2751, DOI 10.1158/1078-0432.CCR-03-0141; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Horwitz KB, 2008, J CLIN ENDOCR METAB, V93, P3295, DOI 10.1210/jc.2008-0938; Horwitzt KB, 2008, P NATL ACAD SCI USA, V105, P5774, DOI 10.1073/pnas.0706216105; Huq MDM, 2006, EMBO J, V25, P5094, DOI 10.1038/sj.emboj.7601389; Ko S, 2011, MOL ENDOCRINOL, V25, P433, DOI 10.1210/me.2010-0482; Konno T, 2010, ENDOCRINOLOGY, V151, P4537, DOI 10.1210/en.2010-0440; Krcmery J, 2010, BIOESSAYS, V32, P100, DOI 10.1002/bies.200900148; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lange CA, 2008, J STEROID BIOCHEM, V108, P203, DOI 10.1016/j.jsbmb.2007.09.019; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Le Romancer M, 2011, ENDOCR REV, V32, P597, DOI 10.1210/er.2010-0016; Leo JCL, 2005, INT J CANCER, V117, P561, DOI 10.1002/ijc.21186; Leo JCL, 2008, INT J CANCER, V122, P230, DOI 10.1002/ijc.23081; Lin VCL, 2000, MOL ENDOCRINOL, V14, P348, DOI 10.1210/me.14.3.348; Lin VCL, 1999, CLIN CANCER RES, V5, P395; Liu YY, 2012, J BIOL CHEM, V287, P36499, DOI 10.1074/jbc.M112.344317; Madauss KP, 2007, MOL ENDOCRINOL, V21, P1066, DOI 10.1210/me.2006-0524; Magklara A, 2009, MOL ENDOCRINOL, V23, P61, DOI 10.1210/me.2008-0028; Malinowski M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050709; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; McKay LI, 1998, MOL ENDOCRINOL, V12, P45, DOI 10.1210/mend.12.1.0044; Merot Y, 2004, J BIOL CHEM, V279, P26184, DOI 10.1074/jbc.M402148200; MEYER ME, 1990, EMBO J, V9, P3923, DOI 10.1002/j.1460-2075.1990.tb07613.x; MEYER ME, 1992, J BIOL CHEM, V267, P10882; Nasabzadeh TJ, 2010, J CUTAN PATHOL, V37, P1164, DOI 10.1111/j.1600-0560.2010.01607.x; Obr AE, 2012, MOL CELL ENDOCRINOL, V357, P4, DOI 10.1016/j.mce.2011.10.030; Ohno K, 2009, J NEUROCHEM, V111, P790, DOI 10.1111/j.1471-4159.2009.06370.x; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Pierson-Mullany LK, 2004, MOL CELL BIOL, V24, P10542, DOI 10.1128/MCB.24.24.10542-10557.2004; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; SARTORIUS CA, 1994, MOL ENDOCRINOL, V8, P1347, DOI 10.1210/me.8.10.1347; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Song LN, 2001, J BIOL CHEM, V276, P24806, DOI 10.1074/jbc.M102610200; Staka CM, 2005, ENDOCR-RELAT CANCER, V12, pS85, DOI 10.1677/erc.1.01006; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Subtil-Rodriguez A, 2008, MOL CELL BIOL, V28, P3830, DOI 10.1128/MCB.01217-07; Sumida T, 2004, CANCER RES, V64, P7886, DOI 10.1158/0008-5472.CAN-04-1155; Thomas RS, 2008, J MOL ENDOCRINOL, V40, P173, DOI 10.1677/JME-07-0165; Tung L, 2006, MOL ENDOCRINOL, V20, P2656, DOI 10.1210/me.2006-0105; TZUKERMAN MT, 1994, MOL ENDOCRINOL, V8, P21, DOI 10.1210/me.8.1.21; Wang DQ, 2005, MOL ENDOCRINOL, V19, P1483, DOI 10.1210/me.2005-0012; Warnmark A, 2003, MOL ENDOCRINOL, V17, P1901, DOI 10.1210/me.2002-0384; Weigel NL, 2007, MOL ENDOCRINOL, V21, P2311, DOI 10.1210/me.2007-0101; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; Zhang X, 1998, MOL ENDOCRINOL, V12, P513, DOI 10.1210/me.12.4.513; Zheng ZY, 2008, BREAST CANCER RES TR, V110, P111, DOI 10.1007/s10549-007-9711-8; Zuo LA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2588; Zwart W, 2007, EMBO J, V26, P3534, DOI 10.1038/sj.emboj.7601791	80	18	19	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5704	5722		10.1074/jbc.M113.522839	http://dx.doi.org/10.1074/jbc.M113.522839			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24415758	Green Published, hybrid			2022-12-28	WOS:000332015500032
J	Das, PK; Merits, A; Lulla, A				Das, Pratyush Kumar; Merits, Andres; Lulla, Aleksei			Functional Cross-talk between Distant Domains of Chikungunya Virus Non-structural Protein 2 Is Decisive for Its RNA-modulating Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzymes; Positive-strand RNA Viruses; Protein Purification; RNA Helicase; Viral Replication; Chikungunya Virus; NTPase; RNA Annealing; SF1 Helicase; Alphavirus	SINDBIS-VIRUS; CRYSTAL-STRUCTURE; HELICASE ACTIVITY; NS3 HELICASE; MOLECULAR DETERMINANTS; REPLICATION COMPLEXES; SERINE-PROTEASE; MINUS-STRAND; BINDING; DNA	Background: RNA helicase activity of chikungunya virus (CHIKV) non-structural protein 2 (nsP2) has not been previously demonstrated. Results: CHIKV nsP2 possesses 5-3 RNA helicase and RNA annealing activities. Conclusion: RNA-modulating activities of nsP2 apparently depend on communication between N-terminal and C-terminal domains of nsP2. Significance: Optimization of RNA helicase assay for nsP2 of highly medically important CHIKV opens opportunities for inhibitor screening studies. Chikungunya virus (CHIKV) non-structural protein 2 (nsP2) is a multifunctional protein that is considered a master regulator of the viral life cycle and a main viral factor responsible for cytopathic effects and subversion of antiviral defense. The C-terminal part of nsP2 possesses protease activity, whereas the N-terminal part exhibits NTPase and RNA triphosphatase activity and is proposed to have helicase activity. Bioinformatics analysis classified CHIKV nsP2 into helicase superfamily 1. However, the biochemical significance of a coexistence of two functionally unrelated modules in this single protein remains unknown. In this study, recombinant nsP2 demonstrated unwinding of double-stranded RNA in a 5-3 directionally biased manner and RNA strand annealing activity. Comparative analysis of NTPase and helicase activities of wild type nsP2 with enzymatic capabilities of different truncated or N-terminally extended variants of nsP2 revealed that the C-terminal part of the protein is indispensable for helicase functionality and presumably provides a platform for RNA binding, whereas the N-terminal-most region is apparently involved in obtaining a conformation of nsP2 that allows for its maximal enzymatic activities. The establishment of the protocols for the production of biochemically active CHIKV nsP2 and optimization of the parameters for helicase and NTPase assays are expected to provide the starting point for a further search of possibilities for therapeutic interventions to suppress alphaviral infections.	[Das, Pratyush Kumar; Merits, Andres; Lulla, Aleksei] Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia	University of Tartu	Merits, A (corresponding author), Univ Tartu, Inst Technol, Nooruse 1, EE-50411 Tartu, Estonia.	andres.merits@ut.ee	Merits, Andres/H-3125-2015	Merits, Andres/0000-0001-8193-0071; Das, Pratyush Kumar/0000-0003-2822-9619	Estonian Science Foundation [9421]; Targeted Financing Project [SF0180087s08]; European Union; European Union through the European Regional Development Fund via the Center of Excellence in Chemical Biology	Estonian Science Foundation; Targeted Financing Project; European Union(European Commission); European Union through the European Regional Development Fund via the Center of Excellence in Chemical Biology	This work was supported in part by Estonian Science Foundation Grant 9421, Targeted Financing Project SF0180087s08, the European Union 7th Framework Integrated Chikungunya Research project, and the European Union through the European Regional Development Fund via the Center of Excellence in Chemical Biology.; Recipient of a scholarship from the European Union Social Fund via Activity 4 of the Doctoral Studies and Internationalisation Programme.	Adedeji AO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036521; Adhikari S, 2010, ANAL BIOCHEM, V400, P203, DOI 10.1016/j.ab.2010.01.011; AHOLA T, 1995, P NATL ACAD SCI USA, V92, P507, DOI 10.1073/pnas.92.2.507; Akhrymuk I, 2012, J VIROL, V86, P7180, DOI 10.1128/JVI.00541-12; Appleby TC, 2011, J MOL BIOL, V405, P1139, DOI 10.1016/j.jmb.2010.11.034; Beran RKF, 2007, J BIOL CHEM, V282, P34913, DOI 10.1074/jbc.M707165200; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X; Caruthers JM, 2002, CURR OPIN STRUC BIOL, V12, P123, DOI 10.1016/S0959-440X(02)00298-1; Cheng ZH, 2007, EMBO J, V26, P253, DOI 10.1038/sj.emboj.7601464; Chernov AV, 2008, J BIOL CHEM, V283, P17270, DOI 10.1074/jbc.M801719200; de Cedron MG, 1999, FEBS LETT, V448, P19, DOI 10.1016/S0014-5793(99)00321-X; DeLano W.L, PYMOL MOL GRAPHICS S; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Frick DN, 2004, J BIOL CHEM, V279, P1269, DOI 10.1074/jbc.M310630200; Garmashova N, 2006, J VIROL, V80, P5686, DOI 10.1128/JVI.02739-05; Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P8413, DOI 10.1093/nar/17.21.8413; Gros C, 1996, VIROLOGY, V217, P367, DOI 10.1006/viro.1996.0125; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; Hardy RW, 2006, VIROLOGY, V345, P520, DOI 10.1016/j.virol.2005.10.018; HARDY WR, 1989, J VIROL, V63, P4653, DOI 10.1128/JVI.63.11.4653-4664.1989; Jankowsky E, 2010, RSC BIOMOL SCI, P1; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Jankowsky Eckhard, 2008, V488, P343, DOI 10.1007/978-1-60327-475-3_22; Karpe YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022336; Karpe YA, 2010, J VIROL, V84, P3595, DOI 10.1128/JVI.02130-09; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khan AH, 2002, J GEN VIROL, V83, P3075, DOI 10.1099/0022-1317-83-12-3075; Kulasegaran-Shylini R, 2009, J VIROL, V83, P8327, DOI 10.1128/JVI.00586-09; Lam AMI, 2004, NUCLEIC ACIDS RES, V32, P4060, DOI 10.1093/nar/gkh743; Lampio A, 2000, J BIOL CHEM, V275, P37853, DOI 10.1074/jbc.M004865200; Lee NR, 2010, NUCLEIC ACIDS RES, V38, P7626, DOI 10.1093/nar/gkq647; LEMM JA, 1993, J VIROL, V67, P1916, DOI 10.1128/JVI.67.4.1916-1926.1993; LEMM JA, 1994, EMBO J, V13, P2925, DOI 10.1002/j.1460-2075.1994.tb06587.x; Leshchiner AD, 2006, J GEN VIROL, V87, P3087, DOI 10.1099/vir.0.81971-0; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Lulla A, 2006, J VIROL, V80, P5413, DOI 10.1128/JVI.00229-06; Lulla A, 2012, J VIROL, V86, P553, DOI 10.1128/JVI.05195-11; Lulla V, 2013, J VIROL, V87, P10207, DOI 10.1128/JVI.01485-13; Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936; Malet H, 2009, J VIROL, V83, P6534, DOI 10.1128/JVI.00189-09; Mayuri, 2008, J VIROL, V82, P7284, DOI 10.1128/JVI.00224-08; MI S, 1991, VIROLOGY, V184, P423, DOI 10.1016/0042-6822(91)90862-6; Nishikiori M, 2012, J VIROL, V86, P7565, DOI 10.1128/JVI.00118-12; Pastorino BAM, 2008, VIRUS RES, V131, P293, DOI 10.1016/j.virusres.2007.09.009; PERANEN J, 1990, J VIROL, V64, P1888; Peroutka RJ, 2011, METHODS MOL BIOL, V705, P15, DOI 10.1007/978-1-61737-967-3_2; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Pyle AM, 2011, CURR OPIN CHEM BIOL, V15, P636, DOI 10.1016/j.cbpa.2011.07.019; Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445; RIKKONEN M, 1992, VIROLOGY, V189, P462, DOI 10.1016/0042-6822(92)90570-F; Rikkonen M, 1996, VIROLOGY, V218, P352, DOI 10.1006/viro.1996.0204; RIKKONEN M, 1994, J VIROL, V68, P5804, DOI 10.1128/JVI.68.9.5804-5810.1994; Rubach JK, 2009, VIROLOGY, V384, P201, DOI 10.1016/j.virol.2008.10.030; Russo AT, 2006, STRUCTURE, V14, P1449, DOI 10.1016/j.str.2006.07.010; Russo AT, 2010, J MOL GRAPH MODEL, V29, P46, DOI 10.1016/j.jmgm.2010.04.005; Saxton-Shaw KD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001931; Shin G, 2012, P NATL ACAD SCI USA, V109, P16534, DOI 10.1073/pnas.1210418109; Shirako Y, 1998, J VIROL, V72, P2310, DOI 10.1128/JVI.72.3.2310-2315.1998; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Springer CL, 2013, J VIROL, V87, P5994, DOI 10.1128/JVI.03491-12; Spuul P, 2010, J VIROL, V84, P7543, DOI 10.1128/JVI.00477-10; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; Taylor SD, 2010, J BIOL CHEM, V285, P11692, DOI 10.1074/jbc.M109.088559; Thal MA, 2007, VIROLOGY, V358, P221, DOI 10.1016/j.virol.2006.08.022; Vasiljeva L, 2003, J BIOL CHEM, V278, P41636, DOI 10.1074/jbc.M307481200; Vasiljeva L, 2001, J BIOL CHEM, V276, P30786, DOI 10.1074/jbc.M104786200; Vasiljeva L, 2000, J BIOL CHEM, V275, P17281, DOI 10.1074/jbc.M910340199; Waugh DS, 2011, PROTEIN EXPRES PURIF, V80, P283, DOI 10.1016/j.pep.2011.08.005; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; WENGLER G, 1979, NATURE, V282, P754, DOI 10.1038/282754a0; Wu YL, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/140601; Yang QS, 2005, BIOCHEMISTRY-US, V44, P13591, DOI 10.1021/bi0508946; Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	82	56	58	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5635	5653		10.1074/jbc.M113.503433	http://dx.doi.org/10.1074/jbc.M113.503433			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24407286	Green Published, hybrid			2022-12-28	WOS:000332015500027
J	Kim, SJ; Cheresh, P; Williams, D; Cheng, Y; Ridge, K; Schumacker, PT; Weitzman, S; Bohr, VA; Kamp, DW				Kim, Seok-Jo; Cheresh, Paul; Williams, David; Cheng, Yuan; Ridge, Karen; Schumacker, Paul T.; Weitzman, Sigmund; Bohr, Vilhelm A.; Kamp, David W.			Mitochondria-targeted Ogg1 and Aconitase-2 Prevent Oxidant-induced Mitochondrial DNA Damage in Alveolar Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Damage; DNA Repair; Epithelial Cell; Fibrosis; Oxidative Stress; Lung Fibrosis; Mitochondrial DNA Damage; Mitochondrial Aconitase; Mitochondrial hOgg1	OXIDATIVE STRESS; SIGNALING PATHWAY; INDUCED APOPTOSIS; REACTIVE OXYGEN; MTDNA DAMAGE; NUCLEAR-DNA; P53; REPAIR; 8-OXOGUANINE; LUNG	Background: Mitochondrial Ogg1 prevents oxidant (H2O2 and asbestos)-induced Aco-2 degradation and apoptosis. Results: Oxidant stress caused preferential AEC mtDNA > nuclear DNA damage, mt-p53 translocation, and apoptosis; effects were blocked by mt-hOgg1 or Aco-2. Conclusion: mt-hOgg1 and Aco-2 preserve AEC mtDNA, preventing oxidant-induced p53 activation and apoptosis. Significance: mt-hOgg1/Aco-2 effects on mtDNA may be an innovative target for preventing degenerative diseases. Mitochondria-targeted human 8-oxoguanine DNA glycosylase (mt-hOgg1) and aconitase-2 (Aco-2) each reduce oxidant-induced alveolar epithelial cell (AEC) apoptosis, but it is unclear whether protection occurs by preventing AEC mitochondrial DNA (mtDNA) damage. Using quantitative PCR-based measurements of mitochondrial and nuclear DNA damage, mtDNA damage was preferentially noted in AEC after exposure to oxidative stress (e.g. amosite asbestos (5-25 g/cm(2)) or H2O2 (100-250 m)) for 24 h. Overexpression of wild-type mt-hOgg1 or mt-long / 317-323 hOgg1 mutant incapable of DNA repair (mt-hOgg1-Mut) each blocked A549 cell oxidant-induced mtDNA damage, mitochondrial p53 translocation, and intrinsic apoptosis as assessed by DNA fragmentation and cleaved caspase-9. In contrast, compared with controls, knockdown of Ogg1 (using Ogg1 shRNA in A549 cells or primary alveolar type 2 cells from ogg1(-/-) mice) augmented mtDNA lesions and intrinsic apoptosis at base line, and these effects were increased further after exposure to oxidative stress. Notably, overexpression of Aco-2 reduced oxidant-induced mtDNA lesions, mitochondrial p53 translocation, and apoptosis, whereas siRNA for Aco-2 (siAco-2) enhanced mtDNA damage, mitochondrial p53 translocation, and apoptosis. Finally, siAco-2 attenuated the protective effects of mt-hOgg1-Mut but not wild-type mt-hOgg1 against oxidant-induced mtDNA damage and apoptosis. Collectively, these data demonstrate a novel role for mt-hOgg1 and Aco-2 in preserving AEC mtDNA integrity, thereby preventing oxidant-induced mitochondrial dysfunction, p53 mitochondrial translocation, and intrinsic apoptosis. Furthermore, mt-hOgg1 chaperoning of Aco-2 in preventing oxidant-mediated mtDNA damage and apoptosis may afford an innovative target for the molecular events underlying oxidant-induced toxicity.	[Kim, Seok-Jo; Cheresh, Paul; Williams, David; Cheng, Yuan; Ridge, Karen; Kamp, David W.] Jesse Brown Vet Affairs Med Ctr, Div Pulm & Crit Care Med, Dept Med, Chicago, IL 60611 USA; [Kim, Seok-Jo; Cheresh, Paul; Williams, David; Cheng, Yuan; Ridge, Karen; Kamp, David W.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Schumacker, Paul T.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Weitzman, Sigmund] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Bohr, Vilhelm A.] NIA, Lab Mol Gerontol, Baltimore, MD 21224 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Kamp, DW (corresponding author), Northwestern Univ, Feinberg Sch Med, McGaw M-330,240 E Huron St, Chicago, IL 60611 USA.	d-kamp@northwestern.edu	Bohr, Vilhelm/AAP-5931-2020	Schumacker, Paul T/0000-0001-9591-2034	National Institutes of Health [RO1 ES020357, P01HL071643]; Veterans Affairs Merit Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL071643, R01HL079190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000727, ZIAAG000733] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 ES020357 (to D. W. K.) and P01HL071643 (to K. R.). This work was also supported by a Veterans Affairs Merit Award (to D. W. K.).	Amaral JD, 2010, DISCOV MED, V9, P145; Arai T, 2002, CARCINOGENESIS, V23, P2005, DOI 10.1093/carcin/23.12.2005; Bohr VA, 2002, GENE, V286, P127, DOI 10.1016/S0378-1119(01)00813-7; Boldogh I, 2012, J BIOL CHEM, V287, P20769, DOI 10.1074/jbc.C112.364620; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Bulteau AL, 2003, BIOCHEMISTRY-US, V42, P14846, DOI 10.1021/bi0353979; Chen XJ, 2007, P NATL ACAD SCI USA, V104, P13738, DOI 10.1073/pnas.0703078104; Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391; Cheresh P, 2013, BBA-MOL BASIS DIS, V1832, P1028, DOI 10.1016/j.bbadis.2012.11.021; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; de Souza-Pinto NC, 2001, CANCER RES, V61, P5378; Ding ZF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01077; Dizdaroglu M, 2002, FREE RADICAL BIO MED, V32, P1102, DOI 10.1016/S0891-5849(02)00826-2; Dobson AW, 2002, AM J PHYSIOL-LUNG C, V283, pL205, DOI 10.1152/ajplung.00443.2001; Essmann F, 2005, J BIOL CHEM, V280, P37169, DOI 10.1074/jbc.M502052200; Figueira TR, 2013, ANTIOXID REDOX SIGN, V18, P2029, DOI 10.1089/ars.2012.4729; Grishko V, 2001, AM J PHYSIOL-LUNG C, V280, pL1300, DOI 10.1152/ajplung.2001.280.6.L1300; Hajas G, 2013, FREE RADICAL BIO MED, V61, P384, DOI 10.1016/j.freeradbiomed.2013.04.011; Hashiguchi K, 2004, NUCLEIC ACIDS RES, V32, P5596, DOI 10.1093/nar/gkh863; Jeong SM, 2013, CANCER CELL, V23, P450, DOI 10.1016/j.ccr.2013.02.024; Kamp DW, 2013, AM J RESP CELL MOL, V49, P892, DOI 10.1165/rcmb.2013-0053OC; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Koczor CA, 2013, MITOCHONDRION, V13, P277, DOI 10.1016/j.mito.2013.03.001; Laing S, 2010, AM J PHYSIOL-CELL PH, V299, pC736, DOI 10.1152/ajpcell.00529.2009; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lim S, 2011, CELL PHYSIOL BIOCHEM, V28, P873, DOI 10.1159/000335802; Liu G, 2013, ANNU REV PATHOL-MECH, V8, P161, DOI 10.1146/annurev-pathol-020712-163942; Ma WW, 2013, NEUROCHEM RES, V38, P1315, DOI 10.1007/s11064-013-1019-y; Mambo E, 2005, ONCOGENE, V24, P4496, DOI 10.1038/sj.onc.1208669; Nantajit D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012341; Noble PW, 2012, J CLIN INVEST, V122, P2756, DOI 10.1172/JCI60323; Panduri V, 2006, AM J RESP CELL MOL, V34, P443, DOI 10.1165/rcmb.2005-0352OC; Panduri V, 2004, AM J PHYSIOL-LUNG C, V286, pL1220, DOI 10.1152/ajplung.00371.2003; Panduri V, 2003, AM J RESP CELL MOL, V28, P241, DOI 10.1165/rcmb.4903; Panduri V, 2009, FREE RADICAL BIO MED, V47, P750, DOI 10.1016/j.freeradbiomed.2009.06.010; Paz-Elizur T, 2003, J NATL CANCER I, V95, P1312, DOI 10.1093/jnci/djg033; Picard M, 2012, AM J RESP CRIT CARE, V186, P1140, DOI 10.1164/rccm.201206-0982OC; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; Roepke M, 2007, CANCER BIOL THER, V6, P160, DOI 10.4161/cbt.6.2.3575; Ruchko M, 2005, AM J PHYSIOL-LUNG C, V288, pL530, DOI 10.1152/ajplung.00255.2004; Ruchko MV, 2011, FREE RADICAL BIO MED, V50, P1107, DOI 10.1016/j.freeradbiomed.2010.10.692; Sakumi K, 2003, CANCER RES, V63, P902; Santos Janine H, 2002, Methods Mol Biol, V197, P159, DOI 10.1385/1-59259-284-8:159; Santos JH, 2003, J BIOL CHEM, V278, P1728, DOI 10.1074/jbc.M208752200; Shukla A, 2003, AM J PHYSIOL-LUNG C, V285, pL1018, DOI 10.1152/ajplung.00038.2003; Sisson TH, 2010, AM J RESP CRIT CARE, V181, P254, DOI 10.1164/rccm.200810-1615OC; Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102; Tsui KH, 2011, PROSTATE, V71, P62, DOI 10.1002/pros.21222; Tsutsui H, 2001, INTERNAL MED, V40, P1177, DOI 10.2169/internalmedicine.40.1177; Van Houten B, 2006, DNA REPAIR, V5, P145, DOI 10.1016/j.dnarep.2005.03.002; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Wang JX, 2011, AM J PHYSIOL-HEART C, V301, pH2073, DOI 10.1152/ajpheart.00157.2011; Wang W, 2011, J NEUROSCI, V31, P9746, DOI 10.1523/JNEUROSCI.0852-11.2011; Wu M, 2008, ENVIRON MOL MUTAGEN, V49, P265, DOI 10.1002/em.20381; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Youn CK, 2007, MOL CANCER RES, V5, P1083, DOI 10.1158/1541-7786.MCR-06-0432; Yuzefovych LV, 2013, ENDOCRINOLOGY, V154, P2640, DOI 10.1210/en.2013-1076	60	70	74	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6165	6176		10.1074/jbc.M113.515130	http://dx.doi.org/10.1074/jbc.M113.515130			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24429287	Green Published, hybrid			2022-12-28	WOS:000332015500070
J	Sahar, S; Masubuchi, S; Eckel-Mahan, K; Vollmer, S; Galla, L; Ceglia, N; Masri, S; Barth, TK; Grimaldi, B; Oluyemi, O; Astarita, G; Hallows, WC; Piomelli, D; Imhof, A; Baldi, P; Denu, JM; Sassone-Corsi, P				Sahar, Saurabh; Masubuchi, Satoru; Eckel-Mahan, Kristin; Vollmer, Simone; Galla, Luisa; Ceglia, Nicholas; Masri, Selma; Barth, Teresa K.; Grimaldi, Benedetto; Oluyemi, Opeyemi; Astarita, Giuseppe; Hallows, William C.; Piomelli, Daniele; Imhof, Axel; Baldi, Pierre; Denu, John M.; Sassone-Corsi, Paolo			Circadian Control of Fatty Acid Elongation by SIRT1 Protein-mediated Deacetylation of Acetyl-coenzyme A Synthetase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Acetyl Coenzyme A; Circadian Clock; Gene Regulation; Post-translational Modification; Signal Transduction; SIRT1	REV-ERB-ALPHA; HISTONE ACETYLATION; CELL-GROWTH; METABOLISM; CLOCK; COA; BEHAVIOR; DISEASE; BETA; PROLIFERATION	Background: Circadian clock regulates various aspects of metabolism. Results: Rhythmic acetylation of AceCS1 controls circadian oscillations in acetyl-CoA levels and in fatty acid elongation. Conclusion: A previously unrecognized regulation of acetyl-CoA provides additional evidence to circadian regulation of metabolism. Significance: Understanding of the role of acetyl-CoA in fatty acid elongation might provide therapeutic benefits for treating metabolic diseases and cancer. The circadian clock regulates a wide range of physiological and metabolic processes, and its disruption leads to metabolic disorders such as diabetes and obesity. Accumulating evidence reveals that the circadian clock regulates levels of metabolites that, in turn, may regulate the clock. Here we demonstrate that the circadian clock regulates the intracellular levels of acetyl-CoA by modulating the enzymatic activity of acetyl-CoA Synthetase 1 (AceCS1). Acetylation of AceCS1 controls the activity of the enzyme. We show that acetylation of AceCS1 is cyclic and that its rhythmicity requires a functional circadian clock and the NAD(+)-dependent deacetylase SIRT1. Cyclic acetylation of AceCS1 contributes to the rhythmicity of acetyl-CoA levels both in vivo and in cultured cells. Down-regulation of AceCS1 causes a significant decrease in the cellular acetyl-CoA pool, leading to reduction in circadian changes in fatty acid elongation. Thus, a nontranscriptional, enzymatic loop is governed by the circadian clock to control acetyl-CoA levels and fatty acid synthesis.	[Sahar, Saurabh; Masubuchi, Satoru; Eckel-Mahan, Kristin; Galla, Luisa; Masri, Selma; Grimaldi, Benedetto; Sassone-Corsi, Paolo] Univ Calif Irvine, Sch Med, Ctr Epigenet & Metab, Irvine, CA 92697 USA; [Vollmer, Simone; Barth, Teresa K.; Imhof, Axel] Univ Munich, Adolf Butenandt Inst, Munich Ctr Integrated Prot Sci, D-80336 Munich, Germany; [Ceglia, Nicholas; Baldi, Pierre] Univ Calif Irvine, Inst Genom & Bioinformat, Dept Comp Sci, Irvine, CA 92697 USA; [Oluyemi, Opeyemi; Astarita, Giuseppe; Piomelli, Daniele] Univ Calif Irvine, Sch Med, Dept Pharmacol, Irvine, CA 92697 USA; [Hallows, William C.; Denu, John M.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Astarita, Giuseppe] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA	University of California System; University of California Irvine; University of Munich; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Wisconsin System; University of Wisconsin Madison; Georgetown University	Sassone-Corsi, P (corresponding author), Univ Calif Irvine, Sch Med, Ctr Epigenet & Metab, Irvine, CA 92697 USA.	psc@uci.edu	Astarita, Giuseppe/AAD-1239-2019; Imhof, Axel/AAU-5313-2021; Astarita, Giuseppe/N-7346-2014	Imhof, Axel/0000-0003-2993-8249; Astarita, Giuseppe/0000-0001-6700-301X; Eckel-Mahan, Kristin/0000-0001-8201-1675; Grimaldi, Benedetto/0000-0002-2589-9302; Galla, Luisa/0000-0001-8160-6052; Masri, Selma/0000-0002-8619-8331	National Institutes of Health; Institut de la Sante et de la Recherche Medicale (France); Sirtris Pharmaceutical Inc.; Bavarian-Californian Technology Center (BaCaTeC); Deutsche Forschungsgemeinschaft; National Institutes of Health Ruth L. Kirschstein postdoctoral fellowships; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065386, R37GM059785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institut de la Sante et de la Recherche Medicale (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Sirtris Pharmaceutical Inc.; Bavarian-Californian Technology Center (BaCaTeC); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health Ruth L. Kirschstein postdoctoral fellowships(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the Sassone-Corsi laboratory was supported by the National Institutes of Health, the Institut de la Sante et de la Recherche Medicale (France), and Sirtris Pharmaceutical Inc. Work in the Imhof laboratory was supported by the Bavarian-Californian Technology Center (BaCaTeC) and the Deutsche Forschungsgemeinschaft.; Supported by National Institutes of Health Ruth L. Kirschstein postdoctoral fellowships.	Albaugh BN, 2011, CHEMBIOCHEM, V12, P290, DOI 10.1002/cbic.201000438; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Cen Y, 2011, CURR MED CHEM, V18, P1919, DOI 10.2174/092986711795590084; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Chu KY, 2010, J BIOL CHEM, V285, P32606, DOI 10.1074/jbc.M110.157172; DeBruyne JP, 2007, CURR BIOL, V17, pR538, DOI 10.1016/j.cub.2007.05.067; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Fritz V, 2010, ONCOGENE, V29, P4369, DOI 10.1038/onc.2010.182; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Hayashi O, 2006, BIOSCI BIOTECH BIOCH, V70, P2676, DOI 10.1271/bbb.60269; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Kaelin WG, 2013, CELL, V153, P56, DOI 10.1016/j.cell.2013.03.004; Kojima S, 2011, J CELL SCI, V124, P311, DOI 10.1242/jcs.065771; Langer MR, 2002, J BIOL CHEM, V277, P27337, DOI 10.1074/jbc.M203251200; Le Martelot G, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001442; Mehra A, 2009, TRENDS BIOCHEM SCI, V34, P483, DOI 10.1016/j.tibs.2009.06.006; Menet JS, 2012, ELIFE, V1, DOI 10.7554/eLife.00011; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Partch CL, 2013, TRENDS CELL BIOL; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Shimazu T, 2010, MECH AGEING DEV, V131, P511, DOI 10.1016/j.mad.2010.05.001; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Wang QO, 2010, J LIPID RES, V51, P2516, DOI 10.1194/jlr.M003335; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yoshii Y, 2009, CANCER SCI, V100, P821, DOI 10.1111/j.1349-7006.2009.01099.x	40	55	56	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6091	6097		10.1074/jbc.M113.537191	http://dx.doi.org/10.1074/jbc.M113.537191			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24425865	Green Published, hybrid			2022-12-28	WOS:000332015500063
J	Zhao, JJ; Ouyang, H; Luo, J; Patel, S; Xue, YC; Quach, J; Sfeir, N; Zhang, MX; Fu, XD; Ding, S; Chen, SC; Zhang, K				Zhao, Jack Jiagang; Ouyang, Hong; Luo, Jing; Patel, Sherrina; Xue, Yuanchao; Quach, John; Sfeir, Nicole; Zhang, Meixia; Fu, Xiangdong; Ding, Sheng; Chen, Shaochen; Zhang, Kang			Induction of Retinal Progenitors and Neurons from Mammalian Muller Glia under Defined Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						p53; Photoreceptors; Proliferation; Regeneration; Reprogramming; Retina; Muller Glia; Muller Glia; Progenitor	PLURIPOTENT STEM-CELLS; NEURAL REGENERATION; VERTEBRATE RETINA; BINDING PROTEIN; PHOTORECEPTORS; GENERATION; PATHWAY; P53; TRANSPLANTATION; PROLIFERATION	Background: Mammalian Muller glia are mitotic quiescent and committed. Results: Loss of p53 enhances Muller glia to proliferate and become progenitor-like cells, which differentiated to photoreceptors in vitro and incorporated into retina after transplantation. Conclusion: Progenitor potential can be induced in mammalian Muller glia. Significance: Induction of Muller glia stemness may serve as an exciting strategy for retinal repair and regeneration. Vision impairment caused by loss of retinal neurons affects millions of people worldwide, and currently, there is no effective treatment. Muller glia of mammalian retina may represent an under-recognized and potential source for regeneration of a wide range of retinal cell types, including retinal ganglion cells and photoreceptors. Here, we demonstrated that mouse Muller glia cells have the capacity to be reprogrammed into the retinal neuronal cell fate and are competent to give rise to photoreceptors under a defined culture condition. Inactivation of p53 released proliferation restriction of Muller glia and significantly enhanced the induction of retinal progenitor from Muller glia in culture. Moreover, following the ocular transplantation, the Muller glia-derived progenitors were differentiated toward the fates of photoreceptors and retinal ganglion cells. Together, these results demonstrate the feasibility of using Muller glia as a potential source for retinal repair and regeneration.	[Zhao, Jack Jiagang; Ouyang, Hong; Luo, Jing; Patel, Sherrina; Quach, John; Sfeir, Nicole; Zhang, Kang] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA; [Zhao, Jack Jiagang; Ouyang, Hong; Luo, Jing; Patel, Sherrina; Xue, Yuanchao; Quach, John; Sfeir, Nicole; Fu, Xiangdong; Zhang, Kang] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Xue, Yuanchao; Fu, Xiangdong] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Luo, Jing] Cent S Univ, Xiangya Hosp 2, Dept Ophthalmol, Changsha 41001, Hunan, Peoples R China; [Zhang, Meixia] West China Hosp, Mol Med Res Ctr, Chengdu 610041, Sichuan, Peoples R China; [Ding, Sheng] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94158 USA; [Chen, Shaochen] Univ Calif San Diego, Dept NanoEngn, La Jolla, CA 92093 USA; [Zhang, Kang] Vet Adm Healthcare Syst, San Diego, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Central South University; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Diego	Zhao, JJ (corresponding author), Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA.	j3zhao@ucsd.edu; kang.zhang@gmail.com	Quach, John/AAS-9482-2021; Zhang, Kang/Y-2740-2019	Zhang, Kang/0000-0002-4549-1697; Ouyang, Hong/0000-0002-7622-7733; Luo, Jing/0000-0002-8905-9388	973 Program [2013CB967504, 2014CB964900]; National Natural Science Foundation of China [NSFC 81130017]; National Institutes of Health Director's Transformative R01 Program [R01 EY021374]; National Institutes of Health [RO1 EY018660, P30EY022589]; Beckman Initiative for Macular Research; Macula Society Research Grant; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research; University of California, San Diego Neuroscience Microscopy Shared Facility Grant [P30 NS047101]; NATIONAL EYE INSTITUTE [R01EY018660, R01EY021374, P30EY022589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health Director's Transformative R01 Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Initiative for Macular Research; Macula Society Research Grant; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); University of California, San Diego Neuroscience Microscopy Shared Facility Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grants from 973 Program (2013CB967504 and 2014CB964900), National Natural Science Foundation of China (NSFC 81130017), National Institutes of Health Director's Transformative R01 Program (R01 EY021374), National Institutes of Health (RO1 EY018660 and P30EY022589), the Beckman Initiative for Macular Research, Macula Society Research Grant, and the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research. Confocal microscopy was supported by University of California, San Diego Neuroscience Microscopy Shared Facility Grant P30 NS047101.	ANCHAN RM, 1991, NEURON, V6, P923, DOI 10.1016/0896-6273(91)90233-P; Barrantes ID, 2003, GENE DEV, V17, P2239, DOI 10.1101/gad.269103; Barry ER, 2013, CURR OPIN CELL BIOL, V25, P247, DOI 10.1016/j.ceb.2012.12.006; Blum B, 2009, CELL CYCLE, V8, P3822, DOI 10.4161/cc.8.23.10067; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Cavodeassi F, 2005, NEURON, V47, P43, DOI 10.1016/j.neuron.2005.05.026; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; EISENFELD AJ, 1985, INVEST OPHTH VIS SCI, V26, P775; Fischer AJ, 2005, PROG RETIN EYE RES, V24, P161, DOI 10.1016/j.preteyeres.2004.07.003; Fischer AJ, 2001, NAT NEUROSCI, V4, P247, DOI 10.1038/85090; Hitchcock P, 2004, PROG RETIN EYE RES, V23, P183, DOI 10.1016/j.preteyeres.2004.01.001; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Karl MO, 2010, TRENDS MOL MED, V16, P193, DOI 10.1016/j.molmed.2010.02.003; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Lamba DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008763; Levine EM, 2000, CELL MOL LIFE SCI, V57, P224, DOI 10.1007/PL00000686; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Lu B, 2013, TRANSL VIS SCI TECHN, V2, DOI 10.1167/tvst.2.1.1; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Moshiri A, 2004, J NEUROSCI, V24, P229, DOI 10.1523/JNEUROSCI.2980-03.2004; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Osakada F, 2009, NAT PROTOC, V4, P811, DOI 10.1038/nprot.2009.51; Pearson RA, 2012, NATURE, V485, P99, DOI 10.1038/nature10997; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; Ueki Y, 2012, GLIA, V60, P1579, DOI 10.1002/glia.22377; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; YOKOYAMA T, 1992, EXP EYE RES, V55, P225, DOI 10.1016/0014-4835(92)90186-V; Yun MH, 2013, P NATL ACAD SCI USA, V110, P17392, DOI 10.1073/pnas.1310519110; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	29	23	25	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2014	289	17					11945	11951		10.1074/jbc.M113.532671	http://dx.doi.org/10.1074/jbc.M113.532671			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF9BR	24523410	Green Published, hybrid			2022-12-28	WOS:000335010600034
J	Lopreiato, R; Giacomello, M; Carafoli, E				Lopreiato, Raffaele; Giacomello, Marta; Carafoli, Ernesto			The Plasma Membrane Calcium Pump: New Ways to Look at an Old Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Calcium ATPase; Calcium Signaling; Calcium Transport; Calmodulin; Phospholipid	CALMODULIN-BINDING DOMAIN; PROTEIN-KINASE-C; NITRIC-OXIDE SYNTHASE; CA2+ PUMP; PHOSPHATIDYLSERINE EXPOSURE; PHOSPHOLIPID SCRAMBLASE; LIPID RAFTS; CA-2+ PUMP; ERYTHROCYTE-MEMBRANES; INHIBITORY INTERACTION	The three-dimensional structure of the PMCA pump has not been solved, but its basic mechanistic properties are known to repeat those of the other Ca2+ pumps. However, the pump also has unique properties. They concern essentially its numerous regulatory mechanisms, the most important of which is the autoinhibition by its C-terminal tail. Other regulatory mechanisms involve protein kinases and the phospholipids of the membrane in which the pump is embedded. Permanent activation of the pump, e.g. by calmodulin, is physiologically as harmful to cells as its absence. The concept is now emerging that the global control of cell Ca2+ may not be the main function of the pump; in some cell types, it could even be irrelevant. The main pump role would be the regulation of Ca2+ in cell microdomains in which the pump co-segregates with partners that modulate the Ca2+ message and transduce it to important cell functions.	[Lopreiato, Raffaele] Univ Padua, Dept Biomed Sci, I-35121 Padua, Italy; [Giacomello, Marta; Carafoli, Ernesto] Univ Padua, Venetian Inst Mol Med, I-35129 Padua, Italy	University of Padua; University of Padua; Veneto Institute Molecular Medicine	Carafoli, E (corresponding author), Univ Padua, Venetian Inst Mol Med, I-35129 Padua, Italy.	ernesto.carafoli@unipd.it	Carafoli, Ernesto/K-5192-2016; GIACOMELLO, MARTA/HGB-1486-2022; Marta, Giacomello/B-6308-2013	Carafoli, Ernesto/0000-0002-7826-0094; LOPREIATO, RAFFAELE/0000-0003-2368-9384; Giacomello, Marta/0000-0002-0290-6602				Armesilla AL, 2004, J BIOL CHEM, V279, P31318, DOI 10.1074/jbc.M307557200; Baldridge RD, 2012, P NATL ACAD SCI USA, V109, pE290, DOI 10.1073/pnas.1115725109; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Bozulic LD, 2007, THROMB HAEMOSTASIS, V97, P587, DOI 10.1160/TH06-08-0438; Bredeston LM, 2004, J BIOL CHEM, V279, P41619, DOI 10.1074/jbc.M403116200; Brini M, 2010, J BIOL CHEM, V285, P30779, DOI 10.1074/jbc.M110.140475; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; BRODIN P, 1992, EUR J BIOCHEM, V204, P939, DOI 10.1111/j.1432-1033.1992.tb16715.x; Buch MH, 2005, J BIOL CHEM, V280, P29479, DOI 10.1074/jbc.M501326200; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; Caride AJ, 2001, CELL CALCIUM, V30, P49, DOI 10.1054/ceca.2001.0212; Caride AJ, 2007, J BIOL CHEM, V282, P25640, DOI 10.1074/jbc.M701129200; CARONI P, 1980, NATURE, V283, P765, DOI 10.1038/283765a0; Cartwright EJ, 2009, PFLUG ARCH EUR J PHY, V457, P665, DOI 10.1007/s00424-008-0455-z; Chicka MC, 2003, J BIOL CHEM, V278, P18464, DOI 10.1074/jbc.M301482200; CHOQUETTE D, 1984, BIOCHEM BIOPH RES CO, V125, P908, DOI 10.1016/0006-291X(84)91369-X; Corradi GR, 2007, J BIOL CHEM, V282, P35440, DOI 10.1074/jbc.M703377200; Daleke DL, 2003, J LIPID RES, V44, P233, DOI 10.1194/jlr.R200019-JLR200; Dasgupta SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084649; Dean WL, 2004, THROMB HAEMOSTASIS, V91, P325, DOI 10.1160/TH03-07-0425; DeMarco SJ, 2002, J BIOL CHEM, V277, P10506, DOI 10.1074/jbc.M111616200; DeMarco SJ, 2001, J BIOL CHEM, V276, P21594, DOI 10.1074/jbc.M101448200; El-Yazbi AF, 2008, EUR J PHARMACOL, V591, P80, DOI 10.1016/j.ejphar.2008.06.098; Elwess NL, 1997, J BIOL CHEM, V272, P17981, DOI 10.1074/jbc.272.29.17981; ENYEDI A, 1991, J BIOL CHEM, V266, P8952; ENYEDI A, 1980, CELL CALCIUM, V1, P299, DOI 10.1016/0143-4160(80)90032-9; ENYEDI A, 1994, J BIOL CHEM, V269, P41; ENYEDI A, 1987, J BIOL CHEM, V262, P6425; FADOK VA, 1992, J IMMUNOL, V148, P2207; FALCHETTO R, 1992, PROTEIN SCI, V1, P1613, DOI 10.1002/pro.5560011209; FALCHETTO R, 1991, J BIOL CHEM, V266, P2930; Ferraro-Peyret C, 2002, J IMMUNOL, V169, P4805, DOI 10.4049/jimmunol.169.9.4805; Filomatori CV, 2003, J BIOL CHEM, V278, P22265, DOI 10.1074/jbc.M302657200; FLECHA FLG, 1990, DIABETES, V39, P707, DOI 10.2337/diab.39.6.707; FUJIMOTO T, 1993, J CELL BIOL, V120, P1147, DOI 10.1083/jcb.120.5.1147; Harper MT, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003701; Hering H, 2003, J NEUROSCI, V23, P3262; HILFIKER H, 1994, J BIOL CHEM, V269, P26178; HOFMANN F, 1993, J BIOL CHEM, V268, P10252; HOFMANN F, 1994, J BIOL CHEM, V269, P24298; Holton Mary Louisa, 2010, World J Biol Chem, V1, P201, DOI 10.4331/wjbc.v1.i6.201; JAMES P, 1989, J BIOL CHEM, V264, P8289; JAMES PH, 1989, BIOCHEMISTRY-US, V28, P4253, DOI 10.1021/bi00436a020; Jiang L, 2007, J NEUROCHEM, V102, P378, DOI 10.1111/j.1471-4159.2007.04480.x; KLINGER R, 1980, CELL CALCIUM, V1, P229, DOI 10.1016/0143-4160(80)90046-9; KOSKKOSICKA D, 1988, J BIOL CHEM, V263, P18184; Linde CI, 2008, CELL CALCIUM, V43, P550, DOI 10.1016/j.ceca.2007.09.003; Mangialavori I, 2011, J BIOL CHEM, V286, P18397, DOI 10.1074/jbc.M110.210088; Mangialavori IC, 2012, BIOCHEM J, V443, P125, DOI 10.1042/BJ20111035; Mohamed TMA, 2011, J BIOL CHEM, V286, P41520, DOI 10.1074/jbc.M111.290411; NIGGLI V, 1979, J BIOL CHEM, V254, P9955; NIGGLI V, 1981, J BIOL CHEM, V256, P8588; Pang YH, 2005, FEBS LETT, V579, P2397, DOI 10.1016/j.febslet.2005.03.038; Paszty K, 2002, J BIOL CHEM, V277, P36146, DOI 10.1074/jbc.M205457200; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; Penheiter AR, 2002, J BIOL CHEM, V277, P17728, DOI 10.1074/jbc.M111608200; Penniston JT, 2014, J CELL SCI, V127, P72, DOI 10.1242/jcs.132548; Penniston JT, 1998, J MEMBRANE BIOL, V165, P101, DOI 10.1007/s002329900424; Poulsen LR, 2008, CELL MOL LIFE SCI, V65, P3119, DOI 10.1007/s00018-008-8341-6; Rimessi A, 2005, J BIOL CHEM, V280, P37195, DOI 10.1074/jbc.M504921200; ROELOFSEN B, 1977, BIOCHIM BIOPHYS ACTA, V464, P17, DOI 10.1016/0005-2736(77)90367-4; RONNER P, 1977, ARCH BIOCHEM BIOPHYS, V179, P578, DOI 10.1016/0003-9861(77)90146-1; Sanchez-Magraner L, 2014, J MEMBRANE BIOL, V247, P155, DOI 10.1007/s00232-013-9619-7; SantiagoGarcia J, 1996, MOL CELL BIOCHEM, V155, P173; SARKADI B, 1980, CELL CALCIUM, V1, P287, DOI 10.1016/0143-4160(80)90031-7; SCHATZMANN HJ, 1966, EXPERIENTIA, V22, P364, DOI 10.1007/BF01901136; SCHNITZER JE, 1995, P NATL ACAD SCI USA, V92, P1759, DOI 10.1073/pnas.92.5.1759; Schuh K, 2003, J BIOL CHEM, V278, P9778, DOI 10.1074/jbc.M212507200; Sepulveda MR, 2006, J BIOL CHEM, V281, P447, DOI 10.1074/jbc.M506950200; Sgambato-Faure V, 2006, BIOCHEM BIOPH RES CO, V343, P630, DOI 10.1016/j.bbrc.2006.03.020; SHULL GE, 1988, J BIOL CHEM, V263, P8646; SMALLWOOD JI, 1988, J BIOL CHEM, V263, P2195; Strehler EE, 2007, BIOCHEM SOC T, V35, P919, DOI 10.1042/BST0350919; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Sun J, 2002, BIOCHEMISTRY-US, V41, P6338, DOI 10.1021/bi025610l; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Tang DX, 2006, CELL CALCIUM, V39, P209, DOI 10.1016/j.ceca.2005.10.010; Tidow H, 2012, NATURE, V491, P468, DOI 10.1038/nature11539; Vanagas L, 2007, BBA-BIOMEMBRANES, V1768, P1641, DOI 10.1016/j.bbamem.2007.03.012; Vanagas L, 2013, CELL BIOCHEM BIOPHYS, V66, P187, DOI 10.1007/s12013-012-9467-6; Vanags DM, 1996, J BIOL CHEM, V271, P31075, DOI 10.1074/jbc.271.49.31075; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; VERMA AK, 1994, J BIOL CHEM, V269, P1687; VERMA AK, 1988, J BIOL CHEM, V263, P14152; VORHERR T, 1991, J BIOL CHEM, V266, P22; WANG KKW, 1991, J BIOL CHEM, V266, P9078; Weiss E, 2012, CELL CALCIUM, V51, P51, DOI 10.1016/j.ceca.2011.10.005; Wiedmer T, 2000, BBA-BIOMEMBRANES, V1467, P244, DOI 10.1016/S0005-2736(00)00236-4; Williams JC, 2006, J BIOL CHEM, V281, P23341, DOI 10.1074/jbc.M513341200; Zhang J, 2009, CELL CALCIUM, V45, P177, DOI [10.1016/j.ceca.2008.09.002, 10.3778/j.issn.1002-8331.2009.04.050]; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240; ZVARITCH E, 1990, BIOCHEMISTRY-US, V29, P8070, DOI 10.1021/bi00487a012	93	86	87	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10261	10268		10.1074/jbc.O114.555565	http://dx.doi.org/10.1074/jbc.O114.555565			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24570005	hybrid, Green Published			2022-12-28	WOS:000334226400002
J	Wallez, Y; Riedl, SJ; Pasquale, EB				Wallez, Yann; Riedl, Stefan J.; Pasquale, Elena B.			Association of the Breast Cancer Antiestrogen Resistance Protein 1 ( BCAR1) and BCAR3 Scaffolding Proteins in Cell Signaling and Antiestrogen Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anticancer Drug; Breast Cancer; Cancer; Drug Resistance; MAP Kinases (MAPKs); Protein-Protein Interactions; ERK1; 2; NSP3; PEA15; Mesenchymal Phenotype	SRC-TRANSFORMED CELLS; GDP EXCHANGE FACTOR; CAS FAMILY-MEMBERS; CYCLIN D1 PROMOTER; TYROSINE PHOSPHORYLATION; TAMOXIFEN RESISTANCE; SUBSTRATE DOMAIN; BCAR1/P130CAS PROTEIN; ADAPTER PROTEINS; DEPENDENT MANNER	Background: BCAR1 (breast cancer antiestrogen resistance protein 1) and BCAR3 promote antiestrogen resistance and malignancy in breast cancer. Results: Mutations preventing the tight BCAR1-BCAR3 association disrupt downstream signaling events required for antiestrogen resistance, including ERK1/2 activation. Conclusion: Complex formation is critical for BCAR1-BCAR3 oncogenic activities. Significance: The BCAR1-BCAR3 complex and associated signaling events represent promising therapeutic targets in breast cancer. Most breast cancers are estrogen receptor-positive and treated with antiestrogens, but aberrant signaling networks can induce drug resistance. One of these networks involves the scaffolding protein BCAR1/p130CAS, which regulates cell growth and migration/invasion. A less investigated scaffolding protein that also confers antiestrogen resistance is the SH2 domain-containing protein BCAR3. BCAR1 and BCAR3 bind tightly to each other through their C-terminal domains, thus potentially connecting their associated signaling networks. However, recent studies using BCAR1 and BCAR3 interaction mutants concluded that association between the two proteins is not critical for many of their interrelated activities regulating breast cancer malignancy. We report that these previously used BCAR mutations fail to cause adequate loss-of-function of the complex. By using structure-based BCAR1 and BCAR3 mutants that lack the ability to interact, we show that BCAR3-induced antiestrogen resistance in MCF7 breast cancer cells critically depends on its ability to bind BCAR1. Interaction with BCAR3 increases the levels of phosphorylated BCAR1, ultimately potentiating BCAR1-dependent antiestrogen resistance. Furthermore, antiestrogen resistance in cells overexpressing BCAR1/BCAR3 correlates with increased ERK1/2 activity. Inhibiting ERK1/2 through overexpression of the regulatory protein PEA15 negates the resistance, revealing a key role for ERK1/2 in BCAR1/BCAR3-induced antiestrogen resistance. Reverse-phase protein array data show that PEA15 levels in invasive breast cancers correlate with patient survival, suggesting that PEA15 can override ERK1/2 activation by BCAR1/BCAR3 and other upstream regulators. We further uncovered that the BCAR3-related NSP3 can also promote antiestrogen resistance. Thus, strategies to disrupt BCAR1-BCAR3/NSP3 complexes and associated signaling networks could ultimately lead to new breast cancer therapies.	[Wallez, Yann; Riedl, Stefan J.; Pasquale, Elena B.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Pasquale, Elena B.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego	Pasquale, EB (corresponding author), Sanford Burnham Med Res Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	elenap@sanfordburnham.org		Wallez, Yann/0000-0001-9654-6187	National Institutes of Health [R01CA160457]; NATIONAL CANCER INSTITUTE [P30CA030199, R01CA160457] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA160457.	Bartholomeusz C, 2012, ONCOLOGIST, V17, P766, DOI 10.1634/theoncologist.2011-0377; Bartholomeusz C, 2010, CLIN CANCER RES, V16, P1802, DOI 10.1158/1078-0432.CCR-09-1456; Borre PV, 2011, CELL SIGNAL, V23, P1030, DOI 10.1016/j.cellsig.2011.01.018; Brabek J, 2005, MOL CANCER RES, V3, P307, DOI 10.1158/1541-7786.MCR-05-0015; Brabek J, 2004, ONCOGENE, V23, P7406, DOI 10.1038/sj.onc.1207965; Brinkman A, 2000, JNCI-J NATL CANCER I, V92, P112, DOI 10.1093/jnci/92.2.112; Brinkman A, 2010, BREAST CANCER RES TR, V120, P401, DOI 10.1007/s10549-009-0403-4; Browne CD, 2010, P NATL ACAD SCI USA, V107, P18944, DOI 10.1073/pnas.1007558107; Cabodi S, 2004, J CELL SCI, V117, P1603, DOI 10.1242/jcs.01025; Cabodi S, 2006, CANCER RES, V66, P4672, DOI 10.1158/0008-5472.CAN-05-2909; Cabodi S, 2010, FASEB J, V24, P3796, DOI 10.1096/fj.10-157347; Cai DP, 1999, J IMMUNOL, V163, P2104; Cai DP, 2003, CANCER RES, V63, P6802; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Condorelli G, 1999, ONCOGENE, V18, P4409, DOI 10.1038/sj.onc.1202831; Cowell LN, 2006, ONCOGENE, V25, P7597, DOI 10.1038/sj.onc.1209747; Cunningham-Edmondson AC, 2009, BREAST CANCER-TARGET, V1, P39; Dail M, 2004, J BIOL CHEM, V279, P41892, DOI 10.1074/jbc.M402929200; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Dodelet VC, 1999, J BIOL CHEM, V274, P31941, DOI 10.1074/jbc.274.45.31941; Dorssers LCJ, 2004, CLIN CANCER RES, V10, P6194, DOI 10.1158/1078-0432.CCR-04-0444; Felekkis KN, 2005, MOL CANCER RES, V3, P32; Felekkis K, 2006, METHOD ENZYMOL, V407, P55, DOI 10.1016/S0076-6879(05)07006-0; Feller SM, 1998, J CELL PHYSIOL, V177, P535, DOI 10.1002/(SICI)1097-4652(199812)177:4<535::AID-JCP5>3.3.CO;2-5; Fiory F, 2009, AM J PHYSIOL-ENDOC M, V297, pE592, DOI 10.1152/ajpendo.00228.2009; Fonseca PM, 2004, CELL SIGNAL, V16, P621, DOI 10.1016/j.cellsig.2003.10.004; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Garron ML, 2009, J MOL BIOL, V386, P190, DOI 10.1016/j.jmb.2008.12.010; Gee JMW, 2001, INT J CANCER, V95, P247, DOI 10.1002/1097-0215(20010720)95:4<247::AID-IJC1042>3.0.CO;2-S; Glading A, 2007, CANCER RES, V67, P1536, DOI 10.1158/0008-5472.CAN-06-1378; Hiscox S, 2004, CLIN EXP METASTAS, V21, P201, DOI 10.1023/B:CLIN.0000037697.76011.1d; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Kumbrink J, 2012, NEOPLASIA, V14, P108, DOI 10.1593/neo.111760; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Lu YM, 1999, J BIOL CHEM, V274, P10047, DOI 10.1074/jbc.274.15.10047; Mace PD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2687; Mace PD, 2011, NAT STRUCT MOL BIOL, V18, P1381, DOI 10.1038/nsmb.2152; Makkinje A, 2012, J BIOL CHEM, V287, P27703, DOI 10.1074/jbc.M112.389981; Makkinje A, 2009, CELL SIGNAL, V21, P1423, DOI 10.1016/j.cellsig.2009.05.006; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Near RI, 2007, J CELL PHYSIOL, V212, P655, DOI 10.1002/jcp.21059; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Patwardhan P, 2006, J BIOL CHEM, V281, P20689, DOI 10.1074/jbc.M602311200; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Regelmann AG, 2006, IMMUNITY, V25, P907, DOI 10.1016/j.immuni.2006.09.014; Riggins RB, 2003, J BIOL CHEM, V278, P28264, DOI 10.1074/jbc.M303535200; Riggins RB, 2007, CANCER LETT, V256, P1, DOI 10.1016/j.canlet.2007.03.016; Riggins RB, 2006, CANCER RES, V66, P7007, DOI 10.1158/0008-5472.CAN-05-3952; Roselli S, 2010, CELL SIGNAL, V22, P1745, DOI 10.1016/j.cellsig.2010.06.015; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Sakakibara A, 2000, J BIOL CHEM, V275, P6404, DOI 10.1074/jbc.275.9.6404; Schrecengost RS, 2007, CANCER RES, V67, P6174, DOI 10.1158/0008-5472.CAN-06-3455; Schuh NR, 2010, J BIOL CHEM, V285, P2309, DOI 10.1074/jbc.M109.046631; Shah AN, 2007, ANTI-CANCER DRUG, V18, P371, DOI 10.1097/CAD.0b013e32801265d7; Soni S, 2009, J CELL BIOCHEM, V107, P364, DOI 10.1002/jcb.22136; Stassi G, 2005, CANCER RES, V65, P6668, DOI 10.1158/0008-5472.CAN-04-4009; Sun GB, 2012, MOL CELL BIOL, V32, P3776, DOI 10.1128/MCB.00214-12; Ta HQ, 2008, CANCER RES, V68, P8796, DOI 10.1158/0008-5472.CAN-08-2426; Tikhmyanova N, 2010, CELL MOL LIFE SCI, V67, P1025, DOI 10.1007/s00018-009-0213-1; Tornillo G, 2013, STEM CELLS, V31, P1422, DOI 10.1002/stem.1403; van Agthoven T, 1998, EMBO J, V17, P2799, DOI 10.1093/emboj/17.10.2799; van Agthoven T, 2012, INT J CANCER, V131, P1998, DOI 10.1002/ijc.27489; van der Flier S, 2000, INT J CANCER, V89, P465, DOI 10.1002/1097-0215(20000920)89:5<465::AID-IJC11>3.0.CO;2-O; van der Flier S, 2000, JNCI-J NATL CANCER I, V92, P120, DOI 10.1093/jnci/92.2.120; van der Flier S, 2001, INT J BIOL MARKER, V16, P172, DOI 10.1177/172460080101600303; Vervoort VS, 2007, GENE, V391, P161, DOI 10.1016/j.gene.2006.12.016; Wallez Yann, 2012, Genes Cancer, V3, P382, DOI 10.1177/1947601912460050; Wendt MK, 2009, J BIOL CHEM, V284, P34145, DOI 10.1074/jbc.M109.023614; Wilson AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065678; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522	72	24	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10431	10444		10.1074/jbc.M113.541839	http://dx.doi.org/10.1074/jbc.M113.541839			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24584939	Green Published, hybrid			2022-12-28	WOS:000334226400017
J	Gurung, B; Muhammad, AB; Hua, XX				Gurung, Buddha; Muhammad, Abdul Bari; Hua, Xianxin			Menin Is Required for Optimal Processing of the MicroRNA let-7a*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Beta Cell; Cancer Biology; MicroRNA; Pancreas; Pancreatic Islets; Tumor Suppressor Gene; IRS2; Menin; let-7a	ENDOCRINE-NEOPLASIA TYPE-1; HISTONE METHYLTRANSFERASE COMPLEX; JUND-ACTIVATED TRANSCRIPTION; PANCREATIC BETA-CELLS; RECEPTOR SUBSTRATE 2; RNA-INTERFERENCE; MOLECULAR-GENETICS; MICROPROCESSOR COMPLEX; INSULIN SENSITIVITY; MTOR PATHWAY	Background: Menin represses pancreatic beta cell proliferation. Results: Menin promotes processing of let-7a, whose target IRS2 plays an important role in insulin signaling and beta cell proliferation. Conclusion: Menin represses beta cell proliferation partly via regulation of miRNA biogenesis. Significance: Understanding how menin represses beta cell proliferation will aid toward improving therapies targeting endocrine tumors and metabolic diseases including diabetes. Multiple endocrine neoplasia type I (MEN1) is an inherited syndrome that includes susceptibility to pancreatic islet hyperplasia. This syndrome results from mutations in the MEN1 gene, which encodes menin protein. Menin interacts with several transcription factors, including JunD, and inhibits their activities. However, the precise mechanism by which menin suppresses gene expression is not well understood. Here, we show that menin interacts with arsenite-resistant protein 2 (ARS2), a component of the nuclear RNA CAP-binding complex that is crucial for biogenesis of certain miRNAs including let-7a. The levels of primary-let-7a (pri-let-7a) are not affected by menin; however, the levels of mature let-7a are substantially decreased upon Men1 excision. Let-7a targets, including Insr and Irs2, pro-proliferative genes that are crucial for insulin-mediated signaling, are up-regulated in Men1-excised cells. Inhibition of let-7a using anti-miRNA in wild type cells is sufficient to enhance the expression of insulin receptor substrate 2 (IRS2) to levels observed in Men1-excised cells. Depletion of menin does not affect the expression of Drosha and CBP80, but substantially impairs the processing of pri-miRNA to pre-miRNA. Ars2 knockdown decreased let-7a processing in menin-expressing cells but had little impact on let-7a levels in menin-excised cells. As IRS2 is known to mediate insulin signaling and insulin/mitogen-induced cell proliferation, these findings collectively unravel a novel mechanism whereby menin suppresses cell proliferation, at least partly by promoting the processing of certain miRNAs, including let-7a, leading to suppression of Irs2 expression and insulin signaling.	[Gurung, Buddha; Muhammad, Abdul Bari; Hua, Xianxin] Univ Penn, Perelman Sch Med, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania	Hua, XX (corresponding author), Univ Penn, Perelman Sch Med, Dept Canc Biol, Abramson Family Canc Res Inst, 421 Curie Blvd,420 BRB II-III, Philadelphia, PA 19104 USA.	huax@mail.med.upenn.edu			National Institutes of Health [R01-CA-113962, R01-DK085121]; Caring for Carcinoid Foundation-AACR Grant Care for Carcinoid Foundation [11-60-33XH]; Institute for Translational Medicine and Therapeutics [400-4130-2-0.4001]; Juvenile Diabetes Research Foundation [5-2012-221]; NATIONAL CANCER INSTITUTE [R01CA113962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085121, R01DK097555] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caring for Carcinoid Foundation-AACR Grant Care for Carcinoid Foundation; Institute for Translational Medicine and Therapeutics; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA-113962 and R01-DK085121 (to X. H.). This work was also supported by Caring for Carcinoid Foundation-AACR Grant Care for Carcinoid Foundation 11-60-33XH, Institute for Translational Medicine and Therapeutics Grant 400-4130-2-0.4001, and Juvenile Diabetes Research Foundation Grant 5-2012-221.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bertolino P, 2003, MECH DEVELOP, V120, P549, DOI 10.1016/S0925-4773(03)00039-X; Burgess JR, 2000, CLIN ENDOCRINOL, V53, P205, DOI 10.1046/j.1365-2265.2000.01032.x; Caldas C, 2005, NAT MED, V11, P712, DOI 10.1038/nm0705-712; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chen G, 2008, MOL CANCER RES, V6, P1894, DOI 10.1158/1541-7786.MCR-07-2206; Crabtree JS, 2003, MOL CELL BIOL, V23, P6075, DOI 10.1128/MCB.23.17.6075-6085.2003; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Di Leva G, 2013, CURR OPIN GENET DEV, V23, P3, DOI 10.1016/j.gde.2013.01.004; Dreijerink KMA, 2009, MOL CELL BIOL, V29, P5060, DOI 10.1128/MCB.01001-08; Fernandez-Valverde SL, 2011, DIABETES, V60, P1825, DOI 10.2337/db11-0171; Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109; Gobl AE, 1999, BBA-GENE STRUCT EXPR, V1447, P51, DOI 10.1016/S0167-4781(99)00132-3; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Gruber JJ, 2009, CELL, V138, P328, DOI 10.1016/j.cell.2009.04.046; Gurung B, 2013, CANCER RES, V73, P2650, DOI 10.1158/0008-5472.CAN-12-3158; Heppner C, 2001, ONCOGENE, V20, P4917, DOI 10.1038/sj.onc.1204529; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Jin SH, 2003, CANCER RES, V63, P4204; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Kusenda Branislav, 2006, Biomedical Papers (Olomouc), V150, P205; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lemmens I, 1997, HUM MOL GENET, V6, P1177, DOI 10.1093/hmg/6.7.1177; Libe R, 2005, EUR J ENDOCRINOL, V153, P477, DOI 10.1530/eje.1.02004; Luzi E, 2012, NUCLEIC ACID THER, V22, P103, DOI 10.1089/nat.2012.0344; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Marx SJ, 2005, NAT REV CANCER, V5, P367, DOI 10.1038/nrc1610; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Perren A, 2004, ANN NY ACAD SCI, V1014, P199, DOI 10.1196/annals.1294.021; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Sabin LR, 2009, CELL, V138, P340, DOI 10.1016/j.cell.2009.04.045; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Schnepp RW, 2006, CANCER RES, V66, P5707, DOI 10.1158/0008-5472.CAN-05-4518; Schuppin GT, 1998, DIABETES, V47, P1074, DOI 10.2337/diabetes.47.7.1074; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Stalberg P, 2004, J CLIN ENDOCR METAB, V89, P2326, DOI 10.1210/jc.2003-031228; Thiel AT, 2013, HAEMATOLOGICA, V98, P918, DOI 10.3324/haematol.2012.074195; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Wang Y, 2013, DIABETES, V62, P887, DOI 10.2337/db12-0451; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wuescher L, 2011, AM J PHYSIOL-ENDOC M, V301, pE474, DOI 10.1152/ajpendo.00022.2011; Yang YM, 2010, J TAIWAN INST CHEM E, V41, P1, DOI 10.1016/j.jtice.2009.11.002; Yang YQ, 2007, MOL CELL ENDOCRINOL, V265, P34, DOI 10.1016/j.mce.2006.12.032; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003	56	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9902	9908		10.1074/jbc.M113.520692	http://dx.doi.org/10.1074/jbc.M113.520692			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24563463	Green Published, hybrid			2022-12-28	WOS:000333807000039
J	Imamura, K; Maeda, S; Kawamura, I; Matsuyama, K; Shinohara, N; Yahiro, Y; Nagano, S; Setoguchi, T; Yokouchi, M; Ishidou, Y; Komiya, S				Imamura, Katsuyuki; Maeda, Shingo; Kawamura, Ichiro; Matsuyama, Kanehiro; Shinohara, Naohiro; Yahiro, Yuhei; Nagano, Satoshi; Setoguchi, Takao; Yokouchi, Masahiro; Ishidou, Yasuhiro; Komiya, Setsuro			Human Immunodeficiency Virus Type 1 Enhancer-binding Protein 3 Is Essential for the Expression of Asparagine-linked Glycosylation 2 in the Regulation of Osteoblast and Chondrocyte Differentiation*.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bone Morphogenetic Protein (BMP); Chondrogenesis; Endoplasmic Reticulum Stress; Endoplasmic Reticulum (ER); Osteoblasts; Alg2; Hivep3; runx2	BONE-FORMATION; CLEIDOCRANIAL DYSPLASIA; CONGENITAL DISORDERS; GROWTH-PLATE; FACTOR CBFA1; GENE; MICE; SCHNURRI-3; TRANSCRIPTION; PATHWAY	Background: The mechanisms by which Hivep3 regulates the osteochondrogenesis remain elusive. Results: Knockdown of Hivep3 down-regulated Alg2 expression. Alg2 suppressed osteoblast differentiation by inhibiting the activity of Runx2. Alg2 silencing suppressed the expression of Creb3l2 and chondrogenesis. Conclusion: Alg2 may be a modulator of osteochondrogenesis. Significance: This is the first report to describe the association of an Alg gene with osteochondrogenesis. Human immunodeficiency virus type 1 enhancer-binding protein 3 (Hivep3) suppresses osteoblast differentiation by inducing proteasomal degradation of the osteogenesis master regulator Runx2. In this study, we tested the possibility of cooperation of Hivep1, Hivep2, and Hivep3 in osteoblast and/or chondrocyte differentiation. Microarray analyses with ST-2 bone stroma cells demonstrated that expression of any known osteochondrogenesis-related genes was not commonly affected by the three Hivep siRNAs. Only Hivep3 siRNA promoted osteoblast differentiation in ST-2 cells, whereas all three siRNAs cooperatively suppressed differentiation in ATDC5 chondrocytes. We further used microarray analysis to identify genes commonly down-regulated in both MC3T3-E1 osteoblasts and ST-2 cells upon knockdown of Hivep3 and identified asparagine-linked glycosylation 2 (Alg2), which encodes a mannosyltransferase residing on the endoplasmic reticulum. The Hivep3 siRNA-mediated promotion of osteoblast differentiation was negated by forced Alg2 expression. Alg2 suppressed osteoblast differentiation and bone formation in cultured calvarial bone. Alg2 was immunoprecipitated with Runx2, whereas the combined transfection of Runx2 and Alg2 interfered with Runx2 nuclear localization, which resulted in suppression of Runx2 activity. Chondrocyte differentiation was promoted by Hivep3 overexpression, in concert with increased expression of Creb3l2, whose gene product is the endoplasmic reticulum stress transducer crucial for chondrogenesis. Alg2 silencing suppressed Creb3l2 expression and chondrogenesis of ATDC5 cells, whereas infection of Alg2-expressing virus promoted chondrocyte maturation in cultured cartilage rudiments. Thus, Alg2, as a downstream mediator of Hivep3, suppresses osteogenesis, whereas it promotes chondrogenesis. To our knowledge, this study is the first to link a mannosyltransferase gene to osteochondrogenesis.	[Imamura, Katsuyuki; Maeda, Shingo; Kawamura, Ichiro; Matsuyama, Kanehiro; Shinohara, Naohiro; Ishidou, Yasuhiro; Komiya, Setsuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Med Joint Mat, Kagoshima 8908544, Japan; [Imamura, Katsuyuki; Kawamura, Ichiro; Matsuyama, Kanehiro; Shinohara, Naohiro; Yahiro, Yuhei; Nagano, Satoshi; Yokouchi, Masahiro; Komiya, Setsuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Orthopaed Surg, Kagoshima 8908544, Japan; [Setoguchi, Takao; Komiya, Setsuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Near Future Locomotor Organ Med Creat Course, Kagoshima 8908544, Japan	Kagoshima University; Kagoshima University; Kagoshima University	Maeda, S (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Med Joint Mat, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	maeda-s@umin.ac.jp		Nagano, Satoshi/0000-0003-2015-1730	Japan Society for the Promotion of Science KAKENHI [23592221, 23592222]; Cell Science Research Foundation; Hip Joint Foundation of Japan; Grants-in-Aid for Scientific Research [23592222] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Hip Joint Foundation of Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 23592221 (to S. M.) and 23592222 (to Y. I.), a grant from the Cell Science Research Foundation (to S. M.), and a grant from the Hip Joint Foundation of Japan (to S. M.).	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Alvarez J, 2002, DEVELOPMENT, V129, P1913; Asada R, 2011, J BIOCHEM, V149, P507, DOI 10.1093/jb/mvr041; Bobick BE, 2004, J BIOL CHEM, V279, P4588, DOI 10.1074/jbc.M309805200; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Coman D, 2008, CLIN GENET, V73, P507, DOI 10.1111/j.1399-0004.2008.01015.x; Dai H, 2000, DEV BIOL, V227, P373, DOI 10.1006/dbio.2000.9901; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Geoffroy V, 2002, MOL CELL BIOL, V22, P6222, DOI 10.1128/MCB.22.17.6222-6233.2002; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Haeuptle MA, 2009, HUM MUTAT, V30, P1628, DOI 10.1002/humu.21126; Ishida W, 2000, J BIOL CHEM, V275, P6075, DOI 10.1074/jbc.275.9.6075; Jin WZ, 2006, DEV CELL, V10, P461, DOI 10.1016/j.devcel.2006.02.016; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Jones DC, 2010, P NATL ACAD SCI USA, V107, P8254, DOI 10.1073/pnas.1003727107; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kawamura I, 2012, J BIOL CHEM, V287, P29101, DOI 10.1074/jbc.M112.349415; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lee JS, 2006, J BONE MINER RES, V21, P921, DOI 10.1359/JBMR.060303; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Liu SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017161; McLarren KW, 2000, J BIOL CHEM, V275, P530, DOI 10.1074/jbc.275.1.530; Moremen KW, 2006, CURR OPIN STRUC BIOL, V16, P592, DOI 10.1016/j.sbi.2006.08.005; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Saita Y, 2007, J BIOL CHEM, V282, P12907, DOI 10.1074/jbc.M611203200; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Shim JH, 2013, J CLIN INVEST, V123, P4010, DOI 10.1172/JCI69443; Thiel C, 2003, J BIOL CHEM, V278, P22498, DOI 10.1074/jbc.M302850200; Tominaga H, 2008, MOL BIOL CELL, V19, P5373, DOI 10.1091/mbc.E08-03-0329; Udagawa Y, 2000, GENES CELLS, V5, P359, DOI 10.1046/j.1365-2443.2000.00328.x; Wein MN, 2012, P NATL ACAD SCI USA, V109, P8173, DOI 10.1073/pnas.1205848109; Wu LC, 2002, GENE EXPRESSION, V10, P137, DOI 10.3727/000000002783992479; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Zaidi SK, 2001, J CELL SCI, V114, P3093; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089	43	11	12	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9865	9879		10.1074/jbc.M113.520585	http://dx.doi.org/10.1074/jbc.M113.520585			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24563464	hybrid, Green Published			2022-12-28	WOS:000333807000036
J	Teng, KL; Zhang, J; Zhang, X; Ge, XX; Gao, Y; Wang, J; Lin, YH; Zhong, J				Teng, Kunling; Zhang, Jie; Zhang, Xue; Ge, Xiaoxuan; Gao, Yong; Wang, Jian; Lin, Yuheng; Zhong, Jin			Identification of Ligand Specificity Determinants in Lantibiotic Bovicin HJ50 and the Receptor BovK, a Multitransmembrane Histidine Kinase*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antimicrobial Peptides; Histidine Kinases; Membrane Proteins; Protein-Protein Interactions; Signal Transduction; BovK; Bovicin HJ50; Lantibiotics	STREPTOCOCCUS-MUTANS; STRUCTURAL-ANALYSIS; PROTEIN-KINASE; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; SENSOR DOMAINS; BIOSYNTHESIS; BACTERIOCIN; DCUS; C-4-DICARBOXYLATE	Background: Many lantibiotic peptides induce their own biosynthesis through histidine kinase receptors. Results: Bovicin HJ50 and BovK form a signaling complex; substitutions of key amino acids in each protein result in disrupted signal transduction. Conclusion: Bovicin HJ50 activates BovK through hydrophobic and electrostatic interaction to start signal transduction. Significance: A novel peptide activating multitransmembrane histidine kinase mechanism was identified. Lantibiotic bovicin HJ50 is produced by Streptococcus bovis HJ50 and acts as the extracellular signal to autoregulate its own biosynthesis through BovK/R two-component system. Bovicin HJ50 shows a linear N-terminal and glubolar C-terminal structure, and the sensor histidine kinase BovK contains eight transmembrane segments lacking any extensive surface-exposed sensory domain. The signal recognition mechanism between bovicin HJ50 and BovK is still unknown. We performed saturated alanine scanning mutagenesis and other amino acid substitutions on bovicin HJ50 using a semi-in vitro biosynthesis. Results of the mutants inducing activities indicated that several charged and hydrophobic amino acids in ring B of bovicin HJ50, as well as two glycines were key residues to recognize BovK. Circular dichroism analyses indicated that both glycines contributed to bovicin HJ50 structural changes in the membrane. Biotin-labeled bovicin HJ50 could interact with the N-terminal sensor of BovK, and several charged residues and a conserved hydrophobic region in the N-terminal portion of BovK sensor domain were important for interacting with the signal bovicin HJ50. By combining the results, we suggested a mechanism of bovicin HJ50 recognizing and activating BovK mainly through electrostatic and hydrophobic interactions.	[Teng, Kunling; Zhang, Jie; Zhang, Xue; Ge, Xiaoxuan; Gao, Yong; Wang, Jian; Zhong, Jin] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing 100101, Peoples R China; [Ge, Xiaoxuan; Wang, Jian] Univ Chinese Acad Sci, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhong, J (corresponding author), 1 Beichen West Rd, Beijing 100101, Peoples R China.	zhongj@im.ac.cn	Wang, Jian/ABG-9051-2021	Wang, Jian/0000-0002-6785-7899; Lin, Yuheng/0000-0002-0796-0130	National Natural Science Foundation of China [31070041, 31200046]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-Q-14, KSCX2-EW-G-14, KSCX2-EW-J-6]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences)	This work was supported by grants from the National Natural Science Foundation of China (31070041 and 31200046) and the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Q-14, KSCX2-EW-G-14, and KSCX2-EW-J-6).	Cheung J, 2008, J BIOL CHEM, V283, P30256, DOI 10.1074/jbc.M805253200; Cheung J, 2010, CURR OPIN MICROBIOL, V13, P116, DOI 10.1016/j.mib.2010.01.016; Cheung J, 2009, STRUCTURE, V17, P190, DOI 10.1016/j.str.2008.12.013; Chiu J, 2008, J MICROBIOL METH, V73, P195, DOI 10.1016/j.mimet.2008.02.013; Cho US, 2006, J MOL BIOL, V356, P1193, DOI 10.1016/j.jmb.2005.12.032; CINTAS LM, 1995, APPL ENVIRON MICROB, V61, P2643, DOI 10.1128/AEM.61.7.2643-2648.1995; Coburn PS, 2004, SCIENCE, V306, P2270, DOI 10.1126/science.1103996; Dufour A, 2007, FEMS MICROBIOL REV, V31, P134, DOI 10.1111/j.1574-6976.2006.00045.x; Georgalaki M, 2013, FOOD MICROBIOL, V33, P124, DOI 10.1016/j.fm.2012.09.008; Grebe TW, 1999, ADV MICROB PHYSIOL, V41, P139, DOI 10.1016/S0065-2911(08)60167-8; Heermann R, 1998, BBA-BIOMEMBRANES, V1415, P114, DOI 10.1016/S0005-2736(98)00181-3; Islam MR, 2009, MOL MICROBIOL, V72, P1438, DOI 10.1111/j.1365-2958.2009.06733.x; Johnsborg O, 2003, J BACTERIOL, V185, P6913, DOI 10.1128/JB.185.23.6913-6920.2003; Kramer J, 2007, J BACTERIOL, V189, P4290, DOI 10.1128/JB.00168-07; KUIPERS OP, 1995, J BIOL CHEM, V270, P27299, DOI 10.1074/jbc.270.45.27299; Lemmin T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002878; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Lin YH, 2011, MICROBIOL RES, V166, P146, DOI 10.1016/j.micres.2010.05.001; Liu G, 2009, MICROBIOL-SGM, V155, P584, DOI 10.1099/mic.0.022707-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; McAuliffe O, 2001, FEMS MICROBIOL REV, V25, P285, DOI 10.1016/S0168-6445(00)00065-6; Merritt J, 2005, MOL MICROBIOL, V57, P960, DOI 10.1111/j.1365-2958.2005.04733.x; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Moore JO, 2009, STRUCTURE, V17, P1195, DOI 10.1016/j.str.2009.07.015; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Neiditch MB, 2005, MOL CELL, V18, P507, DOI 10.1016/j.molcel.2005.04.020; Ni JQ, 2011, APPL ENVIRON MICROB, V77, P407, DOI 10.1128/AEM.01278-10; Pappalardo L, 2003, J BIOL CHEM, V278, P39185, DOI 10.1074/jbc.C300344200; Reinelt S, 2003, J BIOL CHEM, V278, P39189, DOI 10.1074/jbc.M305864200; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schmitz S, 2006, APPL ENVIRON MICROB, V72, P7270, DOI 10.1128/AEM.00723-06; Sevvana M, 2008, J MOL BIOL, V377, P512, DOI 10.1016/j.jmb.2008.01.024; Stein T, 2002, MOL MICROBIOL, V44, P403, DOI 10.1046/j.1365-2958.2002.02869.x; Thoendel M, 2011, CHEM REV, V111, P117, DOI 10.1021/cr100370n; Upton M, 2001, J BACTERIOL, V183, P3931, DOI 10.1128/JB.183.13.3931-3938.2001; Wang J, 2014, APPL ENVIRON MICROB, V80, P1062, DOI 10.1128/AEM.03213-13; Wen ZT, 2004, J BACTERIOL, V186, P2682, DOI 10.1128/JB.186.9.2682-2691.2004; Wescombe PA, 2006, APPL ENVIRON MICROB, V72, P1459, DOI 10.1128/AEM.72.2.1459-1466.2006; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Xiao HJ, 2004, MICROBIOL-SGM, V150, P103, DOI 10.1099/mic.0.26437-0; Yonezawa H, 2005, ANTIMICROB AGENTS CH, V49, P541, DOI 10.1128/AAC.49.2.541-548.2005; Zhou YF, 2008, J MOL BIOL, V383, P49, DOI 10.1016/j.jmb.2008.08.010	43	10	11	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9823	9832		10.1074/jbc.M113.513150	http://dx.doi.org/10.1074/jbc.M113.513150			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24526683	Green Published, hybrid			2022-12-28	WOS:000333807000032
J	Kerner, J; Minkler, P; Lesnefsky, E; Hoppel, C				Kerner, Janos; Minkler, Paul; Lesnefsky, Edward; Hoppel, Charles			Fatty acid chain elongation in palmitate-perfused working rat heart: mitochondrial acetyl-CoA is the source of two-carbon units for chain elongation	FASEB JOURNAL			English	Meeting Abstract	Experimental Biology Meeting	APR 26-30, 2014	San Diego, CA	Cenveo, LI COR, Wiley, Mead Johnson Pediat Nutr Inst, IPRECIO, F1000 Res, Amer Assoc Anatomists, Amer Physiol Soc, Amer Soc Biochem & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Nutr, Amer Soc Pharmacol & Expt Therapeut					[Kerner, Janos; Minkler, Paul; Hoppel, Charles] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Lesnefsky, Edward] Louis Stokes VA Med Ctr, Cleveland, OH USA	Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center					NIA NIH HHS [P01 AG015885, P01 AG15885] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))			0	0	0	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2014	28	1		S		758.2								1	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AX0MP	24558043	hybrid, Green Published			2022-12-28	WOS:000346646704152
J	Deen, AJ; Rilla, K; Oikari, S; Karna, R; Bart, G; Hayrinen, J; Bathina, AR; Ropponen, A; Makkonen, K; Tammi, RH; Tammi, MI				Deen, Ashik Jawahar; Rilla, Kirsi; Oikari, Sanna; Karna, Riikka; Bart, Genevieve; Hayrinen, Jukka; Bathina, Avinash Rahul; Ropponen, Antti; Makkonen, Katri; Tammi, Raija H.; Tammi, Markku I.			Rab10-mediated Endocytosis of the Hyaluronan Synthase HAS3 Regulates Hyaluronan Synthesis and Cell Adhesion to Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Adhesion; Collagen; Endocytosis; Hyaluronate; Intracellular Trafficking; Rab Proteins; Vesicles	RAB GTPASES; MEMBRANE; TRANSLOCATION; ACTIVATION; GLYCOSYLTRANSFERASES; ACCUMULATION; ORGANIZATION; TRAFFICKING; INHIBITION; PROTEOMICS	Background: Hyaluronan synthases (HASs) require transport to plasma membrane for the activation of hyaluronan (HA) synthesis. Results: Rab10 overexpression inhibited, whereas Rab10 silencing increased, cell surface HA coat and HAS3-dependent hyaluronan synthesis. Conclusion: Rab10 reduces the steady-state abundance of HAS3 in the plasma membrane by enhancing HAS3 endocytosis. Significance: HA synthesis is controlled by HAS3 endocytosis mediated by Rab10. Hyaluronan synthases (HAS1-3) are unique in that they are active only when located in the plasma membrane, where they extrude the growing hyaluronan (HA) directly into cell surface and extracellular space. Therefore, traffic of HAS to/from the plasma membrane is crucial for the synthesis of HA. In this study, we have identified Rab10 GTPase as the first protein known to be involved in the control of this traffic. Rab10 colocalized with HAS3 in intracellular vesicular structures and was co-immunoprecipitated with HAS3 from isolated endosomal vesicles. Rab10 silencing increased the plasma membrane residence of HAS3, resulting in a significant increase of HA secretion and an enlarged cell surface HA coat, whereas Rab10 overexpression suppressed HA synthesis. Rab10 silencing blocked the retrograde traffic of HAS3 from the plasma membrane to early endosomes. The cell surface HA coat impaired cell adhesion to type I collagen, as indicated by recovery of adhesion following hyaluronidase treatment. The data indicate a novel function for Rab10 in reducing cell surface HAS3, suppressing HA synthesis, and facilitating cell adhesion to type I collagen. These are processes important in tissue injury, inflammation, and malignant growth.	[Deen, Ashik Jawahar; Rilla, Kirsi; Oikari, Sanna; Karna, Riikka; Bart, Genevieve; Hayrinen, Jukka; Bathina, Avinash Rahul; Makkonen, Katri; Tammi, Raija H.; Tammi, Markku I.] Univ Eastern Finland, Sch Med, Inst Biomed, Kuopio 70210, Finland; [Oikari, Sanna] Univ Eastern Finland, Sch Med, Inst Clin Med, Kuopio 70210, Finland; [Ropponen, Antti] Univ Eastern Finland, Sch Med, Inst Dent, Kuopio 70210, Finland	University of Eastern Finland; University of Eastern Finland; University of Eastern Finland	Tammi, MI (corresponding author), Univ Eastern Finland, Sch Med, Inst Biomed, Yliopistonranta 1E,POB 1627, Kuopio 70211, Finland.	tammi@uef.fi	Tammi, Markku/AAQ-7878-2021	Bart, Genevieve/0000-0001-9809-150X; Rilla, Kirsi/0000-0002-7862-5727	Academy of Finland; Sigrid Juselius Foundation; Kuopio University Hospital; Spearhead Funds from the University of Eastern Finland (Cancer Center of Eastern Finland); Finnish Glycoscience Graduate School; CIMO Foundation; Finnish Cultural Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Kuopio University Hospital; Spearhead Funds from the University of Eastern Finland (Cancer Center of Eastern Finland); Finnish Glycoscience Graduate School; CIMO Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This work was supported by the Academy of Finland (to M. I. T.), the Sigrid Juselius Foundation (to M. T. and R. T.), Kuopio University Hospital (to E. V. O. and M. I. T.), and Spearhead Funds from the University of Eastern Finland (Cancer Center of Eastern Finland) (to M. I. T. and R. T.).; Supported by grants from the Finnish Glycoscience Graduate School, CIMO Foundation, and Finnish Cultural Foundation.	Babbey CM, 2006, MOL BIOL CELL, V17, P3156, DOI 10.1091/mbc.E05-08-0799; Babbey CM, 2010, AM J PHYSIOL-RENAL, V299, pF495, DOI 10.1152/ajprenal.00198.2010; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Boucrot E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010597; Cao Z, 2008, MOL CELL PROTEOMICS, V7, P1651, DOI 10.1074/mcp.M700155-MCP200; Cardoso CMP, 2010, TRAFFIC, V11, P221, DOI 10.1111/j.1600-0854.2009.01013.x; Chen Y, 2012, J CELL BIOL, V198, P545, DOI 10.1083/jcb.201111091; Crowell EF, 2010, CURR OPIN PLANT BIOL, V13, P700, DOI 10.1016/j.pbi.2010.07.005; DeAngelis PL, 2002, ANAT RECORD, V268, P317, DOI 10.1002/ar.10163; Doyon JB, 2011, NAT CELL BIOL, V13, P331, DOI 10.1038/ncb2175; Dube B, 2001, BBA-MOL CELL RES, V1538, P283, DOI 10.1016/S0167-4889(01)00079-9; English AR, 2013, NAT CELL BIOL, V15, P169, DOI 10.1038/ncb2647; Goentzel BJ, 2006, BIOCHEM J, V396, P347, DOI 10.1042/BJ20051782; Hassinen A, 2011, J BIOL CHEM, V286, P38329, DOI 10.1074/jbc.M111.277681; Hassinen A, 2010, J BIOL CHEM, V285, P17771, DOI 10.1074/jbc.M110.103184; Hiltunen ELJ, 2002, CANCER RES, V62, P6410; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Kankaanpaa P, 2012, NAT METHODS, V9, P683, DOI [10.1038/NMETH.2047, 10.1038/nmeth.2047]; Kanomata N, 2005, VIRCHOWS ARCH, V446, P246, DOI 10.1007/s00428-004-1197-8; Karousou E, 2010, J BIOL CHEM, V285, P23647, DOI 10.1074/jbc.M110.127050; KITCHEN JR, 1995, BIOCHEM J, V309, P649, DOI 10.1042/bj3090649; Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200; Lerner DW, 2013, DEV CELL, V24, P159, DOI 10.1016/j.devcel.2012.12.005; Muralidharan-Chari V, 2010, J CELL SCI, V123, P1603, DOI 10.1242/jcs.064386; Nykopp TK, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-512; Ortiz D, 2006, EUR J CELL BIOL, V85, P107, DOI 10.1016/j.ejcb.2005.10.006; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Piltti J, 2008, BIORHEOLOGY, V45, P323, DOI 10.3233/BIR-2008-0481; Pummill PE, 1998, J BIOL CHEM, V273, P4976, DOI 10.1074/jbc.273.9.4976; Rilla K, 2005, J BIOL CHEM, V280, P31890, DOI 10.1074/jbc.M504736200; Rilla K, 2008, J HISTOCHEM CYTOCHEM, V56, P901, DOI 10.1369/jhc.2008.951665; Rilla K, 2013, EXP CELL RES, V319, P2006, DOI 10.1016/j.yexcr.2013.05.021; Rilla K, 2013, J BIOL CHEM, V288, P5973, DOI 10.1074/jbc.M112.443879; Rilla K, 2012, HISTOCHEM CELL BIOL, V137, P153, DOI 10.1007/s00418-011-0896-x; Sanchez-Leon E, 2011, EUKARYOT CELL, V10, P683, DOI 10.1128/EC.00280-10; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Schuck S, 2007, TRAFFIC, V8, P47, DOI 10.1111/j.1600-0854.2006.00506.x; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Shi AB, 2012, P NATL ACAD SCI USA, V109, pE2306, DOI 10.1073/pnas.1205278109; Siiskonen H, 2013, GLYCOBIOLOGY, V23, P222, DOI 10.1093/glycob/cws149; Sironen RK, 2011, EXP CELL RES, V317, P383, DOI 10.1016/j.yexcr.2010.11.017; Starr TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046386; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tammi RH, 2011, FEBS J, V278, P1419, DOI 10.1111/j.1742-4658.2011.08070.x; Tanno H, 2013, J BIOCHEM, V153, P497, DOI 10.1093/jb/mvt028; Teng BP, 2011, ANTI-CANCER AGENT ME, V11, P620; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Twarock S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-30; Tzellos TG, 2011, J EUR ACAD DERMATOL, V25, P679, DOI 10.1111/j.1468-3083.2010.03851.x; Vigetti D, 2012, J BIOL CHEM, V287, P35544, DOI 10.1074/jbc.M112.402347; Wang D, 2010, P NATL ACAD SCI USA, V107, P13806, DOI 10.1073/pnas.1009428107; Wang T, 2011, DEV CELL, V21, P431, DOI 10.1016/j.devcel.2011.07.007; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; YATES JR, 1995, ANAL CHEM, V67, P3202, DOI 10.1021/ac00114a016; Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551	56	24	24	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8375	8389		10.1074/jbc.M114.552133	http://dx.doi.org/10.1074/jbc.M114.552133			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24509846	hybrid, Green Published			2022-12-28	WOS:000333157500030
J	Hsieh, V; Kim, MJ; Gelissen, IC; Brown, AJ; Sandoval, C; Hallab, JC; Kockx, M; Traini, M; Jessup, W; Kritharides, L				Hsieh, Victar; Kim, Mi-Jurng; Gelissen, Ingrid C.; Brown, Andrew J.; Sandoval, Cecilia; Hallab, Jeannette C.; Kockx, Maaike; Traini, Mathew; Jessup, Wendy; Kritharides, Leonard			Cellular Cholesterol Regulates Ubiquitination and Degradation of the Cholesterol Export Proteins ABCA1 and ABCG1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Cholesterol; Proteasome; Protein Degradation; Ubiquitination; ABCA1; ABCG1	CASSETTE TRANSPORTER A1; ATHEROSCLEROTIC LESION DEVELOPMENT; DENSITY-LIPOPROTEIN RECEPTOR; LDL RECEPTOR; HELICAL APOLIPOPROTEINS; LYSOSOMAL DEGRADATION; ENDOPLASMIC-RETICULUM; LOADED MACROPHAGES; PROTEASOME PATHWAY; FOAM CELLS	Background: Cholesterol transporters ABCA1 and ABCG1 export excess cellular cholesterol and protect against atherosclerosis. Results: Cholesterol loading decreases cellular degradation of ABCA1 and ABCG1 and also their ubiquitination. Conclusion: Cholesterol-dependent suppression of ABCA1 and ABCG1 ubiquitination decreases their proteasomal degradation. Significance: This mechanism enhances the capacity of cholesterol-loaded cells to export their excess cholesterol. The objective of this study was to examine the influence of cholesterol in post-translational control of ABCA1 and ABCG1 protein expression. Using CHO cell lines stably expressing human ABCA1 or ABCG1, we observed that the abundance of these proteins is increased by cell cholesterol loading. The response to increased cholesterol is rapid, is independent of transcription, and appears to be specific for these membrane proteins. The effect is mediated through cholesterol-dependent inhibition of transporter protein degradation. Cell cholesterol loading similarly regulates degradation of endogenously expressed ABCA1 and ABCG1 in human THP-1 macrophages. Turnover of ABCA1 and ABCG1 is strongly inhibited by proteasomal inhibitors and is unresponsive to inhibitors of lysosomal proteolysis. Furthermore, cell cholesterol loading inhibits ubiquitination of ABCA1 and ABCG1. Our findings provide evidence for a rapid, cholesterol-dependent, post-translational control of ABCA1 and ABCG1 protein levels, mediated through a specific and sterol-sensitive mechanism for suppression of transporter protein ubiquitination, which in turn decreases proteasomal degradation. This provides a mechanism for acute fine-tuning of cholesterol transporter activity in response to fluctuations in cell cholesterol levels, in addition to the longer term cholesterol-dependent transcriptional regulation of these genes.	[Kockx, Maaike; Traini, Mathew; Jessup, Wendy; Kritharides, Leonard] Concord Hosp, ANZAC Res Inst, Atherosclerosis Lab, Concord, NSW 2139, Australia; [Kritharides, Leonard] Concord Hosp, Dept Cardiol, Concord, NSW 2139, Australia; [Gelissen, Ingrid C.] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Brown, Andrew J.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Hsieh, Victar; Kim, Mi-Jurng; Sandoval, Cecilia; Hallab, Jeannette C.] Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia	Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; Concord Repatriation General Hospital; University of Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Jessup, W (corresponding author), Concord Hosp, ANZAC Res Inst, Atherosclerosis Lab, Hosp Rd, Concord, NSW 2139, Australia.	wendy.jessup@sydney.edu.au	Research Institute, ANZAC/CAE-9030-2022; Kritharides, Leonard/AAQ-2720-2020; Ekanayake, Kanchana/P-8817-2016	Hsieh, Victar/0000-0003-0085-5933; Traini, Mathew/0000-0002-9423-5294	Pfizer CardioVascular Lipid grant; National Health and Medical Research Council of Australia; Principal Research Fellowship	Pfizer CardioVascular Lipid grant; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Principal Research Fellowship	This work was supported by a Pfizer CardioVascular Lipid grant (to V. H.), National Health and Medical Research Council of Australia Program grants (to W. J. and L. K.), and a Principal Research Fellowship (to W. J.).	Arakawa R, 2004, J BIOL CHEM, V279, P6217, DOI 10.1074/jbc.C300553200; Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; Azuma Y, 2009, BIOCHEM BIOPH RES CO, V382, P145, DOI 10.1016/j.bbrc.2009.02.161; Bowden K, 2008, J BIOL CHEM, V283, P18210, DOI 10.1074/jbc.M800918200; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Burns V, 2013, ATHEROSCLEROSIS, V226, P408, DOI 10.1016/j.atherosclerosis.2012.12.009; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Feng B, 2002, J BIOL CHEM, V277, P43271, DOI 10.1074/jbc.M207532200; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; Fitzgerald ML, 2001, J BIOL CHEM, V276, P15137, DOI 10.1074/jbc.M100474200; Garner B, 1997, ATHEROSCLEROSIS, V128, P47, DOI 10.1016/S0021-9150(96)05979-5; Gelissen IC, 2006, ARTERIOSCL THROM VAS, V26, P534, DOI 10.1161/01.ATV.0000200082.58536.e1; Gelissen IC, 1996, J BIOL CHEM, V271, P17852, DOI 10.1074/jbc.271.30.17852; Gelissen IC, 2012, J LIPID RES, V53, P2133, DOI 10.1194/jlr.M028795; Gelissen IC, 2010, ATHEROSCLEROSIS, V208, P75, DOI 10.1016/j.atherosclerosis.2009.06.028; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Hong C, 2010, J BIOL CHEM, V285, P19720, DOI 10.1074/jbc.M110.123729; Hori N, 2011, ATHEROSCLEROSIS, V215, P383, DOI 10.1016/j.atherosclerosis.2010.12.033; Hozoji M, 2008, J BIOL CHEM, V283, P30057, DOI 10.1074/jbc.M804599200; Jessup W, 2006, CURR OPIN LIPIDOL, V17, P247, DOI 10.1097/01.mol.0000226116.35555.eb; Kobayashi A, 2006, J LIPID RES, V47, P1791, DOI 10.1194/jlr.M500546-JLR200; Kockx M, 2012, BIOCHEM J, V447, P51, DOI 10.1042/BJ20111891; KRITHARIDES L, 1995, ARTERIOSCL THROM VAS, V15, P276, DOI 10.1161/01.ATV.15.2.276; Larrede S, 2009, ARTERIOSCL THROM VAS, V29, P1930, DOI 10.1161/ATVBAHA.109.194548; Lee JP, 2010, MOL CANCER RES, V8, P93, DOI 10.1158/1541-7786.MCR-08-0491; Mizuno T, 2011, HEPATOLOGY, V54, P631, DOI 10.1002/hep.24387; Munehira Y, 2004, J BIOL CHEM, V279, P15091, DOI 10.1074/jbc.M313436200; Nagelin MH, 2008, ARTERIOSCL THROM VAS, V28, P1811, DOI 10.1161/ATVBAHA.108.167908; Nagelin MH, 2009, J BIOL CHEM, V284, P31303, DOI 10.1074/jbc.M109.028910; Nakagawa H, 2008, BIOCHEM J, V411, P623, DOI 10.1042/BJ20071229; Ogura M, 2011, ARTERIOSCL THROM VAS, V31, P1980, DOI 10.1161/ATVBAHA.111.228478; Out R, 2008, CIRC RES, V102, P113, DOI 10.1161/CIRCRESAHA.107.161711; Out R, 2007, ARTERIOSCL THROM VAS, V27, P594, DOI 10.1161/01.ATV.0000257136.24308.0c; Out R, 2006, ARTERIOSCL THROM VAS, V26, P2295, DOI 10.1161/01.ATV.0000237629.29842.4c; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ravid T, 2000, J BIOL CHEM, V275, P35840, DOI 10.1074/jbc.M004793200; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Scotti E, 2013, MOL CELL BIOL, V33, P1503, DOI 10.1128/MCB.01716-12; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Stagg HR, 2009, J CELL BIOL, V186, P685, DOI 10.1083/jcb.200906110; Tanaka N, 2010, J LIPID RES, V51, P2591, DOI 10.1194/jlr.M006049; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang N, 2003, ARTERIOSCL THROM VAS, V23, P1178, DOI 10.1161/01.ATV.0000075912.83860.26; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; Wang YT, 2002, J BIOL CHEM, V277, P5692, DOI 10.1074/jbc.M109977200; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wellington CL, 2002, LAB INVEST, V82, P273, DOI 10.1038/labinvest.3780421; Wong J, 2006, BIOCHEM J, V400, P485, DOI 10.1042/BJ20060914; Yokoyama S, 2012, BBA-MOL CELL BIOL L, V1821, P547, DOI 10.1016/j.bbalip.2011.07.017; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Zelcer N, 2009, SCIENCE, V325, P100, DOI 10.1126/science.1168974	54	50	51	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7524	7536		10.1074/jbc.M113.515890	http://dx.doi.org/10.1074/jbc.M113.515890			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24500716	hybrid, Green Published			2022-12-28	WOS:000332761500023
J	Kuhlmann, AS; Steckbeck, JD; Sturgeon, TJ; Craigo, JK; Montelaro, RC				Kuhlmann, Anne-Sophie; Steckbeck, Jonathan D.; Sturgeon, Timothy J.; Craigo, Jodi K.; Montelaro, Ronald C.			Unique Functional Properties of Conserved Arginine Residues in the Lentivirus Lytic Peptide Domains of the C-terminal Tail of HIV-1 gp41	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						HIV-1; Lentivirus; Membrane Proteins; Site-directed Mutagenesis; Viral Replication; C-terminal Tail; Envelope; Arginines	TYPE-1 ENVELOPE GLYCOPROTEIN; CYTOPLASMIC DOMAIN; POINT MUTATIONS; INTRACYTOPLASMIC TAIL; LLP DOMAINS; SIDE-CHAINS; TRANSMEMBRANE; FUSION; PROTEIN; SEQUENCE	Background: The C-terminal tail of the HIV-1 envelope preferentially incorporates arginine over lysine despite the similar physicochemical properties of these two residues. Results: Conservative arginine to lysine substitutions impair HIV-1 Env functions and virus replication. Conclusion: Arginine conservation provides unique functions that cannot be provided by lysines. Significance: These observations conclusively demonstrate unique functional properties for the conserved arginine residues in mediating Env functional properties. A previous study from our laboratory reported a preferential conservation of arginine relative to lysine in the C-terminal tail (CTT) of HIV-1 envelope (Env). Despite substantial overall sequence variation in the CTT, specific arginines are highly conserved in the lentivirus lytic peptide (LLP) motifs and are scarcely substituted by lysines, in contrast to gp120 and the ectodomain of gp41. However, to date, no explanation has been provided to explain the selective incorporation and conservation of arginines over lysines in these motifs. Herein, we address the functions in virus replication of the most conserved arginines by performing conservative mutations of arginine to lysine in the LLP1 and LLP2 motifs. The presence of lysine in place of arginine in the LLP1 motif resulted in significant impairment of Env expression and consequently virus replication kinetics, Env fusogenicity, and incorporation. By contrast, lysine exchanges in LLP2 only affected the level of Env incorporation and fusogenicity. Our findings demonstrate that the conservative lysine substitutions significantly affect Env functional properties indicating a unique functional role for the highly conserved arginines in the LLP motifs. These results provide for the first time a functional explanation to the preferred incorporation of arginine, relative to lysine, in the CTT of HIV-1 Env. We propose that these arginines may provide unique functions for Env interaction with viral or cellular cofactors that then influence overall Env functional properties.	[Kuhlmann, Anne-Sophie; Steckbeck, Jonathan D.; Sturgeon, Timothy J.; Craigo, Jodi K.; Montelaro, Ronald C.] Univ Pittsburgh, Sch Med, Ctr Vaccine Res, Pittsburgh, PA 15261 USA; [Kuhlmann, Anne-Sophie; Steckbeck, Jonathan D.; Craigo, Jodi K.; Montelaro, Ronald C.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Montelaro, RC (corresponding author), 3501 Fifth Ave,9014 Biomed Sci Tower 3, Pittsburgh, PA 15261 USA.	rmont@pitt.edu			National Institutes of Health from the NIAID [5R01 AI087533]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087533] Funding Source: NIH RePORTER	National Institutes of Health from the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01 AI087533 (to R. C. M.) from the NIAID.	Barnes M. R., 2007, BIOINFORMATICS GENET, P249; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Blumenthal R, 2012, J BIOL CHEM, V287, P40841, DOI 10.1074/jbc.R112.406272; Boscia AL, 2013, BIOPHYS J, V105, P657, DOI 10.1016/j.bpj.2013.06.042; Chen SSL, 2001, J VIROL, V75, P9925, DOI 10.1128/JVI.75.20.9925-9938.2001; Cheng DC, 2010, BIOCHEM BIOPH RES CO, V391, P1780, DOI 10.1016/j.bbrc.2009.12.155; COPLEY RR, 1994, J MOL BIOL, V242, P321; Cosson P, 1996, EMBO J, V15, P5783, DOI 10.1002/j.1460-2075.1996.tb00964.x; Costin JM, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-123; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cunyat F, 2012, J BIOMOL SCREEN, V17, P727, DOI 10.1177/1087057112439890; da Silva ES, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-54; Davis MR, 2006, J VIROL, V80, P2405, DOI 10.1128/JVI.80.5.2405-2417.2006; Denner J, 2011, HUM VACCINES, V7, P4, DOI 10.4161/hv.7.0.14555; Durham ND, 2012, J VIROL, V86, P7484, DOI 10.1128/JVI.00230-12; Edwards TG, 2002, J VIROL, V76, P2683, DOI 10.1128/JVI.76.6.2683-2691.2002; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; HAFFAR OK, 1988, J CELL BIOL, V107, P1677, DOI 10.1083/jcb.107.5.1677; HAFFAR OK, 1991, VIROLOGY, V180, P439, DOI 10.1016/0042-6822(91)90054-F; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Jiang JY, 2007, J VIROL, V81, P9999, DOI 10.1128/JVI.00592-07; Joyner AS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002234; Kalia V, 2005, J VIROL, V79, P2097, DOI 10.1128/JVI.79.4.2097-2107.2005; Kalia V, 2003, J VIROL, V77, P3634, DOI 10.1128/JVI.77.6.3634-3646.2003; Kliger Y, 1997, BIOCHEMISTRY-US, V36, P5157, DOI 10.1021/bi962935r; Lee SF, 2000, J BIOL CHEM, V275, P15809, DOI 10.1074/jbc.M000601200; Lee SF, 2002, J BIOL CHEM, V277, P15363, DOI 10.1074/jbc.M201479200; Li LB, 2013, J PHYS CHEM B, V117, P11906, DOI 10.1021/jp405418y; Long YF, 2011, PROTEIN CELL, V2, P369, DOI 10.1007/s13238-011-1051-0; Martinez JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018375; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; MILLER MA, 1991, AIDS RES HUM RETROV, V7, P511, DOI 10.1089/aid.1991.7.511; MILLER MA, 1993, VIROLOGY, V196, P89, DOI 10.1006/viro.1993.1457; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Moreno MR, 2006, BBA-BIOMEMBRANES, V1758, P111, DOI 10.1016/j.bbamem.2006.01.007; Murakami T, 2000, J VIROL, V74, P3548, DOI 10.1128/JVI.74.8.3548-3554.2000; Murakami T, 2000, P NATL ACAD SCI USA, V97, P343, DOI 10.1073/pnas.97.1.343; Murakami T., 2012, MOL BIOL INT, V2012; Newman JT, 2007, VIROLOGY, V367, P102, DOI 10.1016/j.virol.2007.05.027; Paintsil E, 2007, ANTIMICROB AGENTS CH, V51, P3870, DOI 10.1128/AAC.00692-07; Paintsil Elijah, 2009, AIDS Res Ther, V6, P5, DOI 10.1186/1742-6405-6-5; Postler TS, 2013, J VIROL, V87, P2, DOI 10.1128/JVI.02053-12; Sakai N, 2006, SOFT MATTER, V2, P636, DOI 10.1039/b606955j; Schramm CA, 2012, STRUCTURE, V20, P924, DOI 10.1016/j.str.2012.03.016; Senes A, 2007, J MOL BIOL, V366, P436, DOI 10.1016/j.jmb.2006.09.020; SRINIVAS SK, 1992, J BIOL CHEM, V267, P7121; Steckbeck JD, 2013, J GEN VIROL, V94, P1, DOI 10.1099/vir.0.046508-0; Steckbeck JD, 2011, J BIOL CHEM, V286, P27156, DOI 10.1074/jbc.M111.258855; Steckbeck JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015261; TENCZA SB, 1995, J VIROL, V69, P5199, DOI 10.1128/JVI.69.8.5199-5202.1995; van Gils MJ, 2013, VIROLOGY, V435, P46, DOI 10.1016/j.virol.2012.10.004; Vzorov AN, 2011, AIDS RES HUM RETROV, V27, P1213, DOI [10.1089/aid.2010.0321, 10.1089/AID.2010.0321]; Wilen CB, 2012, ADV EXP MED BIOL, V726, P223, DOI 10.1007/978-1-4614-0980-9_10; Wu Z, 2013, J PHYS CHEM B, V117, P12145, DOI 10.1021/jp4068729; Wyss S, 2005, J VIROL, V79, P12231, DOI 10.1128/JVI.79.19.12231-12241.2005; YANG CL, 1995, P NATL ACAD SCI USA, V92, P9871, DOI 10.1073/pnas.92.21.9871; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Zhu Y, 2007, CHEM BIOL DRUG DES, V70, P311, DOI 10.1111/j.1747-0285.2007.00564.x	58	7	8	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7630	7640		10.1074/jbc.M113.529339	http://dx.doi.org/10.1074/jbc.M113.529339			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24497632	Green Published, hybrid			2022-12-28	WOS:000332761500032
J	Ichikawa, M; Scott, DA; Losfeld, ME; Freeze, HH				Ichikawa, Mie; Scott, David A.; Losfeld, Marie-Estelle; Freeze, Hudson H.			The Metabolic Origins of Mannose in Glycoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						GC-MS; Genetic Diseases; Glucose Metabolism; Glycoconjugate; Metabolic Tracers	PHOSPHOMANNOSE ISOMERASE DEFICIENCY; N-GLYCOSYLATION; GLYCOGEN-PHOSPHORYLASE; MASS-SPECTROMETRY; CARBOHYDRATE; FIBROBLASTS; THERAPY; GLUCOSE; ACTIVATION; CORRECTS	Background: Metabolic origins of mannose in glycoproteins have not been studied. Results: Glucose is the major source of N-glycan mannose, but exogenous mannose provides up to 50%. Man salvaged from glycoprotein turnover, glycogen, and gluconeogenesis is insignificant. Conclusion: Exogenous mannose is incorporated into N-glycans much more efficiently than that derived from glucose. Significance: This study provides quantitation of metabolic origins of Man in N-glycans. Mannose in N-glycans is derived from glucose through phosphomannose isomerase (MPI, Fru-6-P Man-6-P) whose deficiency causes a congenital disorder of glycosylation (CDG)-Ib (MPI-CDG). Mannose supplements improve patients' symptoms because exogenous mannose can also directly contribute to N-glycan synthesis through Man-6-P. However, the quantitative contributions of these and other potential pathways to glycosylation are still unknown. We developed a sensitive GC-MS-based method using [1,2-C-13]glucose and [4-C-13]mannose to measure their contribution to N-glycans synthesized under physiological conditions (5 mm glucose and 50 m mannose). Mannose directly provides approximate to 10-45% of the mannose found in N-glycans, showing up to a 100-fold preference for mannose over exogenous glucose based on their exogenous concentrations. Normal human fibroblasts normally derive 25-30% of their mannose directly from exogenous mannose, whereas MPI-deficient CDG fibroblasts with reduced glucose flux secure 80% of their mannose directly. Thus, both MPI activity and exogenous mannose concentration determine the metabolic flux into the N-glycosylation pathway. Using various stable isotopes, we found that gluconeogenesis, glycogen, and mannose salvaged from glycoprotein degradation do not contribute mannose to N-glycans in fibroblasts under physiological conditions. This quantitative assessment of mannose contribution and its metabolic fate provides information that can help bolster therapeutic strategies for treating glycosylation disorders with exogenous mannose.	[Ichikawa, Mie; Losfeld, Marie-Estelle; Freeze, Hudson H.] Sanford Burnham Med Res Inst, Human Genet Program, La Jolla, CA 92037 USA; [Scott, David A.] Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute	Freeze, HH (corresponding author), Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hudson@sanfordburnham.org		Scott, David/0000-0002-8668-2449; Freeze, Hudson/0000-0001-6316-0501	Rocket Fund; National Institutes of Health [R01DK55615]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055615] Funding Source: NIH RePORTER	Rocket Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by The Rocket Fund and by National Institutes of Health Grant R01DK55615 (to H. H. F).	Gill A, 2002, J BIOL CHEM, V277, P44747, DOI 10.1074/jbc.M205001200; Grempler R, 2012, FEBS LETT, V586, P248, DOI 10.1016/j.febslet.2011.12.027; Halket JM, 2003, EUR J MASS SPECTROM, V9, P1, DOI 10.1255/ejms.527; Harms HK, 2002, ACTA PAEDIATR, V91, P1065, DOI 10.1080/080352502760311566; Kjaergaard S, 1998, ACTA PAEDIATR, V87, P884, DOI 10.1080/080352598750013680; Lehrman MA, 2006, CRIT REV BIOCHEM MOL, V41, P51, DOI 10.1080/10409230500542575; Malaisse WJ, 2004, ENDOCRINE, V24, P105, DOI 10.1385/ENDO:24:2:105; Mayatepek E, 1998, EUR J PEDIATR, V157, P605, DOI 10.1007/s004310050889; McMahon RJ, 1996, AM J PHYSIOL-ENDOC M, V270, pE640, DOI 10.1152/ajpendo.1996.270.4.E640; MOORE SEH, 1995, EMBO J, V14, P6034, DOI 10.1002/j.1460-2075.1995.tb00292.x; Nakajima K, 2013, MOL CELL PROTEOMICS, V12, P2468, DOI 10.1074/mcp.M112.027151; Nanchen Annik, 2007, V358, P177, DOI 10.1007/978-1-59745-244-1_11; Niehues R, 1998, J CLIN INVEST, V101, P1414, DOI 10.1172/JCI2350; Panneerselvam K, 1996, J CLIN INVEST, V97, P1478, DOI 10.1172/JCI118570; Panneerselvam K, 1997, J BIOL CHEM, V272, P23123, DOI 10.1074/jbc.272.37.23123; PASSONNEAU JV, 1974, ANAL BIOCHEM, V60, P405, DOI 10.1016/0003-2697(74)90248-6; Portnoy VA, 2010, APPL ENVIRON MICROB, V76, P6529, DOI 10.1128/AEM.01178-10; Price NPJ, 2004, ANAL CHEM, V76, P6566, DOI 10.1021/ac049198m; ROSE IA, 1973, J BIOL CHEM, V248, P2232; Schneider A, 2012, NAT MED, V18, P71, DOI 10.1038/nm.2548; Scott DA, 2011, J BIOL CHEM, V286, P42626, DOI 10.1074/jbc.M111.282046; Shang J, 2004, J BIOL CHEM, V279, P12076, DOI 10.1074/jbc.M400431200; Sharma V, 2011, J BIOL CHEM, V286, P39431, DOI 10.1074/jbc.M111.285502; Sharma V, 2011, J BIOL CHEM, V286, P10193, DOI 10.1074/jbc.M110.194241; Sickmann HM, 2005, NEUROCHEM RES, V30, P1295, DOI 10.1007/s11064-005-8801-4; van Winden WA, 2002, BIOTECHNOL BIOENG, V80, P477, DOI 10.1002/bit.10393	26	42	42	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6751	6761		10.1074/jbc.M113.544064	http://dx.doi.org/10.1074/jbc.M113.544064			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24407290	Green Published, hybrid			2022-12-28	WOS:000332389400036
J	Desai, SS; Modali, SD; Parekh, VI; Kebebew, E; Agarwal, SK				Desai, Shruti S.; Modali, Sita D.; Parekh, Vaishali I.; Kebebew, Electron; Agarwal, Sunita K.			GSK-3 beta Protein Phosphorylates and Stabilizes HLXB9 Protein in Insulinoma Cells to Form a Targetable Mechanism of Controlling Insulinoma Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Differentiation; Neuroendocrinology; Pancreatic Islets; Proliferation; Tumor; GSK-3; HLXB9; Insulinoma; MEN1; Menin	MULTIPLE-ENDOCRINE-NEOPLASIA; GLYCOGEN-SYNTHASE KINASE-3-BETA; MOLECULAR PATHOGENESIS; TYPE-1; MENIN; GENE; EXPRESSION; INACTIVATION; SUPPRESSION; PANCREAS	Background: Germ line heterozygous loss of the MEN1 tumor suppressor gene causes tissue-specific tumors such as insulinomas. Results: GSK-3 and GSK-3-mediated phosphorylation of HLXB9, a -cell differentiation factor, is elevated in insulinomas, and GSK-3 inhibition blocks insulinoma cell proliferation. Conclusion: GSK-3 and phospho-HLXB9 form a targetable mechanism of insulinoma pathogenesis. Significance: Reactivation of a tissue-specific differentiation factor accounts for tumor tissue specificity. Insulinomas (pancreatic islet cell tumors) are the most common type of functioning pancreatic neuroendocrine tumors that occur sporadically or as a part of the MEN1 syndrome that is caused by germ line mutations in MEN1. Tissue-specific tumor predisposition from germ line mutations in ubiquitously expressed genes such as MEN1 could occur because of functional consequences on tissue-specific factors. We previously reported the proapoptotic cell differentiation factor HLXB9 as a downstream target of menin (encoded by MEN1). Here we show that GSK-3 inactivates the proapoptotic activity of HLXB9 by phosphorylating HLXB9 at Ser-78/Ser-80 (pHLXB9). Although HLXB9 is found in the nucleus and cytoplasm, pHLXB9 is predominantly nuclear. Both pHLXB9 and active GSK-3 are elevated in cells with menin knockdown, in MEN1-associated cell tumors (insulinomas), and also in human sporadic insulinomas. Pharmacologic inhibition of GSK-3 blocked cell proliferation in three different rodent insulinoma cell lines by arresting the cells in G(2)/M phase and caused apoptosis. Taken together, these data suggest that the combination of GSK-3 and pHLXB9 forms a therapeutically targetable mechanism of insulinoma pathogenesis. Our results reveal that GSK-3 and pHLXB9 can serve as novel targets for insulinoma treatment and have implications for understanding the pathways associated with cell proliferation.	[Desai, Shruti S.; Modali, Sita D.; Parekh, Vaishali I.; Agarwal, Sunita K.] NIDDK, Metab Dis Branch, NIH, Bethesda, MD 20892 USA; [Kebebew, Electron] NCI, Endocrine Oncol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Agarwal, SK (corresponding author), NIH, Bldg 10,Rm 8C-101, Bethesda, MD 20892 USA.	sunitaa@mail.nih.gov	Agarwal, Sunita K/D-1428-2016	Agarwal, Sunita K/0000-0002-7557-3191; Desai, Shruti/0000-0002-5234-5890	NIDDK, National Institutes of Health [1ZIADK07503503]; NCI, National Institutes of Health [1ZIABC01127503]; NATIONAL CANCER INSTITUTE [ZIABC011286, ZIABC011275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075085] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK, National Institutes of Health Intramural Program Grant 1ZIADK07503503 (to S. K. A.) and NCI, National Institutes of Health Grant 1ZIABC01127503 (to E. K.).	Agarwal SK, 2013, FRONT HORM RES, V41, P1, DOI 10.1159/000345666; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Cao Q, 2006, CELL RES, V16, P671, DOI 10.1038/sj.cr.7310078; Chen G, 2008, MOL CANCER RES, V6, P1894, DOI 10.1158/1541-7786.MCR-07-2206; Crabtree JS, 2001, P NATL ACAD SCI USA, V98, P1118, DOI 10.1073/pnas.98.3.1118; Culbert AA, 2001, FEBS LETT, V507, P288, DOI 10.1016/S0014-5793(01)02990-8; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Geddes JR, 2004, AM J PSYCHIAT, V161, P217, DOI 10.1176/appi.ajp.161.2.217; Greenblatt DY, 2010, AM J TRANSL RES, V2, P248; Guru SC, 1998, P NATL ACAD SCI USA, V95, P1630, DOI 10.1073/pnas.95.4.1630; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrison KA, 1999, NAT GENET, V23, P71, DOI 10.1038/12674; HARRISON KA, 1994, J BIOL CHEM, V269, P19968; Jensen RI, 2008, CANCER-AM CANCER SOC, V113, P1807, DOI 10.1002/cncr.23648; Jiao YC, 2011, SCIENCE, V331, P1199, DOI 10.1126/science.1200609; Kaidanovich-Beilin O, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00040; Kunnimalaiyaan M, 2007, MOL CANCER THER, V6, P1151, DOI 10.1158/1535-7163.MCT-06-0665; Li H, 2001, DEV BIOL, V240, P247, DOI 10.1006/dbio.2001.0440; Li H, 1999, NAT GENET, V23, P67; Lu JL, 2010, GASTROENTEROLOGY, V138, P1954, DOI 10.1053/j.gastro.2010.01.046; Marx SJ, 2005, NAT REV CANCER, V5, P367, DOI 10.1038/nrc1610; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; O'Dowd JF, 2009, METHODS MOL BIOL, V560, P37, DOI 10.1007/978-1-59745-448-3_3; Oberg K, 2013, CLIN CANCER RES, V19, P2842, DOI 10.1158/1078-0432.CCR-12-3458; Ojeda L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023414; Piret SE, 2011, J ENDOCRINOL, V211, P211, DOI 10.1530/JOE-11-0193; Rocques N, 2007, MOL CELL, V28, P584, DOI 10.1016/j.molcel.2007.11.009; Rulifson IC, 2007, P NATL ACAD SCI USA, V104, P6247, DOI 10.1073/pnas.0701509104; Scacheri PC, 2004, MAMM GENOME, V15, P872, DOI 10.1007/s00335-004-2395-z; Scacheri PC, 2006, PLOS GENET, V2, P406, DOI 10.1371/journal.pgen.0020051; Semache M, 2013, J BIOL CHEM, V288, P24825, DOI 10.1074/jbc.M113.495945; Shen HCJ, 2010, ENDOCRINOLOGY, V151, P4024, DOI 10.1210/en.2009-1251; Shen HCJ, 2009, CANCER RES, V69, P1858, DOI 10.1158/0008-5472.CAN-08-3662; Shi K, 2013, ENDOCR-RELAT CANCER, V20, P111, DOI 10.1530/ERC-12-0077; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Sukhodolets KE, 2003, MOL CELL BIOL, V23, P493, DOI 10.1128/MCB.23.2.493-509.2003; Sutherland C, 2011, INT J ALZHEIMERS DIS; Thakker RV, 2012, J CLIN ENDOCR METAB, V97, P2990, DOI 10.1210/jc.2012-1230; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Zhuang ZP, 1997, CANCER RES, V57, P4682	40	13	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5386	5398		10.1074/jbc.M113.533612	http://dx.doi.org/10.1074/jbc.M113.533612			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24425879	Green Published, hybrid			2022-12-28	WOS:000332015500004
J	Liang, T; Xie, L; Chao, C; Kang, YH; Lin, XG; Qin, TR; Xie, HL; Feng, ZP; Gaisano, HY				Liang, Tao; Xie, Li; Chao, Christin; Kang, Youhou; Lin, Xianguang; Qin, Tairan; Xie, Huanli; Feng, Zhong-Ping; Gaisano, Herbert Y.			Phosphatidylinositol 4,5-Biphosphate (PIP2) Modulates Interaction of Syntaxin-1A with Sulfonylurea Receptor 1 to Regulate Pancreatic beta-Cell ATP-sensitive Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Insulin Secretion; Phospholipid; Plasma Membrane; Potassium Channels; SNARE Proteins; ATP-sensitive Potassium Channel; Kir6; 2; PIP2; SUR1; Syntaxin-1A	NUCLEOTIDE-BINDING FOLDS; INSULIN-SECRETION; MEMBRANE-FUSION; PLASMA-MEMBRANE; K+ CHANNELS; PHOSPHOINOSITIDES; 4,5-BISPHOSPHATE; PROTEINS; TRAFFICKING; CHOLESTEROL	In beta-cells, syntaxin (Syn)-1A interacts with SUR1 to inhibit ATP-sensitive potassium channels (K-ATP channels). PIP2 binds the Kir6.2 subunit to open K-ATP channels. PIP2 also modifies Syn-1A clustering in plasma membrane (PM) that may alter Syn-1A actions on PM proteins like SUR1. Here, we assessed whether the actions of PIP2 on activating K-ATP channels is contributed by sequestering Syn-1A from binding SUR1. In vitro binding showed that PIP2 dose-dependently disrupted Syn-1A center dot SUR1 complexes, corroborated by an in vivo Forster resonance energy transfer assay showing disruption of SUR1(-EGFP)/Syn-1A(-mCherry) interaction along with increased Syn-1A cluster formation. Electrophysiological studies of rat beta-cells, INS-1, and SUR1/Kir6.2-expressing HEK293 cells showed that PIP2 dose-dependent activation of K-ATP currents was uniformly reduced by Syn-1A. To unequivocally distinguish between PIP2 actions on Syn-1A and Kir6.2, we employed several strategies. First, we showed that PIP2-insensitive Syn-1A-5RK/A mutant complex with SUR1 could not be disrupted by PIP2, consequently reducing PIP2 activation of K-ATP channels. Next, Syn-1A center dot SUR1 complex modulation of K-ATP channels could be observed at a physiologically low PIP2 concentration that did not disrupt the Syn-1A center dot SUR1 complex, compared with higher PIP2 concentrations acting directly on Kir6.2. These effects were specific to PIP2 and not observed with physiologic concentrations of other phospholipids. Finally, depleting endogenous PIP2 with polyphosphoinositide phosphatase synaptojanin-1, known to disperse Syn-1A clusters, freed Syn-1A from Syn-1A clusters to bind SUR1, causing inhibition of K-ATP channels that could no longer be further inhibited by exogenous Syn-1A. These results taken together indicate that PIP2 affects islet beta-cell K-ATP channels not only by its actions on Kir6.2 but also by sequestering Syn-1A to modulate Syn-1A availability and its interactions with SUR1 on PM.	[Liang, Tao; Xie, Li; Chao, Christin; Kang, Youhou; Lin, Xianguang; Qin, Tairan; Xie, Huanli; Gaisano, Herbert Y.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Chao, Christin; Feng, Zhong-Ping; Gaisano, Herbert Y.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Gaisano, HY (corresponding author), Univ Toronto, 1 Kings Coll Circle,Rm 7368, Toronto, ON M5S 1A8, Canada.	herbert.gaisano@utoronto.ca			Canadian Institutes of Health Research [MOP 69083]; Canadian Foundation for Innovation; Ontario Research Fund [19442]; Canadian Diabetes Association	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Research Fund; Canadian Diabetes Association	This work was supported by Canadian Institutes of Health Research Grant MOP 69083 (to H. Y. G.) and by an equipment grant to the 3D (Diet, Digestive Tract, and Disease) Centre from the Canadian Foundation for Innovation and Ontario Research Fund (Project 19442).; Supported by a fellowship from the Canadian Diabetes Association.	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Aittoniemi J, 2009, PHILOS T R SOC B, V364, P257, DOI 10.1098/rstb.2008.0142; Ashcroft FM, 1999, DIABETOLOGIA, V42, P903, DOI 10.1007/s001250051247; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Chang N, 2011, J BIOL CHEM, V286, P23308, DOI 10.1074/jbc.M111.217950; Chao C, 2011, J MOL CELL CARDIOL, V51, P790, DOI 10.1016/j.yjmcc.2011.08.011; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chung SH, 1998, J BIOL CHEM, V273, P10240, DOI 10.1074/jbc.273.17.10240; Cremona O, 2001, J CELL SCI, V114, P1041; Cui NG, 2004, J BIOL CHEM, V279, P53259, DOI 10.1074/jbc.M410171200; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; Enkvetchakul D, 2000, BIOPHYS J, V78, P2334, DOI 10.1016/S0006-3495(00)76779-8; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; Haider S, 2007, EMBO J, V26, P3749, DOI 10.1038/sj.emboj.7601809; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hou JCQ, 2009, VITAM HORM, V80, P473, DOI 10.1016/S0083-6729(08)00616-X; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Kang YH, 2004, J BIOL CHEM, V279, P47125, DOI 10.1074/jbc.M404954200; Kwiatkowska K, 2010, CELL MOL LIFE SCI, V67, P3927, DOI 10.1007/s00018-010-0432-5; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Leung YM, 2003, J BIOL CHEM, V278, P17532, DOI 10.1074/jbc.M213088200; Leung YM, 2007, ENDOCR REV, V28, P653, DOI 10.1210/er.2007-0010; Lin CW, 2005, DIABETES, V54, P2852, DOI 10.2337/diabetes.54.10.2852; Lin YW, 2003, J GEN PHYSIOL, V122, P225, DOI 10.1085/jgp.200308822; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Murray DH, 2011, BIOCHEMISTRY-US, V50, P9014, DOI 10.1021/bi201307u; Murray DH, 2009, BIOCHEMISTRY-US, V48, P4617, DOI 10.1021/bi9003217; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Olsen HL, 2003, P NATL ACAD SCI USA, V100, P5187, DOI 10.1073/pnas.0931282100; Ostenson CG, 2006, DIABETES, V55, P435, DOI 10.2337/diabetes.55.02.06.db04-1575; Pasyk EA, 2004, J BIOL CHEM, V279, P4234, DOI 10.1074/jbc.M309667200; Pratt EB, 2011, J GEN PHYSIOL, V137, P299, DOI 10.1085/jgp.201010557; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Stansfeld PJ, 2009, BIOCHEMISTRY-US, V48, P10926, DOI 10.1021/bi9013193; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545	39	7	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6028	6040		10.1074/jbc.M113.511808	http://dx.doi.org/10.1074/jbc.M113.511808			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24429282	Green Published, hybrid			2022-12-28	WOS:000332015500058
J	Kabekkodu, SP; Bhat, S; Radhakrishnan, R; Aithal, A; Mascarenhas, R; Pandey, D; Rai, L; Kushtagi, P; Mundyat, GP; Satyamoorthy, K				Kabekkodu, Shama Prasada; Bhat, Samatha; Radhakrishnan, Raghu; Aithal, Abhijit; Mascarenhas, Roshan; Pandey, Deeksha; Rai, Lavanya; Kushtagi, Pralhad; Mundyat, Gopinath Puthiya; Satyamoorthy, Kapaettu			DNA Promoter Methylation-dependent Transcription of the Double C2-like Domain beta( DOC2B) Gene Regulates Tumor Growth in Human Cervical Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Cell Growth; Cell Invasion; Cell Motility; ERK; DNA Promoter Methylation; DOC2B; Human Papillomavirus; Actin Remodeling; Cervical Cancer	ACTIVATED PROTEIN-KINASE; CELL MOTILITY; ACTIN ORGANIZATION; EPIGENETIC THERAPY; SUPPRESSOR GENE; FASCIN; PHOSPHORYLATION; IDENTIFICATION; EXPRESSION; FILOPODIA	Background:DOC2B promoter hypermethylation is an early and frequent event in cervical cancer. Results:DOC2B hypermethylation induces transcriptional repression, reactivated by demethylation; ectopic expression increases Ca2+ flux and inhibits key characteristics of tumorigenesis including proliferation, motility, and invasion. Conclusion:DOC2B gene is epigenetically regulated and inhibits cervical cancer growth. Significance: DNA methylation regulates DOC2B gene expression in cervical cancer. Double C2-like domain (DOC2B) gene encodes for a calcium-binding protein, which is involved in neurotransmitter release, sorting, and exocytosis. We have identified the promoter region of the DOC2B gene as hypermethylated in pre-malignant, malignant cervical tissues, and cervical cancer cell lines by methylation-sensitive dimethyl sulfoxide-polymerase chain reaction and bisulfite genome sequencing; whereas, it was unmethylated in normal cervical tissues (p < 0.05). The promoter hypermethylation was inversely associated with mRNA expression in SiHa, CaSki, and HeLa cells and treatment with demethylating agent 5-aza-2-deoxycytidine restored DOC2B expression. The region -630 to +25 bp of the DOC2B gene showed robust promoter activity by a luciferase reporter assay and was inhibited by in vitro artificial methylation with Sss1 methylase prior to transient transfections. Overexpression of the DOC2B gene in SiHa cells when compared with controls showed significantly reduced colony formation, cell proliferation, induced cell cycle arrest, and repressed cell migration and invasion (p < 0.05). Ectopic expression of DOC2B resulted in anoikis-mediated cell death and repressed tumor growth in a nude mice xenograft model (p < 0.05). DOC2B expressing cells showed a significant increase in intracellular calcium level (p < 0.05), impaired AKT1 and ERK1/2 signaling, and induced actin cytoskeleton remodeling. Our results show that promoter hypermethylation and silencing of the DOC2B gene is an early and frequent event during cervical carcinogenesis and whose reduced expression due to DNA promoter methylation may lead to selective cervical tumor growth.	[Kabekkodu, Shama Prasada; Bhat, Samatha; Radhakrishnan, Raghu; Aithal, Abhijit; Mascarenhas, Roshan; Mundyat, Gopinath Puthiya; Satyamoorthy, Kapaettu] Manipal Univ, Manipal Life Sci Ctr, Div Biotechnol, Manipal 576104, Karnataka, India; [Pandey, Deeksha; Rai, Lavanya] Manipal Univ, Kasturba Med Coll, Dept OBGYN, Manipal 576104, Karnataka, India; [Kushtagi, Pralhad] Manipal Univ, Dept OBGYN, Kasturba Med Coll, Mangalore 575001, India	Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Mangalore	Satyamoorthy, K (corresponding author), Manipal Univ, Manipal Life Sci Ctr, Div Biotechnol, Manipal 576104, Karnataka, India.	ksatyamoorthy@manipal.edu	Satyamoorthy, Kapaettu/H-3254-2015; Aithal, Abhijit/AAR-9856-2021; kabekkodu, Shama Prasada/Q-2810-2018; Radhakrishnan, Raghu/P-1685-2015; Kabekkodu, Shama Prasada/AAD-2947-2021	Radhakrishnan, Raghu/0000-0003-0088-4777; Kabekkodu, Shama Prasada/0000-0002-4158-3893; rai, lavanya/0000-0003-3912-584X; Satyamoorthy, Kapaettu/0000-0002-2368-5490; Kushtagi, Pralhad/0000-0002-5815-9001; Aithal, Abhijit/0000-0001-9035-7529	TIFAC-CORE, Government of India; Indian Council of Medical Research, Government of India; Manipal University	TIFAC-CORE, Government of India; Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR)); Manipal University	This work was supported by grants from TIFAC-CORE, Government of India, the Indian Council of Medical Research, Government of India, and the Manipal University.	Balanathan P, 2004, J MOL ENDOCRINOL, V32, P55, DOI 10.1677/jme.0.0320055; Cohan CS, 2001, CELL MOTIL CYTOSKEL, V48, P109, DOI 10.1002/1097-0169(200102)48:2<109::AID-CM1002>3.0.CO;2-G; Duenas-Gonzalez A, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-38; Duncan RR, 2000, BIOCHIMIE, V82, P421, DOI 10.1016/S0300-9084(00)00214-5; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Estecio MRH, 2006, ONCOGENE, V25, P5018, DOI 10.1038/sj.onc.1209509; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Evans MF, 2005, BMC CLIN PATHOL, V5, DOI 10.1186/1472-6890-5-10; Flanagan JM, 2007, BRIT J CANCER, V96, P183, DOI 10.1038/sj.bjc.6603516; Fukuda N, 2009, DIABETES, V58, P377, DOI 10.2337/db08-0303; Gonzalgo ML, 1997, CANCER RES, V57, P594; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Groffen AJ, 2010, SCIENCE, V327, P1614, DOI 10.1126/science.1183765; Guenin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042704; Han MY, 2007, MOL CELL BIOL, V27, P8190, DOI 10.1128/MCB.00661-07; Haraguchi M, 2008, J BIOL CHEM, V283, P23514, DOI 10.1074/jbc.M801125200; Hu XT, 2013, J PATHOL, V229, P62, DOI 10.1002/path.4093; Janji B, 2006, J CELL SCI, V119, P1947, DOI 10.1242/jcs.02874; June Carl H, 2004, Curr Protoc Immunol, VChapter 5, DOI 10.1002/0471142735.im0505s64; Kaneda A, 2004, CANCER RES, V64, P6410, DOI 10.1158/0008-5472.CAN-04-1543; Ke B, 2007, J BIOL CHEM, V282, P21786, DOI 10.1074/jbc.M701661200; Kholod N, 2007, J MOL DIAGN, V9, P574, DOI 10.2353/jmoldx.2007.070025; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Lai HC, 2008, INT J CANCER, V123, P161, DOI 10.1002/ijc.23519; Malkinson G, 2006, CELL CALCIUM, V39, P85, DOI 10.1016/j.ceca.2005.10.007; McMahon HT, 2010, CELL, V140, P601, DOI 10.1016/j.cell.2010.02.017; ORITA S, 1995, BIOCHEM BIOPH RES CO, V206, P439, DOI 10.1006/bbrc.1995.1062; Sakaguchi G, 1995, BIOCHEM BIOPH RES CO, V217, P1053, DOI 10.1006/bbrc.1995.2876; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Uozaki H, 2008, INT J CLIN EXP PATHO, V1, P198; Vial E, 2004, ANN NY ACAD SCI, V1030, P208, DOI 10.1196/annals.1329.027; Wiggins HL, 2010, BIOTECHNIQUES, V48, P120, DOI 10.2144/000113353; Xu N, 2012, J BIOL CHEM, V287, P29899, DOI 10.1074/jbc.M112.391243; Yamakita Y, 1996, J BIOL CHEM, V271, P12632, DOI 10.1074/jbc.271.21.12632; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Yu J, 2010, ONCOGENE, V29, P6464, DOI 10.1038/onc.2010.370; Zanet J, 2012, J CELL BIOL, V197, P477, DOI 10.1083/jcb.201110135	39	29	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10637	10649		10.1074/jbc.M113.491506	http://dx.doi.org/10.1074/jbc.M113.491506			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24570007	Green Published, hybrid			2022-12-28	WOS:000334226400034
J	Mori, Y; Saito, T; Chang, SH; Kobayashi, H; Ladel, CH; Guehring, H; Chung, UI; Kawaguchi, H				Mori, Yoshifumi; Saito, Taku; Chang, Song Ho; Kobayashi, Hiroshi; Ladel, Christoph H.; Guehring, Hans; Chung, Ung-il; Kawaguchi, Hiroshi			Identification of Fibroblast Growth Factor-18 as a Molecule to Protect Adult Articular Cartilage by Gene Expression Profiling*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cartilage; Chondrocytes; Fibroblast Growth Factor (FGF); Microarray; Osteoarthritis; Regeneration	CELL-SPECIFIC MOLECULE-1; MATRIX METALLOPROTEINASE-13; OSTEOGENIC PROTEIN-1; TISSUE INHIBITORS; FACTOR (FGF)-18; REPAIR; CHONDROCYTES; DEFECTS; CHONDROGENESIS; FIBROBLAST-GROWTH-FACTOR-18	Background: Prevention of adult articular cartilage and treatment of its lesions are essential. Results: Microarray analyses identified Fgf18, which inhibits aggrecan release from cartilage and enhances proliferation of chondrocytes. The intra-articular injection of rhFGF18 prevented cartilage degeneration in a rat osteoarthritis model. Conclusion: Fgf18 protects adult articular cartilage through Timp1 expression. Significance: Fgf18 may represent a therapeutic agent for osteoarthritis. To identify genes that maintain the homeostasis of adult articular cartilage and regenerate its lesions, we initially compared four types of chondrocytes: articular (AA) versus growth plate (AG) cartilage chondrocytes in adult rats, and superficial layer (IS) versus deep layer (ID) chondrocytes of epiphyseal cartilage in infant rats. Microarray analyses revealed that 40 and 186 genes had 10-fold higher expression ratios of AA/AG and IS/ID, respectively, and 16 genes showed 10-fold of both AA/AG and IS/ID ratios. The results were validated by real-time RT-PCR analysis. Among them, Hoxd1, Fgf18, and Esm1 were expressed more strongly in AA than in IS. Fgf18 was the extracellular and secreted factor that decreased glycosaminoglycan release and depletion from the cartilage, and enhanced proliferation of articular chondrocytes. Fgf18 was strongly expressed in the articular cartilage chondrocytes of adult rats. In a surgical rat osteoarthritis model, a once-weekly injection of recombinant human FGF18 (rhFGF18) given 3 weeks after surgery prevented cartilage degeneration in a dose-dependent manner at 6 and 9 weeks after surgery, with significant effect at 10 g/week of rhFGF18. As the underlying mechanism, rhFGF18 strongly up-regulated Timp1 expression in the cell and organ cultures, and inhibition of aggrecan release by rhFGF18 was restored by addition of an antibody to Timp1. In conclusion, we have identified Fgf18 as a molecule that protects articular cartilage by gene expression profiling, and the anticatabolic effects may at least partially be mediated by the Timp1 expression.	[Mori, Yoshifumi; Saito, Taku; Chang, Song Ho; Kobayashi, Hiroshi; Kawaguchi, Hiroshi] Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1138655, Japan; [Chung, Ung-il] Univ Tokyo, Ctr Dis Biol & Integrat Med, Fac Med, Bunkyo Ku, Tokyo 1138655, Japan; [Ladel, Christoph H.; Guehring, Hans] Merck KGaA, Merck Serono Res, D-64293 Darmstadt, Germany	University of Tokyo; University of Tokyo; Merck KGaA; EMD Serono Inc.	Kawaguchi, H (corresponding author), Univ Tokyo, Fac Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kawaguchi0126@gmail.com	Ladel, Christoph/ABG-3165-2021	Ladel, Christoph/0000-0001-8657-6219	Japanese Ministry of Education, Culture, Sports, Science and Technology [19109007, 23689065]; Merck Serono S.A.; Geneva, Switzerland; Grants-in-Aid for Scientific Research [25293316] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Merck Serono S.A.; Geneva, Switzerland; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The gene expression profiling study was supported by Grants-in-aid for Scientific Research 19109007 and 23689065 from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The rat osteoarthritis study was sponsored by Merck Serono S.A., Geneva, Switzerland (a branch of Merck Serono S.A., Coinsins, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany). rhFGF18 (INN: sprifermin) is in clinical development and is not currently approved by any regulatory authority, including the European Medicines Agency (EMA) or the US Food and Drug Administration (FDA). C. H. L. and H. G. are employees of Merck KGaA.	Agah A., 2002, AM J PATHOL, V161, P831; Bechard D, 2000, J VASC RES, V37, P417, DOI 10.1159/000025758; Bornstein P, 2004, INT J BIOCHEM CELL B, V36, P1115, DOI 10.1016/j.biocel.2004.01.012; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Church V, 2005, ANAT EMBRYOL, V209, P461, DOI 10.1007/s00429-005-0464-z; CUEVAS P, 1988, BIOCHEM BIOPH RES CO, V156, P611, DOI 10.1016/S0006-291X(88)80887-8; Darling EM, 2003, TISSUE ENG, V9, P9, DOI 10.1089/107632703762687492; Davidson D, 2005, J BIOL CHEM, V280, P20509, DOI 10.1074/jbc.M410148200; Ellsworth JL, 2002, OSTEOARTHR CARTILAGE, V10, P308, DOI 10.1053/joca.2002.0514; Farr J, 2011, CLIN ORTHOP RELAT R, V469, P2696, DOI 10.1007/s11999-010-1764-z; Frenkel SR, 2000, PLAST RECONSTR SURG, V105, P980, DOI 10.1097/00006534-200003000-00022; Gerwin N, 2010, OSTEOARTHR CARTILAGE, V18, pS24, DOI 10.1016/j.joca.2010.05.030; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Hissnauer TN, 2010, OSTEOARTHR CARTILAGE, V18, P1630, DOI 10.1016/j.joca.2010.10.002; Hunziker EB, 2001, OSTEOARTHR CARTILAGE, V9, P22, DOI 10.1053/joca.2000.0346; Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159; Im HJ, 2007, J BIOL CHEM, V282, P11110, DOI 10.1074/jbc.M609040200; Jelic M, 2001, GROWTH FACTORS, V19, P101, DOI 10.3109/08977190109001079; Kevorkian L, 2004, ARTHRITIS RHEUM-US, V50, P131, DOI 10.1002/art.11433; Koyama E, 2008, DEV BIOL, V316, P62, DOI 10.1016/j.ydbio.2008.01.012; Leijten JCH, 2012, ARTHRITIS RHEUM-US, V64, P3302, DOI 10.1002/art.34535; Liu ZH, 2002, GENE DEV, V16, P859, DOI 10.1101/gad.965602; Louwerse RT, 2000, J BIOMED MATER RES, V49, P506, DOI 10.1002/(SICI)1097-4636(20000315)49:4<506::AID-JBM9>3.0.CO;2-A; Moore EE, 2005, OSTEOARTHR CARTILAGE, V13, P623, DOI 10.1016/j.joca.2005.03.003; Muddasani P, 2007, J BIOL CHEM, V282, P31409, DOI 10.1074/jbc.M706508200; Murphy G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-233; Nixon AJ, 1999, J ORTHOPAED RES, V17, P475, DOI 10.1002/jor.1100170404; Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702; Rajeevan MS, 2001, J MOL DIAGN, V3, P26, DOI 10.1016/S1525-1578(10)60646-0; Rhee DK, 2005, J CLIN INVEST, V115, P622, DOI 10.1172/JCI200522263; Rountree RB, 2004, PLOS BIOL, V2, P1815, DOI 10.1371/journal.pbio.0020355; Sarrazin S, 2006, BBA-REV CANCER, V1765, P25, DOI 10.1016/j.bbcan.2005.08.004; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; SCHUMACHER BL, 1994, ARCH BIOCHEM BIOPHYS, V311, P144, DOI 10.1006/abbi.1994.1219; Shimoaka T, 2002, J BIOL CHEM, V277, P7493, DOI 10.1074/jbc.M108653200; Stanton H, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.179; Tanaka H, 2004, TISSUE ENG, V10, P633, DOI 10.1089/107632704323061988; Wakitani S, 1997, ACTA ORTHOP SCAND, V68, P474, DOI 10.3109/17453679708996266; Whitsett JA, 2002, J BIOL CHEM, V277, P22743, DOI 10.1074/jbc.M202253200; Yamane S, 2007, TISSUE ENG, V13, P2163, DOI 10.1089/ten.2006.0431; Yan D, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3441	42	44	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10192	10200		10.1074/jbc.M113.524090	http://dx.doi.org/10.1074/jbc.M113.524090			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24577103	Green Published, hybrid			2022-12-28	WOS:000333807000064
J	Altonsy, MO; Sasse, SK; Phang, TL; Gerber, AN				Altonsy, Mohammed O.; Sasse, Sarah K.; Phang, Tzu L.; Gerber, Anthony N.			Context-dependent Cooperation between Nuclear Factor kappa B (NF-kappa B) and the Glucocorticoid Receptor at a TNFAIP3 Intronic Enhancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Immunoprecipitation (ChiP); Cooperativity; Glucocorticoid Receptor; NF-kappa B (NF-KB); Transcription Enhancers; TNFAIP3; Negative Feedback	CHROMATIN ACCESSIBILITY; GENE; MECHANISMS; ALPHA; A20; PHOSPHORYLATION; RECRUITMENT; REPRESSION; INHIBITOR; DYNAMICS	Background: The effects of glucocorticoids on the expression of negative feedback regulators of NF-B are not well understood. Results: A novel intronic enhancer for TNFAIP3 was synergistically induced by the glucocorticoid receptor and NF-B. Conclusion: The glucocorticoid receptor can cooperate with NF-B to enhance the expression of anti-inflammatory genes such as TNFAIP3. Significance: These results establish a novel mechanism for anti-inflammatory effects of glucocorticoids. TNF expression is elevated in asthma and other inflammatory airway diseases that are commonly treated with glucocorticoid-based therapies, but the impact of glucocorticoids on negative feedback control of TNF is not well understood. We analyzed the effect of dexamethasone, a potent synthetic glucocorticoid, on TNF-regulated gene expression in cultured airway epithelial cells. Although dexamethasone-mediated activation of the glucocorticoid receptor (GR) potently repressed expression of IL1, IL8, and several other pro-inflammatory TNF targets, the expression of anti-inflammatory TNF targets such as TNFAIP3 (A20) and NFKBIA was selectively spared or augmented by dexamethasone treatment. Despite divergent effects on gene expression, GR and NF-B occupancy at the TNFAIP3 locus and GR-repressed targets was similar. A co-occupied intronic TNFAIP3 regulatory element mediated cooperative enhancement of transcription by GR and NF-B that required the presence of a functional GR binding site (GBS). GBS exchanges between reporters for TNFAIP3 and FKBP5, a canonical GR-induced target, revealed substantial latitude in the GBS sequence requirements for GR/NF-B cooperation, suggesting that the TNFAIP3 GBS acts primarily as a docking site in this context. Supporting this notion, a selective GR ligand with only weak agonist activity for induction of FKBP5 enabled robust GR/NF-B cooperative induction of a mutant TNFAIP3 reporter harboring the FKBP5 GBS. Taken together, our data support a model in which the expression of anti-inflammatory targets of TNF is maintained during treatment with glucocorticoids through context-dependent cooperation between GR and NF-B.	[Altonsy, Mohammed O.; Sasse, Sarah K.; Gerber, Anthony N.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Altonsy, Mohammed O.] Sohag Univ, Dept Zool, Sohag 285224, Egypt; [Phang, Tzu L.; Gerber, Anthony N.] Univ Colorado, Dept Med, Denver, CO 80045 USA	National Jewish Health; Egyptian Knowledge Bank (EKB); Sohag University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Gerber, AN (corresponding author), Natl Jewish Hlth, Dept Med, Rm K621,1400 Jackson St, Denver, CO 80206 USA.	gerbera@njhealth.org			National Institutes of Health [R01HL109557]; National Jewish Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109557] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Jewish Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant R01HL109557 (to A. N. G.) and with institutional funds from National Jewish Health.	Bain DL, 2012, J MOL BIOL, V422, P18, DOI 10.1016/j.jmb.2012.06.005; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bungard CJ, 2011, BIOORGAN MED CHEM, V19, P7374, DOI 10.1016/j.bmc.2011.10.054; Chen WW, 2008, MOL ENDOCRINOL, V22, P1754, DOI 10.1210/me.2007-0219; Chinenov Y, 2012, P NATL ACAD SCI USA, V109, P11776, DOI 10.1073/pnas.1206059109; Clark AR, 2012, PHARMACOL THERAPEUT, V134, P54, DOI 10.1016/j.pharmthera.2011.12.004; Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308; De Bosscher K, 2008, EUR J PHARMACOL, V583, P290, DOI 10.1016/j.ejphar.2007.11.076; De Bosscher K, 2010, CURR OPIN PHARMACOL, V10, P497, DOI 10.1016/j.coph.2010.04.007; Flammer JR, 2011, MOL ENDOCRINOL, V25, P1075, DOI 10.1210/me.2011-0068; Galliher-Beckley AJ, 2008, MOL CELL BIOL, V28, P7309, DOI 10.1128/MCB.00808-08; Grontved L, 2013, EMBO J, V32, P1568, DOI 10.1038/emboj.2013.106; Hofmann TG, 2002, BIOL CHEM, V383, P1947, DOI 10.1515/BC.2002.219; Hu A., 2013, PLOS ONE, V8; Hubler TR, 2004, CELL STRESS CHAPERON, V9, P243, DOI 10.1379/CSC-32R.1; Hudson WH, 2013, NAT STRUCT MOL BIOL, V20, P53, DOI 10.1038/nsmb.2456; Joanny E, 2012, BRIT J PHARMACOL, V165, P1124, DOI 10.1111/j.1476-5381.2011.01574.x; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; King EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053936; Lannan EA, 2012, ENDOCRINOLOGY, V153, P3701, DOI 10.1210/en.2012-1020; Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; McMaster A, 2008, NAT CLIN PRACT ENDOC, V4, P91, DOI 10.1038/ncpendmet0745; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Morjaria Jaymin B, 2007, Expert Rev Respir Med, V1, P51, DOI 10.1586/17476348.1.1.51; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nicolaides NC, 2010, STEROIDS, V75, P1, DOI 10.1016/j.steroids.2009.09.002; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Rao NAS, 2011, GENOME RES, V21, P1404, DOI 10.1101/gr.118042.110; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Sasse SK, 2013, MOL CELL BIOL, V33, P2104, DOI 10.1128/MCB.01474-12; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; Surjit M, 2011, CELL, V145, P224, DOI 10.1016/j.cell.2011.03.027; Uhlenhaut NH, 2013, MOL CELL, V49, P158, DOI 10.1016/j.molcel.2012.10.013; Vandevyver S, 2013, ENDOCRINOLOGY, V154, P993, DOI 10.1210/en.2012-2045; Wang SK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003302; Wang YY, 2004, FEBS LETT, V576, P86, DOI 10.1016/j.febslet.2004.08.071; Weber A., 2010, SCI SIGNAL, V3; Webster JC, 2002, ENDOCRINOLOGY, V143, P3866, DOI 10.1210/en.2002-220188; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708	41	49	50	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8231	8239		10.1074/jbc.M113.545178	http://dx.doi.org/10.1074/jbc.M113.545178			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24500711	Green Published, hybrid			2022-12-28	WOS:000333157500018
J	Elias, BC; Mathew, S; Srichai, MB; Palamuttam, R; Bulus, N; Mernaugh, G; Singh, AB; Sanders, CR; Harris, RC; Pozzi, A; Zent, R				Elias, Bertha C.; Mathew, Sijo; Srichai, Manakan B.; Palamuttam, Riya; Bulus, Nada; Mernaugh, Glenda; Singh, Amar B.; Sanders, Charles R.; Harris, Raymond C.; Pozzi, Ambra; Zent, Roy			The Integrin beta 1 Subunit Regulates Paracellular Permeability of Kidney Proximal Tubule Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adherens Junction; E-cadherin; Epithelial Cell; Renal Physiology; Tight Junctions	TIGHT JUNCTIONS; E-CADHERIN; BRANCHING MORPHOGENESIS; EXTRACELLULAR-MATRIX; EPITHELIAL BARRIER; DOWN-REGULATION; EXPRESSION; NEPHRON; ACTIVATION; BETA-1-INTEGRIN	Background: Proximal tubule kidney epithelial cells differentiate into a loose epithelium by unknown mechanisms. Results: Deleting integrin 1 converts proximal tubule cells from a loose to a tight epithelium. Conclusion: Integrin 1 regulates the composition and function of tight and adherens junctions that define paracellular transport properties of proximal tubule epithelial cells. Significance: Integrins might regulate terminal differentiation of polarized epithelial cells. Epithelial cells lining the gastrointestinal tract and kidney have different abilities to facilitate paracellular and transcellular transport of water and solutes. In the kidney, the proximal tubule allows both transcellular and paracellular transport, while the collecting duct primarily facilitates transcellular transport. The claudins and E-cadherin are major structural and functional components regulating paracellular transport. In this study we present the novel finding that the transmembrane matrix receptors, integrins, play a role in regulating paracellular transport of renal proximal tubule cells. Deleting the integrin 1 subunit in these cells converts them from a loose epithelium, characterized by low expression of E-cadherin and claudin-7 and high expression of claudin-2, to a tight epithelium with increased E-cadherin and claudin-7 expression and decreased claudin-2 expression. This effect is mediated by the integrin 1 cytoplasmic tail and does not entail 1 heterodimerization with an -subunit or its localization to the cell surface. In addition, we demonstrate that deleting the 1 subunit in the proximal tubule of the kidney results in a major urine-concentrating defect. Thus, the integrin 1 tail plays a key role in regulating the composition and function of tight and adherens junctions that define paracellular transport properties of terminally differentiated renal proximal tubule epithelial cells.	[Elias, Bertha C.; Mathew, Sijo; Srichai, Manakan B.; Palamuttam, Riya; Bulus, Nada; Mernaugh, Glenda; Harris, Raymond C.; Pozzi, Ambra; Zent, Roy] Vanderbilt Univ, Sch Med, Dept Med, Div Nephrol & Hypertens, Nashville, TN 37232 USA; [Singh, Amar B.] Vanderbilt Univ, Sch Med, Dept Surg, Nashville, TN 37232 USA; [Sanders, Charles R.] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Pozzi, Ambra; Zent, Roy] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Zent, Roy] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Harris, Raymond C.; Pozzi, Ambra; Zent, Roy] Vet Affairs Hosp, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Zent, R (corresponding author), Vanderbilt Univ Sch Med, MCN, Room C3210, Nashville, TN 37232 USA.	roy.zent@vanderbilt.edu			VA Merit Review [1I01BX002025, 2I01BX000320, 1I01BX002196]; National Institutes of Health [R01-CA162433, R01-DK095761, R01-DK083187, R01-DK075594, R01-DK383069221, R01-DK51265, R01-DK62794, R01-DK95785, R01-DK088902]; NATIONAL CANCER INSTITUTE [R01CA162433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088902, R01DK075594, R01DK095761, R01DK095785, R01DK051265, R01DK083187, R01DK069921, R01DK062794] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000320, I01BX002025, I01BX002196] Funding Source: NIH RePORTER	VA Merit Review(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by VA Merit Review 1I01BX002025 (to A. P.), 2I01BX000320 (to R. C. H.), and 1I01BX002196 (to R. Z.); the National Institutes of Health Grants R01-CA162433 (to A. P.), R01-DK095761 (to A. P.), R01-DK083187 (to R. Z.), R01-DK075594 (to R. Z.), R01-DK383069221 (to R. Z.), R01-DK51265 (to R. C. H.), R01-DK62794 (to R. C. H.), R01-DK95785 (to R. C. H.), and R01-DK088902 (to A. B. S.).	Alexandre MD, 2005, J CELL SCI, V118, P2683, DOI 10.1242/jcs.02406; Basuroy S, 2003, J BIOL CHEM, V278, P11916, DOI 10.1074/jbc.M211710200; Bonegio RGB, 2011, KIDNEY INT, V79, P1099, DOI 10.1038/ki.2010.553; Boyle SC, 2011, DEVELOPMENT, V138, P4245, DOI 10.1242/dev.070433; Bruewer M, 2004, AM J PHYSIOL-CELL PH, V287, pC327, DOI 10.1152/ajpcell.00087.2004; Canel M, 2013, J CELL SCI, V126, P393, DOI 10.1242/jcs.100115; Carrozzino F, 2005, AM J PHYSIOL-CELL PH, V289, pC1002, DOI 10.1152/ajpcell.00175.2005; Chen Y, 2012, J AM SOC NEPHROL, V23, P1506, DOI 10.1681/ASN.2012010079; Cheng HT, 2005, KIDNEY INT, V68, P1951, DOI 10.1111/j.1523-1755.2005.00627.x; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; Contreras RG, 2002, PFLUG ARCH EUR J PHY, V444, P467, DOI 10.1007/s00424-002-0827-8; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Del Pozo MA, 2007, TRENDS CELL BIOL, V17, P246, DOI 10.1016/j.tcb.2007.03.001; Epifano C, 2012, CELL ADHES MIGR, V6, P261, DOI 10.4161/cam.20253; Gewin L, 2012, J AM SOC NEPHROL, V23, P2001, DOI 10.1681/ASN.2012020139; Gimond C, 1999, J CELL BIOL, V147, P1325, DOI 10.1083/jcb.147.6.1325; Hara-Chikuma M, 2006, J AM SOC NEPHROL, V17, P39, DOI 10.1681/ASN.2005080846; Heliot C, 2013, DEVELOPMENT, V140, P873, DOI 10.1242/dev.086538; Hendry CE, 2013, J AM SOC NEPHROL, V24, P1424, DOI 10.1681/ASN.2012121143; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jain S, 2011, BIOCHEM J, V437, P289, DOI 10.1042/BJ20110587; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Kopan R, 2007, J AM SOC NEPHROL, V18, P2014, DOI 10.1681/ASN.2007040453; LAFLAMME SE, 1994, J CELL BIOL, V126, P1287, DOI 10.1083/jcb.126.5.1287; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li JH, 2011, PEDIATR NEPHROL, V26, P2133, DOI 10.1007/s00467-011-1824-y; Lipschutz JH, 2005, J BIOL CHEM, V280, P3780, DOI 10.1074/jbc.M408122200; Massa F, 2013, DEVELOPMENT, V140, P886, DOI 10.1242/dev.086546; Mathew S, 2012, MOL CELL BIOL, V32, P4080, DOI 10.1128/MCB.00568-12; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Perantoni AO, 1999, EXP NEPHROL, V7, P80; Pozzi A, 2003, NEPHRON EXP NEPHROL, V94, pE77, DOI 10.1159/000072025; Pozzi A, 2011, CURR OPIN CELL BIOL, V23, P547, DOI 10.1016/j.ceb.2011.04.003; Prozialeck Walter C, 2004, BMC Physiol, V4, P10, DOI 10.1186/1472-6793-4-10; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Saito M, 2012, J CELL SCI, V125, P2547, DOI 10.1242/jcs.066654; Seth A, 2007, J BIOL CHEM, V282, P11487, DOI 10.1074/jbc.M610597200; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Singh AB, 2004, J BIOL CHEM, V279, P3543, DOI 10.1074/jbc.M308682200; Surendran K, 2010, J AM SOC NEPHROL, V21, P819, DOI 10.1681/ASN.2009090925; Wang Q, 2010, ONCOGENE, V29, P128, DOI 10.1038/onc.2009.302; Winter MC, 2008, AM J PHYSIOL-LUNG C, V294, pL442, DOI 10.1152/ajplung.00404.2007; Wu W, 2009, AM J PHYSIOL-RENAL, V297, pF210, DOI 10.1152/ajprenal.90260.2008; Yamashita S, 2004, J AM SOC NEPHROL, V15, P91, DOI 10.1097/01.ASN.0000103225.68136.E6; Zhang X, 2009, DEVELOPMENT, V136, P3357, DOI 10.1242/dev.036269	48	35	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8532	8544		10.1074/jbc.M113.526509	http://dx.doi.org/10.1074/jbc.M113.526509			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24509849	Green Published, hybrid			2022-12-28	WOS:000333157500044
J	Gadwal, S; Korotkov, KV; Delarosa, JR; Hol, WGJ; Sandkvist, M				Gadwal, Shilpa; Korotkov, Konstantin V.; Delarosa, Jaclyn R.; Hol, Wim G. J.; Sandkvist, Maria			Functional and Structural Characterization of Vibrio cholerae Extracellular Serine Protease B, VesB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Crystal Structure; Protein Domains; Protein Secretion; Proteolytic Enzymes; Serine Protease; Thrombin; Immunoglobulin-fold; Substrate Specificity; Trypsin	REFINED CRYSTAL-STRUCTURE; OUTER-MEMBRANE; SECRETION; TRYPSIN; BACTERIAL; DOMAIN; SITE; FLEXIBILITY; MECHANISM; REVEALS	Background: The extracellular Vibrio cholerae protease, VesB, is expressed in vitro and in stools of cholera patients. Results: VesB is homologous to trypsin and thrombin and the C-terminal domain has an immunoglobulin-fold. Conclusion: In contrast to thrombin, but similar to trypsin, VesB is not activated by sodium. Significance: This is the first structure of a bacterial modular trypsin-like protease. The chymotrypsin subfamily A of serine proteases consists primarily of eukaryotic proteases, including only a few proteases of bacterial origin. VesB, a newly identified serine protease that is secreted by the type II secretion system in Vibrio cholerae, belongs to this subfamily. VesB is likely produced as a zymogen because sequence alignment with trypsinogen identified a putative cleavage site for activation and a catalytic triad, His-Asp-Ser. Using synthetic peptides, VesB efficiently cleaved a trypsin substrate, but not chymotrypsin and elastase substrates. The reversible serine protease inhibitor, benzamidine, inhibited VesB and served as an immobilized ligand for VesB affinity purification, further indicating its relationship with trypsin-like enzymes. Consistent with this family of serine proteases, N-terminal sequencing implied that the propeptide is removed in the secreted form of VesB. Separate mutagenesis of the activation site and catalytic serine rendered VesB inactive, confirming the importance of these features for activity, but not for secretion. Similar to trypsin but, in contrast to thrombin and other coagulation factors, Na+ did not stimulate the activity of VesB, despite containing the Tyr(250) signature. The crystal structure of catalytically inactive pro-VesB revealed that the protease domain is structurally similar to trypsinogen. The C-terminal domain of VesB was found to adopt an immunoglobulin (Ig)-fold that is structurally homologous to Ig-folds of other extracellular Vibrio proteins. Possible roles of the Ig-fold domain in stability, substrate specificity, cell surface association, and type II secretion of VesB, the first bacterial multidomain trypsin-like protease with known structure, are discussed.	[Gadwal, Shilpa; Sandkvist, Maria] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Korotkov, Konstantin V.; Delarosa, Jaclyn R.; Hol, Wim G. J.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Korotkov, Konstantin V.; Delarosa, Jaclyn R.; Hol, Wim G. J.] Univ Washington, Biomol Struct Ctr, Seattle, WA 98195 USA	University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Sandkvist, M (corresponding author), 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	mariasan@umich.edu		Korotkov, Konstantin/0000-0002-2182-6843	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034501, R01AI081705, T32AI007528, R01AI049294] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the staff of beamline 8.2.2 at ALS for assistance during data collection. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract No. DE-AC02-05CH11231.	Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Connell TD, 1998, J BACTERIOL, V180, P5591, DOI 10.1128/JB.180.21.5591-5600.1998; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Dang QD, 1996, P NATL ACAD SCI USA, V93, P10653, DOI 10.1073/pnas.93.20.10653; Deng JP, 2004, ACTA CRYSTALLOGR D, V60, P203, DOI 10.1107/S0907444903024491; Di Cera E, 2007, PHYS CHEM CHEM PHYS, V9, P1292, DOI 10.1039/b616819a; DICERA E, 1995, J BIOL CHEM, V270, P22089, DOI 10.1074/jbc.270.38.22089; Douzi B, 2012, PHILOS T R SOC B, V367, P1059, DOI 10.1098/rstb.2011.0204; Edwin A, 2013, FEBS OPEN BIO, V3, P263, DOI 10.1016/j.fob.2013.06.003; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Forneris F, 2012, CURR OPIN STRUC BIOL, V22, P333, DOI 10.1016/j.sbi.2012.04.001; Friedrich R, 2002, J BIOL CHEM, V277, P2160, DOI 10.1074/jbc.M109830200; Giglio KM, 2013, J BACTERIOL, V195, P3277, DOI 10.1128/JB.00374-13; GORDON VM, 1994, INFECT IMMUN, V62, P333, DOI 10.1128/IAI.62.2.333-340.1994; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Haft DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028886; Harmat V, 2004, J MOL BIOL, V342, P1533, DOI 10.1016/j.jmb.2004.07.014; Hedstrom L., 2002, CURRENT PROTOCOLS PR, V10, P1; Johnson TL, 2007, J BACTERIOL, V189, P9082, DOI 10.1128/JB.01256-07; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; Knight SD, 2002, ACTA CRYSTALLOGR D, V58, P1016, DOI 10.1107/S0907444902005954; Kobayashi H, 2009, J BIOL CHEM, V284, P27655, DOI 10.1074/jbc.M109.006114; Korotkov KV, 2012, NAT REV MICROBIOL, V10, P336, DOI 10.1038/nrmicro2762; Korotkov KV, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002228; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LaRocque RC, 2008, INFECT IMMUN, V76, P4145, DOI 10.1128/IAI.00585-08; LINDBERG F, 1989, J BACTERIOL, V171, P6052, DOI 10.1128/jb.171.11.6052-6058.1989; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lybarger SR, 2009, J BACTERIOL, V191, P3149, DOI 10.1128/JB.01701-08; Magnusdottir A, 2009, NAT METHODS, V6, P477, DOI 10.1038/nmeth0709-477; MARQUART M, 1983, ACTA CRYSTALLOGR B, V39, P480, DOI 10.1107/S010876818300275X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLaughlin LS, 2012, CURR OPIN STRUC BIOL, V22, P208, DOI 10.1016/j.sbi.2012.02.005; Murayama K, 2012, J MOL BIOL, V423, P386, DOI 10.1016/j.jmb.2012.07.013; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nonaka T, 2004, J BIOL CHEM, V279, P47344, DOI 10.1074/jbc.M409089200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page MJ, 2006, BIOCHEMISTRY-US, V45, P2987, DOI 10.1021/bi052481a; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pozzi N, 2013, J BIOL CHEM, V288, P22734, DOI 10.1074/jbc.M113.466946; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P19; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; READ RJ, 1988, J MOL BIOL, V200, P523, DOI 10.1016/0022-2836(88)90541-4; Rojas A, 2002, J MOL EVOL, V55, P790, DOI 10.1007/s00239-002-2361-x; RYPNIEWSKI WR, 1994, PROTEIN ENG, V7, P57, DOI 10.1093/protein/7.1.57; SANDKVIST M, 1993, GENE, V123, P81, DOI 10.1016/0378-1119(93)90543-C; Sauer FG, 2000, SEMIN CELL DEV BIOL, V11, P27, DOI 10.1006/scdb.1999.0348; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Sikora A. E., 2013, PLOS ONE, V9; Sikora AE, 2007, J BACTERIOL, V189, P8484, DOI 10.1128/JB.00583-07; Sikora AE, 2011, J BIOL CHEM, V286, P16555, DOI 10.1074/jbc.M110.211078; Songsiriritthigul C, 2008, J STRUCT BIOL, V162, P491, DOI 10.1016/j.jsb.2008.03.008; Syngkon A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013122; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Uesugi Y, 2008, BBA-PROTEINS PROTEOM, V1784, P716, DOI 10.1016/j.bbapap.2008.01.017; Uesugi Y, 2009, FEBS J, V276, P5634, DOI 10.1111/j.1742-4658.2009.07256.x; VANZONNEVELD AJ, 1986, J CELL BIOCHEM, V32, P169, DOI 10.1002/jcb.240320302; Vezzulli L, 2010, ENV MICROBIOL REP, V2, P27, DOI 10.1111/j.1758-2229.2009.00128.x; Wong E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002373; Xu Q, 2003, P NATL ACAD SCI USA, V100, P1286, DOI 10.1073/pnas.0337479100; YAMANE T, 1995, J BIOCHEM-TOKYO, V118, P882, DOI 10.1093/jb/118.5.882	65	21	21	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8288	8298		10.1074/jbc.M113.525261	http://dx.doi.org/10.1074/jbc.M113.525261			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24459146	Green Published, hybrid			2022-12-28	WOS:000333157500023
J	Su, MF; Mei, Y; Sanishvili, R; Levine, B; Colbert, CL; Sinha, S				Su, Minfei; Mei, Yang; Sanishvili, Ruslan; Levine, Beth; Colbert, Christopher L.; Sinha, Sangita			Targeting gamma-Herpesvirus 68 Bcl-2-mediated Down-regulation of Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; Bcl-2 Family Proteins; Crystal Structure; Herpesvirus; Host Defense; Host-Pathogen Interactions; Protein-Protein Interactions	EPSTEIN-BARR-VIRUS; PEPTIDE COMPLEX; MOLECULAR-BASIS; BCL-2 HOMOLOG; BECLIN 1; JNK1-MEDIATED PHOSPHORYLATION; INHIBITS APOPTOSIS; CELL SURVIVAL; BHRF1 PROTEIN; X-RAY	Background: Cellular and -herpesvirus Bcl-2 homologs down-regulate autophagy. Results: A peptide designed to bind to the -herpesvirus68 Bcl-2, M11, but not cellular Bcl-2 homologs, abrogates M11-mediated down-regulation of autophagy. Conclusion: This peptide is a selective M11 inhibitor. Significance: Such selective inhibitors are important for understanding the role of -herpesvirus Bcl-2 homologs in viral reactivation and oncogenic transformation of host cells. -herpesviruses (HVs) are common human pathogens that encode homologs of the anti-apoptotic cellular Bcl-2 proteins, which are critical to viral reactivation and oncogenic transformation. The murine HV68 provides a tractable in vivo model for understanding general features of these important human pathogens. Bcl-X-L, a cellular Bcl-2 homolog, and the murine HV68 Bcl-2 homolog, M11, both bind to a BH3 domain within the key autophagy effector Beclin 1 with comparable affinities, resulting in the down-regulation of Beclin 1-mediated autophagy. Despite this similarity, differences in residues lining the binding site of M11 and Bcl-X-L dictate varying affinities for the different BH3 domain-containing proteins. Here we delineate Beclin 1 differential specificity determinants for binding to M11 or Bcl-X-L by quantifying autophagy levels in cells expressing different Beclin 1 mutants and either M11 or Bcl-X-L, and we show that a G120E/D121A Beclin 1 mutant selectively prevents down-regulation of Beclin 1-mediated autophagy by Bcl-X-L, but not by M11. We use isothermal titration calorimetry to identify a Beclin 1 BH3 domain-derived peptide that selectively binds to M11, but not to Bcl-X-L. The x-ray crystal structure of this peptide bound to M11 reveals the mechanism by which the M11 BH3 domain-binding groove accommodates this M11-specific peptide. This information was used to develop a cell-permeable peptide inhibitor that selectively inhibits M11-mediated, but not Bcl-X-L-mediated, down-regulation of autophagy.	[Su, Minfei; Mei, Yang; Colbert, Christopher L.; Sinha, Sangita] N Dakota State Univ, Dept Chem & Biochem, Fargo, ND 58108 USA; [Sanishvili, Ruslan] Argonne Natl Lab, Adv Photon Source, Xray Sci Div, GMCA APS, Argonne, IL 60439 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Ctr, Ctr Autophagy Res, Dept Internal Med, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	North Dakota State University Fargo; United States Department of Energy (DOE); Argonne National Laboratory; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sinha, S (corresponding author), N Dakota State Univ, Dept Chem & Biochem, POB 6050,Dept 2710, Fargo, ND 58102 USA.	Sangita.Sinha@ndsu.edu		Mei, Yang/0000-0003-4357-9000	National Institutes of Health [P20 RR015566, P30 GM103332-01, R21 AI078198, RO1 CA109618]; CPRIT [PR120718-P1]; National Science Foundation [EPS-0814442, HRD-0811239]; NATIONAL CANCER INSTITUTE [R01CA109618] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS090939] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1413525] Funding Source: National Science Foundation; EPSCoR [0814442] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 RR015566 and P30 GM103332-01 (to S. S. and C. L. C.), R21 AI078198 (to S. S.), and RO1 CA109618 and CPRIT PR120718-P1 (to B. L.). This work was also supported by National Science Foundation Grants EPS-0814442 (to S. S. and C. L. C.), HRD-0811239 (to S. S.).	Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHY, 1997, P NATL ACAD SCI USA, V94, P690, DOI 10.1073/pnas.94.2.690; Cuconati A, 2002, GENE DEV, V16, P2465, DOI 10.1101/gad.1012702; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DeBartolo J, 2012, J MOL BIOL, V422, P124, DOI 10.1016/j.jmb.2012.05.022; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erlich S, 2007, AUTOPHAGY, V3, P561, DOI 10.4161/auto.4713; Feng W, 2007, J MOL BIOL, V372, P223, DOI 10.1016/j.jmb.2007.06.069; Foghsgaard L, 1997, J VIROL, V71, P7509, DOI 10.1128/JVI.71.10.7509-7517.1997; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Gangappa S, 2002, J EXP MED, V195, P931, DOI 10.1084/jem.20011825; Hardwick JM, 1998, SEMIN CELL DEV BIOL, V9, P339, DOI 10.1006/scdb.1998.0243; HENDERSON S, 1993, P NATL ACAD SCI USA, V90, P8479, DOI 10.1073/pnas.90.18.8479; Huang QL, 2003, J MOL BIOL, V332, P1123, DOI 10.1016/j.jmb.2003.08.007; Huang QL, 2002, P NATL ACAD SCI USA, V99, P3428, DOI 10.1073/pnas.062525799; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Ku B, 2008, AUTOPHAGY, V4, P519, DOI 10.4161/auto.5846; Ku B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040025; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liang XH, 2001, CANCER RES, V61, P3443; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Loh J, 2005, PLOS PATHOG, V1, P80, DOI 10.1371/journal.ppat.0010010; Maity A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076837; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Maiuri MC, 2010, EMBO J, V29, P515, DOI 10.1038/emboj.2009.377; Marshall WL, 1999, J VIROL, V73, P5181, DOI 10.1128/JVI.73.6.5181-5185.1999; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; Mei Y, 2013, PROTEINS; Moroy G, 2009, J BIOL CHEM, V284, P17499, DOI 10.1074/jbc.M805542200; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Ojala PM, 1999, CANCER RES, V59, P4984; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2009, AUTOPHAGY, V5, P558, DOI 10.4161/auto.5.4.8390; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; Roizman B, 2001, FIELDS VIROL, P2381; Sarid R, 1997, NAT MED, V3, P293, DOI 10.1038/nm0397-293; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Sinha S, 2008, ONCOGENE, V27, pS137, DOI 10.1038/onc.2009.51; Sinha S, 2008, AUTOPHAGY, V4, P989, DOI 10.4161/auto.6803; Su MF, 2013, J ONCOL, V2013, DOI 10.1155/2013/102735; Tarakanova VL, 2005, J VIROL, V79, P14668, DOI 10.1128/JVI.79.23.14668-14679.2005; Theodorakis P, 1996, ONCOGENE, V12, P1707; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Wang GH, 1999, J GEN VIROL, V80, P2737, DOI 10.1099/0022-1317-80-10-2737; Wei YJ, 2008, AUTOPHAGY, V4, P949, DOI 10.4161/auto.6788; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001	56	32	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8029	8040		10.1074/jbc.M113.515361	http://dx.doi.org/10.1074/jbc.M113.515361			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24443581	hybrid, Green Published			2022-12-28	WOS:000333157500003
J	Lasry, I; Golan, Y; Berman, B; Amram, N; Glaser, F; Assaraf, YG				Lasry, Inbal; Golan, Yarden; Berman, Bluma; Amram, Noy; Glaser, Fabian; Assaraf, Yehuda G.			In Situ Dimerization of Multiple Wild Type and Mutant Zinc Transporters in Live Cells Using Bimolecular Fluorescence Complementation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Metal Homeostasis; Mutant; Protein-Protein Interactions; Transport Metals; Zinc	DIFFUSION FACILITATOR FAMILY; MAMMALIAN ZINC; FUNCTIONAL-CHARACTERIZATION; ALKALINE-PHOSPHATASES; PROTEIN INTERACTIONS; SLC30 FAMILY; BETA; VISUALIZATION; EXPRESSION; GENE	Background: Zinc transporters (ZnTs) presumably form dimers, thereby modulating zinc transport activity. Results: Bimolecular fluorescence complementation (BiFC) revealed ZnT1-4, ZnT7 homodimers and ZnT5-ZnT6 heterodimers. Conclusion: BiFC pinpointed WT and mutant ZnT2 dimerization in live cells. Significance: BiFC provides the first in situ evidence for the subcellular localization of WT and mutant ZnT2 dimers in live cells, thereby establishing the molecular basis underlying zinc deficiency. Zinc transporters (ZnTs) facilitate zinc efflux and zinc compartmentalization, thereby playing a key role in multiple physiological processes and pathological disorders, presumed to be modulated by transporter dimerization. We recently proposed that ZnT2 homodimerization is the underlying basis for the dominant negative effect of a novel heterozygous G87R mutation identified in women producing zinc-deficient milk. To provide direct visual evidence for the in situ dimerization and function of multiple normal and mutant ZnTs, we applied here the bimolecular fluorescence complementation (BiFC) technique, which enables direct visualization of specific protein-protein interactions. BiFC is based upon reconstitution of an intact fluorescent protein including YFP when its two complementary, non-fluorescent N- and C-terminal fragments (termed YN and YC) are brought together by a pair of specifically interacting proteins. Homodimerization of ZnT1, -2, -3, -4, and -7 was revealed by high subcellular fluorescence observed upon co-transfection of non-fluorescent ZnT-YC and ZnT-YN; this homodimer fluorescence localized in the characteristic compartments of each ZnT. The validity of the BiFC assay in ZnT dimerization was further corroborated when high fluorescence was obtained upon co-transfection of ZnT5-YC and ZnT6-YN, which are known to form heterodimers. We further show that BiFC recapitulated the pathogenic role that ZnT mutations play in transient neonatal zinc deficiency. Zinquin, a fluorescent zinc probe applied along with BiFC, revealed the in situ functionality of ZnT dimers. Hence, the current BiFC-Zinquin technique provides the first in situ evidence for the dimerization and function of wild type and mutant ZnTs in live cells.	[Lasry, Inbal; Golan, Yarden; Berman, Bluma; Amram, Noy; Assaraf, Yehuda G.] Technion Israel Inst Technol, Dept Biol, Fred Wyszkowski Canc Res Lab, IL-32000 Haifa, Israel; [Glaser, Fabian] Technion Israel Inst Technol, Lorry I Lokey Interdisciplinary Ctr Life Sci & En, Bioinformat Knowledge Unit, IL-32000 Haifa, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology	Assaraf, YG (corresponding author), Technion Israel Inst Technol, Dept Biol, Fred Wyszkowski Canc Res Lab, IL-32000 Haifa, Israel.	assaraf@tx.technion.ac.il		Golan, Yarden/0000-0002-3043-3638				Adlard PA, 2010, J NEUROSCI, V30, P1631, DOI 10.1523/JNEUROSCI.5255-09.2010; Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Bozym RA, 2010, EXP BIOL MED, V235, P741, DOI 10.1258/ebm.2010.009258; Chen CD, 2006, J NEUROCHEM, V97, P30, DOI 10.1111/j.1471-4159.2006.03705.x; Cherezov V, 2008, STRUCTURE, V16, P1378, DOI 10.1016/j.str.2008.05.014; Chowanadisai W, 2006, J BIOL CHEM, V281, P39699, DOI 10.1074/jbc.M605821200; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Coudray N, 2013, P NATL ACAD SCI USA, V110, P2140, DOI 10.1073/pnas.1215455110; DARZYNKIEWICZ Z, 1994, METHOD CELL BIOL, V41, P15; Dempsey C, 2012, J NUTR, V142, P655, DOI 10.3945/jn.111.150623; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Falcon-Perez JM, 2007, EXP CELL RES, V313, P1473, DOI 10.1016/j.yexcr.2007.02.006; Fu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005679; Fukunaka A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227173; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Gustin JL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-76; Haider AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025818; Heroux M, 2007, J BIOL CHEM, V282, P31610, DOI 10.1074/jbc.M701790200; Higuchi T, 2009, PROTEINS, V76, P768, DOI 10.1002/prot.22444; Huang LP, 2013, MOL ASPECTS MED, V34, P548, DOI 10.1016/j.mam.2012.05.008; Huang LP, 2002, J BIOL CHEM, V277, P26389, DOI 10.1074/jbc.M200462200; Itsumura N., 2013, PLOS ONE, V8; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Jirakulaporn T, 2004, J BIOL CHEM, V279, P27807, DOI 10.1074/jbc.M401210200; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; Kambe Taiho, 2006, Genomics Proteomics & Bioinformatics, V4, P1, DOI 10.1016/S1672-0229(06)60010-7; Kambe T, 2012, CURR TOP MEMBR, V69, P199, DOI 10.1016/B978-0-12-394390-3.00008-2; Kelleher SL, 2011, ADV NUTR, V2, P101, DOI 10.3945/an.110.000232; Kelleher SL, 2012, J CELL PHYSIOL, V227, P1761, DOI 10.1002/jcp.22900; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kilpatrick LE, 2010, BRIT J PHARMACOL, V160, P892, DOI 10.1111/j.1476-5381.2010.00676.x; Kirschke CP, 2003, J BIOL CHEM, V278, P4096, DOI 10.1074/jbc.M207644200; Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519; Kosel D, 2010, J CELL SCI, V123, P1320, DOI 10.1242/jcs.057919; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lasry I, 2012, J BIOL CHEM, V287, P29348, DOI 10.1074/jbc.M112.368159; Lazarczyk M, 2008, J EXP MED, V205, P35, DOI 10.1084/jem.20071311; Li N, 2007, BIOCHEM J, V407, P363, DOI 10.1042/BJ20070716; Liuzzi JP, 2003, J NUTR, V133, P342, DOI 10.1093/jn/133.2.342; Liuzzi JP, 2001, J NUTR, V131, P46, DOI 10.1093/jn/131.1.46; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ohana E, 2009, J BIOL CHEM, V284, P17677, DOI 10.1074/jbc.M109.007203; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; PALMITER RD, 1995, EMBO J, V14, P639, DOI 10.1002/j.1460-2075.1995.tb07042.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qin Y, 2009, NEUROSCI LETT, V450, P206, DOI 10.1016/j.neulet.2008.11.069; Rose RH, 2010, BRIT J PHARMACOL, V159, P738, DOI 10.1111/j.1476-5381.2009.00480.x; Rothem L, 2005, MOL PHARMACOL, V68, P616, DOI 10.1124/mol.105.013540; Salazar G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005896; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Valente T, 2002, MOL CELL NEUROSCI, V21, P189, DOI 10.1006/mcne.2002.1159; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Weijers RNM, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-33	60	43	43	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7275	7292		10.1074/jbc.M113.533786	http://dx.doi.org/10.1074/jbc.M113.533786			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24451381	hybrid, Green Published			2022-12-28	WOS:000332761500003
J	Miller, BA; Hoffman, NE; Merali, S; Zhang, XQ; Wang, JF; Rajan, S; Shanmughapriya, S; Gao, E; Barrero, CA; Mallilankaraman, K; Song, JL; Gu, TD; Hirschler-Laszkiewicz, I; Koch, WJ; Feldman, AM; Madesh, M; Cheung, JY				Miller, Barbara A.; Hoffman, Nicholas E.; Merali, Salim; Zhang, Xue-Qian; Wang, JuFang; Rajan, Sudarsan; Shanmughapriya, Santhanam; Gao, Erhe; Barrero, Carlos A.; Mallilankaraman, Karthik; Song, Jianliang; Gu, Tongda; Hirschler-Laszkiewicz, Iwona; Koch, Walter J.; Feldman, Arthur M.; Madesh, Muniswamy; Cheung, Joseph Y.			TRPM2 Channels Protect against Cardiac Ischemia-Reperfusion Injury ROLE OF MITOCHONDRIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Channels; Cardiovascular Disease; Electrophysiology; Mitochondria; TRP Channels; Cardiac Ischemia; Global Proteomics Analysis; Mitochondrial Bioenergetics	MYOCYTE CONTRACTILITY; ESSENTIAL COMPONENT; CALCIUM UNIPORTER; CA2+ UPTAKE; ADP-RIBOSE; PHOSPHOLEMMAN; DEFICIENT; APOPTOSIS; MICU1; OVEREXPRESSION	Background: TRPM2 channels are present in the heart, but their function is unknown. Results: Genetic ablation of TRPM2 results in cardiac mitochondrial dysfunction, enhanced ROS production, and exacerbated cardiac ischemic injury. Conclusion: TRPM2 channels preserve cardiac mitochondrial bioenergetics and protect cardiac myocytes from ischemic injury. Significance: TRPM2 is a rational target for treatment of ischemic heart disease. Cardiac TRPM2 channels were activated by intracellular adenosine diphosphate-ribose and blocked by flufenamic acid. In adult cardiac myocytes the ratio of G(Ca) to G(Na) of TRPM2 channels was 0.56 +/- 0.02. To explore the cellular mechanisms by which TRPM2 channels protect against cardiac ischemia/reperfusion (I/R) injury, we analyzed proteomes from WT and TRPM2 KO hearts subjected to I/R. The canonical pathways that exhibited the largest difference between WT-I/R and KO-I/R hearts were mitochondrial dysfunction and the tricarboxylic acid cycle. Complexes I, III, and IV were down-regulated, whereas complexes II and V were up-regulated in KO-I/R compared with WT-I/R hearts. Western blots confirmed reduced expression of the Complex I subunit and other mitochondria-associated proteins in KO-I/R hearts. Bioenergetic analyses revealed that KO myocytes had a lower mitochondrial membrane potential, mitochondrial Ca2+ uptake, ATP levels, and O-2 consumption but higher mitochondrial superoxide levels. Additionally, mitochondrial Ca2+ uniporter (MCU) currents were lower in KO myocytes, indicating reduced mitochondrial Ca2+ uptake was likely due to both lower (m) and MCU activity. Similar to isolated myocytes, O-2 consumption and ATP levels were also reduced in KO hearts. Under a simulated I/R model, aberrant mitochondrial bioenergetics was exacerbated in KO myocytes. Reactive oxygen species levels were also significantly higher in KO-I/R compared with WT-I/R heart slices, consistent with mitochondrial dysfunction in KO-I/R hearts. We conclude that TRPM2 channels protect the heart from I/R injury by ameliorating mitochondrial dysfunction and reducing reactive oxygen species levels.	[Hoffman, Nicholas E.; Zhang, Xue-Qian; Wang, JuFang; Rajan, Sudarsan; Shanmughapriya, Santhanam; Gao, Erhe; Mallilankaraman, Karthik; Song, Jianliang; Gu, Tongda; Koch, Walter J.; Feldman, Arthur M.; Madesh, Muniswamy; Cheung, Joseph Y.] Temple Univ, Sch Med, Ctr Translat Med, Philadelphia, PA 19140 USA; [Cheung, Joseph Y.] Temple Univ, Sch Med, Div Nephrol, Philadelphia, PA 19140 USA; [Hoffman, Nicholas E.; Merali, Salim; Rajan, Sudarsan; Shanmughapriya, Santhanam; Barrero, Carlos A.; Mallilankaraman, Karthik; Madesh, Muniswamy] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Hirschler-Laszkiewicz, Iwona] Penn State Univ, Coll Med, Dept Pediat, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Cheung, JY (corresponding author), Temple Univ, Sch Med, Ctr Translat Med, 3500 N Broad St,MERB 960, Philadelphia, PA 19140 USA.	joseph.cheung@tuhs.temple.edu	; Shanmughapriya, Santhanam/P-2828-2017	Barrero, Carlos/0000-0001-5779-6642; Shanmughapriya, Santhanam/0000-0003-1041-8198; MALLILANKARAMAN, KARTHIK/0000-0002-9492-9050	National Institutes of Health [RO1-DK46778, R21-CA165068, RO1-HL56205, RO1-HL61690, RO1-HL85503, PO1-HL-75443, PO1-HL-91799, PO1-HL91799, 2, RO1-HL86699, RO1-HL58672, RO1-HL74854]; NATIONAL CANCER INSTITUTE [R21CA165068] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058672, P01HL075443, P01HL091799, R01HL056205, R01HL061690, R01HL074854, R01HL086699, R01HL085503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DK46778 (to B. A. M.), R21-CA165068 (to S. M.), RO1-HL56205, RO1-HL61690, RO1-HL85503, PO1-HL-75443, and PO1-HL-91799 (to W. J. K.), PO1-HL91799 (Project 2; to A. M. F.), RO1-HL86699 (to M. M.), and RO1-HL58672 and RO1-HL74854 (to J. Y. C.).	Abriel H, 2012, BIOCHEM PHARMACOL, V84, P873, DOI 10.1016/j.bcp.2012.06.021; Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; Barrero CA, 2013, AM J RESP CRIT CARE, V188, P673, DOI 10.1164/rccm.201302-0342OC; Barrero CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068376; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Cheng ZJ, 2011, BLOOD, V118, P1998, DOI 10.1182/blood-2011-01-333310; CHEUNG JY, 1982, AM J PHYSIOL, V243, pC184, DOI 10.1152/ajpcell.1982.243.3.C184; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Dyrlund TF, 2012, PROTEOMICS, V12, P2792, DOI 10.1002/pmic.201200109; Eder P, 2011, CIRC RES, V108, P265, DOI 10.1161/CIRCRESAHA.110.225888; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hermosura MC, 2008, P NATL ACAD SCI USA, V105, P18029, DOI 10.1073/pnas.0808218105; Hill K, 2004, NEUROPHARMACOLOGY, V47, P450, DOI 10.1016/j.neuropharm.2004.04.014; Hiroi T, 2013, CARDIOVASC RES, V97, P271, DOI 10.1093/cvr/cvs332; Hoffman NE, 2013, CELL REP, V5, P1576, DOI 10.1016/j.celrep.2013.11.026; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; Irrinki KM, 2011, MOL CELL BIOL, V31, P3745, DOI 10.1128/MCB.05303-11; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Li X, 2011, AM J PHYSIOL-HEART C, V301, pH1932, DOI 10.1152/ajpheart.00755.2010; Liu YV, 2007, J BIOL CHEM, V282, P37064, DOI 10.1074/jbc.M705015200; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; Mathar I, 2010, J CLIN INVEST, V120, P3267, DOI 10.1172/JCI41348; Miller B. A., 2012, METHODS PHARM TOXICO, P89; Miller BA, 2013, AM J PHYSIOL-HEART C, V304, pH1010, DOI 10.1152/ajpheart.00906.2012; Miller BA, 2011, ADV EXP MED BIOL, V704, P531, DOI 10.1007/978-94-007-0265-3_29; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Nilius B, 2005, J BIOL CHEM, V280, P22899, DOI 10.1074/jbc.M501686200; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Schnitzler MMY, 2008, FASEB J, V22, P1540, DOI 10.1096/fj.07-9694com; Semenza GL, 2011, BBA-MOL CELL RES, V1813, P1263, DOI 10.1016/j.bbamcr.2010.08.006; Simard Christophe, 2012, Br J Pharmacol, V165, P2354, DOI 10.1111/j.1476-5381.2011.01715.x; Song JL, 2008, AM J PHYSIOL-HEART C, V295, pH1615, DOI 10.1152/ajpheart.00287.2008; Song JL, 2012, AM J PHYSIOL-HEART C, V302, pH770, DOI 10.1152/ajpheart.00733.2011; Sumoza-Toledo A, 2011, J PHYSIOL-LONDON, V589, P1515, DOI 10.1113/jphysiol.2010.201855; Takahashi N, 2011, CELL CALCIUM, V50, P279, DOI 10.1016/j.ceca.2011.04.006; Tello D, 2011, CELL METAB, V14, P768, DOI 10.1016/j.cmet.2011.10.008; Tucker AL, 2006, AM J PHYSIOL-HEART C, V291, pH2199, DOI 10.1152/ajpheart.01181.2005; Wang JF, 2011, AM J PHYSIOL-HEART C, V300, pH859, DOI 10.1152/ajpheart.00894.2010; Wang JF, 2010, AM J PHYSIOL-HEART C, V298, pH807, DOI 10.1152/ajpheart.00877.2009; Wang JF, 2009, AM J PHYSIOL-HEART C, V297, pH590, DOI 10.1152/ajpheart.00190.2009; Watanabe H, 2008, PHARMACOL THERAPEUT, V118, P337, DOI 10.1016/j.pharmthera.2008.03.008; Yang KT, 2006, CELL DEATH DIFFER, V13, P1815, DOI 10.1038/sj.cdd.4401813; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang ZY, 2012, AM J PHYSIOL-ENDOC M, V302, pE807, DOI 10.1152/ajpendo.00239.2011; Zhou YY, 2000, AM J PHYSIOL-HEART C, V279, pH429	58	62	66	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7615	7629		10.1074/jbc.M113.533851	http://dx.doi.org/10.1074/jbc.M113.533851			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24492610	Green Published, hybrid			2022-12-28	WOS:000332761500031
J	Ming, M; Obata, F; Kuranaga, E; Miura, M				Ming, Ming; Obata, Fumiaki; Kuranaga, Erina; Miura, Masayuki			Persephone/Spatzle Pathogen Sensors Mediate the Activation of Toll Receptor Signaling in Response to Endogenous Danger Signals in Apoptosis-deficient Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Caspase; Drosophila; Innate Immunity; Necrosis (Necrotic Death); Serine Protease; Stress Response; Toll Receptors; Damage-associated Molecular Patterns	DEVELOPMENTAL CELL-DEATH; INNATE IMMUNE-RESPONSE; CASPASE DRONC; FUNCTIONAL-ANALYSIS; FUNGAL; PROTEIN; DORSAL; PHOSPHORYLATION; INFLAMMATION; RECOGNITION	Background: Apoptosis deficiency causes necrotic cell death that activates the innate immune response in mammals. Results: Apoptosis-deficient Drosophila exhibited constitutive Toll pathway activation mediated by serine protease Persephone. Conclusion: Apoptosis-deficient Drosophila produces damage-associated molecular patterns (DAMPs) leading to canonical Toll signaling through a Persephone-mediated proteolytic cascade that cleaves the Toll ligand Spatzle. Significance: DAMP-mediated Toll-like receptor signaling is conserved in invertebrates. Apoptosis is an evolutionarily conserved mechanism that removes damaged or unwanted cells, effectively maintaining cellular homeostasis. It has long been suggested that a deficiency in this type of naturally occurring cell death could potentially lead to necrosis, resulting in the release of endogenous immunogenic molecules such as damage-associated molecular patterns (DAMPs) and a noninfectious inflammatory response. However, the details about how danger signals from apoptosis-deficient cells are detected and translated to an immune response are largely unknown. In this study, we found that Drosophila mutants deficient for Dronc, the key initiator caspase required for apoptosis, produced the active form of the endogenous Toll ligand Spatzle (Spz). We speculated that, as a system for sensing potential DAMPs in the hemolymph, the dronc mutants constitutively activate a proteolytic cascade that leads to Spz proteolytic processing. We demonstrated that Toll signaling activation required the action of Persephone, a CLIP domain serine protease that usually reacts to microbial proteolytic activities. Our findings show that the Persephone proteolytic cascade plays a crucial role in mediating DAMP-induced systemic responses in apoptosis-deficient Drosophila mutants.	[Ming, Ming; Obata, Fumiaki; Miura, Masayuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Genet, Bunkyo Ku, Tokyo 1130033, Japan; [Obata, Fumiaki; Miura, Masayuki] Japan Sci & Technol Agcy, Basic Res Program, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan; [Kuranaga, Erina] RIKEN, Ctr Dev Biol, Lab Histogenet Dynam, Kobe, Hyogo 6500047, Japan	University of Tokyo; Japan Science & Technology Agency (JST); RIKEN	Miura, M (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Genet, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	miura@mol.f.u-tokyo.ac.jp	Kuranaga, Erina/AAE-4309-2019	Kuranaga, Erina/0000-0001-6300-2087; Obata, Fumiaki/0000-0002-8641-5818	Japanese Ministry of Education, Science, Sports, Culture, and Technology; Uehara Memorial Foundation	Japanese Ministry of Education, Science, Sports, Culture, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by grants from the Japanese Ministry of Education, Science, Sports, Culture, and Technology (to M. M. and E. K.) and the Uehara Memorial Foundation (E.K.).	Agaisse Herve, 2004, Immunol Rev, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Akdemir F, 2006, DEVELOPMENT, V133, P1457, DOI 10.1242/dev.02332; An S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031920; Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; Bernal A, 2000, P NATL ACAD SCI USA, V97, P6019, DOI 10.1073/pnas.100391597; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Chautan M, 1999, CURR BIOL, V9, P967, DOI 10.1016/S0960-9822(99)80425-4; Chew SK, 2004, DEV CELL, V7, P897, DOI 10.1016/j.devcel.2004.09.016; Cho YS, 2010, CURR BIOL, V20, P1133, DOI 10.1016/j.cub.2010.04.056; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Daish TJ, 2004, DEV CELL, V7, P909, DOI 10.1016/j.devcel.2004.09.018; Dorstyn L, 1999, P NATL ACAD SCI USA, V96, P4307, DOI 10.1073/pnas.96.8.4307; Ekengren S, 2001, CURR BIOL, V11, P714, DOI 10.1016/S0960-9822(01)00203-2; El Chamy L, 2008, NAT IMMUNOL, V9, P1165, DOI 10.1038/ni.1643; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Kondo S, 2006, MOL CELL BIOL, V26, P7258, DOI 10.1128/MCB.00183-06; Kurucz E, 2003, P NATL ACAD SCI USA, V100, P2622, DOI 10.1073/pnas.0436940100; LEMAITRE B, 1995, EMBO J, V14, P536, DOI 10.1002/j.1460-2075.1995.tb07029.x; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Markus R, 2005, IMMUNOL LETT, V101, P108, DOI 10.1016/j.imlet.2005.03.021; Markus R, 2009, P NATL ACAD SCI USA, V106, P4805, DOI 10.1073/pnas.0801766106; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Mukae N, 2002, GENE DEV, V16, P2662, DOI 10.1101/gad.1022802; Nelliot A, 2006, GENESIS, V44, P396, DOI 10.1002/dvg.20229; Pastor-Pareja JC, 2008, DIS MODEL MECH, V1, P144, DOI 10.1242/dmm.000950; Patterson RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061773; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395; Qiu P, 1998, DEVELOPMENT, V125, P1909; Ramsden S, 2008, AGING CELL, V7, P225, DOI 10.1111/j.1474-9726.2008.00370.x; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Seong CS, 2006, CELL IMMUNOL, V240, P5, DOI 10.1016/j.cellimm.2006.05.007; Shia AKH, 2009, J CELL SCI, V122, P4505, DOI 10.1242/jcs.049155; Shim J, 2012, NAT CELL BIOL, V14, P394, DOI 10.1038/ncb2453; Silva MT, 2008, APOPTOSIS, V13, P463, DOI 10.1007/s10495-008-0187-8; Stramer B, 2005, J CELL BIOL, V168, P567, DOI 10.1083/jcb.200405120; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; Tauszig-Delamasure S, 2002, NAT IMMUNOL, V3, P91, DOI 10.1038/ni747; Tettweiler G, 2005, GENE DEV, V19, P1840, DOI 10.1101/gad.1311805; Tsuzuki S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00210; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955; WHALEN AM, 1993, J CELL BIOL, V123, P523, DOI 10.1083/jcb.123.3.523; Wu SC, 2012, CELL HOST MICROBE, V11, P410, DOI 10.1016/j.chom.2012.03.004; Xu DB, 2005, DEVELOPMENT, V132, P2125, DOI 10.1242/dev.01790; Yang CS, 2010, EMBO J, V29, P3196, DOI 10.1038/emboj.2010.191; Zerofsky M, 2005, AGING CELL, V4, P103, DOI 10.1111/j.1474-9728.2005.00147.x; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101	57	49	50	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7558	7568		10.1074/jbc.M113.543884	http://dx.doi.org/10.1074/jbc.M113.543884			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24492611	hybrid, Green Published			2022-12-28	WOS:000332761500026
J	Tran, CM; Schoepflin, ZR; Markova, DZ; Kepler, CK; Anderson, DG; Shapiro, IM; Risbud, MV				Tran, Cassie M.; Schoepflin, Zachary R.; Markova, Dessislava Z.; Kepler, Christopher K.; Anderson, D. Greg; Shapiro, Irving M.; Risbud, Makarand V.			CCN2 Suppresses Catabolic Effects of Interleukin-1 beta through alpha 5 beta 1 and alpha V beta 3 Integrins in Nucleus Pulposus Cells IMPLICATIONS IN INTERVERTEBRAL DISC DEGENERATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cartilage Biology; Chondrocytes; Cytokine; Extracellular Matrix Proteins; Integrins	TISSUE-GROWTH-FACTOR; NF-KAPPA-B; HEPATIC STELLATE CELLS; TNF-ALPHA; EXTRACELLULAR-MATRIX; CYTOKINE EXPRESSION; BINDING-SITES; FACTOR-BETA; CHONDROCYTES; FIBROBLASTS	Background: The relationship between inflammatory cytokines TNF- and IL-1 and CCN2 in nucleus pulposus cells is unknown. Results: Cytokines suppress CCN2 expression, whereas CCN2 represses catabolic action of IL-1. Conclusion: In nucleus pulposus, cytokines and CCN2 form a negative regulatory circuit. Significance: CCN2 may play an important role in pathogenesis of intervertebral disc degeneration. The objective of the study was to examine the regulation of CCN2 by inflammatory cytokines, IL-1, and TNF- and to determine whether CCN2 modulates IL-1-dependent catabolic gene expression in nucleus pulposus (NP) cells. IL-1 and TNF- suppress CCN2 mRNA and protein expression in an NF-B-dependent but MAPK-independent manner. The conserved B sites located at -93/-86 and -546/-537 bp in the CCN2 promoter mediated this suppression. On the other hand, treatment of NP cells with IL-1 in combination with CCN2 suppressed the inductive effect of IL-1 on catabolic genes, including MMP-3, ADAMTS-5, syndecan 4, and prolyl hydroxylase 3. Likewise, silencing of CCN2 in human NP cells resulted in elevated basal expression of several catabolic genes and inflammatory cytokines like IL-6, IL-4, and IL-12 as measured by gene expression and cytokine protein array, respectively. Interestingly, the suppressive effect of CCN2 on IL-1 was independent of modulation of NF-B signaling. Using disintegrins, echistatin, and VLO4, peptide inhibitors to v3 and 51 integrins, we showed that CCN2 binding to both integrins was required for the inhibition of IL-1-induced catabolic gene expression. It is noteworthy that analysis of human tissues showed a trend of altered expression of these integrins during degeneration. Taken together, these results suggest that CCN2 and inflammatory cytokines form a functional negative feedback loop in NP cells that may be important in the pathogenesis of disc disease.	[Risbud, Makarand V.] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Grad Program Cell & Dev Biol, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Risbud, MV (corresponding author), Thomas Jefferson Univ, Dept Orthopaed Surg, 1025 Walnut St,Ste 511 Coll Bldg, Philadelphia, PA 19107 USA.	makarand.risbud@jefferson.edu			National Institutes of Health [AR050087, AR055655, F31AG038125, T32 AR052273]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050087, T32AR052273, R01AR055655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG038125] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AR050087 and AR055655 (to M. V. R.), F31AG038125 (to C. M. T.), and T32 AR052273 (to Z. R. S.).	Abbott RD, 2013, J SPINAL DISORD TECH, V26, pE86, DOI 10.1097/BSD.0b013e31826e0ca4; Abraham DJ, 2000, J BIOL CHEM, V275, P15220, DOI 10.1074/jbc.275.20.15220; Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Aoyama E, 2009, BIOCHEM J, V420, P413, DOI 10.1042/BJ20081991; Bachmeier BE, 2007, ANN NY ACAD SCI, V1096, P44, DOI 10.1196/annals.1397.069; Bedore J, 2013, ARTHRITIS RHEUM-US, V65, P2634, DOI 10.1002/art.38075; Bogatkevich GS, 2007, ARTHRITIS RHEUM-US, V56, P3468, DOI 10.1002/art.22874; Bridgen DT, 2013, J ORTHOP RES, V31, P1661, DOI 10.1002/jor.22395; Burkhart BA, 2005, J BIOL CHEM, V280, P6349, DOI 10.1074/jbc.M411147200; Chaqour B, 2006, J BIOL CHEM, V281, P20608, DOI 10.1074/jbc.M600214200; Chen A, 2008, BRIT J PHARMACOL, V153, P557, DOI 10.1038/sj.bjp.0707542; Davidson ENB, 2006, ARTHRITIS RHEUM-US, V54, P1653, DOI 10.1002/art.21795; Erwin WM, 2006, ARTHRITIS RHEUM-US, V54, P3859, DOI 10.1002/art.22258; Feng HY, 2006, J BONE JOINT SURG AM, V88A, P25, DOI 10.2106/JBJS.E.01341; Fujita N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375964; Gao RP, 2004, J BIOL CHEM, V279, P8848, DOI 10.1074/jbc.M313204200; Gilchrist CL, 2007, J ORTHOP RES, V25, P829, DOI 10.1002/jor.20343; Gressner OA, 2011, WORLD J GASTROENTERO, V17, P151, DOI 10.3748/wjg.v17.i2.151; Hoshijima M, 2006, FEBS LETT, V580, P1376, DOI 10.1016/j.febslet.2006.01.061; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; Le Maitre CL, 2009, ARTHRITIS RHEUM-US, V60, P460, DOI 10.1002/art.24248; Lee JM, 2011, J ORTHOP RES, V29, P265, DOI 10.1002/jor.21210; Liu S, 2012, PLOS ONE, P7; Liu SC, 2013, BBA-MOL CELL RES, V1833, P1114, DOI 10.1016/j.bbamcr.2012.12.014; Maeda A, 2009, J BIOCHEM, V145, P207, DOI 10.1093/jb/mvn159; Marcinkiewicz C, 1996, BIOCHEM J, V317, P817, DOI 10.1042/bj3170817; Masuko Kayo, 2010, BMC Res Notes, V3, P5, DOI 10.1186/1756-0500-3-5; Moritani Norifumi H, 2005, Cell Commun Signal, V3, P6, DOI 10.1186/1478-811X-3-6; Nishida T, 2004, J BONE MINER RES, V19, P1308, DOI 10.1359/JBMR.040322; Nishida T, 2007, J CELL COMMUN SIGNAL, V1, P45, DOI 10.1007/s12079-007-0005-z; Nishida T, 2011, ENDOCRINOLOGY, V152, P4232, DOI 10.1210/en.2011-0234; Peng BG, 2009, SPINE, V34, pE178, DOI 10.1097/BRS.0b013e3181908ab3; Phillips KLE, 2013, ANN RHEUM DIS, V72, P1860, DOI 10.1136/annrheumdis-2012-202266; Risbud MV, 2006, J CELL BIOCHEM, V98, P152, DOI 10.1002/jcb.20765; Risbud MV, 2005, SPINE, V30, P2503, DOI 10.1097/01.brs.0000186326.82747.13; Rittie L, 2011, J CELL COMMUN SIGNAL, V5, P69, DOI 10.1007/s12079-010-0114-y; Sanchez-Lopez E, 2009, J AM SOC NEPHROL, V20, P1513, DOI 10.1681/ASN.2008090999; Setton LA, 2006, J BONE JOINT SURG AM, V88A, P52, DOI 10.2106/JBJS.F.00001; Shamji MF, 2010, ARTHRITIS RHEUM-US, V62, P1974, DOI 10.1002/art.27444; Su G, 2012, AM J RESP CRIT CARE, V185, P58, DOI 10.1164/rccm.201108-1381OC; Tian Y, 2013, AM J PATHOL, V182, P2310, DOI 10.1016/j.ajpath.2013.02.037; Tran CM, 2013, J BIOL CHEM, V288, P12654, DOI 10.1074/jbc.M112.448860; Tran CM, 2011, ARTHRITIS RHEUM-US, V63, P3022, DOI 10.1002/art.30468; Tran CM, 2010, ARTHRITIS RHEUM-US, V62, P1983, DOI 10.1002/art.27445; Wang JR, 2011, J BIOL CHEM, V286, P39738, DOI 10.1074/jbc.M111.264549; Wu QH, 2012, ARTHRITIS RHEUM-US, V64, P3324, DOI 10.1002/art.34570; Xia MS, 2011, J ORTHOP RES, V29, P556, DOI 10.1002/jor.21273; Xia MS, 2008, CONNECT TISSUE RES, V49, P464, DOI 10.1080/03008200802325425; Xia W, 2007, ANN SURG, V246, P886, DOI 10.1097/SLA.0b013e318070d54f	50	47	50	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7374	7387		10.1074/jbc.M113.526111	http://dx.doi.org/10.1074/jbc.M113.526111			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24464580	hybrid, Green Published			2022-12-28	WOS:000332761500010
J	Gilardi, F; Giudici, M; Mitro, N; Maschi, O; Guerrini, U; Rando, G; Maggi, A; Cermenati, G; Laghezza, A; Loiodice, F; Pochetti, G; Lavecchia, A; Caruso, D; De Fabiani, E; Bamberg, K; Crestani, M				Gilardi, Federica; Giudici, Marco; Mitro, Nico; Maschi, Omar; Guerrini, Uliano; Rando, Gianpaolo; Maggi, Adriana; Cermenati, Gaia; Laghezza, Antonio; Loiodice, Fulvio; Pochetti, Giorgio; Lavecchia, Antonio; Caruso, Donatella; De Fabiani, Emma; Bamberg, Krister; Crestani, Maurizio			LT175 Is a Novel PPAR alpha/gamma Ligand with Potent Insulin-sensitizing Effects and Reduced Adipogenic Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipogenesis; Glucose Metabolism; Insulin Resistance; Metabolic Regulation; Peroxisome Proliferator-activated Receptor (PPAR); Transcription Coregulators; Type 2 Diabetes	ACTIVATED-RECEPTOR-GAMMA; MYOCARDIAL-INFARCTION; CARDIAC-HYPERTROPHY; PARTIAL AGONIST; ALPHA; THIAZOLIDINEDIONES; ROSIGLITAZONE; METABOLISM; OBESITY; PHOSPHORYLATION	Background: PPARs are attractive targets of antidiabetic agents. However, PPAR ligands show side effects that hinder their clinical use. Results: LT175 improves insulin sensitivity and reduces body weight via selective gene activation in adipose tissue. Conclusion: LT175 shows an improved pharmacological profile linked to characteristic binding and differential coregulator recruitment. Significance: LT175 may be a scaffold molecule to design a safer generation of PPAR ligands. Peroxisome proliferator-activated receptors (PPARs) are ligand-dependent transcription factors regulating lipid and glucose metabolism. Ongoing drug discovery programs aim to develop dual PPAR/ agonists devoid of the side effects of the marketed antidiabetic agents thiazolidinediones and the dual agonists glitazars. Recently, we described a new dual PPAR/ ligand, LT175, with a partial agonist profile against PPAR and interacting with a newly identified region of the PPAR-ligand binding domain (1). Here we show that LT175 differentially activated PPAR target genes involved in fatty acid esterification and storage in 3T3-L1-derived adipocytes. This resulted in a less severe lipid accumulation compared with that triggered by rosiglitazone, suggesting that LT175 may have a lower adipogenic activity. Consistent with this hypothesis, in vivo administration of LT175 to mice fed a high-fat diet decreased body weight, adipocyte size, and white adipose tissue mass, as assessed by magnetic resonance imaging. Furthermore, LT175 significantly reduced plasma glucose, insulin, non-esterified fatty acids, triglycerides, and cholesterol and increased circulating adiponectin and fibroblast growth factor 21 levels. Oral glucose and insulin tolerance tests showed that the compound improves glucose homeostasis and insulin sensitivity. Moreover, we demonstrate that the peculiar interaction of LT175 with PPAR affected the recruitment of the coregulators cyclic-AMP response element-binding protein-binding protein and nuclear corepressor 1 (NCoR1), fundamentals for the PPAR-mediated adipogenic program. In conclusion, our results describe a new PPAR ligand, modulating lipid and glucose metabolism with reduced adipogenic activity, that may be used as a model for a series of novel molecules with an improved pharmacological profile for the treatment of dyslipidemia and type 2 diabetes.	[Gilardi, Federica; Giudici, Marco; Mitro, Nico; Maschi, Omar; Guerrini, Uliano; Rando, Gianpaolo; Maggi, Adriana; Cermenati, Gaia; Caruso, Donatella; De Fabiani, Emma; Crestani, Maurizio] Univ Milan, Dipartimento Sci Farmacol & Biomol, I-20133 Milan, Italy; [Laghezza, Antonio; Loiodice, Fulvio] Univ Bari Aldo Moro, Dipartimento Farm Sci Farmaco, I-70125 Bari, Italy; [Pochetti, Giorgio] CNR, I-00016 Rome, Italy; [Lavecchia, Antonio] Univ Naples Federico II, Dipartimento Farm, Drug Discovery Lab, I-80131 Naples, Italy; [Bamberg, Krister] AstraZeneca, S-43183 Molndal, Sweden	University of Milan; Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; AstraZeneca	Crestani, M (corresponding author), Univ Milan, Dipartimento Sci Farmacol & Biomol, Giovanni Galli Lab Biochem & Mol Biol Metab, I-20133 Milan, Italy.	maurizio.crestani@unimi.it	Laghezza, Antonio/F-7420-2014; De Fabiani, Emma/B-6936-2015; Lavecchia, Antonio/P-9476-2017; pochetti, giorgio/AAU-7069-2020	De Fabiani, Emma/0000-0003-2406-1468; Lavecchia, Antonio/0000-0002-2181-8026; Gilardi, Federica/0000-0001-5421-2779; Laghezza, Antonio/0000-0001-6221-6155; Maschi, Omar/0000-0002-4879-436X; Maggi, Adriana/0000-0001-5700-5273; Crestani, Maurizio/0000-0001-9230-1078; Mitro, Nico/0000-0002-5000-3619	Universita degli Studi di Milano	Universita degli Studi di Milano	We thank Elda Desiderio Pinto (Universita degli Studi di Milano) for administrative and financial management and Catherine Moret (Center for Integrative Genomics, University of Lausanne) for help with histological analyses.	[Anonymous], 2008, LANCET, V372, P1520, DOI [10.1016/S0140-6736(08)61628-1, 10.2337/dc08-9025]; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Berthou L, 1996, J CLIN INVEST, V97, P2408, DOI 10.1172/JCI118687; Biserni A, 2008, MOL PHARMACOL, V73, P1434, DOI 10.1124/mol.107.042689; Burgermeister E, 2006, MOL ENDOCRINOL, V20, P809, DOI 10.1210/me.2005-0171; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Ciana P, 2007, MOL ENDOCRINOL, V21, P388, DOI 10.1210/me.2006-0152; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Douglas IJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000154; Duan SZ, 2005, CIRC RES, V97, P372, DOI 10.1161/01.RES.0000179226.34112.6d; Duncan JG, 2010, CIRCULATION, V121, P426, DOI 10.1161/CIRCULATIONAHA.109.888735; Fievet C, 2006, CURR OPIN PHARMACOL, V6, P606, DOI 10.1016/j.coph.2006.06.009; Galmozzi A, 2013, DIABETES, V62, P732, DOI 10.2337/db12-0548; Guan YF, 2005, NAT MED, V11, P861, DOI 10.1038/nm1278; Henry RR, 2009, LANCET, V374, P126, DOI 10.1016/S0140-6736(09)60870-9; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Li Y, 2008, J BIOL CHEM, V283, P9168, DOI 10.1074/jbc.M800104200; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Liu Y, 2013, J PROTEOME RES, V12, P5634, DOI 10.1021/pr400587y; Mitro N., 2013, PEROXISOME PROLIFERA, P219; Montanari R, 2008, J MED CHEM, V51, P7768, DOI 10.1021/jm800733h; Mudaliar Sunder, 2003, Endocr Pract, V9, P406; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nissen SE, 2010, ARCH INTERN MED, V170, P1191, DOI 10.1001/archinternmed.2010.207; Pochetti G, 2010, J MED CHEM, V53, P4354, DOI 10.1021/jm9013899; Porcelli L, 2012, J MED CHEM, V55, P37, DOI 10.1021/jm201306q; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Qi C, 2003, J BIOL CHEM, V278, P25281, DOI 10.1074/jbc.C300175200; Rieusset J, 2002, MOL ENDOCRINOL, V16, P2628, DOI 10.1210/me.2002-0036; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Shadid S, 2003, DIABETES CARE, V26, P3148, DOI 10.2337/diacare.26.11.3148; Shockley KR, 2009, J CELL BIOCHEM, V106, P232, DOI 10.1002/jcb.21994; Son NH, 2007, J CLIN INVEST, V117, P2791, DOI 10.1172/JCI30335; Takahashi N, 2002, J BIOL CHEM, V277, P16906, DOI 10.1074/jbc.M200585200; Tang W, 2011, CELL METAB, V14, P116, DOI 10.1016/j.cmet.2011.05.012; Vallon V, 2009, J AM SOC NEPHROL, V20, P721, DOI 10.1681/ASN.2008040415; Wei W, 2010, CELL METAB, V11, P503, DOI 10.1016/j.cmet.2010.04.015; Wilding J, 2006, INT J CLIN PRACT, V60, P1272, DOI 10.1111/j.1742-1241.2006.01128.x; Young ME, 2002, CIRCULATION, V105, P1861, DOI 10.1161/01.CIR.0000012467.61045.87; Zhang H, 2005, P NATL ACAD SCI USA, V102, P9406, DOI 10.1073/pnas.0501744102	46	27	27	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6908	6920		10.1074/jbc.M113.506394	http://dx.doi.org/10.1074/jbc.M113.506394			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24451380	Green Published, hybrid			2022-12-28	WOS:000332389400051
J	Spear, M; Guo, J; Turner, A; Yu, DY; Wang, WF; Meltzer, B; He, SJ; Hu, XH; Shang, H; Kuhn, J; Wu, YT				Spear, Mark; Guo, Jia; Turner, Amy; Yu, Dongyang; Wang, Weifeng; Meltzer, Beatrix; He, Sijia; Hu, Xiaohua; Shang, Hong; Kuhn, Jeffrey; Wu, Yuntao			HIV-1 Triggers WAVE2 Phosphorylation in Primary CD4 T Cells and Macrophages, Mediating Arp2/3-dependent Nuclear Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						HIV-1; Immunology; Microbiology; Signal Transduction; Virology; Arp2; 3; CCR5; CD4; Wav2	ARP2/3 COMPLEX; CORTICAL ACTIN; GAG PROTEIN; VIRUS; TRANSCRIPTION; ENTRY; REPLICATION; BINDING; SPREAD; ASSAY	Background: Arp2/3 and the upstream modulator, WAVE2, regulate actin branching and polymerization. Results: HIV triggers WAVE2 phosphorylation for Arp2/3 activity, which is essential for nuclear migration. Conclusion: Arp2/3 and WAVE2 are cellular cofactors hijacked by HIV for intracellular migration. Significance: HIV-mediated WAVE2-Arp2/3 activity may serve as novel therapeutic targets. The human immunodeficiency virus type 1 (HIV-1) initiates receptor signaling and early actin dynamics during viral entry. This process is required for viral infection of primary targets such as resting CD4 T cells. WAVE2 is a component of a multiprotein complex linking receptor signaling to dynamic remodeling of the actin cytoskeleton. WAVE2 directly activates Arp2/3, leading to actin nucleation and filament branching. Although several bacterial and viral pathogens target Arp2/3 for intracellular mobility, it remains unknown whether HIV-1 actively modulates the Arp2/3 complex through virus-mediated receptor signal transduction. Here we report that HIV-1 triggers WAVE2 phosphorylation at serine 351 through gp120 binding to the chemokine coreceptor CXCR4 or CCR5 during entry. This phosphorylation event involves both G(i)-dependent and -independent pathways, and is conserved both in X4 and R5 viral infection of resting CD4 T cells and primary macrophages. We further demonstrate that inhibition of WAVE2-mediated Arp2/3 activity through stable shRNA knockdown of Arp3 dramatically diminished HIV-1 infection of CD4 T cells, preventing viral nuclear migration. Inhibition of Arp2/3 through a specific inhibitor, CK548, also drastically inhibited HIV-1 nuclear migration and infection of CD4 T cells. Our results suggest that Arp2/3 and the upstream regulator, WAVE2, are essential co-factors hijacked by HIV for intracellular migration, and may serve as novel targets to prevent HIV transmission.	[Spear, Mark; Guo, Jia; Turner, Amy; Yu, Dongyang; Wang, Weifeng; Meltzer, Beatrix; Wu, Yuntao] George Mason Univ, Dept Mol & Microbiol, Natl Ctr Biodef & Infect Dis, Manassas, VA 20110 USA; [He, Sijia; Shang, Hong] China Med Univ, Affiliated Hosp 1, Minist Hlth, Key Lab Immunol AIDS, Shenyang 110001, Liaoning Provin, Peoples R China; [Hu, Xiaohua; Kuhn, Jeffrey] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24060 USA	George Mason University; China Medical University; Virginia Polytechnic Institute & State University	Wu, YT (corresponding author), George Mason Univ, Dept Mol & Microbiol, Natl Ctr Biodef & Infect Dis, 10900 Univ Blvd, Manassas, VA 20110 USA.	ywu8@gmu.edu	He, Sijia/M-1157-2019	He, Sijia/0000-0002-1932-1141	Public Health Service Grants from NIAID, National Institutes of Health [1R01AI081568, 1R03AI093157]; NYCDC AIDS Ride; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081568, R03AI093157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102144] Funding Source: NIH RePORTER	Public Health Service Grants from NIAID, National Institutes of Health; NYCDC AIDS Ride; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by Public Health Service Grants 1R01AI081568 and 1R03AI093157 from NIAID, National Institutes of Health (to Y.W.) and in part by the 2010 NYCDC AIDS Ride (to M.S.).	Alfano M, 2001, J IMMUNOL, V166, P1863, DOI 10.4049/jimmunol.166.3.1863; Alfano M, 1999, J EXP MED, V190, P597, DOI 10.1084/jem.190.5.597; Bukrinskaya A, 1998, J EXP MED, V188, P2113, DOI 10.1084/jem.188.11.2113; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Cameron PU, 2010, P NATL ACAD SCI USA, V107, P16934, DOI 10.1073/pnas.1002894107; Campbell GR, 2008, J BIOL CHEM, V283, P30745, DOI 10.1074/jbc.M804112200; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Contreras X, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-37; Cooper J, 2011, J BIOL CHEM, V286, P28498, DOI 10.1074/jbc.M111.239053; CUDMORE S, 1995, NATURE, V378, P636, DOI 10.1038/378636a0; Danson CM, 2007, J CELL SCI, V120, P4144, DOI 10.1242/jcs.013714; DE BP, 1993, J BIOL CHEM, V268, P5703; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Gladnikoff M, 2009, BIOPHYS J, V97, P2419, DOI 10.1016/j.bpj.2009.08.016; Goley ED, 2006, SCIENCE, V314, P464, DOI 10.1126/science.1133348; Graziano F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023674; Haller C, 2006, J BIOL CHEM, V281, P19618, DOI 10.1074/jbc.M513802200; Harmon B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000956; HOTTIGER M, 1995, NUCLEIC ACIDS RES, V23, P736; Hu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049500; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Jolly C, 2004, TRAFFIC, V5, P643, DOI 10.1111/j.1600-0854.2004.00209.X; Jolly C, 2007, J VIROL, V81, P5547, DOI 10.1128/JVI.01469-06; Kelly J, 2008, VIROLOGY, V372, P300, DOI 10.1016/j.virol.2007.11.007; Komano J, 2004, MOL BIOL CELL, V15, P5197, DOI 10.1091/mbc.E04-04-0279; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Lapham CK, 1996, SCIENCE, V274, P602, DOI 10.1126/science.274.5287.602; Lehmann M, 2011, VIRUSES-BASEL, V3, P1757, DOI 10.3390/v3091757; Liu BD, 1999, J VIROL, V73, P2901, DOI 10.1128/JVI.73.4.2901-2908.1999; Mothes W, 2010, J VIROL, V84, P8360, DOI 10.1128/JVI.00443-10; NIEDERMAN TMJ, 1993, VIROLOGY, V197, P420, DOI 10.1006/viro.1993.1605; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Ott DE, 1996, J VIROL, V70, P7734, DOI 10.1128/JVI.70.11.7734-7743.1996; Ott DE, 2000, VIROLOGY, V266, P42, DOI 10.1006/viro.1999.0075; Pocha SM, 2009, CELL MOTIL CYTOSKEL, V66, P36, DOI 10.1002/cm.20323; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Rey O, 1996, VIROLOGY, V220, P530, DOI 10.1006/viro.1996.0343; Saeed MF, 2006, J VIROL METHODS, V135, P143, DOI 10.1016/j.jviromet.2006.02.011; Sattentau QJ, 2010, VIRUSES-BASEL, V2, P1306, DOI 10.3390/v2061306; Spear M, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-45; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Turlure F, 2004, FRONT BIOSCI-LANDMRK, V9, P3187, DOI 10.2741/1472; Vasiliver-Shamis G, 2009, J VIROL, V83, P11341, DOI 10.1128/JVI.01440-09; Vorster PJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182238; Wang WF, 2012, J BIOL CHEM, V287, P35455, DOI 10.1074/jbc.M112.362400; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Wen X., 2013, 20 C RETR OPP INF MA; Wilk T, 1999, J VIROL, V73, P1931, DOI 10.1128/JVI.73.3.1931-1940.1999; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Wu YT, 2003, J VIROL, V77, P10376, DOI 10.1128/JVI.77.19.10376-10382.2003; Wu YT, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-12; Wu Y, 2007, CURR HIV RES, V5, P394; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; Yu DY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000633; Zaitseva M, 2005, J LEUKOCYTE BIOL, V78, P1306, DOI 10.1189/jlb.0105043	57	22	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6949	6959		10.1074/jbc.M113.492132	http://dx.doi.org/10.1074/jbc.M113.492132			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24415754	Green Published, hybrid			2022-12-28	WOS:000332389400055
J	Marzahn, MR; Hayner, JN; Finkelstein, J; O'Donnell, M; Bloom, LB				Marzahn, Melissa R.; Hayner, Jaclyn N.; Finkelstein, Jeff; O'Donnell, Mike; Bloom, Linda B.			The ATP Sites of AAA plus Clamp Loaders Work Together as a Switch to Assemble Clamps on DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; DNA Enzymes; DNA Replication; Fluorescence; Nucleic Acid Enzymology; AAA plus ATPase; Proliferating Cell Nuclear Antigen; Replication Factor C; Clamp Loader	REPLICATION-FACTOR-C; CELL NUCLEAR ANTIGEN; POLYMERASE III HOLOENZYME; ESCHERICHIA-COLI; SLIDING CLAMP; COMPLEX-FORMATION; LOADING MACHINE; DISTINCT ROLES; BINDING; PCNA	Background: Replication factor C contains four active AAA+ ATPase sites. Results: Mutation of any one ATP binding site affects clamp loader activities. Conclusion: Although ATP sites may fill sequentially, ATP binding to all four sites is needed for RFC activity. Significance: This provides insight into the ATP-dependent conformational changes in RFC that drive the clamp loading reaction. Clamp loaders belong to a family of proteins known as ATPases associated with various cellular activities (AAA+). These proteins utilize the energy from ATP binding and hydrolysis to perform cellular functions. The clamp loader is required to load the clamp onto DNA for use by DNA polymerases to increase processivity. ATP binding and hydrolysis are coordinated by several key residues, including a conserved Lys located within the Walker A motif (or P-loop). This residue is required for each subunit to bind ATP. The specific function of each ATP molecule bound to the Saccharomyces cerevisiae clamp loader is unknown. A series of point mutants, each lacking a single Walker A Lys residue, was generated to study the effects of abolishing ATP binding in individual clamp loader subunits. A variety of biochemical assays were used to analyze the function of ATP binding during discrete steps of the clamp loading reaction. All mutants reduced clamp binding/opening to different degrees. Decreased clamp binding activity was generally correlated with decreases in the population of open clamps, suggesting that differences in the binding affinities of Walker A mutants stem from differences in stabilization of proliferating cell nuclear antigen in an open conformation. Walker A mutations had a smaller effect on DNA binding than clamp binding/opening. Our data do not support a model in which each ATP site functions independently to regulate a different step in the clamp loading cycle to coordinate these steps. Instead, the ATP sites work in unison to promote conformational changes in the clamp loader that drive clamp loading.	[Marzahn, Melissa R.; Hayner, Jaclyn N.; Bloom, Linda B.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Finkelstein, Jeff; O'Donnell, Mike] Howard Hughes Med Inst, New York, NY 10021 USA; [Finkelstein, Jeff; O'Donnell, Mike] Rockefeller Univ, New York, NY 10021 USA	State University System of Florida; University of Florida; Howard Hughes Medical Institute; Rockefeller University	Bloom, LB (corresponding author), Univ Florida, Dept Biochem & Mol Biol, 1600 SW Archer Rd,JHMHC Rm R3-234, Gainesville, FL 32601 USA.	lbloom@ufl.edu	Bloom, Linda B/F-3684-2014	O'Donnell, Michael/0000-0001-9002-4214	National Institutes of Health [GM082849, T32 CA009126-32]; GM38839; NATIONAL CANCER INSTITUTE [T32CA009126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082849, R01GM038839, R37GM038839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GM38839; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM082849 (to L. B. B.), T32 CA009126-32 (to J. N. H. through the University of Florida Shands Cancer Center), and GM38839 (to M. O. D.).	Anderson SG, 2007, J BIOL CHEM, V282, P7035, DOI 10.1074/jbc.M610136200; Anderson SG, 2009, BIOCHEMISTRY-US, V48, P8516, DOI 10.1021/bi900912a; AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; BAUER GA, 1988, P NATL ACAD SCI USA, V85, P7506, DOI 10.1073/pnas.85.20.7506; Bloom LB, 1996, J BIOL CHEM, V271, P30699, DOI 10.1074/jbc.271.48.30699; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Cai JS, 1998, P NATL ACAD SCI USA, V95, P11607, DOI 10.1073/pnas.95.20.11607; Chen SY, 2009, J MOL BIOL, V388, P431, DOI 10.1016/j.jmb.2009.03.014; Chiraniya A, 2013, GENES-BASEL, V4, P134, DOI 10.3390/genes4020134; CRONET P, 1995, J MOL BIOL, V249, P654, DOI 10.1006/jmbi.1995.0326; Davey MJ, 2002, NAT REV MOL CELL BIO, V3, P826, DOI 10.1038/nrm949; Dougan DA, 2002, FEBS LETT, V529, P6, DOI 10.1016/S0014-5793(02)03179-4; Downey CD, 2011, J MOL BIOL, V412, P340, DOI 10.1016/j.jmb.2011.07.051; Duderstadt KE, 2008, CRIT REV BIOCHEM MOL, V43, P163, DOI [10.1080/10409230802058296, 10.1080/10409230802058296 ]; Finkelstein J, 2003, ANAL BIOCHEM, V319, P78, DOI 10.1016/S0003-2697(03)00273-2; Gomes XV, 2001, J BIOL CHEM, V276, P34776, DOI 10.1074/jbc.M011743200; Gomes XV, 2001, J BIOL CHEM, V276, P34768, DOI 10.1074/jbc.M011631200; Gomes XV, 2000, J BIOL CHEM, V275, P14541, DOI 10.1074/jbc.275.19.14541; Grabowski B, 2003, ANNU REV MICROBIOL, V57, P487, DOI 10.1146/annurev.micro.57.030502.090709; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hingorani MM, 1998, J BIOL CHEM, V273, P24550, DOI 10.1074/jbc.273.38.24550; Huebscher Ulrich, 2009, V521, P19, DOI [10.1007/978-1-60327-817-5_2, 10.1007/978-1-60327-815-7_2]; Indiani C, 2006, NAT REV MOL CELL BIO, V7, P751, DOI 10.1038/nrm2022; Johnson A, 2006, J BIOL CHEM, V281, P35531, DOI 10.1074/jbc.M606090200; Kelch BA, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-34; Kelch BA, 2011, SCIENCE, V334, P1675, DOI 10.1126/science.1211884; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Marzahn MR, 2012, PROTEIN EXPRES PURIF, V83, P135, DOI 10.1016/j.pep.2012.03.010; McHenry CS, 2011, ANNU REV BIOCHEM, V80, P403, DOI 10.1146/annurev-biochem-061208-091655; Neuwald AF, 1999, GENOME RES, V9, P27; Podust VN, 1998, J BIOL CHEM, V273, P12935, DOI 10.1074/jbc.273.21.12935; Podust VN, 1998, J BIOL CHEM, V273, P31992, DOI 10.1074/jbc.273.48.31992; Sakato M, 2012, J MOL BIOL, V416, P176, DOI 10.1016/j.jmb.2011.12.018; Sakato M, 2012, J MOL BIOL, V416, P163, DOI 10.1016/j.jmb.2011.12.017; Schmidt SLG, 2001, J BIOL CHEM, V276, P34792, DOI 10.1074/jbc.M011671200; Schmidt SLG, 2001, J BIOL CHEM, V276, P34784, DOI 10.1074/jbc.M011633200; Seybert A, 2004, EMBO J, V23, P1360, DOI 10.1038/sj.emboj.7600130; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; Snider J, 2008, BIOCHEM SOC T, V36, P72, DOI 10.1042/BST0360072; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; Tainer JA, 2010, J AM CHEM SOC, V132, P7372, DOI 10.1021/ja100365x; Thompson JA, 2012, J BIOL CHEM, V287, P2203, DOI 10.1074/jbc.C111.318899; Thompson JA, 2009, J BIOL CHEM, V284, P32147, DOI 10.1074/jbc.M109.045997; Turner J, 1999, EMBO J, V18, P771, DOI 10.1093/emboj/18.3.771; Uhlmann F, 1997, J BIOL CHEM, V272, P10058; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Wieczorek A, 2010, J BIOL CHEM, V285, P29049, DOI 10.1074/jbc.C110.165076; Yao N, 2003, J BIOL CHEM, V278, P50744, DOI 10.1074/jbc.M309206200; Yao N, 1996, GENES CELLS, V1, P101, DOI 10.1046/j.1365-2443.1996.07007.x; Yao NY, 2006, J BIOL CHEM, V281, P17528, DOI 10.1074/jbc.M601273200; Zhuang ZH, 2006, P NATL ACAD SCI USA, V103, P2546, DOI 10.1073/pnas.0511263103	53	8	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5537	5548		10.1074/jbc.M113.541466	http://dx.doi.org/10.1074/jbc.M113.541466			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24436332	Green Published, hybrid			2022-12-28	WOS:000332015500020
J	del Pino, I; Koch, D; Schemm, R; Qualmann, B; Betz, H; Paarmann, I				del Pino, Isabel; Koch, Dennis; Schemm, Rudolf; Qualmann, Britta; Betz, Heinrich; Paarmann, Ingo			Proteomic Analysis of Glycine Receptor beta Subunit ( GlyR beta)interacting Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cys Loop Receptors; Glycine Receptors; Mass Spectrometry (MS); Molecular Modeling; Protein-Protein Interactions; Inhibitory Synapse; Knockdown; Membrane Protein Trafficking; Spinal Cord; Syndapin	ADENOASSOCIATED VIRUS VECTORS; F-BAR PROTEINS; SYNDAPIN-I; VESICLE FORMATION; PLASMA-MEMBRANE; STRUCTURAL BASIS; SPINAL-CORD; SH3 DOMAIN; GEPHYRIN; BINDING	Background: Glycine receptors mediate inhibitory neurotransmission in the central nervous system. Results: Syndapin I is a new interaction partner of the glycine receptor subunit, and its down-regulation reduces synaptic glycine receptor levels. Conclusion: Syndapin I is involved in glycine receptor trafficking to and/or anchoring at inhibitory postsynapses. Significance: Disclosing new determinants of glycine receptor clustering is crucial for understanding inhibitory synapse formation. Glycine receptors (GlyRs) mediate inhibitory neurotransmission in spinal cord and brainstem. They are clustered at inhibitory postsynapses via a tight interaction of their subunits (GlyR) with the scaffolding protein gephyrin. In an attempt to isolate additional proteins interacting with GlyR, we performed pulldown experiments with rat brain extracts using a glutathione S-transferase fusion protein encompassing amino acids 378-455 of the large intracellular loop of GlyR as bait. This identified syndapin I (SdpI) as a novel interaction partner of GlyR that coimmunoprecipitates with native GlyRs from brainstem extracts. Both SdpI and SdpII bound efficiently to the intracellular loop of GlyR in vitro and colocalized with GlyR upon coexpression in COS-7 cells. The SdpI-binding site was mapped to a proline-rich sequence of 22 amino acids within the intracellular loop of GlyR. Deletion and point mutation analysis disclosed that SdpI binding to GlyR is Src homology 3 domain-dependent. In cultured rat spinal cord neurons, SdpI immunoreactivity was found to partially colocalize with marker proteins of inhibitory and excitatory synapses. When SdpI was acutely knocked down in cultured spinal cord neurons by viral miRNA expression, postsynaptic GlyR clusters were significantly reduced in both size and number. Similar changes in GlyR cluster properties were found in spinal cultures from SdpI-deficient mice. Our results are consistent with a role of SdpI in the trafficking and/or cytoskeletal anchoring of synaptic GlyRs.	[del Pino, Isabel; Betz, Heinrich; Paarmann, Ingo] Max Planck Inst Brain Res, Dept Neurochem, D-60438 Frankfurt, Germany; [Koch, Dennis; Qualmann, Britta] Univ Jena, Jena Univ Hosp, Inst Biochem 1, D-07743 Jena, Germany; [Schemm, Rudolf] Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, D-37077 Gottingen, Germany; [Betz, Heinrich] Max Planck Inst Med Res, D-69120 Heidelberg, Germany	Max Planck Society; Friedrich Schiller University of Jena; Max Planck Society; Max Planck Society	Betz, H (corresponding author), Max Planck Inst Med Res, Jahnstr 29, D-69120 Heidelberg, Germany.	heinrich.betz@mpimf-heidelberg.mpg.de; Ingo.Paarmann@gmx.net	del Pino, Isabel/A-6072-2018	del Pino, Isabel/0000-0002-8672-926X	Max Planck Society; Deutsche Forschungsgemeinschaft [PA1623/2-1, Qu116/5-1, -5-2]; Schram-Stiftung; Fonds der Chemische Industrie	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Schram-Stiftung; Fonds der Chemische Industrie	This work was supported by the Max Planck Society (to H. B.), Deutsche Forschungsgemeinschaft Grants PA1623/2-1, Qu116/5-1, and -5-2, Schram-Stiftung (to B. Q.), and Fonds der Chemische Industrie (to H. B.).	Andersson F, 2008, J NEUROSCI, V28, P3925, DOI 10.1523/JNEUROSCI.1754-07.2008; Anggono V, 2007, J NEUROCHEM, V102, P931, DOI 10.1111/j.1471-4159.2007.04574.x; Bausen M, 2006, MOL CELL NEUROSCI, V31, P376, DOI 10.1016/j.mcn.2005.11.004; Braun A, 2005, MOL BIOL CELL, V16, P3642, DOI 10.1091/mbc.E05-01-0076; Brundiers R, 1999, J BIOL CHEM, V274, P35289, DOI 10.1074/jbc.274.50.35289; Charrier C, 2006, J NEUROSCI, V26, P8502, DOI 10.1523/JNEUROSCI.1758-06.2006; del Pino I, 2011, BIOCHEM BIOPH RES CO, V412, P435, DOI 10.1016/j.bbrc.2011.07.110; Dharmalingam E, 2009, J NEUROSCI, V29, P13315, DOI 10.1523/JNEUROSCI.3973-09.2009; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dumoulin A, 2000, EUR J NEUROSCI, V12, P3883, DOI 10.1046/j.1460-9568.2000.00271.x; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Fuhrmann JC, 2002, J NEUROSCI, V22, P5393; Giesemann T, 2003, J NEUROSCI, V23, P8330; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; GRENNINGLOH G, 1990, NEURON, V4, P963, DOI 10.1016/0896-6273(90)90149-A; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; Griffon N, 1999, EMBO J, V18, P4711, DOI 10.1093/emboj/18.17.4711; Grimm D, 2003, MOL THER, V7, P839, DOI 10.1016/S1525-0016(03)00095-9; Grimm D, 1998, HUM GENE THER, V9, P2745, DOI 10.1089/hum.1998.9.18-2745; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hirling H, 2009, NEUROSCIENCE, V158, P36, DOI 10.1016/j.neuroscience.2008.02.057; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kessels MM, 2006, J BIOL CHEM, V281, P13285, DOI 10.1074/jbc.M510226200; Kessels MM, 2006, J CELL SCI, V119, P1504, DOI 10.1242/jcs.02877; Kessels MM, 2004, J CELL SCI, V117, P3077, DOI 10.1242/jcs.01290; KIRSCH J, 1995, J NEUROSCI, V15, P4148; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Kneussel M, 1999, J NEUROCHEM, V72, P1323, DOI 10.1046/j.1471-4159.1999.0721323.x; Koch D, 2011, EMBO J, V30, P4955, DOI 10.1038/emboj.2011.339; Levi S, 1998, J CELL SCI, V111, P335; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Maas C, 2006, J CELL BIOL, V172, P441, DOI 10.1083/jcb.200506066; Maas C, 2009, P NATL ACAD SCI USA, V106, P8731, DOI 10.1073/pnas.0812391106; Mammoto A, 1998, BIOCHEM BIOPH RES CO, V243, P86, DOI 10.1006/bbrc.1997.8068; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Modregger J, 2000, J CELL SCI, V113, P4511; Paarmann I, 2008, PROTEIN SCI, V17, P1946, DOI 10.1110/ps.035550.108; Paarmann I, 2006, J BIOL CHEM, V281, P34918, DOI 10.1074/jbc.M607764200; Perez-Otano I, 2006, NAT NEUROSCI, V9, P611, DOI 10.1038/nn1680; PFEIFFER F, 1984, P NATL ACAD SCI-BIOL, V81, P7224, DOI 10.1073/pnas.81.22.7224; Puntervoll P, 2003, NUCLEIC ACIDS RES, V31, P3625, DOI 10.1093/nar/gkg545; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Qualmann B, 2002, INT REV CYTOL, V220, P93; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Qualmann B, 2011, EMBO J, V30, P3501, DOI 10.1038/emboj.2011.266; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; Reddy-Alla S, 2010, EUR J NEUROSCI, V31, P1173, DOI 10.1111/j.1460-9568.2010.07149.x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHRODER S, 1991, BIOCHEMISTRY-US, V30, P42, DOI 10.1021/bi00215a007; Schwintzer L, 2011, EMBO J, V30, P3147, DOI 10.1038/emboj.2011.207; Shevtsova Z, 2005, EXP PHYSIOL, V90, P53, DOI 10.1113/expphysiol.2004.028159; Sola M, 2004, EMBO J, V23, P2510, DOI 10.1038/sj.emboj.7600256; Weltzien F, 2012, J COMP NEUROL, V520, P3962, DOI 10.1002/cne.23139; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	58	15	15	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11396	11409		10.1074/jbc.M113.504860	http://dx.doi.org/10.1074/jbc.M113.504860			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24509844	hybrid, Green Published			2022-12-28	WOS:000334638500041
J	Williams, SM; Chandran, AV; Vijayabaskar, MS; Roy, S; Balaram, H; Vishveshwara, S; Vijayan, M; Chatterji, D				Williams, Sunanda Margrett; Chandran, Anu V.; Vijayabaskar, Mahalingam S.; Roy, Sourav; Balaram, Hemalatha; Vishveshwara, Saraswathi; Vijayan, Mamannamana; Chatterji, Dipankar			A Histidine Aspartate Ionic Lock Gates the Iron Passage in Miniferritins from Mycobacterium smegmatis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding Protein; Ion Channels; Iron; Mycobacterium; X-ray Crystallography; Mycobacterium smegmatis; Ionic Cluster; Iron Oxidation	DNA-BINDING PROTEIN; COLI RNA-POLYMERASE; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; CARBON NANOTUBES; DPS PROTEIN; FERRITIN; MECHANISM; IDENTIFICATION	Background: DNA-binding protein from starved cells (Dps) are nano-compartments that can oxidize and store iron rendering protection from free radicals. Results: A histidine-aspartate ionic cluster in mycobaterial Dps2 modulates the rate of iron entry and exit in these proteins. Conclusion: Substitutions that disrupt the cluster interface alter the iron uptake/release properties with localized structural changes. Significance: Identifying important gating residues can help in designing nano-delivery vehicles. Dps (DNA-binding protein from starved cells) are dodecameric assemblies belonging to the ferritin family that can bind DNA, carry out ferroxidation, and store iron in their shells. The ferritin-like trimeric pore harbors the channel for the entry and exit of iron. By representing the structure of Dps as a network we have identified a charge-driven interface formed by a histidine aspartate cluster at the pore interface unique to Mycobacterium smegmatis Dps protein, MsDps2. Site-directed mutagenesis was employed to generate mutants to disrupt the charged interactions. Kinetics of iron uptake/release of the wild type and mutants were compared. Crystal structures were solved at a resolution of 1.8-2.2 for the various mutants to compare structural alterations vis a vis the wild type protein. The substitutions at the pore interface resulted in alterations in the side chain conformations leading to an overall weakening of the interface network, especially in cases of substitutions that alter the charge at the pore interface. Contrary to earlier findings where conserved aspartate residues were found crucial for iron release, we propose here that in the case of MsDps2, it is the interplay of negative-positive potentials at the pore that enables proper functioning of the protein. In similar studies in ferritins, negative and positive patches near the iron exit pore were found to be important in iron uptake/release kinetics. The unique ionic cluster in MsDps2 makes it a suitable candidate to act as nano-delivery vehicle, as these gated pores can be manipulated to exhibit conformations allowing for slow or fast rates of iron release.	[Williams, Sunanda Margrett; Chandran, Anu V.; Vishveshwara, Saraswathi; Vijayan, Mamannamana; Chatterji, Dipankar] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Vijayabaskar, Mahalingam S.] Univ Leeds, Sch Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Roy, Sourav; Balaram, Hemalatha; Chatterji, Dipankar] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; University of Leeds; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Chatterji, D (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	dipankar@mbu.iisc.ernet.in	ROY, SOURAV/AAI-2678-2021	ROY, SOURAV/0000-0002-3927-571X; Vijayabaskar, MS/0000-0002-5559-9394; Chatterji, Dipankar/0000-0002-9985-0632	Department of Biotechnology (DBT); Council of Scientific and Industrial Research	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by a grant from the Department of Biotechnology (DBT) infrastructure program for basic biological research.; Supported by senior research fellowships from the Council of Scientific and Industrial Research.	Aisen P, 2001, INT J BIOCHEM CELL B, V33, P940, DOI 10.1016/S1357-2725(01)00063-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bellapadrona G, 2009, J BIOL CHEM, V284, P19101, DOI 10.1074/jbc.M109.014670; Benjamin JAM, 2010, CAN J PHYSIOL PHARM, V88, P264, DOI 10.1139/Y10-014; Bevers Loes E, 2011, Prog Mol Subcell Biol, V52, P29, DOI 10.1007/978-3-642-21230-7_2; Bozzi M, 1997, J BIOL CHEM, V272, P3259, DOI 10.1074/jbc.272.6.3259; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brentjens RJ, 1996, J BACTERIOL, V178, P808, DOI 10.1128/jb.178.3.808-816.1996; Ceci P, 2003, J BIOL CHEM, V278, P20319, DOI 10.1074/jbc.M302114200; Ceci P, 2011, J BIOL INORG CHEM, V16, P869, DOI 10.1007/s00775-011-0784-9; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Choi SH, 2000, APPL ENVIRON MICROB, V66, P3911, DOI 10.1128/AEM.66.9.3911-3916.2000; Chowdhury RP, 2008, BIOCHEMISTRY-US, V47, P11110, DOI 10.1021/bi801158e; Chowdhury RP, 2007, J BACTERIOL, V189, P8973, DOI 10.1128/JB.01222-07; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; Cuypers MG, 2007, J MOL BIOL, V371, P787, DOI 10.1016/j.jmb.2006.11.032; DeLano W.L, PYMOL MOL GRAPHICS S; Dezso Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.055103; Douglas T, 1998, PROTEIN SCI, V7, P1083, DOI 10.1002/pro.5560070502; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Ghatak P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016019; Gupta S, 2003, J BIOL CHEM, V278, P5235, DOI 10.1074/jbc.M208825200; Gupta S, 2002, PROTEIN ENG, V15, P503, DOI 10.1093/protein/15.6.503; Ilari A, 2000, NAT STRUCT BIOL, V7, P38; Ilari A, 2002, J BIOL CHEM, V277, P37619, DOI 10.1074/jbc.M206186200; Jeong GH, 2007, CARBON, V45, P978, DOI 10.1016/j.carbon.2006.12.032; Jin WL, 2001, BIOCHEMISTRY-US, V40, P7525, DOI 10.1021/bi002509c; Jolley CC, 2010, BIOPHYS J, V99, P3385, DOI 10.1016/j.bpj.2010.09.001; JONES T, 1978, BIOCHEMISTRY-US, V17, P4011, DOI 10.1021/bi00612a021; Kanna N, 1999, J MOL BIOL, V292, P441, DOI 10.1006/jmbi.1999.3058; Kannan N, 2001, PROTEIN SCI, V10, P46, DOI 10.1110/ps.26201; Kauko A, 2004, J MOL BIOL, V338, P547, DOI 10.1016/j.jmb.2004.03.009; Kim HJ, 2011, CARBON, V49, P3717, DOI 10.1016/j.carbon.2011.04.037; Kim SG, 2006, J MOL BIOL, V361, P105, DOI 10.1016/j.jmb.2006.06.010; Konagurthu AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010048; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LEONG LM, 1992, ANAL BIOCHEM, V207, P317, DOI 10.1016/0003-2697(92)90018-3; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lewin A, 2005, DALTON T, P3597, DOI 10.1039/b506071k; Li X, 2007, MOL MICROBIOL, V63, P694, DOI 10.1111/j.1365-2958.2006.05550.x; LILLIE RD, 1974, HISTOCHEM J, V6, P679, DOI 10.1007/BF01011507; Liu XF, 2003, P NATL ACAD SCI USA, V100, P3653, DOI 10.1073/pnas.0636928100; Liu XF, 2006, J BIOL CHEM, V281, P27827, DOI 10.1074/jbc.M601398200; Martinez A, 1997, J BACTERIOL, V179, P5188, DOI 10.1128/jb.179.16.5188-5194.1997; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nair S, 2004, J BACTERIOL, V186, P4192, DOI 10.1128/JB.186.13.4192-4198.2004; Nicodeme M, 2004, CURR MICROBIOL, V48, P51, DOI 10.1007/s00284-003-4116-3; Papinutto E, 2002, J BIOL CHEM, V277, P15093, DOI 10.1074/jbc.M112378200; Pulliainen AT, 2005, MOL MICROBIOL, V57, P1086, DOI 10.1111/j.1365-2958.2005.04756.x; Rostkowski M, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-6; Roy S, 2008, J MOL BIOL, V375, P948, DOI 10.1016/j.jmb.2007.10.023; Sabareesh V, 2010, ANALYST, V135, P2723, DOI 10.1039/c0an00130a; Saraswathi R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008017; Simonian Michael H, 2002, Curr Protoc Cell Biol, VAppendix 3, p3B, DOI 10.1002/0471143030.cba03bs15; Swift J, 2006, J AM CHEM SOC, V128, P6611, DOI 10.1021/ja057069x; Takagi H, 1998, J BIOL CHEM, V273, P18685, DOI 10.1074/jbc.273.30.18685; Thumiger A, 2006, PROTEINS, V62, P827, DOI 10.1002/prot.20828; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tosha T, 2012, J BIOL CHEM, V287, P13016, DOI 10.1074/jbc.M111.332734; Uchida M, 2006, J AM CHEM SOC, V128, P16626, DOI 10.1021/ja0655690; WATT GD, 1988, P NATL ACAD SCI USA, V85, P7457, DOI 10.1073/pnas.85.20.7457; Yamamoto Y, 2002, J BACTERIOL, V184, P2931, DOI 10.1128/JB.184.11.2931-2939.2002; Yoshimura H, 2006, COLLOID SURFACE A, V282, P464, DOI 10.1016/j.colsurfa.2006.01.037; Zanotti G, 2002, J MOL BIOL, V323, P125, DOI 10.1016/S0022-2836(02)00879-3; Zhao GH, 2002, J BIOL CHEM, V277, P27689, DOI 10.1074/jbc.M202094200	66	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11042	11058		10.1074/jbc.M113.524421	http://dx.doi.org/10.1074/jbc.M113.524421			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24573673	Green Published, hybrid			2022-12-28	WOS:000334638500010
J	Mazzitelli, LR; Adamo, HP				Mazzitelli, Luciana R.; Adamo, Hugo P.			Hyperactivation of the Human Plasma Membrane Ca2(+) Pump PMCA h4xb by Mutation of Glu99 to Lys	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; Calcium ATPase; Calcium Transport; Enzymes; Transporters	CALMODULIN-BINDING DOMAIN; CA2+ PUMP; CALCIUM-PUMP; CA-2+ PUMP; ISOFORM 4B; CA2+-ATPASE; ATPASE; PROTEINS; SITE; AUTOINHIBITION	Background: The calmodulin-stimulated human plasma membrane Ca2+ pump is regulated by autoinhibition. Results: The E99K mutation deregulates the pump increasing its maximal activity at saturating concentrations of Ca2+. Conclusion: The cytosolic portion of the M1 transmembrane segment is critical for inhibition by the extreme C-terminal autoinhibitory domain. Significance: This work presents new insights into the structure and the mechanism of human PMCA autoinhibition. The transport of calcium to the extracellular space carried out by plasma membrane Ca2+ pumps (PMCAs) is essential for maintaining low Ca2+ concentrations in the cytosol of eukaryotic cells. The activity of PMCAs is controlled by autoinhibition. Autoinhibition is relieved by the binding of Ca2+-calmodulin to the calmodulin-binding autoinhibitory sequence, which in the human PMCA is located in the C-terminal segment and results in a PMCA of high maximal velocity of transport and high affinity for Ca2+. Autoinhibition involves the intramolecular interaction between the autoinhibitory domain and a not well defined region of the molecule near the catalytic site. Here we show that the fusion of GFP to the C terminus of the h4xb PMCA causes partial loss of autoinhibition by specifically increasing the V-max. Mutation of residue Glu(99) to Lys in the cytosolic portion of the M1 transmembrane helix at the other end of the molecule brought the V-max of the h4xb PMCA to near that of the calmodulin-activated enzyme without increasing the apparent affinity for Ca2+. Altogether, the results suggest that the autoinhibitory interaction of the extreme C-terminal segment of the h4 PMCA is disturbed by changes of negatively charged residues of the N-terminal region. This would be consistent with a recently proposed model of an autoinhibited form of the plant ACA8 pump, although some differences are noted.	[Mazzitelli, Luciana R.; Adamo, Hugo P.] Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fisicoquim Biol, Dept Quim Biol, RA-1113 Buenos Aires, DF, Argentina	University of Buenos Aires	Adamo, HP (corresponding author), UBA, Fac Farm & Bioquim, IQUIFIB, Junin 956, RA-1113 Buenos Aires, DF, Argentina.	hpadamo@qb.ffyb.uba.ar	Adamo, Hugo Pedro/ABB-8338-2021	Adamo, Hugo Pedro/0000-0002-1712-8049	Universidad de Buenos Aires [UBACYT 20020100100800]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 2022]; Agencia Nacional de Promocion Cientifica y Tecnologica Prestamo [BID 2134]	Universidad de Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica Prestamo	This work was supported by Grants UBACYT 20020100100800 from Universidad de Buenos Aires, PIP 2022 from Consejo Nacional de Investigaciones Cientificas y Tecnicas, and Agencia Nacional de Promocion Cientifica y Tecnologica Prestamo BID 2134.	Adamo HP, 1998, BIOCHEM J, V331, P763, DOI 10.1042/bj3310763; ADAMO HP, 1992, J BIOL CHEM, V267, P14244; Bauer A, 1996, YEAST, V12, P965, DOI 10.1002/(SICI)1097-0061(199608)12:10<965::AID-YEA999>3.0.CO;2-Q; Bonza MC, 2010, FEBS LETT, V584, P4783, DOI 10.1016/j.febslet.2010.11.008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bredeston LM, 2004, J BIOL CHEM, V279, P41619, DOI 10.1074/jbc.M403116200; Caride AJ, 2001, J BIOL CHEM, V276, P39797, DOI 10.1074/jbc.M104380200; Corradi GR, 2007, J BIOL CHEM, V282, P35440, DOI 10.1074/jbc.M703377200; Corradi GR, 2012, J BIOL CHEM, V287, P30477, DOI 10.1074/jbc.M112.363465; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Cura CI, 2008, BBA-BIOMEMBRANES, V1778, P2757, DOI 10.1016/j.bbamem.2008.08.020; Curran AC, 2000, J BIOL CHEM, V275, P30301, DOI 10.1074/jbc.M002047200; Curry MC, 2012, J BIOL CHEM, V287, P28598, DOI 10.1074/jbc.M112.364737; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; Di Leva F, 2008, ARCH BIOCHEM BIOPHYS, V476, P65, DOI 10.1016/j.abb.2008.02.026; Einholm AP, 2007, J BIOENERG BIOMEMBR, V39, P357, DOI 10.1007/s10863-007-9106-x; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; ENYEDI A, 1991, J BIOL CHEM, V266, P8952; Enyedi A, 1996, J BIOL CHEM, V271, P32461, DOI 10.1074/jbc.271.50.32461; ENYEDI A, 1993, J BIOL CHEM, V268, P10621; ENYEDI A, 1994, J BIOL CHEM, V269, P41; FALCHETTO R, 1992, PROTEIN SCI, V1, P1613, DOI 10.1002/pro.5560011209; FILOTEO AG, 1992, J BIOL CHEM, V267, P11800; JAMES P, 1988, J BIOL CHEM, V263, P2905; Kim E, 1998, J BIOL CHEM, V273, P1591, DOI 10.1074/jbc.273.3.1591; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee AG, 2001, BIOCHEM J, V356, P665, DOI 10.1042/0264-6021:3560665; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; NIGGLI V, 1981, J BIOL CHEM, V256, P395; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Palmgren MG, 1998, BBA-BIOENERGETICS, V1365, P37, DOI 10.1016/S0005-2728(98)00041-3; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; Paszty K, 2005, BIOCHEM J, V391, P687, DOI 10.1042/BJ20051012; RICHARDS DE, 1978, BIOCHIM BIOPHYS ACTA, V511, P194, DOI 10.1016/0005-2736(78)90313-9; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Strehler EE, 2007, ANN NY ACAD SCI, V1099, P226, DOI 10.1196/annals.1387.023; Tidow H, 2012, NATURE, V491, P468, DOI 10.1038/nature11539; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; VERMA AK, 1994, J BIOL CHEM, V269, P1687; VORHERR T, 1992, BIOCHEMISTRY-US, V31, P8245, DOI 10.1021/bi00150a018	42	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10761	10768		10.1074/jbc.M113.535583	http://dx.doi.org/10.1074/jbc.M113.535583			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24584935	hybrid, Green Published			2022-12-28	WOS:000334226400045
J	Tsukagoshi, H; Nakamura, A; Ishida, T; Touhara, KK; Otagiri, M; Moriya, S; Samejima, M; Igarashi, K; Fushinobu, S; Kitamoto, K; Arioka, M				Tsukagoshi, Hikaru; Nakamura, Akihiko; Ishida, Takuya; Touhara, Kouki K.; Otagiri, Masato; Moriya, Shigeharu; Samejima, Masahiro; Igarashi, Kiyohiko; Fushinobu, Shinya; Kitamoto, Katsuhiko; Arioka, Manabu			Structural and Biochemical Analyses of Glycoside Hydrolase Family 26 beta-Mannanase from a Symbiotic Protist of the Termite Reticulitermes speratus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Glycoside Hydrolases; Plant Cell Wall; Polysaccharide; Symbiosis; Mannanase; Symbiotic Protist; Termite	CRYSTAL-STRUCTURE; EXPRESSION; BINDING; SYSTEMS	Background: Symbiotic protists of the termite gut contribute to lignocellulosic biomass degradation. Results: A novel protistan -mannanase efficiently degrades glucomannan and displays glucose/mannose binding properties when complexed with gluco-manno-oligosaccharide. Conclusion: Specific recognition and accommodation of glucose at the distal - subsites provides the structural basis for activity against glucomannan. Significance: The mechanism underlying heteropolysaccharide recognition by mannanase has been clarified. Termites and their symbiotic protists have established a prominent dual lignocellulolytic system, which can be applied to the biorefinery process. One of the major components of lignocellulose from conifers is glucomannan, which comprises a heterogeneous combination of -1,4-linked mannose and glucose. Mannanases are known to hydrolyze the internal linkage of the glucomannan backbone, but the specific mechanism by which they recognize and accommodate heteropolysaccharides is currently unclear. Here, we report biochemical and structural analyses of glycoside hydrolase family 26 mannanase C (RsMan26C) from a symbiotic protist of the termite Reticulitermes speratus. RsMan26C was characterized based on its catalytic efficiency toward glucomannan, compared with pure mannan. The crystal structure of RsMan26C complexed with gluco-manno-oligosaccharide(s) explained its specificities for glucose and mannose at subsites -5 and -2, respectively, in addition to accommodation of both glucose and mannose at subsites -3 and -4. RsMan26C has a long open cleft with a hydrophobic platform of Trp(94) at subsite -5, facilitating enzyme binding to polysaccharides. Notably, a unique oxidized Met(85) specifically interacts with the equatorial O-2 of glucose at subsite -3. Our results collectively indicate that specific recognition and accommodation of glucose at the distal negative subsites confers efficient degradation of the heteropolysaccharide by mannanase.	[Tsukagoshi, Hikaru; Touhara, Kouki K.; Fushinobu, Shinya; Kitamoto, Katsuhiko; Arioka, Manabu] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Tokyo 1138657, Japan; [Nakamura, Akihiko; Ishida, Takuya; Samejima, Masahiro; Igarashi, Kiyohiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo 1138657, Japan; [Otagiri, Masato] RIKEN, Biomass Engn Program Cooperat Div, Yokohama, Kanagawa 2300045, Japan; [Moriya, Shigeharu] Yokohama City Univ, Lab Environm Mol Biol, Grad Sch, Yokohama, Kanagawa 2300045, Japan; [Moriya, Shigeharu] RIKEN Adv Sci Inst, Mol & Informat Life Sci Unit, Yokohama, Kanagawa 2300045, Japan	University of Tokyo; University of Tokyo; RIKEN; Yokohama City University; RIKEN	Arioka, M (corresponding author), 1-1-1 Yayoi,Bunkyo Ku, Tokyo 1138657, Japan.	arioka@mail.ecc.u-tokyo.ac.jp	Nakamura, Akihiko/U-1988-2019; Moriya, Shigeharu/F-4604-2014; Moriya, Shigeharu/AGY-8351-2022; Igarashi, Kiyohiko/E-6799-2016; Fushinobu, Shinya/E-4987-2011	Nakamura, Akihiko/0000-0003-0409-5759; Moriya, Shigeharu/0000-0002-2519-5874; Moriya, Shigeharu/0000-0002-2519-5874; Igarashi, Kiyohiko/0000-0001-5152-7177; Fushinobu, Shinya/0000-0003-1346-6435; Touhara, Kouki/0000-0003-3167-9784	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Japanese Ministry of Education, Culture, Sports, and Technology (MEXT) [24114001, 24114008]; Grants-in-Aid for Scientific Research [24114008] Funding Source: KAKEN	Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN); Japanese Ministry of Education, Culture, Sports, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Program for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (BRAIN) (to M. A.) and by a Grant-in-Aid for Innovative Areas 24114001 and 24114008 (to K. I.) from the Japanese Ministry of Education, Culture, Sports, and Technology (MEXT).	Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Breznak J. A., 1994, ACETOGENESIS CARBON, P551; BRUNE A, 1995, APPL ENVIRON MICROB, V61, P2681, DOI 10.1128/AEM.61.7.2681-2687.1995; Cameron SL, 2007, GENOME, V50, P188, DOI 10.1139/G06-148; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cartmell A, 2008, J BIOL CHEM, V283, P34403, DOI 10.1074/jbc.M804053200; Couturier M, 2013, J BIOL CHEM, V288, P14624, DOI 10.1074/jbc.M113.459438; Couturier M, 2011, APPL ENVIRON MICROB, V77, P237, DOI 10.1128/AEM.01761-10; Ducros VMA, 2002, ANGEW CHEM INT EDIT, V41, P2824, DOI 10.1002/1521-3773(20020802)41:15<2824::AID-ANIE2824>3.0.CO;2-G; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Han YJ, 2010, J BACTERIOL, V192, P4111, DOI 10.1128/JB.00257-10; Hogg D, 2001, J BIOL CHEM, V276, P31186, DOI 10.1074/jbc.M010290200; Hongoh Y, 2011, CELL MOL LIFE SCI, V68, P1311, DOI 10.1007/s00018-011-0648-z; Hungate RE, 1938, ECOLOGY, V19, P1, DOI 10.2307/1930363; Inoue T, 2005, GENE, V349, P67, DOI 10.1016/j.gene.2004.11.048; Inoue T, 1997, J INSECT PHYSIOL, V43, P235, DOI 10.1016/S0022-1910(96)00097-2; JUE CK, 1985, J BIOCHEM BIOPH METH, V11, P109, DOI 10.1016/0165-022X(85)90046-6; Kulcinskaja E, 2013, APPL ENVIRON MICROB, V79, P133, DOI 10.1128/AEM.02118-12; Le Nours K, 2005, BIOCHEMISTRY-US, V44, P12700, DOI 10.1021/bi050779v; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nonaka T, 2004, J BIOL CHEM, V279, P47344, DOI 10.1074/jbc.M409089200; Ohkuma M, 2003, APPL MICROBIOL BIOT, V61, P1, DOI 10.1007/s00253-002-1189-z; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pawar PMA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00118; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Sims REH, 2010, BIORESOURCE TECHNOL, V101, P1570, DOI 10.1016/j.biortech.2009.11.046; Songsiriritthigul C, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-20; Tailford LE, 2009, BIOCHEMISTRY-US, V48, P7009, DOI 10.1021/bi900515d; Teleman A, 2003, CARBOHYD RES, V338, P525, DOI 10.1016/S0008-6215(02)00491-3; Todaka N, 2007, FEMS MICROBIOL ECOL, V59, P592, DOI 10.1111/j.1574-6941.2006.00237.x; Uchima CA, 2012, BIOSCI BIOTECH BIOCH, V76, P368, DOI 10.1271/bbb.110628; Watanabe H, 2001, CELL MOL LIFE SCI, V58, P1167, DOI 10.1007/PL00000931; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; YAMAOKA I, 1977, Zoological Magazine (Tokyo), V86, P34; YAMAOKA I, 1975, Zoological Magazine (Tokyo), V84, P23; Yan XX, 2008, J MOL BIOL, V379, P535, DOI 10.1016/j.jmb.2008.03.068	38	19	19	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10843	10852		10.1074/jbc.M114.555383	http://dx.doi.org/10.1074/jbc.M114.555383			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24570006	hybrid, Green Published			2022-12-28	WOS:000334226400052
J	Cavigiolio, G; Jayaraman, S				Cavigiolio, Giorgio; Jayaraman, Shobini			Proteolysis of Apolipoprotein A-I by Secretory Phospholipase A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apolipoproteins; Atherosclerosis; High Density Lipoprotein (HDL); Inflammation; Phospholipase; Apolipoprotein A-I; Proteolysis; Secretory Phospholipase A2; Inflammation; sPLA2	HIGH-DENSITY-LIPOPROTEIN; GROUP-IIA; HDL CHOLESTEROL; HYDROGEN-EXCHANGE; HELICAL STRUCTURE; TISSUE UPTAKE; APOA-I; A(2); PLASMA; STABILITY	Background: During inflammation, increased levels of secretory phospholipase A(2) (sPLA(2)) impact high density lipoprotein (HDL) cholesterol plasma concentration. Results: sPLA(2) cleaves apolipoprotein A-I (apoA-I) in the central and C-terminal regions. Conclusion: sPLA(2) selectively targets lipid-free apoA-I, whose levels are increased by HDL remodeling during inflammation. Significance: In acute and chronic (atherosclerosis) inflammation, the proteolytic action of sPLA(2) may accelerate clearance of apoA-I, thereby reducing HDL biogenesis. In the acute phase of the inflammatory response, secretory phospholipase A(2) (sPLA(2)) reaches its maximum levels in plasma, where it is mostly associated with high density lipoproteins (HDL). Overexpression of human sPLA(2) in transgenic mice reduces both HDL cholesterol and apolipoprotein A-I (apoA-I) plasma levels through increased HDL catabolism by an unknown mechanism. To identify unknown PLA(2)-mediated activities on the molecular components of HDL, we characterized the protein and lipid products of the PLA(2) reaction with HDL. Consistent with previous studies, hydrolysis of HDL phospholipids by PLA(2) reduced the particle size without changing its protein composition. However, when HDL was destabilized in the presence of PLA(2) by the action of cholesteryl ester transfer protein or by guanidine hydrochloride treatment, a fraction of apoA-I, but no other proteins, dissociated from the particle and was rapidly cleaved. Incubation of PLA(2) with lipid-free apoA-I produced similar protein fragments in the range of 6-15 kDa, suggesting specific and direct reaction of PLA(2) with apoA-I. Mass spectrometry analysis of isolated proteolytic fragments indicated at least two major cleavage sites at the C-terminal and the central domain of apoA-I. ApoA-I proteolysis by PLA(2) was Ca2+-independent, implicating a different mechanism from the Ca2+-dependent PLA(2)-mediated phospholipid hydrolysis. Inhibition of proteolysis by benzamidine suggests that the proteolytic and lipolytic activities of PLA(2) proceed through different mechanisms. Our study identifies a previously unknown proteolytic activity of PLA(2) that is specific to apoA-I and may contribute to the enhanced catabolism of apoA-I in inflammation and atherosclerosis.	[Cavigiolio, Giorgio] Childrens Hosp Oakland Res Inst, Oakland, CA 94609 USA; [Jayaraman, Shobini] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Boston University	Cavigiolio, G (corresponding author), Childrens Hosp Oakland Res Inst, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	gcavigiolio@chori.org; shobini@bu.edu		Cavigiolio, Giorgio/0000-0002-1622-0628; /0000-0003-1616-5347	National Institutes of Health [HL113059]; Tobacco-related Disease Research Program of California [18KT-0021]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco-related Disease Research Program of California(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL113059 (to G. C.). This work was also supported by a new investigator award from the Tobacco-related Disease Research Program of California (18KT-0021) (to G. C.).	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Assmann G, 2004, CIRCULATION, V109, P8, DOI 10.1161/01.CIR.0000131512.50667.46; Baker PW, 2000, J LIPID RES, V41, P1261; BALLOU LR, 1985, P NATL ACAD SCI USA, V82, P371, DOI 10.1073/pnas.82.2.371; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Bashtovyy D, 2011, J LIPID RES, V52, P435, DOI 10.1194/jlr.R012658; BRINTON EA, 1994, ARTERIOSCLER THROMB, V14, P707, DOI 10.1161/01.ATV.14.5.707; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Camejo G, 2010, ATHEROSCLEROSIS, V211, P36, DOI 10.1016/j.atherosclerosis.2010.02.005; Cavazzini D, 2013, J BIOL CHEM, V288, P1533, DOI 10.1074/jbc.M112.384156; Chetty PS, 2012, P NATL ACAD SCI USA, V109, P11687, DOI 10.1073/pnas.1209305109; Chetty PS, 2009, P NATL ACAD SCI USA, V106, P19005, DOI 10.1073/pnas.0909708106; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; DALTON MB, 1993, J BIOL CHEM, V268, P19274; deBeer FC, 1997, J LIPID RES, V38, P2232; DiDonato JA, 2013, CIRCULATION, V128, P1644, DOI 10.1161/CIRCULATIONAHA.113.002624; Eberini I, 2002, BIOCHEM J, V362, P627, DOI 10.1042/0264-6021:3620627; Frank PG, 2000, J LIPID RES, V41, P853; Gao X, 2009, J MOL BIOL, V387, P628, DOI 10.1016/j.jmb.2009.02.036; GIJON MA, 1995, BIOCHEM J, V306, P167, DOI 10.1042/bj3060167; GLASS C, 1983, P NATL ACAD SCI-BIOL, V80, P5435, DOI 10.1073/pnas.80.17.5435; Goodson N, 2002, CURR OPIN RHEUMATOL, V14, P115, DOI 10.1097/00002281-200203000-00007; Gorshkova IN, 2000, BIOCHEMISTRY-US, V39, P15910, DOI 10.1021/bi0014406; HOFFMAN JS, 1982, J BIOL CHEM, V257, P510; Holmes MV, 2013, J AM COLL CARDIOL, V62, P1966, DOI 10.1016/j.jacc.2013.06.044; IKEWAKI K, 1993, J CLIN INVEST, V92, P1650, DOI 10.1172/JCI116750; Ivandic B, 1999, ARTERIOSCL THROM VAS, V19, P1284, DOI 10.1161/01.ATV.19.5.1284; Jahangiri A, 2010, CURR OPIN ENDOCRINOL, V17, P156, DOI 10.1097/MED.0b013e328337278b; Jahangiri A, 2009, ARTERIOSCL THROM VAS, V29, P261, DOI 10.1161/ATVBAHA.108.178681; Jayaraman S, 2006, BIOCHEMISTRY-US, V45, P4620, DOI 10.1021/bi0524565; Jayaraman S, 2012, BIOCHEM J, V442, P703, DOI 10.1042/BJ20111831; Jayaraman S, 2011, J BIOL CHEM, V286, P35610, DOI 10.1074/jbc.M111.262485; JI Y, 1995, J BIOL CHEM, V270, P11290, DOI 10.1074/jbc.270.19.11290; KUNITAKE ST, 1990, ARTERIOSCLEROSIS, V10, P25, DOI 10.1161/01.ATV.10.1.25; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; LIANG HQ, 1994, J LIPID RES, V35, P1187; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Mehta R, 2003, J MOL BIOL, V328, P183, DOI 10.1016/S0022-2836(03)00155-4; Menschikowski M, 2006, PROSTAG OTH LIPID M, V79, P1, DOI 10.1016/j.prostaglandins.2005.10.005; Miyazaki O, 2014, J LIPID RES, V55, P214, DOI 10.1194/jlr.M041038; Nagata KO, 2013, P NATL ACAD SCI USA, V110, P5034, DOI 10.1073/pnas.1220703110; Oda MN, 2013, BIOCHEMISTRY-US, V52, P6766, DOI 10.1021/bi4007012; OHARA O, 1995, PROG LIPID RES, V34, P117, DOI 10.1016/0163-7827(94)00009-B; Oorni K, 2007, ARTERIOSCL THROM VAS, V27, P445, DOI 10.1161/01.ATV.0000258412.58289.ee; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Panagotopulos SE, 2002, J BIOL CHEM, V277, P39477, DOI 10.1074/jbc.M207005200; Pownall HJ, 2005, BIOCHEMISTRY-US, V44, P9714, DOI 10.1021/bi050729q; Pruzanski W, 1998, J LIPID RES, V39, P2150; Rader DJ, 1996, CURR OPIN LIPIDOL, V7, P117, DOI 10.1097/00041433-199606000-00002; Rodriguez-Lee M, 2007, CURR OPIN LIPIDOL, V18, P546, DOI 10.1097/MOL.0b013e3282ef534f; Rosengren B, 2006, BBA-MOL CELL BIOL L, V1761, P1301, DOI 10.1016/j.bbalip.2006.06.008; Rosenson Robert S, 2009, Curr Cardiol Rep, V11, P445; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; SCHAEFER EJ, 1982, J LIPID RES, V23, P850; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; Steinberg D, 2002, NAT MED, V8, P1211, DOI 10.1038/nm1102-1211; Tietge UJF, 2000, J BIOL CHEM, V275, P10077, DOI 10.1074/jbc.275.14.10077; Tietge UJF, 2002, ARTERIOSCL THROM VAS, V22, P1213, DOI 10.1161/01.ATV.0000023228.90866.29; VADAS P, 1993, J LIPID MEDIATOR, V8, P1; WETTERAU JR, 1982, J BIOL CHEM, V257, P961; Williams KR, 1997, MOL BIOTECHNOL, V8, P155, DOI 10.1007/BF02752260; YU BZ, 1993, BIOCHEMISTRY-US, V32, P6485, DOI 10.1021/bi00076a024; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	65	25	27	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10011	10023		10.1074/jbc.M113.525717	http://dx.doi.org/10.1074/jbc.M113.525717			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24523407	Green Published, hybrid			2022-12-28	WOS:000333807000049
J	Hatherley, D; Lea, SM; Johnson, S; Barclay, AN				Hatherley, Deborah; Lea, Susan M.; Johnson, Steven; Barclay, A. Neil			Polymorphisms in the Human Inhibitory Signal-regulatory Protein alpha Do Not Affect Binding to Its Ligand CD47*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cancer Therapy; Cell Surface Receptor; Immunology; Leukocyte; Membrane Proteins; Peptide Interactions; Protein Structure; CD47; Inhibitory Receptor; SIRP	IMMUNOGLOBULIN-LIKE RECEPTOR; PAIRED RECEPTORS; CELL-RECEPTORS; STEM-CELLS; EVOLUTION; CD47; RECOGNITION; KILLER; SELF; ASSOCIATION	Background: CD47 interacts with SIRP to down-regulate myeloid cell activity. Results: The extensive polymorphisms in human SIRP do not affect ligand binding, and a peptide from CD47 does not bind SIRP. Conclusion: The polymorphisms are being selected for other purposes such as evasion from pathogens. Significance: The polymorphisms are not likely to affect this interaction currently of therapeutic interest. CD47 is a widely distributed membrane protein that interacts with signal-regulatory protein (SIRP), an inhibitory receptor on myeloid cells that gives a don't-eat-me signal. Manipulation of the interaction is of considerable interest in the immunotherapy of cancer and in xenotransplantation. The amino-terminal ligand binding domain of SIRP is highly polymorphic in contrast to the single Ig-like domain of CD47. There is confusion as to whether the polymorphisms will affect ligand binding, but this is an important point for this interaction and other paired receptors being considered as targets for therapy. We show by x-ray crystallography that one human SIRP allele differing in 13 amino acid residues has a very similar binding site and that several different alleles all bind CD47 with similar affinity as expected because the residues are mostly surface-exposed and distant from the binding site. A peptide from the binding site of CD47 has been reported to mimic the CD47 interaction with SIRP, but we could find no binding. We discuss the possible pitfalls in determining the affinity of weak interactions and also speculate on how SIRP polymorphisms may have been selected by pathogens and how this may also be true in other paired receptors such as the KIRs.	[Hatherley, Deborah; Lea, Susan M.; Johnson, Steven; Barclay, A. Neil] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Barclay, AN (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	neil.barclay@path.ox.ac.uk	Johnson, Steven J/F-9182-2016; Lea, Susan M/B-7678-2009	Johnson, Steven J/0000-0002-7877-3543; Lea, Susan M/0000-0001-9287-8053	Medical Research Council [G9826026, G0900888]; Wellcome Trust [100298]; MRC [G9826026] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Medical Research Council Grants G9826026 and G0900888 and by Wellcome Trust Senior Investigator Award 100298 (to the S. M. L. group).	Abi-Rached L, 2005, J EXP MED, V201, P1319, DOI 10.1084/jem.20042558; Akkaya M, 2013, EUR J IMMUNOL, V43, P303, DOI 10.1002/eji.201242896; Barclay AN, 2008, IMMUNITY, V29, P675, DOI 10.1016/j.immuni.2008.10.004; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Barclay AN, 2006, NAT REV IMMUNOL, V6, P457, DOI 10.1038/nri1859; Bricogne G.B.E., 2011, BUSTER 2 11 2; Brown MH, 1998, J EXP MED, V188, P2083, DOI 10.1084/jem.188.11.2083; Carlyle JR, 2008, SEMIN IMMUNOL, V20, P321, DOI 10.1016/j.smim.2008.05.004; Chao MP, 2012, CURR OPIN IMMUNOL, V24, P225, DOI 10.1016/j.coi.2012.01.010; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hatherley D, 2004, EUR J IMMUNOL, V34, P1688, DOI 10.1002/eji.200425080; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Hatherley D, 2007, J BIOL CHEM, V282, P14567, DOI 10.1074/jbc.M611511200; Hatherley D, 2013, STRUCTURE, V21, P820, DOI 10.1016/j.str.2013.03.008; Hatherley D, 2009, J BIOL CHEM, V284, P26613, DOI 10.1074/jbc.M109.017566; Hu CMJ, 2013, NANOSCALE, V5, P2664, DOI 10.1039/c3nr00015j; Kuroki K, 2005, HUM MOL GENET, V14, P2469, DOI 10.1093/hmg/ddi247; Kuroki K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00429; Lascorz J, 2013, INT J COLORECTAL DIS, V28, P173, DOI 10.1007/s00384-012-1541-4; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Middleton D, 2010, IMMUNOLOGY, V129, P8, DOI 10.1111/j.1365-2567.2009.03208.x; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Oldenborg Per-Arne, 2013, ISRN Hematol, V2013, P614619, DOI 10.1155/2013/614619; Parham P, 2013, NAT REV IMMUNOL, V13, P133, DOI 10.1038/nri3370; Rodriguez PL, 2013, SCIENCE, V339, P971, DOI 10.1126/science.1229568; Sano S, 1999, BIOCHEM J, V344, P667, DOI 10.1042/0264-6021:3440667; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701	33	28	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10024	10028		10.1074/jbc.M114.550558	http://dx.doi.org/10.1074/jbc.M114.550558			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24550402	Green Published, hybrid			2022-12-28	WOS:000333807000050
J	McCoy, JG; Rusinova, R; Kim, DM; Kowal, J; Banerjee, S; Cartagena, AJ; Thompson, AN; Kolmakova-Partensky, L; Stahlberg, H; Andersen, OS; Nimigean, CM				McCoy, Jason G.; Rusinova, Radda; Kim, Dorothy M.; Kowal, Julia; Banerjee, Sourabh; Cartagena, Alexis Jaramillo; Thompson, Ameer N.; Kolmakova-Partensky, Ludmila; Stahlberg, Henning; Andersen, Olaf S.; Nimigean, Crina M.			A KcsA/MloK1 Chimeric Ion Channel Has Lipid-dependent Ligand-binding Energetics*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Electron Microscopy (EM); Energetics; Fluorescence; Gating; Ion Channels; Isothermal Titration Calorimetry; Nanodisc; Single-channel Recording	NUCLEOTIDE-GATED CHANNELS; HYPERPOLARIZATION-ACTIVATED CHANNEL; PROKARYOTIC K+ CHANNEL; LOTI K1 CHANNEL; POTASSIUM-CHANNEL; STRUCTURAL BASIS; PACEMAKER CHANNELS; SELECTIVITY FILTER; HCN CHANNELS; CAMP	Background: The mechanism of ligand gating in physiologically important cyclic nucleotide-modulated channels is unknown. Results: We constructed and purified a chimeric ion channel with activity modulated by cAMP and used it to measure ligand-binding energetics. Conclusion: cAMP binds with high lipid-dependent affinity to the chimeric channel. Significance: The availability of a good protein preparation enables assays that shed light on ligand gating. Cyclic nucleotide-modulated ion channels play crucial roles in signal transduction in eukaryotes. The molecular mechanism by which ligand binding leads to channel opening remains poorly understood, due in part to the lack of a robust method for preparing sufficient amounts of purified, stable protein required for structural and biochemical characterization. To overcome this limitation, we designed a stable, highly expressed chimeric ion channel consisting of the transmembrane domains of the well characterized potassium channel KcsA and the cyclic nucleotide-binding domains of the prokaryotic cyclic nucleotide-modulated channel MloK1. This chimera demonstrates KcsA-like pH-sensitive activity which is modulated by cAMP, reminiscent of the dual modulation in hyperpolarization-activated and cyclic nucleotide-gated channels that display voltage-dependent activity that is also modulated by cAMP. Using this chimeric construct, we were able to measure for the first time the binding thermodynamics of cAMP to an intact cyclic nucleotide-modulated ion channel using isothermal titration calorimetry. The energetics of ligand binding to channels reconstituted in lipid bilayers are substantially different from those observed in detergent micelles, suggesting that the conformation of the chimera's transmembrane domain is sensitive to its (lipid or lipid-mimetic) environment and that ligand binding induces conformational changes in the transmembrane domain. Nevertheless, because cAMP on its own does not activate these chimeric channels, cAMP binding likely has a smaller energetic contribution to gating than proton binding suggesting that there is only a small difference in cAMP binding energy between the open and closed states of the channel.	[McCoy, Jason G.; Rusinova, Radda; Kim, Dorothy M.; Banerjee, Sourabh; Thompson, Ameer N.; Nimigean, Crina M.] Weill Cornell Med Coll, Dept Anesthesiol, New York, NY 10065 USA; [Rusinova, Radda; Thompson, Ameer N.; Andersen, Olaf S.; Nimigean, Crina M.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA; [Nimigean, Crina M.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA; [Cartagena, Alexis Jaramillo; Andersen, Olaf S.; Nimigean, Crina M.] Weill Cornell Med Coll, Tri Inst Program Chem Biol, New York, NY 10065 USA; [Kolmakova-Partensky, Ludmila] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [Kowal, Julia; Stahlberg, Henning] Univ Basel, Ctr Cellular Imaging & NanoAnalyt, Biozentrum, CH-4058 Basel, Switzerland	Cornell University; Cornell University; Cornell University; Cornell University; Brandeis University; University of Basel	Nimigean, CM (corresponding author), Weill Cornell Med Coll, Dept Anesthesiol, 1300 York Ave, New York, NY 10065 USA.	crn2002@med.cornell.edu	Stahlberg, Henning/H-1868-2011	Stahlberg, Henning/0000-0002-1185-4592; Kowal, Julia/0000-0003-4694-1896; Nimigean, Crina/0000-0002-6254-4447; Jaramillo Cartagena, Alexis/0000-0001-7285-1419	National Institutes of Health [GM077560, GM021342]; Swiss National Science Foundation [315230]; National Center of Competence in Research TransCure; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021342, R01GM077560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research TransCure; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM077560 (to C. M. N.) and GM021342 (to O. S. A.). This work was also supported by Swiss National Science Foundation Grant 315230 and National Center of Competence in Research TransCure (to H. S.).	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Banerjee S, 2008, J MOL BIOL, V377, P1067, DOI 10.1016/j.jmb.2008.01.066; Banerjee S, 2011, J GEN PHYSIOL, V137, P217, DOI 10.1085/jgp.201010558; Berneche S, 2005, STRUCTURE, V13, P591, DOI 10.1016/j.str.2004.12.019; Chen TY, 1996, J GEN PHYSIOL, V108, P237, DOI 10.1085/jgp.108.4.237; Chiu PL, 2007, STRUCTURE, V15, P1053, DOI 10.1016/j.str.2007.06.020; Chow SS, 2012, J BIOL CHEM, V287, P600, DOI 10.1074/jbc.M111.269563; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Cuello LG, 2010, FEBS LETT, V584, P1126, DOI 10.1016/j.febslet.2010.02.003; Cukkemane A, 2007, EMBO REP, V8, P749, DOI 10.1038/sj.embor.7401025; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Flynn GE, 2007, STRUCTURE, V15, P671, DOI 10.1016/j.str.2007.04.008; Gao LZ, 2005, P NATL ACAD SCI USA, V102, P17630, DOI 10.1073/pnas.0505158102; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; Hirano M, 2011, BIOPHYS J, V101, P2157, DOI 10.1016/j.bpj.2011.09.024; Ingolfsson HI, 2010, ASSAY DRUG DEV TECHN, V8, P427, DOI 10.1089/adt.2009.0250; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Kusch J, 2012, NAT CHEM BIOL, V8, P162, DOI 10.1038/nchembio.747; Kusch J, 2010, NEURON, V67, P75, DOI 10.1016/j.neuron.2010.05.022; LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303; Lolicato M, 2011, J BIOL CHEM, V286, P44811, DOI 10.1074/jbc.M111.297606; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Lundbaek JA, 2010, P NATL ACAD SCI USA, V107, P15427, DOI 10.1073/pnas.1007455107; Nache V, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003110; Nimigean CM, 2004, J GEN PHYSIOL, V124, P203, DOI 10.1085/jgp.200409133; Nimigean CM, 2007, J MOL BIOL, V371, P1325, DOI 10.1016/j.jmb.2007.06.030; Ohndorf UM, 2005, J MOL BIOL, V350, P857, DOI 10.1016/j.jmb.2005.05.050; Peuker S, 2013, BIOPHYS J, V104, P63, DOI 10.1016/j.bpj.2012.11.3816; Posson DJ, 2013, J GEN PHYSIOL, V142, P613, DOI 10.1085/jgp.201311057; Quick M, 2012, NAT STRUCT MOL BIOL, V19, P207, DOI 10.1038/nsmb.2197; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rusinova R, 2014, BIOPHYS J, V106, P1070, DOI 10.1016/j.bpj.2014.01.027; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; SCHREMPF H, 1995, EMBO J, V14, P5170, DOI 10.1002/j.1460-2075.1995.tb00201.x; Schunke S, 2011, P NATL ACAD SCI USA, V108, P6121, DOI 10.1073/pnas.1015890108; Schunke S, 2009, EMBO REP, V10, P729, DOI 10.1038/embor.2009.68; Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391; SHABB JB, 1992, J BIOL CHEM, V267, P5723; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; Thompson AN, 2008, P NATL ACAD SCI USA, V105, P6900, DOI 10.1073/pnas.0800873105; Wu SJ, 2011, BIOPHYS J, V100, P1226, DOI 10.1016/j.bpj.2011.01.034; Xu XP, 2010, J BIOL CHEM, V285, P37082, DOI 10.1074/jbc.M110.152033; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315	54	11	11	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9535	9546		10.1074/jbc.M113.543389	http://dx.doi.org/10.1074/jbc.M113.543389			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24515111	Green Published, hybrid			2022-12-28	WOS:000333807000010
J	O'Reilly, S; Ciechomska, M; Cant, R; van Laar, JM				O'Reilly, Steven; Ciechomska, Marzena; Cant, Rachel; van Laar, Jacob M.			Interleukin-6 (IL-6) Trans Signaling Drives a STAT3-dependent Pathway That Leads to Hyperactive Transforming Growth Factor-beta (TGF-beta) Signaling Promoting SMAD3 Activation and Fibrosis via Gremlin Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Collagen; Fibrogenesis; Interleukin; Signal Transduction; Interleukin-6; Extracellular	SYSTEMIC-SCLEROSIS; KELOID PATHOGENESIS; TRABECULAR MESHWORK; COLLAGEN PRODUCTION; RECEPTOR; DISEASE; CELLS; MICE; PROLIFERATION; FIBROBLASTS	Background: IL-6 is a profibrotic molecule, but the mechanism is unclear. Results: IL-6 mediates fibrosis via a STAT3- and Smad3-dependent pathway mediated via a novel cytokine, Gremlin. Conclusion: A novel pathway of IL-6 mediated fibrogenesis has been defined. Significance: Targeting Gremlin is a new therapeutic target in fibrosis downstream of STAT3. Fibrosis is a common and intractable condition associated with various pathologies. It is characterized by accumulation of an excessive amount of extracellular matrix molecules that primarily include collagen type I. IL-6 is a profibrotic cytokine that is elevated in the prototypic fibrotic autoimmune condition systemic sclerosis and is known to induce collagen I expression, but the mechanism(s) behind this induction are currently unknown. Using healthy dermal fibroblasts in vitro, we analyzed the signaling pathways that underscore the IL-6-mediated induction of collagen. We show that IL-6 trans signaling is important and that the effect is dependent on STAT3; however, the effect is indirect and mediated through enhanced TGF- signaling and the classic downstream cellular mediator Smad3. This is due to induction of the bone morphogenetic protein (BMP) antagonist Gremlin-1, and we show that Gremlin-1 is profibrotic and is mediated through canonical TGF- signaling.	[O'Reilly, Steven; Ciechomska, Marzena; Cant, Rachel; van Laar, Jacob M.] Inst Cellular Med, Musculoskeletal Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	O'Reilly, S (corresponding author), Inst Cellular Med, Musculoskeletal Res Grp, 4th Floor Cookson Bldg,Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	steven.o'reilly@newcastle.ac.uk	O'Reilly, Steven/AAX-7038-2020	O'Reilly, Steven/0000-0001-7483-740X; Ciechomska, Marzena/0000-0002-0961-6130				Aoki H, 2006, J CELL BIOCHEM, V99, P221, DOI 10.1002/jcb.20906; Bhattacharyya S, 2012, NAT REV RHEUMATOL, V8, P42, DOI 10.1038/nrrheum.2011.149; Boers W, 2006, J BIOL CHEM, V281, P16289, DOI 10.1074/jbc.M600711200; Cahill E, 2012, CIRCULATION, V125, P920, DOI 10.1161/CIRCULATIONAHA.111.038125; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; Dees C, 2012, ARTHRITIS RHEUM-US, V64, P3006, DOI 10.1002/art.34500; Huu DL, 2012, J INVEST DERMATOL, V132, P2752, DOI 10.1038/jid.2012.226; Frank DA, 1999, NAT MED, V5, P444, DOI 10.1038/7445; Fuchshofer R, 2007, INVEST OPHTH VIS SCI, V48, P715, DOI 10.1167/iovs.06-0226; Ghazizadeh M, 2007, J INVEST DERMATOL, V127, P98, DOI 10.1038/sj.jid.5700564; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hill GR, 2010, BLOOD, V116, P287, DOI 10.1182/blood-2009-12-259598; Hugle T, 2013, ARTHRITIS RHEUM-US, V65, P481, DOI 10.1002/art.37738; IHN H, 1995, ARCH DERMATOL RES, V287, P193, DOI 10.1007/BF01262331; Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev; Khan K, 2012, ANN RHEUM DIS, V71, P1235, DOI 10.1136/annrheumdis-2011-200955; Koli K, 2006, AM J PATHOL, V169, P61, DOI 10.2353/ajpath.2006.051263; KRALING BM, 1995, PATHOBIOLOGY, V63, P48, DOI 10.1159/000163933; Lim CP, 2006, ONCOGENE, V25, P5416, DOI 10.1038/sj.onc.1209531; Matsushita T, 2006, J RHEUMATOL, V33, P275; McMahon R, 2000, J BIOL CHEM, V275, P9901, DOI 10.1074/jbc.275.14.9901; Mitola S, 2010, BLOOD, V116, P3677, DOI 10.1182/blood-2010-06-291930; Mueller KAL, 2013, J CARD FAIL, V19, P678, DOI 10.1016/j.cardfail.2013.09.001; NEEDLEMAN BW, 1992, ARTHRITIS RHEUM, V35, P67, DOI 10.1002/art.1780350111; O'Donoghue RJJ, 2012, EMBO MOL MED, V4, P939, DOI 10.1002/emmm.201100604; O'Reilly S, 2013, CLIN TRANSL IMMUNOL, V2, DOI 10.1038/cti.2013.2; O'Reilly S, 2012, RHEUMATOLOGY, V51, P1540, DOI 10.1093/rheumatology/kes090; O'Reilly S, 2012, CYTOKINE GROWTH F R, V23, P99, DOI 10.1016/j.cytogfr.2012.04.003; Ogata H, 2006, ONCOGENE, V25, P2520, DOI 10.1038/sj.onc.1209281; PENNICA D, 1995, J BIOL CHEM, V270, P10915, DOI 10.1074/jbc.270.18.10915; Ray S, 2013, J INVEST DERMATOL, V133, P1212, DOI 10.1038/jid.2012.499; Roxburgh SA, 2009, DIABETES, V58, P1641, DOI 10.2337/db08-1365; Saito F, 2008, AM J RESP CELL MOL, V38, P566, DOI 10.1165/rcmb.2007-0299OC; Wordinger RJ, 2007, INVEST OPHTH VIS SCI, V48, P1191, DOI 10.1167/iovs.06-0296; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	35	160	164	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9952	9960		10.1074/jbc.M113.545822	http://dx.doi.org/10.1074/jbc.M113.545822			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24550394	Green Published, hybrid			2022-12-28	WOS:000333807000044
J	Reichheld, SE; Muiznieks, LD; Stahl, R; Simonetti, K; Sharpe, S; Keeley, FW				Reichheld, Sean E.; Muiznieks, Lisa D.; Stahl, Richard; Simonetti, Karen; Sharpe, Simon; Keeley, Fred W.			Conformational Transitions of the Cross-linking Domains of Elastin during Self-assembly*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyloid; Elastin; Extracellular Matrix; Protein Self-assembly; Protein Structure; Cross-linking Domain	INVERSE TEMPERATURE TRANSITION; SOLID-STATE NMR; EXPRESSED HUMAN ELASTIN; CHEMICAL-SHIFT DATA; HUMAN TROPOELASTIN; SECONDARY STRUCTURE; POLYALANINE PEPTIDES; HYDROPHOBIC DOMAINS; AMYLOID FIBRILS; MIMETIC POLYPEPTIDE	Background: Elastin is a polymeric protein providing extensibility and elastic recoil to tissues. Results: Cross-linking domain structure shifts from random coil to -strand to -helix during assembly of elastin matrix. Conclusion: Cross-linking domains have a previously unappreciated structural lability during assembly, which is highly susceptible to mutations of lysine residues. Significance: Identification of conformational transitions in cross-linking domains of elastin during self-assembly is essential for understanding the mechanisms of formation of the elastic matrix. Elastin is the intrinsically disordered polymeric protein imparting the exceptional properties of extension and elastic recoil to the extracellular matrix of most vertebrates. The monomeric precursor of elastin, tropoelastin, as well as polypeptides containing smaller subsets of the tropoelastin sequence, can self-assemble through a colloidal phase separation process called coacervation. Present understanding suggests that self-assembly is promoted by association of hydrophobic domains contained within the tropoelastin sequence, whereas polymerization is achieved by covalent joining of lysine side chains within distinct alanine-rich, -helical cross-linking domains. In this study, model elastin polypeptides were used to determine the structure of cross-linking domains during the assembly process and the effect of sequence alterations in these domains on assembly and structure. CD temperature melts indicated that partial -helical structure in cross-linking domains at lower temperatures was absent at physiological temperature. Solid-state NMR demonstrated that -strand structure of the cross-linking domains dominated in the coacervate state, although -helix was predominant after subsequent cross-linking of lysine side chains with genipin. Mutation of lysine residues to hydrophobic amino acids, tyrosine or alanine, leads to increased propensity for -structure and the formation of amyloid-like fibrils, characterized by thioflavin-T binding and transmission electron microscopy. These findings indicate that cross-linking domains are structurally labile during assembly, adapting to changes in their environment and aggregated state. Furthermore, the sequence of cross-linking domains has a dramatic effect on self-assembly properties of elastin-like polypeptides, and the presence of lysine residues in these domains may serve to prevent inappropriate ordered aggregation.	[Reichheld, Sean E.; Muiznieks, Lisa D.; Stahl, Richard; Simonetti, Karen; Sharpe, Simon; Keeley, Fred W.] Hosp Sick Children, Res Inst, Mol Struct & Funct Program, Toronto, ON M5G 1X8, Canada; [Sharpe, Simon; Keeley, Fred W.] Univ Toronto, Dept Biochem, Toronto, ON M5G 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Keeley, FW (corresponding author), Hosp Sick Children, Res Inst, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	fwk@sickkids.ca			Heart and Stroke Foundation of Ontario Operational Grant [T6725]; Canadian Institutes of Health Research Operational Grant [MOP111145]	Heart and Stroke Foundation of Ontario Operational Grant; Canadian Institutes of Health Research Operational Grant(Canadian Institutes of Health Research (CIHR))	This work was supported by Heart and Stroke Foundation of Ontario Operational Grant T6725 and Canadian Institutes of Health Research Operational Grant MOP111145.	Akagawa M, 2000, CONNECT TISSUE RES, V41, P131, DOI 10.3109/03008200009067665; ANDERSEN SO, 1964, BIOCHIM BIOPHYS ACTA, V93, P213, DOI 10.1016/0304-4165(64)90289-2; Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512; Bellingham CM, 2001, BBA-PROTEIN STRUCT M, V1550, P6, DOI 10.1016/S0167-4838(01)00262-X; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Bernacki JP, 2011, BIOCHEMISTRY-US, V50, P9200, DOI 10.1021/bi201155g; BIELECKI A, 1995, J MAGN RESON SER A, V116, P215, DOI 10.1006/jmra.1995.0010; Blondelle SE, 1997, BIOCHEMISTRY-US, V36, P8393, DOI 10.1021/bi963015b; Bolen DW, 2008, ANNU REV BIOCHEM, V77, P339, DOI 10.1146/annurev.biochem.77.061306.131357; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Chung MIS, 2006, MATRIX BIOL, V25, P492, DOI 10.1016/j.matbio.2006.08.258; Cirulis JT, 2008, BIOCHEMISTRY-US, V47, P12601, DOI 10.1021/bi8005384; Cirulis JT, 2010, BIOCHEMISTRY-US, V49, P5726, DOI 10.1021/bi100468v; Clarke AW, 2006, BIOCHEMISTRY-US, V45, P9989, DOI 10.1021/bi0610092; DAVIS NR, 1970, J AM CHEM SOC, V92, P3778, DOI 10.1021/ja00715a040; Debelle L, 1998, EUR J BIOCHEM, V258, P533, DOI 10.1046/j.1432-1327.1998.2580533.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ding F, 2003, PROTEINS, V53, P220, DOI 10.1002/prot.10468; FOSTER JA, 1976, BIOPOLYMERS, V15, P833, DOI 10.1002/bip.1976.360150503; Giri K, 2007, BIOPHYS J, V92, P293, DOI 10.1529/biophysj.106.091769; GOLDBERG ME, 1994, PROTEIN SCI, V3, P883; GRAY WR, 1973, NATURE, V246, P461, DOI 10.1038/246461a0; He D, 2007, MATRIX BIOL, V26, P524, DOI 10.1016/j.matbio.2007.05.005; HODGES R S, 1990, Peptide Research, V3, P123; Hong M, 2003, BIOPOLYMERS, V70, P158, DOI 10.1002/bip.10431; Keeley FW, 2002, PHILOS T R SOC B, V357, P185, DOI 10.1098/rstb.2001.1027; Keeley FW, 2013, EVOLUTION EXTRACELLU, P71; Kenney JM, 2002, EUR J BIOCHEM, V269, P4159, DOI 10.1046/j.1432-1033.2002.03112.x; Kielty Cay M., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S146239940600007X; Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002; Kumashiro KK, 2012, BIOPOLYMERS, V97, P882, DOI 10.1002/bip.22094; Kumashiro KK, 2006, J BIOL CHEM, V281, P23757, DOI 10.1074/jbc.M510833200; Li B, 2001, J MOL BIOL, V305, P581, DOI 10.1006/jmbi.2000.4306; LUAN CH, 1990, BIOPOLYMERS, V29, P1699, DOI 10.1002/bip.360291403; Lyons RE, 2009, BIOMACROMOLECULES, V10, P3009, DOI 10.1021/bm900601h; MacEwan SR, 2010, BIOPOLYMERS, V94, P60, DOI 10.1002/bip.21327; Mant CT, 2009, BIOPOLYMERS, V92, P573, DOI 10.1002/bip.21316; McDaniel JR, 2013, BIOMACROMOLECULES, V14, P2866, DOI 10.1021/bm4007166; Miao M, 2005, BIOCHEMISTRY-US, V44, P14367, DOI 10.1021/bi0510173; Miao M, 2003, J BIOL CHEM, V278, P48553, DOI 10.1074/jbc.M308465200; Miao M, 2013, BIOPOLYMERS, V99, P392, DOI 10.1002/bip.22192; Miller JS, 2001, BIOCHEMISTRY-US, V40, P305, DOI 10.1021/bi0019500; Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9; Morcombe CR, 2004, J AM CHEM SOC, V126, P7196, DOI 10.1021/ja047919t; Morcombe CR, 2003, J MAGN RESON, V162, P479, DOI 10.1016/S1090-7807(03)00082-X; Muiznieks LD, 2003, ARCH BIOCHEM BIOPHYS, V410, P317, DOI 10.1016/S0003-9861(02)00719-1; Muiznieks LD, 2007, BIOCHEMISTRY-US, V46, P8196, DOI 10.1021/bi700139k; Muiznieks LD, 2010, J BIOL CHEM, V285, P39779, DOI 10.1074/jbc.M110.164467; Muiznieks LD, 2010, BIOCHEM CELL BIOL, V88, P239, DOI [10.1139/O09-161, 10.1139/o09-161]; Nguyen HD, 2005, J BIOL CHEM, V280, P9074, DOI 10.1074/jbc.M407338200; Ohgo K, 2012, J BIOL CHEM, V287, P18201, DOI 10.1074/jbc.M111.285163; Perry A, 2002, BIOPHYS J, V82, P1086, DOI 10.1016/S0006-3495(02)75468-4; Phelps EM, 2012, PROTEINS, V80, P1582, DOI 10.1002/prot.24052; Pometun MS, 2004, J BIOL CHEM, V279, P7982, DOI 10.1074/jbc.M310948200; Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008; Rauscher S, 2012, ADV EXP MED BIOL, V725, P159, DOI 10.1007/978-1-4614-0659-4_10; Rauscher S, 2010, BIOCHEM CELL BIOL, V88, P269, DOI [10.1139/O09-169, 10.1139/o09-169]; Riekel C, 2000, BIOMACROMOLECULES, V1, P622, DOI 10.1021/bm000047c; Shinchuk LM, 2005, PROTEINS, V61, P579, DOI 10.1002/prot.20536; Silva SS, 2008, MACROMOL BIOSCI, V8, P766, DOI 10.1002/mabi.200700300; Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84; Su Y, 2001, BRAIN RES, V893, P287, DOI 10.1016/S0006-8993(00)03322-9; SUGIYAMA H, 1970, BIOPOLYMERS, V9, P459, DOI 10.1002/bip.1970.360090408; Sun C, 2011, J PHYS CHEM B, V115, P13935, DOI 10.1021/jp207607r; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tamburro AM, 2003, BIOCHEMISTRY-US, V42, P13347, DOI 10.1021/bi034837t; Tamburro AM, 2006, BIOCHEMISTRY-US, V45, P9518, DOI 10.1021/bi060289i; Toonkool P, 2001, J BIOL CHEM, V276, P44575, DOI 10.1074/jbc.M107920200; URRY DW, 1969, NATURE, V222, P795, DOI 10.1038/222795a0; URRY DW, 1985, BIOCHEMISTRY-US, V24, P5182, DOI 10.1021/bi00340a034; URRY DW, 1988, J PROTEIN CHEM, V7, P1, DOI 10.1007/BF01025411; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Vrhovski B, 1997, EUR J BIOCHEM, V250, P92, DOI 10.1111/j.1432-1033.1997.00092.x; WADDELL WJ, 1956, J LAB CLIN MED, V48, P311; Wang YJ, 2002, PROTEIN SCI, V11, P852, DOI 10.1110/ps.3180102; WENDER DB, 1974, BIOPOLYMERS, V13, P1929, DOI 10.1002/bip.1974.360131002; Wildman KAH, 2002, BIOPOLYMERS, V64, P246, DOI 10.1002/bip.10180; Wise SG, 2005, J STRUCT BIOL, V149, P273, DOI 10.1016/j.jsb.2004.11.006; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u; Yao XL, 2004, MAGN RESON CHEM, V42, P267, DOI 10.1002/mrc.1330; YARON A, 1972, BIOPOLYMERS, V11, P2461, DOI 10.1002/bip.1972.360111207; Yeo GC, 2011, ADV COLLOID INTERFAC, V167, P94, DOI 10.1016/j.cis.2010.10.003; Zurdo J, 2001, J MOL BIOL, V311, P325, DOI 10.1006/jmbi.2001.4858	84	34	34	0	68	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10057	10068		10.1074/jbc.M113.533893	http://dx.doi.org/10.1074/jbc.M113.533893			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24550393	hybrid, Green Published			2022-12-28	WOS:000333807000053
J	De Marchi, U; Thevenet, J; Hermant, A; Dioum, E; Wiederkehr, A				De Marchi, Umberto; Thevenet, Jonathan; Hermant, Aurelie; Dioum, Elhadji; Wiederkehr, Andreas			Calcium Co-regulates Oxidative Metabolism and ATP Synthase-dependent Respiration in Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Energy Metabolism; Insulin; Islet; Mitochondria; NAD	STIMULATED INSULIN-SECRETION; ISOLATED RAT ISLETS; PYRUVATE-DEHYDROGENASE; MATRIX ALKALINIZATION; MITOCHONDRIAL CA2+; OXYGEN-CONSUMPTION; CYTOPLASMIC CA2+; CYTOSOLIC CA2+; GLUCOSE; ATP/ADP	Background: Nutrients stimulate calcium dependent activation of energy metabolism, in pancreatic beta cells. Results: Glucose-induced ATP synthase-dependent respiration is strictly calcium-dependent, with little or no effect of calcium on the NAD(P)H response. Conclusion: Calcium coordinates oxidative metabolism and respiration in pancreatic beta cells. Significance: Calcium has novel mitochondrial targets downstream of mitochondrial dehydrogenases. Mitochondrial energy metabolism is essential for glucose-induced calcium signaling and, therefore, insulin granule exocytosis in pancreatic beta cells. Calcium signals are sensed by mitochondria acting in concert with mitochondrial substrates for the full activation of the organelle. Here we have studied glucose-induced calcium signaling and energy metabolism in INS-1E insulinoma cells and human islet beta cells. In insulin secreting cells a surprisingly large fraction of total respiration under resting conditions is ATP synthase-independent. We observe that ATP synthase-dependent respiration is markedly increased after glucose stimulation. Glucose also causes a very rapid elevation of oxidative metabolism as was followed by NAD(P)H autofluorescence. However, neither the rate of the glucose-induced increase nor the new steady-state NAD(P)H levels are significantly affected by calcium. Our findings challenge the current view, which has focused mainly on calcium-sensitive dehydrogenases as the target for the activation of mitochondrial energy metabolism. We propose a model of tight calcium-dependent regulation of oxidative metabolism and ATP synthase-dependent respiration in beta cell mitochondria. Coordinated activation of matrix dehydrogenases and respiratory chain activity by calcium allows the respiratory rate to change severalfold with only small or no alterations of the NAD(P)H/NAD(P)(+) ratio.	[De Marchi, Umberto; Thevenet, Jonathan; Hermant, Aurelie; Wiederkehr, Andreas] Nestle Inst Hlth Sci, Mitochondrial Funct, CH-1015 Lausanne, Switzerland; [Dioum, Elhadji] Nestle Inst Hlth Sci, Diabet & Metab Hlth, CH-1015 Lausanne, Switzerland	Nestle SA; Nestle SA	Wiederkehr, A (corresponding author), Nestle Inst Hlth Sci, Quartier Innovat Batiment G, CH-1015 Lausanne, Switzerland.	andreas.wiederkehr@rd.nestle.com		De Marchi, Umberto/0000-0002-6011-5446				Affourtit C, 2008, BIOCHEM J, V409, P199, DOI 10.1042/BJ20070954; Akhmedov D, 2012, BBA-MOL CELL RES, V1823, P1815, DOI 10.1016/j.bbamcr.2012.07.005; Akhmedov D, 2010, FASEB J, V24, P4613, DOI 10.1096/fj.10-162222; BALABAN RS, 1986, SCIENCE, V232, P1121, DOI 10.1126/science.3704638; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; DAS AM, 1989, FEBS LETT, V256, P97, DOI 10.1016/0014-5793(89)81725-9; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Detimary P, 1998, J BIOL CHEM, V273, P33905, DOI 10.1074/jbc.273.51.33905; Detimary P, 1998, BIOCHEM J, V333, P269, DOI 10.1042/bj3330269; Doliba NM, 2007, AM J PHYSIOL-ENDOC M, V292, pE1507, DOI 10.1152/ajpendo.00282.2006; Doliba NM, 2003, DIABETES, V52, P394, DOI 10.2337/diabetes.52.2.394; DUCHEN MR, 1993, BIOCHEM J, V294, P35, DOI 10.1042/bj2940035; DUCHEN MR, 1992, BIOCHEM J, V283, P41, DOI 10.1042/bj2830041; GILON P, 1992, J BIOL CHEM, V267, P20713; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; HELLMAN B, 1974, BIOCHEM J, V138, P33, DOI 10.1042/bj1380033; Henquin JC, 2006, DIABETES, V55, P3470, DOI 10.2337/db06-0868; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kennedy ED, 1996, J CLIN INVEST, V98, P2524, DOI 10.1172/JCI119071; LANGHOFER M, 1993, J CELL SCI, V105, P753; Lin AL, 2010, P NATL ACAD SCI USA, V107, P8446, DOI 10.1073/pnas.0909711107; Liu T, 2008, CIRC RES, V103, P279, DOI 10.1161/CIRCRESAHA.108.175919; Luciani DS, 2006, J PHYSIOL-LONDON, V572, P379, DOI 10.1113/jphysiol.2005.101766; MEGLASSON MD, 1989, METABOLISM, V38, P1188, DOI 10.1016/0026-0495(89)90158-3; MORENOSANCHEZ R, 1990, BIOCHEM J, V268, P421, DOI 10.1042/bj2680421; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nicholls LI, 2002, BIOCHEM BIOPH RES CO, V291, P1081, DOI 10.1006/bbrc.2002.6567; OHTA M, 1990, J BIOL CHEM, V265, P17525; OHTA M, 1993, J PHARMACOL EXP THER, V264, P35; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Park KS, 2012, KOREAN J PHYSIOL PHA, V16, P71, DOI 10.4196/kjpp.2012.16.1.71; Patterson GH, 2000, P NATL ACAD SCI USA, V97, P5203, DOI 10.1073/pnas.090098797; PRALONG WF, 1990, EMBO J, V9, P53, DOI 10.1002/j.1460-2075.1990.tb08079.x; Samper E, 2009, FREE RADICAL BIO MED, V46, P387, DOI 10.1016/j.freeradbiomed.2008.10.036; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SCHULTZ V, 1993, ANAL BIOCHEM, V215, P302, DOI 10.1006/abio.1993.1591; Spegel P, 2011, BIOCHEM J, V435, P277, DOI 10.1042/BJ20100655; Sweet IR, 2006, DIABETES, V55, P3509, DOI 10.2337/db06-0400; Sweet IR, 2004, DIABETES, V53, P401, DOI 10.2337/diabetes.53.2.401; Tarasov AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039722; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; Wiederkehr A, 2009, ISLETS, V1, P154, DOI 10.4161/isl.1.2.9058; Wiederkehr A, 2009, EMBO J, V28, P417, DOI 10.1038/emboj.2008.302; Wikstrom JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033023; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006	46	55	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9182	9194		10.1074/jbc.M113.513184	http://dx.doi.org/10.1074/jbc.M113.513184			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24554722	Green Published, hybrid			2022-12-28	WOS:000333472100037
J	Jangani, M; Poolman, TM; Matthews, L; Yang, N; Farrow, SN; Berry, A; Hanley, N; Williamson, AJK; Whetton, AD; Donn, R; Ray, DW				Jangani, Maryam; Poolman, Toryn M.; Matthews, Laura; Yang, Nan; Farrow, Stuart N.; Berry, Andrew; Hanley, Neil; Williamson, Andrew J. K.; Whetton, Anthony D.; Donn, Rachelle; Ray, David W.			The Methyltransferase WBSCR22/Merm1 Enhances Glucocorticoid Receptor Function and Is Regulated in Lung Inflammation and Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Glucocorticoid Receptor; Glucocorticoids; Histone Methylation; Inflammation; Interferon; Lung; Tumor Necrosis Factor (TNF); Ubiquitination	TRANSCRIPTION FACTORS; HISTONE H3; IN-VIVO; CHROMATIN ACCESSIBILITY; LYSINE 9; GENE; METHYLATION; BINDING; PROMOTER; EXPRESSION	Background: Glucocorticoid (GC) action in inflammation is important but poorly understood. Results: Merm1 regulates glucocorticoid receptor (GR) recruitment to the genome and mediates subsequent histone modification. Proinflammatory cytokine induction of GC resistance is accompanied by Merm1 degradation; restoration of Merm1 expression rescues GC action. Conclusion: Merm1 is a novel GR co-modulator. Significance: Merm1 mediates inflammation regulation of GC action. Glucocorticoids (GC) regulate cell fate and immune function. We identified the metastasis-promoting methyltransferase, metastasis-related methyltransferase 1 (WBSCR22/Merm1) as a novel glucocorticoid receptor (GR) regulator relevant to human disease. Merm1 binds the GR co-activator GRIP1 but not GR. Loss of Merm1 impaired both GR transactivation and transrepression by reducing GR recruitment to its binding sites. This was accompanied by loss of GR-dependent H3K4Me3 at a well characterized promoter. Inflammation promotes GC resistance, in part through the actions of TNF and IFN. These cytokines suppressed Merm1 protein expression by driving ubiquitination of two conserved lysine residues. Restoration of Merm1 expression rescued GR transactivation. Cytokine suppression of Merm1 and of GR function was also seen in human lung explants. In addition, striking loss of Merm1 protein was observed in both inflammatory and neoplastic human lung pathologies. In conclusion, Merm1 is a novel regulator of chromatin structure affecting GR recruitment and function, contributing to loss of GC sensitivity in inflammation, with suppressed expression in pulmonary disease.	[Jangani, Maryam; Poolman, Toryn M.; Matthews, Laura; Yang, Nan; Farrow, Stuart N.; Berry, Andrew; Hanley, Neil; Ray, David W.] Univ Manchester, Ctr Endocrinol & Diabet, Inst Human Dev, Manchester M13 9PT, Lancs, England; [Jangani, Maryam; Donn, Rachelle] Univ Manchester, Arthrit Res UK Epidemiol Unit, Manchester M13 9PT, Lancs, England; Manchester Acad Hlth Sci Ctr, Manchester M13 9PT, Lancs, England; [Williamson, Andrew J. K.; Whetton, Anthony D.] Univ Manchester, Stem Cell & Leukaemia Prote Lab, Fac Inst Canc Sci, Manchester Acad Hlth Sci Ctr, Manchester M13 9PT, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester	Donn, R (corresponding author), Univ Manchester, Musckuloskeletal Res Grp, Manchester M13 9PT, Lancs, England.	rachelle.donn@manchester.ac.uk; david.w.ray@manchester.ac.uk		Ray, David/0000-0002-4739-6773; Poolman, Toryn/0000-0002-7427-6603; Yang, Nan/0000-0002-1610-5240; Donn, Rachelle/0000-0001-6976-9828; WHETTON, ANTHONY D/0000-0002-1098-3878; Hanley, Neil/0000-0003-3234-4038	Biotechnology and Biological Sciences Research Council; Wellcome Trust; University of Manchester Strategic Fund; EPSRC [EP/I037253/1] Funding Source: UKRI; MRC [MR/L010240/1, MR/L00254X/1, MR/K015885/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I037253/1] Funding Source: researchfish; Medical Research Council [MR/L00254X/1, MR/L010240/1, MR/K015885/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Manchester Strategic Fund; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We gratefully acknowledge Peter March and Roger Meadows (University of Manchester Bioimaging) for technical assistance. BioImaging Facility microscopes used in this study were purchased with grants from Biotechnology and Biological Sciences Research Council, Wellcome Trust, and the University of Manchester Strategic Fund.	ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; Astrand C, 2009, EXP CELL RES, V315, P2604, DOI 10.1016/j.yexcr.2009.05.012; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; Barr FD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006766; Berry A, 2010, FASEB J, V24, P1700, DOI 10.1096/fj.09-139998; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Chavez S, 1997, P NATL ACAD SCI USA, V94, P2885, DOI 10.1073/pnas.94.7.2885; Chen WW, 2006, MOL ENDOCRINOL, V20, P560, DOI 10.1210/me.2005-0318; CORDINGLEY MG, 1987, CELL, V48, P261, DOI 10.1016/0092-8674(87)90429-6; Cutolo M, 2008, ANN RHEUM DIS, V67, P905, DOI 10.1136/ard.2008.088955; Di Croce L, 1999, MOL CELL, V4, P45, DOI 10.1016/S1097-2765(00)80186-0; Doll A, 2001, CYTOGENET CELL GENET, V95, P20, DOI 10.1159/000057012; Dong S, 2007, MOL ENDOCRINOL, V21, P1617, DOI 10.1210/me.2006-0550; Donn R, 2007, FASEB J, V21, P402, DOI 10.1096/fj.06-7236com; Elsby LA, 2009, ARTHRITIS RHEUM-US, V60, P2220, DOI 10.1002/art.24659; Elsby LM, 2006, EMBO REP, V7, P898, DOI 10.1038/sj.embor.7400767; Farrants AKO, 1997, MOL CELL BIOL, V17, P895, DOI 10.1128/MCB.17.2.895; Figaro S, 2012, MOL CELL BIOL, V32, P2254, DOI 10.1128/MCB.06623-11; Fletcher TM, 2002, MOL CELL BIOL, V22, P3255, DOI 10.1128/MCB.22.10.3255-3263.2002; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; HERRERA RE, 1989, NATURE, V340, P68, DOI 10.1038/340068a0; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Ma H, 2001, CURR BIOL, V11, P1981, DOI 10.1016/S0960-9822(01)00600-5; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; McMaster A, 2008, NAT CLIN PRACT ENDOC, V4, P91, DOI 10.1038/ncpendmet0745; Migliori V, 2012, NAT STRUCT MOL BIOL, V19, P136, DOI 10.1038/nsmb.2209; Nakazawa Y, 2011, CANCER RES, V71, P1146, DOI 10.1158/0008-5472.CAN-10-2695; Ounap K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075686; Paszek P, 2010, CURR OPIN GENET DEV, V20, P670, DOI 10.1016/j.gde.2010.08.004; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Piano F, 2002, CURR BIOL, V12, P1959, DOI 10.1016/S0960-9822(02)01301-5; Pober BR, 2010, NEW ENGL J MED, V362, P239, DOI 10.1056/NEJMra0903074; Qiu Y, 2006, MOL CELL, V22, P669, DOI 10.1016/j.molcel.2006.04.019; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; RENKAWITZ R, 1984, CELL, V37, P503, DOI 10.1016/0092-8674(84)90380-5; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Schaecke H, 2007, MOL CELL ENDOCRINOL, V275, P109, DOI 10.1016/j.mce.2007.05.014; Schulze JM, 2009, MOL CELL, V35, P626, DOI 10.1016/j.molcel.2009.07.017; Sommer P, 2007, ONCOGENE, V26, P7111, DOI 10.1038/sj.onc.1210524; Sommer P, 2008, CURR OPIN INVEST DR, V9, P1070; Sommer P, 2010, ENDOCR-RELAT CANCER, V17, P203, DOI 10.1677/ERC-09-0241; Stavreva DA, 2009, NAT CELL BIOL, V11, P1093, DOI 10.1038/ncb1922; Tliba O, 2008, AM J RESP CELL MOL, V38, P463, DOI 10.1165/rcmb.2007-0226OC; TRUSS M, 1992, J STEROID BIOCHEM, V43, P365, DOI 10.1016/0960-0760(92)90071-P; Uhlenhaut NH, 2013, MOL CELL, V49, P158, DOI 10.1016/j.molcel.2012.10.013; Voss TC, 2011, CELL, V146, P544, DOI 10.1016/j.cell.2011.07.006; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wiench M, 2011, EMBO J, V30, P3028, DOI 10.1038/emboj.2011.210; Wu SC, 2009, MOL ENDOCRINOL, V23, P1323, DOI 10.1210/me.2009-0131; Yang NL, 2008, J CELL BIOCHEM, V103, P1760, DOI 10.1002/jcb.21562	55	22	25	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8931	8946		10.1074/jbc.M113.540906	http://dx.doi.org/10.1074/jbc.M113.540906			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24488492	Green Published, hybrid			2022-12-28	WOS:000333472100017
J	Joshi, PM; Sutor, SL; Huntoon, CJ; Karnitz, LM				Joshi, Poorval M.; Sutor, Shari L.; Huntoon, Catherine J.; Karnitz, Larry M.			Ovarian Cancer-associated Mutations Disable Catalytic Activity of CDK12, a Kinase That Promotes Homologous Recombination Repair and Resistance to Cisplatin and Poly(ADP-ribose) Polymerase Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						BRCA1; CDK (Cyclin-dependent Kinase); DNA Damage; Homologous Recombination; Ovarian Cancer; CDK12; Cisplatin; Poly(ADP)-ribose Polymerase; RAD51; Veliparib	CYCLIN K/CDK12 COMPLEX; DNA-DAMAGE; BRCA1; PHOSPHORYLATION; MAINTENANCE; DEFICIENCY; EXPRESSION; THERAPY; RAD51; CELLS	Background: CDK12 mutations occur in ovarian cancer. Results: These mutations impaired CDK12 kinase activity. Additionally, disabling CDK12 in ovarian cancer cells reduced BRCA1 levels and disrupted homologous recombination repair. Conclusion: CDK12 mutations that impair kinase activity likely disrupt homologous recombination. Significance: Defects in homologous recombination caused by CDK12 mutations may predict sensitivity to chemotherapy agents, including poly(ADP-ribose) polymerase inhibitors. Mutations in the tumor suppressors BRCA1 and BRCA2, which encode proteins that are key participants in homologous recombination (HR) repair, occur in approximate to 20% of high grade serous ovarian cancers. Although only 20% of these tumors have mutations in BRCA1 and BRCA2, nearly 50% of these tumors have defects in HR. Notably, however, the underlying genetic defects that give rise to HR defects in the absence of BRCA1 and BRCA2 mutations have not been fully elucidated. Here we show that the recurrent somatic CDK12 mutations identified in ovarian cancers impair the catalytic activity of this kinase, which is involved in the transcription of a subset of genes, including BRCA1 and other DNA repair genes. Furthermore, we show that disabling CDK12 function in ovarian cancer cells reduces BRCA1 levels, disrupts HR repair, and sensitizes these cells to the cross-linking agents melphalan and cisplatin and to the poly(ADP-ribose) polymerase (PARP) inhibitor veliparib (ABT-888). Taken together, these findings suggest that many CDK12 mutations are an unrecognized cause of HR defects in ovarian cancers.	[Joshi, Poorval M.; Karnitz, Larry M.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Sutor, Shari L.; Huntoon, Catherine J.; Karnitz, Larry M.] Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Karnitz, LM (corresponding author), Mayo Clin, Div Oncol Res, 200 First St SW, Rochester, MN 55905 USA.	karnitz.larry@mayo.edu		Joshi, Poorval/0000-0001-7886-9994	Mayo Clinic Ovarian Cancer SPORE Grant (through the National Institutes of Health) [P50 CA136393]; Mayo Clinic Pobanz Family Predoctoral Research Fellowship; NATIONAL CANCER INSTITUTE [P30CA015083, P50CA136393] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM072474] Funding Source: NIH RePORTER	Mayo Clinic Ovarian Cancer SPORE Grant (through the National Institutes of Health); Mayo Clinic Pobanz Family Predoctoral Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Mayo Clinic Ovarian Cancer SPORE Grant P50 CA136393 (through the National Institutes of Health) and Mayo Clinic Pobanz Family Predoctoral Research Fellowship (to P. M. J.).	Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Bajrami I, 2014, CANCER RES, V74, P287, DOI 10.1158/0008-5472.CAN-13-2541; Banerjee S, 2010, NAT REV CLIN ONCOL, V7, P508, DOI 10.1038/nrclinonc.2010.116; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Bast RC, 2010, J CLIN ONCOL, V28, P3545, DOI 10.1200/JCO.2010.28.5791; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Blazek D, 2012, CELL CYCLE, V11, P1049, DOI 10.4161/cc.11.6.19678; Blazek D, 2011, GENE DEV, V25, P2158, DOI 10.1101/gad.16962311; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Cheng SWG, 2012, MOL CELL BIOL, V32, P4691, DOI 10.1128/MCB.06267-11; Chini CCS, 2006, J BIOL CHEM, V281, P33276, DOI 10.1074/jbc.M604373200; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fong PC, 2010, J CLIN ONCOL, V28, P2512, DOI 10.1200/JCO.2009.26.9589; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Hackbarth JS, 2004, BIOTECHNIQUES, V37, P835; Hennessy BTJ, 2010, J CLIN ONCOL, V28, P3570, DOI 10.1200/JCO.2009.27.2997; Holloman WK, 2011, NAT STRUCT MOL BIOL, V18, P748, DOI 10.1038/nsmb.2096; Huehls AM, 2012, MOL PHARMACOL, V82, P767, DOI 10.1124/mol.112.080614; Huntoon CJ, 2013, CANCER RES, V73, P3683, DOI 10.1158/0008-5472.CAN-13-0110; Huntoon CJ, 2010, CANCER RES, V70, P8642, DOI 10.1158/0008-5472.CAN-10-1345; Ledermann J, 2012, NEW ENGL J MED, V366, P1382, DOI 10.1056/NEJMoa1105535; Martin SA, 2008, CURR OPIN GENET DEV, V18, P80, DOI 10.1016/j.gde.2008.01.016; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Nakada S, 2012, CANCER RES, V72, P4974, DOI 10.1158/0008-5472.CAN-12-1057; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Ratner ES, 2012, CURR OPIN ONCOL, V24, P564, DOI 10.1097/CCO.0b013e3283564230; Roy R, 2012, NAT REV CANCER, V12, P68, DOI 10.1038/nrc3181; Stordal B, 2013, MOL ONCOL, V7, P567, DOI 10.1016/j.molonc.2012.12.007; Tarsounas M, 2003, ONCOGENE, V22, P1115, DOI 10.1038/sj.onc.1206263; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Wagner JM, 2009, MOL PHARMACOL, V76, P208, DOI 10.1124/mol.109.055178; Wang Y, 2008, J BIOL CHEM, V283, P33578, DOI 10.1074/jbc.M807495200	34	125	145	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9247	9253		10.1074/jbc.M114.551143	http://dx.doi.org/10.1074/jbc.M114.551143			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24554720	hybrid, Green Published			2022-12-28	WOS:000333472100042
J	Ren, J; Wang, QW; Morgan, S; Si, Y; Ravichander, A; Dou, CL; Kent, KC; Liu, B				Ren, Jun; Wang, Qiwei; Morgan, Stephanie; Si, Yi; Ravichander, Aarthi; Dou, Changlin; Kent, K. Craig; Liu, Bo			Protein Kinase C- delta ( PKC delta) Regulates Proinflammatory Chemokine Expression through Cytosolic Interaction with the NF- kappa B Subunit p65 in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chemokines; Gene Expression; Inflammation; Protein-Protein Interactions; Vascular Smooth Muscle Cells; Nuclear Factor -Light Chain Enhancer of Activated B Cells (NF-B); Protein Kinase C- (PKC)	MONOCYTE-CHEMOATTRACTANT PROTEIN-1; TUMOR-NECROSIS-FACTOR; ABDOMINAL AORTIC-ANEURYSM; ENDOTHELIAL-CELLS; ARTERIAL INJURY; TRANSCRIPTIONAL REGULATION; HISTONE ACETYLATION; SIGNALING PATHWAY; MCP-1 EXPRESSION; GENE-EXPRESSION	Background: Proinflammatory chemokines released by vascular smooth muscle cells (VSMCs) play a critical role in vascular inflammation. Results: Promoting protein kinase C- (PKC) translocation or inhibition of NF-B pathway diminishes proinflammatory chemokine production. Conclusion: PKC regulates proinflammatory chemokine expression through cytosolic interaction with the NF-B subunit p65, thus modulating inflammation. Significance: Learning how PKC regulates proinflammatory chemokine expression is crucial for understanding vascular inflammation. Proinflammatory chemokines released by vascular smooth muscle cells (VSMCs) play a critical role in vascular inflammation. Protein kinase C- (PKC) has been shown to be up-regulated in VSMCs of injured arteries. PKC knock-out (Prkcd(-/-)) mice are resistant to inflammation as well as apoptosis in models of abdominal aortic aneurysm. However, the precise mechanism by which PKC modulates inflammation remains incompletely understood. In this study, we identified four inflammatory chemokines (Ccl2/Mcp-1, Ccl7, Cxcl16, and Cx3cl1) of over 45 PKC-regulated genes associated with inflammatory response by microarray analysis. Using CCL2 as a prototype, we demonstrated that PKC stimulated chemokine expression at the transcriptional level. Inhibition of the NF-B pathway or siRNA knockdown of subunit p65, but not p50, eliminated the effect of PKC on Ccl2 expression. Overexpressing PKC followed by incubation with phorbol 12-myristate 13-acetate resulted in an increase in p65 Ser-536 phosphorylation and enhanced DNA binding affinity without affecting IB degradation or p65 nuclear translocation. Prkcd gene deficiency impaired p65 Ser-536 phosphorylation and DNA binding affinity in response to TNF. Results from in situ proximity ligation analysis and co-immunoprecipitation performed on cultured VSMCs and aneurysmal aorta demonstrated physical interaction between PKC and p65 that took place largely outside the nucleus. Promoting nuclear translocation of PKC with peptide RACK diminished Ccl2 production, whereas inhibition of PKC translocation with peptide V1-1 enhanced Ccl2 expression. Together, these results suggest that PKC modulates inflammation at least in part through the NF-B-mediated chemokines. Mechanistically, PKC activates NF-B through an IB-independent cytosolic interaction, which subsequently leads to enhanced p65 phosphorylation and DNA binding affinity.	[Ren, Jun; Wang, Qiwei; Morgan, Stephanie; Si, Yi; Ravichander, Aarthi; Kent, K. Craig; Liu, Bo] Univ Wisconsin, Dept Surg, Div Vasc Surg, Madison, WI 53705 USA; [Dou, Changlin] Binzhou Med Univ, Yantai 264003, Shandong, Peoples R China	University of Wisconsin System; University of Wisconsin Madison; Binzhou Medical University	Liu, B (corresponding author), Univ Wisconsin, Dept Surg, Div Vasc Surg, 1111 Highland Ave, Madison, WI 53705 USA.	liub@surgery.wisc.edu		REN, Jun/0000-0002-6358-0765; Wang, Qiwei/0000-0003-3897-2529	National Institutes of Health [R01HL088447]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088447] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HL088447 (to B. L.).	Aiello RJ, 1999, ARTERIOSCL THROM VAS, V19, P1518, DOI 10.1161/01.ATV.19.6.1518; Boekhoudt GH, 2003, J IMMUNOL, V170, P4139, DOI 10.4049/jimmunol.170.8.4139; Brasier AR, 2010, CARDIOVASC RES, V86, P211, DOI 10.1093/cvr/cvq076; Chen H, 2004, J BIOL CHEM, V279, P50829, DOI 10.1074/jbc.M409173200; Chen L, 2001, P NATL ACAD SCI USA, V98, P11114, DOI 10.1073/pnas.191369098; CLOWES AW, 1989, LAB INVEST, V60, P360; Colonnello JS, 2003, J VASC SURG, V38, P138, DOI 10.1016/S0741-5214(03)00125-3; Curci JA, 2004, J CLIN INVEST, V114, P168, DOI 10.1172/JCI200422309; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; FANJUL A, 1994, NATURE, V372, P107, DOI 10.1038/372107a0; Finzer P, 2000, ONCOGENE, V19, P3235, DOI 10.1038/sj.onc.1203643; Fischer JW, 2010, CARDIOVASC RES, V85, P407, DOI 10.1093/cvr/cvp390; Fleenor DL, 2003, INVEST OPHTH VIS SCI, V44, P3494, DOI 10.1167/iovs.02-0757; Furukawa Y, 1999, CIRC RES, V84, P306, DOI 10.1161/01.RES.84.3.306; Hochrainer K, 2013, J BIOL CHEM, V288, P285, DOI 10.1074/jbc.M112.385625; Hsieh CY, 2011, J BIOL CHEM, V286, P5942, DOI 10.1074/jbc.M110.123968; Hu J, 2004, CARCINOGENESIS, V25, P1991, DOI 10.1093/carcin/bgh198; Ikeda U, 2002, CLIN CARDIOL, V25, P143, DOI 10.1002/clc.4960250403; Israel A., 2010, COLD SPRING HARB PER, V2; Junttila I, 2003, J LEUKOCYTE BIOL, V73, P281, DOI 10.1189/jlb.0702359; Kato K, 2009, AM J PHYSIOL-HEART C, V297, pH2253, DOI 10.1152/ajpheart.00274.2009; Kilpatrick LE, 2006, J LEUKOCYTE BIOL, V80, P1512, DOI 10.1189/jlb.0406284; Kim J, 2011, PROSTATE, V71, P946, DOI 10.1002/pros.21310; Kranzhofer R, 1999, ARTERIOSCL THROM VAS, V19, P1623, DOI 10.1161/01.ATV.19.7.1623; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Lengfeld J, 2012, MOL BIOL CELL, V23, P1955, DOI 10.1091/mbc.E11-06-0531; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu B, 2006, J MOL CELL CARDIOL, V41, P160, DOI 10.1016/j.yjmcc.2006.03.426; Liu B, 2010, MOL CELL BIOCHEM, V344, P73, DOI 10.1007/s11010-010-0530-6; Lu ZG, 2009, CANCER RES, V69, P5927, DOI 10.1158/0008-5472.CAN-08-4786; Malavez Y., 2009, ATLAS GENET CYTOGENE, V13, P28; Masoumi KC, 2012, FEBS LETT, V586, P1166, DOI 10.1016/j.febslet.2012.03.033; Matoba K, 2010, BIOCHEM BIOPH RES CO, V402, P725, DOI 10.1016/j.bbrc.2010.10.093; Middleton RK, 2007, J VASC SURG, V45, P574, DOI 10.1016/j.jvs.2006.11.020; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; MOCHLYROSEN D, 1991, P NATL ACAD SCI USA, V88, P3997, DOI 10.1073/pnas.88.9.3997; Morgan S, 2012, ARTERIOSCL THROM VAS, V32, P2493, DOI 10.1161/ATVBAHA.112.255661; Murao K, 2000, BIOCHEM BIOPH RES CO, V276, P791, DOI 10.1006/bbrc.2000.3497; Oeckinghaus A, 2009, COLD SPRING HARB PER, V1; Okhrimenko H, 2005, J BIOL CHEM, V280, P23643, DOI 10.1074/jbc.M501374200; Park SK, 2004, NEPHROL DIAL TRANSPL, V19, P312, DOI 10.1093/ndt/gfg583; Ping DS, 1999, J IMMUNOL, V162, P727; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; Rahman A, 2002, CIRC RES, V91, P398, DOI 10.1161/01.RES.0000033520.95242.A2; Rahman A, 2001, MOL CELL BIOL, V21, P5554, DOI 10.1128/MCB.21.16.5554-5565.2001; Reyland ME, 2007, BIOCHEM SOC T, V35, P1001, DOI 10.1042/BST0351001; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Roque M, 2002, ARTERIOSCL THROM VAS, V22, P554, DOI 10.1161/hq0402.105720; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ryer EJ, 2006, ARTERIOSCL THROM VAS, V26, P780, DOI 10.1161/01.ATV.0000209517.00220.cd; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Schubl S, 2009, J SURG RES, V153, P181, DOI 10.1016/j.jss.2008.04.032; Si Y, 2012, ARTERIOSCL THROM VAS, V32, P943, DOI 10.1161/ATVBAHA.111.244921; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092; Vancurova I, 2001, J BIOL CHEM, V276, P19746, DOI 10.1074/jbc.M100234200; Vanden Berghe W, 1998, J BIOL CHEM, V273, P3285, DOI 10.1074/jbc.273.6.3285; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Yamanouchi D, 2010, CARDIOVASC RES, V85, P434, DOI 10.1093/cvr/cvp328; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335; Zhang F, 2009, J BIOL CHEM, V284, P17564, DOI 10.1074/jbc.M109.013987; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	65	46	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9013	9026		10.1074/jbc.M113.515957	http://dx.doi.org/10.1074/jbc.M113.515957			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24519937	hybrid, Green Published			2022-12-28	WOS:000333472100023
J	Thurner, P; Gsandtner, I; Kudlacek, O; Choquet, D; Nanoff, C; Freissmuth, M; Zezula, J				Thurner, Patrick; Gsandtner, Ingrid; Kudlacek, Oliver; Choquet, Daniel; Nanoff, Christian; Freissmuth, Michael; Zezula, Juergen			A Two-state Model for the Diffusion of the A(2A) Adenosine Receptor in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						7-Helix Receptor; Adenosine; Adenosine Receptor; Adenylate Cyclase (Adenylyl Cyclase); G Protein-coupled Receptor (GPCR); G Protein; Neuron	PROTEIN-COUPLED RECEPTORS; A(2A)-ADENOSINE RECEPTOR; CONSTITUTIVE ACTIVITY; STRUCTURAL BASIS; STIMULATION; CHOLESTEROL; KINASE; PALMITOYLATION; MEMBRANE; TERMINUS	Background: Agonist activation slows diffusion of the A(2A) receptor in the lipid bilayer. Results: In hippocampal neurons, the agonist-induced decrease in mobility was accounted for by both the hydrophobic receptor core and its extended C terminus, which recruited SAP102. Conclusion: The observations are consistent with two diffusion states of the A(2A) receptor in neurons. Significance: SAP102 regulates access of the A(2A) receptor to a compartment with restricted mobility. The A(2A) receptor is a class A/rhodopsin-like G protein-coupled receptor. Coupling to its cognate protein, G(s), occurs via restricted collision coupling and is contingent on the presence of cholesterol. Agonist activation slows diffusion of the A(2A) adenosine receptor in the lipid bilayer. We explored the contribution of the hydrophobic core and of the extended C terminus by examining diffusion of quantum dot-labeled receptor variants in dissociated hippocampal neurons. Single particle tracking of the A(2A) receptor(1-311), which lacks the last 101 residues, revealed that agonist-induced confinement was abolished and that the agonist-induced decrease in diffusivity was reduced substantially. A fragment comprising the SH3 domain and the guanylate kinase domain of synapse-associated protein 102 (SAP102) was identified as a candidate interactor that bound to the A(2A) receptor C terminus. Complex formation between the A(2A) receptor and SAP102 was verified by coimmunoprecipitation and by tracking its impact on receptor diffusion. An analysis of all trajectories by a hidden Markov model was consistent with two diffusion states where agonist activation reduced the transition between the two states and, thus, promoted the accumulation of the A(2A) receptor in the compartment with slow mobility. Overexpression of SAP102 precluded the access of the A(2A) receptor to a compartment with restricted mobility. In contrast, a mutated A(2A) receptor (with (DVELL387)-D-383 replaced by RVRAA) was insensitive to the action of SAP102. These observations show that the hydrophobic core per se does not fully account for the agonist-promoted change in mobility of the A(2A) receptor. The extended carboxyl terminus allows for regulatory input by scaffolding molecules such as SAP102.	[Thurner, Patrick; Gsandtner, Ingrid; Kudlacek, Oliver; Nanoff, Christian; Freissmuth, Michael; Zezula, Juergen] Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria; [Choquet, Daniel] Univ Bordeaux 2, Inst Interdisciplinaire Neurosci, CNRS UMR 5297, F-33077 Bordeaux, France	Medical University of Vienna; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Freissmuth, M (corresponding author), Med Univ Vienna, Inst Pharmacol, Ctr Physiol & Pharmacol, Wahringer Str 13a, A-1090 Vienna, Austria.	michael.freissmuth@meduniwien.ac.at	Choquet, Daniel/K-7893-2018; Choquet, Daniel/GOJ-8825-2022	Choquet, Daniel/0000-0003-4726-9763; Choquet, Daniel/0000-0003-4726-9763; Freissmuth, Michael/0000-0001-9398-1765; Kudlacek, Oliver/0000-0002-3086-8551; nanoff, christian/0000-0002-8857-2470	Austrian Science Fund/FWF [P20012, PIRG-GA-2008-230970]; European Union; Austrian Academy of Sciences; Austrian Science Fund (FWF) [P 21002] Funding Source: researchfish	Austrian Science Fund/FWF(Austrian Science Fund (FWF)); European Union(European Commission); Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund/FWF Grants P20012 and PIRG-GA-2008-230970 and by European Union Seventh Framework Programme Grant FP7/2007-2013).; Supported by a Doc-Forte stipend of the Austrian Academy of Sciences.	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; Bergmayr C, 2013, J BIOL CHEM, V288, P28831, DOI 10.1074/jbc.M113.464776; Bouzigues C, 2007, BIOPHYS J, V92, P654, DOI 10.1529/biophysj.106.094524; Burgueno J, 2003, J BIOL CHEM, V278, P37545, DOI 10.1074/jbc.M302809200; Charalambous C, 2008, J BIOL CHEM, V283, P9276, DOI 10.1074/jbc.M706275200; Chini B, 2009, J MOL ENDOCRINOL, V42, P371, DOI 10.1677/JME-08-0114; CUNHA RA, 1994, BRAIN RES, V649, P208, DOI 10.1016/0006-8993(94)91066-9; Das R., 2009, PLOS COMPUT BIOL, V5; Ferre S, 2008, CURR PHARM DESIGN, V14, P1468, DOI 10.2174/138161208784480108; Fuxe K, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00136; Gsandtner I, 2005, J BIOL CHEM, V280, P31898, DOI 10.1074/jbc.M506515200; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hoetzl S, 2007, J NEUROCHEM, V103, P3, DOI 10.1111/j.1471-4159.2007.04721.x; Ibrisimovic E, 2012, PURINERG SIGNAL, V8, P677, DOI 10.1007/s11302-012-9298-3; Keuerleber S, 2012, J BIOL CHEM, V287, P42104, DOI 10.1074/jbc.M112.393579; Keuerleber S, 2011, BBA-BIOMEMBRANES, V1808, P1350, DOI 10.1016/j.bbamem.2010.05.009; Klinger M, 2002, CELL SIGNAL, V14, P99, DOI 10.1016/S0898-6568(01)00235-2; Klinger M, 2002, N-S ARCH PHARMACOL, V366, P287, DOI 10.1007/s00210-002-0617-z; Kudlacek O, 2001, J BIOL CHEM, V276, P3010, DOI 10.1074/jbc.M007910200; Lee JY, 2012, J AM CHEM SOC, V134, P16512, DOI 10.1021/ja307532d; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Milojevic T, 2006, MOL PHARMACOL, V69, P1083, DOI 10.1124/mol.105.015818; Qanbar R, 2003, PHARMACOL THERAPEUT, V97, P1, DOI 10.1016/S0163-7258(02)00300-5; Richler E, 2011, J NEUROSCI, V31, P16716, DOI 10.1523/JNEUROSCI.3362-11.2011; Ruprecht JJ, 2004, EMBO J, V23, P3609, DOI 10.1038/sj.emboj.7600374; Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325; Seidel MG, 1999, J BIOL CHEM, V274, P25833, DOI 10.1074/jbc.274.36.25833; Sexl V, 1997, J BIOL CHEM, V272, P5792, DOI 10.1074/jbc.272.9.5792; SEXL V, 1995, BRIT J PHARMACOL, V114, P1577, DOI 10.1111/j.1476-5381.1995.tb14942.x; Shen HY, 2008, J NEUROSCI, V28, P2970, DOI 10.1523/JNEUROSCI.5255-07.2008; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; TOLKOVSKY AM, 1978, BIOCHEMISTRY-US, V17, P3811, DOI 10.1021/bi00611a021; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Wei CJ, 2011, BBA-BIOMEMBRANES, V1808, P1358, DOI 10.1016/j.bbamem.2010.12.018; Wilson KM, 1996, J CELL SCI, V109, P2101; Zezula J, 2008, BRIT J PHARMACOL, V153, pS184, DOI 10.1038/sj.bjp.0707674; Zheng CY, 2011, NEUROSCIENTIST, V17, P493, DOI 10.1177/1073858410386384; Zheng CY, 2010, J NEUROSCI, V30, P4757, DOI 10.1523/JNEUROSCI.6108-09.2010	39	19	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9263	9274		10.1074/jbc.M113.505685	http://dx.doi.org/10.1074/jbc.M113.505685			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24509856	hybrid, Green Published			2022-12-28	WOS:000333472100044
J	Gao, Y; Shen, L; Honzatko, RB				Gao, Yang; Shen, Lu; Honzatko, Richard B.			Central Cavity of Fructose-1,6-bisphosphatase and the Evolution of AMP/Fructose 2,6-bisphosphate Synergism in Eukaryotic Organisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Crystal Structure; Enzyme Inhibitors; Enzyme Kinetics; Evolution; Gluconeogenesis; Metabolism	RECOMBINANT PORCINE FRUCTOSE-1,6-BISPHOSPHATASE; ESCHERICHIA-COLI FRUCTOSE-1,6-BISPHOSPHATASE; RABBIT LIVER FRUCTOSE-1,6-BISPHOSPHATASE; PIG-KIDNEY FRUCTOSE-1,6-BISPHOSPHATASE; NUCLEAR-MAGNETIC-RESONANCE; FRUCTOSE 2,6-BISPHOSPHATE; ALLOSTERIC INHIBITION; AMP INHIBITION; DYNAMIC LOOP; R-STATE	Background: AMP and fructose 2,6-bisphosphate (Fru-2,6-P-2) synergistically inhibit eukaryotic fructose-1,6-bisphosphatase (FBPase). How did this property evolve? Results: Directed mutations, kinetics, and structure determinations link the central cavity of FBPase to AMP/Fru-2,6-P-2 synergism. Conclusion: A central cavity in any FBPase implies AMP/Fru-2,6-P-2 and AMP/Fru-6-P synergism. Significance: AMP/Fru-2,6-P-2 synergism of eukaryotic FBPases probably evolved from AMP/Fru-6-P synergism of an ancestral FBPase. The effects of AMP and fructose 2,6-bisphosphate (Fru-2,6-P-2) on porcine fructose-1,6-bisphosphatase (pFBPase) and Escherichia coli FBPase (eFBPase) differ in three respects. AMP/Fru-2,6-P-2 synergism in pFBPase is absent in eFBPase. Fru-2,6-P-2 induces a 13 degrees subunit pair rotation in pFBPase but no rotation in eFBPase. Hydrophilic side chains in eFBPase occupy what otherwise would be a central aqueous cavity observed in pFBPase. Explored here is the linkage of AMP/Fru-2,6-P-2 synergism to the central cavity and the evolution of synergism in FBPases. The single mutation Ser(45) His substantially fills the central cavity of pFBPase, and the triple mutation Ser(45) His, Thr(46) Arg, and Leu(186) Tyr replaces porcine with E. coli type side chains. Both single and triple mutations significantly reduce synergism while retaining other wild-type kinetic properties. Similar to the effect of Fru-2,6-P-2 on eFBPase, the triple mutant of pFBPase with bound Fru-2,6-P-2 exhibits only a 2 degrees subunit pair rotation as opposed to the 13 degrees rotation exhibited by the Fru-2,6-P-2 complex of wild-type pFBPase. The side chain at position 45 is small in all available eukaryotic FBPases but large and hydrophilic in bacterial FBPases, similar to eFBPase. Sequence information indicates the likelihood of synergism in the FBPase from Leptospira interrogans (lFBPase), and indeed recombinant lFBPase exhibits AMP/Fru-2,6-P-2 synergism. Unexpectedly, however, AMP also enhances Fru-6-P binding to lFBPase. Taken together, these observations suggest the evolution of AMP/Fru-2,6-P-2 synergism in eukaryotic FBPases from an ancestral FBPase having a central aqueous cavity and exhibiting synergistic feedback inhibition by AMP and Fru-6-P.	[Gao, Yang; Shen, Lu; Honzatko, Richard B.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University	Honzatko, RB (corresponding author), Iowa State Univ, 4206 Mol Biol Bldg, Ames, IA 50011 USA.	honzatko@iastate.edu	Gao, Yang/O-3445-2016		National Institutes of Health [NS 10546]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010546, R01NS010546, R56NS010546] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS 10546.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; BENKOVIC SJ, 1982, ADV ENZYMOL RAMB, V53, P45; BLANGY D, 1968, J MOL BIOL, V31, P13, DOI 10.1016/0022-2836(68)90051-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choe JY, 2000, BIOCHEMISTRY-US, V39, P8565, DOI 10.1021/bi000574g; Choe JY, 1998, BIOCHEMISTRY-US, V37, P11441, DOI 10.1021/bi981112u; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210; DERR RF, 1972, BIOCHEM BIOPH RES CO, V49, P1385, DOI 10.1016/0006-291X(72)90492-5; ELMAGHRABI MR, 1992, J BIOL CHEM, V267, P6526; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; GANSON NJ, 1985, J BIOL CHEM, V260, P2837; Gao Y, 2013, BIOCHEMISTRY-US, V52, P5206, DOI 10.1021/bi400532n; HAN PF, 1983, EXPERIENTIA, V39, P1305, DOI 10.1007/BF01990383; Hines JK, 2007, J BIOL CHEM, V282, P36121, DOI 10.1074/jbc.M707302200; Hines JK, 2007, J BIOL CHEM, V282, P24697, DOI 10.1074/jbc.M703580200; Hines JK, 2007, J BIOL CHEM, V282, P11696, DOI 10.1074/jbc.M611104200; Hines JK, 2006, J BIOL CHEM, V281, P18386, DOI 10.1074/jbc.M602553200; Iancu CV, 2005, J BIOL CHEM, V280, P19737, DOI 10.1074/jbc.M501011200; KE HM, 1990, P NATL ACAD SCI USA, V87, P5243, DOI 10.1073/pnas.87.14.5243; Kelley-Loughnane N, 2002, BBA-PROTEIN STRUCT M, V1594, P6, DOI 10.1016/S0167-4838(01)00261-8; Kelley-Loughnane N, 2001, BBA-PROTEIN STRUCT M, V1548, P66, DOI 10.1016/S0167-4838(01)00218-7; KRUGER NJ, 1984, PLANT PHYSIOL, V76, P49, DOI 10.1104/pp.76.1.49; Kurbanov FT, 1998, J BIOL CHEM, V273, P17511, DOI 10.1074/jbc.273.28.17511; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leatherbarrow R.J., 2009, GRAFIT VERSION 7; LIU F, 1988, J BIOL CHEM, V263, P10035; LIU F, 1988, J BIOL CHEM, V263, P9122; LIU F, 1988, ARCH BIOCHEM BIOPHYS, V260, P609, DOI 10.1016/0003-9861(88)90488-2; MCGRANE MM, 1983, J BIOL CHEM, V258, P445; Michels PAM, 2006, IUBMB LIFE, V58, P133, DOI 10.1080/15216540600688280; Nelson SW, 2004, J BIOL CHEM, V279, P18481, DOI 10.1074/jbc.M308811200; Nelson SW, 2002, J BIOL CHEM, V277, P15539, DOI 10.1074/jbc.M112304200; Nelson SW, 2001, J BIOL CHEM, V276, P6119, DOI 10.1074/jbc.M009485200; Nelson SW, 2000, BIOCHEMISTRY-US, V39, P11100, DOI 10.1021/bi000609c; Nelson SW, 2000, J BIOL CHEM, V275, P29986, DOI 10.1074/jbc.M000473200; Okar DA, 1999, BIOFACTORS, V10, P1, DOI 10.1002/biof.5520100101; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; PILKIS SJ, 1981, J BIOL CHEM, V256, P3619; PILKIS SJ, 1981, J BIOL CHEM, V256, P3171; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; SCHEFFLER JE, 1986, BIOCHEMISTRY-US, V25, P6659, DOI 10.1021/bi00369a050; Shyur LF, 1996, J BIOL CHEM, V271, P33301, DOI 10.1074/jbc.271.52.33301; Shyur LF, 1997, J BIOL CHEM, V272, P26295, DOI 10.1074/jbc.272.42.26295; Shyur LF, 1996, J BIOL CHEM, V271, P3005, DOI 10.1074/jbc.271.6.3005; TAKETA K, 1965, J BIOL CHEM, V240, P651; TEJWANI GA, 1983, ADV ENZYMOL RAMB, V54, P121; UYEDA K, 1981, J BIOL CHEM, V256, P8394; VANSCHAFTINGEN E, 1981, EUR J BIOCHEM, V117, P319, DOI 10.1111/j.1432-1033.1981.tb06339.x; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P3483; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P2861; XUE YF, 1994, P NATL ACAD SCI USA, V91, P12482, DOI 10.1073/pnas.91.26.12482; Zhang RL, 1996, BIOCHEMISTRY-US, V35, P3038, DOI 10.1021/bi952188i; ZHANG YP, 1994, J MOL BIOL, V244, P609, DOI 10.1006/jmbi.1994.1755	57	10	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8450	8461		10.1074/jbc.M114.548586	http://dx.doi.org/10.1074/jbc.M114.548586			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24436333	Green Published, hybrid			2022-12-28	WOS:000333157500037
J	Kakoi, H; Maeda, S; Shinohara, N; Matsuyama, K; Imamura, K; Kawamura, I; Nagano, S; Setoguchi, T; Yokouchi, M; Ishidou, Y; Komiya, S				Kakoi, Hironori; Maeda, Shingo; Shinohara, Naohiro; Matsuyama, Kanehiro; Imamura, Katsuyuki; Kawamura, Ichiro; Nagano, Satoshi; Setoguchi, Takao; Yokouchi, Masahiro; Ishidou, Yasuhiro; Komiya, Setsuro			Bone Morphogenic Protein (BMP) Signaling Up-regulates Neutral Sphingomyelinase 2 to Suppress Chondrocyte Maturation via the Akt Protein Signaling Pathway as a Negative Feedback Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Bone Morphogenetic Protein (BMP); Ceramide; Chondrogenesis; Sphingomyelinase; Hyaluronan Synthase 2; Sphingomyelin Phosphodiesterase 3	HYALURONAN SYNTHASE 2; GROWTH-FACTOR-BETA; CELL-LINE ATDC5; X COLLAGEN GENE; IN-VITRO; CARTILAGE FORMATION; CROSS-TALK; CHONDROGENIC DIFFERENTIATION; HYPERTROPHIC DIFFERENTIATION; ARTICULAR CHONDROCYTES	Background: It is not clear how BMP-induced chondrocyte maturation is cell-autonomously terminated. Results: BMP-2 induced the ceramide-generating enzyme neutral sphingomyelinase 2 (nSMase2) in chondrocytes, whereas silencing of nSMase2 enhanced maturation in an Akt signaling-dependent manner. Conclusion: nSMase2 signaling regulates BMP-induced chondrocyte maturation as a negative feedback mechanism. Significance: This study elucidated the novel link between BMP and lipid signaling in chondrogenesis. Although bone morphogenic protein (BMP) signaling promotes chondrogenesis, it is not clear whether BMP-induced chondrocyte maturation is cell-autonomously terminated. Loss of function of Smpd3 in mice results in an increase in mature hypertrophic chondrocytes. Here, we report that in chondrocytes the Runx2-dependent expression of Smpd3 was increased by BMP-2 stimulation. Neutral sphingomyelinase 2 (nSMase2), encoded by the Smpd3 gene, was detected both in prehypertrophic and hypertrophic chondrocytes of mouse embryo bone cartilage. An siRNA for Smpd3, as well as the nSMase inhibitor GW4869, significantly enhanced BMP-2-induced differentiation and maturation of chondrocytes. Conversely, overexpression of Smpd3 or C-2-ceramide, which mimics the function of nSMase2, inhibited chondrogenesis. Upon induction of Smpd3 siRNA or GW4869, phosphorylation of both Akt and S6 proteins was increased. The accelerated chondrogenesis induced by Smpd3 silencing was negated by application of the Akt inhibitor MK2206 or the mammalian target of rapamycin inhibitor rapamycin. Importantly, in mouse bone culture, GW4869 treatment significantly promoted BMP-2-induced hypertrophic maturation and calcification of chondrocytes, which subsequently was eliminated by C-2-ceramide. Smpd3 knockdown decreased the apoptosis of terminally matured ATDC5 chondrocytes, probably as a result of decreased ceramide production. In addition, we found that expression of hyaluronan synthase 2 (Has2) was elevated by a loss of Smpd3, which was restored by MK2206. Indeed, expression of Has2 protein decreased in nSMase2-positive hypertrophic chondrocytes in the bones of mouse embryos. Our data suggest that the Smpd3/nSMase2-ceramide-Akt signaling axis negatively regulates BMP-induced chondrocyte maturation and Has2 expression to control the rate of endochondral ossification as a negative feedback mechanism.	[Kakoi, Hironori; Maeda, Shingo; Shinohara, Naohiro; Matsuyama, Kanehiro; Imamura, Katsuyuki; Ishidou, Yasuhiro; Komiya, Setsuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Med Joint Mat, Kagoshima 8908544, Japan; [Shinohara, Naohiro; Matsuyama, Kanehiro; Imamura, Katsuyuki; Kawamura, Ichiro; Nagano, Satoshi; Yokouchi, Masahiro; Komiya, Setsuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Orthopaed Surg, Kagoshima 8908544, Japan; [Setoguchi, Takao; Komiya, Setsuro] Kagoshima Univ, Grad Sch Med & Dent Sci, Near Future Locomotor Organ Med Creat Course, Kagoshima 8908544, Japan	Kagoshima University; Kagoshima University; Kagoshima University	Maeda, S (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Med Joint Mat, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	s-maeda@m3.kufm.kagoshima-u.ac.jp		Nagano, Satoshi/0000-0003-2015-1730	Japan Society for the Promotion of Science KAKENHI [25462376, 23592221, 23592222]; Hip Joint Foundation of Japan; Cell Science Research Foundation; Grants-in-Aid for Scientific Research [23592222] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hip Joint Foundation of Japan; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 25462376 (to H. K.), 23592221 (to S. M.), and 23592222 (to Y. I.), a grant from the Hip Joint Foundation of Japan (to S. M.), and a grant from the Cell Science Research Foundation (to S. M.).	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Alvarez J, 2002, DEVELOPMENT, V129, P1913; ATSUMI T, 1990, CELL DIFFER DEV, V30, P109, DOI 10.1016/0922-3371(90)90079-C; Aubin I, 2005, NAT GENET, V37, P803, DOI 10.1038/ng1603; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Chae YM, 2009, BMB REP, V42, P86, DOI 10.5483/BMBRep.2009.42.2.086; Dreier R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3117; Dumitru CA, 2006, ONCOGENE, V25, P5612, DOI 10.1038/sj.onc.1209568; Ehlert Karoline, 2007, Pediatr Rheumatol Online J, V5, P15; Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695; Fujii M, 1999, MOL BIOL CELL, V10, P3801, DOI 10.1091/mbc.10.11.3801; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Gilbert SJ, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1961; Goldring MB, 1999, CONNECT TISSUE RES, V40, P1, DOI 10.3109/03008209909005273; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Haas AR, 1999, DIFFERENTIATION, V64, P77, DOI 10.1046/j.1432-0436.1999.6420077.x; Hatakeyama Y, 2004, J CELL BIOCHEM, V91, P1204, DOI 10.1002/jcb.20019; Heinonen J, 2011, OSTEOARTHR CARTILAGE, V19, P1026, DOI 10.1016/j.joca.2011.04.016; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Kang MH, 2010, EXP CELL RES, V316, P24, DOI 10.1016/j.yexcr.2009.10.010; Kawamura I, 2012, J BIOL CHEM, V287, P29101, DOI 10.1074/jbc.M112.349415; Kempf H, 2007, DEV DYNAM, V236, P1954, DOI 10.1002/dvdy.21205; Khavandgar Z, 2011, J CELL BIOL, V194, P277, DOI 10.1083/jcb.201102051; Kobayashi T, 2005, P NATL ACAD SCI USA, V102, P18023, DOI 10.1073/pnas.0503617102; Kolesnick R, 1999, TRENDS BIOCHEM SCI, V24, P224, DOI 10.1016/S0968-0004(99)01408-5; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Kultti A, 2010, J BIOL CHEM, V285, P22899, DOI 10.1074/jbc.M109.088435; Leboy PS, 2001, J BONE JOINT SURG AM, V83A, pS15; Lee JT, 2004, J CELL BIOL, V164, P123, DOI 10.1083/jcb.200307017; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Marchesini N, 2003, J BIOL CHEM, V278, P13775, DOI 10.1074/jbc.M212262200; Matsumoto K, 2009, DEVELOPMENT, V136, P2825, DOI 10.1242/dev.038505; Mebarek S, 2007, J CELL SCI, V120, P407, DOI 10.1242/jcs.03331; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Mora A, 2002, CELL SIGNAL, V14, P557, DOI 10.1016/S0898-6568(01)00282-0; Murakami G, 2003, MOL BIOL CELL, V14, P2809, DOI 10.1091/mbc.E02-07-0441; Nelea V, 2005, J BIOMED MATER RES A, V75A, P216, DOI 10.1002/jbm.a.30402; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Origuchi N, 1998, IN VIVO, V12, P473; Pogue R, 2006, CURR TOP DEV BIOL, V76, P1, DOI 10.1016/S0070-2153(06)76001-X; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Pullig O, 2000, CALCIFIED TISSUE INT, V67, P230, DOI 10.1007/s002230001108; Qin JD, 2012, J BIOL CHEM, V287, P13620, DOI 10.1074/jbc.M111.304857; Retting KN, 2009, DEVELOPMENT, V136, P1093, DOI 10.1242/dev.029926; Rokutanda S, 2009, DEV BIOL, V328, P78, DOI 10.1016/j.ydbio.2009.01.009; Sabatini M, 2000, BIOCHEM BIOPH RES CO, V267, P438, DOI 10.1006/bbrc.1999.1983; Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148; Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107; Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199; Sharma K, 1999, CELL RES, V9, P1, DOI 10.1038/sj.cr.7290001; Shukunami C, 1998, EXP CELL RES, V241, P1, DOI 10.1006/excr.1998.4045; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; SJOHOLM A, 1995, FEBS LETT, V367, P283, DOI 10.1016/0014-5793(95)00470-T; Stoffel W, 2005, P NATL ACAD SCI USA, V102, P4554, DOI 10.1073/pnas.0406380102; Stoffel W, 2007, AM J PATHOL, V171, P153, DOI 10.2353/ajpath.2007.061285; Tsumaki N, 2002, J BONE MINER RES, V17, P898, DOI 10.1359/jbmr.2002.17.5.898; Ulici V, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-40; Valcourt U, 2002, J BIOL CHEM, V277, P33545, DOI 10.1074/jbc.M202086200; Volk SW, 1998, J BONE MINER RES, V13, P1521, DOI 10.1359/jbmr.1998.13.10.1521; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; Wiesner DA, 1997, J BIOL CHEM, V272, P9868; Yao YC, 2013, J CELL BIOCHEM, V114, P1223, DOI 10.1002/jcb.24467; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	69	25	27	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8135	8150		10.1074/jbc.M113.509331	http://dx.doi.org/10.1074/jbc.M113.509331			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24505141	Green Published, hybrid			2022-12-28	WOS:000333157500011
J	Park, D; Jagtap, S; Nair, SK				Park, David; Jagtap, Sujit; Nair, Satish K.			Structure of a PL17 Family Alginate Lyase Demonstrates Functional Similarities among Exotype Depolymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Algae; Biofuel; Carbohydrate Processing; Enzyme Catalysis; Protein Structure; Alginate Lyase	CRYSTAL-STRUCTURE; OLIGOALGINATE LYASE; CLASSIFICATION; DEGRADATION; MECHANISM; CHECKING; CLONING	Background: Exotype polysaccharide lyases can cleave glycosidic bonds to catabolize complex carbohydrates into simple monosaccharides. Results: The first characterization of a family 17 polysaccharide lyase (PL17) provides insights into the mechanism of alginate depolymerization. Conclusion: The structure of a PL17 enzyme illustrates unexpected similarities to other polysaccharide lyases despite a lack of sequence conservation. Significance: These studies demonstrate an unexpected evolutionary relationship among the polysaccharide lyases. Brown macroalgae represent an ideal source for complex polysaccharides that can be utilized as precursors for cellulosic biofuels. The lack of recalcitrant lignin components in macroalgae polysaccharide reserves provides a facile route for depolymerization of constituent polysaccharides into simple monosaccharides. The most abundant sugars in macroalgae are alginate, mannitol, and glucan, and although several classes of enzymes that can catabolize the latter two have been characterized, studies of alginate-depolymerizing enzymes have lagged. Here, we present several crystal structures of Alg17c from marine bacterium Saccharophagus degradans along with structure-function characterization of active site residues that are suggested to be involved in the exolytic mechanism of alginate depolymerization. This represents the first structural and biochemical characterization of a family 17 polysaccharide lyase enzyme. Despite the lack of appreciable sequence conservation, the structure and -elimination mechanism for glycolytic bond cleavage by Alg17c are similar to those observed for family 15 polysaccharide lyases and other lyases. This work illuminates the evolutionary relationships among enzymes within this unexplored class of polysaccharide lyases and reinforces the notion of a structure-based hierarchy in the classification of these enzymes.	[Nair, Satish K.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Jagtap, Sujit] Univ Illinois, Dept Chem Engn, Urbana, IL 61801 USA; [Park, David; Nair, Satish K.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Park, David; Nair, Satish K.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Nair, SK (corresponding author), Univ Illinois, Dept Biochem, 427 Roger Adams Lab,600 S Mathews Ave, Urbana, IL 61801 USA.	snair@illinois.edu	Jagtap, Sujit/D-9092-2011; Nair, Satish/AAY-2510-2021	Jagtap, Sujit/0000-0001-9402-2259; 				Blanch HW, 2012, CURR OPIN BIOTECH, V23, P390, DOI 10.1016/j.copbio.2011.10.002; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dong W, 2012, PROTEIN CELL, V3, P950, DOI 10.1007/s13238-012-2056-z; Doublie Sylvie, 2007, Methods Mol Biol, V363, P91, DOI 10.1007/978-1-59745-209-0_5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farrell EK, 2012, BIOCHEMISTRY-US, V51, P10259, DOI 10.1021/bi301425r; GACESA P, 1987, FEBS LETT, V212, P199, DOI 10.1016/0014-5793(87)81344-3; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hu G., 2013, ADV BIOCH ENG BIOTEC, DOI 10.1007/10_2013_245; Jedrzejas MJ, 2002, J BIOL CHEM, V277, P28287, DOI 10.1074/jbc.M112009200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kim HT, 2012, APPL MICROBIOL BIOT, V93, P2233, DOI 10.1007/s00253-012-3882-x; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Kraiwattanapong J, 1997, BIOSCI BIOTECH BIOCH, V61, P1853, DOI 10.1271/bbb.61.1853; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee SJ, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00092; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Markou G, 2012, APPL MICROBIOL BIOT, V96, P631, DOI 10.1007/s00253-012-4398-0; Martin MA, 2010, NEW BIOTECHNOL, V27, P596, DOI 10.1016/j.nbt.2010.06.010; Maruyama Y, 2005, J MOL BIOL, V350, P974, DOI 10.1016/j.jmb.2005.05.055; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ochiai A, 2010, J BIOL CHEM, V285, P24519, DOI 10.1074/jbc.M110.125450; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Park HH, 2012, MAR BIOTECHNOL, V14, P189, DOI 10.1007/s10126-011-9402-7; Rose PW, 2013, NUCLEIC ACIDS RES, V41, pD475, DOI 10.1093/nar/gks1200; Rye CS, 2006, CHEMBIOCHEM, V7, P631, DOI 10.1002/cbic.200500428; Shaya D, 2006, J BIOL CHEM, V281, P15525, DOI 10.1074/jbc.M512055200; Weiner RM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000087; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289	33	62	71	3	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8645	8655		10.1074/jbc.M113.531111	http://dx.doi.org/10.1074/jbc.M113.531111			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24478312	hybrid, Green Published			2022-12-28	WOS:000333157500054
J	Sethi, R; Seppala, J; Tossavainen, H; Ylilauri, M; Ruskamo, S; Pentikainen, OT; Pentikainen, U; Permi, P; Ylanne, J				Sethi, Ritika; Seppala, Jonne; Tossavainen, Helena; Ylilauri, Mikko; Ruskamo, Salla; Pentikainen, Olli T.; Pentikainen, Ulla; Permi, Perttu; Ylanne, Jari			A Novel Structural Unit in the N-terminal Region of Filamins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Filamin; Microfilaments; NMR; Protein-Protein Interactions; Structural Biology; X-ray Crystallography; X-ray Scattering; Immunogloblulin-like Domain; Platelet Glycoprotein Ib	ACTIN-BINDING PROTEIN; GLYCOPROTEIN-IB-ALPHA; MOLECULAR-DYNAMICS; BIOLOGICAL MACROMOLECULES; AUTO-INHIBITION; DOMAIN; INTEGRIN; SCATTERING; SYSTEM; COMPETITION	Background: Filamins are actin cross-linking and signaling scaffolding proteins where C-terminal domains have inter-domain interactions but little is known about the N-terminal domains. Results: Crystal structures of N-terminal domains 3-5 reveal novel domain packing and interaction details of domain 4. Conclusion: Domain 4 is stabilized by interaction with domain 5. Significance: Here, inter-domain interactions positively regulate domain 4 interactions with ligands. Immunoglobulin-like (Ig) domains are a widely expanded superfamily that act as interaction motifs or as structural spacers in multidomain proteins. Vertebrate filamins (FLNs), which are multifunctional actin-binding proteins, consist of 24 Ig domains. We have recently discovered that in the C-terminal rod 2 region of FLN, Ig domains interact with each other forming functional domain pairs, where the interaction with signaling and transmembrane proteins is mechanically regulated by weak actomyosin contraction forces. Here, we investigated if there are similar inter-domain interactions around domain 4 in the N-terminal rod 1 region of FLN. Protein crystal structures revealed a new type of domain organization between domains 3, 4, and 5. In this module, domains 4 and 5 interact rather tightly, whereas domain 3 has a partially flexible interface with domain 4. NMR peptide titration experiments showed that within the three-domain module, domain 4 is capable for interaction with a peptide derived from platelet glycoprotein Ib. Crystal structures of FLN domains 4 and 5 in complex with the peptide revealed a typical sheet augmentation interaction observed for many FLN ligands. Domain 5 was found to stabilize domain 4, and this could provide a mechanism for the regulation of domain 4 interactions.	[Sethi, Ritika; Seppala, Jonne; Ylilauri, Mikko; Pentikainen, Olli T.; Pentikainen, Ulla; Ylanne, Jari] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla 40014, Finland; [Sethi, Ritika; Seppala, Jonne; Ylilauri, Mikko; Pentikainen, Olli T.; Pentikainen, Ulla; Ylanne, Jari] Univ Jyvaskyla, Nanosci Ctr, Jyvaskyla 40014, Finland; [Tossavainen, Helena; Permi, Perttu] Univ Helsinki, Inst Biotechnol, Program Struct Biol & Biophys, FI-00014 Helsinki, Finland; [Ruskamo, Salla] Univ Oulu, Dept Biochem, Oulu 90014, Finland; [Ruskamo, Salla] Univ Oulu, Bioctr Oulu, Oulu 90014, Finland	University of Jyvaskyla; University of Jyvaskyla; University of Helsinki; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu	Sethi, R (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, POB 35,Survontie 9, Jyvaskyla 40014, Finland.	ritika.sethi@jyu.fi; jari.p.ylanne@jyu.fi	Pentikäinen, Olli T/E-1980-2012	Pentikäinen, Olli T/0000-0001-7188-4016; Ylanne, Jari/0000-0003-4627-021X; Sethi, Ritika/0000-0001-6015-7710; Ruskamo, Salla/0000-0002-9740-9077; Pentikainen, Ulla/0000-0001-6547-1282	Marie Curie Actions FP 7; National Doctoral Programme in Informational and Structural Biology; Sigrid Juselius Foundation; Academy of Finland [114713, 138327, 263794, 259447]; CSC-Finnish IT Center for Science computational [jyy2516, jyy2586]	Marie Curie Actions FP 7; National Doctoral Programme in Informational and Structural Biology; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); CSC-Finnish IT Center for Science computational(Finnish IT center for science)	This work was supported by grants from the Marie Curie Actions FP 7 grant to Initial Training Network MUZIC (Muscle Z-disk Protein Complexes: from atomic structure to physiological function) (to R. S. and J. Y.), the National Doctoral Programme in Informational and Structural Biology (to M. Y.), and Sigrid Juselius Foundation and Academy of Finland Grants 114713 and 138327 (to J. Y.) and 263794 and 259447 (to P. P.), and CSC-Finnish IT Center for Science computational Grants jyy2516 and jyy2586 (to O. T. P.).	Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Biersmith BH, 2011, J MOL BIOL, V408, P616, DOI 10.1016/j.jmb.2011.03.013; Chen H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01642; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Ehrlicher AJ, 2011, NATURE, V478, P260, DOI 10.1038/nature10430; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falet H, 2010, J EXP MED, V207, P1967, DOI 10.1084/jem.20100222; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Feng SJ, 2003, BLOOD, V102, P2122, DOI 10.1182/blood-2002-12-3805; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Furst DO, 2013, ACTA NEUROPATHOL, V125, P33, DOI 10.1007/s00401-012-1054-9; Gileadi Opher, 2008, V426, P221, DOI 10.1007/978-1-60327-058-8_14; Glatter O., 1982, ACAD PRESS; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Heikkinen OK, 2009, J BIOL CHEM, V284, P25450, DOI 10.1074/jbc.M109.019661; Ithychanda SS, 2011, BIOCHEMISTRY-US, V50, P4229, DOI 10.1021/bi2003229; Ithychanda SS, 2009, J BIOL CHEM, V284, P35113, DOI 10.1074/jbc.M109.060954; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kley RA, 2012, BRAIN, V135, P2642, DOI 10.1093/brain/aws200; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kyndt F, 2007, CIRCULATION, V115, P40, DOI 10.1161/CIRCULATIONAHA.106.622621; Labrador A, 2013, J PHYS CONF SER, V425, DOI 10.1088/1742-6596/425/7/072019; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Light S, 2012, J STRUCT BIOL, V179, P289, DOI 10.1016/j.jsb.2012.02.010; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer SC, 1997, J BIOL CHEM, V272, P2914, DOI 10.1074/jbc.272.5.2914; Muller R, 2013, P NATL ACAD SCI USA, V110, P10183, DOI 10.1073/pnas.1300547110; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Nakamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004928; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pentikainen U, 2009, J MOL BIOL, V393, P644, DOI 10.1016/j.jmb.2009.08.035; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Playford MP, 2010, J BIOL CHEM, V285, P17156, DOI 10.1074/jbc.M109.080523; Pudas R, 2005, STRUCTURE, V13, P111, DOI 10.1016/j.str.2004.10.014; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Razinia Z, 2012, ANNU REV BIOPHYS, V41, P227, DOI 10.1146/annurev-biophys-050511-102252; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Rognoni L, 2012, P NATL ACAD SCI USA, V109, P19679, DOI 10.1073/pnas.1211274109; Ruskamo S, 2012, BIOCHEM J, V446, P261, DOI 10.1042/BJ20120361; Ruskamo S, 2009, ACTA CRYSTALLOGR D, V65, P1217, DOI 10.1107/S0907444909037330; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schlick T, 1999, J COMPUT PHYS, V151, P9, DOI 10.1006/jcph.1999.6182; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seo MD, 2009, PROTEINS, V75, P258, DOI 10.1002/prot.22336; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smith L, 2010, J BIOL CHEM, V285, P17166, DOI 10.1074/jbc.M109.080911; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Williamson D, 2002, J BIOL CHEM, V277, P2151, DOI 10.1074/jbc.M109384200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wurzburg BA, 2009, J MOL BIOL, V393, P176, DOI 10.1016/j.jmb.2009.08.012; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001	71	15	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8588	8598		10.1074/jbc.M113.537456	http://dx.doi.org/10.1074/jbc.M113.537456			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24469451	Green Published, hybrid			2022-12-28	WOS:000333157500049
J	Brzozowska, I; Zielenkiewicz, U				Brzozowska, Iwona; Zielenkiewicz, Urszula			The ClpXP Protease Is Responsible for the Degradation of the Epsilon Antidote to the Zeta Toxin of the Streptococcal pSM19035 Plasmid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP-dependent Protease; Microbiology; Protease; Protein Degradation; Streptococcus pyogenes	BACILLUS-SUBTILIS; ESCHERICHIA-COLI; ANTITOXIN SYSTEM; CRYSTAL-STRUCTURE; LON PROTEASE; TRANSLATION; RESISTANCE; SEQUENCE; COMPLEX; GROWTH	Background: Epsilon is an antitoxin of the E/ toxin-antitoxin (TA) system family, which is widespread in pathogenic bacteria. Results:In vitro and in vivo degradation of the Epsilon protein is shown. Conclusion: ClpXP protease is responsible for the degradation of the Epsilon antitoxin. Significance: The first demonstration of in vitro degradation of the antitoxin from Gram-positive bacteria. Most bacterial genomes contain different types of toxin-antitoxin (TA) systems. The -E- proteinaceous type II TA cassette from the streptococcal pSM19035 plasmid is a member of the E/ family, which is commonly found in multiresistance plasmids and chromosomes of various human pathogens. Regulation of type II TA systems relies on the proteolysis of antitoxin proteins. Under normal conditions, the Epsilon antidote neutralizes the Zeta toxin through the formation of a tight complex. In this study, we show, using both in vivo and in vitro analyses, that the ClpXP protease is responsible for Epsilon antitoxin degradation. Using in vivo studies, we examined the stability of the plasmids with active or inactive -E- TA cassettes in B. subtilis mutants that were defective for different proteases. Using in vitro assays, the degradation of purified His(6)-Epsilon by the His(6)-Lon(Bs), ClpP(Bs), and ClpX(Bs) proteases from B. subtilis was analyzed. Additionally, we showed that purified Zeta toxin protects the Epsilon protein from rapid ClpXP-catalyzed degradation.	[Brzozowska, Iwona; Zielenkiewicz, Urszula] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Zielenkiewicz, U (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Ul Pawinskiego 5A, PL-02106 Warsaw, Poland.	ulazet@ibb.waw.pl		Zielenkiewicz, Urszula/0000-0003-0615-7546				Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Bakun M, 2009, PROTEOM CLIN APPL, V3, P932, DOI 10.1002/prca.200800111; BEHNKE D, 1979, PLASMID, V2, P605, DOI 10.1016/0147-619X(79)90058-1; BRANTL S, 1990, NUCLEIC ACIDS RES, V18, P4783, DOI 10.1093/nar/18.16.4783; BRON S, 1990, MOL BIOL METHODS BAC, P75; Brzozowska I, 2013, PLASMID, V70, P33, DOI 10.1016/j.plasmid.2013.01.007; Brzozowska I, 2012, PLASMID, V68, P51, DOI 10.1016/j.plasmid.2012.01.010; BURDETT V, 1982, J BACTERIOL, V149, P995, DOI 10.1128/JB.149.3.995-1004.1982; Camacho AG, 2002, BIOL CHEM, V383, P1701, DOI 10.1515/BC.2002.191; CEGLOWSKI P, 1993, MOL GEN GENET, V241, P579, DOI 10.1007/BF00279900; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; de la Hoz AB, 2000, P NATL ACAD SCI USA, V97, P728, DOI 10.1073/pnas.97.2.728; Diago-Navarro E, 2013, PLASMID, V70, P78, DOI 10.1016/j.plasmid.2013.01.010; Dmowski M, 2006, J BACTERIOL, V188, P4362, DOI 10.1128/JB.01922-05; Donegan NP, 2010, J BACTERIOL, V192, P1416, DOI 10.1128/JB.00233-09; FRIEDMAN BM, 1983, MOL GEN GENET, V190, P481, DOI 10.1007/BF00331080; Gerth U, 1996, GENE, V181, P77, DOI 10.1016/S0378-1119(96)00467-2; Gerth U, 2004, J BACTERIOL, V186, P179, DOI 10.1128/JB.186.1.179-191.2004; Gottesman S, 1996, ANNU REV GENET, V30, P465, DOI 10.1146/annurev.genet.30.1.465; HAIMA P, 1987, MOL GEN GENET, V209, P335, DOI 10.1007/BF00329663; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hansen S., 2012, PLOS ONE, V7; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; JENSEN RB, 1995, MOL MICROBIOL, V17, P205, DOI 10.1111/j.1365-2958.1995.mmi_17020205.x; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Khoo SK, 2007, J BIOL CHEM, V282, P19606, DOI 10.1074/jbc.M701703200; Koga M, 2011, GENETICS, V187, P123, DOI 10.1534/genetics.110.121798; Kubik S, 2012, NUCLEIC ACIDS RES, V40, P1148, DOI 10.1093/nar/gkr813; LEHNHERR H, 1995, P NATL ACAD SCI USA, V92, P3274, DOI 10.1073/pnas.92.8.3274; Lioy VS, 2006, MICROBIOL-SGM, V152, P2365, DOI 10.1099/mic.0.28950-0; Lioy VS, 2010, PLASMID, V64, P1, DOI 10.1016/j.plasmid.2010.04.002; Liu JJ, 1999, MOL MICROBIOL, V33, P415, DOI 10.1046/j.1365-2958.1999.01489.x; Meinhart A, 2003, P NATL ACAD SCI USA, V100, P1661, DOI 10.1073/pnas.0434325100; MSADEK T, 1994, P NATL ACAD SCI USA, V91, P5788, DOI 10.1073/pnas.91.13.5788; Msadek T, 1998, MOL MICROBIOL, V27, P899, DOI 10.1046/j.1365-2958.1998.00735.x; Mutschler H, 2011, J MOL MED, V89, P1183, DOI 10.1007/s00109-011-0797-4; Mutschler H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001033; Nakano S, 2002, J BACTERIOL, V184, P3664, DOI 10.1128/JB.184.13.3664-3670.2002; Nakano S, 2003, P NATL ACAD SCI USA, V100, P4233, DOI 10.1073/pnas.0637648100; Overgaard M, 2009, J MOL BIOL, V394, P183, DOI 10.1016/j.jmb.2009.09.006; Pachulec E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009962; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; ROBERTS RC, 1994, J MOL BIOL, V237, P35, DOI 10.1006/jmbi.1994.1207; ROTTLANDER E, 1970, MOL GEN GENET, V108, P47, DOI 10.1007/BF00343184; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; Schwarz FV, 2001, PLASMID, V46, P170, DOI 10.1006/plas.2001.1544; SLACK FJ, 1995, MOL MICROBIOL, V15, P689, DOI 10.1111/j.1365-2958.1995.tb02378.x; Sletvold H, 2008, PLASMID, V60, P75, DOI 10.1016/j.plasmid.2008.04.002; Smith ASG, 1998, J BACTERIOL, V180, P5458, DOI 10.1128/JB.180.20.5458-5462.1998; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; VanMelderen L, 1996, J BIOL CHEM, V271, P27730, DOI 10.1074/jbc.271.44.27730; Wang XX, 2011, NAT CHEM BIOL, V7, P359, DOI [10.1038/NCHEMBIO.560, 10.1038/nchembio.560]; Winther KS, 2012, NUCLEIC ACIDS RES, V40, P4347, DOI 10.1093/nar/gks029; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Zielenkiewicz U, 2005, J BACTERIOL, V187, P6094, DOI 10.1128/JB.187.17.6094-6105.2005; Zielenkiewicz U, 2009, J BACTERIOL, V191, P3677, DOI 10.1128/JB.01763-08	61	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7514	7523		10.1074/jbc.M113.519488	http://dx.doi.org/10.1074/jbc.M113.519488			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24492616	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000332761500022
J	Portnoff, AD; Stephens, EA; Varner, JD; DeLisa, MP				Portnoff, Alyse D.; Stephens, Erin A.; Varner, Jeffrey D.; DeLisa, Matthew P.			Ubiquibodies, Synthetic E3 Ubiquitin Ligases Endowed with Unnatural Substrate Specificity for Targeted Protein Silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antibody Engineering; E3 Ubiquitin Ligase; Molecular Biology; Proteasome; Protein Degradation; Protein Engineering; Synthetic Biology; Ubiquitin; Ubiquitination; Reverse Genetics	GENE TRAP VECTOR; BINDING-PROTEINS; DEGRADATION; CHIP; PROTEASOME; SELECTION; COMPLEX; HSP70; THERAPEUTICS; ANTIBODIES	Background: Techniques that harness the power of the ubiquitin-proteasome pathway (UPP) for protein knock-out are limited to a narrow set of protein targets. Results: Engineered ubiquibodies specifically and systematically removed exogenous target proteins. Conclusion: Diverse protein targets can be redirected to the UPP using this new protein silencing method. Significance: Ubiquibodies offer a simple, reproducible, and customizable technique for selectively and controllably depleting cellular proteins. The ubiquitin-proteasome pathway (UPP) is the main route of protein degradation in eukaryotic cells and is a common mechanism through which numerous cellular pathways are regulated. To date, several reverse genetics techniques have been reported that harness the power of the UPP for selectively reducing the levels of otherwise stable proteins. However, each of these approaches has been narrowly developed for a single substrate and cannot be easily extended to other protein substrates of interest. To address this shortcoming, we created a generalizable protein knock-out method by engineering protein chimeras called ubiquibodies that combine the activity of E3 ubiquitin ligases with designer binding proteins to steer virtually any protein to the UPP for degradation. Specifically, we reprogrammed the substrate specificity of a modular human E3 ubiquitin ligase called CHIP (carboxyl terminus of Hsc70-interacting protein) by replacing its natural substrate-binding domain with a single-chain Fv (scFv) intrabody or a fibronectin type III domain monobody that target their respective antigens with high specificity and affinity. Engineered ubiquibodies reliably transferred ubiquitin to surface exposed lysines on target proteins and even catalyzed the formation of biologically relevant polyubiquitin chains. Following ectopic expression of ubiquibodies in mammalian cells, specific and systematic depletion of desired target proteins was achieved, whereas the levels of a natural substrate of CHIP were unaffected. Taken together, engineered ubiquibodies offer a simple, reproducible, and customizable means for directly removing specific cellular proteins through accelerated proteolysis.	[Portnoff, Alyse D.; Varner, Jeffrey D.; DeLisa, Matthew P.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA; [Stephens, Erin A.] Cornell Univ, Grad Field Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; [Varner, Jeffrey D.; DeLisa, Matthew P.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	DeLisa, MP (corresponding author), Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.	md255@cornell.edu	DeLisa, Matthew/AAE-7361-2019	DeLisa, Matthew/0000-0003-3226-1566	National Science Foundation [CBET-0449080, GK-12 DGE-0841291, DGE-1144153]; National Institutes of Health [CA132223A, T32 GM008500]; New York State Office of Science, Technology, and Academic Research Distinguished Faculty Award; Cornell Presidential Life Science Fellowship; NATIONAL CANCER INSTITUTE [R21CA167100, R21CA132223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007273, T32GM008500] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Office of Science, Technology, and Academic Research Distinguished Faculty Award; Cornell Presidential Life Science Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation Career Award CBET-0449080 (to M. P. D.), National Institutes of Health Grant CA132223A (to M. P. D.), New York State Office of Science, Technology, and Academic Research Distinguished Faculty Award (to M. P. D.), National Institutes of Health Chemical Biology Training Grant T32 GM008500 (fellowship to A. D. P.), National Science Foundation GK-12 DGE-0841291 (fellowship to A. D. P.), a Cornell Presidential Life Science Fellowship (to E. A. S.), and the National Science Foundation Graduate Research Fellowship Program Grant DGE-1144153 (to E. A. S.).	Bloom L, 2009, DRUG DISCOV TODAY, V14, P949, DOI 10.1016/j.drudis.2009.06.007; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; CARLSON JR, 1988, MOL CELL BIOL, V8, P2638, DOI 10.1128/MCB.8.6.2638; Caussinus E, 2012, NAT STRUCT MOL BIOL, V19, P117, DOI 10.1038/nsmb.2180; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Contreras-Martinez LM, 2007, J MOL BIOL, V372, P513, DOI 10.1016/j.jmb.2007.06.070; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Friedel RH, 2005, P NATL ACAD SCI USA, V102, P13188, DOI 10.1073/pnas.0505474102; Hatakeyama S, 2005, CANCER RES, V65, P7874, DOI 10.1158/0008-5472.CAN-05-1581; Karlsson AJ, 2012, J MOL BIOL, V416, P94, DOI 10.1016/j.jmb.2011.12.021; Kawe M, 2006, J BIOL CHEM, V281, P40252, DOI 10.1074/jbc.M602506200; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Koch H, 2006, J MOL BIOL, V357, P427, DOI 10.1016/j.jmb.2005.12.043; Koide A, 2002, P NATL ACAD SCI USA, V99, P1253, DOI 10.1073/pnas.032665299; Koide A, 2007, P NATL ACAD SCI USA, V104, P6632, DOI 10.1073/pnas.0700149104; Kummer L, 2012, P NATL ACAD SCI USA, V109, pE2248, DOI 10.1073/pnas.1205399109; Kundrat L, 2010, J MOL BIOL, V395, P587, DOI 10.1016/j.jmb.2009.11.017; Lelouard H, 2002, NATURE, V417, P177, DOI 10.1038/417177a; Ma YH, 2013, MOL CANCER THER, V12, P286, DOI 10.1158/1535-7163.MCT-12-0650; Martineau P, 1998, J MOL BIOL, V280, P117, DOI 10.1006/jmbi.1998.1840; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Pickart CM, 1997, FASEB J, V11, P1055, DOI 10.1096/fasebj.11.13.9367341; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Qian SB, 2009, J BIOL CHEM, V284, P26797, DOI 10.1074/jbc.M109.032334; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; Stocks M, 2005, CURR OPIN CHEM BIOL, V9, P359, DOI 10.1016/j.cbpa.2005.06.003; Strickland D, 2008, P NATL ACAD SCI USA, V105, P10709, DOI 10.1073/pnas.0709610105; Stumpp MT, 2008, DRUG DISCOV TODAY, V13, P695, DOI 10.1016/j.drudis.2008.04.013; Waraho D, 2009, P NATL ACAD SCI USA, V106, P3692, DOI 10.1073/pnas.0704048106; Wright CM, 2011, P NATL ACAD SCI USA, V108, P16206, DOI 10.1073/pnas.1102803108; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Xu Z, 2006, BIOCHEMISTRY-US, V45, P4749, DOI 10.1021/bi0601508; Zhang JX, 2003, P NATL ACAD SCI USA, V100, P14127, DOI 10.1073/pnas.2233012100; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023; Zheng XQH, 1999, J VIROL, V73, P6946, DOI 10.1128/JVI.73.8.6946-6952.1999; Zhou PB, 2005, CURR OPIN CHEM BIOL, V9, P51, DOI 10.1016/j.cbpa.2004.10.012	39	34	39	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7844	7855		10.1074/jbc.M113.544825	http://dx.doi.org/10.1074/jbc.M113.544825			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24474696	hybrid, Green Published			2022-12-28	WOS:000332761500050
J	DeBosch, BJ; Chen, ZJ; Saben, JL; Finck, BN; Moley, KH				DeBosch, Brian J.; Chen, Zhouji; Saben, Jessica L.; Finck, Brian N.; Moley, Kelle H.			Glucose Transporter 8 (GLUT8) Mediates Fructose- induced de Novo Lipogenesis and Macrosteatosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Fructose Metabolism; Glucose Transport; Hepatocyte; Metabolic Syndrome	FATTY LIVER-DISEASE; INSULIN-RESISTANCE; IDENTIFICATION; TRANSLOCATION; MURINE; NAFLD; MICE	Background: GLUT8 is a facilitative fructose and glucose transporter expressed in liver. Results: GLUT8-deficient mice are resistant to fructose-induced fatty liver disease. Conclusion: Hexose transporters can mediate fructose-induced fatty liver disease. Significance: Hepatic hexose transporters represent a novel class of targets to prevent or modulate non-alcoholic fatty liver disease. Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the world, and it is thought to be the hepatic manifestation of the metabolic syndrome. Excess dietary fructose causes both metabolic syndrome and NAFLD in rodents and humans, but the pathogenic mechanisms of fructose-induced metabolic syndrome and NAFLD are poorly understood. GLUT8 (Slc2A8) is a facilitative glucose and fructose transporter that is highly expressed in liver, heart, and other oxidative tissues. We previously demonstrated that female mice lacking GLUT8 exhibit impaired first-pass hepatic fructose metabolism, suggesting that fructose transport into the hepatocyte, the primary site of fructose metabolism, is in part mediated by GLUT8. Here, we tested the hypothesis that GLUT8 is required for hepatocyte fructose uptake and for the development of fructose-induced NAFLD. We demonstrate that GLUT8 is a cell surface-localized transporter and that GLUT8 overexpression or GLUT8 shRNA-mediated gene silencing significantly induces and blocks radiolabeled fructose uptake in cultured hepatocytes. We further show diminished fructose uptake and de novo lipogenesis in fructose-challenged GLUT8-deficient hepatocytes. Finally, livers from long term high-fructose diet-fed GLUT8-deficient mice exhibited attenuated fructose-induced hepatic triglyceride and cholesterol accumulation without changes in hepatocyte insulin-stimulated Akt phosphorylation. GLUT8 is thus essential for hepatocyte fructose transport and fructose-induced macrosteatosis. Fructose delivery across the hepatocyte membrane is thus a proximal, modifiable disease mechanism that may be exploited to prevent NAFLD.	[DeBosch, Brian J.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Chen, Zhouji; Finck, Brian N.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Saben, Jessica L.; Moley, Kelle H.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Moley, KH (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, 660 S Euclid Ave, St Louis, MO 63110 USA.	moleyk@wustl.edu		Finck, Brian/0000-0001-5411-3674	Diabetes Research and Training Center Grant [P60 DK020579]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD076224, K12HD000850, R01HD040390, T32HD049305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, P60DK020579, R01DK078187, P30DK020579, P30DK052574] Funding Source: NIH RePORTER	Diabetes Research and Training Center Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Washington University Mouse Phenotyping Core is supported by Diabetes Research and Training Center Grant P60 DK020579.	Adastra KL, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.097675; Aerni-Flessner L, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-63; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Carayannopoulos MO, 2000, P NATL ACAD SCI USA, V97, P7313, DOI 10.1073/pnas.97.13.7313; Chen ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051320; Choi P, 2013, J PEDIATR SURG, V48, P1340, DOI 10.1016/j.jpedsurg.2013.03.042; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Comhair TM, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-4; de Meijer V. E., 2011, PLOS ONE, V6; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; DeBosch BJ, 2013, MOL ENDOCRINOL, V27, P1887, DOI 10.1210/me.2013-1137; DeBosch BJ, 2012, ENDOCRINOLOGY, V153, P4181, DOI 10.1210/en.2012-1541; Douard V, 2008, AM J PHYSIOL-ENDOC M, V295, pE227, DOI 10.1152/ajpendo.90245.2008; Frohnert BI, 2013, DIABETES, V62, P3163, DOI 10.2337/db12-1122; Frolova A, 2009, ENDOCRINOLOGY, V150, P1512, DOI 10.1210/en.2008-1081; Frolova AI, 2011, ENDOCRINOLOGY, V152, P2123, DOI 10.1210/en.2010-1266; Gorovits N, 2003, ENDOCRINOLOGY, V144, P1703, DOI 10.1210/en.2002-220968; HUNDAL HS, 1992, J BIOL CHEM, V267, P5040; Leturque A, 2009, AM J PHYSIOL-ENDOC M, V296, pE985, DOI 10.1152/ajpendo.00004.2009; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Lin X, 2002, ARTERIOSCL THROM VAS, V22, P476, DOI 10.1161/hq0302.105271; Nagarajan P, 2012, WORLD J GASTROENTERO, V18, P1141, DOI 10.3748/wjg.v18.i11.1141; Pascale A, 2010, J GASTROINTEST LIVER, V19, P415; Pearse A. G., 2009, HISTOTECHNOLOGY SELF, P150; Rogers S, 2002, AM J PHYSIOL-ENDOC M, V282, pE733, DOI 10.1152/ajpendo.2002.282.3.E733; Saben J, 2014, PLACENTA, V35, P125, DOI 10.1016/j.placenta.2013.11.007; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Yilmaz Y, 2012, ALIMENT PHARM THER, V35, P1135, DOI 10.1111/j.1365-2036.2012.05080.x	34	56	57	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					10989	10998		10.1074/jbc.M113.527002	http://dx.doi.org/10.1074/jbc.M113.527002			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24519932	hybrid, Green Published			2022-12-28	WOS:000334638500005
J	Acharya, S; Safaie, BM; Wongkongkathep, P; Ivanova, MI; Attar, A; Klarner, FG; Schrader, T; Loo, JA; Bitan, G; Lapidus, LJ				Acharya, Srabasti; Safaie, Brian M.; Wongkongkathep, Piriya; Ivanova, Magdalena I.; Attar, Aida; Klaerner, Frank-Gerrit; Schrader, Thomas; Loo, Joseph A.; Bitan, Gal; Lapidus, Lisa J.			Molecular Basis for Preventing alpha-Synuclein Aggregation by a Molecular Tweezer*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-Synuclein; Mass Spectrometry (MS); Parkinson's Disease; Protein Aggregation; Spectroscopy; Inhibitor; Intramolecular Diffusion	INTRINSICALLY DISORDERED PROTEINS; PHOTOCHEMICAL CROSS-LINKING; MASS-SPECTROMETRY; UNMODIFIED PROTEINS; DIFFUSION; OLIGOMERIZATION; INHIBITORS; TETRAMER; PEPTIDE; BINDING	Background: The molecular tweezer, CLR01, binds to Lys and prevents aggregation of -synuclein. Results: CLR01 binds directly to monomeric -synuclein near the N terminus and changes the charge distribution in the sequence, swelling the chain, and increasing the protein reconfiguration rate. Conclusion: Aggregation is inhibited by making the protein more diffusive. Significance: The most effective aggregation inhibitors may change monomer dynamics rather than structure. Recent work on -synuclein has shown that aggregation is controlled kinetically by the rate of reconfiguration of the unstructured chain, such that the faster the reconfiguration, the slower the aggregation. In this work we investigate this relationship by examining -synuclein in the presence of a small molecular tweezer, CLR01, which binds selectively to Lys side chains. We find strong binding to multiple Lys within the chain as measured by fluorescence and mass-spectrometry and a linear increase in the reconfiguration rate with concentration of the inhibitor. Top-down mass-spectrometric analysis shows that the main binding of CLR01 to -synuclein occurs at the N-terminal Lys-10/Lys-12. Photo-induced cross-linking of unmodified proteins (PICUP) analysis shows that under the conditions used for the fluorescence analysis, -synuclein is predominantly monomeric. The results can be successfully modeled using a kinetic scheme in which two aggregation-prone monomers can form an encounter complex that leads to further oligomerization but can also dissociate back to monomers if the reconfiguration rate is sufficiently high. Taken together, the data provide important insights into the preferred binding site of CLR01 on -synuclein and the mechanism by which the molecular tweezer prevents self-assembly into neurotoxic aggregates by -synuclein and presumably other amyloidogenic proteins.	[Acharya, Srabasti; Lapidus, Lisa J.] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA; [Safaie, Brian M.; Attar, Aida; Bitan, Gal] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Wongkongkathep, Piriya; Loo, Joseph A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Ivanova, Magdalena I.; Loo, Joseph A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Attar, Aida; Bitan, Gal] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA; [Loo, Joseph A.; Bitan, Gal] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA; [Klaerner, Frank-Gerrit; Schrader, Thomas] Univ Duisburg Essen, Inst Organ Chem, D-45117 Essen, Germany; [Klaerner, Frank-Gerrit; Schrader, Thomas] Univ Duisburg Essen, Ctr Med Biotechnol, D-45117 Essen, Germany	Michigan State University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Duisburg Essen; University of Duisburg Essen	Lapidus, LJ (corresponding author), Michigan State Univ, Dept Phys & Astron, 567 Wilson Rd Rm 4227, E Lansing, MI 48824 USA.	lapidus@msu.edu	Wongkongkathep, Piriya/E-7139-2011; Bitan, Gal/U-2204-2019	Wongkongkathep, Piriya/0000-0003-0751-8622; Bitan, Gal/0000-0001-7046-3754	National Institutes of Health [R01 GM103479]; NIH High-End Shared Instrumentation Program [S10 RR028893]; NIH [R01 GM100908]; University of California-Los Angeles Jim Easton Consortium for Alzheimer's Drug Discovery and Biomarker Development; RJG Foundation Grant [20095024]; Team Parkinson/Parkinson Alliance Grant; NSF [MCB-0825001]; Development and Promotion of Science and Technology Talents Project (DPST), Royal Thai Government; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103479, R01GM100908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH High-End Shared Instrumentation Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California-Los Angeles Jim Easton Consortium for Alzheimer's Drug Discovery and Biomarker Development; RJG Foundation Grant; Team Parkinson/Parkinson Alliance Grant; NSF(National Science Foundation (NSF)); Development and Promotion of Science and Technology Talents Project (DPST), Royal Thai Government; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported in part by National Institutes of Health Grants R01 GM103479 (to J. A. L.); NIH High-End Shared Instrumentation Program S10 RR028893 (to J. A. L.); NIH R01 GM100908 (to L. J. L.); University of California-Los Angeles Jim Easton Consortium for Alzheimer's Drug Discovery and Biomarker Development (to G. B.); RJG Foundation Grant 20095024 (to G. B.); Team Parkinson/Parkinson Alliance Grant (to G. B.); NSF MCB-0825001 (to L. J. L.); and Development and Promotion of Science and Technology Talents Project (DPST), Royal Thai Government (to P. W.).	Ahmad B, 2012, J BIOL CHEM, V287, P9193, DOI 10.1074/jbc.M111.325548; Ahmad B, 2012, P NATL ACAD SCI USA, V109, P2336, DOI 10.1073/pnas.1109526109; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Bier D, 2013, NAT CHEM, V5, P234, DOI [10.1038/NCHEM.1570, 10.1038/nchem.1570]; Bitan G, 2004, ACCOUNTS CHEM RES, V37, P357, DOI 10.1021/ar000214l; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Bitan G, 2006, METHOD ENZYMOL, V413, P217, DOI 10.1016/S0076-6879(06)13012-8; Chen YJ, 2010, J PHYS CHEM B, V114, P15969, DOI 10.1021/jp104746g; Cho MK, 2009, PROTEIN SCI, V18, P1840, DOI 10.1002/pro.194; Das RK, 2013, P NATL ACAD SCI USA, V110, P13392, DOI 10.1073/pnas.1304749110; Dettmer U, 2013, J BIOL CHEM, V288, P6371, DOI 10.1074/jbc.M112.403311; Dutt S, 2013, J ORG CHEM, V78, P6721, DOI 10.1021/jo4009673; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Lapidus L. J., 2001, PHYS REV LETT, V87, P4; Lapidus LJ, 2002, J MOL BIOL, V319, P19, DOI 10.1016/S0022-2836(02)00193-6; Lapidus LJ, 2002, J PHYS CHEM B, V106, P11628, DOI 10.1021/jp020829v; Loo JA, 1997, MASS SPECTROM REV, V16, P1; Lopes DHJ, 2012, METHODS MOL BIOL, V849, P11, DOI 10.1007/978-1-61779-551-0_2; Mao AH, 2010, P NATL ACAD SCI USA, V107, P8183, DOI 10.1073/pnas.0911107107; Masuda M, 2006, FEBS LETT, V580, P1775, DOI 10.1016/j.febslet.2006.02.032; Prabhudesai S, 2012, NEUROTHERAPEUTICS, V9, P464, DOI 10.1007/s13311-012-0105-1; Singh VR, 2007, BIOCHEMISTRY-US, V46, P10046, DOI 10.1021/bi700270j; Sinha S, 2012, ACS CHEM NEUROSCI, V3, P451, DOI 10.1021/cn200133x; Sinha S, 2011, J AM CHEM SOC, V133, P16958, DOI 10.1021/ja206279b; SZABO A, 1980, J CHEM PHYS, V72, P4350, DOI 10.1063/1.439715; Trexler AJ, 2010, BIOPHYS J, V99, P3048, DOI 10.1016/j.bpj.2010.08.056; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Wang W, 2011, P NATL ACAD SCI USA, V108, P17797, DOI 10.1073/pnas.1113260108; Xie YM, 2006, J AM CHEM SOC, V128, P14432, DOI 10.1021/ja063197p; Yin S, 2011, INT J MASS SPECTROM, V300, P118, DOI 10.1016/j.ijms.2010.06.032; Yin S, 2010, J AM SOC MASS SPECTR, V21, P899, DOI 10.1016/j.jasms.2010.01.002	32	71	71	0	52	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10727	10737		10.1074/jbc.M113.524520	http://dx.doi.org/10.1074/jbc.M113.524520			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24567327	hybrid, Green Published			2022-12-28	WOS:000334226400042
J	Herrmann, J; Ravilious, GE; McKinney, SE; Westfall, CS; Lee, SG; Baraniecka, P; Giovannetti, M; Kopriva, S; Krishnan, HB; Jez, JM				Herrmann, Jonathan; Ravilious, Geoffrey E.; McKinney, Samuel E.; Westfall, Corey S.; Lee, Soon Goo; Baraniecka, Patrycja; Giovannetti, Marco; Kopriva, Stanislav; Krishnan, Hari B.; Jez, Joseph M.			Structure and Mechanism of Soybean ATP Sulfurylase and the Committed Step in Plant Sulfur Assimilation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Mechanisms; Enzyme Structure; Plant; Plant Biochemistry; Protein Structure	CRYSTAL-STRUCTURE; ARABIDOPSIS-THALIANA; SULFATE ASSIMILATION; NUCLEOTIDE-BINDING; ADENOSINE-5'-PHOSPHOSULFATE KINASE; 5'-ADENYLYLSULFATE REDUCTASE; FUNCTIONAL EXPRESSION; SECONDARY METABOLISM; ESCHERICHIA-COLI; CLONING	Background: ATP sulfurylase catalyzes the energetically unfavorable formation of adenosine 5-phosphosulfate in plant sulfur assimilation. Results: Structural and kinetic analyses identifies key active site residues. Conclusion: A reaction mechanism involving distortion of nucleotide conformation and stabilizing interactions is proposed. Significance: These results provide the first molecular insights on a plant ATP sulfurylase and the committed step of plant sulfur assimilation. Enzymes of the sulfur assimilation pathway are potential targets for improving nutrient content and environmental stress responses in plants. The committed step in this pathway is catalyzed by ATP sulfurylase, which synthesizes adenosine 5-phosphosulfate (APS) from sulfate and ATP. To better understand the molecular basis of this energetically unfavorable reaction, the x-ray crystal structure of ATP sulfurylase isoform 1 from soybean (Glycine max ATP sulfurylase) in complex with APS was determined. This structure revealed several highly conserved substrate-binding motifs in the active site and a distinct dimerization interface compared with other ATP sulfurylases but was similar to mammalian 3-phosphoadenosine 5-phosphosulfate synthetase. Steady-state kinetic analysis of 20 G. max ATP sulfurylase point mutants suggests a reaction mechanism in which nucleophilic attack by sulfate on the -phosphate of ATP involves transition state stabilization by Arg-248, Asn-249, His-255, and Arg-349. The structure and kinetic analysis suggest that ATP sulfurylase overcomes the energetic barrier of APS synthesis by distorting nucleotide structure and identifies critical residues for catalysis. Mutations that alter sulfate assimilation in Arabidopsis were mapped to the structure, which provides a molecular basis for understanding their effects on the sulfur assimilation pathway.	[Herrmann, Jonathan; Ravilious, Geoffrey E.; McKinney, Samuel E.; Westfall, Corey S.; Lee, Soon Goo; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Baraniecka, Patrycja; Giovannetti, Marco; Kopriva, Stanislav] John Innes Ctr, Norwich NR4 7UH, Norfolk, England; [Giovannetti, Marco] Univ Turin, Dept Life Sci & Syst Biol, I-10125 Turin, Italy; [Krishnan, Hari B.] Univ Missouri, USDA ARS, Plant Genet Res Unit, Columbia, MO 65211 USA	Washington University (WUSTL); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Turin; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia	Jez, JM (corresponding author), Washington Univ, Dept Biol, One Brookings Dr,Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu	Kopriva, Stanislav/C-7401-2013; Giovannetti, Marco/AGR-6494-2022; Giovannetti, Marco/AAK-4589-2020	Kopriva, Stanislav/0000-0002-7416-6551; Giovannetti, Marco/0000-0003-4637-9880; Giovannetti, Marco/0000-0003-4637-9880; Lee, Soon Goo/0000-0002-1541-8587	Department of Energy Office of Biological and Environmental Research [DE-AC02-06CH11357]; ARS [ARS-0424526] Funding Source: Federal RePORTER	Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Portions of this research were carried out at the Argonne National Laboratory Structural Biology Center of the Advanced Photon Source, a national user facility operated by the University of Chicago for the Department of Energy Office of Biological and Environmental Research and supported by Grant DE-AC02-06CH11357. Product names are necessary to report factually on available data; however, the United States Department of Agriculture neither guarantees nor warrants the standard of product, and the use of the name by the United States Department of Agriculture implies no approval of the product to the exclusion of others that may be suitable.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aharoni A, 2011, CURR OPIN BIOTECH, V22, P239, DOI 10.1016/j.copbio.2010.11.004; ASAHI T, 1964, BIOCHIM BIOPHYS ACTA, V82, P58, DOI 10.1016/0304-4165(64)90007-8; Beynon JD, 2001, BIOCHEMISTRY-US, V40, P14509, DOI 10.1021/bi015643l; Bradley ME, 2009, J MOL EVOL, V68, P1, DOI 10.1007/s00239-008-9181-6; BRUNOLD C, 1984, PLANT PHYSIOL, V76, P579, DOI 10.1104/pp.76.3.579; CACCO G, 1977, PLANT PHYSIOL, V60, P582, DOI 10.1104/pp.60.4.582; Chan KX, 2013, TRENDS PLANT SCI, V18, P18, DOI 10.1016/j.tplants.2012.07.005; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Deyrup AT, 1999, J BIOL CHEM, V274, P28929, DOI 10.1074/jbc.274.41.28929; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Harjes S, 2005, J MOL BIOL, V347, P623, DOI 10.1016/j.jmb.2005.01.005; Hatzfeld Y, 2000, GENE, V248, P51, DOI 10.1016/S0378-1119(00)00132-3; Hawkesford MJ, 2006, PLANT CELL ENVIRON, V29, P382, DOI 10.1111/j.1365-3040.2005.01470.x; Heiss S, 1999, PLANT MOL BIOL, V39, P847, DOI 10.1023/A:1006169717355; Hofgen R, 2001, AMINO ACIDS, V20, P291, DOI 10.1007/s007260170045; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kawashima CG, 2011, PLANT J, V66, P863, DOI 10.1111/j.1365-313X.2011.04547.x; Klein M, 2004, J EXP BOT, V55, P1809, DOI 10.1093/jxb/erh183; KLONUS D, 1994, PLANT J, V6, P105, DOI 10.1046/j.1365-313X.1994.6010105.x; KLONUS D, 1995, PLANT PHYSIOL, V107, P653, DOI 10.1104/pp.107.2.653; Kopriva S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00163; Koprivova A, 2013, PLANT PHYSIOL, V163, P1133, DOI 10.1104/pp.113.225748; Krishnan HB, 2005, CROP SCI, V45, P454, DOI 10.2135/cropsci2005.0454; Leustek T, 2000, ANNU REV PLANT PHYS, V51, P141, DOI 10.1146/annurev.arplant.51.1.141; LEUSTEK T, 1994, PLANT PHYSIOL, V105, P897, DOI 10.1104/pp.105.3.897; Liang G, 2010, PLANT J, V62, P1046, DOI 10.1111/j.1365-313X.2010.04216.x; Logan HM, 1996, J BIOL CHEM, V271, P12227, DOI 10.1074/jbc.271.21.12227; MacRae IJ, 2002, NAT STRUCT BIOL, V9, P945, DOI 10.1038/nsb868; MacRae IJ, 2001, BIOCHEMISTRY-US, V40, P6795, DOI 10.1021/bi010367w; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mougous JD, 2006, MOL CELL, V21, P109, DOI 10.1016/j.molcel.2005.10.034; Mugford SG, 2010, FEBS LETT, V584, P119, DOI 10.1016/j.febslet.2009.11.014; Mugford SG, 2009, PLANT CELL, V21, P910, DOI 10.1105/tpc.109.065581; MURILLO M, 1995, ARCH BIOCHEM BIOPHYS, V323, P195, DOI 10.1006/abbi.1995.0026; Ohkama-Ohtsu N, 2010, PLANT CELL PHYSIOL, V51, P1255, DOI 10.1093/pcp/pcq095; OSSLUND T, 1982, PLANT PHYSIOL, V70, P39, DOI 10.1104/pp.70.1.39; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parey K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074707; Parey K, 2013, METALLOMICS, V5, P302, DOI 10.1039/c2mt20225e; Park YS, 1997, J BIOL CHEM, V272, P15161, DOI 10.1074/jbc.272.24.15161; Patron NJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-39; PERONA JJ, 1993, BIOCHEMISTRY-US, V32, P8758, DOI 10.1021/bi00085a006; Phartiyal P, 2008, PHYTOCHEMISTRY, V69, P356, DOI 10.1016/j.phytochem.2007.07.013; Phartiyal P, 2006, ARCH BIOCHEM BIOPHYS, V450, P20, DOI 10.1016/j.abb.2006.03.033; Ravilious GE, 2013, BIOSCIENCE REP, V33, P585, DOI 10.1042/BSR20130073; Ravilious GE, 2013, J BIOL CHEM, V288, P6107, DOI 10.1074/jbc.M112.439414; Ravilious GE, 2012, NAT PROD REP, V29, P1138, DOI 10.1039/c2np20009k; Ravilious GE, 2012, J BIOL CHEM, V287, P30385, DOI 10.1074/jbc.M112.387001; Ravilious GE, 2012, P NATL ACAD SCI USA, V109, P309, DOI 10.1073/pnas.1115772108; RENOSTO F, 1993, ARCH BIOCHEM BIOPHYS, V307, P272, DOI 10.1006/abbi.1993.1590; Rotte C, 2000, PLANT PHYSIOL, V124, P715, DOI 10.1104/pp.124.2.715; Shin R, 2011, FEBS LETT, V585, P143, DOI 10.1016/j.febslet.2010.11.025; Taguchi Y, 2004, BIOCHEMISTRY-US, V43, P4111, DOI 10.1021/bi036052t; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Ullrich TC, 2001, J MOL BIOL, V313, P1117, DOI 10.1006/jmbi.2001.5098; Ullrich TC, 2001, EMBO J, V20, P316, DOI 10.1093/emboj/20.3.316; Vauclare P, 2002, PLANT J, V31, P729, DOI 10.1046/j.1365-313X.2002.01391.x; Venkatachalam KV, 1999, J BIOL CHEM, V274, P2601, DOI 10.1074/jbc.274.5.2601; Weber CH, 1999, STRUCTURE, V7, P1113, DOI 10.1016/S0969-2126(99)80178-6; White PJ, 2010, ANN BOT-LONDON, V105, P1073, DOI 10.1093/aob/mcq085; Yatusevich R, 2010, PLANT J, V62, P1, DOI 10.1111/j.1365-313X.2009.04118.x; Yi H, 2010, AMINO ACIDS, V39, P963, DOI 10.1007/s00726-010-0572-9; Yi H, 2010, MOL PLANT, V3, P269, DOI 10.1093/mp/ssp112; Yu ZH, 2007, J MOL BIOL, V365, P732, DOI 10.1016/j.jmb.2006.10.035; Zhang M, 2012, J AM CHEM SOC, V134, P16979, DOI 10.1021/ja3078522; Zhu L, 2008, PLANT PHYSIOL BIOCH, V46, P731, DOI 10.1016/j.plaphy.2007.03.029	69	33	34	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10919	10929		10.1074/jbc.M113.540401	http://dx.doi.org/10.1074/jbc.M113.540401			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24584934	hybrid, Green Published			2022-12-28	WOS:000334226400059
J	Rodrigues, JR; Couto, A; Cabezas, A; Pinto, RM; Ribeiro, JM; Canales, J; Costas, MJ; Cameselle, JC				Rui Rodrigues, Joaquim; Couto, Ana; Cabezas, Alicia; Maria Pinto, Rosa; Meireles Ribeiro, Joao; Canales, Jose; Jesus Costas, Maria; Carlos Cameselle, Jose			Bifunctional Homodimeric Triokinase/FMN Cyclase CONTRIBUTION OF PROTEIN DOMAINS TO THE ACTIVITIES OF THE HUMAN ENZYME AND MOLECULAR DYNAMICS SIMULATION OF DOMAIN MOVEMENTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						FAD; Fructose Metabolism; Molecular Docking; Molecular Dynamics; Mutagenesis; Site-specific; Bifunctional Kinase; Cyclase; Cyclic FMN; DAK Gene; Dihydroxyacetone Phosphorylation; Glyceraldehyde Phosphorylation	COLI DIHYDROXYACETONE KINASE; COVALENT SUBSTRATE-BINDING; RIBOFLAVIN 4',5'-CYCLIC PHOSPHATE; ISOLATED RAT HEPATOCYTES; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; CITROBACTER-FREUNDII; FRUCTOSE METABOLISM; NEGATIVE REGULATION; HUMAN ERYTHROCYTES	Background: Triokinase, which phosphorylates dihydroxyacetone and fructose-derived glyceraldehyde, remains molecularly unidentified. Results: Human DAK gene encodes homodimeric triokinase/FMN cyclase formed by two-domain subunits. Although kinase activity requires intact homodimers, cyclase requires only a truncated, single domain subunit. Conclusion: Triokinase/FMN cyclase identity and bifunctionality are established. Significance: This study molecularly dissects a bifunctional enzyme of unusual specificity and finishes the molecular identification of fructose pathway enzymes. Mammalian triokinase, which phosphorylates exogenous dihydroxyacetone and fructose-derived glyceraldehyde, is neither molecularly identified nor firmly associated to an encoding gene. Human FMN cyclase, which splits FAD and other ribonucleoside diphosphate-X compounds to ribonucleoside monophosphate and cyclic X-phosphodiester, is identical to a DAK-encoded dihydroxyacetone kinase. This bifunctional protein was identified as triokinase. It was modeled as a homodimer of two-domain (K and L) subunits. Active centers lie between K1 and L2 or K2 and L1: dihydroxyacetone binds K and ATP binds L in different subunits too distant (approximate to 14 ) for phosphoryl transfer. FAD docked to the ATP site with ribityl 4-OH in a possible near-attack conformation for cyclase activity. Reciprocal inhibition between kinase and cyclase reactants confirmed substrate site locations. The differential roles of protein domains were supported by their individual expression: K was inactive, and L displayed cyclase but not kinase activity. The importance of domain mobility for the kinase activity of dimeric triokinase was highlighted by molecular dynamics simulations: ATP approached dihydroxyacetone at distances below 5 in near-attack conformation. Based upon structure, docking, and molecular dynamics simulations, relevant residues were mutated to alanine, and k(cat) and K-m were assayed whenever kinase and/or cyclase activity was conserved. The results supported the roles of Thr(112) (hydrogen bonding of ATP adenine to K in the closed active center), His(221) (covalent anchoring of dihydroxyacetone to K), Asp(401) and Asp(403) (metal coordination to L), and Asp(556) (hydrogen bonding of ATP or FAD ribose to L domain). Interestingly, the His(221) point mutant acted specifically as a cyclase without kinase activity.	[Rui Rodrigues, Joaquim; Couto, Ana; Cabezas, Alicia; Maria Pinto, Rosa; Meireles Ribeiro, Joao; Canales, Jose; Jesus Costas, Maria; Carlos Cameselle, Jose] Univ Extremadura, Fac Med, Dept Bioquim & Biol Mol & Genet, Grp Enzimol, E-06006 Badajoz, Spain; [Rui Rodrigues, Joaquim] Inst Politecn Leiria, Escola Super Tecnol & Gestao, P-2411901 Leiria, Portugal	Universidad de Extremadura; Polytechnic Institute of Leiria; Polytechnic Institute of Porto	Cameselle, JC (corresponding author), Univ Extremadura, Fac Med, Dept Bioquim & Biol Mol & Genet, Av Elvas S-N,Apartado 108, E-06006 Badajoz, Spain.	camselle@unex.es	Costas, Maria Jesus/K-7394-2014; Rodrigues, Joaquim Rui/L-4137-2014; Cabezas, Alicia/K-6564-2014; Cameselle, Jose Carlos/K-6421-2014; Ribeiro, João Meireles/K-6555-2014; Pinto, Rosa M/K-6560-2014; Canales, Jose/K-8793-2014	Costas, Maria Jesus/0000-0001-8815-1839; Rodrigues, Joaquim Rui/0000-0002-9756-1124; Cabezas, Alicia/0000-0002-2908-9147; Cameselle, Jose Carlos/0000-0003-0005-081X; Ribeiro, João Meireles/0000-0002-6548-1402; Pinto, Rosa M/0000-0003-4594-8113; Canales, Jose/0000-0002-7897-9832	Ministerio de Educacion y Ciencia or Ministerio de Ciencia e Innovacion del Gobierno de Espana [BFU2006-510, BFU2009-07296]; Junta de Extremadura or Gobierno de Extremadura [GRU08043, GRU09135, GR10133]; Fondo Europeo de Desarrollo Regional; Fondo Social Europeo	Ministerio de Educacion y Ciencia or Ministerio de Ciencia e Innovacion del Gobierno de Espana; Junta de Extremadura or Gobierno de Extremadura; Fondo Europeo de Desarrollo Regional(European Commission); Fondo Social Europeo(European Social Fund (ESF)European Commission)	The work was supported in part by Ministerio de Educacion y Ciencia or Ministerio de Ciencia e Innovacion del Gobierno de Espana Grants BFU2006-510 and BFU2009-07296) and Junta de Extremadura or Gobierno de Extremadura Grants GRU08043, GRU09135, and GR10133 cofinanced by Fondo Europeo de Desarrollo Regional and Fondo Social Europeo.	ARGAUD D, 1993, EUR J BIOCHEM, V213, P1341, DOI 10.1111/j.1432-1033.1993.tb17886.x; Bachler C, 2005, J BIOL CHEM, V280, P18321, DOI 10.1074/jbc.M500279200; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BEUTLER E, 1973, BLOOD, V41, P559, DOI 10.1182/blood.V41.4.559.559; BONTHRON DT, 1994, HUM MOL GENET, V3, P1627, DOI 10.1093/hmg/3.9.1627; Burns SP, 2000, BIOCHEM J, V349, P539, DOI 10.1042/0264-6021:3490539; Cabezas A, 2005, BIOCHEM BIOPH RES CO, V338, P1682, DOI 10.1016/j.bbrc.2005.10.142; Cabezas A, 2001, BIOCHEMISTRY-US, V40, P13710, DOI 10.1021/bi0157159; Canales J, 2005, ANAL BIOCHEM, V341, P214, DOI 10.1016/j.ab.2005.01.060; Charifson PS, 1999, J MED CHEM, V42, P5100, DOI 10.1021/jm990352k; Cheek S, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-6; Clark RD, 2002, J MOL GRAPH MODEL, V20, P281, DOI 10.1016/S1093-3263(01)00125-5; Copeland R. A., 2000, ENZYMES PRACTICAL IN, P268; CROSS NCP, 1990, LANCET, V335, P306, DOI 10.1016/0140-6736(90)90603-3; DANIEL R, 1995, J BACTERIOL, V177, P4392, DOI 10.1128/jb.177.15.4392-4401.1995; Dekker MJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE685, DOI 10.1152/ajpendo.00283.2010; Diao FC, 2007, P NATL ACAD SCI USA, V104, P11706, DOI 10.1073/pnas.0700544104; Dong F, 2002, SCIENCE, V298, P1227, DOI 10.1126/science.1076947; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Dupradeau FY, 2008, NUCLEIC ACIDS RES, V36, pD360, DOI 10.1093/nar/gkm887; Erni B, 2006, CELL MOL LIFE SCI, V63, P890, DOI 10.1007/s00018-005-5518-0; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fontes R, 2000, ACTA BIOCHIM POL, V47, P233, DOI 10.18388/abp.2000_4082; Fraiz FJ, 1998, BIOCHEM J, V330, P881, DOI 10.1042/bj3300881; FRANDSEN EK, 1971, EUR J BIOCHEM, V23, P588, DOI 10.1111/j.1432-1033.1971.tb01658.x; GANCEDO C, 1986, EUR J BIOCHEM, V159, P171, DOI 10.1111/j.1432-1033.1986.tb09848.x; Garcia-Alles LF, 2004, BIOCHEMISTRY-US, V43, P13037, DOI 10.1021/bi048575m; Gohlke H, 2000, J MOL BIOL, V295, P337, DOI 10.1006/jmbi.1999.3371; Golaz O, 1996, ELECTROPHORESIS, V17, P573, DOI 10.1002/elps.1150170328; Harrison J., 1976, P1; HAYASHI SI, 1967, J BIOL CHEM, V242, P1030; HERS HG, 1953, BIOCHIM BIOPHYS ACTA, V11, P427, DOI 10.1016/0006-3002(53)90062-6; HERS HG, 1983, ANNU REV BIOCHEM, V52, P617, DOI 10.1146/annurev.bi.52.070183.003153; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOFMANN KH, 1981, Z ALLG MIKROBIOL, V21, P219, DOI 10.1002/jobm.3630210307; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurley JH, 1999, J BIOL CHEM, V274, P7599, DOI 10.1074/jbc.274.12.7599; Ivy JL, 1998, MED SCI SPORT EXER, V30, P837, DOI 10.1097/00005768-199806000-00010; Johnson RJ, 2010, J AM SOC NEPHROL, V21, P2036, DOI 10.1681/ASN.2010050506; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Komuro A, 2008, CYTOKINE, V43, P350, DOI 10.1016/j.cyto.2008.07.011; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Linder JU, 2006, CELL MOL LIFE SCI, V63, P1736, DOI 10.1007/s00018-006-6072-0; Luisi B, 1998, J MOL BIOL, V279, P1123, DOI 10.1006/jmbi.1998.1833; MACDONALD MJ, 1989, ARCH BIOCHEM BIOPHYS, V270, P15, DOI 10.1016/0003-9861(89)90002-7; Madero M, 2011, CURR HYPERTENS REP, V13, P29, DOI 10.1007/s11906-010-0163-x; MAYES PA, 1993, AM J CLIN NUTR, V58, P754; MIWA I, 1994, PREP BIOCHEM, V24, P203, DOI 10.1080/10826069408010094; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Molin M, 2003, J BIOL CHEM, V278, P1415, DOI 10.1074/jbc.M203030200; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Norbeck J, 1997, J BIOL CHEM, V272, P5544, DOI 10.1074/jbc.272.9.5544; Oberholzer AE, 2006, J MOL BIOL, V359, P539, DOI 10.1016/j.jmb.2006.03.057; Pavlovic-Djuranovic S, 2006, BBA-BIOMEMBRANES, V1758, P1012, DOI 10.1016/j.bbamem.2005.12.002; Perdomo AB, 2012, J PROTEOME RES, V11, P717, DOI 10.1021/pr2006445; Petersen AB, 2004, MUTAT RES-GEN TOX EN, V560, P173, DOI 10.1016/j.mrgentox.2004.03.002; PILKIS SJ, 1976, J BIOL CHEM, V251, P7841; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samuel VT, 2011, TRENDS ENDOCRIN MET, V22, P60, DOI 10.1016/j.tem.2010.10.003; Sanchez-Moreno I, 2009, CHEMBIOCHEM, V10, P225, DOI 10.1002/cbic.200800573; Sanner MF, 2005, STRUCTURE, V13, P447, DOI 10.1016/j.str.2005.01.010; Schomburg D., 2007, SPRINGER HDB ENZYMES, V35, P351; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shi R, 2011, P NATL ACAD SCI USA, V108, P1302, DOI 10.1073/pnas.1012596108; Siebold C, 2003, J BIOL CHEM, V278, P48236, DOI 10.1074/jbc.M305942200; Siebold C, 2003, P NATL ACAD SCI USA, V100, P8188, DOI 10.1073/pnas.0932787100; Sievenpiper JL, 2009, DIABETES CARE, V32, P1930, DOI 10.2337/dc09-0619; SILLERO MAG, 1969, EUR J BIOCHEM, V10, P345, DOI 10.1111/j.1432-1033.1969.tb00696.x; Steinmann B, 2001, METABOLIC MOL BASES, P1489; Taguchi T, 2002, CELL BIOCHEM FUNCT, V20, P223, DOI 10.1002/cbf.952; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Tolan DR, 2007, CEREBELLUM, V6, P130, DOI 10.1080/14734220601064759; Uzcategui NL, 2007, AUTOPHAGY, V3, P626, DOI 10.4161/auto.4907; Uzcategui NL, 2007, ANTIMICROB AGENTS CH, V51, P3960, DOI 10.1128/AAC.00423-07; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; WARNETTEHAMMOND ME, 1985, J BIOL CHEM, V260, P2647; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Yamano K, 1996, Z NATURFORSCH C, V51, P155; Zierkiewicz W, 2008, J PHYS CHEM B, V112, P16734, DOI 10.1021/jp8058118; Zurbriggen A, 2008, J BIOL CHEM, V283, P35789, DOI 10.1074/jbc.M804893200	85	14	15	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10620	10636		10.1074/jbc.M113.525626	http://dx.doi.org/10.1074/jbc.M113.525626			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24569995	Green Published, hybrid			2022-12-28	WOS:000334226400033
J	Boroughs, LK; Antonyak, MA; Cerione, RA				Boroughs, Lindsey K.; Antonyak, Marc A.; Cerione, Richard A.			A Novel Mechanism by Which Tissue Transglutaminase Activates Signaling Events That Promote Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Apoptosis; PI3-kinase (PI3K); Src; Transformation; Cell Survival; p70 S6-kinase; Tissue Transglutaminase	BREAST-CANCER CELLS; MIDDLE T-ANTIGEN; FACTOR-KAPPA-B; PHOSPHATIDYLINOSITOL 3-KINASE; TYROSINE PHOSPHORYLATION; INDUCED APOPTOSIS; DRUG-RESISTANCE; EXPRESSION; BINDING; TRANSFORMATION	Background: Tissue transglutaminase (tTG) promotes various aspects of oncogenesis, including cell survival. Results: Ectopically expressed tTG in non-transformed cells triggers a survival response that involves c-Src and PI3-kinase. Conclusion: tTG promotes survival by activating PI3-kinase through a c-Src-dependent mechanism. Significance: These findings demonstrate that tTG has an intrinsic capability to promote cell survival and explains how it contributes to oncogenesis. Tissue transglutaminase (tTG) functions as a GTPase and an acyl transferase that catalyzes the formation of protein cross-links. tTG expression is frequently up-regulated in human cancer, where it has been implicated in various aspects of cancer progression, including cell survival and chemo-resistance. However, the extent to which tTG cooperates with other proteins within the context of a cancer cell, versus its intrinsic ability to confer transformed characteristics to cells, is poorly understood. To address this question, we asked what effect the ectopic expression of tTG in a non-transformed cellular background would have on the behavior of the cells. Using NIH3T3 fibroblasts stably expressing a Myc-tagged form of tTG, we found that tTG strongly protected these cells from serum starvation-induced apoptosis and triggered the activation of the PI3-kinase/mTOR Complex 1 (mTORC1)/p70 S6-kinase pathway. We determined that tTG forms a complex with the non-receptor tyrosine kinase c-Src and PI3-kinase, and that treating cells with inhibitors to block tTG function (monodansylcadaverine; MDC) or c-Src kinase activity (PP2) disrupted the formation of this complex, and prevented tTG from activating the PI3-kinase pathway. Moreover, treatment of fibroblasts over-expressing tTG with PP2, or with inhibitors that inactivate components of the PI3-kinase pathway, including PI3-kinase (LY294002) and mTORC1 (rapamycin), ablated the tTG-promoted survival of the cells. These findings demonstrate that tTG has an intrinsic capability to stimulate cell survival through a novel mechanism that activates PI3-kinase signaling events, thus highlighting tTG as a potential target for the treatment of human cancer.	[Boroughs, Lindsey K.; Antonyak, Marc A.; Cerione, Richard A.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University	Cerione, RA (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu			NIGMS NIH HHS [R01 GM040654, P41 GM103485] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040654, P41GM103485] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AESCHLIMANN D, 1993, J CELL BIOL, V120, P1461, DOI 10.1083/jcb.120.6.1461; Antonyak MA, 2004, J BIOL CHEM, V279, P41461, DOI 10.1074/jbc.M404976200; Antonyak MA, 2003, J BIOL CHEM, V278, P15859, DOI 10.1074/jbc.M300037200; Antonyak MA, 2001, J BIOL CHEM, V276, P33582, DOI 10.1074/jbc.M105318200; Antonyak MA, 2011, P NATL ACAD SCI USA, V108, P4852, DOI 10.1073/pnas.1017667108; Antonyak MA, 2009, J BIOL CHEM, V284, P17914, DOI 10.1074/jbc.M109.013037; AUGER KR, 1992, J BIOL CHEM, V267, P5408; Boroughs LK, 2011, J BIOL CHEM, V286, P37094, DOI 10.1074/jbc.M111.242438; Cao LY, 2008, CARCINOGENESIS, V29, P1893, DOI 10.1093/carcin/bgn158; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; FOLK JE, 1980, ANNU REV BIOCHEM, V49, P517, DOI 10.1146/annurev.bi.49.070180.002505; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; HAEFNER B, 1995, J BIOL CHEM, V270, P7937, DOI 10.1074/jbc.270.14.7937; Hwang JY, 2008, CANCER RES, V68, P5849, DOI 10.1158/0008-5472.CAN-07-6130; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; KhosraviFar R, 1996, MOL CELL BIOL, V16, P3923; Kim DS, 2006, CANCER RES, V66, P10936, DOI 10.1158/0008-5472.CAN-06-1521; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Li B, 2010, P NATL ACAD SCI USA, V107, P1408, DOI 10.1073/pnas.0907907107; LING LE, 1992, J VIROL, V66, P1702, DOI 10.1128/JVI.66.3.1702-1708.1992; LIU XQ, 1993, MOL CELL BIOL, V13, P5225, DOI 10.1128/MCB.13.9.5225; Magdalena J, 2003, J CELL SCI, V116, P743, DOI 10.1242/jcs.00288; Mangala LS, 2007, ONCOGENE, V26, P2459, DOI 10.1038/sj.onc.1210035; Mann AP, 2006, CANCER RES, V66, P8788, DOI 10.1158/0008-5472.CAN-06-1457; Martin GS, 2004, ONCOGENE, V23, P7910, DOI 10.1038/sj.onc.1208077; MEHTA K, 1986, CANCER RES, V46, P1388; NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253; Satpathy N, 2007, CANCER RES, V67, P7194, DOI 10.1158/0008-5472.CAN-07-0307; SERUNIAN LA, 1990, J VIROL, V64, P4718, DOI 10.1128/JVI.64.10.4718-4725.1990; SINGH US, 1995, BIOCHEMISTRY-US, V34, P15863, DOI 10.1021/bi00048a032; Tamguney T, 2007, J CELL SCI, V120, P4071, DOI 10.1242/jcs.015230; Telci D, 2006, FRONT BIOSCI-LANDMRK, V11, P867, DOI 10.2741/1843; Verderio EAM, 2004, AMINO ACIDS, V26, P387, DOI 10.1007/s00726-004-0094-4; Verma A, 2008, CLIN CANCER RES, V14, P1997, DOI 10.1158/1078-0432.CCR-07-1533; Verma A, 2006, CANCER RES, V66, P10525, DOI 10.1158/0008-5472.CAN-06-2387; von Willebrand M, 1998, J BIOL CHEM, V273, P3994, DOI 10.1074/jbc.273.7.3994; Wang JB, CANC CELL, V18, P207; Yuan L, 2007, ONCOGENE, V26, P2563, DOI 10.1038/sj.onc.1210048; Zhang JW, 2013, CELL REP, V3, P2008, DOI 10.1016/j.celrep.2013.05.021; Zhang RL, 2003, GLIA, V42, P194, DOI 10.1002/glia.10222	40	34	34	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10115	10125		10.1074/jbc.M113.464693	http://dx.doi.org/10.1074/jbc.M113.464693			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24569994	hybrid, Green Published			2022-12-28	WOS:000333807000058
J	Emery, AC; Eiden, MV; Eiden, LE				Emery, Andrew C.; Eiden, Maribeth V.; Eiden, Lee E.			Separate Cyclic AMP Sensors for Neuritogenesis, Growth Arrest, and Survival of Neuroendocrine Cells*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclic AMP (cAMP); ERK; Guanine Nucleotide Exchange Factor (GEF); p38 MAPK; Protein Kinase A (PKA); Epac; NCS; Rapgef2	CYCLASE-ACTIVATING POLYPEPTIDE; DEPENDENT PROTEIN-KINASE; PC12 CELLS; ADENYLATE-CYCLASE; NEURITE OUTGROWTH; NEURONAL DIFFERENTIATION; SIGNALING PATHWAY; FARNESYLTHIOSALICYLIC ACID; NEUROTROPHIN RECEPTOR; SUSTAINED ACTIVATION	Background: Three cAMP sensors (PKA, Epac1/2, and NCS/Rapgef2) coexist in neuroendocrine cells. Their roles in differentiation require elucidation. Results: Epac2, PKA, and NCS/Rapgef2 independently gate signaling for growth arrest, cell survival, and neuritogenesis after GPCR-G(s) engagement in PC12 cells. Conclusion: Parallel, insulated pathways effect cAMP-dependent neuroendocrine cell differentiation. Significance: Assays for parcellated cAMP signaling in neuroendocrine cells have a broad application for CNS drug discovery. Dividing neuroendocrine cells differentiate into a neuronal-like phenotype in response to ligands activating G protein-coupled receptors, leading to the elevation of the second messenger cAMP. Growth factors that act at receptor tyrosine kinases, such as nerve growth factor, also cause differentiation. We report here that two aspects of cAMP-induced differentiation, neurite extension and growth arrest, are dissociable at the level of the sensors conveying the cAMP signal in PC12 and NS-1 cells. Following cAMP elevation, neuritogenic cyclic AMP sensor/Rapgef2 is activated for signaling to ERK to mediate neuritogenesis, whereas Epac2 is activated for signaling to the MAP kinase p38 to mediate growth arrest. Neither action of cAMP requires transactivation of TrkA, the receptor for NGF. In fact, the differentiating effects of NGF do not require activation of any of the cAMP sensors protein kinase A, Epac, or neuritogenic cyclic AMP sensor/Rapgef2 but, rather, depend on ERK and p38 activation via completely independent signaling pathways. Hence, cAMP- and NGF-dependent signaling for differentiation are also completely insulated from each other. Cyclic AMP and NGF also protect NS-1 cells from serum withdrawal-induced cell death, again by two wholly separate signaling mechanisms, PKA-dependent for cAMP and PKA-independent for NGF.	[Emery, Andrew C.; Eiden, Lee E.] NIMH, Mol Neurosci Sect, Intramural Res Program, Bethesda, MD 20892 USA; [Eiden, Maribeth V.] NIMH, Sect Directed Gene Transfer, Lab Cellular & Mol Regulat, Intramural Res Program, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Eiden, LE (corresponding author), NIMH, Mol Neurosci Sect, Intramural Res Program, 9000 Rockville Pike,Bldg 49,Rm 5A38, Bethesda, MD 20892 USA.	eidenl@mail.nih.gov		Emery, Andrew/0000-0002-6760-2570; Eiden, Lee/0000-0001-7524-944X	National Institute of Mental Health Intramural Research Program [1ZIAMH002386, 1ZIAMH002592]; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002592, ZIAMH002386] Funding Source: NIH RePORTER	National Institute of Mental Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institute of Mental Health Intramural Research Program Projects 1ZIAMH002386 (to L. E. E.) and 1ZIAMH002592 (to M. V. E.).	BATISTATOU A, 1991, J CELL BIOL, V115, P461, DOI 10.1083/jcb.115.2.461; Botia B, 2007, PEPTIDES, V28, P1746, DOI 10.1016/j.peptides.2007.04.013; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DEUTSCH PJ, 1992, J BIOL CHEM, V267, P5108; DOSTMANN WRG, 1990, J BIOL CHEM, V265, P10484; Emery AC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003993; Emery AC, 2013, MOL PHARMACOL, V83, P95, DOI 10.1124/mol.112.081760; Emery AC, 2012, FASEB J, V26, P3199, DOI 10.1096/fj.11-203042; GINTY DD, 1991, J BIOL CHEM, V266, P15325; Grandoch M, 2010, BRIT J PHARMACOL, V159, P265, DOI 10.1111/j.1476-5381.2009.00458.x; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HAGAG N, 1986, NATURE, V319, P680, DOI 10.1038/319680a0; Hahn AT, 2009, CELL CYCLE, V8, P1044, DOI 10.4161/cc.8.7.8042; Haklai R, 1998, BIOCHEMISTRY-US, V37, P1306, DOI 10.1021/bi972032d; Han JH, 2007, TRENDS BIOCHEM SCI, V32, P364, DOI 10.1016/j.tibs.2007.06.007; Hisata S, 2007, J CELL BIOL, V178, P843, DOI 10.1083/jcb.200610073; Hochbaum D, 2003, J BIOL CHEM, V278, P33738, DOI 10.1074/jbc.M305208200; Hughes AL, 2000, J BIOL CHEM, V275, P37829, DOI 10.1074/jbc.M003146200; Hughes AL, 2001, J NEUROSCI RES, V63, P10, DOI 10.1002/1097-4547(20010101)63:1<10::AID-JNR2>3.0.CO;2-R; Hui LJ, 2007, CELL CYCLE, V6, P2429, DOI 10.4161/cc.6.20.4774; Ji HF, 2013, HEPATOLOGY, V57, P1225, DOI 10.1002/hep.25802; KALMAN D, 1990, NEURON, V4, P355, DOI 10.1016/0896-6273(90)90048-K; Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Klesse LJ, 1999, ONCOGENE, V18, P2055, DOI 10.1038/sj.onc.1202524; KOIZUMI S, 1988, J NEUROSCI, V8, P715; Lazarovici P, 1998, MOL PHARMACOL, V54, P547, DOI 10.1124/mol.54.3.547; Liu XH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018072; MAROM M, 1995, J BIOL CHEM, V270, P22263, DOI 10.1074/jbc.270.38.22263; Mor A, 2011, J INVEST DERMATOL, V131, P2040, DOI 10.1038/jid.2011.152; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pak Y, 2002, MOL CELL BIOL, V22, P7942, DOI 10.1128/MCB.22.22.7942-7952.2002; Pham N, 2000, CURR BIOL, V10, P555, DOI 10.1016/S0960-9822(00)00473-5; Piiper A, 2002, J BIOL CHEM, V277, P43623, DOI 10.1074/jbc.M203926200; Pumiglia KM, 1997, P NATL ACAD SCI USA, V94, P448, DOI 10.1073/pnas.94.2.448; Quilliam LA, 2002, PROG NUCLEIC ACID RE, V71, P391, DOI 10.1016/S0079-6603(02)71047-7; Racz B, 2008, REGUL PEPTIDES, V145, P105, DOI 10.1016/j.regpep.2007.09.015; Racz B, 2007, NEUROTOX RES, V12, P95, DOI 10.1007/BF03033918; RAUSCH DM, 1988, MOL ENDOCRINOL, V2, P921, DOI 10.1210/mend-2-10-921; Ravni A, 2008, MOL PHARMACOL, V73, P1688, DOI 10.1124/mol.107.044792; RICHTERLANDSBERG C, 1986, J CELL BIOL, V102, P821, DOI 10.1083/jcb.102.3.821; Rusyn EV, 2000, ONCOGENE, V19, P4685, DOI 10.1038/sj.onc.1203836; Saragovi HU, 1998, J BIOL CHEM, V273, P34933, DOI 10.1074/jbc.273.52.34933; Shi GX, 2006, MOL CELL BIOL, V26, P9136, DOI 10.1128/MCB.00332-06; Shi GX, 2010, MOL BIOL CELL, V21, P1597, DOI 10.1091/mbc.E09-12-1033; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Ster J, 2007, P NATL ACAD SCI USA, V104, P2519, DOI 10.1073/pnas.0611031104; Ster J, 2009, J PHYSIOL-LONDON, V587, P101, DOI 10.1113/jphysiol.2008.157461; Stessin AM, 2006, J BIOL CHEM, V281, P17253, DOI 10.1074/jbc.M603500200; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Tanaka J, 1997, REGUL PEPTIDES, V72, P1, DOI 10.1016/S0167-0115(97)01038-0; Tanaka K, 2001, PROG NEUROBIOL, V65, P173, DOI 10.1016/S0301-0082(01)00002-8; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Watanabe J, 2007, PEPTIDES, V28, P1713, DOI 10.1016/j.peptides.2007.06.029; Yao H, 1998, J BIOL CHEM, V273, P8240, DOI 10.1074/jbc.273.14.8240; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324	58	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					10126	10139		10.1074/jbc.M113.529321	http://dx.doi.org/10.1074/jbc.M113.529321			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24567337	Green Published, hybrid			2022-12-28	WOS:000333807000059
J	Kennelly, PJ				Kennelly, Peter J.			Protein Ser/Thr/Tyr Phosphorylation in the Archaea*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review						Archaea; Archaebacteria; Evolution; Protein Kinases; Protein Phosphatase; Protein Phosphorylation	SULFOLOBUS-SOLFATARICUS; KINASE-ACTIVITY; IN-VITRO; SERINE/THREONINE PHOSPHATASE; TYROSINE PHOSPHATASES; YEAST PID261/BUD32; CRYSTAL-STRUCTURES; HUMAN GENOME; IDENTIFICATION; EVOLUTION	The third domain of life, the Archaea (formerly Archaebacteria), is populated by a physiologically diverse set of microorganisms, many of which reside at the ecological extremes of our global environment. Although ostensibly prokaryotic in morphology, the Archaea share much closer evolutionary ties with the Eukarya than with the superficially more similar Bacteria. Initial genomic, proteomic, and biochemical analyses have revealed the presence of eukaryotic protein kinases and phosphatases and an intriguing set of serine-, threonine-, and tyrosine-phosphorylated proteins in the Archaea that may offer new insights into this important regulatory mechanism.	Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Kennelly, PJ (corresponding author), Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA.	pjkennel@vt.edu						Aivaliotis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004777; Albers SV, 2005, MICROBIOL-SGM, V151, P763, DOI 10.1099/mic.0.27699-0; ALMAULA N, 1995, J BACTERIOL, V177, P2524, DOI 10.1128/jb.177.9.2524-2529.1995; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Alonso A, 2004, J BIOL CHEM, V279, P35768, DOI 10.1074/jbc.M403412200; Angermayr M, 2002, MOL MICROBIOL, V44, P309, DOI 10.1046/j.1365-2958.2002.02881.x; Barford D, 1996, TRENDS BIOCHEM SCI, V21, P407, DOI 10.1016/S0968-0004(96)10060-8; Bhaduri A, 2005, J MOL BIOL, V352, P736, DOI 10.1016/j.jmb.2005.07.004; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Chu HM, 2007, PROTEINS, V66, P996, DOI 10.1002/prot.21262; Dahche H, 2009, EXTREMOPHILES, V13, P371, DOI 10.1007/s00792-008-0211-5; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Duan X, 2011, BIOCHEM BIOPH RES CO, V407, P242, DOI 10.1016/j.bbrc.2011.03.011; Esser D, 2012, J PROTEOME RES, V11, P4823, DOI 10.1021/pr300190k; Esser D, 2013, BIOCHEM SOC T, V41, P399, DOI 10.1042/BST20120317; Facchin S, 2003, FEBS LETT, V549, P63, DOI 10.1016/S0014-5793(03)00770-1; Facchin S, 2002, BIOCHEM BIOPH RES CO, V296, P1366, DOI 10.1016/S0006-291X(02)02090-9; FOSTER R, 1989, J BACTERIOL, V171, P272, DOI 10.1128/jb.171.1.272-279.1989; Gnad F, 2010, MOL CELL PROTEOMICS, V9, P2642, DOI 10.1074/mcp.M110.001594; Guan K L, 1993, Semin Cell Biol, V4, P389, DOI 10.1006/scel.1993.1046; Haile JD, 2011, ARCH BIOCHEM BIOPHYS, V511, P56, DOI 10.1016/j.abb.2011.04.006; Hecker A, 2008, EMBO J, V27, P2340, DOI 10.1038/emboj.2008.157; Hecker A, 2009, BIOCHEM SOC T, V37, P29, DOI 10.1042/BST0370029; Humbard MA, 2006, J BACTERIOL, V188, P7521, DOI 10.1128/JB.00943-06; Humbard MA, 2010, ARCHAEA, V2010, DOI 10.1155/2010/481725; Hunter T, 2012, PHILOS T R SOC B, V367, P2513, DOI 10.1098/rstb.2012.0013; HURLEY JH, 1990, J BIOL CHEM, V265, P3599; Jeon SJ, 2002, BIOCHEM BIOPH RES CO, V295, P508, DOI 10.1016/S0006-291X(02)00705-2; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kennelly PJ, 2003, BIOCHEM J, V370, P373, DOI 10.1042/BJ20021547; Kennelly PJ, 1996, J BACTERIOL, V178, P4759, DOI 10.1128/jb.178.16.4759-4764.1996; KENNELLY PJ, 1993, J BIOL CHEM, V268, P6505; Kim SH, 2005, BIOCHEM J, V387, P271, DOI 10.1042/BJ20041053; Kisseleva-Romanova E, 2006, EMBO J, V25, P3576, DOI 10.1038/sj.emboj.7601235; LaRonde NA, 2014, J BIOL CHEM, V289, P9488, DOI 10.1074/jbc.R113.538090; LaRonde-LeBlanc N, 2005, FEBS J, V272, P2800, DOI 10.1111/j.1742-4658.2005.04702.x; LENG J, 1995, J BACTERIOL, V177, P6510, DOI 10.1128/jb.177.22.6510-6517.1995; Leonard CJ, 1998, GENOME RES, V8, P1038, DOI 10.1101/gr.8.10.1038; Lower BH, 2004, J BACTERIOL, V186, P463, DOI 10.1128/JB.186.2.463-472.2004; Lower BH, 2003, J BACTERIOL, V185, P3436, DOI 10.1128/JB.185.11.3436-3445.2003; Lower BH, 2002, J BACTERIOL, V184, P2614, DOI 10.1128/JB.184.10.2614-2619.2002; Lower BH, 2000, J BACTERIOL, V182, P3452, DOI 10.1128/JB.182.12.3452-3459.2000; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Mai B, 1998, J BACTERIOL, V180, P4030, DOI 10.1128/JB.180.16.4030-4035.1998; Makarova KS, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-33; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Mao DYL, 2008, MOL CELL, V32, P259, DOI 10.1016/j.molcel.2008.10.002; Moorhead GBG, 2009, BIOCHEM J, V417, P401, DOI 10.1042/BJ20081986; Perrochia L, 2013, NUCLEIC ACIDS RES, V41, P9484, DOI 10.1093/nar/gkt720; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; Ramponi G, 1997, INT J BIOCHEM CELL B, V29, P279, DOI 10.1016/S1357-2725(96)00109-4; Ray WK, 2005, J BACTERIOL, V187, P4270, DOI 10.1128/JB.187.12.4270-4275.2005; Sartori G, 2000, YEAST, V16, P255, DOI 10.1002/(SICI)1097-0061(200002)16:3<255::AID-YEA520>3.0.CO;2-#; She Q, 2001, P NATL ACAD SCI USA, V98, P7835, DOI 10.1073/pnas.141222098; Shi L, 1998, FEMS MICROBIOL REV, V22, P229, DOI 10.1016/S0168-6445(98)00015-1; SKORKO R, 1984, EUR J BIOCHEM, V145, P617, DOI 10.1111/j.1432-1033.1984.tb08601.x; SMITH RF, 1995, PROTEIN SCI, V4, P126; Smith SC, 1997, J BACTERIOL, V179, P2418, DOI 10.1128/jb.179.7.2418-2420.1997; Solow B, 1997, J BACTERIOL, V179, P5072, DOI 10.1128/jb.179.16.5072-5075.1997; Solow B, 1998, PROTEIN SCI, V7, P105, DOI 10.1002/pro.5560070111; SPUDICH JL, 1980, J BIOL CHEM, V255, P5501; Srinivasan M, 2011, EMBO J, V30, P873, DOI 10.1038/emboj.2010.343; Stravopodis DJ, 1999, J MOL EVOL, V48, P625, DOI 10.1007/PL00013155; Tahara M, 2004, J BIOCHEM, V135, P479, DOI 10.1093/jb/mvh055; Wang B, 2010, J BACTERIOL, V192, P1956, DOI 10.1128/JB.01471-09; Waters E, 2003, P NATL ACAD SCI USA, V100, P12984, DOI 10.1073/pnas.1735403100; WOESE CR, 1978, J MOL EVOL, V11, P245, DOI 10.1007/BF01734485; Wolf YI, 2013, BIOESSAYS, V35, P829, DOI 10.1002/bies.201300037; Zhang WW, 2004, MICROBIOL-SGM, V150, P4189, DOI 10.1099/mic.0.27480-0; Zhaxybayeva O, 2005, PROTOPLASMA, V227, P53, DOI 10.1007/s00709-005-0135-1	71	37	38	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9480	9487		10.1074/jbc.R113.529412	http://dx.doi.org/10.1074/jbc.R113.529412			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24554702	hybrid, Green Published			2022-12-28	WOS:000333807000004
J	De Ceunynck, K; Rocha, S; De Meyer, SF; Sadler, JE; Uji-i, H; Deckmyn, H; Hofkens, J; Vanhoorelbeke, K				De Ceunynck, Karen; Rocha, Susana; De Meyer, Simon F.; Sadler, J. Evan; Uji-i, Hiroshi; Deckmyn, Hans; Hofkens, Johan; Vanhoorelbeke, Karen			Single Particle Tracking of ADAMTS13 ( A Disintegrin and Metalloprotease with Thrombospondin Type-1 Repeats) Molecules on Endothelial von Willebrand Factor Strings	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ADAMTS13; Endothelial Cell; Imaging; Single Particle Analysis; Von Willebrand Factor; Fluorescence Microscopy	THROMBOTIC THROMBOCYTOPENIC PURPURA; VONWILLEBRAND-FACTOR MULTIMERS; A2 DOMAIN; IN-VIVO; CELLS; PROTEOLYSIS; PROTEASE; DNA; MICROSCOPY; MUTATIONS	Background: ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type-1 repeats) cleaves pro-thrombotic ultra-large von Willebrand factor (VWF) strings. Results: Customized single particle tracking enabled visualization of single ADAMTS13 enzymes that bind to long platelet-decorated VWF strings. Conclusion: ADAMTS13 readily bind to multiple available sites on VWF strings. Significance: Single molecule imaging can be used to study interactions between enzymes and large biopolymers in flow. von Willebrand factor (VWF) strings are removed from the endothelial surface by ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type-1 repeats)-mediated proteolysis. To visualize how single ADAMTS13 molecules bind to these long strings, we built a customized single molecule fluorescence microscope and developed single particle tracking software. Extensive analysis of over 6,000 single inactive ADAMTS13(E225Q) enzymes demonstrated that 20% of these molecules could be detected in at least two consecutive 60-ms frames and followed two types of trajectories. ADAMTS13(E225Q) molecules either decelerated in the vicinity of VWF strings, whereas sometimes making brief contact with the VWF string before disappearing again, or readily bound to the VWF strings and this for 120 ms or longer. These interactions were observed at several sites along the strings. Control experiments using an IgG protein revealed that only the second type of trajectory reflected a specific interaction of ADAMTS13 with the VWF string. In conclusion, we developed a dedicated single molecule fluorescence microscope for detecting single ADAMTS13 molecules (nm scale) on their long, flow-stretched VWF substrates (m scale) anchored on living cells. Comprehensive analysis of all detected enzymes showed a random interaction mechanism for ADAMTS13 with many available binding sites on the VWF strings.	[De Ceunynck, Karen; De Meyer, Simon F.; Deckmyn, Hans; Vanhoorelbeke, Karen] Katholieke Univ Leuven, Lab Thrombosis Res, B-8500 Kortrijk, Belgium; [De Ceunynck, Karen; Rocha, Susana; Uji-i, Hiroshi; Hofkens, Johan] Katholieke Univ Leuven, Dept Chem Mol Imaging & Photon, B-300 Louvain, Belgium; [Sadler, J. Evan] Washington Univ, Dept Med, St Louis, MO 63110 USA	KU Leuven; KU Leuven; Washington University (WUSTL)	Vanhoorelbeke, K (corresponding author), Katholieke Univ Leuven, IRF Life Sci, KULAK, E Sabbelaan 53, B-8500 Kortrijk, Belgium.	karen.vanhoorelbeke@kuleuven-kulak.be	Deckmyn, Hans/N-8932-2019; Uji-i, Hiroshi/AAK-5275-2020; Rocha, Susana/O-7622-2016; Rocha, Susana/AAH-8343-2020; Deckmyn, Hans/L-9434-2015; Hofkens, Johan/AAL-4204-2020; Hofkens, Johan/AAP-9255-2020; Hofkens, Johan/D-4284-2017	Deckmyn, Hans/0000-0003-3952-5501; Uji-i, Hiroshi/0000-0002-0463-9659; Rocha, Susana/0000-0003-1258-9396; Rocha, Susana/0000-0003-1258-9396; Deckmyn, Hans/0000-0003-3952-5501; Hofkens, Johan/0000-0002-9101-0567; De Meyer, Simon/0000-0002-1807-5882; Vanhoorelbeke, Karen/0000-0003-2288-8277; Sadler, J. Evan/0000-0001-5705-469X	European Research Council under the European Union's Seventh Framework Programme [291593 FLUOROCODE]; Flemish government [METH/08/04 CASAS]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen [G.0197.11, G0484.12, G.0299.06, G.0607.09, G.0402.09, G.0603.10]; KU Leuven Grants [GOA/04/09, GOA/11/003]; Hercules Foundation [HER/08/021]	European Research Council under the European Union's Seventh Framework Programme(European Research Council (ERC)); Flemish government(European Commission); Fonds voor Wetenschappelijk Onderzoek Vlaanderen(FWO); KU Leuven Grants; Hercules Foundation	This work was supported in part by grants from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement number 291593 FLUOROCODE), the Flemish government in the form of long-term structural "Methusalem" Grant METH/08/04 CASAS, "Fonds voor Wetenschappelijk Onderzoek Vlaanderen" Grants G.0197.11, G0484.12, G.0299.06, G.0607.09, G.0402.09, and G.0603.10, KU Leuven Grants GOA/04/09 and GOA/11/003, and Hercules Foundation Grant HER/08/021.	Andre P, 2000, BLOOD, V96, P3322, DOI 10.1182/blood.V96.10.3322.h8003322_3322_3328; Coffman VC, 2012, TRENDS BIOCHEM SCI, V37, P499, DOI 10.1016/j.tibs.2012.08.002; CRAMER EM, 1985, BLOOD, V66, P710; De Ceunynck K, 2013, BLOOD, V121, P270, DOI 10.1182/blood-2012-07-442285; De Ceunynck K, 2011, J BIOL CHEM, V286, P36361, DOI 10.1074/jbc.M111.271890; De Maeyer B, 2010, J THROMB HAEMOST, V8, P2305, DOI 10.1111/j.1538-7836.2010.04008.x; De Meyer SF, 2006, BLOOD, V107, P4728, DOI 10.1182/blood-2005-09-3605; De Meyer SF, 2009, BLOOD, V113, P5049, DOI 10.1182/blood-2008-10-165621; DENT JA, 1991, J CLIN INVEST, V88, P774, DOI 10.1172/JCI115376; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; Feys HB, 2009, J THROMB HAEMOST, V7, P2088, DOI 10.1111/j.1538-7836.2009.03620.x; Feys HB, 2006, J THROMB HAEMOST, V4, P955, DOI 10.1111/j.1538-7836.2006.01833.x; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; Gebhardt JCM, 2013, NAT METHODS, V10, P421, DOI [10.1038/nmeth.2411, 10.1038/NMETH.2411]; Huang J, 2009, BLOOD, V113, P1589, DOI 10.1182/blood-2008-05-158584; Leith JS, 2012, P NATL ACAD SCI USA, V109, P16552, DOI 10.1073/pnas.1120452109; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Lin Y, 2002, BLOOD, V99, P457, DOI 10.1182/blood.V99.2.457; MOAKE JL, 1982, NEW ENGL J MED, V307, P1432, DOI 10.1056/NEJM198212023072306; Motto DG, 2005, J CLIN INVEST, V115, P2752, DOI 10.1172/JCI26007; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Notelaers K, 2012, BBA-BIOMEMBRANES, V1818, P3131, DOI 10.1016/j.bbamem.2012.08.010; Quessada-Vial A, 2012, P NATL ACAD SCI USA, V109, P18243, DOI 10.1073/pnas.1215845109; Rocha S, 2009, CHEMPHYSCHEM, V10, P151, DOI 10.1002/cphc.200800537; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Saxton MJ, 2008, NAT METHODS, V5, P671, DOI 10.1038/nmeth0808-671; SPORN LA, 1986, CELL, V46, P185, DOI 10.1016/0092-8674(86)90735-X; Sutherland JJ, 2004, J MOL MODEL, V10, P259, DOI 10.1007/s00894-004-0194-9; Tafvizi A, 2011, P NATL ACAD SCI USA, V108, P563, DOI 10.1073/pnas.1016020107; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Tsai HM, 2010, INT J HEMATOL, V91, P1, DOI 10.1007/s12185-009-0476-1; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; Vale RD, 1996, NATURE, V380, P451, DOI 10.1038/380451a0; WEIBEL ER, 1964, J CELL BIOL, V23, P101, DOI 10.1083/jcb.23.1.101; Wu T, 2010, BLOOD, V115, P370, DOI 10.1182/blood-2009-03-210369; Ying JY, 2010, BIOPHYS J, V98, P1685, DOI 10.1016/j.bpj.2009.12.4324; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106; Zheng XL, 2001, J BIOL CHEM, V276, P41059, DOI 10.1074/jbc.C100515200	39	0	0	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8903	8915		10.1074/jbc.M113.535963	http://dx.doi.org/10.1074/jbc.M113.535963			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24550384	hybrid, Green Published			2022-12-28	WOS:000333472100015
J	Lee, MM; Nasirikenari, M; Manhardt, CT; Ashline, DJ; Hanneman, AJ; Reinhold, VN; Lau, JTY				Lee, Melissa M.; Nasirikenari, Mehrab; Manhardt, Charles T.; Ashline, David J.; Hanneman, Andrew J.; Reinhold, Vernon N.; Lau, Joseph T. Y.			Platelets Support Extracellular Sialylation by Supplying the Sugar Donor Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Surface; Glycosylation; Plasma; Platelets; Serum; Sialyltransferase	BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; SIALIC-ACID; SERUM GALACTOSYLTRANSFERASE; P1 PROMOTER; SIALYLTRANSFERASE; INFLAMMATION; LIVER; GLYCOSYLTRANSFERASES; MICE; MICROPARTICLES	Background: ST6Gal-1 sialyltransferase is a prominent circulatory glycosyltransferase whose function remained in question because an extracellular source of sugar donor substrate was unknown. Results: Extracellular ST6Gal-1 catalysis uses platelet-supplied sugar donors. Conclusion: Activated platelets release donor substrates to functionally drive extracellular glycosylation by soluble ST6Gal-1. Significance: Remodeling by extracellular glycosyltransferases may be an important mechanism to generate physiologically important glycans. Sizable pools of freely circulating glycosyltransferases are in blood, but understanding their physiologic contributions has been hampered because functional sources of sugar donor substrates needed to drive extracellular glycosylation have not been identified. The blood-borne ST6Gal-1 produced and secreted by the liver is the most noted among the circulatory glycosyltransferases, and decorates marrow hematopoietic progenitor cells with 2,6-linked sialic acids and restricts blood cell production. Platelets, upon activation, secrete a plethora of bioactive molecules including pro- and anti-inflammatory mediators. Cargos of sugar donor substrates for glycosyltransferase activity have also been reported in platelets. Here, we implemented a cell-based system to interrogate platelets for their ability to deliver effectively the sugar donor substrate for extracellular ST6Gal-1 to function. We report that thrombin-activated platelets, at physiologic concentration and pH, can efficiently and effectively substitute for CMP-sialic acid in extracellular ST6Gal-1-mediated sialylation of target cell surfaces. Activated platelets can also supply the sialic acid donor to sialylate the synthetic acceptor, Gal(1,4)GlcNAc-o-benzyl, with the product Sia(2,6)Gal(1,4)GlcNAc-o-benzyl structurally confirmed by LC/MS. Platelet-secreted donor substrate was recovered in the 100,000 x g sediment, strongly suggesting the association of this otherwise soluble substrate, putatively CMP-sialic acid, within platelet microparticles. Sequestration within microparticles may facilitate delivery of glycosylation substrate at effective dosages to sites of extracellular glycosylation while minimizing excessive dilution.	[Lee, Melissa M.; Nasirikenari, Mehrab; Manhardt, Charles T.; Lau, Joseph T. Y.] Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; [Lee, Melissa M.; Nasirikenari, Mehrab; Manhardt, Charles T.; Lau, Joseph T. Y.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; [Ashline, David J.; Hanneman, Andrew J.; Reinhold, Vernon N.] Univ New Hampshire, Glyc Ctr, Div Mol Cellular & Biomed Sci, Durham, NH 03824 USA	Roswell Park Cancer Institute; Roswell Park Cancer Institute; University System Of New Hampshire; University of New Hampshire	Lau, JTY (corresponding author), Roswell Pk Canc Inst, Dept Mol & Cellular Biol, MRC-330,Elm & Carlton St, Buffalo, NY 14263 USA.	joseph.lau@roswellpark.org		Lee-Sundlov, Melissa/0000-0002-8290-8586	National Institutes of Health [P01HL107146, R01AI056082]; NATIONAL CANCER INSTITUTE [P30CA016056] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL107146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL107146 and R01AI056082 (to J.T.Y.L.).	Appenheimer MM, 2003, GLYCOBIOLOGY, V13, P591, DOI 10.1093/glycob/cwg066; Ashline DJ, 2014, J AM SOC MASS SPECTR, V25, P444, DOI 10.1007/s13361-013-0776-9; Bambace NM, 2011, J THROMB HAEMOST, V9, P237, DOI 10.1111/j.1538-7836.2010.04131.x; BERNACKI RJ, 1977, SCIENCE, V195, P577, DOI 10.1126/science.835014; Coppinger JA, 2004, BLOOD, V103, P2096, DOI 10.1182/blood-2003-08-2804; Dalziel M, 1999, GLYCOBIOLOGY, V9, P1003, DOI 10.1093/glycob/9.10.1003; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; GESSNER P, 1993, CANCER LETT, V75, P143, DOI 10.1016/0304-3835(93)90056-F; Gong M, 2007, METABOLISM, V56, P1241, DOI 10.1016/j.metabol.2007.04.022; Hoffmeister KM, 2003, CELL, V112, P87, DOI 10.1016/S0092-8674(02)01253-9; HOFLACK B, 1979, BIOCHIM BIOPHYS ACTA, V568, P348, DOI 10.1016/0005-2744(79)90302-4; Huo YQ, 2004, TRENDS CARDIOVAS MED, V14, P18, DOI 10.1016/j.tcm.2003.09.007; IP C, 1978, CANCER RES, V38, P723; Italiano JE, 2010, CURR OPIN HEMATOL, V17, P578, DOI 10.1097/MOH.0b013e32833e77ee; JAMIESON JC, 1987, COMP BIOCHEM PHYS B, V87, P11, DOI 10.1016/0305-0491(87)90463-9; Kang P, 2005, RAPID COMMUN MASS SP, V19, P3421, DOI 10.1002/rcm.2210; KAPLAN HA, 1983, J BIOL CHEM, V258, P1505; KIM YS, 1972, J CLIN INVEST, V51, P2033, DOI 10.1172/JCI107009; Knijff-Dutmer EAJ, 2002, ARTHRITIS RHEUM-US, V46, P1498, DOI 10.1002/art.10312; Martin LT, 2002, J BIOL CHEM, V277, P32930, DOI 10.1074/jbc.M203362200; Nasirikenari M, 2006, BLOOD, V108, P3397, DOI 10.1182/blood-2006-04-014779; Nasirikenari M, 2014, J BIOL CHEM, V289, P7178, DOI 10.1074/jbc.M113.508457; Nasirikenari M, 2010, J LEUKOCYTE BIOL, V87, P457, DOI 10.1189/jlb.1108704; Ogura H, 2001, J TRAUMA, V50, P801, DOI 10.1097/00005373-200105000-00005; Poon TCW, 2005, WORLD J GASTROENTERO, V11, P6701, DOI 10.3748/wjg.v11.i42.6701; Schmitt-Sody M, 2007, PLATELETS, V18, P365, DOI 10.1080/09537100701191315; Secor D, 2010, INTENS CARE MED, V36, P1928, DOI 10.1007/s00134-010-1969-3; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; Sillanaukee P, 1999, ALCOHOL CLIN EXP RES, V23, P1039, DOI 10.1097/00000374-199906000-00011; Toma V, 2001, HISTOCHEM CELL BIOL, V116, P183; Ujita M, 1998, J BIOL CHEM, V273, P34843, DOI 10.1074/jbc.273.52.34843; Wandall HH, 2012, BLOOD, V120, P626, DOI 10.1182/blood-2012-02-409235; WANG XC, 1989, J BIOL CHEM, V264, P1854; WEISER MM, 1976, P NATL ACAD SCI USA, V73, P1319, DOI 10.1073/pnas.73.4.1319	35	43	45	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8742	8748		10.1074/jbc.C113.546713	http://dx.doi.org/10.1074/jbc.C113.546713			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24550397	hybrid, Green Published			2022-12-28	WOS:000333472100002
J	Bansaghi, S; Golenar, T; Madesh, M; Csordas, G; RamachandraRao, S; Sharma, K; Yule, DI; Joseph, SK; Hajnoczky, G				Bansaghi, Szava; Golenar, Tuende; Madesh, Muniswamy; Csordas, Gyoergy; RamachandraRao, Satish; Sharma, Kumar; Yule, David I.; Joseph, Suresh K.; Hajnoczky, Gyoergy			Isoform-and Species-specific Control of Inositol 1,4,5-Trisphosphate (IP3) Receptors by Reactive Oxygen Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Signaling; Endoplasmic Reticulum (ER); Inositol 1; 4; 5-Trisphosphate; Mitochondria; Reactive Oxygen Species (ROS); IP3 Receptor	PROTEIN S-GLUTATHIONYLATION; AORTIC ENDOTHELIAL-CELLS; ENDOPLASMIC-RETICULUM; RYANODINE RECEPTOR-TYPE-1; TRISPHOSPHATE RECEPTORS; CALCIUM OSCILLATIONS; MAMMALIAN-CELLS; MITOCHONDRIA; SUPEROXIDE; THIMEROSAL	Background: Reactive oxygen species (ROS) affect cytoplasmic calcium signaling. Results: Superoxide anion causes oxidation of the IP3 receptor and sensitization of calcium release to promote cytoplasmic calcium oscillations and mitochondrial calcium uptake. Conclusion: Physiologically relevant ROS controls cytoplasmic and mitochondrial calcium transport through IP3 receptors. Significance: Mechanisms of calcium and ROS interactions are relevant for both physiological and pathophysiological signaling. Reactive oxygen species (ROS) stimulate cytoplasmic [Ca2+] ([Ca2+](c)) signaling, but the exact role of the IP3 receptors (IP3R) in this process remains unclear. IP(3)Rs serve as a potential target of ROS produced by both ER and mitochondrial enzymes, which might locally expose IP(3)Rs at the ER-mitochondrial associations. Also, IP(3)Rs contain multiple reactive thiols, common molecular targets of ROS. Therefore, we have examined the effect of superoxide anion (O2) on IP3R-mediated Ca2+ signaling. In human HepG2, rat RBL-2H3, and chicken DT40 cells, we observed [Ca2+](c) spikes and frequency-modulated oscillations evoked by a O2 donor, xanthine (X) + xanthine oxidase (XO), dose-dependently. The [Ca2+](c) signal was mediated by ER Ca2+ mobilization. X+XO added to permeabilized cells promoted the [Ca2+](c) rise evoked by submaximal doses of IP3, indicating that O2 directly sensitizes IP3R-mediated Ca2+ release. In response to X+XO, DT40 cells lacking two of three IP3R isoforms (DKO) expressing either type 1 (DKO1) or type 2 IP(3)Rs (DKO2) showed a [Ca2+](c) signal, whereas DKO expressing type 3 IP3R (DKO3) did not. By contrast, IgM that stimulates IP3 formation, elicited a [Ca2+](c) signal in every DKO. X+XO also facilitated the Ca2+ release evoked by submaximal IP3 in permeabilized DKO1 and DKO2 but was ineffective in DKO3 or in DT40 lacking every IP3R (TKO). However, X+XO could also facilitate the effect of suboptimal IP3 in TKO transfected with rat IP(3)R3. Although in silico studies failed to identify a thiol missing in the chicken IP(3)R3, an X+XO-induced redox change was documented only in the rat IP(3)R3. Thus, ROS seem to specifically sensitize IP(3)Rs through a thiol group(s) within the IP3R, which is probably inaccessible in the chicken IP(3)R3.	[Bansaghi, Szava; Golenar, Tuende; Madesh, Muniswamy; Csordas, Gyoergy; Joseph, Suresh K.; Hajnoczky, Gyoergy] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, MitoCare Ctr, Philadelphia, PA 19107 USA; [RamachandraRao, Satish; Sharma, Kumar] Thomas Jefferson Univ, Dept Med, Ctr Novel Therapies Kidney Dis, Philadelphia, PA 19107 USA; [Yule, David I.] Univ Rochester, Med Ctr, Dept Physiol & Pharmacol, Rochester, NY 14642 USA	Jefferson University; Jefferson University; University of Rochester	Hajnoczky, G (corresponding author), JAH Thomas Jefferson Univ, MitoCare Ctr, Ste 527, Philadelphia, PA 19107 USA.	gyorgy.hajnoczky@jefferson.edu	Bansaghi, Szava/J-2664-2018	Csordas, Gyorgy/0000-0003-3156-1460	National Institutes of Health [GM059419, DK34804, DK053867]; Hungarian American Enterprise Scholarship Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK094352, R01DK034804, R01DK053867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hungarian American Enterprise Scholarship Fund; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM059419 (to G. H.), DK34804 (to S. K. J.), and DK053867 (to K. S.).r Supported by an international research fellowship from the Hungarian American Enterprise Scholarship Fund.	Akerboom J, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00002; Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Betzenhauser MJ, 2010, CURR TOP MEMBR, V66, P273, DOI 10.1016/S1063-5823(10)66012-7; Betzenhauser MJ, 2008, METHODS, V46, P177, DOI 10.1016/j.ymeth.2008.09.014; BIRD GS, 1993, J BIOL CHEM, V268, P17917; BOOTMAN MD, 1992, J BIOL CHEM, V267, P25113; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Brown GC, 2012, MITOCHONDRION, V12, P1, DOI 10.1016/j.mito.2011.02.001; Bultynck G, 2004, BIOCHEM J, V381, P87, DOI 10.1042/BJ20040072; Csordas G, 2001, CELL CALCIUM, V29, P249, DOI 10.1054/ceca.2000.0191; Csordas G, 1999, EMBO J, V18, P96, DOI 10.1093/emboj/18.1.96; Csordas G, 2013, CELL METAB, V17, P976, DOI 10.1016/j.cmet.2013.04.020; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Donoso P, 2011, FRONT BIOSCI-LANDMRK, V16, P553, DOI 10.2741/3705; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Enyedi B, 2010, ANTIOXID REDOX SIGN, V13, P721, DOI 10.1089/ars.2009.2880; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; Hajnoczky G, 1997, EMBO J, V16, P3533, DOI 10.1093/emboj/16.12.3533; Hawkins BJ, 2007, MOL BIOL CELL, V18, P2002, DOI 10.1091/mbc.E06-09-0830; Higo T, 2005, CELL, V120, P85, DOI 10.1016/j.cell.2004.11.048; JOSEPH SK, 1995, J BIOL CHEM, V270, P23310, DOI 10.1074/jbc.270.40.23310; Joseph SK, 2010, CURR TOP MEMBR, V66, P299, DOI 10.1016/S1063-5823(10)66013-9; Khan SA, 2013, BIOCHEM J, V451, P177, DOI 10.1042/BJ20121600; Leichert LI, 2004, PLOS BIOL, V2, P1723, DOI 10.1371/journal.pbio.0020333; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Lock JT, 2012, J PHYSIOL-LONDON, V590, P3431, DOI [10.1113/jphysiol.2012.230656, 10.1113/jphysiol.2012.232645]; Lock JT, 2011, AM J PHYSIOL-HEART C, V300, pH493, DOI 10.1152/ajpheart.01073.2010; Madesh M, 2005, J CELL BIOL, V170, P1079, DOI 10.1083/jcb.200505022; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Malcuit C, 2006, J CELL PHYSIOL, V206, P565, DOI 10.1002/jcp.20471; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Mendes CCP, 2005, J BIOL CHEM, V280, P40892, DOI 10.1074/jbc.M506623200; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; Mikoshiba K, 2007, J NEUROCHEM, V102, P1426, DOI 10.1111/j.1471-4159.2007.04825.x; Pacher P, 2008, AM J PHYSIOL-RENAL, V295, pF1303, DOI 10.1152/ajprenal.90343.2008; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Petrotchenko EV, 2011, RES REP BIOL, V2, P13, DOI 10.2147/RRB.S15776; Prosser BL, 2013, J MOL CELL CARDIOL, V58, P172, DOI 10.1016/j.yjmcc.2012.11.011; Redondo PC, 2004, BIOCHEM PHARMACOL, V67, P491, DOI 10.1016/j.bcp.2003.09.031; Sanderson Michael J, 2008, Proc Am Thorac Soc, V5, P23, DOI 10.1513/pats.200704-050VS; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; Vanderheyden V, 2009, BBA-MOL CELL RES, V1793, P959, DOI 10.1016/j.bbamcr.2008.12.003; Voss AA, 2004, J BIOL CHEM, V279, P34514, DOI 10.1074/jbc.M404290200; WOJCIKIEWICZ RJH, 1995, BIOCHEM BIOPH RES CO, V213, P334, DOI 10.1006/bbrc.1995.2134; Zheng Y, 2005, REDOX REP, V10, P29, DOI 10.1179/135100005X21660	50	117	118	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8170	8181		10.1074/jbc.M113.504159	http://dx.doi.org/10.1074/jbc.M113.504159			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24469450	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000333157500013
J	Esteve, PO; Terragni, J; Deepti, K; Chin, HG; Dai, N; Espejo, A; Correa, IR; Bedford, MT; Pradhan, S				Esteve, Pierre-Olivier; Terragni, Jolyon; Deepti, Kanneganti; Chin, Hang Gyeong; Dai, Nan; Espejo, Alexsandra; Correa, Ivan R., Jr.; Bedford, Mark T.; Pradhan, Sriharsa			Methyllysine Reader Plant Homeodomain ( PHD) Finger Protein 20-like 1 ( PHF20L1) Antagonizes DNA ( Cytosine-5) Methyltransferase 1 ( DNMT1) Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-binding Protein; DNA Methylation; DNA Methyltransferase; Protein Degradation; Protein Methylation; MBT Domain; PHF20L1; SET7; UNC1215	RIBOSOMAL-RNA GENES; LYSINE METHYLATION; MAMMALIAN-CELLS; HISTONE H3; DE-NOVO; MAINTENANCE; STABILITY; DOMAIN; UBIQUITINATION; ESTABLISHMENT	Background: SET7 monomethylates DNMT1, promoting its proteasomal degradation, yet methylated DNMT1 still remains throughout the cell cycle. Results: The methyllysine reader PHF20L1 stabilizes methylated DNMT1. Disruption of PHF20L1 induces DNMT1 degradation and genome hypomethylation. Conclusion: PHF20L1, an epigenetic reader, cooperates with writer and eraser to regulate epigenetic inheritance. Significance: PHF20L1 can be targeted as a means of regulating DNMT1 activity and DNA methylation in cells. Inheritance of DNA cytosine methylation pattern during successive cell division is mediated by maintenance DNA (cytosine-5) methyltransferase 1 (DNMT1). Lysine 142 of DNMT1 is methylated by the SET domain containing lysine methyltransferase 7 (SET7), leading to its degradation by proteasome. Here we show that PHD finger protein 20-like 1 (PHF20L1) regulates DNMT1 turnover in mammalian cells. Malignant brain tumor (MBT) domain of PHF20L1 binds to monomethylated lysine 142 on DNMT1 (DNMT1K142me1) and colocalizes at the perinucleolar space in a SET7-dependent manner. PHF20L1 knockdown by siRNA resulted in decreased amounts of DNMT1 on chromatin. Ubiquitination of DNMT1K142me1 was abolished by overexpression of PHF20L1, suggesting that its binding may block proteasomal degradation of DNMT1K142me1. Conversely, siRNA-mediated knockdown of PHF20L1 or incubation of a small molecule MBT domain binding inhibitor in cultured cells accelerated the proteasomal degradation of DNMT1. These results demonstrate that the MBT domain of PHF20L1 reads and controls enzyme levels of methylated DNMT1 in cells, thus representing a novel antagonist of DNMT1 degradation.	[Esteve, Pierre-Olivier; Terragni, Jolyon; Deepti, Kanneganti; Chin, Hang Gyeong; Dai, Nan; Correa, Ivan R., Jr.; Pradhan, Sriharsa] New England Biolabs Inc, Ipswich, MA 01938 USA; [Espejo, Alexsandra; Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA	New England Biolabs; University of Texas System; UTMD Anderson Cancer Center	Pradhan, S (corresponding author), New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA.	pradhan@neb.com	Kalra, D/H-6661-2019; Dai, Nan/I-5950-2013	Kalra, D/0000-0001-5254-4067; Espejo, Alexsandra/0000-0002-8841-7219; Correa, Ivan/0000-0002-3169-6878	New England Biolabs, Inc.; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES023206] Funding Source: NIH RePORTER	New England Biolabs, Inc.; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Dr. Richard J. Roberts, Dr. William Jack, James V. Ellard, Dr. Donald G. Comb, and New England Biolabs, Inc., for research support.	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; BESTOR TH, 1985, P NATL ACAD SCI USA, V82, P2674, DOI 10.1073/pnas.82.9.2674; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Bonasio R, 2010, SEMIN CELL DEV BIOL, V21, P221, DOI 10.1016/j.semcdb.2009.09.010; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Chen T, 2006, CURR TOP MICROBIOL, V301, P179; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Citterio E, 2004, MOL CELL BIOL, V24, P2526, DOI 10.1128/MCB.24.6.2526-2535.2004; Cui GF, 2012, NAT STRUCT MOL BIOL, V19, P916, DOI 10.1038/nsmb.2353; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Ehrlich M, 2006, CURR TOP MICROBIOL, V310, P251; Espada J, 2007, NUCLEIC ACIDS RES, V35, P2191, DOI 10.1093/nar/gkm118; Espejo A, 2002, BIOCHEM J, V367, P697, DOI 10.1042/BJ20020860; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Esteve PO, 2011, NAT STRUCT MOL BIOL, V18, P42, DOI 10.1038/nsmb.1939; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Fortschegger K, 2011, EPIGENETICS-US, V6, P4, DOI 10.4161/epi.6.1.13297; Ghoshal K, 2005, MOL CELL BIOL, V25, P4727, DOI 10.1128/MCB.25.11.4727-4741.2005; Guan D, 2013, ONCOGENE, V32, P3819, DOI 10.1038/onc.2012.406; James LI, 2013, NAT CHEM BIOL, V9, P184, DOI [10.1038/NCHEMBIO.1157, 10.1038/nchembio.1157]; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Karpf AR, 2005, CANCER RES, V65, P8635, DOI 10.1158/0008-5472.CAN-05-1961; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kim JK, 2009, CELL MOL LIFE SCI, V66, P596, DOI 10.1007/s00018-008-8432-4; Kinney SRM, 2011, PROG MOL BIOL TRANSL, V101, P311, DOI 10.1016/B978-0-12-387685-0.00009-3; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LEONHARDT H, 1992, CELL, V71, P865, DOI 10.1016/0092-8674(92)90561-P; LI LH, 1970, CANCER RES, V30, P2760; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Nady N, 2012, J MOL BIOL, V423, P702, DOI 10.1016/j.jmb.2012.08.022; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Pradhan S, 2002, EMBO J, V21, P779, DOI 10.1093/emboj/21.4.779; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; Stresemann C, 2006, CANCER RES, V66, P2794, DOI 10.1158/0008-5472.CAN-05-2821; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yang XD, 2009, EPIGENETICS-US, V4, P429, DOI 10.4161/epi.4.7.9787; Zhang LF, 2007, CELL, V129, P693, DOI 10.1016/j.cell.2007.03.036	43	33	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8277	8287		10.1074/jbc.M113.525279	http://dx.doi.org/10.1074/jbc.M113.525279			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24492612	Green Published, hybrid			2022-12-28	WOS:000333157500022
J	Kobe, MJ; Neau, DB; Mitchell, CE; Bartlett, SG; Newcomer, ME				Kobe, Matthew J.; Neau, David B.; Mitchell, Caitlin E.; Bartlett, Sue G.; Newcomer, Marcia E.			The Structure of Human 15-Lipoxygenase-2 with a Substrate Mimic	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Atherosclerosis; Eicosanoid-specific Enzymes; Fatty Acid Oxidation; Lipoxygenase Pathway; Protein Structure	INDUCED ATHEROSCLEROSIS; LIPOXYGENASE; MACROPHAGES; DOMAIN; 15S-LIPOXYGENASE; OXYGENATION; EXPRESSION; MEDIATORS; NANODISCS; SUGGESTS	Background: 15-Lipoxygenase-2 is linked to atherosclerotic plaque formation; the homologous enzyme 5-lipoxygenase initiates the synthesis of proinflammatory leukotrienes. Results: We determined the crystal structure of 15-LOX-2 in the presence of a substrate mimic. Conclusion: 15-Lipoxygenase-2 and 5-lipoxgenase display active site variations that confer distinct product specificities. Significance: These differences can be exploited for the design of isoform-specific anti-inflammatories. Atherosclerosis is associated with chronic inflammation occurring over decades. The enzyme 15-lipoxygenase-2 (15-LOX-2) is highly expressed in large atherosclerotic plaques, and its activity has been linked to the progression of macrophages to the lipid-laden foam cells present in atherosclerotic plaques. We report here the crystal structure of human 15-LOX-2 in complex with an inhibitor that appears to bind as a substrate mimic. 15-LOX-2 contains a long loop, composed of hydrophobic amino acids, which projects from the amino-terminal membrane-binding domain. The loop is flanked by two Ca2+-binding sites that confer Ca2+-dependent membrane binding. A comparison of the human 15-LOX-2 and 5-LOX structures reveals similarities at the active sites, as well striking differences that can be exploited for design of isoform-selective inhibitors.	[Kobe, Matthew J.; Mitchell, Caitlin E.; Bartlett, Sue G.; Newcomer, Marcia E.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Neau, David B.] Argonne Natl Lab, Northeastern Collaborat Access Team, Argonne, IL 60439 USA	Louisiana State University System; Louisiana State University; United States Department of Energy (DOE); Argonne National Laboratory	Newcomer, ME (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	newcomer@lsu.edu			Louisiana Governors' Biotechnology Initiative; Beam Line 24-ID-E of Northeastern Collaborative Access Team's at the Advanced Photon Source; NIGMS at the National Institutes of Health. Use of the Advanced Photon Source; U.S. DOE [DE-AC02-06CH11357]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	Louisiana Governors' Biotechnology Initiative; Beam Line 24-ID-E of Northeastern Collaborative Access Team's at the Advanced Photon Source; NIGMS at the National Institutes of Health. Use of the Advanced Photon Source; U.S. DOE(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Alan Brash for helpful discussions throughout the course of this work. X-ray data were collected at the Center for Advanced Microstructures and Devices (Baton Rouge), funded in part by the Louisiana Governors' Biotechnology Initiative, and at Beam Line 24-ID-E of Northeastern Collaborative Access Team's at the Advanced Photon Source, supported by award P41 GM103403 from the NIGMS at the National Institutes of Health. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract No. DE-AC02-06CH11357.	Bazan NG, 2011, MOL NEUROBIOL, V44, P216, DOI 10.1007/s12035-011-8200-6; Bocan TMA, 1998, ATHEROSCLEROSIS, V136, P203, DOI 10.1016/S0021-9150(97)00204-9; Boldog T, 2007, METHOD ENZYMOL, V423, P317, DOI 10.1016/S0076-6879(07)23014-9; BOYINGTON JC, 1993, SCIENCE, V260, P1482, DOI 10.1126/science.8502991; Brash AR, 1997, P NATL ACAD SCI USA, V94, P6148, DOI 10.1073/pnas.94.12.6148; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Choi J, 2008, PROTEINS, V70, P1023, DOI 10.1002/prot.21590; Cleland W W, 1979, Methods Enzymol, V63, P103; Coffa G, 2004, P NATL ACAD SCI US; Danielsson KN, 2008, ATHEROSCLEROSIS, V199, P34, DOI 10.1016/j.atherosclerosis.2007.10.027; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Eek P, 2012, J BIOL CHEM, V287, P22377, DOI 10.1074/jbc.M112.343285; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Funk CD, 2006, ARTERIOSCL THROM VAS, V26, P1204, DOI 10.1161/01.ATV.0000222960.43792.ff; Funk CD, 2002, PROSTAG OTH LIPID M, V68-9, P303, DOI 10.1016/S0090-6980(02)00036-9; Gertow K, 2011, ATHEROSCLEROSIS, V215, P411, DOI 10.1016/j.atherosclerosis.2011.01.015; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Hammarberg T, 2000, J BIOL CHEM, V275, P38787, DOI 10.1074/jbc.M006136200; Harats D, 2000, ARTERIOSCL THROM VAS, V20, P2100, DOI 10.1161/01.ATV.20.9.2100; Hulten LM, 2010, EUR J CLIN INVEST, V40, P11, DOI 10.1111/j.1365-2362.2009.02223.x; Hutchins PM, 2012, J LIPID RES, V53, P1588, DOI 10.1194/jlr.M026799; Jisaka M, 2000, J BIOL CHEM, V275, P1287, DOI 10.1074/jbc.275.2.1287; Kilty I, 1999, EUR J BIOCHEM, V266, P83, DOI 10.1046/j.1432-1327.1999.00818.x; Knapp MJ, 2001, J AM CHEM SOC, V123, P2931, DOI 10.1021/ja003855k; Kotla S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004214; Kulkarni S, 2002, J BIOL CHEM, V277, P13167, DOI 10.1074/jbc.M112393200; Magnusson LU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043142; Murphy RC, 2007, BIOCHEM J, V405, P379, DOI 10.1042/BJ20070289; Neau DB, 2009, BIOCHEMISTRY-US, V48, P7906, DOI 10.1021/bi900084m; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Sendobry SM, 1997, BRIT J PHARMACOL, V120, P1199, DOI 10.1038/sj.bjp.0701007; Wuest SJA, 2012, ATHEROSCLEROSIS, V225, P121, DOI 10.1016/j.atherosclerosis.2012.07.022; Xu S, 2012, STRUCTURE, V20, P1490, DOI 10.1016/j.str.2012.06.003; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	35	74	76	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8562	8569		10.1074/jbc.M113.543777	http://dx.doi.org/10.1074/jbc.M113.543777			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24497644	Green Published, hybrid			2022-12-28	WOS:000333157500046
J	Mavridou, DAI; Saridakis, E; Kritsiligkou, P; Mozley, EC; Ferguson, SJ; Redfield, C				Mavridou, Despoina A. I.; Saridakis, Emmanuel; Kritsiligkou, Paraskevi; Mozley, Erin C.; Ferguson, Stuart J.; Redfield, Christina			An Extended Active-site Motif Controls the Reactivity of the Thioredoxin Fold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NMR; Oxidase; Reductase; Thioredoxin; X-ray Crystallography; DsbD; Electrostatics; pKa Values; Thiol-Disulfide Exchange; Thioredoxin Fold	DISULFIDE BOND FORMATION; ESCHERICHIA-COLI THIOREDOXIN; TRANSMEMBRANE ELECTRON-TRANSFER; CYTOCHROME-C MATURATION; N-TERMINAL DOMAIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CYSTEINE RESIDUES; PERIPLASMIC PROTEIN; REDOX POTENTIALS	Background: Proteins with a thioredoxin (Trx) fold share several structural features but carry out different reactions. Results: The contribution of the electrostatic environment of the active site to the reactivity of Trx-fold proteins is described. Conclusion: Function and reactivity of the Trx fold depend on an extended active-site motif. Significance: These results are expected to assist with functional prediction for Trx-fold proteins. Proteins belonging to the thioredoxin (Trx) superfamily are abundant in all organisms. They share the same structural features, arranged in a seemingly simple fold, but they perform a multitude of functions in oxidative protein folding and electron transfer pathways. We use the C-terminal domain of the unique transmembrane reductant conductor DsbD as a model for an in-depth analysis of the factors controlling the reactivity of the Trx fold. We employ NMR spectroscopy, x-ray crystallography, mutagenesis, in vivo functional experiments applied to DsbD, and a comparative sequence analysis of Trx-fold proteins to determine the effect of residues in the vicinity of the active site on the ionization of the key nucleophilic cysteine of the -CXXC- motif. We show that the function and reactivity of Trx-fold proteins depend critically on the electrostatic features imposed by an extended active-site motif.	[Mavridou, Despoina A. I.; Kritsiligkou, Paraskevi; Mozley, Erin C.; Ferguson, Stuart J.; Redfield, Christina] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Saridakis, Emmanuel] NCSR Demokritos, Dept Phys Chem, Athens 15310, Greece	University of Oxford; National Centre of Scientific Research "Demokritos"	Mavridou, DAI (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	despoina.mavridou@bioch.ox.ac.uk; christina.redfield@bioch.ox.ac.uk	Mavridou, Despoina/ABG-5940-2020; Kritsiligkou, Paraskevi/W-9399-2019	Mavridou, Despoina/0000-0002-7449-1151; Kritsiligkou, Paraskevi/0000-0003-2452-141X; Emmett, Erin/0000-0003-4575-6760; Redfield, Christina/0000-0001-7297-7708	Wellcome Trust [079440, 092532]; Value-in-People Award; Gustav Born Trust; E.P.A. Cephalosporin Fund; Nuffield Foundation [URB/36783]	Wellcome Trust(Wellcome TrustEuropean Commission); Value-in-People Award; Gustav Born Trust; E.P.A. Cephalosporin Fund; Nuffield Foundation	This work was supported in part by Wellcome Trust Grants 079440 and 092532 and a Value-in-People Award.; Recipient of funding from the Gustav Born Trust and the E.P.A. Cephalosporin Fund. To whom correspondence may be addressed. Tel.: 44-1865-613313; E-mail: despoina.mavridou@bioch.ox.ac.uk.; Recipient of Science Bursary Grant URB/36783 from The Nuffield Foundation.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aslund F, 1997, J BIOL CHEM, V272, P30780, DOI 10.1074/jbc.272.49.30780; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; Buchanan BB, 2012, BBA-GEN SUBJECTS, V1820, P1822, DOI 10.1016/j.bbagen.2012.07.006; Bushnell KMW, 2002, J BIOMOL NMR, V24, P359, DOI 10.1023/A:1021638313691; Calvin M., 1954, GLUTATHIONE, P3; Chayen NE, 1999, J CRYST GROWTH, V196, P434, DOI 10.1016/S0022-0248(98)00837-9; Cheng ZY, 2007, BIOCHEMISTRY-US, V46, P7875, DOI 10.1021/bi700442r; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P14985, DOI 10.1021/bi970071j; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P4061, DOI 10.1021/bi9628580; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P15810, DOI 10.1021/bi971504l; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; CROOKE H, 1995, MOL MICROBIOL, V15, P1139, DOI 10.1111/j.1365-2958.1995.tb02287.x; Crow A, 2004, J BIOL CHEM, V279, P23654, DOI 10.1074/jbc.M402823200; Crow A, 2009, J BIOL CHEM, V284, P23719, DOI 10.1074/jbc.M109.005785; Crow A, 2009, J BIOL CHEM, V284, P10056, DOI 10.1074/jbc.M809566200; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L, PYMOL MOL GRAPHICS S; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; DYSON HJ, 1991, BIOCHEMISTRY-US, V30, P4262, DOI 10.1021/bi00231a023; Dyson HJ, 1997, BIOCHEMISTRY-US, V36, P2622, DOI 10.1021/bi961801a; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erlendsson LS, 2004, J BACTERIOL, V186, P6230, DOI 10.1128/JB.186.18.6230-6238.2004; Erlendsson LS, 2002, J BACTERIOL, V184, P1423, DOI 10.1128/JB.184.5.1423-1429.2002; Fernandes PA, 2004, CHEM-EUR J, V10, P257, DOI 10.1002/chem.200305343; FORMANKAY JD, 1992, BIOCHEMISTRY-US, V31, P3442, DOI 10.1021/bi00128a019; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; Goddard AD, 2010, J BIOL CHEM, V285, P22880, DOI 10.1074/jbc.M110.133421; GOODHEW CF, 1986, BIOCHIM BIOPHYS ACTA, V852, P288, DOI 10.1016/0005-2728(86)90234-3; Gordon EHJ, 2000, MOL MICROBIOL, V35, P1360, DOI 10.1046/j.1365-2958.2000.01796.x; Goulding CW, 2002, BIOCHEMISTRY-US, V41, P6920, DOI 10.1021/bi016038l; GRAUSCHOPF U, 1995, CELL, V83, P947, DOI 10.1016/0092-8674(95)90210-4; Guddat LW, 1998, STRUCT FOLD DES, V6, P757, DOI 10.1016/S0969-2126(98)00077-X; Haebel PW, 2002, EMBO J, V21, P4774, DOI 10.1093/emboj/cdf489; Hansen RE, 2005, BIOCHEMISTRY-US, V44, P5899, DOI 10.1021/bi0500372; Harris TK, 2002, IUBMB LIFE, V53, P85, DOI 10.1080/15216540211468; Heras B, 2004, P NATL ACAD SCI USA, V101, P8876, DOI 10.1073/pnas.0402769101; Heras B, 2007, CURR OPIN STRUC BIOL, V17, P691, DOI 10.1016/j.sbi.2007.08.009; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Karala AR, 2010, J MOL BIOL, V396, P883, DOI 10.1016/j.jmb.2009.12.014; KATTI SK, 1990, J MOL BIOL, V212, P167, DOI 10.1016/0022-2836(90)90313-B; Katzen F, 2000, CELL, V103, P769, DOI 10.1016/S0092-8674(00)00180-X; Kim JH, 2003, FEBS LETT, V543, P164, DOI 10.1016/S0014-5793(03)00434-4; Kouwen TRHM, 2007, MOL MICROBIOL, V64, P984, DOI 10.1111/j.1365-2958.2007.05707.x; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Lewin A, 2006, J BIOL CHEM, V281, P35467, DOI 10.1074/jbc.M607047200; Li Q, 2001, BIOCHEM BIOPH RES CO, V283, P849, DOI 10.1006/bbrc.2001.4876; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Mavridou DAI, 2007, J MOL BIOL, V370, P643, DOI 10.1016/j.jmb.2007.04.038; Mavridou DAI, 2012, BIOMOL NMR ASSIGN, V6, P163, DOI 10.1007/s12104-011-9347-9; Mavridou DAI, 2011, J BIOL CHEM, V286, P24943, DOI 10.1074/jbc.M111.236141; Mavridou DAI, 2009, J BIOL CHEM, V284, P3219, DOI 10.1074/jbc.M805963200; McCarthy AA, 2000, NAT STRUCT BIOL, V7, P196; MISSIAKAS D, 1994, EMBO J, V13, P2013, DOI 10.1002/j.1460-2075.1994.tb06471.x; Moutevelis E, 2004, PROTEIN SCI, V13, P2744, DOI 10.1110/ps.04804504; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouyang N, 2006, PROTEINS, V65, P1021, DOI 10.1002/prot.21184; Qin J, 1996, BIOCHEMISTRY-US, V35, P7, DOI 10.1021/bi952299h; QIN J, 1994, STRUCTURE, V2, P503, DOI 10.1016/S0969-2126(00)00051-4; Reid E, 2001, BIOCHEM J, V355, P51, DOI 10.1042/0264-6021:3550051; Roos G, 2013, ANTIOXID REDOX SIGN, V18, P94, DOI 10.1089/ars.2012.4521; Rozhkova A, 2004, EMBO J, V23, P1709, DOI 10.1038/sj.emboj.7600178; SHAKED Z, 1980, BIOCHEMISTRY-US, V19, P4156, DOI 10.1021/bi00559a004; SHEVCHIK VE, 1994, EMBO J, V13, P2007, DOI 10.1002/j.1460-2075.1994.tb06470.x; SHRAGER RI, 1972, BIOCHEMISTRY-US, V11, P541, DOI 10.1021/bi00754a010; Stevens JM, 2004, FEBS LETT, V576, P81, DOI 10.1016/j.febslet.2004.08.067; Stevens JM, 2011, FEBS J, V278, P4170, DOI 10.1111/j.1742-4658.2011.08376.x; Stewart EJ, 1998, EMBO J, V17, P5543, DOI 10.1093/emboj/17.19.5543; Stirnimann CU, 2006, CELL MOL LIFE SCI, V63, P1642, DOI 10.1007/s00018-006-6055-1; Stirnimann CU, 2006, J MOL BIOL, V358, P829, DOI 10.1016/j.jmb.2006.02.030; Stirnimann CU, 2005, STRUCTURE, V13, P985, DOI 10.1016/j.str.2005.04.014; Thurlkill RL, 2006, PROTEIN SCI, V15, P1214, DOI 10.1110/ps.051840806; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang C, 2012, J BIOL CHEM, V287, P1139, DOI 10.1074/jbc.M111.303149; Waschutza G, 1996, PROTEIN ENG, V9, P905, DOI 10.1093/protein/9.10.905; WETZEL R, 1988, P NATL ACAD SCI USA, V85, P401, DOI 10.1073/pnas.85.2.401	83	6	6	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8681	8696		10.1074/jbc.M113.513457	http://dx.doi.org/10.1074/jbc.M113.513457			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24469455	Green Published, hybrid			2022-12-28	WOS:000333157500057
J	Perrett, RM; Voliotis, M; Armstrong, SP; Fowkes, RC; Pope, GR; Tsaneva-Atanasova, K; McArdle, CA				Perrett, Rebecca M.; Voliotis, Margaritis; Armstrong, Stephen P.; Fowkes, Robert C.; Pope, George R.; Tsaneva-Atanasova, Krasimira; McArdle, Craig A.			Pulsatile Hormonal Signaling to Extracellular Signal-regulated Kinase EXPLORING SYSTEM SENSITIVITY TO GONADOTROPIN-RELEASING HORMONE PULSE FREQUENCY AND WIDTH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; ERK; MAP Kinases (MAPKs); Mathematical Modeling; Receptors; GnRH	ACTIVATED PROTEIN-KINASE; DIFFERENTIAL REGULATION; SPATIOTEMPORAL REGULATION; ELECTRICAL-ACTIVITY; SUBUNIT GENES; RECEPTOR; GNRH; PITUITARY; DURATION; CALCIUM	Background: Cellular decoding of stimulus dynamics is poorly understood. Results: GnRH pulses activate ERK, and response kinetics determine sensitivity to different pulse features. Conclusion: The system is sensitive to pulse frequency but robust to width; this distinction develops through the cascade and is dictated by response kinetics. Significance: We describe mathematical and biochemical design features for pulsatile hormonal signaling. Gonadotropin-releasing hormone (GnRH) is secreted in brief pulses that stimulate synthesis and secretion of pituitary gonadotropin hormones and thereby mediate control of reproduction. It acts via G-protein-coupled receptors to stimulate effectors, including ERK. Information could be encoded in GnRH pulse frequency, width, amplitude, or other features of pulse shape, but the relative importance of these features is unknown. Here we examine this using automated fluorescence microscopy and mathematical modeling, focusing on ERK signaling. The simplest scenario is one in which the system is linear, and response dynamics are relatively fast (compared with the signal dynamics). In this case integrated system output (ERK activation or ERK-driven transcription) will be roughly proportional to integrated input, but we find that this is not the case. Notably, we find that relatively slow response kinetics lead to ERK activity beyond the GnRH pulse, and this reduces sensitivity to pulse width. More generally, we show that the slowing of response kinetics through the signaling cascade creates a system that is robust to pulse width. We, therefore, show how various levels of response kinetics synergize to dictate system sensitivity to different features of pulsatile hormone input. We reveal the mathematical and biochemical basis of a dynamic GnRH signaling system that is robust to changes in pulse amplitude and width but is sensitive to changes in receptor occupancy and frequency, precisely the features that are tightly regulated and exploited to exert physiological control in vivo.	[Perrett, Rebecca M.; Armstrong, Stephen P.; Pope, George R.; McArdle, Craig A.] Univ Bristol, Sch Clin Sci, Labs Integrat Neurosci & Endocrinol, Bristol BS1 3NY, Avon, England; [Voliotis, Margaritis] Univ Bristol, Sch Math, Bristol BS8 1TW, Avon, England; [Fowkes, Robert C.] Univ London Royal Vet Coll, Endocrine Signaling Grp, London NW1 0TU, England; [Tsaneva-Atanasova, Krasimira] Univ Exeter, Coll Engn Math & Phys Sci, Dept Math, Exeter EX4 4QF, Devon, England	University of Bristol; University of Bristol; University of London; University of London Royal Veterinary College; University of Exeter	McArdle, CA (corresponding author), Univ Bristol, Sch Clin Sci, Labs Integrat Neurosci & Endocrinol, Bristol BS1 3NY, Avon, England.	craig.mcardle@bristol.ac.uk	Tsaneva-Atanasova, Krasimira T/AAG-6766-2019; Fowkes, Robert/HHT-0664-2022; Fowkes, Robert/AAI-4756-2020; McArdle, Craig/AAQ-5660-2021	Tsaneva-Atanasova, Krasimira T/0000-0002-6294-7051; Fowkes, Robert/0000-0002-2222-2056; McArdle, Craig/0000-0003-4836-5351; Voliotis, Margaritis/0000-0001-6488-7198	Medical Research Council [G0901763]; Biochemical and Biophysical Science Research Council [BB/J014699/1]; Medical Research Council Biomedical Informatics Fellowship [MR/K021826/1]; BBSRC [BB/J014699/1] Funding Source: UKRI; MRC [G0901763, MR/K021826/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J014699/1] Funding Source: researchfish; Medical Research Council [MR/K021826/1] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biochemical and Biophysical Science Research Council; Medical Research Council Biomedical Informatics Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council Grant G0901763 and Biochemical and Biophysical Science Research Council Grant BB/J014699/1.; Recipient of a Medical Research Council Biomedical Informatics Fellowship (MR/K021826/1).	Armstrong SP, 2011, MOL CELL ENDOCRINOL, V331, P194, DOI 10.1016/j.mce.2010.07.008; Armstrong SP, 2010, J BIOL CHEM, V285, P24360, DOI 10.1074/jbc.M110.115964; Armstrong SP, 2009, J BIOL CHEM, V284, P35746, DOI 10.1074/jbc.M109.063917; Armstrong SP, 2009, MOL ENDOCRINOL, V23, P510, DOI 10.1210/me.2008-0333; BARRELL GK, 1992, BIOL REPROD, V46, P1130, DOI 10.1095/biolreprod46.6.1130; Bedecarrats GY, 2003, ENDOCRINOLOGY, V144, P1802, DOI 10.1210/en.2002-221140; BELCHETZ PE, 1978, SCIENCE, V202, P631, DOI 10.1126/science.100883; Bliss SP, 2010, FRONT NEUROENDOCRIN, V31, P322, DOI 10.1016/j.yfrne.2010.04.002; Bliss SP, 2009, MOL ENDOCRINOL, V23, P1092, DOI 10.1210/me.2009-0030; Burger LL, 2004, J MOL ENDOCRINOL, V33, P559, DOI 10.1677/jme.1.01600; CARDENAS H, 1993, P NATL ACAD SCI USA, V90, P9630, DOI 10.1073/pnas.90.20.9630; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Caunt CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040077; Caunt CJ, 2006, TRENDS ENDOCRIN MET, V17, P308, DOI 10.1016/j.tem.2006.08.001; Chuderland D, 2008, J BIOL CHEM, V283, P11176, DOI 10.1074/jbc.M709030200; Ciccone NA, 2010, MOL CELL BIOL, V30, P1028, DOI 10.1128/MCB.00848-09; CLAYTON RN, 1981, ENDOCR REV, V2, P186, DOI 10.1210/edrv-2-2-186; Crowley W F Jr, 1985, Recent Prog Horm Res, V41, P473; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; Durham PL, 2000, MOL ENDOCRINOL, V14, P1570, DOI 10.1210/me.14.10.1570; Ferris HA, 2006, BIOL REPROD, V74, P993, DOI 10.1095/biolreprod.105.049049; Haisenleder DJ, 1998, ENDOCRINOLOGY, V139, P3104, DOI 10.1210/en.139.7.3104; HAISENLEDER DJ, 1991, ENDOCRINOLOGY, V128, P509, DOI 10.1210/endo-128-1-509; Kanasaki H, 2005, ENDOCRINOLOGY, V146, P5503, DOI 10.1210/en.2004-1317; Lawson MA, 2007, MOL ENDOCRINOL, V21, P1175, DOI 10.1210/me.2006-0392; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Marshall J C, 1993, Trans Am Clin Climatol Assoc, V104, P31; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; MOENTER SM, 1992, ENDOCRINOLOGY, V130, P503, DOI 10.1210/en.130.1.503; Naor Z, 2009, FRONT NEUROENDOCRIN, V30, P10, DOI 10.1016/j.yfrne.2008.07.001; OBYRNE KT, 1993, NEUROENDOCRINOLOGY, V57, P588, DOI 10.1159/000126411; Padmanabhan V, 2003, ENDOCRINOLOGY, V144, P1380, DOI 10.1210/en.2002-220973; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Reiss N, 1997, ENDOCRINOLOGY, V138, P1673, DOI 10.1210/en.138.4.1673; SAVOYMOORE RT, 1980, SCIENCE, V209, P942, DOI 10.1126/science.6250218; SHUPNIK MA, 1990, MOL ENDOCRINOL, V4, P1444, DOI 10.1210/mend-4-10-1444; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Tomida T, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002983; Tsaneva-Atanasova K, 2012, J R SOC INTERFACE, V9, P170, DOI 10.1098/rsif.2011.0215; Tsutsumi R, 2009, ENDOCR J, V56, P729, DOI 10.1507/endocrj.K09E-185; WILLIAMS CL, 1990, P NATL ACAD SCI USA, V87, P8580, DOI 10.1073/pnas.87.21.8580	42	12	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7873	7883		10.1074/jbc.M113.532473	http://dx.doi.org/10.1074/jbc.M113.532473			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24482225	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000332761500052
J	Koag, MC; Min, K; Lee, S				Koag, Myong-Chul; Min, Kyungjin; Lee, Seongmin			Structural Basis for Promutagenicity of 8-Halogenated Guanine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Damage; DNA Polymerase; DNA Repair; Enzyme Structure; Protein Structure; X-ray Crystallography	DNA-POLYMERASE-BETA; ACTIVE-SITE; HYPOCHLOROUS ACID; CRYSTAL-STRUCTURE; INTERMEDIATE; INFLAMMATION; NUCLEOTIDE; SYSTEM; DAMAGE; MYELOPEROXIDASE	Background: 8-Halogenated guanine is a promutagenic lesion that promotes insertion of guanine opposite the lesion during DNA replication. Results: 8-Bromoguanine forms Hoogsteen base pairing with G and Watson-Crick base pairing with C in the active site of pol. Conclusion: 8-Bromoguanine is well accommodated in the nascent base pair binding pocket of pol. Significance: Our structural studies provide insights into potential G to C mutations. 8-Halogenated guanine (haloG), a major DNA adduct formed by reactive halogen species during inflammation, is a promutagenic lesion that promotes misincorporation of G opposite the lesion by various DNA polymerases. Currently, the structural basis for such misincorporation is unknown. To gain insights into the mechanism of misincorporation across haloG by polymerase, we determined seven x-ray structures of human DNA polymerase (pol) bound to DNA bearing 8-bromoguanine (BrG). We determined two pre-catalytic ternary complex structures of pol with an incoming nonhydrolyzable dGTP or dCTP analog paired with templating BrG. We also determined five binary complex structures of pol in complex with DNA containing BrGC/T at post-insertion and post-extension sites. In the BrGdGTP ternary structure, BrG adopts syn conformation and forms Hoogsteen base pairing with the incoming dGTP analog. In the BrGdCTP ternary structure, BrG adopts anti conformation and forms Watson-Crick base pairing with the incoming dCTP analog. In addition, our pol binary post-extension structures show Hoogsteen BrGG base pair and Watson-Crick BrGC base pair. Taken together, the first structures of haloG-containing DNA bound to a protein indicate that both BrGG and BrGC base pairs are accommodated in the active site of pol. Our structures suggest that Hoogsteen-type base pairing between G and C8-modified G could be accommodated in the active site of a DNA polymerase, promoting G to C mutation.	[Koag, Myong-Chul; Min, Kyungjin; Lee, Seongmin] Univ Texas Austin, Coll Pharm, Div Med Chem, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Lee, S (corresponding author), Univ Texas Austin, Coll Pharm, Div Med Chem, 2409 Univ Ave, Austin, TX 78712 USA.	seongminlee@austin.utexas.edu	Lee, Seongmin/AAR-2499-2021		College of Pharmacy at the University of Texas at Austin; Robert Welch Foundation (Welch Grant) [F-1741]	College of Pharmacy at the University of Texas at Austin; Robert Welch Foundation (Welch Grant)(The Welch Foundation)	This work was supported by grants from a start-up fund from the College of Pharmacy at the University of Texas at Austin and the Robert Welch Foundation (Welch Grant F-1741).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Asahi T, 2010, J BIOL CHEM, V285, P9282, DOI 10.1074/jbc.M109.054213; Batra VK, 2008, MOL CELL, V30, P315, DOI 10.1016/j.molcel.2008.02.025; Batra VK, 2013, J AM CHEM SOC, V135, P8078, DOI 10.1021/ja403842j; Batra VK, 2012, P NATL ACAD SCI USA, V109, P113, DOI 10.1073/pnas.1112235108; Batra VK, 2010, NAT STRUCT MOL BIOL, V17, P889, DOI 10.1038/nsmb.1852; Batra VK, 2005, STRUCTURE, V13, P1225, DOI 10.1016/j.str.2005.05.010; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Beard WA, 2009, J BIOL CHEM, V284, P31680, DOI 10.1074/jbc.M109.029843; Clausen AR, 2013, P NATL ACAD SCI USA, V110, P16802, DOI 10.1073/pnas.1309119110; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Efrati E, 1999, J BIOL CHEM, V274, P15920, DOI 10.1074/jbc.274.22.15920; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Freudenthal BD, 2013, CELL, V154, P157, DOI 10.1016/j.cell.2013.05.048; Freudenthal BD, 2013, NUCLEIC ACIDS RES, V41, P1848, DOI 10.1093/nar/gks1276; Freudenthal BD, 2012, STRUCTURE, V20, P1829, DOI 10.1016/j.str.2012.08.008; Fujikawa K, 2002, FEBS LETT, V512, P149, DOI 10.1016/S0014-5793(02)02240-8; Gaut JP, 2001, P NATL ACAD SCI USA, V98, P11961, DOI 10.1073/pnas.211190298; Johnson SJ, 2004, CELL, V116, P803, DOI 10.1016/S0092-8674(04)00252-1; Kino K, 2001, CHEM BIOL, V8, P369, DOI 10.1016/S1074-5521(01)00019-9; Kirby TW, 2012, NUCLEIC ACIDS RES, V40, P2974, DOI 10.1093/nar/gkr1218; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Krahn JM, 2004, STRUCTURE, V12, P1823, DOI 10.1016/j.str.2004.08.001; Lin P, 2008, P NATL ACAD SCI USA, V105, P5670, DOI 10.1073/pnas.0801257105; Masuda M, 2001, J BIOL CHEM, V276, P40486, DOI 10.1074/jbc.M102700200; Meira LB, 2008, J CLIN INVEST, V118, P2516, DOI 10.1172/JCI35073; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan B, 2006, P NATL ACAD SCI USA, V103, P3130, DOI 10.1073/pnas.0507730103; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Pfeifer GP, 2009, HUM GENET, V125, P493, DOI 10.1007/s00439-009-0657-2; Ravelli RBG, 2003, STRUCTURE, V11, P217, DOI 10.1016/S0969-2126(03)00006-6; Sassa A, 2011, J MOL BIOL, V406, P679, DOI 10.1016/j.jmb.2011.01.005; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581; Stanley NR, 2010, CHEM RES TOXICOL, V23, P1293, DOI 10.1021/tx100188b; Stathis D, 2012, J AM CHEM SOC, V134, P4925, DOI 10.1021/ja211435d; Suzuki T, 2002, NUCLEIC ACIDS RES, V30, P2555, DOI 10.1093/nar/30.11.2555; Valinluck V, 2007, CANCER RES, V67, P5583, DOI 10.1158/0008-5472.CAN-07-0846; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WEISS SJ, 1986, SCIENCE, V234, P200, DOI 10.1126/science.3018933; Yang LJ, 2004, J AM CHEM SOC, V126, P8441, DOI 10.1021/ja049412o; Zhao Y, 2012, P NATL ACAD SCI USA, V109, P7269, DOI 10.1073/pnas.1202681109; Zhong XJ, 1998, J AM CHEM SOC, V120, P235, DOI 10.1021/ja973507r	45	5	6	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6289	6298		10.1074/jbc.M113.537803	http://dx.doi.org/10.1074/jbc.M113.537803			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24425881	hybrid, Green Published			2022-12-28	WOS:000332015500080
J	Sriram, S; Subramanian, S; Juvvuna, PK; McFarlane, C; Salerno, MS; Kambadur, R; Sharma, M				Sriram, Sandhya; Subramanian, Subha; Juvvuna, Prasanna Kumar; McFarlane, Craig; Salerno, Monica Senna; Kambadur, Ravi; Sharma, Mridula			Myostatin Induces DNA Damage in Skeletal Muscle of Streptozotocin-induced Type 1 Diabetic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; DNA; DNA Damage; p63; Skeletal Muscle; Myostatin; Type 1 Diabetes	OXIDATIVE DAMAGE; GROWTH; EXPRESSION; REDD1; CELLS; FOXA2; ASSAY; GENE; GLUTATHIONE; METABOLISM	Background: Uncontrolled type 1 diabetes leads to DNA damage and skeletal muscle atrophy. Results: STZ-induced Foxa2 up-regulates Mstn leading to DNA damage via p63/REDD1 pathway in skeletal muscle. Conclusion: Mstn is a target of Foxa2. Blocking Mstn can attenuate DNA damage in the diabetic muscle. Significance: The findings reveal a mechanism of induction of Mstn and DNA damage during diabetes. One of the features of uncontrolled type 1 diabetes is oxidative stress that induces DNA damage and cell death. Skeletal muscle atrophy is also considerable in type 1 diabetes, however, the signaling mechanisms that induce oxidative stress culminating in muscle atrophy are not fully known. Here, we show that in Streptozotocin-induced diabetic wild type mice, hypo-phosphorylation of Akt, resulted in activation of Foxa2 transcription factor in the muscle. Foxa2 transcriptionally up-regulated Myostatin, contributing to exaggerated oxidative stress leading to DNA damage via p63/REDD1 pathway in skeletal muscle of Streptozotocin-treated wild type mice. In Myostatin(-/-) mice however, Streptozotocin treatment did not reduce Akt phosphorylation despite reduced IRS-1 signaling. Moreover, Foxa2 levels remained unaltered in Myostatin(-/-) mice, while levels of p63/REDD1 were higher compared with wild type mice. Consistent with these results, relatively less DNA damage and muscle atrophy was observed in Myostatin(-/-) muscle in response to Streptozotocin treatment. Taken together, our results for the first time show the role of Foxa2 in Myostatin regulation in skeletal muscle in diabetic mice. Altogether, these results demonstrate the mechanism by which Myostatin contributes to DNA damage in skeletal muscle of the diabetic mice that would lead to myofiber degeneration.	[Sriram, Sandhya; Subramanian, Subha; Kambadur, Ravi] Nanyang Technol Univ, Sch Biol Sci, Div Mol Genet & Cell Biol, Singapore 637551, Singapore; [Juvvuna, Prasanna Kumar; Sharma, Mridula] Natl Univ Singapore, YLLSoM, Dept Biochem, Singapore 117599, Singapore; [McFarlane, Craig; Kambadur, Ravi] Singapore Inst Clin Sci, Brenner Ctr Mol Med, Growth Dev & Metab Program, Singapore 117609, Singapore; [Salerno, Monica Senna] AgResearch, Hamilton 3240, New Zealand	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); AgResearch - New Zealand	Sharma, M (corresponding author), Natl Univ Singapore, YLLSoM, Dept Biochem, 14 Med Dr,Ctr Translat Med MD6,Level 14, Singapore 117599, Singapore.	mridula_sharma@nuhs.edu.sg			Academic Research Council (Ministry of Education, Singapore); National Research Foundation, Singapore	Academic Research Council (Ministry of Education, Singapore)(Ministry of Education, Singapore); National Research Foundation, Singapore(National Research Foundation, Singapore)	This work was supported by the Academic Research Council (Ministry of Education, Singapore) and National Research Foundation, Singapore.	Andican G, 2005, CLIN EXP PHARMACOL P, V32, P663, DOI 10.1111/j.0305-1870.2005.04247.x; Aragno M, 2004, DIABETES, V53, P1082, DOI 10.2337/diabetes.53.4.1082; Blasiak J, 2004, CELL BIOL TOXICOL, V20, P83, DOI 10.1023/B:CBTO.0000027919.38379.28; Bochkis IM, 2009, PHYSIOL GENOMICS, V38, P186, DOI 10.1152/physiolgenomics.90376.2008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen YW, 2009, BIOCHEM BIOPH RES CO, V388, P112, DOI 10.1016/j.bbrc.2009.07.129; Clancy S, 2008, NAT ED, V1, P1, DOI DOI https://doi.org/10.1038/nrm2351.pdf; Dutra DB, 2012, CLIN EXP PHARMACOL P, V39, P417, DOI 10.1111/j.1440-1681.2012.05690.x; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Favier FB, 2010, AM J PHYSIOL-REG I, V298, pR1659, DOI 10.1152/ajpregu.00550.2009; Frost RA, 2009, J CELL BIOCHEM, V108, P1192, DOI 10.1002/jcb.22349; Ge XJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE90, DOI 10.1152/ajpendo.00113.2012; Hulmi JJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE307, DOI 10.1152/ajpendo.00398.2011; Imaeda A, 2002, FOOD CHEM TOXICOL, V40, P1415, DOI 10.1016/S0278-6915(02)00111-4; Johnston APW, 2007, AM J PHYSIOL-CELL PH, V292, pC1033, DOI 10.1152/ajpcell.00338.2006; Lin YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000680; Luo M, 2013, J CLIN INVEST, V123, P1262, DOI 10.1172/JCI65268; Mastrocola R, 2008, FREE RADICAL BIO MED, V44, P584, DOI 10.1016/j.freeradbiomed.2007.10.047; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; Narciso L, 2007, P NATL ACAD SCI USA, V104, P17010, DOI 10.1073/pnas.0701743104; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; OLIVER MH, 1989, J CELL SCI, V92, P513; Pacal Lukas, 2011, Archives of Physiology and Biochemistry, V117, P222, DOI 10.3109/13813455.2010.551135; Partridge T A, 1997, Methods Mol Biol, V75, P131; Puigserver P, 2006, NAT MED, V12, P38, DOI 10.1038/nm0106-38; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Salerno MS, 2004, AM J PHYSIOL-CELL PH, V287, pC1031, DOI 10.1152/ajpcell.00492.2003; Siriett V, 2007, MOL THER, V15, P1463, DOI 10.1038/sj.mt.6300182; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Sriram S, 2011, AGING CELL, V10, P931, DOI 10.1111/j.1474-9726.2011.00734.x; Su HX, 2012, J ORAL PATHOL MED, V41, P235, DOI 10.1111/j.1600-0714.2011.01092.x; Suzuki S, 1999, DIABETES RES CLIN PR, V45, P161, DOI 10.1016/S0168-8227(99)00046-7; Turinetto V, 2012, STEM CELLS, V30, P1414, DOI 10.1002/stem.1133; Tyrberg Bjorn, 2002, BMC Endocr Disord, V2, P2, DOI 10.1186/1472-6823-2-2; Wang HY, 2002, J BIOL CHEM, V277, P17564, DOI 10.1074/jbc.M111037200; Wang Q., 2011, BMC P, V6, pP52; West E, 1996, W INDIAN MED J, V45, P60; Wolfrum C, 2003, P NATL ACAD SCI USA, V100, P11624, DOI 10.1073/pnas.1931483100; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Wu YL, 2012, BIOCHIMIE, V94, P384, DOI 10.1016/j.biochi.2011.08.006; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Ye JP, 1996, MOL CELL BIOL, V16, P4744; Zhang C, 2011, DIABETOLOGIA, V54, P1491, DOI 10.1007/s00125-011-2079-7; Zhang C, 2012, AM J PHYSIOL-CELL PH, V302, pC1213, DOI 10.1152/ajpcell.00179.2011; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	47	15	17	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5784	5798		10.1074/jbc.M113.483115	http://dx.doi.org/10.1074/jbc.M113.483115			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24425880	Green Published, hybrid			2022-12-28	WOS:000332015500038
J	Ahmed, S; Xie, J; Horne, D; Williams, JC				Ahmed, Shubbir; Xie, Jun; Horne, David; Williams, John C.			Photocleavable Dimerizer for the Rapid Reversal of Molecular Trap Antagonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dynein; Endosomes; Microscopy; Microtubules; Signaling; Molecular Trap; Organelle; Photocleavable Antagonist	DYNEIN; DYNACTIN; SPECIFICITY; ACTIVATION; APOPTOSIS; SUBUNITS; PROTEIN; CELLS	Background: The ability to rapidly turn on and off an acute antagonist is helpful to understand the initiation of a cellular program. Results: A photocleavable analog was produced and functionally demonstrated. Conclusion: Fine temporal control of endosome dispersion and restoration was obtained. Significance: The combination of traps and the photocleavable analog permits new avenues to study signaling within a single cell in an organism. Herein, we report the development of a photocleavable analog of AP20187, a cell-permeable molecule used to dimerize FK506-binding protein (FKBP) fusion proteins and initiate biological signaling cascades and gene expression or disrupt protein-protein interactions. We demonstrate that this reagent permits the unique ability to rapidly and specifically antagonize a molecular interaction in vitro and follow a biological process due to this acute antagonism (e.g. endosome dispersion) and to release the trap upon photocleavage to follow the cell's return to homeostasis. In addition, this photocleavable AP20187 analog can be used in other systems where the dimerization of FKBP has been used to initiate signaling pathways, offering the ability to correlate the duration of a signaling event and a cellular response.	[Ahmed, Shubbir; Xie, Jun; Horne, David; Williams, John C.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Williams, JC (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, 1710 Flower Ave, Duarte, CA 91010 USA.	jcwilliams@coh.org	Ahmed, Shubbir/AAC-4289-2019	Ahmed, Shubbir/0000-0003-1655-6735	National Institutes of Health [R21NS071166]; National Institutes of Health from the NCI [P30 CA033572]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071166] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R21NS071166 (to J. C. W.) and National Institutes of Health Grant P30 CA033572 from the NCI (to Michael A. Friedman).	Abdel-Azim H, 2008, BLOOD, V111, P4064, DOI 10.1182/blood-2007-08-107466; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Beland M, 2012, J NEUROSCI, V32, P13255, DOI 10.1523/JNEUROSCI.2236-12.2012; Brieke C, 2012, ANGEW CHEM INT EDIT, V51, P8446, DOI 10.1002/anie.201202134; DeRose R., 2012, J VIS EXP, V61, P3794; Di Stasi A, 2011, NEW ENGL J MED, V365, P1673, DOI 10.1056/NEJMoa1106152; Dixit R, 2008, J BIOL CHEM, V283, P33611, DOI 10.1074/jbc.M804840200; Dixon SJ, 2009, CURR OPIN CHEM BIOL, V13, P549, DOI 10.1016/j.cbpa.2009.08.003; Gazdoiu S, 2005, P NATL ACAD SCI USA, V102, P15053, DOI 10.1073/pnas.0507646102; HASTINGS RJ, 1983, BRIT J CANCER, V47, P233, DOI 10.1038/bjc.1983.31; Pajvani UB, 2005, NAT MED, V11, P797, DOI 10.1038/nm1262; Palazzo AF, 2001, CURR BIOL, V11, P1536, DOI 10.1016/S0960-9822(01)00475-4; Palmer KJ, 2009, MOL BIOL CELL, V20, P2885, DOI 10.1091/mbc.E08-12-1160; Piggott AM, 2005, MOLECULES, V10, P1292, DOI 10.3390/10101292; Roostaee A, 2009, J BIOL CHEM, V284, P30907, DOI 10.1074/jbc.M109.057950; Rothman JE, 2010, MOL BIOL CELL, V21, P3776, DOI 10.1091/mbc.E10-05-0418; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Umeda N, 2011, J AM CHEM SOC, V133, P12, DOI 10.1021/ja108258d; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Varma D, 2010, P NATL ACAD SCI USA, V107, P3493, DOI 10.1073/pnas.0908959107; Yang W, 2000, J MED CHEM, V43, P1135, DOI 10.1021/jm9904396; Zhapparova ON, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1233, DOI 10.1134/S0006297907110090; Zlatic SA, 2011, MOL BIOL CELL, V22, P1699, DOI 10.1091/mbc.E10-10-0799	23	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 21	2014	289	8					4546	4552		10.1074/jbc.C113.513622	http://dx.doi.org/10.1074/jbc.C113.513622			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB2FF	24421317	Green Published, hybrid			2022-12-28	WOS:000331607900001
J	Bansal, S; Leu, AN; Gonzalez, FJ; Guengerich, FP; Chowdhury, AR; Anandatheerthavarada, HK; Avadhani, NG				Bansal, Seema; Leu, Adrian N.; Gonzalez, Frank J.; Guengerich, F. Peter; Chowdhury, Anindya Roy; Anandatheerthavarada, Hindupur K.; Avadhani, Narayan G.			Mitochondrial Targeting of Cytochrome P450 (CYP) 1B1 and Its Role in Polycyclic Aromatic Hydrocarbon- induced Mitochondrial Dysfunction*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Carcinogenesis; Cytochrome P450; DNA Damage; Membrane Proteins; Mitochondria; Mitochondrial DNA	KNOCKOUT MOUSE LINES; PROTEIN-KINASE-A; ENDOPLASMIC-RETICULUM; BETA-NAPHTHOFLAVONE; DRUG-METABOLISM; MEDIATED PHOSPHORYLATION; CATALYTIC-PROPERTIES; CHIMERIC SIGNALS; OXIDATIVE STRESS; P4501B1 VARIANTS	Background: Cytochrome P450 (CYP) 1B1 activates diverse polycyclic aromatic hydrocarbons (PAH) to reactive species. Results: Processing by a cytosolic Ser protease activates a mitochondrial (mt) targeting signal of CYP1B1. Conclusion: Mitochondrial CYP1B1 plays a role in PAH-induced mtDNA damage and mitochondrial dysfunction. Significance: PAH-induced mitochondrial dysfunction may be important in tissue injury and inflammation. We report that polycyclic aromatic hydrocarbon (PAH)-inducible CYP1B1 is targeted to mitochondria by sequence-specific cleavage at the N terminus by a cytosolic Ser protease (polyserase 1) to activate the cryptic internal signal. Site-directed mutagenesis, COS-7 cell transfection, and in vitro import studies in isolated mitochondria showed that a positively charged domain at residues 41-48 of human CYP1B1 is part of the mitochondrial (mt) import signal. Ala scanning mutations showed that the Ser protease cleavage site resides between residues 37 and 41 of human CYP1B1. Benzo[a]pyrene (BaP) treatment induced oxidative stress, mitochondrial respiratory defects, and mtDNA damage that was attenuated by a CYP1B1-specific inhibitor, 2,3,4,5-tetramethoxystilbene. In support, the mitochondrial CYP1B1 supported by mitochondrial ferredoxin (adrenodoxin) and ferredoxin reductase showed high aryl hydrocarbon hydroxylase activity. Administration of benzo[a]pyrene or 2,3,7,8-tetrachlorodibenzodioxin induced similar mitochondrial functional abnormalities and oxidative stress in the lungs of wild-type mice and Cyp1a1/1a2-null mice, but the effects were markedly blunted in Cyp1b1-null mice. These results confirm a role for CYP1B1 in inducing PAH-mediated mitochondrial dysfunction. The role of mitochondrial CYP1B1 was assessed using A549 lung epithelial cells stably expressing shRNA against NADPH-cytochrome P450 oxidoreductase or mitochondrial adrenodoxin. Our results not only show conservation of the endoprotease cleavage mechanism for mitochondrial import of family 1 CYPs but also reveal a direct role for mitochondrial CYP1B1 in PAH-mediated oxidative and chemical damage to mitochondria.	[Bansal, Seema; Leu, Adrian N.; Chowdhury, Anindya Roy; Anandatheerthavarada, Hindupur K.; Avadhani, Narayan G.] Univ Penn, Dept Anim Biol, Philadelphia, PA 19104 USA; [Bansal, Seema; Leu, Adrian N.; Chowdhury, Anindya Roy; Anandatheerthavarada, Hindupur K.; Avadhani, Narayan G.] Univ Penn, Sch Vet Med, Mari Lowe Ctr Comparat Oncol, Philadelphia, PA 19104 USA; [Gonzalez, Frank J.] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	University of Pennsylvania; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University; Vanderbilt University	Avadhani, NG (corresponding author), Univ Penn, Dept Anim Biol, Philadelphia, PA 19104 USA.	Narayan@vet.upenn.edu			National Institutes of Health [R01 GM34883, R37 CA090426]; Harret Ellison Woodward Trust; NATIONAL CANCER INSTITUTE [ZIABC005708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harret Ellison Woodward Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM34883 (to N. G. A.) and Grant R37 CA090426 (to F. P. G.). This work was also supported by the Harret Ellison Woodward Trust (to N. G. A).	Addya S, 1997, J CELL BIOL, V139, P589, DOI 10.1083/jcb.139.3.589; Anandatheerthavarada HK, 2009, J BIOL CHEM, V284, P17352, DOI 10.1074/jbc.M109.007492; Anandatheerthavarada HK, 1999, J BIOL CHEM, V274, P6617, DOI 10.1074/jbc.274.10.6617; Anandatheerthavarada HK, 1999, EMBO J, V18, P5494, DOI 10.1093/emboj/18.20.5494; Anandatheerthavarada HK, 1997, ARCH BIOCHEM BIOPHYS, V339, P136, DOI 10.1006/abbi.1996.9855; Avadhani NG, 2011, FEBS J, V278, P4218, DOI 10.1111/j.1742-4658.2011.08356.x; Badawi AF, 2001, METABOLISM, V50, P1001, DOI 10.1053/meta.2001.25592; Bagiyeva S, 2007, MOL VIS, V13, P1458; Bansal S, 2010, J BIOL CHEM, V285, P24609, DOI 10.1074/jbc.M110.121822; BAUER E, 1995, CHEM RES TOXICOL, V8, P136, DOI 10.1021/tx00043a018; Bhagwat SV, 1999, J BIOL CHEM, V274, P24014, DOI 10.1074/jbc.274.34.24014; Bhagwat SV, 1999, TOXICOL APPL PHARM, V156, P231, DOI 10.1006/taap.1999.8646; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Boopathi E, 2000, J BIOL CHEM, V275, P34415, DOI 10.1074/jbc.M004431200; Boopathi E, 2008, MOL CELL, V32, P32, DOI 10.1016/j.molcel.2008.09.008; Buters JTM, 1999, P NATL ACAD SCI USA, V96, P1977, DOI 10.1073/pnas.96.5.1977; CLARK BJ, 1991, J BIOL CHEM, V266, P5898; CONNEY AH, 1982, CANCER RES, V42, P4875; Dasari VR, 2006, J BIOL CHEM, V281, P30834, DOI 10.1074/jbc.M510725200; Dong HB, 2009, MOL PHARMACOL, V75, P555, DOI 10.1124/mol.108.051888; Dragin N, 2007, BIOCHEM BIOPH RES CO, V359, P635, DOI 10.1016/j.bbrc.2007.05.202; Dutheil F, 2008, BIOCHIMIE, V90, P426, DOI 10.1016/j.biochi.2007.10.007; Edwards RJ, 1998, BIOCHEM PHARMACOL, V56, P377, DOI 10.1016/S0006-2952(98)00033-1; GELBOIN HV, 1980, PHYSIOL REV, V60, P1107, DOI 10.1152/physrev.1980.60.4.1107; GONZALEZ FJ, 1986, COLD SPRING HARB SYM, V51, P879, DOI 10.1101/SQB.1986.051.01.101; GUENGERICH FP, 1982, BIOCHEMISTRY-US, V21, P6019, DOI 10.1021/bi00266a045; Hakkola J, 1997, CARCINOGENESIS, V18, P391, DOI 10.1093/carcin/18.2.391; HANKINSON O, 1995, ANNU REV PHARMACOL, V35, P307, DOI 10.1146/annurev.pharmtox.35.1.307; Hayes CL, 1996, P NATL ACAD SCI USA, V93, P9776, DOI 10.1073/pnas.93.18.9776; JERINA DM, 1983, DRUG METAB DISPOS, V11, P1; Kim D, 2005, ANNU REV PHARMACOL, V45, P27, DOI 10.1146/annurev.pharmtox.45.120403.100010; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee AJ, 2003, ENDOCRINOLOGY, V144, P3382, DOI 10.1210/en.2003-0192; Liang HCL, 1996, P NATL ACAD SCI USA, V93, P1671, DOI 10.1073/pnas.93.4.1671; MCKAY JA, 1995, FEBS LETT, V374, P270, DOI 10.1016/0014-5793(95)01126-Y; McKay Judith A., 1996, Biochemical Society Transactions, V24, p327S; Miller KP, 2001, DRUG METAB REV, V33, P1, DOI 10.1081/DMR-100000138; MURRAY GI, 1995, J PATHOL, V177, P147, DOI 10.1002/path.1711770208; Murray GI, 1997, CANCER RES, V57, P3026; Nebert DW, 2013, MOL PHARMACOL, V84, P304, DOI 10.1124/mol.113.086637; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; NEBERT DW, 1968, J BIOL CHEM, V243, P6242; NEBERT DW, 1987, BIOCHEM SOC T, V15, P586, DOI 10.1042/bst0150586; OMURA T, 1964, J BIOL CHEM, V239, P2379; Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200; RAZA H, 1988, J BIOL CHEM, V263, P9533; Robin MA, 2003, J BIOL CHEM, V278, P18960, DOI 10.1074/jbc.M301807200; Robin MA, 2002, J BIOL CHEM, V277, P40583, DOI 10.1074/jbc.M203292200; Robin MA, 2001, J BIOL CHEM, V276, P24680, DOI 10.1074/jbc.M100363200; Sangar MC, 2010, EXPERT OPIN DRUG MET, V6, P1231, DOI 10.1517/17425255.2010.503955; Sangar MC, 2010, MOL GENET METAB, V99, P90, DOI 10.1016/j.ymgme.2009.08.009; Sangar MC, 2009, FEBS J, V276, P3440, DOI 10.1111/j.1742-4658.2009.07067.x; SCHWEIKL H, 1993, PHARMACOGENETICS, V3, P239, DOI 10.1097/00008571-199310000-00003; Sepuri NBV, 2007, FEBS J, V274, P4615, DOI 10.1111/j.1742-4658.2007.05990.x; Shi ZQ, 2010, INT J CANCER, V127, P2334, DOI 10.1002/ijc.25222; Shimada T, 1999, CARCINOGENESIS, V20, P1607, DOI 10.1093/carcin/20.8.1607; Shimada T, 2001, XENOBIOTICA, V31, P163, DOI 10.1080/00498250110043490; Shimada T, 1996, CANCER RES, V56, P2979; SUTTER TR, 1994, J BIOL CHEM, V269, P13092; Tang YM, 1999, DRUG METAB DISPOS, V27, P274; Tsuchiya Y, 2004, CANCER RES, V64, P3119, DOI 10.1158/0008-5472.CAN-04-0166; Uno S, 2006, MOL PHARMACOL, V69, P1103, DOI 10.1124/mol.105.021501; Vasiliou V, 2008, ANNU REV PHARMACOL, V48, P333, DOI 10.1146/annurev.pharmtox.48.061807.154729; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yaks F. M., 1997, P NATL ACAD SCI USA, V94, P514	66	56	60	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9936	9951		10.1074/jbc.M113.525659	http://dx.doi.org/10.1074/jbc.M113.525659			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24497629	Green Published, hybrid			2022-12-28	WOS:000333807000043
J	Imbert-Fernandez, Y; Clem, BF; O'Neal, J; Kerr, DA; Spaulding, R; Lanceta, L; Clem, AL; Telang, S; Chesney, J				Imbert-Fernandez, Yoannis; Clem, Brian F.; O'Neal, Julie; Kerr, Daniel A.; Spaulding, Robert; Lanceta, Lilibeth; Clem, Amy L.; Telang, Sucheta; Chesney, Jason			Estradiol Stimulates Glucose Metabolism via 6-Phosphofructo-2-kinase ( PFKFB3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Breast Cancer; Estrogen; Estrogen Receptor; Glycolysis; Metabolism; PFKFB3	EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; BREAST-CANCER CELLS; ESTROGEN-RECEPTOR; GENE; PHOSPHOFRUCTOKINASE; HEXOKINASE; EXPRESSION; GLUCAGON; HYPOXIA	Background: The regulation of glucose metabolism by estradiol is poorly defined. Results: We find that estradiol stimulates glucose metabolism in part by stimulating the production of fructose 2,6-bisphosphate by PFKFB3. Conclusion: PFKFB3 is a downstream target of estradiol required to stimulate glucose metabolism. Significance: Combined targeting of PFKFB3 and the estrogen receptor may prove beneficial to ER+ stage IV breast cancer patients. Estradiol (E2) administered to estrogen receptor-positive (ER+) breast cancer patients stimulates glucose uptake by tumors. Importantly, this E2-induced metabolic flare is predictive of the clinical effectiveness of anti-estrogens and, as a result, downstream metabolic regulators of E2 are expected to have utility as targets for the development of anti-breast cancer agents. The family of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases (PFKFB1-4) control glycolytic flux via their product, fructose-2,6-bisphosphate (F26BP), which activates 6-phosphofructo-1-kinase (PFK-1). We postulated that E2 might promote PFKFB3 expression, resulting in increased F26BP and glucose uptake. We demonstrate that PFKFB3 expression is highest in stage III lymph node metastases relative to normal breast tissues and that exposure of human MCF-7 breast cancer cells to E2 causes a rapid increase in [C-14]glucose uptake and glycolysis that is coincident with an induction of PFKFB3 mRNA (via ER binding to its promoter), protein expression and the intracellular concentration of its product, F26BP. Importantly, selective inhibition of PFKFB3 expression and activity using siRNA or a PFKFB3 inhibitor markedly reduces the E2-mediated increase in F26BP, [C-14]glucose uptake, and glycolysis. Furthermore, co-treatment of MCF-7 cells with the PFKFB3 inhibitor and the anti-estrogen ICI 182,780 synergistically induces apoptotic cell death. These findings demonstrate for the first time that the estrogen receptor directly promotes PFKFB3 mRNA transcription which, in turn, is required for the glucose metabolism and survival of breast cancer cells. Importantly, these results provide essential preclinical information that may allow for the ultimate design of combinatorial trials of PFKFB3 antagonists with anti-estrogen therapies in ER+ stage IV breast cancer patients.	[Imbert-Fernandez, Yoannis; Clem, Brian F.; O'Neal, Julie; Kerr, Daniel A.; Spaulding, Robert; Lanceta, Lilibeth; Clem, Amy L.; Telang, Sucheta; Chesney, Jason] Univ Louisville, James Graham Brown Canc Ctr, Dept Med, Div Med Oncol & Hematol, Louisville, KY 40202 USA	University of Louisville	Telang, S (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Dept Med, 505 S Hancock St, Louisville, KY 40202 USA.	sucheta.telang@louisville.edu; jason.chesney@louisville.edu			NCI/National Institutes of Health [1R01CA140991, 1R01CA149438]; Congressionally Directed Medical Research Program; American Cancer Society [RSG-10-021-01CNE]; NATIONAL CANCER INSTITUTE [R01CA149438, R01CA140991] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106396] Funding Source: NIH RePORTER	NCI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Congressionally Directed Medical Research Program(United States Department of Defense); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by NCI/National Institutes of Health Grants 1R01CA140991 (to S. T.) and 1R01CA149438 (to J. C.). This work was also supported by Congressionally Directed Medical Research Program post-doctoral fellowships (to Y. I.-F. and J. O.) and American Cancer Society RSG-10-021-01CNE (to S. T.).	Atsumi T, 2002, CANCER RES, V62, P5881; Bourdeau V, 2004, MOL ENDOCRINOL, V18, P1411, DOI 10.1210/me.2003-0441; Clem BF, 2013, MOL CANCER THER, V12, P1461, DOI 10.1158/1535-7163.MCT-13-0097; Constantinidou A, 2011, ANN ONCOL, V22, P307, DOI 10.1093/annonc/mdq343; Dehdashti F, 2009, BREAST CANCER RES TR, V113, P509, DOI 10.1007/s10549-008-9953-0; Garcia-Cao I, 2012, CELL, V149, P49, DOI 10.1016/j.cell.2012.02.030; GREGORIOU M, 1983, EUR J BIOCHEM, V134, P283, DOI 10.1111/j.1432-1033.1983.tb07563.x; GREGORIOU M, 1981, Biochemical Society Transactions, V9, P62; Ingle JN, 2013, J HUM GENET, V58, P306, DOI 10.1038/jhg.2013.35; Ko BH, 2010, J NUCL MED, V51, P1740, DOI 10.2967/jnumed.110.074708; LAZO PA, 1982, H-S Z PHYSIOL CHEM, V363, P635, DOI 10.1515/bchm2.1982.363.1.635; Liu XF, 2004, J BIOL CHEM, V279, P15050, DOI 10.1074/jbc.M311932200; Martoni AA, 2010, CANCER-AM CANCER SOC, V116, P805, DOI 10.1002/cncr.24820; Minchenko A, 2002, J BIOL CHEM, V277, P6183, DOI 10.1074/jbc.M110978200; Niikura N, 2010, J CANCER, V1, P51; Novellasdemunt L, 2012, BIOCHEM J, V442, P345, DOI 10.1042/BJ20111418; Obach M, 2004, J BIOL CHEM, V279, P53562, DOI 10.1074/jbc.M406096200; Pennant M, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14500; Sakakibara R, 1997, J BIOCHEM-TOKYO, V122, P122; Specht JM, 2010, CLIN CANCER RES, V16, P2803, DOI 10.1158/1078-0432.CCR-10-0026; Telang S, 2006, ONCOGENE, V25, P7225, DOI 10.1038/sj.onc.1209709; VANSCHAFTINGEN E, 1980, BIOCHEM J, V192, P887, DOI 10.1042/bj1920887; VANSCHAFTINGEN E, 1980, BIOCHEM J, V192, P897, DOI 10.1042/bj1920897; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003	24	53	54	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9440	9448		10.1074/jbc.M113.529990	http://dx.doi.org/10.1074/jbc.M113.529990			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24515104	hybrid, Green Published			2022-12-28	WOS:000333472100059
J	Jehle, K; Cato, L; Neeb, A; Muhle-Goll, C; Jung, N; Smith, EW; Buzon, V; Carbo, LR; Estebanez-Perpina, E; Schmitz, K; Fruk, L; Luy, B; Chen, Y; Cox, MB; Brase, S; Brown, M; Cato, ACB				Jehle, Katja; Cato, Laura; Neeb, Antje; Muhle-Goll, Claudia; Jung, Nicole; Smith, Emmanuel W.; Buzon, Victor; Carbo, Laia R.; Estebanez-Perpina, Eva; Schmitz, Katja; Fruk, Ljiljana; Luy, Burkhard; Chen, Yu; Cox, Marc B.; Braese, Stefan; Brown, Myles; Cato, Andrew C. B.			Coregulator Control of Androgen Receptor Action by a Novel Nuclear Receptor-binding Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Androgen Receptor; Chromatin Immunoprecipitation (ChiP); Gene Expression; Ligand-binding Protein; Prostate Cancer; Activation Function-2 (AF-2); Androgen Receptor Ligand-binding Domain (AR-LBD); Bag-1L; Binding Function-3 (BF-3); Nuclear Receptors	LIGAND-BINDING; PROSTATE-CANCER; GENE-EXPRESSION; PROTEIN BAG-1; COACTIVATOR; DOMAIN; TRANSACTIVATION; COCHAPERONE; TRANSCRIPTION; MUTATION	Background: The interaction surface of coactivators and the androgen receptor (AR) is an important target for prostate cancer therapeutics. Results: A new interface formed by binding of the sequence (GARRPR) and the allosteric pocket (BF-3) of the AR has been identified. Conclusion: GARRPR binding modulates AR activity. Significance: The GARRPR/BF-3 interaction is a novel regulatory hub for AR activity. The androgen receptor (AR) is a ligand-activated transcription factor that is essential for prostate cancer development. It is activated by androgens through its ligand-binding domain (LBD), which consists predominantly of 11 -helices. Upon ligand binding, the last helix is reorganized to an agonist conformation termed activator function-2 (AF-2) for coactivator binding. Several coactivators bind to the AF-2 pocket through conserved LXXLL or FXXLF sequences to enhance the activity of the receptor. Recently, a small compound-binding surface adjacent to AF-2 has been identified as an allosteric modulator of the AF-2 activity and is termed binding function-3 (BF-3). However, the role of BF-3 in vivo is currently unknown, and little is understood about what proteins can bind to it. Here we demonstrate that a duplicated GARRPR motif at the N terminus of the cochaperone Bag-1L functions through the BF-3 pocket. These findings are supported by the fact that a selective BF-3 inhibitor or mutations within the BF-3 pocket abolish the interaction between the GARRPR motif(s) and the BF-3. Conversely, amino acid exchanges in the two GARRPR motifs of Bag-1L can impair the interaction between Bag-1L and AR without altering the ability of Bag-1L to bind to chromatin. Furthermore, the mutant Bag-1L increases androgen-dependent activation of a subset of AR targets in a genome-wide transcriptome analysis, demonstrating a repressive function of the GARRPR/BF-3 interaction. We have therefore identified GARRPR as a novel BF-3 regulatory sequence important for fine-tuning the activity of the AR.	[Jehle, Katja; Neeb, Antje; Braese, Stefan; Cato, Andrew C. B.] Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76344 Eggenstein Leopoldshafen, Germany; [Cato, Laura; Brown, Myles] Harvard Univ, Sch Med, Div Mol & Cellular Oncol, Dept Med Oncol, Boston, MA 02215 USA; [Cato, Laura; Brown, Myles] Harvard Univ, Sch Med, Ctr Funct Canc Epigenet, Dana Farber Canc Inst, Boston, MA 02215 USA; [Muhle-Goll, Claudia; Jung, Nicole; Luy, Burkhard; Braese, Stefan] Karlsruhe Inst Technol, Inst Organ Chem, D-76131 Karlsruhe, Germany; [Smith, Emmanuel W.; Chen, Yu] Univ S Florida, Coll Med, Dept Mol Med, Tampa, FL 33612 USA; [Buzon, Victor; Carbo, Laia R.; Estebanez-Perpina, Eva] Univ Barcelona, Inst Biomed, Dept Biochem & Mol Biol, Barcelona 08028, Spain; [Schmitz, Katja] Tech Univ Darmstadt, Clemens Schopf Inst Organ Chem & Biochem, D-64287 Darmstadt, Germany; [Fruk, Ljiljana] Karlsruhe Inst Technol, Deutsch Forschungsgemeinschaft Ctr Nanostruct, D-76131 Karlsruhe, Germany; [Cox, Marc B.] Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA; [Cox, Marc B.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA	Helmholtz Association; Karlsruhe Institute of Technology; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Helmholtz Association; Karlsruhe Institute of Technology; State University System of Florida; University of South Florida; University of Barcelona; Technical University of Darmstadt; Helmholtz Association; Karlsruhe Institute of Technology; University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso	Cato, ACB (corresponding author), Karlsruhe Inst Technol, Inst Toxicol & Genet, D-76344 Eggenstein Leopoldshafen, Germany.	andrew.cato@kit.edu	Muhle-Goll, Claudia/AAM-6070-2021; Braese, Stefan/B-9057-2008; Cato, Andrew C. B./H-2071-2013; Luy, Burkhard/I-1918-2013; Brown, Myles/B-6906-2008; Estebanez-Perpina, Eva/L-4021-2014; Schmitz, Katja/B-9342-2008; Brown, Myles/AAX-5332-2021	Braese, Stefan/0000-0003-4845-3191; Cato, Andrew C. B./0000-0001-8508-3834; Luy, Burkhard/0000-0001-9580-6397; Brown, Myles/0000-0002-8213-1658; Jung, Nicole/0000-0001-9513-2468; Schmitz, Katja/0000-0001-9023-318X; Estebanez-Perpina, Eva/0000-0003-2687-5801; Cox, Marc/0000-0001-7854-2676; Neeb, Antje/0000-0002-6516-2938; Smith, Emmanuel/0000-0003-0985-6617; Fruk, Ljiljana/0000-0003-2104-5817	National Institutes of Health from the National Center for Research Resources [5 G12 RR008124]; National Institutes of Health from the National Institute on Minority Health and Health Disparities [8 G12 MD007592]; National Institutes of Health [1P01CA163227-01A1, P50CA090381]; KIT start-up funds; Deutsche Krebshilfe [110237]; Cancer Prevention and Research Institute of Texas [RP110444-P2]; NATIONAL CANCER INSTITUTE [P50CA090381, P01CA163227] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	National Institutes of Health from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health from the National Institute on Minority Health and Health Disparities; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); KIT start-up funds; Deutsche Krebshilfe(Deutsche Krebshilfe); Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants 5 G12 RR008124 (from the National Center for Research Resources) and 8 G12 MD007592 (from the National Institute on Minority Health and Health Disparities) (to M. B. C.) and 1P01CA163227-01A1 (Androgen Receptor Action in Castration Resistant Prostate Cancer) and P50CA090381 (Prostate Cancer SPORE) (to M. B.). This work was also supported by grants from the KIT start-up funds and Deutsche Krebshilfe Grant 110237 (to A. C. B. C.) and Cancer Prevention and Research Institute of Texas Grant RP110444-P2 (to M. B. C.).	Alen P, 1999, MOL CELL BIOL, V19, P6085; Bevan CL, 1999, MOL CELL BIOL, V19, P8383; Brehmer D, 2001, NAT STRUCT BIOL, V8, P427, DOI 10.1038/87588; Briknarova K, 2001, NAT STRUCT BIOL, V8, P349, DOI 10.1038/86236; Buchanan G, 2001, MOL ENDOCRINOL, V15, P46, DOI 10.1210/me.15.1.46; Buzon V, 2012, MOL CELL ENDOCRINOL, V348, P394, DOI 10.1016/j.mce.2011.08.012; Caboni L, 2013, MED RES REV, V33, P1081, DOI 10.1002/med.21275; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; CAREY M, 1990, SCIENCE, V247, P710, DOI 10.1126/science.2405489; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Christiaens V, 2002, J BIOL CHEM, V277, P49230, DOI 10.1074/jbc.M209322200; Claessens Frank, 2008, Nucl Recept Signal, V6, pe008, DOI 10.1621/nrs.06008; Crocoll A, 2000, MECH DEVELOP, V91, P355, DOI 10.1016/S0925-4773(99)00284-1; Da Costa CR, 2010, MOL CELL BIOL, V30, P3842, DOI 10.1128/MCB.01610-09; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; De Leon JT, 2011, P NATL ACAD SCI USA, V108, P11878, DOI 10.1073/pnas.1105160108; Dehm SM, 2007, MOL ENDOCRINOL, V21, P2855, DOI 10.1210/me.2007-0223; Dubbink HJ, 2004, MOL ENDOCRINOL, V18, P2132, DOI 10.1210/me.2003-0375; ELO JP, 1995, J CLIN ENDOCR METAB, V80, P3494, DOI 10.1210/jc.80.12.3494; Estebanez-Perpina E, 2005, J BIOL CHEM, V280, P8060, DOI 10.1074/jbc.M407046200; Estebanez-Perpina E, 2007, P NATL ACAD SCI USA, V104, P16074, DOI 10.1073/pnas.0708036104; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Froesch BA, 1998, J BIOL CHEM, V273, P11660, DOI 10.1074/jbc.273.19.11660; Geisberg JV, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh148; Ghadessy FJ, 1999, J CLIN INVEST, V103, P1517, DOI 10.1172/JCI4289; Grosdidier S, 2012, MOL ENDOCRINOL, V26, P1078, DOI 10.1210/me.2011-1281; Guzey M, 2000, J BIOL CHEM, V275, P40749, DOI 10.1074/jbc.M004977200; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hsu CL, 2003, J BIOL CHEM, V278, P23691, DOI 10.1074/jbc.M211908200; Hur E, 2004, PLOS BIOL, V2, P1303, DOI 10.1371/journal.pbio.0020274; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Itkonen H, 2012, MOL CELL ENDOCRINOL, V360, P44, DOI 10.1016/j.mce.2011.09.037; Jin F, 2012, J BIOL CHEM, V287, P858, DOI 10.1074/jbc.M111.304519; Knee DA, 2001, J BIOL CHEM, V276, P12718, DOI 10.1074/jbc.M010841200; Lee SS, 2007, EXP CELL RES, V313, P3222, DOI 10.1016/j.yexcr.2007.06.010; Lee SR, 2002, MOL ENDOCRINOL, V16, P85, DOI 10.1210/me.16.1.85; Lorber DM, 1998, PROTEIN SCI, V7, P938; Ma C, 2009, PROSTATE, V69, P293, DOI 10.1002/pros.20883; Maddalo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045690; Makkonen H, 2009, NUCLEIC ACIDS RES, V37, P4135, DOI 10.1093/nar/gkp352; Matsumoto T, 2013, ANNU REV PHYSIOL, V75, P201, DOI 10.1146/annurev-physiol-030212-183656; MENG EC, 1993, PROTEINS, V17, P266, DOI 10.1002/prot.340170305; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; Munuganti RSN, 2013, J MED CHEM, V56, P1136, DOI 10.1021/jm3015712; Ni M, 2013, GENE DEV, V27, P734, DOI 10.1101/gad.209569.112; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Riggs DL, 2007, MOL CELL BIOL, V27, P8658, DOI 10.1128/MCB.00985-07; Schmidt U, 2003, J BIOL CHEM, V278, P4926, DOI 10.1074/jbc.M212000200; Schneikert J, 1999, J CELL BIOL, V146, P929, DOI 10.1083/jcb.146.5.929; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; Shatkina L, 2003, MOL CELL BIOL, V23, P7189, DOI 10.1128/MCB.23.20.7189-7197.2003; Shi AD, 2011, BIOORGAN MED CHEM, V19, P2298, DOI 10.1016/j.bmc.2011.02.025; Shi XB, 2002, CANCER RES, V62, P1496; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Takahashi N, 2001, BIOCHEM BIOPH RES CO, V286, P807, DOI 10.1006/bbrc.2001.5473; Takayama S, 1998, CANCER RES, V58, P3116; Takeshita Y, 2006, HUM MOL GENET, V15, P2298, DOI 10.1093/hmg/ddl156; Townsend PA, 2005, INT J BIOCHEM CELL B, V37, P251, DOI 10.1016/j.biocel.2004.03.016; Waltering KK, 2012, MOL CELL ENDOCRINOL, V360, P38, DOI 10.1016/j.mce.2011.12.019; Wong HY, 2008, MOL CELL ENDOCRINOL, V292, P69, DOI 10.1016/j.mce.2008.06.016; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Xu KX, 2012, SCIENCE, V338, P1465, DOI 10.1126/science.1227604; Yang XL, 1998, ONCOGENE, V17, P981, DOI 10.1038/sj.onc.1202032; Yeh SY, 1996, P NATL ACAD SCI USA, V93, P5517, DOI 10.1073/pnas.93.11.5517; YONG EL, 1994, LANCET, V344, P826, DOI 10.1016/S0140-6736(94)92385-X; Zeiner M, 1999, P NATL ACAD SCI USA, V96, P10194, DOI 10.1073/pnas.96.18.10194	71	37	38	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8839	8851		10.1074/jbc.M113.534859	http://dx.doi.org/10.1074/jbc.M113.534859			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24523409	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000333472100010
J	Ramakrishnan, NA; Drescher, MJ; Morley, BJ; Kelley, PM; Drescher, DG				Ramakrishnan, Neeliyath A.; Drescher, Marian J.; Morley, Barbara J.; Kelley, Philip M.; Drescher, Dennis G.			Calcium Regulates Molecular Interactions of Otoferlin with Soluble NSF Attachment Protein Receptor ( SNARE) Proteins Required for Hair Cell Exocytosis*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Exocytosis; Hair Cell; Isothermal Titration Calorimetry; Mass Spectrometry (MS); Phosphoinositides; Snare; Surface Plasmon Resonance (SPR); C2 Domains; Otoferlin	AUTOSOMAL RECESSIVE DEAFNESS; MEMBRANE-FUSION; RIBBON SYNAPSE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; AUDITORY NEUROPATHY; CA2+ BINDING; C2 DOMAIN; DEPENDENT EXOCYTOSIS; PRESYNAPTIC CALCIUM; ENCODING OTOFERLIN	Background: Otoferlin deficiency impairs hair cell exocytosis and causes deafness. Results: Otoferlin binds Ca2+, regulating phosphatidylinositol 4,5-bisphosphate, t-SNARE, and intramolecular C2 interactions; otoferlin directly interacts with SNAP-25 and syntaxin-1B. Conclusion: Low Ca2+ promotes interactions among otoferlin C2C, C2D, C2E, and C2F; high Ca2+ drives t-SNARE and lipid interactions. Significance: Otoferlin may mediate novel modes of Ca2+-driven membrane fusion in hair cells. Mutations in otoferlin, a C2 domain-containing ferlin family protein, cause non-syndromic hearing loss in humans (DFNB9 deafness). Furthermore, transmitter secretion of cochlear inner hair cells is compromised in mice lacking otoferlin. In the present study, we show that the C2F domain of otoferlin directly binds calcium (K-D = 267 m) with diminished binding in a pachanga (D1767G) C2F mouse mutation. Calcium was found to differentially regulate binding of otoferlin C2 domains to target SNARE (t-SNARE) proteins and phospholipids. C2D-F domains interact with the syntaxin-1 t-SNARE motif with maximum binding within the range of 20-50 m Ca2+. At 20 m Ca2+, the dissociation rate was substantially lower, indicating increased binding (K-D = approximate to 10(-9)) compared with 0 m Ca2+ (K-D = approximate to 10(-8)), suggesting a calcium-mediated stabilization of the C2 domaint-SNARE complex. C2A and C2B interactions with t-SNAREs were insensitive to calcium. The C2F domain directly binds the t-SNARE SNAP-25 maximally at 100 m and with reduction at 0 m Ca2+, a pattern repeated for C2F domain interactions with phosphatidylinositol 4,5-bisphosphate. In contrast, C2F did not bind the vesicle SNARE protein synaptobrevin-1 (VAMP-1). Moreover, an antibody targeting otoferlin immunoprecipitated syntaxin-1 and SNAP-25 but not synaptobrevin-1. As opposed to an increase in binding with increased calcium, interactions between otoferlin C2F domain and intramolecular C2 domains occurred in the absence of calcium, consistent with intra-C2 domain interactions forming a closed tertiary structure at low calcium that opens as calcium increases. These results suggest a direct role for otoferlin in exocytosis and modulation of calcium-dependent membrane fusion.	[Ramakrishnan, Neeliyath A.; Drescher, Marian J.; Drescher, Dennis G.] Wayne State Univ, Sch Med, Lab Biootol, Dept Otolaryngol, Detroit, MI 48201 USA; [Drescher, Dennis G.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; [Morley, Barbara J.; Kelley, Philip M.] Boys Town Natl Res Hosp, Omaha, NE 68131 USA	Wayne State University; Wayne State University; Boys Town National Research Hospital	Drescher, DG (corresponding author), Wayne State Univ, Sch Med, Lab Biootol, 259 Lande Med Res Bldg,540 East Canfield Ave, Detroit, MI 48201 USA.	ddresche@med.wayne.edu	Morley, Barbara/AAB-7980-2019		National Institutes of Health [R01 DC000156, R01 DC004076, R01 DC006907]; Hearing Health Foundation; Deafness Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000156, R01DC004076, P30DC005188, R01DC006907] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hearing Health Foundation; Deafness Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DC000156 (to D. G. D.), R01 DC004076 (to M.J.D.), and R01 DC006907 (to B.J.M.). This work was also supported by the Hearing Health Foundation (to N.A.R.) and the Deafness Research Foundation (to N.A.R. and P.M.K.).	Aoyagi K, 2005, J BIOL CHEM, V280, P17346, DOI 10.1074/jbc.M413307200; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Beurg M, 2008, J NEUROSCI, V28, P1798, DOI 10.1523/JNEUROSCI.4653-07.2008; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Brandt A, 2005, J NEUROSCI, V25, P11577, DOI 10.1523/JNEUROSCI.3411-05.2005; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; Choi BY, 2009, CLIN GENET, V75, P237, DOI 10.1111/j.1399-0004.2008.01128.x; Dai H, 2004, NAT STRUCT MOL BIOL, V11, P844, DOI 10.1038/nsmb817; Drescher Dennis G., 2009, V493, P323, DOI 10.1007/978-1-59745-523-7_20; Dulon D, 2009, J NEUROSCI, V29, P10474, DOI 10.1523/JNEUROSCI.1009-09.2009; Edmonds B, 2000, NAT NEUROSCI, V3, P786, DOI 10.1038/77687; Frank T, 2009, P NATL ACAD SCI USA, V106, P4483, DOI 10.1073/pnas.0813213106; Fujiwara T, 2006, J NEUROSCI, V26, P5767, DOI 10.1523/JNEUROSCI.0289-06.2006; Heidrych P, 2008, HUM MOL GENET, V17, P3814, DOI 10.1093/hmg/ddn279; Heidrych P, 2009, HUM MOL GENET, V18, P2779, DOI 10.1093/hmg/ddp213; Helfmann S, 2011, J MOL BIOL, V406, P479, DOI 10.1016/j.jmb.2010.12.031; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Johnson CP, 2010, J CELL BIOL, V191, P187, DOI 10.1083/jcb.201002089; Kaneko Y, 2011, J MOL HISTOL, V42, P483, DOI 10.1007/s10735-011-9346-2; Kelley P. M., 2006, ABSTR SOC NEUROSCI, V32, P4; Kuo WW, 2011, BIOCHEMISTRY-US, V50, P2633, DOI 10.1021/bi200049c; Kuo WW, 2009, J MOL BIOL, V387, P284, DOI 10.1016/j.jmb.2009.01.064; Li LY, 2006, J BIOL CHEM, V281, P15845, DOI 10.1074/jbc.M600888200; Longo-Guess C, 2007, HEARING RES, V234, P21, DOI 10.1016/j.heares.2007.09.005; Marlin S, 2010, BIOCHEM BIOPH RES CO, V394, P737, DOI 10.1016/j.bbrc.2010.03.062; Migliosi V, 2002, J MED GENET, V39, P502, DOI 10.1136/jmg.39.7.502; Mirghomizadeh F, 2002, NEUROBIOL DIS, V10, P157, DOI 10.1006/nbdi.2002.0488; Mishima T., 2011, JAP NEUR RES ABSTR S, pP2; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Nouvian R, 2011, NAT NEUROSCI, V14, P411, DOI 10.1038/nn.2774; Oh CK, 1999, MOL BRAIN RES, V70, P135, DOI 10.1016/S0169-328X(99)00110-2; Pangrsic T, 2010, NAT NEUROSCI, V13, P869, DOI 10.1038/nn.2578; Radhakrishnan A, 2009, J BIOL CHEM, V284, P25749, DOI 10.1074/jbc.M109.042499; Ramakrishnan NA, 2006, NEUROSCIENCE, V139, P1417, DOI 10.1016/j.neuroscience.2006.01.064; Ramakrishnan N. A., 2009, ASS RES OT ABSTR, V32, P16; Ramakrishnan N. A., 2010, ASS RES OT ABSTR, V33, P31; Ramakrishnan NA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375832; Ramakrishnan NA, 2012, MOL CELL NEUROSCI, V50, P58, DOI 10.1016/j.mcn.2012.03.009; Ramakrishnan NA, 2009, J BIOL CHEM, V284, P3227, DOI 10.1074/jbc.M806177200; Ramakrishnan NA, 2009, J BIOL CHEM, V284, P1364, DOI 10.1074/jbc.M803605200; ROBERTS WM, 1993, NATURE, V363, P74, DOI 10.1038/363074a0; Rodriguez-Ballesteros M, 2008, HUM MUTAT, V29, P823, DOI 10.1002/humu.20708; Rouillon I, 2006, INT J PEDIATR OTORHI, V70, P689, DOI 10.1016/j.ijporl.2005.09.006; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Roux I, 2009, HUM MOL GENET, V18, P4615, DOI 10.1093/hmg/ddp429; Safieddine S, 1999, EUR J NEUROSCI, V11, P803, DOI 10.1046/j.1460-9568.1999.00487.x; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Schug N, 2006, EUR J NEUROSCI, V24, P3372, DOI 10.1111/j.1460-9568.2006.05225.x; Schwander M, 2007, J NEUROSCI, V27, P2163, DOI 10.1523/JNEUROSCI.4975-06.2007; Shao XG, 1998, BIOCHEMISTRY-US, V37, P16106, DOI 10.1021/bi981789h; Shin OH, 2009, P NATL ACAD SCI USA, V106, P16469, DOI 10.1073/pnas.0908798106; Sreerama N, 1999, PROTEIN SCI, V8, P370; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Sudhof T. C., 2011, CSH PERSPECT BIOL, V3, P3, DOI DOI 10.1101/CSHPERSPECT.A005637; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tekin M, 2005, AM J MED GENET A, V138A, P6, DOI 10.1002/ajmg.a.30907; Uthaiah RC, 2010, J NEUROSCI, V30, P12387, DOI 10.1523/JNEUROSCI.1014-10.2010; van den Bogaart G, 2012, J BIOL CHEM, V287, P16447, DOI 10.1074/jbc.M112.343418; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; Wang Z, 2010, J BIOL CHEM, V285, P30759, DOI 10.1074/jbc.M110.137745; Wu YC, 1996, BIOPHYS J, V71, P2256, DOI 10.1016/S0006-3495(96)79429-8; Xu L., 2011, PLOS ONE, V6; Yasunaga S, 2000, AM J HUM GENET, V67, P591, DOI 10.1086/303049; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693; Zak M, 2012, CELL PHYSIOL BIOCHEM, V29, P941, DOI 10.1159/000188338	69	23	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8750	8766		10.1074/jbc.M113.480533	http://dx.doi.org/10.1074/jbc.M113.480533			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24478316	hybrid, Green Published			2022-12-28	WOS:000333472100003
J	Mathieu, M; Iampietro, M; Chuchana, P; Guerit, D; Djouad, F; Noel, D; Jorgensen, C				Mathieu, Marc; Iampietro, Mathieu; Chuchana, Paul; Guerit, David; Djouad, Farida; Noel, Daniele; Jorgensen, Christian			Involvement of Angiopoietin-like 4 in Matrix Remodeling during Chondrogenic Differentiation of Mesenchymal Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cartilage; Cell Differentiation; Chondrocytes; Chondrogenesis; Extracellular Matrix Proteins; Integrin; Matrix Metalloproteinase (MMP); Mesenchymal Stem Cells; Tissue Engineering; Transforming Growth Factor Beta (TGFbeta)	IN-VITRO CHONDROGENESIS; COLLAGENASE-3 MMP-13; EXPRESSION; CARTILAGE; HYPOXIA; METALLOPROTEINASES; HYPERTROPHY; OSTEOARTHRITIS; INTERACTS; AGGRECAN	Background: Due to their ability to differentiate into chondrocytes, mesenchymal stem cells (MSCs) are candidates for cartilage repair. Results: During chondrogenic differentiation of MSCs, angiopoietin-like 4 (ANGPTL4) triggers degradation and reduced synthesis of the cartilage matrix. Conclusion: ANGPTL4 promotes cartilage matrix remodeling. Significance: In the perspective of MSC-based cartilage engineering, inhibiting ANGPTL4 expression or action could help to stabilize cartilage formation. Mesenchymal stem cells (MSCs) are considered for cartilage engineering given their ability to differentiate into chondrocytes. Chondrogenic differentiation of MSCs is currently triggered by micromass culture in the presence of a member of the TGF- superfamily. However, the main constituents of the cartilaginous matrix, aggrecan and type II collagen, are degraded at the end of the differentiation process through induction of matrix metallopeptidase (MMP)13. We hypothesized that MSCs undergoing chondrogenic differentiation produce an intermediate cytokine that triggers this matrix remodeling. Analysis of transcriptomic data identified angiopoietin-like 4 (ANGPTL4) as one of the most strongly up-regulated gene encoding a secreted factor during TGF--induced chondrogenesis. To gain insight into the role of ANGPTL4 during chondrogenesis, we used recombinant ANGPTL4 as well as a RNA interference approach. Addition of exogenous ANGPTL4 during the course of TGF--induced differentiation reduced the mRNA levels of aggrecan and type II collagen, although it increased those of MMP1 and MMP13. Accordingly, deposition of aggrecan and total collagens was diminished, whereas release of MMP1 and MMP13 was increased. Conversely, transfection of MSCs with an siRNA targeting ANGPTL4 prior to induction of chondrogenesis increased expression of type II collagen and aggrecan, whereas it repressed that of MMP1, MMP3, and MMP13. A neutralizing antibody against integrin V5, a known receptor for ANGPTL4, mimicked some of the effects observed after siRNA-mediated ANGPTL4 silencing. Our data provide evidence that ANGPTL4 promotes cartilage matrix remodeling by inhibiting expression of its two key components and by up-regulating the level of certain MMPs.	[Mathieu, Marc; Iampietro, Mathieu; Chuchana, Paul; Guerit, David; Djouad, Farida; Noel, Daniele; Jorgensen, Christian] Hop St Eloi, INSERM, U844, F-34091 Montpellier, France; [Mathieu, Marc; Iampietro, Mathieu; Chuchana, Paul; Guerit, David; Djouad, Farida; Noel, Daniele; Jorgensen, Christian] Univ Montpellier I, UFR Med, F-34967 Montpellier, France; [Jorgensen, Christian] Hop Lapeyronie, Serv Immunorhumatol, F-34295 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier	Mathieu, M (corresponding author), Hop St Eloi, INSERM, U844, Batiment INM,80 Rue Augustin Fliche, F-34091 Montpellier 5, France.	marc.mathieu@inserm.fr	Iampietro, Mathieu/G-8025-2019; Noel, Daniele/E-5719-2016; Iampietro, Mathieu/AAH-4527-2019	Iampietro, Mathieu/0000-0002-8946-3049; Noel, Daniele/0000-0002-3498-3776; Djouad, Farida/0000-0001-8248-6822; jorgensen, christian/0000-0001-6947-8094	Inserm Institute; University of Montpellier I; European Community	Inserm Institute(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Montpellier I; European Community(European Commission)	This work was supported by the Inserm Institute, the University of Montpellier I, and the European Community's seventh framework program (FP7/2007-2013) for the collaborative project: "ADIPOA: Adipose-derived stromal cells for osteoarthritis treatment."	Belanger AJ, 2002, J MOL CELL CARDIOL, V34, P765, DOI 10.1006/jmcc.2002.2021; Boeuf S, 2012, EUR CELLS MATER, V23, P320, DOI 10.22203/eCM.v023a25; Bouffi C, 2010, BIOMATERIALS, V31, P6485, DOI 10.1016/j.biomaterials.2010.05.013; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Chomel C, 2009, FASEB J, V23, P940, DOI 10.1096/fj.08-115170; Chuchana P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013518; Chuchana P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm093; Deng SJ, 2000, J BIOL CHEM, V275, P31422, DOI 10.1074/jbc.M004538200; Djouad F, 2005, ARTHRITIS RES THER, V7, pR1304, DOI 10.1186/ar1827; Fosang AJ, 1996, FEBS LETT, V380, P17, DOI 10.1016/0014-5793(95)01539-6; Geyer M, 2009, OSTEOARTHR CARTILAGE, V17, P328, DOI 10.1016/j.joca.2008.07.010; Goh YY, 2010, AM J PATHOL, V177, P2791, DOI 10.2353/ajpath.2010.100129; Goh YY, 2010, J BIOL CHEM, V285, P32999, DOI 10.1074/jbc.M110.108175; Green MJ, 2003, RHEUMATOLOGY, V42, P83, DOI 10.1093/rheumatology/keg037; Hermann LM, 2005, CLIN IMMUNOL, V115, P93, DOI 10.1016/j.clim.2004.12.002; Imai K, 2007, AM J PHYSIOL-CELL PH, V293, pC1209, DOI 10.1152/ajpcell.00213.2007; Jorgensen Christian, 2011, Regen Med, V6, P44, DOI 10.2217/rme.11.80; Kennedy AM, 2005, J CLIN INVEST, V115, P2832, DOI 10.1172/JCI22900; Klein T, 2011, AMINO ACIDS, V41, P271, DOI 10.1007/s00726-010-0689-x; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Knowles HJ, 2010, FASEB J, V24, P4648, DOI 10.1096/fj.10-162230; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Little CB, 2009, ARTHRITIS RHEUM-US, V60, P3723, DOI 10.1002/art.25002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCawley LJ, 2001, CURR OPIN CELL BIOL, V13, P534, DOI 10.1016/S0955-0674(00)00248-9; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; Mrugala D, 2009, CLONING STEM CELLS, V11, P61, DOI 10.1089/clo.2008.0070; Mueller MB, 2008, ARTHRITIS RHEUM-US, V58, P1377, DOI 10.1002/art.23370; Murata M, 2009, J ORTHOP RES, V27, P50, DOI 10.1002/jor.20703; Neuhold LA, 2001, J CLIN INVEST, V107, P35, DOI 10.1172/JCI10564; Peake NJ, 2005, RHEUMATOLOGY, V44, P1383, DOI 10.1093/rheumatology/kei025; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poole AR, 2001, CLIN ORTHOP RELAT R, pS26, DOI 10.1097/00003086-200110001-00004; Rozen S, 2000, Methods Mol Biol, V132, P365; Sandy JD, 2006, OSTEOARTHR CARTILAGE, V14, P95, DOI 10.1016/j.joca.2005.09.004; Shlopov BV, 1997, ARTHRITIS RHEUM-US, V40, P2065, DOI 10.1002/art.1780401120; StahleBackdahl M, 1997, LAB INVEST, V76, P717; Volkmer E, 2008, TISSUE ENG PT A, V14, P1331, DOI 10.1089/ten.tea.2007.0231; Zhu PC, 2011, CANCER CELL, V19, P401, DOI 10.1016/j.ccr.2011.01.018	41	26	26	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8402	8412		10.1074/jbc.M113.539825	http://dx.doi.org/10.1074/jbc.M113.539825			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24505142	hybrid, Green Published			2022-12-28	WOS:000333157500032
J	Moccand, C; Boycheva, S; Surriabre, P; Tambasco-Studart, M; Raschke, M; Kaufmann, M; Fitzpatrick, TB				Moccand, Cyril; Boycheva, Svetlana; Surriabre, Pedro; Tambasco-Studart, Marina; Raschke, Maja; Kaufmann, Markus; Fitzpatrick, Teresa B.			The Pseudoenzyme PDX1.2 Boosts Vitamin B-6 Biosynthesis under Heat and Oxidative Stress in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antioxidants; Biosynthesis; Enzyme Catalysis; Plant Biochemistry; Pyridoxal Phosphate; Stress Response	PYRIDOXAL 5'-PHOSPHATE SYNTHASE; N-TERMINAL ACETYLTRANSFERASES; INTERSUBUNIT CROSS-TALK; SINGLET OXYGEN; GENE; TOLERANCE; THALIANA; PROTEINS; COMPLEX; IDENTIFICATION	Background: A non-catalytic vitamin B-6 biosynthesis protein (PDX1.2) exists in plants, but its role is unknown. Results: PDX1.2 interacts with its catalytic counterparts, enhancing their activity and forming a dodecameric complex induced under abiotic stress. Conclusion: PDX1.2 is a pesudoenzyme that regulates vitamin B-6 biosynthesis under abiotic stress. Significance: This work presents a model for regulation of vitamin B-6 biosynthesis and the existence/significance of pseudoenzymes in plants. Vitamin B-6 is an indispensable compound for survival, well known as a cofactor for numerous central metabolic enzymes and more recently for playing a role in several stress responses, particularly in association with oxidative stress. Regulatory aspects for the use of the vitamin in these roles are not known. Here we show that certain plants carry a pseudoenzyme (PDX1.2), which is involved in regulating vitamin B-6 biosynthesis de novo under stress conditions. Specifically, we demonstrate that Arabidopsis PDX1.2 enhances the activity of its catalytic paralogs by forming a heterododecameric complex. PDX1.2 is strongly induced by heat as well as singlet oxygen stress, concomitant with an enhancement of vitamin B-6 production. Analysis of pdx1.2 knockdown lines demonstrates that boosting vitamin B-6 content is dependent on PDX1.2, revealing that this pseudoenzyme acts as a positive regulator of vitamin B-6 biosynthesis during such stress conditions in plants.	[Moccand, Cyril; Boycheva, Svetlana; Surriabre, Pedro; Kaufmann, Markus; Fitzpatrick, Teresa B.] Univ Geneva, Dept Bot & Plant Biol, CH-1211 Geneva, Switzerland; [Tambasco-Studart, Marina; Raschke, Maja] ETH, Inst Agr Sci, CH-8092 Zurich, Switzerland	University of Geneva; Swiss Federal Institutes of Technology Domain; ETH Zurich	Fitzpatrick, TB (corresponding author), Univ Geneva, Dept Bot & Plant Biol, CH-1211 Geneva, Switzerland.	theresa.fitzpatrick@unige.ch		, Svetlana/0000-0003-1208-6772	Swiss National Science Foundation [PPOOA_1191186, 31003A-141117/1]; University of Geneva	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Geneva	This work was supported by Swiss National Science Foundation Grants PPOOA_1191186 and 31003A-141117/1 (to T. B. F.) and the University of Geneva.	Adrain C, 2012, NAT REV MOL CELL BIO, V13, P489, DOI 10.1038/nrm3392; Arnesen T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001074; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Belitsky BR, 2004, J BACTERIOL, V186, P1191, DOI 10.1128/JB.186.4.1191-1196.2004; Bilski P, 2000, PHOTOCHEM PHOTOBIOL, V71, P129, DOI 10.1562/0031-8655(2000)071&lt;0129:SIPVBP&gt;2.0.CO;2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burns KE, 2005, J AM CHEM SOC, V127, P3682, DOI 10.1021/ja042792t; Charbaut E, 2002, FEBS LETT, V529, P341, DOI 10.1016/S0014-5793(02)03421-X; Chen H, 2005, PLANT J, V44, P396, DOI 10.1111/j.1365-313X.2005.02538.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Densiow SA, 2007, PLANT PHYSIOL BIOCH, V45, P152, DOI 10.1016/j.plaphy.2007.01.007; Denslow SA, 2005, PHYSIOL MOL PLANT P, V66, P244, DOI 10.1016/j.pmpp.2005.09.004; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Derrer B, 2010, FEBS LETT, V584, P4169, DOI 10.1016/j.febslet.2010.09.013; Ehrenshaft M, 1998, MOL CELL, V1, P603, DOI 10.1016/S1097-2765(00)80060-X; Ehrenshaft M, 1999, P NATL ACAD SCI USA, V96, P9374, DOI 10.1073/pnas.96.16.9374; Ehrenshaft M, 2001, J BACTERIOL, V183, P3383, DOI 10.1128/JB.183.11.3383-3390.2001; Fitzpatrick TB, 2007, BIOCHEM J, V407, P1, DOI 10.1042/BJ20070765; Fitzpatrick TB, 2012, PLANT CELL, V24, P395, DOI 10.1105/tpc.111.093120; Guedez G, 2012, STRUCTURE, V20, P172, DOI 10.1016/j.str.2011.11.015; Hanes JW, 2008, NAT CHEM BIOL, V4, P425, DOI 10.1038/nchembio.93; Hanes JW, 2008, J AM CHEM SOC, V130, P3043, DOI 10.1021/ja076604l; Hanes JW, 2008, ANGEW CHEM INT EDIT, V47, P2102, DOI 10.1002/anie.200704390; Havaux M, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-130; Hruz T., 2008, BIOINFORMATICS, V2008; Knockel J, 2012, BIOCHEM J, V443, P397, DOI 10.1042/BJ20111542; Leslie M, 2013, SCIENCE, V340, P25, DOI 10.1126/science.340.6128.27; Leuendorf JE, 2008, FEBS J, V275, P960, DOI 10.1111/j.1742-4658.2008.06275.x; Leuendorf JE, 2010, MOL PLANT, V3, P890, DOI 10.1093/mp/ssq041; Manzano C, 2008, PLANT MOL BIOL, V68, P145, DOI 10.1007/s11103-008-9358-9; Matsuura A, 2012, MOL CELLS, V34, P407, DOI 10.1007/s10059-012-0198-8; Meskauskiene R, 2001, P NATL ACAD SCI USA, V98, P12826, DOI 10.1073/pnas.221252798; Moccand C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016042; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Neuwirth M, 2009, FEBS LETT, V583, P2179, DOI 10.1016/j.febslet.2009.06.009; op den Camp RGL, 2003, PLANT CELL, V15, P2320, DOI 10.1105/tpc.014662; Osmani AH, 1999, J BIOL CHEM, V274, P23565, DOI 10.1074/jbc.274.33.23565; Pils B, 2004, J MOL BIOL, V340, P399, DOI 10.1016/j.jmb.2004.04.063; Raschke M, 2011, PLANT J, V66, P414, DOI 10.1111/j.1365-313X.2011.04499.x; Raschle T, 2005, J BIOL CHEM, V280, P32291, DOI 10.1074/jbc.M501356200; Raschle T, 2007, J BIOL CHEM, V282, P6098, DOI 10.1074/jbc.M610614200; Raschle T, 2009, J BIOL CHEM, V284, P7706, DOI 10.1074/jbc.M804728200; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sakai A, 2002, J BIOSCI BIOENG, V93, P309, DOI 10.1263/jbb.93.309; Starheim KK, 2012, TRENDS BIOCHEM SCI, V37, P152, DOI 10.1016/j.tibs.2012.02.003; Strohmeier M, 2006, P NATL ACAD SCI USA, V103, P19284, DOI 10.1073/pnas.0604950103; Sung DY, 2001, PLANT PHYSIOL, V126, P789, DOI 10.1104/pp.126.2.789; Szydlowski N, 2013, PLANT J, V75, P40, DOI 10.1111/tpj.12195; Tambasco-Studart M, 2005, P NATL ACAD SCI USA, V102, P13687, DOI 10.1073/pnas.0506228102; Tambasco-Studart M, 2007, PLANT PHYSIOL, V144, P915, DOI 10.1104/pp.107.096784; Titiz O, 2006, PLANT J, V48, P933, DOI 10.1111/j.1365-313X.2006.02928.x; Wagner S, 2006, PLANT CELL, V18, P1722, DOI 10.1105/tpc.105.036269; Webb KJ, 2010, BIOCHEMISTRY-US, V49, P5225, DOI 10.1021/bi100428x; Zein F, 2006, BIOCHEMISTRY-US, V45, P14609, DOI 10.1021/bi061464y; Zhang KL, 2004, PROTEOMICS, V4, P1, DOI 10.1002/pmic.200300503	55	28	29	4	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8203	8216		10.1074/jbc.M113.540526	http://dx.doi.org/10.1074/jbc.M113.540526			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24505140	hybrid, Green Published			2022-12-28	WOS:000333157500016
J	Schmidt, EP; Li, GY; Li, LY; Fu, L; Yang, YM; Overdier, KH; Douglas, IS; Linhardt, RJ				Schmidt, Eric P.; Li, Guoyun; Li, Lingyun; Fu, Li; Yang, Yimu; Overdier, Katherine H.; Douglas, Ivor S.; Linhardt, Robert J.			The Circulating Glycosaminoglycan Signature of Respiratory Failure in Critically Ill Adults	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chondroitin Sulfate; Glycobiology; Heparan Sulfate; Hyaluronate; Lung Injury; Sepsis; Endothelial Glycocalyx; Respiratory Failure	ENDOTHELIAL GLYCOCALYX; LIQUID-CHROMATOGRAPHY; LUNG INJURY; INFLAMMATION; HYALURONAN; SULFATE; HEPARIN; PLASMA; DISACCHARIDES; EXPRESSION	Background: Endothelial glycocalyx degradation contributes to the pathogenesis of critical illness. Results: Mechanically ventilated subjects exhibited plasma glycocalyx breakdown signatures (glycosaminoglycan fragments) characteristic of direct versus indirect etiologies of respiratory failure. Conclusion: Circulating glycosaminoglycans provide insight into respiratory failure pathophysiology. Significance: This is the first study to characterize circulating glycosaminoglycans during critical illness, offering insight into the mechanisms underlying respiratory failure. Systemic inflammatory illnesses (such as sepsis) are marked by degradation of the endothelial glycocalyx, a layer of glycosaminoglycans (including heparan sulfate, chondroitin sulfate, and hyaluronic acid) lining the vascular lumen. We hypothesized that different pathophysiologic insults would produce characteristic patterns of released glycocalyx fragments. We collected plasma from healthy donors as well as from subjects with respiratory failure due to altered mental status (intoxication, ischemic brain injury), indirect lung injury (non-pulmonary sepsis, pancreatitis), or direct lung injury (aspiration, pneumonia). Mass spectrometry was employed to determine the quantity and sulfation patterns of circulating glycosaminoglycans. We found that circulating heparan sulfate fragments were significantly (23-fold) elevated in patients with indirect lung injury, while circulating hyaluronic acid concentrations were elevated (32-fold) in patients with direct lung injury. N-Sulfation and tri-sulfation of heparan disaccharides were significantly increased in patients with indirect lung injury. Chondroitin disaccharide sulfation was suppressed in all groups with respiratory failure. Plasma heparan sulfate concentrations directly correlated with intensive care unit length of stay. Serial plasma measurements performed in select patients revealed that circulating highly sulfated heparan fragments persisted for greater than 3 days after the onset of respiratory failure. Our findings demonstrate that circulating glycosaminoglycans are elevated in patterns characteristic of the etiology of respiratory failure and may serve as diagnostic and/or prognostic biomarkers of critical illness.	[Schmidt, Eric P.; Yang, Yimu; Douglas, Ivor S.] Univ Colorado, Sch Med, Div Pulm Sci & Crit Care Med, Program Translat Lung Res,Dept Med, Aurora, CO 80045 USA; [Schmidt, Eric P.; Overdier, Katherine H.; Douglas, Ivor S.] Denver Hlth Med Ctr, Denver, CO 80204 USA; [Li, Guoyun] Ocean Univ China, Coll Food Sci & Technol, Qingdao 266003, Shandong, Peoples R China; [Li, Guoyun; Li, Lingyun; Fu, Li; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Chem Biol, Troy, NY 12180 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Denver Health Medical Center; Ocean University of China; Rensselaer Polytechnic Institute	Schmidt, EP (corresponding author), Univ Colorado, Sch Med, Div Pulm Sci & Crit Care Med, Res Complex 2,Mail Stop C272,12700 E 19th Ave, Aurora, CO 80045 USA.	eric.schmidt@ucdenver.edu	Douglas, Ivor S/AAC-6245-2021	Douglas, Ivor S/0000-0002-4541-1431; Schmidt, Eric/0000-0002-7360-0504	National Institutes of Health/NHLBI [K08 HL105538]; Colorado Clinical and Translational Sciences Institute [UL1 RR025780, GM38060]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL105538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038060] Funding Source: NIH RePORTER	National Institutes of Health/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Colorado Clinical and Translational Sciences Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health/NHLBI Grant K08 HL105538 and Colorado Clinical and Translational Sciences Institute Grants UL1 RR025780 (to E. P. S.) and GM38060 (to R. J. L.).	Berg S, 1997, J INTERN MED, V242, P73, DOI 10.1046/j.1365-2796.1997.00177.x; Burke-Gaffney A, 2012, CRIT CARE, V16, DOI 10.1186/cc11239; Curry FE, 2012, ANN BIOMED ENG, V40, P828, DOI 10.1007/s10439-011-0429-8; de Ru MH, 2013, J INHERIT METAB DIS, V36, P247, DOI 10.1007/s10545-012-9538-2; Donati A, 2013, MICROVASC RES, V90, P86, DOI 10.1016/j.mvr.2013.08.007; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Florian JA, 2003, CIRC RES, V93, pE136, DOI 10.1161/01.RES.0000101744.47866.D5; Galvis MLE, 2007, NAT CHEM BIOL, V3, P773, DOI 10.1038/nchembio.2007.41; Gao F, 2008, J BIOL CHEM, V283, P6058, DOI 10.1074/jbc.M709273200; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; KITAGAWA H, 1995, ANAL BIOCHEM, V232, P114, DOI 10.1006/abio.1995.9952; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; MCKEE RF, 1992, GUT, V33, P1549, DOI 10.1136/gut.33.11.1549; Myburgh JA, 2013, NEW ENGL J MED, V369, P1243, DOI 10.1056/NEJMra1208627; Nelson A, 2008, SHOCK, V30, P623, DOI 10.1097/SHK.0b013e3181777da3; Nieuwdorp A, 2009, ATHEROSCLEROSIS, V202, P296, DOI 10.1016/j.atherosclerosis.2008.03.024; Parish CR, 1998, IMMUNOL CELL BIOL, V76, P104, DOI 10.1046/j.1440-1711.1998.00722.x; Pelosi P, 2003, EUR RESPIR J, V22, p48S, DOI 10.1183/09031936.03.00420803; Peterson SB, 2013, MATRIX BIOL, V32, P223, DOI 10.1016/j.matbio.2013.02.006; Sallisalmi M, 2012, ACTA ANAESTH SCAND, V56, P316, DOI 10.1111/j.1399-6576.2011.02578.x; Sandwall E, 2009, J BIOL CHEM, V284, P3814, DOI 10.1074/jbc.M802196200; Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843; Seeley EJ, 2012, AM J PHYSIOL-LUNG C, V303, pL355, DOI 10.1152/ajplung.00069.2012; Shaya D, 2006, J BIOL CHEM, V281, P15525, DOI 10.1074/jbc.M512055200; Steppan J, 2011, J SURG RES, V165, P136, DOI 10.1016/j.jss.2009.04.034; Wei W, 2013, ANAL CHEM, V85, P5917, DOI 10.1021/ac400690g; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Yagmur E, 2012, CLIN BIOCHEM, V45, P82, DOI 10.1016/j.clinbiochem.2011.10.016; Yang B, 2012, J CHROMATOGR A, V1225, P91, DOI 10.1016/j.chroma.2011.12.063; Yang B, 2011, ANAL BIOCHEM, V415, P59, DOI 10.1016/j.ab.2011.04.003; Yoshida E, 2002, BIOSCI BIOTECH BIOCH, V66, P1873, DOI 10.1271/bbb.66.1873; Zhang FM, 2006, ANAL BIOCHEM, V353, P284, DOI 10.1016/j.ab.2006.01.040	35	89	93	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8194	8202		10.1074/jbc.M113.539452	http://dx.doi.org/10.1074/jbc.M113.539452			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24509853	Green Published, hybrid			2022-12-28	WOS:000333157500015
J	Bahl, CD; Hvorecny, KL; Bridges, AA; Ballok, AE; Bomberger, JM; Cady, KC; O'Toole, GA; Madden, DR				Bahl, Christopher D.; Hvorecny, Kelli L.; Bridges, Andrew A.; Ballok, Alicia E.; Bomberger, Jennifer M.; Cady, Kyle C.; O'Toole, George A.; Madden, Dean R.			Signature Motifs Identify an Acinetobacter Cif Virulence Factor with Epoxide Hydrolase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CFTR; Enzyme Catalysis; Gene Transcription; Mutagenesis Site Specific; Protein Conformation; X-ray Crystallography; Airway Infection; Epoxide Hydrolase; Substrate Specificity	TRANSMEMBRANE CONDUCTANCE REGULATOR; PSEUDOMONAS-AERUGINOSA; DIFFRACTION DATA; PROTEIN; CFTR; RESISTANCE; CRYSTALLIZATION; EXPRESSION; PNEUMONIA; INFECTION	Background: Pathogens target airway clearance mechanisms to facilitate infection. Results: Sequence analysis reveals an Acinetobacter epoxide hydrolase (EH) that triggers loss of the cystic fibrosis transmembrane conductance regulator (CFTR). Conclusion: Homologous EH virulence factors found in a variety of opportunistic pathogens can impair CFTR, a key element of host airway defenses. Significance: EH virulence factors are potential therapeutic targets. Endocytic recycling of the cystic fibrosis transmembrane conductance regulator (CFTR) is blocked by the CFTR inhibitory factor (Cif). Originally discovered in Pseudomonas aeruginosa, Cif is a secreted epoxide hydrolase that is transcriptionally regulated by CifR, an epoxide-sensitive repressor. In this report, we investigate a homologous protein found in strains of the emerging nosocomial pathogens Acinetobacter nosocomialis and Acinetobacter baumannii (aCif). Like Cif, aCif is an epoxide hydrolase that carries an N-terminal secretion signal and can be purified from culture supernatants. When applied directly to polarized airway epithelial cells, mature aCif triggers a reduction in CFTR abundance at the apical membrane. Biochemical and crystallographic studies reveal a dimeric assembly with a stereochemically conserved active site, confirming our motif-based identification of candidate Cif-like pathogenic EH sequences. Furthermore, cif expression is transcriptionally repressed by a CifR homolog (aCifR) and is induced in the presence of epoxides. Overall, this Acinetobacter protein recapitulates the essential attributes of the Pseudomonas Cif system and thus may facilitate airway colonization in nosocomial lung infections.	[Bahl, Christopher D.; Hvorecny, Kelli L.; Bridges, Andrew A.; Madden, Dean R.] Geisel Sch Med Dartmouth, Dept Biochem, Hanover, NH 03755 USA; [Ballok, Alicia E.; Cady, Kyle C.; O'Toole, George A.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH 03755 USA; [Bomberger, Jennifer M.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA	Dartmouth College; Dartmouth College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Madden, DR (corresponding author), 7200 Vail Bldg, Hanover, NH 03755 USA.	drm0001@dartmouth.edu	Bridges, Andrew/U-9907-2019; Bahl, Christopher D/B-9410-2016	Bridges, Andrew/0000-0002-8132-751X; Bahl, Christopher D/0000-0002-3652-3693	National Institutes of Health [R01-AI091699]; Training Grant Predoctoral Fellowships [T32-AI007519, T32-DK007301]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091699, T32AI007519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Training Grant Predoctoral Fellowships; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AI091699 and Training Grant Predoctoral Fellowships T32-AI007519 and T32-DK007301.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Arand M, 2005, METHOD ENZYMOL, V400, P569, DOI 10.1016/S0076-6879(05)00032-7; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bahl CD, 2012, PROTEIN PEPTIDE LETT, V19, P186; Bahl CD, 2010, J BACTERIOL, V192, P1785, DOI 10.1128/JB.01348-09; Bahl CD, 2010, ACTA CRYSTALLOGR F, V66, P26, DOI 10.1107/S1744309109047599; Ballok AE, 2012, J BACTERIOL, V194, P5315, DOI 10.1128/JB.00984-12; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Cantin AM, 2006, AM J RESP CRIT CARE, V173, P1139, DOI 10.1164/rccm.200508-1330OC; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Clunes LA, 2012, FASEB J, V26, P533, DOI 10.1096/fj.11-192377; Davies JC, 2009, RESP CARE, V54, P628, DOI 10.4187/aarc0492; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Diene SM, 2013, EXPERT REV ANTI-INFE, V11, P277, DOI [10.1586/ERI.13.1, 10.1586/eri.13.1]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Grgurich PE, 2012, EXPERT REV RESP MED, V6, P533, DOI [10.1586/ERS.12.45, 10.1586/ers.12.45]; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Horsley A, 2012, COCHRANE DB SYST REV, V10; Howard A, 2012, VIRULENCE, V3, P243, DOI 10.4161/viru.19700; Jitsumori K, 2009, J BACTERIOL, V191, P2630, DOI 10.1128/JB.01654-08; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kochanek Kenneth D, 2011, Natl Vital Stat Rep, V60, P1; Koulenti D, 2006, CURR OPIN PULM MED, V12, P198; Kreindler JL, 2005, AM J PHYSIOL-LUNG C, V288, pL894, DOI 10.1152/ajplung.00376.2004; Lopez-Rojas R, 2013, EXPERT REV ANTI-INFE, V11, P231, DOI [10.1586/eri.13.11, 10.1586/ERI.13.11]; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; MacEachran DP, 2008, INFECT IMMUN, V76, P3197, DOI 10.1128/IAI.00305-08; MacEachran DP, 2007, INFECT IMMUN, V75, P3902, DOI 10.1128/IAI.00338-07; Montero M, 2009, INFECTION, V37, P16, DOI 10.1007/s15010-008-8125-9; Morisseau C, 2005, ANNU REV PHARMACOL, V45, P311, DOI 10.1146/annurev.pharmtox.45.120403.095920; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Murphy TF, 2009, CURR OPIN PULM MED, V15, P138, DOI 10.1097/MCP.0b013e328321861a; Nemec A, 2011, RES MICROBIOL, V162, P393, DOI 10.1016/j.resmic.2011.02.006; Parameswaran GI, 2012, FUTURE MICROBIOL, V7, P1129, DOI [10.2217/fmb.12.88, 10.2217/FMB.12.88]; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; READ RC, 1992, J APPL PHYSIOL, V72, P2271, DOI 10.1152/jappl.1992.72.6.2271; Rice LB, 2008, J INFECT DIS, V197, P1079, DOI 10.1086/533452; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Shanks RMQ, 2006, APPL ENVIRON MICROB, V72, P5027, DOI 10.1128/AEM.00682-06; Sloane PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039809; Swiatecka-Urban A, 2006, AM J PHYSIOL-CELL PH, V290, pC862, DOI 10.1152/ajpcell.00108.2005; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Visca P, 2011, IUBMB LIFE, V63, P1048, DOI 10.1002/iub.534; WILSON R, 1987, J CLIN INVEST, V79, P221, DOI 10.1172/JCI112787; WILSON R, 1985, THORAX, V40, P125, DOI 10.1136/thx.40.2.125; Yamada T, 2000, J BIOL CHEM, V275, P23082, DOI 10.1074/jbc.M001464200	53	14	14	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7460	7469		10.1074/jbc.M113.518092	http://dx.doi.org/10.1074/jbc.M113.518092			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24474692	hybrid, Green Published			2022-12-28	WOS:000332761500017
J	Bonala, S; Lokireddy, S; McFarlane, C; Patnam, S; Sharma, M; Kambadur, R				Bonala, Sabeera; Lokireddy, Sudarsanareddy; McFarlane, Craig; Patnam, Sreekanth; Sharma, Mridula; Kambadur, Ravi			Myostatin Induces Insulin Resistance via Casitas B-Lineage Lymphoma b (Cblb)-mediated Degradation of Insulin Receptor Substrate 1 (IRS1) Protein in Response to High Calorie Diet Intake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Insulin Resistance; Signaling; Skeletal Muscle; Skeletal Muscle Metabolism; Cblb; High Glucose; IRS1; Myostatin; High Fat Diet	SKELETAL-MUSCLE CELLS; ELEMENT-BINDING PROTEIN; CENTER-DOT-MLX; ENERGY-EXPENDITURE; GENE-EXPRESSION; UP-REGULATION; GROWTH-RETARDATION; DEFICIENT MICE; CBL-B; GLUCOSE	Background: Excess nutrient intake and elevated levels of Mstn are both associated with the development of insulin resistance. Results: High calorie diet increases Mstn levels. Mstn induces insulin resistance through Cblb. Conclusion: Mstn promotes insulin resistance via Cblb-mediated degradation of IRS1 in response to energy dense diets. Significance: Inhibition of Mstn is a potential therapeutic to combat insulin resistance and T2D. To date a plethora of evidence has clearly demonstrated that continued high calorie intake leads to insulin resistance and type-2 diabetes with or without obesity. However, the necessary signals that initiate insulin resistance during high calorie intake remain largely unknown. Our results here show that in response to a regimen of high fat or high glucose diets, Mstn levels were induced in muscle and liver of mice. High glucose- or fat- mediated induction of Mstn was controlled at the level of transcription, as highly conserved carbohydrate response and sterol-responsive (E-box) elements were present in the Mstn promoter and were revealed to be critical for ChREBP (carbohydrate-responsive element-binding protein) or SREBP1c (sterol regulatory element-binding protein 1c) regulation of Mstn expression. Further molecular analysis suggested that the increased Mstn levels (due to high glucose or fatty acid loading) resulted in increased expression of Cblb in a Smad3-dependent manner. Casitas B-lineage lymphoma b (Cblb) is an ubiquitin E3 ligase that has been shown to specifically degrade insulin receptor substrate 1 (IRS1) protein. Consistent with this, our results revealed that elevated Mstn levels specifically up-regulated Cblb, resulting in enhanced ubiquitin proteasome-mediated degradation of IRS1. In addition, over expression or knock down of Cblb had a major impact on IRS1 and pAkt levels in the presence or absence of insulin. Collectively, these observations strongly suggest that increased glucose levels and high fat diet, both, result in increased circulatory Mstn levels. The increased Mstn in turn is a potent inducer of insulin resistance by degrading IRS1 protein via the E3 ligase, Cblb, in a Smad3-dependent manner.	[Bonala, Sabeera; Lokireddy, Sudarsanareddy; Patnam, Sreekanth; Kambadur, Ravi] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore; [Lokireddy, Sudarsanareddy; McFarlane, Craig; Kambadur, Ravi] Brenner Ctr Mol Med, Singapore Inst Clin Sci A STAR, Singapore 117609, Singapore; [Sharma, Mridula] Natl Univ Singapore, YLL Sch Med, Dept Biochem, Singapore 117597, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore	Kambadur, R (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	KRavi@ntu.edu.sg			Agency for Science, Technology, and Research (A*STAR); National Research Foundation, Singapore	Agency for Science, Technology, and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); National Research Foundation, Singapore(National Research Foundation, Singapore)	This work was supported by the Agency for Science, Technology, and Research (A*STAR) and National Research Foundation, Singapore.	Allen DL, 2008, AM J PHYSIOL-ENDOC M, V294, pE918, DOI 10.1152/ajpendo.00798.2007; ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Bergholdt R, 2005, J LEUKOCYTE BIOL, V77, P579, DOI 10.1189/jlb.0904524; Bigot A, 2008, BIOL CELL, V100, P189, DOI 10.1042/BC20070085; Billin AN, 2006, CURR TOP MICROBIOL, V302, P255; Bonala S, 2013, MOL ENDOCRINOL, V27, P1518, DOI 10.1210/me.2013-1048; Bonala S, 2012, J BIOL CHEM, V287, P12935, DOI 10.1074/jbc.M111.319145; Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; Brand-Miller JC, 2002, AM J CLIN NUTR, V76, p281S, DOI 10.1093/ajcn/76.1.281S; Brandt C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037236; Bray GA, 2012, JAMA-J AM MED ASSOC, V307, P47, DOI 10.1001/jama.2011.1918; Carvalho E, 1999, FASEB J, V13, P2173, DOI 10.1096/fasebj.13.15.2173; Chen YW, 2009, BIOCHEM BIOPH RES CO, V388, P112, DOI 10.1016/j.bbrc.2009.07.129; Choi YJ, 2011, METABOLISM, V60, P1781, DOI 10.1016/j.metabol.2011.05.003; Denechaud PD, 2008, J CLIN INVEST, V118, P956, DOI 10.1172/JCI34314; Ettenberg SA, 1999, ONCOGENE, V18, P1855, DOI 10.1038/sj.onc.1202499; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Ge XJ, 2011, CELL RES, V21, P1591, DOI 10.1038/cr.2011.72; Grzelkowska-Kowalczyk K, 2013, CELL BIOL INT, V37, P29, DOI 10.1002/cbin.10004; Hittel DS, 2010, MED SCI SPORT EXER, V42, P2023, DOI 10.1249/MSS.0b013e3181e0b9a8; Hittel DS, 2009, DIABETES, V58, P30, DOI 10.2337/db08-0943; Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101; Jacquemin V, 2004, EXP CELL RES, V299, P148, DOI 10.1016/j.yexcr.2004.05.023; Kadowaki T, 1996, DIABETIC MED, V13, pS103; Kato T, 2008, DIABETES, V57, P2382, DOI 10.2337/db06-1806; KIM JB, 1995, MOL CELL BIOL, V15, P2582; Kim M, 1999, GENE, V239, P145, DOI 10.1016/S0378-1119(99)00356-X; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Kosoy R, 2004, GENES IMMUN, V5, P232, DOI 10.1038/sj.gene.6364057; Kovacs P, 2003, DIABETES, V52, P3005, DOI 10.2337/diabetes.52.12.3005; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lokireddy S, 2011, AM J PHYSIOL-CELL PH, V301, pC1316, DOI 10.1152/ajpcell.00114.2011; Lokireddy S, 2011, MOL ENDOCRINOL, V25, P1936, DOI 10.1210/me.2011-1124; Ma K, 2003, AM J PHYSIOL-ENDOC M, V285, pE363, DOI 10.1152/ajpendo.00487.2002; Ma L, 2005, J BIOL CHEM, V280, P12019, DOI 10.1074/jbc.M413063200; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Mailloux RJ, 2010, FASEB J, V24, P2495, DOI 10.1096/fj.09-151803; McFarlane C, 2008, EXP CELL RES, V314, P317, DOI 10.1016/j.yexcr.2007.09.012; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Milan G, 2004, J CLIN ENDOCR METAB, V89, P2724, DOI 10.1210/jc.2003-032047; Molero JC, 2006, DIABETES, V55, P708, DOI 10.2337/diabetes.55.03.06.db05-0312; Molero JC, 2004, J CLIN INVEST, V114, P1326, DOI [10.1172/JCI200421480, 10.1172/JCI21480]; Molero JC, 2006, DIABETES, V55, P3411, DOI 10.2337/db06-0955; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Nakao R, 2009, MOL CELL BIOL, V29, P4798, DOI 10.1128/MCB.01347-08; Nakazato K, 2006, INT J SPORT NUTR EXE, V16, P153, DOI 10.1123/ijsnem.16.2.153; OLEFSKY JM, 1995, AM J CLIN NUTR, V61, p980S, DOI 10.1093/ajcn/61.4.980S; Pedersen KB, 2010, BIOCHEM J, V426, P159, DOI 10.1042/BJ20091266; Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Spiller MP, 2002, MOL CELL BIOL, V22, P7066, DOI 10.1128/MCB.22.20.7066-7082.2002; Stoeckman AK, 2004, J BIOL CHEM, V279, P15662, DOI 10.1074/jbc.M311301200; Suchankova G, 2009, BIOCHEM BIOPH RES CO, V378, P836, DOI 10.1016/j.bbrc.2008.11.130; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; TAMEMOTO H, 1994, NATURE, V372, P182, DOI 10.1038/372182a0; Thirone ACP, 2006, TRENDS ENDOCRIN MET, V17, P70, DOI 10.1016/j.tem.2006.01.005; Towle HC, 2001, P NATL ACAD SCI USA, V98, P13476, DOI 10.1073/pnas.251530798; Wilkes JJ, 2009, DIABETES, V58, P1133, DOI 10.2337/db08-0245; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Xavier GD, 2006, J LIPID RES, V47, P2482, DOI 10.1194/jlr.M600289-JLR200; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yokoi N, 2002, NAT GENET, V31, P391, DOI 10.1038/ng927; Yokoi N, 2008, BIOCHEM BIOPH RES CO, V368, P37, DOI 10.1016/j.bbrc.2008.01.032; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Zhang C, 2011, DIABETOLOGIA, V54, P1491, DOI 10.1007/s00125-011-2079-7	69	33	35	1	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7654	7670		10.1074/jbc.M113.529925	http://dx.doi.org/10.1074/jbc.M113.529925			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24451368	Green Published, hybrid			2022-12-28	WOS:000332761500034
J	Brustovetsky, T; Pellman, JJ; Yang, XF; Khanna, R; Brustovetsky, N				Brustovetsky, Tatiana; Pellman, Jessica J.; Yang, Xiao-Fang; Khanna, Rajesh; Brustovetsky, Nickolay			Collapsin Response Mediator Protein 2 (CRMP2) Interacts with N-Methyl-D-aspartate (NMDA) Receptor and Na+/Ca2+ Exchanger and Regulates Their Functional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium Signaling; Glutamate; Glutamate Receptors; Neurons; Sodium Calcium Exchange; CRMP2; NMDA Receptor; TAT-CBD3	PAINFUL PERIPHERAL NEUROPATHY; EXCITOTOXIC NEURONAL DEATH; GLUTAMATE EXCITOTOXICITY; PERMEABILITY TRANSITION; CALCIUM DEREGULATION; HIPPOCAMPAL-NEURONS; CA2+; MITOCHONDRIA; PEPTIDE; SUBUNIT	Background: NMDA receptor and Na+/Ca2+ exchanger are involved in glutamate-induced calcium dysregulation in neurons. Results: CRMP2 interacts with and modulates activity of the NMDA receptor and Na+/Ca2+ exchanger. Conclusion: CRMP2 is involved in regulation of Ca2+ homeostasis in neurons exposed to glutamate. Significance: CRMP2 interaction with NMDA receptor and Na+/Ca2+ exchanger affects their activity and is important for glutamate-induced Ca2+ dysregulation. Collapsin response mediator protein 2 (CRMP2) is traditionally viewed as an axonal growth protein involved in axon/dendrite specification. Here, we describe novel functions of CRMP2. A 15-amino acid peptide from CRMP2, fused to the TAT cell-penetrating motif of the HIV-1 protein, TAT-CBD3, but not CBD3 without TAT, attenuated N-methyl-d-aspartate receptor (NMDAR) activity and protected neurons against glutamate-induced Ca2+ dysregulation, suggesting the key contribution of CRMP2 in these processes. In addition, TAT-CBD3, but not CBD3 without TAT or TAT-scramble peptide, inhibited increases in cytosolic Ca2+ mediated by the plasmalemmal Na+/Ca2+ exchanger (NCX) operating in the reverse mode. Co-immunoprecipitation experiments revealed an interaction between CRMP2 and NMDAR as well as NCX3 but not NCX1. TAT-CBD3 disrupted CRMP2-NMDAR interaction without change in NMDAR localization. In contrast, TAT-CBD3 augmented the CRMP2-NCX3 co-immunoprecipitation, indicating increased interaction or stabilization of a complex between these proteins. Immunostaining with an anti-NCX3 antibody revealed that TAT-CBD3 induced NCX3 internalization, suggesting that both reverse and forward modes of NCX might be affected. Indeed, the forward mode of NCX, evaluated in experiments with ionomycin-induced Ca2+ influx into neurons, was strongly suppressed by TAT-CBD3. Knockdown of CRMP2 with short interfering RNA (siRNA) prevented NCX3 internalization in response to TAT-CBD3 exposure. Moreover, CRMP2 down-regulation strongly attenuated TAT-CBD3-induced inhibition of reverse NCX. Overall, our results demonstrate that CRMP2 interacts with NCX and NMDAR and that TAT-CBD3 protects against glutamate-induced Ca2+ dysregulation most likely via suppression of both NMDAR and NCX activities. Our results further clarify the mechanism of action of TAT-CBD3 and identify a novel regulatory checkpoint for NMDAR and NCX function based on CRMP2 interaction with these proteins.	[Brustovetsky, Tatiana; Pellman, Jessica J.; Yang, Xiao-Fang; Khanna, Rajesh; Brustovetsky, Nickolay] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Khanna, Rajesh] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Yang, Xiao-Fang; Khanna, Rajesh; Brustovetsky, Nickolay] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Brustovetsky, N (corresponding author), Indiana Univ Sch Med, Dept Pharmacol & Toxicol, 635 Barnhill Dr,MS 547, Indianapolis, IN 46202 USA.	nbrous@iu.edu		Khanna, Rajesh/0000-0002-9066-2969	National Institutes of Health, NINDS [R01 NS078008]; American Heart Association National Scientist Development Grant [SDG5280023]; Department of Defense Congressionally Directed Military Medical Research and Development Program Neurofibromatosis New Investigator Award [NF1000099]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078008] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association National Scientist Development Grant(American Heart Association); Department of Defense Congressionally Directed Military Medical Research and Development Program Neurofibromatosis New Investigator Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, Grant R01 NS078008 (to N. B.). This work was also supported by American Heart Association National Scientist Development Grant SDG5280023 and by Department of Defense Congressionally Directed Military Medical Research and Development Program Neurofibromatosis New Investigator Award NF1000099 (to R. K.).	Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; Annunziato L, 2004, PHARMACOL REV, V56, P633, DOI 10.1124/pr.56.4.5; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bretin S, 2006, J NEUROCHEM, V98, P1252, DOI 10.1111/j.1471-4159.2006.03969.x; Brittain JM, 2012, FEBS LETT, V586, P3813, DOI 10.1016/j.febslet.2012.09.022; Brittain JM, 2011, J BIOL CHEM, V286, P37778, DOI 10.1074/jbc.M111.255455; Brittain JM, 2011, NAT MED, V17, P822, DOI 10.1038/nm.2345; Brittain JM, 2009, J BIOL CHEM, V284, P31375, DOI 10.1074/jbc.M109.009951; Brittain MK, 2012, NEUROPHARMACOLOGY, V63, P974, DOI 10.1016/j.neuropharm.2012.07.012; Brittain MK, 2012, NEUROBIOL DIS, V46, P109, DOI 10.1016/j.nbd.2011.12.051; Brustovetsky T, 2011, BRIT J PHARMACOL, V162, P255, DOI 10.1111/j.1476-5381.2010.01054.x; Brustovetsky T, 2010, J NEUROSCI RES, V88, P1317, DOI 10.1002/jnr.22295; Brustovetsky T, 2009, CELL CALCIUM, V46, P18, DOI 10.1016/j.ceca.2009.03.017; Budd SL, 1996, J NEUROCHEM, V67, P2282; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; Convery MK, 1999, PFLUG ARCH EUR J PHY, V437, P944, DOI 10.1007/s004240050866; Czyz A, 2002, J NEUROCHEM, V83, P1321, DOI 10.1046/j.1471-4159.2002.01227.x; Dietz RM, 2007, HIPPOCAMPUS, V17, P1049, DOI 10.1002/hipo.20336; DUBINSKY JM, 1993, J NEUROSCI, V13, P623; Farooqui AA, 2006, PHARMACOL REV, V58, P591, DOI 10.1124/pr.58.3.7; Feldman P, 2013, NEUROSCI LETT, V557, P27, DOI 10.1016/j.neulet.2013.06.057; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hallett PJ, 2006, J NEUROSCI, V26, P4690, DOI 10.1523/JNEUROSCI.0792-06.2006; Hensley K, 2011, MOL NEUROBIOL, V43, P180, DOI 10.1007/s12035-011-8166-4; Hoyt KR, 1998, MOL PHARMACOL, V53, P742, DOI 10.1124/mol.53.4.742; Ju WN, 2013, J NEUROCHEM, V124, P869, DOI 10.1111/jnc.12070; Khanna R, 2012, FUTUR NEUROL, V7, P749, DOI 10.2217/FNL.12.68; Kiedrowski L, 1999, MOL PHARMACOL, V56, P619, DOI 10.1124/mol.56.3.619; KIEDROWSKI L, 1994, NEURON, V12, P295, DOI 10.1016/0896-6273(94)90272-0; KIMURA J, 1986, NATURE, V319, P596, DOI 10.1038/319596a0; Kowara R, 2005, J NEUROCHEM, V95, P466, DOI 10.1111/j.1471-4159.2005.03383.x; Li V, 2009, EXP NEUROL, V218, P171, DOI 10.1016/j.expneurol.2009.02.007; Liu W, 2009, PROTEOMICS, V9, P3712, DOI 10.1002/pmic.200800979; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; MANEV H, 1989, MOL PHARMACOL, V36, P106; Mattson MP, 2003, NEUROMOL MED, V3, P65, DOI 10.1385/NMM:3:2:65; MECHMANN S, 1986, NATURE, V319, P597, DOI 10.1038/319597a0; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Piekarz AD, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-54; Salinska E, 2005, FOLIA NEUROPATHOL, V43, P322; Schmidt EF, 2007, ADV EXP MED BIOL, V600, P1; Smith Godfrey L, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS57, DOI 10.1111/j.1540-8167.2006.00384.x; Stanika RI, 2009, P NATL ACAD SCI USA, V106, P9854, DOI 10.1073/pnas.0903546106; THAYER SA, 1990, J PHYSIOL-LONDON, V425, P85, DOI 10.1113/jphysiol.1990.sp018094; TYMIANSKI M, 1993, J NEUROSCI, V13, P2085; Wang GJ, 1996, J NEUROPHYSIOL, V76, P1611, DOI 10.1152/jn.1996.76.3.1611; White RJ, 1996, J NEUROSCI, V16, P5688; Wilson SM, 2012, J BIOL CHEM, V287, P35065, DOI 10.1074/jbc.M112.378695; Zhou M, 2006, J NEUROSCI, V26, P2956, DOI 10.1523/JNEUROSCI.4299-05.2006	50	56	56	4	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7470	7482		10.1074/jbc.M113.518472	http://dx.doi.org/10.1074/jbc.M113.518472			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24474686	Green Published, hybrid			2022-12-28	WOS:000332761500018
J	Yamamoto, K; Owen, K; Parker, AE; Scilabra, SD; Dudhia, J; Strickland, DK; Troeberg, L; Nagase, H				Yamamoto, Kazuhiro; Owen, Kathryn; Parker, Andrew E.; Scilabra, Simone D.; Dudhia, Jayesh; Strickland, Dudley K.; Troeberg, Linda; Nagase, Hideaki			Low Density Lipoprotein Receptor-related Protein 1 (LRP1)-mediated Endocytic Clearance of a Disintegrin and Metalloproteinase with Thrombospondin Motifs-4 (ADAMTS-4) FUNCTIONAL DIFFERENCES OF NON-CATALYTIC DOMAINS OF ADAMTS-4 AND ADAMTS-5 IN LRP1 BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chondrocytes; Endocytosis; Extracellular Matrix; Osteoarthritis; Trafficking; Aggrecanase	CARTILAGE MATRIX DEGRADATION; HUMAN SYNOVIAL-FLUID; LIGAND-BINDING; PROTEOLYTIC ACTIVITIES; PENTOSAN POLYSULFATE; AGGRECAN DEGRADATION; IN-VIVO; EXPRESSION; CLEAVAGE; OSTEOARTHRITIS	Background: LRP1 is an endocytic receptor of ADAMTS-5 (aggrecanase 2) in cartilage. Results: ADAMTS-4 (aggrecanase 1) is also internalized via LRP1 but at a slower rate than ADAMTS-5. Conclusion: LRP1 differently regulates the extracellular activities of the two key aggrecanases in cartilage. Significance: LRP1 is a major traffic controller of the two aggrecanases. Degradation of the cartilage proteoglycan aggrecan is an early event in the development of osteoarthritis, and a disintegrin and metalloproteinase with thrombospondin motifs-4 (ADAMTS-4) and ADAMTS-5 are considered to be the major aggrecan-degrading enzymes. We have recently found that ADAMTS-5 is rapidly endocytosed via low density lipoprotein receptor-related protein 1 (LRP1) and degraded by chondrocytes. Here we report that this regulatory mechanism also applies to ADAMTS-4, although its rate of endocytosis is slower than that of ADAMTS-5. Domain deletion mutagenesis of ADAMTS-4 identified that the cysteine-rich and spacer domains are responsible for binding to LRP1, whereas the thrombospondin 1 and spacer domains are responsible in ADAMTS-5. The estimated t(1/2) value of ADAMTS-4 endocytosis was about 220 min, whereas that of ADAMTS-5 was 100 min. The difference in half-lives between the two enzymes is explained by the 13-fold lower affinity of ADAMTS-4 for LRP1 compared with that of ADAMTS-5. Studies using soluble ligand binding clusters of LRP1 showed that ADAMTS-4 binds to clusters II and IV with similar K-D,K-app values of 98 and 73 nm, respectively, whereas ADAMTS-5 binds to cluster II, III, and IV with K-D,K-app values of 3.5, 41, and 9 nm, respectively. Thus, ADAMTS-5 competitively inhibits ADAMTS-4 endocytosis but not vice versa. This study highlights that the affinity between a ligand and LRP1 dictates the rate of internalization and suggests that LRP1 is a major traffic controller of the two aggrecanases, especially under inflammatory conditions, where the protein levels of ADAMTS-4 increase, but those of ADAMTS-5 do not.	[Yamamoto, Kazuhiro; Scilabra, Simone D.; Troeberg, Linda; Nagase, Hideaki] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7FY, England; [Owen, Kathryn; Scilabra, Simone D.; Troeberg, Linda; Nagase, Hideaki] Univ London Imperial Coll Sci Technol & Med, Fac Med, Kennedy Inst Rheumatol, London W6 8LH, England; [Parker, Andrew E.] AstraZeneca, Resp & Inflammat Dept, Macclesfield SK10 4TF, Cheshire, England; [Dudhia, Jayesh] Univ London Royal Vet Coll, Dept Clin Sci & Serv, Hatfield AL9 7TA, Herts, England; [Strickland, Dudley K.] Univ Maryland, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA	University of Oxford; Imperial College London; University of Oxford; AstraZeneca; University of London; University of London Royal Veterinary College; University System of Maryland; University of Maryland Baltimore	Yamamoto, K (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Dept Orthopaed Rheumatol & Musculoskeletal Sci, Matrix Biol Sect, Roosevelt Dr, Oxford OX3 7FY, England.	kazuhiro.yamamoto@kennedy.ox.ac.uk	Yamamoto, Kazuhiro/AAD-9650-2019; scilabra, simone/AAT-4753-2021	Scilabra, Simone Dario/0000-0001-7300-6153; /0000-0003-0939-4651; Dudhia, Jayesh/0000-0002-2503-697X	National Institutes of Health [AR40994, HL072929, HL114379]; Arthritis Research UK; Biotechnology and Biological Sciences Research Council; AstraZeneca; Orthopaedic Research UK;  [19466]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114379, R01HL072929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER; Versus Arthritis [19466, 20563] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Research UK(Versus Arthritis); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); AstraZeneca(AstraZeneca); Orthopaedic Research UK; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Versus Arthritis(Versus Arthritis)	This work was supported, in whole or in part, by National Institutes of Health Grants AR40994 (NIAMS) and HL072929 and HL114379 (NHLBI). This work was also supported by grants from the; Recipient of a CASE Ph.D. studentship from Biotechnology and Biological Sciences Research Council and AstraZeneca. Present address: Imperial Innovations, London, UK.Arthritis Research UK.; Recipient of a grant from Orthopaedic Research UK.; An arthritis Research UK Fellow (Grant 19466).	Barmina OY, 1999, J BIOL CHEM, V274, P30087, DOI 10.1074/jbc.274.42.30087; Bau B, 2002, ARTHRITIS RHEUM, V46, P2648, DOI 10.1002/art.10531; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Emonard H, 2004, J BIOL CHEM, V279, P54944, DOI 10.1074/jbc.M406792200; Flannery CR, 2002, J BIOL CHEM, V277, P42775, DOI 10.1074/jbc.M205309200; Fosang A. J., 2013, OSTEOARTHR CARTILAGE, V18, P1109; Fushimi K, 2008, J BIOL CHEM, V283, P6706, DOI 10.1074/jbc.M708647200; Gao G, 2002, J BIOL CHEM, V277, P11034, DOI 10.1074/jbc.M107443200; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Glasson SS, 2004, ARTHRITIS RHEUM-US, V50, P2547, DOI 10.1002/art.20558; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Gorovoy M, 2010, J LEUKOCYTE BIOL, V88, P769, DOI 10.1189/jlb.0410220; Guttman M, 2010, BIOCHEMISTRY-US, V49, P1207, DOI 10.1021/bi9017208; Hahn-Dantona E, 2001, J BIOL CHEM, V276, P15498, DOI 10.1074/jbc.M100121200; Held-Feindt J, 2006, INT J CANCER, V118, P55, DOI 10.1002/ijc.21258; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Horn IR, 1997, J BIOL CHEM, V272, P13608, DOI 10.1074/jbc.272.21.13608; ILIC MZ, 1992, ARCH BIOCHEM BIOPHYS, V294, P115, DOI 10.1016/0003-9861(92)90144-L; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kawata K, 2012, J CELL SCI, V125, P2965, DOI 10.1242/jcs.101956; Kawata K, 2010, J CELL PHYSIOL, V222, P138, DOI 10.1002/jcp.21930; Kevorkian L, 2004, ARTHRITIS RHEUM-US, V50, P131, DOI 10.1002/art.11433; KOUNNAS MZ, 1993, J BIOL CHEM, V268, P21862; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Lim NH, 2010, BIOCHEM J, V431, P113, DOI 10.1042/BJ20100725; LOHMANDER LS, 1993, ARTHRITIS RHEUM, V36, P1214; Malfait AM, 2002, J BIOL CHEM, V277, P22201, DOI 10.1074/jbc.M200431200; Manning HB, 2013, MATRIX BIOL, V32, P32, DOI 10.1016/j.matbio.2012.11.012; Matthews RT, 2000, J BIOL CHEM, V275, P22695, DOI 10.1074/jbc.M909764199; Medved LV, 1999, J BIOL CHEM, V274, P717, DOI 10.1074/jbc.274.2.717; Mikhailenko I, 2001, J BIOL CHEM, V276, P39484, DOI 10.1074/jbc.M104382200; MOESTRUP SK, 1992, CELL TISSUE RES, V269, P375, DOI 10.1007/BF00353892; Murphy G, 2008, NAT CLIN PRACT RHEUM, V4, P128, DOI 10.1038/ncprheum0727; Naito S, 2007, PATHOL INT, V57, P703, DOI 10.1111/j.1440-1827.2007.02167.x; Nakada M, 2005, ACTA NEUROPATHOL, V110, P239, DOI 10.1007/s00401-005-1032-6; Neels JG, 1999, J BIOL CHEM, V274, P31305, DOI 10.1074/jbc.274.44.31305; Patwari P, 2005, OSTEOARTHR CARTILAGE, V13, P269, DOI 10.1016/j.joca.2004.10.023; Powell AJ, 2007, ARTHRITIS RHEUM-US, V56, P3010, DOI 10.1002/art.22818; Pratta MA, 2003, J BIOL CHEM, V278, P45539, DOI 10.1074/jbc.M303737200; Rao N, 2013, INT J CANCER, V133, P294, DOI 10.1002/ijc.28037; Rozanov DV, 2004, J BIOL CHEM, V279, P4260, DOI 10.1074/jbc.M311569200; SANDY JD, 1992, J CLIN INVEST, V89, P1512, DOI 10.1172/JCI115742; SANDY JD, 1991, J BIOL CHEM, V266, P8683; Scilabra SD, 2013, J BIOL CHEM, V288, P332, DOI 10.1074/jbc.M112.393322; Selvais C, 2011, FASEB J, V25, P2770, DOI 10.1096/fj.10-169508; Song RH, 2007, ARTHRITIS RHEUM-US, V56, P575, DOI 10.1002/art.22334; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Stura EA, 2013, FASEB J, V27, P4395, DOI 10.1096/fj.13-233601; Tauchi R, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-53; Troeberg L, 2008, FASEB J, V22, P3515, DOI 10.1096/fj.08-112680; Troeberg L, 2012, BIOCHEM J, V443, P307, DOI 10.1042/BJ20112159; Troeberg L, 2012, BBA-PROTEINS PROTEOM, V1824, P133, DOI 10.1016/j.bbapap.2011.06.020; Wainwright SD, 2006, MATRIX BIOL, V25, P317, DOI 10.1016/j.matbio.2006.03.006; Wainwright SD, 2013, ARTHRITIS RHEUM-US, V65, P2866, DOI 10.1002/art.38102; Walling HW, 2003, OSTEOARTHR CARTILAGE, V11, P854, DOI 10.1016/S1063-4584(03)00170-5; WILLNOW TE, 1992, J BIOL CHEM, V267, P26172; Yamamoto K, 2013, FASEB J, V27, P511, DOI 10.1096/fj.12-216671; Yamanishi Y, 2002, J IMMUNOL, V168, P1405, DOI 10.4049/jimmunol.168.3.1405; Yu ZX, 2012, J BIOL CHEM, V287, P22988, DOI 10.1074/jbc.M112.348979; Zeng WL, 2006, BBA-GEN SUBJECTS, V1760, P517, DOI 10.1016/j.bbagen.2006.01.013; ZHENG G, 1994, J HISTOCHEM CYTOCHEM, V42, P531, DOI 10.1177/42.4.7510321; Zilberberg A, 2004, J BIOL CHEM, V279, P17535, DOI 10.1074/jbc.M311292200	65	55	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6462	6474		10.1074/jbc.M113.545376	http://dx.doi.org/10.1074/jbc.M113.545376			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24474687	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000332389400014
J	Che, T; Bethel, CR; Pusztai-Carey, M; Bonomo, RA; Carey, PR				Che, Tao; Bethel, Christopher R.; Pusztai-Carey, Marianne; Bonomo, Robert A.; Carey, Paul R.			The Different Inhibition Mechanisms of OXA-1 and OXA-24 beta-Lactamases Are Determined by the Stability of Active Site Carboxylated Lysine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystallography; Enzyme Mechanisms; Physical Methods; Raman Spectroscopy; UV Spectroscopy; OXA-1; OXA-24; Carboxylated Lysine; Penems	RESISTANT STAPHYLOCOCCUS-AUREUS; N-ZETA-DECARBOXYLATION; ACINETOBACTER-BAUMANNII; BLAR1 PROTEIN; SENSOR DOMAIN; CRYSTAL-STRUCTURE; RAMAN CRYSTALLOGRAPHY; SUBSTRATE TURNOVER; CLAVULANIC ACID; CARBON-DIOXIDE	Background: OXA-1 and OXA-24 are class D -lactamases that resist clinically used inhibitors. Results: Spectroscopic methods and kinetic measurements show that penem drug candidates are good inhibitors of OXA-1 but are rapidly hydrolyzed by OXA-24. Conclusion: An active site water in OXA-24 aids the reversible carboxylation of Lys-84, enabling many reaction cycles. Significance: Understanding the mechanism of class D -lactamases is vital for drug development. The catalytic efficiency of class D -lactamases depends critically on an unusual carboxylated lysine as the general base residue for both the acylation and deacylation steps of the enzyme. Microbiological and biochemical studies on the class D -lactamases OXA-1 and OXA-24 showed that the two enzymes behave differently when reacting with two 6-methylidene penems (penem 1 and penem 3): the penems are good inhibitors of OXA-1 but act more like substrates for OXA-24. UV difference and Raman spectroscopy revealed that the respective reaction mechanisms are different. The penems form an unusual intermediate, a 1,4-thiazepine derivative in OXA-1, and undergo deacylation followed by the decarboxylation of Lys-70, rendering OXA-1 inactive. This inactivation could not be reversed by the addition of 100 mm NaHCO3. In OXA-24, under mild conditions (enzyme:inhibitor = 1:4), only hydrolyzed products were detected, and the enzyme remained active. However, under harsh conditions (enzyme:inhibitor = 1:2000), OXA-24 was inhibited via decarboxylation of Lys-84; however, the enzyme could be reactivated by the addition of 100 mm NaHCO3. We conclude that OXA-24 not only decarboxylates with difficulty but also recarboxylates with ease; in contrast, OXA-1 decarboxylates easily but recarboxylates with difficulty. Structural analysis of the active site indicates that a crystallographic water molecule may play an important role in carboxylation in OXA-24 (an analogous water molecule is not found in OXA-1), supporting the suggestion that a water molecule in the active site of OXA-24 can lower the energy barrier for carboxylation significantly.	[Che, Tao; Pusztai-Carey, Marianne; Carey, Paul R.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Bethel, Christopher R.; Bonomo, Robert A.] Louis Stokes Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Carey, PR (corresponding author), Case Western Reserve Univ, Dept Biochem, 10900 Euclid Ave, Cleveland, OH 44106 USA.	prc5@case.edu			National Institutes of Health [GM54072, R01-AI100560, R01-AI063517]; Veterans Integrated Service Network 10 Geriatric Research, Education, and Clinical Center; Veterans Health Administration; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100560, R01AI063517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM054072, R01GM054072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Integrated Service Network 10 Geriatric Research, Education, and Clinical Center; Veterans Health Administration(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM54072 (to P. R. C.) and R01-AI100560 and R01-AI063517 (to R. A. B.).; Supported by the Veterans Integrated Service Network 10 Geriatric Research, Education, and Clinical Center and a merit review award by the Veterans Health Administration.	Altose MD, 2001, P NATL ACAD SCI USA, V98, P3006, DOI 10.1073/pnas.061029598; AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; Baurin S, 2009, BIOCHEMISTRY-US, V48, P11252, DOI 10.1021/bi901548c; BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; Bethel CR, 2008, ANTIMICROB AGENTS CH, V52, P3135, DOI 10.1128/AAC.01677-07; Birck C, 2004, J AM CHEM SOC, V126, P13945, DOI 10.1021/ja044742u; Borbulevych O, 2011, J BIOL CHEM, V286, P31466, DOI 10.1074/jbc.M111.252189; Bou G, 2000, ANTIMICROB AGENTS CH, V44, P1556, DOI 10.1128/AAC.44.6.1556-1561.2000; Bou G, 2010, J AM CHEM SOC, V132, P13320, DOI 10.1021/ja104092z; BROOM NJP, 1992, J CHEM SOC CHEM COMM, P1663, DOI 10.1039/c39920001663; Buchman JS, 2012, BIOCHEMISTRY-US, V51, P3143, DOI 10.1021/bi201896k; BUSH K, 1993, ANTIMICROB AGENTS CH, V37, P851, DOI 10.1128/AAC.37.4.851; Carey PR, 2006, ANNU REV PHYS CHEM, V57, P527, DOI 10.1146/annurev.physchem.57.032905.104521; Cha J, 2007, J AM CHEM SOC, V129, P3834, DOI 10.1021/ja070472e; CHARNAS RL, 1978, BIOCHEMISTRY-US, V17, P2185, DOI 10.1021/bi00604a025; Che T, 2012, J AM CHEM SOC, V134, P11206, DOI 10.1021/ja303168n; Dong J, 2001, BIOCHEMISTRY-US, V40, P9751, DOI 10.1021/bi010955+; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Frisch M.J., 2016, GAUSSIAN16 REV B01; Fuda CCS, 2005, CELL MOL LIFE SCI, V62, P2617, DOI 10.1007/s00018-005-5148-6; Golemi D, 2001, P NATL ACAD SCI USA, V98, P14280, DOI 10.1073/pnas.241442898; Golemi-Kotra D, 2003, J BIOL CHEM, V278, P18419, DOI 10.1074/jbc.M300611200; Helfand MS, 2003, BIOCHEMISTRY-US, V42, P13386, DOI 10.1021/bi035716w; Heritier C, 2005, ANTIMICROB AGENTS CH, V49, P3198, DOI 10.1128/AAC.49.8.3198-3202.2005; Hujer KM, 2005, ANTIMICROB AGENTS CH, V49, P2941, DOI 10.1128/AAC.49.7.2941-2948.2005; JABRI E, 1995, SCIENCE, V268, P998, DOI 10.1126/science.7754395; Kalp M, 2009, J AM CHEM SOC, V131, P2338, DOI 10.1021/ja808311s; Ke W., 2012, PLOS ONE, V7; Kerff F, 2003, BIOCHEMISTRY-US, V42, P12835, DOI 10.1021/bi034976a; KIM K, 1994, J PHYS CHEM-US, V98, P10089, DOI 10.1021/j100091a024; Leonard DA, 2008, BIOCHEM J, V410, P455, DOI 10.1042/BJ20070573; Leonard DA, 2013, ACCOUNTS CHEM RES, V46, P2407, DOI 10.1021/ar300327a; Li J, 2005, PROTEINS, V61, P246, DOI 10.1002/prot.20596; Llarrull LI, 2011, J BIOL CHEM, V286, P38148, DOI 10.1074/jbc.M111.288985; LORIMER GH, 1976, BIOCHEMISTRY-US, V15, P529, DOI 10.1021/bi00648a012; MACCLEMENT BAE, 1981, BIOCHEMISTRY-US, V20, P3438, DOI 10.1021/bi00515a021; Meroueh SO, 2005, J AM CHEM SOC, V127, P15397, DOI 10.1021/ja051592u; Naas T, 1999, CURR PHARM DESIGN, V5, P865; National Committee on Clinical Laboratory Standards, 2003, M2A8 NCCLS; National Committee on Clinical Laboratory Standards, 2005, M100S15 NCCLS; Pattanaik P, 2009, J BIOL CHEM, V284, P945, DOI 10.1074/jbc.M806833200; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P202, DOI 10.1128/AAC.49.1.202-208.2005; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P24, DOI 10.1128/AAC.01512-08; Schneider KD, 2011, J MOL BIOL, V406, P583, DOI 10.1016/j.jmb.2010.12.042; Schneider KD, 2009, BIOCHEMISTRY-US, V48, P6136, DOI 10.1021/bi900448u; Shim H, 2000, BIOCHEMISTRY-US, V39, P7357, DOI 10.1021/bi000291o; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Sulton D, 2005, J BIOL CHEM, V280, P35528, DOI 10.1074/jbc.M501251200; Sun T, 2003, PROTEIN SCI, V12, P82, DOI 10.1110/ps.0224303; Sun T, 2001, ACTA CRYSTALLOGR D, V57, P1912, DOI 10.1107/S0907444901016274; Thumanu K, 2006, P NATL ACAD SCI USA, V103, P10630, DOI 10.1073/pnas.0601971103; Tien M, 1999, P NATL ACAD SCI USA, V96, P7809, DOI 10.1073/pnas.96.14.7809; TONEY MD, 1989, SCIENCE, V243, P1485, DOI 10.1126/science.2538921; Torkabadi HH, 2013, J AM CHEM SOC, V135, P2895, DOI 10.1021/ja311440p; Venkatesan AM, 2004, J MED CHEM, V47, P6556, DOI 10.1021/jm049680x; Wilke MS, 2004, J BIOL CHEM, V279, P47278, DOI 10.1074/jbc.M407054200	56	19	19	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6152	6164		10.1074/jbc.M113.533562	http://dx.doi.org/10.1074/jbc.M113.533562			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24443569	Green Published, hybrid			2022-12-28	WOS:000332015500069
J	Cui, TZ; Conte, A; Fox, JL; Zara, V; Winge, DR				Cui, Tie-Zhong; Conte, Annalea; Fox, Jennifer L.; Zara, Vincenzo; Winge, Dennis R.			Modulation of the Respiratory Supercomplexes in Yeast ENHANCED FORMATION OF CYTOCHROME OXIDASE INCREASES THE STABILITY AND ABUNDANCE OF RESPIRATORY SUPERCOMPLEXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bioenergetics; Electron Transfer Complex; Cardiolipin; Cytochrome Oxidase; Mitochondria; Mitochondrial Metabolism	INNER MITOCHONDRIAL-MEMBRANE; RIESKE FE/S PROTEIN; BC(1) COMPLEX; C-OXIDASE; SACCHAROMYCES-CEREVISIAE; CHAIN SUPERCOMPLEXES; CRYSTAL-STRUCTURE; B SYNTHESIS; CARDIOLIPIN; SINGLE	Background: The cytochrome bc(1) complex weakly associates with cytochrome oxidase (CcO) in the absence of the Rieske Rip1 subunit. Results: The N-terminal domain of Rip1 enhances the stabilization of cytochrome bc(1)-CcO supercomplexes in yeast. Conclusion: Induced stabilization of supercomplexes arises from bc(1)-dependent formation of CcO. Significance: The late assembly intermediate of the bc(1) complex can template the maturation of CcO even without cardiolipin. Yeast cells deficient in the Rieske iron-sulfur subunit (Rip1) of ubiquinol-cytochrome c reductase (bc(1)) accumulate a late core assembly intermediate, which weakly associates with cytochrome oxidase (CcO) in a respiratory supercomplex. Expression of the N-terminal half of Rip1, which lacks the C-terminal FeS-containing globular domain (designated N-Rip1), results in a marked stabilization of trimeric and tetrameric bc(1)-CcO supercomplexes. Another bc(1) mutant (qcr9) stalled at the same assembly intermediate is likewise converted to stable supercomplex species by the expression of N-Rip1, but not by expression of intact Rip1. The N-Rip1-induced stabilization of bc(1)-CcO supercomplexes is independent of the Bcs1 translocase, which mediates Rip1 translocation during bc(1) biogenesis. N-Rip1 induces the stabilization of bc(1)-CcO supercomplexes through an enhanced formation of CcO. The association of N-Rip1 with the late core bc(1) assembly intermediate appears to confer stabilization of a CcO assembly intermediate. This induced stabilization of CcO is dependent on the Rcf1 supercomplex stabilization factor and only partially dependent on the presence of cardiolipin. N-Rip1 exerts a related induction of CcO stabilization in WT yeast, resulting in enhanced respiration. Additionally, the impact of CcO stabilization on supercomplexes was observed by means other than expression of N-Rip1 (via overexpression of CcO subunits Cox4 and Cox5a), demonstrating that this is a general phenomenon. This study presents the first evidence showing that supercomplexes can be stabilized by the stimulated formation of CcO.	[Cui, Tie-Zhong; Fox, Jennifer L.; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA; [Cui, Tie-Zhong; Fox, Jennifer L.; Winge, Dennis R.] Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84132 USA; [Conte, Annalea; Zara, Vincenzo] Univ Salento, Dipartimento Sci & Tecnol Biol Ambientali, I-73100 Lecce, Italy	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Salento	Winge, DR (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA.	dennis.winge@hsc.utah.edu	Zara, Vincenzo/AAC-2900-2019	Conte, Annalea/0000-0002-2833-506X; Zara, Vincenzo/0000-0001-6592-4501	National Institutes of Health from NIEHS [ES03817];  [T32 HL007576-25]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES003817, R37ES003817] Funding Source: NIH RePORTER	National Institutes of Health from NIEHS; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES03817 from NIEHS (to D. R. W.) and Training Grant T32 HL007576-25 (to J. L. F.).	Atkinson A, 2011, MOL CELL BIOL, V31, P3988, DOI 10.1128/MCB.05673-11; Atkinson A, 2010, J BIOL CHEM, V285, P19450, DOI 10.1074/jbc.M110.109793; Bazan S, 2013, J BIOL CHEM, V288, P401, DOI 10.1074/jbc.M112.425876; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Capaldi RA, 1995, METHOD ENZYMOL, V260, P117, DOI 10.1016/0076-6879(95)60134-1; Chen YC, 2012, CELL METAB, V15, P348, DOI 10.1016/j.cmet.2012.02.006; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; CRIVELLONE MD, 1988, J BIOL CHEM, V263, P14323; Cruciat CM, 1999, EMBO J, V18, P5226, DOI 10.1093/emboj/18.19.5226; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; Cui TZ, 2012, MOL CELL BIOL, V32, P4400, DOI 10.1128/MCB.00441-12; Dienhart MK, 2008, MOL BIOL CELL, V19, P3934, DOI 10.1091/mbc.E08-04-0402; Dudkina NV, 2011, P NATL ACAD SCI USA, V108, P15196, DOI 10.1073/pnas.1107819108; Ferramosca A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038797; Gruschke S, 2012, J CELL BIOL, V199, P137, DOI 10.1083/jcb.201206040; Gruschke S, 2011, J CELL BIOL, V193, P1101, DOI 10.1083/jcb.201103132; Heinemeyer J, 2007, J BIOL CHEM, V282, P12240, DOI 10.1074/jbc.M610545200; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Kronekova Z, 2005, CURR GENET, V47, P203, DOI 10.1007/s00294-005-0561-9; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Lange C, 2002, P NATL ACAD SCI USA, V99, P2800, DOI 10.1073/pnas.052704699; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Lee SY, 2001, ARCH BIOCHEM BIOPHYS, V393, P215, DOI 10.1006/abbi.2001.2498; McStay GP, 2013, J BIOL CHEM, V288, P26546, DOI 10.1074/jbc.M113.498592; McStay GP, 2013, MOL BIOL CELL, V24, P440, DOI 10.1091/mbc.E12-10-0749; Mick DU, 2007, EMBO J, V26, P4347, DOI 10.1038/sj.emboj.7601862; Mileykovskaya E, 2012, J BIOL CHEM, V287, P23095, DOI 10.1074/jbc.M112.367888; Muhlenhoff U, 2011, J BIOL CHEM, V286, P41205, DOI 10.1074/jbc.M111.296152; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Pierrel F, 2008, MOL CELL BIOL, V28, P4927, DOI 10.1128/MCB.00057-08; Schagger H, 2001, IUBMB LIFE, V52, P119, DOI 10.1080/15216540152845911; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Wegener N, 2011, MOL CELL, V44, P191, DOI 10.1016/j.molcel.2011.07.036; Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012; Weraarpachai W, 2012, AM J HUM GENET, V90, P142, DOI 10.1016/j.ajhg.2011.11.027; Williams SL, 2004, J BIOL CHEM, V279, P7462, DOI 10.1074/jbc.M309232200; Winge DR, 2012, MOL CELL BIOL, V32, P2647, DOI 10.1128/MCB.00573-12; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Zara V, 2007, FEBS J, V274, P4526, DOI 10.1111/j.1742-4658.2007.05982.x; Zara V, 2009, FEBS J, V276, P1900, DOI 10.1111/j.1742-4658.2009.06916.x; Zara V, 2009, BBA-MOL CELL RES, V1793, P89, DOI 10.1016/j.bbamcr.2008.04.011; Zhang M, 2003, J BIOL CHEM, V278, P35204, DOI 10.1074/jbc.M306729200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	46	28	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6133	6141		10.1074/jbc.M113.523688	http://dx.doi.org/10.1074/jbc.M113.523688			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24421313	hybrid, Green Published			2022-12-28	WOS:000332015500067
J	Zhu, H; Guariglia, S; Li, WJ; Brancho, D; Wang, ZV; Scherer, PE; Chow, CW				Zhu, Hong; Guariglia, Sara; Li, Wenjing; Brancho, Deborah; Wang, Zhao V.; Scherer, Philipp E.; Chow, Chi-Wing			Role of Extracellular Signal- regulated Kinase 5 in Adipocyte Signaling*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adipose tissue; MAP Kinases (MAPKs); Metabolic Regulation; NFAT Transcription Factor; Protein Kinase A (PKA)	ACTIVATED PROTEIN-KINASES; BETA-ADRENERGIC-RECEPTORS; MAP KINASE; TARGETED DELETION; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; DIFFERENTIAL REGULATION; INSULIN-RESISTANCE; LEPTIN RESISTANCE; DOWN-REGULATION	Background: Regulation and function of ERK5 in adipose depots is not known. Results: Deletion of ERK5 in adipose depots increases adiposity and adipokine secretion. Reduced phosphorylation and potentiated NFATc4 nuclear localization are found. ERK5 also modulates PKA activation. Conclusion: ERK5 impinges on NFATc4 nucleo-cytoplasmic shuttling and modulates PKA activation in adipocytes. Significance: These results expand the repertoire of ERK5 physiological function and downstream targets. Increased adiposity due to energy imbalance is a critical factor of the epidemic crisis of obesity and type II diabetes. In addition to the obvious role in energy storage, regulatory factors are secreted from adipose depots to control appetite and cellular homeostasis. Complex signaling cross-talks within adipocyte are also evident due to the metabolic and immune nature of adipose depots. Here, we uncover a role of extracellular signal-regulated kinase 5 (ERK5) in adipocyte signaling. We find that deletion of ERK5 in adipose depots (adipo-ERK5(-/-)) increases adiposity, in part, due to increased food intake. Dysregulated secretion of adipokines, leptin resistance, and impaired glucose handling are also found in adipo-ERK5(-/-) mice. Mechanistically, we show that ERK5 impinges on transcription factor NFATc4. Decreased phosphorylation at the conserved gate-keeping Ser residues and increased nuclear localization of NFATc4 are found in adipo-ERK5(-/-) mice. We also find attenuated PKA activation in adipo-ERK5(-/-) mice. In response to stimulation of -adrenergic G-protein-coupled receptor, we find decreased NFATc4 phosphorylation and impaired PKA activation in adipo-ERK5(-/-) mice. Reduced cAMP accumulation and increased phosphodiesterase activity are also found. Together, these results demonstrate integration of ERK5 with NFATc4 nucleo-cytoplasmic shuttling and PKA activation in adipocyte signaling.	[Zhu, Hong; Li, Wenjing; Brancho, Deborah; Chow, Chi-Wing] Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Guariglia, Sara] CUNY Coll Staten Isl, Dept Biol, New York, NY 10314 USA; [Wang, Zhao V.; Scherer, Philipp E.] Univ Texas SW Med Ctr Dallas, Touchstone Diabet Ctr, Dept Internal Med & Cell Biol, Dallas, TX 75390 USA	Yeshiva University; Albert Einstein College of Medicine; City University of New York (CUNY) System; College of Staten Island (CUNY); University of Texas System; University of Texas Southwestern Medical Center Dallas	Chow, CW (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	chi-wing.chow@einstein.yu.edu	Scherer, Philipp E/K-7819-2012	Scherer, Philipp E/0000-0003-0680-3392; Wang, Zhao/0000-0002-9904-9538	National Institutes of Health [R01-DK0904881, P01-DK088761, R01-DK55758, R01-DK099110]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK088761, R01DK090481, R01DK099110, R01DK055758] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK0904881 (to C.-W.C.) and P01-DK088761, R01-DK55758, and R01-DK099110 (to P.E.S.).	Ahmad F, 2012, HORM METAB RES, V44, P776, DOI 10.1055/s-0032-1312646; Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; Ananieva O, 2008, EUR J IMMUNOL, V38, P2534, DOI 10.1002/eji.200737867; Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Baillie GS, 2009, FEBS J, V276, P1790, DOI 10.1111/j.1742-4658.2009.06926.x; Baillie GS, 2005, CURR OPIN CELL BIOL, V17, P129, DOI 10.1016/j.ceb.2005.01.003; Calabro Paolo, 2007, Subcell Biochem, V42, P63; Cameron SJ, 2003, J BIOL CHEM, V278, P18682, DOI 10.1074/jbc.M213283200; Cavanaugh JE, 2001, J NEUROSCI, V21, P434, DOI 10.1523/JNEUROSCI.21-02-00434.2001; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Collins S, 2004, MOL ENDOCRINOL, V18, P2123, DOI 10.1210/me.2004-0193; Cude K, 2007, J CELL BIOL, V177, P253, DOI 10.1083/jcb.200609166; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Dodge-Kafka KL, 2006, EUR J CELL BIOL, V85, P593, DOI 10.1016/j.ejcb.2006.01.007; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; Dyck DJ, 2009, APPL PHYSIOL NUTR ME, V34, P396, DOI 10.1139/H09-037; English JM, 1998, J BIOL CHEM, V273, P3854, DOI 10.1074/jbc.273.7.3854; Enriori PJ, 2006, OBESITY, V14, P254; Garaude J, 2006, J IMMUNOL, V177, P7607, DOI 10.4049/jimmunol.177.11.7607; Graef IA, 2001, CURR OPIN GENET DEV, V11, P505, DOI 10.1016/S0959-437X(00)00225-2; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Guo KY, 2007, ENDOCRINOLOGY, V148, P3987, DOI 10.1210/en.2007-0261; Hayashi M, 2004, J MOL MED, V82, P800, DOI 10.1007/s00109-004-0602-8; Hayashi M, 2004, J CLIN INVEST, V113, P1138, DOI 10.1172/JCI200419890; Hoffmann R, 1999, EMBO J, V18, P893, DOI 10.1093/emboj/18.4.893; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Holm C, 2003, BIOCHEM SOC T, V31, P1120, DOI 10.1042/BST0311120; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Jin L, 2003, NAT STRUCT BIOL, V10, P807, DOI 10.1038/nsb975; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kim CH, 2006, AM J PHYSIOL-ENDOC M, V291, pE298, DOI 10.1152/ajpendo.00319.2005; Kim HB, 2006, DIABETES, V55, P1342, DOI 10.2337/db05-1507; Kim JJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1694, DOI 10.1152/ajpendo.00430.2006; Kim S, 2000, J NUTR, V130, p3110S; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lazar MA, 2007, HORM METAB RES, V39, P710, DOI 10.1055/s-2007-985897; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; LEE JD, 1995, BIOCHEM BIOPH RES CO, V213, P715, DOI 10.1006/bbrc.1995.2189; Lin HV, 2007, DIABETES, V56, P1969, DOI 10.2337/db07-0127; Liu HG, 1999, J BIOL CHEM, V274, P10557, DOI 10.1074/jbc.274.15.10557; Liu LD, 2003, P NATL ACAD SCI USA, V100, P8532, DOI 10.1073/pnas.1332804100; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; MacKenzie SJ, 2000, J BIOL CHEM, V275, P16609, DOI 10.1074/jbc.275.22.16609; McConnachie G, 2006, TRENDS MOL MED, V12, P317, DOI 10.1016/j.molmed.2006.05.008; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Myers MG, 2010, TRENDS ENDOCRIN MET, V21, P643, DOI 10.1016/j.tem.2010.08.002; Nishimoto S, 2006, EMBO REP, V7, P782, DOI 10.1038/sj.embor.7400755; Niswender KD, 2003, FRONT NEUROENDOCRIN, V24, P1, DOI 10.1016/S0091-3022(02)00105-X; Olson EN, 2000, BIOESSAYS, V22, P510, DOI 10.1002/(SICI)1521-1878(200006)22:6<510::AID-BIES4>3.3.CO;2-T; Pan YW, 2012, J NEUROSCI, V32, P6444, DOI 10.1523/JNEUROSCI.6076-11.2012; Pearson GW, 2006, MOL CELL BIOL, V26, P3039, DOI 10.1128/MCB.26.8.3039-3047.2006; Perez-Madrigal D, 2012, CELL SIGNAL, V24, P2360, DOI 10.1016/j.cellsig.2012.08.001; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ranganathan A, 2006, ARCH BIOCHEM BIOPHYS, V449, P8, DOI 10.1016/j.abb.2006.02.023; Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535; Rao A, 2000, BRIT MED BULL, V56, P969, DOI 10.1258/0007142001903634; Regan CP, 2002, P NATL ACAD SCI USA, V99, P9248, DOI 10.1073/pnas.142293999; Rincon M, 2009, IMMUNOL REV, V228, P212, DOI 10.1111/j.1600-065X.2008.00744.x; Roberts OL, 2009, BIOCHEM SOC T, V37, P1254, DOI 10.1042/BST0371254; Robidoux J, 2004, ANNU REV PHARMACOL, V44, P297, DOI 10.1146/annurev.pharmtox.44.101802.121659; Rosen ED, 2000, GENE DEV, V14, P1293; Semple RK, 2008, DIABETES CARE, V31, P977, DOI 10.2337/dc07-2194; Sohn SJ, 2002, J BIOL CHEM, V277, P43344, DOI 10.1074/jbc.M207573200; Soto-Nieves N, 2009, J EXP MED, V206, P867, DOI 10.1084/jem.20082731; Steppan CM, 2002, TRENDS ENDOCRIN MET, V13, P18, DOI 10.1016/S1043-2760(01)00522-7; Szaszak M, 2008, CELL SIGNAL, V20, P590, DOI 10.1016/j.cellsig.2007.10.020; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Thaler JP, 2010, ENDOCRINOLOGY, V151, P4109, DOI 10.1210/en.2010-0336; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Wang X, 2006, CELL DEATH DIFFER, V13, P2099, DOI 10.1038/sj.cdd.4401969; Wang X, 2006, CELL SIGNAL, V18, P753, DOI 10.1016/j.cellsig.2005.11.003; Wang X, 2005, MOL CELL BIOL, V25, P336, DOI 10.1128/MCB.25.1.336-345.2005; Wang ZV, 2010, ENDOCRINOLOGY, V151, P2933, DOI 10.1210/en.2010-0136; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yan Lijun, 2003, BMC Dev Biol, V3, P11, DOI 10.1186/1471-213X-3-11; Yang TTC, 2008, MOL CELL BIOL, V28, P3489, DOI 10.1128/MCB.01847-07; Yang TTC, 2006, MOL CELL BIOL, V26, P7372, DOI 10.1128/MCB.00580-06; Yang TTC, 2003, J BIOL CHEM, V278, P15874, DOI 10.1074/jbc.M211560200; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665; Zhu H, 2010, MOL CELL BIOL, V30, P4379, DOI 10.1128/MCB.01193-09; Zou JH, 2012, J NEUROSCI, V32, P4118, DOI 10.1523/JNEUROSCI.6260-11.2012	85	15	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6311	6322		10.1074/jbc.M113.506584	http://dx.doi.org/10.1074/jbc.M113.506584			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24425864	Green Published, hybrid			2022-12-28	WOS:000332015500082
J	Siller, M; Goyal, S; Yoshimoto, FK; Xiao, Y; Wei, SZ; Guengerich, FP				Siller, Michal; Goyal, Sandeep; Yoshimoto, Francis K.; Xiao, Yi; Wei, Shouzou; Guengerich, F. Peter			Oxidation of Endogenous N-Arachidonoylserotonin by Human Cytochrome P450 2U1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arachidonic Acid; Cytochrome P450; Eicosanoid; Lipid Oxidation; Mass Spectrometry (MS)	FATTY-ACID HYDROXYLATION; MASS-SPECTROMETRY DATA; OMEGA-HYDROXYLATION; DRUG-METABOLISM; IDENTIFICATION; ENZYMES; PROTEINS; EXPRESSION; PURIFICATION; ELUCIDATION	Background: Cytochrome P450 (P450, CYP) 2U1 is an orphan enzyme, only reported to catalyze some fatty acid oxidations. Results: Metabolomic screening led to the identification of N-arachidonoylserotonin as a substrate. Conclusion: P450 2U1 catalyzes oxygenation at C-2 of the indole ring. Significance: The localization of P450 2U1 and its metabolism of an inhibitor of fatty acid amide hydrolase may indicate a function in brain. Cytochrome P450 (P450) 2U1 has been shown to be expressed, at the mRNA level, in human thymus, brain, and several other tissues. Recombinant P450 2U1 was purified and used as a reagent in a metabolomic search for substrates in bovine brain. In addition to fatty acid oxidation reactions, an oxidation of endogenous N-arachidonoylserotonin was characterized. Subsequent NMR and mass spectrometry and chemical synthesis showed that the main product was the result of C-2 oxidation of the indole ring, in contrast to other human P450s that generated different products. N-Arachidonoylserotonin, first synthesized chemically and described as an inhibitor of fatty acid amide hydrolase, had previously been found in porcine and mouse intestine; we demonstrated its presence in bovine and human brain samples. The product (2-oxo) was 4-fold less active than N-arachidonoylserotonin in inhibiting fatty acid amide hydrolase. The rate of oxidation of N-arachidonoylserotonin was similar to that of arachidonic acid, one of the previously identified fatty acid substrates of P450 2U1. The demonstration of the oxidation of N-arachidonoylserotonin by P450 2U1 suggests a possible role in human brain and possibly other sites.	[Siller, Michal; Goyal, Sandeep; Yoshimoto, Francis K.; Xiao, Yi; Wei, Shouzou; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Siller, Michal; Goyal, Sandeep; Yoshimoto, Francis K.; Xiao, Yi; Wei, Shouzou; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA; [Siller, Michal] Palacky Univ, Inst Mol & Translat Med, Div Pharmacol & Toxicol, Olomouc 77515, Czech Republic	Vanderbilt University; Vanderbilt University; Palacky University Olomouc	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu	GOYAL, SANDEEP/I-2773-2019	GOYAL, SANDEEP/0000-0002-7011-8886; Yoshimoto, Francis/0000-0002-2308-2999	United States Public Health Service [R37 CA090426, P30 ES000267]; Czech Republic [CZ.1.05/2.1.00/01.0030, CZ.1.07/2.4.00/17.0015]; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028, P30ES000267] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Czech Republic(Czech Republic Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was partially supported by United States Public Health Service Grants R37 CA090426 and P30 ES000267 and Czech Republic Projects CZ.1.05/2.1.00/01.0030 (Biomedicine for Development and Human Resources) and CZ.1.07/2.4.00/17.0015 (TransMedChem).	Bisogno T, 1998, BIOCHEM BIOPH RES CO, V248, P515, DOI 10.1006/bbrc.1998.8874; BODDUPALLI SS, 1992, ARCH BIOCHEM BIOPHYS, V292, P20, DOI 10.1016/0003-9861(92)90045-X; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Choudhary D, 2005, ARCH BIOCHEM BIOPHYS, V436, P50, DOI 10.1016/j.abb.2005.02.001; Chuang SS, 2004, J BIOL CHEM, V279, P6305, DOI 10.1074/jbc.M311830200; Chun YJ, 2007, J BIOL CHEM, V282, P17486, DOI 10.1074/jbc.M700863200; Coon MJ, 2005, ANNU REV PHARMACOL, V45, P1, DOI 10.1146/annurev.pharmtox.45.120403.100030; Dierks EA, 1998, J BIOL CHEM, V273, P23055, DOI 10.1074/jbc.273.36.23055; Dong MS, 1996, ARCH BIOCHEM BIOPHYS, V327, P11, DOI 10.1006/abbi.1996.0086; Dong MS, 1996, BIOCHEMISTRY-US, V35, P10031, DOI 10.1021/bi960873z; Fujishiro T, 2011, J BIOL CHEM, V286, P29941, DOI 10.1074/jbc.M111.245225; Gerlt JA, 2012, J BIOL CHEM, V287, P29, DOI 10.1074/jbc.R111.240945; Gillam EMJ, 2000, BIOCHEMISTRY-US, V39, P13817, DOI 10.1021/bi001229u; Gilmore AJ, 2012, BRIT J PHARMACOL, V167, P1076, DOI 10.1111/j.1476-5381.2012.02047.x; Goldstone JV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-643; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich F. P., 2007, PRINCIPLES METHODS T, P1981; Guengerich FP, 2011, PHARMACOL REV, V63, P684, DOI 10.1124/pr.110.003525; Guengerich FP, 2010, MOL INTERV, V10, P153, DOI 10.1124/mi.10.3.6; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; GUENGERICH FP, 1978, BIOCHEMISTRY-US, V17, P3633, DOI 10.1021/bi00610a033; Guengerich FP, 1996, CRIT REV TOXICOL, V26, P551, DOI 10.3109/10408449609037477; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; Hanson AD, 2010, BIOCHEM J, V425, P1, DOI 10.1042/BJ20091328; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Jakoby W. B., 1980, ENZYMATIC BASIS DETO, V1, P1; Jarrar YB, 2013, PROSTAG LEUKOTR ESS, V89, P227, DOI 10.1016/j.plefa.2013.06.008; Johnson EF, 2013, J BIOL CHEM, V288, P17082, DOI 10.1074/jbc.R113.452805; JONES P, 1968, BIOCHEM J, V110, P617, DOI 10.1042/bj1100617; Karlgren M, 2004, BIOCHEM BIOPH RES CO, V315, P679, DOI 10.1016/j.bbrc.2004.01.110; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee DS, 2003, J BIOL CHEM, V278, P9761, DOI 10.1074/jbc.M211575200; Leung D, 2006, BIOCHEMISTRY-US, V45, P4720, DOI 10.1021/bi060163l; LU AYH, 1968, J BIOL CHEM, V243, P1331; Ma XC, 2005, DRUG METAB DISPOS, V33, P489, DOI 10.1124/dmd.104.002410; Maione S, 2007, BRIT J PHARMACOL, V150, P766, DOI 10.1038/sj.bjp.0707145; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Mast N, 2003, BIOCHEMISTRY-US, V42, P14284, DOI 10.1021/bi035512f; Mast N, 2010, J BIOL CHEM, V285, P31783, DOI 10.1074/jbc.M110.143313; MEINNEL T, 1993, BIOCHIMIE, V75, P1061, DOI 10.1016/0300-9084(93)90005-D; Nishihara K, 1998, APPL ENVIRON MICROB, V64, P1694; Nordstrom A, 2006, ANAL CHEM, V78, P3289, DOI 10.1021/ac060245f; OMURA T, 1964, J BIOL CHEM, V239, P2370; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Parikh A, 1997, NAT BIOTECHNOL, V15, P784, DOI 10.1038/nbt0897-784; Patricelli MP, 1999, BIOCHEMISTRY-US, V38, P14125, DOI 10.1021/bi991876p; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Sanchez-Ponce R, 2007, ANAL CHEM, V79, P3355, DOI 10.1021/ac0622781; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; SHIMADA T, 1986, J BIOL CHEM, V261, P909; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Tang ZM, 2009, ANAL CHEM, V81, P3071, DOI 10.1021/ac900021a; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Verhoeckx KCM, 2011, BBA-MOL CELL BIOL L, V1811, P578, DOI 10.1016/j.bbalip.2011.07.008; Wu KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039006; Wu ZL, 2006, MOL PHARMACOL, V69, P2007, DOI 10.1124/mol.106.023648; Wu ZL, 2009, BIOTECHNOL LETT, V31, P1589, DOI 10.1007/s10529-009-0059-5; Xiao Y, 2012, J LIPID RES, V53, P1610, DOI 10.1194/jlr.M027185; Yoo JM, 2013, INT IMMUNOPHARMACOL, V17, P123, DOI 10.1016/j.intimp.2013.05.013	61	22	24	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10476	10487		10.1074/jbc.M114.550004	http://dx.doi.org/10.1074/jbc.M114.550004			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24563460	Green Published, hybrid			2022-12-28	WOS:000334226400021
J	Simon, C; Klose, T; Herbst, S; Han, BG; Sinz, A; Glaeser, RM; Stubbs, MT; Lilie, H				Simon, Claudia; Klose, Thomas; Herbst, Sabine; Han, Bong Gyoon; Sinz, Andrea; Glaeser, Robert M.; Stubbs, Milton T.; Lilie, Hauke			Disulfide Linkage and Structure of Highly Stable Yeastderived Virus-like Particles of Murine Polyomavirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Protein Self-assembly; Protein Stability; Viral Protein; Virus Assembly; Yeast	MAJOR CAPSID PROTEIN; HIGH-LEVEL EXPRESSION; SIMIAN-VIRUS-40 VP1; INSECT CELLS; YEAST-CELLS; RESOLUTION; SOFTWARE; COMPLEX	Background: Polyoma virus-like particles produced in vivo (yVLPs) are more stable than those assembled in vitro. Results: yVLPs exhibit higher disulfide connectivity and additional N-terminal structural features in VP1. Conclusion: An ordered network of cystine-bridged VP1 N-terminal peptides contributes to polyoma virus capsid stability. Significance: These results suggest a role for intracellular components in optimizing capsid assembly. VP1 is the major coat protein of murine polyomavirus and forms virus-like particles (VLPs) in vitro. VLPs consist of 72 pentameric VP1 subunits held together by a terminal clamp structure that is further stabilized by disulfide bonds and chelation of calcium ions. Yeast-derived VLPs (yVLPs) assemble intracellularly in vivo during recombinant protein production. These in vivo assembled yVLPs differ in several properties from VLPs assembled in vitro from bacterially produced pentamers. We found several intermolecular disulfide linkages in yVLPs involving 5 of the 6 cysteines of VP1 (Cys(115)-Cys(20), Cys(12)-Cys(20), Cys(16)-Cys(16), Cys(12)/ Cys(16)-Cys(115), and Cys(274)-Cys(274)), indicating a highly coordinated disulfide network within the in vivo assembled particles involving the N-terminal region of VP1. Cryoelectron microscopy revealed structured termini not resolved in the published crystal structure of the bacterially expressed VLP that appear to clamp the pentameric subunits together. These structural features are probably the reason for the observed higher stability of in vivo assembled yVLPs compared with in vitro assembled bacterially expressed VLPs as monitored by increased thermal stability, higher resistance to trypsin cleavage, and a higher activation enthalpy of the disassembly reaction. This high stability is decreased following disassembly of yVLPs and subsequent in vitro reassembly, suggesting a role for cellular components in optimal assembly.	[Simon, Claudia; Stubbs, Milton T.; Lilie, Hauke] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Germany; [Klose, Thomas] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Herbst, Sabine; Sinz, Andrea] Univ Halle Wittenberg, Inst Pharm, D-06120 Halle, Germany; [Han, Bong Gyoon; Glaeser, Robert M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	Martin Luther University Halle Wittenberg; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Martin Luther University Halle Wittenberg; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Lilie, H (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, Kurt Mothes Str 03, D-06120 Halle, Germany.	hauke.lilie@biochemtech.uni-halle.de	Stubbs, Milton/ABC-7585-2020	Stubbs, Milton/0000-0003-1278-9013; Simon, Claudia/0000-0003-1976-5305	Deutsche Forschungsgemeinschaft [GRK 1026]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant GRK 1026.	Ashcroft AE, 2005, J NANOSCI NANOTECHNO, V5, P2034, DOI 10.1166/jnn.2005.507; Bird G, 2008, J VIROL, V82, P9848, DOI 10.1128/JVI.01221-08; Bundy BC, 2011, J BIOTECHNOL, V154, P230, DOI 10.1016/j.jbiotec.2011.04.011; Chang DC, 1997, J GEN VIROL, V78, P1435, DOI 10.1099/0022-1317-78-6-1435; Chromy LR, 2003, P NATL ACAD SCI USA, V100, P10477, DOI 10.1073/pnas.1832245100; CRIPE TP, 1995, J VIROL, V69, P7807, DOI 10.1128/JVI.69.12.7807-7813.1995; DeLano W.L, PYMOL MOL GRAPHICS S; Erickson KD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002630; Frank J, 2006, 3 DIMENSIONAL ELECT, P71; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Inoue T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002037; Jao CC, 1999, J GEN VIROL, V80, P2481, DOI 10.1099/0022-1317-80-9-2481; LEAVITT AD, 1985, J BIOL CHEM, V260, P2803; Li PP, 2000, J VIROL, V74, P11388, DOI 10.1128/JVI.74.23.11388-11393.2000; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; Liew MWO, 2010, J BIOTECHNOL, V150, P224, DOI 10.1016/j.jbiotec.2010.08.010; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mannova P, 2003, J VIROL, V77, P1672, DOI 10.1128/JVI.77.3.1672-1681.2003; MONTROSS L, 1991, J VIROL, V65, P4991, DOI 10.1128/JVI.65.9.4991-4998.1991; Palkova Z, 2000, FEBS LETT, V478, P281, DOI 10.1016/S0014-5793(00)01787-7; Palkova Z, 2000, FEBS LETT, V467, P359, DOI 10.1016/S0014-5793(00)01170-4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Richterova Z, 2001, J VIROL, V75, P10880, DOI 10.1128/JVI.75.22.10880-10891.2001; SALUNKE DM, 1989, BIOPHYS J, V56, P887, DOI 10.1016/S0006-3495(89)82735-3; SALUNKE DM, 1986, CELL, V46, P895, DOI 10.1016/0092-8674(86)90071-1; Sasnauskas K, 1999, BIOL CHEM, V380, P381, DOI 10.1515/BC.1999.050; Sasnauskas K, 2002, INTERVIROLOGY, V45, P308, DOI 10.1159/000067922; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; Schmidt U, 2000, J VIROL, V74, P1658, DOI 10.1128/JVI.74.4.1658-1662.2000; Simon C, 2013, PREP BIOCHEM BIOTECH, V43, P217, DOI 10.1080/10826068.2012.750613; Stehle T, 1996, STRUCTURE, V4, P183, DOI 10.1016/S0969-2126(96)00021-4; Stehle T, 1997, EMBO J, V16, P5139, DOI 10.1093/emboj/16.16.5139; Typke D, 2005, J STRUCT BIOL, V149, P17, DOI 10.1016/j.jsb.2004.09.003; Walczak CP, 2011, J VIROL, V85, P2386, DOI 10.1128/JVI.01855-10	34	14	14	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10411	10418		10.1074/jbc.M113.484162	http://dx.doi.org/10.1074/jbc.M113.484162			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24567335	Green Published, hybrid			2022-12-28	WOS:000334226400015
J	VanLeeuwen, JE; Rafalovich, I; Sellers, K; Jones, KA; Griffith, TN; Huda, R; Miller, RJ; Srivastava, DP; Penzes, P				VanLeeuwen, Jon-Eric; Rafalovich, Igor; Sellers, Katherine; Jones, Kelly A.; Griffith, Theanne N.; Huda, Rafiq; Miller, Richard J.; Srivastava, Deepak P.; Penzes, Peter			Coordinated Nuclear and Synaptic Shuttling of Afadin Promotes Spine Plasticity and Histone Modifications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Biology; Chromatin Histone Modification; Neurobiology; Nucleus; Signaling; Synapses; Synaptic Plasticity; AF-6; Dendritic Spine; Small GTPase	PHOSPHORYLATION; TRANSCRIPTION; ACTIVATION; STIMULI; NEURONS; PROTEIN; AF-6	Background: Coordinated synaptic and nuclear signaling is required for long lasting changes in neuronal morphology. Results: Afadin undergoes activity-dependent bi-directional shuttling to synapses and the nucleus resulting in dendritic spine remodeling and histone modifications. Conclusion: Afadin is required for coordinated signaling at synapses and the nucleus. Significance: Bi-directional trafficking of afadin is required for coordinated synaptic and nuclear signaling in response to activity-dependent stimulation. The ability of a neuron to transduce extracellular signals into long lasting changes in neuronal morphology is central to its normal function. Increasing evidence shows that coordinated regulation of synaptic and nuclear signaling in response to NMDA receptor activation is crucial for long term memory, synaptic tagging, and epigenetic signaling. Although mechanisms have been proposed for synapse-to-nuclear communication, it is unclear how signaling is coordinated at both subcompartments. Here, we show that activation of NMDA receptors induces the bi-directional and concomitant shuttling of the scaffold protein afadin from the cytosol to the nucleus and synapses. Activity-dependent afadin nuclear translocation peaked 2 h post-stimulation, was independent of protein synthesis, and occurred concurrently with dendritic spine remodeling. Moreover, activity-dependent afadin nuclear translocation coincides with phosphorylation of histone H3 at serine 10 (H3S10p), a marker of epigenetic modification. Critically, blocking afadin nuclear accumulation attenuated activity-dependent dendritic spine remodeling and H3 phosphorylation. Collectively, these data support a novel model of neuronal nuclear signaling whereby dual-residency proteins undergo activity-dependent bi-directional shuttling from the cytosol to synapses and the nucleus, coordinately regulating dendritic spine remodeling and histone modifications.	[VanLeeuwen, Jon-Eric; Rafalovich, Igor; Jones, Kelly A.; Griffith, Theanne N.; Huda, Rafiq; Srivastava, Deepak P.; Penzes, Peter] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Miller, Richard J.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Penzes, Peter] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Sellers, Katherine; Srivastava, Deepak P.] Kings Coll London, Inst Psychiat, Dept Neurosci, James Black Ctr, London SE5 8AF, England; [Sellers, Katherine; Srivastava, Deepak P.] Kings Coll London, Inst Psychiat, James Black Ctr, Ctr Cellular Basis Behav, London SE5 8AF, England	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of London; King's College London; University of London; King's College London	Srivastava, DP (corresponding author), 125 Coldharbour Lane, London SE5 9NU, England.	deepak.srivsatava@kcl.ac.uk; p-penzes@northwestern.edu	Penzes, Peter/L-3987-2016; Griffith, Theanne/AAF-8560-2021	Penzes, Peter/0000-0001-5449-1640; Huda, Rafiq/0000-0002-6814-9966; Sellers, Katherine/0000-0003-0125-657X; Srivastava, Deepak Prakash/0000-0001-6512-9065	National Institutes of Health [DA013141-11A1]; NIMH [MH071316, MH097216]; Ruth L. Kirschstein NRSA [1F31MH087043, 1F31MH085362, 1F31NS076201]; Royal Society United Kingdom; Brain and Behavior Foundation; Psychiatric Research Trust; American Heart Association; National Science Foundation Grant [DGE-0824162]; Autism Speaks; NARSAD; Brain Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071316, F31MH087043, F31MH085362, R01MH097216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS076201] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ruth L. Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society United Kingdom(Royal Society of London); Brain and Behavior Foundation; Psychiatric Research Trust; American Heart Association(American Heart Association); National Science Foundation Grant(National Science Foundation (NSF)); Autism Speaks; NARSAD(NARSAD); Brain Research Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA013141-11A1 (to R. J. M.), Grants MH071316 and MH097216 from NIMH (to P. P.), and Ruth L. Kirschstein NRSA 1F31MH087043 (to J. E. V.), 1F31MH085362 (to K. A. J.), and 1F31NS076201 (to R. H.). This work was also supported by grants from the Royal Society United Kingdom, Brain and Behavior Foundation (formally National Alliance for Research on Schizophrenia and Depression (NARSAD)), Psychiatric Research Trust, and American Heart Association (to D. P. S.), National Science Foundation Grant DGE-0824162 (to I. R.), and Autism Speaks, NARSAD, Brain Research Foundation.	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Brami-Cherrier K, 2007, J NEUROCHEM, V101, P697, DOI 10.1111/j.1471-4159.2006.04352.x; Buchert M, 2007, J CELL PHYSIOL, V210, P212, DOI 10.1002/jcp.20853; Ch'ng TH, 2012, CELL, V150, P207, DOI 10.1016/j.cell.2012.05.027; Ch'ng TH, 2011, CURR OPIN NEUROBIOL, V21, P345, DOI 10.1016/j.conb.2011.01.011; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Crosio C, 2003, J CELL SCI, V116, P4905, DOI 10.1242/jcs.00804; Dieterich DC, 2008, PLOS BIOL, V6, P286, DOI 10.1371/journal.pbio.0060034; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Haskin J, 2013, HUM MOL GENET, V22, P2083, DOI 10.1093/hmg/ddt058; Jordan BA, 2007, NAT NEUROSCI, V10, P427, DOI 10.1038/nn1867; Jordan BA, 2009, TRENDS NEUROSCI, V32, P392, DOI 10.1016/j.tins.2009.04.001; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Lubin FD, 2007, NEURON, V55, P942, DOI 10.1016/j.neuron.2007.07.039; Majima T, 2009, BIOCHEM BIOPH RES CO, V385, P539, DOI 10.1016/j.bbrc.2009.05.097; Maze I, 2013, NEUROPSYCHOPHARMACOL, V38, P3, DOI 10.1038/npp.2012.124; Nishioka H, 2000, J COMP NEUROL, V424, P297, DOI 10.1002/1096-9861(20000821)424:2<297::AID-CNE8>3.0.CO;2-J; Proepper C, 2007, EMBO J, V26, P1397, DOI 10.1038/sj.emboj.7601569; Riccio A, 2010, NAT NEUROSCI, V13, P1330, DOI 10.1038/nn.2671; Saha RN, 2011, NAT NEUROSCI, V14, P848, DOI 10.1038/nn.2839; Sananbenesi F, 2002, MOL CELL NEUROSCI, V21, P463, DOI 10.1006/mcne.2002.1188; Srivastava DP, 2008, P NATL ACAD SCI USA, V105, P14650, DOI 10.1073/pnas.0801581105; Srivastava DP, 2012, J BIOL CHEM, V287, P35964, DOI 10.1074/jbc.M112.363358; Srivastava DP, 2011, JOVE-J VIS EXP, DOI 10.3791/2794; Stipanovich A, 2008, NATURE, V453, P879, DOI 10.1038/nature06994; Thomas GM, 2005, P NATL ACAD SCI USA, V102, P15006, DOI 10.1073/pnas.0507476102; Xie Z, 2008, J NEUROSCI, V28, P6079, DOI 10.1523/JNEUROSCI.1170-08.2008; Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005; Zhai SY, 2013, SCIENCE, V342, P1107, DOI 10.1126/science.1245622	31	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10831	10842		10.1074/jbc.M113.536391	http://dx.doi.org/10.1074/jbc.M113.536391			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24567331	Green Published, hybrid			2022-12-28	WOS:000334226400051
J	Hakim, F; Kaitsuka, T; Raeed, JM; Wei, FY; Shiraki, N; Akagi, T; Yokota, T; Kume, S; Tomizawa, K				Hakim, Farzana; Kaitsuka, Taku; Raeed, Jamiruddin Mohd; Wei, Fan-Yan; Shiraki, Nobuaki; Akagi, Tadayuki; Yokota, Takashi; Kume, Shoen; Tomizawa, Kazuhito			High Oxygen Condition Facilitates the Differentiation of Mouse and Human Pluripotent Stem Cells into Pancreatic Progenitors and Insulin-producing Cells*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Differentiation; Embryonic Stem Cell; Hypoxia-inducible Factor; Induced Pluripotent Stem Cells; Regenerative Medicine	HYPOXIA-INDUCIBLE FACTOR-1; BETA-CELL; EMBRYONIC-DEVELOPMENT; DEFINITIVE ENDODERM; SELF-RENEWAL; EFFICIENT DIFFERENTIATION; ENDOCRINE-CELLS; GENE-EXPRESSION; IN-VITRO; WNT	Background: Oxygen plays a key role in organ development, including pancreatic -cells. Results: High oxygen conditions increase Ngn3-positive and insulin-positive cells from both mouse and human pluripotent stem cells. Conclusion: Culturing under high oxygen conditions has a facilitative effect on pancreatic differentiation. Significance: This new technique provides an efficient method to utilize patient-specific iPS cells for the treatment of diabetes. Pluripotent stem cells have potential applications in regenerative medicine for diabetes. Differentiation of stem cells into insulin-producing cells has been achieved using various protocols. However, both the efficiency of the method and potency of differentiated cells are insufficient. Oxygen tension, the partial pressure of oxygen, has been shown to regulate the embryonic development of several organs, including pancreatic -cells. In this study, we tried to establish an effective method for the differentiation of induced pluripotent stem cells (iPSCs) into insulin-producing cells by culturing under high oxygen (O-2) conditions. Treatment with a high O-2 condition in the early stage of differentiation increased insulin-positive cells at the terminus of differentiation. We found that a high O-2 condition repressed Notch-dependent gene Hes1 expression and increased Ngn3 expression at the stage of pancreatic progenitors. This effect was caused by inhibition of hypoxia-inducible factor-1 protein level. Moreover, a high O-2 condition activated Wnt signaling. Optimal stage-specific treatment with a high O-2 condition resulted in a significant increase in insulin production in both mouse embryonic stem cells and human iPSCs and yielded populations containing up to 10% C-peptide-positive cells in human iPSCs. These results suggest that culturing in a high O-2 condition at a specific stage is useful for the efficient generation of insulin-producing cells.	[Hakim, Farzana; Kaitsuka, Taku; Raeed, Jamiruddin Mohd; Wei, Fan-Yan; Tomizawa, Kazuhito] Kumamoto Univ, Dept Mol Physiol, Fac Life Sci, Chuo Ku, Kumamoto 8608556, Japan; [Hakim, Farzana; Akagi, Tadayuki; Yokota, Takashi] Kanazawa Univ, Grad Sch Med Sci, Dept Stem Cell Biol, Kanazawa, Ishikawa 9208640, Japan; [Shiraki, Nobuaki; Kume, Shoen] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Stem Cell Biol, Chuo Ku, Kumamoto 8600811, Japan; [Shiraki, Nobuaki; Kume, Shoen] Kumamoto Univ, Global Centers Excellence, Chuo Ku, Kumamoto 8600811, Japan	Kumamoto University; Kanazawa University; Kumamoto University; Kumamoto University	Tomizawa, K (corresponding author), Kumamoto Univ, Dept Mol Physiol, Fac Life Sci, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	tomikt@kumamoto-u.ac.jp	Yokota, Takashi/J-8483-2015; Wei, Fan-Yan/AAD-8461-2021; Tomizawa, Kazuhito/F-2405-2015; Kume, Shoen/M-4356-2016; Jamiruddin, Mohd. Raeed/ABA-3747-2020; Akagi, Tadayuki/E-1078-2011	Tomizawa, Kazuhito/0000-0002-5663-2627; Kume, Shoen/0000-0002-4292-205X; Jamiruddin, Mohd. Raeed/0000-0003-0495-4808; Akagi, Tadayuki/0000-0002-1733-9452; shiraki, nobuaki/0000-0001-6708-9976; Wei, Fan-Yan/0000-0002-4843-724X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science through its "Funding Program for Next Generation World-leading Researchers"; Uehara Memorial Foundation; Takeda Science Foundation; Grants-in-Aid for Scientific Research [26253059] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science through its "Funding Program for Next Generation World-leading Researchers"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, by the Japan Society for the Promotion of Science through its "Funding Program for Next Generation World-leading Researchers," by the Uehara Memorial Foundation, and by the Takeda Science Foundation.	Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Baetge EE, 2008, DIABETES OBES METAB, V10, P186, DOI 10.1111/j.1463-1326.2008.00956.x; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; Cheng X, 2012, CELL STEM CELL, V10, P371, DOI 10.1016/j.stem.2012.02.024; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; Fraker CA, 2007, STEM CELLS, V25, P3155, DOI 10.1634/stemcells.2007-0445; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2004, DEVELOPMENT, V131, P165, DOI 10.1242/dev.00921; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Heinis M, 2012, FASEB J, V26, P2734, DOI 10.1096/fj.11-199224; Heinis M, 2010, DIABETES, V59, P662, DOI 10.2337/db09-0891; Higuchi Y, 2010, J CELL SCI, V123, P2733, DOI 10.1242/jcs.066886; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kaitsuka T, 2014, STEM CELL TRANSL MED, V3, P114, DOI 10.5966/sctm.2013-0075; Keenan ID, 2006, DEV BIOL, V299, P478, DOI 10.1016/j.ydbio.2006.08.040; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Kunisada Y, 2012, STEM CELL RES, V8, P274, DOI 10.1016/j.scr.2011.10.002; Lee JC, 2001, DIABETES, V50, P928, DOI 10.2337/diabetes.50.5.928; Lee SW, 2012, EMBO MOL MED, V4, P924, DOI 10.1002/emmm.201101107; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; Mclin VA, 2007, DEVELOPMENT, V134, P2207, DOI 10.1242/dev.001230; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Nostro MC, 2011, DEVELOPMENT, V138, P861, DOI 10.1242/dev.055236; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Pagliuca FW, 2013, DEVELOPMENT, V140, P2472, DOI 10.1242/dev.093187; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sakano D, 2014, NAT CHEM BIOL, V10, P141, DOI 10.1038/nchembio.1410; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schipani E, 2001, GENE DEV, V15, P2865; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shah SR, 2011, DEV BIOL, V349, P342, DOI 10.1016/j.ydbio.2010.10.033; Shiraki N, 2008, STEM CELLS, V26, P874, DOI 10.1634/stemcells.2007-0608; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Sneddon JB, 2012, NATURE, V491, P765, DOI 10.1038/nature11463; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Spence JR, 2007, DEV DYNAM, V236, P3218, DOI 10.1002/dvdy.21366; Sulzbacher S, 2009, STEM CELL REV REP, V5, P159, DOI 10.1007/s12015-009-9061-5; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Tsaniras SC, 2010, J ENDOCRINOL, V206, P13, DOI 10.1677/JOE-10-0073; Yamaguchi TP, 2001, CURR BIOL, V11, pR713, DOI 10.1016/S0960-9822(01)00417-1; Yi F, 2011, NAT CELL BIOL, V13, P762, DOI 10.1038/ncb2283; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28	59	30	34	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9623	9638		10.1074/jbc.M113.524363	http://dx.doi.org/10.1074/jbc.M113.524363			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24554704	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000333807000017
J	Nissim, I; Horyn, O; Daikhin, Y; Chen, P; Li, CH; Wehrli, SL; Nissim, I; Yudkoff, M				Nissim, Itzhak; Horyn, Oksana; Daikhin, Yevgeny; Chen, Pan; Li, Changhong; Wehrli, Suzanne L.; Nissim, Ilana; Yudkoff, Marc			The Molecular and Metabolic Influence of Long Term Agmatine Consumption*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adenylate Cyclase (Adenylyl Cyclase); Carbohydrate Metabolism; Carnitine; Cyclic AMP (cAMP); Fatty Acid Oxidation; Insulin Resistance; Liver; Metabolic Syndrome	ACTIVATED-RECEPTOR-ALPHA; TANDEM MASS-SPECTROMETRY; PERFUSED-RAT-LIVER; CARNITINE BIOSYNTHESIS; HEPATIC GLUCONEOGENESIS; CALORIC RESTRICTION; HORMONAL-REGULATION; GLUCAGON-SECRETION; ADENYLYL-CYCLASE; UP-REGULATION	Background: Little is known about the molecular and metabolic impact of agmatine consumption. Results: We scrutinized the impact of long term agmatine treatment on whole body metabolic profiling and gene expression in rats. Agmatine elevated [cAMP] and triggered widespread changes in gene expression and metabolomic profiling. Conclusion: Agmatine influences on metabolism may be mediated via cAMP-PKA. Significance: Agmatine may curtail the metabolic and hormonal derangements associated with obesity. Agmatine (AGM), a product of arginine decarboxylation, influences multiple physiologic and metabolic functions. However, the mechanism(s) of action, the impact on whole body gene expression and metabolic pathways, and the potential benefits and risks of long term AGM consumption are still a mystery. Here, we scrutinized the impact of AGM on whole body metabolic profiling and gene expression and assessed a plausible mechanism(s) of AGM action. Studies were performed in rats fed a high fat diet or standard chow. AGM was added to drinking water for 4 or 8 weeks. We used C-13 or N-15 tracers to assess metabolic reactions and fluxes and real time quantitative PCR to determine gene expression. The results demonstrate that AGM elevated the synthesis and tissue level of cAMP. Subsequently, AGM had a widespread impact on gene expression and metabolic profiling including (a) activation of peroxisomal proliferator-activated receptor- and its coactivator, PGC1, and (b) increased expression of peroxisomal proliferator-activated receptor- and genes regulating thermogenesis, gluconeogenesis, and carnitine biosynthesis and transport. The changes in gene expression were coupled with improved tissue and systemic levels of carnitine and short chain acylcarnitine, increased -oxidation but diminished incomplete fatty acid oxidation, decreased fat but increased protein mass, and increased hepatic ureagenesis and gluconeogenesis but decreased glycolysis. These metabolic changes were coupled with reduced weight gain and a curtailment of the hormonal and metabolic derangements associated with high fat diet-induced obesity. The findings suggest that AGM elevated the synthesis and levels of cAMP, thereby mimicking the effects of caloric restriction with respect to metabolic reprogramming.	[Nissim, Itzhak; Horyn, Oksana; Daikhin, Yevgeny; Chen, Pan; Li, Changhong; Wehrli, Suzanne L.; Nissim, Ilana; Yudkoff, Marc] Univ Penn, Sch Med, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Nissim, Itzhak; Horyn, Oksana; Daikhin, Yevgeny; Nissim, Ilana; Yudkoff, Marc] Univ Penn, Sch Med, Div Metab Dis, Philadelphia, PA 19104 USA; [Chen, Pan; Li, Changhong] Univ Penn, Sch Med, Div Endocrinol, Philadelphia, PA 19104 USA; [Nissim, Itzhak; Li, Changhong; Yudkoff, Marc] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Nissim, Itzhak] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Nissim, I (corresponding author), Abramson Pediat Res Ctr, Rm 510D,34th St & Civic Ctr Blvd, Philadelphia, PA 19104 USA.	nissim@email.chop.edu			Metabolomic Core of the Children's Hospital of Philadelphia Research Institute; NIH [PO30-DK19525]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD026979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525, R56DK053761, R01DK053761] Funding Source: NIH RePORTER	Metabolomic Core of the Children's Hospital of Philadelphia Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We gratefully acknowledge the support provided by the Metabolomic Core of the Children's Hospital of Philadelphia Research Institute and Heather Collins, Ph.D., for measurement of plasma hormones in the Radioimmunoassay and Biomarkers Core, Penn Diabetes Research Center (supported by NIH Grant PO30-DK19525).	Anderson RM, 2010, TRENDS ENDOCRIN MET, V21, P134, DOI 10.1016/j.tem.2009.11.005; Anghel SI, 2007, CELL RES, V17, P486, DOI 10.1038/cr.2007.48; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Berthon P, 1997, COMP BIOCHEM PHYS A, V117, P141, DOI 10.1016/S0300-9629(96)00239-3; Bevilacqua L, 2005, AM J PHYSIOL-ENDOC M, V289, pE429, DOI 10.1152/ajpendo.00435.2004; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; Burkart EM, 2007, J CLIN INVEST, V117, P3930, DOI 10.1172/JCI32578; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; DIGHE RR, 1984, J CLIN INVEST, V73, P1013, DOI 10.1172/JCI111286; Eder K, 2010, EUR J PHARMACOL, V628, P1, DOI 10.1016/j.ejphar.2009.11.042; EXTON J H, 1987, Diabetes Metabolism Reviews, V3, P163; Fimia GM, 2001, J CELL SCI, V114, P1971; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gutgesell A, 2009, BBA-GEN SUBJECTS, V1790, P1206, DOI 10.1016/j.bbagen.2009.06.012; Hardy AB, 2011, DIABETES OBES METAB, V13, P112, DOI 10.1111/j.1463-1326.2011.01451.x; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Horyn O, 2005, BIOCHEM J, V388, P419, DOI 10.1042/BJ20041260; Jitrapakdee S, 2012, INT J BIOCHEM CELL B, V44, P33, DOI 10.1016/j.biocel.2011.10.001; Kelly DP, 2001, CIRC RES, V89, P935, DOI 10.1161/res.89.11.935; Lamhonwah AM, 2006, BIOCHEM BIOPH RES CO, V345, P1315, DOI 10.1016/j.bbrc.2006.05.026; Lazennec G, 2000, MOL ENDOCRINOL, V14, P1962, DOI 10.1210/me.14.12.1962; Leavens KF, 2009, CELL METAB, V10, P405, DOI 10.1016/j.cmet.2009.10.004; Li CH, 2013, J BIOL CHEM, V288, P3938, DOI 10.1074/jbc.M112.385682; LI G, 1994, SCIENCE, V263, P966, DOI 10.1126/science.7906055; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makowski L, 2009, FASEB J, V23, P586, DOI 10.1096/fj.08-119420; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Minnaard R, 2006, FEBS LETT, V580, P5172, DOI 10.1016/j.febslet.2006.08.066; Muoio DM, 2007, APPL PHYSIOL NUTR ME, V32, P874, DOI 10.1139/H07-083; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; Muoio DM, 2012, CELL METAB, V15, P595, DOI 10.1016/j.cmet.2012.04.010; Nedergaard J, 2005, BBA-MOL BASIS DIS, V1740, P293, DOI 10.1016/j.bbadis.2005.02.003; Nissim I, 2006, J BIOL CHEM, V281, P8486, DOI 10.1074/jbc.M506984200; Nissim I, 1999, J BIOL CHEM, V274, P28958, DOI 10.1074/jbc.274.41.28958; Nissim I, 1996, KIDNEY INT, V49, P684, DOI 10.1038/ki.1996.97; Nissim I, 2006, CANCER RES, V66, P7824, DOI 10.1158/0008-5472.CAN-06-1043; Nissim I, 2012, BIOCHEM J, V444, P537, DOI 10.1042/BJ20120163; Nissim I, 2011, J BIOL CHEM, V286, P22055, DOI 10.1074/jbc.M110.209023; Noland RC, 2009, J BIOL CHEM, V284, P22840, DOI 10.1074/jbc.M109.032888; Nomura M, 2005, GENE, V353, P231, DOI 10.1016/j.gene.2005.04.034; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Piletz JE, 2013, DRUG DISCOV TODAY, V18, P880, DOI 10.1016/j.drudis.2013.05.017; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P817, DOI 10.1210/endo-117-3-817; Ringseis R, 2007, PHARMACOL RES, V56, P175, DOI 10.1016/j.phrs.2007.06.001; Ringseis R, 2011, MOL NUTR FOOD RES, V55, pS193, DOI 10.1002/mnfr.201100040; Robbins D, 2011, INT J MOL SCI, V12, P5285, DOI 10.3390/ijms12085285; Sampey BP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038812; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; Servillo G, 2002, EXP CELL RES, V275, P143, DOI 10.1006/excr.2002.5491; Strijbis K, 2010, IUBMB LIFE, V62, P357, DOI 10.1002/iub.323; Sun Z, 2013, TRENDS ENDOCRIN MET, V24, P4, DOI 10.1016/j.tem.2012.09.005; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; ter Veld F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006449; van Vlies N, 2007, BBA-BIOENERGETICS, V1767, P1134, DOI 10.1016/j.bbabio.2007.07.001; van Vlies N, 2006, ANAL BIOCHEM, V354, P132, DOI 10.1016/j.ab.2006.04.007; Wolf G, 2009, NUTR REV, V67, P167, DOI 10.1111/j.1753-4887.2009.00184.x; Yang LL, 2008, J BIOL CHEM, V283, P21988, DOI 10.1074/jbc.M803455200; Yonezawa T, 2009, IUBMB LIFE, V61, P1123, DOI 10.1002/iub.264	61	33	42	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9710	9729		10.1074/jbc.M113.544726	http://dx.doi.org/10.1074/jbc.M113.544726			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24523404	Green Published, hybrid			2022-12-28	WOS:000333807000024
J	Santhoshkumar, P; Xie, L; Raju, M; Reneker, L; Sharma, KK				Santhoshkumar, Puttur; Xie, Leike; Raju, Murugesan; Reneker, Lixing; Sharma, K. Krishna			Lens Crystallin Modifications and Cataract in Transgenic Mice Overexpressing Acylpeptide Hydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cataract; Lens; Peptides; Protease; Protein Degradation; Transgenic Mice; Crystallins; Acylpeptide Hydrolase	ALPHA-A-CRYSTALLIN; TRYPSIN-MODIFIED BOVINE; AGE-RELATED-CHANGES; HIV-1 PROTEASE; PROTEOMIC ANALYSIS; MOUSE LENS; RAT LENS; PROTEOLYSIS; IDENTIFICATION; DEGRADATION	Background: Acylpeptide hydrolase (APH) in the lens may have an integral role in cataract formation. Results: Transgenic overexpression of APH results in crystallin cleavage, impaired lens development, and cataract. Conclusion: APH may be involved in the generation of peptides that have the potential to induce protein aggregation. Significance: The transgenic APH mouse model could help us understand the role of crystallin fragments in cataractogenesis. The accumulation of crystallin fragments in vivo and their subsequent interaction with crystallins are responsible, in part, for protein aggregation in cataracts. Transgenic mice overexpressing acylpeptide hydrolase (APH) specifically in the lens were prepared to test the role of protease in the generation and accumulation of peptides. Cataract development was seen at various postnatal days in the majority of mice expressing active APH (wt-APH). Cataract onset and severity of the cataracts correlated with the APH protein levels. Lens opacity occurred when APH protein levels were >2.6% of the total lens protein and the specific activity, assayed using Ac-Ala-p-nitroanilide substrate, was >1 unit. Transgenic mice carrying inactive APH (mt-APH) did not develop cataract. Cataract development also correlated with N-terminal cleavage of the APH to generate a 57-kDa protein, along with an increased accumulation of low molecular weight (LMW) peptides, similar to those found in aging human and cataract lenses. Nontransgenic mouse lens proteins incubated with purified wt-APH in vitro resulted in a >20% increase in LMW peptides. Crystallin modifications and cleavage were quite dramatic in transgenic mouse lenses with mature cataract. Affected lenses showed capsule rupture at the posterior pole, with expulsion of the lens nucleus and degenerating fiber cells. Our study suggests that the cleaved APH fragment might exert catalytic activity against crystallins, resulting in the accumulation of distinct LMW peptides that promote protein aggregation in lenses expressing wt-APH. The APH transgenic model we developed will enable in vivo testing of the roles of crystallin fragments in protein aggregation.	[Santhoshkumar, Puttur; Xie, Leike; Raju, Murugesan; Reneker, Lixing; Sharma, K. Krishna] Univ Missouri, Dept Ophthalmol, Columbia, MO 65212 USA; [Sharma, K. Krishna] Univ Missouri, Dept Biochem, Columbia, MO 65212 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Sharma, KK (corresponding author), Univ Missouri, Dept Ophthalmol, Columbia, MO 65212 USA.	Sharmak@health.missouri.edu	Santhoshkumar, Puttur/G-1798-2010	Santhoshkumar, Puttur/0000-0002-6897-7278	National Institutes of Health [EY019878]; University of Missouri Research Board; NATIONAL EYE INSTITUTE [R01EY019878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Missouri Research Board; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant EY019878. This work was also supported by an award from the University of Missouri Research Board.	Alapure BV, 2008, J CATARACT REFR SURG, V34, P2063, DOI 10.1016/j.jcrs.2008.08.016; Asomugha CO, 2010, MOL VIS, V16, P476; Azuma M, 2003, BIOCHEM BIOPH RES CO, V307, P558, DOI 10.1016/S0006-291X(03)01194-X; AZUMA M, 1990, EXP EYE RES, V51, P393, DOI 10.1016/0014-4835(90)90151-J; Bettelheim FA, 1997, EXP EYE RES, V64, P667, DOI 10.1006/exer.1996.0233; Bornheim R, 2008, J CELL SCI, V121, P3737, DOI 10.1242/jcs.030312; Burgess D, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-13; CAPETANAKI Y, 1989, J CELL BIOL, V109, P1653, DOI 10.1083/jcb.109.4.1653; CARMICHAEL PL, 1989, MECH AGEING DEV, V50, P37, DOI 10.1016/0047-6374(89)90057-2; Chauhan BK, 2002, GENES CELLS, V7, P1267, DOI 10.1046/j.1365-2443.2002.00602.x; Chongcharoen K, 1998, BIOCHEM BIOPH RES CO, V247, P136, DOI 10.1006/bbrc.1998.8747; Clement S, 1998, J BIOL CHEM, V273, P7604, DOI 10.1074/jbc.273.13.7604; David L L, 1989, Lens Eye Toxic Res, V6, P725; DAVIES KJA, 1990, ADV EXP MED BIOL, V264, P503; Duncan MK, 2004, INVEST OPHTH VIS SCI, V45, P3589, DOI 10.1167/iovs.04-0151; Faurobert Mireille, 2007, V355, P9; Firtina Z, 2009, J BIOL CHEM, V284, P35872, DOI 10.1074/jbc.M109.060384; Friedrich MG, 2012, J BIOL CHEM, V287, P39012, DOI 10.1074/jbc.M112.391565; Fujino T, 1998, BBA-BIOMEMBRANES, V1374, P47, DOI 10.1016/S0005-2736(98)00131-X; GARBER AT, 1984, J BIOL CHEM, V259, P376; Gong XH, 1997, CELL, V91, P833, DOI 10.1016/S0092-8674(00)80471-7; Grey AC, 2009, INVEST OPHTH VIS SCI, V50, P4319, DOI 10.1167/iovs.09-3522; Hariharapura R, 2013, EXP EYE RES, V109, P51, DOI 10.1016/j.exer.2013.01.016; Harrington V, 2007, MOL VIS, V13, P1680; Hoehenwarter W, 2006, AMINO ACIDS, V30, P369, DOI 10.1007/s00726-005-0283-9; Hsu CD, 2006, INVEST OPHTH VIS SCI, V47, P2036, DOI 10.1167/iovs.05-0524; Inomata M, 1997, BBA-MOL BASIS DIS, V1362, P11, DOI 10.1016/S0925-4439(97)00050-1; Inomata M, 2002, CURR EYE RES, V25, P207, DOI 10.1076/ceyr.25.4.207.13486; IWASAKI N, 1995, INVEST OPHTH VIS SCI, V36, P502; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; Mitta M, 1998, J BIOCHEM-TOKYO, V123, P924; Mitton KP, 1996, J BIOL CHEM, V271, P31803, DOI 10.1074/jbc.271.50.31803; Mou LS, 2010, INVEST OPHTH VIS SCI, V51, P396, DOI 10.1167/iovs.09-3772; MURAKAMI K, 1990, FREE RADICAL BIO MED, V8, P217, DOI 10.1016/0891-5849(90)90066-R; Nakamura Y, 2000, INVEST OPHTH VIS SCI, V41, P1460; Reddy VN, 1997, OPHTHALMOLOGICA, V211, P192, DOI 10.1159/000310788; Reneker LW, 2011, INVEST OPHTH VIS SCI, V52, P2100, DOI 10.1167/iovs.10-5650; Reneker LW, 2004, INVEST OPHTH VIS SCI, V45, P4083, DOI 10.1167/iovs.03-1270; Robertson LJG, 2008, INVEST OPHTH VIS SCI, V49, P1016, DOI 10.1167/iovs.07-0792; Sakamoto-Mizutani K, 2002, EXP EYE RES, V75, P611, DOI 10.1006/exer.2002.2065; Santhoshkumar P, 2008, J BIOL CHEM, V283, P8477, DOI 10.1074/jbc.M705876200; Senthilkumar R, 2002, J BIOL CHEM, V277, P39136, DOI 10.1074/jbc.M204684200; Senthilkumar R, 2001, EXP EYE RES, V72, P301, DOI 10.1006/exer.2000.0955; Sharma KK, 2009, BBA-GEN SUBJECTS, V1790, P1095, DOI 10.1016/j.bbagen.2009.05.008; Sharma KK, 1996, CURR EYE RES, V15, P363, DOI 10.3109/02713689608995826; SHARMA KK, 1992, EXP EYE RES, V54, P1005, DOI 10.1016/0014-4835(92)90165-O; SHARMA KK, 1993, EUR J BIOCHEM, V216, P631, DOI 10.1111/j.1432-1033.1993.tb18183.x; Shearer TR, 1998, CURR EYE RES, V17, P1037, DOI 10.1076/ceyr.17.11.1037.5232; Srivastava K, 2008, EXP EYE RES, V87, P356, DOI 10.1016/j.exer.2008.07.001; Srivastava OP, 1999, BIOCHEM BIOPH RES CO, V258, P632, DOI 10.1006/bbrc.1999.0506; Stella DR, 2010, INVEST OPHTH VIS SCI, V51, P5153, DOI 10.1167/iovs.10-5302; Su S, 2011, INVEST OPHTH VIS SCI, V52, P4182, DOI 10.1167/iovs.10-7094; Su SP, 2010, EXP EYE RES, V91, P97, DOI 10.1016/j.exer.2010.04.010; Sulochana KN, 1999, BRIT J OPHTHALMOL, V83, P885, DOI 10.1136/bjo.83.7.885; TSUNASAWA S, 1975, J BIOCHEM, V77, P89; Tumminia SJ, 1996, J BIOL CHEM, V271, P425, DOI 10.1074/jbc.271.1.425; Ueda Y, 2002, INVEST OPHTH VIS SCI, V43, P205; Viteri G, 2004, ARCH BIOCHEM BIOPHYS, V427, P197, DOI 10.1016/j.abb.2004.05.006; Wang S, 2013, BBA-MOL BASIS DIS, V1832, P302, DOI 10.1016/j.bbadis.2012.11.005; Wride Michael A., 2006, Birth Defects Research, V78, P90, DOI 10.1002/bdrc.20063; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324; Yamauchi Y, 2003, J BIOCHEM, V134, P251, DOI 10.1093/jb/mvg138; Yamin R, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-33; Zetterberg M, 2003, CURR EYE RES, V27, P45, DOI 10.1076/ceyr.27.2.45.15457	64	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9039	9052		10.1074/jbc.M113.510677	http://dx.doi.org/10.1074/jbc.M113.510677			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24554718	hybrid, Green Published			2022-12-28	WOS:000333472100025
J	Aggarwal, S; Gross, CM; Rafikov, R; Kumar, S; Fineman, JR; Ludewig, B; Jonigk, D; Black, SM				Aggarwal, Saurabh; Gross, Christine M.; Rafikov, Ruslan; Kumar, Sanjiv; Fineman, Jeffrey R.; Ludewig, Britta; Jonigk, Danny; Black, Stephen M.			Nitration of Tyrosine 247 Inhibits Protein Kinase G-1 alpha Activity by Attenuating Cyclic Guanosine Monophosphate Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclic GMP (cGMP); Enzyme Catalysis; Mass Spectrometry (MS); Molecular Modeling; Protein Kinase G (PKG); Peroxynitrite	VASCULAR SMOOTH-MUSCLE; APPARENT CONFORMATIONAL-CHANGE; INDUCED PULMONARY-HYPERTENSION; NITRIC-OXIDE; CRYSTAL-STRUCTURE; MOUSE-BRAIN; CGMP; HYPOXIA; GMP; SUPEROXIDE	Background: PKG-1 nitration plays an important role in the development of pulmonary hypertension. Results: We identified Tyr(247) as the key residue susceptible to nitration and inhibition of PKG-1. Conclusion: Nitration attenuates PKG activity by reducing its affinity for cGMP. Significance: Preventing the nitration of PKG-1 could prevent the phenotypic remodeling in the blood vessels during the development of a number of cardiovascular diseases. The cGMP-dependent protein kinase G-1 (PKG-1) is a downstream mediator of nitric oxide and natriuretic peptide signaling. Alterations in this pathway play a key role in the pathogenesis and progression of vascular diseases associated with increased vascular tone and thickness, such as pulmonary hypertension. Previous studies have shown that tyrosine nitration attenuates PKG-1 activity. However, little is known about the mechanisms involved in this event. Utilizing mass spectrometry, we found that PKG-1 is susceptible to nitration at tyrosine 247 and 425. Tyrosine to phenylalanine mutants, Y247F- and Y425F-PKG-1, were both less susceptible to nitration than WT PKG-1, but only Y247F-PKG-1 exhibited preserved activity, suggesting that the nitration of Tyr(247) is critical in attenuating PKG-1 activity. The overexpression of WT- or Y247F-PKG-1 decreased the proliferation of pulmonary artery smooth muscle cells (SMC), increased the expression of SMC contractile markers, and decreased the expression of proliferative markers. Nitrosative stress induced a switch from a contractile to a synthetic phenotype in cells expressing WT- but not Y247F-PKG-1. An antibody generated against 3-NT-Y247 identified increased levels of nitrated PKG-1 in humans with pulmonary hypertension. Finally, to gain a more mechanistic understanding of how nitration attenuates PKG activity, we developed a homology model of PKG-1. This model predicted that the nitration of Tyr(247) would decrease the affinity of PKG-1 for cGMP, which we confirmed using a [H-3]cGMP binding assay. Our study shows that the nitration of Tyr(247) and the attenuation of cGMP binding is an important mechanism regulating in PKG-1 activity and SMC proliferation/differentiation.	[Aggarwal, Saurabh; Gross, Christine M.; Rafikov, Ruslan; Kumar, Sanjiv; Black, Stephen M.] Georgia Regents Univ, Vasc Biol Ctr, Pulm Dis Program, Augusta, GA 30912 USA; [Fineman, Jeffrey R.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Fineman, Jeffrey R.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Ludewig, Britta; Jonigk, Danny] Hannover Med Sch, Inst Pathol, D-30625 Hannover, Germany	University System of Georgia; Augusta University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Hannover Medical School	Black, SM (corresponding author), Georgia Regents Univ, Vasc Biol Ctr, 1459 Laney Walker Blvd,CB 3211-B, Augusta, GA 30912 USA.	sblack@gru.edu	Rafikov, Ruslan/AAG-9352-2019	Rafikov, Ruslan/0000-0001-5950-4076	National Institutes of Health [HL60190, HL67841, HL084739, HL0101902, HL061284]; Cardiovascular Discovery Institute of Georgia Regents University; American Heart Association Predoctoral Fellowship [12PRE12060224]; Deutsche Forschungsgemeinschaft Grant [30743/2-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060190, P01HL101902, R01HL067841, R01HL084739, R01HL061284] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cardiovascular Discovery Institute of Georgia Regents University; American Heart Association Predoctoral Fellowship(American Heart Association); Deutsche Forschungsgemeinschaft Grant(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL60190, HL67841, HL084739, and HL0101902 (to S. M. B.) and HL061284 (to J. R. F.). This work was also supported by incubator and programmatic awards from the Cardiovascular Discovery Institute of Georgia Regents University (to S. M. B.).; Supported in part by American Heart Association Predoctoral Fellowship 12PRE12060224.; Supported by Deutsche Forschungsgemeinschaft Grant 30743/2-1.	Acampora KB, 2010, ANN VASC SURG, V24, P116, DOI 10.1016/j.avsg.2009.07.019; Aggarwal S, 2011, J CELL PHYSIOL, V226, P3104, DOI 10.1002/jcp.22692; AITKEN A, 1984, BIOCHIM BIOPHYS ACTA, V790, P219, DOI 10.1016/0167-4838(84)90025-6; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ATKINSON RA, 1991, BIOCHEMISTRY-US, V30, P9387, DOI 10.1021/bi00103a001; Broughton BRS, 2010, AM J PHYSIOL-LUNG C, V298, pL232, DOI 10.1152/ajplung.00276.2009; Busch JL, 2002, J BIOL CHEM, V277, P34048, DOI 10.1074/jbc.M202761200; Casteel DE, 2010, J BIOL CHEM, V285, P32684, DOI 10.1074/jbc.C110.161430; Chu DM, 1998, J BIOL CHEM, V273, P14649, DOI 10.1074/jbc.273.23.14649; Chu DM, 1997, J BIOL CHEM, V272, P31922, DOI 10.1074/jbc.272.50.31922; CORBIN JD, 1983, J BIOL CHEM, V258, P1391; CORBIN JD, 1986, J BIOL CHEM, V261, P1208; Cruz JA, 2012, AM J PHYSIOL-HEART C, V302, pH2518, DOI 10.1152/ajpheart.01140.2011; DUSSERRE E, 1994, BBA-LIPID LIPID MET, V1212, P235, DOI 10.1016/0005-2760(94)90258-5; Feil S, 2005, NEUROSCIENCE, V135, P863, DOI 10.1016/j.neuroscience.2005.06.051; Francis SH, 1996, J BIOL CHEM, V271, P20748, DOI 10.1074/jbc.271.34.20748; GARBERS DL, 1992, CELL, V71, P1; HEIL WG, 1987, EUR J BIOCHEM, V168, P117, DOI 10.1111/j.1432-1033.1987.tb13395.x; Herranz B, 2012, CIRC RES, V110, P439, DOI 10.1161/CIRCRESAHA.111.253948; HOFMANN F, 1983, FEBS LETT, V164, P350, DOI 10.1016/0014-5793(83)80315-9; HOFMANN F, 1985, EUR J BIOCHEM, V147, P361, DOI 10.1111/j.1432-1033.1985.tb08758.x; Hofmann Franz, 2009, V191, P137, DOI 10.1007/978-3-540-68964-5_8; Ischiropoulos H, 2003, BIOCHEM BIOPH RES CO, V305, P776, DOI 10.1016/S0006-291X(03)00814-3; Jonigk D, 2011, AM J PATHOL, V179, P167, DOI 10.1016/j.ajpath.2011.03.040; Kawashima S, 2001, ARTERIOSCL THROM VAS, V21, P201, DOI 10.1161/01.ATV.21.2.201; Kim JH, 2011, PLOS ONE, V6; King RD, 1996, PROTEIN SCI, V5, P2298, DOI 10.1002/pro.5560051116; Klemm DJ, 2011, J CARDIOVASC PHARM, V58, P181, DOI 10.1097/FJC.0b013e31821f2773; Lincoln TM, 1998, ACTA PHYSIOL SCAND, V164, P507, DOI 10.1111/j.1365-201X.1998.tb10700.x; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Negash S, 2009, AM J PHYSIOL-HEART C, V297, pH304, DOI 10.1152/ajpheart.00077.2008; Negash S, 2007, AM J PHYSIOL-LUNG C, V293, pL1012, DOI 10.1152/ajplung.00061.2007; Nie H, 2006, DIABETES, V55, P3133, DOI 10.2337/db06-0505; Nisbet RE, 2009, AM J RESP CELL MOL, V40, P601, DOI 10.1165/2008-0145OC; Nozik-Grayck E, 2007, ADV EXP MED BIOL, V618, P101; Osborne BW, 2011, STRUCTURE, V19, P1317, DOI 10.1016/j.str.2011.06.012; Pilz RB, 2005, FRONT BIOSCI-LANDMRK, V10, P1239, DOI 10.2741/1616; REDDY VM, 1995, CIRCULATION, V92, P606, DOI 10.1161/01.CIR.92.3.606; Redondo-Horcajo M, 2010, CARDIOVASC RES, V87, P356, DOI 10.1093/cvr/cvq028; Reed RB, 1996, J BIOL CHEM, V271, P17570, DOI 10.1074/jbc.271.29.17570; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Savvides SN, 2002, J BIOL CHEM, V277, P2779, DOI 10.1074/jbc.M108190200; Sharma S, 2008, AM J PHYSIOL-LUNG C, V294, pL46, DOI 10.1152/ajplung.00247.2007; Smith JA, 1996, J BIOL CHEM, V271, P20756, DOI 10.1074/jbc.271.34.20756; Sud N, 2007, AM J PHYSIOL-LUNG C, V293, pL1444, DOI 10.1152/ajplung.00175.2007; TAKIO K, 1984, BIOCHEMISTRY-US, V23, P4207, DOI 10.1021/bi00313a030; UHLER MD, 1993, J BIOL CHEM, V268, P13586; Vaandrager AB, 2005, FRONT BIOSCI-LANDMRK, V10, P2150, DOI 10.2741/1687; Venselaar H, 2010, EUR BIOPHYS J BIOPHY, V39, P551, DOI 10.1007/s00249-009-0531-0; Wang JN, 2012, FREE RADICAL BIO MED, V52, P173, DOI 10.1016/j.freeradbiomed.2011.10.442; Wedgwood S, 2001, CIRC RES, V89, P357, DOI 10.1161/hh1601.094983; Wolfe L, 1989, CURR OPIN CELL BIOL, V1, P215, DOI 10.1016/0955-0674(89)90090-2; WOLFE L, 1989, J BIOL CHEM, V264, P7734; Zhao JK, 1997, J BIOL CHEM, V272, P31929, DOI 10.1074/jbc.272.50.31929; Zhao YY, 2009, J CLIN INVEST, V119, P2009, DOI 10.1172/JCI33338	55	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7948	7961		10.1074/jbc.M113.534313	http://dx.doi.org/10.1074/jbc.M113.534313			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24469460	hybrid, Green Published			2022-12-28	WOS:000332761500059
J	Fujimaki, S; Hidaka, R; Asashima, M; Takemasa, T; Kuwabara, T				Fujimaki, Shin; Hidaka, Ryo; Asashima, Makoto; Takemasa, Tohru; Kuwabara, Tomoko			Wnt Protein-mediated Satellite Cell Conversion in Adult and Aged Mice Following Voluntary Wheel Running	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Aging; Exercise; Fibrosis; Sarcopenia; Wnt Signaling; Adult Stem Cells; Satellite Cells	RAT SKELETAL-MUSCLE; PHYSIOLOGICAL STIMULI; MUSCULAR-DYSTROPHY; BETA-CATENIN; STEM-CELLS; ACTIVATION; EXERCISE; ADAPTATIONS; OVERLOAD; FIBROSIS	Background: Satellite cells are activated in response to muscle injury or mechanical stimuli. Results: Running-induced up-regulation of Wnt/-catenin signaling activates Myf5 and MyoD transcription. Conclusion: Voluntary wheel running induces satellite cell activation by direct regulation of Wnt/-catenin signaling. Significance: Focusing on Wnt signaling may help to understand the function and intrinsic ability of satellite cells in adult myogenesis. Muscle represents an abundant, accessible, and replenishable source of adult stem cells. Skeletal muscle-derived stem cells, called satellite cells, play essential roles in regeneration after muscle injury in adult skeletal muscle. Although the molecular mechanism of muscle regeneration process after an injury has been extensively investigated, the regulation of satellite cells under steady state during the adult stage, including the reaction to exercise stimuli, is relatively unknown. Here, we show that voluntary wheel running exercise, which is a low stress exercise, converts satellite cells to the activated state due to accelerated Wnt signaling. Our analysis showed that up-regulated canonical Wnt/-catenin signaling directly modulated chromatin structures of both MyoD and Myf5 genes, resulting in increases in the mRNA expression of Myf5 and MyoD and the number of proliferative Pax7(+)Myf5(+) and Pax7(+) MyoD(+) cells in skeletal muscle. The effect of Wnt signaling on the activation of satellite cells, rather than Wnt-mediated fibrosis, was observed in both adult and aged mice. The association of -catenin, T-cell factor, and lymphoid enhancer transcription factors of multiple T-cell factor/lymphoid enhancer factor regulatory elements, conserved in mouse, rat, and human species, with the promoters of both the Myf5 and MyoD genes drives the de novo myogenesis in satellite cells even in aged muscle. These results indicate that exercise-stimulated extracellular Wnts play a critical role in the regulation of satellite cells in adult and aged skeletal muscle.	[Fujimaki, Shin; Hidaka, Ryo; Asashima, Makoto; Kuwabara, Tomoko] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki 3050046, Japan; [Fujimaki, Shin; Takemasa, Tohru] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba	Kuwabara, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Cent 4,1-1-4 Higashi, Tsukuba, Ibaraki 3058562, Japan.	t.warashina@aist.go.jp	Asashima, Makoto/O-8389-2018; Kuwabara, Tomoko/M-1639-2018	Asashima, Makoto/0000-0002-0012-026X; Kuwabara, Tomoko/0000-0002-7668-0896	National Institute of Advanced Industrial Science and Technology; Takeda Science Foundation; Mitsubishi Foundation	National Institute of Advanced Industrial Science and Technology; Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Foundation	Supported by the National Institute of Advanced Industrial Science and Technology.; Supported in part by a grant-in-aid for scientific research on innovative areas, The Takeda Science Foundation, and The Mitsubishi Foundation. To whom correspondence should be addressed: Research Center for Stem Cell Engineering, National Institute of Advanced Industrial Science and Technology, Central 4, 1-1-4 Higashi, Tsukuba Science City, Ibaraki 305-8562, Japan. Tel.: 81-29-861-2529; Fax: 81-29-861-2897; E-mail: t.warashina@aist.go.jp.	Allen DL, 2010, AM J PHYSIOL-REG I, V298, pR198, DOI 10.1152/ajpregu.00325.2009; Allen DL, 2001, J APPL PHYSIOL, V90, P1900, DOI 10.1152/jappl.2001.90.5.1900; Armstrong DD, 2005, AM J PHYSIOL-CELL PH, V289, pC853, DOI 10.1152/ajpcell.00093.2005; Arthur ST, 2012, INT J BIOL SCI, V8, P731, DOI 10.7150/ijbs.4262; Aschenbach WG, 2006, AM J PHYSIOL-ENDOC M, V291, pE152, DOI 10.1152/ajpendo.00180.2005; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Chapman MD, 2006, J IMMUNOL METHODS, V310, P62, DOI 10.1016/j.jim.2005.12.004; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Cisternas P, 2014, MOL NEUROBIOL, V49, P574, DOI 10.1007/s12035-013-8540-5; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; De Bono JP, 2006, AM J PHYSIOL-REG I, V290, pR926, DOI 10.1152/ajpregu.00694.2005; EIKELBOOM R, 1988, PHYSIOL BEHAV, V43, P625, DOI 10.1016/0031-9384(88)90217-X; Fujimaki S, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/420164; Hamada K, 2004, FASEB J, V18, P264, DOI 10.1096/fj.03-1286fje; Ikeda S, 2006, ACTA PHYSIOL, V188, P217, DOI 10.1111/j.1748-1716.2006.01623.x; Ishido M, 2006, ACTA PHYSIOL, V187, P407, DOI 10.1111/j.1748-1716.2006.01577.x; Kadi F, 2004, J PHYSIOL-LONDON, V558, P1005, DOI 10.1113/jphysiol.2004.065904; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Kuwabara T, 2011, EMBO MOL MED, V3, P742, DOI 10.1002/emmm.201100177; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; LAMBERT MI, 1990, J APPL PHYSIOL, V68, P400, DOI 10.1152/jappl.1990.68.1.400; Liao P, 2010, AM J PHYSIOL-REG I, V298, pR599, DOI 10.1152/ajpregu.00480.2009; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lorts A, 2012, P NATL ACAD SCI USA, V109, P10978, DOI 10.1073/pnas.1204708109; Machida M, 2010, J PHYSIOL PHARMACOL, V61, P559; Marotta M, 2009, PHYSIOL GENOMICS, V37, P119, DOI 10.1152/physiolgenomics.90370.2008; Mayhew DL, 2009, J APPL PHYSIOL, V107, P1655, DOI 10.1152/japplphysiol.91234.2008; Miyazaki M, 2011, J PHYSIOL-LONDON, V589, P1831, DOI 10.1113/jphysiol.2011.205658; Okamoto M, 2011, FASEB J, V25, P3570, DOI 10.1096/fj.11-184697; Ostrowski K, 1999, J PHYSIOL-LONDON, V515, P287, DOI 10.1111/j.1469-7793.1999.287ad.x; Otto A, 2008, J CELL SCI, V121, P2939, DOI 10.1242/jcs.026534; Perdiguero E, 2009, EPIGENETICS-US, V4, P541, DOI 10.4161/epi.4.8.10258; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Rafael-Fortney JA, 2011, CIRCULATION, V124, P582, DOI 10.1161/CIRCULATIONAHA.111.031716; Renault V, 2002, AGING CELL, V1, P132, DOI 10.1046/j.1474-9728.2002.00017.x; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; Rochat A, 2004, MOL BIOL CELL, V15, P4544, DOI 10.1091/mbc.E03-11-0816; Schultz RL, 2013, PHYSIOL RES, V62, P361, DOI 10.33549/physiolres.932330; Scime A, 2010, MECH AGEING DEV, V131, P9, DOI 10.1016/j.mad.2009.11.001; Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035; Smith HK, 2012, ACTA PHYSIOL, V204, P393, DOI 10.1111/j.1748-1716.2011.02350.x; Smith HK, 2001, J APPL PHYSIOL, V90, P1407, DOI 10.1152/jappl.2001.90.4.1407; Swallow JG, 1999, J EXP BIOL, V202, P2513; Swallow JG, 2001, J COMP PHYSIOL B, V171, P651, DOI 10.1007/s003600100216; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; Trensz F, 2010, AM J PHYSIOL-CELL PH, V299, pC939, DOI 10.1152/ajpcell.00253.2010; Tsivitse S, 2010, INT J BIOL SCI, V6, P268; UMNOVA MM, 1991, INT J SPORTS MED, V12, P501, DOI 10.1055/s-2007-1024723; Varela-Nallar L, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00100; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; Yablonka-Reuveni Z., 2008, J ANIM SCI, V86, P207	53	45	56	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7399	7412		10.1074/jbc.M113.539247	http://dx.doi.org/10.1074/jbc.M113.539247			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24482229	Green Published, hybrid			2022-12-28	WOS:000332761500012
J	Maehara, T; Fujimoto, Z; Ichinose, H; Michikawa, M; Harazono, K; Kaneko, S				Maehara, Tomoko; Fujimoto, Zui; Ichinose, Hitomi; Michikawa, Mari; Harazono, Koichi; Kaneko, Satoshi			Crystal Structure and Characterization of the Glycoside Hydrolase Family 62 alpha-L-Arabinofuranosidase from Streptomyces coelicolor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Enzyme Kinetics; Enzyme Mechanisms; Enzyme Mutation; Enzyme Structure; -l-Arabinofuranosidase; Streptomyces coelicolor; Glycoside Hydrolase Family 62; Substrate Specificity	CARBOHYDRATE-BINDING MODULE; GEOBACILLUS-STEAROTHERMOPHILUS; SUBSTRATE SPECIFICITIES; PURIFICATION; XYLANASE; REVEALS; MECHANISM; SEQUENCE; EXO-1,5-ALPHA-L-ARABINOFURANOSIDASE; ARABINOFURANOHYDROLASE	Background: Glycoside hydrolase family 62 -l-arabinofuranosidases specifically release l-arabinose from arabinoxylan. Results: The crystal structure of glycoside hydrolase family 62 -l-arabinofuranosidase from Streptomyces coelicolor was determined. Conclusion: l-Arabinose and xylohexaose complexed structures revealed the mechanism of substrate specificity of this enzyme. Significance: Efficient catalysis by glycoside hydrolase family 62 -l-arabinofuranosidase requires its binding to terminal xylose sugars at the substrate-binding cleft. -l-Arabinofuranosidase, which belongs to the glycoside hydrolase family 62 (GH62), hydrolyzes arabinoxylan but not arabinan or arabinogalactan. The crystal structures of several -l-arabinofuranosidases have been determined, although the structures, catalytic mechanisms, and substrate specificities of GH62 enzymes remain unclear. To evaluate the substrate specificity of a GH62 enzyme, we determined the crystal structure of -l-arabinofuranosidase, which comprises a carbohydrate-binding module family 13 domain at its N terminus and a catalytic domain at its C terminus, from Streptomyces coelicolor. The catalytic domain was a five-bladed -propeller consisting of five radially oriented anti-parallel -sheets. Sugar complex structures with l-arabinose, xylotriose, and xylohexaose revealed five subsites in the catalytic cleft and an l-arabinose-binding pocket at the bottom of the cleft. The entire structure of this GH62 family enzyme was very similar to that of glycoside hydrolase 43 family enzymes, and the catalytically important acidic residues found in family 43 enzymes were conserved in GH62. Mutagenesis studies revealed that Asp(202) and Glu(361) were catalytic residues, and Trp(270), Tyr(461), and Asn(462) were involved in the substrate-binding site for discriminating the substrate structures. In particular, hydrogen bonding between Asn(462) and xylose at the nonreducing end subsite +2 was important for the higher activity of substituted arabinofuranosyl residues than that for terminal arabinofuranoses.	[Maehara, Tomoko; Ichinose, Hitomi; Michikawa, Mari; Kaneko, Satoshi] Natl Food Res Inst, Food Biotechnol Div, Tsukuba, Ibaraki 3058642, Japan; [Fujimoto, Zui] Natl Inst Agrobiol Sci, Biomol Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Harazono, Koichi] Nagase ChemteX Corp, Enzyme Div, Bio Chem Dept, Fukuchiyama, Kyoto 6200853, Japan	National Agriculture & Food Research Organization - Japan; National Food Research Institute - Japan; National Institute of Agrobiological Sciences - Japan	Kaneko, S (corresponding author), Natl Food Res Inst, Food Biotechnol Div, 2-1-12 Kannondai, Tsukuba, Ibaraki 3058642, Japan.	sakaneko@affrc.go.jp		Fujimoto, Zui/0000-0002-3551-6854	Japan Society for the Promotion of Science KAKENHI Grant [25450140]	Japan Society for the Promotion of Science KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant 25450140.	Alberto F, 2004, J BIOL CHEM, V279, P18903, DOI 10.1074/jbc.M313911200; Alhassid A, 2009, BIOCHEM J, V422, P73, DOI 10.1042/BJ20090180; Beisel HG, 1999, EMBO J, V18, P2313, DOI 10.1093/emboj/18.9.2313; BELDMAN G, 1997, ADV MACROMOL CARB R, V1, P1; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Beylot MH, 2001, BIOCHEM J, V358, P607, DOI 10.1042/0264-6021:3580607; Brux C, 2006, J MOL BIOL, V359, P97, DOI 10.1016/j.jmb.2006.03.005; Brunzelle JS, 2008, ARCH BIOCHEM BIOPHYS, V474, P157, DOI 10.1016/j.abb.2008.03.007; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cartmell A, 2011, J BIOL CHEM, V286, P15483, DOI 10.1074/jbc.M110.215962; Carvalheiro F, 2008, J SCI IND RES INDIA, V67, P849; Chavas LMG, 2012, J SYNCHROTRON RADIAT, V19, P450, DOI 10.1107/S0909049512009727; Chiba S, 2012, BIOSCI BIOTECH BIOCH, V76, P215, DOI 10.1271/bbb.110713; de Sanctis D, 2010, FEBS J, V277, P4562, DOI 10.1111/j.1742-4658.2010.07870.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujimoto Z, 2004, J BIOL CHEM, V279, P9606, DOI 10.1074/jbc.M312293200; Fujimoto Z, 2008, ACTA CRYSTALLOGR F, V64, P1007, DOI 10.1107/S1744309108029692; Fujimoto Z, 2010, J BIOL CHEM, V285, P34134, DOI 10.1074/jbc.M110.164251; Hatanaka T, 2008, PROTEIN EXPRES PURIF, V62, P244, DOI 10.1016/j.pep.2008.09.001; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hovel K, 2003, EMBO J, V22, P4922, DOI 10.1093/emboj/cdg494; Ichinose H, 2008, APPL MICROBIOL BIOT, V80, P399, DOI 10.1007/s00253-008-1551-x; Ichinose H, 2010, PLANT BIOTECHNOL-NAR, V27, P259, DOI 10.5511/plantbiotechnology.27.259; Ito S, 2004, J BIOTECHNOL, V110, P137, DOI 10.1016/j.jbiotec.2004.01.014; Kaneko S, 1998, BIOSCI BIOTECH BIOCH, V62, P695, DOI 10.1271/bbb.62.695; KANEKO S, 1993, BIOSCI BIOTECH BIOCH, V57, P1161, DOI 10.1271/bbb.57.1161; KANEKO S, 1994, APPL ENVIRON MICROB, V60, P3425, DOI 10.1128/AEM.60.9.3425-3428.1994; KANEKO S, 1995, BIOSCI BIOTECH BIOCH, V59, P2132, DOI 10.1271/bbb.59.2132; Kaneko S, 1998, APPL ENVIRON MICROB, V64, P4021; Kaneko S, 1998, BIOSCI BIOTECH BIOCH, V62, P2205, DOI 10.1271/bbb.62.2205; Kaneko S, 1998, J FERMENT BIOENG, V85, P518, DOI 10.1016/S0922-338X(98)80073-1; KELLETT LE, 1990, BIOCHEM J, V272, P369, DOI 10.1042/bj2720369; KORMELINK FJM, 1993, CARBOHYD RES, V249, P345, DOI 10.1016/0008-6215(93)84099-R; KUSAKABE I, 1975, J AGR CHEM SOC JPN, V49, P295, DOI 10.1271/nogeikagaku1924.49.295; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Matsuo N, 2000, BIOCHEM J, V346, P9, DOI 10.1042/0264-6021:3460009; Mckee LS, 2012, P NATL ACAD SCI USA, V109, P6537, DOI 10.1073/pnas.1117686109; Meng GY, 2003, NAT STRUCT BIOL, V10, P935, DOI 10.1038/nsb974; Miyanaga A, 2004, J BIOL CHEM, V279, P44907, DOI 10.1074/jbc.M405390200; Miyanaga A, 2006, BIOCHEM J, V399, P503, DOI 10.1042/BJ20060567; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nurizzo D, 2002, NAT STRUCT BIOL, V9, P665, DOI 10.1038/nsb835; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; Pauly M, 2013, PLANTA, V238, P627, DOI 10.1007/s00425-013-1921-1; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Proctor MR, 2005, P NATL ACAD SCI USA, V102, P2697, DOI 10.1073/pnas.0500051102; Saha BC, 2000, BIOTECHNOL ADV, V18, P403, DOI 10.1016/S0734-9750(00)00044-6; Sakamoto T, 2011, APPL MICROBIOL BIOT, V90, P137, DOI 10.1007/s00253-010-2988-2; Shallom D, 2005, BIOCHEMISTRY-US, V44, P387, DOI 10.1021/bi048059w; Siguier B, 2014, J BIOL CHEM, V289, P5261, DOI 10.1074/jbc.M113.528133; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Vandermarliere E, 2009, BIOCHEM J, V418, P39, DOI 10.1042/BJ20081256; Vincent P, 1997, BIOCHEM J, V322, P845, DOI 10.1042/bj3220845; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamaguchi A, 2005, J BIOCHEM, V137, P587, DOI 10.1093/jb/mvi078; YOSHIDA S, 1990, AGR BIOL CHEM TOKYO, V54, P449, DOI 10.1080/00021369.1990.10869948	61	32	32	1	25	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7962	7972		10.1074/jbc.M113.540542	http://dx.doi.org/10.1074/jbc.M113.540542			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24482228	hybrid, Green Published			2022-12-28	WOS:000332761500060
J	Oganesyan, V; Damschroder, MM; Cook, KE; Li, Q; Gao, CS; Wu, HR; Dall'Acqua, WF				Oganesyan, Vaheh; Damschroder, Melissa M.; Cook, Kimberly E.; Li, Qing; Gao, Changshou; Wu, Herren; Dall'Acqua, William F.			Structural Insights into Neonatal Fc Receptor-based Recycling Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Albumin; Antibodies; Crystal Structure; FC Receptors; Protein Complexes	I-RELATED RECEPTOR; PH-DEPENDENT BINDING; AMINO-ACID-RESIDUES; CRYSTAL-STRUCTURE; HUMAN IGG1; HALF-LIFE; COMPLEX; ANTIBODY; ALBUMIN; SITE	Background: The neonatal Fc receptor (FcRn) regulates the serum half-life of human IgGs and serum albumin (SA). Results: Structures of human FcRn bound to its two ligands shed new lights on the corresponding interactions. Conclusion: Molecular mechanisms for IgG/SA recycling and increased IgG/FcRn binding affinity are presented. Significance: Understanding the molecular basis of the IgG/SA/FcRn interaction is crucial to develop biologics exhibiting beneficial pharmacokinetics properties. We report the three-dimensional structure of human neonatal Fc receptor (FcRn) bound concurrently to its two known ligands. More particularly, we solved the crystal structure of the complex between human FcRn, wild-type human serum albumin (HSA), and a human Fc engineered for improved pharmacokinetics properties (Fc-YTE). The crystal structure of human FcRn bound to wild-type HSA alone is also presented. HSA domain III exhibits an extensive interface of contact with FcRn, whereas domain I plays a lesser role. A molecular explanation for the HSA recycling mechanism is provided with the identification of FcRn His(161) as the only potential direct contributor to the corresponding pH-dependent process. At last, this study also allows an accurate structural definition of residues considered for decades as important to the human IgG/FcRn interaction and reveals Fc His(310) as a significant contributor to pH-dependent binding. Finally, we explain various structural mechanisms by which several Fc mutations (including YTE) result in increased human IgG binding to FcRn. Our study provides an unprecedented relevant understanding of the molecular basis of human Fc interaction with human FcRn.	[Oganesyan, Vaheh; Damschroder, Melissa M.; Cook, Kimberly E.; Li, Qing; Gao, Changshou; Wu, Herren; Dall'Acqua, William F.] MedImmune, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA	AstraZeneca; Medimmune	Dall'Acqua, WF (corresponding author), MedImmune, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA.	dallacquaw@medimmune.com		Damschroder, Melissa/0000-0001-9453-6532				Andersen JT, 2006, EUR J IMMUNOL, V36, P3044, DOI 10.1002/eji.200636556; Andersen JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1607; Andersen JT, 2009, DRUG METAB PHARMACOK, V24, P318, DOI 10.2133/dmpk.24.318; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BURMEISTER WP, 1994, NATURE, V372, P336, DOI 10.1038/372336a0; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Chaudhury C, 2006, BIOCHEMISTRY-US, V45, P4983, DOI 10.1021/bi052628y; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; D'Arcy A, 2007, ACTA CRYSTALLOGR D, V63, P550, DOI 10.1107/S0907444907007652; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Firan M, 2001, INT IMMUNOL, V13, P993, DOI 10.1093/intimm/13.8.993; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; Hinton PR, 2006, J IMMUNOL, V176, P346, DOI 10.4049/jimmunol.176.1.346; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Junghans RP, 1996, P NATL ACAD SCI USA, V93, P5512, DOI 10.1073/pnas.93.11.5512; Kabat EA, 1991, SEQUENCES PROTEINS I; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kim JK, 1999, EUR J IMMUNOL, V29, P2819, DOI 10.1002/(SICI)1521-4141(199909)29:09<2819::AID-IMMU2819>3.0.CO;2-6; KIM JK, 1994, EUR J IMMUNOL, V24, P542, DOI 10.1002/eji.1830240308; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Medesan C, 1997, J IMMUNOL, V158, P2211; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oganesyan V, 2009, MOL IMMUNOL, V46, P1750, DOI 10.1016/j.molimm.2009.01.026; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; RAGHAVAN M, 1995, BIOCHEMISTRY-US, V34, P14649, DOI 10.1021/bi00045a005; Robbie GJ, 2013, ANTIMICROB AGENTS CH, V57, P6147, DOI 10.1128/AAC.01285-13; RODEWALD R, 1976, J CELL BIOL, V71, P666, DOI 10.1083/jcb.71.2.666; Schmidt MM, 2013, STRUCTURE, V21, P1966, DOI 10.1016/j.str.2013.08.022; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; Vaughn DE, 1998, STRUCTURE, V6, P63, DOI 10.1016/S0969-2126(98)00008-2; West AP, 2000, BIOCHEMISTRY-US, V39, P9698, DOI 10.1021/bi000749m; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601	36	152	167	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7812	7824		10.1074/jbc.M113.537563	http://dx.doi.org/10.1074/jbc.M113.537563			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24469444	Green Published, hybrid			2022-12-28	WOS:000332761500047
J	Vasudevarao, MD; Mizar, P; Kumari, S; Mandal, S; Siddhanta, S; Swamy, MMM; Kaypee, S; Kodihalli, RC; Banerjee, A; Naryana, C; Dasgupta, D; Kundu, TK				Vasudevarao, Mohankrishna Dalvoy; Mizar, Pushpak; Kumari, Sujata; Mandal, Somnath; Siddhanta, Soumik; Swamy, Mahadeva M. M.; Kaypee, Stephanie; Kodihalli, Ravindra C.; Banerjee, Amrita; Naryana, Chandrabhas; Dasgupta, Dipak; Kundu, Tapas K.			Naphthoquinone-mediated Inhibition of Lysine Acetyltransferase KAT3B/p300, Basis for Non-toxic Inhibitor Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Inactivation; Enzyme Inhibitors; Histone Acetylase; Reactive Oxygen Species (ROS); Thiol; Lysine Acetyltransferase; N-Acetyl Cysteine; Plumbagin; Structure-Activity Relationship; Toxicity	SURFACE-ENHANCED RAMAN; INDUCED HISTONE HYPOACETYLATION; GLOBAL GENE-EXPRESSION; TRANSCRIPTIONAL COACTIVATOR; CHROMATIN TRANSCRIPTION; SMALL MOLECULES; CANCER CELLS; PLUMBAGIN; P300; SPECTROSCOPY	Background: 1,4-Naphthoquinone analogs, such as plumbagin, are toxic compounds due to their redox cycling and thiol-reactive properties. Results: The p300 inhibitor PTK1, a plumbagin derivative with greatly reduced toxicity, was synthesized and characterized. Conclusion: PTK1 is a reversible, non-competitive inhibitor of p300 KAT activity with reduced toxicity. Significance: These studies provide insight into naphthoquinone-mediated KAT inhibition and describe the synthesis of a therapeutically important, non-toxic inhibitor. Hydroxynaphthoquinone-based inhibitors of the lysine acetyltransferase KAT3B (p300), such as plumbagin, are relatively toxic. Here, we report that free thiol reactivity and redox cycling properties greatly contribute to the toxicity of plumbagin. A reactive 3rd position in the naphthoquinone derivatives is essential for thiol reactivity and enhances redox cycling. Using this clue, we synthesized PTK1, harboring a methyl substitution at the 3rd position of plumbagin. This molecule loses its thiol reactivity completely and its redox cycling ability to a lesser extent. Mechanistically, non-competitive, reversible binding of the inhibitor to the lysine acetyltransferase (KAT) domain of p300 is largely responsible for the acetyltransferase inhibition. Remarkably, the modified inhibitor PTK1 was a nearly non-toxic inhibitor of p300. The present report elucidates the mechanism of acetyltransferase activity inhibition by 1,4-naphthoquinones, which involves redox cycling and nucleophilic adduct formation, and it suggests possible routes of synthesis of the non-toxic inhibitor.	[Vasudevarao, Mohankrishna Dalvoy; Mizar, Pushpak; Kumari, Sujata; Mandal, Somnath; Swamy, Mahadeva M. M.; Kaypee, Stephanie; Kodihalli, Ravindra C.; Kundu, Tapas K.] Jawaharlal Nehru Ctr Adv Sci Res, Transcript & Dis Lab, Bangalore 560064, Karnataka, India; [Siddhanta, Soumik; Naryana, Chandrabhas] Jawaharlal Nehru Ctr Adv Sci Res, Light Scattering Lab, Bangalore 560064, Karnataka, India; [Banerjee, Amrita; Dasgupta, Dipak] Saha Inst Nucl Phys, Biophys & Struct Genom Div, Kolkata 700064, W Bengal, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Saha Institute of Nuclear Physics	Kundu, TK (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Transcript & Dis Lab, Bangalore 560064, Karnataka, India.	tapas@jncasr.ac.in	Siddhanta, Soumik/L-2949-2019; Mizar, Pushpak/ABA-5583-2021	Mandal, Somnath/0000-0002-6021-8955; Kundu, Tapas/0000-0001-7790-214X	Department of Biotechnology, Government of India [BT/01/CEIB/10/III/01]; Jawaharlal Nehru Centre for Advanced Scientific Research	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Jawaharlal Nehru Centre for Advanced Scientific Research(Department of Science & Technology (India))	This work was supported by the Department of Biotechnology, Government of India (Program Support for Chromatin and Disease, Sanction Code BT/01/CEIB/10/III/01/dt-30.09.2011) and the Jawaharlal Nehru Centre for Advanced Scientific Research.	Arif M, 2009, J MED CHEM, V52, P267, DOI 10.1021/jm800657z; Arif M, 2007, J PHYS CHEM B, V111, P11877, DOI 10.1021/jp0762931; Arif Mohammed, 2013, Methods Mol Biol, V981, P239, DOI 10.1007/978-1-62703-305-3_19; Arif M, 2010, CHEM BIOL, V17, P903, DOI 10.1016/j.chembiol.2010.06.014; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Balasubramanyam K, 2004, J BIOL CHEM, V279, P33716, DOI 10.1074/jbc.M402839200; Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; Checker R, 2010, J CELL BIOCHEM, V110, P1082, DOI 10.1002/jcb.22620; Choudhury M, 2010, ALCOHOL, V44, P531, DOI 10.1016/j.alcohol.2010.06.003; Cole PA, 2008, NAT CHEM BIOL, V4, P590, DOI 10.1038/nchembio.111; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Frisch M. J., 2019, GAUSSIAN 16 REVISION; Inbaraj JJ, 2004, CHEM RES TOXICOL, V17, P55, DOI 10.1021/tx034132s; Kang J, 2003, TOXICOL SCI, V74, P279, DOI 10.1093/toxsci/kfg137; Kang JH, 2005, BIOCHEM PHARMACOL, V69, P1205, DOI 10.1016/j.bcp.2005.01.014; Klaus V, 2010, ARCH BIOCHEM BIOPHYS, V496, P93, DOI 10.1016/j.abb.2010.02.002; Kumar GVP, 2008, J PHYS CHEM B, V112, P6703, DOI 10.1021/jp711594z; Kumar GVP, 2007, CURR SCI INDIA, V93, P778; Kumar GVP, 2006, J PHYS CHEM B, V110, P16787, DOI 10.1021/jp063071e; Lau OD, 2000, MOL CELL, V5, P589, DOI 10.1016/S1097-2765(00)80452-9; LEE PC, 1982, J PHYS CHEM-US, V86, P3391, DOI 10.1021/j100214a025; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Mallavadhani UV, 1998, PHYTOCHEMISTRY, V49, P901, DOI 10.1016/S0031-9422(97)01020-0; Mantelingu K, 2007, CHEM BIOL, V14, P645, DOI 10.1016/j.chembiol.2007.04.011; Mantelingu K, 2007, J PHYS CHEM B, V111, P4527, DOI 10.1021/jp067655s; MILLER MG, 1986, BIOCHEM PHARMACOL, V35, P1177, DOI 10.1016/0006-2952(86)90157-7; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Ogihara K, 1997, CHEM PHARM BULL, V45, P437, DOI 10.1248/cpb.45.437; Powolny AA, 2008, PHARM RES-DORDR, V25, P2171, DOI 10.1007/s11095-008-9533-3; Ravindra KC, 2009, J BIOL CHEM, V284, P24453, DOI 10.1074/jbc.M109.023861; REIPA V, 1992, APPL SPECTROSC, V46, P1009, DOI 10.1366/0003702924124501; Sandur SK, 2006, J BIOL CHEM, V281, P17023, DOI 10.1074/jbc.M601595200; Selvi BR, 2010, BBA-GENE REGUL MECH, V1799, P810, DOI 10.1016/j.bbagrm.2010.09.005; Siddhanta S, 2012, NANOMATER NANOTECHNO, V2; Song DD, 2010, CANCER BIOL THER, V9, P96, DOI 10.4161/cbt.9.2.10287; Srinivas P, 2004, MOL CARCINOGEN, V40, P201, DOI 10.1002/mc.20031; Stimson L, 2005, MOL CANCER THER, V4, P1521, DOI 10.1158/1535-7163.MCT-05-0135; Castro FAV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003999; Yu M, 2006, BIOCHEMISTRY-US, V45, P14788, DOI 10.1021/bi061621t	40	25	25	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2014	289	11					7702	7717		10.1074/jbc.M113.486522	http://dx.doi.org/10.1074/jbc.M113.486522			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC8CV	24469461	Green Published, hybrid			2022-12-28	WOS:000332761500038
J	Ghaddar, K; Krammer, EM; Mihajlovic, N; Brohee, S; Andre, B; Prevost, M				Ghaddar, Kassem; Krammer, Eva-Maria; Mihajlovic, Natalija; Brohee, Sylvain; Andre, Bruno; Prevost, Martine			Converting the Yeast Arginine Can1 Permease to a Lysine Permease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amino Acid Transport; Membrane Proteins; Molecular Modeling; Protein Engineering; Proton Transport; Site-directed Mutagenesis; Transporters; Yeast Physiology; Ligand Docking	AMINO-ACID ANTIPORTER; PROTEIN DATA-BANK; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; TRANSPORTING SYSTEM; STRUCTURAL BASIS; LEUT-FOLD; MECHANISM; DOCKING; PREDICTION	Background: Can1 is a yeast plasma membrane permease catalyzing specific uptake of arginine. Results: Two residues in the binding pocket of Can1 affect its selectivity. Conclusion: Subtle amino acid changes can convert Can1 to a lysine-specific permease. Significance: Understanding, at the molecular level, the translocation mechanism(s) of yeast amino acid transporters has bearings on our knowledge of other transporters featuring the same fold. Amino acid uptake in yeast cells is mediated by about 16 plasma membrane permeases, most of which belong to the amino acid-polyamine-organocation (APC) transporter family. These proteins display various substrate specificity ranges. For instance, the general amino acid permease Gap1 transports all amino acids, whereas Can1 and Lyp1 catalyze specific uptake of arginine and lysine, respectively. Although Can1 and Lyp1 have different narrow substrate specificities, they are close homologs. Here we investigated the molecular rules determining the substrate specificity of the H+-driven arginine-specific permease Can1. Using a Can1-Lyp1 sequence alignment as a guideline and a three-dimensional Can1 structural model based on the crystal structure of the bacterial APC family arginine/agmatine antiporter, we introduced amino acid substitutions liable to alter Can1 substrate specificity. We show that the single substitution T456S results in a Can1 variant transporting lysine in addition to arginine and that the combined substitutions T456S and S176N convert Can1 to a Lyp1-like permease. Replacement of a highly conserved glutamate in the Can1 binding site leads to variants (E184Q and E184A) incapable of any amino acid transport, pointing to a potential role for this glutamate in H+ coupling. Measurements of the kinetic parameters of arginine and lysine uptake by the wild-type and mutant Can1 permeases, together with docking calculations for each amino acid in their binding site, suggest a model in which residues at positions 176 and 456 confer substrate selectivity at the ligand-binding stage and/or in the course of conformational changes required for transport.	[Ghaddar, Kassem; Mihajlovic, Natalija; Andre, Bruno] Univ Libre Bruxelles, Lab Physiol Mol Cellule CP300, B-6041 Gosselies, Belgium; [Krammer, Eva-Maria; Prevost, Martine] Univ Libre Bruxelles, Ctr Biol Struct & Bioinformat, B-1050 Brussels, Belgium; [Brohee, Sylvain] Univ Libre Bruxelles, Machine Learning Grp, Dept Comp Sci, Fac Sci, B-1050 Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles	Andre, B (corresponding author), Univ Libre Bruxelles, Lab Physiol Mol Cellule CP300, 11 Rue Pr Jeener & Brachet, B-6041 Gosselies, Belgium.	bran@ulb.ac.be; mprevost@ulb.ac.be	Krammer, Eva-Maria/H-2543-2013	Krammer, Eva-Maria/0000-0002-4821-2550	Fonds de la Recherche Scientifique Medicale [3.4.592.08.F]; Actions de Recherche Concertees Grant of the Federation Wallonie-Bruxelles [AUWB 2010-15-2]	Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Actions de Recherche Concertees Grant of the Federation Wallonie-Bruxelles	This work was supported by Fonds de la Recherche Scientifique Medicale Grant 3.4.592.08.F and Actions de Recherche Concertees Grant AUWB 2010-15-2 of the Federation Wallonie-Bruxelles.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andre B, 1995, YEAST, V11, P1575, DOI 10.1002/yea.320111605; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; BECHET J, 1970, EUR J BIOCHEM, V12, P31, DOI 10.1111/j.1432-1033.1970.tb00817.x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Brohee S, 2011, NUCLEIC ACIDS RES, V39, P6340, DOI 10.1093/nar/gkr264; Brohee S, 2010, BBA-BIOMEMBRANES, V1798, P1908, DOI 10.1016/j.bbamem.2010.06.008; Cheng TJ, 2009, J CHEM INF MODEL, V49, P1079, DOI 10.1021/ci9000053; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; Du J, 2011, J COMPUT CHEM, V32, P2800, DOI 10.1002/jcc.21859; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Fischer WN, 2002, PLANT J, V29, P717, DOI 10.1046/j.1365-313X.2002.01248.x; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gao X, 2010, NATURE, V463, P828, DOI 10.1038/nature08741; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; Graves AP, 2008, J MOL BIOL, V377, P914, DOI 10.1016/j.jmb.2008.01.049; Greenidge PA, 2013, J CHEM INF MODEL, V53, P201, DOI [10.1021/cI300025v, 10.1021/ci300425v]; GRENSON M, 1966, BIOCHIM BIOPHYS ACTA, V127, P325, DOI 10.1016/0304-4165(66)90387-4; GRENSON M, 1966, BIOCHIM BIOPHYS ACTA, V127, P339, DOI 10.1016/0304-4165(66)90388-6; Hayes JM, 2012, IN TECH CH, V9, P171; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Hein C, 1997, MOL MICROBIOL, V24, P607, DOI 10.1046/j.1365-2958.1997.3771735.x; HOFFMANN W, 1985, J BIOL CHEM, V260, P1831; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hou TJ, 2011, J COMPUT CHEM, V32, P866, DOI 10.1002/jcc.21666; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JACOBS P, 1980, J MOL BIOL, V139, P691, DOI 10.1016/0022-2836(80)90055-8; Jeschke G, 2013, EUR BIOPHYS J BIOPHY, V42, P181, DOI 10.1007/s00249-012-0802-z; Khafizov K, 2010, BIOCHEMISTRY-US, V49, P10702, DOI 10.1021/bi101256x; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kowalczyk L, 2011, P NATL ACAD SCI USA, V108, P3935, DOI 10.1073/pnas.1018081108; Kozma D, 2013, NUCLEIC ACIDS RES, V41, pD524, DOI 10.1093/nar/gks1169; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Law CJ, 2007, BIOCHEMISTRY-US, V46, P12190, DOI 10.1021/bi701383g; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li JN, 2011, PROTEINS, V79, P2794, DOI 10.1002/prot.23106; Liang J, 2012, BBA-BIOMEMBRANES, V1818, P927, DOI 10.1016/j.bbamem.2011.09.026; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Lyne PD, 2006, J MED CHEM, V49, P4805, DOI 10.1021/jm060522a; Ma D, 2012, NATURE, V483, P632, DOI 10.1038/nature10917; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Malinsky J, 2010, YEAST, V27, P473, DOI 10.1002/yea.1772; Nilsson J, 2005, PROTEINS, V60, P606, DOI 10.1002/prot.20583; OH BH, 1994, J BIOL CHEM, V269, P26323; Opekarova M, 2002, BBA-BIOMEMBRANES, V1564, P9, DOI 10.1016/S0005-2736(02)00455-8; OPEKAROVA M, 1993, EUR J BIOCHEM, V211, P683, DOI 10.1111/j.1432-1033.1993.tb17596.x; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Spira F, 2012, NAT CELL BIOL, V14, P640, DOI 10.1038/ncb2487; SYCHROVA H, 1993, YEAST, V9, P771, DOI 10.1002/yea.320090711; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Ullmann RT, 2012, J PHYS CHEM B, V116, P9690, DOI 10.1021/jp305440f; Ullmann RT, 2012, J COMPUT CHEM, V33, P887, DOI 10.1002/jcc.22919; Ullmann RT, 2011, J PHYS CHEM B, V115, P10346, DOI 10.1021/jp204644h; Van Belle D, 2001, CURR OPIN CELL BIOL, V13, P389, DOI 10.1016/S0955-0674(00)00226-X; Wong FH, 2012, J MOL MICROB BIOTECH, V22, P105, DOI 10.1159/000338542; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	69	32	32	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7232	7246		10.1074/jbc.M113.525915	http://dx.doi.org/10.1074/jbc.M113.525915			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24448798	Green Published, hybrid			2022-12-28	WOS:000332389400081
J	Kumar, P; Tripathi, S; Pandey, KN				Kumar, Prerna; Tripathi, Satyabha; Pandey, Kailash N.			Histone Deacetylase Inhibitors Modulate the Transcriptional Regulation of Guanylyl Cyclase/Natriuretic Peptide Receptor-A Gene INTERACTIVE ROLES OF MODIFIED HISTONES, HISTONE ACETYLTRANSFERASE, p300, AND Sp1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Chromatin Histone Modification; Gene Transcription; Histone Deacetylase Inhibitors; Natriuretic Peptides; p300; Sp1	MEDULLARY COLLECTING DUCT; ATRIAL-NATRIURETIC-PEPTIDE; CGMP-RESPONSE ELEMENT; ESSENTIAL-HYPERTENSION; CARDIAC-HYPERTROPHY; PROMOTER ACTIVITY; PROTEIN-KINASE; ACETYLATION; EXPRESSION; CELLS	Background: Natriuretic peptide receptor-A (NPRA) lowers blood pressure and blood volume. Results: Data show that histone deacetylase inhibitors (HDACi) enhance NPRA expression by blocking HDACs and interacting with Sp1, histone acetyltransferase, and acetylated histones. Conclusion: Results suggest that epigenetic mechanisms regulate NPRA gene transcription. Significance: Findings will help to identify molecular targets regulating NPRA expression and function in vivo. Atrial natriuretic peptide (ANP) binds guanylyl cyclase-A/natriuretic peptide receptor-A (GC-A/NPRA) and produces the intracellular second messenger, cGMP, which regulates cardiovascular homeostasis. We sought to determine the function of histone deacetylases (HDACs) in regulating Npr1 (coding for GC-A/NPRA) gene transcription, using primary mouse mesangial cells treated with class-specific HDAC inhibitors (HDACi). Trichostatin A, a pan inhibitor, and mocetinostat (MGCD0103), a class I HDAC inhibitor, significantly enhanced Npr1 promoter activity (by 8- and 10-fold, respectively), mRNA levels (4- and 5.3-fold, respectively), and NPRA protein (2.7- and 3.5-fold, respectively). However, MC1568 (class II HDAC inhibitor) had no discernible effect. Overexpression of HDAC1 and HDAC2 significantly attenuated Npr1 promoter activity, whereas HDAC3 and HDAC8 had no effect. HDACi-treated cultured cells in vitro and intact animals in vivo showed significantly reduced binding of HDAC1 and -2 and increased accumulation of acetylated H3-K9/14 and H4-K12 at the Npr1 promoter. Deletional analyses of the Npr1 promoter along with ectopic overexpression and inhibition of Sp1 confirmed that HDACi-induced Npr1 gene transcription is accomplished by Sp1 activation. Furthermore, HDACi attenuated the interaction of Sp1 with HDAC1/2 and promoted Sp1 association with p300 and p300/cAMP-binding protein-associated factor; it also promoted the recruitment of p300 and p300/cAMP-binding protein-associated factor to the Npr1 promoter. Our results demonstrate that trichostatin A and MGCD0103 enhanced Npr1 gene expression through inhibition of HDAC1/2 and increased both acetylation of histones (H3-K9/14, H4-K12) and Sp1 by p300, and their recruitment to Npr1 promoter. Our findings define a novel epigenetic regulatory mechanism that governs Npr1 gene transcription.	[Kumar, Prerna; Tripathi, Satyabha; Pandey, Kailash N.] Tulane Univ, Hlth Sci Ctr, Sch Med, Dept Physiol, New Orleans, LA 70112 USA	Tulane University	Pandey, KN (corresponding author), SL-39 1430 Tulane Ave, New Orleans, LA 70112 USA.	kpandey@tulane.edu			National Institutes of Health [HL 57531]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL057531, R01HL057531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL 57531.	Andres V, 2001, ARTERIOSCL THROM VAS, V21, P342, DOI 10.1161/01.ATV.21.3.342; Arise KK, 2006, BIOCHEM BIOPH RES CO, V349, P131, DOI 10.1016/j.bbrc.2006.08.003; Buchwald M, 2009, CANCER LETT, V280, P160, DOI 10.1016/j.canlet.2009.02.028; Bush EW, 2010, CIRC RES, V106, P272, DOI 10.1161/CIRCRESAHA.109.209338; Cavasin MA, 2012, CIRC RES, V110, P739, DOI 10.1161/CIRCRESAHA.111.258426; Chen S, 2007, KIDNEY INT, V72, P300, DOI 10.1038/sj.ki.5002274; Chen SC, 2002, J BIOL CHEM, V277, P6037, DOI 10.1074/jbc.M111117200; Colussi C, 2010, PHARMACOL RES, V62, P3, DOI 10.1016/j.phrs.2010.02.014; Cong BH, 2014, MOL CELL ENDOCRINOL, V382, P17, DOI 10.1016/j.mce.2013.09.002; Das S, 2012, PHYSIOL GENOMICS, V44, P430, DOI 10.1152/physiolgenomics.00147.2011; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; DEBOLD AJ, 1985, SCIENCE, V230, P767, DOI 10.1126/science.2932797; DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2; DREWETT JG, 1994, ENDOCR REV, V15, P135, DOI 10.1210/er.15.2.135; Ellmers LJ, 2007, J MOL ENDOCRINOL, V38, P245, DOI 10.1677/jme.1.02138; Garg R, 2003, HYPERTENSION, V41, P730, DOI 10.1161/01.HYP.0000051890.68573.94; Garg R, 2002, GENE, V291, P123, DOI 10.1016/S0378-1119(02)00589-9; Gaub P, 2010, CELL DEATH DIFFER, V17, P1392, DOI 10.1038/cdd.2009.216; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Hassig CA, 1997, CURR OPIN CHEM BIOL, V1, P300, DOI 10.1016/S1367-5931(97)80066-X; Huang WQ, 2005, J BIOL CHEM, V280, P10047, DOI 10.1074/jbc.M408680200; Hum D, 2004, HYPERTENSION, V43, P1270, DOI 10.1161/01.HYP.0000126920.93207.53; Kim JH, 2011, BIOCHEM J, V436, P253, DOI 10.1042/BJ20110062; Kim SH, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2562; Kramer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315; Kumar P, 2006, PEPTIDES, V27, P1762, DOI 10.1016/j.peptides.2006.01.004; Kumar P, 2010, J BIOL CHEM, V285, P37521, DOI 10.1074/jbc.M110.132795; Kumar P, 2009, HYPERTENSION, V54, P172, DOI 10.1161/HYPERTENSIONAHA.109.133033; Levin ER, 1998, NEW ENGL J MED, V339, P321; Liu C, 2011, J PHARMACOL EXP THER, V339, P203, DOI 10.1124/jpet.111.184796; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Martel G, 2010, J BIOL CHEM, V285, P20926, DOI 10.1074/jbc.M109.061622; McKinsey TA, 2004, TRENDS GENET, V20, P206, DOI 10.1016/j.tig.2004.02.002; Nakayama T, 2000, CIRC RES, V86, P841, DOI 10.1161/01.RES.86.8.841; Noh H, 2009, AM J PHYSIOL-RENAL, V297, pF729, DOI 10.1152/ajprenal.00086.2009; Oliver PM, 1998, P NATL ACAD SCI USA, V95, P2547, DOI 10.1073/pnas.95.5.2547; Oliver PM, 1997, P NATL ACAD SCI USA, V94, P14730, DOI 10.1073/pnas.94.26.14730; Pandey KN, 2011, CAN J PHYSIOL PHARM, V89, P557, DOI [10.1139/Y11-054, 10.1139/y11-054]; Pandey KN, 2005, PEPTIDES, V26, P901, DOI 10.1016/j.peptides.2004.09.024; PANDEY KN, 1990, J BIOL CHEM, V265, P12342; Pandey KN, 1999, ENDOCRINOLOGY, V140, P5112, DOI 10.1210/en.140.11.5112; Pandey KN, 2000, BIOCHEM BIOPH RES CO, V271, P374, DOI 10.1006/bbrc.2000.2627; Pascual M, 2012, NEUROPHARMACOLOGY, V62, P2309, DOI 10.1016/j.neuropharm.2012.01.011; Peserico A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/371832; Pitzalis MV, 2003, J HYPERTENS, V21, P1491, DOI 10.1097/00004872-200308000-00012; Rubattu S, 2006, J AM COLL CARDIOL, V48, P499, DOI 10.1016/j.jacc.2005.12.081; Swingler TE, 2010, BIOCHEM J, V427, P391, DOI 10.1042/BJ20091798; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Thakur VS, 2012, CARCINOGENESIS, V33, P377, DOI 10.1093/carcin/bgr277; Tremblay J, 2003, HYPERTENSION, V41, P16, DOI 10.1161/01.HYP.0000042664.75193.1B; Tremblay J, 2002, MOL CELL BIOCHEM, V230, P31, DOI 10.1023/A:1014260204524; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Tsai PF, 2011, J VIROL, V85, P2373, DOI 10.1128/JVI.01602-10; Usami S, 2008, HYPERTENS RES, V31, P89, DOI 10.1291/hypres.31.89; Vellaichamy E, 2005, J BIOL CHEM, V280, P19230, DOI 10.1074/jbc.M411373200; Villagra A, 2010, ONCOGENE, V29, P157, DOI 10.1038/onc.2009.334; Wierstra I, 2008, BIOCHEM BIOPH RES CO, V372, P1, DOI 10.1016/j.bbrc.2008.03.074; Wu N, 2010, J BIOL CHEM, V285, P18225, DOI 10.1074/jbc.M110.132142; Xu YC, 2012, EXP CELL RES, V318, P177, DOI 10.1016/j.yexcr.2011.11.010; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9	63	31	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6991	7002		10.1074/jbc.M113.511444	http://dx.doi.org/10.1074/jbc.M113.511444			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24451378	hybrid, Green Published			2022-12-28	WOS:000332389400059
J	Li, KW; Yu, YP; Zhou, CY; Kim, DS; Lin, B; Sharp, K; Steward, O; Luo, ZD				Li, Kang-Wu; Yu, Yanhui Peter; Zhou, Chunyi; Kim, Doo-Sik; Lin, Bin; Sharp, Kelli; Steward, Oswald; Luo, Z. David			Calcium Channel alpha(2)delta(1) Proteins Mediate Trigeminal Neuropathic Pain States Associated with Aberrant Excitatory Synaptogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gene Regulation; Molecular Pharmacology; Neuroscience; Pain; Synaptic Plasticity	SPINAL GLIAL ACTIVATION; CHRONIC CONSTRICTION INJURY; PERIPHERAL-NERVE INJURY; SUBUNIT UP-REGULATION; DORSAL-HORN; GABAPENTIN NEURONTIN; BEHAVIORAL HYPERSENSITIVITY; FUNCTIONAL EXPRESSION; ANTIEPILEPTIC DRUGS; INFRAORBITAL NERVE	Background: Factors mediating orofacial neuropathic pain are not well defined. Results: Trigeminal nerve injury-induced calcium channel (21) protein up-regulation in trigeminal ganglia and spinal complex correlated with enhanced spinal presynaptic neurotransmission, excitatory synaptogenesis, and orofacial pain states. Conclusion: This neuroplasticity may mediate orofacial neuropathic pain states by enhancing dorsal horn excitatory synaptic neurotransmission. Significance: This reveals a mechanism underlying orofacial neuropathic pain states. To investigate a potential mechanism underlying trigeminal nerve injury-induced orofacial hypersensitivity, we used a rat model of chronic constriction injury to the infraorbital nerve (CCI-ION) to study whether CCI-ION caused calcium channel (21) (Ca-v21) protein dysregulation in trigeminal ganglia and associated spinal subnucleus caudalis and C1/C2 cervical dorsal spinal cord (Vc/C2). Furthermore, we studied whether this neuroplasticity contributed to spinal neuron sensitization and neuropathic pain states. CCI-ION caused orofacial hypersensitivity that correlated with Ca-v21 up-regulation in trigeminal ganglion neurons and Vc/C2. Blocking Ca-v21 with gabapentin, a ligand for the Ca-v21 proteins, or Ca-v21 antisense oligodeoxynucleotides led to a reversal of orofacial hypersensitivity, supporting an important role of Ca-v21 in orofacial pain processing. Importantly, increased Ca-v21 in Vc/C2 superficial dorsal horn was associated with increased excitatory synaptogenesis and increased frequency, but not the amplitude, of miniature excitatory postsynaptic currents in dorsal horn neurons that could be blocked by gabapentin. Thus, CCI-ION-induced Ca-v21 up-regulation may contribute to orofacial neuropathic pain states through abnormal excitatory synapse formation and enhanced presynaptic excitatory neurotransmitter release in Vc/C2.	[Li, Kang-Wu; Kim, Doo-Sik; Lin, Bin; Luo, Z. David] Univ Calif Irvine, Dept Anesthesiol & Perioperat Care, Sch Med, Irvine, CA 92697 USA; [Yu, Yanhui Peter; Zhou, Chunyi; Luo, Z. David] Univ Calif Irvine, Dept Pharmacol, Sch Med, Irvine, CA 92697 USA; [Sharp, Kelli; Steward, Oswald; Luo, Z. David] Univ Calif Irvine, Reeve Irvine Res Ctr, Sch Med, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Luo, ZD (corresponding author), Univ Calif Irvine, Dept Anesthesiol & Perioperat Care, Gillespie Bldg,Rm 3113,837 Hlth Sci Rd, Irvine, CA 92697 USA.	zluo@uci.edu		Steward, Oswald/0000-0001-7069-8756	National Institutes of Health [DE014545, DE019298, NS064341, DE021847]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE019298, R21DE014545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DE014545, DE019298, NS064341, and DE021847 (to Z.D.L.).	Backonja M, 2003, CLIN THER, V25, P81, DOI 10.1016/S0149-2918(03)90011-7; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bauer CS, 2009, J NEUROSCI, V29, P4076, DOI 10.1523/JNEUROSCI.0356-09.2009; Boroujerdi A, 2011, PAIN, V152, P649, DOI 10.1016/j.pain.2010.12.014; Brittain JM, 2011, NAT MED, V17, P822, DOI 10.1038/nm.2345; BRUST PF, 1993, NEUROPHARMACOLOGY, V32, P1089, DOI 10.1016/0028-3908(93)90004-M; Cao H, 2008, NEUROSCI BIOBEHAV R, V32, P972, DOI 10.1016/j.neubiorev.2008.03.009; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Clark AK, 2007, EUR J PAIN, V11, P223, DOI 10.1016/j.ejpain.2006.02.003; Clark Glenn T, 2006, J Calif Dent Assoc, V34, P599; DIXON WJ, 1980, ANNU REV PHARMACOL, V20, P441, DOI 10.1146/annurev.pa.20.040180.002301; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Field MJ, 1999, PAIN, V80, P391, DOI 10.1016/S0304-3959(98)00239-5; Field MJ, 1997, BRIT J PHARMACOL, V121, P1513, DOI 10.1038/sj.bjp.0701320; Gee NS, 1996, J BIOL CHEM, V271, P5768, DOI 10.1074/jbc.271.10.5768; Gordh TE, 2008, PAIN, V138, P255, DOI 10.1016/j.pain.2007.12.011; Gurnett CA, 1996, NEURON, V16, P431, DOI 10.1016/S0896-6273(00)80061-6; Hardt J, 2008, PAIN MED, V9, P803, DOI 10.1111/j.1526-4637.2008.00425.x; Hashizume H, 2000, SPINE, V25, P1206, DOI 10.1097/00007632-200005150-00003; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Hunter JC, 1997, EUR J PHARMACOL, V324, P153, DOI 10.1016/S0014-2999(97)00070-8; Hwang JH, 1997, REGION ANESTH, V22, P249, DOI 10.1016/S1098-7339(06)80010-6; Iwata K, 2011, INT REV NEUROBIOL, V97, P227, DOI 10.1016/B978-0-12-385198-7.00009-6; Kang MG, 2002, FEBS LETT, V528, P177, DOI 10.1016/S0014-5793(02)03295-7; Kernisant M, 2008, J NEUROSCI METH, V172, P43, DOI 10.1016/j.jneumeth.2008.04.013; Kim DS, 2012, J NEUROSCI, V32, P8977, DOI 10.1523/JNEUROSCI.6494-11.2012; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Klugbauer N, 1999, J NEUROSCI, V19, P684; Laird MA, 2000, ANN PHARMACOTHER, V34, P802; Leo S, 2009, EUR J PAIN, V13, P1008, DOI 10.1016/j.ejpain.2008.12.001; Li CY, 2006, PAIN, V125, P20, DOI 10.1016/j.pain.2006.04.022; Li CY, 2004, J NEUROSCI, V24, P8494, DOI 10.1523/JNEUROSCI.2982-04.2004; Li K.-W., 2013, EUR J PAIN, DOI 10.1002/j.1532-2149.2013.00396.x; Luo ZD, 2002, J PHARMACOL EXP THER, V303, P1199, DOI 10.1124/jpet.102.041574; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Marais E, 2001, MOL PHARMACOL, V59, P1243, DOI 10.1124/mol.59.5.1243; Moechars D, 2006, J NEUROSCI, V26, P12055, DOI 10.1523/JNEUROSCI.2556-06.2006; MORI Y, 1991, NATURE, V350, P398, DOI 10.1038/350398a0; Neumann S, 2008, J NEUROSCI, V28, P7936, DOI 10.1523/JNEUROSCI.1259-08.2008; Nguyen D, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-6; PEYRONNARD JM, 1989, CELL TISSUE RES, V257, P379, DOI 10.1007/BF00261840; Qin N, 2002, MOL PHARMACOL, V62, P485, DOI 10.1124/mol.62.3.485; Rogawski MA, 2004, NAT MED, V10, P685, DOI 10.1038/nm1074; Rogoz K, 2012, PAIN, V153, P1525, DOI 10.1016/j.pain.2012.04.017; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; Shimoyama M, 2000, PAIN, V85, P405, DOI 10.1016/S0304-3959(99)00283-3; SILVERMAN JD, 1990, J NEUROCYTOL, V19, P789, DOI 10.1007/BF01188046; Singh L, 1996, PSYCHOPHARMACOLOGY, V127, P1, DOI 10.1007/BF02805968; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Stanfa LC, 1997, NEUROREPORT, V8, P587, DOI 10.1097/00001756-199702100-00002; Sun S, 2008, BRAIN RES BULL, V75, P83, DOI 10.1016/j.brainresbull.2007.07.027; Sweitzer SM, 1999, BRAIN RES, V829, P209, DOI 10.1016/S0006-8993(99)01326-8; Valder CR, 2003, J NEUROCHEM, V87, P560, DOI 10.1046/j.1471-4159.2003.02016.x; Vickers E R, 2000, Aust Endod J, V26, P53; VOS BP, 1994, J NEUROSCI, V14, P2708; WAMIL AW, 1994, EPILEPSY RES, V17, P1, DOI 10.1016/0920-1211(94)90074-4; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; Xiao W, 2007, NEUROSCIENCE, V144, P714, DOI 10.1016/j.neuroscience.2006.09.044	60	43	44	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					7025	7037		10.1074/jbc.M114.548990	http://dx.doi.org/10.1074/jbc.M114.548990			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24459143	Green Published, hybrid			2022-12-28	WOS:000332389400062
J	Zhang, RW; Wang, YL; Li, JX; Jin, HL; Song, SJ; Huang, CS				Zhang, Ruowen; Wang, Yulei; Li, Jingxia; Jin, Honglei; Song, Shaojiang; Huang, Chuanshu			The Chinese Herb Isolate Yuanhuacine (YHL-14) Induces G(2)/M Arrest in Human Cancer Cells by Up-regulating p21 Protein Expression through an p53 Protein-independent Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Anticancer Drug; Cell Growth; p38; MAPK; Protein Stability; Sp1; p21; Yuanhuacine	STRESS-ACTIVATED CHECKPOINT; POTENT INHIBITORY-ACTIVITY; DAPHNANE DITERPENE ESTERS; NF-KAPPA-B; CYCLE ARREST; TUMOR-GROWTH; DNA-DAMAGE; P38 MAPK; APOPTOSIS; PHOSPHORYLATION	Background: The potential mechanism of YHL-14 against cancer cells has not been explored. Results: YHL-14 induces G(2)/M phase arrest and inhibition of cancer cell growth by up-regulation of p21 transcription and protein expression via modulation of Sp1 protein stability. Conclusion: YHL-14 inhibits bladder and colon cancer cell growth through up-regulation of p21 expression. Significance: This study identifies a novel mechanism underlying the anticancer effect of YHL-14. Yuanhuacine (YHL-14), the major component of daphnane diterpene ester isolated from the flower buds of Daphne genkwa, has been reported to have activity against cell proliferation in various cancer cell lines. Nevertheless, the potential mechanism has not been explored yet. Here we demonstrate that YHL-14 inhibits bladder and colon cancer cell growth through up-regulation of p21 expression in an Sp1-dependent manner. We found that YHL-14 treatment resulted in up-regulation of p21 expression and a significant G(2)/M phase arrest in T24T and HCT116 cells without affecting p53 protein expression and activation. Further studies indicate that p21 induction by YHL-14 occurs at the transcriptional level via up-regulation of Sp1 protein expression. Moreover, our results show that p38 is essential for YHL-14-mediated Sp1 protein stabilization, G(2)/M growth arrest induction, and anchorage-independent growth inhibition of cancer cells. Taken together, our studies demonstrate a novel mechanism of YHL-14 against cancer cell growth in bladder and colon cancer cell lines, which provides valuable information for the design and synthesis of other new conformation-constrained derivatives on the basis of the structure of YHL-14 for cancer therapy.	[Zhang, Ruowen; Wang, Yulei; Li, Jingxia; Jin, Honglei; Huang, Chuanshu] NYU, Nelson Inst Environm Med, Sch Med, Tuxedo Pk, NY 10987 USA; [Zhang, Ruowen; Song, Shaojiang] Shenyang Pharmaceut Univ, Sch Tradit Chinese Mat Med, Key Lab Struct Based Drug Design & Discovery, Shenyang 110016, Peoples R China	New York University; Shenyang Pharmaceutical University	Song, SJ (corresponding author), Shenyang Pharmaceut Univ, Sch Tradit Chinese Mat Med, Key Lab Struct Based Drug Design & Discovery, Shenyang 110016, Peoples R China.	songsj99@gmail.com; chuanshu.huang@nyumc.org		Zhang, Ruowen/0000-0003-1403-2356; Huang, Chuanshu/0000-0003-4133-5096	NCI, National Institutes of Health [CA177665, CA165980, CA112557]; National Institutes of Health [NSFC81229002, LR2012034]; NATIONAL CANCER INSTITUTE [P01CA165980, R01CA112557, R01CA177665, P30CA016087] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by NCI, National Institutes of Health Grants CA177665, CA165980, and CA112557 and National Institutes of Health Grants NSFC81229002 and LR2012034.	Bhandurge P., 2013, ASIAN J BIOMED PHARM, V3, P1; Bulavin DV, 2001, NATURE, V411, P102, DOI 10.1038/35075107; Cai T, 2011, CURR CANCER DRUG TAR, V11, P548, DOI 10.2174/156800911795656001; Chadalapaka G, 2012, CARCINOGENESIS, V33, P886, DOI 10.1093/carcin/bgs102; Chintharlapalli S, 2007, CANCER RES, V67, P2816, DOI 10.1158/0008-5472.CAN-06-3735; Chuang JY, 2008, MOL BIOL CELL, V19, P1139, DOI 10.1091/mbc.E07-09-0881; Cummins Jordan M., 2004, Cancer Research, V64, P3006; D'Addario M, 2006, GENE, V379, P51, DOI 10.1016/j.gene.2006.04.012; De Souza CPC, 2007, EUKARYOT CELL, V6, P1521, DOI 10.1128/EC.00178-07; Ding J, 2006, J BIOL CHEM, V281, P24405, DOI 10.1074/jbc.M600751200; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Eom HJ, 2010, ENVIRON SCI TECHNOL, V44, P8337, DOI 10.1021/es1020668; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Gartel AL, 2000, ONCOGENE, V19, P5182, DOI 10.1038/sj.onc.1203900; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; HALL IH, 1986, EUR J CANCER CLIN ON, V22, P45, DOI 10.1016/0277-5379(86)90341-X; Harding MA, 2010, EUR J CANCER, V46, P1252, DOI 10.1016/j.ejca.2010.02.025; HARPER JW, 1993, CELL, V75, P805; Hong JY, 2011, J NAT PROD, V74, P2102, DOI 10.1021/np2003512; Hong JY, 2010, CHEM PHARM BULL, V58, P234, DOI 10.1248/cpb.58.234; Hopkins Maton A., 1997, CELLS BUILDING BLOCK, P76; Huang CS, 1999, J BIOL CHEM, V274, P12229, DOI 10.1074/jbc.274.18.12229; Huang CS, 1999, ONCOGENE, V18, P2828, DOI 10.1038/sj.onc.1202639; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jutooru I, 2010, J BIOL CHEM, V285, P25332, DOI 10.1074/jbc.M109.095240; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Liu JY, 2010, J BIOL CHEM, V285, P26058, DOI 10.1074/jbc.M110.100271; Luo WJ, 2008, J BIOL CHEM, V283, P8624, DOI 10.1074/jbc.M707860200; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Mikhailov A, 2005, CELL CYCLE, V4, P57, DOI 10.4161/cc.4.1.1357; Mikhailov A, 2007, CURR BIOL, V17, P2162, DOI 10.1016/j.cub.2007.11.028; Park BY, 2007, J ETHNOPHARMACOL, V111, P496, DOI 10.1016/j.jep.2006.12.023; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Sisodiya D., 2012, IJAPBC, V1, P138; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Vinay K. M., 2004, ROBBINS COTRAN PATHO, P331; Westfall MD, 2003, MOL CELL BIOL, V23, P2264, DOI 10.1128/MCB.23.7.2264-2276.2003; WHO, 2009, WHO TECH REP SER, V958, P1; WHO Library Cataloguing-in-Publication Data, 2010, WHOHRHHPN103, P18; Wood CD, 2009, INT J BIOL SCI, V5, P428; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhan ZJ, 2005, BIOORGAN MED CHEM, V13, P645, DOI 10.1016/j.bmc.2004.10.054; Zhang DY, 2006, J BIOL CHEM, V281, P34113, DOI 10.1074/jbc.M602821200; Zhang DY, 2010, CANCER RES, V70, P813, DOI 10.1158/0008-5472.CAN-09-0448; Zhang SX, 2006, BIOORGAN MED CHEM, V14, P3888, DOI 10.1016/j.bmc.2006.01.055; Zhang SX, 2009, J DRUG TARGET, V17, P286, DOI 10.1080/10611860902737912; Zhou J. J., 2013, ENCY TRADITIONAL CHI, V5, P227	49	28	30	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6394	6403		10.1074/jbc.M113.513960	http://dx.doi.org/10.1074/jbc.M113.513960			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24451377	Green Published, hybrid			2022-12-28	WOS:000332389400008
J	Firon, A; Dinis, M; Raynal, B; Poyart, C; Trieu-Cuot, P; Kaminski, PA				Firon, Arnaud; Dinis, Marcia; Raynal, Bertrand; Poyart, Claire; Trieu-Cuot, Patrick; Kaminski, Pierre Alexandre			Extracellular Nucleotide Catabolism by the Group B Streptococcus Ectonucleotidase NudP Increases Bacterial Survival in Blood	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adenosine; Bacterial Pathogenesis; Enzyme Catalysis; Enzymes; Host-Pathogen Interactions; Metalloenzymes; Nucleoside Nucleotide Metabolism; Streptococcus	ECTO-TRIPHOSPHATE DIPHOSPHOHYDROLASE; ESCHERICHIA-COLI; LEGIONELLA-PNEUMOPHILA; SUBSTRATE-SPECIFICITY; ENZYMATIC-PROPERTIES; ATP RELEASE; AGALACTIAE; 5'-NUCLEOTIDASE; PROTEINS; SURFACE	Background: Ectonucleotidases regulate extracellular nucleotide concentration. Results: The NudP ecto-5-nucleotidase of Streptococcus agalactiae has specific substrate specificities necessary for survival in blood and organ colonization. Conclusion: Extracellular nucleotide catabolism is involved in the control of Group B streptococcal pathogenesis. Significance: Bacterial pathogens exploit different enzymatic specificities to subvert extracellular nucleotide signaling. Streptococcus agalactiae (Group B Streptococcus) is a commensal of the human intestine and vagina of adult women but is the leading cause of invasive infection in neonates. This Gram-positive bacterium displays a set of virulence-associated surface proteins involved in the interaction with the host, such as adhesion to host cells, invasion of tissues, or subversion of the immune system. In this study, we characterized a cell wall-localized protein as an ecto-5-nucleoside diphosphate phosphohydrolase (NudP) involved in the degradation of extracellular nucleotides which are central mediators of the immune response. Biochemical characterization of recombinant NudP revealed a Mn2+-dependent ecto-5-nucleotidase activity on ribo- and deoxyribonucleoside 5-mono- and 5-diphosphates with a substrate specificity different from that of known orthologous enzymes. Deletion of the gene coding the housekeeping enzyme sortase A led to the release of NudP into the culture supernatant, confirming that this enzyme is anchored to the cell wall by its non-canonical LPXTN motif. The NudP ecto-5-nucleotidase activity is reminiscent of the reactions performed by the mammalian ectonucleotidases CD39 and CD73 involved in regulating the extracellular level of ATP and adenosine. We further demonstrated that the absence of NudP activity decreases bacterial survival in mouse blood, a process dependent on extracellular adenosine. In vivo assays in animal models of infection showed that NudP activity is critical for virulence. These results demonstrate that Group B Streptococcus expresses a specific ecto-5-nucleotidase necessary for its pathogenicity and highlight the diversity of reactions performed by this enzyme family. These results suggest that bacterial pathogens have developed specialized strategies to subvert the mammalian immune response controlled by the extracellular nucleotide signaling pathways.	[Firon, Arnaud; Dinis, Marcia; Trieu-Cuot, Patrick; Kaminski, Pierre Alexandre] Inst Pasteur, Unite Biol Bacteries Pathogenes Gram Positif, F-75015 Paris, France; [Raynal, Bertrand] Inst Pasteur, F-75015 Paris, France; [Firon, Arnaud; Dinis, Marcia; Trieu-Cuot, Patrick; Kaminski, Pierre Alexandre] CNRS, ERL3526, F-75015 Paris, France; [Poyart, Claire] Univ Sorbonne Paris Descartes, Inst Cochin, F-75014 Paris, France; [Poyart, Claire] INSERM, U1016, F-75014 Paris, France; [Poyart, Claire] AP HP, Serv Bacteriol, F-75014 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP)	Kaminski, PA (corresponding author), Inst Pasteur, Dept Microbiol, Unite Biol Bacteries Pathogenes Gram Positif, 25-28 Rue Docteur Roux, F-75015 Paris, France.	pierre-alexandre.kaminski@pasteur.fr	POYART, Claire/P-4225-2017	POYART, Claire/0000-0003-2158-6293; raynal, Bertrand/0000-0001-5634-0408; Dinis, Marcia/0000-0001-8734-4276; FIRON, Arnaud/0000-0002-5323-5212; TRIEU-CUOT, Patrick/0000-0002-2768-9587; Kaminski, Pierre Alexandre/0000-0001-9841-6837	Institut Pasteur; CNRS; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]; Fondation pour la Recherche Medicale [DEQ20130326538]	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the Institut Pasteur, the CNRS, the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" Grant ANR-10-LABX-62-IBEID, and Fondation pour la Recherche Medicale Grant DEQ20130326538.	Betton JM, 1996, J BIOL CHEM, V271, P8046, DOI 10.1074/jbc.271.14.8046; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Derre-Bobillot A, 2013, MOL MICROBIOL, V89, P518, DOI 10.1111/mmi.12295; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Fan J., 2012, PLOS ONE, V7; Firon A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003179; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Harder J, 2009, J IMMUNOL, V183, P5823, DOI 10.4049/jimmunol.0900444; Hasko G, 2011, J IMMUNOL, V187, P4256, DOI 10.4049/jimmunol.1003379; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; Henneke P, 2006, INFECT IMMUN, V74, P3085, DOI 10.1128/IAI.01551-05; Henneke P, 2008, J IMMUNOL, V180, P6149, DOI 10.4049/jimmunol.180.9.6149; Johri AK, 2006, NAT REV MICROBIOL, V4, P932, DOI 10.1038/nrmicro1552; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Knofel T, 1999, NAT STRUCT BIOL, V6, P448; Knofel T, 2001, J MOL BIOL, V309, P255, DOI 10.1006/jmbi.2001.4657; Knofel T, 2001, J MOL BIOL, V309, P239, DOI 10.1006/jmbi.2001.4656; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Konto-Ghiorghi Y, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000422; Krug U, 2013, FEBS LETT, V587, P460, DOI 10.1016/j.febslet.2013.01.010; Lalioui L, 2005, INFECT IMMUN, V73, P3342, DOI 10.1128/IAI.73.6.3342-3350.2005; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Miller CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002212; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Pettengill M, 2013, J BIOL CHEM, V288, P27315, DOI 10.1074/jbc.M113.484212; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Sansom FM, 2008, J BIOL CHEM, V283, P12909, DOI 10.1074/jbc.M801006200; Sansom FM, 2007, CELL MICROBIOL, V9, P1922, DOI 10.1111/j.1462-5822.2007.00924.x; Sansom FM, 2008, MICROBIOL MOL BIOL R, V72, P765, DOI 10.1128/MMBR.00013-08; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sitkovsky MV, 2005, TRENDS IMMUNOL, V26, P299, DOI 10.1016/j.it.2005.04.004; Tazi A, 2010, J EXP MED, V207, P2313, DOI 10.1084/jem.20092594; Thammavongsa V, 2013, SCIENCE, V342, P863, DOI 10.1126/science.1242255; Thammavongsa V, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-56; Thammavongsa V, 2009, J EXP MED, V206, P2417, DOI 10.1084/jem.20090097; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Trigo G, 2008, CAN J MICROBIOL, V54, P899, DOI [10.1139/W08-083, 10.1139/w08-083]; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Vitiello L, 2012, BLOOD, V120, P511, DOI 10.1182/blood-2012-01-406496; Vivian JP, 2010, STRUCTURE, V18, P228, DOI 10.1016/j.str.2009.11.014; Whidbey C, 2013, J EXP MED, V210, P1265, DOI 10.1084/jem.20122753; Yip L, 2009, FASEB J, V23, P1685, DOI 10.1096/fj.08-126458; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	54	27	28	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5479	5489		10.1074/jbc.M113.545632	http://dx.doi.org/10.1074/jbc.M113.545632			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24429288	hybrid, Green Published			2022-12-28	WOS:000332015500012
J	Grover, S; Alderwick, LJ; Mishra, AK; Krumbach, K; Marienhagen, J; Eggeling, L; Bhatt, A; Besra, GS				Grover, Shipra; Alderwick, Luke J.; Mishra, Arun K.; Krumbach, Karin; Marienhagen, Jan; Eggeling, Lothar; Bhatt, Apoorva; Besra, Gurdyal S.			Benzothiazinones Mediate Killing of Corynebacterineae by Blocking Decaprenyl Phosphate Recycling Involved in Cell Wall Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Metabolism; Carbohydrate Metabolism; Cell Wall; Drug Resistance; Polysaccharide	MYCOBACTERIUM-TUBERCULOSIS; ARABINAN BIOSYNTHESIS; STRUCTURAL-CHARACTERIZATION; GLUTAMICUM; GENES; IDENTIFICATION; DELETION; STEP; MUTANT; DPRE1	Background: Benzothiazinones inhibit cell wall arabinan biosynthesis, which is lethal for Corynebacterineae.Results:Corynebacteria can evade the action of benzothiazinones in the absence of decaprenyl phosphoribose synthesis by increasing the intracellular decaprenyl phosphate pool. Conclusion: Benzothiazinones induce synthetic lethality in Corynebacterineae by blocking decaprenyl phosphate recycling. Significance: Increased production of decaprenyl phosphate is a new mechanism of resistance to benzothiazinones. Benzothiazinones (BTZs) are a new class of sulfur containing heterocyclic compounds that target DprE1, an oxidoreductase involved in the epimerization of decaprenyl-phosphoribose (DPR) to decaprenyl-phosphoarabinose (DPA) in the Corynebacterineae, such as Corynebacterium glutamicum and Mycobacterium tuberculosis. As a result, BTZ inhibition leads to inhibition of cell wall arabinan biosynthesis. Previous studies have demonstrated the essentiality of dprE1. In contrast, Cg-UbiA a ribosyltransferase, which catalyzes the first step of DPR biosynthesis prior to DprE1, when genetically disrupted, produced a viable mutant, suggesting that although BTZ biochemically targets DprE1, killing also occurs through chemical synthetic lethality, presumably through the lack of decaprenyl phosphate recycling. To test this hypothesis, a derivative of BTZ, BTZ043, was examined in detail against C. glutamicum and C. glutamicum::ubiA. The wild type strain was sensitive to BTZ043; however, C. glutamicum::ubiA was found to be resistant, despite possessing a functional DprE1. When the gene encoding C. glutamicum Z-decaprenyl-diphosphate synthase (NCgl2203) was overexpressed in wild type C. glutamicum, resistance to BTZ043 was further increased. This data demonstrates that in the presence of BTZ, the bacilli accumulate DPR and fail to recycle decaprenyl phosphate, which results in the depletion of decaprenyl phosphate and ultimately leads to cell death.	[Grover, Shipra; Alderwick, Luke J.; Mishra, Arun K.; Bhatt, Apoorva; Besra, Gurdyal S.] Univ Birmingham, Inst Microbiol & Infect, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Krumbach, Karin; Marienhagen, Jan; Eggeling, Lothar] Res Ctr Juelich, Inst Bio & Geosci Biotechnol IBG 1, D-52425 Julich, Germany	University of Birmingham; Helmholtz Association; Research Center Julich	Besra, GS (corresponding author), Univ Birmingham, Inst Microbiol & Infect, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	g.besra@bham.ac.uk	Grover, +Shipra/I-6388-2019; Marienhagen, Jan/E-9593-2011	Grover, +Shipra/0000-0001-7094-6879; Marienhagen, Jan/0000-0001-5513-3730; Besra, Gurdyal/0000-0002-5605-0395; Alderwick, Luke/0000-0002-1257-6053	Royal Society; Medical Research Council [MR/K012118/1]; Wellcome Trust [081569/Z/06/Z]; MRC [MR/K012118/1] Funding Source: UKRI	Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Personal Research Chair from James Bardrick, Royal Society Wolfson Research Merit Award, as a former Lister Institute-Jenner Research Fellow, Medical Research Council Grant MR/K012118/1, and Wellcome Trust Grant 081569/Z/06/Z (to G. S. B.).	Alderwick LJ, 2005, J BIOL CHEM, V280, P32362, DOI 10.1074/jbc.M506339200; Alderwick LJ, 2006, GLYCOBIOLOGY, V16, P1073, DOI 10.1093/glycob/cwl030; Alderwick LJ, 2006, J BIOL CHEM, V281, P15653, DOI 10.1074/jbc.M600045200; Alderwick LJ, 2011, GLYCOBIOLOGY, V21, P410, DOI 10.1093/glycob/cwq173; Batt SM, 2012, P NATL ACAD SCI USA, V109, P11354, DOI 10.1073/pnas.1205735109; Belanger AE, 1996, P NATL ACAD SCI USA, V93, P11919, DOI 10.1073/pnas.93.21.11919; Besra GS, 1997, J BIOL CHEM, V272, P18460, DOI 10.1074/jbc.272.29.18460; Campbell J, 2012, ANTIMICROB AGENTS CH, V56, P1810, DOI 10.1128/AAC.05938-11; Crellin PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016869; D'Elia MA, 2006, J BACTERIOL, V188, P8313, DOI 10.1128/JB.01336-06; D'Elia MA, 2009, J BACTERIOL, V191, P4030, DOI 10.1128/JB.00611-08; Dover LG, 2004, FEMS MICROBIOL REV, V28, P225, DOI 10.1016/j.femsre.2003.10.001; Lee YH, 2013, ANTIMICROB AGENTS CH, V57, P4267, DOI 10.1128/AAC.00794-13; Lothar Eggeling M. B., 2005, HDB CORYNEBACTERIUM; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Manina G, 2010, MOL MICROBIOL, V77, P1172, DOI 10.1111/j.1365-2958.2010.07277.x; Meniche X, 2008, MICROBIOL-SGM, V154, P2315, DOI 10.1099/mic.0.2008/016378-0; Mikusova K, 2005, J BACTERIOL, V187, P8020, DOI 10.1128/JB.187.23.8020-8025.2005; Minnikin D. E., 1978, LIPID COMPOSITION CL; Mishra AK, 2007, MOL MICROBIOL, V65, P1503, DOI 10.1111/j.1365-2958.2007.05884.x; Mishra AK, 2011, MOL MICROBIOL, V80, P1241, DOI 10.1111/j.1365-2958.2011.07640.x; Mishra AK, 2009, J BACTERIOL, V191, P4465, DOI 10.1128/JB.01729-08; Moker N, 2004, MOL MICROBIOL, V54, P420, DOI 10.1111/j.1365-2958.2004.04249.x; Neres J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004395; Pasca MR, 2010, ANTIMICROB AGENTS CH, V54, P1616, DOI 10.1128/AAC.01676-09; Pathak AK, 2002, BIOORGAN MED CHEM, V10, P923, DOI 10.1016/S0968-0896(01)00343-1; Radmacher E, 2005, MICROBIOL-SGM, V151, P1359, DOI 10.1099/mic.0.27804-0; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Scherman MS, 1996, J BIOL CHEM, V271, P29652, DOI 10.1074/jbc.271.47.29652; Seidel M, 2007, J BIOL CHEM, V282, P14729, DOI 10.1074/jbc.M700271200; Tatituri RVV, 2007, MICROBIOL-SGM, V153, P2621, DOI 10.1099/mic.0.2007/008078-0; Telenti A, 1997, NAT MED, V3, P567, DOI 10.1038/nm0597-567; Trefzer C, 2012, J AM CHEM SOC, V134, P912, DOI 10.1021/ja211042r; Trefzer C, 2010, J AM CHEM SOC, V132, P13663, DOI 10.1021/ja106357w; Varela C, 2012, CHEM BIOL, V19, P498, DOI 10.1016/j.chembiol.2012.03.006; Wolucka BA, 2008, FEBS J, V275, P2691, DOI 10.1111/j.1742-4658.2008.06395.x	36	22	22	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6177	6187		10.1074/jbc.M113.522623	http://dx.doi.org/10.1074/jbc.M113.522623			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24446451	Green Published, hybrid			2022-12-28	WOS:000332015500071
J	Tan, KM; Chhor, G; Binkowski, TA; Jedrzejczak, RP; Makowska-Grzyska, M; Joachimiak, A				Tan, Kemin; Chhor, Gekleng; Binkowski, T. Andrew; Jedrzejczak, Robert P.; Makowska-Grzyska, Magdalena; Joachimiak, Andrzej			Sensor Domain of Histidine Kinase KinB of Pseudomonas A HELIX- SWAPPED DIMER	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Signal Transduction; Biosensors; Histidine Kinases; Protein Conformation; Protein Structure; Alginate Biosynthesis; Helix-swapped Dimer; Sensor Domain; Two-component System	LIGAND-BINDING DOMAIN; CRYSTAL-STRUCTURE; SIGNAL-TRANSDUCTION; STRUCTURAL-ANALYSIS; LIGHT-SCATTERING; AERUGINOSA; PROTEINS; MECHANISM; VIRULENCE; RECEPTOR	Background: The sensor domain (SD) of histidine kinase (HK) KinB (KinB-SD) receives signals from the environment and induces a transduction cascade. Results: Structures of the KinB-SD were obtained in ligand-free, phosphate-bound, and mutant forms. Conclusion: The unique helix-swapped KinB-SD structure forms a ligand-binding cavity on the dimer interface. Significance: KinB-SD studies provide insights into the signal transduction and identity of potential signaling molecules. The overproduction of polysaccharide alginate is responsible for the formation of mucus in the lungs of cystic fibrosis patients. Histidine kinase KinB of the KinB-AlgB two-component system in Pseudomonas aeruginosa acts as a negative regulator of alginate biosynthesis. The modular architecture of KinB is similar to other histidine kinases. However, its periplasmic signal sensor domain is unique and is found only in the Pseudomonas genus. Here, we present the first crystal structures of the KinB sensor domain. The domain is a dimer in solution, and in the crystal it shows an atypical dimer of a helix-swapped four-helix bundle. A positively charged cavity is formed on the dimer interface and involves several strictly conserved residues, including Arg-60. A phosphate anion is bound asymmetrically in one of the structures. In silico docking identified several monophosphorylated sugars, including -d-fructose 6-phosphate and -d-mannose 6-phosphate, a precursor and an intermediate of alginate synthesis, respectively, as potential KinB ligands. Ligand binding was confirmed experimentally. Conformational transition from a symmetric to an asymmetric structure and decreasing dimer stability caused by ligand binding may be a part of the signal transduction mechanism of the KinB-AlgB two-component system.	[Tan, Kemin; Chhor, Gekleng; Binkowski, T. Andrew; Jedrzejczak, Robert P.; Joachimiak, Andrzej] Argonne Natl Lab, Midwest Ctr Struct Genom, Argonne, IL 60439 USA; [Tan, Kemin; Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Argonne, IL 60439 USA; [Tan, Kemin; Makowska-Grzyska, Magdalena; Joachimiak, Andrzej] Univ Chicago, Ctr Struct Genom Infect Dis, Chicago, IL 60637 USA	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago	Joachimiak, A (corresponding author), Argonne Natl Lab, Midwest Ctr Struct Genom, 9700 S Cass Ave, Argonne, IL 60439 USA.	andrzejj@anl.gov		Joachimiak, Andrzej/0000-0003-2535-6209	Office of Science of the United States Department of Energy [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942, U54GM094585] Funding Source: NIH RePORTER	Office of Science of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Structural Biology Center at Argonne National Laboratory for their help with data collection at the 19-ID beamline and Kimberly S. Buck for help with cloning. This research used resources of the Argonne Leadership Computing Facility at Argonne National Laboratory, which is supported by the Office of Science of the United States Department of Energy under Contract DE-AC02-06CH11357.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chand NS, 2012, J BACTERIOL, V194, P6537, DOI 10.1128/JB.01168-12; Chand NS, 2011, VIRULENCE, V2, P553, DOI 10.4161/viru.2.6.17987; Chand NS, 2011, J BACTERIOL, V193, P2989, DOI 10.1128/JB.01546-10; Chang C, 2010, J BACTERIOL, V192, P1156, DOI 10.1128/JB.01508-09; Cheung J, 2008, J BIOL CHEM, V283, P30256, DOI 10.1074/jbc.M805253200; Cheung J, 2008, J BIOL CHEM, V283, P13762, DOI 10.1074/jbc.M710592200; Cheung J, 2010, CURR OPIN MICROBIOL, V13, P116, DOI 10.1016/j.mib.2010.01.016; Cheung J, 2009, PROTEINS, V77, P235, DOI 10.1002/prot.22485; Cheung J, 2009, STRUCTURE, V17, P190, DOI 10.1016/j.str.2008.12.013; Cho US, 2006, J MOL BIOL, V356, P1193, DOI 10.1016/j.jmb.2005.12.032; Cimmperman P, 2008, BIOPHYS J, V95, P3222, DOI 10.1529/biophysj.108.134973; Cohen SX, 2004, ACTA CRYSTALLOGR D, V60, P2222, DOI 10.1107/S0907444904027556; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Damron FH, 2012, J BACTERIOL, V194, P1317, DOI 10.1128/JB.06105-11; Damron FH, 2009, J BACTERIOL, V191, P2285, DOI 10.1128/JB.01490-08; DERETIC V, 1987, J BACTERIOL, V169, P351, DOI 10.1128/jb.169.1.351-358.1987; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eschenfeldt William H., 2013, Journal of Structural and Functional Genomics, V14, P135, DOI 10.1007/s10969-013-9163-9; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Gooderham WJ, 2009, FEMS MICROBIOL REV, V33, P279, DOI 10.1111/j.1574-6976.2008.00135.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Herrou J, 2010, P NATL ACAD SCI USA, V107, P17351, DOI 10.1073/pnas.1006267107; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kim Youngchang, 2004, Journal of Structural and Functional Genomics, V5, P111, DOI 10.1023/B:JSFG.0000029206.07778.fc; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kulik V, 2002, J MOL BIOL, V324, P677, DOI 10.1016/S0022-2836(02)01109-9; Lee D, 2013, PHYS CHEM CHEM PHYS, V15, P5844, DOI 10.1039/c3cp00160a; LIN SL, 1995, J MOL BIOL, V248, P151, DOI 10.1006/jmbi.1995.0208; Lowe EC, 2012, P NATL ACAD SCI USA, V109, P7298, DOI 10.1073/pnas.1200479109; Ma S, 1997, J BIOL CHEM, V272, P17952, DOI 10.1074/jbc.272.29.17952; MARTIN DW, 1993, P NATL ACAD SCI USA, V90, P8377, DOI 10.1073/pnas.90.18.8377; Mathee K, 1997, J BACTERIOL, V179, P3711, DOI 10.1128/jb.179.11.3711-3720.1997; MILBURN MV, 1991, SCIENCE, V254, P1342, DOI 10.1126/science.1660187; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Moore JO, 2009, STRUCTURE, V17, P1195, DOI 10.1016/j.str.2009.07.015; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Neiditch MB, 2005, MOL CELL, V18, P507, DOI 10.1016/j.molcel.2005.04.020; Nettleship Joanne E., 2008, V426, P299, DOI 10.1007/978-1-60327-058-8_19; Pappalardo L, 2003, J BIOL CHEM, V278, P39185, DOI 10.1074/jbc.C300344200; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Pawar SN, 2012, BIOMATERIALS, V33, P3279, DOI 10.1016/j.biomaterials.2012.01.007; Perry J, 2011, MOL BIOSYST, V7, P1388, DOI 10.1039/c0mb00329h; Reinelt S, 2003, J BIOL CHEM, V278, P39189, DOI 10.1074/jbc.M305864200; Rocchetta HL, 1999, MICROBIOL MOL BIOL R, V63, P523, DOI 10.1128/MMBR.63.3.523-553.1999; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shiba K, 2010, ANAL SCI, V26, P659, DOI 10.2116/analsci.26.659; Soetens JC, 1997, J PHYS CHEM B, V101, P10910, DOI 10.1021/jp972113j; Stibitz S, 2007, BORDETELLA MOL MICRO, P47; Ulrich LE, 2005, BIOINFORMATICS, V21, P45, DOI 10.1093/bioinformatics/bti1204; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wu R, 2013, PROTEIN SCI, V22, P564, DOI 10.1002/pro.2237; Zhou YF, 2008, J MOL BIOL, V383, P49, DOI 10.1016/j.jmb.2008.08.010	59	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2014	289	18					12232	12244		10.1074/jbc.M113.514836	http://dx.doi.org/10.1074/jbc.M113.514836			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AG7ER	24573685	Green Published, hybrid			2022-12-28	WOS:000335581400005
J	Thaker, TM; Sarwar, M; Preininger, AM; Hamm, HE; Iverson, TM				Thaker, Tarjani M.; Sarwar, Maruf; Preininger, Anita M.; Hamm, Heidi E.; Iverson, T. M.			A Transient Interaction between the Phosphate Binding Loop and Switch I Contributes to the Allosteric Network between Receptor and Nucleotide in G alpha(i1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; G Protein-coupled Receptors (GPCR); G Proteins; Heterotrimeric G Proteins; Rhodopsin; Signal Transduction	HETEROTRIMERIC G-PROTEIN; LIGHT-ACTIVATED RHODOPSIN; COVALENT CROSS-LINKING; ALPHA-SUBUNIT; CRYSTAL-STRUCTURE; STRUCTURAL DETERMINANTS; COMPLEX-FORMATION; AMINO-TERMINUS; CONTACT SITES; C-TERMINUS	Background: G proteins couple receptor binding to nucleotide release via an allosteric network. Results: Mutation of allosteric sites of G(i1) stabilizes a transient signaling conformation and may highlight an allosteric connection between receptor and nucleotide. Conclusion: The P-loop interacts with Switch I in the K345L variant of G(i1). Significance: G protein signaling is critical for numerous cellular functions, and GDP release is the rate-limiting step of the cycle. Receptor-mediated activation of the G subunit of heterotrimeric G proteins requires allosteric communication between the receptor binding site and the guanine nucleotide binding site, which are separated by >30 . Structural changes in the allosteric network connecting these sites are predicted to be transient in the wild-type G subunit, making studies of these connections challenging. In the current work, site-directed mutants that alter the energy barriers between the activation states are used as tools to better understand the transient features of allosteric signaling in the G subunit. The observed differences in relative receptor affinity for intact G(i1) subunits versus C-terminal G(i1) peptides harboring the K345L mutation are consistent with this mutation modulating the allosteric network in the protein subunit. Measurement of nucleotide exchange rates, affinity for metarhodopsin II, and thermostability suggest that the K345L G(i1) variant has reduced stability in both the GDP-bound and nucleotide-free states as compared with wild type but similar stability in the GTPS-bound state. High resolution x-ray crystal structures reveal conformational changes accompanying the destabilization of the GDP-bound state. Of these, the conformation for Switch I was stabilized by an ionic interaction with the phosphate binding loop. Further site-directed mutagenesis suggests that this interaction between Switch I and the phosphate binding loop is important for receptor-mediated nucleotide exchange in the wild-type G(i1) subunit.	[Thaker, Tarjani M.; Iverson, T. M.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Sarwar, Maruf; Preininger, Anita M.; Hamm, Heidi E.; Iverson, T. M.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Hamm, HE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, 442 Robinson Res Bldg, Nashville, TN 37232 USA.	Heidi.hamm@vanderbilt.edu; tina.iverson@vanderbilt.edu	Hamm, Heidi E/G-2374-2014	Preininger, Anita/0000-0001-8011-9391	United States Department of Energy [DE-AC02-06CH11357]; Michigan Economic Development Corp.; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL EYE INSTITUTE [P30EY008126, R01EY006062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095633] Funding Source: NIH RePORTER	United States Department of Energy(United States Department of Energy (DOE)); Michigan Economic Development Corp.; Michigan Technology Tri-Corridor; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Ali I. Kaya both for assistance with the rhodopsin binding studies and for informative discussions, James Gilbert for assistance with G beta<INF>1</INF>gamma<INF>1</INF> preparation, and Dr. Kathryn McCulloch and Chrystal Starbird for critical reading of this manuscript. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and the Michigan Technology Tri-Corridor (Grant 085P1000817).	Abdulaev NG, 2006, BIOCHEMISTRY-US, V45, P12986, DOI 10.1021/bi061088h; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aris L, 2001, J BIOL CHEM, V276, P2333, DOI 10.1074/jbc.M002533200; Bae H, 1999, J BIOL CHEM, V274, P14963, DOI 10.1074/jbc.274.21.14963; Bae H, 1997, J BIOL CHEM, V272, P32071, DOI 10.1074/jbc.272.51.32071; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Cai K, 2001, P NATL ACAD SCI USA, V98, P4877, DOI 10.1073/pnas.051632898; Ceruso MA, 2004, J MOL BIOL, V338, P469, DOI 10.1016/j.jmb.2004.02.064; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Coleman DE, 1999, J BIOL CHEM, V274, P16669, DOI 10.1074/jbc.274.24.16669; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; DRATZ EA, 1993, NATURE, V363, P276, DOI 10.1038/363276a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Grishina G, 2000, MOL PHARMACOL, V57, P1081; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Hamm HE, 2013, J STRUCT BIOL, V184, P63, DOI 10.1016/j.jsb.2013.02.016; Herrmann R, 2006, VISION RES, V46, P4582, DOI 10.1016/j.visres.2006.07.027; Herrmann R, 2006, J BIOL CHEM, V281, P30234, DOI 10.1074/jbc.M600797200; Ho MKC, 2004, BIOCHEM J, V380, P361, DOI 10.1042/BJ20040231; Itoh Y, 2001, P NATL ACAD SCI USA, V98, P4883, DOI 10.1073/pnas.051632998; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Kapoor N, 2009, J MOL BIOL, V393, P882, DOI 10.1016/j.jmb.2009.08.043; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kling RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067244; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li JN, 2011, PROTEINS, V79, P2794, DOI 10.1002/prot.23106; Lichtarge O, 1996, P NATL ACAD SCI USA, V93, P7507, DOI 10.1073/pnas.93.15.7507; Marin EP, 2002, BIOCHEMISTRY-US, V41, P6988, DOI 10.1021/bi025514k; Marin EP, 2001, J BIOL CHEM, V276, P23873, DOI 10.1074/jbc.M101197200; Marin EP, 2001, J BIOL CHEM, V276, P27400, DOI 10.1074/jbc.C100198200; Martin EL, 1996, J BIOL CHEM, V271, P361, DOI 10.1074/jbc.271.1.361; Mazzoni MR, 1996, J BIOL CHEM, V271, P30034, DOI 10.1074/jbc.271.47.30034; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MIXON MB, 1995, SCIENCE, V270, P954, DOI 10.1126/science.270.5238.954; Morikawa T, 2007, ACTA CRYSTALLOGR F, V63, P139, DOI 10.1107/S1744309107003363; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2007, P NATL ACAD SCI USA, V104, P7927, DOI 10.1073/pnas.0702623104; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Posner BA, 1998, J BIOL CHEM, V273, P21752, DOI 10.1074/jbc.273.34.21752; Preininger AM, 2008, BIOCHEMISTRY-US, V47, P10281, DOI 10.1021/bi800741r; Preininger AM, 2013, J MOL BIOL, V425, P2288, DOI 10.1016/j.jmb.2013.04.011; Preininger AM, 2012, BIOCHEMISTRY-US, V51, P1911, DOI 10.1021/bi201472c; Preininger AM, 2009, BIOCHEMISTRY-US, V48, P2630, DOI 10.1021/bi801853a; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ridge KD, 2006, VISION RES, V46, P4482, DOI 10.1016/j.visres.2006.07.024; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Singh G, 2012, BIOCHEMISTRY-US, V51, P3232, DOI 10.1021/bi3001984; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; TAYLOR JM, 1994, J BIOL CHEM, V269, P27618; Thaker TM, 2012, METHODS MOL BIOL, V796, P133, DOI 10.1007/978-1-61779-334-9_8; Thomas CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023197; Thomas CJ, 2004, P NATL ACAD SCI USA, V101, P7560, DOI 10.1073/pnas.0304091101; Van Eps N, 2006, P NATL ACAD SCI USA, V103, P16194, DOI 10.1073/pnas.0607972103; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Zelent B, 2001, BIOCHEMISTRY-US, V40, P9647, DOI 10.1021/bi010272u	79	7	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2014	289	16					11331	11341		10.1074/jbc.M113.539064	http://dx.doi.org/10.1074/jbc.M113.539064			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AF3UT	24596087	hybrid, Green Published			2022-12-28	WOS:000334638500035
J	Batra, N; Riquelme, MA; Burra, S; Kar, R; Gu, SM; Jiang, JX				Batra, Nidhi; Riquelme, Manuel A.; Burra, Sirisha; Kar, Rekha; Gu, Sumin; Jiang, Jean X.			Direct Regulation of Osteocytic Connexin 43 Hemichannels through AKT Kinase Activated by Mechanical Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Connexin; Integrin; Mechanotransduction; Phosphorylation	GAP-JUNCTIONS; ATP RELEASE; BONE; PHOSPHORYLATION; CHANNELS; CELLS; MECHANOTRANSDUCTION; PROSTAGLANDIN; ASTROCYTES; DIVERSITY	Background: Opening of Cx43 hemichannels by mechanical stress releases factors important for bone remodeling; however, the regulatory mechanism is unknown. Result: Upon mechanical stimulation, AKT phosphorylates integrin 5 and Cx43, increases interaction, and opens hemichannels. Conclusion: Phosphorylation of Cx43 and 5 by AKT is critical for hemichannel opening. Significance: This is the first report demonstrating the functional importance of AKT in regulation of Cx43 hemichannels. Connexin (Cx) 43 hemichannels in osteocytes are thought to play a critical role in releasing bone modulators in response to mechanical loading, a process important for bone formation and remodeling. However, the underlying mechanism that regulates the opening of mechanosensitive hemichannels is largely unknown. We have recently shown that Cx43 and integrin 5 interact directly with each other, and activation of PI3K appears to be required for Cx43 hemichannel opening by mechanical stimulation. Here, we show that mechanical loading through fluid flow shear stress (FFSS) increased the level of active AKT, a downstream effector of PI3K, which is correlated with the opening of hemichannels. Both Cx43 and integrin 5 are directly phosphorylated by AKT. Inhibition of AKT activation significantly reduced FFSS-induced opening of hemichannels and disrupted the interaction between Cx43 and integrin 5. Moreover, AKT phosphorylation on Cx43 and integrin 5 enhanced their interaction. In contrast to the C terminus of wild-type Cx43, overexpression of the C-terminal mutant containing S373A, a consensus site previously shown to be phosphorylated by AKT, failed to bind with 5 and hence could not inhibit hemichannel opening. Together, our results suggest that AKT activated by FFSS directly phosphorylates Cx43 and integrin 5, and Ser-373 of Cx43 plays a predominant role in mediating the interaction between these two proteins and Cx43 hemichannel opening, a crucial step to mediate the anabolic function of mechanical loading in the bone.	[Batra, Nidhi; Riquelme, Manuel A.; Burra, Sirisha; Kar, Rekha; Gu, Sumin; Jiang, Jean X.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Jiang, JX (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	jiangj@uthscsa.edu	Riquelme, Manuel/B-1082-2015	Riquelme, Manuel/0000-0002-1915-0434; Jiang, Jean/0000-0002-2185-5716	National Institutes of Health [EY012085, AR46798]; Welch Foundation [AQ-1507]; NATIONAL EYE INSTITUTE [R01EY012085, R29EY012085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR046798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY012085 and AR46798. This work was also supported by Welch Foundation Grant AQ-1507 (to J. X. J).	AARDEN EM, 1994, J CELL BIOCHEM, V55, P287, DOI 10.1002/jcb.240550304; Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Batra N, 2012, P NATL ACAD SCI USA, V109, P3359, DOI 10.1073/pnas.1115967109; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Bruzzone S, 2001, FASEB J, V15, P10; Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; Cheng BX, 2001, J BONE MINER RES, V16, P249, DOI 10.1359/jbmr.2001.16.2.249; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; COWIN SC, 1991, J BIOMECH ENG-T ASME, V113, P191, DOI 10.1115/1.2891234; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Herve JC, 2004, BBA-BIOMEMBRANES, V1662, P22, DOI 10.1016/j.bbamem.2003.10.022; Jiang JX, 2007, FRONT BIOSCI-LANDMRK, V12, P1450, DOI 10.2741/2159; Kato Y, 1997, J BONE MINER RES, V12, P2014, DOI 10.1359/jbmr.1997.12.12.2014; Lampe PD, 2004, INT J BIOCHEM CELL B, V36, P1171, DOI 10.1016/S1357-2725(03)00264-4; Park DJ, 2007, CELL COMMUN ADHES, V14, P211, DOI 10.1080/15419060701755958; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2013, BBA-BIOMEMBRANES, V1828, P15, DOI 10.1016/j.bbamem.2012.01.017; Romanello M, 2001, BIOCHEM BIOPH RES CO, V289, P1275, DOI 10.1006/bbrc.2001.6124; Saez JC, 2005, BBA-BIOMEMBRANES, V1711, P215, DOI 10.1016/j.bbamem.2005.01.014; Siller-Jackson AJ, 2008, J BIOL CHEM, V283, P26374, DOI 10.1074/jbc.M803136200; Solan JL, 2005, BBA-BIOMEMBRANES, V1711, P154, DOI 10.1016/j.bbamem.2004.09.013; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Srinivasan S, 2012, AGEING RES REV, V11, P353, DOI 10.1016/j.arr.2011.12.007; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Yogo K, 2006, J REPROD DEVELOP, V52, P321, DOI 10.1262/jrd.17107	28	57	61	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2014	289	15					10582	10591		10.1074/jbc.M114.550608	http://dx.doi.org/10.1074/jbc.M114.550608			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE8CI	24563481	Green Published, hybrid			2022-12-28	WOS:000334226400030
J	Bao, H; Duong, F				Bao, Huan; Duong, Franck			Nucleotide-free MalK Drives the Transition of the Maltose Transporter to the Inward-facing Conformation*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Lipids; Membrane Proteins; Protein Complexes; Transport; ATPase; Nanodiscs	BINDING CASSETTE TRANSPORTER; ABC TRANSPORTER; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; ATPASE ACTIVITY; PROTEIN; INTERMEDIATE; MUTATIONS; STABILITY; DOMAINS	Background: ATP promotes closure of MalK(2) and opening of MalFG toward the periplasm. Results: Without MalK, MalFG exists in an intermediate conformation. Binding of apo-MalK reverses the conformation of MalFG toward the cytosol. Conclusion: The NBDs exploit energy from ATP binding but also ATP hydrolysis to control the conformation of the transporter. Significance: Tightly bound MalK blocks opening of MalFG to the periplasm. The complex MalFGK(2) hydrolyzes ATP and alternates between inward- and outward-facing conformations during maltose transport. It has been shown that ATP promotes closure of MalK(2) and opening of MalFG toward the periplasm. Yet, why the transporter rests in a conformation facing the cytosol in the absence of nucleotide and how it returns to this state after hydrolysis of ATP is unknown. The membrane domain MalFG may be naturally stable in the inward-facing conformation, or the ABC domain may catalyze the transition. We address this question by analyzing the conformation of MalFG in nanodiscs and in proteoliposomes. We find that MalFG alone exists in an intermediate state until MalK binds and converts the membrane domain to the inward-facing state. We also find that MalK, if overly-bound to MalFG, blocks the transition of the transporter, whereas suppressor mutations that weaken this association restore transport. MalK therefore exploits hydrolysis of ATP to reverse the conformation of MalFG to the inward-facing conformation, a step essential for release of maltose in the cytosol.	[Bao, Huan; Duong, Franck] Univ British Columbia, Dept Biochem & Mol Biol, Inst Life Sci, Fac Med, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Duong, F (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	fduong@mail.ubc.ca		Duong Van Hoa, Franck/0000-0001-7328-6124; Bao, Huan/0000-0002-4301-4627	Canadian Foundation for Innovation; Natural Sciences and Engineering Research Council (NSERC)	Canadian Foundation for Innovation(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by an infrastructure grant from the Canadian Foundation for Innovation and an operating grant from the Natural Sciences and Engineering Research Council (NSERC).	Bao H, 2013, J BIOL CHEM, V288, P23666, DOI 10.1074/jbc.M113.489567; Bao H, 2013, BBA-BIOMEMBRANES, V1828, P1723, DOI 10.1016/j.bbamem.2013.03.024; Bao H, 2013, J BIOL CHEM, V288, P3439, DOI 10.1074/jbc.M112.431932; Bao H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034836; Chen SS, 2013, NATURE, V499, P364, DOI 10.1038/nature12232; COVITZ KMY, 1994, EMBO J, V13, P1752, DOI 10.1002/j.1460-2075.1994.tb06439.x; Dalal K, 2010, METHODS MOL BIOL, V619, P145, DOI 10.1007/978-1-60327-412-8_9; Daus ML, 2007, J BIOL CHEM, V282, P22387, DOI 10.1074/jbc.M701979200; Daus ML, 2006, J BIOL CHEM, V281, P3856, DOI 10.1074/jbc.M511953200; DiBartolo N, 2011, BIOCHEM SOC T, V39, P751, DOI 10.1042/BST0390751; Fulop K, 2009, BIOCHEM BIOPH RES CO, V379, P706, DOI 10.1016/j.bbrc.2008.12.142; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Liu PQ, 1999, J BIOL CHEM, V274, P18310, DOI 10.1074/jbc.274.26.18310; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Orelle C, 2008, P NATL ACAD SCI USA, V105, P12837, DOI 10.1073/pnas.0803799105; Orelle C, 2010, P NATL ACAD SCI USA, V107, P20293, DOI 10.1073/pnas.1006544107; PANAGIOTIDIS CH, 1993, J BIOL CHEM, V268, P23685; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Sharma S, 2005, J BACTERIOL, V187, P2908, DOI 10.1128/JB.187.8.2908-2911.2005; Wen PC, 2011, BIOPHYS J, V101, P680, DOI 10.1016/j.bpj.2011.06.031	25	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9844	9851		10.1074/jbc.M113.545525	http://dx.doi.org/10.1074/jbc.M113.545525			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24526688	Green Published, hybrid			2022-12-28	WOS:000333807000034
J	Xu, YK; Lindemann, P; Vega-Ramos, J; Zhang, JG; Villadangos, JA				Xu, Yuekang; Lindemann, Petra; Vega-Ramos, Javier; Zhang, Jian-Guo; Villadangos, Jose A.			Developmental Regulation of Synthesis and Dimerization of the Amyloidogenic Protease Inhibitor Cystatin C in the Hematopoietic System*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Dendritic Cells; Macrophages; Protease Inhibitor; Protein Folding; Reactive Oxygen Species (ROS); Amyloidosis; Vascular Angiopathy	MURINE DENDRITIC CELLS; ALZHEIMERS-DISEASE; TYROSINE KINASE; GM-CSF; ATHEROSCLEROSIS; MONOCYTES; BETA; INFLAMMATION; DEGRADATION; MACROPHAGES	Background: Dimerization of cystatin C initiates formation of amyloid fibrils in vascular walls. Results: Reactive oxygen species regulate cystatin C dimerization in cells of the hematopoietic system, which are major contributors to the total pool of circulating cystatin C. Conclusion: Cystatin C dimerization is regulated in hematopoietic cells. Significance: Cystatin C synthesis and dimerization might be manipulated for therapeutic gain. The cysteine protease inhibitor cystatin C is thought to be secreted by most cells and eliminated in the kidneys, so its concentration in plasma is diagnostic of kidney function. Low extracellular cystatin C is linked to pathologic protease activity in cancer, arthritis, atherosclerosis, aortic aneurism, and emphysema. Cystatin C forms non-inhibitory dimers and aggregates by a mechanism known as domain swapping, a property that reportedly protects against Alzheimer disease but can also cause amyloid angiopathy. Despite these clinical associations, little is known about the regulation of cystatin C production, dimerization, and secretion. We show that hematopoietic cells are major contributors to extracellular cystatin C levels in healthy mice. Among these cells, macrophages and dendritic cells (DC) are the predominant producers of cystatin C. Both cell types synthesize monomeric and dimeric cystatin C in vivo, but only secrete monomer. Dimerization occurs co-translationally in the endoplasmic reticulum and is regulated by the levels of reactive oxygen species (ROS) derived from mitochondria. Drugs or stimuli that reduce the intracellular concentration of ROS inhibit cystatin C dimerization. The extracellular concentration of inhibitory cystatin C is thus partly dependent on the abundance of macrophages and DC, and the ROS levels. These results have implications for the diagnostic use of serum cystatin C as a marker of kidney function during inflammatory processes that induce changes in DC or macrophage abundance. They also suggest an important role for macrophages, DC, and ROS in diseases associated with the protease inhibitory activity or amyloidogenic properties of cystatin C.	[Xu, Yuekang; Lindemann, Petra; Villadangos, Jose A.] Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3052, Australia; [Zhang, Jian-Guo] Walter & Eliza Hall Inst Med Res, Div Canc & Haematol, Melbourne, Vic 3052, Australia; [Xu, Yuekang; Villadangos, Jose A.] Univ Melbourne, Dept Biochem & Mol Biol, Bio21 Inst, Melbourne, Vic 3010, Australia; [Vega-Ramos, Javier; Villadangos, Jose A.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne	Xu, YK (corresponding author), Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3052, Australia.	yuekangx@unimelb.edu.au; j.villadangos@unimelb.edu.au	Villadangos, Jose A/AAU-1404-2020; Vega-Ramos, Javier/A-9931-2015	Villadangos, Jose A/0000-0001-6771-8891; Vega-Ramos, Javier/0000-0002-9516-3624	National Health and Medical Research Council (NHMRC) of Australia [1006428, 461219]; Victorian Government's Operational Infrastructure Support Program; Gottlieb Daimler and Karl Benz Foundation Fellowship	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; Gottlieb Daimler and Karl Benz Foundation Fellowship	This work was supported in part by National Health and Medical Research Council (NHMRC) of Australia Grants 1006428 (to Y. X.) and 461219 (to J. G. Z.) and the Victorian Government's Operational Infrastructure Support Program.; Formerly known as Petra Schnorrer. Supported by a Gottlieb Daimler and Karl Benz Foundation Fellowship. Present address: Structural and Computational Biology Unit, EMBL Heidelberg, 69117 Heidelberg, Germany.	Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; Belz GT, 2006, EUR J IMMUNOL, V36, P327, DOI 10.1002/eji.200535432; Bird PI, 2009, NAT REV IMMUNOL, V9, P871, DOI 10.1038/nri2671; Bobryshev YV, 2010, LAB INVEST, V90, P970, DOI 10.1038/labinvest.2010.94; Choi JH, 2011, IMMUNITY, V35, P819, DOI 10.1016/j.immuni.2011.09.014; El-Sukkari D, 2003, J IMMUNOL, V171, P5003, DOI 10.4049/jimmunol.171.10.5003; Evangelopoulos AA, 2012, INTERN MED J, V42, P517, DOI 10.1111/j.1445-5994.2011.02500.x; Ganda A, 2013, CIRCULATION, V127, P988, DOI 10.1161/CIRCULATIONAHA.112.000682; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; Grubb A, 2010, SCAND J CLIN LAB INV, V70, P65, DOI 10.3109/00365511003642535; Henskens YMC, 1996, BIOL CHEM H-S, V377, P71; Huh CG, 1999, J CLIN PATHOL-MOL PA, V52, P332, DOI 10.1136/mp.52.6.332; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Kaur G, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00079; Keelan J, 2001, J NEUROSCI RES, V66, P873, DOI 10.1002/jnr.10085; Keppler D, 2006, CANCER LETT, V235, P159, DOI 10.1016/j.canlet.2005.04.001; Kim CC, 2013, CURR OPIN IMMUNOL, V25, P593, DOI 10.1016/j.coi.2013.09.013; Levy E, 2006, BRAIN PATHOL, V16, P60, DOI 10.1111/j.1750-3639.2006.tb00562.x; Liu JA, 2004, ARTERIOSCL THROM VAS, V24, P1359, DOI 10.1161/01.ATV.0000134530.27208.41; Merz GS, 1997, J CELL PHYSIOL, V173, P423; Mi W, 2007, NAT GENET, V39, P1440, DOI 10.1038/ng.2007.29; Mi WQ, 2009, J ALZHEIMERS DIS, V18, P273, DOI 10.3233/JAD-2009-1147; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Nilsson M, 2004, J BIOL CHEM, V279, P24236, DOI 10.1074/jbc.M402621200; Nishiyama K, 2005, BRAIN RES BULL, V67, P94, DOI 10.1016/j.brainresbull.2005.05.020; PALSDOTTIR A, 1988, LANCET, V2, P603; Palsdottir A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000099; Randers E, 1999, CLIN CHEM LAB MED, V37, P389, DOI 10.1515/CCLM.1999.064; Rokadia HK, 2012, LUNG, V190, P283, DOI 10.1007/s00408-012-9374-z; Rosenfeld ME, 1998, SEMIN REPROD ENDOCR, V16, P249, DOI 10.1055/s-2007-1016285; Shi GP, 1999, J CLIN INVEST, V104, P1191, DOI 10.1172/JCI7709; Shlipak MG, 2013, NEW ENGL J MED, V369, P932, DOI 10.1056/NEJMoa1214234; Smith ER, 2013, ATHEROSCLEROSIS, V230, P73, DOI 10.1016/j.atherosclerosis.2013.06.023; Sukhova GK, 2005, CIRC RES, V96, P368, DOI 10.1161/01.RES.0000155964.34150.F7; Sun BG, 2008, NEURON, V60, P247, DOI 10.1016/j.neuron.2008.10.001; Tamura T, 2005, BLOOD, V106, P1938, DOI 10.1182/blood-2005-01-0080; Terry RL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-270; Tizon B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009819; Villadangos JA, 1997, J EXP MED, V186, P549, DOI 10.1084/jem.186.4.549; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Wahlbom M, 2007, J BIOL CHEM, V282, P18318, DOI 10.1074/jbc.M611368200; WARFEL AH, 1987, J EXP MED, V166, P1912, DOI 10.1084/jem.166.6.1912; Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513; Xie LF, 2010, CARDIOVASC RES, V87, P628, DOI 10.1093/cvr/cvq138; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577; Xu YK, 2012, IMMUNOL CELL BIOL, V90, P903, DOI 10.1038/icb.2012.31; Xu YK, 2011, J IMMUNOL, V186, P3666, DOI 10.4049/jimmunol.1001934; Zhan YF, 2012, EUR J IMMUNOL, V42, P2889, DOI 10.1002/eji.201242477	49	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2014	289	14					9730	9740		10.1074/jbc.M113.538041	http://dx.doi.org/10.1074/jbc.M113.538041			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AE2MK	24570004	hybrid, Green Published			2022-12-28	WOS:000333807000025
J	Erdemir, HH; Li, ZG; Sacks, DB				Erdemir, Huseyin H.; Li, Zhigang; Sacks, David B.			IQGAP1 Binds to Estrogen Receptor-alpha and Modulates Its Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Signaling; Estrogen; Estrogen Receptor; Nuclear Receptors; Protein-Protein Interactions; Scaffold Proteins; Transcription; IQGAP1	BREAST-CANCER; TRANSCRIPTION FACTOR; CELL MOTILITY; PROTEIN; CALMODULIN; GROWTH; ACTIVATION; STABILITY; BETA; CA2+/CALMODULIN	Background: IQGAP1 is a scaffold protein that modulates diverse signaling pathways. Results: IQGAP1 binds to estrogen receptor- (ER) and ER, and knockdown of IQGAP1 impairs 17-estradiol (E-2)-stimulated transcriptional activation in human breast epithelial cells. Conclusion: IQGAP1 modulates ER function and is required for maximal E-2 function. Significance: IQGAP1 might be a therapeutic target for patients with breast carcinoma. The estrogen receptor (ER) is a steroid hormone receptor that acts as a transcription factor, modulating genes that regulate a vast range of cellular functions. IQGAP1 interacts with several signaling proteins, cytoskeletal components, and transmembrane receptors, thereby serving as a scaffold to integrate signaling pathways. Both ER and IQGAP1 contribute to breast cancer. In this study, we report that IQGAP1 binds ER and ER. In vitro analysis with pure proteins revealed a direct interaction between IQGAP1 and ER. Investigation with multiple short fragments of each protein showed that ER binds to the IQ domain of IQGAP1, whereas the hinge region of ER is responsible for binding IQGAP1. In addition, IQGAP1 and ER co-immunoprecipitated from cells, and the association was modulated by estradiol. The interaction has functional effects. Knockdown of endogenous IQGAP1 attenuated the ability of estradiol to induce transcription of the estrogen-responsive genes pS2, progesterone receptor, and cyclin D1. These data reveal that IQGAP1 binds to ER and modulates its transcriptional function, suggesting that IQGAP1 might be a target for therapy in patients with breast carcinoma.	[Erdemir, Huseyin H.; Li, Zhigang; Sacks, David B.] NIH, Dept Lab Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Sacks, DB (corresponding author), NIH, Dept Lab Med, 10 Ctr Dr,10-2C306, Bethesda, MD 20892 USA.	david.sacks2@nih.gov		Sacks, David/0000-0003-3100-0735	National Institutes of Health Intramural Research Program; CLINICAL CENTER [ZIACL080017] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CLINICAL CENTER	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program.	Anbalagan Muralidharan, 2012, Nucl Recept Signal, V10, pe001, DOI 10.1621/nrs.10001; ARONICA SM, 1991, ENDOCRINOLOGY, V128, P2045, DOI 10.1210/endo-128-4-2045; Bensenor LB, 2007, J CELL SCI, V120, P658, DOI 10.1242/jcs.03376; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; BROWN AMC, 1984, P NATL ACAD SCI-BIOL, V81, P6344, DOI 10.1073/pnas.81.20.6344; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Burns KA, 2012, ARCH TOXICOL, V86, P1491, DOI 10.1007/s00204-012-0868-5; Burns KA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.187773; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Goto T., 2013, PLOS ONE, V8; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Heldring N, 2007, PHYSIOL REV, V87, P905, DOI 10.1152/physrev.00026.2006; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Jadeski L, 2008, J BIOL CHEM, V283, P1008, DOI 10.1074/jbc.M708466200; Jeong HW, 2007, J BIOL CHEM, V282, P20752, DOI 10.1074/jbc.M700487200; Johnson M, 2011, INT J BIOCHEM CELL B, V43, P65, DOI 10.1016/j.biocel.2010.09.014; Kim JH, 2013, ANTIOXID REDOX SIGN, V19, P89, DOI 10.1089/ars.2012.4586; Kumar R, 2012, ENDOCR REV, V33, P271, DOI 10.1210/er.2011-1033; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Levin ER, 2009, J PHYSIOL-LONDON, V587, P5019, DOI 10.1113/jphysiol.2009.177097; Li L, 2006, J BIOL CHEM, V281, P1978, DOI 10.1074/jbc.M508545200; Li L, 2005, J BIOL CHEM, V280, P13097, DOI 10.1074/jbc.M410642200; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Li ZG, 2001, J BIOL CHEM, V276, P17354, DOI 10.1074/jbc.M010238200; Liu CS, 2013, J CLIN INVEST, V123, P1138, DOI 10.1172/JCI63836; Manavathi B, 2013, ENDOCR REV, V34, P1, DOI 10.1210/er.2011-1057; Mataraza JM, 2003, J BIOL CHEM, V278, P41237, DOI 10.1074/jbc.M304838200; Mbele GO, 2002, J BIOL CHEM, V277, P49998, DOI 10.1074/jbc.M205363200; McNulty DE, 2011, J BIOL CHEM, V286, P15010, DOI 10.1074/jbc.M111.227694; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; PHILIPS A, 1993, J BIOL CHEM, V268, P14103; Porter W, 1997, MOL ENDOCRINOL, V11, P1569, DOI 10.1210/me.11.11.1569; Ren JG, 2005, J BIOL CHEM, V280, P34548, DOI 10.1074/jbc.M507321200; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Schulltz-Norton JR, 2011, TRENDS ENDOCRIN MET, V22, P124, DOI 10.1016/j.tem.2010.11.005; Sharma S, 2011, P NATL ACAD SCI USA, V108, P11381, DOI 10.1073/pnas.1019711108; Stanisic V, 2010, PROG BRAIN RES, V181, P153, DOI 10.1016/S0079-6123(08)81009-6; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Vasilescu J, 2004, PROTEOMICS, V4, P3845, DOI 10.1002/pmic.200400856; Weissbach L, 1998, BIOCHEM BIOPH RES CO, V251, P269, DOI 10.1006/bbrc.1998.9371; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; White CD, 2011, J BIOL CHEM, V286, P29734, DOI 10.1074/jbc.M111.220939; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; Zhang GF, 2010, MOL ENDOCRINOL, V24, P1737, DOI 10.1210/me.2010-0125; Zhang YH, 2012, J BIOL CHEM, V287, P9336, DOI 10.1074/jbc.M111.334797	48	29	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9100	9112		10.1074/jbc.M114.553511	http://dx.doi.org/10.1074/jbc.M114.553511			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24550401	hybrid, Green Published			2022-12-28	WOS:000333472100030
J	Long, L; Thelen, JP; Furgason, M; Haj-Yahya, M; Brik, A; Cheng, DM; Peng, JM; Yao, TT				Long, Lindsey; Thelen, Joseph P.; Furgason, Melonnie; Haj-Yahya, Mahmood; Brik, Ashraf; Cheng, Dongmei; Peng, Junmin; Yao, Tingting			The U4/U6 Recycling Factor SART3 Has Histone Chaperone Activity and Associates with USP15 to Regulate H2B Deubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Deubiquitination; Histone Chaperone; Histone Modification; RNA Splicing; Ubiquitin; SART3; USP15; ubH2B	EXON-INTRON STRUCTURE; DEUBIQUITYLATING ENZYME; H3 METHYLATION; UBIQUITYLATION; UBIQUITIN; MONOUBIQUITINATION; RECRUITMENT; ACTIVATION; COMPLEX; PROTEIN	Background: Ubiquitin conjugation and deconjugation on histone H2B regulate transcription and pre-mRNA splicing. Results: The splicing factor SART3 binds histones and enhances deubiquitination of H2B by the deubiquitinating enzyme, Usp15. Conclusion: SART3 is a dedicated histone chaperone that cooperates with Usp15 to deubiquitinate free histones. Significance: The coordinated activities of Usp15 and SART3 provide a link between H2B deubiquitination and pre-mRNA splicing. Post-translational modifications of histone proteins produce dynamic signals that regulate the structure and function of chromatin. Mono-ubiquitination of H2B in the histone tail (at Lys-123 in yeast or Lys-120 in humans) is a conserved modification that has been implicated in the regulation of transcription, replication, and DNA repair processes. In a search for direct effectors of ubH2B, we identified a deubiquitinating enzyme, Usp15, through affinity purification with a nonhydrolyzable ubH2B mimic. In the nucleus, Usp15 indirectly associates with the ubH2B E3 ligase, RNF20/RNF40, and directly associates with a component of the splicing machinery, SART3 (also known as TIP110 or p110). These physical interactions place Usp15 in the vicinity of actively transcribed DNA. Importantly we found that SART3 has previously unrecognized histone chaperone activities. SART3, but not the well-characterized histone chaperone Nap1, enhances Usp15 binding to ubH2B and facilitates deubiquitination of ubH2B in free histones but not in nucleosomes. These results suggest that SART3 recruits ubH2B, which may be evicted from DNA during transcription, for deubiquitination by Usp15. In light of the function played by SART3 in U4/U6 di-snRNP formation, our discovery points to a direct link between eviction-coupled erasure of the ubiquitin mark from ubH2B and co-transcriptional pre-mRNA splicing.	[Long, Lindsey; Thelen, Joseph P.; Furgason, Melonnie; Yao, Tingting] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Haj-Yahya, Mahmood; Brik, Ashraf] Ben Gurion Univ Negev, Dept Chem, IL-84105 Beer Sheva, Israel; [Cheng, Dongmei; Peng, Junmin] St Jude Childrens Res Hosp, St Jude Prote Facil, Memphis, TN 38105 USA; [Peng, Junmin] St Jude Childrens Res Hosp, Dept Struct Biol & Dev Neurobiol, Memphis, TN 38105 USA	Colorado State University; Ben Gurion University; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Yao, TT (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	Tingting.Yao@ColoState.edu	Peng, Junmin/N-2614-2018	Peng, Junmin/0000-0003-0472-7648; Long, Lindsey/0000-0002-4524-9307	National Institutes of Health [R01GM098401]; National Science Foundation [1158323]; American Cancer Society [RSG-09-181]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098401] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01GM098401 (to T. Y.), National Science Foundation Award 1158323 (to T. Y.), and American Cancer Society Grant RSG-09-181 (to J. P.).	Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Batta K, 2011, GENE DEV, V25, P2254, DOI 10.1101/gad.177238.111; Bell M, 2002, EMBO J, V21, P2724, DOI 10.1093/emboj/21.11.2724; Carlile CM, 2009, J BIOL CHEM, V284, P29326, DOI 10.1074/jbc.M109.043885; Chen JJ, 2011, J BIOL CHEM, V286, P40867, DOI 10.1074/jbc.M111.279984; Dechassa ML, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1320; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Eichhorn PJA, 2012, NAT MED, V18, P429, DOI 10.1038/nm.2619; Elsasser SJ, 2012, BBA-GENE REGUL MECH, V1819, P211, DOI 10.1016/j.bbagrm.2011.07.007; Faronato M, 2013, CELL CYCLE, V12, P1964, DOI 10.4161/cc.25035; Fierz B, 2012, J AM CHEM SOC, V134, P19548, DOI 10.1021/ja308908p; Fierz B, 2011, NAT CHEM BIOL, V7, P113, DOI 10.1038/NCHEMBIO.501; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Fuchs G, 2012, MOL CELL, V46, P662, DOI 10.1016/j.molcel.2012.05.023; Haj-Yahya M, 2012, ANGEW CHEM INT EDIT, V51, P11535, DOI 10.1002/anie.201205771; Hayes SD, 2012, J BIOL CHEM, V287, P43007, DOI 10.1074/jbc.M112.386938; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hetfeld BKJ, 2005, CURR BIOL, V15, P1217, DOI 10.1016/j.cub.2005.05.059; Inui M, 2011, NAT CELL BIOL, V13, P1368, DOI 10.1038/ncb2346; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; Jung I, 2012, GENOME RES, V22, P1026, DOI 10.1101/gr.120634.111; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kim J, 2009, J BIOL CHEM, V284, P20582, DOI 10.1074/jbc.M109.017442; Kohler A, 2010, CELL, V141, P606, DOI 10.1016/j.cell.2010.04.026; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kress TL, 2008, MOL CELL, V32, P727, DOI 10.1016/j.molcel.2008.11.013; Kumar KSA, 2011, BIOCONJUGATE CHEM, V22, P137, DOI 10.1021/bc1004735; Lang G, 2011, MOL CELL BIOL, V31, P3734, DOI 10.1128/MCB.05231-11; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lee JS, 2012, GENE DEV, V26, P914, DOI 10.1101/gad.186841.112; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Lusser A, 2004, NAT METHODS, V1, P19, DOI 10.1038/nmeth709; McBryant SJ, 2003, J BIOL CHEM, V278, P44574, DOI 10.1074/jbc.M305636200; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Moehle EA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003101; Mosbech A, 2013, J BIOL CHEM, V288, P16579, DOI 10.1074/jbc.M113.459917; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Osley Mary Ann, 2006, Briefings in Functional Genomics & Proteomics, V5, P179, DOI 10.1093/bfgp/ell022; Patel DJ, 2013, ANNU REV BIOCHEM, V82, P81, DOI 10.1146/annurev-biochem-072711-165700; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pirngruber J, 2009, EMBO REP, V10, P894, DOI 10.1038/embor.2009.108; Rader SD, 2002, RNA, V8, P1378, DOI 10.1017/s1355838202020010; Raghunathan PL, 1998, SCIENCE, V279, P857, DOI 10.1126/science.279.5352.857; Rodriguez-Navarro S, 2009, EMBO REP, V10, P843, DOI 10.1038/embor.2009.168; Rogakou EP, 2000, BIOTECHNIQUES, V28, P38, DOI 10.2144/00281bm06; Ryu KY, 2006, ANAL BIOCHEM, V353, P153, DOI 10.1016/j.ab.2006.03.038; Samara NL, 2010, SCIENCE, V328, P1025, DOI 10.1126/science.1190049; Shema E, 2011, MOL CELL, V42, P477, DOI 10.1016/j.molcel.2011.03.011; Shema-Yaacoby E, 2013, CELL REP, V4, P601, DOI 10.1016/j.celrep.2013.07.014; Shieh GS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-627; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stanek D, 2003, J CELL BIOL, V160, P505, DOI 10.1083/jcb.200210087; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Turner SD, 2002, MOL CELL BIOL, V22, P4011, DOI 10.1128/MCB.22.12.4011-4019.2002; Villeneuve NF, 2013, MOL CELL, V51, P68, DOI 10.1016/j.molcel.2013.04.022; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Yin LM, 2000, BIOCHEMISTRY-US, V39, P10001, DOI 10.1021/bi0007019; Zhang Z, 2013, GENE DEV, V27, P1581, DOI 10.1101/gad.211037.112	66	69	71	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					8916	8930		10.1074/jbc.M114.551754	http://dx.doi.org/10.1074/jbc.M114.551754			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24526689	hybrid, Green Published			2022-12-28	WOS:000333472100016
J	Mitsche, MA; Packer, LE; Brown, JW; Jiang, ZG; Small, DM; McKnight, CJ				Mitsche, Matthew A.; Packer, Laura E.; Brown, Jeffrey W.; Jiang, Z. Gordon; Small, Donald M.; McKnight, C. James			Surface Tensiometry of Apolipoprotein B Domains at Lipid Interfaces Suggests a New Model for the Initial Steps in Triglyceride-rich Lipoprotein Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apolipoproteins; Atherosclerosis; Lipoprotein Secretion; Lipoprotein Structure; Phosphatidylcholine; Triacylglycerol; Apolipoprotein B; Chylomicron; Drop Tensiometry; Very Low Density Lipoprotein	N-TERMINAL DOMAIN; APO-B; TRANSFER PROTEIN; A-IV; LIPOVITELLIN; ABSORPTION; HOMOLOGY; REGION	Background: Apolipoprotein B (apoB) is the essential protein component of chylomicrons and very low density lipoprotein that transports lipids in plasma. Results: Domains of apoB interact with model membranes dependent on lipid composition and surface pressure. Conclusion: ApoB domains interact with membranes to initiate lipid recruitment. Significance: The apoB lipid recruitment mechanism provides a target to regulate the secretion of VLDL. Apolipoprotein B (apoB) is the principal protein component of triacylglyceride (TAG)-rich lipoproteins, including chylomicrons and very low density lipoprotein, which is the precursor to LDL (the bad cholesterol). TAG-rich lipoprotein assembly is initiated by the N-terminal 1 superdomain of apoB, which co-translationally binds and remodels the luminal leaflet of the rough endoplasmic reticulum. The 1 superdomain contains four domains and is predicted to interact directly with lipids. Using drop tensiometry, we examined the interfacial properties of the -helical and C-sheet domains and several subdomains to establish a detailed structure-function relationship at the lipid/water interface. The adsorption, stress response, exchangeability, and pressure ()-area relationship were studied at both triolein/water and triolein/1-palmitoyl, 2-oleoylphosphatidylcholine/water interfaces that mimic physiological environments. The -helical domain spontaneously adsorbed to a triolein/water interface and formed a viscoelastic surface. It was anchored to the surface by helix 6, and the other helices were ejected and/or remodeled on the surface as a function of surface pressure. The C-sheet instead formed an elastic film on a triolein/water interface and was irreversibly anchored to the lipid surface, which is consistent with the behavior of amphipathic -strands. When both domains were adsorbed together on the surface, the C-sheet shielded a portion of the -helical domain from the surface, which retained its globular structure. Overall, the unique secondary and tertiary structures of the N-terminal domains of apoB support the intrinsic capability of co-translational lipid recruitment. The evidence presented here allows the construction of a detailed model of the initiation of TAG-rich lipoprotein assembly.	[Mitsche, Matthew A.; Packer, Laura E.; Brown, Jeffrey W.; Jiang, Z. Gordon; Small, Donald M.; McKnight, C. James] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	Boston University	McKnight, CJ (corresponding author), Boston Univ, Sch Med, Dept Physiol & Biophys, 700 Albany St, Boston, MA 02118 USA.	cjmck@bu.edu	Brown, Jeffrey Wade/ABA-7141-2021; Jiang, Z. Gordon/U-5256-2017	Brown, Jeffrey Wade/0000-0002-3992-9613; Jiang, Z. Gordon/0000-0003-0495-9940; McKnight, Christopher/0000-0002-3237-0896	National Institutes of Health [RO1 HL094510, PO1 HL026335, T32 HL07969]; Boston University Graduate Student Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094510, T32HL007969, P01HL026335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston University Graduate Student Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	* This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL094510 (to C. J. M.) and PO1 HL026335 (to D. M. S.). This work was also supported by a Boston University Graduate Student Research Fellowship (to J. W. B.).; <SUP>1</SUP> Supported by National Institutes of Health Grant T32 HL07969. Present address: Dept. of Molecular Genetics 5323 Harry Hines Blvd., Dallas, TX 75390-9046.	Carraway M, 2000, BIOCHEMISTRY-US, V39, P9737, DOI 10.1021/bi000791h; Franco M, 2011, AM J MED, V124, P95, DOI 10.1016/j.amjmed.2010.08.015; HAVEL RJ, 2001, METABOLIC MOL BASES, P2705; Herscovitz H, 2001, J LIPID RES, V42, P51; IBDAH JA, 1989, BIOCHIM BIOPHYS ACTA, V1004, P300, DOI 10.1016/0005-2760(89)90077-5; Jiang ZG, 2008, J MOL BIOL, V383, P1181, DOI 10.1016/j.jmb.2008.09.006; Jiang ZG, 2005, BIOCHEMISTRY-US, V44, P1163, DOI 10.1021/bi048286y; Jiang ZG, 2007, BIOPHYS J, V92, P4097, DOI 10.1529/biophysj.106.101105; Jiang ZHG, 2006, BIOCHEMISTRY-US, V45, P11799, DOI 10.1021/bi060600w; Kendrick JS, 2001, BIOCHEM J, V356, P821, DOI 10.1042/0264-6021:3560821; LABOURDENNE S, 1994, CHEM PHYS LIPIDS, V71, P163, DOI 10.1016/0009-3084(94)90068-X; Ledford AS, 2009, J LIPID RES, V50, P108, DOI 10.1194/jlr.M800324-JLR200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mann CJ, 1999, J MOL BIOL, V285, P391, DOI 10.1006/jmbi.1998.2298; Mitsche MA, 2011, BIOPHYS J, V101, P353, DOI 10.1016/j.bpj.2011.03.055; Mitsche MA, 2010, J PHYS CHEM B, V114, P3276, DOI 10.1021/jp908730t; Mitsche MA, 2009, LANGMUIR, V25, P2322, DOI 10.1021/la802663g; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; RAAG R, 1988, J MOL BIOL, V200, P553, DOI 10.1016/0022-2836(88)90542-6; Richardson PE, 2005, BIOPHYS J, V88, P2789, DOI 10.1529/biophysj.104.046235; Segrest JP, 1999, J LIPID RES, V40, P1401; Segrest JP, 2001, J LIPID RES, V42, P1346; SEGREST JP, 1992, J LIPID RES, V33, P141; Shelness GS, 2003, J BIOL CHEM, V278, P44702, DOI 10.1074/jbc.M307562200; Small DM, 2009, J LIPID RES, V50, pS329, DOI 10.1194/jlr.R800083-JLR200; Smolenaars MMW, 2007, J LIPID RES, V48, P489, DOI 10.1194/jlr.R600028-JLR200; Thompson JR, 2002, BIOCHEMISTRY-US, V41, P9398, DOI 10.1021/bi025674w; Wang LB, 2004, J LIPID RES, V45, P1704, DOI 10.1194/jlr.M400106-JLR200; Wang LB, 2010, BIOCHEMISTRY-US, V49, P3898, DOI 10.1021/bi100056v; Wang LB, 2009, J LIPID RES, V50, P1340, DOI 10.1194/jlr.M900040-JLR200; WEINBERG RB, 1992, J BIOL CHEM, V267, P8977; Weinberg RB, 2000, J LIPID RES, V41, P1419; Zannis VI., 2004, MOL MECH ATHEROSCLER, V8, P111	33	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2014	289	13					9000	9012		10.1074/jbc.M113.540955	http://dx.doi.org/10.1074/jbc.M113.540955			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD7UJ	24515109	Green Published, hybrid			2022-12-28	WOS:000333472100022
J	Jiang, MX; He, JH; Kucera, H; Gaikwad, NW; Zhang, B; Xu, MS; O'Doherty, RM; Selcer, KW; Xie, W				Jiang, Mengxi; He, Jinhan; Kucera, Heidi; Gaikwad, Nilesh W.; Zhang, Bin; Xu, Meishu; O'Doherty, Robert M.; Selcer, Kyle W.; Xie, Wen			Hepatic Overexpression of Steroid Sulfatase Ameliorates Mouse Models of Obesity and Type 2 Diabetes through Sex-specific Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Diabetes; Energy Metabolism; Estrogen; Obesity; Steroid Hormone; Transgenic Mice	DEFICIT HYPERACTIVITY DISORDER; X-LINKED ICHTHYOSIS; POSTMENOPAUSAL WOMEN; INSULIN SENSITIVITY; METABOLIC SYNDROME; ESTRONE SULFATE; OB/OB MICE; RECEPTOR; RESISTANCE; PATHWAY	Background: Steroid sulfatase (STS)-mediated desulfation regulates the chemical and functional homeostasis of estrogens. Results: Overexpression of STS in the liver improved metabolic functions in mouse models of obesity and type 2 diabetes through sex-specific mechanisms. Conclusion: STS-mediated estrogen reactivation is beneficial in energy and glucose metabolism. Significance: Liver-specific activation of estrogen signaling may represent a novel approach to manage metabolic syndrome. The steroid sulfatase (STS)-mediated desulfation is a critical metabolic mechanism that regulates the chemical and functional homeostasis of endogenous and exogenous molecules. In this report, we first showed that the liver expression of Sts was induced in both the high fat diet (HFD) and ob/ob models of obesity and type 2 diabetes and during the fed to fasting transition. In defining the functional relevance of STS induction in metabolic disease, we showed that overexpression of STS in the liver of transgenic mice alleviated HFD and ob/ob models of obesity and type 2 diabetes, including reduced body weight, improved insulin sensitivity, and decreased hepatic steatosis and inflammation. Interestingly, STS exerted its metabolic benefit through sex-specific mechanisms. In female mice, STS may have increased hepatic estrogen activity by converting biologically inactive estrogen sulfates to active estrogens and consequently improved the metabolic functions, whereas ovariectomy abolished this protective effect. In contrast, the metabolic benefit of STS in males may have been accounted for by the male-specific decrease of inflammation in white adipose tissue and skeletal muscle as well as a pattern of skeletal muscle gene expression that favors energy expenditure. The metabolic benefit in male STS transgenic mice was retained after castration. Treatment with the STS substrate estrone sulfate also improved metabolic functions in both the HFD and ob/ob models. Our results have uncovered a novel function of STS in energy metabolism and type 2 diabetes. Liver-specific STS induction or estrogen/estrogen sulfate delivery may represent a novel approach to manage metabolic syndrome.	[Jiang, Mengxi; He, Jinhan; Zhang, Bin; Xu, Meishu; Xie, Wen] Univ Pittsburgh, Sch Pharm, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA; [Jiang, Mengxi; He, Jinhan; Zhang, Bin; Xu, Meishu; Xie, Wen] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Kucera, Heidi; Gaikwad, Nilesh W.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Kucera, Heidi; Gaikwad, Nilesh W.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [O'Doherty, Robert M.] Univ Pittsburgh, Dept Med, Div Endocrinol & Metab, Pittsburgh, PA 15261 USA; [Selcer, Kyle W.] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15219 USA; [Xie, Wen] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Davis; University of California System; University of California Davis; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Duquesne University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Xie, W (corresponding author), Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA.	wex6@pitt.edu	Selcer, Kyle/J-8365-2015; Xie, Wen/M-1768-2016	Selcer, Kyle/0000-0002-9054-2457; Jiang, Mengxi/0000-0003-4446-984X	National Institutes of Health [DK083952, HD073070, DK058855, DK072162]; University of Pittsburgh Metabolic Diseases Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD073070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083952, R01DK058855, R01DK072162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh Metabolic Diseases Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK083952 and HD073070 (to W. X.) and DK058855 and DK072162 (to R. O. D.). This work was also supported in part by the University of Pittsburgh Metabolic Diseases Research Center.	Al-Dosari MS, 2006, MOL PHARMACEUT, V3, P322, DOI 10.1021/mp0500824; Aoki K, 2003, J STEROID BIOCHEM, V85, P469, DOI 10.1016/S0960-0760(03)00219-X; Billeci AMR, 2008, CURR VASC PHARMACOL, V6, P112, DOI 10.2174/157016108783955338; Borthwick EB, 2001, HORM METAB RES, V33, P721, DOI 10.1055/s-2001-19136; Brookes KJ, 2008, AM J MED GENET B, V147B, P1531, DOI 10.1002/ajmg.b.30873; Bryzgalova G, 2008, AM J PHYSIOL-ENDOC M, V295, pE904, DOI 10.1152/ajpendo.90248.2008; Cani PD, 2006, DIABETES, V55, P1484, DOI 10.2337/db05-1360; Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242; Falany CN, 1997, FASEB J, V11, P206, DOI 10.1096/fasebj.11.4.9068609; Finan B, 2012, NAT MED, V18, P1847, DOI 10.1038/nm.3009; Friday KE, 2001, J CLIN ENDOCR METAB, V86, P48, DOI 10.1210/jc.86.1.48; Gaikwad NW, 2013, ANAL CHEM, V85, P4951, DOI 10.1021/ac400016e; Gao H, 2006, MOL ENDOCRINOL, V20, P1287, DOI 10.1210/me.2006-0012; Gao J, 2012, DIABETES, V61, P1543, DOI 10.2337/db11-1152; Gao J, 2009, J BIOL CHEM, V284, P25984, DOI 10.1074/jbc.M109.016808; HAWKINS RA, 1974, J ENDOCRINOL, V60, P3, DOI 10.1677/joe.0.0600003; Hazan Carole, 2005, Dermatol Online J, V11, P12; He JH, 2013, DIABETES, V62, P1876, DOI 10.2337/db12-1039; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Hewitt KN, 2004, ENDOCRINOLOGY, V145, P1842, DOI 10.1210/en.2003-1369; Jones MEE, 2000, P NATL ACAD SCI USA, V97, P12735, DOI 10.1073/pnas.97.23.12735; Kent L, 2008, J MED GENET, V45, P519, DOI 10.1136/jmg.2008.057729; LEITER EH, 1994, J CLIN INVEST, V93, P2007, DOI 10.1172/JCI117194; Lin XB, 2005, AM J PHYSIOL-GASTR L, V288, pG1179, DOI 10.1152/ajpgi.00411.2004; Maltais R, 2011, STEROIDS, V76, P929, DOI 10.1016/j.steroids.2011.03.010; Margolis KL, 2004, DIABETOLOGIA, V47, P1175, DOI 10.1007/s00125-004-1448-x; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; MORISHIMA A, 1995, J CLIN ENDOCR METAB, V80, P3689, DOI 10.1210/jc.80.12.3689; Petro AE, 2004, METABOLISM, V53, P454, DOI 10.1016/j.metabol.2003.11.018; Reed MJ, 2005, ENDOCR REV, V26, P171, DOI 10.1210/er.2004-0003; Saini SPS, 2004, MOL PHARMACOL, V65, P292, DOI 10.1124/mol.65.2.292; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; SHAPIRO LJ, 1978, LANCET, V1, P70; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Stanway SJ, 2006, CLIN CANCER RES, V12, P1585, DOI 10.1158/1078-0432.CCR-05-1996; Tiano JP, 2012, NAT REV ENDOCRINOL, V8, P342, DOI 10.1038/nrendo.2011.242; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Xu Y, 2011, CELL METAB, V14, P453, DOI 10.1016/j.cmet.2011.08.009; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200; Zhu L, 2013, DIABETES, V62, P424, DOI 10.2337/db11-1718	40	19	20	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8086	8097		10.1074/jbc.M113.535914	http://dx.doi.org/10.1074/jbc.M113.535914			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24497646	Green Published, hybrid			2022-12-28	WOS:000333157500007
J	Mackness, BC; Tran, MT; McClain, SP; Matthews, CR; Zitzewitz, JA				Mackness, Brian C.; Tran, Meme T.; McClain, Shannan P.; Matthews, C. Robert; Zitzewitz, Jill A.			Folding of the RNA Recognition Motif (RRM) Domains of the Amyotrophic Lateral Sclerosis (ALS)-linked Protein TDP-43 Reveals an Intermediate State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease); Circular Dichroism (CD); Fluorescence; Neurodegenerative Diseases; Protein Folding; Protein Misfolding; Protein-Nucleic Acid Interaction; RNA-binding Protein; Thermodynamics; Frontotemporal Lobar Degeneration (FTLD)	FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN-43; C-TERMINAL FRAGMENTS; INDOLE-3-GLYCEROL PHOSPHATE SYNTHASE; EXCHANGE MASS-SPECTROMETRY; NUCLEIC-ACID BINDING; HEXANUCLEOTIDE REPEAT; TRYPTOPHAN SYNTHASE; SECONDARY STRUCTURE; TARDBP MUTATIONS	Background: TDP-43 aggregates and mutations are observed in patients with ALS and FTLD. Results: The equilibrium unfolding of the RRM domains reveals a highly populated intermediate in RRM2. Conclusion: The stability of RRM2 may result from a large hydrophobic cluster, and the intermediate state may be essential for accessing the nuclear export sequence. Significance: Accessing the RRM2 intermediate state can potentially propagate disease pathogenesis. Pathological alteration of TDP-43 (TAR DNA-binding protein-43), a protein involved in various RNA-mediated processes, is a hallmark feature of the neurodegenerative diseases amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Fragments of TDP-43, composed of the second RNA recognition motif (RRM2) and the disordered C terminus, have been observed in cytoplasmic inclusions in sporadic amyotrophic lateral sclerosis cases, suggesting that conformational changes involving RRM2 together with the disordered C terminus play a role in aggregation and toxicity. The biophysical data collected by CD and fluorescence spectroscopies reveal a three-state equilibrium unfolding model for RRM2, with a partially folded intermediate state that is not observed in RRM1. Strikingly, a portion of RRM2 beginning at position 208, which mimics a cleavage site observed in patient tissues, increases the population of this intermediate state. Mutually stabilizing interactions between the domains in the tethered RRM1 and RRM2 construct reduce the population of the intermediate state and enhance DNA/RNA binding. Despite the high sequence homology of the two domains, a network of large hydrophobic residues in RRM2 provides a possible explanation for the increased stability of RRM2 compared with RRM1. The cluster analysis suggests that the intermediate state may play a functional role by enhancing access to the nuclear export signal contained within its sequence. The intermediate state may also serve as a molecular hazard linking productive folding and function with pathological misfolding and aggregation that may contribute to disease.	[Mackness, Brian C.; Tran, Meme T.; McClain, Shannan P.; Matthews, C. Robert; Zitzewitz, Jill A.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Zitzewitz, JA (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, 364 Plantat St, Worcester, MA 01605 USA.	jill.zitzewitz@umassmed.edu		Mackness, Brian/0000-0002-3587-5603	National Institutes of Health [GM54836]; ALS Therapy Alliance, Inc.; ALS Association; University of Massachusetts Medical School Faculty Scholar Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054836] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ALS Therapy Alliance, Inc.; ALS Association; University of Massachusetts Medical School Faculty Scholar Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54836 (to C. R. M.). This work was also supported by the ALS Therapy Alliance, Inc. (to J. A. Z.), the ALS Association (to J. A. Z.), and a University of Massachusetts Medical School Faculty Scholar Award (to J. A. Z.).	Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2008, J CELL SCI, V121, P3778, DOI 10.1242/jcs.038950; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; BEROVA N, 2000, CIRCULAR DICHROISM P, P601; Bilsel O, 1999, BIOCHEMISTRY-US, V38, P1018, DOI 10.1021/bi982365q; Budini M, 2012, BRAIN RES, V1462, P139, DOI 10.1016/j.brainres.2012.02.031; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Chang CK, 2013, FEBS LETT, V587, P575, DOI 10.1016/j.febslet.2013.01.038; Chen AKH, 2010, J AM CHEM SOC, V132, P1186, DOI 10.1021/ja9066207; Chen S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-28; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; Daubner GM, 2013, CURR OPIN STRUC BIOL, V23, P100, DOI 10.1016/j.sbi.2012.11.006; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dormann D, 2009, J NEUROCHEM, V110, P1082, DOI 10.1111/j.1471-4159.2009.06211.x; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; FINN BE, 1992, PROTEIN ENG PRACTICA, P167; Furukawa Y, 2011, BBA-MOL BASIS DIS, V1812, P1577, DOI 10.1016/j.bbadis.2011.09.005; Geser F, 2010, NEUROPATHOLOGY, V30, P103, DOI 10.1111/j.1440-1789.2009.01091.x; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gu Z, 2007, J MOL BIOL, V374, P528, DOI 10.1016/j.jmb.2007.09.024; Gu ZY, 2007, J MOL BIOL, V368, P582, DOI 10.1016/j.jmb.2007.02.027; Huang YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073890; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Igaz LM, 2009, J BIOL CHEM, V284, P8516, DOI 10.1074/jbc.M809462200; Ihara R, 2013, HUM MOL GENET, V22, P4474, DOI 10.1093/hmg/ddt296; Iko Y, 2004, J BIOL CHEM, V279, P44834, DOI 10.1074/jbc.M408552200; Ito D, 2011, ANN NEUROL, V69, P152, DOI 10.1002/ana.22246; Janssens J, 2013, HUM MOL GENET, V22, pR77, DOI 10.1093/hmg/ddt349; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kathuria SV, 2008, J MOL BIOL, V382, P467, DOI 10.1016/j.jmb.2008.06.054; Kawahara Y, 2012, P NATL ACAD SCI USA, V109, P3347, DOI 10.1073/pnas.1112427109; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Kurihara Y, 1997, GENE, V186, P21, DOI 10.1016/S0378-1119(96)00673-7; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Liu XH, 2013, BBA-MOL BASIS DIS, V1832, P375, DOI 10.1016/j.bbadis.2012.11.012; LU JR, 1995, J MOL BIOL, V247, P739, DOI 10.1016/S0022-2836(05)80152-4; Lucast LJ, 2001, BIOTECHNIQUES, V30, P544, DOI 10.2144/01303st06; Lukavsky PJ, 2013, NAT STRUCT MOL BIOL, V20, P1443, DOI 10.1038/nsmb.2698; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Pace C N, 1986, Methods Enzymol, V131, P266; Pagano JM, 2007, J BIOL CHEM, V282, P8883, DOI 10.1074/jbc.M700079200; Pagano JM, 2011, RNA, V17, P14, DOI 10.1261/rna.2428111; Rayaprolu S, 2013, PARKINSONISM RELAT D, V19, P312, DOI 10.1016/j.parkreldis.2012.11.003; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Saini A, 2011, CHEMBIOCHEM, V12, P2495, DOI 10.1002/cbic.201100427; Schellman JA, 1997, BIOPHYS J, V73, P2960, DOI 10.1016/S0006-3495(97)78324-3; Shodai A, 2013, J BIOL CHEM, V288, P14886, DOI 10.1074/jbc.M113.451849; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Takagi  S., 2013, PLOS ONE, V8; Turner MR, 2013, LANCET NEUROL, V12, P310, DOI 10.1016/S1474-4422(13)70036-X; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Wang YT, 2013, J BIOL CHEM, V288, P9049, DOI 10.1074/jbc.M112.438564; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Wu Y, 2007, J MOL BIOL, V366, P1624, DOI 10.1016/j.jmb.2006.12.005; Xu ZS, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-27; Yang C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015383; Youmans KL, 2012, EXP NEUROL, V237, P90, DOI 10.1016/j.expneurol.2012.05.018; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	78	28	28	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2014	289	12					8264	8276		10.1074/jbc.M113.542779	http://dx.doi.org/10.1074/jbc.M113.542779			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD3PG	24497641	hybrid, Green Published			2022-12-28	WOS:000333157500021
J	Belcher, J; McLean, KJ; Matthews, S; Woodward, LS; Fisher, K; Rigby, SEJ; Nelson, DR; Potts, D; Baynham, MT; Parker, DA; Leys, D; Munro, AW				Belcher, James; McLean, Kirsty J.; Matthews, Sarah; Woodward, Laura S.; Fisher, Karl; Rigby, Stephen E. J.; Nelson, David R.; Potts, Donna; Baynham, Michael T.; Parker, David A.; Leys, David; Munro, Andrew W.			Structure and Biochemical Properties of the Alkene Producing Cytochrome P450 OleTJE (CYP152L1) from the Jeotgalicoccus sp 8456 Bacterium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Biofuel; Crystal Structure; Cytochrome P450; Decarboxylase; Electron Paramagnetic Resonance (EPR); Enzyme Kinetics; Enzyme Mechanisms; Fatty Acid-binding Protein; Hydrogen Peroxide; X-ray Crystallography	ELECTRON-PARAMAGNETIC-RESONANCE; MYCOBACTERIUM-TUBERCULOSIS; CRYSTAL-STRUCTURE; OXYGEN ACTIVATION; HYDROGEN-PEROXIDE; BACILLUS-SUBTILIS; LIGAND-BINDING; PURIFICATION; SUBSTRATE; HYDROXYLATION	Background: OleT(JE) oxidatively decarboxylates fatty acids to produce terminal alkenes. Results: OleT(JE) is an efficient peroxide-dependent lipid decarboxylase, with high affinity substrate binding and the capacity to be resolubilized from precipitate in an active form. Conclusion: OleT(JE) has key differences in active site structure and substrate binding/mechanistic properties from related CYP152 hydroxylases. Significance: OleT(JE) is an efficient and robust biocatalyst with applications in biofuel production. The production of hydrocarbons in nature has been documented for only a limited set of organisms, with many of the molecular components underpinning these processes only recently identified. There is an obvious scope for application of these catalysts and engineered variants thereof in the future production of biofuels. Here we present biochemical characterization and crystal structures of a cytochrome P450 fatty acid peroxygenase: the terminal alkene forming OleT(JE) (CYP152L1) from Jeotgalicoccus sp. 8456. OleT(JE) is stabilized at high ionic strength, but aggregation and precipitation of OleT(JE) in low salt buffer can be turned to advantage for purification, because resolubilized OleT(JE) is fully active and extensively dissociated from lipids. OleT(JE) binds avidly to a range of long chain fatty acids, and structures of both ligand-free and arachidic acid-bound OleT(JE) reveal that the P450 active site is preformed for fatty acid binding. OleT(JE) heme iron has an unusually positive redox potential (-103 mV versus normal hydrogen electrode), which is not significantly affected by substrate binding, despite extensive conversion of the heme iron to a high spin ferric state. Terminal alkenes are produced from a range of saturated fatty acids (C12-C20), and stopped-flow spectroscopy indicates a rapid reaction between peroxide and fatty acid-bound OleT(JE) (167 s(-1) at 200 m H2O2). Surprisingly, the active site is highly similar in structure to the related P450(BS), which catalyzes hydroxylation of fatty acids as opposed to decarboxylation. Our data provide new insights into structural and mechanistic properties of a robust P450 with potential industrial applications.	[Belcher, James; McLean, Kirsty J.; Matthews, Sarah; Woodward, Laura S.; Fisher, Karl; Rigby, Stephen E. J.; Leys, David; Munro, Andrew W.] Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England; [Nelson, David R.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Potts, Donna; Baynham, Michael T.] Agilent Technol UK Ltd, Stockport SK8 3GR, Cheshire, England; [Parker, David A.] Westhollow Technol Ctr, Houston, TX 77028 USA	University of Manchester; University of Tennessee System; University of Tennessee Health Science Center; Agilent Technologies	Munro, AW (corresponding author), Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England.	Andrew.Munro@Manchester.ac.uk	Munro, Andrew/G-5639-2019; McLean, Kirsty J/GXI-2853-2022; Fisher, Karl/A-5956-2013	Munro, Andrew/0000-0002-4642-180X; Fisher, Karl/0000-0003-3539-8939; McLean, Kirsty/0000-0002-7193-5044; Woodward, Laura/0000-0001-7880-5325; Nelson, David/0000-0003-0583-5421	United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) [BB/K017802/1]; Agilent Technologies UK Ltd. [BB/J012645/1]; Biotechnology and Biological Sciences Research Council [BB/F002521/1, BB/K017802/1, 1225743, BB/E013007/1] Funding Source: researchfish; BBSRC [BB/E013007/1, BB/K017802/1, BB/F002521/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Agilent Technologies UK Ltd.; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) Industrial CASE studentship with Agilent Technologies UK Ltd. (BB/J012645/1) (to S. M., A. W. M., and M. T. B.) and Industrial Partnership Award (IPA) BB/K017802/1 (to D. L., A. W. M., and D. P.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Bui SH, 2012, J BIOL CHEM, V287, P19699, DOI 10.1074/jbc.M111.319202; CuppVickery JR, 1997, STEROIDS, V62, P112, DOI 10.1016/S0039-128X(96)00168-7; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; DAWSON JH, 1982, J BIOL CHEM, V257, P3606; de Montellano P. R. O., 1995, CYTCOCHROME P450 STR, P245; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Driscoll MD, 2010, J BIOL CHEM, V285, P38270, DOI 10.1074/jbc.M110.164293; Dutton P L, 1978, Methods Enzymol, V54, P411; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fujishiro T, 2011, J BIOL CHEM, V286, P29941, DOI 10.1074/jbc.M111.245225; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; Girhard M, 2007, BIOCHEM BIOPH RES CO, V362, P114, DOI 10.1016/j.bbrc.2007.07.155; Girvan HM, 2004, J BIOL CHEM, V279, P23274, DOI 10.1074/jbc.M401716200; GROVES JT, 1976, J AM CHEM SOC, V98, P859, DOI 10.1021/ja00419a049; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich FP, 2013, J BIOL CHEM, V288, P17065, DOI 10.1074/jbc.R113.462275; Harford-Cross CF, 2000, PROTEIN ENG, V13, P121, DOI 10.1093/protein/13.2.121; HECKER M, 1989, J BIOL CHEM, V264, P141; HOLLENBERG PF, 1980, J BIOL CHEM, V255, P4801; Isin EM, 2007, BBA-GEN SUBJECTS, V1770, P314, DOI 10.1016/j.bbagen.2006.07.003; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krest CM, 2013, J BIOL CHEM, V288, P17074, DOI 10.1074/jbc.R113.473108; Lee DS, 2003, J BIOL CHEM, V278, P9761, DOI 10.1074/jbc.M211575200; LIPSCOMB JD, 1980, BIOCHEMISTRY-US, V19, P3590, DOI 10.1021/bi00556a027; Matsunaga I, 1999, LIPIDS, V34, P841, DOI 10.1007/s11745-999-0431-3; Matsunaga I, 1997, J BIOL CHEM, V272, P23592, DOI 10.1074/jbc.272.38.23592; Matsunaga I, 2002, BIOCHEMISTRY-US, V41, P1886, DOI 10.1021/bi011883p; Matsunaga I, 2001, ARCH BIOCHEM BIOPHYS, V394, P45, DOI 10.1006/abbi.2001.2512; McLean KJ, 2006, BIOCHEMISTRY-US, V45, P8427, DOI 10.1021/bi0601609; McLean KJ, 2008, J BIOL CHEM, V283, P33406, DOI 10.1074/jbc.M802115200; McLean KJ, 2002, J INORG BIOCHEM, V91, P527, DOI 10.1016/S0162-0134(02)00479-8; MILES JS, 1992, BIOCHEM J, V288, P503, DOI 10.1042/bj2880503; MORRISON JF, 1969, BIOCHIM BIOPHYS ACTA, V185, P269, DOI 10.1016/0005-2744(69)90420-3; Munro AW, 2007, NAT PROD REP, V24, P585, DOI 10.1039/b604190f; Munro AW, 2007, BBA-GEN SUBJECTS, V1770, P345, DOI 10.1016/j.bbagen.2006.08.018; Munro AW, 2013, TRENDS BIOCHEM SCI, V38, P140, DOI 10.1016/j.tibs.2012.11.006; Netto LES, 1996, ARCH BIOCHEM BIOPHYS, V333, P233, DOI 10.1006/abbi.1996.0386; OMURA T, 1964, J BIOL CHEM, V239, P2379; Ost TWB, 2003, J AM CHEM SOC, V125, P15010, DOI 10.1021/ja035731o; Ost TWB, 2001, BIOCHEMISTRY-US, V40, P13421, DOI 10.1021/bi010716m; PORTER TD, 1991, TRENDS BIOCHEM SCI, V16, P154, DOI 10.1016/0968-0004(91)90059-5; Pylypenko O, 2003, J BIOL CHEM, V278, P46727, DOI 10.1074/jbc.M306486200; Quaroni LG, 2004, BIOCHEMISTRY-US, V43, P16416, DOI 10.1021/bi049163g; RAAG R, 1991, BIOCHEMISTRY-US, V30, P11420, DOI 10.1021/bi00112a008; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Rude MA, 2011, APPL ENVIRON MICROB, V77, P1718, DOI 10.1128/AEM.02580-10; SLIGAR SG, 1976, P NATL ACAD SCI USA, V73, P1078, DOI 10.1073/pnas.73.4.1078; SONG WC, 1991, SCIENCE, V253, P781, DOI 10.1126/science.1876834; SONO M, 1982, J BIOL CHEM, V257, P8308; TYSON CA, 1972, J BIOL CHEM, V247, P5777; ULLRICH V, 1975, BIOCHEM SOC T, V3, P803, DOI 10.1042/bst0030803; Warman AJ, 2012, FEBS J, V279, P1675, DOI 10.1111/j.1742-4658.2012.08543.x; YEOM H, 1995, BIOCHEMISTRY-US, V34, P14733, DOI 10.1021/bi00045a014	55	112	124	2	90	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6535	6550		10.1074/jbc.M113.527325	http://dx.doi.org/10.1074/jbc.M113.527325			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24443585	Green Published, hybrid			2022-12-28	WOS:000332389400020
J	Jia, XY; Kwon, S; Wang, CIA; Huang, YH; Chan, LY; Tan, CC; Rosengren, KJ; Mulvenna, JP; Schroeder, CI; Craik, DJ				Jia, Xinying; Kwon, Soohyun; Wang, Ching-I Anderson; Huang, Yen-Hua; Chan, Lai Y.; Tan, Chia Chia; Rosengren, K. Johan; Mulvenna, Jason P.; Schroeder, Christina I.; Craik, David J.			Semienzymatic Cyclization of Disulfide-rich Peptides Using Sortase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Disulfide; NMR; Peptide Chemical Synthesis; Peptides; Toxins; Cyclic Peptides; Cyclotides; Enzymatic Cyclization; Kalata B1; Sortase A	CYCLOTIDE KALATA B1; BACKBONE-CYCLIZED PEPTIDES; PLANT CYCLOTIDES; CIRCULAR PROTEIN; STRUCTURAL-CHARACTERIZATION; ANTIMICROBIAL PEPTIDES; STAPHYLOCOCCUS-AUREUS; SCANNING MUTAGENESIS; MACROCYCLIC PEPTIDES; STRUCTURE VALIDATION	Background: Sortase A (SrtA) is a transpeptidase capable of catalyzing the formation of amide bonds. Results: SrtA was used to backbone-cyclize disulfide-rich peptides, including kalata B1, -conotoxin Vc1.1, and SFTI-1. Conclusion: SrtA-mediated cyclization is applicable to small disulfide-rich peptides. Significance: SrtA-mediated cyclization is an alternative to native chemical ligation for the cyclization of small peptides of therapeutic interest. Disulfide-rich cyclic peptides have generated great interest in the development of peptide-based therapeutics due to their exceptional stability toward chemical, enzymatic, or thermal attack. In particular, they have been used as scaffolds onto which bioactive epitopes can be grafted to take advantage of the favorable biophysical properties of disulfide-rich cyclic peptides. To date, the most commonly used method for the head-to-tail cyclization of peptides has been native chemical ligation. In recent years, however, enzyme-mediated cyclization has become a promising new technology due to its efficiency, safety, and cost-effectiveness. Sortase A (SrtA) is a bacterial enzyme with transpeptidase activity. It recognizes a C-terminal penta-amino acid motif, LPXTG, and cleaves the amide bond between Thr and Gly to form a thioacyl-linked intermediate. This intermediate undergoes nucleophilic attack by an N-terminal poly-Gly sequence to form an amide bond between the Thr and N-terminal Gly. Here, we demonstrate that sortase A can successfully be used to cyclize a variety of small disulfide-rich peptides, including the cyclotide kalata B1, -conotoxin Vc1.1, and sunflower trypsin inhibitor 1. These peptides range in size from 14 to 29 amino acids and contain three, two, or one disulfide bond, respectively, within their head-to-tail cyclic backbones. Our findings provide proof of concept for the potential broad applicability of enzymatic cyclization of disulfide-rich peptides with therapeutic potential.	[Jia, Xinying; Mulvenna, Jason P.] QIMR Berghofer Med Res, Brisbane, Qld 4000, Australia; [Jia, Xinying; Kwon, Soohyun; Wang, Ching-I Anderson; Huang, Yen-Hua; Chan, Lai Y.; Tan, Chia Chia; Schroeder, Christina I.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Rosengren, K. Johan] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland	Schroeder, CI (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	c.schroeder@imb.uq.edu.au; d.craik@imb.uq.edu.au	Schroeder, Cristina I./K-2042-2014; Rosengren, K. Johan/P-4450-2016; Huang, Yen-Hua/J-9056-2014; Jia, Xinying/B-8949-2016; Mulvenna, Jason/H-7110-2014; CHAN, LAI YUE/C-6489-2014; Craik, David/B-1695-2010	Schroeder, Cristina I./0000-0002-6737-6374; Rosengren, K. Johan/0000-0002-5007-8434; Huang, Yen-Hua/0000-0001-6937-2660; Jia, Xinying/0000-0003-0133-8321; Mulvenna, Jason/0000-0003-3521-8061; CHAN, LAI YUE/0000-0002-9346-2487; Craik, David/0000-0003-0007-6796	Australian National Health and Medical Research Council (NHMRC) [APP1047857]; Queensland State Government; Australian NHMRC	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Queensland State Government; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian National Health and Medical Research Council (NHMRC) Project Grant APP1047857. The Queensland NMR Network facilities at the University of Queensland were supported by the Queensland State Government.; Supported by Career Development Awards from the Australian NHMRC.	Aboye TL, 2012, J BIOL CHEM, V287, P27026, DOI 10.1074/jbc.R111.305508; Antos JM, 2009, J AM CHEM SOC, V131, P10800, DOI 10.1021/ja902681k; Antos JM, 2009, J BIOL CHEM, V284, P16028, DOI 10.1074/jbc.M901752200; Barry DG, 2003, BIOCHEMISTRY-US, V42, P6688, DOI 10.1021/bi027323n; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bolscher JGM, 2011, FASEB J, V25, P2650, DOI 10.1096/fj.11-182212; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cascales L, 2011, J BIOL CHEM, V286, P36932, DOI 10.1074/jbc.M111.264424; Cemazar M, 2012, CURR TOP MED CHEM, V12, P1534, DOI 10.2174/156802612802652484; Chan LY, 2011, BLOOD, V118, P6709, DOI 10.1182/blood-2011-06-359141; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clark RJ, 2010, ANGEW CHEM INT EDIT, V49, P6545, DOI 10.1002/anie.201000620; Clark RJ, 2010, BIOPOLYMERS, V94, P414, DOI 10.1002/bip.21372; Clark RJ, 2005, P NATL ACAD SCI USA, V102, P13767, DOI 10.1073/pnas.0504613102; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Conibear AC, 2012, BIOCHEMISTRY-US, V51, P9718, DOI 10.1021/bi301363a; Contreras J, 2011, J CONTROL RELEASE, V155, P134, DOI 10.1016/j.jconrel.2011.08.030; Craik DJ, 2012, EXPERT OPIN DRUG DIS, V7, P179, DOI 10.1517/17460441.2012.661554; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Daly NL, 1999, BIOCHEMISTRY-US, V38, P10606, DOI 10.1021/bi990605b; Daly NL, 2006, J BIOL CHEM, V281, P23668, DOI 10.1074/jbc.M601426200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gould A, 2011, CURR PHARM DESIGN, V17, P4294, DOI 10.2174/138161211798999438; Gran L., 1970, MEDD NOR FARM SELSK, V12, P173; Greenwood KP, 2007, INT J BIOCHEM CELL B, V39, P2252, DOI 10.1016/j.biocel.2007.06.016; GRIESINGER C, 1987, J MAGN RESON, V75, P474, DOI 10.1016/0022-2364(87)90102-8; Gruber CW, 2007, TOXICON, V49, P561, DOI 10.1016/j.toxicon.2006.11.018; Gunasekera S, 2008, J MED CHEM, V51, P7697, DOI 10.1021/jm800704e; Guntert Peter, 2004, Methods Mol Biol, V278, P353; GUSTAFSON KR, 1994, J AM CHEM SOC, V116, P9337, DOI 10.1021/ja00099a064; Henriques ST, 2011, J BIOL CHEM, V286, P24231, DOI 10.1074/jbc.M111.253393; Huang YH, 2010, J BIOL CHEM, V285, P10797, DOI 10.1074/jbc.M109.089854; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Jennings CV, 2005, BIOCHEMISTRY-US, V44, P851, DOI 10.1021/bi047837h; Ji YB, 2013, J AM CHEM SOC, V135, P11623, DOI 10.1021/ja405108p; Kaas Q, 2010, BIOPOLYMERS, V94, P584, DOI 10.1002/bip.21424; Kawakami T, 2009, NAT CHEM BIOL, V5, P888, DOI 10.1038/nchembio.259; Kimura R, 2005, PROTEIN PEPTIDE LETT, V12, P789, DOI 10.2174/0929866054864274; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Levary DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018342; Lindholm P, 2002, MOL CANCER THER, V1, P365; Ling JJJ, 2012, J AM CHEM SOC, V134, P10749, DOI 10.1021/ja302354v; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Long YQ, 2001, BIOORG MED CHEM LETT, V11, P2515, DOI 10.1016/S0960-894X(01)00493-0; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Moffatt F, 2000, J CHROMATOGR A, V891, P235, DOI 10.1016/S0021-9673(00)00620-8; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Mulvenna JR, 2005, STRUCTURE, V13, P691, DOI 10.1016/j.str.2005.02.013; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Parthasarathy R, 2007, BIOCONJUGATE CHEM, V18, P469, DOI 10.1021/bc060339w; Pattabiraman VR, 2011, NATURE, V480, P471, DOI 10.1038/nature10702; Plan MRR, 2008, J AGR FOOD CHEM, V56, P5237, DOI 10.1021/jf800302f; Popp MW, 2011, P NATL ACAD SCI USA, V108, P3169, DOI 10.1073/pnas.1016863108; Popp Maximilian Wei-Lin, 2009, Curr Protoc Protein Sci, VChapter 15, DOI 10.1002/0471140864.ps1503s56; Popp MWL, 2011, ANGEW CHEM INT EDIT, V50, P5024, DOI 10.1002/anie.201008267; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Simonsen SM, 2008, J BIOL CHEM, V283, P9805, DOI 10.1074/jbc.M709303200; Svangard E, 2004, J NAT PROD, V67, P144, DOI 10.1021/np030101l; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Tavassoli A, 2007, NAT PROTOC, V2, P1126, DOI 10.1038/nprot.2007.152; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Thongyoo P, 2008, ORG BIOMOL CHEM, V6, P1462, DOI 10.1039/b801667d; Thongyoo P, 2009, J MED CHEM, V52, P6197, DOI 10.1021/jm901233u; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Trabi M, 2002, TRENDS BIOCHEM SCI, V27, P132, DOI 10.1016/S0968-0004(02)02057-1; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang CK, 2009, BIOPHYS J, V97, P1471, DOI 10.1016/j.bpj.2009.06.032; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Witte MD, 2012, P NATL ACAD SCI USA, V109, P11993, DOI 10.1073/pnas.1205427109; Wong CTT, 2012, ANGEW CHEM INT EDIT, V51, P5620, DOI 10.1002/anie.201200984; Wong JH, 2007, CURR PROTEIN PEPT SC, V8, P446, DOI 10.2174/138920307782411446; Wu ZM, 2011, CHEM COMMUN, V47, P9218, DOI 10.1039/c1cc13322e; Wuthrich K., 1986, NMR PROTEINS NUCL AC, P16	82	59	64	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6627	6638		10.1074/jbc.M113.539262	http://dx.doi.org/10.1074/jbc.M113.539262			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24425873	hybrid, Green Published			2022-12-28	WOS:000332389400027
J	Schuld, NJ; Vervacke, JS; Lorimer, EL; Simon, NC; Hauser, AD; Barbieri, JT; Distefano, MD; Williams, CL				Schuld, Nathan J.; Vervacke, Jeffrey S.; Lorimer, Ellen L.; Simon, Nathan C.; Hauser, Andrew D.; Barbieri, Joseph T.; Distefano, Mark D.; Williams, Carol L.			The Chaperone Protein SmgGDS Interacts with Small GTPases Entering the Prenylation Pathway by Recognizing the Last Amino Acid in the CAAX Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Isoprenoid; Protein Complexes; Protein Farnesylation; Protein Isoprenylation; Small GTPases; FTI; GGTI; K-Ras; Rap1; SmgGDS	GTP EXCHANGE PROTEIN; TRANSFERASE INHIBITOR R115777; PROSTATE-CANCER; PLASMA-MEMBRANE; FARNESYL DIPHOSPHATE; PHOTOACTIVE ANALOGS; POLYBASIC DOMAIN; BINDING PROTEINS; ONCOGENIC RAS; I-TASSER	Background: SmgGDS-607 and SmgGDS-558 regulate GTPase movement through the prenylation pathway. Results: The specificity of SmgGDS for GTPases depends on the GTPase CAAX sequence and the cellular context. Conclusion: SmgGDS-607 binds to nonprenylated GTPases that end in a leucine and enter the geranylgeranylation pathway. Significance: The identification of SmgGDS-607 as a novel CAAX-binding protein will accelerate the development of more effective cancer therapeutics. Ras family small GTPases localize at the plasma membrane, where they can activate oncogenic signaling pathways. Understanding the mechanisms that promote membrane localization of GTPases will aid development of new therapies to inhibit oncogenic signaling. We previously reported that SmgGDS splice variants promote prenylation and trafficking of GTPases containing a C-terminal polybasic region and demonstrated that SmgGDS-607 interacts with nonprenylated GTPases, whereas SmgGDS-558 interacts with prenylated GTPases in cells. The mechanism that SmgGDS-607 and SmgGDS-558 use to differentiate between prenylated and nonprenylated GTPases has not been characterized. Here, we provide evidence that SmgGDS-607 associates with GTPases through recognition of the last amino acid in the CAAX motif. We show that SmgGDS-607 forms more stable complexes in cells with nonprenylated GTPases that will become geranylgeranylated than with nonprenylated GTPases that will become farnesylated. These binding relationships similarly occur with nonprenylated SAAX mutants. Intriguingly, farnesyltransferase inhibitors increase the binding of WT K-Ras to SmgGDS-607, indicating that the pharmacological shunting of K-Ras into the geranylgeranylation pathway promotes K-Ras association with SmgGDS-607. Using recombinant proteins and prenylated peptides corresponding to the C-terminal sequences of K-Ras and Rap1B, we found that both SmgGDS-607 and SmgGDS-558 directly bind the GTPase C-terminal region, but the specificity of the SmgGDS splice variants for prenylated versus nonprenylated GTPases is diminished in vitro. Finally, we present structural homology models and data from functional prediction software to define both similar and unique features of SmgGDS-607 when compared with SmgGDS-558.	[Schuld, Nathan J.; Lorimer, Ellen L.; Williams, Carol L.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Simon, Nathan C.; Barbieri, Joseph T.] Med Coll Wisconsin, Dept Microbiol Immunol & Mol Genet, Milwaukee, WI 53226 USA; [Hauser, Andrew D.] Med Coll Wisconsin, Dept Radiat Oncol, Milwaukee, WI 53226 USA; [Vervacke, Jeffrey S.; Distefano, Mark D.] Univ Minnesota, Dept Chem, Minneapolis, MN 55414 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; University of Minnesota System; University of Minnesota Twin Cities	Williams, CL (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	williams@mcw.edu		Vervacke, Jeffrey/0000-0002-9903-6219	National Institutes of Health [R01 CA136799, R01 GM084152, GM106082, R01 AI30162, U54 AI057153]; Medical College of Wisconsin Cancer Center; Wisconsin Breast Cancer Showhouse; Rock River Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA136799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, R01AI030162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084152, R01GM106082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical College of Wisconsin Cancer Center; Wisconsin Breast Cancer Showhouse; Rock River Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA136799 (to C.L.W.), R01 GM084152 and GM106082 (to M.D.D.), and R01 AI30162 and U54 AI057153 (to J.T.B.). This work was also supported by funds from the Medical College of Wisconsin Cancer Center (to C.L.W.), the Wisconsin Breast Cancer Showhouse (to C.L.W.), and the Rock River Cancer Research Foundation (to C.L.W.).	ALEXANDROV K, 1994, EMBO J, V13, P5262, DOI 10.1002/j.1460-2075.1994.tb06860.x; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Bailey CL, 2009, CANCER RES, V69, P4962, DOI 10.1158/0008-5472.CAN-08-4269; Basso AD, 2006, J LIPID RES, V47, P15, DOI 10.1194/jlr.R500012-JLR200; Berg TJ, 2010, J BIOL CHEM, V285, P35255, DOI 10.1074/jbc.M110.129916; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; CADWALLADER KA, 1994, MOL CELL BIOL, V14, P4722, DOI 10.1128/MCB.14.7.4722; CHOWDHRY V, 1979, ANNU REV BIOCHEM, V48, P293, DOI 10.1146/annurev.bi.48.070179.001453; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; Hamel B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191122; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1995, METHOD ENZYMOL, V255, P237; Hauser AD, 2014, MOL CANCER RES, V12, P130, DOI 10.1158/1541-7786.MCR-13-0362; HIRAOKA K, 1992, BIOCHEM BIOPH RES CO, V182, P921, DOI 10.1016/0006-291X(92)91820-G; ISOMURA M, 1991, ONCOGENE, V6, P119; Janda E, 2002, J CELL BIOL, V156, P299, DOI 10.1083/jcb.200109037; Kale TA, 2001, J AM CHEM SOC, V123, P4373, DOI 10.1021/ja0012016; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; KOTANI K, 1992, ONCOGENE, V7, P1699; Kyro K, 2011, BIOORGAN MED CHEM, V19, P7559, DOI 10.1016/j.bmc.2011.10.027; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; Law BK, 2000, J BIOL CHEM, V275, P10796, DOI 10.1074/jbc.275.15.10796; LERNER EC, 1995, J BIOL CHEM, V270, P26802, DOI 10.1074/jbc.270.45.26802; Lloyd AC, 1998, CURR OPIN GENET DEV, V8, P43, DOI 10.1016/S0959-437X(98)80060-9; Lobell RB, 2001, CANCER RES, V61, P8758; Macdonald JS, 2005, INVEST NEW DRUG, V23, P485, DOI 10.1007/s10637-005-2908-y; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Maresso AW, 2002, PROTEIN EXPRES PURIF, V26, P432, DOI 10.1016/S1046-5928(02)00544-2; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; MIZUNO T, 1991, P NATL ACAD SCI USA, V88, P6442, DOI 10.1073/pnas.88.15.6442; MOORES SL, 1991, J BIOL CHEM, V266, P14603; Ntantie E, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003374; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Rao S, 2004, J CLIN ONCOL, V22, P3950, DOI 10.1200/JCO.2004.10.037; Roy A, 2012, NUCLEIC ACIDS RES, V40, pW471, DOI 10.1093/nar/gks372; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Shin HJ, 2006, J BIOMAT SCI-POLYM E, V17, P103, DOI 10.1163/156856206774879126; SHIRATAKI H, 1991, J BIOL CHEM, V266, P20672; Stenmark H, 2001, GENOME BIOL, V2; Sun JZ, 1998, ONCOGENE, V16, P1467, DOI 10.1038/sj.onc.1201656; Tew GW, 2008, J BIOL CHEM, V283, P963, DOI 10.1074/jbc.M707526200; Thissen JA, 1997, J BIOL CHEM, V272, P30362, DOI 10.1074/jbc.272.48.30362; Turek TC, 1997, BIOORG MED CHEM LETT, V7, P2125, DOI 10.1016/S0960-894X(97)00373-9; Turek TC, 1997, J LABELLED COMPD RAD, V39, P139, DOI 10.1002/(SICI)1099-1344(199702)39:2<139::AID-JLCR951>3.0.CO;2-A; Turek TC, 2001, J ORG CHEM, V66, P3253, DOI 10.1021/jo991130x; Vervacke JS, 2013, CURR MED CHEM, V20, P1585; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; VIOLA MV, 1986, NEW ENGL J MED, V314, P133, DOI 10.1056/NEJM198601163140301; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; YAMAMOTO T, 1990, J BIOL CHEM, V265, P16626; YOSHIDA Y, 1992, MOL CELL BIOL, V12, P3407, DOI 10.1128/MCB.12.8.3407; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhi H, 2009, J PATHOL, V217, P389, DOI 10.1002/path.2456	57	30	30	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2014	289	10					6862	6876		10.1074/jbc.M113.527192	http://dx.doi.org/10.1074/jbc.M113.527192			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3BG	24415755	Green Published, hybrid			2022-12-28	WOS:000332389400047
J	Abdul-Ridha, A; Lopez, L; Keov, P; Thal, DM; Mistry, SN; Sexton, PM; Lane, JR; Canals, M; Christopoulos, A				Abdul-Ridha, Alaa; Lopez, Laura; Keov, Peter; Thal, David M.; Mistry, Shailesh N.; Sexton, Patrick M.; Lane, J. Robert; Canals, Meritxell; Christopoulos, Arthur			Molecular Determinants of Allosteric Modulation at the M-1 Muscarinic Acetylcholine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Drug Discovery; G Protein-coupled Receptors (GPCR); Molecular Dynamics; Site-directed Mutagenesis; Muscarinic Acetylcholine Receptor	PROTEIN-COUPLED RECEPTOR; FUNCTIONAL SELECTIVITY; CRYSTAL-STRUCTURE; GPCR ACTIVATION; CNS DISORDERS; FORCE-FIELD; AMINO-ACIDS; LIGAND; AGONISM; COMPLEX	Background: BQCA is a selective allosteric modulator of the M-1 mAChR. Results: Residues that govern BQCA activity were identified using mutagenesis and molecular modeling. Conclusion: BQCA likely occupies a pocket overlapping prototypical mAChR modulators and gains selectivity through cooperativity with orthosteric ligands. Significance: Understanding the structural basis of BQCA function can provide insight into the design of more tailored allosteric ligands. Benzylquinolone carboxylic acid (BQCA) is an unprecedented example of a selective positive allosteric modulator of acetylcholine at the M-1 muscarinic acetylcholine receptor (mAChR). To probe the structural basis underlying its selectivity, we utilized site-directed mutagenesis, analytical modeling, and molecular dynamics to delineate regions of the M-1 mAChR that govern modulator binding and transmission of cooperativity. We identified Tyr-85(2.64) in transmembrane domain 2 (TMII), Tyr-179 and Phe-182 in the second extracellular loop (ECL2), and Glu-397(7.32) and Trp-400(7.35) in TMVII as residues that contribute to the BQCA binding pocket at the M-1 mAChR, as well as to the transmission of cooperativity with the orthosteric agonist carbachol. As such, the BQCA binding pocket partially overlaps with the previously described common allosteric site in the extracellular vestibule of the M-1 mAChR, suggesting that its high subtype selectivity derives from either additional contacts outside this region or through a subtype-specific cooperativity mechanism. Mutation of amino acid residues that form the orthosteric binding pocket caused a loss of carbachol response that could be rescued by BQCA. Two of these residues (Leu-102(3.29) and Asp-105(3.32)) were also identified as indirect contributors to the binding affinity of the modulator. This new insight into the structural basis of binding and function of BQCA can guide the design of new allosteric ligands with tailored pharmacological properties.	[Abdul-Ridha, Alaa; Lopez, Laura; Keov, Peter; Thal, David M.; Mistry, Shailesh N.; Sexton, Patrick M.; Lane, J. Robert; Canals, Meritxell; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Mistry, Shailesh N.] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia	Monash University; Monash University	Canals, M (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, 399 Royal Parade, Parkville, Vic 3052, Australia.	meri.canals@monash.edu; arthur.christopoulos@monash.edu	Keov, Peter/AGE-7936-2022; Mistry, Shailesh/O-2697-2014; Christopoulos, Arthur/B-6207-2013; Sexton, Patrick M/B-1319-2008; Thal, David/GXH-4911-2022	Mistry, Shailesh/0000-0002-2252-1689; Christopoulos, Arthur/0000-0003-4442-3294; Sexton, Patrick M/0000-0001-8902-2473; Abdul-Ridha, Alaa/0000-0002-1491-3818; Canals, Meritxell/0000-0002-7942-5006; Keov, Peter/0000-0002-3829-6455; Thal, David/0000-0002-0325-2524; Lane, J. Robert/0000-0002-7361-7875	National Health and Medical Research Council of Australia [519461, APP1011796, APP1011920]; Victorian Life Sciences Computation Initiative, Peak Computing Facility, University of Melbourne [VR0024]; Australian Postgraduate Award scholarship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Life Sciences Computation Initiative, Peak Computing Facility, University of Melbourne; Australian Postgraduate Award scholarship	This work was supported in part by National Health and Medical Research Council of Australia Program Grant 519461 (to A. C. and P. M. S.), Project Grant APP1011796 (to M. C.), and Grant APP1011920 (to J. R. L.) and computational studies were supported by Resource Allocation Scheme Grant VR0024 from the Victorian Life Sciences Computation Initiative, Peak Computing Facility, University of Melbourne.; Recipient of an Australian Postgraduate Award scholarship.	Abdul-Ridha A, 2013, MOL PHARMACOL, V83, P521, DOI 10.1124/mol.112.083006; Avlani VA, 2010, MOL PHARMACOL, V78, P94, DOI 10.1124/mol.110.064345; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; Canals M, 2012, J BIOL CHEM, V287, P650, DOI 10.1074/jbc.M111.314278; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Christopoulos A, 1998, TRENDS PHARMACOL SCI, V19, P351, DOI 10.1016/S0165-6147(98)01240-1; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P148, DOI 10.1016/j.tips.2008.12.002; Daval SB, 2013, MOL PHARMACOL, V84, P71, DOI 10.1124/mol.113.085670; Davie BJ, 2013, ACS CHEM NEUROSCI, V4, P1026, DOI 10.1021/cn400086m; De Amici M, 2010, MED RES REV, V30, P463, DOI 10.1002/med.20166; Dror RO, 2013, NATURE, V503, P295, DOI 10.1038/nature12595; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Goodwin JA, 2007, MOL PHARMACOL, V72, P1484, DOI 10.1124/mol.107.038265; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Huang XP, 2005, MOL PHARMACOL, V68, P769, DOI 10.1124/mol.105.014043; Hulme EC, 2003, BIOCHEM SOC T, V31, P29, DOI 10.1042/bst0310029; Hulme EC, 2013, TRENDS PHARMACOL SCI, V34, P67, DOI 10.1016/j.tips.2012.11.002; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Leach K, 2007, TRENDS PHARMACOL SCI, V28, P382, DOI 10.1016/j.tips.2007.06.004; Leach K, 2011, MOL PHARMACOL, V79, P855, DOI 10.1124/mol.111.070938; Leach K, 2010, NEUROPSYCHOPHARMACOL, V35, P855, DOI 10.1038/npp.2009.194; Lebois EP, 2010, ACS CHEM NEUROSCI, V1, P104, DOI 10.1021/cn900003h; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lu ZL, 2001, J BIOL CHEM, V276, P34098, DOI 10.1074/jbc.M104217200; Lu ZL, 1999, J BIOL CHEM, V274, P7309, DOI 10.1074/jbc.274.11.7309; Ma L, 2009, P NATL ACAD SCI USA, V106, P15950, DOI 10.1073/pnas.0900903106; Marquer C, 2011, J BIOL CHEM, V286, P31661, DOI 10.1074/jbc.M111.261404; MATSUI H, 1995, MOL PHARMACOL, V47, P88; May LT, 2007, MOL PHARMACOL, V72, P463, DOI 10.1124/mol.107.037630; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; Miao YL, 2013, P NATL ACAD SCI USA, V110, P10982, DOI 10.1073/pnas.1309755110; Mistry SN, 2013, J MED CHEM, V56, P5151, DOI 10.1021/jm400540b; Motulsky H, 2003, PRACTICAL GUIDE CURV; Nawaratne V, 2008, MOL PHARMACOL, V74, P1119, DOI 10.1124/mol.108.049353; Nawaratne V, 2010, J BIOL CHEM, V285, P19012, DOI 10.1074/jbc.M110.125096; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Prilla S, 2006, MOL PHARMACOL, V70, P181, DOI 10.1124/mol.106.023481; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shirey JK, 2009, J NEUROSCI, V29, P14271, DOI 10.1523/JNEUROSCI.3930-09.2009; Shonberg J, 2013, J MED CHEM, V56, P9199, DOI 10.1021/jm401318w; Spalding TA, 1998, J BIOL CHEM, V273, P21563, DOI 10.1074/jbc.273.34.21563; Stevens RC, 2013, NAT REV DRUG DISCOV, V12, P25, DOI 10.1038/nrd3859; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Valant C, 2008, J BIOL CHEM, V283, P29312, DOI 10.1074/jbc.M803801200; Valant C, 2012, MOL PHARMACOL, V81, P41, DOI 10.1124/mol.111.074872; Valentin-Hansen L, 2012, J BIOL CHEM, V287, P43516, DOI 10.1074/jbc.M112.395137; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Voigtlander U, 2003, MOL PHARMACOL, V64, P21, DOI 10.1124/mol.64.1.21; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035	58	47	47	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					6067	6079		10.1074/jbc.M113.539080	http://dx.doi.org/10.1074/jbc.M113.539080			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24443568	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000332015500061
J	Tsuneki, M; Madri, JA				Tsuneki, Masayuki; Madri, Joseph A.			CD44 Regulation of Endothelial Cell Proliferation and Apoptosis via Modulation of CD31 and VE-cadherin Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Caspase; Cd44; Cell Proliferation; Endothelial Cell; Survivin; Vascular Biology; Western Blotting; Cd31	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HIPPO SIGNALING PATHWAY; BETA-CATENIN; CONTACT INHIBITION; GENE-EXPRESSION; CARCINOMA-CELLS; GROWTH-CONTROL; TUMOR-CELLS; T-CELLS; PECAM-1	Background: CD44 mediates vascular barrier integrity via regulation of VE-cadherin and CD31 expression. Results: CD44 regulates cell proliferation and specific caspase-mediated apoptosis via modulation of CD31 and VE-cadherin expression through the Hippo pathway. Conclusion: CD44 modulates proliferation and apoptosis of microvascular endothelial cells. Significance: CD44 regulates endothelial cell survival by modulating specific cell adhesion molecules via the Hippo pathway. CD44 has been implicated in a diverse array of cell behaviors and in a diverse range of signaling pathway activations under physiological and pathophysiological conditions. We have documented a role for CD44 in mediating vascular barrier integrity via regulation of PECAM-1 (CD31) expression. We now report our findings on the roles of CD44 in modulating proliferation and apoptosis of microvascular endothelial cells via its modulation of CD31 and VE-cadherin expression and the Hippo pathway. In this report, we demonstrate persistent increased proliferation and reduced activations of both effector and initiator caspases in high cell density, postconfluent CD44 knock-out (CD44KO), and CD31KO cultures. We found that reconstitution with murine CD44 or CD31 restored the proliferative and caspase activation rates to WT levels. Moreover, we have confirmed that the CD31 ecto-domain plays a key role in specific caspase cascades as well as cell adhesion-mediated cell growth and found that CD31 deficiency results in a reduction in VE-cadherin expression. Last, we have shown that both CD44KO and CD31KO endothelial cells exhibit a reduced VE-cadherin expression correlating with increased survivin expression and YAP nuclear localization, consistent with inactivation of the Hippo pathway, resulting in increased proliferation and decreased apoptosis. These findings support the concept that CD44 mediates several of its effects on endothelia through modulation of adhesion protein expression, which, in addition to its known modulation of junctional integrity, matrix metalloproteinase levels and activation, interactions with cortical membrane proteins, and selected signaling pathways, plays a key role as a critical regulator of vascular function.	[Tsuneki, Masayuki; Madri, Joseph A.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA	Yale University	Madri, JA (corresponding author), Yale Univ, Sch Med, Dept Pathol, 310 Cedar St, New Haven, CT 06520 USA.	joseph.madri@yale.edu	Tsuneki, Masayuki/AAB-6115-2021	Tsuneki, Masayuki/0000-0003-3409-5485	National Institutes of Health [PO1-NS00344738]; Japan Society for the Promotion of Science; Uehara Memorial Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported, in whole or in part, by National Institutes of Health Grant PO1-NS00344738 (to J. A. M.). This work was also supported by a grant-in-aid from the Japan Society for the Promotion of Science for Fellows and by the Uehara Memorial Foundation (to M. T.).	Allan LA, 2009, FEBS J, V276, P6063, DOI 10.1111/j.1742-4658.2009.07330.x; Badouel C, 2011, CELL, V145, P484, DOI 10.1016/j.cell.2011.04.009; Bai HB, 2012, HEPATOLOGY, V56, P1097, DOI 10.1002/hep.25769; Bao YJ, 2011, J BIOCHEM, V149, P361, DOI 10.1093/jb/mvr021; Biswas P, 2005, BIOCHEM BIOPH RES CO, V329, P1225, DOI 10.1016/j.bbrc.2005.02.095; Biswas P, 2003, BIOCHEM BIOPH RES CO, V303, P212, DOI 10.1016/S0006-291X(03)00313-9; Biswas P, 2006, AM J PATHOL, V169, P314, DOI 10.2353/ajpath.2006.051112; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Bourguignon LYW, 2009, J BIOL CHEM, V284, P2657, DOI 10.1074/jbc.M806708200; Campbell KN, 2013, J BIOL CHEM, V288, P17057, DOI 10.1074/jbc.C113.457390; Cao GY, 2006, AM J PATHOL, V169, P325, DOI 10.2353/ajpath.2006.060206; Cao GY, 2009, AM J PATHOL, V175, P903, DOI 10.2353/ajpath.2009.090206; Carrithers M, 2005, AM J PATHOL, V166, P185, DOI 10.1016/S0002-9440(10)62243-2; Chan SW, 2011, J CELL PHYSIOL, V226, P928, DOI 10.1002/jcp.22435; Chetty C, 2012, CELL SIGNAL, V24, P549, DOI 10.1016/j.cellsig.2011.10.008; Cichy J, 2003, J CELL BIOL, V161, P839, DOI 10.1083/jcb.200302098; Das Thakur M, 2010, CURR BIOL, V20, P657, DOI 10.1016/j.cub.2010.02.035; Enciso JM, 2003, J CELL BIOL, V160, P605, DOI 10.1083/jcb.200209014; Fan R, 2013, P NATL ACAD SCI USA, V110, P2569, DOI 10.1073/pnas.1216462110; Fedorchenko O, 2013, BLOOD, V121, P4126, DOI 10.1182/blood-2012-11-466250; Feng YM, 2012, CELL BIOCHEM BIOPHYS, V64, P5, DOI 10.1007/s12013-012-9362-1; Flynn KM, 2013, ANGIOGENESIS, V16, P689, DOI 10.1007/s10456-013-9346-9; Flynn KM, 2013, AM J PATHOL, V182, P1322, DOI 10.1016/j.ajpath.2013.01.003; Ghazi-Visser L, 2013, FASEB J, V27, P3683, DOI 10.1096/fj.13-228809; Graesser D, 2002, J CLIN INVEST, V109, P383, DOI 10.1172/JCI13595; Gratzinger D, 2003, FASEB J, V17, P1458, DOI 10.1096/fj.02-1040com; Guan HB, 2011, J IMMUNOL, V186, P6955, DOI 10.4049/jimmunol.1004043; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hauptschein RS, 2005, CANCER RES, V65, P1887, DOI 10.1158/0008-5472.CAN-04-3571; Hertweck MK, 2011, ANN HEMATOL, V90, P493, DOI 10.1007/s00277-011-1161-z; Hiraga T, 2013, CANCER RES, V73, P4112, DOI 10.1158/0008-5472.CAN-12-3801; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Huang JM, 2013, ONCOGENE, V32, P2220, DOI 10.1038/onc.2012.231; Ilan N, 2000, J BIOL CHEM, V275, P21435, DOI 10.1074/jbc.M001857200; Ilan N, 2001, FASEB J, V15, P362, DOI 10.1096/fj.00-0372com; Ilan N, 2001, DEV BIOL, V232, P219, DOI 10.1006/dbio.2001.0186; Ilan N, 2003, CURR OPIN CELL BIOL, V15, P515, DOI 10.1016/S0955-0674(03)00100-5; Ilan N, 1999, J CELL SCI, V112, P3005; Iurlaro M, 2004, AM J PATHOL, V165, P181, DOI 10.1016/S0002-9440(10)63287-7; Jijiwa M, 2011, PLOS ONE, V6; Kirschner N, 2011, J INVEST DERMATOL, V131, P932, DOI 10.1038/jid.2010.390; Ladeda V, 1998, EXP CELL RES, V242, P515, DOI 10.1006/excr.1998.4094; Li W, 2012, EMBO REP, V13, P204, DOI 10.1038/embor.2012.11; Marhaba R, 2004, J MOL HISTOL, V35, P211; McClatchey AI, 2012, CURR OPIN CELL BIOL, V24, P685, DOI 10.1016/j.ceb.2012.06.009; McKallip RJ, 2005, INFECT IMMUN, V73, P50, DOI 10.1128/IAI.73.1.50-61.2005; McKallip RJ, 2002, INT IMMUNOL, V14, P1015, DOI 10.1093/intimm/dxf068; Mellor L, 2013, J BIOL CHEM, V288, P25838, DOI 10.1074/jbc.M113.494872; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Nagano O, 2004, CANCER SCI, V95, P930, DOI 10.1111/j.1349-7006.2004.tb03179.x; Perez A, 2013, ORAL ONCOL, V49, P306, DOI 10.1016/j.oraloncology.2012.11.009; Pinter E, 1997, AM J PATHOL, V150, P1523; Qian H, 2012, CANCER BIOL THER, V13, P1276, DOI 10.4161/cbt.21784; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rouschop KMA, 2006, J AM SOC NEPHROL, V17, P746, DOI 10.1681/ASN.2005080808; Sah NK, 2006, CANCER LETT, V244, P164, DOI 10.1016/j.canlet.2006.03.007; Savani RC, 2001, J BIOL CHEM, V276, P36770, DOI 10.1074/jbc.M102273200; Seiki M, 2002, CURR OPIN CELL BIOL, V14, P624, DOI 10.1016/S0955-0674(02)00363-0; Shin S, 2001, BIOCHEMISTRY-US, V40, P1117, DOI 10.1021/bi001603q; Singleton PA, 2007, J BIOL CHEM, V282, P30643, DOI 10.1074/jbc.M702573200; Singleton PA, 2006, J BIOL CHEM, V281, P34381, DOI 10.1074/jbc.M603680200; Stamenkovic I, 2010, CURR PROTEIN PEPT SC, V11, P471, DOI 10.2174/138920310791824011; Sun GP, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004324; Suwan K, 2009, J BIOL CHEM, V284, P8596, DOI 10.1074/jbc.M806927200; Tamm I, 1998, CANCER RES, V58, P5315; Trochon V, 1996, INT J CANCER, V66, P664, DOI 10.1002/(SICI)1097-0215(19960529)66:5<664::AID-IJC14>3.0.CO;2-4; Tsuneki M, 2013, LAB INVEST, V93, P921, DOI 10.1038/labinvest.2013.86; Twarock S, 2010, J BIOL CHEM, V285, P23274, DOI 10.1074/jbc.M109.093146; Winkler CW, 2012, J BIOL CHEM, V287, P33237, DOI 10.1074/jbc.M112.356287; Wu JQ, 2003, J CELL BIOCHEM, V90, P121, DOI 10.1002/jcb.10600; Xu Y, 2010, CANCER RES, V70, P2455, DOI 10.1158/0008-5472.CAN-09-2505; Zhang JJ, 2007, J CELL PHYSIOL, V210, P527, DOI 10.1002/jcp.20908; Zhang LS, 2010, CELL PROLIFERAT, V43, P385, DOI 10.1111/j.1365-2184.2010.00689.x; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	76	50	50	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 28	2014	289	9					5357	5370		10.1074/jbc.M113.529313	http://dx.doi.org/10.1074/jbc.M113.529313			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AB8BQ	24425872	Green Published, hybrid			2022-12-28	WOS:000332015500002
